Citrus Sinensis ID: 045315
Local Sequence Feature Prediction
| Prediction and (Method) | Result |
|---|
|
|
Close Homologs for Annotation Transfer
Close Homologs in SWISS-PROT Database Detected by BLAST 
Original result of BLAST against SWISS-PROT Database
| ID | Alignment graph | Length |
Definition |
RBH(Q2H) |
RBH(H2Q) |
Q cover |
H cover |
Identity |
E-value |
| Query | 476 | 2.2.26 [Sep-21-2011] | |||||||
| Q39086 | 843 | Receptor-like serine/thre | yes | no | 0.470 | 0.265 | 0.543 | 8e-67 | |
| Q9S972 | 847 | Receptor-like serine/thre | no | no | 0.470 | 0.264 | 0.552 | 8e-67 | |
| Q8L7G3 | 659 | Cysteine-rich receptor-li | no | no | 0.451 | 0.326 | 0.563 | 5e-66 | |
| Q8GYA4 | 669 | Cysteine-rich receptor-li | no | no | 0.451 | 0.321 | 0.549 | 4e-65 | |
| O81905 | 850 | Receptor-like serine/thre | no | no | 0.468 | 0.262 | 0.541 | 4e-65 | |
| Q9ZR08 | 852 | G-type lectin S-receptor- | no | no | 0.403 | 0.225 | 0.634 | 2e-64 | |
| Q9LDQ3 | 669 | Putative cysteine-rich re | no | no | 0.474 | 0.337 | 0.527 | 4e-64 | |
| O81906 | 849 | G-type lectin S-receptor- | no | no | 0.388 | 0.217 | 0.58 | 7e-64 | |
| Q8W4G6 | 627 | Cysteine-rich receptor-li | no | no | 0.418 | 0.317 | 0.565 | 3e-63 | |
| Q9C5S9 | 674 | Cysteine-rich receptor-li | no | no | 0.418 | 0.295 | 0.575 | 2e-62 |
| >sp|Q39086|SD17_ARATH Receptor-like serine/threonine-protein kinase SD1-7 OS=Arabidopsis thaliana GN=SD17 PE=1 SV=1 | Back alignment and function desciption |
|---|
Score = 254 bits (650), Expect = 8e-67, Method: Compositional matrix adjust.
Identities = 130/239 (54%), Positives = 170/239 (71%), Gaps = 15/239 (6%)
Query: 252 NPTKKGLLCWGTRVRIIEGIAQGLLYLHQYSRLRVIHRDLKASNILLDKDMNPKISDFGM 311
+ T+ L W R II GIA+GLLYLHQ SR R+IHRDLKASN+LLDK+M PKISDFGM
Sbjct: 606 DQTRSSNLNWQKRFDIINGIARGLLYLHQDSRCRIIHRDLKASNVLLDKNMTPKISDFGM 665
Query: 312 ARMFGGDELQSNTKRIVGTYGYMSPEYALRGLFSIKSDVFSFGVLLLETLSSKKNTHFYN 371
AR+FG +E ++NT+R+VGTYGYMSPEYA+ G+FS+KSDVFSFGVLLLE +S K+N FYN
Sbjct: 666 ARIFGREETEANTRRVVGTYGYMSPEYAMDGIFSMKSDVFSFGVLLLEIISGKRNKGFYN 725
Query: 372 TD-SLTLLGHAWNLWNDGRTWELMDPISQNGAS--YPI--LKRYINVALLCVQEKAADRP 426
++ L LLG W W +G E++DPI+ + S +P + R I + LLCVQE+A DRP
Sbjct: 726 SNRDLNLLGFVWRHWKEGNELEIVDPINIDSLSSKFPTHEILRCIQIGLLCVQERAEDRP 785
Query: 427 AMSEVVSMLSNEFVNLPAPQQPAFSCVNSTNMQSDAFS---------VNCVTHSVIDAR 476
MS V+ ML +E +P P++P F C+ + +++D+ S VN +T SVIDAR
Sbjct: 786 VMSSVMVMLGSETTAIPQPKRPGF-CIGRSPLEADSSSSTQRDDECTVNQITLSVIDAR 843
|
Involved in the regulation of cellular expansion and differentiation. Mediates subcellular relocalization of PUB9 from nucleus to plasma membrane in a protein-phosphorylation-dependent manner. May be involved in the abscisic acid-mediated signaling pathway, at least during germination. Arabidopsis thaliana (taxid: 3702) EC: 2EC: .EC: 7EC: .EC: 1EC: 1EC: .EC: 1 |
| >sp|Q9S972|SD16_ARATH Receptor-like serine/threonine-protein kinase SD1-6 OS=Arabidopsis thaliana GN=SD16 PE=1 SV=2 | Back alignment and function description |
|---|
Score = 254 bits (650), Expect = 8e-67, Method: Compositional matrix adjust.
Identities = 132/239 (55%), Positives = 169/239 (70%), Gaps = 15/239 (6%)
Query: 252 NPTKKGLLCWGTRVRIIEGIAQGLLYLHQYSRLRVIHRDLKASNILLDKDMNPKISDFGM 311
+ T+ L W R II GIA+GLLYLHQ SR R+IHRDLKASN+LLDK+M PKISDFGM
Sbjct: 610 DQTRSSNLNWQKRFDIINGIARGLLYLHQDSRCRIIHRDLKASNVLLDKNMTPKISDFGM 669
Query: 312 ARMFGGDELQSNTKRIVGTYGYMSPEYALRGLFSIKSDVFSFGVLLLETLSSKKNTHFYN 371
AR+FG +E ++NT+R+VGTYGYMSPEYA+ G+FS+KSDVFSFGVLLLE +S K+N FYN
Sbjct: 670 ARIFGREETEANTRRVVGTYGYMSPEYAMDGIFSMKSDVFSFGVLLLEIISGKRNKGFYN 729
Query: 372 TD-SLTLLGHAWNLWNDGRTWELMDPISQNGAS--YPI--LKRYINVALLCVQEKAADRP 426
++ L LLG W W +G+ E++DPI+ + S +P + R I + LLCVQE+A DRP
Sbjct: 730 SNRDLNLLGFVWRHWKEGKELEIVDPINIDALSSEFPTHEILRCIQIGLLCVQERAEDRP 789
Query: 427 AMSEVVSMLSNEFVNLPAPQQPAFSCVN---------STNMQSDAFSVNCVTHSVIDAR 476
MS V+ ML +E +P P++P F CV S+ + D +VN VT SVIDAR
Sbjct: 790 VMSSVMVMLGSETTAIPQPKRPGF-CVGRSSLEVDSSSSTQRDDECTVNQVTLSVIDAR 847
|
Involved in the regulation of cellular expansion and differentiation. Arabidopsis thaliana (taxid: 3702) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
| >sp|Q8L7G3|CRK7_ARATH Cysteine-rich receptor-like protein kinase 7 OS=Arabidopsis thaliana GN=CRK7 PE=2 SV=1 | Back alignment and function description |
|---|
Score = 252 bits (643), Expect = 5e-66, Method: Compositional matrix adjust.
Identities = 125/222 (56%), Positives = 153/222 (68%), Gaps = 7/222 (3%)
Query: 230 FLYEQVLVQSKDEISFWYESYNNPTKKGLLCWGTRVRIIEGIAQGLLYLHQYSRLRVIHR 289
+YE V +S D F +P KKG L W R II GIA+G+LYLHQ SRL +IHR
Sbjct: 407 LVYEYVENKSLDNFLF------DPAKKGQLYWTQRYHIIGGIARGILYLHQDSRLTIIHR 460
Query: 290 DLKASNILLDKDMNPKISDFGMARMFGGDELQSNTKRIVGTYGYMSPEYALRGLFSIKSD 349
DLKASNILLD DMNPKI+DFGMAR+FG D+ Q NT RIVGTYGYMSPEYA+RG FS+KSD
Sbjct: 461 DLKASNILLDADMNPKIADFGMARIFGMDQTQQNTSRIVGTYGYMSPEYAMRGQFSMKSD 520
Query: 350 VFSFGVLLLETLSSKKNTHFYNT-DSLTLLGHAWNLWNDGRTWELMDPISQNGASYPILK 408
V+SFGVL+LE +S +KN F T D+ L+ HAW LW +G +L+DP + +
Sbjct: 521 VYSFGVLVLEIISGRKNNSFIETDDAQDLVTHAWRLWRNGTALDLVDPFIADSCRKSEVV 580
Query: 409 RYINVALLCVQEKAADRPAMSEVVSMLSNEFVNLPAPQQPAF 450
R ++ LLCVQE RPAMS + ML++ + LPAPQQP F
Sbjct: 581 RCTHIGLLCVQEDPVKRPAMSTISVMLTSNTMALPAPQQPGF 622
|
Arabidopsis thaliana (taxid: 3702) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: - |
| >sp|Q8GYA4|CRK10_ARATH Cysteine-rich receptor-like protein kinase 10 OS=Arabidopsis thaliana GN=CRK10 PE=1 SV=3 | Back alignment and function description |
|---|
Score = 249 bits (636), Expect = 4e-65, Method: Compositional matrix adjust.
Identities = 122/222 (54%), Positives = 157/222 (70%), Gaps = 7/222 (3%)
Query: 230 FLYEQVLVQSKDEISFWYESYNNPTKKGLLCWGTRVRIIEGIAQGLLYLHQYSRLRVIHR 289
+YE V +S D F +P KKG L W R +II G+A+G+LYLHQ SRL +IHR
Sbjct: 419 LVYEYVPNKSLDYFLF------DPAKKGQLDWTRRYKIIGGVARGILYLHQDSRLTIIHR 472
Query: 290 DLKASNILLDKDMNPKISDFGMARMFGGDELQSNTKRIVGTYGYMSPEYALRGLFSIKSD 349
DLKASNILLD DMNPKI+DFGMAR+FG D+ + NT RIVGTYGYMSPEYA+ G +S+KSD
Sbjct: 473 DLKASNILLDADMNPKIADFGMARIFGLDQTEENTSRIVGTYGYMSPEYAMHGQYSMKSD 532
Query: 350 VFSFGVLLLETLSSKKNTHFYNTD-SLTLLGHAWNLWNDGRTWELMDPISQNGASYPILK 408
V+SFGVL+LE +S KKN+ FY TD + L+ +AW LW++GR EL+DP +
Sbjct: 533 VYSFGVLVLEIISGKKNSSFYQTDGAHDLVSYAWGLWSNGRPLELVDPAIVENCQRNEVV 592
Query: 409 RYINVALLCVQEKAADRPAMSEVVSMLSNEFVNLPAPQQPAF 450
R +++ LLCVQE A+RP +S +V ML++ V LP P+QP
Sbjct: 593 RCVHIGLLCVQEDPAERPTLSTIVLMLTSNTVTLPVPRQPGL 634
|
Arabidopsis thaliana (taxid: 3702) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: - |
| >sp|O81905|SD18_ARATH Receptor-like serine/threonine-protein kinase SD1-8 OS=Arabidopsis thaliana GN=SD18 PE=1 SV=1 | Back alignment and function description |
|---|
Score = 249 bits (636), Expect = 4e-65, Method: Compositional matrix adjust.
Identities = 130/240 (54%), Positives = 168/240 (70%), Gaps = 17/240 (7%)
Query: 252 NPTKKGLLCWGTRVRIIEGIAQGLLYLHQYSRLRVIHRDLKASNILLDKDMNPKISDFGM 311
+ ++ L W R II GIA+GLLYLHQ SR R+IHRDLKASNILLDK M PKISDFGM
Sbjct: 613 DKSRNSKLNWQMRFDIINGIARGLLYLHQDSRFRIIHRDLKASNILLDKYMTPKISDFGM 672
Query: 312 ARMFGGDELQSNTKRIVGTYGYMSPEYALRGLFSIKSDVFSFGVLLLETLSSKKNTHFYN 371
AR+FG DE ++NT+++VGTYGYMSPEYA+ G+FS+KSDVFSFGVLLLE +SSK+N FYN
Sbjct: 673 ARIFGRDETEANTRKVVGTYGYMSPEYAMDGIFSMKSDVFSFGVLLLEIISSKRNKGFYN 732
Query: 372 TD-SLTLLGHAWNLWNDGRTWELMDPISQNGAS----YPILKRYINVALLCVQEKAADRP 426
+D L LLG W W +G+ E++DPI + +S + IL R I + LLCVQE+A DRP
Sbjct: 733 SDRDLNLLGCVWRNWKEGKGLEIIDPIITDSSSTFRQHEIL-RCIQIGLLCVQERAEDRP 791
Query: 427 AMSEVVSMLSNEFVNLPAPQQPAFSCVN----------STNMQSDAFSVNCVTHSVIDAR 476
MS V+ ML +E +P P+ P + C+ S ++++VN +T SV+DAR
Sbjct: 792 TMSLVILMLGSESTTIPQPKAPGY-CLERSLLDTDSSSSKQRDDESWTVNQITVSVLDAR 850
|
Involved in the regulation of cellular expansion and differentiation. Arabidopsis thaliana (taxid: 3702) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
| >sp|Q9ZR08|Y4230_ARATH G-type lectin S-receptor-like serine/threonine-protein kinase At4g03230 OS=Arabidopsis thaliana GN=At4g03230 PE=3 SV=3 | Back alignment and function description |
|---|
Score = 246 bits (629), Expect = 2e-64, Method: Compositional matrix adjust.
Identities = 123/194 (63%), Positives = 145/194 (74%), Gaps = 2/194 (1%)
Query: 259 LCWGTRVRIIEGIAQGLLYLHQYSRLRVIHRDLKASNILLDKDMNPKISDFGMARMFGGD 318
L W R II GIA+GLLYLHQ SRLR+IHRDLK SNILLD++MNPKISDFG+AR+FGG
Sbjct: 626 LDWKMRCNIILGIARGLLYLHQDSRLRIIHRDLKTSNILLDEEMNPKISDFGLARIFGGS 685
Query: 319 ELQSNTKRIVGTYGYMSPEYALRGLFSIKSDVFSFGVLLLETLSSKKNTHFYNTD-SLTL 377
E +NT R+VGTYGYMSPEYAL GLFS KSDVFSFGV+++ET+S K+NT F+ + SL+L
Sbjct: 686 ETSANTNRVVGTYGYMSPEYALEGLFSFKSDVFSFGVVVIETISGKRNTGFHEPEKSLSL 745
Query: 378 LGHAWNLWNDGRTWELMDPISQNGASYPILKRYINVALLCVQEKAADRPAMSEVVSML-S 436
LGHAW+LW R EL+D Q + +NV LLCVQE DRP MS VV ML S
Sbjct: 746 LGHAWDLWKAERGIELLDQALQESCETEGFLKCLNVGLLCVQEDPNDRPTMSNVVFMLGS 805
Query: 437 NEFVNLPAPQQPAF 450
+E LP P+QPAF
Sbjct: 806 SEAATLPTPKQPAF 819
|
Arabidopsis thaliana (taxid: 3702) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
| >sp|Q9LDQ3|CRK35_ARATH Putative cysteine-rich receptor-like protein kinase 35 OS=Arabidopsis thaliana GN=CRK35 PE=3 SV=3 | Back alignment and function description |
|---|
Score = 245 bits (626), Expect = 4e-64, Method: Compositional matrix adjust.
Identities = 124/235 (52%), Positives = 159/235 (67%), Gaps = 9/235 (3%)
Query: 230 FLYEQVLVQSKDEISFWYESYNNPTKKGLLCWGTRVRIIEGIAQGLLYLHQYSRLRVIHR 289
+YE V +S D F +P K+G L W R II GIA+G+LYLHQ SRL +IHR
Sbjct: 416 LVYEFVPNKSLDYFLF------DPAKQGELDWTRRYNIIGGIARGILYLHQDSRLTIIHR 469
Query: 290 DLKASNILLDKDMNPKISDFGMARMFGGDELQSNTKRIVGTYGYMSPEYALRGLFSIKSD 349
DLKASNILLD DMNPKI+DFGMAR+FG D+ Q+NT+RI GT+GYMSPEYA+RG FS+KSD
Sbjct: 470 DLKASNILLDADMNPKIADFGMARIFGVDQSQANTRRIAGTFGYMSPEYAMRGHFSMKSD 529
Query: 350 VFSFGVLLLETLSSKKNTHFYNTD--SLTLLGHAWNLWNDGRTWELMDPISQNGASYPIL 407
V+SFGVL+LE +S KKN+ FYN D L+ HAW LW +G EL+DP
Sbjct: 530 VYSFGVLVLEIISGKKNSSFYNIDDSGSNLVTHAWRLWRNGSPLELVDPTIGESYQSSEA 589
Query: 408 KRYINVALLCVQEKAADRPAMSEVVSMLSNEFVNLPAPQQPAFSCVNSTNMQSDA 462
R I++ALLCVQE ADRP + ++ ML++ L P+ P F C++ +++ D
Sbjct: 590 TRCIHIALLCVQEDPADRPLLPAIIMMLTSSTTTLHVPRAPGF-CLSGRDLEQDG 643
|
Arabidopsis thaliana (taxid: 3702) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: - |
| >sp|O81906|B120_ARATH G-type lectin S-receptor-like serine/threonine-protein kinase B120 OS=Arabidopsis thaliana GN=B120 PE=1 SV=1 | Back alignment and function description |
|---|
Score = 244 bits (624), Expect = 7e-64, Method: Compositional matrix adjust.
Identities = 116/200 (58%), Positives = 155/200 (77%)
Query: 252 NPTKKGLLCWGTRVRIIEGIAQGLLYLHQYSRLRVIHRDLKASNILLDKDMNPKISDFGM 311
+ TK+ L+ W R IIEGIA+GLLYLH+ SRLR+IHRDLK SN+LLD +MNPKISDFGM
Sbjct: 616 DETKQALIDWKLRFSIIEGIARGLLYLHRDSRLRIIHRDLKVSNVLLDAEMNPKISDFGM 675
Query: 312 ARMFGGDELQSNTKRIVGTYGYMSPEYALRGLFSIKSDVFSFGVLLLETLSSKKNTHFYN 371
AR+FGG++ ++NT R+VGTYGYMSPEYA+ GLFS+KSDV+SFGVLLLE +S K+NT +
Sbjct: 676 ARIFGGNQNEANTVRVVGTYGYMSPEYAMEGLFSVKSDVYSFGVLLLEIVSGKRNTSLRS 735
Query: 372 TDSLTLLGHAWNLWNDGRTWELMDPISQNGASYPILKRYINVALLCVQEKAADRPAMSEV 431
++ +L+G+AW L+ GR+ EL+DP + S R I+VA+LCVQ+ AA+RP M+ V
Sbjct: 736 SEHGSLIGYAWYLYTHGRSEELVDPKIRVTCSKREALRCIHVAMLCVQDSAAERPNMASV 795
Query: 432 VSMLSNEFVNLPAPQQPAFS 451
+ ML ++ L AP+QP F+
Sbjct: 796 LLMLESDTATLAAPRQPTFT 815
|
Arabidopsis thaliana (taxid: 3702) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
| >sp|Q8W4G6|CRK15_ARATH Cysteine-rich receptor-like protein kinase 15 OS=Arabidopsis thaliana GN=CRK15 PE=2 SV=2 | Back alignment and function description |
|---|
Score = 243 bits (619), Expect = 3e-63, Method: Compositional matrix adjust.
Identities = 113/200 (56%), Positives = 147/200 (73%), Gaps = 1/200 (0%)
Query: 252 NPTKKGLLCWGTRVRIIEGIAQGLLYLHQYSRLRVIHRDLKASNILLDKDMNPKISDFGM 311
+P K+ L W R ++I GIA+G+LYLHQ SRL +IHRDLKASNILLD DMNPK++DFG+
Sbjct: 424 DPAKQNQLDWTRRYKVIGGIARGILYLHQDSRLTIIHRDLKASNILLDADMNPKLADFGL 483
Query: 312 ARMFGGDELQSNTKRIVGTYGYMSPEYALRGLFSIKSDVFSFGVLLLETLSSKKNTHFYN 371
AR+FG D+ Q NT RIVGT+GYM+PEYA+ G FS+KSDV+SFGVL+LE +S KKN FY
Sbjct: 484 ARIFGMDQTQENTSRIVGTFGYMAPEYAIHGQFSVKSDVYSFGVLVLEIISGKKNNSFYE 543
Query: 372 TD-SLTLLGHAWNLWNDGRTWELMDPISQNGASYPILKRYINVALLCVQEKAADRPAMSE 430
TD + L+ HAW LW++G +L+DPI + + R I++ LLCVQE A+RP +S
Sbjct: 544 TDGAHDLVTHAWRLWSNGTALDLVDPIIIDNCQKSEVVRCIHICLLCVQEDPAERPILST 603
Query: 431 VVSMLSNEFVNLPAPQQPAF 450
+ ML++ V LP P QP F
Sbjct: 604 IFMMLTSNTVTLPVPLQPGF 623
|
Arabidopsis thaliana (taxid: 3702) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: - |
| >sp|Q9C5S9|CRK6_ARATH Cysteine-rich receptor-like protein kinase 6 OS=Arabidopsis thaliana GN=CRK6 PE=1 SV=1 | Back alignment and function description |
|---|
Score = 240 bits (612), Expect = 2e-62, Method: Compositional matrix adjust.
Identities = 115/200 (57%), Positives = 146/200 (73%), Gaps = 1/200 (0%)
Query: 252 NPTKKGLLCWGTRVRIIEGIAQGLLYLHQYSRLRVIHRDLKASNILLDKDMNPKISDFGM 311
+PTK+ L W R II GIA+G+LYLHQ SRL +IHRDLKASNILLD D+NPKI+DFGM
Sbjct: 438 DPTKQIQLDWMQRYNIIGGIARGILYLHQDSRLTIIHRDLKASNILLDADINPKIADFGM 497
Query: 312 ARMFGGDELQSNTKRIVGTYGYMSPEYALRGLFSIKSDVFSFGVLLLETLSSKKNTHFYN 371
AR+FG D+ Q NT RIVGTYGYM+PEYA+ G FS+KSDV+SFGVL+LE +S +KN+ F
Sbjct: 498 ARIFGLDQTQDNTSRIVGTYGYMAPEYAMHGQFSMKSDVYSFGVLVLEIISGRKNSSFGE 557
Query: 372 TD-SLTLLGHAWNLWNDGRTWELMDPISQNGASYPILKRYINVALLCVQEKAADRPAMSE 430
+D + LL HAW LW + + +L+DP+ + R I++ LLCVQE A RPA+S
Sbjct: 558 SDGAQDLLTHAWRLWTNKKALDLVDPLIAENCQNSEVVRCIHIGLLCVQEDPAKRPAIST 617
Query: 431 VVSMLSNEFVNLPAPQQPAF 450
V ML++ V LP P+QP F
Sbjct: 618 VFMMLTSNTVTLPVPRQPGF 637
|
Arabidopsis thaliana (taxid: 3702) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: - |
Close Homologs in the Non-Redundant Database Detected by BLAST
Original result of BLAST against Nonredundant Database
| GI | Alignment Graph | Length |
Definition |
Q cover |
H cover |
Identity |
E-value |
| Query | 476 | ||||||
| 147781106 | 1479 | hypothetical protein VITISV_025930 [Viti | 0.894 | 0.288 | 0.440 | 1e-104 | |
| 302143124 | 233 | unnamed protein product [Vitis vinifera] | 0.470 | 0.961 | 0.688 | 2e-82 | |
| 359493705 | 830 | PREDICTED: receptor-like serine/threonin | 0.470 | 0.269 | 0.692 | 7e-82 | |
| 302143120 | 674 | unnamed protein product [Vitis vinifera] | 0.470 | 0.332 | 0.692 | 1e-81 | |
| 359493709 | 894 | PREDICTED: receptor-like serine/threonin | 0.436 | 0.232 | 0.741 | 1e-81 | |
| 359484155 | 865 | PREDICTED: receptor-like serine/threonin | 0.470 | 0.258 | 0.679 | 9e-81 | |
| 297742753 | 637 | unnamed protein product [Vitis vinifera] | 0.470 | 0.351 | 0.679 | 9e-81 | |
| 296090091 | 674 | unnamed protein product [Vitis vinifera] | 0.470 | 0.332 | 0.679 | 9e-81 | |
| 302143128 | 692 | unnamed protein product [Vitis vinifera] | 0.506 | 0.348 | 0.616 | 2e-80 | |
| 224106535 | 333 | predicted protein [Populus trichocarpa] | 0.497 | 0.711 | 0.619 | 2e-80 |
| >gi|147781106|emb|CAN64973.1| hypothetical protein VITISV_025930 [Vitis vinifera] | Back alignment and taxonomy information |
|---|
Score = 384 bits (985), Expect = e-104, Method: Compositional matrix adjust.
Identities = 217/493 (44%), Positives = 277/493 (56%), Gaps = 67/493 (13%)
Query: 4 NLLHIYIFSSLI-FLLRMELSLAADTITPETFIRDGEKLVSSSQRFELGFFSPRNSKNRY 62
NL F LI F + +E S A DTI ++D + LVSS Q FELGFFSP SK RY
Sbjct: 402 NLPFCTFFYILISFSIFLEFSSAGDTINETQSLKDRQTLVSSGQSFELGFFSPGESKGRY 461
Query: 63 LGVWYKKIPDTVVWVANRNSPIFNPNTALTFSNNGNLVLLSQRNGIIWSSNMSRKAENPI 122
LG+WYK P TVVWVAN+ I + L+F +GNLV+L+Q GIIWSS++SR ENP+
Sbjct: 462 LGIWYKNSPSTVVWVANKEKEITDSYGVLSFRTDGNLVVLNQSKGIIWSSSLSRIIENPV 521
Query: 123 AQLLDTGNLVIRDNSSGHTTESYLWQSFDYPTDSLLEGMKLGWDLKNGLERYLSSWESTD 182
QLL++GNLV+R+ S E Y+WQSFD+P +LL GMK GW+ K + YL+SW S
Sbjct: 522 VQLLESGNLVLREKSVAD-PEGYIWQSFDFPCHTLLPGMKFGWNSKTRQDWYLTSWRSAS 580
Query: 183 DPSPGNFTFRLVIQVIPKLCAYNGSVEYTCTGPWNGVAF--------------------- 221
+PSPG+FT+R+ +P+ GS + C GPW G F
Sbjct: 581 NPSPGDFTWRIDTVGLPQAVLRKGSEKKFCAGPWIGSHFSDIRKGGSGCLIWFGDLIDIR 640
Query: 222 -----GAAPTYTSFLYEQVLVQSKDE---------ISFWYESYNN----------PTKKG 257
A Y ++ + K E ++ + NN P +
Sbjct: 641 EFTGDAATDIYIRMSASELGLDRKKEEDLDLPLFDLAIVASATNNFSKANMIGKDPKRNT 700
Query: 258 LLCWGTRVRIIEGIAQGLLYLHQYSRLRVIHRDLKASNILLDKDMNPKISDFGMARMFGG 317
L W R I G+A+ LLYLH+ SRLR+IHRDLK SNILLD D+NPKISDFG+ R+F
Sbjct: 701 TLAWQKRFDIAIGVARVLLYLHRDSRLRIIHRDLKTSNILLDTDLNPKISDFGIVRIFER 760
Query: 318 DELQSNTKRIVGTYGYMSPEYALRGLFSIKSDVFSFGVLLLETLSSKKNTHFYNTDSLTL 377
D+ ++ T+R+VGT+GYMSPEYA G FS+KSDVFS GVLLLE
Sbjct: 761 DQTEAKTERVVGTFGYMSPEYAFYGKFSVKSDVFSMGVLLLEI----------------- 803
Query: 378 LGHAWNLWNDGRTWELMDPISQNGASYPILKRYINVALLCVQEKAADRPAMSEVVSMLSN 437
AW LW + + ELMD ++ + R I V LLCVQ+ ADRP MS VV ML N
Sbjct: 804 ---AWLLWTEDKALELMDQCLKDSCVESQVLRCIQVGLLCVQKCLADRPTMSSVVFMLGN 860
Query: 438 EFVNLPAPQQPAF 450
E LP P+QP F
Sbjct: 861 EEAVLPQPKQPGF 873
|
Source: Vitis vinifera Species: Vitis vinifera Genus: Vitis Family: Vitaceae Order: Vitales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|302143124|emb|CBI20419.3| unnamed protein product [Vitis vinifera] | Back alignment and taxonomy information |
|---|
Score = 313 bits (801), Expect = 2e-82, Method: Compositional matrix adjust.
Identities = 159/231 (68%), Positives = 180/231 (77%), Gaps = 7/231 (3%)
Query: 252 NPTKKGLLCWGTRVRIIEGIAQGLLYLHQYSRLRVIHRDLKASNILLDKDMNPKISDFGM 311
+PTK G+L W TRV IIEG+AQGLLYLHQYSRLR+IHRDLKASNILLDKDMNPKISDFGM
Sbjct: 4 DPTKHGILNWKTRVHIIEGVAQGLLYLHQYSRLRIIHRDLKASNILLDKDMNPKISDFGM 63
Query: 312 ARMFGGDELQSNTKRIVGTYGYMSPEYALRGLFSIKSDVFSFGVLLLETLSSKKNTHFYN 371
AR+FGG+E ++ T IVGTYGYMSPEYAL GLFS KSDVFSFGVLLLE LS KKNT FY
Sbjct: 64 ARIFGGNESKA-TNHIVGTYGYMSPEYALEGLFSTKSDVFSFGVLLLEILSGKKNTGFYQ 122
Query: 372 TDSLTLLGHAWNLWNDGRTWELMDPISQNGASYPILKRYINVALLCVQEKAADRPAMSEV 431
TDSL LLG+ W+LW D R ELMDP + IL RYINV LLCVQE A DRP MS+V
Sbjct: 123 TDSLNLLGYVWDLWKDSRGQELMDPGLEETLPTHILLRYINVGLLCVQESADDRPTMSDV 182
Query: 432 VSMLSNEFVNLPAPQQPAFSCVNS------TNMQSDAFSVNCVTHSVIDAR 476
VSML NE V LP+P+QPAFS + S + + + S+N VT SV++AR
Sbjct: 183 VSMLGNESVRLPSPKQPAFSNLRSGVEPHISQNRPEVCSLNGVTLSVMEAR 233
|
Source: Vitis vinifera Species: Vitis vinifera Genus: Vitis Family: Vitaceae Order: Vitales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|359493705|ref|XP_003634654.1| PREDICTED: receptor-like serine/threonine-protein kinase SD1-8-like [Vitis vinifera] | Back alignment and taxonomy information |
|---|
Score = 311 bits (796), Expect = 7e-82, Method: Compositional matrix adjust.
Identities = 160/231 (69%), Positives = 180/231 (77%), Gaps = 7/231 (3%)
Query: 252 NPTKKGLLCWGTRVRIIEGIAQGLLYLHQYSRLRVIHRDLKASNILLDKDMNPKISDFGM 311
+PTK G+L W TRV IIEG+AQGLLYLHQYSRLR+IHRDLKASNILLDKDMNPKISDFGM
Sbjct: 601 DPTKHGILNWKTRVHIIEGVAQGLLYLHQYSRLRIIHRDLKASNILLDKDMNPKISDFGM 660
Query: 312 ARMFGGDELQSNTKRIVGTYGYMSPEYALRGLFSIKSDVFSFGVLLLETLSSKKNTHFYN 371
AR+FGG+E + T IVGTYGYMSPEYAL GLFS KSDVFSFGVLLLE LS KKNT FY
Sbjct: 661 ARIFGGNESKV-TNHIVGTYGYMSPEYALEGLFSTKSDVFSFGVLLLEILSGKKNTGFYQ 719
Query: 372 TDSLTLLGHAWNLWNDGRTWELMDPISQNGASYPILKRYINVALLCVQEKAADRPAMSEV 431
TDSL LLG+AW+LW D R ELMDP + IL RYINV LLCVQE A DRP MS+V
Sbjct: 720 TDSLNLLGYAWDLWKDSRGLELMDPGLEETLPTHILLRYINVGLLCVQESADDRPTMSDV 779
Query: 432 VSMLSNEFVNLPAPQQPAFSCVNS------TNMQSDAFSVNCVTHSVIDAR 476
VSML NE V LP+P+QPAFS + S + + + S+N VT SV++AR
Sbjct: 780 VSMLGNESVRLPSPKQPAFSNLRSGVEPHISQNRPEVCSLNGVTLSVMEAR 830
|
Source: Vitis vinifera Species: Vitis vinifera Genus: Vitis Family: Vitaceae Order: Vitales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|302143120|emb|CBI20415.3| unnamed protein product [Vitis vinifera] | Back alignment and taxonomy information |
|---|
Score = 310 bits (794), Expect = 1e-81, Method: Compositional matrix adjust.
Identities = 160/231 (69%), Positives = 180/231 (77%), Gaps = 7/231 (3%)
Query: 252 NPTKKGLLCWGTRVRIIEGIAQGLLYLHQYSRLRVIHRDLKASNILLDKDMNPKISDFGM 311
+PTK G+L W TRV IIEG+AQGLLYLHQYSRLR+IHRDLKASNILLDKDMNPKISDFGM
Sbjct: 445 DPTKHGILNWKTRVHIIEGVAQGLLYLHQYSRLRIIHRDLKASNILLDKDMNPKISDFGM 504
Query: 312 ARMFGGDELQSNTKRIVGTYGYMSPEYALRGLFSIKSDVFSFGVLLLETLSSKKNTHFYN 371
AR+FGG+E + T IVGTYGYMSPEYAL GLFS KSDVFSFGVLLLE LS KKNT FY
Sbjct: 505 ARIFGGNESKV-TNHIVGTYGYMSPEYALEGLFSTKSDVFSFGVLLLEILSGKKNTGFYQ 563
Query: 372 TDSLTLLGHAWNLWNDGRTWELMDPISQNGASYPILKRYINVALLCVQEKAADRPAMSEV 431
TDSL LLG+AW+LW D R ELMDP + IL RYINV LLCVQE A DRP MS+V
Sbjct: 564 TDSLNLLGYAWDLWKDSRGLELMDPGLEETLPTHILLRYINVGLLCVQESADDRPTMSDV 623
Query: 432 VSMLSNEFVNLPAPQQPAFSCVNS------TNMQSDAFSVNCVTHSVIDAR 476
VSML NE V LP+P+QPAFS + S + + + S+N VT SV++AR
Sbjct: 624 VSMLGNESVRLPSPKQPAFSNLRSGVEPHISQNRPEVCSLNGVTLSVMEAR 674
|
Source: Vitis vinifera Species: Vitis vinifera Genus: Vitis Family: Vitaceae Order: Vitales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|359493709|ref|XP_002281056.2| PREDICTED: receptor-like serine/threonine-protein kinase SD1-8-like [Vitis vinifera] | Back alignment and taxonomy information |
|---|
Score = 310 bits (794), Expect = 1e-81, Method: Compositional matrix adjust.
Identities = 155/209 (74%), Positives = 171/209 (81%), Gaps = 1/209 (0%)
Query: 252 NPTKKGLLCWGTRVRIIEGIAQGLLYLHQYSRLRVIHRDLKASNILLDKDMNPKISDFGM 311
+P K+G+L W TRVRIIEG+AQGLLYLHQYSRLRVIHRDLKASNILLDKDMNPKISDFGM
Sbjct: 605 DPAKRGILNWETRVRIIEGVAQGLLYLHQYSRLRVIHRDLKASNILLDKDMNPKISDFGM 664
Query: 312 ARMFGGDELQSNTKRIVGTYGYMSPEYALRGLFSIKSDVFSFGVLLLETLSSKKNTHFYN 371
AR+FGG+E ++ TK IVGTYGYMSPEYAL GLFS KSDVFSFGVLLLE LS KKNT FY
Sbjct: 665 ARIFGGNESKA-TKHIVGTYGYMSPEYALEGLFSTKSDVFSFGVLLLEILSGKKNTGFYQ 723
Query: 372 TDSLTLLGHAWNLWNDGRTWELMDPISQNGASYPILKRYINVALLCVQEKAADRPAMSEV 431
TDSL LLG+AW+LW D R ELMDP + IL RYINV LLCVQE A DRP MS+V
Sbjct: 724 TDSLNLLGYAWDLWKDSRGQELMDPGLEETLPTHILLRYINVGLLCVQESADDRPTMSDV 783
Query: 432 VSMLSNEFVNLPAPQQPAFSCVNSTNMQS 460
VSML NE V LP+P+QPAFS + S +S
Sbjct: 784 VSMLGNESVRLPSPKQPAFSNLRSGTHKS 812
|
Source: Vitis vinifera Species: Vitis vinifera Genus: Vitis Family: Vitaceae Order: Vitales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|359484155|ref|XP_002272509.2| PREDICTED: receptor-like serine/threonine-protein kinase SD1-8-like [Vitis vinifera] | Back alignment and taxonomy information |
|---|
Score = 307 bits (786), Expect = 9e-81, Method: Compositional matrix adjust.
Identities = 157/231 (67%), Positives = 180/231 (77%), Gaps = 7/231 (3%)
Query: 252 NPTKKGLLCWGTRVRIIEGIAQGLLYLHQYSRLRVIHRDLKASNILLDKDMNPKISDFGM 311
+PTK G+L W TRV II+G+AQGLLYLHQYSRLR+IHRDLKASNILLDKDMNP+ISDFGM
Sbjct: 636 DPTKHGILNWKTRVHIIKGVAQGLLYLHQYSRLRIIHRDLKASNILLDKDMNPQISDFGM 695
Query: 312 ARMFGGDELQSNTKRIVGTYGYMSPEYALRGLFSIKSDVFSFGVLLLETLSSKKNTHFYN 371
AR+FGG+E ++ T IVGTYGYMSPEYAL GLFS KSDVFSFGVLLLE LS KKNT FY
Sbjct: 696 ARIFGGNESKA-TNHIVGTYGYMSPEYALEGLFSTKSDVFSFGVLLLEILSGKKNTGFYQ 754
Query: 372 TDSLTLLGHAWNLWNDGRTWELMDPISQNGASYPILKRYINVALLCVQEKAADRPAMSEV 431
TDSL LLG+AW+LW D R ELMDP + IL RYIN+ LLCVQE A DRP MS+V
Sbjct: 755 TDSLNLLGYAWDLWKDSRGQELMDPGLEETLPTHILLRYINIGLLCVQESADDRPTMSDV 814
Query: 432 VSMLSNEFVNLPAPQQPAFSCVNS------TNMQSDAFSVNCVTHSVIDAR 476
VSML NE V LP+P+QPAFS + S + + S+N VT SV++AR
Sbjct: 815 VSMLGNESVRLPSPKQPAFSNLRSGVEPHISQNKPKICSLNGVTLSVMEAR 865
|
Source: Vitis vinifera Species: Vitis vinifera Genus: Vitis Family: Vitaceae Order: Vitales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|297742753|emb|CBI35387.3| unnamed protein product [Vitis vinifera] | Back alignment and taxonomy information |
|---|
Score = 307 bits (786), Expect = 9e-81, Method: Compositional matrix adjust.
Identities = 157/231 (67%), Positives = 180/231 (77%), Gaps = 7/231 (3%)
Query: 252 NPTKKGLLCWGTRVRIIEGIAQGLLYLHQYSRLRVIHRDLKASNILLDKDMNPKISDFGM 311
+PTK G+L W TRV II+G+AQGLLYLHQYSRLR+IHRDLKASNILLDKDMNP+ISDFGM
Sbjct: 408 DPTKHGILNWKTRVHIIKGVAQGLLYLHQYSRLRIIHRDLKASNILLDKDMNPQISDFGM 467
Query: 312 ARMFGGDELQSNTKRIVGTYGYMSPEYALRGLFSIKSDVFSFGVLLLETLSSKKNTHFYN 371
AR+FGG+E ++ T IVGTYGYMSPEYAL GLFS KSDVFSFGVLLLE LS KKNT FY
Sbjct: 468 ARIFGGNESKA-TNHIVGTYGYMSPEYALEGLFSTKSDVFSFGVLLLEILSGKKNTGFYQ 526
Query: 372 TDSLTLLGHAWNLWNDGRTWELMDPISQNGASYPILKRYINVALLCVQEKAADRPAMSEV 431
TDSL LLG+AW+LW D R ELMDP + IL RYIN+ LLCVQE A DRP MS+V
Sbjct: 527 TDSLNLLGYAWDLWKDSRGQELMDPGLEETLPTHILLRYINIGLLCVQESADDRPTMSDV 586
Query: 432 VSMLSNEFVNLPAPQQPAFSCVNS------TNMQSDAFSVNCVTHSVIDAR 476
VSML NE V LP+P+QPAFS + S + + S+N VT SV++AR
Sbjct: 587 VSMLGNESVRLPSPKQPAFSNLRSGVEPHISQNKPKICSLNGVTLSVMEAR 637
|
Source: Vitis vinifera Species: Vitis vinifera Genus: Vitis Family: Vitaceae Order: Vitales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|296090091|emb|CBI39910.3| unnamed protein product [Vitis vinifera] | Back alignment and taxonomy information |
|---|
Score = 307 bits (786), Expect = 9e-81, Method: Compositional matrix adjust.
Identities = 157/231 (67%), Positives = 181/231 (78%), Gaps = 7/231 (3%)
Query: 252 NPTKKGLLCWGTRVRIIEGIAQGLLYLHQYSRLRVIHRDLKASNILLDKDMNPKISDFGM 311
+PTK G+L W T V IIEG+AQGLLYLHQYSR+R+IHRDLKASNILLDKDMNPKISDFGM
Sbjct: 445 DPTKHGILNWKTWVHIIEGVAQGLLYLHQYSRMRIIHRDLKASNILLDKDMNPKISDFGM 504
Query: 312 ARMFGGDELQSNTKRIVGTYGYMSPEYALRGLFSIKSDVFSFGVLLLETLSSKKNTHFYN 371
AR+FGG+E ++ T IVGTYGYMSPEYAL GLFS KSDVFSFGVLL+E LS KKNT FY
Sbjct: 505 ARIFGGNEPKA-TNHIVGTYGYMSPEYALEGLFSTKSDVFSFGVLLMEILSGKKNTGFYQ 563
Query: 372 TDSLTLLGHAWNLWNDGRTWELMDPISQNGASYPILKRYINVALLCVQEKAADRPAMSEV 431
TDSL LLG+AW+LW D R ELMDP + + IL RYINV LLCVQE A DRP MS+V
Sbjct: 564 TDSLNLLGYAWDLWKDSRGQELMDPGLEETSPTHILLRYINVGLLCVQESADDRPTMSDV 623
Query: 432 VSMLSNEFVNLPAPQQPAFSCVNS------TNMQSDAFSVNCVTHSVIDAR 476
VSML NE V LP+P+QPAFS + S + + +S+N VT SV++AR
Sbjct: 624 VSMLGNESVRLPSPKQPAFSNLRSGVEPHISQNRPGIYSLNGVTLSVMEAR 674
|
Source: Vitis vinifera Species: Vitis vinifera Genus: Vitis Family: Vitaceae Order: Vitales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|302143128|emb|CBI20423.3| unnamed protein product [Vitis vinifera] | Back alignment and taxonomy information |
|---|
Score = 306 bits (783), Expect = 2e-80, Method: Compositional matrix adjust.
Identities = 156/253 (61%), Positives = 186/253 (73%), Gaps = 12/253 (4%)
Query: 230 FLYEQVLVQSKDEISFWYESYNNPTKKGLLCWGTRVRIIEGIAQGLLYLHQYSRLRVIHR 289
+YE + +S D F +P K+G L W RV IIEGIAQGLLYLH+YSRLR+IHR
Sbjct: 446 LIYEYMPNKSLDSFLF------DPNKRGQLDWAKRVSIIEGIAQGLLYLHEYSRLRIIHR 499
Query: 290 DLKASNILLDKDMNPKISDFGMARMFGGDELQSNTKRIVGTYGYMSPEYALRGLFSIKSD 349
DLKASNILLD DMNPKISDFGMARMFGG+E +NT RIVGTYGYMSPEYAL GLFS KSD
Sbjct: 500 DLKASNILLDNDMNPKISDFGMARMFGGNESYANTNRIVGTYGYMSPEYALEGLFSTKSD 559
Query: 350 VFSFGVLLLETLSSKKNTHFYNTDSLTLLGHAWNLWNDGRTWELMDPISQNGASYPILKR 409
VFSFGVL+LE LS KKNT FYN+D+L L+G+AW LW LMDP+ + +S +L R
Sbjct: 560 VFSFGVLMLEILSGKKNTGFYNSDTLNLIGYAWELWKSDMAINLMDPMLEGQSSQYMLLR 619
Query: 410 YINVALLCVQEKAADRPAMSEVVSMLSNEFVNLPAPQQPAFSCVNSTN------MQSDAF 463
YINV LLCV+E AADRP +SEVVSML+NE LP+P+ PAFS V S + + +
Sbjct: 620 YINVGLLCVEEIAADRPTLSEVVSMLTNELAVLPSPKHPAFSTVRSMENPRSSMSRPEIY 679
Query: 464 SVNCVTHSVIDAR 476
S N ++ SV++AR
Sbjct: 680 SANGLSISVMEAR 692
|
Source: Vitis vinifera Species: Vitis vinifera Genus: Vitis Family: Vitaceae Order: Vitales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|224106535|ref|XP_002333668.1| predicted protein [Populus trichocarpa] gi|222837959|gb|EEE76324.1| predicted protein [Populus trichocarpa] | Back alignment and taxonomy information |
|---|
Score = 306 bits (783), Expect = 2e-80, Method: Compositional matrix adjust.
Identities = 156/252 (61%), Positives = 184/252 (73%), Gaps = 15/252 (5%)
Query: 240 KDEISFWYESYNNPT---------KKGLLCWGTRVRIIEGIAQGLLYLHQYSRLRVIHRD 290
+DE YE N + + +L WGTR+RIIEGIAQGLLYLH+YSRLR+IHRD
Sbjct: 82 RDEKMLIYEYMPNKSLDFFLFDANRGQILDWGTRIRIIEGIAQGLLYLHRYSRLRIIHRD 141
Query: 291 LKASNILLDKDMNPKISDFGMARMFGGDELQSNTKRIVGTYGYMSPEYALRGLFSIKSDV 350
LK SNILLD +MNPKISDFGMAR+FGG+E Q+NT RIVGTYGYMSPEYA+ GLFSIKSDV
Sbjct: 142 LKPSNILLDSEMNPKISDFGMARIFGGNETQANTNRIVGTYGYMSPEYAMEGLFSIKSDV 201
Query: 351 FSFGVLLLETLSSKKNTHFYNTDSLTLLGHAWNLWNDGRTWELMDPISQNGASYPILKRY 410
FSFGVL+LE +S KKNT FY++ SL LLGHAW LWN + +LMDPI + S L RY
Sbjct: 202 FSFGVLVLEIVSGKKNTSFYHSGSLNLLGHAWKLWNSNKALDLMDPILGDPPSTATLLRY 261
Query: 411 INVALLCVQEKAADRPAMSEVVSMLSNEFVNLPAPQQPAF----SCVNSTNMQSDAF--S 464
IN+ LLCVQE ADRP MS+V+SM+ NE V LP P+QPAF + ++ S A S
Sbjct: 262 INIGLLCVQESPADRPTMSDVISMIVNEHVALPEPKQPAFVAGRNVAEPRSLMSFAGVPS 321
Query: 465 VNCVTHSVIDAR 476
VN VT + IDAR
Sbjct: 322 VNNVTITTIDAR 333
|
Source: Populus trichocarpa Species: Populus trichocarpa Genus: Populus Family: Salicaceae Order: Malpighiales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
Prediction of Gene Ontology (GO) Terms
Close Homologs with Gene Ontology terms Detected by BLAST
Original result of BLAST against Gene Ontology (AMIGO)
| ID |
Alignment graph |
Length |
Definition |
Q cover |
H cover |
Identity |
E-value |
| Query | 476 | ||||||
| TAIR|locus:2018546 | 843 | RK1 "receptor kinase 1" [Arabi | 0.466 | 0.263 | 0.548 | 2.7e-109 | |
| TAIR|locus:2131684 | 783 | AT4G27290 [Arabidopsis thalian | 0.451 | 0.274 | 0.535 | 4.4e-109 | |
| TAIR|locus:2141181 | 850 | RK3 "receptor kinase 3" [Arabi | 0.464 | 0.26 | 0.554 | 1.2e-108 | |
| TAIR|locus:2018506 | 847 | RK2 "receptor kinase 2" [Arabi | 0.466 | 0.262 | 0.556 | 2.4e-108 | |
| TAIR|locus:2141176 | 849 | B120 [Arabidopsis thaliana (ta | 0.415 | 0.233 | 0.585 | 1.3e-98 | |
| TAIR|locus:2200151 | 830 | SD1-13 "S-domain-1 13" [Arabid | 0.472 | 0.271 | 0.517 | 1.4e-97 | |
| TAIR|locus:2131694 | 815 | AT4G27300 [Arabidopsis thalian | 0.401 | 0.234 | 0.567 | 2.6e-97 | |
| TAIR|locus:2200908 | 842 | AT1G61610 [Arabidopsis thalian | 0.504 | 0.285 | 0.496 | 3.1e-97 | |
| TAIR|locus:2197734 | 814 | AT1G61370 [Arabidopsis thalian | 0.5 | 0.292 | 0.472 | 4e-93 | |
| TAIR|locus:2200888 | 804 | AT1G61500 [Arabidopsis thalian | 0.5 | 0.296 | 0.484 | 8.1e-93 |
| TAIR|locus:2018546 RK1 "receptor kinase 1" [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 632 (227.5 bits), Expect = 2.7e-109, Sum P(2) = 2.7e-109
Identities = 130/237 (54%), Positives = 169/237 (71%)
Query: 254 TKKGLLCWGTRVRIIEGIAQGLLYLHQYSRLRVIHRDLKASNILLDKDMNPKISDFGMAR 313
T+ L W R II GIA+GLLYLHQ SR R+IHRDLKASN+LLDK+M PKISDFGMAR
Sbjct: 608 TRSSNLNWQKRFDIINGIARGLLYLHQDSRCRIIHRDLKASNVLLDKNMTPKISDFGMAR 667
Query: 314 MFGGDELQSNTKRIVGTYGYMSPEYALRGLFSIKSDVFSFGVLLLETLSSKKNTHFYNTD 373
+FG +E ++NT+R+VGTYGYMSPEYA+ G+FS+KSDVFSFGVLLLE +S K+N FYN++
Sbjct: 668 IFGREETEANTRRVVGTYGYMSPEYAMDGIFSMKSDVFSFGVLLLEIISGKRNKGFYNSN 727
Query: 374 -SLTLLGHAWNLWNDGRTWELMDPISQNGAS--YPI--LKRYINVALLCVQEKAADRPAM 428
L LLG W W +G E++DPI+ + S +P + R I + LLCVQE+A DRP M
Sbjct: 728 RDLNLLGFVWRHWKEGNELEIVDPINIDSLSSKFPTHEILRCIQIGLLCVQERAEDRPVM 787
Query: 429 SEVVSMLSNEFVNLPAPQQPAFSCVNSTNMQSDAFS---------VNCVTHSVIDAR 476
S V+ ML +E +P P++P F C+ + +++D+ S VN +T SVIDAR
Sbjct: 788 SSVMVMLGSETTAIPQPKRPGF-CIGRSPLEADSSSSTQRDDECTVNQITLSVIDAR 843
|
|
| TAIR|locus:2131684 AT4G27290 [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 567 (204.7 bits), Expect = 4.4e-109, Sum P(2) = 4.4e-109
Identities = 122/228 (53%), Positives = 158/228 (69%)
Query: 259 LCWGTRVRIIEGIAQGLLYLHQYSRLRVIHRDLKASNILLDKDMNPKISDFGMARMFGGD 318
L W RV II+GIA+G+LYLH+ SRLR+IHRDLKASN+LLD DMN KISDFG+AR GGD
Sbjct: 559 LDWPKRVEIIKGIARGMLYLHEDSRLRIIHRDLKASNVLLDSDMNAKISDFGLARTLGGD 618
Query: 319 ELQSNTKRIVGTYGYMSPEYALRGLFSIKSDVFSFGVLLLETLSSKKNTHFYNTD-SLTL 377
E ++NT R+VGTYGYMSPEY + G FS+KSDVFSFGVL+LE +S ++N F N + L L
Sbjct: 619 ETEANTTRVVGTYGYMSPEYQIDGYFSLKSDVFSFGVLVLEIVSGRRNRGFRNEEHKLNL 678
Query: 378 LGHAWNLWNDGRTWELMDP-ISQNGASYPILKRYINVALLCVQEKAADRPAMSEVVSMLS 436
LGHAW + + + +E++D ++++ + R I++ LLCVQ+ DRP MS VV MLS
Sbjct: 679 LGHAWRQFLEDKAYEIIDEAVNESCTDISEVLRVIHIGLLCVQQDPKDRPNMSVVVLMLS 738
Query: 437 NEFVNLPAPQQPAFSCVNSTNMQ-SDAFSVNCV-------THSVIDAR 476
+E + L P+QP F N N+ SD S+N T SVID R
Sbjct: 739 SEMLLLD-PRQPGF--FNERNLLFSDTVSINLEIPSNNFQTMSVIDPR 783
|
|
| TAIR|locus:2141181 RK3 "receptor kinase 3" [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 625 (225.1 bits), Expect = 1.2e-108, Sum P(2) = 1.2e-108
Identities = 132/238 (55%), Positives = 171/238 (71%)
Query: 254 TKKGLLCWGTRVRIIEGIAQGLLYLHQYSRLRVIHRDLKASNILLDKDMNPKISDFGMAR 313
++ L W R II GIA+GLLYLHQ SR R+IHRDLKASNILLDK M PKISDFGMAR
Sbjct: 615 SRNSKLNWQMRFDIINGIARGLLYLHQDSRFRIIHRDLKASNILLDKYMTPKISDFGMAR 674
Query: 314 MFGGDELQSNTKRIVGTYGYMSPEYALRGLFSIKSDVFSFGVLLLETLSSKKNTHFYNTD 373
+FG DE ++NT+++VGTYGYMSPEYA+ G+FS+KSDVFSFGVLLLE +SSK+N FYN+D
Sbjct: 675 IFGRDETEANTRKVVGTYGYMSPEYAMDGIFSMKSDVFSFGVLLLEIISSKRNKGFYNSD 734
Query: 374 -SLTLLGHAWNLWNDGRTWELMDPISQNGAS----YPILKRYINVALLCVQEKAADRPAM 428
L LLG W W +G+ E++DPI + +S + IL R I + LLCVQE+A DRP M
Sbjct: 735 RDLNLLGCVWRNWKEGKGLEIIDPIITDSSSTFRQHEIL-RCIQIGLLCVQERAEDRPTM 793
Query: 429 SEVVSMLSNEFVNLPAPQQPAFSCV--------NSTNMQSD--AFSVNCVTHSVIDAR 476
S V+ ML +E +P P+ P + C+ +S++ Q D +++VN +T SV+DAR
Sbjct: 794 SLVILMLGSESTTIPQPKAPGY-CLERSLLDTDSSSSKQRDDESWTVNQITVSVLDAR 850
|
|
| TAIR|locus:2018506 RK2 "receptor kinase 2" [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 636 (228.9 bits), Expect = 2.4e-108, Sum P(2) = 2.4e-108
Identities = 132/237 (55%), Positives = 170/237 (71%)
Query: 254 TKKGLLCWGTRVRIIEGIAQGLLYLHQYSRLRVIHRDLKASNILLDKDMNPKISDFGMAR 313
T+ L W R II GIA+GLLYLHQ SR R+IHRDLKASN+LLDK+M PKISDFGMAR
Sbjct: 612 TRSSNLNWQKRFDIINGIARGLLYLHQDSRCRIIHRDLKASNVLLDKNMTPKISDFGMAR 671
Query: 314 MFGGDELQSNTKRIVGTYGYMSPEYALRGLFSIKSDVFSFGVLLLETLSSKKNTHFYNTD 373
+FG +E ++NT+R+VGTYGYMSPEYA+ G+FS+KSDVFSFGVLLLE +S K+N FYN++
Sbjct: 672 IFGREETEANTRRVVGTYGYMSPEYAMDGIFSMKSDVFSFGVLLLEIISGKRNKGFYNSN 731
Query: 374 -SLTLLGHAWNLWNDGRTWELMDPISQNGAS--YPI--LKRYINVALLCVQEKAADRPAM 428
L LLG W W +G+ E++DPI+ + S +P + R I + LLCVQE+A DRP M
Sbjct: 732 RDLNLLGFVWRHWKEGKELEIVDPINIDALSSEFPTHEILRCIQIGLLCVQERAEDRPVM 791
Query: 429 SEVVSMLSNEFVNLPAPQQPAFSCVNSTNMQSDAFS---------VNCVTHSVIDAR 476
S V+ ML +E +P P++P F CV ++++ D+ S VN VT SVIDAR
Sbjct: 792 SSVMVMLGSETTAIPQPKRPGF-CVGRSSLEVDSSSSTQRDDECTVNQVTLSVIDAR 847
|
|
| TAIR|locus:2141176 B120 [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 601 (216.6 bits), Expect = 1.3e-98, Sum P(2) = 1.3e-98
Identities = 116/198 (58%), Positives = 154/198 (77%)
Query: 254 TKKGLLCWGTRVRIIEGIAQGLLYLHQYSRLRVIHRDLKASNILLDKDMNPKISDFGMAR 313
TK+ L+ W R IIEGIA+GLLYLH+ SRLR+IHRDLK SN+LLD +MNPKISDFGMAR
Sbjct: 618 TKQALIDWKLRFSIIEGIARGLLYLHRDSRLRIIHRDLKVSNVLLDAEMNPKISDFGMAR 677
Query: 314 MFGGDELQSNTKRIVGTYGYMSPEYALRGLFSIKSDVFSFGVLLLETLSSKKNTHFYNTD 373
+FGG++ ++NT R+VGTYGYMSPEYA+ GLFS+KSDV+SFGVLLLE +S K+NT +++
Sbjct: 678 IFGGNQNEANTVRVVGTYGYMSPEYAMEGLFSVKSDVYSFGVLLLEIVSGKRNTSLRSSE 737
Query: 374 SLTLLGHAWNLWNDGRTWELMDPISQNGASYPILKRYINVALLCVQEKAADRPAMSEVVS 433
+L+G+AW L+ GR+ EL+DP + S R I+VA+LCVQ+ AA+RP M+ V+
Sbjct: 738 HGSLIGYAWYLYTHGRSEELVDPKIRVTCSKREALRCIHVAMLCVQDSAAERPNMASVLL 797
Query: 434 MLSNEFVNLPAPQQPAFS 451
ML ++ L AP+QP F+
Sbjct: 798 MLESDTATLAAPRQPTFT 815
|
|
| TAIR|locus:2200151 SD1-13 "S-domain-1 13" [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 585 (211.0 bits), Expect = 1.4e-97, Sum P(2) = 1.4e-97
Identities = 120/232 (51%), Positives = 163/232 (70%)
Query: 252 NPTKKGLLCWGTRVRIIEGIAQGLLYLHQYSRLRVIHRDLKASNILLDKDMNPKISDFGM 311
+P K+ LL W TR II+GI +GL+YLH+ SRL++IHRDLKASNILLD+++NPKISDFG+
Sbjct: 599 DPVKQRLLDWKTRFNIIDGICRGLMYLHRDSRLKIIHRDLKASNILLDENLNPKISDFGL 658
Query: 312 ARMFGGDELQSNTKRIVGTYGYMSPEYALRGLFSIKSDVFSFGVLLLETLSSKKNTHFYN 371
AR+F G+E + +T R+VGTYGYM+PEYA+ GLFS KSDVFS GV+LLE +S ++N+ FYN
Sbjct: 659 ARIFQGNEDEVSTVRVVGTYGYMAPEYAMGGLFSEKSDVFSLGVILLEIVSGRRNSSFYN 718
Query: 372 T-DSLTLLGHAWNLWNDGRTWELMDPISQNGASYPILKRYINVALLCVQEKAADRPAMSE 430
+ L +AW LWN G L+DP+ ++R ++V LLCVQ+ A DRP+++
Sbjct: 719 DGQNPNLSAYAWKLWNTGEDIALVDPVIFEECFENEIRRCVHVGLLCVQDHANDRPSVAT 778
Query: 431 VVSMLSNEFVNLPAPQQPAF------SCVNSTNMQSDAFSVNCVTHSVIDAR 476
V+ MLS+E NLP P+QPAF S V S+ S+N V+ + I R
Sbjct: 779 VIWMLSSENSNLPEPKQPAFIPRRGTSEVESSGQSDPRASINNVSLTKITGR 830
|
|
| TAIR|locus:2131694 AT4G27300 [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 553 (199.7 bits), Expect = 2.6e-97, Sum P(2) = 2.6e-97
Identities = 110/194 (56%), Positives = 139/194 (71%)
Query: 259 LCWGTRVRIIEGIAQGLLYLHQYSRLRVIHRDLKASNILLDKDMNPKISDFGMARMFGGD 318
L W R+ II G+A+G+LYLHQ SRLR+IHRDLKA N+LLD DMNPKISDFG+A+ FGGD
Sbjct: 594 LDWKKRMNIINGVARGILYLHQDSRLRIIHRDLKAGNVLLDNDMNPKISDFGLAKSFGGD 653
Query: 319 ELQSNTKRIVGTYGYMSPEYALRGLFSIKSDVFSFGVLLLETLSSKKNTHFYNTD-SLTL 377
+ +S+T R+VGTYGYM PEYA+ G FS+KSDVFSFGVL+LE ++ K N F + D L L
Sbjct: 654 QSESSTNRVVGTYGYMPPEYAIDGHFSVKSDVFSFGVLVLEIITGKTNRGFRHADHDLNL 713
Query: 378 LGHAWNLWNDGRTWELMDPISQNGASY-PILKRYINVALLCVQEKAADRPAMSEVVSMLS 436
LGH W +W + R E+ + S P + R I+VALLCVQ+K DRP M+ VV M
Sbjct: 714 LGHVWKMWVEDREIEVPEEEWLEETSVIPEVLRCIHVALLCVQQKPEDRPTMASVVLMFG 773
Query: 437 NEFVNLPAPQQPAF 450
++ +LP P QP F
Sbjct: 774 SDS-SLPHPTQPGF 786
|
|
| TAIR|locus:2200908 AT1G61610 [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 588 (212.0 bits), Expect = 3.1e-97, Sum P(2) = 3.1e-97
Identities = 125/252 (49%), Positives = 169/252 (67%)
Query: 231 LYEQVLVQSKDEISFWYESYNNPTKKGLLCWGTRVRIIEGIAQGLLYLHQYSRLRVIHRD 290
LYE + +S D F + +K+G L W R +I GIA+GLLYLH+ SRL++IHRD
Sbjct: 597 LYEYMPNKSLDRFLF------DESKQGSLDWRKRWEVIGGIARGLLYLHRDSRLKIIHRD 650
Query: 291 LKASNILLDKDMNPKISDFGMARMFGGDELQSNTKRIVGTYGYMSPEYALRGLFSIKSDV 350
LKASNILLD +MNPKISDFGMAR+F + +NT R+VGTYGYM+PEYA+ G+FS KSDV
Sbjct: 651 LKASNILLDTEMNPKISDFGMARIFNYRQDHANTIRVVGTYGYMAPEYAMEGIFSEKSDV 710
Query: 351 FSFGVLLLETLSSKKNTHFYNTDSLTLLGHAWNLWNDGRTWELMDPISQNGASYPILKRY 410
+SFGVL+LE +S +KN F TD +L+G+AW+LW+ G+T E++DPI ++ R
Sbjct: 711 YSFGVLILEIVSGRKNVSFRGTDHGSLIGYAWHLWSQGKTKEMIDPIVKDTRDVTEAMRC 770
Query: 411 INVALLCVQEKAADRPAMSEVVSMLSNEFVNLPAPQQPAF-SCVNSTNMQ-----SDAFS 464
I+V +LC Q+ RP M V+ ML ++ LP P+QP F S +NS +++ D S
Sbjct: 771 IHVGMLCTQDSVIHRPNMGSVLLMLESQTSQLPPPRQPTFHSFLNSGDIELNFDGHDVAS 830
Query: 465 VNCVTHSVIDAR 476
VN VT + I R
Sbjct: 831 VNDVTFTTIVGR 842
|
|
| TAIR|locus:2197734 AT1G61370 [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 541 (195.5 bits), Expect = 4.0e-93, Sum P(2) = 4.0e-93
Identities = 118/250 (47%), Positives = 171/250 (68%)
Query: 231 LYEQVLVQSKDEISFWYESYNNPTKKGLLCWGTRVRIIEGIAQGLLYLHQYSRLRVIHRD 290
+YE + +K +F ++S TKK L W R II+GIA GLLYLH+ S LRV+HRD
Sbjct: 573 IYE--FMANKSLNTFIFDS----TKKLELDWPKRFEIIQGIACGLLYLHRDSCLRVVHRD 626
Query: 291 LKASNILLDKDMNPKISDFGMARMFGGDELQSNTKRIVGTYGYMSPEYALRGLFSIKSDV 350
+K SNILLD++MNPKISDFG+ARMF G + Q+NT+R+VGT GYMSPEYA G+FS KSD+
Sbjct: 627 MKVSNILLDEEMNPKISDFGLARMFQGTQHQANTRRVVGTLGYMSPEYAWTGMFSEKSDI 686
Query: 351 FSFGVLLLETLSSKKNTHF-YNTDSLTLLGHAWNLWNDGRTWELMDP-ISQNGASYPILK 408
++FGVLLLE ++ K+ + F + TLL AW+ W + +L+D IS +G+ +
Sbjct: 687 YAFGVLLLEIITGKRISSFTIGEEGKTLLEFAWDSWCESGGSDLLDQDISSSGSESEVA- 745
Query: 409 RYINVALLCVQEKAADRPAMSEVVSMLSNEFVNLPAPQQPAFSC-VNSTNMQSDA-FSVN 466
R + + LLC+Q++A DRP +++V+SML+ ++LP P+QP F+ V ++ +S +SVN
Sbjct: 746 RCVQIGLLCIQQQAGDRPNIAQVMSMLTTT-MDLPKPKQPVFAMQVQESDSESKTMYSVN 804
Query: 467 CVTHSVIDAR 476
+T + I R
Sbjct: 805 NITQTAIVGR 814
|
|
| TAIR|locus:2200888 AT1G61500 [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 552 (199.4 bits), Expect = 8.1e-93, Sum P(2) = 8.1e-93
Identities = 121/250 (48%), Positives = 170/250 (68%)
Query: 231 LYEQVLVQSKDEISFWYESYNNPTKKGLLCWGTRVRIIEGIAQGLLYLHQYSRLRVIHRD 290
+YE ++ +S D +F ++S K+ + W R II+GIA+GLLYLH SRLRVIHRD
Sbjct: 563 IYEFMVNKSLD--TFLFDS----RKRLEIDWPKRFDIIQGIARGLLYLHHDSRLRVIHRD 616
Query: 291 LKASNILLDKDMNPKISDFGMARMFGGDELQSNTKRIVGTYGYMSPEYALRGLFSIKSDV 350
LK SNILLD+ MNPKISDFG+ARM+ G E Q NT+R+VGT GYMSPEYA G+FS KSD+
Sbjct: 617 LKVSNILLDEKMNPKISDFGLARMYQGTEYQDNTRRVVGTLGYMSPEYAWTGMFSEKSDI 676
Query: 351 FSFGVLLLETLSSKKNTHF-YNTDSLTLLGHAWNLWNDGRTWELMDPISQNGASYPI-LK 408
+SFGVL+LE +S +K + F Y + TL+ +AW W++ R +L+D + +P+ +
Sbjct: 677 YSFGVLMLEIISGEKISRFSYGVEGKTLIAYAWESWSEYRGIDLLDQDLADSC-HPLEVG 735
Query: 409 RYINVALLCVQEKAADRPAMSEVVSMLSNEFVNLPAPQQP--AFSCVNSTNMQSDAFSVN 466
R I + LLCVQ + ADRP E+++ML+ +LP+P+QP AF + ++ +D +VN
Sbjct: 736 RCIQIGLLCVQHQPADRPNTLELLAMLTTTS-DLPSPKQPTFAFHTRDDESLSNDLITVN 794
Query: 467 CVTHSVIDAR 476
+T SVI R
Sbjct: 795 GMTQSVILGR 804
|
|
Prediction of Enzyme Commission (EC) Number
EC Number Prediction by Annotation Transfer from SWISS-PROT Entries
Original result of BLAST against SWISS-PROT
No confident hit for EC number transfering in SWISSPROT detected by BLAST
EC Number Prediction by Ezypred Server
Original result from Ezypred Server
Fail to connect to Ezypred Server
EC Number Prediction by EFICAz Software
| Prediction Level | EC number | Confidence of Prediction |
| 4th Layer | 2.7.11.1 | 0.824 |
| 3rd Layer | 2.7.11 | 0.766 |
Prediction of Functionally Associated Proteins
Functionally Associated Proteins Detected by STRING
Original result from the STRING server
| Your Input: |  |
 |
 |
 |
 |
 |
 |
 |
 |
||
 | GSVIVG00027546001 | SubName- Full=Chromosome chr19 scaffold_4, whole genome shotgun sequence; (992 aa) | |||||||||
(Vitis vinifera) | |||||||||||
Predicted Functional Partners: | |||||||||||
| Sorry, there are no predicted associations at the current settings. | |||||||||||
Conserved Domains and Related Protein Families
Conserved Domains Detected by RPS-BLAST
Original result of RPS-BLAST against CDD database part I
| ID | Alignment Graph | Length |
Definition |
E-value |
| Query | 476 | |||
| pfam01453 | 109 | pfam01453, B_lectin, D-mannose binding lectin | 3e-38 | |
| cd00028 | 116 | cd00028, B_lectin, Bulb-type mannose-specific lect | 3e-36 | |
| smart00108 | 114 | smart00108, B_lectin, Bulb-type mannose-specific l | 9e-34 | |
| cd00180 | 215 | cd00180, PKc, Catalytic domain of Protein Kinases | 1e-27 | |
| smart00221 | 258 | smart00221, STYKc, Protein kinase; unclassified sp | 2e-27 | |
| cd00192 | 262 | cd00192, PTKc, Catalytic domain of Protein Tyrosin | 5e-27 | |
| pfam00069 | 260 | pfam00069, Pkinase, Protein kinase domain | 6e-27 | |
| smart00219 | 257 | smart00219, TyrKc, Tyrosine kinase, catalytic doma | 9e-27 | |
| smart00220 | 254 | smart00220, S_TKc, Serine/Threonine protein kinase | 1e-25 | |
| cd06623 | 264 | cd06623, PKc_MAPKK_plant_like, Catalytic domain of | 7e-23 | |
| pfam07714 | 258 | pfam07714, Pkinase_Tyr, Protein tyrosine kinase | 2e-22 | |
| cd06606 | 260 | cd06606, STKc_MAPKKK, Catalytic domain of the Prot | 3e-21 | |
| cd05123 | 250 | cd05123, STKc_AGC, Catalytic domain of AGC family | 3e-21 | |
| cd08215 | 258 | cd08215, STKc_Nek, Catalytic domain of the Protein | 7e-19 | |
| cd06621 | 287 | cd06621, PKc_MAPKK_Pek1_like, Catalytic domain of | 2e-18 | |
| cd05122 | 253 | cd05122, PKc_STE, Catalytic domain of STE family P | 2e-18 | |
| cd05034 | 261 | cd05034, PTKc_Src_like, Catalytic domain of Src ki | 4e-18 | |
| cd08217 | 265 | cd08217, STKc_Nek2, Catalytic domain of the Protei | 9e-18 | |
| cd05148 | 261 | cd05148, PTKc_Srm_Brk, Catalytic domain of the Pro | 9e-18 | |
| cd05577 | 277 | cd05577, STKc_GRK, Catalytic domain of the Protein | 1e-17 | |
| cd06614 | 286 | cd06614, STKc_PAK, Catalytic domain of the Protein | 1e-17 | |
| cd06627 | 254 | cd06627, STKc_Cdc7_like, Catalytic domain of Cell | 4e-17 | |
| cd06620 | 284 | cd06620, PKc_MAPKK_Byr1_like, Catalytic domain of | 5e-17 | |
| cd06605 | 265 | cd06605, PKc_MAPKK, Catalytic domain of the dual-s | 6e-17 | |
| cd05581 | 280 | cd05581, STKc_PDK1, Catalytic domain of the Protei | 1e-16 | |
| COG0515 | 384 | COG0515, SPS1, Serine/threonine protein kinase [Ge | 1e-16 | |
| cd05038 | 284 | cd05038, PTKc_Jak_rpt2, Catalytic (repeat 2) domai | 3e-16 | |
| cd05578 | 258 | cd05578, STKc_Yank1, Catalytic domain of the Prote | 8e-16 | |
| cd06612 | 256 | cd06612, STKc_MST1_2, Catalytic domain of the Prot | 8e-16 | |
| cd06610 | 267 | cd06610, STKc_OSR1_SPAK, Catalytic domain of the P | 1e-15 | |
| cd06607 | 307 | cd06607, STKc_TAO, Catalytic domain of the Protein | 2e-15 | |
| cd05032 | 277 | cd05032, PTKc_InsR_like, Catalytic domain of Insul | 2e-15 | |
| cd05036 | 277 | cd05036, PTKc_ALK_LTK, Catalytic domain of the Pro | 4e-15 | |
| cd05068 | 261 | cd05068, PTKc_Frk_like, Catalytic domain of Fyn-re | 5e-15 | |
| cd08529 | 256 | cd08529, STKc_FA2-like, Catalytic domain of the Pr | 7e-15 | |
| cd05608 | 280 | cd05608, STKc_GRK1, Catalytic domain of the Protei | 8e-15 | |
| cd05060 | 257 | cd05060, PTKc_Syk_like, Catalytic domain of Spleen | 9e-15 | |
| cd07840 | 287 | cd07840, STKc_CDK9_like, Catalytic domain of Cycli | 1e-14 | |
| cd05579 | 265 | cd05579, STKc_MAST_like, Catalytic domain of Micro | 1e-14 | |
| cd08221 | 256 | cd08221, STKc_Nek9, Catalytic domain of the Protei | 2e-14 | |
| cd05070 | 260 | cd05070, PTKc_Fyn_Yrk, Catalytic domain of the Pro | 3e-14 | |
| cd05069 | 260 | cd05069, PTKc_Yes, Catalytic domain of the Protein | 3e-14 | |
| cd05112 | 256 | cd05112, PTKc_Itk, Catalytic domain of the Protein | 3e-14 | |
| cd05072 | 261 | cd05072, PTKc_Lyn, Catalytic domain of the Protein | 3e-14 | |
| cd05071 | 262 | cd05071, PTKc_Src, Catalytic domain of the Protein | 4e-14 | |
| cd05570 | 318 | cd05570, STKc_PKC, Catalytic domain of the Protein | 4e-14 | |
| cd05587 | 324 | cd05587, STKc_cPKC, Catalytic domain of the Protei | 5e-14 | |
| cd06632 | 258 | cd06632, STKc_MEKK1_plant, Catalytic domain of the | 5e-14 | |
| cd05067 | 260 | cd05067, PTKc_Lck_Blk, Catalytic domain of the Pro | 5e-14 | |
| cd05057 | 279 | cd05057, PTKc_EGFR_like, Catalytic domain of Epide | 6e-14 | |
| cd06630 | 268 | cd06630, STKc_MEKK1, Catalytic domain of the Prote | 8e-14 | |
| cd05059 | 256 | cd05059, PTKc_Tec_like, Catalytic domain of Tec-li | 8e-14 | |
| cd05073 | 260 | cd05073, PTKc_Hck, Catalytic domain of the Protein | 1e-13 | |
| cd05040 | 257 | cd05040, PTKc_Ack_like, Catalytic domain of the Pr | 1e-13 | |
| cd05041 | 251 | cd05041, PTKc_Fes_like, Catalytic domain of Fes-li | 2e-13 | |
| cd07829 | 282 | cd07829, STKc_CDK_like, Catalytic domain of Cyclin | 2e-13 | |
| cd05039 | 256 | cd05039, PTKc_Csk_like, Catalytic domain of C-term | 2e-13 | |
| cd05049 | 280 | cd05049, PTKc_Trk, Catalytic domain of the Protein | 3e-13 | |
| cd05044 | 269 | cd05044, PTKc_c-ros, Catalytic domain of the Prote | 3e-13 | |
| cd05058 | 262 | cd05058, PTKc_Met_Ron, Catalytic domain of the Pro | 3e-13 | |
| cd05033 | 266 | cd05033, PTKc_EphR, Catalytic domain of Ephrin Rec | 4e-13 | |
| cd08220 | 256 | cd08220, STKc_Nek8, Catalytic domain of the Protei | 4e-13 | |
| cd06617 | 283 | cd06617, PKc_MKK3_6, Catalytic domain of the dual- | 5e-13 | |
| cd05048 | 283 | cd05048, PTKc_Ror, Catalytic Domain of the Protein | 5e-13 | |
| PTZ00283 | 496 | PTZ00283, PTZ00283, serine/threonine protein kinas | 5e-13 | |
| cd05113 | 256 | cd05113, PTKc_Btk_Bmx, Catalytic domain of the Pro | 8e-13 | |
| cd05592 | 316 | cd05592, STKc_nPKC_theta_delta, Catalytic domain o | 1e-12 | |
| cd05066 | 267 | cd05066, PTKc_EphR_A, Catalytic domain of the Prot | 2e-12 | |
| cd06633 | 313 | cd06633, STKc_TAO3, Catalytic domain of the Protei | 2e-12 | |
| cd05043 | 280 | cd05043, PTK_Ryk, Pseudokinase domain of Ryk (Rece | 2e-12 | |
| cd06615 | 308 | cd06615, PKc_MEK, Catalytic domain of the dual-spe | 2e-12 | |
| cd06629 | 272 | cd06629, STKc_MAPKKK_Bck1_like, Catalytic domain o | 2e-12 | |
| cd06609 | 274 | cd06609, STKc_MST3_like, Catalytic domain of Mamma | 2e-12 | |
| cd06608 | 275 | cd06608, STKc_myosinIII_like, Catalytic domain of | 2e-12 | |
| cd06625 | 263 | cd06625, STKc_MEKK3_like, Catalytic domain of MAP/ | 3e-12 | |
| cd06628 | 267 | cd06628, STKc_MAPKKK_Byr2_like, Catalytic domain o | 3e-12 | |
| cd05103 | 343 | cd05103, PTKc_VEGFR2, Catalytic domain of the Prot | 3e-12 | |
| cd05095 | 296 | cd05095, PTKc_DDR2, Catalytic domain of the Protei | 4e-12 | |
| cd06642 | 277 | cd06642, STKc_STK25-YSK1, Catalytic domain of the | 4e-12 | |
| cd05083 | 254 | cd05083, PTKc_Chk, Catalytic domain of the Protein | 5e-12 | |
| cd05046 | 275 | cd05046, PTK_CCK4, Pseudokinase domain of the Prot | 5e-12 | |
| cd06619 | 279 | cd06619, PKc_MKK5, Catalytic domain of the dual-sp | 5e-12 | |
| cd05045 | 290 | cd05045, PTKc_RET, Catalytic domain of the Protein | 7e-12 | |
| cd05114 | 256 | cd05114, PTKc_Tec_Rlk, Catalytic domain of the Pro | 7e-12 | |
| cd07832 | 286 | cd07832, STKc_CCRK, Catalytic domain of the Serine | 8e-12 | |
| cd06635 | 317 | cd06635, STKc_TAO1, Catalytic domain of the Protei | 8e-12 | |
| cd05583 | 288 | cd05583, STKc_MSK_N, N-terminal catalytic domain o | 9e-12 | |
| cd05118 | 283 | cd05118, STKc_CMGC, Catalytic domain of CMGC famil | 9e-12 | |
| cd05619 | 316 | cd05619, STKc_nPKC_theta, Catalytic domain of the | 9e-12 | |
| cd07835 | 283 | cd07835, STKc_CDK1_like, Catalytic domain of Cycli | 1e-11 | |
| cd05051 | 296 | cd05051, PTKc_DDR, Catalytic domain of the Protein | 2e-11 | |
| cd05054 | 337 | cd05054, PTKc_VEGFR, Catalytic domain of the Prote | 2e-11 | |
| cd08224 | 267 | cd08224, STKc_Nek6_Nek7, Catalytic domain of the P | 2e-11 | |
| cd06917 | 277 | cd06917, STKc_NAK1_like, Catalytic domain of Funga | 2e-11 | |
| PLN00034 | 353 | PLN00034, PLN00034, mitogen-activated protein kina | 2e-11 | |
| cd05063 | 268 | cd05063, PTKc_EphR_A2, Catalytic domain of the Pro | 2e-11 | |
| cd05110 | 303 | cd05110, PTKc_HER4, Catalytic domain of the Protei | 2e-11 | |
| cd08222 | 260 | cd08222, STKc_Nek11, Catalytic domain of the Prote | 2e-11 | |
| cd06659 | 297 | cd06659, STKc_PAK6, Catalytic domain of the Protei | 2e-11 | |
| cd06634 | 308 | cd06634, STKc_TAO2, Catalytic domain of the Protei | 3e-11 | |
| cd05582 | 318 | cd05582, STKc_RSK_N, N-terminal catalytic domain o | 3e-11 | |
| cd05572 | 262 | cd05572, STKc_cGK_PKG, Catalytic domain of the Pro | 4e-11 | |
| cd06613 | 262 | cd06613, STKc_MAP4K3_like, Catalytic domain of Mit | 4e-11 | |
| cd06611 | 280 | cd06611, STKc_SLK_like, Catalytic domain of Ste20- | 4e-11 | |
| cd05096 | 304 | cd05096, PTKc_DDR1, Catalytic domain of the Protei | 5e-11 | |
| cd06640 | 277 | cd06640, STKc_MST4, Catalytic domain of the Protei | 5e-11 | |
| cd06648 | 285 | cd06648, STKc_PAK_II, Catalytic domain of the Prot | 6e-11 | |
| cd06618 | 296 | cd06618, PKc_MKK7, Catalytic domain of the dual-sp | 7e-11 | |
| cd08229 | 267 | cd08229, STKc_Nek7, Catalytic domain of the Protei | 8e-11 | |
| cd05109 | 279 | cd05109, PTKc_HER2, Catalytic domain of the Protei | 8e-11 | |
| cd05092 | 280 | cd05092, PTKc_TrkA, Catalytic domain of the Protei | 9e-11 | |
| PHA03209 | 357 | PHA03209, PHA03209, serine/threonine kinase US3; P | 9e-11 | |
| cd05620 | 316 | cd05620, STKc_nPKC_delta, Catalytic domain of the | 9e-11 | |
| cd05606 | 278 | cd05606, STKc_beta_ARK, Catalytic domain of the Pr | 1e-10 | |
| cd08528 | 269 | cd08528, STKc_Nek10, Catalytic domain of the Prote | 1e-10 | |
| cd05580 | 290 | cd05580, STKc_PKA, Catalytic domain of the Protein | 1e-10 | |
| cd07860 | 284 | cd07860, STKc_CDK2_3, Catalytic domain of the Seri | 1e-10 | |
| cd05053 | 293 | cd05053, PTKc_FGFR, Catalytic domain of the Protei | 1e-10 | |
| cd07861 | 285 | cd07861, STKc_CDK1_euk, Catalytic domain of the Se | 2e-10 | |
| cd06616 | 288 | cd06616, PKc_MKK4, Catalytic domain of the dual-sp | 2e-10 | |
| cd05050 | 288 | cd05050, PTKc_Musk, Catalytic domain of the Protei | 2e-10 | |
| cd05630 | 285 | cd05630, STKc_GRK6, Catalytic domain of the Protei | 2e-10 | |
| cd05099 | 314 | cd05099, PTKc_FGFR4, Catalytic domain of the Prote | 2e-10 | |
| cd06626 | 264 | cd06626, STKc_MEKK4, Catalytic domain of the Prote | 2e-10 | |
| cd07841 | 298 | cd07841, STKc_CDK7, Catalytic domain of the Serine | 2e-10 | |
| cd05607 | 277 | cd05607, STKc_GRK7, Catalytic domain of the Protei | 2e-10 | |
| cd05062 | 277 | cd05062, PTKc_IGF-1R, Catalytic domain of the Prot | 2e-10 | |
| cd05055 | 302 | cd05055, PTKc_PDGFR, Catalytic domain of the Prote | 2e-10 | |
| cd07862 | 290 | cd07862, STKc_CDK6, Catalytic domain of the Serine | 2e-10 | |
| cd06641 | 277 | cd06641, STKc_MST3, Catalytic domain of the Protei | 2e-10 | |
| cd05091 | 283 | cd05091, PTKc_Ror2, Catalytic domain of the Protei | 2e-10 | |
| cd06650 | 333 | cd06650, PKc_MEK1, Catalytic domain of the dual-sp | 2e-10 | |
| cd05111 | 279 | cd05111, PTK_HER3, Pseudokinase domain of the Prot | 2e-10 | |
| cd06655 | 296 | cd06655, STKc_PAK2, Catalytic domain of the Protei | 2e-10 | |
| cd06647 | 293 | cd06647, STKc_PAK_I, Catalytic domain of the Prote | 3e-10 | |
| cd06649 | 331 | cd06649, PKc_MEK2, Catalytic domain of the dual-sp | 3e-10 | |
| cd08228 | 267 | cd08228, STKc_Nek6, Catalytic domain of the Protei | 3e-10 | |
| cd05102 | 338 | cd05102, PTKc_VEGFR3, Catalytic domain of the Prot | 3e-10 | |
| cd05061 | 288 | cd05061, PTKc_InsR, Catalytic domain of the Protei | 4e-10 | |
| cd05616 | 323 | cd05616, STKc_cPKC_beta, Catalytic domain of the P | 4e-10 | |
| cd06654 | 296 | cd06654, STKc_PAK1, Catalytic domain of the Protei | 4e-10 | |
| cd05116 | 257 | cd05116, PTKc_Syk, Catalytic domain of the Protein | 4e-10 | |
| cd05052 | 263 | cd05052, PTKc_Abl, Catalytic domain of the Protein | 4e-10 | |
| cd05633 | 279 | cd05633, STKc_GRK3, Catalytic domain of the Protei | 4e-10 | |
| cd07843 | 293 | cd07843, STKc_CDC2L1, Catalytic domain of the Seri | 5e-10 | |
| cd08530 | 256 | cd08530, STKc_CNK2-like, Catalytic domain of the P | 5e-10 | |
| cd07853 | 372 | cd07853, STKc_NLK, Catalytic domain of the Serine/ | 5e-10 | |
| cd05106 | 374 | cd05106, PTKc_CSF-1R, Catalytic domain of the Prot | 5e-10 | |
| cd05094 | 291 | cd05094, PTKc_TrkC, Catalytic domain of the Protei | 6e-10 | |
| cd07865 | 310 | cd07865, STKc_CDK9, Catalytic domain of the Serine | 6e-10 | |
| cd05081 | 284 | cd05081, PTKc_Jak2_Jak3_rpt2, Catalytic (repeat 2) | 6e-10 | |
| cd05085 | 250 | cd05085, PTKc_Fer, Catalytic domain of the Protein | 6e-10 | |
| cd05090 | 283 | cd05090, PTKc_Ror1, Catalytic domain of the Protei | 7e-10 | |
| PRK13184 | 932 | PRK13184, pknD, serine/threonine-protein kinase; R | 7e-10 | |
| cd05615 | 323 | cd05615, STKc_cPKC_alpha, Catalytic domain of the | 7e-10 | |
| cd05108 | 316 | cd05108, PTKc_EGFR, Catalytic domain of the Protei | 7e-10 | |
| cd05097 | 295 | cd05097, PTKc_DDR_like, Catalytic domain of Discoi | 9e-10 | |
| cd06656 | 297 | cd06656, STKc_PAK3, Catalytic domain of the Protei | 9e-10 | |
| cd07852 | 337 | cd07852, STKc_MAPK15, Catalytic domain of the Seri | 1e-09 | |
| cd05115 | 257 | cd05115, PTKc_Zap-70, Catalytic domain of the Prot | 1e-09 | |
| cd05080 | 283 | cd05080, PTKc_Tyk2_rpt2, Catalytic (repeat 2) doma | 1e-09 | |
| cd05047 | 270 | cd05047, PTKc_Tie, Catalytic domain of Tie Protein | 1e-09 | |
| cd05590 | 320 | cd05590, STKc_nPKC_eta, Catalytic domain of the Pr | 1e-09 | |
| cd05084 | 252 | cd05084, PTKc_Fes, Catalytic domain of the Protein | 1e-09 | |
| cd08223 | 257 | cd08223, STKc_Nek4, Catalytic domain of the Protei | 1e-09 | |
| cd05098 | 307 | cd05098, PTKc_FGFR1, Catalytic domain of the Prote | 2e-09 | |
| cd05605 | 285 | cd05605, STKc_GRK4_like, Catalytic domain of G pro | 2e-09 | |
| cd08218 | 256 | cd08218, STKc_Nek1, Catalytic domain of the Protei | 2e-09 | |
| cd05573 | 350 | cd05573, STKc_ROCK_NDR_like, Catalytic domain of R | 2e-09 | |
| cd05065 | 269 | cd05065, PTKc_EphR_B, Catalytic domain of the Prot | 2e-09 | |
| cd06624 | 268 | cd06624, STKc_ASK, Catalytic domain of the Protein | 2e-09 | |
| PLN00009 | 294 | PLN00009, PLN00009, cyclin-dependent kinase A; Pro | 2e-09 | |
| cd05089 | 297 | cd05089, PTKc_Tie1, Catalytic domain of the Protei | 2e-09 | |
| cd05104 | 375 | cd05104, PTKc_Kit, Catalytic domain of the Protein | 2e-09 | |
| cd08225 | 257 | cd08225, STKc_Nek5, Catalytic domain of the Protei | 2e-09 | |
| cd05100 | 334 | cd05100, PTKc_FGFR3, Catalytic domain of the Prote | 3e-09 | |
| cd07834 | 330 | cd07834, STKc_MAPK, Catalytic domain of the Serine | 3e-09 | |
| cd05632 | 285 | cd05632, STKc_GRK5, Catalytic domain of the Protei | 3e-09 | |
| cd07866 | 311 | cd07866, STKc_BUR1, Catalytic domain of the Serine | 3e-09 | |
| cd07838 | 287 | cd07838, STKc_CDK4_6_like, Catalytic domain of Cyc | 3e-09 | |
| cd07855 | 334 | cd07855, STKc_ERK5, Catalytic domain of the Serine | 3e-09 | |
| cd05611 | 260 | cd05611, STKc_Rim15_like, Catalytic domain of fung | 4e-09 | |
| cd05107 | 401 | cd05107, PTKc_PDGFR_beta, Catalytic domain of the | 4e-09 | |
| cd05082 | 256 | cd05082, PTKc_Csk, Catalytic domain of the Protein | 4e-09 | |
| cd07851 | 343 | cd07851, STKc_p38, Catalytic domain of the Serine/ | 4e-09 | |
| cd07845 | 309 | cd07845, STKc_CDK10, Catalytic domain of the Serin | 5e-09 | |
| cd06652 | 265 | cd06652, STKc_MEKK2, Catalytic domain of the Prote | 5e-09 | |
| cd07849 | 336 | cd07849, STKc_ERK1_2_like, Catalytic domain of Ext | 6e-09 | |
| cd05591 | 321 | cd05591, STKc_nPKC_epsilon, Catalytic domain of th | 7e-09 | |
| cd05101 | 304 | cd05101, PTKc_FGFR2, Catalytic domain of the Prote | 7e-09 | |
| cd06622 | 286 | cd06622, PKc_MAPKK_PBS2_like, Catalytic domain of | 8e-09 | |
| cd07864 | 302 | cd07864, STKc_CDK12, Catalytic domain of the Serin | 8e-09 | |
| cd05589 | 324 | cd05589, STKc_PKN, Catalytic domain of the Protein | 9e-09 | |
| cd07856 | 328 | cd07856, STKc_Sty1_Hog1, Catalytic domain of the S | 1e-08 | |
| cd06653 | 264 | cd06653, STKc_MEKK3_like_1, Catalytic domain of MA | 1e-08 | |
| cd07857 | 332 | cd07857, STKc_MPK1, Catalytic domain of the Serine | 1e-08 | |
| cd05035 | 273 | cd05035, PTKc_Axl_like, Catalytic Domain of Axl-li | 1e-08 | |
| cd07877 | 345 | cd07877, STKc_p38alpha_MAPK14, Catalytic domain of | 1e-08 | |
| cd05594 | 325 | cd05594, STKc_PKB_alpha, Catalytic domain of the P | 1e-08 | |
| cd05612 | 291 | cd05612, STKc_PRKX_like, Catalytic domain of PRKX- | 1e-08 | |
| cd05597 | 331 | cd05597, STKc_DMPK_like, Catalytic domain of Myoto | 1e-08 | |
| cd05074 | 273 | cd05074, PTKc_Tyro3, Catalytic domain of the Prote | 1e-08 | |
| cd06651 | 266 | cd06651, STKc_MEKK3, Catalytic domain of the Prote | 2e-08 | |
| cd06644 | 292 | cd06644, STKc_STK10_LOK, Catalytic domain of the P | 2e-08 | |
| cd05614 | 332 | cd05614, STKc_MSK2_N, N-terminal catalytic domain | 2e-08 | |
| cd08219 | 255 | cd08219, STKc_Nek3, Catalytic domain of the Protei | 2e-08 | |
| cd05585 | 312 | cd05585, STKc_YPK1_like, Catalytic domain of Yeast | 2e-08 | |
| cd07863 | 288 | cd07863, STKc_CDK4, Catalytic domain of the Serine | 2e-08 | |
| cd05075 | 272 | cd05075, PTKc_Axl, Catalytic domain of the Protein | 2e-08 | |
| cd06658 | 292 | cd06658, STKc_PAK5, Catalytic domain of the Protei | 2e-08 | |
| cd05079 | 284 | cd05079, PTKc_Jak1_rpt2, Catalytic (repeat 2) doma | 3e-08 | |
| cd05088 | 303 | cd05088, PTKc_Tie2, Catalytic domain of the Protei | 3e-08 | |
| cd05093 | 288 | cd05093, PTKc_TrkB, Catalytic domain of the Protei | 3e-08 | |
| cd06639 | 291 | cd06639, STKc_myosinIIIB, Catalytic domain of the | 3e-08 | |
| cd05595 | 323 | cd05595, STKc_PKB_beta, Catalytic domain of the Pr | 4e-08 | |
| cd05593 | 328 | cd05593, STKc_PKB_gamma, Catalytic domain of the P | 5e-08 | |
| cd05571 | 323 | cd05571, STKc_PKB, Catalytic domain of the Protein | 5e-08 | |
| cd07837 | 295 | cd07837, STKc_CdkB_plant, Catalytic domain of the | 6e-08 | |
| cd05613 | 290 | cd05613, STKc_MSK1_N, N-terminal catalytic domain | 6e-08 | |
| cd07830 | 283 | cd07830, STKc_MAK_like, Catalytic domain of Male g | 7e-08 | |
| cd06657 | 292 | cd06657, STKc_PAK4, Catalytic domain of the Protei | 7e-08 | |
| TIGR03903 | 1266 | TIGR03903, TOMM_kin_cyc, TOMM system kinase/cyclas | 7e-08 | |
| cd06637 | 272 | cd06637, STKc_TNIK, Catalytic domain of the Protei | 7e-08 | |
| cd07842 | 316 | cd07842, STKc_CDK8_like, Catalytic domain of Cycli | 8e-08 | |
| cd05631 | 285 | cd05631, STKc_GRK4, Catalytic domain of the Protei | 9e-08 | |
| cd05600 | 333 | cd05600, STKc_Sid2p_Dbf2p, Catalytic domain of Fun | 9e-08 | |
| cd06643 | 282 | cd06643, STKc_SLK, Catalytic domain of the Protein | 9e-08 | |
| PTZ00024 | 335 | PTZ00024, PTZ00024, cyclin-dependent protein kinas | 1e-07 | |
| cd05105 | 400 | cd05105, PTKc_PDGFR_alpha, Catalytic domain of the | 1e-07 | |
| cd06631 | 265 | cd06631, STKc_YSK4, Catalytic domain of the Protei | 1e-07 | |
| cd07850 | 353 | cd07850, STKc_JNK, Catalytic domain of the Serine/ | 1e-07 | |
| cd05584 | 323 | cd05584, STKc_p70S6K, Catalytic domain of the Prot | 1e-07 | |
| cd07836 | 284 | cd07836, STKc_Pho85, Catalytic domain of the Serin | 1e-07 | |
| cd07858 | 337 | cd07858, STKc_TEY_MAPK_plant, Catalytic domain of | 1e-07 | |
| cd05588 | 329 | cd05588, STKc_aPKC, Catalytic domain of the Protei | 2e-07 | |
| PTZ00263 | 329 | PTZ00263, PTZ00263, protein kinase A catalytic sub | 2e-07 | |
| PTZ00267 | 478 | PTZ00267, PTZ00267, NIMA-related protein kinase; P | 2e-07 | |
| cd07839 | 284 | cd07839, STKc_CDK5, Catalytic domain of the Serine | 2e-07 | |
| PTZ00426 | 340 | PTZ00426, PTZ00426, cAMP-dependent protein kinase | 2e-07 | |
| cd05624 | 331 | cd05624, STKc_MRCK_beta, Catalytic domain of the P | 2e-07 | |
| cd05618 | 329 | cd05618, STKc_aPKC_iota, Catalytic domain of the P | 3e-07 | |
| cd05575 | 323 | cd05575, STKc_SGK, Catalytic domain of the Protein | 3e-07 | |
| cd05617 | 327 | cd05617, STKc_aPKC_zeta, Catalytic domain of the P | 4e-07 | |
| PHA03207 | 392 | PHA03207, PHA03207, serine/threonine kinase US3; P | 4e-07 | |
| cd07878 | 343 | cd07878, STKc_p38beta_MAPK11, Catalytic domain of | 4e-07 | |
| cd07847 | 286 | cd07847, STKc_CDKL1_4, Catalytic domain of the Ser | 5e-07 | |
| cd05586 | 330 | cd05586, STKc_Sck1_like, Catalytic domain of Suppr | 5e-07 | |
| cd06638 | 286 | cd06638, STKc_myosinIIIA, Catalytic domain of the | 5e-07 | |
| cd05609 | 305 | cd05609, STKc_MAST, Catalytic domain of the Protei | 7e-07 | |
| cd06646 | 267 | cd06646, STKc_MAP4K5, Catalytic domain of the Prot | 8e-07 | |
| cd05596 | 370 | cd05596, STKc_ROCK, Catalytic domain of the Protei | 8e-07 | |
| cd07880 | 343 | cd07880, STKc_p38gamma_MAPK12, Catalytic domain of | 9e-07 | |
| cd07868 | 317 | cd07868, STKc_CDK8, Catalytic domain of the Serine | 1e-06 | |
| PLN00113 | 968 | PLN00113, PLN00113, leucine-rich repeat receptor-l | 1e-06 | |
| cd06645 | 267 | cd06645, STKc_MAP4K3, Catalytic domain of the Prot | 1e-06 | |
| cd05603 | 321 | cd05603, STKc_SGK2, Catalytic domain of the Protei | 1e-06 | |
| cd07859 | 338 | cd07859, STKc_TDY_MAPK_plant, Catalytic domain of | 1e-06 | |
| cd06636 | 282 | cd06636, STKc_MAP4K4_6, Catalytic domain of the Pr | 2e-06 | |
| cd07874 | 355 | cd07874, STKc_JNK3, Catalytic domain of the Serine | 2e-06 | |
| cd07875 | 364 | cd07875, STKc_JNK1, Catalytic domain of the Serine | 2e-06 | |
| cd07833 | 288 | cd07833, STKc_CDKL, Catalytic domain of Cyclin-Dep | 2e-06 | |
| PHA03210 | 501 | PHA03210, PHA03210, serine/threonine kinase US3; P | 2e-06 | |
| cd05601 | 330 | cd05601, STKc_CRIK, Catalytic domain of the Protei | 3e-06 | |
| cd07876 | 359 | cd07876, STKc_JNK2, Catalytic domain of the Serine | 3e-06 | |
| cd07879 | 342 | cd07879, STKc_p38delta_MAPK13, Catalytic domain of | 4e-06 | |
| cd05602 | 325 | cd05602, STKc_SGK1, Catalytic domain of the Protei | 4e-06 | |
| cd07854 | 342 | cd07854, STKc_MAPK4_6, Catalytic domain of the Ser | 4e-06 | |
| cd05621 | 370 | cd05621, STKc_ROCK2, Catalytic domain of the Prote | 5e-06 | |
| cd05604 | 325 | cd05604, STKc_SGK3, Catalytic domain of the Protei | 5e-06 | |
| cd05599 | 364 | cd05599, STKc_NDR_like, Catalytic domain of Nuclea | 6e-06 | |
| cd05056 | 270 | cd05056, PTKc_FAK, Catalytic domain of the Protein | 6e-06 | |
| cd05064 | 266 | cd05064, PTKc_EphR_A10, Catalytic domain of the Pr | 8e-06 | |
| cd05598 | 376 | cd05598, STKc_LATS, Catalytic domain of the Protei | 8e-06 | |
| cd05622 | 371 | cd05622, STKc_ROCK1, Catalytic domain of the Prote | 1e-05 | |
| cd05626 | 381 | cd05626, STKc_LATS2, Catalytic domain of the Prote | 1e-05 | |
| cd05629 | 377 | cd05629, STKc_NDR_like_fungal, Catalytic domain of | 1e-05 | |
| cd07867 | 317 | cd07867, STKc_CDC2L6, Catalytic domain of Serine/T | 1e-05 | |
| cd05623 | 332 | cd05623, STKc_MRCK_alpha, Catalytic domain of the | 2e-05 | |
| PTZ00266 | 1021 | PTZ00266, PTZ00266, NIMA-related protein kinase; P | 2e-05 | |
| cd05625 | 382 | cd05625, STKc_LATS1, Catalytic domain of the Prote | 4e-05 | |
| PHA03212 | 391 | PHA03212, PHA03212, serine/threonine kinase US3; P | 4e-05 | |
| cd07848 | 287 | cd07848, STKc_CDKL5, Catalytic domain of the Serin | 5e-05 | |
| cd07831 | 282 | cd07831, STKc_MOK, Catalytic domain of the Serine/ | 5e-05 | |
| cd08216 | 314 | cd08216, PK_STRAD, Pseudokinase domain of STE20-re | 1e-04 | |
| cd07872 | 309 | cd07872, STKc_PCTAIRE2, Catalytic domain of the Se | 1e-04 | |
| cd07844 | 291 | cd07844, STKc_PCTAIRE_like, Catalytic domain of PC | 2e-04 | |
| cd05042 | 269 | cd05042, PTKc_Aatyk, Catalytic domain of the Prote | 2e-04 | |
| cd05610 | 669 | cd05610, STKc_MASTL, Catalytic domain of the Prote | 2e-04 | |
| cd07873 | 301 | cd07873, STKc_PCTAIRE1, Catalytic domain of the Se | 4e-04 | |
| cd07870 | 291 | cd07870, STKc_PFTAIRE2, Catalytic domain of the Se | 4e-04 | |
| PHA03390 | 267 | PHA03390, pk1, serine/threonine-protein kinase 1; | 6e-04 | |
| cd05628 | 363 | cd05628, STKc_NDR1, Catalytic domain of the Protei | 9e-04 | |
| cd07846 | 286 | cd07846, STKc_CDKL2_3, Catalytic domain of the Ser | 0.001 | |
| cd07871 | 288 | cd07871, STKc_PCTAIRE3, Catalytic domain of the Se | 0.002 | |
| pfam11883 | 48 | pfam11883, DUF3403, Domain of unknown function (DU | 0.002 | |
| cd05627 | 360 | cd05627, STKc_NDR2, Catalytic domain of the Protei | 0.002 | |
| cd05120 | 155 | cd05120, APH_ChoK_like, Aminoglycoside 3'-phosphot | 0.002 | |
| PTZ00284 | 467 | PTZ00284, PTZ00284, protein kinase; Provisional | 0.002 | |
| cd07869 | 303 | cd07869, STKc_PFTAIRE1, Catalytic domain of the Se | 0.003 |
| >gnl|CDD|216511 pfam01453, B_lectin, D-mannose binding lectin | Back alignment and domain information |
|---|
Score = 134 bits (340), Expect = 3e-38
Identities = 54/115 (46%), Positives = 70/115 (60%), Gaps = 6/115 (5%)
Query: 71 PDTVVWVANRNSPIFNPNTALTFSNNGNLVLLSQRNGIIWSSNMSRKAENPIAQLLDTGN 130
TVVWVANR +P+ + + L ++GNLVL ++WSSN S K +A L D GN
Sbjct: 1 NQTVVWVANRLNPLTDSSYTLILQSDGNLVLYDGNGRVVWSSNTSGKGSGCVAVLQDDGN 60
Query: 131 LVIRDNSSGHTTESYLWQSFDYPTDSLLEGMKLGWDLKNGLERYLSSWESTDDPS 185
LV+ DNS LWQSFD+PTD+LL G K G ++ G R L+SW+S DPS
Sbjct: 61 LVLYDNSG-----KVLWQSFDHPTDTLLPGQKDG-NVVIGGSRRLTSWKSNTDPS 109
|
These proteins include mannose-specific lectins from plants as well as bacteriocins from bacteria. Length = 109 |
| >gnl|CDD|237995 cd00028, B_lectin, Bulb-type mannose-specific lectin | Back alignment and domain information |
|---|
Score = 129 bits (327), Expect = 3e-36
Identities = 51/119 (42%), Positives = 68/119 (57%), Gaps = 6/119 (5%)
Query: 35 IRDGEKLVSSSQRFELGFFSPRNSKNRYLGVWYKKIPDTVVWVANRNSPIFNPNTALTFS 94
+ G+ LVSS FELGFF Y + YK TVVWVANR++P + LT
Sbjct: 4 LSSGQTLVSSGSLFELGFFKLIMQSRDYNLILYKGSSRTVVWVANRDNPS-GSSCTLTLQ 62
Query: 95 NNGNLVLLSQRNGIIWSSNMSRKAENPIAQLLDTGNLVIRDNSSGHTTESYLWQSFDYP 153
++GNLV+ ++WSSN +R N + LLD GNLV+ D+ ++LWQSFDYP
Sbjct: 63 SDGNLVIYDGSGTVVWSSNTTRVNGNYVLVLLDDGNLVLYDSD-----GNFLWQSFDYP 116
|
The domain contains a three-fold internal repeat (beta-prism architecture). The consensus sequence motif QXDXNXVXY is involved in alpha-D-mannose recognition. Lectins are carbohydrate-binding proteins which specifically recognize diverse carbohydrates and mediate a wide variety of biological processes, such as cell-cell and host-pathogen interactions, serum glycoprotein turnover, and innate immune responses. Length = 116 |
| >gnl|CDD|214519 smart00108, B_lectin, Bulb-type mannose-specific lectin | Back alignment and domain information |
|---|
Score = 122 bits (309), Expect = 9e-34
Identities = 52/118 (44%), Positives = 71/118 (60%), Gaps = 7/118 (5%)
Query: 35 IRDGEKLVSSSQRFELGFFSPRNSKNRYLGVWYKKIPDTVVWVANRNSPIFNPNTALTFS 94
+ G+ LVS + FELGFF+ +N Y + YK TVVWVANR++P+ + T LT
Sbjct: 4 LSSGQTLVSGNSLFELGFFTL-IMQNDYNLILYKSSSRTVVWVANRDNPVSDSCT-LTLQ 61
Query: 95 NNGNLVLLSQRNGIIWSSNMSRKAENPIAQLLDTGNLVIRDNSSGHTTESYLWQSFDY 152
++GNLVL ++WSSN + N + LLD GNLVI D+ ++LWQSFDY
Sbjct: 62 SDGNLVLYDGDGRVVWSSNTTGANGNYVLVLLDDGNLVIYDSDG-----NFLWQSFDY 114
|
Length = 114 |
| >gnl|CDD|173623 cd00180, PKc, Catalytic domain of Protein Kinases | Back alignment and domain information |
|---|
Score = 109 bits (274), Expect = 1e-27
Identities = 47/107 (43%), Positives = 65/107 (60%), Gaps = 7/107 (6%)
Query: 255 KKGLLCWGTRVRIIEGIAQGLLYLHQYSRLRVIHRDLKASNILLDKD-MNPKISDFGMAR 313
+G L +RI+ I +GL YLH +IHRDLK NILLD D K++DFG+++
Sbjct: 85 NEGKLSEDEILRILLQILEGLEYLHS---NGIIHRDLKPENILLDSDNGKVKLADFGLSK 141
Query: 314 MFGGDELQSNTKRIVGTYGYMSPEYAL-RGLFSIKSDVFSFGVLLLE 359
+ D+ T IVGT YM+PE L +G +S KSD++S GV+L E
Sbjct: 142 LLTSDKSLLKT--IVGTPAYMAPEVLLGKGYYSEKSDIWSLGVILYE 186
|
Protein Kinases (PKs), catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The PK family is part of a larger superfamily that includes the catalytic domains of RIO kinases, aminoglycoside phosphotransferase, choline kinase, phosphoinositide 3-kinase (PI3K), and actin-fragmin kinase. PKs make up a large family of serine/threonine kinases, protein tyrosine kinases (PTKs), and dual-specificity PKs that phosphorylate both serine/threonine and tyrosine residues of target proteins. Majority of protein phosphorylation, about 95%, occurs on serine residues while only 1% occurs on tyrosine residues. Protein phosphorylation is a mechanism by which a wide variety of cellular proteins, such as enzymes and membrane channels, are reversibly regulated in response to certain stimuli. PKs often function as components of signal transduction pathways in which one kinase activates a second kinase, which in turn, may act on other kinases; this sequential action transmits a signal from the cell surface to target proteins, which results in cellular responses. The PK family is one of the largest known protein families with more than 100 homologous yeast enzymes and 550 human proteins. A fraction of PK family members are pseudokinases that lack crucial residues for catalytic activity. The mutiplicity of kinases allows for specific regulation according to substrate, tissue distribution, and cellular localization. PKs regulate many cellular processes including proliferation, division, differentiation, motility, survival, metabolism, cell-cycle progression, cytoskeletal rearrangement, immunity, and neuronal functions. Many kinases are implicated in the development of various human diseases including different types of cancer. Length = 215 |
| >gnl|CDD|214568 smart00221, STYKc, Protein kinase; unclassified specificity | Back alignment and domain information |
|---|
Score = 109 bits (276), Expect = 2e-27
Identities = 53/194 (27%), Positives = 80/194 (41%), Gaps = 42/194 (21%)
Query: 254 TKKGLLCWGTRVRIIEGIAQGLLYLHQYSRLRVIHRDLKASNILLDKDMNPKISDFGMAR 313
+ L + IA+G+ YL IHRDL A N L+ +++ KISDFG++R
Sbjct: 95 NRPKELSLSDLLSFALQIARGMEYLE---SKNFIHRDLAARNCLVGENLVVKISDFGLSR 151
Query: 314 -MFGGDELQSNTKRIVGTYGYMSPEYALRGLFSIKSDVFSFGVLLLETLSSKKNTHFYNT 372
++ D + ++ +M+PE G F+ KSDV+SFGVLL
Sbjct: 152 DLYDDDYYKVKGGKL--PIRWMAPESLKEGKFTSKSDVWSFGVLL--------------- 194
Query: 373 DSLTLLGHAWNLWNDGRT-WELMDPIS-----QNGASYPI-----LKRYINVALLCVQEK 421
W ++ G + M + G P + Y + L C E
Sbjct: 195 ---------WEIFTLGEEPYPGMSNAEVLEYLKKGYRLPKPPNCPPELY-KLMLQCWAED 244
Query: 422 AADRPAMSEVVSML 435
DRP SE+V +L
Sbjct: 245 PEDRPTFSELVEIL 258
|
Phosphotransferases. The specificity of this class of kinases can not be predicted. Possible dual-specificity Ser/Thr/Tyr kinase. Length = 258 |
| >gnl|CDD|173624 cd00192, PTKc, Catalytic domain of Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 108 bits (273), Expect = 5e-27
Identities = 56/210 (26%), Positives = 82/210 (39%), Gaps = 65/210 (30%)
Query: 250 YNNPTKKGLLCWGTRVRIIEGIAQGLLYLHQYSRLRVIHRDLKASNILLDKDMNPKISDF 309
+K L + IA+G+ YL + +HRDL A N L+ +D+ KISDF
Sbjct: 93 VFPSPEKSTLSLKDLLSFAIQIAKGMEYLAS---KKFVHRDLAARNCLVGEDLVVKISDF 149
Query: 310 GMAR-MFGGDELQSNTKRIVGTYGYMSPEYALRGLFSIKSDVFSFGVLLLETLSSKKNTH 368
G++R ++ D + T + +M+PE G+F+ KSDV+SFGVLL
Sbjct: 150 GLSRDVYDDDYYRKKTGGKLPIR-WMAPESLKDGIFTSKSDVWSFGVLL----------- 197
Query: 369 FYNTDSLTLLGHAWNLWNDGRTWELMDPISQNGAS-YP------ILKRYIN--------- 412
WE+ GA+ YP +L+
Sbjct: 198 ----------------------WEIFT----LGATPYPGLSNEEVLEYLRKGYRLPKPEY 231
Query: 413 -------VALLCVQEKAADRPAMSEVVSML 435
+ L C Q DRP SE+V L
Sbjct: 232 CPDELYELMLSCWQLDPEDRPTFSELVERL 261
|
Protein Tyrosine Kinase (PTK) family, catalytic domain. This PTKc family is part of a larger superfamily that includes the catalytic domains of protein serine/threonine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. They can be classified into receptor and non-receptor tyr kinases. PTKs play important roles in many cellular processes including, lymphocyte activation, epithelium growth and maintenance, metabolism control, organogenesis regulation, survival, proliferation, differentiation, migration, adhesion, motility, and morphogenesis. Receptor tyr kinases (RTKs) are integral membrane proteins which contain an extracellular ligand-binding region, a transmembrane segment, and an intracellular tyr kinase domain. RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain, leading to intracellular signaling. Some RTKs are orphan receptors with no known ligands. Non-receptor (or cytoplasmic) tyr kinases are distributed in different intracellular compartments and are usually multi-domain proteins containing a catalytic tyr kinase domain as well as various regulatory domains such as SH3 and SH2. PTKs are usually autoinhibited and require a mechanism for activation. In many PTKs, the phosphorylation of tyr residues in the activation loop is essential for optimal activity. Aberrant expression of PTKs is associated with many development abnormalities and cancers. Length = 262 |
| >gnl|CDD|215690 pfam00069, Pkinase, Protein kinase domain | Back alignment and domain information |
|---|
Score = 108 bits (273), Expect = 6e-27
Identities = 48/126 (38%), Positives = 65/126 (51%), Gaps = 8/126 (6%)
Query: 254 TKKGLLCWGTRVRIIEGIAQGLLYLHQYSRLRVIHRDLKASNILLDKDMNPKISDFGMAR 313
++ G L +I I +GL YLH +IHRDLK NILLD++ KI+DFG+A+
Sbjct: 90 SRGGPLSEDEAKKIALQILRGLEYLH---SNGIIHRDLKPENILLDENGVVKIADFGLAK 146
Query: 314 MFGGDELQSNTKRIVGTYGYMSPEYALRGL-FSIKSDVFSFGVLLLETLSSKKNTHFYNT 372
S+ VGT YM+PE L G + K DV+S GV+L E L+ F
Sbjct: 147 KLLKS--SSSLTTFVGTPWYMAPEVLLGGNGYGPKVDVWSLGVILYELLT--GKPPFSGE 202
Query: 373 DSLTLL 378
+ L L
Sbjct: 203 NILDQL 208
|
Length = 260 |
| >gnl|CDD|197581 smart00219, TyrKc, Tyrosine kinase, catalytic domain | Back alignment and domain information |
|---|
Score = 108 bits (271), Expect = 9e-27
Identities = 55/194 (28%), Positives = 81/194 (41%), Gaps = 44/194 (22%)
Query: 255 KKGLLCWGTRVRIIEGIAQGLLYLHQYSRLRVIHRDLKASNILLDKDMNPKISDFGMARM 314
+ L + IA+G+ YL IHRDL A N L+ +++ KISDFG++R
Sbjct: 95 NRPKLSLSDLLSFALQIARGMEYLE---SKNFIHRDLAARNCLVGENLVVKISDFGLSRD 151
Query: 315 FGGDEL--QSNTKRIVGTYGYMSPEYALRGLFSIKSDVFSFGVLLLETLSSKKNTHFYNT 372
D+ + K + +M+PE G F+ KSDV+SFGVLL
Sbjct: 152 LYDDDYYRKRGGKLPI---RWMAPESLKEGKFTSKSDVWSFGVLL--------------- 193
Query: 373 DSLTLLGHAWNLWNDGRT-WELMDPIS-----QNGASYPI-----LKRYINVALLCVQEK 421
W ++ G + M +NG P + Y ++ L C E
Sbjct: 194 ---------WEIFTLGEQPYPGMSNEEVLEYLKNGYRLPQPPNCPPELY-DLMLQCWAED 243
Query: 422 AADRPAMSEVVSML 435
DRP SE+V +L
Sbjct: 244 PEDRPTFSELVEIL 257
|
Phosphotransferases. Tyrosine-specific kinase subfamily. Length = 257 |
| >gnl|CDD|214567 smart00220, S_TKc, Serine/Threonine protein kinases, catalytic domain | Back alignment and domain information |
|---|
Score = 104 bits (263), Expect = 1e-25
Identities = 37/89 (41%), Positives = 49/89 (55%), Gaps = 6/89 (6%)
Query: 271 IAQGLLYLHQYSRLRVIHRDLKASNILLDKDMNPKISDFGMARMFGGDELQSNTKRIVGT 330
I L YLH ++HRDLK NILLD+D + K++DFG+AR E VGT
Sbjct: 106 ILSALEYLHS---KGIVHRDLKPENILLDEDGHVKLADFGLARQLDPGEK---LTTFVGT 159
Query: 331 YGYMSPEYALRGLFSIKSDVFSFGVLLLE 359
YM+PE L + D++S GV+L E
Sbjct: 160 PEYMAPEVLLGKGYGKAVDIWSLGVILYE 188
|
Phosphotransferases. Serine or threonine-specific kinase subfamily. Length = 254 |
| >gnl|CDD|132954 cd06623, PKc_MAPKK_plant_like, Catalytic domain of Plant dual-specificity MAP kinase kinases and similar proteins | Back alignment and domain information |
|---|
Score = 97.3 bits (243), Expect = 7e-23
Identities = 51/179 (28%), Positives = 82/179 (45%), Gaps = 34/179 (18%)
Query: 271 IAQGLLYLHQYSRLRVIHRDLKASNILLDKDMNPKISDFGMARMFGGDELQSNTKRIVGT 330
I +GL YLH + +IHRD+K SN+L++ KI+DFG++++ Q NT VGT
Sbjct: 108 ILKGLDYLHT--KRHIIHRDIKPSNLLINSKGEVKIADFGISKVLENTLDQCNT--FVGT 163
Query: 331 YGYMSPEYALRGLFSIKSDVFSFGVLLLETLSSKKNTHFYNTDSLTLLGHAWNLWNDGRT 390
YMSPE +S +D++S G+ LLE K +
Sbjct: 164 VTYMSPERIQGESYSYAADIWSLGLTLLECALGK---------------FPFLPPGQPSF 208
Query: 391 WELMDPISQNGASYPI--------LKRYINVALLCVQEKAADRPAMSEVVSMLSNEFVN 441
+ELM I +G + + +I+ C+Q+ RP+ +E +L + F+
Sbjct: 209 FELMQAI-CDGPPPSLPAEEFSPEFRDFIS---ACLQKDPKKRPSAAE---LLQHPFIK 260
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, Plant MAPKKs and similar proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include MAPKKs from plants, kinetoplastids, alveolates, and mycetozoa. The MAPKK, LmxPK4, from Leishmania mexicana, is important in differentiation and virulence. Dictyostelium discoideum MEK1 is required for proper chemotaxis. MEK1 null mutants display severe defects in cell polarization and directional movement. Plants contain multiple MAPKKs like other eukaryotes. The Arabidopsis genome encodes for 10 MAPKKs while poplar and rice contain 13 MAPKKs each. The functions of these proteins have not been fully elucidated. There is evidence to suggest that MAPK cascades are involved in plant stress responses. In Arabidopsis, MKK3 plays a role in pathogen signaling, MKK2 is involved in cold and salt stress signaling, MKK4/MKK5 participates in innate immunity, and MKK7 regulates basal and systemic acquired resistance. Length = 264 |
| >gnl|CDD|219530 pfam07714, Pkinase_Tyr, Protein tyrosine kinase | Back alignment and domain information |
|---|
Score = 95.6 bits (239), Expect = 2e-22
Identities = 52/199 (26%), Positives = 77/199 (38%), Gaps = 51/199 (25%)
Query: 254 TKKGLLCWGTRVRIIEGIAQGLLYLHQYSRLRVIHRDLKASNILLDKDMNPKISDFGMAR 313
L +++ IA+G+ YL +HRDL A N L+ +++ KISDFG++R
Sbjct: 94 KHGEKLTLKDLLQMALQIAKGMEYLE---SKNFVHRDLAARNCLVTENLVVKISDFGLSR 150
Query: 314 MFGGDELQSNTKRIVGTYG---YMSPEYALRGLFSIKSDVFSFGVLLLETLS-------S 363
D+ ++ G +M+PE G F+ KSDV+SFGVLL E +
Sbjct: 151 DIYEDD---YYRKRGGGKLPIKWMAPESLKDGKFTSKSDVWSFGVLLWEIFTLGEQPYPG 207
Query: 364 KKNTHFYNTDSLTLLGHAWNLWNDGR-------TWELMDPISQNGASYPILKRYINVALL 416
N L + R EL Y ++ +
Sbjct: 208 MSNEEVLE-----------LLEDGYRLPRPENCPDEL----------YELMLQ------- 239
Query: 417 CVQEKAADRPAMSEVVSML 435
C DRP SE+V L
Sbjct: 240 CWAYDPEDRPTFSELVEDL 258
|
Length = 258 |
| >gnl|CDD|173724 cd06606, STKc_MAPKKK, Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-Activated Protein Kinase Kinase Kinase | Back alignment and domain information |
|---|
Score = 92.6 bits (231), Expect = 3e-21
Identities = 33/94 (35%), Positives = 52/94 (55%), Gaps = 3/94 (3%)
Query: 271 IAQGLLYLHQYSRLRVIHRDLKASNILLDKDMNPKISDFGMARMFGGDELQSNTKRIVGT 330
I +GL YLH ++HRD+K +NIL+D D K++DFG A+ G E T + GT
Sbjct: 110 ILEGLAYLH---SNGIVHRDIKGANILVDSDGVVKLADFGCAKRLGDIETGEGTGSVRGT 166
Query: 331 YGYMSPEYALRGLFSIKSDVFSFGVLLLETLSSK 364
+M+PE + +D++S G ++E + K
Sbjct: 167 PYWMAPEVIRGEEYGRAADIWSLGCTVIEMATGK 200
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKKKs (MKKKs or MAP3Ks) are also called MAP/ERK kinase kinases (MEKKs) in some cases. They phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. This subfamily is composed of the Apoptosis Signal-regulating Kinases ASK1 (or MAPKKK5) and ASK2 (or MAPKKK6), MEKK1, MEKK2, MEKK3, MEKK4, as well as plant and fungal MAPKKKs. Also included in this subfamily are the cell division control proteins Schizosaccharomyces pombe Cdc7 and Saccharomyces cerevisiae Cdc15. Length = 260 |
| >gnl|CDD|173660 cd05123, STKc_AGC, Catalytic domain of AGC family Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 92.2 bits (230), Expect = 3e-21
Identities = 42/104 (40%), Positives = 57/104 (54%), Gaps = 7/104 (6%)
Query: 271 IAQGLLYLHQYSRLRVIHRDLKASNILLDKDMNPKISDFGMARMFGGDELQSNTKRIVGT 330
I L YLH L +I+RDLK NILLD D + K++DFG+A+ + ++NT GT
Sbjct: 102 IVLALEYLH---SLGIIYRDLKPENILLDADGHIKLTDFGLAKELSSEGSRTNT--FCGT 156
Query: 331 YGYMSPEYALRGLFSIKSDVFSFGVLLLETLSSKKNTHFYNTDS 374
Y++PE L + D +S GVLL E L+ K FY D
Sbjct: 157 PEYLAPEVLLGKGYGKAVDWWSLGVLLYEMLTGK--PPFYAEDR 198
|
Serine/Threonine Kinases (STKs), AGC (Protein Kinases A, G and C) family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The AGC family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and Phosphoinositide 3-Kinase (PI3K). Members of this family include cAMP-dependent Protein Kinase (PKA), cGMP-dependent Protein Kinase (PKG), Protein Kinase C (PKC), Protein Kinase B (PKB), G protein-coupled Receptor Kinase (GRK), Serum- and Glucocorticoid-induced Kinase (SGK), and 70 kDa ribosomal Protein S6 Kinase (p70S6K or S6K), among others. AGC kinases share an activation mechanism based on the phosphorylation of up to three sites: the activation loop (A-loop), the hydrophobic motif (HM) and the turn motif. Phosphorylation at the A-loop is required of most AGC kinases, which results in a disorder-to-order transition of the A-loop. The ordered conformation results in the access of substrates and ATP to the active site. A subset of AGC kinases with C-terminal extensions containing the HM also requires phosphorylation at this site. Phosphorylation at the HM allows the C-terminal extension to form an ordered structure that packs into the hydrophobic pocket of the catalytic domain, which then reconfigures the kinase into an active bi-lobed state. In addition, growth factor-activated AGC kinases such as PKB, p70S6K, RSK, MSK, PKC, and SGK, require phosphorylation at the turn motif (also called tail or zipper site), located N-terminal to the HM at the C-terminal extension. AGC kinases regulate many cellular processes including division, growth, survival, metabolism, motility, and differentiation. Many are implicated in the development of various human diseases. Length = 250 |
| >gnl|CDD|173755 cd08215, STKc_Nek, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase | Back alignment and domain information |
|---|
Score = 85.6 bits (213), Expect = 7e-19
Identities = 32/89 (35%), Positives = 51/89 (57%), Gaps = 5/89 (5%)
Query: 271 IAQGLLYLHQYSRLRVIHRDLKASNILLDKDMNPKISDFGMARMFGGDELQSNTKRIVGT 330
+ L YLH SR +++HRD+K NI L + K+ DFG++++ + T +VGT
Sbjct: 112 LCLALKYLH--SR-KILHRDIKPQNIFLTSNGLVKLGDFGISKVLSSTVDLAKT--VVGT 166
Query: 331 YGYMSPEYALRGLFSIKSDVFSFGVLLLE 359
Y+SPE ++ KSD++S G +L E
Sbjct: 167 PYYLSPELCQNKPYNYKSDIWSLGCVLYE 195
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase (Nek) family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The Nek family is composed of 11 different mammalian members (Nek1-11) with similarity to the catalytic domain of Aspergillus nidulans NIMA kinase, the founding member of the Nek family which was identified in a screen for cell cycle mutants that were prevented from entering mitosis. Neks contain a conserved N-terminal catalytic domain and a more divergent C-terminal regulatory region of various sizes and structures. They are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. Length = 258 |
| >gnl|CDD|132952 cd06621, PKc_MAPKK_Pek1_like, Catalytic domain of fungal Pek1-like dual-specificity MAP kinase kinases | Back alignment and domain information |
|---|
Score = 85.2 bits (211), Expect = 2e-18
Identities = 44/112 (39%), Positives = 62/112 (55%), Gaps = 10/112 (8%)
Query: 250 YNNPTKKGLLCWGTRV--RIIEGIAQGLLYLHQYSRLRVIHRDLKASNILLDKDMNPKIS 307
Y K+G G +V +I E + +GL YLH ++IHRD+K SNILL + K+
Sbjct: 92 YKKVKKRGGRI-GEKVLGKIAESVLKGLSYLHSR---KIIHRDIKPSNILLTRKGQVKLC 147
Query: 308 DFGMARMFGGDELQSNTKRIVGTYGYMSPEYALRGLFSIKSDVFSFGVLLLE 359
DFG++ G+ + S GT YM+PE +SI SDV+S G+ LLE
Sbjct: 148 DFGVS----GELVNSLAGTFTGTSFYMAPERIQGKPYSITSDVWSLGLTLLE 195
|
Protein kinases (PKs), MAP kinase kinase(MAPKK) subfamily, fungal Pek1-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include the MAPKKs Pek1/Skh1 from Schizosaccharomyces pombe and MKK2 from Saccharomyces cerevisiae, and related proteins. Both fission yeast Pek1 and baker's yeast MKK2 are components of the cell integrity MAPK pathway. In fission yeast, Pek1 phosphorylates and activates the MAPK Pmk1/Spm1 and is regulated by the MAPKKK Mkh1. In baker's yeast, the pathway involves the MAPK Slt2, the MAPKKs MKK1 and MKK2, and the MAPKKK Bck1. The cell integrity MAPK cascade is activated by multiple stress conditions, and is essential in cell wall construction, morphogenesis, cytokinesis, and ion homeostasis. Length = 287 |
| >gnl|CDD|173659 cd05122, PKc_STE, Catalytic domain of STE family Protein Kinases | Back alignment and domain information |
|---|
Score = 84.2 bits (209), Expect = 2e-18
Identities = 31/93 (33%), Positives = 50/93 (53%), Gaps = 6/93 (6%)
Query: 267 IIEGIAQGLLYLHQYSRLRVIHRDLKASNILLDKDMNPKISDFGMARMFGGDELQSNTKR 326
+ + + +GL YLH +IHRD+KA+NILL D K+ DFG++
Sbjct: 103 VCKELLKGLEYLHSN---GIIHRDIKAANILLTSDGEVKLIDFGLSAQL---SDTKARNT 156
Query: 327 IVGTYGYMSPEYALRGLFSIKSDVFSFGVLLLE 359
+VGT +M+PE + K+D++S G+ +E
Sbjct: 157 MVGTPYWMAPEVINGKPYDYKADIWSLGITAIE 189
|
Protein Kinases (PKs), STE family, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The STE family is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases (STKs), protein tyrosine kinases (PTKs), RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). This family is composed of STKs, and some dual-specificity PKs that phosphorylate both threonine and tyrosine residues of target proteins. Most members are kinases involved in mitogen-activated protein kinase (MAPK) signaling cascades, acting as MAPK kinases (MAPKKs), MAPK kinase kinases (MAPKKKs), or MAPK kinase kinase kinases (MAP4Ks). The MAPK signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAPK, which is phosphorylated and activated by a MAPKK, which itself is phosphorylated and activated by a MAPKKK. Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAPKKK to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. Other STE family members include p21-activated kinases (PAKs) and class III myosins, among others. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain, which can phosphorylate several cytoskeletal proteins, conventional myosin regulatory light chains, as well as autophosphorylate the C-terminal motor domain. They play an important role in maintaining the structural integrity of photoreceptor cell microvilli. Length = 253 |
| >gnl|CDD|173626 cd05034, PTKc_Src_like, Catalytic domain of Src kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 83.5 bits (207), Expect = 4e-18
Identities = 40/91 (43%), Positives = 56/91 (61%), Gaps = 8/91 (8%)
Query: 271 IAQGLLYLHQYSRLRVIHRDLKASNILLDKDMNPKISDFGMARMFGGDEL--QSNTKRIV 328
IA+G+ YL IHRDL A NIL+ +++ KI+DFG+AR+ DE + K +
Sbjct: 112 IAEGMAYLE---SRNYIHRDLAARNILVGENLVCKIADFGLARLIEDDEYTAREGAKFPI 168
Query: 329 GTYGYMSPEYALRGLFSIKSDVFSFGVLLLE 359
+ +PE A G F+IKSDV+SFG+LL E
Sbjct: 169 ---KWTAPEAANYGRFTIKSDVWSFGILLTE 196
|
Protein Tyrosine Kinase (PTK) family; Src kinase subfamily; catalytic (c) domain. Src subfamily members include Src, Lck, Hck, Blk, Lyn, Fgr, Fyn, Yrk, and Yes. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Src (or c-Src) proteins are cytoplasmic (or non-receptor) tyr kinases which are anchored to the plasma membrane. They contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. They were identified as the first proto-oncogene products, and they regulate cell adhesion, invasion, and motility in cancer cells and tumor vasculature, contributing to cancer progression and metastasis. Src kinases are overexpressed in a variety of human cancers, making them attractive targets for therapy. They are also implicated in acute inflammatory responses and osteoclast function. Src, Fyn, Yes, and Yrk are widely expressed, while Blk, Lck, Hck, Fgr, and Lyn show a limited expression pattern. Length = 261 |
| >gnl|CDD|173757 cd08217, STKc_Nek2, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 2 | Back alignment and domain information |
|---|
Score = 82.7 bits (205), Expect = 9e-18
Identities = 42/115 (36%), Positives = 56/115 (48%), Gaps = 7/115 (6%)
Query: 267 IIEGIAQGLLYLH-----QYSRLRVIHRDLKASNILLDKDMNPKISDFGMARMFGGDELQ 321
I + Q LL L+ V+HRDLK +NI LD + N K+ DFG+A++ G D
Sbjct: 107 IWRILTQLLLALYECHNRSDPGNTVLHRDLKPANIFLDANNNVKLGDFGLAKILGHD--S 164
Query: 322 SNTKRIVGTYGYMSPEYALRGLFSIKSDVFSFGVLLLETLSSKKNTHFYNTDSLT 376
S K VGT YMSPE + KSD++S G L+ E + N L
Sbjct: 165 SFAKTYVGTPYYMSPEQLNHMSYDEKSDIWSLGCLIYELCALSPPFTARNQLQLA 219
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 2 (Nek2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek2 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The Nek2 subfamily includes Aspergillus nidulans NIMA kinase, the founding member of the Nek family, which was identified in a screen for cell cycle mutants prevented from entering mitosis. NIMA is essential for mitotic entry and progression through mitosis, and its degradation is essential for mitotic exit. NIMA is involved in nuclear membrane fission. Vertebrate Nek2 is a cell cycle-regulated STK, localized in centrosomes and kinetochores, that regulates centrosome splitting at the G2/M phase. It also interacts with other mitotic kinases such as Polo-like kinase 1 and may play a role in spindle checkpoint. An increase in the expression of the human NEK2 gene is strongly associated with the progression of non-Hodgkin lymphoma. Length = 265 |
| >gnl|CDD|133248 cd05148, PTKc_Srm_Brk, Catalytic domain of the Protein Tyrosine Kinases, Srm and Brk | Back alignment and domain information |
|---|
Score = 82.5 bits (204), Expect = 9e-18
Identities = 41/92 (44%), Positives = 59/92 (64%), Gaps = 5/92 (5%)
Query: 271 IAQGLLYLHQYSRLRVIHRDLKASNILLDKDMNPKISDFGMARMFGGDELQSNTKRIVGT 330
+A+G+ YL + IHRDL A NIL+ +D+ K++DFG+AR+ D S+ K+I
Sbjct: 113 VAEGMAYLEEQ---NSIHRDLAARNILVGEDLVCKVADFGLARLIKEDVYLSSDKKI--P 167
Query: 331 YGYMSPEYALRGLFSIKSDVFSFGVLLLETLS 362
Y + +PE A G FS KSDV+SFG+LL E +
Sbjct: 168 YKWTAPEAASHGTFSTKSDVWSFGILLYEMFT 199
|
Protein Tyrosine Kinase (PTK) family; Src-related kinase lacking C-terminal regulatory tyrosine and N-terminal myristylation sites (Srm) and breast tumor kinase (Brk, also called protein tyrosine kinase 6); catalytic (c) domains. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Srm and Brk are a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases in general contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr; they are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Srm and Brk however, lack the N-terminal myristylation sites. Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Brk has been found to be overexpressed in a majority of breast tumors. Length = 261 |
| >gnl|CDD|173668 cd05577, STKc_GRK, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase | Back alignment and domain information |
|---|
Score = 82.5 bits (204), Expect = 1e-17
Identities = 35/94 (37%), Positives = 49/94 (52%), Gaps = 6/94 (6%)
Query: 271 IAQGLLYLHQYSRLRVIHRDLKASNILLDKDMNPKISDFGMARMFGGDELQSNTKRIVGT 330
I GL +LHQ R+++RDLK N+LLD N +ISD G+A G K GT
Sbjct: 104 IICGLEHLHQ---RRIVYRDLKPENVLLDDHGNVRISDLGLAVELKG---GKKIKGRAGT 157
Query: 331 YGYMSPEYALRGLFSIKSDVFSFGVLLLETLSSK 364
GYM+PE ++ D F+ G L E ++ +
Sbjct: 158 PGYMAPEVLQGEVYDFSVDWFALGCTLYEMIAGR 191
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. GRKs contain a central catalytic domain, flanked by N- and C-terminal extensions. The N-terminus contains an RGS (regulator of G protein signaling) homology (RH) domain and several motifs. The C-terminus diverges among different groups of GRKs. There are seven types of GRKs, named GRK1 to GRK7. They are subdivided into three main groups: visual (GRK1/7); beta-adrenergic receptor kinases (GRK2/3); and GRK4-like (GRK4/5/6). Expression of GRK2/3/5/6 is widespread while GRK1/4/7 show a limited tissue distribution. The substrate spectrum of the widely expressed GRKs partially overlaps. GRKs play important roles in the cardiovascular, immune, respiratory, skeletal, and nervous systems. Length = 277 |
| >gnl|CDD|173728 cd06614, STKc_PAK, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase | Back alignment and domain information |
|---|
Score = 82.6 bits (205), Expect = 1e-17
Identities = 36/94 (38%), Positives = 54/94 (57%), Gaps = 5/94 (5%)
Query: 266 RIIEGIAQGLLYLHQYSRLRVIHRDLKASNILLDKDMNPKISDFGMARMFGGDELQSNTK 325
+ + QGL YLH VIHRD+K+ NILL KD + K++DFG A + +S
Sbjct: 120 YVCREVLQGLEYLHS---QNVIHRDIKSDNILLSKDGSVKLADFGFAAQLT--KEKSKRN 174
Query: 326 RIVGTYGYMSPEYALRGLFSIKSDVFSFGVLLLE 359
+VGT +M+PE R + K D++S G++ +E
Sbjct: 175 SVVGTPYWMAPEVIKRKDYGPKVDIWSLGIMCIE 208
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs are implicated in the regulation of many cellular processes including growth factor receptor-mediated proliferation, cell polarity, cell motility, cell death and survival, and actin cytoskeleton organization. PAK deregulation is associated with tumor development. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). Group II PAKs contain a PBD and a catalytic domain, but lack other motifs found in group I PAKs. Since group II PAKs do not contain an obvious AID, they may be regulated differently from group I PAKs. Group I PAKs interact with the SH3 containing proteins Nck, Grb2 and PIX; no such binding has been demonstrated for group II PAKs. Length = 286 |
| >gnl|CDD|173731 cd06627, STKc_Cdc7_like, Catalytic domain of Cell division control protein 7-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 80.8 bits (200), Expect = 4e-17
Identities = 37/98 (37%), Positives = 55/98 (56%), Gaps = 7/98 (7%)
Query: 268 IEGIAQGLLYLHQYSRLRVIHRDLKASNILLDKDMNPKISDFGMARMFGGDELQSNTKRI 327
+ + QGL YLH+ VIHRD+KA+NIL KD K++DFG+A + +
Sbjct: 105 VYQVLQGLAYLHEQG---VIHRDIKAANILTTKDGVVKLADFGVATKLNDVSKDDAS--V 159
Query: 328 VGTYGYMSPE-YALRGLFSIKSDVFSFGVLLLETLSSK 364
VGT +M+PE + G S SD++S G ++E L+
Sbjct: 160 VGTPYWMAPEVIEMSGA-STASDIWSLGCTVIELLTGN 196
|
Serine/threonine kinases (STKs), (Cdc7)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Cdc7-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily include Schizosaccharomyces pombe Cdc7, Saccharomyces cerevisiae Cdc15, Arabidopsis thaliana mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) epsilon, and related proteins. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Fission yeast Cdc7 is essential for cell division by playing a key role in the initiation of septum formation and cytokinesis. Budding yeast Cdc15 functions to coordinate mitotic exit with cytokinesis. Arabidopsis MAPKKK epsilon is required for pollen development in the plasma membrane. Length = 254 |
| >gnl|CDD|132951 cd06620, PKc_MAPKK_Byr1_like, Catalytic domain of fungal Byr1-like dual-specificity MAP kinase kinases | Back alignment and domain information |
|---|
Score = 81.0 bits (200), Expect = 5e-17
Identities = 38/99 (38%), Positives = 59/99 (59%), Gaps = 6/99 (6%)
Query: 266 RIIEGIAQGLLYLHQYSRLRVIHRDLKASNILLDKDMNPKISDFGMARMFGGDELQSNTK 325
+I + +GL YL Y+ R++HRD+K SNIL++ K+ DFG++ G+ + S
Sbjct: 107 KIAVAVVEGLTYL--YNVHRIMHRDIKPSNILVNSRGQIKLCDFGVS----GELINSIAD 160
Query: 326 RIVGTYGYMSPEYALRGLFSIKSDVFSFGVLLLETLSSK 364
VGT YMSPE G +++KSDV+S G+ ++E K
Sbjct: 161 TFVGTSTYMSPERIQGGKYTVKSDVWSLGISIIELALGK 199
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, fungal Byr1-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include the MAPKKs Byr1 from Schizosaccharomyces pombe, FUZ7 from Ustilago maydis, and related proteins. Byr1 phosphorylates its downstream target, the MAPK Spk1, and is regulated by the MAPKKK Byr2. The Spk1 cascade is pheromone-responsive and is essential for sporulation and sexual differentiation in fission yeast. FUZ7 phosphorylates and activates its target, the MAPK Crk1, which is required in mating and virulence in U. maydis. Length = 284 |
| >gnl|CDD|173723 cd06605, PKc_MAPKK, Catalytic domain of the dual-specificity Protein Kinase, Mitogen-Activated Protein Kinase Kinase | Back alignment and domain information |
|---|
Score = 80.4 bits (199), Expect = 6e-17
Identities = 37/94 (39%), Positives = 57/94 (60%), Gaps = 6/94 (6%)
Query: 266 RIIEGIAQGLLYLHQYSRLRVIHRDLKASNILLDKDMNPKISDFGMARMFGGDELQSNTK 325
+I + +GL YLH + ++IHRD+K SNIL++ K+ DFG++ G + S K
Sbjct: 104 KIAVAVLKGLTYLH--EKHKIIHRDVKPSNILVNSRGQIKLCDFGVS----GQLVNSLAK 157
Query: 326 RIVGTYGYMSPEYALRGLFSIKSDVFSFGVLLLE 359
VGT YM+PE +S+KSD++S G+ L+E
Sbjct: 158 TFVGTSSYMAPERIQGNDYSVKSDIWSLGLSLIE 191
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK or MAP2K), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK or MAP3K). MAPKKs are dual-specificity PKs that phosphorylate their downstream targets, MAPKs, at specific threonine and tyrosine residues. There are three MAPK subfamilies: extracellular signal-regulated kinase (ERK), c-Jun N-terminal kinase (JNK), and p38. In mammalian cells, there are seven MAPKKs (named MKK1-7) and 20 MAPKKKs. Each MAPK subfamily can be activated by at least two cognate MAPKKs and by multiple MAPKKKs. Length = 265 |
| >gnl|CDD|173672 cd05581, STKc_PDK1, Catalytic domain of the Protein Serine/Threonine Kinase, Phosphoinositide-dependent kinase 1 | Back alignment and domain information |
|---|
Score = 79.5 bits (197), Expect = 1e-16
Identities = 37/115 (32%), Positives = 53/115 (46%), Gaps = 24/115 (20%)
Query: 271 IAQ---GLLYLHQYSRLRVIHRDLKASNILLDKDMNPKISDFGMARMFGGDEL------- 320
A+ L YLH +IHRDLK NILLDKDM+ KI+DFG A++ +
Sbjct: 108 AAEILLALEYLHS---KGIIHRDLKPENILLDKDMHIKITDFGTAKVLDPNSSPESNKGD 164
Query: 321 -----------QSNTKRIVGTYGYMSPEYALRGLFSIKSDVFSFGVLLLETLSSK 364
+ VGT Y+SPE SD+++ G ++ + L+ K
Sbjct: 165 ATNIDSQIEKNRRRFASFVGTAEYVSPELLNEKPAGKSSDLWALGCIIYQMLTGK 219
|
Serine/Threonine Kinases (STKs), Phosphoinositide-dependent kinase 1 (PDK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PDK1 carries an N-terminal catalytic domain and a C-terminal pleckstrin homology (PH) domain that binds phosphoinositides. It phosphorylates the activation loop of AGC kinases that are regulated by PI3K such as PKB, SGK, and PKC, among others, and is crucial for their activation. Thus, it contributes in regulating many processes including metabolism, growth, proliferation, and survival. PDK1 also has the ability to autophosphorylate and is constitutively active in mammalian cells. PDK1 is essential for normal embryo development and is important in regulating cell volume. Length = 280 |
| >gnl|CDD|223589 COG0515, SPS1, Serine/threonine protein kinase [General function prediction only / Signal transduction mechanisms / Transcription / DNA replication, recombination, and repair] | Back alignment and domain information |
|---|
Score = 80.9 bits (198), Expect = 1e-16
Identities = 56/238 (23%), Positives = 95/238 (39%), Gaps = 17/238 (7%)
Query: 235 VLVQSKDEISFWYESYNNPTKKGLLCWGTRVRIIEGIAQGLLYLHQYSRLRVIHRDLKAS 294
LV + + +KG L + I+ I L YLH +IHRD+K
Sbjct: 74 YLVMEYVDGGSLEDLLKKIGRKGPLSESEALFILAQILSALEYLH---SKGIIHRDIKPE 130
Query: 295 NILLDKDMN-PKISDFGMARMFGGD----ELQSNTKRIVGTYGYMSPEYALRGLF---SI 346
NILLD+D K+ DFG+A++ + + VGT GYM+PE L S
Sbjct: 131 NILLDRDGRVVKLIDFGLAKLLPDPGSTSSIPALPSTSVGTPGYMAPEVLLGLSLAYASS 190
Query: 347 KSDVFSFGVLLLETLSSKKNTHFYNTDSLTLLGHAWNLWNDGRTWELMDPISQNGASYPI 406
SD++S G+ L E L+ F + + + + T L P+S + I
Sbjct: 191 SSDIWSLGITLYELLTGL--PPFEGEKNSSATSQTLKIILELPTPSLASPLSPSN-PELI 247
Query: 407 LKRYINVALLCVQEKAADRPAMSEVVSMLSNEFVNLPAPQQPAFSCVNSTNMQSDAFS 464
K ++ + + +R + S LS++ + ++ S + + +
Sbjct: 248 SKAASDLLKKLLAKDPKNRLSSSSD---LSHDLLAHLKLKESDLSDLLKPDDSAPLRL 302
|
Length = 384 |
| >gnl|CDD|173628 cd05038, PTKc_Jak_rpt2, Catalytic (repeat 2) domain of the Protein Tyrosine Kinases, Janus kinases | Back alignment and domain information |
|---|
Score = 78.6 bits (194), Expect = 3e-16
Identities = 36/94 (38%), Positives = 48/94 (51%), Gaps = 6/94 (6%)
Query: 271 IAQGLLYLHQYSRLRVIHRDLKASNILLDKDMNPKISDFGMARMF--GGDELQSNTKRIV 328
I +G+ YL R IHRDL A NIL++ + KISDFG+A++ D
Sbjct: 118 ICKGMDYLGS---QRYIHRDLAARNILVESEDLVKISDFGLAKVLPEDKDYYYVKEPGES 174
Query: 329 GTYGYMSPEYALRGLFSIKSDVFSFGVLLLETLS 362
+ Y +PE FS SDV+SFGV L E +
Sbjct: 175 PIFWY-APECLRTSKFSSASDVWSFGVTLYELFT 207
|
Protein Tyrosine Kinase (PTK) family; Janus kinase (Jak) subfamily; catalytic (c) domain (repeat 2). The Jak subfamily is composed of Jak1, Jak2, Jak3, TYK2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase catalytic domain. Most Jaks are expressed in a wide variety of tissues, except for Jak3, which is expressed only in hematopoietic cells. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jaks are also involved in regulating the surface expression of some cytokine receptors. The Jak-STAT pathway is involved in many biological processes including hematopoiesis, immunoregulation, host defense, fertility, lactation, growth, and embryogenesis. Length = 284 |
| >gnl|CDD|173669 cd05578, STKc_Yank1, Catalytic domain of the Protein Serine/Threonine Kinase, Yank1 | Back alignment and domain information |
|---|
Score = 77.0 bits (190), Expect = 8e-16
Identities = 37/95 (38%), Positives = 48/95 (50%), Gaps = 6/95 (6%)
Query: 271 IAQGLLYLHQYSRLRVIHRDLKASNILLDKDMNPKISDFGMARMFGGDELQSNTKRIVGT 330
I L YLH +IHRD+K NILLD+ + I+DF +A D T GT
Sbjct: 109 IVLALEYLHSK---GIIHRDIKPDNILLDEQGHVHITDFNIATKVTPDT---LTTSTSGT 162
Query: 331 YGYMSPEYALRGLFSIKSDVFSFGVLLLETLSSKK 365
GYM+PE R +S+ D +S GV E L K+
Sbjct: 163 PGYMAPEVLCRQGYSVAVDWWSLGVTAYECLRGKR 197
|
Serine/Threonine Kinases (STKs), Yank1 or STK32A subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Yank1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily contains uncharacterized STKs with similarity to the human protein designated Yank1 or STK32A. Length = 258 |
| >gnl|CDD|132943 cd06612, STKc_MST1_2, Catalytic domain of the Protein Serine/Threonine Kinases, Mammalian Ste20-like protein kinase 1 and 2 | Back alignment and domain information |
|---|
Score = 76.9 bits (190), Expect = 8e-16
Identities = 32/93 (34%), Positives = 55/93 (59%), Gaps = 5/93 (5%)
Query: 267 IIEGIAQGLLYLHQYSRLRVIHRDLKASNILLDKDMNPKISDFGMARMFGGDELQSNTKR 326
I+ +GL YLH + IHRD+KA NILL+++ K++DFG++ + NT
Sbjct: 104 ILYQTLKGLEYLHS---NKKIHRDIKAGNILLNEEGQAKLADFGVSGQLTDTMAKRNT-- 158
Query: 327 IVGTYGYMSPEYALRGLFSIKSDVFSFGVLLLE 359
++GT +M+PE ++ K+D++S G+ +E
Sbjct: 159 VIGTPFWMAPEVIQEIGYNNKADIWSLGITAIE 191
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 1 (MST1) and MST2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST1/2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MST1, MST2, and related proteins including Drosophila Hippo and Dictyostelium discoideum Krs1 (kinase responsive to stress 1). MST1/2 and Hippo are involved in a conserved pathway that governs cell contact inhibition, organ size control, and tumor development. MST1 activates the mitogen-activated protein kinases (MAPKs) p38 and c-Jun N-terminal kinase (JNK) through MKK7 (a MAPK kinase) and MEKK1 (a MAPK kinase kinase) by acting as a MAPK kinase kinase kinase (MAPKKKK). Activation of JNK by MST1 leads to caspase activation and apoptosis. MST1 has also been implicated in cell proliferation and differentiation. Krs1 may regulate cell growth arrest and apoptosis in response to cellular stress. Length = 256 |
| >gnl|CDD|173726 cd06610, STKc_OSR1_SPAK, Catalytic domain of the Protein Serine/Threonine Kinases, Oxidative stress response kinase and Ste20-related proline alanine-rich kinase | Back alignment and domain information |
|---|
Score = 76.2 bits (188), Expect = 1e-15
Identities = 38/97 (39%), Positives = 60/97 (61%), Gaps = 8/97 (8%)
Query: 267 IIEGIAQGLLYLHQYSRLRVIHRDLKASNILLDKDMNPKISDFGMARMF--GGDELQSNT 324
+++ + +GL YLH + IHRD+KA NILL +D + KI+DFG++ GGD +
Sbjct: 107 VLKEVLKGLEYLHSNGQ---IHRDIKAGNILLGEDGSVKIADFGVSASLADGGDRTRKVR 163
Query: 325 KRIVGTYGYMSPE--YALRGLFSIKSDVFSFGVLLLE 359
K VGT +M+PE + G + K+D++SFG+ +E
Sbjct: 164 KTFVGTPCWMAPEVMEQVHG-YDFKADIWSFGITAIE 199
|
Serine/threonine kinases (STKs), oxidative stress response kinase (OSR1) and Ste20-related proline alanine-rich kinase (SPAK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The OSR1 and SPAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. SPAK is also referred to as STK39 or PASK (proline-alanine-rich STE20-related kinase). OSR1 and SPAK regulate the activity of cation-chloride cotransporters through direct interaction and phosphorylation. They are also implicated in cytoskeletal rearrangement, cell differentiation, transformation and proliferation. OSR1 and SPAK contain a conserved C-terminal (CCT) domain, which recognizes a unique motif ([RK]FX[VI]) present in their activating kinases (WNK1/WNK4) and their substrates. Length = 267 |
| >gnl|CDD|132938 cd06607, STKc_TAO, Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids proteins | Back alignment and domain information |
|---|
Score = 76.4 bits (188), Expect = 2e-15
Identities = 63/182 (34%), Positives = 87/182 (47%), Gaps = 29/182 (15%)
Query: 267 IIEGIAQGLLYLHQYSRLRVIHRDLKASNILLDKDMNPKISDFGMARMFGGDELQSNTKR 326
I G QGL YLH + R IHRD+KA NILL + K++DFG A L S
Sbjct: 120 ICHGALQGLAYLHSHER---IHRDIKAGNILLTEPGTVKLADFGSA------SLVSPANS 170
Query: 327 IVGTYGYMSPEYAL---RGLFSIKSDVFSFGVLLLETLSSKKNTHFYNTDSLTLLGHAWN 383
VGT +M+PE L G + K DV+S G+ +E L+ +K F N ++++ L H
Sbjct: 171 FVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIE-LAERKPPLF-NMNAMSALYHIAQ 228
Query: 384 LWNDGRTWELMDPISQNGASYPILKRYINVALLCVQEKAADRPAMSEVVSMLSNEFVNLP 443
ND T +S N S + N C+Q+ DRP+ E +L + FV
Sbjct: 229 --NDSPT------LSSNDWS----DYFRNFVDSCLQKIPQDRPSSEE---LLKHRFVLRE 273
Query: 444 AP 445
P
Sbjct: 274 RP 275
|
Serine/threonine kinases (STKs), thousand-and-one amino acids (TAO) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. They activate the MAPKs, p38 and c-Jun N-terminal kinase (JNK), by phosphorylating and activating the respective MAP/ERK kinases (MEKs, also known as MKKs or MAPKKs), MEK3/MEK6 and MKK4/MKK7. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Vertebrates contain three TAO subfamily members, named TAO1, TAO2, and TAO3. Length = 307 |
| >gnl|CDD|173625 cd05032, PTKc_InsR_like, Catalytic domain of Insulin Receptor-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 75.8 bits (187), Expect = 2e-15
Identities = 54/180 (30%), Positives = 79/180 (43%), Gaps = 43/180 (23%)
Query: 271 IAQGLLYLHQYSRLRVIHRDLKASNILLDKDMNPKISDFGMARMFGGDELQSNTKRIVGT 330
IA G+ YL + +HRDL A N ++ +D+ KI DFGM R D +++ R G
Sbjct: 128 IADGMAYLAA---KKFVHRDLAARNCMVAEDLTVKIGDFGMTR----DIYETDYYRKGGK 180
Query: 331 ----YGYMSPEYALRGLFSIKSDVFSFGVLLLE--TLSSKKNTHFYNTDSLTLLGHAWNL 384
+M+PE G+F+ KSDV+SFGV+L E TL+ G L
Sbjct: 181 GLLPVRWMAPESLKDGVFTTKSDVWSFGVVLWEMATLA-----------EQPYQG----L 225
Query: 385 WNDGRTWELMDPISQNGASYPILKRYIN-------VALLCVQEKAADRPAMSEVVSMLSN 437
N+ E++ + G L N + +C Q RP E+VS L +
Sbjct: 226 SNE----EVLKFVIDGG----HLDLPENCPDKLLELMRMCWQYNPKMRPTFLEIVSSLKD 277
|
Protein Tyrosine Kinase (PTK) family; Insulin Receptor (InsR) subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). The InsR subfamily is composed of InsR, Insulin-like Growth Factor-1 Receptor (IGF-1R), and similar proteins. PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. InsR and IGF-1R are receptor tyr kinases (RTKs) composed of two alphabeta heterodimers. Binding of the ligand (insulin, IGF-1, or IGF-2) to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, stimulating downstream kinase activities, which initiate signaling cascades and biological function. InsR and IGF-1R, which share 84% sequence identity in their kinase domains, display physiologically distinct yet overlapping functions in cell growth, differentiation, and metabolism. InsR activation leads primarily to metabolic effects while IGF-1R activation stimulates mitogenic pathways. In cells expressing both receptors, InsR/IGF-1R hybrids are found together with classical receptors. Both receptors can interact with common adaptor molecules such as IRS-1 and IRS-2. Length = 277 |
| >gnl|CDD|133168 cd05036, PTKc_ALK_LTK, Catalytic domain of the Protein Tyrosine Kinases, Anaplastic Lymphoma Kinase and Leukocyte Tyrosine Kinase | Back alignment and domain information |
|---|
Score = 75.2 bits (185), Expect = 4e-15
Identities = 63/225 (28%), Positives = 95/225 (42%), Gaps = 32/225 (14%)
Query: 218 GVAFGAAPTYTSFLYEQVLVQSKDEISFWYESYNNPTKKGLLCWGTRVRIIEGIAQGLLY 277
GV+F P + L E L+ D SF E+ P + L + +A+G Y
Sbjct: 76 GVSFERLPRF--ILLE--LMAGGDLKSFLRENRPRPERPSSLTMKDLLFCARDVAKGCKY 131
Query: 278 LHQYSRLRVIHRDLKASNILLD---KDMNPKISDFGMAR-MFGGDELQSNTKRIVGTYGY 333
L + IHRD+ A N LL KI+DFGMAR ++ + + ++ +
Sbjct: 132 LEEN---HFIHRDIAARNCLLTCKGPGRVAKIADFGMARDIYRASYYRKGGRAML-PIKW 187
Query: 334 MSPEYALRGLFSIKSDVFSFGVLLLE--TLSSKKNTHFYNTDSLTLLGHAWNLWNDGRTW 391
M PE L G+F+ K+DV+SFGVLL E +L N + + + GR
Sbjct: 188 MPPEAFLDGIFTSKTDVWSFGVLLWEIFSLGYMPYPGRTNQEVMEFVTGG------GR-- 239
Query: 392 ELMD-PISQNGASYPILKRYINVALLCVQEKAADRPAMSEVVSML 435
+D P G Y I+ C Q DRP + ++ +
Sbjct: 240 --LDPPKGCPGPVYRIMTD-------CWQHTPEDRPNFATILERI 275
|
Protein Tyrosine Kinase (PTK) family; Anaplastic Lymphoma Kinase (ALK) and Leukocyte Tyrosine (tyr) Kinase (LTK); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyr residues in protein substrates. ALK and LTK are orphan receptor tyr kinases (RTKs) whose ligands are not yet well-defined. RTKs contain an extracellular ligand-binding domain, a transmembrane region, and an intracellular tyr kinase domain. They are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. ALK appears to play an important role in mammalian neural development as well as visceral muscle differentiation in Drosophila. ALK is aberrantly expressed as fusion proteins, due to chromosomal translocations, in about 60% of anaplastic large cell lymphomas (ALCLs). ALK fusion proteins are also found in rare cases of diffuse large B cell lymphomas (DLBCLs). LTK is mainly expressed in B lymphocytes and neuronal tissues. It is important in cell proliferation and survival. Transgenic mice expressing TLK display retarded growth and high mortality rate. In addition, a polymorphism in mouse and human LTK is implicated in the pathogenesis of systemic lupus erythematosus. Length = 277 |
| >gnl|CDD|133199 cd05068, PTKc_Frk_like, Catalytic domain of Fyn-related kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 74.8 bits (184), Expect = 5e-15
Identities = 37/92 (40%), Positives = 54/92 (58%), Gaps = 10/92 (10%)
Query: 271 IAQGLLYLHQYSRLRVIHRDLKASNILLDKDMNPKISDFGMARMFGGDELQSNTKRIVGT 330
+A G+ YL + IHRDL A N+L+ ++ K++DFG+AR+ D ++ G
Sbjct: 112 VASGMAYLEAQN---YIHRDLAARNVLVGENNICKVADFGLARVIKEDIYEARE----GA 164
Query: 331 ---YGYMSPEYALRGLFSIKSDVFSFGVLLLE 359
+ +PE AL FSIKSDV+SFG+LL E
Sbjct: 165 KFPIKWTAPEAALYNRFSIKSDVWSFGILLTE 196
|
Protein Tyrosine Kinase (PTK) family; Human Fyn-related kinase (Frk) and similar proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Frk and Srk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Frk, also known as Rak, is specifically expressed in liver, lung, kidney, intestine, mammary glands, and the islets of Langerhans. Rodent homologs were previously referred to as GTK (gastrointestinal tyr kinase), BSK (beta-cell Src-like kinase), or IYK (intestinal tyr kinase). Studies in mice reveal that Frk is not essential for viability. It plays a role in the signaling that leads to cytokine-induced beta-cell death in Type I diabetes. It also regulates beta-cell number during embryogenesis and early in life. Length = 261 |
| >gnl|CDD|173771 cd08529, STKc_FA2-like, Catalytic domain of the Protein Serine/Threonine Kinase, Chlamydomonas reinhardtii FA2 and similar domains | Back alignment and domain information |
|---|
Score = 74.1 bits (182), Expect = 7e-15
Identities = 35/86 (40%), Positives = 53/86 (61%), Gaps = 5/86 (5%)
Query: 274 GLLYLHQYSRLRVIHRDLKASNILLDKDMNPKISDFGMARMFGGDELQSNTKRIVGTYGY 333
GL +LH +++HRD+K+ N+ LD N KI D G+A++ + +NT IVGT Y
Sbjct: 113 GLAHLHSK---KILHRDIKSLNLFLDAYDNVKIGDLGVAKLLSDNTNFANT--IVGTPYY 167
Query: 334 MSPEYALRGLFSIKSDVFSFGVLLLE 359
+SPE ++ KSDV++ GV+L E
Sbjct: 168 LSPELCEDKPYNEKSDVWALGVVLYE 193
|
Serine/Threonine Kinases (STKs), Chlamydomonas reinhardtii FA2-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Chlamydomonas reinhardtii FA2-like subfamily belongs to the (NIMA)-related kinase (Nek) family. The Nek family includes seven different Chlamydomonas Neks (CNKs 1-6 and Fa2). This subfamily includes FA2 and CNK4. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Chlamydomonas reinhardtii FA2 was discovered in a genetic screen for deflagellation-defective mutants. It is essential for basal-body/centriole-associated microtubule severing, and plays a role in cell cycle progression. No cellular function has yet been ascribed to CNK4. Length = 256 |
| >gnl|CDD|173699 cd05608, STKc_GRK1, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 1 | Back alignment and domain information |
|---|
Score = 74.1 bits (182), Expect = 8e-15
Identities = 39/94 (41%), Positives = 54/94 (57%), Gaps = 5/94 (5%)
Query: 271 IAQGLLYLHQYSRLRVIHRDLKASNILLDKDMNPKISDFGMARMFGGDELQSNTKRIVGT 330
I GL +LHQ R+I+RDLK N+LLD D N +ISD G+A + QS TK GT
Sbjct: 106 IISGLEHLHQR---RIIYRDLKPENVLLDNDGNVRISDLGLAVEL--KDGQSKTKGYAGT 160
Query: 331 YGYMSPEYALRGLFSIKSDVFSFGVLLLETLSSK 364
G+M+PE + D F+ GV L E ++++
Sbjct: 161 PGFMAPELLQGEEYDFSVDYFALGVTLYEMIAAR 194
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK1, also called rhodopsin kinase, belongs to the visual group of GRKs and is expressed in retinal cells. It phosphorylates rhodopsin in rod cells, which leads to termination of the phototransduction cascade. Mutations in GRK1 are associated to a recessively inherited form of stationary nightblindness called Oguchi disease. Length = 280 |
| >gnl|CDD|133191 cd05060, PTKc_Syk_like, Catalytic domain of Spleen Tyrosine Kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 73.9 bits (182), Expect = 9e-15
Identities = 55/173 (31%), Positives = 75/173 (43%), Gaps = 28/173 (16%)
Query: 271 IAQGLLYLHQYSRLRVIHRDLKASNILLDKDMNPKISDFGMARM--FGGDELQSNT--KR 326
+A G+ YL +HRDL A N+LL KISDFGM+R G D ++ T +
Sbjct: 104 VAMGMAYLES---KHFVHRDLAARNVLLVNRHQAKISDFGMSRALGAGSDYYRATTAGRW 160
Query: 327 IVGTYGYMSPEYALRGLFSIKSDVFSFGVLLLETLS--SKKNTHFYNTDSLTLLGHAWNL 384
+ Y +PE G FS KSDV+S+GV L E S +K + + +L L
Sbjct: 161 PLKWY---APECINYGKFSSKSDVWSYGVTLWEAFSYGAKPYGEMKGAEVIAMLESGERL 217
Query: 385 WNDGRTWELMDPISQNGASYPILKRYINVALLCVQEKAADRPAMSEVVSMLSN 437
R E I Y I+ L C + + DRP SE+ S
Sbjct: 218 ---PRPEECPQEI------YSIM-------LSCWKYRPEDRPTFSELESTFRR 254
|
Protein Tyrosine Kinase (PTK) family; Spleen Tyrosine Kinase (Syk) subfamily; catalytic (c) domain. The Syk subfamily is composed of Syk, ZAP-70, Shark, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Syk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. They are involved in the signaling downstream of activated receptors (including B-cell, T-cell, and Fc receptors) that contain ITAMs (immunoreceptor tyr activation motifs), leading to processes such as cell proliferation, differentiation, survival, adhesion, migration, and phagocytosis. Syk is important in B-cell receptor (BCR) signaling, while Zap-70 is primarily expressed in T-cells and NK cells, and is a crucial component in T-cell receptor (TCR) signaling. Syk also plays a central role in Fc receptor-mediated phagocytosis in the adaptive immune system. Shark is exclusively expressed in ectodermally derived epithelia, and is localized preferentially to the apical surface of the epithelial cells, it may play a role in a signaling pathway for epithelial cell polarity. Length = 257 |
| >gnl|CDD|143345 cd07840, STKc_CDK9_like, Catalytic domain of Cyclin-Dependent protein Kinase 9-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 74.1 bits (183), Expect = 1e-14
Identities = 34/96 (35%), Positives = 52/96 (54%), Gaps = 7/96 (7%)
Query: 271 IAQGLLYLHQYSRLRVIHRDLKASNILLDKDMNPKISDFGMARMFGGDELQSNTKRIVGT 330
+ +GL YLH ++HRD+K SNIL++ D K++DFG+AR + T R++ T
Sbjct: 109 LLEGLQYLHSN---GILHRDIKGSNILINNDGVLKLADFGLARPYTKRNSADYTNRVI-T 164
Query: 331 YGYMSPEYALRG--LFSIKSDVFSFGVLLLETLSSK 364
Y PE L G + + D++S G +L E K
Sbjct: 165 LWYRPPELLL-GATRYGPEVDMWSVGCILAELFLGK 199
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 9 (CDK9)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK9-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK9 and CDK12 from higher eukaryotes, yeast BUR1, C-type plant CDKs (CdkC), and similar proteins. CDK9, BUR1, and CdkC are functionally equivalent. They act as a kinase for the C-terminal domain of RNA polymerase II and participate in regulating mutliple steps of gene expression including transcription elongation and RNA processing. CDK9 and CdkC associate with T-type cyclins while BUR1 associates with the cyclin BUR2. CDK12 is a unique CDK that contains an arginine/serine-rich (RS) domain, which is predominantly found in splicing factors. CDK12 interacts with cyclins L1 and L2, and participates in regulating transcription and alternative splicing. Length = 287 |
| >gnl|CDD|173670 cd05579, STKc_MAST_like, Catalytic domain of Microtubule-associated serine/threonine kinase-like proteins | Back alignment and domain information |
|---|
Score = 73.8 bits (182), Expect = 1e-14
Identities = 37/98 (37%), Positives = 51/98 (52%), Gaps = 9/98 (9%)
Query: 271 IAQGLLYLHQYSRLRVIHRDLKASNILLDKDMNPKISDFG------MARMFGGDELQSNT 324
I L YLH +IHRDLK NIL+D + + K++DFG + R ++ +
Sbjct: 102 IVLALEYLHSNG---IIHRDLKPDNILIDSNGHLKLTDFGLSKVGLVRRQINLNDDEKED 158
Query: 325 KRIVGTYGYMSPEYALRGLFSIKSDVFSFGVLLLETLS 362
KRIVGT Y++PE L S D +S G +L E L
Sbjct: 159 KRIVGTPDYIAPEVILGQGHSKTVDWWSLGCILYEFLV 196
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The MAST kinase subfamily includes MAST kinases, MAST-like (MASTL) kinases, and fungal kinases with similarity to Saccharomyces cerevisiae Rim15 and Schizosaccharomyces pombe cek1. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. MASTL kinases carry only a catalytic domain which contains a long insert relative to other kinases. The fungal kinases in this subfamily harbor other domains in addition to a central catalytic domain, which also contains an insert relative to MAST kinases like MASTL. Rim15 contains a C-terminal signal receiver (REC) domain while cek1 contains an N-terminal PAS domain. MAST kinases are cytoskeletal associated kinases of unknown function that are also expressed at neuromuscular junctions and postsynaptic densities. The fungal proteins Rim15 and cek1 are involved in the regulation of meiosis and mitosis, respectively. Length = 265 |
| >gnl|CDD|173761 cd08221, STKc_Nek9, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 9 | Back alignment and domain information |
|---|
Score = 72.5 bits (178), Expect = 2e-14
Identities = 46/169 (27%), Positives = 80/169 (47%), Gaps = 28/169 (16%)
Query: 271 IAQGLLYLHQYSRLRVIHRDLKASNILLDKDMNPKISDFGMARMFGGDELQSNTKRIVGT 330
I + Y+H+ ++HRD+K NI L K K+ DFG++++ G + + T +VGT
Sbjct: 110 IVSAVSYIHKAG---ILHRDIKTLNIFLTKAGLIKLGDFGISKILGSEYSMAET--VVGT 164
Query: 331 YGYMSPEYALRGLFSIKSDVFSFGVLLLETLSSKKNTHFYNTDSLTLLGHAWNLWNDGRT 390
YMSPE ++ KSD+++ G +L E L+ K+ F T+ L L+
Sbjct: 165 PYYMSPELCQGVKYNFKSDIWALGCVLYELLTLKRT--FDATNPLNLV------------ 210
Query: 391 WELMDPISQNGASYPILKRY----INVALLCVQEKAADRPAMSEVVSML 435
+++ G P++ Y I++ +Q+ RP EV+
Sbjct: 211 VKIV-----QGNYTPVVSVYSSELISLVHSLLQQDPEKRPTADEVLDQP 254
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 9 (Nek9) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek9 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek9, also called Nercc1, is primarily a cytoplasmic protein but can also localize in the nucleus. It is involved in modulating chromosome alignment and splitting during mitosis. It interacts with the gamma-tubulin ring complex and the Ran GTPase, and is implicated in microtubule organization. Nek9 associates with FACT (FAcilitates Chromatin Transcription) and modulates interphase progression. It also interacts with Nek6, and Nek7, during mitosis, resulting in their activation. Length = 256 |
| >gnl|CDD|133201 cd05070, PTKc_Fyn_Yrk, Catalytic domain of the Protein Tyrosine Kinases, Fyn and Yrk | Back alignment and domain information |
|---|
Score = 72.3 bits (177), Expect = 3e-14
Identities = 39/94 (41%), Positives = 60/94 (63%), Gaps = 8/94 (8%)
Query: 271 IAQGLLYLHQYSRLRVIHRDLKASNILLDKDMNPKISDFGMARMFGGDELQSNTKRIVGT 330
+A G+ Y+ R+ IHRDL+++NIL+ + KI+DFG+AR+ +E T R
Sbjct: 111 VAAGMAYIE---RMNYIHRDLRSANILVGDGLVCKIADFGLARLIEDNEY---TARQGAK 164
Query: 331 Y--GYMSPEYALRGLFSIKSDVFSFGVLLLETLS 362
+ + +PE AL G F+IKSDV+SFG+LL E ++
Sbjct: 165 FPIKWTAPEAALYGRFTIKSDVWSFGILLTELVT 198
|
Protein Tyrosine Kinase (PTK) family; Fyn and Yrk kinases; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fyn and Yrk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Fyn, together with Lck, plays a critical role in T-cell signal transduction by phosphorylating ITAM (immunoreceptor tyr activation motif) sequences on T-cell receptors, ultimately leading to the proliferation and differentiation of T-cells. In addition, Fyn is involved in the myelination of neurons, and is implicated in Alzheimer's and Parkinson's diseases. Yrk has been detected only in chickens. It is primarily found in neuronal and epithelial cells and in macrophages. It may play a role in inflammation and in response to injury. Length = 260 |
| >gnl|CDD|133200 cd05069, PTKc_Yes, Catalytic domain of the Protein Tyrosine Kinase, Yes | Back alignment and domain information |
|---|
Score = 72.4 bits (177), Expect = 3e-14
Identities = 41/97 (42%), Positives = 62/97 (63%), Gaps = 8/97 (8%)
Query: 271 IAQGLLYLHQYSRLRVIHRDLKASNILLDKDMNPKISDFGMARMFGGDELQSNTKRIVGT 330
IA G+ Y+ R+ IHRDL+A+NIL+ ++ KI+DFG+AR+ +E T R
Sbjct: 111 IADGMAYIE---RMNYIHRDLRAANILVGDNLVCKIADFGLARLIEDNEY---TARQGAK 164
Query: 331 Y--GYMSPEYALRGLFSIKSDVFSFGVLLLETLSSKK 365
+ + +PE AL G F+IKSDV+SFG+LL E ++ +
Sbjct: 165 FPIKWTAPEAALYGRFTIKSDVWSFGILLTELVTKGR 201
|
Protein Tyrosine Kinase (PTK) family; Yes kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Yes (or c-Yes) is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. c-Yes kinase is the cellular homolog of the oncogenic protein (v-Yes) encoded by the Yamaguchi 73 and Esh sarcoma viruses. It displays functional overlap with other Src subfamily members, particularly Src. It also shows some unique functions such as binding to occludins, transmembrane proteins that regulate extracellular interactions in tight junctions. Yes also associates with a number of proteins in different cell types that Src does not interact with, like JAK2 and gp130 in pre-adipocytes, and Pyk2 in treated pulmonary vein endothelial cells. Although the biological function of Yes remains unclear, it appears to have a role in regulating cell-cell interactions and vesicle trafficking in polarized cells. Length = 260 |
| >gnl|CDD|133243 cd05112, PTKc_Itk, Catalytic domain of the Protein Tyrosine Kinase, Interleukin-2-inducible T-cell Kinase | Back alignment and domain information |
|---|
Score = 72.3 bits (177), Expect = 3e-14
Identities = 55/186 (29%), Positives = 89/186 (47%), Gaps = 24/186 (12%)
Query: 254 TKKGLLCWGTRVRIIEGIAQGLLYLHQYSRLRVIHRDLKASNILLDKDMNPKISDFGMAR 313
++G T + + + +G+ YL + VIHRDL A N L+ ++ K+SDFGM R
Sbjct: 92 AQRGKFSQETLLGMCLDVCEGMAYLESSN---VIHRDLAARNCLVGENQVVKVSDFGMTR 148
Query: 314 MFGGDELQSNTKRIVGT---YGYMSPEYALRGLFSIKSDVFSFGVLLLETLSSKKNTHFY 370
D+ S+T GT + SPE +S KSDV+SFGVL+ E S K +
Sbjct: 149 FVLDDQYTSST----GTKFPVKWSSPEVFSFSKYSSKSDVWSFGVLMWEVFSEGKTPYEN 204
Query: 371 NTDSLTLLGHAWNLWNDGRTWELMDPISQNGASYPILKRYINVALLCVQEKAADRPAMSE 430
++S + N G + L P + + Y +++ C +E+ DRP+ S
Sbjct: 205 RSNSEVV-----ETINAG--FRLYKPRLASQSVYELMQH-------CWKERPEDRPSFSL 250
Query: 431 VVSMLS 436
++ L+
Sbjct: 251 LLHQLA 256
|
Protein Tyrosine Kinase (PTK) family; Interleukin-2 (IL-2)-inducible T-cell kinase (Itk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Itk (also known as Tsk or Emt) is a member of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activation. In addition, Itk contains the Tec homology (TH) domain containing one proline-rich region and a zinc-binding region. Tec kinases are expressed mainly by haematopoietic cells. Itk is expressed in T-cells and mast cells, and is important in their development and differentiation. Of the three Tec kinases expressed in T-cells, Itk plays the predominant role in T-cell receptor (TCR) signaling. It is activated by phosphorylation upon TCR crosslinking and is involved in the pathway resulting in phospholipase C-gamma1 activation and actin polymerization. It also plays a role in the downstream signaling of the T-cell costimulatory receptor CD28, the T-cell surface receptor CD2, and the chemokine receptor CXCR4. In addition, Itk is crucial for the development of T-helper(Th)2 effector responses. Length = 256 |
| >gnl|CDD|173641 cd05072, PTKc_Lyn, Catalytic domain of the Protein Tyrosine Kinase, Lyn | Back alignment and domain information |
|---|
Score = 72.0 bits (176), Expect = 3e-14
Identities = 55/173 (31%), Positives = 89/173 (51%), Gaps = 30/173 (17%)
Query: 271 IAQGLLYLHQYSRLRVIHRDLKASNILLDKDMNPKISDFGMARMFGGDELQSNTKRIVGT 330
IA+G+ Y+ R IHRDL+A+N+L+ + + KI+DFG+AR+ +E T R
Sbjct: 112 IAEGMAYIE---RKNYIHRDLRAANVLVSESLMCKIADFGLARVIEDNEY---TAREGAK 165
Query: 331 Y--GYMSPEYALRGLFSIKSDVFSFGVLLLETLSSKKNTH--FYNTDSLTLLGHAWNLWN 386
+ + +PE G F+IKSDV+SFG+LL E ++ K + N+D ++ L + +
Sbjct: 166 FPIKWTAPEAINFGSFTIKSDVWSFGILLYEIVTYGKIPYPGMSNSDVMSALQRGYRM-- 223
Query: 387 DGRTWELMDPISQNGAS--YPILKRYINVALLCVQEKAADRPAMSEVVSMLSN 437
P +N Y I+K C +EKA +RP + S+L +
Sbjct: 224 ---------PRMENCPDELYDIMK-------TCWKEKAEERPTFDYLQSVLDD 260
|
Protein Tyrosine Kinase (PTK) family; Lyn kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Lyn is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Lyn is expressed in B lymphocytes and myeloid cells. It exhibits both positive and negative regulatory roles in B cell receptor (BCR) signaling. Lyn, as well as Fyn and Blk, promotes B cell activation by phosphorylating ITAMs (immunoreceptor tyr activation motifs) in CD19 and in Ig components of BCR. It negatively regulates signaling by its unique ability to phosphorylate ITIMs (immunoreceptor tyr inhibition motifs) in cell surface receptors like CD22 and CD5. Lyn also plays an important role in G-CSF receptor signaling by phosphorylating a variety of adaptor molecules. Length = 261 |
| >gnl|CDD|133202 cd05071, PTKc_Src, Catalytic domain of the Protein Tyrosine Kinase, Src | Back alignment and domain information |
|---|
Score = 72.0 bits (176), Expect = 4e-14
Identities = 41/96 (42%), Positives = 64/96 (66%), Gaps = 9/96 (9%)
Query: 271 IAQGLLYLHQYSRLRVIHRDLKASNILLDKDMNPKISDFGMARMFGGDELQSNTKRIVGT 330
IA G+ Y+ R+ +HRDL+A+NIL+ +++ K++DFG+AR+ +E T R
Sbjct: 111 IASGMAYVE---RMNYVHRDLRAANILVGENLVCKVADFGLARLIEDNEY---TARQGAK 164
Query: 331 Y--GYMSPEYALRGLFSIKSDVFSFGVLLLETLSSK 364
+ + +PE AL G F+IKSDV+SFG+LL E L++K
Sbjct: 165 FPIKWTAPEAALYGRFTIKSDVWSFGILLTE-LTTK 199
|
Protein Tyrosine Kinase (PTK) family; Src kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Src (or c-Src) is a cytoplasmic (or non-receptor) tyr kinase, containing an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region with a conserved tyr. It is activated by autophosphorylation at the tyr kinase domain, and is negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). c-Src is the vertebrate homolog of the oncogenic protein (v-Src) from Rous sarcoma virus. Together with other Src subfamily proteins, it is involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Src also play a role in regulating cell adhesion, invasion, and motility in cancer cells and tumor vasculature, contributing to cancer progression and metastasis. Elevated levels of Src kinase activity have been reported in a variety of human cancers. Several inhibitors of Src have been developed as anti-cancer drugs. Src is also implicated in acute inflammatory responses and osteoclast function. Length = 262 |
| >gnl|CDD|173661 cd05570, STKc_PKC, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase C | Back alignment and domain information |
|---|
Score = 72.8 bits (179), Expect = 4e-14
Identities = 35/93 (37%), Positives = 50/93 (53%), Gaps = 9/93 (9%)
Query: 271 IAQGLLYLHQYSRLRVIHRDLKASNILLDKDMNPKISDFGMAR--MFGGDELQSNTKRIV 328
I GL +LH+ +I+RDLK N+LLD + + KI+DFGM + + GG T
Sbjct: 105 IVLGLQFLHERG---IIYRDLKLDNVLLDSEGHIKIADFGMCKEGILGGV----TTSTFC 157
Query: 329 GTYGYMSPEYALRGLFSIKSDVFSFGVLLLETL 361
GT Y++PE + D ++ GVLL E L
Sbjct: 158 GTPDYIAPEILSYQPYGPAVDWWALGVLLYEML 190
|
Serine/Threonine Kinases (STKs), Protein Kinase C (PKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, classical PKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. Novel PKCs are calcium-independent, but require DAG and PS for activity, while atypical PKCs only require PS. PKCs phosphorylate and modify the activities of a wide variety of cellular proteins including receptors, enzymes, cytoskeletal proteins, transcription factors, and other kinases. They play a central role in signal transduction pathways that regulate cell migration and polarity, proliferation, differentiation, and apoptosis. Also included in this subfamily are the PKC-like proteins, called PKNs. Length = 318 |
| >gnl|CDD|173678 cd05587, STKc_cPKC, Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C | Back alignment and domain information |
|---|
Score = 72.5 bits (178), Expect = 5e-14
Identities = 37/94 (39%), Positives = 54/94 (57%), Gaps = 9/94 (9%)
Query: 271 IAQGLLYLHQYSRLRVIHRDLKASNILLDKDMNPKISDFGMAR--MFGGDELQSNTKRIV 328
IA GL +LH +I+RDLK N++LD + + KI+DFGM + +FGG T+
Sbjct: 110 IAIGLFFLHSKG---IIYRDLKLDNVMLDAEGHIKIADFGMCKENIFGGK----TTRTFC 162
Query: 329 GTYGYMSPEYALRGLFSIKSDVFSFGVLLLETLS 362
GT Y++PE + D ++FGVLL E L+
Sbjct: 163 GTPDYIAPEIIAYQPYGKSVDWWAFGVLLYEMLA 196
|
Serine/Threonine Kinases (STKs), Classical (or Conventional) Protein Kinase C (cPKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. cPKCs contain a calcium-binding C2 region in their regulatory domain. There are four cPKC isoforms, named alpha, betaI, betaII, and gamma. cPKCs are potent kinases for histones, myelin basic protein, and protamine. PKC-gamma is mainly expressed in neuronal tissues. It plays a role in protection from ischemia. Length = 324 |
| >gnl|CDD|132963 cd06632, STKc_MEKK1_plant, Catalytic domain of the Protein Serine/Threonine Kinase, Plant MAP/ERK kinase kinase 1 | Back alignment and domain information |
|---|
Score = 71.7 bits (176), Expect = 5e-14
Identities = 48/171 (28%), Positives = 78/171 (45%), Gaps = 24/171 (14%)
Query: 271 IAQGLLYLHQYSRLRVIHRDLKASNILLDKDMNPKISDFGMARMFGGDELQSNTKRIVGT 330
I GL YLH R +HRD+K +NIL+D + K++DFGMA+ S K G+
Sbjct: 111 ILLGLEYLH--DR-NTVHRDIKGANILVDTNGVVKLADFGMAKQV---VEFSFAKSFKGS 164
Query: 331 YGYMSPEYALR-GLFSIKSDVFSFGVLLLETLSSKKNTHFYNTDSLTLLGHAWNLWNDGR 389
+M+PE + G + + +D++S G +LE + K L + + +
Sbjct: 165 PYWMAPEVIAQQGGYGLAADIWSLGCTVLEMATGKPPWS-----QLEGVAAVFKIGRSKE 219
Query: 390 TWELMDPISQNGASYPILKRYINVALLCVQEKAADRPAMSEVVSMLSNEFV 440
+ D +S K +I L C+Q + RP +E +L + FV
Sbjct: 220 LPPIPDHLSDEA------KDFI---LKCLQRDPSLRPTAAE---LLEHPFV 258
|
Serine/threonine kinases (STKs), plant MAP/ERK kinase kinase 1 (MEKK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The plant MEKK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of plant mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks) including Arabidopsis thaliana MEKK1 and MAPKKK3. MEKK1 is a MAPKKK that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Arabidopsis thaliana MEKK1 activates MPK4, a MAPK that regulates systemic acquired resistance. MEKK1 also participates in the regulation of temperature-sensitive and tissue-specific cell death. Length = 258 |
| >gnl|CDD|173640 cd05067, PTKc_Lck_Blk, Catalytic domain of the Protein Tyrosine Kinases, Lymphocyte-specific kinase and Blk | Back alignment and domain information |
|---|
Score = 71.8 bits (176), Expect = 5e-14
Identities = 37/94 (39%), Positives = 59/94 (62%), Gaps = 8/94 (8%)
Query: 271 IAQGLLYLHQYSRLRVIHRDLKASNILLDKDMNPKISDFGMARMFGGDEL--QSNTKRIV 328
IA+G+ ++ R IHRDL+A+NIL+ + + KI+DFG+AR+ +E + K +
Sbjct: 111 IAEGMAFIE---RKNYIHRDLRAANILVSETLCCKIADFGLARLIEDNEYTAREGAKFPI 167
Query: 329 GTYGYMSPEYALRGLFSIKSDVFSFGVLLLETLS 362
+ +PE G F+IKSDV+SFG+LL E ++
Sbjct: 168 ---KWTAPEAINYGTFTIKSDVWSFGILLTEIVT 198
|
Protein Tyrosine Kinase (PTK) family; Lck and Blk kinases; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Lck (lymphocyte-specific kinase) and Blk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Lck is expressed in T-cells and natural killer (NK) cells. It plays a critical role in T-cell maturation, activation, and T-cell receptor (TCR) signaling. Lck phosphorylates ITAM (immunoreceptor tyr activation motif) sequences on several subunits of TCRs, leading to the activation of different second messenger cascades. Phosphorylated ITAMs serve as binding sites for other signaling factor such as Syk and ZAP-70, leading to their activation and propagation of downstream events. In addition, Lck regulates drug-induced apoptosis by interfering with the mitochondrial death pathway. The apototic role of Lck is independent of its primary function in T-cell signaling. Blk is expressed specifically in B-cells. It is involved in pre-BCR (B-cell receptor) signaling. Length = 260 |
| >gnl|CDD|173636 cd05057, PTKc_EGFR_like, Catalytic domain of Epidermal Growth Factor Receptor-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 71.7 bits (176), Expect = 6e-14
Identities = 35/105 (33%), Positives = 61/105 (58%), Gaps = 9/105 (8%)
Query: 258 LLCWGTRVRIIEGIAQGLLYLHQYSRLRVIHRDLKASNILLDKDMNPKISDFGMARMFGG 317
LL W + IA+G+ YL + R++HRDL A N+L+ + KI+DFG+A++
Sbjct: 111 LLNWCVQ------IAKGMSYLEEK---RLVHRDLAARNVLVKTPQHVKITDFGLAKLLDV 161
Query: 318 DELQSNTKRIVGTYGYMSPEYALRGLFSIKSDVFSFGVLLLETLS 362
DE + + + +M+ E L +++ KSDV+S+GV + E ++
Sbjct: 162 DEKEYHAEGGKVPIKWMALESILHRIYTHKSDVWSYGVTVWELMT 206
|
Protein Tyrosine Kinase (PTK) family; Epidermal Growth Factor Receptor (EGFR) subfamily; catalytic (c) domain. EGFR (HER, ErbB) subfamily members include EGFR (HER1, ErbB1), HER2 (ErbB2), HER3 (ErbB3), HER4 (ErbB4), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The EGFR proteins are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, resulting in the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. Collectively, they can recognize a variety of ligands including EGF, TGFalpha, and neuregulins, among others. All four subfamily members can form homo- or heterodimers. HER3 contains an impaired kinase domain and depends on its heterodimerization partner for activation. EGFR subfamily members are involved in signaling pathways leading to a broad range of cellular responses including cell proliferation, differentiation, migration, growth inhibition, and apoptosis. Gain of function alterations, through their overexpression, deletions, or point mutations in their kinase domains, have been implicated in various cancers. These receptors are targets of many small molecule inhibitors and monoclonal antibodies used in cancer therapy. Length = 279 |
| >gnl|CDD|132961 cd06630, STKc_MEKK1, Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 1 | Back alignment and domain information |
|---|
Score = 71.0 bits (174), Expect = 8e-14
Identities = 50/181 (27%), Positives = 85/181 (46%), Gaps = 37/181 (20%)
Query: 265 VRIIEGIAQGLLYLHQYSRLRVIHRDLKASNILLDKD-MNPKISDFGMA-----RMFGGD 318
+ E + +GL YLH+ ++IHRD+K +N+L+D +I+DFG A + G
Sbjct: 106 INYTEQLLRGLSYLHEN---QIIHRDVKGANLLIDSTGQRLRIADFGAAARLAAKGTGAG 162
Query: 319 ELQSNTKRIVGTYGYMSPEYALRGL-FSIKSDVFSFGVLLLETLSSKKNTHFYNTDSLTL 377
E Q +++GT +M+PE LRG + DV+S G +++E ++K
Sbjct: 163 EFQG---QLLGTIAFMAPE-VLRGEQYGRSCDVWSVGCVIIEMATAKP------------ 206
Query: 378 LGHAWNLWNDGRTWELMDPI-SQNGASYPILKRYIN-----VALLCVQEKAADRPAMSEV 431
WN L+ I S A P + +++ V L C++ + DRP E+
Sbjct: 207 ---PWNAEKHSNHLALIFKIASATTA--PSIPEHLSPGLRDVTLRCLELQPEDRPPSREL 261
Query: 432 V 432
+
Sbjct: 262 L 262
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 1 (MEKK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK1 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK1 activates the extracellular signal-regulated kinase 1/2 (ERK1/2) and c-Jun N-terminal kinase (JNK) pathways by activating their respective MAPKKs, MEK1/2 and MKK4/MKK7, respectively. MEKK1 is important in regulating cell survival and apoptosis. MEKK1 also plays a role in cell migration, tissue maintenance and homeostasis, and wound healing. Length = 268 |
| >gnl|CDD|173637 cd05059, PTKc_Tec_like, Catalytic domain of Tec-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 70.9 bits (174), Expect = 8e-14
Identities = 51/168 (30%), Positives = 72/168 (42%), Gaps = 24/168 (14%)
Query: 271 IAQGLLYLHQYSRLRVIHRDLKASNILLDKDMNPKISDFGMARMFGGDELQSNTKRIVGT 330
+ + + YL IHRDL A N L+ +D K+SDFG+AR D+ S+ GT
Sbjct: 109 VCEAMEYLESNG---FIHRDLAARNCLVGEDNVVKVSDFGLARYVLDDQYTSSQ----GT 161
Query: 331 ---YGYMSPEYALRGLFSIKSDVFSFGVLLLETLSSKKNTHFYNTDSLTLLGHAWNLWND 387
+ PE FS KSDV+SFGVL+ E S K + + ++
Sbjct: 162 KFPVKWAPPEVFDYSRFSSKSDVWSFGVLMWEVFSEGK-MPYERFSNSEVVESV------ 214
Query: 388 GRTWELMDPISQNGASYPILKRYINVALLCVQEKAADRPAMSEVVSML 435
+ L P Y I+ C EK DRPA +++S L
Sbjct: 215 SAGYRLYRPKLAPTEVYTIMY-------SCWHEKPEDRPAFKKLLSQL 255
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase expressed in hepatocellular carcinoma (Tec) subfamily; catalytic (c) domain. The Tec subfamily is composed of Tec, Btk, Bmx (Etk), Itk (Tsk, Emt), Rlk (Txk), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tec kinases are cytoplasmic (or nonreceptor) tyr kinases (nRTKs) with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activation. In addition, some members contain the Tec homology (TH) domain, which contains proline-rich and zinc-binding regions. Tec kinases form the second largest subfamily of nRTKs and are expressed mainly by haematopoietic cells, although Tec and Bmx are also found in endothelial cells. B-cells express Btk and Tec, while T-cells express Itk, Txk, and Tec. Collectively, Tec kinases are expressed in a variety of myeloid cells such as mast cells, platelets, macrophages, and dendritic cells. Each Tec kinase shows a distinct cell-type pattern of expression. The function of Tec kinases in lymphoid cells have been studied extensively. They play important roles in the development, differentiation, maturation, regulation, survival, and function of B-cells and T-cells. Mutations in Btk cause the severe B-cell immunodeficiency, X-linked agammaglobulinaemia (XLA). Length = 256 |
| >gnl|CDD|133204 cd05073, PTKc_Hck, Catalytic domain of the Protein Tyrosine Kinase, Hematopoietic cell kinase | Back alignment and domain information |
|---|
Score = 70.4 bits (172), Expect = 1e-13
Identities = 47/171 (27%), Positives = 85/171 (49%), Gaps = 26/171 (15%)
Query: 271 IAQGLLYLHQYSRLRVIHRDLKASNILLDKDMNPKISDFGMARMFGGDELQSNTKRIVGT 330
IA+G+ ++ Q + IHRDL+A+NIL+ + KI+DFG+AR+ +E T R
Sbjct: 111 IAEGMAFIEQRN---YIHRDLRAANILVSASLVCKIADFGLARVIEDNEY---TAREGAK 164
Query: 331 Y--GYMSPEYALRGLFSIKSDVFSFGVLLLETLSSKKNTH--FYNTDSLTLLGHAWNLWN 386
+ + +PE G F+IKSDV+SFG+LL+E ++ + + N + + L + +
Sbjct: 165 FPIKWTAPEAINFGSFTIKSDVWSFGILLMEIVTYGRIPYPGMSNPEVIRALERGYRM-- 222
Query: 387 DGRTWELMDPISQNGASYPILKRYINVALLCVQEKAADRPAMSEVVSMLSN 437
+ P + N+ + C + + +RP + S+L +
Sbjct: 223 ------------PRPENCP--EELYNIMMRCWKNRPEERPTFEYIQSVLDD 259
|
Protein Tyrosine Kinase (PTK) family; Hematopoietic cell kinase (Hck); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Hck is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Hck is present in myeloid and lymphoid cells that play a role in the development of cancer. It may be important in the oncogenic signaling of the protein Tel-Abl, which induces a chronic myelogenous leukemia (CML)-like disease. Hck also acts as a negative regulator of granulocyte colony-stimulating factor (G-CSF)-induced proliferation of granulocytic precursors, suggesting a possible role in the development of acute myeloid leukemia (AML). In addition, Hck is essential in regulating the degranulation of polymorphonuclear leukocytes (PMNs). Genetic polymorphisms affect the expression level of Hck, which affects PMN mediator release and influences the development of chronic obstructive pulmonary disease (COPD). Length = 260 |
| >gnl|CDD|133172 cd05040, PTKc_Ack_like, Catalytic domain of the Protein Tyrosine Kinase, Activated Cdc42-associated kinase | Back alignment and domain information |
|---|
Score = 70.1 bits (172), Expect = 1e-13
Identities = 51/173 (29%), Positives = 67/173 (38%), Gaps = 29/173 (16%)
Query: 271 IAQGLLYLHQYSRLRVIHRDLKASNILLDKDMNPKISDFGMARMF--GGDELQSNTKRIV 328
IA G+ YL R IHRDL A NILL D KI DFG+ R D V
Sbjct: 106 IANGMRYLESK---RFIHRDLAARNILLASDDKVKIGDFGLMRALPQNEDHYVMEEHLKV 162
Query: 329 GTYGYMSPEYALRGL-FSIKSDVFSFGVLLLETLSSKKNTHFYNTDSLTLLGHAWNLWND 387
+ + +PE +LR FS SDV+ FGV L E + + W
Sbjct: 163 -PFAWCAPE-SLRTRTFSHASDVWMFGVTLWEMFT-----------------YGEEPWAG 203
Query: 388 GRTWELMDPISQNGASYPILK----RYINVALLCVQEKAADRPAMSEVVSMLS 436
+++ I + G + NV L C ADRP + + L
Sbjct: 204 LSGSQILKKIDKEGERLERPEACPQDIYNVMLQCWAHNPADRPTFAALREFLP 256
|
Protein Tyrosine Kinase (PTK) family; Activated Cdc42-associated kinase (Ack) subfamily; catalytic (c) domain. Ack subfamily members include Ack1, thirty-eight-negative kinase 1 (Tnk1), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ack subfamily members are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal catalytic domain, an SH3 domain, a Cdc42-binding CRIB domain, and a proline-rich region. They are mainly expressed in brain and skeletal tissues and are involved in the regulation of cell adhesion and growth, receptor degradation, and axonal guidance. Ack1 is also associated with androgen-independent prostate cancer progression. Tnk1 regulates TNFalpha signaling and may play an important role in cell death. Length = 257 |
| >gnl|CDD|173629 cd05041, PTKc_Fes_like, Catalytic domain of Fes-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 69.8 bits (171), Expect = 2e-13
Identities = 38/94 (40%), Positives = 54/94 (57%), Gaps = 9/94 (9%)
Query: 272 AQGLLYLHQYSRLRVIHRDLKASNILLDKDMNPKISDFGMARMFGGD--ELQSNTKRIVG 329
A G+ YL + IHRDL A N L+ ++ KISDFGM+R G + K+I
Sbjct: 103 AAGMEYLESKN---CIHRDLAARNCLVGENNVLKISDFGMSREEEGGIYTVSDGLKQI-- 157
Query: 330 TYGYMSPEYALR-GLFSIKSDVFSFGVLLLETLS 362
+ +PE AL G ++ +SDV+S+G+LL ET S
Sbjct: 158 PIKWTAPE-ALNYGRYTSESDVWSYGILLWETFS 190
|
Protein Tyrosine Kinase (PTK) family; Fes subfamily; catalytic (c) domain. Fes subfamily members include Fes (or Fps), Fer, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fes subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. The genes for Fes (feline sarcoma) and Fps (Fujinami poultry sarcoma) were first isolated from tumor-causing retroviruses. The viral oncogenes encode chimeric Fes proteins consisting of Gag sequences at the N-termini, resulting in unregulated tyr kinase activity. Fes and Fer kinases play roles in haematopoiesis, inflammation and immunity, growth factor signaling, cytoskeletal regulation, cell migration and adhesion, and the regulation of cell-cell interactions. Fes and Fer show redundancy in their biological functions. Length = 251 |
| >gnl|CDD|173733 cd07829, STKc_CDK_like, Catalytic domain of Cyclin-Dependent protein Kinase-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 69.8 bits (172), Expect = 2e-13
Identities = 36/93 (38%), Positives = 55/93 (59%), Gaps = 6/93 (6%)
Query: 273 QGLLYLHQYSRLRVIHRDLKASNILLDKDMNPKISDFGMARMFGGDELQSNTKRIVGTYG 332
+GL Y H + R++HRDLK NIL+++D K++DFG+AR F G L++ T +V T
Sbjct: 109 RGLAYCHSH---RILHRDLKPQNILINRDGVLKLADFGLARAF-GIPLRTYTHEVV-TLW 163
Query: 333 YMSPEYALRGLF-SIKSDVFSFGVLLLETLSSK 364
Y +PE L S D++S G + E ++ K
Sbjct: 164 YRAPEILLGSKHYSTAVDIWSVGCIFAEMITGK 196
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase (CDK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKs are partly regulated by their subcellular localization, which defines substrate phosphorylation and the resulting specific function. CDK1, CDK2, CDK4, and CDK6 have well-defined functions in the cell cycle, such as the regulation of the early G1 phase by CDK4 or CDK6, the G1/S phase transition by CDK2, or the entry of mitosis by CDK1. They also exhibit overlapping cyclin specificity and functions in certain conditions. Knockout mice with a single CDK deleted remain viable with specific phenotypes, showing that some CDKs can compensate for each other. For example, CDK4 can compensate for the loss of CDK6, however, double knockout mice with both CDK4 and CDK6 deleted die in utero. CDK8 and CDK9 are mainly involved in transcription while CDK5 is implicated in neuronal function. CDK7 plays essential roles in both the cell cycle as a CDK-Activating Kinase (CAK) and in transcription as a component of the general transcription factor TFIIH. Length = 282 |
| >gnl|CDD|133171 cd05039, PTKc_Csk_like, Catalytic domain of C-terminal Src kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 69.4 bits (170), Expect = 2e-13
Identities = 36/95 (37%), Positives = 56/95 (58%), Gaps = 14/95 (14%)
Query: 271 IAQGLLYLHQYSRLRVIHRDLKASNILLDKDMNPKISDFGMARMFGGDELQSNTKRIVGT 330
+ +G+ YL + +HRDL A N+L+ +D+ K+SDFG+A+ +++ + G
Sbjct: 111 VCEGMEYLEEK---NFVHRDLAARNVLVSEDLVAKVSDFGLAK-------EASQGQDSGK 160
Query: 331 Y--GYMSPEYALR-GLFSIKSDVFSFGVLLLETLS 362
+ +PE ALR FS KSDV+SFG+LL E S
Sbjct: 161 LPVKWTAPE-ALREKKFSTKSDVWSFGILLWEIYS 194
|
Protein Tyrosine Kinase (PTK) family; C-terminal Src kinase (Csk) subfamily; catalytic (c) domain. The Csk subfamily is composed of Csk, Chk, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. To inhibit Src kinases, Csk and Chk are translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Csk catalyzes the tyr phosphorylation of the regulatory C-terminal tail of Src kinases, resulting in their inactivation. Chk inhibit Src kinases using a noncatalytic mechanism by simply binding to them. As negative regulators of Src kinases, Csk and Chk play important roles in cell proliferation, survival, and differentiation, and consequently, in cancer development and progression. Length = 256 |
| >gnl|CDD|133180 cd05049, PTKc_Trk, Catalytic domain of the Protein Tyrosine Kinases, Tropomyosin Related Kinases | Back alignment and domain information |
|---|
Score = 69.8 bits (171), Expect = 3e-13
Identities = 39/122 (31%), Positives = 60/122 (49%), Gaps = 11/122 (9%)
Query: 252 NPTKKGLLCWGTRVRIIEGIAQGLLYLHQYSRLRVIHRDLKASNILLDKDMNPKISDFGM 311
+ G L ++I IA G++YL + +HRDL N L+ D+ KI DFGM
Sbjct: 112 PDSPMGELTLSQLLQIAVQIASGMVYL---ASQHFVHRDLATRNCLVGYDLVVKIGDFGM 168
Query: 312 ARMFGGDELQSNTKRIVGT----YGYMSPEYALRGLFSIKSDVFSFGVLLLETLSSKKNT 367
+R D ++ R+ G +M PE + F+ +SDV+SFGV+L E + K
Sbjct: 169 SR----DVYTTDYYRVGGHTMLPIRWMPPESIMYRKFTTESDVWSFGVVLWEIFTYGKQP 224
Query: 368 HF 369
+
Sbjct: 225 WY 226
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase (Trk) subfamily; catalytic (c) domain. The Trk subfamily consists of TrkA, TrkB, TrkC, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Trk subfamily members are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, the nerve growth factor (NGF) family of neutrotrophins, leads to Trk receptor oligomerization and activation of the catalytic domain. Trk receptors are mainly expressed in the peripheral and central nervous systems. They play important roles in cell fate determination, neuronal survival and differentiation, as well as in the regulation of synaptic plasticity. Altered expression of Trk receptors is associated with many human diseases. Length = 280 |
| >gnl|CDD|173630 cd05044, PTKc_c-ros, Catalytic domain of the Protein Tyrosine Kinase, C-ros | Back alignment and domain information |
|---|
Score = 69.5 bits (170), Expect = 3e-13
Identities = 39/98 (39%), Positives = 58/98 (59%), Gaps = 10/98 (10%)
Query: 271 IAQGLLYLHQYSRLRVIHRDLKASNILL-----DKDMNPKISDFGMAR-MFGGDELQSNT 324
+A+G +YL Q + IHRDL A N L+ D D KI DFG+AR ++ D +
Sbjct: 115 VAKGCVYLEQ---MHFIHRDLAARNCLVSEKGYDADRVVKIGDFGLARDIYKSDYYRKEG 171
Query: 325 KRIVGTYGYMSPEYALRGLFSIKSDVFSFGVLLLETLS 362
+ ++ +M+PE L G F+ +SDV+SFGVL+ E L+
Sbjct: 172 EGLLPVR-WMAPESLLDGKFTTQSDVWSFGVLMWEILT 208
|
Protein Tyrosine Kinases (PTK) family; C-ros and Drosophila Sevenless proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The proto-oncogene c-ros encodes an orphan receptor tyr kinase (RTK) with an unknown ligand. RTKs contain an extracellular ligand-binding domain, a transmembrane region, and an intracellular tyr kinase domain. RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. C-ros is expressed in embryonic cells of the kidney, intestine and lung, but disappears soon after birth. It persists only in the adult epididymis. Male mice bearing inactive mutations of c-ros lack the initial segment of the epididymis and are infertile. The Drosophila protein, Sevenless, is required for the specification of the R7 photoreceptor cell during eye development. Length = 269 |
| >gnl|CDD|133189 cd05058, PTKc_Met_Ron, Catalytic domain of the Protein Tyrosine Kinases, Met and Ron | Back alignment and domain information |
|---|
Score = 69.4 bits (170), Expect = 3e-13
Identities = 61/191 (31%), Positives = 86/191 (45%), Gaps = 25/191 (13%)
Query: 251 NNPTKKGLLCWGTRVRIIEGIAQGLLYLHQYSRLRVIHRDLKASNILLDKDMNPKISDFG 310
+NPT K L+ +G +V A+G+ YL + +HRDL A N +LD+ K++DFG
Sbjct: 93 HNPTVKDLIGFGLQV------AKGMEYLASK---KFVHRDLAARNCMLDESFTVKVADFG 143
Query: 311 MARMFGGDELQS--NTKRIVGTYGYMSPEYALRGLFSIKSDVFSFGVLLLETLSSKKNTH 368
+AR E S N +M+ E F+ KSDV+SFGVLL E L ++
Sbjct: 144 LARDIYDKEYYSVHNHTGAKLPVKWMALESLQTQKFTTKSDVWSFGVLLWE-LMTRGAPP 202
Query: 369 FYNTDSLTLLGHAWNLWNDGRTWELMDPISQNGASYPILKRYINVALLCVQEKAADRPAM 428
+ + DS + GR L+ P Y V L C K RP
Sbjct: 203 YPDVDSFDIT----VYLLQGR--RLLQPEYCPDPLY-------EVMLSCWHPKPEMRPTF 249
Query: 429 SEVVSMLSNEF 439
SE+VS + F
Sbjct: 250 SELVSRIEQIF 260
|
Protein Tyrosine Kinase (PTK) family; Met and Ron; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Met and Ron are receptor tyr kinases (RTKs) composed of an alpha-beta heterodimer. The extracellular alpha chain is disulfide linked to the beta chain, which contains an extracellular ligand-binding region with a sema domain, a PSI domain and four IPT repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Met binds to the ligand, hepatocyte growth factor/scatter factor (HGF/SF), and is also called the HGF receptor. HGF/Met signaling plays a role in growth, transformation, cell motility, invasion, metastasis, angiogenesis, wound healing, and tissue regeneration. Aberrant expression of Met through mutations or gene amplification is associated with many human cancers including hereditary papillary renal and gastric carcinomas. The ligand for Ron is macrophage stimulating protein (MSP). Ron signaling is important in regulating cell motility, adhesion, proliferation, and apoptosis. Aberrant Ron expression is implicated in tumorigenesis and metastasis. Length = 262 |
| >gnl|CDD|133165 cd05033, PTKc_EphR, Catalytic domain of Ephrin Receptor Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 68.9 bits (169), Expect = 4e-13
Identities = 39/108 (36%), Positives = 60/108 (55%), Gaps = 7/108 (6%)
Query: 257 GLLCWGTRVRIIEGIAQGLLYLHQYSRLRVIHRDLKASNILLDKDMNPKISDFGMARMFG 316
G G V ++ GIA G+ YL S + +HRDL A NIL++ ++ K+SDFG++R
Sbjct: 101 GKFTVGQLVGMLRGIASGMKYL---SEMNYVHRDLAARNILVNSNLVCKVSDFGLSRRLE 157
Query: 317 GDELQSNTK--RIVGTYGYMSPEYALRGLFSIKSDVFSFGVLLLETLS 362
E TK +I + +PE F+ SDV+SFG+++ E +S
Sbjct: 158 DSEATYTTKGGKI--PIRWTAPEAIAYRKFTSASDVWSFGIVMWEVMS 203
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). They can be classified into two classes (EphA and EphB), according to their extracellular sequences, which largely correspond to binding preferences for either GPI-anchored ephrin-A ligands or transmembrane ephrin-B ligands. Vertebrates have ten EphA and six EhpB receptors, which display promiscuous ligand interactions within each class. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. This allows ephrin/EphR dimers to form, leading to the activation of the intracellular tyr kinase domain. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). The main effect of ephrin/EphR interaction is cell-cell repulsion or adhesion. Ephrin/EphR signaling is important in neural development and plasticity, cell morphogenesis and proliferation, cell-fate determination, embryonic development, tissue patterning, and angiogenesis. Length = 266 |
| >gnl|CDD|173760 cd08220, STKc_Nek8, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 8 | Back alignment and domain information |
|---|
Score = 68.7 bits (168), Expect = 4e-13
Identities = 42/112 (37%), Positives = 60/112 (53%), Gaps = 4/112 (3%)
Query: 267 IIEGIAQGLLYLHQYSRLRVIHRDLKASNILLDK-DMNPKISDFGMARMFGGDELQSNTK 325
I+ Q LL LH ++HRDLK NILLDK M KI DFG++++ +S
Sbjct: 103 ILHFFVQILLALHHVHTKLILHRDLKTQNILLDKHKMVVKIGDFGISKILSS---KSKAY 159
Query: 326 RIVGTYGYMSPEYALRGLFSIKSDVFSFGVLLLETLSSKKNTHFYNTDSLTL 377
+VGT Y+SPE ++ KSD+++ G +L E S K+ N +L L
Sbjct: 160 TVVGTPCYISPELCEGKPYNQKSDIWALGCVLYELASLKRAFEAANLPALVL 211
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 8 (Nek8) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek8 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek8 contains an N-terminal kinase catalytic domain and a C-terminal RCC1 (regulator of chromosome condensation) domain. A double point mutation in Nek8 causes cystic kidney disease in mice that genetically resembles human autosomal recessive polycystic kidney disease (ARPKD). Nek8 is also associated with a rare form of juvenile renal cystic disease, nephronophthisis type 9. It has been suggested that a defect in the ciliary localization of Nek8 contributes to the development of cysts manifested by these diseases. Length = 256 |
| >gnl|CDD|173729 cd06617, PKc_MKK3_6, Catalytic domain of the dual-specificity Protein Kinases, MAP kinase kinases 3 and 6 | Back alignment and domain information |
|---|
Score = 69.0 bits (169), Expect = 5e-13
Identities = 38/100 (38%), Positives = 59/100 (59%), Gaps = 13/100 (13%)
Query: 266 RIIEGIAQGLLYLHQYSRLRVIHRDLKASNILLDKDMNPKISDFGMARMFGGDELQSNTK 325
+I I + L YLH S+L VIHRD+K SN+L++++ K+ DFG++ G + S K
Sbjct: 107 KIAVSIVKALEYLH--SKLSVIHRDVKPSNVLINRNGQVKLCDFGIS----GYLVDSVAK 160
Query: 326 RI-VGTYGYMSPE-----YALRGLFSIKSDVFSFGVLLLE 359
I G YM+PE +G + +KSDV+S G+ ++E
Sbjct: 161 TIDAGCKPYMAPERINPELNQKG-YDVKSDVWSLGITMIE 199
|
Protein kinases (PKs), MAP kinase kinase 3 (MKK3) and MKK6 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK3 and MKK6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK3 and MKK6 are dual-specificity PKs that phosphorylate and activate their downstream target, p38 MAPK, on specific threonine and tyrosine residues. MKK3/6 plays roles in the regulation of cell cycle progression, cytokine- and stress-induced apoptosis, oncogenic transformation, and adult tissue regeneration. In addition, MKK6 plays a critical role in osteoclast survival in inflammatory disease while MKK3 is associated with tumor invasion, progression, and poor patient survival in glioma. Length = 283 |
| >gnl|CDD|133179 cd05048, PTKc_Ror, Catalytic Domain of the Protein Tyrosine Kinases, Receptor tyrosine kinase-like Orphan Receptors | Back alignment and domain information |
|---|
Score = 69.0 bits (169), Expect = 5e-13
Identities = 37/93 (39%), Positives = 56/93 (60%), Gaps = 5/93 (5%)
Query: 271 IAQGLLYLHQYSRLRVIHRDLKASNILLDKDMNPKISDFGMAR-MFGGDELQSNTKRIVG 329
IA G+ YL S +HRDL A N L+ + + KISDFG++R ++ D + +K ++
Sbjct: 133 IAAGMEYL---SSHHFVHRDLAARNCLVGEGLTVKISDFGLSRDIYSADYYRVQSKSLLP 189
Query: 330 TYGYMSPEYALRGLFSIKSDVFSFGVLLLETLS 362
+M PE L G F+ +SD++SFGV+L E S
Sbjct: 190 VR-WMPPEAILYGKFTTESDIWSFGVVLWEIFS 221
|
Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor (Ror) subfamily; catalytic (c) domain. The Ror subfamily consists of Ror1, Ror2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. Ror kinases are expressed in many tissues during development. They play important roles in bone and heart formation. Mutations in human Ror2 result in two different bone development genetic disorders, recessive Robinow syndrome and brachydactyly type B. Drosophila Ror is expressed only in the developing nervous system during neurite outgrowth and neuronal differentiation, suggesting a role for Drosophila Ror in neural development. More recently, mouse Ror1 and Ror2 have also been found to play an important role in regulating neurite growth in central neurons. Ror1 and Ror2 are believed to have some overlapping and redundant functions. Length = 283 |
| >gnl|CDD|240344 PTZ00283, PTZ00283, serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Score = 70.7 bits (173), Expect = 5e-13
Identities = 36/93 (38%), Positives = 54/93 (58%)
Query: 273 QGLLYLHQYSRLRVIHRDLKASNILLDKDMNPKISDFGMARMFGGDELQSNTKRIVGTYG 332
Q LL +H +IHRD+K++NILL + K+ DFG ++M+ + GT
Sbjct: 151 QVLLAVHHVHSKHMIHRDIKSANILLCSNGLVKLGDFGFSKMYAATVSDDVGRTFCGTPY 210
Query: 333 YMSPEYALRGLFSIKSDVFSFGVLLLETLSSKK 365
Y++PE R +S K+D+FS GVLL E L+ K+
Sbjct: 211 YVAPEIWRRKPYSKKADMFSLGVLLYELLTLKR 243
|
Length = 496 |
| >gnl|CDD|173657 cd05113, PTKc_Btk_Bmx, Catalytic domain of the Protein Tyrosine Kinases, Bruton's tyrosine kinase and Bone marrow kinase on the X chromosome | Back alignment and domain information |
|---|
Score = 68.0 bits (166), Expect = 8e-13
Identities = 54/171 (31%), Positives = 80/171 (46%), Gaps = 34/171 (19%)
Query: 271 IAQGLLYL--HQYSRLRVIHRDLKASNILLDKDMNPKISDFGMARMFGGDELQSNTKRIV 328
+ +G+ YL Q+ IHRDL A N L+D K+SDFG++R DE S+ V
Sbjct: 109 VCEGMAYLESKQF-----IHRDLAARNCLVDDQGCVKVSDFGLSRYVLDDEYTSS----V 159
Query: 329 GT---YGYMSPEYALRGLFSIKSDVFSFGVLLLETLSSKKNTHFYNTDSLTLLGHAWNLW 385
G+ + PE L FS KSDV++FGVL+ E S K + +S
Sbjct: 160 GSKFPVRWSPPEVLLYSKFSSKSDVWAFGVLMWEVYSLGKMPYERFNNS----------- 208
Query: 386 NDGRTWELMDPISQNGASY-PIL--KRYINVALLCVQEKAADRPAMSEVVS 433
E ++ +SQ Y P L ++ + C EKA +RP +++S
Sbjct: 209 ------ETVEKVSQGLRLYRPHLASEKVYAIMYSCWHEKAEERPTFQQLLS 253
|
Protein Tyrosine Kinase (PTK) family; Bruton's tyrosine kinase (Btk) and Bone marrow kinase on the X chromosome (Bmx); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Btk and Bmx (also named Etk) are members of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activation. In addition, Btk contains the Tec homology (TH) domain with proline-rich and zinc-binding regions. Tec kinases are expressed mainly by haematopoietic cells. Btk is expressed in B-cells, and a variety of myeloid cells including mast cells, platelets, neutrophils, and dendrictic cells. It interacts with a variety of partners, from cytosolic proteins to nuclear transcription factors, suggesting a diversity of functions. Stimulation of a diverse array of cell surface receptors, including antigen engagement of the B-cell receptor (BCR), leads to PH-mediated membrane translocation of Btk and subsequent phosphorylation by Src kinase and activation. Btk plays an important role in the life cycle of B-cells including their development, differentiation, proliferation, survival, and apoptosis. Mutations in Btk cause the primary immunodeficiency disease, X-linked agammaglobulinaemia (XLA) in humans. Bmx is primarily expressed in bone marrow and the arterial endothelium, and plays an important role in ischemia-induced angiogenesis. It facilitates arterial growth, capillary formation, vessel maturation, and bone marrow-derived endothelial progenitor cell mobilization. Length = 256 |
| >gnl|CDD|173683 cd05592, STKc_nPKC_theta_delta, Catalytic domain of the Protein Serine/Threonine Kinases, Novel Protein Kinase C theta and delta | Back alignment and domain information |
|---|
Score = 67.9 bits (166), Expect = 1e-12
Identities = 41/105 (39%), Positives = 59/105 (56%), Gaps = 5/105 (4%)
Query: 271 IAQGLLYLHQYSRLRVIHRDLKASNILLDKDMNPKISDFGMARMFGGDELQSNTKRIVGT 330
I GL +LH+ +I+RDLK N+LLDKD + KI+DFGM + E +++T GT
Sbjct: 105 IICGLQFLHKKG---IIYRDLKLDNVLLDKDGHIKIADFGMCKENMNGEGKAST--FCGT 159
Query: 331 YGYMSPEYALRGLFSIKSDVFSFGVLLLETLSSKKNTHFYNTDSL 375
Y++PE ++ D +SFGVLL E L + H + D L
Sbjct: 160 PDYIAPEILKGQKYNESVDWWSFGVLLYEMLIGQSPFHGEDEDEL 204
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), theta and delta-like isoforms, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-theta is selectively expressed in T-cells and plays an important and non-redundant role in several aspects of T-cell biology. PKC-delta plays a role in cell cycle regulation and programmed cell death in many cell types. Length = 316 |
| >gnl|CDD|173639 cd05066, PTKc_EphR_A, Catalytic domain of the Protein Tyrosine Kinases, Class EphA Ephrin Receptors | Back alignment and domain information |
|---|
Score = 67.2 bits (164), Expect = 2e-12
Identities = 49/183 (26%), Positives = 85/183 (46%), Gaps = 40/183 (21%)
Query: 265 VRIIEGIAQGLLYLHQYSRLRVIHRDLKASNILLDKDMNPKISDFGMARMFGGDELQSNT 324
V ++ GIA G+ YL S + +HRDL A NIL++ ++ K+SDFG++R+ D + T
Sbjct: 109 VGMLRGIASGMKYL---SDMGYVHRDLAARNILVNSNLVCKVSDFGLSRVLEDDPEAAYT 165
Query: 325 KRIVGTYG------YMSPEYALRGLFSIKSDVFSFGVLLLETLSSKKNTHFYNTDSLTLL 378
R G + +PE F+ SDV+S+G+++ E +S + +
Sbjct: 166 TR-----GGKIPIRWTAPEAIAYRKFTSASDVWSYGIVMWEVMSYGERPY---------- 210
Query: 379 GHAWNLWNDG------RTWELMDPISQNGASYPILKRYINVALLCVQEKAADRPAMSEVV 432
W + N + L P+ A + ++ L C Q+ +RP ++V
Sbjct: 211 ---WEMSNQDVIKAIEEGYRLPAPMDCPAALHQLM-------LDCWQKDRNERPKFEQIV 260
Query: 433 SML 435
S+L
Sbjct: 261 SIL 263
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; most class EphA receptors including EphA3, EphA4, EphA5, and EphA7, but excluding EphA1, EphA2 and EphA10; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. One exception is EphA4, which also binds ephrins-B2/B3. EphRs contain an ephrin-binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). Ephrin/EphR interaction mainly results in cell-cell repulsion or adhesion, making it important in neural development and plasticity, cell morphogenesis, cell-fate determination, embryonic development, tissue patterning, and angiogenesis. EphARs and ephrin-A ligands are expressed in multiple areas of the developing brain, especially in the retina and tectum. They are part of a system controlling retinotectal mapping. Length = 267 |
| >gnl|CDD|132964 cd06633, STKc_TAO3, Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 3 | Back alignment and domain information |
|---|
Score = 68.1 bits (166), Expect = 2e-12
Identities = 55/182 (30%), Positives = 87/182 (47%), Gaps = 29/182 (15%)
Query: 267 IIEGIAQGLLYLHQYSRLRVIHRDLKASNILLDKDMNPKISDFGMARMFGGDELQSNTKR 326
I G QGL YLH ++ IHRD+KA NILL + K++DFG A S
Sbjct: 126 ITHGALQGLAYLHSHNM---IHRDIKAGNILLTEPGQVKLADFGSA------SKSSPANS 176
Query: 327 IVGTYGYMSPEYAL---RGLFSIKSDVFSFGVLLLETLSSKKNTHFYNTDSLTLLGHAWN 383
VGT +M+PE L G + K DV+S G+ +E +++ +N ++++ L H
Sbjct: 177 FVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIEL--AERKPPLFNMNAMSALYHIAQ 234
Query: 384 LWNDGRTWELMDPISQNGASYPILKRYINVALLCVQEKAADRPAMSEVVSMLSNEFVNLP 443
ND P Q+ + +++ C+Q+ +RPA +E +L ++FV
Sbjct: 235 --ND-------SPTLQSNEWTDSFRGFVD---YCLQKIPQERPASAE---LLRHDFVRRD 279
Query: 444 AP 445
P
Sbjct: 280 RP 281
|
Serine/threonine kinases (STKs), thousand-and-one amino acids 3 (TAO3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. TAO3 is also known as JIK (JNK inhibitory kinase) or KFC (kinase from chicken). It specifically activates c-Jun N-terminal kinase (JNK), presumably by phosphorylating and activating MKK4/MKK7. In Saccharomyces cerevisiae, TAO3 is a component of the RAM (regulation of Ace2p activity and cellular morphogenesis) signaling pathway. TAO3 is upregulated in retinal ganglion cells after axotomy, and may play a role in apoptosis. Length = 313 |
| >gnl|CDD|133175 cd05043, PTK_Ryk, Pseudokinase domain of Ryk (Receptor related to tyrosine kinase) | Back alignment and domain information |
|---|
Score = 67.4 bits (165), Expect = 2e-12
Identities = 36/92 (39%), Positives = 54/92 (58%), Gaps = 9/92 (9%)
Query: 271 IAQGLLYLHQYSRLRVIHRDLKASNILLDKDMNPKISDFGMAR-MFGGDE--LQSNTKRI 327
IA G+ YLH + VIH+D+ A N ++D+++ KI+D ++R +F D L N R
Sbjct: 126 IACGMSYLH---KRGVIHKDIAARNCVIDEELQVKITDNALSRDLFPMDYHCLGDNENRP 182
Query: 328 VGTYGYMSPEYALRGLFSIKSDVFSFGVLLLE 359
V +M+ E + +S SDV+SFGVLL E
Sbjct: 183 V---KWMALESLVNKEYSSASDVWSFGVLLWE 211
|
Protein Tyrosine Kinase (PTK) family; Receptor related to tyrosine kinase (Ryk); pseudokinase domain. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ryk is a receptor tyr kinase (RTK) containing an extracellular region with two leucine-rich motifs, a transmembrane segment, and an intracellular inactive pseudokinase domain. The extracellular region of Ryk shows homology to the N-terminal domain of Wnt inhibitory factor-1 (WIF) and serves as the ligand (Wnt) binding domain of Ryk. Ryk is expressed in many different tissues both during development and in adults, suggesting a widespread function. It acts as a chemorepulsive axon guidance receptor of Wnt glycoproteins and is responsible for the establishment of axon tracts during the development of the central nervous system. In addition, studies in mice reveal that Ryk is essential in skeletal, craniofacial, and cardiac development. Thus, it appears Ryk is involved in signal transduction despite its lack of kinase activity. Ryk may function as an accessory protein that modulates the signals coming from catalytically active partner RTKs such as the Eph receptors. Length = 280 |
| >gnl|CDD|132946 cd06615, PKc_MEK, Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase | Back alignment and domain information |
|---|
Score = 67.5 bits (165), Expect = 2e-12
Identities = 33/94 (35%), Positives = 56/94 (59%), Gaps = 6/94 (6%)
Query: 266 RIIEGIAQGLLYLHQYSRLRVIHRDLKASNILLDKDMNPKISDFGMARMFGGDELQSNTK 325
+I + +GL YL + + +++HRD+K SNIL++ K+ DFG++ G + S
Sbjct: 103 KISIAVLRGLTYLRE--KHKIMHRDVKPSNILVNSRGEIKLCDFGVS----GQLIDSMAN 156
Query: 326 RIVGTYGYMSPEYALRGLFSIKSDVFSFGVLLLE 359
VGT YMSPE ++++SD++S G+ L+E
Sbjct: 157 SFVGTRSYMSPERLQGTHYTVQSDIWSLGLSLVE 190
|
Protein kinases (PKs), MAP/ERK kinase (MEK) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK1 and MEK2 are dual-specificity PKs that phosphorylate and activate the downstream targets, ERK(extracellular signal-regulated kinase) 1 and ERK2, on specific threonine and tyrosine residues. The ERK cascade starts with extracellular signals including growth factors, hormones, and neurotransmitters, which act through receptors and ion channels to initiate intracellular signaling that leads to the activation at the MAPKKK (Raf-1 or MOS) level, which leads to the transmission of signals to MEK1/2, and finally to ERK1/2. The ERK cascade plays an important role in cell proliferation, differentiation, oncogenic transformation, and cell cycle control, as well as in apoptosis and cell survival under certain conditions. This cascade has also been implicated in synaptic plasticity, migration, morphological determination, and stress response immunological reactions. Gain-of-function mutations in genes encoding ERK cascade proteins, including MEK1/2, cause cardiofaciocutaneous (CFC) syndrome, a condition leading to multiple congenital anomalies and mental retardation in patients. Length = 308 |
| >gnl|CDD|132960 cd06629, STKc_MAPKKK_Bck1_like, Catalytic domain of fungal Bck1-like MAP Kinase Kinase Kinases | Back alignment and domain information |
|---|
Score = 67.1 bits (164), Expect = 2e-12
Identities = 35/101 (34%), Positives = 60/101 (59%), Gaps = 9/101 (8%)
Query: 269 EGIAQGLLYLHQYSRLRVIHRDLKASNILLDKDMNPKISDFGMARMFGGDELQSN--TKR 326
E + +GL YLH ++HRDLKA N+L+D D KISDFG+++ D++ N
Sbjct: 115 EQVLEGLAYLHSKG---ILHRDLKADNLLVDADGICKISDFGISKK--SDDIYDNDQNMS 169
Query: 327 IVGTYGYMSPE--YALRGLFSIKSDVFSFGVLLLETLSSKK 365
+ G+ +M+PE ++ +S K D++S G ++LE + ++
Sbjct: 170 MQGSVFWMAPEVIHSYSQGYSAKVDIWSLGCVVLEMFAGRR 210
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, fungal Bck1-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include the MAPKKKs Saccharomyces cerevisiae Bck1 and Schizosaccharomyces pombe Mkh1, and related proteins. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Budding yeast Bck1 is part of the cell integrity MAPK pathway, which is activated by stresses and aggressions to the cell wall. The MAPKKK Bck1, MAPKKs Mkk1 and Mkk2, and the MAPK Slt2 make up the cascade that is important in the maintenance of cell wall homeostasis. Fission yeast Mkh1 is involved in MAPK cascades regulating cell morphology, cell wall integrity, salt resistance, and filamentous growth in response to stress. Length = 272 |
| >gnl|CDD|132940 cd06609, STKc_MST3_like, Catalytic domain of Mammalian Ste20-like protein kinase 3-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 66.9 bits (164), Expect = 2e-12
Identities = 33/96 (34%), Positives = 56/96 (58%), Gaps = 11/96 (11%)
Query: 267 IIEGIAQGLLYLHQYSRLRVIHRDLKASNILLDKDMNPKISDFGMARMFGGDELQSNTKR 326
I+ + GL YLH+ IHRD+KA+NILL ++ + K++DFG++ +L S +
Sbjct: 103 ILREVLLGLEYLHEE---GKIHRDIKAANILLSEEGDVKLADFGVS-----GQLTSTMSK 154
Query: 327 ---IVGTYGYMSPEYALRGLFSIKSDVFSFGVLLLE 359
VGT +M+PE + + K+D++S G+ +E
Sbjct: 155 RNTFVGTPFWMAPEVIKQSGYDEKADIWSLGITAIE 190
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 3 (MST3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MST3, MST4, STK25, Schizosaccharomyces pombe Nak1 and Sid1, Saccharomyces cerevisiae sporulation-specific protein 1 (SPS1), and related proteins. Nak1 is required by fission yeast for polarizing the tips of actin cytoskeleton and is involved in cell growth, cell separation, cell morphology and cell-cycle progression. Sid1 is a component in the septation initiation network (SIN) signaling pathway, and plays a role in cytokinesis. SPS1 plays a role in regulating proteins required for spore wall formation. MST4 plays a role in mitogen-activated protein kinase (MAPK) signaling during cytoskeletal rearrangement, morphogenesis, and apoptosis. MST3 phosphorylates the STK NDR and may play a role in cell cycle progression and cell morphology. STK25 may play a role in the regulation of cell migration and polarization. Length = 274 |
| >gnl|CDD|173725 cd06608, STKc_myosinIII_like, Catalytic domain of Class III myosin-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 66.9 bits (164), Expect = 2e-12
Identities = 39/115 (33%), Positives = 59/115 (51%), Gaps = 16/115 (13%)
Query: 256 KGLLCWGTRVR------IIEGIAQGLLYLHQYSRLRVIHRDLKASNILLDKDMNPKISDF 309
KGL G R++ I+ +GL YLH+ +VIHRD+K NILL K+ K+ DF
Sbjct: 101 KGLRKKGKRLKEEWIAYILRETLRGLAYLHEN---KVIHRDIKGQNILLTKNAEVKLVDF 157
Query: 310 GMARMFGGDELQSNTKRIVGTYGYMSPE-----YALRGLFSIKSDVFSFGVLLLE 359
G++ + NT +GT +M+PE + +SDV+S G+ +E
Sbjct: 158 GVSAQLDSTLGRRNT--FIGTPYWMAPEVIACDEQPDASYDARSDVWSLGITAIE 210
|
Serine/threonine kinases (STKs), Class III myosin-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins with an N-terminal kinase catalytic domain and a C-terminal actin-binding motor domain. Class III myosins are present in the photoreceptors of invertebrates and vertebrates and in the auditory hair cells of mammals. The kinase domain of myosin III can phosphorylate several cytoskeletal proteins, conventional myosin regulatory light chains, and can autophosphorylate the C-terminal motor domain. Myosin III may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. It may also function as a cargo carrier during light-dependent translocation, in photoreceptor cells, of proteins such as transducin and arrestin. The Drosophila class III myosin, called NinaC (Neither inactivation nor afterpotential protein C), is critical in normal adaptation and termination of photoresponse. Vertebrates contain two isoforms of class III myosin, IIIA and IIIB. This subfamily also includes mammalian NIK-like embryo-specific kinase (NESK), Traf2- and Nck-interacting kinase (TNIK), mitogen-activated protein kinase (MAPK) kinase kinase kinase 4 (MAPKKKK4 or MAP4K4) and MAPKKKK6 (or MAP4K6). MAP4Ks are involved in some MAPK signaling pathways by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Length = 275 |
| >gnl|CDD|132956 cd06625, STKc_MEKK3_like, Catalytic domain of MAP/ERK kinase kinase 3-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 66.4 bits (162), Expect = 3e-12
Identities = 33/95 (34%), Positives = 51/95 (53%), Gaps = 4/95 (4%)
Query: 271 IAQGLLYLHQYSRLRVIHRDLKASNILLDKDMNPKISDFGMARMFGGDELQ-SNTKRIVG 329
I +G+ YLH ++HRD+K +NIL D N K+ DFG ++ + K + G
Sbjct: 113 ILEGVEYLH---SNMIVHRDIKGANILRDSAGNVKLGDFGASKRLQTICSSGTGMKSVTG 169
Query: 330 TYGYMSPEYALRGLFSIKSDVFSFGVLLLETLSSK 364
T +MSPE + K+DV+S G ++E L+ K
Sbjct: 170 TPYWMSPEVISGEGYGRKADVWSVGCTVVEMLTEK 204
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MEKK3, MEKK2, and related proteins, all containing an N-terminal PB1 domain, which mediates oligomerization, and a C-terminal catalytic domain. MEKK2 and MEKK3 are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks), proteins that phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK2 and MEKK3 activate MEK5 (also called MKK5), which activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK3 plays an essential role in embryonic angiogenesis and early heart development. MEKK2 and MEKK3 can also activate the MAPKs, c-Jun N-terminal kinase (JNK) and p38, through their respective MAPKKs. Length = 263 |
| >gnl|CDD|173732 cd06628, STKc_MAPKKK_Byr2_like, Catalytic domain of fungal Byr2-like MAP Kinase Kinase Kinases | Back alignment and domain information |
|---|
Score = 66.4 bits (162), Expect = 3e-12
Identities = 37/101 (36%), Positives = 62/101 (61%), Gaps = 7/101 (6%)
Query: 268 IEGIAQGLLYLHQYSRLRVIHRDLKASNILLDKDMNPKISDFGMARMFGGDELQS--NTK 325
+ I +GL YLH +R +IHRD+K +NIL+D KISDFG+++ + L + N
Sbjct: 112 VRQILKGLNYLH--NR-GIIHRDIKGANILVDNKGGIKISDFGISKKLEANSLSTKTNGA 168
Query: 326 R--IVGTYGYMSPEYALRGLFSIKSDVFSFGVLLLETLSSK 364
R + G+ +M+PE + ++ K+D++S G L++E L+ K
Sbjct: 169 RPSLQGSVFWMAPEVVKQTSYTRKADIWSLGCLVVEMLTGK 209
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, fungal Byr2-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include the MAPKKKs Schizosaccharomyces pombe Byr2, Saccharomyces cerevisiae and Cryptococcus neoformans Ste11, and related proteins. They contain an N-terminal SAM (sterile alpha-motif) domain, which mediates protein-protein interaction, and a C-terminal catalytic domain. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Fission yeast Byr2 is regulated by Ras1. It responds to pheromone signaling and controls mating through the MAPK pathway. Budding yeast Ste11 functions in MAPK cascades that regulate mating, high osmolarity glycerol, and filamentous growth responses. Length = 267 |
| >gnl|CDD|133234 cd05103, PTKc_VEGFR2, Catalytic domain of the Protein Tyrosine Kinase, Vascular Endothelial Growth Factor Receptor 2 | Back alignment and domain information |
|---|
Score = 67.4 bits (164), Expect = 3e-12
Identities = 48/149 (32%), Positives = 79/149 (53%), Gaps = 14/149 (9%)
Query: 217 NGVAFGAAPTYTSFLYEQVLVQSKDEISFWYESYNNP-TKKGLLCWGTRVRIIEGIAQGL 275
+ + + + F+ E+ L ++E + + Y T + L+C+ +V A+G+
Sbjct: 139 DSITSSQSSASSGFVEEKSLSDVEEEEAEQEDLYKKVLTLEDLICYSFQV------AKGM 192
Query: 276 LYLHQYSRLRVIHRDLKASNILLDKDMNPKISDFGMARMF--GGDELQSNTKRIVGTYGY 333
+L SR + IHRDL A NILL ++ KI DFG+AR D ++ R+ +
Sbjct: 193 EFLA--SR-KCIHRDLAARNILLSENNVVKICDFGLARDIYKDPDYVRKGDARL--PLKW 247
Query: 334 MSPEYALRGLFSIKSDVFSFGVLLLETLS 362
M+PE +++I+SDV+SFGVLL E S
Sbjct: 248 MAPETIFDRVYTIQSDVWSFGVLLWEIFS 276
|
Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor 2 (VEGFR2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR2 (or Flk1) is a member of the VEGFR subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. The carboxyl terminus of VEGFR2 plays an important role in its autophosphorylation and activation. VEGFR2 binds the ligands VEGFA, VEGFC, VEGFD and VEGFE. VEGFR2 signaling is implicated in all aspects of normal and pathological vascular endothelial cell biology. It induces a variety of cellular effects including migration, survival, and proliferation. It is critical in regulating embryonic vascular development and angiogenesis. VEGFR2 is the major signal transducer in pathological angiogenesis including cancer and diabetic retinopathy, and is a target for inhibition in cancer therapy. Length = 343 |
| >gnl|CDD|173651 cd05095, PTKc_DDR2, Catalytic domain of the Protein Tyrosine Kinase, Discoidin Domain Receptor 2 | Back alignment and domain information |
|---|
Score = 66.5 bits (162), Expect = 4e-12
Identities = 56/169 (33%), Positives = 81/169 (47%), Gaps = 17/169 (10%)
Query: 271 IAQGLLYLHQYSRLRVIHRDLKASNILLDKDMNPKISDFGMAR-MFGGD--ELQSNTKRI 327
IA G+ YL S L +HRDL N L+ K+ KI+DFGM+R ++ GD +Q R
Sbjct: 139 IASGMKYL---SSLNFVHRDLATRNCLVGKNYTIKIADFGMSRNLYSGDYYRIQG---RA 192
Query: 328 VGTYGYMSPEYALRGLFSIKSDVFSFGVLLLETLSSKKNTHFYNTDSLTLLGHAWNLWND 387
V +MS E L G F+ SDV++FGV L E L+ K + ++ + + D
Sbjct: 193 VLPIRWMSWESILLGKFTTASDVWAFGVTLWEILTLCKEQPYSQLSDEQVIENTGEFFRD 252
Query: 388 -GRTWELMDPISQNGASYPILKRYINVALLCVQEKAADRPAMSEVVSML 435
GR L P A P + L C + A +RP+ E+ + L
Sbjct: 253 QGRQVYLPKP-----ALCP--DSLYKLMLSCWRRNAKERPSFQEIHATL 294
|
Protein Tyrosine Kinase (PTK) family; mammalian Discoidin Domain Receptor 2 (DDR2) and homologs; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR2 is a member of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDR2 binds mostly to fibrillar collagens. More recently, it has been reported to also bind collagen X. DDR2 is widely expressed in many tissues with the highest levels found in skeletal muscle, skin, kidney and lung. It is important in cell proliferation and development. Mice, with a deletion of DDR2, suffer from dwarfism and delayed healing of epidermal wounds. DDR2 also contributes to collagen (type I) regulation by inhibiting fibrillogenesis and altering the morphology of collagen fibers. It is also expressed in immature dendritic cells (DCs), where it plays a role in DC activation and function. Length = 296 |
| >gnl|CDD|132973 cd06642, STKc_STK25-YSK1, Catalytic domain of the Protein Serine/Threonine Kinase, STK25 or Yeast Sps1/Ste20-related kinase 1 | Back alignment and domain information |
|---|
Score = 66.2 bits (161), Expect = 4e-12
Identities = 35/93 (37%), Positives = 57/93 (61%), Gaps = 5/93 (5%)
Query: 267 IIEGIAQGLLYLHQYSRLRVIHRDLKASNILLDKDMNPKISDFGMARMFGGDELQSNTKR 326
I+ I +GL YLH R IHRD+KA+N+LL + + K++DFG+A +++ NT
Sbjct: 106 ILREILKGLDYLHSE---RKIHRDIKAANVLLSEQGDVKLADFGVAGQLTDTQIKRNT-- 160
Query: 327 IVGTYGYMSPEYALRGLFSIKSDVFSFGVLLLE 359
VGT +M+PE + + K+D++S G+ +E
Sbjct: 161 FVGTPFWMAPEVIKQSAYDFKADIWSLGITAIE 193
|
Serine/threonine kinases (STKs), STK25 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The STK25 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. STK25 is also called Ste20/oxidant stress response kinase 1 (SOK1) or yeast Sps1/Ste20-related kinase 1 (YSK1). STK25 is localized in the Golgi apparatus through its interaction with the Golgi matrix protein GM130. It may play a role in the regulation of cell migration and polarization. STK25 binds and phosphorylates CCM3 (cerebral cavernous malformation 3), also called PCD10 (programmed cell death 10), and may play a role in apoptosis. Human STK25 is a candidate gene responsible for pseudopseudohypoparathyroidism (PPHP), a disease that shares features with the Albright hereditary osteodystrophy (AHO) phenotype. Length = 277 |
| >gnl|CDD|133214 cd05083, PTKc_Chk, Catalytic domain of the Protein Tyrosine Kinase, Csk homologous kinase | Back alignment and domain information |
|---|
Score = 65.7 bits (160), Expect = 5e-12
Identities = 39/92 (42%), Positives = 55/92 (59%), Gaps = 8/92 (8%)
Query: 271 IAQGLLYLHQYSRLRVIHRDLKASNILLDKDMNPKISDFGMARMFGGDELQSNTKRIVGT 330
+A+G+ YL +++HRDL A NIL+ +D K+SDFG+AR+ G N+K V
Sbjct: 109 VAEGMEYLESK---KLVHRDLAARNILVSEDGVAKVSDFGLARV--GSMGVDNSKLPV-- 161
Query: 331 YGYMSPEYALRGLFSIKSDVFSFGVLLLETLS 362
+ +PE FS KSDV+S+GVLL E S
Sbjct: 162 -KWTAPEALKHKKFSSKSDVWSYGVLLWEVFS 192
|
Protein Tyrosine Kinase (PTK) family; Csk homologous kinase (Chk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. Chk is also referred to as megakaryocyte-associated tyrosine kinase (Matk). To inhibit Src kinases, Chk is translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Chk inhibit Src kinases using a noncatalytic mechanism by simply binding to them. As a negative regulator of Src kinases, Chk may play important roles in cell proliferation, survival, and differentiation, and consequently, in cancer development and progression. Chk is expressed in brain and hematopoietic cells. Studies in mice reveal that Chk is not functionally redundant with Csk and that it plays an important role as a regulator of immune responses. Chk also plays a role in neural differentiation in a manner independent of Src by enhancing Mapk activation via Ras-mediated signaling. Length = 254 |
| >gnl|CDD|133178 cd05046, PTK_CCK4, Pseudokinase domain of the Protein Tyrosine Kinase, Colon Carcinoma Kinase 4 | Back alignment and domain information |
|---|
Score = 65.9 bits (161), Expect = 5e-12
Identities = 48/177 (27%), Positives = 77/177 (43%), Gaps = 21/177 (11%)
Query: 263 TRVRIIEGIAQGLLYLHQYSRLRVIHRDLKASNILLDKDMNPKISDFGMARMFGGDELQS 322
+V + IA G+ +L S R +HRDL A N L+ K+S +++ E
Sbjct: 118 QKVALCTQIALGMDHL---SNARFVHRDLAARNCLVSSQREVKVSLLSLSKDVYNSEYYK 174
Query: 323 NTKRIVGTYGYMSPEYALRGLFSIKSDVFSFGVLLLETLSSKKNTHFYNTDSLTLLGHAW 382
++ +++PE FS KSDV+SFGVL+ E + + + +D L
Sbjct: 175 LRNALI-PLRWLAPEAVQEDDFSTKSDVWSFGVLMWEVFTQGELPFYGLSDEEVL----- 228
Query: 383 NLWNDGRTWELMDPISQNGAS--YPILKRYINVALLCVQEKAADRPAMSEVVSMLSN 437
N + +L P+ + S Y ++ R C DRP+ SE+VS L
Sbjct: 229 ---NRLQAGKLELPVPEGCPSRLYKLMTR-------CWAVNPKDRPSFSELVSALGE 275
|
Protein Tyrosine Kinase (PTK) family; Colon Carcinoma Kinase 4 (CCK4); pseudokinase domain. The PTKc (catalytic domain) family, to which this subfamily belongs, includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. CCK4, also called protein tyrosine kinase 7 (PTK7), is an orphan receptor tyr kinase (RTK) containing an extracellular region with seven immunoglobulin domains, a transmembrane segment, and an intracellular inactive pseudokinase domain. Studies in mice reveal that CCK4 is essential for neural development. Mouse embryos containing a truncated CCK4 die perinatally and display craniorachischisis, a severe form of neural tube defect. The mechanism of action of the CCK4 pseudokinase is still unknown. Other pseudokinases such as HER3 rely on the activity of partner RTKs. Length = 275 |
| >gnl|CDD|132950 cd06619, PKc_MKK5, Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 5 | Back alignment and domain information |
|---|
Score = 66.1 bits (161), Expect = 5e-12
Identities = 34/94 (36%), Positives = 52/94 (55%), Gaps = 7/94 (7%)
Query: 266 RIIEGIAQGLLYLHQYSRLRVIHRDLKASNILLDKDMNPKISDFGMARMFGGDELQSNTK 325
RI + +GL YL L+++HRD+K SN+L++ K+ DFG++ + S K
Sbjct: 99 RIAVAVVKGLTYLWS---LKILHRDVKPSNMLVNTRGQVKLCDFGVSTQL----VNSIAK 151
Query: 326 RIVGTYGYMSPEYALRGLFSIKSDVFSFGVLLLE 359
VGT YM+PE + I SDV+S G+ +E
Sbjct: 152 TYVGTNAYMAPERISGEQYGIHSDVWSLGISFME 185
|
Protein kinases (PKs), MAP kinase kinase 5 (MKK5) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK5, also referred to as MEK5, is a dual-specificity PK that phosphorylates its downstream target, extracellular signal-regulated kinase 5 (ERK5), on specific threonine and tyrosine residues. MKK5 is activated by MEKK2 and MEKK3 in response to mitogenic and stress stimuli. The ERK5 cascade promotes cell proliferation, differentiation, neuronal survival, and neuroprotection. This cascade plays an essential role in heart development. Mice deficient in either ERK5 or MKK5 die around embryonic day 10 due to cardiovascular defects including underdevelopment of the myocardium. In addition, MKK5 is associated with metastasis and unfavorable prognosis in prostate cancer. Length = 279 |
| >gnl|CDD|173631 cd05045, PTKc_RET, Catalytic domain of the Protein Tyrosine Kinase, REarranged during Transfection protein | Back alignment and domain information |
|---|
Score = 65.8 bits (160), Expect = 7e-12
Identities = 48/180 (26%), Positives = 86/180 (47%), Gaps = 35/180 (19%)
Query: 271 IAQGLLYLHQYSRLRVIHRDLKASNILLDKDMNPKISDFGMARMFGGDELQSNTKRIVG- 329
I++G+ YL + ++++HRDL A N+L+ + KISDFG++R ++ S KR G
Sbjct: 136 ISRGMQYL---AEMKLVHRDLAARNVLVAEGRKMKISDFGLSRDVYEED--SYVKRSKGR 190
Query: 330 -TYGYMSPEYALRGLFSIKSDVFSFGVLLLETLSSKKNTHFYNTDSLTLLGHAW------ 382
+M+ E +++ +SDV+SFGVLL E +TL G+ +
Sbjct: 191 IPVKWMAIESLFDHIYTTQSDVWSFGVLLWEI--------------VTLGGNPYPGIAPE 236
Query: 383 NLWNDGRTWELMD-PISQNGASYPILKRYINVALLCVQEKAADRPAMSEVVSMLSNEFVN 441
L+N +T M+ P + + Y ++ C +++ RP +++ L V
Sbjct: 237 RLFNLLKTGYRMERPENCSEEMYNLMLT-------CWKQEPDKRPTFADISKELEKMMVK 289
|
Protein Tyrosine Kinase (PTK) family; RET (REarranged during Transfection) protein; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. RET is a receptor tyr kinase (RTK) containing an extracellular region with four cadherin-like repeats, a calcium-binding site, and a cysteine-rich domain, a transmembrane segment, and an intracellular catalytic domain. It is part of a multisubunit complex that binds glial-derived neurotropic factor (GDNF) family ligands (GFLs) including GDNF, neurturin, artemin, and persephin. GFLs bind RET along with four GPI-anchored coreceptors, bringing two RET molecules together, leading to autophosphorylation, activation, and intracellular signaling. RET is essential for the development of the sympathetic, parasympathetic and enteric nervous systems, and the kidney. RET disruption by germline mutations causes diseases in humans including congenital aganglionosis of the gastrointestinal tract (Hirschsprung's disease) and three related inherited cancers: multiple endocrine neoplasia type 2A (MEN2A), MEN2B, and familial medullary thyroid carcinoma (FMTC). Length = 290 |
| >gnl|CDD|173658 cd05114, PTKc_Tec_Rlk, Catalytic domain of the Protein Tyrosine Kinases, Tyrosine kinase expressed in hepatocellular carcinoma and Resting lymphocyte kinase | Back alignment and domain information |
|---|
Score = 65.3 bits (159), Expect = 7e-12
Identities = 54/187 (28%), Positives = 82/187 (43%), Gaps = 28/187 (14%)
Query: 255 KKGLLCWGTRVRIIEGIAQGLLYLHQYSRLRVIHRDLKASNILLDKDMNPKISDFGMARM 314
++G L + + + + +G+ YL + S IHRDL A N L+ K+SDFGM R
Sbjct: 93 RQGKLSKDMLLSMCQDVCEGMEYLERNS---FIHRDLAARNCLVSSTGVVKVSDFGMTRY 149
Query: 315 FGGDELQSNT--KRIVGTYGYMSPEYALRGLFSIKSDVFSFGVLLLETLSSKKNTHFYNT 372
DE S++ K V + PE +S KSDV+SFGVL+ E + K F
Sbjct: 150 VLDDEYTSSSGAKFPV---KWSPPEVFNFSKYSSKSDVWSFGVLMWEVFTEGK-MPFEKK 205
Query: 373 DSLTLLGHAWNLWNDGRTWELMDPISQNGASY-PIL--KRYINVALLCVQEKAADRPAMS 429
+ E+++ IS+ Y P L V C EK RP +
Sbjct: 206 SNY----------------EVVEMISRGFRLYRPKLASMTVYEVMYSCWHEKPEGRPTFA 249
Query: 430 EVVSMLS 436
E++ ++
Sbjct: 250 ELLRAIT 256
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase expressed in hepatocellular carcinoma (Tec) and Resting lymphocyte kinase (Rlk); catalytic (c) domain. The PTKc family is part of a larger superfamily, that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tec and Rlk (also named Txk) are members of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activation. Instead of PH, Rlk contains an N-terminal cysteine-rich region. In addition to PH, Tec also contains the Tec homology (TH) domain with proline-rich and zinc-binding regions. Tec kinases are expressed mainly by haematopoietic cells. Tec is more widely-expressed than other Tec subfamily kinases. It is found in endothelial cells, both B- and T-cells, and a variety of myeloid cells including mast cells, erythroid cells, platelets, macrophages and neutrophils. Rlk is expressed in T-cells and mast cell lines. Tec and Rlk are both key components of T-cell receptor (TCR) signaling. They are important in TCR-stimulated proliferation, IL-2 production and phopholipase C-gamma1 activation. Length = 256 |
| >gnl|CDD|173736 cd07832, STKc_CCRK, Catalytic domain of the Serine/Threonine Kinase, Cell Cycle-Related Kinase | Back alignment and domain information |
|---|
Score = 65.4 bits (160), Expect = 8e-12
Identities = 25/64 (39%), Positives = 40/64 (62%), Gaps = 4/64 (6%)
Query: 274 GLLYLHQYSRLRVIHRDLKASNILLDKDMNPKISDFGMARMFGGDELQSNTKRIVGTYGY 333
G+ Y+H ++HRDLK +N+L+ D KI+DFG+AR+F +E + + + V T Y
Sbjct: 111 GVAYMHA---NGIMHRDLKPANLLISADGVLKIADFGLARLFSEEEPRLYSHQ-VATRWY 166
Query: 334 MSPE 337
+PE
Sbjct: 167 RAPE 170
|
Serine/Threonine Kinases (STKs), Cell Cycle-Related Kinase (CCRK) p42 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CCRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CCRK was previously called p42. It is a Cyclin-Dependent Kinase (CDK)-Activating Kinase (CAK) which is essential for the activation of CDK2. It is indispensable for cell growth and has been implicated in the progression of glioblastoma multiforme. In the heart, a splice variant of CCRK with a different C-terminal half is expressed, this variant promotes cardiac cell growth and survival and is significantly down-regulated during the development of heart failure. Length = 286 |
| >gnl|CDD|132966 cd06635, STKc_TAO1, Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 1 | Back alignment and domain information |
|---|
Score = 65.9 bits (160), Expect = 8e-12
Identities = 57/189 (30%), Positives = 88/189 (46%), Gaps = 41/189 (21%)
Query: 267 IIEGIAQGLLYLHQYSRLRVIHRDLKASNILLDKDMNPKISDFGMARMFGGDELQSNTKR 326
I G QGL YLH ++ +IHRD+KA NILL + K++DFG A + S
Sbjct: 130 ITHGALQGLAYLHSHN---MIHRDIKAGNILLTEPGQVKLADFGSASI------ASPANS 180
Query: 327 IVGTYGYMSPEYAL---RGLFSIKSDVFSFGVLLLETLSSKKNTHFYNTDSLTLLGHAWN 383
VGT +M+PE L G + K DV+S G+ +E +++ +N ++++ L H
Sbjct: 181 FVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIEL--AERKPPLFNMNAMSALYH--- 235
Query: 384 LWNDGRTWELMDPISQNGASYPILKR------YINVALLCVQEKAADRPAMSEVVSMLSN 437
I+QN + P L+ + N C+Q+ DRP E +L +
Sbjct: 236 -------------IAQNES--PTLQSNEWSDYFRNFVDSCLQKIPQDRPTSEE---LLKH 277
Query: 438 EFVNLPAPQ 446
FV P+
Sbjct: 278 MFVLRERPE 286
|
Serine/threonine kinases (STKs), thousand-and-one amino acids 1 (TAO1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. TAO1 is sometimes referred to as prostate-derived sterile 20-like kinase 2 (PSK2). TAO1 activates the p38 MAPK through direct interaction with and activation of MEK3. TAO1 is highly expressed in the brain and may play a role in neuronal apoptosis. TAO1 interacts with the checkpoint proteins BubR1 and Mad2, and plays an important role in regulating mitotic progression, which is required for both chromosome congression and checkpoint-induced anaphase delay. TAO1 may play a role in protecting genomic stability. Length = 317 |
| >gnl|CDD|173674 cd05583, STKc_MSK_N, N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase | Back alignment and domain information |
|---|
Score = 65.2 bits (159), Expect = 9e-12
Identities = 35/101 (34%), Positives = 54/101 (53%), Gaps = 5/101 (4%)
Query: 264 RVRIIEGIAQGLLYLHQYSRLRVIHRDLKASNILLDKDMNPKISDFGMARMFGGDELQSN 323
VR+ IA+ +L L +L +I+RD+K NILLD + + ++DFG+++ F +E +
Sbjct: 106 EVRVY--IAEIVLALDHLHQLGIIYRDIKLENILLDSEGHVVLTDFGLSKEFLAEEEE-R 162
Query: 324 TKRIVGTYGYMSPEYALRGL--FSIKSDVFSFGVLLLETLS 362
GT YM+PE G D +S GVL E L+
Sbjct: 163 AYSFCGTIEYMAPEVIRGGSGGHDKAVDWWSLGVLTFELLT 203
|
Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, in response to various stimuli such as growth factors, hormones, neurotransmitters, cellular stress, and pro-inflammatory cytokines. This triggers phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydrophobic motif (HM) in the C-terminal extension of NTD, which facilitates the phosphorylation of the A-loop and activates the NTD, which in turn phosphorylates downstream targets. MSKs are predominantly nuclear proteins. They are widely expressed in many tissues including heart, brain, lung, liver, kidney, and pancreas. There are two isoforms of MSK, called MSK1 and MSK2. Length = 288 |
| >gnl|CDD|143333 cd05118, STKc_CMGC, Catalytic domain of CMGC family Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 65.0 bits (159), Expect = 9e-12
Identities = 32/93 (34%), Positives = 49/93 (52%), Gaps = 6/93 (6%)
Query: 271 IAQGLLYLHQYSRLRVIHRDLKASNILLDKDMNPKISDFGMARMFGGDELQSNTKRIVGT 330
+ QGL + H + ++HRDLK N+L++ + K++DFG+AR FG V T
Sbjct: 107 LLQGLAFCHSH---GILHRDLKPENLLINTEGVLKLADFGLARSFGSP--VRPYTHYVVT 161
Query: 331 YGYMSPEYALR-GLFSIKSDVFSFGVLLLETLS 362
Y +PE L +S D++S G + E LS
Sbjct: 162 RWYRAPELLLGDKGYSTPVDIWSVGCIFAELLS 194
|
Serine/Threonine Kinases (STKs), CMGC family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CMGC family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The CMGC family consists of Cyclin-Dependent protein Kinases (CDKs), Mitogen-activated protein kinases (MAPKs) such as Extracellular signal-regulated kinase (ERKs), c-Jun N-terminal kinases (JNKs), and p38, and similar proteins. CDKs belong to a large subfamily of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. MAPKs serve as important mediators of cellular responses to extracellular signals. They control critical cellular functions including differentiation, proliferation, migration, and apoptosis. They are also implicated in the pathogenesis of many diseases including multiple types of cancer, stroke, diabetes, and chronic inflammation. Length = 283 |
| >gnl|CDD|173709 cd05619, STKc_nPKC_theta, Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C theta | Back alignment and domain information |
|---|
Score = 65.8 bits (160), Expect = 9e-12
Identities = 41/107 (38%), Positives = 58/107 (54%), Gaps = 9/107 (8%)
Query: 271 IAQGLLYLHQYSRLRVIHRDLKASNILLDKDMNPKISDFGMAR--MFGGDELQSNTKRIV 328
I GL +LH +++RDLK NILLD D + KI+DFGM + M G + T
Sbjct: 105 IICGLQFLHSKG---IVYRDLKLDNILLDTDGHIKIADFGMCKENMLG----DAKTCTFC 157
Query: 329 GTYGYMSPEYALRGLFSIKSDVFSFGVLLLETLSSKKNTHFYNTDSL 375
GT Y++PE L ++ D +SFGVLL E L + H ++ + L
Sbjct: 158 GTPDYIAPEILLGQKYNTSVDWWSFGVLLYEMLIGQSPFHGHDEEEL 204
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), theta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-theta is selectively expressed in T-cells and plays an important and non-redundant role in several aspects of T-cell biology. Although T-cells also express other PKC isoforms, PKC-theta is unique in that upon antigen stimulation, it is translocated to the plasma membrane at the immunological synapse, where it mediates signals essential for T-cell activation. It is essential for TCR-induced proliferation, cytokine production, T-cell survival, and the differentiation and effector function of T-helper (Th) cells, particularly Th2 and Th17. PKC-theta is being developed as a therapeutic target for Th2-mediated allergic inflammation and Th17-mediated autoimmune diseases. Length = 316 |
| >gnl|CDD|173738 cd07835, STKc_CDK1_like, Catalytic domain of Cyclin-Dependent protein Kinase 1-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 65.0 bits (159), Expect = 1e-11
Identities = 34/90 (37%), Positives = 54/90 (60%), Gaps = 6/90 (6%)
Query: 271 IAQGLLYLHQYSRLRVIHRDLKASNILLDKDMNPKISDFGMARMFGGDELQSNTKRIVGT 330
+ QG+ Y H + RV+HRDLK N+L+D++ K++DFG+AR F G +++ T +V T
Sbjct: 108 LLQGIAYCHSH---RVLHRDLKPQNLLIDREGALKLADFGLARAF-GVPVRTYTHEVV-T 162
Query: 331 YGYMSPEYALRG-LFSIKSDVFSFGVLLLE 359
Y +PE L +S D++S G + E
Sbjct: 163 LWYRAPEILLGSRQYSTPVDIWSIGCIFAE 192
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 1 (CDK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK1 from higher eukaryotes, plants, and yeasts, as well as CDK2 and CDK3. CDK1 is also called Cell division control protein 2 (Cdc2) or p34 protein kinase, and is regulated by cyclins A, B, and E. The CDK1/cyclin A complex controls G2 phase entry and progression while the CDK1/cyclin B complex is critical for G2 to M phase transition. CDK2 is regulated by cyclin E or cyclin A. Upon activation by cyclin E, it phosphorylates the retinoblastoma (pRb) protein which activates E2F mediated transcription and allows cells to move into S phase. The CDK2/cyclin A complex plays a role in regulating DNA replication. Studies in knockout mice revealed that CDK1 can compensate for the loss of the cdk2 gene as it can also bind cyclin E and drive G1 to S phase transition. CDK3 is regulated by cyclin C and it phosphorylates pRB specifically during the G0/G1 transition. This phosphorylation is required for cells to exit G0 efficiently and enter the G1 phase. Length = 283 |
| >gnl|CDD|173632 cd05051, PTKc_DDR, Catalytic domain of the Protein Tyrosine Kinases, Discoidin Domain Receptors | Back alignment and domain information |
|---|
Score = 64.7 bits (158), Expect = 2e-11
Identities = 39/104 (37%), Positives = 56/104 (53%), Gaps = 9/104 (8%)
Query: 262 GTRVRIIEGIAQGLLYLHQYSRLRVIHRDLKASNILLDKDMNPKISDFGMAR-MFGGD-- 318
T + + IA G+ YL L +HRDL N L+ K+ KI+DFGM+R ++ D
Sbjct: 130 STLLYMATQIASGMRYL---ESLNFVHRDLATRNCLVGKNYTIKIADFGMSRNLYSSDYY 186
Query: 319 ELQSNTKRIVGTYGYMSPEYALRGLFSIKSDVFSFGVLLLETLS 362
+Q R +M+ E L G F+ KSDV++FGV L E L+
Sbjct: 187 RVQG---RAPLPIRWMAWESVLLGKFTTKSDVWAFGVTLWEILT 227
|
Protein Tyrosine Kinase (PTK) family; Discoidin Domain Receptor (DDR) subfamily; catalytic (c) domain. The DDR subfamily consists of homologs of mammalian DDR1, DDR2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR subfamily members are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDRs regulate cell adhesion, proliferation, and extracellular matrix remodeling. They have been linked to a variety of human cancers including breast, colon, ovarian, brain, and lung. There is no evidence showing that DDRs act as transforming oncogenes. They are more likely to play a role in the regulation of tumor growth and metastasis. Length = 296 |
| >gnl|CDD|173635 cd05054, PTKc_VEGFR, Catalytic domain of the Protein Tyrosine Kinases, Vascular Endothelial Growth Factor Receptors | Back alignment and domain information |
|---|
Score = 64.9 bits (158), Expect = 2e-11
Identities = 45/125 (36%), Positives = 67/125 (53%), Gaps = 14/125 (11%)
Query: 241 DEISFWYESYNNP-TKKGLLCWGTRVRIIEGIAQGLLYLHQYSRLRVIHRDLKASNILLD 299
+E E Y P T + L+ + +V A+G+ +L SR + IHRDL A NILL
Sbjct: 157 EEDEEGDELYKEPLTLEDLISYSFQV------ARGMEFLA--SR-KCIHRDLAARNILLS 207
Query: 300 KDMNPKISDFGMARMF--GGDELQSNTKRIVGTYGYMSPEYALRGLFSIKSDVFSFGVLL 357
++ KI DFG+AR D ++ R+ +M+PE +++ +SDV+SFGVLL
Sbjct: 208 ENNVVKICDFGLARDIYKDPDYVRKGDARL--PLKWMAPESIFDKVYTTQSDVWSFGVLL 265
Query: 358 LETLS 362
E S
Sbjct: 266 WEIFS 270
|
Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor (VEGFR) subfamily; catalytic (c) domain. The VEGFR subfamily consists of VEGFR1 (Flt1), VEGFR2 (Flk1), VEGFR3 (Flt4), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. In VEGFR3, the fifth Ig-like domain is replaced by a disulfide bridge. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. There are five VEGF ligands in mammals, which bind, in an overlapping pattern to the three VEGFRs, which can form homo or heterodimers. VEGFRs regulate the cardiovascular system. They are critical for vascular development during embryogenesis and blood vessel formation in adults. They induce cellular functions common to other growth factor receptors such as cell migration, survival, and proliferation. VEGFR1 binds VEGFA, VEGFB, and placenta growth factor (PLGF). It regulates monocyte and macrophage migration, vascular permeability, haematopoiesis, and the recruitment of haematopietic progenitor cells from the bone marrow. Length = 337 |
| >gnl|CDD|173764 cd08224, STKc_Nek6_Nek7, Catalytic domain of the Protein Serine/Threonine Kinases, Never In Mitosis gene A-related kinase 6 and 7 | Back alignment and domain information |
|---|
Score = 64.0 bits (156), Expect = 2e-11
Identities = 29/89 (32%), Positives = 47/89 (52%), Gaps = 5/89 (5%)
Query: 271 IAQGLLYLHQYSRLRVIHRDLKASNILLDKDMNPKISDFGMARMFGGDELQSNTKRIVGT 330
+ L ++H R++HRD+K +N+ + K+ D G+ R F +++ VGT
Sbjct: 115 LCSALEHMHSK---RIMHRDIKPANVFITATGVVKLGDLGLGRFFSSKTTAAHSL--VGT 169
Query: 331 YGYMSPEYALRGLFSIKSDVFSFGVLLLE 359
YMSPE ++ KSD++S G LL E
Sbjct: 170 PYYMSPERIHENGYNFKSDIWSLGCLLYE 198
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 6 (Nek6) and Nek7 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek6/7 subfamily is part of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek6 and Nek7 are the shortest Neks, consisting only of the catalytic domain and a very short N-terminal extension. They show distinct expression patterns and both appear to be downstream substrates of Nek9. They are required for mitotic spindle formation and cytokinesis. They may also be regulators of the p70 ribosomal S6 kinase. Length = 267 |
| >gnl|CDD|132991 cd06917, STKc_NAK1_like, Catalytic domain of Fungal Nak1-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 64.4 bits (157), Expect = 2e-11
Identities = 36/96 (37%), Positives = 56/96 (58%), Gaps = 10/96 (10%)
Query: 267 IIEGIAQGLLYLHQYSRLRVIHRDLKASNILLDKDMNPKISDFGMARMFGGDELQSNTKR 326
II + L Y+H+ VIHRD+KA+NIL+ N K+ DFG+A + Q+++KR
Sbjct: 106 IIREVLVALKYIHKVG---VIHRDIKAANILVTNTGNVKLCDFGVAALLN----QNSSKR 158
Query: 327 I--VGTYGYMSPEYALRG-LFSIKSDVFSFGVLLLE 359
VGT +M+PE G + K+D++S G+ + E
Sbjct: 159 STFVGTPYWMAPEVITEGKYYDTKADIWSLGITIYE 194
|
Serine/threonine kinases (STKs), Nak1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nak1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of Schizosaccharomyces pombe Nak1, Saccharomyces cerevisiae Kic1p (kinase that interacts with Cdc31p) and related proteins. Nak1 (also known as N-rich kinase 1), is required by fission yeast for polarizing the tips of actin cytoskeleton and is involved in cell growth, cell separation, cell morphology and cell-cycle progression. Kic1p is required by budding yeast for cell integrity and morphogenesis. Kic1p interacts with Cdc31p, the yeast homologue of centrin, and phosphorylates substrates in a Cdc31p-dependent manner. Length = 277 |
| >gnl|CDD|215036 PLN00034, PLN00034, mitogen-activated protein kinase kinase; Provisional | Back alignment and domain information |
|---|
Score = 64.8 bits (158), Expect = 2e-11
Identities = 37/102 (36%), Positives = 52/102 (50%), Gaps = 26/102 (25%)
Query: 271 IAQGLLYLHQYSRLRVIHRDLKASNILLDKDMNPKISDFGMARMFGGDELQSNTKRIVGT 330
I G+ YLH R ++HRD+K SN+L++ N KI+DFG++R+ N+ VGT
Sbjct: 177 ILSGIAYLH---RRHIVHRDIKPSNLLINSAKNVKIADFGVSRILAQTMDPCNSS--VGT 231
Query: 331 YGYMSPE-------------YALRGLFSIKSDVFSFGVLLLE 359
YMSPE YA D++S GV +LE
Sbjct: 232 IAYMSPERINTDLNHGAYDGYA--------GDIWSLGVSILE 265
|
Length = 353 |
| >gnl|CDD|133194 cd05063, PTKc_EphR_A2, Catalytic domain of the Protein Tyrosine Kinase, Ephrin Receptor A2 | Back alignment and domain information |
|---|
Score = 63.8 bits (155), Expect = 2e-11
Identities = 52/177 (29%), Positives = 89/177 (50%), Gaps = 28/177 (15%)
Query: 265 VRIIEGIAQGLLYLHQYSRLRVIHRDLKASNILLDKDMNPKISDFGMARMFGGDELQSNT 324
V ++ GIA G+ YL S + +HRDL A NIL++ ++ K+SDFG++R+ D + T
Sbjct: 110 VGMLRGIAAGMKYL---SDMNYVHRDLAARNILVNSNLECKVSDFGLSRVLEDDPEGTYT 166
Query: 325 KRIVGTYG------YMSPEYALRGLFSIKSDVFSFGVLLLETLSSKKNTHFYNTDSLTLL 378
T G + +PE F+ SDV+SFG+++ E +S + ++ ++ +
Sbjct: 167 -----TSGGKIPIRWTAPEAIAYRKFTSASDVWSFGIVMWEVMSFGERPYWDMSNHEVM- 220
Query: 379 GHAWNLWNDGRTWELMDPISQNGASYPILKRYINVALLCVQEKAADRPAMSEVVSML 435
NDG + L P+ A Y ++ L C Q+ A RP ++V++L
Sbjct: 221 ----KAINDG--FRLPAPMDCPSAVYQLM-------LQCWQQDRARRPRFVDIVNLL 264
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; EphA2 receptor; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). Ephrin/EphR interaction mainly results in cell-cell repulsion or adhesion, making it important in neural development and plasticity, cell morphogenesis, cell-fate determination, embryonic development, tissue patterning, and angiogenesis. The EphA2 receptor is overexpressed in tumor cells and tumor blood vessels in a variety of cancers including breast, prostate, lung, and colon. As a result, it is an attractive target for drug design since its inhibition could affect several aspects of tumor progression. Length = 268 |
| >gnl|CDD|173655 cd05110, PTKc_HER4, Catalytic domain of the Protein Tyrosine Kinase, HER4 | Back alignment and domain information |
|---|
Score = 64.3 bits (156), Expect = 2e-11
Identities = 39/120 (32%), Positives = 67/120 (55%), Gaps = 9/120 (7%)
Query: 243 ISFWYESYNNPTKKGLLCWGTRVRIIEGIAQGLLYLHQYSRLRVIHRDLKASNILLDKDM 302
+ + +E +N + LL W + IA+G++YL + R++HRDL A N+L+
Sbjct: 96 LDYVHEHKDNIGSQLLLNWCVQ------IAKGMMYLEER---RLVHRDLAARNVLVKSPN 146
Query: 303 NPKISDFGMARMFGGDELQSNTKRIVGTYGYMSPEYALRGLFSIKSDVFSFGVLLLETLS 362
+ KI+DFG+AR+ GDE + N +M+ E F+ +SDV+S+GV + E ++
Sbjct: 147 HVKITDFGLARLLEGDEKEYNADGGKMPIKWMALECIHYRKFTHQSDVWSYGVTIWELMT 206
|
Protein Tyrosine Kinase (PTK) family; HER4 (ErbB4); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER4 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. Ligands that bind HER4 fall into two groups, the neuregulins (or heregulins) and some EGFR (HER1) ligands including betacellulin, HBEGF, and epiregulin. All four neuregulins (NRG1-4) interact with HER4. Upon ligand binding, HER4 forms homo- or heterodimers with other HER proteins. HER4 is essential in embryonic development. It is implicated in mammary gland, cardiac, and neural development. As a postsynaptic receptor of NRG1, HER4 plays an important role in synaptic plasticity and maturation. The impairment of NRG1/HER4 signaling may contribute to schizophrenia. Length = 303 |
| >gnl|CDD|173762 cd08222, STKc_Nek11, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 11 | Back alignment and domain information |
|---|
Score = 63.8 bits (155), Expect = 2e-11
Identities = 37/94 (39%), Positives = 53/94 (56%), Gaps = 3/94 (3%)
Query: 266 RIIEGIAQGLLYLHQYSRLRVIHRDLKASNILLDKDMNPKISDFGMARMFGGDELQSNTK 325
++ E Q LL +H + R++HRDLKA NI L ++ KI DFG++R+ G + T
Sbjct: 107 QVCEWFIQLLLGVHYMHQRRILHRDLKAKNIFLKNNL-LKIGDFGVSRLLMGSCDLATT- 164
Query: 326 RIVGTYGYMSPEYALRGLFSIKSDVFSFGVLLLE 359
GT YMSPE + KSD++S G +L E
Sbjct: 165 -FTGTPYYMSPEALKHQGYDSKSDIWSLGCILYE 197
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 11 (Nek11) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek11 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek11 is involved, through direct phosphorylation, in regulating the degradation of Cdc25A (Cell Division Cycle 25 homolog A), which plays a role in cell cycle progression and in activating cyclin dependent kinases. Nek11 is activated by CHK1 (CHeckpoint Kinase 1) and may be involved in the G2/M checkpoint. Nek11 may also play a role in the S-phase checkpoint as well as in DNA replication and genotoxic stress responses. Length = 260 |
| >gnl|CDD|132990 cd06659, STKc_PAK6, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 6 | Back alignment and domain information |
|---|
Score = 64.3 bits (156), Expect = 2e-11
Identities = 34/93 (36%), Positives = 51/93 (54%), Gaps = 5/93 (5%)
Query: 267 IIEGIAQGLLYLHQYSRLRVIHRDLKASNILLDKDMNPKISDFGMARMFGGDELQSNTKR 326
+ E + Q L YLH VIHRD+K+ +ILL D K+SDFG D K
Sbjct: 122 VCESVLQALCYLHSQG---VIHRDIKSDSILLTLDGRVKLSDFGFCAQISKD--VPKRKS 176
Query: 327 IVGTYGYMSPEYALRGLFSIKSDVFSFGVLLLE 359
+VGT +M+PE R + + D++S G++++E
Sbjct: 177 LVGTPYWMAPEVISRTPYGTEVDIWSLGIMVIE 209
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 6, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK6 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK6 may play a role in stress responses through its activation by the mitogen-activated protein kinase (MAPK) p38 and MAPK kinase 6 (MKK6) pathway. PAK6 is highly expressed in the brain. It is not required for viability, but together with PAK5, it is required for normal levels of locomotion and activity, and for learning and memory. Increased expression of PAK6 is found in primary and metastatic prostate cancer. PAK6 may play a role in the regulation of motility. Length = 297 |
| >gnl|CDD|132965 cd06634, STKc_TAO2, Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 2 | Back alignment and domain information |
|---|
Score = 63.9 bits (155), Expect = 3e-11
Identities = 57/189 (30%), Positives = 88/189 (46%), Gaps = 41/189 (21%)
Query: 267 IIEGIAQGLLYLHQYSRLRVIHRDLKASNILLDKDMNPKISDFGMARMFGGDELQSNTKR 326
+ G QGL YLH ++ +IHRD+KA NILL + K+ DFG A + +
Sbjct: 120 VTHGALQGLAYLHSHN---MIHRDVKAGNILLSEPGLVKLGDFGSA------SIMAPANX 170
Query: 327 IVGTYGYMSPEYAL---RGLFSIKSDVFSFGVLLLETLSSKKNTHFYNTDSLTLLGHAWN 383
VGT +M+PE L G + K DV+S G+ +E +++ +N ++++ L H
Sbjct: 171 FVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIEL--AERKPPLFNMNAMSALYH--- 225
Query: 384 LWNDGRTWELMDPISQNGASYPILKR------YINVALLCVQEKAADRPAMSEVVSMLSN 437
I+QN + P L+ + N C+Q+ DRP SEV +L +
Sbjct: 226 -------------IAQNES--PALQSGHWSEYFRNFVDSCLQKIPQDRPT-SEV--LLKH 267
Query: 438 EFVNLPAPQ 446
FV P
Sbjct: 268 RFVLRERPP 276
|
Serine/threonine kinases (STKs), thousand-and-one amino acids 2 (TAO2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Human TAO2 is also known as prostate-derived Ste20-like kinase (PSK) and was identified in a screen for overexpressed RNAs in prostate cancer. TAO2 activates both p38 and c-Jun N-terminal kinase (JNK), by phosphorylating and activating the respective MAP/ERK kinases (MEKs, also known as MKKs or MAPKKs), MEK3/MEK6 and MKK4/MKK7. TAO2 contains a long C-terminal extension with autoinhibitory segments. It is activated by the release of this inhibition and the phosphorylation of its activation loop serine. TAO2 functions as a regulator of actin cytoskeletal and microtubule organization. In addition, it regulates the transforming growth factor-activated kinase 1 (TAK1), which is a MAPKKK that plays an essential role in the signaling pathways of tumor necrosis factor (TNF), interleukin 1 (IL-1), and Toll-like receptor (TLR). Length = 308 |
| >gnl|CDD|173673 cd05582, STKc_RSK_N, N-terminal catalytic domain of the Protein Serine/Threonine Kinase, 90 kDa ribosomal protein S6 kinase | Back alignment and domain information |
|---|
Score = 64.1 bits (156), Expect = 3e-11
Identities = 35/92 (38%), Positives = 53/92 (57%), Gaps = 5/92 (5%)
Query: 271 IAQGLLYLHQYSRLRVIHRDLKASNILLDKDMNPKISDFGMARMFGGDELQSNTKRIVGT 330
+A L +LH L +I+RDLK NILLD++ + K++DFG+++ E GT
Sbjct: 107 LALALDHLH---SLGIIYRDLKPENILLDEEGHIKLTDFGLSKESIDHE--KKAYSFCGT 161
Query: 331 YGYMSPEYALRGLFSIKSDVFSFGVLLLETLS 362
YM+PE R + +D +SFGVL+ E L+
Sbjct: 162 VEYMAPEVVNRRGHTQSADWWSFGVLMFEMLT 193
|
Serine/Threonine Kinases (STKs), 90 kDa ribosomal protein S6 kinase (RSK) subfamily, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The RSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. RSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family. They are activated by signaling inputs from extracellular regulated kinase (ERK) and phosphoinositide dependent kinase 1 (PDK1). ERK phosphorylates and activates the CTD of RSK, serving as a docking site for PDK1, which phosphorylates and activates the NTD, which in turn phosphorylates all known RSK substrates. RSKs act as downstream effectors of mitogen-activated protein kinase (MAPK) and play key roles in mitogen-activated cell growth, differentiation, and survival. Mammals possess four RSK isoforms (RSK1-4) from distinct genes. RSK proteins are also referred to as MAP kinase-activated protein kinases (MAPKAPKs), p90-RSKs, or p90S6Ks. Length = 318 |
| >gnl|CDD|173663 cd05572, STKc_cGK_PKG, Catalytic domain of the Protein Serine/Threonine Kinase, cGMP-dependent protein kinase | Back alignment and domain information |
|---|
Score = 63.0 bits (154), Expect = 4e-11
Identities = 31/85 (36%), Positives = 43/85 (50%), Gaps = 6/85 (7%)
Query: 277 YLHQYSRLRVIHRDLKASNILLDKDMNPKISDFGMARMFGGDELQSNTKRIVGTYGYMSP 336
YLH +I+RDLK N+LLD + K+ DFG A+ + T GT Y++P
Sbjct: 108 YLH---NRGIIYRDLKPENLLLDSNGYVKLVDFGFAKKLKSGQ---KTWTFCGTPEYVAP 161
Query: 337 EYALRGLFSIKSDVFSFGVLLLETL 361
E L + D +S G+LL E L
Sbjct: 162 EIILNKGYDFSVDYWSLGILLYELL 186
|
Serine/Threonine Kinases (STKs), cGMP-dependent protein kinase (cGK or PKG) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Mammals have two cGK isoforms from different genes, cGKI and cGKII. cGKI exists as two splice variants, cGKI-alpha and cGKI-beta. cGK consists of an N-terminal regulatory domain containing a dimerization and an autoinhibitory pseudosubstrate region, two cGMP-binding domains, and a C-terminal catalytic domain. Binding of cGMP to both binding sites releases the inhibition of the catalytic center by the pseudosubstrate region, allowing autophosphorylation and activation of the kinase. cGKI is a soluble protein expressed in all smooth muscles, platelets, cerebellum, and kidney. It is also expressed at lower concentrations in other tissues. cGKII is a membrane-bound protein that is most abundantly expressed in the intestine. It is also present in the brain nuclei, adrenal cortex, kidney, lung, and prostate. cGKI is involved in the regulation of smooth muscle tone, smooth cell proliferation, and platelet activation. cGKII plays a role in the regulation of secretion, such as renin secretion by the kidney and aldosterone secretion by the adrenal. It also regulates bone growth and the circadian rhythm. Length = 262 |
| >gnl|CDD|173727 cd06613, STKc_MAP4K3_like, Catalytic domain of Mitogen-activated protein kinase kinase kinase kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 63.1 bits (154), Expect = 4e-11
Identities = 32/92 (34%), Positives = 53/92 (57%), Gaps = 12/92 (13%)
Query: 273 QGLLYLHQYSRLRVIHRDLKASNILLDKDMNPKISDFGMARMFGGDELQSNTKR--IVGT 330
+GL YLH+ IHRD+K +NILL +D + K++DFG++ + KR +GT
Sbjct: 112 KGLAYLHE---TGKIHRDIKGANILLTEDGDVKLADFGVSAQLT----ATIAKRKSFIGT 164
Query: 331 YGYMSPEYA---LRGLFSIKSDVFSFGVLLLE 359
+M+PE A +G + K D+++ G+ +E
Sbjct: 165 PYWMAPEVAAVERKGGYDGKCDIWALGITAIE 196
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 3 (MAPKKKK3 or MAP4K3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily includes MAP4K3, MAP4K1, MAP4K2, MAP4K5, and related proteins. Vertebrate members contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAP4K1, also called haematopoietic progenitor kinase 1 (HPK1), is a hematopoietic-specific STK involved in many cellular signaling cascades including MAPK, antigen receptor, apoptosis, growth factor, and cytokine signaling. It participates in the regulation of T cell receptor signaling and T cell-mediated immune responses. MAP4K2 was referred to as germinal center (GC) kinase because of its preferred location in GC B cells. MAP4K3 plays a role in the nutrient-responsive pathway of mTOR (mammalian target of rapamycin) signaling. It is required in the activation of S6 kinase by amino acids and for the phosphorylation of the mTOR-regulated inhibitor of eukaryotic initiation factor 4E. MAP4K5, also called germinal center kinase-related enzyme (GCKR), has been shown to activate the MAPK c-Jun N-terminal kinase (JNK). Length = 262 |
| >gnl|CDD|132942 cd06611, STKc_SLK_like, Catalytic domain of Ste20-like kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 63.2 bits (154), Expect = 4e-11
Identities = 36/94 (38%), Positives = 53/94 (56%), Gaps = 14/94 (14%)
Query: 273 QGLLYLHQYSRLRVIHRDLKASNILLDKDMNPKISDFGMARMFGGDELQSNTKR--IVGT 330
+ L +LH + +VIHRDLKA NILL D + K++DFG++ LQ KR +GT
Sbjct: 114 EALNFLHSH---KVIHRDLKAGNILLTLDGDVKLADFGVSAK-NKSTLQ---KRDTFIGT 166
Query: 331 YGYMSPEYALRGLFS-----IKSDVFSFGVLLLE 359
+M+PE F K+D++S G+ L+E
Sbjct: 167 PYWMAPEVVACETFKDNPYDYKADIWSLGITLIE 200
|
Serine/threonine kinases (STKs), Ste20-like kinase (SLK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SLK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of the subfamily include SLK, STK10 (also called LOK for lymphocyte-oriented kinase), SmSLK (Schistosoma mansoni SLK), and related proteins. SLK promotes apoptosis through apoptosis signal-regulating kinase 1 (ASK1) and the mitogen-activated protein kinase (MAPK) p38. It also plays a role in mediating actin reorganization. STK10 is responsible in regulating the CD28 responsive element in T cells, as well as leukocyte function associated antigen (LFA-1)-mediated lymphocyte adhesion. SmSLK is capable of activating the MAPK Jun N-terminal kinase (JNK) pathway in human embryonic kidney (HEK) cells as well as in Xenopus oocytes. It may participate in regulating MAPK cascades during host-parasite interactions. Length = 280 |
| >gnl|CDD|133227 cd05096, PTKc_DDR1, Catalytic domain of the Protein Tyrosine Kinase, Discoidin Domain Receptor 1 | Back alignment and domain information |
|---|
Score = 63.4 bits (154), Expect = 5e-11
Identities = 52/168 (30%), Positives = 81/168 (48%), Gaps = 13/168 (7%)
Query: 271 IAQGLLYLHQYSRLRVIHRDLKASNILLDKDMNPKISDFGMAR-MFGGDELQSNTKRIVG 329
IA G+ YL S L +HRDL N L+ +++ KI+DFGM+R ++ GD + R V
Sbjct: 147 IASGMKYL---SSLNFVHRDLATRNCLVGENLTIKIADFGMSRNLYAGDYYRIQ-GRAVL 202
Query: 330 TYGYMSPEYALRGLFSIKSDVFSFGVLLLETLSSKKNTHFYNTDSLTLLGHAWNLWND-G 388
+M+ E L G F+ SDV++FGV L E L K + ++ +A + D G
Sbjct: 203 PIRWMAWECILMGKFTTASDVWAFGVTLWEILMLCKEQPYGELTDEQVIENAGEFFRDQG 262
Query: 389 RTWELMDPISQNGASYPILKRYINVALLCVQEKAADRPAMSEVVSMLS 436
R L P Y ++ L C +RP+ S++ + L+
Sbjct: 263 RQVYLFRPPPCPQGLYELM-------LQCWSRDCRERPSFSDIHAFLT 303
|
Protein Tyrosine Kinase (PTK) family; mammalian Discoidin Domain Receptor 1 (DDR1) and homologs; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR1 is a member of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDR1 binds to all collagens tested to date (types I-IV). It is widely expressed in many tissues. It is abundant in the brain and is also found in keratinocytes, colonic mucosa epithelium, lung epithelium, thyroid follicles, and the islets of Langerhans. During embryonic development, it is found in the developing neuroectoderm. DDR1 is a key regulator of cell morphogenesis, differentiation and proliferation. It is important in the development of the mammary gland, the vasculator and the kidney. DDR1 is also found in human leukocytes, where it facilitates cell adhesion, migration, maturation, and cytokine production. Length = 304 |
| >gnl|CDD|132971 cd06640, STKc_MST4, Catalytic domain of the Protein Serine/Threonine Kinase, Mammalian Ste20-like protein kinase 4 | Back alignment and domain information |
|---|
Score = 62.8 bits (152), Expect = 5e-11
Identities = 33/93 (35%), Positives = 58/93 (62%), Gaps = 5/93 (5%)
Query: 267 IIEGIAQGLLYLHQYSRLRVIHRDLKASNILLDKDMNPKISDFGMARMFGGDELQSNTKR 326
+++ I +GL YLH + IHRD+KA+N+LL + + K++DFG+A +++ NT
Sbjct: 106 MLKEILKGLDYLHSEKK---IHRDIKAANVLLSEQGDVKLADFGVAGQLTDTQIKRNT-- 160
Query: 327 IVGTYGYMSPEYALRGLFSIKSDVFSFGVLLLE 359
VGT +M+PE + + K+D++S G+ +E
Sbjct: 161 FVGTPFWMAPEVIQQSAYDSKADIWSLGITAIE 193
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 4 (MST4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MST4 is sometimes referred to as MASK (MST3 and SOK1-related kinase). It plays a role in mitogen-activated protein kinase (MAPK) signaling during cytoskeletal rearrangement, morphogenesis, and apoptosis. It influences cell growth and transformation by modulating the extracellular signal-regulated kinase (ERK) pathway. MST4 may also play a role in tumor formation and progression. It localizes in the Golgi apparatus by interacting with the Golgi matrix protein GM130 and may play a role in cell migration. Length = 277 |
| >gnl|CDD|132979 cd06648, STKc_PAK_II, Catalytic domain of the Protein Serine/Threonine Kinase, Group II p21-activated kinase | Back alignment and domain information |
|---|
Score = 62.8 bits (153), Expect = 6e-11
Identities = 31/95 (32%), Positives = 52/95 (54%), Gaps = 9/95 (9%)
Query: 267 IIEGIAQGLLYLHQYSRLRVIHRDLKASNILLDKDMNPKISDFGMARMFGGDELQSNTKR 326
+ + + L +LH VIHRD+K+ +ILL D K+SDFG F + +R
Sbjct: 120 VCLAVLKALSFLHAQ---GVIHRDIKSDSILLTSDGRVKLSDFG----FCAQVSKEVPRR 172
Query: 327 --IVGTYGYMSPEYALRGLFSIKSDVFSFGVLLLE 359
+VGT +M+PE R + + D++S G++++E
Sbjct: 173 KSLVGTPYWMAPEVISRLPYGTEVDIWSLGIMVIE 207
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, Group II, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. Group II PAKs, also called non-conventional PAKs, include PAK4, PAK5, and PAK6. Group II PAKs contain PBD (p21-binding domain) and catalytic domains, but lack other motifs found in group I PAKs, such as an AID (autoinhibitory domain) and SH3 binding sites. Since group II PAKs do not contain an obvious AID, they may be regulated differently from group I PAKs. While group I PAKs interact with the SH3 containing proteins Nck, Grb2 and PIX, no such binding has been demonstrated for group II PAKs. Some known substrates of group II PAKs are also substrates of group I PAKs such as Raf, BAD, LIMK and GEFH1. Unique group II substrates include MARK/Par-1 and PDZ-RhoGEF. Group II PAKs play important roles in filopodia formation, neuron extension, cytoskeletal organization, and cell survival. Length = 285 |
| >gnl|CDD|132949 cd06618, PKc_MKK7, Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 7 | Back alignment and domain information |
|---|
Score = 62.8 bits (153), Expect = 7e-11
Identities = 37/97 (38%), Positives = 53/97 (54%), Gaps = 17/97 (17%)
Query: 271 IAQGLLYL---HQYSRLRVIHRDLKASNILLDKDMNPKISDFGMA-RMFGGDELQSNTKR 326
I + L YL H VIHRD+K SNILLD N K+ DFG++ R+ + ++ T R
Sbjct: 123 IVKALHYLKEKHG-----VIHRDVKPSNILLDASGNVKLCDFGISGRLV---DSKAKT-R 173
Query: 327 IVGTYGYMSPEY----ALRGLFSIKSDVFSFGVLLLE 359
G YM+PE + I++DV+S G+ L+E
Sbjct: 174 SAGCAAYMAPERIDPPDPNPKYDIRADVWSLGISLVE 210
|
Protein kinases (PKs), MAP kinase kinase 7 (MKK7) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK7 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK7 is a dual-specificity PK that phosphorylates and activates its downstream target, c-Jun N-terminal kinase (JNK), on specific threonine and tyrosine residues. Although MKK7 is capable of dual phosphorylation, it prefers to phosphorylate the threonine residue of JNK. Thus, optimal activation of JNK requires both MKK4 (not included in this subfamily) and MKK7. MKK7 is primarily activated by cytokines. MKK7 is essential for liver formation during embryogenesis. It plays roles in G2/M cell cycle arrest and cell growth. In addition, it is involved in the control of programmed cell death, which is crucial in oncogenesis, cancer chemoresistance, and antagonism to TNFalpha-induced killing, through its inhibition by Gadd45beta and the subsequent suppression of the JNK cascade. Length = 296 |
| >gnl|CDD|173769 cd08229, STKc_Nek7, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 7 | Back alignment and domain information |
|---|
Score = 62.3 bits (151), Expect = 8e-11
Identities = 46/158 (29%), Positives = 78/158 (49%), Gaps = 19/158 (12%)
Query: 279 HQYSRLRVIHRDLKASNILLDKDMNPKISDFGMARMFGGDELQSNTKRIVGTYGYMSPEY 338
H +SR RV+HRD+K +N+ + K+ D G+ R F +++ +VGT YMSPE
Sbjct: 121 HMHSR-RVMHRDIKPANVFITATGVVKLGDLGLGRFFSSKTTAAHS--LVGTPYYMSPER 177
Query: 339 ALRGLFSIKSDVFSFGVLLLETLSSKKNTHFYNTDSLTLLGHAWNLWNDGRTWELMD--P 396
++ KSD++S G LL E + + + FY G NL++ + E D P
Sbjct: 178 IHENGYNFKSDIWSLGCLLYEMAALQ--SPFY--------GDKMNLYSLCKKIEQCDYPP 227
Query: 397 ISQNGASYPILKRYINVALLCVQEKAADRPAMSEVVSM 434
+ + S L++ +N +C+ RP ++ V +
Sbjct: 228 LPSDHYSEE-LRQLVN---MCINPDPEKRPDITYVYDV 261
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 7 (Nek7) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek7 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek7 is required for mitotic spindle formation and cytokinesis. It is enriched in the centrosome and is critical for microtubule nucleation. Nek7 is activated by Nek9 during mitosis, and may regulate the p70 ribosomal S6 kinase. Length = 267 |
| >gnl|CDD|133240 cd05109, PTKc_HER2, Catalytic domain of the Protein Tyrosine Kinase, HER2 | Back alignment and domain information |
|---|
Score = 62.3 bits (151), Expect = 8e-11
Identities = 33/92 (35%), Positives = 56/92 (60%), Gaps = 3/92 (3%)
Query: 271 IAQGLLYLHQYSRLRVIHRDLKASNILLDKDMNPKISDFGMARMFGGDELQSNTKRIVGT 330
IA+G+ YL + +R++HRDL A N+L+ + KI+DFG+AR+ DE + +
Sbjct: 118 IAKGMSYLEE---VRLVHRDLAARNVLVKSPNHVKITDFGLARLLDIDETEYHADGGKVP 174
Query: 331 YGYMSPEYALRGLFSIKSDVFSFGVLLLETLS 362
+M+ E L F+ +SDV+S+GV + E ++
Sbjct: 175 IKWMALESILHRRFTHQSDVWSYGVTVWELMT 206
|
Protein Tyrosine Kinase (PTK) family; HER2 (ErbB2, HER2/neu); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER2 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. HER2 does not bind to any known EGFR subfamily ligands, but contributes to the kinase activity of all possible heterodimers. It acts as the preferred partner with other ligand-bound EGFR proteins and functions as a signal amplifier, with the HER2-HER3 heterodimer being the most potent pair in mitogenic signaling. HER2 plays an important role in cell development, proliferation, survival and motility. Overexpression of HER2 results in its activation and downstream signaling, even in the absence of ligand. HER2 overexpression, mainly due to gene amplification, has been shown in a variety of human cancers. Its role in breast cancer is especially well-documented. HER2 is up-regulated in about 25% of breast tumors and is associated with increases in tumor aggressiveness, recurrence and mortality. HER2 is a target for monoclonal antibodies and small molecule inhibitors, which are being developed as treatments for cancer. The first humanized antibody approved for clinical use is Trastuzumab (Herceptin), which is being used in combination with other therapies to improve the survival rates of patients with HER2-overexpressing breast cancer. Length = 279 |
| >gnl|CDD|173648 cd05092, PTKc_TrkA, Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase A | Back alignment and domain information |
|---|
Score = 62.3 bits (151), Expect = 9e-11
Identities = 38/109 (34%), Positives = 56/109 (51%), Gaps = 3/109 (2%)
Query: 257 GLLCWGTRVRIIEGIAQGLLYLHQYSRLRVIHRDLKASNILLDKDMNPKISDFGMARMFG 316
G L G + I IA G++YL + L +HRDL N L+ + + KI DFGM+R
Sbjct: 117 GQLTLGQMLAIASQIASGMVYL---ASLHFVHRDLATRNCLVGQGLVVKIGDFGMSRDIY 173
Query: 317 GDELQSNTKRIVGTYGYMSPEYALRGLFSIKSDVFSFGVLLLETLSSKK 365
+ R + +M PE L F+ +SD++SFGV+L E + K
Sbjct: 174 STDYYRVGGRTMLPIRWMPPESILYRKFTTESDIWSFGVVLWEIFTYGK 222
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase A (TrkA); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkA is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkA to its ligand, nerve growth factor (NGF), results in receptor oligomerization and activation of the catalytic domain. TrkA is expressed mainly in neural-crest-derived sensory and sympathetic neurons of the peripheral nervous system, and in basal forebrain cholinergic neurons of the central nervous system. It is critical for neuronal growth, differentiation and survival. Alternative TrkA splicing has been implicated as a pivotal regulator of neuroblastoma (NB) behavior. Normal TrkA expression is associated with better NB prognosis, while the hypoxia-regulated TrkAIII splice variant promotes NB pathogenesis and progression. Aberrant TrkA expression has also been demonstrated in non-neural tumors including prostate, breast, lung, and pancreatic cancers. Length = 280 |
| >gnl|CDD|177557 PHA03209, PHA03209, serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Score = 63.0 bits (153), Expect = 9e-11
Identities = 36/114 (31%), Positives = 54/114 (47%), Gaps = 19/114 (16%)
Query: 267 IIEGIAQGLLYLHQYSRLRVIHRDLKASNILLDKDMNPKISDFGMAR------MFGGDEL 320
I + I +GL YLH R+IHRD+K NI ++ I D G A+ F G
Sbjct: 162 IEKQILEGLRYLHAQ---RIIHRDVKTENIFINDVDQVCIGDLGAAQFPVVAPAFLG--- 215
Query: 321 QSNTKRIVGTYGYMSPEYALRGLFSIKSDVFSFGVLLLETLSSKKNTHFYNTDS 374
+ GT +PE R ++ K+D++S G++L E L+ T F + S
Sbjct: 216 ------LAGTVETNAPEVLARDKYNSKADIWSAGIVLFEMLAYPS-TIFEDPPS 262
|
Length = 357 |
| >gnl|CDD|173710 cd05620, STKc_nPKC_delta, Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C delta | Back alignment and domain information |
|---|
Score = 62.7 bits (152), Expect = 9e-11
Identities = 42/108 (38%), Positives = 61/108 (56%), Gaps = 11/108 (10%)
Query: 271 IAQGLLYLHQYSRLRVIHRDLKASNILLDKDMNPKISDFGMAR--MFGGDELQSNTKRIV 328
I GL +LH +I+RDLK N++LD+D + KI+DFGM + +FG +
Sbjct: 105 IVCGLQFLHSKG---IIYRDLKLDNVMLDRDGHIKIADFGMCKENVFG----DNRASTFC 157
Query: 329 GTYGYMSPEYALRGL-FSIKSDVFSFGVLLLETLSSKKNTHFYNTDSL 375
GT Y++PE L+GL ++ D +SFGVLL E L + H + D L
Sbjct: 158 GTPDYIAPE-ILQGLKYTFSVDWWSFGVLLYEMLIGQSPFHGDDEDEL 204
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), delta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-delta plays a role in cell cycle regulation and programmed cell death in many cell types. It slows down cell proliferation, inducing cell cycle arrest and enhancing cell differentiation. PKC-delta is also involved in the regulation of transcription as well as immune and inflammatory responses. It plays a central role in the genotoxic stress response that leads to DNA damaged-induced apoptosis. Length = 316 |
| >gnl|CDD|173697 cd05606, STKc_beta_ARK, Catalytic domain of the Protein Serine/Threonine Kinase, beta-adrenergic receptor kinase | Back alignment and domain information |
|---|
Score = 62.3 bits (151), Expect = 1e-10
Identities = 33/84 (39%), Positives = 53/84 (63%), Gaps = 6/84 (7%)
Query: 279 HQYSRLRVIHRDLKASNILLDKDMNPKISDFGMARMFGGDELQSNTKRIVGTYGYMSPEY 338
H ++R V++RDLK +NILLD+ + +ISD G+A F + ++ VGT+GYM+PE
Sbjct: 112 HMHNRF-VVYRDLKPANILLDEHGHVRISDLGLACDFSKKKPHAS----VGTHGYMAPEV 166
Query: 339 ALRGL-FSIKSDVFSFGVLLLETL 361
+G+ + +D FS G +L + L
Sbjct: 167 LQKGVAYDSSADWFSLGCMLFKLL 190
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, beta-adrenergic receptor kinase (beta-ARK) group, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. The beta-ARK group is composed of GRK2, GRK3, and similar proteins. GRK2 and GRK3 are both widely expressed in many tissues, although GRK2 is present at higher levels. They contain an N-terminal RGS homology (RH) domain, a central catalytic domain, and C-terminal pleckstrin homology (PH) domain that mediates PIP2 and G protein betagamma-subunit translocation to the membrane. GRK2 (also called beta-ARK or beta-ARK1) is important in regulating several cardiac receptor responses. It plays a role in cardiac development and in hypertension. Deletion of GRK2 in mice results in embryonic lethality, caused by hypoplasia of the ventricular myocardium. GRK2 also plays important roles in the liver (as a regulator of portal blood pressure), in immune cells, and in the nervous system. Altered GRK2 expression has been reported in several disorders including major depression, schizophrenia, bipolar disorder, and Parkinsonism. Length = 278 |
| >gnl|CDD|173770 cd08528, STKc_Nek10, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 10 | Back alignment and domain information |
|---|
Score = 61.7 bits (150), Expect = 1e-10
Identities = 46/163 (28%), Positives = 78/163 (47%), Gaps = 19/163 (11%)
Query: 275 LLYLHQYSRLRVIHRDLKASNILLDKDMNPKISDFGMARMFGGDELQSNTKRIVGTYGYM 334
L YLH+ R ++HRDL +NI+L +D I+DFG+A+ + S +VGT Y
Sbjct: 126 LRYLHKEKR--IVHRDLTPNNIMLGEDDKVTITDFGLAKQKQPE---SKLTSVVGTILYS 180
Query: 335 SPEYALRGLFSIKSDVFSFGVLLLETLSSKKNTHFYNTDSLTLLGHAWNLWNDGRTWELM 394
PE + K+DV++FG +L + FY+T+ L+L +
Sbjct: 181 CPEIVKNEPYGEKADVWAFGCILYQM--CTLQPPFYSTNMLSLATKIVE--------AVY 230
Query: 395 DPISQNGASYPILKRYINVALLCVQEKAADRPAMSEVVSMLSN 437
+P+ + S + +V C+ A RP + +V +M+S+
Sbjct: 231 EPLPEGMYS----EDVTDVITSCLTPDAEARPDIIQVSAMISD 269
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 10 (Nek10) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek10 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. No function has yet been ascribed to Nek10. The gene encoding Nek10 is a putative causative gene for breast cancer; it is located within a breast cancer susceptibility loci on chromosome 3p24. Length = 269 |
| >gnl|CDD|173671 cd05580, STKc_PKA, Catalytic domain of the Protein Serine/Threonine Kinase, cAMP-dependent protein kinase | Back alignment and domain information |
|---|
Score = 61.8 bits (151), Expect = 1e-10
Identities = 32/91 (35%), Positives = 49/91 (53%), Gaps = 8/91 (8%)
Query: 271 IAQGLLYLHQYSRLRVIHRDLKASNILLDKDMNPKISDFGMARMFGGDELQSNTKRIVGT 330
+ L YLH L +++RDLK N+LLD D KI+DFG A+ ++ T + GT
Sbjct: 110 VVLALEYLHS---LDIVYRDLKPENLLLDSDGYIKITDFGFAK-----RVKGRTYTLCGT 161
Query: 331 YGYMSPEYALRGLFSIKSDVFSFGVLLLETL 361
Y++PE L + D ++ G+L+ E L
Sbjct: 162 PEYLAPEIILSKGYGKAVDWWALGILIYEML 192
|
Serine/Threonine Kinases (STKs), cAMP-dependent protein kinase (PKA) subfamily, catalytic (c) subunit. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKA subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). This subfamily is composed of the cAMP-dependent proteins kinases, PKA and PRKX. The inactive PKA holoenzyme is a heterotetramer composed of two phosphorylated and active catalytic (C) subunits with a dimer of regulatory (R) subunits. Activation is achieved through the binding of the important second messenger cAMP to the R subunits, which leads to the dissociation of PKA into the R dimer and two active C subunits. PKA is present ubiquitously in cells and interacts with many different downstream targets. It plays a role in the regulation of diverse processes such as growth, development, memory, metabolism, gene expression, immunity, and lipolysis. Length = 290 |
| >gnl|CDD|173751 cd07860, STKc_CDK2_3, Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase 2 and 3 | Back alignment and domain information |
|---|
Score = 61.7 bits (150), Expect = 1e-10
Identities = 33/93 (35%), Positives = 55/93 (59%), Gaps = 6/93 (6%)
Query: 273 QGLLYLHQYSRLRVIHRDLKASNILLDKDMNPKISDFGMARMFGGDELQSNTKRIVGTYG 332
QGL + H + RV+HRDLK N+L++ + K++DFG+AR F G +++ T +V T
Sbjct: 111 QGLAFCHSH---RVLHRDLKPQNLLINTEGAIKLADFGLARAF-GVPVRTYTHEVV-TLW 165
Query: 333 YMSPEYAL-RGLFSIKSDVFSFGVLLLETLSSK 364
Y +PE L +S D++S G + E ++ +
Sbjct: 166 YRAPEILLGCKYYSTAVDIWSLGCIFAEMVTRR 198
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 2 (CDK2) and CDK3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK2/3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK2 is regulated by cyclin E or cyclin A. Upon activation by cyclin E, it phosphorylates the retinoblastoma (pRb) protein which activates E2F mediated transcription and allows cells to move into S phase. The CDK2/cyclin A complex plays a role in regulating DNA replication. CDK2, together with CDK4, also regulates embryonic cell proliferation. Despite these important roles, mice deleted for the cdk2 gene are viable and normal except for being sterile. This may be due to compensation provided by CDK1 (also called Cdc2), which can also bind cyclin E and drive the G1 to S phase transition. CDK3 is regulated by cyclin C and it phosphorylates pRB specifically during the G0/G1 transition. This phosphorylation is required for cells to exit G0 efficiently and enter the G1 phase. Length = 284 |
| >gnl|CDD|173634 cd05053, PTKc_FGFR, Catalytic domain of the Protein Tyrosine Kinases, Fibroblast Growth Factor Receptors | Back alignment and domain information |
|---|
Score = 61.7 bits (150), Expect = 1e-10
Identities = 33/92 (35%), Positives = 52/92 (56%), Gaps = 3/92 (3%)
Query: 271 IAQGLLYLHQYSRLRVIHRDLKASNILLDKDMNPKISDFGMARMFGGDELQSNTKRIVGT 330
+A+G+ +L + IHRDL A N+L+ +D KI+DFG+AR + T
Sbjct: 141 VARGMEFLASK---KCIHRDLAARNVLVTEDHVMKIADFGLARDIHHIDYYRKTTNGRLP 197
Query: 331 YGYMSPEYALRGLFSIKSDVFSFGVLLLETLS 362
+M+PE +++ +SDV+SFGVLL E +
Sbjct: 198 VKWMAPEALFDRVYTHQSDVWSFGVLLWEIFT 229
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor (FGFR) subfamily; catalytic (c) domain. The FGFR subfamily consists of FGFR1, FGFR2, FGFR3, FGFR4, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K).PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, and to heparin/heparan sulfate (HS) results in the formation of a ternary complex, which leads to receptor dimerization and activation, and intracellular signaling. There are at least 23 FGFs and four types of FGFRs. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. FGF/FGFR signaling is important in the regulation of embryonic development, homeostasis, and regenerative processes. Depending on the cell type and stage, FGFR signaling produces diverse cellular responses including proliferation, growth arrest, differentiation, and apoptosis. Aberrant signaling leads to many human diseases such as skeletal, olfactory, and metabolic disorders, as well as cancer. Length = 293 |
| >gnl|CDD|173752 cd07861, STKc_CDK1_euk, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 1 from higher eukaryotes-like | Back alignment and domain information |
|---|
Score = 61.3 bits (149), Expect = 2e-10
Identities = 36/95 (37%), Positives = 53/95 (55%), Gaps = 6/95 (6%)
Query: 271 IAQGLLYLHQYSRLRVIHRDLKASNILLDKDMNPKISDFGMARMFGGDELQSNTKRIVGT 330
I QG+L+ H RV+HRDLK N+L+D K++DFG+AR F G ++ T +V T
Sbjct: 110 ILQGILFCH---SRRVLHRDLKPQNLLIDNKGVIKLADFGLARAF-GIPVRVYTHEVV-T 164
Query: 331 YGYMSPEYALRG-LFSIKSDVFSFGVLLLETLSSK 364
Y +PE L +S D++S G + E + K
Sbjct: 165 LWYRAPEVLLGSPRYSTPVDIWSIGTIFAEMATKK 199
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 1 (CDK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK1 from higher eukaryotes. CDK1 is also called Cell division control protein 2 (Cdc2) or p34 protein kinase, and is regulated by cyclins A, B, and E. The CDK1/cyclin A complex controls G2 phase entry and progression. CDK1/cyclin A2 has also been implicated as an important regulator of S phase events. The CDK1/cyclin B complex is critical for G2 to M phase transition. It induces mitosis by activating nuclear enzymes that regulate chromatin condensation, nuclear membrane degradation, mitosis-specific microtubule and cytoskeletal reorganization. CDK1 also associates with cyclin E and plays a role in the entry into S phase. CDK1 transcription is stable throughout the cell cycle but is modulated in some pathological conditions. It may play a role in regulating apoptosis under these conditions. In breast cancer cells, HER2 can mediate apoptosis by inactivating CDK1. Activation of CDK1 may contribute to HIV-1 induced apoptosis and neuronal apoptosis in neurodegenerative diseases. Length = 285 |
| >gnl|CDD|132947 cd06616, PKc_MKK4, Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 4 | Back alignment and domain information |
|---|
Score = 61.6 bits (150), Expect = 2e-10
Identities = 34/80 (42%), Positives = 49/80 (61%), Gaps = 8/80 (10%)
Query: 284 LRVIHRDLKASNILLDKDMNPKISDFGMARMFGGDELQSNTK-RIVGTYGYMSPEYAL-- 340
L++IHRD+K SNILLD++ N K+ DFG++ G + S K R G YM+PE
Sbjct: 127 LKIIHRDVKPSNILLDRNGNIKLCDFGIS----GQLVDSIAKTRDAGCRPYMAPERIDPS 182
Query: 341 -RGLFSIKSDVFSFGVLLLE 359
R + ++SDV+S G+ L E
Sbjct: 183 ARDGYDVRSDVWSLGITLYE 202
|
Protein kinases (PKs), MAP kinase kinase 4 (MKK4) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK4 is a dual-specificity PK that phosphorylates and activates the downstream targets, c-Jun N-terminal kinase (JNK) and p38 MAPK, on specific threonine and tyrosine residues. JNK and p38 are collectively known as stress-activated MAPKs, as they are activated in response to a variety of environmental stresses and pro-inflammatory cytokines. Their activation is associated with the induction of cell death. Mice deficient in MKK4 die during embryogenesis and display anemia, severe liver hemorrhage, and abnormal hepatogenesis. MKK4 may also play roles in the immune system and in cardiac hypertrophy. It plays a major role in cancer as a tumor and metastasis suppressor. Under certain conditions, MKK4 is pro-oncogenic. Length = 288 |
| >gnl|CDD|133181 cd05050, PTKc_Musk, Catalytic domain of the Protein Tyrosine Kinase, Muscle-specific kinase | Back alignment and domain information |
|---|
Score = 61.4 bits (149), Expect = 2e-10
Identities = 32/105 (30%), Positives = 59/105 (56%), Gaps = 5/105 (4%)
Query: 259 LCWGTRVRIIEGIAQGLLYLHQYSRLRVIHRDLKASNILLDKDMNPKISDFGMAR-MFGG 317
L ++ I + +A G+ YL S + +HRDL N L+ ++M KI+DFG++R ++
Sbjct: 127 LSCTEQLCIAKQVAAGMAYL---SERKFVHRDLATRNCLVGENMVVKIADFGLSRNIYSA 183
Query: 318 DELQSNTKRIVGTYGYMSPEYALRGLFSIKSDVFSFGVLLLETLS 362
D +++ + +M PE ++ +SDV+++GV+L E S
Sbjct: 184 DYYKASENDAIPIR-WMPPESIFYNRYTTESDVWAYGVVLWEIFS 227
|
Protein Tyrosine Kinase (PTK) family; Muscle-specific kinase (Musk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Musk is a receptor tyr kinase (RTK) containing an extracellular region with four immunoglobulin-like domains and a cysteine-rich cluster, a transmembrane segment, and an intracellular catalytic domain. Musk is expressed and concentrated in the postsynaptic membrane in skeletal muscle. It is essential for the establishment of the neuromuscular junction (NMJ), a peripheral synapse that conveys signals from motor neurons to muscle cells. Agrin, a large proteoglycan released from motor neurons, stimulates Musk autophosphorylation and activation, leading to the clustering of acetylcholine receptors (AChRs). To date, there is no evidence to suggest that agrin binds directly to Musk. Mutations in AChR, Musk and other partners are responsible for diseases of the NMJ, such as the autoimmune syndrome myasthenia gravis. Length = 288 |
| >gnl|CDD|173719 cd05630, STKc_GRK6, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 6 | Back alignment and domain information |
|---|
Score = 61.2 bits (148), Expect = 2e-10
Identities = 35/94 (37%), Positives = 50/94 (53%), Gaps = 6/94 (6%)
Query: 271 IAQGLLYLHQYSRLRVIHRDLKASNILLDKDMNPKISDFGMARMFGGDELQSNTKRIVGT 330
I GL LHQ R+++RDLK NILLD + +ISD G+A + K VGT
Sbjct: 111 ICCGLEDLHQE---RIVYRDLKPENILLDDHGHIRISDLGLAVHVPEGQ---TIKGRVGT 164
Query: 331 YGYMSPEYALRGLFSIKSDVFSFGVLLLETLSSK 364
GYM+PE ++ D ++ G LL E ++ +
Sbjct: 165 VGYMAPEVVKNERYTFSPDWWALGCLLYEMIAGQ 198
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK6 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK6 is widely expressed in many tissues. t is expressed as multiple splice variants with different domain architectures. It is post-translationally palmitoylated and localized in the membrane. GRK6 plays important roles in the regulation of dopamine, M3 muscarinic, opioid, and chemokine receptor signaling. It also plays maladaptive roles in addiction and Parkinson's disease. GRK6-deficient mice exhibit altered dopamine receptor regulation, decreased lymphocyte chemotaxis, and increased acute inflammation and neutrophil chemotaxis. Length = 285 |
| >gnl|CDD|133230 cd05099, PTKc_FGFR4, Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 4 | Back alignment and domain information |
|---|
Score = 61.5 bits (149), Expect = 2e-10
Identities = 37/107 (34%), Positives = 58/107 (54%), Gaps = 3/107 (2%)
Query: 256 KGLLCWGTRVRIIEGIAQGLLYLHQYSRLRVIHRDLKASNILLDKDMNPKISDFGMARMF 315
+ L + V +A+G+ YL SR R IHRDL A N+L+ +D KI+DFG+AR
Sbjct: 128 EEQLSFKDLVSCAYQVARGMEYLE--SR-RCIHRDLAARNVLVTEDNVMKIADFGLARGV 184
Query: 316 GGDELQSNTKRIVGTYGYMSPEYALRGLFSIKSDVFSFGVLLLETLS 362
+ T +M+PE +++ +SDV+SFG+L+ E +
Sbjct: 185 HDIDYYKKTSNGRLPVKWMAPEALFDRVYTHQSDVWSFGILMWEIFT 231
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 4 (FGFR4); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR4 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. Unlike other FGFRs, there is only one splice form of FGFR4. It binds FGF1, FGF2, FGF6, FGF19, and FGF23. FGF19 is a selective ligand for FGFR4. Although disruption of FGFR4 in mice causes no obvious phenotype, in vivo inhibition of FGFR4 in cultured skeletal muscle cells resulted in an arrest of muscle progenitor differentiation. FGF6 and FGFR4 are uniquely expressed in myofibers and satellite cells. FGF6/FGFR4 signaling appears to play a key role in the regulation of muscle regeneration. A polymorphism in FGFR4 is found in head and neck squamous cell carcinoma. Length = 314 |
| >gnl|CDD|132957 cd06626, STKc_MEKK4, Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 4 | Back alignment and domain information |
|---|
Score = 60.8 bits (148), Expect = 2e-10
Identities = 34/109 (31%), Positives = 53/109 (48%), Gaps = 18/109 (16%)
Query: 274 GLLYLHQYSRLRVIHRDLKASNILLDKDMNPKISDFGMARMFGGDELQSNTKRI------ 327
GL YLH + ++HRD+K +NI LD + K+ DFG A L++NT +
Sbjct: 111 GLAYLHSH---GIVHRDIKPANIFLDHNGVIKLGDFGCAVK-----LKNNTTTMGEEVQS 162
Query: 328 -VGTYGYMSPEYALRGLFSIK---SDVFSFGVLLLETLSSKKNTHFYNT 372
GT YM+PE G +D++S G ++LE + K+ +
Sbjct: 163 LAGTPAYMAPEVITGGKGKGHGRAADIWSLGCVVLEMATGKRPWSELDN 211
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 4 (MEKK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK4 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK4 activates the c-Jun N-terminal kinase (JNK) and p38 MAPK signaling pathways by directly activating their respective MAPKKs, MKK4/MKK7 and MKK3/MKK6. JNK and p38 are collectively known as stress-activated MAPKs, as they are activated in response to a variety of environmental stresses and pro-inflammatory cytokines. MEKK4 also plays roles in the re-polarization of the actin cytoskeleton in response to osmotic stress, in the proper closure of the neural tube, in cardiovascular development, and in immune responses. Length = 264 |
| >gnl|CDD|143346 cd07841, STKc_CDK7, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 7 | Back alignment and domain information |
|---|
Score = 61.4 bits (150), Expect = 2e-10
Identities = 33/96 (34%), Positives = 49/96 (51%), Gaps = 18/96 (18%)
Query: 273 QGLLYLHQYSRLRVIHRDLKASNILLDKDMNPKISDFGMARMFG--GDELQSNTKRIVGT 330
+GL YLH ++HRDLK +N+L+ D K++DFG+AR FG ++ V T
Sbjct: 113 RGLEYLHSNW---ILHRDLKPNNLLIASDGVLKLADFGLARSFGSPNRKMTHQ----VVT 165
Query: 331 YGYMSPEYALRGLFSIKS-----DVFSFGVLLLETL 361
Y +PE LF + D++S G + E L
Sbjct: 166 RWYRAPEL----LFGARHYGVGVDMWSVGCIFAELL 197
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 7 (CDK7) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK7 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK7 plays essential roles in the cell cycle and in transcription. It associates with cyclin H and MAT1 and acts as a CDK-Activating Kinase (CAK) by phosphorylating and activating cell cycle CDKs (CDK1/2/4/6). In the brain, it activates CDK5. CDK7 is also a component of the general transcription factor TFIIH, which phosphorylates the C-terminal domain (CTD) of RNA polymerase II when it is bound with unphosphorylated DNA, as present in the pre-initiation complex. Following phosphorylation, the CTD dissociates from the DNA which allows transcription initiation. Length = 298 |
| >gnl|CDD|173698 cd05607, STKc_GRK7, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 7 | Back alignment and domain information |
|---|
Score = 61.1 bits (148), Expect = 2e-10
Identities = 32/95 (33%), Positives = 54/95 (56%), Gaps = 8/95 (8%)
Query: 271 IAQGLLYLHQYSRLRVIHRDLKASNILLDKDMNPKISDFGMA-RMFGGDELQSNTKRIVG 329
I G+L+LH + +++RD+K N+LLD N ++SD G+A + G ++ T+R G
Sbjct: 104 ITCGILHLHS---MDIVYRDMKPENVLLDDQGNCRLSDLGLAVELKDG---KTITQR-AG 156
Query: 330 TYGYMSPEYALRGLFSIKSDVFSFGVLLLETLSSK 364
T GYM+PE +S D F+ G + E ++ +
Sbjct: 157 TNGYMAPEILKEEPYSYPVDWFAMGCSIYEMVAGR 191
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK7 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK7, also called iodopsin kinase, belongs to the visual group of GRKs. It is primarily found in the retina and plays a role in the regulation of opsin light receptors. GRK7 is located in retinal cone outer segments and plays an important role in regulating photoresponse of the cones. Length = 277 |
| >gnl|CDD|133193 cd05062, PTKc_IGF-1R, Catalytic domain of the Protein Tyrosine Kinase, Insulin-like Growth Factor-1 Receptor | Back alignment and domain information |
|---|
Score = 61.2 bits (148), Expect = 2e-10
Identities = 36/90 (40%), Positives = 53/90 (58%), Gaps = 5/90 (5%)
Query: 271 IAQGLLYLHQYSRLRVIHRDLKASNILLDKDMNPKISDFGMAR-MFGGDELQSNTKRIVG 329
IA G+ YL+ + +HRDL A N ++ +D KI DFGM R ++ D + K ++
Sbjct: 128 IADGMAYLNAN---KFVHRDLAARNCMVAEDFTVKIGDFGMTRDIYETDYYRKGGKGLLP 184
Query: 330 TYGYMSPEYALRGLFSIKSDVFSFGVLLLE 359
+MSPE G+F+ SDV+SFGV+L E
Sbjct: 185 VR-WMSPESLKDGVFTTYSDVWSFGVVLWE 213
|
Protein Tyrosine Kinase (PTK) family; Insulin-like Growth Factor-1 Receptor (IGF-1R); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. IGF-1R is a receptor tyr kinases (RTK) that is composed of two alphabeta heterodimers. Binding of the ligand (IGF-1 or IGF-2) to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, which stimulates downstream kinase activities and biological function. IGF-1R signaling is important in the differentiation, growth, and survival of normal cells. In cancer cells, where it is frequently overexpressed, IGF-1R is implicated in proliferation, the suppression of apoptosis, invasion, and metastasis. IGF-1R is being developed as a therapeutic target in cancer treatment. Length = 277 |
| >gnl|CDD|133186 cd05055, PTKc_PDGFR, Catalytic domain of the Protein Tyrosine Kinases, Platelet Derived Growth Factor Receptors | Back alignment and domain information |
|---|
Score = 61.3 bits (149), Expect = 2e-10
Identities = 37/108 (34%), Positives = 57/108 (52%), Gaps = 15/108 (13%)
Query: 258 LLCWGTRVRIIEGIAQGLLYLHQYSRLRVIHRDLKASNILLDKDMNPKISDFGMARMFGG 317
LL + +V A+G+ +L + IHRDL A N+LL KI DFG+AR
Sbjct: 143 LLSFSYQV------AKGMAFLASKN---CIHRDLAARNVLLTHGKIVKICDFGLARDIMN 193
Query: 318 DE---LQSNTKRIVGTYGYMSPEYALRGLFSIKSDVFSFGVLLLETLS 362
D ++ N + V +M+PE +++ +SDV+S+G+LL E S
Sbjct: 194 DSNYVVKGNARLPV---KWMAPESIFNCVYTFESDVWSYGILLWEIFS 238
|
Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) subfamily; catalytic (c) domain. The PDGFR subfamily consists of PDGFR alpha, PDGFR beta, KIT, CSF-1R, the mammalian FLT3, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. PDGFR kinase domains are autoinhibited by their juxtamembrane regions containing tyr residues. The binding to their ligands leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR subfamily receptors are important in the development of a variety of cells. PDGFRs are expressed in a many cells including fibroblasts, neurons, endometrial cells, mammary epithelial cells, and vascular smooth muscle cells. PDGFR signaling is critical in normal embryonic development, angiogenesis, and wound healing. PDGFRs transduce mitogenic signals for connective tissue cells and are important for cell shape and motility. Kit is important in the development of melanocytes, germ cells, mast cells, hematopoietic stem cells, the interstitial cells of Cajal, and the pacemaker cells of the GI tract. CSF-1R signaling is critical in the regulation of macrophages and osteoclasts. Mammalian FLT3 plays an important role in the survival, proliferation, and differentiation of stem cells. Length = 302 |
| >gnl|CDD|143367 cd07862, STKc_CDK6, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 6 | Back alignment and domain information |
|---|
Score = 61.2 bits (148), Expect = 2e-10
Identities = 32/92 (34%), Positives = 50/92 (54%), Gaps = 6/92 (6%)
Query: 273 QGLLYLHQYSRLRVIHRDLKASNILLDKDMNPKISDFGMARMFGGDELQSNTKRIVGTYG 332
+GL +LH + RV+HRDLK NIL+ K++DFG+AR++ Q +V T
Sbjct: 121 RGLDFLHSH---RVVHRDLKPQNILVTSSGQIKLADFGLARIY---SFQMALTSVVVTLW 174
Query: 333 YMSPEYALRGLFSIKSDVFSFGVLLLETLSSK 364
Y +PE L+ ++ D++S G + E K
Sbjct: 175 YRAPEVLLQSSYATPVDLWSVGCIFAEMFRRK 206
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 6 (CDK6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK6 is regulated by D-type cyclins and INK4 inhibitors. It is active towards the retinoblastoma (pRb) protein, implicating it to function in regulating the early G1 phase of the cell cycle. It is expressed ubiquitously and is localized in the cytoplasm. It is also present in the ruffling edge of spreading fibroblasts and may play a role in cell spreading. It binds to the p21 inhibitor without any effect on its own activity and it is overexpressed in squamous cell carcinomas and neuroblastomas. CDK6 has also been shown to inhibit cell differentiation in many cell types. Length = 290 |
| >gnl|CDD|132972 cd06641, STKc_MST3, Catalytic domain of the Protein Serine/Threonine Kinase, Mammalian Ste20-like protein kinase 3 | Back alignment and domain information |
|---|
Score = 61.2 bits (148), Expect = 2e-10
Identities = 33/93 (35%), Positives = 55/93 (59%), Gaps = 5/93 (5%)
Query: 267 IIEGIAQGLLYLHQYSRLRVIHRDLKASNILLDKDMNPKISDFGMARMFGGDELQSNTKR 326
I+ I +GL YLH + IHRD+KA+N+LL + K++DFG+A +++ N
Sbjct: 106 ILREILKGLDYLHSEKK---IHRDIKAANVLLSEHGEVKLADFGVAGQLTDTQIKRN--T 160
Query: 327 IVGTYGYMSPEYALRGLFSIKSDVFSFGVLLLE 359
VGT +M+PE + + K+D++S G+ +E
Sbjct: 161 FVGTPFWMAPEVIKQSAYDSKADIWSLGITAIE 193
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 3 (MST3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MST3 phosphorylates the STK NDR and may play a role in cell cycle progression and cell morphology. It may also regulate paxillin and consequently, cell migration. MST3 is present in human placenta, where it plays an essential role in the oxidative stress-induced apoptosis of trophoblasts in normal spontaneous delivery. Dysregulation of trophoblast apoptosis may result in pregnancy complications such as preeclampsia and intrauterine growth retardation. Length = 277 |
| >gnl|CDD|173647 cd05091, PTKc_Ror2, Catalytic domain of the Protein Tyrosine Kinase, Receptor tyrosine kinase-like Orphan Receptor 2 | Back alignment and domain information |
|---|
Score = 61.2 bits (148), Expect = 2e-10
Identities = 39/101 (38%), Positives = 59/101 (58%), Gaps = 9/101 (8%)
Query: 265 VRIIEGIAQGLLYLHQYSRLRVIHRDLKASNILLDKDMNPKISDFGMAR-MFGGD--ELQ 321
V I+ IA G+ +L S V+H+DL N+L+ +N KISD G+ R ++ D +L
Sbjct: 127 VHIVTQIAAGMEFL---SSHHVVHKDLATRNVLVFDKLNVKISDLGLFREVYAADYYKLM 183
Query: 322 SNTKRIVGTYGYMSPEYALRGLFSIKSDVFSFGVLLLETLS 362
N+ + +MSPE + G FSI SD++S+GV+L E S
Sbjct: 184 GNSLLPIR---WMSPEAIMYGKFSIDSDIWSYGVVLWEVFS 221
|
Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor 2 (Ror2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. Ror2 plays important roles in skeletal and heart formation. Ror2-deficient mice show widespread bone abnormalities, ventricular defects in the heart, and respiratory dysfunction. Mutations in human Ror2 result in two different bone development genetic disorders, recessive Robinow syndrome and brachydactyly type B. Ror2 is also implicated in neural development. Length = 283 |
| >gnl|CDD|132981 cd06650, PKc_MEK1, Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase 1 | Back alignment and domain information |
|---|
Score = 61.6 bits (149), Expect = 2e-10
Identities = 33/90 (36%), Positives = 54/90 (60%), Gaps = 6/90 (6%)
Query: 270 GIAQGLLYLHQYSRLRVIHRDLKASNILLDKDMNPKISDFGMARMFGGDELQSNTKRIVG 329
+ +GL YL + + +++HRD+K SNIL++ K+ DFG++ G + S VG
Sbjct: 111 AVIKGLTYLRE--KHKIMHRDVKPSNILVNSRGEIKLCDFGVS----GQLIDSMANSFVG 164
Query: 330 TYGYMSPEYALRGLFSIKSDVFSFGVLLLE 359
T YMSPE +S++SD++S G+ L+E
Sbjct: 165 TRSYMSPERLQGTHYSVQSDIWSMGLSLVE 194
|
Protein kinases (PKs), MAP/ERK kinase (MEK) 1 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK1 is a dual-specificity PK that phosphorylates and activates the downstream targets, extracellular signal-regulated kinase (ERK) 1 and ERK2, on specific threonine and tyrosine residues. The ERK cascade starts with extracellular signals including growth factors, hormones, and neurotransmitters, which act through receptors and ion channels to initiate intracellular signaling that leads to the activation at the MAPKKK (Raf-1 or MOS) level, which leads to the transmission of signals to MEK1, and finally to ERK1/2. The ERK cascade plays an important role in cell proliferation, differentiation, oncogenic transformation, and cell cycle control, as well as in apoptosis and cell survival under certain conditions. Gain-of-function mutations in genes encoding ERK cascade proteins, including MEK1, cause cardiofaciocutaneous (CFC) syndrome, a condition leading to multiple congenital anomalies and mental retardation in patients. MEK1 also plays a role in cell cycle control. Length = 333 |
| >gnl|CDD|173656 cd05111, PTK_HER3, Pseudokinase domain of the Protein Tyrosine Kinase, HER3 | Back alignment and domain information |
|---|
Score = 61.1 bits (148), Expect = 2e-10
Identities = 36/105 (34%), Positives = 59/105 (56%), Gaps = 9/105 (8%)
Query: 258 LLCWGTRVRIIEGIAQGLLYLHQYSRLRVIHRDLKASNILLDKDMNPKISDFGMARMFGG 317
LL W + IA+G+ YL ++ R++HR+L A NILL D +I+DFG+A +
Sbjct: 111 LLNWCVQ------IAKGMYYLEEH---RMVHRNLAARNILLKSDSIVQIADFGVADLLYP 161
Query: 318 DELQSNTKRIVGTYGYMSPEYALRGLFSIKSDVFSFGVLLLETLS 362
D+ + +M+ E L G ++ +SDV+S+GV + E +S
Sbjct: 162 DDKKYFYSEHKTPIKWMALESILFGRYTHQSDVWSYGVTVWEMMS 206
|
Protein Tyrosine Kinase (PTK) family; HER3 (ErbB3); pseudokinase domain. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER3 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. HER3 binds the neuregulin ligands, NRG1 and NRG2. HER3 contains an impaired tyr kinase domain and relies on its heterodimerization partners for activity following ligand binding. The HER2-HER3 heterodimer constitutes a high affinity co-receptor capable of potent mitogenic signaling. HER3 participates in a signaling pathway involved in the proliferation, survival, adhesion, and motility of tumor cells. Length = 279 |
| >gnl|CDD|132986 cd06655, STKc_PAK2, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 2 | Back alignment and domain information |
|---|
Score = 61.3 bits (148), Expect = 2e-10
Identities = 50/173 (28%), Positives = 83/173 (47%), Gaps = 21/173 (12%)
Query: 273 QGLLYLHQYSRLRVIHRDLKASNILLDKDMNPKISDFGMARMFGGDELQSNTKRIVGTYG 332
Q L +LH +VIHRD+K+ N+LL D + K++DFG + QS +VGT
Sbjct: 126 QALEFLHAN---QVIHRDIKSDNVLLGMDGSVKLTDFGFCAQITPE--QSKRSTMVGTPY 180
Query: 333 YMSPEYALRGLFSIKSDVFSFGVLLLETLSSKKNTHFYNTDSLTLLGHAWNLWNDGRTWE 392
+M+PE R + K D++S G++ +E + + + N + L A L T E
Sbjct: 181 WMAPEVVTRKAYGPKVDIWSLGIMAIEMVEGEPP--YLNENPL----RALYLIATNGTPE 234
Query: 393 LMDPISQNGASYPILKRYINVALLCVQEKAADRPAMSEVVSMLSNEFVNLPAP 445
L +P + PI + ++N C++ R + E +L + F+ L P
Sbjct: 235 LQNPEKLS----PIFRDFLN---RCLEMDVEKRGSAKE---LLQHPFLKLAKP 277
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 2, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK2 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). PAK2 plays a role in pro-apoptotic signaling. It is cleaved and activated by caspases leading to morphological changes during apoptosis. PAK2 is also activated in response to a variety of stresses including DNA damage, hyperosmolarity, serum starvation, and contact inhibition, and may play a role in coordinating the stress response. PAK2 also contributes to cancer cell invasion through a mechanism distinct from that of PAK1. Length = 296 |
| >gnl|CDD|132978 cd06647, STKc_PAK_I, Catalytic domain of the Protein Serine/Threonine Kinase, Group I p21-activated kinase | Back alignment and domain information |
|---|
Score = 61.1 bits (148), Expect = 3e-10
Identities = 33/87 (37%), Positives = 50/87 (57%), Gaps = 5/87 (5%)
Query: 273 QGLLYLHQYSRLRVIHRDLKASNILLDKDMNPKISDFGMARMFGGDELQSNTKRIVGTYG 332
Q L +LH +VIHRD+K+ NILL D + K++DFG + QS +VGT
Sbjct: 126 QALEFLHSN---QVIHRDIKSDNILLGMDGSVKLTDFGFCAQITPE--QSKRSTMVGTPY 180
Query: 333 YMSPEYALRGLFSIKSDVFSFGVLLLE 359
+M+PE R + K D++S G++ +E
Sbjct: 181 WMAPEVVTRKAYGPKVDIWSLGIMAIE 207
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, Group I, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs are implicated in the regulation of many cellular processes including growth factor receptor-mediated proliferation, cell polarity, cell motility, cell death and survival, and actin cytoskeleton organization. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. Group I PAKs, also called conventional PAKs, include PAK1, PAK2, and PAK3. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). They interact with the SH3 domain containing proteins Nck, Grb2 and PIX. Binding of group I PAKs to activated GTPases leads to conformational changes that destabilize the AID, allowing autophosphorylation and full activation of the kinase domain. Known group I PAK substrates include MLCK, Bad, Raf, MEK1, LIMK, Merlin, Vimentin, Myc, Stat5a, and Aurora A, among others. Length = 293 |
| >gnl|CDD|132980 cd06649, PKc_MEK2, Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase 2 | Back alignment and domain information |
|---|
Score = 61.2 bits (148), Expect = 3e-10
Identities = 33/90 (36%), Positives = 54/90 (60%), Gaps = 6/90 (6%)
Query: 270 GIAQGLLYLHQYSRLRVIHRDLKASNILLDKDMNPKISDFGMARMFGGDELQSNTKRIVG 329
+ +GL YL + + +++HRD+K SNIL++ K+ DFG++ G + S VG
Sbjct: 111 AVLRGLAYLRE--KHQIMHRDVKPSNILVNSRGEIKLCDFGVS----GQLIDSMANSFVG 164
Query: 330 TYGYMSPEYALRGLFSIKSDVFSFGVLLLE 359
T YMSPE +S++SD++S G+ L+E
Sbjct: 165 TRSYMSPERLQGTHYSVQSDIWSMGLSLVE 194
|
Protein kinases (PKs), MAP/ERK Kinase (MEK) 2 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK2 is a dual-specificity PK that phosphorylates and activates the downstream targets, extracellular signal-regulated kinase (ERK) 1 and ERK2, on specific threonine and tyrosine residues. The ERK cascade starts with extracellular signals including growth factors, hormones, and neurotransmitters, which act through receptors and ion channels to initiate intracellular signaling that leads to the activation at the MAPKKK (Raf-1 or MOS) level, which leads to the transmission of signals to MEK2, and finally to ERK1/2. The ERK cascade plays an important role in cell proliferation, differentiation, oncogenic transformation, and cell cycle control, as well as in apoptosis and cell survival under certain conditions. Gain-of-function mutations in genes encoding ERK cascade proteins, including MEK2, cause cardiofaciocutaneous (CFC) syndrome, a condition leading to multiple congenital anomalies and mental retardation in patients. Length = 331 |
| >gnl|CDD|173768 cd08228, STKc_Nek6, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 6 | Back alignment and domain information |
|---|
Score = 60.4 bits (146), Expect = 3e-10
Identities = 31/81 (38%), Positives = 47/81 (58%), Gaps = 3/81 (3%)
Query: 279 HQYSRLRVIHRDLKASNILLDKDMNPKISDFGMARMFGGDELQSNTKRIVGTYGYMSPEY 338
H +SR RV+HRD+K +N+ + K+ D G+ R F +++ +VGT YMSPE
Sbjct: 121 HMHSR-RVMHRDIKPANVFITATGVVKLGDLGLGRFFSSKTTAAHS--LVGTPYYMSPER 177
Query: 339 ALRGLFSIKSDVFSFGVLLLE 359
++ KSD++S G LL E
Sbjct: 178 IHENGYNFKSDIWSLGCLLYE 198
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 6 (Nek6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek6 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek6 is required for the transition from metaphase to anaphase. It also plays important roles in mitotic spindle formation and cytokinesis. Activated by Nek9 during mitosis, Nek6 phosphorylates Eg5, a kinesin that is important for spindle bipolarity. Nek6 localizes to spindle microtubules during metaphase and anaphase, and to the midbody during cytokinesis. Length = 267 |
| >gnl|CDD|133233 cd05102, PTKc_VEGFR3, Catalytic domain of the Protein Tyrosine Kinase, Vascular Endothelial Growth Factor Receptor 3 | Back alignment and domain information |
|---|
Score = 61.2 bits (148), Expect = 3e-10
Identities = 42/111 (37%), Positives = 64/111 (57%), Gaps = 13/111 (11%)
Query: 254 TKKGLLCWGTRVRIIEGIAQGLLYLHQYSRLRVIHRDLKASNILLDKDMNPKISDFGMAR 313
T + L+C+ +V A+G+ +L SR + IHRDL A NILL ++ KI DFG+AR
Sbjct: 172 TMEDLICYSFQV------ARGMEFLA--SR-KCIHRDLAARNILLSENNVVKICDFGLAR 222
Query: 314 MF--GGDELQSNTKRIVGTYGYMSPEYALRGLFSIKSDVFSFGVLLLETLS 362
D ++ + R+ +M+PE +++ +SDV+SFGVLL E S
Sbjct: 223 DIYKDPDYVRKGSARL--PLKWMAPESIFDKVYTTQSDVWSFGVLLWEIFS 271
|
Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor 3 (VEGFR3); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR3 (or Flt4) is a member of the VEGFR subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. In VEGFR3, the fifth Ig-like domain is replaced by a disulfide bridge. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. VEGFR3 preferentially binds the ligands VEGFC and VEGFD. VEGFR3 is essential for lymphatic endothelial cell (EC) development and function. It has been shown to regulate adaptive immunity during corneal transplantation. VEGFR3 is upregulated on blood vascular ECs in pathological conditions such as vascular tumors and the periphery of solid tumors. It plays a role in cancer progression and lymph node metastasis. Missense mutations in the VEGFR3 gene are associated with primary human lymphedema. Length = 338 |
| >gnl|CDD|133192 cd05061, PTKc_InsR, Catalytic domain of the Protein Tyrosine Kinase, Insulin Receptor | Back alignment and domain information |
|---|
Score = 60.4 bits (146), Expect = 4e-10
Identities = 50/183 (27%), Positives = 84/183 (45%), Gaps = 25/183 (13%)
Query: 271 IAQGLLYLHQYSRLRVIHRDLKASNILLDKDMNPKISDFGMAR-MFGGDELQSNTKRIVG 329
IA G+ YL+ + +HRDL A N ++ D KI DFGM R ++ D + K ++
Sbjct: 128 IADGMAYLNAK---KFVHRDLAARNCMVAHDFTVKIGDFGMTRDIYETDYYRKGGKGLLP 184
Query: 330 TYGYMSPEYALRGLFSIKSDVFSFGVLLLE--TLSSKKNTHFYNTDSLTLLGHAWNLWND 387
M+PE G+F+ SD++SFGV+L E +L+ + N L + D
Sbjct: 185 VRW-MAPESLKDGVFTTSSDMWSFGVVLWEITSLAEQPYQGLSNEQVLKFV-------MD 236
Query: 388 GRTWELMDPISQNGASYPILKRYINVALLCVQEKAADRPAMSEVVSMLSNEFVNLPAPQQ 447
G + D + R ++ +C Q RP E+V++L ++ P+ +
Sbjct: 237 GGYLDQPDNCPE---------RVTDLMRMCWQFNPKMRPTFLEIVNLLKDDL--HPSFPE 285
Query: 448 PAF 450
+F
Sbjct: 286 VSF 288
|
Protein Tyrosine Kinase (PTK) family; Insulin Receptor (InsR); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. InsR is a receptor tyr kinase (RTK) that is composed of two alphabeta heterodimers. Binding of the insulin ligand to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, stimulating downstream kinase activities, which initiate signaling cascades and biological function. InsR signaling plays an important role in many cellular processes including glucose homeostasis, glycogen synthesis, lipid and protein metabolism, ion and amino acid transport, cell cycle and proliferation, cell differentiation, gene transcription, and nitric oxide synthesis. Insulin resistance, caused by abnormalities in InsR signaling, has been described in diabetes, hypertension, cardiovascular disease, metabolic syndrome, heart failure, and female infertility. Length = 288 |
| >gnl|CDD|173707 cd05616, STKc_cPKC_beta, Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C beta | Back alignment and domain information |
|---|
Score = 60.8 bits (147), Expect = 4e-10
Identities = 37/96 (38%), Positives = 54/96 (56%), Gaps = 9/96 (9%)
Query: 271 IAQGLLYLHQYSRLRVIHRDLKASNILLDKDMNPKISDFGMAR--MFGGDELQSNTKRIV 328
IA GL +LH +I+RDLK N++LD + + KI+DFGM + M+ G TK
Sbjct: 110 IAIGLFFLHSKG---IIYRDLKLDNVMLDSEGHIKIADFGMCKENMWDG----VTTKTFC 162
Query: 329 GTYGYMSPEYALRGLFSIKSDVFSFGVLLLETLSSK 364
GT Y++PE + D ++FGVLL E L+ +
Sbjct: 163 GTPDYIAPEIIAYQPYGKSVDWWAFGVLLYEMLAGQ 198
|
Serine/Threonine Kinases (STKs), Classical Protein Kinase C (cPKC) subfamily, beta isoforms, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. There are four cPKC isoforms, named alpha, betaI, betaII, and gamma. The PKC beta isoforms (I and II), generated by alternative splicing of a single gene, are preferentially activated by hyperglycemia-induced DAG in retinal tissues. This is implicated in diabetic microangiopathy such as ischemia, neovascularization, and abnormal vasodilator function. PKC-beta also plays an important role in VEGF signaling. In addition, glucose regulates proliferation in retinal endothelial cells via PKC-betaI. PKC-beta is also being explored as a therapeutic target in cancer. It contributes to tumor formation and is involved in the tumor host mechanisms of inflammation and angiogenesis. Length = 323 |
| >gnl|CDD|132985 cd06654, STKc_PAK1, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 1 | Back alignment and domain information |
|---|
Score = 60.5 bits (146), Expect = 4e-10
Identities = 33/92 (35%), Positives = 52/92 (56%), Gaps = 5/92 (5%)
Query: 273 QGLLYLHQYSRLRVIHRDLKASNILLDKDMNPKISDFGMARMFGGDELQSNTKRIVGTYG 332
Q L +LH +VIHRD+K+ NILL D + K++DFG + QS +VGT
Sbjct: 127 QALEFLHSN---QVIHRDIKSDNILLGMDGSVKLTDFGFCAQITPE--QSKRSTMVGTPY 181
Query: 333 YMSPEYALRGLFSIKSDVFSFGVLLLETLSSK 364
+M+PE R + K D++S G++ +E + +
Sbjct: 182 WMAPEVVTRKAYGPKVDIWSLGIMAIEMIEGE 213
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 1, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK1 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). PAK1 is important in the regulation of many cellular processes including cytoskeletal dynamics, cell motility, growth, and proliferation. Although PAK1 has been regarded mainly as a cytosolic protein, recent reports indicate that PAK1 also exists in significant amounts in the nucleus, where it is involved in transcription modulation and in cell cycle regulatory events. PAK1 is also involved in transformation and tumorigenesis. Its overexpression, hyperactivation and increased nuclear accumulation is correlated to breast cancer invasiveness and progression. Nuclear accumulation is also linked to tamoxifen resistance in breast cancer cells. Length = 296 |
| >gnl|CDD|133247 cd05116, PTKc_Syk, Catalytic domain of the Protein Tyrosine Kinase, Spleen tyrosine kinase | Back alignment and domain information |
|---|
Score = 60.0 bits (145), Expect = 4e-10
Identities = 38/102 (37%), Positives = 56/102 (54%), Gaps = 10/102 (9%)
Query: 265 VRIIEGIAQGLLYLHQYSRLRVIHRDLKASNILLDKDMNPKISDFGMARMFGGDE----L 320
++ ++ G+ YL + + +HRDL A N+LL KISDFG+++ G DE
Sbjct: 98 TELVHQVSMGMKYLEETN---FVHRDLAARNVLLVTQHYAKISDFGLSKALGADENYYKA 154
Query: 321 QSNTKRIVGTYGYMSPEYALRGLFSIKSDVFSFGVLLLETLS 362
+++ K V Y +PE FS KSDV+SFGVL+ E S
Sbjct: 155 KTHGKWPVKWY---APECMNYYKFSSKSDVWSFGVLMWEAFS 193
|
Protein Tyrosine Kinase (PTK) family; Spleen tyrosine kinase (Syk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Syk, together with Zap-70, form the Syk subfamily of kinases which are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. Syk was first cloned from the spleen, and its function in hematopoietic cells is well-established. Syk is involved in the signaling downstream of activated receptors (including B-cell and Fc receptors) that contain ITAMs (immunoreceptor tyr activation motifs), leading to processes such as cell proliferation, differentiation, survival, adhesion, migration, and phagocytosis. More recently, Syk expression has been detected in other cell types (including epithelial cells, vascular endothelial cells, neurons, hepatocytes, and melanocytes), suggesting a variety of biological functions in non-immune cells. Syk plays a critical role in maintaining vascular integrity and in wound healing during embryogenesis. It also regulates Vav3, which is important in osteoclast function including bone development. In breast epithelial cells, where Syk acts as a negative regulator for epidermal growth factor receptor (EGFR) signaling, loss of Syk expression is associated with abnormal proliferation during cancer development suggesting a potential role as a tumor suppressor. In mice, Syk has been shown to inhibit malignant transformation of mammary epithelial cells induced with murine mammary tumor virus (MMTV). Length = 257 |
| >gnl|CDD|173633 cd05052, PTKc_Abl, Catalytic domain of the Protein Tyrosine Kinase, Abelson kinase | Back alignment and domain information |
|---|
Score = 59.9 bits (145), Expect = 4e-10
Identities = 34/91 (37%), Positives = 52/91 (57%), Gaps = 8/91 (8%)
Query: 271 IAQGLLYLHQYSRLRVIHRDLKASNILLDKDMNPKISDFGMARMFGGDEL--QSNTKRIV 328
I+ + YL + + IHRDL A N L+ ++ K++DFG++R+ GD + K +
Sbjct: 113 ISSAMEYLEKKN---FIHRDLAARNCLVGENHLVKVADFGLSRLMTGDTYTAHAGAKFPI 169
Query: 329 GTYGYMSPEYALRGLFSIKSDVFSFGVLLLE 359
+ +PE FSIKSDV++FGVLL E
Sbjct: 170 ---KWTAPESLAYNKFSIKSDVWAFGVLLWE 197
|
Protein Tyrosine Kinase (PTK) family; Abelson (Abl) kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Abl (or c-Abl) is a ubiquitously-expressed cytoplasmic (or nonreceptor) tyr kinase that contains SH3, SH2, and tyr kinase domains in its N-terminal region, as well as nuclear localization motifs, a putative DNA-binding domain, and F- and G-actin binding domains in its C-terminal tail. It also contains a short autoinhibitory cap region in its N-terminus. Abl is normally inactive and requires phosphorylation and myristoylation for activation. Abl function depends on its subcellular localization. In the cytoplasm, Abl plays a role in cell proliferation and survival. In response to DNA damage or oxidative stress, Abl is transported to the nucleus where it induces apoptosis. In chronic myelogenous leukemia (CML) patients, an aberrant translocation results in the replacement of the first exon of Abl with the BCR (breakpoint cluster region) gene. The resulting BCR-Abl fusion protein is constitutively active and associates into tetramers, resulting in a hyperactive kinase sending a continuous signal. This leads to uncontrolled proliferation, morphological transformation and anti-apoptotic effects. BCR-Abl is the target of selective inhibitors, such as imatinib (Gleevec), used in the treatment of CML. Abl2, also known as ARG (Abelson-related gene), is thought to play a cooperative role with Abl in the proper development of the nervous system. The Tel-ARG fusion protein, resulting from reciprocal translocation between chromosomes 1 and 12, is associated with acute myeloid leukemia (AML). The TEL gene is a frequent fusion partner of other tyr kinase oncogenes, including Tel/Abl, Tel/PDGFRbeta, and Tel/Jak2, found in patients with leukemia and myeloproliferative disorders. Length = 263 |
| >gnl|CDD|173722 cd05633, STKc_GRK3, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 3 | Back alignment and domain information |
|---|
Score = 60.0 bits (145), Expect = 4e-10
Identities = 33/84 (39%), Positives = 52/84 (61%), Gaps = 6/84 (7%)
Query: 279 HQYSRLRVIHRDLKASNILLDKDMNPKISDFGMARMFGGDELQSNTKRIVGTYGYMSPEY 338
H ++R V++RDLK +NILLD+ + +ISD G+A F + ++ VGT+GYM+PE
Sbjct: 112 HMHNRF-VVYRDLKPANILLDEHGHVRISDLGLACDFSKKKPHAS----VGTHGYMAPEV 166
Query: 339 ALRGL-FSIKSDVFSFGVLLLETL 361
+G + +D FS G +L + L
Sbjct: 167 LQKGTAYDSSADWFSLGCMLFKLL 190
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK3 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK3 (also known as beta-adrenergic receptor kinase 2) is widely expressed in many tissues. GRK3-deficient mice show a lack of olfactory receptor desensitization and altered regulation of the M2 muscarinic airway. GRK3 is involved in modulating the cholinergic response of airway smooth muscles. It also plays a role in dopamine receptor regulation. GRK3 promoter polymorphisms may be associated with bipolar disorder. Length = 279 |
| >gnl|CDD|173741 cd07843, STKc_CDC2L1, Catalytic domain of the Serine/Threonine Kinase, Cell Division Cycle 2-like 1 | Back alignment and domain information |
|---|
Score = 60.3 bits (147), Expect = 5e-10
Identities = 35/92 (38%), Positives = 52/92 (56%), Gaps = 6/92 (6%)
Query: 274 GLLYLHQYSRLRVIHRDLKASNILLDKDMNPKISDFGMARMFGGDELQSNTKRIVGTYGY 333
G+ +LH ++HRDLK SN+LL+ KI DFG+AR + G L+ T+ +V T Y
Sbjct: 118 GVAHLHDNW---ILHRDLKTSNLLLNNRGILKICDFGLAREY-GSPLKPYTQLVV-TLWY 172
Query: 334 MSPEYAL-RGLFSIKSDVFSFGVLLLETLSSK 364
+PE L +S D++S G + E L+ K
Sbjct: 173 RAPELLLGAKEYSTAIDMWSVGCIFAELLTKK 204
|
Serine/Threonine Kinases (STKs), Cell Division Cycle 2-like 1 (CDC2L1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDC2L1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDC2L1, also called PITSLRE, exists in different isoforms which are named using the alias CDK11(p). The CDC2L1 gene produces two protein products, CDK11(p110) and CDK11(p58). CDC2L1 is also represented by the caspase-processed CDK11(p46). CDK11(p110), the major isoform, associates with cyclin L and is expressed throughout the cell cycle. It is involved in RNA processing and the regulation of transcription. CDK11(p58) associates with cyclin D3 and is expressed during the G2/M phase of the cell cycle. It plays roles in spindle morphogenesis, centrosome maturation, sister chromatid cohesion, and the completion of mitosis. CDK11(p46) is formed from the larger isoforms by caspases during TNFalpha- and Fas-induced apoptosis. It functions as a downstream effector kinase in apoptotic signaling pathways and interacts with eukaryotic initiation factor 3f (eIF3f), p21-activated kinase (PAK1), and Ran-binding protein (RanBPM). Length = 293 |
| >gnl|CDD|173772 cd08530, STKc_CNK2-like, Catalytic domain of the Protein Serine/Threonine Kinase, Chlamydomonas reinhardtii CNK2, and similar domains | Back alignment and domain information |
|---|
Score = 59.8 bits (145), Expect = 5e-10
Identities = 49/171 (28%), Positives = 76/171 (44%), Gaps = 32/171 (18%)
Query: 266 RIIEGIAQGLLYLHQYSRLRVIHRDLKASNILLDKDMNPKISDFGMARMFGGDELQSN-T 324
RI + +GL LH+ +++HRDLK++NILL + KI D G++++ L+ N
Sbjct: 107 RIFIQLLRGLQALHE---QKILHRDLKSANILLVANDLVKIGDLGISKV-----LKKNMA 158
Query: 325 KRIVGTYGYMSPEYALRGLFSIKSDVFSFGVLLLETLSSKKNTHFYNTDSLTLLGHAWNL 384
K +GT YM+PE +S KSD++S G LL E + F
Sbjct: 159 KTQIGTPHYMAPEVWKGRPYSYKSDIWSLGCLLYEMATFA--PPF--------------- 201
Query: 385 WNDGRTWELMDPISQNGASYPILKRY----INVALLCVQEKAADRPAMSEV 431
+ R+ + + Q G PI Y N +Q K RP ++
Sbjct: 202 --EARSMQDLRYKVQRGKYPPIPPIYSQDLQNFIRSMLQVKPKLRPNCDKI 250
|
Serine/Threonine Kinases (STKs), Chlamydomonas reinhardtii Never In Mitosis gene A (NIMA)-related kinase 1 (CNK2)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Chlamydomonas reinhardtii CNK2-like subfamily belongs to the (NIMA)-related kinase (Nek) family. The Nek family includes seven different Chlamydomonas Neks (CNKs 1-6 and Fa2). This subfamily includes CNK1, and -2. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Chlamydomonas reinhardtii CNK2 has both cilliary and cell cycle functions. It influences flagellar length through promoting flagellar disassembly, and it regulates cell size, through influencing the size threshold at which cells commit to mitosis. Length = 256 |
| >gnl|CDD|173748 cd07853, STKc_NLK, Catalytic domain of the Serine/Threonine Kinase, Nemo-Like Kinase | Back alignment and domain information |
|---|
Score = 60.5 bits (147), Expect = 5e-10
Identities = 34/96 (35%), Positives = 54/96 (56%), Gaps = 7/96 (7%)
Query: 271 IAQGLLYLHQYSRLRVIHRDLKASNILLDKDMNPKISDFGMARMFGGDELQSNTKRIVGT 330
I +GL YLH ++HRD+K N+L++ + KI DFG+AR+ DE + T+ +V
Sbjct: 112 ILRGLKYLHS---AGILHRDIKPGNLLVNSNCVLKICDFGLARVEEPDESKHMTQEVVTQ 168
Query: 331 YGYMSPEYALRGL--FSIKSDVFSFGVLLLETLSSK 364
Y Y +PE L G ++ D++S G + E L +
Sbjct: 169 Y-YRAPEI-LMGSRHYTSAVDIWSVGCIFAELLGRR 202
|
Serine/Threonine Kinases (STKs), Nemo-Like Kinase (NLK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NLK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Mitogen-activated protein kinases (MAPKs) are important mediators of cellular responses to extracellular signals. NLK is an atypical MAPK that is not regulated by a MAPK kinase. It functions downstream of the MAPK kinase kinase Tak1, which also plays a role in activating the JNK and p38 MAPKs. The Tak1/NLK pathways are regulated by Wnts, a family of secreted proteins that is critical in the control of asymmetric division and cell polarity. NLK can phosphorylate transcription factors from the TCF/LEF family, inhibiting their ability to activate the transcription of target genes. In prostate cancer cells, NLK is involved in regulating androgen receptor-mediated transcription and its expression is altered during cancer progression. Length = 372 |
| >gnl|CDD|133237 cd05106, PTKc_CSF-1R, Catalytic domain of the Protein Tyrosine Kinase, Colony-Stimulating Factor-1 Receptor | Back alignment and domain information |
|---|
Score = 60.6 bits (147), Expect = 5e-10
Identities = 38/112 (33%), Positives = 59/112 (52%), Gaps = 17/112 (15%)
Query: 271 IAQGLLYLHQYSRLRVIHRDLKASNILLDKDMNPKISDFGMARMFGGDE---LQSNTKRI 327
+AQG+ +L + IHRD+ A N+LL KI DFG+AR D ++ N +
Sbjct: 221 VAQGMDFL---ASKNCIHRDVAARNVLLTDGRVAKICDFGLARDIMNDSNYVVKGNARLP 277
Query: 328 VGTYGYMSPEYALRGLFSIKSDVFSFGVLLLETLSSKK--------NTHFYN 371
V +M+PE +++++SDV+S+G+LL E S K N+ FY
Sbjct: 278 V---KWMAPESIFDCVYTVQSDVWSYGILLWEIFSLGKSPYPGILVNSKFYK 326
|
Protein Tyrosine Kinase (PTK) family; Colony-Stimulating Factor-1 Receptor (CSF-1R); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. CSF-1R, also called c-Fms, is a member of the Platelet Derived Growth Factor Receptor (PDGFR) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of CSF-1R to its ligand, CSF-1, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. CSF-1R signaling is critical in the regulation of macrophages and osteoclasts. It leads to increases in gene transcription and protein translation, and induces cytoskeletal remodeling. CSF-1R signaling leads to a variety of cellular responses including survival, proliferation, and differentiation of target cells. It plays an important role in innate immunity, tissue development and function, and the pathogenesis of some diseases including atherosclerosis and cancer. CSF-1R signaling is also implicated in mammary gland development during pregnancy and lactation. Aberrant CSF-1/CSF-1R expression correlates with tumor cell invasiveness, poor clinical prognosis, and bone metastasis in breast cancer. Although the structure of the human CSF-1R catalytic domain is known, it is excluded from this specific alignment model because it contains a deletion in its sequence. Length = 374 |
| >gnl|CDD|173650 cd05094, PTKc_TrkC, Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase C | Back alignment and domain information |
|---|
Score = 60.0 bits (145), Expect = 6e-10
Identities = 40/126 (31%), Positives = 63/126 (50%), Gaps = 11/126 (8%)
Query: 256 KGLLCWGTRVRIIEGIAQGLLYLHQYSRLRVIHRDLKASNILLDKDMNPKISDFGMARMF 315
KG L + I IA G++YL + +HRDL N L+ ++ KI DFGM+R
Sbjct: 117 KGELGLSQMLHIASQIASGMVYL---ASQHFVHRDLATRNCLVGANLLVKIGDFGMSR-- 171
Query: 316 GGDELQSNTKRIVG----TYGYMSPEYALRGLFSIKSDVFSFGVLLLETLSSKKNTHFYN 371
D ++ R+ G +M PE + F+ +SDV+SFGV+L E + K F
Sbjct: 172 --DVYSTDYYRVGGHTMLPIRWMPPESIMYRKFTTESDVWSFGVILWEIFTYGKQPWFQL 229
Query: 372 TDSLTL 377
+++ +
Sbjct: 230 SNTEVI 235
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase C (TrkC); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkC is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkC to its ligand, neurotrophin 3 (NT3), results in receptor oligomerization and activation of the catalytic domain. TrkC is broadly expressed in the nervous system and in some non-neural tissues including the developing heart. NT3/TrkC signaling plays an important role in the innervation of the cardiac conducting system and the development of smooth muscle cells. Mice deficient with NT3 and TrkC have multiple heart defects. NT3/TrkC signaling is also critical for the development and maintenance of enteric neurons that are important for the control of gut peristalsis. Length = 291 |
| >gnl|CDD|173754 cd07865, STKc_CDK9, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 9 | Back alignment and domain information |
|---|
Score = 60.1 bits (146), Expect = 6e-10
Identities = 30/78 (38%), Positives = 47/78 (60%), Gaps = 7/78 (8%)
Query: 266 RIIEGIAQGLLYLHQYSRLRVIHRDLKASNILLDKDMNPKISDFGMARMFG---GDELQS 322
++++ + GL Y+H R +++HRD+KA+NIL+ KD K++DFG+AR F +
Sbjct: 123 KVMKMLLNGLYYIH---RNKILHRDMKAANILITKDGILKLADFGLARAFSLSKNSKPNR 179
Query: 323 NTKRIVGTYGYMSPEYAL 340
T R+V T Y PE L
Sbjct: 180 YTNRVV-TLWYRPPELLL 196
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 9 (CDK9) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK9 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK9 together with a cyclin partner (cyclin T1, T2a, T2b, or K) is the main component of distinct positive transcription elongation factors (P-TEFb), which function as Ser2 C-terminal domain kinases of RNA polymerase II. P-TEFb participates in multiple steps of gene expression including transcription elongation, mRNA synthesis, processing, export, and translation. It also plays a role in mediating cytokine induced transcription networks such as IL6-induced STAT3 signaling. In addition, the CDK9/cyclin T2a complex promotes muscle differentiation and enhances the function of some myogenic regulatory factors. Length = 310 |
| >gnl|CDD|133212 cd05081, PTKc_Jak2_Jak3_rpt2, Catalytic (repeat 2) domain of the Protein Tyrosine Kinases, Janus kinases 2 and 3 | Back alignment and domain information |
|---|
Score = 59.8 bits (145), Expect = 6e-10
Identities = 36/100 (36%), Positives = 54/100 (54%), Gaps = 9/100 (9%)
Query: 271 IAQGLLYLHQYSRLRVIHRDLKASNILLDKDMNPKISDFGMARMFGGDELQSNTKRIVG- 329
I +G+ YL R +HRDL NIL++ + KI DFG+ ++ D+ + R G
Sbjct: 117 ICKGMEYL---GSKRYVHRDLATRNILVESENRVKIGDFGLTKVLPQDK-EYYKVREPGE 172
Query: 330 --TYGYMSPEYALRGLFSIKSDVFSFGVLLLETLS-SKKN 366
+ Y +PE FS+ SDV+SFGV+L E + S K+
Sbjct: 173 SPIFWY-APESLTESKFSVASDVWSFGVVLYELFTYSDKS 211
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 2 (Jak2) and Jak3; catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak2 and Jak3 are members of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal catalytic tyr kinase domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jak2 is widely expressed in many tissues while Jak3 is expressed only in hematopoietic cells. Jak2 is essential for the signaling of hormone-like cytokines such as growth hormone, erythropoietin, thrombopoietin, and prolactin, as well as some IFNs and cytokines that signal through the IL-3 and gp130 receptors. Jak3 binds the shared receptor subunit common gamma chain and thus, is essential in the signaling of cytokines that use it such as IL-2, IL-4, IL-7, IL-9, IL-15, and IL-21. Disruption of Jak2 in mice results in an embryonic lethal phenotype with multiple defects including erythropoietic and cardiac abnormalities. It is the only Jak gene that results in a lethal phenotype when disrupted in mice. A mutation in the pseudokinase domain of Jak2, V617F, is present in many myeloproliferative diseases, including almost all patients with polycythemia vera, and 50% of patients with essential thrombocytosis and myelofibrosis. Jak3 is important in lymphoid development and myeloid cell differentiation. Inactivating mutations in Jak3 have been reported in humans with severe combined immunodeficiency (SCID). Length = 284 |
| >gnl|CDD|133216 cd05085, PTKc_Fer, Catalytic domain of the Protein Tyrosine Kinase, Fer | Back alignment and domain information |
|---|
Score = 59.2 bits (143), Expect = 6e-10
Identities = 38/92 (41%), Positives = 52/92 (56%), Gaps = 6/92 (6%)
Query: 272 AQGLLYLHQYSRLRVIHRDLKASNILLDKDMNPKISDFGMARMF-GGDELQSNTKRIVGT 330
A G+ YL + IHRDL A N L+ ++ KISDFGM+R G S K+I
Sbjct: 103 AAGMAYLESKN---CIHRDLAARNCLVGENNVLKISDFGMSRQEDDGIYSSSGLKQI--P 157
Query: 331 YGYMSPEYALRGLFSIKSDVFSFGVLLLETLS 362
+ +PE G +S +SDV+S+G+LL ET S
Sbjct: 158 IKWTAPEALNYGRYSSESDVWSYGILLWETFS 189
|
Protein Tyrosine Kinase (PTK) family; Fer kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fer kinase is a member of the Fes subfamily of proteins which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. Fer kinase is expressed in a wide variety of tissues, and is found to reside in both the cytoplasm and the nucleus. It plays important roles in neuronal polarization and neurite development, cytoskeletal reorganization, cell migration, growth factor signaling, and the regulation of cell-cell interactions mediated by adherens junctions and focal adhesions. Fer kinase also regulates cell cycle progression in malignant cells. Length = 250 |
| >gnl|CDD|133221 cd05090, PTKc_Ror1, Catalytic domain of the Protein Tyrosine Kinase, Receptor tyrosine kinase-like Orphan Receptor 1 | Back alignment and domain information |
|---|
Score = 59.6 bits (144), Expect = 7e-10
Identities = 40/110 (36%), Positives = 61/110 (55%), Gaps = 5/110 (4%)
Query: 254 TKKGLLCWGTRVRIIEGIAQGLLYLHQYSRLRVIHRDLKASNILLDKDMNPKISDFGMAR 313
T K L G + I IA G+ YL + +H+DL A NIL+ + ++ KISD G++R
Sbjct: 116 TVKSSLDHGDFLHIAIQIAAGMEYLSSHF---FVHKDLAARNILIGEQLHVKISDLGLSR 172
Query: 314 -MFGGDELQSNTKRIVGTYGYMSPEYALRGLFSIKSDVFSFGVLLLETLS 362
++ D + K ++ +M PE + G FS SD++SFGV+L E S
Sbjct: 173 EIYSADYYRVQPKSLLPIR-WMPPEAIMYGKFSSDSDIWSFGVVLWEIFS 221
|
Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor 1 (Ror1); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. Ror kinases are expressed in many tissues during development. Avian Ror1 was found to be involved in late limb development. Studies in mice reveal that Ror1 is important in the regulation of neurite growth in central neurons, as well as in respiratory development. Loss of Ror1 also enhances the heart and skeletal abnormalities found in Ror2-deficient mice. Length = 283 |
| >gnl|CDD|183880 PRK13184, pknD, serine/threonine-protein kinase; Reviewed | Back alignment and domain information |
|---|
Score = 60.9 bits (148), Expect = 7e-10
Identities = 38/117 (32%), Positives = 55/117 (47%), Gaps = 19/117 (16%)
Query: 262 GTRVRIIEGIAQGLLYLHQYSRLRVIHRDLKASNILLDKDMNPKISDFGMARMFGGDE-- 319
G + I I + Y+H S+ V+HRDLK NILL I D+G A +E
Sbjct: 113 GAFLSIFHKICATIEYVH--SK-GVLHRDLKPDNILLGLFGEVVILDWGAAIFKKLEEED 169
Query: 320 -----------LQSN-TK--RIVGTYGYMSPEYALRGLFSIKSDVFSFGVLLLETLS 362
S+ T +IVGT YM+PE L S +D+++ GV+L + L+
Sbjct: 170 LLDIDVDERNICYSSMTIPGKIVGTPDYMAPERLLGVPASESTDIYALGVILYQMLT 226
|
Length = 932 |
| >gnl|CDD|173706 cd05615, STKc_cPKC_alpha, Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C alpha | Back alignment and domain information |
|---|
Score = 60.0 bits (145), Expect = 7e-10
Identities = 35/96 (36%), Positives = 54/96 (56%), Gaps = 9/96 (9%)
Query: 271 IAQGLLYLHQYSRLRVIHRDLKASNILLDKDMNPKISDFGMAR--MFGGDELQSNTKRIV 328
I+ GL +LH R +I+RDLK N++LD + + KI+DFGM + M G T+
Sbjct: 110 ISVGLFFLH---RRGIIYRDLKLDNVMLDSEGHIKIADFGMCKEHMVDG----VTTRTFC 162
Query: 329 GTYGYMSPEYALRGLFSIKSDVFSFGVLLLETLSSK 364
GT Y++PE + D +++GVLL E L+ +
Sbjct: 163 GTPDYIAPEIIAYQPYGKSVDWWAYGVLLYEMLAGQ 198
|
Serine/Threonine Kinases (STKs), Classical Protein Kinase C (cPKC) subfamily, alpha isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. There are four cPKC isoforms, named alpha, betaI, betaII, and gamma. PKC-alpha is expressed in many tissues and is associated with cell proliferation, apoptosis, and cell motility. It plays a role in the signaling of the growth factors PDGF, VEGF, EGF, and FGF. Abnormal levels of PKC-alpha have been detected in many transformed cell lines and several human tumors. In addition, PKC-alpha is required for HER2 dependent breast cancer invasion. Length = 323 |
| >gnl|CDD|173654 cd05108, PTKc_EGFR, Catalytic domain of the Protein Tyrosine Kinase, Epidermal Growth Factor Receptor | Back alignment and domain information |
|---|
Score = 59.6 bits (144), Expect = 7e-10
Identities = 32/92 (34%), Positives = 58/92 (63%), Gaps = 3/92 (3%)
Query: 271 IAQGLLYLHQYSRLRVIHRDLKASNILLDKDMNPKISDFGMARMFGGDELQSNTKRIVGT 330
IA+G+ YL + R++HRDL A N+L+ + KI+DFG+A++ G DE + + +
Sbjct: 118 IAKGMNYLEER---RLVHRDLAARNVLVKTPQHVKITDFGLAKLLGADEKEYHAEGGKVP 174
Query: 331 YGYMSPEYALRGLFSIKSDVFSFGVLLLETLS 362
+M+ E L +++ +SDV+S+GV + E ++
Sbjct: 175 IKWMALESILHRIYTHQSDVWSYGVTVWELMT 206
|
Protein Tyrosine Kinase (PTK) family; Epidermal Growth Factor Receptor (EGFR); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EGFR (HER1, ErbB1) is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. Ligands for EGFR include EGF, heparin binding EGF-like growth factor (HBEGF), epiregulin, amphiregulin, TGFalpha, and betacellulin. Upon ligand binding, EGFR can form homo- or heterodimers with other EGFR subfamily members. The EGFR signaling pathway is one of the most important pathways regulating cell proliferation, differentiation, survival, and growth. Overexpression and mutation in the kinase domain of EGFR have been implicated in the development and progression of a variety of cancers. A number of monoclonal antibodies and small molecule inhibitors have been developed that target EGFR, including the antibodies Cetuximab and Panitumumab, which are used in combination with other therapies for the treatment of colorectal cancer and non-small cell lung carcinoma (NSCLC). The small molecule inhibitors Gefitinib (Iressa) and Erlotinib (Tarceva), already used for NSCLC, are undergoing clinical trials for other types of cancer including gastrointestinal, breast, head and neck, and bladder. Length = 316 |
| >gnl|CDD|133228 cd05097, PTKc_DDR_like, Catalytic domain of Discoidin Domain Receptor-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 59.2 bits (143), Expect = 9e-10
Identities = 36/93 (38%), Positives = 51/93 (54%), Gaps = 5/93 (5%)
Query: 271 IAQGLLYLHQYSRLRVIHRDLKASNILLDKDMNPKISDFGMAR-MFGGDELQSNTKRIVG 329
IA G+ YL + L +HRDL N L+ KI+DFGM+R ++ GD + R V
Sbjct: 138 IASGMKYL---ASLNFVHRDLATRNCLVGNHYTIKIADFGMSRNLYSGDYYRIQ-GRAVL 193
Query: 330 TYGYMSPEYALRGLFSIKSDVFSFGVLLLETLS 362
+M+ E L G F+ SDV++FGV L E +
Sbjct: 194 PIRWMAWESILLGKFTTASDVWAFGVTLWEMFT 226
|
Protein Tyrosine Kinase (PTK) family; Discoidin Domain Receptor (DDR)-like proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR-like proteins are members of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDRs regulate cell adhesion, proliferation, and extracellular matrix remodeling. They have been linked to a variety of human cancers including breast, colon, ovarian, brain, and lung. There is no evidence showing that DDRs act as transforming oncogenes. They are more likely to play a role in the regulation of tumor growth and metastasis. Length = 295 |
| >gnl|CDD|132987 cd06656, STKc_PAK3, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 3 | Back alignment and domain information |
|---|
Score = 59.3 bits (143), Expect = 9e-10
Identities = 33/92 (35%), Positives = 52/92 (56%), Gaps = 5/92 (5%)
Query: 273 QGLLYLHQYSRLRVIHRDLKASNILLDKDMNPKISDFGMARMFGGDELQSNTKRIVGTYG 332
Q L +LH +VIHRD+K+ NILL D + K++DFG + QS +VGT
Sbjct: 126 QALDFLHSN---QVIHRDIKSDNILLGMDGSVKLTDFGFCAQITPE--QSKRSTMVGTPY 180
Query: 333 YMSPEYALRGLFSIKSDVFSFGVLLLETLSSK 364
+M+PE R + K D++S G++ +E + +
Sbjct: 181 WMAPEVVTRKAYGPKVDIWSLGIMAIEMVEGE 212
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 3, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK3 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). PAK3 is highly expressed in the brain. It is implicated in neuronal plasticity, synapse formation, dendritic spine morphogenesis, cell cycle progression, neuronal migration, and apoptosis. Inactivating mutations in the PAK3 gene cause X-linked non-syndromic mental retardation, the severity of which depends on the site of the mutation. Length = 297 |
| >gnl|CDD|173747 cd07852, STKc_MAPK15, Catalytic domain of the Serine/Threonine Kinase, Mitogen-Activated Protein Kinase 15 | Back alignment and domain information |
|---|
Score = 59.5 bits (145), Expect = 1e-09
Identities = 34/84 (40%), Positives = 44/84 (52%), Gaps = 16/84 (19%)
Query: 277 YLHQYSRLRVIHRDLKASNILLDKDMNPKISDFGMARMFGGDELQSNTKRI-----VGTY 331
Y+H S VIHRDLK SNILL+ D K++DFG+AR EL+ N + V T
Sbjct: 122 YIH--SG-NVIHRDLKPSNILLNSDCRVKLADFGLARSL--SELEENPENPVLTDYVATR 176
Query: 332 GYMSPEYALRGLFSIKSDVFSFGV 355
Y +PE L S ++ GV
Sbjct: 177 WYRAPEILL------GSTRYTKGV 194
|
Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase 15 (MAPK15) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK15 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. Human MAPK15 is also called Extracellular signal Regulated Kinase 8 (ERK8) while the rat protein is called ERK7. ERK7 and ERK8 display both similar and different biochemical properties. They autophosphorylate and activate themselves and do not require upstream activating kinases. ERK7 is constitutively active and is not affected by extracellular stimuli whereas ERK8 shows low basal activity and is activated by DNA-damaging agents. ERK7 and ERK8 also have different substrate profiles. Genome analysis shows that they are orthologs with similar gene structures. ERK7 and ERK 8 may be involved in the signaling of some nuclear receptor transcription factors. ERK7 regulates hormone-dependent degradation of estrogen receptor alpha while ERK8 down-regulates the transcriptional co-activation androgen and glucocorticoid receptors. Length = 337 |
| >gnl|CDD|133246 cd05115, PTKc_Zap-70, Catalytic domain of the Protein Tyrosine Kinase, Zeta-chain-associated protein of 70kDa | Back alignment and domain information |
|---|
Score = 58.8 bits (142), Expect = 1e-09
Identities = 33/100 (33%), Positives = 53/100 (53%), Gaps = 6/100 (6%)
Query: 265 VRIIEGIAQGLLYLHQYSRLRVIHRDLKASNILLDKDMNPKISDFGMARMFGGDELQSNT 324
V ++ ++ G+ YL + +HRDL A N+LL KISDFG+++ G D+
Sbjct: 98 VELMHQVSMGMKYLEGKN---FVHRDLAARNVLLVNQHYAKISDFGLSKALGADD-SYYK 153
Query: 325 KRIVGTY--GYMSPEYALRGLFSIKSDVFSFGVLLLETLS 362
R G + + +PE FS +SDV+S+G+ + E S
Sbjct: 154 ARSAGKWPLKWYAPECINFRKFSSRSDVWSYGITMWEAFS 193
|
Protein Tyrosine Kinase (PTK) family; Zeta-chain-associated protein of 70kDa (Zap-70); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Zap-70 is a member of the Syk subfamily of kinases, which are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. Zap-70 is primarily expressed in T-cells and NK cells, and is a crucial component in T-cell receptor (TCR) signaling. Zap-70 binds the phosphorylated ITAM (immunoreceptor tyr activation motif) sequences of the activated TCR zeta-chain through its SH2 domains, leading to its phosphorylation and activation. It then phosphorylates target proteins, which propagate the signals to downstream pathways. Zap-70 is hardly detected in normal peripheral B-cells, but is present in some B-cell malignancies. It is used as a diagnostic marker for chronic lymphocytic leukemia (CLL) as it is associated with the more aggressive subtype of the disease. Length = 257 |
| >gnl|CDD|133211 cd05080, PTKc_Tyk2_rpt2, Catalytic (repeat 2) domain of the Protein Tyrosine Kinase, Tyrosine kinase 2 | Back alignment and domain information |
|---|
Score = 58.8 bits (142), Expect = 1e-09
Identities = 41/126 (32%), Positives = 56/126 (44%), Gaps = 4/126 (3%)
Query: 271 IAQGLLYLHQYSRLRVIHRDLKASNILLDKDMNPKISDFGMARMF-GGDELQSNTKRIVG 329
I +G+ YLH IHRDL A N+LLD D KI DFG+A+ G E +
Sbjct: 116 ICEGMAYLHSQ---HYIHRDLAARNVLLDNDRLVKIGDFGLAKAVPEGHEYYRVREDGDS 172
Query: 330 TYGYMSPEYALRGLFSIKSDVFSFGVLLLETLSSKKNTHFYNTDSLTLLGHAWNLWNDGR 389
+ + E FS SDV+SFGV L E L+ + ++G R
Sbjct: 173 PVFWYAVECLKENKFSYASDVWSFGVTLYELLTHCDSKQSPPKKFEEMIGPKQGQMTVVR 232
Query: 390 TWELMD 395
EL++
Sbjct: 233 LIELLE 238
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase 2 (Tyk2); catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyk2 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase catalytic domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Tyk2 is widely expressed in many tissues. It is involved in signaling via the cytokine receptors IFN-alphabeta, IL-6, IL-10, IL-12, IL-13, and IL-23. It mediates cell surface urokinase receptor (uPAR) signaling and plays a role in modulating vascular smooth muscle cell (VSMC) functional behavior in response to injury. Tyk2 is also important in dendritic cell function and T helper (Th)1 cell differentiation. A homozygous mutation of Tyk2 was found in a patient with hyper-IgE syndrome (HIES), a primary immunodeficiency characterized by recurrent skin abscesses, pneumonia, and elevated serum IgE. This suggests that Tyk2 may play important roles in multiple cytokine signaling involved in innate and adaptive immunity. Length = 283 |
| >gnl|CDD|88330 cd05047, PTKc_Tie, Catalytic domain of Tie Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 58.5 bits (141), Expect = 1e-09
Identities = 36/100 (36%), Positives = 59/100 (59%), Gaps = 10/100 (10%)
Query: 265 VRIIEGIAQGLLYLHQYSRLRVIHRDLKASNILLDKDMNPKISDFGMARMFGGDELQSNT 324
+ +A+G+ YL S+ + IHRDL A NIL+ ++ KI+DFG++R G E+
Sbjct: 115 LHFAADVARGMDYL---SQKQFIHRDLAARNILVGENYVAKIADFGLSR---GQEVY--V 166
Query: 325 KRIVGTYG--YMSPEYALRGLFSIKSDVFSFGVLLLETLS 362
K+ +G +M+ E +++ SDV+S+GVLL E +S
Sbjct: 167 KKTMGRLPVRWMAIESLNYSVYTTNSDVWSYGVLLWEIVS 206
|
Protein Tyrosine Kinase (PTK) family; Tie subfamily; catalytic (c) domain. The Tie subfamily consists of Tie1 and Tie2. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie proteins are receptor tyr kinases (RTKs) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie receptors are specifically expressed in endothelial cells and hematopoietic stem cells. The angiopoietins (Ang-1 to Ang-4) serve as ligands for Tie2, while no specific ligand has been identified for Tie1. The binding of Ang-1 to Tie2 leads to receptor autophosphorylation and activation, promoting cell migration and survival. In contrast, Ang-2 binding to Tie2 does not result in the same response, suggesting that Ang-2 may function as an antagonist. In vivo studies of Tie1 show that it is critical in vascular development. Length = 270 |
| >gnl|CDD|173681 cd05590, STKc_nPKC_eta, Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C eta | Back alignment and domain information |
|---|
Score = 59.1 bits (143), Expect = 1e-09
Identities = 37/107 (34%), Positives = 53/107 (49%), Gaps = 9/107 (8%)
Query: 271 IAQGLLYLHQYSRLRVIHRDLKASNILLDKDMNPKISDFGMAR--MFGGDELQSNTKRIV 328
I L++LH +I+RDLK N+LLD + + K++DFGM + +F G T
Sbjct: 105 ITSALMFLHDKG---IIYRDLKLDNVLLDHEGHCKLADFGMCKEGIFNG----KTTSTFC 157
Query: 329 GTYGYMSPEYALRGLFSIKSDVFSFGVLLLETLSSKKNTHFYNTDSL 375
GT Y++PE L+ D ++ GVLL E L N D L
Sbjct: 158 GTPDYIAPEILQEMLYGPSVDWWAMGVLLYEMLCGHAPFEAENEDDL 204
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), eta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-eta is predominantly expressed in squamous epithelia, where it plays a crucial role in the signaling of cell-type specific differentiation. It is also expressed in pro-B cells and early-stage thymocytes, and acts as a key regulator in early B-cell development. PKC-eta increases glioblastoma multiforme (GBM) proliferation and resistance to radiation, and is being developed as a therapeutic target for the management of GBM. Length = 320 |
| >gnl|CDD|173645 cd05084, PTKc_Fes, Catalytic domain of the Protein Tyrosine Kinase, Fes | Back alignment and domain information |
|---|
Score = 58.5 bits (141), Expect = 1e-09
Identities = 46/130 (35%), Positives = 66/130 (50%), Gaps = 15/130 (11%)
Query: 236 LVQSKDEISFWYESYNNPTKKGLLCWGTRVRIIEGIAQGLLYLHQYSRLRVIHRDLKASN 295
LVQ D ++F K L+ +++E A G+ YL IHRDL A N
Sbjct: 74 LVQGGDFLTFLRTEGPRLKVKELI------QMVENAAAGMEYLESKH---CIHRDLAARN 124
Query: 296 ILLDKDMNPKISDFGMARMFGGDELQSNT---KRIVGTYGYMSPEYALRGLFSIKSDVFS 352
L+ + KISDFGM+R D + ++T K+I + +PE G +S +SDV+S
Sbjct: 125 CLVTEKNVLKISDFGMSRE-EEDGVYASTGGMKQI--PVKWTAPEALNYGRYSSESDVWS 181
Query: 353 FGVLLLETLS 362
FG+LL E S
Sbjct: 182 FGILLWEAFS 191
|
Protein Tyrosine Kinase (PTK) family; Fes (or Fps) kinase subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fes subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. The genes for Fes (feline sarcoma) and Fps (Fujinami poultry sarcoma) were first isolated from tumor-causing retroviruses. The viral oncogenes encode chimeric Fes proteins consisting of Gag sequences at the N-termini, resulting in unregulated tyr kinase activity. Fes kinase is expressed in myeloid, vascular endothelial, epithelial, and neuronal cells. It plays important roles in cell growth and differentiation, angiogenesis, inflammation and immunity, and cytoskeletal regulation. A recent study implicates Fes kinase as a tumor suppressor in colorectal cancer. Length = 252 |
| >gnl|CDD|173763 cd08223, STKc_Nek4, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 4 | Back alignment and domain information |
|---|
Score = 58.4 bits (141), Expect = 1e-09
Identities = 36/108 (33%), Positives = 56/108 (51%), Gaps = 8/108 (7%)
Query: 271 IAQGLLYLHQYSRLRVIHRDLKASNILLDKDMNPKISDFGMARMFGGDELQSNTKRIVGT 330
IA L YLH+ ++HRDLK N+ L + K+ D G+AR+ ++T ++GT
Sbjct: 111 IAMALQYLHEK---HILHRDLKTQNVFLTRTNIIKVGDLGIARVLENQCDMAST--LIGT 165
Query: 331 YGYMSPEYALRGLFSIKSDVFSFGVLLLETLSSKKNTHFYNTDSLTLL 378
YMSPE ++ KSDV++ G + E + K H +N + L
Sbjct: 166 PYYMSPELFSNKPYNYKSDVWALGCCVYEMATLK---HAFNAKDMNSL 210
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 4 (Nek4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek4 subfamily is one of a family of 11 different Neks (Nek1-11). The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Neks are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. Nek4 is highly abundant in the testis. Its specific function is unknown. Length = 257 |
| >gnl|CDD|133229 cd05098, PTKc_FGFR1, Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 1 | Back alignment and domain information |
|---|
Score = 58.9 bits (142), Expect = 2e-09
Identities = 34/92 (36%), Positives = 53/92 (57%), Gaps = 3/92 (3%)
Query: 271 IAQGLLYLHQYSRLRVIHRDLKASNILLDKDMNPKISDFGMARMFGGDELQSNTKRIVGT 330
+A+G+ YL + + IHRDL A N+L+ +D KI+DFG+AR + T
Sbjct: 149 VARGMEYL---ASKKCIHRDLAARNVLVTEDNVMKIADFGLARDIHHIDYYKKTTNGRLP 205
Query: 331 YGYMSPEYALRGLFSIKSDVFSFGVLLLETLS 362
+M+PE +++ +SDV+SFGVLL E +
Sbjct: 206 VKWMAPEALFDRIYTHQSDVWSFGVLLWEIFT 237
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 1 (FGFR1); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR1 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. Alternative splicing of FGFR1 transcripts produces a variety of isoforms, which are differentially expressed in cells. FGFR1 binds the ligands, FGF1 and FGF2, with high affinity and has also been reported to bind FGF4, FGF6, and FGF9. FGFR1 signaling is critical in the control of cell migration during embryo development. It promotes cell proliferation in fibroblasts. Nuclear FGFR1 plays a role in the regulation of transcription. Mutations, insertions or deletions of FGFR1 have been identified in patients with Kallman's syndrome (KS), an inherited disorder characterized by hypogonadotropic hypogonadism and loss of olfaction. Aberrant FGFR1 expression has been found in some human cancers including 8P11 myeloproliferative syndrome (EMS), breast cancer, and pancreatic adenocarcinoma. Length = 307 |
| >gnl|CDD|173696 cd05605, STKc_GRK4_like, Catalytic domain of G protein-coupled Receptor Kinase 4-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 58.3 bits (141), Expect = 2e-09
Identities = 35/94 (37%), Positives = 48/94 (51%), Gaps = 6/94 (6%)
Query: 271 IAQGLLYLHQYSRLRVIHRDLKASNILLDKDMNPKISDFGMARMFGGDELQSNTKRIVGT 330
I GL LH R R+++RDLK NILLD + +ISD G+A E + VGT
Sbjct: 111 ITCGLEDLH---RERIVYRDLKPENILLDDYGHIRISDLGLAVEIPEGET---IRGRVGT 164
Query: 331 YGYMSPEYALRGLFSIKSDVFSFGVLLLETLSSK 364
GYM+PE ++ D + G L+ E + K
Sbjct: 165 VGYMAPEVVKNERYTFSPDWWGLGCLIYEMIEGK 198
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK4-like group, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. Members of the GRK4-like group include GRK4, GRK5, GRK6, and similar GRKs. GRKs in this group contain an N-terminal RGS homology (RH) domain and a catalytic domain, but lack a G protein betagamma-subunit binding domain. They are localized to the plasma membrane through post-translational lipid modification or direct binding to PIP2. Length = 285 |
| >gnl|CDD|173758 cd08218, STKc_Nek1, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 1 | Back alignment and domain information |
|---|
Score = 57.9 bits (140), Expect = 2e-09
Identities = 35/100 (35%), Positives = 55/100 (55%), Gaps = 5/100 (5%)
Query: 279 HQYSRLRVIHRDLKASNILLDKDMNPKISDFGMARMFGGD-ELQSNTKRIVGTYGYMSPE 337
H + R +++HRD+K+ NI L KD K+ DFG+AR+ EL + +GT Y+SPE
Sbjct: 116 HVHDR-KILHRDIKSQNIFLTKDGTIKLGDFGIARVLNSTVEL---ARTCIGTPYYLSPE 171
Query: 338 YALRGLFSIKSDVFSFGVLLLETLSSKKNTHFYNTDSLTL 377
++ KSD+++ G +L E + K N +L L
Sbjct: 172 ICENRPYNNKSDIWALGCVLYEMCTLKHAFEAGNMKNLVL 211
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 1 (Nek1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek1 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek1 is associated with centrosomes throughout the cell cycle. It is involved in the formation of primary cilium and in the maintenance of centrosomes. It cycles through the nucleus and may be capable of relaying signals between the cilium and the nucleus. Nek1 is implicated in the development of polycystic kidney disease, which is characterized by benign polycystic tumors formed by abnormal overgrowth of renal epithelial cells. It appears also to be involved in DNA damage response, and may be important for both correct DNA damage checkpoint activation and DNA repair. Length = 256 |
| >gnl|CDD|173664 cd05573, STKc_ROCK_NDR_like, Catalytic domain of ROCK- and NDR kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 58.8 bits (143), Expect = 2e-09
Identities = 37/119 (31%), Positives = 57/119 (47%), Gaps = 29/119 (24%)
Query: 271 IAQGLLYLHQYSRLRVIHRDLKASNILLDKDMNPKISDFGMA--------RMFGGDELQS 322
IA+ +L L +L IHRD+K NIL+D D + K++DFG+ R + ++ +
Sbjct: 107 IAELVLALDSVHKLGFIHRDIKPDNILIDADGHIKLADFGLCKKMNKAKDREYYLNDSHN 166
Query: 323 NTKR-------------------IVGTYGYMSPEYALRGL-FSIKSDVFSFGVLLLETL 361
R VGT Y++PE LRG + ++ D +S GV+L E L
Sbjct: 167 LLFRDNVLVRRRDHKQRRVRANSTVGTPDYIAPE-VLRGTPYGLECDWWSLGVILYEML 224
|
Serine/Threonine Kinases (STKs), Rho-associated coiled-coil containing protein kinase (ROCK) and Nuclear Dbf2-Related (NDR)-like kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK- and NDR-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily include ROCK and ROCK-like proteins such as DMPK, MRCK, and CRIK, as well as NDR and NDR-like proteins such as LATS, CBK1 and Sid2p. ROCK and CRIK are effectors of the small GTPase Rho, while MRCK is an effector of the small GTPase Cdc42. NDR and NDR-like kinases contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Proteins in this subfamily are involved in regulating many cellular functions including contraction, motility, division, proliferation, apoptosis, morphogenesis, and cytokinesis. Length = 350 |
| >gnl|CDD|173638 cd05065, PTKc_EphR_B, Catalytic domain of the Protein Tyrosine Kinases, Class EphB Ephrin Receptors | Back alignment and domain information |
|---|
Score = 58.0 bits (140), Expect = 2e-09
Identities = 47/177 (26%), Positives = 85/177 (48%), Gaps = 26/177 (14%)
Query: 265 VRIIEGIAQGLLYLHQYSRLRVIHRDLKASNILLDKDMNPKISDFGMARMFGGDELQSNT 324
V ++ GIA G+ YL S + +HRDL A NIL++ ++ K+SDFG++R D
Sbjct: 109 VGMLRGIAAGMKYL---SEMNYVHRDLAARNILVNSNLVCKVSDFGLSRFLEDDTSDPTY 165
Query: 325 KRIVG---TYGYMSPEYALRGLFSIKSDVFSFGVLLLETLSSKKNTHFYNTDSLTLLGHA 381
+G + +PE F+ SDV+S+G+++ E +S + +
Sbjct: 166 TSSLGGKIPIRWTAPEAIAYRKFTSASDVWSYGIVMWEVMSYGERPY------------- 212
Query: 382 WNLWNDGRTWELMDPISQNGASYPILK--RYINVALL-CVQEKAADRPAMSEVVSML 435
W++ N ++++ I Q+ P + ++ +L C Q+ RP ++VS L
Sbjct: 213 WDMSNQ----DVINAIEQDYRLPPPMDCPTALHQLMLDCWQKDRNARPKFGQIVSTL 265
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; class EphB receptors; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). Class EphB receptors bind to transmembrane ephrin-B ligands. There are six vertebrate EhpB receptors (EphB1-6), which display promiscuous interactions with three ephrin-B ligands. One exception is EphB2, which also interacts with ephrin A5. EphRs contain an ephrin-binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). Ephrin/EphR interaction mainly results in cell-cell repulsion or adhesion. EphBRs play important roles in synapse formation and plasticity, spine morphogenesis, axon guidance, and angiogenesis. In the intestinal epithelium, EphBRs are Wnt signaling target genes that control cell compartmentalization. They function as suppressors of color cancer progression. Length = 269 |
| >gnl|CDD|173730 cd06624, STKc_ASK, Catalytic domain of the Protein Serine/Threonine Kinase, Apoptosis signal-regulating kinase | Back alignment and domain information |
|---|
Score = 57.9 bits (140), Expect = 2e-09
Identities = 32/97 (32%), Positives = 53/97 (54%), Gaps = 8/97 (8%)
Query: 271 IAQGLLYLHQYSRLRVIHRDLKASNILLDKDMNP-KISDFGMARMFGGDELQSNTKRIVG 329
I +GL YLH +++HRD+K N+L++ KISDFG ++ G + T+ G
Sbjct: 117 ILEGLKYLHD---NQIVHRDIKGDNVLVNTYSGVVKISDFGTSKRLAG--INPCTETFTG 171
Query: 330 TYGYMSPEYALRGL--FSIKSDVFSFGVLLLETLSSK 364
T YM+PE +G + +D++S G ++E + K
Sbjct: 172 TLQYMAPEVIDKGPRGYGAPADIWSLGCTIVEMATGK 208
|
Serine/threonine kinases (STKs), Apoptosis signal-regulating kinase (ASK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ASK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Subfamily members are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks) and include ASK1, ASK2, and MAPKKK15. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. ASK1 (also called MAPKKK5) functions in the c-Jun N-terminal kinase (JNK) and p38 MAPK signaling pathways by directly activating their respective MAPKKs, MKK4/MKK7 and MKK3/MKK6. It plays important roles in cytokine and stress responses, as well as in reactive oxygen species (ROS)-mediated cellular responses. ASK1 is implicated in various diseases mediated by oxidative stress including inschemic heart disease, hypertension, vessel injury, brain ischemia, Fanconi anemia, asthma, and pulmonary edema, among others. ASK2 (also called MAPKKK6) functions only in a heteromeric complex with ASK1, and can activate ASK1 by direct phosphorylation. The function of MAPKKK15 is still unknown. Length = 268 |
| >gnl|CDD|177649 PLN00009, PLN00009, cyclin-dependent kinase A; Provisional | Back alignment and domain information |
|---|
Score = 58.3 bits (141), Expect = 2e-09
Identities = 36/96 (37%), Positives = 57/96 (59%), Gaps = 7/96 (7%)
Query: 271 IAQGLLYLHQYSRLRVIHRDLKASNILLDKDMNP-KISDFGMARMFGGDELQSNTKRIVG 329
I +G+ Y H + RV+HRDLK N+L+D+ N K++DFG+AR F G +++ T +V
Sbjct: 111 ILRGIAYCHSH---RVLHRDLKPQNLLIDRRTNALKLADFGLARAF-GIPVRTFTHEVV- 165
Query: 330 TYGYMSPEYALRGL-FSIKSDVFSFGVLLLETLSSK 364
T Y +PE L +S D++S G + E ++ K
Sbjct: 166 TLWYRAPEILLGSRHYSTPVDIWSVGCIFAEMVNQK 201
|
Length = 294 |
| >gnl|CDD|133220 cd05089, PTKc_Tie1, Catalytic domain of the Protein Tyrosine Kinase, Tie1 | Back alignment and domain information |
|---|
Score = 58.1 bits (140), Expect = 2e-09
Identities = 37/100 (37%), Positives = 61/100 (61%), Gaps = 10/100 (10%)
Query: 265 VRIIEGIAQGLLYLHQYSRLRVIHRDLKASNILLDKDMNPKISDFGMARMFGGDELQSNT 324
++ +A G+ YL S + IHRDL A N+L+ +++ KI+DFG++R G+E+
Sbjct: 122 LQFASDVATGMQYL---SEKQFIHRDLAARNVLVGENLASKIADFGLSR---GEEVY--V 173
Query: 325 KRIVGTYG--YMSPEYALRGLFSIKSDVFSFGVLLLETLS 362
K+ +G +M+ E +++ KSDV+SFGVLL E +S
Sbjct: 174 KKTMGRLPVRWMAIESLNYSVYTTKSDVWSFGVLLWEIVS 213
|
Protein Tyrosine Kinase (PTK) family; Tie1; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie1 is a receptor tyr kinase (RTK) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie receptors are specifically expressed in endothelial cells and hematopoietic stem cells. No specific ligand has been identified for Tie1, although the angiopoietin, Ang-1, binds to Tie1 through integrins at high concentrations. In vivo studies of Tie1 show that it is critical in vascular development. Length = 297 |
| >gnl|CDD|133235 cd05104, PTKc_Kit, Catalytic domain of the Protein Tyrosine Kinase, Kit | Back alignment and domain information |
|---|
Score = 58.8 bits (142), Expect = 2e-09
Identities = 35/95 (36%), Positives = 53/95 (55%), Gaps = 9/95 (9%)
Query: 271 IAQGLLYLHQYSRLRVIHRDLKASNILLDKDMNPKISDFGMARMFGGDE---LQSNTKRI 327
+A+G+ +L + IHRDL A NILL KI DFG+AR D ++ N +
Sbjct: 223 VAKGMSFL---ASKNCIHRDLAARNILLTHGRITKICDFGLARDIRNDSNYVVKGNARLP 279
Query: 328 VGTYGYMSPEYALRGLFSIKSDVFSFGVLLLETLS 362
V +M+PE +++ +SDV+S+G+LL E S
Sbjct: 280 V---KWMAPESIFNCVYTFESDVWSYGILLWEIFS 311
|
Protein Tyrosine Kinase (PTK) family; Kit (or c-Kit); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Kit is a member of the Platelet Derived Growth Factor Receptor (PDGFR) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of Kit to its ligand, the stem-cell factor (SCF), leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. Kit is important in the development of melanocytes, germ cells, mast cells, hematopoietic stem cells, the interstitial cells of Cajal, and the pacemaker cells of the GI tract. Kit signaling is involved in major cellular functions including cell survival, proliferation, differentiation, adhesion, and chemotaxis. Mutations in Kit, which result in constitutive ligand-independent activation, are found in human cancers such as gastrointestinal stromal tumor (GIST) and testicular germ cell tumor (TGCT). The aberrant expression of Kit and/or SCF is associated with other tumor types such as systemic mastocytosis and cancers of the breast, neurons, lung, prostate, colon, and rectum. Although the structure of the human Kit catalytic domain is known, it is excluded from this specific alignment model because it contains a deletion in its sequence. Length = 375 |
| >gnl|CDD|173765 cd08225, STKc_Nek5, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 5 | Back alignment and domain information |
|---|
Score = 57.7 bits (139), Expect = 2e-09
Identities = 39/122 (31%), Positives = 64/122 (52%), Gaps = 15/122 (12%)
Query: 258 LLCWGTRVRIIEGIAQGLLYLHQYSRLRVIHRDLKASNILLDKD-MNPKISDFGMARMFG 316
+L W + I+ GL ++H +++HRD+K+ NI L K+ M K+ DFG+AR
Sbjct: 103 ILSWFVQ------ISLGLKHIHDR---KILHRDIKSQNIFLSKNGMVAKLGDFGIARQLN 153
Query: 317 GDELQSNTKRIVGTYGYMSPEYALRGLFSIKSDVFSFGVLLLETLSSKKNTHFYNTDSLT 376
+ T VGT Y+SPE ++ K+D++S G +L E + K H + ++L
Sbjct: 154 DSMELAYT--CVGTPYYLSPEICQNRPYNNKTDIWSLGCVLYELCTLK---HPFEGNNLH 208
Query: 377 LL 378
L
Sbjct: 209 QL 210
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 5 (Nek5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek5 subfamily is one of a family of 11 different Neks (Nek1-11). The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Neks are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. The specific function of Nek5 is unknown. Length = 257 |
| >gnl|CDD|173652 cd05100, PTKc_FGFR3, Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 3 | Back alignment and domain information |
|---|
Score = 58.5 bits (141), Expect = 3e-09
Identities = 34/92 (36%), Positives = 53/92 (57%), Gaps = 3/92 (3%)
Query: 271 IAQGLLYLHQYSRLRVIHRDLKASNILLDKDMNPKISDFGMARMFGGDELQSNTKRIVGT 330
+A+G+ YL + + IHRDL A N+L+ +D KI+DFG+AR + T
Sbjct: 143 VARGMEYL---ASQKCIHRDLAARNVLVTEDNVMKIADFGLARDVHNIDYYKKTTNGRLP 199
Query: 331 YGYMSPEYALRGLFSIKSDVFSFGVLLLETLS 362
+M+PE +++ +SDV+SFGVLL E +
Sbjct: 200 VKWMAPEALFDRVYTHQSDVWSFGVLLWEIFT 231
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 3 (FGFR3); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR3 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. Many FGFR3 splice variants have been reported with the IIIb and IIIc isoforms being the predominant forms. FGFR3 IIIc is the isoform expressed in chondrocytes, the cells affected in dwarfism, while IIIb is expressed in epithelial cells. FGFR3 ligands include FGF1, FGF2, FGF4, FGF8, FGF9, and FGF23. It is a negative regulator of long bone growth. In the cochlear duct and in the lens, FGFR3 is involved in differentiation while it appears to have a role in cell proliferation in epithelial cells. Germline mutations in FGFR3 are associated with skeletal disorders including several forms of dwarfism. Some missense mutations are associated with multiple myeloma and carcinomas of the bladder and cervix. Overexpression of FGFR3 is found in thyroid carcinoma. Length = 334 |
| >gnl|CDD|173737 cd07834, STKc_MAPK, Catalytic domain of the Serine/Threonine Kinase, Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Score = 58.3 bits (142), Expect = 3e-09
Identities = 25/46 (54%), Positives = 30/46 (65%), Gaps = 3/46 (6%)
Query: 274 GLLYLHQYSRLRVIHRDLKASNILLDKDMNPKISDFGMARMFGGDE 319
GL YLH VIHRDLK SNIL++ + + KI DFG+AR DE
Sbjct: 115 GLKYLH---SANVIHRDLKPSNILVNSNCDLKICDFGLARGVDPDE 157
|
Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs serve as important mediators of cellular responses to extracellular signals. They control critical cellular functions including differentiation, proliferation, migration, and apoptosis. They are also implicated in the pathogenesis of many diseases including multiple types of cancer, stroke, diabetes, and chronic inflammation. Typical MAPK pathways involve a triple kinase core cascade comprising of the MAPK, which is phosphorylated and activated by a MAPK kinase (MAP2K or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAP3K or MKKK). Each cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. There are three main typical MAPK subfamilies: Extracellular signal-Regulated Kinase (ERK), c-Jun N-terminal Kinase (JNK), and p38. Some MAPKs are atypical in that they are not regulated by MAP2Ks. These include MAPK4, MAPK6, NLK, and ERK7. Length = 330 |
| >gnl|CDD|173721 cd05632, STKc_GRK5, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 5 | Back alignment and domain information |
|---|
Score = 57.7 bits (139), Expect = 3e-09
Identities = 32/95 (33%), Positives = 52/95 (54%), Gaps = 8/95 (8%)
Query: 271 IAQGLLYLHQYSRLRVIHRDLKASNILLDKDMNPKISDFGMA-RMFGGDELQSNTKRIVG 329
I GL LH+ + ++RDLK NILLD + +ISD G+A ++ G+ ++ VG
Sbjct: 111 ILCGLEDLHREN---TVYRDLKPENILLDDYGHIRISDLGLAVKIPEGESIRGR----VG 163
Query: 330 TYGYMSPEYALRGLFSIKSDVFSFGVLLLETLSSK 364
T GYM+PE +++ D + G L+ E + +
Sbjct: 164 TVGYMAPEVLNNQRYTLSPDYWGLGCLIYEMIEGQ 198
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK5 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK5 is widely expressed in many tissues. It associates with the membrane though an N-terminal PIP2 binding domain and also binds phospholipids via its C-terminus. GRK5 deficiency is associated with early Alzheimer's disease in humans and mouse models. GRK5 also plays a crucial role in the pathogenesis of sporadic Parkinson's disease. It participates in the regulation and desensitization of PDGFRbeta, a receptor tyrosine kinase involved in a variety of downstream cellular effects including cell growth, chemotaxis, apoptosis, and angiogenesis. GRK5 also regulates Toll-like receptor 4, which is involved in innate and adaptive immunity. Length = 285 |
| >gnl|CDD|143371 cd07866, STKc_BUR1, Catalytic domain of the Serine/Threonine Kinase, Fungal Cyclin-Dependent protein Kinase Bypass UAS Requirement 1 and similar proteins | Back alignment and domain information |
|---|
Score = 57.7 bits (140), Expect = 3e-09
Identities = 24/69 (34%), Positives = 38/69 (55%), Gaps = 3/69 (4%)
Query: 267 IIEGIAQGLLYLHQYSRLRVIHRDLKASNILLDKDMNPKISDFGMARMFGGDELQSNTKR 326
+ + +G+ YLH+ ++HRD+KA+NIL+D KI+DFG+AR + G
Sbjct: 120 YMLQLLEGINYLHEN---HILHRDIKAANILIDNQGILKIADFGLARPYDGPPPNPKGGG 176
Query: 327 IVGTYGYMS 335
GT Y +
Sbjct: 177 GGGTRKYTN 185
|
Serine/Threonine Kinases (STKs), Bypass UAS Requirement 1 (BUR1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The BUR1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. BUR1, also called SGV1, is a yeast Cyclin-Dependent protein Kinase (CDK) that is functionally equivalent to mammalian CDK9. It associates with the cyclin BUR2. BUR genes were orginally identified in a genetic screen as factors involved in general transcription. The BUR1/BUR2 complex phosphorylates the C-terminal domain of RNA polymerase II. In addition, this complex regulates histone modification by phosporylating Rad6 and mediating the association of the Paf1 complex with chromatin. Length = 311 |
| >gnl|CDD|173739 cd07838, STKc_CDK4_6_like, Catalytic domain of Cyclin-Dependent protein Kinase 4 and 6-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 57.6 bits (140), Expect = 3e-09
Identities = 30/94 (31%), Positives = 53/94 (56%), Gaps = 6/94 (6%)
Query: 266 RIIEGIAQGLLYLHQYSRLRVIHRDLKASNILLDKDMNPKISDFGMARMFGGDELQSNTK 325
++ + +G+ +LH + R++HRDLK NIL+ D KI+DFG+AR++ +
Sbjct: 111 DLMRQLLRGVDFLHSH---RIVHRDLKPQNILVTSDGQVKIADFGLARIYS---FEMALT 164
Query: 326 RIVGTYGYMSPEYALRGLFSIKSDVFSFGVLLLE 359
+V T Y +PE L+ ++ D++S G + E
Sbjct: 165 SVVVTLWYRAPEVLLQSSYATPVDMWSVGCIFAE 198
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 4 (CDK4) and CDK6-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK4/6-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK4 and CDK6 partner with D-type cyclins to regulate the early G1 phase of the cell cycle. They are the first kinase activated by mitogenic signals to release cells from the G0 arrested state. CDK4 and CDK6 are both expressed ubiquitously, associate with all three D cyclins (D1, D2 and D3), and phosphorylate the retinoblastoma (pRb) protein. They are also regulated by the INK4 family of inhibitors which associate with either the CDK alone or the CDK/cyclin complex. CDK4 and CDK6 show differences in subcellular localization, sensitivity to some inhibitors, timing in activation, tumor selectivity, and possibly substrate profiles. Although CDK4 and CDK6 seem to show some redundancy, they also have discrete, nonoverlapping functions. CDK6 plays an important role in cell differentiation. Length = 287 |
| >gnl|CDD|173749 cd07855, STKc_ERK5, Catalytic domain of the Serine/Threonine Kinase, Extracellular signal-Regulated Kinase 5 | Back alignment and domain information |
|---|
Score = 57.7 bits (140), Expect = 3e-09
Identities = 34/94 (36%), Positives = 50/94 (53%), Gaps = 6/94 (6%)
Query: 271 IAQGLLYLHQYSRLRVIHRDLKASNILLDKDMNPKISDFGMAR--MFGGDELQSNTKRIV 328
+ +GL Y+H + VIHRDLK SN+L+++D +I DFGMAR E + V
Sbjct: 116 LLRGLKYIHSAN---VIHRDLKPSNLLVNEDCELRIGDFGMARGLSSSPTEHKYFMTEYV 172
Query: 329 GTYGYMSPEYALR-GLFSIKSDVFSFGVLLLETL 361
T Y +PE L ++ D++S G + E L
Sbjct: 173 ATRWYRAPELLLSLPEYTTAIDMWSVGCIFAEML 206
|
Serine/Threonine Kinases (STKs), Extracellular signal-Regulated Kinase 5 (ERK5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ERK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. ERK5, also called Big MAPK1 (BMK1) or MAPK7, has a unique C-terminal extension, making it approximately twice as big as other MAPKs. This extension contains transcriptional activation capability which is inhibited by the N-terminal half. ERK5 is activated in response to growth factors and stress by a cascade that leads to its phosphorylation by the MAP2K MEK5, which in turn is regulated by the MAP3Ks MEKK2 and MEKK3. Activated ERK5 phosphorylates its targets including myocyte enhancer factor 2 (MEF2), Sap1a, c-Myc, and RSK. It plays a role in EGF-induced cell proliferation during the G1/S phase transition. Studies on knockout mice revealed that ERK5 is essential for cardiovascular development and plays an important role in angiogenesis. It is also critical for neural differentiation and survival. The ERK5 pathway has been implicated in the pathogenesis of many diseases including cancer, cardiac hypertrophy, and atherosclerosis. Length = 334 |
| >gnl|CDD|173702 cd05611, STKc_Rim15_like, Catalytic domain of fungal Rim15-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 57.1 bits (138), Expect = 4e-09
Identities = 34/89 (38%), Positives = 53/89 (59%), Gaps = 11/89 (12%)
Query: 274 GLLYLHQYSRLRVIHRDLKASNILLDKDMNPKISDFGMARMFGGDELQSNTKRIVGTYGY 333
G+ LHQ +IHRD+K N+L+D+ + K++DFG++R G E K+ VGT Y
Sbjct: 109 GVEDLHQRG---IIHRDIKPENLLIDQTGHLKLTDFGLSRN--GLE----NKKFVGTPDY 159
Query: 334 MSPEYALRGLFSIK-SDVFSFGVLLLETL 361
++PE + G+ K SD +S G ++ E L
Sbjct: 160 LAPE-TILGVGDDKMSDWWSLGCVIFEFL 187
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, fungal Rim15-like kinases, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include Saccharomyces cerevisiae Rim15, Schizosaccharomyces pombe cek1, and similar fungal proteins. They contain a central catalytic domain, which contains an insert relative to MAST kinases. In addition, Rim15 contains a C-terminal signal receiver (REC) domain while cek1 contains an N-terminal PAS domain. Rim15 (or Rim15p) functions as a regulator of meiosis. It acts as a downstream effector of PKA and regulates entry into stationary phase (G0). Thus, it plays a crucial role in regulating yeast proliferation, differentiation, and aging. Cek1 may facilitate progression of mitotic anaphase. Length = 260 |
| >gnl|CDD|133238 cd05107, PTKc_PDGFR_beta, Catalytic domain of the Protein Tyrosine Kinase, Platelet Derived Growth Factor Receptor beta | Back alignment and domain information |
|---|
Score = 58.1 bits (140), Expect = 4e-09
Identities = 48/175 (27%), Positives = 76/175 (43%), Gaps = 32/175 (18%)
Query: 271 IAQGLLYLHQYSRLRVIHRDLKASNILLDKDMNPKISDFGMARMFGGDELQSNTKRIVGT 330
+A G+ +L + +HRDL A N+L+ + KI DFG+AR D +
Sbjct: 248 VANGMEFL---ASKNCVHRDLAARNVLICEGKLVKICDFGLARDIMRDSNYISKGSTFLP 304
Query: 331 YGYMSPEYALRGLFSIKSDVFSFGVLLLE--TLSSKK------NTHFYNTDSLTLLGHAW 382
+M+PE L++ SDV+SFG+LL E TL N FYN
Sbjct: 305 LKWMAPESIFNNLYTTLSDVWSFGILLWEIFTLGGTPYPELPMNEQFYNAIK-------- 356
Query: 383 NLWNDGRTWELMDPISQNGASYPILKRYINVALLCVQEKAADRPAMSEVVSMLSN 437
R + + P + Y I+++ C +EK RP S++V ++ +
Sbjct: 357 ------RGYRMAKPAHASDEIYEIMQK-------CWEEKFEIRPDFSQLVHLVGD 398
|
Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) beta; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR beta is a receptor tyr kinase (RTK) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding to its ligands, the PDGFs, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR beta forms homodimers or heterodimers with PDGFR alpha, depending on the nature of the PDGF ligand. PDGF-BB and PDGF-DD induce PDGFR beta homodimerization. PDGFR signaling plays many roles in normal embryonic development and adult physiology. PDGFR beta signaling leads to a variety of cellular effects including the stimulation of cell growth and chemotaxis, as well as the inhibition of apoptosis and GAP junctional communication. It is critical in normal angiogenesis as it is involved in the recruitment of pericytes and smooth muscle cells essential for vessel stability. Aberrant PDGFR beta expression is associated with some human cancers. The continuously-active fusion proteins of PDGFR beta with COL1A1 and TEL are associated with dermatofibrosarcoma protuberans (DFSP) and a subset of chronic myelomonocytic leukemia (CMML), respectively. Length = 401 |
| >gnl|CDD|133213 cd05082, PTKc_Csk, Catalytic domain of the Protein Tyrosine Kinase, C-terminal Src kinase | Back alignment and domain information |
|---|
Score = 56.9 bits (137), Expect = 4e-09
Identities = 33/92 (35%), Positives = 48/92 (52%), Gaps = 8/92 (8%)
Query: 271 IAQGLLYLHQYSRLRVIHRDLKASNILLDKDMNPKISDFGMARMFGGDELQSNTKRIVGT 330
+ + + YL + +HRDL A N+L+ +D K+SDFG+ + Q K V
Sbjct: 111 VCEAMEYLEANN---FVHRDLAARNVLVSEDNVAKVSDFGLTKE--ASSTQDTGKLPV-- 163
Query: 331 YGYMSPEYALRGLFSIKSDVFSFGVLLLETLS 362
+ +PE FS KSDV+SFG+LL E S
Sbjct: 164 -KWTAPEALREKKFSTKSDVWSFGILLWEIYS 194
|
Protein Tyrosine Kinase (PTK) family; C-terminal Src kinase (Csk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. To inhibit Src kinases, Csk is translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Csk catalyzes the tyr phosphorylation of the regulatory C-terminal tail of Src kinases, resulting in their inactivation. Csk is expressed in a wide variety of tissues. As a negative regulator of Src, Csk plays a role in cell proliferation, survival, and differentiation, and consequently, in cancer development and progression. In addition, Csk also shows Src-independent functions. It is a critical component in G-protein signaling, and plays a role in cytoskeletal reorganization and cell migration. Length = 256 |
| >gnl|CDD|143356 cd07851, STKc_p38, Catalytic domain of the Serine/Threonine Kinase, p38 Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Score = 57.7 bits (140), Expect = 4e-09
Identities = 36/99 (36%), Positives = 54/99 (54%), Gaps = 9/99 (9%)
Query: 267 IIEGIAQGLLYLHQYSRLRVIHRDLKASNILLDKDMNPKISDFGMARMFGGDELQSNTKR 326
++ I +GL Y+H +IHRDLK SNI +++D KI DFG+AR DE+
Sbjct: 123 LVYQILRGLKYIHS---AGIIHRDLKPSNIAVNEDCELKILDFGLARH-TDDEMTG---- 174
Query: 327 IVGTYGYMSPEYAL-RGLFSIKSDVFSFGVLLLETLSSK 364
V T Y +PE L ++ D++S G ++ E L+ K
Sbjct: 175 YVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGK 213
|
Serine/Threonine Kinases (STKs), p38 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They function in the regulation of the cell cycle, cell development, cell differentiation, senescence, tumorigenesis, apoptosis, pain development and pain progression, and immune responses. p38 kinases are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. p38 substrates include other protein kinases and factors that regulate transcription, nuclear export, mRNA stability and translation. p38 kinases are drug targets for the inflammatory diseases psoriasis, rheumatoid arthritis, and chronic pulmonary disease. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta, which show varying substrate specificity and expression patterns. p38alpha and p38beta are ubiquitously expressed, p38gamma is predominantly found in skeletal muscle, and p38delta is found in the heart, lung, testis, pancreas, and small intestine. Length = 343 |
| >gnl|CDD|173742 cd07845, STKc_CDK10, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 10 | Back alignment and domain information |
|---|
Score = 57.4 bits (139), Expect = 5e-09
Identities = 36/92 (39%), Positives = 52/92 (56%), Gaps = 6/92 (6%)
Query: 274 GLLYLHQYSRLRVIHRDLKASNILLDKDMNPKISDFGMARMFGGDELQSNTKRIVGTYGY 333
GL YLH+ +IHRDLK SN+LL KI+DFG+AR + G + T ++V T Y
Sbjct: 120 GLQYLHENF---IIHRDLKVSNLLLTDKGCLKIADFGLARTY-GLPAKPMTPKVV-TLWY 174
Query: 334 MSPEYALRGLFSIKS-DVFSFGVLLLETLSSK 364
+PE L + D+++ G +L E L+ K
Sbjct: 175 RAPELLLGCTTYTTAIDMWAVGCILAELLAHK 206
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein Kinase 10 (CDK10) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK10 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK10, also called PISSLRE, is essential for cell growth and proliferation, and acts through the G2/M phase of the cell cycle. CDK10 has also been identified as an important factor in endocrine therapy resistance in breast cancer. CDK10 silencing increases the transcription of c-RAF and the activation of the p42/p44 MAPK pathway, which leads to antiestrogen resistance. Patients who express low levels of CDK10 relapse early on tamoxifen. Length = 309 |
| >gnl|CDD|132983 cd06652, STKc_MEKK2, Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 2 | Back alignment and domain information |
|---|
Score = 57.0 bits (137), Expect = 5e-09
Identities = 33/95 (34%), Positives = 52/95 (54%), Gaps = 4/95 (4%)
Query: 271 IAQGLLYLHQYSRLRVIHRDLKASNILLDKDMNPKISDFGMARMFGGDELQ-SNTKRIVG 329
I +G+ YLH ++HRD+K +NIL D N K+ DFG ++ L + K + G
Sbjct: 115 ILEGVSYLHSN---MIVHRDIKGANILRDSVGNVKLGDFGASKRLQTICLSGTGMKSVTG 171
Query: 330 TYGYMSPEYALRGLFSIKSDVFSFGVLLLETLSSK 364
T +MSPE + K+D++S G ++E L+ K
Sbjct: 172 TPYWMSPEVISGEGYGRKADIWSVGCTVVEMLTEK 206
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 2 (MEKK2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK2 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates the MAPK kinase MEK5 (or MKK5), which in turn phosphorylates and activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK2 also activates ERK1/2, c-Jun N-terminal kinase (JNK) and p38 through their respective MAPKKs MEK1/2, JNK-activating kinase 2 (JNKK2), and MKK3/6. MEKK2 plays roles in T cell receptor signaling, immune synapse formation, cytokine gene expression, as well as in EGF and FGF receptor signaling. Length = 265 |
| >gnl|CDD|143354 cd07849, STKc_ERK1_2_like, Catalytic domain of Extracellular signal-Regulated Kinase 1 and 2-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 56.9 bits (138), Expect = 6e-09
Identities = 38/98 (38%), Positives = 57/98 (58%), Gaps = 9/98 (9%)
Query: 271 IAQGLLYLHQYSRLRVIHRDLKASNILLDKDMNPKISDFGMARMFGGDELQSNTKRI--- 327
I +GL Y+H + V+HRDLK SN+LL+ + + KI DFG+AR+ D +T +
Sbjct: 115 ILRGLKYIHSAN---VLHRDLKPSNLLLNTNCDLKICDFGLARI--ADPEHDHTGFLTEY 169
Query: 328 VGTYGYMSPEYALRGLFSIKS-DVFSFGVLLLETLSSK 364
V T Y +PE L K+ D++S G +L E LS++
Sbjct: 170 VATRWYRAPEIMLNSKGYTKAIDIWSVGCILAEMLSNR 207
|
Serine/Threonine Kinases (STKs), Extracellular signal-regulated kinases 1 and 2 (ERK1/2) and Fus3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. This ERK1/2-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the mitogen-activated protein kinases (MAPKs) ERK1, ERK2, baker's yeast Fus3, and similar proteins. MAPK pathways are important mediators of cellular responses to extracellular signals. ERK1/2 activation is preferentially by mitogenic factors, differentiation stimuli, and cytokines, through a kinase cascade involving the MAPK kinases MEK1/2 and a MAPK kinase kinase from the Raf family. ERK1/2 have numerous substrates, many of which are nuclear and participate in transcriptional regulation of many cellular processes. They regulate cell growth, cell proliferation, and cell cycle progression from G1 to S phase. Although the distinct roles of ERK1 and ERK2 have not been fully determined, it is known that ERK2 can maintain most functions in the absence of ERK1, and that the deletion of ERK2 is embryonically lethal. The MAPK, Fus3, regulates yeast mating processes including mating-specific gene expression, G1 arrest, mating projection, and cell fusion. Length = 336 |
| >gnl|CDD|173682 cd05591, STKc_nPKC_epsilon, Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C epsilon | Back alignment and domain information |
|---|
Score = 56.8 bits (137), Expect = 7e-09
Identities = 34/103 (33%), Positives = 54/103 (52%), Gaps = 9/103 (8%)
Query: 275 LLYLHQYSRLRVIHRDLKASNILLDKDMNPKISDFGMAR--MFGGDELQSNTKRIVGTYG 332
L++LH++ VI+RDLK NILLD + + K++DFGM + + G T GT
Sbjct: 109 LMFLHRHG---VIYRDLKLDNILLDAEGHCKLADFGMCKEGILNG----VTTTTFCGTPD 161
Query: 333 YMSPEYALRGLFSIKSDVFSFGVLLLETLSSKKNTHFYNTDSL 375
Y++PE + D ++ GVL+ E ++ + N D L
Sbjct: 162 YIAPEILQELEYGPSVDWWALGVLMYEMMAGQPPFEADNEDDL 204
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), epsilon isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-epsilon has been shown to behave as an oncoprotein. Its overexpression contributes to neoplastic transformation depending on the cell type. It contributes to oncogenesis by inducing disordered cell growth and inhibiting cell death. It also plays a role in tumor invasion and metastasis. PKC-epsilon has also been found to confer cardioprotection against ischemia and reperfusion-mediated damage. Other cellular functions include the regulation of gene expression, cell adhesion, and cell motility. Length = 321 |
| >gnl|CDD|133232 cd05101, PTKc_FGFR2, Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 2 | Back alignment and domain information |
|---|
Score = 57.0 bits (137), Expect = 7e-09
Identities = 32/92 (34%), Positives = 53/92 (57%), Gaps = 3/92 (3%)
Query: 271 IAQGLLYLHQYSRLRVIHRDLKASNILLDKDMNPKISDFGMARMFGGDELQSNTKRIVGT 330
+A+G+ YL + + IHRDL A N+L+ ++ KI+DFG+AR + T
Sbjct: 146 VARGMEYL---ASQKCIHRDLAARNVLVTENNVMKIADFGLARDVNNIDYYKKTTNGRLP 202
Query: 331 YGYMSPEYALRGLFSIKSDVFSFGVLLLETLS 362
+M+PE +++ +SDV+SFGVL+ E +
Sbjct: 203 VKWMAPEALFDRVYTHQSDVWSFGVLMWEIFT 234
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 2 (FGFR2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR2 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. There are many splice variants of FGFR2 which show differential expression and binding to FGF ligands. Disruption of either FGFR2 or FGFR2b is lethal in mice, due to defects in the placenta or severe impairment of tissue development including lung, limb, and thyroid, respectively. Disruption of FGFR2c in mice results in defective bone and skull development. Genetic alterations of FGFR2 are associated with many human skeletal disorders including Apert syndrome, Crouzon syndrome, Jackson-Weiss syndrome, and Pfeiffer syndrome. Length = 304 |
| >gnl|CDD|132953 cd06622, PKc_MAPKK_PBS2_like, Catalytic domain of fungal PBS2-like dual-specificity MAP kinase kinases | Back alignment and domain information |
|---|
Score = 56.4 bits (136), Expect = 8e-09
Identities = 31/100 (31%), Positives = 56/100 (56%), Gaps = 12/100 (12%)
Query: 266 RIIEGIAQGLLYLHQYSRLRVIHRDLKASNILLDKDMNPKISDFGMARMFGGDELQSNTK 325
RI + +GL +L + +IHRD+K +N+L++ + K+ DFG++ G+ + S K
Sbjct: 106 RITYAVVKGLKFLKE--EHNIIHRDVKPTNVLVNGNGQVKLCDFGVS----GNLVASLAK 159
Query: 326 RIVGTYGYMSPEY------ALRGLFSIKSDVFSFGVLLLE 359
+G YM+PE ++++SDV+S G+ +LE
Sbjct: 160 TNIGCQSYMAPERIKSGGPNQNPTYTVQSDVWSLGLSILE 199
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, fungal PBS2-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include the MAPKKs Polymyxin B resistance protein 2 (PBS2) from Saccharomyces cerevisiae, Wis1 from Schizosaccharomyces pombe, and related proteins. PBS2 and Wis1 are components of stress-activated MAPK cascades in budding and fission yeast, respectively. PBS2 is the specific activator of the MAPK Hog1, which plays a central role in the response of budding yeast to stress including exposure to arsenite and hyperosmotic environments. Wis1 phosphorylates and activates the MAPK Sty1 (also called Spc1 or Phh1), which stimulates a transcriptional response to a wide range of cellular insults through the bZip transcription factors Atf1, Pcr1, and Pap1. Length = 286 |
| >gnl|CDD|173753 cd07864, STKc_CDK12, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 12 | Back alignment and domain information |
|---|
Score = 56.3 bits (136), Expect = 8e-09
Identities = 34/93 (36%), Positives = 53/93 (56%), Gaps = 5/93 (5%)
Query: 273 QGLLYLHQYSRLRVIHRDLKASNILLDKDMNPKISDFGMARMFGGDELQSNTKRIVGTYG 332
+GL Y H+ + L HRD+K SNILL+ K++DFG+AR++ +E + T +++ T
Sbjct: 127 EGLNYCHKKNFL---HRDIKCSNILLNNKGQIKLADFGLARLYNSEESRPYTNKVI-TLW 182
Query: 333 YMSPEYAL-RGLFSIKSDVFSFGVLLLETLSSK 364
Y PE L + DV+S G +L E + K
Sbjct: 183 YRPPELLLGEERYGPAIDVWSCGCILGELFTKK 215
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 12 (CDK12) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK12 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK12 is also called Cdc2-related protein kinase 7 (CRK7) or Cdc2-related kinase arginine/serine-rich (CrkRS). It is a unique CDK that contains an arginine/serine-rich (RS) domain, which is predominantly found in splicing factors. CDK12 is widely expressed in tissues. It interacts with cyclins L1 and L2, and plays roles in regulating transcription and alternative splicing. Length = 302 |
| >gnl|CDD|173680 cd05589, STKc_PKN, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase N | Back alignment and domain information |
|---|
Score = 56.6 bits (137), Expect = 9e-09
Identities = 32/90 (35%), Positives = 49/90 (54%), Gaps = 9/90 (10%)
Query: 274 GLLYLHQYSRLRVIHRDLKASNILLDKDMNPKISDFGMAR--MFGGDELQSNTKRIVGTY 331
GL YLH+ ++++RDLK N+LLD + KI+DFG+ + M GD T GT
Sbjct: 113 GLQYLHEN---KIVYRDLKLDNLLLDTEGFVKIADFGLCKEGMGFGDR----TSTFCGTP 165
Query: 332 GYMSPEYALRGLFSIKSDVFSFGVLLLETL 361
+++PE ++ D + GVL+ E L
Sbjct: 166 EFLAPEVLTETSYTRAVDWWGLGVLIYEML 195
|
Serine/Threonine Kinases (STKs), Protein Kinase N (PKN) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKN subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKN has a C-terminal catalytic domain that is highly homologous to PKCs. Its unique N-terminal regulatory region contains antiparallel coiled-coil (ACC) domains. In mammals, there are three PKN isoforms from different genes (designated PKN-alpha, beta, and gamma), which show different enzymatic properties, tissue distribution, and varied functions. PKN can be activated by the small GTPase Rho, and by fatty acids such as arachidonic and linoleic acids. It is involved in many biological processes including cytokeletal regulation, cell adhesion, vesicle transport, glucose transport, regulation of meiotic maturation and embryonic cell cycles, signaling to the nucleus, and tumorigenesis. Length = 324 |
| >gnl|CDD|143361 cd07856, STKc_Sty1_Hog1, Catalytic domain of the Serine/Threonine Kinases, Fungal Mitogen-Activated Protein Kinases Sty1 and Hog1 | Back alignment and domain information |
|---|
Score = 56.4 bits (136), Expect = 1e-08
Identities = 34/95 (35%), Positives = 51/95 (53%), Gaps = 9/95 (9%)
Query: 271 IAQGLLYLHQYSRLRVIHRDLKASNILLDKDMNPKISDFGMARMFGGDELQSNTKRIVGT 330
I +GL Y+H V+HRDLK SNIL++++ + KI DFG+AR+ V T
Sbjct: 117 ILRGLKYVHSAG---VVHRDLKPSNILINENCDLKICDFGLARI-----QDPQMTGYVST 168
Query: 331 YGYMSPEYALR-GLFSIKSDVFSFGVLLLETLSSK 364
Y +PE L + ++ D++S G + E L K
Sbjct: 169 RYYRAPEIMLTWQKYDVEVDIWSAGCIFAEMLEGK 203
|
Serine/Threonine Kinases (STKs), Fungal Mitogen-Activated Protein Kinase (MAPK) Sty1/Hog1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sty1/Hog1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the MAPKs Sty1 from Schizosaccharomyces pombe, Hog1 from Saccharomyces cerevisiae, and similar proteins. MAPKs are important mediators of cellular responses to extracellular signals. Sty1 and Hog1 are stress-activated MAPKs that partipate in transcriptional regulation in response to stress. Sty1 is activated in response to oxidative stress, osmotic stress, and UV radiation. Sty1 is regulated by the MAP2K Wis1, which is activated by the MAP3Ks Wis4 and Win1, which receive signals of the stress condition from membrane-spanning histidine kinases Mak1-3. Activated Sty1 stabilizes the Atf1 transcription factor and induces transcription of Atf1-dependent genes of the core environmetal stress response (CESR). Hog1 is the key element in the high osmolarity glycerol (HOG) pathway and is activated upon hyperosmotic stress. Activated Hog1 accumulates in the nucleus and regulates stress-induced transcription. The HOG pathway is mediated by two transmembrane osmosensors, Sln1 and Sho1. Length = 328 |
| >gnl|CDD|132984 cd06653, STKc_MEKK3_like_1, Catalytic domain of MAP/ERK kinase kinase 3-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 55.8 bits (134), Expect = 1e-08
Identities = 36/105 (34%), Positives = 53/105 (50%), Gaps = 14/105 (13%)
Query: 266 RIIEGIAQGLLYLHQYSRLRVIHRDLKASNILLDKDMNPKISDFGMAR------MFGGDE 319
R I QG+ YLH ++HRD+K +NIL D N K+ DFG ++ M G
Sbjct: 110 RYTRQILQGVSYLHSN---MIVHRDIKGANILRDSAGNVKLGDFGASKRIQTICMSG--- 163
Query: 320 LQSNTKRIVGTYGYMSPEYALRGLFSIKSDVFSFGVLLLETLSSK 364
+ K + GT +MSPE + K+DV+S ++E L+ K
Sbjct: 164 --TGIKSVTGTPYWMSPEVISGEGYGRKADVWSVACTVVEMLTEK 206
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3)-like subfamily, catalytic (c) domain, functionally uncharacterized subgroup 1. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The MEKK3-like subfamily is composed of MEKK3, MEKK2, and related proteins, all containing an N-terminal PB1 domain, which mediates oligomerization, and a C-terminal catalytic domain. MEKK2 and MEKK3 are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks), proteins that phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK2 and MEKK3 activate MEK5 (also called MKK5), which activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK3 plays an essential role in embryonic angiogenesis and early heart development. MEKK2 and MEKK3 can also activate the MAPKs, c-Jun N-terminal kinase (JNK) and p38, through their respective MAPKKs. Length = 264 |
| >gnl|CDD|173750 cd07857, STKc_MPK1, Catalytic domain of the Serine/Threonine Kinase, Fungal Mitogen-Activated Protein Kinase MPK1 | Back alignment and domain information |
|---|
Score = 56.3 bits (136), Expect = 1e-08
Identities = 38/97 (39%), Positives = 49/97 (50%), Gaps = 6/97 (6%)
Query: 271 IAQGLLYLHQYSRLRVIHRDLKASNILLDKDMNPKISDFGMARMF--GGDELQSNTKRIV 328
I GL Y+H + V+HRDLK N+L++ D KI DFG+AR F E V
Sbjct: 114 ILCGLKYIHSAN---VLHRDLKPGNLLVNADCELKICDFGLARGFSENPGENAGFMTEYV 170
Query: 329 GTYGYMSPEYALRGLFSIKS-DVFSFGVLLLETLSSK 364
T Y +PE L K+ DV+S G +L E L K
Sbjct: 171 ATRWYRAPEIMLSFQSYTKAIDVWSVGCILAELLGRK 207
|
Serine/Threonine Kinases (STKs), Fungal Mitogen-Activated Protein Kinase (MAPK) MPK1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MPK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the MAPKs MPK1 from Saccharomyces cerevisiae, Pmk1 from Schizosaccharomyces pombe, and similar proteins. MAPKs are important mediators of cellular responses to extracellular signals. MPK1 (also called Slt2) and Pmk1 (also called Spm1) are stress-activated MAPKs that regulate the cell wall integrity (CWI) pathway, and are therefore important in the maintainance of cell shape, cell wall construction, morphogenesis, and ion homeostasis. MPK1 is activated in response to cell wall stress including heat stimulation, osmotic shock, UV irradiation, and any agents that interfere with cell wall biogenesis such as chitin antagonists, caffeine, or zymolase. MPK1 is regulated by the MAP2Ks Mkk1/2, which are regulated by the MAP3K Bck1. Pmk1 is also activated by multiple stresses including elevated temperatures, hyper- or hypotonic stress, glucose deprivation, exposure to cell-wall damaging compounds, and oxidative stress. It is regulated by the MAP2K Pek1, which is regulated by the MAP3K Mkh1. Length = 332 |
| >gnl|CDD|133167 cd05035, PTKc_Axl_like, Catalytic Domain of Axl-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 55.6 bits (134), Expect = 1e-08
Identities = 33/103 (32%), Positives = 57/103 (55%), Gaps = 9/103 (8%)
Query: 263 TRVRIIEGIAQGLLYLHQYSRLRVIHRDLKASNILLDKDMNPKISDFGMAR-MFGGDELQ 321
T ++ + IA G+ YL S IHRDL A N +L +DM ++DFG+++ ++ GD +
Sbjct: 114 TLLKFMVDIALGMEYL---SNRNFIHRDLAARNCMLREDMTVCVADFGLSKKIYSGDYYR 170
Query: 322 SN--TKRIVGTYGYMSPEYALRGLFSIKSDVFSFGVLLLETLS 362
K V +++ E +++ KSDV++FGV + E +
Sbjct: 171 QGRIAKMPV---KWIAIESLADRVYTSKSDVWAFGVTMWEIAT 210
|
Protein Tyrosine Kinase (PTK) family; Axl subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). The Axl subfamily consists of Axl, Tyro3 (or Sky), Mer (or Mertk), and similar proteins. PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Axl subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Axl subfamily members are implicated in a variety of cellular effects including survival, proliferation, migration, and phagocytosis. They are also associated with several types of cancer as well as inflammatory, autoimmune, vascular, and kidney diseases. Mer is named after its original reported expression pattern (monocytes, epithelial, and reproductive tissues). It is required for the ingestion of apoptotic cells by phagocytes such as macrophages, retinal pigment epithelial cells, and dendritic cells. Mer is also important in maintaining immune homeostasis. Length = 273 |
| >gnl|CDD|143382 cd07877, STKc_p38alpha_MAPK14, Catalytic domain of the Serine/Threonine Kinase, p38alpha Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Score = 56.2 bits (135), Expect = 1e-08
Identities = 40/113 (35%), Positives = 61/113 (53%), Gaps = 11/113 (9%)
Query: 267 IIEGIAQGLLYLHQYSRLRVIHRDLKASNILLDKDMNPKISDFGMARMFGGDELQSNTKR 326
+I I +GL Y+H +IHRDLK SN+ +++D KI DFG+AR DE+
Sbjct: 125 LIYQILRGLKYIHSAD---IIHRDLKPSNLAVNEDCELKILDFGLAR-HTDDEMTG---- 176
Query: 327 IVGTYGYMSPEYALRGL-FSIKSDVFSFGVLLLETLSSKKNTHFYNTDSLTLL 378
V T Y +PE L + ++ D++S G ++ E L+ + T F TD + L
Sbjct: 177 YVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGR--TLFPGTDHIDQL 227
|
Serine/Threonine Kinases (STKs), p38alpha subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38alpha subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38alpha, also called MAPK14, is expressed in most tissues and is the major isoform involved in the immune and inflammatory response. It is the central p38 MAPK involved in myogenesis. It plays a role in regulating cell cycle check-point transition and promoting cell differentiation. p38alpha also regulates cell proliferation and death through crosstalk with the JNK pathway. Its substrates include MAPK activated protein kinase 2 (MK2), MK5, and the transcription factors ATF2 and Mitf. Length = 345 |
| >gnl|CDD|173685 cd05594, STKc_PKB_alpha, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B alpha | Back alignment and domain information |
|---|
Score = 56.2 bits (135), Expect = 1e-08
Identities = 36/103 (34%), Positives = 54/103 (52%), Gaps = 6/103 (5%)
Query: 271 IAQGLLYLHQYSRLRVIHRDLKASNILLDKDMNPKISDFGMARMFGGDELQSNTKRIVGT 330
I L YLH S V++RDLK N++LDKD + KI+DFG+ + G + + K GT
Sbjct: 104 IVSALDYLH--SEKNVVYRDLKLENLMLDKDGHIKITDFGLCKE--GIKDGATMKTFCGT 159
Query: 331 YGYMSPEYALRGLFSIKSDVFSFGVLLLETLSSKKNTHFYNTD 373
Y++PE + D + GV++ E + + FYN D
Sbjct: 160 PEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGR--LPFYNQD 200
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, alpha (or Akt1) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-alpha is predominantly expressed in endothelial cells. It is critical for the regulation of angiogenesis and the maintenance of vascular integrity. It also plays a role in adipocyte differentiation. Mice deficient in PKB-alpha exhibit perinatal morbidity, growth retardation, reduction in body weight accompanied by reduced sizes of multiple organs, and enhanced apoptosis in some cell types. PKB-alpha activity has been reported to be frequently elevated in breast and prostate cancers. In some cancer cells, PKB-alpha may act as a suppressor of metastasis. Length = 325 |
| >gnl|CDD|173703 cd05612, STKc_PRKX_like, Catalytic domain of PRKX-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 55.9 bits (135), Expect = 1e-08
Identities = 32/94 (34%), Positives = 50/94 (53%), Gaps = 8/94 (8%)
Query: 271 IAQGLLYLHQYSRLRVIHRDLKASNILLDKDMNPKISDFGMARMFGGDELQSNTKRIVGT 330
I L YLH +++RDLK NILLDK+ + K++DFG A+ +L+ T + GT
Sbjct: 110 IVCALEYLHS---KEIVYRDLKPENILLDKEGHIKLTDFGFAK-----KLRDRTWTLCGT 161
Query: 331 YGYMSPEYALRGLFSIKSDVFSFGVLLLETLSSK 364
Y++PE + D ++ G+L+ E L
Sbjct: 162 PEYLAPEVIQSKGHNKAVDWWALGILIYEMLVGY 195
|
Serine/Threonine Kinases (STKs), cAMP-dependent protein kinase (PKA) subfamily, PRKX-like kinases, catalytic (c) subunit. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKA subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include human PRKX (X chromosome-encoded protein kinase), Drosophila DC2, and similar proteins. PRKX is present in many tissues including fetal and adult brain, kidney, and lung. The PRKX gene is located in the Xp22.3 subregion and has a homolog called PRKY on the Y chromosome. An abnormal interchange between PRKX aand PRKY leads to the sex reversal disorder of XX males and XY females. PRKX is implicated in granulocyte/macrophage lineage differentiation, renal cell epithelial migration, and tubular morphogenesis in the developing kidney. Length = 291 |
| >gnl|CDD|173688 cd05597, STKc_DMPK_like, Catalytic domain of Myotonic Dystrophy protein kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 55.9 bits (135), Expect = 1e-08
Identities = 39/111 (35%), Positives = 63/111 (56%), Gaps = 11/111 (9%)
Query: 271 IAQGLLYLHQYSRLRVIHRDLKASNILLDKDMNPKISDFGMA-RMFGGDELQSNTKRIVG 329
+A+ +L + +L +HRD+K N+LLDK+ + +++DFG R+ +QSN VG
Sbjct: 108 LAEMVLAIDSVHQLGYVHRDIKPDNVLLDKNGHIRLADFGSCLRLLADGTVQSNVA--VG 165
Query: 330 TYGYMSPEY--AL---RGLFSIKSDVFSFGVLLLETLSSKKNTHFYNTDSL 375
T Y+SPE A+ +G + + D +S GV + E L + T FY +SL
Sbjct: 166 TPDYISPEILQAMEDGKGRYGPECDWWSLGVCMYEMLYGE--TPFY-AESL 213
|
Serine/Threonine Kinases (STKs), Myotonic Dystrophy protein kinase (DMPK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The DMPK-like subfamily is composed of DMPK and DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK). Three isoforms of MRCK are known, named alpha, beta and gamma. The DMPK gene is implicated in myotonic dystrophy 1 (DM1), an inherited multisystemic disorder with symptoms that include muscle hyperexcitability, progressive muscle weakness and wasting, cataract development, testicular atrophy, and cardiac conduction defects. The genetic basis for DM1 is the mutational expansion of a CTG repeat in the 3'-UTR of DMPK. DMPK is expressed in skeletal and cardiac muscles, and in central nervous tissues. The functional role of DMPK is not fully understood. It may play a role in the signal transduction and homeostasis of calcium. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKgamma is expressed in heart and skeletal muscles, unlike MRCKalpha and MRCKbeta, which are expressed ubiquitously. Length = 331 |
| >gnl|CDD|133205 cd05074, PTKc_Tyro3, Catalytic domain of the Protein Tyrosine Kinase, Tyro3 | Back alignment and domain information |
|---|
Score = 55.3 bits (133), Expect = 1e-08
Identities = 33/103 (32%), Positives = 59/103 (57%), Gaps = 9/103 (8%)
Query: 263 TRVRIIEGIAQGLLYLHQYSRLRVIHRDLKASNILLDKDMNPKISDFGMAR-MFGGDELQ 321
T VR + IA G+ YL S IHRDL A N +L+++M ++DFG+++ ++ GD +
Sbjct: 114 TLVRFMIDIASGMEYL---SSKNFIHRDLAARNCMLNENMTVCVADFGLSKKIYSGDYYR 170
Query: 322 --SNTKRIVGTYGYMSPEYALRGLFSIKSDVFSFGVLLLETLS 362
+K V +++ E +++ SDV++FGV + E ++
Sbjct: 171 QGCASKLPV---KWLALESLADNVYTTHSDVWAFGVTMWEIMT 210
|
Protein Tyrosine Kinase (PTK) family; Tyro3; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyro3 (or Sky) is a member of the Axl subfamily, which is composed of receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Tyro3 is predominantly expressed in the central nervous system and the brain, and functions as a neurotrophic factor. It is also expressed in osteoclasts and has a role in bone resorption. Length = 273 |
| >gnl|CDD|132982 cd06651, STKc_MEKK3, Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 3 | Back alignment and domain information |
|---|
Score = 55.5 bits (133), Expect = 2e-08
Identities = 33/95 (34%), Positives = 51/95 (53%), Gaps = 4/95 (4%)
Query: 271 IAQGLLYLHQYSRLRVIHRDLKASNILLDKDMNPKISDFGMARMFGGDELQSNTKR-IVG 329
I +G+ YLH ++HRD+K +NIL D N K+ DFG ++ + R + G
Sbjct: 115 ILEGMSYLHSN---MIVHRDIKGANILRDSAGNVKLGDFGASKRLQTICMSGTGIRSVTG 171
Query: 330 TYGYMSPEYALRGLFSIKSDVFSFGVLLLETLSSK 364
T +MSPE + K+DV+S G ++E L+ K
Sbjct: 172 TPYWMSPEVISGEGYGRKADVWSLGCTVVEMLTEK 206
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK3 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates the MAPK kinase MEK5 (or MKK5), which in turn phosphorylates and activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK3 plays an essential role in embryonic angiogenesis and early heart development. In addition, MEKK3 is involved in interleukin-1 receptor and Toll-like receptor 4 signaling. It is also a specific regulator of the proinflammatory cytokines IL-6 and GM-CSF in some immune cells. MEKK3 also regulates calcineurin, which plays a critical role in T cell activation, apoptosis, skeletal myocyte differentiation, and cardiac hypertrophy. Length = 266 |
| >gnl|CDD|132975 cd06644, STKc_STK10_LOK, Catalytic domain of the Protein Serine/Threonine Kinase, STK10 or Lymphocyte-oriented kinase | Back alignment and domain information |
|---|
Score = 55.4 bits (133), Expect = 2e-08
Identities = 32/100 (32%), Positives = 57/100 (57%), Gaps = 14/100 (14%)
Query: 267 IIEGIAQGLLYLHQYSRLRVIHRDLKASNILLDKDMNPKISDFGMARMFGGDELQSNTKR 326
I + + L YLH +++IHRDLKA N+LL D + K++DFG++ +++ +R
Sbjct: 115 ICRQMLEALQYLHS---MKIIHRDLKAGNVLLTLDGDIKLADFGVS----AKNVKTLQRR 167
Query: 327 --IVGTYGYMSPEYAL-----RGLFSIKSDVFSFGVLLLE 359
+GT +M+PE + + K+D++S G+ L+E
Sbjct: 168 DSFIGTPYWMAPEVVMCETMKDTPYDYKADIWSLGITLIE 207
|
Serine/threonine kinases (STKs), STK10 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The STK10 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Other names for STK10 include lymphocyte-oriented kinase (LOK) and Xenopus polo-like kinase kinase 1 (xPlkk1). STK10 is highly expressed in lymphocytes and is responsible in regulating leukocyte function associated antigen (LFA-1)-mediated lymphocyte adhesion. It plays a role in regulating the CD28 responsive element in T cells, and may also function as a regulator of polo-like kinase 1 (Plk1), a protein which is overexpressed in multiple tumor types. Length = 292 |
| >gnl|CDD|173705 cd05614, STKc_MSK2_N, N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase 2 | Back alignment and domain information |
|---|
Score = 55.7 bits (134), Expect = 2e-08
Identities = 40/119 (33%), Positives = 62/119 (52%), Gaps = 24/119 (20%)
Query: 265 VRIIEG-IAQGLLYLHQYSRLRVIHRDLKASNILLDKDMNPKISDFGMARMFGGDELQSN 323
VR G I L +LH +L +++RD+K NILLD + + ++DFG+++ F +E +
Sbjct: 107 VRFYSGEIILALEHLH---KLGIVYRDIKLENILLDSEGHVVLTDFGLSKEFLSEE-KER 162
Query: 324 TKRIVGTYGYMSPEYALRGLFSIKS------DVFSFGVLLLE--------TLSSKKNTH 368
T GT YM+PE +RG K D +S G+L+ E TL ++NT
Sbjct: 163 TYSFCGTIEYMAPE-IIRG----KGGHGKAVDWWSLGILIFELLTGASPFTLEGERNTQ 216
|
Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, MSK2, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, which trigger phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydrophobic motif (HM) of NTD, which facilitates the phosphorylation of the A-loop and activates the NTD, which in turn phosphorylates downstream targets. MSK2 and MSK1 play nonredundant roles in activating histone H3 kinases, which play pivotal roles in compaction of the chromatin fiber. MSK2 is the required H3 kinase in response to stress stimuli and activation of the p38 MAPK pathway. MSK2 also plays a role in the pathogenesis of psoriasis. Length = 332 |
| >gnl|CDD|173759 cd08219, STKc_Nek3, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 3 | Back alignment and domain information |
|---|
Score = 55.0 bits (132), Expect = 2e-08
Identities = 33/106 (31%), Positives = 55/106 (51%), Gaps = 11/106 (10%)
Query: 254 TKKGLLCWGTRVRIIEGIAQGLLYLHQYSRLRVIHRDLKASNILLDKDMNPKISDFGMAR 313
+ +L W + + G+ ++H+ RV+HRD+K+ NI L ++ K+ DFG AR
Sbjct: 98 PEDTILQWFVQ------MCLGVQHIHEK---RVLHRDIKSKNIFLTQNGKVKLGDFGSAR 148
Query: 314 MFGGDELQSNTKRIVGTYGYMSPEYALRGLFSIKSDVFSFGVLLLE 359
+ + T VGT Y+ PE ++ KSD++S G +L E
Sbjct: 149 LLTSPGAYACT--YVGTPYYVPPEIWENMPYNNKSDIWSLGCILYE 192
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 3 (Nek3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek3 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek3 is primarily localized in the cytoplasm and shows no cell cycle-dependent changes in its activity. It is present in the axons of neurons and affects morphogenesis and polarity through its regulation of microtubule acetylation. Nek3 modulates the signaling of the prolactin receptor through its activation of Vav2 and contributes to prolactin-mediated motility of breast cancer cells. Length = 255 |
| >gnl|CDD|173676 cd05585, STKc_YPK1_like, Catalytic domain of Yeast Protein Kinase 1-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 55.3 bits (133), Expect = 2e-08
Identities = 33/92 (35%), Positives = 51/92 (55%), Gaps = 2/92 (2%)
Query: 271 IAQGLLYLHQYSRLRVIHRDLKASNILLDKDMNPKISDFGMARMFGGDELQSNTKRIVGT 330
A+ L L + VI+RDLK NILLD + + DFG+ ++ D+ ++NT GT
Sbjct: 99 TAELLCALENLHKFNVIYRDLKPENILLDYQGHIALCDFGLCKLNMKDDDKTNT--FCGT 156
Query: 331 YGYMSPEYALRGLFSIKSDVFSFGVLLLETLS 362
Y++PE L ++ D ++ GVLL E L+
Sbjct: 157 PEYLAPELLLGHGYTKAVDWWTLGVLLYEMLT 188
|
Serine/Threonine Kinases (STKs), Yeast protein kinase 1 (YPK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The YPK1-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of fungal proteins with similarity to the AGC STKs, Saccharomyces cerevisiae YPK1 and Schizosaccharomyces pombe Gad8p. YPK1 is required for cell growth and acts as a downstream kinase in the sphingolipid-mediated signaling pathway of yeast. It also plays a role in efficient endocytosis and in the maintenance of cell wall integrity. Gad8p is a downstream target of Tor1p, the fission yeast homolog of mTOR. It plays a role in cell growth and sexual development. Length = 312 |
| >gnl|CDD|143368 cd07863, STKc_CDK4, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 4 | Back alignment and domain information |
|---|
Score = 55.0 bits (132), Expect = 2e-08
Identities = 30/91 (32%), Positives = 47/91 (51%), Gaps = 6/91 (6%)
Query: 274 GLLYLHQYSRLRVIHRDLKASNILLDKDMNPKISDFGMARMFGGDELQSNTKRIVGTYGY 333
GL +LH ++HRDLK NIL+ K++DFG+AR++ Q +V T Y
Sbjct: 120 GLDFLHAN---CIVHRDLKPENILVTSGGQVKLADFGLARIY---SCQMALTPVVVTLWY 173
Query: 334 MSPEYALRGLFSIKSDVFSFGVLLLETLSSK 364
+PE L+ ++ D++S G + E K
Sbjct: 174 RAPEVLLQSTYATPVDMWSVGCIFAEMFRRK 204
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 4 (CDK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK4 partners with all three D-type cyclins (D1, D2, and D3) and is also regulated by INK4 inhibitors. It is active towards the retinoblastoma (pRb) protein and plays a role in regulating the early G1 phase of the cell cycle. It is expressed ubiquitously and is localized in the nucleus. CDK4 also shows kinase activity towards Smad3, a signal transducer of transforming growth factor (TGF)-beta signaling which modulates transcription and plays a role in cell proliferation and apoptosis. CDK4 is inhibited by the p21 inhibitor and is specifically mutated in human melanoma. Length = 288 |
| >gnl|CDD|173642 cd05075, PTKc_Axl, Catalytic domain of the Protein Tyrosine Kinase, Axl | Back alignment and domain information |
|---|
Score = 54.7 bits (131), Expect = 2e-08
Identities = 34/99 (34%), Positives = 57/99 (57%), Gaps = 7/99 (7%)
Query: 263 TRVRIIEGIAQGLLYLHQYSRLRVIHRDLKASNILLDKDMNPKISDFGMA-RMFGGDELQ 321
V+ + IA G+ YL S IHRDL A N +L+++MN ++DFG++ +++ GD +
Sbjct: 113 MLVKFMTDIASGMEYL---SSKSFIHRDLAARNCMLNENMNVCVADFGLSKKIYNGDYYR 169
Query: 322 SNTKRIVGT-YGYMSPEYALRGLFSIKSDVFSFGVLLLE 359
RI +++ E +++ KSDV+SFGV + E
Sbjct: 170 QG--RIAKMPVKWIAIESLADRVYTTKSDVWSFGVTMWE 206
|
Protein Tyrosine Kinase (PTK) family; Axl; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Axl is a member of the Axl subfamily, which is composed of receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Axl is widely expressed in a variety of organs and cells including epithelial, mesenchymal, hematopoietic, as well as non-transformed cells. Axl signaling is important in many cellular functions such as survival, anti-apoptosis, proliferation, migration, and adhesion. Axl was originally isolated from patients with chronic myelogenous leukemia and a chronic myeloproliferative disorder. Axl is overexpressed in many human cancers including colon, squamous cell, thyroid, breast, and lung carcinomas. Length = 272 |
| >gnl|CDD|132989 cd06658, STKc_PAK5, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 5 | Back alignment and domain information |
|---|
Score = 55.0 bits (132), Expect = 2e-08
Identities = 31/94 (32%), Positives = 51/94 (54%), Gaps = 5/94 (5%)
Query: 271 IAQGLLYLHQYSRLRVIHRDLKASNILLDKDMNPKISDFGMARMFGGDELQSNTKRIVGT 330
+ + L YLH VIHRD+K+ +ILL D K+SDFG + K +VGT
Sbjct: 127 VLRALSYLHNQG---VIHRDIKSDSILLTSDGRIKLSDFGFCAQVSKE--VPKRKSLVGT 181
Query: 331 YGYMSPEYALRGLFSIKSDVFSFGVLLLETLSSK 364
+M+PE R + + D++S G++++E + +
Sbjct: 182 PYWMAPEVISRLPYGTEVDIWSLGIMVIEMIDGE 215
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 5, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK5 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK5 is mainly expressed in the brain. It is not required for viability, but together with PAK6, it is required for normal levels of locomotion and activity, and for learning and memory. PAK5 cooperates with Inca (induced in neural crest by AP2) in the regulation of cell adhesion and cytoskeletal organization in the embryo and in neural crest cells during craniofacial development. PAK5 may also play a role in controlling the signaling of Raf-1, an effector of Ras, at the mitochondria. Length = 292 |
| >gnl|CDD|173644 cd05079, PTKc_Jak1_rpt2, Catalytic (repeat 2) domain of the Protein Tyrosine Kinase, Janus kinase 1 | Back alignment and domain information |
|---|
Score = 54.9 bits (132), Expect = 3e-08
Identities = 34/95 (35%), Positives = 52/95 (54%), Gaps = 8/95 (8%)
Query: 271 IAQGLLYL--HQYSRLRVIHRDLKASNILLDKDMNPKISDFGMARMFGGDELQSNTKRIV 328
I +G+ YL QY +HRDL A N+L++ + KI DFG+ + D+ K +
Sbjct: 118 ICKGMDYLGSRQY-----VHRDLAARNVLVESEHQVKIGDFGLTKAIETDKEYYTVKDDL 172
Query: 329 GT-YGYMSPEYALRGLFSIKSDVFSFGVLLLETLS 362
+ + +PE ++ F I SDV+SFGV L E L+
Sbjct: 173 DSPVFWYAPECLIQSKFYIASDVWSFGVTLYELLT 207
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 1 (Jak1); catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak1 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jak1 is widely expressed in many tissues. Many cytokines are dependent on Jak1 for signaling, including those that use the shared receptor subunits common gamma chain (IL-2, IL-4, IL-7, IL-9, IL-15, IL-21) and gp130 (IL-6, IL-11, oncostatin M, G-CSF, and IFNs, among others). The many varied interactions of Jak1 and its ubiquitous expression suggest many biological roles. Jak1 is important in neurological development, as well as in lymphoid development and function. It also plays a role in the pathophysiology of cardiac hypertrophy and heart failure. A mutation in the ATP-binding site of Jak1 was identified in a human uterine leiomyosarcoma cell line, resulting in defective cytokine induction and antigen presentation, thus allowing the tumor to evade the immune system. Length = 284 |
| >gnl|CDD|133219 cd05088, PTKc_Tie2, Catalytic domain of the Protein Tyrosine Kinase, Tie2 | Back alignment and domain information |
|---|
Score = 55.0 bits (132), Expect = 3e-08
Identities = 36/94 (38%), Positives = 57/94 (60%), Gaps = 10/94 (10%)
Query: 271 IAQGLLYLHQYSRLRVIHRDLKASNILLDKDMNPKISDFGMARMFGGDELQSNTKRIVGT 330
+A+G+ YL Q + IHRDL A NIL+ ++ KI+DFG++R G E+ K+ +G
Sbjct: 133 VARGMDYLSQK---QFIHRDLAARNILVGENYVAKIADFGLSR---GQEVY--VKKTMGR 184
Query: 331 YG--YMSPEYALRGLFSIKSDVFSFGVLLLETLS 362
+M+ E +++ SDV+S+GVLL E +S
Sbjct: 185 LPVRWMAIESLNYSVYTTNSDVWSYGVLLWEIVS 218
|
Protein Tyrosine Kinase (PTK) family; Tie2; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie2 is a receptor tyr kinase (RTK) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie2 is expressed mainly in endothelial cells and hematopoietic stem cells. It is also found in a subset of tumor-associated monocytes and eosinophils. The angiopoietins (Ang-1 to Ang-4) serve as ligands for Tie2. The binding of Ang-1 to Tie2 leads to receptor autophosphorylation and activation, promoting cell migration and survival. In contrast, Ang-2 binding to Tie2 does not result in the same response, suggesting that Ang-2 may function as an antagonist. Tie2 signaling plays key regulatory roles in vascular integrity and quiescence, and in inflammation. Length = 303 |
| >gnl|CDD|173649 cd05093, PTKc_TrkB, Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase B | Back alignment and domain information |
|---|
Score = 54.7 bits (131), Expect = 3e-08
Identities = 38/119 (31%), Positives = 60/119 (50%), Gaps = 14/119 (11%)
Query: 251 NNPTKKGLLCWGTRVRIIEGIAQGLLYLHQYSRLRVIHRDLKASNILLDKDMNPKISDFG 310
N P + L + I + IA G++YL + +HRDL N L+ +++ KI DFG
Sbjct: 112 NRPAE---LTQSQMLHIAQQIAAGMVYL---ASQHFVHRDLATRNCLVGENLLVKIGDFG 165
Query: 311 MARMFGGDELQSNTKRIVG----TYGYMSPEYALRGLFSIKSDVFSFGVLLLETLSSKK 365
M+R D ++ R+ G +M PE + F+ +SDV+S GV+L E + K
Sbjct: 166 MSR----DVYSTDYYRVGGHTMLPIRWMPPESIMYRKFTTESDVWSLGVVLWEIFTYGK 220
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase B (TrkB); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkB is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkB to its ligands, brain-derived neurotrophic factor (BDNF) or neurotrophin 4 (NT4), results in receptor oligomerization and activation of the catalytic domain. TrkB is broadly expressed in the nervous system and in some non-neural tissues. It plays important roles in cell proliferation, differentiation, and survival. BDNF/Trk signaling plays a key role in regulating activity-dependent synaptic plasticity. TrkB also contributes to protection against gp120-induced neuronal cell death. TrkB overexpression is associated with poor prognosis in neuroblastoma (NB) and other human cancers. It acts as a suppressor of anoikis (detachment-induced apoptosis) and contributes to tumor metastasis. Length = 288 |
| >gnl|CDD|132970 cd06639, STKc_myosinIIIB, Catalytic domain of the Protein Serine/Threonine Kinase, Class IIIB myosin | Back alignment and domain information |
|---|
Score = 54.6 bits (131), Expect = 3e-08
Identities = 40/115 (34%), Positives = 58/115 (50%), Gaps = 16/115 (13%)
Query: 256 KGLLCWGTRVR------IIEGIAQGLLYLHQYSRLRVIHRDLKASNILLDKDMNPKISDF 309
KGLL G R+ I+ G GL +LH R+IHRD+K +NILL + K+ DF
Sbjct: 116 KGLLICGQRLDEAMISYILYGALLGLQHLHNN---RIIHRDVKGNNILLTTEGGVKLVDF 172
Query: 310 GMARMFGGDELQSNTKRIVGTYGYMSPEY-----ALRGLFSIKSDVFSFGVLLLE 359
G++ L+ NT VGT +M+PE + + DV+S G+ +E
Sbjct: 173 GVSAQLTSTRLRRNTS--VGTPFWMAPEVIACEQQYDYSYDARCDVWSLGITAIE 225
|
Serine/threonine kinases (STKs), class IIIB myosin subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain. Class III myosins may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. They may also function as cargo carriers during light-dependent translocation, in photoreceptor cells, of proteins such as transducin and arrestin. Class IIIB myosin is expressed highly in retina. It is also present in the brain and testis. The human class IIIB myosin gene maps to a region that overlaps the locus for Bardet-Biedl syndrome, which is characterized by dysmorphic extremities, retinal dystrophy, obesity, male hypogenitalism, and renal abnormalities. Length = 291 |
| >gnl|CDD|173686 cd05595, STKc_PKB_beta, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B beta | Back alignment and domain information |
|---|
Score = 54.6 bits (131), Expect = 4e-08
Identities = 34/103 (33%), Positives = 52/103 (50%), Gaps = 7/103 (6%)
Query: 271 IAQGLLYLHQYSRLRVIHRDLKASNILLDKDMNPKISDFGMARMFGGDELQSNTKRIVGT 330
I L YLH V++RD+K N++LDKD + KI+DFG+ + D + K GT
Sbjct: 104 IVSALEYLHSRD---VVYRDIKLENLMLDKDGHIKITDFGLCKEGISDG--ATMKTFCGT 158
Query: 331 YGYMSPEYALRGLFSIKSDVFSFGVLLLETLSSKKNTHFYNTD 373
Y++PE + D + GV++ E + + FYN D
Sbjct: 159 PEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGR--LPFYNQD 199
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, beta (or Akt2) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-beta is the predominant PKB isoform expressed in insulin-responsive tissues. It plays a critical role in the regulation of glucose homeostasis. It is also implicated in muscle cell differentiation. Mice deficient in PKB-beta display normal growth weights but exhibit severe insulin resistance and diabetes, accompanied by lipoatrophy and B-cell failure. Length = 323 |
| >gnl|CDD|173684 cd05593, STKc_PKB_gamma, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B gamma | Back alignment and domain information |
|---|
Score = 54.3 bits (130), Expect = 5e-08
Identities = 47/158 (29%), Positives = 70/158 (44%), Gaps = 22/158 (13%)
Query: 225 PTYTSFLYEQVLVQSKDEISFWYESYNNPTKKGLLCWGTRVRIIEG---------IAQGL 275
P TS Y Q+KD + F E N L +R R+ I L
Sbjct: 55 PFLTSLKYS---FQTKDRLCFVMEYVNGGE---LFFHLSRERVFSEDRTRFYGAEIVSAL 108
Query: 276 LYLHQYSRLRVIHRDLKASNILLDKDMNPKISDFGMARMFGGDELQSNTKRIVGTYGYMS 335
YLH ++++RDLK N++LDKD + KI+DFG+ + G + K GT Y++
Sbjct: 109 DYLHSG---KIVYRDLKLENLMLDKDGHIKITDFGLCKE--GITDAATMKTFCGTPEYLA 163
Query: 336 PEYALRGLFSIKSDVFSFGVLLLETLSSKKNTHFYNTD 373
PE + D + GV++ E + + FYN D
Sbjct: 164 PEVLEDNDYGRAVDWWGLGVVMYEMMCGR--LPFYNQD 199
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, gamma (or Akt3) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-gamma is predominantly expressed in neuronal tissues. Mice deficient in PKB-gamma show a reduction in brain weight due to the decreases in cell size and cell number. PKB-gamma has also been shown to be upregulated in estrogen-deficient breast cancer cells, androgen-independent prostate cancer cells, and primary ovarian tumors. It acts as a key mediator in the genesis of ovarian cancer. Length = 328 |
| >gnl|CDD|173662 cd05571, STKc_PKB, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B | Back alignment and domain information |
|---|
Score = 54.0 bits (130), Expect = 5e-08
Identities = 35/103 (33%), Positives = 52/103 (50%), Gaps = 7/103 (6%)
Query: 271 IAQGLLYLHQYSRLRVIHRDLKASNILLDKDMNPKISDFGMARMFGGDELQSNTKRIVGT 330
I L YLH V++RDLK N++LDKD + KI+DFG+ + G + K GT
Sbjct: 104 IVSALGYLH---SCDVVYRDLKLENLMLDKDGHIKITDFGLCKE--GISDGATMKTFCGT 158
Query: 331 YGYMSPEYALRGLFSIKSDVFSFGVLLLETLSSKKNTHFYNTD 373
Y++PE + D + GV++ E + + FYN D
Sbjct: 159 PEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGR--LPFYNQD 199
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. It is activated downstream of PI3K and plays important roles in diverse cellular functions including cell survival, growth, proliferation, angiogenesis, motility, and migration. PKB also has a central role in a variety of human cancers, having been implicated in tumor initiation, progression, and metastasis. Length = 323 |
| >gnl|CDD|143342 cd07837, STKc_CdkB_plant, Catalytic domain of the Serine/Threonine Kinase, Plant B-type Cyclin-Dependent protein Kinase | Back alignment and domain information |
|---|
Score = 54.0 bits (130), Expect = 6e-08
Identities = 32/91 (35%), Positives = 49/91 (53%), Gaps = 7/91 (7%)
Query: 273 QGLLYLHQYSRLRVIHRDLKASNILLDKDMNP-KISDFGMARMFGGDELQSNTKRIVGTY 331
+G+ + H++ V+HRDLK N+L+DK KI+D G+ R F ++S T IV T
Sbjct: 121 KGVAHCHKHG---VMHRDLKPQNLLVDKQKGLLKIADLGLGRAF-SIPVKSYTHEIV-TL 175
Query: 332 GYMSPEYALRGL-FSIKSDVFSFGVLLLETL 361
Y +PE L +S D++S G + E
Sbjct: 176 WYRAPEVLLGSTHYSTPVDIWSVGCIFAEMS 206
|
Serine/Threonine Kinases (STKs), Plant B-type Cyclin-Dependent protein Kinase (CdkB) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CdkB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. The plant-specific B-type CDKs are expressed from the late S to the M phase of the cell cycle. They are characterized by the cyclin binding motif PPT[A/T]LRE. They play a role in controlling mitosis and integrating developmental pathways, such as stomata and leaf development. CdkB has been shown to associate with both cyclin B, which controls G2/M transition, and cyclin D, which acts as a mediator in linking extracellular signals to the cell cycle. Length = 295 |
| >gnl|CDD|173704 cd05613, STKc_MSK1_N, N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase 1 | Back alignment and domain information |
|---|
Score = 53.5 bits (128), Expect = 6e-08
Identities = 34/106 (32%), Positives = 54/106 (50%), Gaps = 8/106 (7%)
Query: 264 RVRIIEG-----IAQGLLYLHQYSRLRVIHRDLKASNILLDKDMNPKISDFGMARMFGGD 318
R R E + +L L +L +I+RD+K NILLD + + ++DFG+++ F D
Sbjct: 99 RERFKEQEVQIYSGEIVLALEHLHKLGIIYRDIKLENILLDSNGHVVLTDFGLSKEFHED 158
Query: 319 ELQSNTKRIVGTYGYMSPEYALRGL--FSIKSDVFSFGVLLLETLS 362
E++ GT YM+P+ G D +S GVL+ E L+
Sbjct: 159 EVE-RAYSFCGTIEYMAPDIVRGGDGGHDKAVDWWSMGVLMYELLT 203
|
Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, MSK1, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, which trigger phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydrophobic motif (HM) of NTD, which facilitates the phosphorylation of the A-loop and activates the NTD, which in turn phosphorylates downstream targets. MSK1 plays a role in the regulation of translational control and transcriptional activation. It phosphorylates the transcription factors, CREB and NFkappaB. It also phosphorylates the nucleosomal proteins H3 and HMG-14. Increased phosphorylation of MEK1 is associated with the development of cerebral ischemic/hypoxic preconditioning. Length = 290 |
| >gnl|CDD|173734 cd07830, STKc_MAK_like, Catalytic domain of Male germ cell-Associated Kinase-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 53.7 bits (130), Expect = 7e-08
Identities = 36/103 (34%), Positives = 54/103 (52%), Gaps = 18/103 (17%)
Query: 264 RVR-IIEGIAQGLLYLHQ--YSRLRVIHRDLKASNILLDKDMNPKISDFGMARMFGGDEL 320
+R II I QGL ++H+ + HRDLK N+L+ KI+DFG+AR E+
Sbjct: 100 VIRSIIYQILQGLAHIHKHGF-----FHRDLKPENLLVSGPEVVKIADFGLAR-----EI 149
Query: 321 QSN---TKRIVGTYGYMSPEYALR-GLFSIKSDVFSFGVLLLE 359
+S T V T Y +PE LR +S D+++ G ++ E
Sbjct: 150 RSRPPYTD-YVSTRWYRAPEILLRSTSYSSPVDIWALGCIMAE 191
|
Serine/Threonine Kinases (STKs), Male germ cell-Associated Kinase (MAK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of human MAK and MAK-related kinase (MRK), Saccharomyces cerevisiae Ime2p, Schizosaccharomyces pombe Mei4-dependent protein 3 (Mde3) and Pit1, Caenorhabditis elegans dyf-5, Arabidopsis thaliana MHK, and similar proteins. These proteins play important roles during meiosis. MAK is highly expressed in testicular cells specifically in the meiotic phase, but is not essential for spermatogenesis and fertility. It functions as a coactivator of the androgen receptor in prostate cells. MRK, also called Intestinal Cell Kinase (ICK), is expressed ubiquitously, with highest expression in the ovary and uterus. A missense mutation in MRK causes endocrine-cerebro-osteodysplasia (ECO), suggesting that this protein plays an important role in the development of many organs. MAK and MRK may be involved in regulating cell cycle and cell fate. Ime2p is a meiosis-specific kinase that is important during meiotic initiation and during the later stages of meiosis. Mde3 functions downstream of the transcription factor Mei-4 which is essential for meiotic prophase I. Length = 283 |
| >gnl|CDD|132988 cd06657, STKc_PAK4, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 4 | Back alignment and domain information |
|---|
Score = 53.5 bits (128), Expect = 7e-08
Identities = 31/89 (34%), Positives = 49/89 (55%), Gaps = 5/89 (5%)
Query: 271 IAQGLLYLHQYSRLRVIHRDLKASNILLDKDMNPKISDFGMARMFGGDELQSNTKRIVGT 330
+ + L LH VIHRD+K+ +ILL D K+SDFG E+ K +VGT
Sbjct: 125 VLKALSVLHAQG---VIHRDIKSDSILLTHDGRVKLSDFGFCAQV-SKEVPRR-KSLVGT 179
Query: 331 YGYMSPEYALRGLFSIKSDVFSFGVLLLE 359
+M+PE R + + D++S G++++E
Sbjct: 180 PYWMAPELISRLPYGPEVDIWSLGIMVIE 208
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 4, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK4 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK4 regulates cell morphology and cytoskeletal organization. It is essential for embryonic viability and proper neural development. Mice lacking PAK4 die due to defects in the fetal heart. In addition, their spinal cord motor neurons showed failure to differentiate and migrate. PAK4 also plays a role in cell survival and tumorigenesis. It is overexpressed in many primary tumors including colon, esophageal, and mammary tumors. PAK4 has also been implicated in viral and bacterial infection pathways. Length = 292 |
| >gnl|CDD|234389 TIGR03903, TOMM_kin_cyc, TOMM system kinase/cyclase fusion protein | Back alignment and domain information |
|---|
Score = 54.9 bits (132), Expect = 7e-08
Identities = 34/117 (29%), Positives = 58/117 (49%), Gaps = 13/117 (11%)
Query: 257 GLLCWGTRVRIIEGIAQGLLYLHQYSRLRVIHRDLKASNILL---DKDMNPKISDFGMAR 313
G L G R++ + L H ++HRDLK NI++ + K+ DFG+
Sbjct: 74 GALPAGETGRLMLQVLDALACAH---NQGIVHRDLKPQNIMVSQTGVRPHAKVLDFGIGT 130
Query: 314 MFGG----DELQ-SNTKRIVGTYGYMSPEYALRG-LFSIKSDVFSFGVLLLETLSSK 364
+ G D + T ++GT Y +PE LRG + SD++++G++ LE L+ +
Sbjct: 131 LLPGVRDADVATLTRTTEVLGTPTYCAPE-QLRGEPVTPNSDLYAWGLIFLECLTGQ 186
|
This model represents proteins of 1350 in length, in multiple species of Burkholderia, in Acidovorax avenae subsp. citrulli AAC00-1 and Delftia acidovorans SPH-1, and in multiple copies in Sorangium cellulosum, in genomic neighborhoods that include a cyclodehydratase/docking scaffold fusion protein (TIGR03882) and a member of the thiazole/oxazole modified metabolite (TOMM) precursor family TIGR03795. It has a kinase domain in the N-terminal 300 amino acids, followed by a cyclase homology domain, followed by regions without named domain definitions. It is a probable bacteriocin-like metabolite biosynthesis protein [Cellular processes, Toxin production and resistance]. Length = 1266 |
| >gnl|CDD|132968 cd06637, STKc_TNIK, Catalytic domain of the Protein Serine/Threonine Kinase, Traf2- and Nck-interacting kinase | Back alignment and domain information |
|---|
Score = 53.6 bits (128), Expect = 7e-08
Identities = 33/98 (33%), Positives = 53/98 (54%), Gaps = 10/98 (10%)
Query: 267 IIEGIAQGLLYLHQYSRLRVIHRDLKASNILLDKDMNPKISDFGMARMFGGDELQSNTKR 326
I I +GL +LHQ+ +VIHRD+K N+LL ++ K+ DFG++ + NT
Sbjct: 116 ICREILRGLSHLHQH---KVIHRDIKGQNVLLTENAEVKLVDFGVSAQLDRTVGRRNT-- 170
Query: 327 IVGTYGYMSPEYAL-----RGLFSIKSDVFSFGVLLLE 359
+GT +M+PE + KSD++S G+ +E
Sbjct: 171 FIGTPYWMAPEVIACDENPDATYDFKSDLWSLGITAIE 208
|
Serine/threonine kinases (STKs), Traf2- and Nck-interacting kinase (TNIK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TNIK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to mitogen-activated protein kinase (MAPK), kinase kinase kinase 4 (MAP4K4), and MAP4K6. MAP4Ks participate in some MAPK signaling pathways by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). TNIK is an effector of Rap2, a small GTP-binding protein from the Ras family. TNIK specifically activates the c-Jun N-terminal kinase (JNK) pathway and plays a role in regulating the actin cytoskeleton. Length = 272 |
| >gnl|CDD|173740 cd07842, STKc_CDK8_like, Catalytic domain of Cyclin-Dependent protein Kinase 8-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 53.4 bits (129), Expect = 8e-08
Identities = 33/101 (32%), Positives = 51/101 (50%), Gaps = 11/101 (10%)
Query: 271 IAQGLLYLHQYSRLRVIHRDLKASNILLDKDMNP----KISDFGMARMFGGDELQS--NT 324
I G+ YLH V+HRDLK +NIL+ + KI D G+AR+F L+ +
Sbjct: 117 ILNGVHYLHSN---WVLHRDLKPANILVMGEGPERGVVKIGDLGLARLF-NAPLKPLADL 172
Query: 325 KRIVGTYGYMSPEYALRGLFSIKS-DVFSFGVLLLETLSSK 364
+V T Y +PE L K+ D+++ G + E L+ +
Sbjct: 173 DPVVVTIWYRAPELLLGARHYTKAIDIWAIGCIFAELLTLE 213
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 8 (CDK8)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK8-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK8, CDC2L6, and similar proteins. CDK8 functions as a negative or positive regulator of transcription, depending on the scenario. Together with its regulator, cyclin C, it reversibly associates with the multi-subunit core Mediator complex, a cofactor that is involved in regulating RNA polymerase II (RNAP II)-dependent transcription. CDC2L6 also associates with Mediator in complexes lacking CDK8. In VP16-dependent transcriptional activation, CDK8 and CDC2L6 exerts opposing effects by positive and negative regulation, respectively, in similar conditions. Length = 316 |
| >gnl|CDD|173720 cd05631, STKc_GRK4, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 4 | Back alignment and domain information |
|---|
Score = 53.1 bits (127), Expect = 9e-08
Identities = 30/84 (35%), Positives = 43/84 (51%), Gaps = 3/84 (3%)
Query: 278 LHQYSRLRVIHRDLKASNILLDKDMNPKISDFGMARMFGGDELQSNTKRIVGTYGYMSPE 337
L R R+++RDLK NILLD + +ISD G+A E + VGT GYM+PE
Sbjct: 115 LEDLQRERIVYRDLKPENILLDDRGHIRISDLGLAVQIPEGE---TVRGRVGTVGYMAPE 171
Query: 338 YALRGLFSIKSDVFSFGVLLLETL 361
++ D + G L+ E +
Sbjct: 172 VINNEKYTFSPDWWGLGCLIYEMI 195
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK4 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK4 has a limited tissue distribution. It is mainly found in the testis, but is also present in the cerebellum and kidney. It is expressed as multiple splice variants with different domain architectures. It is post-translationally palmitoylated and localized in the membrane. GRK4 polymorphisms are associated with hypertension and salt sensitivity, as they cause hyperphosphorylation, desensitization, and internalization of the dopamine 1 (D1) receptor while increasing the expression of the angiotensin II type 1 receptor. GRK4 plays a crucial role in the D1 receptor regulation of sodium excretion and blood pressure. Length = 285 |
| >gnl|CDD|173691 cd05600, STKc_Sid2p_Dbf2p, Catalytic domain of Fungal Sid2p- and Dbf2p-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 53.6 bits (129), Expect = 9e-08
Identities = 31/86 (36%), Positives = 46/86 (53%), Gaps = 10/86 (11%)
Query: 278 LHQYSRLRVIHRDLKASNILLDKDMNPKISDFGMARMFGGDELQSNTKRIVGTYGYMSPE 337
LH L IHRDLK N L+D + K++DFG+++ + + +VG+ YM+PE
Sbjct: 117 LH---ELGYIHRDLKPENFLIDASGHIKLTDFGLSK-----GIVTYANSVVGSPDYMAPE 168
Query: 338 YALRGL-FSIKSDVFSFGVLLLETLS 362
LRG + D +S G +L E L
Sbjct: 169 -VLRGKGYDFTVDYWSLGCMLYEFLC 193
|
Serine/Threonine Kinases (STKs), ROCK- and NDR-like subfamily, fungal Sid2p- and Dbf2p-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sid2p- and Dbf2p-like group is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This group contains fungal kinases including Schizosaccharomyces pombe Sid2p and Saccharomyces cerevisiae Dbf2p. Group members show similarity to NDR kinases in that they contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Sid2p plays a crucial role in the septum initiation network (SIN) and in the initiation of cytokinesis. Dbf2p is important in regulating the mitotic exit network (MEN) and in cytokinesis. Length = 333 |
| >gnl|CDD|132974 cd06643, STKc_SLK, Catalytic domain of the Protein Serine/Threonine Kinase, Ste20-like kinase | Back alignment and domain information |
|---|
Score = 53.1 bits (127), Expect = 9e-08
Identities = 34/98 (34%), Positives = 53/98 (54%), Gaps = 22/98 (22%)
Query: 273 QGLLYLHQYSRLRVIHRDLKASNILLDKDMNPKISDFGMARMFGGDELQSNTKRI----- 327
+ L YLH+ ++IHRDLKA NIL D + K++DFG++ NT+ I
Sbjct: 114 EALNYLHEN---KIIHRDLKAGNILFTLDGDIKLADFGVS--------AKNTRTIQRRDS 162
Query: 328 -VGTYGYMSPEYALRGL-----FSIKSDVFSFGVLLLE 359
+GT +M+PE + + K+DV+S G+ L+E
Sbjct: 163 FIGTPYWMAPEVVMCETSKDRPYDYKADVWSLGITLIE 200
|
Serine/threonine kinases (STKs), Ste20-like kinase (SLK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SLK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. SLK promotes apoptosis through apoptosis signal-regulating kinase 1 (ASK1) and the mitogen-activated protein kinase (MAPK) p38. It acts as a MAPK kinase kinase (MAPKKK) by phosphorylating ASK1, resulting in the phosphorylation of p38. SLK also plays a role in mediating actin reorganization. It is part of a microtubule-associated complex that is targeted at adhesion sites, and is required in focal adhesion turnover and in regulating cell migration. Length = 282 |
| >gnl|CDD|240233 PTZ00024, PTZ00024, cyclin-dependent protein kinase; Provisional | Back alignment and domain information |
|---|
Score = 53.2 bits (128), Expect = 1e-07
Identities = 35/131 (26%), Positives = 56/131 (42%), Gaps = 18/131 (13%)
Query: 267 IIEGIAQGLLYLHQYSRLRVIHRDLKASNILLDKDMNPKISDFGMARMFGGDELQSNTKR 326
I+ I GL LH++ +HRDL +NI ++ KI+DFG+AR +G +
Sbjct: 124 ILLQILNGLNVLHKWY---FMHRDLSPANIFINSKGICKIADFGLARRYGYPPYSDTLSK 180
Query: 327 I------------VGTYGYMSPEYALRG-LFSIKSDVFSFGVLLLETLSSKKNTHFYNTD 373
V T Y +PE + + D++S G + E L+ K F +
Sbjct: 181 DETMQRREEMTSKVVTLWYRAPELLMGAEKYHFAVDMWSVGCIFAELLTGK--PLFPGEN 238
Query: 374 SLTLLGHAWNL 384
+ LG + L
Sbjct: 239 EIDQLGRIFEL 249
|
Length = 335 |
| >gnl|CDD|173653 cd05105, PTKc_PDGFR_alpha, Catalytic domain of the Protein Tyrosine Kinase, Platelet Derived Growth Factor Receptor alpha | Back alignment and domain information |
|---|
Score = 53.5 bits (128), Expect = 1e-07
Identities = 32/92 (34%), Positives = 49/92 (53%), Gaps = 3/92 (3%)
Query: 271 IAQGLLYLHQYSRLRVIHRDLKASNILLDKDMNPKISDFGMARMFGGDELQSNTKRIVGT 330
+A+G+ +L + +HRDL A N+LL + KI DFG+AR D +
Sbjct: 246 VARGMEFL---ASKNCVHRDLAARNVLLAQGKIVKICDFGLARDIMHDSNYVSKGSTFLP 302
Query: 331 YGYMSPEYALRGLFSIKSDVFSFGVLLLETLS 362
+M+PE L++ SDV+S+G+LL E S
Sbjct: 303 VKWMAPESIFDNLYTTLSDVWSYGILLWEIFS 334
|
Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) alpha; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR alpha is a receptor tyr kinase (RTK) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding to its ligands, the PDGFs, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR alpha forms homodimers or heterodimers with PDGFR beta, depending on the nature of the PDGF ligand. PDGF-AA, PDGF-AB, and PDGF-CC induce PDGFR alpha homodimerization. PDGFR signaling plays many roles in normal embryonic development and adult physiology. PDGFR alpha signaling is important in the formation of lung alveoli, intestinal villi, mesenchymal dermis, and hair follicles, as well as in the development of oligodendrocytes, retinal astrocytes, neural crest cells, and testicular cells. Aberrant PDGFR alpha expression is associated with some human cancers. Mutations in PDGFR alpha have been found within a subset of gastrointestinal stromal tumors (GISTs). An active fusion protein FIP1L1-PDGFR alpha, derived from interstitial deletion, is associated with idiopathic hypereosinophilic syndrome (HES) and chronic eosinophilic leukemia (CEL). Length = 400 |
| >gnl|CDD|132962 cd06631, STKc_YSK4, Catalytic domain of the Protein Serine/Threonine Kinase, Yeast Sps1/Ste20-related kinase 4 | Back alignment and domain information |
|---|
Score = 52.6 bits (126), Expect = 1e-07
Identities = 34/98 (34%), Positives = 50/98 (51%), Gaps = 7/98 (7%)
Query: 271 IAQGLLYLHQYSRLRVIHRDLKASNILLDKDMNPKISDFGMAR---MFGGDELQSNT-KR 326
I G+ YLH V+HRD+K +N++L + K+ DFG AR G SN K
Sbjct: 111 ILDGVAYLHNNC---VVHRDIKGNNVMLMPNGIIKLIDFGCARRLAWVGLHGTHSNMLKS 167
Query: 327 IVGTYGYMSPEYALRGLFSIKSDVFSFGVLLLETLSSK 364
+ GT +M+PE + KSD++S G + E + K
Sbjct: 168 MHGTPYWMAPEVINESGYGRKSDIWSIGCTVFEMATGK 205
|
Serine/threonine kinases (STKs), yeast Sps1/Ste20-related kinase 4 (YSK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The YSK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. YSK4 is a putative MAPKKK, whose mammalian gene has been isolated. MAPKKKs (MKKKs or MAP3Ks) phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Length = 265 |
| >gnl|CDD|173746 cd07850, STKc_JNK, Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase | Back alignment and domain information |
|---|
Score = 53.2 bits (128), Expect = 1e-07
Identities = 32/86 (37%), Positives = 46/86 (53%), Gaps = 6/86 (6%)
Query: 274 GLLYLHQYSRLRVIHRDLKASNILLDKDMNPKISDFGMARMFGGDELQSNTKRIVGTYGY 333
G+ +LH +IHRDLK SNI++ D KI DFG+AR G + T +V Y Y
Sbjct: 130 GIKHLHSAG---IIHRDLKPSNIVVKSDCTLKILDFGLARTAGTSFMM--TPYVVTRY-Y 183
Query: 334 MSPEYALRGLFSIKSDVFSFGVLLLE 359
+PE L + D++S G ++ E
Sbjct: 184 RAPEVILGMGYKENVDIWSVGCIMGE 209
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase (JNK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. They are also essential regulators of physiological and pathological processes and are involved in the pathogenesis of several diseases such as diabetes, atherosclerosis, stroke, Parkinson's and Alzheimer's. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3) that are alternatively spliced to produce at least 10 isoforms. JNKs are specifically activated by the MAPK kinases MKK4 and MKK7, which are in turn activated by upstream MAPK kinase kinases as a result of different stimuli including stresses such as ultraviolet (UV) irradiation, hyperosmolarity, heat shock, or cytokines. JNKs activate a large number of different substrates based on specific stimulus, cell type, and cellular condition, and may be implicated in seemingly contradictory functions. Length = 353 |
| >gnl|CDD|173675 cd05584, STKc_p70S6K, Catalytic domain of the Protein Serine/Threonine Kinase, 70 kDa ribosomal protein S6 kinase | Back alignment and domain information |
|---|
Score = 52.9 bits (127), Expect = 1e-07
Identities = 33/94 (35%), Positives = 50/94 (53%), Gaps = 9/94 (9%)
Query: 271 IAQGLLYLHQYSRLRVIHRDLKASNILLDKDMNPKISDFGMAR--MFGGDELQSNTKRIV 328
I+ L +LHQ +I+RDLK NILLD + K++DFG+ + + G + T
Sbjct: 109 ISLALEHLHQ---QGIIYRDLKPENILLDAQGHVKLTDFGLCKESIHEG----TVTHTFC 161
Query: 329 GTYGYMSPEYALRGLFSIKSDVFSFGVLLLETLS 362
GT YM+PE +R D +S G L+ + L+
Sbjct: 162 GTIEYMAPEILMRSGHGKAVDWWSLGALMYDMLT 195
|
Serine/Threonine Kinases (STKs), 70 kDa ribosomal protein S6 kinase (p70S6K) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p70S6K subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p70S6K (or S6K) contains only one catalytic kinase domain, unlike p90 ribosomal S6 kinases (RSKs). It acts as a downstream effector of the STK mTOR (mammalian Target of Rapamycin) and plays a role in the regulation of the translation machinery during protein synthesis. p70S6K also plays a pivotal role in regulating cell size and glucose homeostasis. Its targets include S6, the translation initiation factor eIF3, and the insulin receptor substrate IRS-1, among others. Mammals contain two isoforms of p70S6K, named S6K1 and S6K2 (or S6K-beta). Length = 323 |
| >gnl|CDD|143341 cd07836, STKc_Pho85, Catalytic domain of the Serine/Threonine Kinase, Fungal Cyclin-Dependent protein Kinase Pho85 | Back alignment and domain information |
|---|
Score = 52.5 bits (126), Expect = 1e-07
Identities = 32/94 (34%), Positives = 54/94 (57%), Gaps = 8/94 (8%)
Query: 273 QGLLYLHQYSRLRVIHRDLKASNILLDKDMNPKISDFGMARMFGGDELQSNT-KRIVGTY 331
+G+ + H+ RV+HRDLK N+L++K K++DFG+AR FG + NT V T
Sbjct: 111 KGIAFCHEN---RVLHRDLKPQNLLINKRGELKLADFGLARAFG---IPVNTFSNEVVTL 164
Query: 332 GYMSPEYALRG-LFSIKSDVFSFGVLLLETLSSK 364
Y +P+ L +S D++S G ++ E ++ +
Sbjct: 165 WYRAPDVLLGSRTYSTSIDIWSVGCIMAEMITGR 198
|
Serine/Threonine Kinases (STKs), Pho85 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Pho85 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Pho85 is a multifunctional Cyclin-Dependent protein Kinase (CDK) in yeast. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. Pho85 is regulated by 10 different cyclins (Pcls) and plays a role in G1 progression, cell polarity, phosphate and glycogen metabolism, gene expression, and in signaling changes in the environment. It is not essential for yeast viability and is the functional homolog of mammalian CDK5, which plays a role in central nervous system development. Length = 284 |
| >gnl|CDD|143363 cd07858, STKc_TEY_MAPK_plant, Catalytic domain of the Serine/Threonine Kinases, TEY Mitogen-Activated Protein Kinases from Plants | Back alignment and domain information |
|---|
Score = 53.1 bits (128), Expect = 1e-07
Identities = 35/95 (36%), Positives = 54/95 (56%), Gaps = 6/95 (6%)
Query: 271 IAQGLLYLHQYSRLRVIHRDLKASNILLDKDMNPKISDFGMARMFGGDELQSNTKRIVGT 330
+ +GL Y+H + V+HRDLK SN+LL+ + + KI DFG+AR ++ T+ +V T
Sbjct: 117 LLRGLKYIHSAN---VLHRDLKPSNLLLNANCDLKICDFGLART-TSEKGDFMTEYVV-T 171
Query: 331 YGYMSPEYALR-GLFSIKSDVFSFGVLLLETLSSK 364
Y +PE L ++ DV+S G + E L K
Sbjct: 172 RWYRAPELLLNCSEYTTAIDVWSVGCIFAELLGRK 206
|
Serine/Threonine Kinases (STKs), Plant TEY Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TEY MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. In plants, MAPKs are associated with physiological, developmental, hormonal, and stress responses. Some plants show numerous gene duplications of MAPKs. Arabidopsis thaliana harbors at least 20 MAPKs, named AtMPK1-20. There are two subtypes of plant MAPKs based on the conserved phosphorylation motif present in the activation loop, TEY and TDY. This subfamily represents the TEY subtype and is further subdivided into three groups (A, B, and C). Group A is represented by AtMPK3, AtMPK6, Nicotiana tabacum BTF4 (NtNTF4), among others. They are mostly involved in environmental and hormonal responses. AtMPK3 and AtMPK6 are also key regulators for stomatal development and patterning. Group B is represented by AtMPK4, AtMPK13, and NtNTF6, among others. They may be involved in both cell division and environmental stress response. AtMPK4 also participates in regulating innate immunity. Group C is represented by AtMPK1, AtMPK2, NtNTF3, Oryza sativa MAPK4 (OsMAPK4), among others. They may also be involved in stress responses. AtMPK1 and AtMPK2 are activated following mechanical injury and in the presence of stress chemicals such as jasmonic acid, hydrogen peroxide and abscisic acid. OsMAPK4 is also called OsMSRMK3 for Multiple Stress-Responsive MAPK3. Length = 337 |
| >gnl|CDD|173679 cd05588, STKc_aPKC, Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C | Back alignment and domain information |
|---|
Score = 52.9 bits (127), Expect = 2e-07
Identities = 35/99 (35%), Positives = 57/99 (57%), Gaps = 15/99 (15%)
Query: 271 IAQGLLYLHQYSRLRVIHRDLKASNILLDKDMNPKISDFGMAR--MFGGDELQSNTKRIV 328
I+ L +LH+ +I+RDLK N+LLD + + K++D+GM + + GD T
Sbjct: 105 ISLALNFLHERG---IIYRDLKLDNVLLDAEGHIKLTDYGMCKEGIRPGD----TTSTFC 157
Query: 329 GTYGYMSPEYALRGL---FSIKSDVFSFGVLLLETLSSK 364
GT Y++PE LRG FS+ D ++ GVL+ E ++ +
Sbjct: 158 GTPNYIAPE-ILRGEDYGFSV--DWWALGVLMFEMMAGR 193
|
Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. They contain a C2-like region, instead of a calcium-binding (C2) region found in classical PKCs, in their regulatory domain. There are two aPKC isoforms, zeta and iota. aPKCs are involved in many cellular functions including proliferation, migration, apoptosis, polarity maintenance and cytoskeletal regulation. They also play a critical role in the regulation of glucose metabolism and in the pathogenesis of type 2 diabetes. Length = 329 |
| >gnl|CDD|140289 PTZ00263, PTZ00263, protein kinase A catalytic subunit; Provisional | Back alignment and domain information |
|---|
Score = 52.5 bits (126), Expect = 2e-07
Identities = 29/85 (34%), Positives = 44/85 (51%), Gaps = 8/85 (9%)
Query: 277 YLHQYSRLRVIHRDLKASNILLDKDMNPKISDFGMARMFGGDELQSNTKRIVGTYGYMSP 336
YLH +I+RDLK N+LLD + K++DFG A+ ++ T + GT Y++P
Sbjct: 133 YLHS---KDIIYRDLKPENLLLDNKGHVKVTDFGFAK-----KVPDRTFTLCGTPEYLAP 184
Query: 337 EYALRGLFSIKSDVFSFGVLLLETL 361
E D ++ GVLL E +
Sbjct: 185 EVIQSKGHGKAVDWWTMGVLLYEFI 209
|
Length = 329 |
| >gnl|CDD|140293 PTZ00267, PTZ00267, NIMA-related protein kinase; Provisional | Back alignment and domain information |
|---|
Score = 53.1 bits (127), Expect = 2e-07
Identities = 30/90 (33%), Positives = 49/90 (54%)
Query: 273 QGLLYLHQYSRLRVIHRDLKASNILLDKDMNPKISDFGMARMFGGDELQSNTKRIVGTYG 332
Q +L L + +++HRDLK++NI L K+ DFG ++ + GT
Sbjct: 177 QIVLALDEVHSRKMMHRDLKSANIFLMPTGIIKLGDFGFSKQYSDSVSLDVASSFCGTPY 236
Query: 333 YMSPEYALRGLFSIKSDVFSFGVLLLETLS 362
Y++PE R +S K+D++S GV+L E L+
Sbjct: 237 YLAPELWERKRYSKKADMWSLGVILYELLT 266
|
Length = 478 |
| >gnl|CDD|143344 cd07839, STKc_CDK5, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 5 | Back alignment and domain information |
|---|
Score = 52.1 bits (125), Expect = 2e-07
Identities = 30/88 (34%), Positives = 50/88 (56%), Gaps = 6/88 (6%)
Query: 273 QGLLYLHQYSRLRVIHRDLKASNILLDKDMNPKISDFGMARMFGGDELQSNTKRIVGTYG 332
+GL + H + V+HRDLK N+L++K+ K++DFG+AR F G ++ + +V T
Sbjct: 110 KGLAFCHSH---NVLHRDLKPQNLLINKNGELKLADFGLARAF-GIPVRCYSAEVV-TLW 164
Query: 333 YMSPEYALRG-LFSIKSDVFSFGVLLLE 359
Y P+ L+S D++S G + E
Sbjct: 165 YRPPDVLFGAKLYSTSIDMWSAGCIFAE 192
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 5 (CDK5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK5 is unusual in that it is regulated by non-cyclin proteins, p35 and p39. It is highly expressed in the nervous system and is critical in normal neural development and function. It plays a role in neuronal migration and differentiation, and is also important in synaptic plasticity and learning. CDK5 also participates in protecting against cell death and promoting angiogenesis. Impaired CDK5 activity is implicated in Alzheimer's disease, amyotrophic lateral sclerosis, Parkinson's disease, Huntington's disease and acute neuronal injury. Length = 284 |
| >gnl|CDD|173616 PTZ00426, PTZ00426, cAMP-dependent protein kinase catalytic subunit; Provisional | Back alignment and domain information |
|---|
Score = 52.3 bits (125), Expect = 2e-07
Identities = 30/90 (33%), Positives = 49/90 (54%), Gaps = 5/90 (5%)
Query: 272 AQGLLYLHQYSRLRVIHRDLKASNILLDKDMNPKISDFGMARMFGGDELQSNTKRIVGTY 331
AQ +L L +++RDLK N+LLDKD K++DFG A++ + + T + GT
Sbjct: 138 AQIVLIFEYLQSLNIVYRDLKPENLLLDKDGFIKMTDFGFAKV-----VDTRTYTLCGTP 192
Query: 332 GYMSPEYALRGLFSIKSDVFSFGVLLLETL 361
Y++PE L +D ++ G+ + E L
Sbjct: 193 EYIAPEILLNVGHGKAADWWTLGIFIYEIL 222
|
Length = 340 |
| >gnl|CDD|173713 cd05624, STKc_MRCK_beta, Catalytic domain of the Protein Serine/Threonine Kinase, DMPK-related cell division control protein 42 binding kinase beta | Back alignment and domain information |
|---|
Score = 52.3 bits (125), Expect = 2e-07
Identities = 37/106 (34%), Positives = 59/106 (55%), Gaps = 10/106 (9%)
Query: 271 IAQGLLYLHQYSRLRVIHRDLKASNILLDKDMNPKISDFGMA-RMFGGDELQSNTKRIVG 329
IA+ +L +H +L +HRD+K N+LLD + + +++DFG +M +QS+ VG
Sbjct: 108 IAEMVLAIHSIHQLHYVHRDIKPDNVLLDMNGHIRLADFGSCLKMNQDGTVQSSVA--VG 165
Query: 330 TYGYMSPEY--ALR---GLFSIKSDVFSFGVLLLETLSSKKNTHFY 370
T Y+SPE A+ G + + D +S GV + E L + T FY
Sbjct: 166 TPDYISPEILQAMEDGMGKYGPECDWWSLGVCMYEMLYGE--TPFY 209
|
Serine/Threonine Kinases (STKs), DMPK-like subfamily, DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK) beta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKbeta is expressed ubiquitously in many tissues. Length = 331 |
| >gnl|CDD|88519 cd05618, STKc_aPKC_iota, Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C iota | Back alignment and domain information |
|---|
Score = 52.0 bits (124), Expect = 3e-07
Identities = 33/95 (34%), Positives = 53/95 (55%), Gaps = 7/95 (7%)
Query: 271 IAQGLLYLHQYSRLRVIHRDLKASNILLDKDMNPKISDFGMARMFGGDELQSNTKRIVGT 330
I+ L YLH+ +I+RDLK N+LLD + + K++D+GM + G T GT
Sbjct: 105 ISLALNYLHERG---IIYRDLKLDNVLLDSEGHIKLTDYGMCKE--GLRPGDTTSTFCGT 159
Query: 331 YGYMSPEYALRGL-FSIKSDVFSFGVLLLETLSSK 364
Y++PE LRG + D ++ GVL+ E ++ +
Sbjct: 160 PNYIAPE-ILRGEDYGFSVDWWALGVLMFEMMAGR 193
|
Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, iota isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. There are two aPKC isoforms, zeta and iota. PKC-iota is directly implicated in carcinogenesis. It is critical to oncogenic signaling mediated by Ras and Bcr-Abl. The PKC-iota gene is the target of tumor-specific gene amplification in many human cancers, and has been identified as a human oncogene. In addition to its role in transformed growth, PKC-iota also promotes invasion, chemoresistance, and tumor cell survival. Expression profiling of PKC-iota is a prognostic marker of poor clinical outcome in several human cancers. PKC-iota also plays a role in establishing cell polarity, and has critical embryonic functions. Length = 329 |
| >gnl|CDD|173666 cd05575, STKc_SGK, Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase | Back alignment and domain information |
|---|
Score = 51.7 bits (124), Expect = 3e-07
Identities = 33/92 (35%), Positives = 46/92 (50%), Gaps = 5/92 (5%)
Query: 271 IAQGLLYLHQYSRLRVIHRDLKASNILLDKDMNPKISDFGMARMFGGDELQSNTKRIVGT 330
IA L YLH L +I+RDLK NILLD + ++DFG+ + G E T GT
Sbjct: 105 IASALGYLHS---LNIIYRDLKPENILLDSQGHVVLTDFGLCKE--GIEHSKTTSTFCGT 159
Query: 331 YGYMSPEYALRGLFSIKSDVFSFGVLLLETLS 362
Y++PE + + D + G +L E L
Sbjct: 160 PEYLAPEVLRKQPYDRTVDWWCLGAVLYEMLY 191
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3 (also called cytokine-independent survival kinase CISK). SGKs are activated by insulin and growth factors via phosphoinositide 3-kinase and PDK1. They activate ion channels, ion carriers, and the Na-K-ATPase, as well as regulate the activity of enzymes and transcription factors. SGKs play important roles in transport, hormone release, neuroexcitability, cell proliferation, and apoptosis. Length = 323 |
| >gnl|CDD|173708 cd05617, STKc_aPKC_zeta, Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C zeta | Back alignment and domain information |
|---|
Score = 51.6 bits (123), Expect = 4e-07
Identities = 33/95 (34%), Positives = 52/95 (54%), Gaps = 7/95 (7%)
Query: 271 IAQGLLYLHQYSRLRVIHRDLKASNILLDKDMNPKISDFGMARMFGGDELQSNTKRIVGT 330
I L +LH+ +I+RDLK N+LLD D + K++D+GM + G T GT
Sbjct: 105 ICIALNFLHERG---IIYRDLKLDNVLLDADGHIKLTDYGMCKE--GLGPGDTTSTFCGT 159
Query: 331 YGYMSPEYALRGL-FSIKSDVFSFGVLLLETLSSK 364
Y++PE LRG + D ++ GVL+ E ++ +
Sbjct: 160 PNYIAPE-ILRGEEYGFSVDWWALGVLMFEMMAGR 193
|
Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, zeta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. There are two aPKC isoforms, zeta and iota. PKC-zeta plays a critical role in activating the glucose transport response. It is activated by glucose, insulin, and exercise through diverse pathways. PKC-zeta also plays a central role in maintaining cell polarity in yeast and mammalian cells. In addition, it affects actin remodeling in muscle cells. Length = 327 |
| >gnl|CDD|165473 PHA03207, PHA03207, serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Score = 51.8 bits (124), Expect = 4e-07
Identities = 34/103 (33%), Positives = 47/103 (45%), Gaps = 4/103 (3%)
Query: 267 IIEGIAQGLLYLHQYSRLRVIHRDLKASNILLDKDMNPKISDFGMARMFGGDELQSNTKR 326
I + + L YLH +IHRD+K NI LD+ N + DFG A
Sbjct: 190 IQRRLLEALAYLHGRG---IIHRDVKTENIFLDEPENAVLGDFGAACKLDAHPDTPQCYG 246
Query: 327 IVGTYGYMSPEYALRGLFSIKSDVFSFGVLLLETLSSKKNTHF 369
GT SPE + K+D++S G++L E +S K T F
Sbjct: 247 WSGTLETNSPELLALDPYCAKTDIWSAGLVLFE-MSVKNVTLF 288
|
Length = 392 |
| >gnl|CDD|143383 cd07878, STKc_p38beta_MAPK11, Catalytic domain of the Serine/Threonine Kinase, p38beta Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Score = 51.6 bits (123), Expect = 4e-07
Identities = 34/99 (34%), Positives = 54/99 (54%), Gaps = 9/99 (9%)
Query: 267 IIEGIAQGLLYLHQYSRLRVIHRDLKASNILLDKDMNPKISDFGMARMFGGDELQSNTKR 326
+I + +GL Y+H +IHRDLK SN+ +++D +I DFG+AR DE+
Sbjct: 123 LIYQLLRGLKYIHSAG---IIHRDLKPSNVAVNEDCELRILDFGLARQ-ADDEMTG---- 174
Query: 327 IVGTYGYMSPEYALRGL-FSIKSDVFSFGVLLLETLSSK 364
V T Y +PE L + ++ D++S G ++ E L K
Sbjct: 175 YVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLKGK 213
|
Serine/Threonine Kinases (STKs), p38beta subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38beta subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38beta, also called MAPK11, is widely expressed in tissues and shows more similarity with p38alpha than with the other isoforms. Both are sensitive to pyridinylimidazoles and share some common substrates such as MAPK activated protein kinase 2 (MK2) and the transcription factors ATF2, c-Fos and, ELK-1. p38beta is involved in regulating the activation of the cyclooxygenase-2 promoter and the expression of TGFbeta-induced alpha-smooth muscle cell actin. Length = 343 |
| >gnl|CDD|173744 cd07847, STKc_CDKL1_4, Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase Like 1 and 4 | Back alignment and domain information |
|---|
Score = 50.8 bits (122), Expect = 5e-07
Identities = 26/74 (35%), Positives = 38/74 (51%), Gaps = 9/74 (12%)
Query: 266 RIIEGIAQGLLYLHQYSRLRVIHRDLKASNILLDKDMNPKISDFGMARMF--GGDELQSN 323
+II Q + + H+++ IHRD+K NIL+ K K+ DFG AR+ GD+
Sbjct: 104 KIIWQTLQAVNFCHKHN---CIHRDVKPENILITKQGQIKLCDFGFARILTGPGDDYTD- 159
Query: 324 TKRIVGTYGYMSPE 337
V T Y +PE
Sbjct: 160 ---YVATRWYRAPE 170
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 1 (CDKL1) and CDKL4 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL1 and CDKL4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKL1, also called p42 KKIALRE, is a glial protein that is upregulated in gliosis. It is present in neuroblastoma and A431 human carcinoma cells, and may be implicated in neoplastic transformation. The function of CDKL4 is unknown. Length = 286 |
| >gnl|CDD|173677 cd05586, STKc_Sck1_like, Catalytic domain of Suppressor of loss of cAMP-dependent protein kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 51.1 bits (122), Expect = 5e-07
Identities = 32/91 (35%), Positives = 51/91 (56%), Gaps = 5/91 (5%)
Query: 271 IAQGLLYLHQYSRLRVIHRDLKASNILLDKDMNPKISDFGMARMFGGDELQSNTKRIVGT 330
IA+ +L L + +++RDLK NILLD + + DFG+++ D +NT GT
Sbjct: 102 IAELVLALEHLHKYDIVYRDLKPENILLDATGHIALCDFGLSKANLTDNKTTNT--FCGT 159
Query: 331 YGYMSPEYAL--RGLFSIKSDVFSFGVLLLE 359
Y++PE L +G ++ D +S GVL+ E
Sbjct: 160 TEYLAPEVLLDEKG-YTKHVDFWSLGVLVFE 189
|
Serine/Threonine Kinases (STKs), Fission yeast Suppressor of loss of cAMP-dependent protein kinase (Sck1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sck1-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of fungal proteins with similarity to the Schizosaccharomyces pombe STK Sck1. Sck1 plays a role in trehalase activation triggered by glucose and a nitrogen source. Trehalase catalyzes the cleavage of the disaccharide trehalose to glucose. Trehalose, as a carbohydrate reserve and stress metabolite, plays an important role in the response of yeast to environmental changes. Length = 330 |
| >gnl|CDD|132969 cd06638, STKc_myosinIIIA, Catalytic domain of the Protein Serine/Threonine Kinase, Class IIIA myosin | Back alignment and domain information |
|---|
Score = 50.8 bits (121), Expect = 5e-07
Identities = 38/115 (33%), Positives = 56/115 (48%), Gaps = 16/115 (13%)
Query: 256 KGLLCWGTRVR------IIEGIAQGLLYLHQYSRLRVIHRDLKASNILLDKDMNPKISDF 309
KG L G R+ I+ GL +LH + IHRD+K +NILL + K+ DF
Sbjct: 112 KGFLKRGERMEEPIIAYILHEALMGLQHLHVN---KTIHRDVKGNNILLTTEGGVKLVDF 168
Query: 310 GMARMFGGDELQSNTKRIVGTYGYMSPEY-----ALRGLFSIKSDVFSFGVLLLE 359
G++ L+ NT VGT +M+PE L + + DV+S G+ +E
Sbjct: 169 GVSAQLTSTRLRRNTS--VGTPFWMAPEVIACEQQLDSTYDARCDVWSLGITAIE 221
|
Serine/threonine kinases (STKs), class IIIA myosin subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain. Class III myosins may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. In photoreceptor cells, they may also function as cargo carriers during light-dependent translocation of proteins such as transducin and arrestin. Class IIIA myosin is highly expressed in retina and in inner ear hair cells. It is localized to the distal ends of actin-bundled structures. Mutations in human myosin IIIA are responsible for progressive nonsyndromic hearing loss. Human myosin IIIA possesses ATPase and kinase activities, and the ability to move actin filaments in a motility assay. It may function as a cellular transporter capable of moving along actin bundles in sensory cells. Length = 286 |
| >gnl|CDD|173700 cd05609, STKc_MAST, Catalytic domain of the Protein Serine/Threonine Kinase, Microtubule-associated serine/threonine kinase | Back alignment and domain information |
|---|
Score = 50.6 bits (121), Expect = 7e-07
Identities = 31/100 (31%), Positives = 53/100 (53%), Gaps = 16/100 (16%)
Query: 275 LLYLHQYSRLRVIHRDLKASNILLDKDMNPKISDFGMARM---------FGG----DELQ 321
L YLH Y ++HRDLK N+L+ + K++DFG++++ + G D +
Sbjct: 114 LEYLHNYG---IVHRDLKPDNLLITSMGHIKLTDFGLSKIGLMSLTTNLYEGHIEKDTRE 170
Query: 322 SNTKRIVGTYGYMSPEYALRGLFSIKSDVFSFGVLLLETL 361
K++ GT Y++PE LR + D ++ G++L E L
Sbjct: 171 FLDKQVCGTPEYIAPEVILRQGYGKPVDWWAMGIILYEFL 210
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, MAST, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. There are four mammalian MAST kinases, named MAST1-MAST4. MAST1 is also referred to as syntrophin-associated STK (SAST), while MAST2 is also called MAST205. MAST kinases are cytoskeletal associated kinases of unknown function that are also expressed at neuromuscular junctions and postsynaptic densities. MAST1, MAST2, and MAST3 bind and phosphorylate the tumor suppressor PTEN, and may contribute to the regulation and stabilization of PTEN. MAST2 is involved in the regulation of the Fc-gamma receptor of the innate immune response in macrophages, and may also be involved in the regulation of the Na+/H+ exchanger NHE3. Length = 305 |
| >gnl|CDD|132977 cd06646, STKc_MAP4K5, Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-activated protein kinase kinase kinase kinase 5 | Back alignment and domain information |
|---|
Score = 50.0 bits (119), Expect = 8e-07
Identities = 30/90 (33%), Positives = 50/90 (55%), Gaps = 8/90 (8%)
Query: 273 QGLLYLHQYSRLRVIHRDLKASNILLDKDMNPKISDFGMARMFGGDELQSNTKRIVGTYG 332
QGL YLH ++ HRD+K +NILL + + K++DFG+A + K +GT
Sbjct: 117 QGLAYLHSKGKM---HRDIKGANILLTDNGDVKLADFGVAAKITAT--IAKRKSFIGTPY 171
Query: 333 YMSPEYAL---RGLFSIKSDVFSFGVLLLE 359
+M+PE A G ++ D+++ G+ +E
Sbjct: 172 WMAPEVAAVEKNGGYNQLCDIWAVGITAIE 201
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 5 (MAPKKKK5 or MAP4K5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAP4K5, also called germinal center kinase-related enzyme (GCKR), has been shown to activate the MAPK c-Jun N-terminal kinase (JNK). MAP4K5 also facilitates Wnt signaling in B cells, and may therefore be implicated in the control of cell fate, proliferation, and polarity. Length = 267 |
| >gnl|CDD|173687 cd05596, STKc_ROCK, Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase | Back alignment and domain information |
|---|
Score = 50.9 bits (122), Expect = 8e-07
Identities = 40/110 (36%), Positives = 57/110 (51%), Gaps = 10/110 (9%)
Query: 271 IAQGLLYLHQYSRLRVIHRDLKASNILLDKDMNPKISDFGMA-RMFGGDELQSNTKRIVG 329
A+ +L L + IHRD+K N+LLDK + K++DFG +M ++ +T VG
Sbjct: 148 TAEVVLALDAIHSMGFIHRDVKPDNMLLDKSGHLKLADFGTCMKMDANGMVRCDTA--VG 205
Query: 330 TYGYMSPEYALR----GLFSIKSDVFSFGVLLLETLSSKKNTHFYNTDSL 375
T Y+SPE G + + D +S GV L E L +T FY DSL
Sbjct: 206 TPDYISPEVLKSQGGDGYYGRECDWWSVGVFLYEMLVG--DTPFY-ADSL 252
|
Serine/Threonine Kinases (STKs), Rho-associated coiled-coil containing protein kinase (ROCK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK is also referred to as Rho-associated kinase or simply as Rho kinase. It contains an N-terminal extension, a catalytic kinase domain, and a long C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain. It is activated via interaction with Rho GTPases and is involved in many cellular functions including contraction, adhesion, migration, motility, proliferation, and apoptosis. The ROCK subfamily consists of two isoforms, ROCK1 and ROCK2, which may be functionally redundant in some systems, but exhibit different tissue distributions. Both isoforms are ubiquitously expressed in most tissues, but ROCK2 is more prominent in brain and skeletal muscle while ROCK1 is more pronounced in the liver, testes, and kidney. Studies in knockout mice result in different phenotypes, suggesting that the two isoforms do not compensate for each other during embryonic development. Length = 370 |
| >gnl|CDD|143385 cd07880, STKc_p38gamma_MAPK12, Catalytic domain of the Serine/Threonine Kinase, p38gamma Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Score = 50.3 bits (120), Expect = 9e-07
Identities = 36/109 (33%), Positives = 55/109 (50%), Gaps = 11/109 (10%)
Query: 271 IAQGLLYLHQYSRLRVIHRDLKASNILLDKDMNPKISDFGMARMFGGDELQSNTKRIVGT 330
+ +GL Y+H +IHRDLK N+ +++D KI DFG+AR + S V T
Sbjct: 127 MLKGLKYIHAAG---IIHRDLKPGNLAVNEDCELKILDFGLAR-----QTDSEMTGYVVT 178
Query: 331 YGYMSPEYALRGL-FSIKSDVFSFGVLLLETLSSKKNTHFYNTDSLTLL 378
Y +PE L + ++ D++S G ++ E L+ K F D L L
Sbjct: 179 RWYRAPEVILNWMHYTQTVDIWSVGCIMAEMLTGK--PLFKGHDHLDQL 225
|
Serine/Threonine Kinases (STKs), p38gamma subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38gamma subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38gamma, also called MAPK12, is predominantly expressed in skeletal muscle. Unlike p38alpha and p38beta, p38gamma is insensitive to pyridinylimidazoles. It displays an antagonizing function compared to p38alpha. p38gamma inhibits, while p38alpha stimulates, c-Jun phosphorylation and AP-1 mediated transcription. p38gamma also plays a role in the signaling between Ras and the estrogen receptor and has been implicated to increase cell invasion and breast cancer progression. In Xenopus, p38gamma is critical in the meiotic maturation of oocytes. Length = 343 |
| >gnl|CDD|143373 cd07868, STKc_CDK8, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 8 | Back alignment and domain information |
|---|
Score = 50.1 bits (119), Expect = 1e-06
Identities = 48/185 (25%), Positives = 86/185 (46%), Gaps = 24/185 (12%)
Query: 265 VRIIEGIAQGLLY-----LHQYSRLRVIHRDLKASNILL----DKDMNPKISDFGMARMF 315
V++ G+ + LLY +H V+HRDLK +NIL+ + KI+D G AR+F
Sbjct: 103 VQLPRGMVKSLLYQILDGIHYLHANWVLHRDLKPANILVMGEGPERGRVKIADMGFARLF 162
Query: 316 GGD-ELQSNTKRIVGTYGYMSPEYALRGLFSIKS-DVFSFGVLLLETLSSK--------- 364
+ ++ +V T+ Y +PE L K+ D+++ G + E L+S+
Sbjct: 163 NSPLKPLADLDPVVVTFWYRAPELLLGARHYTKAIDIWAIGCIFAELLTSEPIFHCRQED 222
Query: 365 -KNTHFYNTDSLTLLGHAWNLWNDGRTWELMDPISQNGASYPILKR--YINVALLCVQEK 421
K ++ Y+ D L + + D + WE + + ++ +R Y N +L+ EK
Sbjct: 223 IKTSNPYHHDQLDRIFNVMGFPAD-KDWEDIKKMPEHSTLMKDFRRNTYTNCSLIKYMEK 281
Query: 422 AADRP 426
+P
Sbjct: 282 HKVKP 286
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 8 (CDK8) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK8 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK8 can act as a negative or positive regulator of transcription, depending on the scenario. Together with its regulator, cyclin C, it reversibly associates with the multi-subunit core Mediator complex, a cofactor that is involved in regulating RNA polymerase II (RNAP II)-dependent transcription. CDK8 phosphorylates cyclin H, a subunit of the general transcription factor TFIIH, which results in the inhibition of TFIIH-dependent phosphorylation of the C-terminal domain (CTD) of RNAP II, facilitating the inhibition of transcription. It has also been shown to promote transcription by a mechanism that is likely to involve RNAP II phosphorylation. CDK8 also functions as a stimulus-specific positive coregulator of p53 transcriptional responses. Length = 317 |
| >gnl|CDD|215061 PLN00113, PLN00113, leucine-rich repeat receptor-like protein kinase; Provisional | Back alignment and domain information |
|---|
Score = 51.0 bits (122), Expect = 1e-06
Identities = 43/181 (23%), Positives = 76/181 (41%), Gaps = 13/181 (7%)
Query: 259 LCWGTRVRIIEGIAQGLLYLHQYSRLRVIHRDLKASNILLDKDMNPKISDFGMARMFGGD 318
L W R +I GIA+ L +LH V+ +L I++D P + + + D
Sbjct: 777 LSWERRRKIAIGIAKALRFLHCRCSPAVVVGNLSPEKIIIDGKDEPHLR-LSLPGLLCTD 835
Query: 319 ELQSNTKRIVGTYGYMSPEYALRGLFSIKSDVFSFGVLLLETLSSKKNTHFYNTDSLTLL 378
I + Y++PE + KSD++ FG++L+E L+ K +++
Sbjct: 836 ----TKCFI--SSAYVAPETRETKDITEKSDIYGFGLILIELLTGKSPADAEFGVHGSIV 889
Query: 379 GHAWNLWNDGRTWELMDPISQNGASYPILKRYI----NVALLCVQEKAADRPAMSEVVSM 434
A ++D +DP + S + + I N+AL C RP ++V+
Sbjct: 890 EWARYCYSDCHLDMWIDPSIRGDVS--VNQNEIVEVMNLALHCTATDPTARPCANDVLKT 947
Query: 435 L 435
L
Sbjct: 948 L 948
|
Length = 968 |
| >gnl|CDD|132976 cd06645, STKc_MAP4K3, Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-activated protein kinase kinase kinase kinase 3 | Back alignment and domain information |
|---|
Score = 49.7 bits (118), Expect = 1e-06
Identities = 29/90 (32%), Positives = 51/90 (56%), Gaps = 8/90 (8%)
Query: 273 QGLLYLHQYSRLRVIHRDLKASNILLDKDMNPKISDFGMARMFGGDELQSNTKRIVGTYG 332
QGL YLH + +HRD+K +NILL + + K++DFG++ + K +GT
Sbjct: 117 QGLYYLHSKGK---MHRDIKGANILLTDNGHVKLADFGVSAQITAT--IAKRKSFIGTPY 171
Query: 333 YMSPEYAL---RGLFSIKSDVFSFGVLLLE 359
+M+PE A +G ++ D+++ G+ +E
Sbjct: 172 WMAPEVAAVERKGGYNQLCDIWAVGITAIE 201
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 3 (MAPKKKK3 or MAP4K3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAP4K3 plays a role in the nutrient-responsive pathway of mTOR (mammalian target of rapamycin) signaling. MAP4K3 is required in the activation of S6 kinase by amino acids and for the phosphorylation of the mTOR-regulated inhibitor of eukaryotic initiation factor 4E. mTOR regulates ribosome biogenesis and protein translation, and is frequently deregulated in cancer. Length = 267 |
| >gnl|CDD|173694 cd05603, STKc_SGK2, Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 2 | Back alignment and domain information |
|---|
Score = 50.0 bits (119), Expect = 1e-06
Identities = 34/103 (33%), Positives = 51/103 (49%), Gaps = 7/103 (6%)
Query: 271 IAQGLLYLHQYSRLRVIHRDLKASNILLDKDMNPKISDFGMARMFGGDELQSNTKRIVGT 330
+A + YLH L +I+RDLK NILLD + ++DFG+ + G E + T GT
Sbjct: 105 VASAIGYLHS---LNIIYRDLKPENILLDSQGHVVLTDFGLCKE--GVEPEETTSTFCGT 159
Query: 331 YGYMSPEYALRGLFSIKSDVFSFGVLLLETLSSKKNTHFYNTD 373
Y++PE + + D + G +L E L FY+ D
Sbjct: 160 PEYLAPEVLRKEPYDRTVDWWCLGAVLYEMLYGLPP--FYSRD 200
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3. SGK2 shows a more restricted distribution that SGK1 and is most abundantly expressed in epithelial tissues including kidney, liver, pancreas, and the choroid plexus of the brain. In vitro cellular assays show that SGK2 can stimulate the activity of ion channels, the glutamate transporter EEAT4, and the glutamate receptors, GluR6 and GLUR1. Length = 321 |
| >gnl|CDD|143364 cd07859, STKc_TDY_MAPK_plant, Catalytic domain of the Serine/Threonine Kinases, TDY Mitogen-Activated Protein Kinases from Plants | Back alignment and domain information |
|---|
Score = 49.8 bits (119), Expect = 1e-06
Identities = 36/97 (37%), Positives = 46/97 (47%), Gaps = 10/97 (10%)
Query: 273 QGLLYLHQYSRLRVIHRDLKASNILLDKDMNPKISDFGMAR-MFGGDELQSNTKRIVGTY 331
+ L Y+H + V HRDLK NIL + D KI DFG+AR F V T
Sbjct: 114 RALKYIHTAN---VFHRDLKPKNILANADCKLKICDFGLARVAFNDTPTAIFWTDYVATR 170
Query: 332 GYMSPEYALRGLFSIKS----DVFSFGVLLLETLSSK 364
Y +PE L G F K D++S G + E L+ K
Sbjct: 171 WYRAPE--LCGSFFSKYTPAIDIWSIGCIFAEVLTGK 205
|
Serine/Threonine Kinases (STKs), Plant TDY Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TDY MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. In plants, MAPKs are associated with physiological, developmental, hormonal, and stress responses. Some plants show numerous gene duplications of MAPKs. Arabidopsis thaliana harbors at least 20 MAPKs, named AtMPK1-20. Oryza sativa contains at least 17 MAPKs. There are two subtypes of plant MAPKs based on the conserved phosphorylation motif present in the activation loop, TEY and TDY. Arabidopsis thaliana contains more TEY-type MAPKs than TDY-type, whereas the reverse is true for Oryza sativa. This subfamily represents the TDY subtype and is composed of Group D plant MAPKs including Arabidopsis thaliana MPK18 (AtMPK18), Oryza sativa Blast- and Wound-induced MAPK1 (OsBWMK1), OsWJUMK1 (Wound- and JA-Uninducible MAPK1), Zea mays MPK6, and the Medicago sativa TDY1 gene product. OsBWMK1 enhances resistance to pathogenic infections. It mediates stress-activated defense responses by activating a transcription factor that affects the expression of stress-related genes. AtMPK18 is involved in microtubule-related functions. Length = 338 |
| >gnl|CDD|132967 cd06636, STKc_MAP4K4_6, Catalytic domain of the Protein Serine/Threonine Kinases, Mitogen-Activated Protein Kinase Kinase Kinase Kinase 4 and 6 | Back alignment and domain information |
|---|
Score = 49.2 bits (117), Expect = 2e-06
Identities = 31/98 (31%), Positives = 52/98 (53%), Gaps = 10/98 (10%)
Query: 267 IIEGIAQGLLYLHQYSRLRVIHRDLKASNILLDKDMNPKISDFGMARMFGGDELQSNTKR 326
I I +GL +LH + +VIHRD+K N+LL ++ K+ DFG++ + NT
Sbjct: 126 ICREILRGLAHLHAH---KVIHRDIKGQNVLLTENAEVKLVDFGVSAQLDRTVGRRNT-- 180
Query: 327 IVGTYGYMSPEYAL-----RGLFSIKSDVFSFGVLLLE 359
+GT +M+PE + +SD++S G+ +E
Sbjct: 181 FIGTPYWMAPEVIACDENPDATYDYRSDIWSLGITAIE 218
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 4 (MAPKKKK4 or MAP4K4) and MAPKKKK6 (or MAP4K6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K4/MAP4K6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain. MAP4Ks (or MAPKKKKs) are involved in MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAP4K4 is also called Nck Interacting kinase (NIK). It facilitates the activation of the MAPKs, extracellular signal-regulated kinase (ERK) 1, ERK2, and c-Jun N-terminal kinase (JNK), by phosphorylating and activating MEKK1. MAP4K4 plays a role in tumor necrosis factor (TNF) alpha-induced insulin resistance. MAP4K4 silencing in skeletal muscle cells from type II diabetic patients restores insulin-mediated glucose uptake. MAP4K4, through JNK, also plays a broad role in cell motility, which impacts inflammation, homeostasis, as well as the invasion and spread of cancer. MAP4K4 is found to be highly expressed in most tumor cell lines relative to normal tissue. MAP4K6 (also called MINK for Misshapen/NIKs-related kinase) is activated after Ras induction and mediates activation of p38 MAPK. MAP4K6 plays a role in cell cycle arrest, cytoskeleton organization, cell adhesion, and cell motility. Length = 282 |
| >gnl|CDD|143379 cd07874, STKc_JNK3, Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 3 | Back alignment and domain information |
|---|
Score = 49.3 bits (117), Expect = 2e-06
Identities = 33/91 (36%), Positives = 48/91 (52%), Gaps = 6/91 (6%)
Query: 274 GLLYLHQYSRLRVIHRDLKASNILLDKDMNPKISDFGMARMFGGDELQSNTKRIVGTYGY 333
G+ +LH +IHRDLK SNI++ D KI DFG+AR G + T +V Y Y
Sbjct: 131 GIKHLHSAG---IIHRDLKPSNIVVKSDCTLKILDFGLARTAGTSFMM--TPYVVTRY-Y 184
Query: 334 MSPEYALRGLFSIKSDVFSFGVLLLETLSSK 364
+PE L + D++S G ++ E + K
Sbjct: 185 RAPEVILGMGYKENVDIWSVGCIMGEMVRHK 215
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 3 (JNK3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK3 is expressed primarily in the brain, and to a lesser extent in the heart and testis. Mice deficient in Jnk3 are protected against kainic acid-induced seizures, stroke, sciatic axotomy neural death, and neuronal death due to NGF deprivation, oxidative stress, or exposure to beta-amyloid peptide. This suggests that JNK3 may play roles in the pathogenesis of these diseases. Length = 355 |
| >gnl|CDD|143380 cd07875, STKc_JNK1, Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 1 | Back alignment and domain information |
|---|
Score = 49.3 bits (117), Expect = 2e-06
Identities = 32/91 (35%), Positives = 47/91 (51%), Gaps = 6/91 (6%)
Query: 274 GLLYLHQYSRLRVIHRDLKASNILLDKDMNPKISDFGMARMFGGDELQSNTKRIVGTYGY 333
G+ +LH +IHRDLK SNI++ D KI DFG+AR G + T +V Y Y
Sbjct: 138 GIKHLHSAG---IIHRDLKPSNIVVKSDCTLKILDFGLARTAGTSFMM--TPYVVTRY-Y 191
Query: 334 MSPEYALRGLFSIKSDVFSFGVLLLETLSSK 364
+PE L + D++S G ++ E +
Sbjct: 192 RAPEVILGMGYKENVDIWSVGCIMGEMIKGG 222
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 1 (JNK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK1, like JNK2, is expressed in every cell and tissue type. Initially it was thought that JNK1 and JNK2 were functionally redundant as mice deficient in either genes (Jnk1 or Jnk2) could survive but disruption of both genes resulted in lethality. However, recent studies have shown that JNK1 and JNK2 perform distinct functions through specific binding partners and substrates. JNK1 specifically binds with JAMP (JNK1-associated membrane protein), which regulates the duration of JNK1 activity in response to stimuli. Specific JNK1 substrates include Itch and SG10, which are implicated in Th2 responses and airway inflammation, and microtubule dynamics and axodendritic length, respectively. Mice deficient in Jnk1 are protected against arthritis, obesity, type 2 diabetes, cardiac cell death, and non-alcoholic liver disease, suggesting that JNK1 may play roles in the pathogenesis of these diseases. Length = 364 |
| >gnl|CDD|143338 cd07833, STKc_CDKL, Catalytic domain of Cyclin-Dependent protein Kinase Like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 48.9 bits (117), Expect = 2e-06
Identities = 24/72 (33%), Positives = 32/72 (44%), Gaps = 4/72 (5%)
Query: 266 RIIEGIAQGLLYLHQYSRLRVIHRDLKASNILLDKDMNPKISDFGMARMFGGDELQSNTK 325
I + Q + Y H +IHRD+K NIL+ + K+ DFG AR S
Sbjct: 104 SYIWQLLQAIAYCH---SHNIIHRDIKPENILVSESGVLKLCDFGFARALRARP-ASPLT 159
Query: 326 RIVGTYGYMSPE 337
V T Y +PE
Sbjct: 160 DYVATRWYRAPE 171
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like (CDKL) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDKL1-5 and similar proteins. Some CDKLs, like CDKL1 and CDKL3, may be implicated in transformation and others, like CDKL3 and CDKL5, are associated with mental retardation when impaired. CDKL2 plays a role in learning and memory. Length = 288 |
| >gnl|CDD|165476 PHA03210, PHA03210, serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Score = 49.7 bits (118), Expect = 2e-06
Identities = 34/104 (32%), Positives = 53/104 (50%), Gaps = 5/104 (4%)
Query: 259 LCWGTRVRIIEGIAQGLLYLHQYSRLRVIHRDLKASNILLDKDMNPKISDFGMARMFGGD 318
L TR I++ + + Y+H ++IHRD+K NI L+ D + DFG A F
Sbjct: 265 LLKQTR-AIMKQLLCAVEYIHDK---KLIHRDIKLENIFLNCDGKIVLGDFGTAMPF-EK 319
Query: 319 ELQSNTKRIVGTYGYMSPEYALRGLFSIKSDVFSFGVLLLETLS 362
E ++ VGT SPE + +D++S G++LL+ LS
Sbjct: 320 EREAFDYGWVGTVATNSPEILAGDGYCEITDIWSCGLILLDMLS 363
|
Length = 501 |
| >gnl|CDD|173692 cd05601, STKc_CRIK, Catalytic domain of the Protein Serine/Threonine Kinase, Citron Rho-interacting kinase | Back alignment and domain information |
|---|
Score = 48.7 bits (116), Expect = 3e-06
Identities = 29/97 (29%), Positives = 55/97 (56%), Gaps = 7/97 (7%)
Query: 271 IAQGLLYLHQYSRLRVIHRDLKASNILLDKDMNPKISDFGMARMFGGDELQSNTKRIVGT 330
+A+ +L +H ++ +HRD+K N+L+D+ + K++DFG A ++ N+K VGT
Sbjct: 108 LAELVLAIHSVHQMGYVHRDIKPENVLIDRTGHIKLADFGSAARLTANK-MVNSKLPVGT 166
Query: 331 YGYMSPEY------ALRGLFSIKSDVFSFGVLLLETL 361
Y++PE +G + ++ D +S GV+ E +
Sbjct: 167 PDYIAPEVLTTMNGDGKGTYGVECDWWSLGVIAYEMI 203
|
Serine/Threonine Kinases (STKs), Citron Rho-interacting kinase (CRIK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CRIK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CRIK is also called citron kinase. It contains a catalytic domain, a central coiled-coil domain, and a C-terminal region containing a Rho-binding domain (RBD), a zinc finger, and a pleckstrin homology (PH) domain, in addition to other motifs. CRIK, an effector of the small GTPase Rho, plays an important function during cytokinesis and affects its contractile process. CRIK-deficient mice show severe ataxia and epilepsy as a result of abnormal cytokinesis and massive apoptosis in neuronal precursors. A Down syndrome critical region protein TTC3 interacts with CRIK and inhibits CRIK-dependent neuronal differentiation and neurite extension. Length = 330 |
| >gnl|CDD|143381 cd07876, STKc_JNK2, Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 2 | Back alignment and domain information |
|---|
Score = 48.9 bits (116), Expect = 3e-06
Identities = 37/110 (33%), Positives = 55/110 (50%), Gaps = 12/110 (10%)
Query: 274 GLLYLHQYSRLRVIHRDLKASNILLDKDMNPKISDFGMARMFGGDELQSNTKRIVGTYGY 333
G+ +LH +IHRDLK SNI++ D KI DFG+AR + + T +V Y Y
Sbjct: 135 GIKHLHSAG---IIHRDLKPSNIVVKSDCTLKILDFGLARTACTNFMM--TPYVVTRY-Y 188
Query: 334 MSPEYALRGLFSIKSDVFSFGVLLLETLSSKKNTHFYNTDSLTLLGHAWN 383
+PE L + D++S G ++ E + K + F TD + WN
Sbjct: 189 RAPEVILGMGYKENVDIWSVGCIMGELV--KGSVIFQGTDHID----QWN 232
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 2 (JNK2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK1, like JNK2, is expressed in every cell and tissue type. Initially it was thought that JNK1 and JNK2 were functionally redundant as mice deficient in either genes (Jnk1 or Jnk2) could survive but disruption of both genes resulted in lethality. However, recent studies have shown that JNK1 and JNK2 perform distinct functions through specific binding partners and substrates. JNK2 is specifically translocated to the mitochondria during dopaminergic cell death. Specific substrates include the microtubule-associated proteins DCX and Tau, as well as TIF-IA which is involved in ribosomal RNA synthesis regulation. Mice deficient in Jnk2 show protection against arthritis, type 1 diabetes, atherosclerosis, abdominal aortic aneurysm, cardiac cell death, TNF-induced liver damage, and tumor growth, indicating that JNK2 may play roles in the pathogenesis of these diseases. Length = 359 |
| >gnl|CDD|143384 cd07879, STKc_p38delta_MAPK13, Catalytic domain of the Serine/Threonine Kinase, p38delta Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Score = 48.4 bits (115), Expect = 4e-06
Identities = 36/106 (33%), Positives = 53/106 (50%), Gaps = 11/106 (10%)
Query: 274 GLLYLHQYSRLRVIHRDLKASNILLDKDMNPKISDFGMARMFGGDELQSNTKRIVGTYGY 333
GL Y+H +IHRDLK N+ +++D KI DFG+AR + V T Y
Sbjct: 129 GLKYIHSAG---IIHRDLKPGNLAVNEDCELKILDFGLAR-----HADAEMTGYVVTRWY 180
Query: 334 MSPEYALRGLFSIKS-DVFSFGVLLLETLSSKKNTHFYNTDSLTLL 378
+PE L + ++ D++S G ++ E L+ K T F D L L
Sbjct: 181 RAPEVILNWMHYNQTVDIWSVGCIMAEMLTGK--TLFKGKDYLDQL 224
|
Serine/Threonine Kinases (STKs), p38delta subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38delta subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38delta, also called MAPK13, is found in skeletal muscle, heart, lung, testis, pancreas, and small intestine. It regulates microtubule function by phosphorylating Tau. It activates the c-jun promoter and plays a role in G2 cell cycle arrest. It also controls the degration of c-Myb, which is associated with myeloid leukemia and poor prognosis in colorectal cancer. p38delta is the main isoform involved in regulating the differentiation and apoptosis of keratinocytes. Length = 342 |
| >gnl|CDD|173693 cd05602, STKc_SGK1, Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 1 | Back alignment and domain information |
|---|
Score = 48.5 bits (115), Expect = 4e-06
Identities = 31/91 (34%), Positives = 45/91 (49%), Gaps = 5/91 (5%)
Query: 271 IAQGLLYLHQYSRLRVIHRDLKASNILLDKDMNPKISDFGMARMFGGDELQSNTKRIVGT 330
IA L YLH L +++RDLK NILLD + ++DFG+ + E T GT
Sbjct: 105 IASALGYLHS---LNIVYRDLKPENILLDSQGHIVLTDFGLCKE--NIEHNGTTSTFCGT 159
Query: 331 YGYMSPEYALRGLFSIKSDVFSFGVLLLETL 361
Y++PE + + D + G +L E L
Sbjct: 160 PEYLAPEVLHKQPYDRTVDWWCLGAVLYEML 190
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3. SGK1 is ubiquitously expressed and is under transcriptional control of numerous stimuli including cell stress (cell shrinkage), serum, hormones (gluco- and mineralocorticoids), gonadotropins, growth factors, interleukin-6, and other cytokines. It plays roles in sodium retention and potassium elimination in the kidney, nutrient transport, salt sensitivity, memory consolidation, and cardiac repolarization. A common SGK1 variant is associated with increased blood pressure and body weight. SGK1 may also contribute to tumor growth, neurodegeneration, fibrosing disease, and ischemia. Length = 325 |
| >gnl|CDD|143359 cd07854, STKc_MAPK4_6, Catalytic domain of the Serine/Threonine Kinases, Mitogen-Activated Protein Kinases 4 and 6 | Back alignment and domain information |
|---|
Score = 48.2 bits (115), Expect = 4e-06
Identities = 30/96 (31%), Positives = 52/96 (54%), Gaps = 8/96 (8%)
Query: 273 QGLLYLHQYSRLRVIHRDLKASNILLD-KDMNPKISDFGMARMFGGDELQSN--TKRIVG 329
+GL Y+H + V+HRDLK +N+ ++ +D+ KI DFG+AR+ ++ +V
Sbjct: 125 RGLKYIHSAN---VLHRDLKPANVFINTEDLVLKIGDFGLARIVDPHYSHKGYLSEGLVT 181
Query: 330 TYGYMSPEYALRGLFSIKS-DVFSFGVLLLETLSSK 364
+ Y SP L K+ D+++ G + E L+ K
Sbjct: 182 KW-YRSPRLLLSPNNYTKAIDMWAAGCIFAEMLTGK 216
|
Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase 4 (MAPK4) and MAPK6 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK4/6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. MAPK4 is also called ERK4 or p63MAPK, while MAPK6 is also called ERK3 or p97MAPK. MAPK4 and MAPK6 are atypical MAPKs that are not regulated by MAP2Ks. MAPK6 is expressed ubiquitously with highest amounts in brain and skeletal muscle. It may be involved in the control of cell differentiation by negatively regulating cell cycle progression in certain conditions. It may also play a role in glucose-induced insulin secretion. MAPK6 and MAPK4 cooperate to regulate the activity of MAPK-activated protein kinase 5 (MK5), leading to its relocation to the cytoplasm and exclusion from the nucleus. The MAPK6/MK5 and MAPK4/MK5 pathways may play critical roles in embryonic and post-natal development. Length = 342 |
| >gnl|CDD|173711 cd05621, STKc_ROCK2, Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase 2 | Back alignment and domain information |
|---|
Score = 48.1 bits (114), Expect = 5e-06
Identities = 40/109 (36%), Positives = 58/109 (53%), Gaps = 10/109 (9%)
Query: 272 AQGLLYLHQYSRLRVIHRDLKASNILLDKDMNPKISDFGMA-RMFGGDELQSNTKRIVGT 330
A+ +L L + +IHRD+K N+LLDK + K++DFG +M ++ +T VGT
Sbjct: 149 AEVVLALDAIHSMGLIHRDVKPDNMLLDKHGHLKLADFGTCMKMDETGMVRCDTA--VGT 206
Query: 331 YGYMSPEYALR----GLFSIKSDVFSFGVLLLETLSSKKNTHFYNTDSL 375
Y+SPE G + + D +S GV L E L +T FY DSL
Sbjct: 207 PDYISPEVLKSQGGDGYYGRECDWWSVGVFLFEMLVG--DTPFY-ADSL 252
|
Serine/Threonine Kinases (STKs), ROCK subfamily, ROCK2 (or ROK-alpha) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK contains an N-terminal extension, a catalytic kinase domain, and a C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain, and is activated via interaction with Rho GTPases. ROCK2 was the first identified target of activated RhoA, and was found to play a role in stress fiber and focal adhesion formation. It is prominently expressed in the brain, heart, and skeletal muscles. It is implicated in vascular and neurological disorders, such as hypertension and vasospasm of the coronary and cerebral arteries. ROCK2 is also activated by caspase-2 cleavage, resulting in thrombin-induced microparticle generation in response to cell activation. Mice deficient in ROCK2 show intrauterine growth retardation and embryonic lethality because of placental dysfunction. Length = 370 |
| >gnl|CDD|173695 cd05604, STKc_SGK3, Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 3 | Back alignment and domain information |
|---|
Score = 48.1 bits (114), Expect = 5e-06
Identities = 30/91 (32%), Positives = 45/91 (49%), Gaps = 5/91 (5%)
Query: 271 IAQGLLYLHQYSRLRVIHRDLKASNILLDKDMNPKISDFGMARMFGGDELQSNTKRIVGT 330
IA L YLH + +++RDLK NILLD + ++DFG+ + G T GT
Sbjct: 105 IASALGYLHS---INIVYRDLKPENILLDSQGHVVLTDFGLCKE--GIAQSDTTTTFCGT 159
Query: 331 YGYMSPEYALRGLFSIKSDVFSFGVLLLETL 361
Y++PE + + D + G +L E L
Sbjct: 160 PEYLAPEVIRKQPYDNTVDWWCLGAVLYEML 190
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK3 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3 (also called cytokine-independent survival kinase CISK). SGK3 is expressed in most tissues and is most abundant in the embryo and adult heart and spleen. It was originally discovered in a screen for antiapoptotic genes. It phosphorylates and inhibits the proapoptotic proteins, Bad and FKHRL1. SGK3 also regulates many transporters, ion channels, and receptors. It plays a critical role in hair follicle morphogenesis and hair cycling. Length = 325 |
| >gnl|CDD|173690 cd05599, STKc_NDR_like, Catalytic domain of Nuclear Dbf2-Related kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 48.1 bits (115), Expect = 6e-06
Identities = 34/127 (26%), Positives = 53/127 (41%), Gaps = 36/127 (28%)
Query: 271 IAQGLLYLHQYSRLRVIHRDLKASNILLDKDMNPKISDFGM------------ARMFGGD 318
IA+ +L + +L IHRD+K N+LLD + K+SDFG+ R+
Sbjct: 107 IAETILAIDSIHKLGYIHRDIKPDNLLLDAKGHIKLSDFGLCTGLKKSHRTEFYRILSHA 166
Query: 319 ----------------ELQSNTKR--------IVGTYGYMSPEYALRGLFSIKSDVFSFG 354
KR VGT Y++PE L+ ++ + D +S G
Sbjct: 167 LPSNFLDFISKPMSSKRKAETWKRNRRALAYSTVGTPDYIAPEVFLQTGYNKECDWWSLG 226
Query: 355 VLLLETL 361
V++ E L
Sbjct: 227 VIMYEML 233
|
Serine/Threonine Kinases (STKs), Nuclear Dbf2-Related (NDR) kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. NDR kinases regulate mitosis, cell growth, embryonic development, and neurological processes. They are also required for proper centrosome duplication. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. This subfamily also contains fungal NDR-like kinases. Length = 364 |
| >gnl|CDD|133187 cd05056, PTKc_FAK, Catalytic domain of the Protein Tyrosine Kinase, Focal Adhesion Kinase | Back alignment and domain information |
|---|
Score = 47.4 bits (113), Expect = 6e-06
Identities = 31/94 (32%), Positives = 46/94 (48%), Gaps = 8/94 (8%)
Query: 271 IAQGLLYLHQYSRLRVIHRDLKASNILLDKDMNPKISDFGMARMFGGDELQSNTKRIVGT 330
++ L YL R +HRD+ A N+L+ K+ DFG++R E +S K G
Sbjct: 116 LSTALAYLES---KRFVHRDIAARNVLVSSPDCVKLGDFGLSRYL---EDESYYKASKGK 169
Query: 331 Y--GYMSPEYALRGLFSIKSDVFSFGVLLLETLS 362
+M+PE F+ SDV+ FGV + E L
Sbjct: 170 LPIKWMAPESINFRRFTSASDVWMFGVCMWEILM 203
|
Protein Tyrosine Kinase (PTK) family; Focal Adhesion Kinase (FAK); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FAK is a cytoplasmic (or nonreceptor) tyr kinase that contains an autophosphorylation site and a FERM domain at the N-terminus, a central tyr kinase domain, proline-rich regions, and a C-terminal FAT (focal adhesion targeting) domain. FAK activity is dependent on integrin-mediated cell adhesion, which facilitates N-terminal autophosphorylation. Full activation is achieved by the phosphorylation of its two adjacent A-loop tyrosines. FAK is important in mediating signaling initiated at sites of cell adhesions and at growth factor receptors. Through diverse molecular interactions, FAK functions as a biosensor or integrator to control cell motility. It is a key regulator of cell survival, proliferation, migration and invasion, and thus plays an important role in the development and progression of cancer. Src binds to autophosphorylated FAK forming the FAK-Src dual kinase complex, which is activated in a wide variety of tumor cells and generates signals promoting growth and metastasis. FAK is being developed as a target for cancer therapy. Length = 270 |
| >gnl|CDD|133195 cd05064, PTKc_EphR_A10, Catalytic domain of the Protein Tyrosine Kinase, Ephrin Receptor A10 | Back alignment and domain information |
|---|
Score = 46.8 bits (111), Expect = 8e-06
Identities = 49/192 (25%), Positives = 85/192 (44%), Gaps = 40/192 (20%)
Query: 256 KGLLCWGTRVRIIEGIAQGLLYLHQYSRLRVIHRDLKASNILLDKDMNPKISDFGMARMF 315
+G L G + ++ G+A G+ YL S + +H+ L A +L++ D+ KIS F
Sbjct: 101 EGQLVAGQLMGMLPGLASGMKYL---SEMGYVHKGLAAHKVLVNSDLVCKISGFR----- 152
Query: 316 GGDELQSNTKRIVGTYGYMS---------PEYALRGLFSIKSDVFSFGVLLLETLSSKKN 366
LQ + + Y MS PE FS SDV+SFG+++ E +S +
Sbjct: 153 ---RLQED--KSEAIYTTMSGKSPVLWAAPEAIQYHHFSSASDVWSFGIVMWEVMSYGER 207
Query: 367 THF--YNTDSLTLLGHAWNLWNDGRTWELMDPISQNGASYPILKRYINVALLCVQEKAAD 424
++ D + + + L P +N +L + + L C Q++ +
Sbjct: 208 PYWDMSGQDVIKAVEDGFRL-----------PAPRN--CPNLLHQLM---LDCWQKERGE 251
Query: 425 RPAMSEVVSMLS 436
RP S++ S+LS
Sbjct: 252 RPRFSQIHSILS 263
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; EphA10 receptor; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). EphA10, which contains an inactive tyr kinase domain, may function to attenuate signals of co-clustered active receptors. EphA10 is mainly expressed in the testis. Ephrin/EphR interaction results in cell-cell repulsion or adhesion, making it important in neural development and plasticity, cell morphogenesis, cell-fate determination, embryonic development, tissue patterning, and angiogenesis. Length = 266 |
| >gnl|CDD|173689 cd05598, STKc_LATS, Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor | Back alignment and domain information |
|---|
Score = 47.5 bits (113), Expect = 8e-06
Identities = 34/132 (25%), Positives = 54/132 (40%), Gaps = 41/132 (31%)
Query: 271 IAQGLLYLHQYSRLRVIHRDLKASNILLDKDMNPKISDFGMARMF-----------GG-- 317
IA+ + ++ IHRD+K NIL+D+D + K++DFG+ F G
Sbjct: 107 IAELTCAIESVHKMGFIHRDIKPDNILIDRDGHIKLTDFGLCTGFRWTHDSKYYQKGDHH 166
Query: 318 --------DELQSNTKR--------------------IVGTYGYMSPEYALRGLFSIKSD 349
+E + +VGT Y++PE LR ++ D
Sbjct: 167 RQDSMEPSEEWSEIDRCRLKPLERRRKRQHQRCLAHSLVGTPNYIAPEVLLRTGYTQLCD 226
Query: 350 VFSFGVLLLETL 361
+S GV+L E L
Sbjct: 227 WWSVGVILYEML 238
|
Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS was originally identified in Drosophila using a screen for genes whose inactivation led to overproliferation of cells. In tetrapods, there are two LATS isoforms, LATS1 and LATS2. Inactivation of LATS1 in mice results in the development of various tumors, including sarcomas and ovarian cancer. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. Length = 376 |
| >gnl|CDD|173712 cd05622, STKc_ROCK1, Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase 1 | Back alignment and domain information |
|---|
Score = 47.3 bits (112), Expect = 1e-05
Identities = 38/108 (35%), Positives = 53/108 (49%), Gaps = 8/108 (7%)
Query: 272 AQGLLYLHQYSRLRVIHRDLKASNILLDKDMNPKISDFGMARMFGGDELQSNTKRIVGTY 331
A+ +L L + IHRD+K N+LLDK + K++DFG + + VGT
Sbjct: 149 AEVVLALDAIHSMGFIHRDVKPDNMLLDKSGHLKLADFGTCMKMNKEGM-VRCDTAVGTP 207
Query: 332 GYMSPEYALR----GLFSIKSDVFSFGVLLLETLSSKKNTHFYNTDSL 375
Y+SPE G + + D +S GV L E L +T FY DSL
Sbjct: 208 DYISPEVLKSQGGDGYYGRECDWWSVGVFLYEMLVG--DTPFY-ADSL 252
|
Serine/Threonine Kinases (STKs), ROCK subfamily, ROCK1 (or ROK-beta) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK contains an N-terminal extension, a catalytic kinase domain, and a C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain, and is activated via interaction with Rho GTPases. ROCK1 is preferentially expressed in the liver, lung, spleen, testes, and kidney. It mediates signaling from Rho to the actin cytoskeleton. It is implicated in the development of cardiac fibrosis, cardiomyocyte apoptosis, and hyperglycemia. Mice deficient with ROCK1 display eyelids open at birth (EOB) and omphalocele phenotypes due to the disorganization of actin filaments in the eyelids and the umbilical ring. Length = 371 |
| >gnl|CDD|173715 cd05626, STKc_LATS2, Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor 2 | Back alignment and domain information |
|---|
Score = 46.9 bits (111), Expect = 1e-05
Identities = 37/136 (27%), Positives = 57/136 (41%), Gaps = 45/136 (33%)
Query: 271 IAQGLLYLHQYSRLRVIHRDLKASNILLDKDMNPKISDFGMARMFG-------------- 316
IA+ L + ++ IHRD+K NIL+D D + K++DFG+ F
Sbjct: 107 IAELTLAIESVHKMGFIHRDIKPDNILIDLDGHIKLTDFGLCTGFRWTHNSKYYQKGSHI 166
Query: 317 -------------------GDELQSNTKR------------IVGTYGYMSPEYALRGLFS 345
GD L++ +R +VGT Y++PE LR ++
Sbjct: 167 RQDSMEPSDLWDDVSNCRCGDRLKTLEQRATKQHQRCLAHSLVGTPNYIAPEVLLRKGYT 226
Query: 346 IKSDVFSFGVLLLETL 361
D +S GV+L E L
Sbjct: 227 QLCDWWSVGVILFEML 242
|
Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, LATS2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. LATS2 is an essential mitotic regulator responsible for coordinating accurate cytokinesis completion and governing the stabilization of other mitotic regulators. It is also critical in the maintenance of proper chromosome number, genomic stability, mitotic fidelity, and the integrity of centrosome duplication. Downregulation of LATS2 is associated with poor prognosis in acute lymphoblastic leukemia and breast cancer. Length = 381 |
| >gnl|CDD|173718 cd05629, STKc_NDR_like_fungal, Catalytic domain of Fungal Nuclear Dbf2-Related kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 46.8 bits (111), Expect = 1e-05
Identities = 32/136 (23%), Positives = 57/136 (41%), Gaps = 45/136 (33%)
Query: 271 IAQGLLYLHQYSRLRVIHRDLKASNILLDKDMNPKISDFGMA-------------RMFGG 317
+A+ +L + +L IHRD+K NIL+D+ + K+SDFG++ ++ G
Sbjct: 107 MAECVLAIEAVHKLGFIHRDIKPDNILIDRGGHIKLSDFGLSTGFHKQHDSAYYQKLLQG 166
Query: 318 DELQ------------------SNTKRI--------------VGTYGYMSPEYALRGLFS 345
+ S+ +I VGT Y++PE L+ +
Sbjct: 167 KSNKNRIDNRNSVAVDSINLTMSSKDQIATWKKNRRLMAYSTVGTPDYIAPEIFLQQGYG 226
Query: 346 IKSDVFSFGVLLLETL 361
+ D +S G ++ E L
Sbjct: 227 QECDWWSLGAIMFECL 242
|
Serine/Threonine Kinases (STKs), NDR kinase subfamily, fungal NDR-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This group is composed of fungal NDR-like proteins including Saccharomyces cerevisiae CBK1 (or CBK1p), Schizosaccharomyces pombe Orb6 (or Orb6p), Ustilago maydis Ukc1 (or Ukc1p), and Neurospora crassa Cot1. Like NDR kinase, group members contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. CBK1 is an essential component in the RAM (regulation of Ace2p activity and cellular morphogenesis) network. CBK1 and Orb6 play similar roles in coordinating cell morphology with cell cycle progression. Ukc1 is involved in morphogenesis, pathogenicity, and pigment formation. Cot1 plays a role in polar tip extension. Length = 377 |
| >gnl|CDD|143372 cd07867, STKc_CDC2L6, Catalytic domain of Serine/Threonine Kinase, Cell Division Cycle 2-like 6 | Back alignment and domain information |
|---|
Score = 46.6 bits (110), Expect = 1e-05
Identities = 48/178 (26%), Positives = 82/178 (46%), Gaps = 30/178 (16%)
Query: 271 IAQGLLYLHQYSRLRVIHRDLKASNILL----DKDMNPKISDFGMARMFGGD-ELQSNTK 325
I G+ YLH V+HRDLK +NIL+ + KI+D G AR+F + ++
Sbjct: 117 ILDGIHYLHAN---WVLHRDLKPANILVMGEGPERGRVKIADMGFARLFNSPLKPLADLD 173
Query: 326 RIVGTYGYMSPEYALRGLFSIKS-DVFSFGVLLLETLSSK----------KNTHFYNTDS 374
+V T+ Y +PE L K+ D+++ G + E L+S+ K ++ ++ D
Sbjct: 174 PVVVTFWYRAPELLLGARHYTKAIDIWAIGCIFAELLTSEPIFHCRQEDIKTSNPFHHDQ 233
Query: 375 LTLLGHAWNLWNDGRTWELMDPISQNGASYPILKR------YINVALLCVQEKAADRP 426
L + D + WE + + + YP L++ Y N +L+ EK +P
Sbjct: 234 LDRIFSVMGFPAD-KDWEDIRKMPE----YPTLQKDFRRTTYANSSLIKYMEKHKVKP 286
|
Serine/Threonine Kinases (STKs), Cell Division Cycle 2-like 6 (CDC2L6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDC2L6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDC2L6 is also called CDK8-like and was previously referred to as CDK11. However, this is a confusing nomenclature as CDC2L6 is distinct from CDC2L1, which is represented by the two protein products from its gene, called CDK11(p110) and CDK11(p58), as well as the caspase-processed CDK11(p46). CDK11(p110), CDK11(p58), and CDK11(p46)do not belong to this subfamily. CDC2L6 is an associated protein of Mediator, a multiprotein complex that provides a platform to connect transcriptional and chromatin regulators and cofactors, in order to activate and mediate RNA polymerase II transcription. CDC2L6 is localized mainly in the nucleus amd exerts an opposing effect to CDK8 in VP16-dependent transcriptional activation by being a negative regulator. Length = 317 |
| >gnl|CDD|88524 cd05623, STKc_MRCK_alpha, Catalytic domain of the Protein Serine/Threonine Kinase, DMPK-related cell division control protein 42 binding kinase alpha | Back alignment and domain information |
|---|
Score = 46.2 bits (109), Expect = 2e-05
Identities = 34/119 (28%), Positives = 60/119 (50%), Gaps = 10/119 (8%)
Query: 271 IAQGLLYLHQYSRLRVIHRDLKASNILLDKDMNPKISDFGMA-RMFGGDELQSNTKRIVG 329
+A+ ++ + +L +HRD+K NIL+D + + +++DFG ++ +QS+ VG
Sbjct: 108 LAEMVIAIDSVHQLHYVHRDIKPDNILMDMNGHIRLADFGSCLKLMEDGTVQSSVA--VG 165
Query: 330 TYGYMSPEYAL-----RGLFSIKSDVFSFGVLLLETLSSKKNTHFYNTDSLTLLGHAWN 383
T Y+SPE +G + + D +S GV + E L + T FY + G N
Sbjct: 166 TPDYISPEILQAMEDGKGKYGPECDWWSLGVCMYEMLYGE--TPFYAESLVETYGKIMN 222
|
Serine/Threonine Kinases (STKs), DMPK-like subfamily, DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK) alpha isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKalpha is expressed ubiquitously in many tissues. It plays a role in the regulation of peripheral actin reorganization and neurite outgrowth. It may also play a role in the transferrin iron uptake pathway. Length = 332 |
| >gnl|CDD|173502 PTZ00266, PTZ00266, NIMA-related protein kinase; Provisional | Back alignment and domain information |
|---|
Score = 47.0 bits (111), Expect = 2e-05
Identities = 37/109 (33%), Positives = 50/109 (45%), Gaps = 22/109 (20%)
Query: 285 RVIHRDLKASNILLD-------------KDMN----PKISDFGMARMFGGDELQSNTKRI 327
RV+HRDLK NI L ++N KI DFG+++ G ++S
Sbjct: 145 RVLHRDLKPQNIFLSTGIRHIGKITAQANNLNGRPIAKIGDFGLSKNIG---IESMAHSC 201
Query: 328 VGTYGYMSPEYALRGLFSI--KSDVFSFGVLLLETLSSKKNTHFYNTDS 374
VGT Y SPE L S KSD+++ G ++ E S K H N S
Sbjct: 202 VGTPYYWSPELLLHETKSYDDKSDMWALGCIIYELCSGKTPFHKANNFS 250
|
Length = 1021 |
| >gnl|CDD|173714 cd05625, STKc_LATS1, Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor 1 | Back alignment and domain information |
|---|
Score = 45.8 bits (108), Expect = 4e-05
Identities = 36/136 (26%), Positives = 56/136 (41%), Gaps = 45/136 (33%)
Query: 271 IAQGLLYLHQYSRLRVIHRDLKASNILLDKDMNPKISDFGMARMFG-------------- 316
IA+ + ++ IHRD+K NIL+D+D + K++DFG+ F
Sbjct: 107 IAELTCAVESVHKMGFIHRDIKPDNILIDRDGHIKLTDFGLCTGFRWTHDSKYYQSGDHV 166
Query: 317 -------------------GDELQSNTKR------------IVGTYGYMSPEYALRGLFS 345
GD L+ +R +VGT Y++PE LR ++
Sbjct: 167 RQDSMDFSNEWGDPANCRCGDRLKPLERRAARQHQRCLAHSLVGTPNYIAPEVLLRTGYT 226
Query: 346 IKSDVFSFGVLLLETL 361
D +S GV+L E L
Sbjct: 227 QLCDWWSVGVILYEML 242
|
Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, LATS1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. Inactivation of LATS1 in mice results in the development of various tumors, including sarcomas and ovarian cancer. Promoter methylation, loss of heterozygosity, and missense mutations targeting the LATS1 gene have also been found in human sarcomas and ovarian cancers. In addition, decreased expression of LATS1 is associated with an aggressive phenotype and poor prognosis. LATS1 induces G2 arrest and promotes cytokinesis. It may be a component of the mitotic exit network in higher eukaryotes. Length = 382 |
| >gnl|CDD|165478 PHA03212, PHA03212, serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Score = 45.4 bits (107), Expect = 4e-05
Identities = 29/93 (31%), Positives = 46/93 (49%), Gaps = 4/93 (4%)
Query: 267 IIEGIAQGLLYLHQYSRLRVIHRDLKASNILLDKDMNPKISDFGMARMFGGDELQSNTKR 326
I + + + YLH+ R+IHRD+KA NI ++ + + DFG A F D +
Sbjct: 187 IERSVLRAIQYLHEN---RIIHRDIKAENIFINHPGDVCLGDFGAA-CFPVDINANKYYG 242
Query: 327 IVGTYGYMSPEYALRGLFSIKSDVFSFGVLLLE 359
GT +PE R + D++S G++L E
Sbjct: 243 WAGTIATNAPELLARDPYGPAVDIWSAGIVLFE 275
|
Length = 391 |
| >gnl|CDD|173745 cd07848, STKc_CDKL5, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase Like 5 | Back alignment and domain information |
|---|
Score = 44.6 bits (105), Expect = 5e-05
Identities = 28/89 (31%), Positives = 44/89 (49%), Gaps = 1/89 (1%)
Query: 271 IAQGLLYLHQYSRLRVIHRDLKASNILLDKDMNPKISDFGMARMFGGDELQSNTKRIVGT 330
I Q + +H + ++HRD+K N+L+ + K+ DFG AR + +N V T
Sbjct: 106 IYQLIKAIHWCHKNDIVHRDIKPENLLISHNDVLKLCDFGFARNL-SEGSNANYTEYVAT 164
Query: 331 YGYMSPEYALRGLFSIKSDVFSFGVLLLE 359
Y SPE L + D++S G +L E
Sbjct: 165 RWYRSPELLLGAPYGKAVDMWSVGCILGE 193
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 5 (CDKL5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. Mutations in the gene encoding CDKL5, previously called STK9, are associated with early onset epilepsy and severe mental retardation [X-linked infantile spasm syndrome (ISSX) or West syndrome]. In addition, CDKL5 mutations also sometimes cause a phenotype similar to Rett syndrome (RTT), a progressive neurodevelopmental disorder. These pathogenic mutations are located in the N-terminal portion of the protein within the kinase domain. Length = 287 |
| >gnl|CDD|173735 cd07831, STKc_MOK, Catalytic domain of the Serine/Threonine Kinase, MAPK/MAK/MRK Overlapping Kinase | Back alignment and domain information |
|---|
Score = 44.6 bits (106), Expect = 5e-05
Identities = 31/90 (34%), Positives = 45/90 (50%), Gaps = 8/90 (8%)
Query: 274 GLLYLHQYSRLRVIHRDLKASNILLDKDMNPKISDFGMARMFGGDELQSNTKRIVGTYGY 333
L ++H R + HRD+K NIL+ D K++DFG R G T+ I T Y
Sbjct: 112 SLDHMH---RNGIFHRDIKPENILIKDD-ILKLADFGSCR--GIYSKPPYTEYI-STRWY 164
Query: 334 MSPEYALR-GLFSIKSDVFSFGVLLLETLS 362
+PE L G + K D+++ G + E LS
Sbjct: 165 RAPECLLTDGYYGPKMDIWAVGCVFFEILS 194
|
Serine/Threonine Kinases (STKs), MAPK/MAK/MRK Overlapping Kinase (MOK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MOK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MOK, also called Renal tumor antigen 1 (RAGE-1), is widely expressed and is enriched in testis, kidney, lung, and brain. It is expressed in approximately 50% of renal cell carcinomas (RCC) and is a potential target for immunotherapy. MOK is stabilized by its association with the HSP90 molecular chaperone. It is induced by the transcription factor Cdx2 and may be involved in regulating intestinal epithelial development and differentiation. Length = 282 |
| >gnl|CDD|173756 cd08216, PK_STRAD, Pseudokinase domain of STE20-related kinase adapter protein | Back alignment and domain information |
|---|
Score = 43.5 bits (103), Expect = 1e-04
Identities = 29/97 (29%), Positives = 46/97 (47%), Gaps = 12/97 (12%)
Query: 267 IIEGIAQGLLYLHQYSRLRVIHRDLKASNILLDKDMNPKISDFGMAR-MFGGDELQ---- 321
I++ + L Y+H IHR +KAS+ILL D +S + M + Q
Sbjct: 106 ILKDVLNALDYIHS---KGFIHRSVKASHILLSGDGKVVLSGLRYSVSMIKHGKRQRVVH 162
Query: 322 SNTKRIVGTYGYMSPEY---ALRGLFSIKSDVFSFGV 355
K V ++SPE L+G ++ KSD++S G+
Sbjct: 163 DFPKSSVKNLPWLSPEVLQQNLQG-YNEKSDIYSVGI 198
|
Protein Kinase family, STE20-related kinase adapter protein (STRAD) subfamily, pseudokinase domain. The STRAD subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hyperpigmentation of the buccal mucosa. There are two forms of STRAD, alpha and beta, that complex with LKB1 and MO25. The structure of STRAD-alpha is available and shows that this protein binds ATP, has an ordered activation loop, and adopts a closed conformation typical of fully active protein kinases. It does not possess activity due to nonconservative substitutions of essential catalytic residues. ATP binding enhances the affinity of STRAD for MO25. The conformation of STRAD-alpha stabilized through ATP and MO25 may be needed to activate LKB1. Length = 314 |
| >gnl|CDD|143377 cd07872, STKc_PCTAIRE2, Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-2 kinase | Back alignment and domain information |
|---|
Score = 43.8 bits (103), Expect = 1e-04
Identities = 31/96 (32%), Positives = 50/96 (52%), Gaps = 8/96 (8%)
Query: 271 IAQGLLYLHQYSRLRVIHRDLKASNILLDKDMNPKISDFGMARMFGGDELQSNT-KRIVG 329
I +GL Y H R +V+HRDLK N+L+++ K++DFG+AR + + T V
Sbjct: 113 ILRGLAYCH---RRKVLHRDLKPQNLLINERGELKLADFGLAR---AKSVPTKTYSNEVV 166
Query: 330 TYGYMSPEYAL-RGLFSIKSDVFSFGVLLLETLSSK 364
T Y P+ L +S + D++ G + E S +
Sbjct: 167 TLWYRPPDVLLGSSEYSTQIDMWGVGCIFFEMASGR 202
|
Serine/Threonine Kinases (STKs), PCTAIRE-2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-2 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-2 is specifically expressed in neurons in the central nervous system, mainly in terminally differentiated neurons. It associates with Trap (Tudor repeat associator with PCTAIRE-2) and could play a role in regulating mitochondrial function in neurons. Length = 309 |
| >gnl|CDD|143349 cd07844, STKc_PCTAIRE_like, Catalytic domain of PCTAIRE-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 42.8 bits (101), Expect = 2e-04
Identities = 20/40 (50%), Positives = 27/40 (67%), Gaps = 3/40 (7%)
Query: 274 GLLYLHQYSRLRVIHRDLKASNILLDKDMNPKISDFGMAR 313
GL Y HQ RV+HRDLK N+L+ + K++DFG+AR
Sbjct: 115 GLAYCHQR---RVLHRDLKPQNLLISERGELKLADFGLAR 151
|
Serine/Threonine Kinases (STKs), PCTAIRE-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily share sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. The association of PCTAIRE-like proteins with cyclins has not been widely studied, although PFTAIRE-1 has been shown to function as a CDK which is regulated by cyclin D3 as well as the membrane-associated cyclin Y. PCTAIRE-like proteins show unusual expression patterns with high levels in post-mitotic tissues, suggesting that they may be involved in regulating post-mitotic cellular events. Length = 291 |
| >gnl|CDD|133174 cd05042, PTKc_Aatyk, Catalytic domain of the Protein Tyrosine Kinases, Apoptosis-associated tyrosine kinases | Back alignment and domain information |
|---|
Score = 42.6 bits (100), Expect = 2e-04
Identities = 31/105 (29%), Positives = 48/105 (45%), Gaps = 12/105 (11%)
Query: 263 TRVRIIEGIAQGLLYLHQYSRLRVIHRDLKASNILLDKDMNPKISDFGMA-RMFGGDELQ 321
R+ +A GLL+LHQ IH DL N L D++ KI D+G+A + D
Sbjct: 101 VLQRMACEVASGLLWLHQ---ADFIHSDLALRNCQLTADLSVKIGDYGLALEQYPEDYYI 157
Query: 322 SNTKRIVGTYGYMSPEYA-------LRGLFSIKSDVFSFGVLLLE 359
+ V +++PE L + KS+++S GV + E
Sbjct: 158 TKDCHAV-PLRWLAPELVEIRGQDLLPKDQTKKSNIWSLGVTMWE 201
|
Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase (Aatyk) subfamily; catalytic (c) domain. The Aatyk subfamily is also referred to as the lemur tyrosine kinase (Lmtk) subfamily. It consists of Aatyk1 (Lmtk1), Aatyk2 (Lmtk2, Brek), Aatyk3 (Lmtk3), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk proteins are mostly receptor tyr kinases (RTKs) containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk1 does not contain a transmembrane segment and is a cytoplasmic (or nonreceptor) kinase. Aatyk proteins are classified as tyr kinases based on overall sequence similarity and the phylogenetic tree. However, analysis of catalytic residues suggests that Aatyk proteins may be multispecific kinases, functioning also as serine/threonine kinases. They are involved in neural differentiation, nerve growth factor (NGF) signaling, apoptosis, and spermatogenesis. Length = 269 |
| >gnl|CDD|173701 cd05610, STKc_MASTL, Catalytic domain of the Protein Serine/Threonine Kinase, Microtubule-associated serine/threonine-like kinase | Back alignment and domain information |
|---|
Score = 43.3 bits (102), Expect = 2e-04
Identities = 19/52 (36%), Positives = 34/52 (65%), Gaps = 3/52 (5%)
Query: 263 TRVRIIEGIAQGLLYLHQYSRLRVIHRDLKASNILLDKDMNPKISDFGMARM 314
V+ I +A L YLH++ +IHRDLK N+L+ + + K++DFG++++
Sbjct: 105 MAVKYISEVALALDYLHRHG---IIHRDLKPDNMLISNEGHIKLTDFGLSKV 153
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, MAST-like (MASTL) kinases, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. The MASTL kinases in this group carry only a catalytic domain, which contains a long insertion relative to MAST kinases. The human MASTL gene has also been labelled FLJ14813. A missense mutation in FLJ14813 is associated with autosomal dominant thrombocytopenia. To date, the function of MASTL is unknown. Length = 669 |
| >gnl|CDD|143378 cd07873, STKc_PCTAIRE1, Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-1 kinase | Back alignment and domain information |
|---|
Score = 41.9 bits (98), Expect = 4e-04
Identities = 19/41 (46%), Positives = 29/41 (70%), Gaps = 3/41 (7%)
Query: 273 QGLLYLHQYSRLRVIHRDLKASNILLDKDMNPKISDFGMAR 313
+GL Y H R +V+HRDLK N+L+++ K++DFG+AR
Sbjct: 115 RGLNYCH---RRKVLHRDLKPQNLLINERGELKLADFGLAR 152
|
Serine/Threonine Kinases (STKs), PCTAIRE-1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-1 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-1 is expressed ubiquitously and is localized in the cytoplasm. Its kinase activity is cell cycle dependent and peaks at the S and G2 phases. PCTAIRE-1 is highly expressed in the brain and may play a role in regulating neurite outgrowth. It can also associate with Trap (Tudor repeat associator with PCTAIRE-2), a physiological partner of PCTAIRE-2; with p11, a small dimeric protein with similarity to S100; and with 14-3-3 proteins, mediators of phosphorylation-dependent interactions in many different proteins. Length = 301 |
| >gnl|CDD|143375 cd07870, STKc_PFTAIRE2, Catalytic domain of the Serine/Threonine Kinase, PFTAIRE-2 kinase | Back alignment and domain information |
|---|
Score = 41.9 bits (98), Expect = 4e-04
Identities = 35/134 (26%), Positives = 65/134 (48%), Gaps = 14/134 (10%)
Query: 236 LVQSKDEISFWYE-------SYNNPTKKGLLCWGTRVRIIEGIAQGLLYLHQYSRLRVIH 288
++ +K+ ++F +E Y GL + R+ + + + +GL Y+H ++H
Sbjct: 71 IIHTKETLTFVFEYMHTDLAQYMIQHPGGLHPYNVRLFMFQ-LLRGLAYIH---GQHILH 126
Query: 289 RDLKASNILLDKDMNPKISDFGMARMFGGDELQSNTKRIVGTYGYMSPEYALRGL-FSIK 347
RDLK N+L+ K++DFG+AR Q+ + +V T Y P+ L +S
Sbjct: 127 RDLKPQNLLISYLGELKLADFGLARA-KSIPSQTYSSEVV-TLWYRPPDVLLGATDYSSA 184
Query: 348 SDVFSFGVLLLETL 361
D++ G + +E L
Sbjct: 185 LDIWGAGCIFIEML 198
|
Serine/Threonine Kinases (STKs), PFTAIRE-2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PFTAIRE-2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PFTAIRE-2 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PFTAIRE-2 is also referred to as ALS2CR7 (amyotrophic lateral sclerosis 2 (juvenile) chromosome region candidate 7). It may be associated with amyotrophic lateral sclerosis 2 (ALS2), an autosomal recessive form of juvenile ALS. The function of PFTAIRE-2 is not yet known. Length = 291 |
| >gnl|CDD|223069 PHA03390, pk1, serine/threonine-protein kinase 1; Provisional | Back alignment and domain information |
|---|
Score = 41.0 bits (97), Expect = 6e-04
Identities = 28/99 (28%), Positives = 47/99 (47%), Gaps = 10/99 (10%)
Query: 267 IIEGIAQGLLYLHQYSRLRVIHRDLKASNILLDKDMNP-KISDFGMARMFGGDELQSNTK 325
II + + L LH++ +IH D+K N+L D+ + + D+G+ ++ G
Sbjct: 114 IIRQLVEALNDLHKH---NIIHNDIKLENVLYDRAKDRIYLCDYGLCKIIGTPSCYD--- 167
Query: 326 RIVGTYGYMSPEYALRGLFSIKSDVFSFGVLLLETLSSK 364
GT Y SPE + + D ++ GVL E L+ K
Sbjct: 168 ---GTLDYFSPEKIKGHNYDVSFDWWAVGVLTYELLTGK 203
|
Length = 267 |
| >gnl|CDD|173717 cd05628, STKc_NDR1, Catalytic domain of the Protein Serine/Threonine Kinase, Nuclear Dbf2-Related kinase 1 | Back alignment and domain information |
|---|
Score = 41.2 bits (96), Expect = 9e-04
Identities = 35/124 (28%), Positives = 54/124 (43%), Gaps = 33/124 (26%)
Query: 271 IAQGLLYLHQYSRLRVIHRDLKASNILLDKDMNPKISDFGMARMFG-----------GDE 319
IA+ +L + +L IHRD+K N+LLD + K+SDFG+
Sbjct: 107 IAETVLAIDSIHQLGFIHRDIKPDNLLLDSKGHVKLSDFGLCTGLKKAHRTEFYRNLNHS 166
Query: 320 LQS-------NTKR---------------IVGTYGYMSPEYALRGLFSIKSDVFSFGVLL 357
L S N+KR VGT Y++PE ++ ++ D +S GV++
Sbjct: 167 LPSDFTFQNMNSKRKAETWKRNRRQLAFSTVGTPDYIAPEVFMQTGYNKLCDWWSLGVIM 226
Query: 358 LETL 361
E L
Sbjct: 227 YEML 230
|
Serine/Threonine Kinases (STKs), NDR kinase subfamily, NDR1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. Both isoforms play a role in proper centrosome duplication. NDR1 is highly expressed in thymus, muscle, lung and spleen. It is not an essential protein because mice deficient of NDR1 remain viable and fertile. However, these mice develop T-cell lymphomas and appear to be hypersenstive to carcinogenic treatment. NDR1 appears to act as a tumor suppressor. NDR1 is also called STK38. Length = 363 |
| >gnl|CDD|173743 cd07846, STKc_CDKL2_3, Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase Like 2 and 3 | Back alignment and domain information |
|---|
Score = 40.5 bits (95), Expect = 0.001
Identities = 28/99 (28%), Positives = 51/99 (51%), Gaps = 8/99 (8%)
Query: 266 RIIEGIAQGLLYLHQYSRLRVIHRDLKASNILLDKDMNPKISDFGMARMF-GGDELQSNT 324
+ + I +G+ + H ++ +IHRD+K NIL+ + K+ DFG AR E+ ++
Sbjct: 104 KYLFQILRGIEFCHSHN---IIHRDIKPENILVSQSGVVKLCDFGFARTLAAPGEVYTD- 159
Query: 325 KRIVGTYGYMSPEYALRGL-FSIKSDVFSFGVLLLETLS 362
V T Y +PE + + D+++ G L+ E L+
Sbjct: 160 --YVATRWYRAPELLVGDTKYGRAVDIWAVGCLVTEMLT 196
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 2 (CDKL2) and CDKL3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL2 and CDKL3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKL2, also called p56 KKIAMRE, is expressed in testis, kidney, lung, and brain. It functions mainly in mature neurons and plays an important role in learning and memory. Inactivation of CDKL3, also called NKIAMRE (NKIATRE in rat), by translocation is associated with mild mental retardation. It has been reported that CDKL3 is lost in leukemic cells having a chromosome arm 5q deletion, and may contribute to the transformed phenotype. Length = 286 |
| >gnl|CDD|143376 cd07871, STKc_PCTAIRE3, Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-3 kinase | Back alignment and domain information |
|---|
Score = 40.0 bits (93), Expect = 0.002
Identities = 17/41 (41%), Positives = 29/41 (70%), Gaps = 3/41 (7%)
Query: 273 QGLLYLHQYSRLRVIHRDLKASNILLDKDMNPKISDFGMAR 313
+GL Y H + +++HRDLK N+L+++ K++DFG+AR
Sbjct: 114 RGLSYCH---KRKILHRDLKPQNLLINEKGELKLADFGLAR 151
|
Serine/Threonine Kinases (STKs), PCTAIRE-3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-3 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-3 shows a restricted pattern of expression and is present in brain, kidney, and intestine. It is elevated in Alzheimer's disease (AD) and has been shown to associate with paired helical filaments (PHFs) and stimulate Tau phosphorylation. As AD progresses, phosphorylated Tau aggregates and forms PHFs, which leads to the formation of neurofibrillary tangles (NFTs). In human glioma cells, PCTAIRE-3 induces cell cycle arrest and cell death. Length = 288 |
| >gnl|CDD|221289 pfam11883, DUF3403, Domain of unknown function (DUF3403) | Back alignment and domain information |
|---|
Score = 35.8 bits (83), Expect = 0.002
Identities = 19/49 (38%), Positives = 29/49 (59%), Gaps = 10/49 (20%)
Query: 437 NEFVNLPAPQQPAFSCV---------NSTNMQSDAFSVNCVTHSVIDAR 476
+E +P P+QP F CV +S+ + ++++VN VT SVIDAR
Sbjct: 1 SETTEIPQPKQPGF-CVGRSPYETDSSSSTQRDESWTVNQVTVSVIDAR 48
|
This domain is functionally uncharacterized. This domain is found in eukaryotes. This presumed domain is about 50 amino acids in length. This domain is found associated with pfam00069, pfam08276, pfam00954, pfam01453. Length = 48 |
| >gnl|CDD|173716 cd05627, STKc_NDR2, Catalytic domain of the Protein Serine/Threonine Kinase, Nuclear Dbf2-Related kinase 2 | Back alignment and domain information |
|---|
Score = 40.0 bits (93), Expect = 0.002
Identities = 33/124 (26%), Positives = 52/124 (41%), Gaps = 33/124 (26%)
Query: 271 IAQGLLYLHQYSRLRVIHRDLKASNILLDKDMNPKISDFGMARM---------------- 314
IA+ +L + +L IHRD+K N+LLD + K+SDFG+
Sbjct: 107 IAETVLAIDAIHQLGFIHRDIKPDNLLLDAKGHVKLSDFGLCTGLKKAHRTEFYRNLTHN 166
Query: 315 ----FGGDELQSNTK-------------RIVGTYGYMSPEYALRGLFSIKSDVFSFGVLL 357
F + S K VGT Y++PE ++ ++ D +S GV++
Sbjct: 167 PPSDFSFQNMNSKRKAETWKKNRRQLAYSTVGTPDYIAPEVFMQTGYNKLCDWWSLGVIM 226
Query: 358 LETL 361
E L
Sbjct: 227 YEML 230
|
Serine/Threonine Kinases (STKs), NDR kinase subfamily, NDR2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. Both isoforms play a role in proper centrosome duplication. In addition, NDR2 plays a role in regulating neuronal growth and differentiation, as well as in facilitating neurite outgrowth. It is also implicated in fear conditioning as it contributes to the coupling of neuronal morphological changes with fear-memory consolidation. NDR2 is also referred to as STK38-like. Length = 360 |
| >gnl|CDD|240159 cd05120, APH_ChoK_like, Aminoglycoside 3'-phosphotransferase (APH) and Choline Kinase (ChoK) family | Back alignment and domain information |
|---|
Score = 38.2 bits (89), Expect = 0.002
Identities = 14/37 (37%), Positives = 17/37 (45%)
Query: 278 LHQYSRLRVIHRDLKASNILLDKDMNPKISDFGMARM 314
LHQ L + H DL NIL+D I D+ A
Sbjct: 102 LHQLPLLVLCHGDLHPGNILVDDGKILGIIDWEYAGY 138
|
The APH/ChoK family is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). The family is composed of APH, ChoK, ethanolamine kinase (ETNK), macrolide 2'-phosphotransferase (MPH2'), an unusual homoserine kinase, and uncharacterized proteins with similarity to the N-terminal domain of acyl-CoA dehydrogenase 10 (ACAD10). The members of this family catalyze the transfer of the gamma-phosphoryl group from ATP (or CTP) to small molecule substrates such as aminoglycosides, macrolides, choline, ethanolamine, and homoserine. Phosphorylation of the antibiotics, aminoglycosides and macrolides, leads to their inactivation and to bacterial antibiotic resistance. Phosphorylation of choline, ethanolamine, and homoserine serves as precursors to the synthesis of important biological compounds, such as the major phospholipids, phosphatidylcholine and phosphatidylethanolamine and the amino acids, threonine, methionine, and isoleucine. Length = 155 |
| >gnl|CDD|140307 PTZ00284, PTZ00284, protein kinase; Provisional | Back alignment and domain information |
|---|
Score = 39.9 bits (93), Expect = 0.002
Identities = 37/121 (30%), Positives = 53/121 (43%), Gaps = 25/121 (20%)
Query: 266 RIIEGIAQGLLYLHQYSRLRVIHRDLKASNILL---DKDMNP-------------KISDF 309
+II L Y H + L ++H DLK NIL+ D ++P +I D
Sbjct: 235 QIIFQTGVALDYFH--TELHLMHTDLKPENILMETSDTVVDPVTNRALPPDPCRVRICDL 292
Query: 310 GMARMFGGDELQSNTKRIVGTYGYMSPEYALRGLFSIKSDVFSFGVLLLETLSSK--KNT 367
G DE S T IV T Y SPE L + +D++S G ++ E + K +T
Sbjct: 293 GGC----CDERHSRTA-IVSTRHYRSPEVVLGLGWMYSTDMWSMGCIIYELYTGKLLYDT 347
Query: 368 H 368
H
Sbjct: 348 H 348
|
Length = 467 |
| >gnl|CDD|143374 cd07869, STKc_PFTAIRE1, Catalytic domain of the Serine/Threonine Kinase, PFTAIRE-1 kinase | Back alignment and domain information |
|---|
Score = 39.3 bits (91), Expect = 0.003
Identities = 29/93 (31%), Positives = 48/93 (51%), Gaps = 8/93 (8%)
Query: 271 IAQGLLYLHQYSRLRVIHRDLKASNILLDKDMNPKISDFGMARMFGGDELQSNT-KRIVG 329
+ +GL Y+HQ ++HRDLK N+L+ K++DFG+AR + S+T V
Sbjct: 112 LLRGLSYIHQRY---ILHRDLKPQNLLISDTGELKLADFGLAR---AKSVPSHTYSNEVV 165
Query: 330 TYGYMSPEYALRGL-FSIKSDVFSFGVLLLETL 361
T Y P+ L +S D++ G + +E +
Sbjct: 166 TLWYRPPDVLLGSTEYSTCLDMWGVGCIFVEMI 198
|
Serine/Threonine Kinases (STKs), PFTAIRE-1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PFTAIRE-1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PFTAIRE-1 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PFTAIRE-1 is widely expressed except in the spleen and thymus. It is highly expressed in the brain, heart, pancreas, testis, and ovary, and is localized in the cytoplasm. It is regulated by cyclin D3 and is inhibited by the p21 cell cycle inhibitor. It has also been shown to interact with the membrane-associated cyclin Y, which recruits the protein to the plasma membrane. Length = 303 |
Conserved Domains Detected by HHsearch
Original result of HHsearch against CDD database
| ID | Alignment Graph | Length |
Definition |
Probability |
| Query | 476 | |||
| KOG1187 | 361 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| KOG0581 | 364 | consensus Mitogen-activated protein kinase kinase | 99.97 | |
| KOG0192 | 362 | consensus Tyrosine kinase specific for activated ( | 99.97 | |
| PF01453 | 114 | B_lectin: D-mannose binding lectin; InterPro: IPR0 | 99.97 | |
| KOG0197 | 468 | consensus Tyrosine kinases [Signal transduction me | 99.96 | |
| KOG0575 | 592 | consensus Polo-like serine/threonine protein kinas | 99.96 | |
| KOG0661 | 538 | consensus MAPK related serine/threonine protein ki | 99.96 | |
| KOG0615 | 475 | consensus Serine/threonine protein kinase Chk2 and | 99.96 | |
| KOG0198 | 313 | consensus MEKK and related serine/threonine protei | 99.95 | |
| KOG0591 | 375 | consensus NIMA (never in mitosis)-related G2-speci | 99.95 | |
| cd00028 | 116 | B_lectin Bulb-type mannose-specific lectin. The do | 99.95 | |
| cd05102 | 338 | PTKc_VEGFR3 Catalytic domain of the Protein Tyrosi | 99.95 | |
| KOG0593 | 396 | consensus Predicted protein kinase KKIAMRE [Genera | 99.95 | |
| KOG0592 | 604 | consensus 3-phosphoinositide-dependent protein kin | 99.95 | |
| KOG0578 | 550 | consensus p21-activated serine/threonine protein k | 99.95 | |
| KOG0600 | 560 | consensus Cdc2-related protein kinase [Cell cycle | 99.95 | |
| KOG0598 | 357 | consensus Ribosomal protein S6 kinase and related | 99.95 | |
| cd05096 | 304 | PTKc_DDR1 Catalytic domain of the Protein Tyrosine | 99.94 | |
| KOG0193 | 678 | consensus Serine/threonine protein kinase RAF [Sig | 99.94 | |
| cd05080 | 283 | PTKc_Tyk2_rpt2 Catalytic (repeat 2) domain of the | 99.94 | |
| cd07862 | 290 | STKc_CDK6 Catalytic domain of the Serine/Threonine | 99.94 | |
| smart00108 | 114 | B_lectin Bulb-type mannose-specific lectin. | 99.94 | |
| cd05048 | 283 | PTKc_Ror Catalytic Domain of the Protein Tyrosine | 99.94 | |
| cd05094 | 291 | PTKc_TrkC Catalytic domain of the Protein Tyrosine | 99.94 | |
| PHA02988 | 283 | hypothetical protein; Provisional | 99.94 | |
| KOG0595 | 429 | consensus Serine/threonine-protein kinase involved | 99.94 | |
| KOG0588 | 786 | consensus Serine/threonine protein kinase [Cell cy | 99.94 | |
| KOG4721 | 904 | consensus Serine/threonine protein kinase, contain | 99.94 | |
| KOG0583 | 370 | consensus Serine/threonine protein kinase [Signal | 99.94 | |
| cd05111 | 279 | PTK_HER3 Pseudokinase domain of the Protein Tyrosi | 99.94 | |
| cd05052 | 263 | PTKc_Abl Catalytic domain of the Protein Tyrosine | 99.94 | |
| cd05053 | 293 | PTKc_FGFR Catalytic domain of the Protein Tyrosine | 99.94 | |
| KOG1989 | 738 | consensus ARK protein kinase family [Signal transd | 99.94 | |
| cd05075 | 272 | PTKc_Axl Catalytic domain of the Protein Tyrosine | 99.93 | |
| cd07848 | 287 | STKc_CDKL5 Catalytic domain of the Serine/Threonin | 99.93 | |
| cd05571 | 323 | STKc_PKB Catalytic domain of the Protein Serine/Th | 99.93 | |
| KOG0658 | 364 | consensus Glycogen synthase kinase-3 [Carbohydrate | 99.93 | |
| KOG0659 | 318 | consensus Cdk activating kinase (CAK)/RNA polymera | 99.93 | |
| cd05631 | 285 | STKc_GRK4 Catalytic domain of the Protein Serine/T | 99.93 | |
| cd05035 | 273 | PTKc_Axl_like Catalytic Domain of Axl-like Protein | 99.93 | |
| KOG0660 | 359 | consensus Mitogen-activated protein kinase [Signal | 99.93 | |
| KOG0663 | 419 | consensus Protein kinase PITSLRE and related kinas | 99.93 | |
| KOG0616 | 355 | consensus cAMP-dependent protein kinase catalytic | 99.93 | |
| KOG1026 | 774 | consensus Nerve growth factor receptor TRKA and re | 99.93 | |
| cd05072 | 261 | PTKc_Lyn Catalytic domain of the Protein Tyrosine | 99.93 | |
| cd05614 | 332 | STKc_MSK2_N N-terminal catalytic domain of the Pro | 99.93 | |
| cd05108 | 316 | PTKc_EGFR Catalytic domain of the Protein Tyrosine | 99.93 | |
| KOG0582 | 516 | consensus Ste20-like serine/threonine protein kina | 99.93 | |
| cd05093 | 288 | PTKc_TrkB Catalytic domain of the Protein Tyrosine | 99.93 | |
| cd05106 | 374 | PTKc_CSF-1R Catalytic domain of the Protein Tyrosi | 99.93 | |
| PTZ00283 | 496 | serine/threonine protein kinase; Provisional | 99.93 | |
| cd05585 | 312 | STKc_YPK1_like Catalytic domain of Yeast Protein K | 99.93 | |
| cd07859 | 338 | STKc_TDY_MAPK_plant Catalytic domain of the Serine | 99.93 | |
| cd05109 | 279 | PTKc_HER2 Catalytic domain of the Protein Tyrosine | 99.93 | |
| KOG0201 | 467 | consensus Serine/threonine protein kinase [Signal | 99.93 | |
| cd05593 | 328 | STKc_PKB_gamma Catalytic domain of the Protein Ser | 99.93 | |
| PF07714 | 259 | Pkinase_Tyr: Protein tyrosine kinase Protein kinas | 99.93 | |
| cd05594 | 325 | STKc_PKB_alpha Catalytic domain of the Protein Ser | 99.93 | |
| cd05051 | 296 | PTKc_DDR Catalytic domain of the Protein Tyrosine | 99.93 | |
| cd05054 | 337 | PTKc_VEGFR Catalytic domain of the Protein Tyrosin | 99.93 | |
| cd05049 | 280 | PTKc_Trk Catalytic domain of the Protein Tyrosine | 99.93 | |
| PTZ00267 | 478 | NIMA-related protein kinase; Provisional | 99.93 | |
| cd05116 | 257 | PTKc_Syk Catalytic domain of the Protein Tyrosine | 99.93 | |
| KOG0585 | 576 | consensus Ca2+/calmodulin-dependent protein kinase | 99.93 | |
| cd05091 | 283 | PTKc_Ror2 Catalytic domain of the Protein Tyrosine | 99.93 | |
| cd07871 | 288 | STKc_PCTAIRE3 Catalytic domain of the Serine/Threo | 99.93 | |
| cd05600 | 333 | STKc_Sid2p_Dbf2p Catalytic domain of Fungal Sid2p- | 99.93 | |
| cd05618 | 329 | STKc_aPKC_iota Catalytic domain of the Protein Ser | 99.93 | |
| cd07863 | 288 | STKc_CDK4 Catalytic domain of the Serine/Threonine | 99.93 | |
| KOG0694 | 694 | consensus Serine/threonine protein kinase [Signal | 99.93 | |
| cd07869 | 303 | STKc_PFTAIRE1 Catalytic domain of the Serine/Threo | 99.93 | |
| cd05591 | 321 | STKc_nPKC_epsilon Catalytic domain of the Protein | 99.93 | |
| PLN00034 | 353 | mitogen-activated protein kinase kinase; Provision | 99.93 | |
| cd05045 | 290 | PTKc_RET Catalytic domain of the Protein Tyrosine | 99.93 | |
| cd05608 | 280 | STKc_GRK1 Catalytic domain of the Protein Serine/T | 99.93 | |
| cd05068 | 261 | PTKc_Frk_like Catalytic domain of Fyn-related kina | 99.93 | |
| cd05084 | 252 | PTKc_Fes Catalytic domain of the Protein Tyrosine | 99.93 | |
| cd05104 | 375 | PTKc_Kit Catalytic domain of the Protein Tyrosine | 99.93 | |
| cd05032 | 277 | PTKc_InsR_like Catalytic domain of Insulin Recepto | 99.93 | |
| cd05064 | 266 | PTKc_EphR_A10 Catalytic domain of the Protein Tyro | 99.93 | |
| cd05590 | 320 | STKc_nPKC_eta Catalytic domain of the Protein Seri | 99.93 | |
| cd05617 | 327 | STKc_aPKC_zeta Catalytic domain of the Protein Ser | 99.93 | |
| cd05055 | 302 | PTKc_PDGFR Catalytic domain of the Protein Tyrosin | 99.93 | |
| cd07868 | 317 | STKc_CDK8 Catalytic domain of the Serine/Threonine | 99.93 | |
| cd05062 | 277 | PTKc_IGF-1R Catalytic domain of the Protein Tyrosi | 99.93 | |
| cd05079 | 284 | PTKc_Jak1_rpt2 Catalytic (repeat 2) domain of the | 99.93 | |
| cd05033 | 266 | PTKc_EphR Catalytic domain of Ephrin Receptor Prot | 99.93 | |
| cd05070 | 260 | PTKc_Fyn_Yrk Catalytic domain of the Protein Tyros | 99.93 | |
| PTZ00036 | 440 | glycogen synthase kinase; Provisional | 99.93 | |
| cd05097 | 295 | PTKc_DDR_like Catalytic domain of Discoidin Domain | 99.93 | |
| KOG2345 | 302 | consensus Serine/threonine protein kinase/TGF-beta | 99.93 | |
| cd05616 | 323 | STKc_cPKC_beta Catalytic domain of the Protein Ser | 99.93 | |
| cd05115 | 257 | PTKc_Zap-70 Catalytic domain of the Protein Tyrosi | 99.93 | |
| cd05592 | 316 | STKc_nPKC_theta_delta Catalytic domain of the Prot | 99.93 | |
| PHA03212 | 391 | serine/threonine kinase US3; Provisional | 99.93 | |
| cd06649 | 331 | PKc_MEK2 Catalytic domain of the dual-specificity | 99.92 | |
| cd08228 | 267 | STKc_Nek6 Catalytic domain of the Protein Serine/T | 99.92 | |
| cd05589 | 324 | STKc_PKN Catalytic domain of the Protein Serine/Th | 99.92 | |
| cd05092 | 280 | PTKc_TrkA Catalytic domain of the Protein Tyrosine | 99.92 | |
| cd05595 | 323 | STKc_PKB_beta Catalytic domain of the Protein Seri | 99.92 | |
| cd05148 | 261 | PTKc_Srm_Brk Catalytic domain of the Protein Tyros | 99.92 | |
| cd05101 | 304 | PTKc_FGFR2 Catalytic domain of the Protein Tyrosin | 99.92 | |
| cd05082 | 256 | PTKc_Csk Catalytic domain of the Protein Tyrosine | 99.92 | |
| cd05588 | 329 | STKc_aPKC Catalytic domain of the Protein Serine/T | 99.92 | |
| KOG0589 | 426 | consensus Serine/threonine protein kinase [General | 99.92 | |
| cd05587 | 324 | STKc_cPKC Catalytic domain of the Protein Serine/T | 99.92 | |
| cd05036 | 277 | PTKc_ALK_LTK Catalytic domain of the Protein Tyros | 99.92 | |
| cd05069 | 260 | PTKc_Yes Catalytic domain of the Protein Tyrosine | 99.92 | |
| PHA03207 | 392 | serine/threonine kinase US3; Provisional | 99.92 | |
| KOG0599 | 411 | consensus Phosphorylase kinase gamma subunit [Carb | 99.92 | |
| cd05095 | 296 | PTKc_DDR2 Catalytic domain of the Protein Tyrosine | 99.92 | |
| cd05573 | 350 | STKc_ROCK_NDR_like Catalytic domain of ROCK- and N | 99.92 | |
| cd05584 | 323 | STKc_p70S6K Catalytic domain of the Protein Serine | 99.92 | |
| cd05090 | 283 | PTKc_Ror1 Catalytic domain of the Protein Tyrosine | 99.92 | |
| cd08229 | 267 | STKc_Nek7 Catalytic domain of the Protein Serine/T | 99.92 | |
| cd05620 | 316 | STKc_nPKC_delta Catalytic domain of the Protein Se | 99.92 | |
| cd05043 | 280 | PTK_Ryk Pseudokinase domain of Ryk (Receptor relat | 99.92 | |
| cd05114 | 256 | PTKc_Tec_Rlk Catalytic domain of the Protein Tyros | 99.92 | |
| cd05071 | 262 | PTKc_Src Catalytic domain of the Protein Tyrosine | 99.92 | |
| cd05582 | 318 | STKc_RSK_N N-terminal catalytic domain of the Prot | 99.92 | |
| cd08224 | 267 | STKc_Nek6_Nek7 Catalytic domain of the Protein Ser | 99.92 | |
| cd05099 | 314 | PTKc_FGFR4 Catalytic domain of the Protein Tyrosin | 99.92 | |
| cd05604 | 325 | STKc_SGK3 Catalytic domain of the Protein Serine/T | 99.92 | |
| PHA03211 | 461 | serine/threonine kinase US3; Provisional | 99.92 | |
| KOG0596 | 677 | consensus Dual specificity; serine/threonine and t | 99.92 | |
| PTZ00263 | 329 | protein kinase A catalytic subunit; Provisional | 99.92 | |
| cd05602 | 325 | STKc_SGK1 Catalytic domain of the Protein Serine/T | 99.92 | |
| cd05575 | 323 | STKc_SGK Catalytic domain of the Protein Serine/Th | 99.92 | |
| KOG0594 | 323 | consensus Protein kinase PCTAIRE and related kinas | 99.92 | |
| cd05060 | 257 | PTKc_Syk_like Catalytic domain of Spleen Tyrosine | 99.92 | |
| PHA02882 | 294 | putative serine/threonine kinase; Provisional | 99.92 | |
| cd05105 | 400 | PTKc_PDGFR_alpha Catalytic domain of the Protein T | 99.92 | |
| cd05059 | 256 | PTKc_Tec_like Catalytic domain of Tec-like Protein | 99.92 | |
| cd05586 | 330 | STKc_Sck1_like Catalytic domain of Suppressor of l | 99.92 | |
| cd05038 | 284 | PTKc_Jak_rpt2 Catalytic (repeat 2) domain of the P | 99.92 | |
| cd07867 | 317 | STKc_CDC2L6 Catalytic domain of Serine/Threonine K | 99.92 | |
| cd05570 | 318 | STKc_PKC Catalytic domain of the Protein Serine/Th | 99.92 | |
| cd05619 | 316 | STKc_nPKC_theta Catalytic domain of the Protein Se | 99.92 | |
| cd00192 | 262 | PTKc Catalytic domain of Protein Tyrosine Kinases. | 99.92 | |
| cd05044 | 269 | PTKc_c-ros Catalytic domain of the Protein Tyrosin | 99.92 | |
| cd05098 | 307 | PTKc_FGFR1 Catalytic domain of the Protein Tyrosin | 99.92 | |
| cd05113 | 256 | PTKc_Btk_Bmx Catalytic domain of the Protein Tyros | 99.92 | |
| cd05601 | 330 | STKc_CRIK Catalytic domain of the Protein Serine/T | 99.92 | |
| cd06637 | 272 | STKc_TNIK Catalytic domain of the Protein Serine/T | 99.92 | |
| cd05089 | 297 | PTKc_Tie1 Catalytic domain of the Protein Tyrosine | 99.92 | |
| cd05067 | 260 | PTKc_Lck_Blk Catalytic domain of the Protein Tyros | 99.92 | |
| cd07875 | 364 | STKc_JNK1 Catalytic domain of the Serine/Threonine | 99.92 | |
| cd05612 | 291 | STKc_PRKX_like Catalytic domain of PRKX-like Prote | 99.92 | |
| cd05063 | 268 | PTKc_EphR_A2 Catalytic domain of the Protein Tyros | 99.92 | |
| cd07874 | 355 | STKc_JNK3 Catalytic domain of the Serine/Threonine | 99.92 | |
| cd05047 | 270 | PTKc_Tie Catalytic domain of Tie Protein Tyrosine | 99.92 | |
| cd05100 | 334 | PTKc_FGFR3 Catalytic domain of the Protein Tyrosin | 99.92 | |
| cd05081 | 284 | PTKc_Jak2_Jak3_rpt2 Catalytic (repeat 2) domain of | 99.92 | |
| cd05087 | 269 | PTKc_Aatyk1_Aatyk3 Catalytic domain of the Protein | 99.92 | |
| cd05110 | 303 | PTKc_HER4 Catalytic domain of the Protein Tyrosine | 99.92 | |
| cd05607 | 277 | STKc_GRK7 Catalytic domain of the Protein Serine/T | 99.92 | |
| cd05041 | 251 | PTKc_Fes_like Catalytic domain of Fes-like Protein | 99.92 | |
| cd05088 | 303 | PTKc_Tie2 Catalytic domain of the Protein Tyrosine | 99.92 | |
| cd05058 | 262 | PTKc_Met_Ron Catalytic domain of the Protein Tyros | 99.92 | |
| cd05603 | 321 | STKc_SGK2 Catalytic domain of the Protein Serine/T | 99.92 | |
| KOG0605 | 550 | consensus NDR and related serine/threonine kinases | 99.92 | |
| cd05085 | 250 | PTKc_Fer Catalytic domain of the Protein Tyrosine | 99.92 | |
| cd08529 | 256 | STKc_FA2-like Catalytic domain of the Protein Seri | 99.92 | |
| cd07853 | 372 | STKc_NLK Catalytic domain of the Serine/Threonine | 99.92 | |
| cd05615 | 323 | STKc_cPKC_alpha Catalytic domain of the Protein Se | 99.92 | |
| PTZ00426 | 340 | cAMP-dependent protein kinase catalytic subunit; P | 99.92 | |
| cd05073 | 260 | PTKc_Hck Catalytic domain of the Protein Tyrosine | 99.92 | |
| PLN00113 | 968 | leucine-rich repeat receptor-like protein kinase; | 99.92 | |
| PTZ00284 | 467 | protein kinase; Provisional | 99.92 | |
| cd07876 | 359 | STKc_JNK2 Catalytic domain of the Serine/Threonine | 99.92 | |
| cd05077 | 262 | PTK_Jak1_rpt1 Pseudokinase (repeat 1) domain of th | 99.92 | |
| cd05057 | 279 | PTKc_EGFR_like Catalytic domain of Epidermal Growt | 99.92 | |
| cd05040 | 257 | PTKc_Ack_like Catalytic domain of the Protein Tyro | 99.91 | |
| cd05065 | 269 | PTKc_EphR_B Catalytic domain of the Protein Tyrosi | 99.91 | |
| cd05061 | 288 | PTKc_InsR Catalytic domain of the Protein Tyrosine | 99.91 | |
| cd07872 | 309 | STKc_PCTAIRE2 Catalytic domain of the Serine/Threo | 99.91 | |
| cd06654 | 296 | STKc_PAK1 Catalytic domain of the Protein Serine/T | 99.91 | |
| cd08223 | 257 | STKc_Nek4 Catalytic domain of the Protein Serine/T | 99.91 | |
| PHA03209 | 357 | serine/threonine kinase US3; Provisional | 99.91 | |
| cd05042 | 269 | PTKc_Aatyk Catalytic domain of the Protein Tyrosin | 99.91 | |
| KOG0597 | 808 | consensus Serine-threonine protein kinase FUSED [G | 99.91 | |
| cd05037 | 259 | PTK_Jak_rpt1 Pseudokinase (repeat 1) domain of the | 99.91 | |
| cd05596 | 370 | STKc_ROCK Catalytic domain of the Protein Serine/T | 99.91 | |
| cd05605 | 285 | STKc_GRK4_like Catalytic domain of G protein-coupl | 99.91 | |
| cd05050 | 288 | PTKc_Musk Catalytic domain of the Protein Tyrosine | 99.91 | |
| cd05083 | 254 | PTKc_Chk Catalytic domain of the Protein Tyrosine | 99.91 | |
| cd05039 | 256 | PTKc_Csk_like Catalytic domain of C-terminal Src k | 99.91 | |
| cd08219 | 255 | STKc_Nek3 Catalytic domain of the Protein Serine/T | 99.91 | |
| KOG1095 | 1025 | consensus Protein tyrosine kinase [Signal transduc | 99.91 | |
| cd08528 | 269 | STKc_Nek10 Catalytic domain of the Protein Serine/ | 99.91 | |
| cd05626 | 381 | STKc_LATS2 Catalytic domain of the Protein Serine/ | 99.91 | |
| cd06643 | 282 | STKc_SLK Catalytic domain of the Protein Serine/Th | 99.91 | |
| cd05074 | 273 | PTKc_Tyro3 Catalytic domain of the Protein Tyrosin | 99.91 | |
| cd07839 | 284 | STKc_CDK5 Catalytic domain of the Serine/Threonine | 99.91 | |
| cd05599 | 364 | STKc_NDR_like Catalytic domain of Nuclear Dbf2-Rel | 99.91 | |
| cd05621 | 370 | STKc_ROCK2 Catalytic domain of the Protein Serine/ | 99.91 | |
| cd06616 | 288 | PKc_MKK4 Catalytic domain of the dual-specificity | 99.91 | |
| cd07861 | 285 | STKc_CDK1_euk Catalytic domain of the Serine/Threo | 99.91 | |
| cd06612 | 256 | STKc_MST1_2 Catalytic domain of the Protein Serine | 99.91 | |
| cd05633 | 279 | STKc_GRK3 Catalytic domain of the Protein Serine/T | 99.91 | |
| cd06619 | 279 | PKc_MKK5 Catalytic domain of the dual-specificity | 99.91 | |
| cd06625 | 263 | STKc_MEKK3_like Catalytic domain of MAP/ERK kinase | 99.91 | |
| cd05078 | 258 | PTK_Jak2_Jak3_rpt1 Pseudokinase (repeat 1) domain | 99.91 | |
| cd05628 | 363 | STKc_NDR1 Catalytic domain of the Protein Serine/T | 99.91 | |
| cd07873 | 301 | STKc_PCTAIRE1 Catalytic domain of the Serine/Threo | 99.91 | |
| cd05625 | 382 | STKc_LATS1 Catalytic domain of the Protein Serine/ | 99.91 | |
| cd06650 | 333 | PKc_MEK1 Catalytic domain of the dual-specificity | 99.91 | |
| cd05066 | 267 | PTKc_EphR_A Catalytic domain of the Protein Tyrosi | 99.91 | |
| cd05034 | 261 | PTKc_Src_like Catalytic domain of Src kinase-like | 99.91 | |
| cd05598 | 376 | STKc_LATS Catalytic domain of the Protein Serine/T | 99.91 | |
| cd05056 | 270 | PTKc_FAK Catalytic domain of the Protein Tyrosine | 99.91 | |
| KOG0033 | 355 | consensus Ca2+/calmodulin-dependent protein kinase | 99.91 | |
| cd05112 | 256 | PTKc_Itk Catalytic domain of the Protein Tyrosine | 99.91 | |
| cd07878 | 343 | STKc_p38beta_MAPK11 Catalytic domain of the Serine | 99.91 | |
| cd08227 | 327 | PK_STRAD_alpha Pseudokinase domain of STE20-relate | 99.91 | |
| cd06636 | 282 | STKc_MAP4K4_6 Catalytic domain of the Protein Seri | 99.91 | |
| cd06642 | 277 | STKc_STK25-YSK1 Catalytic domain of the Protein Se | 99.91 | |
| KOG0604 | 400 | consensus MAP kinase-activated protein kinase 2 [S | 99.91 | |
| cd06658 | 292 | STKc_PAK5 Catalytic domain of the Protein Serine/T | 99.91 | |
| KOG0667 | 586 | consensus Dual-specificity tyrosine-phosphorylatio | 99.91 | |
| cd05086 | 268 | PTKc_Aatyk2 Catalytic domain of the Protein Tyrosi | 99.91 | |
| cd06617 | 283 | PKc_MKK3_6 Catalytic domain of the dual-specificit | 99.91 | |
| cd05630 | 285 | STKc_GRK6 Catalytic domain of the Protein Serine/T | 99.91 | |
| cd06646 | 267 | STKc_MAP4K5 Catalytic domain of the Protein Serine | 99.9 | |
| cd05632 | 285 | STKc_GRK5 Catalytic domain of the Protein Serine/T | 99.9 | |
| cd05076 | 274 | PTK_Tyk2_rpt1 Pseudokinase (repeat 1) domain of th | 99.9 | |
| KOG0983 | 391 | consensus Mitogen-activated protein kinase (MAPK) | 99.9 | |
| PF00069 | 260 | Pkinase: Protein kinase domain Protein kinase; unc | 99.9 | |
| cd05622 | 371 | STKc_ROCK1 Catalytic domain of the Protein Serine/ | 99.9 | |
| cd05629 | 377 | STKc_NDR_like_fungal Catalytic domain of Fungal Nu | 99.9 | |
| cd06639 | 291 | STKc_myosinIIIB Catalytic domain of the Protein Se | 99.9 | |
| cd06613 | 262 | STKc_MAP4K3_like Catalytic domain of Mitogen-activ | 99.9 | |
| cd07847 | 286 | STKc_CDKL1_4 Catalytic domain of the Serine/Threon | 99.9 | |
| cd06645 | 267 | STKc_MAP4K3 Catalytic domain of the Protein Serine | 99.9 | |
| cd06628 | 267 | STKc_MAPKKK_Byr2_like Catalytic domain of fungal B | 99.9 | |
| smart00750 | 176 | KIND kinase non-catalytic C-lobe domain. It is an | 99.9 | |
| cd06644 | 292 | STKc_STK10_LOK Catalytic domain of the Protein Ser | 99.9 | |
| cd06656 | 297 | STKc_PAK3 Catalytic domain of the Protein Serine/T | 99.9 | |
| cd05103 | 343 | PTKc_VEGFR2 Catalytic domain of the Protein Tyrosi | 99.9 | |
| cd05627 | 360 | STKc_NDR2 Catalytic domain of the Protein Serine/T | 99.9 | |
| cd06608 | 275 | STKc_myosinIII_like Catalytic domain of Class III | 99.9 | |
| cd06651 | 266 | STKc_MEKK3 Catalytic domain of the Protein Serine/ | 99.9 | |
| cd06659 | 297 | STKc_PAK6 Catalytic domain of the Protein Serine/T | 99.9 | |
| cd06640 | 277 | STKc_MST4 Catalytic domain of the Protein Serine/T | 99.9 | |
| cd06655 | 296 | STKc_PAK2 Catalytic domain of the Protein Serine/T | 99.9 | |
| cd06638 | 286 | STKc_myosinIIIA Catalytic domain of the Protein Se | 99.9 | |
| cd06609 | 274 | STKc_MST3_like Catalytic domain of Mammalian Ste20 | 99.9 | |
| cd07849 | 336 | STKc_ERK1_2_like Catalytic domain of Extracellular | 99.9 | |
| KOG0611 | 668 | consensus Predicted serine/threonine protein kinas | 99.9 | |
| KOG0603 | 612 | consensus Ribosomal protein S6 kinase [Signal tran | 99.9 | |
| cd05118 | 283 | STKc_CMGC Catalytic domain of CMGC family Serine/T | 99.9 | |
| smart00219 | 258 | TyrKc Tyrosine kinase, catalytic domain. Phosphotr | 99.9 | |
| cd08217 | 265 | STKc_Nek2 Catalytic domain of the Protein Serine/T | 99.9 | |
| cd07833 | 288 | STKc_CDKL Catalytic domain of Cyclin-Dependent pro | 99.9 | |
| cd07842 | 316 | STKc_CDK8_like Catalytic domain of Cyclin-Dependen | 99.9 | |
| cd08218 | 256 | STKc_Nek1 Catalytic domain of the Protein Serine/T | 99.9 | |
| cd06605 | 265 | PKc_MAPKK Catalytic domain of the dual-specificity | 99.9 | |
| KOG0196 | 996 | consensus Tyrosine kinase, EPH (ephrin) receptor f | 99.9 | |
| cd07846 | 286 | STKc_CDKL2_3 Catalytic domain of the Serine/Threon | 99.9 | |
| KOG4279 | 1226 | consensus Serine/threonine protein kinase [Signal | 99.9 | |
| cd06629 | 272 | STKc_MAPKKK_Bck1_like Catalytic domain of fungal B | 99.9 | |
| KOG0194 | 474 | consensus Protein tyrosine kinase [Signal transduc | 99.9 | |
| cd07841 | 298 | STKc_CDK7 Catalytic domain of the Serine/Threonine | 99.9 | |
| cd07865 | 310 | STKc_CDK9 Catalytic domain of the Serine/Threonine | 99.9 | |
| cd08221 | 256 | STKc_Nek9 Catalytic domain of the Protein Serine/T | 99.9 | |
| cd07831 | 282 | STKc_MOK Catalytic domain of the Serine/Threonine | 99.9 | |
| PHA03390 | 267 | pk1 serine/threonine-protein kinase 1; Provisional | 99.9 | |
| cd07850 | 353 | STKc_JNK Catalytic domain of the Serine/Threonine | 99.9 | |
| cd06615 | 308 | PKc_MEK Catalytic domain of the dual-specificity P | 99.9 | |
| cd07837 | 295 | STKc_CdkB_plant Catalytic domain of the Serine/Thr | 99.9 | |
| cd07843 | 293 | STKc_CDC2L1 Catalytic domain of the Serine/Threoni | 99.9 | |
| cd05611 | 260 | STKc_Rim15_like Catalytic domain of fungal Rim15-l | 99.9 | |
| cd07858 | 337 | STKc_TEY_MAPK_plant Catalytic domain of the Serine | 99.9 | |
| cd07845 | 309 | STKc_CDK10 Catalytic domain of the Serine/Threonin | 99.9 | |
| cd05623 | 332 | STKc_MRCK_alpha Catalytic domain of the Protein Se | 99.9 | |
| PHA03210 | 501 | serine/threonine kinase US3; Provisional | 99.9 | |
| cd05606 | 278 | STKc_beta_ARK Catalytic domain of the Protein Seri | 99.9 | |
| cd07860 | 284 | STKc_CDK2_3 Catalytic domain of the Serine/Threoni | 99.9 | |
| cd08216 | 314 | PK_STRAD Pseudokinase domain of STE20-related kina | 99.9 | |
| cd06624 | 268 | STKc_ASK Catalytic domain of the Protein Serine/Th | 99.9 | |
| cd07835 | 283 | STKc_CDK1_like Catalytic domain of Cyclin-Dependen | 99.89 | |
| cd05107 | 401 | PTKc_PDGFR_beta Catalytic domain of the Protein Ty | 99.89 | |
| cd07838 | 287 | STKc_CDK4_6_like Catalytic domain of Cyclin-Depend | 99.89 | |
| cd05624 | 331 | STKc_MRCK_beta Catalytic domain of the Protein Ser | 99.89 | |
| cd05597 | 331 | STKc_DMPK_like Catalytic domain of Myotonic Dystro | 99.89 | |
| cd06610 | 267 | STKc_OSR1_SPAK Catalytic domain of the Protein Ser | 99.89 | |
| cd06618 | 296 | PKc_MKK7 Catalytic domain of the dual-specificity | 99.89 | |
| KOG0584 | 632 | consensus Serine/threonine protein kinase [General | 99.89 | |
| cd06648 | 285 | STKc_PAK_II Catalytic domain of the Protein Serine | 99.89 | |
| PRK13184 | 932 | pknD serine/threonine-protein kinase; Reviewed | 99.89 | |
| cd05046 | 275 | PTK_CCK4 Pseudokinase domain of the Protein Tyrosi | 99.89 | |
| cd07870 | 291 | STKc_PFTAIRE2 Catalytic domain of the Serine/Threo | 99.89 | |
| cd05122 | 253 | PKc_STE Catalytic domain of STE family Protein Kin | 99.89 | |
| KOG4645 | 1509 | consensus MAPKKK (MAP kinase kinase kinase) SSK2 a | 99.89 | |
| cd07844 | 291 | STKc_PCTAIRE_like Catalytic domain of PCTAIRE-like | 99.89 | |
| cd05572 | 262 | STKc_cGK_PKG Catalytic domain of the Protein Serin | 99.89 | |
| cd06611 | 280 | STKc_SLK_like Catalytic domain of Ste20-like kinas | 99.89 | |
| cd06631 | 265 | STKc_YSK4 Catalytic domain of the Protein Serine/T | 99.89 | |
| cd08220 | 256 | STKc_Nek8 Catalytic domain of the Protein Serine/T | 99.89 | |
| cd07840 | 287 | STKc_CDK9_like Catalytic domain of Cyclin-Dependen | 99.89 | |
| cd07866 | 311 | STKc_BUR1 Catalytic domain of the Serine/Threonine | 99.89 | |
| cd06622 | 286 | PKc_MAPKK_PBS2_like Catalytic domain of fungal PBS | 99.89 | |
| cd06632 | 258 | STKc_MEKK1_plant Catalytic domain of the Protein S | 99.89 | |
| KOG4278 | 1157 | consensus Protein tyrosine kinase [Signal transduc | 99.89 | |
| cd05574 | 316 | STKc_phototropin_like Catalytic domain of Phototro | 99.89 | |
| cd07855 | 334 | STKc_ERK5 Catalytic domain of the Serine/Threonine | 99.89 | |
| cd06621 | 287 | PKc_MAPKK_Pek1_like Catalytic domain of fungal Pek | 99.89 | |
| cd06620 | 284 | PKc_MAPKK_Byr1_like Catalytic domain of fungal Byr | 99.89 | |
| cd06606 | 260 | STKc_MAPKKK Catalytic domain of the Protein Serine | 99.89 | |
| cd06607 | 307 | STKc_TAO Catalytic domain of the Protein Serine/Th | 99.89 | |
| KOG0577 | 948 | consensus Serine/threonine protein kinase [Signal | 99.89 | |
| cd07832 | 286 | STKc_CCRK Catalytic domain of the Serine/Threonine | 99.89 | |
| cd06626 | 264 | STKc_MEKK4 Catalytic domain of the Protein Serine/ | 99.89 | |
| KOG1035 | 1351 | consensus eIF-2alpha kinase GCN2 [Translation, rib | 99.89 | |
| cd06917 | 277 | STKc_NAK1_like Catalytic domain of Fungal Nak1-lik | 99.89 | |
| cd07864 | 302 | STKc_CDK12 Catalytic domain of the Serine/Threonin | 99.89 | |
| PLN00181 | 793 | protein SPA1-RELATED; Provisional | 99.89 | |
| cd07834 | 330 | STKc_MAPK Catalytic domain of the Serine/Threonine | 99.89 | |
| cd06647 | 293 | STKc_PAK_I Catalytic domain of the Protein Serine/ | 99.89 | |
| cd06623 | 264 | PKc_MAPKK_plant_like Catalytic domain of Plant dua | 99.89 | |
| cd05609 | 305 | STKc_MAST Catalytic domain of the Protein Serine/T | 99.89 | |
| KOG0610 | 459 | consensus Putative serine/threonine protein kinase | 99.89 | |
| cd07852 | 337 | STKc_MAPK15 Catalytic domain of the Serine/Threoni | 99.89 | |
| cd06652 | 265 | STKc_MEKK2 Catalytic domain of the Protein Serine/ | 99.89 | |
| PTZ00266 | 1021 | NIMA-related protein kinase; Provisional | 99.89 | |
| cd08226 | 328 | PK_STRAD_beta Pseudokinase domain of STE20-related | 99.89 | |
| cd05577 | 277 | STKc_GRK Catalytic domain of the Protein Serine/Th | 99.89 | |
| cd08530 | 256 | STKc_CNK2-like Catalytic domain of the Protein Ser | 99.89 | |
| cd06635 | 317 | STKc_TAO1 Catalytic domain of the Protein Serine/T | 99.89 | |
| cd05583 | 288 | STKc_MSK_N N-terminal catalytic domain of the Prot | 99.89 | |
| cd07830 | 283 | STKc_MAK_like Catalytic domain of Male germ cell-A | 99.88 | |
| PLN00009 | 294 | cyclin-dependent kinase A; Provisional | 99.88 | |
| cd08225 | 257 | STKc_Nek5 Catalytic domain of the Protein Serine/T | 99.88 | |
| cd07836 | 284 | STKc_Pho85 Catalytic domain of the Serine/Threonin | 99.88 | |
| cd06630 | 268 | STKc_MEKK1 Catalytic domain of the Protein Serine/ | 99.88 | |
| cd06634 | 308 | STKc_TAO2 Catalytic domain of the Protein Serine/T | 99.88 | |
| cd06641 | 277 | STKc_MST3 Catalytic domain of the Protein Serine/T | 99.88 | |
| cd05579 | 265 | STKc_MAST_like Catalytic domain of Microtubule-ass | 99.88 | |
| KOG0986 | 591 | consensus G protein-coupled receptor kinase [Signa | 99.88 | |
| cd07857 | 332 | STKc_MPK1 Catalytic domain of the Serine/Threonine | 99.88 | |
| cd06614 | 286 | STKc_PAK Catalytic domain of the Protein Serine/Th | 99.88 | |
| KOG1094 | 807 | consensus Discoidin domain receptor DDR1 [Signal t | 99.88 | |
| cd08215 | 258 | STKc_Nek Catalytic domain of the Protein Serine/Th | 99.88 | |
| KOG0580 | 281 | consensus Serine/threonine protein kinase [Cell cy | 99.88 | |
| cd07879 | 342 | STKc_p38delta_MAPK13 Catalytic domain of the Serin | 99.88 | |
| cd05580 | 290 | STKc_PKA Catalytic domain of the Protein Serine/Th | 99.88 | |
| cd06657 | 292 | STKc_PAK4 Catalytic domain of the Protein Serine/T | 99.88 | |
| KOG0690 | 516 | consensus Serine/threonine protein kinase [Signal | 99.88 | |
| cd07829 | 282 | STKc_CDK_like Catalytic domain of Cyclin-Dependent | 99.88 | |
| cd05578 | 258 | STKc_Yank1 Catalytic domain of the Protein Serine/ | 99.88 | |
| cd05576 | 237 | STKc_RPK118_like Catalytic domain of the Protein S | 99.88 | |
| KOG0032 | 382 | consensus Ca2+/calmodulin-dependent protein kinase | 99.88 | |
| KOG0574 | 502 | consensus STE20-like serine/threonine kinase MST [ | 99.88 | |
| cd06627 | 254 | STKc_Cdc7_like Catalytic domain of Cell division c | 99.87 | |
| KOG0671 | 415 | consensus LAMMER dual specificity kinases [Signal | 99.87 | |
| cd06633 | 313 | STKc_TAO3 Catalytic domain of the Protein Serine/T | 99.87 | |
| cd07854 | 342 | STKc_MAPK4_6 Catalytic domain of the Serine/Threon | 99.87 | |
| cd05613 | 290 | STKc_MSK1_N N-terminal catalytic domain of the Pro | 99.87 | |
| cd08222 | 260 | STKc_Nek11 Catalytic domain of the Protein Serine/ | 99.87 | |
| PLN03225 | 566 | Serine/threonine-protein kinase SNT7; Provisional | 99.87 | |
| PTZ00024 | 335 | cyclin-dependent protein kinase; Provisional | 99.87 | |
| cd06653 | 264 | STKc_MEKK3_like_1 Catalytic domain of MAP/ERK kina | 99.87 | |
| cd07851 | 343 | STKc_p38 Catalytic domain of the Serine/Threonine | 99.87 | |
| KOG0666 | 438 | consensus Cyclin C-dependent kinase CDK8 [Transcri | 99.87 | |
| KOG0696 | 683 | consensus Serine/threonine protein kinase [Signal | 99.87 | |
| KOG1006 | 361 | consensus Mitogen-activated protein kinase (MAPK) | 99.87 | |
| KOG4257 | 974 | consensus Focal adhesion tyrosine kinase FAK, cont | 99.87 | |
| KOG3653 | 534 | consensus Transforming growth factor beta/activin | 99.86 | |
| cd05581 | 280 | STKc_PDK1 Catalytic domain of the Protein Serine/T | 99.86 | |
| cd07880 | 343 | STKc_p38gamma_MAPK12 Catalytic domain of the Serin | 99.86 | |
| KOG0579 | 1187 | consensus Ste20-like serine/threonine protein kina | 99.86 | |
| KOG0614 | 732 | consensus cGMP-dependent protein kinase [Signal tr | 99.86 | |
| cd07877 | 345 | STKc_p38alpha_MAPK14 Catalytic domain of the Serin | 99.86 | |
| KOG0199 | 1039 | consensus ACK and related non-receptor tyrosine ki | 99.86 | |
| cd05123 | 250 | STKc_AGC Catalytic domain of AGC family Protein Se | 99.86 | |
| cd07856 | 328 | STKc_Sty1_Hog1 Catalytic domain of the Serine/Thre | 99.85 | |
| KOG4717 | 864 | consensus Serine/threonine protein kinase [Signal | 99.85 | |
| KOG0200 | 609 | consensus Fibroblast/platelet-derived growth facto | 99.85 | |
| smart00220 | 244 | S_TKc Serine/Threonine protein kinases, catalytic | 99.85 | |
| KOG0669 | 376 | consensus Cyclin T-dependent kinase CDK9 [Cell cyc | 99.84 | |
| KOG0665 | 369 | consensus Jun-N-terminal kinase (JNK) [Signal tran | 99.84 | |
| KOG2052 | 513 | consensus Activin A type IB receptor, serine/threo | 99.84 | |
| KOG0586 | 596 | consensus Serine/threonine protein kinase [General | 99.83 | |
| KOG0612 | 1317 | consensus Rho-associated, coiled-coil containing p | 99.83 | |
| KOG0695 | 593 | consensus Serine/threonine protein kinase [Signal | 99.83 | |
| KOG4250 | 732 | consensus TANK binding protein kinase TBK1 [Signal | 99.82 | |
| KOG0984 | 282 | consensus Mitogen-activated protein kinase (MAPK) | 99.82 | |
| KOG1027 | 903 | consensus Serine/threonine protein kinase and endo | 99.82 | |
| KOG1151 | 775 | consensus Tousled-like protein kinase [Signal tran | 99.82 | |
| KOG4236 | 888 | consensus Serine/threonine protein kinase PKC mu/P | 99.82 | |
| KOG0664 | 449 | consensus Nemo-like MAPK-related serine/threonine | 99.82 | |
| KOG0608 | 1034 | consensus Warts/lats-like serine threonine kinases | 99.82 | |
| KOG1025 | 1177 | consensus Epidermal growth factor receptor EGFR an | 99.82 | |
| KOG1024 | 563 | consensus Receptor-like protein tyrosine kinase RY | 99.81 | |
| cd05610 | 669 | STKc_MASTL Catalytic domain of the Protein Serine/ | 99.81 | |
| KOG0607 | 463 | consensus MAP kinase-interacting kinase and relate | 99.8 | |
| KOG0587 | 953 | consensus Traf2- and Nck-interacting kinase and re | 99.79 | |
| PLN03224 | 507 | probable serine/threonine protein kinase; Provisio | 99.78 | |
| KOG1345 | 378 | consensus Serine/threonine kinase [Signal transduc | 99.75 | |
| KOG0670 | 752 | consensus U4/U6-associated splicing factor PRP4 [R | 99.75 | |
| cd00180 | 215 | PKc Catalytic domain of Protein Kinases. Protein K | 99.75 | |
| KOG0662 | 292 | consensus Cyclin-dependent kinase CDK5 [Intracellu | 99.74 | |
| KOG0668 | 338 | consensus Casein kinase II, alpha subunit [Signal | 99.74 | |
| KOG1290 | 590 | consensus Serine/threonine protein kinase [Signal | 99.73 | |
| KOG0590 | 601 | consensus Checkpoint kinase and related serine/thr | 99.7 | |
| KOG1167 | 418 | consensus Serine/threonine protein kinase of the C | 99.69 | |
| KOG1152 | 772 | consensus Signal transduction serine/threonine kin | 99.61 | |
| smart00221 | 225 | STYKc Protein kinase; unclassified specificity. Ph | 99.61 | |
| KOG0576 | 829 | consensus Mitogen-activated protein kinase kinase | 99.57 | |
| KOG1023 | 484 | consensus Natriuretic peptide receptor, guanylate | 99.56 | |
| PF14531 | 288 | Kinase-like: Kinase-like; PDB: 3DZO_A 2W1Z_A 3BYV_ | 99.55 | |
| KOG1033 | 516 | consensus eIF-2alpha kinase PEK/EIF2AK3 [Translati | 99.53 | |
| COG0515 | 384 | SPS1 Serine/threonine protein kinase [General func | 99.47 | |
| KOG1164 | 322 | consensus Casein kinase (serine/threonine/tyrosine | 99.46 | |
| KOG1240 | 1431 | consensus Protein kinase containing WD40 repeats [ | 99.44 | |
| KOG0195 | 448 | consensus Integrin-linked kinase [Signal transduct | 99.43 | |
| KOG4158 | 598 | consensus BRPK/PTEN-induced protein kinase [Signal | 99.43 | |
| KOG0603 | 612 | consensus Ribosomal protein S6 kinase [Signal tran | 99.3 | |
| PRK09188 | 365 | serine/threonine protein kinase; Provisional | 99.3 | |
| KOG0606 | 1205 | consensus Microtubule-associated serine/threonine | 99.27 | |
| PRK12274 | 218 | serine/threonine protein kinase; Provisional | 99.18 | |
| KOG1166 | 974 | consensus Mitotic checkpoint serine/threonine prot | 99.18 | |
| PRK10359 | 232 | lipopolysaccharide core biosynthesis protein; Prov | 99.17 | |
| cd05145 | 190 | RIO1_like RIO kinase family; RIO1, RIO3 and simila | 99.14 | |
| cd05147 | 190 | RIO1_euk RIO kinase family; eukaryotic RIO1, catal | 99.14 | |
| KOG1165 | 449 | consensus Casein kinase (serine/threonine/tyrosine | 99.09 | |
| KOG1266 | 458 | consensus Protein kinase [Signal transduction mech | 98.98 | |
| KOG1163 | 341 | consensus Casein kinase (serine/threonine/tyrosine | 98.95 | |
| KOG0590 | 601 | consensus Checkpoint kinase and related serine/thr | 98.95 | |
| PF01453 | 114 | B_lectin: D-mannose binding lectin; InterPro: IPR0 | 98.81 | |
| smart00108 | 114 | B_lectin Bulb-type mannose-specific lectin. | 98.8 | |
| cd05144 | 198 | RIO2_C RIO kinase family; RIO2, C-terminal catalyt | 98.8 | |
| COG4248 | 637 | Uncharacterized protein with protein kinase and he | 98.77 | |
| smart00090 | 237 | RIO RIO-like kinase. | 98.77 | |
| cd00028 | 116 | B_lectin Bulb-type mannose-specific lectin. The do | 98.75 | |
| KOG2137 | 700 | consensus Protein kinase [Signal transduction mech | 98.64 | |
| cd05119 | 187 | RIO RIO kinase family, catalytic domain. The RIO k | 98.61 | |
| TIGR03724 | 199 | arch_bud32 Kae1-associated kinase Bud32. Members o | 98.56 | |
| PRK01723 | 239 | 3-deoxy-D-manno-octulosonic-acid kinase; Reviewed | 98.53 | |
| PRK09605 | 535 | bifunctional UGMP family protein/serine/threonine | 98.52 | |
| PRK14879 | 211 | serine/threonine protein kinase; Provisional | 98.45 | |
| cd05120 | 155 | APH_ChoK_like Aminoglycoside 3'-phosphotransferase | 98.45 | |
| KOG0601 | 524 | consensus Cyclin-dependent kinase WEE1 [Cell cycle | 98.37 | |
| PRK10345 | 210 | hypothetical protein; Provisional | 98.35 | |
| cd05146 | 197 | RIO3_euk RIO kinase family; eukaryotic RIO3, catal | 98.31 | |
| cd05151 | 170 | ChoK Choline Kinase (ChoK). The ChoK subfamily is | 98.17 | |
| TIGR01982 | 437 | UbiB 2-polyprenylphenol 6-hydroxylase. This model | 98.06 | |
| PF11883 | 48 | DUF3403: Domain of unknown function (DUF3403); Int | 98.04 | |
| KOG0606 | 1205 | consensus Microtubule-associated serine/threonine | 98.03 | |
| KOG0601 | 524 | consensus Cyclin-dependent kinase WEE1 [Cell cycle | 98.01 | |
| COG3642 | 204 | Mn2+-dependent serine/threonine protein kinase [Si | 97.98 | |
| PRK15123 | 268 | lipopolysaccharide core heptose(I) kinase RfaP; Pr | 97.94 | |
| PF01163 | 188 | RIO1: RIO1 family; InterPro: IPR018934 Protein pho | 97.74 | |
| PF06293 | 206 | Kdo: Lipopolysaccharide kinase (Kdo/WaaP) family; | 97.68 | |
| KOG3087 | 229 | consensus Serine/threonine protein kinase [General | 97.52 | |
| PF06176 | 229 | WaaY: Lipopolysaccharide core biosynthesis protein | 97.42 | |
| KOG1243 | 690 | consensus Protein kinase [General function predict | 97.34 | |
| KOG3741 | 655 | consensus Poly(A) ribonuclease subunit [RNA proces | 97.3 | |
| PRK04750 | 537 | ubiB putative ubiquinone biosynthesis protein UbiB | 97.28 | |
| cd05154 | 223 | ACAD10_11_like Acyl-CoA dehydrogenase (ACAD) 10 an | 97.24 | |
| PRK09902 | 216 | hypothetical protein; Provisional | 96.9 | |
| PF12260 | 188 | PIP49_C: Protein-kinase domain of FAM69; InterPro: | 96.65 | |
| COG0478 | 304 | RIO-like serine/threonine protein kinase fused to | 96.48 | |
| COG1718 | 268 | RIO1 Serine/threonine protein kinase involved in c | 96.06 | |
| cd05150 | 244 | APH Aminoglycoside 3'-phosphotransferase (APH). Th | 94.88 | |
| COG0661 | 517 | AarF Predicted unusual protein kinase [General fun | 94.01 | |
| KOG1035 | 1351 | consensus eIF-2alpha kinase GCN2 [Translation, rib | 93.09 | |
| PF00954 | 110 | S_locus_glycop: S-locus glycoprotein family; Inter | 92.61 | |
| cd05156 | 302 | ChoK_euk Choline Kinase (ChoK) in eukaryotes. The | 92.45 | |
| COG3173 | 321 | Predicted aminoglycoside phosphotransferase [Gener | 92.07 | |
| PF01636 | 239 | APH: Phosphotransferase enzyme family This family | 92.0 | |
| COG5072 | 488 | ALK1 Serine/threonine kinase of the haspin family | 91.77 | |
| cd05155 | 235 | APH_ChoK_like_1 Uncharacterized bacterial proteins | 91.5 | |
| KOG1235 | 538 | consensus Predicted unusual protein kinase [Genera | 91.43 | |
| TIGR00938 | 307 | thrB_alt homoserine kinase, Neisseria type. Homose | 90.71 | |
| KOG0576 | 829 | consensus Mitogen-activated protein kinase kinase | 90.33 | |
| cd05157 | 235 | ETNK_euk Ethanolamine kinase (ETNK) in eukaryotes. | 90.23 | |
| PRK05231 | 319 | homoserine kinase; Provisional | 90.1 | |
| COG2334 | 331 | Putative homoserine kinase type II (protein kinase | 89.32 | |
| cd05153 | 296 | HomoserineK_II Homoserine Kinase, type II. Homoser | 89.03 | |
| TIGR02172 | 226 | Fb_sc_TIGR02172 Fibrobacter succinogenes paralogou | 88.71 | |
| TIGR02906 | 313 | spore_CotS spore coat protein, CotS family. Member | 88.55 | |
| PF01633 | 211 | Choline_kinase: Choline/ethanolamine kinase; Inter | 88.22 | |
| PLN02876 | 822 | acyl-CoA dehydrogenase | 88.09 | |
| PRK10271 | 188 | thiK thiamine kinase; Provisional | 87.57 | |
| TIGR02721 | 256 | ycfN_thiK thiamine kinase. Members of this family | 87.52 | |
| KOG2268 | 465 | consensus Serine/threonine protein kinase [Signal | 87.22 | |
| PHA03111 | 444 | Ser/Thr kinase; Provisional | 87.11 | |
| COG0510 | 269 | ycfN Thiamine kinase and related kinases [Coenzyme | 85.32 | |
| TIGR02904 | 309 | spore_ysxE spore coat protein YsxE. Members of thi | 85.28 | |
| PLN02236 | 344 | choline kinase | 85.07 | |
| cd05152 | 276 | MPH2' Macrolide 2'-Phosphotransferase (MPH2'). MPH | 84.64 | |
| PRK11138 | 394 | outer membrane biogenesis protein BamB; Provisiona | 84.59 | |
| KOG1826 | 2724 | consensus Ras GTPase activating protein RasGAP/neu | 83.32 | |
| PF07387 | 308 | Seadorna_VP7: Seadornavirus VP7; InterPro: IPR0099 | 82.37 | |
| smart00587 | 196 | CHK ZnF_C4 abd HLH domain containing kinases domai | 81.44 | |
| PRK06148 | 1013 | hypothetical protein; Provisional | 80.49 |
| >KOG1187 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-35 Score=299.22 Aligned_cols=196 Identities=39% Similarity=0.645 Sum_probs=168.1
Q ss_pred ccceeeccCCCCC-------CCC-CCChhhHHHHHHHHHHHHHHHhhcCCCceeecCCCccceEecCCCCceecccccee
Q 045315 242 EISFWYESYNNPT-------KKG-LLCWGTRVRIIEGIAQGLLYLHQYSRLRVIHRDLKASNILLDKDMNPKISDFGMAR 313 (476)
Q Consensus 242 ~~~l~~Ey~~~~~-------~~~-~L~~~~~~~i~~qIa~gL~yLH~~~~~~ivH~DLkp~NILld~~~~~kL~DFGla~ 313 (476)
..++|||||++++ +.. +|+|.+|++||.++|+||+|||+...++|||||||++|||||+++.+||+|||+|+
T Consensus 146 ~~~LVYEym~nGsL~d~L~~~~~~~L~W~~R~kIa~g~A~gL~yLH~~~~~~iiHrDiKssNILLD~~~~aKlsDFGLa~ 225 (361)
T KOG1187|consen 146 HRLLVYEYMPNGSLEDHLHGKKGEPLDWETRLKIALGAARGLAYLHEGCPPPIIHRDIKSSNILLDEDFNAKLSDFGLAK 225 (361)
T ss_pred eEEEEEEccCCCCHHHHhCCCCCCCCCHHHHHHHHHHHHHHHHHHccCCCCCEecCCCCHHHeeECCCCCEEccCccCcc
Confidence 3899999999432 222 89999999999999999999999988899999999999999999999999999997
Q ss_pred ecCCCcccccceee-eeccCCCChhhhccCCCCccceEEeehhhhhhhhhCCCCCCcCC-CCchhhhhhhhhhhcCCCcc
Q 045315 314 MFGGDELQSNTKRI-VGTYGYMSPEYALRGLFSIKSDVFSFGVLLLETLSSKKNTHFYN-TDSLTLLGHAWNLWNDGRTW 391 (476)
Q Consensus 314 ~~~~~~~~~~~~~~-~gt~~y~aPE~l~~~~~s~ksDVwSlGvvl~elltG~~p~~~~~-~~~~~~~~~~~~~~~~~~~~ 391 (476)
...... ...... .||.+|+|||++..+..+.|+|||||||+++||++|+++.+... .....+..+++..+.+++..
T Consensus 226 ~~~~~~--~~~~~~~~gt~gY~~PEy~~~g~lt~KsDVySFGVvllElitgr~~~d~~~~~~~~~l~~w~~~~~~~~~~~ 303 (361)
T KOG1187|consen 226 LGPEGD--TSVSTTVMGTFGYLAPEYASTGKLTEKSDVYSFGVVLLELITGRKAVDQSRPRGELSLVEWAKPLLEEGKLR 303 (361)
T ss_pred cCCccc--cceeeecCCCCccCChhhhccCCcCcccccccchHHHHHHHhCCcccCCCCCcccccHHHHHHHHHHCcchh
Confidence 654311 111112 79999999999999999999999999999999999999887654 44555888888899999999
Q ss_pred cccCcccC-CCCCH-HHHHHHHHHHHHchhhcccCCCCHHHHHHHHhccc
Q 045315 392 ELMDPISQ-NGASY-PILKRYINVALLCVQEKAADRPAMSEVVSMLSNEF 439 (476)
Q Consensus 392 ~~~d~~~~-~~~~~-~~~~~l~~li~~Cl~~dP~~RPt~~eVl~~L~~~~ 439 (476)
+++|+.+. ..... .+..++..++.+|++.+|.+||+|.||+++|+.+.
T Consensus 304 eiiD~~l~~~~~~~~~~~~~~~~~a~~C~~~~~~~RP~m~~Vv~~L~~~~ 353 (361)
T KOG1187|consen 304 EIVDPRLKEGEYPDEKEVKKLAELALRCLRPDPKERPTMSQVVKELEGIL 353 (361)
T ss_pred heeCCCccCCCCChHHHHHHHHHHHHHHcCcCCCcCcCHHHHHHHHHhhc
Confidence 99999987 44443 68899999999999999999999999999997755
|
|
| >KOG0581 consensus Mitogen-activated protein kinase kinase (MAP2K) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.97 E-value=2.5e-32 Score=263.13 Aligned_cols=176 Identities=27% Similarity=0.425 Sum_probs=140.2
Q ss_pred ccceeeccCCCCC------CCCCCChhhHHHHHHHHHHHHHHHhh-cCCCceeecCCCccceEecCCCCceeccccceee
Q 045315 242 EISFWYESYNNPT------KKGLLCWGTRVRIIEGIAQGLLYLHQ-YSRLRVIHRDLKASNILLDKDMNPKISDFGMARM 314 (476)
Q Consensus 242 ~~~l~~Ey~~~~~------~~~~L~~~~~~~i~~qIa~gL~yLH~-~~~~~ivH~DLkp~NILld~~~~~kL~DFGla~~ 314 (476)
+..+.||||..+. ..+.+++...-+|+.+|++||.|||+ ++ ||||||||+|||++..|.+||||||.+..
T Consensus 152 ~isI~mEYMDgGSLd~~~k~~g~i~E~~L~~ia~~VL~GL~YLh~~~~---IIHRDIKPsNlLvNskGeVKicDFGVS~~ 228 (364)
T KOG0581|consen 152 EISICMEYMDGGSLDDILKRVGRIPEPVLGKIARAVLRGLSYLHEERK---IIHRDIKPSNLLVNSKGEVKICDFGVSGI 228 (364)
T ss_pred eEEeehhhcCCCCHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHhhccC---eeeccCCHHHeeeccCCCEEeccccccHH
Confidence 4899999999443 23679999999999999999999996 66 99999999999999999999999999988
Q ss_pred cCCCcccccceeeeeccCCCChhhhccCCCCccceEEeehhhhhhhhhCCCCCCcCCCCchhhhhhhhhhhcCCCccccc
Q 045315 315 FGGDELQSNTKRIVGTYGYMSPEYALRGLFSIKSDVFSFGVLLLETLSSKKNTHFYNTDSLTLLGHAWNLWNDGRTWELM 394 (476)
Q Consensus 315 ~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~s~ksDVwSlGvvl~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 394 (476)
+.+. ....+.||..|||||.+.+..|+.++||||||+.++|+.+|+.|+.................. .+..
T Consensus 229 lvnS----~a~tfvGT~~YMsPERi~g~~Ys~~sDIWSLGLsllE~a~GrfP~~~~~~~~~~~~~Ll~~Iv-~~pp---- 299 (364)
T KOG0581|consen 229 LVNS----IANTFVGTSAYMSPERISGESYSVKSDIWSLGLSLLELAIGRFPYPPPNPPYLDIFELLCAIV-DEPP---- 299 (364)
T ss_pred hhhh----hcccccccccccChhhhcCCcCCcccceecccHHHHHHhhCCCCCCCcCCCCCCHHHHHHHHh-cCCC----
Confidence 7654 345588999999999999999999999999999999999999998765322222221111111 1111
Q ss_pred CcccCCCCCH-HHHHHHHHHHHHchhhcccCCCCHHHHHHH
Q 045315 395 DPISQNGASY-PILKRYINVALLCVQEKAADRPAMSEVVSM 434 (476)
Q Consensus 395 d~~~~~~~~~-~~~~~l~~li~~Cl~~dP~~RPt~~eVl~~ 434 (476)
| ..+. ...+++.+++..||++||.+||++.|+++.
T Consensus 300 -P----~lP~~~fS~ef~~FV~~CL~Kdp~~R~s~~qLl~H 335 (364)
T KOG0581|consen 300 -P----RLPEGEFSPEFRSFVSCCLRKDPSERPSAKQLLQH 335 (364)
T ss_pred -C----CCCcccCCHHHHHHHHHHhcCCcccCCCHHHHhcC
Confidence 1 1111 356789999999999999999999998753
|
|
| >KOG0192 consensus Tyrosine kinase specific for activated (GTP-bound) p21cdc42Hs [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.97 E-value=7.4e-32 Score=270.55 Aligned_cols=184 Identities=29% Similarity=0.389 Sum_probs=147.1
Q ss_pred ccceeeccCCCCC--------CCCCCChhhHHHHHHHHHHHHHHHhhcCCCceeecCCCccceEecCCC-Cceeccccce
Q 045315 242 EISFWYESYNNPT--------KKGLLCWGTRVRIIEGIAQGLLYLHQYSRLRVIHRDLKASNILLDKDM-NPKISDFGMA 312 (476)
Q Consensus 242 ~~~l~~Ey~~~~~--------~~~~L~~~~~~~i~~qIa~gL~yLH~~~~~~ivH~DLkp~NILld~~~-~~kL~DFGla 312 (476)
.+.+++|||+.+. .+..|++..+++++.|||+||.|||+++. ||||||||+|||++.+. .+||+|||++
T Consensus 114 ~~~iVtEy~~~GsL~~~l~~~~~~~l~~~~~l~~aldiArGm~YLH~~~~--iIHrDLK~~NiLv~~~~~~~KI~DFGls 191 (362)
T KOG0192|consen 114 SLCIVTEYMPGGSLSVLLHKKRKRKLPLKVRLRIALDIARGMEYLHSEGP--IIHRDLKSDNILVDLKGKTLKIADFGLS 191 (362)
T ss_pred ceEEEEEeCCCCcHHHHHhhcccCCCCHHHHHHHHHHHHHHHHHHhcCCC--eeecccChhhEEEcCCCCEEEECCCccc
Confidence 5889999999432 46899999999999999999999999874 99999999999999997 9999999999
Q ss_pred eecCCCcccccceeeeeccCCCChhhhc--cCCCCccceEEeehhhhhhhhhCCCCCCcCCCCchhhhhhhhhhhcCCCc
Q 045315 313 RMFGGDELQSNTKRIVGTYGYMSPEYAL--RGLFSIKSDVFSFGVLLLETLSSKKNTHFYNTDSLTLLGHAWNLWNDGRT 390 (476)
Q Consensus 313 ~~~~~~~~~~~~~~~~gt~~y~aPE~l~--~~~~s~ksDVwSlGvvl~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~ 390 (476)
+...... .......||+.|||||++. ...|+.|+||||||+++|||+||+.||..... .+.+......+..
T Consensus 192 r~~~~~~--~~~~~~~GT~~wMAPEv~~~~~~~~~~K~DvySFgIvlWEl~t~~~Pf~~~~~-----~~~~~~v~~~~~R 264 (362)
T KOG0192|consen 192 REKVISK--TSMTSVAGTYRWMAPEVLRGEKSPYTEKSDVYSFGIVLWELLTGEIPFEDLAP-----VQVASAVVVGGLR 264 (362)
T ss_pred eeecccc--ccccCCCCCccccChhhhcCCCCcCCccchhhhHHHHHHHHHHCCCCCCCCCH-----HHHHHHHHhcCCC
Confidence 8765432 2222367999999999999 56999999999999999999999999875442 1112222222222
Q ss_pred ccccCcccCCCCCHHHHHHHHHHHHHchhhcccCCCCHHHHHHHHhccccCCC
Q 045315 391 WELMDPISQNGASYPILKRYINVALLCVQEKAADRPAMSEVVSMLSNEFVNLP 443 (476)
Q Consensus 391 ~~~~d~~~~~~~~~~~~~~l~~li~~Cl~~dP~~RPt~~eVl~~L~~~~~~~~ 443 (476)
.. .+......+..++.+||+.||.+||++.+++..|+.+...+.
T Consensus 265 p~---------~p~~~~~~l~~l~~~CW~~dp~~RP~f~ei~~~l~~~~~~~~ 308 (362)
T KOG0192|consen 265 PP---------IPKECPPHLSSLMERCWLVDPSRRPSFLEIVSRLESIMSHIS 308 (362)
T ss_pred CC---------CCccCCHHHHHHHHHhCCCCCCcCCCHHHHHHHHHHHHHhhc
Confidence 11 122245678899999999999999999999999998765444
|
|
| >PF01453 B_lectin: D-mannose binding lectin; InterPro: IPR001480 A bulb lectin super-family (Amaryllidaceae, Orchidaceae and Aliaceae) contains a ~115-residue-long domain whose overall three dimensional fold is very similar to that of [, ]: Dictyostelium discoideum comitin, an actin binding protein Curculigo latifolia curculin, a sweet tasting and taste-modifying protein This domain generally binds mannose, but in at least one protein, curculin, it is apparently devoid of mannose-binding activity | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.5e-31 Score=225.12 Aligned_cols=109 Identities=51% Similarity=0.816 Sum_probs=82.2
Q ss_pred CceEEeecCCCCCCCC--CceEEEecCCceEEEccCCeEEEee-cCCCCC-CCceeeeccCCCeEEEeCCCCCCcCceee
Q 045315 72 DTVVWVANRNSPIFNP--NTALTFSNNGNLVLLSQRNGIIWSS-NMSRKA-ENPIAQLLDTGNLVIRDNSSGHTTESYLW 147 (476)
Q Consensus 72 ~~~vW~an~~~p~~~~--~~~l~~~~~G~lvl~~~~~~~vWss-~~~~~~-~~~~~~l~d~GNlVl~~~~~~~~~~~~~W 147 (476)
+|+||+|||+.|+... .+.|.|+.||||||++..++++|+| ++.+.+ ....|+|+|+|||||++.. +.++|
T Consensus 2 ~tvvW~an~~~p~~~~s~~~~L~l~~dGnLvl~~~~~~~iWss~~t~~~~~~~~~~~L~~~GNlvl~d~~-----~~~lW 76 (114)
T PF01453_consen 2 RTVVWVANRNSPLTSSSGNYTLILQSDGNLVLYDSNGSVIWSSNNTSGRGNSGCYLVLQDDGNLVLYDSS-----GNVLW 76 (114)
T ss_dssp --------TTEEEEECETTEEEEEETTSEEEEEETTTEEEEE--S-TTSS-SSEEEEEETTSEEEEEETT-----SEEEE
T ss_pred cccccccccccccccccccccceECCCCeEEEEcCCCCEEEEecccCCccccCeEEEEeCCCCEEEEeec-----ceEEE
Confidence 6899999999999553 4899999999999999999999999 555544 5889999999999999964 78999
Q ss_pred ccccCCCcccccCCcccCCCCCCcceEEEEeCCCCCCC
Q 045315 148 QSFDYPTDSLLEGMKLGWDLKNGLERYLSSWESTDDPS 185 (476)
Q Consensus 148 qSFd~ptdtll~~~~l~~~~~~g~~~~l~s~~~~~~~s 185 (476)
|||||||||+||||+|+.+..+|....++||++.+|||
T Consensus 77 ~Sf~~ptdt~L~~q~l~~~~~~~~~~~~~sw~s~~dps 114 (114)
T PF01453_consen 77 QSFDYPTDTLLPGQKLGDGNVTGKNDSLTSWSSNTDPS 114 (114)
T ss_dssp ESTTSSS-EEEEEET--TSEEEEESTSSEEEESS----
T ss_pred eecCCCccEEEeccCcccCCCccccceEEeECCCCCCC
Confidence 99999999999999999887777667899999999997
|
Each bulb-type lectin domain consists of three sequential beta-sheet subdomains (I, II, III) that are inter-related by pseudo three-fold symmetry. The three subdomains are flat four-stranded, antiparrallel beta-sheets. Together they form a 12-stranded beta-barrel in which the barrel axis coincides with the pseudo 3-fold axis.; GO: 0005529 sugar binding; PDB: 3M7H_A 3M7J_B 3MEZ_D 1DLP_A 1BWU_D 1KJ1_A 1B2P_A 1XD6_A 2DPF_C 2D04_B .... |
| >KOG0197 consensus Tyrosine kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.96 E-value=2.2e-30 Score=260.30 Aligned_cols=180 Identities=32% Similarity=0.421 Sum_probs=142.7
Q ss_pred ccceeeccCCCC--------CCCCCCChhhHHHHHHHHHHHHHHHhhcCCCceeecCCCccceEecCCCCceecccccee
Q 045315 242 EISFWYESYNNP--------TKKGLLCWGTRVRIIEGIAQGLLYLHQYSRLRVIHRDLKASNILLDKDMNPKISDFGMAR 313 (476)
Q Consensus 242 ~~~l~~Ey~~~~--------~~~~~L~~~~~~~i~~qIa~gL~yLH~~~~~~ivH~DLkp~NILld~~~~~kL~DFGla~ 313 (476)
.++|++|||+.+ ..++.+...+.+.++.|||+|++||++++ +|||||.++||||+++..+||+|||+|+
T Consensus 275 piyIVtE~m~~GsLl~yLr~~~~~~l~~~~Ll~~a~qIaeGM~YLes~~---~IHRDLAARNiLV~~~~~vKIsDFGLAr 351 (468)
T KOG0197|consen 275 PIYIVTEYMPKGSLLDYLRTREGGLLNLPQLLDFAAQIAEGMAYLESKN---YIHRDLAARNILVDEDLVVKISDFGLAR 351 (468)
T ss_pred ceEEEEEecccCcHHHHhhhcCCCccchHHHHHHHHHHHHHHHHHHhCC---ccchhhhhhheeeccCceEEEccccccc
Confidence 489999999933 35778999999999999999999999999 9999999999999999999999999999
Q ss_pred ecCCCcccccceeeeeccCCCChhhhccCCCCccceEEeehhhhhhhhh-CCCCCCcCCCCchhhhhhhhhhhcCCCccc
Q 045315 314 MFGGDELQSNTKRIVGTYGYMSPEYALRGLFSIKSDVFSFGVLLLETLS-SKKNTHFYNTDSLTLLGHAWNLWNDGRTWE 392 (476)
Q Consensus 314 ~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~s~ksDVwSlGvvl~ellt-G~~p~~~~~~~~~~~~~~~~~~~~~~~~~~ 392 (476)
....+....... ..-+..|.|||.+..+.++.|||||||||+||||+| |+.|++... ...+ .+.+..|.
T Consensus 352 ~~~d~~Y~~~~~-~kfPIkWtAPEa~~~~~FS~kSDVWSFGVlL~E~fT~G~~py~~ms--n~ev----~~~le~Gy--- 421 (468)
T KOG0197|consen 352 LIGDDEYTASEG-GKFPIKWTAPEALNYGKFSSKSDVWSFGVLLWELFTYGRVPYPGMS--NEEV----LELLERGY--- 421 (468)
T ss_pred ccCCCceeecCC-CCCCceecCHHHHhhCCcccccceeehhhhHHHHhccCCCCCCCCC--HHHH----HHHHhccC---
Confidence 666554433222 334678999999999999999999999999999998 555544332 1111 11222222
Q ss_pred ccCcccCCCCCHHHHHHHHHHHHHchhhcccCCCCHHHHHHHHhcccc
Q 045315 393 LMDPISQNGASYPILKRYINVALLCVQEKAADRPAMSEVVSMLSNEFV 440 (476)
Q Consensus 393 ~~d~~~~~~~~~~~~~~l~~li~~Cl~~dP~~RPt~~eVl~~L~~~~~ 440 (476)
+-..+...+..+.++|..||+.+|++|||++.+...|+.+..
T Consensus 422 ------Rlp~P~~CP~~vY~lM~~CW~~~P~~RPtF~~L~~~l~~~~~ 463 (468)
T KOG0197|consen 422 ------RLPRPEGCPDEVYELMKSCWHEDPEDRPTFETLREVLEDFFT 463 (468)
T ss_pred ------cCCCCCCCCHHHHHHHHHHhhCCcccCCCHHHHHHHHHHhhh
Confidence 222233345678899999999999999999999999988763
|
|
| >KOG0575 consensus Polo-like serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=99.96 E-value=1e-29 Score=258.18 Aligned_cols=173 Identities=24% Similarity=0.382 Sum_probs=140.7
Q ss_pred ccccceeeccCCCC------CCCCCCChhhHHHHHHHHHHHHHHHhhcCCCceeecCCCccceEecCCCCceecccccee
Q 045315 240 KDEISFWYESYNNP------TKKGLLCWGTRVRIIEGIAQGLLYLHQYSRLRVIHRDLKASNILLDKDMNPKISDFGMAR 313 (476)
Q Consensus 240 ~~~~~l~~Ey~~~~------~~~~~L~~~~~~~i~~qIa~gL~yLH~~~~~~ivH~DLkp~NILld~~~~~kL~DFGla~ 313 (476)
+...|++.|.++.+ .++++|++.++..+++||+.||.|||+++ |||||||..|+||+++.++||+|||+|.
T Consensus 90 s~nVYivLELC~~~sL~el~Krrk~ltEpEary~l~QIv~GlkYLH~~~---IiHRDLKLGNlfL~~~~~VKIgDFGLAt 166 (592)
T KOG0575|consen 90 SNNVYIVLELCHRGSLMELLKRRKPLTEPEARYFLRQIVEGLKYLHSLG---IIHRDLKLGNLFLNENMNVKIGDFGLAT 166 (592)
T ss_pred CCceEEEEEecCCccHHHHHHhcCCCCcHHHHHHHHHHHHHHHHHHhcC---ceecccchhheeecCcCcEEecccceee
Confidence 35688888888733 26789999999999999999999999999 9999999999999999999999999999
Q ss_pred ecCCCcccccceeeeeccCCCChhhhccCCCCccceEEeehhhhhhhhhCCCCCCcCCCCchhhhhhhhhhhcCCCcccc
Q 045315 314 MFGGDELQSNTKRIVGTYGYMSPEYALRGLFSIKSDVFSFGVLLLETLSSKKNTHFYNTDSLTLLGHAWNLWNDGRTWEL 393 (476)
Q Consensus 314 ~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~s~ksDVwSlGvvl~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~ 393 (476)
.+...... .....||+.|.|||++.....+..+||||+||++|-|++|++||........ +..+...+.
T Consensus 167 ~le~~~Er--k~TlCGTPNYIAPEVl~k~gHsfEvDiWSlGcvmYtLL~G~PPFetk~vket------y~~Ik~~~Y--- 235 (592)
T KOG0575|consen 167 QLEYDGER--KKTLCGTPNYIAPEVLNKSGHSFEVDIWSLGCVMYTLLVGRPPFETKTVKET------YNKIKLNEY--- 235 (592)
T ss_pred eecCcccc--cceecCCCcccChhHhccCCCCCchhhhhhhhHHHhhhhCCCCcccchHHHH------HHHHHhcCc---
Confidence 88754333 3347899999999999999999999999999999999999999976531111 111111111
Q ss_pred cCcccCCCCCHHHHHHHHHHHHHchhhcccCCCCHHHHHH
Q 045315 394 MDPISQNGASYPILKRYINVALLCVQEKAADRPAMSEVVS 433 (476)
Q Consensus 394 ~d~~~~~~~~~~~~~~l~~li~~Cl~~dP~~RPt~~eVl~ 433 (476)
..+........+||.++|+.+|.+|||+++|+.
T Consensus 236 -------~~P~~ls~~A~dLI~~lL~~~P~~Rpsl~~vL~ 268 (592)
T KOG0575|consen 236 -------SMPSHLSAEAKDLIRKLLRPNPSERPSLDEVLD 268 (592)
T ss_pred -------ccccccCHHHHHHHHHHhcCCcccCCCHHHHhc
Confidence 112234456789999999999999999999985
|
|
| >KOG0661 consensus MAPK related serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.96 E-value=7.4e-30 Score=251.87 Aligned_cols=195 Identities=22% Similarity=0.246 Sum_probs=147.0
Q ss_pred hhhhhccccccceeeccCC------CCCCCCCCChhhHHHHHHHHHHHHHHHhhcCCCceeecCCCccceEecCCCCcee
Q 045315 233 EQVLVQSKDEISFWYESYN------NPTKKGLLCWGTRVRIIEGIAQGLLYLHQYSRLRVIHRDLKASNILLDKDMNPKI 306 (476)
Q Consensus 233 ~~~~~~~~~~~~l~~Ey~~------~~~~~~~L~~~~~~~i~~qIa~gL~yLH~~~~~~ivH~DLkp~NILld~~~~~kL 306 (476)
+++.+.+. .+++|||||+ -+.+++++++.++..|+.||++||+|+|++| +.|||+||+|||+..+..+||
T Consensus 76 Evi~d~~~-~L~fVfE~Md~NLYqLmK~R~r~fse~~irnim~QilqGL~hiHk~G---fFHRDlKPENiLi~~~~~iKi 151 (538)
T KOG0661|consen 76 EVIRDNDR-ILYFVFEFMDCNLYQLMKDRNRLFSESDIRNIMYQILQGLAHIHKHG---FFHRDLKPENILISGNDVIKI 151 (538)
T ss_pred HHhhccCc-eEeeeHHhhhhhHHHHHhhcCCcCCHHHHHHHHHHHHHHHHHHHhcC---cccccCChhheEecccceeEe
Confidence 34444432 6889999999 2345889999999999999999999999999 999999999999998899999
Q ss_pred ccccceeecCCCcccccceeeeeccCCCChhhhc-cCCCCccceEEeehhhhhhhhhCCCCCCcCC-CCchhhhhhhhhh
Q 045315 307 SDFGMARMFGGDELQSNTKRIVGTYGYMSPEYAL-RGLFSIKSDVFSFGVLLLETLSSKKNTHFYN-TDSLTLLGHAWNL 384 (476)
Q Consensus 307 ~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~l~-~~~~s~ksDVwSlGvvl~elltG~~p~~~~~-~~~~~~~~~~~~~ 384 (476)
+|||+|+.+..... -+.++.|+.|+|||++. .+.|+.+.|+||+||+++|+.+-++-|++.+ .++...+..+...
T Consensus 152 aDFGLARev~SkpP---YTeYVSTRWYRAPEvLLrs~~Ys~pvD~wA~GcI~aEl~sLrPLFPG~sE~Dqi~KIc~VLGt 228 (538)
T KOG0661|consen 152 ADFGLAREVRSKPP---YTEYVSTRWYRAPEVLLRSGYYSSPVDMWAVGCIMAELYSLRPLFPGASEIDQIYKICEVLGT 228 (538)
T ss_pred cccccccccccCCC---cchhhhcccccchHHhhhccccCCchHHHHHHHHHHHHHHhcccCCCCcHHHHHHHHHHHhCC
Confidence 99999998765432 23367899999999886 6789999999999999999999999998776 3333333222211
Q ss_pred hcCCCccc------c-------cCcccCCCCCHHHHHHHHHHHHHchhhcccCCCCHHHHHHH
Q 045315 385 WNDGRTWE------L-------MDPISQNGASYPILKRYINVALLCVQEKAADRPAMSEVVSM 434 (476)
Q Consensus 385 ~~~~~~~~------~-------~d~~~~~~~~~~~~~~l~~li~~Cl~~dP~~RPt~~eVl~~ 434 (476)
..+....+ . +.+......-.....++++++.+|+++||.+|||+.|+++.
T Consensus 229 P~~~~~~eg~~La~~mnf~~P~~~~~~l~~L~p~~s~~~~~li~~ll~WDP~kRpTA~~al~~ 291 (538)
T KOG0661|consen 229 PDKDSWPEGYNLASAMNFRFPQVKPSPLKDLLPNASSEAASLIERLLAWDPDKRPTASQALQH 291 (538)
T ss_pred CccccchhHHHHHHHhccCCCcCCCCChHHhCcccCHHHHHHHHHHhcCCCccCccHHHHhcC
Confidence 11111100 0 00000011112256789999999999999999999999875
|
|
| >KOG0615 consensus Serine/threonine protein kinase Chk2 and related proteins [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=99.96 E-value=2.8e-29 Score=243.92 Aligned_cols=176 Identities=26% Similarity=0.294 Sum_probs=139.1
Q ss_pred cccceeeccCCCCC------CCCCCChhhHHHHHHHHHHHHHHHhhcCCCceeecCCCccceEecCC---CCceeccccc
Q 045315 241 DEISFWYESYNNPT------KKGLLCWGTRVRIIEGIAQGLLYLHQYSRLRVIHRDLKASNILLDKD---MNPKISDFGM 311 (476)
Q Consensus 241 ~~~~l~~Ey~~~~~------~~~~L~~~~~~~i~~qIa~gL~yLH~~~~~~ivH~DLkp~NILld~~---~~~kL~DFGl 311 (476)
+..|+|+|||.++. .++.+.+.....++.|++.|+.|||+.| |+||||||+|||+..+ ..+||+|||+
T Consensus 249 ds~YmVlE~v~GGeLfd~vv~nk~l~ed~~K~~f~Qll~avkYLH~~G---I~HRDiKPeNILl~~~~e~~llKItDFGl 325 (475)
T KOG0615|consen 249 DSSYMVLEYVEGGELFDKVVANKYLREDLGKLLFKQLLTAVKYLHSQG---IIHRDIKPENILLSNDAEDCLLKITDFGL 325 (475)
T ss_pred CceEEEEEEecCccHHHHHHhccccccchhHHHHHHHHHHHHHHHHcC---cccccCCcceEEeccCCcceEEEecccch
Confidence 34699999999543 4678889999999999999999999999 9999999999999765 6789999999
Q ss_pred eeecCCCcccccceeeeeccCCCChhhhccCCC---CccceEEeehhhhhhhhhCCCCCCcCCCCchhhhhhhhhhhcCC
Q 045315 312 ARMFGGDELQSNTKRIVGTYGYMSPEYALRGLF---SIKSDVFSFGVLLLETLSSKKNTHFYNTDSLTLLGHAWNLWNDG 388 (476)
Q Consensus 312 a~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~---s~ksDVwSlGvvl~elltG~~p~~~~~~~~~~~~~~~~~~~~~~ 388 (476)
|+..++.. ...+.+||+.|.|||++.+..+ ..+.|+||+||+||-+++|.+||.....+.. + .+.+..|
T Consensus 326 AK~~g~~s---fm~TlCGTpsYvAPEVl~~kg~~~~~~kVDiWSlGcvLfvcLsG~pPFS~~~~~~s-l----~eQI~~G 397 (475)
T KOG0615|consen 326 AKVSGEGS---FMKTLCGTPSYVAPEVLASKGVEYYPSKVDIWSLGCVLFVCLSGYPPFSEEYTDPS-L----KEQILKG 397 (475)
T ss_pred hhccccce---ehhhhcCCccccChhheecCCeecccchheeeeccceEEEEeccCCCcccccCCcc-H----HHHHhcC
Confidence 99876432 2344789999999999986543 3588999999999999999999986543321 1 1122222
Q ss_pred CcccccCcccCCCCCHHHHHHHHHHHHHchhhcccCCCCHHHHHH
Q 045315 389 RTWELMDPISQNGASYPILKRYINVALLCVQEKAADRPAMSEVVS 433 (476)
Q Consensus 389 ~~~~~~d~~~~~~~~~~~~~~l~~li~~Cl~~dP~~RPt~~eVl~ 433 (476)
+.. ..+....+..++..+++.+||..||++|||+.|+++
T Consensus 398 ~y~------f~p~~w~~Iseea~dlI~~mL~VdP~~R~s~~eaL~ 436 (475)
T KOG0615|consen 398 RYA------FGPLQWDRISEEALDLINWMLVVDPENRPSADEALN 436 (475)
T ss_pred ccc------ccChhhhhhhHHHHHHHHHhhEeCcccCcCHHHHhc
Confidence 221 122334556788999999999999999999999875
|
|
| >KOG0198 consensus MEKK and related serine/threonine protein kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.95 E-value=5.1e-29 Score=243.31 Aligned_cols=180 Identities=24% Similarity=0.348 Sum_probs=136.3
Q ss_pred ccceeeccCCCCC-------CCCCCChhhHHHHHHHHHHHHHHHhhcCCCceeecCCCccceEecC-CCCceecccccee
Q 045315 242 EISFWYESYNNPT-------KKGLLCWGTRVRIIEGIAQGLLYLHQYSRLRVIHRDLKASNILLDK-DMNPKISDFGMAR 313 (476)
Q Consensus 242 ~~~l~~Ey~~~~~-------~~~~L~~~~~~~i~~qIa~gL~yLH~~~~~~ivH~DLkp~NILld~-~~~~kL~DFGla~ 313 (476)
.+.+.|||++.++ .+.+|++..+.++++||++||+|||+++ ||||||||+|||++. ++.+||+|||++.
T Consensus 90 ~~~i~mEy~~~GsL~~~~~~~g~~l~E~~v~~ytr~iL~GL~ylHs~g---~vH~DiK~~NiLl~~~~~~~KlaDFG~a~ 166 (313)
T KOG0198|consen 90 EYNIFMEYAPGGSLSDLIKRYGGKLPEPLVRRYTRQILEGLAYLHSKG---IVHCDIKPANILLDPSNGDVKLADFGLAK 166 (313)
T ss_pred eeEeeeeccCCCcHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhCC---EeccCcccceEEEeCCCCeEEeccCcccc
Confidence 4889999999432 1227999999999999999999999999 999999999999999 7999999999998
Q ss_pred ecCCC-cccccceeeeeccCCCChhhhccC-CCCccceEEeehhhhhhhhhCCCCCCcCCCCchhhhhhhhhhhcCCCcc
Q 045315 314 MFGGD-ELQSNTKRIVGTYGYMSPEYALRG-LFSIKSDVFSFGVLLLETLSSKKNTHFYNTDSLTLLGHAWNLWNDGRTW 391 (476)
Q Consensus 314 ~~~~~-~~~~~~~~~~gt~~y~aPE~l~~~-~~s~ksDVwSlGvvl~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~ 391 (476)
..... ..........||+.|||||++..+ ....++|||||||++.||+||++||.... +.. ............
T Consensus 167 ~~~~~~~~~~~~~~~~Gtp~~maPEvi~~g~~~~~~sDiWSlGCtVvEM~Tg~~PW~~~~-~~~---~~~~~ig~~~~~- 241 (313)
T KOG0198|consen 167 KLESKGTKSDSELSVQGTPNYMAPEVIRNGEVARRESDIWSLGCTVVEMLTGKPPWSEFF-EEA---EALLLIGREDSL- 241 (313)
T ss_pred ccccccccccccccccCCccccCchhhcCCCcCCccchhhhcCCEEEeccCCCCcchhhc-chH---HHHHHHhccCCC-
Confidence 76641 111223347899999999999864 33469999999999999999999987531 100 001111111111
Q ss_pred cccCcccCCCCCHHHHHHHHHHHHHchhhcccCCCCHHHHHHHHhc
Q 045315 392 ELMDPISQNGASYPILKRYINVALLCVQEKAADRPAMSEVVSMLSN 437 (476)
Q Consensus 392 ~~~d~~~~~~~~~~~~~~l~~li~~Cl~~dP~~RPt~~eVl~~L~~ 437 (476)
| ..+........+++.+|++.||++||||+++++.---
T Consensus 242 ----P----~ip~~ls~~a~~Fl~~C~~~~p~~Rpta~eLL~hpf~ 279 (313)
T KOG0198|consen 242 ----P----EIPDSLSDEAKDFLRKCFKRDPEKRPTAEELLEHPFL 279 (313)
T ss_pred ----C----CCCcccCHHHHHHHHHHhhcCcccCcCHHHHhhChhh
Confidence 1 2222345678899999999999999999999876443
|
|
| >KOG0591 consensus NIMA (never in mitosis)-related G2-specific serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=99.95 E-value=3.3e-29 Score=232.61 Aligned_cols=182 Identities=25% Similarity=0.324 Sum_probs=143.1
Q ss_pred cccceeeccCCCC----------CCCCCCChhhHHHHHHHHHHHHHHHhhcC-CCceeecCCCccceEecCCCCceeccc
Q 045315 241 DEISFWYESYNNP----------TKKGLLCWGTRVRIIEGIAQGLLYLHQYS-RLRVIHRDLKASNILLDKDMNPKISDF 309 (476)
Q Consensus 241 ~~~~l~~Ey~~~~----------~~~~~L~~~~~~~i~~qIa~gL~yLH~~~-~~~ivH~DLkp~NILld~~~~~kL~DF 309 (476)
+-.+++|||+..+ ..++.++++++++++.|++.||.++|++- +..|+||||||.||+++.+|.+||+||
T Consensus 93 evlnivmE~c~~GDLsqmIk~~K~qkr~ipE~~Vwk~f~QL~~AL~~cH~~~~r~~VmHRDIKPaNIFl~~~gvvKLGDf 172 (375)
T KOG0591|consen 93 EVLNIVMELCDAGDLSQMIKHFKKQKRLIPEKTVWKYFVQLCRALYHCHSKIPRGTVMHRDIKPANIFLTANGVVKLGDF 172 (375)
T ss_pred hhhHHHHHhhcccCHHHHHHHHHhccccCchHHHHHHHHHHHHHHHHHhccccccceeeccCcchheEEcCCCceeeccc
Confidence 3488999999832 35678999999999999999999999832 124999999999999999999999999
Q ss_pred cceeecCCCcccccceeeeeccCCCChhhhccCCCCccceEEeehhhhhhhhhCCCCCCcCCCCchhhhhhhhhhhcCCC
Q 045315 310 GMARMFGGDELQSNTKRIVGTYGYMSPEYALRGLFSIKSDVFSFGVLLLETLSSKKNTHFYNTDSLTLLGHAWNLWNDGR 389 (476)
Q Consensus 310 Gla~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~s~ksDVwSlGvvl~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~ 389 (476)
|+++.+...... ....+||+.||+||.+.+.+|+.||||||+||++|||+.-++||...+ -..+. ..+..++
T Consensus 173 GL~r~l~s~~tf--A~S~VGTPyYMSPE~i~~~~Y~~kSDiWslGCllyEMcaL~~PF~g~n--~~~L~----~KI~qgd 244 (375)
T KOG0591|consen 173 GLGRFLSSKTTF--AHSLVGTPYYMSPERIHESGYNFKSDIWSLGCLLYEMCALQSPFYGDN--LLSLC----KKIEQGD 244 (375)
T ss_pred hhHhHhcchhHH--HHhhcCCCcccCHHHHhcCCCCcchhHHHHHHHHHHHHhcCCCccccc--HHHHH----HHHHcCC
Confidence 999998765433 344799999999999999999999999999999999999999997642 11121 1222222
Q ss_pred cccccCcccCCCCCHHHHHHHHHHHHHchhhcccCCCCHHHHHHHHhcc
Q 045315 390 TWELMDPISQNGASYPILKRYINVALLCVQEKAADRPAMSEVVSMLSNE 438 (476)
Q Consensus 390 ~~~~~d~~~~~~~~~~~~~~l~~li~~Cl~~dP~~RPt~~eVl~~L~~~ 438 (476)
...+ .+......+..|+..|+..||+.||+.-.+++.+...
T Consensus 245 ~~~~--------p~~~YS~~l~~li~~ci~vd~~~RP~t~~~v~di~~~ 285 (375)
T KOG0591|consen 245 YPPL--------PDEHYSTDLRELINMCIAVDPEQRPDTVPYVQDIQSE 285 (375)
T ss_pred CCCC--------cHHHhhhHHHHHHHHHccCCcccCCCcchHHHHHHHH
Confidence 2111 1244567888999999999999999966665555543
|
|
| >cd00028 B_lectin Bulb-type mannose-specific lectin | Back alignment and domain information |
|---|
Probab=99.95 E-value=1.1e-27 Score=203.03 Aligned_cols=115 Identities=44% Similarity=0.763 Sum_probs=102.8
Q ss_pred CcccCCCEEeeCCCeEEEEeeCCCCCCCeEEEEEEccCCCceEEeecCCCCCCCCCceEEEecCCceEEEccCCeEEEee
Q 045315 33 TFIRDGEKLVSSSQRFELGFFSPRNSKNRYLGVWYKKIPDTVVWVANRNSPIFNPNTALTFSNNGNLVLLSQRNGIIWSS 112 (476)
Q Consensus 33 ~~l~~~~~l~S~~g~f~lgf~~~~~~~~~~~~iw~~~~~~~~vW~an~~~p~~~~~~~l~~~~~G~lvl~~~~~~~vWss 112 (476)
+.|+.|++|+|+++.|++|||.+......|.+|||++.+.++||.|||+.|. ...+.|.|+.||||||+|.+|.++|+|
T Consensus 2 ~~l~~~~~l~s~~~~f~~G~~~~~~q~~dgnlv~~~~~~~~~vW~snt~~~~-~~~~~l~l~~dGnLvl~~~~g~~vW~S 80 (116)
T cd00028 2 NPLSSGQTLVSSGSLFELGFFKLIMQSRDYNLILYKGSSRTVVWVANRDNPS-GSSCTLTLQSDGNLVIYDGSGTVVWSS 80 (116)
T ss_pred cCcCCCCEEEeCCCcEEEecccCCCCCCeEEEEEEeCCCCeEEEECCCCCCC-CCCEEEEEecCCCeEEEcCCCcEEEEe
Confidence 5688999999999999999999877644899999997667899999999984 667899999999999999999999999
Q ss_pred cCCCCCCCceeeeccCCCeEEEeCCCCCCcCceeeccccCC
Q 045315 113 NMSRKAENPIAQLLDTGNLVIRDNSSGHTTESYLWQSFDYP 153 (476)
Q Consensus 113 ~~~~~~~~~~~~l~d~GNlVl~~~~~~~~~~~~~WqSFd~p 153 (476)
++.+......|+|+||||||||+.+ +.++|||||||
T Consensus 81 ~~~~~~~~~~~~L~ddGnlvl~~~~-----~~~~W~Sf~~P 116 (116)
T cd00028 81 NTTRVNGNYVLVLLDDGNLVLYDSD-----GNFLWQSFDYP 116 (116)
T ss_pred cccCCCCceEEEEeCCCCEEEECCC-----CCEEEcCCCCC
Confidence 9876445678899999999999876 78999999999
|
The domain contains a three-fold internal repeat (beta-prism architecture). The consensus sequence motif QXDXNXVXY is involved in alpha-D-mannose recognition. Lectins are carbohydrate-binding proteins which specifically recognize diverse carbohydrates and mediate a wide variety of biological processes, such as cell-cell and host-pathogen interactions, serum glycoprotein turnover, and innate immune responses. |
| >cd05102 PTKc_VEGFR3 Catalytic domain of the Protein Tyrosine Kinase, Vascular Endothelial Growth Factor Receptor 3 | Back alignment and domain information |
|---|
Probab=99.95 E-value=1.1e-28 Score=248.07 Aligned_cols=167 Identities=28% Similarity=0.371 Sum_probs=129.6
Q ss_pred CCCChhhHHHHHHHHHHHHHHHhhcCCCceeecCCCccceEecCCCCceeccccceeecCCCcccccceeeeeccCCCCh
Q 045315 257 GLLCWGTRVRIIEGIAQGLLYLHQYSRLRVIHRDLKASNILLDKDMNPKISDFGMARMFGGDELQSNTKRIVGTYGYMSP 336 (476)
Q Consensus 257 ~~L~~~~~~~i~~qIa~gL~yLH~~~~~~ivH~DLkp~NILld~~~~~kL~DFGla~~~~~~~~~~~~~~~~gt~~y~aP 336 (476)
.++++.++.+++.||++||+|||+.+ |+||||||+|||++.++.+||+|||+++...............++..|+||
T Consensus 169 ~~l~~~~~~~~~~qi~~aL~~LH~~~---ivHrDiKp~Nil~~~~~~~kl~DfG~a~~~~~~~~~~~~~~~~~~~~y~aP 245 (338)
T cd05102 169 SPLTMEDLICYSFQVARGMEFLASRK---CIHRDLAARNILLSENNVVKICDFGLARDIYKDPDYVRKGSARLPLKWMAP 245 (338)
T ss_pred CCCCHHHHHHHHHHHHHHHHHHHHCC---EECCCCccceEEEcCCCcEEEeecccccccccCcchhcccCCCCCccccCc
Confidence 46899999999999999999999998 999999999999999999999999999865433222222223456789999
Q ss_pred hhhccCCCCccceEEeehhhhhhhhh-CCCCCCcCCCCchhhhhhhhhhhcCCCcccccCcccCCCCCHHHHHHHHHHHH
Q 045315 337 EYALRGLFSIKSDVFSFGVLLLETLS-SKKNTHFYNTDSLTLLGHAWNLWNDGRTWELMDPISQNGASYPILKRYINVAL 415 (476)
Q Consensus 337 E~l~~~~~s~ksDVwSlGvvl~ellt-G~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~l~~li~ 415 (476)
|.+.+..++.++|||||||++|||++ |..||........ .. .....+.... .+......+.+++.
T Consensus 246 E~~~~~~~~~~sDiwslG~il~el~~~g~~pf~~~~~~~~-~~----~~~~~~~~~~---------~~~~~~~~l~~li~ 311 (338)
T cd05102 246 ESIFDKVYTTQSDVWSFGVLLWEIFSLGASPYPGVQINEE-FC----QRLKDGTRMR---------APENATPEIYRIML 311 (338)
T ss_pred HHhhcCCCCcccCHHHHHHHHHHHHhCCCCCCCCCCccHH-HH----HHHhcCCCCC---------CCCCCCHHHHHHHH
Confidence 99999999999999999999999997 9999875432211 11 1111111111 01122356889999
Q ss_pred HchhhcccCCCCHHHHHHHHhcccc
Q 045315 416 LCVQEKAADRPAMSEVVSMLSNEFV 440 (476)
Q Consensus 416 ~Cl~~dP~~RPt~~eVl~~L~~~~~ 440 (476)
+||+.||++|||+.||+++|+.+..
T Consensus 312 ~cl~~dp~~RPs~~el~~~l~~~~~ 336 (338)
T cd05102 312 ACWQGDPKERPTFSALVEILGDLLQ 336 (338)
T ss_pred HHccCChhhCcCHHHHHHHHHHHHh
Confidence 9999999999999999999998653
|
Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor 3 (VEGFR3); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR3 (or Flt4) is a member of the VEGFR subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. In VEGFR3, the fifth Ig-like domain is replaced by a disulfide bridge. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. V |
| >KOG0593 consensus Predicted protein kinase KKIAMRE [General function prediction only] | Back alignment and domain information |
|---|
Probab=99.95 E-value=1.1e-28 Score=231.14 Aligned_cols=188 Identities=19% Similarity=0.290 Sum_probs=141.5
Q ss_pred ccccceeeccCC------CCCCCCCCChhhHHHHHHHHHHHHHHHhhcCCCceeecCCCccceEecCCCCceecccccee
Q 045315 240 KDEISFWYESYN------NPTKKGLLCWGTRVRIIEGIAQGLLYLHQYSRLRVIHRDLKASNILLDKDMNPKISDFGMAR 313 (476)
Q Consensus 240 ~~~~~l~~Ey~~------~~~~~~~L~~~~~~~i~~qIa~gL~yLH~~~~~~ivH~DLkp~NILld~~~~~kL~DFGla~ 313 (476)
|....+|+||++ -......++.+...+++.|+++|+.|+|+++ +|||||||+|||++.++.+||||||+|+
T Consensus 73 krklhLVFE~~dhTvL~eLe~~p~G~~~~~vk~~l~Q~l~ai~~cHk~n---~IHRDIKPENILit~~gvvKLCDFGFAR 149 (396)
T KOG0593|consen 73 KRKLHLVFEYCDHTVLHELERYPNGVPSELVKKYLYQLLKAIHFCHKNN---CIHRDIKPENILITQNGVVKLCDFGFAR 149 (396)
T ss_pred cceeEEEeeecchHHHHHHHhccCCCCHHHHHHHHHHHHHHhhhhhhcC---eecccCChhheEEecCCcEEeccchhhH
Confidence 467899999998 2344556899999999999999999999999 9999999999999999999999999999
Q ss_pred ecCCCcccccceeeeeccCCCChhhhcc-CCCCccceEEeehhhhhhhhhCCCCCCcCC-CCchhhhhhh--------hh
Q 045315 314 MFGGDELQSNTKRIVGTYGYMSPEYALR-GLFSIKSDVFSFGVLLLETLSSKKNTHFYN-TDSLTLLGHA--------WN 383 (476)
Q Consensus 314 ~~~~~~~~~~~~~~~gt~~y~aPE~l~~-~~~s~ksDVwSlGvvl~elltG~~p~~~~~-~~~~~~~~~~--------~~ 383 (476)
.+.... ..-+.++.|..|+|||.+.+ .+|....||||+||++.||++|.+-|+..+ .++...+... ..
T Consensus 150 ~L~~pg--d~YTDYVATRWYRaPELLvGDtqYG~pVDiWAiGCv~aEl~~G~pL~PG~SDiDQLy~I~ktLG~L~prhq~ 227 (396)
T KOG0593|consen 150 TLSAPG--DNYTDYVATRWYRAPELLVGDTQYGKPVDIWAIGCVFAELLTGEPLWPGRSDIDQLYLIRKTLGNLIPRHQS 227 (396)
T ss_pred hhcCCc--chhhhhhhhhhccChhhhcccCcCCCcccchhhhHHHHHHhcCCcCCCCcchHHHHHHHHHHHcccCHHHHH
Confidence 876321 12234678999999999987 789999999999999999999999988765 3333322221 12
Q ss_pred hhcCCCcc-cccCcccCC-----CCCHHHHHHHHHHHHHchhhcccCCCCHHHHH
Q 045315 384 LWNDGRTW-ELMDPISQN-----GASYPILKRYINVALLCVQEKAADRPAMSEVV 432 (476)
Q Consensus 384 ~~~~~~~~-~~~d~~~~~-----~~~~~~~~~l~~li~~Cl~~dP~~RPt~~eVl 432 (476)
.+...... -+.-|.... ..-+....-+++++..||+.||.+|++-+|++
T Consensus 228 iF~~N~~F~Gv~lP~~~~~epLe~k~p~~s~~~ld~~k~cL~~dP~~R~sc~qll 282 (396)
T KOG0593|consen 228 IFSSNPFFHGVRLPEPEHPEPLERKYPKISNVLLDLLKKCLKMDPDDRLSCEQLL 282 (396)
T ss_pred HhccCCceeeeecCCCCCccchhhhcccchHHHHHHHHHHhcCCccccccHHHHh
Confidence 22221111 111111111 11122345688999999999999999999986
|
|
| >KOG0592 consensus 3-phosphoinositide-dependent protein kinase (PDK1) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.95 E-value=1.3e-28 Score=246.66 Aligned_cols=175 Identities=26% Similarity=0.308 Sum_probs=140.8
Q ss_pred cccceeeccCCCC------CCCCCCChhhHHHHHHHHHHHHHHHhhcCCCceeecCCCccceEecCCCCceeccccceee
Q 045315 241 DEISFWYESYNNP------TKKGLLCWGTRVRIIEGIAQGLLYLHQYSRLRVIHRDLKASNILLDKDMNPKISDFGMARM 314 (476)
Q Consensus 241 ~~~~l~~Ey~~~~------~~~~~L~~~~~~~i~~qIa~gL~yLH~~~~~~ivH~DLkp~NILld~~~~~kL~DFGla~~ 314 (476)
..+|+++||++++ .+.+.|++.-..-++.+|+.||+|||+.| ||||||||+|||||+++++||.|||-|+.
T Consensus 147 ~sLYFvLe~A~nGdll~~i~K~Gsfde~caR~YAAeIldAleylH~~G---IIHRDlKPENILLd~dmhikITDFGsAK~ 223 (604)
T KOG0592|consen 147 ESLYFVLEYAPNGDLLDLIKKYGSFDETCARFYAAEILDALEYLHSNG---IIHRDLKPENILLDKDGHIKITDFGSAKI 223 (604)
T ss_pred cceEEEEEecCCCcHHHHHHHhCcchHHHHHHHHHHHHHHHHHHHhcC---ceeccCChhheeEcCCCcEEEeecccccc
Confidence 4689999999954 46788999999999999999999999999 99999999999999999999999999998
Q ss_pred cCCCccc-----------ccceeeeeccCCCChhhhccCCCCccceEEeehhhhhhhhhCCCCCCcCCCCchhhhhhhhh
Q 045315 315 FGGDELQ-----------SNTKRIVGTYGYMSPEYALRGLFSIKSDVFSFGVLLLETLSSKKNTHFYNTDSLTLLGHAWN 383 (476)
Q Consensus 315 ~~~~~~~-----------~~~~~~~gt~~y~aPE~l~~~~~s~ksDVwSlGvvl~elltG~~p~~~~~~~~~~~~~~~~~ 383 (476)
+...... .....++||..|.+||++.....+..+|+|+|||++|+|+.|++||...++- ...+.+
T Consensus 224 l~~~~~~~~~~~~~~~a~s~~~SFVGTAeYVSPElL~~~~~~~~sDiWAlGCilyQmlaG~PPFra~Ney--liFqkI-- 299 (604)
T KOG0592|consen 224 LSPSQKSQENPVDPNQASSRRSSFVGTAEYVSPELLNDSPAGPSSDLWALGCILYQMLAGQPPFRAANEY--LIFQKI-- 299 (604)
T ss_pred CChhhccccCccCcccccCcccceeeeecccCHHHhcCCCCCcccchHHHHHHHHHHhcCCCCCccccHH--HHHHHH--
Confidence 8543211 1124589999999999999999999999999999999999999999754321 111111
Q ss_pred hhcCCCcccccCcccCCCCCHHHHHHHHHHHHHchhhcccCCCCHHHHHHH
Q 045315 384 LWNDGRTWELMDPISQNGASYPILKRYINVALLCVQEKAADRPAMSEVVSM 434 (476)
Q Consensus 384 ~~~~~~~~~~~d~~~~~~~~~~~~~~l~~li~~Cl~~dP~~RPt~~eVl~~ 434 (476)
++ +.-..+....+.+.+|+.+.|..||.+|+|..||.+.
T Consensus 300 ----------~~--l~y~fp~~fp~~a~dLv~KLLv~dp~~Rlt~~qIk~H 338 (604)
T KOG0592|consen 300 ----------QA--LDYEFPEGFPEDARDLIKKLLVRDPSDRLTSQQIKAH 338 (604)
T ss_pred ----------HH--hcccCCCCCCHHHHHHHHHHHccCccccccHHHHhhC
Confidence 00 0111222233678899999999999999999888764
|
|
| >KOG0578 consensus p21-activated serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.95 E-value=5e-28 Score=244.10 Aligned_cols=176 Identities=26% Similarity=0.384 Sum_probs=141.7
Q ss_pred cccceeeccCCCC-----CCCCCCChhhHHHHHHHHHHHHHHHhhcCCCceeecCCCccceEecCCCCceeccccceeec
Q 045315 241 DEISFWYESYNNP-----TKKGLLCWGTRVRIIEGIAQGLLYLHQYSRLRVIHRDLKASNILLDKDMNPKISDFGMARMF 315 (476)
Q Consensus 241 ~~~~l~~Ey~~~~-----~~~~~L~~~~~~~i~~qIa~gL~yLH~~~~~~ivH~DLkp~NILld~~~~~kL~DFGla~~~ 315 (476)
++.-.+||||+.+ .....+++.++..|++++++||+|||.++ |+|||||.+|||+..++.+||+|||++..+
T Consensus 343 deLWVVMEym~ggsLTDvVt~~~~~E~qIA~Icre~l~aL~fLH~~g---IiHrDIKSDnILL~~~g~vKltDFGFcaqi 419 (550)
T KOG0578|consen 343 DELWVVMEYMEGGSLTDVVTKTRMTEGQIAAICREILQGLKFLHARG---IIHRDIKSDNILLTMDGSVKLTDFGFCAQI 419 (550)
T ss_pred ceeEEEEeecCCCchhhhhhcccccHHHHHHHHHHHHHHHHHHHhcc---eeeeccccceeEeccCCcEEEeeeeeeecc
Confidence 5678899999943 33556999999999999999999999999 999999999999999999999999999987
Q ss_pred CCCcccccceeeeeccCCCChhhhccCCCCccceEEeehhhhhhhhhCCCCCCcCCCCchhhhhhhhhhhcCCCcccccC
Q 045315 316 GGDELQSNTKRIVGTYGYMSPEYALRGLFSIKSDVFSFGVLLLETLSSKKNTHFYNTDSLTLLGHAWNLWNDGRTWELMD 395 (476)
Q Consensus 316 ~~~~~~~~~~~~~gt~~y~aPE~l~~~~~s~ksDVwSlGvvl~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~d 395 (476)
..... .....+||+.|||||+.....|.+|.||||||+++.||+-|.+||-..+. . ...+.....+.. ++
T Consensus 420 ~~~~~--KR~TmVGTPYWMAPEVvtrk~YG~KVDIWSLGIMaIEMveGEPPYlnE~P--l---rAlyLIa~ng~P-~l-- 489 (550)
T KOG0578|consen 420 SEEQS--KRSTMVGTPYWMAPEVVTRKPYGPKVDIWSLGIMAIEMVEGEPPYLNENP--L---RALYLIATNGTP-KL-- 489 (550)
T ss_pred ccccC--ccccccCCCCccchhhhhhcccCccccchhhhhHHHHHhcCCCCccCCCh--H---HHHHHHhhcCCC-Cc--
Confidence 66543 34457899999999999999999999999999999999999999864221 1 111111122221 11
Q ss_pred cccCCCCCHHHHHHHHHHHHHchhhcccCCCCHHHHHHH
Q 045315 396 PISQNGASYPILKRYINVALLCVQEKAADRPAMSEVVSM 434 (476)
Q Consensus 396 ~~~~~~~~~~~~~~l~~li~~Cl~~dP~~RPt~~eVl~~ 434 (476)
.........+.+++.+||+.|+++||++.|+|+.
T Consensus 490 -----k~~~klS~~~kdFL~~cL~~dv~~RasA~eLL~H 523 (550)
T KOG0578|consen 490 -----KNPEKLSPELKDFLDRCLVVDVEQRASAKELLEH 523 (550)
T ss_pred -----CCccccCHHHHHHHHHHhhcchhcCCCHHHHhcC
Confidence 1223345678899999999999999999999863
|
|
| >KOG0600 consensus Cdc2-related protein kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=99.95 E-value=1.4e-27 Score=237.43 Aligned_cols=206 Identities=22% Similarity=0.278 Sum_probs=147.6
Q ss_pred ccccceeeccCCC------CCCCCCCChhhHHHHHHHHHHHHHHHhhcCCCceeecCCCccceEecCCCCceecccccee
Q 045315 240 KDEISFWYESYNN------PTKKGLLCWGTRVRIIEGIAQGLLYLHQYSRLRVIHRDLKASNILLDKDMNPKISDFGMAR 313 (476)
Q Consensus 240 ~~~~~l~~Ey~~~------~~~~~~L~~~~~~~i~~qIa~gL~yLH~~~~~~ivH~DLkp~NILld~~~~~kL~DFGla~ 313 (476)
++..|+|+|||++ .+..-.++..++..+..||+.||+|+|.++ |+|||||.+|||||.+|.+||+|||+|+
T Consensus 190 ~~siYlVFeYMdhDL~GLl~~p~vkft~~qIKc~mkQLl~Gl~~cH~~g---vlHRDIK~SNiLidn~G~LKiaDFGLAr 266 (560)
T KOG0600|consen 190 SGSIYLVFEYMDHDLSGLLSSPGVKFTEPQIKCYMKQLLEGLEYCHSRG---VLHRDIKGSNILIDNNGVLKIADFGLAR 266 (560)
T ss_pred CceEEEEEecccchhhhhhcCCCcccChHHHHHHHHHHHHHHHHHhhcC---eeeccccccceEEcCCCCEEecccccee
Confidence 4689999999992 233457999999999999999999999999 9999999999999999999999999999
Q ss_pred ecCCCcccccceeeeeccCCCChhhhcc-CCCCccceEEeehhhhhhhhhCCCCCCcCCC-Cchhhhhhhhh-----hhc
Q 045315 314 MFGGDELQSNTKRIVGTYGYMSPEYALR-GLFSIKSDVFSFGVLLLETLSSKKNTHFYNT-DSLTLLGHAWN-----LWN 386 (476)
Q Consensus 314 ~~~~~~~~~~~~~~~gt~~y~aPE~l~~-~~~s~ksDVwSlGvvl~elltG~~p~~~~~~-~~~~~~~~~~~-----~~~ 386 (476)
++........+ ..+-|..|+|||.+.+ ..|+.+.|+||.|||+.||+.|++.+....+ ++...+-.... .|.
T Consensus 267 ~y~~~~~~~~T-~rVvTLWYRpPELLLG~t~Yg~aVDlWS~GCIl~El~~gkPI~~G~tEveQl~kIfklcGSP~e~~W~ 345 (560)
T KOG0600|consen 267 FYTPSGSAPYT-SRVVTLWYRPPELLLGATSYGTAVDLWSVGCILAELFLGKPILQGRTEVEQLHKIFKLCGSPTEDYWP 345 (560)
T ss_pred eccCCCCcccc-cceEEeeccChHHhcCCcccccceeehhhhHHHHHHHcCCCCcCCccHHHHHHHHHHHhCCCChhccc
Confidence 88766544433 3567999999999986 5799999999999999999999999876542 22221111110 111
Q ss_pred CCCcc--cccCcccCCCC-----CHHHHHHHHHHHHHchhhcccCCCCHHHHHHHHhccccCCCCCCCCcce
Q 045315 387 DGRTW--ELMDPISQNGA-----SYPILKRYINVALLCVQEKAADRPAMSEVVSMLSNEFVNLPAPQQPAFS 451 (476)
Q Consensus 387 ~~~~~--~~~d~~~~~~~-----~~~~~~~l~~li~~Cl~~dP~~RPt~~eVl~~L~~~~~~~~~p~~p~~~ 451 (476)
..+.. ..+.+...... ........++|+..+|..||.+|.|+.++++. ..+...|.|..|..+
T Consensus 346 ~~kLP~~~~~kp~~~y~r~l~E~~~~~~~~~l~Ll~~lL~ldP~kR~tA~~aL~s--eyF~t~p~~~~p~~L 415 (560)
T KOG0600|consen 346 VSKLPHATIFKPQQPYKRRLRETFKDFPASALDLLEKLLSLDPDKRGTASSALQS--EYFTTEPLPCDPSSL 415 (560)
T ss_pred cccCCcccccCCCCcccchHHHHhccCCHHHHHHHHHHhccCccccccHHHHhcC--cccccCCCCCCcccC
Confidence 00000 11111110000 11123567889999999999999999987642 222344555555443
|
|
| >KOG0598 consensus Ribosomal protein S6 kinase and related proteins [General function prediction only; Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.95 E-value=2.6e-28 Score=235.29 Aligned_cols=167 Identities=24% Similarity=0.318 Sum_probs=133.8
Q ss_pred ccccceeeccCCCC------CCCCCCChhhHHHHHHHHHHHHHHHhhcCCCceeecCCCccceEecCCCCceecccccee
Q 045315 240 KDEISFWYESYNNP------TKKGLLCWGTRVRIIEGIAQGLLYLHQYSRLRVIHRDLKASNILLDKDMNPKISDFGMAR 313 (476)
Q Consensus 240 ~~~~~l~~Ey~~~~------~~~~~L~~~~~~~i~~qIa~gL~yLH~~~~~~ivH~DLkp~NILld~~~~~kL~DFGla~ 313 (476)
.+..+++.||+.++ .+.+.+++..+.-++.+|+.||.|||+++ ||||||||+|||||.+|.++|+|||+++
T Consensus 97 ~~kLylVld~~~GGeLf~hL~~eg~F~E~~arfYlaEi~lAL~~LH~~g---IiyRDlKPENILLd~~GHi~LtDFgL~k 173 (357)
T KOG0598|consen 97 EEKLYLVLDYLNGGELFYHLQREGRFSEDRARFYLAEIVLALGYLHSKG---IIYRDLKPENILLDEQGHIKLTDFGLCK 173 (357)
T ss_pred CCeEEEEEeccCCccHHHHHHhcCCcchhHHHHHHHHHHHHHHHHHhCC---eeeccCCHHHeeecCCCcEEEeccccch
Confidence 46799999999953 45778999999999999999999999999 9999999999999999999999999998
Q ss_pred ecCCCcccccceeeeeccCCCChhhhccCCCCccceEEeehhhhhhhhhCCCCCCcCCCCchhhhhhhhhhhcCCCcccc
Q 045315 314 MFGGDELQSNTKRIVGTYGYMSPEYALRGLFSIKSDVFSFGVLLLETLSSKKNTHFYNTDSLTLLGHAWNLWNDGRTWEL 393 (476)
Q Consensus 314 ~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~s~ksDVwSlGvvl~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~ 393 (476)
...... ..+..+.||+.|||||++.+..|+..+|.||+|+++|||++|.+||...+.... .+.+..++.
T Consensus 174 ~~~~~~--~~t~tfcGT~eYmAPEil~~~gy~~~vDWWsLGillYeML~G~pPF~~~~~~~~------~~~I~~~k~--- 242 (357)
T KOG0598|consen 174 EDLKDG--DATRTFCGTPEYMAPEILLGKGYDKAVDWWSLGILLYEMLTGKPPFYAEDVKKM------YDKILKGKL--- 242 (357)
T ss_pred hcccCC--CccccccCCccccChHHHhcCCCCcccchHhHHHHHHHHhhCCCCCcCccHHHH------HHHHhcCcC---
Confidence 644332 233447999999999999999999999999999999999999999976542111 111111110
Q ss_pred cCcccCCCCCHHHHHHHHHHHHHchhhcccCCC
Q 045315 394 MDPISQNGASYPILKRYINVALLCVQEKAADRP 426 (476)
Q Consensus 394 ~d~~~~~~~~~~~~~~l~~li~~Cl~~dP~~RP 426 (476)
...+.-......+++.+.|+.||++|.
T Consensus 243 ------~~~p~~ls~~ardll~~LL~rdp~~RL 269 (357)
T KOG0598|consen 243 ------PLPPGYLSEEARDLLKKLLKRDPRQRL 269 (357)
T ss_pred ------CCCCccCCHHHHHHHHHHhccCHHHhc
Confidence 011111345678899999999999995
|
|
| >cd05096 PTKc_DDR1 Catalytic domain of the Protein Tyrosine Kinase, Discoidin Domain Receptor 1 | Back alignment and domain information |
|---|
Probab=99.94 E-value=1.7e-27 Score=235.80 Aligned_cols=172 Identities=26% Similarity=0.394 Sum_probs=125.1
Q ss_pred CCCChhhHHHHHHHHHHHHHHHhhcCCCceeecCCCccceEecCCCCceeccccceeecCCCcccccceeeeeccCCCCh
Q 045315 257 GLLCWGTRVRIIEGIAQGLLYLHQYSRLRVIHRDLKASNILLDKDMNPKISDFGMARMFGGDELQSNTKRIVGTYGYMSP 336 (476)
Q Consensus 257 ~~L~~~~~~~i~~qIa~gL~yLH~~~~~~ivH~DLkp~NILld~~~~~kL~DFGla~~~~~~~~~~~~~~~~gt~~y~aP 336 (476)
..+++.++.+++.||+.||+|||+.+ |+||||||+|||++.++.+||+|||+++...............++..|+||
T Consensus 133 ~~~~~~~~~~i~~~i~~al~~lH~~~---ivH~dlkp~Nill~~~~~~kl~DfG~~~~~~~~~~~~~~~~~~~~~~y~aP 209 (304)
T cd05096 133 PAISYSSLLHVALQIASGMKYLSSLN---FVHRDLATRNCLVGENLTIKIADFGMSRNLYAGDYYRIQGRAVLPIRWMAW 209 (304)
T ss_pred ccccHHHHHHHHHHHHHHHHHHHHCC---ccccCcchhheEEcCCccEEECCCccceecccCceeEecCcCCCCccccCH
Confidence 45788999999999999999999998 999999999999999999999999999865433222222223457789999
Q ss_pred hhhccCCCCccceEEeehhhhhhhhhCCCCCCcCCCCchhhhhhhhhhhcCCCcccccCcccCCCCCHHHHHHHHHHHHH
Q 045315 337 EYALRGLFSIKSDVFSFGVLLLETLSSKKNTHFYNTDSLTLLGHAWNLWNDGRTWELMDPISQNGASYPILKRYINVALL 416 (476)
Q Consensus 337 E~l~~~~~s~ksDVwSlGvvl~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~l~~li~~ 416 (476)
|.+....++.++||||||+++|||+++..+.++........................ ...+......+.+++.+
T Consensus 210 E~~~~~~~~~~~Dv~slG~~l~el~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~------~~~~~~~~~~~~~li~~ 283 (304)
T cd05096 210 ECILMGKFTTASDVWAFGVTLWEILMLCKEQPYGELTDEQVIENAGEFFRDQGRQVY------LFRPPPCPQGLYELMLQ 283 (304)
T ss_pred HHHhcCCCCchhhhHHHHHHHHHHHHccCCCCCCcCCHHHHHHHHHHHhhhcccccc------ccCCCCCCHHHHHHHHH
Confidence 999888999999999999999999875443333222222222222111111110000 00111234578899999
Q ss_pred chhhcccCCCCHHHHHHHHhc
Q 045315 417 CVQEKAADRPAMSEVVSMLSN 437 (476)
Q Consensus 417 Cl~~dP~~RPt~~eVl~~L~~ 437 (476)
||+.||++|||+.+|.+.|++
T Consensus 284 cl~~~p~~RPs~~~i~~~l~~ 304 (304)
T cd05096 284 CWSRDCRERPSFSDIHAFLTE 304 (304)
T ss_pred HccCCchhCcCHHHHHHHHhC
Confidence 999999999999999999863
|
Protein Tyrosine Kinase (PTK) family; mammalian Discoidin Domain Receptor 1 (DDR1) and homologs; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR1 is a member of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDR1 binds to all collagens tested to date (types I-IV). It is widely expressed in many tissues. It is abundant in the brain and is also found in k |
| >KOG0193 consensus Serine/threonine protein kinase RAF [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.94 E-value=1.8e-27 Score=240.97 Aligned_cols=172 Identities=28% Similarity=0.424 Sum_probs=133.6
Q ss_pred CCCCChhhHHHHHHHHHHHHHHHhhcCCCceeecCCCccceEecCCCCceeccccceeecCCCcccccceeeeeccCCCC
Q 045315 256 KGLLCWGTRVRIIEGIAQGLLYLHQYSRLRVIHRDLKASNILLDKDMNPKISDFGMARMFGGDELQSNTKRIVGTYGYMS 335 (476)
Q Consensus 256 ~~~L~~~~~~~i~~qIa~gL~yLH~~~~~~ivH~DLkp~NILld~~~~~kL~DFGla~~~~~~~~~~~~~~~~gt~~y~a 335 (476)
+.+|...+.+.|++|||+|+.|||.++ |||||||..|||+.+++.+||+|||++..-..-..........|...|||
T Consensus 482 etkfdm~~~idIAqQiaqGM~YLHAK~---IIHrDLKSnNIFl~~~~kVkIgDFGLatvk~~w~g~~q~~qp~gsilwmA 558 (678)
T KOG0193|consen 482 ETKFDMNTTIDIAQQIAQGMDYLHAKN---IIHRDLKSNNIFLHEDLKVKIGDFGLATVKTRWSGEQQLEQPHGSLLWMA 558 (678)
T ss_pred hhhhhHHHHHHHHHHHHHhhhhhhhhh---hhhhhccccceEEccCCcEEEecccceeeeeeeccccccCCCccchhhhc
Confidence 567999999999999999999999999 99999999999999999999999999975432211122233457889999
Q ss_pred hhhhc---cCCCCccceEEeehhhhhhhhhCCCCCCcCCCCchhhhhhhhhhhcCCCcccccCcccCCCCCHHHHHHHHH
Q 045315 336 PEYAL---RGLFSIKSDVFSFGVLLLETLSSKKNTHFYNTDSLTLLGHAWNLWNDGRTWELMDPISQNGASYPILKRYIN 412 (476)
Q Consensus 336 PE~l~---~~~~s~ksDVwSlGvvl~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~l~~ 412 (476)
||+++ ..+|++.+||||||+|+|||++|..|+.....+.+ ++.-|+-.-..|.... .....+.+.+
T Consensus 559 PEvIRmqd~nPfS~qSDVYaFGiV~YELltg~lPysi~~~dqI--------ifmVGrG~l~pd~s~~---~s~~pk~mk~ 627 (678)
T KOG0193|consen 559 PEVIRMQDDNPFSFQSDVYAFGIVWYELLTGELPYSIQNRDQI--------IFMVGRGYLMPDLSKI---RSNCPKAMKR 627 (678)
T ss_pred HHHHhhcccCCCCcccchhhhhHHHHHHHhCcCCcCCCChhhe--------EEEecccccCccchhh---hccCHHHHHH
Confidence 99997 35799999999999999999999999884333332 1222333222222221 2233557888
Q ss_pred HHHHchhhcccCCCCHHHHHHHHhccccC
Q 045315 413 VALLCVQEKAADRPAMSEVVSMLSNEFVN 441 (476)
Q Consensus 413 li~~Cl~~dP~~RPt~~eVl~~L~~~~~~ 441 (476)
|+..||..++++||.+.+|+.+|+.+...
T Consensus 628 Ll~~C~~~~~~eRP~F~~il~~l~~l~~~ 656 (678)
T KOG0193|consen 628 LLSDCWKFDREERPLFPQLLSKLEELLPS 656 (678)
T ss_pred HHHHHHhcCcccCccHHHHHHHHHHhhhc
Confidence 99999999999999999999999887643
|
|
| >cd05080 PTKc_Tyk2_rpt2 Catalytic (repeat 2) domain of the Protein Tyrosine Kinase, Tyrosine kinase 2 | Back alignment and domain information |
|---|
Probab=99.94 E-value=2e-27 Score=232.69 Aligned_cols=194 Identities=24% Similarity=0.264 Sum_probs=139.1
Q ss_pred ccceeeccCCCCC-----CCCCCChhhHHHHHHHHHHHHHHHhhcCCCceeecCCCccceEecCCCCceeccccceeecC
Q 045315 242 EISFWYESYNNPT-----KKGLLCWGTRVRIIEGIAQGLLYLHQYSRLRVIHRDLKASNILLDKDMNPKISDFGMARMFG 316 (476)
Q Consensus 242 ~~~l~~Ey~~~~~-----~~~~L~~~~~~~i~~qIa~gL~yLH~~~~~~ivH~DLkp~NILld~~~~~kL~DFGla~~~~ 316 (476)
.++++|||++... ....+++.++..++.|++.||+|||+++ ++||||||+||+++.++.+||+|||+++...
T Consensus 82 ~~~lv~e~~~~~~l~~~~~~~~l~~~~~~~i~~~l~~~l~~lH~~~---i~H~dlkp~Nili~~~~~~~l~dfg~~~~~~ 158 (283)
T cd05080 82 GLQLIMEYVPLGSLRDYLPKHKLNLAQLLLFAQQICEGMAYLHSQH---YIHRDLAARNVLLDNDRLVKIGDFGLAKAVP 158 (283)
T ss_pred eEEEEecCCCCCCHHHHHHHcCCCHHHHHHHHHHHHHHHHHHHHCC---eeccccChheEEEcCCCcEEEeecccccccC
Confidence 4678889887332 2346999999999999999999999998 9999999999999999999999999998765
Q ss_pred CCccccc-ceeeeeccCCCChhhhccCCCCccceEEeehhhhhhhhhCCCCCCcCCCCchhhhhhhhhhhcCCCcccccC
Q 045315 317 GDELQSN-TKRIVGTYGYMSPEYALRGLFSIKSDVFSFGVLLLETLSSKKNTHFYNTDSLTLLGHAWNLWNDGRTWELMD 395 (476)
Q Consensus 317 ~~~~~~~-~~~~~gt~~y~aPE~l~~~~~s~ksDVwSlGvvl~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~d 395 (476)
....... .....++..|+|||.+.+..++.++||||||++++||++|+.|+........................+.++
T Consensus 159 ~~~~~~~~~~~~~~~~~~~~PE~~~~~~~~~~~Di~slG~~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 238 (283)
T cd05080 159 EGHEYYRVREDGDSPVFWYAVECLKENKFSYASDVWSFGVTLYELLTHCDSKQSPPKKFEEMIGPKQGQMTVVRLIELLE 238 (283)
T ss_pred CcchhhccCCCCCCCceeeCHhHhcccCCCcccccHHHHHHHHHHHhCCCCCCCCcchhhhhhcccccccchhhhhhhhh
Confidence 3321111 111234567999999988889999999999999999999999875432111111111110011111111111
Q ss_pred cccCCCCCHHHHHHHHHHHHHchhhcccCCCCHHHHHHHHhcc
Q 045315 396 PISQNGASYPILKRYINVALLCVQEKAADRPAMSEVVSMLSNE 438 (476)
Q Consensus 396 ~~~~~~~~~~~~~~l~~li~~Cl~~dP~~RPt~~eVl~~L~~~ 438 (476)
.......+......+.+++.+||+.+|++||++++|+++|+.+
T Consensus 239 ~~~~~~~~~~~~~~~~~li~~cl~~~p~~Rps~~~i~~~l~~~ 281 (283)
T cd05080 239 RGMRLPCPKNCPQEVYILMKNCWETEAKFRPTFRSLIPILKEM 281 (283)
T ss_pred cCCCCCCCCCCCHHHHHHHHHHhccChhhCCCHHHHHHHHHHh
Confidence 1111112223346788999999999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase 2 (Tyk2); catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyk2 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase catalytic domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of sign |
| >cd07862 STKc_CDK6 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 6 | Back alignment and domain information |
|---|
Probab=99.94 E-value=4e-27 Score=231.26 Aligned_cols=184 Identities=22% Similarity=0.282 Sum_probs=132.5
Q ss_pred ccceeeccCCC-------CCCCCCCChhhHHHHHHHHHHHHHHHhhcCCCceeecCCCccceEecCCCCceeccccceee
Q 045315 242 EISFWYESYNN-------PTKKGLLCWGTRVRIIEGIAQGLLYLHQYSRLRVIHRDLKASNILLDKDMNPKISDFGMARM 314 (476)
Q Consensus 242 ~~~l~~Ey~~~-------~~~~~~L~~~~~~~i~~qIa~gL~yLH~~~~~~ivH~DLkp~NILld~~~~~kL~DFGla~~ 314 (476)
..++++||++. ......+++.++..++.||+.||+|||+.+ |+||||||+|||++.++.+||+|||+++.
T Consensus 83 ~~~lv~e~~~~~l~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~lH~~~---iiH~dlkp~Nil~~~~~~~kl~Dfg~~~~ 159 (290)
T cd07862 83 KLTLVFEHVDQDLTTYLDKVPEPGVPTETIKDMMFQLLRGLDFLHSHR---VVHRDLKPQNILVTSSGQIKLADFGLARI 159 (290)
T ss_pred cEEEEEccCCCCHHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHHCC---eeeCCCCHHHEEEcCCCCEEEccccceEe
Confidence 46678888762 123346899999999999999999999999 99999999999999999999999999987
Q ss_pred cCCCcccccceeeeeccCCCChhhhccCCCCccceEEeehhhhhhhhhCCCCCCcCCCCchhhhhhhhhhhc---CCCcc
Q 045315 315 FGGDELQSNTKRIVGTYGYMSPEYALRGLFSIKSDVFSFGVLLLETLSSKKNTHFYNTDSLTLLGHAWNLWN---DGRTW 391 (476)
Q Consensus 315 ~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~s~ksDVwSlGvvl~elltG~~p~~~~~~~~~~~~~~~~~~~~---~~~~~ 391 (476)
..... ......|+..|+|||.+.+..++.++|||||||++|||++|++||....... .......... .....
T Consensus 160 ~~~~~---~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~~f~~~~~~~--~~~~i~~~~~~~~~~~~~ 234 (290)
T cd07862 160 YSFQM---ALTSVVVTLWYRAPEVLLQSSYATPVDLWSVGCIFAEMFRRKPLFRGSSDVD--QLGKILDVIGLPGEEDWP 234 (290)
T ss_pred ccCCc---ccccccccccccChHHHhCCCCCCccchHHHHHHHHHHHcCCCCcCCCCHHH--HHHHHHHHhCCCChhhch
Confidence 64331 2233568999999999988899999999999999999999999987543211 1111100000 00000
Q ss_pred c---ccCcccC--CC-----CCHHHHHHHHHHHHHchhhcccCCCCHHHHHH
Q 045315 392 E---LMDPISQ--NG-----ASYPILKRYINVALLCVQEKAADRPAMSEVVS 433 (476)
Q Consensus 392 ~---~~d~~~~--~~-----~~~~~~~~l~~li~~Cl~~dP~~RPt~~eVl~ 433 (476)
. ....... .. ........+.+++.+||+.||++|||+.|+++
T Consensus 235 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~s~~~~l~ 286 (290)
T cd07862 235 RDVALPRQAFHSKSAQPIEKFVTDIDELGKDLLLKCLTFNPAKRISAYSALS 286 (290)
T ss_pred hhhcccchhccCCCCCCHHHHccCCCHHHHHHHHHHhccCchhcCCHHHHhc
Confidence 0 0000000 00 00112356779999999999999999999884
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 6 (CDK6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK6 is regulated by D-type cyclins and INK4 inhibitors. It is active towards the retinoblastoma (pRb) protein, implicating it to function in regulating the early G1 phase of the cell cycle. It is expressed ubiquitously and is localized in the cytopla |
| >smart00108 B_lectin Bulb-type mannose-specific lectin | Back alignment and domain information |
|---|
Probab=99.94 E-value=3.6e-26 Score=193.25 Aligned_cols=113 Identities=45% Similarity=0.777 Sum_probs=100.3
Q ss_pred CcccCCCEEeeCCCeEEEEeeCCCCCCCeEEEEEEccCCCceEEeecCCCCCCCCCceEEEecCCceEEEccCCeEEEee
Q 045315 33 TFIRDGEKLVSSSQRFELGFFSPRNSKNRYLGVWYKKIPDTVVWVANRNSPIFNPNTALTFSNNGNLVLLSQRNGIIWSS 112 (476)
Q Consensus 33 ~~l~~~~~l~S~~g~f~lgf~~~~~~~~~~~~iw~~~~~~~~vW~an~~~p~~~~~~~l~~~~~G~lvl~~~~~~~vWss 112 (476)
+.|..|++|+|+++.|++|||.+... ..+.+|||+..+.++||+|||+.|+.+ .+.|.|+.||||||++.+|.++|+|
T Consensus 2 ~~l~~~~~l~s~~~~f~~G~~~~~~q-~dgnlV~~~~~~~~~vW~snt~~~~~~-~~~l~l~~dGnLvl~~~~g~~vW~S 79 (114)
T smart00108 2 NTLSSGQTLVSGNSLFELGFFTLIMQ-NDYNLILYKSSSRTVVWVANRDNPVSD-SCTLTLQSDGNLVLYDGDGRVVWSS 79 (114)
T ss_pred cccCCCCEEecCCCcEeeeccccCCC-CCEEEEEEECCCCcEEEECCCCCCCCC-CEEEEEeCCCCEEEEeCCCCEEEEe
Confidence 56888999999999999999998765 589999999765789999999999744 4899999999999999999999999
Q ss_pred cCCCCCCCceeeeccCCCeEEEeCCCCCCcCceeeccccC
Q 045315 113 NMSRKAENPIAQLLDTGNLVIRDNSSGHTTESYLWQSFDY 152 (476)
Q Consensus 113 ~~~~~~~~~~~~l~d~GNlVl~~~~~~~~~~~~~WqSFd~ 152 (476)
++........|+|+||||||||+.. +.++||||||
T Consensus 80 ~t~~~~~~~~~~L~ddGnlvl~~~~-----~~~~W~Sf~~ 114 (114)
T smart00108 80 NTTGANGNYVLVLLDDGNLVIYDSD-----GNFLWQSFDY 114 (114)
T ss_pred cccCCCCceEEEEeCCCCEEEECCC-----CCEEeCCCCC
Confidence 9874455678999999999999876 7899999997
|
|
| >cd05048 PTKc_Ror Catalytic Domain of the Protein Tyrosine Kinases, Receptor tyrosine kinase-like Orphan Receptors | Back alignment and domain information |
|---|
Probab=99.94 E-value=2.9e-27 Score=231.30 Aligned_cols=163 Identities=26% Similarity=0.394 Sum_probs=128.2
Q ss_pred CCCChhhHHHHHHHHHHHHHHHhhcCCCceeecCCCccceEecCCCCceeccccceeecCCCcccccceeeeeccCCCCh
Q 045315 257 GLLCWGTRVRIIEGIAQGLLYLHQYSRLRVIHRDLKASNILLDKDMNPKISDFGMARMFGGDELQSNTKRIVGTYGYMSP 336 (476)
Q Consensus 257 ~~L~~~~~~~i~~qIa~gL~yLH~~~~~~ivH~DLkp~NILld~~~~~kL~DFGla~~~~~~~~~~~~~~~~gt~~y~aP 336 (476)
..+++.+++.++.|++.||+|||+.+ ++|+||||+||++++++.+||+|||+++...............++..|+||
T Consensus 119 ~~l~~~~~~~~~~~l~~al~~lH~~~---i~H~dlkp~Nil~~~~~~~~L~dfg~~~~~~~~~~~~~~~~~~~~~~y~aP 195 (283)
T cd05048 119 SSLDCSDFLHIAIQIAAGMEYLSSHH---FVHRDLAARNCLVGEGLTVKISDFGLSRDIYSADYYRVQSKSLLPVRWMPP 195 (283)
T ss_pred CCCCHHHHHHHHHHHHHHHHHHHhCC---eeccccccceEEEcCCCcEEECCCcceeeccccccccccCCCcccccccCH
Confidence 56899999999999999999999998 999999999999999999999999999865433222222234567889999
Q ss_pred hhhccCCCCccceEEeehhhhhhhhh-CCCCCCcCCCCchhhhhhhhhhhcCCCcccccCcccCCCCCHHHHHHHHHHHH
Q 045315 337 EYALRGLFSIKSDVFSFGVLLLETLS-SKKNTHFYNTDSLTLLGHAWNLWNDGRTWELMDPISQNGASYPILKRYINVAL 415 (476)
Q Consensus 337 E~l~~~~~s~ksDVwSlGvvl~ellt-G~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~l~~li~ 415 (476)
|.+.+..++.++|||||||++|||++ |..||...... ... ..+..+... ..+.....++.+++.
T Consensus 196 E~~~~~~~~~~sDv~slG~il~el~~~g~~p~~~~~~~--~~~----~~i~~~~~~---------~~~~~~~~~~~~l~~ 260 (283)
T cd05048 196 EAILYGKFTTESDIWSFGVVLWEIFSYGLQPYYGFSNQ--EVI----EMIRSRQLL---------PCPEDCPARVYALMI 260 (283)
T ss_pred HHhccCcCchhhhHHHHHHHHHHHHcCCCCCCCCCCHH--HHH----HHHHcCCcC---------CCcccCCHHHHHHHH
Confidence 99998899999999999999999998 98887643321 111 111111111 112233467889999
Q ss_pred HchhhcccCCCCHHHHHHHHhc
Q 045315 416 LCVQEKAADRPAMSEVVSMLSN 437 (476)
Q Consensus 416 ~Cl~~dP~~RPt~~eVl~~L~~ 437 (476)
+||+.||++||++.+|++.|++
T Consensus 261 ~c~~~~p~~Rp~~~~i~~~l~~ 282 (283)
T cd05048 261 ECWNEIPARRPRFKDIHTRLRS 282 (283)
T ss_pred HHccCChhhCcCHHHHHHHHhc
Confidence 9999999999999999999976
|
Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor (Ror) subfamily; catalytic (c) domain. The Ror subfamily consists of Ror1, Ror2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimer |
| >cd05094 PTKc_TrkC Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase C | Back alignment and domain information |
|---|
Probab=99.94 E-value=3.6e-27 Score=232.11 Aligned_cols=166 Identities=27% Similarity=0.390 Sum_probs=129.5
Q ss_pred CCCChhhHHHHHHHHHHHHHHHhhcCCCceeecCCCccceEecCCCCceeccccceeecCCCcccccceeeeeccCCCCh
Q 045315 257 GLLCWGTRVRIIEGIAQGLLYLHQYSRLRVIHRDLKASNILLDKDMNPKISDFGMARMFGGDELQSNTKRIVGTYGYMSP 336 (476)
Q Consensus 257 ~~L~~~~~~~i~~qIa~gL~yLH~~~~~~ivH~DLkp~NILld~~~~~kL~DFGla~~~~~~~~~~~~~~~~gt~~y~aP 336 (476)
+.+++.++++++.||+.||+|||+++ ++||||||+||+++.++.+||+|||++................++..|+||
T Consensus 118 ~~~~~~~~~~i~~~i~~al~~lH~~~---i~H~dlkp~Nil~~~~~~~~l~dfg~a~~~~~~~~~~~~~~~~~~~~y~aP 194 (291)
T cd05094 118 GELGLSQMLHIASQIASGMVYLASQH---FVHRDLATRNCLVGANLLVKIGDFGMSRDVYSTDYYRVGGHTMLPIRWMPP 194 (291)
T ss_pred CCCCHHHHHHHHHHHHHHHHHHHhCC---eeecccCcceEEEccCCcEEECCCCcccccCCCceeecCCCCCcceeecCh
Confidence 45899999999999999999999999 999999999999999999999999999765433222222234467889999
Q ss_pred hhhccCCCCccceEEeehhhhhhhhh-CCCCCCcCCCCchhhhhhhhhhhcCCCcccccCcccCCCCCHHHHHHHHHHHH
Q 045315 337 EYALRGLFSIKSDVFSFGVLLLETLS-SKKNTHFYNTDSLTLLGHAWNLWNDGRTWELMDPISQNGASYPILKRYINVAL 415 (476)
Q Consensus 337 E~l~~~~~s~ksDVwSlGvvl~ellt-G~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~l~~li~ 415 (476)
|.+.+..++.++|||||||++|||++ |+.||...... ... .....+..... .......+.+++.
T Consensus 195 E~~~~~~~~~~~Di~slG~il~el~t~g~~p~~~~~~~--~~~----~~~~~~~~~~~---------~~~~~~~~~~li~ 259 (291)
T cd05094 195 ESIMYRKFTTESDVWSFGVILWEIFTYGKQPWFQLSNT--EVI----ECITQGRVLER---------PRVCPKEVYDIML 259 (291)
T ss_pred HHhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCHH--HHH----HHHhCCCCCCC---------CccCCHHHHHHHH
Confidence 99998899999999999999999998 89887543311 111 11112211111 1122456889999
Q ss_pred HchhhcccCCCCHHHHHHHHhcccc
Q 045315 416 LCVQEKAADRPAMSEVVSMLSNEFV 440 (476)
Q Consensus 416 ~Cl~~dP~~RPt~~eVl~~L~~~~~ 440 (476)
+||+.+|++||++.+|+++|+++..
T Consensus 260 ~~l~~~P~~Rpt~~~v~~~l~~~~~ 284 (291)
T cd05094 260 GCWQREPQQRLNIKEIYKILHALGK 284 (291)
T ss_pred HHcccChhhCcCHHHHHHHHHHHHh
Confidence 9999999999999999999999864
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase C (TrkC); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkC is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkC to its ligand, neurotrophin 3 (NT3), results in receptor oligomerization and activation of the catalytic domain. TrkC is broadly expressed in the nervous system and in some n |
| >PHA02988 hypothetical protein; Provisional | Back alignment and domain information |
|---|
Probab=99.94 E-value=2.9e-27 Score=232.23 Aligned_cols=176 Identities=19% Similarity=0.274 Sum_probs=136.5
Q ss_pred ccceeeccCCCC------CCCCCCChhhHHHHHHHHHHHHHHHhhc-CCCceeecCCCccceEecCCCCceeccccceee
Q 045315 242 EISFWYESYNNP------TKKGLLCWGTRVRIIEGIAQGLLYLHQY-SRLRVIHRDLKASNILLDKDMNPKISDFGMARM 314 (476)
Q Consensus 242 ~~~l~~Ey~~~~------~~~~~L~~~~~~~i~~qIa~gL~yLH~~-~~~~ivH~DLkp~NILld~~~~~kL~DFGla~~ 314 (476)
..++++||++.+ .+.+.+++.++.+++.|++.||+|||+. + ++||||||+||++++++.+||+|||+++.
T Consensus 96 ~~~lv~Ey~~~g~L~~~l~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~---~~Hrdlkp~nill~~~~~~kl~dfg~~~~ 172 (283)
T PHA02988 96 RLSLILEYCTRGYLREVLDKEKDLSFKTKLDMAIDCCKGLYNLYKYTN---KPYKNLTSVSFLVTENYKLKIICHGLEKI 172 (283)
T ss_pred ceEEEEEeCCCCcHHHHHhhCCCCChhHHHHHHHHHHHHHHHHHhcCC---CCCCcCChhhEEECCCCcEEEcccchHhh
Confidence 467889999843 2346799999999999999999999985 6 78999999999999999999999999986
Q ss_pred cCCCcccccceeeeeccCCCChhhhcc--CCCCccceEEeehhhhhhhhhCCCCCCcCCCCchhhhhhhhhhhcCCCccc
Q 045315 315 FGGDELQSNTKRIVGTYGYMSPEYALR--GLFSIKSDVFSFGVLLLETLSSKKNTHFYNTDSLTLLGHAWNLWNDGRTWE 392 (476)
Q Consensus 315 ~~~~~~~~~~~~~~gt~~y~aPE~l~~--~~~s~ksDVwSlGvvl~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~ 392 (476)
..... ....++..|+|||++.+ ..++.++|||||||++|||++|+.||...... ..... ....+...
T Consensus 173 ~~~~~-----~~~~~~~~y~aPE~~~~~~~~~~~k~Di~SlGvil~el~~g~~Pf~~~~~~--~~~~~---i~~~~~~~- 241 (283)
T PHA02988 173 LSSPP-----FKNVNFMVYFSYKMLNDIFSEYTIKDDIYSLGVVLWEIFTGKIPFENLTTK--EIYDL---IINKNNSL- 241 (283)
T ss_pred hcccc-----ccccCcccccCHHHhhhccccccchhhhhHHHHHHHHHHHCCCCCCCCCHH--HHHHH---HHhcCCCC-
Confidence 54321 12457889999999976 68899999999999999999999998744311 11111 11111110
Q ss_pred ccCcccCCCCCHHHHHHHHHHHHHchhhcccCCCCHHHHHHHHhccc
Q 045315 393 LMDPISQNGASYPILKRYINVALLCVQEKAADRPAMSEVVSMLSNEF 439 (476)
Q Consensus 393 ~~d~~~~~~~~~~~~~~l~~li~~Cl~~dP~~RPt~~eVl~~L~~~~ 439 (476)
..+......+.+++.+||+.||++|||+.||++.|+...
T Consensus 242 --------~~~~~~~~~l~~li~~cl~~dp~~Rps~~ell~~l~~~~ 280 (283)
T PHA02988 242 --------KLPLDCPLEIKCIVEACTSHDSIKRPNIKEILYNLSLYK 280 (283)
T ss_pred --------CCCCcCcHHHHHHHHHHhcCCcccCcCHHHHHHHHHHHH
Confidence 111123457889999999999999999999999998754
|
|
| >KOG0595 consensus Serine/threonine-protein kinase involved in autophagy [Posttranslational modification, protein turnover, chaperones; Intracellular trafficking, secretion, and vesicular transport; Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.94 E-value=3.6e-27 Score=229.53 Aligned_cols=125 Identities=32% Similarity=0.499 Sum_probs=110.6
Q ss_pred cccceeeccCCCC------CCCCCCChhhHHHHHHHHHHHHHHHhhcCCCceeecCCCccceEecCC------CCceecc
Q 045315 241 DEISFWYESYNNP------TKKGLLCWGTRVRIIEGIAQGLLYLHQYSRLRVIHRDLKASNILLDKD------MNPKISD 308 (476)
Q Consensus 241 ~~~~l~~Ey~~~~------~~~~~L~~~~~~~i~~qIa~gL~yLH~~~~~~ivH~DLkp~NILld~~------~~~kL~D 308 (476)
+.|++||||+..+ .+++.|++.++..+..|||.||++||+++ ||||||||+||||+.. -.+||+|
T Consensus 82 ~~i~lVMEyC~gGDLs~yi~~~~~l~e~t~r~Fm~QLA~alq~L~~~~---IiHRDLKPQNiLLs~~~~~~~~~~LKIAD 158 (429)
T KOG0595|consen 82 DFIYLVMEYCNGGDLSDYIRRRGRLPEATARHFMQQLASALQFLHENN---IIHRDLKPQNILLSTTARNDTSPVLKIAD 158 (429)
T ss_pred CeEEEEEEeCCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCC---eeeccCCcceEEeccCCCCCCCceEEecc
Confidence 5789999999943 35668999999999999999999999999 9999999999999865 4579999
Q ss_pred ccceeecCCCcccccceeeeeccCCCChhhhccCCCCccceEEeehhhhhhhhhCCCCCCcCC
Q 045315 309 FGMARMFGGDELQSNTKRIVGTYGYMSPEYALRGLFSIKSDVFSFGVLLLETLSSKKNTHFYN 371 (476)
Q Consensus 309 FGla~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~s~ksDVwSlGvvl~elltG~~p~~~~~ 371 (476)
||+|+.+..... .....|++.|||||+++.+.|+.|+|+||+|+++|++++|+.||....
T Consensus 159 FGfAR~L~~~~~---a~tlcGSplYMAPEV~~~~~YdAKADLWSiG~Ilyq~l~g~~Pf~a~t 218 (429)
T KOG0595|consen 159 FGFARFLQPGSM---AETLCGSPLYMAPEVIMSQQYDAKADLWSIGTILYQCLTGKPPFDAET 218 (429)
T ss_pred cchhhhCCchhH---HHHhhCCccccCHHHHHhccccchhhHHHHHHHHHHHHhCCCCccccC
Confidence 999998875432 344689999999999999999999999999999999999999997543
|
|
| >KOG0588 consensus Serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=99.94 E-value=5.5e-27 Score=239.42 Aligned_cols=173 Identities=27% Similarity=0.332 Sum_probs=141.2
Q ss_pred ccccceeeccCCCC------CCCCCCChhhHHHHHHHHHHHHHHHhhcCCCceeecCCCccceEecCCCCceecccccee
Q 045315 240 KDEISFWYESYNNP------TKKGLLCWGTRVRIIEGIAQGLLYLHQYSRLRVIHRDLKASNILLDKDMNPKISDFGMAR 313 (476)
Q Consensus 240 ~~~~~l~~Ey~~~~------~~~~~L~~~~~~~i~~qIa~gL~yLH~~~~~~ivH~DLkp~NILld~~~~~kL~DFGla~ 313 (476)
+...|++.||++++ .++++|++.++.+++.||+.|+.|+|..+ |+||||||+|+|||..+++||+|||+|.
T Consensus 84 ~~~lylvlEyv~gGELFdylv~kG~l~e~eaa~ff~QIi~gv~yCH~~~---icHRDLKpENlLLd~~~nIKIADFGMAs 160 (786)
T KOG0588|consen 84 KQHLYLVLEYVPGGELFDYLVRKGPLPEREAAHFFRQILDGVSYCHAFN---ICHRDLKPENLLLDVKNNIKIADFGMAS 160 (786)
T ss_pred CceEEEEEEecCCchhHHHHHhhCCCCCHHHHHHHHHHHHHHHHHhhhc---ceeccCCchhhhhhcccCEeeeccceee
Confidence 46889999999954 36889999999999999999999999999 9999999999999999999999999998
Q ss_pred ecCCCcccccceeeeeccCCCChhhhccCCC-CccceEEeehhhhhhhhhCCCCCCcCCCCchhhhhhhhhhhcCCCccc
Q 045315 314 MFGGDELQSNTKRIVGTYGYMSPEYALRGLF-SIKSDVFSFGVLLLETLSSKKNTHFYNTDSLTLLGHAWNLWNDGRTWE 392 (476)
Q Consensus 314 ~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~-s~ksDVwSlGvvl~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~ 392 (476)
.-.++. .....+|.++|.|||++++.+| ..++||||.||+||.|++|+.||+..+ -..++..+ ..|.. +
T Consensus 161 Le~~gk---lLeTSCGSPHYA~PEIV~G~pYdG~~sDVWSCGVILfALLtG~LPFdDdN--ir~LLlKV----~~G~f-~ 230 (786)
T KOG0588|consen 161 LEVPGK---LLETSCGSPHYAAPEIVSGRPYDGRPSDVWSCGVILFALLTGKLPFDDDN--IRVLLLKV----QRGVF-E 230 (786)
T ss_pred cccCCc---cccccCCCcccCCchhhcCCCCCCCccccchhHHHHHHHHhCCCCCCCcc--HHHHHHHH----HcCcc-c
Confidence 754433 2334679999999999999998 589999999999999999999997433 22222222 22222 1
Q ss_pred ccCcccCCCCCHHHHHHHHHHHHHchhhcccCCCCHHHHHHH
Q 045315 393 LMDPISQNGASYPILKRYINVALLCVQEKAADRPAMSEVVSM 434 (476)
Q Consensus 393 ~~d~~~~~~~~~~~~~~l~~li~~Cl~~dP~~RPt~~eVl~~ 434 (476)
+ +.....++.+|+.+|+..||++|.|++||++.
T Consensus 231 M---------Ps~Is~eaQdLLr~ml~VDp~~RiT~~eI~kH 263 (786)
T KOG0588|consen 231 M---------PSNISSEAQDLLRRMLDVDPSTRITTEEILKH 263 (786)
T ss_pred C---------CCcCCHHHHHHHHHHhccCccccccHHHHhhC
Confidence 1 22334578899999999999999999999875
|
|
| >KOG4721 consensus Serine/threonine protein kinase, contains leucine zipper domain [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.94 E-value=3.4e-27 Score=236.58 Aligned_cols=180 Identities=27% Similarity=0.378 Sum_probs=142.3
Q ss_pred ccc-eeeccCCCC------CCCCCCChhhHHHHHHHHHHHHHHHhhcCCCceeecCCCccceEecCCCCceeccccceee
Q 045315 242 EIS-FWYESYNNP------TKKGLLCWGTRVRIIEGIAQGLLYLHQYSRLRVIHRDLKASNILLDKDMNPKISDFGMARM 314 (476)
Q Consensus 242 ~~~-l~~Ey~~~~------~~~~~L~~~~~~~i~~qIa~gL~yLH~~~~~~ivH~DLkp~NILld~~~~~kL~DFGla~~ 314 (476)
-|| ++|||++.+ ..+.++.......+..+||.|+.|||.+. |||||||.-||||..+..+||+|||-++.
T Consensus 185 PcyCIiMEfCa~GqL~~VLka~~~itp~llv~Wsk~IA~GM~YLH~hK---IIHRDLKSPNiLIs~~d~VKIsDFGTS~e 261 (904)
T KOG4721|consen 185 PCYCIIMEFCAQGQLYEVLKAGRPITPSLLVDWSKGIAGGMNYLHLHK---IIHRDLKSPNILISYDDVVKISDFGTSKE 261 (904)
T ss_pred ceeEEeeeccccccHHHHHhccCccCHHHHHHHHHHhhhhhHHHHHhh---HhhhccCCCceEeeccceEEeccccchHh
Confidence 454 789999843 34667888889999999999999999998 99999999999999999999999999987
Q ss_pred cCCCcccccceeeeeccCCCChhhhccCCCCccceEEeehhhhhhhhhCCCCCCcCCCCchhhhhhhhhhhcCCCccccc
Q 045315 315 FGGDELQSNTKRIVGTYGYMSPEYALRGLFSIKSDVFSFGVLLLETLSSKKNTHFYNTDSLTLLGHAWNLWNDGRTWELM 394 (476)
Q Consensus 315 ~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~s~ksDVwSlGvvl~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 394 (476)
.... .....+.||..|||||++.+.+.+.|.||||||||||||+||.-|+...+ ...++ |.. ......+.
T Consensus 262 ~~~~---STkMSFaGTVaWMAPEvIrnePcsEKVDIwSfGVVLWEmLT~EiPYkdVd--ssAII---wGV--GsNsL~Lp 331 (904)
T KOG4721|consen 262 LSDK---STKMSFAGTVAWMAPEVIRNEPCSEKVDIWSFGVVLWEMLTGEIPYKDVD--SSAII---WGV--GSNSLHLP 331 (904)
T ss_pred hhhh---hhhhhhhhhHhhhCHHHhhcCCcccccceehhHHHHHHHHhcCCCccccc--hheeE---Eec--cCCccccc
Confidence 6543 22345789999999999999999999999999999999999999976432 11111 111 11122222
Q ss_pred CcccCCCCCHHHHHHHHHHHHHchhhcccCCCCHHHHHHHHhccccC
Q 045315 395 DPISQNGASYPILKRYINVALLCVQEKAADRPAMSEVVSMLSNEFVN 441 (476)
Q Consensus 395 d~~~~~~~~~~~~~~l~~li~~Cl~~dP~~RPt~~eVl~~L~~~~~~ 441 (476)
.+...++-+.-|+++||+-.|..||++++++..|+-...+
T Consensus 332 -------vPstcP~GfklL~Kqcw~sKpRNRPSFrqil~HldIa~pe 371 (904)
T KOG4721|consen 332 -------VPSTCPDGFKLLLKQCWNSKPRNRPSFRQILLHLDIASPE 371 (904)
T ss_pred -------CcccCchHHHHHHHHHHhcCCCCCccHHHHHHHHhhcCHH
Confidence 2233456678889999999999999999999999765433
|
|
| >KOG0583 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.94 E-value=1.3e-26 Score=234.53 Aligned_cols=171 Identities=25% Similarity=0.323 Sum_probs=135.8
Q ss_pred cccceeeccCCCC------CCCCCCChhhHHHHHHHHHHHHHHHhhcCCCceeecCCCccceEecCC-CCceecccccee
Q 045315 241 DEISFWYESYNNP------TKKGLLCWGTRVRIIEGIAQGLLYLHQYSRLRVIHRDLKASNILLDKD-MNPKISDFGMAR 313 (476)
Q Consensus 241 ~~~~l~~Ey~~~~------~~~~~L~~~~~~~i~~qIa~gL~yLH~~~~~~ivH~DLkp~NILld~~-~~~kL~DFGla~ 313 (476)
...+++|||+..+ .+.++|.+.++.++++|++.|++|||+++ |+||||||+|||+|.+ +.+||+|||++.
T Consensus 93 ~~~~ivmEy~~gGdL~~~i~~~g~l~E~~ar~~F~Qlisav~y~H~~g---i~HRDLK~ENilld~~~~~~Kl~DFG~s~ 169 (370)
T KOG0583|consen 93 TKIYIVMEYCSGGDLFDYIVNKGRLKEDEARKYFRQLISAVAYCHSRG---IVHRDLKPENILLDGNEGNLKLSDFGLSA 169 (370)
T ss_pred CeEEEEEEecCCccHHHHHHHcCCCChHHHHHHHHHHHHHHHHHHhCC---EeeCCCCHHHEEecCCCCCEEEecccccc
Confidence 3589999999842 23678999999999999999999999999 9999999999999999 999999999999
Q ss_pred ecCCCcccccceeeeeccCCCChhhhccCC-CC-ccceEEeehhhhhhhhhCCCCCCcCCCCchhhhhhhhhhhcCCCcc
Q 045315 314 MFGGDELQSNTKRIVGTYGYMSPEYALRGL-FS-IKSDVFSFGVLLLETLSSKKNTHFYNTDSLTLLGHAWNLWNDGRTW 391 (476)
Q Consensus 314 ~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~-~s-~ksDVwSlGvvl~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~ 391 (476)
..... ........|++.|+|||++.+.. |+ .++||||+||+||.|++|+.||...+. ..+... +..+..
T Consensus 170 ~~~~~--~~~l~t~cGsp~Y~aPEvl~~~~~Y~g~~aDvWS~GViLy~ml~G~~PF~d~~~--~~l~~k----i~~~~~- 240 (370)
T KOG0583|consen 170 ISPGE--DGLLKTFCGSPAYAAPEVLSGKGTYSGKAADVWSLGVILYVLLCGRLPFDDSNV--PNLYRK----IRKGEF- 240 (370)
T ss_pred ccCCC--CCcccCCCCCcccCCHHHhCCCCCcCCchhhhhhhHHHHHHHHhCCCCCCCccH--HHHHHH----HhcCCc-
Confidence 87311 12233468999999999999877 85 889999999999999999999976321 111111 111111
Q ss_pred cccCcccCCCCCHHH-HHHHHHHHHHchhhcccCCCCHHHHH
Q 045315 392 ELMDPISQNGASYPI-LKRYINVALLCVQEKAADRPAMSEVV 432 (476)
Q Consensus 392 ~~~d~~~~~~~~~~~-~~~l~~li~~Cl~~dP~~RPt~~eVl 432 (476)
. .+... ...+..++.+|++.||.+|+++.+|+
T Consensus 241 ~---------~p~~~~S~~~~~Li~~mL~~~P~~R~t~~~i~ 273 (370)
T KOG0583|consen 241 K---------IPSYLLSPEARSLIEKMLVPDPSTRITLLEIL 273 (370)
T ss_pred c---------CCCCcCCHHHHHHHHHHcCCCcccCCCHHHHh
Confidence 0 01111 56789999999999999999999998
|
|
| >cd05111 PTK_HER3 Pseudokinase domain of the Protein Tyrosine Kinase, HER3 | Back alignment and domain information |
|---|
Probab=99.94 E-value=6.6e-27 Score=228.90 Aligned_cols=180 Identities=23% Similarity=0.289 Sum_probs=136.3
Q ss_pred ccceeeccCCCCC-------CCCCCChhhHHHHHHHHHHHHHHHhhcCCCceeecCCCccceEecCCCCceeccccceee
Q 045315 242 EISFWYESYNNPT-------KKGLLCWGTRVRIIEGIAQGLLYLHQYSRLRVIHRDLKASNILLDKDMNPKISDFGMARM 314 (476)
Q Consensus 242 ~~~l~~Ey~~~~~-------~~~~L~~~~~~~i~~qIa~gL~yLH~~~~~~ivH~DLkp~NILld~~~~~kL~DFGla~~ 314 (476)
..++++||++.++ +.+.+++..++.++.||+.||+|||+++ ++||||||+||+++.++.+||+|||+++.
T Consensus 82 ~~~~i~e~~~~gsL~~~l~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~---iiH~dlkp~nili~~~~~~kl~Dfg~~~~ 158 (279)
T cd05111 82 SLQLVTQLSPLGSLLDHVRQHRDSLDPQRLLNWCVQIAKGMYYLEEHR---MVHRNLAARNILLKSDSIVQIADFGVADL 158 (279)
T ss_pred ccEEEEEeCCCCcHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHHCC---EeccccCcceEEEcCCCcEEEcCCcccee
Confidence 3456777777322 3457899999999999999999999998 99999999999999999999999999987
Q ss_pred cCCCcccccceeeeeccCCCChhhhccCCCCccceEEeehhhhhhhhh-CCCCCCcCCCCchhhhhhhhhhhcCCCcccc
Q 045315 315 FGGDELQSNTKRIVGTYGYMSPEYALRGLFSIKSDVFSFGVLLLETLS-SKKNTHFYNTDSLTLLGHAWNLWNDGRTWEL 393 (476)
Q Consensus 315 ~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~s~ksDVwSlGvvl~ellt-G~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~ 393 (476)
..............++..|+|||.+.++.++.++||||||+++||+++ |+.|+...... ... .....+....
T Consensus 159 ~~~~~~~~~~~~~~~~~~y~~pE~~~~~~~~~~~Dv~slG~il~el~t~g~~p~~~~~~~--~~~----~~~~~~~~~~- 231 (279)
T cd05111 159 LYPDDKKYFYSEHKTPIKWMALESILFGRYTHQSDVWSYGVTVWEMMSYGAEPYAGMRPH--EVP----DLLEKGERLA- 231 (279)
T ss_pred ccCCCcccccCCCCCcccccCHHHhccCCcCchhhHHHHHHHHHHHHcCCCCCCCCCCHH--HHH----HHHHCCCcCC-
Confidence 643322222223456778999999998899999999999999999998 88887543211 111 1111221111
Q ss_pred cCcccCCCCCHHHHHHHHHHHHHchhhcccCCCCHHHHHHHHhccc
Q 045315 394 MDPISQNGASYPILKRYINVALLCVQEKAADRPAMSEVVSMLSNEF 439 (476)
Q Consensus 394 ~d~~~~~~~~~~~~~~l~~li~~Cl~~dP~~RPt~~eVl~~L~~~~ 439 (476)
.+. .....+.+++.+||+.+|++||++.|+++.|..+.
T Consensus 232 -~~~-------~~~~~~~~li~~c~~~~p~~Rps~~el~~~l~~~~ 269 (279)
T cd05111 232 -QPQ-------ICTIDVYMVMVKCWMIDENVRPTFKELANEFTRMA 269 (279)
T ss_pred -CCC-------CCCHHHHHHHHHHcCCCcccCcCHHHHHHHHHHHH
Confidence 111 11235678899999999999999999999998865
|
Protein Tyrosine Kinase (PTK) family; HER3 (ErbB3); pseudokinase domain. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER3 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr r |
| >cd05052 PTKc_Abl Catalytic domain of the Protein Tyrosine Kinase, Abelson kinase | Back alignment and domain information |
|---|
Probab=99.94 E-value=1e-26 Score=225.30 Aligned_cols=179 Identities=23% Similarity=0.312 Sum_probs=135.8
Q ss_pred cccceeeccCCCC--------CCCCCCChhhHHHHHHHHHHHHHHHhhcCCCceeecCCCccceEecCCCCceeccccce
Q 045315 241 DEISFWYESYNNP--------TKKGLLCWGTRVRIIEGIAQGLLYLHQYSRLRVIHRDLKASNILLDKDMNPKISDFGMA 312 (476)
Q Consensus 241 ~~~~l~~Ey~~~~--------~~~~~L~~~~~~~i~~qIa~gL~yLH~~~~~~ivH~DLkp~NILld~~~~~kL~DFGla 312 (476)
+..++++||+++. .....+++..++.++.|+++||+|||+.+ ++||||||+||++++++.+||+|||++
T Consensus 75 ~~~~lv~e~~~~~~L~~~~~~~~~~~l~~~~~~~~~~ql~~~l~~lH~~~---i~H~dlkp~nil~~~~~~~kl~df~~~ 151 (263)
T cd05052 75 PPFYIITEFMTYGNLLDYLRECNRQEVNAVVLLYMATQISSAMEYLEKKN---FIHRDLAARNCLVGENHLVKVADFGLS 151 (263)
T ss_pred CCcEEEEEeCCCCcHHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHhCC---EeecccCcceEEEcCCCcEEeCCCccc
Confidence 3467888988732 23456899999999999999999999998 999999999999999999999999999
Q ss_pred eecCCCcccccceeeeeccCCCChhhhccCCCCccceEEeehhhhhhhhh-CCCCCCcCCCCchhhhhhhhhhhcCCCcc
Q 045315 313 RMFGGDELQSNTKRIVGTYGYMSPEYALRGLFSIKSDVFSFGVLLLETLS-SKKNTHFYNTDSLTLLGHAWNLWNDGRTW 391 (476)
Q Consensus 313 ~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~s~ksDVwSlGvvl~ellt-G~~p~~~~~~~~~~~~~~~~~~~~~~~~~ 391 (476)
.......... .....++..|+|||.+.+..++.++|||||||++|||++ |..|+.....+ ... .......
T Consensus 152 ~~~~~~~~~~-~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~el~t~g~~p~~~~~~~--~~~----~~~~~~~-- 222 (263)
T cd05052 152 RLMTGDTYTA-HAGAKFPIKWTAPESLAYNKFSIKSDVWAFGVLLWEIATYGMSPYPGIDLS--QVY----ELLEKGY-- 222 (263)
T ss_pred cccccceeec-cCCCCCccccCCHHHhccCCCCchhHHHHHHHHHHHHHcCCCCCCCCCCHH--HHH----HHHHCCC--
Confidence 8765432211 111233567999999998899999999999999999998 88887643311 111 1111110
Q ss_pred cccCcccCCCCCHHHHHHHHHHHHHchhhcccCCCCHHHHHHHHhcc
Q 045315 392 ELMDPISQNGASYPILKRYINVALLCVQEKAADRPAMSEVVSMLSNE 438 (476)
Q Consensus 392 ~~~d~~~~~~~~~~~~~~l~~li~~Cl~~dP~~RPt~~eVl~~L~~~ 438 (476)
....+......+.+++.+||+.+|++||++.+++++|+.+
T Consensus 223 -------~~~~~~~~~~~~~~li~~cl~~~p~~Rp~~~~l~~~l~~~ 262 (263)
T cd05052 223 -------RMERPEGCPPKVYELMRACWQWNPSDRPSFAEIHQAFETM 262 (263)
T ss_pred -------CCCCCCCCCHHHHHHHHHHccCCcccCCCHHHHHHHHHhh
Confidence 0011122345788999999999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Abelson (Abl) kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Abl (or c-Abl) is a ubiquitously-expressed cytoplasmic (or nonreceptor) tyr kinase that contains SH3, SH2, and tyr kinase domains in its N-terminal region, as well as nuclear localization motifs, a putative DNA-binding domain, and F- and G-actin binding domains in its C-terminal tail. It also contains a short autoinhibitory cap region in its N-terminus. Abl is normally inactive and requires phosphorylation and myristoylation for activation. Abl function depends on its subcellular localization. In the cytoplasm, Abl plays |
| >cd05053 PTKc_FGFR Catalytic domain of the Protein Tyrosine Kinases, Fibroblast Growth Factor Receptors | Back alignment and domain information |
|---|
Probab=99.94 E-value=1.1e-26 Score=228.59 Aligned_cols=166 Identities=27% Similarity=0.372 Sum_probs=128.0
Q ss_pred CCCCChhhHHHHHHHHHHHHHHHhhcCCCceeecCCCccceEecCCCCceeccccceeecCCCcccccceeeeeccCCCC
Q 045315 256 KGLLCWGTRVRIIEGIAQGLLYLHQYSRLRVIHRDLKASNILLDKDMNPKISDFGMARMFGGDELQSNTKRIVGTYGYMS 335 (476)
Q Consensus 256 ~~~L~~~~~~~i~~qIa~gL~yLH~~~~~~ivH~DLkp~NILld~~~~~kL~DFGla~~~~~~~~~~~~~~~~gt~~y~a 335 (476)
...+++.++++++.||+.||+|||+.+ |+||||||+||+++.++.+||+|||+++...............++..|+|
T Consensus 126 ~~~l~~~~~~~i~~qi~~al~~LH~~~---ivH~dlkp~Nil~~~~~~~kL~Dfg~~~~~~~~~~~~~~~~~~~~~~y~a 202 (293)
T cd05053 126 EETLTQKDLVSFAYQVARGMEFLASKK---CIHRDLAARNVLVTEDHVMKIADFGLARDIHHIDYYRKTTNGRLPVKWMA 202 (293)
T ss_pred ccccCHHHHHHHHHHHHHHHHHHHHCC---ccccccceeeEEEcCCCeEEeCccccccccccccceeccCCCCCCccccC
Confidence 457999999999999999999999998 99999999999999999999999999987654322222222334678999
Q ss_pred hhhhccCCCCccceEEeehhhhhhhhh-CCCCCCcCCCCchhhhhhhhhhhcCCCcccccCcccCCCCCHHHHHHHHHHH
Q 045315 336 PEYALRGLFSIKSDVFSFGVLLLETLS-SKKNTHFYNTDSLTLLGHAWNLWNDGRTWELMDPISQNGASYPILKRYINVA 414 (476)
Q Consensus 336 PE~l~~~~~s~ksDVwSlGvvl~ellt-G~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~l~~li 414 (476)
||.+.+..++.++|||||||++||+++ |..|+....... .. .....+... ..+......+.+++
T Consensus 203 PE~~~~~~~~~~~Di~slG~il~el~~~g~~p~~~~~~~~--~~----~~~~~~~~~---------~~~~~~~~~~~~li 267 (293)
T cd05053 203 PEALFDRVYTHQSDVWSFGVLLWEIFTLGGSPYPGIPVEE--LF----KLLKEGYRM---------EKPQNCTQELYHLM 267 (293)
T ss_pred HHHhccCCcCcccceeehhhHHHHHhcCCCCCCCCCCHHH--HH----HHHHcCCcC---------CCCCCCCHHHHHHH
Confidence 999988889999999999999999997 888875432111 11 111111110 11122345788999
Q ss_pred HHchhhcccCCCCHHHHHHHHhccc
Q 045315 415 LLCVQEKAADRPAMSEVVSMLSNEF 439 (476)
Q Consensus 415 ~~Cl~~dP~~RPt~~eVl~~L~~~~ 439 (476)
.+|++.+|++|||+.++++.|+.+.
T Consensus 268 ~~~l~~~p~~Rps~~eil~~l~~~~ 292 (293)
T cd05053 268 RDCWHEVPSQRPTFKQLVEDLDRML 292 (293)
T ss_pred HHHcccCcccCcCHHHHHHHHHHhh
Confidence 9999999999999999999998764
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor (FGFR) subfamily; catalytic (c) domain. The FGFR subfamily consists of FGFR1, FGFR2, FGFR3, FGFR4, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K).PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, and to heparin/heparan sulfate (HS) results in the formation of a ternary complex, which leads to receptor dimerization and activation, |
| >KOG1989 consensus ARK protein kinase family [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.94 E-value=4.4e-27 Score=248.43 Aligned_cols=179 Identities=21% Similarity=0.192 Sum_probs=141.6
Q ss_pred ccceeeccCCCC--------CCCCCCChhhHHHHHHHHHHHHHHHhhcCCCceeecCCCccceEecCCCCceecccccee
Q 045315 242 EISFWYESYNNP--------TKKGLLCWGTRVRIIEGIAQGLLYLHQYSRLRVIHRDLKASNILLDKDMNPKISDFGMAR 313 (476)
Q Consensus 242 ~~~l~~Ey~~~~--------~~~~~L~~~~~~~i~~qIa~gL~yLH~~~~~~ivH~DLkp~NILld~~~~~kL~DFGla~ 313 (476)
++++.|||++.+ +....|++.++++|+.|+++|+++||... ++|||||||.+||||+.++..||||||-|.
T Consensus 116 EvllLmEyC~gg~Lvd~mn~Rlq~~lte~eVLkIf~dv~~AVa~mH~~~-pPiIHRDLKiENvLls~~g~~KLCDFGSat 194 (738)
T KOG1989|consen 116 EVLLLMEYCKGGSLVDFMNTRLQTRLTEDEVLKIFYDVCEAVAAMHYLK-PPIIHRDLKIENVLLSADGNYKLCDFGSAT 194 (738)
T ss_pred EEEeehhhccCCcHHHHHHHHHhccCChHHHHHHHHHHHHHHHHHhcCC-CccchhhhhhhheEEcCCCCEEeCcccccc
Confidence 789999999832 23344999999999999999999999975 789999999999999999999999999986
Q ss_pred ecCCCcccc-------cceeeeeccCCCChhhhc---cCCCCccceEEeehhhhhhhhhCCCCCCcCCCCchhhhhhhhh
Q 045315 314 MFGGDELQS-------NTKRIVGTYGYMSPEYAL---RGLFSIKSDVFSFGVLLLETLSSKKNTHFYNTDSLTLLGHAWN 383 (476)
Q Consensus 314 ~~~~~~~~~-------~~~~~~gt~~y~aPE~l~---~~~~s~ksDVwSlGvvl~elltG~~p~~~~~~~~~~~~~~~~~ 383 (476)
..-...... ..-...-|+.|+|||.+. +.++++|+|||||||+||.|+....||+...
T Consensus 195 t~~~~~~~~~e~~~ve~eI~k~TTp~YRsPEMIDlysg~pI~eKsDIWALGclLYkLCy~t~PFe~sg------------ 262 (738)
T KOG1989|consen 195 TKILSPTSAQEVNYVEEEIEKYTTPQYRSPEMIDLYSGLPIGEKSDIWALGCLLYKLCYFTTPFEESG------------ 262 (738)
T ss_pred cccCCCccHHHHHHHHHHHHhhCCccccChHHHhhhcCCCCcchhHHHHHHHHHHHHHHhCCCcCcCc------------
Confidence 432111000 001123588999999874 6789999999999999999999999996431
Q ss_pred hhcCCCcccccCcccCCCCCHHHHHHHHHHHHHchhhcccCCCCHHHHHHHHhccc
Q 045315 384 LWNDGRTWELMDPISQNGASYPILKRYINVALLCVQEKAADRPAMSEVVSMLSNEF 439 (476)
Q Consensus 384 ~~~~~~~~~~~d~~~~~~~~~~~~~~l~~li~~Cl~~dP~~RPt~~eVl~~L~~~~ 439 (476)
...++.....-........++.+||..||+.||.+||++.+|+..+..+.
T Consensus 263 ------~laIlng~Y~~P~~p~ys~~l~~LI~~mL~~nP~~RPnI~Qv~~~~~~l~ 312 (738)
T KOG1989|consen 263 ------KLAILNGNYSFPPFPNYSDRLKDLIRTMLQPNPDERPNIYQVLEEIFELA 312 (738)
T ss_pred ------ceeEEeccccCCCCccHHHHHHHHHHHHhccCcccCCCHHHHHHHHHHHh
Confidence 11222333333334577889999999999999999999999999988865
|
|
| >cd05075 PTKc_Axl Catalytic domain of the Protein Tyrosine Kinase, Axl | Back alignment and domain information |
|---|
Probab=99.93 E-value=7.3e-27 Score=226.97 Aligned_cols=179 Identities=21% Similarity=0.289 Sum_probs=135.2
Q ss_pred ccceeeccCCCC------------CCCCCCChhhHHHHHHHHHHHHHHHhhcCCCceeecCCCccceEecCCCCceeccc
Q 045315 242 EISFWYESYNNP------------TKKGLLCWGTRVRIIEGIAQGLLYLHQYSRLRVIHRDLKASNILLDKDMNPKISDF 309 (476)
Q Consensus 242 ~~~l~~Ey~~~~------------~~~~~L~~~~~~~i~~qIa~gL~yLH~~~~~~ivH~DLkp~NILld~~~~~kL~DF 309 (476)
..++++||++.+ .+...+++..+..++.||+.||+|||+++ |+||||||+||++++++.+||+||
T Consensus 80 ~~~~v~e~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~---i~H~dlkp~Nil~~~~~~~kl~Df 156 (272)
T cd05075 80 SPVVILPFMKHGDLHSFLLYSRLGDCPQYLPTQMLVKFMTDIASGMEYLSSKS---FIHRDLAARNCMLNENMNVCVADF 156 (272)
T ss_pred CcEEEEEeCCCCcHHHHHHHhcccCCcccCCHHHHHHHHHHHHHHHHHHHHCC---eeccccchhheEEcCCCCEEECCC
Confidence 356778888722 12346899999999999999999999998 999999999999999999999999
Q ss_pred cceeecCCCcccccceeeeeccCCCChhhhccCCCCccceEEeehhhhhhhhh-CCCCCCcCCCCchhhhhhhhhhhcCC
Q 045315 310 GMARMFGGDELQSNTKRIVGTYGYMSPEYALRGLFSIKSDVFSFGVLLLETLS-SKKNTHFYNTDSLTLLGHAWNLWNDG 388 (476)
Q Consensus 310 Gla~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~s~ksDVwSlGvvl~ellt-G~~p~~~~~~~~~~~~~~~~~~~~~~ 388 (476)
|+++...............++..|++||...+..++.++||||||+++||+++ |+.||..... ..... ....+
T Consensus 157 g~~~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~~Di~slG~il~el~~~g~~p~~~~~~--~~~~~----~~~~~ 230 (272)
T cd05075 157 GLSKKIYNGDYYRQGRIAKMPVKWIAIESLADRVYTTKSDVWSFGVTMWEIATRGQTPYPGVEN--SEIYD----YLRQG 230 (272)
T ss_pred CcccccCcccceecCCcccCCcccCCHHHccCCCcChHHHHHHHHHHHHHHHcCCCCCCCCCCH--HHHHH----HHHcC
Confidence 99987643322111122345678999999998899999999999999999999 7888754321 11111 11111
Q ss_pred CcccccCcccCCCCCHHHHHHHHHHHHHchhhcccCCCCHHHHHHHHhcc
Q 045315 389 RTWELMDPISQNGASYPILKRYINVALLCVQEKAADRPAMSEVVSMLSNE 438 (476)
Q Consensus 389 ~~~~~~d~~~~~~~~~~~~~~l~~li~~Cl~~dP~~RPt~~eVl~~L~~~ 438 (476)
.... ........+.+++.+||+.+|++|||+.+|++.|+.+
T Consensus 231 ~~~~---------~~~~~~~~~~~li~~~l~~~p~~Rps~~~l~~~l~~~ 271 (272)
T cd05075 231 NRLK---------QPPDCLDGLYSLMSSCWLLNPKDRPSFETLRCELEKA 271 (272)
T ss_pred CCCC---------CCCCCCHHHHHHHHHHcCCCcccCcCHHHHHHHHHhh
Confidence 1111 0112235688999999999999999999999999874
|
Protein Tyrosine Kinase (PTK) family; Axl; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Axl is a member of the Axl subfamily, which is composed of receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Axl is widely expressed in a variety of organs and cells including epithelial, mesenchymal, hematopoietic, as well as non-transfor |
| >cd07848 STKc_CDKL5 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase Like 5 | Back alignment and domain information |
|---|
Probab=99.93 E-value=2.1e-26 Score=225.89 Aligned_cols=189 Identities=18% Similarity=0.204 Sum_probs=135.6
Q ss_pred cccceeeccCCCC------CCCCCCChhhHHHHHHHHHHHHHHHhhcCCCceeecCCCccceEecCCCCceeccccceee
Q 045315 241 DEISFWYESYNNP------TKKGLLCWGTRVRIIEGIAQGLLYLHQYSRLRVIHRDLKASNILLDKDMNPKISDFGMARM 314 (476)
Q Consensus 241 ~~~~l~~Ey~~~~------~~~~~L~~~~~~~i~~qIa~gL~yLH~~~~~~ivH~DLkp~NILld~~~~~kL~DFGla~~ 314 (476)
+..+++|||++.. .....+++..+..++.||+.||+|||+.+ ++||||||+||+++.++.+||+|||++..
T Consensus 73 ~~~~lv~e~~~~~~l~~~~~~~~~~~~~~~~~~~~qi~~~L~~lH~~~---i~H~dlkp~Nill~~~~~~kl~Dfg~~~~ 149 (287)
T cd07848 73 GKLYLVFEYVEKNMLELLEEMPNGVPPEKVRSYIYQLIKAIHWCHKND---IVHRDIKPENLLISHNDVLKLCDFGFARN 149 (287)
T ss_pred CEEEEEEecCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCCHHHEEEcCCCcEEEeeccCccc
Confidence 4678999999832 13457999999999999999999999998 99999999999999999999999999987
Q ss_pred cCCCcccccceeeeeccCCCChhhhccCCCCccceEEeehhhhhhhhhCCCCCCcCCCCchhh-hhhh--------hhhh
Q 045315 315 FGGDELQSNTKRIVGTYGYMSPEYALRGLFSIKSDVFSFGVLLLETLSSKKNTHFYNTDSLTL-LGHA--------WNLW 385 (476)
Q Consensus 315 ~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~s~ksDVwSlGvvl~elltG~~p~~~~~~~~~~~-~~~~--------~~~~ 385 (476)
....... ......|+..|+|||++.+..++.++|||||||++|||++|+.||.......... .... ...+
T Consensus 150 ~~~~~~~-~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslGvil~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~ 228 (287)
T cd07848 150 LSEGSNA-NYTEYVATRWYRSPELLLGAPYGKAVDMWSVGCILGELSDGQPLFPGESEIDQLFTIQKVLGPLPAEQMKLF 228 (287)
T ss_pred ccccccc-cccccccccccCCcHHHcCCCCCCchhHHhHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhhCCCCHHHHHhh
Confidence 6432211 1223568999999999998889999999999999999999999987543211100 0000 0000
Q ss_pred -cCCCcccccCcccCCC------CCHHHHHHHHHHHHHchhhcccCCCCHHHHHH
Q 045315 386 -NDGRTWELMDPISQNG------ASYPILKRYINVALLCVQEKAADRPAMSEVVS 433 (476)
Q Consensus 386 -~~~~~~~~~d~~~~~~------~~~~~~~~l~~li~~Cl~~dP~~RPt~~eVl~ 433 (476)
..........+..... ........+.+++.+||+.||++|||++|+++
T Consensus 229 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dll~~~L~~~P~~R~s~~~~l~ 283 (287)
T cd07848 229 YSNPRFHGLRFPAVNHPQSLERRYLGILSGVLLDLMKNLLKLNPTDRYLTEQCLN 283 (287)
T ss_pred hccchhcccccCcccCcccHHHhhhcccCHHHHHHHHHHccCCcccCCCHHHHhc
Confidence 0000000000000000 01113456899999999999999999999874
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 5 (CDKL5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. Mutations in the gene encoding CDKL5, previously called STK9, are associated with early onset epilepsy and severe mental retardation [X-linked infantile spasm syndrome (ISSX) or West syndrome]. In addition, CDKL5 mutations also sometimes |
| >cd05571 STKc_PKB Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B | Back alignment and domain information |
|---|
Probab=99.93 E-value=1.1e-26 Score=232.34 Aligned_cols=172 Identities=22% Similarity=0.273 Sum_probs=133.4
Q ss_pred cccceeeccCCCCC------CCCCCChhhHHHHHHHHHHHHHHHhhcCCCceeecCCCccceEecCCCCceeccccceee
Q 045315 241 DEISFWYESYNNPT------KKGLLCWGTRVRIIEGIAQGLLYLHQYSRLRVIHRDLKASNILLDKDMNPKISDFGMARM 314 (476)
Q Consensus 241 ~~~~l~~Ey~~~~~------~~~~L~~~~~~~i~~qIa~gL~yLH~~~~~~ivH~DLkp~NILld~~~~~kL~DFGla~~ 314 (476)
+..+++|||++... +.+.+++.++..++.||+.||+|||+.+ |+||||||+||+++.++.+||+|||+++.
T Consensus 68 ~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~qi~~~L~~lH~~~---ivHrDlkp~NIll~~~~~~kl~DfG~a~~ 144 (323)
T cd05571 68 DRLCFVMEYANGGELFFHLSRERVFSEDRARFYGAEIVSALGYLHSCD---VVYRDLKLENLMLDKDGHIKITDFGLCKE 144 (323)
T ss_pred CEEEEEEeCCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHhCC---eEeCCCCHHHEEECCCCCEEEeeCCCCcc
Confidence 45778999998432 3567999999999999999999999999 99999999999999999999999999875
Q ss_pred cCCCcccccceeeeeccCCCChhhhccCCCCccceEEeehhhhhhhhhCCCCCCcCCCCchhhhhhhhhhhcCCCccccc
Q 045315 315 FGGDELQSNTKRIVGTYGYMSPEYALRGLFSIKSDVFSFGVLLLETLSSKKNTHFYNTDSLTLLGHAWNLWNDGRTWELM 394 (476)
Q Consensus 315 ~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~s~ksDVwSlGvvl~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 394 (476)
..... .......|++.|+|||.+.+..++.++|||||||++|||++|+.||...... ..... ...+..
T Consensus 145 ~~~~~--~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~elltg~~Pf~~~~~~--~~~~~----~~~~~~---- 212 (323)
T cd05571 145 GISDG--ATMKTFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHE--KLFEL----ILMEEI---- 212 (323)
T ss_pred cccCC--CcccceecCccccChhhhcCCCCCccccCcccchhhhhhhcCCCCCCCCCHH--HHHHH----HHcCCC----
Confidence 32211 1123357999999999999999999999999999999999999998643211 11111 111110
Q ss_pred CcccCCCCCHHHHHHHHHHHHHchhhcccCCC-----CHHHHHH
Q 045315 395 DPISQNGASYPILKRYINVALLCVQEKAADRP-----AMSEVVS 433 (476)
Q Consensus 395 d~~~~~~~~~~~~~~l~~li~~Cl~~dP~~RP-----t~~eVl~ 433 (476)
..+......+.+++.+||+.||++|| ++.++++
T Consensus 213 ------~~p~~~~~~~~~li~~~L~~dP~~R~~~~~~~~~~ll~ 250 (323)
T cd05571 213 ------RFPRTLSPEAKSLLAGLLKKDPKQRLGGGPEDAKEIME 250 (323)
T ss_pred ------CCCCCCCHHHHHHHHHHccCCHHHcCCCCCCCHHHHHc
Confidence 01122345688999999999999999 7888875
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. It is activated downstream of PI3K and plays important roles in diverse cellular functions including cell survival, growth, proliferation, angiogenesis, motility, and migration. PKB also has a central role in a variety of human cancers, having be |
| >KOG0658 consensus Glycogen synthase kinase-3 [Carbohydrate transport and metabolism] | Back alignment and domain information |
|---|
Probab=99.93 E-value=1.2e-26 Score=223.56 Aligned_cols=185 Identities=19% Similarity=0.186 Sum_probs=137.8
Q ss_pred cceeeccCCC---------CCCCCCCChhhHHHHHHHHHHHHHHHhhcCCCceeecCCCccceEecCC-CCceeccccce
Q 045315 243 ISFWYESYNN---------PTKKGLLCWGTRVRIIEGIAQGLLYLHQYSRLRVIHRDLKASNILLDKD-MNPKISDFGMA 312 (476)
Q Consensus 243 ~~l~~Ey~~~---------~~~~~~L~~~~~~~i~~qIa~gL~yLH~~~~~~ivH~DLkp~NILld~~-~~~kL~DFGla 312 (476)
..+++||||. -..+..++.-.+.-+..||.+||+|||+.+ |+||||||+|+|+|.+ +.+||||||.|
T Consensus 97 lnlVleymP~tL~~~~r~~~~~~~~mp~~~iKLYt~Qlfrgl~yLh~~~---IcHRDIKPqNlLvD~~tg~LKicDFGSA 173 (364)
T KOG0658|consen 97 LNLVLEYMPETLYRVIRHYTRANQRMPLLEIKLYTYQLFRGLAYLHSHG---ICHRDIKPQNLLVDPDTGVLKICDFGSA 173 (364)
T ss_pred HHHHHHhchHHHHHHHHHHhhcCCCCceeeeHHHHHHHHHHHHHHHhcC---cccCCCChheEEEcCCCCeEEeccCCcc
Confidence 3478899991 123678999999999999999999999998 9999999999999965 89999999999
Q ss_pred eecCCCcccccceeeeeccCCCChhhhcc-CCCCccceEEeehhhhhhhhhCCCCCCcCC-CCchhhhhhhhhhhcC---
Q 045315 313 RMFGGDELQSNTKRIVGTYGYMSPEYALR-GLFSIKSDVFSFGVLLLETLSSKKNTHFYN-TDSLTLLGHAWNLWND--- 387 (476)
Q Consensus 313 ~~~~~~~~~~~~~~~~gt~~y~aPE~l~~-~~~s~ksDVwSlGvvl~elltG~~p~~~~~-~~~~~~~~~~~~~~~~--- 387 (476)
+.+..++.. .....+..|+|||.+.+ ..|+.+.||||.|||+.||+-|++-|+..+ .++...+..+......
T Consensus 174 K~L~~~epn---iSYicSRyYRaPELifga~~Yt~~IDiWSaGCV~aELl~g~plFpG~s~~dQL~eIik~lG~Pt~e~I 250 (364)
T KOG0658|consen 174 KVLVKGEPN---ISYICSRYYRAPELIFGATEYTTSIDIWSAGCVMAELLKGQPLFPGDSSVDQLVEIIKVLGTPTREDI 250 (364)
T ss_pred eeeccCCCc---eeEEEeccccCHHHHcCccccCceeEEhhhhHHHHHHhcCCcccCCCCHHHHHHHHHHHhCCCCHHHH
Confidence 987654432 34778999999999986 569999999999999999999999998755 2222222111111111
Q ss_pred ----CCcccccCcccCC-----CCCHHHHHHHHHHHHHchhhcccCCCCHHHHHH
Q 045315 388 ----GRTWELMDPISQN-----GASYPILKRYINVALLCVQEKAADRPAMSEVVS 433 (476)
Q Consensus 388 ----~~~~~~~d~~~~~-----~~~~~~~~~l~~li~~Cl~~dP~~RPt~~eVl~ 433 (476)
....+...+.+.. -.......+.++++.++++.+|.+|.++.|++.
T Consensus 251 ~~mn~~y~~~~~p~ik~~~~~~~~~~~~~~d~~dll~~~L~Y~P~~R~~~~~~l~ 305 (364)
T KOG0658|consen 251 KSMNPNYTEFKFPQIKAHPWHKVFFKRLPPDALDLLSKLLQYSPSKRLSALEALA 305 (364)
T ss_pred hhcCcccccccCcccccccceeecccCCCHHHHHHHHHHhccChhhcCCHHHHhc
Confidence 0101111111111 122334567899999999999999999998874
|
|
| >KOG0659 consensus Cdk activating kinase (CAK)/RNA polymerase II transcription initiation/nucleotide excision repair factor TFIIH/TFIIK, kinase subunit CDK7 [Cell cycle control, cell division, chromosome partitioning; Transcription; Replication, recombination and repair] | Back alignment and domain information |
|---|
Probab=99.93 E-value=1.7e-26 Score=213.25 Aligned_cols=204 Identities=24% Similarity=0.256 Sum_probs=149.6
Q ss_pred ccccceeeccCC------CCCCCCCCChhhHHHHHHHHHHHHHHHhhcCCCceeecCCCccceEecCCCCceecccccee
Q 045315 240 KDEISFWYESYN------NPTKKGLLCWGTRVRIIEGIAQGLLYLHQYSRLRVIHRDLKASNILLDKDMNPKISDFGMAR 313 (476)
Q Consensus 240 ~~~~~l~~Ey~~------~~~~~~~L~~~~~~~i~~qIa~gL~yLH~~~~~~ivH~DLkp~NILld~~~~~kL~DFGla~ 313 (476)
++...+++|||+ -+.+...|+..++..++.++++||+|||++. |+||||||.|+|++.+|.+||+|||+|+
T Consensus 73 ~~~l~lVfEfm~tdLe~vIkd~~i~l~pa~iK~y~~m~LkGl~y~H~~~---IlHRDlKPnNLLis~~g~lKiADFGLAr 149 (318)
T KOG0659|consen 73 KSNLSLVFEFMPTDLEVVIKDKNIILSPADIKSYMLMTLKGLAYCHSKW---ILHRDLKPNNLLISSDGQLKIADFGLAR 149 (318)
T ss_pred CCceEEEEEeccccHHHHhcccccccCHHHHHHHHHHHHHHHHHHHhhh---hhcccCCccceEEcCCCcEEeecccchh
Confidence 467889999999 3456778999999999999999999999999 9999999999999999999999999999
Q ss_pred ecCCCcccccceeeeeccCCCChhhhcc-CCCCccceEEeehhhhhhhhhCCCCCCcCC-CCchhhhhhhhhhhcCCCcc
Q 045315 314 MFGGDELQSNTKRIVGTYGYMSPEYALR-GLFSIKSDVFSFGVLLLETLSSKKNTHFYN-TDSLTLLGHAWNLWNDGRTW 391 (476)
Q Consensus 314 ~~~~~~~~~~~~~~~gt~~y~aPE~l~~-~~~s~ksDVwSlGvvl~elltG~~p~~~~~-~~~~~~~~~~~~~~~~~~~~ 391 (476)
.++...... ...+-|..|+|||.+.+ ..|+...|+||.||++.||+-|.+-|+... .++....-.+.....+..+.
T Consensus 150 ~f~~p~~~~--~~~V~TRWYRAPELLfGsr~Yg~~VDmWavGCI~AELllr~P~fpG~sDidQL~~If~~LGTP~~~~WP 227 (318)
T KOG0659|consen 150 FFGSPNRIQ--THQVVTRWYRAPELLFGSRQYGTGVDMWAVGCIFAELLLRVPFFPGDSDIDQLSKIFRALGTPTPDQWP 227 (318)
T ss_pred ccCCCCccc--ccceeeeeccChHHhccchhcCCcchhhhHHHHHHHHHccCCCCCCCchHHHHHHHHHHcCCCCcccCc
Confidence 987543222 22367999999999986 579999999999999999999998887654 23322222222111111111
Q ss_pred ---cccC--------cccCCCCCHHHHHHHHHHHHHchhhcccCCCCHHHHHHHHhccccCCCCCCCCcc
Q 045315 392 ---ELMD--------PISQNGASYPILKRYINVALLCVQEKAADRPAMSEVVSMLSNEFVNLPAPQQPAF 450 (476)
Q Consensus 392 ---~~~d--------~~~~~~~~~~~~~~l~~li~~Cl~~dP~~RPt~~eVl~~L~~~~~~~~~p~~p~~ 450 (476)
.+.| .......-.......++++..++..||.+|+++.|++++= -+.+.|.|-.|.-
T Consensus 228 ~~~~lpdY~~~~~~P~~~~~~lf~aas~d~ldLl~~m~~ynP~~Rita~qaL~~~--yf~~~P~pt~~~~ 295 (318)
T KOG0659|consen 228 EMTSLPDYVKIQQFPKPPLNNLFPAASSDALDLLSKMLTYNPKKRITASQALKHP--YFKSLPLPTPPSK 295 (318)
T ss_pred cccccccHHHHhcCCCCccccccccccHHHHHHHHhhhccCchhcccHHHHhcch--hhhcCCCCCChhh
Confidence 1111 1111112233456679999999999999999999988652 2334566555543
|
|
| >cd05631 STKc_GRK4 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 4 | Back alignment and domain information |
|---|
Probab=99.93 E-value=3.3e-26 Score=224.70 Aligned_cols=175 Identities=20% Similarity=0.239 Sum_probs=133.1
Q ss_pred cccceeeccCCCCC--------CCCCCChhhHHHHHHHHHHHHHHHhhcCCCceeecCCCccceEecCCCCceeccccce
Q 045315 241 DEISFWYESYNNPT--------KKGLLCWGTRVRIIEGIAQGLLYLHQYSRLRVIHRDLKASNILLDKDMNPKISDFGMA 312 (476)
Q Consensus 241 ~~~~l~~Ey~~~~~--------~~~~L~~~~~~~i~~qIa~gL~yLH~~~~~~ivH~DLkp~NILld~~~~~kL~DFGla 312 (476)
+..++++||++.+. ....+++.++..++.|++.||+|||+.+ |+||||||+|||++.++.+||+|||++
T Consensus 73 ~~~~lv~e~~~~g~L~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~---iiH~dikp~Nill~~~~~~kl~Dfg~~ 149 (285)
T cd05631 73 DALCLVLTIMNGGDLKFHIYNMGNPGFDEQRAIFYAAELCCGLEDLQRER---IVYRDLKPENILLDDRGHIRISDLGLA 149 (285)
T ss_pred CeEEEEEEecCCCcHHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHhCC---EEeCCCCHHHEEECCCCCEEEeeCCCc
Confidence 35778889988321 2346899999999999999999999998 999999999999999999999999999
Q ss_pred eecCCCcccccceeeeeccCCCChhhhccCCCCccceEEeehhhhhhhhhCCCCCCcCCCCchhhhhhhhhhhcCCCccc
Q 045315 313 RMFGGDELQSNTKRIVGTYGYMSPEYALRGLFSIKSDVFSFGVLLLETLSSKKNTHFYNTDSLTLLGHAWNLWNDGRTWE 392 (476)
Q Consensus 313 ~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~s~ksDVwSlGvvl~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~ 392 (476)
........ .....|+..|+|||++.+..++.++|||||||++|||++|+.||........ ............
T Consensus 150 ~~~~~~~~---~~~~~g~~~y~aPE~~~~~~~~~~~DvwslGvil~el~~g~~pf~~~~~~~~--~~~~~~~~~~~~--- 221 (285)
T cd05631 150 VQIPEGET---VRGRVGTVGYMAPEVINNEKYTFSPDWWGLGCLIYEMIQGQSPFRKRKERVK--REEVDRRVKEDQ--- 221 (285)
T ss_pred EEcCCCCe---ecCCCCCCCccCHhhhcCCCCCcccCchhHHHHHHHHHhCCCCCCCCCcchh--HHHHHHHhhccc---
Confidence 87543221 1234689999999999999999999999999999999999999875432111 000111111000
Q ss_pred ccCcccCCCCCHHHHHHHHHHHHHchhhcccCCCC-----HHHHHH
Q 045315 393 LMDPISQNGASYPILKRYINVALLCVQEKAADRPA-----MSEVVS 433 (476)
Q Consensus 393 ~~d~~~~~~~~~~~~~~l~~li~~Cl~~dP~~RPt-----~~eVl~ 433 (476)
..........+.+++.+||+.||.+||+ ++++++
T Consensus 222 -------~~~~~~~s~~~~~li~~~l~~~P~~R~~~~~~~~~~~~~ 260 (285)
T cd05631 222 -------EEYSEKFSEDAKSICRMLLTKNPKERLGCRGNGAAGVKQ 260 (285)
T ss_pred -------ccCCccCCHHHHHHHHHHhhcCHHHhcCCCCCCHHHHhc
Confidence 0111223457889999999999999997 777775
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK4 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK4 has a limited tissue distribution. It is mainly found i |
| >cd05035 PTKc_Axl_like Catalytic Domain of Axl-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=99.93 E-value=1.7e-26 Score=224.11 Aligned_cols=178 Identities=21% Similarity=0.301 Sum_probs=134.8
Q ss_pred cceeeccCCCC------------CCCCCCChhhHHHHHHHHHHHHHHHhhcCCCceeecCCCccceEecCCCCceecccc
Q 045315 243 ISFWYESYNNP------------TKKGLLCWGTRVRIIEGIAQGLLYLHQYSRLRVIHRDLKASNILLDKDMNPKISDFG 310 (476)
Q Consensus 243 ~~l~~Ey~~~~------------~~~~~L~~~~~~~i~~qIa~gL~yLH~~~~~~ivH~DLkp~NILld~~~~~kL~DFG 310 (476)
.++++||++.. .....+++..+..++.|++.||+|||+.+ ++||||||+||++++++.+||+|||
T Consensus 82 ~~~v~e~~~~~~l~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~aL~~lH~~~---i~H~dlkp~Nil~~~~~~~kl~dfg 158 (273)
T cd05035 82 PMVILPFMKHGDLHSFLLYSRLGGLPEKLPLQTLLKFMVDIALGMEYLSNRN---FIHRDLAARNCMLREDMTVCVADFG 158 (273)
T ss_pred cEEEEeccCCCCHHHHHHHhhccCCcccCCHHHHHHHHHHHHHHHHHHHhCC---eeccccchheEEECCCCeEEECCcc
Confidence 56777887622 23357899999999999999999999998 9999999999999999999999999
Q ss_pred ceeecCCCcccccceeeeeccCCCChhhhccCCCCccceEEeehhhhhhhhh-CCCCCCcCCCCchhhhhhhhhhhcCCC
Q 045315 311 MARMFGGDELQSNTKRIVGTYGYMSPEYALRGLFSIKSDVFSFGVLLLETLS-SKKNTHFYNTDSLTLLGHAWNLWNDGR 389 (476)
Q Consensus 311 la~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~s~ksDVwSlGvvl~ellt-G~~p~~~~~~~~~~~~~~~~~~~~~~~ 389 (476)
+++...............++..|+|||.+....++.++|||||||++|||++ |..|+..... ....... ..+.
T Consensus 159 ~~~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~~Dv~SlG~il~el~~~g~~p~~~~~~--~~~~~~~----~~~~ 232 (273)
T cd05035 159 LSKKIYSGDYYRQGRIAKMPVKWIAIESLADRVYTSKSDVWAFGVTMWEIATRGQTPYPGVEN--HEIYDYL----RHGN 232 (273)
T ss_pred ceeeccccccccccccccCCccccCHhhcccCCCCcccchHHHHHHHHHHHhCCCCCCCCCCH--HHHHHHH----HcCC
Confidence 9987644322222222334678999999988889999999999999999999 7787754321 1111111 1111
Q ss_pred cccccCcccCCCCCHHHHHHHHHHHHHchhhcccCCCCHHHHHHHHhcc
Q 045315 390 TWELMDPISQNGASYPILKRYINVALLCVQEKAADRPAMSEVVSMLSNE 438 (476)
Q Consensus 390 ~~~~~d~~~~~~~~~~~~~~l~~li~~Cl~~dP~~RPt~~eVl~~L~~~ 438 (476)
... .+......+.+++.+||+.||++||++.||++.|+++
T Consensus 233 ~~~---------~~~~~~~~~~~li~~~l~~~p~~Rp~~~e~~~~l~~~ 272 (273)
T cd05035 233 RLK---------QPEDCLDELYDLMYSCWRADPKDRPTFTKLREVLENI 272 (273)
T ss_pred CCC---------CCcCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHhh
Confidence 111 1122345789999999999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Axl subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). The Axl subfamily consists of Axl, Tyro3 (or Sky), Mer (or Mertk), and similar proteins. PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Axl subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Axl subfamily members are implicated in a variety of cellu |
| >KOG0660 consensus Mitogen-activated protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.93 E-value=3.7e-27 Score=226.63 Aligned_cols=195 Identities=24% Similarity=0.270 Sum_probs=143.0
Q ss_pred cccceeeccCC-C----CCCCCCCChhhHHHHHHHHHHHHHHHhhcCCCceeecCCCccceEecCCCCceeccccceeec
Q 045315 241 DEISFWYESYN-N----PTKKGLLCWGTRVRIIEGIAQGLLYLHQYSRLRVIHRDLKASNILLDKDMNPKISDFGMARMF 315 (476)
Q Consensus 241 ~~~~l~~Ey~~-~----~~~~~~L~~~~~~~i~~qIa~gL~yLH~~~~~~ivH~DLkp~NILld~~~~~kL~DFGla~~~ 315 (476)
.+.|+++|+|+ + ...+..|+...+.-++.||+.||+|+|+.+ |+||||||.|+|++.+...||+|||+|+..
T Consensus 99 ~DvYiV~elMetDL~~iik~~~~L~d~H~q~f~YQiLrgLKyiHSAn---ViHRDLKPsNll~n~~c~lKI~DFGLAR~~ 175 (359)
T KOG0660|consen 99 NDVYLVFELMETDLHQIIKSQQDLTDDHAQYFLYQILRGLKYIHSAN---VIHRDLKPSNLLLNADCDLKICDFGLARYL 175 (359)
T ss_pred ceeEEehhHHhhHHHHHHHcCccccHHHHHHHHHHHHHhcchhhccc---ccccccchhheeeccCCCEEeccccceeec
Confidence 47899999998 1 123445999999999999999999999999 999999999999999999999999999987
Q ss_pred CCCcccccceeeeeccCCCChhhhcc-CCCCccceEEeehhhhhhhhhCCCCCCcCC-CCchhhhhhhhhhhcC------
Q 045315 316 GGDELQSNTKRIVGTYGYMSPEYALR-GLFSIKSDVFSFGVLLLETLSSKKNTHFYN-TDSLTLLGHAWNLWND------ 387 (476)
Q Consensus 316 ~~~~~~~~~~~~~gt~~y~aPE~l~~-~~~s~ksDVwSlGvvl~elltG~~p~~~~~-~~~~~~~~~~~~~~~~------ 387 (476)
.........+..+.|..|.|||.+.. ..|+.+.||||.||++.||++|++-|++.+ .++..++........+
T Consensus 176 ~~~~~~~~mTeYVaTRWYRAPElll~~~~Yt~aiDiWSvGCI~AEmL~gkplFpG~d~v~Ql~lI~~~lGtP~~e~l~~i 255 (359)
T KOG0660|consen 176 DKFFEDGFMTEYVATRWYRAPELLLNSSEYTKAIDIWSVGCILAEMLTGKPLFPGKDYVHQLQLILELLGTPSEEDLQKI 255 (359)
T ss_pred cccCcccchhcceeeeeecCHHHHhccccccchhhhhhhhHHHHHHHcCCCCCCCCchHHHHHHHHHhcCCCCHHHHHHh
Confidence 65422233345788999999998864 679999999999999999999999998765 3333332221111110
Q ss_pred --CCcccccCcccC-CCC-----CHHHHHHHHHHHHHchhhcccCCCCHHHHHHH--Hhcc
Q 045315 388 --GRTWELMDPISQ-NGA-----SYPILKRYINVALLCVQEKAADRPAMSEVVSM--LSNE 438 (476)
Q Consensus 388 --~~~~~~~d~~~~-~~~-----~~~~~~~l~~li~~Cl~~dP~~RPt~~eVl~~--L~~~ 438 (476)
......+..... ... -+......++++.+||..||.+|+|++|.++. |+..
T Consensus 256 ~s~~ar~yi~slp~~p~~~f~~~fp~a~p~AidLlekmL~fdP~kRita~eAL~hPYl~~~ 316 (359)
T KOG0660|consen 256 RSEKARPYIKSLPQIPKQPFSSIFPNANPLAIDLLEKMLVFDPKKRITAEEALAHPYLAPY 316 (359)
T ss_pred ccHHHHHHHHhCCCCCCCCHHHHcCCCCHHHHHHHHHHhccCccccCCHHHHhcChhhhhh
Confidence 001011110000 000 11234578899999999999999999998763 4443
|
|
| >KOG0663 consensus Protein kinase PITSLRE and related kinases [General function prediction only] | Back alignment and domain information |
|---|
Probab=99.93 E-value=1.6e-26 Score=219.34 Aligned_cols=212 Identities=23% Similarity=0.248 Sum_probs=154.6
Q ss_pred hhhhccccccceeeccCCC------CCCCCCCChhhHHHHHHHHHHHHHHHhhcCCCceeecCCCccceEecCCCCceec
Q 045315 234 QVLVQSKDEISFWYESYNN------PTKKGLLCWGTRVRIIEGIAQGLLYLHQYSRLRVIHRDLKASNILLDKDMNPKIS 307 (476)
Q Consensus 234 ~~~~~~~~~~~l~~Ey~~~------~~~~~~L~~~~~~~i~~qIa~gL~yLH~~~~~~ivH~DLkp~NILld~~~~~kL~ 307 (476)
+++.++.+..+++|||+++ .+.+.++...++..+..|+++|++|||... |+|||||++|+|++..|.+||+
T Consensus 143 VVvG~~~d~iy~VMe~~EhDLksl~d~m~q~F~~~evK~L~~QlL~glk~lH~~w---ilHRDLK~SNLLm~~~G~lKia 219 (419)
T KOG0663|consen 143 VVVGSNMDKIYIVMEYVEHDLKSLMETMKQPFLPGEVKTLMLQLLRGLKHLHDNW---ILHRDLKTSNLLLSHKGILKIA 219 (419)
T ss_pred EEeccccceeeeeHHHHHhhHHHHHHhccCCCchHHHHHHHHHHHHHHHHHhhce---eEecccchhheeeccCCcEEec
Confidence 4444555789999999992 244578999999999999999999999998 9999999999999999999999
Q ss_pred cccceeecCCCcccccceeeeeccCCCChhhhccC-CCCccceEEeehhhhhhhhhCCCCCCcCC-CCchhhhhhhhhhh
Q 045315 308 DFGMARMFGGDELQSNTKRIVGTYGYMSPEYALRG-LFSIKSDVFSFGVLLLETLSSKKNTHFYN-TDSLTLLGHAWNLW 385 (476)
Q Consensus 308 DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~-~~s~ksDVwSlGvvl~elltG~~p~~~~~-~~~~~~~~~~~~~~ 385 (476)
|||+|+.++... ...+..+-|..|+|||.+.+. .|+...|+||+||++.|++.+++-|+... .++...+-......
T Consensus 220 DFGLAR~ygsp~--k~~T~lVVTLWYRaPELLLG~~tyst~iDMWSvGCI~aE~l~~kPlf~G~sE~dQl~~If~llGtP 297 (419)
T KOG0663|consen 220 DFGLAREYGSPL--KPYTPLVVTLWYRAPELLLGAKTYSTAVDMWSVGCIFAELLTQKPLFPGKSEIDQLDKIFKLLGTP 297 (419)
T ss_pred ccchhhhhcCCc--ccCcceEEEeeecCHHHhcCCcccCcchhhhhHHHHHHHHHhcCCCCCCCchHHHHHHHHHHhCCC
Confidence 999999887542 223346779999999999874 68999999999999999999999988765 22222211111111
Q ss_pred cCCC-----cccccC---------cccCCCCCHH-HHHHHHHHHHHchhhcccCCCCHHHHHHHHhccccCCCCCCCCcc
Q 045315 386 NDGR-----TWELMD---------PISQNGASYP-ILKRYINVALLCVQEKAADRPAMSEVVSMLSNEFVNLPAPQQPAF 450 (476)
Q Consensus 386 ~~~~-----~~~~~d---------~~~~~~~~~~-~~~~l~~li~~Cl~~dP~~RPt~~eVl~~L~~~~~~~~~p~~p~~ 450 (476)
.+.. ....+. ..+...+... ..+.-.+++..+|..||.+|.|++|.++. +.+.+.|.|..|.+
T Consensus 298 te~iwpg~~~lp~~k~~~f~~~pyn~lr~kF~~~~lse~g~~Lln~llt~dP~kR~tA~~~L~h--~~F~e~P~p~~P~~ 375 (419)
T KOG0663|consen 298 SEAIWPGYSELPAVKKMTFSEHPYNNLRKKFGALSLSEQGFDLLNKLLTYDPGKRITAEDGLKH--EYFRETPLPIDPSM 375 (419)
T ss_pred ccccCCCccccchhhccccCCCCchhhhhhccccccchhHHHHHHHHhccCccccccHHHhhcc--cccccCCCCCChhh
Confidence 1100 000000 0001111111 23566788899999999999999997652 44578888888877
Q ss_pred ee
Q 045315 451 SC 452 (476)
Q Consensus 451 ~~ 452 (476)
+-
T Consensus 376 ~P 377 (419)
T KOG0663|consen 376 FP 377 (419)
T ss_pred cC
Confidence 63
|
|
| >KOG0616 consensus cAMP-dependent protein kinase catalytic subunit (PKA) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.93 E-value=1.6e-26 Score=216.32 Aligned_cols=161 Identities=25% Similarity=0.292 Sum_probs=132.7
Q ss_pred cccceeeccCCCC------CCCCCCChhhHHHHHHHHHHHHHHHhhcCCCceeecCCCccceEecCCCCceeccccceee
Q 045315 241 DEISFWYESYNNP------TKKGLLCWGTRVRIIEGIAQGLLYLHQYSRLRVIHRDLKASNILLDKDMNPKISDFGMARM 314 (476)
Q Consensus 241 ~~~~l~~Ey~~~~------~~~~~L~~~~~~~i~~qIa~gL~yLH~~~~~~ivH~DLkp~NILld~~~~~kL~DFGla~~ 314 (476)
+..+++|||.+.+ ++.+++++..+.-++.||+.||+|||+.+ |++|||||+|||+|.+|.+||.|||+|+.
T Consensus 117 ~~lymvmeyv~GGElFS~Lrk~~rF~e~~arFYAAeivlAleylH~~~---iiYRDLKPENiLlD~~G~iKitDFGFAK~ 193 (355)
T KOG0616|consen 117 SNLYMVMEYVPGGELFSYLRKSGRFSEPHARFYAAEIVLALEYLHSLD---IIYRDLKPENLLLDQNGHIKITDFGFAKR 193 (355)
T ss_pred CeEEEEEeccCCccHHHHHHhcCCCCchhHHHHHHHHHHHHHHHHhcC---eeeccCChHHeeeccCCcEEEEeccceEE
Confidence 4688999999944 46678999999999999999999999999 99999999999999999999999999998
Q ss_pred cCCCcccccceeeeeccCCCChhhhccCCCCccceEEeehhhhhhhhhCCCCCCcCCCCchhhhhhhhhhhcCCCccccc
Q 045315 315 FGGDELQSNTKRIVGTYGYMSPEYALRGLFSIKSDVFSFGVLLLETLSSKKNTHFYNTDSLTLLGHAWNLWNDGRTWELM 394 (476)
Q Consensus 315 ~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~s~ksDVwSlGvvl~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 394 (476)
... .+...+||+.|+|||.+...++..++|-|||||++|||+.|.+||...+... .++.+.+++.
T Consensus 194 v~~-----rT~TlCGTPeYLAPEii~sk~ynkavDWWalGVLIYEMlaG~pPF~~~~~~~------iY~KI~~~~v---- 258 (355)
T KOG0616|consen 194 VSG-----RTWTLCGTPEYLAPEIIQSKGYNKAVDWWALGVLIYEMLAGYPPFYDDNPIQ------IYEKILEGKV---- 258 (355)
T ss_pred ecC-----cEEEecCCccccChHHhhcCCCCcchhHHHHHHHHHHHHcCCCCCcCCChHH------HHHHHHhCcc----
Confidence 654 3556889999999999999999999999999999999999999997654311 1122222221
Q ss_pred CcccCCCCCHHHHHHHHHHHHHchhhcccCC
Q 045315 395 DPISQNGASYPILKRYINVALLCVQEKAADR 425 (476)
Q Consensus 395 d~~~~~~~~~~~~~~l~~li~~Cl~~dP~~R 425 (476)
..+......+.+|+...|+.|-.+|
T Consensus 259 ------~fP~~fs~~~kdLl~~LL~vD~t~R 283 (355)
T KOG0616|consen 259 ------KFPSYFSSDAKDLLKKLLQVDLTKR 283 (355)
T ss_pred ------cCCcccCHHHHHHHHHHHhhhhHhh
Confidence 1122334567788888999998888
|
|
| >KOG1026 consensus Nerve growth factor receptor TRKA and related tyrosine kinases [Signal transduction mechanisms; Intracellular trafficking, secretion, and vesicular transport] | Back alignment and domain information |
|---|
Probab=99.93 E-value=1e-26 Score=244.67 Aligned_cols=181 Identities=27% Similarity=0.365 Sum_probs=144.8
Q ss_pred cccceeeccCCCC-------------------C-CCCCCChhhHHHHHHHHHHHHHHHhhcCCCceeecCCCccceEecC
Q 045315 241 DEISFWYESYNNP-------------------T-KKGLLCWGTRVRIIEGIAQGLLYLHQYSRLRVIHRDLKASNILLDK 300 (476)
Q Consensus 241 ~~~~l~~Ey~~~~-------------------~-~~~~L~~~~~~~i~~qIa~gL~yLH~~~~~~ivH~DLkp~NILld~ 300 (476)
+-.++++|||..+ . .+.+|+..+.+.||.|||.|+.||-++. +|||||-.+|+||.+
T Consensus 562 ~P~~MvFEYm~~GDL~eFLra~sP~a~~~~~g~~~~~~L~~~q~L~iA~QIAaGM~YLs~~~---FVHRDLATRNCLVge 638 (774)
T KOG1026|consen 562 DPLCMVFEYMDHGDLHEFLRARSPKADKLASGQDTPPPLSTSQFLHIATQIAAGMEYLSSHH---FVHRDLATRNCLVGE 638 (774)
T ss_pred CeeEEEEEecccccHHHHHHhhCCccccccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCc---ccccchhhhhceecc
Confidence 3467899999811 1 1445999999999999999999999988 999999999999999
Q ss_pred CCCceeccccceeecCCCcccccceeeeeccCCCChhhhccCCCCccceEEeehhhhhhhhh-CCCCCCcCCCCchhhhh
Q 045315 301 DMNPKISDFGMARMFGGDELQSNTKRIVGTYGYMSPEYALRGLFSIKSDVFSFGVLLLETLS-SKKNTHFYNTDSLTLLG 379 (476)
Q Consensus 301 ~~~~kL~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~s~ksDVwSlGvvl~ellt-G~~p~~~~~~~~~~~~~ 379 (476)
+..+||+|||+++-.-..+.........-+.+|||||.+..+.|+.+||||||||+|||+++ |+.|+.....++
T Consensus 639 ~l~VKIsDfGLsRdiYssDYYk~~~~t~lPIRWMppEsIly~kFTteSDVWs~GVvLWEIFsyG~QPy~glSn~E----- 713 (774)
T KOG1026|consen 639 NLVVKISDFGLSRDIYSSDYYKVRGNTLLPIRWMPPESILYGKFTTESDVWSFGVVLWEIFSYGKQPYYGLSNQE----- 713 (774)
T ss_pred ceEEEecccccchhhhhhhhhcccCCceeeeecCCHHHhhcCcccchhhhhhhhhhhhhhhccccCcccccchHH-----
Confidence 99999999999997655444443333455789999999999999999999999999999997 777765443211
Q ss_pred hhhhhhcCCCcccccCcccCCCCCHHHHHHHHHHHHHchhhcccCCCCHHHHHHHHhccc
Q 045315 380 HAWNLWNDGRTWELMDPISQNGASYPILKRYINVALLCVQEKAADRPAMSEVVSMLSNEF 439 (476)
Q Consensus 380 ~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~l~~li~~Cl~~dP~~RPt~~eVl~~L~~~~ 439 (476)
+.+.+..++... .+...+.++..||+.||+.+|++||+++||-..|+...
T Consensus 714 -VIe~i~~g~lL~---------~Pe~CP~~vY~LM~~CW~~~P~~RPsF~eI~~~L~~~~ 763 (774)
T KOG1026|consen 714 -VIECIRAGQLLS---------CPENCPTEVYSLMLECWNENPKRRPSFKEIHSRLQAWA 763 (774)
T ss_pred -HHHHHHcCCccc---------CCCCCCHHHHHHHHHHhhcCcccCCCHHHHHHHHHHHH
Confidence 222334444422 23344578999999999999999999999999999865
|
|
| >cd05072 PTKc_Lyn Catalytic domain of the Protein Tyrosine Kinase, Lyn | Back alignment and domain information |
|---|
Probab=99.93 E-value=2.1e-26 Score=222.58 Aligned_cols=178 Identities=27% Similarity=0.411 Sum_probs=136.1
Q ss_pred cccceeeccCCCC--------CCCCCCChhhHHHHHHHHHHHHHHHhhcCCCceeecCCCccceEecCCCCceeccccce
Q 045315 241 DEISFWYESYNNP--------TKKGLLCWGTRVRIIEGIAQGLLYLHQYSRLRVIHRDLKASNILLDKDMNPKISDFGMA 312 (476)
Q Consensus 241 ~~~~l~~Ey~~~~--------~~~~~L~~~~~~~i~~qIa~gL~yLH~~~~~~ivH~DLkp~NILld~~~~~kL~DFGla 312 (476)
+..++++||++.. .....+++.+++.++.|++.||+|||+.+ ++||||||+||+++.++.+||+|||++
T Consensus 74 ~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~l~~~l~~LH~~~---i~H~dl~p~nili~~~~~~~l~dfg~~ 150 (261)
T cd05072 74 EPIYIITEYMAKGSLLDFLKSDEGGKVLLPKLIDFSAQIAEGMAYIERKN---YIHRDLRAANVLVSESLMCKIADFGLA 150 (261)
T ss_pred CCcEEEEecCCCCcHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCC---eeccccchhhEEecCCCcEEECCCccc
Confidence 4578889998732 23457899999999999999999999998 999999999999999999999999999
Q ss_pred eecCCCcccccceeeeeccCCCChhhhccCCCCccceEEeehhhhhhhhh-CCCCCCcCCCCchhhhhhhhhhhcCCCcc
Q 045315 313 RMFGGDELQSNTKRIVGTYGYMSPEYALRGLFSIKSDVFSFGVLLLETLS-SKKNTHFYNTDSLTLLGHAWNLWNDGRTW 391 (476)
Q Consensus 313 ~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~s~ksDVwSlGvvl~ellt-G~~p~~~~~~~~~~~~~~~~~~~~~~~~~ 391 (476)
.......... .....++..|+|||++....++.++|||||||++|+|++ |+.||...... ...... ..+...
T Consensus 151 ~~~~~~~~~~-~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~t~g~~p~~~~~~~--~~~~~~----~~~~~~ 223 (261)
T cd05072 151 RVIEDNEYTA-REGAKFPIKWTAPEAINFGSFTIKSDVWSFGILLYEIVTYGKIPYPGMSNS--DVMSAL----QRGYRM 223 (261)
T ss_pred eecCCCceec-cCCCccceecCCHHHhccCCCChhhhhhhhHHHHHHHHccCCCCCCCCCHH--HHHHHH----HcCCCC
Confidence 8765432211 112345678999999988889999999999999999998 88887643211 111111 111100
Q ss_pred cccCcccCCCCCHHHHHHHHHHHHHchhhcccCCCCHHHHHHHHhc
Q 045315 392 ELMDPISQNGASYPILKRYINVALLCVQEKAADRPAMSEVVSMLSN 437 (476)
Q Consensus 392 ~~~d~~~~~~~~~~~~~~l~~li~~Cl~~dP~~RPt~~eVl~~L~~ 437 (476)
.........+.+++.+|++.+|++||+++++.+.|+.
T Consensus 224 ---------~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~i~~~l~~ 260 (261)
T cd05072 224 ---------PRMENCPDELYDIMKTCWKEKAEERPTFDYLQSVLDD 260 (261)
T ss_pred ---------CCCCCCCHHHHHHHHHHccCCcccCcCHHHHHHHHhc
Confidence 0111223568899999999999999999999999986
|
Protein Tyrosine Kinase (PTK) family; Lyn kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Lyn is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth fa |
| >cd05614 STKc_MSK2_N N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase 2 | Back alignment and domain information |
|---|
Probab=99.93 E-value=4e-26 Score=229.07 Aligned_cols=176 Identities=20% Similarity=0.266 Sum_probs=131.8
Q ss_pred cccceeeccCCCCC------CCCCCChhhHHHHHHHHHHHHHHHhhcCCCceeecCCCccceEecCCCCceeccccceee
Q 045315 241 DEISFWYESYNNPT------KKGLLCWGTRVRIIEGIAQGLLYLHQYSRLRVIHRDLKASNILLDKDMNPKISDFGMARM 314 (476)
Q Consensus 241 ~~~~l~~Ey~~~~~------~~~~L~~~~~~~i~~qIa~gL~yLH~~~~~~ivH~DLkp~NILld~~~~~kL~DFGla~~ 314 (476)
+.++++|||++.+. .+..+++.++..++.||+.||+|||+++ |+||||||+|||++.++.+||+|||+++.
T Consensus 78 ~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~qi~~~l~~lH~~~---ivHrDlkp~Nili~~~~~~kl~DfG~~~~ 154 (332)
T cd05614 78 AKLHLILDYVSGGEMFTHLYQRDNFSEDEVRFYSGEIILALEHLHKLG---IVYRDIKLENILLDSEGHVVLTDFGLSKE 154 (332)
T ss_pred CEEEEEEeCCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCC---cEecCCCHHHeEECCCCCEEEeeCcCCcc
Confidence 45778999998432 3567999999999999999999999998 99999999999999999999999999986
Q ss_pred cCCCcccccceeeeeccCCCChhhhccC-CCCccceEEeehhhhhhhhhCCCCCCcCCCC-chhhhhhhhhhhcCCCccc
Q 045315 315 FGGDELQSNTKRIVGTYGYMSPEYALRG-LFSIKSDVFSFGVLLLETLSSKKNTHFYNTD-SLTLLGHAWNLWNDGRTWE 392 (476)
Q Consensus 315 ~~~~~~~~~~~~~~gt~~y~aPE~l~~~-~~s~ksDVwSlGvvl~elltG~~p~~~~~~~-~~~~~~~~~~~~~~~~~~~ 392 (476)
+...... ......|+..|+|||.+.+. .++.++|||||||++|||++|+.||...... ..... ..... ..
T Consensus 155 ~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~~~~~~~~~--~~~~~-~~---- 226 (332)
T cd05614 155 FLSEEKE-RTYSFCGTIEYMAPEIIRGKGGHGKAVDWWSLGILIFELLTGASPFTLEGERNTQSEV--SRRIL-KC---- 226 (332)
T ss_pred ccccCCC-ccccccCCccccCHHHhcCCCCCCCccccccchhhhhhhhcCCCCCCCCCCCCCHHHH--HHHHh-cC----
Confidence 5332211 22235689999999998865 4789999999999999999999998644321 11111 00111 00
Q ss_pred ccCcccCCCCCHHHHHHHHHHHHHchhhcccCCC-----CHHHHHH
Q 045315 393 LMDPISQNGASYPILKRYINVALLCVQEKAADRP-----AMSEVVS 433 (476)
Q Consensus 393 ~~d~~~~~~~~~~~~~~l~~li~~Cl~~dP~~RP-----t~~eVl~ 433 (476)
++ ..+......+.+++.+||+.||++|| +++++++
T Consensus 227 --~~----~~~~~~~~~~~~li~~~l~~dp~~R~~~~~~~~~~~l~ 266 (332)
T cd05614 227 --DP----PFPSFIGPEAQDLLHKLLRKDPKKRLGAGPQGASEIKE 266 (332)
T ss_pred --CC----CCCCCCCHHHHHHHHHHcCCCHHHcCCCCCCCHHHHHc
Confidence 11 11112345678999999999999999 6667764
|
Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, MSK2, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, which trigger phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydroph |
| >cd05108 PTKc_EGFR Catalytic domain of the Protein Tyrosine Kinase, Epidermal Growth Factor Receptor | Back alignment and domain information |
|---|
Probab=99.93 E-value=1.2e-26 Score=231.37 Aligned_cols=180 Identities=22% Similarity=0.316 Sum_probs=134.8
Q ss_pred ccceeeccCCCC-------CCCCCCChhhHHHHHHHHHHHHHHHhhcCCCceeecCCCccceEecCCCCceeccccceee
Q 045315 242 EISFWYESYNNP-------TKKGLLCWGTRVRIIEGIAQGLLYLHQYSRLRVIHRDLKASNILLDKDMNPKISDFGMARM 314 (476)
Q Consensus 242 ~~~l~~Ey~~~~-------~~~~~L~~~~~~~i~~qIa~gL~yLH~~~~~~ivH~DLkp~NILld~~~~~kL~DFGla~~ 314 (476)
...+++||++.+ .+...+++..+++++.||+.||+|||+.+ |+||||||+||+++.++.+||+|||+++.
T Consensus 82 ~~~~v~e~~~~g~l~~~l~~~~~~~~~~~~~~~~~qi~~~L~~LH~~~---iiH~dlkp~Nill~~~~~~kl~DfG~a~~ 158 (316)
T cd05108 82 TVQLITQLMPFGCLLDYVREHKDNIGSQYLLNWCVQIAKGMNYLEERR---LVHRDLAARNVLVKTPQHVKITDFGLAKL 158 (316)
T ss_pred CceeeeecCCCCCHHHHHHhccccCCHHHHHHHHHHHHHHHHHHHhcC---eeccccchhheEecCCCcEEEcccccccc
Confidence 345677777732 22446899999999999999999999998 99999999999999999999999999987
Q ss_pred cCCCcccccceeeeeccCCCChhhhccCCCCccceEEeehhhhhhhhh-CCCCCCcCCCCchhhhhhhhhhhcCCCcccc
Q 045315 315 FGGDELQSNTKRIVGTYGYMSPEYALRGLFSIKSDVFSFGVLLLETLS-SKKNTHFYNTDSLTLLGHAWNLWNDGRTWEL 393 (476)
Q Consensus 315 ~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~s~ksDVwSlGvvl~ellt-G~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~ 393 (476)
..............++..|+|||.+.+..++.++|||||||++|||++ |+.|+...... .+. .....+...
T Consensus 159 ~~~~~~~~~~~~~~~~~~y~apE~~~~~~~~~~~Di~slGv~l~el~t~g~~p~~~~~~~--~~~----~~~~~~~~~-- 230 (316)
T cd05108 159 LGADEKEYHAEGGKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPAS--EIS----SILEKGERL-- 230 (316)
T ss_pred ccCCCcceeccCCccceeecChHHhccCCCCchhhhHHHHHHHHHHHcCCCCCCCCCCHH--HHH----HHHhCCCCC--
Confidence 654332222222234668999999999999999999999999999997 88887643211 111 111111110
Q ss_pred cCcccCCCCCHHHHHHHHHHHHHchhhcccCCCCHHHHHHHHhccc
Q 045315 394 MDPISQNGASYPILKRYINVALLCVQEKAADRPAMSEVVSMLSNEF 439 (476)
Q Consensus 394 ~d~~~~~~~~~~~~~~l~~li~~Cl~~dP~~RPt~~eVl~~L~~~~ 439 (476)
.. +......+.+++.+||+.+|++||++.+++..|..+.
T Consensus 231 ~~-------~~~~~~~~~~li~~cl~~~p~~Rps~~~l~~~l~~~~ 269 (316)
T cd05108 231 PQ-------PPICTIDVYMIMVKCWMIDADSRPKFRELIIEFSKMA 269 (316)
T ss_pred CC-------CCCCCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHH
Confidence 00 1112346788999999999999999999999998765
|
Protein Tyrosine Kinase (PTK) family; Epidermal Growth Factor Receptor (EGFR); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EGFR (HER1, ErbB1) is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphor |
| >KOG0582 consensus Ste20-like serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.93 E-value=2.8e-26 Score=225.07 Aligned_cols=183 Identities=25% Similarity=0.346 Sum_probs=134.9
Q ss_pred ccceeeccCCCCC--------CCCCCChhhHHHHHHHHHHHHHHHhhcCCCceeecCCCccceEecCCCCceecccccee
Q 045315 242 EISFWYESYNNPT--------KKGLLCWGTRVRIIEGIAQGLLYLHQYSRLRVIHRDLKASNILLDKDMNPKISDFGMAR 313 (476)
Q Consensus 242 ~~~l~~Ey~~~~~--------~~~~L~~~~~~~i~~qIa~gL~yLH~~~~~~ivH~DLkp~NILld~~~~~kL~DFGla~ 313 (476)
...+||-||..+. -...|++..+..|++++++||.|||.+| .||||||+.||||+.+|.+||+|||.+.
T Consensus 98 ~LWvVmpfMa~GS~ldIik~~~~~Gl~E~~Ia~iLre~LkaL~YLH~~G---~IHRdvKAgnILi~~dG~VkLadFgvsa 174 (516)
T KOG0582|consen 98 ELWVVMPFMAGGSLLDIIKTYYPDGLEEASIATILREVLKALDYLHQNG---HIHRDVKAGNILIDSDGTVKLADFGVSA 174 (516)
T ss_pred eeEEeehhhcCCcHHHHHHHHccccccHHHHHHHHHHHHHHHHHHHhcC---ceecccccccEEEcCCCcEEEcCceeee
Confidence 4556666666221 2334999999999999999999999999 9999999999999999999999999977
Q ss_pred ecCCCccc--ccceeeeeccCCCChhhhcc--CCCCccceEEeehhhhhhhhhCCCCCCcCCCCchhhhhhhhhhhcCCC
Q 045315 314 MFGGDELQ--SNTKRIVGTYGYMSPEYALR--GLFSIKSDVFSFGVLLLETLSSKKNTHFYNTDSLTLLGHAWNLWNDGR 389 (476)
Q Consensus 314 ~~~~~~~~--~~~~~~~gt~~y~aPE~l~~--~~~s~ksDVwSlGvvl~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~ 389 (476)
.+-..... .+.....|++.|||||+++. ..|+.|+||||||+..+||.+|..||..+.....-+.. + .+.
T Consensus 175 ~l~~~G~R~~~rf~tfvgtp~wmAPEvl~q~~~GYdfKaDIwSfGITA~ELA~G~aPf~k~pPmkvLl~t-----L-qn~ 248 (516)
T KOG0582|consen 175 SLFDSGDRQVTRFNTFVGTPCWMAPEVLMQQLHGYDFKADIWSFGITACELAHGHAPFSKYPPMKVLLLT-----L-QND 248 (516)
T ss_pred eecccCceeeEeeccccCcccccChHHhhhcccCccchhhhhhhhHHHHHHhcCCCCcccCChHHHHHHH-----h-cCC
Confidence 65332211 11145689999999999664 46999999999999999999999999866433221111 1 111
Q ss_pred cccccCcccCCCCCHHHHHHHHHHHHHchhhcccCCCCHHHHHH
Q 045315 390 TWELMDPISQNGASYPILKRYINVALLCVQEKAADRPAMSEVVS 433 (476)
Q Consensus 390 ~~~~~d~~~~~~~~~~~~~~l~~li~~Cl~~dP~~RPt~~eVl~ 433 (476)
...+.-..+..+........+.+++..||++||++|||++++++
T Consensus 249 pp~~~t~~~~~d~~k~~~ksf~e~i~~CL~kDP~kRptAskLlk 292 (516)
T KOG0582|consen 249 PPTLLTSGLDKDEDKKFSKSFREMIALCLVKDPSKRPTASKLLK 292 (516)
T ss_pred CCCcccccCChHHhhhhcHHHHHHHHHHhhcCcccCCCHHHHhc
Confidence 11111111222223344568889999999999999999999875
|
|
| >cd05093 PTKc_TrkB Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase B | Back alignment and domain information |
|---|
Probab=99.93 E-value=1.5e-26 Score=227.37 Aligned_cols=167 Identities=26% Similarity=0.373 Sum_probs=128.6
Q ss_pred CCCCChhhHHHHHHHHHHHHHHHhhcCCCceeecCCCccceEecCCCCceeccccceeecCCCcccccceeeeeccCCCC
Q 045315 256 KGLLCWGTRVRIIEGIAQGLLYLHQYSRLRVIHRDLKASNILLDKDMNPKISDFGMARMFGGDELQSNTKRIVGTYGYMS 335 (476)
Q Consensus 256 ~~~L~~~~~~~i~~qIa~gL~yLH~~~~~~ivH~DLkp~NILld~~~~~kL~DFGla~~~~~~~~~~~~~~~~gt~~y~a 335 (476)
...+++.+++.++.|++.||+|||+++ ++||||||+||++++++.+||+|||+++...............++..|+|
T Consensus 114 ~~~l~~~~~~~~~~ql~~aL~~lH~~~---i~H~dlkp~Nili~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~a 190 (288)
T cd05093 114 PAELTQSQMLHIAQQIAAGMVYLASQH---FVHRDLATRNCLVGENLLVKIGDFGMSRDVYSTDYYRVGGHTMLPIRWMP 190 (288)
T ss_pred CCCCCHHHHHHHHHHHHHHHHHHHhCC---eeecccCcceEEEccCCcEEeccCCccccccCCceeecCCCCCccccccC
Confidence 346999999999999999999999998 99999999999999999999999999986543322222222345678999
Q ss_pred hhhhccCCCCccceEEeehhhhhhhhh-CCCCCCcCCCCchhhhhhhhhhhcCCCcccccCcccCCCCCHHHHHHHHHHH
Q 045315 336 PEYALRGLFSIKSDVFSFGVLLLETLS-SKKNTHFYNTDSLTLLGHAWNLWNDGRTWELMDPISQNGASYPILKRYINVA 414 (476)
Q Consensus 336 PE~l~~~~~s~ksDVwSlGvvl~ellt-G~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~l~~li 414 (476)
||.+.+..++.++|||||||+++||++ |..||...... ... .....+..... .......+.+++
T Consensus 191 PE~~~~~~~~~~sDiwslG~il~~l~t~g~~p~~~~~~~--~~~----~~i~~~~~~~~---------~~~~~~~l~~li 255 (288)
T cd05093 191 PESIMYRKFTTESDVWSLGVVLWEIFTYGKQPWYQLSNN--EVI----ECITQGRVLQR---------PRTCPKEVYDLM 255 (288)
T ss_pred HHHhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCHH--HHH----HHHHcCCcCCC---------CCCCCHHHHHHH
Confidence 999998889999999999999999998 88887543211 111 11111111110 111234689999
Q ss_pred HHchhhcccCCCCHHHHHHHHhcccc
Q 045315 415 LLCVQEKAADRPAMSEVVSMLSNEFV 440 (476)
Q Consensus 415 ~~Cl~~dP~~RPt~~eVl~~L~~~~~ 440 (476)
.+||+.+|.+|||+.+|++.|+++..
T Consensus 256 ~~~l~~~p~~Rpt~~~v~~~l~~~~~ 281 (288)
T cd05093 256 LGCWQREPHMRLNIKEIHSLLQNLAK 281 (288)
T ss_pred HHHccCChhhCCCHHHHHHHHHHHHH
Confidence 99999999999999999999998763
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase B (TrkB); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkB is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkB to its ligands, brain-derived neurotrophic factor (BDNF) or neurotrophin 4 (NT4), results in receptor oligomerization and activation of the catalytic domain. TrkB is broadly |
| >cd05106 PTKc_CSF-1R Catalytic domain of the Protein Tyrosine Kinase, Colony-Stimulating Factor-1 Receptor | Back alignment and domain information |
|---|
Probab=99.93 E-value=1.9e-26 Score=235.52 Aligned_cols=168 Identities=24% Similarity=0.370 Sum_probs=128.5
Q ss_pred CCCCCChhhHHHHHHHHHHHHHHHhhcCCCceeecCCCccceEecCCCCceeccccceeecCCCcccccceeeeeccCCC
Q 045315 255 KKGLLCWGTRVRIIEGIAQGLLYLHQYSRLRVIHRDLKASNILLDKDMNPKISDFGMARMFGGDELQSNTKRIVGTYGYM 334 (476)
Q Consensus 255 ~~~~L~~~~~~~i~~qIa~gL~yLH~~~~~~ivH~DLkp~NILld~~~~~kL~DFGla~~~~~~~~~~~~~~~~gt~~y~ 334 (476)
...++++.++++++.||++||+|||+++ |+||||||+||++++++.+||+|||+++...............++..|+
T Consensus 205 ~~~~l~~~~~~~i~~qi~~aL~yLH~~g---iiHrDLkp~Nil~~~~~~~kL~DfGla~~~~~~~~~~~~~~~~~~~~y~ 281 (374)
T cd05106 205 DSWPLDLDDLLRFSSQVAQGMDFLASKN---CIHRDVAARNVLLTDGRVAKICDFGLARDIMNDSNYVVKGNARLPVKWM 281 (374)
T ss_pred CCCCcCHHHHHHHHHHHHHHHHHHHHCC---EEeccCchheEEEeCCCeEEEeeceeeeeccCCcceeeccCCCCcccee
Confidence 4557999999999999999999999998 9999999999999999999999999998654332211111223456899
Q ss_pred ChhhhccCCCCccceEEeehhhhhhhhh-CCCCCCcCCCCchhhhhhhhhhhcCCCcccccCcccCCCCCHHHHHHHHHH
Q 045315 335 SPEYALRGLFSIKSDVFSFGVLLLETLS-SKKNTHFYNTDSLTLLGHAWNLWNDGRTWELMDPISQNGASYPILKRYINV 413 (476)
Q Consensus 335 aPE~l~~~~~s~ksDVwSlGvvl~ellt-G~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~l~~l 413 (476)
|||++.+..++.++|||||||++|||++ |+.||........ .. .....+.. . ..+......+.++
T Consensus 282 aPE~~~~~~~~~~~DvwSlGvil~ellt~G~~Pf~~~~~~~~-~~----~~~~~~~~--~-------~~~~~~~~~l~~l 347 (374)
T cd05106 282 APESIFDCVYTVQSDVWSYGILLWEIFSLGKSPYPGILVNSK-FY----KMVKRGYQ--M-------SRPDFAPPEIYSI 347 (374)
T ss_pred CHHHhcCCCCCccccHHHHHHHHHHHHhCCCCCCccccccHH-HH----HHHHcccC--c-------cCCCCCCHHHHHH
Confidence 9999998899999999999999999997 9999865432211 11 11111100 0 0011123578899
Q ss_pred HHHchhhcccCCCCHHHHHHHHhccc
Q 045315 414 ALLCVQEKAADRPAMSEVVSMLSNEF 439 (476)
Q Consensus 414 i~~Cl~~dP~~RPt~~eVl~~L~~~~ 439 (476)
+.+||+.||++||++.+|+++|+++.
T Consensus 348 i~~cl~~dp~~RPs~~~l~~~l~~~~ 373 (374)
T cd05106 348 MKMCWNLEPTERPTFSQISQLIQRQL 373 (374)
T ss_pred HHHHcCCChhhCcCHHHHHHHHHHHh
Confidence 99999999999999999999998753
|
Protein Tyrosine Kinase (PTK) family; Colony-Stimulating Factor-1 Receptor (CSF-1R); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. CSF-1R, also called c-Fms, is a member of the Platelet Derived Growth Factor Receptor (PDGFR) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of CSF-1R to its ligand, CSF-1, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. CSF-1R signaling is criti |
| >PTZ00283 serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=99.93 E-value=2.1e-26 Score=243.22 Aligned_cols=174 Identities=25% Similarity=0.297 Sum_probs=135.2
Q ss_pred cceeeccCCCCC----------CCCCCChhhHHHHHHHHHHHHHHHhhcCCCceeecCCCccceEecCCCCceeccccce
Q 045315 243 ISFWYESYNNPT----------KKGLLCWGTRVRIIEGIAQGLLYLHQYSRLRVIHRDLKASNILLDKDMNPKISDFGMA 312 (476)
Q Consensus 243 ~~l~~Ey~~~~~----------~~~~L~~~~~~~i~~qIa~gL~yLH~~~~~~ivH~DLkp~NILld~~~~~kL~DFGla 312 (476)
.+++|||++.+. ....+++.++..++.|++.||+|||+.+ |+||||||+|||++.++.+||+|||++
T Consensus 114 i~lV~Ey~~~gsL~~~l~~~~~~~~~l~e~~~~~i~~qll~aL~~lH~~~---IiHrDLKP~NILl~~~~~vkL~DFGls 190 (496)
T PTZ00283 114 IALVLDYANAGDLRQEIKSRAKTNRTFREHEAGLLFIQVLLAVHHVHSKH---MIHRDIKSANILLCSNGLVKLGDFGFS 190 (496)
T ss_pred EEEEEeCCCCCcHHHHHHHhhccCCCCCHHHHHHHHHHHHHHHHHHHhCC---EecCCCCHHHEEEeCCCCEEEEecccC
Confidence 467889988321 2457899999999999999999999998 999999999999999999999999999
Q ss_pred eecCCCcccccceeeeeccCCCChhhhccCCCCccceEEeehhhhhhhhhCCCCCCcCCCCchhhhhhhhhhhcCCCccc
Q 045315 313 RMFGGDELQSNTKRIVGTYGYMSPEYALRGLFSIKSDVFSFGVLLLETLSSKKNTHFYNTDSLTLLGHAWNLWNDGRTWE 392 (476)
Q Consensus 313 ~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~s~ksDVwSlGvvl~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~ 392 (476)
+.+.............||+.|+|||++.+..++.++|||||||++|||++|+.||..... ..... ....+...
T Consensus 191 ~~~~~~~~~~~~~~~~Gt~~Y~aPE~~~~~~~s~k~DVwSlGvilyeLltG~~Pf~~~~~--~~~~~----~~~~~~~~- 263 (496)
T PTZ00283 191 KMYAATVSDDVGRTFCGTPYYVAPEIWRRKPYSKKADMFSLGVLLYELLTLKRPFDGENM--EEVMH----KTLAGRYD- 263 (496)
T ss_pred eeccccccccccccccCCcceeCHHHhCCCCCCcHHHHHHHHHHHHHHHHCCCCCCCCCH--HHHHH----HHhcCCCC-
Confidence 876543323333346789999999999999999999999999999999999999864321 11111 11111110
Q ss_pred ccCcccCCCCCHHHHHHHHHHHHHchhhcccCCCCHHHHHHH
Q 045315 393 LMDPISQNGASYPILKRYINVALLCVQEKAADRPAMSEVVSM 434 (476)
Q Consensus 393 ~~d~~~~~~~~~~~~~~l~~li~~Cl~~dP~~RPt~~eVl~~ 434 (476)
..+......+.+++.+||+.||.+||++.++++.
T Consensus 264 --------~~~~~~~~~l~~li~~~L~~dP~~RPs~~ell~~ 297 (496)
T PTZ00283 264 --------PLPPSISPEMQEIVTALLSSDPKRRPSSSKLLNM 297 (496)
T ss_pred --------CCCCCCCHHHHHHHHHHcccChhhCcCHHHHHhC
Confidence 1112234578899999999999999999998763
|
|
| >cd05585 STKc_YPK1_like Catalytic domain of Yeast Protein Kinase 1-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=99.93 E-value=2.2e-26 Score=229.09 Aligned_cols=174 Identities=21% Similarity=0.259 Sum_probs=131.9
Q ss_pred cccceeeccCCCCC------CCCCCChhhHHHHHHHHHHHHHHHhhcCCCceeecCCCccceEecCCCCceeccccceee
Q 045315 241 DEISFWYESYNNPT------KKGLLCWGTRVRIIEGIAQGLLYLHQYSRLRVIHRDLKASNILLDKDMNPKISDFGMARM 314 (476)
Q Consensus 241 ~~~~l~~Ey~~~~~------~~~~L~~~~~~~i~~qIa~gL~yLH~~~~~~ivH~DLkp~NILld~~~~~kL~DFGla~~ 314 (476)
+.+++++||++... +.+.+++.++..++.||+.||+|||+++ |+||||||+||+++.++.+||+|||+++.
T Consensus 66 ~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~qi~~~l~~lH~~~---i~HrDlkp~Nili~~~~~~kl~Dfg~~~~ 142 (312)
T cd05585 66 EKLYLVLAFINGGELFHHLQREGRFDLSRARFYTAELLCALENLHKFN---VIYRDLKPENILLDYQGHIALCDFGLCKL 142 (312)
T ss_pred CeEEEEEcCCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCC---eEeCCCCHHHeEECCCCcEEEEECccccc
Confidence 46889999998432 3557999999999999999999999999 99999999999999999999999999975
Q ss_pred cCCCcccccceeeeeccCCCChhhhccCCCCccceEEeehhhhhhhhhCCCCCCcCCCCchhhhhhhhhhhcCCCccccc
Q 045315 315 FGGDELQSNTKRIVGTYGYMSPEYALRGLFSIKSDVFSFGVLLLETLSSKKNTHFYNTDSLTLLGHAWNLWNDGRTWELM 394 (476)
Q Consensus 315 ~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~s~ksDVwSlGvvl~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 394 (476)
...... ......|++.|+|||.+.+..++.++|||||||++|||++|+.||...... ... ..... +..
T Consensus 143 ~~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslGvil~el~tg~~pf~~~~~~--~~~---~~~~~-~~~---- 210 (312)
T cd05585 143 NMKDDD--KTNTFCGTPEYLAPELLLGHGYTKAVDWWTLGVLLYEMLTGLPPFYDENVN--EMY---RKILQ-EPL---- 210 (312)
T ss_pred CccCCC--ccccccCCcccCCHHHHcCCCCCCccceechhHHHHHHHhCCCCcCCCCHH--HHH---HHHHc-CCC----
Confidence 432221 223356899999999999999999999999999999999999998643211 111 11111 100
Q ss_pred CcccCCCCCHHHHHHHHHHHHHchhhcccCCCCHHHHHHHH
Q 045315 395 DPISQNGASYPILKRYINVALLCVQEKAADRPAMSEVVSML 435 (476)
Q Consensus 395 d~~~~~~~~~~~~~~l~~li~~Cl~~dP~~RPt~~eVl~~L 435 (476)
..+......+.+++.+||+.||++||++.++.+.|
T Consensus 211 ------~~~~~~~~~~~~li~~~L~~dp~~R~~~~~~~e~l 245 (312)
T cd05585 211 ------RFPDGFDRDAKDLLIGLLSRDPTRRLGYNGAQEIK 245 (312)
T ss_pred ------CCCCcCCHHHHHHHHHHcCCCHHHcCCCCCHHHHH
Confidence 01112335678999999999999998644333333
|
Serine/Threonine Kinases (STKs), Yeast protein kinase 1 (YPK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The YPK1-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of fungal proteins with similarity to the AGC STKs, Saccharomyces cerevisiae YPK1 and Schizosaccharomyces pombe Gad8p. YPK1 is required for cell growth and acts as a downstream kinase in the sphingolipid-mediated signaling pathway of yeast. It also plays a role in efficient endocytosis and in the maintenance of cell wall integrity. Gad8p is a downstream target of Tor1p, the fission yeast homolog of mTOR. It pl |
| >cd07859 STKc_TDY_MAPK_plant Catalytic domain of the Serine/Threonine Kinases, TDY Mitogen-Activated Protein Kinases from Plants | Back alignment and domain information |
|---|
Probab=99.93 E-value=7e-27 Score=234.63 Aligned_cols=190 Identities=22% Similarity=0.229 Sum_probs=132.1
Q ss_pred ccceeeccCCCC-----CCCCCCChhhHHHHHHHHHHHHHHHhhcCCCceeecCCCccceEecCCCCceeccccceeecC
Q 045315 242 EISFWYESYNNP-----TKKGLLCWGTRVRIIEGIAQGLLYLHQYSRLRVIHRDLKASNILLDKDMNPKISDFGMARMFG 316 (476)
Q Consensus 242 ~~~l~~Ey~~~~-----~~~~~L~~~~~~~i~~qIa~gL~yLH~~~~~~ivH~DLkp~NILld~~~~~kL~DFGla~~~~ 316 (476)
..+++|||++.. .....+++..+..++.||++||+|||+.+ |+||||||+|||++.++.+||+|||+++...
T Consensus 78 ~~~lv~e~~~~~L~~~l~~~~~~~~~~~~~i~~qi~~aL~~LH~~~---ivH~dlkp~NIll~~~~~~kL~Dfg~~~~~~ 154 (338)
T cd07859 78 DIYVVFELMESDLHQVIKANDDLTPEHHQFFLYQLLRALKYIHTAN---VFHRDLKPKNILANADCKLKICDFGLARVAF 154 (338)
T ss_pred eEEEEEecCCCCHHHHHHhcccCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCCHHHeEECCCCcEEEccCccccccc
Confidence 467889998721 23456999999999999999999999999 9999999999999999999999999998643
Q ss_pred CCcc-cccceeeeeccCCCChhhhcc--CCCCccceEEeehhhhhhhhhCCCCCCcCCCCc-hhhhhh--------hhhh
Q 045315 317 GDEL-QSNTKRIVGTYGYMSPEYALR--GLFSIKSDVFSFGVLLLETLSSKKNTHFYNTDS-LTLLGH--------AWNL 384 (476)
Q Consensus 317 ~~~~-~~~~~~~~gt~~y~aPE~l~~--~~~s~ksDVwSlGvvl~elltG~~p~~~~~~~~-~~~~~~--------~~~~ 384 (476)
.... ........|+..|+|||++.+ ..++.++|||||||++|||++|+.||....... ...... ....
T Consensus 155 ~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~~DvwSlGvvl~el~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~ 234 (338)
T cd07859 155 NDTPTAIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLTGKPLFPGKNVVHQLDLITDLLGTPSPETISR 234 (338)
T ss_pred cccCccccccCCCCCCCcCCHHHHhccccccCchhHHHHHHHHHHHHHcCCCCCCCCChHHHHHHHHHHhCCCCHHHHHH
Confidence 2211 111123568999999999875 678999999999999999999999986543110 000000 0000
Q ss_pred hcCCCcccccC---cccCC---CCCHHHHHHHHHHHHHchhhcccCCCCHHHHHHH
Q 045315 385 WNDGRTWELMD---PISQN---GASYPILKRYINVALLCVQEKAADRPAMSEVVSM 434 (476)
Q Consensus 385 ~~~~~~~~~~d---~~~~~---~~~~~~~~~l~~li~~Cl~~dP~~RPt~~eVl~~ 434 (476)
+.......... ..... .........+.+++.+||+.||++||+++|+++.
T Consensus 235 i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~e~l~h 290 (338)
T cd07859 235 VRNEKARRYLSSMRKKQPVPFSQKFPNADPLALRLLERLLAFDPKDRPTAEEALAD 290 (338)
T ss_pred hhhhhHHHHHHhhcccCCCchHHhcCCCChHHHHHHHHHcCcCcccCCCHHHHhcC
Confidence 00000000000 00000 0001123467899999999999999999999864
|
Serine/Threonine Kinases (STKs), Plant TDY Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TDY MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. In plants, MAPKs are associated with physiological, developmental, hormonal, and stress responses. Some plants show numerous gene duplications of MAPKs. Arabidopsis thaliana harbors at least 20 MAPKs, named AtMPK1-20. Oryza sativa contains at least 17 MAPKs. There are two subtypes of plant MAPKs based on the conserved phos |
| >cd05109 PTKc_HER2 Catalytic domain of the Protein Tyrosine Kinase, HER2 | Back alignment and domain information |
|---|
Probab=99.93 E-value=1.7e-26 Score=225.64 Aligned_cols=180 Identities=23% Similarity=0.292 Sum_probs=135.0
Q ss_pred ccceeeccCCCC-------CCCCCCChhhHHHHHHHHHHHHHHHhhcCCCceeecCCCccceEecCCCCceeccccceee
Q 045315 242 EISFWYESYNNP-------TKKGLLCWGTRVRIIEGIAQGLLYLHQYSRLRVIHRDLKASNILLDKDMNPKISDFGMARM 314 (476)
Q Consensus 242 ~~~l~~Ey~~~~-------~~~~~L~~~~~~~i~~qIa~gL~yLH~~~~~~ivH~DLkp~NILld~~~~~kL~DFGla~~ 314 (476)
...+++||++.+ .+.+.+++.+++.++.||+.||+|||+.+ ++||||||+||+++.++.+||+|||+++.
T Consensus 82 ~~~l~~~~~~~g~l~~~l~~~~~~~~~~~~~~~~~qi~~~L~~lH~~~---iiH~dlkp~Nil~~~~~~~kL~dfG~~~~ 158 (279)
T cd05109 82 TVQLVTQLMPYGCLLDYVRENKDRIGSQDLLNWCVQIAKGMSYLEEVR---LVHRDLAARNVLVKSPNHVKITDFGLARL 158 (279)
T ss_pred CcEEEEEcCCCCCHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHHCC---eeccccccceEEEcCCCcEEECCCCceee
Confidence 345677877732 22457999999999999999999999998 99999999999999999999999999987
Q ss_pred cCCCcccccceeeeeccCCCChhhhccCCCCccceEEeehhhhhhhhh-CCCCCCcCCCCchhhhhhhhhhhcCCCcccc
Q 045315 315 FGGDELQSNTKRIVGTYGYMSPEYALRGLFSIKSDVFSFGVLLLETLS-SKKNTHFYNTDSLTLLGHAWNLWNDGRTWEL 393 (476)
Q Consensus 315 ~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~s~ksDVwSlGvvl~ellt-G~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~ 393 (476)
..............++..|+|||...+..++.++|||||||++||+++ |..|+..... ..+.. ....+....
T Consensus 159 ~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~~l~el~t~g~~p~~~~~~--~~~~~----~~~~~~~~~- 231 (279)
T cd05109 159 LDIDETEYHADGGKVPIKWMALESILHRRFTHQSDVWSYGVTVWELMTFGAKPYDGIPA--REIPD----LLEKGERLP- 231 (279)
T ss_pred cccccceeecCCCccchhhCCHHHhccCCCCchhHHHHHHHHHHHHHcCCCCCCCCCCH--HHHHH----HHHCCCcCC-
Confidence 653322111111234678999999988889999999999999999998 8888753321 11111 111111110
Q ss_pred cCcccCCCCCHHHHHHHHHHHHHchhhcccCCCCHHHHHHHHhccc
Q 045315 394 MDPISQNGASYPILKRYINVALLCVQEKAADRPAMSEVVSMLSNEF 439 (476)
Q Consensus 394 ~d~~~~~~~~~~~~~~l~~li~~Cl~~dP~~RPt~~eVl~~L~~~~ 439 (476)
........+.+++.+||+.||++||++.++++.|+.+.
T Consensus 232 --------~~~~~~~~~~~li~~~l~~dp~~Rp~~~~l~~~l~~~~ 269 (279)
T cd05109 232 --------QPPICTIDVYMIMVKCWMIDSECRPRFRELVDEFSRMA 269 (279)
T ss_pred --------CCccCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHhh
Confidence 11123356789999999999999999999999998864
|
Protein Tyrosine Kinase (PTK) family; HER2 (ErbB2, HER2/neu); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER2 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve |
| >KOG0201 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.93 E-value=1.1e-26 Score=227.86 Aligned_cols=171 Identities=23% Similarity=0.322 Sum_probs=135.4
Q ss_pred cceeeccCCCC------CCCCCCChhhHHHHHHHHHHHHHHHhhcCCCceeecCCCccceEecCCCCceeccccceeecC
Q 045315 243 ISFWYESYNNP------TKKGLLCWGTRVRIIEGIAQGLLYLHQYSRLRVIHRDLKASNILLDKDMNPKISDFGMARMFG 316 (476)
Q Consensus 243 ~~l~~Ey~~~~------~~~~~L~~~~~~~i~~qIa~gL~yLH~~~~~~ivH~DLkp~NILld~~~~~kL~DFGla~~~~ 316 (476)
.-++|||+..+ ..+..+++.++.-|++++..||.|||.++ .+|||||+.|||+..+|.+||+|||++..+.
T Consensus 86 LwiiMey~~gGsv~~lL~~~~~~~E~~i~~ilre~l~~l~ylH~~~---kiHrDIKaanil~s~~g~vkl~DfgVa~ql~ 162 (467)
T KOG0201|consen 86 LWIIMEYCGGGSVLDLLKSGNILDEFEIAVILREVLKGLDYLHSEK---KIHRDIKAANILLSESGDVKLADFGVAGQLT 162 (467)
T ss_pred HHHHHHHhcCcchhhhhccCCCCccceeeeehHHHHHHhhhhhhcc---eecccccccceeEeccCcEEEEecceeeeee
Confidence 34567888733 23445588899999999999999999999 9999999999999999999999999998876
Q ss_pred CCcccccceeeeeccCCCChhhhccCCCCccceEEeehhhhhhhhhCCCCCCcCCCCchhhhhhhhhhhcCCCcccccCc
Q 045315 317 GDELQSNTKRIVGTYGYMSPEYALRGLFSIKSDVFSFGVLLLETLSSKKNTHFYNTDSLTLLGHAWNLWNDGRTWELMDP 396 (476)
Q Consensus 317 ~~~~~~~~~~~~gt~~y~aPE~l~~~~~s~ksDVwSlGvvl~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~ 396 (476)
...... ..++||+.|||||++....|+.|+||||||++.+||.+|.+|+........ .-++..
T Consensus 163 ~~~~rr--~tfvGTPfwMAPEVI~~~~Y~~KADIWSLGITaiEla~GePP~s~~hPmrv---------------lflIpk 225 (467)
T KOG0201|consen 163 NTVKRR--KTFVGTPFWMAPEVIKQSGYDTKADIWSLGITAIELAKGEPPHSKLHPMRV---------------LFLIPK 225 (467)
T ss_pred chhhcc--ccccccccccchhhhccccccchhhhhhhhHHHHHHhcCCCCCcccCcceE---------------EEeccC
Confidence 554333 458999999999999988999999999999999999999999875543211 111111
Q ss_pred ccCCCCCHHHHHHHHHHHHHchhhcccCCCCHHHHHH
Q 045315 397 ISQNGASYPILKRYINVALLCVQEKAADRPAMSEVVS 433 (476)
Q Consensus 397 ~~~~~~~~~~~~~l~~li~~Cl~~dP~~RPt~~eVl~ 433 (476)
...+.......+.+.+++..||.+||+.||++.++++
T Consensus 226 ~~PP~L~~~~S~~~kEFV~~CL~k~P~~RpsA~~LLK 262 (467)
T KOG0201|consen 226 SAPPRLDGDFSPPFKEFVEACLDKNPEFRPSAKELLK 262 (467)
T ss_pred CCCCccccccCHHHHHHHHHHhhcCcccCcCHHHHhh
Confidence 1111112234556889999999999999999999875
|
|
| >cd05593 STKc_PKB_gamma Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B gamma | Back alignment and domain information |
|---|
Probab=99.93 E-value=2.6e-26 Score=230.32 Aligned_cols=173 Identities=22% Similarity=0.262 Sum_probs=133.5
Q ss_pred cccceeeccCCCCC------CCCCCChhhHHHHHHHHHHHHHHHhhcCCCceeecCCCccceEecCCCCceeccccceee
Q 045315 241 DEISFWYESYNNPT------KKGLLCWGTRVRIIEGIAQGLLYLHQYSRLRVIHRDLKASNILLDKDMNPKISDFGMARM 314 (476)
Q Consensus 241 ~~~~l~~Ey~~~~~------~~~~L~~~~~~~i~~qIa~gL~yLH~~~~~~ivH~DLkp~NILld~~~~~kL~DFGla~~ 314 (476)
+..+++|||++... ..+.+++.++..++.||+.||+|||+++ |+||||||+|||++.++.+||+|||+++.
T Consensus 68 ~~~~lv~Ey~~~g~L~~~l~~~~~l~~~~~~~~~~qi~~aL~~LH~~~---ivHrDikp~NIll~~~~~~kL~DfG~~~~ 144 (328)
T cd05593 68 DRLCFVMEYVNGGELFFHLSRERVFSEDRTRFYGAEIVSALDYLHSGK---IVYRDLKLENLMLDKDGHIKITDFGLCKE 144 (328)
T ss_pred CEEEEEEeCCCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCC---eEecccCHHHeEECCCCcEEEecCcCCcc
Confidence 46788999998432 3457999999999999999999999998 99999999999999999999999999875
Q ss_pred cCCCcccccceeeeeccCCCChhhhccCCCCccceEEeehhhhhhhhhCCCCCCcCCCCchhhhhhhhhhhcCCCccccc
Q 045315 315 FGGDELQSNTKRIVGTYGYMSPEYALRGLFSIKSDVFSFGVLLLETLSSKKNTHFYNTDSLTLLGHAWNLWNDGRTWELM 394 (476)
Q Consensus 315 ~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~s~ksDVwSlGvvl~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 394 (476)
..... .......|++.|+|||.+.+..++.++|||||||++|||++|+.||...... .... .......
T Consensus 145 ~~~~~--~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslGvil~elltG~~Pf~~~~~~--~~~~----~~~~~~~---- 212 (328)
T cd05593 145 GITDA--ATMKTFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHE--KLFE----LILMEDI---- 212 (328)
T ss_pred CCCcc--cccccccCCcCccChhhhcCCCCCccCCccccchHHHHHhhCCCCCCCCCHH--HHHH----HhccCCc----
Confidence 33221 1122356899999999999889999999999999999999999998643211 1111 1100100
Q ss_pred CcccCCCCCHHHHHHHHHHHHHchhhcccCCC-----CHHHHHHH
Q 045315 395 DPISQNGASYPILKRYINVALLCVQEKAADRP-----AMSEVVSM 434 (476)
Q Consensus 395 d~~~~~~~~~~~~~~l~~li~~Cl~~dP~~RP-----t~~eVl~~ 434 (476)
..+......+.+++.+||+.||++|| ++.++++.
T Consensus 213 ------~~p~~~~~~~~~li~~~L~~dP~~R~~~~~~~~~~il~h 251 (328)
T cd05593 213 ------KFPRTLSADAKSLLSGLLIKDPNKRLGGGPDDAKEIMRH 251 (328)
T ss_pred ------cCCCCCCHHHHHHHHHHcCCCHHHcCCCCCCCHHHHhcC
Confidence 01112345678999999999999997 88888753
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, gamma (or Akt3) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-gamma is predominantly expressed in neuronal tissues. Mice deficient in PKB-gamma show a reduction in brain weight due to the decreases in cell size and cell number. PKB-gamma has also been shown to be upregulate |
| >PF07714 Pkinase_Tyr: Protein tyrosine kinase Protein kinase; unclassified specificity | Back alignment and domain information |
|---|
Probab=99.93 E-value=5.3e-27 Score=227.24 Aligned_cols=177 Identities=29% Similarity=0.416 Sum_probs=129.7
Q ss_pred cccceeeccCCCC--------CCCCCCChhhHHHHHHHHHHHHHHHhhcCCCceeecCCCccceEecCCCCceeccccce
Q 045315 241 DEISFWYESYNNP--------TKKGLLCWGTRVRIIEGIAQGLLYLHQYSRLRVIHRDLKASNILLDKDMNPKISDFGMA 312 (476)
Q Consensus 241 ~~~~l~~Ey~~~~--------~~~~~L~~~~~~~i~~qIa~gL~yLH~~~~~~ivH~DLkp~NILld~~~~~kL~DFGla 312 (476)
+.+.+++||++.+ .....+++.++.+|+.||++||+|||+++ ++|+||+++||+++.++.+||+|||++
T Consensus 74 ~~~~lv~e~~~~g~L~~~L~~~~~~~~~~~~~~~i~~~i~~~l~~Lh~~~---iiH~~l~~~nill~~~~~~Kl~~f~~~ 150 (259)
T PF07714_consen 74 EPLFLVMEYCPGGSLDDYLKSKNKEPLSEQQRLSIAIQIAEALSYLHSNN---IIHGNLSPSNILLDSNGQVKLSDFGLS 150 (259)
T ss_dssp SSEEEEEE--TTEBHHHHHHHTCTTTSBHHHHHHHHHHHHHHHHHHHHTT---EEEST-SGGGEEEETTTEEEEESTTTG
T ss_pred cccccccccccccccccccccccccccccccccccccccccccccccccc---ccccccccccccccccccccccccccc
Confidence 4588999999832 23568999999999999999999999998 999999999999999999999999999
Q ss_pred eecCCCcccccceeeeeccCCCChhhhccCCCCccceEEeehhhhhhhhh-CCCCCCcCCCCchhhhhhhhhhhcCCCcc
Q 045315 313 RMFGGDELQSNTKRIVGTYGYMSPEYALRGLFSIKSDVFSFGVLLLETLS-SKKNTHFYNTDSLTLLGHAWNLWNDGRTW 391 (476)
Q Consensus 313 ~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~s~ksDVwSlGvvl~ellt-G~~p~~~~~~~~~~~~~~~~~~~~~~~~~ 391 (476)
....................|+|||.+....++.++||||||+++||+++ |+.|+.... ...+... ..++...
T Consensus 151 ~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~ksDVysfG~~l~ei~~~~~~p~~~~~--~~~~~~~----~~~~~~~ 224 (259)
T PF07714_consen 151 RPISEKSKYKNDSSQQLPLRYLAPEVLKDGEYTKKSDVYSFGMLLYEILTLGKFPFSDYD--NEEIIEK----LKQGQRL 224 (259)
T ss_dssp EETTTSSSEEESTTSESGGGGS-HHHHHHSEESHHHHHHHHHHHHHHHHTTSSGTTTTSC--HHHHHHH----HHTTEET
T ss_pred cccccccccccccccccccccccccccccccccccccccccccccccccccccccccccc--ccccccc----ccccccc
Confidence 88733222222222456789999999999889999999999999999999 667765432 1221111 1111111
Q ss_pred cccCcccCCCCCHHHHHHHHHHHHHchhhcccCCCCHHHHHHHH
Q 045315 392 ELMDPISQNGASYPILKRYINVALLCVQEKAADRPAMSEVVSML 435 (476)
Q Consensus 392 ~~~d~~~~~~~~~~~~~~l~~li~~Cl~~dP~~RPt~~eVl~~L 435 (476)
. .+......+.+++.+||+.+|++||++.+|++.|
T Consensus 225 ~---------~~~~~~~~~~~li~~C~~~~p~~RPs~~~i~~~L 259 (259)
T PF07714_consen 225 P---------IPDNCPKDIYSLIQQCWSHDPEKRPSFQEILQEL 259 (259)
T ss_dssp T---------SBTTSBHHHHHHHHHHT-SSGGGS--HHHHHHHH
T ss_pred e---------eccchhHHHHHHHHHHcCCChhhCcCHHHHHhcC
Confidence 1 1112245688999999999999999999999987
|
Tyrosine kinase, catalytic domain; InterPro: IPR001245 Protein phosphorylation, which plays a key role in most cellular activities, is a reversible process mediated by protein kinases and phosphoprotein phosphatases. Protein kinases catalyse the transfer of the gamma phosphate from nucleotide triphosphates (often ATP) to one or more amino acid residues in a protein substrate side chain, resulting in a conformational change affecting protein function. Phosphoprotein phosphatases catalyse the reverse process. Protein kinases fall into three broad classes, characterised with respect to substrate specificity []: Serine/threonine-protein kinases Tyrosine-protein kinases Dual specific protein kinases (e.g. MEK - phosphorylates both Thr and Tyr on target proteins) Protein kinase function has been evolutionarily conserved from Escherichia coli to human []. Protein kinases play a role in a multitude of cellular processes, including division, proliferation, apoptosis, and differentiation []. Phosphorylation usually results in a functional change of the target protein by changing enzyme activity, cellular location, or association with other proteins. The catalytic subunits of protein kinases are highly conserved, and several structures have been solved [], leading to large screens to develop kinase-specific inhibitors for the treatments of a number of diseases []. Tyrosine-protein kinases can transfer a phosphate group from ATP to a tyrosine residue in a protein. These enzymes can be divided into two main groups []: Receptor tyrosine kinases (RTK), which are transmembrane proteins involved in signal transduction; they play key roles in growth, differentiation, metabolism, adhesion, motility, death and oncogenesis []. RTKs are composed of 3 domains: an extracellular domain (binds ligand), a transmembrane (TM) domain, and an intracellular catalytic domain (phosphorylates substrate). The TM domain plays an important role in the dimerisation process necessary for signal transduction []. Cytoplasmic / non-receptor tyrosine kinases, which act as regulatory proteins, playing key roles in cell differentiation, motility, proliferation, and survival. For example, the Src-family of protein-tyrosine kinases []. ; GO: 0004672 protein kinase activity, 0006468 protein phosphorylation; PDB: 2HYY_C 1OPL_A 2V7A_A 2G2H_B 2G1T_A 3PYY_A 3CS9_D 2HZI_A 2E2B_A 2HIW_A .... |
| >cd05594 STKc_PKB_alpha Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B alpha | Back alignment and domain information |
|---|
Probab=99.93 E-value=2.6e-26 Score=229.92 Aligned_cols=173 Identities=23% Similarity=0.270 Sum_probs=133.0
Q ss_pred cccceeeccCCCC------CCCCCCChhhHHHHHHHHHHHHHHHhh-cCCCceeecCCCccceEecCCCCceecccccee
Q 045315 241 DEISFWYESYNNP------TKKGLLCWGTRVRIIEGIAQGLLYLHQ-YSRLRVIHRDLKASNILLDKDMNPKISDFGMAR 313 (476)
Q Consensus 241 ~~~~l~~Ey~~~~------~~~~~L~~~~~~~i~~qIa~gL~yLH~-~~~~~ivH~DLkp~NILld~~~~~kL~DFGla~ 313 (476)
+..+++|||++.. .+.+.+++.++..++.||+.||+|||+ .+ |+||||||+|||++.++.+||+|||+++
T Consensus 68 ~~~~lv~E~~~~~~L~~~l~~~~~l~~~~~~~~~~qi~~aL~~lH~~~~---ivHrDikp~NIll~~~~~~kL~Dfg~~~ 144 (325)
T cd05594 68 DRLCFVMEYANGGELFFHLSRERVFSEDRARFYGAEIVSALDYLHSEKN---VVYRDLKLENLMLDKDGHIKITDFGLCK 144 (325)
T ss_pred CEEEEEEeCCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhcCC---EEecCCCCCeEEECCCCCEEEecCCCCe
Confidence 4578999999843 235679999999999999999999997 67 9999999999999999999999999987
Q ss_pred ecCCCcccccceeeeeccCCCChhhhccCCCCccceEEeehhhhhhhhhCCCCCCcCCCCchhhhhhhhhhhcCCCcccc
Q 045315 314 MFGGDELQSNTKRIVGTYGYMSPEYALRGLFSIKSDVFSFGVLLLETLSSKKNTHFYNTDSLTLLGHAWNLWNDGRTWEL 393 (476)
Q Consensus 314 ~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~s~ksDVwSlGvvl~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~ 393 (476)
....... ......|+..|+|||++.+..++.++|||||||++|||++|+.||....... ... .......
T Consensus 145 ~~~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~tG~~Pf~~~~~~~--~~~----~i~~~~~--- 213 (325)
T cd05594 145 EGIKDGA--TMKTFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHEK--LFE----LILMEEI--- 213 (325)
T ss_pred ecCCCCc--ccccccCCcccCCHHHHccCCCCCccccccccceeeeeccCCCCCCCCCHHH--HHH----HHhcCCC---
Confidence 5432211 1223568999999999999899999999999999999999999986433211 111 0000000
Q ss_pred cCcccCCCCCHHHHHHHHHHHHHchhhcccCCC-----CHHHHHHH
Q 045315 394 MDPISQNGASYPILKRYINVALLCVQEKAADRP-----AMSEVVSM 434 (476)
Q Consensus 394 ~d~~~~~~~~~~~~~~l~~li~~Cl~~dP~~RP-----t~~eVl~~ 434 (476)
. .+......+.+++.+||+.||++|+ ++.++++.
T Consensus 214 ---~----~p~~~~~~~~~li~~~L~~dP~~R~~~~~~~~~~il~h 252 (325)
T cd05594 214 ---R----FPRTLSPEAKSLLSGLLKKDPKQRLGGGPDDAKEIMQH 252 (325)
T ss_pred ---C----CCCCCCHHHHHHHHHHhhcCHHHhCCCCCCCHHHHhcC
Confidence 0 1112235678999999999999996 89988743
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, alpha (or Akt1) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-alpha is predominantly expressed in endothelial cells. It is critical for the regulation of angiogenesis and the maintenance of vascular integrity. It also plays a role in adipocyte differentiation. Mice deficien |
| >cd05051 PTKc_DDR Catalytic domain of the Protein Tyrosine Kinases, Discoidin Domain Receptors | Back alignment and domain information |
|---|
Probab=99.93 E-value=6.7e-26 Score=223.13 Aligned_cols=170 Identities=28% Similarity=0.404 Sum_probs=126.2
Q ss_pred CCCChhhHHHHHHHHHHHHHHHhhcCCCceeecCCCccceEecCCCCceeccccceeecCCCcccccceeeeeccCCCCh
Q 045315 257 GLLCWGTRVRIIEGIAQGLLYLHQYSRLRVIHRDLKASNILLDKDMNPKISDFGMARMFGGDELQSNTKRIVGTYGYMSP 336 (476)
Q Consensus 257 ~~L~~~~~~~i~~qIa~gL~yLH~~~~~~ivH~DLkp~NILld~~~~~kL~DFGla~~~~~~~~~~~~~~~~gt~~y~aP 336 (476)
..+++..++.++.|++.||+|||+.+ ++|+||||+||+++.++.++|+|||+++...............++..|+||
T Consensus 125 ~~~~~~~~~~~~~~i~~al~~LH~~~---i~H~dlkp~Nili~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~y~aP 201 (296)
T cd05051 125 KSLSFSTLLYMATQIASGMRYLESLN---FVHRDLATRNCLVGKNYTIKIADFGMSRNLYSSDYYRVQGRAPLPIRWMAW 201 (296)
T ss_pred CCCCHHHHHHHHHHHHHHHHHHHHcC---ccccccchhceeecCCCceEEccccceeecccCcceeecCcCCCCceecCH
Confidence 37899999999999999999999998 999999999999999999999999999865433222222334567789999
Q ss_pred hhhccCCCCccceEEeehhhhhhhhh--CCCCCCcCCCCchhhhhhhhhhhcCCCcccccCcccCCCCCHHHHHHHHHHH
Q 045315 337 EYALRGLFSIKSDVFSFGVLLLETLS--SKKNTHFYNTDSLTLLGHAWNLWNDGRTWELMDPISQNGASYPILKRYINVA 414 (476)
Q Consensus 337 E~l~~~~~s~ksDVwSlGvvl~ellt--G~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~l~~li 414 (476)
|.+.+..++.++|||||||++|||++ +..|+... ............+......... .........+.+++
T Consensus 202 E~~~~~~~~~~~Dv~slG~~l~el~~~~~~~p~~~~--~~~~~~~~~~~~~~~~~~~~~~------~~~~~~~~~l~~li 273 (296)
T cd05051 202 ESVLLGKFTTKSDVWAFGVTLWEILTLCREQPYEHL--TDQQVIENAGHFFRDDGRQIYL------PRPPNCPKDIYELM 273 (296)
T ss_pred HHhhcCCCCccchhhhhHHHHHHHHhcCCCCCCCCc--ChHHHHHHHHhccccccccccC------CCccCCCHHHHHHH
Confidence 99988889999999999999999998 45554322 1222222222221111111111 11122335789999
Q ss_pred HHchhhcccCCCCHHHHHHHHhc
Q 045315 415 LLCVQEKAADRPAMSEVVSMLSN 437 (476)
Q Consensus 415 ~~Cl~~dP~~RPt~~eVl~~L~~ 437 (476)
.+||+.||++||++.||++.|+.
T Consensus 274 ~~cl~~~p~~Rpt~~el~~~L~~ 296 (296)
T cd05051 274 LECWRRDEEDRPTFREIHLFLQR 296 (296)
T ss_pred HHHhccChhcCCCHHHHHHHhcC
Confidence 99999999999999999999863
|
Protein Tyrosine Kinase (PTK) family; Discoidin Domain Receptor (DDR) subfamily; catalytic (c) domain. The DDR subfamily consists of homologs of mammalian DDR1, DDR2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR subfamily members are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDRs regulate cell adhesion, proliferation, and extracellular matrix remodeling. They have been linke |
| >cd05054 PTKc_VEGFR Catalytic domain of the Protein Tyrosine Kinases, Vascular Endothelial Growth Factor Receptors | Back alignment and domain information |
|---|
Probab=99.93 E-value=2.4e-26 Score=231.46 Aligned_cols=167 Identities=29% Similarity=0.387 Sum_probs=130.0
Q ss_pred CCCCChhhHHHHHHHHHHHHHHHhhcCCCceeecCCCccceEecCCCCceeccccceeecCCCcccccceeeeeccCCCC
Q 045315 256 KGLLCWGTRVRIIEGIAQGLLYLHQYSRLRVIHRDLKASNILLDKDMNPKISDFGMARMFGGDELQSNTKRIVGTYGYMS 335 (476)
Q Consensus 256 ~~~L~~~~~~~i~~qIa~gL~yLH~~~~~~ivH~DLkp~NILld~~~~~kL~DFGla~~~~~~~~~~~~~~~~gt~~y~a 335 (476)
...+++..+.+++.||+.||+|||+.+ |+||||||+||+++.++.+||+|||+++.+.............++..|+|
T Consensus 167 ~~~l~~~~~~~~~~qi~~aL~~lH~~~---ivHrDikp~Nill~~~~~vkL~DfG~a~~~~~~~~~~~~~~~~~~~~y~a 243 (337)
T cd05054 167 KEPLTLEDLISYSFQVARGMEFLASRK---CIHRDLAARNILLSENNVVKICDFGLARDIYKDPDYVRKGDARLPLKWMA 243 (337)
T ss_pred hcCCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCCcceEEEeCCCcEEEeccccchhcccCcchhhccCCCCCccccC
Confidence 457999999999999999999999998 99999999999999999999999999987643322222233455678999
Q ss_pred hhhhccCCCCccceEEeehhhhhhhhh-CCCCCCcCCCCchhhhhhhhhhhcCCCcccccCcccCCCCCHHHHHHHHHHH
Q 045315 336 PEYALRGLFSIKSDVFSFGVLLLETLS-SKKNTHFYNTDSLTLLGHAWNLWNDGRTWELMDPISQNGASYPILKRYINVA 414 (476)
Q Consensus 336 PE~l~~~~~s~ksDVwSlGvvl~ellt-G~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~l~~li 414 (476)
||++.+..++.++|||||||++||+++ |..||........ +. .....+.... .+......+.+++
T Consensus 244 PE~~~~~~~~~~~Di~SlGv~l~el~t~g~~p~~~~~~~~~-~~----~~~~~~~~~~---------~~~~~~~~~~~l~ 309 (337)
T cd05054 244 PESIFDKVYTTQSDVWSFGVLLWEIFSLGASPYPGVQIDEE-FC----RRLKEGTRMR---------APEYATPEIYSIM 309 (337)
T ss_pred cHHhcCCCCCccccHHHHHHHHHHHHHcCCCCCCCCCccHH-HH----HHHhccCCCC---------CCccCCHHHHHHH
Confidence 999999999999999999999999997 9988864322111 11 1111111100 0112235688999
Q ss_pred HHchhhcccCCCCHHHHHHHHhccc
Q 045315 415 LLCVQEKAADRPAMSEVVSMLSNEF 439 (476)
Q Consensus 415 ~~Cl~~dP~~RPt~~eVl~~L~~~~ 439 (476)
.+||+.+|++||++.||++.|+.+.
T Consensus 310 ~~cl~~~p~~RPs~~ell~~l~~~~ 334 (337)
T cd05054 310 LDCWHNNPEDRPTFSELVEILGDLL 334 (337)
T ss_pred HHHccCChhhCcCHHHHHHHHHHHH
Confidence 9999999999999999999999865
|
Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor (VEGFR) subfamily; catalytic (c) domain. The VEGFR subfamily consists of VEGFR1 (Flt1), VEGFR2 (Flk1), VEGFR3 (Flt4), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. In VEGFR3, the fifth Ig-like domain is replaced by a disulfide bridge. The binding of VEGFRs to their ligands, the VEGFs, leads to recepto |
| >cd05049 PTKc_Trk Catalytic domain of the Protein Tyrosine Kinases, Tropomyosin Related Kinases | Back alignment and domain information |
|---|
Probab=99.93 E-value=3.1e-26 Score=223.49 Aligned_cols=164 Identities=26% Similarity=0.383 Sum_probs=126.7
Q ss_pred CCCCChhhHHHHHHHHHHHHHHHhhcCCCceeecCCCccceEecCCCCceeccccceeecCCCcccccceeeeeccCCCC
Q 045315 256 KGLLCWGTRVRIIEGIAQGLLYLHQYSRLRVIHRDLKASNILLDKDMNPKISDFGMARMFGGDELQSNTKRIVGTYGYMS 335 (476)
Q Consensus 256 ~~~L~~~~~~~i~~qIa~gL~yLH~~~~~~ivH~DLkp~NILld~~~~~kL~DFGla~~~~~~~~~~~~~~~~gt~~y~a 335 (476)
...+++.++..++.||+.||+|||+++ ++||||||+||+++.++.+||+|||+++...............++..|+|
T Consensus 116 ~~~l~~~~~~~~~~~i~~~l~~lH~~~---i~h~dlkp~nili~~~~~~kl~d~g~~~~~~~~~~~~~~~~~~~~~~y~a 192 (280)
T cd05049 116 MGELTLSQLLQIAVQIASGMVYLASQH---FVHRDLATRNCLVGYDLVVKIGDFGMSRDVYTTDYYRVGGHTMLPIRWMP 192 (280)
T ss_pred cccccHHHHHHHHHHHHHHHHHHhhCC---eeccccccceEEEcCCCeEEECCcccceecccCcceecCCCCcccceecC
Confidence 356899999999999999999999998 99999999999999999999999999986533222111222345678999
Q ss_pred hhhhccCCCCccceEEeehhhhhhhhh-CCCCCCcCCCCchhhhhhhhhhhcCCCcccccCcccCCCCCHHHHHHHHHHH
Q 045315 336 PEYALRGLFSIKSDVFSFGVLLLETLS-SKKNTHFYNTDSLTLLGHAWNLWNDGRTWELMDPISQNGASYPILKRYINVA 414 (476)
Q Consensus 336 PE~l~~~~~s~ksDVwSlGvvl~ellt-G~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~l~~li 414 (476)
||.+.+..++.++|||||||++|||++ |+.||...... ..... ...+.... .+......+.+++
T Consensus 193 PE~~~~~~~~~~~Di~slG~il~e~~~~g~~p~~~~~~~--~~~~~----~~~~~~~~---------~~~~~~~~~~~li 257 (280)
T cd05049 193 PESIMYRKFTTESDVWSFGVVLWEIFTYGKQPWYGLSNE--EVIEC----ITQGRLLQ---------RPRTCPSEVYDIM 257 (280)
T ss_pred hhhhccCCcchhhhHHHHHHHHHHHHhcCCCCCCCCCHH--HHHHH----HHcCCcCC---------CCCCCCHHHHHHH
Confidence 999999999999999999999999998 99887543321 11111 11111111 1112345788999
Q ss_pred HHchhhcccCCCCHHHHHHHHhc
Q 045315 415 LLCVQEKAADRPAMSEVVSMLSN 437 (476)
Q Consensus 415 ~~Cl~~dP~~RPt~~eVl~~L~~ 437 (476)
.+||+.||++||++.||++.|++
T Consensus 258 ~~~l~~~p~~Rp~~~eil~~l~~ 280 (280)
T cd05049 258 LGCWKRDPQQRINIKDIHERLQK 280 (280)
T ss_pred HHHcCCCcccCCCHHHHHHHhhC
Confidence 99999999999999999999863
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase (Trk) subfamily; catalytic (c) domain. The Trk subfamily consists of TrkA, TrkB, TrkC, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Trk subfamily members are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, the nerve growth factor (NGF) family of neutrotrophins, leads to Trk receptor oligomerization and activation of the catalyt |
| >PTZ00267 NIMA-related protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=99.93 E-value=3.2e-26 Score=241.15 Aligned_cols=175 Identities=22% Similarity=0.260 Sum_probs=135.7
Q ss_pred cccceeeccCCCCC----------CCCCCChhhHHHHHHHHHHHHHHHhhcCCCceeecCCCccceEecCCCCceecccc
Q 045315 241 DEISFWYESYNNPT----------KKGLLCWGTRVRIIEGIAQGLLYLHQYSRLRVIHRDLKASNILLDKDMNPKISDFG 310 (476)
Q Consensus 241 ~~~~l~~Ey~~~~~----------~~~~L~~~~~~~i~~qIa~gL~yLH~~~~~~ivH~DLkp~NILld~~~~~kL~DFG 310 (476)
+..+++|||++.+. ...++++.++..++.||+.||+|||+.+ |+||||||+|||++.++.+||+|||
T Consensus 138 ~~~~lv~E~~~gg~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~aL~~lH~~~---ivHrDlkp~NIll~~~~~~kL~DFg 214 (478)
T PTZ00267 138 DKLLLIMEYGSGGDLNKQIKQRLKEHLPFQEYEVGLLFYQIVLALDEVHSRK---MMHRDLKSANIFLMPTGIIKLGDFG 214 (478)
T ss_pred CEEEEEEECCCCCCHHHHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHhCC---EEECCcCHHhEEECCCCcEEEEeCc
Confidence 46789999998432 2456899999999999999999999998 9999999999999999999999999
Q ss_pred ceeecCCCcccccceeeeeccCCCChhhhccCCCCccceEEeehhhhhhhhhCCCCCCcCCCCchhhhhhhhhhhcCCCc
Q 045315 311 MARMFGGDELQSNTKRIVGTYGYMSPEYALRGLFSIKSDVFSFGVLLLETLSSKKNTHFYNTDSLTLLGHAWNLWNDGRT 390 (476)
Q Consensus 311 la~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~s~ksDVwSlGvvl~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~ 390 (476)
+++.+.............||+.|+|||++.+..++.++|||||||++|||++|+.||..... ...... .. .+..
T Consensus 215 la~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~~l~el~tg~~Pf~~~~~--~~~~~~---~~-~~~~ 288 (478)
T PTZ00267 215 FSKQYSDSVSLDVASSFCGTPYYLAPELWERKRYSKKADMWSLGVILYELLTLHRPFKGPSQ--REIMQQ---VL-YGKY 288 (478)
T ss_pred CceecCCccccccccccCCCccccCHhHhCCCCCCcHHhHHHHHHHHHHHHhCCCCCCCCCH--HHHHHH---HH-hCCC
Confidence 99876543322223345689999999999999999999999999999999999999864321 111111 11 1111
Q ss_pred ccccCcccCCCCCHHHHHHHHHHHHHchhhcccCCCCHHHHHH
Q 045315 391 WELMDPISQNGASYPILKRYINVALLCVQEKAADRPAMSEVVS 433 (476)
Q Consensus 391 ~~~~d~~~~~~~~~~~~~~l~~li~~Cl~~dP~~RPt~~eVl~ 433 (476)
. + .+......+.+++.+||+.+|++||++++++.
T Consensus 289 ~----~-----~~~~~s~~~~~li~~~L~~dP~~Rps~~~~l~ 322 (478)
T PTZ00267 289 D----P-----FPCPVSSGMKALLDPLLSKNPALRPTTQQLLH 322 (478)
T ss_pred C----C-----CCccCCHHHHHHHHHHhccChhhCcCHHHHHh
Confidence 0 0 11122356889999999999999999999864
|
|
| >cd05116 PTKc_Syk Catalytic domain of the Protein Tyrosine Kinase, Spleen tyrosine kinase | Back alignment and domain information |
|---|
Probab=99.93 E-value=1.8e-26 Score=222.71 Aligned_cols=179 Identities=26% Similarity=0.335 Sum_probs=135.7
Q ss_pred ccceeeccCCCC------CCCCCCChhhHHHHHHHHHHHHHHHhhcCCCceeecCCCccceEecCCCCceeccccceeec
Q 045315 242 EISFWYESYNNP------TKKGLLCWGTRVRIIEGIAQGLLYLHQYSRLRVIHRDLKASNILLDKDMNPKISDFGMARMF 315 (476)
Q Consensus 242 ~~~l~~Ey~~~~------~~~~~L~~~~~~~i~~qIa~gL~yLH~~~~~~ivH~DLkp~NILld~~~~~kL~DFGla~~~ 315 (476)
..++++||++.. .+.+.+++..+.+++.|++.||+|||+++ ++||||||+||+++.++.+||+|||+++..
T Consensus 69 ~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~i~~qi~~al~~lH~~~---i~H~dlkp~nill~~~~~~kl~Dfg~~~~~ 145 (257)
T cd05116 69 SWMLVMELAELGPLNKFLQKNKHVTEKNITELVHQVSMGMKYLEETN---FVHRDLAARNVLLVTQHYAKISDFGLSKAL 145 (257)
T ss_pred CcEEEEecCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCC---EeecccchhhEEEcCCCeEEECCCcccccc
Confidence 456788888833 13457899999999999999999999998 999999999999999999999999999876
Q ss_pred CCCcccc-cceeeeeccCCCChhhhccCCCCccceEEeehhhhhhhhh-CCCCCCcCCCCchhhhhhhhhhhcCCCcccc
Q 045315 316 GGDELQS-NTKRIVGTYGYMSPEYALRGLFSIKSDVFSFGVLLLETLS-SKKNTHFYNTDSLTLLGHAWNLWNDGRTWEL 393 (476)
Q Consensus 316 ~~~~~~~-~~~~~~gt~~y~aPE~l~~~~~s~ksDVwSlGvvl~ellt-G~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~ 393 (476)
....... ......++..|+|||.+....++.++|+|||||++||+++ |+.||...... .... ....+....
T Consensus 146 ~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~t~g~~p~~~~~~~--~~~~----~i~~~~~~~- 218 (257)
T cd05116 146 GADENYYKAKTHGKWPVKWYAPECMNYYKFSSKSDVWSFGVLMWEAFSYGQKPYKGMKGN--EVTQ----MIESGERME- 218 (257)
T ss_pred CCCCCeeeecCCCCCCccccCHhHhccCCcCchhHHHHHHHHHHHHHhCCCCCCCCCCHH--HHHH----HHHCCCCCC-
Confidence 4432211 1111233578999999988889999999999999999997 89888643211 1111 111111111
Q ss_pred cCcccCCCCCHHHHHHHHHHHHHchhhcccCCCCHHHHHHHHhcc
Q 045315 394 MDPISQNGASYPILKRYINVALLCVQEKAADRPAMSEVVSMLSNE 438 (476)
Q Consensus 394 ~d~~~~~~~~~~~~~~l~~li~~Cl~~dP~~RPt~~eVl~~L~~~ 438 (476)
.+......+.+++.+||+.||++||++.+|.+.|++-
T Consensus 219 --------~~~~~~~~l~~li~~~~~~~p~~Rp~~~~i~~~l~~~ 255 (257)
T cd05116 219 --------CPQRCPPEMYDLMKLCWTYGVDERPGFAVVELRLRNY 255 (257)
T ss_pred --------CCCCCCHHHHHHHHHHhccCchhCcCHHHHHHHHhcc
Confidence 1122345688999999999999999999999999874
|
Protein Tyrosine Kinase (PTK) family; Spleen tyrosine kinase (Syk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Syk, together with Zap-70, form the Syk subfamily of kinases which are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. Syk was first cloned from the spleen, and its function in hematopoietic cells is well-established. Syk is involved in the signaling downstream of activated receptors (including B-cell and Fc receptors) that contain ITAMs (immunoreceptor tyr activation motifs), leading to processes such as cell proliferatio |
| >KOG0585 consensus Ca2+/calmodulin-dependent protein kinase kinase beta and related serine/threonine protein kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.93 E-value=2.8e-26 Score=226.39 Aligned_cols=180 Identities=23% Similarity=0.296 Sum_probs=137.1
Q ss_pred ccccceeeccCCCC-----CCCCC-CChhhHHHHHHHHHHHHHHHhhcCCCceeecCCCccceEecCCCCceecccccee
Q 045315 240 KDEISFWYESYNNP-----TKKGL-LCWGTRVRIIEGIAQGLLYLHQYSRLRVIHRDLKASNILLDKDMNPKISDFGMAR 313 (476)
Q Consensus 240 ~~~~~l~~Ey~~~~-----~~~~~-L~~~~~~~i~~qIa~gL~yLH~~~~~~ivH~DLkp~NILld~~~~~kL~DFGla~ 313 (476)
.+..|+|+||+..+ ...++ |++.++.+++++++.||+|||.++ ||||||||+|+||+.++.+||+|||.+.
T Consensus 182 s~~~YlVley~s~G~v~w~p~d~~els~~~Ar~ylrDvv~GLEYLH~Qg---iiHRDIKPsNLLl~~~g~VKIsDFGVs~ 258 (576)
T KOG0585|consen 182 SDKLYLVLEYCSKGEVKWCPPDKPELSEQQARKYLRDVVLGLEYLHYQG---IIHRDIKPSNLLLSSDGTVKISDFGVSN 258 (576)
T ss_pred cCceEEEEEeccCCccccCCCCcccccHHHHHHHHHHHHHHHHHHHhcC---eeccccchhheEEcCCCcEEeeccceee
Confidence 35789999999822 22334 999999999999999999999999 9999999999999999999999999998
Q ss_pred ecCCC---cccccceeeeeccCCCChhhhccCC----CCccceEEeehhhhhhhhhCCCCCCcCCCCchhhhhhhhhhhc
Q 045315 314 MFGGD---ELQSNTKRIVGTYGYMSPEYALRGL----FSIKSDVFSFGVLLLETLSSKKNTHFYNTDSLTLLGHAWNLWN 386 (476)
Q Consensus 314 ~~~~~---~~~~~~~~~~gt~~y~aPE~l~~~~----~s~ksDVwSlGvvl~elltG~~p~~~~~~~~~~~~~~~~~~~~ 386 (476)
.+... ..........||+.|+|||.+.++. .+.+.||||+||+||.++.|+.||-.... ..+..
T Consensus 259 ~~~~~~~~~~d~~L~~tvGTPAF~APE~c~~~~~~~~~g~a~DiWalGVTLYCllfG~~PF~~~~~--~~l~~------- 329 (576)
T KOG0585|consen 259 EFPQGSDEGSDDQLSRTVGTPAFFAPELCSGGNSFSYSGFALDIWALGVTLYCLLFGQLPFFDDFE--LELFD------- 329 (576)
T ss_pred ecccCCccccHHHHhhcCCCccccchHhhcCCCCccccchhhhhhhhhhhHHHhhhccCCcccchH--HHHHH-------
Confidence 77322 1122223468999999999987632 35789999999999999999999853211 11110
Q ss_pred CCCcccccCcccCCCCCHHHHHHHHHHHHHchhhcccCCCCHHHHHHHHh
Q 045315 387 DGRTWELMDPISQNGASYPILKRYINVALLCVQEKAADRPAMSEVVSMLS 436 (476)
Q Consensus 387 ~~~~~~~~d~~~~~~~~~~~~~~l~~li~~Cl~~dP~~RPt~~eVl~~L~ 436 (476)
.++...+.-....++.+.+.+|+.++|++||++|.+..+|....-
T Consensus 330 -----KIvn~pL~fP~~pe~~e~~kDli~~lL~KdP~~Ri~l~~ik~Hpw 374 (576)
T KOG0585|consen 330 -----KIVNDPLEFPENPEINEDLKDLIKRLLEKDPEQRITLPDIKLHPW 374 (576)
T ss_pred -----HHhcCcccCCCcccccHHHHHHHHHHhhcChhheeehhhheecce
Confidence 111111222222355678899999999999999999999876653
|
|
| >cd05091 PTKc_Ror2 Catalytic domain of the Protein Tyrosine Kinase, Receptor tyrosine kinase-like Orphan Receptor 2 | Back alignment and domain information |
|---|
Probab=99.93 E-value=2.3e-26 Score=225.12 Aligned_cols=164 Identities=27% Similarity=0.382 Sum_probs=125.8
Q ss_pred CCCCChhhHHHHHHHHHHHHHHHhhcCCCceeecCCCccceEecCCCCceeccccceeecCCCcccccceeeeeccCCCC
Q 045315 256 KGLLCWGTRVRIIEGIAQGLLYLHQYSRLRVIHRDLKASNILLDKDMNPKISDFGMARMFGGDELQSNTKRIVGTYGYMS 335 (476)
Q Consensus 256 ~~~L~~~~~~~i~~qIa~gL~yLH~~~~~~ivH~DLkp~NILld~~~~~kL~DFGla~~~~~~~~~~~~~~~~gt~~y~a 335 (476)
+..+++..+.+++.|++.||+|||+++ ++||||||+||++++++.+||+|||+++...............++..|+|
T Consensus 118 ~~~~~~~~~~~~~~ql~~aL~~lH~~g---i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~a 194 (283)
T cd05091 118 KSTLEPADFVHIVTQIAAGMEFLSSHH---VVHKDLATRNVLVFDKLNVKISDLGLFREVYAADYYKLMGNSLLPIRWMS 194 (283)
T ss_pred ccccCHHHHHHHHHHHHHHHHHHHHcC---ccccccchhheEecCCCceEecccccccccccchheeeccCccCCccccC
Confidence 456899999999999999999999998 99999999999999999999999999886543322222222345778999
Q ss_pred hhhhccCCCCccceEEeehhhhhhhhh-CCCCCCcCCCCchhhhhhhhhhhcCCCcccccCcccCCCCCHHHHHHHHHHH
Q 045315 336 PEYALRGLFSIKSDVFSFGVLLLETLS-SKKNTHFYNTDSLTLLGHAWNLWNDGRTWELMDPISQNGASYPILKRYINVA 414 (476)
Q Consensus 336 PE~l~~~~~s~ksDVwSlGvvl~ellt-G~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~l~~li 414 (476)
||.+.++.++.++|||||||++|||++ |..|+..... ..... ....+... ..+......+.+++
T Consensus 195 PE~~~~~~~~~~~Dv~slG~~l~el~~~g~~p~~~~~~--~~~~~----~i~~~~~~---------~~~~~~~~~~~~li 259 (283)
T cd05091 195 PEAIMYGKFSIDSDIWSYGVVLWEVFSYGLQPYCGYSN--QDVIE----MIRNRQVL---------PCPDDCPAWVYTLM 259 (283)
T ss_pred HHHHhcCCCCcchhHHHHHHHHHHHHcCCCCCCCCCCH--HHHHH----HHHcCCcC---------CCCCCCCHHHHHHH
Confidence 999988889999999999999999998 7777654321 11111 11111111 11122345688999
Q ss_pred HHchhhcccCCCCHHHHHHHHhc
Q 045315 415 LLCVQEKAADRPAMSEVVSMLSN 437 (476)
Q Consensus 415 ~~Cl~~dP~~RPt~~eVl~~L~~ 437 (476)
.+||+.+|++||++.+|++.|+.
T Consensus 260 ~~cl~~~p~~RP~~~~i~~~l~~ 282 (283)
T cd05091 260 LECWNEFPSRRPRFKDIHSRLRT 282 (283)
T ss_pred HHHhCCCcccCCCHHHHHHHhhC
Confidence 99999999999999999999975
|
Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor 2 (Ror2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase cataly |
| >cd07871 STKc_PCTAIRE3 Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-3 kinase | Back alignment and domain information |
|---|
Probab=99.93 E-value=2.5e-26 Score=225.99 Aligned_cols=185 Identities=19% Similarity=0.251 Sum_probs=130.7
Q ss_pred ccceeeccCCC------CCCCCCCChhhHHHHHHHHHHHHHHHhhcCCCceeecCCCccceEecCCCCceeccccceeec
Q 045315 242 EISFWYESYNN------PTKKGLLCWGTRVRIIEGIAQGLLYLHQYSRLRVIHRDLKASNILLDKDMNPKISDFGMARMF 315 (476)
Q Consensus 242 ~~~l~~Ey~~~------~~~~~~L~~~~~~~i~~qIa~gL~yLH~~~~~~ivH~DLkp~NILld~~~~~kL~DFGla~~~ 315 (476)
..++++||++. ......+++.++..++.||+.||+|||+++ |+||||||+|||++.++.+||+|||+++..
T Consensus 77 ~~~lv~e~~~~~l~~~l~~~~~~~~~~~~~~~~~qi~~aL~~LH~~~---ivH~dlkp~Nil~~~~~~~kl~DfG~~~~~ 153 (288)
T cd07871 77 CLTLVFEYLDSDLKQYLDNCGNLMSMHNVKIFMFQLLRGLSYCHKRK---ILHRDLKPQNLLINEKGELKLADFGLARAK 153 (288)
T ss_pred eEEEEEeCCCcCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCC---cccCCCCHHHEEECCCCCEEECcCcceeec
Confidence 45678888872 123446889999999999999999999998 999999999999999999999999999865
Q ss_pred CCCcccccceeeeeccCCCChhhhcc-CCCCccceEEeehhhhhhhhhCCCCCCcCCCCchhhhhhhhhh--------hc
Q 045315 316 GGDELQSNTKRIVGTYGYMSPEYALR-GLFSIKSDVFSFGVLLLETLSSKKNTHFYNTDSLTLLGHAWNL--------WN 386 (476)
Q Consensus 316 ~~~~~~~~~~~~~gt~~y~aPE~l~~-~~~s~ksDVwSlGvvl~elltG~~p~~~~~~~~~~~~~~~~~~--------~~ 386 (476)
..... ......++..|+|||.+.+ ..++.++||||+||++|||++|+.||........ ....... +.
T Consensus 154 ~~~~~--~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~~l~~l~~g~~pf~~~~~~~~--~~~~~~~~~~~~~~~~~ 229 (288)
T cd07871 154 SVPTK--TYSNEVVTLWYRPPDVLLGSTEYSTPIDMWGVGCILYEMATGRPMFPGSTVKEE--LHLIFRLLGTPTEETWP 229 (288)
T ss_pred cCCCc--cccCceecccccChHHhcCCcccCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHH--HHHHHHHhCCCChHHhh
Confidence 43221 1223467899999998875 5689999999999999999999999865432111 1111000 00
Q ss_pred C----CCcccccCcccCCC----CCHHHHHHHHHHHHHchhhcccCCCCHHHHHH
Q 045315 387 D----GRTWELMDPISQNG----ASYPILKRYINVALLCVQEKAADRPAMSEVVS 433 (476)
Q Consensus 387 ~----~~~~~~~d~~~~~~----~~~~~~~~l~~li~~Cl~~dP~~RPt~~eVl~ 433 (476)
. ........+..... ........+++++.+||+.||.+|||++|+++
T Consensus 230 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dll~~mL~~dp~~R~t~~~~l~ 284 (288)
T cd07871 230 GITSNEEFRSYLFPQYRAQPLINHAPRLDTDGIDLLSSLLLYETKSRISAEAALR 284 (288)
T ss_pred ccccchhhhccccCccCCCchHHhCCCCCHHHHHHHHHhcCcCcccCCCHHHHhc
Confidence 0 00000010100000 00112356789999999999999999999874
|
Serine/Threonine Kinases (STKs), PCTAIRE-3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-3 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-3 shows a restricted pattern of expression and is present in brain, kidney, and intestine. It is elevated in Alzheimer's disease (AD) and has been shown to associate with paired helical filament |
| >cd05600 STKc_Sid2p_Dbf2p Catalytic domain of Fungal Sid2p- and Dbf2p-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=99.93 E-value=4.3e-26 Score=229.01 Aligned_cols=178 Identities=18% Similarity=0.270 Sum_probs=135.7
Q ss_pred cccceeeccCCCC------CCCCCCChhhHHHHHHHHHHHHHHHhhcCCCceeecCCCccceEecCCCCceeccccceee
Q 045315 241 DEISFWYESYNNP------TKKGLLCWGTRVRIIEGIAQGLLYLHQYSRLRVIHRDLKASNILLDKDMNPKISDFGMARM 314 (476)
Q Consensus 241 ~~~~l~~Ey~~~~------~~~~~L~~~~~~~i~~qIa~gL~yLH~~~~~~ivH~DLkp~NILld~~~~~kL~DFGla~~ 314 (476)
+..+++|||++.. .....+++.++..++.||+.||+|||+.+ |+||||||+||+++.++.+||+|||++..
T Consensus 74 ~~~~lv~e~~~g~~L~~~l~~~~~l~~~~~~~~~~qi~~~l~~lH~~~---ivH~dlkp~Nil~~~~~~~kL~Dfg~a~~ 150 (333)
T cd05600 74 EYLYLAMEYVPGGDFRTLLNNLGVLSEDHARFYMAEMFEAVDALHELG---YIHRDLKPENFLIDASGHIKLTDFGLSKG 150 (333)
T ss_pred CEEEEEEeCCCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCC---ccccCCCHHHEEECCCCCEEEEeCcCCcc
Confidence 4678999999843 23457899999999999999999999999 99999999999999999999999999976
Q ss_pred cCCCcccccceeeeeccCCCChhhhccCCCCccceEEeehhhhhhhhhCCCCCCcCCCCchhhhhhhhhhhcCCCccccc
Q 045315 315 FGGDELQSNTKRIVGTYGYMSPEYALRGLFSIKSDVFSFGVLLLETLSSKKNTHFYNTDSLTLLGHAWNLWNDGRTWELM 394 (476)
Q Consensus 315 ~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~s~ksDVwSlGvvl~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 394 (476)
... ......|++.|+|||++.+..++.++|||||||++|||++|+.||....... ...... .+. ...
T Consensus 151 ~~~-----~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~ell~g~~pf~~~~~~~--~~~~i~-~~~-----~~~ 217 (333)
T cd05600 151 IVT-----YANSVVGSPDYMAPEVLRGKGYDFTVDYWSLGCMLYEFLCGFPPFSGSTPNE--TWENLK-YWK-----ETL 217 (333)
T ss_pred ccc-----ccCCcccCccccChhHhcCCCCCCccceecchHHHhhhhhCCCCCCCCCHHH--HHHHHH-hcc-----ccc
Confidence 543 1223568999999999998899999999999999999999999986543211 111000 000 000
Q ss_pred CcccCCCCCHHHHHHHHHHHHHchhhcccCCCCHHHHHHH
Q 045315 395 DPISQNGASYPILKRYINVALLCVQEKAADRPAMSEVVSM 434 (476)
Q Consensus 395 d~~~~~~~~~~~~~~l~~li~~Cl~~dP~~RPt~~eVl~~ 434 (476)
...............+.+++.+||+.+|.+||+++++++.
T Consensus 218 ~~~~~~~~~~~~s~~~~~li~~~l~~~~~rr~s~~~ll~h 257 (333)
T cd05600 218 QRPVYDDPRFNLSDEAWDLITKLINDPSRRFGSLEDIKNH 257 (333)
T ss_pred cCCCCCccccccCHHHHHHHHHHhhChhhhcCCHHHHHhC
Confidence 0000011112335678899999999999999999999865
|
Serine/Threonine Kinases (STKs), ROCK- and NDR-like subfamily, fungal Sid2p- and Dbf2p-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sid2p- and Dbf2p-like group is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This group contains fungal kinases including Schizosaccharomyces pombe Sid2p and Saccharomyces cerevisiae Dbf2p. Group members show similarity to NDR kinases in that they contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Sid2p plays a crucial role in the septum initiation network (SIN) and in the initiation of cytokinesis. |
| >cd05618 STKc_aPKC_iota Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C iota | Back alignment and domain information |
|---|
Probab=99.93 E-value=6.9e-26 Score=227.36 Aligned_cols=173 Identities=20% Similarity=0.269 Sum_probs=130.2
Q ss_pred cccceeeccCCCCC------CCCCCChhhHHHHHHHHHHHHHHHhhcCCCceeecCCCccceEecCCCCceeccccceee
Q 045315 241 DEISFWYESYNNPT------KKGLLCWGTRVRIIEGIAQGLLYLHQYSRLRVIHRDLKASNILLDKDMNPKISDFGMARM 314 (476)
Q Consensus 241 ~~~~l~~Ey~~~~~------~~~~L~~~~~~~i~~qIa~gL~yLH~~~~~~ivH~DLkp~NILld~~~~~kL~DFGla~~ 314 (476)
+..+++|||++... +.+.+++..+..++.||+.||+|||+++ |+||||||+||+++.++.+||+|||+++.
T Consensus 69 ~~~~lv~E~~~~~~L~~~~~~~~~l~~~~~~~i~~qi~~~l~~lH~~~---ivH~Dikp~Nili~~~~~~kL~DfG~~~~ 145 (329)
T cd05618 69 SRLFFVIEYVNGGDLMFHMQRQRKLPEEHARFYSAEISLALNYLHERG---IIYRDLKLDNVLLDSEGHIKLTDYGMCKE 145 (329)
T ss_pred CEEEEEEeCCCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCC---eeeCCCCHHHEEECCCCCEEEeeCCcccc
Confidence 46789999998432 3467999999999999999999999999 99999999999999999999999999875
Q ss_pred cCCCcccccceeeeeccCCCChhhhccCCCCccceEEeehhhhhhhhhCCCCCCcCCCC---chhhhhhhhhhhcCCCcc
Q 045315 315 FGGDELQSNTKRIVGTYGYMSPEYALRGLFSIKSDVFSFGVLLLETLSSKKNTHFYNTD---SLTLLGHAWNLWNDGRTW 391 (476)
Q Consensus 315 ~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~s~ksDVwSlGvvl~elltG~~p~~~~~~~---~~~~~~~~~~~~~~~~~~ 391 (476)
..... .......|+..|+|||++.+..++.++|||||||++|||++|+.||...... .................
T Consensus 146 ~~~~~--~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~Pf~~~~~~~~~~~~~~~~~~~~i~~~~~- 222 (329)
T cd05618 146 GLRPG--DTTSTFCGTPNYIAPEILRGEDYGFSVDWWALGVLMFEMMAGRSPFDIVGSSDNPDQNTEDYLFQVILEKQI- 222 (329)
T ss_pred ccCCC--CccccccCCccccCHHHHcCCCCCCccceecccHHHHHHhhCCCCCccCCCcCCcccccHHHHHHHHhcCCC-
Confidence 32211 1122356899999999999999999999999999999999999998632211 11111111111111111
Q ss_pred cccCcccCCCCCHHHHHHHHHHHHHchhhcccCCCCH
Q 045315 392 ELMDPISQNGASYPILKRYINVALLCVQEKAADRPAM 428 (476)
Q Consensus 392 ~~~d~~~~~~~~~~~~~~l~~li~~Cl~~dP~~RPt~ 428 (476)
..+......+.+++.+||+.||++||++
T Consensus 223 ---------~~p~~~~~~~~~ll~~~L~~dP~~R~~~ 250 (329)
T cd05618 223 ---------RIPRSLSVKAASVLKSFLNKDPKERLGC 250 (329)
T ss_pred ---------CCCCCCCHHHHHHHHHHhcCCHHHcCCC
Confidence 0112234567899999999999999983
|
Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, iota isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. There are two aPKC isoforms, zeta and iota. PKC-iota is directly implicated in carcinogenesis. It is critical to oncogenic signaling mediated by Ras and Bcr-Abl. The PKC-iota gene is the target o |
| >cd07863 STKc_CDK4 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 4 | Back alignment and domain information |
|---|
Probab=99.93 E-value=6e-26 Score=222.58 Aligned_cols=184 Identities=21% Similarity=0.292 Sum_probs=131.3
Q ss_pred ccceeeccCCC-------CCCCCCCChhhHHHHHHHHHHHHHHHhhcCCCceeecCCCccceEecCCCCceeccccceee
Q 045315 242 EISFWYESYNN-------PTKKGLLCWGTRVRIIEGIAQGLLYLHQYSRLRVIHRDLKASNILLDKDMNPKISDFGMARM 314 (476)
Q Consensus 242 ~~~l~~Ey~~~-------~~~~~~L~~~~~~~i~~qIa~gL~yLH~~~~~~ivH~DLkp~NILld~~~~~kL~DFGla~~ 314 (476)
..++++||++. ......+++.++..++.||+.||+|||+.+ ++||||||+||+++.++.+||+|||+++.
T Consensus 81 ~~~lv~e~~~~~l~~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~---ivH~dikp~Nili~~~~~~kl~dfg~~~~ 157 (288)
T cd07863 81 KVTLVFEHVDQDLRTYLDKVPPPGLPAETIKDLMRQFLRGLDFLHANC---IVHRDLKPENILVTSGGQVKLADFGLARI 157 (288)
T ss_pred eEEEEEcccccCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCCHHHEEECCCCCEEECccCcccc
Confidence 35677787762 122345899999999999999999999999 99999999999999999999999999987
Q ss_pred cCCCcccccceeeeeccCCCChhhhccCCCCccceEEeehhhhhhhhhCCCCCCcCCCCchhhhhhhhhhhc---CCCcc
Q 045315 315 FGGDELQSNTKRIVGTYGYMSPEYALRGLFSIKSDVFSFGVLLLETLSSKKNTHFYNTDSLTLLGHAWNLWN---DGRTW 391 (476)
Q Consensus 315 ~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~s~ksDVwSlGvvl~elltG~~p~~~~~~~~~~~~~~~~~~~~---~~~~~ 391 (476)
...... .....++..|+|||.+.+..++.++|||||||++|||++|++||....... .......... .....
T Consensus 158 ~~~~~~---~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~~l~~l~~g~~~f~~~~~~~--~~~~~~~~~~~~~~~~~~ 232 (288)
T cd07863 158 YSCQMA---LTPVVVTLWYRAPEVLLQSTYATPVDMWSVGCIFAEMFRRKPLFCGNSEAD--QLGKIFDLIGLPPEDDWP 232 (288)
T ss_pred ccCccc---CCCccccccccCchHhhCCCCCCcchhhhHHHHHHHHHhCCcCcCCCCHHH--HHHHHHHHhCCCChhhCc
Confidence 643221 122467889999999998899999999999999999999999986433111 0000000000 00000
Q ss_pred ---c----ccCccc---CCCCCHHHHHHHHHHHHHchhhcccCCCCHHHHHH
Q 045315 392 ---E----LMDPIS---QNGASYPILKRYINVALLCVQEKAADRPAMSEVVS 433 (476)
Q Consensus 392 ---~----~~d~~~---~~~~~~~~~~~l~~li~~Cl~~dP~~RPt~~eVl~ 433 (476)
. ...+.. .........+.+.+++.+||+.||++|||+.|++.
T Consensus 233 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~~~l~ 284 (288)
T cd07863 233 RDVTLPRGAFSPRGPRPVQSVVPEIEESGAQLLLEMLTFNPHKRISAFRALQ 284 (288)
T ss_pred ccccccccccCCCCCCchHHhCcCcCHHHHHHHHHHhccCcccCCCHHHHhc
Confidence 0 000000 00011123456789999999999999999999874
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 4 (CDK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK4 partners with all three D-type cyclins (D1, D2, and D3) and is also regulated by INK4 inhibitors. It is active towards the retinoblastoma (pRb) protein and plays a role in regulating the early G1 phase of the cell cycle. It is expressed ubiquitou |
| >KOG0694 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.93 E-value=1.7e-26 Score=237.40 Aligned_cols=166 Identities=23% Similarity=0.326 Sum_probs=138.3
Q ss_pred ccccceeeccCCCC-----CCCCCCChhhHHHHHHHHHHHHHHHhhcCCCceeecCCCccceEecCCCCceeccccceee
Q 045315 240 KDEISFWYESYNNP-----TKKGLLCWGTRVRIIEGIAQGLLYLHQYSRLRVIHRDLKASNILLDKDMNPKISDFGMARM 314 (476)
Q Consensus 240 ~~~~~l~~Ey~~~~-----~~~~~L~~~~~~~i~~qIa~gL~yLH~~~~~~ivH~DLkp~NILld~~~~~kL~DFGla~~ 314 (476)
++..+++|||...+ .+...+++..+.-++..|+.||+|||+++ |||||||.+|||||.+|.+||+|||+++.
T Consensus 441 ~~~l~fvmey~~Ggdm~~~~~~~~F~e~rarfyaAev~l~L~fLH~~~---IIYRDlKLdNiLLD~eGh~kiADFGlcKe 517 (694)
T KOG0694|consen 441 KEHLFFVMEYVAGGDLMHHIHTDVFSEPRARFYAAEVVLGLQFLHENG---IIYRDLKLDNLLLDTEGHVKIADFGLCKE 517 (694)
T ss_pred CCeEEEEEEecCCCcEEEEEecccccHHHHHHHHHHHHHHHHHHHhcC---ceeeecchhheEEcccCcEEecccccccc
Confidence 45788999999843 34678999999999999999999999999 99999999999999999999999999986
Q ss_pred cCCCcccccceeeeeccCCCChhhhccCCCCccceEEeehhhhhhhhhCCCCCCcCCCCchhhhhhhhhhhcCCCccccc
Q 045315 315 FGGDELQSNTKRIVGTYGYMSPEYALRGLFSIKSDVFSFGVLLLETLSSKKNTHFYNTDSLTLLGHAWNLWNDGRTWELM 394 (476)
Q Consensus 315 ~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~s~ksDVwSlGvvl~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 394 (476)
-... ...+.++.||+.|+|||++.+..|+...|.|||||++|||+.|..||+..+++.. .
T Consensus 518 ~m~~--g~~TsTfCGTpey~aPEil~e~~Yt~aVDWW~lGVLlyeML~Gq~PF~gddEee~------------------F 577 (694)
T KOG0694|consen 518 GMGQ--GDRTSTFCGTPEFLAPEVLTEQSYTRAVDWWGLGVLLYEMLVGESPFPGDDEEEV------------------F 577 (694)
T ss_pred cCCC--CCccccccCChhhcChhhhccCcccchhhHHHHHHHHHHHHcCCCCCCCCCHHHH------------------H
Confidence 4322 2345668999999999999999999999999999999999999999987654321 1
Q ss_pred CcccCC--CCCHHHHHHHHHHHHHchhhcccCCCCH
Q 045315 395 DPISQN--GASYPILKRYINVALLCVQEKAADRPAM 428 (476)
Q Consensus 395 d~~~~~--~~~~~~~~~l~~li~~Cl~~dP~~RPt~ 428 (476)
|..+.+ .++.-...+.+.|+.+++..+|++|.-+
T Consensus 578 dsI~~d~~~yP~~ls~ea~~il~~ll~k~p~kRLG~ 613 (694)
T KOG0694|consen 578 DSIVNDEVRYPRFLSKEAIAIMRRLLRKNPEKRLGS 613 (694)
T ss_pred HHHhcCCCCCCCcccHHHHHHHHHHhccCcccccCC
Confidence 222211 2233346788999999999999999865
|
|
| >cd07869 STKc_PFTAIRE1 Catalytic domain of the Serine/Threonine Kinase, PFTAIRE-1 kinase | Back alignment and domain information |
|---|
Probab=99.93 E-value=5.9e-26 Score=224.83 Aligned_cols=187 Identities=19% Similarity=0.211 Sum_probs=130.6
Q ss_pred cccceeeccCCC------CCCCCCCChhhHHHHHHHHHHHHHHHhhcCCCceeecCCCccceEecCCCCceeccccceee
Q 045315 241 DEISFWYESYNN------PTKKGLLCWGTRVRIIEGIAQGLLYLHQYSRLRVIHRDLKASNILLDKDMNPKISDFGMARM 314 (476)
Q Consensus 241 ~~~~l~~Ey~~~------~~~~~~L~~~~~~~i~~qIa~gL~yLH~~~~~~ivH~DLkp~NILld~~~~~kL~DFGla~~ 314 (476)
+..+++|||++. ......++..++..++.||+.||+|||+++ |+||||||+||+++.++.+||+|||++..
T Consensus 76 ~~~~lv~e~~~~~l~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~---ivH~dlkp~Nill~~~~~~kl~Dfg~~~~ 152 (303)
T cd07869 76 ETLTLVFEYVHTDLCQYMDKHPGGLHPENVKLFLFQLLRGLSYIHQRY---ILHRDLKPQNLLISDTGELKLADFGLARA 152 (303)
T ss_pred CeEEEEEECCCcCHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCCHHHEEECCCCCEEECCCCccee
Confidence 356788899872 123456899999999999999999999999 99999999999999999999999999976
Q ss_pred cCCCcccccceeeeeccCCCChhhhcc-CCCCccceEEeehhhhhhhhhCCCCCCcCCCCchhhhhhhhhhhcC---CCc
Q 045315 315 FGGDELQSNTKRIVGTYGYMSPEYALR-GLFSIKSDVFSFGVLLLETLSSKKNTHFYNTDSLTLLGHAWNLWND---GRT 390 (476)
Q Consensus 315 ~~~~~~~~~~~~~~gt~~y~aPE~l~~-~~~s~ksDVwSlGvvl~elltG~~p~~~~~~~~~~~~~~~~~~~~~---~~~ 390 (476)
...... ......++..|+|||.+.+ ..++.++|||||||++|||++|+.||.........+.... ..... ...
T Consensus 153 ~~~~~~--~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~~~~-~~~~~~~~~~~ 229 (303)
T cd07869 153 KSVPSH--TYSNEVVTLWYRPPDVLLGSTEYSTCLDMWGVGCIFVEMIQGVAAFPGMKDIQDQLERIF-LVLGTPNEDTW 229 (303)
T ss_pred ccCCCc--cCCCCcccCCCCChHHHcCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCccHHHHHHHHH-HHhCCCChhhc
Confidence 432211 1122467899999998875 4578999999999999999999999975432111111110 00000 000
Q ss_pred -----ccccCcc-cC--CCCCH-------HHHHHHHHHHHHchhhcccCCCCHHHHHH
Q 045315 391 -----WELMDPI-SQ--NGASY-------PILKRYINVALLCVQEKAADRPAMSEVVS 433 (476)
Q Consensus 391 -----~~~~d~~-~~--~~~~~-------~~~~~l~~li~~Cl~~dP~~RPt~~eVl~ 433 (476)
.....+. .. ..... .....+.+++.+||+.||++|||+.|+++
T Consensus 230 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dli~~mL~~dp~~R~s~~~~l~ 287 (303)
T cd07869 230 PGVHSLPHFKPERFTLYSPKNLRQAWNKLSYVNHAEDLASKLLQCFPKNRLSAQAALS 287 (303)
T ss_pred cchhhccccccccccccCCccHHHHhhccCCChHHHHHHHHHhccCchhccCHHHHhc
Confidence 0000000 00 00000 11246779999999999999999999875
|
Serine/Threonine Kinases (STKs), PFTAIRE-1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PFTAIRE-1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PFTAIRE-1 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PFTAIRE-1 is widely expressed except in the spleen and thymus. It is highly expressed in the brain, heart, pancreas, testis, and ovary, and is localized in the cytoplasm. It is regulated by cyclin D3 an |
| >cd05591 STKc_nPKC_epsilon Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C epsilon | Back alignment and domain information |
|---|
Probab=99.93 E-value=7.7e-26 Score=226.09 Aligned_cols=173 Identities=23% Similarity=0.278 Sum_probs=133.5
Q ss_pred cccceeeccCCCC------CCCCCCChhhHHHHHHHHHHHHHHHhhcCCCceeecCCCccceEecCCCCceeccccceee
Q 045315 241 DEISFWYESYNNP------TKKGLLCWGTRVRIIEGIAQGLLYLHQYSRLRVIHRDLKASNILLDKDMNPKISDFGMARM 314 (476)
Q Consensus 241 ~~~~l~~Ey~~~~------~~~~~L~~~~~~~i~~qIa~gL~yLH~~~~~~ivH~DLkp~NILld~~~~~kL~DFGla~~ 314 (476)
+.++++|||++.. .+...+++..+..++.||+.||+|||+++ |+||||||+||+++.++.+||+|||++..
T Consensus 69 ~~~~lv~E~~~~~~L~~~l~~~~~~~~~~~~~~~~qi~~aL~~LH~~~---ivHrDikp~Nill~~~~~~kL~Dfg~~~~ 145 (321)
T cd05591 69 DRLFFVMEYVNGGDLMFQIQRSRKFDEPRSRFYAAEVTLALMFLHRHG---VIYRDLKLDNILLDAEGHCKLADFGMCKE 145 (321)
T ss_pred CeEEEEEeCCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCC---eeccCCCHHHeEECCCCCEEEeeccccee
Confidence 4688999999843 23557899999999999999999999999 99999999999999999999999999876
Q ss_pred cCCCcccccceeeeeccCCCChhhhccCCCCccceEEeehhhhhhhhhCCCCCCcCCCCchhhhhhhhhhhcCCCccccc
Q 045315 315 FGGDELQSNTKRIVGTYGYMSPEYALRGLFSIKSDVFSFGVLLLETLSSKKNTHFYNTDSLTLLGHAWNLWNDGRTWELM 394 (476)
Q Consensus 315 ~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~s~ksDVwSlGvvl~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 394 (476)
...... ......|+..|+|||++.+..++.++|||||||++|||++|+.||...... ..... ...+.. .
T Consensus 146 ~~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~el~tg~~Pf~~~~~~--~~~~~----i~~~~~---~ 214 (321)
T cd05591 146 GILNGV--TTTTFCGTPDYIAPEILQELEYGPSVDWWALGVLMYEMMAGQPPFEADNED--DLFES----ILHDDV---L 214 (321)
T ss_pred cccCCc--cccccccCccccCHHHHcCCCCCCccceechhHHHHHHhcCCCCCCCCCHH--HHHHH----HHcCCC---C
Confidence 432221 122356899999999999889999999999999999999999998754321 11111 111110 0
Q ss_pred CcccCCCCCHHHHHHHHHHHHHchhhcccCCC-------CHHHHHHH
Q 045315 395 DPISQNGASYPILKRYINVALLCVQEKAADRP-------AMSEVVSM 434 (476)
Q Consensus 395 d~~~~~~~~~~~~~~l~~li~~Cl~~dP~~RP-------t~~eVl~~ 434 (476)
.+......+.+++.+||+.||++|| ++.++++.
T Consensus 215 -------~p~~~~~~~~~ll~~~L~~dp~~R~~~~~~~~~~~~~~~h 254 (321)
T cd05591 215 -------YPVWLSKEAVSILKAFMTKNPNKRLGCVASQGGEDAIKQH 254 (321)
T ss_pred -------CCCCCCHHHHHHHHHHhccCHHHcCCCCCCCCCHHHHhcC
Confidence 0111235678999999999999999 77777643
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), epsilon isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-epsilon has been shown to behave as an oncoprotein. Its overexpression contributes to |
| >PLN00034 mitogen-activated protein kinase kinase; Provisional | Back alignment and domain information |
|---|
Probab=99.93 E-value=9.4e-26 Score=228.52 Aligned_cols=177 Identities=24% Similarity=0.332 Sum_probs=130.9
Q ss_pred cccceeeccCCCCC--CCCCCChhhHHHHHHHHHHHHHHHhhcCCCceeecCCCccceEecCCCCceeccccceeecCCC
Q 045315 241 DEISFWYESYNNPT--KKGLLCWGTRVRIIEGIAQGLLYLHQYSRLRVIHRDLKASNILLDKDMNPKISDFGMARMFGGD 318 (476)
Q Consensus 241 ~~~~l~~Ey~~~~~--~~~~L~~~~~~~i~~qIa~gL~yLH~~~~~~ivH~DLkp~NILld~~~~~kL~DFGla~~~~~~ 318 (476)
+..++++||++... ....+++..+..++.||+.||+|||+.+ |+||||||+|||++.++.+||+|||+++.+...
T Consensus 145 ~~~~lv~e~~~~~~L~~~~~~~~~~~~~i~~qi~~aL~~LH~~~---ivHrDlkp~NIll~~~~~~kL~DfG~~~~~~~~ 221 (353)
T PLN00034 145 GEIQVLLEFMDGGSLEGTHIADEQFLADVARQILSGIAYLHRRH---IVHRDIKPSNLLINSAKNVKIADFGVSRILAQT 221 (353)
T ss_pred CeEEEEEecCCCCcccccccCCHHHHHHHHHHHHHHHHHHHHCC---EeecCCCHHHEEEcCCCCEEEcccccceecccc
Confidence 46788999998443 2345677888899999999999999998 999999999999999999999999999876432
Q ss_pred cccccceeeeeccCCCChhhhcc-----CCCCccceEEeehhhhhhhhhCCCCCCcCCCCchhhhhhhhhhhcCCCcccc
Q 045315 319 ELQSNTKRIVGTYGYMSPEYALR-----GLFSIKSDVFSFGVLLLETLSSKKNTHFYNTDSLTLLGHAWNLWNDGRTWEL 393 (476)
Q Consensus 319 ~~~~~~~~~~gt~~y~aPE~l~~-----~~~s~ksDVwSlGvvl~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~ 393 (476)
.. ......|+..|+|||.+.. ...+.++|||||||++|||++|+.||........... ...... ..
T Consensus 222 ~~--~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DvwslGvil~el~~g~~pf~~~~~~~~~~~--~~~~~~-~~---- 292 (353)
T PLN00034 222 MD--PCNSSVGTIAYMSPERINTDLNHGAYDGYAGDIWSLGVSILEFYLGRFPFGVGRQGDWASL--MCAICM-SQ---- 292 (353)
T ss_pred cc--cccccccCccccCccccccccccCcCCCcchhHHHHHHHHHHHHhCCCCCCCCCCccHHHH--HHHHhc-cC----
Confidence 21 1223568999999998743 2345689999999999999999999873322111110 000000 00
Q ss_pred cCcccCCCCCHHHHHHHHHHHHHchhhcccCCCCHHHHHHH
Q 045315 394 MDPISQNGASYPILKRYINVALLCVQEKAADRPAMSEVVSM 434 (476)
Q Consensus 394 ~d~~~~~~~~~~~~~~l~~li~~Cl~~dP~~RPt~~eVl~~ 434 (476)
...........+.+++.+||+.||++||++.|+++.
T Consensus 293 -----~~~~~~~~~~~l~~li~~~l~~~P~~Rpt~~ell~h 328 (353)
T PLN00034 293 -----PPEAPATASREFRHFISCCLQREPAKRWSAMQLLQH 328 (353)
T ss_pred -----CCCCCCccCHHHHHHHHHHccCChhhCcCHHHHhcC
Confidence 001112234578899999999999999999999874
|
|
| >cd05045 PTKc_RET Catalytic domain of the Protein Tyrosine Kinase, REarranged during Transfection protein | Back alignment and domain information |
|---|
Probab=99.93 E-value=2.3e-26 Score=226.10 Aligned_cols=165 Identities=25% Similarity=0.391 Sum_probs=127.8
Q ss_pred CCCChhhHHHHHHHHHHHHHHHhhcCCCceeecCCCccceEecCCCCceeccccceeecCCCcccccceeeeeccCCCCh
Q 045315 257 GLLCWGTRVRIIEGIAQGLLYLHQYSRLRVIHRDLKASNILLDKDMNPKISDFGMARMFGGDELQSNTKRIVGTYGYMSP 336 (476)
Q Consensus 257 ~~L~~~~~~~i~~qIa~gL~yLH~~~~~~ivH~DLkp~NILld~~~~~kL~DFGla~~~~~~~~~~~~~~~~gt~~y~aP 336 (476)
.++++.+++.++.|++.||+|||+.+ ++||||||+||++++++.+||+|||+++...............++..|+||
T Consensus 122 ~~l~~~~~~~i~~~i~~~l~~LH~~~---ivH~dikp~nill~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~ap 198 (290)
T cd05045 122 RALTMGDLISFAWQISRGMQYLAEMK---LVHRDLAARNVLVAEGRKMKISDFGLSRDVYEEDSYVKRSKGRIPVKWMAI 198 (290)
T ss_pred cccCHHHHHHHHHHHHHHHHHHHHCC---eehhhhhhheEEEcCCCcEEeccccccccccCccchhcccCCCCCccccCH
Confidence 46899999999999999999999998 999999999999999999999999999865432221112223456789999
Q ss_pred hhhccCCCCccceEEeehhhhhhhhh-CCCCCCcCCCCchhhhhhhhhhhcCCCcccccCcccCCCCCHHHHHHHHHHHH
Q 045315 337 EYALRGLFSIKSDVFSFGVLLLETLS-SKKNTHFYNTDSLTLLGHAWNLWNDGRTWELMDPISQNGASYPILKRYINVAL 415 (476)
Q Consensus 337 E~l~~~~~s~ksDVwSlGvvl~ellt-G~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~l~~li~ 415 (476)
|.+.+..++.++||||||++++||++ |+.||..... ..+. ....... ....+......+.+++.
T Consensus 199 E~~~~~~~~~~~Di~slG~~l~el~t~g~~p~~~~~~--~~~~----~~~~~~~---------~~~~~~~~~~~~~~~i~ 263 (290)
T cd05045 199 ESLFDHIYTTQSDVWSFGVLLWEIVTLGGNPYPGIAP--ERLF----NLLKTGY---------RMERPENCSEEMYNLML 263 (290)
T ss_pred HHHccCCcchHhHHHHHHHHHHHHHhcCCCCCCCCCH--HHHH----HHHhCCC---------CCCCCCCCCHHHHHHHH
Confidence 99988889999999999999999998 8888754321 1111 1111111 01111223357889999
Q ss_pred HchhhcccCCCCHHHHHHHHhccc
Q 045315 416 LCVQEKAADRPAMSEVVSMLSNEF 439 (476)
Q Consensus 416 ~Cl~~dP~~RPt~~eVl~~L~~~~ 439 (476)
+||+.+|++||++.++++.|+++.
T Consensus 264 ~cl~~~P~~Rp~~~~i~~~l~~~~ 287 (290)
T cd05045 264 TCWKQEPDKRPTFADISKELEKMM 287 (290)
T ss_pred HHccCCcccCCCHHHHHHHHHHHH
Confidence 999999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; RET (REarranged during Transfection) protein; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. RET is a receptor tyr kinase (RTK) containing an extracellular region with four cadherin-like repeats, a calcium-binding site, and a cysteine-rich domain, a transmembrane segment, and an intracellular catalytic domain. It is part of a multisubunit complex that binds glial-derived neurotropic factor (GDNF) family ligands (GFLs) including GDNF, neurturin, artemin, and persephin. GFLs bind RET along with four GPI-anchored coreceptors, bringing two RET molecules together, leadi |
| >cd05608 STKc_GRK1 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 1 | Back alignment and domain information |
|---|
Probab=99.93 E-value=1.2e-25 Score=220.22 Aligned_cols=176 Identities=22% Similarity=0.242 Sum_probs=133.8
Q ss_pred cccceeeccCCCC----------CCCCCCChhhHHHHHHHHHHHHHHHhhcCCCceeecCCCccceEecCCCCceecccc
Q 045315 241 DEISFWYESYNNP----------TKKGLLCWGTRVRIIEGIAQGLLYLHQYSRLRVIHRDLKASNILLDKDMNPKISDFG 310 (476)
Q Consensus 241 ~~~~l~~Ey~~~~----------~~~~~L~~~~~~~i~~qIa~gL~yLH~~~~~~ivH~DLkp~NILld~~~~~kL~DFG 310 (476)
+..+++|||++.+ .....+++.+++.++.||+.||+|||+.+ |+||||||+||+++.++.+||+|||
T Consensus 66 ~~~~lv~e~~~~g~L~~~~~~~~~~~~~l~~~~~~~~~~qi~~~l~~lH~~~---i~H~dlkp~Nili~~~~~~~l~dfg 142 (280)
T cd05608 66 TDLCLVMTIMNGGDLRYHIYNVDEENPGFPEPRACFYTAQIISGLEHLHQRR---IIYRDLKPENVLLDNDGNVRISDLG 142 (280)
T ss_pred CeEEEEEeCCCCCCHHHHHHhccccCCCCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCCHHHEEECCCCCEEEeeCc
Confidence 3577899999832 13457999999999999999999999998 9999999999999999999999999
Q ss_pred ceeecCCCcccccceeeeeccCCCChhhhccCCCCccceEEeehhhhhhhhhCCCCCCcCCCCchhhhhhhhhhhcCCCc
Q 045315 311 MARMFGGDELQSNTKRIVGTYGYMSPEYALRGLFSIKSDVFSFGVLLLETLSSKKNTHFYNTDSLTLLGHAWNLWNDGRT 390 (476)
Q Consensus 311 la~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~s~ksDVwSlGvvl~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~ 390 (476)
++..+...... .....|+..|+|||.+.+..++.++|+|||||++|||++|+.||.......... ....... ..
T Consensus 143 ~~~~~~~~~~~--~~~~~g~~~y~aPE~~~~~~~~~~~DvwslG~il~el~~g~~pf~~~~~~~~~~-~~~~~~~-~~-- 216 (280)
T cd05608 143 LAVELKDGQSK--TKGYAGTPGFMAPELLQGEEYDFSVDYFALGVTLYEMIAARGPFRARGEKVENK-ELKQRIL-ND-- 216 (280)
T ss_pred cceecCCCCcc--ccccCCCcCccCHHHhcCCCCCccccHHHHHHHHHHHHhCCCCCCCCCcchhHH-HHHHhhc-cc--
Confidence 99876543221 223468999999999999999999999999999999999999986543211100 0000000 00
Q ss_pred ccccCcccCCCCCHHHHHHHHHHHHHchhhcccCCC-----CHHHHHH
Q 045315 391 WELMDPISQNGASYPILKRYINVALLCVQEKAADRP-----AMSEVVS 433 (476)
Q Consensus 391 ~~~~d~~~~~~~~~~~~~~l~~li~~Cl~~dP~~RP-----t~~eVl~ 433 (476)
+ ...+......+.+++.+||+.||++|| +++++++
T Consensus 217 -----~---~~~~~~~~~~~~~li~~~l~~~P~~R~~~~~~~~~~~l~ 256 (280)
T cd05608 217 -----S---VTYPDKFSPASKSFCEALLAKDPEKRLGFRDGNCDGLRT 256 (280)
T ss_pred -----C---CCCcccCCHHHHHHHHHHhcCCHHHhcCCCCCCHHHHhc
Confidence 0 011122345788999999999999999 6777775
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK1, also called rhodopsin kinase, belongs to the visual g |
| >cd05068 PTKc_Frk_like Catalytic domain of Fyn-related kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=99.93 E-value=4.9e-26 Score=220.07 Aligned_cols=178 Identities=28% Similarity=0.368 Sum_probs=134.5
Q ss_pred cccceeeccCCCC--------CCCCCCChhhHHHHHHHHHHHHHHHhhcCCCceeecCCCccceEecCCCCceeccccce
Q 045315 241 DEISFWYESYNNP--------TKKGLLCWGTRVRIIEGIAQGLLYLHQYSRLRVIHRDLKASNILLDKDMNPKISDFGMA 312 (476)
Q Consensus 241 ~~~~l~~Ey~~~~--------~~~~~L~~~~~~~i~~qIa~gL~yLH~~~~~~ivH~DLkp~NILld~~~~~kL~DFGla 312 (476)
+.+++++||++.. .....+++.++.+++.|++.||.|||+.+ ++||||||+||+++.++.+||+|||++
T Consensus 74 ~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~---i~H~dl~p~Nil~~~~~~~~l~dfg~~ 150 (261)
T cd05068 74 EPIYIVTELMKYGSLLEYLQGGAGRALKLPQLIDMAAQVASGMAYLEAQN---YIHRDLAARNVLVGENNICKVADFGLA 150 (261)
T ss_pred CCeeeeeecccCCcHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHHhCC---eeeccCCcceEEEcCCCCEEECCcceE
Confidence 4567888888622 22347899999999999999999999998 999999999999999999999999999
Q ss_pred eecCCCcccccceeeeeccCCCChhhhccCCCCccceEEeehhhhhhhhh-CCCCCCcCCCCchhhhhhhhhhhcCCCcc
Q 045315 313 RMFGGDELQSNTKRIVGTYGYMSPEYALRGLFSIKSDVFSFGVLLLETLS-SKKNTHFYNTDSLTLLGHAWNLWNDGRTW 391 (476)
Q Consensus 313 ~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~s~ksDVwSlGvvl~ellt-G~~p~~~~~~~~~~~~~~~~~~~~~~~~~ 391 (476)
+......... ......+..|+|||++.+..++.++|+||||+++|||++ |+.||..... ..... .......
T Consensus 151 ~~~~~~~~~~-~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~t~g~~p~~~~~~--~~~~~----~~~~~~~- 222 (261)
T cd05068 151 RVIKEDIYEA-REGAKFPIKWTAPEAALYNRFSIKSDVWSFGILLTEIVTYGRMPYPGMTN--AEVLQ----QVDQGYR- 222 (261)
T ss_pred EEccCCcccc-cCCCcCceeccCccccccCCCCchhhHHHHHHHHHHHHhcCCCCCCCCCH--HHHHH----HHHcCCC-
Confidence 8775322111 111223457999999988889999999999999999999 8888754321 11111 1111100
Q ss_pred cccCcccCCCCCHHHHHHHHHHHHHchhhcccCCCCHHHHHHHHhc
Q 045315 392 ELMDPISQNGASYPILKRYINVALLCVQEKAADRPAMSEVVSMLSN 437 (476)
Q Consensus 392 ~~~d~~~~~~~~~~~~~~l~~li~~Cl~~dP~~RPt~~eVl~~L~~ 437 (476)
..........+.+++.+|++.+|++||++.++++.|+.
T Consensus 223 --------~~~~~~~~~~~~~li~~~l~~~P~~Rp~~~~l~~~l~~ 260 (261)
T cd05068 223 --------MPCPPGCPKELYDIMLDCWKEDPDDRPTFETLQWKLED 260 (261)
T ss_pred --------CCCCCcCCHHHHHHHHHHhhcCcccCCCHHHHHHHHhc
Confidence 01112234678899999999999999999999999986
|
Protein Tyrosine Kinase (PTK) family; Human Fyn-related kinase (Frk) and similar proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Frk and Srk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins a |
| >cd05084 PTKc_Fes Catalytic domain of the Protein Tyrosine Kinase, Fes | Back alignment and domain information |
|---|
Probab=99.93 E-value=2.5e-26 Score=220.78 Aligned_cols=178 Identities=26% Similarity=0.275 Sum_probs=132.1
Q ss_pred cccceeeccCCCC-------CCCCCCChhhHHHHHHHHHHHHHHHhhcCCCceeecCCCccceEecCCCCceecccccee
Q 045315 241 DEISFWYESYNNP-------TKKGLLCWGTRVRIIEGIAQGLLYLHQYSRLRVIHRDLKASNILLDKDMNPKISDFGMAR 313 (476)
Q Consensus 241 ~~~~l~~Ey~~~~-------~~~~~L~~~~~~~i~~qIa~gL~yLH~~~~~~ivH~DLkp~NILld~~~~~kL~DFGla~ 313 (476)
+..++++||++.. .+...+++.++..++.|+++||+|||+.+ ++|+||||+||+++.++.+||+|||++.
T Consensus 66 ~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~qi~~~L~~lH~~~---i~H~dl~p~nil~~~~~~~kl~dfg~~~ 142 (252)
T cd05084 66 QPIYIVMELVQGGDFLTFLRTEGPRLKVKELIQMVENAAAGMEYLESKH---CIHRDLAARNCLVTEKNVLKISDFGMSR 142 (252)
T ss_pred CCeEEEEeeccCCcHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHhCC---ccccccchheEEEcCCCcEEECccccCc
Confidence 4567888998732 23456899999999999999999999998 9999999999999999999999999987
Q ss_pred ecCCCcccccceeeeeccCCCChhhhccCCCCccceEEeehhhhhhhhh-CCCCCCcCCCCchhhhhhhhhhhcCCCccc
Q 045315 314 MFGGDELQSNTKRIVGTYGYMSPEYALRGLFSIKSDVFSFGVLLLETLS-SKKNTHFYNTDSLTLLGHAWNLWNDGRTWE 392 (476)
Q Consensus 314 ~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~s~ksDVwSlGvvl~ellt-G~~p~~~~~~~~~~~~~~~~~~~~~~~~~~ 392 (476)
................+..|+|||.+.++.++.++|+||||+++||+++ |..|+..... ..... ......
T Consensus 143 ~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~e~~~~~~~p~~~~~~--~~~~~----~~~~~~--- 213 (252)
T cd05084 143 EEEDGVYASTGGMKQIPVKWTAPEALNYGRYSSESDVWSFGILLWEAFSLGAVPYANLSN--QQTRE----AIEQGV--- 213 (252)
T ss_pred ccccccccccCCCCCCceeecCchhhcCCCCChHHHHHHHHHHHHHHHhCCCCCccccCH--HHHHH----HHHcCC---
Confidence 6543211111111123457999999998889999999999999999997 7777653221 11111 111100
Q ss_pred ccCcccCCCCCHHHHHHHHHHHHHchhhcccCCCCHHHHHHHHh
Q 045315 393 LMDPISQNGASYPILKRYINVALLCVQEKAADRPAMSEVVSMLS 436 (476)
Q Consensus 393 ~~d~~~~~~~~~~~~~~l~~li~~Cl~~dP~~RPt~~eVl~~L~ 436 (476)
....+......+.+++.+|++.+|++||++.+|.++|+
T Consensus 214 ------~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~~~~~l~ 251 (252)
T cd05084 214 ------RLPCPELCPDAVYRLMERCWEYDPGQRPSFSTVHQELQ 251 (252)
T ss_pred ------CCCCcccCCHHHHHHHHHHcCCChhhCcCHHHHHHHHh
Confidence 00111223457889999999999999999999999986
|
Protein Tyrosine Kinase (PTK) family; Fes (or Fps) kinase subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fes subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. The genes for Fes (feline sarcoma) and Fps (Fujinami poultry sarcoma) were first isolated from tumor-causing retroviruses. The viral oncogenes encode chimeric Fes proteins consisting of Gag sequences at the N-termini, resulting in unregulated tyr kinase activity. Fes kinase is expressed in myeloid, vascular |
| >cd05104 PTKc_Kit Catalytic domain of the Protein Tyrosine Kinase, Kit | Back alignment and domain information |
|---|
Probab=99.93 E-value=5.2e-26 Score=232.41 Aligned_cols=166 Identities=25% Similarity=0.361 Sum_probs=127.1
Q ss_pred CCCCChhhHHHHHHHHHHHHHHHhhcCCCceeecCCCccceEecCCCCceeccccceeecCCCcccccceeeeeccCCCC
Q 045315 256 KGLLCWGTRVRIIEGIAQGLLYLHQYSRLRVIHRDLKASNILLDKDMNPKISDFGMARMFGGDELQSNTKRIVGTYGYMS 335 (476)
Q Consensus 256 ~~~L~~~~~~~i~~qIa~gL~yLH~~~~~~ivH~DLkp~NILld~~~~~kL~DFGla~~~~~~~~~~~~~~~~gt~~y~a 335 (476)
...+++.++++++.||+.||+|||+.+ |+||||||+|||++.++.+||+|||+++...............++..|+|
T Consensus 208 ~~~l~~~~~~~~~~qi~~~l~~lH~~~---ivH~Dlkp~Nill~~~~~~kl~DfG~a~~~~~~~~~~~~~~~~~~~~y~a 284 (375)
T cd05104 208 ELALDTEDLLSFSYQVAKGMSFLASKN---CIHRDLAARNILLTHGRITKICDFGLARDIRNDSNYVVKGNARLPVKWMA 284 (375)
T ss_pred CCCCCHHHHHHHHHHHHHHHHHHHHCC---eeccCCchhhEEEECCCcEEEecCccceeccCcccccccCCCCCCcceeC
Confidence 457999999999999999999999998 99999999999999999999999999987654322221222334667999
Q ss_pred hhhhccCCCCccceEEeehhhhhhhhh-CCCCCCcCCCCchhhhhhhhhhhcCCCcccccCcccCCCCCHHHHHHHHHHH
Q 045315 336 PEYALRGLFSIKSDVFSFGVLLLETLS-SKKNTHFYNTDSLTLLGHAWNLWNDGRTWELMDPISQNGASYPILKRYINVA 414 (476)
Q Consensus 336 PE~l~~~~~s~ksDVwSlGvvl~ellt-G~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~l~~li 414 (476)
||.+.+..++.++|||||||++|||++ |..||.....+. ... .....+.... .+......+.+++
T Consensus 285 PE~~~~~~~~~~sDi~slG~~l~ellt~g~~p~~~~~~~~-~~~----~~~~~~~~~~---------~~~~~~~~l~~li 350 (375)
T cd05104 285 PESIFNCVYTFESDVWSYGILLWEIFSLGSSPYPGMPVDS-KFY----KMIKEGYRML---------SPECAPSEMYDIM 350 (375)
T ss_pred hhHhcCCCCCCCCCHHHHHHHHHHHHhcCCCCCCCCCchH-HHH----HHHHhCccCC---------CCCCCCHHHHHHH
Confidence 999999999999999999999999998 777775432211 111 1111111100 0111234688999
Q ss_pred HHchhhcccCCCCHHHHHHHHhcc
Q 045315 415 LLCVQEKAADRPAMSEVVSMLSNE 438 (476)
Q Consensus 415 ~~Cl~~dP~~RPt~~eVl~~L~~~ 438 (476)
.+||+.||++||++.||+++|++.
T Consensus 351 ~~cl~~dP~~RPs~~eil~~l~~~ 374 (375)
T cd05104 351 KSCWDADPLKRPTFKQIVQLIEQQ 374 (375)
T ss_pred HHHccCChhHCcCHHHHHHHHHhh
Confidence 999999999999999999999863
|
Protein Tyrosine Kinase (PTK) family; Kit (or c-Kit); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Kit is a member of the Platelet Derived Growth Factor Receptor (PDGFR) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of Kit to its ligand, the stem-cell factor (SCF), leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. Kit is important in the development of melanocytes, germ cells, mast cells, hematopoietic stem ce |
| >cd05032 PTKc_InsR_like Catalytic domain of Insulin Receptor-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=99.93 E-value=6.5e-26 Score=220.89 Aligned_cols=163 Identities=29% Similarity=0.450 Sum_probs=126.0
Q ss_pred CCCChhhHHHHHHHHHHHHHHHhhcCCCceeecCCCccceEecCCCCceeccccceeecCCCcccccceeeeeccCCCCh
Q 045315 257 GLLCWGTRVRIIEGIAQGLLYLHQYSRLRVIHRDLKASNILLDKDMNPKISDFGMARMFGGDELQSNTKRIVGTYGYMSP 336 (476)
Q Consensus 257 ~~L~~~~~~~i~~qIa~gL~yLH~~~~~~ivH~DLkp~NILld~~~~~kL~DFGla~~~~~~~~~~~~~~~~gt~~y~aP 336 (476)
..+++..++.++.||+.||+|||+.+ ++||||||+||+++.++.+||+|||+++...............++..|+||
T Consensus 114 ~~~~~~~~~~~~~~i~~~l~~lH~~~---i~H~di~p~nill~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~aP 190 (277)
T cd05032 114 GPPTLQKFIQMAAEIADGMAYLAAKK---FVHRDLAARNCMVAEDLTVKIGDFGMTRDIYETDYYRKGGKGLLPVRWMAP 190 (277)
T ss_pred CCCCHHHHHHHHHHHHHHHHHHHhCC---ccccccChheEEEcCCCCEEECCcccchhhccCcccccCCCCCccccccCH
Confidence 45889999999999999999999998 999999999999999999999999999865443222222223467889999
Q ss_pred hhhccCCCCccceEEeehhhhhhhhh-CCCCCCcCCCCchhhhhhhhhhhcCCCcccccCcccCCCCCHHHHHHHHHHHH
Q 045315 337 EYALRGLFSIKSDVFSFGVLLLETLS-SKKNTHFYNTDSLTLLGHAWNLWNDGRTWELMDPISQNGASYPILKRYINVAL 415 (476)
Q Consensus 337 E~l~~~~~s~ksDVwSlGvvl~ellt-G~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~l~~li~ 415 (476)
|.+.+..++.++|||||||++||+++ |+.|+...... .... ....+..... +......+.+++.
T Consensus 191 E~~~~~~~~~~~Di~slG~il~el~t~g~~p~~~~~~~--~~~~----~~~~~~~~~~---------~~~~~~~~~~li~ 255 (277)
T cd05032 191 ESLKDGVFTTKSDVWSFGVVLWEMATLAEQPYQGLSNE--EVLK----FVIDGGHLDL---------PENCPDKLLELMR 255 (277)
T ss_pred HHHhcCCCCcccchHHHHHHHHHhhccCCCCCccCCHH--HHHH----HHhcCCCCCC---------CCCCCHHHHHHHH
Confidence 99988889999999999999999998 88887543211 1111 1111111111 1112457889999
Q ss_pred HchhhcccCCCCHHHHHHHHhc
Q 045315 416 LCVQEKAADRPAMSEVVSMLSN 437 (476)
Q Consensus 416 ~Cl~~dP~~RPt~~eVl~~L~~ 437 (476)
+||+.+|++|||+.++++.|+.
T Consensus 256 ~~l~~~p~~Rpt~~~l~~~l~~ 277 (277)
T cd05032 256 MCWQYNPKMRPTFLEIVSSLKD 277 (277)
T ss_pred HHcCCChhhCCCHHHHHHHhcC
Confidence 9999999999999999999863
|
Protein Tyrosine Kinase (PTK) family; Insulin Receptor (InsR) subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). The InsR subfamily is composed of InsR, Insulin-like Growth Factor-1 Receptor (IGF-1R), and similar proteins. PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. InsR and IGF-1R are receptor tyr kinases (RTKs) composed of two alphabeta heterodimers. Binding of the ligand (insulin, IGF-1, or IGF-2) to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, stimulating downstream kinase activities, which initiate signaling cascades and biological |
| >cd05064 PTKc_EphR_A10 Catalytic domain of the Protein Tyrosine Kinase, Ephrin Receptor A10 | Back alignment and domain information |
|---|
Probab=99.93 E-value=3.3e-26 Score=222.28 Aligned_cols=179 Identities=25% Similarity=0.350 Sum_probs=134.8
Q ss_pred cccceeeccCCCC-------CCCCCCChhhHHHHHHHHHHHHHHHhhcCCCceeecCCCccceEecCCCCceecccccee
Q 045315 241 DEISFWYESYNNP-------TKKGLLCWGTRVRIIEGIAQGLLYLHQYSRLRVIHRDLKASNILLDKDMNPKISDFGMAR 313 (476)
Q Consensus 241 ~~~~l~~Ey~~~~-------~~~~~L~~~~~~~i~~qIa~gL~yLH~~~~~~ivH~DLkp~NILld~~~~~kL~DFGla~ 313 (476)
+..+++|||++.. .+...+++.+++.++.||+.||+|||+.+ ++||||||+||+++.++.+|++|||.+.
T Consensus 79 ~~~~lv~e~~~~~~L~~~l~~~~~~l~~~~~~~~~~~i~~al~~lH~~~---iiH~dikp~nili~~~~~~~l~dfg~~~ 155 (266)
T cd05064 79 NTMMIVTEYMSNGALDSFLRKHEGQLVAGQLMGMLPGLASGMKYLSEMG---YVHKGLAAHKVLVNSDLVCKISGFRRLQ 155 (266)
T ss_pred CCcEEEEEeCCCCcHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHHCC---EeeccccHhhEEEcCCCcEEECCCcccc
Confidence 4678899999832 22457999999999999999999999998 9999999999999999999999999876
Q ss_pred ecCCCcccccceeeeeccCCCChhhhccCCCCccceEEeehhhhhhhhh-CCCCCCcCCCCchhhhhhhhhhhcCCCccc
Q 045315 314 MFGGDELQSNTKRIVGTYGYMSPEYALRGLFSIKSDVFSFGVLLLETLS-SKKNTHFYNTDSLTLLGHAWNLWNDGRTWE 392 (476)
Q Consensus 314 ~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~s~ksDVwSlGvvl~ellt-G~~p~~~~~~~~~~~~~~~~~~~~~~~~~~ 392 (476)
........ ......++..|+|||.+.+..++.++|||||||++||+++ |+.||...... ..... ...+...
T Consensus 156 ~~~~~~~~-~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~ell~~g~~p~~~~~~~--~~~~~----~~~~~~~- 227 (266)
T cd05064 156 EDKSEAIY-TTMSGKSPVLWAAPEAIQYHHFSSASDVWSFGIVMWEVMSYGERPYWDMSGQ--DVIKA----VEDGFRL- 227 (266)
T ss_pred cccccchh-cccCCCCceeecCHHHHhhCCccchhHHHHHHHHHHHHhcCCCCCcCcCCHH--HHHHH----HHCCCCC-
Confidence 54322111 1111234578999999999999999999999999999775 99888643211 11111 1111110
Q ss_pred ccCcccCCCCCHHHHHHHHHHHHHchhhcccCCCCHHHHHHHHhcc
Q 045315 393 LMDPISQNGASYPILKRYINVALLCVQEKAADRPAMSEVVSMLSNE 438 (476)
Q Consensus 393 ~~d~~~~~~~~~~~~~~l~~li~~Cl~~dP~~RPt~~eVl~~L~~~ 438 (476)
..+......+.+++.+||+.+|.+||++++|++.|+..
T Consensus 228 --------~~~~~~~~~~~~li~~c~~~~p~~RP~~~~i~~~l~~~ 265 (266)
T cd05064 228 --------PAPRNCPNLLHQLMLDCWQKERGERPRFSQIHSILSKM 265 (266)
T ss_pred --------CCCCCCCHHHHHHHHHHcCCCchhCCCHHHHHHHHHhh
Confidence 11122345688999999999999999999999999764
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; EphA10 receptor; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchor |
| >cd05590 STKc_nPKC_eta Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C eta | Back alignment and domain information |
|---|
Probab=99.93 E-value=5.1e-26 Score=227.36 Aligned_cols=167 Identities=25% Similarity=0.287 Sum_probs=130.2
Q ss_pred cccceeeccCCCC------CCCCCCChhhHHHHHHHHHHHHHHHhhcCCCceeecCCCccceEecCCCCceeccccceee
Q 045315 241 DEISFWYESYNNP------TKKGLLCWGTRVRIIEGIAQGLLYLHQYSRLRVIHRDLKASNILLDKDMNPKISDFGMARM 314 (476)
Q Consensus 241 ~~~~l~~Ey~~~~------~~~~~L~~~~~~~i~~qIa~gL~yLH~~~~~~ivH~DLkp~NILld~~~~~kL~DFGla~~ 314 (476)
+.++++|||++.+ .+...+++.++..++.||+.||+|||+++ |+||||||+|||++.++.+||+|||+++.
T Consensus 69 ~~~~iv~Ey~~~g~L~~~i~~~~~l~~~~~~~~~~ql~~~L~~lH~~~---ivH~dlkp~NIli~~~~~~kL~DfG~~~~ 145 (320)
T cd05590 69 DRLFFVMEFVNGGDLMFHIQKSRRFDEARARFYAAEITSALMFLHDKG---IIYRDLKLDNVLLDHEGHCKLADFGMCKE 145 (320)
T ss_pred CEEEEEEcCCCCchHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCC---eEeCCCCHHHeEECCCCcEEEeeCCCCee
Confidence 4688999999843 23567999999999999999999999998 99999999999999999999999999875
Q ss_pred cCCCcccccceeeeeccCCCChhhhccCCCCccceEEeehhhhhhhhhCCCCCCcCCCCchhhhhhhhhhhcCCCccccc
Q 045315 315 FGGDELQSNTKRIVGTYGYMSPEYALRGLFSIKSDVFSFGVLLLETLSSKKNTHFYNTDSLTLLGHAWNLWNDGRTWELM 394 (476)
Q Consensus 315 ~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~s~ksDVwSlGvvl~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 394 (476)
..... .......|++.|+|||.+.+..++.++|||||||++|||++|+.||...... .... ....+..
T Consensus 146 ~~~~~--~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~Pf~~~~~~--~~~~----~i~~~~~---- 213 (320)
T cd05590 146 GIFNG--KTTSTFCGTPDYIAPEILQEMLYGPSVDWWAMGVLLYEMLCGHAPFEAENED--DLFE----AILNDEV---- 213 (320)
T ss_pred cCcCC--CcccccccCccccCHHHHcCCCCCCccchhhhHHHHHHHhhCCCCCCCCCHH--HHHH----HHhcCCC----
Confidence 43221 1122356899999999999889999999999999999999999998654321 1111 1111111
Q ss_pred CcccCCCCCHHHHHHHHHHHHHchhhcccCCCCH
Q 045315 395 DPISQNGASYPILKRYINVALLCVQEKAADRPAM 428 (476)
Q Consensus 395 d~~~~~~~~~~~~~~l~~li~~Cl~~dP~~RPt~ 428 (476)
..+......+.+++.+||+.||++||++
T Consensus 214 ------~~~~~~~~~~~~li~~~L~~dP~~R~~~ 241 (320)
T cd05590 214 ------VYPTWLSQDAVDILKAFMTKNPTMRLGS 241 (320)
T ss_pred ------CCCCCCCHHHHHHHHHHcccCHHHCCCC
Confidence 0011123567899999999999999998
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), eta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-eta is predominantly expressed in squamous epithelia, where it plays a crucial role in the signal |
| >cd05617 STKc_aPKC_zeta Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C zeta | Back alignment and domain information |
|---|
Probab=99.93 E-value=9.9e-26 Score=226.00 Aligned_cols=173 Identities=20% Similarity=0.266 Sum_probs=130.5
Q ss_pred cccceeeccCCCCC------CCCCCChhhHHHHHHHHHHHHHHHhhcCCCceeecCCCccceEecCCCCceeccccceee
Q 045315 241 DEISFWYESYNNPT------KKGLLCWGTRVRIIEGIAQGLLYLHQYSRLRVIHRDLKASNILLDKDMNPKISDFGMARM 314 (476)
Q Consensus 241 ~~~~l~~Ey~~~~~------~~~~L~~~~~~~i~~qIa~gL~yLH~~~~~~ivH~DLkp~NILld~~~~~kL~DFGla~~ 314 (476)
+..+++|||++... +.+.+++.++..++.||+.||+|||+++ |+||||||+||+++.++.+||+|||+++.
T Consensus 69 ~~~~lv~e~~~~~~L~~~~~~~~~l~~~~~~~~~~qi~~al~~lH~~~---ivHrDlkp~Nili~~~~~~kl~Dfg~~~~ 145 (327)
T cd05617 69 SRLFLVIEYVNGGDLMFHMQRQRKLPEEHARFYAAEICIALNFLHERG---IIYRDLKLDNVLLDADGHIKLTDYGMCKE 145 (327)
T ss_pred CEEEEEEeCCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCC---eeccCCCHHHEEEeCCCCEEEecccccee
Confidence 45789999998432 3467999999999999999999999998 99999999999999999999999999875
Q ss_pred cCCCcccccceeeeeccCCCChhhhccCCCCccceEEeehhhhhhhhhCCCCCCcCCCC-chhhhhhhhhhhcCCCcccc
Q 045315 315 FGGDELQSNTKRIVGTYGYMSPEYALRGLFSIKSDVFSFGVLLLETLSSKKNTHFYNTD-SLTLLGHAWNLWNDGRTWEL 393 (476)
Q Consensus 315 ~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~s~ksDVwSlGvvl~elltG~~p~~~~~~~-~~~~~~~~~~~~~~~~~~~~ 393 (476)
..... .......|++.|+|||++.+..++.++|||||||++|||++|+.||...... .................
T Consensus 146 ~~~~~--~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslGvil~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~--- 220 (327)
T cd05617 146 GLGPG--DTTSTFCGTPNYIAPEILRGEEYGFSVDWWALGVLMFEMMAGRSPFDIITDNPDMNTEDYLFQVILEKPI--- 220 (327)
T ss_pred ccCCC--CceecccCCcccCCHHHHCCCCCCchheeehhHHHHHHHHhCCCCCCccCCCcccccHHHHHHHHHhCCC---
Confidence 32211 1123356899999999999999999999999999999999999999643311 11111111111111110
Q ss_pred cCcccCCCCCHHHHHHHHHHHHHchhhcccCCCCH
Q 045315 394 MDPISQNGASYPILKRYINVALLCVQEKAADRPAM 428 (476)
Q Consensus 394 ~d~~~~~~~~~~~~~~l~~li~~Cl~~dP~~RPt~ 428 (476)
..+......+.+++.+||+.||++|+++
T Consensus 221 -------~~p~~~~~~~~~li~~~L~~dP~~R~~~ 248 (327)
T cd05617 221 -------RIPRFLSVKASHVLKGFLNKDPKERLGC 248 (327)
T ss_pred -------CCCCCCCHHHHHHHHHHhccCHHHcCCC
Confidence 0111223567899999999999999984
|
Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, zeta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. There are two aPKC isoforms, zeta and iota. PKC-zeta plays a critical role in activating the glucose transport response. It is activated by glucose, insulin, and exercise through diverse pathways |
| >cd05055 PTKc_PDGFR Catalytic domain of the Protein Tyrosine Kinases, Platelet Derived Growth Factor Receptors | Back alignment and domain information |
|---|
Probab=99.93 E-value=5.7e-26 Score=225.08 Aligned_cols=181 Identities=24% Similarity=0.348 Sum_probs=136.8
Q ss_pred cccceeeccCCCC--------CCCCCCChhhHHHHHHHHHHHHHHHhhcCCCceeecCCCccceEecCCCCceeccccce
Q 045315 241 DEISFWYESYNNP--------TKKGLLCWGTRVRIIEGIAQGLLYLHQYSRLRVIHRDLKASNILLDKDMNPKISDFGMA 312 (476)
Q Consensus 241 ~~~~l~~Ey~~~~--------~~~~~L~~~~~~~i~~qIa~gL~yLH~~~~~~ivH~DLkp~NILld~~~~~kL~DFGla 312 (476)
+..++++||++.. .....+++.++..++.||+.||+|||+++ ++|+||||+||+++.++.+||+|||++
T Consensus 112 ~~~~lv~e~~~~~~L~~~i~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~---ivH~dlkp~Nil~~~~~~~~l~dfg~~ 188 (302)
T cd05055 112 GPILVITEYCCYGDLLNFLRRKRESFLTLEDLLSFSYQVAKGMAFLASKN---CIHRDLAARNVLLTHGKIVKICDFGLA 188 (302)
T ss_pred CceEEEEEcCCCCcHHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHHCC---eehhhhccceEEEcCCCeEEECCCccc
Confidence 4578999999832 12334899999999999999999999998 999999999999999999999999999
Q ss_pred eecCCCcccccceeeeeccCCCChhhhccCCCCccceEEeehhhhhhhhh-CCCCCCcCCCCchhhhhhhhhhhcCCCcc
Q 045315 313 RMFGGDELQSNTKRIVGTYGYMSPEYALRGLFSIKSDVFSFGVLLLETLS-SKKNTHFYNTDSLTLLGHAWNLWNDGRTW 391 (476)
Q Consensus 313 ~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~s~ksDVwSlGvvl~ellt-G~~p~~~~~~~~~~~~~~~~~~~~~~~~~ 391 (476)
+...............++..|+|||.+.+..++.++|||||||++||+++ |+.|+........ +. .....+..
T Consensus 189 ~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslGvil~el~t~g~~p~~~~~~~~~-~~----~~~~~~~~- 262 (302)
T cd05055 189 RDIMNDSNYVVKGNARLPVKWMAPESIFNCVYTFESDVWSYGILLWEIFSLGSNPYPGMPVDSK-FY----KLIKEGYR- 262 (302)
T ss_pred ccccCCCceeecCCCCcccccCCHhhhccCCCCcHhHHHHHHHHHHHHHhCCCCCcCCCCchHH-HH----HHHHcCCc-
Confidence 86543321111122345678999999998899999999999999999998 8888754332111 11 11111110
Q ss_pred cccCcccCCCCCHHHHHHHHHHHHHchhhcccCCCCHHHHHHHHhcc
Q 045315 392 ELMDPISQNGASYPILKRYINVALLCVQEKAADRPAMSEVVSMLSNE 438 (476)
Q Consensus 392 ~~~d~~~~~~~~~~~~~~l~~li~~Cl~~dP~~RPt~~eVl~~L~~~ 438 (476)
..........+.+++.+|++.+|++||++.||++.|++.
T Consensus 263 --------~~~~~~~~~~~~~li~~cl~~~p~~Rpt~~ell~~l~~~ 301 (302)
T cd05055 263 --------MAQPEHAPAEIYDIMKTCWDADPLKRPTFKQIVQLIGKQ 301 (302)
T ss_pred --------CCCCCCCCHHHHHHHHHHcCCCchhCcCHHHHHHHHHhh
Confidence 001112235788999999999999999999999999864
|
Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) subfamily; catalytic (c) domain. The PDGFR subfamily consists of PDGFR alpha, PDGFR beta, KIT, CSF-1R, the mammalian FLT3, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. PDGFR kinase domains are autoinhibited by their juxtamembrane regions containing tyr residues. The binding to their ligands leads to recept |
| >cd07868 STKc_CDK8 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 8 | Back alignment and domain information |
|---|
Probab=99.93 E-value=8.5e-26 Score=224.94 Aligned_cols=111 Identities=32% Similarity=0.472 Sum_probs=94.0
Q ss_pred CCCChhhHHHHHHHHHHHHHHHhhcCCCceeecCCCccceEe----cCCCCceeccccceeecCCCccc-ccceeeeecc
Q 045315 257 GLLCWGTRVRIIEGIAQGLLYLHQYSRLRVIHRDLKASNILL----DKDMNPKISDFGMARMFGGDELQ-SNTKRIVGTY 331 (476)
Q Consensus 257 ~~L~~~~~~~i~~qIa~gL~yLH~~~~~~ivH~DLkp~NILl----d~~~~~kL~DFGla~~~~~~~~~-~~~~~~~gt~ 331 (476)
..+++..+..++.||+.||+|||+++ |+||||||+|||+ +.++.+||+|||+++........ .......+|+
T Consensus 103 ~~l~~~~~~~i~~qi~~al~~LH~~~---ivHrDlkp~Nil~~~~~~~~~~~kl~DfG~a~~~~~~~~~~~~~~~~~~t~ 179 (317)
T cd07868 103 VQLPRGMVKSLLYQILDGIHYLHANW---VLHRDLKPANILVMGEGPERGRVKIADMGFARLFNSPLKPLADLDPVVVTF 179 (317)
T ss_pred ccCCHHHHHHHHHHHHHHHHHHHhCC---EEcCCCCHHHEEEecCCCCcCcEEEeecCceeccCCCCccccccCCccccc
Confidence 46899999999999999999999999 9999999999999 45678999999999876533211 1223356899
Q ss_pred CCCChhhhcc-CCCCccceEEeehhhhhhhhhCCCCCCcC
Q 045315 332 GYMSPEYALR-GLFSIKSDVFSFGVLLLETLSSKKNTHFY 370 (476)
Q Consensus 332 ~y~aPE~l~~-~~~s~ksDVwSlGvvl~elltG~~p~~~~ 370 (476)
.|+|||++.+ ..++.++||||+||++|||++|++||...
T Consensus 180 ~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~~f~~~ 219 (317)
T cd07868 180 WYRAPELLLGARHYTKAIDIWAIGCIFAELLTSEPIFHCR 219 (317)
T ss_pred cccCCHHHcCCCCcCchhhHHHHHHHHHHHHhCCCCccCC
Confidence 9999999876 45899999999999999999999998643
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 8 (CDK8) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK8 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK8 can act as a negative or positive regulator of transcription, depending on the scenario. Together with its regulator, cyclin C, it reversibly associates with the multi-subunit core Mediator complex, a cofactor that is involved in regulating RNA p |
| >cd05062 PTKc_IGF-1R Catalytic domain of the Protein Tyrosine Kinase, Insulin-like Growth Factor-1 Receptor | Back alignment and domain information |
|---|
Probab=99.93 E-value=3.3e-26 Score=223.35 Aligned_cols=162 Identities=26% Similarity=0.390 Sum_probs=123.4
Q ss_pred CCChhhHHHHHHHHHHHHHHHhhcCCCceeecCCCccceEecCCCCceeccccceeecCCCcccccceeeeeccCCCChh
Q 045315 258 LLCWGTRVRIIEGIAQGLLYLHQYSRLRVIHRDLKASNILLDKDMNPKISDFGMARMFGGDELQSNTKRIVGTYGYMSPE 337 (476)
Q Consensus 258 ~L~~~~~~~i~~qIa~gL~yLH~~~~~~ivH~DLkp~NILld~~~~~kL~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE 337 (476)
.+++.+++.++.|+++||+|||+.+ ++|+||||+||++++++.+||+|||+++...............++..|+|||
T Consensus 115 ~~~~~~~~~~~~~l~~~l~~lH~~~---~vH~dlkp~Nil~~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE 191 (277)
T cd05062 115 PPSLKKMIQMAGEIADGMAYLNANK---FVHRDLAARNCMVAEDFTVKIGDFGMTRDIYETDYYRKGGKGLLPVRWMSPE 191 (277)
T ss_pred CCCHHHHHHHHHHHHHHHHHHHHCC---cccCCcchheEEEcCCCCEEECCCCCccccCCcceeecCCCCccCHhhcChh
Confidence 4688899999999999999999998 9999999999999999999999999987654332222122234567899999
Q ss_pred hhccCCCCccceEEeehhhhhhhhh-CCCCCCcCCCCchhhhhhhhhhhcCCCcccccCcccCCCCCHHHHHHHHHHHHH
Q 045315 338 YALRGLFSIKSDVFSFGVLLLETLS-SKKNTHFYNTDSLTLLGHAWNLWNDGRTWELMDPISQNGASYPILKRYINVALL 416 (476)
Q Consensus 338 ~l~~~~~s~ksDVwSlGvvl~ellt-G~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~l~~li~~ 416 (476)
.+.+..++.++|||||||++|||++ |..|+..... ..... ....+..... +......+.+++.+
T Consensus 192 ~~~~~~~~~~~Di~slG~~l~el~~~~~~p~~~~~~--~~~~~----~~~~~~~~~~---------~~~~~~~~~~li~~ 256 (277)
T cd05062 192 SLKDGVFTTYSDVWSFGVVLWEIATLAEQPYQGMSN--EQVLR----FVMEGGLLDK---------PDNCPDMLFELMRM 256 (277)
T ss_pred HhhcCCcCchhHHHHHHHHHHHHHcCCCCCCCCCCH--HHHHH----HHHcCCcCCC---------CCCCCHHHHHHHHH
Confidence 9998889999999999999999998 6777754321 11111 1111111110 11223568899999
Q ss_pred chhhcccCCCCHHHHHHHHhc
Q 045315 417 CVQEKAADRPAMSEVVSMLSN 437 (476)
Q Consensus 417 Cl~~dP~~RPt~~eVl~~L~~ 437 (476)
||+.+|++||++.|+++.|++
T Consensus 257 ~l~~~p~~Rps~~e~l~~l~~ 277 (277)
T cd05062 257 CWQYNPKMRPSFLEIISSIKE 277 (277)
T ss_pred HcCCChhhCcCHHHHHHHhhC
Confidence 999999999999999999863
|
Protein Tyrosine Kinase (PTK) family; Insulin-like Growth Factor-1 Receptor (IGF-1R); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. IGF-1R is a receptor tyr kinases (RTK) that is composed of two alphabeta heterodimers. Binding of the ligand (IGF-1 or IGF-2) to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, which stimulates downstream kinase activities and biological function. IGF-1R signaling is important in the differentiation, growth, and survival of normal cells. In cancer cells, wh |
| >cd05079 PTKc_Jak1_rpt2 Catalytic (repeat 2) domain of the Protein Tyrosine Kinase, Janus kinase 1 | Back alignment and domain information |
|---|
Probab=99.93 E-value=5e-26 Score=223.01 Aligned_cols=186 Identities=21% Similarity=0.298 Sum_probs=135.5
Q ss_pred cccceeeccCCCCC-------CCCCCChhhHHHHHHHHHHHHHHHhhcCCCceeecCCCccceEecCCCCceecccccee
Q 045315 241 DEISFWYESYNNPT-------KKGLLCWGTRVRIIEGIAQGLLYLHQYSRLRVIHRDLKASNILLDKDMNPKISDFGMAR 313 (476)
Q Consensus 241 ~~~~l~~Ey~~~~~-------~~~~L~~~~~~~i~~qIa~gL~yLH~~~~~~ivH~DLkp~NILld~~~~~kL~DFGla~ 313 (476)
...++++||++... ....+++.++..++.||+.||+|||+.+ ++||||||+||+++.++.+||+|||+++
T Consensus 81 ~~~~lv~e~~~g~~L~~~l~~~~~~~~~~~~~~i~~~i~~aL~~lH~~g---i~H~dlkp~Nil~~~~~~~~l~dfg~~~ 157 (284)
T cd05079 81 NGIKLIMEFLPSGSLKEYLPRNKNKINLKQQLKYAVQICKGMDYLGSRQ---YVHRDLAARNVLVESEHQVKIGDFGLTK 157 (284)
T ss_pred CceEEEEEccCCCCHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHHCC---eeecccchheEEEcCCCCEEECCCcccc
Confidence 35678999998332 2346899999999999999999999998 9999999999999999999999999998
Q ss_pred ecCCCccc-ccceeeeeccCCCChhhhccCCCCccceEEeehhhhhhhhhCCCCCCcCCCCch---------hhhhhhhh
Q 045315 314 MFGGDELQ-SNTKRIVGTYGYMSPEYALRGLFSIKSDVFSFGVLLLETLSSKKNTHFYNTDSL---------TLLGHAWN 383 (476)
Q Consensus 314 ~~~~~~~~-~~~~~~~gt~~y~aPE~l~~~~~s~ksDVwSlGvvl~elltG~~p~~~~~~~~~---------~~~~~~~~ 383 (476)
.+...... .......++..|+|||.+.+..++.++|||||||++||+++++.|......... ........
T Consensus 158 ~~~~~~~~~~~~~~~~~~~~y~apE~~~~~~~~~~~Di~slG~il~ellt~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 237 (284)
T cd05079 158 AIETDKEYYTVKDDLDSPVFWYAPECLIQSKFYIASDVWSFGVTLYELLTYCDSESSPMTLFLKMIGPTHGQMTVTRLVR 237 (284)
T ss_pred ccccCccceeecCCCCCCccccCHHHhccCCCCccccchhhhhhhhhhhcCCCCCccccchhhhhcccccccccHHHHHH
Confidence 76433211 111224466789999999888899999999999999999998765422110000 00000000
Q ss_pred hhcCCCcccccCcccCCCCCHHHHHHHHHHHHHchhhcccCCCCHHHHHHHHhcc
Q 045315 384 LWNDGRTWELMDPISQNGASYPILKRYINVALLCVQEKAADRPAMSEVVSMLSNE 438 (476)
Q Consensus 384 ~~~~~~~~~~~d~~~~~~~~~~~~~~l~~li~~Cl~~dP~~RPt~~eVl~~L~~~ 438 (476)
....+.. ..........+.+++.+||+.+|++||++.++++.|+.+
T Consensus 238 ~~~~~~~---------~~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~il~~l~~~ 283 (284)
T cd05079 238 VLEEGKR---------LPRPPNCPEEVYQLMRKCWEFQPSKRTTFQNLIEGFEAI 283 (284)
T ss_pred HHHcCcc---------CCCCCCCCHHHHHHHHHHccCCcccCcCHHHHHHHHHhh
Confidence 1111111 011122346789999999999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 1 (Jak1); catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak1 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers a |
| >cd05033 PTKc_EphR Catalytic domain of Ephrin Receptor Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=99.93 E-value=4.1e-26 Score=221.29 Aligned_cols=180 Identities=28% Similarity=0.420 Sum_probs=135.9
Q ss_pred cccceeeccCCCC-------CCCCCCChhhHHHHHHHHHHHHHHHhhcCCCceeecCCCccceEecCCCCceecccccee
Q 045315 241 DEISFWYESYNNP-------TKKGLLCWGTRVRIIEGIAQGLLYLHQYSRLRVIHRDLKASNILLDKDMNPKISDFGMAR 313 (476)
Q Consensus 241 ~~~~l~~Ey~~~~-------~~~~~L~~~~~~~i~~qIa~gL~yLH~~~~~~ivH~DLkp~NILld~~~~~kL~DFGla~ 313 (476)
+..++++||++.. ...+.+++.++++++.|++.||+|||+.+ |+|+||||+||+++.++.+||+|||+++
T Consensus 78 ~~~~iv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~l~~~l~~Lh~~~---i~H~di~p~nili~~~~~~~l~dfg~~~ 154 (266)
T cd05033 78 RPVMIITEYMENGSLDKFLRENDGKFTVGQLVGMLRGIASGMKYLSEMN---YVHRDLAARNILVNSNLVCKVSDFGLSR 154 (266)
T ss_pred CceEEEEEcCCCCCHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHhCC---cccCCCCcceEEEcCCCCEEECccchhh
Confidence 3467788988743 22457999999999999999999999998 9999999999999999999999999998
Q ss_pred ecCCCcccccceeeeeccCCCChhhhccCCCCccceEEeehhhhhhhhh-CCCCCCcCCCCchhhhhhhhhhhcCCCccc
Q 045315 314 MFGGDELQSNTKRIVGTYGYMSPEYALRGLFSIKSDVFSFGVLLLETLS-SKKNTHFYNTDSLTLLGHAWNLWNDGRTWE 392 (476)
Q Consensus 314 ~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~s~ksDVwSlGvvl~ellt-G~~p~~~~~~~~~~~~~~~~~~~~~~~~~~ 392 (476)
...............++..|+|||.+.+..++.++||||||+++||+++ |..|+..... ...... ...+...
T Consensus 155 ~~~~~~~~~~~~~~~~~~~y~~Pe~~~~~~~~~~~Dv~slG~~l~~l~~~g~~p~~~~~~--~~~~~~----~~~~~~~- 227 (266)
T cd05033 155 RLEDSEATYTTKGGKIPIRWTAPEAIAYRKFTSASDVWSFGIVMWEVMSYGERPYWDMSN--QDVIKA----VEDGYRL- 227 (266)
T ss_pred cccccccceeccCCCCCccccChhhhccCCCccccchHHHHHHHHHHHccCCCCCCCCCH--HHHHHH----HHcCCCC-
Confidence 7752222111212234578999999998889999999999999999997 8888743221 111111 1111000
Q ss_pred ccCcccCCCCCHHHHHHHHHHHHHchhhcccCCCCHHHHHHHHhcc
Q 045315 393 LMDPISQNGASYPILKRYINVALLCVQEKAADRPAMSEVVSMLSNE 438 (476)
Q Consensus 393 ~~d~~~~~~~~~~~~~~l~~li~~Cl~~dP~~RPt~~eVl~~L~~~ 438 (476)
.........+.+++.+||+.+|++||++.+|++.|+++
T Consensus 228 --------~~~~~~~~~l~~li~~cl~~~p~~Rp~~~ei~~~l~~~ 265 (266)
T cd05033 228 --------PPPMDCPSALYQLMLDCWQKDRNERPTFSQIVSTLDKM 265 (266)
T ss_pred --------CCCCCCCHHHHHHHHHHcCCCcccCcCHHHHHHHHHhh
Confidence 01112345688999999999999999999999999874
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). They can be classified into two classes (EphA and EphB), according to their extracellular sequences, which largely correspond to binding preferences for either GPI-anchored ephrin-A ligands or transmembrane ephrin-B ligands. Vertebrates have ten EphA and six EhpB receptors, which display promiscuous ligand interactions within each class. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment |
| >cd05070 PTKc_Fyn_Yrk Catalytic domain of the Protein Tyrosine Kinases, Fyn and Yrk | Back alignment and domain information |
|---|
Probab=99.93 E-value=6.4e-26 Score=219.14 Aligned_cols=177 Identities=28% Similarity=0.407 Sum_probs=134.3
Q ss_pred ccceeeccCCCC--------CCCCCCChhhHHHHHHHHHHHHHHHhhcCCCceeecCCCccceEecCCCCceecccccee
Q 045315 242 EISFWYESYNNP--------TKKGLLCWGTRVRIIEGIAQGLLYLHQYSRLRVIHRDLKASNILLDKDMNPKISDFGMAR 313 (476)
Q Consensus 242 ~~~l~~Ey~~~~--------~~~~~L~~~~~~~i~~qIa~gL~yLH~~~~~~ivH~DLkp~NILld~~~~~kL~DFGla~ 313 (476)
..+++|||++.. .....+++.++.+++.|++.||+|||+.+ ++|+||||+||++++++.+||+|||++.
T Consensus 74 ~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~l~~al~~lH~~~---i~H~di~p~Nili~~~~~~~l~dfg~~~ 150 (260)
T cd05070 74 PIYIVTEYMSKGSLLDFLKDGEGRALKLPNLVDMAAQVAAGMAYIERMN---YIHRDLRSANILVGDGLVCKIADFGLAR 150 (260)
T ss_pred CcEEEEEecCCCcHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCccceEEEeCCceEEeCCceeee
Confidence 467888888732 22446899999999999999999999998 9999999999999999999999999998
Q ss_pred ecCCCcccccceeeeeccCCCChhhhccCCCCccceEEeehhhhhhhhh-CCCCCCcCCCCchhhhhhhhhhhcCCCccc
Q 045315 314 MFGGDELQSNTKRIVGTYGYMSPEYALRGLFSIKSDVFSFGVLLLETLS-SKKNTHFYNTDSLTLLGHAWNLWNDGRTWE 392 (476)
Q Consensus 314 ~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~s~ksDVwSlGvvl~ellt-G~~p~~~~~~~~~~~~~~~~~~~~~~~~~~ 392 (476)
......... .....++..|+|||.+.+..++.++|+||||+++||+++ |+.||..... ...... ...+..
T Consensus 151 ~~~~~~~~~-~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~~g~~p~~~~~~--~~~~~~----~~~~~~-- 221 (260)
T cd05070 151 LIEDNEYTA-RQGAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELVTKGRVPYPGMNN--REVLEQ----VERGYR-- 221 (260)
T ss_pred eccCccccc-ccCCCCCccccChHHHhcCCCcchhhhHHHHHHHHHHHhcCCCCCCCCCH--HHHHHH----HHcCCC--
Confidence 765432111 111234668999999988889999999999999999999 8888754321 111111 111100
Q ss_pred ccCcccCCCCCHHHHHHHHHHHHHchhhcccCCCCHHHHHHHHhc
Q 045315 393 LMDPISQNGASYPILKRYINVALLCVQEKAADRPAMSEVVSMLSN 437 (476)
Q Consensus 393 ~~d~~~~~~~~~~~~~~l~~li~~Cl~~dP~~RPt~~eVl~~L~~ 437 (476)
...+......+.+++.+|++.+|++|||+.++.+.|++
T Consensus 222 -------~~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~l~~~l~~ 259 (260)
T cd05070 222 -------MPCPQDCPISLHELMLQCWKKDPEERPTFEYLQSFLED 259 (260)
T ss_pred -------CCCCCcCCHHHHHHHHHHcccCcccCcCHHHHHHHHhc
Confidence 01112234568899999999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Fyn and Yrk kinases; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fyn and Yrk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that r |
| >PTZ00036 glycogen synthase kinase; Provisional | Back alignment and domain information |
|---|
Probab=99.93 E-value=4.7e-26 Score=237.36 Aligned_cols=183 Identities=17% Similarity=0.164 Sum_probs=130.4
Q ss_pred cceeeccCCCC---------CCCCCCChhhHHHHHHHHHHHHHHHhhcCCCceeecCCCccceEecCCC-Cceeccccce
Q 045315 243 ISFWYESYNNP---------TKKGLLCWGTRVRIIEGIAQGLLYLHQYSRLRVIHRDLKASNILLDKDM-NPKISDFGMA 312 (476)
Q Consensus 243 ~~l~~Ey~~~~---------~~~~~L~~~~~~~i~~qIa~gL~yLH~~~~~~ivH~DLkp~NILld~~~-~~kL~DFGla 312 (476)
.+++|||++.. .....+++..+..++.||+.||+|||+.+ |+||||||+|||++.++ .+||+|||++
T Consensus 142 l~lvmE~~~~~l~~~~~~~~~~~~~l~~~~~~~~~~qi~~gL~yLH~~~---IiHrDLKp~NILl~~~~~~vkL~DFGla 218 (440)
T PTZ00036 142 LNVVMEFIPQTVHKYMKHYARNNHALPLFLVKLYSYQLCRALAYIHSKF---ICHRDLKPQNLLIDPNTHTLKLCDFGSA 218 (440)
T ss_pred EEEEEecCCccHHHHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHHHCC---EecCCcCHHHEEEcCCCCceeeeccccc
Confidence 45789999831 24567999999999999999999999999 99999999999999665 6999999999
Q ss_pred eecCCCcccccceeeeeccCCCChhhhcc-CCCCccceEEeehhhhhhhhhCCCCCCcCCCCchhhhhhhhhhhcCC---
Q 045315 313 RMFGGDELQSNTKRIVGTYGYMSPEYALR-GLFSIKSDVFSFGVLLLETLSSKKNTHFYNTDSLTLLGHAWNLWNDG--- 388 (476)
Q Consensus 313 ~~~~~~~~~~~~~~~~gt~~y~aPE~l~~-~~~s~ksDVwSlGvvl~elltG~~p~~~~~~~~~~~~~~~~~~~~~~--- 388 (476)
+.+..... .....|++.|+|||++.+ ..++.++|||||||++|||++|++||....... .+.... ......
T Consensus 219 ~~~~~~~~---~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlGvil~elltG~~pf~~~~~~~-~~~~i~-~~~~~p~~~ 293 (440)
T PTZ00036 219 KNLLAGQR---SVSYICSRFYRAPELMLGATNYTTHIDLWSLGCIIAEMILGYPIFSGQSSVD-QLVRII-QVLGTPTED 293 (440)
T ss_pred hhccCCCC---cccCCCCcCccCHHHhcCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCChHH-HHHHHH-HHhCCCCHH
Confidence 86643221 122467899999999876 468999999999999999999999986543211 111110 000000
Q ss_pred -------Ccccc-----cCcccCCCCCHHHHHHHHHHHHHchhhcccCCCCHHHHHH
Q 045315 389 -------RTWEL-----MDPISQNGASYPILKRYINVALLCVQEKAADRPAMSEVVS 433 (476)
Q Consensus 389 -------~~~~~-----~d~~~~~~~~~~~~~~l~~li~~Cl~~dP~~RPt~~eVl~ 433 (476)
...+. ....+....+......+.+++.+||+.||.+|||+.|+++
T Consensus 294 ~~~~~~~~~~~~~~~~~~~~~l~~~~p~~~~~~~~~li~~~L~~dP~~R~ta~e~l~ 350 (440)
T PTZ00036 294 QLKEMNPNYADIKFPDVKPKDLKKVFPKGTPDDAINFISQFLKYEPLKRLNPIEALA 350 (440)
T ss_pred HHHHhchhhhcccCCccCchhHHHHhccCCCHHHHHHHHHHCCCChhHCcCHHHHhC
Confidence 00000 0000000011122457889999999999999999999874
|
|
| >cd05097 PTKc_DDR_like Catalytic domain of Discoidin Domain Receptor-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=99.93 E-value=1.3e-25 Score=221.52 Aligned_cols=169 Identities=22% Similarity=0.334 Sum_probs=123.1
Q ss_pred CCChhhHHHHHHHHHHHHHHHhhcCCCceeecCCCccceEecCCCCceeccccceeecCCCcccccceeeeeccCCCChh
Q 045315 258 LLCWGTRVRIIEGIAQGLLYLHQYSRLRVIHRDLKASNILLDKDMNPKISDFGMARMFGGDELQSNTKRIVGTYGYMSPE 337 (476)
Q Consensus 258 ~L~~~~~~~i~~qIa~gL~yLH~~~~~~ivH~DLkp~NILld~~~~~kL~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE 337 (476)
.+++.++++++.|++.||+|||+.+ ++|+||||+||+++.++.+||+|||++................++..|+|||
T Consensus 125 ~~~~~~~~~i~~~i~~al~~lH~~~---i~H~dlkp~Nill~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE 201 (295)
T cd05097 125 SVSIANLLYMAVQIASGMKYLASLN---FVHRDLATRNCLVGNHYTIKIADFGMSRNLYSGDYYRIQGRAVLPIRWMAWE 201 (295)
T ss_pred cccHHHHHHHHHHHHHHHHHHHhcC---eeccccChhhEEEcCCCcEEecccccccccccCcceeccCcCcCceeecChh
Confidence 4789999999999999999999998 9999999999999999999999999997654322222222234567899999
Q ss_pred hhccCCCCccceEEeehhhhhhhhhCC--CCCCcCCCCchhhhhhhhhhhcCCCcccccCcccCCCCCHHHHHHHHHHHH
Q 045315 338 YALRGLFSIKSDVFSFGVLLLETLSSK--KNTHFYNTDSLTLLGHAWNLWNDGRTWELMDPISQNGASYPILKRYINVAL 415 (476)
Q Consensus 338 ~l~~~~~s~ksDVwSlGvvl~elltG~--~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~l~~li~ 415 (476)
.+.++.++.++|+|||||+++||+++. .||.... ...........+........ ...+......+.+++.
T Consensus 202 ~~~~~~~~~~~DvwSlG~~l~el~~~~~~~p~~~~~--~~~~~~~~~~~~~~~~~~~~------~~~~~~~~~~l~~li~ 273 (295)
T cd05097 202 SILLGKFTTASDVWAFGVTLWEMFTLCKEQPYSLLS--DEQVIENTGEFFRNQGRQIY------LSQTPLCPSPVFKLMM 273 (295)
T ss_pred hhccCCcCchhhHHHHHHHHHHHHHcCCCCCCcccC--hHHHHHHHHHhhhhcccccc------CCCCCCCCHHHHHHHH
Confidence 999888999999999999999999854 4443322 11121111111111100000 0011122357899999
Q ss_pred HchhhcccCCCCHHHHHHHHhc
Q 045315 416 LCVQEKAADRPAMSEVVSMLSN 437 (476)
Q Consensus 416 ~Cl~~dP~~RPt~~eVl~~L~~ 437 (476)
+||+.+|++||++.+|++.|+.
T Consensus 274 ~~l~~~p~~RPs~~~i~~~l~~ 295 (295)
T cd05097 274 RCWSRDIKDRPTFNKIHHFLRE 295 (295)
T ss_pred HHcCCCchhCcCHHHHHHHHhC
Confidence 9999999999999999999863
|
Protein Tyrosine Kinase (PTK) family; Discoidin Domain Receptor (DDR)-like proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR-like proteins are members of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDRs regulate cell adhesion, proliferation, and extracellular matrix remodeling. They have been linked to a variety of human cancers including |
| >KOG2345 consensus Serine/threonine protein kinase/TGF-beta stimulated factor [Transcription; Lipid transport and metabolism; Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.93 E-value=3.9e-26 Score=208.91 Aligned_cols=185 Identities=21% Similarity=0.222 Sum_probs=139.9
Q ss_pred cccceeeccCCCC----------CCCCCCChhhHHHHHHHHHHHHHHHhhcCCCceeecCCCccceEecCCCCceecccc
Q 045315 241 DEISFWYESYNNP----------TKKGLLCWGTRVRIIEGIAQGLLYLHQYSRLRVIHRDLKASNILLDKDMNPKISDFG 310 (476)
Q Consensus 241 ~~~~l~~Ey~~~~----------~~~~~L~~~~~~~i~~qIa~gL~yLH~~~~~~ivH~DLkp~NILld~~~~~kL~DFG 310 (476)
.+.++++.|...+ .++..+++.+.+.|+.+|++||++||+.. +++.||||||.|||+.+++.++|.|||
T Consensus 96 ~~~yll~Pyy~~Gsl~d~i~~~k~kg~~~sE~~iL~if~gic~gL~~lH~~~-~~yAH~DiKP~NILls~~~~~vl~D~G 174 (302)
T KOG2345|consen 96 HEAYLLLPYYKRGSLLDEIERLKIKGNFVSEAQILWIFLGICRGLEALHEKE-PPYAHRDIKPANILLSDSGLPVLMDLG 174 (302)
T ss_pred eeEEEEeehhccccHHHHHHHHhhcCCccCHHHHHHHHHHHHHHHHHHhccC-CcccccCCCcceeEecCCCceEEEecc
Confidence 4688888887732 35568999999999999999999999986 579999999999999999999999999
Q ss_pred ceeecCCC---ccc----ccceeeeeccCCCChhhhc---cCCCCccceEEeehhhhhhhhhCCCCCCcCCCCchhhhhh
Q 045315 311 MARMFGGD---ELQ----SNTKRIVGTYGYMSPEYAL---RGLFSIKSDVFSFGVLLLETLSSKKNTHFYNTDSLTLLGH 380 (476)
Q Consensus 311 la~~~~~~---~~~----~~~~~~~gt~~y~aPE~l~---~~~~s~ksDVwSlGvvl~elltG~~p~~~~~~~~~~~~~~ 380 (476)
.+....-. ..+ ........|..|+|||.+. +..++.++|||||||++|+|+.|..||.........+.
T Consensus 175 S~~~a~i~i~~~~~a~~lQe~a~e~Ct~pyRAPELf~vk~~~ti~ertDIWSLGCtLYa~mf~~sPfe~~~~~GgSla-- 252 (302)
T KOG2345|consen 175 SATQAPIQIEGSRQALRLQEWAEERCTIPYRAPELFNVKSHCTITERTDIWSLGCTLYAMMFGESPFERIYQQGGSLA-- 252 (302)
T ss_pred CccccceEeechHHHHHHHHHHHHhCCCcccCchheecccCcccccccchhhhhHHHHHHHHcCCcchHHhhcCCeEE--
Confidence 98754311 000 0111235688999999885 55678999999999999999999999975332111111
Q ss_pred hhhhhcCCCcccccCcccCCCCCHHHHHHHHHHHHHchhhcccCCCCHHHHHHHHhcc
Q 045315 381 AWNLWNDGRTWELMDPISQNGASYPILKRYINVALLCVQEKAADRPAMSEVVSMLSNE 438 (476)
Q Consensus 381 ~~~~~~~~~~~~~~d~~~~~~~~~~~~~~l~~li~~Cl~~dP~~RPt~~eVl~~L~~~ 438 (476)
.....+...-.......+.+.+++.+|++.||.+||++.+++..++.+
T Consensus 253 ----------LAv~n~q~s~P~~~~yse~l~~lik~mlqvdP~qRP~i~~ll~~~d~L 300 (302)
T KOG2345|consen 253 ----------LAVQNAQISIPNSSRYSEALHQLIKSMLQVDPNQRPTIPELLSKLDDL 300 (302)
T ss_pred ----------EeeeccccccCCCCCccHHHHHHHHHHhcCCcccCCCHHHHHHHHHhh
Confidence 011111222222333677899999999999999999999999998775
|
|
| >cd05616 STKc_cPKC_beta Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C beta | Back alignment and domain information |
|---|
Probab=99.93 E-value=6.4e-26 Score=226.86 Aligned_cols=167 Identities=28% Similarity=0.355 Sum_probs=129.9
Q ss_pred cccceeeccCCCCC------CCCCCChhhHHHHHHHHHHHHHHHhhcCCCceeecCCCccceEecCCCCceeccccceee
Q 045315 241 DEISFWYESYNNPT------KKGLLCWGTRVRIIEGIAQGLLYLHQYSRLRVIHRDLKASNILLDKDMNPKISDFGMARM 314 (476)
Q Consensus 241 ~~~~l~~Ey~~~~~------~~~~L~~~~~~~i~~qIa~gL~yLH~~~~~~ivH~DLkp~NILld~~~~~kL~DFGla~~ 314 (476)
+..+++|||++.+. +.+.+++.++..++.||+.||+|||+.+ |+||||||+|||++.++.+||+|||+++.
T Consensus 74 ~~~~lv~E~~~~g~L~~~~~~~~~~~~~~~~~~~~qi~~aL~~LH~~~---ivHrDlkp~Nill~~~~~~kL~DfG~~~~ 150 (323)
T cd05616 74 DRLYFVMEYVNGGDLMYQIQQVGRFKEPHAVFYAAEIAIGLFFLHSKG---IIYRDLKLDNVMLDSEGHIKIADFGMCKE 150 (323)
T ss_pred CEEEEEEcCCCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCC---EEecCCCHHHeEECCCCcEEEccCCCcee
Confidence 45789999998432 3457899999999999999999999998 99999999999999999999999999975
Q ss_pred cCCCcccccceeeeeccCCCChhhhccCCCCccceEEeehhhhhhhhhCCCCCCcCCCCchhhhhhhhhhhcCCCccccc
Q 045315 315 FGGDELQSNTKRIVGTYGYMSPEYALRGLFSIKSDVFSFGVLLLETLSSKKNTHFYNTDSLTLLGHAWNLWNDGRTWELM 394 (476)
Q Consensus 315 ~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~s~ksDVwSlGvvl~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 394 (476)
...... ......|++.|+|||++.+..++.++|+|||||++|||++|+.||...... ..... ......
T Consensus 151 ~~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvil~elltg~~Pf~~~~~~--~~~~~----i~~~~~---- 218 (323)
T cd05616 151 NMWDGV--TTKTFCGTPDYIAPEIIAYQPYGKSVDWWAFGVLLYEMLAGQAPFEGEDED--ELFQS----IMEHNV---- 218 (323)
T ss_pred cCCCCC--ccccCCCChhhcCHHHhcCCCCCCccchhchhHHHHHHHhCCCCCCCCCHH--HHHHH----HHhCCC----
Confidence 432211 122356899999999999999999999999999999999999998654321 11111 111110
Q ss_pred CcccCCCCCHHHHHHHHHHHHHchhhcccCCCCH
Q 045315 395 DPISQNGASYPILKRYINVALLCVQEKAADRPAM 428 (476)
Q Consensus 395 d~~~~~~~~~~~~~~l~~li~~Cl~~dP~~RPt~ 428 (476)
..+......+.+++.+|++.+|++|++.
T Consensus 219 ------~~p~~~s~~~~~li~~~l~~~p~~R~~~ 246 (323)
T cd05616 219 ------AYPKSMSKEAVAICKGLMTKHPGKRLGC 246 (323)
T ss_pred ------CCCCcCCHHHHHHHHHHcccCHHhcCCC
Confidence 0112234568899999999999999984
|
Serine/Threonine Kinases (STKs), Classical Protein Kinase C (cPKC) subfamily, beta isoforms, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. There are four cPKC isoforms, named alpha, betaI, betaII, and |
| >cd05115 PTKc_Zap-70 Catalytic domain of the Protein Tyrosine Kinase, Zeta-chain-associated protein of 70kDa | Back alignment and domain information |
|---|
Probab=99.93 E-value=4.9e-26 Score=220.01 Aligned_cols=179 Identities=23% Similarity=0.342 Sum_probs=135.0
Q ss_pred ccceeeccCCCC-------CCCCCCChhhHHHHHHHHHHHHHHHhhcCCCceeecCCCccceEecCCCCceeccccceee
Q 045315 242 EISFWYESYNNP-------TKKGLLCWGTRVRIIEGIAQGLLYLHQYSRLRVIHRDLKASNILLDKDMNPKISDFGMARM 314 (476)
Q Consensus 242 ~~~l~~Ey~~~~-------~~~~~L~~~~~~~i~~qIa~gL~yLH~~~~~~ivH~DLkp~NILld~~~~~kL~DFGla~~ 314 (476)
..++++||++.. .+...+++.++++++.||+.||+|||+++ ++||||||+||+++.++.+||+|||++..
T Consensus 68 ~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~---i~H~dlkp~nil~~~~~~~kl~dfg~~~~ 144 (257)
T cd05115 68 ALMLVMEMASGGPLNKFLSGKKDEITVSNVVELMHQVSMGMKYLEGKN---FVHRDLAARNVLLVNQHYAKISDFGLSKA 144 (257)
T ss_pred CeEEEEEeCCCCCHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHhcC---eeecccchheEEEcCCCcEEeccCCcccc
Confidence 467888988732 23457999999999999999999999998 99999999999999999999999999986
Q ss_pred cCCCccccc-ceeeeeccCCCChhhhccCCCCccceEEeehhhhhhhhh-CCCCCCcCCCCchhhhhhhhhhhcCCCccc
Q 045315 315 FGGDELQSN-TKRIVGTYGYMSPEYALRGLFSIKSDVFSFGVLLLETLS-SKKNTHFYNTDSLTLLGHAWNLWNDGRTWE 392 (476)
Q Consensus 315 ~~~~~~~~~-~~~~~gt~~y~aPE~l~~~~~s~ksDVwSlGvvl~ellt-G~~p~~~~~~~~~~~~~~~~~~~~~~~~~~ 392 (476)
......... .....++..|+|||.+....++.++|||||||++||+++ |..||...... ... .....+...
T Consensus 145 ~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~~~~~~--~~~----~~~~~~~~~- 217 (257)
T cd05115 145 LGADDSYYKARSAGKWPLKWYAPECINFRKFSSRSDVWSYGITMWEAFSYGQKPYKKMKGP--EVM----SFIEQGKRL- 217 (257)
T ss_pred ccCCccceeccCCCCCCcccCCHHHHccCCCCchhhHHHHHHHHHHHhcCCCCCcCcCCHH--HHH----HHHHCCCCC-
Confidence 543322111 111223568999999988889999999999999999996 89887543211 111 111111111
Q ss_pred ccCcccCCCCCHHHHHHHHHHHHHchhhcccCCCCHHHHHHHHhcc
Q 045315 393 LMDPISQNGASYPILKRYINVALLCVQEKAADRPAMSEVVSMLSNE 438 (476)
Q Consensus 393 ~~d~~~~~~~~~~~~~~l~~li~~Cl~~dP~~RPt~~eVl~~L~~~ 438 (476)
..+......+.+++.+||+.+|++||++.+|.+.|+..
T Consensus 218 --------~~~~~~~~~l~~li~~c~~~~~~~Rp~~~~i~~~l~~~ 255 (257)
T cd05115 218 --------DCPAECPPEMYALMKDCWIYKWEDRPNFAKVEERMRTY 255 (257)
T ss_pred --------CCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHhhh
Confidence 11122345788899999999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Zeta-chain-associated protein of 70kDa (Zap-70); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Zap-70 is a member of the Syk subfamily of kinases, which are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. Zap-70 is primarily expressed in T-cells and NK cells, and is a crucial component in T-cell receptor (TCR) signaling. Zap-70 binds the phosphorylated ITAM (immunoreceptor tyr activation motif) sequences of the activated TCR zeta-chain through its SH2 domains, leading to its pho |
| >cd05592 STKc_nPKC_theta_delta Catalytic domain of the Protein Serine/Threonine Kinases, Novel Protein Kinase C theta and delta | Back alignment and domain information |
|---|
Probab=99.93 E-value=6.5e-26 Score=226.23 Aligned_cols=171 Identities=29% Similarity=0.358 Sum_probs=131.7
Q ss_pred cccceeeccCCCCC------CCCCCChhhHHHHHHHHHHHHHHHhhcCCCceeecCCCccceEecCCCCceeccccceee
Q 045315 241 DEISFWYESYNNPT------KKGLLCWGTRVRIIEGIAQGLLYLHQYSRLRVIHRDLKASNILLDKDMNPKISDFGMARM 314 (476)
Q Consensus 241 ~~~~l~~Ey~~~~~------~~~~L~~~~~~~i~~qIa~gL~yLH~~~~~~ivH~DLkp~NILld~~~~~kL~DFGla~~ 314 (476)
+..+++|||++.+. ....++..++..++.||+.||+|||+.+ |+||||||+||+++.++.+||+|||+++.
T Consensus 69 ~~~~lv~e~~~gg~L~~~~~~~~~~~~~~~~~~~~qi~~al~~LH~~~---ivH~dlkp~Nill~~~~~~kL~Dfg~a~~ 145 (316)
T cd05592 69 EHLFFVMEYLNGGDLMFHIQSSGRFDEARARFYAAEIICGLQFLHKKG---IIYRDLKLDNVLLDKDGHIKIADFGMCKE 145 (316)
T ss_pred CEEEEEEcCCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCC---EEeCCCCHHHeEECCCCCEEEccCcCCeE
Confidence 45788999998432 3457999999999999999999999998 99999999999999999999999999986
Q ss_pred cCCCcccccceeeeeccCCCChhhhccCCCCccceEEeehhhhhhhhhCCCCCCcCCCCchhhhhhhhhhhcCCCccccc
Q 045315 315 FGGDELQSNTKRIVGTYGYMSPEYALRGLFSIKSDVFSFGVLLLETLSSKKNTHFYNTDSLTLLGHAWNLWNDGRTWELM 394 (476)
Q Consensus 315 ~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~s~ksDVwSlGvvl~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 394 (476)
..... .......|+..|+|||.+.+..++.++|||||||++|||++|+.||...... ..... .....
T Consensus 146 ~~~~~--~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~ell~G~~Pf~~~~~~--~~~~~----i~~~~----- 212 (316)
T cd05592 146 NMNGE--GKASTFCGTPDYIAPEILKGQKYNESVDWWSFGVLLYEMLIGQSPFHGEDED--ELFDS----ILNDR----- 212 (316)
T ss_pred CCCCC--CccccccCCccccCHHHHcCCCCCCcccchhHHHHHHHHHhCCCCCCCCCHH--HHHHH----HHcCC-----
Confidence 53322 1223356899999999999889999999999999999999999998654321 11111 11100
Q ss_pred CcccCCCCCHHHHHHHHHHHHHchhhcccCCCCHH-HHH
Q 045315 395 DPISQNGASYPILKRYINVALLCVQEKAADRPAMS-EVV 432 (476)
Q Consensus 395 d~~~~~~~~~~~~~~l~~li~~Cl~~dP~~RPt~~-eVl 432 (476)
+ ..+......+.+++.+||+.||++||++. +++
T Consensus 213 -~----~~~~~~~~~~~~ll~~~l~~~P~~R~~~~~~l~ 246 (316)
T cd05592 213 -P----HFPRWISKEAKDCLSKLFERDPTKRLGVDGDIR 246 (316)
T ss_pred -C----CCCCCCCHHHHHHHHHHccCCHHHcCCChHHHH
Confidence 0 11112235678899999999999999875 453
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), theta and delta-like isoforms, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-theta is selectively expressed in T-cells and plays an imp |
| >PHA03212 serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Probab=99.93 E-value=7.3e-26 Score=232.42 Aligned_cols=188 Identities=20% Similarity=0.233 Sum_probs=130.4
Q ss_pred ccceeeccCCCC-----CCCCCCChhhHHHHHHHHHHHHHHHhhcCCCceeecCCCccceEecCCCCceeccccceeecC
Q 045315 242 EISFWYESYNNP-----TKKGLLCWGTRVRIIEGIAQGLLYLHQYSRLRVIHRDLKASNILLDKDMNPKISDFGMARMFG 316 (476)
Q Consensus 242 ~~~l~~Ey~~~~-----~~~~~L~~~~~~~i~~qIa~gL~yLH~~~~~~ivH~DLkp~NILld~~~~~kL~DFGla~~~~ 316 (476)
..++++||+... ..+..+++.+++.++.||+.||+|||+++ |+||||||+|||++.++.+||+|||+++...
T Consensus 157 ~~~lv~e~~~~~L~~~l~~~~~l~~~~~~~i~~qi~~aL~ylH~~~---IvHrDiKP~NIll~~~~~vkL~DFG~a~~~~ 233 (391)
T PHA03212 157 FTCLILPRYKTDLYCYLAAKRNIAICDILAIERSVLRAIQYLHENR---IIHRDIKAENIFINHPGDVCLGDFGAACFPV 233 (391)
T ss_pred eeEEEEecCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCC---cccCCCChHhEEEcCCCCEEEEeCCcccccc
Confidence 456677777621 23457899999999999999999999998 9999999999999999999999999997543
Q ss_pred CCcccccceeeeeccCCCChhhhccCCCCccceEEeehhhhhhhhhCCCCCCcCCC-C----chhhhhhhhhhhcC--CC
Q 045315 317 GDELQSNTKRIVGTYGYMSPEYALRGLFSIKSDVFSFGVLLLETLSSKKNTHFYNT-D----SLTLLGHAWNLWND--GR 389 (476)
Q Consensus 317 ~~~~~~~~~~~~gt~~y~aPE~l~~~~~s~ksDVwSlGvvl~elltG~~p~~~~~~-~----~~~~~~~~~~~~~~--~~ 389 (476)
... ........||+.|+|||++.+..++.++|||||||++|||++|+.|+..... + .............. ..
T Consensus 234 ~~~-~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvil~elltg~~p~~~~~~~~~~~~~~~~l~~i~~~~g~~p~~ 312 (391)
T PHA03212 234 DIN-ANKYYGWAGTIATNAPELLARDPYGPAVDIWSAGIVLFEMATCHDSLFEKDGLDGDCDSDRQIKLIIRRSGTHPNE 312 (391)
T ss_pred ccc-ccccccccCccCCCChhhhcCCCCCcHHHHHHHHHHHHHHHHCCCCcCCcccccccCchhHHHHHHHHHhcCChhh
Confidence 211 1122235689999999999998999999999999999999999987643221 0 00000000000000 00
Q ss_pred --------cccc---------cCcccCC--CCCHHHHHHHHHHHHHchhhcccCCCCHHHHHH
Q 045315 390 --------TWEL---------MDPISQN--GASYPILKRYINVALLCVQEKAADRPAMSEVVS 433 (476)
Q Consensus 390 --------~~~~---------~d~~~~~--~~~~~~~~~l~~li~~Cl~~dP~~RPt~~eVl~ 433 (476)
.... ..+.... .........+.+++.+||+.||++|||++|+++
T Consensus 313 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~Li~~mL~~dP~~Rpta~elL~ 375 (391)
T PHA03212 313 FPIDAQANLDEIYIGLAKKSSRKPGSRPLWTNLYELPIDLEYLICKMLAFDAHHRPSAEALLD 375 (391)
T ss_pred cCcchhHHHHHHHHHHHhccCCCCCCCCCHHHHhhhhhhHHHHHHHHhcCChhhCCCHHHHhc
Confidence 0000 0000000 001123457889999999999999999999985
|
|
| >cd06649 PKc_MEK2 Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase 2 | Back alignment and domain information |
|---|
Probab=99.92 E-value=7.4e-26 Score=227.26 Aligned_cols=186 Identities=24% Similarity=0.340 Sum_probs=134.0
Q ss_pred cccceeeccCCCC------CCCCCCChhhHHHHHHHHHHHHHHHhhcCCCceeecCCCccceEecCCCCceeccccceee
Q 045315 241 DEISFWYESYNNP------TKKGLLCWGTRVRIIEGIAQGLLYLHQYSRLRVIHRDLKASNILLDKDMNPKISDFGMARM 314 (476)
Q Consensus 241 ~~~~l~~Ey~~~~------~~~~~L~~~~~~~i~~qIa~gL~yLH~~~~~~ivH~DLkp~NILld~~~~~kL~DFGla~~ 314 (476)
+..+++|||++.. ...+.+++..+..++.|++.||+|||+.+ .|+||||||+||+++.++.+||+|||++..
T Consensus 76 ~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~l~~lH~~~--~ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~ 153 (331)
T cd06649 76 GEISICMEHMDGGSLDQVLKEAKRIPEEILGKVSIAVLRGLAYLREKH--QIMHRDVKPSNILVNSRGEIKLCDFGVSGQ 153 (331)
T ss_pred CEEEEEeecCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHhhcC--CEEcCCCChhhEEEcCCCcEEEccCccccc
Confidence 4678999999843 23456899999999999999999999853 299999999999999999999999999976
Q ss_pred cCCCcccccceeeeeccCCCChhhhccCCCCccceEEeehhhhhhhhhCCCCCCcCCCCchhhhhhhhhhhcC---CCc-
Q 045315 315 FGGDELQSNTKRIVGTYGYMSPEYALRGLFSIKSDVFSFGVLLLETLSSKKNTHFYNTDSLTLLGHAWNLWND---GRT- 390 (476)
Q Consensus 315 ~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~s~ksDVwSlGvvl~elltG~~p~~~~~~~~~~~~~~~~~~~~~---~~~- 390 (476)
..... .....|+..|+|||.+.+..++.++|||||||++|||++|+.||....... +.......... +..
T Consensus 154 ~~~~~----~~~~~g~~~y~aPE~~~~~~~~~~~DiwslG~il~el~tg~~p~~~~~~~~--~~~~~~~~~~~~~~~~~~ 227 (331)
T cd06649 154 LIDSM----ANSFVGTRSYMSPERLQGTHYSVQSDIWSMGLSLVELAIGRYPIPPPDAKE--LEAIFGRPVVDGEEGEPH 227 (331)
T ss_pred ccccc----cccCCCCcCcCCHhHhcCCCCCchHhHHHHHHHHHHHHhCCCCCCCCCHHH--HHHHhcccccccccCCcc
Confidence 54321 223468999999999998899999999999999999999999986433111 11000000000 000
Q ss_pred --------------------------ccccCcc----cCCCCCHHHHHHHHHHHHHchhhcccCCCCHHHHHHH
Q 045315 391 --------------------------WELMDPI----SQNGASYPILKRYINVALLCVQEKAADRPAMSEVVSM 434 (476)
Q Consensus 391 --------------------------~~~~d~~----~~~~~~~~~~~~l~~li~~Cl~~dP~~RPt~~eVl~~ 434 (476)
.++.+.. ............+.+++.+||+.||++|||++++++.
T Consensus 228 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~~P~~Rpt~~ell~h 301 (331)
T cd06649 228 SISPRPRPPGRPVSGHGMDSRPAMAIFELLDYIVNEPPPKLPNGVFTPDFQEFVNKCLIKNPAERADLKMLMNH 301 (331)
T ss_pred ccCcccccccccccccccccccchhHHHHHHHHHhCCCcCCCCccccHHHHHHHHHHccCCcccCCCHHHHhcC
Confidence 0000000 0000011234578999999999999999999999864
|
Protein kinases (PKs), MAP/ERK Kinase (MEK) 2 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK2 is a dual-specificity PK that phosphorylates and activates the downst |
| >cd08228 STKc_Nek6 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 6 | Back alignment and domain information |
|---|
Probab=99.92 E-value=1.2e-25 Score=217.90 Aligned_cols=181 Identities=22% Similarity=0.324 Sum_probs=138.5
Q ss_pred cccceeeccCCCC----------CCCCCCChhhHHHHHHHHHHHHHHHhhcCCCceeecCCCccceEecCCCCceecccc
Q 045315 241 DEISFWYESYNNP----------TKKGLLCWGTRVRIIEGIAQGLLYLHQYSRLRVIHRDLKASNILLDKDMNPKISDFG 310 (476)
Q Consensus 241 ~~~~l~~Ey~~~~----------~~~~~L~~~~~~~i~~qIa~gL~yLH~~~~~~ivH~DLkp~NILld~~~~~kL~DFG 310 (476)
+..++++||++.. .+...++..++..++.||+.||+|||+++ ++|+||||+||+++.++.++|+|||
T Consensus 75 ~~~~~v~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~---i~H~dl~~~nil~~~~~~~~l~d~g 151 (267)
T cd08228 75 NELNIVLELADAGDLSQMIKYFKKQKRLIPERTVWKYFVQLCSAVEHMHSRR---VMHRDIKPANVFITATGVVKLGDLG 151 (267)
T ss_pred CeEEEEEEecCCCcHHHHHHHhhhccCCCCHHHHHHHHHHHHHHHHHHhhCC---eeCCCCCHHHEEEcCCCCEEECccc
Confidence 4567788888732 13456899999999999999999999998 9999999999999999999999999
Q ss_pred ceeecCCCcccccceeeeeccCCCChhhhccCCCCccceEEeehhhhhhhhhCCCCCCcCCCCchhhhhhhhhhhcCCCc
Q 045315 311 MARMFGGDELQSNTKRIVGTYGYMSPEYALRGLFSIKSDVFSFGVLLLETLSSKKNTHFYNTDSLTLLGHAWNLWNDGRT 390 (476)
Q Consensus 311 la~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~s~ksDVwSlGvvl~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~ 390 (476)
++......... .....++..|+|||.+.+..++.++|+||||+++|||++|+.|+.....+........ .....
T Consensus 152 ~~~~~~~~~~~--~~~~~~~~~~~aPE~~~~~~~~~~~Di~slG~~l~el~~g~~p~~~~~~~~~~~~~~~----~~~~~ 225 (267)
T cd08228 152 LGRFFSSKTTA--AHSLVGTPYYMSPERIHENGYNFKSDIWSLGCLLYEMAALQSPFYGDKMNLFSLCQKI----EQCDY 225 (267)
T ss_pred cceeccchhHH--HhcCCCCccccChhhhccCCCCchhhHHHHHHHHHHHhcCCCCCccccccHHHHHHHH----hcCCC
Confidence 99876543221 1224578899999999888899999999999999999999999854332222221111 11110
Q ss_pred ccccCcccCCCCCHHHHHHHHHHHHHchhhcccCCCCHHHHHHHHhcc
Q 045315 391 WELMDPISQNGASYPILKRYINVALLCVQEKAADRPAMSEVVSMLSNE 438 (476)
Q Consensus 391 ~~~~d~~~~~~~~~~~~~~l~~li~~Cl~~dP~~RPt~~eVl~~L~~~ 438 (476)
+ ..........+.+++.+||+.+|++||++.+|++.|+++
T Consensus 226 -----~---~~~~~~~~~~~~~li~~cl~~~p~~Rp~~~~vl~~~~~~ 265 (267)
T cd08228 226 -----P---PLPTEHYSEKLRELVSMCIYPDPDQRPDIGYVHQIAKQM 265 (267)
T ss_pred -----C---CCChhhcCHHHHHHHHHHCCCCcccCcCHHHHHHHHHHh
Confidence 0 011123346788999999999999999999999999875
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 6 (Nek6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek6 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek6 is required for the transition from metaphase to anaphase. It also plays important roles in mitotic spindle formation and cytokinesis. Activated by Nek9 during mitosis, Nek6 phosphorylates Eg5, a kinesin that is important for spindle bipolarity. Nek6 localizes to spindle microtubules during metaphase |
| >cd05589 STKc_PKN Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase N | Back alignment and domain information |
|---|
Probab=99.92 E-value=7.5e-26 Score=226.45 Aligned_cols=172 Identities=22% Similarity=0.291 Sum_probs=132.2
Q ss_pred cccceeeccCCCCC-----CCCCCChhhHHHHHHHHHHHHHHHhhcCCCceeecCCCccceEecCCCCceeccccceeec
Q 045315 241 DEISFWYESYNNPT-----KKGLLCWGTRVRIIEGIAQGLLYLHQYSRLRVIHRDLKASNILLDKDMNPKISDFGMARMF 315 (476)
Q Consensus 241 ~~~~l~~Ey~~~~~-----~~~~L~~~~~~~i~~qIa~gL~yLH~~~~~~ivH~DLkp~NILld~~~~~kL~DFGla~~~ 315 (476)
+.++++|||++... +.+.+++.++..++.||+.||+|||+.+ ++||||||+||+++.++.+||+|||+++..
T Consensus 75 ~~~~lv~E~~~~~~L~~~~~~~~l~~~~~~~~~~qi~~al~~lH~~~---ivHrdlkp~Nill~~~~~~kL~Dfg~~~~~ 151 (324)
T cd05589 75 DHVCFVMEYAAGGDLMMHIHTDVFSEPRAVFYAACVVLGLQYLHENK---IVYRDLKLDNLLLDTEGFVKIADFGLCKEG 151 (324)
T ss_pred CEEEEEEcCCCCCcHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHhCC---eEecCCCHHHeEECCCCcEEeCcccCCccC
Confidence 56889999998432 3567999999999999999999999998 999999999999999999999999998753
Q ss_pred CCCcccccceeeeeccCCCChhhhccCCCCccceEEeehhhhhhhhhCCCCCCcCCCCchhhhhhhhhhhcCCCcccccC
Q 045315 316 GGDELQSNTKRIVGTYGYMSPEYALRGLFSIKSDVFSFGVLLLETLSSKKNTHFYNTDSLTLLGHAWNLWNDGRTWELMD 395 (476)
Q Consensus 316 ~~~~~~~~~~~~~gt~~y~aPE~l~~~~~s~ksDVwSlGvvl~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~d 395 (476)
.... .......|+..|+|||.+.+..++.++|||||||++|||++|+.||...... ..... ...+..
T Consensus 152 ~~~~--~~~~~~~g~~~y~aPE~~~~~~~~~~~DiwslG~il~el~~G~~pf~~~~~~--~~~~~----i~~~~~----- 218 (324)
T cd05589 152 MGFG--DRTSTFCGTPEFLAPEVLTETSYTRAVDWWGLGVLIYEMLVGESPFPGDDEE--EVFDS----IVNDEV----- 218 (324)
T ss_pred CCCC--CcccccccCccccCHhHhcCCCCCcccchhhHHHHHHHHHhCCCCCCCCCHH--HHHHH----HHhCCC-----
Confidence 3221 1223356899999999999989999999999999999999999998643311 11111 111110
Q ss_pred cccCCCCCHHHHHHHHHHHHHchhhcccCCC-----CHHHHHH
Q 045315 396 PISQNGASYPILKRYINVALLCVQEKAADRP-----AMSEVVS 433 (476)
Q Consensus 396 ~~~~~~~~~~~~~~l~~li~~Cl~~dP~~RP-----t~~eVl~ 433 (476)
..+......+.+++.+||+.||.+|| ++.++++
T Consensus 219 -----~~p~~~~~~~~~li~~~L~~dP~~R~~~~~~~~~~l~~ 256 (324)
T cd05589 219 -----RYPRFLSREAISIMRRLLRRNPERRLGSGEKDAEDVKK 256 (324)
T ss_pred -----CCCCCCCHHHHHHHHHHhhcCHhHcCCCCCCCHHHHhh
Confidence 01112245678999999999999999 4666654
|
Serine/Threonine Kinases (STKs), Protein Kinase N (PKN) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKN subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKN has a C-terminal catalytic domain that is highly homologous to PKCs. Its unique N-terminal regulatory region contains antiparallel coiled-coil (ACC) domains. In mammals, there are three PKN isoforms from different genes (designated PKN-alpha, beta, and gamma), which show different enzymatic properties, tissue distribution, and varied functions. PKN can be activated by the small GTPase Rho, and by fatty acids such as arachidonic and linoleic acids. It is involved |
| >cd05092 PTKc_TrkA Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase A | Back alignment and domain information |
|---|
Probab=99.92 E-value=4.7e-26 Score=222.87 Aligned_cols=163 Identities=28% Similarity=0.406 Sum_probs=124.4
Q ss_pred CCCChhhHHHHHHHHHHHHHHHhhcCCCceeecCCCccceEecCCCCceeccccceeecCCCcccccceeeeeccCCCCh
Q 045315 257 GLLCWGTRVRIIEGIAQGLLYLHQYSRLRVIHRDLKASNILLDKDMNPKISDFGMARMFGGDELQSNTKRIVGTYGYMSP 336 (476)
Q Consensus 257 ~~L~~~~~~~i~~qIa~gL~yLH~~~~~~ivH~DLkp~NILld~~~~~kL~DFGla~~~~~~~~~~~~~~~~gt~~y~aP 336 (476)
..+++.+++.++.||+.||+|||+.+ ++|+||||+||++++++.+||+|||++................++..|+||
T Consensus 117 ~~l~~~~~~~~~~qi~~al~~LH~~~---i~H~dlkp~nil~~~~~~~kL~dfg~~~~~~~~~~~~~~~~~~~~~~y~aP 193 (280)
T cd05092 117 GQLTLGQMLAIASQIASGMVYLASLH---FVHRDLATRNCLVGQGLVVKIGDFGMSRDIYSTDYYRVGGRTMLPIRWMPP 193 (280)
T ss_pred cccCHHHHHHHHHHHHHHHHHHHHCC---eecccccHhhEEEcCCCCEEECCCCceeEcCCCceeecCCCccccccccCH
Confidence 45899999999999999999999998 999999999999999999999999999865433221112223456789999
Q ss_pred hhhccCCCCccceEEeehhhhhhhhh-CCCCCCcCCCCchhhhhhhhhhhcCCCcccccCcccCCCCCHHHHHHHHHHHH
Q 045315 337 EYALRGLFSIKSDVFSFGVLLLETLS-SKKNTHFYNTDSLTLLGHAWNLWNDGRTWELMDPISQNGASYPILKRYINVAL 415 (476)
Q Consensus 337 E~l~~~~~s~ksDVwSlGvvl~ellt-G~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~l~~li~ 415 (476)
|.+.+..++.++|||||||++|||++ |++||..... ..... ....+.... .+......+.+++.
T Consensus 194 E~~~~~~~~~~~Di~slG~il~el~~~g~~p~~~~~~--~~~~~----~~~~~~~~~---------~~~~~~~~~~~li~ 258 (280)
T cd05092 194 ESILYRKFTTESDIWSFGVVLWEIFTYGKQPWYQLSN--TEAIE----CITQGRELE---------RPRTCPPEVYAIMQ 258 (280)
T ss_pred HHhccCCcCchhhHHHHHHHHHHHHcCCCCCCccCCH--HHHHH----HHHcCccCC---------CCCCCCHHHHHHHH
Confidence 99998899999999999999999998 8888753221 11111 011111100 01122356789999
Q ss_pred HchhhcccCCCCHHHHHHHHhc
Q 045315 416 LCVQEKAADRPAMSEVVSMLSN 437 (476)
Q Consensus 416 ~Cl~~dP~~RPt~~eVl~~L~~ 437 (476)
+||+.||++||++.+|++.|+.
T Consensus 259 ~cl~~~P~~Rp~~~~l~~~l~~ 280 (280)
T cd05092 259 GCWQREPQQRMVIKDIHSRLQA 280 (280)
T ss_pred HHccCChhhCCCHHHHHHHHhC
Confidence 9999999999999999999863
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase A (TrkA); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkA is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkA to its ligand, nerve growth factor (NGF), results in receptor oligomerization and activation of the catalytic domain. TrkA is expressed mainly in neural-crest-derived sensory |
| >cd05595 STKc_PKB_beta Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B beta | Back alignment and domain information |
|---|
Probab=99.92 E-value=4.4e-26 Score=228.14 Aligned_cols=172 Identities=22% Similarity=0.277 Sum_probs=132.5
Q ss_pred cccceeeccCCCCC------CCCCCChhhHHHHHHHHHHHHHHHhhcCCCceeecCCCccceEecCCCCceeccccceee
Q 045315 241 DEISFWYESYNNPT------KKGLLCWGTRVRIIEGIAQGLLYLHQYSRLRVIHRDLKASNILLDKDMNPKISDFGMARM 314 (476)
Q Consensus 241 ~~~~l~~Ey~~~~~------~~~~L~~~~~~~i~~qIa~gL~yLH~~~~~~ivH~DLkp~NILld~~~~~kL~DFGla~~ 314 (476)
+..+++|||++.+. +.+.+++.++..++.||+.||+|||+++ |+||||||+|||++.++.+||+|||+++.
T Consensus 68 ~~~~lv~E~~~~~~L~~~l~~~~~~~~~~~~~~~~qi~~aL~~LH~~~---ivH~Dlkp~NIll~~~~~~kL~Dfg~~~~ 144 (323)
T cd05595 68 DRLCFVMEYANGGELFFHLSRERVFTEERARFYGAEIVSALEYLHSRD---VVYRDIKLENLMLDKDGHIKITDFGLCKE 144 (323)
T ss_pred CEEEEEEeCCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCC---eEecCCCHHHEEEcCCCCEEecccHHhcc
Confidence 45778999998432 3557999999999999999999999998 99999999999999999999999999875
Q ss_pred cCCCcccccceeeeeccCCCChhhhccCCCCccceEEeehhhhhhhhhCCCCCCcCCCCchhhhhhhhhhhcCCCccccc
Q 045315 315 FGGDELQSNTKRIVGTYGYMSPEYALRGLFSIKSDVFSFGVLLLETLSSKKNTHFYNTDSLTLLGHAWNLWNDGRTWELM 394 (476)
Q Consensus 315 ~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~s~ksDVwSlGvvl~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 394 (476)
...... ......|+..|+|||.+.+..++.++|||||||++|||++|+.||....... .... .. ....
T Consensus 145 ~~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvil~ell~g~~Pf~~~~~~~--~~~~---~~-~~~~---- 212 (323)
T cd05595 145 GISDGA--TMKTFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHER--LFEL---IL-MEEI---- 212 (323)
T ss_pred ccCCCC--ccccccCCcCcCCcccccCCCCCchhchhhhHHHHHHHHhCCCCCCCCCHHH--HHHH---Hh-cCCC----
Confidence 322211 1223568999999999998899999999999999999999999986433211 1110 00 0000
Q ss_pred CcccCCCCCHHHHHHHHHHHHHchhhcccCCC-----CHHHHHH
Q 045315 395 DPISQNGASYPILKRYINVALLCVQEKAADRP-----AMSEVVS 433 (476)
Q Consensus 395 d~~~~~~~~~~~~~~l~~li~~Cl~~dP~~RP-----t~~eVl~ 433 (476)
..+......+.+++.+||+.||++|| ++.++++
T Consensus 213 ------~~p~~~~~~~~~li~~~L~~dP~~R~~~~~~~~~~~l~ 250 (323)
T cd05595 213 ------RFPRTLSPEAKSLLAGLLKKDPKQRLGGGPSDAKEVME 250 (323)
T ss_pred ------CCCCCCCHHHHHHHHHHccCCHHHhCCCCCCCHHHHHc
Confidence 01112245678999999999999998 7888764
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, beta (or Akt2) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-beta is the predominant PKB isoform expressed in insulin-responsive tissues. It plays a critical role in the regulation of glucose homeostasis. It is also implicated in muscle cell differentiation. Mice deficient in |
| >cd05148 PTKc_Srm_Brk Catalytic domain of the Protein Tyrosine Kinases, Srm and Brk | Back alignment and domain information |
|---|
Probab=99.92 E-value=5.5e-26 Score=219.44 Aligned_cols=177 Identities=28% Similarity=0.419 Sum_probs=135.8
Q ss_pred cccceeeccCCCC--------CCCCCCChhhHHHHHHHHHHHHHHHhhcCCCceeecCCCccceEecCCCCceeccccce
Q 045315 241 DEISFWYESYNNP--------TKKGLLCWGTRVRIIEGIAQGLLYLHQYSRLRVIHRDLKASNILLDKDMNPKISDFGMA 312 (476)
Q Consensus 241 ~~~~l~~Ey~~~~--------~~~~~L~~~~~~~i~~qIa~gL~yLH~~~~~~ivH~DLkp~NILld~~~~~kL~DFGla 312 (476)
+..++++||++.. .....+++.++..++.||+.||+|||+.+ ++|+||||+||+++.++.+||+|||.+
T Consensus 75 ~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~i~~al~~lH~~~---i~h~dl~~~nilv~~~~~~kl~d~g~~ 151 (261)
T cd05148 75 EPVYIITELMEKGSLLAFLRSPEGQVLPVASLIDMACQVAEGMAYLEEQN---SIHRDLAARNILVGEDLVCKVADFGLA 151 (261)
T ss_pred CCeEEEEeecccCCHHHHHhcCCCCCCCHHHHHHHHHHHHHHHHHHHHCC---eeccccCcceEEEcCCceEEEccccch
Confidence 3567889998732 23457899999999999999999999998 999999999999999999999999999
Q ss_pred eecCCCcccccceeeeeccCCCChhhhccCCCCccceEEeehhhhhhhhh-CCCCCCcCCCCchhhhhhhhhhhcCCCcc
Q 045315 313 RMFGGDELQSNTKRIVGTYGYMSPEYALRGLFSIKSDVFSFGVLLLETLS-SKKNTHFYNTDSLTLLGHAWNLWNDGRTW 391 (476)
Q Consensus 313 ~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~s~ksDVwSlGvvl~ellt-G~~p~~~~~~~~~~~~~~~~~~~~~~~~~ 391 (476)
.......... ....++..|+|||.+....++.++||||||+++|+|++ |+.|+..... ....... ..+..
T Consensus 152 ~~~~~~~~~~--~~~~~~~~~~~PE~~~~~~~~~~~DiwslG~~l~~l~~~g~~p~~~~~~--~~~~~~~----~~~~~- 222 (261)
T cd05148 152 RLIKEDVYLS--SDKKIPYKWTAPEAASHGTFSTKSDVWSFGILLYEMFTYGQVPYPGMNN--HEVYDQI----TAGYR- 222 (261)
T ss_pred hhcCCccccc--cCCCCceEecCHHHHccCCCCchhhHHHHHHHHHHHHcCCCCCCCcCCH--HHHHHHH----HhCCc-
Confidence 8664322111 12335678999999988889999999999999999998 7888754331 1111111 11100
Q ss_pred cccCcccCCCCCHHHHHHHHHHHHHchhhcccCCCCHHHHHHHHhc
Q 045315 392 ELMDPISQNGASYPILKRYINVALLCVQEKAADRPAMSEVVSMLSN 437 (476)
Q Consensus 392 ~~~d~~~~~~~~~~~~~~l~~li~~Cl~~dP~~RPt~~eVl~~L~~ 437 (476)
..........+.+++.+||+.+|.+|||+.++++.|+.
T Consensus 223 --------~~~~~~~~~~~~~~i~~~l~~~p~~Rpt~~~l~~~L~~ 260 (261)
T cd05148 223 --------MPCPAKCPQEIYKIMLECWAAEPEDRPSFKALREELDN 260 (261)
T ss_pred --------CCCCCCCCHHHHHHHHHHcCCCchhCcCHHHHHHHHhc
Confidence 01112334578899999999999999999999999986
|
Protein Tyrosine Kinase (PTK) family; Src-related kinase lacking C-terminal regulatory tyrosine and N-terminal myristylation sites (Srm) and breast tumor kinase (Brk, also called protein tyrosine kinase 6); catalytic (c) domains. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Srm and Brk are a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases in general contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr; they are activated by autophosphorylation at the tyr kinase dom |
| >cd05101 PTKc_FGFR2 Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 2 | Back alignment and domain information |
|---|
Probab=99.92 E-value=6.3e-26 Score=224.65 Aligned_cols=165 Identities=25% Similarity=0.360 Sum_probs=127.2
Q ss_pred CCCChhhHHHHHHHHHHHHHHHhhcCCCceeecCCCccceEecCCCCceeccccceeecCCCcccccceeeeeccCCCCh
Q 045315 257 GLLCWGTRVRIIEGIAQGLLYLHQYSRLRVIHRDLKASNILLDKDMNPKISDFGMARMFGGDELQSNTKRIVGTYGYMSP 336 (476)
Q Consensus 257 ~~L~~~~~~~i~~qIa~gL~yLH~~~~~~ivH~DLkp~NILld~~~~~kL~DFGla~~~~~~~~~~~~~~~~gt~~y~aP 336 (476)
..+++.+++.++.||++||+|||+++ ++||||||+||+++.++.+||+|||+++...............++..|+||
T Consensus 132 ~~~~~~~~~~~~~qi~~al~~LH~~g---ivH~dlkp~Nili~~~~~~kl~D~g~~~~~~~~~~~~~~~~~~~~~~y~aP 208 (304)
T cd05101 132 EQMTFKDLVSCTYQVARGMEYLASQK---CIHRDLAARNVLVTENNVMKIADFGLARDVNNIDYYKKTTNGRLPVKWMAP 208 (304)
T ss_pred ccccHHHHHHHHHHHHHHHHHHHHCC---eeecccccceEEEcCCCcEEECCCccceecccccccccccCCCCCceeeCc
Confidence 46889999999999999999999998 999999999999999999999999999876543322222223456789999
Q ss_pred hhhccCCCCccceEEeehhhhhhhhh-CCCCCCcCCCCchhhhhhhhhhhcCCCcccccCcccCCCCCHHHHHHHHHHHH
Q 045315 337 EYALRGLFSIKSDVFSFGVLLLETLS-SKKNTHFYNTDSLTLLGHAWNLWNDGRTWELMDPISQNGASYPILKRYINVAL 415 (476)
Q Consensus 337 E~l~~~~~s~ksDVwSlGvvl~ellt-G~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~l~~li~ 415 (476)
|.+.+..++.++||||||+++||+++ |..|+..... .... .....+.... ........+.+++.
T Consensus 209 E~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~~~~~--~~~~----~~~~~~~~~~---------~~~~~~~~~~~li~ 273 (304)
T cd05101 209 EALFDRVYTHQSDVWSFGVLMWEIFTLGGSPYPGIPV--EELF----KLLKEGHRMD---------KPANCTNELYMMMR 273 (304)
T ss_pred hhhccCCCCchhhHHHHHHHHHHHHcCCCCCcccCCH--HHHH----HHHHcCCcCC---------CCCCCCHHHHHHHH
Confidence 99988889999999999999999998 6777643321 1111 1111111110 11123456888999
Q ss_pred HchhhcccCCCCHHHHHHHHhccc
Q 045315 416 LCVQEKAADRPAMSEVVSMLSNEF 439 (476)
Q Consensus 416 ~Cl~~dP~~RPt~~eVl~~L~~~~ 439 (476)
+||+.+|++||++.+|++.|+++.
T Consensus 274 ~cl~~~p~~Rps~~e~l~~l~~~~ 297 (304)
T cd05101 274 DCWHAIPSHRPTFKQLVEDLDRIL 297 (304)
T ss_pred HHcccChhhCCCHHHHHHHHHHHH
Confidence 999999999999999999998875
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 2 (FGFR2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR2 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to |
| >cd05082 PTKc_Csk Catalytic domain of the Protein Tyrosine Kinase, C-terminal Src kinase | Back alignment and domain information |
|---|
Probab=99.92 E-value=7.9e-26 Score=217.99 Aligned_cols=174 Identities=24% Similarity=0.298 Sum_probs=133.0
Q ss_pred ccceeeccCCCC--------CCCCCCChhhHHHHHHHHHHHHHHHhhcCCCceeecCCCccceEecCCCCceecccccee
Q 045315 242 EISFWYESYNNP--------TKKGLLCWGTRVRIIEGIAQGLLYLHQYSRLRVIHRDLKASNILLDKDMNPKISDFGMAR 313 (476)
Q Consensus 242 ~~~l~~Ey~~~~--------~~~~~L~~~~~~~i~~qIa~gL~yLH~~~~~~ivH~DLkp~NILld~~~~~kL~DFGla~ 313 (476)
.+++++||++.. .....+++..+++++.||+.||+|||+++ ++||||||+||+++.++.+||+|||+++
T Consensus 74 ~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~---i~H~dlkp~nil~~~~~~~kl~dfg~~~ 150 (256)
T cd05082 74 GLYIVTEYMAKGSLVDYLRSRGRSVLGGDCLLKFSLDVCEAMEYLEANN---FVHRDLAARNVLVSEDNVAKVSDFGLTK 150 (256)
T ss_pred ceEEEEECCCCCcHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCC---EeccccchheEEEcCCCcEEecCCccce
Confidence 477889998732 23345899999999999999999999998 9999999999999999999999999988
Q ss_pred ecCCCcccccceeeeeccCCCChhhhccCCCCccceEEeehhhhhhhhh-CCCCCCcCCCCchhhhhhhhhhhcCCCccc
Q 045315 314 MFGGDELQSNTKRIVGTYGYMSPEYALRGLFSIKSDVFSFGVLLLETLS-SKKNTHFYNTDSLTLLGHAWNLWNDGRTWE 392 (476)
Q Consensus 314 ~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~s~ksDVwSlGvvl~ellt-G~~p~~~~~~~~~~~~~~~~~~~~~~~~~~ 392 (476)
...... ....++..|+|||++.+..++.++|||||||++|||++ |+.|+..... ...... ...+....
T Consensus 151 ~~~~~~-----~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~i~~~l~~~g~~p~~~~~~--~~~~~~----~~~~~~~~ 219 (256)
T cd05082 151 EASSTQ-----DTGKLPVKWTAPEALREKKFSTKSDVWSFGILLWEIYSFGRVPYPRIPL--KDVVPR----VEKGYKMD 219 (256)
T ss_pred eccccC-----CCCccceeecCHHHHccCCCCchhhhHHHHHHHHHHHhCCCCCCCCCCH--HHHHHH----HhcCCCCC
Confidence 654322 11234568999999988889999999999999999997 8888753321 111111 11111100
Q ss_pred ccCcccCCCCCHHHHHHHHHHHHHchhhcccCCCCHHHHHHHHhcc
Q 045315 393 LMDPISQNGASYPILKRYINVALLCVQEKAADRPAMSEVVSMLSNE 438 (476)
Q Consensus 393 ~~d~~~~~~~~~~~~~~l~~li~~Cl~~dP~~RPt~~eVl~~L~~~ 438 (476)
........+.+++.+|++.+|++|||+.++++.|+.+
T Consensus 220 ---------~~~~~~~~~~~li~~~l~~~p~~Rpt~~~l~~~l~~~ 256 (256)
T cd05082 220 ---------APDGCPPVVYDVMKQCWHLDAATRPSFLQLREQLEHI 256 (256)
T ss_pred ---------CCCCCCHHHHHHHHHHhcCChhhCcCHHHHHHHHhcC
Confidence 1112245688999999999999999999999999763
|
Protein Tyrosine Kinase (PTK) family; C-terminal Src kinase (Csk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. To inhibit Src kinases, Csk is translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Csk catalyzes the tyr phosphorylation of the regulatory C-terminal tail of Src kinases, re |
| >cd05588 STKc_aPKC Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C | Back alignment and domain information |
|---|
Probab=99.92 E-value=1.3e-25 Score=225.26 Aligned_cols=178 Identities=19% Similarity=0.257 Sum_probs=133.2
Q ss_pred cccceeeccCCCCC------CCCCCChhhHHHHHHHHHHHHHHHhhcCCCceeecCCCccceEecCCCCceeccccceee
Q 045315 241 DEISFWYESYNNPT------KKGLLCWGTRVRIIEGIAQGLLYLHQYSRLRVIHRDLKASNILLDKDMNPKISDFGMARM 314 (476)
Q Consensus 241 ~~~~l~~Ey~~~~~------~~~~L~~~~~~~i~~qIa~gL~yLH~~~~~~ivH~DLkp~NILld~~~~~kL~DFGla~~ 314 (476)
+..+++|||++... +.+.+++..+..++.||+.||+|||+++ ++||||||+||+++.++.+||+|||+++.
T Consensus 69 ~~~~lv~e~~~~g~L~~~~~~~~~l~~~~~~~~~~qi~~~l~~lH~~~---ivH~dlkp~Nili~~~~~~kL~Dfg~~~~ 145 (329)
T cd05588 69 SRLFFVIEFVSGGDLMFHMQRQRKLPEEHARFYSAEISLALNFLHERG---IIYRDLKLDNVLLDAEGHIKLTDYGMCKE 145 (329)
T ss_pred CEEEEEEeCCCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCC---eEecCCCHHHeEECCCCCEEECcCccccc
Confidence 45789999998432 3567999999999999999999999999 99999999999999999999999999874
Q ss_pred cCCCcccccceeeeeccCCCChhhhccCCCCccceEEeehhhhhhhhhCCCCCCcCCCC---chhhhhhhhhhhcCCCcc
Q 045315 315 FGGDELQSNTKRIVGTYGYMSPEYALRGLFSIKSDVFSFGVLLLETLSSKKNTHFYNTD---SLTLLGHAWNLWNDGRTW 391 (476)
Q Consensus 315 ~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~s~ksDVwSlGvvl~elltG~~p~~~~~~~---~~~~~~~~~~~~~~~~~~ 391 (476)
..... .......|+..|+|||++.+..++.++|+|||||++|||++|+.||...... .................
T Consensus 146 ~~~~~--~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~~l~el~~g~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~- 222 (329)
T cd05588 146 GIRPG--DTTSTFCGTPNYIAPEILRGEDYGFSVDWWALGVLMFEMMAGRSPFDIVGMSDNPDQNTEDYLFQVILEKQI- 222 (329)
T ss_pred cccCC--CccccccCCccccCHHHHcCCCCCCccceechHHHHHHHHHCCCCcccccccccccccchHHHHHHHHcCCC-
Confidence 32111 1222357899999999999999999999999999999999999999643211 11111111111111111
Q ss_pred cccCcccCCCCCHHHHHHHHHHHHHchhhcccCCCC------HHHHHH
Q 045315 392 ELMDPISQNGASYPILKRYINVALLCVQEKAADRPA------MSEVVS 433 (476)
Q Consensus 392 ~~~d~~~~~~~~~~~~~~l~~li~~Cl~~dP~~RPt------~~eVl~ 433 (476)
. .+......+.+++.+||+.||++||+ ++++++
T Consensus 223 ~---------~p~~~~~~~~~li~~~L~~dP~~R~~~~~~~~~~~i~~ 261 (329)
T cd05588 223 R---------IPRSLSVKASSVLKGFLNKDPKERLGCHPQTGFRDIKS 261 (329)
T ss_pred C---------CCCCCCHHHHHHHHHHhccCHHHcCCCCCCCCHHHHhc
Confidence 0 11122356889999999999999997 566653
|
Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. They contain a C2-like region, instead of a calcium-binding (C2) region found in classical PKCs, in their regulatory domain. There are two aPKC isoforms, zeta and iota. aPKCs are involved in many cellular functions incl |
| >KOG0589 consensus Serine/threonine protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=99.92 E-value=4.4e-26 Score=228.48 Aligned_cols=172 Identities=25% Similarity=0.305 Sum_probs=141.6
Q ss_pred cceeeccCCCC--------CCCCCCChhhHHHHHHHHHHHHHHHhhcCCCceeecCCCccceEecCCCCceeccccceee
Q 045315 243 ISFWYESYNNP--------TKKGLLCWGTRVRIIEGIAQGLLYLHQYSRLRVIHRDLKASNILLDKDMNPKISDFGMARM 314 (476)
Q Consensus 243 ~~l~~Ey~~~~--------~~~~~L~~~~~~~i~~qIa~gL~yLH~~~~~~ivH~DLkp~NILld~~~~~kL~DFGla~~ 314 (476)
.+++|||++++ .++..++++++.+++.|++.|+.|||++. |+|||||++|||+.++..+||+|||+|+.
T Consensus 79 l~Ivm~Y~eGg~l~~~i~~~k~~~f~E~~i~~~~~Q~~~av~ylH~~~---iLHRDlK~~Nifltk~~~VkLgDfGlaK~ 155 (426)
T KOG0589|consen 79 LCIVMEYCEGGDLAQLIKEQKGVLFPEERILKWFVQILLAVNYLHENR---VLHRDLKCANIFLTKDKKVKLGDFGLAKI 155 (426)
T ss_pred EEEEEeecCCCCHHHHHHHHhhccccHHHHHHHHHHHHHHHHHHHhhh---hhcccchhhhhhccccCceeecchhhhhh
Confidence 57899999933 34678999999999999999999999887 99999999999999999999999999999
Q ss_pred cCCCcccccceeeeeccCCCChhhhccCCCCccceEEeehhhhhhhhhCCCCCCcCCCCchhhhhhhhhhhcCCCccccc
Q 045315 315 FGGDELQSNTKRIVGTYGYMSPEYALRGLFSIKSDVFSFGVLLLETLSSKKNTHFYNTDSLTLLGHAWNLWNDGRTWELM 394 (476)
Q Consensus 315 ~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~s~ksDVwSlGvvl~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 394 (476)
+..... ......||+.|++||.+.+.+|..|+|||||||++|||++-+++|...+... +.... ..
T Consensus 156 l~~~~~--~a~tvvGTp~YmcPEil~d~pYn~KSDiWsLGC~~yEm~~lk~aF~a~~m~~--Li~ki---~~-------- 220 (426)
T KOG0589|consen 156 LNPEDS--LASTVVGTPYYMCPEILSDIPYNEKSDIWSLGCCLYEMCTLKPAFKASNMSE--LILKI---NR-------- 220 (426)
T ss_pred cCCchh--hhheecCCCcccCHHHhCCCCCCccCcchhhcchHHHHHhcccccCccchHH--HHHHH---hh--------
Confidence 876542 3345899999999999999999999999999999999999999987654322 21111 10
Q ss_pred CcccCCCCCHHHHHHHHHHHHHchhhcccCCCCHHHHHHH
Q 045315 395 DPISQNGASYPILKRYINVALLCVQEKAADRPAMSEVVSM 434 (476)
Q Consensus 395 d~~~~~~~~~~~~~~l~~li~~Cl~~dP~~RPt~~eVl~~ 434 (476)
......+......+..++..|++.+|+.||++.+++.+
T Consensus 221 --~~~~Plp~~ys~el~~lv~~~l~~~P~~RPsa~~LL~~ 258 (426)
T KOG0589|consen 221 --GLYSPLPSMYSSELRSLVKSMLRKNPEHRPSALELLRR 258 (426)
T ss_pred --ccCCCCCccccHHHHHHHHHHhhcCCccCCCHHHHhhC
Confidence 11122334456778899999999999999999999865
|
|
| >cd05587 STKc_cPKC Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C | Back alignment and domain information |
|---|
Probab=99.92 E-value=6.8e-26 Score=226.79 Aligned_cols=167 Identities=26% Similarity=0.327 Sum_probs=129.2
Q ss_pred cccceeeccCCCCC------CCCCCChhhHHHHHHHHHHHHHHHhhcCCCceeecCCCccceEecCCCCceeccccceee
Q 045315 241 DEISFWYESYNNPT------KKGLLCWGTRVRIIEGIAQGLLYLHQYSRLRVIHRDLKASNILLDKDMNPKISDFGMARM 314 (476)
Q Consensus 241 ~~~~l~~Ey~~~~~------~~~~L~~~~~~~i~~qIa~gL~yLH~~~~~~ivH~DLkp~NILld~~~~~kL~DFGla~~ 314 (476)
+.++++|||++.+. ....+++.++..++.||+.||+|||+++ |+||||||+|||++.++.+||+|||+++.
T Consensus 74 ~~~~lv~E~~~~g~L~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~---ivH~dlkp~Nill~~~~~~kL~Dfg~~~~ 150 (324)
T cd05587 74 DRLYFVMEYVNGGDLMYHIQQVGKFKEPHAVFYAAEIAIGLFFLHSKG---IIYRDLKLDNVMLDAEGHIKIADFGMCKE 150 (324)
T ss_pred CEEEEEEcCCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCC---eEecCCCHHHeEEcCCCCEEEeecCccee
Confidence 46889999998432 3457899999999999999999999998 99999999999999999999999999875
Q ss_pred cCCCcccccceeeeeccCCCChhhhccCCCCccceEEeehhhhhhhhhCCCCCCcCCCCchhhhhhhhhhhcCCCccccc
Q 045315 315 FGGDELQSNTKRIVGTYGYMSPEYALRGLFSIKSDVFSFGVLLLETLSSKKNTHFYNTDSLTLLGHAWNLWNDGRTWELM 394 (476)
Q Consensus 315 ~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~s~ksDVwSlGvvl~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 394 (476)
..... .......|+..|+|||++.+..++.++|||||||++|||++|+.||..... ....... .....
T Consensus 151 ~~~~~--~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslGvil~elltG~~pf~~~~~--~~~~~~i----~~~~~---- 218 (324)
T cd05587 151 NIFGG--KTTRTFCGTPDYIAPEIIAYQPYGKSVDWWAFGVLLYEMLAGQPPFDGEDE--DELFQSI----MEHNV---- 218 (324)
T ss_pred cCCCC--CceeeecCCccccChhhhcCCCCCcccchhhhHHHHHHHHhCCCCCCCCCH--HHHHHHH----HcCCC----
Confidence 32211 122335689999999999999999999999999999999999999864331 1111111 11110
Q ss_pred CcccCCCCCHHHHHHHHHHHHHchhhcccCCCCH
Q 045315 395 DPISQNGASYPILKRYINVALLCVQEKAADRPAM 428 (476)
Q Consensus 395 d~~~~~~~~~~~~~~l~~li~~Cl~~dP~~RPt~ 428 (476)
..+......+.+++.+||+.||++|++.
T Consensus 219 ------~~~~~~~~~~~~li~~~l~~~P~~R~~~ 246 (324)
T cd05587 219 ------SYPKSLSKEAVSICKGLLTKHPAKRLGC 246 (324)
T ss_pred ------CCCCCCCHHHHHHHHHHhhcCHHHcCCC
Confidence 0111233567899999999999999976
|
Serine/Threonine Kinases (STKs), Classical (or Conventional) Protein Kinase C (cPKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. cPKCs contain a calcium-binding C2 region in their regulatory |
| >cd05036 PTKc_ALK_LTK Catalytic domain of the Protein Tyrosine Kinases, Anaplastic Lymphoma Kinase and Leukocyte Tyrosine Kinase | Back alignment and domain information |
|---|
Probab=99.92 E-value=6.3e-26 Score=221.53 Aligned_cols=177 Identities=26% Similarity=0.326 Sum_probs=130.2
Q ss_pred ccceeeccCCCC-------------CCCCCCChhhHHHHHHHHHHHHHHHhhcCCCceeecCCCccceEecCCC---Cce
Q 045315 242 EISFWYESYNNP-------------TKKGLLCWGTRVRIIEGIAQGLLYLHQYSRLRVIHRDLKASNILLDKDM---NPK 305 (476)
Q Consensus 242 ~~~l~~Ey~~~~-------------~~~~~L~~~~~~~i~~qIa~gL~yLH~~~~~~ivH~DLkp~NILld~~~---~~k 305 (476)
..++++||++.. .....+++.++++++.||+.||+|||+.+ ++||||||+||+++.++ .+|
T Consensus 83 ~~~lv~e~~~g~~L~~~i~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~LH~~~---ivH~dlkp~nil~~~~~~~~~~k 159 (277)
T cd05036 83 PRFILLELMAGGDLKSFLRENRPRPERPSSLTMKDLLFCARDVAKGCKYLEENH---FIHRDIAARNCLLTCKGPGRVAK 159 (277)
T ss_pred CcEEEEecCCCCCHHHHHHHhCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHHCC---EeecccchheEEEeccCCCcceE
Confidence 456778887621 11236899999999999999999999998 99999999999998654 589
Q ss_pred eccccceeecCCCcccccceeeeeccCCCChhhhccCCCCccceEEeehhhhhhhhh-CCCCCCcCCCCchhhhhhhhhh
Q 045315 306 ISDFGMARMFGGDELQSNTKRIVGTYGYMSPEYALRGLFSIKSDVFSFGVLLLETLS-SKKNTHFYNTDSLTLLGHAWNL 384 (476)
Q Consensus 306 L~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~s~ksDVwSlGvvl~ellt-G~~p~~~~~~~~~~~~~~~~~~ 384 (476)
|+|||+++................+..|+|||++.+..++.++|||||||++|||++ |..||...... .....
T Consensus 160 l~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~il~el~~~g~~pf~~~~~~--~~~~~---- 233 (277)
T cd05036 160 IADFGMARDIYRASYYRKGGRAMLPIKWMPPEAFLDGIFTSKTDVWSFGVLLWEIFSLGYMPYPGRTNQ--EVMEF---- 233 (277)
T ss_pred eccCccccccCCccceecCCCCCccHhhCCHHHHhcCCcCchhHHHHHHHHHHHHHcCCCCCCCCCCHH--HHHHH----
Confidence 999999987643222111112233568999999998899999999999999999997 88887643321 11111
Q ss_pred hcCCCcccccCcccCCCCCHHHHHHHHHHHHHchhhcccCCCCHHHHHHHHh
Q 045315 385 WNDGRTWELMDPISQNGASYPILKRYINVALLCVQEKAADRPAMSEVVSMLS 436 (476)
Q Consensus 385 ~~~~~~~~~~d~~~~~~~~~~~~~~l~~li~~Cl~~dP~~RPt~~eVl~~L~ 436 (476)
....... ..+......+.+++.+|++.+|++||++.+|++.|+
T Consensus 234 ~~~~~~~---------~~~~~~~~~~~~~i~~cl~~~p~~Rps~~~vl~~l~ 276 (277)
T cd05036 234 VTGGGRL---------DPPKGCPGPVYRIMTDCWQHTPEDRPNFATILERIQ 276 (277)
T ss_pred HHcCCcC---------CCCCCCCHHHHHHHHHHcCCCcccCcCHHHHHHHhh
Confidence 1111100 111222457889999999999999999999999885
|
Protein Tyrosine Kinase (PTK) family; Anaplastic Lymphoma Kinase (ALK) and Leukocyte Tyrosine (tyr) Kinase (LTK); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyr residues in protein substrates. ALK and LTK are orphan receptor tyr kinases (RTKs) whose ligands are not yet well-defined. RTKs contain an extracellular ligand-binding domain, a transmembrane region, and an intracellular tyr kinase domain. They are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. ALK appears to play an important role in mammalian neural development as well |
| >cd05069 PTKc_Yes Catalytic domain of the Protein Tyrosine Kinase, Yes | Back alignment and domain information |
|---|
Probab=99.92 E-value=1e-25 Score=217.88 Aligned_cols=177 Identities=28% Similarity=0.409 Sum_probs=134.1
Q ss_pred ccceeeccCCCC--------CCCCCCChhhHHHHHHHHHHHHHHHhhcCCCceeecCCCccceEecCCCCceecccccee
Q 045315 242 EISFWYESYNNP--------TKKGLLCWGTRVRIIEGIAQGLLYLHQYSRLRVIHRDLKASNILLDKDMNPKISDFGMAR 313 (476)
Q Consensus 242 ~~~l~~Ey~~~~--------~~~~~L~~~~~~~i~~qIa~gL~yLH~~~~~~ivH~DLkp~NILld~~~~~kL~DFGla~ 313 (476)
..+++|||++.. .....+++..+..++.|++.||+|||+.+ ++|+||||+||++++++.++|+|||++.
T Consensus 74 ~~~~v~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~l~~al~~lH~~~---i~H~dl~~~Nill~~~~~~~l~dfg~~~ 150 (260)
T cd05069 74 PIYIVTEFMGKGSLLDFLKEGDGKYLKLPQLVDMAAQIADGMAYIERMN---YIHRDLRAANILVGDNLVCKIADFGLAR 150 (260)
T ss_pred CcEEEEEcCCCCCHHHHHhhCCCCCCCHHHHHHHHHHHHHHHHHHHhCC---EeecccCcceEEEcCCCeEEECCCccce
Confidence 456788888732 23345899999999999999999999998 9999999999999999999999999998
Q ss_pred ecCCCcccccceeeeeccCCCChhhhccCCCCccceEEeehhhhhhhhh-CCCCCCcCCCCchhhhhhhhhhhcCCCccc
Q 045315 314 MFGGDELQSNTKRIVGTYGYMSPEYALRGLFSIKSDVFSFGVLLLETLS-SKKNTHFYNTDSLTLLGHAWNLWNDGRTWE 392 (476)
Q Consensus 314 ~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~s~ksDVwSlGvvl~ellt-G~~p~~~~~~~~~~~~~~~~~~~~~~~~~~ 392 (476)
......... .....++..|+|||...+..++.++|+||||+++||+++ |+.|+..... ...... ...+..
T Consensus 151 ~~~~~~~~~-~~~~~~~~~y~~Pe~~~~~~~~~~~Di~slG~~l~el~t~g~~p~~~~~~--~~~~~~----~~~~~~-- 221 (260)
T cd05069 151 LIEDNEYTA-RQGAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELVTKGRVPYPGMVN--REVLEQ----VERGYR-- 221 (260)
T ss_pred EccCCcccc-cCCCccchhhCCHHHhccCCcChHHHHHHHHHHHHHHHhCCCCCCCCCCH--HHHHHH----HHcCCC--
Confidence 764332111 112345678999999988889999999999999999999 8888754321 111111 111100
Q ss_pred ccCcccCCCCCHHHHHHHHHHHHHchhhcccCCCCHHHHHHHHhc
Q 045315 393 LMDPISQNGASYPILKRYINVALLCVQEKAADRPAMSEVVSMLSN 437 (476)
Q Consensus 393 ~~d~~~~~~~~~~~~~~l~~li~~Cl~~dP~~RPt~~eVl~~L~~ 437 (476)
..........+.+++.+||+.+|++||++++|++.|+.
T Consensus 222 -------~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~i~~~l~~ 259 (260)
T cd05069 222 -------MPCPQGCPESLHELMKLCWKKDPDERPTFEYIQSFLED 259 (260)
T ss_pred -------CCCCcccCHHHHHHHHHHccCCcccCcCHHHHHHHHhc
Confidence 01112234678899999999999999999999999975
|
Protein Tyrosine Kinase (PTK) family; Yes kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Yes (or c-Yes) is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine an |
| >PHA03207 serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Probab=99.92 E-value=8.5e-26 Score=232.18 Aligned_cols=190 Identities=21% Similarity=0.247 Sum_probs=135.3
Q ss_pred ccceeeccCCCC-----CCCCCCChhhHHHHHHHHHHHHHHHhhcCCCceeecCCCccceEecCCCCceeccccceeecC
Q 045315 242 EISFWYESYNNP-----TKKGLLCWGTRVRIIEGIAQGLLYLHQYSRLRVIHRDLKASNILLDKDMNPKISDFGMARMFG 316 (476)
Q Consensus 242 ~~~l~~Ey~~~~-----~~~~~L~~~~~~~i~~qIa~gL~yLH~~~~~~ivH~DLkp~NILld~~~~~kL~DFGla~~~~ 316 (476)
..+++|||+... .....+++.+++.++.||+.||+|||+++ |+||||||+|||++.++.+||+|||++....
T Consensus 160 ~~~lv~e~~~~~l~~~l~~~~~l~~~~~~~i~~ql~~aL~~LH~~g---ivHrDlkp~Nill~~~~~~~l~DfG~a~~~~ 236 (392)
T PHA03207 160 TVCMVMPKYKCDLFTYVDRSGPLPLEQAITIQRRLLEALAYLHGRG---IIHRDVKTENIFLDEPENAVLGDFGAACKLD 236 (392)
T ss_pred EEEEEehhcCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCC---ccccCCCHHHEEEcCCCCEEEccCccccccC
Confidence 456777777621 24567999999999999999999999998 9999999999999999999999999998765
Q ss_pred CCcccccceeeeeccCCCChhhhccCCCCccceEEeehhhhhhhhhCCCCCCcCCCCc-hhhhhhhhhhhcCCCc-----
Q 045315 317 GDELQSNTKRIVGTYGYMSPEYALRGLFSIKSDVFSFGVLLLETLSSKKNTHFYNTDS-LTLLGHAWNLWNDGRT----- 390 (476)
Q Consensus 317 ~~~~~~~~~~~~gt~~y~aPE~l~~~~~s~ksDVwSlGvvl~elltG~~p~~~~~~~~-~~~~~~~~~~~~~~~~----- 390 (476)
............||..|+|||++....++.++|||||||++|||++|+.||....... ................
T Consensus 237 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslGvil~el~~g~~pf~~~~~~~~~~~l~~i~~~~~~~~~~~~~~ 316 (392)
T PHA03207 237 AHPDTPQCYGWSGTLETNSPELLALDPYCAKTDIWSAGLVLFEMSVKNVTLFGKQVKSSSSQLRSIIRCMQVHPLEFPQN 316 (392)
T ss_pred cccccccccccccccCccCHhHhcCCCCCchhhHHHHHHHHHHHHHCCCCCCCCCCCCcHHHHHHHHHHhccCccccCCc
Confidence 4333233334578999999999998899999999999999999999999986543211 1111111110000000
Q ss_pred --cc------ccCcccCCCCC-------HHHHHHHHHHHHHchhhcccCCCCHHHHHHH
Q 045315 391 --WE------LMDPISQNGAS-------YPILKRYINVALLCVQEKAADRPAMSEVVSM 434 (476)
Q Consensus 391 --~~------~~d~~~~~~~~-------~~~~~~l~~li~~Cl~~dP~~RPt~~eVl~~ 434 (476)
.. ........... ......+.+++.+||+.||++||++.|++..
T Consensus 317 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~ml~~dp~~Rpsa~e~l~~ 375 (392)
T PHA03207 317 GSTNLCKHFKQYAIVLRPPYTIPPVIRKYGMHMDVEYLIAKMLTFDQEFRPSAQDILSL 375 (392)
T ss_pred cchhHHHHHHhhcccccCCccccchhhccCcchhHHHHHHHHhccChhhCCCHHHHhhC
Confidence 00 00000000000 1123467789999999999999999999865
|
|
| >KOG0599 consensus Phosphorylase kinase gamma subunit [Carbohydrate transport and metabolism] | Back alignment and domain information |
|---|
Probab=99.92 E-value=4.5e-26 Score=210.86 Aligned_cols=173 Identities=26% Similarity=0.332 Sum_probs=133.7
Q ss_pred cceeeccCCC------CCCCCCCChhhHHHHHHHHHHHHHHHhhcCCCceeecCCCccceEecCCCCceeccccceeecC
Q 045315 243 ISFWYESYNN------PTKKGLLCWGTRVRIIEGIAQGLLYLHQYSRLRVIHRDLKASNILLDKDMNPKISDFGMARMFG 316 (476)
Q Consensus 243 ~~l~~Ey~~~------~~~~~~L~~~~~~~i~~qIa~gL~yLH~~~~~~ivH~DLkp~NILld~~~~~kL~DFGla~~~~ 316 (476)
.++++|.|+. .+..-.|++++..+|.+|+.+|++|||..+ ||||||||+|||+|++.++||+|||++..+.
T Consensus 98 ~FlVFdl~prGELFDyLts~VtlSEK~tR~iMrqlfegVeylHa~~---IVHRDLKpENILlddn~~i~isDFGFa~~l~ 174 (411)
T KOG0599|consen 98 VFLVFDLMPRGELFDYLTSKVTLSEKETRRIMRQLFEGVEYLHARN---IVHRDLKPENILLDDNMNIKISDFGFACQLE 174 (411)
T ss_pred hhhhhhhcccchHHHHhhhheeecHHHHHHHHHHHHHHHHHHHHhh---hhhcccChhheeeccccceEEeccceeeccC
Confidence 3445555552 234557999999999999999999999999 9999999999999999999999999999876
Q ss_pred CCcccccceeeeeccCCCChhhhcc------CCCCccceEEeehhhhhhhhhCCCCCCcCCCCchhhhhhhhhhhcCCCc
Q 045315 317 GDELQSNTKRIVGTYGYMSPEYALR------GLFSIKSDVFSFGVLLLETLSSKKNTHFYNTDSLTLLGHAWNLWNDGRT 390 (476)
Q Consensus 317 ~~~~~~~~~~~~gt~~y~aPE~l~~------~~~s~ksDVwSlGvvl~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~ 390 (476)
.... .....||++|+|||.+.. ..|+...|.|++||++|.|+.|.+||.-.. .....+.+.+|+.
T Consensus 175 ~Gek---LrelCGTPgYLAPEtikC~m~e~~pGYs~EVD~Wa~GVImyTLLaGcpPFwHRk------QmlMLR~ImeGky 245 (411)
T KOG0599|consen 175 PGEK---LRELCGTPGYLAPETIKCSMYENHPGYSKEVDEWACGVIMYTLLAGCPPFWHRK------QMLMLRMIMEGKY 245 (411)
T ss_pred Cchh---HHHhcCCCcccChhheeeecccCCCCccchhhHHHHHHHHHHHHcCCCchhHHH------HHHHHHHHHhccc
Confidence 5432 233679999999998852 458899999999999999999999985211 0111223333333
Q ss_pred ccccCcccCCCCCHHHHHHHHHHHHHchhhcccCCCCHHHHHH
Q 045315 391 WELMDPISQNGASYPILKRYINVALLCVQEKAADRPAMSEVVS 433 (476)
Q Consensus 391 ~~~~d~~~~~~~~~~~~~~l~~li~~Cl~~dP~~RPt~~eVl~ 433 (476)
. ...+...+......+++.+||+.||.+|.|++|+++
T Consensus 246 q------F~speWadis~~~KdLIsrlLqVdp~~Ritake~La 282 (411)
T KOG0599|consen 246 Q------FRSPEWADISATVKDLISRLLQVDPTKRITAKEALA 282 (411)
T ss_pred c------cCCcchhhccccHHHHHHHHHeeCchhcccHHHHhc
Confidence 1 122233445667889999999999999999999875
|
|
| >cd05095 PTKc_DDR2 Catalytic domain of the Protein Tyrosine Kinase, Discoidin Domain Receptor 2 | Back alignment and domain information |
|---|
Probab=99.92 E-value=2.7e-25 Score=219.26 Aligned_cols=170 Identities=27% Similarity=0.391 Sum_probs=123.4
Q ss_pred CCCChhhHHHHHHHHHHHHHHHhhcCCCceeecCCCccceEecCCCCceeccccceeecCCCcccccceeeeeccCCCCh
Q 045315 257 GLLCWGTRVRIIEGIAQGLLYLHQYSRLRVIHRDLKASNILLDKDMNPKISDFGMARMFGGDELQSNTKRIVGTYGYMSP 336 (476)
Q Consensus 257 ~~L~~~~~~~i~~qIa~gL~yLH~~~~~~ivH~DLkp~NILld~~~~~kL~DFGla~~~~~~~~~~~~~~~~gt~~y~aP 336 (476)
..+++.++..++.||+.||+|||+.+ ++|+||||+||+++.++.+||+|||+++.+.............++..|++|
T Consensus 125 ~~~~~~~~~~~~~~i~~al~~lH~~~---i~H~dlkp~Nili~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~~~~p 201 (296)
T cd05095 125 VTISYSTLIFMATQIASGMKYLSSLN---FVHRDLATRNCLVGKNYTIKIADFGMSRNLYSGDYYRIQGRAVLPIRWMSW 201 (296)
T ss_pred cccCHHHHHHHHHHHHHHHHHHHHCC---eecccCChheEEEcCCCCEEeccCcccccccCCcceeccCcCcCccccCCH
Confidence 35888899999999999999999998 999999999999999999999999999865433221112223346789999
Q ss_pred hhhccCCCCccceEEeehhhhhhhhh--CCCCCCcCCCCchhhhhhhhhhhcCCCcccccCcccCCCCCHHHHHHHHHHH
Q 045315 337 EYALRGLFSIKSDVFSFGVLLLETLS--SKKNTHFYNTDSLTLLGHAWNLWNDGRTWELMDPISQNGASYPILKRYINVA 414 (476)
Q Consensus 337 E~l~~~~~s~ksDVwSlGvvl~ellt--G~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~l~~li 414 (476)
|....+.++.++|+|||||++|||++ |..|+..... ................... .+ ........+.+++
T Consensus 202 e~~~~~~~~~~~DiwSlG~~l~el~~~~~~~p~~~~~~--~~~~~~~~~~~~~~~~~~~-~~-----~~~~~~~~~~~li 273 (296)
T cd05095 202 ESILLGKFTTASDVWAFGVTLWEILTLCKEQPYSQLSD--EQVIENTGEFFRDQGRQVY-LP-----KPALCPDSLYKLM 273 (296)
T ss_pred HHHhcCCccchhhhhHHHHHHHHHHHhCCCCCccccCh--HHHHHHHHHHHhhcccccc-CC-----CCCCCCHHHHHHH
Confidence 99888889999999999999999998 5556543221 1111111111111100000 00 1112236788999
Q ss_pred HHchhhcccCCCCHHHHHHHHhc
Q 045315 415 LLCVQEKAADRPAMSEVVSMLSN 437 (476)
Q Consensus 415 ~~Cl~~dP~~RPt~~eVl~~L~~ 437 (476)
.+||+.||.+||++.+|++.|++
T Consensus 274 ~~cl~~~p~~Rp~~~~i~~~l~~ 296 (296)
T cd05095 274 LSCWRRNAKERPSFQEIHATLLE 296 (296)
T ss_pred HHHcCCCcccCCCHHHHHHHHhC
Confidence 99999999999999999999863
|
Protein Tyrosine Kinase (PTK) family; mammalian Discoidin Domain Receptor 2 (DDR2) and homologs; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR2 is a member of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDR2 binds mostly to fibrillar collagens. More recently, it has been reported to also bind collagen X. DDR2 is widely expressed in many tissues wit |
| >cd05573 STKc_ROCK_NDR_like Catalytic domain of ROCK- and NDR kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=99.92 E-value=9.8e-26 Score=227.65 Aligned_cols=178 Identities=22% Similarity=0.292 Sum_probs=134.6
Q ss_pred cccceeeccCCCC------CCCCCCChhhHHHHHHHHHHHHHHHhhcCCCceeecCCCccceEecCCCCceeccccceee
Q 045315 241 DEISFWYESYNNP------TKKGLLCWGTRVRIIEGIAQGLLYLHQYSRLRVIHRDLKASNILLDKDMNPKISDFGMARM 314 (476)
Q Consensus 241 ~~~~l~~Ey~~~~------~~~~~L~~~~~~~i~~qIa~gL~yLH~~~~~~ivH~DLkp~NILld~~~~~kL~DFGla~~ 314 (476)
+..+++|||++.. .+...+++.++..++.||+.||+|||+.+ |+||||||+||+++.++.+||+|||++..
T Consensus 74 ~~~~lv~e~~~~~~L~~~l~~~~~l~~~~~~~i~~qi~~aL~~LH~~g---iiH~Dlkp~NIll~~~~~~kL~Dfg~~~~ 150 (350)
T cd05573 74 EHLYLVMEYMPGGDLMNLLIRKDVFPEETARFYIAELVLALDSVHKLG---FIHRDIKPDNILIDADGHIKLADFGLCKK 150 (350)
T ss_pred CeEEEEEcCCCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCC---eeccCCCHHHeEECCCCCEEeecCCCCcc
Confidence 4678899999843 23467999999999999999999999998 99999999999999999999999999986
Q ss_pred cCCCc---------------------------ccccceeeeeccCCCChhhhccCCCCccceEEeehhhhhhhhhCCCCC
Q 045315 315 FGGDE---------------------------LQSNTKRIVGTYGYMSPEYALRGLFSIKSDVFSFGVLLLETLSSKKNT 367 (476)
Q Consensus 315 ~~~~~---------------------------~~~~~~~~~gt~~y~aPE~l~~~~~s~ksDVwSlGvvl~elltG~~p~ 367 (476)
..... .........|+..|+|||.+.+..++.++|||||||++|||++|+.||
T Consensus 151 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~ell~g~~Pf 230 (350)
T cd05573 151 MNKAKDREYYLNDSHNLLFRDNVLVRRRDHKQRRVRANSTVGTPDYIAPEVLRGTPYGLECDWWSLGVILYEMLYGFPPF 230 (350)
T ss_pred CcccCcccccccccccccccccccccccccccccccccccccCccccCHHHHcCCCCCCceeeEecchhhhhhccCCCCC
Confidence 54332 001123356899999999999999999999999999999999999998
Q ss_pred CcCCCCchhhhhhhhhhhcCCCcccccCcccCCCCCHHHHHHHHHHHHHchhhcccCCCC-HHHHHHH
Q 045315 368 HFYNTDSLTLLGHAWNLWNDGRTWELMDPISQNGASYPILKRYINVALLCVQEKAADRPA-MSEVVSM 434 (476)
Q Consensus 368 ~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~l~~li~~Cl~~dP~~RPt-~~eVl~~ 434 (476)
....... ... ........ ............+.+++.+|++ ||.+||+ ++++++.
T Consensus 231 ~~~~~~~--~~~---~i~~~~~~-------~~~p~~~~~~~~~~~li~~ll~-dp~~R~~s~~~ll~h 285 (350)
T cd05573 231 YSDTLQE--TYN---KIINWKES-------LRFPPDPPVSPEAIDLICRLLC-DPEDRLGSFEEIKSH 285 (350)
T ss_pred CCCCHHH--HHH---HHhccCCc-------ccCCCCCCCCHHHHHHHHHHcc-ChhhcCCCHHHHhcC
Confidence 6543111 110 11110000 0000011134568889999997 9999999 9999874
|
Serine/Threonine Kinases (STKs), Rho-associated coiled-coil containing protein kinase (ROCK) and Nuclear Dbf2-Related (NDR)-like kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK- and NDR-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily include ROCK and ROCK-like proteins such as DMPK, MRCK, and CRIK, as well as NDR and NDR-like proteins such as LATS, CBK1 and Sid2p. ROCK and CRIK are effectors of the small GTPase Rho, while MRCK is an effector of the small GTPase Cdc42. NDR and NDR-like kinases contain an N-terminal regulatory (NTR) domain and an insert within the |
| >cd05584 STKc_p70S6K Catalytic domain of the Protein Serine/Threonine Kinase, 70 kDa ribosomal protein S6 kinase | Back alignment and domain information |
|---|
Probab=99.92 E-value=1.1e-25 Score=225.30 Aligned_cols=172 Identities=24% Similarity=0.309 Sum_probs=132.5
Q ss_pred cccceeeccCCCC------CCCCCCChhhHHHHHHHHHHHHHHHhhcCCCceeecCCCccceEecCCCCceeccccceee
Q 045315 241 DEISFWYESYNNP------TKKGLLCWGTRVRIIEGIAQGLLYLHQYSRLRVIHRDLKASNILLDKDMNPKISDFGMARM 314 (476)
Q Consensus 241 ~~~~l~~Ey~~~~------~~~~~L~~~~~~~i~~qIa~gL~yLH~~~~~~ivH~DLkp~NILld~~~~~kL~DFGla~~ 314 (476)
+..+++|||++.. .+.+.+++..+..++.||+.||+|||+.+ |+||||||+|||++.++.+||+|||+++.
T Consensus 73 ~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~---ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~ 149 (323)
T cd05584 73 GKLYLILEYLSGGELFMHLEREGIFMEDTACFYLSEISLALEHLHQQG---IIYRDLKPENILLDAQGHVKLTDFGLCKE 149 (323)
T ss_pred CeEEEEEeCCCCchHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCCHHHeEECCCCCEEEeeCcCCee
Confidence 4678899999843 23557888999999999999999999999 99999999999999999999999999875
Q ss_pred cCCCcccccceeeeeccCCCChhhhccCCCCccceEEeehhhhhhhhhCCCCCCcCCCCchhhhhhhhhhhcCCCccccc
Q 045315 315 FGGDELQSNTKRIVGTYGYMSPEYALRGLFSIKSDVFSFGVLLLETLSSKKNTHFYNTDSLTLLGHAWNLWNDGRTWELM 394 (476)
Q Consensus 315 ~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~s~ksDVwSlGvvl~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 394 (476)
...... ......|+..|+|||++.+..++.++|||||||++|||++|+.||...... ... .... .+..
T Consensus 150 ~~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~G~~pf~~~~~~--~~~---~~~~-~~~~---- 217 (323)
T cd05584 150 SIHEGT--VTHTFCGTIEYMAPEILMRSGHGKAVDWWSLGALMYDMLTGAPPFTAENRK--KTI---DKIL-KGKL---- 217 (323)
T ss_pred cccCCC--cccccCCCccccChhhccCCCCCCcceecccHHHHHHHhcCCCCCCCCCHH--HHH---HHHH-cCCC----
Confidence 432221 122356899999999999888999999999999999999999998643311 111 1111 1110
Q ss_pred CcccCCCCCHHHHHHHHHHHHHchhhcccCCC-----CHHHHHH
Q 045315 395 DPISQNGASYPILKRYINVALLCVQEKAADRP-----AMSEVVS 433 (476)
Q Consensus 395 d~~~~~~~~~~~~~~l~~li~~Cl~~dP~~RP-----t~~eVl~ 433 (476)
..+......+.+++.+||+.+|++|| +++++++
T Consensus 218 ------~~~~~~~~~~~~li~~~l~~~p~~R~~~~~~~~~~l~~ 255 (323)
T cd05584 218 ------NLPPYLTPEARDLLKKLLKRNPSSRLGAGPGDAAEVQS 255 (323)
T ss_pred ------CCCCCCCHHHHHHHHHHcccCHhHcCCCCCCCHHHHhc
Confidence 01112235688999999999999999 7888765
|
Serine/Threonine Kinases (STKs), 70 kDa ribosomal protein S6 kinase (p70S6K) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p70S6K subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p70S6K (or S6K) contains only one catalytic kinase domain, unlike p90 ribosomal S6 kinases (RSKs). It acts as a downstream effector of the STK mTOR (mammalian Target of Rapamycin) and plays a role in the regulation of the translation machinery during protein synthesis. p70S6K also plays a pivotal role in regulating cell size and glucose homeostasis. Its targets include S6, the translation initiation factor eIF3, and the in |
| >cd05090 PTKc_Ror1 Catalytic domain of the Protein Tyrosine Kinase, Receptor tyrosine kinase-like Orphan Receptor 1 | Back alignment and domain information |
|---|
Probab=99.92 E-value=6.7e-26 Score=221.90 Aligned_cols=163 Identities=27% Similarity=0.386 Sum_probs=125.1
Q ss_pred CCCChhhHHHHHHHHHHHHHHHhhcCCCceeecCCCccceEecCCCCceeccccceeecCCCcccccceeeeeccCCCCh
Q 045315 257 GLLCWGTRVRIIEGIAQGLLYLHQYSRLRVIHRDLKASNILLDKDMNPKISDFGMARMFGGDELQSNTKRIVGTYGYMSP 336 (476)
Q Consensus 257 ~~L~~~~~~~i~~qIa~gL~yLH~~~~~~ivH~DLkp~NILld~~~~~kL~DFGla~~~~~~~~~~~~~~~~gt~~y~aP 336 (476)
..+++.+.+.++.|++.||+|||+++ ++||||||+||+++.++.+||+|||+++...............++..|+||
T Consensus 119 ~~~~~~~~~~i~~~i~~al~~lH~~~---i~H~dlkp~nili~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~aP 195 (283)
T cd05090 119 SSLDHGDFLHIAIQIAAGMEYLSSHF---FVHKDLAARNILIGEQLHVKISDLGLSREIYSADYYRVQPKSLLPIRWMPP 195 (283)
T ss_pred cccCHHHHHHHHHHHHHHHHHHHhcC---eehhccccceEEEcCCCcEEeccccccccccCCcceecccCCCccceecCh
Confidence 45889999999999999999999998 999999999999999999999999999865433222222223456789999
Q ss_pred hhhccCCCCccceEEeehhhhhhhhh-CCCCCCcCCCCchhhhhhhhhhhcCCCcccccCcccCCCCCHHHHHHHHHHHH
Q 045315 337 EYALRGLFSIKSDVFSFGVLLLETLS-SKKNTHFYNTDSLTLLGHAWNLWNDGRTWELMDPISQNGASYPILKRYINVAL 415 (476)
Q Consensus 337 E~l~~~~~s~ksDVwSlGvvl~ellt-G~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~l~~li~ 415 (476)
|++.+..++.++|+||||+++|||++ |..||..... ...... ........ .+......+.+++.
T Consensus 196 E~~~~~~~~~~~Dv~slG~il~el~~~g~~p~~~~~~--~~~~~~----~~~~~~~~---------~~~~~~~~~~~li~ 260 (283)
T cd05090 196 EAIMYGKFSSDSDIWSFGVVLWEIFSFGLQPYYGFSN--QEVIEM----VRKRQLLP---------CSEDCPPRMYSLMT 260 (283)
T ss_pred HHhccCCCCchhhhHHHHHHHHHHHcCCCCCCCCCCH--HHHHHH----HHcCCcCC---------CCCCCCHHHHHHHH
Confidence 99988889999999999999999998 8888754321 111111 11111110 11122356888999
Q ss_pred HchhhcccCCCCHHHHHHHHhc
Q 045315 416 LCVQEKAADRPAMSEVVSMLSN 437 (476)
Q Consensus 416 ~Cl~~dP~~RPt~~eVl~~L~~ 437 (476)
+||+.+|++||++.+|++.|..
T Consensus 261 ~cl~~~p~~Rp~~~~i~~~l~~ 282 (283)
T cd05090 261 ECWQEGPSRRPRFKDIHTRLRS 282 (283)
T ss_pred HHcccCcccCcCHHHHHHHhhc
Confidence 9999999999999999999865
|
Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor 1 (Ror1); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase cataly |
| >cd08229 STKc_Nek7 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 7 | Back alignment and domain information |
|---|
Probab=99.92 E-value=2.4e-25 Score=215.67 Aligned_cols=182 Identities=23% Similarity=0.321 Sum_probs=138.8
Q ss_pred cccceeeccCCCC----------CCCCCCChhhHHHHHHHHHHHHHHHhhcCCCceeecCCCccceEecCCCCceecccc
Q 045315 241 DEISFWYESYNNP----------TKKGLLCWGTRVRIIEGIAQGLLYLHQYSRLRVIHRDLKASNILLDKDMNPKISDFG 310 (476)
Q Consensus 241 ~~~~l~~Ey~~~~----------~~~~~L~~~~~~~i~~qIa~gL~yLH~~~~~~ivH~DLkp~NILld~~~~~kL~DFG 310 (476)
+..++++||++.. .....+++.++..++.||+.||+|||+.+ ++|+||||+||+++.++.++|+|||
T Consensus 75 ~~~~~v~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~---i~H~dl~p~nili~~~~~~~l~dfg 151 (267)
T cd08229 75 NELNIVLELADAGDLSRMIKHFKKQKRLIPEKTVWKYFVQLCSALEHMHSRR---VMHRDIKPANVFITATGVVKLGDLG 151 (267)
T ss_pred CeEEEEEEecCCCCHHHHHHHhhccCCCCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCCHHHEEEcCCCCEEECcch
Confidence 4567888888732 13457899999999999999999999998 9999999999999999999999999
Q ss_pred ceeecCCCcccccceeeeeccCCCChhhhccCCCCccceEEeehhhhhhhhhCCCCCCcCCCCchhhhhhhhhhhcCCCc
Q 045315 311 MARMFGGDELQSNTKRIVGTYGYMSPEYALRGLFSIKSDVFSFGVLLLETLSSKKNTHFYNTDSLTLLGHAWNLWNDGRT 390 (476)
Q Consensus 311 la~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~s~ksDVwSlGvvl~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~ 390 (476)
++......... .....++..|+|||.+.+..++.++|+||||+++|+|++|..|+.....+........ ....
T Consensus 152 ~~~~~~~~~~~--~~~~~~~~~~~ape~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~~~~~~----~~~~- 224 (267)
T cd08229 152 LGRFFSSKTTA--AHSLVGTPYYMSPERIHENGYNFKSDIWSLGCLLYEMAALQSPFYGDKMNLYSLCKKI----EQCD- 224 (267)
T ss_pred hhhccccCCcc--cccccCCcCccCHHHhcCCCccchhhHHHHHHHHHHHHhCCCCcccccchHHHHhhhh----hcCC-
Confidence 98866433221 1224578899999999888899999999999999999999999854322211111110 0000
Q ss_pred ccccCcccCCCCCHHHHHHHHHHHHHchhhcccCCCCHHHHHHHHhccc
Q 045315 391 WELMDPISQNGASYPILKRYINVALLCVQEKAADRPAMSEVVSMLSNEF 439 (476)
Q Consensus 391 ~~~~d~~~~~~~~~~~~~~l~~li~~Cl~~dP~~RPt~~eVl~~L~~~~ 439 (476)
.+ ..........+.+++.+||+.+|++|||+.+|++++++..
T Consensus 225 ----~~---~~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~i~~~~~~~~ 266 (267)
T cd08229 225 ----YP---PLPSDHYSEELRQLVNMCINPDPEKRPDITYVYDVAKRMH 266 (267)
T ss_pred ----CC---CCCcccccHHHHHHHHHhcCCCcccCCCHHHHHHHHhhhc
Confidence 01 0111224557889999999999999999999999998753
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 7 (Nek7) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek7 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek7 is required for mitotic spindle formation and cytokinesis. It is enriched in the centrosome and is critical for microtubule nucleation. Nek7 is activated by Nek9 during mitosis, and may regulate the p70 ribosomal S6 kinase. |
| >cd05620 STKc_nPKC_delta Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C delta | Back alignment and domain information |
|---|
Probab=99.92 E-value=7.9e-26 Score=225.62 Aligned_cols=171 Identities=26% Similarity=0.318 Sum_probs=131.3
Q ss_pred cccceeeccCCCCC------CCCCCChhhHHHHHHHHHHHHHHHhhcCCCceeecCCCccceEecCCCCceeccccceee
Q 045315 241 DEISFWYESYNNPT------KKGLLCWGTRVRIIEGIAQGLLYLHQYSRLRVIHRDLKASNILLDKDMNPKISDFGMARM 314 (476)
Q Consensus 241 ~~~~l~~Ey~~~~~------~~~~L~~~~~~~i~~qIa~gL~yLH~~~~~~ivH~DLkp~NILld~~~~~kL~DFGla~~ 314 (476)
+.++++|||++... ....+++.++..++.||+.||+|||+.+ |+||||||+||+++.++.+||+|||+++.
T Consensus 69 ~~~~lv~E~~~~g~L~~~i~~~~~~~~~~~~~~~~qi~~~l~~lH~~~---ivHrDlkp~Nil~~~~~~~kl~Dfg~~~~ 145 (316)
T cd05620 69 EHLFFVMEFLNGGDLMFHIQDKGRFDLYRATFYAAEIVCGLQFLHSKG---IIYRDLKLDNVMLDRDGHIKIADFGMCKE 145 (316)
T ss_pred CEEEEEECCCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCC---eEecCCCHHHeEECCCCCEEeCccCCCee
Confidence 46789999998432 3457899999999999999999999998 99999999999999999999999999875
Q ss_pred cCCCcccccceeeeeccCCCChhhhccCCCCccceEEeehhhhhhhhhCCCCCCcCCCCchhhhhhhhhhhcCCCccccc
Q 045315 315 FGGDELQSNTKRIVGTYGYMSPEYALRGLFSIKSDVFSFGVLLLETLSSKKNTHFYNTDSLTLLGHAWNLWNDGRTWELM 394 (476)
Q Consensus 315 ~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~s~ksDVwSlGvvl~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 394 (476)
..... .......|+..|+|||.+.+..++.++|||||||++|||++|+.||..... ...... .....
T Consensus 146 ~~~~~--~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslGvil~el~~g~~Pf~~~~~--~~~~~~----~~~~~----- 212 (316)
T cd05620 146 NVFGD--NRASTFCGTPDYIAPEILQGLKYTFSVDWWSFGVLLYEMLIGQSPFHGDDE--DELFES----IRVDT----- 212 (316)
T ss_pred cccCC--CceeccCCCcCccCHHHHcCCCCCcccchhhhHHHHHHHHhCCCCCCCCCH--HHHHHH----HHhCC-----
Confidence 32111 122335689999999999999999999999999999999999999864331 111111 11110
Q ss_pred CcccCCCCCHHHHHHHHHHHHHchhhcccCCCCHH-HHH
Q 045315 395 DPISQNGASYPILKRYINVALLCVQEKAADRPAMS-EVV 432 (476)
Q Consensus 395 d~~~~~~~~~~~~~~l~~li~~Cl~~dP~~RPt~~-eVl 432 (476)
+.. +......+.+++.+||+.||++||++. +++
T Consensus 213 -~~~----~~~~~~~~~~li~~~l~~dP~~R~~~~~~~~ 246 (316)
T cd05620 213 -PHY----PRWITKESKDILEKLFERDPTRRLGVVGNIR 246 (316)
T ss_pred -CCC----CCCCCHHHHHHHHHHccCCHHHcCCChHHHH
Confidence 001 111235678899999999999999984 554
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), delta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-delta plays a role in cell cycle regulation and programmed cell death in many cell types. I |
| >cd05043 PTK_Ryk Pseudokinase domain of Ryk (Receptor related to tyrosine kinase) | Back alignment and domain information |
|---|
Probab=99.92 E-value=8.3e-26 Score=220.78 Aligned_cols=167 Identities=25% Similarity=0.339 Sum_probs=128.7
Q ss_pred CCCChhhHHHHHHHHHHHHHHHhhcCCCceeecCCCccceEecCCCCceeccccceeecCCCcccccceeeeeccCCCCh
Q 045315 257 GLLCWGTRVRIIEGIAQGLLYLHQYSRLRVIHRDLKASNILLDKDMNPKISDFGMARMFGGDELQSNTKRIVGTYGYMSP 336 (476)
Q Consensus 257 ~~L~~~~~~~i~~qIa~gL~yLH~~~~~~ivH~DLkp~NILld~~~~~kL~DFGla~~~~~~~~~~~~~~~~gt~~y~aP 336 (476)
..+++.+++.++.||+.||+|||+.+ ++|+||||+||+++.++.+||+|||+++.+.............++..|+||
T Consensus 112 ~~l~~~~~~~i~~~i~~~l~~LH~~~---i~H~di~p~nil~~~~~~~kl~d~g~~~~~~~~~~~~~~~~~~~~~~y~ap 188 (280)
T cd05043 112 QALSTQQLVHMAIQIACGMSYLHKRG---VIHKDIAARNCVIDEELQVKITDNALSRDLFPMDYHCLGDNENRPVKWMAL 188 (280)
T ss_pred cCCCHHHHHHHHHHHHHHHHHHHHCC---EeecccCHhhEEEcCCCcEEECCCCCcccccCCceEEeCCCCCcchhccCH
Confidence 56999999999999999999999998 999999999999999999999999999865433222111223456789999
Q ss_pred hhhccCCCCccceEEeehhhhhhhhh-CCCCCCcCCCCchhhhhhhhhhhcCCCcccccCcccCCCCCHHHHHHHHHHHH
Q 045315 337 EYALRGLFSIKSDVFSFGVLLLETLS-SKKNTHFYNTDSLTLLGHAWNLWNDGRTWELMDPISQNGASYPILKRYINVAL 415 (476)
Q Consensus 337 E~l~~~~~s~ksDVwSlGvvl~ellt-G~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~l~~li~ 415 (476)
|.+.+..++.++|||||||++||+++ |+.||.... ....... ...+... .........+.+++.
T Consensus 189 E~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~~~~--~~~~~~~----~~~~~~~---------~~~~~~~~~~~~li~ 253 (280)
T cd05043 189 ESLVNKEYSSASDVWSFGVLLWELMTLGQTPYVEID--PFEMAAY----LKDGYRL---------AQPINCPDELFAVMA 253 (280)
T ss_pred HHHhcCCCCchhhHHHhHHHHHHHhcCCCCCcCcCC--HHHHHHH----HHcCCCC---------CCCCcCCHHHHHHHH
Confidence 99988889999999999999999998 998875432 1111111 1111100 001112356889999
Q ss_pred HchhhcccCCCCHHHHHHHHhccccC
Q 045315 416 LCVQEKAADRPAMSEVVSMLSNEFVN 441 (476)
Q Consensus 416 ~Cl~~dP~~RPt~~eVl~~L~~~~~~ 441 (476)
+||+.+|++|||+.+|++.|+.+.++
T Consensus 254 ~~l~~~p~~Rps~~~~~~~l~~~~~~ 279 (280)
T cd05043 254 CCWALDPEERPSFSQLVQCLTDFHAQ 279 (280)
T ss_pred HHcCCChhhCCCHHHHHHHHHHHHhc
Confidence 99999999999999999999987543
|
Protein Tyrosine Kinase (PTK) family; Receptor related to tyrosine kinase (Ryk); pseudokinase domain. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ryk is a receptor tyr kinase (RTK) containing an extracellular region with two leucine-rich motifs, a transmembrane segment, and an intracellular inactive pseudokinase domain. The extracellular region of Ryk shows homology to the N-terminal domain of Wnt inhibitory factor-1 (WIF) and serves as the ligand (Wnt) binding domain of Ryk. Ryk is expressed in many different tissues both during development and in adults, suggesting a widespread function. It |
| >cd05114 PTKc_Tec_Rlk Catalytic domain of the Protein Tyrosine Kinases, Tyrosine kinase expressed in hepatocellular carcinoma and Resting lymphocyte kinase | Back alignment and domain information |
|---|
Probab=99.92 E-value=8.8e-26 Score=217.64 Aligned_cols=177 Identities=28% Similarity=0.382 Sum_probs=133.3
Q ss_pred cccceeeccCCCC-------CCCCCCChhhHHHHHHHHHHHHHHHhhcCCCceeecCCCccceEecCCCCceecccccee
Q 045315 241 DEISFWYESYNNP-------TKKGLLCWGTRVRIIEGIAQGLLYLHQYSRLRVIHRDLKASNILLDKDMNPKISDFGMAR 313 (476)
Q Consensus 241 ~~~~l~~Ey~~~~-------~~~~~L~~~~~~~i~~qIa~gL~yLH~~~~~~ivH~DLkp~NILld~~~~~kL~DFGla~ 313 (476)
+..+++|||++.+ .....+++..++.++.|++.||+|||+.+ ++|+||||+||+++.++.+||+|||.++
T Consensus 72 ~~~~iv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~---i~H~dl~p~ni~i~~~~~~kl~d~g~~~ 148 (256)
T cd05114 72 KPLYIVTEFMENGCLLNYLRQRQGKLSKDMLLSMCQDVCEGMEYLERNS---FIHRDLAARNCLVSSTGVVKVSDFGMTR 148 (256)
T ss_pred CCEEEEEEcCCCCcHHHHHHhCccCCCHHHHHHHHHHHHHHHHHHHHCC---ccccccCcceEEEcCCCeEEECCCCCcc
Confidence 4577889998732 12346899999999999999999999998 9999999999999999999999999988
Q ss_pred ecCCCcccccceeeeeccCCCChhhhccCCCCccceEEeehhhhhhhhh-CCCCCCcCCCCchhhhhhhhhhhcCCCccc
Q 045315 314 MFGGDELQSNTKRIVGTYGYMSPEYALRGLFSIKSDVFSFGVLLLETLS-SKKNTHFYNTDSLTLLGHAWNLWNDGRTWE 392 (476)
Q Consensus 314 ~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~s~ksDVwSlGvvl~ellt-G~~p~~~~~~~~~~~~~~~~~~~~~~~~~~ 392 (476)
......... .....++..|+|||.+.+..++.++|+||||+++||+++ |+.||..... ....... ..+..
T Consensus 149 ~~~~~~~~~-~~~~~~~~~y~aPE~~~~~~~~~~~Di~s~G~~l~el~~~g~~p~~~~~~--~~~~~~i----~~~~~-- 219 (256)
T cd05114 149 YVLDDEYTS-SSGAKFPVKWSPPEVFNFSKYSSKSDVWSFGVLMWEVFTEGKMPFEKKSN--YEVVEMI----SRGFR-- 219 (256)
T ss_pred ccCCCceec-cCCCCCchhhCChhhcccCccchhhhhHHHHHHHHHHHcCCCCCCCCCCH--HHHHHHH----HCCCC--
Confidence 654322111 111234568999999988889999999999999999999 8888754321 1111111 11111
Q ss_pred ccCcccCCCCCHHHHHHHHHHHHHchhhcccCCCCHHHHHHHHh
Q 045315 393 LMDPISQNGASYPILKRYINVALLCVQEKAADRPAMSEVVSMLS 436 (476)
Q Consensus 393 ~~d~~~~~~~~~~~~~~l~~li~~Cl~~dP~~RPt~~eVl~~L~ 436 (476)
...+ ......+.+++.+||+.+|++||++.++++.|.
T Consensus 220 ~~~~-------~~~~~~~~~li~~c~~~~p~~Rps~~~l~~~l~ 256 (256)
T cd05114 220 LYRP-------KLASMTVYEVMYSCWHEKPEGRPTFAELLRAIT 256 (256)
T ss_pred CCCC-------CCCCHHHHHHHHHHccCCcccCcCHHHHHHhhC
Confidence 0011 112346889999999999999999999999874
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase expressed in hepatocellular carcinoma (Tec) and Resting lymphocyte kinase (Rlk); catalytic (c) domain. The PTKc family is part of a larger superfamily, that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tec and Rlk (also named Txk) are members of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin h |
| >cd05071 PTKc_Src Catalytic domain of the Protein Tyrosine Kinase, Src | Back alignment and domain information |
|---|
Probab=99.92 E-value=1.1e-25 Score=218.10 Aligned_cols=180 Identities=26% Similarity=0.396 Sum_probs=136.5
Q ss_pred cccceeeccCCCC--------CCCCCCChhhHHHHHHHHHHHHHHHhhcCCCceeecCCCccceEecCCCCceeccccce
Q 045315 241 DEISFWYESYNNP--------TKKGLLCWGTRVRIIEGIAQGLLYLHQYSRLRVIHRDLKASNILLDKDMNPKISDFGMA 312 (476)
Q Consensus 241 ~~~~l~~Ey~~~~--------~~~~~L~~~~~~~i~~qIa~gL~yLH~~~~~~ivH~DLkp~NILld~~~~~kL~DFGla 312 (476)
+..++++||++.. .....+++.++..++.|+++||+|||+.+ ++|+||||+||++++++.+||+|||.+
T Consensus 73 ~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~l~~aL~~lH~~~---i~H~dl~p~Nill~~~~~~~L~dfg~~ 149 (262)
T cd05071 73 EPIYIVTEYMSKGSLLDFLKGEMGKYLRLPQLVDMAAQIASGMAYVERMN---YVHRDLRAANILVGENLVCKVADFGLA 149 (262)
T ss_pred CCcEEEEEcCCCCcHHHHHhhccccCCCHHHHHHHHHHHHHHHHHHHHCC---ccccccCcccEEEcCCCcEEeccCCce
Confidence 3467888988732 22346899999999999999999999998 999999999999999999999999999
Q ss_pred eecCCCcccccceeeeeccCCCChhhhccCCCCccceEEeehhhhhhhhh-CCCCCCcCCCCchhhhhhhhhhhcCCCcc
Q 045315 313 RMFGGDELQSNTKRIVGTYGYMSPEYALRGLFSIKSDVFSFGVLLLETLS-SKKNTHFYNTDSLTLLGHAWNLWNDGRTW 391 (476)
Q Consensus 313 ~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~s~ksDVwSlGvvl~ellt-G~~p~~~~~~~~~~~~~~~~~~~~~~~~~ 391 (476)
+.+....... .....++..|+|||+..+..++.++|+||||+++||+++ |+.||...... .... ....+..
T Consensus 150 ~~~~~~~~~~-~~~~~~~~~y~~PE~~~~~~~~~~~DvwslG~~l~ellt~g~~p~~~~~~~--~~~~----~~~~~~~- 221 (262)
T cd05071 150 RLIEDNEYTA-RQGAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELTTKGRVPYPGMVNR--EVLD----QVERGYR- 221 (262)
T ss_pred eecccccccc-ccCCcccceecCHhHhccCCCCchhhHHHHHHHHHHHHcCCCCCCCCCChH--HHHH----HHhcCCC-
Confidence 8765332211 112345678999999988889999999999999999999 77777533211 1111 1111100
Q ss_pred cccCcccCCCCCHHHHHHHHHHHHHchhhcccCCCCHHHHHHHHhccc
Q 045315 392 ELMDPISQNGASYPILKRYINVALLCVQEKAADRPAMSEVVSMLSNEF 439 (476)
Q Consensus 392 ~~~d~~~~~~~~~~~~~~l~~li~~Cl~~dP~~RPt~~eVl~~L~~~~ 439 (476)
..........+.+++.+|++.+|++||++.++++.|+..+
T Consensus 222 --------~~~~~~~~~~l~~li~~~l~~~p~~Rp~~~~~~~~l~~~~ 261 (262)
T cd05071 222 --------MPCPPECPESLHDLMCQCWRKEPEERPTFEYLQAFLEDYF 261 (262)
T ss_pred --------CCCccccCHHHHHHHHHHccCCcccCCCHHHHHHHHHHhc
Confidence 0112234467889999999999999999999999998753
|
Protein Tyrosine Kinase (PTK) family; Src kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Src (or c-Src) is a cytoplasmic (or non-receptor) tyr kinase, containing an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region with a conserved tyr. It is activated by autophosphorylation at the tyr kinase domain, and is negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). c-Src is the vertebrate homolog of the oncogenic protein (v-Src) from Rous sarcoma virus. Together with other Src subfamily proteins, it is invo |
| >cd05582 STKc_RSK_N N-terminal catalytic domain of the Protein Serine/Threonine Kinase, 90 kDa ribosomal protein S6 kinase | Back alignment and domain information |
|---|
Probab=99.92 E-value=5.7e-26 Score=226.66 Aligned_cols=169 Identities=22% Similarity=0.285 Sum_probs=130.6
Q ss_pred cccceeeccCCCCC------CCCCCChhhHHHHHHHHHHHHHHHhhcCCCceeecCCCccceEecCCCCceeccccceee
Q 045315 241 DEISFWYESYNNPT------KKGLLCWGTRVRIIEGIAQGLLYLHQYSRLRVIHRDLKASNILLDKDMNPKISDFGMARM 314 (476)
Q Consensus 241 ~~~~l~~Ey~~~~~------~~~~L~~~~~~~i~~qIa~gL~yLH~~~~~~ivH~DLkp~NILld~~~~~kL~DFGla~~ 314 (476)
+..++++||++... +...+++.++..++.||++||+|||+.+ |+||||||+||+++.++.+||+|||+++.
T Consensus 71 ~~~~lv~e~~~~~~L~~~l~~~~~l~~~~~~~~~~qi~~~l~~lH~~~---i~H~dlkp~Nil~~~~~~~kL~Dfg~~~~ 147 (318)
T cd05582 71 GKLYLILDFLRGGDLFTRLSKEVMFTEEDVKFYLAELALALDHLHSLG---IIYRDLKPENILLDEEGHIKLTDFGLSKE 147 (318)
T ss_pred CEEEEEEcCCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCC---EecCCCCHHHeEECCCCcEEEeeccCCcc
Confidence 46788999998432 3557999999999999999999999999 99999999999999999999999999876
Q ss_pred cCCCcccccceeeeeccCCCChhhhccCCCCccceEEeehhhhhhhhhCCCCCCcCCCCchhhhhhhhhhhcCCCccccc
Q 045315 315 FGGDELQSNTKRIVGTYGYMSPEYALRGLFSIKSDVFSFGVLLLETLSSKKNTHFYNTDSLTLLGHAWNLWNDGRTWELM 394 (476)
Q Consensus 315 ~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~s~ksDVwSlGvvl~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 394 (476)
..... .......|+..|+|||.+.+..++.++|||||||++|||++|+.||..... ...... .. ....
T Consensus 148 ~~~~~--~~~~~~~g~~~y~aPE~~~~~~~~~~~DiwslG~il~el~tg~~p~~~~~~--~~~~~~---i~-~~~~---- 215 (318)
T cd05582 148 SIDHE--KKAYSFCGTVEYMAPEVVNRRGHTQSADWWSFGVLMFEMLTGSLPFQGKDR--KETMTM---IL-KAKL---- 215 (318)
T ss_pred cCCCC--CceecccCChhhcCHHHHcCCCCCCccceeccceEeeeeccCCCCCCCCCH--HHHHHH---HH-cCCC----
Confidence 54321 122235689999999999988899999999999999999999999864321 111111 11 1110
Q ss_pred CcccCCCCCHHHHHHHHHHHHHchhhcccCCCCHHH
Q 045315 395 DPISQNGASYPILKRYINVALLCVQEKAADRPAMSE 430 (476)
Q Consensus 395 d~~~~~~~~~~~~~~l~~li~~Cl~~dP~~RPt~~e 430 (476)
..+......+.+++.+||+.||++||++.+
T Consensus 216 ------~~p~~~~~~~~~li~~~l~~~P~~R~~a~~ 245 (318)
T cd05582 216 ------GMPQFLSPEAQSLLRALFKRNPANRLGAGP 245 (318)
T ss_pred ------CCCCCCCHHHHHHHHHHhhcCHhHcCCCCC
Confidence 011122356789999999999999999655
|
Serine/Threonine Kinases (STKs), 90 kDa ribosomal protein S6 kinase (RSK) subfamily, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The RSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. RSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family. They are activated by signaling inputs from extracellular regulated kinase (ERK) and phosphoinositide dependent kinase 1 (PDK1). ERK phosphorylates and activates the CTD of RSK, serving as a docking site for PDK1, which phosphorylates and activates the NTD, which in turn phosphorylate |
| >cd08224 STKc_Nek6_Nek7 Catalytic domain of the Protein Serine/Threonine Kinases, Never In Mitosis gene A-related kinase 6 and 7 | Back alignment and domain information |
|---|
Probab=99.92 E-value=3.1e-25 Score=214.59 Aligned_cols=182 Identities=21% Similarity=0.292 Sum_probs=138.8
Q ss_pred cccceeeccCCCC----------CCCCCCChhhHHHHHHHHHHHHHHHhhcCCCceeecCCCccceEecCCCCceecccc
Q 045315 241 DEISFWYESYNNP----------TKKGLLCWGTRVRIIEGIAQGLLYLHQYSRLRVIHRDLKASNILLDKDMNPKISDFG 310 (476)
Q Consensus 241 ~~~~l~~Ey~~~~----------~~~~~L~~~~~~~i~~qIa~gL~yLH~~~~~~ivH~DLkp~NILld~~~~~kL~DFG 310 (476)
+..++++||++.. ..+..+++.+++.++.++++||+|||+.+ ++|+||||+||+++.++.++|+|||
T Consensus 75 ~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~---i~h~dl~p~nil~~~~~~~~l~d~~ 151 (267)
T cd08224 75 NELNIVLELADAGDLSRMIKHFKKQKRLIPERTIWKYFVQLCSALEHMHSKR---IMHRDIKPANVFITATGVVKLGDLG 151 (267)
T ss_pred CeEEEEEecCCCCCHHHHHHHhcccCCCcCHHHHHHHHHHHHHHHHHHHhCC---EecCCcChhhEEECCCCcEEEeccc
Confidence 3567788888732 23456899999999999999999999998 9999999999999999999999999
Q ss_pred ceeecCCCcccccceeeeeccCCCChhhhccCCCCccceEEeehhhhhhhhhCCCCCCcCCCCchhhhhhhhhhhcCCCc
Q 045315 311 MARMFGGDELQSNTKRIVGTYGYMSPEYALRGLFSIKSDVFSFGVLLLETLSSKKNTHFYNTDSLTLLGHAWNLWNDGRT 390 (476)
Q Consensus 311 la~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~s~ksDVwSlGvvl~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~ 390 (476)
++......... .....++..|+|||.+.+..++.++|+|||||++|++++|+.|+............ ....+..
T Consensus 152 ~~~~~~~~~~~--~~~~~~~~~y~apE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~----~~~~~~~ 225 (267)
T cd08224 152 LGRFFSSKTTA--AHSLVGTPYYMSPERIHENGYNFKSDIWSLGCLLYEMAALQSPFYGDKMNLYSLCK----KIEKCDY 225 (267)
T ss_pred eeeeccCCCcc--cceecCCccccCHHHhccCCCCchhcHHHHHHHHHHHHHCCCCcccCCccHHHHHh----hhhcCCC
Confidence 99866433211 22346788999999998888999999999999999999999998543322111111 1111111
Q ss_pred ccccCcccCCCCCHHHHHHHHHHHHHchhhcccCCCCHHHHHHHHhccc
Q 045315 391 WELMDPISQNGASYPILKRYINVALLCVQEKAADRPAMSEVVSMLSNEF 439 (476)
Q Consensus 391 ~~~~d~~~~~~~~~~~~~~l~~li~~Cl~~dP~~RPt~~eVl~~L~~~~ 439 (476)
.. .........+.+++.+||+.+|++||++.+|+++|+++.
T Consensus 226 ~~--------~~~~~~~~~~~~~i~~cl~~~p~~Rp~~~~il~~~~~~~ 266 (267)
T cd08224 226 PP--------LPADHYSEELRDLVSRCINPDPEKRPDISYVLQVAKEMH 266 (267)
T ss_pred CC--------CChhhcCHHHHHHHHHHcCCCcccCCCHHHHHHHHHHhc
Confidence 00 011133457889999999999999999999999998753
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 6 (Nek6) and Nek7 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek6/7 subfamily is part of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek6 and Nek7 are the shortest Neks, consisting only of the catalytic domain and a very short N-terminal extension. They show distinct expression patterns and both appear to be downstream substrates of Nek9. They are required for mitotic spindle formation and cytokinesis. They may a |
| >cd05099 PTKc_FGFR4 Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 4 | Back alignment and domain information |
|---|
Probab=99.92 E-value=1.1e-25 Score=224.22 Aligned_cols=167 Identities=25% Similarity=0.366 Sum_probs=127.1
Q ss_pred CCCChhhHHHHHHHHHHHHHHHhhcCCCceeecCCCccceEecCCCCceeccccceeecCCCcccccceeeeeccCCCCh
Q 045315 257 GLLCWGTRVRIIEGIAQGLLYLHQYSRLRVIHRDLKASNILLDKDMNPKISDFGMARMFGGDELQSNTKRIVGTYGYMSP 336 (476)
Q Consensus 257 ~~L~~~~~~~i~~qIa~gL~yLH~~~~~~ivH~DLkp~NILld~~~~~kL~DFGla~~~~~~~~~~~~~~~~gt~~y~aP 336 (476)
..+++.++++++.||+.||+|||+++ ++||||||+||+++.++.+||+|||+++...............++..|+||
T Consensus 129 ~~l~~~~~~~~~~qi~~aL~~lH~~g---i~H~dlkp~Nill~~~~~~kL~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aP 205 (314)
T cd05099 129 EQLSFKDLVSCAYQVARGMEYLESRR---CIHRDLAARNVLVTEDNVMKIADFGLARGVHDIDYYKKTSNGRLPVKWMAP 205 (314)
T ss_pred cccCHHHHHHHHHHHHHHHHHHHHCC---eeeccccceeEEEcCCCcEEEccccccccccccccccccccCCCCccccCH
Confidence 46899999999999999999999998 999999999999999999999999999866432221111112234679999
Q ss_pred hhhccCCCCccceEEeehhhhhhhhh-CCCCCCcCCCCchhhhhhhhhhhcCCCcccccCcccCCCCCHHHHHHHHHHHH
Q 045315 337 EYALRGLFSIKSDVFSFGVLLLETLS-SKKNTHFYNTDSLTLLGHAWNLWNDGRTWELMDPISQNGASYPILKRYINVAL 415 (476)
Q Consensus 337 E~l~~~~~s~ksDVwSlGvvl~ellt-G~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~l~~li~ 415 (476)
|.+.+..++.++||||||+++||+++ |..||..... ..... ....+.... ........+.+++.
T Consensus 206 E~~~~~~~~~~~DiwslG~~l~el~~~g~~p~~~~~~--~~~~~----~~~~~~~~~---------~~~~~~~~l~~li~ 270 (314)
T cd05099 206 EALFDRVYTHQSDVWSFGILMWEIFTLGGSPYPGIPV--EELFK----LLREGHRMD---------KPSNCTHELYMLMR 270 (314)
T ss_pred HHHccCCcCccchhhHHHHHHHHHHhCCCCCCCCCCH--HHHHH----HHHcCCCCC---------CCCCCCHHHHHHHH
Confidence 99998889999999999999999999 7887754321 11111 111111111 11222346789999
Q ss_pred HchhhcccCCCCHHHHHHHHhccccC
Q 045315 416 LCVQEKAADRPAMSEVVSMLSNEFVN 441 (476)
Q Consensus 416 ~Cl~~dP~~RPt~~eVl~~L~~~~~~ 441 (476)
+||+.+|++||++.++++.|+++...
T Consensus 271 ~cl~~~p~~Rps~~~ll~~l~~~~~~ 296 (314)
T cd05099 271 ECWHAVPTQRPTFKQLVEALDKVLAA 296 (314)
T ss_pred HHcCCCcccCcCHHHHHHHHHHHHHH
Confidence 99999999999999999999987643
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 4 (FGFR4); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR4 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to |
| >cd05604 STKc_SGK3 Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 3 | Back alignment and domain information |
|---|
Probab=99.92 E-value=8.5e-26 Score=226.19 Aligned_cols=171 Identities=20% Similarity=0.233 Sum_probs=131.0
Q ss_pred cccceeeccCCCC------CCCCCCChhhHHHHHHHHHHHHHHHhhcCCCceeecCCCccceEecCCCCceeccccceee
Q 045315 241 DEISFWYESYNNP------TKKGLLCWGTRVRIIEGIAQGLLYLHQYSRLRVIHRDLKASNILLDKDMNPKISDFGMARM 314 (476)
Q Consensus 241 ~~~~l~~Ey~~~~------~~~~~L~~~~~~~i~~qIa~gL~yLH~~~~~~ivH~DLkp~NILld~~~~~kL~DFGla~~ 314 (476)
+..+++|||++.. .+...+++.++..++.||+.||+|||+.+ |+||||||+|||++.++.+||+|||+++.
T Consensus 69 ~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~qi~~al~~lH~~g---ivH~Dlkp~NIll~~~~~~kL~DfG~~~~ 145 (325)
T cd05604 69 EKLYFVLDFVNGGELFFHLQRERSFPEPRARFYAAEIASALGYLHSIN---IVYRDLKPENILLDSQGHVVLTDFGLCKE 145 (325)
T ss_pred CEEEEEEcCCCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCC---eeecCCCHHHeEECCCCCEEEeecCCccc
Confidence 4678899999843 24567999999999999999999999999 99999999999999999999999999875
Q ss_pred cCCCcccccceeeeeccCCCChhhhccCCCCccceEEeehhhhhhhhhCCCCCCcCCCCchhhhhhhhhhhcCCCccccc
Q 045315 315 FGGDELQSNTKRIVGTYGYMSPEYALRGLFSIKSDVFSFGVLLLETLSSKKNTHFYNTDSLTLLGHAWNLWNDGRTWELM 394 (476)
Q Consensus 315 ~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~s~ksDVwSlGvvl~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 394 (476)
..... .......|+..|+|||.+.+..++.++|||||||++|||++|+.||...... .... ... ....
T Consensus 146 ~~~~~--~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~el~~G~~pf~~~~~~--~~~~---~~~-~~~~---- 213 (325)
T cd05604 146 GIAQS--DTTTTFCGTPEYLAPEVIRKQPYDNTVDWWCLGAVLYEMLYGLPPFYCRDVA--EMYD---NIL-HKPL---- 213 (325)
T ss_pred CCCCC--CCcccccCChhhCCHHHHcCCCCCCcCccccccceehhhhcCCCCCCCCCHH--HHHH---HHH-cCCc----
Confidence 32211 1223356899999999999999999999999999999999999998643311 1111 111 1110
Q ss_pred CcccCCCCCHHHHHHHHHHHHHchhhcccCCCCHHHHH
Q 045315 395 DPISQNGASYPILKRYINVALLCVQEKAADRPAMSEVV 432 (476)
Q Consensus 395 d~~~~~~~~~~~~~~l~~li~~Cl~~dP~~RPt~~eVl 432 (476)
.. .......+.+++.+|++.+|++||++.+.+
T Consensus 214 --~~----~~~~~~~~~~ll~~ll~~~p~~R~~~~~~~ 245 (325)
T cd05604 214 --VL----RPGASLTAWSILEELLEKDRQRRLGAKEDF 245 (325)
T ss_pred --cC----CCCCCHHHHHHHHHHhccCHHhcCCCCCCH
Confidence 00 112335678899999999999999886433
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK3 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3 (also called cytokine-independent survival kinase CISK). SGK3 is expressed in most tissues and is most abundant in the embryo and adult heart and spleen. It was originally discovered in a screen for antiapoptotic genes. It phosphorylates and inhibits the proapoptotic proteins, Bad and FKHRL1. SGK3 also regulates many transporters, ion channels, |
| >PHA03211 serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Probab=99.92 E-value=1.8e-25 Score=233.11 Aligned_cols=191 Identities=17% Similarity=0.227 Sum_probs=131.7
Q ss_pred cccceeeccCCC------CCCCCCCChhhHHHHHHHHHHHHHHHhhcCCCceeecCCCccceEecCCCCceeccccceee
Q 045315 241 DEISFWYESYNN------PTKKGLLCWGTRVRIIEGIAQGLLYLHQYSRLRVIHRDLKASNILLDKDMNPKISDFGMARM 314 (476)
Q Consensus 241 ~~~~l~~Ey~~~------~~~~~~L~~~~~~~i~~qIa~gL~yLH~~~~~~ivH~DLkp~NILld~~~~~kL~DFGla~~ 314 (476)
+..++++||+.. ......+++.+++.|+.||+.||+|||+++ |+||||||+|||++.++.+||+|||+++.
T Consensus 233 ~~~~lv~e~~~~~L~~~l~~~~~~l~~~~~~~i~~qi~~aL~yLH~~g---IvHrDLKP~NILl~~~~~vkL~DFGla~~ 309 (461)
T PHA03211 233 GLTCLVLPKYRSDLYTYLGARLRPLGLAQVTAVARQLLSAIDYIHGEG---IIHRDIKTENVLVNGPEDICLGDFGAACF 309 (461)
T ss_pred CEEEEEEEccCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCC---EEECcCCHHHEEECCCCCEEEcccCCcee
Confidence 446677777751 122347999999999999999999999999 99999999999999999999999999987
Q ss_pred cCCCcccccceeeeeccCCCChhhhccCCCCccceEEeehhhhhhhhhCCCCCCcCCCC--chhhhhhhhhhhcCCCc--
Q 045315 315 FGGDELQSNTKRIVGTYGYMSPEYALRGLFSIKSDVFSFGVLLLETLSSKKNTHFYNTD--SLTLLGHAWNLWNDGRT-- 390 (476)
Q Consensus 315 ~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~s~ksDVwSlGvvl~elltG~~p~~~~~~~--~~~~~~~~~~~~~~~~~-- 390 (476)
..............||..|+|||++.+..++.++|||||||++|||++|..++...... .........+.+.....
T Consensus 310 ~~~~~~~~~~~~~~GT~~Y~APE~~~~~~~~~~sDvwSlGviL~El~~g~~~lf~~~~~~~~~~~~~~l~~~i~~~~~~~ 389 (461)
T PHA03211 310 ARGSWSTPFHYGIAGTVDTNAPEVLAGDPYTPSVDIWSAGLVIFEAAVHTASLFSASRGDERRPYDAQILRIIRQAQVHV 389 (461)
T ss_pred cccccccccccccCCCcCCcCHHHHcCCCCCchHHHHHHHHHHHHHHHcCCCcccCCcccccCCcHHHHHHHHHhhcccc
Confidence 64432222222356899999999999999999999999999999999988654322110 00000001111110000
Q ss_pred cccc-------------------CcccCCCC---CHHHHHHHHHHHHHchhhcccCCCCHHHHHHH
Q 045315 391 WELM-------------------DPISQNGA---SYPILKRYINVALLCVQEKAADRPAMSEVVSM 434 (476)
Q Consensus 391 ~~~~-------------------d~~~~~~~---~~~~~~~l~~li~~Cl~~dP~~RPt~~eVl~~ 434 (476)
.+.. .+...... .......+.+++.+||+.||++|||+.|+++.
T Consensus 390 ~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dli~~mL~~DP~~RPsa~elL~h 455 (461)
T PHA03211 390 DEFPQHAGSRLVSQYRHRAARNRRPAYTRPAWTRYYKLDLDVEYLVCRALTFDGARRPSAAELLRL 455 (461)
T ss_pred ccCCCCcchHHHHHHHhhhhcccCCccCCcchhhhccccchHHHHHHHHcccChhhCcCHHHHhhC
Confidence 0000 00000000 00122367889999999999999999999864
|
|
| >KOG0596 consensus Dual specificity; serine/threonine and tyrosine kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=99.92 E-value=1.4e-25 Score=224.85 Aligned_cols=177 Identities=24% Similarity=0.269 Sum_probs=132.0
Q ss_pred cccceeeccCC-C-----CCCCCCCChhhHHHHHHHHHHHHHHHhhcCCCceeecCCCccceEecCCCCceeccccceee
Q 045315 241 DEISFWYESYN-N-----PTKKGLLCWGTRVRIIEGIAQGLLYLHQYSRLRVIHRDLKASNILLDKDMNPKISDFGMARM 314 (476)
Q Consensus 241 ~~~~l~~Ey~~-~-----~~~~~~L~~~~~~~i~~qIa~gL~yLH~~~~~~ivH~DLkp~NILld~~~~~kL~DFGla~~ 314 (476)
+-+|++|||=+ + ..+...++--.+..+..|++.|+.++|.++ |||.||||.|+|+- .|.+||+|||.|..
T Consensus 433 ~~lYmvmE~Gd~DL~kiL~k~~~~~~~~~lk~ywkqML~aV~~IH~~g---IVHSDLKPANFLlV-kG~LKLIDFGIA~a 508 (677)
T KOG0596|consen 433 GYLYMVMECGDIDLNKILKKKKSIDPDWFLKFYWKQMLLAVKTIHQHG---IVHSDLKPANFLLV-KGRLKLIDFGIANA 508 (677)
T ss_pred ceEEEEeecccccHHHHHHhccCCCchHHHHHHHHHHHHHHHHHHHhc---eeecCCCcccEEEE-eeeEEeeeechhcc
Confidence 45789999977 1 112222332278889999999999999999 99999999999987 57899999999999
Q ss_pred cCCCcccccceeeeeccCCCChhhhccC-----------CCCccceEEeehhhhhhhhhCCCCCCcCCCCchhhhhhhhh
Q 045315 315 FGGDELQSNTKRIVGTYGYMSPEYALRG-----------LFSIKSDVFSFGVLLLETLSSKKNTHFYNTDSLTLLGHAWN 383 (476)
Q Consensus 315 ~~~~~~~~~~~~~~gt~~y~aPE~l~~~-----------~~s~ksDVwSlGvvl~elltG~~p~~~~~~~~~~~~~~~~~ 383 (476)
+..+.........+||..||+||.+... ..+.++||||+||+||+|+.|+.||.... +...
T Consensus 509 I~~DTTsI~kdsQvGT~NYMsPEAl~~~~s~~~~~~~k~Ki~r~SDvWSLGCILYqMvYgktPf~~~~----n~~a---- 580 (677)
T KOG0596|consen 509 IQPDTTSIVKDSQVGTVNYMSPEALTDMSSSRENGKSKIKISRKSDVWSLGCILYQMVYGKTPFGQII----NQIA---- 580 (677)
T ss_pred cCccccceeeccccCcccccCHHHHhhccccccCCCcceeecCccchhhhhhHHHHHHhcCCchHHHH----HHHH----
Confidence 8877766666778999999999988532 25789999999999999999999986321 1111
Q ss_pred hhcCCCcccccCcccCCCC-CHHHHHHHHHHHHHchhhcccCCCCHHHHHHH
Q 045315 384 LWNDGRTWELMDPISQNGA-SYPILKRYINVALLCVQEKAADRPAMSEVVSM 434 (476)
Q Consensus 384 ~~~~~~~~~~~d~~~~~~~-~~~~~~~l~~li~~Cl~~dP~~RPt~~eVl~~ 434 (476)
+...+.++.-.-++ .......+++++..||+.||.+||+..++++.
T Consensus 581 -----Kl~aI~~P~~~Iefp~~~~~~~li~~mK~CL~rdPkkR~si~eLLqh 627 (677)
T KOG0596|consen 581 -----KLHAITDPNHEIEFPDIPENDELIDVMKCCLARDPKKRWSIPELLQH 627 (677)
T ss_pred -----HHHhhcCCCccccccCCCCchHHHHHHHHHHhcCcccCCCcHHHhcC
Confidence 11223333211111 11112238999999999999999999998853
|
|
| >PTZ00263 protein kinase A catalytic subunit; Provisional | Back alignment and domain information |
|---|
Probab=99.92 E-value=1.3e-25 Score=225.21 Aligned_cols=169 Identities=22% Similarity=0.257 Sum_probs=132.0
Q ss_pred cccceeeccCCCCC------CCCCCChhhHHHHHHHHHHHHHHHhhcCCCceeecCCCccceEecCCCCceeccccceee
Q 045315 241 DEISFWYESYNNPT------KKGLLCWGTRVRIIEGIAQGLLYLHQYSRLRVIHRDLKASNILLDKDMNPKISDFGMARM 314 (476)
Q Consensus 241 ~~~~l~~Ey~~~~~------~~~~L~~~~~~~i~~qIa~gL~yLH~~~~~~ivH~DLkp~NILld~~~~~kL~DFGla~~ 314 (476)
+..+++|||++... +.+.+++..+..++.||+.||+|||+++ |+||||||+|||++.++.+||+|||+++.
T Consensus 91 ~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~qi~~aL~~LH~~~---ivH~dlkp~NIll~~~~~~kl~Dfg~~~~ 167 (329)
T PTZ00263 91 NRVYFLLEFVVGGELFTHLRKAGRFPNDVAKFYHAELVLAFEYLHSKD---IIYRDLKPENLLLDNKGHVKVTDFGFAKK 167 (329)
T ss_pred CEEEEEEcCCCCChHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCC---eeecCCCHHHEEECCCCCEEEeeccCceE
Confidence 46788999998432 3567899999999999999999999999 99999999999999999999999999987
Q ss_pred cCCCcccccceeeeeccCCCChhhhccCCCCccceEEeehhhhhhhhhCCCCCCcCCCCchhhhhhhhhhhcCCCccccc
Q 045315 315 FGGDELQSNTKRIVGTYGYMSPEYALRGLFSIKSDVFSFGVLLLETLSSKKNTHFYNTDSLTLLGHAWNLWNDGRTWELM 394 (476)
Q Consensus 315 ~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~s~ksDVwSlGvvl~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 394 (476)
..... ....|++.|+|||.+.+..++.++|||||||++|||++|+.||..... .... .....+.. .
T Consensus 168 ~~~~~-----~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~~--~~~~----~~i~~~~~-~-- 233 (329)
T PTZ00263 168 VPDRT-----FTLCGTPEYLAPEVIQSKGHGKAVDWWTMGVLLYEFIAGYPPFFDDTP--FRIY----EKILAGRL-K-- 233 (329)
T ss_pred cCCCc-----ceecCChhhcCHHHHcCCCCCCcceeechHHHHHHHHcCCCCCCCCCH--HHHH----HHHhcCCc-C--
Confidence 64322 235689999999999998899999999999999999999999864321 1111 11111111 0
Q ss_pred CcccCCCCCHHHHHHHHHHHHHchhhcccCCCC-----HHHHHH
Q 045315 395 DPISQNGASYPILKRYINVALLCVQEKAADRPA-----MSEVVS 433 (476)
Q Consensus 395 d~~~~~~~~~~~~~~l~~li~~Cl~~dP~~RPt-----~~eVl~ 433 (476)
.+......+.+++.+||+.||++||+ +++++.
T Consensus 234 -------~p~~~~~~~~~li~~~L~~dP~~R~~~~~~~~~~ll~ 270 (329)
T PTZ00263 234 -------FPNWFDGRARDLVKGLLQTDHTKRLGTLKGGVADVKN 270 (329)
T ss_pred -------CCCCCCHHHHHHHHHHhhcCHHHcCCCCCCCHHHHhc
Confidence 01112346789999999999999997 677663
|
|
| >cd05602 STKc_SGK1 Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 1 | Back alignment and domain information |
|---|
Probab=99.92 E-value=7.7e-26 Score=226.49 Aligned_cols=171 Identities=22% Similarity=0.258 Sum_probs=131.1
Q ss_pred cccceeeccCCCC------CCCCCCChhhHHHHHHHHHHHHHHHhhcCCCceeecCCCccceEecCCCCceeccccceee
Q 045315 241 DEISFWYESYNNP------TKKGLLCWGTRVRIIEGIAQGLLYLHQYSRLRVIHRDLKASNILLDKDMNPKISDFGMARM 314 (476)
Q Consensus 241 ~~~~l~~Ey~~~~------~~~~~L~~~~~~~i~~qIa~gL~yLH~~~~~~ivH~DLkp~NILld~~~~~kL~DFGla~~ 314 (476)
+..++++||++.. .+...++..++..++.||++||+|||+.+ |+||||||+|||++.++.+||+|||+++.
T Consensus 69 ~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~qi~~~L~~lH~~g---iiHrDlkp~Nili~~~~~~kl~DfG~a~~ 145 (325)
T cd05602 69 DKLYFVLDYINGGELFYHLQRERCFLEPRARFYAAEIASALGYLHSLN---IVYRDLKPENILLDSQGHIVLTDFGLCKE 145 (325)
T ss_pred CeEEEEEeCCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCC---eEecCCCHHHeEECCCCCEEEccCCCCcc
Confidence 4578899999843 23456888899999999999999999999 99999999999999999999999999975
Q ss_pred cCCCcccccceeeeeccCCCChhhhccCCCCccceEEeehhhhhhhhhCCCCCCcCCCCchhhhhhhhhhhcCCCccccc
Q 045315 315 FGGDELQSNTKRIVGTYGYMSPEYALRGLFSIKSDVFSFGVLLLETLSSKKNTHFYNTDSLTLLGHAWNLWNDGRTWELM 394 (476)
Q Consensus 315 ~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~s~ksDVwSlGvvl~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 394 (476)
..... .......|+..|+|||++.+..++.++|||||||++|||++|+.||...... ..... .. ....
T Consensus 146 ~~~~~--~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~--~~~~~---i~-~~~~---- 213 (325)
T cd05602 146 NIEHN--GTTSTFCGTPEYLAPEVLHKQPYDRTVDWWCLGAVLYEMLYGLPPFYSRNTA--EMYDN---IL-NKPL---- 213 (325)
T ss_pred cccCC--CCcccccCCccccCHHHHcCCCCCCccccccccHHHHHHhcCCCCCCCCCHH--HHHHH---HH-hCCc----
Confidence 43221 1223356899999999999999999999999999999999999998643311 11111 11 1100
Q ss_pred CcccCCCCCHHHHHHHHHHHHHchhhcccCCCCHHHHH
Q 045315 395 DPISQNGASYPILKRYINVALLCVQEKAADRPAMSEVV 432 (476)
Q Consensus 395 d~~~~~~~~~~~~~~l~~li~~Cl~~dP~~RPt~~eVl 432 (476)
.........+.+++.+|++.+|.+||++.+.+
T Consensus 214 ------~~~~~~~~~~~~li~~~l~~~p~~R~~~~~~~ 245 (325)
T cd05602 214 ------QLKPNITNSARHLLEGLLQKDRTKRLGAKDDF 245 (325)
T ss_pred ------CCCCCCCHHHHHHHHHHcccCHHHCCCCCCCH
Confidence 01112345688999999999999999987543
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3. SGK1 is ubiquitously expressed and is under transcriptional control of numerous stimuli including cell stress (cell shrinkage), serum, hormones (gluco- and mineralocorticoids), gonadotropins, growth factors, interleukin-6, and other cytokines. It plays roles in sodium retention and potassium elimination in the kidney, nutrient transport, salt |
| >cd05575 STKc_SGK Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase | Back alignment and domain information |
|---|
Probab=99.92 E-value=7.4e-26 Score=226.40 Aligned_cols=168 Identities=23% Similarity=0.245 Sum_probs=129.8
Q ss_pred cccceeeccCCCCC------CCCCCChhhHHHHHHHHHHHHHHHhhcCCCceeecCCCccceEecCCCCceeccccceee
Q 045315 241 DEISFWYESYNNPT------KKGLLCWGTRVRIIEGIAQGLLYLHQYSRLRVIHRDLKASNILLDKDMNPKISDFGMARM 314 (476)
Q Consensus 241 ~~~~l~~Ey~~~~~------~~~~L~~~~~~~i~~qIa~gL~yLH~~~~~~ivH~DLkp~NILld~~~~~kL~DFGla~~ 314 (476)
+..+++|||++... +.+.+++..+..++.||+.||+|||+++ |+||||||+|||++.++.+||+|||+++.
T Consensus 69 ~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~qi~~~l~~lH~~g---ivH~dikp~NIll~~~~~~kl~Dfg~~~~ 145 (323)
T cd05575 69 DKLYFVLDYVNGGELFFHLQRERSFPEPRARFYAAEIASALGYLHSLN---IIYRDLKPENILLDSQGHVVLTDFGLCKE 145 (323)
T ss_pred CEEEEEEcCCCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCC---eEeCCCCHHHeEECCCCcEEEeccCCCcc
Confidence 45788999998432 3567899999999999999999999999 99999999999999999999999999875
Q ss_pred cCCCcccccceeeeeccCCCChhhhccCCCCccceEEeehhhhhhhhhCCCCCCcCCCCchhhhhhhhhhhcCCCccccc
Q 045315 315 FGGDELQSNTKRIVGTYGYMSPEYALRGLFSIKSDVFSFGVLLLETLSSKKNTHFYNTDSLTLLGHAWNLWNDGRTWELM 394 (476)
Q Consensus 315 ~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~s~ksDVwSlGvvl~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 394 (476)
..... .......|+..|+|||++.+..++.++|||||||++|||++|+.||...... .... ... .+..
T Consensus 146 ~~~~~--~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~ell~g~~pf~~~~~~--~~~~---~i~-~~~~---- 213 (323)
T cd05575 146 GIEHS--KTTSTFCGTPEYLAPEVLRKQPYDRTVDWWCLGAVLYEMLYGLPPFYSRDTA--EMYD---NIL-NKPL---- 213 (323)
T ss_pred cccCC--CccccccCChhhcChhhhcCCCCCccccccccchhhhhhhcCCCCCCCCCHH--HHHH---HHH-cCCC----
Confidence 32221 1223356899999999999999999999999999999999999998643211 1111 111 1110
Q ss_pred CcccCCCCCHHHHHHHHHHHHHchhhcccCCCCHH
Q 045315 395 DPISQNGASYPILKRYINVALLCVQEKAADRPAMS 429 (476)
Q Consensus 395 d~~~~~~~~~~~~~~l~~li~~Cl~~dP~~RPt~~ 429 (476)
.. .......+.+++.+||+.||++||++.
T Consensus 214 --~~----~~~~~~~~~~li~~~l~~~p~~R~~~~ 242 (323)
T cd05575 214 --RL----KPNISVSARHLLEGLLQKDRTKRLGAK 242 (323)
T ss_pred --CC----CCCCCHHHHHHHHHHhhcCHHhCCCCC
Confidence 00 112245688999999999999999984
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3 (also called cytokine-independent survival kinase CISK). SGKs are activated by insulin and growth factors via phosphoinositide 3-kinase and PDK1. They activate ion channels, ion carriers, and the Na-K-ATPase, as well as regulate the activity of enzymes and transcription factors. SGKs play important roles in transport, hormone release, neuroexcitability, cell pr |
| >KOG0594 consensus Protein kinase PCTAIRE and related kinases [General function prediction only] | Back alignment and domain information |
|---|
Probab=99.92 E-value=1.5e-25 Score=215.92 Aligned_cols=189 Identities=21% Similarity=0.216 Sum_probs=134.2
Q ss_pred cccceeeccCC-------CCCCC--CCCChhhHHHHHHHHHHHHHHHhhcCCCceeecCCCccceEecCCCCceeccccc
Q 045315 241 DEISFWYESYN-------NPTKK--GLLCWGTRVRIIEGIAQGLLYLHQYSRLRVIHRDLKASNILLDKDMNPKISDFGM 311 (476)
Q Consensus 241 ~~~~l~~Ey~~-------~~~~~--~~L~~~~~~~i~~qIa~gL~yLH~~~~~~ivH~DLkp~NILld~~~~~kL~DFGl 311 (476)
+..++|+||+. +.... ..++...+..+..||+.||+|||+++ |+||||||+|||++++|.+||+|||+
T Consensus 90 ~~l~lvfe~~d~DL~~ymd~~~~~~~g~~~~~ik~~m~Qll~gl~~~H~~~---IlHRDLKPQNlLi~~~G~lKlaDFGl 166 (323)
T KOG0594|consen 90 GKLYLVFEFLDRDLKKYMDSLPKKPQGLPPRLIKSFMRQLLRGLAFLHSHG---ILHRDLKPQNLLISSSGVLKLADFGL 166 (323)
T ss_pred ceEEEEEEeecccHHHHHHhccccccCCCHHHHHHHHHHHHHHHHHHHhCC---eecccCCcceEEECCCCcEeeeccch
Confidence 45778999887 11111 46778899999999999999999999 99999999999999999999999999
Q ss_pred eeecCCCcccccceeeeeccCCCChhhhccC-CCCccceEEeehhhhhhhhhCCCCCCcCCCCc-hhhhhhhhhhhcCCC
Q 045315 312 ARMFGGDELQSNTKRIVGTYGYMSPEYALRG-LFSIKSDVFSFGVLLLETLSSKKNTHFYNTDS-LTLLGHAWNLWNDGR 389 (476)
Q Consensus 312 a~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~-~~s~ksDVwSlGvvl~elltG~~p~~~~~~~~-~~~~~~~~~~~~~~~ 389 (476)
|+.+.-... .....++|..|+|||++.+. .|+...|+||+||++.||+++++-|+...+.. ...+-.......+..
T Consensus 167 Ara~~ip~~--~yt~evvTlWYRaPEvLlGs~~Ys~~vDiWs~GcIfaEm~~~~~LFpG~se~~ql~~If~~lGtP~e~~ 244 (323)
T KOG0594|consen 167 ARAFSIPMR--TYTPEVVTLWYRAPEVLLGSTSYSTSVDIWSLGCIFAEMFTRRPLFPGDSEIDQLFRIFRLLGTPNEKD 244 (323)
T ss_pred HHHhcCCcc--cccccEEEeeccCHHHhcCCCcCCCCcchHhHHHHHHHHHhCCCCCCCCcHHHHHHHHHHHcCCCCccC
Confidence 996642211 13346789999999999876 79999999999999999999998887654311 111100111111111
Q ss_pred ccccc---C-----cccCCCCC--H---HHHHHHHHHHHHchhhcccCCCCHHHHHHH
Q 045315 390 TWELM---D-----PISQNGAS--Y---PILKRYINVALLCVQEKAADRPAMSEVVSM 434 (476)
Q Consensus 390 ~~~~~---d-----~~~~~~~~--~---~~~~~l~~li~~Cl~~dP~~RPt~~eVl~~ 434 (476)
..... + +......+ . .......+++.+||+.+|++|.|++..++.
T Consensus 245 Wp~v~~~~~~k~~f~~~~~~~~l~~~~~~~~~~~~dll~~~L~y~p~~R~Sa~~al~h 302 (323)
T KOG0594|consen 245 WPGVSSLPDYKAPFPKWPGPKDLSSILPKLDPDGIELLSKLLQYDPAKRISAKGALTH 302 (323)
T ss_pred CCCccccccccccCcCCCCccchHHhccccCccHHHHHHHHhccCcccCcCHHHHhcC
Confidence 10000 0 00000000 0 011467899999999999999999998875
|
|
| >cd05060 PTKc_Syk_like Catalytic domain of Spleen Tyrosine Kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=99.92 E-value=1.3e-25 Score=216.55 Aligned_cols=180 Identities=27% Similarity=0.346 Sum_probs=135.4
Q ss_pred ccceeeccCCCCC------CCCCCChhhHHHHHHHHHHHHHHHhhcCCCceeecCCCccceEecCCCCceeccccceeec
Q 045315 242 EISFWYESYNNPT------KKGLLCWGTRVRIIEGIAQGLLYLHQYSRLRVIHRDLKASNILLDKDMNPKISDFGMARMF 315 (476)
Q Consensus 242 ~~~l~~Ey~~~~~------~~~~L~~~~~~~i~~qIa~gL~yLH~~~~~~ivH~DLkp~NILld~~~~~kL~DFGla~~~ 315 (476)
..++++||++... +.+.+++..++.++.|++.||+|||..+ ++|+||||+||+++.++.+||+|||+++..
T Consensus 69 ~~~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~qi~~~l~~lh~~~---i~H~di~p~nili~~~~~~kl~df~~~~~~ 145 (257)
T cd05060 69 PLMLVMELAPLGPLLKYLKKRREIPVSDLKELAHQVAMGMAYLESKH---FVHRDLAARNVLLVNRHQAKISDFGMSRAL 145 (257)
T ss_pred ceEEEEEeCCCCcHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHhhcC---eeccCcccceEEEcCCCcEEecccccccee
Confidence 4567788876322 3347999999999999999999999998 999999999999999999999999999876
Q ss_pred CCCccccc-ceeeeeccCCCChhhhccCCCCccceEEeehhhhhhhhh-CCCCCCcCCCCchhhhhhhhhhhcCCCcccc
Q 045315 316 GGDELQSN-TKRIVGTYGYMSPEYALRGLFSIKSDVFSFGVLLLETLS-SKKNTHFYNTDSLTLLGHAWNLWNDGRTWEL 393 (476)
Q Consensus 316 ~~~~~~~~-~~~~~gt~~y~aPE~l~~~~~s~ksDVwSlGvvl~ellt-G~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~ 393 (476)
........ .....++..|+|||.+.+..++.++||||||+++||+++ |+.||..... ....... ......
T Consensus 146 ~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~~~~~g~~p~~~~~~--~~~~~~~----~~~~~~-- 217 (257)
T cd05060 146 GAGSDYYRATTAGRWPLKWYAPECINYGKFSSKSDVWSYGVTLWEAFSYGAKPYGEMKG--AEVIAML----ESGERL-- 217 (257)
T ss_pred ecCCcccccccCccccccccCHHHhcCCCCCccchHHHHHHHHHHHHcCCCCCcccCCH--HHHHHHH----HcCCcC--
Confidence 43322111 111223467999999988889999999999999999998 8988754321 1111111 111110
Q ss_pred cCcccCCCCCHHHHHHHHHHHHHchhhcccCCCCHHHHHHHHhccc
Q 045315 394 MDPISQNGASYPILKRYINVALLCVQEKAADRPAMSEVVSMLSNEF 439 (476)
Q Consensus 394 ~d~~~~~~~~~~~~~~l~~li~~Cl~~dP~~RPt~~eVl~~L~~~~ 439 (476)
..+......+.+++.+||+.+|++||++.+|++.|++..
T Consensus 218 -------~~~~~~~~~l~~li~~cl~~~p~~Rp~~~~l~~~l~~~~ 256 (257)
T cd05060 218 -------PRPEECPQEIYSIMLSCWKYRPEDRPTFSELESTFRRDP 256 (257)
T ss_pred -------CCCCCCCHHHHHHHHHHhcCChhhCcCHHHHHHHHHhcc
Confidence 011122356889999999999999999999999998864
|
Protein Tyrosine Kinase (PTK) family; Spleen Tyrosine Kinase (Syk) subfamily; catalytic (c) domain. The Syk subfamily is composed of Syk, ZAP-70, Shark, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Syk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. They are involved in the signaling downstream of activated receptors (including B-cell, T-cell, and Fc receptors) that contain ITAMs (immunoreceptor tyr activation motifs), leading to processes such as cell proliferation, differentiation, survival, adhesion, mi |
| >PHA02882 putative serine/threonine kinase; Provisional | Back alignment and domain information |
|---|
Probab=99.92 E-value=2.1e-25 Score=220.18 Aligned_cols=164 Identities=17% Similarity=0.193 Sum_probs=125.0
Q ss_pred CCChhhHHHHHHHHHHHHHHHhhcCCCceeecCCCccceEecCCCCceeccccceeecCCCcc-----cccceeeeeccC
Q 045315 258 LLCWGTRVRIIEGIAQGLLYLHQYSRLRVIHRDLKASNILLDKDMNPKISDFGMARMFGGDEL-----QSNTKRIVGTYG 332 (476)
Q Consensus 258 ~L~~~~~~~i~~qIa~gL~yLH~~~~~~ivH~DLkp~NILld~~~~~kL~DFGla~~~~~~~~-----~~~~~~~~gt~~ 332 (476)
..++..+..++.|+++||+|||+.+ |+||||||+|||++.++.+||+|||+++.+..... ........||+.
T Consensus 122 ~~~~~~~~~i~~qi~~~l~~lH~~~---iiHrDiKp~Nill~~~~~~~l~DFGla~~~~~~~~~~~~~~~~~~~~~gt~~ 198 (294)
T PHA02882 122 CKNKKLIKNIMKDMLTTLEYIHEHG---ISHGDIKPENIMVDGNNRGYIIDYGIASHFIIHGKHIEYSKEQKDLHRGTLY 198 (294)
T ss_pred cCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCCHHHEEEcCCCcEEEEEcCCceeeccCCcccccccccccccCCCcc
Confidence 3577888999999999999999998 99999999999999999999999999987643211 111222468999
Q ss_pred CCChhhhccCCCCccceEEeehhhhhhhhhCCCCCCcCCCCchhhhhhhh----hhhcCCCcccccCcccCCCCCHHHHH
Q 045315 333 YMSPEYALRGLFSIKSDVFSFGVLLLETLSSKKNTHFYNTDSLTLLGHAW----NLWNDGRTWELMDPISQNGASYPILK 408 (476)
Q Consensus 333 y~aPE~l~~~~~s~ksDVwSlGvvl~elltG~~p~~~~~~~~~~~~~~~~----~~~~~~~~~~~~d~~~~~~~~~~~~~ 408 (476)
|+|||...+..++.++|||||||+++||++|+.||........ ...... .....+.. . .....+
T Consensus 199 y~ape~~~~~~~~~~~DiwSlG~~l~el~~g~~P~~~~~~~~~-~~~~~~~~~~~~~~~~~~--------~---~~~~~~ 266 (294)
T PHA02882 199 YAGLDAHNGACVTRRGDLESLGYCMLKWAGIKLPWKGFGHNGN-LIHAAKCDFIKRLHEGKI--------K---IKNANK 266 (294)
T ss_pred ccCHHHhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCccccchH-HHHHhHHHHHHHhhhhhh--------c---cCCCCH
Confidence 9999999999999999999999999999999999975532211 111110 11111110 0 011135
Q ss_pred HHHHHHHHchhhcccCCCCHHHHHHHHh
Q 045315 409 RYINVALLCVQEKAADRPAMSEVVSMLS 436 (476)
Q Consensus 409 ~l~~li~~Cl~~dP~~RPt~~eVl~~L~ 436 (476)
.+.+++..|++.+|++||++.++++.|+
T Consensus 267 ~~~~~~~~~~~~~~~~rp~~~~l~~~~~ 294 (294)
T PHA02882 267 FIYDFIECVTKLSYEEKPDYDALIKIFD 294 (294)
T ss_pred HHHHHHHHHHhCCCCCCCCHHHHHHhhC
Confidence 6889999999999999999999998774
|
|
| >cd05105 PTKc_PDGFR_alpha Catalytic domain of the Protein Tyrosine Kinase, Platelet Derived Growth Factor Receptor alpha | Back alignment and domain information |
|---|
Probab=99.92 E-value=1.4e-25 Score=230.87 Aligned_cols=166 Identities=24% Similarity=0.334 Sum_probs=128.6
Q ss_pred CCCChhhHHHHHHHHHHHHHHHhhcCCCceeecCCCccceEecCCCCceeccccceeecCCCcccccceeeeeccCCCCh
Q 045315 257 GLLCWGTRVRIIEGIAQGLLYLHQYSRLRVIHRDLKASNILLDKDMNPKISDFGMARMFGGDELQSNTKRIVGTYGYMSP 336 (476)
Q Consensus 257 ~~L~~~~~~~i~~qIa~gL~yLH~~~~~~ivH~DLkp~NILld~~~~~kL~DFGla~~~~~~~~~~~~~~~~gt~~y~aP 336 (476)
+.+++.++++++.||++||+|||+.+ |+||||||+||+++.++.+||+|||+++...............++..|+||
T Consensus 232 ~~l~~~~~~~~~~qi~~aL~~LH~~~---ivH~dikp~Nill~~~~~~kL~DfGla~~~~~~~~~~~~~~~~~~~~y~aP 308 (400)
T cd05105 232 EGLTTLDLLSFTYQVARGMEFLASKN---CVHRDLAARNVLLAQGKIVKICDFGLARDIMHDSNYVSKGSTFLPVKWMAP 308 (400)
T ss_pred CCCCHHHHHHHHHHHHHHHHHHHhCC---eeCCCCChHhEEEeCCCEEEEEeCCcceeccccccccccCCcCCCcceECh
Confidence 46899999999999999999999998 999999999999999999999999999876433222222234567789999
Q ss_pred hhhccCCCCccceEEeehhhhhhhhh-CCCCCCcCCCCchhhhhhhhhhhcCCCcccccCcccCCCCCHHHHHHHHHHHH
Q 045315 337 EYALRGLFSIKSDVFSFGVLLLETLS-SKKNTHFYNTDSLTLLGHAWNLWNDGRTWELMDPISQNGASYPILKRYINVAL 415 (476)
Q Consensus 337 E~l~~~~~s~ksDVwSlGvvl~ellt-G~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~l~~li~ 415 (476)
|.+.+..++.++|||||||++|||++ |+.|+.....+.. .. .....+... .........+.+++.
T Consensus 309 E~~~~~~~~~~~DiwSlGvil~ellt~g~~P~~~~~~~~~-~~----~~~~~~~~~---------~~~~~~~~~l~~li~ 374 (400)
T cd05105 309 ESIFDNLYTTLSDVWSYGILLWEIFSLGGTPYPGMIVDST-FY----NKIKSGYRM---------AKPDHATQEVYDIMV 374 (400)
T ss_pred hhhcCCCCCchhhHHHHHHHHHHHHHCCCCCCcccchhHH-HH----HHHhcCCCC---------CCCccCCHHHHHHHH
Confidence 99998889999999999999999997 8888764332211 11 111111100 011223457889999
Q ss_pred HchhhcccCCCCHHHHHHHHhccc
Q 045315 416 LCVQEKAADRPAMSEVVSMLSNEF 439 (476)
Q Consensus 416 ~Cl~~dP~~RPt~~eVl~~L~~~~ 439 (476)
+||+.||++||++.+|+++|+.+.
T Consensus 375 ~cl~~dP~~RPt~~~l~~~l~~l~ 398 (400)
T cd05105 375 KCWNSEPEKRPSFLHLSDIVESLL 398 (400)
T ss_pred HHCccCHhHCcCHHHHHHHHHHHc
Confidence 999999999999999999999865
|
Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) alpha; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR alpha is a receptor tyr kinase (RTK) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding to its ligands, the PDGFs, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR alpha forms homodimers or heterodimers with PDGFR beta, depending on the nature of the PDGF ligand. PDGF-AA, PDGF- |
| >cd05059 PTKc_Tec_like Catalytic domain of Tec-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=99.92 E-value=8.1e-26 Score=218.05 Aligned_cols=177 Identities=29% Similarity=0.375 Sum_probs=133.0
Q ss_pred cccceeeccCCCC-------CCCCCCChhhHHHHHHHHHHHHHHHhhcCCCceeecCCCccceEecCCCCceecccccee
Q 045315 241 DEISFWYESYNNP-------TKKGLLCWGTRVRIIEGIAQGLLYLHQYSRLRVIHRDLKASNILLDKDMNPKISDFGMAR 313 (476)
Q Consensus 241 ~~~~l~~Ey~~~~-------~~~~~L~~~~~~~i~~qIa~gL~yLH~~~~~~ivH~DLkp~NILld~~~~~kL~DFGla~ 313 (476)
+..++++||++.. .+...+++..++.++.||+.||+|||+.+ ++||||||+||+++.++.+||+|||+++
T Consensus 72 ~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~---i~H~dl~p~ni~i~~~~~~kl~dfg~~~ 148 (256)
T cd05059 72 RPIFIVTEYMANGCLLNYLRERKGKLGTEWLLDMCSDVCEAMEYLESNG---FIHRDLAARNCLVGEDNVVKVSDFGLAR 148 (256)
T ss_pred CceEEEEecCCCCCHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHHCC---cccccccHhhEEECCCCcEEECCcccce
Confidence 3567888988733 12447899999999999999999999999 9999999999999999999999999998
Q ss_pred ecCCCcccccceeeeeccCCCChhhhccCCCCccceEEeehhhhhhhhh-CCCCCCcCCCCchhhhhhhhhhhcCCCccc
Q 045315 314 MFGGDELQSNTKRIVGTYGYMSPEYALRGLFSIKSDVFSFGVLLLETLS-SKKNTHFYNTDSLTLLGHAWNLWNDGRTWE 392 (476)
Q Consensus 314 ~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~s~ksDVwSlGvvl~ellt-G~~p~~~~~~~~~~~~~~~~~~~~~~~~~~ 392 (476)
......... .....++..|+|||.+.+..++.++|+||||+++||+++ |+.||...... ...... ..+..
T Consensus 149 ~~~~~~~~~-~~~~~~~~~y~~Pe~~~~~~~~~~~Di~slG~il~~l~~~g~~p~~~~~~~--~~~~~~----~~~~~-- 219 (256)
T cd05059 149 YVLDDQYTS-SQGTKFPVKWAPPEVFDYSRFSSKSDVWSFGVLMWEVFSEGKMPYERFSNS--EVVESV----SAGYR-- 219 (256)
T ss_pred ecccccccc-cCCCCCCccccCHHHhccCCCCchhhHHHHHHHHHHHhccCCCCCCCCCHH--HHHHHH----HcCCc--
Confidence 654322111 111223457999999998899999999999999999998 78887643211 111111 11100
Q ss_pred ccCcccCCCCCHHHHHHHHHHHHHchhhcccCCCCHHHHHHHHh
Q 045315 393 LMDPISQNGASYPILKRYINVALLCVQEKAADRPAMSEVVSMLS 436 (476)
Q Consensus 393 ~~d~~~~~~~~~~~~~~l~~li~~Cl~~dP~~RPt~~eVl~~L~ 436 (476)
. ..+......+.+++.+||+.+|++||++.++++.|.
T Consensus 220 ---~----~~~~~~~~~~~~li~~cl~~~p~~Rpt~~~~l~~l~ 256 (256)
T cd05059 220 ---L----YRPKLAPTEVYTIMYSCWHEKPEDRPAFKKLLSQLT 256 (256)
T ss_pred ---C----CCCCCCCHHHHHHHHHHhcCChhhCcCHHHHHHHhC
Confidence 0 111123457889999999999999999999999873
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase expressed in hepatocellular carcinoma (Tec) subfamily; catalytic (c) domain. The Tec subfamily is composed of Tec, Btk, Bmx (Etk), Itk (Tsk, Emt), Rlk (Txk), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tec kinases are cytoplasmic (or nonreceptor) tyr kinases (nRTKs) with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows |
| >cd05586 STKc_Sck1_like Catalytic domain of Suppressor of loss of cAMP-dependent protein kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=99.92 E-value=8.2e-26 Score=226.69 Aligned_cols=173 Identities=21% Similarity=0.269 Sum_probs=129.6
Q ss_pred cccceeeccCCCC------CCCCCCChhhHHHHHHHHHHHHHHHhhcCCCceeecCCCccceEecCCCCceeccccceee
Q 045315 241 DEISFWYESYNNP------TKKGLLCWGTRVRIIEGIAQGLLYLHQYSRLRVIHRDLKASNILLDKDMNPKISDFGMARM 314 (476)
Q Consensus 241 ~~~~l~~Ey~~~~------~~~~~L~~~~~~~i~~qIa~gL~yLH~~~~~~ivH~DLkp~NILld~~~~~kL~DFGla~~ 314 (476)
...+++|||++.+ .+.+.+++.++..++.||++||+|||+++ |+||||||+|||++.++.+||+|||+++.
T Consensus 69 ~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~qil~al~~LH~~~---ivHrDlkp~Nili~~~~~~kl~Dfg~a~~ 145 (330)
T cd05586 69 SDLYLVTDYMSGGELFWHLQKEGRFSEDRAKFYIAELVLALEHLHKYD---IVYRDLKPENILLDATGHIALCDFGLSKA 145 (330)
T ss_pred CeEEEEEcCCCCChHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCC---eEeccCCHHHeEECCCCCEEEecCCcCcC
Confidence 3578899999843 24567999999999999999999999999 99999999999999999999999999875
Q ss_pred cCCCcccccceeeeeccCCCChhhhccC-CCCccceEEeehhhhhhhhhCCCCCCcCCCCchhhhhhhhhhhcCCCcccc
Q 045315 315 FGGDELQSNTKRIVGTYGYMSPEYALRG-LFSIKSDVFSFGVLLLETLSSKKNTHFYNTDSLTLLGHAWNLWNDGRTWEL 393 (476)
Q Consensus 315 ~~~~~~~~~~~~~~gt~~y~aPE~l~~~-~~s~ksDVwSlGvvl~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~ 393 (476)
...... ......|+..|+|||.+.+. .++.++|||||||++|||++|+.||...... ... .....+.. .+
T Consensus 146 ~~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~~DvwslGvil~elltG~~Pf~~~~~~--~~~----~~i~~~~~-~~ 216 (330)
T cd05586 146 NLTDNK--TTNTFCGTTEYLAPEVLLDEKGYTKHVDFWSLGVLVFEMCCGWSPFYAEDTQ--QMY----RNIAFGKV-RF 216 (330)
T ss_pred CCCCCC--CccCccCCccccCHHHHcCCCCCCCccceeccccEEEEeccCCCCCCCCCHH--HHH----HHHHcCCC-CC
Confidence 432221 12235689999999998754 4799999999999999999999998643211 111 11111111 00
Q ss_pred cCcccCCCCCHHHHHHHHHHHHHchhhcccCCC----CHHHHHH
Q 045315 394 MDPISQNGASYPILKRYINVALLCVQEKAADRP----AMSEVVS 433 (476)
Q Consensus 394 ~d~~~~~~~~~~~~~~l~~li~~Cl~~dP~~RP----t~~eVl~ 433 (476)
. .......+.+++.+||+.||++|| ++.++++
T Consensus 217 ~--------~~~~~~~~~~li~~~L~~~P~~R~~~~~~~~~ll~ 252 (330)
T cd05586 217 P--------KNVLSDEGRQFVKGLLNRNPQHRLGAHRDAVELKE 252 (330)
T ss_pred C--------CccCCHHHHHHHHHHcCCCHHHCCCCCCCHHHHhc
Confidence 0 011235678899999999999998 4555554
|
Serine/Threonine Kinases (STKs), Fission yeast Suppressor of loss of cAMP-dependent protein kinase (Sck1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sck1-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of fungal proteins with similarity to the Schizosaccharomyces pombe STK Sck1. Sck1 plays a role in trehalase activation triggered by glucose and a nitrogen source. Trehalase catalyzes the cleavage of the disaccharide trehalose to glucose. Trehalose, as a carbohydrate reserve and stress metabolite, plays an important role in the response of |
| >cd05038 PTKc_Jak_rpt2 Catalytic (repeat 2) domain of the Protein Tyrosine Kinases, Janus kinases | Back alignment and domain information |
|---|
Probab=99.92 E-value=8.2e-26 Score=220.67 Aligned_cols=185 Identities=23% Similarity=0.334 Sum_probs=135.1
Q ss_pred ccceeeccCCCC-------CCCCCCChhhHHHHHHHHHHHHHHHhhcCCCceeecCCCccceEecCCCCceeccccceee
Q 045315 242 EISFWYESYNNP-------TKKGLLCWGTRVRIIEGIAQGLLYLHQYSRLRVIHRDLKASNILLDKDMNPKISDFGMARM 314 (476)
Q Consensus 242 ~~~l~~Ey~~~~-------~~~~~L~~~~~~~i~~qIa~gL~yLH~~~~~~ivH~DLkp~NILld~~~~~kL~DFGla~~ 314 (476)
..++++||++.. .....+++.++..++.|++.||+|||+.+ ++|+||||+||+++.++.+||+|||++..
T Consensus 82 ~~~lv~e~~~~~~l~~~l~~~~~~~~~~~~~~~~~~l~~aL~~lH~~~---i~H~dl~p~nil~~~~~~~~l~dfg~~~~ 158 (284)
T cd05038 82 SLRLIMEYLPSGSLRDYLQRHRDQINLKRLLLFSSQICKGMDYLGSQR---YIHRDLAARNILVESEDLVKISDFGLAKV 158 (284)
T ss_pred ceEEEEecCCCCCHHHHHHhCccccCHHHHHHHHHHHHHHHHHHHhCC---eecCCCCHHhEEEcCCCCEEEcccccccc
Confidence 456788888732 12336999999999999999999999998 99999999999999999999999999987
Q ss_pred cCCCccc-ccceeeeeccCCCChhhhccCCCCccceEEeehhhhhhhhhCCCCCCcCCCCchh---------hhhhhhhh
Q 045315 315 FGGDELQ-SNTKRIVGTYGYMSPEYALRGLFSIKSDVFSFGVLLLETLSSKKNTHFYNTDSLT---------LLGHAWNL 384 (476)
Q Consensus 315 ~~~~~~~-~~~~~~~gt~~y~aPE~l~~~~~s~ksDVwSlGvvl~elltG~~p~~~~~~~~~~---------~~~~~~~~ 384 (476)
....... .......++..|++||.+.+..++.++|+||||++++||++|+.|+......... ........
T Consensus 159 ~~~~~~~~~~~~~~~~~~~~~~Pe~~~~~~~~~~~Di~slG~~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~ 238 (284)
T cd05038 159 LPEDKDYYYVKEPGESPIFWYAPECLRTSKFSSASDVWSFGVTLYELFTYGDPSQSPPAEFLRMIGIAQGQMIVTRLLEL 238 (284)
T ss_pred cccCCcceeccCCCCCcccccCcHHHccCCCCcccchHHHhhhhheeeccCCCcccccchhccccccccccccHHHHHHH
Confidence 6532211 1111123456799999998889999999999999999999999887543211110 00000011
Q ss_pred hcCCCcccccCcccCCCCCHHHHHHHHHHHHHchhhcccCCCCHHHHHHHHhcc
Q 045315 385 WNDGRTWELMDPISQNGASYPILKRYINVALLCVQEKAADRPAMSEVVSMLSNE 438 (476)
Q Consensus 385 ~~~~~~~~~~d~~~~~~~~~~~~~~l~~li~~Cl~~dP~~RPt~~eVl~~L~~~ 438 (476)
..... ...........+.+++.+||+.+|++||++.||+++|+.+
T Consensus 239 ~~~~~---------~~~~~~~~~~~~~~li~~cl~~~p~~Rpt~~ei~~~l~~i 283 (284)
T cd05038 239 LKEGE---------RLPRPPSCPDEVYDLMKLCWEAEPQDRPSFADLILIVDRL 283 (284)
T ss_pred HHcCC---------cCCCCccCCHHHHHHHHHHhccChhhCCCHHHHHHHHhhc
Confidence 11110 1111112235788999999999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Janus kinase (Jak) subfamily; catalytic (c) domain (repeat 2). The Jak subfamily is composed of Jak1, Jak2, Jak3, TYK2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase catalytic domain. Most Jaks are expressed in a wide variety of tissues, except for Jak3, which is expressed only in hematopoietic cells. Jaks are crucial for cytokine receptor signaling. They are activated by aut |
| >cd07867 STKc_CDC2L6 Catalytic domain of Serine/Threonine Kinase, Cell Division Cycle 2-like 6 | Back alignment and domain information |
|---|
Probab=99.92 E-value=1.9e-25 Score=222.19 Aligned_cols=111 Identities=31% Similarity=0.453 Sum_probs=93.8
Q ss_pred CCCChhhHHHHHHHHHHHHHHHhhcCCCceeecCCCccceEe----cCCCCceeccccceeecCCCccc-ccceeeeecc
Q 045315 257 GLLCWGTRVRIIEGIAQGLLYLHQYSRLRVIHRDLKASNILL----DKDMNPKISDFGMARMFGGDELQ-SNTKRIVGTY 331 (476)
Q Consensus 257 ~~L~~~~~~~i~~qIa~gL~yLH~~~~~~ivH~DLkp~NILl----d~~~~~kL~DFGla~~~~~~~~~-~~~~~~~gt~ 331 (476)
..+++..+..++.||+.||+|||+.+ |+||||||+||++ +.++.+||+|||+++........ .......++.
T Consensus 103 ~~l~~~~~~~i~~qi~~aL~~lH~~~---ivH~Dlkp~Nil~~~~~~~~~~~kl~DfG~a~~~~~~~~~~~~~~~~~~t~ 179 (317)
T cd07867 103 MQLPRSMVKSLLYQILDGIHYLHANW---VLHRDLKPANILVMGEGPERGRVKIADMGFARLFNSPLKPLADLDPVVVTF 179 (317)
T ss_pred ccCCHHHHHHHHHHHHHHHHHHHhCC---EEcCCCCHHHEEEccCCCCCCcEEEeeccceeccCCCcccccccCcceecc
Confidence 35889999999999999999999998 9999999999999 56678999999999876543211 1223356899
Q ss_pred CCCChhhhcc-CCCCccceEEeehhhhhhhhhCCCCCCcC
Q 045315 332 GYMSPEYALR-GLFSIKSDVFSFGVLLLETLSSKKNTHFY 370 (476)
Q Consensus 332 ~y~aPE~l~~-~~~s~ksDVwSlGvvl~elltG~~p~~~~ 370 (476)
.|+|||.+.+ ..++.++|||||||++|||++|++||...
T Consensus 180 ~y~aPE~~~~~~~~~~~~DiwSlG~il~el~tg~~~f~~~ 219 (317)
T cd07867 180 WYRAPELLLGARHYTKAIDIWAIGCIFAELLTSEPIFHCR 219 (317)
T ss_pred cccCcHHhcCCCccCcHHHHHhHHHHHHHHHhCCCCcccc
Confidence 9999999876 45799999999999999999999998643
|
Serine/Threonine Kinases (STKs), Cell Division Cycle 2-like 6 (CDC2L6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDC2L6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDC2L6 is also called CDK8-like and was previously referred to as CDK11. However, this is a confusing nomenclature as CDC2L6 is distinct from CDC2L1, which is represented by the two protein products from its gene, called CDK11(p110) and CDK11(p58), as well as |
| >cd05570 STKc_PKC Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase C | Back alignment and domain information |
|---|
Probab=99.92 E-value=1.1e-25 Score=224.60 Aligned_cols=172 Identities=24% Similarity=0.282 Sum_probs=133.4
Q ss_pred cccceeeccCCCCC------CCCCCChhhHHHHHHHHHHHHHHHhhcCCCceeecCCCccceEecCCCCceeccccceee
Q 045315 241 DEISFWYESYNNPT------KKGLLCWGTRVRIIEGIAQGLLYLHQYSRLRVIHRDLKASNILLDKDMNPKISDFGMARM 314 (476)
Q Consensus 241 ~~~~l~~Ey~~~~~------~~~~L~~~~~~~i~~qIa~gL~yLH~~~~~~ivH~DLkp~NILld~~~~~kL~DFGla~~ 314 (476)
+..+++|||++... +...+++.++..++.||+.||+|||+.+ |+||||||+||++++++.+||+|||+++.
T Consensus 69 ~~~~lv~e~~~~~~L~~~~~~~~~l~~~~~~~~~~qi~~~l~~LH~~~---ivH~dlkp~Nill~~~~~~kl~Dfg~~~~ 145 (318)
T cd05570 69 DRLFFVMEYVNGGDLMFHIQRSGRFDEPRARFYAAEIVLGLQFLHERG---IIYRDLKLDNVLLDSEGHIKIADFGMCKE 145 (318)
T ss_pred CEEEEEEcCCCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHhCC---eEccCCCHHHeEECCCCcEEecccCCCee
Confidence 46889999998432 3457999999999999999999999998 99999999999999999999999999875
Q ss_pred cCCCcccccceeeeeccCCCChhhhccCCCCccceEEeehhhhhhhhhCCCCCCcCCCCchhhhhhhhhhhcCCCccccc
Q 045315 315 FGGDELQSNTKRIVGTYGYMSPEYALRGLFSIKSDVFSFGVLLLETLSSKKNTHFYNTDSLTLLGHAWNLWNDGRTWELM 394 (476)
Q Consensus 315 ~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~s~ksDVwSlGvvl~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 394 (476)
..... .......|+..|+|||++.+..++.++|+|||||++|||++|+.||...... .... .......
T Consensus 146 ~~~~~--~~~~~~~g~~~y~aPE~~~~~~~~~~~DiwslGvil~~l~~G~~pf~~~~~~--~~~~----~i~~~~~---- 213 (318)
T cd05570 146 GILGG--VTTSTFCGTPDYIAPEILSYQPYGPAVDWWALGVLLYEMLAGQSPFEGDDED--ELFQ----SILEDEV---- 213 (318)
T ss_pred cCcCC--CcccceecCccccCHHHhcCCCCCcchhhhhHHHHHHHHhhCCCCCCCCCHH--HHHH----HHHcCCC----
Confidence 32221 1122356899999999999999999999999999999999999998643311 1111 1111110
Q ss_pred CcccCCCCCHHHHHHHHHHHHHchhhcccCCCCH-----HHHHH
Q 045315 395 DPISQNGASYPILKRYINVALLCVQEKAADRPAM-----SEVVS 433 (476)
Q Consensus 395 d~~~~~~~~~~~~~~l~~li~~Cl~~dP~~RPt~-----~eVl~ 433 (476)
..+......+.+++.+||+.||++||++ .++++
T Consensus 214 ------~~~~~~~~~~~~li~~~l~~dP~~R~s~~~~~~~~ll~ 251 (318)
T cd05570 214 ------RYPRWLSKEAKSILKSFLTKNPEKRLGCLPTGEQDIKG 251 (318)
T ss_pred ------CCCCcCCHHHHHHHHHHccCCHHHcCCCCCCCHHHHhc
Confidence 0111224568899999999999999999 77764
|
Serine/Threonine Kinases (STKs), Protein Kinase C (PKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, classical PKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. Novel PKCs are calcium-independent, but require DAG and PS for activity, while atypical PKCs only re |
| >cd05619 STKc_nPKC_theta Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C theta | Back alignment and domain information |
|---|
Probab=99.92 E-value=1.2e-25 Score=224.40 Aligned_cols=171 Identities=26% Similarity=0.319 Sum_probs=131.9
Q ss_pred cccceeeccCCCCC------CCCCCChhhHHHHHHHHHHHHHHHhhcCCCceeecCCCccceEecCCCCceeccccceee
Q 045315 241 DEISFWYESYNNPT------KKGLLCWGTRVRIIEGIAQGLLYLHQYSRLRVIHRDLKASNILLDKDMNPKISDFGMARM 314 (476)
Q Consensus 241 ~~~~l~~Ey~~~~~------~~~~L~~~~~~~i~~qIa~gL~yLH~~~~~~ivH~DLkp~NILld~~~~~kL~DFGla~~ 314 (476)
+..+++|||++.+. ....+++.++..++.||+.||+|||+.+ |+||||||+|||++.++.+||+|||+++.
T Consensus 69 ~~~~lv~ey~~~g~L~~~l~~~~~~~~~~~~~~~~qi~~al~~LH~~~---ivHrdikp~Nil~~~~~~~kl~Dfg~~~~ 145 (316)
T cd05619 69 ENLFFVMEYLNGGDLMFHIQSCHKFDLPRATFYAAEIICGLQFLHSKG---IVYRDLKLDNILLDTDGHIKIADFGMCKE 145 (316)
T ss_pred CEEEEEEeCCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHhCC---eEeCCCCHHHEEECCCCCEEEccCCcceE
Confidence 46789999998432 2457899999999999999999999998 99999999999999999999999999875
Q ss_pred cCCCcccccceeeeeccCCCChhhhccCCCCccceEEeehhhhhhhhhCCCCCCcCCCCchhhhhhhhhhhcCCCccccc
Q 045315 315 FGGDELQSNTKRIVGTYGYMSPEYALRGLFSIKSDVFSFGVLLLETLSSKKNTHFYNTDSLTLLGHAWNLWNDGRTWELM 394 (476)
Q Consensus 315 ~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~s~ksDVwSlGvvl~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 394 (476)
..... .......|+..|+|||++.+..++.++|||||||++|||++|+.||..... ....... ....
T Consensus 146 ~~~~~--~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~el~~G~~pf~~~~~--~~~~~~i----~~~~----- 212 (316)
T cd05619 146 NMLGD--AKTCTFCGTPDYIAPEILLGQKYNTSVDWWSFGVLLYEMLIGQSPFHGHDE--EELFQSI----RMDN----- 212 (316)
T ss_pred CCCCC--CceeeecCCccccCHHHHcCCCCCchhhhhhHHHHHHHHHhCCCCCCCCCH--HHHHHHH----HhCC-----
Confidence 32211 122335689999999999988999999999999999999999999864331 1111111 1110
Q ss_pred CcccCCCCCHHHHHHHHHHHHHchhhcccCCCCHH-HHH
Q 045315 395 DPISQNGASYPILKRYINVALLCVQEKAADRPAMS-EVV 432 (476)
Q Consensus 395 d~~~~~~~~~~~~~~l~~li~~Cl~~dP~~RPt~~-eVl 432 (476)
+. .+......+.+++.+||+.||++||++. ++.
T Consensus 213 -~~----~~~~~~~~~~~li~~~l~~~P~~R~~~~~~l~ 246 (316)
T cd05619 213 -PC----YPRWLTREAKDILVKLFVREPERRLGVKGDIR 246 (316)
T ss_pred -CC----CCccCCHHHHHHHHHHhccCHhhcCCChHHHH
Confidence 00 0111235678999999999999999997 554
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), theta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-theta is selectively expressed in T-cells and plays an important and non-redundant role in |
| >cd00192 PTKc Catalytic domain of Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=99.92 E-value=1.4e-25 Score=215.74 Aligned_cols=178 Identities=30% Similarity=0.389 Sum_probs=137.1
Q ss_pred cccceeeccCCCCC------C---------CCCCChhhHHHHHHHHHHHHHHHhhcCCCceeecCCCccceEecCCCCce
Q 045315 241 DEISFWYESYNNPT------K---------KGLLCWGTRVRIIEGIAQGLLYLHQYSRLRVIHRDLKASNILLDKDMNPK 305 (476)
Q Consensus 241 ~~~~l~~Ey~~~~~------~---------~~~L~~~~~~~i~~qIa~gL~yLH~~~~~~ivH~DLkp~NILld~~~~~k 305 (476)
+..++++||++..+ . ...+++.++..++.|++.||+|||+++ ++|+||||+||+++.++.+|
T Consensus 69 ~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~l~~al~~lH~~~---i~H~di~p~nili~~~~~~~ 145 (262)
T cd00192 69 EPLYLVLEYMEGGDLLDYLRKSRPVFPSPEKSTLSLKDLLSFAIQIAKGMEYLASKK---FVHRDLAARNCLVGEDLVVK 145 (262)
T ss_pred CceEEEEEeccCCcHHHHHhhccccccccccccCCHHHHHHHHHHHHHHHHHHHcCC---cccCccCcceEEECCCCcEE
Confidence 46778899986221 1 478999999999999999999999998 99999999999999999999
Q ss_pred eccccceeecCCCcccccceeeeeccCCCChhhhccCCCCccceEEeehhhhhhhhh-CCCCCCcCCCCchhhhhhhhhh
Q 045315 306 ISDFGMARMFGGDELQSNTKRIVGTYGYMSPEYALRGLFSIKSDVFSFGVLLLETLS-SKKNTHFYNTDSLTLLGHAWNL 384 (476)
Q Consensus 306 L~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~s~ksDVwSlGvvl~ellt-G~~p~~~~~~~~~~~~~~~~~~ 384 (476)
|+|||.+................++..|+|||.+....++.++||||||+++|||++ |..|+..... ..... .
T Consensus 146 l~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~~g~~p~~~~~~--~~~~~----~ 219 (262)
T cd00192 146 ISDFGLSRDVYDDDYYRKKTGGKLPIRWMAPESLKDGIFTSKSDVWSFGVLLWEIFTLGATPYPGLSN--EEVLE----Y 219 (262)
T ss_pred EcccccccccccccccccccCCCcCccccCHHHhccCCcchhhccHHHHHHHHHHHhcCCCCCCCCCH--HHHHH----H
Confidence 999999987754432222233457889999999988889999999999999999999 5888765421 11111 1
Q ss_pred hcCCCcccccCcccCCCCCHHHHHHHHHHHHHchhhcccCCCCHHHHHHHHh
Q 045315 385 WNDGRTWELMDPISQNGASYPILKRYINVALLCVQEKAADRPAMSEVVSMLS 436 (476)
Q Consensus 385 ~~~~~~~~~~d~~~~~~~~~~~~~~l~~li~~Cl~~dP~~RPt~~eVl~~L~ 436 (476)
...+... .........+.+++.+||+.+|++||++.|+++.|+
T Consensus 220 ~~~~~~~---------~~~~~~~~~~~~li~~~l~~~p~~Rps~~~l~~~l~ 262 (262)
T cd00192 220 LRKGYRL---------PKPEYCPDELYELMLSCWQLDPEDRPTFSELVERLE 262 (262)
T ss_pred HHcCCCC---------CCCccCChHHHHHHHHHccCCcccCcCHHHHHHhhC
Confidence 1111110 111122467889999999999999999999999874
|
Protein Tyrosine Kinase (PTK) family, catalytic domain. This PTKc family is part of a larger superfamily that includes the catalytic domains of protein serine/threonine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. They can be classified into receptor and non-receptor tyr kinases. PTKs play important roles in many cellular processes including, lymphocyte activation, epithelium growth and maintenance, metabolism control, organogenesis regulation, survival, proliferation, differentiation, migration, adhesion, motility, and morphogenesis. Receptor tyr kinases (RTKs) are integral membrane proteins which contain an extracellular ligand-binding region, a transmembrane segment, and an intracellular tyr kinase domain. RTKs are usually activated through ligan |
| >cd05044 PTKc_c-ros Catalytic domain of the Protein Tyrosine Kinase, C-ros | Back alignment and domain information |
|---|
Probab=99.92 E-value=1.8e-25 Score=216.79 Aligned_cols=179 Identities=27% Similarity=0.388 Sum_probs=133.9
Q ss_pred cccceeeccCCCCC-------------CCCCCChhhHHHHHHHHHHHHHHHhhcCCCceeecCCCccceEecCCC-----
Q 045315 241 DEISFWYESYNNPT-------------KKGLLCWGTRVRIIEGIAQGLLYLHQYSRLRVIHRDLKASNILLDKDM----- 302 (476)
Q Consensus 241 ~~~~l~~Ey~~~~~-------------~~~~L~~~~~~~i~~qIa~gL~yLH~~~~~~ivH~DLkp~NILld~~~----- 302 (476)
+..++++||++... ....+++.+++.++.|++.||+|||+.+ ++|+||||+||+++.+.
T Consensus 72 ~~~~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~---i~H~dl~p~nil~~~~~~~~~~ 148 (269)
T cd05044 72 EPQYIIMELMEGGDLLSYLRDARVERFGPPLLTLKELLDICLDVAKGCVYLEQMH---FIHRDLAARNCLVSEKGYDADR 148 (269)
T ss_pred CCeEEEEeccCCCcHHHHHHHhhhcccCCccccHHHHHHHHHHHHHHHHHHHhCC---cccCCCChheEEEecCCCCCCc
Confidence 35778888887211 2345889999999999999999999998 99999999999999877
Q ss_pred CceeccccceeecCCCcccccceeeeeccCCCChhhhccCCCCccceEEeehhhhhhhhh-CCCCCCcCCCCchhhhhhh
Q 045315 303 NPKISDFGMARMFGGDELQSNTKRIVGTYGYMSPEYALRGLFSIKSDVFSFGVLLLETLS-SKKNTHFYNTDSLTLLGHA 381 (476)
Q Consensus 303 ~~kL~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~s~ksDVwSlGvvl~ellt-G~~p~~~~~~~~~~~~~~~ 381 (476)
.+||+|||+++...............++..|+|||.+.+..++.++|||||||++|||++ |+.||..... ......
T Consensus 149 ~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~ellt~g~~p~~~~~~--~~~~~~- 225 (269)
T cd05044 149 VVKIGDFGLARDIYKSDYYRKEGEGLLPVRWMAPESLLDGKFTTQSDVWSFGVLMWEILTLGQQPYPALNN--QEVLQH- 225 (269)
T ss_pred ceEECCcccccccccccccccCcccCCCccccCHHHHccCCcccchhHHHHHHHHHHHHHcCCCCCcccCH--HHHHHH-
Confidence 899999999976543322222222345678999999999999999999999999999998 8988764321 111111
Q ss_pred hhhhcCCCcccccCcccCCCCCHHHHHHHHHHHHHchhhcccCCCCHHHHHHHHhc
Q 045315 382 WNLWNDGRTWELMDPISQNGASYPILKRYINVALLCVQEKAADRPAMSEVVSMLSN 437 (476)
Q Consensus 382 ~~~~~~~~~~~~~d~~~~~~~~~~~~~~l~~li~~Cl~~dP~~RPt~~eVl~~L~~ 437 (476)
...+... .........+.+++.+||+.+|++||++.+|++.|++
T Consensus 226 ---~~~~~~~---------~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~i~~~l~~ 269 (269)
T cd05044 226 ---VTAGGRL---------QKPENCPDKIYQLMTNCWAQDPSERPTFDRIQEILQN 269 (269)
T ss_pred ---HhcCCcc---------CCcccchHHHHHHHHHHcCCCcccCCCHHHHHHHHhC
Confidence 1111100 1112234578899999999999999999999999863
|
Protein Tyrosine Kinases (PTK) family; C-ros and Drosophila Sevenless proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The proto-oncogene c-ros encodes an orphan receptor tyr kinase (RTK) with an unknown ligand. RTKs contain an extracellular ligand-binding domain, a transmembrane region, and an intracellular tyr kinase domain. RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. C-ros is expressed in embryonic cells of the kidney, intestine and lung, but disappears soon after birth. It persists only in the adult epididymis. Male |
| >cd05098 PTKc_FGFR1 Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 1 | Back alignment and domain information |
|---|
Probab=99.92 E-value=1e-25 Score=223.60 Aligned_cols=165 Identities=27% Similarity=0.359 Sum_probs=125.9
Q ss_pred CCCChhhHHHHHHHHHHHHHHHhhcCCCceeecCCCccceEecCCCCceeccccceeecCCCcccccceeeeeccCCCCh
Q 045315 257 GLLCWGTRVRIIEGIAQGLLYLHQYSRLRVIHRDLKASNILLDKDMNPKISDFGMARMFGGDELQSNTKRIVGTYGYMSP 336 (476)
Q Consensus 257 ~~L~~~~~~~i~~qIa~gL~yLH~~~~~~ivH~DLkp~NILld~~~~~kL~DFGla~~~~~~~~~~~~~~~~gt~~y~aP 336 (476)
..+++.++++++.|++.||+|||+.+ ++||||||+||+++.++.+||+|||+++...............++..|+||
T Consensus 135 ~~l~~~~~~~~~~qi~~aL~~lH~~g---i~H~dlkp~Nill~~~~~~kL~dfg~a~~~~~~~~~~~~~~~~~~~~y~aP 211 (307)
T cd05098 135 EQLSFKDLVSCAYQVARGMEYLASKK---CIHRDLAARNVLVTEDNVMKIADFGLARDIHHIDYYKKTTNGRLPVKWMAP 211 (307)
T ss_pred ccCCHHHHHHHHHHHHHHHHHHHHCC---cccccccHHheEEcCCCcEEECCCcccccccccchhhccccCCCccceeCh
Confidence 35899999999999999999999998 999999999999999999999999999765432211111112245689999
Q ss_pred hhhccCCCCccceEEeehhhhhhhhh-CCCCCCcCCCCchhhhhhhhhhhcCCCcccccCcccCCCCCHHHHHHHHHHHH
Q 045315 337 EYALRGLFSIKSDVFSFGVLLLETLS-SKKNTHFYNTDSLTLLGHAWNLWNDGRTWELMDPISQNGASYPILKRYINVAL 415 (476)
Q Consensus 337 E~l~~~~~s~ksDVwSlGvvl~ellt-G~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~l~~li~ 415 (476)
|.+.+..++.++|+|||||++|||++ |+.|+..... ..... ....+... ..+......+.+++.
T Consensus 212 E~~~~~~~~~~~DvwslG~~l~el~~~g~~p~~~~~~--~~~~~----~~~~~~~~---------~~~~~~~~~~~~li~ 276 (307)
T cd05098 212 EALFDRIYTHQSDVWSFGVLLWEIFTLGGSPYPGVPV--EELFK----LLKEGHRM---------DKPSNCTNELYMMMR 276 (307)
T ss_pred HHhccCCCCcHHHHHHHHHHHHHHHcCCCCCCCcCCH--HHHHH----HHHcCCCC---------CCCCcCCHHHHHHHH
Confidence 99998889999999999999999998 7777753321 11111 11111111 111123457788999
Q ss_pred HchhhcccCCCCHHHHHHHHhccc
Q 045315 416 LCVQEKAADRPAMSEVVSMLSNEF 439 (476)
Q Consensus 416 ~Cl~~dP~~RPt~~eVl~~L~~~~ 439 (476)
+||+.+|++||++.+|++.|+.+.
T Consensus 277 ~~l~~~p~~Rps~~evl~~l~~~~ 300 (307)
T cd05098 277 DCWHAVPSQRPTFKQLVEDLDRIL 300 (307)
T ss_pred HHcccChhhCcCHHHHHHHHHHHH
Confidence 999999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 1 (FGFR1); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR1 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to |
| >cd05113 PTKc_Btk_Bmx Catalytic domain of the Protein Tyrosine Kinases, Bruton's tyrosine kinase and Bone marrow kinase on the X chromosome | Back alignment and domain information |
|---|
Probab=99.92 E-value=1.4e-25 Score=216.71 Aligned_cols=176 Identities=28% Similarity=0.377 Sum_probs=132.9
Q ss_pred ccceeeccCCCC-------CCCCCCChhhHHHHHHHHHHHHHHHhhcCCCceeecCCCccceEecCCCCceeccccceee
Q 045315 242 EISFWYESYNNP-------TKKGLLCWGTRVRIIEGIAQGLLYLHQYSRLRVIHRDLKASNILLDKDMNPKISDFGMARM 314 (476)
Q Consensus 242 ~~~l~~Ey~~~~-------~~~~~L~~~~~~~i~~qIa~gL~yLH~~~~~~ivH~DLkp~NILld~~~~~kL~DFGla~~ 314 (476)
..++++||++.. .....+++.++++++.||+.||+|||+.+ ++|+||||+||+++.++.+||+|||.++.
T Consensus 73 ~~~lv~e~~~~~~l~~~i~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~---i~H~dl~p~nili~~~~~~kl~d~g~~~~ 149 (256)
T cd05113 73 PIYIVTEYMSNGCLLNYLREHGKRFQPSQLLEMCKDVCEGMAYLESKQ---FIHRDLAARNCLVDDQGCVKVSDFGLSRY 149 (256)
T ss_pred CcEEEEEcCCCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCC---eeccccCcceEEEcCCCCEEECCCcccee
Confidence 467888888732 12347899999999999999999999998 99999999999999999999999999986
Q ss_pred cCCCcccccceeeeeccCCCChhhhccCCCCccceEEeehhhhhhhhh-CCCCCCcCCCCchhhhhhhhhhhcCCCcccc
Q 045315 315 FGGDELQSNTKRIVGTYGYMSPEYALRGLFSIKSDVFSFGVLLLETLS-SKKNTHFYNTDSLTLLGHAWNLWNDGRTWEL 393 (476)
Q Consensus 315 ~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~s~ksDVwSlGvvl~ellt-G~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~ 393 (476)
........ .....++..|+|||.+.+..++.++||||||+++|||++ |+.|+...... ...... ..+...
T Consensus 150 ~~~~~~~~-~~~~~~~~~y~~pe~~~~~~~~~~~Di~slG~~l~~l~~~g~~p~~~~~~~--~~~~~~----~~~~~~-- 220 (256)
T cd05113 150 VLDDEYTS-SVGSKFPVRWSPPEVLLYSKFSSKSDVWAFGVLMWEVYSLGKMPYERFNNS--ETVEKV----SQGLRL-- 220 (256)
T ss_pred cCCCceee-cCCCccChhhCCHHHHhcCcccchhHHHHHHHHHHHHhcCCCCCcCcCCHH--HHHHHH----hcCCCC--
Confidence 54332111 111235678999999988889999999999999999998 88887543311 111111 111110
Q ss_pred cCcccCCCCCHHHHHHHHHHHHHchhhcccCCCCHHHHHHHHh
Q 045315 394 MDPISQNGASYPILKRYINVALLCVQEKAADRPAMSEVVSMLS 436 (476)
Q Consensus 394 ~d~~~~~~~~~~~~~~l~~li~~Cl~~dP~~RPt~~eVl~~L~ 436 (476)
.........+.+++.+||+.+|.+||++.++++.|+
T Consensus 221 -------~~~~~~~~~~~~li~~cl~~~p~~Rp~~~~ll~~~~ 256 (256)
T cd05113 221 -------YRPHLASEKVYAIMYSCWHEKAEERPTFQQLLSSIE 256 (256)
T ss_pred -------CCCCCCCHHHHHHHHHHcCCCcccCCCHHHHHHhhC
Confidence 001112467889999999999999999999998874
|
Protein Tyrosine Kinase (PTK) family; Bruton's tyrosine kinase (Btk) and Bone marrow kinase on the X chromosome (Bmx); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Btk and Bmx (also named Etk) are members of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds |
| >cd05601 STKc_CRIK Catalytic domain of the Protein Serine/Threonine Kinase, Citron Rho-interacting kinase | Back alignment and domain information |
|---|
Probab=99.92 E-value=1.8e-25 Score=224.18 Aligned_cols=176 Identities=20% Similarity=0.301 Sum_probs=132.0
Q ss_pred cccceeeccCCCCC-------CCCCCChhhHHHHHHHHHHHHHHHhhcCCCceeecCCCccceEecCCCCceecccccee
Q 045315 241 DEISFWYESYNNPT-------KKGLLCWGTRVRIIEGIAQGLLYLHQYSRLRVIHRDLKASNILLDKDMNPKISDFGMAR 313 (476)
Q Consensus 241 ~~~~l~~Ey~~~~~-------~~~~L~~~~~~~i~~qIa~gL~yLH~~~~~~ivH~DLkp~NILld~~~~~kL~DFGla~ 313 (476)
+..+++|||++... ....+++..+..++.||+.||+|||+.+ |+||||||+||+++.++.+||+|||++.
T Consensus 74 ~~~~lv~e~~~~~~L~~~l~~~~~~l~~~~~~~~~~qi~~aL~~lH~~~---i~H~Dlkp~NIll~~~~~~kL~Dfg~a~ 150 (330)
T cd05601 74 DNLYLVMEYQPGGDLLSLLNRYEDQFDEDMAQFYLAELVLAIHSVHQMG---YVHRDIKPENVLIDRTGHIKLADFGSAA 150 (330)
T ss_pred CeEEEEECCCCCCCHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCC---eEcccCchHheEECCCCCEEeccCCCCe
Confidence 45789999998432 2357999999999999999999999999 9999999999999999999999999998
Q ss_pred ecCCCcccccceeeeeccCCCChhhhc------cCCCCccceEEeehhhhhhhhhCCCCCCcCCCCchhhhhhhhhhhcC
Q 045315 314 MFGGDELQSNTKRIVGTYGYMSPEYAL------RGLFSIKSDVFSFGVLLLETLSSKKNTHFYNTDSLTLLGHAWNLWND 387 (476)
Q Consensus 314 ~~~~~~~~~~~~~~~gt~~y~aPE~l~------~~~~s~ksDVwSlGvvl~elltG~~p~~~~~~~~~~~~~~~~~~~~~ 387 (476)
.+...... ......|++.|+|||++. ...++.++|||||||++|||++|+.||....... .. ......
T Consensus 151 ~~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~DiwslG~il~el~~g~~Pf~~~~~~~--~~---~~i~~~ 224 (330)
T cd05601 151 RLTANKMV-NSKLPVGTPDYIAPEVLTTMNGDGKGTYGVECDWWSLGVIAYEMIYGRSPFHEGTSAK--TY---NNIMNF 224 (330)
T ss_pred ECCCCCce-eeecccCCccccCHHHhccccccccCCCCCcceeecccceeeeeccCCCCCCCCCHHH--HH---HHHHcC
Confidence 76543222 122346899999999986 4567899999999999999999999986433111 11 111111
Q ss_pred CCcccccCcccCCCCCHHHHHHHHHHHHHchhhcccCCCCHHHHHH
Q 045315 388 GRTWELMDPISQNGASYPILKRYINVALLCVQEKAADRPAMSEVVS 433 (476)
Q Consensus 388 ~~~~~~~d~~~~~~~~~~~~~~l~~li~~Cl~~dP~~RPt~~eVl~ 433 (476)
....... ........+.+++..|++ +|++||+++++++
T Consensus 225 ~~~~~~~-------~~~~~~~~~~~li~~ll~-~p~~R~t~~~l~~ 262 (330)
T cd05601 225 QRFLKFP-------EDPKVSSDFLDLIQSLLC-GQKERLGYEGLCC 262 (330)
T ss_pred CCccCCC-------CCCCCCHHHHHHHHHHcc-ChhhCCCHHHHhC
Confidence 1111110 111234567889999998 9999999999875
|
Serine/Threonine Kinases (STKs), Citron Rho-interacting kinase (CRIK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CRIK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CRIK is also called citron kinase. It contains a catalytic domain, a central coiled-coil domain, and a C-terminal region containing a Rho-binding domain (RBD), a zinc finger, and a pleckstrin homology (PH) domain, in addition to other motifs. CRIK, an effector of the small GTPase Rho, plays an important function during cytokinesis and affects its contractile process. CRIK-deficient mice show severe ataxia and epilepsy as a result of abnor |
| >cd06637 STKc_TNIK Catalytic domain of the Protein Serine/Threonine Kinase, Traf2- and Nck-interacting kinase | Back alignment and domain information |
|---|
Probab=99.92 E-value=1.9e-25 Score=216.99 Aligned_cols=173 Identities=24% Similarity=0.316 Sum_probs=130.1
Q ss_pred ccceeeccCCCC--------CCCCCCChhhHHHHHHHHHHHHHHHhhcCCCceeecCCCccceEecCCCCceecccccee
Q 045315 242 EISFWYESYNNP--------TKKGLLCWGTRVRIIEGIAQGLLYLHQYSRLRVIHRDLKASNILLDKDMNPKISDFGMAR 313 (476)
Q Consensus 242 ~~~l~~Ey~~~~--------~~~~~L~~~~~~~i~~qIa~gL~yLH~~~~~~ivH~DLkp~NILld~~~~~kL~DFGla~ 313 (476)
.+++++||++.. .+...+++..+..++.|++.||+|||+++ |+|+||||+||++++++.+||+|||++.
T Consensus 83 ~~~iv~e~~~~~~L~~~l~~~~~~~l~~~~~~~~~~qi~~~l~~LH~~~---ivh~dl~~~nili~~~~~~~l~Dfg~~~ 159 (272)
T cd06637 83 QLWLVMEFCGAGSVTDLIKNTKGNTLKEEWIAYICREILRGLSHLHQHK---VIHRDIKGQNVLLTENAEVKLVDFGVSA 159 (272)
T ss_pred EEEEEEEcCCCCcHHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHHCC---CccCCCCHHHEEECCCCCEEEccCCCce
Confidence 467889998732 23457899999999999999999999998 9999999999999999999999999998
Q ss_pred ecCCCcccccceeeeeccCCCChhhhc-----cCCCCccceEEeehhhhhhhhhCCCCCCcCCCCchhhhhhhhhhhcCC
Q 045315 314 MFGGDELQSNTKRIVGTYGYMSPEYAL-----RGLFSIKSDVFSFGVLLLETLSSKKNTHFYNTDSLTLLGHAWNLWNDG 388 (476)
Q Consensus 314 ~~~~~~~~~~~~~~~gt~~y~aPE~l~-----~~~~s~ksDVwSlGvvl~elltG~~p~~~~~~~~~~~~~~~~~~~~~~ 388 (476)
....... ......|+..|+|||++. +..++.++|+|||||++|||++|+.|+.......... .....
T Consensus 160 ~~~~~~~--~~~~~~g~~~y~aPE~~~~~~~~~~~~~~~~Dv~slGv~l~el~~g~~p~~~~~~~~~~~-----~~~~~- 231 (272)
T cd06637 160 QLDRTVG--RRNTFIGTPYWMAPEVIACDENPDATYDFKSDLWSLGITAIEMAEGAPPLCDMHPMRALF-----LIPRN- 231 (272)
T ss_pred ecccccc--cCCcccccccccCHhHhccccCcCCCCCchhhHHHHHHHHHHHHhCCCCccccCHHHHHH-----HHhcC-
Confidence 6543221 223356889999999986 3457889999999999999999999985432111100 00100
Q ss_pred CcccccCcccCCCCCHHHHHHHHHHHHHchhhcccCCCCHHHHHH
Q 045315 389 RTWELMDPISQNGASYPILKRYINVALLCVQEKAADRPAMSEVVS 433 (476)
Q Consensus 389 ~~~~~~d~~~~~~~~~~~~~~l~~li~~Cl~~dP~~RPt~~eVl~ 433 (476)
.. ... ........+.+++.+||+.+|.+|||+.++++
T Consensus 232 ~~-----~~~---~~~~~~~~~~~li~~~l~~~p~~Rpt~~~il~ 268 (272)
T cd06637 232 PA-----PRL---KSKKWSKKFQSFIESCLVKNHSQRPTTEQLMK 268 (272)
T ss_pred CC-----CCC---CCCCcCHHHHHHHHHHcCCChhhCCCHHHHhh
Confidence 00 000 11122356889999999999999999999875
|
Serine/threonine kinases (STKs), Traf2- and Nck-interacting kinase (TNIK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TNIK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to mitogen-activated protein kinase (MAPK), kinase kinase kinase 4 (MAP4K4), and MAP4K6. MAP4Ks participate in some MAPK signaling pathways by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). TNIK is an effector of Rap2, a small GTP-binding protein from the Ras family. TNIK specifically activ |
| >cd05089 PTKc_Tie1 Catalytic domain of the Protein Tyrosine Kinase, Tie1 | Back alignment and domain information |
|---|
Probab=99.92 E-value=1.5e-25 Score=221.23 Aligned_cols=164 Identities=24% Similarity=0.320 Sum_probs=124.6
Q ss_pred CCCChhhHHHHHHHHHHHHHHHhhcCCCceeecCCCccceEecCCCCceeccccceeecCCCcccccceeeeeccCCCCh
Q 045315 257 GLLCWGTRVRIIEGIAQGLLYLHQYSRLRVIHRDLKASNILLDKDMNPKISDFGMARMFGGDELQSNTKRIVGTYGYMSP 336 (476)
Q Consensus 257 ~~L~~~~~~~i~~qIa~gL~yLH~~~~~~ivH~DLkp~NILld~~~~~kL~DFGla~~~~~~~~~~~~~~~~gt~~y~aP 336 (476)
..+++.+++.++.||+.||+|||+.+ ++||||||+||+++.++.+||+|||++....... .......+..|+||
T Consensus 114 ~~l~~~~~~~i~~qi~~al~~lH~~~---ivH~dlkp~Nill~~~~~~kl~dfg~~~~~~~~~---~~~~~~~~~~y~aP 187 (297)
T cd05089 114 STLTSQQLLQFASDVATGMQYLSEKQ---FIHRDLAARNVLVGENLASKIADFGLSRGEEVYV---KKTMGRLPVRWMAI 187 (297)
T ss_pred CCCCHHHHHHHHHHHHHHHHHHHHCC---cccCcCCcceEEECCCCeEEECCcCCCcccccee---ccCCCCcCccccCc
Confidence 36899999999999999999999998 9999999999999999999999999986432110 11111234579999
Q ss_pred hhhccCCCCccceEEeehhhhhhhhh-CCCCCCcCCCCchhhhhhhhhhhcCCCcccccCcccCCCCCHHHHHHHHHHHH
Q 045315 337 EYALRGLFSIKSDVFSFGVLLLETLS-SKKNTHFYNTDSLTLLGHAWNLWNDGRTWELMDPISQNGASYPILKRYINVAL 415 (476)
Q Consensus 337 E~l~~~~~s~ksDVwSlGvvl~ellt-G~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~l~~li~ 415 (476)
|.+....++.++|||||||++|||++ |+.||...... .... ....+. ....+......+.+++.
T Consensus 188 E~~~~~~~~~~~DvwSlG~il~el~t~g~~pf~~~~~~--~~~~----~~~~~~---------~~~~~~~~~~~~~~li~ 252 (297)
T cd05089 188 ESLNYSVYTTKSDVWSFGVLLWEIVSLGGTPYCGMTCA--ELYE----KLPQGY---------RMEKPRNCDDEVYELMR 252 (297)
T ss_pred hhhccCCCCchhhHHHHHHHHHHHHcCCCCCCCCCCHH--HHHH----HHhcCC---------CCCCCCCCCHHHHHHHH
Confidence 99988889999999999999999997 98888543211 1111 111110 00111123356889999
Q ss_pred HchhhcccCCCCHHHHHHHHhccccC
Q 045315 416 LCVQEKAADRPAMSEVVSMLSNEFVN 441 (476)
Q Consensus 416 ~Cl~~dP~~RPt~~eVl~~L~~~~~~ 441 (476)
+||+.+|.+||+++++++.|+.+...
T Consensus 253 ~~l~~~p~~Rp~~~~i~~~l~~~~~~ 278 (297)
T cd05089 253 QCWRDRPYERPPFAQISVQLSRMLEA 278 (297)
T ss_pred HHcCCChhhCcCHHHHHHHHHHHHHh
Confidence 99999999999999999999987643
|
Protein Tyrosine Kinase (PTK) family; Tie1; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie1 is a receptor tyr kinase (RTK) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie receptors are specifically expressed in endothelial cells and hematopoietic stem cells. No specific ligand has been identified for Tie1, although the angiopoietin, Ang-1, binds to Tie1 through integrins at high concentrations. |
| >cd05067 PTKc_Lck_Blk Catalytic domain of the Protein Tyrosine Kinases, Lymphocyte-specific kinase and Blk | Back alignment and domain information |
|---|
Probab=99.92 E-value=2.2e-25 Score=215.45 Aligned_cols=178 Identities=27% Similarity=0.402 Sum_probs=135.9
Q ss_pred cccceeeccCCCC--------CCCCCCChhhHHHHHHHHHHHHHHHhhcCCCceeecCCCccceEecCCCCceeccccce
Q 045315 241 DEISFWYESYNNP--------TKKGLLCWGTRVRIIEGIAQGLLYLHQYSRLRVIHRDLKASNILLDKDMNPKISDFGMA 312 (476)
Q Consensus 241 ~~~~l~~Ey~~~~--------~~~~~L~~~~~~~i~~qIa~gL~yLH~~~~~~ivH~DLkp~NILld~~~~~kL~DFGla 312 (476)
+.+++++||++.. ..+..+++.+++.++.|++.||+|||+.+ ++|+||||+||+++.++.++|+|||++
T Consensus 73 ~~~~~v~e~~~~~~L~~~~~~~~~~~~~~~~~~~i~~~i~~al~~LH~~~---i~H~dl~p~ni~i~~~~~~~l~dfg~~ 149 (260)
T cd05067 73 EPIYIITEYMENGSLVDFLKTPEGIKLTINKLIDMAAQIAEGMAFIERKN---YIHRDLRAANILVSETLCCKIADFGLA 149 (260)
T ss_pred CCcEEEEEcCCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHhcCC---eecccccHHhEEEcCCCCEEEccCcce
Confidence 4578888988732 23457899999999999999999999998 999999999999999999999999999
Q ss_pred eecCCCcccccceeeeeccCCCChhhhccCCCCccceEEeehhhhhhhhh-CCCCCCcCCCCchhhhhhhhhhhcCCCcc
Q 045315 313 RMFGGDELQSNTKRIVGTYGYMSPEYALRGLFSIKSDVFSFGVLLLETLS-SKKNTHFYNTDSLTLLGHAWNLWNDGRTW 391 (476)
Q Consensus 313 ~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~s~ksDVwSlGvvl~ellt-G~~p~~~~~~~~~~~~~~~~~~~~~~~~~ 391 (476)
.......... .....++..|+|||.+....++.++||||||+++||+++ |+.||..... ..... ....+...
T Consensus 150 ~~~~~~~~~~-~~~~~~~~~y~~pe~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~~~~~--~~~~~----~~~~~~~~ 222 (260)
T cd05067 150 RLIEDNEYTA-REGAKFPIKWTAPEAINYGTFTIKSDVWSFGILLTEIVTYGRIPYPGMTN--PEVIQ----NLERGYRM 222 (260)
T ss_pred eecCCCCccc-ccCCcccccccCHHHhccCCcCcccchHHHHHHHHHHHhCCCCCCCCCCh--HHHHH----HHHcCCCC
Confidence 8765322211 112345678999999988889999999999999999998 9998864321 11111 11111100
Q ss_pred cccCcccCCCCCHHHHHHHHHHHHHchhhcccCCCCHHHHHHHHhc
Q 045315 392 ELMDPISQNGASYPILKRYINVALLCVQEKAADRPAMSEVVSMLSN 437 (476)
Q Consensus 392 ~~~d~~~~~~~~~~~~~~l~~li~~Cl~~dP~~RPt~~eVl~~L~~ 437 (476)
.........+.+++.+|++.+|++||++++++..|+.
T Consensus 223 ---------~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~l~~~l~~ 259 (260)
T cd05067 223 ---------PRPDNCPEELYELMRLCWKEKPEERPTFEYLRSVLED 259 (260)
T ss_pred ---------CCCCCCCHHHHHHHHHHccCChhhCCCHHHHHHHhhc
Confidence 0111223568899999999999999999999999975
|
Protein Tyrosine Kinase (PTK) family; Lck and Blk kinases; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Lck (lymphocyte-specific kinase) and Blk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Sr |
| >cd07875 STKc_JNK1 Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 1 | Back alignment and domain information |
|---|
Probab=99.92 E-value=1.3e-25 Score=228.50 Aligned_cols=185 Identities=20% Similarity=0.180 Sum_probs=133.3
Q ss_pred ccceeeccCCCCC---CCCCCChhhHHHHHHHHHHHHHHHhhcCCCceeecCCCccceEecCCCCceeccccceeecCCC
Q 045315 242 EISFWYESYNNPT---KKGLLCWGTRVRIIEGIAQGLLYLHQYSRLRVIHRDLKASNILLDKDMNPKISDFGMARMFGGD 318 (476)
Q Consensus 242 ~~~l~~Ey~~~~~---~~~~L~~~~~~~i~~qIa~gL~yLH~~~~~~ivH~DLkp~NILld~~~~~kL~DFGla~~~~~~ 318 (476)
..+++|||++... ....+++.++..++.|++.||+|||+++ |+||||||+||+++.++.+||+|||+++.....
T Consensus 103 ~~~lv~e~~~~~l~~~~~~~~~~~~~~~~~~qi~~aL~~LH~~~---ivH~Dlkp~NIll~~~~~~kL~DfG~a~~~~~~ 179 (364)
T cd07875 103 DVYIVMELMDANLCQVIQMELDHERMSYLLYQMLCGIKHLHSAG---IIHRDLKPSNIVVKSDCTLKILDFGLARTAGTS 179 (364)
T ss_pred eEEEEEeCCCCCHHHHHHhcCCHHHHHHHHHHHHHHHHHHhhCC---eecCCCCHHHEEECCCCcEEEEeCCCccccCCC
Confidence 4688999997321 1345889999999999999999999998 999999999999999999999999999865432
Q ss_pred cccccceeeeeccCCCChhhhccCCCCccceEEeehhhhhhhhhCCCCCCcCCCCchhhhhhhhhh--------------
Q 045315 319 ELQSNTKRIVGTYGYMSPEYALRGLFSIKSDVFSFGVLLLETLSSKKNTHFYNTDSLTLLGHAWNL-------------- 384 (476)
Q Consensus 319 ~~~~~~~~~~gt~~y~aPE~l~~~~~s~ksDVwSlGvvl~elltG~~p~~~~~~~~~~~~~~~~~~-------------- 384 (476)
. ......++..|+|||++.+..++.++|||||||++|||++|+.||...+... ........
T Consensus 180 ~---~~~~~~~t~~y~aPE~~~~~~~~~~~DiwSlG~il~ell~g~~pf~~~~~~~--~~~~~~~~~~~~~~~~~~~~~~ 254 (364)
T cd07875 180 F---MMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMIKGGVLFPGTDHID--QWNKVIEQLGTPCPEFMKKLQP 254 (364)
T ss_pred C---cccCCcccCCcCCHHHHhCCCCCchhhHHhHHHHHHHHHhCCCCCCCCCHHH--HHHHHHHhcCCCCHHHHHhhhH
Confidence 2 1223468999999999999999999999999999999999999986543110 00000000
Q ss_pred -----hcCC-Cc-----ccccCccc---CCCCCHHHHHHHHHHHHHchhhcccCCCCHHHHHHH
Q 045315 385 -----WNDG-RT-----WELMDPIS---QNGASYPILKRYINVALLCVQEKAADRPAMSEVVSM 434 (476)
Q Consensus 385 -----~~~~-~~-----~~~~d~~~---~~~~~~~~~~~l~~li~~Cl~~dP~~RPt~~eVl~~ 434 (476)
.... .. ........ ...........+.+++.+||+.||.+|||+.|+++.
T Consensus 255 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dll~~mL~~dP~~R~t~~e~L~h 318 (364)
T cd07875 255 TVRTYVENRPKYAGYSFEKLFPDVLFPADSEHNKLKASQARDLLSKMLVIDASKRISVDEALQH 318 (364)
T ss_pred HHHHHHhhCCCcCCCChHhhCccccccccccccccccHHHHHHHHHhcCcCcccCCCHHHHhcC
Confidence 0000 00 00000000 001111123568899999999999999999999874
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 1 (JNK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK1, like JNK2, is expressed in every cell and tissue type. Initially it was thought that JNK1 and JNK2 were functionally redundant as mice deficient in either genes (Jn |
| >cd05612 STKc_PRKX_like Catalytic domain of PRKX-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=99.92 E-value=1e-25 Score=222.03 Aligned_cols=170 Identities=22% Similarity=0.249 Sum_probs=132.6
Q ss_pred cccceeeccCCCC------CCCCCCChhhHHHHHHHHHHHHHHHhhcCCCceeecCCCccceEecCCCCceeccccceee
Q 045315 241 DEISFWYESYNNP------TKKGLLCWGTRVRIIEGIAQGLLYLHQYSRLRVIHRDLKASNILLDKDMNPKISDFGMARM 314 (476)
Q Consensus 241 ~~~~l~~Ey~~~~------~~~~~L~~~~~~~i~~qIa~gL~yLH~~~~~~ivH~DLkp~NILld~~~~~kL~DFGla~~ 314 (476)
+..+++|||++.. .+.+.+++.++..++.||+.||+|||+++ |+||||||+|||++.++.+||+|||+++.
T Consensus 74 ~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~---i~H~dlkp~NIli~~~~~~kl~Dfg~~~~ 150 (291)
T cd05612 74 RFLYMLMEYVPGGELFSYLRNSGRFSNSTGLFYASEIVCALEYLHSKE---IVYRDLKPENILLDKEGHIKLTDFGFAKK 150 (291)
T ss_pred CeEEEEEeCCCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCC---eeecCCCHHHeEECCCCCEEEEecCcchh
Confidence 4578899999843 23567999999999999999999999999 99999999999999999999999999986
Q ss_pred cCCCcccccceeeeeccCCCChhhhccCCCCccceEEeehhhhhhhhhCCCCCCcCCCCchhhhhhhhhhhcCCCccccc
Q 045315 315 FGGDELQSNTKRIVGTYGYMSPEYALRGLFSIKSDVFSFGVLLLETLSSKKNTHFYNTDSLTLLGHAWNLWNDGRTWELM 394 (476)
Q Consensus 315 ~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~s~ksDVwSlGvvl~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 394 (476)
.... .....|++.|+|||.+.+..++.++|||||||++|||++|+.||..... ...... ...+..
T Consensus 151 ~~~~-----~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~~l~~g~~pf~~~~~--~~~~~~----i~~~~~---- 215 (291)
T cd05612 151 LRDR-----TWTLCGTPEYLAPEVIQSKGHNKAVDWWALGILIYEMLVGYPPFFDDNP--FGIYEK----ILAGKL---- 215 (291)
T ss_pred ccCC-----cccccCChhhcCHHHHcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCH--HHHHHH----HHhCCc----
Confidence 5432 1234689999999999988899999999999999999999999864331 111111 111110
Q ss_pred CcccCCCCCHHHHHHHHHHHHHchhhcccCCCC-----HHHHHHH
Q 045315 395 DPISQNGASYPILKRYINVALLCVQEKAADRPA-----MSEVVSM 434 (476)
Q Consensus 395 d~~~~~~~~~~~~~~l~~li~~Cl~~dP~~RPt-----~~eVl~~ 434 (476)
..+......+.+++.+||+.||.+||+ ++++++.
T Consensus 216 ------~~~~~~~~~~~~li~~~l~~dp~~R~~~~~~~~~~~l~h 254 (291)
T cd05612 216 ------EFPRHLDLYAKDLIKKLLVVDRTRRLGNMKNGADDVKNH 254 (291)
T ss_pred ------CCCccCCHHHHHHHHHHcCCCHHHccCCccCCHHHHhcC
Confidence 011112346789999999999999995 7777654
|
Serine/Threonine Kinases (STKs), cAMP-dependent protein kinase (PKA) subfamily, PRKX-like kinases, catalytic (c) subunit. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKA subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include human PRKX (X chromosome-encoded protein kinase), Drosophila DC2, and similar proteins. PRKX is present in many tissues including fetal and adult brain, kidney, and lung. The PRKX gene is located in the Xp22.3 subregion and has a homolog called PRKY on the Y chromosome. An abnormal interchange between PRKX aand PRKY leads to the sex reversal disorder of XX males and XY females. PRKX is implicated in granulocyt |
| >cd05063 PTKc_EphR_A2 Catalytic domain of the Protein Tyrosine Kinase, Ephrin Receptor A2 | Back alignment and domain information |
|---|
Probab=99.92 E-value=1.3e-25 Score=217.77 Aligned_cols=180 Identities=27% Similarity=0.402 Sum_probs=135.2
Q ss_pred cccceeeccCCCCC-------CCCCCChhhHHHHHHHHHHHHHHHhhcCCCceeecCCCccceEecCCCCceecccccee
Q 045315 241 DEISFWYESYNNPT-------KKGLLCWGTRVRIIEGIAQGLLYLHQYSRLRVIHRDLKASNILLDKDMNPKISDFGMAR 313 (476)
Q Consensus 241 ~~~~l~~Ey~~~~~-------~~~~L~~~~~~~i~~qIa~gL~yLH~~~~~~ivH~DLkp~NILld~~~~~kL~DFGla~ 313 (476)
+..+++|||++... +.+.+++.++..++.|++.||+|||+.+ ++|+||||+||+++.++.+||+|||++.
T Consensus 79 ~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~l~~al~~lH~~~---i~H~dlkp~Nili~~~~~~kl~dfg~~~ 155 (268)
T cd05063 79 KPAMIITEYMENGALDKYLRDHDGEFSSYQLVGMLRGIAAGMKYLSDMN---YVHRDLAARNILVNSNLECKVSDFGLSR 155 (268)
T ss_pred CCcEEEEEcCCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCC---eeccccchhhEEEcCCCcEEECCCccce
Confidence 34678889988332 3457999999999999999999999998 9999999999999999999999999998
Q ss_pred ecCCCcccccc-eeeeeccCCCChhhhccCCCCccceEEeehhhhhhhhh-CCCCCCcCCCCchhhhhhhhhhhcCCCcc
Q 045315 314 MFGGDELQSNT-KRIVGTYGYMSPEYALRGLFSIKSDVFSFGVLLLETLS-SKKNTHFYNTDSLTLLGHAWNLWNDGRTW 391 (476)
Q Consensus 314 ~~~~~~~~~~~-~~~~gt~~y~aPE~l~~~~~s~ksDVwSlGvvl~ellt-G~~p~~~~~~~~~~~~~~~~~~~~~~~~~ 391 (476)
........... .....+..|+|||.+....++.++|||||||++||+++ |+.|+...... .... ....+..
T Consensus 156 ~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~Dv~slG~il~ell~~g~~p~~~~~~~--~~~~----~i~~~~~- 228 (268)
T cd05063 156 VLEDDPEGTYTTSGGKIPIRWTAPEAIAYRKFTSASDVWSFGIVMWEVMSFGERPYWDMSNH--EVMK----AINDGFR- 228 (268)
T ss_pred ecccccccceeccCCCcCceecCHHHhhcCCcChHhHHHHHHHHHHHHHhCCCCCCCcCCHH--HHHH----HHhcCCC-
Confidence 66432211111 11123457999999988889999999999999999997 99987543211 1111 1111110
Q ss_pred cccCcccCCCCCHHHHHHHHHHHHHchhhcccCCCCHHHHHHHHhcc
Q 045315 392 ELMDPISQNGASYPILKRYINVALLCVQEKAADRPAMSEVVSMLSNE 438 (476)
Q Consensus 392 ~~~d~~~~~~~~~~~~~~l~~li~~Cl~~dP~~RPt~~eVl~~L~~~ 438 (476)
..........+.+++.+||+.+|++||++.+|++.|+++
T Consensus 229 --------~~~~~~~~~~~~~li~~c~~~~p~~Rp~~~~i~~~l~~~ 267 (268)
T cd05063 229 --------LPAPMDCPSAVYQLMLQCWQQDRARRPRFVDIVNLLDKL 267 (268)
T ss_pred --------CCCCCCCCHHHHHHHHHHcCCCcccCcCHHHHHHHHHhh
Confidence 011112345688999999999999999999999999874
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; EphA2 receptor; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored |
| >cd07874 STKc_JNK3 Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 3 | Back alignment and domain information |
|---|
Probab=99.92 E-value=7.3e-26 Score=229.39 Aligned_cols=186 Identities=22% Similarity=0.177 Sum_probs=132.8
Q ss_pred ccceeeccCCCCC---CCCCCChhhHHHHHHHHHHHHHHHhhcCCCceeecCCCccceEecCCCCceeccccceeecCCC
Q 045315 242 EISFWYESYNNPT---KKGLLCWGTRVRIIEGIAQGLLYLHQYSRLRVIHRDLKASNILLDKDMNPKISDFGMARMFGGD 318 (476)
Q Consensus 242 ~~~l~~Ey~~~~~---~~~~L~~~~~~~i~~qIa~gL~yLH~~~~~~ivH~DLkp~NILld~~~~~kL~DFGla~~~~~~ 318 (476)
..+++|||++... ....+++.++..++.|+++||+|||+++ |+||||||+|||++.++.+||+|||+++.....
T Consensus 96 ~~~lv~e~~~~~l~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~g---ivHrDikp~Nill~~~~~~kl~Dfg~~~~~~~~ 172 (355)
T cd07874 96 DVYLVMELMDANLCQVIQMELDHERMSYLLYQMLCGIKHLHSAG---IIHRDLKPSNIVVKSDCTLKILDFGLARTAGTS 172 (355)
T ss_pred eeEEEhhhhcccHHHHHhhcCCHHHHHHHHHHHHHHHHHHHhCC---cccCCCChHHEEECCCCCEEEeeCcccccCCCc
Confidence 4578888887321 1345889999999999999999999999 999999999999999999999999999865432
Q ss_pred cccccceeeeeccCCCChhhhccCCCCccceEEeehhhhhhhhhCCCCCCcCCCCchhhhhhh-----------------
Q 045315 319 ELQSNTKRIVGTYGYMSPEYALRGLFSIKSDVFSFGVLLLETLSSKKNTHFYNTDSLTLLGHA----------------- 381 (476)
Q Consensus 319 ~~~~~~~~~~gt~~y~aPE~l~~~~~s~ksDVwSlGvvl~elltG~~p~~~~~~~~~~~~~~~----------------- 381 (476)
. ......++..|+|||.+.+..++.++|||||||++|||++|+.||........ .....
T Consensus 173 ~---~~~~~~~t~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~ 248 (355)
T cd07874 173 F---MMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMVRHKILFPGRDYIDQ-WNKVIEQLGTPCPEFMKKLQPT 248 (355)
T ss_pred c---ccCCccccCCccCHHHHcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHH-HHHHHHHhCCCCHHHHHhhcHH
Confidence 2 12234689999999999988999999999999999999999999865431000 00000
Q ss_pred -hhhhcC-CCccccc------Cccc--CCCCCHHHHHHHHHHHHHchhhcccCCCCHHHHHHH
Q 045315 382 -WNLWND-GRTWELM------DPIS--QNGASYPILKRYINVALLCVQEKAADRPAMSEVVSM 434 (476)
Q Consensus 382 -~~~~~~-~~~~~~~------d~~~--~~~~~~~~~~~l~~li~~Cl~~dP~~RPt~~eVl~~ 434 (476)
...... ....... +... ...........+.+++.+||+.||++|||+.|+++.
T Consensus 249 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~mL~~dP~~Rps~~ell~h 311 (355)
T cd07874 249 VRNYVENRPKYAGLTFPKLFPDSLFPADSEHNKLKASQARDLLSKMLVIDPAKRISVDEALQH 311 (355)
T ss_pred HHHHHhcCCccccccchhhccccccccccccccccchHHHHHHHHHhcCCchhcCCHHHHhcC
Confidence 000000 0000000 0000 001111224567899999999999999999999984
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 3 (JNK3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK3 is expressed primarily in the brain, and to a lesser extent in the heart and testis. Mice deficient in Jnk3 are protected against kainic acid-induced seizures, strok |
| >cd05047 PTKc_Tie Catalytic domain of Tie Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=99.92 E-value=1.9e-25 Score=217.36 Aligned_cols=162 Identities=26% Similarity=0.334 Sum_probs=123.0
Q ss_pred CCCChhhHHHHHHHHHHHHHHHhhcCCCceeecCCCccceEecCCCCceeccccceeecCCCcccccceeeeeccCCCCh
Q 045315 257 GLLCWGTRVRIIEGIAQGLLYLHQYSRLRVIHRDLKASNILLDKDMNPKISDFGMARMFGGDELQSNTKRIVGTYGYMSP 336 (476)
Q Consensus 257 ~~L~~~~~~~i~~qIa~gL~yLH~~~~~~ivH~DLkp~NILld~~~~~kL~DFGla~~~~~~~~~~~~~~~~gt~~y~aP 336 (476)
..+++.+++.++.|++.||+|||+.+ ++|+||||+||++++++.+||+|||++...... ........+..|+||
T Consensus 107 ~~l~~~~~~~~~~~i~~al~~lH~~~---i~H~dikp~nili~~~~~~kl~dfgl~~~~~~~---~~~~~~~~~~~y~ap 180 (270)
T cd05047 107 STLSSQQLLHFAADVARGMDYLSQKQ---FIHRDLAARNILVGENYVAKIADFGLSRGQEVY---VKKTMGRLPVRWMAI 180 (270)
T ss_pred CCCCHHHHHHHHHHHHHHHHHHHHCC---EeecccccceEEEcCCCeEEECCCCCccccchh---hhccCCCCccccCCh
Confidence 35899999999999999999999998 999999999999999999999999998632211 011112235679999
Q ss_pred hhhccCCCCccceEEeehhhhhhhhh-CCCCCCcCCCCchhhhhhhhhhhcCCCcccccCcccCCCCCHHHHHHHHHHHH
Q 045315 337 EYALRGLFSIKSDVFSFGVLLLETLS-SKKNTHFYNTDSLTLLGHAWNLWNDGRTWELMDPISQNGASYPILKRYINVAL 415 (476)
Q Consensus 337 E~l~~~~~s~ksDVwSlGvvl~ellt-G~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~l~~li~ 415 (476)
|++....++.++|+|||||++|||++ |..||..... ..... ....+...+ ........+.+++.
T Consensus 181 E~~~~~~~~~~~Di~slG~il~el~~~g~~pf~~~~~--~~~~~----~~~~~~~~~---------~~~~~~~~~~~li~ 245 (270)
T cd05047 181 ESLNYSVYTTNSDVWSYGVLLWEIVSLGGTPYCGMTC--AELYE----KLPQGYRLE---------KPLNCDDEVYDLMR 245 (270)
T ss_pred HHHccCCCCchhhHHHHHHHHHHHHcCCCCCccccCH--HHHHH----HHhCCCCCC---------CCCcCCHHHHHHHH
Confidence 99988889999999999999999997 8888754321 11111 111111000 11122346789999
Q ss_pred HchhhcccCCCCHHHHHHHHhccc
Q 045315 416 LCVQEKAADRPAMSEVVSMLSNEF 439 (476)
Q Consensus 416 ~Cl~~dP~~RPt~~eVl~~L~~~~ 439 (476)
+|++.+|.+||++.++++.|++++
T Consensus 246 ~~l~~~p~~Rps~~~il~~l~~~~ 269 (270)
T cd05047 246 QCWREKPYERPSFAQILVSLNRML 269 (270)
T ss_pred HHcccChhhCCCHHHHHHHHHHhh
Confidence 999999999999999999998764
|
Protein Tyrosine Kinase (PTK) family; Tie subfamily; catalytic (c) domain. The Tie subfamily consists of Tie1 and Tie2. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie proteins are receptor tyr kinases (RTKs) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie receptors are specifically expressed in endothelial cells and hematopoietic stem cells. The angiopoietins (Ang-1 to Ang-4) serve as ligands for Tie2, while no specific l |
| >cd05100 PTKc_FGFR3 Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 3 | Back alignment and domain information |
|---|
Probab=99.92 E-value=3.6e-25 Score=222.40 Aligned_cols=167 Identities=26% Similarity=0.362 Sum_probs=127.6
Q ss_pred CCCChhhHHHHHHHHHHHHHHHhhcCCCceeecCCCccceEecCCCCceeccccceeecCCCcccccceeeeeccCCCCh
Q 045315 257 GLLCWGTRVRIIEGIAQGLLYLHQYSRLRVIHRDLKASNILLDKDMNPKISDFGMARMFGGDELQSNTKRIVGTYGYMSP 336 (476)
Q Consensus 257 ~~L~~~~~~~i~~qIa~gL~yLH~~~~~~ivH~DLkp~NILld~~~~~kL~DFGla~~~~~~~~~~~~~~~~gt~~y~aP 336 (476)
..+++.+++.++.||+.||+|||+++ ++||||||+||+++.++.+||+|||+++...............++..|+||
T Consensus 129 ~~l~~~~~~~~~~qi~~al~~LH~~g---ivH~dlkp~Nill~~~~~~kL~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aP 205 (334)
T cd05100 129 EQLTFKDLVSCAYQVARGMEYLASQK---CIHRDLAARNVLVTEDNVMKIADFGLARDVHNIDYYKKTTNGRLPVKWMAP 205 (334)
T ss_pred ccCCHHHHHHHHHHHHHHHHHHHHCC---eeccccccceEEEcCCCcEEECCcccceecccccccccccCCCcCceEcCH
Confidence 45889999999999999999999998 999999999999999999999999999876543222212222345679999
Q ss_pred hhhccCCCCccceEEeehhhhhhhhh-CCCCCCcCCCCchhhhhhhhhhhcCCCcccccCcccCCCCCHHHHHHHHHHHH
Q 045315 337 EYALRGLFSIKSDVFSFGVLLLETLS-SKKNTHFYNTDSLTLLGHAWNLWNDGRTWELMDPISQNGASYPILKRYINVAL 415 (476)
Q Consensus 337 E~l~~~~~s~ksDVwSlGvvl~ellt-G~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~l~~li~ 415 (476)
|.+.+..++.++||||||+++|||++ |..||..... ..... ....+.... ........+.+++.
T Consensus 206 E~~~~~~~~~~~Di~slG~il~el~~~g~~p~~~~~~--~~~~~----~~~~~~~~~---------~~~~~~~~l~~li~ 270 (334)
T cd05100 206 EALFDRVYTHQSDVWSFGVLLWEIFTLGGSPYPGIPV--EELFK----LLKEGHRMD---------KPANCTHELYMIMR 270 (334)
T ss_pred HHhccCCcCchhhhHHHHHHHHHHHhcCCCCCCCCCH--HHHHH----HHHcCCCCC---------CCCCCCHHHHHHHH
Confidence 99999899999999999999999998 7777754321 11111 111111111 11122356889999
Q ss_pred HchhhcccCCCCHHHHHHHHhccccC
Q 045315 416 LCVQEKAADRPAMSEVVSMLSNEFVN 441 (476)
Q Consensus 416 ~Cl~~dP~~RPt~~eVl~~L~~~~~~ 441 (476)
+|++.+|++||++.|+++.|+.+...
T Consensus 271 ~cl~~~p~~Rps~~ell~~l~~~~~~ 296 (334)
T cd05100 271 ECWHAVPSQRPTFKQLVEDLDRVLTV 296 (334)
T ss_pred HHcccChhhCcCHHHHHHHHHHHhhh
Confidence 99999999999999999999987643
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 3 (FGFR3); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR3 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to |
| >cd05081 PTKc_Jak2_Jak3_rpt2 Catalytic (repeat 2) domain of the Protein Tyrosine Kinases, Janus kinases 2 and 3 | Back alignment and domain information |
|---|
Probab=99.92 E-value=1.2e-25 Score=220.04 Aligned_cols=194 Identities=21% Similarity=0.271 Sum_probs=133.0
Q ss_pred ccceeeccCCCC-------CCCCCCChhhHHHHHHHHHHHHHHHhhcCCCceeecCCCccceEecCCCCceeccccceee
Q 045315 242 EISFWYESYNNP-------TKKGLLCWGTRVRIIEGIAQGLLYLHQYSRLRVIHRDLKASNILLDKDMNPKISDFGMARM 314 (476)
Q Consensus 242 ~~~l~~Ey~~~~-------~~~~~L~~~~~~~i~~qIa~gL~yLH~~~~~~ivH~DLkp~NILld~~~~~kL~DFGla~~ 314 (476)
..++++||++.. ..+..+++..+..++.|++.||+|||+.+ ++||||||+||+++.++.+||+|||+++.
T Consensus 81 ~~~lv~e~~~~~~L~~~l~~~~~~l~~~~~~~~~~~l~~aL~~LH~~~---i~H~dlkp~nili~~~~~~~l~dfg~~~~ 157 (284)
T cd05081 81 NLRLVMEYLPYGSLRDYLQKHRERLDHRKLLLYASQICKGMEYLGSKR---YVHRDLATRNILVESENRVKIGDFGLTKV 157 (284)
T ss_pred ceEEEEEecCCCCHHHHHHhcCcCCCHHHHHHHHHHHHHHHHHHHHCC---ceeccCCHhhEEECCCCeEEECCCccccc
Confidence 466888998732 22456899999999999999999999998 99999999999999999999999999987
Q ss_pred cCCCcccc-cceeeeeccCCCChhhhccCCCCccceEEeehhhhhhhhhCCCCCCcCCCCchhhhhhhhh-hhcCCCccc
Q 045315 315 FGGDELQS-NTKRIVGTYGYMSPEYALRGLFSIKSDVFSFGVLLLETLSSKKNTHFYNTDSLTLLGHAWN-LWNDGRTWE 392 (476)
Q Consensus 315 ~~~~~~~~-~~~~~~gt~~y~aPE~l~~~~~s~ksDVwSlGvvl~elltG~~p~~~~~~~~~~~~~~~~~-~~~~~~~~~ 392 (476)
........ ......++..|+|||.+.+..++.++|+|||||+++||++|..++................ ........+
T Consensus 158 ~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 237 (284)
T cd05081 158 LPQDKEYYKVREPGESPIFWYAPESLTESKFSVASDVWSFGVVLYELFTYSDKSCSPPAEFMRMMGNDKQGQMIVYHLIE 237 (284)
T ss_pred ccCCCcceeecCCCCCceEeeCHHHhccCCcChHHHHHHHHHHHHHHhhcCCcCCCcchhhhhhcccccccccchHHHHH
Confidence 64322111 1111123446999999998889999999999999999999877643221100000000000 000000000
Q ss_pred ccCcccCCCCCHHHHHHHHHHHHHchhhcccCCCCHHHHHHHHhcc
Q 045315 393 LMDPISQNGASYPILKRYINVALLCVQEKAADRPAMSEVVSMLSNE 438 (476)
Q Consensus 393 ~~d~~~~~~~~~~~~~~l~~li~~Cl~~dP~~RPt~~eVl~~L~~~ 438 (476)
.+...............+.+++.+||+.+|++|||+.+|++.|+.+
T Consensus 238 ~~~~~~~~~~~~~~~~~~~~li~~cl~~~p~~Rpt~~ei~~~l~~~ 283 (284)
T cd05081 238 LLKNNGRLPAPPGCPAEIYAIMKECWNNDPSQRPSFSELALQVEAI 283 (284)
T ss_pred HHhcCCcCCCCCCCCHHHHHHHHHHccCChhhCCCHHHHHHHHHhc
Confidence 0000000011122345788999999999999999999999999874
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 2 (Jak2) and Jak3; catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak2 and Jak3 are members of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal catalytic tyr kinase domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as th |
| >cd05087 PTKc_Aatyk1_Aatyk3 Catalytic domain of the Protein Tyrosine Kinases, Apoptosis-associated tyrosine kinases 1 and 3 | Back alignment and domain information |
|---|
Probab=99.92 E-value=4.5e-25 Score=214.41 Aligned_cols=182 Identities=24% Similarity=0.292 Sum_probs=129.3
Q ss_pred cccceeeccCCCCC-----------CCCCCChhhHHHHHHHHHHHHHHHhhcCCCceeecCCCccceEecCCCCceeccc
Q 045315 241 DEISFWYESYNNPT-----------KKGLLCWGTRVRIIEGIAQGLLYLHQYSRLRVIHRDLKASNILLDKDMNPKISDF 309 (476)
Q Consensus 241 ~~~~l~~Ey~~~~~-----------~~~~L~~~~~~~i~~qIa~gL~yLH~~~~~~ivH~DLkp~NILld~~~~~kL~DF 309 (476)
...+++|||++.+. ....+++..+..++.|++.||+|||+.+ ++|+||||+||+++.++.+||+||
T Consensus 68 ~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~---i~H~dlkp~nil~~~~~~~kL~df 144 (269)
T cd05087 68 TPYLLVMEFCPLGDLKGYLRSCRKAELMTPDPTTLQRMACEIALGLLHLHKNN---FIHSDLALRNCLLTADLTVKIGDY 144 (269)
T ss_pred CCcEEEEECCCCCcHHHHHHHhhhcccccccHHHHHHHHHHHHHHHHHHHHCC---EeccccCcceEEEcCCCcEEECCc
Confidence 34678889987321 1234677788899999999999999998 999999999999999999999999
Q ss_pred cceeecCCCcccccceeeeeccCCCChhhhccC-------CCCccceEEeehhhhhhhhh-CCCCCCcCCCCchhhhhhh
Q 045315 310 GMARMFGGDELQSNTKRIVGTYGYMSPEYALRG-------LFSIKSDVFSFGVLLLETLS-SKKNTHFYNTDSLTLLGHA 381 (476)
Q Consensus 310 Gla~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~-------~~s~ksDVwSlGvvl~ellt-G~~p~~~~~~~~~~~~~~~ 381 (476)
|++................++..|+|||++.+. .++.++|+||||+++|||++ |+.||........ ....
T Consensus 145 g~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~~DiwslG~~l~el~~~g~~p~~~~~~~~~--~~~~ 222 (269)
T cd05087 145 GLSHNKYKEDYYVTPDQLWVPLRWIAPELVDEVHGNLLVVDQTKESNVWSLGVTIWELFELGSQPYRHLSDEQV--LTYT 222 (269)
T ss_pred cccccccCcceeecCCCcCCcccccCHhHhccccccccccCCCccchhHHHHHHHHHHHhCCCCCCCCCChHHH--HHHH
Confidence 999764433222222234567889999988632 35789999999999999996 9989865432211 1110
Q ss_pred hhhhcCCCcccccCcccCCCCCHHHHHHHHHHHHHchhhcccCCCCHHHHHHHHh
Q 045315 382 WNLWNDGRTWELMDPISQNGASYPILKRYINVALLCVQEKAADRPAMSEVVSMLS 436 (476)
Q Consensus 382 ~~~~~~~~~~~~~d~~~~~~~~~~~~~~l~~li~~Cl~~dP~~RPt~~eVl~~L~ 436 (476)
. .+......++... ....+.+.+++..|+ .+|++|||++||++.|+
T Consensus 223 ---~-~~~~~~~~~~~~~----~~~~~~~~~l~~~c~-~~P~~Rpt~~~l~~~l~ 268 (269)
T cd05087 223 ---V-REQQLKLPKPRLK----LPLSDRWYEVMQFCW-LQPEQRPSAEEVHLLLS 268 (269)
T ss_pred ---h-hcccCCCCCCccC----CCCChHHHHHHHHHh-cCcccCCCHHHHHHHhc
Confidence 0 1111111122111 122345778889998 58999999999999885
|
Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase 1 (Aatyk1) and Aatyk3; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk1 and Aatyk3 are members of the Aatyk subfamily of proteins. Aatyk3 is a receptor kinase containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk1 has a similar domain arrangement but without the transmembrane segment and is thus, a cytoplasmic (or nonreceptor) kinase. The expression of Aatyk1 (also referred simply as Aatyk) is upregulated during growth arrest and apoptosis in myeloid cells |
| >cd05110 PTKc_HER4 Catalytic domain of the Protein Tyrosine Kinase, HER4 | Back alignment and domain information |
|---|
Probab=99.92 E-value=1.3e-25 Score=222.42 Aligned_cols=179 Identities=26% Similarity=0.328 Sum_probs=133.8
Q ss_pred cceeeccCCCC-------CCCCCCChhhHHHHHHHHHHHHHHHhhcCCCceeecCCCccceEecCCCCceeccccceeec
Q 045315 243 ISFWYESYNNP-------TKKGLLCWGTRVRIIEGIAQGLLYLHQYSRLRVIHRDLKASNILLDKDMNPKISDFGMARMF 315 (476)
Q Consensus 243 ~~l~~Ey~~~~-------~~~~~L~~~~~~~i~~qIa~gL~yLH~~~~~~ivH~DLkp~NILld~~~~~kL~DFGla~~~ 315 (476)
..+++||++.+ .+...+++..+..++.|++.||+|||+++ |+|+||||+||+++.++.+||+|||+++..
T Consensus 83 ~~~v~e~~~~g~l~~~~~~~~~~~~~~~~~~~~~qi~~~L~~LH~~~---ivH~dikp~Nill~~~~~~kL~Dfg~~~~~ 159 (303)
T cd05110 83 IQLVTQLMPHGCLLDYVHEHKDNIGSQLLLNWCVQIAKGMMYLEERR---LVHRDLAARNVLVKSPNHVKITDFGLARLL 159 (303)
T ss_pred ceeeehhcCCCCHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHhhcC---eeccccccceeeecCCCceEEccccccccc
Confidence 34566777632 23446899999999999999999999998 999999999999999999999999999876
Q ss_pred CCCcccccceeeeeccCCCChhhhccCCCCccceEEeehhhhhhhhh-CCCCCCcCCCCchhhhhhhhhhhcCCCccccc
Q 045315 316 GGDELQSNTKRIVGTYGYMSPEYALRGLFSIKSDVFSFGVLLLETLS-SKKNTHFYNTDSLTLLGHAWNLWNDGRTWELM 394 (476)
Q Consensus 316 ~~~~~~~~~~~~~gt~~y~aPE~l~~~~~s~ksDVwSlGvvl~ellt-G~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 394 (476)
.............++..|+|||.+.+..++.++|||||||++||+++ |+.|+..... .... .....+....
T Consensus 160 ~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~DiwslG~~l~el~t~g~~p~~~~~~--~~~~----~~~~~~~~~~-- 231 (303)
T cd05110 160 EGDEKEYNADGGKMPIKWMALECIHYRKFTHQSDVWSYGVTIWELMTFGGKPYDGIPT--REIP----DLLEKGERLP-- 231 (303)
T ss_pred cCcccccccCCCccccccCCHHHhccCCCChHHHHHHHHHHHHHHHhCCCCCCCCCCH--HHHH----HHHHCCCCCC--
Confidence 54332222222345678999999988889999999999999999997 8888754321 1111 1111111110
Q ss_pred CcccCCCCCHHHHHHHHHHHHHchhhcccCCCCHHHHHHHHhccc
Q 045315 395 DPISQNGASYPILKRYINVALLCVQEKAADRPAMSEVVSMLSNEF 439 (476)
Q Consensus 395 d~~~~~~~~~~~~~~l~~li~~Cl~~dP~~RPt~~eVl~~L~~~~ 439 (476)
. .......+.+++.+||..+|++||+++++++.|+.+.
T Consensus 232 ~-------~~~~~~~~~~li~~c~~~~p~~Rp~~~~l~~~l~~~~ 269 (303)
T cd05110 232 Q-------PPICTIDVYMVMVKCWMIDADSRPKFKELAAEFSRMA 269 (303)
T ss_pred C-------CCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHH
Confidence 0 1112346789999999999999999999999999865
|
Protein Tyrosine Kinase (PTK) family; HER4 (ErbB4); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER4 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as bindin |
| >cd05607 STKc_GRK7 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 7 | Back alignment and domain information |
|---|
Probab=99.92 E-value=5e-25 Score=215.46 Aligned_cols=177 Identities=20% Similarity=0.253 Sum_probs=132.5
Q ss_pred cccceeeccCCCC--------CCCCCCChhhHHHHHHHHHHHHHHHhhcCCCceeecCCCccceEecCCCCceeccccce
Q 045315 241 DEISFWYESYNNP--------TKKGLLCWGTRVRIIEGIAQGLLYLHQYSRLRVIHRDLKASNILLDKDMNPKISDFGMA 312 (476)
Q Consensus 241 ~~~~l~~Ey~~~~--------~~~~~L~~~~~~~i~~qIa~gL~yLH~~~~~~ivH~DLkp~NILld~~~~~kL~DFGla 312 (476)
...+++|||++.. .....+++..+..++.||+.||+|||+.+ ++||||||+||+++.++.++|+|||++
T Consensus 66 ~~~~lv~e~~~g~~L~~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~---ivH~dikp~Nili~~~~~~~l~Dfg~~ 142 (277)
T cd05607 66 THLCLVMSLMNGGDLKYHIYNVGERGLEMERVIHYSAQITCGILHLHSMD---IVYRDMKPENVLLDDQGNCRLSDLGLA 142 (277)
T ss_pred CeEEEEEecCCCCCHHHHHHhccccCCCHHHHHHHHHHHHHHHHHHHHCC---EEEccCChHhEEEcCCCCEEEeeceee
Confidence 3577889998732 23346899999999999999999999998 999999999999999999999999999
Q ss_pred eecCCCcccccceeeeeccCCCChhhhccCCCCccceEEeehhhhhhhhhCCCCCCcCCCCchhhhhhhhhhhcCCCccc
Q 045315 313 RMFGGDELQSNTKRIVGTYGYMSPEYALRGLFSIKSDVFSFGVLLLETLSSKKNTHFYNTDSLTLLGHAWNLWNDGRTWE 392 (476)
Q Consensus 313 ~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~s~ksDVwSlGvvl~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~ 392 (476)
........ .....|+..|+|||++.+..++.++|||||||++|||++|+.||........ ......... ....
T Consensus 143 ~~~~~~~~---~~~~~~~~~y~aPE~~~~~~~~~~~DvwslGv~l~el~~g~~p~~~~~~~~~-~~~~~~~~~-~~~~-- 215 (277)
T cd05607 143 VELKDGKT---ITQRAGTNGYMAPEILKEEPYSYPVDWFAMGCSIYEMVAGRTPFKDHKEKVA-KEELKRRTL-EDEV-- 215 (277)
T ss_pred eecCCCce---eeccCCCCCccCHHHHccCCCCCchhHHHHHHHHHHHHhCCCCCCCCcchhh-HHHHHHHhh-cccc--
Confidence 87654321 1224588999999999988899999999999999999999999864332111 001111111 1110
Q ss_pred ccCcccCCCCCHHHHHHHHHHHHHchhhcccCCCCHHHHHHH
Q 045315 393 LMDPISQNGASYPILKRYINVALLCVQEKAADRPAMSEVVSM 434 (476)
Q Consensus 393 ~~d~~~~~~~~~~~~~~l~~li~~Cl~~dP~~RPt~~eVl~~ 434 (476)
.. ........+.+++.+||+.||++||+++|+++.
T Consensus 216 --~~-----~~~~~~~~~~~li~~~L~~~P~~R~~~~~~~~~ 250 (277)
T cd05607 216 --KF-----EHQNFTEESKDICRLFLAKKPEDRLGSREKNDD 250 (277)
T ss_pred --cc-----ccccCCHHHHHHHHHHhccCHhhCCCCccchhh
Confidence 00 001224567899999999999999999776643
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK7 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK7, also called iodopsin kinase, belongs to the visual gr |
| >cd05041 PTKc_Fes_like Catalytic domain of Fes-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=99.92 E-value=2.6e-25 Score=213.49 Aligned_cols=179 Identities=27% Similarity=0.303 Sum_probs=132.7
Q ss_pred cccceeeccCCCC-------CCCCCCChhhHHHHHHHHHHHHHHHhhcCCCceeecCCCccceEecCCCCceecccccee
Q 045315 241 DEISFWYESYNNP-------TKKGLLCWGTRVRIIEGIAQGLLYLHQYSRLRVIHRDLKASNILLDKDMNPKISDFGMAR 313 (476)
Q Consensus 241 ~~~~l~~Ey~~~~-------~~~~~L~~~~~~~i~~qIa~gL~yLH~~~~~~ivH~DLkp~NILld~~~~~kL~DFGla~ 313 (476)
+..++++||++.. .....+++..++.++.+++.||+|||+++ ++||||||+||+++.++.+||+|||++.
T Consensus 65 ~~~~~v~e~~~~~~l~~~l~~~~~~~~~~~~~~~~~~~~~~l~~lH~~~---i~h~di~p~nili~~~~~~~l~d~g~~~ 141 (251)
T cd05041 65 QPIYIVMELVPGGSLLTFLRKKKNRLTVKKLLQMSLDAAAGMEYLESKN---CIHRDLAARNCLVGENNVLKISDFGMSR 141 (251)
T ss_pred CCeEEEEEcCCCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCC---EehhhcCcceEEEcCCCcEEEeeccccc
Confidence 3466788888632 22446899999999999999999999998 9999999999999999999999999998
Q ss_pred ecCCCcccccceeeeeccCCCChhhhccCCCCccceEEeehhhhhhhhh-CCCCCCcCCCCchhhhhhhhhhhcCCCccc
Q 045315 314 MFGGDELQSNTKRIVGTYGYMSPEYALRGLFSIKSDVFSFGVLLLETLS-SKKNTHFYNTDSLTLLGHAWNLWNDGRTWE 392 (476)
Q Consensus 314 ~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~s~ksDVwSlGvvl~ellt-G~~p~~~~~~~~~~~~~~~~~~~~~~~~~~ 392 (476)
................+..|+|||.+.++.++.++|+|||||++||+++ |..|+....... ... ......
T Consensus 142 ~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~i~~~l~t~~~~p~~~~~~~~--~~~----~~~~~~--- 212 (251)
T cd05041 142 EEEGGIYTVSDGLKQIPIKWTAPEALNYGRYTSESDVWSYGILLWETFSLGDTPYPGMSNQQ--TRE----RIESGY--- 212 (251)
T ss_pred cccCCcceeccccCcceeccCChHhhccCCCCcchhHHHHHHHHHHHHhccCCCCccCCHHH--HHH----HHhcCC---
Confidence 6543221111111233567999999988889999999999999999998 777775432111 111 111110
Q ss_pred ccCcccCCCCCHHHHHHHHHHHHHchhhcccCCCCHHHHHHHHhc
Q 045315 393 LMDPISQNGASYPILKRYINVALLCVQEKAADRPAMSEVVSMLSN 437 (476)
Q Consensus 393 ~~d~~~~~~~~~~~~~~l~~li~~Cl~~dP~~RPt~~eVl~~L~~ 437 (476)
....+......+.+++.+|++.+|.+||++.||++.|+.
T Consensus 213 ------~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~ell~~l~~ 251 (251)
T cd05041 213 ------RMPAPQLCPEEIYRLMLQCWAYDPENRPSFSEIYNELQI 251 (251)
T ss_pred ------CCCCCccCCHHHHHHHHHHhccChhhCcCHHHHHHHhhC
Confidence 001112234578899999999999999999999999863
|
Protein Tyrosine Kinase (PTK) family; Fes subfamily; catalytic (c) domain. Fes subfamily members include Fes (or Fps), Fer, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fes subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. The genes for Fes (feline sarcoma) and Fps (Fujinami poultry sarcoma) were first isolated from tumor-causing retroviruses. The viral oncogenes encode chimeric Fes proteins consisting of Gag sequences at the N-termini, resulting in unregulated tyr k |
| >cd05088 PTKc_Tie2 Catalytic domain of the Protein Tyrosine Kinase, Tie2 | Back alignment and domain information |
|---|
Probab=99.92 E-value=2.1e-25 Score=221.00 Aligned_cols=162 Identities=25% Similarity=0.333 Sum_probs=123.5
Q ss_pred CCCChhhHHHHHHHHHHHHHHHhhcCCCceeecCCCccceEecCCCCceeccccceeecCCCcccccceeeeeccCCCCh
Q 045315 257 GLLCWGTRVRIIEGIAQGLLYLHQYSRLRVIHRDLKASNILLDKDMNPKISDFGMARMFGGDELQSNTKRIVGTYGYMSP 336 (476)
Q Consensus 257 ~~L~~~~~~~i~~qIa~gL~yLH~~~~~~ivH~DLkp~NILld~~~~~kL~DFGla~~~~~~~~~~~~~~~~gt~~y~aP 336 (476)
..+++.+++.++.||+.||+|||+.+ ++||||||+||+++.++.+||+|||+++..... ........+..|+||
T Consensus 119 ~~l~~~~~~~~~~qi~~al~~LH~~g---i~H~dlkp~Nili~~~~~~kl~dfg~~~~~~~~---~~~~~~~~~~~y~aP 192 (303)
T cd05088 119 STLSSQQLLHFAADVARGMDYLSQKQ---FIHRDLAARNILVGENYVAKIADFGLSRGQEVY---VKKTMGRLPVRWMAI 192 (303)
T ss_pred CcCCHHHHHHHHHHHHHHHHHHHhCC---ccccccchheEEecCCCcEEeCccccCcccchh---hhcccCCCcccccCH
Confidence 46899999999999999999999998 999999999999999999999999998643211 111112245679999
Q ss_pred hhhccCCCCccceEEeehhhhhhhhh-CCCCCCcCCCCchhhhhhhhhhhcCCCcccccCcccCCCCCHHHHHHHHHHHH
Q 045315 337 EYALRGLFSIKSDVFSFGVLLLETLS-SKKNTHFYNTDSLTLLGHAWNLWNDGRTWELMDPISQNGASYPILKRYINVAL 415 (476)
Q Consensus 337 E~l~~~~~s~ksDVwSlGvvl~ellt-G~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~l~~li~ 415 (476)
|++.+..++.++|||||||++||+++ |..||...... ..... ...+... .........+.+++.
T Consensus 193 E~~~~~~~~~~~Di~slG~il~ellt~g~~p~~~~~~~--~~~~~----~~~~~~~---------~~~~~~~~~~~~li~ 257 (303)
T cd05088 193 ESLNYSVYTTNSDVWSYGVLLWEIVSLGGTPYCGMTCA--ELYEK----LPQGYRL---------EKPLNCDDEVYDLMR 257 (303)
T ss_pred HHHhccCCcccccchhhhhHHHHHHhcCCCCcccCChH--HHHHH----HhcCCcC---------CCCCCCCHHHHHHHH
Confidence 99988889999999999999999998 89887543211 11111 1111000 011122346789999
Q ss_pred HchhhcccCCCCHHHHHHHHhccc
Q 045315 416 LCVQEKAADRPAMSEVVSMLSNEF 439 (476)
Q Consensus 416 ~Cl~~dP~~RPt~~eVl~~L~~~~ 439 (476)
+||+.+|++||++.++++.|+.+.
T Consensus 258 ~~l~~~p~~Rp~~~~il~~l~~~~ 281 (303)
T cd05088 258 QCWREKPYERPSFAQILVSLNRML 281 (303)
T ss_pred HHcCCChhhCcCHHHHHHHHHHHH
Confidence 999999999999999999998765
|
Protein Tyrosine Kinase (PTK) family; Tie2; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie2 is a receptor tyr kinase (RTK) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie2 is expressed mainly in endothelial cells and hematopoietic stem cells. It is also found in a subset of tumor-associated monocytes and eosinophils. The angiopoietins (Ang-1 to Ang-4) serve as ligands for Tie2. The binding of A |
| >cd05058 PTKc_Met_Ron Catalytic domain of the Protein Tyrosine Kinases, Met and Ron | Back alignment and domain information |
|---|
Probab=99.92 E-value=1.6e-25 Score=216.27 Aligned_cols=180 Identities=27% Similarity=0.299 Sum_probs=131.7
Q ss_pred ccceeeccCCCCC-------CCCCCChhhHHHHHHHHHHHHHHHhhcCCCceeecCCCccceEecCCCCceeccccceee
Q 045315 242 EISFWYESYNNPT-------KKGLLCWGTRVRIIEGIAQGLLYLHQYSRLRVIHRDLKASNILLDKDMNPKISDFGMARM 314 (476)
Q Consensus 242 ~~~l~~Ey~~~~~-------~~~~L~~~~~~~i~~qIa~gL~yLH~~~~~~ivH~DLkp~NILld~~~~~kL~DFGla~~ 314 (476)
..++++||++... ....+++..++.++.||++||+|||+.+ ++||||||+||+++.++.+||+|||+++.
T Consensus 71 ~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~---i~H~dlk~~nili~~~~~~kl~dfg~~~~ 147 (262)
T cd05058 71 SPLVVLPYMKHGDLRNFIRSETHNPTVKDLIGFGLQVAKGMEYLASKK---FVHRDLAARNCMLDESFTVKVADFGLARD 147 (262)
T ss_pred CcEEEEecCCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCC---ccccccCcceEEEcCCCcEEECCcccccc
Confidence 3567788887322 2345778888999999999999999998 99999999999999999999999999976
Q ss_pred cCCCccc--ccceeeeeccCCCChhhhccCCCCccceEEeehhhhhhhhhCC-CCCCcCCCCchhhhhhhhhhhcCCCcc
Q 045315 315 FGGDELQ--SNTKRIVGTYGYMSPEYALRGLFSIKSDVFSFGVLLLETLSSK-KNTHFYNTDSLTLLGHAWNLWNDGRTW 391 (476)
Q Consensus 315 ~~~~~~~--~~~~~~~gt~~y~aPE~l~~~~~s~ksDVwSlGvvl~elltG~-~p~~~~~~~~~~~~~~~~~~~~~~~~~ 391 (476)
....... .......++..|+|||.+.+..++.++|||||||++|||++|+ +|+.... ........ . .+...
T Consensus 148 ~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~~~~~~~~~~--~~~~~~~~---~-~~~~~ 221 (262)
T cd05058 148 IYDKEYYSVHNHTGAKLPVKWMALESLQTQKFTTKSDVWSFGVLLWELMTRGAPPYPDVD--SFDITVYL---L-QGRRL 221 (262)
T ss_pred ccCCcceeecccccCcCCccccChhHhccCccchHHHHHHHHHHHHHHHcCCCCCCCCCC--HHHHHHHH---h-cCCCC
Confidence 5332111 1111234567899999998888999999999999999999965 4443221 11111111 1 11100
Q ss_pred cccCcccCCCCCHHHHHHHHHHHHHchhhcccCCCCHHHHHHHHhccc
Q 045315 392 ELMDPISQNGASYPILKRYINVALLCVQEKAADRPAMSEVVSMLSNEF 439 (476)
Q Consensus 392 ~~~d~~~~~~~~~~~~~~l~~li~~Cl~~dP~~RPt~~eVl~~L~~~~ 439 (476)
. .+......+.+++.+||+.+|++||++.+|++.|+++.
T Consensus 222 ~---------~~~~~~~~~~~li~~cl~~~p~~Rp~~~~il~~l~~~~ 260 (262)
T cd05058 222 L---------QPEYCPDPLYEVMLSCWHPKPEMRPTFSELVSRIEQIF 260 (262)
T ss_pred C---------CCCcCCHHHHHHHHHHcCCChhhCCCHHHHHHHHHHHh
Confidence 0 01112356889999999999999999999999999865
|
Protein Tyrosine Kinase (PTK) family; Met and Ron; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Met and Ron are receptor tyr kinases (RTKs) composed of an alpha-beta heterodimer. The extracellular alpha chain is disulfide linked to the beta chain, which contains an extracellular ligand-binding region with a sema domain, a PSI domain and four IPT repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Met binds to the ligand, hepatocyte growth factor/scatter factor (HGF/SF), and is also ca |
| >cd05603 STKc_SGK2 Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 2 | Back alignment and domain information |
|---|
Probab=99.92 E-value=1.8e-25 Score=223.44 Aligned_cols=168 Identities=19% Similarity=0.225 Sum_probs=129.2
Q ss_pred cccceeeccCCCCC------CCCCCChhhHHHHHHHHHHHHHHHhhcCCCceeecCCCccceEecCCCCceeccccceee
Q 045315 241 DEISFWYESYNNPT------KKGLLCWGTRVRIIEGIAQGLLYLHQYSRLRVIHRDLKASNILLDKDMNPKISDFGMARM 314 (476)
Q Consensus 241 ~~~~l~~Ey~~~~~------~~~~L~~~~~~~i~~qIa~gL~yLH~~~~~~ivH~DLkp~NILld~~~~~kL~DFGla~~ 314 (476)
+..+++|||++... +.+.++..++..++.||++||+|||+.+ |+||||||+||+++.++.+||+|||+++.
T Consensus 69 ~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~qi~~~L~~lH~~~---ivH~Dlkp~NIll~~~~~~kl~Dfg~~~~ 145 (321)
T cd05603 69 EKLYFVLDYVNGGELFFHLQRERCFLEPRARFYAAEVASAIGYLHSLN---IIYRDLKPENILLDSQGHVVLTDFGLCKE 145 (321)
T ss_pred CEEEEEEcCCCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCC---eEeccCCHHHeEECCCCCEEEccCCCCcc
Confidence 46788999998432 3467889999999999999999999998 99999999999999999999999999875
Q ss_pred cCCCcccccceeeeeccCCCChhhhccCCCCccceEEeehhhhhhhhhCCCCCCcCCCCchhhhhhhhhhhcCCCccccc
Q 045315 315 FGGDELQSNTKRIVGTYGYMSPEYALRGLFSIKSDVFSFGVLLLETLSSKKNTHFYNTDSLTLLGHAWNLWNDGRTWELM 394 (476)
Q Consensus 315 ~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~s~ksDVwSlGvvl~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 394 (476)
..... .......|++.|+|||.+.+..++.++|||||||++|||++|+.||...+. ...... . .....
T Consensus 146 ~~~~~--~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~--~~~~~~---i-~~~~~---- 213 (321)
T cd05603 146 GVEPE--ETTSTFCGTPEYLAPEVLRKEPYDRTVDWWCLGAVLYEMLYGLPPFYSRDV--SQMYDN---I-LHKPL---- 213 (321)
T ss_pred CCCCC--CccccccCCcccCCHHHhcCCCCCCcCcccccchhhhhhhcCCCCCCCCCH--HHHHHH---H-hcCCC----
Confidence 32211 122335689999999999988999999999999999999999999865331 111111 1 11110
Q ss_pred CcccCCCCCHHHHHHHHHHHHHchhhcccCCCCHH
Q 045315 395 DPISQNGASYPILKRYINVALLCVQEKAADRPAMS 429 (476)
Q Consensus 395 d~~~~~~~~~~~~~~l~~li~~Cl~~dP~~RPt~~ 429 (476)
..+......+.+++.+||+.+|++||++.
T Consensus 214 ------~~~~~~~~~~~~li~~~l~~~p~~R~~~~ 242 (321)
T cd05603 214 ------QLPGGKTVAACDLLVGLLHKDQRRRLGAK 242 (321)
T ss_pred ------CCCCCCCHHHHHHHHHHccCCHhhcCCCC
Confidence 01112345688999999999999999764
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3. SGK2 shows a more restricted distribution that SGK1 and is most abundantly expressed in epithelial tissues including kidney, liver, pancreas, and the choroid plexus of the brain. In vitro cellular assays show that SGK2 can stimulate the activity of ion channels, the glutamate transporter EEAT4, and the glutamate receptors, GluR6 and GLUR1. |
| >KOG0605 consensus NDR and related serine/threonine kinases [General function prediction only] | Back alignment and domain information |
|---|
Probab=99.92 E-value=1.7e-25 Score=224.34 Aligned_cols=179 Identities=20% Similarity=0.225 Sum_probs=135.4
Q ss_pred cccccceeeccCCCC------CCCCCCChhhHHHHHHHHHHHHHHHhhcCCCceeecCCCccceEecCCCCceeccccce
Q 045315 239 SKDEISFWYESYNNP------TKKGLLCWGTRVRIIEGIAQGLLYLHQYSRLRVIHRDLKASNILLDKDMNPKISDFGMA 312 (476)
Q Consensus 239 ~~~~~~l~~Ey~~~~------~~~~~L~~~~~~~i~~qIa~gL~yLH~~~~~~ivH~DLkp~NILld~~~~~kL~DFGla 312 (476)
+++-+||+|||+|++ .+...|++..+...+.+++.|+..||+.| +|||||||+|+|||..|++||+|||++
T Consensus 212 D~~~LYLiMEylPGGD~mTLL~~~~~L~e~~arfYiaE~vlAI~~iH~~g---yIHRDIKPdNlLiD~~GHiKLSDFGLs 288 (550)
T KOG0605|consen 212 DKEYLYLIMEYLPGGDMMTLLMRKDTLTEDWARFYIAETVLAIESIHQLG---YIHRDIKPDNLLIDAKGHIKLSDFGLS 288 (550)
T ss_pred CCCeeEEEEEecCCccHHHHHHhcCcCchHHHHHHHHHHHHHHHHHHHcC---cccccCChhheeecCCCCEeecccccc
Confidence 356799999999955 35778999999999999999999999999 999999999999999999999999998
Q ss_pred eecCCC----------------------ccc-----------------------ccceeeeeccCCCChhhhccCCCCcc
Q 045315 313 RMFGGD----------------------ELQ-----------------------SNTKRIVGTYGYMSPEYALRGLFSIK 347 (476)
Q Consensus 313 ~~~~~~----------------------~~~-----------------------~~~~~~~gt~~y~aPE~l~~~~~s~k 347 (476)
.-+... ... ......+||+-|+|||++.+..|+..
T Consensus 289 ~gl~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~w~~nrr~~a~StVGTPDYiAPEVll~kgY~~~ 368 (550)
T KOG0605|consen 289 TGLDKKHRIESYRLDEQMQINLSEAKPSDFPKFNTPRSTMSRREQLQTWKRNRRQLAYSTVGTPDYIAPEVLLGKGYGKE 368 (550)
T ss_pred chhhhhhhhhhhcchhhhhhhhccCCCccccccccccchhhHHHHHHHHHhhhhhhhhcccCCccccchHHHhcCCCCcc
Confidence 643110 000 00123679999999999999999999
Q ss_pred ceEEeehhhhhhhhhCCCCCCcCCCCchhhhhhhhhhhcCCCcccccCcccCCCCCHHHHHHHHHHHHHchhhcccCCCC
Q 045315 348 SDVFSFGVLLLETLSSKKNTHFYNTDSLTLLGHAWNLWNDGRTWELMDPISQNGASYPILKRYINVALLCVQEKAADRPA 427 (476)
Q Consensus 348 sDVwSlGvvl~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~l~~li~~Cl~~dP~~RPt 427 (476)
.|.||||||+|||+.|.+||.........-....|+. .+.-+...+...+..++|.+|+. ||++|.-
T Consensus 369 cDwWSLG~ImyEmLvGyPPF~s~tp~~T~rkI~nwr~------------~l~fP~~~~~s~eA~DLI~rll~-d~~~RLG 435 (550)
T KOG0605|consen 369 CDWWSLGCIMYEMLVGYPPFCSETPQETYRKIVNWRE------------TLKFPEEVDLSDEAKDLITRLLC-DPENRLG 435 (550)
T ss_pred ccHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhh------------hccCCCcCcccHHHHHHHHHHhc-CHHHhcC
Confidence 9999999999999999999986553322111111111 01111112223678899999998 9999975
Q ss_pred ---HHHHHH
Q 045315 428 ---MSEVVS 433 (476)
Q Consensus 428 ---~~eVl~ 433 (476)
++||.+
T Consensus 436 ~~G~~EIK~ 444 (550)
T KOG0605|consen 436 SKGAEEIKK 444 (550)
T ss_pred cccHHHHhc
Confidence 555543
|
|
| >cd05085 PTKc_Fer Catalytic domain of the Protein Tyrosine Kinase, Fer | Back alignment and domain information |
|---|
Probab=99.92 E-value=2.3e-25 Score=213.66 Aligned_cols=177 Identities=28% Similarity=0.293 Sum_probs=134.0
Q ss_pred cccceeeccCCCC-------CCCCCCChhhHHHHHHHHHHHHHHHhhcCCCceeecCCCccceEecCCCCceecccccee
Q 045315 241 DEISFWYESYNNP-------TKKGLLCWGTRVRIIEGIAQGLLYLHQYSRLRVIHRDLKASNILLDKDMNPKISDFGMAR 313 (476)
Q Consensus 241 ~~~~l~~Ey~~~~-------~~~~~L~~~~~~~i~~qIa~gL~yLH~~~~~~ivH~DLkp~NILld~~~~~kL~DFGla~ 313 (476)
+..++++||++.. .+...+++.+++.++.|++.||.|||+.+ ++|+||||+||+++.++.+||+|||++.
T Consensus 65 ~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~---~~H~dl~p~nili~~~~~~~l~d~g~~~ 141 (250)
T cd05085 65 QPIYIVMELVPGGDFLSFLRKKKDELKTKQLVKFALDAAAGMAYLESKN---CIHRDLAARNCLVGENNVLKISDFGMSR 141 (250)
T ss_pred CccEEEEECCCCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCC---eeecccChheEEEcCCCeEEECCCccce
Confidence 4577889998732 23456899999999999999999999998 9999999999999999999999999997
Q ss_pred ecCCCcccccceeeeeccCCCChhhhccCCCCccceEEeehhhhhhhhh-CCCCCCcCCCCchhhhhhhhhhhcCCCccc
Q 045315 314 MFGGDELQSNTKRIVGTYGYMSPEYALRGLFSIKSDVFSFGVLLLETLS-SKKNTHFYNTDSLTLLGHAWNLWNDGRTWE 392 (476)
Q Consensus 314 ~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~s~ksDVwSlGvvl~ellt-G~~p~~~~~~~~~~~~~~~~~~~~~~~~~~ 392 (476)
......... .....++..|+|||++.+..++.++||||||+++||+++ |..||...... .... ....+...
T Consensus 142 ~~~~~~~~~-~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~ll~~~~~~g~~p~~~~~~~--~~~~----~~~~~~~~- 213 (250)
T cd05085 142 QEDDGIYSS-SGLKQIPIKWTAPEALNYGRYSSESDVWSYGILLWETFSLGVCPYPGMTNQ--QARE----QVEKGYRM- 213 (250)
T ss_pred ecccccccc-CCCCCCcccccCHHHhccCCCCchhHHHHHHHHHHHHhcCCCCCCCCCCHH--HHHH----HHHcCCCC-
Confidence 654322111 111234567999999988889999999999999999998 88888643211 1111 11111100
Q ss_pred ccCcccCCCCCHHHHHHHHHHHHHchhhcccCCCCHHHHHHHHh
Q 045315 393 LMDPISQNGASYPILKRYINVALLCVQEKAADRPAMSEVVSMLS 436 (476)
Q Consensus 393 ~~d~~~~~~~~~~~~~~l~~li~~Cl~~dP~~RPt~~eVl~~L~ 436 (476)
.........+.+++.+|++.+|++||++.+++++|.
T Consensus 214 --------~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~l~~~l~ 249 (250)
T cd05085 214 --------SCPQKCPDDVYKVMQRCWDYKPENRPKFSELQKELA 249 (250)
T ss_pred --------CCCCCCCHHHHHHHHHHcccCcccCCCHHHHHHHhc
Confidence 111223467889999999999999999999999885
|
Protein Tyrosine Kinase (PTK) family; Fer kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fer kinase is a member of the Fes subfamily of proteins which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. Fer kinase is expressed in a wide variety of tissues, and is found to reside in both the cytoplasm and the nucleus. It plays important roles in neuronal polarization and neurite development, cytoskeletal reorganization, cell migration, growth factor signaling, and the regulation of cell-c |
| >cd08529 STKc_FA2-like Catalytic domain of the Protein Serine/Threonine Kinase, Chlamydomonas reinhardtii FA2 and similar domains | Back alignment and domain information |
|---|
Probab=99.92 E-value=2.5e-25 Score=213.83 Aligned_cols=174 Identities=26% Similarity=0.314 Sum_probs=135.0
Q ss_pred cccceeeccCCCCC--------CCCCCChhhHHHHHHHHHHHHHHHhhcCCCceeecCCCccceEecCCCCceeccccce
Q 045315 241 DEISFWYESYNNPT--------KKGLLCWGTRVRIIEGIAQGLLYLHQYSRLRVIHRDLKASNILLDKDMNPKISDFGMA 312 (476)
Q Consensus 241 ~~~~l~~Ey~~~~~--------~~~~L~~~~~~~i~~qIa~gL~yLH~~~~~~ivH~DLkp~NILld~~~~~kL~DFGla 312 (476)
+..++++||++... ....+++.++.+++.|++.||.|||+.+ ++|+||||+||+++.++.+||+|||++
T Consensus 72 ~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~i~~~l~~al~~lH~~~---i~h~dl~~~nili~~~~~~~l~df~~~ 148 (256)
T cd08529 72 GKLNIVMEYAENGDLHKLLKMQRGRPLPEDQVWRFFIQILLGLAHLHSKK---ILHRDIKSLNLFLDAYDNVKIGDLGVA 148 (256)
T ss_pred CEEEEEEEeCCCCcHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCCcceEEEeCCCCEEEcccccc
Confidence 45788899987322 2467999999999999999999999998 999999999999999999999999999
Q ss_pred eecCCCcccccceeeeeccCCCChhhhccCCCCccceEEeehhhhhhhhhCCCCCCcCCCCchhhhhhhhhhhcCCCccc
Q 045315 313 RMFGGDELQSNTKRIVGTYGYMSPEYALRGLFSIKSDVFSFGVLLLETLSSKKNTHFYNTDSLTLLGHAWNLWNDGRTWE 392 (476)
Q Consensus 313 ~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~s~ksDVwSlGvvl~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~ 392 (476)
+........ .....++..|+|||+..+..++.++|+||||++++||++|+.||..... ..... ....+...
T Consensus 149 ~~~~~~~~~--~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~--~~~~~----~~~~~~~~- 219 (256)
T cd08529 149 KLLSDNTNF--ANTIVGTPYYLSPELCEDKPYNEKSDVWALGVVLYECCTGKHPFDANNQ--GALIL----KIIRGVFP- 219 (256)
T ss_pred eeccCccch--hhccccCccccCHHHhcCCCCCCccchHHHHHHHHHHHhCCCCCCCCCH--HHHHH----HHHcCCCC-
Confidence 876543222 1224578899999999998899999999999999999999999864431 11111 11111110
Q ss_pred ccCcccCCCCCHHHHHHHHHHHHHchhhcccCCCCHHHHHHH
Q 045315 393 LMDPISQNGASYPILKRYINVALLCVQEKAADRPAMSEVVSM 434 (476)
Q Consensus 393 ~~d~~~~~~~~~~~~~~l~~li~~Cl~~dP~~RPt~~eVl~~ 434 (476)
.........+.+++.+||+.+|++||++.++++.
T Consensus 220 --------~~~~~~~~~~~~~i~~~l~~~p~~Rp~~~~ll~~ 253 (256)
T cd08529 220 --------PVSQMYSQQLAQLIDQCLTKDYRQRPDTFQLLRN 253 (256)
T ss_pred --------CCccccCHHHHHHHHHHccCCcccCcCHHHHhhC
Confidence 1111334578999999999999999999999863
|
Serine/Threonine Kinases (STKs), Chlamydomonas reinhardtii FA2-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Chlamydomonas reinhardtii FA2-like subfamily belongs to the (NIMA)-related kinase (Nek) family. The Nek family includes seven different Chlamydomonas Neks (CNKs 1-6 and Fa2). This subfamily includes FA2 and CNK4. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Chlamydomonas reinhardtii FA2 was discovered in a genetic screen for deflagellation-defective mutants. It is essential for basal-body/centriole-associated microtubule severing, and plays a role in cell cyc |
| >cd07853 STKc_NLK Catalytic domain of the Serine/Threonine Kinase, Nemo-Like Kinase | Back alignment and domain information |
|---|
Probab=99.92 E-value=2.5e-25 Score=227.05 Aligned_cols=187 Identities=21% Similarity=0.250 Sum_probs=132.4
Q ss_pred ccceeeccCCCC-----CCCCCCChhhHHHHHHHHHHHHHHHhhcCCCceeecCCCccceEecCCCCceeccccceeecC
Q 045315 242 EISFWYESYNNP-----TKKGLLCWGTRVRIIEGIAQGLLYLHQYSRLRVIHRDLKASNILLDKDMNPKISDFGMARMFG 316 (476)
Q Consensus 242 ~~~l~~Ey~~~~-----~~~~~L~~~~~~~i~~qIa~gL~yLH~~~~~~ivH~DLkp~NILld~~~~~kL~DFGla~~~~ 316 (476)
.+++++||+... .....+++.++..++.||+.||+|||+.+ ++||||||+|||++.++.+||+|||+++...
T Consensus 78 ~~~lv~e~~~~~l~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~~---ivH~dlkp~Nili~~~~~~kL~Dfg~a~~~~ 154 (372)
T cd07853 78 EIYVVTELMQSDLHKIIVSPQPLSSDHVKVFLYQILRGLKYLHSAG---ILHRDIKPGNLLVNSNCVLKICDFGLARVEE 154 (372)
T ss_pred eEEEEeeccccCHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCC---eeCCCCChHHEEECCCCCEEeccccceeecc
Confidence 567888998721 23567999999999999999999999999 9999999999999999999999999998654
Q ss_pred CCcccccceeeeeccCCCChhhhccC-CCCccceEEeehhhhhhhhhCCCCCCcCCCCchhhhhhhhhhhcCCCcc----
Q 045315 317 GDELQSNTKRIVGTYGYMSPEYALRG-LFSIKSDVFSFGVLLLETLSSKKNTHFYNTDSLTLLGHAWNLWNDGRTW---- 391 (476)
Q Consensus 317 ~~~~~~~~~~~~gt~~y~aPE~l~~~-~~s~ksDVwSlGvvl~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~---- 391 (476)
...... .....++..|+|||.+.+. .++.++|||||||++|||++|+.||....... ...............
T Consensus 155 ~~~~~~-~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~--~~~~i~~~~g~~~~~~~~~ 231 (372)
T cd07853 155 PDESKH-MTQEVVTQYYRAPEILMGSRHYTSAVDIWSVGCIFAELLGRRILFQAQSPIQ--QLDLITDLLGTPSLEAMRS 231 (372)
T ss_pred cCcccc-CCCCCcCCCcCCHHHHcCCCCCCcHHHHHhHHHHHHHHHcCCCCCCCCCHHH--HHHHHHHHcCCCCHHHHHH
Confidence 322111 1224578899999998864 47999999999999999999999986543111 000000000000000
Q ss_pred -------ccc----Cc-cc--CCCCCHHHHHHHHHHHHHchhhcccCCCCHHHHHHH
Q 045315 392 -------ELM----DP-IS--QNGASYPILKRYINVALLCVQEKAADRPAMSEVVSM 434 (476)
Q Consensus 392 -------~~~----d~-~~--~~~~~~~~~~~l~~li~~Cl~~dP~~RPt~~eVl~~ 434 (476)
.+. .+ .. .........+.+.+++.+||+.||++|||+.|+++.
T Consensus 232 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~mL~~dP~~R~t~~e~l~h 288 (372)
T cd07853 232 ACEGARAHILRGPHKPPSLPVLYTLSSQATHEAVHLLCRMLVFDPDKRISAADALAH 288 (372)
T ss_pred hhHHHHHHHHhCCCCCCchHHhcccCCCCCHHHHHHHHHhCCCChhhCcCHHHHhcC
Confidence 000 00 00 000111224578899999999999999999999863
|
Serine/Threonine Kinases (STKs), Nemo-Like Kinase (NLK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NLK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Mitogen-activated protein kinases (MAPKs) are important mediators of cellular responses to extracellular signals. NLK is an atypical MAPK that is not regulated by a MAPK kinase. It functions downstream of the MAPK kinase kinase Tak1, which also plays a role in activating the JNK and p38 MAPKs. The Tak1/NLK pathways are regulated by Wnts, a family of secreted proteins that is critical in the control of asymmetric division and cell polarity. NLK can phosphorylate transcription |
| >cd05615 STKc_cPKC_alpha Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C alpha | Back alignment and domain information |
|---|
Probab=99.92 E-value=4.3e-25 Score=220.98 Aligned_cols=167 Identities=25% Similarity=0.357 Sum_probs=129.3
Q ss_pred cccceeeccCCCCC------CCCCCChhhHHHHHHHHHHHHHHHhhcCCCceeecCCCccceEecCCCCceeccccceee
Q 045315 241 DEISFWYESYNNPT------KKGLLCWGTRVRIIEGIAQGLLYLHQYSRLRVIHRDLKASNILLDKDMNPKISDFGMARM 314 (476)
Q Consensus 241 ~~~~l~~Ey~~~~~------~~~~L~~~~~~~i~~qIa~gL~yLH~~~~~~ivH~DLkp~NILld~~~~~kL~DFGla~~ 314 (476)
+..+++|||++.+. +.+.+++.++..++.||+.||+|||+++ |+||||||+|||++.++.+||+|||+++.
T Consensus 74 ~~~~lv~Ey~~~g~L~~~i~~~~~l~~~~~~~i~~qi~~al~~lH~~~---ivHrDikp~Nill~~~~~ikL~Dfg~~~~ 150 (323)
T cd05615 74 DRLYFVMEYVNGGDLMYHIQQVGKFKEPQAVFYAAEISVGLFFLHRRG---IIYRDLKLDNVMLDSEGHIKIADFGMCKE 150 (323)
T ss_pred CEEEEEEcCCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCC---eeccCCCHHHeEECCCCCEEEeccccccc
Confidence 45789999998432 3467999999999999999999999998 99999999999999999999999999875
Q ss_pred cCCCcccccceeeeeccCCCChhhhccCCCCccceEEeehhhhhhhhhCCCCCCcCCCCchhhhhhhhhhhcCCCccccc
Q 045315 315 FGGDELQSNTKRIVGTYGYMSPEYALRGLFSIKSDVFSFGVLLLETLSSKKNTHFYNTDSLTLLGHAWNLWNDGRTWELM 394 (476)
Q Consensus 315 ~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~s~ksDVwSlGvvl~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 394 (476)
...... ......|+..|+|||++.+..++.++|+|||||++|||++|+.||..... ...... .. ....
T Consensus 151 ~~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslGvil~elltG~~pf~~~~~--~~~~~~---i~-~~~~---- 218 (323)
T cd05615 151 HMVDGV--TTRTFCGTPDYIAPEIIAYQPYGKSVDWWAYGVLLYEMLAGQPPFDGEDE--DELFQS---IM-EHNV---- 218 (323)
T ss_pred cCCCCc--cccCccCCccccCHHHHcCCCCCCccchhhhHHHHHHHHhCCCCCCCCCH--HHHHHH---HH-hCCC----
Confidence 432211 12234689999999999988999999999999999999999999865432 111111 11 1110
Q ss_pred CcccCCCCCHHHHHHHHHHHHHchhhcccCCCCH
Q 045315 395 DPISQNGASYPILKRYINVALLCVQEKAADRPAM 428 (476)
Q Consensus 395 d~~~~~~~~~~~~~~l~~li~~Cl~~dP~~RPt~ 428 (476)
..+......+.+++.+||+.+|.+|++.
T Consensus 219 ------~~p~~~~~~~~~li~~~l~~~p~~R~~~ 246 (323)
T cd05615 219 ------SYPKSLSKEAVSICKGLMTKHPSKRLGC 246 (323)
T ss_pred ------CCCccCCHHHHHHHHHHcccCHhhCCCC
Confidence 0111223567899999999999999974
|
Serine/Threonine Kinases (STKs), Classical Protein Kinase C (cPKC) subfamily, alpha isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. There are four cPKC isoforms, named alpha, betaI, betaII, a |
| >PTZ00426 cAMP-dependent protein kinase catalytic subunit; Provisional | Back alignment and domain information |
|---|
Probab=99.92 E-value=3.1e-25 Score=223.67 Aligned_cols=188 Identities=20% Similarity=0.227 Sum_probs=141.6
Q ss_pred cccceeeccCCCCC------CCCCCChhhHHHHHHHHHHHHHHHhhcCCCceeecCCCccceEecCCCCceeccccceee
Q 045315 241 DEISFWYESYNNPT------KKGLLCWGTRVRIIEGIAQGLLYLHQYSRLRVIHRDLKASNILLDKDMNPKISDFGMARM 314 (476)
Q Consensus 241 ~~~~l~~Ey~~~~~------~~~~L~~~~~~~i~~qIa~gL~yLH~~~~~~ivH~DLkp~NILld~~~~~kL~DFGla~~ 314 (476)
+..+++|||++.+. +.+.+++..+..++.||+.||+|||+.+ |+||||||+|||++.++.+||+|||++..
T Consensus 104 ~~~~lv~Ey~~~g~L~~~i~~~~~~~~~~~~~~~~qi~~aL~~LH~~~---ivHrDLkp~NILl~~~~~ikL~DFG~a~~ 180 (340)
T PTZ00426 104 SYLYLVLEFVIGGEFFTFLRRNKRFPNDVGCFYAAQIVLIFEYLQSLN---IVYRDLKPENLLLDKDGFIKMTDFGFAKV 180 (340)
T ss_pred CEEEEEEeCCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCC---eEccCCCHHHEEECCCCCEEEecCCCCee
Confidence 45788999998432 3567999999999999999999999999 99999999999999999999999999987
Q ss_pred cCCCcccccceeeeeccCCCChhhhccCCCCccceEEeehhhhhhhhhCCCCCCcCCCCchhhhhhhhhhhcCCCccccc
Q 045315 315 FGGDELQSNTKRIVGTYGYMSPEYALRGLFSIKSDVFSFGVLLLETLSSKKNTHFYNTDSLTLLGHAWNLWNDGRTWELM 394 (476)
Q Consensus 315 ~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~s~ksDVwSlGvvl~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 394 (476)
.... .....||+.|+|||++.+..++.++|+|||||++|||++|+.||..... ..... ....+.. .
T Consensus 181 ~~~~-----~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvil~ell~G~~Pf~~~~~--~~~~~----~i~~~~~-~-- 246 (340)
T PTZ00426 181 VDTR-----TYTLCGTPEYIAPEILLNVGHGKAADWWTLGIFIYEILVGCPPFYANEP--LLIYQ----KILEGII-Y-- 246 (340)
T ss_pred cCCC-----cceecCChhhcCHHHHhCCCCCccccccchhhHHHHHhcCCCCCCCCCH--HHHHH----HHhcCCC-C--
Confidence 6432 2235789999999999988899999999999999999999999864321 11111 1111111 0
Q ss_pred CcccCCCCCHHHHHHHHHHHHHchhhcccCCC-----CHHHHHHH--Hhcc------ccCCCCCCCCccee
Q 045315 395 DPISQNGASYPILKRYINVALLCVQEKAADRP-----AMSEVVSM--LSNE------FVNLPAPQQPAFSC 452 (476)
Q Consensus 395 d~~~~~~~~~~~~~~l~~li~~Cl~~dP~~RP-----t~~eVl~~--L~~~------~~~~~~p~~p~~~~ 452 (476)
.+......+.+++.+|++.||++|+ +++++++. +.+. ...++.|..|.+..
T Consensus 247 -------~p~~~~~~~~~li~~~l~~dp~~R~~~~~~~~~~~~~hp~f~~~~~~~~~~~~~~~~~~p~~~~ 310 (340)
T PTZ00426 247 -------FPKFLDNNCKHLMKKLLSHDLTKRYGNLKKGAQNVKEHPWFGNIDWVSLLHKNVEVPYKPKYKN 310 (340)
T ss_pred -------CCCCCCHHHHHHHHHHcccCHHHcCCCCCCCHHHHHcCCCcCCCCHHHHHhCCCCCCcCCCCCC
Confidence 0111234578999999999999995 88888764 2221 12456666676543
|
|
| >cd05073 PTKc_Hck Catalytic domain of the Protein Tyrosine Kinase, Hematopoietic cell kinase | Back alignment and domain information |
|---|
Probab=99.92 E-value=4.3e-25 Score=213.46 Aligned_cols=178 Identities=25% Similarity=0.392 Sum_probs=135.5
Q ss_pred cccceeeccCCCC--------CCCCCCChhhHHHHHHHHHHHHHHHhhcCCCceeecCCCccceEecCCCCceeccccce
Q 045315 241 DEISFWYESYNNP--------TKKGLLCWGTRVRIIEGIAQGLLYLHQYSRLRVIHRDLKASNILLDKDMNPKISDFGMA 312 (476)
Q Consensus 241 ~~~~l~~Ey~~~~--------~~~~~L~~~~~~~i~~qIa~gL~yLH~~~~~~ivH~DLkp~NILld~~~~~kL~DFGla 312 (476)
+.+++++||++.. .....+++.+++.++.|++.||+|||+.+ ++|+||||+||+++.++.+||+|||.+
T Consensus 73 ~~~~~v~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~l~~aL~~lH~~~---i~H~dl~p~ni~i~~~~~~~l~d~~~~ 149 (260)
T cd05073 73 EPIYIITEFMAKGSLLDFLKSDEGSKQPLPKLIDFSAQIAEGMAFIEQRN---YIHRDLRAANILVSASLVCKIADFGLA 149 (260)
T ss_pred CCeEEEEEeCCCCcHHHHHHhCCccccCHHHHHHHHHHHHHHHHHHHhCC---ccccccCcceEEEcCCCcEEECCCcce
Confidence 3578889998732 23456889999999999999999999998 999999999999999999999999999
Q ss_pred eecCCCcccccceeeeeccCCCChhhhccCCCCccceEEeehhhhhhhhh-CCCCCCcCCCCchhhhhhhhhhhcCCCcc
Q 045315 313 RMFGGDELQSNTKRIVGTYGYMSPEYALRGLFSIKSDVFSFGVLLLETLS-SKKNTHFYNTDSLTLLGHAWNLWNDGRTW 391 (476)
Q Consensus 313 ~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~s~ksDVwSlGvvl~ellt-G~~p~~~~~~~~~~~~~~~~~~~~~~~~~ 391 (476)
..+....... .....++..|+|||++....++.++|+|||||++|++++ |+.||...... .... ....+...
T Consensus 150 ~~~~~~~~~~-~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~~l~~l~t~g~~p~~~~~~~--~~~~----~~~~~~~~ 222 (260)
T cd05073 150 RVIEDNEYTA-REGAKFPIKWTAPEAINFGSFTIKSDVWSFGILLMEIVTYGRIPYPGMSNP--EVIR----ALERGYRM 222 (260)
T ss_pred eeccCCCccc-ccCCcccccccCHhHhccCCcCccccchHHHHHHHHHHhcCCCCCCCCCHH--HHHH----HHhCCCCC
Confidence 8765332211 112345678999999988889999999999999999998 88887643211 1111 11111110
Q ss_pred cccCcccCCCCCHHHHHHHHHHHHHchhhcccCCCCHHHHHHHHhc
Q 045315 392 ELMDPISQNGASYPILKRYINVALLCVQEKAADRPAMSEVVSMLSN 437 (476)
Q Consensus 392 ~~~d~~~~~~~~~~~~~~l~~li~~Cl~~dP~~RPt~~eVl~~L~~ 437 (476)
.........+.+++.+|++.+|++||++.++.+.|+.
T Consensus 223 ---------~~~~~~~~~~~~~i~~~l~~~p~~Rp~~~~l~~~L~~ 259 (260)
T cd05073 223 ---------PRPENCPEELYNIMMRCWKNRPEERPTFEYIQSVLDD 259 (260)
T ss_pred ---------CCcccCCHHHHHHHHHHcccCcccCcCHHHHHHHHhc
Confidence 0112234568899999999999999999999999975
|
Protein Tyrosine Kinase (PTK) family; Hematopoietic cell kinase (Hck); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Hck is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pa |
| >PLN00113 leucine-rich repeat receptor-like protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=99.92 E-value=5.4e-25 Score=251.02 Aligned_cols=192 Identities=21% Similarity=0.326 Sum_probs=146.6
Q ss_pred cccceeeccCCCCCC---CCCCChhhHHHHHHHHHHHHHHHhhcCCCceeecCCCccceEecCCCCceeccccceeecCC
Q 045315 241 DEISFWYESYNNPTK---KGLLCWGTRVRIIEGIAQGLLYLHQYSRLRVIHRDLKASNILLDKDMNPKISDFGMARMFGG 317 (476)
Q Consensus 241 ~~~~l~~Ey~~~~~~---~~~L~~~~~~~i~~qIa~gL~yLH~~~~~~ivH~DLkp~NILld~~~~~kL~DFGla~~~~~ 317 (476)
+..+++|||++++.- -..++|.++.+++.||++||+|||..+...|+||||||+||+++.++.+++. |+.......
T Consensus 756 ~~~~lv~Ey~~~g~L~~~l~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~dlkp~Nil~~~~~~~~~~-~~~~~~~~~ 834 (968)
T PLN00113 756 KGAYLIHEYIEGKNLSEVLRNLSWERRRKIAIGIAKALRFLHCRCSPAVVVGNLSPEKIIIDGKDEPHLR-LSLPGLLCT 834 (968)
T ss_pred CCCEEEEeCCCCCcHHHHHhcCCHHHHHHHHHHHHHHHHHhccCCCCCeecCCCCHHhEEECCCCceEEE-ecccccccc
Confidence 457899999985432 1248999999999999999999996544559999999999999998888875 555543221
Q ss_pred CcccccceeeeeccCCCChhhhccCCCCccceEEeehhhhhhhhhCCCCCCcCCCCchhhhhhhhhhhcCCCcccccCcc
Q 045315 318 DELQSNTKRIVGTYGYMSPEYALRGLFSIKSDVFSFGVLLLETLSSKKNTHFYNTDSLTLLGHAWNLWNDGRTWELMDPI 397 (476)
Q Consensus 318 ~~~~~~~~~~~gt~~y~aPE~l~~~~~s~ksDVwSlGvvl~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~ 397 (476)
. ....++..|+|||++.+..++.++|||||||++|||++|+.|+............++............+|+.
T Consensus 835 ~------~~~~~t~~y~aPE~~~~~~~~~~sDv~S~Gvvl~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 908 (968)
T PLN00113 835 D------TKCFISSAYVAPETRETKDITEKSDIYGFGLILIELLTGKSPADAEFGVHGSIVEWARYCYSDCHLDMWIDPS 908 (968)
T ss_pred C------CCccccccccCcccccCCCCCcccchhhHHHHHHHHHhCCCCCCcccCCCCcHHHHHHHhcCccchhheeCcc
Confidence 1 1235788999999999999999999999999999999999998543333333444444333334444455555
Q ss_pred cCC--CCCHHHHHHHHHHHHHchhhcccCCCCHHHHHHHHhccc
Q 045315 398 SQN--GASYPILKRYINVALLCVQEKAADRPAMSEVVSMLSNEF 439 (476)
Q Consensus 398 ~~~--~~~~~~~~~l~~li~~Cl~~dP~~RPt~~eVl~~L~~~~ 439 (476)
... ....++..++.+++.+||+.||++||+|+||+++|+++.
T Consensus 909 ~~~~~~~~~~~~~~~~~l~~~Cl~~~P~~RPt~~evl~~L~~~~ 952 (968)
T PLN00113 909 IRGDVSVNQNEIVEVMNLALHCTATDPTARPCANDVLKTLESAS 952 (968)
T ss_pred ccCCCCccHHHHHHHHHHHHhhCcCCchhCcCHHHHHHHHHHhh
Confidence 433 234566778899999999999999999999999999875
|
|
| >PTZ00284 protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=99.92 E-value=1.3e-25 Score=235.98 Aligned_cols=184 Identities=21% Similarity=0.256 Sum_probs=128.0
Q ss_pred ccceeeccCCC-----CCCCCCCChhhHHHHHHHHHHHHHHHhh-cCCCceeecCCCccceEecCCC-------------
Q 045315 242 EISFWYESYNN-----PTKKGLLCWGTRVRIIEGIAQGLLYLHQ-YSRLRVIHRDLKASNILLDKDM------------- 302 (476)
Q Consensus 242 ~~~l~~Ey~~~-----~~~~~~L~~~~~~~i~~qIa~gL~yLH~-~~~~~ivH~DLkp~NILld~~~------------- 302 (476)
..++++|++.. ..+.+.+++.++..|+.||+.||+|||+ .+ ||||||||+|||++.++
T Consensus 206 ~~~iv~~~~g~~l~~~l~~~~~l~~~~~~~i~~qi~~aL~yLH~~~g---IiHrDlKP~NILl~~~~~~~~~~~~~~~~~ 282 (467)
T PTZ00284 206 HMCIVMPKYGPCLLDWIMKHGPFSHRHLAQIIFQTGVALDYFHTELH---LMHTDLKPENILMETSDTVVDPVTNRALPP 282 (467)
T ss_pred eEEEEEeccCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHhcCC---eecCCCCHHHEEEecCCcccccccccccCC
Confidence 35667777652 1234679999999999999999999998 47 99999999999998765
Q ss_pred ---CceeccccceeecCCCcccccceeeeeccCCCChhhhccCCCCccceEEeehhhhhhhhhCCCCCCcCCCCc-hhhh
Q 045315 303 ---NPKISDFGMARMFGGDELQSNTKRIVGTYGYMSPEYALRGLFSIKSDVFSFGVLLLETLSSKKNTHFYNTDS-LTLL 378 (476)
Q Consensus 303 ---~~kL~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~s~ksDVwSlGvvl~elltG~~p~~~~~~~~-~~~~ 378 (476)
.+||+|||.+..... ......||..|+|||++.+..++.++|||||||++|||++|+.||....... ....
T Consensus 283 ~~~~vkl~DfG~~~~~~~-----~~~~~~gt~~Y~APE~~~~~~~~~~~DiwSlGvil~elltG~~pf~~~~~~~~~~~i 357 (467)
T PTZ00284 283 DPCRVRICDLGGCCDERH-----SRTAIVSTRHYRSPEVVLGLGWMYSTDMWSMGCIIYELYTGKLLYDTHDNLEHLHLM 357 (467)
T ss_pred CCceEEECCCCccccCcc-----ccccccCCccccCcHHhhcCCCCcHHHHHHHHHHHHHHHhCCCCCCCCChHHHHHHH
Confidence 489999998754221 1223578999999999999999999999999999999999999997543211 1111
Q ss_pred hhhhh-----------------hhcC-CCcccccCcc-----cC--CCCCHHHHHHHHHHHHHchhhcccCCCCHHHHHH
Q 045315 379 GHAWN-----------------LWND-GRTWELMDPI-----SQ--NGASYPILKRYINVALLCVQEKAADRPAMSEVVS 433 (476)
Q Consensus 379 ~~~~~-----------------~~~~-~~~~~~~d~~-----~~--~~~~~~~~~~l~~li~~Cl~~dP~~RPt~~eVl~ 433 (476)
..... .+.. +......++. .. ..........+++++.+||+.||++|||++|+++
T Consensus 358 ~~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dli~~mL~~dP~~R~ta~e~L~ 437 (467)
T PTZ00284 358 EKTLGRLPSEWAGRCGTEEARLLYNSAGQLRPCTDPKHLARIARARPVREVIRDDLLCDLIYGLLHYDRQKRLNARQMTT 437 (467)
T ss_pred HHHcCCCCHHHHhhccchhHHHHhhhcccccccCCHHHHHhhhcccchhhhhchHHHHHHHHHhCCcChhhCCCHHHHhc
Confidence 00000 0000 0000000000 00 0000112356789999999999999999999986
|
|
| >cd07876 STKc_JNK2 Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 2 | Back alignment and domain information |
|---|
Probab=99.92 E-value=3.5e-25 Score=224.79 Aligned_cols=187 Identities=20% Similarity=0.169 Sum_probs=132.4
Q ss_pred ccceeeccCCCCC---CCCCCChhhHHHHHHHHHHHHHHHhhcCCCceeecCCCccceEecCCCCceeccccceeecCCC
Q 045315 242 EISFWYESYNNPT---KKGLLCWGTRVRIIEGIAQGLLYLHQYSRLRVIHRDLKASNILLDKDMNPKISDFGMARMFGGD 318 (476)
Q Consensus 242 ~~~l~~Ey~~~~~---~~~~L~~~~~~~i~~qIa~gL~yLH~~~~~~ivH~DLkp~NILld~~~~~kL~DFGla~~~~~~ 318 (476)
..+++|||++... ....++..++..++.||+.||+|||+++ |+||||||+||+++.++.+||+|||+++.....
T Consensus 100 ~~~lv~e~~~~~l~~~~~~~~~~~~~~~~~~qi~~~L~~LH~~~---ivHrDlkp~NIl~~~~~~~kl~Dfg~a~~~~~~ 176 (359)
T cd07876 100 DVYLVMELMDANLCQVIHMELDHERMSYLLYQMLCGIKHLHSAG---IIHRDLKPSNIVVKSDCTLKILDFGLARTACTN 176 (359)
T ss_pred eeEEEEeCCCcCHHHHHhccCCHHHHHHHHHHHHHHHHHHHhCC---cccCCCCHHHEEECCCCCEEEecCCCccccccC
Confidence 3578899987321 1345889999999999999999999999 999999999999999999999999999764332
Q ss_pred cccccceeeeeccCCCChhhhccCCCCccceEEeehhhhhhhhhCCCCCCcCCCCch-------------hhhh----hh
Q 045315 319 ELQSNTKRIVGTYGYMSPEYALRGLFSIKSDVFSFGVLLLETLSSKKNTHFYNTDSL-------------TLLG----HA 381 (476)
Q Consensus 319 ~~~~~~~~~~gt~~y~aPE~l~~~~~s~ksDVwSlGvvl~elltG~~p~~~~~~~~~-------------~~~~----~~ 381 (476)
. ......++..|+|||.+.+..++.++|||||||++|||++|+.||...+.... .... ..
T Consensus 177 ~---~~~~~~~t~~y~aPE~~~~~~~~~~~DiwSlG~il~el~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 253 (359)
T cd07876 177 F---MMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGELVKGSVIFQGTDHIDQWNKVIEQLGTPSAEFMNRLQPTV 253 (359)
T ss_pred c---cCCCCcccCCCCCchhccCCCCCcchhhHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhcCCCcHHHHHHHHHHH
Confidence 2 12234688999999999999999999999999999999999999875431100 0000 00
Q ss_pred hhhhcCCC------cccccCccc---CCCCCHHHHHHHHHHHHHchhhcccCCCCHHHHHHH
Q 045315 382 WNLWNDGR------TWELMDPIS---QNGASYPILKRYINVALLCVQEKAADRPAMSEVVSM 434 (476)
Q Consensus 382 ~~~~~~~~------~~~~~d~~~---~~~~~~~~~~~l~~li~~Cl~~dP~~RPt~~eVl~~ 434 (476)
........ ..+...... ...........+.+++.+||+.||++|||+.|+++.
T Consensus 254 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~mL~~dP~~R~t~~e~l~h 315 (359)
T cd07876 254 RNYVENRPQYPGISFEELFPDWIFPSESERDKLKTSQARDLLSKMLVIDPDKRISVDEALRH 315 (359)
T ss_pred HHHHhhCCCCCCcchhhhccccccccccccccccchhHHHHHHHHhccCcccCCCHHHHhcC
Confidence 00000000 000000000 000111123567899999999999999999999873
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 2 (JNK2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK1, like JNK2, is expressed in every cell and tissue type. Initially it was thought that JNK1 and JNK2 were functionally redundant as mice deficient in either genes (Jn |
| >cd05077 PTK_Jak1_rpt1 Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinase, Janus kinase 1 | Back alignment and domain information |
|---|
Probab=99.92 E-value=4.6e-25 Score=213.95 Aligned_cols=170 Identities=21% Similarity=0.269 Sum_probs=127.5
Q ss_pred cccceeeccCCCC-------CCCCCCChhhHHHHHHHHHHHHHHHhhcCCCceeecCCCccceEecCCCC-------cee
Q 045315 241 DEISFWYESYNNP-------TKKGLLCWGTRVRIIEGIAQGLLYLHQYSRLRVIHRDLKASNILLDKDMN-------PKI 306 (476)
Q Consensus 241 ~~~~l~~Ey~~~~-------~~~~~L~~~~~~~i~~qIa~gL~yLH~~~~~~ivH~DLkp~NILld~~~~-------~kL 306 (476)
...++++||++.. .+...+++..+++++.||++||+|||+++ |+||||||+|||++.++. +|+
T Consensus 77 ~~~~lv~e~~~~~~l~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~---ivH~dlkp~Nill~~~~~~~~~~~~~~l 153 (262)
T cd05077 77 VENIMVEEFVEFGPLDLFMHRKSDVLTTPWKFKVAKQLASALSYLEDKD---LVHGNVCTKNILLAREGIDGECGPFIKL 153 (262)
T ss_pred CCCEEEEecccCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHhhhCC---eECCCCCcccEEEecCCccCCCCceeEe
Confidence 4567889998732 23457999999999999999999999998 999999999999987664 799
Q ss_pred ccccceeecCCCcccccceeeeeccCCCChhhhc-cCCCCccceEEeehhhhhhhh-hCCCCCCcCCCCchhhhhhhhhh
Q 045315 307 SDFGMARMFGGDELQSNTKRIVGTYGYMSPEYAL-RGLFSIKSDVFSFGVLLLETL-SSKKNTHFYNTDSLTLLGHAWNL 384 (476)
Q Consensus 307 ~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~l~-~~~~s~ksDVwSlGvvl~ell-tG~~p~~~~~~~~~~~~~~~~~~ 384 (476)
+|||++...... ....++..|+|||.+. +..++.++|||||||++|||+ .|+.|+........ . ..
T Consensus 154 ~d~g~~~~~~~~------~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~~l~el~~~~~~p~~~~~~~~~--~----~~ 221 (262)
T cd05077 154 SDPGIPITVLSR------QECVERIPWIAPECVEDSKNLSIAADKWSFGTTLWEICYNGEIPLKDKTLAEK--E----RF 221 (262)
T ss_pred CCCCCCccccCc------ccccccccccChhhhcCCCCCCchhHHHHHHHHHHHHHhCCCCCCCCcchhHH--H----HH
Confidence 999998754321 1245778899999887 467899999999999999998 47776643221110 0 00
Q ss_pred hcCCCcccccCcccCCCCCHHHHHHHHHHHHHchhhcccCCCCHHHHHHHHh
Q 045315 385 WNDGRTWELMDPISQNGASYPILKRYINVALLCVQEKAADRPAMSEVVSMLS 436 (476)
Q Consensus 385 ~~~~~~~~~~d~~~~~~~~~~~~~~l~~li~~Cl~~dP~~RPt~~eVl~~L~ 436 (476)
. .+.. .. ..+....+.+++.+||+.||.+||++.+|++.|+
T Consensus 222 ~-~~~~-~~---------~~~~~~~~~~li~~cl~~dp~~Rp~~~~il~~~~ 262 (262)
T cd05077 222 Y-EGQC-ML---------VTPSCKELADLMTHCMNYDPNQRPFFRAIMRDIN 262 (262)
T ss_pred H-hcCc-cC---------CCCChHHHHHHHHHHcCCChhhCcCHHHHHHhcC
Confidence 0 1100 00 1112356889999999999999999999998763
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 1 (Jak1); pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak1 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalytic dom |
| >cd05057 PTKc_EGFR_like Catalytic domain of Epidermal Growth Factor Receptor-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=99.92 E-value=3.3e-25 Score=216.58 Aligned_cols=181 Identities=23% Similarity=0.301 Sum_probs=136.3
Q ss_pred ccceeeccCCCC-------CCCCCCChhhHHHHHHHHHHHHHHHhhcCCCceeecCCCccceEecCCCCceeccccceee
Q 045315 242 EISFWYESYNNP-------TKKGLLCWGTRVRIIEGIAQGLLYLHQYSRLRVIHRDLKASNILLDKDMNPKISDFGMARM 314 (476)
Q Consensus 242 ~~~l~~Ey~~~~-------~~~~~L~~~~~~~i~~qIa~gL~yLH~~~~~~ivH~DLkp~NILld~~~~~kL~DFGla~~ 314 (476)
..++++||++.+ .....+++..++.++.||+.||+|||+.+ ++|+||||+||+++.++.+||+|||+++.
T Consensus 82 ~~~~v~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~qi~~~l~~LH~~~---i~H~di~p~nil~~~~~~~kL~dfg~~~~ 158 (279)
T cd05057 82 QVQLITQLMPLGCLLDYVRNHKDNIGSQYLLNWCVQIAKGMSYLEEKR---LVHRDLAARNVLVKTPQHVKITDFGLAKL 158 (279)
T ss_pred ceEEEEecCCCCcHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHhCC---EEecccCcceEEEcCCCeEEECCCccccc
Confidence 566788888732 23456999999999999999999999988 99999999999999999999999999987
Q ss_pred cCCCcccccceeeeeccCCCChhhhccCCCCccceEEeehhhhhhhhh-CCCCCCcCCCCchhhhhhhhhhhcCCCcccc
Q 045315 315 FGGDELQSNTKRIVGTYGYMSPEYALRGLFSIKSDVFSFGVLLLETLS-SKKNTHFYNTDSLTLLGHAWNLWNDGRTWEL 393 (476)
Q Consensus 315 ~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~s~ksDVwSlGvvl~ellt-G~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~ 393 (476)
..............++..|+|||.+....++.++|+||||+++||+++ |+.|+...... .+.. ....+...
T Consensus 159 ~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~~~~~~--~~~~----~~~~~~~~-- 230 (279)
T cd05057 159 LDVDEKEYHAEGGKVPIKWMALESILHRIYTHKSDVWSYGVTVWELMTFGAKPYEGIPAV--EIPD----LLEKGERL-- 230 (279)
T ss_pred ccCcccceecCCCcccccccCHHHhhcCCcCchhhHHHHHHHHHHHhcCCCCCCCCCCHH--HHHH----HHhCCCCC--
Confidence 653322111111223568999999988889999999999999999998 99988643321 1111 11111110
Q ss_pred cCcccCCCCCHHHHHHHHHHHHHchhhcccCCCCHHHHHHHHhcccc
Q 045315 394 MDPISQNGASYPILKRYINVALLCVQEKAADRPAMSEVVSMLSNEFV 440 (476)
Q Consensus 394 ~d~~~~~~~~~~~~~~l~~li~~Cl~~dP~~RPt~~eVl~~L~~~~~ 440 (476)
..+......+.+++.+||..+|++||++.++++.|+.+..
T Consensus 231 -------~~~~~~~~~~~~~~~~~l~~~p~~Rp~~~~l~~~l~~~~~ 270 (279)
T cd05057 231 -------PQPPICTIDVYMVLVKCWMIDAESRPTFKELINEFSKMAR 270 (279)
T ss_pred -------CCCCCCCHHHHHHHHHHcCCChhhCCCHHHHHHHHHHHHh
Confidence 0011122467889999999999999999999999998753
|
Protein Tyrosine Kinase (PTK) family; Epidermal Growth Factor Receptor (EGFR) subfamily; catalytic (c) domain. EGFR (HER, ErbB) subfamily members include EGFR (HER1, ErbB1), HER2 (ErbB2), HER3 (ErbB3), HER4 (ErbB4), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The EGFR proteins are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instea |
| >cd05040 PTKc_Ack_like Catalytic domain of the Protein Tyrosine Kinase, Activated Cdc42-associated kinase | Back alignment and domain information |
|---|
Probab=99.91 E-value=3.8e-25 Score=213.06 Aligned_cols=178 Identities=28% Similarity=0.351 Sum_probs=134.0
Q ss_pred ccceeeccCCCC--------CCCCCCChhhHHHHHHHHHHHHHHHhhcCCCceeecCCCccceEecCCCCceecccccee
Q 045315 242 EISFWYESYNNP--------TKKGLLCWGTRVRIIEGIAQGLLYLHQYSRLRVIHRDLKASNILLDKDMNPKISDFGMAR 313 (476)
Q Consensus 242 ~~~l~~Ey~~~~--------~~~~~L~~~~~~~i~~qIa~gL~yLH~~~~~~ivH~DLkp~NILld~~~~~kL~DFGla~ 313 (476)
..++++||++.. .....+++..+..++.|+++||+|||+.+ ++|+||||+||+++.++.+||+|||+++
T Consensus 69 ~~~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~qi~~~L~~lH~~~---i~H~di~p~nil~~~~~~~kl~dfg~~~ 145 (257)
T cd05040 69 PLMMVTELAPLGSLLDRLRKDALGHFLISTLCDYAVQIANGMRYLESKR---FIHRDLAARNILLASDDKVKIGDFGLMR 145 (257)
T ss_pred eEEEEEEecCCCcHHHHHHhcccccCcHHHHHHHHHHHHHHHHHHHhCC---ccccccCcccEEEecCCEEEeccccccc
Confidence 467788888622 11157899999999999999999999998 9999999999999999999999999998
Q ss_pred ecCCCccc-ccceeeeeccCCCChhhhccCCCCccceEEeehhhhhhhhh-CCCCCCcCCCCchhhhhhhhhhhcCCCcc
Q 045315 314 MFGGDELQ-SNTKRIVGTYGYMSPEYALRGLFSIKSDVFSFGVLLLETLS-SKKNTHFYNTDSLTLLGHAWNLWNDGRTW 391 (476)
Q Consensus 314 ~~~~~~~~-~~~~~~~gt~~y~aPE~l~~~~~s~ksDVwSlGvvl~ellt-G~~p~~~~~~~~~~~~~~~~~~~~~~~~~ 391 (476)
.+...... .......++..|+|||++.+..++.++|||||||++|||++ |+.|+...... ...... .......
T Consensus 146 ~~~~~~~~~~~~~~~~~~~~y~~pE~~~~~~~~~~~Di~slG~~l~el~t~g~~p~~~~~~~--~~~~~~---~~~~~~~ 220 (257)
T cd05040 146 ALPQNEDHYVMEEHLKVPFAWCAPESLRTRTFSHASDVWMFGVTLWEMFTYGEEPWAGLSGS--QILKKI---DKEGERL 220 (257)
T ss_pred cccccccceecccCCCCCceecCHHHhcccCcCchhhhHHHHHHHHHHHhCCCCCCCCCCHH--HHHHHH---HhcCCcC
Confidence 76542211 11122456788999999998899999999999999999998 99987533211 111111 0011000
Q ss_pred cccCcccCCCCCHHHHHHHHHHHHHchhhcccCCCCHHHHHHHHh
Q 045315 392 ELMDPISQNGASYPILKRYINVALLCVQEKAADRPAMSEVVSMLS 436 (476)
Q Consensus 392 ~~~d~~~~~~~~~~~~~~l~~li~~Cl~~dP~~RPt~~eVl~~L~ 436 (476)
..+......+.+++.+|++.+|++||++.+|++.|.
T Consensus 221 ---------~~~~~~~~~~~~li~~~l~~~p~~Rps~~~~~~~l~ 256 (257)
T cd05040 221 ---------ERPEACPQDIYNVMLQCWAHNPADRPTFAALREFLP 256 (257)
T ss_pred ---------CCCccCCHHHHHHHHHHCCCCcccCCCHHHHHHHhc
Confidence 001122457889999999999999999999999885
|
Protein Tyrosine Kinase (PTK) family; Activated Cdc42-associated kinase (Ack) subfamily; catalytic (c) domain. Ack subfamily members include Ack1, thirty-eight-negative kinase 1 (Tnk1), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ack subfamily members are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal catalytic domain, an SH3 domain, a Cdc42-binding CRIB domain, and a proline-rich region. They are mainly expressed in brain and skeletal tissues and are involved in the regulation of cell adhesion and growth, receptor degradation, and axonal guidance. Ack1 is also associated with and |
| >cd05065 PTKc_EphR_B Catalytic domain of the Protein Tyrosine Kinases, Class EphB Ephrin Receptors | Back alignment and domain information |
|---|
Probab=99.91 E-value=3.8e-25 Score=214.81 Aligned_cols=180 Identities=24% Similarity=0.388 Sum_probs=133.5
Q ss_pred cccceeeccCCCC-------CCCCCCChhhHHHHHHHHHHHHHHHhhcCCCceeecCCCccceEecCCCCceecccccee
Q 045315 241 DEISFWYESYNNP-------TKKGLLCWGTRVRIIEGIAQGLLYLHQYSRLRVIHRDLKASNILLDKDMNPKISDFGMAR 313 (476)
Q Consensus 241 ~~~~l~~Ey~~~~-------~~~~~L~~~~~~~i~~qIa~gL~yLH~~~~~~ivH~DLkp~NILld~~~~~kL~DFGla~ 313 (476)
+..++++||++.. .+.+.+++.+++.++.|++.||+|||+.+ ++|+||||+||+++.++.+||+|||++.
T Consensus 78 ~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~~l~~al~~lH~~g---~~H~dl~p~nili~~~~~~kl~dfg~~~ 154 (269)
T cd05065 78 RPVMIITEFMENGALDSFLRQNDGQFTVIQLVGMLRGIAAGMKYLSEMN---YVHRDLAARNILVNSNLVCKVSDFGLSR 154 (269)
T ss_pred CceEEEEecCCCCcHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHHCC---EeecccChheEEEcCCCcEEECCCcccc
Confidence 3567888998732 23456899999999999999999999998 9999999999999999999999999987
Q ss_pred ecCCCcccccceeee---eccCCCChhhhccCCCCccceEEeehhhhhhhhh-CCCCCCcCCCCchhhhhhhhhhhcCCC
Q 045315 314 MFGGDELQSNTKRIV---GTYGYMSPEYALRGLFSIKSDVFSFGVLLLETLS-SKKNTHFYNTDSLTLLGHAWNLWNDGR 389 (476)
Q Consensus 314 ~~~~~~~~~~~~~~~---gt~~y~aPE~l~~~~~s~ksDVwSlGvvl~ellt-G~~p~~~~~~~~~~~~~~~~~~~~~~~ 389 (476)
............... .+..|+|||.+.+..++.++|||||||++||+++ |..||..... ....... ....
T Consensus 155 ~~~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~DvwslG~~l~e~l~~g~~p~~~~~~--~~~~~~i----~~~~ 228 (269)
T cd05065 155 FLEDDTSDPTYTSSLGGKIPIRWTAPEAIAYRKFTSASDVWSYGIVMWEVMSYGERPYWDMSN--QDVINAI----EQDY 228 (269)
T ss_pred ccccCccccccccccCCCcceeecCHhHhccCcccchhhhhhhHHHHHHHhcCCCCCCCCCCH--HHHHHHH----HcCC
Confidence 654332211111111 1357999999998899999999999999999886 8888754321 1111111 1100
Q ss_pred cccccCcccCCCCCHHHHHHHHHHHHHchhhcccCCCCHHHHHHHHhcc
Q 045315 390 TWELMDPISQNGASYPILKRYINVALLCVQEKAADRPAMSEVVSMLSNE 438 (476)
Q Consensus 390 ~~~~~d~~~~~~~~~~~~~~l~~li~~Cl~~dP~~RPt~~eVl~~L~~~ 438 (476)
.. ..+......+.+++.+||+.+|++||++.+|+.+|+..
T Consensus 229 --~~-------~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~i~~~l~~~ 268 (269)
T cd05065 229 --RL-------PPPMDCPTALHQLMLDCWQKDRNARPKFGQIVSTLDKM 268 (269)
T ss_pred --cC-------CCcccCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHhh
Confidence 00 01112235678999999999999999999999999864
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; class EphB receptors; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). Class EphB receptors bind to transmembrane ephrin-B ligands. There are six vertebrate EhpB receptors (EphB1-6), which display promiscuous interactions with three ephrin-B ligands. One exception is EphB2, which also interacts with ephrin A5. EphRs contain an ephrin-binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephr |
| >cd05061 PTKc_InsR Catalytic domain of the Protein Tyrosine Kinase, Insulin Receptor | Back alignment and domain information |
|---|
Probab=99.91 E-value=2.7e-25 Score=218.35 Aligned_cols=180 Identities=25% Similarity=0.382 Sum_probs=133.2
Q ss_pred ccceeeccCCCC----------------CCCCCCChhhHHHHHHHHHHHHHHHhhcCCCceeecCCCccceEecCCCCce
Q 045315 242 EISFWYESYNNP----------------TKKGLLCWGTRVRIIEGIAQGLLYLHQYSRLRVIHRDLKASNILLDKDMNPK 305 (476)
Q Consensus 242 ~~~l~~Ey~~~~----------------~~~~~L~~~~~~~i~~qIa~gL~yLH~~~~~~ivH~DLkp~NILld~~~~~k 305 (476)
..+++|||++.+ .....+++..+.+++.||+.||+|||+++ ++||||||+||+++.++.+|
T Consensus 83 ~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~---i~H~dikp~nili~~~~~~~ 159 (288)
T cd05061 83 PTLVVMELMAHGDLKSYLRSLRPEAENNPGRPPPTLQEMIQMAAEIADGMAYLNAKK---FVHRDLAARNCMVAHDFTVK 159 (288)
T ss_pred CcEEEEeCCCCCCHHHHHHHhccccccCCCCCCCCHHHHHHHHHHHHHHHHHHHhCC---CcCCCCChheEEEcCCCcEE
Confidence 467778887621 11345677888999999999999999998 99999999999999999999
Q ss_pred eccccceeecCCCcccccceeeeeccCCCChhhhccCCCCccceEEeehhhhhhhhh-CCCCCCcCCCCchhhhhhhhhh
Q 045315 306 ISDFGMARMFGGDELQSNTKRIVGTYGYMSPEYALRGLFSIKSDVFSFGVLLLETLS-SKKNTHFYNTDSLTLLGHAWNL 384 (476)
Q Consensus 306 L~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~s~ksDVwSlGvvl~ellt-G~~p~~~~~~~~~~~~~~~~~~ 384 (476)
|+|||+++...............++..|+|||.+.++.++.++|+|||||++||+++ |..|+...... .... .
T Consensus 160 L~Dfg~~~~~~~~~~~~~~~~~~~~~~y~~pE~~~~~~~~~~~DvwslG~~l~el~~~~~~p~~~~~~~--~~~~----~ 233 (288)
T cd05061 160 IGDFGMTRDIYETDYYRKGGKGLLPVRWMAPESLKDGVFTTSSDMWSFGVVLWEITSLAEQPYQGLSNE--QVLK----F 233 (288)
T ss_pred ECcCCccccccccccccccCCCcccccccCHHHhccCCCChHhHHHHHHHHHHHHHhCCCCCCCCCCHH--HHHH----H
Confidence 999999986543222222222345678999999998899999999999999999998 67776532211 1111 1
Q ss_pred hcCCCcccccCcccCCCCCHHHHHHHHHHHHHchhhcccCCCCHHHHHHHHhccc
Q 045315 385 WNDGRTWELMDPISQNGASYPILKRYINVALLCVQEKAADRPAMSEVVSMLSNEF 439 (476)
Q Consensus 385 ~~~~~~~~~~d~~~~~~~~~~~~~~l~~li~~Cl~~dP~~RPt~~eVl~~L~~~~ 439 (476)
...+.... .+......+.+++.+||+.+|++||++.++++.|+...
T Consensus 234 ~~~~~~~~---------~~~~~~~~~~~li~~~l~~~p~~Rps~~~ll~~l~~~~ 279 (288)
T cd05061 234 VMDGGYLD---------QPDNCPERVTDLMRMCWQFNPKMRPTFLEIVNLLKDDL 279 (288)
T ss_pred HHcCCCCC---------CCCCCCHHHHHHHHHHcCCChhHCcCHHHHHHHHHhhc
Confidence 11111111 01122357899999999999999999999999998854
|
Protein Tyrosine Kinase (PTK) family; Insulin Receptor (InsR); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. InsR is a receptor tyr kinase (RTK) that is composed of two alphabeta heterodimers. Binding of the insulin ligand to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, stimulating downstream kinase activities, which initiate signaling cascades and biological function. InsR signaling plays an important role in many cellular processes including glucose homeostasis, glycogen synthesis, lipid and protein meta |
| >cd07872 STKc_PCTAIRE2 Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-2 kinase | Back alignment and domain information |
|---|
Probab=99.91 E-value=2.3e-25 Score=221.20 Aligned_cols=188 Identities=20% Similarity=0.279 Sum_probs=131.3
Q ss_pred cccceeeccCCC------CCCCCCCChhhHHHHHHHHHHHHHHHhhcCCCceeecCCCccceEecCCCCceeccccceee
Q 045315 241 DEISFWYESYNN------PTKKGLLCWGTRVRIIEGIAQGLLYLHQYSRLRVIHRDLKASNILLDKDMNPKISDFGMARM 314 (476)
Q Consensus 241 ~~~~l~~Ey~~~------~~~~~~L~~~~~~~i~~qIa~gL~yLH~~~~~~ivH~DLkp~NILld~~~~~kL~DFGla~~ 314 (476)
+..+++|||++. ...+..+++.++..++.||+.||+|||+.+ |+||||||+||+++.++.+||+|||+++.
T Consensus 77 ~~~~lv~e~~~~~l~~~~~~~~~~~~~~~~~~~~~qi~~aL~~lH~~~---ivH~dlkp~Nill~~~~~~kl~Dfg~~~~ 153 (309)
T cd07872 77 KSLTLVFEYLDKDLKQYMDDCGNIMSMHNVKIFLYQILRGLAYCHRRK---VLHRDLKPQNLLINERGELKLADFGLARA 153 (309)
T ss_pred CeEEEEEeCCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCCHHHEEECCCCCEEECcccccee
Confidence 457788899872 122446899999999999999999999998 99999999999999999999999999976
Q ss_pred cCCCcccccceeeeeccCCCChhhhcc-CCCCccceEEeehhhhhhhhhCCCCCCcCCCCch-hhhhhh--------hhh
Q 045315 315 FGGDELQSNTKRIVGTYGYMSPEYALR-GLFSIKSDVFSFGVLLLETLSSKKNTHFYNTDSL-TLLGHA--------WNL 384 (476)
Q Consensus 315 ~~~~~~~~~~~~~~gt~~y~aPE~l~~-~~~s~ksDVwSlGvvl~elltG~~p~~~~~~~~~-~~~~~~--------~~~ 384 (476)
....... .....++..|+|||.+.+ ..++.++|||||||++|||++|+.||........ ...... +..
T Consensus 154 ~~~~~~~--~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~el~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~ 231 (309)
T cd07872 154 KSVPTKT--YSNEVVTLWYRPPDVLLGSSEYSTQIDMWGVGCIFFEMASGRPLFPGSTVEDELHLIFRLLGTPTEETWPG 231 (309)
T ss_pred cCCCccc--cccccccccccCCHHHhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCHHHHhh
Confidence 5332211 122457889999998865 4689999999999999999999999875432111 110000 000
Q ss_pred hcCCCcccccC-cccCC----CCCHHHHHHHHHHHHHchhhcccCCCCHHHHHH
Q 045315 385 WNDGRTWELMD-PISQN----GASYPILKRYINVALLCVQEKAADRPAMSEVVS 433 (476)
Q Consensus 385 ~~~~~~~~~~d-~~~~~----~~~~~~~~~l~~li~~Cl~~dP~~RPt~~eVl~ 433 (476)
+.........+ +.... .........+.+++.+||+.||++|||+.|+++
T Consensus 232 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~t~~e~l~ 285 (309)
T cd07872 232 ISSNDEFKNYNFPKYKPQPLINHAPRLDTEGIELLTKFLQYESKKRISAEEAMK 285 (309)
T ss_pred hcchhhhhhhhcCccCCCchhhhccCCCHHHHHHHHHhccCChhhCCCHHHHhc
Confidence 00000000000 00000 001122456789999999999999999999886
|
Serine/Threonine Kinases (STKs), PCTAIRE-2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-2 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-2 is specifically expressed in neurons in the central nervous system, mainly in terminally differentiated neurons. It associates with Trap (Tudor repeat associator with PCTAIRE-2) and could play |
| >cd06654 STKc_PAK1 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 1 | Back alignment and domain information |
|---|
Probab=99.91 E-value=3.2e-25 Score=219.04 Aligned_cols=175 Identities=24% Similarity=0.347 Sum_probs=133.3
Q ss_pred cccceeeccCCCCC-----CCCCCChhhHHHHHHHHHHHHHHHhhcCCCceeecCCCccceEecCCCCceeccccceeec
Q 045315 241 DEISFWYESYNNPT-----KKGLLCWGTRVRIIEGIAQGLLYLHQYSRLRVIHRDLKASNILLDKDMNPKISDFGMARMF 315 (476)
Q Consensus 241 ~~~~l~~Ey~~~~~-----~~~~L~~~~~~~i~~qIa~gL~yLH~~~~~~ivH~DLkp~NILld~~~~~kL~DFGla~~~ 315 (476)
+..++++||++... ....+++.++..++.|++.||+|||+.+ |+|+||||+||+++.++.+||+|||++...
T Consensus 90 ~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~i~~ql~~aL~~LH~~g---i~H~dLkp~Nill~~~~~~kl~dfg~~~~~ 166 (296)
T cd06654 90 DELWVVMEYLAGGSLTDVVTETCMDEGQIAAVCRECLQALEFLHSNQ---VIHRDIKSDNILLGMDGSVKLTDFGFCAQI 166 (296)
T ss_pred CEEEEeecccCCCCHHHHHHhcCCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCCHHHEEEcCCCCEEECccccchhc
Confidence 45788999998432 2346899999999999999999999998 999999999999999999999999998765
Q ss_pred CCCcccccceeeeeccCCCChhhhccCCCCccceEEeehhhhhhhhhCCCCCCcCCCCchhhhhhhhhhhcCCCcccccC
Q 045315 316 GGDELQSNTKRIVGTYGYMSPEYALRGLFSIKSDVFSFGVLLLETLSSKKNTHFYNTDSLTLLGHAWNLWNDGRTWELMD 395 (476)
Q Consensus 316 ~~~~~~~~~~~~~gt~~y~aPE~l~~~~~s~ksDVwSlGvvl~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~d 395 (476)
...... .....++..|+|||.+.+..++.++|||||||++|+|++|+.||........ .. .....+.. .
T Consensus 167 ~~~~~~--~~~~~~~~~y~aPE~~~~~~~~~~~Dv~s~Gvil~~l~~g~~pf~~~~~~~~-~~----~~~~~~~~-~--- 235 (296)
T cd06654 167 TPEQSK--RSTMVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMIEGEPPYLNENPLRA-LY----LIATNGTP-E--- 235 (296)
T ss_pred cccccc--cCcccCCccccCHHHHcCCCCCccchHHHHHHHHHHHHhCCCCCCCCCHHHh-HH----HHhcCCCC-C---
Confidence 432211 1224578899999999888899999999999999999999999864332111 00 01111100 0
Q ss_pred cccCCCCCHHHHHHHHHHHHHchhhcccCCCCHHHHHH
Q 045315 396 PISQNGASYPILKRYINVALLCVQEKAADRPAMSEVVS 433 (476)
Q Consensus 396 ~~~~~~~~~~~~~~l~~li~~Cl~~dP~~RPt~~eVl~ 433 (476)
. .........+.+++.+||+.+|++||++.++++
T Consensus 236 --~--~~~~~~~~~l~~li~~~l~~~p~~Rpt~~eil~ 269 (296)
T cd06654 236 --L--QNPEKLSAIFRDFLNRCLDMDVEKRGSAKELLQ 269 (296)
T ss_pred --C--CCccccCHHHHHHHHHHCcCCcccCcCHHHHhh
Confidence 0 111223456889999999999999999999987
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 1, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK1 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding |
| >cd08223 STKc_Nek4 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 4 | Back alignment and domain information |
|---|
Probab=99.91 E-value=7.7e-25 Score=210.78 Aligned_cols=172 Identities=24% Similarity=0.332 Sum_probs=133.4
Q ss_pred ccceeeccCCCC--------CCCCCCChhhHHHHHHHHHHHHHHHhhcCCCceeecCCCccceEecCCCCceecccccee
Q 045315 242 EISFWYESYNNP--------TKKGLLCWGTRVRIIEGIAQGLLYLHQYSRLRVIHRDLKASNILLDKDMNPKISDFGMAR 313 (476)
Q Consensus 242 ~~~l~~Ey~~~~--------~~~~~L~~~~~~~i~~qIa~gL~yLH~~~~~~ivH~DLkp~NILld~~~~~kL~DFGla~ 313 (476)
..++++||++.. .....+++.++..++.|++.||++||+.+ ++|+||||+||+++.++.++|+|||++.
T Consensus 74 ~~~lv~e~~~~~~l~~~l~~~~~~~l~~~~~~~~~~~l~~~l~~lH~~~---i~H~di~p~nil~~~~~~~~l~df~~~~ 150 (257)
T cd08223 74 LLYIVMGFCEGGDLYHKLKEQKGKLLPENQVVEWFVQIAMALQYLHEKH---ILHRDLKTQNVFLTRTNIIKVGDLGIAR 150 (257)
T ss_pred EEEEEecccCCCcHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCC---eeccCCCchhEEEecCCcEEEecccceE
Confidence 356888998732 23456899999999999999999999999 9999999999999999999999999998
Q ss_pred ecCCCcccccceeeeeccCCCChhhhccCCCCccceEEeehhhhhhhhhCCCCCCcCCCCchhhhhhhhhhhcCCCcccc
Q 045315 314 MFGGDELQSNTKRIVGTYGYMSPEYALRGLFSIKSDVFSFGVLLLETLSSKKNTHFYNTDSLTLLGHAWNLWNDGRTWEL 393 (476)
Q Consensus 314 ~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~s~ksDVwSlGvvl~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~ 393 (476)
....... ......++..|+|||.+.+..++.++|+||||++++++++|+.||....... . .... ..+...
T Consensus 151 ~~~~~~~--~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~~l~~g~~~~~~~~~~~--~---~~~~-~~~~~~-- 220 (257)
T cd08223 151 VLENQCD--MASTLIGTPYYMSPELFSNKPYNYKSDVWALGCCVYEMATLKHAFNAKDMNS--L---VYRI-IEGKLP-- 220 (257)
T ss_pred EecccCC--ccccccCCcCccChhHhcCCCCCchhhhHHHHHHHHHHHcCCCCCCCCCHHH--H---HHHH-HhcCCC--
Confidence 7643321 1223467889999999999889999999999999999999999886432111 1 1111 111110
Q ss_pred cCcccCCCCCHHHHHHHHHHHHHchhhcccCCCCHHHHHH
Q 045315 394 MDPISQNGASYPILKRYINVALLCVQEKAADRPAMSEVVS 433 (476)
Q Consensus 394 ~d~~~~~~~~~~~~~~l~~li~~Cl~~dP~~RPt~~eVl~ 433 (476)
.........+.+++.+|++.+|++||++.++++
T Consensus 221 -------~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~~l~ 253 (257)
T cd08223 221 -------PMPKDYSPELGELIATMLSKRPEKRPSVKSILR 253 (257)
T ss_pred -------CCccccCHHHHHHHHHHhccCcccCCCHHHHhc
Confidence 112234467889999999999999999999875
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 4 (Nek4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek4 subfamily is one of a family of 11 different Neks (Nek1-11). The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Neks are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. Nek4 is highly abundant in the testis. Its specific function is unknown. |
| >PHA03209 serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Probab=99.91 E-value=4.2e-25 Score=224.18 Aligned_cols=120 Identities=27% Similarity=0.369 Sum_probs=100.7
Q ss_pred ccceeeccCCC------CCCCCCCChhhHHHHHHHHHHHHHHHhhcCCCceeecCCCccceEecCCCCceeccccceeec
Q 045315 242 EISFWYESYNN------PTKKGLLCWGTRVRIIEGIAQGLLYLHQYSRLRVIHRDLKASNILLDKDMNPKISDFGMARMF 315 (476)
Q Consensus 242 ~~~l~~Ey~~~------~~~~~~L~~~~~~~i~~qIa~gL~yLH~~~~~~ivH~DLkp~NILld~~~~~kL~DFGla~~~ 315 (476)
..++++||+.. ....+.+++.++..|+.||+.||+|||+++ |+||||||+|||++.++.+||+|||+++..
T Consensus 131 ~~~lv~e~~~~~l~~~l~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~---ivHrDlkp~Nill~~~~~~kl~DfG~a~~~ 207 (357)
T PHA03209 131 ITCMVLPHYSSDLYTYLTKRSRPLPIDQALIIEKQILEGLRYLHAQR---IIHRDVKTENIFINDVDQVCIGDLGAAQFP 207 (357)
T ss_pred eeEEEEEccCCcHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCCHHHEEECCCCCEEEecCcccccc
Confidence 45677777762 123567999999999999999999999998 999999999999999999999999999753
Q ss_pred CCCcccccceeeeeccCCCChhhhccCCCCccceEEeehhhhhhhhhCCCCC
Q 045315 316 GGDELQSNTKRIVGTYGYMSPEYALRGLFSIKSDVFSFGVLLLETLSSKKNT 367 (476)
Q Consensus 316 ~~~~~~~~~~~~~gt~~y~aPE~l~~~~~s~ksDVwSlGvvl~elltG~~p~ 367 (476)
.... ......|+..|+|||++.+..++.++|||||||++|||+++..++
T Consensus 208 ~~~~---~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvvl~ell~~~~~~ 256 (357)
T PHA03209 208 VVAP---AFLGLAGTVETNAPEVLARDKYNSKADIWSAGIVLFEMLAYPSTI 256 (357)
T ss_pred ccCc---ccccccccccccCCeecCCCCCCchhhHHHHHHHHHHHHHcCCcc
Confidence 3221 122356899999999999989999999999999999999876654
|
|
| >cd05042 PTKc_Aatyk Catalytic domain of the Protein Tyrosine Kinases, Apoptosis-associated tyrosine kinases | Back alignment and domain information |
|---|
Probab=99.91 E-value=5.7e-25 Score=213.57 Aligned_cols=182 Identities=22% Similarity=0.271 Sum_probs=126.9
Q ss_pred cccceeeccCCCCC-----------CCCCCChhhHHHHHHHHHHHHHHHhhcCCCceeecCCCccceEecCCCCceeccc
Q 045315 241 DEISFWYESYNNPT-----------KKGLLCWGTRVRIIEGIAQGLLYLHQYSRLRVIHRDLKASNILLDKDMNPKISDF 309 (476)
Q Consensus 241 ~~~~l~~Ey~~~~~-----------~~~~L~~~~~~~i~~qIa~gL~yLH~~~~~~ivH~DLkp~NILld~~~~~kL~DF 309 (476)
+..+++|||++.+. ....+++.....++.||+.||+|||+.+ |+||||||+||+++.++.+||+||
T Consensus 68 ~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~---ivH~dlkp~Nill~~~~~~kl~df 144 (269)
T cd05042 68 IPYLLVLEFCPLGDLKNYLRSNRGMVAQMAQKDVLQRMACEVASGLLWLHQAD---FIHSDLALRNCQLTADLSVKIGDY 144 (269)
T ss_pred CceEEEEEeCCCCcHHHHHHhccccccccccHHHHHHHHHHHHHHHHHHHhcC---EecccccHhheEecCCCcEEEecc
Confidence 45788999997321 1233567888999999999999999998 999999999999999999999999
Q ss_pred cceeecCCCcccccceeeeeccCCCChhhhcc-------CCCCccceEEeehhhhhhhhh-CCCCCCcCCCCchhhhhhh
Q 045315 310 GMARMFGGDELQSNTKRIVGTYGYMSPEYALR-------GLFSIKSDVFSFGVLLLETLS-SKKNTHFYNTDSLTLLGHA 381 (476)
Q Consensus 310 Gla~~~~~~~~~~~~~~~~gt~~y~aPE~l~~-------~~~s~ksDVwSlGvvl~ellt-G~~p~~~~~~~~~~~~~~~ 381 (476)
|++................++..|+|||+... ..++.++|||||||++|||++ |..|+...... ....
T Consensus 145 g~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~~DiwslG~~l~el~~~~~~p~~~~~~~--~~~~-- 220 (269)
T cd05042 145 GLALEQYPEDYYITKDCHAVPLRWLAPELVEIRGQDLLPKDQTKKSNIWSLGVTMWELFTAADQPYPDLSDE--QVLK-- 220 (269)
T ss_pred ccccccccchheeccCCCCCcccccCHHHHhhccccccccccchhhHHHHHHHHHHHHHhCCCCCCCcCCHH--HHHH--
Confidence 99875432221111122345678999998753 356889999999999999999 67776543211 1111
Q ss_pred hhhhcCCCcccccCcccCCCCCHHHHHHHHHHHHHchhhcccCCCCHHHHHHHHh
Q 045315 382 WNLWNDGRTWELMDPISQNGASYPILKRYINVALLCVQEKAADRPAMSEVVSMLS 436 (476)
Q Consensus 382 ~~~~~~~~~~~~~d~~~~~~~~~~~~~~l~~li~~Cl~~dP~~RPt~~eVl~~L~ 436 (476)
...... ......+.. .......+.+++..|+ .||++||++++|++.|.
T Consensus 221 -~~~~~~-~~~~~~~~~----~~~~~~~~~~~~~~~~-~dp~~Rpt~~~v~~~l~ 268 (269)
T cd05042 221 -QVVREQ-DIKLPKPQL----DLKYSDRWYEVMQFCW-LDPETRPTAEEVHELLT 268 (269)
T ss_pred -HHhhcc-CccCCCCcc----cccCCHHHHHHHHHHh-cCcccccCHHHHHHHhc
Confidence 111111 111222211 1223355667888888 59999999999999874
|
Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase (Aatyk) subfamily; catalytic (c) domain. The Aatyk subfamily is also referred to as the lemur tyrosine kinase (Lmtk) subfamily. It consists of Aatyk1 (Lmtk1), Aatyk2 (Lmtk2, Brek), Aatyk3 (Lmtk3), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk proteins are mostly receptor tyr kinases (RTKs) containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk1 does not contain a transmembrane segment and is a cytoplasmic (or nonreceptor) kinase. Aatyk proteins are classified as tyr kina |
| >KOG0597 consensus Serine-threonine protein kinase FUSED [General function prediction only] | Back alignment and domain information |
|---|
Probab=99.91 E-value=1.2e-25 Score=225.67 Aligned_cols=192 Identities=24% Similarity=0.304 Sum_probs=150.6
Q ss_pred cccceeeccCCC-----CCCCCCCChhhHHHHHHHHHHHHHHHhhcCCCceeecCCCccceEecCCCCceeccccceeec
Q 045315 241 DEISFWYESYNN-----PTKKGLLCWGTRVRIIEGIAQGLLYLHQYSRLRVIHRDLKASNILLDKDMNPKISDFGMARMF 315 (476)
Q Consensus 241 ~~~~l~~Ey~~~-----~~~~~~L~~~~~~~i~~qIa~gL~yLH~~~~~~ivH~DLkp~NILld~~~~~kL~DFGla~~~ 315 (476)
....+|.||+.. ....+.|+++.+..|+.+++.||.|||+.+ |+|||+||+|||++..+.+|+||||+|+.+
T Consensus 74 ~~~~vVte~a~g~L~~il~~d~~lpEe~v~~~a~~LVsaL~yLhs~r---ilhrd~kPqniLl~~~~~~KlcdFg~Ar~m 150 (808)
T KOG0597|consen 74 AHLWVVTEYAVGDLFTILEQDGKLPEEQVRAIAYDLVSALYYLHSNR---ILHRDMKPQNILLEKGGTLKLCDFGLARAM 150 (808)
T ss_pred ceEEEEehhhhhhHHHHHHhccCCCHHHHHHHHHHHHHHHHHHHhcC---cccccCCcceeeecCCCceeechhhhhhhc
Confidence 467778898873 235678999999999999999999999998 999999999999999999999999999987
Q ss_pred CCCcccccceeeeeccCCCChhhhccCCCCccceEEeehhhhhhhhhCCCCCCcCCCCchhhhhhhhhhhcCCCcccccC
Q 045315 316 GGDELQSNTKRIVGTYGYMSPEYALRGLFSIKSDVFSFGVLLLETLSSKKNTHFYNTDSLTLLGHAWNLWNDGRTWELMD 395 (476)
Q Consensus 316 ~~~~~~~~~~~~~gt~~y~aPE~l~~~~~s~ksDVwSlGvvl~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~d 395 (476)
..+. .......||+.|||||...+++|+..+|.||+||++||+++|++||.... +.+.+.....+
T Consensus 151 ~~~t--~vltsikGtPlYmAPElv~e~pyd~~sDlWslGcilYE~~~G~PPF~a~s-----i~~Lv~~I~~d-------- 215 (808)
T KOG0597|consen 151 STNT--SVLTSIKGTPLYMAPELVEEQPYDHTSDLWSLGCILYELYVGQPPFYARS-----ITQLVKSILKD-------- 215 (808)
T ss_pred ccCc--eeeeeccCcccccCHHHHcCCCccchhhHHHHHHHHHHHhcCCCCchHHH-----HHHHHHHHhcC--------
Confidence 6543 23445789999999999999999999999999999999999999986321 11111111111
Q ss_pred cccCCCCCHHHHHHHHHHHHHchhhcccCCCCHHHHHHH--HhccccCCCCCCCCcceec
Q 045315 396 PISQNGASYPILKRYINVALLCVQEKAADRPAMSEVVSM--LSNEFVNLPAPQQPAFSCV 453 (476)
Q Consensus 396 ~~~~~~~~~~~~~~l~~li~~Cl~~dP~~RPt~~eVl~~--L~~~~~~~~~p~~p~~~~~ 453 (476)
+ ...+......+..++...|++||.+|.+..+++.. .++....+..|..|.+...
T Consensus 216 ~---v~~p~~~S~~f~nfl~gLL~kdP~~RltW~~Ll~HpF~k~~~~~~~~~~~~a~~sp 272 (808)
T KOG0597|consen 216 P---VKPPSTASSSFVNFLQGLLIKDPAQRLTWTDLLGHPFWKGKINIAELPAQVAFDSP 272 (808)
T ss_pred C---CCCcccccHHHHHHHHHHhhcChhhcccHHHHhcChHHhhhhhhhcccccccccCc
Confidence 1 01223556788999999999999999999998753 4444445566666666543
|
|
| >cd05037 PTK_Jak_rpt1 Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinases, Janus kinases | Back alignment and domain information |
|---|
Probab=99.91 E-value=7.2e-25 Score=211.06 Aligned_cols=169 Identities=21% Similarity=0.288 Sum_probs=128.1
Q ss_pred ccceeeccCCCCC-------CCCCCChhhHHHHHHHHHHHHHHHhhcCCCceeecCCCccceEecCCC-------Cceec
Q 045315 242 EISFWYESYNNPT-------KKGLLCWGTRVRIIEGIAQGLLYLHQYSRLRVIHRDLKASNILLDKDM-------NPKIS 307 (476)
Q Consensus 242 ~~~l~~Ey~~~~~-------~~~~L~~~~~~~i~~qIa~gL~yLH~~~~~~ivH~DLkp~NILld~~~-------~~kL~ 307 (476)
..++++||++... ....+++..++.++.||+.||+|||+.+ |+||||||+||+++.++ .+||+
T Consensus 74 ~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~---i~H~dlkp~Nill~~~~~~~~~~~~~kl~ 150 (259)
T cd05037 74 ENIMVEEYVKFGPLDVFLHREKNNVSLHWKLDVAKQLASALHYLEDKK---LVHGNVCGKNILVARYGLNEGYVPFIKLS 150 (259)
T ss_pred CcEEEEEcCCCCcHHHHHHhhccCCCHHHHHHHHHHHHHHHHHHhhCC---eecccCccceEEEecCccccCCceeEEeC
Confidence 5678899998332 2237899999999999999999999998 99999999999999887 79999
Q ss_pred cccceeecCCCcccccceeeeeccCCCChhhhccC--CCCccceEEeehhhhhhhhhC-CCCCCcCCCCchhhhhhhhhh
Q 045315 308 DFGMARMFGGDELQSNTKRIVGTYGYMSPEYALRG--LFSIKSDVFSFGVLLLETLSS-KKNTHFYNTDSLTLLGHAWNL 384 (476)
Q Consensus 308 DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~--~~s~ksDVwSlGvvl~elltG-~~p~~~~~~~~~~~~~~~~~~ 384 (476)
|||++...... ....++..|+|||++... .++.++|+||||+++|||++| ..|+...... .... .
T Consensus 151 Dfg~a~~~~~~------~~~~~~~~y~aPE~~~~~~~~~~~~~Di~slG~~~~~l~~~~~~p~~~~~~~--~~~~----~ 218 (259)
T cd05037 151 DPGIPITVLSR------EERVERIPWIAPECIRNGQASLTIAADKWSFGTTLLEICSNGEEPLSTLSSS--EKER----F 218 (259)
T ss_pred CCCcccccccc------cccccCCCccChhhhcCCCCCcchhhHHHHHHHHHHHHHhCCCCCcccCCch--hHHH----H
Confidence 99999865431 123466789999998876 789999999999999999995 5555433211 1100 0
Q ss_pred hcCCCcccccCcccCCCCCHHHHHHHHHHHHHchhhcccCCCCHHHHHHHHh
Q 045315 385 WNDGRTWELMDPISQNGASYPILKRYINVALLCVQEKAADRPAMSEVVSMLS 436 (476)
Q Consensus 385 ~~~~~~~~~~d~~~~~~~~~~~~~~l~~li~~Cl~~dP~~RPt~~eVl~~L~ 436 (476)
+..... . .......+.+++.+||+.+|.+||++.+|++.|+
T Consensus 219 ~~~~~~--~---------~~~~~~~~~~li~~~l~~~p~~Rpt~~~il~~l~ 259 (259)
T cd05037 219 YQDQHR--L---------PMPDCAELANLINQCWTYDPTKRPSFRAILRDLN 259 (259)
T ss_pred HhcCCC--C---------CCCCchHHHHHHHHHhccChhhCCCHHHHHHhcC
Confidence 000000 0 0011167889999999999999999999999874
|
Protein Tyrosine Kinase (PTK) family; Janus kinase (Jak) subfamily; pseudokinase domain (repeat1). The Jak subfamily is composed of Jak1, Jak2, Jak3, TYK2, and similar proteins. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal catalytic tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the ki |
| >cd05596 STKc_ROCK Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase | Back alignment and domain information |
|---|
Probab=99.91 E-value=5.8e-25 Score=224.24 Aligned_cols=178 Identities=20% Similarity=0.228 Sum_probs=132.3
Q ss_pred cccceeeccCCCCC-----CCCCCChhhHHHHHHHHHHHHHHHhhcCCCceeecCCCccceEecCCCCceeccccceeec
Q 045315 241 DEISFWYESYNNPT-----KKGLLCWGTRVRIIEGIAQGLLYLHQYSRLRVIHRDLKASNILLDKDMNPKISDFGMARMF 315 (476)
Q Consensus 241 ~~~~l~~Ey~~~~~-----~~~~L~~~~~~~i~~qIa~gL~yLH~~~~~~ivH~DLkp~NILld~~~~~kL~DFGla~~~ 315 (476)
+..+++|||++.+. ++..++...+..++.||+.||+|||+++ |+||||||+|||++.++.+||+|||++...
T Consensus 116 ~~~~lv~Ey~~gg~L~~~l~~~~l~~~~~~~~~~qi~~aL~~LH~~~---ivHrDLkp~NILl~~~~~~kL~DfG~~~~~ 192 (370)
T cd05596 116 KYLYMVMEYMPGGDLVNLMSNYDIPEKWARFYTAEVVLALDAIHSMG---FIHRDVKPDNMLLDKSGHLKLADFGTCMKM 192 (370)
T ss_pred CEEEEEEcCCCCCcHHHHHHhcCCCHHHHHHHHHHHHHHHHHHHHCC---eeccCCCHHHEEEcCCCCEEEEeccceeec
Confidence 35789999998432 2346888999999999999999999998 999999999999999999999999999876
Q ss_pred CCCcccccceeeeeccCCCChhhhccC----CCCccceEEeehhhhhhhhhCCCCCCcCCCCchhhhhhhhhhhcCCCcc
Q 045315 316 GGDELQSNTKRIVGTYGYMSPEYALRG----LFSIKSDVFSFGVLLLETLSSKKNTHFYNTDSLTLLGHAWNLWNDGRTW 391 (476)
Q Consensus 316 ~~~~~~~~~~~~~gt~~y~aPE~l~~~----~~s~ksDVwSlGvvl~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~ 391 (476)
...... ......|++.|+|||.+.+. .++.++|||||||++|||++|+.||...... ... ..........
T Consensus 193 ~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~DiwSlGvilyelltG~~Pf~~~~~~--~~~---~~i~~~~~~~ 266 (370)
T cd05596 193 DANGMV-RCDTAVGTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLYEMLVGDTPFYADSLV--GTY---SKIMDHKNSL 266 (370)
T ss_pred cCCCcc-cCCCCCCCcCeECHHHhccCCCCCCCCCceeeeehhHHHHHHHhCCCCcCCCCHH--HHH---HHHHcCCCcC
Confidence 433211 11235689999999998653 4789999999999999999999998654321 111 1111111100
Q ss_pred cccCcccCCCCCHHHHHHHHHHHHHchhhcccC--CCCHHHHHHH
Q 045315 392 ELMDPISQNGASYPILKRYINVALLCVQEKAAD--RPAMSEVVSM 434 (476)
Q Consensus 392 ~~~d~~~~~~~~~~~~~~l~~li~~Cl~~dP~~--RPt~~eVl~~ 434 (476)
.. .........+.+++.+||+.+|.+ ||+++++++.
T Consensus 267 ~~-------~~~~~~s~~~~~li~~~L~~~p~r~~R~s~~ell~h 304 (370)
T cd05596 267 TF-------PDDIEISKQAKDLICAFLTDREVRLGRNGVDEIKSH 304 (370)
T ss_pred CC-------CCcCCCCHHHHHHHHHHccChhhccCCCCHHHHhcC
Confidence 10 111123467889999999999988 9999999753
|
Serine/Threonine Kinases (STKs), Rho-associated coiled-coil containing protein kinase (ROCK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK is also referred to as Rho-associated kinase or simply as Rho kinase. It contains an N-terminal extension, a catalytic kinase domain, and a long C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain. It is activated via in |
| >cd05605 STKc_GRK4_like Catalytic domain of G protein-coupled Receptor Kinase 4-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=99.91 E-value=2.6e-24 Score=211.23 Aligned_cols=175 Identities=23% Similarity=0.242 Sum_probs=133.4
Q ss_pred cccceeeccCCCC--------CCCCCCChhhHHHHHHHHHHHHHHHhhcCCCceeecCCCccceEecCCCCceeccccce
Q 045315 241 DEISFWYESYNNP--------TKKGLLCWGTRVRIIEGIAQGLLYLHQYSRLRVIHRDLKASNILLDKDMNPKISDFGMA 312 (476)
Q Consensus 241 ~~~~l~~Ey~~~~--------~~~~~L~~~~~~~i~~qIa~gL~yLH~~~~~~ivH~DLkp~NILld~~~~~kL~DFGla 312 (476)
+..+++|||++.. .....+++.++..++.|++.||+|||+.+ ++||||||+||++++++.++|+|||++
T Consensus 73 ~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~---ivH~dlkp~Nil~~~~~~~~l~Dfg~~ 149 (285)
T cd05605 73 DALCLVLTLMNGGDLKFHIYNMGNPGFDEERAVFYAAEITCGLEDLHRER---IVYRDLKPENILLDDYGHIRISDLGLA 149 (285)
T ss_pred CeEEEEEeccCCCcHHHHHHhcCcCCCCHHHHHHHHHHHHHHHHHHHHCC---cEecCCCHHHEEECCCCCEEEeeCCCc
Confidence 3578899998732 12356999999999999999999999998 999999999999999999999999999
Q ss_pred eecCCCcccccceeeeeccCCCChhhhccCCCCccceEEeehhhhhhhhhCCCCCCcCCCCchhhhhhhhhhhcCCCccc
Q 045315 313 RMFGGDELQSNTKRIVGTYGYMSPEYALRGLFSIKSDVFSFGVLLLETLSSKKNTHFYNTDSLTLLGHAWNLWNDGRTWE 392 (476)
Q Consensus 313 ~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~s~ksDVwSlGvvl~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~ 392 (476)
........ .....|+..|+|||.+.+..++.++||||+||++||+++|+.||........ ...........
T Consensus 150 ~~~~~~~~---~~~~~~~~~y~aPE~~~~~~~~~~~Diws~G~~l~el~~g~~pf~~~~~~~~--~~~~~~~~~~~---- 220 (285)
T cd05605 150 VEIPEGET---IRGRVGTVGYMAPEVVKNERYTFSPDWWGLGCLIYEMIEGKSPFRQRKEKVK--REEVERRVKED---- 220 (285)
T ss_pred eecCCCCc---cccccCCCCccCcHHhcCCCCCccccchhHHHHHHHHHHCCCCCCCCchhhH--HHHHHHHhhhc----
Confidence 87543221 1224688999999999988899999999999999999999999875432111 00111111100
Q ss_pred ccCcccCCCCCHHHHHHHHHHHHHchhhcccCCC-----CHHHHHH
Q 045315 393 LMDPISQNGASYPILKRYINVALLCVQEKAADRP-----AMSEVVS 433 (476)
Q Consensus 393 ~~d~~~~~~~~~~~~~~l~~li~~Cl~~dP~~RP-----t~~eVl~ 433 (476)
....+......+.+++.+||+.||++|| +++++++
T Consensus 221 ------~~~~~~~~~~~~~~li~~~l~~~P~~R~~~~~~~~~~l~~ 260 (285)
T cd05605 221 ------QEEYSEKFSEAARSICRQLLTKDPGFRLGCRGEGAEEVKA 260 (285)
T ss_pred ------ccccCcccCHHHHHHHHHHccCCHHHhcCCCCCCHHHHhc
Confidence 0111223445688999999999999999 8888854
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK4-like group, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. Members of the GRK4-like group include GRK4, GRK5, |
| >cd05050 PTKc_Musk Catalytic domain of the Protein Tyrosine Kinase, Muscle-specific kinase | Back alignment and domain information |
|---|
Probab=99.91 E-value=5.7e-25 Score=215.86 Aligned_cols=163 Identities=24% Similarity=0.378 Sum_probs=124.0
Q ss_pred CCCChhhHHHHHHHHHHHHHHHhhcCCCceeecCCCccceEecCCCCceeccccceeecCCCcccccceeeeeccCCCCh
Q 045315 257 GLLCWGTRVRIIEGIAQGLLYLHQYSRLRVIHRDLKASNILLDKDMNPKISDFGMARMFGGDELQSNTKRIVGTYGYMSP 336 (476)
Q Consensus 257 ~~L~~~~~~~i~~qIa~gL~yLH~~~~~~ivH~DLkp~NILld~~~~~kL~DFGla~~~~~~~~~~~~~~~~gt~~y~aP 336 (476)
..+++.+++.++.||+.||+|||+.+ ++||||||+||+++.++.+||+|||++.................+..|+||
T Consensus 125 ~~l~~~~~~~~~~~i~~aL~~lH~~~---i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~y~aP 201 (288)
T cd05050 125 LPLSCTEQLCIAKQVAAGMAYLSERK---FVHRDLATRNCLVGENMVVKIADFGLSRNIYSADYYKASENDAIPIRWMPP 201 (288)
T ss_pred cccCHHHHHHHHHHHHHHHHHHHhCC---eecccccHhheEecCCCceEECccccceecccCccccccCCCccChhhcCH
Confidence 35889999999999999999999998 999999999999999999999999998865433221112222346679999
Q ss_pred hhhccCCCCccceEEeehhhhhhhhh-CCCCCCcCCCCchhhhhhhhhhhcCCCcccccCcccCCCCCHHHHHHHHHHHH
Q 045315 337 EYALRGLFSIKSDVFSFGVLLLETLS-SKKNTHFYNTDSLTLLGHAWNLWNDGRTWELMDPISQNGASYPILKRYINVAL 415 (476)
Q Consensus 337 E~l~~~~~s~ksDVwSlGvvl~ellt-G~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~l~~li~ 415 (476)
|.+.+..++.++|||||||++|||++ |..||..... .... .....+.... .+.....++.+++.
T Consensus 202 E~~~~~~~~~~~Dv~slG~il~el~~~~~~p~~~~~~--~~~~----~~~~~~~~~~---------~~~~~~~~l~~li~ 266 (288)
T cd05050 202 ESIFYNRYTTESDVWAYGVVLWEIFSYGMQPYYGMAH--EEVI----YYVRDGNVLS---------CPDNCPLELYNLMR 266 (288)
T ss_pred HHHhcCCCCchhHHHHHHHHHHHHHhCCCCCCCCCCH--HHHH----HHHhcCCCCC---------CCCCCCHHHHHHHH
Confidence 99988899999999999999999997 7777643221 1111 1111121111 11123457889999
Q ss_pred HchhhcccCCCCHHHHHHHHhc
Q 045315 416 LCVQEKAADRPAMSEVVSMLSN 437 (476)
Q Consensus 416 ~Cl~~dP~~RPt~~eVl~~L~~ 437 (476)
+||+.+|++||++.|+++.|++
T Consensus 267 ~~l~~~p~~Rpt~~el~~~l~~ 288 (288)
T cd05050 267 LCWSKLPSDRPSFASINRILQR 288 (288)
T ss_pred HHcccCcccCCCHHHHHHHhhC
Confidence 9999999999999999999974
|
Protein Tyrosine Kinase (PTK) family; Muscle-specific kinase (Musk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Musk is a receptor tyr kinase (RTK) containing an extracellular region with four immunoglobulin-like domains and a cysteine-rich cluster, a transmembrane segment, and an intracellular catalytic domain. Musk is expressed and concentrated in the postsynaptic membrane in skeletal muscle. It is essential for the establishment of the neuromuscular junction (NMJ), a peripheral synapse that conveys signals from motor neurons to muscle cells. Agrin, a large proteoglycan released from motor neurons, stimulates M |
| >cd05083 PTKc_Chk Catalytic domain of the Protein Tyrosine Kinase, Csk homologous kinase | Back alignment and domain information |
|---|
Probab=99.91 E-value=6.5e-25 Score=211.35 Aligned_cols=173 Identities=24% Similarity=0.307 Sum_probs=132.2
Q ss_pred ccceeeccCCCC--------CCCCCCChhhHHHHHHHHHHHHHHHhhcCCCceeecCCCccceEecCCCCceecccccee
Q 045315 242 EISFWYESYNNP--------TKKGLLCWGTRVRIIEGIAQGLLYLHQYSRLRVIHRDLKASNILLDKDMNPKISDFGMAR 313 (476)
Q Consensus 242 ~~~l~~Ey~~~~--------~~~~~L~~~~~~~i~~qIa~gL~yLH~~~~~~ivH~DLkp~NILld~~~~~kL~DFGla~ 313 (476)
+.++++||++.. .....+++.++++++.|++.||+|||+.+ ++||||||+||+++.++.+||+|||++.
T Consensus 72 ~~~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~---~~H~dl~p~nili~~~~~~kl~Dfg~~~ 148 (254)
T cd05083 72 GLYIVMELMSKGNLVNFLRTRGRALVSVIQLLQFSLDVAEGMEYLESKK---LVHRDLAARNILVSEDGVAKVSDFGLAR 148 (254)
T ss_pred CcEEEEECCCCCCHHHHHHhcCcCCCCHHHHHHHHHHHHHHHHHHHhCC---eeccccCcceEEEcCCCcEEECCCccce
Confidence 457788888732 22346899999999999999999999998 9999999999999999999999999987
Q ss_pred ecCCCcccccceeeeeccCCCChhhhccCCCCccceEEeehhhhhhhhh-CCCCCCcCCCCchhhhhhhhhhhcCCCccc
Q 045315 314 MFGGDELQSNTKRIVGTYGYMSPEYALRGLFSIKSDVFSFGVLLLETLS-SKKNTHFYNTDSLTLLGHAWNLWNDGRTWE 392 (476)
Q Consensus 314 ~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~s~ksDVwSlGvvl~ellt-G~~p~~~~~~~~~~~~~~~~~~~~~~~~~~ 392 (476)
...... .....+..|+|||.+.+..++.++|+||||+++|||++ |+.||...... .... ....+...
T Consensus 149 ~~~~~~-----~~~~~~~~y~~pe~~~~~~~~~~~Dv~slG~~l~el~~~g~~p~~~~~~~--~~~~----~~~~~~~~- 216 (254)
T cd05083 149 VGSMGV-----DNSKLPVKWTAPEALKHKKFSSKSDVWSYGVLLWEVFSYGRAPYPKMSLK--EVKE----CVEKGYRM- 216 (254)
T ss_pred eccccC-----CCCCCCceecCHHHhccCCcCchhhHHHHHHHHHHHHhCCCCCCccCCHH--HHHH----HHhCCCCC-
Confidence 643221 11233567999999988899999999999999999997 88887643311 1111 11111110
Q ss_pred ccCcccCCCCCHHHHHHHHHHHHHchhhcccCCCCHHHHHHHHhc
Q 045315 393 LMDPISQNGASYPILKRYINVALLCVQEKAADRPAMSEVVSMLSN 437 (476)
Q Consensus 393 ~~d~~~~~~~~~~~~~~l~~li~~Cl~~dP~~RPt~~eVl~~L~~ 437 (476)
.........+.+++.+||+.+|++||++.++++.|+.
T Consensus 217 --------~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~l~~~l~~ 253 (254)
T cd05083 217 --------EPPEGCPADVYVLMTSCWETEPKKRPSFHKLREKLEK 253 (254)
T ss_pred --------CCCCcCCHHHHHHHHHHcCCChhhCcCHHHHHHHHcc
Confidence 0111234577899999999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Csk homologous kinase (Chk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. Chk is also referred to as megakaryocyte-associated tyrosine kinase (Matk). To inhibit Src kinases, Chk is translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Chk inhibit Src ki |
| >cd05039 PTKc_Csk_like Catalytic domain of C-terminal Src kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=99.91 E-value=3.4e-25 Score=213.45 Aligned_cols=174 Identities=25% Similarity=0.344 Sum_probs=133.9
Q ss_pred cccceeeccCCCC--------CCCCCCChhhHHHHHHHHHHHHHHHhhcCCCceeecCCCccceEecCCCCceeccccce
Q 045315 241 DEISFWYESYNNP--------TKKGLLCWGTRVRIIEGIAQGLLYLHQYSRLRVIHRDLKASNILLDKDMNPKISDFGMA 312 (476)
Q Consensus 241 ~~~~l~~Ey~~~~--------~~~~~L~~~~~~~i~~qIa~gL~yLH~~~~~~ivH~DLkp~NILld~~~~~kL~DFGla 312 (476)
+..++++||++.. .....+++.++..++.|++.||.|||+.+ ++|+||||+||+++.++.+||+|||.+
T Consensus 73 ~~~~~v~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lh~~~---i~H~di~p~Nili~~~~~~~l~d~g~~ 149 (256)
T cd05039 73 NPLYIVTEYMAKGSLVDYLRSRGRAVITLAQQLGFALDVCEGMEYLEEKN---FVHRDLAARNVLVSEDLVAKVSDFGLA 149 (256)
T ss_pred CCeEEEEEecCCCcHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCC---ccchhcccceEEEeCCCCEEEcccccc
Confidence 4577888988732 22337999999999999999999999999 999999999999999999999999999
Q ss_pred eecCCCcccccceeeeeccCCCChhhhccCCCCccceEEeehhhhhhhhh-CCCCCCcCCCCchhhhhhhhhhhcCCCcc
Q 045315 313 RMFGGDELQSNTKRIVGTYGYMSPEYALRGLFSIKSDVFSFGVLLLETLS-SKKNTHFYNTDSLTLLGHAWNLWNDGRTW 391 (476)
Q Consensus 313 ~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~s~ksDVwSlGvvl~ellt-G~~p~~~~~~~~~~~~~~~~~~~~~~~~~ 391 (476)
+....... ....+..|+|||.+....++.++|+||||++++|+++ |+.|+..... ..+.... ..+...
T Consensus 150 ~~~~~~~~-----~~~~~~~~~ape~~~~~~~~~~~Di~slG~il~~l~~~g~~p~~~~~~--~~~~~~~----~~~~~~ 218 (256)
T cd05039 150 KEASQGQD-----SGKLPVKWTAPEALREKKFSTKSDVWSFGILLWEIYSFGRVPYPRIPL--KDVVPHV----EKGYRM 218 (256)
T ss_pred cccccccc-----cCCCcccccCchhhcCCcCCcHHHHHHHHHHHHHHHhcCCCCCCCCCH--HHHHHHH----hcCCCC
Confidence 87633221 1234568999999988889999999999999999997 8888754321 1111111 111000
Q ss_pred cccCcccCCCCCHHHHHHHHHHHHHchhhcccCCCCHHHHHHHHhc
Q 045315 392 ELMDPISQNGASYPILKRYINVALLCVQEKAADRPAMSEVVSMLSN 437 (476)
Q Consensus 392 ~~~d~~~~~~~~~~~~~~l~~li~~Cl~~dP~~RPt~~eVl~~L~~ 437 (476)
. .+......+.+++.+||+.+|++||++++++++|+.
T Consensus 219 ~---------~~~~~~~~~~~li~~~l~~~p~~Rp~~~~l~~~l~~ 255 (256)
T cd05039 219 E---------APEGCPPEVYKVMKDCWELDPAKRPTFKQLREQLAL 255 (256)
T ss_pred C---------CccCCCHHHHHHHHHHhccChhhCcCHHHHHHHHhc
Confidence 0 111224678899999999999999999999999976
|
Protein Tyrosine Kinase (PTK) family; C-terminal Src kinase (Csk) subfamily; catalytic (c) domain. The Csk subfamily is composed of Csk, Chk, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. To inhibit Src kinases, Csk and Chk are translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Csk |
| >cd08219 STKc_Nek3 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 3 | Back alignment and domain information |
|---|
Probab=99.91 E-value=1.1e-24 Score=209.82 Aligned_cols=174 Identities=22% Similarity=0.276 Sum_probs=133.6
Q ss_pred cccceeeccCCCC--------CCCCCCChhhHHHHHHHHHHHHHHHhhcCCCceeecCCCccceEecCCCCceeccccce
Q 045315 241 DEISFWYESYNNP--------TKKGLLCWGTRVRIIEGIAQGLLYLHQYSRLRVIHRDLKASNILLDKDMNPKISDFGMA 312 (476)
Q Consensus 241 ~~~~l~~Ey~~~~--------~~~~~L~~~~~~~i~~qIa~gL~yLH~~~~~~ivH~DLkp~NILld~~~~~kL~DFGla 312 (476)
+..++++||++.. .....++...++.++.||+.||.|||+.+ ++|+||||+||+++.++.++|+|||.+
T Consensus 71 ~~~~lv~e~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~al~~lH~~~---i~H~dl~p~nili~~~~~~~l~dfg~~ 147 (255)
T cd08219 71 GHLYIVMEYCDGGDLMQKIKLQRGKLFPEDTILQWFVQMCLGVQHIHEKR---VLHRDIKSKNIFLTQNGKVKLGDFGSA 147 (255)
T ss_pred CEEEEEEeeCCCCcHHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHhhCC---cccCCCCcceEEECCCCcEEEcccCcc
Confidence 4577888998732 23456899999999999999999999998 999999999999999999999999999
Q ss_pred eecCCCcccccceeeeeccCCCChhhhccCCCCccceEEeehhhhhhhhhCCCCCCcCCCCchhhhhhhhhhhcCCCccc
Q 045315 313 RMFGGDELQSNTKRIVGTYGYMSPEYALRGLFSIKSDVFSFGVLLLETLSSKKNTHFYNTDSLTLLGHAWNLWNDGRTWE 392 (476)
Q Consensus 313 ~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~s~ksDVwSlGvvl~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~ 392 (476)
......... .....++..|+|||.+.+..++.++|+||||+++|+|++|+.||..... ..... .. ..+....
T Consensus 148 ~~~~~~~~~--~~~~~~~~~~~aPE~~~~~~~~~~~Dv~slG~i~~~l~~g~~p~~~~~~--~~~~~---~~-~~~~~~~ 219 (255)
T cd08219 148 RLLTSPGAY--ACTYVGTPYYVPPEIWENMPYNNKSDIWSLGCILYELCTLKHPFQANSW--KNLIL---KV-CQGSYKP 219 (255)
T ss_pred eeecccccc--cccccCCccccCHHHHccCCcCchhhhhhhchhheehhhccCCCCCCCH--HHHHH---HH-hcCCCCC
Confidence 876432211 1224688899999999888899999999999999999999999864321 11111 11 1111111
Q ss_pred ccCcccCCCCCHHHHHHHHHHHHHchhhcccCCCCHHHHHHH
Q 045315 393 LMDPISQNGASYPILKRYINVALLCVQEKAADRPAMSEVVSM 434 (476)
Q Consensus 393 ~~d~~~~~~~~~~~~~~l~~li~~Cl~~dP~~RPt~~eVl~~ 434 (476)
.+......+.+++.+||+.||++||++.+|+..
T Consensus 220 ---------~~~~~~~~~~~li~~~l~~~P~~Rp~~~~il~~ 252 (255)
T cd08219 220 ---------LPSHYSYELRSLIKQMFKRNPRSRPSATTILSR 252 (255)
T ss_pred ---------CCcccCHHHHHHHHHHHhCCcccCCCHHHHhhc
Confidence 111223467899999999999999999999864
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 3 (Nek3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek3 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek3 is primarily localized in the cytoplasm and shows no cell cycle-dependent changes in its activity. It is present in the axons of neurons and affects morphogenesis and polarity through its regulation of microtubule acetylation. Nek3 modulates the signaling of the prolactin receptor through its activati |
| >KOG1095 consensus Protein tyrosine kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.91 E-value=6.3e-25 Score=238.96 Aligned_cols=182 Identities=26% Similarity=0.352 Sum_probs=139.9
Q ss_pred cccceeeccCCCC-------------CCCCCCChhhHHHHHHHHHHHHHHHhhcCCCceeecCCCccceEecCCCCceec
Q 045315 241 DEISFWYESYNNP-------------TKKGLLCWGTRVRIIEGIAQGLLYLHQYSRLRVIHRDLKASNILLDKDMNPKIS 307 (476)
Q Consensus 241 ~~~~l~~Ey~~~~-------------~~~~~L~~~~~~~i~~qIa~gL~yLH~~~~~~ivH~DLkp~NILld~~~~~kL~ 307 (476)
+..++++|||+.+ .....|+..+.+.++.|||+|+.||+++. +|||||.++|+||++...+||+
T Consensus 768 ~~~~i~leyM~gGDL~sflr~~r~~~~~~~~L~~~dLl~~a~dvA~G~~YLe~~~---fvHRDLAaRNCLL~~~r~VKIa 844 (1025)
T KOG1095|consen 768 GPPLILLEYMEGGDLLSFLRESRPAPFQPSNLSMRDLLAFALDVAKGMNYLESKH---FVHRDLAARNCLLDERRVVKIA 844 (1025)
T ss_pred CCcEEEehhcccCcHHHHHHhcccccCCCCCCCHHHHHHHHHHHhhhhHHHHhCC---CcCcchhhhheeecccCcEEEc
Confidence 3456788999922 12557999999999999999999999998 9999999999999999999999
Q ss_pred cccceeecCCCcccccceeeeeccCCCChhhhccCCCCccceEEeehhhhhhhhh-CCCCCCcCCCCchhhhhhhhhhhc
Q 045315 308 DFGMARMFGGDELQSNTKRIVGTYGYMSPEYALRGLFSIKSDVFSFGVLLLETLS-SKKNTHFYNTDSLTLLGHAWNLWN 386 (476)
Q Consensus 308 DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~s~ksDVwSlGvvl~ellt-G~~p~~~~~~~~~~~~~~~~~~~~ 386 (476)
|||+|+-+.............-+..|||||.+..+.++.|+|||||||++||+++ |..|++..+. ..+... ...
T Consensus 845 DFGlArDiy~~~yyr~~~~a~lPvkWm~PEsl~d~iFtskSDvWsFGVllWEifslG~~PY~~~~n--~~v~~~---~~~ 919 (1025)
T KOG1095|consen 845 DFGLARDIYDKDYYRKHGEAMLPVKWMPPESLKDGIFTSKSDVWSFGVLLWEIFSLGATPYPSRSN--FEVLLD---VLE 919 (1025)
T ss_pred ccchhHhhhhchheeccCccccceecCCHHHHhhcccccccchhhhHHHHHHHHhCCCCCCCCcch--HHHHHH---HHh
Confidence 9999995443332222222344578999999999999999999999999999998 5666654332 112111 122
Q ss_pred CCCcccccCcccCCCCCHHHHHHHHHHHHHchhhcccCCCCHHHHHHHHhcccc
Q 045315 387 DGRTWELMDPISQNGASYPILKRYINVALLCVQEKAADRPAMSEVVSMLSNEFV 440 (476)
Q Consensus 387 ~~~~~~~~d~~~~~~~~~~~~~~l~~li~~Cl~~dP~~RPt~~eVl~~L~~~~~ 440 (476)
.+ .+ +.+...++.+.++|.+||+.+|++||++..|++.+..+..
T Consensus 920 gg---RL-------~~P~~CP~~ly~lM~~CW~~~pe~RP~F~~i~~q~~~i~~ 963 (1025)
T KOG1095|consen 920 GG---RL-------DPPSYCPEKLYQLMLQCWKHDPEDRPSFRTIVEQDPAISN 963 (1025)
T ss_pred CC---cc-------CCCCCCChHHHHHHHHHccCChhhCccHHHHHhhhhhhhh
Confidence 22 11 1233345678899999999999999999999999888763
|
|
| >cd08528 STKc_Nek10 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 10 | Back alignment and domain information |
|---|
Probab=99.91 E-value=7.7e-25 Score=212.53 Aligned_cols=177 Identities=25% Similarity=0.369 Sum_probs=135.9
Q ss_pred cccceeeccCCCC----------CCCCCCChhhHHHHHHHHHHHHHHHhh-cCCCceeecCCCccceEecCCCCceeccc
Q 045315 241 DEISFWYESYNNP----------TKKGLLCWGTRVRIIEGIAQGLLYLHQ-YSRLRVIHRDLKASNILLDKDMNPKISDF 309 (476)
Q Consensus 241 ~~~~l~~Ey~~~~----------~~~~~L~~~~~~~i~~qIa~gL~yLH~-~~~~~ivH~DLkp~NILld~~~~~kL~DF 309 (476)
+..++++||++.. .....+++..+++++.|++.||.|||+ .+ ++|+||||+||+++.++.+||+||
T Consensus 82 ~~~~lv~e~~~~~~l~~~l~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~~---i~H~dl~~~nil~~~~~~~~l~df 158 (269)
T cd08528 82 DRLYIVMDLIEGAPLGEHFNSLKEKKQRFTEERIWNIFVQMVLALRYLHKEKR---IVHRDLTPNNIMLGEDDKVTITDF 158 (269)
T ss_pred CeEEEEEecCCCCcHHHHHHHHHhccCCCCHHHHHHHHHHHHHHHHHhccCCc---eeecCCCHHHEEECCCCcEEEecc
Confidence 4678889998732 234578999999999999999999996 56 999999999999999999999999
Q ss_pred cceeecCCCcccccceeeeeccCCCChhhhccCCCCccceEEeehhhhhhhhhCCCCCCcCCCCchhhhhhhhhhhcCCC
Q 045315 310 GMARMFGGDELQSNTKRIVGTYGYMSPEYALRGLFSIKSDVFSFGVLLLETLSSKKNTHFYNTDSLTLLGHAWNLWNDGR 389 (476)
Q Consensus 310 Gla~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~s~ksDVwSlGvvl~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~ 389 (476)
|++....... ......++..|++||.+.+..++.++|+||||+++|||++|+.|+..... ...... ...+.
T Consensus 159 g~~~~~~~~~---~~~~~~~~~~~~~Pe~~~~~~~~~~~Dv~slG~ll~~l~~g~~p~~~~~~--~~~~~~----~~~~~ 229 (269)
T cd08528 159 GLAKQKQPES---KLTSVVGTILYSCPEIVKNEPYGEKADVWAFGCILYQMCTLQPPFYSTNM--LSLATK----IVEAV 229 (269)
T ss_pred cceeeccccc---ccccccCcccCcChhhhcCCCCchHHHHHHHHHHHHHHHhCCCcccccCH--HHHHHH----Hhhcc
Confidence 9998765432 22335688899999999988899999999999999999999999753321 111111 11111
Q ss_pred cccccCcccCCCCCHHHHHHHHHHHHHchhhcccCCCCHHHHHHHHhc
Q 045315 390 TWELMDPISQNGASYPILKRYINVALLCVQEKAADRPAMSEVVSMLSN 437 (476)
Q Consensus 390 ~~~~~d~~~~~~~~~~~~~~l~~li~~Cl~~dP~~RPt~~eVl~~L~~ 437 (476)
.. +. ........+.+++.+||+.||++||++.||.++|+.
T Consensus 230 ~~----~~----~~~~~~~~l~~li~~cl~~~p~~Rp~~~e~~~~~~~ 269 (269)
T cd08528 230 YE----PL----PEGMYSEDVTDVITSCLTPDAEARPDIIQVSAMISD 269 (269)
T ss_pred CC----cC----CcccCCHHHHHHHHHHCCCCCccCCCHHHHHHHhcC
Confidence 11 00 011223568899999999999999999999999863
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 10 (Nek10) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek10 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. No function has yet been ascribed to Nek10. The gene encoding Nek10 is a putative causative gene for breast cancer; it is located within a breast cancer susceptibility loci on chromosome 3p24. |
| >cd05626 STKc_LATS2 Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor 2 | Back alignment and domain information |
|---|
Probab=99.91 E-value=1.5e-24 Score=222.01 Aligned_cols=179 Identities=22% Similarity=0.309 Sum_probs=129.3
Q ss_pred cccceeeccCCCCC------CCCCCChhhHHHHHHHHHHHHHHHhhcCCCceeecCCCccceEecCCCCceeccccceee
Q 045315 241 DEISFWYESYNNPT------KKGLLCWGTRVRIIEGIAQGLLYLHQYSRLRVIHRDLKASNILLDKDMNPKISDFGMARM 314 (476)
Q Consensus 241 ~~~~l~~Ey~~~~~------~~~~L~~~~~~~i~~qIa~gL~yLH~~~~~~ivH~DLkp~NILld~~~~~kL~DFGla~~ 314 (476)
+..+++|||++.+. +.+.+++..+..++.||+.||+|||+.+ |+||||||+|||++.++.+||+|||+++.
T Consensus 74 ~~~~lv~E~~~gg~L~~~l~~~~~~~e~~~~~~~~qi~~aL~~LH~~g---ivHrDlKp~Nili~~~~~~kL~DFGl~~~ 150 (381)
T cd05626 74 DNLYFVMDYIPGGDMMSLLIRMEVFPEVLARFYIAELTLAIESVHKMG---FIHRDIKPDNILIDLDGHIKLTDFGLCTG 150 (381)
T ss_pred CEEEEEEecCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCC---eeecCCcHHHEEECCCCCEEEeeCcCCcc
Confidence 46788999998432 3457899999999999999999999998 99999999999999999999999999764
Q ss_pred cCCCcc---------------------------------------------cccceeeeeccCCCChhhhccCCCCccce
Q 045315 315 FGGDEL---------------------------------------------QSNTKRIVGTYGYMSPEYALRGLFSIKSD 349 (476)
Q Consensus 315 ~~~~~~---------------------------------------------~~~~~~~~gt~~y~aPE~l~~~~~s~ksD 349 (476)
+..... ........||..|+|||.+.+..++.++|
T Consensus 151 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~~~~~D 230 (381)
T cd05626 151 FRWTHNSKYYQKGSHIRQDSMEPSDLWDDVSNCRCGDRLKTLEQRATKQHQRCLAHSLVGTPNYIAPEVLLRKGYTQLCD 230 (381)
T ss_pred cccccccccccccccccccccCcccccccccccccccccchhhccccccccccccccccCCccccCHHHHcCCCCCCccc
Confidence 321000 00012346899999999999888999999
Q ss_pred EEeehhhhhhhhhCCCCCCcCCCCchhhhhhhhhhhcCCCcccccCcccCCCCCHHHHHHHHHHHHH--chhhcccCCCC
Q 045315 350 VFSFGVLLLETLSSKKNTHFYNTDSLTLLGHAWNLWNDGRTWELMDPISQNGASYPILKRYINVALL--CVQEKAADRPA 427 (476)
Q Consensus 350 VwSlGvvl~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~l~~li~~--Cl~~dP~~RPt 427 (476)
||||||++|||++|+.||.......... ........... .........+.+++.+ |+..++..||+
T Consensus 231 iwSlG~il~elltG~~Pf~~~~~~~~~~-----~i~~~~~~~~~-------~~~~~~s~~~~dli~~ll~~~~~~~~R~~ 298 (381)
T cd05626 231 WWSVGVILFEMLVGQPPFLAPTPTETQL-----KVINWENTLHI-------PPQVKLSPEAVDLITKLCCSAEERLGRNG 298 (381)
T ss_pred eeehhhHHHHHHhCCCCCcCCCHHHHHH-----HHHccccccCC-------CCCCCCCHHHHHHHHHHccCcccccCCCC
Confidence 9999999999999999987543211111 01100000000 0011123456677766 56667777999
Q ss_pred HHHHHHH
Q 045315 428 MSEVVSM 434 (476)
Q Consensus 428 ~~eVl~~ 434 (476)
+++++..
T Consensus 299 ~~~~l~h 305 (381)
T cd05626 299 ADDIKAH 305 (381)
T ss_pred HHHHhcC
Confidence 9999864
|
Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, LATS2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. LATS2 is an essential mitotic regulator responsible for coordinating accurate cytokinesis completion and governing the stabilization of other mitotic regulators. It is also critical in the maintenance of proper chromosome number, genomic stability, mitotic fidelity, and the integrity of centrosome duplication. Downregulation of LATS2 is associated with po |
| >cd06643 STKc_SLK Catalytic domain of the Protein Serine/Threonine Kinase, Ste20-like kinase | Back alignment and domain information |
|---|
Probab=99.91 E-value=1e-24 Score=213.49 Aligned_cols=176 Identities=22% Similarity=0.304 Sum_probs=130.8
Q ss_pred cccceeeccCCCC-------CCCCCCChhhHHHHHHHHHHHHHHHhhcCCCceeecCCCccceEecCCCCceecccccee
Q 045315 241 DEISFWYESYNNP-------TKKGLLCWGTRVRIIEGIAQGLLYLHQYSRLRVIHRDLKASNILLDKDMNPKISDFGMAR 313 (476)
Q Consensus 241 ~~~~l~~Ey~~~~-------~~~~~L~~~~~~~i~~qIa~gL~yLH~~~~~~ivH~DLkp~NILld~~~~~kL~DFGla~ 313 (476)
+..++++||++.. ....++++.++..++.||++||+|||+.+ ++||||||+||+++.++.+||+|||++.
T Consensus 75 ~~~~~v~e~~~~~~l~~~~~~~~~~l~~~~~~~~~~qi~~~L~~LH~~~---i~H~dlkp~nili~~~~~~kl~dfg~~~ 151 (282)
T cd06643 75 NNLWILIEFCAGGAVDAVMLELERPLTEPQIRVVCKQTLEALNYLHENK---IIHRDLKAGNILFTLDGDIKLADFGVSA 151 (282)
T ss_pred CEEEEEEEecCCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCC---eeecCCCcccEEEccCCCEEEccccccc
Confidence 4577889998732 23467999999999999999999999998 9999999999999999999999999987
Q ss_pred ecCCCcccccceeeeeccCCCChhhhc-----cCCCCccceEEeehhhhhhhhhCCCCCCcCCCCchhhhhhhhhhhcCC
Q 045315 314 MFGGDELQSNTKRIVGTYGYMSPEYAL-----RGLFSIKSDVFSFGVLLLETLSSKKNTHFYNTDSLTLLGHAWNLWNDG 388 (476)
Q Consensus 314 ~~~~~~~~~~~~~~~gt~~y~aPE~l~-----~~~~s~ksDVwSlGvvl~elltG~~p~~~~~~~~~~~~~~~~~~~~~~ 388 (476)
....... ......++..|+|||.+. +..++.++|+|||||++|||++|++||....... .. .... ..
T Consensus 152 ~~~~~~~--~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Dv~slGvil~el~~g~~p~~~~~~~~--~~---~~~~-~~ 223 (282)
T cd06643 152 KNTRTIQ--RRDSFIGTPYWMAPEVVMCETSKDRPYDYKADVWSLGITLIEMAQIEPPHHELNPMR--VL---LKIA-KS 223 (282)
T ss_pred ccccccc--ccccccccccccCHhhccccCCCCCCCCccchhhhHHHHHHHHccCCCCccccCHHH--HH---HHHh-hc
Confidence 6533211 122346889999999874 3457889999999999999999999986432111 11 0010 01
Q ss_pred CcccccCcccCCCCCHHHHHHHHHHHHHchhhcccCCCCHHHHHHH
Q 045315 389 RTWELMDPISQNGASYPILKRYINVALLCVQEKAADRPAMSEVVSM 434 (476)
Q Consensus 389 ~~~~~~d~~~~~~~~~~~~~~l~~li~~Cl~~dP~~RPt~~eVl~~ 434 (476)
...... .+......+.+++.+||+.+|.+||++.++++.
T Consensus 224 ~~~~~~-------~~~~~~~~~~~li~~~l~~~p~~Rp~~~~il~~ 262 (282)
T cd06643 224 EPPTLA-------QPSRWSSEFKDFLKKCLEKNVDARWTTTQLLQH 262 (282)
T ss_pred CCCCCC-------CccccCHHHHHHHHHHccCChhhCcCHHHHhcC
Confidence 000100 111223568899999999999999999998753
|
Serine/threonine kinases (STKs), Ste20-like kinase (SLK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SLK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. SLK promotes apoptosis through apoptosis signal-regulating kinase 1 (ASK1) and the mitogen-activated protein kinase (MAPK) p38. It acts as a MAPK kinase kinase (MAPKKK) by phosphorylating ASK1, resulting in the phosphorylation of p38. SLK also plays a role in mediating actin reorganization. It is part of a microtubule-associated complex that is targeted at adhesion sites, and is required in focal adhesion turnover and in regulating cell migration. |
| >cd05074 PTKc_Tyro3 Catalytic domain of the Protein Tyrosine Kinase, Tyro3 | Back alignment and domain information |
|---|
Probab=99.91 E-value=6.9e-25 Score=213.21 Aligned_cols=163 Identities=21% Similarity=0.309 Sum_probs=125.4
Q ss_pred CCChhhHHHHHHHHHHHHHHHhhcCCCceeecCCCccceEecCCCCceeccccceeecCCCcccccceeeeeccCCCChh
Q 045315 258 LLCWGTRVRIIEGIAQGLLYLHQYSRLRVIHRDLKASNILLDKDMNPKISDFGMARMFGGDELQSNTKRIVGTYGYMSPE 337 (476)
Q Consensus 258 ~L~~~~~~~i~~qIa~gL~yLH~~~~~~ivH~DLkp~NILld~~~~~kL~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE 337 (476)
.+++....+++.||+.||+|||+++ |+||||||+||+++.++.+||+|||+++...............++..|++||
T Consensus 109 ~l~~~~~~~~~~~i~~~l~~lH~~~---i~H~dikp~nili~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~~~pe 185 (273)
T cd05074 109 TLPLQTLVRFMIDIASGMEYLSSKN---FIHRDLAARNCMLNENMTVCVADFGLSKKIYSGDYYRQGCASKLPVKWLALE 185 (273)
T ss_pred CCCHHHHHHHHHHHHHHHHHHHhCC---EeecccchhhEEEcCCCCEEECcccccccccCCcceecCCCccCchhhcCHh
Confidence 5889999999999999999999998 9999999999999999999999999998664332211122234567899999
Q ss_pred hhccCCCCccceEEeehhhhhhhhh-CCCCCCcCCCCchhhhhhhhhhhcCCCcccccCcccCCCCCHHHHHHHHHHHHH
Q 045315 338 YALRGLFSIKSDVFSFGVLLLETLS-SKKNTHFYNTDSLTLLGHAWNLWNDGRTWELMDPISQNGASYPILKRYINVALL 416 (476)
Q Consensus 338 ~l~~~~~s~ksDVwSlGvvl~ellt-G~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~l~~li~~ 416 (476)
.+....++.++|||||||++|||++ |++|+..... ..+.... ..+.... ........+.+++.+
T Consensus 186 ~~~~~~~~~~sDi~slG~il~el~~~g~~p~~~~~~--~~~~~~~----~~~~~~~---------~~~~~~~~~~~l~~~ 250 (273)
T cd05074 186 SLADNVYTTHSDVWAFGVTMWEIMTRGQTPYAGVEN--SEIYNYL----IKGNRLK---------QPPDCLEDVYELMCQ 250 (273)
T ss_pred HHhcCccchhhhhHHHHHHHHHHhhCCCCCCCCCCH--HHHHHHH----HcCCcCC---------CCCCCCHHHHHHHHH
Confidence 9988889999999999999999999 7787753321 1111111 1111000 011234578999999
Q ss_pred chhhcccCCCCHHHHHHHHhcc
Q 045315 417 CVQEKAADRPAMSEVVSMLSNE 438 (476)
Q Consensus 417 Cl~~dP~~RPt~~eVl~~L~~~ 438 (476)
|++.+|++||++.++++.|+++
T Consensus 251 ~l~~~p~~Rps~~~~~~~l~~~ 272 (273)
T cd05074 251 CWSPEPKCRPSFQHLRDQLELI 272 (273)
T ss_pred HcCCChhhCcCHHHHHHHHHhh
Confidence 9999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Tyro3; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyro3 (or Sky) is a member of the Axl subfamily, which is composed of receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Tyro3 is predominantly expressed in the central nervous system and the brain, and functions as a neurotrophic fac |
| >cd07839 STKc_CDK5 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 5 | Back alignment and domain information |
|---|
Probab=99.91 E-value=8.3e-25 Score=214.03 Aligned_cols=187 Identities=21% Similarity=0.249 Sum_probs=130.6
Q ss_pred cccceeeccCCCC------CCCCCCChhhHHHHHHHHHHHHHHHhhcCCCceeecCCCccceEecCCCCceeccccceee
Q 045315 241 DEISFWYESYNNP------TKKGLLCWGTRVRIIEGIAQGLLYLHQYSRLRVIHRDLKASNILLDKDMNPKISDFGMARM 314 (476)
Q Consensus 241 ~~~~l~~Ey~~~~------~~~~~L~~~~~~~i~~qIa~gL~yLH~~~~~~ivH~DLkp~NILld~~~~~kL~DFGla~~ 314 (476)
+..++++||++.. .....+++..+..++.||++||.|||+.+ ++|+||||+||+++.++.+||+|||+++.
T Consensus 72 ~~~~lv~e~~~~~l~~~~~~~~~~~~~~~~~~~~~qi~~al~~LH~~~---i~H~dl~~~nil~~~~~~~~l~dfg~~~~ 148 (284)
T cd07839 72 KKLTLVFEYCDQDLKKYFDSCNGDIDPEIVKSFMFQLLKGLAFCHSHN---VLHRDLKPQNLLINKNGELKLADFGLARA 148 (284)
T ss_pred CceEEEEecCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCC---EecCCCCHHHEEEcCCCcEEECccchhhc
Confidence 4677888998721 23467999999999999999999999998 99999999999999999999999999986
Q ss_pred cCCCcccccceeeeeccCCCChhhhccC-CCCccceEEeehhhhhhhhhCCCCCCcCCCCchhhhhhhhhhhcCCC----
Q 045315 315 FGGDELQSNTKRIVGTYGYMSPEYALRG-LFSIKSDVFSFGVLLLETLSSKKNTHFYNTDSLTLLGHAWNLWNDGR---- 389 (476)
Q Consensus 315 ~~~~~~~~~~~~~~gt~~y~aPE~l~~~-~~s~ksDVwSlGvvl~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~---- 389 (476)
....... .....++..|+|||.+.+. .++.++|||||||++|||++|+.|+.........+ ...........
T Consensus 149 ~~~~~~~--~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~tg~~p~~~~~~~~~~~-~~~~~~~~~~~~~~~ 225 (284)
T cd07839 149 FGIPVRC--YSAEVVTLWYRPPDVLFGAKLYSTSIDMWSAGCIFAELANAGRPLFPGNDVDDQL-KRIFRLLGTPTEESW 225 (284)
T ss_pred cCCCCCC--cCCCccccCCcChHHHhCCcccCcHHHHHHHHHHHHHHHhcCCCCcCCCCHHHHH-HHHHHHhCCCChHHh
Confidence 5432211 1223568899999998764 47899999999999999999998864322111111 00000000000
Q ss_pred --cccccCc----ccC-----CCCCHHHHHHHHHHHHHchhhcccCCCCHHHHHH
Q 045315 390 --TWELMDP----ISQ-----NGASYPILKRYINVALLCVQEKAADRPAMSEVVS 433 (476)
Q Consensus 390 --~~~~~d~----~~~-----~~~~~~~~~~l~~li~~Cl~~dP~~RPt~~eVl~ 433 (476)
..+..+. ... ..........+.+++.+||+.||.+|||++++++
T Consensus 226 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~t~~~il~ 280 (284)
T cd07839 226 PGVSKLPDYKPYPMYPATTSLVNVVPKLNSTGRDLLQNLLVCNPVQRISAEEALQ 280 (284)
T ss_pred HHhhhcccccccCCCCCcchhhhhcccCCHHHHHHHHHHhcCChhhcCCHHHHhc
Confidence 0000000 000 0011123457789999999999999999999875
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 5 (CDK5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK5 is unusual in that it is regulated by non-cyclin proteins, p35 and p39. It is highly expressed in the nervous system and is critical in normal neural development and function. It plays a role in neuronal migration and differentiation, and is also |
| >cd05599 STKc_NDR_like Catalytic domain of Nuclear Dbf2-Related kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=99.91 E-value=1.8e-24 Score=219.87 Aligned_cols=177 Identities=23% Similarity=0.256 Sum_probs=130.4
Q ss_pred cccceeeccCCCC------CCCCCCChhhHHHHHHHHHHHHHHHhhcCCCceeecCCCccceEecCCCCceeccccceee
Q 045315 241 DEISFWYESYNNP------TKKGLLCWGTRVRIIEGIAQGLLYLHQYSRLRVIHRDLKASNILLDKDMNPKISDFGMARM 314 (476)
Q Consensus 241 ~~~~l~~Ey~~~~------~~~~~L~~~~~~~i~~qIa~gL~yLH~~~~~~ivH~DLkp~NILld~~~~~kL~DFGla~~ 314 (476)
+..+++|||++.+ .+++.+++.++..++.||+.||+|||+.+ |+||||||+|||++.++.+||+|||++..
T Consensus 74 ~~~~lv~E~~~~g~L~~~l~~~~~l~~~~~~~~~~qi~~aL~~lH~~~---ivH~Dlkp~NIl~~~~~~~kl~Dfg~~~~ 150 (364)
T cd05599 74 NYLYLIMEYLPGGDMMTLLMKKDTFTEEETRFYIAETILAIDSIHKLG---YIHRDIKPDNLLLDAKGHIKLSDFGLCTG 150 (364)
T ss_pred CeEEEEECCCCCcHHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCC---eEeccCCHHHeEECCCCCEEEeeccccee
Confidence 4577899999843 23567999999999999999999999999 99999999999999999999999999876
Q ss_pred cCCCcccc------------------------------------cceeeeeccCCCChhhhccCCCCccceEEeehhhhh
Q 045315 315 FGGDELQS------------------------------------NTKRIVGTYGYMSPEYALRGLFSIKSDVFSFGVLLL 358 (476)
Q Consensus 315 ~~~~~~~~------------------------------------~~~~~~gt~~y~aPE~l~~~~~s~ksDVwSlGvvl~ 358 (476)
+....... ......||+.|+|||++....++.++|||||||++|
T Consensus 151 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~ 230 (364)
T cd05599 151 LKKSHRTEFYRILSHALPSNFLDFISKPMSSKRKAETWKRNRRALAYSTVGTPDYIAPEVFLQTGYNKECDWWSLGVIMY 230 (364)
T ss_pred ccccccccccccccccccccccccccccccccccccchhhcccccccccccCccccCHHHHcCCCCCCeeeeecchhHHH
Confidence 53211000 011245899999999999989999999999999999
Q ss_pred hhhhCCCCCCcCCCCchhhhhhhhhhhcCCCcccccCcccCCCCCHHHHHHHHHHHHHchhhcccCCCC---HHHHHH
Q 045315 359 ETLSSKKNTHFYNTDSLTLLGHAWNLWNDGRTWELMDPISQNGASYPILKRYINVALLCVQEKAADRPA---MSEVVS 433 (476)
Q Consensus 359 elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~l~~li~~Cl~~dP~~RPt---~~eVl~ 433 (476)
||++|+.||...... .... ........... .......+.+.+++.+|+. +|.+|++ ++|+++
T Consensus 231 el~~G~~Pf~~~~~~--~~~~---~i~~~~~~~~~-------~~~~~~s~~~~~li~~ll~-~p~~R~~~~~~~~ll~ 295 (364)
T cd05599 231 EMLVGYPPFCSDNPQ--ETYR---KIINWKETLQF-------PDEVPLSPEAKDLIKRLCC-EAERRLGNNGVNEIKS 295 (364)
T ss_pred HhhcCCCCCCCCCHH--HHHH---HHHcCCCccCC-------CCCCCCCHHHHHHHHHHcc-CHhhcCCCCCHHHHhc
Confidence 999999998654311 1111 11110000000 0011223467788888886 8999998 888876
|
Serine/Threonine Kinases (STKs), Nuclear Dbf2-Related (NDR) kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. NDR kinases regulate mitosis, cell growth, embryonic development, and neurological processes. They are also required for proper centrosome duplica |
| >cd05621 STKc_ROCK2 Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase 2 | Back alignment and domain information |
|---|
Probab=99.91 E-value=1.3e-24 Score=221.61 Aligned_cols=178 Identities=20% Similarity=0.226 Sum_probs=130.3
Q ss_pred cccceeeccCCCCC-----CCCCCChhhHHHHHHHHHHHHHHHhhcCCCceeecCCCccceEecCCCCceeccccceeec
Q 045315 241 DEISFWYESYNNPT-----KKGLLCWGTRVRIIEGIAQGLLYLHQYSRLRVIHRDLKASNILLDKDMNPKISDFGMARMF 315 (476)
Q Consensus 241 ~~~~l~~Ey~~~~~-----~~~~L~~~~~~~i~~qIa~gL~yLH~~~~~~ivH~DLkp~NILld~~~~~kL~DFGla~~~ 315 (476)
+..+++|||++.+. +...++...+..++.||+.||+|||+.+ |+||||||+|||+++++.+||+|||++...
T Consensus 116 ~~~~lv~Ey~~gg~L~~~l~~~~~~~~~~~~~~~qil~aL~~LH~~~---IvHrDLKp~NILl~~~~~~kL~DFG~a~~~ 192 (370)
T cd05621 116 KYLYMVMEYMPGGDLVNLMSNYDVPEKWAKFYTAEVVLALDAIHSMG---LIHRDVKPDNMLLDKHGHLKLADFGTCMKM 192 (370)
T ss_pred CEEEEEEcCCCCCcHHHHHHhcCCCHHHHHHHHHHHHHHHHHHHHCC---eEecCCCHHHEEECCCCCEEEEecccceec
Confidence 45889999998432 2346889999999999999999999998 999999999999999999999999999876
Q ss_pred CCCcccccceeeeeccCCCChhhhccC----CCCccceEEeehhhhhhhhhCCCCCCcCCCCchhhhhhhhhhhcCCCcc
Q 045315 316 GGDELQSNTKRIVGTYGYMSPEYALRG----LFSIKSDVFSFGVLLLETLSSKKNTHFYNTDSLTLLGHAWNLWNDGRTW 391 (476)
Q Consensus 316 ~~~~~~~~~~~~~gt~~y~aPE~l~~~----~~s~ksDVwSlGvvl~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~ 391 (476)
..... .......||+.|+|||.+.+. .++.++|+|||||++|||++|+.||....... . ...........
T Consensus 193 ~~~~~-~~~~~~~gt~~Y~aPE~~~~~~~~~~~~~~~DiwSlG~ilyell~G~~Pf~~~~~~~--~---~~~i~~~~~~~ 266 (370)
T cd05621 193 DETGM-VRCDTAVGTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLFEMLVGDTPFYADSLVG--T---YSKIMDHKNSL 266 (370)
T ss_pred ccCCc-eecccCCCCcccCCHHHHhccCCCCCCCcccCEEeehHHHHHHHhCCCCCCCCCHHH--H---HHHHHhCCccc
Confidence 43221 112235689999999998753 37899999999999999999999986443111 1 11111111110
Q ss_pred cccCcccCCCCCHHHHHHHHHHHHHchhhcccC--CCCHHHHHHH
Q 045315 392 ELMDPISQNGASYPILKRYINVALLCVQEKAAD--RPAMSEVVSM 434 (476)
Q Consensus 392 ~~~d~~~~~~~~~~~~~~l~~li~~Cl~~dP~~--RPt~~eVl~~ 434 (476)
.. .........+.+++..|++.++.+ ||++.|+++.
T Consensus 267 ~~-------p~~~~~s~~~~~li~~~L~~~~~r~~R~~~~e~l~h 304 (370)
T cd05621 267 NF-------PEDVEISKHAKNLICAFLTDREVRLGRNGVEEIKQH 304 (370)
T ss_pred CC-------CCcccCCHHHHHHHHHHccCchhccCCCCHHHHhcC
Confidence 10 111223456778888899755543 8899998875
|
Serine/Threonine Kinases (STKs), ROCK subfamily, ROCK2 (or ROK-alpha) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK contains an N-terminal extension, a catalytic kinase domain, and a C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain, and is activated via interaction with Rho GTPases. ROCK2 was the first identified target of activated RhoA, and was found |
| >cd06616 PKc_MKK4 Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 4 | Back alignment and domain information |
|---|
Probab=99.91 E-value=9.7e-25 Score=214.12 Aligned_cols=178 Identities=26% Similarity=0.396 Sum_probs=131.5
Q ss_pred cccceeeccCCC----------CCCCCCCChhhHHHHHHHHHHHHHHHhhc-CCCceeecCCCccceEecCCCCceeccc
Q 045315 241 DEISFWYESYNN----------PTKKGLLCWGTRVRIIEGIAQGLLYLHQY-SRLRVIHRDLKASNILLDKDMNPKISDF 309 (476)
Q Consensus 241 ~~~~l~~Ey~~~----------~~~~~~L~~~~~~~i~~qIa~gL~yLH~~-~~~~ivH~DLkp~NILld~~~~~kL~DF 309 (476)
+.+++++||++. ......+++..+.+++.|++.||+|||+. + ++||||||+||+++.++.+||+||
T Consensus 76 ~~~~~~~e~~~~~l~~l~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~lh~~~~---i~H~dlkp~Nil~~~~~~~kl~df 152 (288)
T cd06616 76 GDCWICMELMDISLDKFYKYVYEVLKSVIPEEILGKIAVATVKALNYLKEELK---IIHRDVKPSNILLDRNGNIKLCDF 152 (288)
T ss_pred CcEEEEEecccCCHHHHHHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHhhcCC---eeccCCCHHHEEEccCCcEEEeec
Confidence 356677787651 11346799999999999999999999975 6 999999999999999999999999
Q ss_pred cceeecCCCcccccceeeeeccCCCChhhhccC---CCCccceEEeehhhhhhhhhCCCCCCcCCCCchhhhhhhhhhhc
Q 045315 310 GMARMFGGDELQSNTKRIVGTYGYMSPEYALRG---LFSIKSDVFSFGVLLLETLSSKKNTHFYNTDSLTLLGHAWNLWN 386 (476)
Q Consensus 310 Gla~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~---~~s~ksDVwSlGvvl~elltG~~p~~~~~~~~~~~~~~~~~~~~ 386 (476)
|+++....... .....++..|+|||.+.+. .++.++|||||||++|||++|+.||..... ..........
T Consensus 153 g~~~~~~~~~~---~~~~~~~~~y~aPE~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~----~~~~~~~~~~ 225 (288)
T cd06616 153 GISGQLVDSIA---KTRDAGCRPYMAPERIDPSARDGYDVRSDVWSLGITLYEVATGKFPYPKWNS----VFDQLTQVVK 225 (288)
T ss_pred chhHHhccCCc---cccccCccCccCHHHhccccccCCcchhhhhHHHHHHHHHHhCCCCchhcch----HHHHHhhhcC
Confidence 99976543221 1223578899999998765 689999999999999999999999864431 1111111111
Q ss_pred CCCcccccCcccCCCCCHHHHHHHHHHHHHchhhcccCCCCHHHHHHH
Q 045315 387 DGRTWELMDPISQNGASYPILKRYINVALLCVQEKAADRPAMSEVVSM 434 (476)
Q Consensus 387 ~~~~~~~~d~~~~~~~~~~~~~~l~~li~~Cl~~dP~~RPt~~eVl~~ 434 (476)
+.. +.+...........+.+++.+||+.+|++||++++|++.
T Consensus 226 -~~~-----~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rpt~~~i~~~ 267 (288)
T cd06616 226 -GDP-----PILSNSEEREFSPSFVNFINLCLIKDESKRPKYKELLEH 267 (288)
T ss_pred -CCC-----CcCCCcCCCccCHHHHHHHHHHccCChhhCcCHHHHhcC
Confidence 111 111111122345678899999999999999999998864
|
Protein kinases (PKs), MAP kinase kinase 4 (MKK4) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK4 is a dual-specificity PK that phosphorylates and activates |
| >cd07861 STKc_CDK1_euk Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 1 from higher eukaryotes-like | Back alignment and domain information |
|---|
Probab=99.91 E-value=9.7e-25 Score=213.50 Aligned_cols=187 Identities=22% Similarity=0.257 Sum_probs=129.6
Q ss_pred cccceeeccCCC--------CCCCCCCChhhHHHHHHHHHHHHHHHhhcCCCceeecCCCccceEecCCCCceeccccce
Q 045315 241 DEISFWYESYNN--------PTKKGLLCWGTRVRIIEGIAQGLLYLHQYSRLRVIHRDLKASNILLDKDMNPKISDFGMA 312 (476)
Q Consensus 241 ~~~~l~~Ey~~~--------~~~~~~L~~~~~~~i~~qIa~gL~yLH~~~~~~ivH~DLkp~NILld~~~~~kL~DFGla 312 (476)
+.+++++||++. ......+++.++..++.||++||+|||+.+ ++|+||||+||+++.++.+||+|||++
T Consensus 72 ~~~~~v~e~~~~~l~~~~~~~~~~~~~~~~~~~~~~~qi~~~L~~lH~~~---i~H~dl~p~nil~~~~~~~~l~dfg~~ 148 (285)
T cd07861 72 SRLYLIFEFLSMDLKKYLDSLPKGQYMDAELVKSYLYQILQGILFCHSRR---VLHRDLKPQNLLIDNKGVIKLADFGLA 148 (285)
T ss_pred CeEEEEEecCCCCHHHHHhcCCCCCcCCHHHHHHHHHHHHHHHHHHHhCC---eeecCCCHHHEEEcCCCcEEECcccce
Confidence 457778888862 122367999999999999999999999998 999999999999999999999999999
Q ss_pred eecCCCcccccceeeeeccCCCChhhhccC-CCCccceEEeehhhhhhhhhCCCCCCcCCCCchhhhhhhh-------hh
Q 045315 313 RMFGGDELQSNTKRIVGTYGYMSPEYALRG-LFSIKSDVFSFGVLLLETLSSKKNTHFYNTDSLTLLGHAW-------NL 384 (476)
Q Consensus 313 ~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~-~~s~ksDVwSlGvvl~elltG~~p~~~~~~~~~~~~~~~~-------~~ 384 (476)
........ ......++..|+|||.+.+. .++.++|+|||||+++||++|+.||........ ...... ..
T Consensus 149 ~~~~~~~~--~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~~l~tg~~~~~~~~~~~~-~~~~~~~~~~~~~~~ 225 (285)
T cd07861 149 RAFGIPVR--VYTHEVVTLWYRAPEVLLGSPRYSTPVDIWSIGTIFAEMATKKPLFHGDSEIDQ-LFRIFRILGTPTEDV 225 (285)
T ss_pred eecCCCcc--cccCCcccccccChHHhcCCCCcCcHHHHHHHHHHHHHHHHCCCCCCCCCHHHH-HHHHHHHhCCCChhh
Confidence 86543211 11223568899999988754 578999999999999999999999864321110 000000 00
Q ss_pred hcCCC----cccccCcccC---CCCCHHHHHHHHHHHHHchhhcccCCCCHHHHHH
Q 045315 385 WNDGR----TWELMDPISQ---NGASYPILKRYINVALLCVQEKAADRPAMSEVVS 433 (476)
Q Consensus 385 ~~~~~----~~~~~d~~~~---~~~~~~~~~~l~~li~~Cl~~dP~~RPt~~eVl~ 433 (476)
+.... .....+.... .........++.+++.+||+.||++|||+.+|+.
T Consensus 226 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~Rpt~~~ll~ 281 (285)
T cd07861 226 WPGVTSLPDYKNTFPKWKKGSLRSAVKNLDEDGLDLLEKMLIYDPAKRISAKKALN 281 (285)
T ss_pred hhcchhhHHHHhhccccCcchhHHhcCCCCHHHHHHHHHHhcCChhhCCCHHHHhc
Confidence 00000 0000000000 0001113456789999999999999999999875
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 1 (CDK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK1 from higher eukaryotes. CDK1 is also called Cell division control protein 2 (Cdc2) or p34 protein kinase, and is regulated by cyclins A, B, and E. The CDK1/cyclin A complex controls G2 |
| >cd06612 STKc_MST1_2 Catalytic domain of the Protein Serine/Threonine Kinases, Mammalian Ste20-like protein kinase 1 and 2 | Back alignment and domain information |
|---|
Probab=99.91 E-value=1.3e-24 Score=208.90 Aligned_cols=175 Identities=21% Similarity=0.320 Sum_probs=134.0
Q ss_pred cccceeeccCCCC-------CCCCCCChhhHHHHHHHHHHHHHHHhhcCCCceeecCCCccceEecCCCCceecccccee
Q 045315 241 DEISFWYESYNNP-------TKKGLLCWGTRVRIIEGIAQGLLYLHQYSRLRVIHRDLKASNILLDKDMNPKISDFGMAR 313 (476)
Q Consensus 241 ~~~~l~~Ey~~~~-------~~~~~L~~~~~~~i~~qIa~gL~yLH~~~~~~ivH~DLkp~NILld~~~~~kL~DFGla~ 313 (476)
+.+++++||++.. ..+..+++.++..++.|++.||.|||+.+ ++|+||+|+||+++.++.+||+|||++.
T Consensus 71 ~~~~l~~e~~~~~~L~~~l~~~~~~l~~~~~~~~~~~l~~~l~~lh~~~---i~H~dl~~~ni~~~~~~~~~l~dfg~~~ 147 (256)
T cd06612 71 TDLWIVMEYCGAGSVSDIMKITNKTLTEEEIAAILYQTLKGLEYLHSNK---KIHRDIKAGNILLNEEGQAKLADFGVSG 147 (256)
T ss_pred CcEEEEEecCCCCcHHHHHHhCccCCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCCcceEEECCCCcEEEcccccch
Confidence 4577888998732 23567999999999999999999999998 9999999999999999999999999998
Q ss_pred ecCCCcccccceeeeeccCCCChhhhccCCCCccceEEeehhhhhhhhhCCCCCCcCCCCchhhhhhhhhhhcCCCcccc
Q 045315 314 MFGGDELQSNTKRIVGTYGYMSPEYALRGLFSIKSDVFSFGVLLLETLSSKKNTHFYNTDSLTLLGHAWNLWNDGRTWEL 393 (476)
Q Consensus 314 ~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~s~ksDVwSlGvvl~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~ 393 (476)
....... ......++..|+|||.+.+..++.++||||||+++++|++|+.|+........... ......
T Consensus 148 ~~~~~~~--~~~~~~~~~~y~~PE~~~~~~~~~~~Di~s~G~il~~l~~g~~p~~~~~~~~~~~~------~~~~~~--- 216 (256)
T cd06612 148 QLTDTMA--KRNTVIGTPFWMAPEVIQEIGYNNKADIWSLGITAIEMAEGKPPYSDIHPMRAIFM------IPNKPP--- 216 (256)
T ss_pred hcccCcc--ccccccCCccccCHHHHhcCCCCchhhHHHHHHHHHHHHhCCCCCCCcchhhhhhh------hccCCC---
Confidence 7654321 12234578899999999888899999999999999999999999864332111100 000000
Q ss_pred cCcccCCCCCHHHHHHHHHHHHHchhhcccCCCCHHHHHH
Q 045315 394 MDPISQNGASYPILKRYINVALLCVQEKAADRPAMSEVVS 433 (476)
Q Consensus 394 ~d~~~~~~~~~~~~~~l~~li~~Cl~~dP~~RPt~~eVl~ 433 (476)
+.. ..+......+.+++.+||+.+|++||++.||++
T Consensus 217 --~~~--~~~~~~~~~~~~~i~~~l~~~P~~Rps~~~il~ 252 (256)
T cd06612 217 --PTL--SDPEKWSPEFNDFVKKCLVKDPEERPSAIQLLQ 252 (256)
T ss_pred --CCC--CchhhcCHHHHHHHHHHHhcChhhCcCHHHHhc
Confidence 000 111223457889999999999999999999985
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 1 (MST1) and MST2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST1/2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MST1, MST2, and related proteins including Drosophila Hippo and Dictyostelium discoideum Krs1 (kinase responsive to stress 1). MST1/2 and Hippo are involved in a conserved pathway that governs cell contact inhibition, organ size control, and tumor development. MST1 activates the mitogen-activated protein kinases (MAPKs) p38 and c-Jun N-terminal kinase (JNK) through MKK7 (a |
| >cd05633 STKc_GRK3 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 3 | Back alignment and domain information |
|---|
Probab=99.91 E-value=1.3e-24 Score=212.93 Aligned_cols=174 Identities=25% Similarity=0.310 Sum_probs=132.3
Q ss_pred cccceeeccCCCCC------CCCCCChhhHHHHHHHHHHHHHHHhhcCCCceeecCCCccceEecCCCCceeccccceee
Q 045315 241 DEISFWYESYNNPT------KKGLLCWGTRVRIIEGIAQGLLYLHQYSRLRVIHRDLKASNILLDKDMNPKISDFGMARM 314 (476)
Q Consensus 241 ~~~~l~~Ey~~~~~------~~~~L~~~~~~~i~~qIa~gL~yLH~~~~~~ivH~DLkp~NILld~~~~~kL~DFGla~~ 314 (476)
+..+++|||++... ..+.+++.++..++.|++.||+|||+.+ ++|+||||+||++++++.+||+|||++..
T Consensus 70 ~~~~lv~e~~~~~~L~~~i~~~~~l~~~~~~~i~~qi~~al~~lH~~~---ivH~dikp~Nil~~~~~~~~l~dfg~~~~ 146 (279)
T cd05633 70 DKLCFILDLMNGGDLHYHLSQHGVFSEKEMRFYATEIILGLEHMHNRF---VVYRDLKPANILLDEHGHVRISDLGLACD 146 (279)
T ss_pred CeEEEEEecCCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCC---cCCCCCCHHHEEECCCCCEEEccCCccee
Confidence 45788999998432 3467999999999999999999999999 99999999999999999999999999876
Q ss_pred cCCCcccccceeeeeccCCCChhhhcc-CCCCccceEEeehhhhhhhhhCCCCCCcCCCCchhhhhhhhhhhcCCCcccc
Q 045315 315 FGGDELQSNTKRIVGTYGYMSPEYALR-GLFSIKSDVFSFGVLLLETLSSKKNTHFYNTDSLTLLGHAWNLWNDGRTWEL 393 (476)
Q Consensus 315 ~~~~~~~~~~~~~~gt~~y~aPE~l~~-~~~s~ksDVwSlGvvl~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~ 393 (476)
..... .....|+..|+|||.+.+ ..++.++|+|||||++|||++|+.||.............. ...
T Consensus 147 ~~~~~----~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~~~~~~---~~~------ 213 (279)
T cd05633 147 FSKKK----PHASVGTHGYMAPEVLQKGTAYDSSADWFSLGCMLFKLLRGHSPFRQHKTKDKHEIDRM---TLT------ 213 (279)
T ss_pred ccccC----ccCcCCCcCccCHHHhcCCCCCCchhhhHHHHHHHHHHHhCCCCcCCCCCcCHHHHHHH---hhc------
Confidence 54322 112458999999998864 5689999999999999999999999864432111111100 000
Q ss_pred cCcccCCCCCHHHHHHHHHHHHHchhhcccCCC-----CHHHHHHH
Q 045315 394 MDPISQNGASYPILKRYINVALLCVQEKAADRP-----AMSEVVSM 434 (476)
Q Consensus 394 ~d~~~~~~~~~~~~~~l~~li~~Cl~~dP~~RP-----t~~eVl~~ 434 (476)
... ..+......+.+++.+||+.||++|| ++.++++.
T Consensus 214 ~~~----~~~~~~~~~~~~li~~~l~~~p~~R~~~~~~~~~~~~~h 255 (279)
T cd05633 214 VNV----ELPDSFSPELKSLLEGLLQRDVSKRLGCLGRGAQEVKEH 255 (279)
T ss_pred CCc----CCccccCHHHHHHHHHHhcCCHHHhcCCCCCCHHHHHhC
Confidence 001 11222345788999999999999999 59888774
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK3 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK3 (also known as beta-adrenergic receptor kinase 2) is wi |
| >cd06619 PKc_MKK5 Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 5 | Back alignment and domain information |
|---|
Probab=99.91 E-value=1.2e-24 Score=212.77 Aligned_cols=179 Identities=23% Similarity=0.367 Sum_probs=133.3
Q ss_pred cccceeeccCCCCCC--CCCCChhhHHHHHHHHHHHHHHHhhcCCCceeecCCCccceEecCCCCceeccccceeecCCC
Q 045315 241 DEISFWYESYNNPTK--KGLLCWGTRVRIIEGIAQGLLYLHQYSRLRVIHRDLKASNILLDKDMNPKISDFGMARMFGGD 318 (476)
Q Consensus 241 ~~~~l~~Ey~~~~~~--~~~L~~~~~~~i~~qIa~gL~yLH~~~~~~ivH~DLkp~NILld~~~~~kL~DFGla~~~~~~ 318 (476)
+..++++||++.... ...+++..+..++.|++.||+|||+.+ |+|+||||+||+++.++.+||+|||++......
T Consensus 72 ~~~~lv~e~~~~~~l~~~~~~~~~~~~~~~~qi~~~l~~lH~~~---i~H~dlkp~Nill~~~~~~~l~dfg~~~~~~~~ 148 (279)
T cd06619 72 NRISICTEFMDGGSLDVYRKIPEHVLGRIAVAVVKGLTYLWSLK---ILHRDVKPSNMLVNTRGQVKLCDFGVSTQLVNS 148 (279)
T ss_pred CEEEEEEecCCCCChHHhhcCCHHHHHHHHHHHHHHHHHHHHCC---EeeCCCCHHHEEECCCCCEEEeeCCcceecccc
Confidence 356788999985432 346788999999999999999999998 999999999999999999999999999865432
Q ss_pred cccccceeeeeccCCCChhhhccCCCCccceEEeehhhhhhhhhCCCCCCcCCCCchhhh-hhhhhhhcCCCcccccCcc
Q 045315 319 ELQSNTKRIVGTYGYMSPEYALRGLFSIKSDVFSFGVLLLETLSSKKNTHFYNTDSLTLL-GHAWNLWNDGRTWELMDPI 397 (476)
Q Consensus 319 ~~~~~~~~~~gt~~y~aPE~l~~~~~s~ksDVwSlGvvl~elltG~~p~~~~~~~~~~~~-~~~~~~~~~~~~~~~~d~~ 397 (476)
. .....++..|+|||.+.+..++.++|+||||+++|+|++|+.||........... ............ +.
T Consensus 149 ~----~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~-----~~ 219 (279)
T cd06619 149 I----AKTYVGTNAYMAPERISGEQYGIHSDVWSLGISFMELALGRFPYPQIQKNQGSLMPLQLLQCIVDEDP-----PV 219 (279)
T ss_pred c----ccCCCCChhhcCceeecCCCCCCcchHHHHHHHHHHHHhCCCCchhhcccccccchHHHHHHHhccCC-----CC
Confidence 1 2224688999999999988899999999999999999999999864321111000 000001000000 00
Q ss_pred cCCCCCHHHHHHHHHHHHHchhhcccCCCCHHHHHHH
Q 045315 398 SQNGASYPILKRYINVALLCVQEKAADRPAMSEVVSM 434 (476)
Q Consensus 398 ~~~~~~~~~~~~l~~li~~Cl~~dP~~RPt~~eVl~~ 434 (476)
. ........+.+++.+|++.+|++||+++++++.
T Consensus 220 ~---~~~~~~~~~~~li~~~l~~~P~~Rp~~~eil~~ 253 (279)
T cd06619 220 L---PVGQFSEKFVHFITQCMRKQPKERPAPENLMDH 253 (279)
T ss_pred C---CCCcCCHHHHHHHHHHhhCChhhCCCHHHHhcC
Confidence 0 011123468899999999999999999998864
|
Protein kinases (PKs), MAP kinase kinase 5 (MKK5) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK5, also referred to as MEK5, is a dual-specificity PK that p |
| >cd06625 STKc_MEKK3_like Catalytic domain of MAP/ERK kinase kinase 3-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=99.91 E-value=6.2e-25 Score=212.15 Aligned_cols=177 Identities=24% Similarity=0.334 Sum_probs=132.9
Q ss_pred cccceeeccCCCCC------CCCCCChhhHHHHHHHHHHHHHHHhhcCCCceeecCCCccceEecCCCCceeccccceee
Q 045315 241 DEISFWYESYNNPT------KKGLLCWGTRVRIIEGIAQGLLYLHQYSRLRVIHRDLKASNILLDKDMNPKISDFGMARM 314 (476)
Q Consensus 241 ~~~~l~~Ey~~~~~------~~~~L~~~~~~~i~~qIa~gL~yLH~~~~~~ivH~DLkp~NILld~~~~~kL~DFGla~~ 314 (476)
+..++++||++... +.+.++...+.+++.|++.||+|||+.+ ++|+||+|+||+++.++.++|+|||+++.
T Consensus 77 ~~~~~v~e~~~~~~l~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~---i~H~dl~p~nilv~~~~~~~l~dfg~~~~ 153 (263)
T cd06625 77 ETLSIFMEYMPGGSVKDQLKAYGALTETVTRKYTRQILEGVEYLHSNM---IVHRDIKGANILRDSAGNVKLGDFGASKR 153 (263)
T ss_pred CeEEEEEEECCCCcHHHHHHHhCCCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCCHHHEEEcCCCCEEEeeccccee
Confidence 46778889987432 3456889999999999999999999998 99999999999999999999999999986
Q ss_pred cCCCccccc-ceeeeeccCCCChhhhccCCCCccceEEeehhhhhhhhhCCCCCCcCCCCchhhhhhhhhhhcCCCcccc
Q 045315 315 FGGDELQSN-TKRIVGTYGYMSPEYALRGLFSIKSDVFSFGVLLLETLSSKKNTHFYNTDSLTLLGHAWNLWNDGRTWEL 393 (476)
Q Consensus 315 ~~~~~~~~~-~~~~~gt~~y~aPE~l~~~~~s~ksDVwSlGvvl~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~ 393 (476)
......... .....++..|+|||.+.+..++.++||||||+++||+++|+.||..... .... .........
T Consensus 154 ~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~--~~~~---~~~~~~~~~--- 225 (263)
T cd06625 154 LQTICSSGTGMKSVTGTPYWMSPEVISGEGYGRKADVWSVGCTVVEMLTEKPPWAEFEA--MAAI---FKIATQPTN--- 225 (263)
T ss_pred ccccccccccccCCCcCccccCcceeccCCCCchhhhHHHHHHHHHHHhCCCCccccch--HHHH---HHHhccCCC---
Confidence 543221111 0224577899999999988899999999999999999999999753221 1110 001001000
Q ss_pred cCcccCCCCCHHHHHHHHHHHHHchhhcccCCCCHHHHHHH
Q 045315 394 MDPISQNGASYPILKRYINVALLCVQEKAADRPAMSEVVSM 434 (476)
Q Consensus 394 ~d~~~~~~~~~~~~~~l~~li~~Cl~~dP~~RPt~~eVl~~ 434 (476)
...+......+.+++.+||+.+|.+||++.++++.
T Consensus 226 ------~~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~ll~~ 260 (263)
T cd06625 226 ------PQLPSHVSPDARNFLRRTFVENAKKRPSAEELLRH 260 (263)
T ss_pred ------CCCCccCCHHHHHHHHHHhhcCcccCCCHHHHhhC
Confidence 11112234567899999999999999999999864
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MEKK3, MEKK2, and related proteins, all containing an N-terminal PB1 domain, which mediates oligomerization, and a C-terminal catalytic domain. MEKK2 and MEKK3 are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks), proteins that phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades t |
| >cd05078 PTK_Jak2_Jak3_rpt1 Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinases, Janus kinases 2 and 3 | Back alignment and domain information |
|---|
Probab=99.91 E-value=9.7e-25 Score=210.88 Aligned_cols=170 Identities=21% Similarity=0.303 Sum_probs=126.7
Q ss_pred cccceeeccCCCC-------CCCCCCChhhHHHHHHHHHHHHHHHhhcCCCceeecCCCccceEecCCCC--------ce
Q 045315 241 DEISFWYESYNNP-------TKKGLLCWGTRVRIIEGIAQGLLYLHQYSRLRVIHRDLKASNILLDKDMN--------PK 305 (476)
Q Consensus 241 ~~~~l~~Ey~~~~-------~~~~~L~~~~~~~i~~qIa~gL~yLH~~~~~~ivH~DLkp~NILld~~~~--------~k 305 (476)
+..+++|||++.+ .++..+++..+++++.||+.||+|||+++ |+||||||+||+++.++. ++
T Consensus 72 ~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~---iiH~dlkp~nili~~~~~~~~~~~~~~~ 148 (258)
T cd05078 72 DESIMVQEYVKFGSLDTYLKKNKNLINISWKLEVAKQLAWALHFLEDKG---LTHGNVCAKNVLLIREEDRKTGNPPFIK 148 (258)
T ss_pred CCcEEEEecCCCCcHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCccceEEEecccccccCCCceEE
Confidence 3567889999833 22446899999999999999999999998 999999999999987765 58
Q ss_pred eccccceeecCCCcccccceeeeeccCCCChhhhcc-CCCCccceEEeehhhhhhhhhCC-CCCCcCCCCchhhhhhhhh
Q 045315 306 ISDFGMARMFGGDELQSNTKRIVGTYGYMSPEYALR-GLFSIKSDVFSFGVLLLETLSSK-KNTHFYNTDSLTLLGHAWN 383 (476)
Q Consensus 306 L~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~l~~-~~~s~ksDVwSlGvvl~elltG~-~p~~~~~~~~~~~~~~~~~ 383 (476)
++|||++...... ....++..|+|||.+.+ ..++.++||||||+++||+++|. .|+..... .....
T Consensus 149 l~d~g~~~~~~~~------~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~~l~~l~~g~~~~~~~~~~--~~~~~---- 216 (258)
T cd05078 149 LSDPGISITVLPK------EILLERIPWVPPECIENPQNLSLAADKWSFGTTLWEIFSGGDKPLSALDS--QKKLQ---- 216 (258)
T ss_pred ecccccccccCCc------hhccccCCccCchhccCCCCCCchhhHHHHHHHHHHHHcCCCCChhhccH--HHHHH----
Confidence 9999988654321 22457889999999876 45799999999999999999995 44432211 11110
Q ss_pred hhcCCCcccccCcccCCCCCHHHHHHHHHHHHHchhhcccCCCCHHHHHHHHh
Q 045315 384 LWNDGRTWELMDPISQNGASYPILKRYINVALLCVQEKAADRPAMSEVVSMLS 436 (476)
Q Consensus 384 ~~~~~~~~~~~d~~~~~~~~~~~~~~l~~li~~Cl~~dP~~RPt~~eVl~~L~ 436 (476)
.... ... .+......+.+++.+||+.+|++|||++++++.|+
T Consensus 217 ~~~~--~~~---------~~~~~~~~~~~li~~~l~~~p~~Rps~~~il~~l~ 258 (258)
T cd05078 217 FYED--RHQ---------LPAPKWTELANLINQCMDYEPDFRPSFRAIIRDLN 258 (258)
T ss_pred HHHc--ccc---------CCCCCcHHHHHHHHHHhccChhhCCCHHHHHHhcC
Confidence 0000 000 11112346889999999999999999999999874
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 2 (Jak2) and Jak3; pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak2 and Jak3 are members of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity |
| >cd05628 STKc_NDR1 Catalytic domain of the Protein Serine/Threonine Kinase, Nuclear Dbf2-Related kinase 1 | Back alignment and domain information |
|---|
Probab=99.91 E-value=9.6e-25 Score=222.01 Aligned_cols=127 Identities=26% Similarity=0.300 Sum_probs=107.2
Q ss_pred cccceeeccCCCCC------CCCCCChhhHHHHHHHHHHHHHHHhhcCCCceeecCCCccceEecCCCCceeccccceee
Q 045315 241 DEISFWYESYNNPT------KKGLLCWGTRVRIIEGIAQGLLYLHQYSRLRVIHRDLKASNILLDKDMNPKISDFGMARM 314 (476)
Q Consensus 241 ~~~~l~~Ey~~~~~------~~~~L~~~~~~~i~~qIa~gL~yLH~~~~~~ivH~DLkp~NILld~~~~~kL~DFGla~~ 314 (476)
+..+++|||++.+. +.+.+++.++..++.||+.||+|||+++ |+||||||+|||++.++.+||+|||+++.
T Consensus 74 ~~~~lv~E~~~gg~L~~~l~~~~~l~~~~~~~~~~qi~~aL~~lH~~g---ivHrDlKp~NILi~~~~~vkL~DFGla~~ 150 (363)
T cd05628 74 LNLYLIMEFLPGGDMMTLLMKKDTLTEEETQFYIAETVLAIDSIHQLG---FIHRDIKPDNLLLDSKGHVKLSDFGLCTG 150 (363)
T ss_pred CeEEEEEcCCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCC---eEecCCCHHHeEECCCCCEEEeeccCccc
Confidence 45789999998432 4568999999999999999999999999 99999999999999999999999999875
Q ss_pred cCCCcc---------------------------------cccceeeeeccCCCChhhhccCCCCccceEEeehhhhhhhh
Q 045315 315 FGGDEL---------------------------------QSNTKRIVGTYGYMSPEYALRGLFSIKSDVFSFGVLLLETL 361 (476)
Q Consensus 315 ~~~~~~---------------------------------~~~~~~~~gt~~y~aPE~l~~~~~s~ksDVwSlGvvl~ell 361 (476)
+..... ........||+.|+|||.+.+..++.++|||||||++|||+
T Consensus 151 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Gt~~Y~aPE~~~~~~~~~~~DvwSlGvil~ell 230 (363)
T cd05628 151 LKKAHRTEFYRNLNHSLPSDFTFQNMNSKRKAETWKRNRRQLAFSTVGTPDYIAPEVFMQTGYNKLCDWWSLGVIMYEML 230 (363)
T ss_pred ccccccccccccccccccccccccccccccccchhhhccccccccccCCccccCHHHHcCCCCCCchhhhhhHHHHHHHH
Confidence 432110 00012346899999999999999999999999999999999
Q ss_pred hCCCCCCcC
Q 045315 362 SSKKNTHFY 370 (476)
Q Consensus 362 tG~~p~~~~ 370 (476)
+|+.||...
T Consensus 231 ~G~~Pf~~~ 239 (363)
T cd05628 231 IGYPPFCSE 239 (363)
T ss_pred hCCCCCCCC
Confidence 999998643
|
Serine/Threonine Kinases (STKs), NDR kinase subfamily, NDR1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. Both isoforms play a role in proper centrosome duplication. NDR1 is highly expressed in thymus, mus |
| >cd07873 STKc_PCTAIRE1 Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-1 kinase | Back alignment and domain information |
|---|
Probab=99.91 E-value=8.4e-25 Score=216.26 Aligned_cols=186 Identities=18% Similarity=0.226 Sum_probs=131.0
Q ss_pred cccceeeccCCC------CCCCCCCChhhHHHHHHHHHHHHHHHhhcCCCceeecCCCccceEecCCCCceeccccceee
Q 045315 241 DEISFWYESYNN------PTKKGLLCWGTRVRIIEGIAQGLLYLHQYSRLRVIHRDLKASNILLDKDMNPKISDFGMARM 314 (476)
Q Consensus 241 ~~~~l~~Ey~~~------~~~~~~L~~~~~~~i~~qIa~gL~yLH~~~~~~ivH~DLkp~NILld~~~~~kL~DFGla~~ 314 (476)
+.+++++||++. ......+++..+..++.||++||+|||+.+ ++|+||||+||+++.++.+||+|||++..
T Consensus 77 ~~~~lv~e~~~~~l~~~l~~~~~~~~~~~~~~~~~qi~~aL~~lH~~~---i~H~dlkp~Nil~~~~~~~kl~dfg~~~~ 153 (301)
T cd07873 77 KSLTLVFEYLDKDLKQYLDDCGNSINMHNVKLFLFQLLRGLNYCHRRK---VLHRDLKPQNLLINERGELKLADFGLARA 153 (301)
T ss_pred CeEEEEEeccccCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCC---eeCCCCCHHHEEECCCCcEEECcCcchhc
Confidence 457788999872 123456899999999999999999999998 99999999999999999999999999976
Q ss_pred cCCCcccccceeeeeccCCCChhhhcc-CCCCccceEEeehhhhhhhhhCCCCCCcCCCCchhhhhhhhhhhc---CCCc
Q 045315 315 FGGDELQSNTKRIVGTYGYMSPEYALR-GLFSIKSDVFSFGVLLLETLSSKKNTHFYNTDSLTLLGHAWNLWN---DGRT 390 (476)
Q Consensus 315 ~~~~~~~~~~~~~~gt~~y~aPE~l~~-~~~s~ksDVwSlGvvl~elltG~~p~~~~~~~~~~~~~~~~~~~~---~~~~ 390 (476)
...... ......++..|+|||.+.+ ..++.++|||||||++|||++|++||....... .......... ....
T Consensus 154 ~~~~~~--~~~~~~~~~~y~~PE~~~~~~~~~~~~Dv~slG~~l~el~tg~~~f~~~~~~~--~~~~~~~~~~~~~~~~~ 229 (301)
T cd07873 154 KSIPTK--TYSNEVVTLWYRPPDILLGSTDYSTQIDMWGVGCIFYEMSTGRPLFPGSTVEE--QLHFIFRILGTPTEETW 229 (301)
T ss_pred cCCCCC--cccccceeecccCcHHHhCCCCCccHHHHHHHHHHHHHHHhCCCCCCCCCHHH--HHHHHHHHcCCCChhhc
Confidence 432221 1122456889999998875 457899999999999999999999987543211 1110000000 0000
Q ss_pred ccccC---------cccCC----CCCHHHHHHHHHHHHHchhhcccCCCCHHHHHH
Q 045315 391 WELMD---------PISQN----GASYPILKRYINVALLCVQEKAADRPAMSEVVS 433 (476)
Q Consensus 391 ~~~~d---------~~~~~----~~~~~~~~~l~~li~~Cl~~dP~~RPt~~eVl~ 433 (476)
..... +.... .........+.+++.+||+.||.+|||++|+++
T Consensus 230 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~ml~~dp~~R~t~~eil~ 285 (301)
T cd07873 230 PGILSNEEFKSYNYPKYRADCLHNHAPRLDSDGAELLSKLLQFEGRKRISAEEAMK 285 (301)
T ss_pred hhhhccccccccccCccccccHHhhcCCCCHHHHHHHHHHhcCCcccCcCHHHHhc
Confidence 00000 00000 001122446789999999999999999999987
|
Serine/Threonine Kinases (STKs), PCTAIRE-1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-1 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-1 is expressed ubiquitously and is localized in the cytoplasm. Its kinase activity is cell cycle dependent and peaks at the S and G2 phases. PCTAIRE-1 is highly expressed in the brain and may pl |
| >cd05625 STKc_LATS1 Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor 1 | Back alignment and domain information |
|---|
Probab=99.91 E-value=1.7e-24 Score=221.60 Aligned_cols=177 Identities=22% Similarity=0.291 Sum_probs=126.3
Q ss_pred cccceeeccCCCC------CCCCCCChhhHHHHHHHHHHHHHHHhhcCCCceeecCCCccceEecCCCCceeccccceee
Q 045315 241 DEISFWYESYNNP------TKKGLLCWGTRVRIIEGIAQGLLYLHQYSRLRVIHRDLKASNILLDKDMNPKISDFGMARM 314 (476)
Q Consensus 241 ~~~~l~~Ey~~~~------~~~~~L~~~~~~~i~~qIa~gL~yLH~~~~~~ivH~DLkp~NILld~~~~~kL~DFGla~~ 314 (476)
+..+++|||++.+ .+.+.+++..+..++.||+.||+|||+.+ |+||||||+|||++.++.+||+|||++..
T Consensus 74 ~~~~lv~E~~~gg~L~~~l~~~~~~~e~~~~~~~~qi~~al~~lH~~~---ivHrDlKp~NILl~~~g~~kL~DFGla~~ 150 (382)
T cd05625 74 DNLYFVMDYIPGGDMMSLLIRMGIFPEDLARFYIAELTCAVESVHKMG---FIHRDIKPDNILIDRDGHIKLTDFGLCTG 150 (382)
T ss_pred CEEEEEEeCCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCCHHHEEECCCCCEEEeECCCCcc
Confidence 4678999999843 23457899999999999999999999999 99999999999999999999999999753
Q ss_pred cCCCc---------------------------------------------ccccceeeeeccCCCChhhhccCCCCccce
Q 045315 315 FGGDE---------------------------------------------LQSNTKRIVGTYGYMSPEYALRGLFSIKSD 349 (476)
Q Consensus 315 ~~~~~---------------------------------------------~~~~~~~~~gt~~y~aPE~l~~~~~s~ksD 349 (476)
+.... .........||+.|+|||++.+..++.++|
T Consensus 151 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~~~~~D 230 (382)
T cd05625 151 FRWTHDSKYYQSGDHVRQDSMDFSNEWGDPANCRCGDRLKPLERRAARQHQRCLAHSLVGTPNYIAPEVLLRTGYTQLCD 230 (382)
T ss_pred ccccccccccccccccccccccccccccccccccccccccchhhhhccccccccccccccCcccCCHHHhcCCCCCCeee
Confidence 31100 000012246899999999999989999999
Q ss_pred EEeehhhhhhhhhCCCCCCcCCCCchhhhhhhhhhhcCCCcccccCcccCCCCCHHHHHHHHHHHHHchhhcccCCCC--
Q 045315 350 VFSFGVLLLETLSSKKNTHFYNTDSLTLLGHAWNLWNDGRTWELMDPISQNGASYPILKRYINVALLCVQEKAADRPA-- 427 (476)
Q Consensus 350 VwSlGvvl~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~l~~li~~Cl~~dP~~RPt-- 427 (476)
||||||++|||++|+.||........ .. ........... .........+.+++.+|+ .+|++|++
T Consensus 231 iwSlGvil~elltG~~Pf~~~~~~~~--~~---~i~~~~~~~~~-------p~~~~~s~~~~~li~~l~-~~p~~R~~~~ 297 (382)
T cd05625 231 WWSVGVILYEMLVGQPPFLAQTPLET--QM---KVINWQTSLHI-------PPQAKLSPEASDLIIKLC-RGPEDRLGKN 297 (382)
T ss_pred EEechHHHHHHHhCCCCCCCCCHHHH--HH---HHHccCCCcCC-------CCcccCCHHHHHHHHHHc-cCHhHcCCCC
Confidence 99999999999999999975432111 10 01100000000 011112345566666665 49999997
Q ss_pred -HHHHHH
Q 045315 428 -MSEVVS 433 (476)
Q Consensus 428 -~~eVl~ 433 (476)
+.++++
T Consensus 298 ~~~ei~~ 304 (382)
T cd05625 298 GADEIKA 304 (382)
T ss_pred CHHHHhc
Confidence 777664
|
Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, LATS1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. Inactivation of LATS1 in mice results in the development of various tumors, including sarcomas and ovarian cancer. Promoter methylation, loss of heterozygosity, and missense mutations targeting the LATS1 gene have also been found in human sarcomas and ovarian cancers. In addition, decreased expression of LATS1 is associated with an aggressive phenotype an |
| >cd06650 PKc_MEK1 Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase 1 | Back alignment and domain information |
|---|
Probab=99.91 E-value=9.5e-25 Score=219.45 Aligned_cols=123 Identities=30% Similarity=0.434 Sum_probs=104.5
Q ss_pred cccceeeccCCCC------CCCCCCChhhHHHHHHHHHHHHHHHhhc-CCCceeecCCCccceEecCCCCceecccccee
Q 045315 241 DEISFWYESYNNP------TKKGLLCWGTRVRIIEGIAQGLLYLHQY-SRLRVIHRDLKASNILLDKDMNPKISDFGMAR 313 (476)
Q Consensus 241 ~~~~l~~Ey~~~~------~~~~~L~~~~~~~i~~qIa~gL~yLH~~-~~~~ivH~DLkp~NILld~~~~~kL~DFGla~ 313 (476)
+..+++|||++.. .+.+.+++..+..++.|++.||.|||+. + ++|+||||+||+++.++.+||+|||++.
T Consensus 76 ~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~l~~~l~~lH~~~~---ivH~dlkp~Nili~~~~~~kL~Dfg~~~ 152 (333)
T cd06650 76 GEISICMEHMDGGSLDQVLKKAGRIPEQILGKVSIAVIKGLTYLREKHK---IMHRDVKPSNILVNSRGEIKLCDFGVSG 152 (333)
T ss_pred CEEEEEEecCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHhcCC---EEecCCChhhEEEcCCCCEEEeeCCcch
Confidence 4678899999843 2345689999999999999999999974 5 9999999999999999999999999987
Q ss_pred ecCCCcccccceeeeeccCCCChhhhccCCCCccceEEeehhhhhhhhhCCCCCCcC
Q 045315 314 MFGGDELQSNTKRIVGTYGYMSPEYALRGLFSIKSDVFSFGVLLLETLSSKKNTHFY 370 (476)
Q Consensus 314 ~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~s~ksDVwSlGvvl~elltG~~p~~~~ 370 (476)
...... .....|+..|+|||.+.+..++.++|+|||||++||+++|+.||...
T Consensus 153 ~~~~~~----~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~il~~l~~g~~p~~~~ 205 (333)
T cd06650 153 QLIDSM----ANSFVGTRSYMSPERLQGTHYSVQSDIWSMGLSLVEMAIGRYPIPPP 205 (333)
T ss_pred hhhhhc----cccCCCCccccCHHHhcCCCCCcHHHHHHHHHHHHHHHHCCCCCCCc
Confidence 653221 12246889999999999888999999999999999999999998643
|
Protein kinases (PKs), MAP/ERK kinase (MEK) 1 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK1 is a dual-specificity PK that phosphorylates and activates the downst |
| >cd05066 PTKc_EphR_A Catalytic domain of the Protein Tyrosine Kinases, Class EphA Ephrin Receptors | Back alignment and domain information |
|---|
Probab=99.91 E-value=7.6e-25 Score=212.58 Aligned_cols=180 Identities=26% Similarity=0.409 Sum_probs=135.4
Q ss_pred cccceeeccCCCC-------CCCCCCChhhHHHHHHHHHHHHHHHhhcCCCceeecCCCccceEecCCCCceecccccee
Q 045315 241 DEISFWYESYNNP-------TKKGLLCWGTRVRIIEGIAQGLLYLHQYSRLRVIHRDLKASNILLDKDMNPKISDFGMAR 313 (476)
Q Consensus 241 ~~~~l~~Ey~~~~-------~~~~~L~~~~~~~i~~qIa~gL~yLH~~~~~~ivH~DLkp~NILld~~~~~kL~DFGla~ 313 (476)
+..++++||++.. ...+.+++.+++.++.|++.||+|||+.+ ++||||||+||+++.++.+||+|||++.
T Consensus 78 ~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~---i~h~dlkp~nili~~~~~~~l~dfg~~~ 154 (267)
T cd05066 78 KPVMIVTEYMENGSLDAFLRKHDGQFTVIQLVGMLRGIASGMKYLSDMG---YVHRDLAARNILVNSNLVCKVSDFGLSR 154 (267)
T ss_pred CccEEEEEcCCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCC---EeehhhchhcEEECCCCeEEeCCCCccc
Confidence 4577889999843 22356899999999999999999999998 9999999999999999999999999998
Q ss_pred ecCCCcccccc-eeeeeccCCCChhhhccCCCCccceEEeehhhhhhhhh-CCCCCCcCCCCchhhhhhhhhhhcCCCcc
Q 045315 314 MFGGDELQSNT-KRIVGTYGYMSPEYALRGLFSIKSDVFSFGVLLLETLS-SKKNTHFYNTDSLTLLGHAWNLWNDGRTW 391 (476)
Q Consensus 314 ~~~~~~~~~~~-~~~~gt~~y~aPE~l~~~~~s~ksDVwSlGvvl~ellt-G~~p~~~~~~~~~~~~~~~~~~~~~~~~~ 391 (476)
.+......... ....++..|+|||.+.+..++.++|+||||+++||+++ |+.||...... ..... ..++..
T Consensus 155 ~~~~~~~~~~~~~~~~~~~~y~~pe~~~~~~~~~~~Dv~slG~~l~ell~~g~~p~~~~~~~--~~~~~----~~~~~~- 227 (267)
T cd05066 155 VLEDDPEAAYTTRGGKIPIRWTAPEAIAYRKFTSASDVWSYGIVMWEVMSYGERPYWEMSNQ--DVIKA----IEEGYR- 227 (267)
T ss_pred ccccccceeeecCCCccceeecCHhHhccCccCchhhhHHHHHHHHHHhcCCCCCcccCCHH--HHHHH----HhCCCc-
Confidence 76543221111 11223467999999998889999999999999999886 99887543321 11111 111100
Q ss_pred cccCcccCCCCCHHHHHHHHHHHHHchhhcccCCCCHHHHHHHHhcc
Q 045315 392 ELMDPISQNGASYPILKRYINVALLCVQEKAADRPAMSEVVSMLSNE 438 (476)
Q Consensus 392 ~~~d~~~~~~~~~~~~~~l~~li~~Cl~~dP~~RPt~~eVl~~L~~~ 438 (476)
. .........+.+++.+|++.+|++||++.++++.|+.+
T Consensus 228 -~-------~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~i~~~l~~~ 266 (267)
T cd05066 228 -L-------PAPMDCPAALHQLMLDCWQKDRNERPKFEQIVSILDKL 266 (267)
T ss_pred -C-------CCCCCCCHHHHHHHHHHcccCchhCCCHHHHHHHHHhh
Confidence 0 01112245678999999999999999999999999864
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; most class EphA receptors including EphA3, EphA4, EphA5, and EphA7, but excluding EphA1, EphA2 and EphA10; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. One exception is EphA4, which also binds ephrins-B2/B3. EphRs contain an ephrin-binding domain and two fibronectin repeats extracellul |
| >cd05034 PTKc_Src_like Catalytic domain of Src kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=99.91 E-value=8.4e-25 Score=211.16 Aligned_cols=178 Identities=29% Similarity=0.407 Sum_probs=134.1
Q ss_pred cccceeeccCCCC--------CCCCCCChhhHHHHHHHHHHHHHHHhhcCCCceeecCCCccceEecCCCCceeccccce
Q 045315 241 DEISFWYESYNNP--------TKKGLLCWGTRVRIIEGIAQGLLYLHQYSRLRVIHRDLKASNILLDKDMNPKISDFGMA 312 (476)
Q Consensus 241 ~~~~l~~Ey~~~~--------~~~~~L~~~~~~~i~~qIa~gL~yLH~~~~~~ivH~DLkp~NILld~~~~~kL~DFGla 312 (476)
+..++++||++.. .....+++.++..++.|++.||+|||+.+ ++|+||||+||+++.++.+||+|||++
T Consensus 74 ~~~~~v~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~i~~al~~lh~~~---i~h~di~p~nili~~~~~~~l~d~g~~ 150 (261)
T cd05034 74 EPIYIVTEYMSKGSLLDFLKSGEGKKLRLPQLVDMAAQIAEGMAYLESRN---YIHRDLAARNILVGENLVCKIADFGLA 150 (261)
T ss_pred CceEEEEeccCCCCHHHHHhccccCCCCHHHHHHHHHHHHHHHHHHHhCC---cccCCcchheEEEcCCCCEEECccccc
Confidence 3567788888632 22347899999999999999999999998 999999999999999999999999999
Q ss_pred eecCCCcccccceeeeeccCCCChhhhccCCCCccceEEeehhhhhhhhh-CCCCCCcCCCCchhhhhhhhhhhcCCCcc
Q 045315 313 RMFGGDELQSNTKRIVGTYGYMSPEYALRGLFSIKSDVFSFGVLLLETLS-SKKNTHFYNTDSLTLLGHAWNLWNDGRTW 391 (476)
Q Consensus 313 ~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~s~ksDVwSlGvvl~ellt-G~~p~~~~~~~~~~~~~~~~~~~~~~~~~ 391 (476)
..+....... ......+..|+|||.+.+..++.++|+||||++++|+++ |+.||..... ....... ..+..
T Consensus 151 ~~~~~~~~~~-~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~il~~l~t~g~~p~~~~~~--~~~~~~~----~~~~~- 222 (261)
T cd05034 151 RLIEDDEYTA-REGAKFPIKWTAPEAANYGRFTIKSDVWSFGILLTEIVTYGRVPYPGMTN--REVLEQV----ERGYR- 222 (261)
T ss_pred eeccchhhhh-hhccCCCccccCHHHhccCCcCchhHHHHHHHHHHHHHhCCCCCCCCCCH--HHHHHHH----HcCCC-
Confidence 8765422111 111234568999999998889999999999999999998 8888754321 1111111 11100
Q ss_pred cccCcccCCCCCHHHHHHHHHHHHHchhhcccCCCCHHHHHHHHhc
Q 045315 392 ELMDPISQNGASYPILKRYINVALLCVQEKAADRPAMSEVVSMLSN 437 (476)
Q Consensus 392 ~~~d~~~~~~~~~~~~~~l~~li~~Cl~~dP~~RPt~~eVl~~L~~ 437 (476)
...+......+.+++.+|++.+|++||+++++++.|+.
T Consensus 223 --------~~~~~~~~~~~~~~i~~~l~~~p~~Rp~~~~l~~~l~~ 260 (261)
T cd05034 223 --------MPRPPNCPEELYDLMLQCWDKDPEERPTFEYLQSFLED 260 (261)
T ss_pred --------CCCCCCCCHHHHHHHHHHcccCcccCCCHHHHHHHHhc
Confidence 00011124568899999999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Src kinase subfamily; catalytic (c) domain. Src subfamily members include Src, Lck, Hck, Blk, Lyn, Fgr, Fyn, Yrk, and Yes. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Src (or c-Src) proteins are cytoplasmic (or non-receptor) tyr kinases which are anchored to the plasma membrane. They contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-t |
| >cd05598 STKc_LATS Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor | Back alignment and domain information |
|---|
Probab=99.91 E-value=1.4e-24 Score=221.88 Aligned_cols=178 Identities=24% Similarity=0.300 Sum_probs=128.3
Q ss_pred cccceeeccCCCC------CCCCCCChhhHHHHHHHHHHHHHHHhhcCCCceeecCCCccceEecCCCCceeccccceee
Q 045315 241 DEISFWYESYNNP------TKKGLLCWGTRVRIIEGIAQGLLYLHQYSRLRVIHRDLKASNILLDKDMNPKISDFGMARM 314 (476)
Q Consensus 241 ~~~~l~~Ey~~~~------~~~~~L~~~~~~~i~~qIa~gL~yLH~~~~~~ivH~DLkp~NILld~~~~~kL~DFGla~~ 314 (476)
+..+++|||++.+ .+.+.++...+..++.||+.||+|||+++ |+||||||+|||++.++.+||+|||++..
T Consensus 74 ~~~~lv~E~~~~g~L~~~i~~~~~~~~~~~~~~~~qi~~al~~lH~~~---ivHrDlkp~Nill~~~~~ikL~DFG~a~~ 150 (376)
T cd05598 74 DNLYFVMDYIPGGDMMSLLIRLGIFEEDLARFYIAELTCAIESVHKMG---FIHRDIKPDNILIDRDGHIKLTDFGLCTG 150 (376)
T ss_pred CEEEEEEeCCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCC---eEeCCCCHHHEEECCCCCEEEEeCCCCcc
Confidence 4678899999843 23567899999999999999999999999 99999999999999999999999999753
Q ss_pred cCCCc-----------------------------------------ccccceeeeeccCCCChhhhccCCCCccceEEee
Q 045315 315 FGGDE-----------------------------------------LQSNTKRIVGTYGYMSPEYALRGLFSIKSDVFSF 353 (476)
Q Consensus 315 ~~~~~-----------------------------------------~~~~~~~~~gt~~y~aPE~l~~~~~s~ksDVwSl 353 (476)
+.... .........||+.|+|||++.+..++.++|||||
T Consensus 151 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSl 230 (376)
T cd05598 151 FRWTHDSKYYQKGDHHRQDSMEPSEEWSEIDRCRLKPLERRRKRQHQRCLAHSLVGTPNYIAPEVLLRTGYTQLCDWWSV 230 (376)
T ss_pred ccccccccccccccccccccccccccccccccccccchhhhhhhhcccccccccCCCccccCHHHHcCCCCCcceeeeec
Confidence 31100 0000112468999999999999999999999999
Q ss_pred hhhhhhhhhCCCCCCcCCCCchhhhhhhhhhhcCCCcccccCcccCCCCCHHHHHHHHHHHHHchhhcccCCC---CHHH
Q 045315 354 GVLLLETLSSKKNTHFYNTDSLTLLGHAWNLWNDGRTWELMDPISQNGASYPILKRYINVALLCVQEKAADRP---AMSE 430 (476)
Q Consensus 354 Gvvl~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~l~~li~~Cl~~dP~~RP---t~~e 430 (476)
||++|||++|+.||........ ... .......... .........+.+++.+|+ .+|.+|+ ++.+
T Consensus 231 Gvilyell~G~~Pf~~~~~~~~--~~~---i~~~~~~~~~-------~~~~~~s~~~~~li~~l~-~~p~~R~~~~t~~e 297 (376)
T cd05598 231 GVILYEMLVGQPPFLADTPAET--QLK---VINWETTLHI-------PSQAKLSREASDLILRLC-CGAEDRLGKNGADE 297 (376)
T ss_pred cceeeehhhCCCCCCCCCHHHH--HHH---HhccCccccC-------CCCCCCCHHHHHHHHHHh-cCHhhcCCCCCHHH
Confidence 9999999999999875432111 100 0000000000 001112345666777765 4999999 8888
Q ss_pred HHHH
Q 045315 431 VVSM 434 (476)
Q Consensus 431 Vl~~ 434 (476)
+++.
T Consensus 298 ll~h 301 (376)
T cd05598 298 IKAH 301 (376)
T ss_pred HhCC
Confidence 8754
|
Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS was originally identified in Drosophila using a screen for genes whose inactivation led to overproliferation of cells. In tetrapods, there are two LATS isoforms, LATS1 and LATS2. Inactivation of LATS1 in mice results in the development of various tumors, including sarcomas and ovarian cancer. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. |
| >cd05056 PTKc_FAK Catalytic domain of the Protein Tyrosine Kinase, Focal Adhesion Kinase | Back alignment and domain information |
|---|
Probab=99.91 E-value=1e-24 Score=211.93 Aligned_cols=179 Identities=21% Similarity=0.275 Sum_probs=135.2
Q ss_pred ccceeeccCCCC-------CCCCCCChhhHHHHHHHHHHHHHHHhhcCCCceeecCCCccceEecCCCCceeccccceee
Q 045315 242 EISFWYESYNNP-------TKKGLLCWGTRVRIIEGIAQGLLYLHQYSRLRVIHRDLKASNILLDKDMNPKISDFGMARM 314 (476)
Q Consensus 242 ~~~l~~Ey~~~~-------~~~~~L~~~~~~~i~~qIa~gL~yLH~~~~~~ivH~DLkp~NILld~~~~~kL~DFGla~~ 314 (476)
..++++||++.. .....+++.+++.++.|++.||+|||+.+ ++|+||||+||+++.++.+||+|||+++.
T Consensus 80 ~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~---~~H~dl~p~nili~~~~~~~l~d~g~~~~ 156 (270)
T cd05056 80 PVWIVMELAPLGELRSYLQVNKYSLDLASLILYSYQLSTALAYLESKR---FVHRDIAARNVLVSSPDCVKLGDFGLSRY 156 (270)
T ss_pred CcEEEEEcCCCCcHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHhCC---eeccccChheEEEecCCCeEEccCceeee
Confidence 356788888732 22346899999999999999999999998 99999999999999999999999999987
Q ss_pred cCCCcccccceeeeeccCCCChhhhccCCCCccceEEeehhhhhhhhh-CCCCCCcCCCCchhhhhhhhhhhcCCCcccc
Q 045315 315 FGGDELQSNTKRIVGTYGYMSPEYALRGLFSIKSDVFSFGVLLLETLS-SKKNTHFYNTDSLTLLGHAWNLWNDGRTWEL 393 (476)
Q Consensus 315 ~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~s~ksDVwSlGvvl~ellt-G~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~ 393 (476)
......... ....++..|+|||.+....++.++||||||++++|+++ |..||...... ..... ...+....
T Consensus 157 ~~~~~~~~~-~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~g~~pf~~~~~~--~~~~~----~~~~~~~~- 228 (270)
T cd05056 157 LEDESYYKA-SKGKLPIKWMAPESINFRRFTSASDVWMFGVCMWEILMLGVKPFQGVKNN--DVIGR----IENGERLP- 228 (270)
T ss_pred cccccceec-CCCCccccccChhhhccCCCCchhhhHHHHHHHHHHHHcCCCCCCCCCHH--HHHHH----HHcCCcCC-
Confidence 654322111 12234568999999988889999999999999999986 99998644321 11111 11111110
Q ss_pred cCcccCCCCCHHHHHHHHHHHHHchhhcccCCCCHHHHHHHHhccc
Q 045315 394 MDPISQNGASYPILKRYINVALLCVQEKAADRPAMSEVVSMLSNEF 439 (476)
Q Consensus 394 ~d~~~~~~~~~~~~~~l~~li~~Cl~~dP~~RPt~~eVl~~L~~~~ 439 (476)
........+.+++.+|+..+|++|||+.++++.|+++.
T Consensus 229 --------~~~~~~~~~~~li~~~l~~~P~~Rpt~~~~~~~l~~~~ 266 (270)
T cd05056 229 --------MPPNCPPTLYSLMTKCWAYDPSKRPRFTELKAQLSDIL 266 (270)
T ss_pred --------CCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHH
Confidence 11122357888999999999999999999999998865
|
Protein Tyrosine Kinase (PTK) family; Focal Adhesion Kinase (FAK); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FAK is a cytoplasmic (or nonreceptor) tyr kinase that contains an autophosphorylation site and a FERM domain at the N-terminus, a central tyr kinase domain, proline-rich regions, and a C-terminal FAT (focal adhesion targeting) domain. FAK activity is dependent on integrin-mediated cell adhesion, which facilitates N-terminal autophosphorylation. Full activation is achieved by the phosphorylation of its two adjacent A-loop tyrosines. FAK is important in mediating signaling initiated at sites of cell adhesions |
| >KOG0033 consensus Ca2+/calmodulin-dependent protein kinase, EF-Hand protein superfamily [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.91 E-value=8.2e-25 Score=199.78 Aligned_cols=174 Identities=21% Similarity=0.269 Sum_probs=133.5
Q ss_pred cccceeeccCCCC------CCCCCCChhhHHHHHHHHHHHHHHHhhcCCCceeecCCCccceEecC---CCCceeccccc
Q 045315 241 DEISFWYESYNNP------TKKGLLCWGTRVRIIEGIAQGLLYLHQYSRLRVIHRDLKASNILLDK---DMNPKISDFGM 311 (476)
Q Consensus 241 ~~~~l~~Ey~~~~------~~~~~L~~~~~~~i~~qIa~gL~yLH~~~~~~ivH~DLkp~NILld~---~~~~kL~DFGl 311 (476)
+-.++++|+|... ..+..+++..+-..++||+++|.|+|.++ |||||+||+|+++.. ..-+||+|||+
T Consensus 83 ~~~ylvFe~m~G~dl~~eIV~R~~ySEa~aSH~~rQiLeal~yCH~n~---IvHRDvkP~nllLASK~~~A~vKL~~FGv 159 (355)
T KOG0033|consen 83 SFHYLVFDLVTGGELFEDIVAREFYSEADASHCIQQILEALAYCHSNG---IVHRDLKPENLLLASKAKGAAVKLADFGL 159 (355)
T ss_pred ceeEEEEecccchHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHhcC---ceeccCChhheeeeeccCCCceeecccce
Confidence 3477889998732 24466778888889999999999999999 999999999999953 34579999999
Q ss_pred eeecCCCcccccceeeeeccCCCChhhhccCCCCccceEEeehhhhhhhhhCCCCCCcCCCCchhhhhhhhhhhcCCCcc
Q 045315 312 ARMFGGDELQSNTKRIVGTYGYMSPEYALRGLFSIKSDVFSFGVLLLETLSSKKNTHFYNTDSLTLLGHAWNLWNDGRTW 391 (476)
Q Consensus 312 a~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~s~ksDVwSlGvvl~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~ 391 (476)
|..+.... ....+.||++|||||++...+|+..+|||+.||+||-|+.|++||...+. ..+. +.+..+..
T Consensus 160 Ai~l~~g~---~~~G~~GtP~fmaPEvvrkdpy~kpvDiW~cGViLfiLL~G~~PF~~~~~--~rly----e~I~~g~y- 229 (355)
T KOG0033|consen 160 AIEVNDGE---AWHGFAGTPGYLSPEVLKKDPYSKPVDIWACGVILYILLVGYPPFWDEDQ--HRLY----EQIKAGAY- 229 (355)
T ss_pred EEEeCCcc---ccccccCCCcccCHHHhhcCCCCCcchhhhhhHHHHHHHhCCCCCCCccH--HHHH----HHHhcccc-
Confidence 99887332 23347899999999999999999999999999999999999999875332 1111 11222211
Q ss_pred cccCcccCCCCCHHHHHHHHHHHHHchhhcccCCCCHHHHH
Q 045315 392 ELMDPISQNGASYPILKRYINVALLCVQEKAADRPAMSEVV 432 (476)
Q Consensus 392 ~~~d~~~~~~~~~~~~~~l~~li~~Cl~~dP~~RPt~~eVl 432 (476)
+ .....-....++..+++++||..||++|.|+.|.+
T Consensus 230 d-----~~~~~w~~is~~Ak~LvrrML~~dP~kRIta~EAL 265 (355)
T KOG0033|consen 230 D-----YPSPEWDTVTPEAKSLIRRMLTVNPKKRITADEAL 265 (355)
T ss_pred C-----CCCcccCcCCHHHHHHHHHHhccChhhhccHHHHh
Confidence 1 11112233456788999999999999999998865
|
|
| >cd05112 PTKc_Itk Catalytic domain of the Protein Tyrosine Kinase, Interleukin-2-inducible T-cell Kinase | Back alignment and domain information |
|---|
Probab=99.91 E-value=9.1e-25 Score=210.30 Aligned_cols=176 Identities=30% Similarity=0.421 Sum_probs=132.4
Q ss_pred ccceeeccCCCC-------CCCCCCChhhHHHHHHHHHHHHHHHhhcCCCceeecCCCccceEecCCCCceeccccceee
Q 045315 242 EISFWYESYNNP-------TKKGLLCWGTRVRIIEGIAQGLLYLHQYSRLRVIHRDLKASNILLDKDMNPKISDFGMARM 314 (476)
Q Consensus 242 ~~~l~~Ey~~~~-------~~~~~L~~~~~~~i~~qIa~gL~yLH~~~~~~ivH~DLkp~NILld~~~~~kL~DFGla~~ 314 (476)
..++++||++.. .+...++++.+..++.|++.||+|||+.+ ++|+||||+||+++.++.+||+|||+++.
T Consensus 73 ~~~~v~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~---i~h~dl~p~ni~i~~~~~~~l~d~g~~~~ 149 (256)
T cd05112 73 PICLVFEFMEHGCLSDYLRAQRGKFSQETLLGMCLDVCEGMAYLESSN---VIHRDLAARNCLVGENQVVKVSDFGMTRF 149 (256)
T ss_pred ceEEEEEcCCCCcHHHHHHhCccCCCHHHHHHHHHHHHHHHHHHHHCC---ccccccccceEEEcCCCeEEECCCcceee
Confidence 466788888732 23456899999999999999999999998 99999999999999999999999999986
Q ss_pred cCCCcccccceeeeeccCCCChhhhccCCCCccceEEeehhhhhhhhh-CCCCCCcCCCCchhhhhhhhhhhcCCCcccc
Q 045315 315 FGGDELQSNTKRIVGTYGYMSPEYALRGLFSIKSDVFSFGVLLLETLS-SKKNTHFYNTDSLTLLGHAWNLWNDGRTWEL 393 (476)
Q Consensus 315 ~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~s~ksDVwSlGvvl~ellt-G~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~ 393 (476)
........ .....++.+|+|||.+.++.++.++|+||||+++||+++ |+.||..... ...... ...+. ..
T Consensus 150 ~~~~~~~~-~~~~~~~~~~~aPe~~~~~~~~~~~Dv~slG~~l~el~~~g~~p~~~~~~--~~~~~~----~~~~~--~~ 220 (256)
T cd05112 150 VLDDQYTS-STGTKFPVKWSSPEVFSFSKYSSKSDVWSFGVLMWEVFSEGKTPYENRSN--SEVVET----INAGF--RL 220 (256)
T ss_pred cccCcccc-cCCCccchhhcCHhHhccCCcChHHHHHHHHHHHHHHHcCCCCCCCcCCH--HHHHHH----HhCCC--CC
Confidence 64332111 111234578999999988889999999999999999998 8888754321 111111 11110 11
Q ss_pred cCcccCCCCCHHHHHHHHHHHHHchhhcccCCCCHHHHHHHHh
Q 045315 394 MDPISQNGASYPILKRYINVALLCVQEKAADRPAMSEVVSMLS 436 (476)
Q Consensus 394 ~d~~~~~~~~~~~~~~l~~li~~Cl~~dP~~RPt~~eVl~~L~ 436 (476)
..+. ...+.+.+++.+||+.+|++||++.+|++.|.
T Consensus 221 ~~~~-------~~~~~~~~l~~~~l~~~p~~Rp~~~~~l~~l~ 256 (256)
T cd05112 221 YKPR-------LASQSVYELMQHCWKERPEDRPSFSLLLHQLA 256 (256)
T ss_pred CCCC-------CCCHHHHHHHHHHcccChhhCCCHHHHHHhhC
Confidence 1111 12357889999999999999999999999873
|
Protein Tyrosine Kinase (PTK) family; Interleukin-2 (IL-2)-inducible T-cell kinase (Itk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Itk (also known as Tsk or Emt) is a member of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activ |
| >cd07878 STKc_p38beta_MAPK11 Catalytic domain of the Serine/Threonine Kinase, p38beta Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Probab=99.91 E-value=6.5e-25 Score=221.31 Aligned_cols=183 Identities=22% Similarity=0.247 Sum_probs=128.4
Q ss_pred ccceeeccCCC----CCCCCCCChhhHHHHHHHHHHHHHHHhhcCCCceeecCCCccceEecCCCCceeccccceeecCC
Q 045315 242 EISFWYESYNN----PTKKGLLCWGTRVRIIEGIAQGLLYLHQYSRLRVIHRDLKASNILLDKDMNPKISDFGMARMFGG 317 (476)
Q Consensus 242 ~~~l~~Ey~~~----~~~~~~L~~~~~~~i~~qIa~gL~yLH~~~~~~ivH~DLkp~NILld~~~~~kL~DFGla~~~~~ 317 (476)
..++++|++.. ..+...+++.++..++.||+.||+|||+.+ |+||||||+||+++.++.+||+|||+++....
T Consensus 94 ~~~~~~~~~~~~l~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~---ivHrdikp~Nil~~~~~~~kl~Dfg~~~~~~~ 170 (343)
T cd07878 94 EVYLVTNLMGADLNNIVKCQKLSDEHVQFLIYQLLRGLKYIHSAG---IIHRDLKPSNVAVNEDCELRILDFGLARQADD 170 (343)
T ss_pred cEEEEeecCCCCHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCC---eecccCChhhEEECCCCCEEEcCCccceecCC
Confidence 35666777651 123456999999999999999999999999 99999999999999999999999999986543
Q ss_pred CcccccceeeeeccCCCChhhhcc-CCCCccceEEeehhhhhhhhhCCCCCCcCCCCchhhhhhhhhhh-----------
Q 045315 318 DELQSNTKRIVGTYGYMSPEYALR-GLFSIKSDVFSFGVLLLETLSSKKNTHFYNTDSLTLLGHAWNLW----------- 385 (476)
Q Consensus 318 ~~~~~~~~~~~gt~~y~aPE~l~~-~~~s~ksDVwSlGvvl~elltG~~p~~~~~~~~~~~~~~~~~~~----------- 385 (476)
. .....|+..|+|||.+.+ ..++.++|||||||++|+|++|+.||....... .........
T Consensus 171 ~-----~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~--~~~~~~~~~~~~~~~~~~~~ 243 (343)
T cd07878 171 E-----MTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLKGKALFPGNDYID--QLKRIMEVVGTPSPEVLKKI 243 (343)
T ss_pred C-----cCCccccccccCchHhcCCccCCchhhhHhHHHHHHHHHHCCCCCCCCCHHH--HHHHHHHHhCCCCHHHHHhc
Confidence 2 123468999999999876 568999999999999999999999986432110 000000000
Q ss_pred cCCCcccccCccc-CCCCC-----HHHHHHHHHHHHHchhhcccCCCCHHHHHHH
Q 045315 386 NDGRTWELMDPIS-QNGAS-----YPILKRYINVALLCVQEKAADRPAMSEVVSM 434 (476)
Q Consensus 386 ~~~~~~~~~d~~~-~~~~~-----~~~~~~l~~li~~Cl~~dP~~RPt~~eVl~~ 434 (476)
............. ..... ......+.+++.+||+.||++|||+.|+++.
T Consensus 244 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~mL~~dp~~R~s~~ell~h 298 (343)
T cd07878 244 SSEHARKYIQSLPHMPQQDLKKIFRGANPLAIDLLEKMLVLDSDKRISASEALAH 298 (343)
T ss_pred chhhHHHHhhccccccchhHHHhccCCCHHHHHHHHHHcCCChhhCCCHHHHhcC
Confidence 0000000000000 00000 0112357799999999999999999999854
|
Serine/Threonine Kinases (STKs), p38beta subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38beta subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38beta, also called MAPK11, is |
| >cd08227 PK_STRAD_alpha Pseudokinase domain of STE20-related kinase adapter protein alpha | Back alignment and domain information |
|---|
Probab=99.91 E-value=2e-24 Score=216.38 Aligned_cols=190 Identities=19% Similarity=0.204 Sum_probs=128.9
Q ss_pred cccceeeccCCCC--------CCCCCCChhhHHHHHHHHHHHHHHHhhcCCCceeecCCCccceEecCCCCceeccccce
Q 045315 241 DEISFWYESYNNP--------TKKGLLCWGTRVRIIEGIAQGLLYLHQYSRLRVIHRDLKASNILLDKDMNPKISDFGMA 312 (476)
Q Consensus 241 ~~~~l~~Ey~~~~--------~~~~~L~~~~~~~i~~qIa~gL~yLH~~~~~~ivH~DLkp~NILld~~~~~kL~DFGla 312 (476)
+.+++++||++.. ...+.+++.+++.++.||+.||+|||+++ |+||||||+||+++.++.++++||+.+
T Consensus 72 ~~~~lv~e~~~~~~l~~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~---iiH~dlkp~Nil~~~~~~~~l~~~~~~ 148 (327)
T cd08227 72 NELWVVTSFMAYGSAKDLICTHFMDGMSELAIAYILQGVLKALDYIHHMG---YVHRSVKASHILISVDGKVYLSGLRSN 148 (327)
T ss_pred CEEEEEEeccCCCcHHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHHCC---EecCCCChhhEEEecCCcEEEcccchh
Confidence 4678899999832 22356899999999999999999999998 999999999999999999999999865
Q ss_pred eecCCCccc-----ccceeeeeccCCCChhhhcc--CCCCccceEEeehhhhhhhhhCCCCCCcCCCCchhhhhhhhh--
Q 045315 313 RMFGGDELQ-----SNTKRIVGTYGYMSPEYALR--GLFSIKSDVFSFGVLLLETLSSKKNTHFYNTDSLTLLGHAWN-- 383 (476)
Q Consensus 313 ~~~~~~~~~-----~~~~~~~gt~~y~aPE~l~~--~~~s~ksDVwSlGvvl~elltG~~p~~~~~~~~~~~~~~~~~-- 383 (476)
......... .......++..|+|||++.+ ..++.++|||||||++|||++|+.||................
T Consensus 149 ~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~ 228 (327)
T cd08227 149 LSMINHGQRLRVVHDFPKYSVKVLPWLSPEVLQQNLQGYDAKSDIYSVGITACELANGHVPFKDMPATQMLLEKLNGTVP 228 (327)
T ss_pred hccccccccccccccccccccceecccChHHhhcccCCCCchhhHHHHHHHHHHHHHCCCCCCCcchhHHHHHHhcCCcc
Confidence 433211100 01112346678999999876 468999999999999999999999986432111000000000
Q ss_pred -hhc------------------CCCccc--c---cCcc----cCCCCCHHHHHHHHHHHHHchhhcccCCCCHHHHHH
Q 045315 384 -LWN------------------DGRTWE--L---MDPI----SQNGASYPILKRYINVALLCVQEKAADRPAMSEVVS 433 (476)
Q Consensus 384 -~~~------------------~~~~~~--~---~d~~----~~~~~~~~~~~~l~~li~~Cl~~dP~~RPt~~eVl~ 433 (476)
... .....+ . ..+. ............+.+++.+||+.||++|||++|+++
T Consensus 229 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~Rpt~~ell~ 306 (327)
T cd08227 229 CLLDTTTIPAEELTMKPSRSGANSGLGESTTVSTPRPSNGESSSHPYNRTFSPHFHHFVEQCLQRNPDARPSASTLLN 306 (327)
T ss_pred ccccccchhhhhcccCCcccCCcCCCCcccccCCcCccccCCcccccccccCHHHHHHHHHHHhhCchhcCCHHHHhc
Confidence 000 000000 0 0000 000011123457889999999999999999999986
|
Protein Kinase family, STE20-related kinase adapter protein (STRAD) alpha subfamily, pseudokinase domain. The STRAD alpha subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hype |
| >cd06636 STKc_MAP4K4_6 Catalytic domain of the Protein Serine/Threonine Kinases, Mitogen-Activated Protein Kinase Kinase Kinase Kinase 4 and 6 | Back alignment and domain information |
|---|
Probab=99.91 E-value=1.6e-24 Score=211.95 Aligned_cols=173 Identities=24% Similarity=0.319 Sum_probs=129.1
Q ss_pred ccceeeccCCCC--------CCCCCCChhhHHHHHHHHHHHHHHHhhcCCCceeecCCCccceEecCCCCceecccccee
Q 045315 242 EISFWYESYNNP--------TKKGLLCWGTRVRIIEGIAQGLLYLHQYSRLRVIHRDLKASNILLDKDMNPKISDFGMAR 313 (476)
Q Consensus 242 ~~~l~~Ey~~~~--------~~~~~L~~~~~~~i~~qIa~gL~yLH~~~~~~ivH~DLkp~NILld~~~~~kL~DFGla~ 313 (476)
.++++|||++.. .+...+++..+..++.||+.||+|||+.+ ++|+||||+||+++.++.++|+|||++.
T Consensus 93 ~~~iv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~qi~~al~~LH~~~---ivH~dl~~~nili~~~~~~~l~dfg~~~ 169 (282)
T cd06636 93 QLWLVMEFCGAGSVTDLVKNTKGNALKEDWIAYICREILRGLAHLHAHK---VIHRDIKGQNVLLTENAEVKLVDFGVSA 169 (282)
T ss_pred EEEEEEEeCCCCcHHHHHHHccCCCCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCCHHHEEECCCCCEEEeeCcchh
Confidence 567899999732 23456888899999999999999999998 9999999999999999999999999987
Q ss_pred ecCCCcccccceeeeeccCCCChhhhc-----cCCCCccceEEeehhhhhhhhhCCCCCCcCCCCchhhhhhhhhhhcCC
Q 045315 314 MFGGDELQSNTKRIVGTYGYMSPEYAL-----RGLFSIKSDVFSFGVLLLETLSSKKNTHFYNTDSLTLLGHAWNLWNDG 388 (476)
Q Consensus 314 ~~~~~~~~~~~~~~~gt~~y~aPE~l~-----~~~~s~ksDVwSlGvvl~elltG~~p~~~~~~~~~~~~~~~~~~~~~~ 388 (476)
....... ......|+..|+|||.+. ...++.++|+|||||++|||++|+.||........ .. ... ..
T Consensus 170 ~~~~~~~--~~~~~~~~~~y~aPE~l~~~~~~~~~~~~~~DvwslG~~l~el~~g~~p~~~~~~~~~-~~----~~~-~~ 241 (282)
T cd06636 170 QLDRTVG--RRNTFIGTPYWMAPEVIACDENPDATYDYRSDIWSLGITAIEMAEGAPPLCDMHPMRA-LF----LIP-RN 241 (282)
T ss_pred hhhcccc--CCCcccccccccCHhhcCcccCcCcCCCcccchhHHHHHHHHHHhCCCCccccCHHhh-hh----hHh-hC
Confidence 6532211 122356889999999875 34578899999999999999999999854321110 00 000 00
Q ss_pred CcccccCcccCCCCCHHHHHHHHHHHHHchhhcccCCCCHHHHHH
Q 045315 389 RTWELMDPISQNGASYPILKRYINVALLCVQEKAADRPAMSEVVS 433 (476)
Q Consensus 389 ~~~~~~d~~~~~~~~~~~~~~l~~li~~Cl~~dP~~RPt~~eVl~ 433 (476)
. .+.. ........+.+++.+||+.||.+||++.|+++
T Consensus 242 ~-----~~~~---~~~~~~~~~~~li~~cl~~~p~~Rp~~~ell~ 278 (282)
T cd06636 242 P-----PPKL---KSKKWSKKFIDFIEGCLVKNYLSRPSTEQLLK 278 (282)
T ss_pred C-----CCCC---cccccCHHHHHHHHHHhCCChhhCcCHHHHhc
Confidence 0 0000 01123457889999999999999999999874
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 4 (MAPKKKK4 or MAP4K4) and MAPKKKK6 (or MAP4K6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K4/MAP4K6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain. MAP4Ks (or MAPKKKKs) are involved in MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Ea |
| >cd06642 STKc_STK25-YSK1 Catalytic domain of the Protein Serine/Threonine Kinase, STK25 or Yeast Sps1/Ste20-related kinase 1 | Back alignment and domain information |
|---|
Probab=99.91 E-value=1.5e-24 Score=211.64 Aligned_cols=174 Identities=25% Similarity=0.359 Sum_probs=133.8
Q ss_pred cccceeeccCCCCC-----CCCCCChhhHHHHHHHHHHHHHHHhhcCCCceeecCCCccceEecCCCCceeccccceeec
Q 045315 241 DEISFWYESYNNPT-----KKGLLCWGTRVRIIEGIAQGLLYLHQYSRLRVIHRDLKASNILLDKDMNPKISDFGMARMF 315 (476)
Q Consensus 241 ~~~~l~~Ey~~~~~-----~~~~L~~~~~~~i~~qIa~gL~yLH~~~~~~ivH~DLkp~NILld~~~~~kL~DFGla~~~ 315 (476)
...++++||++... ....+++..+..++.||++||.|||+++ ++|+||+|+||++++++.++|+|||++..+
T Consensus 75 ~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~---ivH~dl~p~ni~i~~~~~~~l~dfg~~~~~ 151 (277)
T cd06642 75 TKLWIIMEYLGGGSALDLLKPGPLEETYIATILREILKGLDYLHSER---KIHRDIKAANVLLSEQGDVKLADFGVAGQL 151 (277)
T ss_pred CceEEEEEccCCCcHHHHhhcCCCCHHHHHHHHHHHHHHHHHHhcCC---eeccCCChheEEEeCCCCEEEccccccccc
Confidence 35678999998322 3457899999999999999999999998 999999999999999999999999999866
Q ss_pred CCCcccccceeeeeccCCCChhhhccCCCCccceEEeehhhhhhhhhCCCCCCcCCCCchhhhhhhhhhhcCCCcccccC
Q 045315 316 GGDELQSNTKRIVGTYGYMSPEYALRGLFSIKSDVFSFGVLLLETLSSKKNTHFYNTDSLTLLGHAWNLWNDGRTWELMD 395 (476)
Q Consensus 316 ~~~~~~~~~~~~~gt~~y~aPE~l~~~~~s~ksDVwSlGvvl~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~d 395 (476)
..... ......++..|+|||++.+..++.++|+|||||+++|+++|+.|+........ .. ....+.
T Consensus 152 ~~~~~--~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~el~tg~~p~~~~~~~~~--~~----~~~~~~------ 217 (277)
T cd06642 152 TDTQI--KRNTFVGTPFWMAPEVIKQSAYDFKADIWSLGITAIELAKGEPPNSDLHPMRV--LF----LIPKNS------ 217 (277)
T ss_pred cCcch--hhhcccCcccccCHHHhCcCCCchhhhHHHHHHHHHHHHhCCCCCcccchhhH--Hh----hhhcCC------
Confidence 43321 11224578899999999988899999999999999999999998753321110 00 000110
Q ss_pred cccCCCCCHHHHHHHHHHHHHchhhcccCCCCHHHHHHH
Q 045315 396 PISQNGASYPILKRYINVALLCVQEKAADRPAMSEVVSM 434 (476)
Q Consensus 396 ~~~~~~~~~~~~~~l~~li~~Cl~~dP~~RPt~~eVl~~ 434 (476)
...........+.+++.+||+.+|++||++.+|++.
T Consensus 218 ---~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~il~~ 253 (277)
T cd06642 218 ---PPTLEGQYSKPFKEFVEACLNKDPRFRPTAKELLKH 253 (277)
T ss_pred ---CCCCCcccCHHHHHHHHHHccCCcccCcCHHHHHHh
Confidence 011112234568899999999999999999999974
|
Serine/threonine kinases (STKs), STK25 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The STK25 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. STK25 is also called Ste20/oxidant stress response kinase 1 (SOK1) or yeast Sps1/Ste20-related kinase 1 (YSK1). STK25 is localized in the Golgi apparatus through its interaction with the Golgi matrix protein GM130. It may play a role in the regulation of cell migration and polarization. STK25 binds and phosphorylates CCM3 (cerebral cavernous malformation 3), also called PCD10 (programmed cell death 10), and may play a role in apoptosis. Human STK25 |
| >KOG0604 consensus MAP kinase-activated protein kinase 2 [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.91 E-value=2.4e-24 Score=201.89 Aligned_cols=179 Identities=18% Similarity=0.200 Sum_probs=136.6
Q ss_pred ccceeeccCCC--------CCCCCCCChhhHHHHHHHHHHHHHHHhhcCCCceeecCCCccceEec---CCCCceecccc
Q 045315 242 EISFWYESYNN--------PTKKGLLCWGTRVRIIEGIAQGLLYLHQYSRLRVIHRDLKASNILLD---KDMNPKISDFG 310 (476)
Q Consensus 242 ~~~l~~Ey~~~--------~~~~~~L~~~~~~~i~~qIa~gL~yLH~~~~~~ivH~DLkp~NILld---~~~~~kL~DFG 310 (476)
-.++|||+|+. .+....++++++-.|.+||+.|+.|||+.+ |.||||||+|+|.. .|..+||+|||
T Consensus 133 cLLiVmE~meGGeLfsriq~~g~~afTErea~eI~~qI~~Av~~lH~~n---IAHRDlKpENLLyt~t~~na~lKLtDfG 209 (400)
T KOG0604|consen 133 CLLIVMECMEGGELFSRIQDRGDQAFTEREASEIMKQIGLAVRYLHSMN---IAHRDLKPENLLYTTTSPNAPLKLTDFG 209 (400)
T ss_pred eeEeeeecccchHHHHHHHHcccccchHHHHHHHHHHHHHHHHHHHhcc---hhhccCChhheeeecCCCCcceEecccc
Confidence 35578999993 234567999999999999999999999999 99999999999996 45568999999
Q ss_pred ceeecCCCcccccceeeeeccCCCChhhhccCCCCccceEEeehhhhhhhhhCCCCCCcCCCCchhhhhhhhhhhcCCCc
Q 045315 311 MARMFGGDELQSNTKRIVGTYGYMSPEYALRGLFSIKSDVFSFGVLLLETLSSKKNTHFYNTDSLTLLGHAWNLWNDGRT 390 (476)
Q Consensus 311 la~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~s~ksDVwSlGvvl~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~ 390 (476)
+|+.-.. ........-|+.|.|||++....|....|+||+||++|-|+||.+||....... +.--....+..+..
T Consensus 210 FAK~t~~---~~~L~TPc~TPyYvaPevlg~eKydkscdmwSlgVimYIlLCGyPPFYS~hg~a--ispgMk~rI~~gqy 284 (400)
T KOG0604|consen 210 FAKETQE---PGDLMTPCFTPYYVAPEVLGPEKYDKSCDMWSLGVIMYILLCGYPPFYSNHGLA--ISPGMKRRIRTGQY 284 (400)
T ss_pred cccccCC---CccccCCcccccccCHHHhCchhcCCCCCccchhHHHHHhhcCCCcccccCCcc--CChhHHhHhhccCc
Confidence 9986543 222334567999999999998899999999999999999999999997543211 11111111111111
Q ss_pred ccccCcccCCCCCHHHHHHHHHHHHHchhhcccCCCCHHHHHHH
Q 045315 391 WELMDPISQNGASYPILKRYINVALLCVQEKAADRPAMSEVVSM 434 (476)
Q Consensus 391 ~~~~d~~~~~~~~~~~~~~l~~li~~Cl~~dP~~RPt~~eVl~~ 434 (476)
++ ..+......+...++++.+|..+|.+|.|+.+++..
T Consensus 285 -~F-----P~pEWs~VSe~aKdlIR~LLkt~PteRlTI~~~m~h 322 (400)
T KOG0604|consen 285 -EF-----PEPEWSCVSEAAKDLIRKLLKTEPTERLTIEEVMDH 322 (400)
T ss_pred -cC-----CChhHhHHHHHHHHHHHHHhcCCchhheeHHHhhcC
Confidence 11 122234557788899999999999999999999864
|
|
| >cd06658 STKc_PAK5 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 5 | Back alignment and domain information |
|---|
Probab=99.91 E-value=1.5e-24 Score=213.76 Aligned_cols=176 Identities=23% Similarity=0.333 Sum_probs=133.8
Q ss_pred cccceeeccCCCCC-----CCCCCChhhHHHHHHHHHHHHHHHhhcCCCceeecCCCccceEecCCCCceeccccceeec
Q 045315 241 DEISFWYESYNNPT-----KKGLLCWGTRVRIIEGIAQGLLYLHQYSRLRVIHRDLKASNILLDKDMNPKISDFGMARMF 315 (476)
Q Consensus 241 ~~~~l~~Ey~~~~~-----~~~~L~~~~~~~i~~qIa~gL~yLH~~~~~~ivH~DLkp~NILld~~~~~kL~DFGla~~~ 315 (476)
+..++++||++... ..+.+++.++..++.||+.||+|||+++ ++||||||+||++++++.+||+|||++...
T Consensus 92 ~~~~lv~e~~~~~~L~~~~~~~~l~~~~~~~~~~qi~~~l~~LH~~~---ivH~dlkp~Nill~~~~~~kL~dfg~~~~~ 168 (292)
T cd06658 92 DELWVVMEFLEGGALTDIVTHTRMNEEQIATVCLSVLRALSYLHNQG---VIHRDIKSDSILLTSDGRIKLSDFGFCAQV 168 (292)
T ss_pred CeEEEEEeCCCCCcHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCC---EeecCCCHHHEEEcCCCCEEEccCcchhhc
Confidence 45788999998432 2456899999999999999999999998 999999999999999999999999998765
Q ss_pred CCCcccccceeeeeccCCCChhhhccCCCCccceEEeehhhhhhhhhCCCCCCcCCCCchhhhhhhhhhhcCCCcccccC
Q 045315 316 GGDELQSNTKRIVGTYGYMSPEYALRGLFSIKSDVFSFGVLLLETLSSKKNTHFYNTDSLTLLGHAWNLWNDGRTWELMD 395 (476)
Q Consensus 316 ~~~~~~~~~~~~~gt~~y~aPE~l~~~~~s~ksDVwSlGvvl~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~d 395 (476)
..... ......++..|+|||...+..++.++|+||||+++||+++|+.||..... ....... .. ...
T Consensus 169 ~~~~~--~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slGvil~el~~g~~p~~~~~~--~~~~~~~----~~-----~~~ 235 (292)
T cd06658 169 SKEVP--KRKSLVGTPYWMAPEVISRLPYGTEVDIWSLGIMVIEMIDGEPPYFNEPP--LQAMRRI----RD-----NLP 235 (292)
T ss_pred ccccc--cCceeecCccccCHHHHccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCH--HHHHHHH----Hh-----cCC
Confidence 43221 12235688999999999888899999999999999999999999864321 1111111 00 011
Q ss_pred cccCCCCCHHHHHHHHHHHHHchhhcccCCCCHHHHHHH
Q 045315 396 PISQNGASYPILKRYINVALLCVQEKAADRPAMSEVVSM 434 (476)
Q Consensus 396 ~~~~~~~~~~~~~~l~~li~~Cl~~dP~~RPt~~eVl~~ 434 (476)
+.... .......+.+++.+|++.||++|||++++++.
T Consensus 236 ~~~~~--~~~~~~~~~~li~~~l~~~P~~Rpt~~~il~~ 272 (292)
T cd06658 236 PRVKD--SHKVSSVLRGFLDLMLVREPSQRATAQELLQH 272 (292)
T ss_pred Ccccc--ccccCHHHHHHHHHHccCChhHCcCHHHHhhC
Confidence 11111 11223467789999999999999999999874
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 5, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK5 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK5 is mainly express |
| >KOG0667 consensus Dual-specificity tyrosine-phosphorylation regulated kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=99.91 E-value=3.3e-24 Score=220.28 Aligned_cols=121 Identities=26% Similarity=0.318 Sum_probs=102.3
Q ss_pred cceeeccCC-------CCCCCCCCChhhHHHHHHHHHHHHHHHhhcCCCceeecCCCccceEecCCC--Cceecccccee
Q 045315 243 ISFWYESYN-------NPTKKGLLCWGTRVRIIEGIAQGLLYLHQYSRLRVIHRDLKASNILLDKDM--NPKISDFGMAR 313 (476)
Q Consensus 243 ~~l~~Ey~~-------~~~~~~~L~~~~~~~i~~qIa~gL~yLH~~~~~~ivH~DLkp~NILld~~~--~~kL~DFGla~ 313 (476)
.++|+|-+. ..++-..|+...+..|+.||+.||.+||+.+ |||+||||+||||.... .+||+|||.+.
T Consensus 263 lciVfELL~~NLYellK~n~f~Glsl~~ir~~~~Qil~~L~~L~~l~---IIHcDLKPENILL~~~~r~~vKVIDFGSSc 339 (586)
T KOG0667|consen 263 LCIVFELLSTNLYELLKNNKFRGLSLPLVRKFAQQILTALLFLHELG---IIHCDLKPENILLKDPKRSRIKVIDFGSSC 339 (586)
T ss_pred eeeeehhhhhhHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCC---eeeccCChhheeeccCCcCceeEEeccccc
Confidence 345555544 2455667999999999999999999999999 99999999999997433 68999999998
Q ss_pred ecCCCcccccceeeeeccCCCChhhhccCCCCccceEEeehhhhhhhhhCCCCCCcCC
Q 045315 314 MFGGDELQSNTKRIVGTYGYMSPEYALRGLFSIKSDVFSFGVLLLETLSSKKNTHFYN 371 (476)
Q Consensus 314 ~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~s~ksDVwSlGvvl~elltG~~p~~~~~ 371 (476)
...... .....+..|+|||++.+.+|+.+.|+||||||+.||++|.+-|+..+
T Consensus 340 ~~~q~v-----ytYiQSRfYRAPEVILGlpY~~~IDmWSLGCIlAEL~tG~PLfpG~n 392 (586)
T KOG0667|consen 340 FESQRV-----YTYIQSRFYRAPEVILGLPYDTAIDMWSLGCILAELFTGEPLFPGDN 392 (586)
T ss_pred ccCCcc-----eeeeeccccccchhhccCCCCCccceeehhhhHHhHhcCccccCCCC
Confidence 755432 24678899999999999999999999999999999999988887655
|
|
| >cd05086 PTKc_Aatyk2 Catalytic domain of the Protein Tyrosine Kinase, Apoptosis-associated tyrosine kinase 2 | Back alignment and domain information |
|---|
Probab=99.91 E-value=5.2e-24 Score=207.05 Aligned_cols=181 Identities=19% Similarity=0.266 Sum_probs=126.7
Q ss_pred ccceeeccCCCCC----------CCCCCChhhHHHHHHHHHHHHHHHhhcCCCceeecCCCccceEecCCCCceeccccc
Q 045315 242 EISFWYESYNNPT----------KKGLLCWGTRVRIIEGIAQGLLYLHQYSRLRVIHRDLKASNILLDKDMNPKISDFGM 311 (476)
Q Consensus 242 ~~~l~~Ey~~~~~----------~~~~L~~~~~~~i~~qIa~gL~yLH~~~~~~ivH~DLkp~NILld~~~~~kL~DFGl 311 (476)
..+++|||++.+. ....++...+..++.||++||+|||+.+ ++||||||+|||++.++.+||+|||+
T Consensus 69 ~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~i~~al~~lH~~~---i~H~dikp~nil~~~~~~~~l~Dfg~ 145 (268)
T cd05086 69 PYLLVFEYCELGDLKSYLSQEQWHRRNSQLLLLQRMACEIAAGVTHMHKHN---FLHSDLALRNCFLTSDLTVKVGDYGI 145 (268)
T ss_pred ccEEEEecCCCCcHHHHHHhhhcccccccHHHHHHHHHHHHHHHHHHHHCC---eeccCCccceEEEcCCccEEeccccc
Confidence 4678899987321 2345677788899999999999999998 99999999999999999999999999
Q ss_pred eeecCCCcccccceeeeeccCCCChhhhcc-------CCCCccceEEeehhhhhhhhhC-CCCCCcCCCCchhhhhhhhh
Q 045315 312 ARMFGGDELQSNTKRIVGTYGYMSPEYALR-------GLFSIKSDVFSFGVLLLETLSS-KKNTHFYNTDSLTLLGHAWN 383 (476)
Q Consensus 312 a~~~~~~~~~~~~~~~~gt~~y~aPE~l~~-------~~~s~ksDVwSlGvvl~elltG-~~p~~~~~~~~~~~~~~~~~ 383 (476)
+................++..|+|||++.. ..++.++|||||||++|||+++ ..|+.... .......
T Consensus 146 ~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~~DiwslG~~l~el~~~~~~p~~~~~--~~~~~~~--- 220 (268)
T cd05086 146 GPSRYKEDYIETEDDKCVPLRWLAPELVGEFHGGLITAEQTKPSNVWALGVTLWELFENAAQPYSHLS--DREVLNH--- 220 (268)
T ss_pred ccccCcchhhhcccCCcCcccccCchhcccccCccccCCCCCcchhHHHHHHHHHHHhCCCCCCCCCC--HHHHHHH---
Confidence 864322211111223457889999998743 2457899999999999999975 55654322 1111111
Q ss_pred hhcCCCcccccCcccCCCCCHHHHHHHHHHHHHchhhcccCCCCHHHHHHHHh
Q 045315 384 LWNDGRTWELMDPISQNGASYPILKRYINVALLCVQEKAADRPAMSEVVSMLS 436 (476)
Q Consensus 384 ~~~~~~~~~~~d~~~~~~~~~~~~~~l~~li~~Cl~~dP~~RPt~~eVl~~L~ 436 (476)
... +....+.++..... ....+.+++..|| .+|++||++++|++.|.
T Consensus 221 ~~~-~~~~~~~~~~~~~~----~~~~~~~l~~~c~-~~P~~Rp~~~~i~~~l~ 267 (268)
T cd05086 221 VIK-DQQVKLFKPQLELP----YSERWYEVLQFCW-LSPEKRATAEEVHRLLT 267 (268)
T ss_pred HHh-hcccccCCCccCCC----CcHHHHHHHHHHh-hCcccCCCHHHHHHHhc
Confidence 111 11222333332222 3356778888999 57999999999999884
|
Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase 2 (Aatyk2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk2 is a member of the Aatyk subfamily of proteins, which are receptor kinases containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk2 is also called lemur tyrosine kinase 2 (Lmtk2) or brain-enriched kinase (Brek). It is expressed at high levels in early postnatal brain, and has been shown to play a role in nerve growth factor (NGF) signaling. Studies with knockout mice reveal that Aatyk2 is essential for late stage |
| >cd06617 PKc_MKK3_6 Catalytic domain of the dual-specificity Protein Kinases, MAP kinase kinases 3 and 6 | Back alignment and domain information |
|---|
Probab=99.91 E-value=3.4e-24 Score=209.42 Aligned_cols=174 Identities=24% Similarity=0.342 Sum_probs=129.2
Q ss_pred cccceeeccCCC---------CCCCCCCChhhHHHHHHHHHHHHHHHhhc-CCCceeecCCCccceEecCCCCceecccc
Q 045315 241 DEISFWYESYNN---------PTKKGLLCWGTRVRIIEGIAQGLLYLHQY-SRLRVIHRDLKASNILLDKDMNPKISDFG 310 (476)
Q Consensus 241 ~~~~l~~Ey~~~---------~~~~~~L~~~~~~~i~~qIa~gL~yLH~~-~~~~ivH~DLkp~NILld~~~~~kL~DFG 310 (476)
+..++++||++. ...+..+++.++..++.||+.||+|||++ + ++||||||+||+++.++.+||+|||
T Consensus 73 ~~~~lv~e~~~~~l~~~l~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~~---i~h~dlkp~nil~~~~~~~kl~dfg 149 (283)
T cd06617 73 GDVWICMEVMDTSLDKFYKKVYDKGLTIPEDILGKIAVSIVKALEYLHSKLS---VIHRDVKPSNVLINRNGQVKLCDFG 149 (283)
T ss_pred CcEEEEhhhhcccHHHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHhhcCC---eecCCCCHHHEEECCCCCEEEeecc
Confidence 356778888862 12345799999999999999999999987 6 9999999999999999999999999
Q ss_pred ceeecCCCcccccceeeeeccCCCChhhhcc----CCCCccceEEeehhhhhhhhhCCCCCCcCCCCchhhhhhhhhhhc
Q 045315 311 MARMFGGDELQSNTKRIVGTYGYMSPEYALR----GLFSIKSDVFSFGVLLLETLSSKKNTHFYNTDSLTLLGHAWNLWN 386 (476)
Q Consensus 311 la~~~~~~~~~~~~~~~~gt~~y~aPE~l~~----~~~s~ksDVwSlGvvl~elltG~~p~~~~~~~~~~~~~~~~~~~~ 386 (476)
++........ .....++..|+|||.+.+ ..++.++|+|||||++|||++|+.|+.........+. ...
T Consensus 150 ~~~~~~~~~~---~~~~~~~~~y~aPE~~~~~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~~~----~~~- 221 (283)
T cd06617 150 ISGYLVDSVA---KTIDAGCKPYMAPERINPELNQKGYDVKSDVWSLGITMIELATGRFPYDSWKTPFQQLK----QVV- 221 (283)
T ss_pred cccccccccc---cccccCCccccChhhcCCcccccccCccccchhhHHHHHHHHhCCCCCCccccCHHHHH----HHH-
Confidence 9986543211 122457889999998864 4568999999999999999999999853322111111 111
Q ss_pred CCCcccccCcccCCCCCHHHHHHHHHHHHHchhhcccCCCCHHHHHH
Q 045315 387 DGRTWELMDPISQNGASYPILKRYINVALLCVQEKAADRPAMSEVVS 433 (476)
Q Consensus 387 ~~~~~~~~d~~~~~~~~~~~~~~l~~li~~Cl~~dP~~RPt~~eVl~ 433 (476)
.+...... .......+.+++.+||+.+|++||++.++++
T Consensus 222 ~~~~~~~~--------~~~~~~~l~~li~~~l~~~p~~Rp~~~~il~ 260 (283)
T cd06617 222 EEPSPQLP--------AEKFSPEFQDFVNKCLKKNYKERPNYPELLQ 260 (283)
T ss_pred hcCCCCCC--------ccccCHHHHHHHHHHccCChhhCcCHHHHhc
Confidence 11000000 1112456889999999999999999999986
|
Protein kinases (PKs), MAP kinase kinase 3 (MKK3) and MKK6 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK3 and MKK6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK3 and MKK6 are dual-specificity PKs |
| >cd05630 STKc_GRK6 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 6 | Back alignment and domain information |
|---|
Probab=99.91 E-value=4.1e-24 Score=209.95 Aligned_cols=175 Identities=25% Similarity=0.280 Sum_probs=131.2
Q ss_pred cccceeeccCCCC--------CCCCCCChhhHHHHHHHHHHHHHHHhhcCCCceeecCCCccceEecCCCCceeccccce
Q 045315 241 DEISFWYESYNNP--------TKKGLLCWGTRVRIIEGIAQGLLYLHQYSRLRVIHRDLKASNILLDKDMNPKISDFGMA 312 (476)
Q Consensus 241 ~~~~l~~Ey~~~~--------~~~~~L~~~~~~~i~~qIa~gL~yLH~~~~~~ivH~DLkp~NILld~~~~~kL~DFGla 312 (476)
+..++++||++.. .....+++.++..++.|++.||.|||+.+ |+||||||+||+++.++.++|+|||++
T Consensus 73 ~~~~lv~e~~~g~~L~~~l~~~~~~~l~~~~~~~~~~qi~~~l~~lH~~~---iiH~dikp~Nil~~~~~~~~l~Dfg~~ 149 (285)
T cd05630 73 DALCLVLTLMNGGDLKFHIYHMGEAGFEEGRAVFYAAEICCGLEDLHQER---IVYRDLKPENILLDDHGHIRISDLGLA 149 (285)
T ss_pred CEEEEEEEecCCCcHHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHhCC---EEeCCCCHHHEEECCCCCEEEeeccce
Confidence 3467888888732 12346899999999999999999999998 999999999999999999999999999
Q ss_pred eecCCCcccccceeeeeccCCCChhhhccCCCCccceEEeehhhhhhhhhCCCCCCcCCCCchhhhhhhhhhhcCCCccc
Q 045315 313 RMFGGDELQSNTKRIVGTYGYMSPEYALRGLFSIKSDVFSFGVLLLETLSSKKNTHFYNTDSLTLLGHAWNLWNDGRTWE 392 (476)
Q Consensus 313 ~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~s~ksDVwSlGvvl~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~ 392 (476)
........ .....|+..|+|||.+.+..++.++||||||+++|||++|+.||......... ...........
T Consensus 150 ~~~~~~~~---~~~~~g~~~y~aPE~~~~~~~~~~~DiwslG~~l~~l~~g~~Pf~~~~~~~~~--~~~~~~~~~~~--- 221 (285)
T cd05630 150 VHVPEGQT---IKGRVGTVGYMAPEVVKNERYTFSPDWWALGCLLYEMIAGQSPFQQRKKKIKR--EEVERLVKEVQ--- 221 (285)
T ss_pred eecCCCcc---ccCCCCCccccChHHHcCCCCCCccccHHHHHHHHHHHhCCCCCCCCCccchH--HHHHhhhhhhh---
Confidence 76543221 12246899999999999889999999999999999999999998653321100 00000100000
Q ss_pred ccCcccCCCCCHHHHHHHHHHHHHchhhcccCCCC-----HHHHHH
Q 045315 393 LMDPISQNGASYPILKRYINVALLCVQEKAADRPA-----MSEVVS 433 (476)
Q Consensus 393 ~~d~~~~~~~~~~~~~~l~~li~~Cl~~dP~~RPt-----~~eVl~ 433 (476)
. .........+.+++.+||+.||++||+ ++|+++
T Consensus 222 ---~----~~~~~~~~~~~~li~~~l~~~p~~R~s~~~~~~~~~~~ 260 (285)
T cd05630 222 ---E----EYSEKFSPDARSLCKMLLCKDPKERLGCQGGGAREVKE 260 (285)
T ss_pred ---h----hcCccCCHHHHHHHHHHhhcCHHHccCCCCCchHHHHc
Confidence 0 011122346789999999999999999 778776
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK6 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK6 is widely expressed in many tissues. t is expressed as |
| >cd06646 STKc_MAP4K5 Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-activated protein kinase kinase kinase kinase 5 | Back alignment and domain information |
|---|
Probab=99.90 E-value=1.3e-24 Score=210.71 Aligned_cols=179 Identities=22% Similarity=0.318 Sum_probs=131.8
Q ss_pred cccceeeccCCCC------CCCCCCChhhHHHHHHHHHHHHHHHhhcCCCceeecCCCccceEecCCCCceeccccceee
Q 045315 241 DEISFWYESYNNP------TKKGLLCWGTRVRIIEGIAQGLLYLHQYSRLRVIHRDLKASNILLDKDMNPKISDFGMARM 314 (476)
Q Consensus 241 ~~~~l~~Ey~~~~------~~~~~L~~~~~~~i~~qIa~gL~yLH~~~~~~ivH~DLkp~NILld~~~~~kL~DFGla~~ 314 (476)
+..++++||++.. .+++++++.++..++.|++.||+|||+.+ |+||||||+||+++.++.+||+|||++..
T Consensus 79 ~~~~iv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~---i~H~dl~p~nill~~~~~~~l~dfg~~~~ 155 (267)
T cd06646 79 EKLWICMEYCGGGSLQDIYHVTGPLSELQIAYVCRETLQGLAYLHSKG---KMHRDIKGANILLTDNGDVKLADFGVAAK 155 (267)
T ss_pred CEEEEEEeCCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCC---ccccCCCHHHEEECCCCCEEECcCcccee
Confidence 4567889998732 23567899999999999999999999998 99999999999999999999999999987
Q ss_pred cCCCcccccceeeeeccCCCChhhhc---cCCCCccceEEeehhhhhhhhhCCCCCCcCCCCchhhhhhhhhhhcCCCcc
Q 045315 315 FGGDELQSNTKRIVGTYGYMSPEYAL---RGLFSIKSDVFSFGVLLLETLSSKKNTHFYNTDSLTLLGHAWNLWNDGRTW 391 (476)
Q Consensus 315 ~~~~~~~~~~~~~~gt~~y~aPE~l~---~~~~s~ksDVwSlGvvl~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~ 391 (476)
...... ......++..|+|||.+. ...++.++|+|||||++|||++|+.|+.......... .......
T Consensus 156 ~~~~~~--~~~~~~~~~~y~~PE~~~~~~~~~~~~~~Dvws~G~il~el~~g~~p~~~~~~~~~~~------~~~~~~~- 226 (267)
T cd06646 156 ITATIA--KRKSFIGTPYWMAPEVAAVEKNGGYNQLCDIWAVGITAIELAELQPPMFDLHPMRALF------LMSKSNF- 226 (267)
T ss_pred eccccc--ccCccccCccccCHhHcccccCCCCcchhhHHHHHHHHHHHHhCCCCccccchhhhhe------eeecCCC-
Confidence 643221 112246788999999874 3457889999999999999999999875332111100 0000000
Q ss_pred cccCcccCCCCCHHHHHHHHHHHHHchhhcccCCCCHHHHHHHH
Q 045315 392 ELMDPISQNGASYPILKRYINVALLCVQEKAADRPAMSEVVSML 435 (476)
Q Consensus 392 ~~~d~~~~~~~~~~~~~~l~~li~~Cl~~dP~~RPt~~eVl~~L 435 (476)
..+... ........+.+++.+||+.+|++||+++++++.|
T Consensus 227 --~~~~~~--~~~~~~~~~~~li~~~l~~~P~~Rp~~~~il~~l 266 (267)
T cd06646 227 --QPPKLK--DKTKWSSTFHNFVKISLTKNPKKRPTAERLLTHL 266 (267)
T ss_pred --CCCCCc--cccccCHHHHHHHHHHhhCChhhCcCHHHHhcCC
Confidence 001110 0112345788999999999999999999998643
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 5 (MAPKKKK5 or MAP4K5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated |
| >cd05632 STKc_GRK5 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 5 | Back alignment and domain information |
|---|
Probab=99.90 E-value=4.3e-24 Score=209.73 Aligned_cols=175 Identities=22% Similarity=0.222 Sum_probs=130.6
Q ss_pred cccceeeccCCCC--------CCCCCCChhhHHHHHHHHHHHHHHHhhcCCCceeecCCCccceEecCCCCceeccccce
Q 045315 241 DEISFWYESYNNP--------TKKGLLCWGTRVRIIEGIAQGLLYLHQYSRLRVIHRDLKASNILLDKDMNPKISDFGMA 312 (476)
Q Consensus 241 ~~~~l~~Ey~~~~--------~~~~~L~~~~~~~i~~qIa~gL~yLH~~~~~~ivH~DLkp~NILld~~~~~kL~DFGla 312 (476)
+..++++||++.. .....+++..+..++.|++.||.|||+.+ |+||||||+||+++.++.+||+|||++
T Consensus 73 ~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~ql~~~l~~lH~~~---iiH~dikp~Nili~~~~~~kl~Dfg~~ 149 (285)
T cd05632 73 DALCLVLTIMNGGDLKFHIYNMGNPGFEEERALFYAAEILCGLEDLHREN---TVYRDLKPENILLDDYGHIRISDLGLA 149 (285)
T ss_pred CEEEEEEEeccCccHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCC---eeecCCCHHHEEECCCCCEEEecCCcc
Confidence 3567888888732 12346999999999999999999999998 999999999999999999999999999
Q ss_pred eecCCCcccccceeeeeccCCCChhhhccCCCCccceEEeehhhhhhhhhCCCCCCcCCCCchhhhhhhhhhhcCCCccc
Q 045315 313 RMFGGDELQSNTKRIVGTYGYMSPEYALRGLFSIKSDVFSFGVLLLETLSSKKNTHFYNTDSLTLLGHAWNLWNDGRTWE 392 (476)
Q Consensus 313 ~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~s~ksDVwSlGvvl~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~ 392 (476)
........ .....|+..|+|||.+.+..++.++|+|||||++||+++|+.||........ .............
T Consensus 150 ~~~~~~~~---~~~~~g~~~~~aPE~~~~~~~~~~~Di~slG~~l~~l~~g~~P~~~~~~~~~--~~~~~~~~~~~~~-- 222 (285)
T cd05632 150 VKIPEGES---IRGRVGTVGYMAPEVLNNQRYTLSPDYWGLGCLIYEMIEGQSPFRGRKEKVK--REEVDRRVLETEE-- 222 (285)
T ss_pred eecCCCCc---ccCCCCCcCccChHHhcCCCCCcccchHHHHHHHHHHHhCCCCCCCCCHHHH--HHHHHHhhhcccc--
Confidence 76543211 1224689999999999988899999999999999999999999864332111 0111111111100
Q ss_pred ccCcccCCCCCHHHHHHHHHHHHHchhhcccCCCC-----HHHHHH
Q 045315 393 LMDPISQNGASYPILKRYINVALLCVQEKAADRPA-----MSEVVS 433 (476)
Q Consensus 393 ~~d~~~~~~~~~~~~~~l~~li~~Cl~~dP~~RPt-----~~eVl~ 433 (476)
.........+.+++..|++.||++||+ +.+++.
T Consensus 223 --------~~~~~~~~~~~~li~~~l~~~P~~R~~~~~~~~~~l~~ 260 (285)
T cd05632 223 --------VYSAKFSEEAKSICKMLLTKDPKQRLGCQEEGAGEVKR 260 (285)
T ss_pred --------ccCccCCHHHHHHHHHHccCCHhHcCCCcccChHHHHc
Confidence 011122346788999999999999999 566655
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK5 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK5 is widely expressed in many tissues. It associates with |
| >cd05076 PTK_Tyk2_rpt1 Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinase, Tyrosine kinase 2 | Back alignment and domain information |
|---|
Probab=99.90 E-value=1.9e-24 Score=211.15 Aligned_cols=170 Identities=21% Similarity=0.257 Sum_probs=126.7
Q ss_pred cccceeeccCCCC-------CCCCCCChhhHHHHHHHHHHHHHHHhhcCCCceeecCCCccceEecCCC-------Ccee
Q 045315 241 DEISFWYESYNNP-------TKKGLLCWGTRVRIIEGIAQGLLYLHQYSRLRVIHRDLKASNILLDKDM-------NPKI 306 (476)
Q Consensus 241 ~~~~l~~Ey~~~~-------~~~~~L~~~~~~~i~~qIa~gL~yLH~~~~~~ivH~DLkp~NILld~~~-------~~kL 306 (476)
+..+++|||++.. ..++.+++..+++++.||++||+|||+++ |+||||||+||+++..+ .+|+
T Consensus 89 ~~~~lv~ey~~~g~L~~~l~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~---iiH~dlkp~Nill~~~~~~~~~~~~~kl 165 (274)
T cd05076 89 SENIMVEEFVEHGPLDVCLRKEKGRVPVAWKITVAQQLASALSYLEDKN---LVHGNVCAKNILLARLGLAEGTSPFIKL 165 (274)
T ss_pred CceEEEEecCCCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHcCC---ccCCCCCcccEEEeccCcccCccceeee
Confidence 3567889999833 23567899999999999999999999998 99999999999997643 3799
Q ss_pred ccccceeecCCCcccccceeeeeccCCCChhhhcc-CCCCccceEEeehhhhhhhh-hCCCCCCcCCCCchhhhhhhhhh
Q 045315 307 SDFGMARMFGGDELQSNTKRIVGTYGYMSPEYALR-GLFSIKSDVFSFGVLLLETL-SSKKNTHFYNTDSLTLLGHAWNL 384 (476)
Q Consensus 307 ~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~l~~-~~~s~ksDVwSlGvvl~ell-tG~~p~~~~~~~~~~~~~~~~~~ 384 (476)
+|||++...... ....++..|+|||.+.+ ..++.++|||||||++||++ +|+.|+........ ...
T Consensus 166 ~d~g~~~~~~~~------~~~~~~~~~~aPe~~~~~~~~~~~~Dv~slG~~l~el~~~g~~p~~~~~~~~~--~~~---- 233 (274)
T cd05076 166 SDPGVSFTALSR------EERVERIPWIAPECVPGGNSLSTAADKWSFGTTLLEICFDGEVPLKERTPSEK--ERF---- 233 (274)
T ss_pred cCCccccccccc------cccccCCcccCchhhcCCCCCCcHHHHHHHHHHHHHHHhCCCCCccccChHHH--HHH----
Confidence 999988643221 11346788999998875 56899999999999999985 68888754322111 100
Q ss_pred hcCCCcccccCcccCCCCCHHHHHHHHHHHHHchhhcccCCCCHHHHHHHHh
Q 045315 385 WNDGRTWELMDPISQNGASYPILKRYINVALLCVQEKAADRPAMSEVVSMLS 436 (476)
Q Consensus 385 ~~~~~~~~~~d~~~~~~~~~~~~~~l~~li~~Cl~~dP~~RPt~~eVl~~L~ 436 (476)
..... . . +......+.+++.+||+.+|++||++.+|++.|+
T Consensus 234 ~~~~~--~-----~----~~~~~~~~~~li~~cl~~~p~~Rps~~~il~~L~ 274 (274)
T cd05076 234 YEKKH--R-----L----PEPSCKELATLISQCLTYEPTQRPSFRTILRDLT 274 (274)
T ss_pred HHhcc--C-----C----CCCCChHHHHHHHHHcccChhhCcCHHHHHHhhC
Confidence 00000 0 0 0111246889999999999999999999999874
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase 2 (Tyk2); pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyk2 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalyt |
| >KOG0983 consensus Mitogen-activated protein kinase (MAPK) kinase MKK7/JNKK2 [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.90 E-value=3.1e-24 Score=198.87 Aligned_cols=163 Identities=26% Similarity=0.394 Sum_probs=127.5
Q ss_pred CCCCCCChhhHHHHHHHHHHHHHHHhhcCCCceeecCCCccceEecCCCCceeccccceeecCCCcccccceeeeeccCC
Q 045315 254 TKKGLLCWGTRVRIIEGIAQGLLYLHQYSRLRVIHRDLKASNILLDKDMNPKISDFGMARMFGGDELQSNTKRIVGTYGY 333 (476)
Q Consensus 254 ~~~~~L~~~~~~~i~~qIa~gL~yLH~~~~~~ivH~DLkp~NILld~~~~~kL~DFGla~~~~~~~~~~~~~~~~gt~~y 333 (476)
+-++++++.-.=++...+++||.||.++. .|+|||+||+|||+|+.|++|+||||.+..+-....+. +..|.+.|
T Consensus 183 rik~piPE~ilGk~tva~v~AL~YLKeKH--~viHRDvKPSNILlDe~GniKlCDFGIsGrlvdSkAht---rsAGC~~Y 257 (391)
T KOG0983|consen 183 RIKGPIPERILGKMTVAIVKALYYLKEKH--GVIHRDVKPSNILLDERGNIKLCDFGISGRLVDSKAHT---RSAGCAAY 257 (391)
T ss_pred HhcCCchHHhhhhhHHHHHHHHHHHHHhc--ceeecccCccceEEccCCCEEeecccccceeecccccc---cccCCccc
Confidence 34667888888899999999999998754 59999999999999999999999999998765443322 34688999
Q ss_pred CChhhhc---cCCCCccceEEeehhhhhhhhhCCCCCCcCCCCchhhhhhhhhhhcCCCcccccCcccCCCCCHHHHHHH
Q 045315 334 MSPEYAL---RGLFSIKSDVFSFGVLLLETLSSKKNTHFYNTDSLTLLGHAWNLWNDGRTWELMDPISQNGASYPILKRY 410 (476)
Q Consensus 334 ~aPE~l~---~~~~s~ksDVwSlGvvl~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~l 410 (476)
||||.+. ...|..++||||||+.++||.||+.|+...+.+...+.... .... |.+.... .....+
T Consensus 258 MaPERidp~~~~kYDiRaDVWSlGITlveLaTg~yPy~~c~tdFe~ltkvl-----n~eP-----P~L~~~~--gFSp~F 325 (391)
T KOG0983|consen 258 MAPERIDPPDKPKYDIRADVWSLGITLVELATGQYPYKGCKTDFEVLTKVL-----NEEP-----PLLPGHM--GFSPDF 325 (391)
T ss_pred cCccccCCCCCCccchhhhhhhhccchhhhhcccCCCCCCCccHHHHHHHH-----hcCC-----CCCCccc--CcCHHH
Confidence 9999886 34689999999999999999999999987765544332211 1111 2222111 145678
Q ss_pred HHHHHHchhhcccCCCCHHHHHH
Q 045315 411 INVALLCVQEKAADRPAMSEVVS 433 (476)
Q Consensus 411 ~~li~~Cl~~dP~~RPt~~eVl~ 433 (476)
++++..||++|+.+||.-.++++
T Consensus 326 ~~fv~~CL~kd~r~RP~Y~~Ll~ 348 (391)
T KOG0983|consen 326 QSFVKDCLTKDHRKRPKYNKLLE 348 (391)
T ss_pred HHHHHHHhhcCcccCcchHHHhc
Confidence 89999999999999999988775
|
|
| >PF00069 Pkinase: Protein kinase domain Protein kinase; unclassified specificity | Back alignment and domain information |
|---|
Probab=99.90 E-value=9.5e-25 Score=210.19 Aligned_cols=179 Identities=26% Similarity=0.376 Sum_probs=134.4
Q ss_pred ccccceeeccCCCCC------CCCCCChhhHHHHHHHHHHHHHHHhhcCCCceeecCCCccceEecCCCCceecccccee
Q 045315 240 KDEISFWYESYNNPT------KKGLLCWGTRVRIIEGIAQGLLYLHQYSRLRVIHRDLKASNILLDKDMNPKISDFGMAR 313 (476)
Q Consensus 240 ~~~~~l~~Ey~~~~~------~~~~L~~~~~~~i~~qIa~gL~yLH~~~~~~ivH~DLkp~NILld~~~~~kL~DFGla~ 313 (476)
...+++++||++... +...+++.++..++.||++||++||+.+ ++|+||||+||+++.++.++|+|||.+.
T Consensus 70 ~~~~~~v~~~~~~~~L~~~l~~~~~~~~~~~~~~~~qi~~~L~~Lh~~~---i~H~dikp~NIl~~~~~~~~l~Dfg~~~ 146 (260)
T PF00069_consen 70 DNYLYIVMEYCPGGSLQDYLQKNKPLSEEEILKIAYQILEALAYLHSKG---IVHRDIKPENILLDENGEVKLIDFGSSV 146 (260)
T ss_dssp SSEEEEEEEEETTEBHHHHHHHHSSBBHHHHHHHHHHHHHHHHHHHHTT---EEESSBSGGGEEESTTSEEEESSGTTTE
T ss_pred ccccccccccccccccccccccccccccccccccccccccccccccccc---cccccccccccccccccccccccccccc
Confidence 356889999998421 3678999999999999999999999998 9999999999999999999999999998
Q ss_pred ecCCCcccccceeeeeccCCCChhhhc-cCCCCccceEEeehhhhhhhhhCCCCCCcCC-CCchhhhhhhhhhhcCCCcc
Q 045315 314 MFGGDELQSNTKRIVGTYGYMSPEYAL-RGLFSIKSDVFSFGVLLLETLSSKKNTHFYN-TDSLTLLGHAWNLWNDGRTW 391 (476)
Q Consensus 314 ~~~~~~~~~~~~~~~gt~~y~aPE~l~-~~~~s~ksDVwSlGvvl~elltG~~p~~~~~-~~~~~~~~~~~~~~~~~~~~ 391 (476)
..... ........++..|+|||.+. +..++.++|+||+|+++++|++|+.|+.... .+........ ...
T Consensus 147 ~~~~~--~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~~~~p~~~~~~~~~~~~~~~~---~~~---- 217 (260)
T PF00069_consen 147 KLSEN--NENFNPFVGTPEYMAPEVLQQGKKYTRKSDIWSLGIILYELLTGKLPFEESNSDDQLEIIEKI---LKR---- 217 (260)
T ss_dssp ESTST--TSEBSSSSSSGGGSCHHHHTTTSSBSTHHHHHHHHHHHHHHHHSSSSSTTSSHHHHHHHHHHH---HHT----
T ss_pred ccccc--ccccccccccccccccccccccccccccccccccccccccccccccccccccchhhhhhhhhc---ccc----
Confidence 64211 12223356788999999998 7889999999999999999999999987542 1111111100 000
Q ss_pred cccCcccCCCCCHHHHHHHHHHHHHchhhcccCCCCHHHHHH
Q 045315 392 ELMDPISQNGASYPILKRYINVALLCVQEKAADRPAMSEVVS 433 (476)
Q Consensus 392 ~~~d~~~~~~~~~~~~~~l~~li~~Cl~~dP~~RPt~~eVl~ 433 (476)
....... ........+.+++.+||+.||++||++.++++
T Consensus 218 ~~~~~~~---~~~~~~~~l~~li~~~l~~~p~~R~~~~~l~~ 256 (260)
T PF00069_consen 218 PLPSSSQ---QSREKSEELRDLIKKMLSKDPEQRPSAEELLK 256 (260)
T ss_dssp HHHHHTT---SHTTSHHHHHHHHHHHSSSSGGGSTTHHHHHT
T ss_pred ccccccc---ccchhHHHHHHHHHHHccCChhHCcCHHHHhc
Confidence 0000000 00011268899999999999999999999875
|
Serine/Threonine protein kinases, catalytic domain Tyrosine kinase, catalytic domain; InterPro: IPR017442 Protein phosphorylation, which plays a key role in most cellular activities, is a reversible process mediated by protein kinases and phosphoprotein phosphatases. Protein kinases catalyse the transfer of the gamma phosphate from nucleotide triphosphates (often ATP) to one or more amino acid residues in a protein substrate side chain, resulting in a conformational change affecting protein function. Phosphoprotein phosphatases catalyse the reverse process. Protein kinases fall into three broad classes, characterised with respect to substrate specificity []: Serine/threonine-protein kinases Tyrosine-protein kinases Dual specific protein kinases (e.g. MEK - phosphorylates both Thr and Tyr on target proteins) Protein kinase function has been evolutionarily conserved from Escherichia coli to human []. Protein kinases play a role in a multitude of cellular processes, including division, proliferation, apoptosis, and differentiation []. Phosphorylation usually results in a functional change of the target protein by changing enzyme activity, cellular location, or association with other proteins. The catalytic subunits of protein kinases are highly conserved, and several structures have been solved [], leading to large screens to develop kinase-specific inhibitors for the treatments of a number of diseases []. Eukaryotic protein kinases [, , , , ] are enzymes that belong to a very extensive family of proteins which share a conserved catalytic core common with both serine/threonine and tyrosine protein kinases. There are a number of conserved regions in the catalytic domain of protein kinases. In the N-terminal extremity of the catalytic domain there is a glycine-rich stretch of residues in the vicinity of a lysine residue, which has been shown to be involved in ATP binding. In the central part of the catalytic domain there is a conserved aspartic acid residue which is important for the catalytic activity of the enzyme []. This entry includes protein kinases from eukaryotes and viruses and may include some bacterial hits too.; GO: 0004672 protein kinase activity, 0005524 ATP binding, 0006468 protein phosphorylation; PDB: 3GC7_A 3ZYA_A 3MPT_A 3NEW_A 3MVM_A 1R3C_A 2FST_X 3E93_A 3HV5_B 3OCG_A .... |
| >cd05622 STKc_ROCK1 Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase 1 | Back alignment and domain information |
|---|
Probab=99.90 E-value=7e-24 Score=216.38 Aligned_cols=178 Identities=21% Similarity=0.215 Sum_probs=129.9
Q ss_pred cccceeeccCCCCC-----CCCCCChhhHHHHHHHHHHHHHHHhhcCCCceeecCCCccceEecCCCCceeccccceeec
Q 045315 241 DEISFWYESYNNPT-----KKGLLCWGTRVRIIEGIAQGLLYLHQYSRLRVIHRDLKASNILLDKDMNPKISDFGMARMF 315 (476)
Q Consensus 241 ~~~~l~~Ey~~~~~-----~~~~L~~~~~~~i~~qIa~gL~yLH~~~~~~ivH~DLkp~NILld~~~~~kL~DFGla~~~ 315 (476)
+.++++|||++.+. +...++...+..++.||+.||+|||+++ |+||||||+|||++.++.+||+|||+++..
T Consensus 116 ~~~~lv~Ey~~gg~L~~~~~~~~~~~~~~~~~~~qi~~aL~~LH~~~---ivHrDLkp~NIll~~~~~ikL~DfG~a~~~ 192 (371)
T cd05622 116 RYLYMVMEYMPGGDLVNLMSNYDVPEKWARFYTAEVVLALDAIHSMG---FIHRDVKPDNMLLDKSGHLKLADFGTCMKM 192 (371)
T ss_pred CEEEEEEcCCCCCcHHHHHHhcCCCHHHHHHHHHHHHHHHHHHHHCC---EEeCCCCHHHEEECCCCCEEEEeCCceeEc
Confidence 45788999998432 2346888999999999999999999999 999999999999999999999999999876
Q ss_pred CCCcccccceeeeeccCCCChhhhccC----CCCccceEEeehhhhhhhhhCCCCCCcCCCCchhhhhhhhhhhcCCCcc
Q 045315 316 GGDELQSNTKRIVGTYGYMSPEYALRG----LFSIKSDVFSFGVLLLETLSSKKNTHFYNTDSLTLLGHAWNLWNDGRTW 391 (476)
Q Consensus 316 ~~~~~~~~~~~~~gt~~y~aPE~l~~~----~~s~ksDVwSlGvvl~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~ 391 (476)
...... ......||+.|+|||++.+. .++.++|||||||++|||++|+.||...... .. ...........
T Consensus 193 ~~~~~~-~~~~~~gt~~y~aPE~l~~~~~~~~~~~~~DiwSlGvilyell~G~~Pf~~~~~~--~~---~~~i~~~~~~~ 266 (371)
T cd05622 193 NKEGMV-RCDTAVGTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLYEMLVGDTPFYADSLV--GT---YSKIMNHKNSL 266 (371)
T ss_pred CcCCcc-cccCcccCccccCHHHHhccCCCccCCCccceeehhHHHHHHHhCCCCCCCCCHH--HH---HHHHHcCCCcc
Confidence 433211 12235699999999998753 3789999999999999999999998643311 11 11111111111
Q ss_pred cccCcccCCCCCHHHHHHHHHHHHHchhhcccC--CCCHHHHHHH
Q 045315 392 ELMDPISQNGASYPILKRYINVALLCVQEKAAD--RPAMSEVVSM 434 (476)
Q Consensus 392 ~~~d~~~~~~~~~~~~~~l~~li~~Cl~~dP~~--RPt~~eVl~~ 434 (476)
... ........+.+++.+|++.++.+ ||+++++++.
T Consensus 267 ~~~-------~~~~~s~~~~~li~~~L~~~~~r~~r~~~~ei~~h 304 (371)
T cd05622 267 TFP-------DDNDISKEAKNLICAFLTDREVRLGRNGVEEIKRH 304 (371)
T ss_pred cCC-------CcCCCCHHHHHHHHHHcCChhhhcCCCCHHHHhcC
Confidence 111 11223456788999999844433 7889988874
|
Serine/Threonine Kinases (STKs), ROCK subfamily, ROCK1 (or ROK-beta) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK contains an N-terminal extension, a catalytic kinase domain, and a C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain, and is activated via interaction with Rho GTPases. ROCK1 is preferentially expressed in the liver, lung, spleen, testes, an |
| >cd05629 STKc_NDR_like_fungal Catalytic domain of Fungal Nuclear Dbf2-Related kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=99.90 E-value=3.9e-24 Score=218.64 Aligned_cols=178 Identities=21% Similarity=0.240 Sum_probs=128.6
Q ss_pred cccceeeccCCCCC------CCCCCChhhHHHHHHHHHHHHHHHhhcCCCceeecCCCccceEecCCCCceeccccceee
Q 045315 241 DEISFWYESYNNPT------KKGLLCWGTRVRIIEGIAQGLLYLHQYSRLRVIHRDLKASNILLDKDMNPKISDFGMARM 314 (476)
Q Consensus 241 ~~~~l~~Ey~~~~~------~~~~L~~~~~~~i~~qIa~gL~yLH~~~~~~ivH~DLkp~NILld~~~~~kL~DFGla~~ 314 (476)
+..+++|||++.+. +.+.+++..+..++.|++.||+|||+.+ |+||||||+|||++.++.+||+|||+++.
T Consensus 74 ~~~~lv~E~~~gg~L~~~l~~~~~~~~~~~~~~~~ql~~aL~~LH~~g---ivHrDlkp~NIll~~~~~~kl~DfGla~~ 150 (377)
T cd05629 74 QYLYLIMEFLPGGDLMTMLIKYDTFSEDVTRFYMAECVLAIEAVHKLG---FIHRDIKPDNILIDRGGHIKLSDFGLSTG 150 (377)
T ss_pred CeeEEEEeCCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCC---eeccCCCHHHEEECCCCCEEEeecccccc
Confidence 45788999998432 3567899999999999999999999999 99999999999999999999999999864
Q ss_pred cCCCcc-------------c--------------------------------ccceeeeeccCCCChhhhccCCCCccce
Q 045315 315 FGGDEL-------------Q--------------------------------SNTKRIVGTYGYMSPEYALRGLFSIKSD 349 (476)
Q Consensus 315 ~~~~~~-------------~--------------------------------~~~~~~~gt~~y~aPE~l~~~~~s~ksD 349 (476)
+..... . .......||+.|+|||++.+..++.++|
T Consensus 151 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~D 230 (377)
T cd05629 151 FHKQHDSAYYQKLLQGKSNKNRIDNRNSVAVDSINLTMSSKDQIATWKKNRRLMAYSTVGTPDYIAPEIFLQQGYGQECD 230 (377)
T ss_pred cccccccccccccccccccccccccccccccccccccccchhhhhhhhhcccccccccCCCccccCHHHHccCCCCCcee
Confidence 321000 0 0001246899999999999889999999
Q ss_pred EEeehhhhhhhhhCCCCCCcCCCCchhhhhhhhhhhcCCCcccccCcccCCCCCHHHHHHHHHHHHHchhhcccCC---C
Q 045315 350 VFSFGVLLLETLSSKKNTHFYNTDSLTLLGHAWNLWNDGRTWELMDPISQNGASYPILKRYINVALLCVQEKAADR---P 426 (476)
Q Consensus 350 VwSlGvvl~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~l~~li~~Cl~~dP~~R---P 426 (476)
||||||++|||++|+.||...... ..... ...........+ .......+.+++.+|++ +|.+| +
T Consensus 231 iwSlGvil~elltG~~Pf~~~~~~--~~~~~---i~~~~~~~~~p~-------~~~~s~~~~dli~~lL~-~~~~r~~r~ 297 (377)
T cd05629 231 WWSLGAIMFECLIGWPPFCSENSH--ETYRK---IINWRETLYFPD-------DIHLSVEAEDLIRRLIT-NAENRLGRG 297 (377)
T ss_pred eEecchhhhhhhcCCCCCCCCCHH--HHHHH---HHccCCccCCCC-------CCCCCHHHHHHHHHHhc-CHhhcCCCC
Confidence 999999999999999998643321 11111 110000001100 11123467788899997 66665 5
Q ss_pred CHHHHHHH
Q 045315 427 AMSEVVSM 434 (476)
Q Consensus 427 t~~eVl~~ 434 (476)
++.|+++.
T Consensus 298 ~~~~~l~h 305 (377)
T cd05629 298 GAHEIKSH 305 (377)
T ss_pred CHHHHhcC
Confidence 99988774
|
Serine/Threonine Kinases (STKs), NDR kinase subfamily, fungal NDR-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This group is composed of fungal NDR-like proteins including Saccharomyces cerevisiae CBK1 (or CBK1p), Schizosaccharomyces pombe Orb6 (or Orb6p), Ustilago maydis Ukc1 (or Ukc1p), and Neurospora crassa Cot1. Like NDR kinase, group members contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. CBK1 is an essential component in the RAM (regulation of |
| >cd06639 STKc_myosinIIIB Catalytic domain of the Protein Serine/Threonine Kinase, Class IIIB myosin | Back alignment and domain information |
|---|
Probab=99.90 E-value=3.6e-24 Score=210.53 Aligned_cols=174 Identities=23% Similarity=0.301 Sum_probs=130.0
Q ss_pred ccceeeccCCCC----------CCCCCCChhhHHHHHHHHHHHHHHHhhcCCCceeecCCCccceEecCCCCceeccccc
Q 045315 242 EISFWYESYNNP----------TKKGLLCWGTRVRIIEGIAQGLLYLHQYSRLRVIHRDLKASNILLDKDMNPKISDFGM 311 (476)
Q Consensus 242 ~~~l~~Ey~~~~----------~~~~~L~~~~~~~i~~qIa~gL~yLH~~~~~~ivH~DLkp~NILld~~~~~kL~DFGl 311 (476)
..++++||++.. .....+++..+..++.|++.||+|||+.+ ++|+||||+||+++.++.+||+|||+
T Consensus 98 ~~~lv~ey~~~~sL~~~~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~---ivH~dlkp~nili~~~~~~kl~dfg~ 174 (291)
T cd06639 98 QLWLVLELCNGGSVTELVKGLLICGQRLDEAMISYILYGALLGLQHLHNNR---IIHRDVKGNNILLTTEGGVKLVDFGV 174 (291)
T ss_pred eeEEEEEECCCCcHHHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHHhCC---eeccCCCHHHEEEcCCCCEEEeeccc
Confidence 467888998732 23467999999999999999999999998 99999999999999999999999999
Q ss_pred eeecCCCcccccceeeeeccCCCChhhhccC-----CCCccceEEeehhhhhhhhhCCCCCCcCCCCchhhhhhhhhhhc
Q 045315 312 ARMFGGDELQSNTKRIVGTYGYMSPEYALRG-----LFSIKSDVFSFGVLLLETLSSKKNTHFYNTDSLTLLGHAWNLWN 386 (476)
Q Consensus 312 a~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~-----~~s~ksDVwSlGvvl~elltG~~p~~~~~~~~~~~~~~~~~~~~ 386 (476)
+......... .....++..|+|||.+... .++.++|+|||||++|||++|+.|+...... ..+. . ..
T Consensus 175 ~~~~~~~~~~--~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Di~slGvi~~el~~g~~p~~~~~~~-~~~~----~-~~ 246 (291)
T cd06639 175 SAQLTSTRLR--RNTSVGTPFWMAPEVIACEQQYDYSYDARCDVWSLGITAIELGDGDPPLFDMHPV-KTLF----K-IP 246 (291)
T ss_pred chhccccccc--ccCccCCccccChhhhcCCCCcccccCCccchHHHHHHHHHHhhCCCCCCCCcHH-HHHH----H-Hh
Confidence 8865432211 1224578899999987643 3689999999999999999999998643211 1111 0 11
Q ss_pred CCCcccccCcccCCCCCHHHHHHHHHHHHHchhhcccCCCCHHHHHH
Q 045315 387 DGRTWELMDPISQNGASYPILKRYINVALLCVQEKAADRPAMSEVVS 433 (476)
Q Consensus 387 ~~~~~~~~d~~~~~~~~~~~~~~l~~li~~Cl~~dP~~RPt~~eVl~ 433 (476)
......+.+ .......+.+++.+||+.+|++||++.|+++
T Consensus 247 ~~~~~~~~~-------~~~~~~~l~~li~~~l~~~p~~Rps~~~il~ 286 (291)
T cd06639 247 RNPPPTLLH-------PEKWCRSFNHFISQCLIKDFEARPSVTHLLE 286 (291)
T ss_pred cCCCCCCCc-------ccccCHHHHHHHHHHhhcChhhCcCHHHHhc
Confidence 111111111 1122346889999999999999999999875
|
Serine/threonine kinases (STKs), class IIIB myosin subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain. Class III myosins may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. They may also function as cargo carriers during light-dependent translocation, in photoreceptor cells, of proteins such as transducin and arrestin. Class IIIB myosin is expressed highly in retina. It is also pre |
| >cd06613 STKc_MAP4K3_like Catalytic domain of Mitogen-activated protein kinase kinase kinase kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=99.90 E-value=3e-24 Score=207.09 Aligned_cols=177 Identities=21% Similarity=0.311 Sum_probs=133.0
Q ss_pred cccceeeccCCCC-------CCCCCCChhhHHHHHHHHHHHHHHHhhcCCCceeecCCCccceEecCCCCceecccccee
Q 045315 241 DEISFWYESYNNP-------TKKGLLCWGTRVRIIEGIAQGLLYLHQYSRLRVIHRDLKASNILLDKDMNPKISDFGMAR 313 (476)
Q Consensus 241 ~~~~l~~Ey~~~~-------~~~~~L~~~~~~~i~~qIa~gL~yLH~~~~~~ivH~DLkp~NILld~~~~~kL~DFGla~ 313 (476)
+..+++|||++.. ..+..++..++..++.|++.||+|||+.+ ++|+||||+||+++.++.+||+|||++.
T Consensus 73 ~~~~l~~e~~~~~~l~~~~~~~~~~l~~~~~~~~~~ql~~~l~~lh~~~---i~h~dl~p~ni~i~~~~~~~l~d~g~~~ 149 (262)
T cd06613 73 DKLWIVMEYCGGGSLQDIYQVTRGPLSELQIAYVCRETLKGLAYLHETG---KIHRDIKGANILLTEDGDVKLADFGVSA 149 (262)
T ss_pred CEEEEEEeCCCCCcHHHHHHhhccCCCHHHHHHHHHHHHHHHHHHHhCC---ceecCCChhhEEECCCCCEEECccccch
Confidence 4577888998732 12367999999999999999999999998 9999999999999999999999999987
Q ss_pred ecCCCcccccceeeeeccCCCChhhhccC---CCCccceEEeehhhhhhhhhCCCCCCcCCCCchhhhhhhhhhhcCCCc
Q 045315 314 MFGGDELQSNTKRIVGTYGYMSPEYALRG---LFSIKSDVFSFGVLLLETLSSKKNTHFYNTDSLTLLGHAWNLWNDGRT 390 (476)
Q Consensus 314 ~~~~~~~~~~~~~~~gt~~y~aPE~l~~~---~~s~ksDVwSlGvvl~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~ 390 (476)
....... ......++..|+|||.+... .++.++|+||||+++|||++|+.|+.......... . .. ...
T Consensus 150 ~~~~~~~--~~~~~~~~~~y~~Pe~~~~~~~~~~~~~~Di~slG~~l~~~~tg~~p~~~~~~~~~~~-~----~~-~~~- 220 (262)
T cd06613 150 QLTATIA--KRKSFIGTPYWMAPEVAAVERKGGYDGKCDIWALGITAIELAELQPPMFDLHPMRALF-L----IS-KSN- 220 (262)
T ss_pred hhhhhhh--ccccccCCccccCchhhcccccCCcCchhhhHHHHHHHHHHHhCCCCCCCCCHHHHHH-H----HH-hcc-
Confidence 6543211 11224678899999998776 78999999999999999999999986433111110 0 00 000
Q ss_pred ccccCcccCCCCCHHHHHHHHHHHHHchhhcccCCCCHHHHHH
Q 045315 391 WELMDPISQNGASYPILKRYINVALLCVQEKAADRPAMSEVVS 433 (476)
Q Consensus 391 ~~~~d~~~~~~~~~~~~~~l~~li~~Cl~~dP~~RPt~~eVl~ 433 (476)
...+.. .........+.+++.+||+.+|.+||++.+|+.
T Consensus 221 --~~~~~~--~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~il~ 259 (262)
T cd06613 221 --FPPPKL--KDKEKWSPVFHDFIKKCLTKDPKKRPTATKLLQ 259 (262)
T ss_pred --CCCccc--cchhhhhHHHHHHHHHHcCCChhhCCCHHHHhc
Confidence 000011 112234567899999999999999999999875
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 3 (MAPKKKK3 or MAP4K3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily includes MAP4K3, MAP4K1, MAP4K2, MAP4K5, and related proteins. Vertebrate members contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activ |
| >cd07847 STKc_CDKL1_4 Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase Like 1 and 4 | Back alignment and domain information |
|---|
Probab=99.90 E-value=2.7e-24 Score=210.37 Aligned_cols=187 Identities=20% Similarity=0.255 Sum_probs=131.9
Q ss_pred ccceeeccCCCC------CCCCCCChhhHHHHHHHHHHHHHHHhhcCCCceeecCCCccceEecCCCCceeccccceeec
Q 045315 242 EISFWYESYNNP------TKKGLLCWGTRVRIIEGIAQGLLYLHQYSRLRVIHRDLKASNILLDKDMNPKISDFGMARMF 315 (476)
Q Consensus 242 ~~~l~~Ey~~~~------~~~~~L~~~~~~~i~~qIa~gL~yLH~~~~~~ivH~DLkp~NILld~~~~~kL~DFGla~~~ 315 (476)
..++++||++.. .+...+++.++..++.||+.||+|||+.+ ++|+||||+||+++.++.+||+|||++...
T Consensus 74 ~~~~v~e~~~~~~l~~~~~~~~~~~~~~~~~~~~ql~~~l~~LH~~~---i~H~dl~p~nil~~~~~~~~l~dfg~~~~~ 150 (286)
T cd07847 74 KLHLVFEYCDHTVLNELEKNPRGVPEHLIKKIIWQTLQAVNFCHKHN---CIHRDVKPENILITKQGQIKLCDFGFARIL 150 (286)
T ss_pred EEEEEEeccCccHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHHCC---ceecCCChhhEEEcCCCcEEECccccceec
Confidence 567888998832 23456999999999999999999999998 999999999999999999999999999876
Q ss_pred CCCcccccceeeeeccCCCChhhhcc-CCCCccceEEeehhhhhhhhhCCCCCCcCCCCchhh-hhhh-h-------hhh
Q 045315 316 GGDELQSNTKRIVGTYGYMSPEYALR-GLFSIKSDVFSFGVLLLETLSSKKNTHFYNTDSLTL-LGHA-W-------NLW 385 (476)
Q Consensus 316 ~~~~~~~~~~~~~gt~~y~aPE~l~~-~~~s~ksDVwSlGvvl~elltG~~p~~~~~~~~~~~-~~~~-~-------~~~ 385 (476)
...... .....++..|+|||.+.+ ..++.++|+||||+++|||++|+.||.......... .... . ..+
T Consensus 151 ~~~~~~--~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~i~~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 228 (286)
T cd07847 151 TGPGDD--YTDYVATRWYRAPELLVGDTQYGPPVDVWAIGCVFAELLTGQPLWPGKSDVDQLYLIRKTLGDLIPRHQQIF 228 (286)
T ss_pred CCCccc--ccCcccccccCCHHHHhCCCCcCchhhhHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCChHHhhhc
Confidence 543211 122457789999999876 557899999999999999999999987543211100 0000 0 000
Q ss_pred cCCCc-ccccCcccCCCCC-----HHHHHHHHHHHHHchhhcccCCCCHHHHHH
Q 045315 386 NDGRT-WELMDPISQNGAS-----YPILKRYINVALLCVQEKAADRPAMSEVVS 433 (476)
Q Consensus 386 ~~~~~-~~~~d~~~~~~~~-----~~~~~~l~~li~~Cl~~dP~~RPt~~eVl~ 433 (476)
..... .....+....... ......+.+++.+||+.+|++||++.|++.
T Consensus 229 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~eil~ 282 (286)
T cd07847 229 STNQFFKGLSIPEPETREPLESKFPNISSPALSFLKGCLQMDPTERLSCEELLE 282 (286)
T ss_pred ccccccccccCCCcccccCHHHHhccCCHHHHHHHHHHhcCCccccCCHHHHhc
Confidence 00000 0000010000001 112456889999999999999999999875
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 1 (CDKL1) and CDKL4 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL1 and CDKL4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKL1, also called p42 KKIALRE, is a glial protein that is upregulated in gliosis. It is present in neuroblastoma and A431 human carcinoma cells, and may be implicated in neoplastic transformation. The functio |
| >cd06645 STKc_MAP4K3 Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-activated protein kinase kinase kinase kinase 3 | Back alignment and domain information |
|---|
Probab=99.90 E-value=5.1e-24 Score=206.52 Aligned_cols=177 Identities=21% Similarity=0.331 Sum_probs=131.1
Q ss_pred cccceeeccCCCC------CCCCCCChhhHHHHHHHHHHHHHHHhhcCCCceeecCCCccceEecCCCCceeccccceee
Q 045315 241 DEISFWYESYNNP------TKKGLLCWGTRVRIIEGIAQGLLYLHQYSRLRVIHRDLKASNILLDKDMNPKISDFGMARM 314 (476)
Q Consensus 241 ~~~~l~~Ey~~~~------~~~~~L~~~~~~~i~~qIa~gL~yLH~~~~~~ivH~DLkp~NILld~~~~~kL~DFGla~~ 314 (476)
+..++++||++.. ...+.+++.++..++.|++.||+|||+.+ ++|+||||+||+++.++.+||+|||++..
T Consensus 79 ~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~---i~H~dlkp~nili~~~~~~~l~dfg~~~~ 155 (267)
T cd06645 79 DKLWICMEFCGGGSLQDIYHVTGPLSESQIAYVSRETLQGLYYLHSKG---KMHRDIKGANILLTDNGHVKLADFGVSAQ 155 (267)
T ss_pred CEEEEEEeccCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCCHHHEEECCCCCEEECcceeeeE
Confidence 4577889998732 23457999999999999999999999998 99999999999999999999999999986
Q ss_pred cCCCcccccceeeeeccCCCChhhhc---cCCCCccceEEeehhhhhhhhhCCCCCCcCCCCchhhhhhhhhhhcCCCcc
Q 045315 315 FGGDELQSNTKRIVGTYGYMSPEYAL---RGLFSIKSDVFSFGVLLLETLSSKKNTHFYNTDSLTLLGHAWNLWNDGRTW 391 (476)
Q Consensus 315 ~~~~~~~~~~~~~~gt~~y~aPE~l~---~~~~s~ksDVwSlGvvl~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~ 391 (476)
..... .......|+..|+|||.+. ...++.++|+|||||++|+|++|+.|+........ ..... ....
T Consensus 156 ~~~~~--~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~DvwSlG~il~~l~~~~~p~~~~~~~~~-~~~~~-----~~~~- 226 (267)
T cd06645 156 ITATI--AKRKSFIGTPYWMAPEVAAVERKGGYNQLCDIWAVGITAIELAELQPPMFDLHPMRA-LFLMT-----KSNF- 226 (267)
T ss_pred ccCcc--cccccccCcccccChhhhccccCCCCCchhhhHHHHHHHHHHhcCCCCcccccchhh-HHhhh-----ccCC-
Confidence 64322 1122356889999999874 45688999999999999999999998754321111 00000 0000
Q ss_pred cccCcccCCCCCHHHHHHHHHHHHHchhhcccCCCCHHHHHH
Q 045315 392 ELMDPISQNGASYPILKRYINVALLCVQEKAADRPAMSEVVS 433 (476)
Q Consensus 392 ~~~d~~~~~~~~~~~~~~l~~li~~Cl~~dP~~RPt~~eVl~ 433 (476)
..+.... .......+.+++.+|++.+|++||++++|++
T Consensus 227 --~~~~~~~--~~~~~~~~~~li~~~l~~~P~~R~~~~~ll~ 264 (267)
T cd06645 227 --QPPKLKD--KMKWSNSFHHFVKMALTKNPKKRPTAEKLLQ 264 (267)
T ss_pred --CCCcccc--cCCCCHHHHHHHHHHccCCchhCcCHHHHhc
Confidence 0000000 0112346789999999999999999999875
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 3 (MAPKKKK3 or MAP4K3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated |
| >cd06628 STKc_MAPKKK_Byr2_like Catalytic domain of fungal Byr2-like MAP Kinase Kinase Kinases | Back alignment and domain information |
|---|
Probab=99.90 E-value=2.8e-24 Score=208.27 Aligned_cols=175 Identities=25% Similarity=0.408 Sum_probs=132.7
Q ss_pred cccceeeccCCCCC------CCCCCChhhHHHHHHHHHHHHHHHhhcCCCceeecCCCccceEecCCCCceeccccceee
Q 045315 241 DEISFWYESYNNPT------KKGLLCWGTRVRIIEGIAQGLLYLHQYSRLRVIHRDLKASNILLDKDMNPKISDFGMARM 314 (476)
Q Consensus 241 ~~~~l~~Ey~~~~~------~~~~L~~~~~~~i~~qIa~gL~yLH~~~~~~ivH~DLkp~NILld~~~~~kL~DFGla~~ 314 (476)
+..++++||++... ..+.+++..+..++.|++.||+|||+.+ ++||||+|+||+++.++.+||+|||+++.
T Consensus 79 ~~~~lv~e~~~~~~L~~~l~~~~~l~~~~~~~~~~~l~~~l~~lH~~~---ivH~di~p~nil~~~~~~~~l~dfg~~~~ 155 (267)
T cd06628 79 DHLNIFLEYVPGGSVAALLNNYGAFEETLVRNFVRQILKGLNYLHNRG---IIHRDIKGANILVDNKGGIKISDFGISKK 155 (267)
T ss_pred CccEEEEEecCCCCHHHHHHhccCccHHHHHHHHHHHHHHHHHHHhcC---cccccCCHHHEEEcCCCCEEecccCCCcc
Confidence 45678889887432 3467899999999999999999999998 99999999999999999999999999987
Q ss_pred cCCCcccc----cceeeeeccCCCChhhhccCCCCccceEEeehhhhhhhhhCCCCCCcCCCCchhhhhhhhhhhcCCCc
Q 045315 315 FGGDELQS----NTKRIVGTYGYMSPEYALRGLFSIKSDVFSFGVLLLETLSSKKNTHFYNTDSLTLLGHAWNLWNDGRT 390 (476)
Q Consensus 315 ~~~~~~~~----~~~~~~gt~~y~aPE~l~~~~~s~ksDVwSlGvvl~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~ 390 (476)
........ ......++..|+|||.+.+..++.++|+|||||++|+|++|+.||....... .. .... ..
T Consensus 156 ~~~~~~~~~~~~~~~~~~~~~~y~~pe~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~-~~----~~~~-~~-- 227 (267)
T cd06628 156 LEANSLSTKTNGARPSLQGSVFWMAPEVVKQTSYTRKADIWSLGCLVVEMLTGKHPFPDCTQLQ-AI----FKIG-EN-- 227 (267)
T ss_pred cccccccCCccccccccCCCcCccChhHhccCCCCchhhhHHHHHHHHHHhhCCCCCCCccHHH-HH----HHHh-cc--
Confidence 65321111 1112457889999999998889999999999999999999999986432111 00 0000 00
Q ss_pred ccccCcccCCCCCHHHHHHHHHHHHHchhhcccCCCCHHHHHH
Q 045315 391 WELMDPISQNGASYPILKRYINVALLCVQEKAADRPAMSEVVS 433 (476)
Q Consensus 391 ~~~~d~~~~~~~~~~~~~~l~~li~~Cl~~dP~~RPt~~eVl~ 433 (476)
..+ ..+......+.+++.+||+.||.+||++.+|++
T Consensus 228 ---~~~----~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~il~ 263 (267)
T cd06628 228 ---ASP----EIPSNISSEAIDFLEKTFEIDHNKRPTAAELLK 263 (267)
T ss_pred ---CCC----cCCcccCHHHHHHHHHHccCCchhCcCHHHHhh
Confidence 011 111223457889999999999999999999875
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, fungal Byr2-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include the MAPKKKs Schizosaccharomyces pombe Byr2, Saccharomyces cerevisiae and Cryptococcus neoformans Ste11, and related proteins. They contain an N-terminal SAM (sterile alpha-motif) domain, which mediates protein-protein interaction, and a C-terminal catalytic domain. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate |
| >smart00750 KIND kinase non-catalytic C-lobe domain | Back alignment and domain information |
|---|
Probab=99.90 E-value=4.8e-24 Score=193.89 Aligned_cols=158 Identities=19% Similarity=0.134 Sum_probs=119.0
Q ss_pred CCCCChhhHHHHHHHHHHHHHHHhhcCCCceeecCCCccceEecCCCCceeccccceeecCCCcccccceeeeeccCCCC
Q 045315 256 KGLLCWGTRVRIIEGIAQGLLYLHQYSRLRVIHRDLKASNILLDKDMNPKISDFGMARMFGGDELQSNTKRIVGTYGYMS 335 (476)
Q Consensus 256 ~~~L~~~~~~~i~~qIa~gL~yLH~~~~~~ivH~DLkp~NILld~~~~~kL~DFGla~~~~~~~~~~~~~~~~gt~~y~a 335 (476)
+.+|++.++..|+.||+.||+|||+++ ||+||+++.++.+|+ ||+++...... ..|+..|+|
T Consensus 11 ~~~l~~~~~~~i~~qi~~~L~~lH~~~---------kp~Nil~~~~~~~~~--fG~~~~~~~~~-------~~g~~~y~a 72 (176)
T smart00750 11 GRPLNEEEIWAVCLQCLRALRELHRQA---------KSGNILLTWDGLLKL--DGSVAFKTPEQ-------SRVDPYFMA 72 (176)
T ss_pred CCCCCHHHHHHHHHHHHHHHHHHHhcC---------CcccEeEcCccceee--ccceEeecccc-------CCCcccccC
Confidence 457999999999999999999999976 999999999999999 99998764322 257899999
Q ss_pred hhhhccCCCCccceEEeehhhhhhhhhCCCCCCcCCCCchhhhhhhhhhhcCCCcccccCcccCCCCCHHHHH--HHHHH
Q 045315 336 PEYALRGLFSIKSDVFSFGVLLLETLSSKKNTHFYNTDSLTLLGHAWNLWNDGRTWELMDPISQNGASYPILK--RYINV 413 (476)
Q Consensus 336 PE~l~~~~~s~ksDVwSlGvvl~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~--~l~~l 413 (476)
||++.+..++.++|||||||++|||++|+.||.........+..... ..... ++... ........ .+.++
T Consensus 73 PE~~~~~~~~~~~DiwSlG~il~elltg~~p~~~~~~~~~~~~~~~~-~~~~~------~~~~~-~~~~~~~~~~~~~~~ 144 (176)
T smart00750 73 PEVIQGQSYTEKADIYSLGITLYEALDYELPYNEERELSAILEILLN-GMPAD------DPRDR-SNLESVSAARSFADF 144 (176)
T ss_pred hHHhcCCCCcchhhHHHHHHHHHHHHhCCCCccccchhcHHHHHHHH-HhccC------Ccccc-ccHHHHHhhhhHHHH
Confidence 99999999999999999999999999999998543321111111110 00000 00000 01112222 68999
Q ss_pred HHHchhhcccCCCCHHHHHHHHhccc
Q 045315 414 ALLCVQEKAADRPAMSEVVSMLSNEF 439 (476)
Q Consensus 414 i~~Cl~~dP~~RPt~~eVl~~L~~~~ 439 (476)
+.+||+.+|.+||++.|+++.+....
T Consensus 145 i~~cl~~~p~~Rp~~~~ll~~~~~~~ 170 (176)
T smart00750 145 MRVCASRLPQRREAANHYLAHCRALF 170 (176)
T ss_pred HHHHHhcccccccCHHHHHHHHHHHH
Confidence 99999999999999999999886643
|
It is an interaction domain identified as being similar to the C-terminal protein kinase catalytic fold (C lobe). Its presence at the N terminus of signalling proteins and the absence of the active-site residues in the catalytic and activation loops suggest that it folds independently and is likely to be non-catalytic. The occurrence of KIND only in metazoa implies that it has evolved from the catalytic protein kinase domain into an interaction domain possibly by keeping the substrate-binding features |
| >cd06644 STKc_STK10_LOK Catalytic domain of the Protein Serine/Threonine Kinase, STK10 or Lymphocyte-oriented kinase | Back alignment and domain information |
|---|
Probab=99.90 E-value=3.5e-24 Score=210.80 Aligned_cols=175 Identities=22% Similarity=0.330 Sum_probs=130.7
Q ss_pred cccceeeccCCCCC-------CCCCCChhhHHHHHHHHHHHHHHHhhcCCCceeecCCCccceEecCCCCceecccccee
Q 045315 241 DEISFWYESYNNPT-------KKGLLCWGTRVRIIEGIAQGLLYLHQYSRLRVIHRDLKASNILLDKDMNPKISDFGMAR 313 (476)
Q Consensus 241 ~~~~l~~Ey~~~~~-------~~~~L~~~~~~~i~~qIa~gL~yLH~~~~~~ivH~DLkp~NILld~~~~~kL~DFGla~ 313 (476)
+.++++|||++... ....+++.++..++.|++.||+|||+.+ ++||||||+||+++.++.+||+|||++.
T Consensus 82 ~~~~lv~e~~~~~~l~~~~~~~~~~l~~~~~~~~~~ql~~~l~~lH~~~---i~H~dlkp~Nili~~~~~~kl~dfg~~~ 158 (292)
T cd06644 82 GKLWIMIEFCPGGAVDAIMLELDRGLTEPQIQVICRQMLEALQYLHSMK---IIHRDLKAGNVLLTLDGDIKLADFGVSA 158 (292)
T ss_pred CeEEEEEecCCCCcHHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHhcCC---eeecCCCcceEEEcCCCCEEEccCccce
Confidence 46788999998432 2457899999999999999999999998 9999999999999999999999999987
Q ss_pred ecCCCcccccceeeeeccCCCChhhhc-----cCCCCccceEEeehhhhhhhhhCCCCCCcCCCCchhhhhhhhhhhcCC
Q 045315 314 MFGGDELQSNTKRIVGTYGYMSPEYAL-----RGLFSIKSDVFSFGVLLLETLSSKKNTHFYNTDSLTLLGHAWNLWNDG 388 (476)
Q Consensus 314 ~~~~~~~~~~~~~~~gt~~y~aPE~l~-----~~~~s~ksDVwSlGvvl~elltG~~p~~~~~~~~~~~~~~~~~~~~~~ 388 (476)
...... .......++..|+|||++. ...++.++|+|||||++|||++|+.|+........ . ... ...
T Consensus 159 ~~~~~~--~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Dv~slG~il~el~~g~~p~~~~~~~~~-~----~~~-~~~ 230 (292)
T cd06644 159 KNVKTL--QRRDSFIGTPYWMAPEVVMCETMKDTPYDYKADIWSLGITLIEMAQIEPPHHELNPMRV-L----LKI-AKS 230 (292)
T ss_pred eccccc--cccceecCCccccCceeeccccccCCCCCchhhhHhHHHHHHHHhcCCCCCccccHHHH-H----HHH-hcC
Confidence 643321 1122356788999999884 34568899999999999999999999864331110 0 011 111
Q ss_pred CcccccCcccCCCCCHHHHHHHHHHHHHchhhcccCCCCHHHHHH
Q 045315 389 RTWELMDPISQNGASYPILKRYINVALLCVQEKAADRPAMSEVVS 433 (476)
Q Consensus 389 ~~~~~~d~~~~~~~~~~~~~~l~~li~~Cl~~dP~~RPt~~eVl~ 433 (476)
.. +.. ..+......+.+++.+||+.+|++||+++++++
T Consensus 231 ~~-----~~~--~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~il~ 268 (292)
T cd06644 231 EP-----PTL--SQPSKWSMEFRDFLKTALDKHPETRPSAAQLLE 268 (292)
T ss_pred CC-----ccC--CCCcccCHHHHHHHHHHhcCCcccCcCHHHHhc
Confidence 10 000 011223356889999999999999999999975
|
Serine/threonine kinases (STKs), STK10 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The STK10 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Other names for STK10 include lymphocyte-oriented kinase (LOK) and Xenopus polo-like kinase kinase 1 (xPlkk1). STK10 is highly expressed in lymphocytes and is responsible in regulating leukocyte function associated antigen (LFA-1)-mediated lymphocyte adhesion. It plays a role in regulating the CD28 responsive element in T cells, and may also function as a regulator of polo-like kinase 1 (Plk1), a protein which is overexpressed in multiple tumor types. |
| >cd06656 STKc_PAK3 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 3 | Back alignment and domain information |
|---|
Probab=99.90 E-value=2.3e-24 Score=212.99 Aligned_cols=175 Identities=24% Similarity=0.346 Sum_probs=133.2
Q ss_pred cccceeeccCCCCC-----CCCCCChhhHHHHHHHHHHHHHHHhhcCCCceeecCCCccceEecCCCCceeccccceeec
Q 045315 241 DEISFWYESYNNPT-----KKGLLCWGTRVRIIEGIAQGLLYLHQYSRLRVIHRDLKASNILLDKDMNPKISDFGMARMF 315 (476)
Q Consensus 241 ~~~~l~~Ey~~~~~-----~~~~L~~~~~~~i~~qIa~gL~yLH~~~~~~ivH~DLkp~NILld~~~~~kL~DFGla~~~ 315 (476)
+..++++||+++.. .+..+++.++..++.|++.||.|||+.+ ++|+||||+||+++.++.+||+|||++...
T Consensus 89 ~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~l~~~L~~LH~~~---i~H~dL~p~Nili~~~~~~~l~Dfg~~~~~ 165 (297)
T cd06656 89 DELWVVMEYLAGGSLTDVVTETCMDEGQIAAVCRECLQALDFLHSNQ---VIHRDIKSDNILLGMDGSVKLTDFGFCAQI 165 (297)
T ss_pred CEEEEeecccCCCCHHHHHHhCCCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCCHHHEEECCCCCEEECcCccceEc
Confidence 45788899998432 2456899999999999999999999998 999999999999999999999999999865
Q ss_pred CCCcccccceeeeeccCCCChhhhccCCCCccceEEeehhhhhhhhhCCCCCCcCCCCchhhhhhhhhhhcCCCcccccC
Q 045315 316 GGDELQSNTKRIVGTYGYMSPEYALRGLFSIKSDVFSFGVLLLETLSSKKNTHFYNTDSLTLLGHAWNLWNDGRTWELMD 395 (476)
Q Consensus 316 ~~~~~~~~~~~~~gt~~y~aPE~l~~~~~s~ksDVwSlGvvl~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~d 395 (476)
...... .....++..|+|||.+.+..++.++|+|||||++|++++|+.||........... ....+.
T Consensus 166 ~~~~~~--~~~~~~~~~y~aPE~~~~~~~~~~~Di~slGvil~~l~tg~~pf~~~~~~~~~~~-----~~~~~~------ 232 (297)
T cd06656 166 TPEQSK--RSTMVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMVEGEPPYLNENPLRALYL-----IATNGT------ 232 (297)
T ss_pred cCCccC--cCcccCCccccCHHHHcCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCcchheee-----eccCCC------
Confidence 433221 1224578899999999988899999999999999999999999864332111000 000000
Q ss_pred cccCCCCCHHHHHHHHHHHHHchhhcccCCCCHHHHHH
Q 045315 396 PISQNGASYPILKRYINVALLCVQEKAADRPAMSEVVS 433 (476)
Q Consensus 396 ~~~~~~~~~~~~~~l~~li~~Cl~~dP~~RPt~~eVl~ 433 (476)
+. ..........+.+++.+||+.+|++||++++|++
T Consensus 233 ~~--~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~il~ 268 (297)
T cd06656 233 PE--LQNPERLSAVFRDFLNRCLEMDVDRRGSAKELLQ 268 (297)
T ss_pred CC--CCCccccCHHHHHHHHHHccCChhhCcCHHHHhc
Confidence 00 0011223456788999999999999999999987
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 3, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK3 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding |
| >cd05103 PTKc_VEGFR2 Catalytic domain of the Protein Tyrosine Kinase, Vascular Endothelial Growth Factor Receptor 2 | Back alignment and domain information |
|---|
Probab=99.90 E-value=2.1e-24 Score=217.87 Aligned_cols=167 Identities=29% Similarity=0.380 Sum_probs=127.2
Q ss_pred CCCCChhhHHHHHHHHHHHHHHHhhcCCCceeecCCCccceEecCCCCceeccccceeecCCCcccccceeeeeccCCCC
Q 045315 256 KGLLCWGTRVRIIEGIAQGLLYLHQYSRLRVIHRDLKASNILLDKDMNPKISDFGMARMFGGDELQSNTKRIVGTYGYMS 335 (476)
Q Consensus 256 ~~~L~~~~~~~i~~qIa~gL~yLH~~~~~~ivH~DLkp~NILld~~~~~kL~DFGla~~~~~~~~~~~~~~~~gt~~y~a 335 (476)
...+++.++.+++.||++||+|||+++ |+||||||+||+++.++.+||+|||++................++..|+|
T Consensus 173 ~~~~~~~~~~~~~~qi~~al~~lH~~~---i~H~dikp~Nil~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~a 249 (343)
T cd05103 173 KKVLTLEDLICYSFQVAKGMEFLASRK---CIHRDLAARNILLSENNVVKICDFGLARDIYKDPDYVRKGDARLPLKWMA 249 (343)
T ss_pred hccCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCccCeEEEcCCCcEEEEecccccccccCcchhhcCCCCCCcceEC
Confidence 346899999999999999999999998 99999999999999999999999999986543222122222345678999
Q ss_pred hhhhccCCCCccceEEeehhhhhhhhh-CCCCCCcCCCCchhhhhhhhhhhcCCCcccccCcccCCCCCHHHHHHHHHHH
Q 045315 336 PEYALRGLFSIKSDVFSFGVLLLETLS-SKKNTHFYNTDSLTLLGHAWNLWNDGRTWELMDPISQNGASYPILKRYINVA 414 (476)
Q Consensus 336 PE~l~~~~~s~ksDVwSlGvvl~ellt-G~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~l~~li 414 (476)
||.+.+..++.++||||||+++||+++ |..|+....... ... .....+..... +......+.+++
T Consensus 250 PE~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~~~~~~~-~~~----~~~~~~~~~~~---------~~~~~~~~~~~~ 315 (343)
T cd05103 250 PETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYPGVKIDE-EFC----RRLKEGTRMRA---------PDYTTPEMYQTM 315 (343)
T ss_pred cHHhcCCCCCchhhHHHHHHHHHHHHHCCCCCCCCccccH-HHH----HHHhccCCCCC---------CCCCCHHHHHHH
Confidence 999988899999999999999999997 888876433211 111 11111111110 011124678999
Q ss_pred HHchhhcccCCCCHHHHHHHHhccc
Q 045315 415 LLCVQEKAADRPAMSEVVSMLSNEF 439 (476)
Q Consensus 415 ~~Cl~~dP~~RPt~~eVl~~L~~~~ 439 (476)
.+||+.+|++||++.+|++.|+.+.
T Consensus 316 ~~cl~~~p~~Rps~~eil~~l~~~~ 340 (343)
T cd05103 316 LDCWHGEPSQRPTFSELVEHLGNLL 340 (343)
T ss_pred HHHccCChhhCcCHHHHHHHHHHHH
Confidence 9999999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor 2 (VEGFR2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR2 (or Flk1) is a member of the VEGFR subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. The carboxyl terminus of VEGFR2 plays an important role in its autophosp |
| >cd05627 STKc_NDR2 Catalytic domain of the Protein Serine/Threonine Kinase, Nuclear Dbf2-Related kinase 2 | Back alignment and domain information |
|---|
Probab=99.90 E-value=3.6e-24 Score=217.53 Aligned_cols=177 Identities=24% Similarity=0.291 Sum_probs=127.8
Q ss_pred cccceeeccCCCC------CCCCCCChhhHHHHHHHHHHHHHHHhhcCCCceeecCCCccceEecCCCCceeccccceee
Q 045315 241 DEISFWYESYNNP------TKKGLLCWGTRVRIIEGIAQGLLYLHQYSRLRVIHRDLKASNILLDKDMNPKISDFGMARM 314 (476)
Q Consensus 241 ~~~~l~~Ey~~~~------~~~~~L~~~~~~~i~~qIa~gL~yLH~~~~~~ivH~DLkp~NILld~~~~~kL~DFGla~~ 314 (476)
+..+++|||++.+ .+.+.+++..+..++.||+.||+|||+.+ |+||||||+|||++.++.+||+|||++..
T Consensus 74 ~~~~lv~E~~~gg~L~~~l~~~~~l~~~~~~~~~~qi~~~L~~lH~~g---ivHrDLkp~NIli~~~~~vkL~DfG~~~~ 150 (360)
T cd05627 74 RNLYLIMEFLPGGDMMTLLMKKDTLSEEATQFYIAETVLAIDAIHQLG---FIHRDIKPDNLLLDAKGHVKLSDFGLCTG 150 (360)
T ss_pred CEEEEEEeCCCCccHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCC---eEccCCCHHHEEECCCCCEEEeeccCCcc
Confidence 4578999999843 24567999999999999999999999999 99999999999999999999999999875
Q ss_pred cCCCcc---------------------------------cccceeeeeccCCCChhhhccCCCCccceEEeehhhhhhhh
Q 045315 315 FGGDEL---------------------------------QSNTKRIVGTYGYMSPEYALRGLFSIKSDVFSFGVLLLETL 361 (476)
Q Consensus 315 ~~~~~~---------------------------------~~~~~~~~gt~~y~aPE~l~~~~~s~ksDVwSlGvvl~ell 361 (476)
+..... ........||..|+|||++.+..++.++|+|||||++|||+
T Consensus 151 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~APE~~~~~~~~~~~DiwSlGvilyel~ 230 (360)
T cd05627 151 LKKAHRTEFYRNLTHNPPSDFSFQNMNSKRKAETWKKNRRQLAYSTVGTPDYIAPEVFMQTGYNKLCDWWSLGVIMYEML 230 (360)
T ss_pred cccccccccccccccCCcccccccccccccccccccccccccccccCCCccccCHHHHcCCCCCCcceeccccceeeecc
Confidence 432110 00011346899999999999999999999999999999999
Q ss_pred hCCCCCCcCCCCchhhhhhhhhhhcCCCcccccCcccCCCCCHHHHHHHHHHHHHchhhcccCCCC---HHHHHH
Q 045315 362 SSKKNTHFYNTDSLTLLGHAWNLWNDGRTWELMDPISQNGASYPILKRYINVALLCVQEKAADRPA---MSEVVS 433 (476)
Q Consensus 362 tG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~l~~li~~Cl~~dP~~RPt---~~eVl~ 433 (476)
+|+.||....... .... .......... .+ .......+.+++.+|+. +|.+|++ +.++++
T Consensus 231 tG~~Pf~~~~~~~--~~~~---i~~~~~~~~~-p~------~~~~s~~~~~li~~l~~-~p~~R~~~~~~~ei~~ 292 (360)
T cd05627 231 IGYPPFCSETPQE--TYRK---VMNWKETLVF-PP------EVPISEKAKDLILRFCT-DSENRIGSNGVEEIKS 292 (360)
T ss_pred cCCCCCCCCCHHH--HHHH---HHcCCCceec-CC------CCCCCHHHHHHHHHhcc-ChhhcCCCCCHHHHhc
Confidence 9999986543211 1111 1110000000 00 11123466777777664 9999986 555544
|
Serine/Threonine Kinases (STKs), NDR kinase subfamily, NDR2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. Both isoforms play a role in proper centrosome duplication. In addition, NDR2 plays a role in regul |
| >cd06608 STKc_myosinIII_like Catalytic domain of Class III myosin-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=99.90 E-value=4.9e-24 Score=206.74 Aligned_cols=174 Identities=25% Similarity=0.335 Sum_probs=130.7
Q ss_pred ccceeeccCCCC----------CCCCCCChhhHHHHHHHHHHHHHHHhhcCCCceeecCCCccceEecCCCCceeccccc
Q 045315 242 EISFWYESYNNP----------TKKGLLCWGTRVRIIEGIAQGLLYLHQYSRLRVIHRDLKASNILLDKDMNPKISDFGM 311 (476)
Q Consensus 242 ~~~l~~Ey~~~~----------~~~~~L~~~~~~~i~~qIa~gL~yLH~~~~~~ivH~DLkp~NILld~~~~~kL~DFGl 311 (476)
..++++||++.. ..+..+++..+..++.|+++||+|||+.+ ++|+||+|+||+++.++.+||+|||+
T Consensus 83 ~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~ql~~al~~lH~~~---i~H~~l~p~ni~~~~~~~~~l~d~~~ 159 (275)
T cd06608 83 QLWLVMELCGGGSVTDLVKGLRKKGKRLKEEWIAYILRETLRGLAYLHENK---VIHRDIKGQNILLTKNAEVKLVDFGV 159 (275)
T ss_pred EEEEEEEcCCCCcHHHHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHhcCC---cccCCCCHHHEEEccCCeEEECCCcc
Confidence 467888998832 12467999999999999999999999998 99999999999999999999999999
Q ss_pred eeecCCCcccccceeeeeccCCCChhhhcc-----CCCCccceEEeehhhhhhhhhCCCCCCcCCCCchhhhhhhhhhhc
Q 045315 312 ARMFGGDELQSNTKRIVGTYGYMSPEYALR-----GLFSIKSDVFSFGVLLLETLSSKKNTHFYNTDSLTLLGHAWNLWN 386 (476)
Q Consensus 312 a~~~~~~~~~~~~~~~~gt~~y~aPE~l~~-----~~~s~ksDVwSlGvvl~elltG~~p~~~~~~~~~~~~~~~~~~~~ 386 (476)
+........ ......++..|+|||.+.. ..++.++|||||||+++++++|+.||....... ... .. .
T Consensus 160 ~~~~~~~~~--~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~-~~~----~~-~ 231 (275)
T cd06608 160 SAQLDSTLG--RRNTFIGTPYWMAPEVIACDEQPDASYDARSDVWSLGITAIELADGKPPLCDMHPMR-ALF----KI-P 231 (275)
T ss_pred ceecccchh--hhcCccccccccCHhHhcccccccCCccccccHHHhHHHHHHHHhCCCCccccchHH-HHH----Hh-h
Confidence 986543221 1223468889999998753 346789999999999999999999986432111 111 01 1
Q ss_pred CCCcccccCcccCCCCCHHHHHHHHHHHHHchhhcccCCCCHHHHHH
Q 045315 387 DGRTWELMDPISQNGASYPILKRYINVALLCVQEKAADRPAMSEVVS 433 (476)
Q Consensus 387 ~~~~~~~~d~~~~~~~~~~~~~~l~~li~~Cl~~dP~~RPt~~eVl~ 433 (476)
...... . .........+.+++.+||+.||++|||+.++++
T Consensus 232 ~~~~~~-----~--~~~~~~~~~~~~li~~~l~~dp~~Rpt~~~ll~ 271 (275)
T cd06608 232 RNPPPT-----L--KSPENWSKKFNDFISECLIKNYEQRPFMEELLE 271 (275)
T ss_pred ccCCCC-----C--CchhhcCHHHHHHHHHHhhcChhhCcCHHHHhc
Confidence 111101 1 111223467889999999999999999999985
|
Serine/threonine kinases (STKs), Class III myosin-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins with an N-terminal kinase catalytic domain and a C-terminal actin-binding motor domain. Class III myosins are present in the photoreceptors of invertebrates and vertebrates and in the auditory hair cells of mammals. The kinase domain of myosin III can phosphorylate several cytoskeletal proteins, conventional myosin regulatory light chains, and can autophosphorylate the C-terminal motor domain. Myosin I |
| >cd06651 STKc_MEKK3 Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 3 | Back alignment and domain information |
|---|
Probab=99.90 E-value=3.6e-24 Score=207.71 Aligned_cols=174 Identities=25% Similarity=0.388 Sum_probs=127.0
Q ss_pred ccceeeccCCCC------CCCCCCChhhHHHHHHHHHHHHHHHhhcCCCceeecCCCccceEecCCCCceeccccceeec
Q 045315 242 EISFWYESYNNP------TKKGLLCWGTRVRIIEGIAQGLLYLHQYSRLRVIHRDLKASNILLDKDMNPKISDFGMARMF 315 (476)
Q Consensus 242 ~~~l~~Ey~~~~------~~~~~L~~~~~~~i~~qIa~gL~yLH~~~~~~ivH~DLkp~NILld~~~~~kL~DFGla~~~ 315 (476)
..++++||++.. .+...+++..+..++.|++.||+|||+.+ ++|+||||+||+++.++.+||+|||+++..
T Consensus 80 ~~~l~~e~~~~~~L~~~l~~~~~l~~~~~~~~~~qi~~~l~~LH~~~---i~H~~l~p~nil~~~~~~~~l~dfg~~~~~ 156 (266)
T cd06651 80 TLTIFMEYMPGGSVKDQLKAYGALTESVTRKYTRQILEGMSYLHSNM---IVHRDIKGANILRDSAGNVKLGDFGASKRL 156 (266)
T ss_pred EEEEEEeCCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHhCC---eeeCCCCHHHEEECCCCCEEEccCCCcccc
Confidence 466788888732 23456899999999999999999999998 999999999999999999999999998765
Q ss_pred CCCcc-cccceeeeeccCCCChhhhccCCCCccceEEeehhhhhhhhhCCCCCCcCCCCchhhhhhhhhhhcCCCccccc
Q 045315 316 GGDEL-QSNTKRIVGTYGYMSPEYALRGLFSIKSDVFSFGVLLLETLSSKKNTHFYNTDSLTLLGHAWNLWNDGRTWELM 394 (476)
Q Consensus 316 ~~~~~-~~~~~~~~gt~~y~aPE~l~~~~~s~ksDVwSlGvvl~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 394 (476)
..... ........++..|+|||.+.+..++.++|+|||||++|||++|+.||....... .. ........
T Consensus 157 ~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~i~~el~~g~~pf~~~~~~~-~~----~~~~~~~~----- 226 (266)
T cd06651 157 QTICMSGTGIRSVTGTPYWMSPEVISGEGYGRKADVWSLGCTVVEMLTEKPPWAEYEAMA-AI----FKIATQPT----- 226 (266)
T ss_pred ccccccCCccccCCccccccCHHHhCCCCCCchhhhHHHHHHHHHHHHCCCCccccchHH-HH----HHHhcCCC-----
Confidence 32111 111122457889999999988889999999999999999999999986432111 00 00100000
Q ss_pred CcccCCCCCHHHHHHHHHHHHHchhhcccCCCCHHHHHH
Q 045315 395 DPISQNGASYPILKRYINVALLCVQEKAADRPAMSEVVS 433 (476)
Q Consensus 395 d~~~~~~~~~~~~~~l~~li~~Cl~~dP~~RPt~~eVl~ 433 (476)
.+ ..+....+.+.+++ +||..+|++||+++||++
T Consensus 227 ~~----~~~~~~~~~~~~li-~~~~~~p~~Rp~~~eil~ 260 (266)
T cd06651 227 NP----QLPSHISEHARDFL-GCIFVEARHRPSAEELLR 260 (266)
T ss_pred CC----CCchhcCHHHHHHH-HHhcCChhhCcCHHHHhc
Confidence 11 11122233445555 688899999999999974
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK3 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates the MAPK kinase MEK5 (or MKK5), which in turn phosphorylates and activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK3 plays an essential role in embryonic angiogenesis and early heart development |
| >cd06659 STKc_PAK6 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 6 | Back alignment and domain information |
|---|
Probab=99.90 E-value=2.3e-24 Score=213.11 Aligned_cols=176 Identities=23% Similarity=0.324 Sum_probs=133.7
Q ss_pred cccceeeccCCCCC-----CCCCCChhhHHHHHHHHHHHHHHHhhcCCCceeecCCCccceEecCCCCceeccccceeec
Q 045315 241 DEISFWYESYNNPT-----KKGLLCWGTRVRIIEGIAQGLLYLHQYSRLRVIHRDLKASNILLDKDMNPKISDFGMARMF 315 (476)
Q Consensus 241 ~~~~l~~Ey~~~~~-----~~~~L~~~~~~~i~~qIa~gL~yLH~~~~~~ivH~DLkp~NILld~~~~~kL~DFGla~~~ 315 (476)
+..++++||++... ....+++.++..++.|++.||+|||+.+ ++|+||||+||+++.++.+||+|||++..+
T Consensus 91 ~~~~iv~e~~~~~~L~~~~~~~~~~~~~~~~~~~qi~~~L~~LH~~~---ivH~dl~p~Nill~~~~~~kL~dfg~~~~~ 167 (297)
T cd06659 91 EELWVLMEFLQGGALTDIVSQTRLNEEQIATVCESVLQALCYLHSQG---VIHRDIKSDSILLTLDGRVKLSDFGFCAQI 167 (297)
T ss_pred CeEEEEEecCCCCCHHHHHhhcCCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCCHHHeEEccCCcEEEeechhHhhc
Confidence 45778899998322 2456899999999999999999999998 999999999999999999999999998765
Q ss_pred CCCcccccceeeeeccCCCChhhhccCCCCccceEEeehhhhhhhhhCCCCCCcCCCCchhhhhhhhhhhcCCCcccccC
Q 045315 316 GGDELQSNTKRIVGTYGYMSPEYALRGLFSIKSDVFSFGVLLLETLSSKKNTHFYNTDSLTLLGHAWNLWNDGRTWELMD 395 (476)
Q Consensus 316 ~~~~~~~~~~~~~gt~~y~aPE~l~~~~~s~ksDVwSlGvvl~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~d 395 (476)
...... .....++..|+|||++.+..++.++|+|||||+++||++|+.||...... ..... ........
T Consensus 168 ~~~~~~--~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~el~~g~~p~~~~~~~--~~~~~----~~~~~~~~--- 236 (297)
T cd06659 168 SKDVPK--RKSLVGTPYWMAPEVISRTPYGTEVDIWSLGIMVIEMVDGEPPYFSDSPV--QAMKR----LRDSPPPK--- 236 (297)
T ss_pred cccccc--ccceecCccccCHHHHccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHH--HHHHH----HhccCCCC---
Confidence 433211 22356889999999999888999999999999999999999998643211 11111 11110000
Q ss_pred cccCCCCCHHHHHHHHHHHHHchhhcccCCCCHHHHHHH
Q 045315 396 PISQNGASYPILKRYINVALLCVQEKAADRPAMSEVVSM 434 (476)
Q Consensus 396 ~~~~~~~~~~~~~~l~~li~~Cl~~dP~~RPt~~eVl~~ 434 (476)
.. ........+.+++.+||+.+|++||+++++++.
T Consensus 237 --~~--~~~~~~~~l~~~i~~~l~~~P~~Rps~~~ll~~ 271 (297)
T cd06659 237 --LK--NAHKISPVLRDFLERMLTREPQERATAQELLDH 271 (297)
T ss_pred --cc--ccCCCCHHHHHHHHHHhcCCcccCcCHHHHhhC
Confidence 00 011223467889999999999999999999984
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 6, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK6 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK6 may play a role i |
| >cd06640 STKc_MST4 Catalytic domain of the Protein Serine/Threonine Kinase, Mammalian Ste20-like protein kinase 4 | Back alignment and domain information |
|---|
Probab=99.90 E-value=5.9e-24 Score=207.56 Aligned_cols=174 Identities=23% Similarity=0.344 Sum_probs=135.0
Q ss_pred cccceeeccCCCCC-----CCCCCChhhHHHHHHHHHHHHHHHhhcCCCceeecCCCccceEecCCCCceeccccceeec
Q 045315 241 DEISFWYESYNNPT-----KKGLLCWGTRVRIIEGIAQGLLYLHQYSRLRVIHRDLKASNILLDKDMNPKISDFGMARMF 315 (476)
Q Consensus 241 ~~~~l~~Ey~~~~~-----~~~~L~~~~~~~i~~qIa~gL~yLH~~~~~~ivH~DLkp~NILld~~~~~kL~DFGla~~~ 315 (476)
...++++||++... ...++++.++..++.|++.||+|||+.+ ++|+||+|+||+++.++.++|+|||++...
T Consensus 75 ~~~~lv~e~~~~~~L~~~i~~~~l~~~~~~~~~~~l~~~l~~lh~~~---ivH~dl~p~Nil~~~~~~~~l~dfg~~~~~ 151 (277)
T cd06640 75 TKLWIIMEYLGGGSALDLLRAGPFDEFQIATMLKEILKGLDYLHSEK---KIHRDIKAANVLLSEQGDVKLADFGVAGQL 151 (277)
T ss_pred CEEEEEEecCCCCcHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCC---ccCcCCChhhEEEcCCCCEEEcccccceec
Confidence 35678899987432 3456899999999999999999999998 999999999999999999999999999876
Q ss_pred CCCcccccceeeeeccCCCChhhhccCCCCccceEEeehhhhhhhhhCCCCCCcCCCCchhhhhhhhhhhcCCCcccccC
Q 045315 316 GGDELQSNTKRIVGTYGYMSPEYALRGLFSIKSDVFSFGVLLLETLSSKKNTHFYNTDSLTLLGHAWNLWNDGRTWELMD 395 (476)
Q Consensus 316 ~~~~~~~~~~~~~gt~~y~aPE~l~~~~~s~ksDVwSlGvvl~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~d 395 (476)
...... .....++..|+|||.+.+..++.++|+|||||++|||++|+.|+........ .. .. .
T Consensus 152 ~~~~~~--~~~~~~~~~y~apE~~~~~~~~~~~Dv~slG~il~el~tg~~p~~~~~~~~~--~~----~~---------~ 214 (277)
T cd06640 152 TDTQIK--RNTFVGTPFWMAPEVIQQSAYDSKADIWSLGITAIELAKGEPPNSDMHPMRV--LF----LI---------P 214 (277)
T ss_pred cCCccc--cccccCcccccCHhHhccCCCccHHHHHHHHHHHHHHHHCCCCCCCcChHhH--hh----hh---------h
Confidence 543221 2224578899999999888899999999999999999999999864321110 00 00 0
Q ss_pred cccCCCCCHHHHHHHHHHHHHchhhcccCCCCHHHHHHH
Q 045315 396 PISQNGASYPILKRYINVALLCVQEKAADRPAMSEVVSM 434 (476)
Q Consensus 396 ~~~~~~~~~~~~~~l~~li~~Cl~~dP~~RPt~~eVl~~ 434 (476)
..............+.+++.+||+.+|++||++.++++.
T Consensus 215 ~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~il~~ 253 (277)
T cd06640 215 KNNPPTLTGEFSKPFKEFIDACLNKDPSFRPTAKELLKH 253 (277)
T ss_pred cCCCCCCchhhhHHHHHHHHHHcccCcccCcCHHHHHhC
Confidence 001112233456678899999999999999999999764
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 4 (MST4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MST4 is sometimes referred to as MASK (MST3 and SOK1-related kinase). It plays a role in mitogen-activated protein kinase (MAPK) signaling during cytoskeletal rearrangement, morphogenesis, and apoptosis. It influences cell growth and transformation by modulating the extracellular signal-regulated kinase (ERK) pathway. MST4 may also play a role in tumor formation and progression. It localizes in the Golgi apparatus by inter |
| >cd06655 STKc_PAK2 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 2 | Back alignment and domain information |
|---|
Probab=99.90 E-value=1.8e-24 Score=213.78 Aligned_cols=176 Identities=24% Similarity=0.336 Sum_probs=132.6
Q ss_pred cccceeeccCCCCC-----CCCCCChhhHHHHHHHHHHHHHHHhhcCCCceeecCCCccceEecCCCCceeccccceeec
Q 045315 241 DEISFWYESYNNPT-----KKGLLCWGTRVRIIEGIAQGLLYLHQYSRLRVIHRDLKASNILLDKDMNPKISDFGMARMF 315 (476)
Q Consensus 241 ~~~~l~~Ey~~~~~-----~~~~L~~~~~~~i~~qIa~gL~yLH~~~~~~ivH~DLkp~NILld~~~~~kL~DFGla~~~ 315 (476)
+..++++||++... ....+++.++..++.|++.||+|||+.+ ++|+||||+||+++.++.+||+|||++...
T Consensus 89 ~~~~lv~e~~~~~~L~~~~~~~~l~~~~~~~i~~~l~~al~~LH~~~---i~H~dL~p~Nili~~~~~~kl~dfg~~~~~ 165 (296)
T cd06655 89 DELFVVMEYLAGGSLTDVVTETCMDEAQIAAVCRECLQALEFLHANQ---VIHRDIKSDNVLLGMDGSVKLTDFGFCAQI 165 (296)
T ss_pred ceEEEEEEecCCCcHHHHHHhcCCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCCHHHEEECCCCCEEEccCccchhc
Confidence 35677888887332 2346899999999999999999999998 999999999999999999999999998765
Q ss_pred CCCcccccceeeeeccCCCChhhhccCCCCccceEEeehhhhhhhhhCCCCCCcCCCCchhhhhhhhhhhcCCCcccccC
Q 045315 316 GGDELQSNTKRIVGTYGYMSPEYALRGLFSIKSDVFSFGVLLLETLSSKKNTHFYNTDSLTLLGHAWNLWNDGRTWELMD 395 (476)
Q Consensus 316 ~~~~~~~~~~~~~gt~~y~aPE~l~~~~~s~ksDVwSlGvvl~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~d 395 (476)
...... .....++..|+|||.+.+..++.++|+|||||++|++++|+.||........ .. ...... ....
T Consensus 166 ~~~~~~--~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slGvil~~lltg~~pf~~~~~~~~-~~----~~~~~~-~~~~-- 235 (296)
T cd06655 166 TPEQSK--RSTMVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMVEGEPPYLNENPLRA-LY----LIATNG-TPEL-- 235 (296)
T ss_pred cccccc--CCCcCCCccccCcchhcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHH-HH----HHHhcC-Cccc--
Confidence 433211 1224578899999999888899999999999999999999999865432111 00 000000 0000
Q ss_pred cccCCCCCHHHHHHHHHHHHHchhhcccCCCCHHHHHHH
Q 045315 396 PISQNGASYPILKRYINVALLCVQEKAADRPAMSEVVSM 434 (476)
Q Consensus 396 ~~~~~~~~~~~~~~l~~li~~Cl~~dP~~RPt~~eVl~~ 434 (476)
..+......+.+++.+||+.||++||++.++++.
T Consensus 236 -----~~~~~~~~~~~~li~~~l~~dp~~Rpt~~~il~~ 269 (296)
T cd06655 236 -----QNPEKLSPIFRDFLNRCLEMDVEKRGSAKELLQH 269 (296)
T ss_pred -----CCcccCCHHHHHHHHHHhhcChhhCCCHHHHhhC
Confidence 0111233467889999999999999999998853
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 2, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK2 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding |
| >cd06638 STKc_myosinIIIA Catalytic domain of the Protein Serine/Threonine Kinase, Class IIIA myosin | Back alignment and domain information |
|---|
Probab=99.90 E-value=7.2e-24 Score=207.57 Aligned_cols=175 Identities=22% Similarity=0.297 Sum_probs=130.3
Q ss_pred ccceeeccCCCC----------CCCCCCChhhHHHHHHHHHHHHHHHhhcCCCceeecCCCccceEecCCCCceeccccc
Q 045315 242 EISFWYESYNNP----------TKKGLLCWGTRVRIIEGIAQGLLYLHQYSRLRVIHRDLKASNILLDKDMNPKISDFGM 311 (476)
Q Consensus 242 ~~~l~~Ey~~~~----------~~~~~L~~~~~~~i~~qIa~gL~yLH~~~~~~ivH~DLkp~NILld~~~~~kL~DFGl 311 (476)
..+++|||++.. .....+++..+..++.|+++||.|||+.+ ++||||||+||+++.++.+||+|||+
T Consensus 94 ~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~---i~H~dlkp~nili~~~~~~kl~dfg~ 170 (286)
T cd06638 94 QLWLVLELCNGGSVTDLVKGFLKRGERMEEPIIAYILHEALMGLQHLHVNK---TIHRDVKGNNILLTTEGGVKLVDFGV 170 (286)
T ss_pred eEEEEEeecCCCCHHHHHHHhhccCccccHHHHHHHHHHHHHHHHHHHhCC---ccccCCCHHhEEECCCCCEEEccCCc
Confidence 367888988732 23457889999999999999999999998 99999999999999999999999999
Q ss_pred eeecCCCcccccceeeeeccCCCChhhhcc-----CCCCccceEEeehhhhhhhhhCCCCCCcCCCCchhhhhhhhhhhc
Q 045315 312 ARMFGGDELQSNTKRIVGTYGYMSPEYALR-----GLFSIKSDVFSFGVLLLETLSSKKNTHFYNTDSLTLLGHAWNLWN 386 (476)
Q Consensus 312 a~~~~~~~~~~~~~~~~gt~~y~aPE~l~~-----~~~s~ksDVwSlGvvl~elltG~~p~~~~~~~~~~~~~~~~~~~~ 386 (476)
++........ .....|+..|+|||.+.. ..++.++|||||||++|||++|+.|+....... .+. ...
T Consensus 171 ~~~~~~~~~~--~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Dv~slGvi~~el~~g~~p~~~~~~~~-~~~-----~~~ 242 (286)
T cd06638 171 SAQLTSTRLR--RNTSVGTPFWMAPEVIACEQQLDSTYDARCDVWSLGITAIELGDGDPPLADLHPMR-ALF-----KIP 242 (286)
T ss_pred eeecccCCCc--cccccCCCcccChhhhchhhhccccccchhhhhhHHHHHHHHhcCCCCCCCCchhH-HHh-----hcc
Confidence 9876432221 223468899999998753 457899999999999999999999986432111 000 000
Q ss_pred CCCcccccCcccCCCCCHHHHHHHHHHHHHchhhcccCCCCHHHHHHH
Q 045315 387 DGRTWELMDPISQNGASYPILKRYINVALLCVQEKAADRPAMSEVVSM 434 (476)
Q Consensus 387 ~~~~~~~~d~~~~~~~~~~~~~~l~~li~~Cl~~dP~~RPt~~eVl~~ 434 (476)
.........+ ......+.+++.+||+.+|++||++.|+++.
T Consensus 243 ~~~~~~~~~~-------~~~~~~~~~li~~~l~~~p~~Rps~~ell~~ 283 (286)
T cd06638 243 RNPPPTLHQP-------ELWSNEFNDFIRKCLTKDYEKRPTVSDLLQH 283 (286)
T ss_pred ccCCCcccCC-------CCcCHHHHHHHHHHccCCcccCCCHHHHhhc
Confidence 0100011111 1123468899999999999999999999864
|
Serine/threonine kinases (STKs), class IIIA myosin subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain. Class III myosins may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. In photoreceptor cells, they may also function as cargo carriers during light-dependent translocation of proteins such as transducin and arrestin. Class IIIA myosin is highly expressed in retina and in inner ear |
| >cd06609 STKc_MST3_like Catalytic domain of Mammalian Ste20-like protein kinase 3-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=99.90 E-value=2.6e-24 Score=209.54 Aligned_cols=173 Identities=25% Similarity=0.384 Sum_probs=132.6
Q ss_pred ccceeeccCCCCC-----CCCCCChhhHHHHHHHHHHHHHHHhhcCCCceeecCCCccceEecCCCCceeccccceeecC
Q 045315 242 EISFWYESYNNPT-----KKGLLCWGTRVRIIEGIAQGLLYLHQYSRLRVIHRDLKASNILLDKDMNPKISDFGMARMFG 316 (476)
Q Consensus 242 ~~~l~~Ey~~~~~-----~~~~L~~~~~~~i~~qIa~gL~yLH~~~~~~ivH~DLkp~NILld~~~~~kL~DFGla~~~~ 316 (476)
..++++||++... ...++++.++..++.|++.||.|||+.+ ++|+||+|+||++++++.++|+|||+++...
T Consensus 73 ~~~~v~e~~~~~~L~~~~~~~~~~~~~~~~~~~ql~~~l~~lh~~~---i~h~dl~p~ni~i~~~~~~~l~d~g~~~~~~ 149 (274)
T cd06609 73 KLWIIMEYCGGGSCLDLLKPGKLDETYIAFILREVLLGLEYLHEEG---KIHRDIKAANILLSEEGDVKLADFGVSGQLT 149 (274)
T ss_pred eEEEEEEeeCCCcHHHHHhhcCCCHHHHHHHHHHHHHHHHHHHhCC---cccCCCCHHHEEECCCCCEEEcccccceeec
Confidence 4678888887321 2338999999999999999999999998 9999999999999999999999999998775
Q ss_pred CCcccccceeeeeccCCCChhhhccCCCCccceEEeehhhhhhhhhCCCCCCcCCCCchhhhhhhhhhhcCCCcccccCc
Q 045315 317 GDELQSNTKRIVGTYGYMSPEYALRGLFSIKSDVFSFGVLLLETLSSKKNTHFYNTDSLTLLGHAWNLWNDGRTWELMDP 396 (476)
Q Consensus 317 ~~~~~~~~~~~~gt~~y~aPE~l~~~~~s~ksDVwSlGvvl~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~ 396 (476)
.... ......++..|+|||.+.+..++.++|+||||+++|++++|+.||...... .... ....... +
T Consensus 150 ~~~~--~~~~~~~~~~y~~PE~~~~~~~~~~sDv~slG~il~~l~tg~~p~~~~~~~--~~~~----~~~~~~~-----~ 216 (274)
T cd06609 150 STMS--KRNTFVGTPFWMAPEVIKQSGYDEKADIWSLGITAIELAKGEPPLSDLHPM--RVLF----LIPKNNP-----P 216 (274)
T ss_pred cccc--ccccccCCccccChhhhccCCCCchhhHHHHHHHHHHHHhCCCCcccCchH--HHHH----HhhhcCC-----C
Confidence 4321 122346788999999999888999999999999999999999998643311 1110 0111111 1
Q ss_pred ccCCCCCHHHHHHHHHHHHHchhhcccCCCCHHHHHH
Q 045315 397 ISQNGASYPILKRYINVALLCVQEKAADRPAMSEVVS 433 (476)
Q Consensus 397 ~~~~~~~~~~~~~l~~li~~Cl~~dP~~RPt~~eVl~ 433 (476)
..... .....+.+++.+||+.+|++||+++++++
T Consensus 217 ~~~~~---~~~~~~~~~l~~~l~~~p~~Rpt~~~il~ 250 (274)
T cd06609 217 SLEGN---KFSKPFKDFVSLCLNKDPKERPSAKELLK 250 (274)
T ss_pred CCccc---ccCHHHHHHHHHHhhCChhhCcCHHHHhh
Confidence 11110 13456889999999999999999999976
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 3 (MST3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MST3, MST4, STK25, Schizosaccharomyces pombe Nak1 and Sid1, Saccharomyces cerevisiae sporulation-specific protein 1 (SPS1), and related proteins. Nak1 is required by fission yeast for polarizing the tips of actin cytoskeleton and is involved in cell growth, cell separation, cell morphology and cell-cycle progression. Sid1 is a component in the septation initiation network (SIN) |
| >cd07849 STKc_ERK1_2_like Catalytic domain of Extracellular signal-Regulated Kinase 1 and 2-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=99.90 E-value=1.7e-24 Score=217.74 Aligned_cols=193 Identities=22% Similarity=0.252 Sum_probs=134.7
Q ss_pred ccceeeccCCCC----CCCCCCChhhHHHHHHHHHHHHHHHhhcCCCceeecCCCccceEecCCCCceeccccceeecCC
Q 045315 242 EISFWYESYNNP----TKKGLLCWGTRVRIIEGIAQGLLYLHQYSRLRVIHRDLKASNILLDKDMNPKISDFGMARMFGG 317 (476)
Q Consensus 242 ~~~l~~Ey~~~~----~~~~~L~~~~~~~i~~qIa~gL~yLH~~~~~~ivH~DLkp~NILld~~~~~kL~DFGla~~~~~ 317 (476)
..++++||++.. .+...+++..+..++.||++||+|||+.+ |+||||||+||+++.++.+||+|||++.....
T Consensus 82 ~~~lv~e~~~~~l~~~~~~~~l~~~~~~~i~~ql~~aL~~LH~~~---ivH~dlkp~Nill~~~~~~kl~dfg~~~~~~~ 158 (336)
T cd07849 82 DVYIVQELMETDLYKLIKTQHLSNDHIQYFLYQILRGLKYIHSAN---VLHRDLKPSNLLLNTNCDLKICDFGLARIADP 158 (336)
T ss_pred eEEEEehhcccCHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCC---eeccCCCHHHEEECCCCCEEECcccceeeccc
Confidence 357788888731 23457999999999999999999999999 99999999999999999999999999987543
Q ss_pred Ccccc-cceeeeeccCCCChhhhcc-CCCCccceEEeehhhhhhhhhCCCCCCcCCCCchhhhhhhhhhhcCC-------
Q 045315 318 DELQS-NTKRIVGTYGYMSPEYALR-GLFSIKSDVFSFGVLLLETLSSKKNTHFYNTDSLTLLGHAWNLWNDG------- 388 (476)
Q Consensus 318 ~~~~~-~~~~~~gt~~y~aPE~l~~-~~~s~ksDVwSlGvvl~elltG~~p~~~~~~~~~~~~~~~~~~~~~~------- 388 (476)
..... ......++..|+|||.+.+ ..++.++|||||||++|+|++|+.||...+.. .............
T Consensus 159 ~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DvwslGvil~el~~G~~~f~~~~~~--~~~~~~~~~~~~~~~~~~~~ 236 (336)
T cd07849 159 EHDHTGFLTEYVATRWYRAPEIMLNSKGYTKAIDIWSVGCILAEMLSNRPLFPGKDYL--HQLNLILGVLGTPSQEDLNC 236 (336)
T ss_pred cccccCCcCCcCcCCCccChHHhhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHH--HHHHHHHHHcCCCCHHHHHH
Confidence 22111 1122467889999998764 56899999999999999999999998643210 0000000000000
Q ss_pred ----CcccccCc-ccCCCC-----CHHHHHHHHHHHHHchhhcccCCCCHHHHHHH--Hhccc
Q 045315 389 ----RTWELMDP-ISQNGA-----SYPILKRYINVALLCVQEKAADRPAMSEVVSM--LSNEF 439 (476)
Q Consensus 389 ----~~~~~~d~-~~~~~~-----~~~~~~~l~~li~~Cl~~dP~~RPt~~eVl~~--L~~~~ 439 (476)
........ ...... .......+.+++.+||+.+|++|||+.|+++. ++...
T Consensus 237 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~Rpt~~e~l~hp~~~~~~ 299 (336)
T cd07849 237 IISLRARNYIKSLPFKPKVPWNKLFPNADPKALDLLDKMLTFNPHKRITVEEALAHPYLEQYH 299 (336)
T ss_pred hhchhhhhHHhhcCcCCcccHHHHhcccCcHHHHHHHHHcCCChhhCcCHHHHhcCccccccC
Confidence 00000000 000000 01124568899999999999999999999886 66554
|
Serine/Threonine Kinases (STKs), Extracellular signal-regulated kinases 1 and 2 (ERK1/2) and Fus3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. This ERK1/2-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the mitogen-activated protein kinases (MAPKs) ERK1, ERK2, baker's yeast Fus3, and similar proteins. MAPK pathways are important mediators of cellular responses to extracellular signals. ERK1/2 activation is preferentially by mitogenic factors, differentiation stimuli, and cytokines, through a kinase cascade involving the MAPK kinases MEK1/2 and a MAPK kinase |
| >KOG0611 consensus Predicted serine/threonine protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=99.90 E-value=2.7e-24 Score=208.34 Aligned_cols=172 Identities=24% Similarity=0.334 Sum_probs=139.6
Q ss_pred ccccceeeccCCCC------CCCCCCChhhHHHHHHHHHHHHHHHhhcCCCceeecCCCccceEecCCCCceecccccee
Q 045315 240 KDEISFWYESYNNP------TKKGLLCWGTRVRIIEGIAQGLLYLHQYSRLRVIHRDLKASNILLDKDMNPKISDFGMAR 313 (476)
Q Consensus 240 ~~~~~l~~Ey~~~~------~~~~~L~~~~~~~i~~qIa~gL~yLH~~~~~~ivH~DLkp~NILld~~~~~kL~DFGla~ 313 (476)
|+.++++|||...+ ..++.|++.++..+++||..|+.|+|.++ ++|||||.+|||+|.++++||+|||++.
T Consensus 125 kdKIvivMEYaS~GeLYDYiSer~~LsErEaRhfFRQIvSAVhYCHknr---VvHRDLKLENILLD~N~NiKIADFGLSN 201 (668)
T KOG0611|consen 125 KDKIVIVMEYASGGELYDYISERGSLSEREARHFFRQIVSAVHYCHKNR---VVHRDLKLENILLDQNNNIKIADFGLSN 201 (668)
T ss_pred CceEEEEEEecCCccHHHHHHHhccccHHHHHHHHHHHHHHHHHHhhcc---ceecccchhheeecCCCCeeeeccchhh
Confidence 57899999999843 45788999999999999999999999998 9999999999999999999999999998
Q ss_pred ecCCCcccccceeeeeccCCCChhhhccCCC-CccceEEeehhhhhhhhhCCCCCCcCCCCchhhhhhhhhhhcCCCccc
Q 045315 314 MFGGDELQSNTKRIVGTYGYMSPEYALRGLF-SIKSDVFSFGVLLLETLSSKKNTHFYNTDSLTLLGHAWNLWNDGRTWE 392 (476)
Q Consensus 314 ~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~-s~ksDVwSlGvvl~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~ 392 (476)
.+.... ....++|++.|.+||++.+.+| .+..|.|||||+||-|+.|..||+..+.. .++ +.+..|...+
T Consensus 202 ly~~~k---fLqTFCGSPLYASPEIvNG~PY~GPEVDsWsLGvLLYtLVyGtMPFDG~Dhk--~lv----rQIs~GaYrE 272 (668)
T KOG0611|consen 202 LYADKK---FLQTFCGSPLYASPEIVNGTPYKGPEVDSWSLGVLLYTLVYGTMPFDGRDHK--RLV----RQISRGAYRE 272 (668)
T ss_pred hhcccc---HHHHhcCCcccCCccccCCCCCCCCccchhhHHHHHHHHhhcccccCCchHH--HHH----HHhhcccccC
Confidence 876543 2345789999999999999988 58899999999999999999999865421 111 1122222211
Q ss_pred ccCcccCCCCCHHHHHHHHHHHHHchhhcccCCCCHHHHHHH
Q 045315 393 LMDPISQNGASYPILKRYINVALLCVQEKAADRPAMSEVVSM 434 (476)
Q Consensus 393 ~~d~~~~~~~~~~~~~~l~~li~~Cl~~dP~~RPt~~eVl~~ 434 (476)
++.+....-+|+|||..+|++|.|+++|...
T Consensus 273 -----------P~~PSdA~gLIRwmLmVNP~RRATieDiAsH 303 (668)
T KOG0611|consen 273 -----------PETPSDASGLIRWMLMVNPERRATIEDIASH 303 (668)
T ss_pred -----------CCCCchHHHHHHHHHhcCcccchhHHHHhhh
Confidence 1112346678999999999999999998754
|
|
| >KOG0603 consensus Ribosomal protein S6 kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.90 E-value=2.1e-24 Score=220.88 Aligned_cols=168 Identities=21% Similarity=0.211 Sum_probs=131.9
Q ss_pred ccceeeccCCC-----CCCCCCCChhhHHHHHHHHHHHHHHHhhcCCCceeecCCCccceEe-cCCCCceeccccceeec
Q 045315 242 EISFWYESYNN-----PTKKGLLCWGTRVRIIEGIAQGLLYLHQYSRLRVIHRDLKASNILL-DKDMNPKISDFGMARMF 315 (476)
Q Consensus 242 ~~~l~~Ey~~~-----~~~~~~L~~~~~~~i~~qIa~gL~yLH~~~~~~ivH~DLkp~NILl-d~~~~~kL~DFGla~~~ 315 (476)
..+++||.+.. .....+....++..|+++|+.|+.|||+++ +|||||||+|||+ +..+.++|+|||.++..
T Consensus 390 ~~~~v~e~l~g~ell~ri~~~~~~~~e~~~w~~~lv~Av~~LH~~g---vvhRDLkp~NIL~~~~~g~lrltyFG~a~~~ 466 (612)
T KOG0603|consen 390 EIYLVMELLDGGELLRRIRSKPEFCSEASQWAAELVSAVDYLHEQG---VVHRDLKPGNILLDGSAGHLRLTYFGFWSEL 466 (612)
T ss_pred eeeeeehhccccHHHHHHHhcchhHHHHHHHHHHHHHHHHHHHhcC---eeecCCChhheeecCCCCcEEEEEechhhhC
Confidence 56788888872 223334444788889999999999999999 9999999999999 58899999999999876
Q ss_pred CCCcccccceeeeeccCCCChhhhccCCCCccceEEeehhhhhhhhhCCCCCCcCCCCchhhhhhhhhhhcCCCcccccC
Q 045315 316 GGDELQSNTKRIVGTYGYMSPEYALRGLFSIKSDVFSFGVLLLETLSSKKNTHFYNTDSLTLLGHAWNLWNDGRTWELMD 395 (476)
Q Consensus 316 ~~~~~~~~~~~~~gt~~y~aPE~l~~~~~s~ksDVwSlGvvl~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~d 395 (476)
... .....-|..|.|||++....|++++|+||||++||+|++|+.||.....+ ..+. ..+..+
T Consensus 467 ~~~-----~~tp~~t~~y~APEvl~~~~yt~acD~WSLGvlLy~ML~G~tp~~~~P~~-~ei~----~~i~~~------- 529 (612)
T KOG0603|consen 467 ERS-----CDTPALTLQYVAPEVLAIQEYTEACDWWSLGVLLYEMLTGRTLFAAHPAG-IEIH----TRIQMP------- 529 (612)
T ss_pred chh-----hcccchhhcccChhhhccCCCCcchhhHHHHHHHHHHHhCCCccccCCch-HHHH----HhhcCC-------
Confidence 544 22245688999999999999999999999999999999999998755433 1111 111111
Q ss_pred cccCCCCCHHHHHHHHHHHHHchhhcccCCCCHHHHHHH
Q 045315 396 PISQNGASYPILKRYINVALLCVQEKAADRPAMSEVVSM 434 (476)
Q Consensus 396 ~~~~~~~~~~~~~~l~~li~~Cl~~dP~~RPt~~eVl~~ 434 (476)
...........+|+.+||+.||.+||+|.++...
T Consensus 530 -----~~s~~vS~~AKdLl~~LL~~dP~~Rl~~~~i~~h 563 (612)
T KOG0603|consen 530 -----KFSECVSDEAKDLLQQLLQVDPALRLGADEIGAH 563 (612)
T ss_pred -----ccccccCHHHHHHHHHhccCChhhCcChhhhccC
Confidence 1224455678899999999999999999998753
|
|
| >cd05118 STKc_CMGC Catalytic domain of CMGC family Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=99.90 E-value=3.3e-24 Score=209.25 Aligned_cols=186 Identities=19% Similarity=0.218 Sum_probs=134.2
Q ss_pred cccceeeccCCCC------CCCCCCChhhHHHHHHHHHHHHHHHhhcCCCceeecCCCccceEecCCCCceeccccceee
Q 045315 241 DEISFWYESYNNP------TKKGLLCWGTRVRIIEGIAQGLLYLHQYSRLRVIHRDLKASNILLDKDMNPKISDFGMARM 314 (476)
Q Consensus 241 ~~~~l~~Ey~~~~------~~~~~L~~~~~~~i~~qIa~gL~yLH~~~~~~ivH~DLkp~NILld~~~~~kL~DFGla~~ 314 (476)
+.+++++||++.. .+...+++.++..++.||++||.|||+.+ ++|+||||+||+++.++.+||+|||.+..
T Consensus 71 ~~~~~v~e~~~~~l~~~l~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~---i~H~dl~p~nili~~~~~~~l~df~~~~~ 147 (283)
T cd05118 71 GDLYLVFEFMDTDLYKLIKDRQRGLPESLIKSYLYQLLQGLAFCHSHG---ILHRDLKPENLLINTEGVLKLADFGLARS 147 (283)
T ss_pred CCEEEEEeccCCCHHHHHHhhcccCCHHHHHHHHHHHHHHHHHHHHCC---eeecCcCHHHEEECCCCcEEEeeeeeeEe
Confidence 5678899998731 12358999999999999999999999999 99999999999999999999999999987
Q ss_pred cCCCcccccceeeeeccCCCChhhhccC-CCCccceEEeehhhhhhhhhCCCCCCcCCCCchhhhhhhhhhhcC---CCc
Q 045315 315 FGGDELQSNTKRIVGTYGYMSPEYALRG-LFSIKSDVFSFGVLLLETLSSKKNTHFYNTDSLTLLGHAWNLWND---GRT 390 (476)
Q Consensus 315 ~~~~~~~~~~~~~~gt~~y~aPE~l~~~-~~s~ksDVwSlGvvl~elltG~~p~~~~~~~~~~~~~~~~~~~~~---~~~ 390 (476)
...... ......++..|+|||.+.+. .++.++|+||||+++|++++|+.||...+... ........... ...
T Consensus 148 ~~~~~~--~~~~~~~~~~~~~PE~~~~~~~~~~~~Di~slG~~l~~l~tg~~~~~~~~~~~--~~~~~~~~~~~~~~~~~ 223 (283)
T cd05118 148 FGSPVR--PYTHYVVTRWYRAPELLLGDKGYSTPVDIWSVGCIFAELLSRRPLFPGKSEID--QLFKIFRTLGTPDPEVW 223 (283)
T ss_pred cCCCcc--cccCccCcccccCcHHHhcCCCCCchhHHHHHHHHHHHHHhCCCCCCCCCHHH--HHHHHHHHcCCCchHhc
Confidence 754331 11224577889999998876 78999999999999999999999886543211 10000000000 000
Q ss_pred ccccC-----------cccC--CCCCHHHHHHHHHHHHHchhhcccCCCCHHHHHH
Q 045315 391 WELMD-----------PISQ--NGASYPILKRYINVALLCVQEKAADRPAMSEVVS 433 (476)
Q Consensus 391 ~~~~d-----------~~~~--~~~~~~~~~~l~~li~~Cl~~dP~~RPt~~eVl~ 433 (476)
....+ .... ..........+.+++.+||+.||.+||++++++.
T Consensus 224 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~P~~Rp~~~~ll~ 279 (283)
T cd05118 224 PKFTSLARNYKFSFPKKAGMPLPKLFPNASPQALDLLSQMLHYDPHKRITAEQALA 279 (283)
T ss_pred ccchhhhhhhhhhhccccccCHHHhhhhhCHHHHHHHHHHhccCcccCcCHHHHhh
Confidence 00000 0000 0011223567899999999999999999999875
|
Serine/Threonine Kinases (STKs), CMGC family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CMGC family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The CMGC family consists of Cyclin-Dependent protein Kinases (CDKs), Mitogen-activated protein kinases (MAPKs) such as Extracellular signal-regulated kinase (ERKs), c-Jun N-terminal kinases (JNKs), and p38, and similar proteins. CDKs belong to a large subfamily of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. MAPKs serve as important mediators of cellular responses to extracellular signals. They |
| >smart00219 TyrKc Tyrosine kinase, catalytic domain | Back alignment and domain information |
|---|
Probab=99.90 E-value=3.4e-24 Score=205.89 Aligned_cols=176 Identities=29% Similarity=0.397 Sum_probs=132.0
Q ss_pred cccceeeccCCCCC-------CCCC-CChhhHHHHHHHHHHHHHHHhhcCCCceeecCCCccceEecCCCCceeccccce
Q 045315 241 DEISFWYESYNNPT-------KKGL-LCWGTRVRIIEGIAQGLLYLHQYSRLRVIHRDLKASNILLDKDMNPKISDFGMA 312 (476)
Q Consensus 241 ~~~~l~~Ey~~~~~-------~~~~-L~~~~~~~i~~qIa~gL~yLH~~~~~~ivH~DLkp~NILld~~~~~kL~DFGla 312 (476)
+..++++||++... .... +++.++..++.|++.||+|||+.+ ++|+||||+||+++.++.++|+|||++
T Consensus 74 ~~~~~i~e~~~~~~l~~~~~~~~~~~~~~~~~~~~~~ql~~~l~~lh~~~---~~h~dl~~~nil~~~~~~~~l~dfg~~ 150 (258)
T smart00219 74 EPLMIVMEYMEGGDLLDYLRKNRPKELSLSDLLSFALQIARGMEYLESKN---FIHRDLAARNCLVGENLVVKISDFGLS 150 (258)
T ss_pred CeeEEEEeccCCCCHHHHHHhhhhccCCHHHHHHHHHHHHHHHHHHhcCC---eeecccccceEEEccCCeEEEcccCCc
Confidence 45778888887321 1222 999999999999999999999998 999999999999999999999999999
Q ss_pred eecCCCcccccceeeeeccCCCChhhhccCCCCccceEEeehhhhhhhhh-CCCCCCcCCCCchhhhhhhhhhhcCCCcc
Q 045315 313 RMFGGDELQSNTKRIVGTYGYMSPEYALRGLFSIKSDVFSFGVLLLETLS-SKKNTHFYNTDSLTLLGHAWNLWNDGRTW 391 (476)
Q Consensus 313 ~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~s~ksDVwSlGvvl~ellt-G~~p~~~~~~~~~~~~~~~~~~~~~~~~~ 391 (476)
............ ...++..|+|||.+.+..++.++|+||||+++++|++ |+.|+..... ...... ...+...
T Consensus 151 ~~~~~~~~~~~~-~~~~~~~y~~Pe~~~~~~~~~~~Di~slG~i~~~l~~~g~~p~~~~~~--~~~~~~----~~~~~~~ 223 (258)
T smart00219 151 RDLYDDDYYKKK-GGKLPIRWMAPESLKDGKFTSKSDVWSFGVLLWEIFTLGESPYPGMSN--EEVLEY----LKKGYRL 223 (258)
T ss_pred eecccccccccc-cCCCcccccChHHhccCCCCcchhHHHHHHHHHHHHhCCCCCCCCCCH--HHHHHH----HhcCCCC
Confidence 876544222211 1236789999999988889999999999999999998 6777653221 111111 1111111
Q ss_pred cccCcccCCCCCHHHHHHHHHHHHHchhhcccCCCCHHHHHHHH
Q 045315 392 ELMDPISQNGASYPILKRYINVALLCVQEKAADRPAMSEVVSML 435 (476)
Q Consensus 392 ~~~d~~~~~~~~~~~~~~l~~li~~Cl~~dP~~RPt~~eVl~~L 435 (476)
. ........+.+++.+|+..+|++|||+.++++.|
T Consensus 224 ~---------~~~~~~~~~~~~i~~~l~~~p~~Rpt~~~ll~~l 258 (258)
T smart00219 224 P---------KPENCPPEIYKLMLQCWAEDPEDRPTFSELVEIL 258 (258)
T ss_pred C---------CCCcCCHHHHHHHHHHCcCChhhCcCHHHHHhhC
Confidence 0 0111345788899999999999999999999865
|
Phosphotransferases. Tyrosine-specific kinase subfamily. |
| >cd08217 STKc_Nek2 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 2 | Back alignment and domain information |
|---|
Probab=99.90 E-value=4.8e-24 Score=205.51 Aligned_cols=173 Identities=28% Similarity=0.373 Sum_probs=134.6
Q ss_pred ccceeeccCCCC----------CCCCCCChhhHHHHHHHHHHHHHHHh-----hcCCCceeecCCCccceEecCCCCcee
Q 045315 242 EISFWYESYNNP----------TKKGLLCWGTRVRIIEGIAQGLLYLH-----QYSRLRVIHRDLKASNILLDKDMNPKI 306 (476)
Q Consensus 242 ~~~l~~Ey~~~~----------~~~~~L~~~~~~~i~~qIa~gL~yLH-----~~~~~~ivH~DLkp~NILld~~~~~kL 306 (476)
..++++||++.. ....++++.+++.++.||+.||+||| +.+ ++|+||||+||+++.++.+||
T Consensus 75 ~~~~~~e~~~~~~L~~~l~~~~~~~~~l~~~~~~~~~~~i~~~l~~lH~~~~~~~~---i~h~dl~p~nili~~~~~~kl 151 (265)
T cd08217 75 TLYIVMEYCEGGDLAQLIQKCKKERKYIEEEFIWRILTQLLLALYECHNRSDPGNT---VLHRDLKPANIFLDANNNVKL 151 (265)
T ss_pred EEEEEehhccCCCHHHHHHHHhhcccCCCHHHHHHHHHHHHHHHHHHhcCccccCc---ceecCCCHHHEEEecCCCEEE
Confidence 467888988732 22567999999999999999999999 666 999999999999999999999
Q ss_pred ccccceeecCCCcccccceeeeeccCCCChhhhccCCCCccceEEeehhhhhhhhhCCCCCCcCCCCchhhhhhhhhhhc
Q 045315 307 SDFGMARMFGGDELQSNTKRIVGTYGYMSPEYALRGLFSIKSDVFSFGVLLLETLSSKKNTHFYNTDSLTLLGHAWNLWN 386 (476)
Q Consensus 307 ~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~s~ksDVwSlGvvl~elltG~~p~~~~~~~~~~~~~~~~~~~~ 386 (476)
+|||++......... .....++..|+|||.+.+..++.++|+||||+++++|++|+.|+.... ...... ...
T Consensus 152 ~d~g~~~~~~~~~~~--~~~~~~~~~~~~pE~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~--~~~~~~----~~~ 223 (265)
T cd08217 152 GDFGLAKILGHDSSF--AKTYVGTPYYMSPEQLNHMSYDEKSDIWSLGCLIYELCALSPPFTARN--QLQLAS----KIK 223 (265)
T ss_pred ecccccccccCCccc--ccccccCCCccChhhhcCCCCCchhHHHHHHHHHHHHHHCCCcccCcC--HHHHHH----HHh
Confidence 999999876543321 122468899999999988889999999999999999999999986543 111111 111
Q ss_pred CCCcccccCcccCCCCCHHHHHHHHHHHHHchhhcccCCCCHHHHHHH
Q 045315 387 DGRTWELMDPISQNGASYPILKRYINVALLCVQEKAADRPAMSEVVSM 434 (476)
Q Consensus 387 ~~~~~~~~d~~~~~~~~~~~~~~l~~li~~Cl~~dP~~RPt~~eVl~~ 434 (476)
.+.. ...+......+.+++.+|++.+|++||++.+|++.
T Consensus 224 ~~~~---------~~~~~~~~~~~~~l~~~~l~~~p~~Rp~~~~il~~ 262 (265)
T cd08217 224 EGKF---------RRIPYRYSSELNEVIKSMLNVDPDKRPSTEELLQL 262 (265)
T ss_pred cCCC---------CCCccccCHHHHHHHHHHccCCcccCCCHHHHhhC
Confidence 1111 11122344678899999999999999999999863
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 2 (Nek2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek2 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The Nek2 subfamily includes Aspergillus nidulans NIMA kinase, the founding member of the Nek family, which was identified in a screen for cell cycle mutants prevented from entering mitosis. NIMA is essential for mitotic entry and progression through mitosis, and its degradation is essential for mitotic exi |
| >cd07833 STKc_CDKL Catalytic domain of Cyclin-Dependent protein Kinase Like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=99.90 E-value=3.8e-24 Score=209.50 Aligned_cols=188 Identities=20% Similarity=0.262 Sum_probs=134.6
Q ss_pred cccceeeccCCCC------CCCCCCChhhHHHHHHHHHHHHHHHhhcCCCceeecCCCccceEecCCCCceeccccceee
Q 045315 241 DEISFWYESYNNP------TKKGLLCWGTRVRIIEGIAQGLLYLHQYSRLRVIHRDLKASNILLDKDMNPKISDFGMARM 314 (476)
Q Consensus 241 ~~~~l~~Ey~~~~------~~~~~L~~~~~~~i~~qIa~gL~yLH~~~~~~ivH~DLkp~NILld~~~~~kL~DFGla~~ 314 (476)
+..++++||++.. .+...+++.++..++.||+.||+|||+.+ ++|+||+|+||++++++.+||+|||++..
T Consensus 73 ~~~~iv~e~~~~~~l~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~---i~H~dl~~~ni~~~~~~~~kl~d~g~~~~ 149 (288)
T cd07833 73 GRLYLVFEYVERTLLELLEASPGGLPPDAVRSYIWQLLQAIAYCHSHN---IIHRDIKPENILVSESGVLKLCDFGFARA 149 (288)
T ss_pred CEEEEEEecCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCCHHHeEECCCCCEEEEeeecccc
Confidence 4578889999832 23456899999999999999999999998 99999999999999999999999999987
Q ss_pred cCCCcccccceeeeeccCCCChhhhccC-CCCccceEEeehhhhhhhhhCCCCCCcCCCCchhhhhhhh----------h
Q 045315 315 FGGDELQSNTKRIVGTYGYMSPEYALRG-LFSIKSDVFSFGVLLLETLSSKKNTHFYNTDSLTLLGHAW----------N 383 (476)
Q Consensus 315 ~~~~~~~~~~~~~~gt~~y~aPE~l~~~-~~s~ksDVwSlGvvl~elltG~~p~~~~~~~~~~~~~~~~----------~ 383 (476)
....... ......++..|+|||++.+. .++.++|+||||+++|++++|+.||....... .+..... .
T Consensus 150 ~~~~~~~-~~~~~~~~~~~~~PE~~~~~~~~~~~~Dv~slG~~l~~l~~g~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~ 227 (288)
T cd07833 150 LRARPAS-PLTDYVATRWYRAPELLVGDTNYGKPVDVWAIGCIMAELLDGEPLFPGDSDID-QLYLIQKCLGPLPPSHQE 227 (288)
T ss_pred cCCCccc-cccCcccccCCcCCchhcCCCCcCchhhHHHHHHHHHHHHhCCCCCCCCCHHH-HHHHHHHHhCCCCHHHhh
Confidence 6543321 12235678899999999887 78999999999999999999999886432111 0100000 0
Q ss_pred hhcC-CCc--ccccCccc----CCCCCHHHHHHHHHHHHHchhhcccCCCCHHHHHH
Q 045315 384 LWND-GRT--WELMDPIS----QNGASYPILKRYINVALLCVQEKAADRPAMSEVVS 433 (476)
Q Consensus 384 ~~~~-~~~--~~~~d~~~----~~~~~~~~~~~l~~li~~Cl~~dP~~RPt~~eVl~ 433 (476)
.+.. ... .+..+... ....+......+.+++.+||+.+|++||+++++++
T Consensus 228 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~il~ 284 (288)
T cd07833 228 LFSSNPRFAGVAFPEPSQPESLERRYPGKVSSPALDFLKACLRMDPKERLTCDELLQ 284 (288)
T ss_pred hcccCccccccccCCCCCcHHHHHhcCCccchHHHHHHHHHhccCchhcccHHHHhc
Confidence 0000 000 00000000 00011122567899999999999999999999875
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like (CDKL) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDKL1-5 and similar proteins. Some CDKLs, like CDKL1 and CDKL3, may be implicated in transformation and others, like CDKL3 and CDKL5, are associated with mental retardation when impaired. CDKL2 plays a role in learning |
| >cd07842 STKc_CDK8_like Catalytic domain of Cyclin-Dependent protein Kinase 8-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=99.90 E-value=5.2e-24 Score=211.48 Aligned_cols=190 Identities=19% Similarity=0.236 Sum_probs=131.4
Q ss_pred cccceeeccCCC---------C-CCCCCCChhhHHHHHHHHHHHHHHHhhcCCCceeecCCCccceEecC----CCCcee
Q 045315 241 DEISFWYESYNN---------P-TKKGLLCWGTRVRIIEGIAQGLLYLHQYSRLRVIHRDLKASNILLDK----DMNPKI 306 (476)
Q Consensus 241 ~~~~l~~Ey~~~---------~-~~~~~L~~~~~~~i~~qIa~gL~yLH~~~~~~ivH~DLkp~NILld~----~~~~kL 306 (476)
+..++++||++. . .....++...+..++.||+.||+|||+.+ ++||||||+||+++. ++.+||
T Consensus 77 ~~~~lv~e~~~~~l~~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~---i~h~dlkp~Nil~~~~~~~~~~~kl 153 (316)
T cd07842 77 KSVYLLFDYAEHDLWQIIKFHRQAKRVSIPPSMVKSLLWQILNGVHYLHSNW---VLHRDLKPANILVMGEGPERGVVKI 153 (316)
T ss_pred ceEEEEEeCCCcCHHHHHHhhccCCCcCcCHHHHHHHHHHHHHHHHHHHhCC---EeeCCCCHHHEEEcCCCCccceEEE
Confidence 457788888861 1 12247899999999999999999999998 999999999999999 899999
Q ss_pred ccccceeecCCCcc-cccceeeeeccCCCChhhhcc-CCCCccceEEeehhhhhhhhhCCCCCCcCCCCchh-------h
Q 045315 307 SDFGMARMFGGDEL-QSNTKRIVGTYGYMSPEYALR-GLFSIKSDVFSFGVLLLETLSSKKNTHFYNTDSLT-------L 377 (476)
Q Consensus 307 ~DFGla~~~~~~~~-~~~~~~~~gt~~y~aPE~l~~-~~~s~ksDVwSlGvvl~elltG~~p~~~~~~~~~~-------~ 377 (476)
+|||++........ ........++..|+|||.+.+ ..++.++|+|||||++++|++|++||......... .
T Consensus 154 ~Dfg~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~~l~~~~~~~~~~~~~~~~~~~~~~~~ 233 (316)
T cd07842 154 GDLGLARLFNAPLKPLADLDPVVVTIWYRAPELLLGARHYTKAIDIWAIGCIFAELLTLEPIFKGREAKIKKSNPFQRDQ 233 (316)
T ss_pred CCCccccccCCCcccccccCCccccccccCHHHHhCCCCCCcHHHHHHHHHHHHHHHhcCCCCcCCcccccccchhHHHH
Confidence 99999987643322 112223467889999998876 45789999999999999999999998754422200 0
Q ss_pred hhhhhhhhcC------------CCcccccCcccCCCCC---H--------HHHHHHHHHHHHchhhcccCCCCHHHHHH
Q 045315 378 LGHAWNLWND------------GRTWELMDPISQNGAS---Y--------PILKRYINVALLCVQEKAADRPAMSEVVS 433 (476)
Q Consensus 378 ~~~~~~~~~~------------~~~~~~~d~~~~~~~~---~--------~~~~~l~~li~~Cl~~dP~~RPt~~eVl~ 433 (476)
.......+.. .......+........ . .....+.+++.+||+.||++|||+.|+++
T Consensus 234 ~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~P~~Rps~~eil~ 312 (316)
T cd07842 234 LERIFEVLGTPTEKDWPDIKKMPEYDTLMKDFKTKTYPSNSLAKWMEKHKKPDSQGFDLLRKLLEYDPTKRITAEEALE 312 (316)
T ss_pred HHHHHHHhCCCchhHHHHHhhcccchhhhhhccCCCCCCccHHHHHHhccCCCHHHHHHHHHHhcCCcccCcCHHHHhc
Confidence 0000000000 0000000000000000 0 22356889999999999999999999875
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 8 (CDK8)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK8-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK8, CDC2L6, and similar proteins. CDK8 functions as a negative or positive regulator of transcription, depending on the scenario. Together with its regulator, cyclin C, it reversibly associates with the |
| >cd08218 STKc_Nek1 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 1 | Back alignment and domain information |
|---|
Probab=99.90 E-value=6.8e-24 Score=204.19 Aligned_cols=173 Identities=23% Similarity=0.319 Sum_probs=132.8
Q ss_pred cccceeeccCCCC--------CCCCCCChhhHHHHHHHHHHHHHHHhhcCCCceeecCCCccceEecCCCCceeccccce
Q 045315 241 DEISFWYESYNNP--------TKKGLLCWGTRVRIIEGIAQGLLYLHQYSRLRVIHRDLKASNILLDKDMNPKISDFGMA 312 (476)
Q Consensus 241 ~~~~l~~Ey~~~~--------~~~~~L~~~~~~~i~~qIa~gL~yLH~~~~~~ivH~DLkp~NILld~~~~~kL~DFGla 312 (476)
+.+++++||++.. .....+++.++++++.|++.||+|||+.+ ++|+||+|+||+++.++.++|+|||++
T Consensus 72 ~~~~lv~e~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~---i~h~~l~~~nil~~~~~~~~l~d~~~~ 148 (256)
T cd08218 72 GNLYIVMDYCEGGDLYKKINAQRGVLFPEDQILDWFVQICLALKHVHDRK---ILHRDIKSQNIFLTKDGTIKLGDFGIA 148 (256)
T ss_pred CeEEEEEecCCCCcHHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHhCC---EecCCCCHHHEEEcCCCCEEEeeccce
Confidence 4677889998732 22346889999999999999999999998 999999999999999999999999999
Q ss_pred eecCCCcccccceeeeeccCCCChhhhccCCCCccceEEeehhhhhhhhhCCCCCCcCCCCchhhhhhhhhhhcCCCccc
Q 045315 313 RMFGGDELQSNTKRIVGTYGYMSPEYALRGLFSIKSDVFSFGVLLLETLSSKKNTHFYNTDSLTLLGHAWNLWNDGRTWE 392 (476)
Q Consensus 313 ~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~s~ksDVwSlGvvl~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~ 392 (476)
......... .....++..|+|||++.+..++.++|+|||||+++++++|+.|+...... .. ...... +...
T Consensus 149 ~~~~~~~~~--~~~~~~~~~~~~pe~~~~~~~~~~~Dv~slG~i~~~l~~g~~~~~~~~~~--~~---~~~~~~-~~~~- 219 (256)
T cd08218 149 RVLNSTVEL--ARTCIGTPYYLSPEICENRPYNNKSDIWALGCVLYEMCTLKHAFEAGNMK--NL---VLKIIR-GSYP- 219 (256)
T ss_pred eecCcchhh--hhhccCCccccCHHHhCCCCCCCccchhHHHHHHHHHHcCCCCccCCCHH--HH---HHHHhc-CCCC-
Confidence 876443211 12245788999999998888999999999999999999999997643211 11 111111 1110
Q ss_pred ccCcccCCCCCHHHHHHHHHHHHHchhhcccCCCCHHHHHH
Q 045315 393 LMDPISQNGASYPILKRYINVALLCVQEKAADRPAMSEVVS 433 (476)
Q Consensus 393 ~~d~~~~~~~~~~~~~~l~~li~~Cl~~dP~~RPt~~eVl~ 433 (476)
.........+.+++.+||+.+|.+||++.+|++
T Consensus 220 --------~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~vl~ 252 (256)
T cd08218 220 --------PVSSHYSYDLRNLVSQLFKRNPRDRPSVNSILE 252 (256)
T ss_pred --------CCcccCCHHHHHHHHHHhhCChhhCcCHHHHhh
Confidence 011223456889999999999999999999986
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 1 (Nek1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek1 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek1 is associated with centrosomes throughout the cell cycle. It is involved in the formation of primary cilium and in the maintenance of centrosomes. It cycles through the nucleus and may be capable of relaying signals between the cilium and the nucleus. Nek1 is implicated in the development of polycysti |
| >cd06605 PKc_MAPKK Catalytic domain of the dual-specificity Protein Kinase, Mitogen-Activated Protein Kinase Kinase | Back alignment and domain information |
|---|
Probab=99.90 E-value=4.2e-24 Score=206.58 Aligned_cols=177 Identities=27% Similarity=0.384 Sum_probs=133.8
Q ss_pred cccceeeccCCCC-------CCCCCCChhhHHHHHHHHHHHHHHHhh-cCCCceeecCCCccceEecCCCCceeccccce
Q 045315 241 DEISFWYESYNNP-------TKKGLLCWGTRVRIIEGIAQGLLYLHQ-YSRLRVIHRDLKASNILLDKDMNPKISDFGMA 312 (476)
Q Consensus 241 ~~~~l~~Ey~~~~-------~~~~~L~~~~~~~i~~qIa~gL~yLH~-~~~~~ivH~DLkp~NILld~~~~~kL~DFGla 312 (476)
+.+++++||++.. .....++...+.+++.|+++||+|||+ .+ ++|+||||+||+++.++.+||+|||.+
T Consensus 72 ~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~~---i~H~dl~~~ni~~~~~~~~~l~d~g~~ 148 (265)
T cd06605 72 GDISICMEYMDGGSLDKILKEVQGRIPERILGKIAVAVLKGLTYLHEKHK---IIHRDVKPSNILVNSRGQIKLCDFGVS 148 (265)
T ss_pred CEEEEEEEecCCCcHHHHHHHccCCCCHHHHHHHHHHHHHHHHHHcCCCC---eecCCCCHHHEEECCCCCEEEeecccc
Confidence 5688899999822 122688999999999999999999999 88 999999999999999999999999998
Q ss_pred eecCCCcccccceeeeeccCCCChhhhccCCCCccceEEeehhhhhhhhhCCCCCCcCCCCchhhhhhhhhhhcCCCccc
Q 045315 313 RMFGGDELQSNTKRIVGTYGYMSPEYALRGLFSIKSDVFSFGVLLLETLSSKKNTHFYNTDSLTLLGHAWNLWNDGRTWE 392 (476)
Q Consensus 313 ~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~s~ksDVwSlGvvl~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~ 392 (476)
......... ...++..|+|||.+.+..++.++|+||||++++++++|+.|+................... ...
T Consensus 149 ~~~~~~~~~----~~~~~~~y~~PE~~~~~~~~~~~Dv~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~-~~~-- 221 (265)
T cd06605 149 GQLVNSLAK----TFVGTSSYMAPERIQGNDYSVKSDIWSLGLSLIELATGRFPYPPENDPPDGIFELLQYIVN-EPP-- 221 (265)
T ss_pred hhhHHHHhh----cccCChhccCHHHHcCCCCCchhhHHHHHHHHHHHHhCCCCCCccccccccHHHHHHHHhc-CCC--
Confidence 765322111 1567889999999998899999999999999999999999986543211111111111111 110
Q ss_pred ccCcccCCCCCHHHHHHHHHHHHHchhhcccCCCCHHHHHH
Q 045315 393 LMDPISQNGASYPILKRYINVALLCVQEKAADRPAMSEVVS 433 (476)
Q Consensus 393 ~~d~~~~~~~~~~~~~~l~~li~~Cl~~dP~~RPt~~eVl~ 433 (476)
+... .......+.+++.+||+.+|++||++.+++.
T Consensus 222 ---~~~~---~~~~~~~~~~li~~~l~~~p~~Rpt~~~ll~ 256 (265)
T cd06605 222 ---PRLP---SGKFSPDFQDFVNLCLIKDPRERPSYKELLE 256 (265)
T ss_pred ---CCCC---hhhcCHHHHHHHHHHcCCCchhCcCHHHHhh
Confidence 0000 1113456889999999999999999999875
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK or MAP2K), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK or MAP3K). MAPKKs are dual-specificity |
| >KOG0196 consensus Tyrosine kinase, EPH (ephrin) receptor family [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.90 E-value=8.2e-25 Score=226.73 Aligned_cols=181 Identities=25% Similarity=0.407 Sum_probs=143.7
Q ss_pred ccceeeccCCCC-------CCCCCCChhhHHHHHHHHHHHHHHHhhcCCCceeecCCCccceEecCCCCceeccccceee
Q 045315 242 EISFWYESYNNP-------TKKGLLCWGTRVRIIEGIAQGLLYLHQYSRLRVIHRDLKASNILLDKDMNPKISDFGMARM 314 (476)
Q Consensus 242 ~~~l~~Ey~~~~-------~~~~~L~~~~~~~i~~qIa~gL~yLH~~~~~~ivH~DLkp~NILld~~~~~kL~DFGla~~ 314 (476)
-.+++.|||+++ .+.+.+++-+...++++||.|++||-+.+ +|||||.+.|||++.+..+|++|||+++.
T Consensus 704 PvMIiTEyMENGsLDsFLR~~DGqftviQLVgMLrGIAsGMkYLsdm~---YVHRDLAARNILVNsnLvCKVsDFGLSRv 780 (996)
T KOG0196|consen 704 PVMIITEYMENGSLDSFLRQNDGQFTVIQLVGMLRGIASGMKYLSDMN---YVHRDLAARNILVNSNLVCKVSDFGLSRV 780 (996)
T ss_pred eeEEEhhhhhCCcHHHHHhhcCCceEeehHHHHHHHHHHHhHHHhhcC---chhhhhhhhheeeccceEEEeccccceee
Confidence 366888999943 34566999999999999999999999999 99999999999999999999999999998
Q ss_pred cCCCcccccceeeee--ccCCCChhhhccCCCCccceEEeehhhhhhhhh-CCCCCCcCCCCchhhhhhhhhhhcCCCcc
Q 045315 315 FGGDELQSNTKRIVG--TYGYMSPEYALRGLFSIKSDVFSFGVLLLETLS-SKKNTHFYNTDSLTLLGHAWNLWNDGRTW 391 (476)
Q Consensus 315 ~~~~~~~~~~~~~~g--t~~y~aPE~l~~~~~s~ksDVwSlGvvl~ellt-G~~p~~~~~~~~~~~~~~~~~~~~~~~~~ 391 (476)
+.++. ........| +.+|.|||.+...+++.+|||||||+|+||.++ |.+|+-.... ...+
T Consensus 781 ledd~-~~~ytt~GGKIPiRWTAPEAIa~RKFTsASDVWSyGIVmWEVmSyGERPYWdmSN--QdVI------------- 844 (996)
T KOG0196|consen 781 LEDDP-EAAYTTLGGKIPIRWTAPEAIAYRKFTSASDVWSYGIVMWEVMSYGERPYWDMSN--QDVI------------- 844 (996)
T ss_pred cccCC-CccccccCCccceeecChhHhhhcccCchhhccccceEEEEecccCCCcccccch--HHHH-------------
Confidence 76554 222222223 468999999999999999999999999999875 7777543221 1111
Q ss_pred cccCcccCCCCCHHHHHHHHHHHHHchhhcccCCCCHHHHHHHHhccccC
Q 045315 392 ELMDPISQNGASYPILKRYINVALLCVQEKAADRPAMSEVVSMLSNEFVN 441 (476)
Q Consensus 392 ~~~d~~~~~~~~~~~~~~l~~li~~Cl~~dP~~RPt~~eVl~~L~~~~~~ 441 (476)
..++...+-+.+.+.+..+.+||+.|||+|-.+||++.||+..|.++..+
T Consensus 845 kaIe~gyRLPpPmDCP~aL~qLMldCWqkdR~~RP~F~qiV~~lDklIrn 894 (996)
T KOG0196|consen 845 KAIEQGYRLPPPMDCPAALYQLMLDCWQKDRNRRPKFAQIVSTLDKLIRN 894 (996)
T ss_pred HHHHhccCCCCCCCCcHHHHHHHHHHHHHHhhcCCCHHHHHHHHHHHhcC
Confidence 12222333345566678899999999999999999999999999997644
|
|
| >cd07846 STKc_CDKL2_3 Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase Like 2 and 3 | Back alignment and domain information |
|---|
Probab=99.90 E-value=3.7e-24 Score=209.52 Aligned_cols=186 Identities=20% Similarity=0.276 Sum_probs=131.9
Q ss_pred cccceeeccCCCC------CCCCCCChhhHHHHHHHHHHHHHHHhhcCCCceeecCCCccceEecCCCCceeccccceee
Q 045315 241 DEISFWYESYNNP------TKKGLLCWGTRVRIIEGIAQGLLYLHQYSRLRVIHRDLKASNILLDKDMNPKISDFGMARM 314 (476)
Q Consensus 241 ~~~~l~~Ey~~~~------~~~~~L~~~~~~~i~~qIa~gL~yLH~~~~~~ivH~DLkp~NILld~~~~~kL~DFGla~~ 314 (476)
+..++++||++.. .....+++.++..++.||++||+|||+.+ ++|+||+|+||++++++.++|+|||++..
T Consensus 73 ~~~~lv~e~~~~~~l~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~---i~h~~l~p~ni~~~~~~~~~l~dfg~~~~ 149 (286)
T cd07846 73 KRLYLVFEFVDHTVLDDLEKYPNGLDESRVRKYLFQILRGIEFCHSHN---IIHRDIKPENILVSQSGVVKLCDFGFART 149 (286)
T ss_pred CeEEEEEecCCccHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHHCC---ccccCCCHHHEEECCCCcEEEEeeeeeee
Confidence 4678899999832 23446899999999999999999999998 99999999999999999999999999987
Q ss_pred cCCCcccccceeeeeccCCCChhhhcc-CCCCccceEEeehhhhhhhhhCCCCCCcCCCCchhhhhhhhhh---------
Q 045315 315 FGGDELQSNTKRIVGTYGYMSPEYALR-GLFSIKSDVFSFGVLLLETLSSKKNTHFYNTDSLTLLGHAWNL--------- 384 (476)
Q Consensus 315 ~~~~~~~~~~~~~~gt~~y~aPE~l~~-~~~s~ksDVwSlGvvl~elltG~~p~~~~~~~~~~~~~~~~~~--------- 384 (476)
....... .....++..|+|||++.+ ..++.++||||||++++||++|++||...... .........
T Consensus 150 ~~~~~~~--~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~el~~g~~~~~~~~~~--~~~~~~~~~~~~~~~~~~ 225 (286)
T cd07846 150 LAAPGEV--YTDYVATRWYRAPELLVGDTKYGRAVDIWAVGCLVTEMLTGEPLFPGDSDI--DQLYHIIKCLGNLIPRHQ 225 (286)
T ss_pred ccCCccc--cCcccceeeccCcHHhccccccCchHhHHHHHHHHHHHHcCCCCCCCCchH--HHHHHHHHHhCCCchhhH
Confidence 6443211 122457889999999875 45788999999999999999999888643211 000000000
Q ss_pred --hcCCCcc-cccCcccCC-----CCCHHHHHHHHHHHHHchhhcccCCCCHHHHHH
Q 045315 385 --WNDGRTW-ELMDPISQN-----GASYPILKRYINVALLCVQEKAADRPAMSEVVS 433 (476)
Q Consensus 385 --~~~~~~~-~~~d~~~~~-----~~~~~~~~~l~~li~~Cl~~dP~~RPt~~eVl~ 433 (476)
....... ....+.... .........+.+++.+||+.+|++||++.++++
T Consensus 226 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rp~~~~il~ 282 (286)
T cd07846 226 EIFQKNPLFAGMRLPEVKEIEPLEKRFPKLSGLVLDLAKQCLRIDPDDRPSSSQLLH 282 (286)
T ss_pred HHhccchHhhccccccccCcchHHHhCCCcCHHHHHHHHHHhcCCcccchhHHHHhc
Confidence 0000000 000000000 001123467889999999999999999999875
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 2 (CDKL2) and CDKL3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL2 and CDKL3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKL2, also called p56 KKIAMRE, is expressed in testis, kidney, lung, and brain. It functions mainly in mature neurons and plays an important role in learning and memory. Inactivation of CDKL3, also called NKI |
| >KOG4279 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.90 E-value=4.1e-24 Score=218.56 Aligned_cols=173 Identities=25% Similarity=0.408 Sum_probs=137.8
Q ss_pred cceeeccCCCC-------CCCCCC--ChhhHHHHHHHHHHHHHHHhhcCCCceeecCCCccceEec-CCCCceeccccce
Q 045315 243 ISFWYESYNNP-------TKKGLL--CWGTRVRIIEGIAQGLLYLHQYSRLRVIHRDLKASNILLD-KDMNPKISDFGMA 312 (476)
Q Consensus 243 ~~l~~Ey~~~~-------~~~~~L--~~~~~~~i~~qIa~gL~yLH~~~~~~ivH~DLkp~NILld-~~~~~kL~DFGla 312 (476)
..+.||-.|.+ ++-++| ++.+.--+.+||++||.|||+.. |||||||-+|+|++ -.|.+||+|||-+
T Consensus 647 ~kIFMEqVPGGSLSsLLrskWGPlKDNEstm~fYtkQILeGLkYLHen~---IVHRDIKGDNVLvNTySGvlKISDFGTs 723 (1226)
T KOG4279|consen 647 FKIFMEQVPGGSLSSLLRSKWGPLKDNESTMNFYTKQILEGLKYLHENK---IVHRDIKGDNVLVNTYSGVLKISDFGTS 723 (1226)
T ss_pred EEEEeecCCCCcHHHHHHhccCCCccchhHHHHHHHHHHHHhhhhhhcc---eeeccccCCcEEEeeccceEEecccccc
Confidence 34667888843 466778 77788888999999999999998 99999999999997 5789999999999
Q ss_pred eecCCCcccccceeeeeccCCCChhhhccCC--CCccceEEeehhhhhhhhhCCCCCCcCCCCchhhhhhhhhhhcCCCc
Q 045315 313 RMFGGDELQSNTKRIVGTYGYMSPEYALRGL--FSIKSDVFSFGVLLLETLSSKKNTHFYNTDSLTLLGHAWNLWNDGRT 390 (476)
Q Consensus 313 ~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~--~s~ksDVwSlGvvl~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~ 390 (476)
+.+..- ...+..+-||..|||||++..++ |..++|||||||.+.||.||++||......... +++-|-.
T Consensus 724 KRLAgi--nP~TETFTGTLQYMAPEvIDqG~RGYG~aADIWS~GCT~vEMATGrPPF~ElgspqAA-------MFkVGmy 794 (1226)
T KOG4279|consen 724 KRLAGI--NPCTETFTGTLQYMAPEVIDQGPRGYGKAADIWSFGCTMVEMATGRPPFVELGSPQAA-------MFKVGMY 794 (1226)
T ss_pred hhhccC--CccccccccchhhhChHhhccCCcCCCchhhhhhccceeEeeccCCCCeeecCChhHh-------hhhhcce
Confidence 887653 34556688999999999998654 889999999999999999999998643322111 1111111
Q ss_pred ccccCcccCCCCCHHHHHHHHHHHHHchhhcccCCCCHHHHHH
Q 045315 391 WELMDPISQNGASYPILKRYINVALLCVQEKAADRPAMSEVVS 433 (476)
Q Consensus 391 ~~~~d~~~~~~~~~~~~~~l~~li~~Cl~~dP~~RPt~~eVl~ 433 (476)
...++.+.+...++..++++|+..||.+||++.++++
T Consensus 795 ------KvHP~iPeelsaeak~FilrcFepd~~~R~sA~~LL~ 831 (1226)
T KOG4279|consen 795 ------KVHPPIPEELSAEAKNFILRCFEPDPCDRPSAKDLLQ 831 (1226)
T ss_pred ------ecCCCCcHHHHHHHHHHHHHHcCCCcccCccHHHhcc
Confidence 1233456677889999999999999999999999875
|
|
| >cd06629 STKc_MAPKKK_Bck1_like Catalytic domain of fungal Bck1-like MAP Kinase Kinase Kinases | Back alignment and domain information |
|---|
Probab=99.90 E-value=6.6e-24 Score=206.29 Aligned_cols=180 Identities=24% Similarity=0.334 Sum_probs=132.4
Q ss_pred cccceeeccCCCCC------CCCCCChhhHHHHHHHHHHHHHHHhhcCCCceeecCCCccceEecCCCCceeccccceee
Q 045315 241 DEISFWYESYNNPT------KKGLLCWGTRVRIIEGIAQGLLYLHQYSRLRVIHRDLKASNILLDKDMNPKISDFGMARM 314 (476)
Q Consensus 241 ~~~~l~~Ey~~~~~------~~~~L~~~~~~~i~~qIa~gL~yLH~~~~~~ivH~DLkp~NILld~~~~~kL~DFGla~~ 314 (476)
+..++++||++... +..++++..+..++.||+.||.|||+.+ ++|+||+|+||+++.++.++|+|||+++.
T Consensus 81 ~~~~lv~e~~~~~~L~~~l~~~~~l~~~~~~~~~~qi~~~l~~lH~~~---i~H~dl~~~nil~~~~~~~~l~d~~~~~~ 157 (272)
T cd06629 81 EYLSIFLEYVPGGSIGSCLRTYGRFEEQLVRFFTEQVLEGLAYLHSKG---ILHRDLKADNLLVDADGICKISDFGISKK 157 (272)
T ss_pred CceEEEEecCCCCcHHHHHhhccCCCHHHHHHHHHHHHHHHHHHhhCC---eeecCCChhhEEEcCCCeEEEeecccccc
Confidence 35678889987332 3367999999999999999999999998 99999999999999999999999999976
Q ss_pred cCCCcccccceeeeeccCCCChhhhccCC--CCccceEEeehhhhhhhhhCCCCCCcCCCCchhhhhhhhhhhcCCCccc
Q 045315 315 FGGDELQSNTKRIVGTYGYMSPEYALRGL--FSIKSDVFSFGVLLLETLSSKKNTHFYNTDSLTLLGHAWNLWNDGRTWE 392 (476)
Q Consensus 315 ~~~~~~~~~~~~~~gt~~y~aPE~l~~~~--~s~ksDVwSlGvvl~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~ 392 (476)
..............++..|+|||.+.... ++.++|+||||++++|+++|+.|+...... ... ......... .
T Consensus 158 ~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~~~Dv~slG~~l~~l~~g~~p~~~~~~~--~~~---~~~~~~~~~-~ 231 (272)
T cd06629 158 SDDIYDNDQNMSMQGSVFWMAPEVIHSYSQGYSAKVDIWSLGCVVLEMFAGRRPWSDEEAI--AAM---FKLGNKRSA-P 231 (272)
T ss_pred ccccccccccccccCCccccCHHHhccccCCCCccchhHHHHHHHHHHHhCCCCCcCcchH--HHH---HHhhccccC-C
Confidence 54322222223345788999999987654 789999999999999999999998532211 000 001101000 0
Q ss_pred ccCcccCCCCCHHHHHHHHHHHHHchhhcccCCCCHHHHHH
Q 045315 393 LMDPISQNGASYPILKRYINVALLCVQEKAADRPAMSEVVS 433 (476)
Q Consensus 393 ~~d~~~~~~~~~~~~~~l~~li~~Cl~~dP~~RPt~~eVl~ 433 (476)
.+. ..........+.+++.+||+.+|++||++++|++
T Consensus 232 ~~~----~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~il~ 268 (272)
T cd06629 232 PIP----PDVSMNLSPVALDFLNACFTINPDNRPTARELLQ 268 (272)
T ss_pred cCC----ccccccCCHHHHHHHHHHhcCChhhCCCHHHHhh
Confidence 011 1111223467889999999999999999999886
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, fungal Bck1-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include the MAPKKKs Saccharomyces cerevisiae Bck1 and Schizosaccharomyces pombe Mkh1, and related proteins. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Budding yeast Bck1 is part of the cell inte |
| >KOG0194 consensus Protein tyrosine kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.90 E-value=1.9e-24 Score=220.56 Aligned_cols=184 Identities=28% Similarity=0.339 Sum_probs=139.0
Q ss_pred cccceeeccCCCCC-------CCCCCChhhHHHHHHHHHHHHHHHhhcCCCceeecCCCccceEecCCCCceecccccee
Q 045315 241 DEISFWYESYNNPT-------KKGLLCWGTRVRIIEGIAQGLLYLHQYSRLRVIHRDLKASNILLDKDMNPKISDFGMAR 313 (476)
Q Consensus 241 ~~~~l~~Ey~~~~~-------~~~~L~~~~~~~i~~qIa~gL~yLH~~~~~~ivH~DLkp~NILld~~~~~kL~DFGla~ 313 (476)
.-.+++||+++++. ..+.++..++++++.+.|.||+|||+++ +|||||-++|+|++.++.+||+|||+++
T Consensus 234 ~Pl~ivmEl~~gGsL~~~L~k~~~~v~~~ek~~~~~~AA~Gl~YLh~k~---~IHRDIAARNcL~~~~~~vKISDFGLs~ 310 (474)
T KOG0194|consen 234 EPLMLVMELCNGGSLDDYLKKNKKSLPTLEKLRFCYDAARGLEYLHSKN---CIHRDIAARNCLYSKKGVVKISDFGLSR 310 (474)
T ss_pred CccEEEEEecCCCcHHHHHHhCCCCCCHHHHHHHHHHHHhHHHHHHHCC---CcchhHhHHHheecCCCeEEeCcccccc
Confidence 46889999999542 2336999999999999999999999999 9999999999999999999999999987
Q ss_pred ecCCCcccccceeeeeccCCCChhhhccCCCCccceEEeehhhhhhhhh-CCCCCCcCCCCchhhhhhhhhhhcCCCccc
Q 045315 314 MFGGDELQSNTKRIVGTYGYMSPEYALRGLFSIKSDVFSFGVLLLETLS-SKKNTHFYNTDSLTLLGHAWNLWNDGRTWE 392 (476)
Q Consensus 314 ~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~s~ksDVwSlGvvl~ellt-G~~p~~~~~~~~~~~~~~~~~~~~~~~~~~ 392 (476)
.-. ..........-+..|+|||.+..+.|+.++|||||||++||+++ |..|+..... ..+.. .....+....
T Consensus 311 ~~~--~~~~~~~~~klPirWLAPEtl~~~~~s~kTDV~sfGV~~~Eif~~g~~Py~g~~~--~~v~~---kI~~~~~r~~ 383 (474)
T KOG0194|consen 311 AGS--QYVMKKFLKKLPIRWLAPETLNTGIFSFKTDVWSFGVLLWEIFENGAEPYPGMKN--YEVKA---KIVKNGYRMP 383 (474)
T ss_pred CCc--ceeeccccccCcceecChhhhccCccccccchhheeeeEEeeeccCCCCCCCCCH--HHHHH---HHHhcCccCC
Confidence 543 11111111234679999999999999999999999999999998 7777764331 11111 1112222111
Q ss_pred ccCcccCCCCCHHHHHHHHHHHHHchhhcccCCCCHHHHHHHHhccccCCC
Q 045315 393 LMDPISQNGASYPILKRYINVALLCVQEKAADRPAMSEVVSMLSNEFVNLP 443 (476)
Q Consensus 393 ~~d~~~~~~~~~~~~~~l~~li~~Cl~~dP~~RPt~~eVl~~L~~~~~~~~ 443 (476)
.+...+..+..++.+||+.+|++||+|.++.+.|+.+.....
T Consensus 384 ---------~~~~~p~~~~~~~~~c~~~~p~~R~tm~~i~~~l~~~~~~~~ 425 (474)
T KOG0194|consen 384 ---------IPSKTPKELAKVMKQCWKKDPEDRPTMSTIKKKLEALEKKKE 425 (474)
T ss_pred ---------CCCCCHHHHHHHHHHhccCChhhccCHHHHHHHHHHHHhccc
Confidence 111334566778889999999999999999999999874433
|
|
| >cd07841 STKc_CDK7 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 7 | Back alignment and domain information |
|---|
Probab=99.90 E-value=1.1e-23 Score=207.66 Aligned_cols=186 Identities=20% Similarity=0.235 Sum_probs=131.4
Q ss_pred cccceeeccCCCC------CCC-CCCChhhHHHHHHHHHHHHHHHhhcCCCceeecCCCccceEecCCCCceecccccee
Q 045315 241 DEISFWYESYNNP------TKK-GLLCWGTRVRIIEGIAQGLLYLHQYSRLRVIHRDLKASNILLDKDMNPKISDFGMAR 313 (476)
Q Consensus 241 ~~~~l~~Ey~~~~------~~~-~~L~~~~~~~i~~qIa~gL~yLH~~~~~~ivH~DLkp~NILld~~~~~kL~DFGla~ 313 (476)
+.+++++||+. . ... ..+++.++..++.||++||+|||+++ ++|+||||+||+++.++.+||+|||+++
T Consensus 75 ~~~~lv~e~~~-~~L~~~i~~~~~~~~~~~~~~~~~qi~~al~~lH~~~---i~H~dl~p~nill~~~~~~~l~dfg~~~ 150 (298)
T cd07841 75 SNINLVFEFME-TDLEKVIKDKSIVLTPADIKSYMLMTLRGLEYLHSNW---ILHRDLKPNNLLIASDGVLKLADFGLAR 150 (298)
T ss_pred CEEEEEEcccC-CCHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHhCC---eeecCCChhhEEEcCCCCEEEccceeee
Confidence 46788899984 2 122 37999999999999999999999999 9999999999999999999999999998
Q ss_pred ecCCCcccccceeeeeccCCCChhhhcc-CCCCccceEEeehhhhhhhhhCCCCCCcCCCCchhhhhhhhhhhcC-----
Q 045315 314 MFGGDELQSNTKRIVGTYGYMSPEYALR-GLFSIKSDVFSFGVLLLETLSSKKNTHFYNTDSLTLLGHAWNLWND----- 387 (476)
Q Consensus 314 ~~~~~~~~~~~~~~~gt~~y~aPE~l~~-~~~s~ksDVwSlGvvl~elltG~~p~~~~~~~~~~~~~~~~~~~~~----- 387 (476)
........ .....++..|+|||.+.+ ..++.++|+|||||+++|+++|.++|...... ............
T Consensus 151 ~~~~~~~~--~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~e~~~g~~~~~~~~~~--~~~~~~~~~~~~~~~~~ 226 (298)
T cd07841 151 SFGSPNRK--MTHQVVTRWYRAPELLFGARHYGVGVDMWSVGCIFAELLLRVPFLPGDSDI--DQLGKIFEALGTPTEEN 226 (298)
T ss_pred eccCCCcc--ccccccceeeeCHHHHhCCCCCCcHHHHHHHHHHHHHHHcCCccccCCccH--HHHHHHHHHcCCCchhh
Confidence 76543211 122346778999998864 46789999999999999999998776543211 111111000000
Q ss_pred ----CCcccccCcccCCC-----CCHHHHHHHHHHHHHchhhcccCCCCHHHHHHH
Q 045315 388 ----GRTWELMDPISQNG-----ASYPILKRYINVALLCVQEKAADRPAMSEVVSM 434 (476)
Q Consensus 388 ----~~~~~~~d~~~~~~-----~~~~~~~~l~~li~~Cl~~dP~~RPt~~eVl~~ 434 (476)
.............. ........+.+++.+||+.+|++|||+.||++.
T Consensus 227 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~s~~e~l~~ 282 (298)
T cd07841 227 WPGVTSLPDYVEFKPFPPTPLKQIFPAASDDALDLLQRLLTLNPNKRITARQALEH 282 (298)
T ss_pred hhhcccccccccccccCCcchhhhcccccHHHHHHHHHHhcCCcccCcCHHHHhhC
Confidence 00000000000000 112234678899999999999999999999984
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 7 (CDK7) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK7 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK7 plays essential roles in the cell cycle and in transcription. It associates with cyclin H and MAT1 and acts as a CDK-Activating Kinase (CAK) by phosphorylating and activating cell cycle CDKs (CDK1/2/4/6). In the brain, it activates CDK5. CDK7 is |
| >cd07865 STKc_CDK9 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 9 | Back alignment and domain information |
|---|
Probab=99.90 E-value=4.6e-24 Score=211.14 Aligned_cols=190 Identities=22% Similarity=0.326 Sum_probs=129.6
Q ss_pred cccceeeccCCCC------CCCCCCChhhHHHHHHHHHHHHHHHhhcCCCceeecCCCccceEecCCCCceeccccceee
Q 045315 241 DEISFWYESYNNP------TKKGLLCWGTRVRIIEGIAQGLLYLHQYSRLRVIHRDLKASNILLDKDMNPKISDFGMARM 314 (476)
Q Consensus 241 ~~~~l~~Ey~~~~------~~~~~L~~~~~~~i~~qIa~gL~yLH~~~~~~ivH~DLkp~NILld~~~~~kL~DFGla~~ 314 (476)
+..++++||+... .....+++.++..++.||++||+|||+++ ++|+||||+||+++.++.+||+|||++..
T Consensus 92 ~~~~lv~e~~~~~l~~~l~~~~~~~~~~~~~~i~~qi~~al~~lH~~~---i~H~dl~p~nil~~~~~~~kl~dfg~~~~ 168 (310)
T cd07865 92 GSFYLVFEFCEHDLAGLLSNKNVKFTLSEIKKVMKMLLNGLYYIHRNK---ILHRDMKAANILITKDGILKLADFGLARA 168 (310)
T ss_pred ceEEEEEcCCCcCHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHHCC---eeccCCCHHHEEECCCCcEEECcCCCccc
Confidence 3467788887621 22346899999999999999999999998 99999999999999999999999999986
Q ss_pred cCCCccc--ccceeeeeccCCCChhhhccC-CCCccceEEeehhhhhhhhhCCCCCCcCCCCc-hhhhhhhhhh-----h
Q 045315 315 FGGDELQ--SNTKRIVGTYGYMSPEYALRG-LFSIKSDVFSFGVLLLETLSSKKNTHFYNTDS-LTLLGHAWNL-----W 385 (476)
Q Consensus 315 ~~~~~~~--~~~~~~~gt~~y~aPE~l~~~-~~s~ksDVwSlGvvl~elltG~~p~~~~~~~~-~~~~~~~~~~-----~ 385 (476)
....... .......++..|+|||.+.+. .++.++||||||+++|||++|+.|+....... .......... +
T Consensus 169 ~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~~l~el~t~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 248 (310)
T cd07865 169 FSLSKNSKPNRYTNRVVTLWYRPPELLLGERDYGPPIDMWGAGCIMAEMWTRSPIMQGNTEQHQLTLISQLCGSITPEVW 248 (310)
T ss_pred ccCCcccCCCCccCcccCccccCcHHhcCCcccCchhhhHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCChhhc
Confidence 6432211 111234577889999988754 47889999999999999999999886443211 0010000000 0
Q ss_pred cCCCcccccCccc-CCC---------CCHHHHHHHHHHHHHchhhcccCCCCHHHHHH
Q 045315 386 NDGRTWELMDPIS-QNG---------ASYPILKRYINVALLCVQEKAADRPAMSEVVS 433 (476)
Q Consensus 386 ~~~~~~~~~d~~~-~~~---------~~~~~~~~l~~li~~Cl~~dP~~RPt~~eVl~ 433 (476)
......+..+... ... ........+.+++.+||+.||++|||++|+++
T Consensus 249 ~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~dli~~~l~~~P~~R~t~~e~l~ 306 (310)
T cd07865 249 PGVDKLELFKKMELPQGQKRKVKERLKPYVKDPHALDLIDKLLVLDPAKRIDADTALN 306 (310)
T ss_pred ccccchhhhhhccCCCccchhhHHhcccccCCHHHHHHHHHHhcCChhhccCHHHHhc
Confidence 0000000000000 000 00011345678999999999999999999875
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 9 (CDK9) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK9 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK9 together with a cyclin partner (cyclin T1, T2a, T2b, or K) is the main component of distinct positive transcription elongation factors (P-TEFb), which function as Ser2 C-terminal domain kinases of RNA polymerase II. P-TEFb participates in multipl |
| >cd08221 STKc_Nek9 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 9 | Back alignment and domain information |
|---|
Probab=99.90 E-value=5.2e-24 Score=205.01 Aligned_cols=175 Identities=26% Similarity=0.361 Sum_probs=134.4
Q ss_pred cccceeeccCCCC--------CCCCCCChhhHHHHHHHHHHHHHHHhhcCCCceeecCCCccceEecCCCCceeccccce
Q 045315 241 DEISFWYESYNNP--------TKKGLLCWGTRVRIIEGIAQGLLYLHQYSRLRVIHRDLKASNILLDKDMNPKISDFGMA 312 (476)
Q Consensus 241 ~~~~l~~Ey~~~~--------~~~~~L~~~~~~~i~~qIa~gL~yLH~~~~~~ivH~DLkp~NILld~~~~~kL~DFGla 312 (476)
+..++++||++.. .....+++.++..++.|++.||+|||+.+ ++|+||+|+||++++++.+||+|||++
T Consensus 72 ~~~~~~~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~---i~h~dl~p~ni~~~~~~~~kl~d~~~~ 148 (256)
T cd08221 72 NTLLIEMEYANGGTLYDKIVRQKGQLFEEEMVLWYLFQIVSAVSYIHKAG---ILHRDIKTLNIFLTKAGLIKLGDFGIS 148 (256)
T ss_pred CeEEEEEEecCCCcHHHHHHhccccCCCHHHHHHHHHHHHHHHHHHHhCC---ccccCCChHhEEEeCCCCEEECcCcce
Confidence 4577788988732 22456899999999999999999999998 999999999999999999999999999
Q ss_pred eecCCCcccccceeeeeccCCCChhhhccCCCCccceEEeehhhhhhhhhCCCCCCcCCCCchhhhhhhhhhhcCCCccc
Q 045315 313 RMFGGDELQSNTKRIVGTYGYMSPEYALRGLFSIKSDVFSFGVLLLETLSSKKNTHFYNTDSLTLLGHAWNLWNDGRTWE 392 (476)
Q Consensus 313 ~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~s~ksDVwSlGvvl~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~ 392 (476)
........ ......++..|+|||.+.+..++.++|+||||++++||++|+.||...... ... ... ..+....
T Consensus 149 ~~~~~~~~--~~~~~~~~~~y~ape~~~~~~~~~~~Dv~slG~i~~~l~~g~~~~~~~~~~--~~~---~~~-~~~~~~~ 220 (256)
T cd08221 149 KILGSEYS--MAETVVGTPYYMSPELCQGVKYNFKSDIWALGCVLYELLTLKRTFDATNPL--NLV---VKI-VQGNYTP 220 (256)
T ss_pred EEcccccc--cccccCCCccccCHhhcCCCCCCCcchhHHHHHHHHHHHHCCCCCCCCCHH--HHH---HHH-HcCCCCC
Confidence 87644332 122346889999999998888899999999999999999999998643211 111 111 1111111
Q ss_pred ccCcccCCCCCHHHHHHHHHHHHHchhhcccCCCCHHHHHHHH
Q 045315 393 LMDPISQNGASYPILKRYINVALLCVQEKAADRPAMSEVVSML 435 (476)
Q Consensus 393 ~~d~~~~~~~~~~~~~~l~~li~~Cl~~dP~~RPt~~eVl~~L 435 (476)
........+.+++.+||+.+|.+||++.++++.+
T Consensus 221 ---------~~~~~~~~~~~~i~~~l~~~p~~R~s~~~ll~~~ 254 (256)
T cd08221 221 ---------VVSVYSSELISLVHSLLQQDPEKRPTADEVLDQP 254 (256)
T ss_pred ---------CccccCHHHHHHHHHHcccCcccCCCHHHHhhCc
Confidence 1122345688999999999999999999998753
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 9 (Nek9) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek9 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek9, also called Nercc1, is primarily a cytoplasmic protein but can also localize in the nucleus. It is involved in modulating chromosome alignment and splitting during mitosis. It interacts with the gamma-tubulin ring complex and the Ran GTPase, and is implicated in microtubule organization. Nek9 associa |
| >cd07831 STKc_MOK Catalytic domain of the Serine/Threonine Kinase, MAPK/MAK/MRK Overlapping Kinase | Back alignment and domain information |
|---|
Probab=99.90 E-value=4.6e-24 Score=208.24 Aligned_cols=184 Identities=18% Similarity=0.207 Sum_probs=130.8
Q ss_pred cccceeeccCCCC------CCCCCCChhhHHHHHHHHHHHHHHHhhcCCCceeecCCCccceEecCCCCceeccccceee
Q 045315 241 DEISFWYESYNNP------TKKGLLCWGTRVRIIEGIAQGLLYLHQYSRLRVIHRDLKASNILLDKDMNPKISDFGMARM 314 (476)
Q Consensus 241 ~~~~l~~Ey~~~~------~~~~~L~~~~~~~i~~qIa~gL~yLH~~~~~~ivH~DLkp~NILld~~~~~kL~DFGla~~ 314 (476)
+..++++||++.. .+...+++.++..++.||+.||+|||+.+ ++|+||||+||+++. +.+||+|||+++.
T Consensus 73 ~~~~lv~e~~~~~l~~~l~~~~~~~~~~~~~~~~~qi~~~L~~LH~~~---i~H~dl~p~ni~l~~-~~~kl~dfg~~~~ 148 (282)
T cd07831 73 GRLALVFELMDMNLYELIKGRKRPLPEKRVKSYMYQLLKSLDHMHRNG---IFHRDIKPENILIKD-DILKLADFGSCRG 148 (282)
T ss_pred CcEEEEEecCCccHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHHCC---ceecccCHHHEEEcC-CCeEEEecccccc
Confidence 4567888888721 22457999999999999999999999998 999999999999999 9999999999987
Q ss_pred cCCCcccccceeeeeccCCCChhhhc-cCCCCccceEEeehhhhhhhhhCCCCCCcCCCCchhhhhhhhh----------
Q 045315 315 FGGDELQSNTKRIVGTYGYMSPEYAL-RGLFSIKSDVFSFGVLLLETLSSKKNTHFYNTDSLTLLGHAWN---------- 383 (476)
Q Consensus 315 ~~~~~~~~~~~~~~gt~~y~aPE~l~-~~~~s~ksDVwSlGvvl~elltG~~p~~~~~~~~~~~~~~~~~---------- 383 (476)
....... ....++..|+|||.+. +..++.++|||||||++|||++|+.||...+... .......
T Consensus 149 ~~~~~~~---~~~~~~~~y~aPE~~~~~~~~~~~~Di~slGv~l~el~~~~~p~~~~~~~~--~~~~~~~~~~~~~~~~~ 223 (282)
T cd07831 149 IYSKPPY---TEYISTRWYRAPECLLTDGYYGPKMDIWAVGCVFFEILSLFPLFPGTNELD--QIAKIHDVLGTPDAEVL 223 (282)
T ss_pred cccCCCc---CCCCCCcccCChhHhhcCCCCCcchhHHHHHHHHHHHHcCCcCCCCCCHHH--HHHHHHHHcCCCCHHHH
Confidence 6433221 1245788999999765 4567899999999999999999999986543211 1111100
Q ss_pred -hhcCCCcccccCcccCC----CCCHHHHHHHHHHHHHchhhcccCCCCHHHHHH
Q 045315 384 -LWNDGRTWELMDPISQN----GASYPILKRYINVALLCVQEKAADRPAMSEVVS 433 (476)
Q Consensus 384 -~~~~~~~~~~~d~~~~~----~~~~~~~~~l~~li~~Cl~~dP~~RPt~~eVl~ 433 (476)
............+.... .........+.+++.+||+.+|++||+++++++
T Consensus 224 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~~~~~~l~ 278 (282)
T cd07831 224 KKFRKSRHMNYNFPSKKGTGLRKLLPNASAEGLDLLKKLLAYDPDERITAKQALR 278 (282)
T ss_pred HhhcccccccccCcccccccHHHHcccccHHHHHHHHHHhccCcccccCHHHHhh
Confidence 00000000000000000 001123578999999999999999999999875
|
Serine/Threonine Kinases (STKs), MAPK/MAK/MRK Overlapping Kinase (MOK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MOK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MOK, also called Renal tumor antigen 1 (RAGE-1), is widely expressed and is enriched in testis, kidney, lung, and brain. It is expressed in approximately 50% of renal cell carcinomas (RCC) and is a potential target for immunotherapy. MOK is stabilized by its association with the HSP90 molecular chaperone. It is induced by the transcription factor Cdx2 and may be involved in regulating intestinal epithelial development and differentiation. |
| >PHA03390 pk1 serine/threonine-protein kinase 1; Provisional | Back alignment and domain information |
|---|
Probab=99.90 E-value=1.1e-23 Score=204.97 Aligned_cols=172 Identities=21% Similarity=0.282 Sum_probs=131.9
Q ss_pred cccceeeccCCCCC------CCCCCChhhHHHHHHHHHHHHHHHhhcCCCceeecCCCccceEecCCC-Cceecccccee
Q 045315 241 DEISFWYESYNNPT------KKGLLCWGTRVRIIEGIAQGLLYLHQYSRLRVIHRDLKASNILLDKDM-NPKISDFGMAR 313 (476)
Q Consensus 241 ~~~~l~~Ey~~~~~------~~~~L~~~~~~~i~~qIa~gL~yLH~~~~~~ivH~DLkp~NILld~~~-~~kL~DFGla~ 313 (476)
+..+++|||+++.+ ....+++.++..++.||++||.|||+.+ ++||||||+||+++.++ .++|+|||+++
T Consensus 82 ~~~~iv~e~~~~~~L~~~l~~~~~l~~~~~~~~~~qi~~~l~~lH~~~---i~H~dl~p~nil~~~~~~~~~l~dfg~~~ 158 (267)
T PHA03390 82 KGHVLIMDYIKDGDLFDLLKKEGKLSEAEVKKIIRQLVEALNDLHKHN---IIHNDIKLENVLYDRAKDRIYLCDYGLCK 158 (267)
T ss_pred CeeEEEEEcCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCC---eeeCCCCHHHEEEeCCCCeEEEecCccce
Confidence 35788999998432 2348999999999999999999999998 99999999999999988 99999999998
Q ss_pred ecCCCcccccceeeeeccCCCChhhhccCCCCccceEEeehhhhhhhhhCCCCCCcCCCCchhhhhhhhhhhcCCCcccc
Q 045315 314 MFGGDELQSNTKRIVGTYGYMSPEYALRGLFSIKSDVFSFGVLLLETLSSKKNTHFYNTDSLTLLGHAWNLWNDGRTWEL 393 (476)
Q Consensus 314 ~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~s~ksDVwSlGvvl~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~ 393 (476)
...... ...++..|+|||.+.+..++.++|+||||+++|||++|+.||.....+........... . ...
T Consensus 159 ~~~~~~------~~~~~~~y~aPE~~~~~~~~~~~DvwslG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~--~-~~~-- 227 (267)
T PHA03390 159 IIGTPS------CYDGTLDYFSPEKIKGHNYDVSFDWWAVGVLTYELLTGKHPFKEDEDEELDLESLLKRQ--Q-KKL-- 227 (267)
T ss_pred ecCCCc------cCCCCCcccChhhhcCCCCCchhhHHHHHHHHHHHHHCCCCCCCCCcchhhHHHHHHhh--c-ccC--
Confidence 664322 23578899999999988899999999999999999999999874332221111111100 0 000
Q ss_pred cCcccCCCCCHHHHHHHHHHHHHchhhcccCCCC-HHHHHH
Q 045315 394 MDPISQNGASYPILKRYINVALLCVQEKAADRPA-MSEVVS 433 (476)
Q Consensus 394 ~d~~~~~~~~~~~~~~l~~li~~Cl~~dP~~RPt-~~eVl~ 433 (476)
.........+.+++.+||+.+|.+||+ ++++++
T Consensus 228 -------~~~~~~~~~~~~li~~~l~~~p~~R~~~~~~~l~ 261 (267)
T PHA03390 228 -------PFIKNVSKNANDFVQSMLKYNINYRLTNYNEIIK 261 (267)
T ss_pred -------CcccccCHHHHHHHHHHhccChhhCCchHHHHhc
Confidence 011134457889999999999999996 588763
|
|
| >cd07850 STKc_JNK Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase | Back alignment and domain information |
|---|
Probab=99.90 E-value=5.9e-24 Score=215.28 Aligned_cols=187 Identities=19% Similarity=0.196 Sum_probs=132.6
Q ss_pred ccceeeccCCCCC---CCCCCChhhHHHHHHHHHHHHHHHhhcCCCceeecCCCccceEecCCCCceeccccceeecCCC
Q 045315 242 EISFWYESYNNPT---KKGLLCWGTRVRIIEGIAQGLLYLHQYSRLRVIHRDLKASNILLDKDMNPKISDFGMARMFGGD 318 (476)
Q Consensus 242 ~~~l~~Ey~~~~~---~~~~L~~~~~~~i~~qIa~gL~yLH~~~~~~ivH~DLkp~NILld~~~~~kL~DFGla~~~~~~ 318 (476)
..++++||++... ....++..++..++.|++.||+|||+.+ ++||||||+||+++.++.+||+|||+++.....
T Consensus 95 ~~~lv~e~~~~~l~~~~~~~l~~~~~~~~~~ql~~aL~~LH~~g---i~H~dlkp~Nil~~~~~~~kL~Dfg~~~~~~~~ 171 (353)
T cd07850 95 DVYLVMELMDANLCQVIQMDLDHERMSYLLYQMLCGIKHLHSAG---IIHRDLKPSNIVVKSDCTLKILDFGLARTAGTS 171 (353)
T ss_pred cEEEEEeccCCCHHHHHhhcCCHHHHHHHHHHHHHHHHHHHhCC---eeeCCCCHHHEEECCCCCEEEccCccceeCCCC
Confidence 3578889887311 1223899999999999999999999998 999999999999999999999999999876443
Q ss_pred cccccceeeeeccCCCChhhhccCCCCccceEEeehhhhhhhhhCCCCCCcCCCCch-------------hhhhh---hh
Q 045315 319 ELQSNTKRIVGTYGYMSPEYALRGLFSIKSDVFSFGVLLLETLSSKKNTHFYNTDSL-------------TLLGH---AW 382 (476)
Q Consensus 319 ~~~~~~~~~~gt~~y~aPE~l~~~~~s~ksDVwSlGvvl~elltG~~p~~~~~~~~~-------------~~~~~---~~ 382 (476)
.. .....++..|+|||.+.+..++.++|||||||++|+|++|+.||...+.... .+... ..
T Consensus 172 ~~---~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 248 (353)
T cd07850 172 FM---MTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMIRGTVLFPGTDHIDQWNKIIEQLGTPSDEFMSRLQPTV 248 (353)
T ss_pred CC---CCCCcccccccCHHHHhCCCCCCchhhHhHHHHHHHHHHCCCCCCCCCHHHHHHHHHHhcCCCCHHHHHHhhhhh
Confidence 21 2224578899999999999999999999999999999999999865431100 00000 00
Q ss_pred h-hhcCC------CcccccCcc----cCCCCCHHHHHHHHHHHHHchhhcccCCCCHHHHHHH
Q 045315 383 N-LWNDG------RTWELMDPI----SQNGASYPILKRYINVALLCVQEKAADRPAMSEVVSM 434 (476)
Q Consensus 383 ~-~~~~~------~~~~~~d~~----~~~~~~~~~~~~l~~li~~Cl~~dP~~RPt~~eVl~~ 434 (476)
. ..... ...+..... ............+.+++.+||+.||++|||+.|+++.
T Consensus 249 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~eiL~~ 311 (353)
T cd07850 249 RNYVENRPKYAGYSFEELFPDVLFPPDSESHNKLKASQARDLLSKMLVIDPEKRISVDDALQH 311 (353)
T ss_pred hHHhhcCCCCCCcchhhhCcccccCcccccccccchhHHHHHHHHHcCCChhhCcCHHHHhcC
Confidence 0 00000 000111000 0011112335668899999999999999999999854
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase (JNK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. They are also essential regulators of physiological and pathological processes and are involved in the pathogenesis of several diseases such as diabetes, atherosclerosis, stroke, Parkinson's and Alzheimer's. Vetebrates harbor three different JNK |
| >cd06615 PKc_MEK Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase | Back alignment and domain information |
|---|
Probab=99.90 E-value=8e-24 Score=210.22 Aligned_cols=187 Identities=25% Similarity=0.395 Sum_probs=132.2
Q ss_pred cccceeeccCCCCC------CCCCCChhhHHHHHHHHHHHHHHHhh-cCCCceeecCCCccceEecCCCCceecccccee
Q 045315 241 DEISFWYESYNNPT------KKGLLCWGTRVRIIEGIAQGLLYLHQ-YSRLRVIHRDLKASNILLDKDMNPKISDFGMAR 313 (476)
Q Consensus 241 ~~~~l~~Ey~~~~~------~~~~L~~~~~~~i~~qIa~gL~yLH~-~~~~~ivH~DLkp~NILld~~~~~kL~DFGla~ 313 (476)
+..++++||++... +.+.+++..+..++.||++||.|||+ .+ ++|+||||+||+++.++.+||+|||++.
T Consensus 72 ~~~~lv~ey~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~l~~lH~~~~---i~H~dl~p~nil~~~~~~~~l~dfg~~~ 148 (308)
T cd06615 72 GEISICMEHMDGGSLDQVLKKAGRIPENILGKISIAVLRGLTYLREKHK---IMHRDVKPSNILVNSRGEIKLCDFGVSG 148 (308)
T ss_pred CEEEEEeeccCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhhCC---EEECCCChHHEEEecCCcEEEccCCCcc
Confidence 46788999998332 34678999999999999999999997 46 9999999999999999999999999987
Q ss_pred ecCCCcccccceeeeeccCCCChhhhccCCCCccceEEeehhhhhhhhhCCCCCCcCCCCchh-hhhhhhhhhcCCCc--
Q 045315 314 MFGGDELQSNTKRIVGTYGYMSPEYALRGLFSIKSDVFSFGVLLLETLSSKKNTHFYNTDSLT-LLGHAWNLWNDGRT-- 390 (476)
Q Consensus 314 ~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~s~ksDVwSlGvvl~elltG~~p~~~~~~~~~~-~~~~~~~~~~~~~~-- 390 (476)
...... .....++..|+|||.+.+..++.++|+||||+++|++++|+.|+......... ..............
T Consensus 149 ~~~~~~----~~~~~~~~~~~aPE~~~~~~~~~~~DiwslG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~ 224 (308)
T cd06615 149 QLIDSM----ANSFVGTRSYMSPERLQGTHYTVQSDIWSLGLSLVEMAIGRYPIPPPDAKELEAMFGRPVSEGEAKESHR 224 (308)
T ss_pred cccccc----cccCCCCcCccChhHhcCCCCCccchHHHHHHHHHHHHhCCCCCCCcchhhHHHhhcCccccccccCCcc
Confidence 553221 12346788999999998888999999999999999999999998643311110 00000000000000
Q ss_pred ---------------ccccCccc---CCC-CCHHHHHHHHHHHHHchhhcccCCCCHHHHHHH
Q 045315 391 ---------------WELMDPIS---QNG-ASYPILKRYINVALLCVQEKAADRPAMSEVVSM 434 (476)
Q Consensus 391 ---------------~~~~d~~~---~~~-~~~~~~~~l~~li~~Cl~~dP~~RPt~~eVl~~ 434 (476)
.+..+... ... ........+.+++.+||+.+|++||++++|++.
T Consensus 225 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~ll~~ 287 (308)
T cd06615 225 PVSGHPPDSPRPMAIFELLDYIVNEPPPKLPSGAFSDEFQDFVDKCLKKNPKERADLKELTKH 287 (308)
T ss_pred cccCCCCCccchhhHHHHHHHHhcCCCccCcCcccCHHHHHHHHHHccCChhhCcCHHHHhcC
Confidence 00000000 000 001133468899999999999999999998875
|
Protein kinases (PKs), MAP/ERK kinase (MEK) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK1 and MEK2 are dual-specificity PKs that phosphorylate and activate the down |
| >cd07837 STKc_CdkB_plant Catalytic domain of the Serine/Threonine Kinase, Plant B-type Cyclin-Dependent protein Kinase | Back alignment and domain information |
|---|
Probab=99.90 E-value=6.5e-24 Score=208.86 Aligned_cols=184 Identities=22% Similarity=0.266 Sum_probs=128.5
Q ss_pred cceeeccCCCC----------CCCCCCChhhHHHHHHHHHHHHHHHhhcCCCceeecCCCccceEecC-CCCceeccccc
Q 045315 243 ISFWYESYNNP----------TKKGLLCWGTRVRIIEGIAQGLLYLHQYSRLRVIHRDLKASNILLDK-DMNPKISDFGM 311 (476)
Q Consensus 243 ~~l~~Ey~~~~----------~~~~~L~~~~~~~i~~qIa~gL~yLH~~~~~~ivH~DLkp~NILld~-~~~~kL~DFGl 311 (476)
+++++||++.. .....+++.++..++.||++||+|||+.+ ++||||||+||+++. ++.+||+|||+
T Consensus 81 ~~lv~e~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~qi~~~L~~LH~~~---i~H~dl~~~nil~~~~~~~~kl~dfg~ 157 (295)
T cd07837 81 LYLVFEYLDSDLKKFMDSNGRGPGRPLPAKTIKSFMYQLLKGVAHCHKHG---VMHRDLKPQNLLVDKQKGLLKIADLGL 157 (295)
T ss_pred EEEEeeccCcCHHHHHHHhcccCCCCCCHHHHHHHHHHHHHHHHHHHHCC---eeecCCChHHEEEecCCCeEEEeeccc
Confidence 67888888721 11357899999999999999999999998 999999999999998 88999999999
Q ss_pred eeecCCCcccccceeeeeccCCCChhhhcc-CCCCccceEEeehhhhhhhhhCCCCCCcCCCCchhhhhhhhhhhcCCC-
Q 045315 312 ARMFGGDELQSNTKRIVGTYGYMSPEYALR-GLFSIKSDVFSFGVLLLETLSSKKNTHFYNTDSLTLLGHAWNLWNDGR- 389 (476)
Q Consensus 312 a~~~~~~~~~~~~~~~~gt~~y~aPE~l~~-~~~s~ksDVwSlGvvl~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~- 389 (476)
++.+...... .....+++.|+|||++.+ ..++.++|+||||+++|+|++|..||....... .+.. .........
T Consensus 158 ~~~~~~~~~~--~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~~~~~~~~~~-~~~~-~~~~~~~~~~ 233 (295)
T cd07837 158 GRAFSIPVKS--YTHEIVTLWYRAPEVLLGSTHYSTPVDIWSVGCIFAEMSRKQPLFPGDSELQ-QLLH-IFKLLGTPTE 233 (295)
T ss_pred ceecCCCccc--cCCcccccCCCChHHhhCCCCCCchHHHHHHHHHHHHHHcCCCCCCCCCHHH-HHHH-HHHHhCCCCh
Confidence 9865432111 112346788999998865 457899999999999999999999986533111 1110 000000000
Q ss_pred -cc----cccC----cccC----CCCCHHHHHHHHHHHHHchhhcccCCCCHHHHHH
Q 045315 390 -TW----ELMD----PISQ----NGASYPILKRYINVALLCVQEKAADRPAMSEVVS 433 (476)
Q Consensus 390 -~~----~~~d----~~~~----~~~~~~~~~~l~~li~~Cl~~dP~~RPt~~eVl~ 433 (476)
.. ...+ +... ..........+.+++.+||+.||++||++.|++.
T Consensus 234 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~P~~R~~~~eil~ 290 (295)
T cd07837 234 QVWPGVSKLRDWHEFPQWKPQDLSRAVPDLSPEGLDLLQKMLRYDPAKRISAKAALT 290 (295)
T ss_pred hhCcchhhccchhhcCcccchhHHHhccccCHHHHHHHHHHccCChhhcCCHHHHhc
Confidence 00 0000 0000 0001123466889999999999999999999874
|
Serine/Threonine Kinases (STKs), Plant B-type Cyclin-Dependent protein Kinase (CdkB) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CdkB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. The plant-specific B-type CDKs are expressed from the late S to the M phase of the cell cycle. They are characterized by the cyclin binding motif PPT[A/T]LRE. They play a role in controlling mitosis and integrating developm |
| >cd07843 STKc_CDC2L1 Catalytic domain of the Serine/Threonine Kinase, Cell Division Cycle 2-like 1 | Back alignment and domain information |
|---|
Probab=99.90 E-value=6.4e-24 Score=208.95 Aligned_cols=186 Identities=23% Similarity=0.250 Sum_probs=132.1
Q ss_pred cccceeeccCCC------CCCCCCCChhhHHHHHHHHHHHHHHHhhcCCCceeecCCCccceEecCCCCceeccccceee
Q 045315 241 DEISFWYESYNN------PTKKGLLCWGTRVRIIEGIAQGLLYLHQYSRLRVIHRDLKASNILLDKDMNPKISDFGMARM 314 (476)
Q Consensus 241 ~~~~l~~Ey~~~------~~~~~~L~~~~~~~i~~qIa~gL~yLH~~~~~~ivH~DLkp~NILld~~~~~kL~DFGla~~ 314 (476)
+..++++||++. ..+...+++.++..++.||+.||+|||+++ ++|+||||+||+++.++.+||+|||++..
T Consensus 79 ~~~~lv~e~~~~~L~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~---i~H~dl~p~nili~~~~~~~l~d~g~~~~ 155 (293)
T cd07843 79 DKIYMVMEYVEHDLKSLMETMKQPFLQSEVKCLMLQLLSGVAHLHDNW---ILHRDLKTSNLLLNNRGILKICDFGLARE 155 (293)
T ss_pred CcEEEEehhcCcCHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHHCC---eeeccCCHHHEEECCCCcEEEeecCceee
Confidence 467788898872 122346999999999999999999999998 99999999999999999999999999987
Q ss_pred cCCCcccccceeeeeccCCCChhhhccC-CCCccceEEeehhhhhhhhhCCCCCCcCCCCchhhhhhhhhh---------
Q 045315 315 FGGDELQSNTKRIVGTYGYMSPEYALRG-LFSIKSDVFSFGVLLLETLSSKKNTHFYNTDSLTLLGHAWNL--------- 384 (476)
Q Consensus 315 ~~~~~~~~~~~~~~gt~~y~aPE~l~~~-~~s~ksDVwSlGvvl~elltG~~p~~~~~~~~~~~~~~~~~~--------- 384 (476)
....... .....++..|+|||.+.+. .++.++|+||||++++||++|+.||....... ........
T Consensus 156 ~~~~~~~--~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~~f~~~~~~~--~~~~~~~~~~~~~~~~~ 231 (293)
T cd07843 156 YGSPLKP--YTQLVVTLWYRAPELLLGAKEYSTAIDMWSVGCIFAELLTKKPLFPGKSEID--QLNKIFKLLGTPTEKIW 231 (293)
T ss_pred ccCCccc--cccccccccccCchhhcCCccccchhhHHHHHHHHHHHHhCCCCCCCCChHH--HHHHHHHHhCCCchHHH
Confidence 6543211 1224578899999988754 46899999999999999999999986543111 00000000
Q ss_pred --hcC------CCcccccCcccCCCCCHH-HHHHHHHHHHHchhhcccCCCCHHHHHH
Q 045315 385 --WND------GRTWELMDPISQNGASYP-ILKRYINVALLCVQEKAADRPAMSEVVS 433 (476)
Q Consensus 385 --~~~------~~~~~~~d~~~~~~~~~~-~~~~l~~li~~Cl~~dP~~RPt~~eVl~ 433 (476)
+.. ..........+....... ..+.+.+++.+||+.+|++|||+.|+++
T Consensus 232 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~R~t~~ell~ 289 (293)
T cd07843 232 PGFSELPGAKKKTFTKYPYNQLRKKFPALSLSDNGFDLLNRLLTYDPAKRISAEDALK 289 (293)
T ss_pred HHhhccchhcccccccccchhhhccccccCCChHHHHHHHHHhccCccccCCHHHHhc
Confidence 000 000000000111111111 3566889999999999999999999875
|
Serine/Threonine Kinases (STKs), Cell Division Cycle 2-like 1 (CDC2L1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDC2L1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDC2L1, also called PITSLRE, exists in different isoforms which are named using the alias CDK11(p). The CDC2L1 gene produces two protein products, CDK11(p110) and CDK11(p58). CDC2L1 is also represented by the caspase-processed CDK11(p46). CDK11(p110), the |
| >cd05611 STKc_Rim15_like Catalytic domain of fungal Rim15-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=99.90 E-value=8e-24 Score=204.34 Aligned_cols=176 Identities=24% Similarity=0.238 Sum_probs=133.8
Q ss_pred cccceeeccCCCCC------CCCCCChhhHHHHHHHHHHHHHHHhhcCCCceeecCCCccceEecCCCCceeccccceee
Q 045315 241 DEISFWYESYNNPT------KKGLLCWGTRVRIIEGIAQGLLYLHQYSRLRVIHRDLKASNILLDKDMNPKISDFGMARM 314 (476)
Q Consensus 241 ~~~~l~~Ey~~~~~------~~~~L~~~~~~~i~~qIa~gL~yLH~~~~~~ivH~DLkp~NILld~~~~~kL~DFGla~~ 314 (476)
+..++++||+++.. ..+.+++..+..++.||++||.|||+.+ ++|+||+|+||+++.++.+||+|||+++.
T Consensus 70 ~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~i~~qi~~aL~~lH~~~---i~H~dl~p~nil~~~~~~~~l~dfg~~~~ 146 (260)
T cd05611 70 DYLYLVMEYLNGGDCASLIKTLGGLPEDWAKQYIAEVVLGVEDLHQRG---IIHRDIKPENLLIDQTGHLKLTDFGLSRN 146 (260)
T ss_pred CeEEEEEeccCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCCHHHeEECCCCcEEEeeccccee
Confidence 45788999998432 3457899999999999999999999998 99999999999999999999999999876
Q ss_pred cCCCcccccceeeeeccCCCChhhhccCCCCccceEEeehhhhhhhhhCCCCCCcCCCCchhhhhhhhhhhcCCCccccc
Q 045315 315 FGGDELQSNTKRIVGTYGYMSPEYALRGLFSIKSDVFSFGVLLLETLSSKKNTHFYNTDSLTLLGHAWNLWNDGRTWELM 394 (476)
Q Consensus 315 ~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~s~ksDVwSlGvvl~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 394 (476)
... .....++..|++||.+.+..++.++||||||+++||+++|..||...... ... .....+...
T Consensus 147 ~~~------~~~~~~~~~y~~pe~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~--~~~----~~~~~~~~~--- 211 (260)
T cd05611 147 GLE------NKKFVGTPDYLAPETILGVGDDKMSDWWSLGCVIFEFLFGYPPFHAETPD--AVF----DNILSRRIN--- 211 (260)
T ss_pred ccc------cccCCCCcCccChhhhcCCCCcchhhhHHHHHHHHHHHHCCCCCCCCCHH--HHH----HHHHhcccC---
Confidence 432 12245788999999998888899999999999999999999998643221 111 111111100
Q ss_pred CcccCCCCCHHHHHHHHHHHHHchhhcccCCCCHHHHHHHHhc
Q 045315 395 DPISQNGASYPILKRYINVALLCVQEKAADRPAMSEVVSMLSN 437 (476)
Q Consensus 395 d~~~~~~~~~~~~~~l~~li~~Cl~~dP~~RPt~~eVl~~L~~ 437 (476)
............+.+++.+||+.+|++||++.++.+.|+.
T Consensus 212 ---~~~~~~~~~~~~~~~~i~~~l~~~p~~R~~~~~~~~~l~~ 251 (260)
T cd05611 212 ---WPEEVKEFCSPEAVDLINRLLCMDPAKRLGANGYQEIKSH 251 (260)
T ss_pred ---CCCcccccCCHHHHHHHHHHccCCHHHccCCCcHHHHHcC
Confidence 0000111234578899999999999999988777766654
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, fungal Rim15-like kinases, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include Saccharomyces cerevisiae Rim15, Schizosaccharomyces pombe cek1, and similar fungal proteins. They contain a central catalytic domain, which contains an insert relative to MAST kinases. In addition, Rim15 contains a C-terminal signal receiver (REC) domain while cek1 contains an N-terminal PAS domain. Rim15 (or Rim15p) functions as a regulator of meiosis. It acts as a do |
| >cd07858 STKc_TEY_MAPK_plant Catalytic domain of the Serine/Threonine Kinases, TEY Mitogen-Activated Protein Kinases from Plants | Back alignment and domain information |
|---|
Probab=99.90 E-value=5e-24 Score=214.45 Aligned_cols=189 Identities=23% Similarity=0.242 Sum_probs=134.4
Q ss_pred ccceeeccCCCC-----CCCCCCChhhHHHHHHHHHHHHHHHhhcCCCceeecCCCccceEecCCCCceeccccceeecC
Q 045315 242 EISFWYESYNNP-----TKKGLLCWGTRVRIIEGIAQGLLYLHQYSRLRVIHRDLKASNILLDKDMNPKISDFGMARMFG 316 (476)
Q Consensus 242 ~~~l~~Ey~~~~-----~~~~~L~~~~~~~i~~qIa~gL~yLH~~~~~~ivH~DLkp~NILld~~~~~kL~DFGla~~~~ 316 (476)
..++++||+... ...+.+++..+..++.||+.||.|||+++ ++|+||||+||+++.++.+||+|||++....
T Consensus 83 ~~~lv~e~~~~~L~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~---i~H~dlkp~Nil~~~~~~~kL~Dfg~~~~~~ 159 (337)
T cd07858 83 DVYIVYELMDTDLHQIIRSSQTLSDDHCQYFLYQLLRGLKYIHSAN---VLHRDLKPSNLLLNANCDLKICDFGLARTTS 159 (337)
T ss_pred cEEEEEeCCCCCHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCC---EecCCCCHHHEEEcCCCCEEECcCccccccC
Confidence 468889998621 23467999999999999999999999998 9999999999999999999999999998654
Q ss_pred CCcccccceeeeeccCCCChhhhcc-CCCCccceEEeehhhhhhhhhCCCCCCcCCCCchhhhhhhhhhh----------
Q 045315 317 GDELQSNTKRIVGTYGYMSPEYALR-GLFSIKSDVFSFGVLLLETLSSKKNTHFYNTDSLTLLGHAWNLW---------- 385 (476)
Q Consensus 317 ~~~~~~~~~~~~gt~~y~aPE~l~~-~~~s~ksDVwSlGvvl~elltG~~p~~~~~~~~~~~~~~~~~~~---------- 385 (476)
.... ......++..|+|||.+.. ..++.++|+|||||++|+|++|+.||...+.. ..........
T Consensus 160 ~~~~--~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~--~~~~~~~~~~~~~~~~~~~~ 235 (337)
T cd07858 160 EKGD--FMTEYVVTRWYRAPELLLNCSEYTTAIDVWSVGCIFAELLGRKPLFPGKDYV--HQLKLITELLGSPSEEDLGF 235 (337)
T ss_pred CCcc--cccccccccCccChHHHhcCCCCCCcccHHHHHHHHHHHHcCCCCCCCCChH--HHHHHHHHHhCCCChHHhhh
Confidence 3221 1122457889999998865 46899999999999999999999998643211 0000000000
Q ss_pred -cCCCccccc-------CcccCCCCCHHHHHHHHHHHHHchhhcccCCCCHHHHHHH--Hhcc
Q 045315 386 -NDGRTWELM-------DPISQNGASYPILKRYINVALLCVQEKAADRPAMSEVVSM--LSNE 438 (476)
Q Consensus 386 -~~~~~~~~~-------d~~~~~~~~~~~~~~l~~li~~Cl~~dP~~RPt~~eVl~~--L~~~ 438 (476)
........+ ++... .........+.+++.+||+.+|++|||++++++. ++..
T Consensus 236 ~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~li~~~l~~~P~~Rps~~ell~h~~~~~~ 297 (337)
T cd07858 236 IRNEKARRYIRSLPYTPRQSFA-RLFPHANPLAIDLLEKMLVFDPSKRITVEEALAHPYLASL 297 (337)
T ss_pred cCchhhhHHHHhcCcccccCHH-HHcccCCHHHHHHHHHHhcCChhhccCHHHHHcCcchhhh
Confidence 000000000 00000 0011234678899999999999999999999876 5553
|
Serine/Threonine Kinases (STKs), Plant TEY Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TEY MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. In plants, MAPKs are associated with physiological, developmental, hormonal, and stress responses. Some plants show numerous gene duplications of MAPKs. Arabidopsis thaliana harbors at least 20 MAPKs, named AtMPK1-20. There are two subtypes of plant MAPKs based on the conserved phosphorylation motif present in the activati |
| >cd07845 STKc_CDK10 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 10 | Back alignment and domain information |
|---|
Probab=99.90 E-value=8.7e-24 Score=209.82 Aligned_cols=187 Identities=24% Similarity=0.264 Sum_probs=131.2
Q ss_pred cccceeeccCCC------CCCCCCCChhhHHHHHHHHHHHHHHHhhcCCCceeecCCCccceEecCCCCceeccccceee
Q 045315 241 DEISFWYESYNN------PTKKGLLCWGTRVRIIEGIAQGLLYLHQYSRLRVIHRDLKASNILLDKDMNPKISDFGMARM 314 (476)
Q Consensus 241 ~~~~l~~Ey~~~------~~~~~~L~~~~~~~i~~qIa~gL~yLH~~~~~~ivH~DLkp~NILld~~~~~kL~DFGla~~ 314 (476)
+.+++++||++. ......+++.++..++.||++||+|||+.+ ++||||||+||+++.++.+||+|||++..
T Consensus 81 ~~~~lv~e~~~~~l~~~l~~~~~~l~~~~~~~~~~qi~~~l~~lH~~~---i~H~dl~p~nil~~~~~~~kL~dfg~~~~ 157 (309)
T cd07845 81 DSIFLVMEYCEQDLASLLDNMPTPFSESQVKCLMLQLLRGLQYLHENF---IIHRDLKVSNLLLTDKGCLKIADFGLART 157 (309)
T ss_pred CeEEEEEecCCCCHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCCHHHEEECCCCCEEECccceeee
Confidence 346788888872 122467999999999999999999999999 99999999999999999999999999987
Q ss_pred cCCCcccccceeeeeccCCCChhhhcc-CCCCccceEEeehhhhhhhhhCCCCCCcCCCCchhhhhhhhhhhcC--CCcc
Q 045315 315 FGGDELQSNTKRIVGTYGYMSPEYALR-GLFSIKSDVFSFGVLLLETLSSKKNTHFYNTDSLTLLGHAWNLWND--GRTW 391 (476)
Q Consensus 315 ~~~~~~~~~~~~~~gt~~y~aPE~l~~-~~~s~ksDVwSlGvvl~elltG~~p~~~~~~~~~~~~~~~~~~~~~--~~~~ 391 (476)
....... .....++..|+|||.+.+ ..++.++|||||||++|||++|+.||..... ............. ....
T Consensus 158 ~~~~~~~--~~~~~~~~~y~aPE~~~~~~~~~~~~DvwslG~il~el~~g~~~f~~~~~--~~~~~~~~~~~~~~~~~~~ 233 (309)
T cd07845 158 YGLPAKP--MTPKVVTLWYRAPELLLGCTTYTTAIDMWAVGCILAELLAHKPLLPGKSE--IEQLDLIIQLLGTPNESIW 233 (309)
T ss_pred cCCccCC--CCcccccccccChhhhcCCCCcCchHHHHHHHHHHHHHHhCCCCCCCCCH--HHHHHHHHHhcCCCChhhc
Confidence 6543211 112345778999999875 4578999999999999999999999864331 1111111111000 0000
Q ss_pred ---------cccCcccCCCC-----CHHHHHHHHHHHHHchhhcccCCCCHHHHHHH
Q 045315 392 ---------ELMDPISQNGA-----SYPILKRYINVALLCVQEKAADRPAMSEVVSM 434 (476)
Q Consensus 392 ---------~~~d~~~~~~~-----~~~~~~~l~~li~~Cl~~dP~~RPt~~eVl~~ 434 (476)
........... .....+.+.+++.+|++.||++|||+.++++.
T Consensus 234 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~ml~~dp~~R~t~~~il~h 290 (309)
T cd07845 234 PGFSDLPLVGKFTLPKQPYNNLKHKFPWLSEAGLRLLNFLLMYDPKKRATAEEALES 290 (309)
T ss_pred hhhhcccccccccccCCCCCchHHhccccCHHHHHHHHHHhcCChhhCcCHHHHhcC
Confidence 00000000000 01124567889999999999999999998863
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein Kinase 10 (CDK10) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK10 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK10, also called PISSLRE, is essential for cell growth and proliferation, and acts through the G2/M phase of the cell cycle. CDK10 has also been identified as an important factor in endocrine therapy resistance in breast cancer. CDK10 silencing |
| >cd05623 STKc_MRCK_alpha Catalytic domain of the Protein Serine/Threonine Kinase, DMPK-related cell division control protein 42 binding kinase alpha | Back alignment and domain information |
|---|
Probab=99.90 E-value=1.4e-23 Score=210.89 Aligned_cols=179 Identities=18% Similarity=0.255 Sum_probs=127.6
Q ss_pred cccceeeccCCCCC-------CCCCCChhhHHHHHHHHHHHHHHHhhcCCCceeecCCCccceEecCCCCceecccccee
Q 045315 241 DEISFWYESYNNPT-------KKGLLCWGTRVRIIEGIAQGLLYLHQYSRLRVIHRDLKASNILLDKDMNPKISDFGMAR 313 (476)
Q Consensus 241 ~~~~l~~Ey~~~~~-------~~~~L~~~~~~~i~~qIa~gL~yLH~~~~~~ivH~DLkp~NILld~~~~~kL~DFGla~ 313 (476)
+..+++|||++.+. ....+++..+..++.||+.||+|||+.+ |+||||||+|||++.++.+||+|||++.
T Consensus 74 ~~~~lv~ey~~~g~L~~~l~~~~~~l~~~~~~~~~~qi~~al~~lH~~~---iiHrDlkp~Nili~~~~~~kL~DfG~a~ 150 (332)
T cd05623 74 NNLYLVMDYYVGGDLLTLLSKFEDRLPEDMARFYLAEMVIAIDSVHQLH---YVHRDIKPDNILMDMNGHIRLADFGSCL 150 (332)
T ss_pred CEEEEEEeccCCCcHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCC---eEecCCCHHHEEECCCCCEEEeecchhe
Confidence 45788999988332 2457899999999999999999999998 9999999999999999999999999997
Q ss_pred ecCCCcccccceeeeeccCCCChhhhc-----cCCCCccceEEeehhhhhhhhhCCCCCCcCCCCchhhhhhhhhhhcCC
Q 045315 314 MFGGDELQSNTKRIVGTYGYMSPEYAL-----RGLFSIKSDVFSFGVLLLETLSSKKNTHFYNTDSLTLLGHAWNLWNDG 388 (476)
Q Consensus 314 ~~~~~~~~~~~~~~~gt~~y~aPE~l~-----~~~~s~ksDVwSlGvvl~elltG~~p~~~~~~~~~~~~~~~~~~~~~~ 388 (476)
........ ......||+.|+|||++. ...++.++|||||||++|||++|+.||..... .... .......
T Consensus 151 ~~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DvwSlGvil~ell~g~~Pf~~~~~--~~~~---~~i~~~~ 224 (332)
T cd05623 151 KLMEDGTV-QSSVAVGTPDYISPEILQAMEDGKGKYGPECDWWSLGVCMYEMLYGETPFYAESL--VETY---GKIMNHK 224 (332)
T ss_pred ecccCCcc-eecccccCccccCHHHHhccccCCCCCCCcCCEEeeHHHHHHHhcCCCCCCCCCH--HHHH---HHHhCCC
Confidence 65432211 122346899999999986 34678999999999999999999999864321 1111 1111111
Q ss_pred CcccccCcccCCCCCHHHHHHHHHHHHHchhhcc--cCCCCHHHHHHH
Q 045315 389 RTWELMDPISQNGASYPILKRYINVALLCVQEKA--ADRPAMSEVVSM 434 (476)
Q Consensus 389 ~~~~~~d~~~~~~~~~~~~~~l~~li~~Cl~~dP--~~RPt~~eVl~~ 434 (476)
..... + .........+.+++.+|+..++ ..|++++|+++.
T Consensus 225 ~~~~~--p----~~~~~~s~~~~~li~~ll~~~~~r~~r~~~~~~~~h 266 (332)
T cd05623 225 ERFQF--P----AQVTDVSEDAKDLIRRLICSREHRLGQNGIEDFKQH 266 (332)
T ss_pred ccccC--C----CccccCCHHHHHHHHHHccChhhhcCCCCHHHHhCC
Confidence 10000 0 0111234567778888775544 446889888765
|
Serine/Threonine Kinases (STKs), DMPK-like subfamily, DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK) alpha isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKalpha is expressed ubiquitously in many tissues. It plays a role in the regulation of peripheral actin reorganization and neurite outgrowth. It may also play a role in the transferrin iron uptake pathw |
| >PHA03210 serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Probab=99.90 E-value=6.2e-24 Score=224.89 Aligned_cols=171 Identities=22% Similarity=0.259 Sum_probs=118.3
Q ss_pred CChhhHHHHHHHHHHHHHHHhhcCCCceeecCCCccceEecCCCCceeccccceeecCCCcccccceeeeeccCCCChhh
Q 045315 259 LCWGTRVRIIEGIAQGLLYLHQYSRLRVIHRDLKASNILLDKDMNPKISDFGMARMFGGDELQSNTKRIVGTYGYMSPEY 338 (476)
Q Consensus 259 L~~~~~~~i~~qIa~gL~yLH~~~~~~ivH~DLkp~NILld~~~~~kL~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~ 338 (476)
....++..++.||+.||+|||+++ |+||||||+|||++.++.+||+|||+++.+...... ......|+..|+|||+
T Consensus 264 ~~~~~~~~i~~ql~~aL~yLH~~g---IiHrDLKP~NILl~~~~~vkL~DFGla~~~~~~~~~-~~~~~~gt~~y~aPE~ 339 (501)
T PHA03210 264 PLLKQTRAIMKQLLCAVEYIHDKK---LIHRDIKLENIFLNCDGKIVLGDFGTAMPFEKEREA-FDYGWVGTVATNSPEI 339 (501)
T ss_pred ccHHHHHHHHHHHHHHHHHHHhCC---eecCCCCHHHEEECCCCCEEEEeCCCceecCccccc-ccccccCCcCCCCchh
Confidence 446678889999999999999998 999999999999999999999999999876543221 1223568999999999
Q ss_pred hccCCCCccceEEeehhhhhhhhhCCCCCCcCC-CCc-hhhhhhhhhhhc--CCCc-------ccccCcc-c--CCCC--
Q 045315 339 ALRGLFSIKSDVFSFGVLLLETLSSKKNTHFYN-TDS-LTLLGHAWNLWN--DGRT-------WELMDPI-S--QNGA-- 402 (476)
Q Consensus 339 l~~~~~s~ksDVwSlGvvl~elltG~~p~~~~~-~~~-~~~~~~~~~~~~--~~~~-------~~~~d~~-~--~~~~-- 402 (476)
+.+..++.++|||||||++|||++|+.++.... ... ..+.... .... .... .+.++.. . ....
T Consensus 340 ~~~~~~~~~~DiwSlGvil~ell~~~~~p~~~~~~~~~~~~~~~~-~~~~~~~~~~p~~~~~~~~~i~~~~~~~~~~~~~ 418 (501)
T PHA03210 340 LAGDGYCEITDIWSCGLILLDMLSHDFCPIGDGGGKPGKQLLKII-DSLSVCDEEFPDPPCKLFDYIDSAEIDHAGHSVP 418 (501)
T ss_pred hcCCCCCcHHHHHHHHHHHHHHHHCCCCCccCCCCCHHHHHHHHH-HhcccChhhcCCcHHHHHHHhhhhhcccCccchh
Confidence 999999999999999999999999875433221 111 1111111 0000 0000 0000000 0 0000
Q ss_pred ----CHHHHHHHHHHHHHchhhcccCCCCHHHHHHH
Q 045315 403 ----SYPILKRYINVALLCVQEKAADRPAMSEVVSM 434 (476)
Q Consensus 403 ----~~~~~~~l~~li~~Cl~~dP~~RPt~~eVl~~ 434 (476)
.......+.+++.+||+.||++|||+.|+++.
T Consensus 419 ~~~~~~~~~~~~~~li~kmL~~DP~~Rpsa~elL~h 454 (501)
T PHA03210 419 PLIRNLGLPADFEYPLVKMLTFDWHLRPGAAELLAL 454 (501)
T ss_pred hHHHhcCCChHHHHHHHHHhccCcccCcCHHHHhhC
Confidence 00112356778899999999999999999863
|
|
| >cd05606 STKc_beta_ARK Catalytic domain of the Protein Serine/Threonine Kinase, beta-adrenergic receptor kinase | Back alignment and domain information |
|---|
Probab=99.90 E-value=8.8e-24 Score=206.74 Aligned_cols=173 Identities=27% Similarity=0.338 Sum_probs=131.1
Q ss_pred cccceeeccCCCC------CCCCCCChhhHHHHHHHHHHHHHHHhhcCCCceeecCCCccceEecCCCCceeccccceee
Q 045315 241 DEISFWYESYNNP------TKKGLLCWGTRVRIIEGIAQGLLYLHQYSRLRVIHRDLKASNILLDKDMNPKISDFGMARM 314 (476)
Q Consensus 241 ~~~~l~~Ey~~~~------~~~~~L~~~~~~~i~~qIa~gL~yLH~~~~~~ivH~DLkp~NILld~~~~~kL~DFGla~~ 314 (476)
+..++++||++.. .+.+.+++.++..++.|++.||+|||+.+ ++||||||+||+++.++.+||+|||++..
T Consensus 70 ~~~~~v~e~~~g~~L~~~l~~~~~l~~~~~~~~~~ql~~~l~~lH~~~---i~H~di~p~nili~~~~~~kl~dfg~~~~ 146 (278)
T cd05606 70 DKLSFILDLMNGGDLHYHLSQHGVFSEAEMRFYAAEIILGLEHMHNRF---VVYRDLKPANILLDEHGHVRISDLGLACD 146 (278)
T ss_pred CEEEEEEecCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCC---EEcCCCCHHHEEECCCCCEEEccCcCccc
Confidence 3466788998733 23457999999999999999999999998 99999999999999999999999999876
Q ss_pred cCCCcccccceeeeeccCCCChhhhccC-CCCccceEEeehhhhhhhhhCCCCCCcCCCCchhhhhhhhhhhcCCCcccc
Q 045315 315 FGGDELQSNTKRIVGTYGYMSPEYALRG-LFSIKSDVFSFGVLLLETLSSKKNTHFYNTDSLTLLGHAWNLWNDGRTWEL 393 (476)
Q Consensus 315 ~~~~~~~~~~~~~~gt~~y~aPE~l~~~-~~s~ksDVwSlGvvl~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~ 393 (476)
+.... .....|+..|+|||.+.++ .++.++||||+||++|||++|+.||............ .....
T Consensus 147 ~~~~~----~~~~~~~~~y~aPE~~~~~~~~~~~~Di~s~G~~l~~l~~g~~p~~~~~~~~~~~~~---~~~~~------ 213 (278)
T cd05606 147 FSKKK----PHASVGTHGYMAPEVLQKGVAYDSSADWFSLGCMLFKLLRGHSPFRQHKTKDKHEID---RMTLT------ 213 (278)
T ss_pred cCccC----CcCcCCCcCCcCcHHhcCCCCCCcccchHhHHHHHHHHHhCCCCCCCCCccchHHHH---HHhhc------
Confidence 54322 1224688999999998754 6899999999999999999999998654321111110 00000
Q ss_pred cCcccCCCCCHHHHHHHHHHHHHchhhcccCCC-----CHHHHHH
Q 045315 394 MDPISQNGASYPILKRYINVALLCVQEKAADRP-----AMSEVVS 433 (476)
Q Consensus 394 ~d~~~~~~~~~~~~~~l~~li~~Cl~~dP~~RP-----t~~eVl~ 433 (476)
.... .+......+.+++.+|++.+|++|| ++.++++
T Consensus 214 ~~~~----~~~~~s~~~~~li~~~l~~~p~~R~~~~~~~~~~ll~ 254 (278)
T cd05606 214 MAVE----LPDSFSPELRSLLEGLLQRDVNRRLGCLGRGAQEVKE 254 (278)
T ss_pred cCCC----CCCcCCHHHHHHHHHHhhcCHHhccCCCCCCHHHHHh
Confidence 0011 1112245788999999999999999 9999875
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, beta-adrenergic receptor kinase (beta-ARK) group, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. The beta-ARK group is co |
| >cd07860 STKc_CDK2_3 Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase 2 and 3 | Back alignment and domain information |
|---|
Probab=99.90 E-value=4.2e-24 Score=209.04 Aligned_cols=185 Identities=19% Similarity=0.209 Sum_probs=129.7
Q ss_pred cccceeeccCCC-------CCCCCCCChhhHHHHHHHHHHHHHHHhhcCCCceeecCCCccceEecCCCCceecccccee
Q 045315 241 DEISFWYESYNN-------PTKKGLLCWGTRVRIIEGIAQGLLYLHQYSRLRVIHRDLKASNILLDKDMNPKISDFGMAR 313 (476)
Q Consensus 241 ~~~~l~~Ey~~~-------~~~~~~L~~~~~~~i~~qIa~gL~yLH~~~~~~ivH~DLkp~NILld~~~~~kL~DFGla~ 313 (476)
+..++++||++. ...+..+++..+..++.|++.||+|||+.+ ++|+||+|+||+++.++.+||+|||++.
T Consensus 72 ~~~~~v~e~~~~~l~~~~~~~~~~~l~~~~~~~~~~~i~~~l~~lh~~~---i~H~~l~p~nill~~~~~~~l~dfg~~~ 148 (284)
T cd07860 72 NKLYLVFEFLHQDLKKFMDASPLSGIPLPLIKSYLFQLLQGLAFCHSHR---VLHRDLKPQNLLINTEGAIKLADFGLAR 148 (284)
T ss_pred CcEEEEeeccccCHHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCCHHHEEECCCCCEEEeeccchh
Confidence 456788898862 123467899999999999999999999998 9999999999999999999999999987
Q ss_pred ecCCCcccccceeeeeccCCCChhhhccCC-CCccceEEeehhhhhhhhhCCCCCCcCCCCchhhhhhhhhhhcCC----
Q 045315 314 MFGGDELQSNTKRIVGTYGYMSPEYALRGL-FSIKSDVFSFGVLLLETLSSKKNTHFYNTDSLTLLGHAWNLWNDG---- 388 (476)
Q Consensus 314 ~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~-~s~ksDVwSlGvvl~elltG~~p~~~~~~~~~~~~~~~~~~~~~~---- 388 (476)
........ .....++..|+|||.+.+.. ++.++||||||+++|||++|+.||....... ...... ......
T Consensus 149 ~~~~~~~~--~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~~l~tg~~p~~~~~~~~-~~~~~~-~~~~~~~~~~ 224 (284)
T cd07860 149 AFGVPVRT--YTHEVVTLWYRAPEILLGCKYYSTAVDIWSLGCIFAEMVTRRALFPGDSEID-QLFRIF-RTLGTPDEVV 224 (284)
T ss_pred hcccCccc--cccccccccccCCeEEecCCCCCcHHHHHHHHHHHHHHHHCCCCCCCCCHHH-HHHHHH-HHhCCCChhh
Confidence 65432211 12234678899999887644 6889999999999999999999986543211 111100 000000
Q ss_pred ------------CcccccCcccCCCCCHHHHHHHHHHHHHchhhcccCCCCHHHHHH
Q 045315 389 ------------RTWELMDPISQNGASYPILKRYINVALLCVQEKAADRPAMSEVVS 433 (476)
Q Consensus 389 ------------~~~~~~d~~~~~~~~~~~~~~l~~li~~Cl~~dP~~RPt~~eVl~ 433 (476)
........... .........+.+++.+||+.||++||+++++++
T Consensus 225 ~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~~l~ 280 (284)
T cd07860 225 WPGVTSLPDYKPSFPKWARQDFS-KVVPPLDEDGRDLLSQMLHYDPNKRISAKAALA 280 (284)
T ss_pred hhhhhHHHHHHhhcccccccCHH-HHcccCCHHHHHHHHHhcCCCcccCCCHHHHhc
Confidence 00000000000 000112346778999999999999999999874
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 2 (CDK2) and CDK3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK2/3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK2 is regulated by cyclin E or cyclin A. Upon activation by cyclin E, it phosphorylates the retinoblastoma (pRb) protein which activates E2F mediated transcription and allows cells to move into S phase. The CDK2/cyclin A complex |
| >cd08216 PK_STRAD Pseudokinase domain of STE20-related kinase adapter protein | Back alignment and domain information |
|---|
Probab=99.90 E-value=1.8e-23 Score=207.78 Aligned_cols=190 Identities=20% Similarity=0.217 Sum_probs=132.5
Q ss_pred cccceeeccCCCC--------CCCCCCChhhHHHHHHHHHHHHHHHhhcCCCceeecCCCccceEecCCCCceeccccce
Q 045315 241 DEISFWYESYNNP--------TKKGLLCWGTRVRIIEGIAQGLLYLHQYSRLRVIHRDLKASNILLDKDMNPKISDFGMA 312 (476)
Q Consensus 241 ~~~~l~~Ey~~~~--------~~~~~L~~~~~~~i~~qIa~gL~yLH~~~~~~ivH~DLkp~NILld~~~~~kL~DFGla 312 (476)
+.+++++||++.. .....+++..+..++.|+++||+|||+++ |+||||||+||+++.++.+||+|||.+
T Consensus 72 ~~~~~~~e~~~~~~l~~~l~~~~~~~~~~~~~~~~~~~l~~~L~~LH~~~---ivH~dlk~~Nili~~~~~~kl~d~~~~ 148 (314)
T cd08216 72 SELYVVSPLMAYGSCEDLLKTHFPEGLPELAIAFILKDVLNALDYIHSKG---FIHRSVKASHILLSGDGKVVLSGLRYS 148 (314)
T ss_pred CeEEEEEeccCCCCHHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCCcceEEEecCCceEEecCccc
Confidence 4678889999832 22356899999999999999999999998 999999999999999999999999988
Q ss_pred eecCCCcc-----cccceeeeeccCCCChhhhcc--CCCCccceEEeehhhhhhhhhCCCCCCcCCCCchhhhhhhhh--
Q 045315 313 RMFGGDEL-----QSNTKRIVGTYGYMSPEYALR--GLFSIKSDVFSFGVLLLETLSSKKNTHFYNTDSLTLLGHAWN-- 383 (476)
Q Consensus 313 ~~~~~~~~-----~~~~~~~~gt~~y~aPE~l~~--~~~s~ksDVwSlGvvl~elltG~~p~~~~~~~~~~~~~~~~~-- 383 (476)
........ ........++..|+|||.+.. ..++.++|+|||||+++||++|+.||........ .......
T Consensus 149 ~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~Diws~G~il~el~~g~~pf~~~~~~~~-~~~~~~~~~ 227 (314)
T cd08216 149 VSMIKHGKRQRVVHDFPKSSVKNLPWLSPEVLQQNLQGYNEKSDIYSVGITACELANGHVPFKDMPATQM-LLEKVRGTV 227 (314)
T ss_pred eeeccccccccccccccccccccccccCHHHhcCCCCCCCcchhHHHHHHHHHHHHhCCCCCCCCCHHHH-HHHHHhccC
Confidence 75532211 111122456778999999875 3588999999999999999999999864331111 1110000
Q ss_pred --hhcC-------CCccc----ccCcc----cCCCCCHHHHHHHHHHHHHchhhcccCCCCHHHHHHH
Q 045315 384 --LWND-------GRTWE----LMDPI----SQNGASYPILKRYINVALLCVQEKAADRPAMSEVVSM 434 (476)
Q Consensus 384 --~~~~-------~~~~~----~~d~~----~~~~~~~~~~~~l~~li~~Cl~~dP~~RPt~~eVl~~ 434 (476)
.... ..... ..++. ............+.+++.+||+.||++|||++++++.
T Consensus 228 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~ll~~ 295 (314)
T cd08216 228 PCLLDKSTYPLYEDSMSQSRSSNEHPNNRDSVDHPYTRTFSEHFHQFVELCLQRDPESRPSASQLLNH 295 (314)
T ss_pred ccccccCchhhhcCCcCcccccccccchhhhhhcchhhHHHHHHHHHHHHHhhcCCCcCcCHHHHhcC
Confidence 0000 00000 00000 0011122334678899999999999999999998863
|
Protein Kinase family, STE20-related kinase adapter protein (STRAD) subfamily, pseudokinase domain. The STRAD subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hyperpigmentation of the buc |
| >cd06624 STKc_ASK Catalytic domain of the Protein Serine/Threonine Kinase, Apoptosis signal-regulating kinase | Back alignment and domain information |
|---|
Probab=99.90 E-value=9.6e-24 Score=204.84 Aligned_cols=174 Identities=24% Similarity=0.365 Sum_probs=126.9
Q ss_pred ccceeeccCCCCC-------CCCCC--ChhhHHHHHHHHHHHHHHHhhcCCCceeecCCCccceEecC-CCCceeccccc
Q 045315 242 EISFWYESYNNPT-------KKGLL--CWGTRVRIIEGIAQGLLYLHQYSRLRVIHRDLKASNILLDK-DMNPKISDFGM 311 (476)
Q Consensus 242 ~~~l~~Ey~~~~~-------~~~~L--~~~~~~~i~~qIa~gL~yLH~~~~~~ivH~DLkp~NILld~-~~~~kL~DFGl 311 (476)
..++++||++... +..++ ++..+..++.||+.||+|||+.+ |+||||||+||+++. ++.+||+|||+
T Consensus 79 ~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~---i~h~dl~p~nil~~~~~~~~~l~dfg~ 155 (268)
T cd06624 79 FFKIFMEQVPGGSLSALLRSKWGPLKDNEQTIIFYTKQILEGLKYLHDNQ---IVHRDIKGDNVLVNTYSGVVKISDFGT 155 (268)
T ss_pred EEEEEEecCCCCCHHHHHHHhcccCCCcHHHHHHHHHHHHHHHHHHHHCC---EeecCCCHHHEEEcCCCCeEEEecchh
Confidence 4667888887321 22345 78888999999999999999998 999999999999986 67899999999
Q ss_pred eeecCCCcccccceeeeeccCCCChhhhccCC--CCccceEEeehhhhhhhhhCCCCCCcCCCCchhhhhhhhhhhcCCC
Q 045315 312 ARMFGGDELQSNTKRIVGTYGYMSPEYALRGL--FSIKSDVFSFGVLLLETLSSKKNTHFYNTDSLTLLGHAWNLWNDGR 389 (476)
Q Consensus 312 a~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~--~s~ksDVwSlGvvl~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~ 389 (476)
+......... .....++..|+|||++.... ++.++|+||||+++|+|++|+.|+............ ...
T Consensus 156 ~~~~~~~~~~--~~~~~~~~~~~aPE~~~~~~~~~~~~~Dv~slGvvl~~l~~g~~p~~~~~~~~~~~~~-------~~~ 226 (268)
T cd06624 156 SKRLAGINPC--TETFTGTLQYMAPEVIDKGPRGYGAPADIWSLGCTIVEMATGKPPFIELGEPQAAMFK-------VGM 226 (268)
T ss_pred heecccCCCc--cccCCCCccccChhhhccccccCCchhhhHHHHHHHHHHHhCCCCCccccChhhhHhh-------hhh
Confidence 9765432221 12235788999999986543 789999999999999999999998643211111100 000
Q ss_pred cccccCcccCCCCCHHHHHHHHHHHHHchhhcccCCCCHHHHHH
Q 045315 390 TWELMDPISQNGASYPILKRYINVALLCVQEKAADRPAMSEVVS 433 (476)
Q Consensus 390 ~~~~~d~~~~~~~~~~~~~~l~~li~~Cl~~dP~~RPt~~eVl~ 433 (476)
. ......+......+.+++.+||+.+|++||++.|+++
T Consensus 227 ~------~~~~~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~ll~ 264 (268)
T cd06624 227 F------KIHPEIPESLSAEAKNFILRCFEPDPDKRASAHDLLQ 264 (268)
T ss_pred h------ccCCCCCcccCHHHHHHHHHHcCCCchhCCCHHHHHh
Confidence 0 0001112223456889999999999999999999875
|
Serine/threonine kinases (STKs), Apoptosis signal-regulating kinase (ASK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ASK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Subfamily members are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks) and include ASK1, ASK2, and MAPKKK15. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. ASK1 (also called MAPKKK5) functions in the c-Jun N-terminal kina |
| >cd07835 STKc_CDK1_like Catalytic domain of Cyclin-Dependent protein Kinase 1-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=99.89 E-value=6.8e-24 Score=207.43 Aligned_cols=187 Identities=20% Similarity=0.224 Sum_probs=129.7
Q ss_pred cccceeeccCCC-------CCCCCCCChhhHHHHHHHHHHHHHHHhhcCCCceeecCCCccceEecCCCCceecccccee
Q 045315 241 DEISFWYESYNN-------PTKKGLLCWGTRVRIIEGIAQGLLYLHQYSRLRVIHRDLKASNILLDKDMNPKISDFGMAR 313 (476)
Q Consensus 241 ~~~~l~~Ey~~~-------~~~~~~L~~~~~~~i~~qIa~gL~yLH~~~~~~ivH~DLkp~NILld~~~~~kL~DFGla~ 313 (476)
+..++++||++. ......+++.++++++.|+++||+|||+.+ ++|+||+|+||+++.++.++|+|||++.
T Consensus 71 ~~~~iv~e~~~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~~L~~lH~~~---~~H~dl~p~nil~~~~~~~~l~df~~~~ 147 (283)
T cd07835 71 NKLYLVFEFLDLDLKKYMDSSPLTGLDPPLIKSYLYQLLQGIAYCHSHR---VLHRDLKPQNLLIDREGALKLADFGLAR 147 (283)
T ss_pred CeEEEEEeccCcCHHHHHhhCCCCCCCHHHHHHHHHHHHHHHHHHHHCC---eeCCCCCHHHEEEcCCCcEEEeeccccc
Confidence 457788888861 122246999999999999999999999998 9999999999999999999999999997
Q ss_pred ecCCCcccccceeeeeccCCCChhhhccC-CCCccceEEeehhhhhhhhhCCCCCCcCCCCchhhhhhhhhhhcCC-C--
Q 045315 314 MFGGDELQSNTKRIVGTYGYMSPEYALRG-LFSIKSDVFSFGVLLLETLSSKKNTHFYNTDSLTLLGHAWNLWNDG-R-- 389 (476)
Q Consensus 314 ~~~~~~~~~~~~~~~gt~~y~aPE~l~~~-~~s~ksDVwSlGvvl~elltG~~p~~~~~~~~~~~~~~~~~~~~~~-~-- 389 (476)
........ .....++..|+|||++.+. .++.++|+||||+++|+|++|+.||....... .+........... .
T Consensus 148 ~~~~~~~~--~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~-~~~~~~~~~~~~~~~~~ 224 (283)
T cd07835 148 AFGVPVRT--YTHEVVTLWYRAPEILLGSRQYSTPVDIWSIGCIFAEMVNRRPLFPGDSEID-QLFRIFRTLGTPDEDVW 224 (283)
T ss_pred ccCCCccc--cCccccccCCCCCceeecCcccCcHHHHHHHHHHHHHHHhCCCCCCCCCHHH-HHHHHHHHhCCCChHHh
Confidence 65432111 1123467899999987654 57899999999999999999999986433111 1111000000000 0
Q ss_pred --cc---cc---cC---cccCCCCCHHHHHHHHHHHHHchhhcccCCCCHHHHHH
Q 045315 390 --TW---EL---MD---PISQNGASYPILKRYINVALLCVQEKAADRPAMSEVVS 433 (476)
Q Consensus 390 --~~---~~---~d---~~~~~~~~~~~~~~l~~li~~Cl~~dP~~RPt~~eVl~ 433 (476)
.. +. .. ..............+.+++.+|++.+|++||+++|+++
T Consensus 225 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~il~ 279 (283)
T cd07835 225 PGVTSLPDYKPTFPKWARQDLSKVVPNLDEDGLDLLSKMLVYDPAKRISAKAALQ 279 (283)
T ss_pred hhhhhchhhhhhcccccccchhhhcCCCCHHHHHHHHHHhcCChhhCcCHHHHhc
Confidence 00 00 00 00000111122357889999999999999999999875
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 1 (CDK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK1 from higher eukaryotes, plants, and yeasts, as well as CDK2 and CDK3. CDK1 is also called Cell division control protein 2 (Cdc2) or p34 protein kinase, and is regulated by cyclins A, B, and E. The CDK1/cyc |
| >cd05107 PTKc_PDGFR_beta Catalytic domain of the Protein Tyrosine Kinase, Platelet Derived Growth Factor Receptor beta | Back alignment and domain information |
|---|
Probab=99.89 E-value=5.7e-24 Score=218.82 Aligned_cols=168 Identities=25% Similarity=0.352 Sum_probs=128.3
Q ss_pred CCCCCChhhHHHHHHHHHHHHHHHhhcCCCceeecCCCccceEecCCCCceeccccceeecCCCcccccceeeeeccCCC
Q 045315 255 KKGLLCWGTRVRIIEGIAQGLLYLHQYSRLRVIHRDLKASNILLDKDMNPKISDFGMARMFGGDELQSNTKRIVGTYGYM 334 (476)
Q Consensus 255 ~~~~L~~~~~~~i~~qIa~gL~yLH~~~~~~ivH~DLkp~NILld~~~~~kL~DFGla~~~~~~~~~~~~~~~~gt~~y~ 334 (476)
....+++..+.+++.||+.||+|||+.+ ++||||||+|||+++++.+||+|||+++...............++..|+
T Consensus 232 ~~~~l~~~~~~~~~~qi~~aL~~LH~~~---ivHrdlkp~NiLl~~~~~~kL~DfGla~~~~~~~~~~~~~~~~~~~~y~ 308 (401)
T cd05107 232 ESPALSYMDLVGFSYQVANGMEFLASKN---CVHRDLAARNVLICEGKLVKICDFGLARDIMRDSNYISKGSTFLPLKWM 308 (401)
T ss_pred CCCCCCHHHHHHHHHHHHHHHHHHhcCC---cCcccCCcceEEEeCCCEEEEEecCcceecccccccccCCCcCCCCcee
Confidence 3457999999999999999999999988 9999999999999999999999999998654322111122234678899
Q ss_pred ChhhhccCCCCccceEEeehhhhhhhhh-CCCCCCcCCCCchhhhhhhhhhhcCCCcccccCcccCCCCCHHHHHHHHHH
Q 045315 335 SPEYALRGLFSIKSDVFSFGVLLLETLS-SKKNTHFYNTDSLTLLGHAWNLWNDGRTWELMDPISQNGASYPILKRYINV 413 (476)
Q Consensus 335 aPE~l~~~~~s~ksDVwSlGvvl~ellt-G~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~l~~l 413 (476)
|||.+.+..++.++|||||||++|||++ |+.|+........ .. .....+... ..+......+.++
T Consensus 309 aPE~~~~~~~~~~~DvwslGvil~e~l~~g~~P~~~~~~~~~-~~----~~~~~~~~~---------~~p~~~~~~l~~l 374 (401)
T cd05107 309 APESIFNNLYTTLSDVWSFGILLWEIFTLGGTPYPELPMNEQ-FY----NAIKRGYRM---------AKPAHASDEIYEI 374 (401)
T ss_pred ChHHhcCCCCCcHhHHHHHHHHHHHHHHcCCCCCCCCCchHH-HH----HHHHcCCCC---------CCCCCCCHHHHHH
Confidence 9999998889999999999999999998 8888754321111 11 111111100 0111224578899
Q ss_pred HHHchhhcccCCCCHHHHHHHHhccc
Q 045315 414 ALLCVQEKAADRPAMSEVVSMLSNEF 439 (476)
Q Consensus 414 i~~Cl~~dP~~RPt~~eVl~~L~~~~ 439 (476)
+.+||+.+|++||++++|++.|+.+.
T Consensus 375 i~~cl~~~P~~RPs~~ell~~L~~~~ 400 (401)
T cd05107 375 MQKCWEEKFEIRPDFSQLVHLVGDLL 400 (401)
T ss_pred HHHHcCCChhHCcCHHHHHHHHHHHh
Confidence 99999999999999999999998764
|
Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) beta; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR beta is a receptor tyr kinase (RTK) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding to its ligands, the PDGFs, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR beta forms homodimers or heterodimers with PDGFR alpha, depending on the nature of the PDGF ligand. PDGF-BB and PDGF-D |
| >cd07838 STKc_CDK4_6_like Catalytic domain of Cyclin-Dependent protein Kinase 4 and 6-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=99.89 E-value=1.8e-23 Score=204.43 Aligned_cols=183 Identities=20% Similarity=0.283 Sum_probs=130.0
Q ss_pred cceeeccCCC-------CCCCCCCChhhHHHHHHHHHHHHHHHhhcCCCceeecCCCccceEecCCCCceeccccceeec
Q 045315 243 ISFWYESYNN-------PTKKGLLCWGTRVRIIEGIAQGLLYLHQYSRLRVIHRDLKASNILLDKDMNPKISDFGMARMF 315 (476)
Q Consensus 243 ~~l~~Ey~~~-------~~~~~~L~~~~~~~i~~qIa~gL~yLH~~~~~~ivH~DLkp~NILld~~~~~kL~DFGla~~~ 315 (476)
.++++||++. ......+++.++..++.||++||+|||+.+ ++|+||+|+||+++.++.+||+|||++...
T Consensus 81 ~~l~~e~~~~~l~~~l~~~~~~~l~~~~~~~~~~~i~~al~~LH~~~---i~h~~l~~~nili~~~~~~~l~dfg~~~~~ 157 (287)
T cd07838 81 LTLVFEHVDQDLATYLSKCPKPGLPPETIKDLMRQLLRGVDFLHSHR---IVHRDLKPQNILVTSDGQVKIADFGLARIY 157 (287)
T ss_pred eEEEehhcccCHHHHHHHccCCCCCHHHHHHHHHHHHHHHHHHHHCC---eeeccCChhhEEEccCCCEEEeccCcceec
Confidence 5566777652 112236899999999999999999999998 999999999999999999999999999876
Q ss_pred CCCcccccceeeeeccCCCChhhhccCCCCccceEEeehhhhhhhhhCCCCCCcCCCCchhhhhhhhhhhcC--------
Q 045315 316 GGDELQSNTKRIVGTYGYMSPEYALRGLFSIKSDVFSFGVLLLETLSSKKNTHFYNTDSLTLLGHAWNLWND-------- 387 (476)
Q Consensus 316 ~~~~~~~~~~~~~gt~~y~aPE~l~~~~~s~ksDVwSlGvvl~elltG~~p~~~~~~~~~~~~~~~~~~~~~-------- 387 (476)
...... ....++..|+|||.+.+..++.++|+|||||++|||++|++||....... .. .........
T Consensus 158 ~~~~~~---~~~~~~~~~~~PE~~~~~~~~~~~Di~s~G~~l~~l~~~~~~~~~~~~~~-~~-~~~~~~~~~~~~~~~~~ 232 (287)
T cd07838 158 SFEMAL---TSVVVTLWYRAPEVLLQSSYATPVDMWSVGCIFAELFRRRPLFRGTSEAD-QL-DKIFDVIGLPSEEEWPR 232 (287)
T ss_pred cCCccc---ccccccccccChHHhccCCCCCcchhhhHHHHHHHHHhCCCcccCCChHH-HH-HHHHHHcCCCChHhcCC
Confidence 433211 12347889999999998889999999999999999999998876433111 11 101000000
Q ss_pred CCc--ccccCcccC---CCCCHHHHHHHHHHHHHchhhcccCCCCHHHHHH
Q 045315 388 GRT--WELMDPISQ---NGASYPILKRYINVALLCVQEKAADRPAMSEVVS 433 (476)
Q Consensus 388 ~~~--~~~~d~~~~---~~~~~~~~~~l~~li~~Cl~~dP~~RPt~~eVl~ 433 (476)
... ......... ..........+.+++.+||+.||.+||++.++++
T Consensus 233 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rp~~~~il~ 283 (287)
T cd07838 233 NVSLPRSSFPSYTPRSFKSFVPEICEEGLDLLKKMLTFNPHKRISAFEALQ 283 (287)
T ss_pred CcccchhhcccccccchhhhhhhhhHHHHHHHHHHhccCCccCCCHHHHhc
Confidence 000 000000000 0111223467789999999999999999999874
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 4 (CDK4) and CDK6-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK4/6-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK4 and CDK6 partner with D-type cyclins to regulate the early G1 phase of the cell cycle. They are the first kinase activated by mitogenic signals to release cells from the G0 arrested state. CDK4 and CDK6 are both |
| >cd05624 STKc_MRCK_beta Catalytic domain of the Protein Serine/Threonine Kinase, DMPK-related cell division control protein 42 binding kinase beta | Back alignment and domain information |
|---|
Probab=99.89 E-value=1.8e-23 Score=210.05 Aligned_cols=179 Identities=18% Similarity=0.233 Sum_probs=128.8
Q ss_pred cccceeeccCCCCC-------CCCCCChhhHHHHHHHHHHHHHHHhhcCCCceeecCCCccceEecCCCCceecccccee
Q 045315 241 DEISFWYESYNNPT-------KKGLLCWGTRVRIIEGIAQGLLYLHQYSRLRVIHRDLKASNILLDKDMNPKISDFGMAR 313 (476)
Q Consensus 241 ~~~~l~~Ey~~~~~-------~~~~L~~~~~~~i~~qIa~gL~yLH~~~~~~ivH~DLkp~NILld~~~~~kL~DFGla~ 313 (476)
+..+++|||++.+. ....+++..+..++.||+.||+|||+++ |+||||||+|||++.++.+||+|||++.
T Consensus 74 ~~~~lv~Ey~~gg~L~~~l~~~~~~l~~~~~~~~~~qi~~~L~~lH~~~---iiHrDlkp~Nill~~~~~~kl~DfG~a~ 150 (331)
T cd05624 74 NYLYLVMDYYVGGDLLTLLSKFEDRLPEDMARFYIAEMVLAIHSIHQLH---YVHRDIKPDNVLLDMNGHIRLADFGSCL 150 (331)
T ss_pred CEEEEEEeCCCCCcHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCC---eeeccCchHHEEEcCCCCEEEEecccee
Confidence 45789999998431 2457899999999999999999999999 9999999999999999999999999998
Q ss_pred ecCCCcccccceeeeeccCCCChhhhcc-----CCCCccceEEeehhhhhhhhhCCCCCCcCCCCchhhhhhhhhhhcCC
Q 045315 314 MFGGDELQSNTKRIVGTYGYMSPEYALR-----GLFSIKSDVFSFGVLLLETLSSKKNTHFYNTDSLTLLGHAWNLWNDG 388 (476)
Q Consensus 314 ~~~~~~~~~~~~~~~gt~~y~aPE~l~~-----~~~s~ksDVwSlGvvl~elltG~~p~~~~~~~~~~~~~~~~~~~~~~ 388 (476)
........ ......|++.|+|||++.+ +.++.++|+|||||++|||++|+.||...... ... .......
T Consensus 151 ~~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DiwSlGvil~ell~g~~Pf~~~~~~--~~~---~~i~~~~ 224 (331)
T cd05624 151 KMNQDGTV-QSSVAVGTPDYISPEILQAMEDGMGKYGPECDWWSLGVCMYEMLYGETPFYAESLV--ETY---GKIMNHE 224 (331)
T ss_pred eccCCCce-eeccccCCcccCCHHHHhccccCCCCCCCcccEEeeehhhhhhhhCCCCccCCCHH--HHH---HHHHcCC
Confidence 76543221 1223468999999999875 56789999999999999999999998643311 111 1111111
Q ss_pred CcccccCcccCCCCCHHHHHHHHHHHHHchhhcccC--CCCHHHHHHH
Q 045315 389 RTWELMDPISQNGASYPILKRYINVALLCVQEKAAD--RPAMSEVVSM 434 (476)
Q Consensus 389 ~~~~~~d~~~~~~~~~~~~~~l~~li~~Cl~~dP~~--RPt~~eVl~~ 434 (476)
..... . .......+.+.+++.+|+..++++ |++++++++.
T Consensus 225 ~~~~~-p-----~~~~~~~~~~~~li~~ll~~~~~~~~~~~~~~~~~h 266 (331)
T cd05624 225 ERFQF-P-----SHITDVSEEAKDLIQRLICSRERRLGQNGIEDFKKH 266 (331)
T ss_pred CcccC-C-----CccccCCHHHHHHHHHHccCchhhcCCCCHHHHhcC
Confidence 10000 0 001123456788888888865544 4678887653
|
Serine/Threonine Kinases (STKs), DMPK-like subfamily, DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK) beta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKbeta is expressed ubiquitously in many tissues. |
| >cd05597 STKc_DMPK_like Catalytic domain of Myotonic Dystrophy protein kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=99.89 E-value=3e-23 Score=208.42 Aligned_cols=179 Identities=18% Similarity=0.233 Sum_probs=127.1
Q ss_pred cccceeeccCCCCC-------CCCCCChhhHHHHHHHHHHHHHHHhhcCCCceeecCCCccceEecCCCCceecccccee
Q 045315 241 DEISFWYESYNNPT-------KKGLLCWGTRVRIIEGIAQGLLYLHQYSRLRVIHRDLKASNILLDKDMNPKISDFGMAR 313 (476)
Q Consensus 241 ~~~~l~~Ey~~~~~-------~~~~L~~~~~~~i~~qIa~gL~yLH~~~~~~ivH~DLkp~NILld~~~~~kL~DFGla~ 313 (476)
+..++++||++... ....+++.++..++.||+.||+|||+++ |+||||||+|||++.++.+||+|||++.
T Consensus 74 ~~~~lv~e~~~g~~L~~~l~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~---ivH~dlkp~Nill~~~~~~kl~Dfg~~~ 150 (331)
T cd05597 74 NNLYLVMDYYVGGDLLTLLSKFEDRLPEDMARFYLAEMVLAIDSVHQLG---YVHRDIKPDNVLLDKNGHIRLADFGSCL 150 (331)
T ss_pred CeEEEEEecCCCCcHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCC---eEECCCCHHHEEECCCCCEEEEECCcee
Confidence 45789999997332 2457899999999999999999999999 9999999999999999999999999997
Q ss_pred ecCCCcccccceeeeeccCCCChhhhcc-----CCCCccceEEeehhhhhhhhhCCCCCCcCCCCchhhhhhhhhhhcCC
Q 045315 314 MFGGDELQSNTKRIVGTYGYMSPEYALR-----GLFSIKSDVFSFGVLLLETLSSKKNTHFYNTDSLTLLGHAWNLWNDG 388 (476)
Q Consensus 314 ~~~~~~~~~~~~~~~gt~~y~aPE~l~~-----~~~s~ksDVwSlGvvl~elltG~~p~~~~~~~~~~~~~~~~~~~~~~ 388 (476)
........ ......|++.|+|||++.. ..++.++|||||||++|||++|+.||...... ... .......
T Consensus 151 ~~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DiwslG~~l~el~~g~~Pf~~~~~~--~~~---~~i~~~~ 224 (331)
T cd05597 151 RLLADGTV-QSNVAVGTPDYISPEILQAMEDGKGRYGPECDWWSLGVCMYEMLYGETPFYAESLV--ETY---GKIMNHK 224 (331)
T ss_pred ecCCCCCc-cccceeccccccCHHHHhhccccccCCCCcceeehhhhHHHHHhhCCCCCCCCCHH--HHH---HHHHcCC
Confidence 65433221 1222468999999999863 45788999999999999999999998643211 111 1111111
Q ss_pred CcccccCcccCCCCCHHHHHHHHHHHHHchhh--cccCCCCHHHHHHH
Q 045315 389 RTWELMDPISQNGASYPILKRYINVALLCVQE--KAADRPAMSEVVSM 434 (476)
Q Consensus 389 ~~~~~~d~~~~~~~~~~~~~~l~~li~~Cl~~--dP~~RPt~~eVl~~ 434 (476)
....+.. ........+.+++.+|+.. ++..||+++++++.
T Consensus 225 ~~~~~~~------~~~~~~~~~~~li~~ll~~~~~r~~r~~~~~~l~h 266 (331)
T cd05597 225 EHFQFPP------DVTDVSEEAKDLIRRLICSPETRLGRNGLQDFKDH 266 (331)
T ss_pred CcccCCC------ccCCCCHHHHHHHHHHccCcccccCCCCHHHHhcC
Confidence 1111100 0111334567777776654 34447899888765
|
Serine/Threonine Kinases (STKs), Myotonic Dystrophy protein kinase (DMPK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The DMPK-like subfamily is composed of DMPK and DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK). Three isoforms of MRCK are known, named alpha, beta and gamma. The DMPK gene is implicated in myotonic dystrophy 1 (DM1), an inherited multisystemic disorder with symptoms that include muscle hyperexcitability, progressive muscle weakness and wasting, cataract development, testicular atrophy, |
| >cd06610 STKc_OSR1_SPAK Catalytic domain of the Protein Serine/Threonine Kinases, Oxidative stress response kinase and Ste20-related proline alanine-rich kinase | Back alignment and domain information |
|---|
Probab=99.89 E-value=1.9e-23 Score=201.95 Aligned_cols=178 Identities=28% Similarity=0.421 Sum_probs=132.2
Q ss_pred ccceeeccCCCCC---------CCCCCChhhHHHHHHHHHHHHHHHhhcCCCceeecCCCccceEecCCCCceeccccce
Q 045315 242 EISFWYESYNNPT---------KKGLLCWGTRVRIIEGIAQGLLYLHQYSRLRVIHRDLKASNILLDKDMNPKISDFGMA 312 (476)
Q Consensus 242 ~~~l~~Ey~~~~~---------~~~~L~~~~~~~i~~qIa~gL~yLH~~~~~~ivH~DLkp~NILld~~~~~kL~DFGla 312 (476)
..++++||++... ....+++..+..++.|++.||+|||+.+ ++|+||||+||++++++.+||+|||++
T Consensus 73 ~~~iv~e~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~ql~~al~~lh~~~---i~h~~l~p~ni~~~~~~~~~l~df~~~ 149 (267)
T cd06610 73 ELWLVMPYLSGGSLLDIMKSSYPRGGLDEAIIATVLKEVLKGLEYLHSNG---QIHRDIKAGNILLGEDGSVKIADFGVS 149 (267)
T ss_pred EEEEEEeccCCCcHHHHHHHhcccCCCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCCHHhEEEcCCCCEEEcccchH
Confidence 4667788886321 1356899999999999999999999998 999999999999999999999999998
Q ss_pred eecCCCccc--ccceeeeeccCCCChhhhccC-CCCccceEEeehhhhhhhhhCCCCCCcCCCCchhhhhhhhhhhcCCC
Q 045315 313 RMFGGDELQ--SNTKRIVGTYGYMSPEYALRG-LFSIKSDVFSFGVLLLETLSSKKNTHFYNTDSLTLLGHAWNLWNDGR 389 (476)
Q Consensus 313 ~~~~~~~~~--~~~~~~~gt~~y~aPE~l~~~-~~s~ksDVwSlGvvl~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~ 389 (476)
......... .......++..|+|||.+... .++.++|+|||||+++||++|+.|+....... .... .... .
T Consensus 150 ~~~~~~~~~~~~~~~~~~~~~~y~~Pe~~~~~~~~~~~~Dv~slG~i~~~l~~g~~p~~~~~~~~-~~~~----~~~~-~ 223 (267)
T cd06610 150 ASLADGGDRTRKVRKTFVGTPCWMAPEVMEQVHGYDFKADIWSFGITAIELATGAAPYSKYPPMK-VLML----TLQN-D 223 (267)
T ss_pred HHhccCccccccccccccCChhhcChHHHccccCcCcccchHhHhHHHHHHHhCCCCccccChhh-hHHH----HhcC-C
Confidence 766543221 122334688899999998876 78999999999999999999999986433211 1111 1111 0
Q ss_pred cccccCcccCCCC-CHHHHHHHHHHHHHchhhcccCCCCHHHHHH
Q 045315 390 TWELMDPISQNGA-SYPILKRYINVALLCVQEKAADRPAMSEVVS 433 (476)
Q Consensus 390 ~~~~~d~~~~~~~-~~~~~~~l~~li~~Cl~~dP~~RPt~~eVl~ 433 (476)
. +...... .......+.+++.+||+.||++||++++|++
T Consensus 224 ~-----~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~ll~ 263 (267)
T cd06610 224 P-----PSLETGADYKKYSKSFRKMISLCLQKDPSKRPTAEELLK 263 (267)
T ss_pred C-----CCcCCccccccccHHHHHHHHHHcCCChhhCcCHHHHhh
Confidence 0 0111100 1233467889999999999999999999875
|
Serine/threonine kinases (STKs), oxidative stress response kinase (OSR1) and Ste20-related proline alanine-rich kinase (SPAK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The OSR1 and SPAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. SPAK is also referred to as STK39 or PASK (proline-alanine-rich STE20-related kinase). OSR1 and SPAK regulate the activity of cation-chloride cotransporters through direct interaction and phosphorylation. They are also implicated in cytoskeletal rearrangement, cell differentiation, transformation and proliferation. OSR1 |
| >cd06618 PKc_MKK7 Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 7 | Back alignment and domain information |
|---|
Probab=99.89 E-value=1e-23 Score=208.08 Aligned_cols=176 Identities=25% Similarity=0.370 Sum_probs=129.4
Q ss_pred cccceeeccCCCC------CCCCCCChhhHHHHHHHHHHHHHHHhh-cCCCceeecCCCccceEecCCCCceecccccee
Q 045315 241 DEISFWYESYNNP------TKKGLLCWGTRVRIIEGIAQGLLYLHQ-YSRLRVIHRDLKASNILLDKDMNPKISDFGMAR 313 (476)
Q Consensus 241 ~~~~l~~Ey~~~~------~~~~~L~~~~~~~i~~qIa~gL~yLH~-~~~~~ivH~DLkp~NILld~~~~~kL~DFGla~ 313 (476)
...++++||++.. .....+++.++..++.||+.||+|||+ .+ |+||||+|+||++++++.+||+|||++.
T Consensus 87 ~~~~~v~e~~~~~l~~l~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~---i~H~dl~p~nill~~~~~~kL~dfg~~~ 163 (296)
T cd06618 87 SDVFICMELMSTCLDKLLKRIQGPIPEDILGKMTVAIVKALHYLKEKHG---VIHRDVKPSNILLDASGNVKLCDFGISG 163 (296)
T ss_pred CeEEEEeeccCcCHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhhCC---EecCCCcHHHEEEcCCCCEEECccccch
Confidence 3567788888621 124579999999999999999999997 46 9999999999999999999999999987
Q ss_pred ecCCCcccccceeeeeccCCCChhhhccC----CCCccceEEeehhhhhhhhhCCCCCCcCCCCchhhhhhhhhhhcCCC
Q 045315 314 MFGGDELQSNTKRIVGTYGYMSPEYALRG----LFSIKSDVFSFGVLLLETLSSKKNTHFYNTDSLTLLGHAWNLWNDGR 389 (476)
Q Consensus 314 ~~~~~~~~~~~~~~~gt~~y~aPE~l~~~----~~s~ksDVwSlGvvl~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~ 389 (476)
.+...... ....++..|+|||.+... .++.++|+||||+++|||++|+.||.....+...+ . ..... .
T Consensus 164 ~~~~~~~~---~~~~~~~~y~aPE~~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~~~~-~---~~~~~-~ 235 (296)
T cd06618 164 RLVDSKAK---TRSAGCAAYMAPERIDPPDPNPKYDIRADVWSLGISLVELATGQFPYKNCKTEFEVL-T---KILQE-E 235 (296)
T ss_pred hccCCCcc---cCCCCCccccCHhhcCCCCCccccccchhHHHHHHHHHHHHhCCCCCCcchhHHHHH-H---HHhcC-C
Confidence 65432221 123467899999998754 37899999999999999999999986432211111 1 11111 1
Q ss_pred cccccCcccCCCCCHHHHHHHHHHHHHchhhcccCCCCHHHHHHH
Q 045315 390 TWELMDPISQNGASYPILKRYINVALLCVQEKAADRPAMSEVVSM 434 (476)
Q Consensus 390 ~~~~~d~~~~~~~~~~~~~~l~~li~~Cl~~dP~~RPt~~eVl~~ 434 (476)
.... . ........+.+++.+||+.||++||++.++++.
T Consensus 236 ~~~~-----~--~~~~~~~~l~~li~~~l~~~p~~Rp~~~~il~~ 273 (296)
T cd06618 236 PPSL-----P--PNEGFSPDFCSFVDLCLTKDHRKRPKYRELLQH 273 (296)
T ss_pred CCCC-----C--CCCCCCHHHHHHHHHHccCChhhCCCHHHHhcC
Confidence 1000 0 001234568899999999999999999999764
|
Protein kinases (PKs), MAP kinase kinase 7 (MKK7) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK7 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK7 is a dual-specificity PK that phosphorylates and activates it |
| >KOG0584 consensus Serine/threonine protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=99.89 E-value=6e-24 Score=216.77 Aligned_cols=174 Identities=24% Similarity=0.362 Sum_probs=135.0
Q ss_pred ccccceeeccCCCCC------CCCCCChhhHHHHHHHHHHHHHHHhhcCCCceeecCCCccceEecC-CCCceeccccce
Q 045315 240 KDEISFWYESYNNPT------KKGLLCWGTRVRIIEGIAQGLLYLHQYSRLRVIHRDLKASNILLDK-DMNPKISDFGMA 312 (476)
Q Consensus 240 ~~~~~l~~Ey~~~~~------~~~~L~~~~~~~i~~qIa~gL~yLH~~~~~~ivH~DLkp~NILld~-~~~~kL~DFGla 312 (476)
+....++.|.|..++ +-+.++.+...+|++||++||.|||++. +||||||||.+||||+. .|.+||+|+|+|
T Consensus 115 n~~in~iTEL~TSGtLr~Y~kk~~~vn~kaik~W~RQILkGL~yLHs~~-PPIIHRDLKCDNIFinG~~G~VKIGDLGLA 193 (632)
T KOG0584|consen 115 NKTINFITELFTSGTLREYRKKHRRVNIKAIKSWCRQILKGLVYLHSQD-PPIIHRDLKCDNIFVNGNLGEVKIGDLGLA 193 (632)
T ss_pred CceeeeeeecccCCcHHHHHHHhccCCHHHHHHHHHHHHHHhhhhhcCC-CCccccccccceEEEcCCcCceeecchhHH
Confidence 355778888888443 3457899999999999999999999986 78999999999999985 578999999999
Q ss_pred eecCCCcccccceeeeeccCCCChhhhccCCCCccceEEeehhhhhhhhhCCCCCCcCCCCchhhhhhhhhhhcCCCccc
Q 045315 313 RMFGGDELQSNTKRIVGTYGYMSPEYALRGLFSIKSDVFSFGVLLLETLSSKKNTHFYNTDSLTLLGHAWNLWNDGRTWE 392 (476)
Q Consensus 313 ~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~s~ksDVwSlGvvl~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~ 392 (476)
....... ...+.||+.|||||... ..|+...||||||++++||+|+..|+..... . ...++....|....
T Consensus 194 tl~r~s~----aksvIGTPEFMAPEmYE-E~YnE~VDVYaFGMCmLEMvT~eYPYsEC~n-~----AQIYKKV~SGiKP~ 263 (632)
T KOG0584|consen 194 TLLRKSH----AKSVIGTPEFMAPEMYE-ENYNELVDVYAFGMCMLEMVTSEYPYSECTN-P----AQIYKKVTSGIKPA 263 (632)
T ss_pred HHhhccc----cceeccCccccChHHHh-hhcchhhhhhhhhHHHHHHHhccCChhhhCC-H----HHHHHHHHcCCCHH
Confidence 8865432 33478999999999876 7899999999999999999999999864431 1 12223333333222
Q ss_pred ccCcccCCCCCHHHHHHHHHHHHHchhhcccCCCCHHHHHH
Q 045315 393 LMDPISQNGASYPILKRYINVALLCVQEKAADRPAMSEVVS 433 (476)
Q Consensus 393 ~~d~~~~~~~~~~~~~~l~~li~~Cl~~dP~~RPt~~eVl~ 433 (476)
.+.... ...+.++|.+||.. .++|||+.|++.
T Consensus 264 sl~kV~--------dPevr~fIekCl~~-~~~R~sa~eLL~ 295 (632)
T KOG0584|consen 264 ALSKVK--------DPEVREFIEKCLAT-KSERLSAKELLK 295 (632)
T ss_pred HhhccC--------CHHHHHHHHHHhcC-chhccCHHHHhh
Confidence 222111 23577899999999 999999999986
|
|
| >cd06648 STKc_PAK_II Catalytic domain of the Protein Serine/Threonine Kinase, Group II p21-activated kinase | Back alignment and domain information |
|---|
Probab=99.89 E-value=6.7e-24 Score=208.34 Aligned_cols=175 Identities=23% Similarity=0.326 Sum_probs=132.2
Q ss_pred cccceeeccCCCCC-----CCCCCChhhHHHHHHHHHHHHHHHhhcCCCceeecCCCccceEecCCCCceeccccceeec
Q 045315 241 DEISFWYESYNNPT-----KKGLLCWGTRVRIIEGIAQGLLYLHQYSRLRVIHRDLKASNILLDKDMNPKISDFGMARMF 315 (476)
Q Consensus 241 ~~~~l~~Ey~~~~~-----~~~~L~~~~~~~i~~qIa~gL~yLH~~~~~~ivH~DLkp~NILld~~~~~kL~DFGla~~~ 315 (476)
+.+++++||++... ...++++.++..++.|++.||+|||+.+ ++||||+|+||+++.++.++|+|||++...
T Consensus 89 ~~~~~v~e~~~~~~L~~~~~~~~~~~~~~~~~~~ql~~~l~~lH~~~---i~H~dl~p~Nil~~~~~~~~l~d~g~~~~~ 165 (285)
T cd06648 89 DELWVVMEFLEGGALTDIVTHTRMNEEQIATVCLAVLKALSFLHAQG---VIHRDIKSDSILLTSDGRVKLSDFGFCAQV 165 (285)
T ss_pred CeEEEEEeccCCCCHHHHHHhCCCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCChhhEEEcCCCcEEEcccccchhh
Confidence 45778888887322 2256899999999999999999999998 999999999999999999999999988765
Q ss_pred CCCcccccceeeeeccCCCChhhhccCCCCccceEEeehhhhhhhhhCCCCCCcCCCCchhhhhhhhhhhcCCCcccccC
Q 045315 316 GGDELQSNTKRIVGTYGYMSPEYALRGLFSIKSDVFSFGVLLLETLSSKKNTHFYNTDSLTLLGHAWNLWNDGRTWELMD 395 (476)
Q Consensus 316 ~~~~~~~~~~~~~gt~~y~aPE~l~~~~~s~ksDVwSlGvvl~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~d 395 (476)
...... .....|+..|+|||.+.+..++.++|+|||||+++||++|+.||..... ...... ......
T Consensus 166 ~~~~~~--~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slGv~l~ell~g~~p~~~~~~--~~~~~~----~~~~~~----- 232 (285)
T cd06648 166 SKEVPR--RKSLVGTPYWMAPEVISRLPYGTEVDIWSLGIMVIEMVDGEPPYFNEPP--LQAMKR----IRDNLP----- 232 (285)
T ss_pred ccCCcc--cccccCCccccCHHHhcCCCCCCcccHHHHHHHHHHHHhCCCCCcCCCH--HHHHHH----HHhcCC-----
Confidence 432211 1224588899999999888899999999999999999999999754321 111111 111110
Q ss_pred cccCCCCCHHHHHHHHHHHHHchhhcccCCCCHHHHHH
Q 045315 396 PISQNGASYPILKRYINVALLCVQEKAADRPAMSEVVS 433 (476)
Q Consensus 396 ~~~~~~~~~~~~~~l~~li~~Cl~~dP~~RPt~~eVl~ 433 (476)
+.... .......+.+++.+||+.+|++||++.++++
T Consensus 233 ~~~~~--~~~~~~~l~~li~~~l~~~p~~Rpt~~~il~ 268 (285)
T cd06648 233 PKLKN--LHKVSPRLRSFLDRMLVRDPAQRATAAELLN 268 (285)
T ss_pred CCCcc--cccCCHHHHHHHHHHcccChhhCcCHHHHcc
Confidence 01100 1113357899999999999999999999885
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, Group II, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. Group II PAKs, also called non-conventional PAKs, include PAK4, PAK5, and PAK6. Group II PAKs contain PBD (p21-binding domain) and catalytic domains, but lack other motifs foun |
| >PRK13184 pknD serine/threonine-protein kinase; Reviewed | Back alignment and domain information |
|---|
Probab=99.89 E-value=1.1e-23 Score=230.67 Aligned_cols=183 Identities=25% Similarity=0.289 Sum_probs=133.1
Q ss_pred cccceeeccCCCCC-----------------CCCCCChhhHHHHHHHHHHHHHHHhhcCCCceeecCCCccceEecCCCC
Q 045315 241 DEISFWYESYNNPT-----------------KKGLLCWGTRVRIIEGIAQGLLYLHQYSRLRVIHRDLKASNILLDKDMN 303 (476)
Q Consensus 241 ~~~~l~~Ey~~~~~-----------------~~~~L~~~~~~~i~~qIa~gL~yLH~~~~~~ivH~DLkp~NILld~~~~ 303 (476)
+..+++|||++..+ ....+++.++++++.||++||+|||+.+ |+||||||+||+++.++.
T Consensus 75 ~~lyLVMEY~eGGSL~~lL~s~~~~~~l~e~~~~~lsv~~iL~I~~QIa~AL~yLHs~G---IIHRDLKPeNILLd~dg~ 151 (932)
T PRK13184 75 DPVYYTMPYIEGYTLKSLLKSVWQKESLSKELAEKTSVGAFLSIFHKICATIEYVHSKG---VLHRDLKPDNILLGLFGE 151 (932)
T ss_pred CEEEEEEEcCCCCCHHHHHHHhhhccccchhhhcccCHHHHHHHHHHHHHHHHHHHHCC---ccccCCchheEEEcCCCC
Confidence 35677888877321 1234677888999999999999999998 999999999999999999
Q ss_pred ceeccccceeecCCCcc----------------cccceeeeeccCCCChhhhccCCCCccceEEeehhhhhhhhhCCCCC
Q 045315 304 PKISDFGMARMFGGDEL----------------QSNTKRIVGTYGYMSPEYALRGLFSIKSDVFSFGVLLLETLSSKKNT 367 (476)
Q Consensus 304 ~kL~DFGla~~~~~~~~----------------~~~~~~~~gt~~y~aPE~l~~~~~s~ksDVwSlGvvl~elltG~~p~ 367 (476)
+||+|||+++....... ........||+.|+|||.+.+..++.++|||||||++|||++|+.||
T Consensus 152 vKLiDFGLAk~i~~~~~~~~~l~~~~~~s~~s~~t~~g~~vGT~~YmAPE~l~g~~~S~kSDIWSLGVILyELLTG~~PF 231 (932)
T PRK13184 152 VVILDWGAAIFKKLEEEDLLDIDVDERNICYSSMTIPGKIVGTPDYMAPERLLGVPASESTDIYALGVILYQMLTLSFPY 231 (932)
T ss_pred EEEEecCcceecccccccccccccccccccccccccCCCCCCCCCCCCHHHhcCCCCCcHhHHHHHHHHHHHHHHCCCCC
Confidence 99999999987621100 00112246899999999999999999999999999999999999998
Q ss_pred CcCCCCchhhhhhhhhhhcCCCcccccCcccCCCCCHHHHHHHHHHHHHchhhcccCCC-CHHHHHHHHhccc
Q 045315 368 HFYNTDSLTLLGHAWNLWNDGRTWELMDPISQNGASYPILKRYINVALLCVQEKAADRP-AMSEVVSMLSNEF 439 (476)
Q Consensus 368 ~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~l~~li~~Cl~~dP~~RP-t~~eVl~~L~~~~ 439 (476)
........... . ...++... .........+.+++.+|++.||++|| +++++++.|+...
T Consensus 232 ~~~~~~ki~~~---------~---~i~~P~~~-~p~~~iP~~L~~LI~rcL~~DP~kR~ss~eeLl~~Le~~l 291 (932)
T PRK13184 232 RRKKGRKISYR---------D---VILSPIEV-APYREIPPFLSQIAMKALAVDPAERYSSVQELKQDLEPHL 291 (932)
T ss_pred CCcchhhhhhh---------h---hccChhhc-cccccCCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHH
Confidence 64321111000 0 00000000 00112335678899999999999996 5778888887764
|
|
| >cd05046 PTK_CCK4 Pseudokinase domain of the Protein Tyrosine Kinase, Colon Carcinoma Kinase 4 | Back alignment and domain information |
|---|
Probab=99.89 E-value=1.5e-23 Score=204.18 Aligned_cols=178 Identities=25% Similarity=0.280 Sum_probs=131.5
Q ss_pred cccceeeccCCCCC--------C-------CCCCChhhHHHHHHHHHHHHHHHhhcCCCceeecCCCccceEecCCCCce
Q 045315 241 DEISFWYESYNNPT--------K-------KGLLCWGTRVRIIEGIAQGLLYLHQYSRLRVIHRDLKASNILLDKDMNPK 305 (476)
Q Consensus 241 ~~~~l~~Ey~~~~~--------~-------~~~L~~~~~~~i~~qIa~gL~yLH~~~~~~ivH~DLkp~NILld~~~~~k 305 (476)
+..++++||++... . ...+++.+++.++.||+.||+|||+.+ |+||||||+||+++.++.++
T Consensus 81 ~~~~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~l~~~~~~~~~~~l~~~l~~LH~~~---i~H~dlkp~Nili~~~~~~~ 157 (275)
T cd05046 81 EPHYMILEYTDLGDLKQFLRATKSKDEKLKPPPLSTKQKVALCTQIALGMDHLSNAR---FVHRDLAARNCLVSSQREVK 157 (275)
T ss_pred CcceEEEEecCCCcHHHHHHhcccccccccccCCCHHHHHHHHHHHHHHHHHhhhcC---cccCcCccceEEEeCCCcEE
Confidence 34677888887211 1 126999999999999999999999998 99999999999999999999
Q ss_pred eccccceeecCCCcccccceeeeeccCCCChhhhccCCCCccceEEeehhhhhhhhh-CCCCCCcCCCCchhhhhhhhhh
Q 045315 306 ISDFGMARMFGGDELQSNTKRIVGTYGYMSPEYALRGLFSIKSDVFSFGVLLLETLS-SKKNTHFYNTDSLTLLGHAWNL 384 (476)
Q Consensus 306 L~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~s~ksDVwSlGvvl~ellt-G~~p~~~~~~~~~~~~~~~~~~ 384 (476)
++|||++......... ......++..|+|||.+.+..++.++||||||+++|++++ |..||..... ..... .
T Consensus 158 l~~~~~~~~~~~~~~~-~~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~~l~~l~~~~~~p~~~~~~--~~~~~----~ 230 (275)
T cd05046 158 VSLLSLSKDVYNSEYY-KLRNALIPLRWLAPEAVQEDDFSTKSDVWSFGVLMWEVFTQGELPFYGLSD--EEVLN----R 230 (275)
T ss_pred EcccccccccCccccc-ccCCceeEEeecChhhhccCCCCchhhHHHHHHHHHHHHhCCCCCccccch--HHHHH----H
Confidence 9999998754322211 1222356778999999988888999999999999999998 6777643221 11111 1
Q ss_pred hcCCCcccccCcccCCCCCHHHHHHHHHHHHHchhhcccCCCCHHHHHHHHh
Q 045315 385 WNDGRTWELMDPISQNGASYPILKRYINVALLCVQEKAADRPAMSEVVSMLS 436 (476)
Q Consensus 385 ~~~~~~~~~~d~~~~~~~~~~~~~~l~~li~~Cl~~dP~~RPt~~eVl~~L~ 436 (476)
...+.... .........+.+++.+||+.+|++||++.|++++|.
T Consensus 231 ~~~~~~~~--------~~~~~~~~~l~~~i~~~l~~~p~~Rp~~~~~l~~l~ 274 (275)
T cd05046 231 LQAGKLEL--------PVPEGCPSRLYKLMTRCWAVNPKDRPSFSELVSALG 274 (275)
T ss_pred HHcCCcCC--------CCCCCCCHHHHHHHHHHcCCCcccCCCHHHHHHHhc
Confidence 11111100 001123357889999999999999999999999886
|
Protein Tyrosine Kinase (PTK) family; Colon Carcinoma Kinase 4 (CCK4); pseudokinase domain. The PTKc (catalytic domain) family, to which this subfamily belongs, includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. CCK4, also called protein tyrosine kinase 7 (PTK7), is an orphan receptor tyr kinase (RTK) containing an extracellular region with seven immunoglobulin domains, a transmembrane segment, and an intracellular inactive pseudokinase domain. Studies in mice reveal that CCK4 is essential for neural development. Mouse embryos containing a truncated CCK4 die perinatally and display craniorachischisis, a severe form of neural tube defect. The mechanism of action of the CCK4 pseudokinase is s |
| >cd07870 STKc_PFTAIRE2 Catalytic domain of the Serine/Threonine Kinase, PFTAIRE-2 kinase | Back alignment and domain information |
|---|
Probab=99.89 E-value=9.2e-24 Score=207.59 Aligned_cols=186 Identities=20% Similarity=0.226 Sum_probs=128.2
Q ss_pred ccceeeccCCCC------CCCCCCChhhHHHHHHHHHHHHHHHhhcCCCceeecCCCccceEecCCCCceeccccceeec
Q 045315 242 EISFWYESYNNP------TKKGLLCWGTRVRIIEGIAQGLLYLHQYSRLRVIHRDLKASNILLDKDMNPKISDFGMARMF 315 (476)
Q Consensus 242 ~~~l~~Ey~~~~------~~~~~L~~~~~~~i~~qIa~gL~yLH~~~~~~ivH~DLkp~NILld~~~~~kL~DFGla~~~ 315 (476)
..++++||++.. .....+++.++..++.||+.||+|||+.+ ++|+||||+||+++.++.+||+|||+++..
T Consensus 77 ~~~lv~e~~~~~l~~~~~~~~~~~~~~~~~~~~~qi~~~L~~lH~~~---i~H~dlkp~Nil~~~~~~~~l~Dfg~~~~~ 153 (291)
T cd07870 77 TLTFVFEYMHTDLAQYMIQHPGGLHPYNVRLFMFQLLRGLAYIHGQH---ILHRDLKPQNLLISYLGELKLADFGLARAK 153 (291)
T ss_pred eEEEEEecccCCHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHhCC---cccCCCChHHEEEcCCCcEEEecccccccc
Confidence 466788888621 22356888999999999999999999998 999999999999999999999999998764
Q ss_pred CCCcccccceeeeeccCCCChhhhccC-CCCccceEEeehhhhhhhhhCCCCCCcCCCCchhhhhhhhhhhcCC------
Q 045315 316 GGDELQSNTKRIVGTYGYMSPEYALRG-LFSIKSDVFSFGVLLLETLSSKKNTHFYNTDSLTLLGHAWNLWNDG------ 388 (476)
Q Consensus 316 ~~~~~~~~~~~~~gt~~y~aPE~l~~~-~~s~ksDVwSlGvvl~elltG~~p~~~~~~~~~~~~~~~~~~~~~~------ 388 (476)
...... .....++..|+|||.+.+. .++.++|||||||++|||++|+.||........ .....+......
T Consensus 154 ~~~~~~--~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~~l~~g~~~f~~~~~~~~-~~~~~~~~~~~~~~~~~~ 230 (291)
T cd07870 154 SIPSQT--YSSEVVTLWYRPPDVLLGATDYSSALDIWGAGCIFIEMLQGQPAFPGVSDVFE-QLEKIWTVLGVPTEDTWP 230 (291)
T ss_pred CCCCCC--CCCccccccccCCceeecCCCCCcHHHHHHHHHHHHHHHhCCCCCCCchhHHH-HHHHHHHHcCCCChhhhh
Confidence 322111 1223568899999988754 578899999999999999999999864432111 111111100000
Q ss_pred ------C-cccccCcccCC-----CCCHHHHHHHHHHHHHchhhcccCCCCHHHHHH
Q 045315 389 ------R-TWELMDPISQN-----GASYPILKRYINVALLCVQEKAADRPAMSEVVS 433 (476)
Q Consensus 389 ------~-~~~~~d~~~~~-----~~~~~~~~~l~~li~~Cl~~dP~~RPt~~eVl~ 433 (476)
. ........... .........+.+++.+|++.||++|||+.|++.
T Consensus 231 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ll~~~l~~dp~~R~t~~~~l~ 287 (291)
T cd07870 231 GVSKLPNYKPEWFLPCKPQQLRVVWKRLSRPPKAEDLASQMLMMFPKDRISAQDALL 287 (291)
T ss_pred hhhhcccccchhccccCCcchhhhccccCCChHHHHHHHHHhCcCcccCcCHHHHhc
Confidence 0 00000000000 000112356778999999999999999999864
|
Serine/Threonine Kinases (STKs), PFTAIRE-2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PFTAIRE-2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PFTAIRE-2 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PFTAIRE-2 is also referred to as ALS2CR7 (amyotrophic lateral sclerosis 2 (juvenile) chromosome region candidate 7). It may be associated with amyotrophic lateral sclerosis 2 (ALS2), an autosomal recess |
| >cd05122 PKc_STE Catalytic domain of STE family Protein Kinases | Back alignment and domain information |
|---|
Probab=99.89 E-value=1.4e-23 Score=200.19 Aligned_cols=174 Identities=24% Similarity=0.349 Sum_probs=133.4
Q ss_pred cccceeeccCCCCC-------CCCCCChhhHHHHHHHHHHHHHHHhhcCCCceeecCCCccceEecCCCCceecccccee
Q 045315 241 DEISFWYESYNNPT-------KKGLLCWGTRVRIIEGIAQGLLYLHQYSRLRVIHRDLKASNILLDKDMNPKISDFGMAR 313 (476)
Q Consensus 241 ~~~~l~~Ey~~~~~-------~~~~L~~~~~~~i~~qIa~gL~yLH~~~~~~ivH~DLkp~NILld~~~~~kL~DFGla~ 313 (476)
+.+++++||++..+ ..+.+++.++..++.|+++||+|||+.+ ++|+||+|+||+++.++.++|+|||.+.
T Consensus 70 ~~~~l~~e~~~~~~L~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~---i~h~dl~p~ni~i~~~~~~~l~d~~~~~ 146 (253)
T cd05122 70 DELWIVMEFCSGGSLKDLLKSTNQTLTESQIAYVCKELLKGLEYLHSNG---IIHRDIKAANILLTSDGEVKLIDFGLSA 146 (253)
T ss_pred CeEEEEEecCCCCcHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHhhcCC---EecCCCCHHHEEEccCCeEEEeeccccc
Confidence 46778889988322 2257999999999999999999999988 9999999999999999999999999998
Q ss_pred ecCCCcccccceeeeeccCCCChhhhccCCCCccceEEeehhhhhhhhhCCCCCCcCCCCchhhhhhhhhhhcCCCcccc
Q 045315 314 MFGGDELQSNTKRIVGTYGYMSPEYALRGLFSIKSDVFSFGVLLLETLSSKKNTHFYNTDSLTLLGHAWNLWNDGRTWEL 393 (476)
Q Consensus 314 ~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~s~ksDVwSlGvvl~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~ 393 (476)
....... .....++..|+|||.+.+..++.++|+||||++++++++|+.|+........ .... ........
T Consensus 147 ~~~~~~~---~~~~~~~~~~~~PE~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~--~~~~----~~~~~~~~ 217 (253)
T cd05122 147 QLSDTKA---RNTMVGTPYWMAPEVINGKPYDYKADIWSLGITAIELAEGKPPYSELPPMKA--LFKI----ATNGPPGL 217 (253)
T ss_pred ccccccc---ccceecCCcccCHHHHcCCCCCccccHHHHHHHHHHHHhCCCCCCCCchHHH--HHHH----HhcCCCCc
Confidence 7654322 2335688999999999888899999999999999999999999864321111 1000 00111111
Q ss_pred cCcccCCCCCHHHHHHHHHHHHHchhhcccCCCCHHHHHH
Q 045315 394 MDPISQNGASYPILKRYINVALLCVQEKAADRPAMSEVVS 433 (476)
Q Consensus 394 ~d~~~~~~~~~~~~~~l~~li~~Cl~~dP~~RPt~~eVl~ 433 (476)
.. .......+.+++.+||+.||++|||+.++++
T Consensus 218 ~~-------~~~~~~~~~~~i~~~l~~~p~~R~t~~~~l~ 250 (253)
T cd05122 218 RN-------PEKWSDEFKDFLKKCLQKNPEKRPTAEQLLK 250 (253)
T ss_pred Cc-------ccccCHHHHHHHHHHccCChhhCCCHHHHhc
Confidence 00 1111456889999999999999999999875
|
Protein Kinases (PKs), STE family, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The STE family is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases (STKs), protein tyrosine kinases (PTKs), RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). This family is composed of STKs, and some dual-specificity PKs that phosphorylate both threonine and tyrosine residues of target proteins. Most members are kinases involved in mitogen-activated protein kinase (MAPK) signaling cascades, acting as MAPK kinases (MAPKKs), MAPK kinase kinases (MAPKKKs), or MAPK kinase kinase kinases (MAP4Ks). The MAPK signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core |
| >KOG4645 consensus MAPKKK (MAP kinase kinase kinase) SSK2 and related serine/threonine protein kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.89 E-value=4.3e-24 Score=231.74 Aligned_cols=177 Identities=21% Similarity=0.291 Sum_probs=135.1
Q ss_pred cccceeeccCCCCC------CCCCCChhhHHHHHHHHHHHHHHHhhcCCCceeecCCCccceEecCCCCceeccccceee
Q 045315 241 DEISFWYESYNNPT------KKGLLCWGTRVRIIEGIAQGLLYLHQYSRLRVIHRDLKASNILLDKDMNPKISDFGMARM 314 (476)
Q Consensus 241 ~~~~l~~Ey~~~~~------~~~~L~~~~~~~i~~qIa~gL~yLH~~~~~~ivH~DLkp~NILld~~~~~kL~DFGla~~ 314 (476)
+..++-|||++.+. +++.+++.....+..|++.|++|||++| ||||||||+||+|+.+|.+|++|||.|..
T Consensus 1307 ekv~IFMEyC~~GsLa~ll~~gri~dE~vt~vyt~qll~gla~LH~~g---IVHRDIK~aNI~Ld~~g~iK~~DFGsa~k 1383 (1509)
T KOG4645|consen 1307 EKVYIFMEYCEGGSLASLLEHGRIEDEMVTRVYTKQLLEGLAYLHEHG---IVHRDIKPANILLDFNGLIKYGDFGSAVK 1383 (1509)
T ss_pred HHHHHHHHHhccCcHHHHHHhcchhhhhHHHHHHHHHHHHHHHHHhcC---ceecCCCccceeeecCCcEEeecccceeE
Confidence 56778889988543 3445667677778999999999999999 99999999999999999999999999998
Q ss_pred cCCCc--ccccceeeeeccCCCChhhhccC---CCCccceEEeehhhhhhhhhCCCCCCcCCCCchhhhhhhhhhhcCCC
Q 045315 315 FGGDE--LQSNTKRIVGTYGYMSPEYALRG---LFSIKSDVFSFGVLLLETLSSKKNTHFYNTDSLTLLGHAWNLWNDGR 389 (476)
Q Consensus 315 ~~~~~--~~~~~~~~~gt~~y~aPE~l~~~---~~s~ksDVwSlGvvl~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~ 389 (476)
+.+.. .........||+.|||||.+.+. .-..++||||+|||++||+||++||...+.+-. +.-++ ..|+
T Consensus 1384 i~~~~~~~~~el~~~~GT~~YMAPEvit~t~~kG~~~A~DiWslGCVVlEM~tGkrPW~~~dne~a-IMy~V----~~gh 1458 (1509)
T KOG4645|consen 1384 IKNNAQTMPGELQSMMGTPMYMAPEVITGTKGKGHGGAADIWSLGCVVLEMATGKRPWAELDNEWA-IMYHV----AAGH 1458 (1509)
T ss_pred ecCchhcCCHHHHhhcCCchhcCchhhcccccCCCCcchhhhcccceEEEeecCCCchhhccchhH-HHhHH----hccC
Confidence 76542 12233457899999999999753 346789999999999999999999976553321 11111 1122
Q ss_pred cccccCcccCCCCCHHHHHHHHHHHHHchhhcccCCCCHHHHHHH
Q 045315 390 TWELMDPISQNGASYPILKRYINVALLCVQEKAADRPAMSEVVSM 434 (476)
Q Consensus 390 ~~~~~d~~~~~~~~~~~~~~l~~li~~Cl~~dP~~RPt~~eVl~~ 434 (476)
.. ..+......-.+++.+||+.||++|.++.|+++.
T Consensus 1459 ~P---------q~P~~ls~~g~dFle~Cl~~dP~~Rw~~~qlle~ 1494 (1509)
T KOG4645|consen 1459 KP---------QIPERLSSEGRDFLEHCLEQDPKMRWTASQLLEH 1494 (1509)
T ss_pred CC---------CCchhhhHhHHHHHHHHHhcCchhhhHHHHHHHh
Confidence 21 2233355667789999999999999988877653
|
|
| >cd07844 STKc_PCTAIRE_like Catalytic domain of PCTAIRE-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=99.89 E-value=1.2e-23 Score=206.57 Aligned_cols=187 Identities=20% Similarity=0.220 Sum_probs=128.4
Q ss_pred cccceeeccCCCC------CCCCCCChhhHHHHHHHHHHHHHHHhhcCCCceeecCCCccceEecCCCCceeccccceee
Q 045315 241 DEISFWYESYNNP------TKKGLLCWGTRVRIIEGIAQGLLYLHQYSRLRVIHRDLKASNILLDKDMNPKISDFGMARM 314 (476)
Q Consensus 241 ~~~~l~~Ey~~~~------~~~~~L~~~~~~~i~~qIa~gL~yLH~~~~~~ivH~DLkp~NILld~~~~~kL~DFGla~~ 314 (476)
+..++++||++.. .....+++.++..++.|+++||.|||+.+ ++|+||||+||+++.++.+||+|||+++.
T Consensus 76 ~~~~lv~e~~~~~L~~~~~~~~~~~~~~~~~~~~~ql~~al~~lH~~~---i~H~dl~p~nil~~~~~~~kl~dfg~~~~ 152 (291)
T cd07844 76 KTLTLVFEYLDTDLKQYMDDCGGGLSMHNVRLFLFQLLRGLAYCHQRR---VLHRDLKPQNLLISERGELKLADFGLARA 152 (291)
T ss_pred CeEEEEEecCCCCHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHhCC---eecccCCHHHEEEcCCCCEEECccccccc
Confidence 3467888888721 22347899999999999999999999998 99999999999999999999999999875
Q ss_pred cCCCcccccceeeeeccCCCChhhhcc-CCCCccceEEeehhhhhhhhhCCCCCCcCCCCchhhhhhhhhhhcC---CCc
Q 045315 315 FGGDELQSNTKRIVGTYGYMSPEYALR-GLFSIKSDVFSFGVLLLETLSSKKNTHFYNTDSLTLLGHAWNLWND---GRT 390 (476)
Q Consensus 315 ~~~~~~~~~~~~~~gt~~y~aPE~l~~-~~~s~ksDVwSlGvvl~elltG~~p~~~~~~~~~~~~~~~~~~~~~---~~~ 390 (476)
....... .....++..|+|||.+.+ ..++.++||||||+++|||++|+.||.........+ ......... ...
T Consensus 153 ~~~~~~~--~~~~~~~~~~~aPE~~~~~~~~~~~~Dv~slG~il~~l~~g~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~ 229 (291)
T cd07844 153 KSVPSKT--YSNEVVTLWYRPPDVLLGSTEYSTSLDMWGVGCIFYEMATGRPLFPGSTDVEDQL-HKIFRVLGTPTEETW 229 (291)
T ss_pred cCCCCcc--ccccccccccCCcHHhhcCcccCcHHHHHHHHHHHHHHHhCCCCCCCCccHHHHH-HHHHHhcCCCChhhh
Confidence 4321111 111346788999998875 457899999999999999999999986443111111 111111000 000
Q ss_pred cc-------------ccC-cccCCC-CCHHHHHHHHHHHHHchhhcccCCCCHHHHHH
Q 045315 391 WE-------------LMD-PISQNG-ASYPILKRYINVALLCVQEKAADRPAMSEVVS 433 (476)
Q Consensus 391 ~~-------------~~d-~~~~~~-~~~~~~~~l~~li~~Cl~~dP~~RPt~~eVl~ 433 (476)
.. ... ...... ........+.+++.+||+.+|++||++.|+++
T Consensus 230 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~~p~~Rps~~e~l~ 287 (291)
T cd07844 230 PGVSSNPEFKPYSFPFYPPRPLINHAPRLDRIPHGEELALKFLQYEPKKRISAAEAMK 287 (291)
T ss_pred hhhhhccccccccccccCChhHHHhCcCCCCchhHHHHHHHHhccCcccccCHHHHhc
Confidence 00 000 000000 00111256789999999999999999999875
|
Serine/Threonine Kinases (STKs), PCTAIRE-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily share sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. The association of PCTAIRE-like proteins with cyclins has not been widely studied, although PFTAIRE-1 has been shown to function as a CDK which is regulated by cyclin D3 as well as the |
| >cd05572 STKc_cGK_PKG Catalytic domain of the Protein Serine/Threonine Kinase, cGMP-dependent protein kinase | Back alignment and domain information |
|---|
Probab=99.89 E-value=2.5e-23 Score=201.16 Aligned_cols=175 Identities=23% Similarity=0.311 Sum_probs=132.9
Q ss_pred cccceeeccCCCC------CCCCCCChhhHHHHHHHHHHHHHHHhhcCCCceeecCCCccceEecCCCCceeccccceee
Q 045315 241 DEISFWYESYNNP------TKKGLLCWGTRVRIIEGIAQGLLYLHQYSRLRVIHRDLKASNILLDKDMNPKISDFGMARM 314 (476)
Q Consensus 241 ~~~~l~~Ey~~~~------~~~~~L~~~~~~~i~~qIa~gL~yLH~~~~~~ivH~DLkp~NILld~~~~~kL~DFGla~~ 314 (476)
...++++||++.. .+...+++.++..++.||++||+|||+.+ ++|+||||+||+++.++.++|+|||++..
T Consensus 66 ~~~~lv~e~~~~~~L~~~l~~~~~l~~~~~~~~~~~i~~~l~~lH~~~---~~h~dl~~~nilv~~~~~~~l~df~~~~~ 142 (262)
T cd05572 66 KYIYMLMEYCLGGELWTILRDRGLFDEYTARFYIACVVLAFEYLHNRG---IIYRDLKPENLLLDSNGYVKLVDFGFAKK 142 (262)
T ss_pred CccEEEEecCCCCcHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHhhCC---cccCCCCHHHEEEcCCCCEEEeeCCcccc
Confidence 3577889998732 23456899999999999999999999998 99999999999999999999999999987
Q ss_pred cCCCcccccceeeeeccCCCChhhhccCCCCccceEEeehhhhhhhhhCCCCCCcCCCCchhhhhhhhhhhcCCCccccc
Q 045315 315 FGGDELQSNTKRIVGTYGYMSPEYALRGLFSIKSDVFSFGVLLLETLSSKKNTHFYNTDSLTLLGHAWNLWNDGRTWELM 394 (476)
Q Consensus 315 ~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~s~ksDVwSlGvvl~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 394 (476)
..... ......++..|++||.+.+..++.++|+||||+++|++++|..|+.....+........ .....
T Consensus 143 ~~~~~---~~~~~~~~~~~~~PE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~---~~~~~----- 211 (262)
T cd05572 143 LKSGQ---KTWTFCGTPEYVAPEIILNKGYDFSVDYWSLGILLYELLTGRPPFGEDDEDPMEIYNDI---LKGNG----- 211 (262)
T ss_pred cCccc---ccccccCCcCccChhHhcCCCCCChhhhhhhHHHHHHHHhCCCCcCCCCCCHHHHHHHH---hccCC-----
Confidence 65432 12224578899999999888899999999999999999999999875443222211111 10000
Q ss_pred CcccCCCCCHHHHHHHHHHHHHchhhcccCCCC-----HHHHHH
Q 045315 395 DPISQNGASYPILKRYINVALLCVQEKAADRPA-----MSEVVS 433 (476)
Q Consensus 395 d~~~~~~~~~~~~~~l~~li~~Cl~~dP~~RPt-----~~eVl~ 433 (476)
....+......+.+++.+||+.+|++||+ ++|+++
T Consensus 212 ----~~~~~~~~~~~~~~~i~~~l~~~p~~R~~~~~~~~~~l~~ 251 (262)
T cd05572 212 ----KLEFPNYIDKAAKDLIKQLLRRNPEERLGNLKGGIKDIKK 251 (262)
T ss_pred ----CCCCCcccCHHHHHHHHHHccCChhhCcCCcccCHHHHhc
Confidence 01111122467899999999999999999 666654
|
Serine/Threonine Kinases (STKs), cGMP-dependent protein kinase (cGK or PKG) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Mammals have two cGK isoforms from different genes, cGKI and cGKII. cGKI exists as two splice variants, cGKI-alpha and cGKI-beta. cGK consists of an N-terminal regulatory domain containing a dimerization and an autoinhibitory pseudosubstrate region, two cGMP-binding domains, and a C-terminal catalytic domain. Binding of cGMP to both binding sites releases the inhibition of the catalytic center by the pseudosubstrate region, allowi |
| >cd06611 STKc_SLK_like Catalytic domain of Ste20-like kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=99.89 E-value=1e-23 Score=205.96 Aligned_cols=176 Identities=24% Similarity=0.332 Sum_probs=131.5
Q ss_pred cccceeeccCCCC-------CCCCCCChhhHHHHHHHHHHHHHHHhhcCCCceeecCCCccceEecCCCCceecccccee
Q 045315 241 DEISFWYESYNNP-------TKKGLLCWGTRVRIIEGIAQGLLYLHQYSRLRVIHRDLKASNILLDKDMNPKISDFGMAR 313 (476)
Q Consensus 241 ~~~~l~~Ey~~~~-------~~~~~L~~~~~~~i~~qIa~gL~yLH~~~~~~ivH~DLkp~NILld~~~~~kL~DFGla~ 313 (476)
+..++++||++.. ...+.+++.++..++.|++.||+|||+.+ |+|+||||+||+++.++.++|+|||++.
T Consensus 75 ~~~~lv~e~~~~~~L~~~~~~~~~~l~~~~~~~~~~ql~~~l~~lh~~~---i~h~dl~p~nili~~~~~~~l~d~g~~~ 151 (280)
T cd06611 75 NKLWILIEFCDGGALDSIMLELERGLTEPQIRYVCRQMLEALNFLHSHK---VIHRDLKAGNILLTLDGDVKLADFGVSA 151 (280)
T ss_pred CeEEEEeeccCCCcHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCChhhEEECCCCCEEEccCccch
Confidence 4678899999842 22457999999999999999999999999 9999999999999999999999999987
Q ss_pred ecCCCcccccceeeeeccCCCChhhhc-----cCCCCccceEEeehhhhhhhhhCCCCCCcCCCCchhhhhhhhhhhcCC
Q 045315 314 MFGGDELQSNTKRIVGTYGYMSPEYAL-----RGLFSIKSDVFSFGVLLLETLSSKKNTHFYNTDSLTLLGHAWNLWNDG 388 (476)
Q Consensus 314 ~~~~~~~~~~~~~~~gt~~y~aPE~l~-----~~~~s~ksDVwSlGvvl~elltG~~p~~~~~~~~~~~~~~~~~~~~~~ 388 (476)
....... ......++..|+|||.+. ...++.++|+||||+++|||++|+.||....... ... . ...+
T Consensus 152 ~~~~~~~--~~~~~~~~~~y~~PE~~~~~~~~~~~~~~~sDi~slG~il~~l~~g~~p~~~~~~~~--~~~---~-~~~~ 223 (280)
T cd06611 152 KNKSTLQ--KRDTFIGTPYWMAPEVVACETFKDNPYDYKADIWSLGITLIELAQMEPPHHELNPMR--VLL---K-ILKS 223 (280)
T ss_pred hhccccc--ccceeecchhhcCHHHHhhcccCCCCCCccccHHHHHHHHHHHHhCCCCcccCCHHH--HHH---H-HhcC
Confidence 6433221 122356889999999875 3457789999999999999999999986432111 110 1 1111
Q ss_pred CcccccCcccCCCCCHHHHHHHHHHHHHchhhcccCCCCHHHHHHH
Q 045315 389 RTWELMDPISQNGASYPILKRYINVALLCVQEKAADRPAMSEVVSM 434 (476)
Q Consensus 389 ~~~~~~d~~~~~~~~~~~~~~l~~li~~Cl~~dP~~RPt~~eVl~~ 434 (476)
.. +... .+......+.+++.+||+.+|.+||++.++++.
T Consensus 224 ~~-----~~~~--~~~~~~~~~~~li~~~l~~~p~~Rps~~~il~~ 262 (280)
T cd06611 224 EP-----PTLD--QPSKWSSSFNDFLKSCLVKDPDDRPTAAELLKH 262 (280)
T ss_pred CC-----CCcC--CcccCCHHHHHHHHHHhccChhhCcCHHHHhcC
Confidence 11 0000 011223467899999999999999999999764
|
Serine/threonine kinases (STKs), Ste20-like kinase (SLK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SLK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of the subfamily include SLK, STK10 (also called LOK for lymphocyte-oriented kinase), SmSLK (Schistosoma mansoni SLK), and related proteins. SLK promotes apoptosis through apoptosis signal-regulating kinase 1 (ASK1) and the mitogen-activated protein kinase (MAPK) p38. It also plays a role in mediating actin reorganization. STK10 is responsible in regulating the CD28 responsive element in T cells, as well as leukocyte function associated anti |
| >cd06631 STKc_YSK4 Catalytic domain of the Protein Serine/Threonine Kinase, Yeast Sps1/Ste20-related kinase 4 | Back alignment and domain information |
|---|
Probab=99.89 E-value=6.6e-24 Score=205.51 Aligned_cols=177 Identities=24% Similarity=0.326 Sum_probs=132.1
Q ss_pred cccceeeccCCCCC------CCCCCChhhHHHHHHHHHHHHHHHhhcCCCceeecCCCccceEecCCCCceeccccceee
Q 045315 241 DEISFWYESYNNPT------KKGLLCWGTRVRIIEGIAQGLLYLHQYSRLRVIHRDLKASNILLDKDMNPKISDFGMARM 314 (476)
Q Consensus 241 ~~~~l~~Ey~~~~~------~~~~L~~~~~~~i~~qIa~gL~yLH~~~~~~ivH~DLkp~NILld~~~~~kL~DFGla~~ 314 (476)
+..++++||++... +..++++..+..++.|++.||+|||+.+ ++|+||+|+||+++.++.+||+|||++..
T Consensus 75 ~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~qi~~~l~~lH~~~---i~H~dl~p~nil~~~~~~~~l~dfg~~~~ 151 (265)
T cd06631 75 NTISIFMEFVPGGSISSILNRFGPLPEPVFCKYTKQILDGVAYLHNNC---VVHRDIKGNNVMLMPNGIIKLIDFGCARR 151 (265)
T ss_pred CeEEEEEecCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCC---cccCCcCHHhEEECCCCeEEeccchhhHh
Confidence 45678889987432 3357899999999999999999999998 99999999999999999999999999876
Q ss_pred cCCCcc----cccceeeeeccCCCChhhhccCCCCccceEEeehhhhhhhhhCCCCCCcCCCCchhhhhhhhhhhcCCCc
Q 045315 315 FGGDEL----QSNTKRIVGTYGYMSPEYALRGLFSIKSDVFSFGVLLLETLSSKKNTHFYNTDSLTLLGHAWNLWNDGRT 390 (476)
Q Consensus 315 ~~~~~~----~~~~~~~~gt~~y~aPE~l~~~~~s~ksDVwSlGvvl~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~ 390 (476)
...... ........++..|+|||.+.+..++.++|+|||||++|++++|+.||........ ... ......
T Consensus 152 ~~~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~~Dv~slG~~~~~l~~g~~p~~~~~~~~~-~~~----~~~~~~- 225 (265)
T cd06631 152 LAWVGLHGTHSNMLKSMHGTPYWMAPEVINESGYGRKSDIWSIGCTVFEMATGKPPLASMDRLAA-MFY----IGAHRG- 225 (265)
T ss_pred hhhccccccccccccccCCCccccChhhhcCCCCcchhhHHHHHHHHHHHHhCCCccccCChHHH-HHH----hhhccC-
Confidence 532111 1111234578899999999888899999999999999999999999864321111 000 000000
Q ss_pred ccccCcccCCCCCHHHHHHHHHHHHHchhhcccCCCCHHHHHH
Q 045315 391 WELMDPISQNGASYPILKRYINVALLCVQEKAADRPAMSEVVS 433 (476)
Q Consensus 391 ~~~~d~~~~~~~~~~~~~~l~~li~~Cl~~dP~~RPt~~eVl~ 433 (476)
..+ ..+......+.+++.+||+.+|++||++.++++
T Consensus 226 ---~~~----~~~~~~~~~~~~~i~~~l~~~p~~Rp~~~~~l~ 261 (265)
T cd06631 226 ---LMP----RLPDSFSAAAIDFVTSCLTRDQHERPSALQLLR 261 (265)
T ss_pred ---CCC----CCCCCCCHHHHHHHHHHhcCCcccCCCHHHHhc
Confidence 001 111223456889999999999999999999874
|
Serine/threonine kinases (STKs), yeast Sps1/Ste20-related kinase 4 (YSK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The YSK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. YSK4 is a putative MAPKKK, whose mammalian gene has been isolated. MAPKKKs (MKKKs or MAP3Ks) phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. |
| >cd08220 STKc_Nek8 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 8 | Back alignment and domain information |
|---|
Probab=99.89 E-value=1.8e-23 Score=201.00 Aligned_cols=172 Identities=27% Similarity=0.347 Sum_probs=131.3
Q ss_pred cccceeeccCCCC--------CCCCCCChhhHHHHHHHHHHHHHHHhhcCCCceeecCCCccceEecCCC-Cceeccccc
Q 045315 241 DEISFWYESYNNP--------TKKGLLCWGTRVRIIEGIAQGLLYLHQYSRLRVIHRDLKASNILLDKDM-NPKISDFGM 311 (476)
Q Consensus 241 ~~~~l~~Ey~~~~--------~~~~~L~~~~~~~i~~qIa~gL~yLH~~~~~~ivH~DLkp~NILld~~~-~~kL~DFGl 311 (476)
+..++++||++.. .....+++.++.+++.|+++||+|||+++ ++|+||||+||+++.+. .+||+|||+
T Consensus 72 ~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lh~~~---i~h~dl~~~nil~~~~~~~~~l~d~~~ 148 (256)
T cd08220 72 KALMIVMEYAPGGTLAEYIQKRCNSLLDEDTILHFFVQILLALHHVHTKL---ILHRDLKTQNILLDKHKMVVKIGDFGI 148 (256)
T ss_pred CEEEEEEecCCCCCHHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCCHHHEEEcCCCCEEEEccCCC
Confidence 4578889998732 22456899999999999999999999998 99999999999998554 579999999
Q ss_pred eeecCCCcccccceeeeeccCCCChhhhccCCCCccceEEeehhhhhhhhhCCCCCCcCCCCchhhhhhhhhhhcCCCcc
Q 045315 312 ARMFGGDELQSNTKRIVGTYGYMSPEYALRGLFSIKSDVFSFGVLLLETLSSKKNTHFYNTDSLTLLGHAWNLWNDGRTW 391 (476)
Q Consensus 312 a~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~s~ksDVwSlGvvl~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~ 391 (476)
+........ .....++..|+|||.+.+..++.++|+||||+++++|++|+.|+....... .... .. .+...
T Consensus 149 ~~~~~~~~~---~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~~l~~l~~~~~~~~~~~~~~--~~~~---~~-~~~~~ 219 (256)
T cd08220 149 SKILSSKSK---AYTVVGTPCYISPELCEGKPYNQKSDIWALGCVLYELASLKRAFEAANLPA--LVLK---IM-SGTFA 219 (256)
T ss_pred ceecCCCcc---ccccccCCcccCchhccCCCCCcccchHHHHHHHHHHHhCCCCcccCchHH--HHHH---HH-hcCCC
Confidence 987654321 122457889999999988888999999999999999999999986443211 1111 11 11111
Q ss_pred cccCcccCCCCCHHHHHHHHHHHHHchhhcccCCCCHHHHHH
Q 045315 392 ELMDPISQNGASYPILKRYINVALLCVQEKAADRPAMSEVVS 433 (476)
Q Consensus 392 ~~~d~~~~~~~~~~~~~~l~~li~~Cl~~dP~~RPt~~eVl~ 433 (476)
. ........+.+++.+||+.+|++|||+.|+++
T Consensus 220 ~---------~~~~~~~~l~~li~~~l~~~p~~Rpt~~~ll~ 252 (256)
T cd08220 220 P---------ISDRYSPDLRQLILSMLNLDPSKRPQLSQIMA 252 (256)
T ss_pred C---------CCCCcCHHHHHHHHHHccCChhhCCCHHHHhh
Confidence 1 11123456889999999999999999999986
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 8 (Nek8) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek8 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek8 contains an N-terminal kinase catalytic domain and a C-terminal RCC1 (regulator of chromosome condensation) domain. A double point mutation in Nek8 causes cystic kidney disease in mice that genetically resembles human autosomal recessive polycystic kidney disease (ARPKD). Nek8 is also associated with |
| >cd07840 STKc_CDK9_like Catalytic domain of Cyclin-Dependent protein Kinase 9-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=99.89 E-value=1.1e-23 Score=205.72 Aligned_cols=187 Identities=21% Similarity=0.257 Sum_probs=131.9
Q ss_pred cccceeeccCCCC------CCCCCCChhhHHHHHHHHHHHHHHHhhcCCCceeecCCCccceEecCCCCceeccccceee
Q 045315 241 DEISFWYESYNNP------TKKGLLCWGTRVRIIEGIAQGLLYLHQYSRLRVIHRDLKASNILLDKDMNPKISDFGMARM 314 (476)
Q Consensus 241 ~~~~l~~Ey~~~~------~~~~~L~~~~~~~i~~qIa~gL~yLH~~~~~~ivH~DLkp~NILld~~~~~kL~DFGla~~ 314 (476)
+.+++++||++.. .....+++.+++.++.||++||+|||+.+ ++|+||||+||++++++.+||+|||++..
T Consensus 73 ~~~~lv~e~~~~~l~~~~~~~~~~~~~~~~~~i~~~i~~al~~LH~~~---~~h~dl~p~nil~~~~~~~~l~d~g~~~~ 149 (287)
T cd07840 73 GSIYMVFEYMDHDLTGLLDSPEVKFTESQIKCYMKQLLEGLQYLHSNG---ILHRDIKGSNILINNDGVLKLADFGLARP 149 (287)
T ss_pred CcEEEEeccccccHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHHCC---ceeccCcHHHeEEcCCCCEEEccccceee
Confidence 4678888988721 12357999999999999999999999998 99999999999999999999999999987
Q ss_pred cCCCcccccceeeeeccCCCChhhhcc-CCCCccceEEeehhhhhhhhhCCCCCCcCCCCchhhhhhhhhhhc---CCCc
Q 045315 315 FGGDELQSNTKRIVGTYGYMSPEYALR-GLFSIKSDVFSFGVLLLETLSSKKNTHFYNTDSLTLLGHAWNLWN---DGRT 390 (476)
Q Consensus 315 ~~~~~~~~~~~~~~gt~~y~aPE~l~~-~~~s~ksDVwSlGvvl~elltG~~p~~~~~~~~~~~~~~~~~~~~---~~~~ 390 (476)
....... ......++..|+|||.+.+ ..++.++||||||++++||++|+.|+....... .......... ....
T Consensus 150 ~~~~~~~-~~~~~~~~~~y~~PE~~~~~~~~~~~~Dv~slG~~l~el~t~~~p~~~~~~~~--~~~~~~~~~~~~~~~~~ 226 (287)
T cd07840 150 YTKRNSA-DYTNRVITLWYRPPELLLGATRYGPEVDMWSVGCILAELFLGKPIFQGSTELE--QLEKIFELCGSPTDENW 226 (287)
T ss_pred ccCCCcc-cccccccccccCCceeeEccccCChHHHHHHHHHHHHHHHhCCCCCCCCChHH--HHHHHHHHhCCCchhhc
Confidence 6543211 1122346788999997764 457899999999999999999999986543211 1111111000 0000
Q ss_pred ccc--------cCc------ccCCCCCHHHHHHHHHHHHHchhhcccCCCCHHHHHH
Q 045315 391 WEL--------MDP------ISQNGASYPILKRYINVALLCVQEKAADRPAMSEVVS 433 (476)
Q Consensus 391 ~~~--------~d~------~~~~~~~~~~~~~l~~li~~Cl~~dP~~RPt~~eVl~ 433 (476)
... ..+ .+...........+.+++.+||+.+|++||+++++++
T Consensus 227 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~P~~Rp~~~~~l~ 283 (287)
T cd07840 227 PGVSKLPWFENLKPKKPYKRRLREFFKHLIDPSALDLLDKLLTLDPKKRISADQALQ 283 (287)
T ss_pred cccccchhhhhccccccchhHHHHHhcccCCHHHHHHHHHHcCCChhhCcCHHHHhh
Confidence 000 000 0000000112567889999999999999999999875
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 9 (CDK9)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK9-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK9 and CDK12 from higher eukaryotes, yeast BUR1, C-type plant CDKs (CdkC), and similar proteins. CDK9, BUR1, and CdkC are functionally equivalent. They act as a kinase for the C-terminal domain of RNA po |
| >cd07866 STKc_BUR1 Catalytic domain of the Serine/Threonine Kinase, Fungal Cyclin-Dependent protein Kinase Bypass UAS Requirement 1 and similar proteins | Back alignment and domain information |
|---|
Probab=99.89 E-value=2.4e-23 Score=206.14 Aligned_cols=187 Identities=19% Similarity=0.204 Sum_probs=129.5
Q ss_pred ccceeeccCCC------CCCCCCCChhhHHHHHHHHHHHHHHHhhcCCCceeecCCCccceEecCCCCceeccccceeec
Q 045315 242 EISFWYESYNN------PTKKGLLCWGTRVRIIEGIAQGLLYLHQYSRLRVIHRDLKASNILLDKDMNPKISDFGMARMF 315 (476)
Q Consensus 242 ~~~l~~Ey~~~------~~~~~~L~~~~~~~i~~qIa~gL~yLH~~~~~~ivH~DLkp~NILld~~~~~kL~DFGla~~~ 315 (476)
..++++||+.. ......+++.++..++.||++||+|||+.+ ++|+||||+||++++++.+||+|||+++..
T Consensus 89 ~~~lv~~~~~~~l~~~~~~~~~~~~~~~~~~i~~~l~~al~~lH~~~---i~H~dl~p~nil~~~~~~~~l~dfg~~~~~ 165 (311)
T cd07866 89 SVYMVTPYMDHDLSGLLENPSVKLTESQIKCYMLQLLEGINYLHENH---ILHRDIKAANILIDNQGILKIADFGLARPY 165 (311)
T ss_pred eEEEEEecCCcCHHHHHhccccCCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCCHHHEEECCCCCEEECcCccchhc
Confidence 35677888762 123457999999999999999999999998 999999999999999999999999999865
Q ss_pred CCCccc---------ccceeeeeccCCCChhhhcc-CCCCccceEEeehhhhhhhhhCCCCCCcCCCCchhhhhhhhhhh
Q 045315 316 GGDELQ---------SNTKRIVGTYGYMSPEYALR-GLFSIKSDVFSFGVLLLETLSSKKNTHFYNTDSLTLLGHAWNLW 385 (476)
Q Consensus 316 ~~~~~~---------~~~~~~~gt~~y~aPE~l~~-~~~s~ksDVwSlGvvl~elltG~~p~~~~~~~~~~~~~~~~~~~ 385 (476)
...... .......++..|+|||.+.+ ..++.++|||||||++|||++|++||....... .........
T Consensus 166 ~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~el~~g~~~~~~~~~~~--~~~~~~~~~ 243 (311)
T cd07866 166 DGPPPNPKGGGGGGTRKYTNLVVTRWYRPPELLLGERRYTTAVDIWGIGCVFAEMFTRRPILQGKSDID--QLHLIFKLC 243 (311)
T ss_pred cCCCcccccCCcccccccccceeccCcCChHHhhCCCccCchhHhHHHHHHHHHHHhCCCCCCCCCHHH--HHHHHHHHh
Confidence 432211 11122456888999998865 457899999999999999999999986443211 111111000
Q ss_pred cCC---------Cccccc----CcccCCC---CCHHHHHHHHHHHHHchhhcccCCCCHHHHHH
Q 045315 386 NDG---------RTWELM----DPISQNG---ASYPILKRYINVALLCVQEKAADRPAMSEVVS 433 (476)
Q Consensus 386 ~~~---------~~~~~~----d~~~~~~---~~~~~~~~l~~li~~Cl~~dP~~RPt~~eVl~ 433 (476)
... ...... ....... ........+.+++.+||+.||++|||+.|++.
T Consensus 244 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~p~~R~t~~ell~ 307 (311)
T cd07866 244 GTPTEETWPGWRSLPGCEGVHSFTNYPRTLEERFGKLGPEGLDLLSKLLSLDPYKRLTASDALE 307 (311)
T ss_pred CCCChhhchhhhhcccccccccCCCCCccHHHHcccCChhHHHHHHHHcccCcccCcCHHHHhc
Confidence 000 000000 0000000 00112256889999999999999999998874
|
Serine/Threonine Kinases (STKs), Bypass UAS Requirement 1 (BUR1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The BUR1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. BUR1, also called SGV1, is a yeast Cyclin-Dependent protein Kinase (CDK) that is functionally equivalent to mammalian CDK9. It associates with the cyclin BUR2. BUR genes were orginally identified in a genetic |
| >cd06622 PKc_MAPKK_PBS2_like Catalytic domain of fungal PBS2-like dual-specificity MAP kinase kinases | Back alignment and domain information |
|---|
Probab=99.89 E-value=2.5e-23 Score=203.87 Aligned_cols=174 Identities=21% Similarity=0.332 Sum_probs=129.7
Q ss_pred cccceeeccCCCCC---------CCCCCChhhHHHHHHHHHHHHHHHhh-cCCCceeecCCCccceEecCCCCceecccc
Q 045315 241 DEISFWYESYNNPT---------KKGLLCWGTRVRIIEGIAQGLLYLHQ-YSRLRVIHRDLKASNILLDKDMNPKISDFG 310 (476)
Q Consensus 241 ~~~~l~~Ey~~~~~---------~~~~L~~~~~~~i~~qIa~gL~yLH~-~~~~~ivH~DLkp~NILld~~~~~kL~DFG 310 (476)
+..++++||++... ....+++..+..++.||+.||.|||+ .+ ++|+||||+||+++.++.+||+|||
T Consensus 72 ~~~~lv~e~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~~---i~H~dl~p~nil~~~~~~~~l~dfg 148 (286)
T cd06622 72 GAVYMCMEYMDAGSLDKLYAGGVATEGIPEDVLRRITYAVVKGLKFLKEEHN---IIHRDVKPTNVLVNGNGQVKLCDFG 148 (286)
T ss_pred CeEEEEEeecCCCCHHHHHHhccccCCCCHHHHHHHHHHHHHHHHHHHhcCC---EeeCCCCHHHEEECCCCCEEEeecC
Confidence 46788999998321 13479999999999999999999997 46 9999999999999999999999999
Q ss_pred ceeecCCCcccccceeeeeccCCCChhhhccC------CCCccceEEeehhhhhhhhhCCCCCCcCCCCchhhhhhhhhh
Q 045315 311 MARMFGGDELQSNTKRIVGTYGYMSPEYALRG------LFSIKSDVFSFGVLLLETLSSKKNTHFYNTDSLTLLGHAWNL 384 (476)
Q Consensus 311 la~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~------~~s~ksDVwSlGvvl~elltG~~p~~~~~~~~~~~~~~~~~~ 384 (476)
++....... .....++..|+|||.+.+. .++.++|+|||||++|++++|+.||...... ....... .
T Consensus 149 ~~~~~~~~~----~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~--~~~~~~~-~ 221 (286)
T cd06622 149 VSGNLVASL----AKTNIGCQSYMAPERIKSGGPNQNPTYTVQSDVWSLGLSILEMALGRYPYPPETYA--NIFAQLS-A 221 (286)
T ss_pred CcccccCCc----cccCCCccCccCcchhcCCCCCccCCCCcccchHhHHHHHHHHHhCCCCCCCcchh--hHHHHHH-H
Confidence 997654322 1223578899999988543 3588999999999999999999998643211 1111110 0
Q ss_pred hcCCCcccccCcccCCCCCHHHHHHHHHHHHHchhhcccCCCCHHHHHH
Q 045315 385 WNDGRTWELMDPISQNGASYPILKRYINVALLCVQEKAADRPAMSEVVS 433 (476)
Q Consensus 385 ~~~~~~~~~~d~~~~~~~~~~~~~~l~~li~~Cl~~dP~~RPt~~eVl~ 433 (476)
...+.. ...+......+.+++.+||+.+|++||++.+++.
T Consensus 222 ~~~~~~---------~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~l~~ 261 (286)
T cd06622 222 IVDGDP---------PTLPSGYSDDAQDFVAKCLNKIPNRRPTYAQLLE 261 (286)
T ss_pred HhhcCC---------CCCCcccCHHHHHHHHHHcccCcccCCCHHHHhc
Confidence 001111 1112234567889999999999999999999886
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, fungal PBS2-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include |
| >cd06632 STKc_MEKK1_plant Catalytic domain of the Protein Serine/Threonine Kinase, Plant MAP/ERK kinase kinase 1 | Back alignment and domain information |
|---|
Probab=99.89 E-value=1.9e-23 Score=200.91 Aligned_cols=173 Identities=24% Similarity=0.326 Sum_probs=132.2
Q ss_pred cccceeeccCCCC------CCCCCCChhhHHHHHHHHHHHHHHHhhcCCCceeecCCCccceEecCCCCceeccccceee
Q 045315 241 DEISFWYESYNNP------TKKGLLCWGTRVRIIEGIAQGLLYLHQYSRLRVIHRDLKASNILLDKDMNPKISDFGMARM 314 (476)
Q Consensus 241 ~~~~l~~Ey~~~~------~~~~~L~~~~~~~i~~qIa~gL~yLH~~~~~~ivH~DLkp~NILld~~~~~kL~DFGla~~ 314 (476)
+.+++++||++.. .+...+++.++..++.||++||+|||+.+ ++|+||+|+||+++.++.+||+|||++..
T Consensus 75 ~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~---i~H~dl~~~ni~~~~~~~~kl~d~~~~~~ 151 (258)
T cd06632 75 DNLYIFLELVPGGSLAKLLKKYGSFPEPVIRLYTRQILLGLEYLHDRN---TVHRDIKGANILVDTNGVVKLADFGMAKQ 151 (258)
T ss_pred CeEEEEEEecCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCCHHHEEECCCCCEEEccCcccee
Confidence 4678889998743 23456899999999999999999999998 99999999999999999999999999887
Q ss_pred cCCCcccccceeeeeccCCCChhhhccCC-CCccceEEeehhhhhhhhhCCCCCCcCCCCchhhhhhhhhhhcCCCcccc
Q 045315 315 FGGDELQSNTKRIVGTYGYMSPEYALRGL-FSIKSDVFSFGVLLLETLSSKKNTHFYNTDSLTLLGHAWNLWNDGRTWEL 393 (476)
Q Consensus 315 ~~~~~~~~~~~~~~gt~~y~aPE~l~~~~-~s~ksDVwSlGvvl~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~ 393 (476)
..... ......++..|++||.+.... ++.++|+||||+++|++++|+.||..... ... ...........
T Consensus 152 ~~~~~---~~~~~~~~~~y~~pe~~~~~~~~~~~~D~~slG~~l~~l~~g~~pf~~~~~--~~~---~~~~~~~~~~~-- 221 (258)
T cd06632 152 VVEFS---FAKSFKGSPYWMAPEVIAQQGGYGLAADIWSLGCTVLEMATGKPPWSQLEG--VAA---VFKIGRSKELP-- 221 (258)
T ss_pred ccccc---cccccCCCcceeCHHHhcCCCCCCchhhhHHHHHHHHHHHhCCCCcccCcH--HHH---HHHHHhcccCC--
Confidence 54332 122345788999999987766 89999999999999999999999864331 111 01111101110
Q ss_pred cCcccCCCCCHHHHHHHHHHHHHchhhcccCCCCHHHHHH
Q 045315 394 MDPISQNGASYPILKRYINVALLCVQEKAADRPAMSEVVS 433 (476)
Q Consensus 394 ~d~~~~~~~~~~~~~~l~~li~~Cl~~dP~~RPt~~eVl~ 433 (476)
..+......+.+++.+||+.+|++||++.++++
T Consensus 222 -------~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~~l~ 254 (258)
T cd06632 222 -------PIPDHLSDEAKDFILKCLQRDPSLRPTAAELLE 254 (258)
T ss_pred -------CcCCCcCHHHHHHHHHHhhcCcccCcCHHHHhc
Confidence 111123456788999999999999999999875
|
Serine/threonine kinases (STKs), plant MAP/ERK kinase kinase 1 (MEKK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The plant MEKK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of plant mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks) including Arabidopsis thaliana MEKK1 and MAPKKK3. MEKK1 is a MAPKKK that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Arabidops |
| >KOG4278 consensus Protein tyrosine kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.89 E-value=2.2e-24 Score=218.13 Aligned_cols=179 Identities=24% Similarity=0.344 Sum_probs=141.6
Q ss_pred ccceeeccCCC--------CCCCCCCChhhHHHHHHHHHHHHHHHhhcCCCceeecCCCccceEecCCCCceecccccee
Q 045315 242 EISFWYESYNN--------PTKKGLLCWGTRVRIIEGIAQGLLYLHQYSRLRVIHRDLKASNILLDKDMNPKISDFGMAR 313 (476)
Q Consensus 242 ~~~l~~Ey~~~--------~~~~~~L~~~~~~~i~~qIa~gL~yLH~~~~~~ivH~DLkp~NILld~~~~~kL~DFGla~ 313 (476)
-.|++.|||.. +.++..++--..+.++.||+.|++||..++ +|||||...|+|+.++..+|++|||+++
T Consensus 337 PFYIiTEfM~yGNLLdYLRecnr~ev~avvLlyMAtQIsSaMeYLEkkn---FIHRDLAARNCLVgEnhiVKvADFGLsR 413 (1157)
T KOG4278|consen 337 PFYIITEFMCYGNLLDYLRECNRSEVPAVVLLYMATQISSAMEYLEKKN---FIHRDLAARNCLVGENHIVKVADFGLSR 413 (1157)
T ss_pred CeEEEEecccCccHHHHHHHhchhhcchhHHHHHHHHHHHHHHHHHHhh---hhhhhhhhhhccccccceEEeeccchhh
Confidence 36789999993 345667888888999999999999999999 9999999999999999999999999999
Q ss_pred ecCCCcccccceeeeeccCCCChhhhccCCCCccceEEeehhhhhhhhh-CCCCCCcCCCCchhhhhhhhhhhcCCCccc
Q 045315 314 MFGGDELQSNTKRIVGTYGYMSPEYALRGLFSIKSDVFSFGVLLLETLS-SKKNTHFYNTDSLTLLGHAWNLWNDGRTWE 392 (476)
Q Consensus 314 ~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~s~ksDVwSlGvvl~ellt-G~~p~~~~~~~~~~~~~~~~~~~~~~~~~~ 392 (476)
++..+....... ..-...|.|||-+....++.|+|||+|||+||||.| |..|++..+ ...++.++..+-..
T Consensus 414 lMtgDTYTAHAG-AKFPIKWTAPEsLAyNtFSiKSDVWAFGVLLWEIATYGMsPYPGid------lSqVY~LLEkgyRM- 485 (1157)
T KOG4278|consen 414 LMTGDTYTAHAG-AKFPIKWTAPESLAYNTFSIKSDVWAFGVLLWEIATYGMSPYPGID------LSQVYGLLEKGYRM- 485 (1157)
T ss_pred hhcCCceecccC-ccCcccccCcccccccccccchhhHHHHHHHHHHHhcCCCCCCCcc------HHHHHHHHhccccc-
Confidence 987654333221 223568999999999999999999999999999987 556665432 12233343333222
Q ss_pred ccCcccCCCCCHHHHHHHHHHHHHchhhcccCCCCHHHHHHHHhccc
Q 045315 393 LMDPISQNGASYPILKRYINVALLCVQEKAADRPAMSEVVSMLSNEF 439 (476)
Q Consensus 393 ~~d~~~~~~~~~~~~~~l~~li~~Cl~~dP~~RPt~~eVl~~L~~~~ 439 (476)
+.+..+.+.+.+||+.||++.|.+||+++|+-+.+|.++
T Consensus 486 --------~~PeGCPpkVYeLMraCW~WsPsDRPsFaeiHqafEtmf 524 (1157)
T KOG4278|consen 486 --------DGPEGCPPKVYELMRACWNWSPSDRPSFAEIHQAFETMF 524 (1157)
T ss_pred --------cCCCCCCHHHHHHHHHHhcCCcccCccHHHHHHHHHHHh
Confidence 222334567899999999999999999999999998765
|
|
| >cd05574 STKc_phototropin_like Catalytic domain of Phototropin-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=99.89 E-value=1.5e-23 Score=208.70 Aligned_cols=175 Identities=20% Similarity=0.216 Sum_probs=130.6
Q ss_pred ccceeeccCCCC--------CCCCCCChhhHHHHHHHHHHHHHHHhhcCCCceeecCCCccceEecCCCCceecccccee
Q 045315 242 EISFWYESYNNP--------TKKGLLCWGTRVRIIEGIAQGLLYLHQYSRLRVIHRDLKASNILLDKDMNPKISDFGMAR 313 (476)
Q Consensus 242 ~~~l~~Ey~~~~--------~~~~~L~~~~~~~i~~qIa~gL~yLH~~~~~~ivH~DLkp~NILld~~~~~kL~DFGla~ 313 (476)
..++++||+.+. .....+++..+..++.||++||+|||+.+ ++|+||||+||+++.++.++|+|||++.
T Consensus 75 ~~~lv~e~~~~~~L~~~~~~~~~~~l~~~~~~~~~~qi~~~l~~lH~~~---i~H~dlkp~Nili~~~~~~~l~dfg~~~ 151 (316)
T cd05574 75 YLCLVMDYCPGGELFRLLQRQPGKCLSEEVARFYAAEVLLALEYLHLLG---IVYRDLKPENILLHESGHIMLSDFDLSK 151 (316)
T ss_pred EEEEEEEecCCCCHHHHHHhCCCCccCHHHHHHHHHHHHHHHHHHHHCC---eeccCCChHHeEEcCCCCEEEeecchhh
Confidence 467888888632 23467999999999999999999999998 9999999999999999999999999987
Q ss_pred ecCCCccc---------------------------ccceeeeeccCCCChhhhccCCCCccceEEeehhhhhhhhhCCCC
Q 045315 314 MFGGDELQ---------------------------SNTKRIVGTYGYMSPEYALRGLFSIKSDVFSFGVLLLETLSSKKN 366 (476)
Q Consensus 314 ~~~~~~~~---------------------------~~~~~~~gt~~y~aPE~l~~~~~s~ksDVwSlGvvl~elltG~~p 366 (476)
........ .......|+..|+|||.+.+..++.++||||||+++|+|++|+.|
T Consensus 152 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~Di~slG~ll~~l~~g~~p 231 (316)
T cd05574 152 QSDVEPPPVSKALRKGSRRSSVNSIPSETFSEEPSFRSNSFVGTEEYIAPEVISGDGHGSAVDWWTLGILLYEMLYGTTP 231 (316)
T ss_pred cccccccccccccccccccccccccchhhhcccccCCCCCCcCccCCcCHHHHcCCCCCchHHHHHHHHHHHHHhhCCCC
Confidence 54321100 011124678899999999988899999999999999999999999
Q ss_pred CCcCCCCchhhhhhhhhhhcCCCcccccCcccCCCCCHHHHHHHHHHHHHchhhcccCCCC----HHHHHH
Q 045315 367 THFYNTDSLTLLGHAWNLWNDGRTWELMDPISQNGASYPILKRYINVALLCVQEKAADRPA----MSEVVS 433 (476)
Q Consensus 367 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~l~~li~~Cl~~dP~~RPt----~~eVl~ 433 (476)
|........ +. .... ..............+.+++.+||+.+|++||+ +++++.
T Consensus 232 f~~~~~~~~-~~----~~~~---------~~~~~~~~~~~~~~~~~li~~~l~~~p~~R~s~~~~~~~ll~ 288 (316)
T cd05574 232 FKGSNRDET-FS----NILK---------KEVTFPGSPPVSSSARDLIRKLLVKDPSKRLGSKRGAAEIKQ 288 (316)
T ss_pred CCCCchHHH-HH----HHhc---------CCccCCCccccCHHHHHHHHHHccCCHhHCCCchhhHHHHHc
Confidence 864432111 10 0110 00000111114567899999999999999999 666655
|
Serine/Threonine Kinases (STKs), Phototropin-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The phototropin-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Included in this subfamily are plant phototropins and predominantly uncharacterized fungal STKs whose catalytic domains resemble the phototropin kinase domain. One protein from Neurospora crassa is called nrc-2. Phototropins are blue-light receptors that control responses such as phototropism, stromatal opening, and chloroplast movement in order to optimize the photosynthetic efficiency of plants. They are light-activated STKs that contain an N-termin |
| >cd07855 STKc_ERK5 Catalytic domain of the Serine/Threonine Kinase, Extracellular signal-Regulated Kinase 5 | Back alignment and domain information |
|---|
Probab=99.89 E-value=1.3e-23 Score=211.02 Aligned_cols=190 Identities=21% Similarity=0.264 Sum_probs=132.9
Q ss_pred ccceeeccCCC-----CCCCCCCChhhHHHHHHHHHHHHHHHhhcCCCceeecCCCccceEecCCCCceeccccceeecC
Q 045315 242 EISFWYESYNN-----PTKKGLLCWGTRVRIIEGIAQGLLYLHQYSRLRVIHRDLKASNILLDKDMNPKISDFGMARMFG 316 (476)
Q Consensus 242 ~~~l~~Ey~~~-----~~~~~~L~~~~~~~i~~qIa~gL~yLH~~~~~~ivH~DLkp~NILld~~~~~kL~DFGla~~~~ 316 (476)
..++++||+.. ....+.+++.++..++.||+.||+|||+.+ ++||||||+||+++.++.+||+|||++....
T Consensus 82 ~~~lv~e~~~~~l~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~---ivH~dlkp~Nil~~~~~~~kl~dfg~~~~~~ 158 (334)
T cd07855 82 DVYVVMDLMESDLHHIIHSDQPLTEEHIRYFLYQLLRGLKYIHSAN---VIHRDLKPSNLLVNEDCELRIGDFGMARGLS 158 (334)
T ss_pred eEEEEEehhhhhHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCCHHHEEEcCCCcEEecccccceeec
Confidence 46788899862 123456999999999999999999999998 9999999999999999999999999998764
Q ss_pred CCccc--ccceeeeeccCCCChhhhcc-CCCCccceEEeehhhhhhhhhCCCCCCcCCCCch-hhhhh--------hhhh
Q 045315 317 GDELQ--SNTKRIVGTYGYMSPEYALR-GLFSIKSDVFSFGVLLLETLSSKKNTHFYNTDSL-TLLGH--------AWNL 384 (476)
Q Consensus 317 ~~~~~--~~~~~~~gt~~y~aPE~l~~-~~~s~ksDVwSlGvvl~elltG~~p~~~~~~~~~-~~~~~--------~~~~ 384 (476)
..... .......++..|+|||.+.+ ..++.++|||||||++|||++|+.||........ ..... ....
T Consensus 159 ~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~~Di~slG~~l~el~~g~~pf~~~~~~~~~~~~~~~~g~~~~~~~~~ 238 (334)
T cd07855 159 SSPTEHKYFMTEYVATRWYRAPELLLSLPEYTTAIDMWSVGCIFAEMLGRRQLFPGKNYVHQLKLILSVLGSPSEEVLNR 238 (334)
T ss_pred ccCcCCCcccccccccccccChHHhcCCcccccccchHHHHHHHHHHHcCCCccCCCChHHHHHHHHHHhCCChhHhhhh
Confidence 32211 11123467889999998865 4588999999999999999999999865331100 00000 0000
Q ss_pred hcCCCcccccCcc-cCCCC-----CHHHHHHHHHHHHHchhhcccCCCCHHHHHHH
Q 045315 385 WNDGRTWELMDPI-SQNGA-----SYPILKRYINVALLCVQEKAADRPAMSEVVSM 434 (476)
Q Consensus 385 ~~~~~~~~~~d~~-~~~~~-----~~~~~~~l~~li~~Cl~~dP~~RPt~~eVl~~ 434 (476)
..........+.. ..... .......+.+++.+||+.+|++||++++++..
T Consensus 239 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~~l~~ 294 (334)
T cd07855 239 IGSDRVRKYIQNLPRKQPVPWSKIFPKASPEALDLLSQMLQFDPEERITVEQALQH 294 (334)
T ss_pred hchhhHHHHHhhcccCCCCCHHHHcccCCHHHHHHHHHHccCChhhCcCHHHHHhC
Confidence 0000000000000 00000 11235678999999999999999999998873
|
Serine/Threonine Kinases (STKs), Extracellular signal-Regulated Kinase 5 (ERK5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ERK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. ERK5, also called Big MAPK1 (BMK1) or MAPK7, has a unique C-terminal extension, making it approximately twice as big as other MAPKs. This extension contains transcriptional activation capability which is inhibited by the N-terminal half. ERK5 is activated in response to growth factors and stress by a cascade that leads to its phosphorylation by the |
| >cd06621 PKc_MAPKK_Pek1_like Catalytic domain of fungal Pek1-like dual-specificity MAP kinase kinases | Back alignment and domain information |
|---|
Probab=99.89 E-value=3.3e-23 Score=203.42 Aligned_cols=182 Identities=26% Similarity=0.353 Sum_probs=134.1
Q ss_pred cccceeeccCCCC----------CCCCCCChhhHHHHHHHHHHHHHHHhhcCCCceeecCCCccceEecCCCCceecccc
Q 045315 241 DEISFWYESYNNP----------TKKGLLCWGTRVRIIEGIAQGLLYLHQYSRLRVIHRDLKASNILLDKDMNPKISDFG 310 (476)
Q Consensus 241 ~~~~l~~Ey~~~~----------~~~~~L~~~~~~~i~~qIa~gL~yLH~~~~~~ivH~DLkp~NILld~~~~~kL~DFG 310 (476)
+..+++|||++.. .+...++...+..++.||+.||+|||+.+ ++|+||+|+||+++.++.++|+|||
T Consensus 74 ~~~~lv~e~~~~~~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~~lH~~~---i~H~dl~~~nil~~~~~~~~l~dfg 150 (287)
T cd06621 74 SSIGIAMEYCEGGSLDSIYKKVKKRGGRIGEKVLGKIAESVLKGLSYLHSRK---IIHRDIKPSNILLTRKGQVKLCDFG 150 (287)
T ss_pred CeEEEEEEecCCCCHHHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCCHHHEEEecCCeEEEeecc
Confidence 3567899999732 23456899999999999999999999998 9999999999999999999999999
Q ss_pred ceeecCCCcccccceeeeeccCCCChhhhccCCCCccceEEeehhhhhhhhhCCCCCCcCCCCchhhhhhhhhhhcCCCc
Q 045315 311 MARMFGGDELQSNTKRIVGTYGYMSPEYALRGLFSIKSDVFSFGVLLLETLSSKKNTHFYNTDSLTLLGHAWNLWNDGRT 390 (476)
Q Consensus 311 la~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~s~ksDVwSlGvvl~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~ 390 (476)
++........ ....++..|+|||.+.+..++.++|+||||+++|+|++|+.|+.............. ........
T Consensus 151 ~~~~~~~~~~----~~~~~~~~y~~pE~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~~~~~~-~~~~~~~~ 225 (287)
T cd06621 151 VSGELVNSLA----GTFTGTSFYMAPERIQGKPYSITSDVWSLGLTLLEVAQNRFPFPPEGEPPLGPIELL-SYIVNMPN 225 (287)
T ss_pred cccccccccc----ccccCCccccCHHHhcCCCCCchhhHHHHHHHHHHHHhCCCCCCcccCCCCChHHHH-HHHhcCCc
Confidence 9876543211 124568899999999988999999999999999999999999875432111111111 11111111
Q ss_pred ccccCcccCCCCCHHHHHHHHHHHHHchhhcccCCCCHHHHHH
Q 045315 391 WELMDPISQNGASYPILKRYINVALLCVQEKAADRPAMSEVVS 433 (476)
Q Consensus 391 ~~~~d~~~~~~~~~~~~~~l~~li~~Cl~~dP~~RPt~~eVl~ 433 (476)
..+.+. . .......+.+.+++.+||+.+|++|||+.||++
T Consensus 226 ~~~~~~-~--~~~~~~~~~~~~li~~~l~~~p~~Rpt~~eil~ 265 (287)
T cd06621 226 PELKDE-P--GNGIKWSEEFKDFIKQCLEKDPTRRPTPWDMLE 265 (287)
T ss_pred hhhccC-C--CCCCchHHHHHHHHHHHcCCCcccCCCHHHHHh
Confidence 111111 0 111223567899999999999999999999987
|
Protein kinases (PKs), MAP kinase kinase(MAPKK) subfamily, fungal Pek1-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include |
| >cd06620 PKc_MAPKK_Byr1_like Catalytic domain of fungal Byr1-like dual-specificity MAP kinase kinases | Back alignment and domain information |
|---|
Probab=99.89 E-value=7.6e-24 Score=207.55 Aligned_cols=179 Identities=27% Similarity=0.407 Sum_probs=134.4
Q ss_pred cccceeeccCCCCC------CCCCCChhhHHHHHHHHHHHHHHHhh-cCCCceeecCCCccceEecCCCCceecccccee
Q 045315 241 DEISFWYESYNNPT------KKGLLCWGTRVRIIEGIAQGLLYLHQ-YSRLRVIHRDLKASNILLDKDMNPKISDFGMAR 313 (476)
Q Consensus 241 ~~~~l~~Ey~~~~~------~~~~L~~~~~~~i~~qIa~gL~yLH~-~~~~~ivH~DLkp~NILld~~~~~kL~DFGla~ 313 (476)
+..++++||++... +.+.+++..+..++.+++.||.|||+ .+ ++|+||||+||+++.++.++|+|||++.
T Consensus 76 ~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~~---i~H~dl~p~nil~~~~~~~~l~d~gl~~ 152 (284)
T cd06620 76 NNICMCMEFMDCGSLDRIYKKGGPIPVEILGKIAVAVVEGLTYLYNVHR---IMHRDIKPSNILVNSRGQIKLCDFGVSG 152 (284)
T ss_pred CEEEEEEecCCCCCHHHHHHhccCCCHHHHHHHHHHHHHHHHHHHHhcC---eeccCCCHHHEEECCCCcEEEccCCccc
Confidence 45789999998432 34578999999999999999999997 46 9999999999999999999999999987
Q ss_pred ecCCCcccccceeeeeccCCCChhhhccCCCCccceEEeehhhhhhhhhCCCCCCcCCCCc------hhhhhhhhhhhcC
Q 045315 314 MFGGDELQSNTKRIVGTYGYMSPEYALRGLFSIKSDVFSFGVLLLETLSSKKNTHFYNTDS------LTLLGHAWNLWND 387 (476)
Q Consensus 314 ~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~s~ksDVwSlGvvl~elltG~~p~~~~~~~~------~~~~~~~~~~~~~ 387 (476)
...... .....++..|+|||.+.+..++.++|+|||||++|++++|+.||....... ..+..........
T Consensus 153 ~~~~~~----~~~~~~~~~~~aPE~~~~~~~~~~~Di~slG~~l~~l~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~ 228 (284)
T cd06620 153 ELINSI----ADTFVGTSTYMSPERIQGGKYTVKSDVWSLGISIIELALGKFPFAFSNIDDDGQDDPMGILDLLQQIVQE 228 (284)
T ss_pred chhhhc----cCccccCcccCCHHHHccCCCCccchHHHHHHHHHHHHhCCCCCcccchhhhhhhhhhHHHHHHHHHhhc
Confidence 543221 123468899999999988889999999999999999999999987543210 0011111111100
Q ss_pred CCcccccCcccCCCCCHHHHHHHHHHHHHchhhcccCCCCHHHHHHHH
Q 045315 388 GRTWELMDPISQNGASYPILKRYINVALLCVQEKAADRPAMSEVVSML 435 (476)
Q Consensus 388 ~~~~~~~d~~~~~~~~~~~~~~l~~li~~Cl~~dP~~RPt~~eVl~~L 435 (476)
. .+.. ........+.+++.+|++.||++||++.|++++.
T Consensus 229 -~-----~~~~---~~~~~~~~~~~li~~~l~~dp~~Rpt~~e~~~~~ 267 (284)
T cd06620 229 -P-----PPRL---PSSDFPEDLRDFVDACLLKDPTERPTPQQLCAMP 267 (284)
T ss_pred -c-----CCCC---CchhcCHHHHHHHHHHhcCCcccCcCHHHHhcCc
Confidence 0 0000 0112345688999999999999999999999864
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, fungal Byr1-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include |
| >cd06606 STKc_MAPKKK Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-Activated Protein Kinase Kinase Kinase | Back alignment and domain information |
|---|
Probab=99.89 E-value=1.8e-23 Score=200.33 Aligned_cols=177 Identities=24% Similarity=0.371 Sum_probs=135.6
Q ss_pred cccceeeccCCCCC------CCCCCChhhHHHHHHHHHHHHHHHhhcCCCceeecCCCccceEecCCCCceeccccceee
Q 045315 241 DEISFWYESYNNPT------KKGLLCWGTRVRIIEGIAQGLLYLHQYSRLRVIHRDLKASNILLDKDMNPKISDFGMARM 314 (476)
Q Consensus 241 ~~~~l~~Ey~~~~~------~~~~L~~~~~~~i~~qIa~gL~yLH~~~~~~ivH~DLkp~NILld~~~~~kL~DFGla~~ 314 (476)
+..++++||++..+ +...+++.++..++.|++.||+|||+.+ ++|+||+|+||+++.++.++|+|||.+..
T Consensus 74 ~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~---~~h~dl~p~ni~i~~~~~~~l~d~~~~~~ 150 (260)
T cd06606 74 NTLNIFLEYVSGGSLSSLLKKFGKLPEPVIRKYTRQILEGLAYLHSNG---IVHRDIKGANILVDSDGVVKLADFGCAKR 150 (260)
T ss_pred CeEEEEEEecCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCC---ccccCCCHHHEEEcCCCCEEEcccccEEe
Confidence 45778889886321 2348999999999999999999999988 99999999999999999999999999987
Q ss_pred cCCCcccccceeeeeccCCCChhhhccCCCCccceEEeehhhhhhhhhCCCCCCcCCCCchhhhhhhhhhhcCCCccccc
Q 045315 315 FGGDELQSNTKRIVGTYGYMSPEYALRGLFSIKSDVFSFGVLLLETLSSKKNTHFYNTDSLTLLGHAWNLWNDGRTWELM 394 (476)
Q Consensus 315 ~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~s~ksDVwSlGvvl~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 394 (476)
..............++..|+|||.+.+...+.++|+||||+++++|++|+.|+....... ............
T Consensus 151 ~~~~~~~~~~~~~~~~~~y~~pE~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~----~~~~~~~~~~~~---- 222 (260)
T cd06606 151 LGDIETGEGTGSVRGTPYWMAPEVIRGEEYGRAADIWSLGCTVIEMATGKPPWSELGNPM----AALYKIGSSGEP---- 222 (260)
T ss_pred cccccccccccCCCCCccccCHhhhcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCchH----HHHHhccccCCC----
Confidence 765432111223567889999999988889999999999999999999999986544111 111111110111
Q ss_pred CcccCCCCCHHHHHHHHHHHHHchhhcccCCCCHHHHHH
Q 045315 395 DPISQNGASYPILKRYINVALLCVQEKAADRPAMSEVVS 433 (476)
Q Consensus 395 d~~~~~~~~~~~~~~l~~li~~Cl~~dP~~RPt~~eVl~ 433 (476)
...+......+.+++.+|++.+|++||++.++++
T Consensus 223 -----~~~~~~~~~~l~~~i~~~l~~~p~~Rp~~~~ll~ 256 (260)
T cd06606 223 -----PEIPEHLSEEAKDFLRKCLRRDPKKRPTADELLQ 256 (260)
T ss_pred -----cCCCcccCHHHHHHHHHhCcCChhhCCCHHHHhh
Confidence 1111222567889999999999999999999975
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKKKs (MKKKs or MAP3Ks) are also called MAP/ERK kinase kinases (MEKKs) in some cases. They phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. This subfamily is composed of the Apoptosis Signal-regulating Kinases ASK1 (or MAPKK |
| >cd06607 STKc_TAO Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids proteins | Back alignment and domain information |
|---|
Probab=99.89 E-value=1.7e-23 Score=207.65 Aligned_cols=171 Identities=31% Similarity=0.396 Sum_probs=130.3
Q ss_pred cccceeeccCCCC------CCCCCCChhhHHHHHHHHHHHHHHHhhcCCCceeecCCCccceEecCCCCceeccccceee
Q 045315 241 DEISFWYESYNNP------TKKGLLCWGTRVRIIEGIAQGLLYLHQYSRLRVIHRDLKASNILLDKDMNPKISDFGMARM 314 (476)
Q Consensus 241 ~~~~l~~Ey~~~~------~~~~~L~~~~~~~i~~qIa~gL~yLH~~~~~~ivH~DLkp~NILld~~~~~kL~DFGla~~ 314 (476)
+..++++||++.. .....+++.++..++.||+.||.|||+.+ ++|+||+|+||+++.++.+||+|||++..
T Consensus 88 ~~~~lv~e~~~g~l~~~~~~~~~~l~~~~~~~~~~ql~~~L~~LH~~~---i~H~dl~p~nIl~~~~~~~kL~dfg~~~~ 164 (307)
T cd06607 88 HTAWLVMEYCLGSASDILEVHKKPLQEVEIAAICHGALQGLAYLHSHE---RIHRDIKAGNILLTEPGTVKLADFGSASL 164 (307)
T ss_pred CeEEEEHHhhCCCHHHHHHHcccCCCHHHHHHHHHHHHHHHHHHHHCC---ceecCCCcccEEECCCCCEEEeecCccee
Confidence 4677889998721 23457999999999999999999999998 99999999999999999999999999876
Q ss_pred cCCCcccccceeeeeccCCCChhhhc---cCCCCccceEEeehhhhhhhhhCCCCCCcCCCCchhhhhhhhhhhcCCCcc
Q 045315 315 FGGDELQSNTKRIVGTYGYMSPEYAL---RGLFSIKSDVFSFGVLLLETLSSKKNTHFYNTDSLTLLGHAWNLWNDGRTW 391 (476)
Q Consensus 315 ~~~~~~~~~~~~~~gt~~y~aPE~l~---~~~~s~ksDVwSlGvvl~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~ 391 (476)
.... ....++..|+|||.+. ...++.++||||||+++|||++|+.|+....... .. .... ....
T Consensus 165 ~~~~------~~~~~~~~y~aPE~~~~~~~~~~~~~sDv~s~G~il~el~tg~~p~~~~~~~~--~~---~~~~-~~~~- 231 (307)
T cd06607 165 VSPA------NSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMS--AL---YHIA-QNDS- 231 (307)
T ss_pred cCCC------CCccCCccccCceeeeccCCCCCCcccchHHHHHHHHHHHcCCCCCCCccHHH--HH---HHHh-cCCC-
Confidence 5322 1245788999999874 4568899999999999999999999875432111 10 0000 0000
Q ss_pred cccCcccCCCCCHHHHHHHHHHHHHchhhcccCCCCHHHHHHH
Q 045315 392 ELMDPISQNGASYPILKRYINVALLCVQEKAADRPAMSEVVSM 434 (476)
Q Consensus 392 ~~~d~~~~~~~~~~~~~~l~~li~~Cl~~dP~~RPt~~eVl~~ 434 (476)
+.. ........+.+++.+||+.+|++||++.+|+..
T Consensus 232 ----~~~---~~~~~~~~~~~li~~~l~~~p~~Rp~~~~il~~ 267 (307)
T cd06607 232 ----PTL---SSNDWSDYFRNFVDSCLQKIPQDRPSSEELLKH 267 (307)
T ss_pred ----CCC---CchhhCHHHHHHHHHHhcCChhhCcCHHHHhcC
Confidence 000 111234578999999999999999999999874
|
Serine/threonine kinases (STKs), thousand-and-one amino acids (TAO) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. They activate the MAPKs, p38 and c-Jun N-terminal kinase (JNK), by phosphorylating and activating the respective MAP/ERK kinases (MEKs, also known as MKKs or MAPKKs), MEK3/MEK6 and MKK4/MKK7. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Vertebrates contain three TAO subfamily |
| >KOG0577 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.89 E-value=7e-24 Score=213.70 Aligned_cols=168 Identities=32% Similarity=0.394 Sum_probs=133.7
Q ss_pred cceeeccCCC------CCCCCCCChhhHHHHHHHHHHHHHHHhhcCCCceeecCCCccceEecCCCCceeccccceeecC
Q 045315 243 ISFWYESYNN------PTKKGLLCWGTRVRIIEGIAQGLLYLHQYSRLRVIHRDLKASNILLDKDMNPKISDFGMARMFG 316 (476)
Q Consensus 243 ~~l~~Ey~~~------~~~~~~L~~~~~~~i~~qIa~gL~yLH~~~~~~ivH~DLkp~NILld~~~~~kL~DFGla~~~~ 316 (476)
|-+||||+-+ ...+++|-+.++..|+.+.+.||+|||+++ .||||||+.|||+++.|.+||+|||.|....
T Consensus 101 aWLVMEYClGSAsDlleVhkKplqEvEIAAi~~gaL~gLaYLHS~~---~IHRDiKAGNILLse~g~VKLaDFGSAsi~~ 177 (948)
T KOG0577|consen 101 AWLVMEYCLGSASDLLEVHKKPLQEVEIAAITHGALQGLAYLHSHN---RIHRDIKAGNILLSEPGLVKLADFGSASIMA 177 (948)
T ss_pred HHHHHHHHhccHHHHHHHHhccchHHHHHHHHHHHHHHHHHHHHhh---HHhhhccccceEecCCCeeeeccccchhhcC
Confidence 4478999873 246889999999999999999999999999 9999999999999999999999999997754
Q ss_pred CCcccccceeeeeccCCCChhhhc---cCCCCccceEEeehhhhhhhhhCCCCCCcCCCCchhhhhhhhhhhcCCCcccc
Q 045315 317 GDELQSNTKRIVGTYGYMSPEYAL---RGLFSIKSDVFSFGVLLLETLSSKKNTHFYNTDSLTLLGHAWNLWNDGRTWEL 393 (476)
Q Consensus 317 ~~~~~~~~~~~~gt~~y~aPE~l~---~~~~s~ksDVwSlGvvl~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~ 393 (476)
. ...++||+.|||||++. .+.|+-|+||||||+...||.-.++|.-..+... .+...+ ...
T Consensus 178 P------AnsFvGTPywMAPEVILAMDEGqYdgkvDvWSLGITCIELAERkPPlFnMNAMS-ALYHIA-----QNe---- 241 (948)
T KOG0577|consen 178 P------ANSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMS-ALYHIA-----QNE---- 241 (948)
T ss_pred c------hhcccCCccccchhHheeccccccCCccceeeccchhhhhhhcCCCccCchHHH-HHHHHH-----hcC----
Confidence 3 34589999999999986 5889999999999999999999999865433111 111111 111
Q ss_pred cCcccCCCCCHHHHHHHHHHHHHchhhcccCCCCHHHHHH
Q 045315 394 MDPISQNGASYPILKRYINVALLCVQEKAADRPAMSEVVS 433 (476)
Q Consensus 394 ~d~~~~~~~~~~~~~~l~~li~~Cl~~dP~~RPt~~eVl~ 433 (476)
.|.+. ..+-...++.++..||++-|.+|||.++++.
T Consensus 242 -sPtLq---s~eWS~~F~~Fvd~CLqKipqeRptse~ll~ 277 (948)
T KOG0577|consen 242 -SPTLQ---SNEWSDYFRNFVDSCLQKIPQERPTSEELLK 277 (948)
T ss_pred -CCCCC---CchhHHHHHHHHHHHHhhCcccCCcHHHHhh
Confidence 11222 2334567889999999999999999998753
|
|
| >cd07832 STKc_CCRK Catalytic domain of the Serine/Threonine Kinase, Cell Cycle-Related Kinase | Back alignment and domain information |
|---|
Probab=99.89 E-value=1.4e-23 Score=205.34 Aligned_cols=186 Identities=20% Similarity=0.230 Sum_probs=130.9
Q ss_pred cccceeeccCCCC-------CCCCCCChhhHHHHHHHHHHHHHHHhhcCCCceeecCCCccceEecCCCCceecccccee
Q 045315 241 DEISFWYESYNNP-------TKKGLLCWGTRVRIIEGIAQGLLYLHQYSRLRVIHRDLKASNILLDKDMNPKISDFGMAR 313 (476)
Q Consensus 241 ~~~~l~~Ey~~~~-------~~~~~L~~~~~~~i~~qIa~gL~yLH~~~~~~ivH~DLkp~NILld~~~~~kL~DFGla~ 313 (476)
..+++++||+. . .....+++.++..++.||++||+|||+.+ ++|+||||+||+++.++.++|+|||++.
T Consensus 72 ~~~~~v~e~~~-~~L~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~---i~H~dl~p~ni~~~~~~~~~l~dfg~~~ 147 (286)
T cd07832 72 SGFVLVMEYMP-SDLSEVLRDEERPLPEAQVKSYMRMLLKGVAYMHANG---IMHRDLKPANLLISADGVLKIADFGLAR 147 (286)
T ss_pred CeeEEEecccC-CCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCC---eecCCcCHHHEEEcCCCcEEEeeeeecc
Confidence 45778888884 2 23467999999999999999999999998 9999999999999999999999999998
Q ss_pred ecCCCcccccceeeeeccCCCChhhhccC-CCCccceEEeehhhhhhhhhCCCCCCcCCCCchhhhhhhhhhhcCC----
Q 045315 314 MFGGDELQSNTKRIVGTYGYMSPEYALRG-LFSIKSDVFSFGVLLLETLSSKKNTHFYNTDSLTLLGHAWNLWNDG---- 388 (476)
Q Consensus 314 ~~~~~~~~~~~~~~~gt~~y~aPE~l~~~-~~s~ksDVwSlGvvl~elltG~~p~~~~~~~~~~~~~~~~~~~~~~---- 388 (476)
....... .......++..|+|||.+.+. .++.++||||+|++++||++|++++..... .. ............
T Consensus 148 ~~~~~~~-~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~~l~~l~tg~~~~~~~~~-~~-~~~~~~~~~~~~~~~~ 224 (286)
T cd07832 148 LFSEEEP-RLYSHQVATRWYRAPELLYGARKYDPGVDLWAVGCIFAELLNGSPLFPGEND-IE-QLAIVFRTLGTPNEET 224 (286)
T ss_pred cccCCCC-CccccccCcccccCceeeeccccCCchhHHHHHHHHHHHHHcCCcCcCCCCH-HH-HHHHHHHHcCCCChHH
Confidence 7654321 112234688899999988654 468999999999999999999777654321 11 111111000000
Q ss_pred --------CcccccCcccC----CCCCHHHHHHHHHHHHHchhhcccCCCCHHHHHH
Q 045315 389 --------RTWELMDPISQ----NGASYPILKRYINVALLCVQEKAADRPAMSEVVS 433 (476)
Q Consensus 389 --------~~~~~~d~~~~----~~~~~~~~~~l~~li~~Cl~~dP~~RPt~~eVl~ 433 (476)
.......+... ..........+.+++.+||+.+|++||+++++++
T Consensus 225 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~R~~~~~~l~ 281 (286)
T cd07832 225 WPGLTSLPDYNKITFPESKPIPLEEIFPDASPEALDLLKGLLVYDPSKRLSAAEALR 281 (286)
T ss_pred HhhccCcchhhcccCCCCCcchHHHhCCCccHHHHHHHHHHhccChhhCCCHHHHhh
Confidence 00000000000 0001123477899999999999999999999875
|
Serine/Threonine Kinases (STKs), Cell Cycle-Related Kinase (CCRK) p42 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CCRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CCRK was previously called p42. It is a Cyclin-Dependent Kinase (CDK)-Activating Kinase (CAK) which is essential for the activation of CDK2. It is indispensable for cell growth and has been implicated in the progression of glioblastoma multiforme. In the heart, a splice variant of CCRK with a different C-terminal half is expressed, this variant promotes cardiac cell growth and survival and is significantly down-regulated during the development of hea |
| >cd06626 STKc_MEKK4 Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 4 | Back alignment and domain information |
|---|
Probab=99.89 E-value=3.7e-23 Score=199.69 Aligned_cols=178 Identities=22% Similarity=0.362 Sum_probs=132.0
Q ss_pred cccceeeccCCCC------CCCCCCChhhHHHHHHHHHHHHHHHhhcCCCceeecCCCccceEecCCCCceeccccceee
Q 045315 241 DEISFWYESYNNP------TKKGLLCWGTRVRIIEGIAQGLLYLHQYSRLRVIHRDLKASNILLDKDMNPKISDFGMARM 314 (476)
Q Consensus 241 ~~~~l~~Ey~~~~------~~~~~L~~~~~~~i~~qIa~gL~yLH~~~~~~ivH~DLkp~NILld~~~~~kL~DFGla~~ 314 (476)
+.+++++||++.. .+...+++..+..++.|++.||+|||+.+ ++|+||+|+||+++.++.+||+|||++..
T Consensus 72 ~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~---i~H~dl~~~nil~~~~~~~kl~d~g~~~~ 148 (264)
T cd06626 72 EKVYIFMEYCSGGTLEELLEHGRILDEHVIRVYTLQLLEGLAYLHSHG---IVHRDIKPANIFLDHNGVIKLGDFGCAVK 148 (264)
T ss_pred CEEEEEEecCCCCcHHHHHhhcCCCChHHHHHHHHHHHHHHHHHHHCC---cccCCCCHHHEEECCCCCEEEcccccccc
Confidence 4678889998732 23456899999999999999999999998 99999999999999999999999999987
Q ss_pred cCCCccccc--ceeeeeccCCCChhhhccCC---CCccceEEeehhhhhhhhhCCCCCCcCCCCchhhhhhhhhhhcCCC
Q 045315 315 FGGDELQSN--TKRIVGTYGYMSPEYALRGL---FSIKSDVFSFGVLLLETLSSKKNTHFYNTDSLTLLGHAWNLWNDGR 389 (476)
Q Consensus 315 ~~~~~~~~~--~~~~~gt~~y~aPE~l~~~~---~s~ksDVwSlGvvl~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~ 389 (476)
......... .....++..|+|||++.+.. ++.++||||||++++|+++|+.||........ .. .... .+.
T Consensus 149 ~~~~~~~~~~~~~~~~~~~~~~~PE~~~~~~~~~~~~~~Dv~s~G~il~~l~~g~~pf~~~~~~~~-~~---~~~~-~~~ 223 (264)
T cd06626 149 LKNNTTTMGEEVQSLAGTPAYMAPEVITGGKGKGHGRAADIWSLGCVVLEMATGKRPWSELDNEFQ-IM---FHVG-AGH 223 (264)
T ss_pred cCCCCCcccccccCCcCCcCccChhhccCCCCCCCCcccchHHHHHHHHHHHhCCCCccCCcchHH-HH---HHHh-cCC
Confidence 654322111 11245788999999998766 88999999999999999999999864331111 11 0000 011
Q ss_pred cccccCcccCCCCCHHHHHHHHHHHHHchhhcccCCCCHHHHHH
Q 045315 390 TWELMDPISQNGASYPILKRYINVALLCVQEKAADRPAMSEVVS 433 (476)
Q Consensus 390 ~~~~~d~~~~~~~~~~~~~~l~~li~~Cl~~dP~~RPt~~eVl~ 433 (476)
... .. ........+.+++.+||+.+|.+||++.+++.
T Consensus 224 ~~~-----~~--~~~~~~~~~~~li~~~l~~~p~~R~~~~~i~~ 260 (264)
T cd06626 224 KPP-----IP--DSLQLSPEGKDFLDRCLESDPKKRPTASELLQ 260 (264)
T ss_pred CCC-----CC--cccccCHHHHHHHHHHccCCcccCCCHHHHhc
Confidence 100 00 01112456779999999999999999999864
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 4 (MEKK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK4 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK4 activates the c-Jun N-terminal kinase (JNK) and p38 MAPK signaling pathways by directly activating their respective MAPKKs, MKK4 |
| >KOG1035 consensus eIF-2alpha kinase GCN2 [Translation, ribosomal structure and biogenesis] | Back alignment and domain information |
|---|
Probab=99.89 E-value=1.4e-23 Score=226.66 Aligned_cols=174 Identities=24% Similarity=0.347 Sum_probs=124.4
Q ss_pred cceeeccCCCC-----CCCCCC--ChhhHHHHHHHHHHHHHHHhhcCCCceeecCCCccceEecCCCCceeccccceeec
Q 045315 243 ISFWYESYNNP-----TKKGLL--CWGTRVRIIEGIAQGLLYLHQYSRLRVIHRDLKASNILLDKDMNPKISDFGMARMF 315 (476)
Q Consensus 243 ~~l~~Ey~~~~-----~~~~~L--~~~~~~~i~~qIa~gL~yLH~~~~~~ivH~DLkp~NILld~~~~~kL~DFGla~~~ 315 (476)
.++-|||++.. .++..+ .-...++++++|++||+|+|+.+ ||||||||.||++|++..+||+|||+|...
T Consensus 671 LYIQMEyCE~~ll~~iI~~N~~~~~~d~~wrLFreIlEGLaYIH~~g---iIHRDLKP~NIFLd~~~~VKIGDFGLAt~~ 747 (1351)
T KOG1035|consen 671 LYIQMEYCEKTLLRDIIRRNHFNSQRDEAWRLFREILEGLAYIHDQG---IIHRDLKPRNIFLDSRNSVKIGDFGLATDL 747 (1351)
T ss_pred EEEEHhhhhhhHHHHHHHhcccchhhHHHHHHHHHHHHHHHHHHhCc---eeeccCCcceeEEcCCCCeeecccccchhh
Confidence 56677888721 122223 36778999999999999999999 999999999999999999999999999872
Q ss_pred C----------------CCcccccceeeeeccCCCChhhhccC---CCCccceEEeehhhhhhhhhCCCCCCcCCCCchh
Q 045315 316 G----------------GDELQSNTKRIVGTYGYMSPEYALRG---LFSIKSDVFSFGVLLLETLSSKKNTHFYNTDSLT 376 (476)
Q Consensus 316 ~----------------~~~~~~~~~~~~gt~~y~aPE~l~~~---~~s~ksDVwSlGvvl~elltG~~p~~~~~~~~~~ 376 (476)
. ........+..+||.-|+|||.+.+. .|+.|+|+||||+|++||+. ||...- +...
T Consensus 748 ~~~~~~~d~~~~~~~~~~g~~~~~~Ts~VGTalYvAPEll~~~~~~~Yn~KiDmYSLGIVlFEM~y---PF~TsM-ERa~ 823 (1351)
T KOG1035|consen 748 KENLESIDQDLSFSTNRAGSNDGDLTSQVGTALYVAPELLSDTSSNKYNSKIDMYSLGIVLFEMLY---PFGTSM-ERAS 823 (1351)
T ss_pred hhhhhhHhhccCccccccCCCCcccccccceeeeecHHHhcccccccccchhhhHHHHHHHHHHhc---cCCchH-HHHH
Confidence 1 00111133457899999999999754 59999999999999999984 443221 1111
Q ss_pred hhhhhhhhhcCCCcccccCcccCCCCCHHHHHHHHHHHHHchhhcccCCCCHHHHHH
Q 045315 377 LLGHAWNLWNDGRTWELMDPISQNGASYPILKRYINVALLCVQEKAADRPAMSEVVS 433 (476)
Q Consensus 377 ~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~l~~li~~Cl~~dP~~RPt~~eVl~ 433 (476)
+...++.+.+..- .....+....-.++++++++.||++|||+.|++.
T Consensus 824 ----iL~~LR~g~iP~~------~~f~~~~~~~e~slI~~Ll~hdP~kRPtA~eLL~ 870 (1351)
T KOG1035|consen 824 ----ILTNLRKGSIPEP------ADFFDPEHPEEASLIRWLLSHDPSKRPTATELLN 870 (1351)
T ss_pred ----HHHhcccCCCCCC------cccccccchHHHHHHHHHhcCCCccCCCHHHHhh
Confidence 1122223332221 1223333445568999999999999999999874
|
|
| >cd06917 STKc_NAK1_like Catalytic domain of Fungal Nak1-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=99.89 E-value=1.8e-23 Score=203.85 Aligned_cols=173 Identities=24% Similarity=0.367 Sum_probs=130.7
Q ss_pred ccceeeccCCCCC-----CCCCCChhhHHHHHHHHHHHHHHHhhcCCCceeecCCCccceEecCCCCceeccccceeecC
Q 045315 242 EISFWYESYNNPT-----KKGLLCWGTRVRIIEGIAQGLLYLHQYSRLRVIHRDLKASNILLDKDMNPKISDFGMARMFG 316 (476)
Q Consensus 242 ~~~l~~Ey~~~~~-----~~~~L~~~~~~~i~~qIa~gL~yLH~~~~~~ivH~DLkp~NILld~~~~~kL~DFGla~~~~ 316 (476)
..++++||++... +...+++..++.++.|++.||.|||+.+ ++|+||+|+||+++.++.++|+|||++....
T Consensus 76 ~~~lv~e~~~~~~L~~~~~~~~l~~~~~~~i~~~i~~~l~~lh~~~---i~H~dl~p~ni~i~~~~~~~l~dfg~~~~~~ 152 (277)
T cd06917 76 RLWIIMEYAEGGSVRTLMKAGPIAEKYISVIIREVLVALKYIHKVG---VIHRDIKAANILVTNTGNVKLCDFGVAALLN 152 (277)
T ss_pred EEEEEEecCCCCcHHHHHHccCCCHHHHHHHHHHHHHHHHHHHhCC---cccCCcCHHHEEEcCCCCEEEccCCceeecC
Confidence 4667888887331 2347999999999999999999999998 9999999999999999999999999998765
Q ss_pred CCcccccceeeeeccCCCChhhhcc-CCCCccceEEeehhhhhhhhhCCCCCCcCCCCchhhhhhhhhhhcCCCcccccC
Q 045315 317 GDELQSNTKRIVGTYGYMSPEYALR-GLFSIKSDVFSFGVLLLETLSSKKNTHFYNTDSLTLLGHAWNLWNDGRTWELMD 395 (476)
Q Consensus 317 ~~~~~~~~~~~~gt~~y~aPE~l~~-~~~s~ksDVwSlGvvl~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~d 395 (476)
..... .....|+..|+|||.+.+ ..++.++|+|||||++|+|++|+.||........ .. .......
T Consensus 153 ~~~~~--~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~~ll~g~~p~~~~~~~~~--~~----~~~~~~~----- 219 (277)
T cd06917 153 QNSSK--RSTFVGTPYWMAPEVITEGKYYDTKADIWSLGITIYEMATGNPPYSDVDAFRA--MM----LIPKSKP----- 219 (277)
T ss_pred CCccc--cccccCCcceeCHHHhccCCccccchhHHHHHHHHHHHHhCCCCCCCCChhhh--hh----ccccCCC-----
Confidence 43321 223468889999998875 4568999999999999999999999864321110 00 0000000
Q ss_pred cccCCCCCHHHHHHHHHHHHHchhhcccCCCCHHHHHH
Q 045315 396 PISQNGASYPILKRYINVALLCVQEKAADRPAMSEVVS 433 (476)
Q Consensus 396 ~~~~~~~~~~~~~~l~~li~~Cl~~dP~~RPt~~eVl~ 433 (476)
+.+.. ......+.+++.+||+.||++||++.+++.
T Consensus 220 ~~~~~---~~~~~~~~~~i~~~l~~~p~~R~~~~~il~ 254 (277)
T cd06917 220 PRLED---NGYSKLLREFVAACLDEEPKERLSAEELLK 254 (277)
T ss_pred CCCCc---ccCCHHHHHHHHHHcCCCcccCcCHHHHhh
Confidence 11111 013456889999999999999999999976
|
Serine/threonine kinases (STKs), Nak1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nak1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of Schizosaccharomyces pombe Nak1, Saccharomyces cerevisiae Kic1p (kinase that interacts with Cdc31p) and related proteins. Nak1 (also known as N-rich kinase 1), is required by fission yeast for polarizing the tips of actin cytoskeleton and is involved in cell growth, cell separation, cell morphology and cell-cycle progression. Kic1p is required by budding yeast for cell integrity and morphogenesis. Kic1p interacts with Cdc31p, the yeast homologue of cent |
| >cd07864 STKc_CDK12 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 12 | Back alignment and domain information |
|---|
Probab=99.89 E-value=2.7e-23 Score=205.19 Aligned_cols=186 Identities=23% Similarity=0.279 Sum_probs=130.4
Q ss_pred ccceeeccCCC------CCCCCCCChhhHHHHHHHHHHHHHHHhhcCCCceeecCCCccceEecCCCCceeccccceeec
Q 045315 242 EISFWYESYNN------PTKKGLLCWGTRVRIIEGIAQGLLYLHQYSRLRVIHRDLKASNILLDKDMNPKISDFGMARMF 315 (476)
Q Consensus 242 ~~~l~~Ey~~~------~~~~~~L~~~~~~~i~~qIa~gL~yLH~~~~~~ivH~DLkp~NILld~~~~~kL~DFGla~~~ 315 (476)
..++++||++. ..+...+++.++..++.||+.||+|||+.+ |+|+||||+||++++++.+||+|||++...
T Consensus 90 ~~~lv~e~~~~~l~~~l~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~---i~H~dl~p~nili~~~~~~kl~dfg~~~~~ 166 (302)
T cd07864 90 AFYLVFEYMDHDLMGLLESGLVHFSEDHIKSFMKQLLEGLNYCHKKN---FLHRDIKCSNILLNNKGQIKLADFGLARLY 166 (302)
T ss_pred cEEEEEcccCccHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCCHHHEEECCCCcEEeCcccccccc
Confidence 57788899873 123457999999999999999999999998 999999999999999999999999999876
Q ss_pred CCCcccccceeeeeccCCCChhhhcc-CCCCccceEEeehhhhhhhhhCCCCCCcCCCCchhhhhhhhhhhcCCC---cc
Q 045315 316 GGDELQSNTKRIVGTYGYMSPEYALR-GLFSIKSDVFSFGVLLLETLSSKKNTHFYNTDSLTLLGHAWNLWNDGR---TW 391 (476)
Q Consensus 316 ~~~~~~~~~~~~~gt~~y~aPE~l~~-~~~s~ksDVwSlGvvl~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~---~~ 391 (476)
....... .....++..|+|||.+.+ ..++.++|||||||+++||++|++||..... ............... ..
T Consensus 167 ~~~~~~~-~~~~~~~~~y~~PE~~~~~~~~~~~~Di~slG~~~~el~~g~~~~~~~~~--~~~~~~~~~~~~~~~~~~~~ 243 (302)
T cd07864 167 NSEESRP-YTNKVITLWYRPPELLLGEERYGPAIDVWSCGCILGELFTKKPIFQANQE--LAQLELISRLCGSPCPAVWP 243 (302)
T ss_pred cCCcccc-cccceeccCccChHHhcCCCCCCchhHHHHHHHHHHHHHhCCCCCCCCCh--HHHHHHHHHHhCCCChhhcc
Confidence 4332111 112345778999998864 4578999999999999999999998864321 111111111100000 00
Q ss_pred cc--------cCcccC--C---CCCHHHHHHHHHHHHHchhhcccCCCCHHHHHH
Q 045315 392 EL--------MDPISQ--N---GASYPILKRYINVALLCVQEKAADRPAMSEVVS 433 (476)
Q Consensus 392 ~~--------~d~~~~--~---~~~~~~~~~l~~li~~Cl~~dP~~RPt~~eVl~ 433 (476)
.+ .+.... . .........+.+++.+||+.+|++||+++++++
T Consensus 244 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rp~~~~il~ 298 (302)
T cd07864 244 DVIKLPYFNTMKPKKQYRRRLREEFSFIPTPALDLLDHMLTLDPSKRCTAEEALN 298 (302)
T ss_pred cccccccccccccccccccchhhhcCCCCHHHHHHHHHHccCChhhCCCHHHHhc
Confidence 00 000000 0 000112457889999999999999999999875
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 12 (CDK12) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK12 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK12 is also called Cdc2-related protein kinase 7 (CRK7) or Cdc2-related kinase arginine/serine-rich (CrkRS). It is a unique CDK that contains an arginine/serine-rich (RS) domain, which is predominantly found in splicing factors. CDK12 is widely |
| >PLN00181 protein SPA1-RELATED; Provisional | Back alignment and domain information |
|---|
Probab=99.89 E-value=9.1e-24 Score=235.58 Aligned_cols=171 Identities=17% Similarity=0.151 Sum_probs=119.2
Q ss_pred cceeeccCCC------CCCCCCCChhhHHHHHHHHHHHHHHHhhcCCCceeecCCCccceEecC----------------
Q 045315 243 ISFWYESYNN------PTKKGLLCWGTRVRIIEGIAQGLLYLHQYSRLRVIHRDLKASNILLDK---------------- 300 (476)
Q Consensus 243 ~~l~~Ey~~~------~~~~~~L~~~~~~~i~~qIa~gL~yLH~~~~~~ivH~DLkp~NILld~---------------- 300 (476)
.++.+||++. ......+++.+++.++.||++||+|||+++ |+||||||+||||+.
T Consensus 55 ~~~~~e~~~~~L~~~l~~~~~~~~~~~~~~i~~qi~~al~~lH~~g---IvHrDlKP~NiLl~~~~~~k~~d~~~~~~~~ 131 (793)
T PLN00181 55 IVRALECEDVSLRQWLDNPDRSVDAFECFHVFRQIVEIVNAAHSQG---IVVHNVRPSCFVMSSFNHVSFIESASCSDSG 131 (793)
T ss_pred hhhhhccCCccHHHHHhcccccccHHHHHHHHHHHHHHHHHHHhCC---eeeccCCchhEEEcccCcEEEeeccccCccc
Confidence 3455677651 122456999999999999999999999999 999999999999954
Q ss_pred ---CCCceeccccceeecCCCcc--------------cccceeeeeccCCCChhhhccCCCCccceEEeehhhhhhhhhC
Q 045315 301 ---DMNPKISDFGMARMFGGDEL--------------QSNTKRIVGTYGYMSPEYALRGLFSIKSDVFSFGVLLLETLSS 363 (476)
Q Consensus 301 ---~~~~kL~DFGla~~~~~~~~--------------~~~~~~~~gt~~y~aPE~l~~~~~s~ksDVwSlGvvl~elltG 363 (476)
++.+|++|||+++....... ........||+.|+|||++.+..++.++|||||||++|||++|
T Consensus 132 ~~~~~~~ki~DfG~a~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~APE~~~~~~~~~~sDVwSlGviL~ELl~~ 211 (793)
T PLN00181 132 SDEDATTKSREIGSSRREEILSERRIEKLEEVKKQPFPMKQILAMEMSWYTSPEEDNGSSSNCASDVYRLGVLLFELFCP 211 (793)
T ss_pred ccccCcccccccccccccccccccchhhhhccccCCCcccccccCCCcceEChhhhccCCCCchhhhhhHHHHHHHHhhC
Confidence 45567777777764321000 0001113578889999999999999999999999999999998
Q ss_pred CCCCCcCCCCchhhhhhhhhhhcCCCcccccCcccCCCCCHHHHHHHHHHHHHchhhcccCCCCHHHHHH
Q 045315 364 KKNTHFYNTDSLTLLGHAWNLWNDGRTWELMDPISQNGASYPILKRYINVALLCVQEKAADRPAMSEVVS 433 (476)
Q Consensus 364 ~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~l~~li~~Cl~~dP~~RPt~~eVl~ 433 (476)
.+|+..... ...... . ....+. ..........++.+||+.+|.+||++.||++
T Consensus 212 ~~~~~~~~~---~~~~~~-----~----~~~~~~-----~~~~~~~~~~~~~~~L~~~P~~Rps~~eil~ 264 (793)
T PLN00181 212 VSSREEKSR---TMSSLR-----H----RVLPPQ-----ILLNWPKEASFCLWLLHPEPSCRPSMSELLQ 264 (793)
T ss_pred CCchhhHHH---HHHHHH-----H----hhcChh-----hhhcCHHHHHHHHHhCCCChhhCcChHHHhh
Confidence 877542110 000000 0 000110 0111234567888999999999999999975
|
|
| >cd07834 STKc_MAPK Catalytic domain of the Serine/Threonine Kinase, Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Probab=99.89 E-value=1.4e-23 Score=210.12 Aligned_cols=192 Identities=23% Similarity=0.245 Sum_probs=137.0
Q ss_pred ccceeeccCCC-----CCCCCCCChhhHHHHHHHHHHHHHHHhhcCCCceeecCCCccceEecCCCCceeccccceeecC
Q 045315 242 EISFWYESYNN-----PTKKGLLCWGTRVRIIEGIAQGLLYLHQYSRLRVIHRDLKASNILLDKDMNPKISDFGMARMFG 316 (476)
Q Consensus 242 ~~~l~~Ey~~~-----~~~~~~L~~~~~~~i~~qIa~gL~yLH~~~~~~ivH~DLkp~NILld~~~~~kL~DFGla~~~~ 316 (476)
.+++++||++. ..++..+++..+..++.||+.||+|||+.+ ++|+||||+||+++.++.++|+|||++....
T Consensus 78 ~~~lv~e~~~~~l~~~l~~~~~l~~~~~~~i~~~l~~~l~~LH~~g---i~H~dlkp~nili~~~~~~~L~dfg~~~~~~ 154 (330)
T cd07834 78 DVYIVTELMETDLHKVIKSPQPLTDDHIQYFLYQILRGLKYLHSAN---VIHRDLKPSNILVNSNCDLKICDFGLARGVD 154 (330)
T ss_pred ceEEEecchhhhHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCCHHHEEEcCCCCEEEcccCceEeec
Confidence 57888999882 123448999999999999999999999999 9999999999999999999999999998765
Q ss_pred CCcc-cccceeeeeccCCCChhhhccC-CCCccceEEeehhhhhhhhhCCCCCCcCCCCchhhhhhhhhhh---------
Q 045315 317 GDEL-QSNTKRIVGTYGYMSPEYALRG-LFSIKSDVFSFGVLLLETLSSKKNTHFYNTDSLTLLGHAWNLW--------- 385 (476)
Q Consensus 317 ~~~~-~~~~~~~~gt~~y~aPE~l~~~-~~s~ksDVwSlGvvl~elltG~~p~~~~~~~~~~~~~~~~~~~--------- 385 (476)
.... ........++..|+|||.+.+. .++.++|+||||+++++|++|+.||....... .........
T Consensus 155 ~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~sDi~slG~il~~l~~g~~pf~~~~~~~--~~~~i~~~~~~~~~~~~~ 232 (330)
T cd07834 155 PDEDEKGFLTEYVVTRWYRAPELLLSSSRYTKAIDIWSVGCIFAELLTRKPLFPGRDYID--QLNLIVEVLGTPSEEDLK 232 (330)
T ss_pred ccccccccccccccccCcCCceeeecccCCCcchhHHHHHHHHHHHHcCCCCcCCCCHHH--HHHHHHHhcCCCChhHhh
Confidence 4321 0112234578899999999877 78999999999999999999999986543211 000000000
Q ss_pred --cCCCcccccCcc-cCCC-----CCHHHHHHHHHHHHHchhhcccCCCCHHHHHHH--Hhcc
Q 045315 386 --NDGRTWELMDPI-SQNG-----ASYPILKRYINVALLCVQEKAADRPAMSEVVSM--LSNE 438 (476)
Q Consensus 386 --~~~~~~~~~d~~-~~~~-----~~~~~~~~l~~li~~Cl~~dP~~RPt~~eVl~~--L~~~ 438 (476)
........+... .... ........+.+++.+||+.+|++||+++++++. +++.
T Consensus 233 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~ll~~~~~~~~ 295 (330)
T cd07834 233 FITSEKARNYLKSLPKKPKKPLSKLFPGASPEAIDLLEKMLVFDPKKRITADEALAHPYLAQL 295 (330)
T ss_pred hccccchhhHHhhcccCCcchhHHhcccCCHHHHHHHHHHccCChhhCCCHHHHHhCccHHhh
Confidence 000000000000 0000 011134568899999999999999999999874 5554
|
Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs serve as important mediators of cellular responses to extracellular signals. They control critical cellular functions including differentiation, proliferation, migration, and apoptosis. They are also implicated in the pathogenesis of many diseases including multiple types of cancer, stroke, diabetes, and chronic inflammation. Typical MAPK pathways involve a triple kinase core cascade comprising of the MAPK, which is phosphorylated and |
| >cd06647 STKc_PAK_I Catalytic domain of the Protein Serine/Threonine Kinase, Group I p21-activated kinase | Back alignment and domain information |
|---|
Probab=99.89 E-value=2.8e-23 Score=204.80 Aligned_cols=176 Identities=24% Similarity=0.359 Sum_probs=133.8
Q ss_pred cccceeeccCCCCC-----CCCCCChhhHHHHHHHHHHHHHHHhhcCCCceeecCCCccceEecCCCCceeccccceeec
Q 045315 241 DEISFWYESYNNPT-----KKGLLCWGTRVRIIEGIAQGLLYLHQYSRLRVIHRDLKASNILLDKDMNPKISDFGMARMF 315 (476)
Q Consensus 241 ~~~~l~~Ey~~~~~-----~~~~L~~~~~~~i~~qIa~gL~yLH~~~~~~ivH~DLkp~NILld~~~~~kL~DFGla~~~ 315 (476)
+..++++||+++.. .+..+++.++..++.|++.||+|||+.+ ++|+||||+||+++.++.+||+|||++...
T Consensus 89 ~~~~lv~e~~~~~~L~~~~~~~~l~~~~~~~i~~~l~~al~~LH~~g---i~H~dL~p~Nili~~~~~~kL~dfg~~~~~ 165 (293)
T cd06647 89 DELWVVMEYLAGGSLTDVVTETCMDEGQIAAVCRECLQALEFLHSNQ---VIHRDIKSDNILLGMDGSVKLTDFGFCAQI 165 (293)
T ss_pred CcEEEEEecCCCCcHHHHHhhcCCCHHHHHHHHHHHHHHHHHHHhCC---EeeccCCHHHEEEcCCCCEEEccCcceecc
Confidence 45788999998432 2346899999999999999999999998 999999999999999999999999998765
Q ss_pred CCCcccccceeeeeccCCCChhhhccCCCCccceEEeehhhhhhhhhCCCCCCcCCCCchhhhhhhhhhhcCCCcccccC
Q 045315 316 GGDELQSNTKRIVGTYGYMSPEYALRGLFSIKSDVFSFGVLLLETLSSKKNTHFYNTDSLTLLGHAWNLWNDGRTWELMD 395 (476)
Q Consensus 316 ~~~~~~~~~~~~~gt~~y~aPE~l~~~~~s~ksDVwSlGvvl~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~d 395 (476)
...... .....++..|++||.+....++.++|+||||+++|++++|+.||........ + ......+.
T Consensus 166 ~~~~~~--~~~~~~~~~y~~PE~~~~~~~~~~~Dv~slG~ll~~ll~g~~pf~~~~~~~~-~----~~~~~~~~------ 232 (293)
T cd06647 166 TPEQSK--RSTMVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMVEGEPPYLNENPLRA-L----YLIATNGT------ 232 (293)
T ss_pred cccccc--cccccCChhhcCchhhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCChhhh-e----eehhcCCC------
Confidence 433221 1224578899999999888899999999999999999999999864332111 0 00000000
Q ss_pred cccCCCCCHHHHHHHHHHHHHchhhcccCCCCHHHHHHH
Q 045315 396 PISQNGASYPILKRYINVALLCVQEKAADRPAMSEVVSM 434 (476)
Q Consensus 396 ~~~~~~~~~~~~~~l~~li~~Cl~~dP~~RPt~~eVl~~ 434 (476)
+ ...........+.+++.+||+.+|++||++.+++..
T Consensus 233 ~--~~~~~~~~~~~l~~li~~~l~~~p~~Rp~~~~il~h 269 (293)
T cd06647 233 P--ELQNPEKLSAIFRDFLNRCLEMDVEKRGSAKELLQH 269 (293)
T ss_pred C--CCCCccccCHHHHHHHHHHccCChhhCcCHHHHhcC
Confidence 0 001112234568899999999999999999999875
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, Group I, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs are implicated in the regulation of many cellular processes including growth factor receptor-mediated proliferation, cell polarity, cell motility, cell death and survival, and actin cytoskeleton organization. PAKs from higher eukaryotes are classified into two groups (I and II), according to their bi |
| >cd06623 PKc_MAPKK_plant_like Catalytic domain of Plant dual-specificity MAP kinase kinases and similar proteins | Back alignment and domain information |
|---|
Probab=99.89 E-value=1.5e-23 Score=202.20 Aligned_cols=176 Identities=30% Similarity=0.429 Sum_probs=136.2
Q ss_pred cccceeeccCCCC------CCCCCCChhhHHHHHHHHHHHHHHHhh-cCCCceeecCCCccceEecCCCCceecccccee
Q 045315 241 DEISFWYESYNNP------TKKGLLCWGTRVRIIEGIAQGLLYLHQ-YSRLRVIHRDLKASNILLDKDMNPKISDFGMAR 313 (476)
Q Consensus 241 ~~~~l~~Ey~~~~------~~~~~L~~~~~~~i~~qIa~gL~yLH~-~~~~~ivH~DLkp~NILld~~~~~kL~DFGla~ 313 (476)
+.+++++||++.. .....++...+..++.|+++||+|||+ .+ ++|+||+|+||+++.++.++|+|||++.
T Consensus 72 ~~~~lv~e~~~~~~L~~~l~~~~~l~~~~~~~~~~~l~~~l~~lh~~~~---~~H~~l~~~ni~~~~~~~~~l~df~~~~ 148 (264)
T cd06623 72 GEISIVLEYMDGGSLADLLKKVGKIPEPVLAYIARQILKGLDYLHTKRH---IIHRDIKPSNLLINSKGEVKIADFGISK 148 (264)
T ss_pred CeEEEEEEecCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHhccCC---CccCCCCHHHEEECCCCCEEEccCccce
Confidence 4678889998832 123679999999999999999999999 88 9999999999999999999999999998
Q ss_pred ecCCCcccccceeeeeccCCCChhhhccCCCCccceEEeehhhhhhhhhCCCCCCcCCC-CchhhhhhhhhhhcCCCccc
Q 045315 314 MFGGDELQSNTKRIVGTYGYMSPEYALRGLFSIKSDVFSFGVLLLETLSSKKNTHFYNT-DSLTLLGHAWNLWNDGRTWE 392 (476)
Q Consensus 314 ~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~s~ksDVwSlGvvl~elltG~~p~~~~~~-~~~~~~~~~~~~~~~~~~~~ 392 (476)
......... ....++..|+|||.+.+..++.++|+||||+++|++++|+.|+..... ........ .. ....
T Consensus 149 ~~~~~~~~~--~~~~~~~~y~~pE~~~~~~~~~~~Dv~slG~il~~l~tg~~p~~~~~~~~~~~~~~~---~~-~~~~-- 220 (264)
T cd06623 149 VLENTLDQC--NTFVGTVTYMSPERIQGESYSYAADIWSLGLTLLECALGKFPFLPPGQPSFFELMQA---IC-DGPP-- 220 (264)
T ss_pred ecccCCCcc--cceeecccccCHhhhCCCCCCchhhHHHHHHHHHHHHhCCCCCccccccCHHHHHHH---Hh-cCCC--
Confidence 765433221 235688999999999988899999999999999999999999865432 11111111 11 1111
Q ss_pred ccCcccCCCCCHH-HHHHHHHHHHHchhhcccCCCCHHHHHHH
Q 045315 393 LMDPISQNGASYP-ILKRYINVALLCVQEKAADRPAMSEVVSM 434 (476)
Q Consensus 393 ~~d~~~~~~~~~~-~~~~l~~li~~Cl~~dP~~RPt~~eVl~~ 434 (476)
+ ..+.. ....+.+++.+||+.+|++||++.++++.
T Consensus 221 ---~----~~~~~~~~~~l~~li~~~l~~~p~~R~~~~~ll~~ 256 (264)
T cd06623 221 ---P----SLPAEEFSPEFRDFISACLQKDPKKRPSAAELLQH 256 (264)
T ss_pred ---C----CCCcccCCHHHHHHHHHHccCChhhCCCHHHHHhC
Confidence 0 11111 34678899999999999999999999874
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, Plant MAPKKs and similar proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of |
| >cd05609 STKc_MAST Catalytic domain of the Protein Serine/Threonine Kinase, Microtubule-associated serine/threonine kinase | Back alignment and domain information |
|---|
Probab=99.89 E-value=1.2e-23 Score=208.56 Aligned_cols=183 Identities=20% Similarity=0.257 Sum_probs=134.0
Q ss_pred cccceeeccCCCCC------CCCCCChhhHHHHHHHHHHHHHHHhhcCCCceeecCCCccceEecCCCCceeccccceee
Q 045315 241 DEISFWYESYNNPT------KKGLLCWGTRVRIIEGIAQGLLYLHQYSRLRVIHRDLKASNILLDKDMNPKISDFGMARM 314 (476)
Q Consensus 241 ~~~~l~~Ey~~~~~------~~~~L~~~~~~~i~~qIa~gL~yLH~~~~~~ivH~DLkp~NILld~~~~~kL~DFGla~~ 314 (476)
+..++++||++... ..+.+++..+..++.|++.||+|||+.+ ++||||||+||+++.++.+||+|||+++.
T Consensus 74 ~~~~lv~e~~~g~~L~~~l~~~~~~~~~~~~~~~~~i~~~l~~lH~~~---i~H~dl~p~NIll~~~~~~~l~dfg~~~~ 150 (305)
T cd05609 74 RHLCMVMEYVEGGDCATLLKNIGALPVDMARMYFAETVLALEYLHNYG---IVHRDLKPDNLLITSMGHIKLTDFGLSKI 150 (305)
T ss_pred CEEEEEEecCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCC---ccccCCchHHEEECCCCCEEEeeCCCccc
Confidence 34678899987432 3457899999999999999999999998 99999999999999999999999999864
Q ss_pred cCCCc-------------ccccceeeeeccCCCChhhhccCCCCccceEEeehhhhhhhhhCCCCCCcCCCCchhhhhhh
Q 045315 315 FGGDE-------------LQSNTKRIVGTYGYMSPEYALRGLFSIKSDVFSFGVLLLETLSSKKNTHFYNTDSLTLLGHA 381 (476)
Q Consensus 315 ~~~~~-------------~~~~~~~~~gt~~y~aPE~l~~~~~s~ksDVwSlGvvl~elltG~~p~~~~~~~~~~~~~~~ 381 (476)
..... .........++..|+|||.+.+..++.++|+|||||++||+++|+.||..... ..+...
T Consensus 151 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~vl~el~~g~~pf~~~~~--~~~~~~- 227 (305)
T cd05609 151 GLMSLTTNLYEGHIEKDTREFLDKQVCGTPEYIAPEVILRQGYGKPVDWWAMGIILYEFLVGCVPFFGDTP--EELFGQ- 227 (305)
T ss_pred cCcCccccccccccccchhhccccCCccCccccCchhccCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCH--HHHHHH-
Confidence 21100 00011123567889999999888899999999999999999999999864321 111111
Q ss_pred hhhhcCCCcccccCcccCCCCCHHHHHHHHHHHHHchhhcccCCCCHHHHHHHHhccc
Q 045315 382 WNLWNDGRTWELMDPISQNGASYPILKRYINVALLCVQEKAADRPAMSEVVSMLSNEF 439 (476)
Q Consensus 382 ~~~~~~~~~~~~~d~~~~~~~~~~~~~~l~~li~~Cl~~dP~~RPt~~eVl~~L~~~~ 439 (476)
...+.. ..+.. .......+.+++.+||+.+|++||++.++.+.|+.-+
T Consensus 228 ---~~~~~~---~~~~~----~~~~~~~~~~li~~~l~~~P~~R~~~~~~~~ll~~~~ 275 (305)
T cd05609 228 ---VISDDI---EWPEG----DEALPADAQDLISRLLRQNPLERLGTGGAFEVKQHRF 275 (305)
T ss_pred ---HHhccc---CCCCc----cccCCHHHHHHHHHHhccChhhccCccCHHHHHhCcc
Confidence 111100 01111 0123456789999999999999999888887777743
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, MAST, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. There are four mammalian MAST kinases, named MAST1-MAST4. MAST1 is also referred to as syntrophin-associated STK (SAST), while MAST2 is also called MAST205. MAST kinases are cytoskeletal associated kinases of unknown function that a |
| >KOG0610 consensus Putative serine/threonine protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=99.89 E-value=3.3e-23 Score=202.08 Aligned_cols=176 Identities=18% Similarity=0.180 Sum_probs=136.5
Q ss_pred cccceeeccCCC--------CCCCCCCChhhHHHHHHHHHHHHHHHhhcCCCceeecCCCccceEecCCCCceeccccce
Q 045315 241 DEISFWYESYNN--------PTKKGLLCWGTRVRIIEGIAQGLLYLHQYSRLRVIHRDLKASNILLDKDMNPKISDFGMA 312 (476)
Q Consensus 241 ~~~~l~~Ey~~~--------~~~~~~L~~~~~~~i~~qIa~gL~yLH~~~~~~ivH~DLkp~NILld~~~~~kL~DFGla 312 (476)
.-.+++|||+++ ....+.+++..+.-++.+|+-||+|||-.| ||+|||||+||||-++|.+.|+||.++
T Consensus 150 ~~~cl~meyCpGGdL~~LrqkQp~~~fse~~aRFYaAEvl~ALEYLHmlG---ivYRDLKPENILvredGHIMLsDFDLS 226 (459)
T KOG0610|consen 150 KYSCLVMEYCPGGDLHSLRQKQPGKRFSESAARFYAAEVLLALEYLHMLG---IVYRDLKPENILVREDGHIMLSDFDLS 226 (459)
T ss_pred ceeEEEEecCCCccHHHHHhhCCCCccchhhHHHHHHHHHHHHHHHHhhc---eeeccCCcceeEEecCCcEEeeecccc
Confidence 346688999993 345678999999999999999999999999 999999999999999999999999987
Q ss_pred eecCCC----------------------------------c--------------------ccccceeeeeccCCCChhh
Q 045315 313 RMFGGD----------------------------------E--------------------LQSNTKRIVGTYGYMSPEY 338 (476)
Q Consensus 313 ~~~~~~----------------------------------~--------------------~~~~~~~~~gt~~y~aPE~ 338 (476)
...... . ...+...++||-.|+|||+
T Consensus 227 ~~~~~~Pt~~~s~~~~~~~~~~~~~~~~~s~f~~r~~~~~~~~~k~~~~~~~~~p~~~aep~~~RSnSFVGThEYlAPEv 306 (459)
T KOG0610|consen 227 LRCPVSPTLVKSSSPRSSGSQPSCRSRQPSCFSPRCLSSSKKRKKKDESASRSLPELVAEPTGARSNSFVGTHEYLAPEV 306 (459)
T ss_pred ccCCCCCeeeccCCCCCCCCCcccccccccccccchhccccccccccccccccchhhhcCCCCcccccccccccccccee
Confidence 543100 0 0012235789999999999
Q ss_pred hccCCCCccceEEeehhhhhhhhhCCCCCCcCCCCchhhhhhhhhhhcCCCcccccCcccCCCCCHHHHHHHHHHHHHch
Q 045315 339 ALRGLFSIKSDVFSFGVLLLETLSSKKNTHFYNTDSLTLLGHAWNLWNDGRTWELMDPISQNGASYPILKRYINVALLCV 418 (476)
Q Consensus 339 l~~~~~s~ksDVwSlGvvl~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~l~~li~~Cl 418 (476)
+.+...+.+.|.|+|||++|||+.|+-||...+.+.. +... +...+.-.........+.+||++.|
T Consensus 307 I~G~GHgsAVDWWtfGIflYEmLyG~TPFKG~~~~~T-l~NI-------------v~~~l~Fp~~~~vs~~akDLIr~LL 372 (459)
T KOG0610|consen 307 IRGEGHGSAVDWWTFGIFLYEMLYGTTPFKGSNNKET-LRNI-------------VGQPLKFPEEPEVSSAAKDLIRKLL 372 (459)
T ss_pred eecCCCCchhhHHHHHHHHHHHHhCCCCcCCCCchhh-HHHH-------------hcCCCcCCCCCcchhHHHHHHHHHh
Confidence 9999999999999999999999999999987663321 1111 1111111112245567899999999
Q ss_pred hhcccCCCC----HHHHHH
Q 045315 419 QEKAADRPA----MSEVVS 433 (476)
Q Consensus 419 ~~dP~~RPt----~~eVl~ 433 (476)
.+||++|.- +.||.+
T Consensus 373 vKdP~kRlg~~rGA~eIK~ 391 (459)
T KOG0610|consen 373 VKDPSKRLGSKRGAAEIKR 391 (459)
T ss_pred ccChhhhhccccchHHhhc
Confidence 999999998 777754
|
|
| >cd07852 STKc_MAPK15 Catalytic domain of the Serine/Threonine Kinase, Mitogen-Activated Protein Kinase 15 | Back alignment and domain information |
|---|
Probab=99.89 E-value=8.2e-24 Score=212.76 Aligned_cols=189 Identities=24% Similarity=0.242 Sum_probs=131.8
Q ss_pred ccceeeccCCCC----CCCCCCChhhHHHHHHHHHHHHHHHhhcCCCceeecCCCccceEecCCCCceeccccceeecCC
Q 045315 242 EISFWYESYNNP----TKKGLLCWGTRVRIIEGIAQGLLYLHQYSRLRVIHRDLKASNILLDKDMNPKISDFGMARMFGG 317 (476)
Q Consensus 242 ~~~l~~Ey~~~~----~~~~~L~~~~~~~i~~qIa~gL~yLH~~~~~~ivH~DLkp~NILld~~~~~kL~DFGla~~~~~ 317 (476)
..++++||++.. .....+++..+..++.||+.||+|||+.+ |+|+||||+||+++.++.+||+|||++.....
T Consensus 83 ~~~lv~e~~~~~L~~~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~---i~H~dl~p~nill~~~~~~kl~d~g~~~~~~~ 159 (337)
T cd07852 83 DIYLVFEYMETDLHAVIRANILEDVHKRYIMYQLLKALKYIHSGN---VIHRDLKPSNILLNSDCRVKLADFGLARSLSE 159 (337)
T ss_pred eEEEEecccccCHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCCHHHEEEcCCCcEEEeeccchhcccc
Confidence 467888998721 12237899999999999999999999998 99999999999999999999999999986643
Q ss_pred Cccc---ccceeeeeccCCCChhhhcc-CCCCccceEEeehhhhhhhhhCCCCCCcCCCCchhhhhhhh----------h
Q 045315 318 DELQ---SNTKRIVGTYGYMSPEYALR-GLFSIKSDVFSFGVLLLETLSSKKNTHFYNTDSLTLLGHAW----------N 383 (476)
Q Consensus 318 ~~~~---~~~~~~~gt~~y~aPE~l~~-~~~s~ksDVwSlGvvl~elltG~~p~~~~~~~~~~~~~~~~----------~ 383 (476)
.... .......++..|+|||.+.+ ..++.++|+||||+++|+|++|+.||........ ...... .
T Consensus 160 ~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~sDi~slG~~l~el~tg~~pf~~~~~~~~-~~~~~~~~~~~~~~~~~ 238 (337)
T cd07852 160 LEENPENPVLTDYVATRWYRAPEILLGSTRYTKGVDMWSVGCILGEMLLGKPLFPGTSTLNQ-LEKIIEVIGPPSAEDIE 238 (337)
T ss_pred ccccccCcchhcccccccccCceeeeccccccccchHHHHHHHHHHHHhCCCCCCCCChHHH-HHHHHHHhCCCCHHHHH
Confidence 3211 12233568899999998764 5578999999999999999999999864331110 000000 0
Q ss_pred hhcCCCcccccCcccC------CCCCHHHHHHHHHHHHHchhhcccCCCCHHHHHHH
Q 045315 384 LWNDGRTWELMDPISQ------NGASYPILKRYINVALLCVQEKAADRPAMSEVVSM 434 (476)
Q Consensus 384 ~~~~~~~~~~~d~~~~------~~~~~~~~~~l~~li~~Cl~~dP~~RPt~~eVl~~ 434 (476)
.+.......+++.... ..........+.+++.+||+.+|++|||+.++++.
T Consensus 239 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~P~~Rps~~~il~~ 295 (337)
T cd07852 239 SIKSPFAATMLDSLPSRPRKPLDELLPKASDDALDLLKKLLVFNPNKRLTAEEALEH 295 (337)
T ss_pred HHHhhhHHHhhhhcccccccchhhhccCCCHHHHHHHHHhccCCcccccCHHHHhhC
Confidence 0000000000000000 00011134578899999999999999999999865
|
Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase 15 (MAPK15) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK15 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. Human MAPK15 is also called Extracellular signal Regulated Kinase 8 (ERK8) while the rat protein is called ERK7. ERK7 and ERK8 display both similar and different biochemical properties. They autophosphorylate and activate themselves and do not require upstream activating kinases. ERK7 is constitutively active and is not affected by extracellular stimul |
| >cd06652 STKc_MEKK2 Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 2 | Back alignment and domain information |
|---|
Probab=99.89 E-value=2.4e-23 Score=201.69 Aligned_cols=173 Identities=24% Similarity=0.327 Sum_probs=128.3
Q ss_pred cceeeccCCCCC------CCCCCChhhHHHHHHHHHHHHHHHhhcCCCceeecCCCccceEecCCCCceeccccceeecC
Q 045315 243 ISFWYESYNNPT------KKGLLCWGTRVRIIEGIAQGLLYLHQYSRLRVIHRDLKASNILLDKDMNPKISDFGMARMFG 316 (476)
Q Consensus 243 ~~l~~Ey~~~~~------~~~~L~~~~~~~i~~qIa~gL~yLH~~~~~~ivH~DLkp~NILld~~~~~kL~DFGla~~~~ 316 (476)
.++++||++... +...+++..+.+++.|++.||+|||+.+ ++|+||||+||+++.++.+||+|||+++...
T Consensus 81 ~~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~l~~~l~~lH~~~---i~H~dl~p~nil~~~~~~~~l~Dfg~~~~~~ 157 (265)
T cd06652 81 LSIFMEHMPGGSIKDQLKSYGALTENVTRKYTRQILEGVSYLHSNM---IVHRDIKGANILRDSVGNVKLGDFGASKRLQ 157 (265)
T ss_pred EEEEEEecCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHhCC---EecCCCCHHHEEecCCCCEEECcCccccccc
Confidence 457788887331 2356889999999999999999999998 9999999999999999999999999987653
Q ss_pred CCccc-ccceeeeeccCCCChhhhccCCCCccceEEeehhhhhhhhhCCCCCCcCCCCchhhhhhhhhhhcCCCcccccC
Q 045315 317 GDELQ-SNTKRIVGTYGYMSPEYALRGLFSIKSDVFSFGVLLLETLSSKKNTHFYNTDSLTLLGHAWNLWNDGRTWELMD 395 (476)
Q Consensus 317 ~~~~~-~~~~~~~gt~~y~aPE~l~~~~~s~ksDVwSlGvvl~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~d 395 (476)
..... .......++..|+|||.+.+..++.++|+|||||++|||++|+.||...... .... ......
T Consensus 158 ~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~el~~g~~p~~~~~~~-~~~~----~~~~~~------- 225 (265)
T cd06652 158 TICLSGTGMKSVTGTPYWMSPEVISGEGYGRKADIWSVGCTVVEMLTEKPPWAEFEAM-AAIF----KIATQP------- 225 (265)
T ss_pred cccccccccccCCCCccccChhhhcCCCCCcchhHHHHHHHHHHHhhCCCCCCccchH-HHHH----HHhcCC-------
Confidence 22111 1122245788999999998888999999999999999999999998533211 1110 010000
Q ss_pred cccCCCCCHHHHHHHHHHHHHchhhcccCCCCHHHHHH
Q 045315 396 PISQNGASYPILKRYINVALLCVQEKAADRPAMSEVVS 433 (476)
Q Consensus 396 ~~~~~~~~~~~~~~l~~li~~Cl~~dP~~RPt~~eVl~ 433 (476)
.....+......+.+++.+|+. +|++||++++|++
T Consensus 226 --~~~~~~~~~~~~~~~~i~~~l~-~p~~Rp~~~~il~ 260 (265)
T cd06652 226 --TNPVLPPHVSDHCRDFLKRIFV-EAKLRPSADELLR 260 (265)
T ss_pred --CCCCCchhhCHHHHHHHHHHhc-ChhhCCCHHHHhc
Confidence 0111223445677888889985 9999999999875
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 2 (MEKK2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK2 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates the MAPK kinase MEK5 (or MKK5), which in turn phosphorylates and activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK2 also activates ERK1/2, c-Jun N-terminal kinase (JNK) and p38 through their re |
| >PTZ00266 NIMA-related protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=99.89 E-value=2e-23 Score=229.41 Aligned_cols=175 Identities=26% Similarity=0.324 Sum_probs=128.9
Q ss_pred cccceeeccCCCCC----------CCCCCChhhHHHHHHHHHHHHHHHhhcCC----CceeecCCCccceEecC------
Q 045315 241 DEISFWYESYNNPT----------KKGLLCWGTRVRIIEGIAQGLLYLHQYSR----LRVIHRDLKASNILLDK------ 300 (476)
Q Consensus 241 ~~~~l~~Ey~~~~~----------~~~~L~~~~~~~i~~qIa~gL~yLH~~~~----~~ivH~DLkp~NILld~------ 300 (476)
+.++++|||++... ....|++..++.|+.||+.||+|||+.+. ..||||||||+||||+.
T Consensus 87 ~~lyIVMEY~~gGSL~~lL~k~~~~~g~L~E~~Il~Ia~QIL~ALaYLHs~g~~~~~k~IVHRDLKPeNILL~s~~~~lg 166 (1021)
T PTZ00266 87 QKLYILMEFCDAGDLSRNIQKCYKMFGKIEEHAIVDITRQLLHALAYCHNLKDGPNGERVLHRDLKPQNIFLSTGIRHIG 166 (1021)
T ss_pred CEEEEEEeCCCCCcHHHHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHhcccccccCCceeccCcHHHeEeecCccccc
Confidence 45789999998321 23579999999999999999999998431 23999999999999964
Q ss_pred -----------CCCceeccccceeecCCCcccccceeeeeccCCCChhhhcc--CCCCccceEEeehhhhhhhhhCCCCC
Q 045315 301 -----------DMNPKISDFGMARMFGGDELQSNTKRIVGTYGYMSPEYALR--GLFSIKSDVFSFGVLLLETLSSKKNT 367 (476)
Q Consensus 301 -----------~~~~kL~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~l~~--~~~s~ksDVwSlGvvl~elltG~~p~ 367 (476)
...+||+|||++..+..... .....|++.|+|||++.+ ..++.++|||||||++|||++|+.||
T Consensus 167 ~i~~~~~n~ng~~iVKLsDFGlAr~l~~~s~---~~s~vGTp~YmAPEvL~ge~~~~s~KSDVWSLG~ILYELLTGk~PF 243 (1021)
T PTZ00266 167 KITAQANNLNGRPIAKIGDFGLSKNIGIESM---AHSCVGTPYYWSPELLLHETKSYDDKSDMWALGCIIYELCSGKTPF 243 (1021)
T ss_pred cccccccccCCCCceEEccCCcccccccccc---ccccCCCccccCHHHHhccCCCCCchhHHHHHHHHHHHHHHCCCCC
Confidence 23489999999987643221 223468999999999864 45889999999999999999999998
Q ss_pred CcCCCCchhhhhhhhhhhcCCCcccccCcccCCCCCHHHHHHHHHHHHHchhhcccCCCCHHHHHH
Q 045315 368 HFYNTDSLTLLGHAWNLWNDGRTWELMDPISQNGASYPILKRYINVALLCVQEKAADRPAMSEVVS 433 (476)
Q Consensus 368 ~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~l~~li~~Cl~~dP~~RPt~~eVl~ 433 (476)
...... ..+.. ....+.. +. .......+.+|+..||+.+|.+||++.|++.
T Consensus 244 ~~~~~~-~qli~----~lk~~p~-------lp---i~~~S~eL~dLI~~~L~~dPeeRPSa~QlL~ 294 (1021)
T PTZ00266 244 HKANNF-SQLIS----ELKRGPD-------LP---IKGKSKELNILIKNLLNLSAKERPSALQCLG 294 (1021)
T ss_pred CcCCcH-HHHHH----HHhcCCC-------CC---cCCCCHHHHHHHHHHhcCChhHCcCHHHHhc
Confidence 643211 11111 1111100 00 0112356889999999999999999999983
|
|
| >cd08226 PK_STRAD_beta Pseudokinase domain of STE20-related kinase adapter protein beta | Back alignment and domain information |
|---|
Probab=99.89 E-value=3.7e-23 Score=207.27 Aligned_cols=190 Identities=21% Similarity=0.206 Sum_probs=127.8
Q ss_pred cccceeeccCCCC--------CCCCCCChhhHHHHHHHHHHHHHHHhhcCCCceeecCCCccceEecCCCCceeccccce
Q 045315 241 DEISFWYESYNNP--------TKKGLLCWGTRVRIIEGIAQGLLYLHQYSRLRVIHRDLKASNILLDKDMNPKISDFGMA 312 (476)
Q Consensus 241 ~~~~l~~Ey~~~~--------~~~~~L~~~~~~~i~~qIa~gL~yLH~~~~~~ivH~DLkp~NILld~~~~~kL~DFGla 312 (476)
+..++++||++.. .....+++..+..++.||+.||+|||+.+ ++||||||+||+++.++.+|++||+.+
T Consensus 72 ~~~~~v~e~~~~~~l~~~l~~~~~~~~~~~~~~~~~~qi~~aL~~lH~~~---ivHrDlkp~Nill~~~~~~~~~~~~~~ 148 (328)
T cd08226 72 SWLWVISPFMAYGSANSLLKTYFPEGMSEALIGNILFGALRGLNYLHQNG---YIHRNIKASHILISGDGLVSLSGLSHL 148 (328)
T ss_pred CceEEEEecccCCCHHHHHHhhcccCCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCCHHHEEEeCCCcEEEechHHH
Confidence 3567788887722 12345889999999999999999999998 999999999999999999999999865
Q ss_pred eecCCCccc-----ccceeeeeccCCCChhhhccC--CCCccceEEeehhhhhhhhhCCCCCCcCCCCchhhhhhhhhh-
Q 045315 313 RMFGGDELQ-----SNTKRIVGTYGYMSPEYALRG--LFSIKSDVFSFGVLLLETLSSKKNTHFYNTDSLTLLGHAWNL- 384 (476)
Q Consensus 313 ~~~~~~~~~-----~~~~~~~gt~~y~aPE~l~~~--~~s~ksDVwSlGvvl~elltG~~p~~~~~~~~~~~~~~~~~~- 384 (476)
......... .......++..|+|||++.+. .++.++|||||||+++||++|+.||.................
T Consensus 149 ~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~DiwslG~~l~el~~g~~p~~~~~~~~~~~~~~~~~~~ 228 (328)
T cd08226 149 YSLVRNGQKAKVVYDFPQFSTSVLPWLSPELLRQDLYGYNVKSDIYSVGITACELATGRVPFQDMLRTQMLLQKLKGPPY 228 (328)
T ss_pred hhhhccCccccccccccccccCccCccChhhhcCCCCCCCchhhHHHHHHHHHHHHhCCCCCCCcChHHHHHHHhcCCCC
Confidence 432211100 001112345679999998763 478999999999999999999999865432111000000000
Q ss_pred ---------------------h---------cCCCcccccCcccCCCCCHHHHHHHHHHHHHchhhcccCCCCHHHHHH
Q 045315 385 ---------------------W---------NDGRTWELMDPISQNGASYPILKRYINVALLCVQEKAADRPAMSEVVS 433 (476)
Q Consensus 385 ---------------------~---------~~~~~~~~~d~~~~~~~~~~~~~~l~~li~~Cl~~dP~~RPt~~eVl~ 433 (476)
. .........+..............+.+++.+||+.||++|||+.|+++
T Consensus 229 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~Rpta~e~l~ 307 (328)
T cd08226 229 SPLDITTFPCEESRMKNSQSGVDSGIGESVVAAGMTQTMTSERLRTPSSKTFSPAFQNLVELCLQQDPEKRPSASSLLS 307 (328)
T ss_pred CCccccccchhhhhhccchhhhhcccccchhccccccccccccccchhhhhhhHHHHHHHHHHccCCcccCCCHHHHhh
Confidence 0 000000111111112222345677899999999999999999999974
|
Protein Kinase family, STE20-related kinase adapter protein (STRAD) beta subfamily, pseudokinase domain. The STRAD-beta subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hyperpig |
| >cd05577 STKc_GRK Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase | Back alignment and domain information |
|---|
Probab=99.89 E-value=4.6e-23 Score=201.28 Aligned_cols=175 Identities=23% Similarity=0.250 Sum_probs=130.2
Q ss_pred cccceeeccCCCC--------CCCCCCChhhHHHHHHHHHHHHHHHhhcCCCceeecCCCccceEecCCCCceeccccce
Q 045315 241 DEISFWYESYNNP--------TKKGLLCWGTRVRIIEGIAQGLLYLHQYSRLRVIHRDLKASNILLDKDMNPKISDFGMA 312 (476)
Q Consensus 241 ~~~~l~~Ey~~~~--------~~~~~L~~~~~~~i~~qIa~gL~yLH~~~~~~ivH~DLkp~NILld~~~~~kL~DFGla 312 (476)
+..++++||++.. .....+++.++..++.|++.||.|||+.+ ++|+||+|+||+++.++.+||+|||.+
T Consensus 66 ~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~ql~~~l~~lH~~~---i~H~di~p~Nil~~~~~~~~l~dfg~~ 142 (277)
T cd05577 66 DDLCLVMTLMNGGDLKYHIYNVGEPGFPEARAIFYAAQIICGLEHLHQRR---IVYRDLKPENVLLDDHGNVRISDLGLA 142 (277)
T ss_pred CeEEEEEecCCCCcHHHHHHHcCcCCCCHHHHHHHHHHHHHHHHHHHhCC---cccCCCCHHHEEECCCCCEEEccCcch
Confidence 4678899999732 12247999999999999999999999998 999999999999999999999999998
Q ss_pred eecCCCcccccceeeeeccCCCChhhhccCCCCccceEEeehhhhhhhhhCCCCCCcCCCCchhhhhhhhhhhcCCCccc
Q 045315 313 RMFGGDELQSNTKRIVGTYGYMSPEYALRGLFSIKSDVFSFGVLLLETLSSKKNTHFYNTDSLTLLGHAWNLWNDGRTWE 392 (476)
Q Consensus 313 ~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~s~ksDVwSlGvvl~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~ 392 (476)
....... ......++..|+|||.+.+..++.++|+||||+++++|++|+.||.......... .........
T Consensus 143 ~~~~~~~---~~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~--~~~~~~~~~---- 213 (277)
T cd05577 143 VELKGGK---KIKGRAGTPGYMAPEVLQGEVYDFSVDWFALGCTLYEMIAGRSPFRQRKEKVEKE--ELKRRTLEM---- 213 (277)
T ss_pred hhhccCC---ccccccCCCCcCCHHHhcCCCCCchhhhHHHHHHHHHHhhCCCCCCCCcccccHH--HHHhccccc----
Confidence 7654321 1122457789999999988889999999999999999999999986543211100 000000000
Q ss_pred ccCcccCCCCCHHHHHHHHHHHHHchhhcccCCC-----CHHHHHH
Q 045315 393 LMDPISQNGASYPILKRYINVALLCVQEKAADRP-----AMSEVVS 433 (476)
Q Consensus 393 ~~d~~~~~~~~~~~~~~l~~li~~Cl~~dP~~RP-----t~~eVl~ 433 (476)
....+......+.+++.+||+.+|++|| ++.+++.
T Consensus 214 ------~~~~~~~~~~~~~~li~~~l~~~p~~R~~~~~~~~~~ll~ 253 (277)
T cd05577 214 ------AVEYPDKFSPEAKDLCEALLQKDPEKRLGCRGGSADEVRE 253 (277)
T ss_pred ------cccCCccCCHHHHHHHHHHccCChhHccCCCcccHHHHHh
Confidence 0011112245688999999999999999 6666653
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. GRKs contain a central catalytic domain, flanked by N- and C-terminal extensions. The N-terminus contains an RGS (regulator of |
| >cd08530 STKc_CNK2-like Catalytic domain of the Protein Serine/Threonine Kinase, Chlamydomonas reinhardtii CNK2, and similar domains | Back alignment and domain information |
|---|
Probab=99.89 E-value=1.9e-23 Score=200.58 Aligned_cols=171 Identities=26% Similarity=0.309 Sum_probs=134.2
Q ss_pred cccceeeccCCCCC----------CCCCCChhhHHHHHHHHHHHHHHHhhcCCCceeecCCCccceEecCCCCceecccc
Q 045315 241 DEISFWYESYNNPT----------KKGLLCWGTRVRIIEGIAQGLLYLHQYSRLRVIHRDLKASNILLDKDMNPKISDFG 310 (476)
Q Consensus 241 ~~~~l~~Ey~~~~~----------~~~~L~~~~~~~i~~qIa~gL~yLH~~~~~~ivH~DLkp~NILld~~~~~kL~DFG 310 (476)
...++++||++... .+..+++.++..++.|++.||+|||+.+ ++|+||+|+||+++.++.+||+|||
T Consensus 72 ~~~~~v~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~~l~~al~~lh~~~---i~h~~l~~~ni~~~~~~~~kl~d~g 148 (256)
T cd08530 72 NKLCIVMEYAPFGDLSKAISKRKKKRKLIPEQEIWRIFIQLLRGLQALHEQK---ILHRDLKSANILLVANDLVKIGDLG 148 (256)
T ss_pred CEEEEEehhcCCCCHHHHHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHhhCC---cccCCCCcceEEEecCCcEEEeecc
Confidence 46788899987321 2467899999999999999999999998 9999999999999999999999999
Q ss_pred ceeecCCCcccccceeeeeccCCCChhhhccCCCCccceEEeehhhhhhhhhCCCCCCcCCCCchhhhhhhhhhhcCCCc
Q 045315 311 MARMFGGDELQSNTKRIVGTYGYMSPEYALRGLFSIKSDVFSFGVLLLETLSSKKNTHFYNTDSLTLLGHAWNLWNDGRT 390 (476)
Q Consensus 311 la~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~s~ksDVwSlGvvl~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~ 390 (476)
++....... .....++..|++||.+.+..++.++|+||||++++|+++|+.|+...... .+... ...+..
T Consensus 149 ~~~~~~~~~----~~~~~~~~~~~~Pe~~~~~~~~~~~D~~slG~~~~~l~~g~~p~~~~~~~--~~~~~----~~~~~~ 218 (256)
T cd08530 149 ISKVLKKNM----AKTQIGTPHYMAPEVWKGRPYSYKSDIWSLGCLLYEMATFAPPFEARSMQ--DLRYK----VQRGKY 218 (256)
T ss_pred chhhhccCC----cccccCCccccCHHHHCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHH--HHHHH----HhcCCC
Confidence 998765431 11245788999999999888999999999999999999999998644321 11111 111111
Q ss_pred ccccCcccCCCCCHHHHHHHHHHHHHchhhcccCCCCHHHHHH
Q 045315 391 WELMDPISQNGASYPILKRYINVALLCVQEKAADRPAMSEVVS 433 (476)
Q Consensus 391 ~~~~d~~~~~~~~~~~~~~l~~li~~Cl~~dP~~RPt~~eVl~ 433 (476)
..........+.+++.+|++.+|++||++.++++
T Consensus 219 ---------~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~~l~ 252 (256)
T cd08530 219 ---------PPIPPIYSQDLQNFIRSMLQVKPKLRPNCDKILA 252 (256)
T ss_pred ---------CCCchhhCHHHHHHHHHHcCCCcccCCCHHHHhc
Confidence 1112234567899999999999999999999875
|
Serine/Threonine Kinases (STKs), Chlamydomonas reinhardtii Never In Mitosis gene A (NIMA)-related kinase 1 (CNK2)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Chlamydomonas reinhardtii CNK2-like subfamily belongs to the (NIMA)-related kinase (Nek) family. The Nek family includes seven different Chlamydomonas Neks (CNKs 1-6 and Fa2). This subfamily includes CNK1, and -2. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Chlamydomonas reinhardtii CNK2 has both cilliary and cell cycle functions. It influences flagellar length through promoting flagellar disassembly, an |
| >cd06635 STKc_TAO1 Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 1 | Back alignment and domain information |
|---|
Probab=99.89 E-value=3.1e-23 Score=206.86 Aligned_cols=175 Identities=30% Similarity=0.358 Sum_probs=133.0
Q ss_pred cccceeeccCCCC------CCCCCCChhhHHHHHHHHHHHHHHHhhcCCCceeecCCCccceEecCCCCceeccccceee
Q 045315 241 DEISFWYESYNNP------TKKGLLCWGTRVRIIEGIAQGLLYLHQYSRLRVIHRDLKASNILLDKDMNPKISDFGMARM 314 (476)
Q Consensus 241 ~~~~l~~Ey~~~~------~~~~~L~~~~~~~i~~qIa~gL~yLH~~~~~~ivH~DLkp~NILld~~~~~kL~DFGla~~ 314 (476)
..+++++||++.. ..+.++++.++..++.||+.||.|||+.+ ++||||+|+||+++.++.+||+|||++..
T Consensus 98 ~~~~lv~e~~~g~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~---i~H~dL~p~Nil~~~~~~~kl~dfg~~~~ 174 (317)
T cd06635 98 HTAWLVMEYCLGSASDLLEVHKKPLQEVEIAAITHGALQGLAYLHSHN---MIHRDIKAGNILLTEPGQVKLADFGSASI 174 (317)
T ss_pred CeEEEEEeCCCCCHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCCcccEEECCCCCEEEecCCCccc
Confidence 4578899998731 23567999999999999999999999998 99999999999999999999999999875
Q ss_pred cCCCcccccceeeeeccCCCChhhhc---cCCCCccceEEeehhhhhhhhhCCCCCCcCCCCchhhhhhhhhhhcCCCcc
Q 045315 315 FGGDELQSNTKRIVGTYGYMSPEYAL---RGLFSIKSDVFSFGVLLLETLSSKKNTHFYNTDSLTLLGHAWNLWNDGRTW 391 (476)
Q Consensus 315 ~~~~~~~~~~~~~~gt~~y~aPE~l~---~~~~s~ksDVwSlGvvl~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~ 391 (476)
.... ....++..|+|||++. .+.++.++|+|||||++|||++|+.|+...... .... .....+.
T Consensus 175 ~~~~------~~~~~~~~y~aPE~~~~~~~~~~~~~~Dv~slGvil~el~~g~~p~~~~~~~--~~~~---~~~~~~~-- 241 (317)
T cd06635 175 ASPA------NSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAM--SALY---HIAQNES-- 241 (317)
T ss_pred cCCc------ccccCCccccChhhhhcCCCCCCCccccHHHHHHHHHHHHhCCCCCCCccHH--HHHH---HHHhccC--
Confidence 4321 2245788999999874 456889999999999999999999987543211 1110 0111110
Q ss_pred cccCcccCCCCCHHHHHHHHHHHHHchhhcccCCCCHHHHHHHHhcc
Q 045315 392 ELMDPISQNGASYPILKRYINVALLCVQEKAADRPAMSEVVSMLSNE 438 (476)
Q Consensus 392 ~~~d~~~~~~~~~~~~~~l~~li~~Cl~~dP~~RPt~~eVl~~L~~~ 438 (476)
+ ..........+.+++.+||+.+|.+||++.+|++.+-..
T Consensus 242 ----~---~~~~~~~~~~l~~li~~~l~~~p~~Rpt~~~il~~~~~~ 281 (317)
T cd06635 242 ----P---TLQSNEWSDYFRNFVDSCLQKIPQDRPTSEELLKHMFVL 281 (317)
T ss_pred ----C---CCCCccccHHHHHHHHHHccCCcccCcCHHHHHhChhhh
Confidence 0 011112345688999999999999999999999876553
|
Serine/threonine kinases (STKs), thousand-and-one amino acids 1 (TAO1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. TAO1 is sometimes referred to as prostate-derived sterile 20-like kinase 2 (PSK2). TAO1 activates the p38 MAPK through direct interaction with and activation of MEK3. TAO1 is highly expressed in the brain and may play a role in neuron |
| >cd05583 STKc_MSK_N N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase | Back alignment and domain information |
|---|
Probab=99.89 E-value=5.9e-23 Score=201.55 Aligned_cols=182 Identities=20% Similarity=0.256 Sum_probs=135.0
Q ss_pred cccceeeccCCCC------CCCCCCChhhHHHHHHHHHHHHHHHhhcCCCceeecCCCccceEecCCCCceeccccceee
Q 045315 241 DEISFWYESYNNP------TKKGLLCWGTRVRIIEGIAQGLLYLHQYSRLRVIHRDLKASNILLDKDMNPKISDFGMARM 314 (476)
Q Consensus 241 ~~~~l~~Ey~~~~------~~~~~L~~~~~~~i~~qIa~gL~yLH~~~~~~ivH~DLkp~NILld~~~~~kL~DFGla~~ 314 (476)
+..++++||++.. .+...+++.++..++.|+++||.|||+.+ ++|+||||+||+++.++.++|+|||+++.
T Consensus 78 ~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~ql~~~l~~lH~~~---~~H~dl~p~nil~~~~~~~~l~dfg~~~~ 154 (288)
T cd05583 78 TKLHLILDYVNGGELFTHLYQREHFTESEVRVYIAEIVLALDHLHQLG---IIYRDIKLENILLDSEGHVVLTDFGLSKE 154 (288)
T ss_pred CEEEEEEecCCCCcHHHHHhhcCCcCHHHHHHHHHHHHHHHHHHHHCC---eeccCCCHHHeEECCCCCEEEEECccccc
Confidence 3567899999732 23457899999999999999999999998 99999999999999999999999999876
Q ss_pred cCCCcccccceeeeeccCCCChhhhccCC--CCccceEEeehhhhhhhhhCCCCCCcCCCCchhhhhhhhhhhcCCCccc
Q 045315 315 FGGDELQSNTKRIVGTYGYMSPEYALRGL--FSIKSDVFSFGVLLLETLSSKKNTHFYNTDSLTLLGHAWNLWNDGRTWE 392 (476)
Q Consensus 315 ~~~~~~~~~~~~~~gt~~y~aPE~l~~~~--~s~ksDVwSlGvvl~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~ 392 (476)
+...... ......++..|++||.+.+.. .+.++|+||||++++||++|..|+........ ...........
T Consensus 155 ~~~~~~~-~~~~~~~~~~y~aPE~~~~~~~~~~~~~Dv~slG~il~el~tg~~p~~~~~~~~~-~~~~~~~~~~~----- 227 (288)
T cd05583 155 FLAEEEE-RAYSFCGTIEYMAPEVIRGGSGGHDKAVDWWSLGVLTFELLTGASPFTVDGEQNS-QSEISRRILKS----- 227 (288)
T ss_pred ccccccc-ccccccCCccccCHHHhcCCCCCCcchhhhHHHHHHHHHHHhCCCCcccCcccch-HHHHHHHHHcc-----
Confidence 5433211 122245788999999987654 78899999999999999999999864321110 01111111110
Q ss_pred ccCcccCCCCCHHHHHHHHHHHHHchhhcccCCCCHHHHHHHHhcc
Q 045315 393 LMDPISQNGASYPILKRYINVALLCVQEKAADRPAMSEVVSMLSNE 438 (476)
Q Consensus 393 ~~d~~~~~~~~~~~~~~l~~li~~Cl~~dP~~RPt~~eVl~~L~~~ 438 (476)
.+ ..+......+.+++.+||+.+|++|||+.++.+.|+..
T Consensus 228 --~~----~~~~~~~~~l~~li~~~l~~~p~~R~t~~~~~~~l~~~ 267 (288)
T cd05583 228 --KP----PFPKTMSAEARDFIQKLLEKDPKKRLGANGADEIKNHP 267 (288)
T ss_pred --CC----CCCcccCHHHHHHHHHHhcCCHhhccCcchHHHHhcCc
Confidence 00 11112234678899999999999999999998888775
|
Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, in response to various stimuli such as growth factors, hormones, neurotransmitters, cellular stress, and pro-inflammatory cytokines |
| >cd07830 STKc_MAK_like Catalytic domain of Male germ cell-Associated Kinase-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=99.88 E-value=5.4e-23 Score=200.96 Aligned_cols=188 Identities=22% Similarity=0.250 Sum_probs=131.6
Q ss_pred ccccceeeccCCC-------CCCCCCCChhhHHHHHHHHHHHHHHHhhcCCCceeecCCCccceEecCCCCceeccccce
Q 045315 240 KDEISFWYESYNN-------PTKKGLLCWGTRVRIIEGIAQGLLYLHQYSRLRVIHRDLKASNILLDKDMNPKISDFGMA 312 (476)
Q Consensus 240 ~~~~~l~~Ey~~~-------~~~~~~L~~~~~~~i~~qIa~gL~yLH~~~~~~ivH~DLkp~NILld~~~~~kL~DFGla 312 (476)
.+.+++++||+.. ......+++.+++.++.|++.+|.|||+++ ++|+||+|+||+++.++.++|+|||++
T Consensus 70 ~~~~~lv~e~~~~~l~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~Lh~~~---i~H~dl~~~ni~i~~~~~~~l~d~~~~ 146 (283)
T cd07830 70 NDELYFVFEYMEGNLYQLMKDRKGKPFSESVIRSIIYQILQGLAHIHKHG---FFHRDLKPENLLVSGPEVVKIADFGLA 146 (283)
T ss_pred CCcEEEEEecCCCCHHHHHHhcccccCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCChhhEEEcCCCCEEEeecccc
Confidence 3578899999961 112347899999999999999999999998 999999999999999999999999999
Q ss_pred eecCCCcccccceeeeeccCCCChhhhcc-CCCCccceEEeehhhhhhhhhCCCCCCcCCCCchhhh-hhh-----hhhh
Q 045315 313 RMFGGDELQSNTKRIVGTYGYMSPEYALR-GLFSIKSDVFSFGVLLLETLSSKKNTHFYNTDSLTLL-GHA-----WNLW 385 (476)
Q Consensus 313 ~~~~~~~~~~~~~~~~gt~~y~aPE~l~~-~~~s~ksDVwSlGvvl~elltG~~p~~~~~~~~~~~~-~~~-----~~~~ 385 (476)
......... ....++..|+|||.+.. ..++.++|+||||++++||++|+.||........... ... ...+
T Consensus 147 ~~~~~~~~~---~~~~~~~~~~aPE~~~~~~~~~~~~Di~s~G~~l~el~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 223 (283)
T cd07830 147 REIRSRPPY---TDYVSTRWYRAPEILLRSTSYSSPVDIWALGCIMAELYTLRPLFPGSSEIDQLYKICSVLGTPTKQDW 223 (283)
T ss_pred eeccCCCCc---CCCCCcccccCceeeecCcCcCCccchhhHHHHHHHHHhCCCccCCCChHHHHHHHHHhcCCCChhhh
Confidence 876432211 12457889999998754 4578999999999999999999998865432111000 000 0000
Q ss_pred cC-----CCcccccCcccC---CCCCHHHHHHHHHHHHHchhhcccCCCCHHHHHH
Q 045315 386 ND-----GRTWELMDPISQ---NGASYPILKRYINVALLCVQEKAADRPAMSEVVS 433 (476)
Q Consensus 386 ~~-----~~~~~~~d~~~~---~~~~~~~~~~l~~li~~Cl~~dP~~RPt~~eVl~ 433 (476)
.+ ......+..... ..........+.+++.+||+.+|++||+++|++.
T Consensus 224 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~~p~~Rpt~~ei~~ 279 (283)
T cd07830 224 PEGYKLASKLGFRFPQFAPTSLHQLIPNASPEAIDLIKDMLRWDPKKRPTASQALQ 279 (283)
T ss_pred hhHhhhhccccccccccccccHHHHcccCCHHHHHHHHHhcccCcccCCCHHHHhh
Confidence 00 000000000000 0000111367889999999999999999999875
|
Serine/Threonine Kinases (STKs), Male germ cell-Associated Kinase (MAK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of human MAK and MAK-related kinase (MRK), Saccharomyces cerevisiae Ime2p, Schizosaccharomyces pombe Mei4-dependent protein 3 (Mde3) and Pit1, Caenorhabditis elegans dyf-5, Arabidopsis thaliana MHK, and similar proteins. These proteins play important roles during meiosis. MAK is highly expressed in testicular cells specifically in the meiotic phase, but is not essential for spermatogenesis and fertili |
| >PLN00009 cyclin-dependent kinase A; Provisional | Back alignment and domain information |
|---|
Probab=99.88 E-value=2.9e-23 Score=204.39 Aligned_cols=186 Identities=22% Similarity=0.279 Sum_probs=127.4
Q ss_pred cccceeeccCCC-------CCCCCCCChhhHHHHHHHHHHHHHHHhhcCCCceeecCCCccceEecC-CCCceeccccce
Q 045315 241 DEISFWYESYNN-------PTKKGLLCWGTRVRIIEGIAQGLLYLHQYSRLRVIHRDLKASNILLDK-DMNPKISDFGMA 312 (476)
Q Consensus 241 ~~~~l~~Ey~~~-------~~~~~~L~~~~~~~i~~qIa~gL~yLH~~~~~~ivH~DLkp~NILld~-~~~~kL~DFGla 312 (476)
+..++++||++. ......+++..+..++.||+.||+|||+++ ++|+||+|+||+++. ++.+||+|||++
T Consensus 74 ~~~~lv~e~~~~~l~~~~~~~~~~~~~~~~~~~~~~qi~~aL~~LH~~~---i~H~dl~p~nill~~~~~~~kl~dfg~~ 150 (294)
T PLN00009 74 KRLYLVFEYLDLDLKKHMDSSPDFAKNPRLIKTYLYQILRGIAYCHSHR---VLHRDLKPQNLLIDRRTNALKLADFGLA 150 (294)
T ss_pred CeEEEEEecccccHHHHHHhCCCCCcCHHHHHHHHHHHHHHHHHHHhCC---eeCCCCCcceEEEECCCCEEEEcccccc
Confidence 357788888862 112234678888899999999999999998 999999999999985 557899999999
Q ss_pred eecCCCcccccceeeeeccCCCChhhhcc-CCCCccceEEeehhhhhhhhhCCCCCCcCCCCchhhhhhhhhhhcCC--C
Q 045315 313 RMFGGDELQSNTKRIVGTYGYMSPEYALR-GLFSIKSDVFSFGVLLLETLSSKKNTHFYNTDSLTLLGHAWNLWNDG--R 389 (476)
Q Consensus 313 ~~~~~~~~~~~~~~~~gt~~y~aPE~l~~-~~~s~ksDVwSlGvvl~elltG~~p~~~~~~~~~~~~~~~~~~~~~~--~ 389 (476)
......... .....++..|+|||.+.+ ..++.++|||||||++|+|++|+.||....... .+.. ........ .
T Consensus 151 ~~~~~~~~~--~~~~~~~~~y~~PE~~~~~~~~~~~~Dv~slG~i~~~l~tg~~pf~~~~~~~-~~~~-~~~~~~~~~~~ 226 (294)
T PLN00009 151 RAFGIPVRT--FTHEVVTLWYRAPEILLGSRHYSTPVDIWSVGCIFAEMVNQKPLFPGDSEID-ELFK-IFRILGTPNEE 226 (294)
T ss_pred cccCCCccc--cccCceeecccCHHHHhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHH-HHHH-HHHHhCCCChh
Confidence 765432111 122456889999998876 457899999999999999999999986533111 1111 00000000 0
Q ss_pred cc----cccC-----cccCC----CCCHHHHHHHHHHHHHchhhcccCCCCHHHHHH
Q 045315 390 TW----ELMD-----PISQN----GASYPILKRYINVALLCVQEKAADRPAMSEVVS 433 (476)
Q Consensus 390 ~~----~~~d-----~~~~~----~~~~~~~~~l~~li~~Cl~~dP~~RPt~~eVl~ 433 (476)
.. .+.+ +.... .........+.+++.+|++.+|++||++.++++
T Consensus 227 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~P~~Rps~~~~l~ 283 (294)
T PLN00009 227 TWPGVTSLPDYKSAFPKWPPKDLATVVPTLEPAGVDLLSKMLRLDPSKRITARAALE 283 (294)
T ss_pred hccccccchhhhhhcccCCCCCHHHhCcCCChHHHHHHHHHccCChhhCcCHHHHhc
Confidence 00 0000 00000 001123456889999999999999999999986
|
|
| >cd08225 STKc_Nek5 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 5 | Back alignment and domain information |
|---|
Probab=99.88 E-value=3.4e-23 Score=199.15 Aligned_cols=173 Identities=24% Similarity=0.327 Sum_probs=131.1
Q ss_pred cccceeeccCCCC--------CCCCCCChhhHHHHHHHHHHHHHHHhhcCCCceeecCCCccceEecCCC-Cceeccccc
Q 045315 241 DEISFWYESYNNP--------TKKGLLCWGTRVRIIEGIAQGLLYLHQYSRLRVIHRDLKASNILLDKDM-NPKISDFGM 311 (476)
Q Consensus 241 ~~~~l~~Ey~~~~--------~~~~~L~~~~~~~i~~qIa~gL~yLH~~~~~~ivH~DLkp~NILld~~~-~~kL~DFGl 311 (476)
+.+++++||++.. .....+++..+..++.|+++||+|||+.+ ++|+||||+||++++++ .+||+|||.
T Consensus 72 ~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~---i~H~dl~~~nil~~~~~~~~~l~d~~~ 148 (257)
T cd08225 72 GRLFIVMEYCDGGDLMKRINRQRGVLFSEDQILSWFVQISLGLKHIHDRK---ILHRDIKSQNIFLSKNGMVAKLGDFGI 148 (257)
T ss_pred CeEEEEEecCCCCcHHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHHCC---cccccCCHHHEEEcCCCCeEEeccccc
Confidence 4678899999732 23346899999999999999999999998 99999999999999875 469999999
Q ss_pred eeecCCCcccccceeeeeccCCCChhhhccCCCCccceEEeehhhhhhhhhCCCCCCcCCCCchhhhhhhhhhhcCCCcc
Q 045315 312 ARMFGGDELQSNTKRIVGTYGYMSPEYALRGLFSIKSDVFSFGVLLLETLSSKKNTHFYNTDSLTLLGHAWNLWNDGRTW 391 (476)
Q Consensus 312 a~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~s~ksDVwSlGvvl~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~ 391 (476)
+......... .....|+..|+|||...+..++.++|+||||++++|+++|+.|+...... ....... .+...
T Consensus 149 ~~~~~~~~~~--~~~~~~~~~~~ape~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~-----~~~~~~~-~~~~~ 220 (257)
T cd08225 149 ARQLNDSMEL--AYTCVGTPYYLSPEICQNRPYNNKTDIWSLGCVLYELCTLKHPFEGNNLH-----QLVLKIC-QGYFA 220 (257)
T ss_pred chhccCCccc--ccccCCCccccCHHHHcCCCCCchhhHHHHHHHHHHHHhCCCCCCCccHH-----HHHHHHh-cccCC
Confidence 9876433211 12245788999999998888999999999999999999999998543211 1111111 11110
Q ss_pred cccCcccCCCCCHHHHHHHHHHHHHchhhcccCCCCHHHHHH
Q 045315 392 ELMDPISQNGASYPILKRYINVALLCVQEKAADRPAMSEVVS 433 (476)
Q Consensus 392 ~~~d~~~~~~~~~~~~~~l~~li~~Cl~~dP~~RPt~~eVl~ 433 (476)
+ ........+.+++.+|++.+|++|||+.++++
T Consensus 221 ----~-----~~~~~~~~~~~~i~~~l~~~p~~Rpt~~~ll~ 253 (257)
T cd08225 221 ----P-----ISPNFSRDLRSLISQLFKVSPRDRPSITSILK 253 (257)
T ss_pred ----C-----CCCCCCHHHHHHHHHHhccChhhCcCHHHHhh
Confidence 0 11122356889999999999999999999975
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 5 (Nek5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek5 subfamily is one of a family of 11 different Neks (Nek1-11). The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Neks are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. The specific function of Nek5 is unknown. |
| >cd07836 STKc_Pho85 Catalytic domain of the Serine/Threonine Kinase, Fungal Cyclin-Dependent protein Kinase Pho85 | Back alignment and domain information |
|---|
Probab=99.88 E-value=3.9e-23 Score=202.05 Aligned_cols=186 Identities=21% Similarity=0.258 Sum_probs=129.7
Q ss_pred cccceeeccCCC--------CCCCCCCChhhHHHHHHHHHHHHHHHhhcCCCceeecCCCccceEecCCCCceeccccce
Q 045315 241 DEISFWYESYNN--------PTKKGLLCWGTRVRIIEGIAQGLLYLHQYSRLRVIHRDLKASNILLDKDMNPKISDFGMA 312 (476)
Q Consensus 241 ~~~~l~~Ey~~~--------~~~~~~L~~~~~~~i~~qIa~gL~yLH~~~~~~ivH~DLkp~NILld~~~~~kL~DFGla 312 (476)
+..++++||++. ......+++.++.+++.||+.||+|||+.+ ++|+||||+||++++++.+||+|||++
T Consensus 71 ~~~~lv~e~~~~~l~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~---i~h~dl~p~ni~~~~~~~~~l~d~g~~ 147 (284)
T cd07836 71 NKLMLVFEYMDKDLKKYMDTHGVRGALDPNTVKSFTYQLLKGIAFCHENR---VLHRDLKPQNLLINKRGELKLADFGLA 147 (284)
T ss_pred CcEEEEEecCCccHHHHHHhcCCCCCcCHHHHHHHHHHHHHHHHHHHHCC---eeeCCCCHHHEEECCCCcEEEeecchh
Confidence 346778888872 122356999999999999999999999998 999999999999999999999999999
Q ss_pred eecCCCcccccceeeeeccCCCChhhhccC-CCCccceEEeehhhhhhhhhCCCCCCcCCCCchhhhhhhhhhhc---CC
Q 045315 313 RMFGGDELQSNTKRIVGTYGYMSPEYALRG-LFSIKSDVFSFGVLLLETLSSKKNTHFYNTDSLTLLGHAWNLWN---DG 388 (476)
Q Consensus 313 ~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~-~~s~ksDVwSlGvvl~elltG~~p~~~~~~~~~~~~~~~~~~~~---~~ 388 (476)
........ ......++..|++||.+.+. .++.++|+|||||++|++++|+.||....... .......... ..
T Consensus 148 ~~~~~~~~--~~~~~~~~~~y~~PE~~~~~~~~~~~~Dv~slG~~l~~l~~g~~~~~~~~~~~--~~~~~~~~~~~~~~~ 223 (284)
T cd07836 148 RAFGIPVN--TFSNEVVTLWYRAPDVLLGSRTYSTSIDIWSVGCIMAEMITGRPLFPGTNNED--QLLKIFRIMGTPTES 223 (284)
T ss_pred hhhcCCcc--ccccccccccccChHHhcCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCcHH--HHHHHHHHhCCCChh
Confidence 76543211 11224568899999988654 56899999999999999999999986543211 1110000000 00
Q ss_pred Ccc-----cccCcccC-------CCCCHHHHHHHHHHHHHchhhcccCCCCHHHHHH
Q 045315 389 RTW-----ELMDPISQ-------NGASYPILKRYINVALLCVQEKAADRPAMSEVVS 433 (476)
Q Consensus 389 ~~~-----~~~d~~~~-------~~~~~~~~~~l~~li~~Cl~~dP~~RPt~~eVl~ 433 (476)
... ........ ..........+.+++.+|++.||.+||++.++++
T Consensus 224 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~p~~R~~~~~~l~ 280 (284)
T cd07836 224 TWPGISQLPEYKPTFPRYPPQDLQQLFPHADPLGIDLLHRLLQLNPELRISAHDALQ 280 (284)
T ss_pred hHHHHhcCchhcccccCCChHHHHHHhhhcCcHHHHHHHHHhcCCcccCCCHHHHhc
Confidence 000 00000000 0001122456889999999999999999999874
|
Serine/Threonine Kinases (STKs), Pho85 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Pho85 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Pho85 is a multifunctional Cyclin-Dependent protein Kinase (CDK) in yeast. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. Pho85 is regulated by 10 different cyclins (Pcls) and plays a role in G1 progression, cell polarity, phosphate and glycogen metabolism, gene expression, and in signaling changes in the environment. |
| >cd06630 STKc_MEKK1 Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 1 | Back alignment and domain information |
|---|
Probab=99.88 E-value=5.4e-23 Score=199.15 Aligned_cols=179 Identities=22% Similarity=0.378 Sum_probs=133.1
Q ss_pred cccceeeccCCCCC------CCCCCChhhHHHHHHHHHHHHHHHhhcCCCceeecCCCccceEecCCC-Cceecccccee
Q 045315 241 DEISFWYESYNNPT------KKGLLCWGTRVRIIEGIAQGLLYLHQYSRLRVIHRDLKASNILLDKDM-NPKISDFGMAR 313 (476)
Q Consensus 241 ~~~~l~~Ey~~~~~------~~~~L~~~~~~~i~~qIa~gL~yLH~~~~~~ivH~DLkp~NILld~~~-~~kL~DFGla~ 313 (476)
+..++++||++... +.+++++..+..++.||+.||+|||+++ ++|+||||+||+++.++ .+||+|||.+.
T Consensus 76 ~~~~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~ql~~al~~LH~~~---i~H~~i~~~nil~~~~~~~~~l~dfg~~~ 152 (268)
T cd06630 76 SHFNLFVEWMAGGSVSHLLSKYGAFKEAVIINYTEQLLRGLSYLHENQ---IIHRDVKGANLLIDSTGQRLRIADFGAAA 152 (268)
T ss_pred CeEEEEEeccCCCcHHHHHHHhCCCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCCHHHEEEcCCCCEEEEccccccc
Confidence 45678889988432 3457899999999999999999999998 99999999999998776 58999999998
Q ss_pred ecCCCccc--ccceeeeeccCCCChhhhccCCCCccceEEeehhhhhhhhhCCCCCCcCCCCchhhhhhhhhhhcCCCcc
Q 045315 314 MFGGDELQ--SNTKRIVGTYGYMSPEYALRGLFSIKSDVFSFGVLLLETLSSKKNTHFYNTDSLTLLGHAWNLWNDGRTW 391 (476)
Q Consensus 314 ~~~~~~~~--~~~~~~~gt~~y~aPE~l~~~~~s~ksDVwSlGvvl~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~ 391 (476)
........ .......++..|+|||.+.+..++.++|+||+|++++++++|+.||......... .........
T Consensus 153 ~~~~~~~~~~~~~~~~~~~~~~~~PE~~~~~~~~~~~Dv~slG~~l~~l~~g~~p~~~~~~~~~~--~~~~~~~~~---- 226 (268)
T cd06630 153 RLAAKGTGAGEFQGQLLGTIAFMAPEVLRGEQYGRSCDVWSVGCVIIEMATAKPPWNAEKHSNHL--ALIFKIASA---- 226 (268)
T ss_pred ccccccccCCccccccccccceeCHhHhccCCCCcccchHHHHHHHHHHHhCCCCCCCCCCcchH--HHHHHHhcc----
Confidence 76433111 1112346788999999998888999999999999999999999998643311110 000000000
Q ss_pred cccCcccCCCCCHHHHHHHHHHHHHchhhcccCCCCHHHHHH
Q 045315 392 ELMDPISQNGASYPILKRYINVALLCVQEKAADRPAMSEVVS 433 (476)
Q Consensus 392 ~~~d~~~~~~~~~~~~~~l~~li~~Cl~~dP~~RPt~~eVl~ 433 (476)
......+......+.+++.+|++.+|.+||++.+++.
T Consensus 227 -----~~~~~~~~~~~~~~~~~i~~~l~~~p~~R~~~~~ll~ 263 (268)
T cd06630 227 -----TTAPSIPEHLSPGLRDVTLRCLELQPEDRPPSRELLK 263 (268)
T ss_pred -----CCCCCCchhhCHHHHHHHHHHcCCCcccCcCHHHHhc
Confidence 0111222334567889999999999999999999874
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 1 (MEKK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK1 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK1 activates the extracellular signal-regulated kinase 1/2 (ERK1/2) and c-Jun N-terminal kinase (JNK) pathways by activating their |
| >cd06634 STKc_TAO2 Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 2 | Back alignment and domain information |
|---|
Probab=99.88 E-value=6e-23 Score=203.94 Aligned_cols=173 Identities=30% Similarity=0.356 Sum_probs=130.7
Q ss_pred cccceeeccCCCC------CCCCCCChhhHHHHHHHHHHHHHHHhhcCCCceeecCCCccceEecCCCCceeccccceee
Q 045315 241 DEISFWYESYNNP------TKKGLLCWGTRVRIIEGIAQGLLYLHQYSRLRVIHRDLKASNILLDKDMNPKISDFGMARM 314 (476)
Q Consensus 241 ~~~~l~~Ey~~~~------~~~~~L~~~~~~~i~~qIa~gL~yLH~~~~~~ivH~DLkp~NILld~~~~~kL~DFGla~~ 314 (476)
...++++||+... ..+.++++.++..++.|++.||.|||+.+ ++||||||+||+++.++.+||+|||++..
T Consensus 88 ~~~~lv~e~~~~~l~~~~~~~~~~l~~~~~~~~~~~l~~~l~~LH~~~---i~H~dl~p~nil~~~~~~~kl~dfg~~~~ 164 (308)
T cd06634 88 HTAWLVMEYCLGSASDLLEVHKKPLQEVEIAAVTHGALQGLAYLHSHN---MIHRDVKAGNILLSEPGLVKLGDFGSASI 164 (308)
T ss_pred CeeEEEEEccCCCHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhCC---cccCCCCHHhEEECCCCcEEECCccccee
Confidence 4577888988721 23456899999999999999999999998 99999999999999999999999999876
Q ss_pred cCCCcccccceeeeeccCCCChhhhc---cCCCCccceEEeehhhhhhhhhCCCCCCcCCCCchhhhhhhhhhhcCCCcc
Q 045315 315 FGGDELQSNTKRIVGTYGYMSPEYAL---RGLFSIKSDVFSFGVLLLETLSSKKNTHFYNTDSLTLLGHAWNLWNDGRTW 391 (476)
Q Consensus 315 ~~~~~~~~~~~~~~gt~~y~aPE~l~---~~~~s~ksDVwSlGvvl~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~ 391 (476)
.... ....++..|+|||.+. ...++.++|||||||++|+|++|+.|+....... .... ...+..
T Consensus 165 ~~~~------~~~~~~~~y~aPE~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~--~~~~----~~~~~~- 231 (308)
T cd06634 165 MAPA------NXFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMS--ALYH----IAQNES- 231 (308)
T ss_pred ecCc------ccccCCccccCHHHHhhcccCCCCcccchHHHHHHHHHHHcCCCCCccccHHH--HHHH----HhhcCC-
Confidence 5432 1245788999999975 3567889999999999999999999875432111 1100 011111
Q ss_pred cccCcccCCCCCHHHHHHHHHHHHHchhhcccCCCCHHHHHHHHh
Q 045315 392 ELMDPISQNGASYPILKRYINVALLCVQEKAADRPAMSEVVSMLS 436 (476)
Q Consensus 392 ~~~d~~~~~~~~~~~~~~l~~li~~Cl~~dP~~RPt~~eVl~~L~ 436 (476)
+.. ........+.+++.+||+.+|++||++.++++...
T Consensus 232 ----~~~---~~~~~~~~~~~li~~cl~~~P~~Rp~~~~ll~~~~ 269 (308)
T cd06634 232 ----PAL---QSGHWSEYFRNFVDSCLQKIPQDRPTSEVLLKHRF 269 (308)
T ss_pred ----CCc---CcccccHHHHHHHHHHhhCCcccCCCHHHHhhCcc
Confidence 000 11223456889999999999999999999987643
|
Serine/threonine kinases (STKs), thousand-and-one amino acids 2 (TAO2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Human TAO2 is also known as prostate-derived Ste20-like kinase (PSK) and was identified in a screen for overexpressed RNAs in prostate cancer. TAO2 activates both p38 and c-Jun N-terminal kinase (JNK), by phosphorylating and activatin |
| >cd06641 STKc_MST3 Catalytic domain of the Protein Serine/Threonine Kinase, Mammalian Ste20-like protein kinase 3 | Back alignment and domain information |
|---|
Probab=99.88 E-value=4e-23 Score=201.69 Aligned_cols=173 Identities=24% Similarity=0.347 Sum_probs=132.5
Q ss_pred ccceeeccCCCCC-----CCCCCChhhHHHHHHHHHHHHHHHhhcCCCceeecCCCccceEecCCCCceeccccceeecC
Q 045315 242 EISFWYESYNNPT-----KKGLLCWGTRVRIIEGIAQGLLYLHQYSRLRVIHRDLKASNILLDKDMNPKISDFGMARMFG 316 (476)
Q Consensus 242 ~~~l~~Ey~~~~~-----~~~~L~~~~~~~i~~qIa~gL~yLH~~~~~~ivH~DLkp~NILld~~~~~kL~DFGla~~~~ 316 (476)
..++++||++... .+..+++..+..++.|++.|+.|||+.+ ++|+||||+||+++.++.++|+|||++....
T Consensus 76 ~~~lv~e~~~~~~l~~~i~~~~~~~~~~~~~~~~l~~~l~~lh~~~---i~h~dl~p~Ni~i~~~~~~~l~dfg~~~~~~ 152 (277)
T cd06641 76 KLWIIMEYLGGGSALDLLEPGPLDETQIATILREILKGLDYLHSEK---KIHRDIKAANVLLSEHGEVKLADFGVAGQLT 152 (277)
T ss_pred eEEEEEEeCCCCcHHHHHhcCCCCHHHHHHHHHHHHHHHHHHccCC---eecCCCCHHhEEECCCCCEEEeecccceecc
Confidence 4677888887432 3457899999999999999999999998 9999999999999999999999999998664
Q ss_pred CCcccccceeeeeccCCCChhhhccCCCCccceEEeehhhhhhhhhCCCCCCcCCCCchhhhhhhhhhhcCCCcccccCc
Q 045315 317 GDELQSNTKRIVGTYGYMSPEYALRGLFSIKSDVFSFGVLLLETLSSKKNTHFYNTDSLTLLGHAWNLWNDGRTWELMDP 396 (476)
Q Consensus 317 ~~~~~~~~~~~~gt~~y~aPE~l~~~~~s~ksDVwSlGvvl~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~ 396 (476)
.... ......++..|+|||.+.+..++.++|+|||||+++++++|..|+...... .... .......
T Consensus 153 ~~~~--~~~~~~~~~~y~~PE~~~~~~~~~~~Dv~slG~~l~~l~~g~~p~~~~~~~--~~~~----~~~~~~~------ 218 (277)
T cd06641 153 DTQI--KRNTFVGTPFWMAPEVIKQSAYDSKADIWSLGITAIELAKGEPPHSELHPM--KVLF----LIPKNNP------ 218 (277)
T ss_pred cchh--hhccccCCccccChhhhccCCCCchhhHHHHHHHHHHHHcCCCCCCccchH--HHHH----HHhcCCC------
Confidence 3221 112245788999999998888899999999999999999999998543211 1110 0111111
Q ss_pred ccCCCCCHHHHHHHHHHHHHchhhcccCCCCHHHHHHH
Q 045315 397 ISQNGASYPILKRYINVALLCVQEKAADRPAMSEVVSM 434 (476)
Q Consensus 397 ~~~~~~~~~~~~~l~~li~~Cl~~dP~~RPt~~eVl~~ 434 (476)
..........+.+++.+||+.+|.+||++.++++.
T Consensus 219 ---~~~~~~~~~~~~~~i~~~l~~~p~~Rp~~~~~l~~ 253 (277)
T cd06641 219 ---PTLEGNYSKPLKEFVEACLNKEPSFRPTAKELLKH 253 (277)
T ss_pred ---CCCCcccCHHHHHHHHHHccCChhhCcCHHHHHhC
Confidence 01112234567899999999999999999999984
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 3 (MST3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MST3 phosphorylates the STK NDR and may play a role in cell cycle progression and cell morphology. It may also regulate paxillin and consequently, cell migration. MST3 is present in human placenta, where it plays an essential role in the oxidative stress-induced apoptosis of trophoblasts in normal spontaneous delivery. Dysregulation of trophoblast apoptosis may result in pregnancy complications such as preeclampsia and int |
| >cd05579 STKc_MAST_like Catalytic domain of Microtubule-associated serine/threonine kinase-like proteins | Back alignment and domain information |
|---|
Probab=99.88 E-value=2.3e-23 Score=200.71 Aligned_cols=181 Identities=25% Similarity=0.321 Sum_probs=135.1
Q ss_pred cccceeeccCCCCC------CCCCCChhhHHHHHHHHHHHHHHHhhcCCCceeecCCCccceEecCCCCceeccccceee
Q 045315 241 DEISFWYESYNNPT------KKGLLCWGTRVRIIEGIAQGLLYLHQYSRLRVIHRDLKASNILLDKDMNPKISDFGMARM 314 (476)
Q Consensus 241 ~~~~l~~Ey~~~~~------~~~~L~~~~~~~i~~qIa~gL~yLH~~~~~~ivH~DLkp~NILld~~~~~kL~DFGla~~ 314 (476)
+..++++||++... +.+.+++.++.+++.||++||+|||+.+ ++|+||+|+||+++.++.+||+|||++..
T Consensus 66 ~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~i~~qi~~~L~~lH~~~---i~H~di~~~nil~~~~~~~~l~dfg~~~~ 142 (265)
T cd05579 66 KNLYLVMEYLPGGDLASLLENVGSLDEDVARIYIAEIVLALEYLHSNG---IIHRDLKPDNILIDSNGHLKLTDFGLSKV 142 (265)
T ss_pred cEEEEEEecCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHcC---eecCCCCHHHeEEcCCCCEEEEecccchh
Confidence 45788999997432 2347899999999999999999999998 99999999999999999999999999876
Q ss_pred cCCCcc------cccceeeeeccCCCChhhhccCCCCccceEEeehhhhhhhhhCCCCCCcCCCCchhhhhhhhhhhcCC
Q 045315 315 FGGDEL------QSNTKRIVGTYGYMSPEYALRGLFSIKSDVFSFGVLLLETLSSKKNTHFYNTDSLTLLGHAWNLWNDG 388 (476)
Q Consensus 315 ~~~~~~------~~~~~~~~gt~~y~aPE~l~~~~~s~ksDVwSlGvvl~elltG~~p~~~~~~~~~~~~~~~~~~~~~~ 388 (476)
...... ........++..|++||.......+.++|+||||++++++++|+.||...... ..... . ..+
T Consensus 143 ~~~~~~~~~~~~~~~~~~~~~~~~~~~Pe~~~~~~~~~~~Dv~slG~~~~~l~~g~~p~~~~~~~--~~~~~---~-~~~ 216 (265)
T cd05579 143 GLVRRQINLNDDEKEDKRIVGTPDYIAPEVILGQGHSKTVDWWSLGCILYEFLVGIPPFHGETPE--EIFQN---I-LNG 216 (265)
T ss_pred cccCcccccccccccccCcccCccccCHHHhcCCCCCcchhhHHHHHHHHHHHhCCCCCCCCCHH--HHHHH---H-hcC
Confidence 433211 01122345778999999998888899999999999999999999998643311 11110 1 111
Q ss_pred CcccccCcccCCCCCHHHHHHHHHHHHHchhhcccCCCCHHHHHHHHhcc
Q 045315 389 RTWELMDPISQNGASYPILKRYINVALLCVQEKAADRPAMSEVVSMLSNE 438 (476)
Q Consensus 389 ~~~~~~d~~~~~~~~~~~~~~l~~li~~Cl~~dP~~RPt~~eVl~~L~~~ 438 (476)
.. . ..........+.+++.+||+.+|.+|||+.++.+.|+.-
T Consensus 217 ~~-~-------~~~~~~~~~~~~~~i~~~l~~~p~~Rpt~~~~~~~l~~~ 258 (265)
T cd05579 217 KI-E-------WPEDVEVSDEAIDLISKLLVPDPEKRLGAKSIEEIKNHP 258 (265)
T ss_pred Cc-C-------CCccccCCHHHHHHHHHHhcCCHhhcCCCccHHHHhcCc
Confidence 10 0 000111246788999999999999999997777776643
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The MAST kinase subfamily includes MAST kinases, MAST-like (MASTL) kinases, and fungal kinases with similarity to Saccharomyces cerevisiae Rim15 and Schizosaccharomyces pombe cek1. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. MASTL kinases carry only a catalytic domain which contains a long insert re |
| >KOG0986 consensus G protein-coupled receptor kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.88 E-value=3.3e-23 Score=203.65 Aligned_cols=168 Identities=24% Similarity=0.262 Sum_probs=132.3
Q ss_pred ccccceeeccCCCC--------CCCCCCChhhHHHHHHHHHHHHHHHhhcCCCceeecCCCccceEecCCCCceeccccc
Q 045315 240 KDEISFWYESYNNP--------TKKGLLCWGTRVRIIEGIAQGLLYLHQYSRLRVIHRDLKASNILLDKDMNPKISDFGM 311 (476)
Q Consensus 240 ~~~~~l~~Ey~~~~--------~~~~~L~~~~~~~i~~qIa~gL~yLH~~~~~~ivH~DLkp~NILld~~~~~kL~DFGl 311 (476)
|+...+|+.-|..+ .....++++.++-++.+|+-||++||... ||+||+||+|||+|+.|+++|+|+|+
T Consensus 257 kd~LClVLtlMNGGDLkfHiyn~g~~gF~e~ra~FYAAEi~cGLehlH~~~---iVYRDLKPeNILLDd~GhvRISDLGL 333 (591)
T KOG0986|consen 257 KDALCLVLTLMNGGDLKFHIYNHGNPGFDEQRARFYAAEIICGLEHLHRRR---IVYRDLKPENILLDDHGHVRISDLGL 333 (591)
T ss_pred CCceEEEEEeecCCceeEEeeccCCCCCchHHHHHHHHHHHhhHHHHHhcc---eeeccCChhheeeccCCCeEeeccce
Confidence 56677778777722 22457999999999999999999999998 99999999999999999999999999
Q ss_pred eeecCCCcccccceeeeeccCCCChhhhccCCCCccceEEeehhhhhhhhhCCCCCCcCCCCchhhhhhhhhhhcCCCcc
Q 045315 312 ARMFGGDELQSNTKRIVGTYGYMSPEYALRGLFSIKSDVFSFGVLLLETLSSKKNTHFYNTDSLTLLGHAWNLWNDGRTW 391 (476)
Q Consensus 312 a~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~s~ksDVwSlGvvl~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~ 391 (476)
|..+....... ..+||.+|||||++.+..|+...|.|||||++|||+.|+.||....+....
T Consensus 334 Avei~~g~~~~---~rvGT~GYMAPEvl~ne~Y~~s~Dwf~lGCllYemi~G~sPFr~~KeKvk~--------------- 395 (591)
T KOG0986|consen 334 AVEIPEGKPIR---GRVGTVGYMAPEVLQNEVYDFSPDWFSLGCLLYEMIAGHSPFRQRKEKVKR--------------- 395 (591)
T ss_pred EEecCCCCccc---cccCcccccCHHHHcCCcccCCccHHHHHhHHHHHHcccCchhhhhhhhhH---------------
Confidence 99887654332 247999999999999999999999999999999999999999754321110
Q ss_pred cccCccc---CCCCCHHHHHHHHHHHHHchhhcccCCCCH
Q 045315 392 ELMDPIS---QNGASYPILKRYINVALLCVQEKAADRPAM 428 (476)
Q Consensus 392 ~~~d~~~---~~~~~~~~~~~l~~li~~Cl~~dP~~RPt~ 428 (476)
+-+|.+. ....+....+++.++....|+.||++|.-.
T Consensus 396 eEvdrr~~~~~~ey~~kFS~eakslc~~LL~Kdp~~RLGc 435 (591)
T KOG0986|consen 396 EEVDRRTLEDPEEYSDKFSEEAKSLCEGLLTKDPEKRLGC 435 (591)
T ss_pred HHHHHHHhcchhhcccccCHHHHHHHHHHHccCHHHhccC
Confidence 0111110 112334455677888888999999999643
|
|
| >cd07857 STKc_MPK1 Catalytic domain of the Serine/Threonine Kinase, Fungal Mitogen-Activated Protein Kinase MPK1 | Back alignment and domain information |
|---|
Probab=99.88 E-value=1.9e-23 Score=209.75 Aligned_cols=187 Identities=24% Similarity=0.254 Sum_probs=129.1
Q ss_pred ccceeeccCCC-----CCCCCCCChhhHHHHHHHHHHHHHHHhhcCCCceeecCCCccceEecCCCCceeccccceeecC
Q 045315 242 EISFWYESYNN-----PTKKGLLCWGTRVRIIEGIAQGLLYLHQYSRLRVIHRDLKASNILLDKDMNPKISDFGMARMFG 316 (476)
Q Consensus 242 ~~~l~~Ey~~~-----~~~~~~L~~~~~~~i~~qIa~gL~yLH~~~~~~ivH~DLkp~NILld~~~~~kL~DFGla~~~~ 316 (476)
..++++||+.. ......+++.++..++.||+.||+|||+.+ ++||||||+||+++.++.+||+|||+++...
T Consensus 80 ~~~~~~e~~~~~L~~~l~~~~~~~~~~~~~~~~qi~~aL~~LH~~g---ivH~dlkp~Nili~~~~~~kl~Dfg~a~~~~ 156 (332)
T cd07857 80 ELYLYEELMEADLHQIIRSGQPLTDAHFQSFIYQILCGLKYIHSAN---VLHRDLKPGNLLVNADCELKICDFGLARGFS 156 (332)
T ss_pred cEEEEEecccCCHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCC---cccCCCCHHHeEEcCCCCEEeCcCCCceecc
Confidence 35566677652 124567999999999999999999999999 9999999999999999999999999998654
Q ss_pred CCccc--ccceeeeeccCCCChhhhcc-CCCCccceEEeehhhhhhhhhCCCCCCcCCCCchhhhhhhhh----------
Q 045315 317 GDELQ--SNTKRIVGTYGYMSPEYALR-GLFSIKSDVFSFGVLLLETLSSKKNTHFYNTDSLTLLGHAWN---------- 383 (476)
Q Consensus 317 ~~~~~--~~~~~~~gt~~y~aPE~l~~-~~~s~ksDVwSlGvvl~elltG~~p~~~~~~~~~~~~~~~~~---------- 383 (476)
..... .......|+..|+|||.+.+ ..++.++|+|||||++|++++|+.||...+.. ........
T Consensus 157 ~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~~Di~slGv~l~~l~~g~~pf~~~~~~--~~~~~~~~~~~~~~~~~~ 234 (332)
T cd07857 157 ENPGENAGFMTEYVATRWYRAPEIMLSFQSYTKAIDVWSVGCILAELLGRKPVFKGKDYV--DQLNQILQVLGTPDEETL 234 (332)
T ss_pred cccccccccccCcccCccccCcHHHhCCCCCCcHHHHHHHHHHHHHHHhCCcCCCCCCHH--HHHHHHHHHhCCCCHHHH
Confidence 32211 11223468899999998765 46899999999999999999999988643311 00000000
Q ss_pred -hhcCCCccccc---Ccc---cCCCCCHHHHHHHHHHHHHchhhcccCCCCHHHHHH
Q 045315 384 -LWNDGRTWELM---DPI---SQNGASYPILKRYINVALLCVQEKAADRPAMSEVVS 433 (476)
Q Consensus 384 -~~~~~~~~~~~---d~~---~~~~~~~~~~~~l~~li~~Cl~~dP~~RPt~~eVl~ 433 (476)
.+......... ... ............+.+++.+|++.||++|||+.+++.
T Consensus 235 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~t~~~ll~ 291 (332)
T cd07857 235 SRIGSPKAQNYIRSLPNIPKKPFESIFPNANPLALDLLEKLLAFDPTKRISVEEALE 291 (332)
T ss_pred HhhhhhhHHHHHHhccccCCcchHhhCCCCCHHHHHHHHHHccCCcccCCCHHHHhc
Confidence 00000000000 000 000000112356889999999999999999999864
|
Serine/Threonine Kinases (STKs), Fungal Mitogen-Activated Protein Kinase (MAPK) MPK1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MPK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the MAPKs MPK1 from Saccharomyces cerevisiae, Pmk1 from Schizosaccharomyces pombe, and similar proteins. MAPKs are important mediators of cellular responses to extracellular signals. MPK1 (also called Slt2) and Pmk1 (also called Spm1) are stress-activated MAPKs that regulate the cell wall integrity (CWI) pathway, and are therefore important in the maintainance of cell shape, cell wall co |
| >cd06614 STKc_PAK Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase | Back alignment and domain information |
|---|
Probab=99.88 E-value=4.9e-23 Score=201.91 Aligned_cols=175 Identities=25% Similarity=0.341 Sum_probs=131.5
Q ss_pred cccceeeccCCCCC------CC-CCCChhhHHHHHHHHHHHHHHHhhcCCCceeecCCCccceEecCCCCceecccccee
Q 045315 241 DEISFWYESYNNPT------KK-GLLCWGTRVRIIEGIAQGLLYLHQYSRLRVIHRDLKASNILLDKDMNPKISDFGMAR 313 (476)
Q Consensus 241 ~~~~l~~Ey~~~~~------~~-~~L~~~~~~~i~~qIa~gL~yLH~~~~~~ivH~DLkp~NILld~~~~~kL~DFGla~ 313 (476)
+.+++++||++..+ .. ..+++.++..++.|++.||+|||+.+ ++|+||+|+||+++.++.++|+|||++.
T Consensus 88 ~~~~lv~e~~~~~~L~~~l~~~~~~l~~~~~~~i~~~i~~~L~~lH~~g---i~H~dl~p~ni~i~~~~~~~l~d~~~~~ 164 (286)
T cd06614 88 DELWVVMEYMDGGSLTDIITQNFVRMNEPQIAYVCREVLQGLEYLHSQN---VIHRDIKSDNILLSKDGSVKLADFGFAA 164 (286)
T ss_pred CEEEEEEeccCCCcHHHHHHHhccCCCHHHHHHHHHHHHHHHHHHHhCC---eeeCCCChhhEEEcCCCCEEECccchhh
Confidence 46788899998321 12 37999999999999999999999998 9999999999999999999999999987
Q ss_pred ecCCCcccccceeeeeccCCCChhhhccCCCCccceEEeehhhhhhhhhCCCCCCcCCCCchhhhhhhhhhhcCCCcccc
Q 045315 314 MFGGDELQSNTKRIVGTYGYMSPEYALRGLFSIKSDVFSFGVLLLETLSSKKNTHFYNTDSLTLLGHAWNLWNDGRTWEL 393 (476)
Q Consensus 314 ~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~s~ksDVwSlGvvl~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~ 393 (476)
....... ......++..|++||.+.+..++.++|+|||||++|+|++|+.|+....... .... . ........
T Consensus 165 ~~~~~~~--~~~~~~~~~~y~~PE~~~~~~~~~~~Dv~slGvil~~l~~g~~p~~~~~~~~--~~~~---~-~~~~~~~~ 236 (286)
T cd06614 165 QLTKEKS--KRNSVVGTPYWMAPEVIKRKDYGPKVDIWSLGIMCIEMAEGEPPYLREPPLR--ALFL---I-TTKGIPPL 236 (286)
T ss_pred hhccchh--hhccccCCcccCCHhHhcCCCCCCccccHHHHHHHHHHHhCCCCCCCCCHHH--HHHH---H-HhcCCCCC
Confidence 5543211 1122457789999999988889999999999999999999999976432111 1100 0 01111000
Q ss_pred cCcccCCCCCHHHHHHHHHHHHHchhhcccCCCCHHHHHH
Q 045315 394 MDPISQNGASYPILKRYINVALLCVQEKAADRPAMSEVVS 433 (476)
Q Consensus 394 ~d~~~~~~~~~~~~~~l~~li~~Cl~~dP~~RPt~~eVl~ 433 (476)
. ........+.+++.+|++.+|.+||++.++++
T Consensus 237 -----~--~~~~~~~~l~~li~~~l~~~p~~Rpt~~~il~ 269 (286)
T cd06614 237 -----K--NPEKWSPEFKDFLNKCLVKDPEKRPSAEELLQ 269 (286)
T ss_pred -----c--chhhCCHHHHHHHHHHhccChhhCcCHHHHhh
Confidence 0 01112356889999999999999999999985
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs are implicated in the regulation of many cellular processes including growth factor receptor-mediated proliferation, cell polarity, cell motility, cell death and survival, and actin cytoskeleton organization. PAK deregulation is associated with tumor development. PAKs from higher eukaryotes are classified into two grou |
| >KOG1094 consensus Discoidin domain receptor DDR1 [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.88 E-value=3.1e-23 Score=209.03 Aligned_cols=185 Identities=24% Similarity=0.356 Sum_probs=140.4
Q ss_pred cceeeccCCCCC--------CCCCCChhhHHHHHHHHHHHHHHHhhcCCCceeecCCCccceEecCCCCceeccccceee
Q 045315 243 ISFWYESYNNPT--------KKGLLCWGTRVRIIEGIAQGLLYLHQYSRLRVIHRDLKASNILLDKDMNPKISDFGMARM 314 (476)
Q Consensus 243 ~~l~~Ey~~~~~--------~~~~L~~~~~~~i~~qIa~gL~yLH~~~~~~ivH~DLkp~NILld~~~~~kL~DFGla~~ 314 (476)
..+++|||+++. .-+.+.-+..++|+.||+.|++||.+.+ +|||||.+.|||+|.++.+||+|||+++.
T Consensus 610 icmI~EYmEnGDLnqFl~aheapt~~t~~~vsi~tqiasgmaYLes~n---fVHrd~a~rNcLv~~e~~iKiadfgmsR~ 686 (807)
T KOG1094|consen 610 LCMITEYMENGDLNQFLSAHELPTAETAPGVSICTQIASGMAYLESLN---FVHRDLATRNCLVDGEFTIKIADFGMSRN 686 (807)
T ss_pred hHHHHHHHhcCcHHHHHHhccCcccccchhHHHHHHHHHHHHHHHhhc---hhhccccccceeecCcccEEecCcccccc
Confidence 457789999432 1222455677889999999999999998 99999999999999999999999999997
Q ss_pred cCCCcccccceeeeeccCCCChhhhccCCCCccceEEeehhhhhhhh--hCCCCCCcCCCCchhhhhhhhhhhcCCCccc
Q 045315 315 FGGDELQSNTKRIVGTYGYMSPEYALRGLFSIKSDVFSFGVLLLETL--SSKKNTHFYNTDSLTLLGHAWNLWNDGRTWE 392 (476)
Q Consensus 315 ~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~s~ksDVwSlGvvl~ell--tG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~ 392 (476)
+-.........+.+-+.+|||+|.+.-++++.++|+|+||+.+||++ |..+|+.... .....+.....+..+....
T Consensus 687 lysg~yy~vqgr~vlpiRwmawEsillgkFttaSDvWafgvTlwE~~~~C~e~Py~~lt--~e~vven~~~~~~~~~~~~ 764 (807)
T KOG1094|consen 687 LYSGDYYRVQGRAVLPIRWMAWESILLGKFTTASDVWAFGVTLWEVFMLCREQPYSQLT--DEQVVENAGEFFRDQGRQV 764 (807)
T ss_pred cccCCceeeecceeeeeeehhHHHHHhccccchhhhhhhHHHHHHHHHHHhhCchhhhh--HHHHHHhhhhhcCCCCcce
Confidence 76665555555667789999999999999999999999999999985 4556654322 2223333333333322221
Q ss_pred ccCcccCCCCCHHHHHHHHHHHHHchhhcccCCCCHHHHHHHHhcc
Q 045315 393 LMDPISQNGASYPILKRYINVALLCVQEKAADRPAMSEVVSMLSNE 438 (476)
Q Consensus 393 ~~d~~~~~~~~~~~~~~l~~li~~Cl~~dP~~RPt~~eVl~~L~~~ 438 (476)
.+ ..+.-....+.+++++||..|-.+||+++++...|.+.
T Consensus 765 ~l------~~P~~cp~~lyelml~Cw~~es~~RPsFe~lh~~lq~~ 804 (807)
T KOG1094|consen 765 VL------SRPPACPQGLYELMLRCWRRESEQRPSFEQLHLFLQED 804 (807)
T ss_pred ec------cCCCcCcHHHHHHHHHHhchhhhcCCCHHHHHHHHHHh
Confidence 11 11233346788999999999999999999999988764
|
|
| >cd08215 STKc_Nek Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase | Back alignment and domain information |
|---|
Probab=99.88 E-value=5.5e-23 Score=197.12 Aligned_cols=173 Identities=23% Similarity=0.314 Sum_probs=133.7
Q ss_pred cccceeeccCCCCC----------CCCCCChhhHHHHHHHHHHHHHHHhhcCCCceeecCCCccceEecCCCCceecccc
Q 045315 241 DEISFWYESYNNPT----------KKGLLCWGTRVRIIEGIAQGLLYLHQYSRLRVIHRDLKASNILLDKDMNPKISDFG 310 (476)
Q Consensus 241 ~~~~l~~Ey~~~~~----------~~~~L~~~~~~~i~~qIa~gL~yLH~~~~~~ivH~DLkp~NILld~~~~~kL~DFG 310 (476)
+..++++||++..+ +...+++.++..++.++++||+|||+.+ ++|+||+|+||+++.++.++|+|||
T Consensus 72 ~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~---~~H~dl~~~nil~~~~~~~~l~d~~ 148 (258)
T cd08215 72 GKLCIVMEYADGGDLSQKIKKQKKEGKPFPEEQILDWFVQLCLALKYLHSRK---ILHRDIKPQNIFLTSNGLVKLGDFG 148 (258)
T ss_pred CEEEEEEEecCCCcHHHHHHHhhccCCCcCHHHHHHHHHHHHHHHHHHHhCC---EecccCChHHeEEcCCCcEEECCcc
Confidence 45667888887321 2478999999999999999999999998 9999999999999999999999999
Q ss_pred ceeecCCCcccccceeeeeccCCCChhhhccCCCCccceEEeehhhhhhhhhCCCCCCcCCCCchhhhhhhhhhhcCCCc
Q 045315 311 MARMFGGDELQSNTKRIVGTYGYMSPEYALRGLFSIKSDVFSFGVLLLETLSSKKNTHFYNTDSLTLLGHAWNLWNDGRT 390 (476)
Q Consensus 311 la~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~s~ksDVwSlGvvl~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~ 390 (476)
++........ ......++..|+|||...+..++.++|+||+|++++++++|+.|+...... .... ... ....
T Consensus 149 ~~~~~~~~~~--~~~~~~~~~~y~~pe~~~~~~~~~~~Dv~slG~~~~~l~~g~~p~~~~~~~--~~~~---~~~-~~~~ 220 (258)
T cd08215 149 ISKVLSSTVD--LAKTVVGTPYYLSPELCQNKPYNYKSDIWSLGCVLYELCTLKHPFEGENLL--ELAL---KIL-KGQY 220 (258)
T ss_pred ceeecccCcc--eecceeeeecccChhHhccCCCCccccHHHHHHHHHHHHcCCCCCCCCcHH--HHHH---HHh-cCCC
Confidence 9987654331 222346888999999998888999999999999999999999998543311 1111 111 1111
Q ss_pred ccccCcccCCCCCHHHHHHHHHHHHHchhhcccCCCCHHHHHH
Q 045315 391 WELMDPISQNGASYPILKRYINVALLCVQEKAADRPAMSEVVS 433 (476)
Q Consensus 391 ~~~~d~~~~~~~~~~~~~~l~~li~~Cl~~dP~~RPt~~eVl~ 433 (476)
.. .+......+.+++.+||+.+|++||++.++++
T Consensus 221 ~~---------~~~~~~~~~~~~i~~~l~~~p~~Rp~~~~ll~ 254 (258)
T cd08215 221 PP---------IPSQYSSELRNLVSSLLQKDPEERPSIAQILQ 254 (258)
T ss_pred CC---------CCCCCCHHHHHHHHHHcCCChhhCcCHHHHhc
Confidence 11 11123457889999999999999999999875
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase (Nek) family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The Nek family is composed of 11 different mammalian members (Nek1-11) with similarity to the catalytic domain of Aspergillus nidulans NIMA kinase, the founding member of the Nek family which was identified in a screen for cell cycle mutants that were prevented from entering mitosis. Neks contain a conserved N-terminal catalytic domain and a more divergent C-terminal regulatory region of various sizes and structures. They |
| >KOG0580 consensus Serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=99.88 E-value=6.4e-23 Score=187.08 Aligned_cols=171 Identities=25% Similarity=0.272 Sum_probs=138.5
Q ss_pred ccccceeeccCCCC--------CCCCCCChhhHHHHHHHHHHHHHHHhhcCCCceeecCCCccceEecCCCCceeccccc
Q 045315 240 KDEISFWYESYNNP--------TKKGLLCWGTRVRIIEGIAQGLLYLHQYSRLRVIHRDLKASNILLDKDMNPKISDFGM 311 (476)
Q Consensus 240 ~~~~~l~~Ey~~~~--------~~~~~L~~~~~~~i~~qIa~gL~yLH~~~~~~ivH~DLkp~NILld~~~~~kL~DFGl 311 (476)
....+++.||.+++ ...+.+++.....++.|+|.||.|+|.++ +|||||||+|+|++..+..||+|||-
T Consensus 94 ~~riyLilEya~~gel~k~L~~~~~~~f~e~~~a~Yi~q~A~Al~y~h~k~---VIhRdiKpenlLlg~~~~lkiAdfGw 170 (281)
T KOG0580|consen 94 SKRIYLILEYAPRGELYKDLQEGRMKRFDEQRAATYIKQLANALLYCHLKR---VIHRDIKPENLLLGSAGELKIADFGW 170 (281)
T ss_pred cceeEEEEEecCCchHHHHHHhcccccccccchhHHHHHHHHHHHHhccCC---cccCCCCHHHhccCCCCCeeccCCCc
Confidence 45788999999933 25667999999999999999999999999 99999999999999999999999999
Q ss_pred eeecCCCcccccceeeeeccCCCChhhhccCCCCccceEEeehhhhhhhhhCCCCCCcCCCCchhhhhhhhhhhcCCCcc
Q 045315 312 ARMFGGDELQSNTKRIVGTYGYMSPEYALRGLFSIKSDVFSFGVLLLETLSSKKNTHFYNTDSLTLLGHAWNLWNDGRTW 391 (476)
Q Consensus 312 a~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~s~ksDVwSlGvvl~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~ 391 (476)
+..... .......||..|.+||...+...+.+.|+|++|++.||++.|.+||.....+.. . ..+.. .
T Consensus 171 sV~~p~----~kR~tlcgt~dyl~pEmv~~~~hd~~Vd~w~lgvl~yeflvg~ppFes~~~~et-Y-----krI~k---~ 237 (281)
T KOG0580|consen 171 SVHAPS----NKRKTLCGTLDYLPPEMVEGRGHDKFVDLWSLGVLCYEFLVGLPPFESQSHSET-Y-----KRIRK---V 237 (281)
T ss_pred eeecCC----CCceeeecccccCCHhhcCCCCccchhhHHHHHHHHHHHHhcCCchhhhhhHHH-H-----HHHHH---c
Confidence 876432 234457899999999999999999999999999999999999999976542111 1 11111 1
Q ss_pred cccCcccCCCCCHHHHHHHHHHHHHchhhcccCCCCHHHHHH
Q 045315 392 ELMDPISQNGASYPILKRYINVALLCVQEKAADRPAMSEVVS 433 (476)
Q Consensus 392 ~~~d~~~~~~~~~~~~~~l~~li~~Cl~~dP~~RPt~~eVl~ 433 (476)
++..| ......+.+++.+|+..+|.+|....|++.
T Consensus 238 ~~~~p-------~~is~~a~dlI~~ll~~~p~~r~~l~~v~~ 272 (281)
T KOG0580|consen 238 DLKFP-------STISGGAADLISRLLVKNPIERLALTEVMD 272 (281)
T ss_pred cccCC-------cccChhHHHHHHHHhccCccccccHHHHhh
Confidence 11111 334467889999999999999999999875
|
|
| >cd07879 STKc_p38delta_MAPK13 Catalytic domain of the Serine/Threonine Kinase, p38delta Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Probab=99.88 E-value=2.5e-23 Score=209.80 Aligned_cols=188 Identities=19% Similarity=0.222 Sum_probs=131.6
Q ss_pred ccceeeccCCCC---CCCCCCChhhHHHHHHHHHHHHHHHhhcCCCceeecCCCccceEecCCCCceeccccceeecCCC
Q 045315 242 EISFWYESYNNP---TKKGLLCWGTRVRIIEGIAQGLLYLHQYSRLRVIHRDLKASNILLDKDMNPKISDFGMARMFGGD 318 (476)
Q Consensus 242 ~~~l~~Ey~~~~---~~~~~L~~~~~~~i~~qIa~gL~yLH~~~~~~ivH~DLkp~NILld~~~~~kL~DFGla~~~~~~ 318 (476)
..++++||+... ..+..+++.++..++.|++.||+|||+.+ ++||||||+||+++.++.+||+|||+++.....
T Consensus 94 ~~~lv~e~~~~~l~~~~~~~~~~~~~~~~~~qi~~aL~~LH~~~---i~H~dlkp~NIll~~~~~~kL~dfg~~~~~~~~ 170 (342)
T cd07879 94 DFYLVMPYMQTDLQKIMGHPLSEDKVQYLVYQMLCGLKYIHSAG---IIHRDLKPGNLAVNEDCELKILDFGLARHADAE 170 (342)
T ss_pred eEEEEecccccCHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCCHHHEEECCCCCEEEeeCCCCcCCCCC
Confidence 346778887621 12346899999999999999999999998 999999999999999999999999998764321
Q ss_pred cccccceeeeeccCCCChhhhcc-CCCCccceEEeehhhhhhhhhCCCCCCcCCCCchhhhhhhhhh-----------hc
Q 045315 319 ELQSNTKRIVGTYGYMSPEYALR-GLFSIKSDVFSFGVLLLETLSSKKNTHFYNTDSLTLLGHAWNL-----------WN 386 (476)
Q Consensus 319 ~~~~~~~~~~gt~~y~aPE~l~~-~~~s~ksDVwSlGvvl~elltG~~p~~~~~~~~~~~~~~~~~~-----------~~ 386 (476)
.....++..|+|||.+.+ ..++.++|+|||||++|||++|+.||....... ........ ..
T Consensus 171 -----~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slGvil~el~~g~~pf~~~~~~~--~~~~~~~~~~~~~~~~~~~~~ 243 (342)
T cd07879 171 -----MTGYVVTRWYRAPEVILNWMHYNQTVDIWSVGCIMAEMLTGKTLFKGKDYLD--QLTQILKVTGVPGPEFVQKLE 243 (342)
T ss_pred -----CCCceeeecccChhhhcCccccCchHHHHHHHHHHHHHHhCCCCCCCCCHHH--HHHHHHHhcCCCCHHHHHHhc
Confidence 122457889999999876 468899999999999999999999987543111 11100000 00
Q ss_pred CCCcccccC---cccCCCC---CHHHHHHHHHHHHHchhhcccCCCCHHHHHHH--Hhccc
Q 045315 387 DGRTWELMD---PISQNGA---SYPILKRYINVALLCVQEKAADRPAMSEVVSM--LSNEF 439 (476)
Q Consensus 387 ~~~~~~~~d---~~~~~~~---~~~~~~~l~~li~~Cl~~dP~~RPt~~eVl~~--L~~~~ 439 (476)
......... ....... .......+.+++.+||+.||++||++++++.. ++...
T Consensus 244 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~R~~~~e~l~h~~f~~~~ 304 (342)
T cd07879 244 DKAAKSYIKSLPKYPRKDFSTLFPKASPQAVDLLEKMLELDVDKRLTATEALEHPYFDSFR 304 (342)
T ss_pred ccchHHHHhhcCCcccchHHHHhcCCCHHHHHHHHHHcCCChhhCcCHHHHhcCcchhhcc
Confidence 000000000 0000000 01123568899999999999999999999854 66643
|
Serine/Threonine Kinases (STKs), p38delta subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38delta subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38delta, also called MAPK13 |
| >cd05580 STKc_PKA Catalytic domain of the Protein Serine/Threonine Kinase, cAMP-dependent protein kinase | Back alignment and domain information |
|---|
Probab=99.88 E-value=7.1e-23 Score=201.38 Aligned_cols=168 Identities=23% Similarity=0.294 Sum_probs=130.5
Q ss_pred cccceeeccCCCC------CCCCCCChhhHHHHHHHHHHHHHHHhhcCCCceeecCCCccceEecCCCCceeccccceee
Q 045315 241 DEISFWYESYNNP------TKKGLLCWGTRVRIIEGIAQGLLYLHQYSRLRVIHRDLKASNILLDKDMNPKISDFGMARM 314 (476)
Q Consensus 241 ~~~~l~~Ey~~~~------~~~~~L~~~~~~~i~~qIa~gL~yLH~~~~~~ivH~DLkp~NILld~~~~~kL~DFGla~~ 314 (476)
+..++++||+++. .+...++..++..++.||++||+|||+.+ ++|+||+|+||+++.++.+||+|||++..
T Consensus 74 ~~~~~v~e~~~~~~L~~~~~~~~~l~~~~~~~~~~qil~~l~~lH~~~---i~H~dl~p~nili~~~~~~kl~dfg~~~~ 150 (290)
T cd05580 74 SNLYLVMEYVPGGELFSHLRKSGRFPEPVARFYAAQVVLALEYLHSLD---IVYRDLKPENLLLDSDGYIKITDFGFAKR 150 (290)
T ss_pred CeEEEEEecCCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCC---EecCCCCHHHEEECCCCCEEEeeCCCccc
Confidence 4577899999733 23467999999999999999999999998 99999999999999999999999999987
Q ss_pred cCCCcccccceeeeeccCCCChhhhccCCCCccceEEeehhhhhhhhhCCCCCCcCCCCchhhhhhhhhhhcCCCccccc
Q 045315 315 FGGDELQSNTKRIVGTYGYMSPEYALRGLFSIKSDVFSFGVLLLETLSSKKNTHFYNTDSLTLLGHAWNLWNDGRTWELM 394 (476)
Q Consensus 315 ~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~s~ksDVwSlGvvl~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 394 (476)
.... .....++..|+|||.+.+...+.++|+||||+++|+|++|+.||..... ..... ....+..
T Consensus 151 ~~~~-----~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~--~~~~~----~~~~~~~---- 215 (290)
T cd05580 151 VKGR-----TYTLCGTPEYLAPEIILSKGYGKAVDWWALGILIYEMLAGYPPFFDDNP--IQIYE----KILEGKV---- 215 (290)
T ss_pred cCCC-----CCCCCCCccccChhhhcCCCCCccccHHHHHHHHHHHHhCCCCCCCCCH--HHHHH----HHhcCCc----
Confidence 6543 2224578899999999888889999999999999999999999864331 11111 1111111
Q ss_pred CcccCCCCCHHHHHHHHHHHHHchhhcccCCC-----CHHHHH
Q 045315 395 DPISQNGASYPILKRYINVALLCVQEKAADRP-----AMSEVV 432 (476)
Q Consensus 395 d~~~~~~~~~~~~~~l~~li~~Cl~~dP~~RP-----t~~eVl 432 (476)
..+......+.+++.+||+.+|.+|| +++|++
T Consensus 216 ------~~~~~~~~~l~~li~~~l~~~p~~R~~~~~~~~~~l~ 252 (290)
T cd05580 216 ------RFPSFFSPDAKDLIRNLLQVDLTKRLGNLKNGVNDIK 252 (290)
T ss_pred ------cCCccCCHHHHHHHHHHccCCHHHccCcccCCHHHHH
Confidence 01111245788999999999999999 666665
|
Serine/Threonine Kinases (STKs), cAMP-dependent protein kinase (PKA) subfamily, catalytic (c) subunit. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKA subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). This subfamily is composed of the cAMP-dependent proteins kinases, PKA and PRKX. The inactive PKA holoenzyme is a heterotetramer composed of two phosphorylated and active catalytic (C) subunits with a dimer of regulatory (R) subunits. Activation is achieved through the binding of the important second messenger cAMP to the R subunits, which leads to the dissociation of PKA into the R dimer and two active C subunits. PKA is present ubi |
| >cd06657 STKc_PAK4 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 4 | Back alignment and domain information |
|---|
Probab=99.88 E-value=1.2e-22 Score=200.42 Aligned_cols=175 Identities=22% Similarity=0.283 Sum_probs=131.6
Q ss_pred cccceeeccCCCCC-----CCCCCChhhHHHHHHHHHHHHHHHhhcCCCceeecCCCccceEecCCCCceeccccceeec
Q 045315 241 DEISFWYESYNNPT-----KKGLLCWGTRVRIIEGIAQGLLYLHQYSRLRVIHRDLKASNILLDKDMNPKISDFGMARMF 315 (476)
Q Consensus 241 ~~~~l~~Ey~~~~~-----~~~~L~~~~~~~i~~qIa~gL~yLH~~~~~~ivH~DLkp~NILld~~~~~kL~DFGla~~~ 315 (476)
+..++++||++... ....+++..+..++.|++.||+|||+.+ ++|+||+|+||++++++.++|+|||++...
T Consensus 90 ~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~ql~~~l~~lH~~g---ivH~dl~p~Nilv~~~~~~~l~dfg~~~~~ 166 (292)
T cd06657 90 DELWVVMEFLEGGALTDIVTHTRMNEEQIAAVCLAVLKALSVLHAQG---VIHRDIKSDSILLTHDGRVKLSDFGFCAQV 166 (292)
T ss_pred CEEEEEEecCCCCcHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCCHHHEEECCCCCEEEcccccceec
Confidence 35678899988432 2346899999999999999999999998 999999999999999999999999998765
Q ss_pred CCCcccccceeeeeccCCCChhhhccCCCCccceEEeehhhhhhhhhCCCCCCcCCCCchhhhhhhhhhhcCCCcccccC
Q 045315 316 GGDELQSNTKRIVGTYGYMSPEYALRGLFSIKSDVFSFGVLLLETLSSKKNTHFYNTDSLTLLGHAWNLWNDGRTWELMD 395 (476)
Q Consensus 316 ~~~~~~~~~~~~~gt~~y~aPE~l~~~~~s~ksDVwSlGvvl~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~d 395 (476)
...... .....++..|+|||.+.+..++.++|+||||+++|++++|+.|+...... ...... .... .
T Consensus 167 ~~~~~~--~~~~~~~~~y~~pE~~~~~~~~~~~Dv~slGvil~el~tg~~p~~~~~~~--~~~~~~----~~~~-----~ 233 (292)
T cd06657 167 SKEVPR--RKSLVGTPYWMAPELISRLPYGPEVDIWSLGIMVIEMVDGEPPYFNEPPL--KAMKMI----RDNL-----P 233 (292)
T ss_pred cccccc--ccccccCccccCHHHhcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHH--HHHHHH----HhhC-----C
Confidence 432211 12245788999999998888899999999999999999999997643211 111100 0000 0
Q ss_pred cccCCCCCHHHHHHHHHHHHHchhhcccCCCCHHHHHH
Q 045315 396 PISQNGASYPILKRYINVALLCVQEKAADRPAMSEVVS 433 (476)
Q Consensus 396 ~~~~~~~~~~~~~~l~~li~~Cl~~dP~~RPt~~eVl~ 433 (476)
..... .......+.+++.+||+.+|.+||++.++++
T Consensus 234 ~~~~~--~~~~~~~l~~li~~~l~~~P~~R~~~~~ll~ 269 (292)
T cd06657 234 PKLKN--LHKVSPSLKGFLDRLLVRDPAQRATAAELLK 269 (292)
T ss_pred cccCC--cccCCHHHHHHHHHHHhCCcccCcCHHHHhc
Confidence 00000 1112345778999999999999999999887
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 4, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK4 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK4 regulates cell mo |
| >KOG0690 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.88 E-value=5e-23 Score=194.77 Aligned_cols=165 Identities=24% Similarity=0.277 Sum_probs=129.9
Q ss_pred cccceeeccCC------CCCCCCCCChhhHHHHHHHHHHHHHHHhhcCCCceeecCCCccceEecCCCCceeccccceee
Q 045315 241 DEISFWYESYN------NPTKKGLLCWGTRVRIIEGIAQGLLYLHQYSRLRVIHRDLKASNILLDKDMNPKISDFGMARM 314 (476)
Q Consensus 241 ~~~~l~~Ey~~------~~~~~~~L~~~~~~~i~~qIa~gL~yLH~~~~~~ivH~DLkp~NILld~~~~~kL~DFGla~~ 314 (476)
+.+.+||||.. +..+.+.+++....-....|+.||.|||+++ ||+||||.+|.|+|++|.+||.|||+++.
T Consensus 241 drlCFVMeyanGGeLf~HLsrer~FsE~RtRFYGaEIvsAL~YLHs~~---ivYRDlKLENLlLDkDGHIKitDFGLCKE 317 (516)
T KOG0690|consen 241 DRLCFVMEYANGGELFFHLSRERVFSEDRTRFYGAEIVSALGYLHSRN---IVYRDLKLENLLLDKDGHIKITDFGLCKE 317 (516)
T ss_pred ceEEEEEEEccCceEeeehhhhhcccchhhhhhhHHHHHHhhhhhhCC---eeeeechhhhheeccCCceEeeecccchh
Confidence 57889999998 3356677888888889999999999999999 99999999999999999999999999985
Q ss_pred cCCCcccccceeeeeccCCCChhhhccCCCCccceEEeehhhhhhhhhCCCCCCcCCCCchhhhhhhhhhhcCCCccccc
Q 045315 315 FGGDELQSNTKRIVGTYGYMSPEYALRGLFSIKSDVFSFGVLLLETLSSKKNTHFYNTDSLTLLGHAWNLWNDGRTWELM 394 (476)
Q Consensus 315 ~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~s~ksDVwSlGvvl~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 394 (476)
--. ....+..+.||+.|+|||++....|..+.|.|.+|||+|||+||+.||...+.+..--+. +..+-
T Consensus 318 ~I~--~g~t~kTFCGTPEYLAPEVleDnDYgraVDWWG~GVVMYEMmCGRLPFyn~dh~kLFeLI----l~ed~------ 385 (516)
T KOG0690|consen 318 EIK--YGDTTKTFCGTPEYLAPEVLEDNDYGRAVDWWGVGVVMYEMMCGRLPFYNKDHEKLFELI----LMEDL------ 385 (516)
T ss_pred ccc--ccceeccccCChhhcCchhhccccccceeehhhhhHHHHHHHhccCcccccchhHHHHHH----Hhhhc------
Confidence 321 223445689999999999999999999999999999999999999998765432211100 00000
Q ss_pred CcccCCCCCHHHHHHHHHHHHHchhhcccCCC
Q 045315 395 DPISQNGASYPILKRYINVALLCVQEKAADRP 426 (476)
Q Consensus 395 d~~~~~~~~~~~~~~l~~li~~Cl~~dP~~RP 426 (476)
..+.....+...++...|.+||.+|.
T Consensus 386 ------kFPr~ls~eAktLLsGLL~kdP~kRL 411 (516)
T KOG0690|consen 386 ------KFPRTLSPEAKTLLSGLLKKDPKKRL 411 (516)
T ss_pred ------cCCccCCHHHHHHHHHHhhcChHhhc
Confidence 11122234566778889999999995
|
|
| >cd07829 STKc_CDK_like Catalytic domain of Cyclin-Dependent protein Kinase-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=99.88 E-value=1.4e-22 Score=197.58 Aligned_cols=186 Identities=23% Similarity=0.262 Sum_probs=131.5
Q ss_pred cccceeeccCCCC------CCCCCCChhhHHHHHHHHHHHHHHHhhcCCCceeecCCCccceEecCCCCceeccccceee
Q 045315 241 DEISFWYESYNNP------TKKGLLCWGTRVRIIEGIAQGLLYLHQYSRLRVIHRDLKASNILLDKDMNPKISDFGMARM 314 (476)
Q Consensus 241 ~~~~l~~Ey~~~~------~~~~~L~~~~~~~i~~qIa~gL~yLH~~~~~~ivH~DLkp~NILld~~~~~kL~DFGla~~ 314 (476)
+..++++||++.. .....+++.++.+++.|++.||+|||+.+ ++||||+|+||++++++.+||+|||++..
T Consensus 71 ~~~~~v~e~~~~~l~~~i~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~---i~H~~l~~~ni~~~~~~~~~l~d~g~~~~ 147 (282)
T cd07829 71 RKLYLVFEYCDMDLKKYLDKRPGPLSPNLIKSIMYQLLRGLAYCHSHR---ILHRDLKPQNILINRDGVLKLADFGLARA 147 (282)
T ss_pred CceEEEecCcCcCHHHHHHhhccCCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCChheEEEcCCCCEEEecCCcccc
Confidence 5688899998721 11257999999999999999999999998 99999999999999999999999999987
Q ss_pred cCCCcccccceeeeeccCCCChhhhccC-CCCccceEEeehhhhhhhhhCCCCCCcCCCCchhhhhhhhhh---------
Q 045315 315 FGGDELQSNTKRIVGTYGYMSPEYALRG-LFSIKSDVFSFGVLLLETLSSKKNTHFYNTDSLTLLGHAWNL--------- 384 (476)
Q Consensus 315 ~~~~~~~~~~~~~~gt~~y~aPE~l~~~-~~s~ksDVwSlGvvl~elltG~~p~~~~~~~~~~~~~~~~~~--------- 384 (476)
....... .....++..|+|||.+.+. .++.++|+||||++++|+++|+.||....... ........
T Consensus 148 ~~~~~~~--~~~~~~~~~~~aPE~~~~~~~~~~~~Dv~slG~~l~~l~~~~~~~~~~~~~~--~~~~~~~~~~~~~~~~~ 223 (282)
T cd07829 148 FGIPLRT--YTHEVVTLWYRAPEILLGSKHYSTAVDIWSVGCIFAEMITGKPLFPGDSEID--QLFKIFQILGTPTEESW 223 (282)
T ss_pred cCCCccc--cCccccCcCcCChHHhcCCcCCCccccHHHHHHHHHHHHhCCCCCCCccHHH--HHHHHHHHhCCCcHHHH
Confidence 6433211 1123456789999998766 78999999999999999999998886433111 00000000
Q ss_pred --hcCCC-cccccCcc---cCCCCCHHHHHHHHHHHHHchhhcccCCCCHHHHHH
Q 045315 385 --WNDGR-TWELMDPI---SQNGASYPILKRYINVALLCVQEKAADRPAMSEVVS 433 (476)
Q Consensus 385 --~~~~~-~~~~~d~~---~~~~~~~~~~~~l~~li~~Cl~~dP~~RPt~~eVl~ 433 (476)
+..-. ........ ............+.+++.+||+.+|++||++++++.
T Consensus 224 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~P~~Rp~~~~~l~ 278 (282)
T cd07829 224 PGVTKLPDYKPTFPKFPPKDLEKVLPRLDPEGIDLLSKMLQYNPAKRISAKEALK 278 (282)
T ss_pred HhhcccccccccccccCccchHHhcccccHHHHHHHHHhhccCcccCCCHHHHhh
Confidence 00000 00000000 000001112457899999999999999999999875
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase (CDK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKs are partly regulated by their subcellular localization, which defines substrate phosphorylation and the resulting specific function. CDK1, CDK2, CDK4, and CDK6 have well-defined functions in the cell cycle, such as the regulation of the |
| >cd05578 STKc_Yank1 Catalytic domain of the Protein Serine/Threonine Kinase, Yank1 | Back alignment and domain information |
|---|
Probab=99.88 E-value=2.5e-22 Score=193.64 Aligned_cols=173 Identities=24% Similarity=0.236 Sum_probs=132.2
Q ss_pred cccceeeccCCCCC------CCCCCChhhHHHHHHHHHHHHHHHhhcCCCceeecCCCccceEecCCCCceeccccceee
Q 045315 241 DEISFWYESYNNPT------KKGLLCWGTRVRIIEGIAQGLLYLHQYSRLRVIHRDLKASNILLDKDMNPKISDFGMARM 314 (476)
Q Consensus 241 ~~~~l~~Ey~~~~~------~~~~L~~~~~~~i~~qIa~gL~yLH~~~~~~ivH~DLkp~NILld~~~~~kL~DFGla~~ 314 (476)
...++++||++... +..+++..++..++.||++||.|||+.+ ++|+||+|+||++++++.++|+|||++..
T Consensus 73 ~~~~lv~e~~~~~~L~~~l~~~~~l~~~~~~~~~~~i~~~l~~lh~~~---i~h~dl~~~nil~~~~~~~~l~d~~~~~~ 149 (258)
T cd05578 73 ENMYLVVDLLLGGDLRYHLSQKVKFSEEQVKFWICEIVLALEYLHSKG---IIHRDIKPDNILLDEQGHVHITDFNIATK 149 (258)
T ss_pred CeEEEEEeCCCCCCHHHHHHhcCCcCHHHHHHHHHHHHHHHHHHHhCC---eeccCCCHHHeEEcCCCCEEEeecccccc
Confidence 46788999997432 2358999999999999999999999998 99999999999999999999999999886
Q ss_pred cCCCcccccceeeeeccCCCChhhhccCCCCccceEEeehhhhhhhhhCCCCCCcCCCCchhhhhhhhhhhcCCCccccc
Q 045315 315 FGGDELQSNTKRIVGTYGYMSPEYALRGLFSIKSDVFSFGVLLLETLSSKKNTHFYNTDSLTLLGHAWNLWNDGRTWELM 394 (476)
Q Consensus 315 ~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~s~ksDVwSlGvvl~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 394 (476)
..... ......++..|+|||.+.+..++.++|+||||+++|++++|+.|+........... ...... .
T Consensus 150 ~~~~~---~~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~~~---~~~~~~-~----- 217 (258)
T cd05578 150 VTPDT---LTTSTSGTPGYMAPEVLCRQGYSVAVDWWSLGVTAYECLRGKRPYRGHSRTIRDQI---RAKQET-A----- 217 (258)
T ss_pred cCCCc---cccccCCChhhcCHHHHcccCCCCcccchhhHHHHHHHHhCCCCCCCCCccHHHHH---HHHhcc-c-----
Confidence 54332 11224578899999999888899999999999999999999999875442211111 011110 0
Q ss_pred CcccCCCCCHHHHHHHHHHHHHchhhcccCCCCH--HHHH
Q 045315 395 DPISQNGASYPILKRYINVALLCVQEKAADRPAM--SEVV 432 (476)
Q Consensus 395 d~~~~~~~~~~~~~~l~~li~~Cl~~dP~~RPt~--~eVl 432 (476)
....+......+.+++.+||+.||.+||++ .|++
T Consensus 218 ----~~~~~~~~~~~~~~~i~~~l~~~p~~R~~~~~~~l~ 253 (258)
T cd05578 218 ----DVLYPATWSTEAIDAINKLLERDPQKRLGDNLKDLK 253 (258)
T ss_pred ----cccCcccCcHHHHHHHHHHccCChhHcCCccHHHHh
Confidence 011112233678899999999999999999 5543
|
Serine/Threonine Kinases (STKs), Yank1 or STK32A subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Yank1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily contains uncharacterized STKs with similarity to the human protein designated Yank1 or STK32A. |
| >cd05576 STKc_RPK118_like Catalytic domain of the Protein Serine/Threonine Kinases, RPK118 and similar proteins | Back alignment and domain information |
|---|
Probab=99.88 E-value=5.8e-23 Score=196.20 Aligned_cols=161 Identities=17% Similarity=0.105 Sum_probs=124.2
Q ss_pred cccceeeccCCCCC------CCCCCChhhHHHHHHHHHHHHHHHhhcCCCceeecCCCccceEecCCCCceeccccceee
Q 045315 241 DEISFWYESYNNPT------KKGLLCWGTRVRIIEGIAQGLLYLHQYSRLRVIHRDLKASNILLDKDMNPKISDFGMARM 314 (476)
Q Consensus 241 ~~~~l~~Ey~~~~~------~~~~L~~~~~~~i~~qIa~gL~yLH~~~~~~ivH~DLkp~NILld~~~~~kL~DFGla~~ 314 (476)
+..++++||+++.. +...+++..+..++.|+++||+|||+.+ ++||||||+||+++.++.++++|||.+..
T Consensus 58 ~~~~lv~e~~~~~~L~~~l~~~~~l~~~~~~~~~~ql~~~l~~lH~~~---i~H~dlkp~Nil~~~~~~~~l~df~~~~~ 134 (237)
T cd05576 58 DSVFLVLQHAEGGKLWSHISKFLNIPEECVKRWAAEMVVALDALHREG---IVCRDLNPNNILLDDRGHIQLTYFSRWSE 134 (237)
T ss_pred CeEEEEEecCCCCCHHHHHHHhcCCCHHHHHHHHHHHHHHHHHHHhCC---eeccCCCHHHEEEcCCCCEEEecccchhc
Confidence 46778899998432 3346999999999999999999999998 99999999999999999999999998866
Q ss_pred cCCCcccccceeeeeccCCCChhhhccCCCCccceEEeehhhhhhhhhCCCCCCcCCCCchhhhhhhhhhhcCCCccccc
Q 045315 315 FGGDELQSNTKRIVGTYGYMSPEYALRGLFSIKSDVFSFGVLLLETLSSKKNTHFYNTDSLTLLGHAWNLWNDGRTWELM 394 (476)
Q Consensus 315 ~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~s~ksDVwSlGvvl~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 394 (476)
..... ....++..|+|||.+....++.++|+||+|+++||+++|+.++....... .... .
T Consensus 135 ~~~~~-----~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~il~el~~g~~~~~~~~~~~-----------~~~~--~-- 194 (237)
T cd05576 135 VEDSC-----DGEAVENMYCAPEVGGISEETEACDWWSLGAILFELLTGKTLVECHPSGI-----------NTHT--T-- 194 (237)
T ss_pred ccccc-----ccCCcCccccCCcccCCCCCCchhhHHHHHHHHHHHHHCcchhhcCchhc-----------cccc--c--
Confidence 54321 12345678999999988888999999999999999999998764321100 0000 0
Q ss_pred CcccCCCCCHHHHHHHHHHHHHchhhcccCCCCHH
Q 045315 395 DPISQNGASYPILKRYINVALLCVQEKAADRPAMS 429 (476)
Q Consensus 395 d~~~~~~~~~~~~~~l~~li~~Cl~~dP~~RPt~~ 429 (476)
. ..+......+.+++.+|++.||++||++.
T Consensus 195 -~----~~~~~~~~~~~~li~~~l~~dp~~R~~~~ 224 (237)
T cd05576 195 -L----NIPEWVSEEARSLLQQLLQFNPTERLGAG 224 (237)
T ss_pred -c----CCcccCCHHHHHHHHHHccCCHHHhcCCC
Confidence 0 01112335688999999999999999973
|
Serine/Threonine Kinases (STKs), RPK118-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The RPK118-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily show similarity to human RPK118, which contains an N-terminal Phox homology (PX) domain, a Microtubule Interacting and Trafficking (MIT) domain, and a kinase domain containing a long insert. Also included in the family is human RPK60 (or ribosomal protein S6 kinase-like 1), which also contains MIT and kinase domains but lacks a PX domain. RPK118 binds sphingosine kinase, a key enzyme in the synthesis of sphingosine 1-phospha |
| >KOG0032 consensus Ca2+/calmodulin-dependent protein kinase, EF-Hand protein superfamily [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.88 E-value=1e-22 Score=206.16 Aligned_cols=175 Identities=25% Similarity=0.255 Sum_probs=139.9
Q ss_pred cccceeeccCCCCC------CCCCCChhhHHHHHHHHHHHHHHHhhcCCCceeecCCCccceEecC----CCCceecccc
Q 045315 241 DEISFWYESYNNPT------KKGLLCWGTRVRIIEGIAQGLLYLHQYSRLRVIHRDLKASNILLDK----DMNPKISDFG 310 (476)
Q Consensus 241 ~~~~l~~Ey~~~~~------~~~~L~~~~~~~i~~qIa~gL~yLH~~~~~~ivH~DLkp~NILld~----~~~~kL~DFG 310 (476)
...+++||++..+. +. .+++..+..++.||+.+++|||+.+ |+||||||+|+|+.. ++.+|++|||
T Consensus 109 ~~~~lvmEL~~GGeLfd~i~~~-~~sE~da~~~~~~il~av~~lH~~g---vvHrDlKpEN~L~~~~~~~~~~ik~~DFG 184 (382)
T KOG0032|consen 109 DSVYLVMELCEGGELFDRIVKK-HYSERDAAGIIRQILEAVKYLHSLG---VVHRDLKPENLLLASKDEGSGRIKLIDFG 184 (382)
T ss_pred CeEEEEEEecCCchHHHHHHHc-cCCHHHHHHHHHHHHHHHHHHHhCC---ceeccCCHHHeeeccccCCCCcEEEeeCC
Confidence 46888999988321 11 3999999999999999999999999 999999999999963 3479999999
Q ss_pred ceeecCCCcccccceeeeeccCCCChhhhccCCCCccceEEeehhhhhhhhhCCCCCCcCCCCchhhhhhhhhhhcCCCc
Q 045315 311 MARMFGGDELQSNTKRIVGTYGYMSPEYALRGLFSIKSDVFSFGVLLLETLSSKKNTHFYNTDSLTLLGHAWNLWNDGRT 390 (476)
Q Consensus 311 la~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~s~ksDVwSlGvvl~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~ 390 (476)
++..... .......+||+.|+|||.+....|+..+|+||+||++|.|++|.+||.......... ....++.
T Consensus 185 la~~~~~---~~~~~~~~Gtp~y~APEvl~~~~y~~~~DiWS~Gvi~yiLL~G~~PF~~~~~~~~~~------~i~~~~~ 255 (382)
T KOG0032|consen 185 LAKFIKP---GERLHTIVGTPEYVAPEVLGGRPYGDEVDVWSIGVILYILLSGVPPFWGETEFEIFL------AILRGDF 255 (382)
T ss_pred CceEccC---CceEeeecCCccccCchhhcCCCCCcccchhHHHHHHHHHhhCCCCCcCCChhHHHH------HHHcCCC
Confidence 9998765 234455789999999999999999999999999999999999999997654332222 1111211
Q ss_pred ccccCcccCCCCCHHHHHHHHHHHHHchhhcccCCCCHHHHHHH
Q 045315 391 WELMDPISQNGASYPILKRYINVALLCVQEKAADRPAMSEVVSM 434 (476)
Q Consensus 391 ~~~~d~~~~~~~~~~~~~~l~~li~~Cl~~dP~~RPt~~eVl~~ 434 (476)
.............+.+++..|+..||.+|+|+.++++.
T Consensus 256 ------~f~~~~w~~is~~akd~i~~ll~~dp~~R~ta~~~L~H 293 (382)
T KOG0032|consen 256 ------DFTSEPWDDISESAKDFIRKLLEFDPRKRLTAAQALQH 293 (382)
T ss_pred ------CCCCCCccccCHHHHHHHHHhcccCcccCCCHHHHhcC
Confidence 22333344456788999999999999999999999984
|
|
| >KOG0574 consensus STE20-like serine/threonine kinase MST [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.88 E-value=2e-23 Score=195.58 Aligned_cols=172 Identities=21% Similarity=0.319 Sum_probs=138.0
Q ss_pred ccceeeccCCCC-------CCCCCCChhhHHHHHHHHHHHHHHHhhcCCCceeecCCCccceEecCCCCceeccccceee
Q 045315 242 EISFWYESYNNP-------TKKGLLCWGTRVRIIEGIAQGLLYLHQYSRLRVIHRDLKASNILLDKDMNPKISDFGMARM 314 (476)
Q Consensus 242 ~~~l~~Ey~~~~-------~~~~~L~~~~~~~i~~qIa~gL~yLH~~~~~~ivH~DLkp~NILld~~~~~kL~DFGla~~ 314 (476)
+.-+||||+..+ .++++|++.++..+++.-++||+|||... -||||||+.|||++.+|.+||+|||.|..
T Consensus 102 DLWIVMEYCGAGSiSDI~R~R~K~L~E~EIs~iL~~TLKGL~YLH~~~---KIHRDIKAGNILLNT~G~AKLADFGVAGQ 178 (502)
T KOG0574|consen 102 DLWIVMEYCGAGSISDIMRARRKPLSEQEISAVLRDTLKGLQYLHDLK---KIHRDIKAGNILLNTDGIAKLADFGVAGQ 178 (502)
T ss_pred ceEeehhhcCCCcHHHHHHHhcCCccHHHHHHHHHHHHhHHHHHHHHH---HHHhhcccccEEEcccchhhhhhccccch
Confidence 577899999832 46889999999999999999999999877 89999999999999999999999999987
Q ss_pred cCCCcccccceeeeeccCCCChhhhccCCCCccceEEeehhhhhhhhhCCCCCCcCCCCchhhhhhhhhhhcCCCccccc
Q 045315 315 FGGDELQSNTKRIVGTYGYMSPEYALRGLFSIKSDVFSFGVLLLETLSSKKNTHFYNTDSLTLLGHAWNLWNDGRTWELM 394 (476)
Q Consensus 315 ~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~s~ksDVwSlGvvl~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 394 (476)
+...- .....+.||+.|||||++..-.|..++||||||+...||..|++|+........-+ ++
T Consensus 179 LTDTM--AKRNTVIGTPFWMAPEVI~EIGY~~~ADIWSLGITaIEMAEG~PPYsDIHPMRAIF---------------MI 241 (502)
T KOG0574|consen 179 LTDTM--AKRNTVIGTPFWMAPEVIEEIGYDTKADIWSLGITAIEMAEGRPPYSDIHPMRAIF---------------MI 241 (502)
T ss_pred hhhhH--HhhCccccCcccccHHHHHHhccchhhhHhhhcchhhhhhcCCCCcccccccceeE---------------ec
Confidence 65432 22345789999999999999999999999999999999999999986443211100 11
Q ss_pred CcccCCC--CCHHHHHHHHHHHHHchhhcccCCCCHHHHHH
Q 045315 395 DPISQNG--ASYPILKRYINVALLCVQEKAADRPAMSEVVS 433 (476)
Q Consensus 395 d~~~~~~--~~~~~~~~l~~li~~Cl~~dP~~RPt~~eVl~ 433 (476)
.....+. .+..-...+.++++.||-++|++|-|+.++++
T Consensus 242 PT~PPPTF~KPE~WS~~F~DFi~~CLiK~PE~R~TA~~L~~ 282 (502)
T KOG0574|consen 242 PTKPPPTFKKPEEWSSEFNDFIRSCLIKKPEERKTALRLCE 282 (502)
T ss_pred cCCCCCCCCChHhhhhHHHHHHHHHhcCCHHHHHHHHHHhh
Confidence 1111111 12233678899999999999999999988765
|
|
| >cd06627 STKc_Cdc7_like Catalytic domain of Cell division control protein 7-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=99.87 E-value=1.3e-22 Score=194.35 Aligned_cols=173 Identities=27% Similarity=0.336 Sum_probs=132.9
Q ss_pred cccceeeccCCCC------CCCCCCChhhHHHHHHHHHHHHHHHhhcCCCceeecCCCccceEecCCCCceeccccceee
Q 045315 241 DEISFWYESYNNP------TKKGLLCWGTRVRIIEGIAQGLLYLHQYSRLRVIHRDLKASNILLDKDMNPKISDFGMARM 314 (476)
Q Consensus 241 ~~~~l~~Ey~~~~------~~~~~L~~~~~~~i~~qIa~gL~yLH~~~~~~ivH~DLkp~NILld~~~~~kL~DFGla~~ 314 (476)
+.+++++||++.. .....+++..+..++.|++.||.|||+.+ ++|+||||+||+++.++.++|+|||++..
T Consensus 72 ~~~~~v~e~~~~~~L~~~~~~~~~l~~~~~~~~~~~i~~~l~~lH~~~---i~H~dl~p~ni~i~~~~~~~l~d~~~~~~ 148 (254)
T cd06627 72 DSLYIILEYAENGSLRQIIKKFGPFPESLVAVYVYQVLQGLAYLHEQG---VIHRDIKAANILTTKDGVVKLADFGVATK 148 (254)
T ss_pred CEEEEEEecCCCCcHHHHHHhccCCCHHHHHHHHHHHHHHHHHHhhCC---cccCCCCHHHEEECCCCCEEEecccccee
Confidence 4577888888732 12367999999999999999999999998 99999999999999999999999999987
Q ss_pred cCCCcccccceeeeeccCCCChhhhccCCCCccceEEeehhhhhhhhhCCCCCCcCCCCchhhhhhhhhhhcCCCccccc
Q 045315 315 FGGDELQSNTKRIVGTYGYMSPEYALRGLFSIKSDVFSFGVLLLETLSSKKNTHFYNTDSLTLLGHAWNLWNDGRTWELM 394 (476)
Q Consensus 315 ~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~s~ksDVwSlGvvl~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 394 (476)
....... .....++..|+|||...+..++.++|+|++|++++++++|+.|+...... .. .+... ....
T Consensus 149 ~~~~~~~--~~~~~~~~~y~~pe~~~~~~~~~~~Dv~~lG~~l~~l~~g~~p~~~~~~~--~~---~~~~~-~~~~---- 216 (254)
T cd06627 149 LNDVSKD--DASVVGTPYWMAPEVIEMSGASTASDIWSLGCTVIELLTGNPPYYDLNPM--AA---LFRIV-QDDH---- 216 (254)
T ss_pred cCCCccc--ccccccchhhcCHhhhcCCCCCcchhHHHHHHHHHHHHhCCCCCCCccHH--HH---HHHHh-ccCC----
Confidence 6543321 12346788999999998877899999999999999999999987643211 10 01111 0100
Q ss_pred CcccCCCCCHHHHHHHHHHHHHchhhcccCCCCHHHHHH
Q 045315 395 DPISQNGASYPILKRYINVALLCVQEKAADRPAMSEVVS 433 (476)
Q Consensus 395 d~~~~~~~~~~~~~~l~~li~~Cl~~dP~~RPt~~eVl~ 433 (476)
...+......+.+++.+||+.+|++||++.+++.
T Consensus 217 -----~~~~~~~~~~~~~~i~~~l~~~p~~R~~~~~~l~ 250 (254)
T cd06627 217 -----PPLPEGISPELKDFLMQCFQKDPNLRPTAKQLLK 250 (254)
T ss_pred -----CCCCCCCCHHHHHHHHHHHhCChhhCcCHHHHhc
Confidence 0111223457889999999999999999999874
|
Serine/threonine kinases (STKs), (Cdc7)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Cdc7-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily include Schizosaccharomyces pombe Cdc7, Saccharomyces cerevisiae Cdc15, Arabidopsis thaliana mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) epsilon, and related proteins. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Fission yeast |
| >KOG0671 consensus LAMMER dual specificity kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.87 E-value=1.9e-22 Score=194.98 Aligned_cols=172 Identities=22% Similarity=0.246 Sum_probs=126.1
Q ss_pred CCCCCCChhhHHHHHHHHHHHHHHHhhcCCCceeecCCCccceEec--------------------CCCCceecccccee
Q 045315 254 TKKGLLCWGTRVRIIEGIAQGLLYLHQYSRLRVIHRDLKASNILLD--------------------KDMNPKISDFGMAR 313 (476)
Q Consensus 254 ~~~~~L~~~~~~~i~~qIa~gL~yLH~~~~~~ivH~DLkp~NILld--------------------~~~~~kL~DFGla~ 313 (476)
++..+++...+..|+.|++++++|||+.+ ++|-||||+|||+. ++..+||+|||.|.
T Consensus 184 N~y~~fpi~~ir~m~~QL~~sv~fLh~~k---l~HTDLKPENILfvss~~~~~~~~k~~~~~~r~~ks~~I~vIDFGsAt 260 (415)
T KOG0671|consen 184 NNYIPFPIDHIRHMGYQLLESVAFLHDLK---LTHTDLKPENILFVSSEYFKTYNPKKKVCFIRPLKSTAIKVIDFGSAT 260 (415)
T ss_pred CCccccchHHHHHHHHHHHHHHHHHHhcc---eeecCCChheEEEeccceEEEeccCCccceeccCCCcceEEEecCCcc
Confidence 45568999999999999999999999998 99999999999983 13457999999998
Q ss_pred ecCCCcccccceeeeeccCCCChhhhccCCCCccceEEeehhhhhhhhhCCCCCCcCC-CCchhhhhhhh----------
Q 045315 314 MFGGDELQSNTKRIVGTYGYMSPEYALRGLFSIKSDVFSFGVLLLETLSSKKNTHFYN-TDSLTLLGHAW---------- 382 (476)
Q Consensus 314 ~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~s~ksDVwSlGvvl~elltG~~p~~~~~-~~~~~~~~~~~---------- 382 (476)
...... ...+.|..|.|||++.+...+.++||||+||+|.|+.+|..-|...+ .+.....+.+.
T Consensus 261 f~~e~h-----s~iVsTRHYRAPEViLgLGwS~pCDvWSiGCIL~ElytG~~LFqtHen~EHLaMMerIlGp~P~~mi~r 335 (415)
T KOG0671|consen 261 FDHEHH-----STIVSTRHYRAPEVILGLGWSQPCDVWSIGCILVELYTGETLFQTHENLEHLAMMERILGPIPSRMIKK 335 (415)
T ss_pred eeccCc-----ceeeeccccCCchheeccCcCCccCceeeeeEEEEeeccceecccCCcHHHHHHHHHhhCCCcHHHhhh
Confidence 754433 34678999999999999999999999999999999999999887654 11111111111
Q ss_pred ----hhhcCCCc-----------ccccCccc----CCCCCHHHHHHHHHHHHHchhhcccCCCCHHHHHH
Q 045315 383 ----NLWNDGRT-----------WELMDPIS----QNGASYPILKRYINVALLCVQEKAADRPAMSEVVS 433 (476)
Q Consensus 383 ----~~~~~~~~-----------~~~~d~~~----~~~~~~~~~~~l~~li~~Cl~~dP~~RPt~~eVl~ 433 (476)
..+..+++ ....++.. .-.....+..++.+|+.+||..||.+|+|+.|++.
T Consensus 336 ~~~~Kyf~~~rldw~e~~~~~~~k~v~~~ckpl~~~~~~~d~e~~~LfDLl~~mL~fDP~~RiTl~EAL~ 405 (415)
T KOG0671|consen 336 TRKEKYFRRGRLDWPEVSSKGKSKYVFEPCKPLKKYMLQDDLEHVQLFDLLRRMLEFDPARRITLREALS 405 (415)
T ss_pred hhhHhhhhcccccCccccccccchhhhcCCccHHHHhccCcHHHhHHHHHHHHHHccCccccccHHHHhc
Confidence 01111100 00000000 01123345567999999999999999999999875
|
|
| >cd06633 STKc_TAO3 Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 3 | Back alignment and domain information |
|---|
Probab=99.87 E-value=1.2e-22 Score=202.34 Aligned_cols=171 Identities=30% Similarity=0.369 Sum_probs=128.7
Q ss_pred cccceeeccCCCC------CCCCCCChhhHHHHHHHHHHHHHHHhhcCCCceeecCCCccceEecCCCCceeccccceee
Q 045315 241 DEISFWYESYNNP------TKKGLLCWGTRVRIIEGIAQGLLYLHQYSRLRVIHRDLKASNILLDKDMNPKISDFGMARM 314 (476)
Q Consensus 241 ~~~~l~~Ey~~~~------~~~~~L~~~~~~~i~~qIa~gL~yLH~~~~~~ivH~DLkp~NILld~~~~~kL~DFGla~~ 314 (476)
...++++||++.. ....++++.++..++.||+.||+|||+.+ ++|+||+|+||+++.++.+||+|||++..
T Consensus 94 ~~~~lv~e~~~~~l~~~l~~~~~~l~~~~~~~~~~qi~~al~~LH~~g---i~H~dl~p~nili~~~~~~kL~dfg~~~~ 170 (313)
T cd06633 94 HTAWLVMEYCLGSASDLLEVHKKPLQEVEIAAITHGALQGLAYLHSHN---MIHRDIKAGNILLTEPGQVKLADFGSASK 170 (313)
T ss_pred CEEEEEEecCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCChhhEEECCCCCEEEeecCCCcc
Confidence 3577889998721 23557999999999999999999999998 99999999999999999999999999864
Q ss_pred cCCCcccccceeeeeccCCCChhhhc---cCCCCccceEEeehhhhhhhhhCCCCCCcCCCCchhhhhhhhhhhcCCCcc
Q 045315 315 FGGDELQSNTKRIVGTYGYMSPEYAL---RGLFSIKSDVFSFGVLLLETLSSKKNTHFYNTDSLTLLGHAWNLWNDGRTW 391 (476)
Q Consensus 315 ~~~~~~~~~~~~~~gt~~y~aPE~l~---~~~~s~ksDVwSlGvvl~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~ 391 (476)
... .....|+..|+|||++. ...++.++|||||||++|||++|..|+....... ... ..... ...
T Consensus 171 ~~~------~~~~~~~~~y~aPE~~~~~~~~~~~~~sDv~slGvil~el~~g~~p~~~~~~~~--~~~---~~~~~-~~~ 238 (313)
T cd06633 171 SSP------ANSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMS--ALY---HIAQN-DSP 238 (313)
T ss_pred cCC------CCCccccccccChhhccccCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCChHH--HHH---HHHhc-CCC
Confidence 322 12346788999999984 4568899999999999999999999875432111 110 01100 000
Q ss_pred cccCcccCCCCCHHHHHHHHHHHHHchhhcccCCCCHHHHHHH
Q 045315 392 ELMDPISQNGASYPILKRYINVALLCVQEKAADRPAMSEVVSM 434 (476)
Q Consensus 392 ~~~d~~~~~~~~~~~~~~l~~li~~Cl~~dP~~RPt~~eVl~~ 434 (476)
.. ........+.+++.+||+.+|.+||++.+++..
T Consensus 239 ~~--------~~~~~~~~l~~li~~~l~~~P~~Rp~~~~~l~~ 273 (313)
T cd06633 239 TL--------QSNEWTDSFRGFVDYCLQKIPQERPASAELLRH 273 (313)
T ss_pred CC--------CccccCHHHHHHHHHHccCChhhCcCHHHHhcC
Confidence 00 011123457889999999999999999998854
|
Serine/threonine kinases (STKs), thousand-and-one amino acids 3 (TAO3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. TAO3 is also known as JIK (JNK inhibitory kinase) or KFC (kinase from chicken). It specifically activates c-Jun N-terminal kinase (JNK), presumably by phosphorylating and activating MKK4/MKK7. In Saccharomyces cerevisiae, TAO3 is a co |
| >cd07854 STKc_MAPK4_6 Catalytic domain of the Serine/Threonine Kinases, Mitogen-Activated Protein Kinases 4 and 6 | Back alignment and domain information |
|---|
Probab=99.87 E-value=5.4e-23 Score=207.41 Aligned_cols=188 Identities=19% Similarity=0.180 Sum_probs=127.2
Q ss_pred ccceeeccCCCC----CCCCCCChhhHHHHHHHHHHHHHHHhhcCCCceeecCCCccceEecC-CCCceeccccceeecC
Q 045315 242 EISFWYESYNNP----TKKGLLCWGTRVRIIEGIAQGLLYLHQYSRLRVIHRDLKASNILLDK-DMNPKISDFGMARMFG 316 (476)
Q Consensus 242 ~~~l~~Ey~~~~----~~~~~L~~~~~~~i~~qIa~gL~yLH~~~~~~ivH~DLkp~NILld~-~~~~kL~DFGla~~~~ 316 (476)
.+++++||++.. .....+++..+..++.||++||.|||+.+ ++||||||+||+++. ++.+||+|||++....
T Consensus 90 ~~~lv~e~~~~~L~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~g---ivH~dikp~Nili~~~~~~~kl~dfg~~~~~~ 166 (342)
T cd07854 90 SVYIVQEYMETDLANVLEQGPLSEEHARLFMYQLLRGLKYIHSAN---VLHRDLKPANVFINTEDLVLKIGDFGLARIVD 166 (342)
T ss_pred eEEEEeecccccHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHhCC---cccCCCCHHHEEEcCCCceEEECCcccceecC
Confidence 467888888721 12346899999999999999999999998 999999999999984 5578999999998654
Q ss_pred CCcccc-cceeeeeccCCCChhhhcc-CCCCccceEEeehhhhhhhhhCCCCCCcCCCCchhhhhhhhhh----------
Q 045315 317 GDELQS-NTKRIVGTYGYMSPEYALR-GLFSIKSDVFSFGVLLLETLSSKKNTHFYNTDSLTLLGHAWNL---------- 384 (476)
Q Consensus 317 ~~~~~~-~~~~~~gt~~y~aPE~l~~-~~~s~ksDVwSlGvvl~elltG~~p~~~~~~~~~~~~~~~~~~---------- 384 (476)
...... ......++..|+|||.+.. ..++.++|||||||++|||++|+.||........ ........
T Consensus 167 ~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwSlGvil~el~~g~~pf~~~~~~~~-~~~~~~~~~~~~~~~~~~ 245 (342)
T cd07854 167 PHYSHKGYLSEGLVTKWYRSPRLLLSPNNYTKAIDMWAAGCIFAEMLTGKPLFAGAHELEQ-MQLILESVPVVREEDRNE 245 (342)
T ss_pred CccccccccccccccccccCHHHHhCccccCchhhHHHHHHHHHHHHhCCCCCCCCCHHHH-HHHHHHhcCCCChHHhhh
Confidence 321111 1122356889999998754 5678999999999999999999999864331110 00000000
Q ss_pred hcCCCcccccCcccCCCC-----CHHHHHHHHHHHHHchhhcccCCCCHHHHHH
Q 045315 385 WNDGRTWELMDPISQNGA-----SYPILKRYINVALLCVQEKAADRPAMSEVVS 433 (476)
Q Consensus 385 ~~~~~~~~~~d~~~~~~~-----~~~~~~~l~~li~~Cl~~dP~~RPt~~eVl~ 433 (476)
.................. .......+.+++.+||+.||++|||+.++++
T Consensus 246 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~ell~ 299 (342)
T cd07854 246 LLNVIPSFVRNDGGEPRRPLRDLLPGVNPEALDFLEQILTFNPMDRLTAEEALM 299 (342)
T ss_pred hhhhhhhhhhhcccccCCCHHHHccCCCHHHHHHHHHHhCCCchhccCHHHHhC
Confidence 000000000000000000 0112356889999999999999999999984
|
Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase 4 (MAPK4) and MAPK6 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK4/6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. MAPK4 is also called ERK4 or p63MAPK, while MAPK6 is also called ERK3 or p97MAPK. MAPK4 and MAPK6 are atypical MAPKs that are not regulated by MAP2Ks. MAPK6 is expressed ubiquitously with highest amounts in brain and skeletal muscle. It may be involved in the control of cell differentiation by negatively regulating cell cycle progressi |
| >cd05613 STKc_MSK1_N N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase 1 | Back alignment and domain information |
|---|
Probab=99.87 E-value=2.6e-22 Score=197.17 Aligned_cols=176 Identities=20% Similarity=0.270 Sum_probs=128.7
Q ss_pred ccceeeccCCCC------CCCCCCChhhHHHHHHHHHHHHHHHhhcCCCceeecCCCccceEecCCCCceeccccceeec
Q 045315 242 EISFWYESYNNP------TKKGLLCWGTRVRIIEGIAQGLLYLHQYSRLRVIHRDLKASNILLDKDMNPKISDFGMARMF 315 (476)
Q Consensus 242 ~~~l~~Ey~~~~------~~~~~L~~~~~~~i~~qIa~gL~yLH~~~~~~ivH~DLkp~NILld~~~~~kL~DFGla~~~ 315 (476)
..++++||++.. .....+++.++..++.||++||.|||+.+ ++||||||+||+++.++.+||+|||++...
T Consensus 79 ~~~lv~e~~~~~~L~~~l~~~~~l~~~~~~~~~~qi~~al~~lH~~~---i~H~dl~p~nil~~~~~~~kl~dfg~~~~~ 155 (290)
T cd05613 79 KLHLILDYINGGELFTHLSQRERFKEQEVQIYSGEIVLALEHLHKLG---IIYRDIKLENILLDSNGHVVLTDFGLSKEF 155 (290)
T ss_pred eEEEEEecCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHhCC---eeccCCCHHHeEECCCCCEEEeeCccceec
Confidence 467899999833 23457899999999999999999999998 999999999999999999999999999876
Q ss_pred CCCcccccceeeeeccCCCChhhhcc--CCCCccceEEeehhhhhhhhhCCCCCCcCCCCchhhhhhhhhhhcCCCcccc
Q 045315 316 GGDELQSNTKRIVGTYGYMSPEYALR--GLFSIKSDVFSFGVLLLETLSSKKNTHFYNTDSLTLLGHAWNLWNDGRTWEL 393 (476)
Q Consensus 316 ~~~~~~~~~~~~~gt~~y~aPE~l~~--~~~s~ksDVwSlGvvl~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~ 393 (476)
...... ......|+..|+|||.+.+ ..++.++||||||+++|+|++|+.|+...... ..............
T Consensus 156 ~~~~~~-~~~~~~~~~~y~aPE~~~~~~~~~~~~~Dv~slG~~l~~ll~g~~p~~~~~~~-~~~~~~~~~~~~~~----- 228 (290)
T cd05613 156 HEDEVE-RAYSFCGTIEYMAPDIVRGGDGGHDKAVDWWSMGVLMYELLTGASPFTVDGEK-NSQAEISRRILKSE----- 228 (290)
T ss_pred cccccc-ccccccCCcccCChhhccCCCCCCCccccHHHHHHHHHHHhcCCCCCCcCCcc-ccHHHHHHHhhccC-----
Confidence 433221 1223558889999999875 34688999999999999999999998643211 11111111111110
Q ss_pred cCcccCCCCCHHHHHHHHHHHHHchhhcccCCC-----CHHHHHH
Q 045315 394 MDPISQNGASYPILKRYINVALLCVQEKAADRP-----AMSEVVS 433 (476)
Q Consensus 394 ~d~~~~~~~~~~~~~~l~~li~~Cl~~dP~~RP-----t~~eVl~ 433 (476)
+ ..+......+.+++.+||+.+|++|| ++++++.
T Consensus 229 --~----~~~~~~~~~~~~ll~~~l~~~p~~R~~~~~~~~~~l~~ 267 (290)
T cd05613 229 --P----PYPQEMSALAKDIIQRLLMKDPKKRLGCGPSDADEIKK 267 (290)
T ss_pred --C----CCCccCCHHHHHHHHHHhcCCHHHhcCCCCCCHHHHHc
Confidence 0 11112345678999999999999997 5666544
|
Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, MSK1, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, which trigger phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydroph |
| >cd08222 STKc_Nek11 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 11 | Back alignment and domain information |
|---|
Probab=99.87 E-value=3.1e-22 Score=193.19 Aligned_cols=172 Identities=26% Similarity=0.342 Sum_probs=130.9
Q ss_pred cccceeeccCCCC----------CCCCCCChhhHHHHHHHHHHHHHHHhhcCCCceeecCCCccceEecCCCCceecccc
Q 045315 241 DEISFWYESYNNP----------TKKGLLCWGTRVRIIEGIAQGLLYLHQYSRLRVIHRDLKASNILLDKDMNPKISDFG 310 (476)
Q Consensus 241 ~~~~l~~Ey~~~~----------~~~~~L~~~~~~~i~~qIa~gL~yLH~~~~~~ivH~DLkp~NILld~~~~~kL~DFG 310 (476)
...++++||++.. ..+..+++.+++.++.|+++||.|||+.+ ++|+||||+||+++. +.+||+|||
T Consensus 75 ~~~~lv~e~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~---i~h~~l~~~nili~~-~~~~l~d~g 150 (260)
T cd08222 75 DAFCIITEYCEGRDLDCKLEELKHTGKTLSENQVCEWFIQLLLGVHYMHQRR---ILHRDLKAKNIFLKN-NLLKIGDFG 150 (260)
T ss_pred CceEEEEEeCCCCCHHHHHHHHhhcccccCHHHHHHHHHHHHHHHHHHHHcC---ccccCCChhheEeec-CCEeecccC
Confidence 3577899999832 23467999999999999999999999998 999999999999985 569999999
Q ss_pred ceeecCCCcccccceeeeeccCCCChhhhccCCCCccceEEeehhhhhhhhhCCCCCCcCCCCchhhhhhhhhhhcCCCc
Q 045315 311 MARMFGGDELQSNTKRIVGTYGYMSPEYALRGLFSIKSDVFSFGVLLLETLSSKKNTHFYNTDSLTLLGHAWNLWNDGRT 390 (476)
Q Consensus 311 la~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~s~ksDVwSlGvvl~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~ 390 (476)
++........ ......++..|+|||...+..++.++|+||||+++++|++|..|+..... .... ... ..+..
T Consensus 151 ~~~~~~~~~~--~~~~~~~~~~~~~pe~~~~~~~~~~~Dv~slG~~~~~l~~~~~~~~~~~~--~~~~---~~~-~~~~~ 222 (260)
T cd08222 151 VSRLLMGSCD--LATTFTGTPYYMSPEALKHQGYDSKSDIWSLGCILYEMCCLAHAFEGQNF--LSVV---LRI-VEGPT 222 (260)
T ss_pred ceeecCCCcc--cccCCCCCcCccCHHHHccCCCCchhhHHHHHHHHHHHHhCCCCCCCccH--HHHH---HHH-HcCCC
Confidence 9987643321 11224578899999999888889999999999999999999999853221 1111 111 11111
Q ss_pred ccccCcccCCCCCHHHHHHHHHHHHHchhhcccCCCCHHHHHH
Q 045315 391 WELMDPISQNGASYPILKRYINVALLCVQEKAADRPAMSEVVS 433 (476)
Q Consensus 391 ~~~~d~~~~~~~~~~~~~~l~~li~~Cl~~dP~~RPt~~eVl~ 433 (476)
...+......+.+++.+||+.+|++||++.++++
T Consensus 223 ---------~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~il~ 256 (260)
T cd08222 223 ---------PSLPETYSRQLNSIMQSMLNKDPSLRPSAAEILR 256 (260)
T ss_pred ---------CCCcchhcHHHHHHHHHHhcCChhhCcCHHHHhh
Confidence 1112234467889999999999999999999875
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 11 (Nek11) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek11 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek11 is involved, through direct phosphorylation, in regulating the degradation of Cdc25A (Cell Division Cycle 25 homolog A), which plays a role in cell cycle progression and in activating cyclin dependent kinases. Nek11 is activated by CHK1 (CHeckpoint Kinase 1) and may be involved in the G2/M check |
| >PLN03225 Serine/threonine-protein kinase SNT7; Provisional | Back alignment and domain information |
|---|
Probab=99.87 E-value=3.1e-22 Score=213.84 Aligned_cols=166 Identities=17% Similarity=0.118 Sum_probs=106.7
Q ss_pred hhHHHHHHHHHHHHHHHhhcCCCceeecCCCccceEecC-CCCceeccccceeecCCCcccccceeeeeccCCCChhhhc
Q 045315 262 GTRVRIIEGIAQGLLYLHQYSRLRVIHRDLKASNILLDK-DMNPKISDFGMARMFGGDELQSNTKRIVGTYGYMSPEYAL 340 (476)
Q Consensus 262 ~~~~~i~~qIa~gL~yLH~~~~~~ivH~DLkp~NILld~-~~~~kL~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~l~ 340 (476)
..+..++.||+.||+|||+++ |+||||||+|||++. ++.+||+|||+++.+..... .......+++.|+|||.+.
T Consensus 255 ~~i~~i~~qll~aL~yLH~~g---IiHRDLKP~NILl~~~~~~~KL~DFGlA~~l~~~~~-~~~~~~~~t~~Y~APE~~~ 330 (566)
T PLN03225 255 KIIQTIMRQILFALDGLHSTG---IVHRDVKPQNIIFSEGSGSFKIIDLGAAADLRVGIN-YIPKEFLLDPRYAAPEQYI 330 (566)
T ss_pred HHHHHHHHHHHHHHHHHHHCC---EEeCcCCHHHEEEeCCCCcEEEEeCCCccccccccc-cCCcccccCCCccChHHhh
Confidence 345679999999999999998 999999999999985 57899999999986543221 1223357889999999664
Q ss_pred cC----------------------CCCccceEEeehhhhhhhhhCCCCCCcCCCCchhhhhhhhhhhcC-CCcccccCcc
Q 045315 341 RG----------------------LFSIKSDVFSFGVLLLETLSSKKNTHFYNTDSLTLLGHAWNLWND-GRTWELMDPI 397 (476)
Q Consensus 341 ~~----------------------~~s~ksDVwSlGvvl~elltG~~p~~~~~~~~~~~~~~~~~~~~~-~~~~~~~d~~ 397 (476)
.. .+..++|||||||++|||+++..+.... ...+.......-.. ........+.
T Consensus 331 ~~~~~~~~~~~~~~~~~sp~l~~~~~~~k~DVwSlGviL~el~~~~~~~~~~---~~~~~~~l~~~~~~~~~~~~~~~~~ 407 (566)
T PLN03225 331 MSTQTPSAPSAPVATALSPVLWQLNLPDRFDIYSAGLIFLQMAFPNLRSDSN---LIQFNRQLKRNDYDLVAWRKLVEPR 407 (566)
T ss_pred ccCCCCCCccccccccccchhccccCCCCcccHHHHHHHHHHHhCcCCCchH---HHHHHHHHHhcCCcHHHHHHhhccc
Confidence 21 2345679999999999999876553211 00110000000000 0000000110
Q ss_pred cCCC------CCHHHHHHHHHHHHHchhhcccCCCCHHHHHHH
Q 045315 398 SQNG------ASYPILKRYINVALLCVQEKAADRPAMSEVVSM 434 (476)
Q Consensus 398 ~~~~------~~~~~~~~l~~li~~Cl~~dP~~RPt~~eVl~~ 434 (476)
.... ..........+++.+||+.||++|||+.|+++.
T Consensus 408 ~~~~~~~~~~~~d~~~~~~~dLi~~mL~~dP~kR~ta~e~L~H 450 (566)
T PLN03225 408 ASPDLRRGFEVLDLDGGAGWELLKSMMRFKGRQRISAKAALAH 450 (566)
T ss_pred cchhhhhhhhhccccchHHHHHHHHHccCCcccCCCHHHHhCC
Confidence 0000 000012245689999999999999999999874
|
|
| >PTZ00024 cyclin-dependent protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=99.87 E-value=1.5e-22 Score=203.42 Aligned_cols=187 Identities=22% Similarity=0.260 Sum_probs=129.8
Q ss_pred ccceeeccCCCC-----CCCCCCChhhHHHHHHHHHHHHHHHhhcCCCceeecCCCccceEecCCCCceeccccceeecC
Q 045315 242 EISFWYESYNNP-----TKKGLLCWGTRVRIIEGIAQGLLYLHQYSRLRVIHRDLKASNILLDKDMNPKISDFGMARMFG 316 (476)
Q Consensus 242 ~~~l~~Ey~~~~-----~~~~~L~~~~~~~i~~qIa~gL~yLH~~~~~~ivH~DLkp~NILld~~~~~kL~DFGla~~~~ 316 (476)
..++++||++.. .....+++.....++.|++.||+|||+.+ ++|+||+|+||+++.++.+||+|||++....
T Consensus 94 ~~~lv~e~~~~~l~~~l~~~~~~~~~~~~~~~~ql~~aL~~LH~~~---i~H~dl~~~nill~~~~~~kl~dfg~~~~~~ 170 (335)
T PTZ00024 94 FINLVMDIMASDLKKVVDRKIRLTESQVKCILLQILNGLNVLHKWY---FMHRDLSPANIFINSKGICKIADFGLARRYG 170 (335)
T ss_pred cEEEEEeccccCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCC---eecccccHHHeEECCCCCEEECCccceeecc
Confidence 466778888621 23456899999999999999999999998 9999999999999999999999999998765
Q ss_pred CCcc------------cccceeeeeccCCCChhhhccC-CCCccceEEeehhhhhhhhhCCCCCCcCCCCchhhhhhhhh
Q 045315 317 GDEL------------QSNTKRIVGTYGYMSPEYALRG-LFSIKSDVFSFGVLLLETLSSKKNTHFYNTDSLTLLGHAWN 383 (476)
Q Consensus 317 ~~~~------------~~~~~~~~gt~~y~aPE~l~~~-~~s~ksDVwSlGvvl~elltG~~p~~~~~~~~~~~~~~~~~ 383 (476)
.... ........++..|+|||.+.+. .++.++|+|||||++|||++|+.||...... ........
T Consensus 171 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~el~tg~~p~~~~~~~--~~~~~i~~ 248 (335)
T PTZ00024 171 YPPYSDTLSKDETMQRREEMTSKVVTLWYRAPELLMGAEKYHFAVDMWSVGCIFAELLTGKPLFPGENEI--DQLGRIFE 248 (335)
T ss_pred cccccccccccccccccccccccccccCCCCChhcccCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHH--HHHHHHHH
Confidence 2110 0111123467889999998764 4689999999999999999999998654321 11111111
Q ss_pred hhcCCC---cccc--------cCcccC---CCCCHHHHHHHHHHHHHchhhcccCCCCHHHHHH
Q 045315 384 LWNDGR---TWEL--------MDPISQ---NGASYPILKRYINVALLCVQEKAADRPAMSEVVS 433 (476)
Q Consensus 384 ~~~~~~---~~~~--------~d~~~~---~~~~~~~~~~l~~li~~Cl~~dP~~RPt~~eVl~ 433 (476)
...... ..+. ...... ..........+.+++.+||+.+|++||+++|++.
T Consensus 249 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~s~~~~l~ 312 (335)
T PTZ00024 249 LLGTPNEDNWPQAKKLPLYTEFTPRKPKDLKTIFPNASDDAIDLLQSLLKLNPLERISAKEALK 312 (335)
T ss_pred HhCCCchhhCcchhhcccccccCcCCcccHHHhCcCCChHHHHHHHHHcCCCchhccCHHHHhc
Confidence 110000 0000 000000 0001112456889999999999999999999986
|
|
| >cd06653 STKc_MEKK3_like_1 Catalytic domain of MAP/ERK kinase kinase 3-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=99.87 E-value=2.1e-22 Score=195.07 Aligned_cols=174 Identities=24% Similarity=0.306 Sum_probs=129.6
Q ss_pred ccceeeccCCCC------CCCCCCChhhHHHHHHHHHHHHHHHhhcCCCceeecCCCccceEecCCCCceeccccceeec
Q 045315 242 EISFWYESYNNP------TKKGLLCWGTRVRIIEGIAQGLLYLHQYSRLRVIHRDLKASNILLDKDMNPKISDFGMARMF 315 (476)
Q Consensus 242 ~~~l~~Ey~~~~------~~~~~L~~~~~~~i~~qIa~gL~yLH~~~~~~ivH~DLkp~NILld~~~~~kL~DFGla~~~ 315 (476)
..++++||++.. ...+.+++..+.+++.||+.||.|||+.+ ++|+||||+||+++.++.++|+|||+++..
T Consensus 80 ~~~~v~e~~~~~~L~~~~~~~~~l~~~~~~~~~~~i~~al~~LH~~~---i~H~dl~p~ni~i~~~~~~~l~dfg~~~~~ 156 (264)
T cd06653 80 KLSIFVEYMPGGSIKDQLKAYGALTENVTRRYTRQILQGVSYLHSNM---IVHRDIKGANILRDSAGNVKLGDFGASKRI 156 (264)
T ss_pred EEEEEEEeCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHhCC---EecCCCCHHHEEEcCCCCEEECcccccccc
Confidence 466788888732 23456899999999999999999999998 999999999999999999999999999865
Q ss_pred CCCccc-ccceeeeeccCCCChhhhccCCCCccceEEeehhhhhhhhhCCCCCCcCCCCchhhhhhhhhhhcCCCccccc
Q 045315 316 GGDELQ-SNTKRIVGTYGYMSPEYALRGLFSIKSDVFSFGVLLLETLSSKKNTHFYNTDSLTLLGHAWNLWNDGRTWELM 394 (476)
Q Consensus 316 ~~~~~~-~~~~~~~gt~~y~aPE~l~~~~~s~ksDVwSlGvvl~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 394 (476)
...... .......++..|+|||.+.+..++.++|+|||||+++++++|+.||...... .... ......
T Consensus 157 ~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~-~~~~----~~~~~~------ 225 (264)
T cd06653 157 QTICMSGTGIKSVTGTPYWMSPEVISGEGYGRKADVWSVACTVVEMLTEKPPWAEYEAM-AAIF----KIATQP------ 225 (264)
T ss_pred ccccccCccccccCCcccccCHhhhcCCCCCccccHHHHHHHHHHHHhCCCCCCccCHH-HHHH----HHHcCC------
Confidence 321111 1112345788999999998888899999999999999999999998643211 1111 111000
Q ss_pred CcccCCCCCHHHHHHHHHHHHHchhhcccCCCCHHHHHH
Q 045315 395 DPISQNGASYPILKRYINVALLCVQEKAADRPAMSEVVS 433 (476)
Q Consensus 395 d~~~~~~~~~~~~~~l~~li~~Cl~~dP~~RPt~~eVl~ 433 (476)
.....+....+.+.+++.+|++ +|..||++.+++.
T Consensus 226 ---~~~~~p~~~~~~~~~~i~~~l~-~~~~r~~~~~~~~ 260 (264)
T cd06653 226 ---TKPMLPDGVSDACRDFLKQIFV-EEKRRPTAEFLLR 260 (264)
T ss_pred ---CCCCCCcccCHHHHHHHHHHhc-CcccCccHHHHhc
Confidence 0111223344678899999999 5799999998764
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3)-like subfamily, catalytic (c) domain, functionally uncharacterized subgroup 1. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The MEKK3-like subfamily is composed of MEKK3, MEKK2, and related proteins, all containing an N-terminal PB1 domain, which mediates oligomerization, and a C-terminal catalytic domain. MEKK2 and MEKK3 are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks), proteins that phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phospho |
| >cd07851 STKc_p38 Catalytic domain of the Serine/Threonine Kinase, p38 Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Probab=99.87 E-value=8.3e-23 Score=206.14 Aligned_cols=182 Identities=23% Similarity=0.262 Sum_probs=129.9
Q ss_pred ccceeeccCCC----CCCCCCCChhhHHHHHHHHHHHHHHHhhcCCCceeecCCCccceEecCCCCceeccccceeecCC
Q 045315 242 EISFWYESYNN----PTKKGLLCWGTRVRIIEGIAQGLLYLHQYSRLRVIHRDLKASNILLDKDMNPKISDFGMARMFGG 317 (476)
Q Consensus 242 ~~~l~~Ey~~~----~~~~~~L~~~~~~~i~~qIa~gL~yLH~~~~~~ivH~DLkp~NILld~~~~~kL~DFGla~~~~~ 317 (476)
.+++++||+.. ......+++.++..++.||++||+|||+.+ ++|+||||+||+++.++.+||+|||++.....
T Consensus 94 ~~~lv~e~~~~~L~~~~~~~~l~~~~~~~~~~ql~~aL~~LH~~g---i~H~dlkp~Nill~~~~~~kL~dfg~~~~~~~ 170 (343)
T cd07851 94 DVYLVTHLMGADLNNIVKCQKLSDDHIQFLVYQILRGLKYIHSAG---IIHRDLKPSNIAVNEDCELKILDFGLARHTDD 170 (343)
T ss_pred cEEEEEecCCCCHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCCHHHeEECCCCCEEEccccccccccc
Confidence 37888898862 112357999999999999999999999998 99999999999999999999999999986543
Q ss_pred CcccccceeeeeccCCCChhhhcc-CCCCccceEEeehhhhhhhhhCCCCCCcCCCCchhhhhhhhhhh-----------
Q 045315 318 DELQSNTKRIVGTYGYMSPEYALR-GLFSIKSDVFSFGVLLLETLSSKKNTHFYNTDSLTLLGHAWNLW----------- 385 (476)
Q Consensus 318 ~~~~~~~~~~~gt~~y~aPE~l~~-~~~s~ksDVwSlGvvl~elltG~~p~~~~~~~~~~~~~~~~~~~----------- 385 (476)
. .....++..|+|||.+.+ ..++.++|||||||++||+++|+.||...... ..........
T Consensus 171 ~-----~~~~~~~~~y~aPE~~~~~~~~~~~~DvwslGv~l~elltg~~pf~~~~~~--~~~~~i~~~~~~~~~~~~~~~ 243 (343)
T cd07851 171 E-----MTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGKTLFPGSDHI--DQLKRIMNLVGTPDEELLQKI 243 (343)
T ss_pred c-----ccCCcccccccCHHHHhCCCCCCchHhHHHHHHHHHHHHhCCCCCCCCChH--HHHHHHHHhcCCCCHHHHhhc
Confidence 2 122457888999998865 46789999999999999999999998643311 1000000000
Q ss_pred cCCCcccccCc---ccCCC---CCHHHHHHHHHHHHHchhhcccCCCCHHHHHH
Q 045315 386 NDGRTWELMDP---ISQNG---ASYPILKRYINVALLCVQEKAADRPAMSEVVS 433 (476)
Q Consensus 386 ~~~~~~~~~d~---~~~~~---~~~~~~~~l~~li~~Cl~~dP~~RPt~~eVl~ 433 (476)
........+.. ..... ........+.+++.+||+.+|++|||+.+|++
T Consensus 244 ~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~l~dli~~~l~~~P~~Rpt~~ell~ 297 (343)
T cd07851 244 SSESARNYIQSLPQMPKKDFKEVFSGANPLAIDLLEKMLVLDPDKRITAAEALA 297 (343)
T ss_pred cchhHHHHHHhccccCCCCHHHHhccCCHHHHHHHHHhCCCChhhCCCHHHHhc
Confidence 00000000000 00000 00112467889999999999999999999876
|
Serine/Threonine Kinases (STKs), p38 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They function in the regulation of the cell cycle, cell development, cell differentiation, senescence, tumorigenesis, apoptosis, pain development and pain progression, and immune responses. p38 kinases are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK |
| >KOG0666 consensus Cyclin C-dependent kinase CDK8 [Transcription] | Back alignment and domain information |
|---|
Probab=99.87 E-value=3.6e-22 Score=188.17 Aligned_cols=205 Identities=21% Similarity=0.265 Sum_probs=140.8
Q ss_pred cccceeeccCC----------CCCCCCCCChhhHHHHHHHHHHHHHHHhhcCCCceeecCCCccceEecCC----CCcee
Q 045315 241 DEISFWYESYN----------NPTKKGLLCWGTRVRIIEGIAQGLLYLHQYSRLRVIHRDLKASNILLDKD----MNPKI 306 (476)
Q Consensus 241 ~~~~l~~Ey~~----------~~~~~~~L~~~~~~~i~~qIa~gL~yLH~~~~~~ivH~DLkp~NILld~~----~~~kL 306 (476)
+...+++||.+ ...+.+.++-..+..|+.||+.|+.|||++- |+||||||.|||+..+ |.+||
T Consensus 101 ~~v~l~fdYAEhDL~~II~fHr~~~~~~lp~~mvKsilwQil~Gv~YLH~NW---vlHRDLKPaNIlvmgdgperG~VKI 177 (438)
T KOG0666|consen 101 KKVWLLFDYAEHDLWHIIKFHRASKAKQLPRSMVKSILWQILDGVHYLHSNW---VLHRDLKPANILVMGDGPERGRVKI 177 (438)
T ss_pred ceEEEEehhhhhhHHHHHHHhccchhccCCHHHHHHHHHHHHhhhHHHhhhh---eeeccCCcceEEEeccCCccCeeEe
Confidence 45678899998 2234568999999999999999999999998 9999999999999877 89999
Q ss_pred ccccceeecCCCccc-ccceeeeeccCCCChhhhcc-CCCCccceEEeehhhhhhhhhCCCCCCcCCCCc--h-hh-hhh
Q 045315 307 SDFGMARMFGGDELQ-SNTKRIVGTYGYMSPEYALR-GLFSIKSDVFSFGVLLLETLSSKKNTHFYNTDS--L-TL-LGH 380 (476)
Q Consensus 307 ~DFGla~~~~~~~~~-~~~~~~~gt~~y~aPE~l~~-~~~s~ksDVwSlGvvl~elltG~~p~~~~~~~~--~-~~-~~~ 380 (476)
+|||+++.+.+.-.. .....++-|..|+|||.+.+ ..|+++.|+||.||++.||++-++-|.....+. . .+ .+.
T Consensus 178 aDlGlaR~~~~plkpl~s~d~VVVTiWYRAPELLLGa~hYT~AiDvWAiGCIfaElLtl~PlF~g~E~k~~~~~Pfq~dQ 257 (438)
T KOG0666|consen 178 ADLGLARLFNNPLKPLASLDPVVVTIWYRAPELLLGARHYTKAIDVWAIGCIFAELLTLEPLFKGREEKIKTKNPFQHDQ 257 (438)
T ss_pred ecccHHHHhhccccccccCCceEEEEEecChHHhcccccccchhhhHHHHHHHHHHHccCccccchhhhcccCCCchHHH
Confidence 999999988653222 23345678999999999987 469999999999999999999998886543111 0 00 011
Q ss_pred hhhhh------cCCCccccc---C------ccc---CCCCCHH--------HHHHHHHHHHHchhhcccCCCCHHHHHHH
Q 045315 381 AWNLW------NDGRTWELM---D------PIS---QNGASYP--------ILKRYINVALLCVQEKAADRPAMSEVVSM 434 (476)
Q Consensus 381 ~~~~~------~~~~~~~~~---d------~~~---~~~~~~~--------~~~~l~~li~~Cl~~dP~~RPt~~eVl~~ 434 (476)
..+.+ .+.....+. + ... ....... ..+...+++.++|+.||-+|.|+++.++-
T Consensus 258 l~rIf~vLG~Pt~~~Wp~lkk~Pe~q~~ls~f~~~~~~n~sL~~~~~~~k~k~~~a~~LL~klL~yDP~kRIta~qAleh 337 (438)
T KOG0666|consen 258 LDRIFEVLGTPTDKDWPDLKKMPEYQTLLSDFRRHYYDNVSLHKYYHKHKVKDPSALDLLQKLLTYDPIKRITAEQALEH 337 (438)
T ss_pred HHHHHHHcCCCccccchhhhhCcchHHHHHHhHHhhcCcchHHHHHHHhcCCCchHHHHHHHHhccCchhhccHHHHhcc
Confidence 11111 011110000 0 000 0000000 01236788999999999999999986643
Q ss_pred HhccccCCCCCCCCcc
Q 045315 435 LSNEFVNLPAPQQPAF 450 (476)
Q Consensus 435 L~~~~~~~~~p~~p~~ 450 (476)
. -+.+-+.||.|..
T Consensus 338 ~--yF~~d~lpp~pt~ 351 (438)
T KOG0666|consen 338 P--YFTEDPLPPLPTS 351 (438)
T ss_pred c--ccccCCCCCCccc
Confidence 2 1245566666654
|
|
| >KOG0696 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.87 E-value=1.1e-22 Score=197.64 Aligned_cols=165 Identities=28% Similarity=0.362 Sum_probs=132.8
Q ss_pred cccceeeccCCCC------CCCCCCChhhHHHHHHHHHHHHHHHhhcCCCceeecCCCccceEecCCCCceeccccceee
Q 045315 241 DEISFWYESYNNP------TKKGLLCWGTRVRIIEGIAQGLLYLHQYSRLRVIHRDLKASNILLDKDMNPKISDFGMARM 314 (476)
Q Consensus 241 ~~~~l~~Ey~~~~------~~~~~L~~~~~~~i~~qIa~gL~yLH~~~~~~ivH~DLkp~NILld~~~~~kL~DFGla~~ 314 (476)
+..++||||+..+ .+-+++-+..+.-++.+||-||-+||+++ ||+||||.+||++|.+|.+||+|||+++.
T Consensus 423 DRLyFVMEyvnGGDLMyhiQQ~GkFKEp~AvFYAaEiaigLFFLh~kg---IiYRDLKLDNvmLd~eGHiKi~DFGmcKE 499 (683)
T KOG0696|consen 423 DRLYFVMEYVNGGDLMYHIQQVGKFKEPVAVFYAAEIAIGLFFLHSKG---IIYRDLKLDNVMLDSEGHIKIADFGMCKE 499 (683)
T ss_pred hheeeEEEEecCchhhhHHHHhcccCCchhhhhhHHHHHHhhhhhcCC---eeeeeccccceEeccCCceEeeecccccc
Confidence 5789999999833 34667888899999999999999999999 99999999999999999999999999985
Q ss_pred cCCCcccccceeeeeccCCCChhhhccCCCCccceEEeehhhhhhhhhCCCCCCcCCCCchhhhhhhhhhhcCCCccccc
Q 045315 315 FGGDELQSNTKRIVGTYGYMSPEYALRGLFSIKSDVFSFGVLLLETLSSKKNTHFYNTDSLTLLGHAWNLWNDGRTWELM 394 (476)
Q Consensus 315 ~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~s~ksDVwSlGvvl~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 394 (476)
---. ...+..+.||+.|+|||++...+|+..+|.|||||+||||+.|++||+..+++. +.+. +.
T Consensus 500 ni~~--~~TTkTFCGTPdYiAPEIi~YqPYgksvDWWa~GVLLyEmlaGQpPFdGeDE~e--lF~a------------I~ 563 (683)
T KOG0696|consen 500 NIFD--GVTTKTFCGTPDYIAPEIIAYQPYGKSVDWWAFGVLLYEMLAGQPPFDGEDEDE--LFQA------------IM 563 (683)
T ss_pred cccC--CcceeeecCCCcccccceEEecccccchhHHHHHHHHHHHHcCCCCCCCCCHHH--HHHH------------HH
Confidence 3222 233456899999999999999999999999999999999999999998765432 2111 11
Q ss_pred CcccCCCCCHHHHHHHHHHHHHchhhcccCCC
Q 045315 395 DPISQNGASYPILKRYINVALLCVQEKAADRP 426 (476)
Q Consensus 395 d~~~~~~~~~~~~~~l~~li~~Cl~~dP~~RP 426 (476)
+.. -.++.....+.+.+....+...|.+|.
T Consensus 564 ehn--vsyPKslSkEAv~ickg~ltK~P~kRL 593 (683)
T KOG0696|consen 564 EHN--VSYPKSLSKEAVAICKGLLTKHPGKRL 593 (683)
T ss_pred Hcc--CcCcccccHHHHHHHHHHhhcCCcccc
Confidence 111 123344556778888888999999984
|
|
| >KOG1006 consensus Mitogen-activated protein kinase (MAPK) kinase MKK4 [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.87 E-value=1.1e-23 Score=194.44 Aligned_cols=181 Identities=23% Similarity=0.297 Sum_probs=136.7
Q ss_pred ccccceeeccCC----------CCCCCCCCChhhHHHHHHHHHHHHHHHhhcCCCceeecCCCccceEecCCCCceeccc
Q 045315 240 KDEISFWYESYN----------NPTKKGLLCWGTRVRIIEGIAQGLLYLHQYSRLRVIHRDLKASNILLDKDMNPKISDF 309 (476)
Q Consensus 240 ~~~~~l~~Ey~~----------~~~~~~~L~~~~~~~i~~qIa~gL~yLH~~~~~~ivH~DLkp~NILld~~~~~kL~DF 309 (476)
.|+|-+.||.|. ...++..++++-.-.|+...+.||.||.+. ..|||||+||+|||+|..|.+|||||
T Consensus 135 EGdcWiCMELMd~SlDklYk~vy~vq~~~ipE~Ilg~ItvatV~AL~yLK~~--lkiIHRDvKPSNILldr~G~vKLCDF 212 (361)
T KOG1006|consen 135 EGDCWICMELMDISLDKLYKRVYSVQKSRIPENILGHITVATVDALDYLKEE--LKIIHRDVKPSNILLDRHGDVKLCDF 212 (361)
T ss_pred CCceeeeHHHHhhhHHHHHHHHHHHHhccCcHhhhhheeeeehhHHHHHHHH--hhhhhccCChhheEEecCCCEeeecc
Confidence 478999999887 123456788888888888899999999874 36999999999999999999999999
Q ss_pred cceeecCCCcccccceeeeeccCCCChhhhc--cCCCCccceEEeehhhhhhhhhCCCCCCcCCCCchhhhhhhhhhhcC
Q 045315 310 GMARMFGGDELQSNTKRIVGTYGYMSPEYAL--RGLFSIKSDVFSFGVLLLETLSSKKNTHFYNTDSLTLLGHAWNLWND 387 (476)
Q Consensus 310 Gla~~~~~~~~~~~~~~~~gt~~y~aPE~l~--~~~~s~ksDVwSlGvvl~elltG~~p~~~~~~~~~~~~~~~~~~~~~ 387 (476)
|.+..+.... ..+...|...|||||.+. ...|..+|||||||+.|+|+.||+.|+...+.. .++... ...
T Consensus 213 GIcGqLv~Si---AkT~daGCrpYmAPERi~p~~~gyDiRSDvWSLGITL~EvAtG~fPyr~w~sv----feql~~-Vv~ 284 (361)
T KOG1006|consen 213 GICGQLVDSI---AKTVDAGCRPYMAPERIDPSDKGYDIRSDVWSLGITLYEVATGNFPYRKWDSV----FEQLCQ-VVI 284 (361)
T ss_pred cchHhHHHHH---HhhhccCCccccChhccCCccCCcchhhhhhhhcceEeeeecCCCCcchHHHH----HHHHHH-HHc
Confidence 9987654322 122356889999999986 345899999999999999999999998765432 222211 222
Q ss_pred CCcccccCcccCCCCCHHHHHHHHHHHHHchhhcccCCCCHHHHHHH
Q 045315 388 GRTWELMDPISQNGASYPILKRYINVALLCVQEKAADRPAMSEVVSM 434 (476)
Q Consensus 388 ~~~~~~~d~~~~~~~~~~~~~~l~~li~~Cl~~dP~~RPt~~eVl~~ 434 (476)
|....+.. +....+....+++++..|+.+|.++||...++.++
T Consensus 285 gdpp~l~~----~~~~~~~s~~~~~fintCl~Kd~~~Rpky~~Lk~~ 327 (361)
T KOG1006|consen 285 GDPPILLF----DKECVHYSFSMVRFINTCLIKDRSDRPKYDDLKKF 327 (361)
T ss_pred CCCCeecC----cccccccCHHHHHHHHHHhhcccccCcchhhhhcC
Confidence 33322222 12234456778999999999999999999988754
|
|
| >KOG4257 consensus Focal adhesion tyrosine kinase FAK, contains FERM domain [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.87 E-value=8.7e-23 Score=206.97 Aligned_cols=178 Identities=25% Similarity=0.296 Sum_probs=141.9
Q ss_pred cceeeccCC-------CCCCCCCCChhhHHHHHHHHHHHHHHHhhcCCCceeecCCCccceEecCCCCceeccccceeec
Q 045315 243 ISFWYESYN-------NPTKKGLLCWGTRVRIIEGIAQGLLYLHQYSRLRVIHRDLKASNILLDKDMNPKISDFGMARMF 315 (476)
Q Consensus 243 ~~l~~Ey~~-------~~~~~~~L~~~~~~~i~~qIa~gL~yLH~~~~~~ivH~DLkp~NILld~~~~~kL~DFGla~~~ 315 (476)
.-++||.++ -..++..|+......++.||+.||+|||++. .|||||...|||+.....+||+|||+++.+
T Consensus 465 ~WivmEL~~~GELr~yLq~nk~sL~l~tL~ly~~Qi~talaYLeSkr---fVHRDIAaRNiLVsSp~CVKLaDFGLSR~~ 541 (974)
T KOG4257|consen 465 MWIVMELAPLGELREYLQQNKDSLPLRTLTLYCYQICTALAYLESKR---FVHRDIAARNILVSSPQCVKLADFGLSRYL 541 (974)
T ss_pred eeEEEecccchhHHHHHHhccccchHHHHHHHHHHHHHHHHHHHhhc---hhhhhhhhhheeecCcceeeecccchhhhc
Confidence 447788777 2345678999999999999999999999998 999999999999999999999999999988
Q ss_pred CCCcccccceeeeeccCCCChhhhccCCCCccceEEeehhhhhhhhh-CCCCCCcCC-CCchhhhhhhhhhhcCCCcccc
Q 045315 316 GGDELQSNTKRIVGTYGYMSPEYALRGLFSIKSDVFSFGVLLLETLS-SKKNTHFYN-TDSLTLLGHAWNLWNDGRTWEL 393 (476)
Q Consensus 316 ~~~~~~~~~~~~~gt~~y~aPE~l~~~~~s~ksDVwSlGvvl~ellt-G~~p~~~~~-~~~~~~~~~~~~~~~~~~~~~~ 393 (476)
......... ...-+..|||||-+.-..++.++|||-|||++||++. |.+||.... .+.+. .+..|.
T Consensus 542 ed~~yYkaS-~~kLPIKWmaPESINfRrFTtASDVWMFgVCmWEIl~lGvkPfqgvkNsDVI~-------~iEnGe---- 609 (974)
T KOG4257|consen 542 EDDAYYKAS-RGKLPIKWMAPESINFRRFTTASDVWMFGVCMWEILSLGVKPFQGVKNSDVIG-------HIENGE---- 609 (974)
T ss_pred cccchhhcc-ccccceeecCccccchhcccchhhHHHHHHHHHHHHHhcCCccccccccceEE-------EecCCC----
Confidence 765443322 3445678999999999999999999999999999865 889987643 22221 112222
Q ss_pred cCcccCCCCCHHHHHHHHHHHHHchhhcccCCCCHHHHHHHHhcccc
Q 045315 394 MDPISQNGASYPILKRYINVALLCVQEKAADRPAMSEVVSMLSNEFV 440 (476)
Q Consensus 394 ~d~~~~~~~~~~~~~~l~~li~~Cl~~dP~~RPt~~eVl~~L~~~~~ 440 (476)
+.+.+...+..+..++.+||+.||.+||.+.++...|+.+..
T Consensus 610 -----RlP~P~nCPp~LYslmskcWayeP~kRPrftei~~~lsdv~q 651 (974)
T KOG4257|consen 610 -----RLPCPPNCPPALYSLMSKCWAYEPSKRPRFTEIKAILSDVLQ 651 (974)
T ss_pred -----CCCCCCCCChHHHHHHHHHhccCcccCCcHHHHHHHHHHHHH
Confidence 223344456788899999999999999999999988877653
|
|
| >KOG3653 consensus Transforming growth factor beta/activin receptor subfamily of serine/threonine kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.86 E-value=2.7e-22 Score=198.43 Aligned_cols=194 Identities=24% Similarity=0.313 Sum_probs=142.1
Q ss_pred ccceeeccCCCCC-----CCCCCChhhHHHHHHHHHHHHHHHhhcC------CCceeecCCCccceEecCCCCceecccc
Q 045315 242 EISFWYESYNNPT-----KKGLLCWGTRVRIIEGIAQGLLYLHQYS------RLRVIHRDLKASNILLDKDMNPKISDFG 310 (476)
Q Consensus 242 ~~~l~~Ey~~~~~-----~~~~L~~~~~~~i~~qIa~gL~yLH~~~------~~~ivH~DLkp~NILld~~~~~kL~DFG 310 (476)
+..+++||.+.+. +...++|.+..+|+..+++||+|||+.- +++|+|||||.+||||..++.+.|+|||
T Consensus 282 eywLVt~fh~kGsL~dyL~~ntisw~~~cria~SmarGLa~LHee~p~~d~~Kp~IaHRDlkSkNVLvK~DlTccIaDFG 361 (534)
T KOG3653|consen 282 EYWLVTEFHPKGSLCDYLKANTISWNSLCRIAESMARGLAHLHEELPRGDHHKPPIAHRDLKSKNVLVKNDLTCCIADFG 361 (534)
T ss_pred ceeEEeeeccCCcHHHHHHhccccHHHHHHHHHHHHHHHHHhcccCCcCCCCCCccccccccccceEEccCCcEEeeccc
Confidence 5678889988543 4567999999999999999999999743 5789999999999999999999999999
Q ss_pred ceeecCCCcccccceeeeeccCCCChhhhccCC-CC-----ccceEEeehhhhhhhhhCCCCCCcCCCCc--hhhhhh--
Q 045315 311 MARMFGGDELQSNTKRIVGTYGYMSPEYALRGL-FS-----IKSDVFSFGVLLLETLSSKKNTHFYNTDS--LTLLGH-- 380 (476)
Q Consensus 311 la~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~-~s-----~ksDVwSlGvvl~elltG~~p~~~~~~~~--~~~~~~-- 380 (476)
+|..+............+||.+|||||++.+.. +. .+.||||+|.|+||+++...-+....... ..+...
T Consensus 362 LAl~~~p~~~~~d~~~qVGT~RYMAPEvLEgainl~d~~Afkr~DvYamgLVLWEi~SRC~~~~~~~vp~Yqlpfe~evG 441 (534)
T KOG3653|consen 362 LALRLEPGKPQGDTHGQVGTRRYMAPEVLEGAINLQDRDAFKRIDVYAMGLVLWEIASRCTDADPGPVPEYQLPFEAEVG 441 (534)
T ss_pred eeEEecCCCCCcchhhhhhhhhhcCHHHHhhhcccccHHHHHHHHHHHHHHHHHHHHhhcccccCCCCCcccCchhHHhc
Confidence 999987766666666689999999999997532 22 46999999999999998776543211110 011101
Q ss_pred -------hhhh-hcCCCcccccCcccCCCCCHHHHHHHHHHHHHchhhcccCCCCHHHHHHHHhccc
Q 045315 381 -------AWNL-WNDGRTWELMDPISQNGASYPILKRYINVALLCVQEKAADRPAMSEVVSMLSNEF 439 (476)
Q Consensus 381 -------~~~~-~~~~~~~~~~d~~~~~~~~~~~~~~l~~li~~Cl~~dP~~RPt~~eVl~~L~~~~ 439 (476)
.+.. ..++....+.+.-. ....+..+++.+..||..||+.|.|+.=|-+++..+.
T Consensus 442 ~hPt~e~mq~~VV~kK~RP~~p~~W~----~h~~~~~l~et~EeCWDhDaeARLTA~Cv~eR~~~l~ 504 (534)
T KOG3653|consen 442 NHPTLEEMQELVVRKKQRPKIPDAWR----KHAGMAVLCETIEECWDHDAEARLTAGCVEERMAELM 504 (534)
T ss_pred CCCCHHHHHHHHHhhccCCCChhhhh----cCccHHHHHHHHHHHcCCchhhhhhhHHHHHHHHHHh
Confidence 1111 11111111111111 1234667889999999999999999999988888765
|
|
| >cd05581 STKc_PDK1 Catalytic domain of the Protein Serine/Threonine Kinase, Phosphoinositide-dependent kinase 1 | Back alignment and domain information |
|---|
Probab=99.86 E-value=3e-22 Score=194.91 Aligned_cols=174 Identities=27% Similarity=0.308 Sum_probs=133.0
Q ss_pred cccceeeccCCCC------CCCCCCChhhHHHHHHHHHHHHHHHhhcCCCceeecCCCccceEecCCCCceeccccceee
Q 045315 241 DEISFWYESYNNP------TKKGLLCWGTRVRIIEGIAQGLLYLHQYSRLRVIHRDLKASNILLDKDMNPKISDFGMARM 314 (476)
Q Consensus 241 ~~~~l~~Ey~~~~------~~~~~L~~~~~~~i~~qIa~gL~yLH~~~~~~ivH~DLkp~NILld~~~~~kL~DFGla~~ 314 (476)
+..+++|||++.. .+.+.+++.++..++.|++.||+|||+.+ ++|+||+|+||+++.++.++|+|||++..
T Consensus 75 ~~~~lv~e~~~~~~L~~~l~~~~~l~~~~~~~i~~ql~~~l~~Lh~~~---~~H~dl~~~ni~i~~~~~~~l~df~~~~~ 151 (280)
T cd05581 75 ENLYFVLEYAPNGELLQYIRKYGSLDEKCTRFYAAEILLALEYLHSKG---IIHRDLKPENILLDKDMHIKITDFGTAKV 151 (280)
T ss_pred ceEEEEEcCCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCC---eeecCCCHHHeEECCCCCEEecCCccccc
Confidence 4678899999632 23447999999999999999999999998 99999999999999999999999999987
Q ss_pred cCCCccc------------------ccceeeeeccCCCChhhhccCCCCccceEEeehhhhhhhhhCCCCCCcCCCCchh
Q 045315 315 FGGDELQ------------------SNTKRIVGTYGYMSPEYALRGLFSIKSDVFSFGVLLLETLSSKKNTHFYNTDSLT 376 (476)
Q Consensus 315 ~~~~~~~------------------~~~~~~~gt~~y~aPE~l~~~~~s~ksDVwSlGvvl~elltG~~p~~~~~~~~~~ 376 (476)
....... .......++..|+|||......++.++|+||||++++++++|+.|+...... .
T Consensus 152 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Pe~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~--~ 229 (280)
T cd05581 152 LDPNSSPESNKGDATNIDSQIEKNRRRFASFVGTAEYVSPELLNEKPAGKSSDLWALGCIIYQMLTGKPPFRGSNEY--L 229 (280)
T ss_pred cCCccccccCCCCCccccccccccccccccccCCccccCHHHhCCCCCChhhhHHHHHHHHHHHHhCCCCCCCccHH--H
Confidence 6543211 1223345788999999998888999999999999999999999998644311 1
Q ss_pred hhhhhhhhhcCCCcccccCcccCCCCCHHHHHHHHHHHHHchhhcccCCCCH----HHHHH
Q 045315 377 LLGHAWNLWNDGRTWELMDPISQNGASYPILKRYINVALLCVQEKAADRPAM----SEVVS 433 (476)
Q Consensus 377 ~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~l~~li~~Cl~~dP~~RPt~----~eVl~ 433 (476)
... ... .. ....+....+.+.+++.+||+.+|.+||++ +++++
T Consensus 230 ~~~---~~~-~~----------~~~~~~~~~~~~~~li~~~l~~~p~~R~~~~~~~~~ll~ 276 (280)
T cd05581 230 TFQ---KIL-KL----------EYSFPPNFPPDAKDLIEKLLVLDPQDRLGVNEGYDELKA 276 (280)
T ss_pred HHH---HHH-hc----------CCCCCCccCHHHHHHHHHHhcCCHhhCCCcccCHHHHhc
Confidence 110 000 00 001112224678899999999999999999 66653
|
Serine/Threonine Kinases (STKs), Phosphoinositide-dependent kinase 1 (PDK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PDK1 carries an N-terminal catalytic domain and a C-terminal pleckstrin homology (PH) domain that binds phosphoinositides. It phosphorylates the activation loop of AGC kinases that are regulated by PI3K such as PKB, SGK, and PKC, among others, and is crucial for their activation. Thus, it contributes in regulating many processes including metabolism, growth, proliferation, and survival. PDK1 also has the ability to auto |
| >cd07880 STKc_p38gamma_MAPK12 Catalytic domain of the Serine/Threonine Kinase, p38gamma Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Probab=99.86 E-value=1.2e-22 Score=205.01 Aligned_cols=187 Identities=21% Similarity=0.225 Sum_probs=130.2
Q ss_pred cceeeccCCC----CCCCCCCChhhHHHHHHHHHHHHHHHhhcCCCceeecCCCccceEecCCCCceeccccceeecCCC
Q 045315 243 ISFWYESYNN----PTKKGLLCWGTRVRIIEGIAQGLLYLHQYSRLRVIHRDLKASNILLDKDMNPKISDFGMARMFGGD 318 (476)
Q Consensus 243 ~~l~~Ey~~~----~~~~~~L~~~~~~~i~~qIa~gL~yLH~~~~~~ivH~DLkp~NILld~~~~~kL~DFGla~~~~~~ 318 (476)
.++++||+.. ......+++..+..++.||++||+|||+.+ |+||||||+||+++.++.+||+|||++......
T Consensus 95 ~~lv~e~~~~~l~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~g---i~H~dlkp~Nill~~~~~~kl~dfg~~~~~~~~ 171 (343)
T cd07880 95 FYLVMPFMGTDLGKLMKHEKLSEDRIQFLVYQMLKGLKYIHAAG---IIHRDLKPGNLAVNEDCELKILDFGLARQTDSE 171 (343)
T ss_pred EEEEEecCCCCHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCCHHHEEEcCCCCEEEeecccccccccC
Confidence 4677888751 112457999999999999999999999998 999999999999999999999999999865432
Q ss_pred cccccceeeeeccCCCChhhhcc-CCCCccceEEeehhhhhhhhhCCCCCCcCCCCchhhhhhh----------hhhhcC
Q 045315 319 ELQSNTKRIVGTYGYMSPEYALR-GLFSIKSDVFSFGVLLLETLSSKKNTHFYNTDSLTLLGHA----------WNLWND 387 (476)
Q Consensus 319 ~~~~~~~~~~gt~~y~aPE~l~~-~~~s~ksDVwSlGvvl~elltG~~p~~~~~~~~~~~~~~~----------~~~~~~ 387 (476)
.....++..|+|||.+.+ ..++.++|+||||+++|++++|+.||........ ..... ...+..
T Consensus 172 -----~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~ll~~l~~g~~pf~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~ 245 (343)
T cd07880 172 -----MTGYVVTRWYRAPEVILNWMHYTQTVDIWSVGCIMAEMLTGKPLFKGHDHLDQ-LMEIMKVTGTPSKEFVQKLQS 245 (343)
T ss_pred -----ccccccCCcccCHHHHhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHH-HHHHHHhcCCCCHHHHHhhcc
Confidence 122456889999999876 4588999999999999999999999864331100 00000 000000
Q ss_pred CCcccccC--cccC----CCCCHHHHHHHHHHHHHchhhcccCCCCHHHHH--HHHhcc
Q 045315 388 GRTWELMD--PISQ----NGASYPILKRYINVALLCVQEKAADRPAMSEVV--SMLSNE 438 (476)
Q Consensus 388 ~~~~~~~d--~~~~----~~~~~~~~~~l~~li~~Cl~~dP~~RPt~~eVl--~~L~~~ 438 (476)
........ +... ..........+.+++.+|++.||++|||+.+++ ..++..
T Consensus 246 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~R~t~~~~l~~~~~~~~ 304 (343)
T cd07880 246 EDAKNYVKKLPRFRKKDFRSLLPNANPLAVNVLEKMLVLDAESRITAAEALAHPYFEEF 304 (343)
T ss_pred hhHHHHHHhccccCcchHHHhccCCChHHHHHHHHHcCCChhhCCCHHHHhcCccHhhh
Confidence 00000000 0000 000112234688999999999999999999998 345554
|
Serine/Threonine Kinases (STKs), p38gamma subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38gamma subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38gamma, also called MAPK12 |
| >KOG0579 consensus Ste20-like serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.86 E-value=2.7e-22 Score=203.39 Aligned_cols=174 Identities=22% Similarity=0.342 Sum_probs=133.7
Q ss_pred ccceeeccCCCC-------CCCCCCChhhHHHHHHHHHHHHHHHhhcCCCceeecCCCccceEecCCCCceeccccceee
Q 045315 242 EISFWYESYNNP-------TKKGLLCWGTRVRIIEGIAQGLLYLHQYSRLRVIHRDLKASNILLDKDMNPKISDFGMARM 314 (476)
Q Consensus 242 ~~~l~~Ey~~~~-------~~~~~L~~~~~~~i~~qIa~gL~yLH~~~~~~ivH~DLkp~NILld~~~~~kL~DFGla~~ 314 (476)
.+-+..||+.++ .....|...++.-+++|++.||.|||+++ |||||||+.|||+.-+|.++|+|||++..
T Consensus 103 kLwiliEFC~GGAVDaimlEL~r~LtE~QIqvvc~q~ldALn~LHs~~---iIHRDLKAGNiL~TldGdirLADFGVSAK 179 (1187)
T KOG0579|consen 103 KLWILIEFCGGGAVDAIMLELGRVLTEDQIQVVCYQVLDALNWLHSQN---IIHRDLKAGNILLTLDGDIRLADFGVSAK 179 (1187)
T ss_pred ceEEEEeecCCchHhHHHHHhccccchHHHHHHHHHHHHHHHHHhhcc---hhhhhccccceEEEecCcEeeeccccccc
Confidence 344556888843 24678999999999999999999999999 99999999999999999999999999864
Q ss_pred cCCCcccccceeeeeccCCCChhhhc-----cCCCCccceEEeehhhhhhhhhCCCCCCcCCCCchhhhhhhhhhhcCCC
Q 045315 315 FGGDELQSNTKRIVGTYGYMSPEYAL-----RGLFSIKSDVFSFGVLLLETLSSKKNTHFYNTDSLTLLGHAWNLWNDGR 389 (476)
Q Consensus 315 ~~~~~~~~~~~~~~gt~~y~aPE~l~-----~~~~s~ksDVwSlGvvl~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~ 389 (476)
... .......+.||++|||||+.+ ..+|..++||||||+.|.||..+.+|....+... +.-.+....
T Consensus 180 n~~--t~qkRDsFIGTPYWMAPEVvmCET~KD~PYDykaDiWSlGITLIEMAqiEPPHhelnpMR------VllKiaKSe 251 (1187)
T KOG0579|consen 180 NKS--TRQKRDSFIGTPYWMAPEVVMCETFKDQPYDYKADIWSLGITLIEMAQIEPPHHELNPMR------VLLKIAKSE 251 (1187)
T ss_pred chh--HHhhhccccCCcccccchheeeccccCCCchhhhhHHhhhhHHHHHhccCCCccccchHH------HHHHHhhcC
Confidence 322 223344589999999999875 5789999999999999999999999865433211 111111222
Q ss_pred cccccCcccCCCCCHHHHHHHHHHHHHchhhcccCCCCHHHHHH
Q 045315 390 TWELMDPISQNGASYPILKRYINVALLCVQEKAADRPAMSEVVS 433 (476)
Q Consensus 390 ~~~~~d~~~~~~~~~~~~~~l~~li~~Cl~~dP~~RPt~~eVl~ 433 (476)
...++.| ..-...+.+++.+||..||..||+++++++
T Consensus 252 PPTLlqP-------S~Ws~~F~DfLk~cL~Knp~~Rp~aaqll~ 288 (1187)
T KOG0579|consen 252 PPTLLQP-------SHWSRSFSDFLKRCLVKNPRNRPPAAQLLK 288 (1187)
T ss_pred CCcccCc-------chhhhHHHHHHHHHHhcCCccCCCHHHHhh
Confidence 2222222 233457889999999999999999999864
|
|
| >KOG0614 consensus cGMP-dependent protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.86 E-value=1.9e-22 Score=200.52 Aligned_cols=155 Identities=25% Similarity=0.330 Sum_probs=127.2
Q ss_pred CCCCCCCChhhHHHHHHHHHHHHHHHhhcCCCceeecCCCccceEecCCCCceeccccceeecCCCcccccceeeeeccC
Q 045315 253 PTKKGLLCWGTRVRIIEGIAQGLLYLHQYSRLRVIHRDLKASNILLDKDMNPKISDFGMARMFGGDELQSNTKRIVGTYG 332 (476)
Q Consensus 253 ~~~~~~L~~~~~~~i~~qIa~gL~yLH~~~~~~ivH~DLkp~NILld~~~~~kL~DFGla~~~~~~~~~~~~~~~~gt~~ 332 (476)
.++++.++..+..-++..+++|++|||+++ ||+|||||+|.++|.+|-+||.|||+|+.++.. ..+..+.||+.
T Consensus 511 LrdRg~Fdd~tarF~~acv~EAfeYLH~k~---iIYRDLKPENllLd~~Gy~KLVDFGFAKki~~g---~KTwTFcGTpE 584 (732)
T KOG0614|consen 511 LRDRGSFDDYTARFYVACVLEAFEYLHRKG---IIYRDLKPENLLLDNRGYLKLVDFGFAKKIGSG---RKTWTFCGTPE 584 (732)
T ss_pred hhhcCCcccchhhhhHHHHHHHHHHHHhcC---ceeccCChhheeeccCCceEEeehhhHHHhccC---CceeeecCCcc
Confidence 367889999999999999999999999999 999999999999999999999999999988754 35667899999
Q ss_pred CCChhhhccCCCCccceEEeehhhhhhhhhCCCCCCcCCCCchhhhhhhhhhhcCCCcccccCcccCCCCCHHHHHHHHH
Q 045315 333 YMSPEYALRGLFSIKSDVFSFGVLLLETLSSKKNTHFYNTDSLTLLGHAWNLWNDGRTWELMDPISQNGASYPILKRYIN 412 (476)
Q Consensus 333 y~aPE~l~~~~~s~ksDVwSlGvvl~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~l~~ 412 (476)
|.|||++.+.....++|.||||+++|||++|.+||...+.... +..+..| +|. -..+....+...+
T Consensus 585 YVAPEIILnKGHD~avDyWaLGIli~ELL~G~pPFs~~dpmkt------Yn~ILkG-----id~---i~~Pr~I~k~a~~ 650 (732)
T KOG0614|consen 585 YVAPEIILNKGHDRAVDYWALGILIYELLTGSPPFSGVDPMKT------YNLILKG-----IDK---IEFPRRITKTATD 650 (732)
T ss_pred cccchhhhccCcchhhHHHHHHHHHHHHHcCCCCCCCCchHHH------HHHHHhh-----hhh---hhcccccchhHHH
Confidence 9999999999999999999999999999999999986653221 1111111 111 1123344567888
Q ss_pred HHHHchhhcccCCCC
Q 045315 413 VALLCVQEKAADRPA 427 (476)
Q Consensus 413 li~~Cl~~dP~~RPt 427 (476)
++++.+..+|.+|.-
T Consensus 651 Lik~LCr~~P~ERLG 665 (732)
T KOG0614|consen 651 LIKKLCRDNPTERLG 665 (732)
T ss_pred HHHHHHhcCcHhhhc
Confidence 999999999999975
|
|
| >cd07877 STKc_p38alpha_MAPK14 Catalytic domain of the Serine/Threonine Kinase, p38alpha Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Probab=99.86 E-value=2.4e-22 Score=203.02 Aligned_cols=169 Identities=21% Similarity=0.241 Sum_probs=120.2
Q ss_pred CCCChhhHHHHHHHHHHHHHHHhhcCCCceeecCCCccceEecCCCCceeccccceeecCCCcccccceeeeeccCCCCh
Q 045315 257 GLLCWGTRVRIIEGIAQGLLYLHQYSRLRVIHRDLKASNILLDKDMNPKISDFGMARMFGGDELQSNTKRIVGTYGYMSP 336 (476)
Q Consensus 257 ~~L~~~~~~~i~~qIa~gL~yLH~~~~~~ivH~DLkp~NILld~~~~~kL~DFGla~~~~~~~~~~~~~~~~gt~~y~aP 336 (476)
..+++..+..++.||++||+|||+.+ ++||||||+||+++.++.+||+|||+++..... .....++..|+||
T Consensus 115 ~~l~~~~~~~i~~qi~~aL~~LH~~~---ivH~dlkp~NIll~~~~~~kl~dfg~~~~~~~~-----~~~~~~~~~y~aP 186 (345)
T cd07877 115 QKLTDDHVQFLIYQILRGLKYIHSAD---IIHRDLKPSNLAVNEDCELKILDFGLARHTDDE-----MTGYVATRWYRAP 186 (345)
T ss_pred CCCCHHHHHHHHHHHHHHHHHHHHCC---eeecCCChHHEEEcCCCCEEEeccccccccccc-----ccccccCCCccCH
Confidence 46899999999999999999999998 999999999999999999999999998764322 1224578899999
Q ss_pred hhhcc-CCCCccceEEeehhhhhhhhhCCCCCCcCCCCchhhhhhhhhh----------hcCCCcc---cccCcccCC--
Q 045315 337 EYALR-GLFSIKSDVFSFGVLLLETLSSKKNTHFYNTDSLTLLGHAWNL----------WNDGRTW---ELMDPISQN-- 400 (476)
Q Consensus 337 E~l~~-~~~s~ksDVwSlGvvl~elltG~~p~~~~~~~~~~~~~~~~~~----------~~~~~~~---~~~d~~~~~-- 400 (476)
|.+.+ ..++.++|||||||++|||++|+.||....... .+....... ....... ..+......
T Consensus 187 E~~~~~~~~~~~~DvwslG~il~el~~g~~pf~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 265 (345)
T cd07877 187 EIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHID-QLKLILRLVGTPGAELLKKISSESARNYIQSLTQMPKMNF 265 (345)
T ss_pred HHHhCccCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHH-HHHHHHHHhCCCCHHHHhhcccHhHHHHHHHhcccCCcch
Confidence 98866 568899999999999999999999986433111 000000000 0000000 000000000
Q ss_pred -CCCHHHHHHHHHHHHHchhhcccCCCCHHHHHHH
Q 045315 401 -GASYPILKRYINVALLCVQEKAADRPAMSEVVSM 434 (476)
Q Consensus 401 -~~~~~~~~~l~~li~~Cl~~dP~~RPt~~eVl~~ 434 (476)
.........+.+++.+|++.||.+||++.+++..
T Consensus 266 ~~~~~~~~~~~~~li~~~L~~dp~~R~t~~e~l~h 300 (345)
T cd07877 266 ANVFIGANPLAVDLLEKMLVLDSDKRITAAQALAH 300 (345)
T ss_pred hhhcCCCCHHHHHHHHHHcCCChhhcCCHHHHhcC
Confidence 0000123567899999999999999999998764
|
Serine/Threonine Kinases (STKs), p38alpha subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38alpha subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38alpha, also called MAPK14 |
| >KOG0199 consensus ACK and related non-receptor tyrosine kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.86 E-value=2.3e-22 Score=206.28 Aligned_cols=176 Identities=24% Similarity=0.310 Sum_probs=137.1
Q ss_pred ccceeeccCC--------CCCCCCCCChhhHHHHHHHHHHHHHHHhhcCCCceeecCCCccceEecCCCCceecccccee
Q 045315 242 EISFWYESYN--------NPTKKGLLCWGTRVRIIEGIAQGLLYLHQYSRLRVIHRDLKASNILLDKDMNPKISDFGMAR 313 (476)
Q Consensus 242 ~~~l~~Ey~~--------~~~~~~~L~~~~~~~i~~qIa~gL~yLH~~~~~~ivH~DLkp~NILld~~~~~kL~DFGla~ 313 (476)
...+|+|.++ ...++..|-......++.|||.|+.||.+++ +|||||...|+||.....+||+|||+.+
T Consensus 184 p~mMV~ELaplGSLldrLrka~~~~llv~~Lcdya~QiA~aM~YLeskr---lvHRDLAARNlllasprtVKI~DFGLmR 260 (1039)
T KOG0199|consen 184 PAMMVFELAPLGSLLDRLRKAKKAILLVSRLCDYAMQIAKAMQYLESKR---LVHRDLAARNLLLASPRTVKICDFGLMR 260 (1039)
T ss_pred hhhHHhhhcccchHHHHHhhccccceeHHHHHHHHHHHHHHHHHHhhhh---hhhhhhhhhhheecccceeeeeccccee
Confidence 4667777776 2246778889999999999999999999998 9999999999999999999999999999
Q ss_pred ecCCCcccc-cceeeeeccCCCChhhhccCCCCccceEEeehhhhhhhhh-CCCCCCcCCCCchhhhhhhhhhhcCCCcc
Q 045315 314 MFGGDELQS-NTKRIVGTYGYMSPEYALRGLFSIKSDVFSFGVLLLETLS-SKKNTHFYNTDSLTLLGHAWNLWNDGRTW 391 (476)
Q Consensus 314 ~~~~~~~~~-~~~~~~gt~~y~aPE~l~~~~~s~ksDVwSlGvvl~ellt-G~~p~~~~~~~~~~~~~~~~~~~~~~~~~ 391 (476)
.++..+... ......-.+.|+|||.+....++.++|||+|||.||||++ |..||..... ..+ .
T Consensus 261 aLg~ned~Yvm~p~rkvPfAWCaPEsLrh~kFShaSDvWmyGVTiWEMFtyGEePW~G~~g--~qI-------------L 325 (1039)
T KOG0199|consen 261 ALGENEDMYVMAPQRKVPFAWCAPESLRHRKFSHASDVWMYGVTIWEMFTYGEEPWVGCRG--IQI-------------L 325 (1039)
T ss_pred ccCCCCcceEecCCCcCcccccCHhHhccccccccchhhhhhhhHHhhhccCCCCCCCCCH--HHH-------------H
Confidence 887654322 1222234678999999999999999999999999999998 5556654321 111 1
Q ss_pred cccCcccCCCCCHHHHHHHHHHHHHchhhcccCCCCHHHHHHHH
Q 045315 392 ELMDPISQNGASYPILKRYINVALLCVQEKAADRPAMSEVVSML 435 (476)
Q Consensus 392 ~~~d~~~~~~~~~~~~~~l~~li~~Cl~~dP~~RPt~~eVl~~L 435 (476)
+.+|....-..+....+++.++++.||..+|++|||+..|.+.+
T Consensus 326 ~~iD~~erLpRPk~csedIY~imk~cWah~paDRptFsair~~~ 369 (1039)
T KOG0199|consen 326 KNIDAGERLPRPKYCSEDIYQIMKNCWAHNPADRPTFSAIREDL 369 (1039)
T ss_pred HhccccccCCCCCCChHHHHHHHHHhccCCccccccHHHHHHhH
Confidence 22332222334556678999999999999999999999997443
|
|
| >cd05123 STKc_AGC Catalytic domain of AGC family Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=99.86 E-value=7.2e-22 Score=189.12 Aligned_cols=169 Identities=25% Similarity=0.287 Sum_probs=130.1
Q ss_pred cccceeeccCCCCC------CCCCCChhhHHHHHHHHHHHHHHHhhcCCCceeecCCCccceEecCCCCceeccccceee
Q 045315 241 DEISFWYESYNNPT------KKGLLCWGTRVRIIEGIAQGLLYLHQYSRLRVIHRDLKASNILLDKDMNPKISDFGMARM 314 (476)
Q Consensus 241 ~~~~l~~Ey~~~~~------~~~~L~~~~~~~i~~qIa~gL~yLH~~~~~~ivH~DLkp~NILld~~~~~kL~DFGla~~ 314 (476)
+..+++|||++... ....+++..+..++.|+++||.|||+.+ ++|+||+|+||+++.++.++|+|||++..
T Consensus 66 ~~~~~v~e~~~~~~L~~~l~~~~~l~~~~~~~~~~qi~~~l~~lh~~~---~~H~~l~p~ni~~~~~~~~~l~d~~~~~~ 142 (250)
T cd05123 66 EKLYLVLEYAPGGELFSHLSKEGRFSEERARFYAAEIVLALEYLHSLG---IIYRDLKPENILLDADGHIKLTDFGLAKE 142 (250)
T ss_pred CeeEEEEecCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCC---ceecCCCcceEEEcCCCcEEEeecCccee
Confidence 46788999996321 2346899999999999999999999988 99999999999999999999999999987
Q ss_pred cCCCcccccceeeeeccCCCChhhhccCCCCccceEEeehhhhhhhhhCCCCCCcCCCCchhhhhhhhhhhcCCCccccc
Q 045315 315 FGGDELQSNTKRIVGTYGYMSPEYALRGLFSIKSDVFSFGVLLLETLSSKKNTHFYNTDSLTLLGHAWNLWNDGRTWELM 394 (476)
Q Consensus 315 ~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~s~ksDVwSlGvvl~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 394 (476)
...... ......++..|++||...+...+.++|+||||+++|++++|+.||..... ....... . ...
T Consensus 143 ~~~~~~--~~~~~~~~~~~~~Pe~~~~~~~~~~~D~~slG~~~~~l~~g~~p~~~~~~--~~~~~~~---~-~~~----- 209 (250)
T cd05123 143 LSSEGS--RTNTFCGTPEYLAPEVLLGKGYGKAVDWWSLGVLLYEMLTGKPPFYAEDR--KEIYEKI---L-KDP----- 209 (250)
T ss_pred cccCCC--cccCCcCCccccChHHhCCCCCCchhhHHHHHHHHHHHHHCCCCCCCCCH--HHHHHHH---h-cCC-----
Confidence 644321 12235678899999999888889999999999999999999999854332 1111111 0 000
Q ss_pred CcccCCCCCHHHHHHHHHHHHHchhhcccCCCCHHH
Q 045315 395 DPISQNGASYPILKRYINVALLCVQEKAADRPAMSE 430 (476)
Q Consensus 395 d~~~~~~~~~~~~~~l~~li~~Cl~~dP~~RPt~~e 430 (476)
...+......+.+++.+||..||++||++.+
T Consensus 210 -----~~~~~~~~~~l~~~i~~~l~~~p~~R~~~~~ 240 (250)
T cd05123 210 -----LRFPEFLSPEARDLISGLLQKDPTKRLGSGG 240 (250)
T ss_pred -----CCCCCCCCHHHHHHHHHHhcCCHhhCCCccc
Confidence 0111112467889999999999999999954
|
Serine/Threonine Kinases (STKs), AGC (Protein Kinases A, G and C) family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The AGC family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and Phosphoinositide 3-Kinase (PI3K). Members of this family include cAMP-dependent Protein Kinase (PKA), cGMP-dependent Protein Kinase (PKG), Protein Kinase C (PKC), Protein Kinase B (PKB), G protein-coupled Receptor Kinase (GRK), Serum- and Glucocorticoid-induced Kinase (SGK), and 70 kDa ribosomal Protein S6 Kinase (p70S6K or S6K), among others. AGC kinases share an activation mechanism based on the phosphorylation of up to three sites: the activation loop (A-loop), the hydrophobic motif (HM) and the |
| >cd07856 STKc_Sty1_Hog1 Catalytic domain of the Serine/Threonine Kinases, Fungal Mitogen-Activated Protein Kinases Sty1 and Hog1 | Back alignment and domain information |
|---|
Probab=99.85 E-value=4.6e-22 Score=199.51 Aligned_cols=185 Identities=23% Similarity=0.292 Sum_probs=129.2
Q ss_pred ccceeeccCCCC----CCCCCCChhhHHHHHHHHHHHHHHHhhcCCCceeecCCCccceEecCCCCceeccccceeecCC
Q 045315 242 EISFWYESYNNP----TKKGLLCWGTRVRIIEGIAQGLLYLHQYSRLRVIHRDLKASNILLDKDMNPKISDFGMARMFGG 317 (476)
Q Consensus 242 ~~~l~~Ey~~~~----~~~~~L~~~~~~~i~~qIa~gL~yLH~~~~~~ivH~DLkp~NILld~~~~~kL~DFGla~~~~~ 317 (476)
.+++++||+... .+...++...+..++.|+++||+|||+.+ ++|+||+|+||+++.++.+||+|||++.....
T Consensus 84 ~~~lv~e~~~~~L~~~~~~~~~~~~~~~~~~~ql~~aL~~LH~~~---iiH~dl~p~Nili~~~~~~~l~dfg~~~~~~~ 160 (328)
T cd07856 84 DIYFVTELLGTDLHRLLTSRPLEKQFIQYFLYQILRGLKYVHSAG---VVHRDLKPSNILINENCDLKICDFGLARIQDP 160 (328)
T ss_pred cEEEEeehhccCHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCC---cccCCCCHHHEeECCCCCEEeCccccccccCC
Confidence 567888887621 12456888899999999999999999998 99999999999999999999999999875432
Q ss_pred CcccccceeeeeccCCCChhhhcc-CCCCccceEEeehhhhhhhhhCCCCCCcCCCCc-hhhh-hh-------hhhhhcC
Q 045315 318 DELQSNTKRIVGTYGYMSPEYALR-GLFSIKSDVFSFGVLLLETLSSKKNTHFYNTDS-LTLL-GH-------AWNLWND 387 (476)
Q Consensus 318 ~~~~~~~~~~~gt~~y~aPE~l~~-~~~s~ksDVwSlGvvl~elltG~~p~~~~~~~~-~~~~-~~-------~~~~~~~ 387 (476)
. .....++..|+|||.+.+ ..++.++|+||||+++|++++|+.||....... .... .. .......
T Consensus 161 ~-----~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~el~tg~~~f~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 235 (328)
T cd07856 161 Q-----MTGYVSTRYYRAPEIMLTWQKYDVEVDIWSAGCIFAEMLEGKPLFPGKDHVNQFSIITDLLGTPPDDVINTICS 235 (328)
T ss_pred C-----cCCCcccccccCceeeeccCCcCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCHHHHHhccc
Confidence 1 122356788999998765 568999999999999999999999986543110 0000 00 0000000
Q ss_pred CCcccccCcc-cCCCCC-----HHHHHHHHHHHHHchhhcccCCCCHHHHHHH
Q 045315 388 GRTWELMDPI-SQNGAS-----YPILKRYINVALLCVQEKAADRPAMSEVVSM 434 (476)
Q Consensus 388 ~~~~~~~d~~-~~~~~~-----~~~~~~l~~li~~Cl~~dP~~RPt~~eVl~~ 434 (476)
....+++... .....+ ......+.+++.+||+.+|++||++++++..
T Consensus 236 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~t~~ell~~ 288 (328)
T cd07856 236 ENTLRFVQSLPKREPVPFSEKFKNADPSAIDLLEKMLVFDPQKRISAAEALAH 288 (328)
T ss_pred hhhHHHHhhccccCCCcHHHHcCCCCHHHHHHHHHHcCCChhhCCCHHHHhcC
Confidence 0000110000 000001 1123678899999999999999999998765
|
Serine/Threonine Kinases (STKs), Fungal Mitogen-Activated Protein Kinase (MAPK) Sty1/Hog1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sty1/Hog1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the MAPKs Sty1 from Schizosaccharomyces pombe, Hog1 from Saccharomyces cerevisiae, and similar proteins. MAPKs are important mediators of cellular responses to extracellular signals. Sty1 and Hog1 are stress-activated MAPKs that partipate in transcriptional regulation in response to stress. Sty1 is activated in response to oxidative stress, osmotic stress, and U |
| >KOG4717 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.85 E-value=1e-21 Score=195.47 Aligned_cols=158 Identities=24% Similarity=0.349 Sum_probs=128.7
Q ss_pred CCCCCChhhHHHHHHHHHHHHHHHhhcCCCceeecCCCccceEe-cCCCCceeccccceeecCCCcccccceeeeeccCC
Q 045315 255 KKGLLCWGTRVRIIEGIAQGLLYLHQYSRLRVIHRDLKASNILL-DKDMNPKISDFGMARMFGGDELQSNTKRIVGTYGY 333 (476)
Q Consensus 255 ~~~~L~~~~~~~i~~qIa~gL~yLH~~~~~~ivH~DLkp~NILl-d~~~~~kL~DFGla~~~~~~~~~~~~~~~~gt~~y 333 (476)
+.+.|++..+.++++||+.|+.|+|+.. +|||||||+|+.+ .+-|.+||.|||++..+.... ......|...|
T Consensus 111 He~Gl~E~La~kYF~QI~~AI~YCHqLH---VVHRDLKPENVVFFEKlGlVKLTDFGFSNkf~PG~---kL~TsCGSLAY 184 (864)
T KOG4717|consen 111 HEEGLNEDLAKKYFAQIVHAISYCHQLH---VVHRDLKPENVVFFEKLGLVKLTDFGFSNKFQPGK---KLTTSCGSLAY 184 (864)
T ss_pred hhccccHHHHHHHHHHHHHHHHHHhhhh---hhcccCCcceeEEeeecCceEeeeccccccCCCcc---hhhcccchhhc
Confidence 4567999999999999999999999987 9999999999866 567889999999998776543 23346899999
Q ss_pred CChhhhccCCCC-ccceEEeehhhhhhhhhCCCCCCcCCCCchhhhhhhhhhhcCCCcccccCcccCCCCCHHHHHHHHH
Q 045315 334 MSPEYALRGLFS-IKSDVFSFGVLLLETLSSKKNTHFYNTDSLTLLGHAWNLWNDGRTWELMDPISQNGASYPILKRYIN 412 (476)
Q Consensus 334 ~aPE~l~~~~~s-~ksDVwSlGvvl~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~l~~ 412 (476)
.|||++.+..|. ++.|||||||+||-|+||++||...+... .+ ..++|. .-..+.....+|.+
T Consensus 185 SAPEILLGDsYDAPAVDiWSLGVILyMLVCGq~PFqeANDSE-TL-------------TmImDC--KYtvPshvS~eCrd 248 (864)
T KOG4717|consen 185 SAPEILLGDSYDAPAVDIWSLGVILYMLVCGQPPFQEANDSE-TL-------------TMIMDC--KYTVPSHVSKECRD 248 (864)
T ss_pred cCchhhhcCccCCcchhhhHHHHHHHHHHhCCCccccccchh-hh-------------hhhhcc--cccCchhhhHHHHH
Confidence 999999998885 68999999999999999999997554211 11 122222 12335567789999
Q ss_pred HHHHchhhcccCCCCHHHHHHH
Q 045315 413 VALLCVQEKAADRPAMSEVVSM 434 (476)
Q Consensus 413 li~~Cl~~dP~~RPt~~eVl~~ 434 (476)
+|..||..||.+|.+.+||+..
T Consensus 249 LI~sMLvRdPkkRAslEeI~s~ 270 (864)
T KOG4717|consen 249 LIQSMLVRDPKKRASLEEIVST 270 (864)
T ss_pred HHHHHHhcCchhhccHHHHhcc
Confidence 9999999999999999999853
|
|
| >KOG0200 consensus Fibroblast/platelet-derived growth factor receptor and related receptor tyrosine kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.85 E-value=8.7e-22 Score=212.30 Aligned_cols=181 Identities=26% Similarity=0.371 Sum_probs=136.5
Q ss_pred cccceeeccCCCCC-------CC---------------CCCChhhHHHHHHHHHHHHHHHhhcCCCceeecCCCccceEe
Q 045315 241 DEISFWYESYNNPT-------KK---------------GLLCWGTRVRIIEGIAQGLLYLHQYSRLRVIHRDLKASNILL 298 (476)
Q Consensus 241 ~~~~l~~Ey~~~~~-------~~---------------~~L~~~~~~~i~~qIa~gL~yLH~~~~~~ivH~DLkp~NILl 298 (476)
+..+++.||+..+. ++ ..|+..+.+.++.|||.|++||++.. +|||||-++|||+
T Consensus 375 ~~~~~v~Ey~~~G~L~~~Lr~~r~~~~~~~~~~~~~~~~~L~~~dLlsfa~QIa~GMe~L~~~~---~vHRDLAaRNVLi 451 (609)
T KOG0200|consen 375 GPLYVIVEYAEHGDLLEFLRKKRVTESIDGSGVFPNERDALTTKDLLSFAYQIANGMEYLASVP---CVHRDLAARNVLI 451 (609)
T ss_pred CceEEEEEeccCCcHHHHHHhccccccccccCCCccccCCcCHHHHHHHHHHHHHHHHHHhhCC---ccchhhhhhhEEe
Confidence 45677889988321 12 24999999999999999999999998 9999999999999
Q ss_pred cCCCCceeccccceeecCCCcccccceeee--eccCCCChhhhccCCCCccceEEeehhhhhhhhh-CCCCCCcCCCCch
Q 045315 299 DKDMNPKISDFGMARMFGGDELQSNTKRIV--GTYGYMSPEYALRGLFSIKSDVFSFGVLLLETLS-SKKNTHFYNTDSL 375 (476)
Q Consensus 299 d~~~~~kL~DFGla~~~~~~~~~~~~~~~~--gt~~y~aPE~l~~~~~s~ksDVwSlGvvl~ellt-G~~p~~~~~~~~~ 375 (476)
.++..+||+|||+|+............ -. -+..|||||.+....|+.|+|||||||++|||++ |..|++.... ..
T Consensus 452 ~~~~~~kIaDFGlar~~~~~~~y~~~~-~~~~LP~kWmApEsl~~~~ft~kSDVWSfGI~L~EifsLG~~PYp~~~~-~~ 529 (609)
T KOG0200|consen 452 TKNKVIKIADFGLARDHYNKDYYRTKS-SAGTLPVKWMAPESLFDRVFTSKSDVWSFGILLWEIFTLGGTPYPGIPP-TE 529 (609)
T ss_pred cCCCEEEEccccceeccCCCCceEecC-CCCccceeecCHHHhccCcccccchhhHHHHHHHHHhhCCCCCCCCCCc-HH
Confidence 999999999999999654433222111 11 2456999999999999999999999999999998 5556543111 11
Q ss_pred hhhhhhhhhhcCCCcccccCcccCCCCCHHHHHHHHHHHHHchhhcccCCCCHHHHHHHHhccc
Q 045315 376 TLLGHAWNLWNDGRTWELMDPISQNGASYPILKRYINVALLCVQEKAADRPAMSEVVSMLSNEF 439 (476)
Q Consensus 376 ~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~l~~li~~Cl~~dP~~RPt~~eVl~~L~~~~ 439 (476)
.+ .+...+|...+. +.....++.++|+.||+.+|++||++.++++.|+..+
T Consensus 530 ~l----~~~l~~G~r~~~---------P~~c~~eiY~iM~~CW~~~p~~RP~F~~~~~~~~~~l 580 (609)
T KOG0200|consen 530 EL----LEFLKEGNRMEQ---------PEHCSDEIYDLMKSCWNADPEDRPTFSECVEFFEKHL 580 (609)
T ss_pred HH----HHHHhcCCCCCC---------CCCCCHHHHHHHHHHhCCCcccCCCHHHHHHHHHHHH
Confidence 11 223334433222 2223467889999999999999999999999999954
|
|
| >smart00220 S_TKc Serine/Threonine protein kinases, catalytic domain | Back alignment and domain information |
|---|
Probab=99.85 E-value=1.5e-21 Score=184.76 Aligned_cols=175 Identities=29% Similarity=0.345 Sum_probs=132.1
Q ss_pred cccceeeccCCCCC------CCCCCChhhHHHHHHHHHHHHHHHhhcCCCceeecCCCccceEecCCCCceeccccceee
Q 045315 241 DEISFWYESYNNPT------KKGLLCWGTRVRIIEGIAQGLLYLHQYSRLRVIHRDLKASNILLDKDMNPKISDFGMARM 314 (476)
Q Consensus 241 ~~~~l~~Ey~~~~~------~~~~L~~~~~~~i~~qIa~gL~yLH~~~~~~ivH~DLkp~NILld~~~~~kL~DFGla~~ 314 (476)
+..++++||++... ....+++..+..++.+++.++.|||+.+ ++|+||+|+||+++.++.++|+|||.+..
T Consensus 60 ~~~~l~~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~---i~h~~i~~~ni~~~~~~~~~l~d~~~~~~ 136 (244)
T smart00220 60 DKLYLVMEYCDGGDLFDLLKKRGRLSEDEARFYARQILSALEYLHSNG---IIHRDLKPENILLDEDGHVKLADFGLARQ 136 (244)
T ss_pred CEEEEEEeCCCCCCHHHHHHhccCCCHHHHHHHHHHHHHHHHHHHHcC---eecCCcCHHHeEECCCCcEEEccccceee
Confidence 45778888887422 2223899999999999999999999998 99999999999999999999999999987
Q ss_pred cCCCcccccceeeeeccCCCChhhhccCCCCccceEEeehhhhhhhhhCCCCCCcCCCCchhhhhhhhhhhcCCCccccc
Q 045315 315 FGGDELQSNTKRIVGTYGYMSPEYALRGLFSIKSDVFSFGVLLLETLSSKKNTHFYNTDSLTLLGHAWNLWNDGRTWELM 394 (476)
Q Consensus 315 ~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~s~ksDVwSlGvvl~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 394 (476)
..... ......++..|++||.+....++.++|+|+||++++++++|..|+...... ..... ....+....
T Consensus 137 ~~~~~---~~~~~~~~~~~~~pE~~~~~~~~~~~Di~slG~~l~~l~~~~~p~~~~~~~-~~~~~----~~~~~~~~~-- 206 (244)
T smart00220 137 LDPGG---LLTTFVGTPEYMAPEVLLGKGYGKAVDVWSLGVILYELLTGKPPFPGDDQL-LELFK----KIGKPKPPF-- 206 (244)
T ss_pred ecccc---ccccccCCcCCCCHHHHccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCcH-HHHHH----HHhccCCCC--
Confidence 65432 122345788999999998888899999999999999999999988642211 11111 111111100
Q ss_pred CcccCCCCCHHHHHHHHHHHHHchhhcccCCCCHHHHHH
Q 045315 395 DPISQNGASYPILKRYINVALLCVQEKAADRPAMSEVVS 433 (476)
Q Consensus 395 d~~~~~~~~~~~~~~l~~li~~Cl~~dP~~RPt~~eVl~ 433 (476)
..........+.+++.+|+..+|++||++.++++
T Consensus 207 -----~~~~~~~~~~~~~~i~~~l~~~p~~Rp~~~~~~~ 240 (244)
T smart00220 207 -----PPPEWKISPEAKDLIRKLLVKDPEKRLTAEEALQ 240 (244)
T ss_pred -----ccccccCCHHHHHHHHHHccCCchhccCHHHHhh
Confidence 0000003357889999999999999999999986
|
Phosphotransferases. Serine or threonine-specific kinase subfamily. |
| >KOG0669 consensus Cyclin T-dependent kinase CDK9 [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=99.84 E-value=2.8e-21 Score=177.38 Aligned_cols=190 Identities=19% Similarity=0.344 Sum_probs=134.6
Q ss_pred cccceeeccCC------CCCCCCCCChhhHHHHHHHHHHHHHHHhhcCCCceeecCCCccceEecCCCCceeccccceee
Q 045315 241 DEISFWYESYN------NPTKKGLLCWGTRVRIIEGIAQGLLYLHQYSRLRVIHRDLKASNILLDKDMNPKISDFGMARM 314 (476)
Q Consensus 241 ~~~~l~~Ey~~------~~~~~~~L~~~~~~~i~~qIa~gL~yLH~~~~~~ivH~DLkp~NILld~~~~~kL~DFGla~~ 314 (476)
...++|+++++ -....-+++..++.++..++..||.|+|... |+|||+|++|+|++.++.+||+|||+++.
T Consensus 97 ~t~ylVf~~cehDLaGlLsn~~vr~sls~Ikk~Mk~Lm~GL~~iHr~k---ilHRDmKaaNvLIt~dgilklADFGlar~ 173 (376)
T KOG0669|consen 97 ATFYLVFDFCEHDLAGLLSNRKVRFSLSEIKKVMKGLMNGLYYIHRNK---ILHRDMKAANVLITKDGILKLADFGLARA 173 (376)
T ss_pred ceeeeeHHHhhhhHHHHhcCccccccHHHHHHHHHHHHHHHHHHHHhh---HHhhcccHhhEEEcCCceEEeeccccccc
Confidence 45788998887 2234567999999999999999999999988 99999999999999999999999999987
Q ss_pred cCCC--cccccceeeeeccCCCChhhhcc-CCCCccceEEeehhhhhhhhhCCCCCCcCCCC-chhhhhhh-----hhhh
Q 045315 315 FGGD--ELQSNTKRIVGTYGYMSPEYALR-GLFSIKSDVFSFGVLLLETLSSKKNTHFYNTD-SLTLLGHA-----WNLW 385 (476)
Q Consensus 315 ~~~~--~~~~~~~~~~gt~~y~aPE~l~~-~~~s~ksDVwSlGvvl~elltG~~p~~~~~~~-~~~~~~~~-----~~~~ 385 (476)
+... .........+-|..|++||.+.+ ..|+++.|+|+.||++.||+++.+.+....+. ...++... .+.|
T Consensus 174 fs~~~n~~kprytnrvvTLwYrppEllLG~r~yg~~iDiWgAgCimaeMwtrspimqgnteqqql~~Is~LcGs~tkevW 253 (376)
T KOG0669|consen 174 FSTSKNVVKPRYTNRVVTLWYRPPELLLGDREYGPPIDIWGAGCIMAEMWTRSPIMQGNTEQQQLHLISQLCGSITKEVW 253 (376)
T ss_pred eecccccCCCCcccceeeeecCCHHHhhcccccCCcchhHhHHHHHHHHHccCccccCChHHHHHHHHHHHhccCCcccC
Confidence 6432 12222233556899999999986 56899999999999999999999887654321 11111111 1111
Q ss_pred cC---CCccccc--CcccCCC--CCHHH------HHHHHHHHHHchhhcccCCCCHHHHHH
Q 045315 386 ND---GRTWELM--DPISQNG--ASYPI------LKRYINVALLCVQEKAADRPAMSEVVS 433 (476)
Q Consensus 386 ~~---~~~~~~~--d~~~~~~--~~~~~------~~~l~~li~~Cl~~dP~~RPt~~eVl~ 433 (476)
.+ -...+.+ .|..... .-.+. ....++++.+++..||.+|+++.+++.
T Consensus 254 P~~d~lpL~~sie~ePl~~~~~rkv~n~~kp~~kd~~a~dLle~ll~~DP~kR~~ad~aln 314 (376)
T KOG0669|consen 254 PNVDNLPLYQSIELEPLPKGQKRKVKNRLKPYVKDDEALDLLEKLLKLDPTKRIDADQALN 314 (376)
T ss_pred CCcccchHHHhccCCCCCcchhhhhhhhcccccCChhHHHHHHHHhccCcccCcchHhhhc
Confidence 11 1111111 1100000 00111 236778999999999999999998764
|
|
| >KOG0665 consensus Jun-N-terminal kinase (JNK) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.84 E-value=1.3e-21 Score=185.20 Aligned_cols=203 Identities=22% Similarity=0.180 Sum_probs=143.2
Q ss_pred ccceeeccCCCC---CCCCCCChhhHHHHHHHHHHHHHHHhhcCCCceeecCCCccceEecCCCCceeccccceeecCCC
Q 045315 242 EISFWYESYNNP---TKKGLLCWGTRVRIIEGIAQGLLYLHQYSRLRVIHRDLKASNILLDKDMNPKISDFGMARMFGGD 318 (476)
Q Consensus 242 ~~~l~~Ey~~~~---~~~~~L~~~~~~~i~~qIa~gL~yLH~~~~~~ivH~DLkp~NILld~~~~~kL~DFGla~~~~~~ 318 (476)
+.+++||||... .-.-.++-++...|..|++.|++|||+.+ |+||||||+||++..+..+||.|||+|+.....
T Consensus 95 e~y~v~e~m~~nl~~vi~~elDH~tis~i~yq~~~~ik~lhs~~---IihRdLkPsnivv~~~~~lKi~dfg~ar~e~~~ 171 (369)
T KOG0665|consen 95 EVYLVMELMDANLCQVILMELDHETISYILYQMLCGIKHLHSAG---IIHRDLKPSNIVVNSDCTLKILDFGLARTEDTD 171 (369)
T ss_pred hHHHHHHhhhhHHHHHHHHhcchHHHHHHHHHHHHHHHHHHhcc---eeecccCcccceecchhheeeccchhhcccCcc
Confidence 688999999821 11246788899999999999999999999 999999999999999999999999999865433
Q ss_pred cccccceeeeeccCCCChhhhccCCCCccceEEeehhhhhhhhhCCCCCCcCC-CCchhhhh----------------hh
Q 045315 319 ELQSNTKRIVGTYGYMSPEYALRGLFSIKSDVFSFGVLLLETLSSKKNTHFYN-TDSLTLLG----------------HA 381 (476)
Q Consensus 319 ~~~~~~~~~~gt~~y~aPE~l~~~~~s~ksDVwSlGvvl~elltG~~p~~~~~-~~~~~~~~----------------~~ 381 (476)
...+..+.+..|.|||++.+..+.+.+||||.||++.||+.|+--|...+ .++..... .+
T Consensus 172 ---~~mtpyVvtRyyrapevil~~~~ke~vdiwSvGci~gEli~~~Vlf~g~d~idQ~~ki~~~lgtpd~~F~~qL~~~~ 248 (369)
T KOG0665|consen 172 ---FMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGELILGTVLFPGKDHIDQWNKIIEQLGTPDPSFMKQLQPTV 248 (369)
T ss_pred ---cccCchhheeeccCchheeccCCcccchhhhhhhHHHHHhhceEEecCchHHHHHHHHHHHhcCCCHHHHHHhhHHH
Confidence 23445678999999999998889999999999999999999998776543 11111110 01
Q ss_pred hhhhcCC------Cccc-ccCcccCC--CCCHHHHHHHHHHHHHchhhcccCCCCHHHHHHH--Hhc--cccCCCCCCCC
Q 045315 382 WNLWNDG------RTWE-LMDPISQN--GASYPILKRYINVALLCVQEKAADRPAMSEVVSM--LSN--EFVNLPAPQQP 448 (476)
Q Consensus 382 ~~~~~~~------~~~~-~~d~~~~~--~~~~~~~~~l~~li~~Cl~~dP~~RPt~~eVl~~--L~~--~~~~~~~p~~p 448 (476)
....... ...+ +.|..... +.+......+.+++.+||-.+|++|.++.++++. ++- ...+++.|++|
T Consensus 249 r~yv~~~~~y~~~~f~~~fpD~~f~~~~e~~~~~~~~ardll~~MLvi~pe~Risv~daL~HPY~~vw~~~~ev~ap~pe 328 (369)
T KOG0665|consen 249 RNYVENRPQYQAISFSELFPDSLFPVVLEGSKLDCSLARDLLSKMLVIDPEKRISVDDALRHPYIKVWYDPDEVEAPPPE 328 (369)
T ss_pred HHHhhcChHhhccchhhhCCcccccccccCCccchHHHHHHHHHhhccChhhcccHHHHhcCCeeeeecccccccCCCCc
Confidence 1111100 0000 11111110 1112234567789999999999999999999874 330 12356677776
Q ss_pred cc
Q 045315 449 AF 450 (476)
Q Consensus 449 ~~ 450 (476)
.+
T Consensus 329 ~~ 330 (369)
T KOG0665|consen 329 IY 330 (369)
T ss_pred hh
Confidence 44
|
|
| >KOG2052 consensus Activin A type IB receptor, serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.84 E-value=2.4e-21 Score=190.47 Aligned_cols=193 Identities=22% Similarity=0.267 Sum_probs=140.6
Q ss_pred ccceeeccCCCCC-----CCCCCChhhHHHHHHHHHHHHHHHhh-----cCCCceeecCCCccceEecCCCCceeccccc
Q 045315 242 EISFWYESYNNPT-----KKGLLCWGTRVRIIEGIAQGLLYLHQ-----YSRLRVIHRDLKASNILLDKDMNPKISDFGM 311 (476)
Q Consensus 242 ~~~l~~Ey~~~~~-----~~~~L~~~~~~~i~~qIa~gL~yLH~-----~~~~~ivH~DLkp~NILld~~~~~kL~DFGl 311 (476)
...++.+|.+.++ ++..++-+..++++..+|.||+|||. +|++.|.|||||+.|||+.+++.+.|+|+|+
T Consensus 283 QLwLvTdYHe~GSL~DyL~r~tv~~~~ml~LalS~AsGLaHLH~eI~GTqgKPaIAHRDlKSKNILVKkn~~C~IADLGL 362 (513)
T KOG2052|consen 283 QLWLVTDYHEHGSLYDYLNRNTVTTEGMLKLALSIASGLAHLHMEIVGTQGKPAIAHRDLKSKNILVKKNGTCCIADLGL 362 (513)
T ss_pred EEEEeeecccCCcHHHHHhhccCCHHHHHHHHHHHhhhHHHHHHHHhcCCCCchhhccccccccEEEccCCcEEEeecee
Confidence 4678899999543 46789999999999999999999994 6788999999999999999999999999999
Q ss_pred eeecCCC--cccccceeeeeccCCCChhhhccCC----C-C-ccceEEeehhhhhhhhhCC----------CCCCcCCCC
Q 045315 312 ARMFGGD--ELQSNTKRIVGTYGYMSPEYALRGL----F-S-IKSDVFSFGVLLLETLSSK----------KNTHFYNTD 373 (476)
Q Consensus 312 a~~~~~~--~~~~~~~~~~gt~~y~aPE~l~~~~----~-s-~ksDVwSlGvvl~elltG~----------~p~~~~~~~ 373 (476)
|...... .........+||.+|||||++.+.. + + ..+||||||+|+||+.... .||...-..
T Consensus 363 Av~h~~~t~~idi~~N~rVGTKRYMAPEvLdetin~~~Fesyk~ADIYafgLVlWEiarRc~~ggi~eey~~Pyyd~Vp~ 442 (513)
T KOG2052|consen 363 AVRHDSDTDTIDIPPNPRVGTKRYMAPEVLDETINMKHFESYKRADIYAFGLVLWEIARRCESGGIVEEYQLPYYDVVPS 442 (513)
T ss_pred eEEecccCCcccCCCCCccceeeccChHHhhhhcChhhhhhhhHHHHHHHHHHHHHHHHHhhcCCEehhhcCCcccCCCC
Confidence 9876543 2333445578999999999996532 2 1 4699999999999997532 233221111
Q ss_pred chhhhhhhhhhhcCCCcccccCcccC-CCCCHHHHHHHHHHHHHchhhcccCCCCHHHHHHHHhccc
Q 045315 374 SLTLLGHAWNLWNDGRTWELMDPISQ-NGASYPILKRYINVALLCVQEKAADRPAMSEVVSMLSNEF 439 (476)
Q Consensus 374 ~~~~~~~~~~~~~~~~~~~~~d~~~~-~~~~~~~~~~l~~li~~Cl~~dP~~RPt~~eVl~~L~~~~ 439 (476)
+..+.+ ..... ..+-+.|.+. .-.+.+.+..+.++|..||..+|.-|-|+-.|.+.|.++.
T Consensus 443 DPs~ee-MrkVV----Cv~~~RP~ipnrW~s~~~l~~m~klMkeCW~~Np~aRltALriKKtl~~l~ 504 (513)
T KOG2052|consen 443 DPSFEE-MRKVV----CVQKLRPNIPNRWKSDPALRVMAKLMKECWYANPAARLTALRIKKTLAKLS 504 (513)
T ss_pred CCCHHH-Hhcce----eecccCCCCCcccccCHHHHHHHHHHHHhhcCCchhhhHHHHHHHHHHHHh
Confidence 111110 00000 0011112111 1234567888999999999999999999999999998876
|
|
| >KOG0586 consensus Serine/threonine protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=99.83 E-value=2.4e-21 Score=197.55 Aligned_cols=170 Identities=22% Similarity=0.294 Sum_probs=135.2
Q ss_pred cccceeeccCCCC------CCCCCCChhhHHHHHHHHHHHHHHHhhcCCCceeecCCCccceEecCCCCceeccccceee
Q 045315 241 DEISFWYESYNNP------TKKGLLCWGTRVRIIEGIAQGLLYLHQYSRLRVIHRDLKASNILLDKDMNPKISDFGMARM 314 (476)
Q Consensus 241 ~~~~l~~Ey~~~~------~~~~~L~~~~~~~i~~qIa~gL~yLH~~~~~~ivH~DLkp~NILld~~~~~kL~DFGla~~ 314 (476)
...++||||.... .+.+.+...++..++.|+..|++|||+++ |||||||++||||+.+.++||+|||++..
T Consensus 128 ~~lylV~eya~~ge~~~yl~~~gr~~e~~ar~~F~q~vsaveYcH~k~---ivHrdLk~eNilL~~~mnikIaDfgfS~~ 204 (596)
T KOG0586|consen 128 ATLYLVMEYASGGELFDYLVKHGRMKEKEARAKFRQIVSAVEYCHSKN---IVHRDLKAENILLDENMNIKIADFGFSTF 204 (596)
T ss_pred ceeEEEEEeccCchhHHHHHhcccchhhhhhhhhHHHHHHHHHHhhcc---eeccccchhhcccccccceeeecccccee
Confidence 5789999998732 24556777899999999999999999999 99999999999999999999999999998
Q ss_pred cCCCcccccceeeeeccCCCChhhhccCCC-CccceEEeehhhhhhhhhCCCCCCcCCCCchhhhhhhhhhhcCCCcccc
Q 045315 315 FGGDELQSNTKRIVGTYGYMSPEYALRGLF-SIKSDVFSFGVLLLETLSSKKNTHFYNTDSLTLLGHAWNLWNDGRTWEL 393 (476)
Q Consensus 315 ~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~-s~ksDVwSlGvvl~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~ 393 (476)
+.... ......|++.|.|||++.+..| .++.|+||+|+++|-|++|..||+...-. ++
T Consensus 205 ~~~~~---~lqt~cgsppyAaPEl~~g~~y~gpe~D~Wslgvvly~LV~GsLPFDG~~lk------------------~L 263 (596)
T KOG0586|consen 205 FDYGL---MLQTFCGSPPYAAPELFNGKKYDGPEVDIWSLGVVLYALVEGSLPFDGQNLK------------------EL 263 (596)
T ss_pred ecccc---cccccCCCCCccChHhhcCcccCCcceehhhhhhhheeeeecccccCCcccc------------------cc
Confidence 87443 2334689999999999998776 68999999999999999999999754311 11
Q ss_pred cCcccCCC--CCHHHHHHHHHHHHHchhhcccCCCCHHHHHHH
Q 045315 394 MDPISQNG--ASYPILKRYINVALLCVQEKAADRPAMSEVVSM 434 (476)
Q Consensus 394 ~d~~~~~~--~~~~~~~~l~~li~~Cl~~dP~~RPt~~eVl~~ 434 (476)
-++.+... .+......|.++++++|-.+|.+|++++++.+.
T Consensus 264 r~rvl~gk~rIp~~ms~dce~lLrk~lvl~Pskr~~~dqim~~ 306 (596)
T KOG0586|consen 264 RPRVLRGKYRIPFYMSCDCEDLLRKFLVLNPSKRGPCDQIMKD 306 (596)
T ss_pred cchheeeeecccceeechhHHHHHHhhccCccccCCHHHhhhh
Confidence 11111111 122234568899999999999999999998653
|
|
| >KOG0612 consensus Rho-associated, coiled-coil containing protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.83 E-value=7.3e-21 Score=204.51 Aligned_cols=196 Identities=21% Similarity=0.229 Sum_probs=141.2
Q ss_pred cccceeeccCCCC------CCCCCCChhhHHHHHHHHHHHHHHHhhcCCCceeecCCCccceEecCCCCceeccccceee
Q 045315 241 DEISFWYESYNNP------TKKGLLCWGTRVRIIEGIAQGLLYLHQYSRLRVIHRDLKASNILLDKDMNPKISDFGMARM 314 (476)
Q Consensus 241 ~~~~l~~Ey~~~~------~~~~~L~~~~~~~i~~qIa~gL~yLH~~~~~~ivH~DLkp~NILld~~~~~kL~DFGla~~ 314 (476)
...|+|||||+++ ++..+++++-+.-++..|+.||.-||+.| +|||||||+|||||..|++||+|||.+-.
T Consensus 148 ~~LYlVMdY~pGGDlltLlSk~~~~pE~~ArFY~aEiVlAldslH~mg---yVHRDiKPDNvLld~~GHikLADFGsClk 224 (1317)
T KOG0612|consen 148 RYLYLVMDYMPGGDLLTLLSKFDRLPEDWARFYTAEIVLALDSLHSMG---YVHRDIKPDNVLLDKSGHIKLADFGSCLK 224 (1317)
T ss_pred cceEEEEecccCchHHHHHhhcCCChHHHHHHHHHHHHHHHHHHHhcc---ceeccCCcceeEecccCcEeeccchhHHh
Confidence 5689999999954 34448999999999999999999999999 99999999999999999999999999987
Q ss_pred cCCCcccccceeeeeccCCCChhhhc----c-CCCCccceEEeehhhhhhhhhCCCCCCcCCCCchhhhhhhhhhhcCCC
Q 045315 315 FGGDELQSNTKRIVGTYGYMSPEYAL----R-GLFSIKSDVFSFGVLLLETLSSKKNTHFYNTDSLTLLGHAWNLWNDGR 389 (476)
Q Consensus 315 ~~~~~~~~~~~~~~gt~~y~aPE~l~----~-~~~s~ksDVwSlGvvl~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~ 389 (476)
+..+.. ......+|||-|.+||++. + +.|++..|.||+||++|||++|.-||.... +............
T Consensus 225 m~~dG~-V~s~~aVGTPDYISPEvLqs~~~~~g~yG~ecDwWSlGV~~YEMlyG~TPFYads-----lveTY~KIm~hk~ 298 (1317)
T KOG0612|consen 225 MDADGT-VRSSVAVGTPDYISPEVLQSQGDGKGEYGRECDWWSLGVFMYEMLYGETPFYADS-----LVETYGKIMNHKE 298 (1317)
T ss_pred cCCCCc-EEeccccCCCCccCHHHHHhhcCCccccCCccchhhhHHHHHHHHcCCCcchHHH-----HHHHHHHHhchhh
Confidence 764432 2233468999999999996 2 568999999999999999999999997533 1111111122122
Q ss_pred cccccCcccCCCCCHHHHHHHHHHHHHchhhcccCCCC---HHHHHHH--Hhcc----ccCCCCCCCCcceec
Q 045315 390 TWELMDPISQNGASYPILKRYINVALLCVQEKAADRPA---MSEVVSM--LSNE----FVNLPAPQQPAFSCV 453 (476)
Q Consensus 390 ~~~~~d~~~~~~~~~~~~~~l~~li~~Cl~~dP~~RPt---~~eVl~~--L~~~----~~~~~~p~~p~~~~~ 453 (476)
...+.+ ....++...++|++.+. +|+.|.. ++++-.. ++++ ..+..+|-.|-+...
T Consensus 299 ~l~FP~-------~~~VSeeakdLI~~ll~-~~e~RLgrngiedik~HpFF~g~~W~~iR~~~pP~vPevssd 363 (1317)
T KOG0612|consen 299 SLSFPD-------ETDVSEEAKDLIEALLC-DREVRLGRNGIEDIKNHPFFEGIDWDNIRESVPPVVPEVSSD 363 (1317)
T ss_pred hcCCCc-------ccccCHHHHHHHHHHhc-ChhhhcccccHHHHHhCccccCCChhhhhhcCCCCCCcCCCC
Confidence 222221 12345677788877664 6778877 7776542 2222 124445555555433
|
|
| >KOG0695 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.83 E-value=6.4e-21 Score=181.10 Aligned_cols=171 Identities=20% Similarity=0.279 Sum_probs=130.0
Q ss_pred cccceeeccCCCC------CCCCCCChhhHHHHHHHHHHHHHHHhhcCCCceeecCCCccceEecCCCCceeccccceee
Q 045315 241 DEISFWYESYNNP------TKKGLLCWGTRVRIIEGIAQGLLYLHQYSRLRVIHRDLKASNILLDKDMNPKISDFGMARM 314 (476)
Q Consensus 241 ~~~~l~~Ey~~~~------~~~~~L~~~~~~~i~~qIa~gL~yLH~~~~~~ivH~DLkp~NILld~~~~~kL~DFGla~~ 314 (476)
...+++.||.+.+ .+..+|+++.+.-+...|+.||.|||+.| ||+||||.+|+|+|.+|.+||.|+|+++.
T Consensus 324 srlffvieyv~ggdlmfhmqrqrklpeeharfys~ei~lal~flh~rg---iiyrdlkldnvlldaeghikltdygmcke 400 (593)
T KOG0695|consen 324 SRLFFVIEYVNGGDLMFHMQRQRKLPEEHARFYSAEICLALNFLHERG---IIYRDLKLDNVLLDAEGHIKLTDYGMCKE 400 (593)
T ss_pred ceEEEEEEEecCcceeeehhhhhcCcHHHhhhhhHHHHHHHHHHhhcC---eeeeeccccceEEccCCceeecccchhhc
Confidence 3578899999833 45678999999999999999999999999 99999999999999999999999999985
Q ss_pred cCCCcccccceeeeeccCCCChhhhccCCCCccceEEeehhhhhhhhhCCCCCCcCC--CCchhhhhhhhhhhcCCCccc
Q 045315 315 FGGDELQSNTKRIVGTYGYMSPEYALRGLFSIKSDVFSFGVLLLETLSSKKNTHFYN--TDSLTLLGHAWNLWNDGRTWE 392 (476)
Q Consensus 315 ~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~s~ksDVwSlGvvl~elltG~~p~~~~~--~~~~~~~~~~~~~~~~~~~~~ 392 (476)
--. ....+..+.||+.|.|||++++..|....|.|+|||+++||+.|+.||.... ....+..++..+.+.+..+
T Consensus 401 ~l~--~gd~tstfcgtpnyiapeilrgeeygfsvdwwalgvlmfemmagrspfdivgm~n~d~ntedylfqvilekqi-- 476 (593)
T KOG0695|consen 401 GLG--PGDTTSTFCGTPNYIAPEILRGEEYGFSVDWWALGVLMFEMMAGRSPFDIVGMDNPDMNTEDYLFQVILEKQI-- 476 (593)
T ss_pred CCC--CCcccccccCCCcccchhhhcccccCceehHHHHHHHHHHHHcCCCCcceecCCCcccchhHHHHHHHhhhcc--
Confidence 322 1233456899999999999999999999999999999999999999997543 1122222222222222211
Q ss_pred ccCcccCCCCCHHHHHHHHHHHHHchhhcccCCC
Q 045315 393 LMDPISQNGASYPILKRYINVALLCVQEKAADRP 426 (476)
Q Consensus 393 ~~d~~~~~~~~~~~~~~l~~li~~Cl~~dP~~RP 426 (476)
+- +....-+...++..-|.+||.+|.
T Consensus 477 ------ri--prslsvkas~vlkgflnkdp~erl 502 (593)
T KOG0695|consen 477 ------RI--PRSLSVKASHVLKGFLNKDPKERL 502 (593)
T ss_pred ------cc--cceeehhhHHHHHHhhcCCcHHhc
Confidence 00 111122445667778889999884
|
|
| >KOG4250 consensus TANK binding protein kinase TBK1 [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.82 E-value=2.6e-20 Score=192.59 Aligned_cols=191 Identities=19% Similarity=0.235 Sum_probs=135.6
Q ss_pred cccceeeccCCCC---------CCCCCCChhhHHHHHHHHHHHHHHHhhcCCCceeecCCCccceEec--CCC--Cceec
Q 045315 241 DEISFWYESYNNP---------TKKGLLCWGTRVRIIEGIAQGLLYLHQYSRLRVIHRDLKASNILLD--KDM--NPKIS 307 (476)
Q Consensus 241 ~~~~l~~Ey~~~~---------~~~~~L~~~~~~~i~~qIa~gL~yLH~~~~~~ivH~DLkp~NILld--~~~--~~kL~ 307 (476)
..-+++|||+..+ .+...|++.+.+.++.+++.||.|||+++ |+||||||.||++- +++ ..||+
T Consensus 90 ~~~vlvmEyC~gGsL~~~L~~PEN~~GLpE~e~l~lL~d~~~al~~LrEn~---IvHRDlKP~NIvl~~Gedgq~IyKLt 166 (732)
T KOG4250|consen 90 RLPVLVMEYCSGGSLRKVLNSPENAYGLPESEFLDLLSDLVSALRHLRENG---IVHRDLKPGNIVLQIGEDGQSIYKLT 166 (732)
T ss_pred ccceEEEeecCCCcHHHHhcCcccccCCCHHHHHHHHHHHHHHHHHHHHcC---ceeccCCCCcEEEeecCCCceEEeee
Confidence 3567899999832 34557999999999999999999999999 99999999999983 333 46999
Q ss_pred cccceeecCCCcccccceeeeeccCCCChhhhc-cCCCCccceEEeehhhhhhhhhCCCCCCcCCCCchhhhhhhhhhhc
Q 045315 308 DFGMARMFGGDELQSNTKRIVGTYGYMSPEYAL-RGLFSIKSDVFSFGVLLLETLSSKKNTHFYNTDSLTLLGHAWNLWN 386 (476)
Q Consensus 308 DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~l~-~~~~s~ksDVwSlGvvl~elltG~~p~~~~~~~~~~~~~~~~~~~~ 386 (476)
|||.|+....+. ......||..|++||... .+.|+...|.|||||++|+++||..||....... +.....+....
T Consensus 167 DfG~Arel~d~s---~~~S~vGT~~YLhPel~E~q~~y~~tVDLWS~GvtlY~caTG~lPF~p~~~pk-~~~~~~~~~~t 242 (732)
T KOG4250|consen 167 DFGAARELDDNS---LFTSLVGTEEYLHPELYERQKKYTATVDLWSFGVTLYECATGELPFIPFGGPK-NNKEIMWHIIT 242 (732)
T ss_pred cccccccCCCCC---eeeeecCchhhcChHHHhhccCcCceeehhhhhhHHHHHhccCCCCCcCCCcc-ccchhhhhhhc
Confidence 999999887654 345689999999999998 4889999999999999999999999997544221 11111222211
Q ss_pred CCCccccc--Ccc------------cCCCCCHHHHHHHHHHHHHchhhcccCCC--CHHHHHHHHhcc
Q 045315 387 DGRTWELM--DPI------------SQNGASYPILKRYINVALLCVQEKAADRP--AMSEVVSMLSNE 438 (476)
Q Consensus 387 ~~~~~~~~--d~~------------~~~~~~~~~~~~l~~li~~Cl~~dP~~RP--t~~eVl~~L~~~ 438 (476)
.......+ ++. ...........++.++...++..+|++|- ...+....+..+
T Consensus 243 kkp~~v~i~~~~~eNgpv~~s~~lP~p~~Ls~~l~~~~~kwLa~~L~~~~~~~~~~~~~~~Fa~~~dI 310 (732)
T KOG4250|consen 243 KKPSGVAIGAQEEENGPVEWSSTLPQPNHLSRGLATRLTKWLASMLEWNPRKRGHEGFDRFFAEVDDI 310 (732)
T ss_pred cCCCceeEeeecccCCceeeeccCCCcccccHHHHhhhhHHHHHHHhhhHHHhCCCCcchHHHHHHHH
Confidence 11100000 000 01122334456777788888899999998 555555444443
|
|
| >KOG0984 consensus Mitogen-activated protein kinase (MAPK) kinase MKK3/MKK6 [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.82 E-value=4e-21 Score=171.78 Aligned_cols=133 Identities=29% Similarity=0.373 Sum_probs=106.6
Q ss_pred cccceeeccCC---------CCCCCCCCChhhHHHHHHHHHHHHHHHhhcCCCceeecCCCccceEecCCCCceeccccc
Q 045315 241 DEISFWYESYN---------NPTKKGLLCWGTRVRIIEGIAQGLLYLHQYSRLRVIHRDLKASNILLDKDMNPKISDFGM 311 (476)
Q Consensus 241 ~~~~l~~Ey~~---------~~~~~~~L~~~~~~~i~~qIa~gL~yLH~~~~~~ivH~DLkp~NILld~~~~~kL~DFGl 311 (476)
++.-+.||-|. -..+++.+++.-.=+|+..|..||.|||++ ..+||||+||+|||++.+|++|+||||.
T Consensus 118 gdvwIcME~M~tSldkfy~~v~~~g~~ipE~vlGkIa~Svv~al~~L~~k--L~vIHRDvKPsNiLIn~~GqVKiCDFGI 195 (282)
T KOG0984|consen 118 GDVWICMELMDTSLDKFYRKVLKKGGTIPEDVLGKIAVSVVHALEFLHSK--LSVIHRDVKPSNILINYDGQVKICDFGI 195 (282)
T ss_pred ccEEEeHHHhhhhHHHHHHHHHhcCCcCchHHhhHhHHHHHHHHHHHHHH--hhhhhccCCcceEEEccCCcEEEccccc
Confidence 34555667665 224567889999999999999999999995 4699999999999999999999999999
Q ss_pred eeecCCCcccccceeeeeccCCCChhhhc----cCCCCccceEEeehhhhhhhhhCCCCCCcCCCCchhhh
Q 045315 312 ARMFGGDELQSNTKRIVGTYGYMSPEYAL----RGLFSIKSDVFSFGVLLLETLSSKKNTHFYNTDSLTLL 378 (476)
Q Consensus 312 a~~~~~~~~~~~~~~~~gt~~y~aPE~l~----~~~~s~ksDVwSlGvvl~elltG~~p~~~~~~~~~~~~ 378 (476)
+..+.+.-. .+...|...|||||.+. ...|+.|+||||||+.+.||.+++.|++........+.
T Consensus 196 sG~L~dSiA---kt~daGCkpYmaPEri~~e~n~~gY~vksDvWSLGItmiElA~lr~PY~~w~tpF~qLk 263 (282)
T KOG0984|consen 196 SGYLVDSIA---KTMDAGCKPYMAPERINPELNQKGYSVKSDVWSLGITMIEMAILRFPYESWGTPFQQLK 263 (282)
T ss_pred ceeehhhhH---HHHhcCCCccCChhhcCcccCcccceeehhhhhhhhhhhhhhhccccccccCCHHHHHH
Confidence 987654321 11245788999999885 34799999999999999999999999876655444433
|
|
| >KOG1027 consensus Serine/threonine protein kinase and endoribonuclease ERN1/IRE1, sensor of the unfolded protein response pathway [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.82 E-value=6.4e-21 Score=199.72 Aligned_cols=153 Identities=25% Similarity=0.357 Sum_probs=117.1
Q ss_pred hhHHHHHHHHHHHHHHHhhcCCCceeecCCCccceEecC-----CCCceeccccceeecCCCcc-cccceeeeeccCCCC
Q 045315 262 GTRVRIIEGIAQGLLYLHQYSRLRVIHRDLKASNILLDK-----DMNPKISDFGMARMFGGDEL-QSNTKRIVGTYGYMS 335 (476)
Q Consensus 262 ~~~~~i~~qIa~gL~yLH~~~~~~ivH~DLkp~NILld~-----~~~~kL~DFGla~~~~~~~~-~~~~~~~~gt~~y~a 335 (476)
...+.+..|+++||++||+.+ ||||||||+||||+. ..+++|+|||+++.+..+.. ........||.+|+|
T Consensus 606 i~~~~~l~q~~~GlaHLHsl~---iVHRDLkPQNILI~~~~~~~~~ra~iSDfglsKkl~~~~sS~~r~s~~sGt~GW~A 682 (903)
T KOG1027|consen 606 IDPISVLSQIASGLAHLHSLK---IVHRDLKPQNILISVPSADGTLRAKISDFGLSKKLAGGKSSFSRLSGGSGTSGWQA 682 (903)
T ss_pred ccHHHHHHHHHHHHHHHHhcc---cccccCCCceEEEEccCCCcceeEEecccccccccCCCcchhhcccCCCCcccccC
Confidence 345788999999999999988 999999999999975 25689999999998865432 223445679999999
Q ss_pred hhhhccCCCCccceEEeehhhhhhhhhC-CCCCCcCCCCchhhhhhhhhhhcCCCcccccCcccCCCCCHHHHHHHHHHH
Q 045315 336 PEYALRGLFSIKSDVFSFGVLLLETLSS-KKNTHFYNTDSLTLLGHAWNLWNDGRTWELMDPISQNGASYPILKRYINVA 414 (476)
Q Consensus 336 PE~l~~~~~s~ksDVwSlGvvl~elltG-~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~l~~li 414 (476)
||++....-+.++||||+|||+|+.++| ..||......+.++.... .....+.+ ..+. ...++|
T Consensus 683 PE~L~~~~~~~avDiFslGCvfyYvltgG~HpFGd~~~R~~NIl~~~-------~~L~~L~~------~~d~--eA~dLI 747 (903)
T KOG1027|consen 683 PEQLREDRKTQAVDIFSLGCVFYYVLTGGSHPFGDSLERQANILTGN-------YTLVHLEP------LPDC--EAKDLI 747 (903)
T ss_pred HHHHhccccCcccchhhcCceEEEEecCCccCCCchHHhhhhhhcCc-------cceeeecc------CchH--HHHHHH
Confidence 9999988888899999999999999987 788875443333332211 11111111 1111 678999
Q ss_pred HHchhhcccCCCCHHHHH
Q 045315 415 LLCVQEKAADRPAMSEVV 432 (476)
Q Consensus 415 ~~Cl~~dP~~RPt~~eVl 432 (476)
.+|++.+|..||++.+|+
T Consensus 748 ~~ml~~dP~~RPsa~~VL 765 (903)
T KOG1027|consen 748 SRMLNPDPQLRPSATDVL 765 (903)
T ss_pred HHhcCCCcccCCCHHHHh
Confidence 999999999999999985
|
|
| >KOG1151 consensus Tousled-like protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.82 E-value=1.4e-20 Score=184.54 Aligned_cols=177 Identities=26% Similarity=0.334 Sum_probs=129.5
Q ss_pred eeeccCCCC------CCCCCCChhhHHHHHHHHHHHHHHHhhcCCCceeecCCCccceEec---CCCCceeccccceeec
Q 045315 245 FWYESYNNP------TKKGLLCWGTRVRIIEGIAQGLLYLHQYSRLRVIHRDLKASNILLD---KDMNPKISDFGMARMF 315 (476)
Q Consensus 245 l~~Ey~~~~------~~~~~L~~~~~~~i~~qIa~gL~yLH~~~~~~ivH~DLkp~NILld---~~~~~kL~DFGla~~~ 315 (476)
-|.||++.. ...+.++++++..|+.||+.||.||.+.. ++|||-||||.|||+. ..|.+||.|||+++++
T Consensus 545 TVLEYceGNDLDFYLKQhklmSEKEARSIiMQiVnAL~YLNEik-pPIIHYDLKPgNILLv~GtacGeIKITDFGLSKIM 623 (775)
T KOG1151|consen 545 TVLEYCEGNDLDFYLKQHKLMSEKEARSIIMQIVNALKYLNEIK-PPIIHYDLKPGNILLVNGTACGEIKITDFGLSKIM 623 (775)
T ss_pred eeeeecCCCchhHHHHhhhhhhHHHHHHHHHHHHHHHHHHhccC-CCeeeeccCCccEEEecCcccceeEeeecchhhhc
Confidence 456888832 34678999999999999999999999985 7799999999999995 4577899999999998
Q ss_pred CCCcccc-----cceeeeeccCCCChhhhccC----CCCccceEEeehhhhhhhhhCCCCCCcCCCCchhhhhhhhhhhc
Q 045315 316 GGDELQS-----NTKRIVGTYGYMSPEYALRG----LFSIKSDVFSFGVLLLETLSSKKNTHFYNTDSLTLLGHAWNLWN 386 (476)
Q Consensus 316 ~~~~~~~-----~~~~~~gt~~y~aPE~l~~~----~~s~ksDVwSlGvvl~elltG~~p~~~~~~~~~~~~~~~~~~~~ 386 (476)
..+.... .+....||+.|++||.+.-+ .++.|.||||.||++|+++.|++||........-+ .
T Consensus 624 dddSy~~vdGmeLTSQgAGTYWYLPPEcFvVgkePPKIsnKVDVWSvGVIFyQClYGrKPFGhnqsQQdIL--------q 695 (775)
T KOG1151|consen 624 DDDSYNSVDGMELTSQGAGTYWYLPPECFVVGKEPPKISNKVDVWSVGVIFYQCLYGRKPFGHNQSQQDIL--------Q 695 (775)
T ss_pred cCCccCcccceeeecccCceeeecCcceeecCCCCCccccceeeEeeehhhhhhhccCCCCCCchhHHHHH--------h
Confidence 7654331 23446799999999988633 47899999999999999999999997543222111 1
Q ss_pred CCCcccccCcccCCCCCHHHHHHHHHHHHHchhhcccCCCCHHHHH
Q 045315 387 DGRTWELMDPISQNGASYPILKRYINVALLCVQEKAADRPAMSEVV 432 (476)
Q Consensus 387 ~~~~~~~~d~~~~~~~~~~~~~~l~~li~~Cl~~dP~~RPt~~eVl 432 (476)
+..+...-.. .-+..+....+...+|++||++.-++|....++.
T Consensus 696 eNTIlkAtEV--qFP~KPvVsseAkaFIRRCLaYRKeDR~DV~qLA 739 (775)
T KOG1151|consen 696 ENTILKATEV--QFPPKPVVSSEAKAFIRRCLAYRKEDRIDVQQLA 739 (775)
T ss_pred hhchhcceec--cCCCCCccCHHHHHHHHHHHHhhhhhhhhHHHHc
Confidence 1111111111 1111223345678899999999999998665543
|
|
| >KOG4236 consensus Serine/threonine protein kinase PKC mu/PKD and related proteins [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.82 E-value=1.3e-20 Score=187.96 Aligned_cols=172 Identities=24% Similarity=0.322 Sum_probs=134.9
Q ss_pred cccceeeccCC-------CCCCCCCCChhhHHHHHHHHHHHHHHHhhcCCCceeecCCCccceEecCC---CCceecccc
Q 045315 241 DEISFWYESYN-------NPTKKGLLCWGTRVRIIEGIAQGLLYLHQYSRLRVIHRDLKASNILLDKD---MNPKISDFG 310 (476)
Q Consensus 241 ~~~~l~~Ey~~-------~~~~~~~L~~~~~~~i~~qIa~gL~yLH~~~~~~ivH~DLkp~NILld~~---~~~kL~DFG 310 (476)
+..+.|||-+. -...++.|++..-.-++.||+.||.|||.++ |+|+||||+|||+... -++||||||
T Consensus 636 ervFVVMEKl~GDMLEMILSsEkgRL~er~TkFlvtQIL~ALr~LH~kn---IvHCDLKPENVLLas~~~FPQvKlCDFG 712 (888)
T KOG4236|consen 636 ERVFVVMEKLHGDMLEMILSSEKGRLPERITKFLVTQILVALRYLHFKN---IVHCDLKPENVLLASASPFPQVKLCDFG 712 (888)
T ss_pred ceEEEEehhhcchHHHHHHHhhcccchHHHHHHHHHHHHHHHHHhhhcc---eeeccCCchheeeccCCCCCceeecccc
Confidence 45677888776 2345778999999999999999999999999 9999999999999643 368999999
Q ss_pred ceeecCCCcccccceeeeeccCCCChhhhccCCCCccceEEeehhhhhhhhhCCCCCCcCCCCchhhhhhhhhhhcCCCc
Q 045315 311 MARMFGGDELQSNTKRIVGTYGYMSPEYALRGLFSIKSDVFSFGVLLLETLSSKKNTHFYNTDSLTLLGHAWNLWNDGRT 390 (476)
Q Consensus 311 la~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~s~ksDVwSlGvvl~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~ 390 (476)
+|+++++.... ..++||+.|+|||+++++.|...-|+||.||++|--++|..||.....-...+. .+
T Consensus 713 fARiIgEksFR---rsVVGTPAYLaPEVLrnkGyNrSLDMWSVGVIiYVsLSGTFPFNEdEdIndQIQ-NA--------- 779 (888)
T KOG4236|consen 713 FARIIGEKSFR---RSVVGTPAYLAPEVLRNKGYNRSLDMWSVGVIIYVSLSGTFPFNEDEDINDQIQ-NA--------- 779 (888)
T ss_pred ceeecchhhhh---hhhcCCccccCHHHHhhccccccccceeeeEEEEEEecccccCCCccchhHHhh-cc---------
Confidence 99999875432 347899999999999999999999999999999999999998864321111111 11
Q ss_pred ccccCcccCCCCCHHHHHHHHHHHHHchhhcccCCCCHHHHH
Q 045315 391 WELMDPISQNGASYPILKRYINVALLCVQEKAADRPAMSEVV 432 (476)
Q Consensus 391 ~~~~d~~~~~~~~~~~~~~l~~li~~Cl~~dP~~RPt~~eVl 432 (476)
.++- ......+.....+++|...||..-++|.+..+.+
T Consensus 780 -aFMy---Pp~PW~eis~~AidlIn~LLqVkm~kRysvdk~l 817 (888)
T KOG4236|consen 780 -AFMY---PPNPWSEISPEAIDLINNLLQVKMRKRYSVDKSL 817 (888)
T ss_pred -cccc---CCCchhhcCHHHHHHHHHHHHHHHHHhcchHhhc
Confidence 1111 1223345567889999999999999999987754
|
|
| >KOG0664 consensus Nemo-like MAPK-related serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.82 E-value=3.6e-21 Score=178.43 Aligned_cols=192 Identities=20% Similarity=0.244 Sum_probs=131.6
Q ss_pred cccceeeccCC-CC----CCCCCCChhhHHHHHHHHHHHHHHHhhcCCCceeecCCCccceEecCCCCceeccccceeec
Q 045315 241 DEISFWYESYN-NP----TKKGLLCWGTRVRIIEGIAQGLLYLHQYSRLRVIHRDLKASNILLDKDMNPKISDFGMARMF 315 (476)
Q Consensus 241 ~~~~l~~Ey~~-~~----~~~~~L~~~~~~~i~~qIa~gL~yLH~~~~~~ivH~DLkp~NILld~~~~~kL~DFGla~~~ 315 (476)
.++|.+.|.|. +. .....|+-..+.-++.||++||+|||+.+ |.||||||.|.|++.|-..||||||+++.-
T Consensus 130 qEiYV~TELmQSDLHKIIVSPQ~Ls~DHvKVFlYQILRGLKYLHsA~---ILHRDIKPGNLLVNSNCvLKICDFGLARve 206 (449)
T KOG0664|consen 130 QELYVLTELMQSDLHKIIVSPQALTPDHVKVFVYQILRGLKYLHTAN---ILHRDIKPGNLLVNSNCILKICDFGLARTW 206 (449)
T ss_pred HHHHHHHHHHHhhhhheeccCCCCCcchhhhhHHHHHhhhHHHhhcc---hhhccCCCccEEeccCceEEeccccccccc
Confidence 35677778776 22 23567899999999999999999999999 999999999999999999999999999976
Q ss_pred CCCcccccceeeeeccCCCChhhhcc-CCCCccceEEeehhhhhhhhhCCCCCCcCC-CCchhhhhhh--------hhhh
Q 045315 316 GGDELQSNTKRIVGTYGYMSPEYALR-GLFSIKSDVFSFGVLLLETLSSKKNTHFYN-TDSLTLLGHA--------WNLW 385 (476)
Q Consensus 316 ~~~~~~~~~~~~~gt~~y~aPE~l~~-~~~s~ksDVwSlGvvl~elltG~~p~~~~~-~~~~~~~~~~--------~~~~ 385 (476)
..++....+ ..+-|..|+|||++++ ..|+.+.||||.||++.||+..+--|.... .+...++... .+.-
T Consensus 207 e~d~~~hMT-qEVVTQYYRAPEiLMGaRhYs~AvDiWSVGCIFaELLgRrILFQAq~PiqQL~lItdLLGTPs~EaMr~A 285 (449)
T KOG0664|consen 207 DQRDRLNMT-HEVVTQYYRAPELLMGARRYTGAVDIWSVGCIFAELLQRKILFQAAGPIEQLQMIIDLLGTPSQEAMKYA 285 (449)
T ss_pred chhhhhhhH-HHHHHHHhccHHHhhcchhhcCccceehhhHHHHHHHhhhhhhhccChHHHHHHHHHHhCCCcHHHHHHH
Confidence 554433332 2456889999999997 569999999999999999997776664433 1111111100 0000
Q ss_pred cCCCcccccCcccCC---------CCCHHHHHHHHHHHHHchhhcccCCCCHHHHHHHHh
Q 045315 386 NDGRTWELMDPISQN---------GASYPILKRYINVALLCVQEKAADRPAMSEVVSMLS 436 (476)
Q Consensus 386 ~~~~~~~~~d~~~~~---------~~~~~~~~~l~~li~~Cl~~dP~~RPt~~eVl~~L~ 436 (476)
-+|....++...... ..........+.+.++++..||++|.+.++.+..+.
T Consensus 286 CEGAk~H~LR~~~k~Ps~~vLYtlsS~~~~~heav~~~~~~l~~d~dkris~~~A~~~~~ 345 (449)
T KOG0664|consen 286 CEGAKNHVLRAGLRAPDTQRLYKIASPDDKNHEAVDLLQKLLHFDPDKRISVEEALQHRY 345 (449)
T ss_pred hhhhHHHhhccCCCCCCccceeeecCCcccchHHHHHHHHHhCCCCcccccHhhhccccc
Confidence 011111111111100 011122234567777889999999999888776553
|
|
| >KOG0608 consensus Warts/lats-like serine threonine kinases [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=99.82 E-value=2e-20 Score=190.15 Aligned_cols=129 Identities=27% Similarity=0.389 Sum_probs=109.9
Q ss_pred ccccceeeccCCCCC------CCCCCChhhHHHHHHHHHHHHHHHhhcCCCceeecCCCccceEecCCCCceecccccee
Q 045315 240 KDEISFWYESYNNPT------KKGLLCWGTRVRIIEGIAQGLLYLHQYSRLRVIHRDLKASNILLDKDMNPKISDFGMAR 313 (476)
Q Consensus 240 ~~~~~l~~Ey~~~~~------~~~~L~~~~~~~i~~qIa~gL~yLH~~~~~~ivH~DLkp~NILld~~~~~kL~DFGla~ 313 (476)
|+.+|+||||++.+. +.+.+.+..+.-++.++..|+++.|..| +|||||||+|||||.+|.+||.|||++.
T Consensus 701 kdnLYFVMdYIPGGDmMSLLIrmgIFeE~LARFYIAEltcAiesVHkmG---FIHRDiKPDNILIDrdGHIKLTDFGLCT 777 (1034)
T KOG0608|consen 701 KDNLYFVMDYIPGGDMMSLLIRMGIFEEDLARFYIAELTCAIESVHKMG---FIHRDIKPDNILIDRDGHIKLTDFGLCT 777 (1034)
T ss_pred CCceEEEEeccCCccHHHHHHHhccCHHHHHHHHHHHHHHHHHHHHhcc---ceecccCccceEEccCCceeeeeccccc
Confidence 567899999999543 5677889999999999999999999999 9999999999999999999999999997
Q ss_pred ecCCCc----------------------------------------ccccceeeeeccCCCChhhhccCCCCccceEEee
Q 045315 314 MFGGDE----------------------------------------LQSNTKRIVGTYGYMSPEYALRGLFSIKSDVFSF 353 (476)
Q Consensus 314 ~~~~~~----------------------------------------~~~~~~~~~gt~~y~aPE~l~~~~~s~ksDVwSl 353 (476)
-+.... ........+||..|+|||++....++...|.||.
T Consensus 778 GfRWTHdskYYq~gdH~RqDSmep~~e~~d~~~~lkvL~~ra~~~h~r~~ahslvgt~nyiapevl~r~g~~q~cdwws~ 857 (1034)
T KOG0608|consen 778 GFRWTHDSKYYQEGDHHRQDSMEPSPEWADISKCLKVLERRAMRQHQRILAHSLVGTPNYIAPEVLARTGYTQLCDWWSV 857 (1034)
T ss_pred cceeccccccccCCCccccccCCCchhhccccccchHHHHHHHhhhhhhhhhhhcCCCcccChHHhcccCccccchhhHh
Confidence 552110 0011123579999999999999999999999999
Q ss_pred hhhhhhhhhCCCCCCcCC
Q 045315 354 GVLLLETLSSKKNTHFYN 371 (476)
Q Consensus 354 Gvvl~elltG~~p~~~~~ 371 (476)
||+||||+.|+.||....
T Consensus 858 gvil~em~~g~~pf~~~t 875 (1034)
T KOG0608|consen 858 GVILYEMLVGQPPFLADT 875 (1034)
T ss_pred hHHHHHHhhCCCCccCCC
Confidence 999999999999997654
|
|
| >KOG1025 consensus Epidermal growth factor receptor EGFR and related tyrosine kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.82 E-value=6.2e-21 Score=198.82 Aligned_cols=183 Identities=22% Similarity=0.270 Sum_probs=143.4
Q ss_pred ccceeeccCCC-------CCCCCCCChhhHHHHHHHHHHHHHHHhhcCCCceeecCCCccceEecCCCCceeccccceee
Q 045315 242 EISFWYESYNN-------PTKKGLLCWGTRVRIIEGIAQGLLYLHQYSRLRVIHRDLKASNILLDKDMNPKISDFGMARM 314 (476)
Q Consensus 242 ~~~l~~Ey~~~-------~~~~~~L~~~~~~~i~~qIa~gL~yLH~~~~~~ivH~DLkp~NILld~~~~~kL~DFGla~~ 314 (476)
...++.+|||. +.++..+-.+..+.|+.|||+||.|||++. ++||||-.+|||+.....+||.|||+++.
T Consensus 771 ~~qlvtq~mP~G~LlDyvr~hr~~igsq~lLnw~~QIAkgM~YLe~qr---lVHrdLaaRNVLVksP~hvkitdfgla~l 847 (1177)
T KOG1025|consen 771 TLQLVTQLMPLGCLLDYVREHRDNIGSQDLLNWCYQIAKGMKYLEEQR---LVHRDLAARNVLVKSPNHVKITDFGLAKL 847 (1177)
T ss_pred hHHHHHHhcccchHHHHHHHhhccccHHHHHHHHHHHHHHHHHHHhcc---hhhhhhhhhheeecCCCeEEEEecchhhc
Confidence 35577789883 246778999999999999999999999988 99999999999999999999999999998
Q ss_pred cCCCcccccceeeeeccCCCChhhhccCCCCccceEEeehhhhhhhhh-CCCCCCcCCCCchhhhhhhhhhhcCCCcccc
Q 045315 315 FGGDELQSNTKRIVGTYGYMSPEYALRGLFSIKSDVFSFGVLLLETLS-SKKNTHFYNTDSLTLLGHAWNLWNDGRTWEL 393 (476)
Q Consensus 315 ~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~s~ksDVwSlGvvl~ellt-G~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~ 393 (476)
..............-.+.|||-|.+....|+.++|||||||.+||++| |.+|+.....+++ ...++.+..
T Consensus 848 l~~d~~ey~~~~gK~pikwmale~i~~~~~thqSDVWsfGVtiWElmTFGa~Py~gi~~~eI------~dlle~geR--- 918 (1177)
T KOG1025|consen 848 LAPDEKEYSAPGGKVPIKWMALESIRIRKYTHQSDVWSFGVTIWELMTFGAKPYDGIPAEEI------PDLLEKGER--- 918 (1177)
T ss_pred cCcccccccccccccCcHHHHHHHhhccCCCchhhhhhhhhhHHHHHhcCCCccCCCCHHHh------hHHHhcccc---
Confidence 876654444433344667888898899999999999999999999987 7777665432211 112222222
Q ss_pred cCcccCCCCCHHHHHHHHHHHHHchhhcccCCCCHHHHHHHHhccccCC
Q 045315 394 MDPISQNGASYPILKRYINVALLCVQEKAADRPAMSEVVSMLSNEFVNL 442 (476)
Q Consensus 394 ~d~~~~~~~~~~~~~~l~~li~~Cl~~dP~~RPt~~eVl~~L~~~~~~~ 442 (476)
-..++.....+..++.+||..|+..||+++++...+.+...+.
T Consensus 919 ------LsqPpiCtiDVy~~mvkCwmid~~~rp~fkel~~~fs~~ardp 961 (1177)
T KOG1025|consen 919 ------LSQPPICTIDVYMVMVKCWMIDADSRPTFKELAEEFSRMARDP 961 (1177)
T ss_pred ------CCCCCCccHHHHHHHHHHhccCcccCccHHHHHHHHHHHhcCc
Confidence 1223334567888999999999999999999999998876543
|
|
| >KOG1024 consensus Receptor-like protein tyrosine kinase RYK/derailed [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.81 E-value=7.4e-21 Score=184.10 Aligned_cols=168 Identities=23% Similarity=0.294 Sum_probs=130.7
Q ss_pred CCCCChhhHHHHHHHHHHHHHHHhhcCCCceeecCCCccceEecCCCCceeccccceeecCCCcccccceeeeeccCCCC
Q 045315 256 KGLLCWGTRVRIIEGIAQGLLYLHQYSRLRVIHRDLKASNILLDKDMNPKISDFGMARMFGGDELQSNTKRIVGTYGYMS 335 (476)
Q Consensus 256 ~~~L~~~~~~~i~~qIa~gL~yLH~~~~~~ivH~DLkp~NILld~~~~~kL~DFGla~~~~~~~~~~~~~~~~gt~~y~a 335 (476)
...++-.+...++.|++.|++|||+++ +||.||..+|+++|+..++||+|=.+++-+-....+......-.+..||+
T Consensus 390 aqtvtt~qlV~masQla~am~hlh~~~---ViHkDiAaRNCvIdd~LqVkltDsaLSRDLFP~DYhcLGDnEnRPvkWMs 466 (563)
T KOG1024|consen 390 AQTVTTIQLVLMASQLAMAMEHLHNHG---VIHKDIAARNCVIDDQLQVKLTDSALSRDLFPGDYHCLGDNENRPVKWMS 466 (563)
T ss_pred ccchhHHHHHHHHHHHHHHHHHHHhcC---cccchhhhhcceehhheeEEeccchhccccCcccccccCCCCCCcccccC
Confidence 445777888999999999999999999 99999999999999999999999999986544444433333345678999
Q ss_pred hhhhccCCCCccceEEeehhhhhhhhh-CCCCCCcCCCCchhhhhhhhhhhcCCCcccccCcccCCCCCHHHHHHHHHHH
Q 045315 336 PEYALRGLFSIKSDVFSFGVLLLETLS-SKKNTHFYNTDSLTLLGHAWNLWNDGRTWELMDPISQNGASYPILKRYINVA 414 (476)
Q Consensus 336 PE~l~~~~~s~ksDVwSlGvvl~ellt-G~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~l~~li 414 (476)
||.+.+..|+.++|+|||||++|||++ |+.|+...+ ..+.. ..+++|... ..+...++++..+|
T Consensus 467 lEal~n~~yssasDvWsfGVllWELmtlg~~PyaeID--PfEm~----~ylkdGyRl---------aQP~NCPDeLf~vM 531 (563)
T KOG1024|consen 467 LEALQNSHYSSASDVWSFGVLLWELMTLGKLPYAEID--PFEME----HYLKDGYRL---------AQPFNCPDELFTVM 531 (563)
T ss_pred HHHHhhhhhcchhhhHHHHHHHHHHHhcCCCCccccC--HHHHH----HHHhcccee---------cCCCCCcHHHHHHH
Confidence 999999999999999999999999988 777765333 22111 122233221 11233456788999
Q ss_pred HHchhhcccCCCCHHHHHHHHhccccC
Q 045315 415 LLCVQEKAADRPAMSEVVSMLSNEFVN 441 (476)
Q Consensus 415 ~~Cl~~dP~~RPt~~eVl~~L~~~~~~ 441 (476)
.-||...|++||+++|++.-|.+...+
T Consensus 532 acCWallpeeRPsf~Qlv~cLseF~~q 558 (563)
T KOG1024|consen 532 ACCWALLPEERPSFSQLVICLSEFHTQ 558 (563)
T ss_pred HHHHhcCcccCCCHHHHHHHHHHHHHH
Confidence 999999999999999999999875433
|
|
| >cd05610 STKc_MASTL Catalytic domain of the Protein Serine/Threonine Kinase, Microtubule-associated serine/threonine-like kinase | Back alignment and domain information |
|---|
Probab=99.81 E-value=3.4e-20 Score=202.57 Aligned_cols=70 Identities=30% Similarity=0.486 Sum_probs=62.0
Q ss_pred cccceeeccCCCCC------CCCCCChhhHHHHHHHHHHHHHHHhhcCCCceeecCCCccceEecCCCCceecccccee
Q 045315 241 DEISFWYESYNNPT------KKGLLCWGTRVRIIEGIAQGLLYLHQYSRLRVIHRDLKASNILLDKDMNPKISDFGMAR 313 (476)
Q Consensus 241 ~~~~l~~Ey~~~~~------~~~~L~~~~~~~i~~qIa~gL~yLH~~~~~~ivH~DLkp~NILld~~~~~kL~DFGla~ 313 (476)
+..+++|||++... ..+.+++..++.++.||+.||+|||.++ |+||||||+|||++.++.+||+|||+++
T Consensus 77 ~~~~lVmEy~~g~~L~~li~~~~~l~~~~~~~i~~qil~aL~yLH~~g---IiHrDLKP~NILl~~~g~vkL~DFGls~ 152 (669)
T cd05610 77 NNVYLVMEYLIGGDVKSLLHIYGYFDEEMAVKYISEVALALDYLHRHG---IIHRDLKPDNMLISNEGHIKLTDFGLSK 152 (669)
T ss_pred CEEEEEEeCCCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCC---EEeCCccHHHEEEcCCCCEEEEeCCCCc
Confidence 45788999997432 3456899999999999999999999998 9999999999999999999999999986
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, MAST-like (MASTL) kinases, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. The MASTL kinases in this group carry only a catalytic domain, which contains a long insertion relative to MAST kinases. The human MASTL gene has also been labelled FLJ14813. A missense mutation in FLJ1481 |
| >KOG0607 consensus MAP kinase-interacting kinase and related serine/threonine protein kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.80 E-value=1.8e-20 Score=177.18 Aligned_cols=184 Identities=21% Similarity=0.271 Sum_probs=133.4
Q ss_pred cccceeeccCCCC------CCCCCCChhhHHHHHHHHHHHHHHHhhcCCCceeecCCCccceEecCCCC---ceeccccc
Q 045315 241 DEISFWYESYNNP------TKKGLLCWGTRVRIIEGIAQGLLYLHQYSRLRVIHRDLKASNILLDKDMN---PKISDFGM 311 (476)
Q Consensus 241 ~~~~l~~Ey~~~~------~~~~~L~~~~~~~i~~qIa~gL~yLH~~~~~~ivH~DLkp~NILld~~~~---~kL~DFGl 311 (476)
...|+|||-|..+ .+++.+++.++-+++.+|+.||.|||.++ |.|||+||+|||-..... +|||||.+
T Consensus 149 ~~FYLVfEKm~GGplLshI~~~~~F~E~EAs~vvkdia~aLdFlH~kg---IAHRDlKPENiLC~~pn~vsPvKiCDfDL 225 (463)
T KOG0607|consen 149 TRFYLVFEKMRGGPLLSHIQKRKHFNEREASRVVKDIASALDFLHTKG---IAHRDLKPENILCESPNKVSPVKICDFDL 225 (463)
T ss_pred ceEEEEEecccCchHHHHHHHhhhccHHHHHHHHHHHHHHHHHHhhcC---cccccCCccceeecCCCCcCceeeecccc
Confidence 4689999999843 46778999999999999999999999999 999999999999875544 69999988
Q ss_pred eeecCCCc-----ccccceeeeeccCCCChhhhc-----cCCCCccceEEeehhhhhhhhhCCCCCCcCCCCch------
Q 045315 312 ARMFGGDE-----LQSNTKRIVGTYGYMSPEYAL-----RGLFSIKSDVFSFGVLLLETLSSKKNTHFYNTDSL------ 375 (476)
Q Consensus 312 a~~~~~~~-----~~~~~~~~~gt~~y~aPE~l~-----~~~~s~ksDVwSlGvvl~elltG~~p~~~~~~~~~------ 375 (476)
..-+..+. .........|+..|||||+.. ...|..+.|.|||||++|-|++|.+||...-....
T Consensus 226 gSg~k~~~~~spastP~L~tPvGSAEfMAPEVVd~fv~qA~~YDKrCDlwSLGvIlYImLsGYpPFvG~Cg~dCGWdrGe 305 (463)
T KOG0607|consen 226 GSGIKLNNDCSPASTPELLTPVGSAEFMAPEVVDVFVDQATFYDKRCDLWSLGVILYIMLSGYPPFVGHCGADCGWDRGE 305 (463)
T ss_pred ccccccCCCCCCCCCccccCcccchhhcchhHHhhhccccccccccccHHHHHHHHHHHHhCCCCccCccCCcCCccCCC
Confidence 76443211 112223467899999999874 24589999999999999999999999976432111
Q ss_pred --hhhhh-hhhhhcCCCcccccCcccCCCCCHHHHHHHHHHHHHchhhcccCCCCHHHHHH
Q 045315 376 --TLLGH-AWNLWNDGRTWELMDPISQNGASYPILKRYINVALLCVQEKAADRPAMSEVVS 433 (476)
Q Consensus 376 --~~~~~-~~~~~~~~~~~~~~d~~~~~~~~~~~~~~l~~li~~Cl~~dP~~RPt~~eVl~ 433 (476)
...+. .-+.+.+|+. ++.|. ..........+++...+..|+.+|.++.+++.
T Consensus 306 ~Cr~CQ~~LFesIQEGkY-eFPdk-----dWahIS~eakdlisnLlvrda~~rlsa~~vln 360 (463)
T KOG0607|consen 306 VCRVCQNKLFESIQEGKY-EFPDK-----DWAHISSEAKDLISNLLVRDAKQRLSAAQVLN 360 (463)
T ss_pred ccHHHHHHHHHHHhccCC-cCChh-----hhHHhhHHHHHHHHHHHhccHHhhhhhhhccC
Confidence 11100 0111122221 22221 12234567788888999999999999999886
|
|
| >KOG0587 consensus Traf2- and Nck-interacting kinase and related germinal center kinase (GCK) family protein kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.79 E-value=1.8e-19 Score=189.74 Aligned_cols=175 Identities=23% Similarity=0.345 Sum_probs=137.7
Q ss_pred cccceeeccCC--------CCCCCCCCChhhHHHHHHHHHHHHHHHhhcCCCceeecCCCccceEecCCCCceeccccce
Q 045315 241 DEISFWYESYN--------NPTKKGLLCWGTRVRIIEGIAQGLLYLHQYSRLRVIHRDLKASNILLDKDMNPKISDFGMA 312 (476)
Q Consensus 241 ~~~~l~~Ey~~--------~~~~~~~L~~~~~~~i~~qIa~gL~yLH~~~~~~ivH~DLkp~NILld~~~~~kL~DFGla 312 (476)
+.+-|||||+. ...++..|.|..+.-|++.++.||.+||... ++|||||-.|||+..++.+||+|||++
T Consensus 94 DqLWLVMEfC~gGSVTDLVKn~~g~rl~E~~IaYI~re~lrgl~HLH~nk---viHRDikG~NiLLT~e~~VKLvDFGvS 170 (953)
T KOG0587|consen 94 DQLWLVMEFCGGGSVTDLVKNTKGNRLKEEWIAYILREILRGLAHLHNNK---VIHRDIKGQNVLLTENAEVKLVDFGVS 170 (953)
T ss_pred CeEEEEeeccCCccHHHHHhhhcccchhhHHHHHHHHHHHHHHHHHhhcc---eeeecccCceEEEeccCcEEEeeeeee
Confidence 56889999998 2345788999999999999999999999988 999999999999999999999999999
Q ss_pred eecCCCcccccceeeeeccCCCChhhhcc-----CCCCccceEEeehhhhhhhhhCCCCCCcCCCCchhhhhhhhhhhcC
Q 045315 313 RMFGGDELQSNTKRIVGTYGYMSPEYALR-----GLFSIKSDVFSFGVLLLETLSSKKNTHFYNTDSLTLLGHAWNLWND 387 (476)
Q Consensus 313 ~~~~~~~~~~~~~~~~gt~~y~aPE~l~~-----~~~s~ksDVwSlGvvl~elltG~~p~~~~~~~~~~~~~~~~~~~~~ 387 (476)
..+.... .+.....||+.|||||++.. ..|+.++|+||||++..||.-|.+|+........-+ .+..
T Consensus 171 aQldsT~--grRnT~iGtP~WMAPEViac~e~~d~tyd~R~D~WsLGITaIEladG~PPl~DmHPmraLF------~IpR 242 (953)
T KOG0587|consen 171 AQLDSTV--GRRNTFIGTPYWMAPEVIACDESPDATYDYRSDLWSLGITAIEMAEGAPPLCDMHPMRALF------LIPR 242 (953)
T ss_pred eeeeccc--ccccCcCCCcccccceeeecccCCCCCcccccchhhccceeehhcCCCCCccCcchhhhhc------cCCC
Confidence 8775433 33344789999999999863 347889999999999999999999975433211100 0000
Q ss_pred CCcccccCcccCCCCCHHHHHHHHHHHHHchhhcccCCCCHHHHHH
Q 045315 388 GRTWELMDPISQNGASYPILKRYINVALLCVQEKAADRPAMSEVVS 433 (476)
Q Consensus 388 ~~~~~~~d~~~~~~~~~~~~~~l~~li~~Cl~~dP~~RPt~~eVl~ 433 (476)
.|......+..=.+++.++|..||..|.++||++.++++
T Consensus 243 -------NPPPkLkrp~kWs~~FndFIs~cL~Kd~e~RP~~~~ll~ 281 (953)
T KOG0587|consen 243 -------NPPPKLKRPKKWSKKFNDFISTCLVKDYEQRPSTEELLK 281 (953)
T ss_pred -------CCCccccchhhHHHHHHHHHHHHHhhccccCcchhhhcc
Confidence 011111223445678999999999999999999988764
|
|
| >PLN03224 probable serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=99.78 E-value=3.9e-19 Score=186.09 Aligned_cols=164 Identities=20% Similarity=0.204 Sum_probs=110.5
Q ss_pred CCChhhHHHHHHHHHHHHHHHhhcCCCceeecCCCccceEecCCCCceeccccceeecCCCcccccceeeeeccCCCChh
Q 045315 258 LLCWGTRVRIIEGIAQGLLYLHQYSRLRVIHRDLKASNILLDKDMNPKISDFGMARMFGGDELQSNTKRIVGTYGYMSPE 337 (476)
Q Consensus 258 ~L~~~~~~~i~~qIa~gL~yLH~~~~~~ivH~DLkp~NILld~~~~~kL~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE 337 (476)
.+++..+..++.|++.||.|||+.+ |+||||||+||+++.++.+||+|||++......... ......+++.|+|||
T Consensus 305 ~~~~~~~~~i~~ql~~aL~~lH~~~---ivHrDLKp~NILl~~~~~~kL~DFGla~~~~~~~~~-~~~~g~~tp~Y~aPE 380 (507)
T PLN03224 305 KRDINVIKGVMRQVLTGLRKLHRIG---IVHRDIKPENLLVTVDGQVKIIDFGAAVDMCTGINF-NPLYGMLDPRYSPPE 380 (507)
T ss_pred cCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCchHhEEECCCCcEEEEeCcCccccccCCcc-CccccCCCcceeChh
Confidence 4577889999999999999999998 999999999999999999999999999765432111 111123478999999
Q ss_pred hhccCC--------------------C--CccceEEeehhhhhhhhhCCC-CCCcCCCCchhhh--h---hhhhhhcCCC
Q 045315 338 YALRGL--------------------F--SIKSDVFSFGVLLLETLSSKK-NTHFYNTDSLTLL--G---HAWNLWNDGR 389 (476)
Q Consensus 338 ~l~~~~--------------------~--s~ksDVwSlGvvl~elltG~~-p~~~~~~~~~~~~--~---~~~~~~~~~~ 389 (476)
.+.... + ..+.|+||+||+++||+++.. |+.....-...+. . ..|+......
T Consensus 381 ~l~~~~~~~~~~~~~~~~~l~~~~~~yg~~~~~DvwSlGvil~em~~~~l~p~~~~~~f~~~~~~~~~~~~~~r~~~~~~ 460 (507)
T PLN03224 381 ELVMPQSCPRAPAPAMAALLSPFAWLYGRPDLFDSYTAGVLLMQMCVPELRPVANIRLFNTELRQYDNDLNRWRMYKGQK 460 (507)
T ss_pred hhcCCCCCCccchhhhhhhhhhhHHhcCCCCccchhhHHHHHHHHHhCCCCCccchhhhhhHHhhccchHHHHHhhcccC
Confidence 875322 1 234799999999999999875 5432110000000 0 0111111111
Q ss_pred cccccCcccCCCCCHHHHHHHHHHHHHchhhcc---cCCCCHHHHHH
Q 045315 390 TWELMDPISQNGASYPILKRYINVALLCVQEKA---ADRPAMSEVVS 433 (476)
Q Consensus 390 ~~~~~d~~~~~~~~~~~~~~l~~li~~Cl~~dP---~~RPt~~eVl~ 433 (476)
. +- ...........+++.+||..+| .+|+|++|+++
T Consensus 461 ~----~~----~~~d~~s~~~~dLi~~LL~~~~~~~~~RlSa~eaL~ 499 (507)
T PLN03224 461 Y----DF----SLLDRNKEAGWDLACKLITKRDQANRGRLSVGQALS 499 (507)
T ss_pred C----Cc----ccccccChHHHHHHHHHhccCCCCcccCCCHHHHhC
Confidence 1 00 0111234567889999998765 68999999875
|
|
| >KOG1345 consensus Serine/threonine kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.75 E-value=1.5e-18 Score=161.11 Aligned_cols=181 Identities=19% Similarity=0.281 Sum_probs=129.2
Q ss_pred cccceeeccCCCCC-----CCCCCChhhHHHHHHHHHHHHHHHhhcCCCceeecCCCccceEec--CCCCceecccccee
Q 045315 241 DEISFWYESYNNPT-----KKGLLCWGTRVRIIEGIAQGLLYLHQYSRLRVIHRDLKASNILLD--KDMNPKISDFGMAR 313 (476)
Q Consensus 241 ~~~~l~~Ey~~~~~-----~~~~L~~~~~~~i~~qIa~gL~yLH~~~~~~ivH~DLkp~NILld--~~~~~kL~DFGla~ 313 (476)
+-.++++||+|.+. ....+.+....+++.|++.|+.|||+++ +||||||.+|||+- +..++||||||..+
T Consensus 95 d~YvF~qE~aP~gdL~snv~~~GigE~~~K~v~~ql~SAi~fMHskn---lVHRdlK~eNiLif~~df~rvKlcDFG~t~ 171 (378)
T KOG1345|consen 95 DAYVFVQEFAPRGDLRSNVEAAGIGEANTKKVFAQLLSAIEFMHSKN---LVHRDLKAENILIFDADFYRVKLCDFGLTR 171 (378)
T ss_pred ceEEEeeccCccchhhhhcCcccccHHHHHHHHHHHHHHHHHhhccc---hhhcccccceEEEecCCccEEEeeeccccc
Confidence 56778999999322 2345778888999999999999999999 99999999999993 34479999999987
Q ss_pred ecCCCcccccceeeeeccCCCChhhhccC-----CCCccceEEeehhhhhhhhhCCCCCCcCCCCchhhhhhhhhhhcCC
Q 045315 314 MFGGDELQSNTKRIVGTYGYMSPEYALRG-----LFSIKSDVFSFGVLLLETLSSKKNTHFYNTDSLTLLGHAWNLWNDG 388 (476)
Q Consensus 314 ~~~~~~~~~~~~~~~gt~~y~aPE~l~~~-----~~s~ksDVwSlGvvl~elltG~~p~~~~~~~~~~~~~~~~~~~~~~ 388 (476)
..+... .....+..|.+||..... ...+.+|+|.||++++.+++|+.|+........... .+..|..+
T Consensus 172 k~g~tV-----~~~~~~~~y~~pe~~~~~~ne~~~~~ps~D~WqfGIi~f~cltG~~PWQka~~~d~~Y~--~~~~w~~r 244 (378)
T KOG1345|consen 172 KVGTTV-----KYLEYVNNYHAPELCDTVVNEKLVVNPSTDIWQFGIIFFYCLTGKFPWQKASIMDKPYW--EWEQWLKR 244 (378)
T ss_pred ccCcee-----hhhhhhcccCCcHHHhhccccceEecccccchheeeeeeeeecCCCcchhhhccCchHH--HHHHHhcc
Confidence 654321 112346689999987532 246889999999999999999999985443333222 23344444
Q ss_pred CcccccCcccCCCCCHHHHHHHHHHHHHchhhcccCCCCHHHHHHHHhc
Q 045315 389 RTWELMDPISQNGASYPILKRYINVALLCVQEKAADRPAMSEVVSMLSN 437 (476)
Q Consensus 389 ~~~~~~d~~~~~~~~~~~~~~l~~li~~Cl~~dP~~RPt~~eVl~~L~~ 437 (476)
....+.+. -....+++.++..+-+..++++|-...++.++...
T Consensus 245 k~~~~P~~------F~~fs~~a~r~Fkk~lt~~~~drcki~~~kk~rk~ 287 (378)
T KOG1345|consen 245 KNPALPKK------FNPFSEKALRLFKKSLTPRFKDRCKIWTAKKMRKC 287 (378)
T ss_pred cCccCchh------hcccCHHHHHHHHHhcCCcccccchhHHHHHHHHH
Confidence 33322221 11234567778888899999999666666555444
|
|
| >KOG0670 consensus U4/U6-associated splicing factor PRP4 [RNA processing and modification] | Back alignment and domain information |
|---|
Probab=99.75 E-value=1.2e-18 Score=174.10 Aligned_cols=123 Identities=22% Similarity=0.260 Sum_probs=102.2
Q ss_pred ccceeeccCC--------CCCCCCCCChhhHHHHHHHHHHHHHHHhhcCCCceeecCCCccceEecCCC-Cceeccccce
Q 045315 242 EISFWYESYN--------NPTKKGLLCWGTRVRIIEGIAQGLLYLHQYSRLRVIHRDLKASNILLDKDM-NPKISDFGMA 312 (476)
Q Consensus 242 ~~~l~~Ey~~--------~~~~~~~L~~~~~~~i~~qIa~gL~yLH~~~~~~ivH~DLkp~NILld~~~-~~kL~DFGla 312 (476)
-+.+|+|-+. .-.++-.|....+..++.|+..||..|...+ |+|+||||+|||+++.. .+||||||.|
T Consensus 508 HLClVFE~LslNLRevLKKyG~nvGL~ikaVRsYaqQLflALklLK~c~---vlHaDIKPDNiLVNE~k~iLKLCDfGSA 584 (752)
T KOG0670|consen 508 HLCLVFEPLSLNLREVLKKYGRNVGLHIKAVRSYAQQLFLALKLLKKCG---VLHADIKPDNILVNESKNILKLCDFGSA 584 (752)
T ss_pred eeEEEehhhhchHHHHHHHhCcccceeehHHHHHHHHHHHHHHHHHhcC---eeecccCccceEeccCcceeeeccCccc
Confidence 3557777665 1123446888999999999999999999998 99999999999999654 5799999999
Q ss_pred eecCCCcccccceeeeeccCCCChhhhccCCCCccceEEeehhhhhhhhhCCCCCCcCC
Q 045315 313 RMFGGDELQSNTKRIVGTYGYMSPEYALRGLFSIKSDVFSFGVLLLETLSSKKNTHFYN 371 (476)
Q Consensus 313 ~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~s~ksDVwSlGvvl~elltG~~p~~~~~ 371 (476)
.....+.... +.-+..|.|||++.+.+|+...|+||.||+||||.||+--|+...
T Consensus 585 ~~~~eneitP----YLVSRFYRaPEIiLG~~yd~~iD~WSvgctLYElYtGkIlFpG~T 639 (752)
T KOG0670|consen 585 SFASENEITP----YLVSRFYRAPEIILGLPYDYPIDTWSVGCTLYELYTGKILFPGRT 639 (752)
T ss_pred cccccccccH----HHHHHhccCcceeecCcccCCccceeeceeeEEeeccceecCCCC
Confidence 8876654332 334668999999999999999999999999999999998887653
|
|
| >cd00180 PKc Catalytic domain of Protein Kinases | Back alignment and domain information |
|---|
Probab=99.75 E-value=2.7e-18 Score=158.10 Aligned_cols=143 Identities=36% Similarity=0.570 Sum_probs=119.6
Q ss_pred cccceeeccCCCCC-------CCCCCChhhHHHHHHHHHHHHHHHhhcCCCceeecCCCccceEecC-CCCceeccccce
Q 045315 241 DEISFWYESYNNPT-------KKGLLCWGTRVRIIEGIAQGLLYLHQYSRLRVIHRDLKASNILLDK-DMNPKISDFGMA 312 (476)
Q Consensus 241 ~~~~l~~Ey~~~~~-------~~~~L~~~~~~~i~~qIa~gL~yLH~~~~~~ivH~DLkp~NILld~-~~~~kL~DFGla 312 (476)
+..++++||++..+ ....+++..+..++.+++++|++||+.+ ++|+||+|.||+++. ++.++|+|||.+
T Consensus 64 ~~~~~~~e~~~~~~l~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~---~~H~dl~~~ni~~~~~~~~~~l~d~~~~ 140 (215)
T cd00180 64 NHLYLVMEYCEGGSLKDLLKENEGKLSEDEILRILLQILEGLEYLHSNG---IIHRDLKPENILLDSDNGKVKLADFGLS 140 (215)
T ss_pred CeEEEEEecCCCCcHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHhCC---eeccCCCHhhEEEeCCCCcEEEecCCce
Confidence 35667788887222 1146899999999999999999999998 999999999999999 899999999999
Q ss_pred eecCCCcccccceeeeeccCCCChhhhccC-CCCccceEEeehhhhhhhhhCCCCCCcCCCCchhhhhhhhhhhcCCCcc
Q 045315 313 RMFGGDELQSNTKRIVGTYGYMSPEYALRG-LFSIKSDVFSFGVLLLETLSSKKNTHFYNTDSLTLLGHAWNLWNDGRTW 391 (476)
Q Consensus 313 ~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~-~~s~ksDVwSlGvvl~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~ 391 (476)
........ ......+...|++||..... ..+.+.|+|++|++++++
T Consensus 141 ~~~~~~~~--~~~~~~~~~~~~~pe~~~~~~~~~~~~D~~~lg~~~~~l------------------------------- 187 (215)
T cd00180 141 KLLTSDKS--LLKTIVGTPAYMAPEVLLGKGYYSEKSDIWSLGVILYEL------------------------------- 187 (215)
T ss_pred EEccCCcc--hhhcccCCCCccChhHhcccCCCCchhhhHHHHHHHHHH-------------------------------
Confidence 87654321 12224578899999998877 788999999999999998
Q ss_pred cccCcccCCCCCHHHHHHHHHHHHHchhhcccCCCCHHHHHHHH
Q 045315 392 ELMDPISQNGASYPILKRYINVALLCVQEKAADRPAMSEVVSML 435 (476)
Q Consensus 392 ~~~d~~~~~~~~~~~~~~l~~li~~Cl~~dP~~RPt~~eVl~~L 435 (476)
..+.+++.+|++.+|++||++.++++.|
T Consensus 188 ----------------~~~~~~l~~~l~~~p~~R~~~~~l~~~~ 215 (215)
T cd00180 188 ----------------PELKDLIRKMLQKDPEKRPSAKEILEHL 215 (215)
T ss_pred ----------------HHHHHHHHHHhhCCcccCcCHHHHhhCC
Confidence 4678999999999999999999998643
|
Protein Kinases (PKs), catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The PK family is part of a larger superfamily that includes the catalytic domains of RIO kinases, aminoglycoside phosphotransferase, choline kinase, phosphoinositide 3-kinase (PI3K), and actin-fragmin kinase. PKs make up a large family of serine/threonine kinases, protein tyrosine kinases (PTKs), and dual-specificity PKs that phosphorylate both serine/threonine and tyrosine residues of target proteins. Majority of protein phosphorylation, about 95%, occurs on serine residues while only 1% occurs on tyrosine residues. Protein phosphorylation is a mechanism by which a wide variety of cellular proteins, such as enzymes and membrane channels, are reversibly regulated in response to certain stimuli. PKs often function as components of signal transduction pathways in which |
| >KOG0662 consensus Cyclin-dependent kinase CDK5 [Intracellular trafficking, secretion, and vesicular transport; Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.74 E-value=2e-18 Score=151.25 Aligned_cols=188 Identities=21% Similarity=0.225 Sum_probs=130.2
Q ss_pred ccccceeeccCCC------CCCCCCCChhhHHHHHHHHHHHHHHHhhcCCCceeecCCCccceEecCCCCceecccccee
Q 045315 240 KDEISFWYESYNN------PTKKGLLCWGTRVRIIEGIAQGLLYLHQYSRLRVIHRDLKASNILLDKDMNPKISDFGMAR 313 (476)
Q Consensus 240 ~~~~~l~~Ey~~~------~~~~~~L~~~~~~~i~~qIa~gL~yLH~~~~~~ivH~DLkp~NILld~~~~~kL~DFGla~ 313 (476)
....-+++||+.. ..-++.++.+.+..+..|+++||.++|+++ +.|||+||+|.|++.+|..|++|||+++
T Consensus 73 dkkltlvfe~cdqdlkkyfdslng~~d~~~~rsfmlqllrgl~fchshn---vlhrdlkpqnllin~ngelkladfglar 149 (292)
T KOG0662|consen 73 DKKLTLVFEFCDQDLKKYFDSLNGDLDPEIVRSFMLQLLRGLGFCHSHN---VLHRDLKPQNLLINRNGELKLADFGLAR 149 (292)
T ss_pred CceeEEeHHHhhHHHHHHHHhcCCcCCHHHHHHHHHHHHhhhhhhhhhh---hhhccCCcceEEeccCCcEEecccchhh
Confidence 3567788999872 234678999999999999999999999999 9999999999999999999999999999
Q ss_pred ecCCCcccccceeeeeccCCCChhhhccC-CCCccceEEeehhhhhhhhh-CCCCCCcCCCCchhhhhhhh--hhhcCCC
Q 045315 314 MFGGDELQSNTKRIVGTYGYMSPEYALRG-LFSIKSDVFSFGVLLLETLS-SKKNTHFYNTDSLTLLGHAW--NLWNDGR 389 (476)
Q Consensus 314 ~~~~~~~~~~~~~~~gt~~y~aPE~l~~~-~~s~ksDVwSlGvvl~ellt-G~~p~~~~~~~~~~~~~~~~--~~~~~~~ 389 (476)
.++-.... .....-|..|.+|.++.+. -|+...|+||.||++.|+.. |++-|+..+.+.. +....+ ....+..
T Consensus 150 afgipvrc--ysaevvtlwyrppdvlfgakly~tsidmwsagcifaelanagrplfpg~dvddq-lkrif~~lg~p~ed~ 226 (292)
T KOG0662|consen 150 AFGIPVRC--YSAEVVTLWYRPPDVLFGAKLYSTSIDMWSAGCIFAELANAGRPLFPGNDVDDQ-LKRIFRLLGTPTEDQ 226 (292)
T ss_pred hcCCceEe--eeceeeeeeccCcceeeeeehhccchHhhhcchHHHHHhhcCCCCCCCCcHHHH-HHHHHHHhCCCcccc
Confidence 87643222 1224568899999999874 58999999999999999986 5555665543322 222221 1111221
Q ss_pred c---ccccCcccCCCCC-----HHHH----HHHHHHHHHchhhcccCCCCHHHHHH
Q 045315 390 T---WELMDPISQNGAS-----YPIL----KRYINVALLCVQEKAADRPAMSEVVS 433 (476)
Q Consensus 390 ~---~~~~d~~~~~~~~-----~~~~----~~l~~li~~Cl~~dP~~RPt~~eVl~ 433 (476)
. ..+.|-..-+.++ .... ..=.++.++.+.-+|.+|.++++.++
T Consensus 227 wps~t~lpdyk~yp~ypattswsqivp~lns~grdllqkll~cnp~qrisaeaalq 282 (292)
T KOG0662|consen 227 WPSMTKLPDYKPYPIYPATTSWSQIVPKLNSTGRDLLQKLLKCNPAQRISAEAALQ 282 (292)
T ss_pred CCccccCCCCcccCCccccchHHHHhhhhcchhHHHHHHHhccCcccccCHHHHhc
Confidence 1 1122211111111 1111 22346666777779999999988664
|
|
| >KOG0668 consensus Casein kinase II, alpha subunit [Signal transduction mechanisms; Cell cycle control, cell division, chromosome partitioning; Transcription] | Back alignment and domain information |
|---|
Probab=99.74 E-value=1.8e-18 Score=157.04 Aligned_cols=197 Identities=18% Similarity=0.222 Sum_probs=140.1
Q ss_pred hhhhhhhccccccceeeccCCCCC---CCCCCChhhHHHHHHHHHHHHHHHhhcCCCceeecCCCccceEecCC-CCcee
Q 045315 231 LYEQVLVQSKDEISFWYESYNNPT---KKGLLCWGTRVRIIEGIAQGLLYLHQYSRLRVIHRDLKASNILLDKD-MNPKI 306 (476)
Q Consensus 231 ~~~~~~~~~~~~~~l~~Ey~~~~~---~~~~L~~~~~~~i~~qIa~gL~yLH~~~~~~ivH~DLkp~NILld~~-~~~kL 306 (476)
.++.+.|+.+..-.+++||+.+.. -...|+...+.-.+.+++.||.|+|+.| |.|||+||.|+++|.. -.++|
T Consensus 98 L~DiV~Dp~SktpaLiFE~v~n~Dfk~ly~tl~d~dIryY~~elLkALdyCHS~G---ImHRDVKPhNvmIdh~~rkLrl 174 (338)
T KOG0668|consen 98 LLDIVKDPESKTPSLIFEYVNNTDFKQLYPTLTDYDIRYYIYELLKALDYCHSMG---IMHRDVKPHNVMIDHELRKLRL 174 (338)
T ss_pred hhhhhcCccccCchhHhhhhccccHHHHhhhhchhhHHHHHHHHHHHHhHHHhcC---cccccCCcceeeechhhceeee
Confidence 344566666667888999998543 3456888889999999999999999999 9999999999999954 46899
Q ss_pred ccccceeecCCCcccccceeeeeccCCCChhhhcc-CCCCccceEEeehhhhhhhhhCCCCCCcCCCCchhhhhhhhhhh
Q 045315 307 SDFGMARMFGGDELQSNTKRIVGTYGYMSPEYALR-GLFSIKSDVFSFGVLLLETLSSKKNTHFYNTDSLTLLGHAWNLW 385 (476)
Q Consensus 307 ~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~l~~-~~~s~ksDVwSlGvvl~elltG~~p~~~~~~~~~~~~~~~~~~~ 385 (476)
+|+|+|......... ...+.+..|--||.+.. ..|...-|+|||||++..|+..+.||-....+...+...+.-+-
T Consensus 175 IDWGLAEFYHp~~eY---nVRVASRyfKGPELLVdy~~YDYSLD~WS~GcmlA~miFrkepFFhG~dN~DQLVkIakVLG 251 (338)
T KOG0668|consen 175 IDWGLAEFYHPGKEY---NVRVASRYFKGPELLVDYQMYDYSLDMWSLGCMLASMIFRKEPFFHGHDNYDQLVKIAKVLG 251 (338)
T ss_pred eecchHhhcCCCcee---eeeeehhhcCCchheeechhccccHHHHHHHHHHHHHHhccCcccCCCCCHHHHHHHHHHhC
Confidence 999999876544321 22456778899999875 55789999999999999999999998655444444443322111
Q ss_pred c--------------CCCcccccCcccC--------CCCCHHHHHHHHHHHHHchhhcccCCCCHHHHHH
Q 045315 386 N--------------DGRTWELMDPISQ--------NGASYPILKRYINVALLCVQEKAADRPAMSEVVS 433 (476)
Q Consensus 386 ~--------------~~~~~~~~d~~~~--------~~~~~~~~~~l~~li~~Cl~~dP~~RPt~~eVl~ 433 (476)
. ..+...++....+ .+...-...+.++++.+.|..|-++|+|+.|...
T Consensus 252 t~el~~Yl~KY~i~Ldp~~~~i~~~~~rk~w~~Fi~~~n~hl~~peaiDlldklLrYDHqeRlTakEam~ 321 (338)
T KOG0668|consen 252 TDELYAYLNKYQIDLDPQFEDILGRHSRKPWSRFINSENQHLVSPEAIDLLDKLLRYDHQERLTAKEAMA 321 (338)
T ss_pred hHHHHHHHHHHccCCChhHhhHhhccccccHHHhCCccccccCChHHHHHHHHHHhhccccccchHHHhc
Confidence 0 1111111111100 0111112367889999999999999999998753
|
|
| >KOG1290 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.73 E-value=3.2e-18 Score=170.17 Aligned_cols=106 Identities=12% Similarity=0.118 Sum_probs=72.5
Q ss_pred eeccCCCChhhhccCCCCccceEEeehhhhhhhhhCCCCCCcCCCC-----chhhhhhh-------hhhhcCC-Cccccc
Q 045315 328 VGTYGYMSPEYALRGLFSIKSDVFSFGVLLLETLSSKKNTHFYNTD-----SLTLLGHA-------WNLWNDG-RTWELM 394 (476)
Q Consensus 328 ~gt~~y~aPE~l~~~~~s~ksDVwSlGvvl~elltG~~p~~~~~~~-----~~~~~~~~-------~~~~~~~-~~~~~~ 394 (476)
..|..|+|||++.+..|++.+||||++|+++||+||..-|.....+ ..-+.... +.+...| ...+++
T Consensus 412 IQTRQYRapEVllGsgY~~~ADiWS~AC~~FELaTGDyLFePhsG~~Y~rDEDHiA~i~ELLG~iPr~ia~~Gk~SRdFF 491 (590)
T KOG1290|consen 412 IQTRQYRAPEVLLGSGYSTSADIWSTACMAFELATGDYLFEPHSGENYSRDEDHIALIMELLGKIPRKIALGGKYSRDFF 491 (590)
T ss_pred hhhhhccCcceeecCCCCCchhHHHHHHHHHHhhcCceeecCCCCCCCCccHHHHHHHHHHHhhccHHHHhcCcchHhhh
Confidence 3467899999999999999999999999999999999888765421 11111100 0111111 111222
Q ss_pred Ccc------------------c-CCCCCHHHHHHHHHHHHHchhhcccCCCCHHHHHH
Q 045315 395 DPI------------------S-QNGASYPILKRYINVALLCVQEKAADRPAMSEVVS 433 (476)
Q Consensus 395 d~~------------------~-~~~~~~~~~~~l~~li~~Cl~~dP~~RPt~~eVl~ 433 (476)
... . .-..+.++...+.+++.-||+.+|++|||+.++++
T Consensus 492 nr~G~LrhI~~LK~WpL~~VL~eKY~~s~e~A~~fsdFL~PmLef~PeKR~tA~~cl~ 549 (590)
T KOG1290|consen 492 NRRGELRHIRRLKPWPLYEVLIEKYEWSEEDAQQFSDFLSPMLEFDPEKRPTAAQCLK 549 (590)
T ss_pred ccccceecccccCCCcHHHHHHHHhCCCHHHHHHHHHHHHHHHhcCccccccHHHHhc
Confidence 110 0 12345667788999999999999999999999875
|
|
| >KOG0590 consensus Checkpoint kinase and related serine/threonine protein kinases [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=99.70 E-value=1.7e-17 Score=177.30 Aligned_cols=181 Identities=19% Similarity=0.216 Sum_probs=134.8
Q ss_pred cceeeccCCC----C-CCCCCCChhhHHHHHHHHHHHHHHHhhcCCCceeecCCCccceEecCCCCceeccccceeecCC
Q 045315 243 ISFWYESYNN----P-TKKGLLCWGTRVRIIEGIAQGLLYLHQYSRLRVIHRDLKASNILLDKDMNPKISDFGMARMFGG 317 (476)
Q Consensus 243 ~~l~~Ey~~~----~-~~~~~L~~~~~~~i~~qIa~gL~yLH~~~~~~ivH~DLkp~NILld~~~~~kL~DFGla~~~~~ 317 (476)
.+-.|||++. . .....+...++..++.|+..|++|||+.| |.|||+|++|+++..++.+||+|||.+..+..
T Consensus 396 ~~~~mE~~~~Dlf~~~~~~~~~~~~e~~c~fKqL~~Gv~y~h~~G---iahrdlK~enll~~~~g~lki~Dfg~~~vf~~ 472 (601)
T KOG0590|consen 396 ILQSMEYCPYDLFSLVMSNGKLTPLEADCFFKQLLRGVKYLHSMG---LAHRDLKLENLLVTENGILKIIDFGAASVFRY 472 (601)
T ss_pred chhhhhcccHHHHHHHhcccccchhhhhHHHHHHHHHHHHHHhcC---ceeccCccccEEEecCCceEEeecCcceeecc
Confidence 3334899884 1 23348999999999999999999999999 99999999999999999999999999987654
Q ss_pred Cccc--ccceeeeeccCCCChhhhccCCCCc-cceEEeehhhhhhhhhCCCCCCcCCCCchhhhhhhhhhhcCCCccccc
Q 045315 318 DELQ--SNTKRIVGTYGYMSPEYALRGLFSI-KSDVFSFGVLLLETLSSKKNTHFYNTDSLTLLGHAWNLWNDGRTWELM 394 (476)
Q Consensus 318 ~~~~--~~~~~~~gt~~y~aPE~l~~~~~s~-ksDVwSlGvvl~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 394 (476)
.... .......|+..|+|||.+.+..|.+ ..||||.|+++..|++|+.||.........+..... ......
T Consensus 473 ~~e~~~~~~~g~~gS~pY~apE~~~~~~ydpr~vDiwS~~ii~~~m~~~~~~Wk~a~~~~~~~~~~~~----~~~~~~-- 546 (601)
T KOG0590|consen 473 PWEKNIHESSGIVGSDPYLAPEVLTGKEYDPRAVDVWSCGIIYICMILGRFPWKVAKKSDNSFKTNNY----SDQRNI-- 546 (601)
T ss_pred CcchhhhhhcCcccCCcCcCcccccccccCcchhhhhhccceEEEEecCCCccccccccccchhhhcc----cccccc--
Confidence 3322 3445578999999999999988865 599999999999999999998765433222111000 000000
Q ss_pred CcccCCCCCHHHHHHHHHHHHHchhhcccCCCCHHHHHH
Q 045315 395 DPISQNGASYPILKRYINVALLCVQEKAADRPAMSEVVS 433 (476)
Q Consensus 395 d~~~~~~~~~~~~~~l~~li~~Cl~~dP~~RPt~~eVl~ 433 (476)
..-..........+...++.++|+.+|.+|.|+++|++
T Consensus 547 -~~~~~~~~~~lp~~~~~~~~~~l~~~P~~R~ti~~i~~ 584 (601)
T KOG0590|consen 547 -FEGPNRLLSLLPRETRIIIYRMLQLDPTKRITIEQILN 584 (601)
T ss_pred -ccChHHHHHhchhhHHHHHHHHccCChhheecHHHHhh
Confidence 00001112234567788999999999999999999875
|
|
| >KOG1167 consensus Serine/threonine protein kinase of the CDC7 subfamily involved in DNA synthesis, repair and recombination [Replication, recombination and repair] | Back alignment and domain information |
|---|
Probab=99.69 E-value=5.2e-17 Score=159.39 Aligned_cols=190 Identities=22% Similarity=0.318 Sum_probs=130.1
Q ss_pred cccceeeccCCCCCC---CCCCChhhHHHHHHHHHHHHHHHhhcCCCceeecCCCccceEecC-CCCceeccccceeecC
Q 045315 241 DEISFWYESYNNPTK---KGLLCWGTRVRIIEGIAQGLLYLHQYSRLRVIHRDLKASNILLDK-DMNPKISDFGMARMFG 316 (476)
Q Consensus 241 ~~~~l~~Ey~~~~~~---~~~L~~~~~~~i~~qIa~gL~yLH~~~~~~ivH~DLkp~NILld~-~~~~kL~DFGla~~~~ 316 (476)
+...+++||+++... ...++..++...++.+..||+++|.+| ||||||||.|+|.+. .+.-.|.|||+|....
T Consensus 108 d~v~ivlp~~~H~~f~~l~~~l~~~~i~~Yl~~ll~Al~~~h~~G---IvHRDiKpsNFL~n~~t~rg~LvDFgLA~~~d 184 (418)
T KOG1167|consen 108 DQVAIVLPYFEHDRFRDLYRSLSLAEIRWYLRNLLKALAHLHKNG---IVHRDIKPSNFLYNRRTQRGVLVDFGLAQRYD 184 (418)
T ss_pred CeeEEEecccCccCHHHHHhcCCHHHHHHHHHHHHHHhhhhhccC---ccccCCCccccccccccCCceEEechhHHHHH
Confidence 456788999995443 346889999999999999999999999 999999999999984 4567899999997221
Q ss_pred CC-------------cc-----------------------------cccceeeeeccCCCChhhhccC-CCCccceEEee
Q 045315 317 GD-------------EL-----------------------------QSNTKRIVGTYGYMSPEYALRG-LFSIKSDVFSF 353 (476)
Q Consensus 317 ~~-------------~~-----------------------------~~~~~~~~gt~~y~aPE~l~~~-~~s~ksDVwSl 353 (476)
.. .. ........||++|.|||++... ..+++.||||.
T Consensus 185 ~~~~~~~s~~~~~~~~~~~~g~~~~~~~~~~~~~p~g~~~~~~~~r~~~~anrAGT~GfRaPEvL~k~~~QttaiDiws~ 264 (418)
T KOG1167|consen 185 GYQQTEHSRSYSGRHATPAMGKDVHCQSVATASKPAGYYRRCNDGRPSERANRAGTPGFRAPEVLFRCPRQTTAIDIWSA 264 (418)
T ss_pred hhhhhhhhhhhhcccCCccccCcccccccccccCCCCceeccCCCccceecccCCCCCCCchHHHhhccCcCCccceeec
Confidence 00 00 0001135689999999999865 46899999999
Q ss_pred hhhhhhhhhCCCCCCcCCCCchhhhhhhh---------hhhcCCC--ccc---------------ccC--cccCC-----
Q 045315 354 GVLLLETLSSKKNTHFYNTDSLTLLGHAW---------NLWNDGR--TWE---------------LMD--PISQN----- 400 (476)
Q Consensus 354 Gvvl~elltG~~p~~~~~~~~~~~~~~~~---------~~~~~~~--~~~---------------~~d--~~~~~----- 400 (476)
||+++-+++++.||-....+...+.+.+- .....|. ..+ -++ .....
T Consensus 265 GVI~Lslls~~~PFf~a~dd~~al~ei~tifG~~~mrk~A~l~g~~~l~~ksn~~~~~e~~~~f~s~~~~~~~~~~q~n~ 344 (418)
T KOG1167|consen 265 GVILLSLLSRRYPFFKAKDDADALAEIATIFGSAEMRKCAALPGRILLWQKSNIPTIPELRVNFETLHIESIYKSRQPNT 344 (418)
T ss_pred cceeehhhccccccccCccccchHHHHHHHhChHHHHHHhhcCCceeeeccccccccHHHHhchhccChhhcccccccce
Confidence 99999999999998654433332222111 0000111 000 000 00000
Q ss_pred ---CCCHHHHHHHHHHHHHchhhcccCCCCHHHHHH
Q 045315 401 ---GASYPILKRYINVALLCVQEKAADRPAMSEVVS 433 (476)
Q Consensus 401 ---~~~~~~~~~l~~li~~Cl~~dP~~RPt~~eVl~ 433 (476)
.........+.+++.+|++.||.+|.|+++.++
T Consensus 345 ~~~~~~d~~~~~~~dlLdk~le~np~kRitAEeALk 380 (418)
T KOG1167|consen 345 EREIGSDVFPALLLDLLDKCLELNPQKRITAEDALK 380 (418)
T ss_pred eeccccccccHHHHHHHHHHccCChhhcccHHHHhc
Confidence 001112347889999999999999999998764
|
|
| >KOG1152 consensus Signal transduction serine/threonine kinase with PAS/PAC sensor domain [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.61 E-value=2.8e-16 Score=159.07 Aligned_cols=107 Identities=24% Similarity=0.357 Sum_probs=95.9
Q ss_pred CCCCCChhhHHHHHHHHHHHHHHHhhcCCCceeecCCCccceEecCCCCceeccccceeecCCCcccccceeeeeccCCC
Q 045315 255 KKGLLCWGTRVRIIEGIAQGLLYLHQYSRLRVIHRDLKASNILLDKDMNPKISDFGMARMFGGDELQSNTKRIVGTYGYM 334 (476)
Q Consensus 255 ~~~~L~~~~~~~i~~qIa~gL~yLH~~~~~~ivH~DLkp~NILld~~~~~kL~DFGla~~~~~~~~~~~~~~~~gt~~y~ 334 (476)
.++.+++.++.-|+.||+.|+++||+.+ |||||||-+|+.++.+|-+||+|||.+....... ...++||..|.
T Consensus 663 ~kp~m~E~eAk~IFkQV~agi~hlh~~~---ivhrdikdenvivd~~g~~klidfgsaa~~ksgp----fd~f~gtv~~a 735 (772)
T KOG1152|consen 663 FKPRMDEPEAKLIFKQVVAGIKHLHDQG---IVHRDIKDENVIVDSNGFVKLIDFGSAAYTKSGP----FDVFVGTVDYA 735 (772)
T ss_pred ccCccchHHHHHHHHHHHhccccccccC---ceecccccccEEEecCCeEEEeeccchhhhcCCC----cceeeeecccc
Confidence 4667999999999999999999999999 9999999999999999999999999998765543 34488999999
Q ss_pred ChhhhccCCC-CccceEEeehhhhhhhhhCCCCCC
Q 045315 335 SPEYALRGLF-SIKSDVFSFGVLLLETLSSKKNTH 368 (476)
Q Consensus 335 aPE~l~~~~~-s~ksDVwSlGvvl~elltG~~p~~ 368 (476)
|||++.+.+| ...-|||++|++||.++....|+.
T Consensus 736 apevl~g~~y~gk~qdiwalgillytivykenpyy 770 (772)
T KOG1152|consen 736 APEVLGGEKYLGKPQDIWALGILLYTIVYKENPYY 770 (772)
T ss_pred chhhhCCCccCCCcchhhhhhheeeEEEeccCCCc
Confidence 9999998887 567899999999999998887764
|
|
| >smart00221 STYKc Protein kinase; unclassified specificity | Back alignment and domain information |
|---|
Probab=99.61 E-value=7.4e-16 Score=144.37 Aligned_cols=125 Identities=32% Similarity=0.393 Sum_probs=103.2
Q ss_pred cccceeeccCCCCC------CCCC-CChhhHHHHHHHHHHHHHHHhhcCCCceeecCCCccceEecCCCCceecccccee
Q 045315 241 DEISFWYESYNNPT------KKGL-LCWGTRVRIIEGIAQGLLYLHQYSRLRVIHRDLKASNILLDKDMNPKISDFGMAR 313 (476)
Q Consensus 241 ~~~~l~~Ey~~~~~------~~~~-L~~~~~~~i~~qIa~gL~yLH~~~~~~ivH~DLkp~NILld~~~~~kL~DFGla~ 313 (476)
..+++++||++..+ .... +++..+..++.+++.++.+||+.+ ++|+||+|.||+++.++.++|+|||.+.
T Consensus 70 ~~~~~v~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~---i~h~di~~~ni~v~~~~~~~l~d~g~~~ 146 (225)
T smart00221 70 EPLYLVMEYCEGGDLFDYLRKKGGKLSEEEARFYLRQILEALEYLHSLG---IVHRDLKPENILLGMDGLVKLADFGLAR 146 (225)
T ss_pred CceEEEEeccCCCCHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCCHHHEEEcCCCCEEEeeCceee
Confidence 35777888887422 1223 899999999999999999999998 9999999999999999999999999998
Q ss_pred ecCCCcccccceeeeeccCCCChhhh-ccCCCCccceEEeehhhhhhhhhCCCCCCc
Q 045315 314 MFGGDELQSNTKRIVGTYGYMSPEYA-LRGLFSIKSDVFSFGVLLLETLSSKKNTHF 369 (476)
Q Consensus 314 ~~~~~~~~~~~~~~~gt~~y~aPE~l-~~~~~s~ksDVwSlGvvl~elltG~~p~~~ 369 (476)
........ ......++..|++||.+ ....++.++|+|+||++++||++|+.||..
T Consensus 147 ~~~~~~~~-~~~~~~~~~~~~~pe~~~~~~~~~~~~Dv~~lG~~~~~l~~g~~pf~~ 202 (225)
T smart00221 147 FIHRDLAA-LLKTVKGTPFYLAPEVLLGGKGYGEAVDIWSLGVILYELLWGPEPFSG 202 (225)
T ss_pred EecCcccc-cccceeccCCcCCHhHhcCCCCCCchhhHHHHHHHHHHHHHCCCCccc
Confidence 76543211 22335678899999998 666778899999999999999999999854
|
Phosphotransferases. The specificity of this class of kinases can not be predicted. Possible dual-specificity Ser/Thr/Tyr kinase. |
| >KOG0576 consensus Mitogen-activated protein kinase kinase kinase kinase (MAP4K), germinal center kinase family [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.57 E-value=3.6e-15 Score=153.35 Aligned_cols=175 Identities=23% Similarity=0.324 Sum_probs=129.3
Q ss_pred cccceeeccCCCCC------CCCCCChhhHHHHHHHHHHHHHHHhhcCCCceeecCCCccceEecCCCCceeccccceee
Q 045315 241 DEISFWYESYNNPT------KKGLLCWGTRVRIIEGIAQGLLYLHQYSRLRVIHRDLKASNILLDKDMNPKISDFGMARM 314 (476)
Q Consensus 241 ~~~~l~~Ey~~~~~------~~~~L~~~~~~~i~~qIa~gL~yLH~~~~~~ivH~DLkp~NILld~~~~~kL~DFGla~~ 314 (476)
++.-+.|||+.++. --++|++.++.-.++..++||+|||+.+ -+|||||-.||++++.+.+|++|||.+-.
T Consensus 85 dklwicMEycgggslQdiy~~TgplselqiayvcRetl~gl~ylhs~g---k~hRdiKGanilltd~gDvklaDfgvsaq 161 (829)
T KOG0576|consen 85 DKLWICMEYCGGGSLQDIYHVTGPLSELQIAYVCRETLQGLKYLHSQG---KIHRDIKGANILLTDEGDVKLADFGVSAQ 161 (829)
T ss_pred cCcEEEEEecCCCcccceeeecccchhHHHHHHHhhhhccchhhhcCC---cccccccccceeecccCceeecccCchhh
Confidence 35567789998443 2568999999999999999999999999 89999999999999999999999999876
Q ss_pred cCCCcccccceeeeeccCCCChhhhc---cCCCCccceEEeehhhhhhhhhCCCCCCcCCCCchhhhhhhhhhhcCCCcc
Q 045315 315 FGGDELQSNTKRIVGTYGYMSPEYAL---RGLFSIKSDVFSFGVLLLETLSSKKNTHFYNTDSLTLLGHAWNLWNDGRTW 391 (476)
Q Consensus 315 ~~~~~~~~~~~~~~gt~~y~aPE~l~---~~~~s~ksDVwSlGvvl~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~ 391 (476)
++.. -.....+.||+.|||||+.. .+.|..++|||++|+..-|+---.+|.-.... .. +..+....
T Consensus 162 itat--i~KrksfiGtpywmapEvaaverkggynqlcdiwa~gitAiel~eLqpplfdlhp-mr-----~l~LmTkS--- 230 (829)
T KOG0576|consen 162 ITAT--IAKRKSFIGTPYWMAPEVAAVERKGGYNQLCDIWALGITAIELGELQPPLFDLHP-MR-----ALFLMTKS--- 230 (829)
T ss_pred hhhh--hhhhhcccCCccccchhHHHHHhcccccccccccccccchhhhhhcCCcccccch-HH-----HHHHhhcc---
Confidence 6542 22344588999999999874 57799999999999999998776666321111 11 11111111
Q ss_pred cccC-cccCCCCCHHHHHHHHHHHHHchhhcccCCCCHHHHH
Q 045315 392 ELMD-PISQNGASYPILKRYINVALLCVQEKAADRPAMSEVV 432 (476)
Q Consensus 392 ~~~d-~~~~~~~~~~~~~~l~~li~~Cl~~dP~~RPt~~eVl 432 (476)
..+ +.+.+ ...-.+.+.++++.|+..+|.+||+++.++
T Consensus 231 -~~qpp~lkD--k~kws~~fh~fvK~altknpKkRptaeklL 269 (829)
T KOG0576|consen 231 -GFQPPTLKD--KTKWSEFFHNFVKGALTKNPKKRPTAEKLL 269 (829)
T ss_pred -CCCCCcccC--CccchHHHHHHHHHHhcCCCccCCChhhhe
Confidence 111 11111 112235677889999999999999998765
|
|
| >KOG1023 consensus Natriuretic peptide receptor, guanylate cyclase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.56 E-value=6.7e-15 Score=151.17 Aligned_cols=176 Identities=22% Similarity=0.281 Sum_probs=127.0
Q ss_pred CCCCCChhhHHHHHHHHHHHHHHHhhcCCCceeecCCCccceEecCCCCceeccccceeecCCCcccccceeeeeccCCC
Q 045315 255 KKGLLCWGTRVRIIEGIAQGLLYLHQYSRLRVIHRDLKASNILLDKDMNPKISDFGMARMFGGDELQSNTKRIVGTYGYM 334 (476)
Q Consensus 255 ~~~~L~~~~~~~i~~qIa~gL~yLH~~~~~~ivH~DLkp~NILld~~~~~kL~DFGla~~~~~~~~~~~~~~~~gt~~y~ 334 (476)
..-.+++.-...++++|+.||+|||... -..|+.+++.|+++|....+||.|||+.................-...|.
T Consensus 41 ~~~~~d~~F~~s~~rdi~~Gl~ylh~s~--i~~hg~l~s~nClvd~~w~lklt~~Gl~~~~~~~~~~~~~~~~~~~~lw~ 118 (484)
T KOG1023|consen 41 EDIKLDYFFILSFIRDISKGLAYLHNSP--IGYHGALKSSNCLVDSRWVLKLTDFGLNSLLEETAEPEAHHPIRKALLWT 118 (484)
T ss_pred cccCccHHHHHHHHHHHHHHHHHHhcCc--ceeeeeeccccceeeeeEEEEechhhhcccccccccccccchhHHHHhcc
Confidence 3456889999999999999999999875 23999999999999999999999999987764311111111122456799
Q ss_pred ChhhhccC-------CCCccceEEeehhhhhhhhhCCCCCCcCCC--CchhhhhhhhhhhcCCCcccccCcccCCCCCHH
Q 045315 335 SPEYALRG-------LFSIKSDVFSFGVLLLETLSSKKNTHFYNT--DSLTLLGHAWNLWNDGRTWELMDPISQNGASYP 405 (476)
Q Consensus 335 aPE~l~~~-------~~s~ksDVwSlGvvl~elltG~~p~~~~~~--~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~ 405 (476)
|||.+... ..+.+.||||||++++|+++.+.||+.... +...+...+.. .....+.|.+.... +
T Consensus 119 aPellr~~~~~~~~~~~~~~gdiYs~~ii~~ei~~r~~~~~~~~~~~~~~eii~~~~~-----~~~~~~rP~i~~~~--e 191 (484)
T KOG1023|consen 119 APELLRGALSQSLESALTQKGDIYSFGIIMYEILFRSGPFDLRNLVEDPDEIILRVKK-----GGSNPFRPSIELLN--E 191 (484)
T ss_pred CHHHhcccccccccccccccCCeehHHHHHHHHHhccCccccccccCChHHHHHHHHh-----cCCCCcCcchhhhh--h
Confidence 99998753 146789999999999999999999986542 22222222211 11122222222111 3
Q ss_pred HHHHHHHHHHHchhhcccCCCCHHHHHHHHhccc
Q 045315 406 ILKRYINVALLCVQEKAADRPAMSEVVSMLSNEF 439 (476)
Q Consensus 406 ~~~~l~~li~~Cl~~dP~~RPt~~eVl~~L~~~~ 439 (476)
....+..++.+||..+|.+||++++|-..++.+.
T Consensus 192 ~~~~l~~l~~~cw~e~P~~rPs~~~i~~~~~~~~ 225 (484)
T KOG1023|consen 192 LPPELLLLVARCWEEIPEKRPSIEQIRSKLLTIN 225 (484)
T ss_pred cchHHHHHHHHhcccChhhCccHHHHHhhhhhhc
Confidence 3347889999999999999999999999988865
|
|
| >PF14531 Kinase-like: Kinase-like; PDB: 3DZO_A 2W1Z_A 3BYV_A 3Q5Z_A 3Q60_A | Back alignment and domain information |
|---|
Probab=99.55 E-value=4.4e-15 Score=143.71 Aligned_cols=142 Identities=17% Similarity=0.227 Sum_probs=99.4
Q ss_pred CCCCChhhHHHHHHHHHHHHHHHhhcCCCceeecCCCccceEecCCCCceeccccceeecCCCcccccceeeeeccCCCC
Q 045315 256 KGLLCWGTRVRIIEGIAQGLLYLHQYSRLRVIHRDLKASNILLDKDMNPKISDFGMARMFGGDELQSNTKRIVGTYGYMS 335 (476)
Q Consensus 256 ~~~L~~~~~~~i~~qIa~gL~yLH~~~~~~ivH~DLkp~NILld~~~~~kL~DFGla~~~~~~~~~~~~~~~~gt~~y~a 335 (476)
...+....++.+..|+++.+++||..| ++|+||||+|++++++|.++|+||+.....+..... ...+..|.+
T Consensus 139 ~~~l~~~arl~lT~Q~I~lvA~Lh~~G---lVHgdi~~~nfll~~~G~v~Lg~F~~~~r~g~~~~~-----~~~~~~~~P 210 (288)
T PF14531_consen 139 HSPLAFAARLSLTVQMIRLVANLHSYG---LVHGDIKPENFLLDQDGGVFLGDFSSLVRAGTRYRC-----SEFPVAFTP 210 (288)
T ss_dssp SHHHHHHHHHHHHHHHHHHHHHHHHTT---EEEST-SGGGEEE-TTS-EEE--GGGEEETTEEEEG-----GGS-TTTS-
T ss_pred cchhHHHHHHHHHHHHHHHHHHHhhcc---eEecccceeeEEEcCCCCEEEcChHHHeecCceeec-----cCCCcccCC
Confidence 345667778888999999999999999 999999999999999999999999988876543221 123578999
Q ss_pred hhhhcc--------CCCCccceEEeehhhhhhhhhCCCCCCcCCCCchhhhhhhhhhhcCCCcccccCcccCCCCCHHHH
Q 045315 336 PEYALR--------GLFSIKSDVFSFGVLLLETLSSKKNTHFYNTDSLTLLGHAWNLWNDGRTWELMDPISQNGASYPIL 407 (476)
Q Consensus 336 PE~l~~--------~~~s~ksDVwSlGvvl~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~ 407 (476)
||.... ..++.+.|.|++|+++|.|+|++.||........... .-..+. +.+
T Consensus 211 Pe~~~~~~~~~~~~~~~t~~~DaW~LG~~ly~lWC~~lPf~~~~~~~~~~~-------------------~f~~C~-~~P 270 (288)
T PF14531_consen 211 PELESCAGQFGQNNAPYTFATDAWQLGITLYSLWCGRLPFGLSSPEADPEW-------------------DFSRCR-DMP 270 (288)
T ss_dssp HHHHHHHTSCHHSEEEE-HHHHHHHHHHHHHHHHHSS-STCCCGGGSTSGG-------------------GGTTSS----
T ss_pred hhhhhhhcccCcccceeeeccCHHHHHHHHHHHHHccCCCCCCCccccccc-------------------cchhcC-CcC
Confidence 997753 2478999999999999999999999875431111000 111223 566
Q ss_pred HHHHHHHHHchhhcccCC
Q 045315 408 KRYINVALLCVQEKAADR 425 (476)
Q Consensus 408 ~~l~~li~~Cl~~dP~~R 425 (476)
+.+..++..+|+.+|++|
T Consensus 271 e~v~~LI~~lL~~~~~~R 288 (288)
T PF14531_consen 271 EPVQFLIRGLLQRNPEDR 288 (288)
T ss_dssp HHHHHHHHHHT-SSGGGS
T ss_pred HHHHHHHHHHccCCcccC
Confidence 788899999999999998
|
|
| >KOG1033 consensus eIF-2alpha kinase PEK/EIF2AK3 [Translation, ribosomal structure and biogenesis] | Back alignment and domain information |
|---|
Probab=99.53 E-value=2.1e-15 Score=152.47 Aligned_cols=154 Identities=27% Similarity=0.324 Sum_probs=111.0
Q ss_pred CCCCCCCChhhHHHHHHHHHHHHHHHhhcCCCceeecCCCccceEecCCCCceeccccceeecCCCc----ccccceeee
Q 045315 253 PTKKGLLCWGTRVRIIEGIAQGLLYLHQYSRLRVIHRDLKASNILLDKDMNPKISDFGMARMFGGDE----LQSNTKRIV 328 (476)
Q Consensus 253 ~~~~~~L~~~~~~~i~~qIa~gL~yLH~~~~~~ivH~DLkp~NILld~~~~~kL~DFGla~~~~~~~----~~~~~~~~~ 328 (476)
.......++.....++.|++.|+.| ++ .+|+|+||.||+...+..+||.|||+........ .........
T Consensus 350 r~~~e~~s~s~~~~~~~q~~~~~~y---k~---~ihrdlkp~nif~~~d~q~kIgDFgl~ts~~~~~~~~~~~a~~t~~~ 423 (516)
T KOG1033|consen 350 RRTGEERSLSLMLDIFKQIAPAVEY---KG---LIHRDLKPSNIFFSDDDQLKIGDFGLVTSQDKDETVAPAAASHTQQV 423 (516)
T ss_pred CCcccccchhHHHHHHHhhccchhh---cc---chhhhccccccccccchhhhhhhhhheeecccCCcccchhhhhhhcc
Confidence 3445678889999999999999999 66 9999999999999999999999999998765544 122334467
Q ss_pred eccCCCChhhhccCCCCccceEEeehhhhhhhhh-CCCCCCcCCCCchhhhhhhhhhhcCCCcccccCcccCCCCCHHHH
Q 045315 329 GTYGYMSPEYALRGLFSIKSDVFSFGVLLLETLS-SKKNTHFYNTDSLTLLGHAWNLWNDGRTWELMDPISQNGASYPIL 407 (476)
Q Consensus 329 gt~~y~aPE~l~~~~~s~ksDVwSlGvvl~ellt-G~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~ 407 (476)
||..||+||.+.+..|+.|+||||||++|+|++. -...+... .+..-++.+.+. +.... ..
T Consensus 424 gt~~YmsPEQi~g~~y~~kvdIyaLGlil~EL~~~f~T~~er~---------~t~~d~r~g~ip----~~~~~-----d~ 485 (516)
T KOG1033|consen 424 GTLLYMSPEQIRGQQYSEKVDIYALGLILAELLIQFSTQFERI---------ATLTDIRDGIIP----PEFLQ-----DY 485 (516)
T ss_pred cccccCCHHHHhhhhhhhhcchhhHHHHHHHHHHHhccHHHHH---------HhhhhhhcCCCC----hHHhh-----cC
Confidence 9999999999999999999999999999999996 22111100 011111111111 11111 11
Q ss_pred HHHHHHHHHchhhcccCCCCHHH
Q 045315 408 KRYINVALLCVQEKAADRPAMSE 430 (476)
Q Consensus 408 ~~l~~li~~Cl~~dP~~RPt~~e 430 (476)
..-..++.+++...|.+||++.+
T Consensus 486 p~e~~ll~~lls~~p~~RP~~~~ 508 (516)
T KOG1033|consen 486 PEEYTLLQQLLSPSPEERPSAIE 508 (516)
T ss_pred cHHHHHHHHhcCCCcccCchHHH
Confidence 23346788999999999995444
|
|
| >COG0515 SPS1 Serine/threonine protein kinase [General function prediction only / Signal transduction mechanisms / Transcription / DNA replication, recombination, and repair] | Back alignment and domain information |
|---|
Probab=99.47 E-value=1.9e-13 Score=133.45 Aligned_cols=170 Identities=29% Similarity=0.331 Sum_probs=123.4
Q ss_pred CCCChhhHHHHHHHHHHHHHHHhhcCCCceeecCCCccceEecCCC-CceeccccceeecCCCcccc----cceeeeecc
Q 045315 257 GLLCWGTRVRIIEGIAQGLLYLHQYSRLRVIHRDLKASNILLDKDM-NPKISDFGMARMFGGDELQS----NTKRIVGTY 331 (476)
Q Consensus 257 ~~L~~~~~~~i~~qIa~gL~yLH~~~~~~ivH~DLkp~NILld~~~-~~kL~DFGla~~~~~~~~~~----~~~~~~gt~ 331 (476)
..++......++.|++.++.|+|+.+ ++|||+||+||+++... .++++|||.++......... ......|+.
T Consensus 96 ~~~~~~~~~~~~~~~~~~l~~~H~~~---~~hrd~kp~nil~~~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~~t~ 172 (384)
T COG0515 96 GPLSESEALFILAQILSALEYLHSKG---IIHRDIKPENILLDRDGRVVKLIDFGLAKLLPDPGSTSSIPALPSTSVGTP 172 (384)
T ss_pred cCCCHHHHHHHHHHHHHHHHHHHhCC---eeccCCCHHHeeecCCCCeEEEeccCcceecCCCCcccccccccccccccc
Confidence 37889999999999999999999999 99999999999999988 69999999998665443221 234578999
Q ss_pred CCCChhhhcc---CCCCccceEEeehhhhhhhhhCCCCCCcCCCC--chhhhhhhhhhhcCCCcccccCcccCCCCCHHH
Q 045315 332 GYMSPEYALR---GLFSIKSDVFSFGVLLLETLSSKKNTHFYNTD--SLTLLGHAWNLWNDGRTWELMDPISQNGASYPI 406 (476)
Q Consensus 332 ~y~aPE~l~~---~~~s~ksDVwSlGvvl~elltG~~p~~~~~~~--~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~ 406 (476)
.|++||.+.+ ..++...|+|++|++++++++|..|+...... .............. ..............
T Consensus 173 ~~~~pe~~~~~~~~~~~~~~D~~s~g~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~-----~~~~~~~~~~~~~~ 247 (384)
T COG0515 173 GYMAPEVLLGLSLAYASSSSDIWSLGITLYELLTGLPPFEGEKNSSATSQTLKIILELPTP-----SLASPLSPSNPELI 247 (384)
T ss_pred ccCCHHHhcCCCCCCCCchHhHHHHHHHHHHHHhCCCCCCCCCccccHHHHHHHHHhcCCc-----ccccccCccccchh
Confidence 9999999987 57899999999999999999999996544321 11111111111100 00000000000222
Q ss_pred HHHHHHHHHHchhhcccCCCCHHHHHHH
Q 045315 407 LKRYINVALLCVQEKAADRPAMSEVVSM 434 (476)
Q Consensus 407 ~~~l~~li~~Cl~~dP~~RPt~~eVl~~ 434 (476)
...+.+++..|+..+|..|.++.+....
T Consensus 248 ~~~~~~~~~~~~~~~~~~r~~~~~~~~~ 275 (384)
T COG0515 248 SKAASDLLKKLLAKDPKNRLSSSSDLSH 275 (384)
T ss_pred hHHHHHHHHHHHhcCchhcCCHHHHhhc
Confidence 3567889999999999999998876653
|
|
| >KOG1164 consensus Casein kinase (serine/threonine/tyrosine protein kinase) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.46 E-value=2.7e-13 Score=135.72 Aligned_cols=171 Identities=22% Similarity=0.222 Sum_probs=122.3
Q ss_pred CCCCChhhHHHHHHHHHHHHHHHhhcCCCceeecCCCccceEecCC-----CCceecccccee--ecCCCc----cccc-
Q 045315 256 KGLLCWGTRVRIIEGIAQGLLYLHQYSRLRVIHRDLKASNILLDKD-----MNPKISDFGMAR--MFGGDE----LQSN- 323 (476)
Q Consensus 256 ~~~L~~~~~~~i~~qIa~gL~yLH~~~~~~ivH~DLkp~NILld~~-----~~~kL~DFGla~--~~~~~~----~~~~- 323 (476)
.+.++..+.++|+.|++.+|++||+.| ++||||||+|+++... ..+.|.|||+++ .+.... ....
T Consensus 116 ~~~fs~~T~l~ia~q~l~~l~~lH~~G---~iHRDiKp~N~~~g~~~~~~~~~~~llDfGlar~~~~~~~~~~~~~~~r~ 192 (322)
T KOG1164|consen 116 PGRFSRKTVLRIAIQNLNALEDLHSKG---FIHRDIKPENFVVGQSSRSEVRTLYLLDFGLARRFKYVGDSGGNLRPPRP 192 (322)
T ss_pred CCCcCHhHHHHHHHHHHHHHHHHHhcC---cccCCcCHHHeeecCCCCcccceEEEEecCCCccccccCCCCcccccCCC
Confidence 578999999999999999999999999 9999999999999855 358999999998 332111 1111
Q ss_pred -ceeeeeccCCCChhhhccCCCCccceEEeehhhhhhhhhCCCCCCcCCCC-chhhhhhhhhhhcCCCcccccCcccCCC
Q 045315 324 -TKRIVGTYGYMSPEYALRGLFSIKSDVFSFGVLLLETLSSKKNTHFYNTD-SLTLLGHAWNLWNDGRTWELMDPISQNG 401 (476)
Q Consensus 324 -~~~~~gt~~y~aPE~l~~~~~s~ksDVwSlGvvl~elltG~~p~~~~~~~-~~~~~~~~~~~~~~~~~~~~~d~~~~~~ 401 (476)
.....||..|.++....+...+.+.|+||++.++.|++.|..|+...... ....... .... ..... ...
T Consensus 193 ~~~~~rGT~ry~S~~~H~~~e~~r~DDles~~Y~l~el~~g~LPW~~~~~~~~~~~~~~---~~~~----~~~~~--~~~ 263 (322)
T KOG1164|consen 193 QKGLFRGTLRYASINVHLGIEQGRRDDLESLFYMLLELLKGSLPWEALEMTDLKSKFEK---DPRK----LLTDR--FGD 263 (322)
T ss_pred CccCCCCccccccHHHhCCCccCCchhhhhHHHHHHHHhcCCCCCccccccchHHHHHH---Hhhh----hcccc--ccC
Confidence 22356999999999999999999999999999999999999988544321 1111100 0000 00000 111
Q ss_pred CCHHHHHHHHHHHHHchhhcccCCCCHHHHHHHHhccccC
Q 045315 402 ASYPILKRYINVALLCVQEKAADRPAMSEVVSMLSNEFVN 441 (476)
Q Consensus 402 ~~~~~~~~l~~li~~Cl~~dP~~RPt~~eVl~~L~~~~~~ 441 (476)
.. ...+.++...+-..+..++|....+...|++....
T Consensus 264 ~~---~~~~~~~~~~~~~~~~~~~Pdy~~~~~~l~~~~~~ 300 (322)
T KOG1164|consen 264 LK---PEEFAKILEYIDSLDYEDKPDYEKLAELLKDVFDS 300 (322)
T ss_pred CC---hHHHHHHHHHhhccCCcCCCCHHHHHHHHHHHHHh
Confidence 12 23444555545557999999999999998776543
|
|
| >KOG1240 consensus Protein kinase containing WD40 repeats [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.44 E-value=6.1e-14 Score=151.42 Aligned_cols=177 Identities=16% Similarity=0.161 Sum_probs=119.3
Q ss_pred ccceeeccCC-----CCCCCCCCChhhHHHHHHHHHHHHHHHhhcCCCceeecCCCccceEecCCCCceeccccceeec-
Q 045315 242 EISFWYESYN-----NPTKKGLLCWGTRVRIIEGIAQGLLYLHQYSRLRVIHRDLKASNILLDKDMNPKISDFGMARMF- 315 (476)
Q Consensus 242 ~~~l~~Ey~~-----~~~~~~~L~~~~~~~i~~qIa~gL~yLH~~~~~~ivH~DLkp~NILld~~~~~kL~DFGla~~~- 315 (476)
..|++-+|.. ...-+.-|..-+..-|+.|++.||..+|..+ |+|||||.+|||+..=.-+.|+||.-.+..
T Consensus 95 AAylvRqyvkhnLyDRlSTRPFL~~iEKkWiaFQLL~al~qcH~~g---VcHGDIKsENILiTSWNW~~LtDFAsFKPtY 171 (1431)
T KOG1240|consen 95 AAYLVRQYVKHNLYDRLSTRPFLVLIEKKWIAFQLLKALSQCHKLG---VCHGDIKSENILITSWNWLYLTDFASFKPTY 171 (1431)
T ss_pred HHHHHHHHHhhhhhhhhccchHHHHHHHHHHHHHHHHHHHHHHHcC---ccccccccceEEEeeechhhhhcccccCCcc
Confidence 3555556665 2344666788888999999999999999999 999999999999998888999999876532
Q ss_pred -CCCcccccceeee----eccCCCChhhhccC----------C-CCccceEEeehhhhhhhhhC-CCCCCcCCCCchhhh
Q 045315 316 -GGDELQSNTKRIV----GTYGYMSPEYALRG----------L-FSIKSDVFSFGVLLLETLSS-KKNTHFYNTDSLTLL 378 (476)
Q Consensus 316 -~~~~~~~~~~~~~----gt~~y~aPE~l~~~----------~-~s~ksDVwSlGvvl~elltG-~~p~~~~~~~~~~~~ 378 (476)
.++... ....+. .-.-|.|||.+... + .+++.||||+||++.||++- +++|... .+.
T Consensus 172 LPeDNPa-df~fFFDTSrRRtCYiAPERFv~~~~~~~~~q~~~~L~paMDIFS~GCViaELf~Eg~PlF~LS-----QL~ 245 (1431)
T KOG1240|consen 172 LPEDNPA-DFTFFFDTSRRRTCYIAPERFVSALGKTSVGQDAPLLTPAMDIFSAGCVIAELFLEGRPLFTLS-----QLL 245 (1431)
T ss_pred CCCCCcc-cceEEEecCCceeeecChHhhhccccccccCCcccccChhhhhhhhhHHHHHHHhcCCCcccHH-----HHH
Confidence 222111 111111 22369999987531 2 57899999999999999885 6666421 111
Q ss_pred hhhhhhhcCCCcccccCcccCCCCCHHHHHHHHHHHHHchhhcccCCCCHHHHHHHHhc
Q 045315 379 GHAWNLWNDGRTWELMDPISQNGASYPILKRYINVALLCVQEKAADRPAMSEVVSMLSN 437 (476)
Q Consensus 379 ~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~l~~li~~Cl~~dP~~RPt~~eVl~~L~~ 437 (476)
.+ +.+. .......+..- +...+.++++.|++.||.+|.++++.++.-.+
T Consensus 246 aY-----r~~~-~~~~e~~Le~I----ed~~~Rnlil~Mi~rdPs~RlSAedyL~~yrG 294 (1431)
T KOG1240|consen 246 AY-----RSGN-ADDPEQLLEKI----EDVSLRNLILSMIQRDPSKRLSAEDYLQKYRG 294 (1431)
T ss_pred hH-----hccC-ccCHHHHHHhC----cCccHHHHHHHHHccCchhccCHHHHHHhhhc
Confidence 11 0110 00000001100 11257789999999999999999999987444
|
|
| >KOG0195 consensus Integrin-linked kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.43 E-value=1.1e-13 Score=129.02 Aligned_cols=173 Identities=18% Similarity=0.214 Sum_probs=124.3
Q ss_pred ccceeeccCC--------CCCCCCCCChhhHHHHHHHHHHHHHHHhhcCCCceeecCCCccceEecCCCCceec--cccc
Q 045315 242 EISFWYESYN--------NPTKKGLLCWGTRVRIIEGIAQGLLYLHQYSRLRVIHRDLKASNILLDKDMNPKIS--DFGM 311 (476)
Q Consensus 242 ~~~l~~Ey~~--------~~~~~~~L~~~~~~~i~~qIa~gL~yLH~~~~~~ivH~DLkp~NILld~~~~~kL~--DFGl 311 (476)
...++..||| .+...-..+..++.+++.+||+|++|||+... .|..--|+...+++|++..++|+ |--+
T Consensus 261 nlv~isq~mp~gslynvlhe~t~vvvd~sqav~faldiargmaflhslep-~ipr~~lns~hvmidedltarismad~kf 339 (448)
T KOG0195|consen 261 NLVIISQYMPFGSLYNVLHEQTSVVVDHSQAVRFALDIARGMAFLHSLEP-MIPRFYLNSKHVMIDEDLTARISMADTKF 339 (448)
T ss_pred CceEeeeeccchHHHHHHhcCccEEEecchHHHHHHHHHhhHHHHhhcch-hhhhhhcccceEEecchhhhheeccccee
Confidence 4567788998 23334467888999999999999999999762 24455688999999999988764 3222
Q ss_pred eeecCCCcccccceeeeeccCCCChhhhccCCC---CccceEEeehhhhhhhhhCCCCCCcCCCCchhhhhhhhhhhcCC
Q 045315 312 ARMFGGDELQSNTKRIVGTYGYMSPEYALRGLF---SIKSDVFSFGVLLLETLSSKKNTHFYNTDSLTLLGHAWNLWNDG 388 (476)
Q Consensus 312 a~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~---s~ksDVwSlGvvl~elltG~~p~~~~~~~~~~~~~~~~~~~~~~ 388 (476)
+.. .....-.+.|++||.+...+- -.++|.|||++++|||.|...||......+..... +
T Consensus 340 sfq---------e~gr~y~pawmspealqrkped~n~raadmwsfaillwel~trevpfadlspmecgmki-a------- 402 (448)
T KOG0195|consen 340 SFQ---------EVGRAYSPAWMSPEALQRKPEDLNIRAADMWSFAILLWELNTREVPFADLSPMECGMKI-A------- 402 (448)
T ss_pred eee---------ccccccCcccCCHHHHhcCchhcchhhhhHHHHHHHHHHhhccccccccCCchhhhhhh-h-------
Confidence 211 111334678999999986654 36799999999999999999999755432221110 0
Q ss_pred CcccccCcccCCCCCHHHHHHHHHHHHHchhhcccCCCCHHHHHHHHhcc
Q 045315 389 RTWELMDPISQNGASYPILKRYINVALLCVQEKAADRPAMSEVVSMLSNE 438 (476)
Q Consensus 389 ~~~~~~d~~~~~~~~~~~~~~l~~li~~Cl~~dP~~RPt~~eVl~~L~~~ 438 (476)
-..++...++.....+.+++.-|..+||.+||.+..|+-.||..
T Consensus 403 ------leglrv~ippgis~hm~klm~icmnedpgkrpkfdmivpilekm 446 (448)
T KOG0195|consen 403 ------LEGLRVHIPPGISRHMNKLMNICMNEDPGKRPKFDMIVPILEKM 446 (448)
T ss_pred ------hccccccCCCCccHHHHHHHHHHhcCCCCcCCCcceehhhHHHh
Confidence 01122233344556788899999999999999999999999875
|
|
| >KOG4158 consensus BRPK/PTEN-induced protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.43 E-value=3.3e-13 Score=131.78 Aligned_cols=156 Identities=21% Similarity=0.207 Sum_probs=107.9
Q ss_pred CCChhhHHHHHHHHHHHHHHHhhcCCCceeecCCCccceEec--CCCC--ceeccccceeecCCCccc----ccceeeee
Q 045315 258 LLCWGTRVRIIEGIAQGLLYLHQYSRLRVIHRDLKASNILLD--KDMN--PKISDFGMARMFGGDELQ----SNTKRIVG 329 (476)
Q Consensus 258 ~L~~~~~~~i~~qIa~gL~yLH~~~~~~ivH~DLkp~NILld--~~~~--~kL~DFGla~~~~~~~~~----~~~~~~~g 329 (476)
.++...+.-|+.|+++|+.|||+++ |.|||+|.+|||+. +++. ..|+|||++-.......+ .......|
T Consensus 337 ~~s~r~~~~~laQlLEav~hL~~hg---vAhRDlKSDNiL~ElddD~~P~LVvaDFGCcLAd~~hGlqlpy~S~~Vd~GG 413 (598)
T KOG4158|consen 337 HRSYRTGRVILAQLLEAVTHLHKHG---VAHRDLKSDNILLELDDDEIPQLVVADFGCCLADDNHGLQLPYESDEVDLGG 413 (598)
T ss_pred CCchHHHHHHHHHHHHHHHHHHHcc---chhhcccccceEEEecCCCCcEEEEcccceeeeccccccccccccccccCCC
Confidence 3566778889999999999999999 99999999999983 4443 578999998654332111 11123457
Q ss_pred ccCCCChhhhccCC--C----CccceEEeehhhhhhhhhCCCCCCcCCCCchhhhhhhhhhhcCCCcccccCcccCCCCC
Q 045315 330 TYGYMSPEYALRGL--F----SIKSDVFSFGVLLLETLSSKKNTHFYNTDSLTLLGHAWNLWNDGRTWELMDPISQNGAS 403 (476)
Q Consensus 330 t~~y~aPE~l~~~~--~----s~ksDVwSlGvvl~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~ 403 (476)
...-||||+....+ . -.|+|.|+.|.+.||++....||....+....... ..+.... ..+
T Consensus 414 Na~lmAPEi~ta~PGp~avvny~kAD~WA~GalaYEIfg~~NPFY~rGem~L~~r~-----Yqe~qLP---------alp 479 (598)
T KOG4158|consen 414 NAKLMAPEIATAVPGPNAVVNYEKADTWAAGALAYEIFGRSNPFYKRGEMLLDTRT-----YQESQLP---------ALP 479 (598)
T ss_pred cceecchhhhhcCCCCceeeccchhhhhhhhhhHHHHhccCCcccccchheechhh-----hhhhhCC---------CCc
Confidence 77889999886432 1 26899999999999999999998753222111111 1111111 112
Q ss_pred HHHHHHHHHHHHHchhhcccCCCCHHH
Q 045315 404 YPILKRYINVALLCVQEKAADRPAMSE 430 (476)
Q Consensus 404 ~~~~~~l~~li~~Cl~~dP~~RPt~~e 430 (476)
......+.+++...|+.||++|++..-
T Consensus 480 ~~vpp~~rqlV~~lL~r~pskRvsp~i 506 (598)
T KOG4158|consen 480 SRVPPVARQLVFDLLKRDPSKRVSPNI 506 (598)
T ss_pred ccCChHHHHHHHHHhcCCccccCCccH
Confidence 223345778889999999999998643
|
|
| >KOG0603 consensus Ribosomal protein S6 kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.30 E-value=1.7e-12 Score=133.94 Aligned_cols=144 Identities=21% Similarity=0.229 Sum_probs=109.0
Q ss_pred CCCCCCChhhHHHHHHHHHHHHHHHhhcCCCceeecCCCccceEecCCCCceeccccceeecCCCcccccceeeeeccCC
Q 045315 254 TKKGLLCWGTRVRIIEGIAQGLLYLHQYSRLRVIHRDLKASNILLDKDMNPKISDFGMARMFGGDELQSNTKRIVGTYGY 333 (476)
Q Consensus 254 ~~~~~L~~~~~~~i~~qIa~gL~yLH~~~~~~ivH~DLkp~NILld~~~~~kL~DFGla~~~~~~~~~~~~~~~~gt~~y 333 (476)
.+...+...........++-+++++|+.+ |+|||+|++||+++.+|.+|+.|||+++..-.... ..||..|
T Consensus 89 ~~~~~f~~~~~~~~~aelaLald~lh~l~---iiyrd~k~enilld~~Ghi~~tdfglske~v~~~~------~cgt~ey 159 (612)
T KOG0603|consen 89 SKEVMFDELDVAFYLAELALALDHLHKLG---IAYRDYKLENVLLLLEGHIKLTDFGLSKEAVKEKI------ACGTYEY 159 (612)
T ss_pred ccCCchHHHHHHHHHHHHHHHHhhcchhH---HHHhcccccceeecccCccccCCchhhhHhHhhhh------cccchhh
Confidence 34445666677778889999999999999 99999999999999999999999999987643322 2789999
Q ss_pred CChhhhccCCCCccceEEeehhhhhhhhhCCCCCCcCCCCchhhhhhhhhhhcCCCcccccCcccCCCCCHHHHHHHHHH
Q 045315 334 MSPEYALRGLFSIKSDVFSFGVLLLETLSSKKNTHFYNTDSLTLLGHAWNLWNDGRTWELMDPISQNGASYPILKRYINV 413 (476)
Q Consensus 334 ~aPE~l~~~~~s~ksDVwSlGvvl~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~l~~l 413 (476)
||||++. .....+|.||||++.+||++|..||.. ... ..... .....+......+.++
T Consensus 160 mApEI~~--gh~~a~D~ws~gvl~felltg~~pf~~------~~~---~~Il~-----------~~~~~p~~l~~~a~~~ 217 (612)
T KOG0603|consen 160 RAPEIIN--GHLSAADWWSFGVLAFELLTGTLPFGG------DTM---KRILK-----------AELEMPRELSAEARSL 217 (612)
T ss_pred hhhHhhh--ccCCcccchhhhhhHHHHhhCCCCCch------HHH---HHHhh-----------hccCCchhhhHHHHHH
Confidence 9999988 567899999999999999999999864 111 01110 0111223334456677
Q ss_pred HHHchhhcccCCCCH
Q 045315 414 ALLCVQEKAADRPAM 428 (476)
Q Consensus 414 i~~Cl~~dP~~RPt~ 428 (476)
+..+...+|.+|--.
T Consensus 218 ~~~l~~r~p~nrLg~ 232 (612)
T KOG0603|consen 218 FRQLFKRNPENRLGA 232 (612)
T ss_pred HHHHHhhCHHHHhcc
Confidence 777888888888644
|
|
| >PRK09188 serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=99.30 E-value=2.3e-12 Score=129.96 Aligned_cols=107 Identities=16% Similarity=0.127 Sum_probs=77.0
Q ss_pred cccceeeccCCCCCCCCCCChhhHHHHHHHHHHHHHHHhhcCCCceeecCC-CccceEecCCCCceeccccceeecCCCc
Q 045315 241 DEISFWYESYNNPTKKGLLCWGTRVRIIEGIAQGLLYLHQYSRLRVIHRDL-KASNILLDKDMNPKISDFGMARMFGGDE 319 (476)
Q Consensus 241 ~~~~l~~Ey~~~~~~~~~L~~~~~~~i~~qIa~gL~yLH~~~~~~ivH~DL-kp~NILld~~~~~kL~DFGla~~~~~~~ 319 (476)
+..+++|||++...-.. +.......++.++++||.|||+.+ |+|||| ||+|||++.++.+||+|||+++.+....
T Consensus 91 ~~~~LVmE~~~G~~L~~-~~~~~~~~~~~~i~~aL~~lH~~g---IiHrDL~KP~NILv~~~~~ikLiDFGlA~~~~~~~ 166 (365)
T PRK09188 91 GKDGLVRGWTEGVPLHL-ARPHGDPAWFRSAHRALRDLHRAG---ITHNDLAKPQNWLMGPDGEAAVIDFQLASVFRRRG 166 (365)
T ss_pred CCcEEEEEccCCCCHHH-hCccchHHHHHHHHHHHHHHHHCC---CeeCCCCCcceEEEcCCCCEEEEECccceecccCc
Confidence 45789999998432211 111113578999999999999999 999999 9999999999999999999999775432
Q ss_pred cccc------ceeeeeccCCCChhhhccCC------CCccceEE
Q 045315 320 LQSN------TKRIVGTYGYMSPEYALRGL------FSIKSDVF 351 (476)
Q Consensus 320 ~~~~------~~~~~gt~~y~aPE~l~~~~------~s~ksDVw 351 (476)
.... .....+++.|+|||.+.... .+..+|-|
T Consensus 167 ~~~~~~~~~d~~~~~~~~~~~~pe~~~~~~~~~~~~~~~~~dgW 210 (365)
T PRK09188 167 ALYRIAAYEDLRHLLKHKRTYAPDALTPRERKILARKSLPSRIW 210 (365)
T ss_pred chhhhhhhhhhhhhhccCccCCcccCChhhhccccccccccCcE
Confidence 1111 12356788899999885321 23446666
|
|
| >KOG0606 consensus Microtubule-associated serine/threonine kinase and related proteins [Signal transduction mechanisms; General function prediction only] | Back alignment and domain information |
|---|
Probab=99.27 E-value=9.8e-13 Score=142.10 Aligned_cols=139 Identities=23% Similarity=0.317 Sum_probs=102.9
Q ss_pred HHHHHHHhhcCCCceeecCCCccceEecCCCCceeccccceeecCCC-------------cccccceeeeeccCCCChhh
Q 045315 272 AQGLLYLHQYSRLRVIHRDLKASNILLDKDMNPKISDFGMARMFGGD-------------ELQSNTKRIVGTYGYMSPEY 338 (476)
Q Consensus 272 a~gL~yLH~~~~~~ivH~DLkp~NILld~~~~~kL~DFGla~~~~~~-------------~~~~~~~~~~gt~~y~aPE~ 338 (476)
+.+++|||+.+ |+|||+||+|.+|..-|.+|+.|||+.+..... ..+.....+.||+.|.|||+
T Consensus 153 vla~Eylh~yg---ivhrdlkpdnllIT~mGhiKlTDfgLsk~GLms~atnl~eg~I~k~t~Ef~dKqvcgTPeyiaPeV 229 (1205)
T KOG0606|consen 153 VLAVEYLHSYG---IVHRDLKPDNLLITSMGHIKLTDFGLSKKGLMSLATNLKEGHIEKDTHEFQDKQVCGTPEYIAPEV 229 (1205)
T ss_pred hHHhHhhccCC---eecCCCCCCcceeeecccccccchhhhhhhhhhccchhhhcchHHHHHHhhhccccCCccccChhh
Confidence 78999999999 999999999999999999999999998753211 01112234689999999999
Q ss_pred hccCCCCccceEEeehhhhhhhhhCCCCCCcCCCCchhhhhhhhhhhcCCCcccccCcccCCCCCHHHHHHHHHHHHHch
Q 045315 339 ALRGLFSIKSDVFSFGVLLLETLSSKKNTHFYNTDSLTLLGHAWNLWNDGRTWELMDPISQNGASYPILKRYINVALLCV 418 (476)
Q Consensus 339 l~~~~~s~ksDVwSlGvvl~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~l~~li~~Cl 418 (476)
+....|....|.|++|+++||.+.|+.||.....+ .+...+... .... .+.+.....++.+++.+.|
T Consensus 230 ilrqgygkpvdwwamGiIlyeFLVgcvpffGdtpe--elfg~visd--~i~w---------pE~dea~p~Ea~dli~~LL 296 (1205)
T KOG0606|consen 230 ILRQGYGKPVDWWAMGIILYEFLVGCVPFFGDTPE--ELFGQVISD--DIEW---------PEEDEALPPEAQDLIEQLL 296 (1205)
T ss_pred hhhhccCCCccHHHHHHHHHHHheeeeeccCCCHH--HHHhhhhhh--hccc---------cccCcCCCHHHHHHHHHHH
Confidence 99999999999999999999999999998654322 222211100 0011 0112223346778888999
Q ss_pred hhcccCCC
Q 045315 419 QEKAADRP 426 (476)
Q Consensus 419 ~~dP~~RP 426 (476)
+.+|.+|-
T Consensus 297 ~qnp~~Rl 304 (1205)
T KOG0606|consen 297 RQNPLCRL 304 (1205)
T ss_pred HhChHhhc
Confidence 99999995
|
|
| >PRK12274 serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=99.18 E-value=1.5e-11 Score=113.62 Aligned_cols=125 Identities=17% Similarity=0.080 Sum_probs=90.0
Q ss_pred cccceeeccCCCCCCCCCCChhhHHHHHHHHHHHHHHHhhcCCCceeecCC-CccceEecCCCCceeccccceeecCCCc
Q 045315 241 DEISFWYESYNNPTKKGLLCWGTRVRIIEGIAQGLLYLHQYSRLRVIHRDL-KASNILLDKDMNPKISDFGMARMFGGDE 319 (476)
Q Consensus 241 ~~~~l~~Ey~~~~~~~~~L~~~~~~~i~~qIa~gL~yLH~~~~~~ivH~DL-kp~NILld~~~~~kL~DFGla~~~~~~~ 319 (476)
++++++|||+........++. ....++.|++++|+++|+.+ |+|||| ||+|||++.++.++|+|||++.......
T Consensus 71 ~~~~lvmeyI~G~~L~~~~~~-~~~~~~~qi~~~L~~lH~~G---IvHrDL~kp~NILv~~~g~i~LIDFG~A~~~~~~~ 146 (218)
T PRK12274 71 DGRHLDRSYLAGAAMYQRPPR-GDLAYFRAARRLLQQLHRCG---VAHNDLAKEANWLVQEDGSPAVIDFQLAVRGNPRA 146 (218)
T ss_pred cCEEEEEeeecCccHHhhhhh-hhHHHHHHHHHHHHHHHHCc---CccCCCCCcceEEEcCCCCEEEEECCCceecCCcc
Confidence 467899999884332222222 23568899999999999999 999999 7999999999999999999998654332
Q ss_pred cc----cc-------ceeeeeccCCCChhhhccC-CCC-ccceEEeehhhhhhhhhCCCCCCc
Q 045315 320 LQ----SN-------TKRIVGTYGYMSPEYALRG-LFS-IKSDVFSFGVLLLETLSSKKNTHF 369 (476)
Q Consensus 320 ~~----~~-------~~~~~gt~~y~aPE~l~~~-~~s-~ksDVwSlGvvl~elltG~~p~~~ 369 (476)
.. .. ......++.|++|+...-. ..+ ...+.++-|.-+|.++|++.+.-.
T Consensus 147 ~~~r~L~~rDl~~llk~~~~y~~~~l~~~~~~~l~~~~~~~~~w~~~g~~~~~~~~~~~~~~~ 209 (218)
T PRK12274 147 RWMRLLAREDLRHLLKHKRMYCPAALTPVERRVLKRTSWIRELWFATGKPVYRFVTRRVLHWE 209 (218)
T ss_pred hHHHHHHHHHHHHHHHHHHhcCCCCCCHHHHhhhccchhHHHHHHHhcchHHHHHhccCCccc
Confidence 10 00 1112356778888754322 333 567888999999999999987543
|
|
| >KOG1166 consensus Mitotic checkpoint serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=99.18 E-value=1.9e-11 Score=134.30 Aligned_cols=123 Identities=16% Similarity=0.052 Sum_probs=103.3
Q ss_pred cccceeeccCCC------CCCCCCCChhhHHHHHHHHHHHHHHHhhcCCCceeecCCCccceEec-------CCCCceec
Q 045315 241 DEISFWYESYNN------PTKKGLLCWGTRVRIIEGIAQGLLYLHQYSRLRVIHRDLKASNILLD-------KDMNPKIS 307 (476)
Q Consensus 241 ~~~~l~~Ey~~~------~~~~~~L~~~~~~~i~~qIa~gL~yLH~~~~~~ivH~DLkp~NILld-------~~~~~kL~ 307 (476)
++|++|+||.+- .+..+.++|.-.+.++.|++.-+++||..+ |||+||||+|++|. .+..++|+
T Consensus 767 ~~S~lv~ey~~~Gtlld~~N~~~~m~e~lv~~~~~qml~ive~lH~~~---IIHgDiKPDNfll~~~~~~~~~~~~l~lI 843 (974)
T KOG1166|consen 767 NASVLVSEYSPYGTLLDLINTNKVMDEYLVMFFSCQMLRIVEHLHAMG---IIHGDIKPDNFLLRREICADSDSKGLYLI 843 (974)
T ss_pred CcceeeeeccccccHHHhhccCCCCCchhhhHHHHHHHHHHHHHHhcc---eecccCCcceeEeecccCCCCcccceEEE
Confidence 689999999982 235678999999999999999999999999 99999999999994 34568999
Q ss_pred cccceeecCCCcccccceeeeeccCCCChhhhccCCCCccceEEeehhhhhhhhhCCCC
Q 045315 308 DFGMARMFGGDELQSNTKRIVGTYGYMSPEYALRGLFSIKSDVFSFGVLLLETLSSKKN 366 (476)
Q Consensus 308 DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~s~ksDVwSlGvvl~elltG~~p 366 (476)
|||.+--+.--..........+|-.+-.+|...+++.+...|.|.|+.+++-|+.|+..
T Consensus 844 DfG~siDm~lfp~~~~F~~~~~td~f~C~EM~~grpWtYq~DyfGlAa~~h~mLFG~y~ 902 (974)
T KOG1166|consen 844 DFGRSIDMKLFPDGTKFKAVWHTDLFDCIEMREGRPWTYQIDYFGLAATVHVMLFGKYM 902 (974)
T ss_pred ecccceeeeEcCCCcEEeeeeccccchhHHHhcCCCCchhhhhHHHHHHHHHHHHHHHH
Confidence 99998644221112334456788999999999999999999999999999999999853
|
|
| >PRK10359 lipopolysaccharide core biosynthesis protein; Provisional | Back alignment and domain information |
|---|
Probab=99.17 E-value=1.2e-11 Score=116.39 Aligned_cols=101 Identities=17% Similarity=0.181 Sum_probs=74.0
Q ss_pred cccceeeccCCCCCCCCCCChhhHHHHHHHHHHHHHHHhhcCCCceeecCCCccceEecCCCCceeccccceeecCCCcc
Q 045315 241 DEISFWYESYNNPTKKGLLCWGTRVRIIEGIAQGLLYLHQYSRLRVIHRDLKASNILLDKDMNPKISDFGMARMFGGDEL 320 (476)
Q Consensus 241 ~~~~l~~Ey~~~~~~~~~L~~~~~~~i~~qIa~gL~yLH~~~~~~ivH~DLkp~NILld~~~~~kL~DFGla~~~~~~~~ 320 (476)
+..+++|||++..+-....... .....+++.+|..+|+.+ ++|||+||+||+++.++ ++|+|||..........
T Consensus 116 ~~~~lvmEyi~G~tL~~~~~~~--~~~~~~i~~~l~~lH~~g---i~H~Dikp~Nili~~~g-i~liDfg~~~~~~e~~a 189 (232)
T PRK10359 116 HTYIMLIEYIEGVELNDMPEIS--EDVKAKIKASIESLHQHG---MVSGDPHKGNFIVSKNG-LRIIDLSGKRCTAQRKA 189 (232)
T ss_pred CCeEEEEEEECCccHHHhhhcc--HHHHHHHHHHHHHHHHcC---CccCCCChHHEEEeCCC-EEEEECCCcccccchhh
Confidence 3578899999854332221111 245679999999999999 99999999999999888 99999998865432111
Q ss_pred cccceeeeeccCCCChhhhccCCCCccceEEeehhhhhhhh
Q 045315 321 QSNTKRIVGTYGYMSPEYALRGLFSIKSDVFSFGVLLLETL 361 (476)
Q Consensus 321 ~~~~~~~~gt~~y~aPE~l~~~~~s~ksDVwSlGvvl~ell 361 (476)
...+.....+..++|+|+||+.+....
T Consensus 190 --------------~d~~vler~y~~~~di~~lg~~~~~~~ 216 (232)
T PRK10359 190 --------------KDRIDLERHYGIKNEIKDLGYYLLIYK 216 (232)
T ss_pred --------------HHHHHHHhHhcccccccceeEeehHHH
Confidence 111445556778999999999987654
|
|
| >cd05145 RIO1_like RIO kinase family; RIO1, RIO3 and similar proteins, catalytic domain | Back alignment and domain information |
|---|
Probab=99.14 E-value=5.9e-11 Score=109.59 Aligned_cols=71 Identities=24% Similarity=0.190 Sum_probs=61.4
Q ss_pred cceeeccCCCC------CCCCCCChhhHHHHHHHHHHHHHHHhh-cCCCceeecCCCccceEecCCCCceeccccceeec
Q 045315 243 ISFWYESYNNP------TKKGLLCWGTRVRIIEGIAQGLLYLHQ-YSRLRVIHRDLKASNILLDKDMNPKISDFGMARMF 315 (476)
Q Consensus 243 ~~l~~Ey~~~~------~~~~~L~~~~~~~i~~qIa~gL~yLH~-~~~~~ivH~DLkp~NILld~~~~~kL~DFGla~~~ 315 (476)
.+++|||++.. .....++..+..+++.|++.++.+||+ .+ |+||||||+||+++ ++.++|+|||++...
T Consensus 92 ~~lVmE~~~g~~~~~~~l~~~~~~~~~~~~i~~~l~~~l~~lH~~~g---ivHrDlkP~NIll~-~~~~~liDFG~a~~~ 167 (190)
T cd05145 92 NVLVMEFIGDDGSPAPRLKDVPLEEEEAEELYEQVVEQMRRLYQEAG---LVHGDLSEYNILYH-DGKPYIIDVSQAVEL 167 (190)
T ss_pred CEEEEEEecCCCchhhhhhhccCCHHHHHHHHHHHHHHHHHHHHhCC---EecCCCChhhEEEE-CCCEEEEEcccceec
Confidence 47899999843 123467888999999999999999999 88 99999999999999 789999999999876
Q ss_pred CC
Q 045315 316 GG 317 (476)
Q Consensus 316 ~~ 317 (476)
..
T Consensus 168 ~~ 169 (190)
T cd05145 168 DH 169 (190)
T ss_pred CC
Confidence 43
|
The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases containing a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. RIO1 is present in archaea, bacteria and eukaryotes. In addition, RIO3 is present in multicellular eukaryotes. RIO1 is essential for survival and is required for 18S rRNA processing, proper cell cycle pro |
| >cd05147 RIO1_euk RIO kinase family; eukaryotic RIO1, catalytic domain | Back alignment and domain information |
|---|
Probab=99.14 E-value=5.6e-11 Score=109.69 Aligned_cols=70 Identities=19% Similarity=0.146 Sum_probs=60.2
Q ss_pred ccceeeccCCCC------CCCCCCChhhHHHHHHHHHHHHHHH-hhcCCCceeecCCCccceEecCCCCceeccccceee
Q 045315 242 EISFWYESYNNP------TKKGLLCWGTRVRIIEGIAQGLLYL-HQYSRLRVIHRDLKASNILLDKDMNPKISDFGMARM 314 (476)
Q Consensus 242 ~~~l~~Ey~~~~------~~~~~L~~~~~~~i~~qIa~gL~yL-H~~~~~~ivH~DLkp~NILld~~~~~kL~DFGla~~ 314 (476)
..+++|||++.. .....++..+..+++.|++.+|.|+ |+.+ |+||||||+||+++ ++.++|+|||++..
T Consensus 91 ~~~iVmE~i~g~~l~~~~~~~~~~~~~~~~~i~~qi~~~L~~l~H~~g---iiHrDlkP~NIli~-~~~v~LiDFG~a~~ 166 (190)
T cd05147 91 SHVLVMEFIGDDGWAAPRLKDAPLSESKARELYLQVIQIMRILYQDCR---LVHADLSEYNLLYH-DGKLYIIDVSQSVE 166 (190)
T ss_pred CCEEEEEEeCCCCCcchhhhcCCCCHHHHHHHHHHHHHHHHHHHHhCC---cccCCCCHHHEEEE-CCcEEEEEcccccc
Confidence 357999999842 1345789999999999999999999 6888 99999999999998 47899999999975
Q ss_pred c
Q 045315 315 F 315 (476)
Q Consensus 315 ~ 315 (476)
.
T Consensus 167 ~ 167 (190)
T cd05147 167 H 167 (190)
T ss_pred C
Confidence 4
|
The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases containing a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. RIO1 is present in archaea, bacteria and eukaryotes. This subfamily is composed of RIO1 proteins from eukaryotes. RIO1 is essential for survival and is required for 18S rRNA processing, proper cell cycle progression and c |
| >KOG1165 consensus Casein kinase (serine/threonine/tyrosine protein kinase) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.09 E-value=2.4e-10 Score=109.71 Aligned_cols=113 Identities=24% Similarity=0.296 Sum_probs=95.6
Q ss_pred CCCCChhhHHHHHHHHHHHHHHHhhcCCCceeecCCCccceEecCC-----CCceeccccceeecCCCccc-----ccce
Q 045315 256 KGLLCWGTRVRIIEGIAQGLLYLHQYSRLRVIHRDLKASNILLDKD-----MNPKISDFGMARMFGGDELQ-----SNTK 325 (476)
Q Consensus 256 ~~~L~~~~~~~i~~qIa~gL~yLH~~~~~~ivH~DLkp~NILld~~-----~~~kL~DFGla~~~~~~~~~-----~~~~ 325 (476)
+..++.++++.+|.|++.-++|+|++. +|.|||||+|+||... ..+.|+|||+|+........ ....
T Consensus 118 gR~FSvKTV~miA~Qmi~rie~vH~k~---LIYRDIKPdNFLIGrp~~k~~n~IhiiDFGmAK~YrDp~TkqHIPYrE~K 194 (449)
T KOG1165|consen 118 GRRFSVKTVAMIAKQMITRIEYVHEKD---LIYRDIKPDNFLIGRPGTKDANVIHIIDFGMAKEYRDPKTKQHIPYREHK 194 (449)
T ss_pred cCcccHHhHHHHHHHHHHHHHHHHhcc---eeecccCccceeecCCCCCCCceEEEEeccchhhhcCccccccCcccccc
Confidence 457999999999999999999999999 9999999999999643 34789999999976432211 1123
Q ss_pred eeeeccCCCChhhhccCCCCccceEEeehhhhhhhhhCCCCCCcCC
Q 045315 326 RIVGTYGYMSPEYALRGLFSIKSDVFSFGVLLLETLSSKKNTHFYN 371 (476)
Q Consensus 326 ~~~gt~~y~aPE~l~~~~~s~ksDVwSlGvvl~elltG~~p~~~~~ 371 (476)
...||.+||+-....+...+.+-|.=|||-+++..+-|..||....
T Consensus 195 SLsGTARYMSINTHlGrEQSRRDDLEaLGHvFmYFLRGsLPWQGLK 240 (449)
T KOG1165|consen 195 SLSGTARYMSINTHLGREQSRRDDLEALGHVFMYFLRGSLPWQGLK 240 (449)
T ss_pred ccccceeeeEeeccccchhhhhhhHHHhhhhhhhhccCCCcccccc
Confidence 4569999999998889999999999999999999999999997654
|
|
| >KOG1266 consensus Protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=98.98 E-value=5.2e-10 Score=107.36 Aligned_cols=124 Identities=19% Similarity=0.207 Sum_probs=92.2
Q ss_pred cccceeeccCCCC----------CCCCCCChhhHHHHHHHHHHHHHHHhhcCCCceeecCCCccceEecCCCCceecccc
Q 045315 241 DEISFWYESYNNP----------TKKGLLCWGTRVRIIEGIAQGLLYLHQYSRLRVIHRDLKASNILLDKDMNPKISDFG 310 (476)
Q Consensus 241 ~~~~l~~Ey~~~~----------~~~~~L~~~~~~~i~~qIa~gL~yLH~~~~~~ivH~DLkp~NILld~~~~~kL~DFG 310 (476)
-+..|+.|||..+ ...+.+..+.-.+++-||..||.|||+.. ++|+|+++..+.|++..++-+|+.--.
T Consensus 145 ~rviFiteymssgs~~~fLkrt~~~~~a~~~~~wkkw~tqIlsal~yLhs~~-PpiihgnlTc~tifiq~ngLIkig~~a 223 (458)
T KOG1266|consen 145 PRVIFITEYMSSGSLKQFLKRTKKNQKALFQKAWKKWCTQILSALSYLHSCD-PPIIHGNLTCDTIFIQHNGLIKIGSVA 223 (458)
T ss_pred cceEEEEecccchhHHHHHHHHHHhhhhhhHHHHHHHHHHHHhhhhhhhccC-CccccCCcchhheeecCCceEEecccC
Confidence 3677889999822 23556888888999999999999999975 789999999999999999988874321
Q ss_pred ceee--cCCCcccccceeeeeccCCCChhhhccCCCCccceEEeehhhhhhhhhCCC
Q 045315 311 MARM--FGGDELQSNTKRIVGTYGYMSPEYALRGLFSIKSDVFSFGVLLLETLSSKK 365 (476)
Q Consensus 311 la~~--~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~s~ksDVwSlGvvl~elltG~~ 365 (476)
.... .-.......+....+-++|.+||+-.....+.++|||+||+..+||..+.-
T Consensus 224 p~s~h~s~~~~~~~Ek~~~~~~~g~~a~~sg~~tn~~~a~dIy~fgmcAlemailEi 280 (458)
T KOG1266|consen 224 PDSTHPSVNSTREAEKSVNTSLPGFSAPESGTTTNTTGASDIYKFGMCALEMAILEI 280 (458)
T ss_pred ccccchhhhhhhHhhhhccccCCccccCCcCcccccccchhhhhhhHHHHHHHHhee
Confidence 1111 000111112223346789999998777777889999999999999987664
|
|
| >KOG1163 consensus Casein kinase (serine/threonine/tyrosine protein kinase) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=98.95 E-value=1.1e-09 Score=100.98 Aligned_cols=113 Identities=21% Similarity=0.245 Sum_probs=92.5
Q ss_pred CCCCChhhHHHHHHHHHHHHHHHhhcCCCceeecCCCccceEecC---CCCceeccccceeecCCCccc-----ccceee
Q 045315 256 KGLLCWGTRVRIIEGIAQGLLYLHQYSRLRVIHRDLKASNILLDK---DMNPKISDFGMARMFGGDELQ-----SNTKRI 327 (476)
Q Consensus 256 ~~~L~~~~~~~i~~qIa~gL~yLH~~~~~~ivH~DLkp~NILld~---~~~~kL~DFGla~~~~~~~~~-----~~~~~~ 327 (476)
.+.++.++++-++-|++.-++|+|.++ .|||||||+|+|..- ...+.++|||+++.+...... ......
T Consensus 105 ~R~ftmkTvLMLaDQml~RiEyvH~r~---fiHRDIKPdNFLMGlgrh~~kl~LIDFGLaKky~d~~t~~HIpyre~r~l 181 (341)
T KOG1163|consen 105 SRRFTMKTVLMLADQMLSRIEYVHLRN---FIHRDIKPDNFLMGLGRHCNKLYLIDFGLAKKYRDIRTRQHIPYREDRNL 181 (341)
T ss_pred hhhhhHHhHHHHHHHHHHHHHHHHhhc---cccccCCccceeeccccccceEEEEeccchhhhccccccccCccccCCcc
Confidence 346889999999999999999999999 999999999999863 345789999999876432211 122335
Q ss_pred eeccCCCChhhhccCCCCccceEEeehhhhhhhhhCCCCCCcCC
Q 045315 328 VGTYGYMSPEYALRGLFSIKSDVFSFGVLLLETLSSKKNTHFYN 371 (476)
Q Consensus 328 ~gt~~y~aPE~l~~~~~s~ksDVwSlGvvl~elltG~~p~~~~~ 371 (476)
.||.+|.+-....+...+.+.|.-|+|.++...--|..||....
T Consensus 182 tGTaRYASinAh~g~eqSRRDDmeSvgYvLmYfnrG~LPWQglk 225 (341)
T KOG1163|consen 182 TGTARYASINAHLGIEQSRRDDMESVGYVLMYFNRGSLPWQGLK 225 (341)
T ss_pred ceeeeehhhhhhhhhhhhhhhhhhhhcceeeeeecCCCcccccc
Confidence 68999998877777777899999999999999999999987654
|
|
| >KOG0590 consensus Checkpoint kinase and related serine/threonine protein kinases [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=98.95 E-value=2.6e-10 Score=122.43 Aligned_cols=162 Identities=23% Similarity=0.293 Sum_probs=119.9
Q ss_pred CCChhhHHHHHHHHHHHHHHHh-hcCCCceeecCCCccceEecCCC-CceeccccceeecCC-Ccccccceeeee-ccCC
Q 045315 258 LLCWGTRVRIIEGIAQGLLYLH-QYSRLRVIHRDLKASNILLDKDM-NPKISDFGMARMFGG-DELQSNTKRIVG-TYGY 333 (476)
Q Consensus 258 ~L~~~~~~~i~~qIa~gL~yLH-~~~~~~ivH~DLkp~NILld~~~-~~kL~DFGla~~~~~-~~~~~~~~~~~g-t~~y 333 (476)
..+....-..+.|+..++.|+| ..+ +.|+|+||+|.+++..+ ..|++|||+|..+.. ...........| ++.|
T Consensus 119 ~~~~~~~~~~~~ql~s~l~~~H~~~~---~~h~~ikP~n~~l~~s~~~l~~~df~~At~~~~~~g~~~~~~~~~g~s~~y 195 (601)
T KOG0590|consen 119 GTSSSSASRYLPQLNSGLSYLHPENG---VTHRDIKPSNSLLDESGSALKIADFGLATAYRNKNGAERSLKDRCGSSPPY 195 (601)
T ss_pred CCCCcchhhhhhhhccCccccCcccc---cccCCCCCccchhccCCCcccCCCchhhccccccCCcceeeecccCCCCCC
Confidence 4566677789999999999999 887 99999999999999999 999999999998766 444444455667 9999
Q ss_pred CChhhhccC-CCCccceEEeehhhhhhhhhCCCCCCcCCCCchhhhhhhhhhhcCCCcccccCcccCCCCCHHHHHHHHH
Q 045315 334 MSPEYALRG-LFSIKSDVFSFGVLLLETLSSKKNTHFYNTDSLTLLGHAWNLWNDGRTWELMDPISQNGASYPILKRYIN 412 (476)
Q Consensus 334 ~aPE~l~~~-~~s~ksDVwSlGvvl~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~l~~ 412 (476)
+|||...+. ...+..|+||.|+++.-+++|..|+............+ .+... ...............+
T Consensus 196 ~a~E~~~~~~~~~~~~d~~S~g~~l~~~~~g~~p~~~~~~~~~~~~~~-----~~~~~------~~~~~~~~~~~~~~~~ 264 (601)
T KOG0590|consen 196 GAPEHLSGKAYRGPSVDVWSLGIVLSAMLTGELPWDFPSRKDGRYSSW-----KSNKG------RFTQLPWNSISDQAHD 264 (601)
T ss_pred CCcccccchhhcCCCcccccccccccccccCCCCccccccccccceee-----ccccc------ccccCccccCChhhhh
Confidence 999998874 45788999999999999999999987654222111111 11100 0011112223345667
Q ss_pred HHHHchhhcccCCCCHHHHHH
Q 045315 413 VALLCVQEKAADRPAMSEVVS 433 (476)
Q Consensus 413 li~~Cl~~dP~~RPt~~eVl~ 433 (476)
+..+++..+|..|.+.+++..
T Consensus 265 ~l~k~l~~~~~~r~s~~~~~~ 285 (601)
T KOG0590|consen 265 LLHKILKENPSNRLSIEELKL 285 (601)
T ss_pred cccccccCCchhccccccccc
Confidence 788888899999999887643
|
|
| >PF01453 B_lectin: D-mannose binding lectin; InterPro: IPR001480 A bulb lectin super-family (Amaryllidaceae, Orchidaceae and Aliaceae) contains a ~115-residue-long domain whose overall three dimensional fold is very similar to that of [, ]: Dictyostelium discoideum comitin, an actin binding protein Curculigo latifolia curculin, a sweet tasting and taste-modifying protein This domain generally binds mannose, but in at least one protein, curculin, it is apparently devoid of mannose-binding activity | Back alignment and domain information |
|---|
Probab=98.81 E-value=5e-08 Score=82.14 Aligned_cols=100 Identities=27% Similarity=0.421 Sum_probs=71.3
Q ss_pred CEEeeCCCeEEEEeeCCCCCCCeEEEEEEccCCCceEEee-cCCCCCCCCCceEEEecCCceEEEccCCeEEEeecCCCC
Q 045315 39 EKLVSSSQRFELGFFSPRNSKNRYLGVWYKKIPDTVVWVA-NRNSPIFNPNTALTFSNNGNLVLLSQRNGIIWSSNMSRK 117 (476)
Q Consensus 39 ~~l~S~~g~f~lgf~~~~~~~~~~~~iw~~~~~~~~vW~a-n~~~p~~~~~~~l~~~~~G~lvl~~~~~~~vWss~~~~~ 117 (476)
+.+.+.+|.|.|-|..+|+. +.|+. ..+++|.+ +..... ...+.+.|+.||||||+|.++.++|+|.. .
T Consensus 12 ~p~~~~s~~~~L~l~~dGnL------vl~~~-~~~~iWss~~t~~~~-~~~~~~~L~~~GNlvl~d~~~~~lW~Sf~--~ 81 (114)
T PF01453_consen 12 SPLTSSSGNYTLILQSDGNL------VLYDS-NGSVIWSSNNTSGRG-NSGCYLVLQDDGNLVLYDSSGNVLWQSFD--Y 81 (114)
T ss_dssp EEEEECETTEEEEEETTSEE------EEEET-TTEEEEE--S-TTSS--SSEEEEEETTSEEEEEETTSEEEEESTT--S
T ss_pred cccccccccccceECCCCeE------EEEcC-CCCEEEEecccCCcc-ccCeEEEEeCCCCEEEEeecceEEEeecC--C
Confidence 45656558999999999884 33432 25779999 555553 16789999999999999999999999942 2
Q ss_pred CCCceeeecc--CCCeEEEeCCCCCCcCceeeccccCCC
Q 045315 118 AENPIAQLLD--TGNLVIRDNSSGHTTESYLWQSFDYPT 154 (476)
Q Consensus 118 ~~~~~~~l~d--~GNlVl~~~~~~~~~~~~~WqSFd~pt 154 (476)
...+.+..|+ +||++ +... ..+.|.|=+.|+
T Consensus 82 ptdt~L~~q~l~~~~~~-~~~~-----~~~sw~s~~dps 114 (114)
T PF01453_consen 82 PTDTLLPGQKLGDGNVT-GKND-----SLTSWSSNTDPS 114 (114)
T ss_dssp SS-EEEEEET--TSEEE-EEST-----SSEEEESS----
T ss_pred CccEEEeccCcccCCCc-cccc-----eEEeECCCCCCC
Confidence 4577788999 99999 7553 578999876663
|
Each bulb-type lectin domain consists of three sequential beta-sheet subdomains (I, II, III) that are inter-related by pseudo three-fold symmetry. The three subdomains are flat four-stranded, antiparrallel beta-sheets. Together they form a 12-stranded beta-barrel in which the barrel axis coincides with the pseudo 3-fold axis.; GO: 0005529 sugar binding; PDB: 3M7H_A 3M7J_B 3MEZ_D 1DLP_A 1BWU_D 1KJ1_A 1B2P_A 1XD6_A 2DPF_C 2D04_B .... |
| >smart00108 B_lectin Bulb-type mannose-specific lectin | Back alignment and domain information |
|---|
Probab=98.80 E-value=2e-08 Score=84.71 Aligned_cols=88 Identities=22% Similarity=0.321 Sum_probs=65.0
Q ss_pred eEEEecCCceEEEccC-CeEEEeecCCCCC-CCceeeeccCCCeEEEeCCCCCCcCceeeccccCCCcccccCCcccCCC
Q 045315 90 ALTFSNNGNLVLLSQR-NGIIWSSNMSRKA-ENPIAQLLDTGNLVIRDNSSGHTTESYLWQSFDYPTDSLLEGMKLGWDL 167 (476)
Q Consensus 90 ~l~~~~~G~lvl~~~~-~~~vWss~~~~~~-~~~~~~l~d~GNlVl~~~~~~~~~~~~~WqSFd~ptdtll~~~~l~~~~ 167 (476)
.+.++.||+||+++.. +.++|++++.... ....+.|+++|||||++.+ +.++|+|= |-
T Consensus 23 ~~~~q~dgnlV~~~~~~~~~vW~snt~~~~~~~~~l~l~~dGnLvl~~~~-----g~~vW~S~-----t~---------- 82 (114)
T smart00108 23 TLIMQNDYNLILYKSSSRTVVWVANRDNPVSDSCTLTLQSDGNLVLYDGD-----GRVVWSSN-----TT---------- 82 (114)
T ss_pred ccCCCCCEEEEEEECCCCcEEEECCCCCCCCCCEEEEEeCCCCEEEEeCC-----CCEEEEec-----cc----------
Confidence 4567789999999765 5899999986542 2378899999999999876 67899982 10
Q ss_pred CCCcceEEEEeCCCCCCCCcccEEEEEecCcceEEEEcCCcceeecC
Q 045315 168 KNGLERYLSSWESTDDPSPGNFTFRLVIQVIPKLCAYNGSVEYTCTG 214 (476)
Q Consensus 168 ~~g~~~~l~s~~~~~~~s~g~~~~~~~~~~~~~~~~~~gs~~y~~sg 214 (476)
...+.+.+.++.+|..+++-..+ ...|.+.
T Consensus 83 ----------------~~~~~~~~~L~ddGnlvl~~~~~-~~~W~Sf 112 (114)
T smart00108 83 ----------------GANGNYVLVLLDDGNLVIYDSDG-NFLWQSF 112 (114)
T ss_pred ----------------CCCCceEEEEeCCCCEEEECCCC-CEEeCCC
Confidence 12466888999999887653333 4567753
|
|
| >cd05144 RIO2_C RIO kinase family; RIO2, C-terminal catalytic domain | Back alignment and domain information |
|---|
Probab=98.80 E-value=6e-09 Score=96.70 Aligned_cols=73 Identities=18% Similarity=0.162 Sum_probs=59.3
Q ss_pred ccceeeccCCCCCCCCCCChhhHHHHHHHHHHHHHHHhhcCCCceeecCCCccceEecCCCCceeccccceeecCC
Q 045315 242 EISFWYESYNNPTKKGLLCWGTRVRIIEGIAQGLLYLHQYSRLRVIHRDLKASNILLDKDMNPKISDFGMARMFGG 317 (476)
Q Consensus 242 ~~~l~~Ey~~~~~~~~~L~~~~~~~i~~qIa~gL~yLH~~~~~~ivH~DLkp~NILld~~~~~kL~DFGla~~~~~ 317 (476)
..+++|||++...-...........++.+++.++.++|+.+ ++|+||||+||++++++.++|+|||++.....
T Consensus 105 ~~~lv~e~~~g~~L~~~~~~~~~~~~~~~i~~~l~~lh~~g---i~H~Dl~p~Nill~~~~~~~liDfg~~~~~~~ 177 (198)
T cd05144 105 RHAVVMEYIDGVELYRVRVLEDPEEVLDEILEEIVKAYKHG---IIHGDLSEFNILVDDDEKIYIIDWPQMVSTDH 177 (198)
T ss_pred CceEEEEEeCCcchhhccccccHHHHHHHHHHHHHHHHHCC---CCcCCCCcccEEEcCCCcEEEEECCccccCCC
Confidence 45788999985433222222566789999999999999998 99999999999999999999999999976543
|
The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases containing a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. RIO2 is present in archaea and eukaryotes. It contains an N-terminal winged helix (wHTH) domain and a C-terminal RIO kinase catalytic domain. The wHTH domain is primarily seen in DNA-binding proteins, although some wHTH dom |
| >COG4248 Uncharacterized protein with protein kinase and helix-hairpin-helix DNA-binding domains [General function prediction only] | Back alignment and domain information |
|---|
Probab=98.77 E-value=5.4e-08 Score=96.76 Aligned_cols=177 Identities=18% Similarity=0.162 Sum_probs=118.0
Q ss_pred CCCCCCChhhHHHHHHHHHHHHHHHhhcCCCceeecCCCccceEecCCCCceeccccceeecCCCcccccceeeeeccCC
Q 045315 254 TKKGLLCWGTRVRIIEGIAQGLLYLHQYSRLRVIHRDLKASNILLDKDMNPKISDFGMARMFGGDELQSNTKRIVGTYGY 333 (476)
Q Consensus 254 ~~~~~L~~~~~~~i~~qIa~gL~yLH~~~~~~ivH~DLkp~NILld~~~~~kL~DFGla~~~~~~~~~~~~~~~~gt~~y 333 (476)
......+|.-.++.++.++.+.+.||..| .+-+|++++|+|+++++.+.|.|-.......++.. ....+|...|
T Consensus 109 qs~P~~~w~fllrvaRnlA~aFA~lH~~G---h~vGDVn~~~~lVsd~~~V~LVdsDsfqi~~ng~~---~~cpVg~~ef 182 (637)
T COG4248 109 QSYPHCAWDFLLRVARNLASAFATLHEHG---HVVGDVNQNSFLVSDDSKVVLVDSDSFQINANGTL---HLCPVGVSEF 182 (637)
T ss_pred ccCCccccHHHHHHHHHHHHHHHHHHhcC---CcccccCccceeeecCceEEEEcccceeeccCCce---EecccCcccc
Confidence 34456789999999999999999999999 88999999999999999999988655444332221 1225688999
Q ss_pred CChhhhc-----cCCCCccceEEeehhhhhhhhhC-CCCCCcCC--CCchhhhhhhhhhhcCCCcccccC------cccC
Q 045315 334 MSPEYAL-----RGLFSIKSDVFSFGVLLLETLSS-KKNTHFYN--TDSLTLLGHAWNLWNDGRTWELMD------PISQ 399 (476)
Q Consensus 334 ~aPE~l~-----~~~~s~ksDVwSlGvvl~elltG-~~p~~~~~--~~~~~~~~~~~~~~~~~~~~~~~d------~~~~ 399 (476)
.+||... +-..+...|.|.|||++++++.| ++|+.... .+..+-.+. .+..+......+ +...
T Consensus 183 tPPElQ~~~sf~g~~r~~~hD~FGLavLiF~lL~ggrHPysGI~~~~~ap~p~E~---~Ia~g~f~ya~~~~~g~~p~P~ 259 (637)
T COG4248 183 TPPELQTLPSFVGFERTANHDNFGLAVLIFHLLFGGRHPYSGIPLISDAPNPLET---DIAHGRFAYASDQRRGLKPPPR 259 (637)
T ss_pred CCHHHhccccccccCCCccccchhHHHHHHHHHhcCCCCCCcccccCCCCCcchh---hhhcceeeechhccCCCCCCCC
Confidence 9999765 33457889999999999999887 88987542 111110000 011111111111 1111
Q ss_pred CCCCHHHHHHHHHHHHHchhhc--ccCCCCHHHHHHHHhccc
Q 045315 400 NGASYPILKRYINVALLCVQEK--AADRPAMSEVVSMLSNEF 439 (476)
Q Consensus 400 ~~~~~~~~~~l~~li~~Cl~~d--P~~RPt~~eVl~~L~~~~ 439 (476)
.....-....+..+..+|+... +.-|||++..+..|..+.
T Consensus 260 ~~P~~~Lpp~vqAlF~qaF~~~~~~~~RP~a~aW~aAl~al~ 301 (637)
T COG4248 260 SIPLSMLPPDVQALFQQAFTESGVATPRPTAKAWVAALDALR 301 (637)
T ss_pred CCChhhcCHHHHHHHHHHhcccCCCCCCCCHHHHHHHHHHHH
Confidence 1111122345667778888763 668999999888776654
|
|
| >smart00090 RIO RIO-like kinase | Back alignment and domain information |
|---|
Probab=98.77 E-value=9.4e-09 Score=98.22 Aligned_cols=72 Identities=18% Similarity=0.124 Sum_probs=59.0
Q ss_pred ccceeeccCCCCC------CCCCCChhhHHHHHHHHHHHHHHHhhcCCCceeecCCCccceEecCCCCceeccccceeec
Q 045315 242 EISFWYESYNNPT------KKGLLCWGTRVRIIEGIAQGLLYLHQYSRLRVIHRDLKASNILLDKDMNPKISDFGMARMF 315 (476)
Q Consensus 242 ~~~l~~Ey~~~~~------~~~~L~~~~~~~i~~qIa~gL~yLH~~~~~~ivH~DLkp~NILld~~~~~kL~DFGla~~~ 315 (476)
..+++|||++... ....+...+...++.||+.+|++||+.+ .++||||||+||+++ ++.++|+|||.+...
T Consensus 122 ~~~lV~E~~~g~~L~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~g--~iiH~Dikp~NIli~-~~~i~LiDFg~a~~~ 198 (237)
T smart00090 122 RNVLVMEFIGGDGLPAPRLKDVEPEEEEEFELYDDILEEMRKLYKEG--ELVHGDLSEYNILVH-DGKVVIIDVSQSVEL 198 (237)
T ss_pred CceEEEEEecCCcccccccccCCcchHHHHHHHHHHHHHHHHHHhcC--CEEeCCCChhhEEEE-CCCEEEEEChhhhcc
Confidence 3578999988421 2334556667899999999999999976 499999999999999 889999999998754
Q ss_pred C
Q 045315 316 G 316 (476)
Q Consensus 316 ~ 316 (476)
+
T Consensus 199 ~ 199 (237)
T smart00090 199 D 199 (237)
T ss_pred C
Confidence 3
|
|
| >cd00028 B_lectin Bulb-type mannose-specific lectin | Back alignment and domain information |
|---|
Probab=98.75 E-value=3e-08 Score=83.86 Aligned_cols=89 Identities=22% Similarity=0.274 Sum_probs=66.0
Q ss_pred eEEEec-CCceEEEccC-CeEEEeecCCCC-CCCceeeeccCCCeEEEeCCCCCCcCceeeccccCCCcccccCCcccCC
Q 045315 90 ALTFSN-NGNLVLLSQR-NGIIWSSNMSRK-AENPIAQLLDTGNLVIRDNSSGHTTESYLWQSFDYPTDSLLEGMKLGWD 166 (476)
Q Consensus 90 ~l~~~~-~G~lvl~~~~-~~~vWss~~~~~-~~~~~~~l~d~GNlVl~~~~~~~~~~~~~WqSFd~ptdtll~~~~l~~~ 166 (476)
.+.++. ||+||+++.. +.++|++++... .....+.|+++|||||++.+ +.++|+|=-.
T Consensus 23 ~~~~q~~dgnlv~~~~~~~~~vW~snt~~~~~~~~~l~l~~dGnLvl~~~~-----g~~vW~S~~~-------------- 83 (116)
T cd00028 23 KLIMQSRDYNLILYKGSSRTVVWVANRDNPSGSSCTLTLQSDGNLVIYDGS-----GTVVWSSNTT-------------- 83 (116)
T ss_pred cCCCCCCeEEEEEEeCCCCeEEEECCCCCCCCCCEEEEEecCCCeEEEcCC-----CcEEEEeccc--------------
Confidence 345676 9999999765 589999998753 34667899999999999875 6789998310
Q ss_pred CCCCcceEEEEeCCCCCCCCcccEEEEEecCcceEEEEcCCcceeecCC
Q 045315 167 LKNGLERYLSSWESTDDPSPGNFTFRLVIQVIPKLCAYNGSVEYTCTGP 215 (476)
Q Consensus 167 ~~~g~~~~l~s~~~~~~~s~g~~~~~~~~~~~~~~~~~~gs~~y~~sg~ 215 (476)
.+.+.+.+.|+.+|...++-.+ +...|.+..
T Consensus 84 -----------------~~~~~~~~~L~ddGnlvl~~~~-~~~~W~Sf~ 114 (116)
T cd00028 84 -----------------RVNGNYVLVLLDDGNLVLYDSD-GNFLWQSFD 114 (116)
T ss_pred -----------------CCCCceEEEEeCCCCEEEECCC-CCEEEcCCC
Confidence 0246788899999988776433 455787654
|
The domain contains a three-fold internal repeat (beta-prism architecture). The consensus sequence motif QXDXNXVXY is involved in alpha-D-mannose recognition. Lectins are carbohydrate-binding proteins which specifically recognize diverse carbohydrates and mediate a wide variety of biological processes, such as cell-cell and host-pathogen interactions, serum glycoprotein turnover, and innate immune responses. |
| >KOG2137 consensus Protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=98.64 E-value=2.3e-08 Score=105.02 Aligned_cols=155 Identities=21% Similarity=0.282 Sum_probs=102.2
Q ss_pred HHHHHHHHHHHHHHHhhcCCCceeecCCCccceEecCCCCceeccccceeecCCC-cccccc------eeeeeccCCCCh
Q 045315 264 RVRIIEGIAQGLLYLHQYSRLRVIHRDLKASNILLDKDMNPKISDFGMARMFGGD-ELQSNT------KRIVGTYGYMSP 336 (476)
Q Consensus 264 ~~~i~~qIa~gL~yLH~~~~~~ivH~DLkp~NILld~~~~~kL~DFGla~~~~~~-~~~~~~------~~~~gt~~y~aP 336 (476)
...=+.+++.||.|+|... .+||++|.|++|.++.++..||+.|+++....+. ...... ........|.||
T Consensus 101 ~f~nl~~v~dgl~flh~sA--k~VH~ni~p~~i~~na~~~wkl~Gf~f~v~~~~~~~~p~~~yd~~lp~~~~~~~~f~ap 178 (700)
T KOG2137|consen 101 GFANLGNVADGLAFLHRSA--KVVHGNIQPEAIVVNANGDWKLAGFSFCVNANGPTEYPFSEYDPPLPLLLQPHLNFLAP 178 (700)
T ss_pred hhhhhhcccchhhhhccCc--ceeecccchhheeeccCcceeeccchhhhccCCCCccccccCCCCCChhhccCcccccc
Confidence 3444567779999999865 6999999999999999999999999988755431 111100 112235689999
Q ss_pred hhhccCCCCccceEEeehhhhhhhhhCCCC-CCcCCCCchhhhhhhhhhhcCCCcccccCcccCCCCCHHHHHHHHHHHH
Q 045315 337 EYALRGLFSIKSDVFSFGVLLLETLSSKKN-THFYNTDSLTLLGHAWNLWNDGRTWELMDPISQNGASYPILKRYINVAL 415 (476)
Q Consensus 337 E~l~~~~~s~ksDVwSlGvvl~elltG~~p-~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~l~~li~ 415 (476)
|++.+...+.++|+||+||++|.+..|+++ +.........- ..... +.............++.+=+.
T Consensus 179 E~~~~~~~~~~sd~fSlG~li~~i~~~gk~i~~a~~~~~~~~--~~~~~----------~~~~~~~~s~~~p~el~~~l~ 246 (700)
T KOG2137|consen 179 EYLLGTTNTPASDVFSLGVLIYTIYNGGKSIIAANGGLLSYS--FSRNL----------LNAGAFGYSNNLPSELRESLK 246 (700)
T ss_pred hhhccccccccccceeeeeEEEEEecCCcchhhccCCcchhh--hhhcc----------cccccccccccCcHHHHHHHH
Confidence 999998889999999999999999954444 33221111000 00000 000011112334456677777
Q ss_pred HchhhcccCCCCHHHHH
Q 045315 416 LCVQEKAADRPAMSEVV 432 (476)
Q Consensus 416 ~Cl~~dP~~RPt~~eVl 432 (476)
+++..++..||++.++.
T Consensus 247 k~l~~~~~~rp~~~~l~ 263 (700)
T KOG2137|consen 247 KLLNGDSAVRPTLDLLL 263 (700)
T ss_pred HHhcCCcccCcchhhhh
Confidence 88899999999776653
|
|
| >cd05119 RIO RIO kinase family, catalytic domain | Back alignment and domain information |
|---|
Probab=98.61 E-value=3.6e-08 Score=90.27 Aligned_cols=70 Identities=21% Similarity=0.152 Sum_probs=56.5
Q ss_pred cceeeccCCCCCC-----CCCCChhhHHHHHHHHHHHHHHHhh-cCCCceeecCCCccceEecCCCCceeccccceeecC
Q 045315 243 ISFWYESYNNPTK-----KGLLCWGTRVRIIEGIAQGLLYLHQ-YSRLRVIHRDLKASNILLDKDMNPKISDFGMARMFG 316 (476)
Q Consensus 243 ~~l~~Ey~~~~~~-----~~~L~~~~~~~i~~qIa~gL~yLH~-~~~~~ivH~DLkp~NILld~~~~~kL~DFGla~~~~ 316 (476)
.+++|||++.... .......++.+++.+++.++.++|. .+ |+|+||||+||+++ ++.++|+|||.+....
T Consensus 90 ~~lv~e~~~g~~~~~~~l~~~~~~~~~~~~~~~~~~~l~~lh~~~~---ivH~Dl~p~Nili~-~~~~~liDfg~a~~~~ 165 (187)
T cd05119 90 HVLVMEFIGGDGIPAPRLKDVRLLEDPEELYDQILELMRKLYREAG---LVHGDLSEYNILVD-DGKVYIIDVPQAVEID 165 (187)
T ss_pred CEEEEEEeCCCCccChhhhhhhhcccHHHHHHHHHHHHHHHhhccC---cCcCCCChhhEEEE-CCcEEEEECccccccc
Confidence 4688999985221 1111116788999999999999999 88 99999999999999 8899999999997554
|
The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases present in archaea, bacteria and eukaryotes. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. RIO kinases contain a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. Most organisms contain at least two RIO kinases, RIO1 and RIO2. A third protein, RIO3, is present in multicellular eukaryotes. In yeast, RIO1 and RIO2 are essential for survival. They funct |
| >TIGR03724 arch_bud32 Kae1-associated kinase Bud32 | Back alignment and domain information |
|---|
Probab=98.56 E-value=4.2e-08 Score=90.82 Aligned_cols=69 Identities=25% Similarity=0.391 Sum_probs=54.7
Q ss_pred cccceeeccCCCCCCCCCCChhhHHHHHHHHHHHHHHHhhcCCCceeecCCCccceEecCCCCceeccccceee
Q 045315 241 DEISFWYESYNNPTKKGLLCWGTRVRIIEGIAQGLLYLHQYSRLRVIHRDLKASNILLDKDMNPKISDFGMARM 314 (476)
Q Consensus 241 ~~~~l~~Ey~~~~~~~~~L~~~~~~~i~~qIa~gL~yLH~~~~~~ivH~DLkp~NILld~~~~~kL~DFGla~~ 314 (476)
...+++|||++...-...+..... .++.+++.+|.+||+.+ ++|+|++|.||+++ ++.++++|||++..
T Consensus 70 ~~~~lv~e~~~g~~l~~~~~~~~~-~~~~~i~~~l~~lH~~g---i~H~Dl~~~Nil~~-~~~~~liDfg~a~~ 138 (199)
T TIGR03724 70 DNKTIVMEYIEGKPLKDVIEEGND-ELLREIGRLVGKLHKAG---IVHGDLTTSNIIVR-DDKLYLIDFGLGKY 138 (199)
T ss_pred CCCEEEEEEECCccHHHHHhhcHH-HHHHHHHHHHHHHHHCC---eecCCCCcceEEEE-CCcEEEEECCCCcC
Confidence 356789999985432222211111 88999999999999999 99999999999999 78999999999865
|
Members of this protein family are the Bud32 protein associated with Kae1 (kinase-associated endopeptidase 1) in the Archaea. In many Archaeal genomes, Kae1 and Bud32 are fused. The complex is homologous to the Kae1 and Bud32 subunits of the eukaryotic KEOPS complex, an apparently ancient protein kinase-containing molecular machine. |
| >PRK01723 3-deoxy-D-manno-octulosonic-acid kinase; Reviewed | Back alignment and domain information |
|---|
Probab=98.53 E-value=5.9e-08 Score=92.85 Aligned_cols=64 Identities=28% Similarity=0.329 Sum_probs=50.5
Q ss_pred ceeeccCCCC-C-----CCCCCChhhHHHHHHHHHHHHHHHhhcCCCceeecCCCccceEecCCCCceeccccceee
Q 045315 244 SFWYESYNNP-T-----KKGLLCWGTRVRIIEGIAQGLLYLHQYSRLRVIHRDLKASNILLDKDMNPKISDFGMARM 314 (476)
Q Consensus 244 ~l~~Ey~~~~-~-----~~~~L~~~~~~~i~~qIa~gL~yLH~~~~~~ivH~DLkp~NILld~~~~~kL~DFGla~~ 314 (476)
.+++||+++. . ....++. ..+.+|+.+|.+||+.+ |+|+||||.|||++.++.++|+|||.+..
T Consensus 122 ~lV~e~l~G~~~L~~~l~~~~l~~----~~~~~i~~~l~~lH~~G---I~HrDlkp~NILv~~~~~v~LIDfg~~~~ 191 (239)
T PRK01723 122 DILIERIEGARDLVALLQEAPLSE----EQWQAIGQLIARFHDAG---VYHADLNAHNILLDPDGKFWLIDFDRGEL 191 (239)
T ss_pred eEEEEecCCCCCHHHHHhcCCCCH----HHHHHHHHHHHHHHHCC---CCCCCCCchhEEEcCCCCEEEEECCCccc
Confidence 3677777631 1 1223333 34678999999999999 99999999999999988999999998875
|
|
| >PRK09605 bifunctional UGMP family protein/serine/threonine protein kinase; Validated | Back alignment and domain information |
|---|
Probab=98.52 E-value=4.4e-08 Score=104.92 Aligned_cols=68 Identities=22% Similarity=0.398 Sum_probs=55.9
Q ss_pred cccceeeccCCCCCCCCCCChhhHHHHHHHHHHHHHHHhhcCCCceeecCCCccceEecCCCCceeccccceee
Q 045315 241 DEISFWYESYNNPTKKGLLCWGTRVRIIEGIAQGLLYLHQYSRLRVIHRDLKASNILLDKDMNPKISDFGMARM 314 (476)
Q Consensus 241 ~~~~l~~Ey~~~~~~~~~L~~~~~~~i~~qIa~gL~yLH~~~~~~ivH~DLkp~NILld~~~~~kL~DFGla~~ 314 (476)
...+++|||++...-...+ ..+..++.+++++|.+||+.+ ++||||||+||++ .++.++|+|||+++.
T Consensus 409 ~~~~lv~E~~~g~~L~~~l--~~~~~~~~~i~~~L~~lH~~g---iiHrDlkp~NILl-~~~~~~liDFGla~~ 476 (535)
T PRK09605 409 EEKTIVMEYIGGKDLKDVL--EGNPELVRKVGEIVAKLHKAG---IVHGDLTTSNFIV-RDDRLYLIDFGLGKY 476 (535)
T ss_pred CCCEEEEEecCCCcHHHHH--HHHHHHHHHHHHHHHHHHhCC---CccCCCChHHEEE-ECCcEEEEeCccccc
Confidence 3567899999754322222 246789999999999999999 9999999999999 577899999999975
|
|
| >PRK14879 serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=98.45 E-value=1e-07 Score=89.02 Aligned_cols=69 Identities=25% Similarity=0.325 Sum_probs=55.9
Q ss_pred cccceeeccCCCCCCCCC---CChhhHHHHHHHHHHHHHHHhhcCCCceeecCCCccceEecCCCCceeccccceee
Q 045315 241 DEISFWYESYNNPTKKGL---LCWGTRVRIIEGIAQGLLYLHQYSRLRVIHRDLKASNILLDKDMNPKISDFGMARM 314 (476)
Q Consensus 241 ~~~~l~~Ey~~~~~~~~~---L~~~~~~~i~~qIa~gL~yLH~~~~~~ivH~DLkp~NILld~~~~~kL~DFGla~~ 314 (476)
+..+++|||++...-... ... ++..++.+++.+|.+||+.+ ++|+|++|.||+++ ++.++|+|||.+..
T Consensus 72 ~~~~lv~e~~~G~~L~~~~~~~~~-~~~~i~~~i~~~l~~lH~~~---i~H~Dl~p~Nil~~-~~~~~liDf~~a~~ 143 (211)
T PRK14879 72 ENFIIVMEYIEGEPLKDLINSNGM-EELELSREIGRLVGKLHSAG---IIHGDLTTSNMILS-GGKIYLIDFGLAEF 143 (211)
T ss_pred CCCEEEEEEeCCcCHHHHHHhccH-HHHHHHHHHHHHHHHHHhCC---cccCCCCcccEEEE-CCCEEEEECCcccC
Confidence 457789999974322111 111 67899999999999999999 99999999999999 78899999998864
|
|
| >cd05120 APH_ChoK_like Aminoglycoside 3'-phosphotransferase (APH) and Choline Kinase (ChoK) family | Back alignment and domain information |
|---|
Probab=98.45 E-value=3.4e-07 Score=79.63 Aligned_cols=73 Identities=27% Similarity=0.232 Sum_probs=60.3
Q ss_pred cccceeeccCCCCCCCCCCChhhHHHHHHHHHHHHHHHhhcCCCceeecCCCccceEecCCCCceeccccceee
Q 045315 241 DEISFWYESYNNPTKKGLLCWGTRVRIIEGIAQGLLYLHQYSRLRVIHRDLKASNILLDKDMNPKISDFGMARM 314 (476)
Q Consensus 241 ~~~~l~~Ey~~~~~~~~~L~~~~~~~i~~qIa~gL~yLH~~~~~~ivH~DLkp~NILld~~~~~kL~DFGla~~ 314 (476)
+..++++||++...... ++......++.+++++|++||......++|+|++|.||++++.+.+++.||+.+..
T Consensus 66 ~~~~~v~e~~~g~~~~~-~~~~~~~~~~~~~~~~l~~lh~~~~~~i~H~Dl~~~Nil~~~~~~~~l~Df~~~~~ 138 (155)
T cd05120 66 GWSYLLMEWIEGETLDE-VSEEEKEDIAEQLAELLAKLHQLPLLVLCHGDLHPGNILVDDGKILGIIDWEYAGY 138 (155)
T ss_pred CccEEEEEecCCeeccc-CCHHHHHHHHHHHHHHHHHHhCCCceEEEecCCCcceEEEECCcEEEEEecccccC
Confidence 45788899987433322 26788889999999999999986444599999999999999988999999998864
|
The APH/ChoK family is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). The family is composed of APH, ChoK, ethanolamine kinase (ETNK), macrolide 2'-phosphotransferase (MPH2'), an unusual homoserine kinase, and uncharacterized proteins with similarity to the N-terminal domain of acyl-CoA dehydrogenase 10 (ACAD10). The members of this family catalyze the transfer of the gamma-phosphoryl group from ATP (or CTP) to small molecule substrates such as aminoglycosides, macrolides, choline, ethanolamine, and homoserine. Phosphorylation of the antibiotics, aminoglycosides and macrolides, leads to their inactivation and to bacterial antibiotic resistance. Phosphorylation of choline, ethanolamine, and homoserine serves |
| >KOG0601 consensus Cyclin-dependent kinase WEE1 [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=98.37 E-value=3.2e-07 Score=95.15 Aligned_cols=157 Identities=22% Similarity=0.286 Sum_probs=109.1
Q ss_pred CCCChhhHHHHHHHHHH----HHHHHhhcCCCceeecCCCccceEecCC-CCceeccccceeecCCCccccc---ceeee
Q 045315 257 GLLCWGTRVRIIEGIAQ----GLLYLHQYSRLRVIHRDLKASNILLDKD-MNPKISDFGMARMFGGDELQSN---TKRIV 328 (476)
Q Consensus 257 ~~L~~~~~~~i~~qIa~----gL~yLH~~~~~~ivH~DLkp~NILld~~-~~~kL~DFGla~~~~~~~~~~~---~~~~~ 328 (476)
..++.........+..+ ||.++|+.. ++|-|+||+||++..+ ...++.|||+...++....... ..+..
T Consensus 213 ~~~p~~~l~~~~~~~~~~~~~al~~~hs~~---~~~~~~kp~~i~~~~~~~s~~~~df~~v~~i~~~~~~~~~~~~~r~~ 289 (524)
T KOG0601|consen 213 NFLPDNLLWNSLRDWLSRDVTALSHLHSNN---IVHDDLKPANIFTTSDWTSCKLTDFGLVSKISDGNFSSVFKVSKRPE 289 (524)
T ss_pred ccCCchhhhhHHhhhhhcccccccccCCCc---ccccccchhheecccccceeecCCcceeEEccCCccccceeeeecCC
Confidence 34666777777777777 999999998 9999999999999999 8899999999998876542221 12235
Q ss_pred eccCCCChhhhccCCCCccceEEeehhhhhhhhhCCCCCCcCCCCchhhhhhhhhhhcCCCcccccCcccCCCCCHHHHH
Q 045315 329 GTYGYMSPEYALRGLFSIKSDVFSFGVLLLETLSSKKNTHFYNTDSLTLLGHAWNLWNDGRTWELMDPISQNGASYPILK 408 (476)
Q Consensus 329 gt~~y~aPE~l~~~~~s~ksDVwSlGvvl~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~ 408 (476)
|...|++||.. .+.++.+.|+|++|.++++..++.......... .|...+.+. +..+.......
T Consensus 290 ~~~~Y~~ke~~-~~l~~~~~di~sl~ev~l~~~l~~~~~~~g~~~-------~W~~~r~~~--------ip~e~~~~~s~ 353 (524)
T KOG0601|consen 290 GDCIYAAKELL-NGLATFASDIFSLGEVILEAILGSHLPSVGKNS-------SWSQLRQGY--------IPLEFCEGGSS 353 (524)
T ss_pred CCceEeChhhh-ccccchHhhhcchhhhhHhhHhhcccccCCCCC-------Ccccccccc--------CchhhhcCcch
Confidence 77789999965 556789999999999999999887664322100 111111111 11111111223
Q ss_pred HHHHHHHHchhhcccCCCCHHHHH
Q 045315 409 RYINVALLCVQEKAADRPAMSEVV 432 (476)
Q Consensus 409 ~l~~li~~Cl~~dP~~RPt~~eVl 432 (476)
++...+.++++.+|..|++.+.+.
T Consensus 354 ~l~~~~~~~~d~~~~~~~~~q~~~ 377 (524)
T KOG0601|consen 354 SLRSVTSQMLDEDPRLRLTAQILT 377 (524)
T ss_pred hhhhHHHHhcCcchhhhhHHHHHh
Confidence 344477889999999999876654
|
|
| >PRK10345 hypothetical protein; Provisional | Back alignment and domain information |
|---|
Probab=98.35 E-value=6.4e-07 Score=83.85 Aligned_cols=50 Identities=22% Similarity=0.264 Sum_probs=39.6
Q ss_pred CCChhhHHHHHHHHHHHH-HHHhhcCCCceeecCCCccceEecC----CCCceeccccce
Q 045315 258 LLCWGTRVRIIEGIAQGL-LYLHQYSRLRVIHRDLKASNILLDK----DMNPKISDFGMA 312 (476)
Q Consensus 258 ~L~~~~~~~i~~qIa~gL-~yLH~~~~~~ivH~DLkp~NILld~----~~~~kL~DFGla 312 (476)
.+++. ..++.+++.++ +|||+++ |+||||||+|||++. +..++|+||+.+
T Consensus 102 ~~~e~--~~~~~~~L~~l~~yLh~~~---IvhrDlKp~NILl~~~~~~~~~~~LiDg~G~ 156 (210)
T PRK10345 102 RYEED--VAQLRQLLKKLKRYLLDNR---IVTMELKPQNILCQRISESEVIPVVCDNIGE 156 (210)
T ss_pred cccHh--HHHHHHHHHHHHHHHHHCC---EeecCCCHHHEEEeccCCCCCcEEEEECCCC
Confidence 35444 46678888888 9999999 999999999999974 347999995433
|
|
| >cd05146 RIO3_euk RIO kinase family; eukaryotic RIO3, catalytic domain | Back alignment and domain information |
|---|
Probab=98.31 E-value=1.2e-06 Score=80.85 Aligned_cols=72 Identities=14% Similarity=0.043 Sum_probs=57.2
Q ss_pred cccceeeccCCCC------CCCCCCChhhHHHHHHHHHHHHHHH-hhcCCCceeecCCCccceEecCCCCceecccccee
Q 045315 241 DEISFWYESYNNP------TKKGLLCWGTRVRIIEGIAQGLLYL-HQYSRLRVIHRDLKASNILLDKDMNPKISDFGMAR 313 (476)
Q Consensus 241 ~~~~l~~Ey~~~~------~~~~~L~~~~~~~i~~qIa~gL~yL-H~~~~~~ivH~DLkp~NILld~~~~~kL~DFGla~ 313 (476)
.+.+++|||+.+. -+...++.++...+..+++.+|..| |..+ +||+||++.||+++ ++.+.|+|||.+.
T Consensus 97 ~~~~lvME~Ig~~~~~~~~Lkd~~~~~~~~~~i~~~i~~~l~~l~H~~g---lVHGDLs~~NIL~~-~~~v~iIDF~qav 172 (197)
T cd05146 97 KKHVLVMSFIGDDQVPAPKLKDAKLNDEEMKNAYYQVLSMMKQLYKECN---LVHADLSEYNMLWH-DGKVWFIDVSQSV 172 (197)
T ss_pred cCCEEEEEEcCCCCccchhhhccccCHHHHHHHHHHHHHHHHHHHHhCC---eecCCCCHHHEEEE-CCcEEEEECCCce
Confidence 3678899999742 1122455556778889999999999 8888 99999999999997 4679999999987
Q ss_pred ecC
Q 045315 314 MFG 316 (476)
Q Consensus 314 ~~~ 316 (476)
...
T Consensus 173 ~~~ 175 (197)
T cd05146 173 EPT 175 (197)
T ss_pred eCC
Confidence 653
|
The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases containing a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. RIO3 is present only in multicellular eukaryotes. Its function is still unknown. |
| >cd05151 ChoK Choline Kinase (ChoK) | Back alignment and domain information |
|---|
Probab=98.17 E-value=2.3e-06 Score=76.81 Aligned_cols=70 Identities=27% Similarity=0.144 Sum_probs=53.2
Q ss_pred ccceeeccCCCCCCCCCCChhhHHHHHHHHHHHHHHHhhcC--CCceeecCCCccceEecCCCCceeccccceee
Q 045315 242 EISFWYESYNNPTKKGLLCWGTRVRIIEGIAQGLLYLHQYS--RLRVIHRDLKASNILLDKDMNPKISDFGMARM 314 (476)
Q Consensus 242 ~~~l~~Ey~~~~~~~~~L~~~~~~~i~~qIa~gL~yLH~~~--~~~ivH~DLkp~NILld~~~~~kL~DFGla~~ 314 (476)
..+++|||++....... ......++.+++++|+.||..+ ...++|+|++|.||+++ ++.++++||+.+..
T Consensus 65 ~~~lv~e~i~G~~l~~~--~~~~~~~~~~l~~~l~~LH~~~~~~~~~~HgD~~~~Nil~~-~~~~~liDf~~a~~ 136 (170)
T cd05151 65 TGVLITEFIEGSELLTE--DFSDPENLEKIAKLLKKLHSSPLPDLVPCHNDLLPGNFLLD-DGRLWLIDWEYAGM 136 (170)
T ss_pred CCeEEEEecCCCccccc--cccCHHHHHHHHHHHHHHhCCCCCCceeecCCCCcCcEEEE-CCeEEEEecccccC
Confidence 35788999985433221 1223456789999999999977 23469999999999999 66899999998864
|
The ChoK subfamily is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). It is composed of bacterial and eukaryotic choline kinases, as well as eukaryotic ethanolamine kinase. ChoK catalyzes the transfer of the gamma-phosphoryl group from ATP (or CTP) to its substrate, choline, producing phosphorylcholine (PCho), a precursor to the biosynthesis of two major membrane phospholipids, phosphatidylcholine (PC), and sphingomyelin (SM). Although choline is the preferred substrate, ChoK also shows substantial activity towards ethanolamine and its N-methylated derivatives. Bacterial ChoK is also referred to as licA protein. ETNK catalyzes the transfer of the gamma-phosphoryl group from CTP to ethanolamine (Etn), the first step in the CDP-Etn pathway for the formation of the major ph |
| >TIGR01982 UbiB 2-polyprenylphenol 6-hydroxylase | Back alignment and domain information |
|---|
Probab=98.06 E-value=4.9e-06 Score=86.67 Aligned_cols=73 Identities=22% Similarity=0.204 Sum_probs=55.6
Q ss_pred cccceeeccCCCCCCCCCCCh----hhHHHHHHHHHH-HHHHHhhcCCCceeecCCCccceEecCCCCceeccccceeec
Q 045315 241 DEISFWYESYNNPTKKGLLCW----GTRVRIIEGIAQ-GLLYLHQYSRLRVIHRDLKASNILLDKDMNPKISDFGMARMF 315 (476)
Q Consensus 241 ~~~~l~~Ey~~~~~~~~~L~~----~~~~~i~~qIa~-gL~yLH~~~~~~ivH~DLkp~NILld~~~~~kL~DFGla~~~ 315 (476)
...+++|||++...-...... ..+.+++..++. .+..+|..+ ++|+|+||.||+++.++.++++|||++..+
T Consensus 231 ~~~vLvmE~i~G~~L~~~~~~~~~~~~~~~ia~~~~~~~l~ql~~~g---~~H~D~hPgNilv~~~g~i~liDfG~~~~l 307 (437)
T TIGR01982 231 SERVLTMEWIDGIPLSDIAALDEAGLDRKALAENLARSFLNQVLRDG---FFHADLHPGNIFVLKDGKIIALDFGIVGRL 307 (437)
T ss_pred CCceEEEEeECCcccccHHHHHhcCCCHHHHHHHHHHHHHHHHHhCC---ceeCCCCcccEEECCCCcEEEEeCCCeeEC
Confidence 357899999984332211111 135567777776 478899988 999999999999999999999999999876
Q ss_pred C
Q 045315 316 G 316 (476)
Q Consensus 316 ~ 316 (476)
.
T Consensus 308 ~ 308 (437)
T TIGR01982 308 S 308 (437)
T ss_pred C
Confidence 5
|
This model represents the enzyme (UbiB) which catalyzes the first hydroxylation step in the ubiquinone biosynthetic pathway in bacteria. It is believed that the reaction is 2-polyprenylphenol - 6-hydroxy-2-polyprenylphenol. This model finds hits primarily in the proteobacteria. The gene is also known as AarF in certain species. |
| >PF11883 DUF3403: Domain of unknown function (DUF3403); InterPro: IPR021820 This functionally uncharacterised domain of around 50 amino acids is found in the C terminus of eukaryotic S-locus receptor kinase proteins | Back alignment and domain information |
|---|
Probab=98.04 E-value=5.6e-06 Score=57.52 Aligned_cols=37 Identities=38% Similarity=0.592 Sum_probs=29.9
Q ss_pred cCCCCCCCCcceecc---CC--C-CC--CCCccccceEeeeeecC
Q 045315 440 VNLPAPQQPAFSCVN---ST--N-MQ--SDAFSVNCVTHSVIDAR 476 (476)
Q Consensus 440 ~~~~~p~~p~~~~~~---~~--~-~~--~~~~~~~~~~~~~~~~~ 476 (476)
..+|.|++|+|+..+ +. + .. ++.+|+|+||+|.|+||
T Consensus 4 ~~LP~PKqPgF~~~r~~~e~~sSss~~~~~~~SvNevTiT~l~~R 48 (48)
T PF11883_consen 4 ATLPQPKQPGFFTGRSPSETDSSSSKQRDESCSVNEVTITMLEAR 48 (48)
T ss_pred ccCCCCCCCCEEeEcCCCCcCCCcccccCCCCCeeeEEEEeEecC
Confidence 579999999999883 22 2 22 37899999999999999
|
; GO: 0004674 protein serine/threonine kinase activity |
| >KOG0606 consensus Microtubule-associated serine/threonine kinase and related proteins [Signal transduction mechanisms; General function prediction only] | Back alignment and domain information |
|---|
Probab=98.03 E-value=3e-06 Score=92.84 Aligned_cols=172 Identities=22% Similarity=0.232 Sum_probs=115.7
Q ss_pred ccceeeccCCCC------CCCCCCChhhHHHHHHHHHHHHHHHhhcCCCceeecCCCccceEecCCCCceeccccceeec
Q 045315 242 EISFWYESYNNP------TKKGLLCWGTRVRIIEGIAQGLLYLHQYSRLRVIHRDLKASNILLDKDMNPKISDFGMARMF 315 (476)
Q Consensus 242 ~~~l~~Ey~~~~------~~~~~L~~~~~~~i~~qIa~gL~yLH~~~~~~ivH~DLkp~NILld~~~~~kL~DFGla~~~ 315 (476)
...++++|+... .+.+.++.+-....+..+.++++|||... ++|+|++|.|++...++..++.||+.....
T Consensus 878 P~~L~~~~~~~~~~~Skl~~~~~~saepaRs~i~~~vqs~e~L~s~~---r~h~~~~p~~~l~~~~gh~~l~~~~t~~~v 954 (1205)
T KOG0606|consen 878 PLPLVGHYLNGGDLPSKLHNSGCLSAEPARSPILERVQSLESLHSSL---RKHRDLKPDSLLIAYDGHRPLTDFGTLSKV 954 (1205)
T ss_pred CcchhhHHhccCCchhhhhcCCCcccccccchhHHHHhhhhccccch---hhcccccccchhhcccCCcccCcccccccc
Confidence 456777877421 22334666677777888999999999987 899999999999999999999999843322
Q ss_pred CC---------------------C----ccc----ccceeeeeccCCCChhhhccCCCCccceEEeehhhhhhhhhCCCC
Q 045315 316 GG---------------------D----ELQ----SNTKRIVGTYGYMSPEYALRGLFSIKSDVFSFGVLLLETLSSKKN 366 (476)
Q Consensus 316 ~~---------------------~----~~~----~~~~~~~gt~~y~aPE~l~~~~~s~ksDVwSlGvvl~elltG~~p 366 (476)
+- . ... .......+|..|.+||...+......+|.|++|++++|.++|.+|
T Consensus 955 g~~~p~~~~sg~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~t~~~laPe~~lg~~hgs~ad~~~~g~~l~e~l~g~pp 1034 (1205)
T KOG0606|consen 955 GLIPPTTDLSGPSSSGTPRRLSRSERRPQLSADEARRKHAVVGTPDYLAPEILLGRRHGSAADWWSSGVCLFEVLTGIPP 1034 (1205)
T ss_pred ccccCcCCcccccccCccccccccccccccccchhhccccccCCCcccCCcccccccCCCcchhhhhhhhhhhhhcCCCC
Confidence 10 0 000 112345689999999999999999999999999999999999999
Q ss_pred CCcCCCCchhhhhhhhhhhcCCCcccccCcccCCCCCHHHHHHHHHHHHHchhhcccCCCCHH
Q 045315 367 THFYNTDSLTLLGHAWNLWNDGRTWELMDPISQNGASYPILKRYINVALLCVQEKAADRPAMS 429 (476)
Q Consensus 367 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~l~~li~~Cl~~dP~~RPt~~ 429 (476)
|........ . .... .+.. + -..-......+..+++...+..+|.+|-.+.
T Consensus 1035 ~na~tpq~~--f---~ni~-~~~~-----~--~p~g~~~~s~~aq~~~~~ll~~~~~qr~~a~ 1084 (1205)
T KOG0606|consen 1035 FNAETPQQI--F---ENIL-NRDI-----P--WPEGPEEGSYEAQDLINRLLTEEPTQRLGAK 1084 (1205)
T ss_pred CCCcchhhh--h---hccc-cCCC-----C--CCCCccccChhhhhhhhhhhccCchhccCcc
Confidence 864332111 0 0000 0000 0 0011112233455666677788888887654
|
|
| >KOG0601 consensus Cyclin-dependent kinase WEE1 [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=98.01 E-value=5.3e-06 Score=86.22 Aligned_cols=152 Identities=19% Similarity=0.178 Sum_probs=101.3
Q ss_pred CCChhhHHHHHHHHHHHHHHHhhcCCCceeecCCCccceEecCC-CCceeccccceeecCCCcccccceeeeeccCCC--
Q 045315 258 LLCWGTRVRIIEGIAQGLLYLHQYSRLRVIHRDLKASNILLDKD-MNPKISDFGMARMFGGDELQSNTKRIVGTYGYM-- 334 (476)
Q Consensus 258 ~L~~~~~~~i~~qIa~gL~yLH~~~~~~ivH~DLkp~NILld~~-~~~kL~DFGla~~~~~~~~~~~~~~~~gt~~y~-- 334 (476)
.++...++++..|++.++.++|+.. ++|+|+||+||++..+ +..++.||+....+.-.. ....+.-+++
T Consensus 362 ~~d~~~~~~~~~q~~~~l~~i~s~~---~~~~d~~psni~i~~~~~~~~~~~~~~~t~~~~~~-----~~~~~~~r~~p~ 433 (524)
T KOG0601|consen 362 MLDEDPRLRLTAQILTALNVIHSKL---FVHLDVKPSNILISNDGFFSKLGDFGCWTRLAFSS-----GVFHHIDRLYPI 433 (524)
T ss_pred hcCcchhhhhHHHHHhccccccchh---hhcccccccceeeccchhhhhccccccccccceec-----cccccccccccc
Confidence 4667788999999999999999988 9999999999999886 778999999986432111 1112222333
Q ss_pred ChhhhccCCCCccceEEeehhhhhhhhhCCCCCCcCCCCchhhhhhhhhhhcCCCcccccCcccCCCCCHHHHHHHHHHH
Q 045315 335 SPEYALRGLFSIKSDVFSFGVLLLETLSSKKNTHFYNTDSLTLLGHAWNLWNDGRTWELMDPISQNGASYPILKRYINVA 414 (476)
Q Consensus 335 aPE~l~~~~~s~ksDVwSlGvvl~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~l~~li 414 (476)
+++......+..+.|+++||.-+.|.+++..-.... .. +.....+.. ...+. ..+.+..+.
T Consensus 434 ~~~~~e~~~~~~~~~~~sl~~~~~e~~~~~~ls~~~-~~--------~~~i~~~~~---------p~~~~-~~~~~q~~~ 494 (524)
T KOG0601|consen 434 AEILLEDYPHLSKADIFSLGLSVDEAITGSPLSESG-VQ--------SLTIRSGDT---------PNLPG-LKLQLQVLL 494 (524)
T ss_pred chhhccccccccccccccccccccccccCcccCccc-cc--------ceeeecccc---------cCCCc-hHHhhhhhh
Confidence 555555677889999999999999999887543211 00 000111111 00011 113444555
Q ss_pred HHchhhcccCCCCHHHHHHHHh
Q 045315 415 LLCVQEKAADRPAMSEVVSMLS 436 (476)
Q Consensus 415 ~~Cl~~dP~~RPt~~eVl~~L~ 436 (476)
..+...++..||.+.++....+
T Consensus 495 kv~~~~~~~~~~l~~~l~~~~~ 516 (524)
T KOG0601|consen 495 KVMINPDRKRRPSAVELSLHSE 516 (524)
T ss_pred hhhcCCccccchhhhhhcccch
Confidence 6677889999998877765543
|
|
| >COG3642 Mn2+-dependent serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=97.98 E-value=3.9e-06 Score=75.48 Aligned_cols=69 Identities=25% Similarity=0.300 Sum_probs=54.9
Q ss_pred cccceeeccCCCCCCCCCCChhhHHHHHHHHHHHHHHHhhcCCCceeecCCCccceEecCCCCceeccccceee
Q 045315 241 DEISFWYESYNNPTKKGLLCWGTRVRIIEGIAQGLLYLHQYSRLRVIHRDLKASNILLDKDMNPKISDFGMARM 314 (476)
Q Consensus 241 ~~~~l~~Ey~~~~~~~~~L~~~~~~~i~~qIa~gL~yLH~~~~~~ivH~DLkp~NILld~~~~~kL~DFGla~~ 314 (476)
+.-.++|||++...-+..+... +..++..|-.-+.-||..+ |+|+||.++||++.... +.++|||++..
T Consensus 72 ~~~~I~me~I~G~~lkd~l~~~-~~~~~r~vG~~vg~lH~~g---ivHGDLTtsNiIl~~~~-i~~IDfGLg~~ 140 (204)
T COG3642 72 DNGLIVMEYIEGELLKDALEEA-RPDLLREVGRLVGKLHKAG---IVHGDLTTSNIILSGGR-IYFIDFGLGEF 140 (204)
T ss_pred CCCEEEEEEeCChhHHHHHHhc-chHHHHHHHHHHHHHHhcC---eecCCCccceEEEeCCc-EEEEECCcccc
Confidence 4567899999854433223222 4678888888999999999 99999999999998664 99999999974
|
|
| >PRK15123 lipopolysaccharide core heptose(I) kinase RfaP; Provisional | Back alignment and domain information |
|---|
Probab=97.94 E-value=1.3e-05 Score=77.79 Aligned_cols=70 Identities=17% Similarity=0.140 Sum_probs=57.5
Q ss_pred ccceeeccCCCCC---------CCCCCChhhHHHHHHHHHHHHHHHhhcCCCceeecCCCccceEecC-------CCCce
Q 045315 242 EISFWYESYNNPT---------KKGLLCWGTRVRIIEGIAQGLLYLHQYSRLRVIHRDLKASNILLDK-------DMNPK 305 (476)
Q Consensus 242 ~~~l~~Ey~~~~~---------~~~~L~~~~~~~i~~qIa~gL~yLH~~~~~~ivH~DLkp~NILld~-------~~~~k 305 (476)
..++++|++++.. .....+...+..++.+++..+.-||..| |+|+|+++.|||++. +..+.
T Consensus 109 ~s~LVte~l~~~~sL~~~~~~~~~~~~~~~~~~~ll~~la~~i~~LH~~G---i~HgDL~~~NiLl~~~~~~~~~~~~~~ 185 (268)
T PRK15123 109 TSFIITEDLAPTISLEDYCADWATNPPDPRLKRMLIKRVATMVRDMHAAG---INHRDCYICHFLLHLPFPGREEDLKLS 185 (268)
T ss_pred eeEEEEeeCCCCccHHHHHHhhcccCCCHHHHHHHHHHHHHHHHHHHHCc---CccCCCChhhEEEeccccCCCCCceEE
Confidence 5789999998431 1234556678899999999999999999 999999999999985 46789
Q ss_pred eccccceee
Q 045315 306 ISDFGMARM 314 (476)
Q Consensus 306 L~DFGla~~ 314 (476)
++||+.++.
T Consensus 186 LIDl~r~~~ 194 (268)
T PRK15123 186 VIDLHRAQI 194 (268)
T ss_pred EEECCcccc
Confidence 999998864
|
|
| >PF01163 RIO1: RIO1 family; InterPro: IPR018934 Protein phosphorylation, which plays a key role in most cellular activities, is a reversible process mediated by protein kinases and phosphoprotein phosphatases | Back alignment and domain information |
|---|
Probab=97.74 E-value=3.4e-05 Score=70.77 Aligned_cols=72 Identities=25% Similarity=0.270 Sum_probs=49.7
Q ss_pred cccceeeccCC--CCCC----CCCCChhhHHHHHHHHHHHHHH-HhhcCCCceeecCCCccceEecCCCCceecccccee
Q 045315 241 DEISFWYESYN--NPTK----KGLLCWGTRVRIIEGIAQGLLY-LHQYSRLRVIHRDLKASNILLDKDMNPKISDFGMAR 313 (476)
Q Consensus 241 ~~~~l~~Ey~~--~~~~----~~~L~~~~~~~i~~qIa~gL~y-LH~~~~~~ivH~DLkp~NILld~~~~~kL~DFGla~ 313 (476)
.+..++|||++ .... ...++.++...++.+++..+.. +|..+ |+|+||.+.||+++++ .+.|+|||.+.
T Consensus 79 ~~~~ivME~I~~~G~~~~~l~~~~~~~~~~~~~~~~il~~~~~~~~~~g---ivHGDLs~~NIlv~~~-~~~iIDf~qav 154 (188)
T PF01163_consen 79 NRNVIVMEYIGEDGVPLPRLKDVDLSPEEPKELLEEILEEIIKMLHKAG---IVHGDLSEYNILVDDG-KVYIIDFGQAV 154 (188)
T ss_dssp ETTEEEEE--EETTEEGGCHHHCGGGGSTHHHHHHHHHHHHHHHHHCTT---EEESS-STTSEEEETT-CEEE--GTTEE
T ss_pred eCCEEEEEecCCCccchhhHHhccccchhHHHHHHHHHHHHHHHHHhcC---ceecCCChhhEEeecc-eEEEEecCcce
Confidence 35779999998 2111 1122245677888899886666 57888 9999999999999987 89999999987
Q ss_pred ecC
Q 045315 314 MFG 316 (476)
Q Consensus 314 ~~~ 316 (476)
...
T Consensus 155 ~~~ 157 (188)
T PF01163_consen 155 DSS 157 (188)
T ss_dssp ETT
T ss_pred ecC
Confidence 643
|
Protein kinases catalyse the transfer of the gamma phosphate from nucleotide triphosphates (often ATP) to one or more amino acid residues in a protein substrate side chain, resulting in a conformational change affecting protein function. Phosphoprotein phosphatases catalyse the reverse process. Protein kinases fall into three broad classes, characterised with respect to substrate specificity []: Serine/threonine-protein kinases Tyrosine-protein kinases Dual specific protein kinases (e.g. MEK - phosphorylates both Thr and Tyr on target proteins) Protein kinase function has been evolutionarily conserved from Escherichia coli to human []. Protein kinases play a role in a multitude of cellular processes, including division, proliferation, apoptosis, and differentiation []. Phosphorylation usually results in a functional change of the target protein by changing enzyme activity, cellular location, or association with other proteins. The catalytic subunits of protein kinases are highly conserved, and several structures have been solved [], leading to large screens to develop kinase-specific inhibitors for the treatments of a number of diseases []. This entry represents RIO kinase, they exhibit little sequence similarity with eukaryotic protein kinases, and are classified as atypical protein kinases []. The conformation of ATP when bound to the RIO kinases is unique when compared with ePKs, such as serine/threonine kinases or the insulin receptor tyrosine kinase, suggesting that the detailed mechanism by which the catalytic aspartate of RIO kinases participates in phosphoryl transfer may not be identical to that employed in known serine/threonine ePKs. Representatives of the RIO family are present in organisms varying from Archaea to humans, although the RIO3 proteins have only been identified in multicellular eukaryotes, to date. Yeast Rio1 and Rio2 proteins are required for proper cell cycle progression and chromosome maintenance, and are necessary for survival of the cells. These proteins are involved in the processing of 20 S pre-rRNA via late 18 S rRNA processing. ; GO: 0003824 catalytic activity, 0005524 ATP binding; PDB: 1TQP_A 1ZAR_A 1TQI_A 1ZAO_A 1TQM_A 3RE4_A 1ZTH_B 1ZP9_A 1ZTF_A. |
| >PF06293 Kdo: Lipopolysaccharide kinase (Kdo/WaaP) family; InterPro: IPR010440 Protein phosphorylation, which plays a key role in most cellular activities, is a reversible process mediated by protein kinases and phosphoprotein phosphatases | Back alignment and domain information |
|---|
Probab=97.68 E-value=3.7e-05 Score=71.83 Aligned_cols=71 Identities=24% Similarity=0.253 Sum_probs=57.9
Q ss_pred ccceeeccCCCCC-------CCCCCChhhHHHHHHHHHHHHHHHhhcCCCceeecCCCccceEecCCC---Cceeccccc
Q 045315 242 EISFWYESYNNPT-------KKGLLCWGTRVRIIEGIAQGLLYLHQYSRLRVIHRDLKASNILLDKDM---NPKISDFGM 311 (476)
Q Consensus 242 ~~~l~~Ey~~~~~-------~~~~L~~~~~~~i~~qIa~gL~yLH~~~~~~ivH~DLkp~NILld~~~---~~kL~DFGl 311 (476)
..++++|++++.. ....++...+..++.++++.++-||..+ |+|+|+++.|||++.+. .+.++||+.
T Consensus 91 ~s~lite~l~~~~~L~~~~~~~~~~~~~~~~~ll~~l~~~i~~lH~~g---i~H~Dl~~~NILv~~~~~~~~~~lIDld~ 167 (206)
T PF06293_consen 91 RSYLITEALPGAQDLRDLLQQWEQLDPSQRRELLRALARLIAKLHDAG---IYHGDLNPSNILVDPDDGQYRFYLIDLDR 167 (206)
T ss_pred eEEEEEEeCCCcccHHHHHHhhcccchhhHHHHHHHHHHHHHHHHHCc---CCCCCCCcccEEEeCCCCceeEEEEcchh
Confidence 3578888887321 1112667788899999999999999999 99999999999999887 789999998
Q ss_pred eeec
Q 045315 312 ARMF 315 (476)
Q Consensus 312 a~~~ 315 (476)
++..
T Consensus 168 ~~~~ 171 (206)
T PF06293_consen 168 MRFR 171 (206)
T ss_pred ceeC
Confidence 8753
|
Protein kinases catalyse the transfer of the gamma phosphate from nucleotide triphosphates (often ATP) to one or more amino acid residues in a protein substrate side chain, resulting in a conformational change affecting protein function. Phosphoprotein phosphatases catalyse the reverse process. Protein kinases fall into three broad classes, characterised with respect to substrate specificity []: Serine/threonine-protein kinases Tyrosine-protein kinases Dual specific protein kinases (e.g. MEK - phosphorylates both Thr and Tyr on target proteins) Protein kinase function has been evolutionarily conserved from Escherichia coli to human []. Protein kinases play a role in a multitude of cellular processes, including division, proliferation, apoptosis, and differentiation []. Phosphorylation usually results in a functional change of the target protein by changing enzyme activity, cellular location, or association with other proteins. The catalytic subunits of protein kinases are highly conserved, and several structures have been solved [], leading to large screens to develop kinase-specific inhibitors for the treatments of a number of diseases []. This entry represents lipopolysaccharide kinases which are related to protein kinases IPR000719 from INTERPRO. This family includes waaP (rfaP) gene product is required for the addition of phosphate to O-4 of the first heptose residue of the lipopolysaccharide (LPS) inner core region. It has previously been shown that WaaP is necessary for resistance to hydrophobic and polycationic antimicrobials in E. coli and that it is required for virulence in invasive strains of Salmonella enterica [].; GO: 0005524 ATP binding, 0016773 phosphotransferase activity, alcohol group as acceptor, 0009103 lipopolysaccharide biosynthetic process, 0016020 membrane |
| >KOG3087 consensus Serine/threonine protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=97.52 E-value=0.00012 Score=65.97 Aligned_cols=70 Identities=27% Similarity=0.341 Sum_probs=50.9
Q ss_pred ccceeeccCCCCC---------CCCCCChhhHHHHHHHHHHHHHHHhhcCCCceeecCCCccceEecCCCC---ceeccc
Q 045315 242 EISFWYESYNNPT---------KKGLLCWGTRVRIIEGIAQGLLYLHQYSRLRVIHRDLKASNILLDKDMN---PKISDF 309 (476)
Q Consensus 242 ~~~l~~Ey~~~~~---------~~~~L~~~~~~~i~~qIa~gL~yLH~~~~~~ivH~DLkp~NILld~~~~---~kL~DF 309 (476)
+-.+||||++... ....-..+....++..|-+.+.-||..+ |||+||..+||++..++. +.++||
T Consensus 84 ~~~i~ME~~~g~~~vk~~i~~~~~~~~~d~~~~~~~~~iG~~igklH~nd---iiHGDLTTSNill~~~~~~~~~~lIdf 160 (229)
T KOG3087|consen 84 GGQIYMEFIDGASTVKDFILSTMEDESEDEGLAELARRIGELIGKLHDND---IIHGDLTTSNILLRSDGNQITPILIDF 160 (229)
T ss_pred CCeEEEEeccchhHHHHHHHHHccCcccchhHHHHHHHHHHHHHHhhhCC---eecccccccceEEecCCCcCceEEEee
Confidence 3457889887311 1111122222678899999999999999 999999999999976553 479999
Q ss_pred cceee
Q 045315 310 GMARM 314 (476)
Q Consensus 310 Gla~~ 314 (476)
|++..
T Consensus 161 gls~~ 165 (229)
T KOG3087|consen 161 GLSSV 165 (229)
T ss_pred cchhc
Confidence 99864
|
|
| >PF06176 WaaY: Lipopolysaccharide core biosynthesis protein (WaaY); InterPro: IPR009330 This family consists of several bacterial lipopolysaccharide core biosynthesis proteins (WaaY or RfaY) | Back alignment and domain information |
|---|
Probab=97.42 E-value=0.00017 Score=67.30 Aligned_cols=67 Identities=19% Similarity=0.223 Sum_probs=50.1
Q ss_pred ccceeeccCCCCCCCCCCChhhHHHHHHHHHHHHHHHhhcCCCceeecCCCccceEecCCCCceeccccceee
Q 045315 242 EISFWYESYNNPTKKGLLCWGTRVRIIEGIAQGLLYLHQYSRLRVIHRDLKASNILLDKDMNPKISDFGMARM 314 (476)
Q Consensus 242 ~~~l~~Ey~~~~~~~~~L~~~~~~~i~~qIa~gL~yLH~~~~~~ivH~DLkp~NILld~~~~~kL~DFGla~~ 314 (476)
..+++|||+++..-....+..+ .++..|++++.-||+.| ++|+|.+|.|++++.+ .++++||+..+.
T Consensus 117 ~~~ll~EYIeG~~l~d~~~i~e--~~~~ki~~~ikqlH~~G---~~HGD~hpgNFlv~~~-~i~iID~~~k~~ 183 (229)
T PF06176_consen 117 SYVLLMEYIEGVELNDIEDIDE--DLAEKIVEAIKQLHKHG---FYHGDPHPGNFLVSNN-GIRIIDTQGKRM 183 (229)
T ss_pred EEEEEEEEecCeecccchhcCH--HHHHHHHHHHHHHHHcC---CccCCCCcCcEEEECC-cEEEEECccccc
Confidence 4568999998543322221111 35567888999999999 9999999999999965 489999987654
|
The waaY, waaQ, and waaP genes are located in the central operon of the waa (formerly rfa) locus on the chromosome of Escherichia coli. This locus contains genes whose products are involved in the assembly of the core region of the lipopolysaccharide molecule. WaaY is the enzyme that phosphorylates HepII in this system [].; GO: 0009244 lipopolysaccharide core region biosynthetic process |
| >KOG1243 consensus Protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=97.34 E-value=0.00022 Score=75.37 Aligned_cols=117 Identities=14% Similarity=0.124 Sum_probs=78.9
Q ss_pred cccceeeccCC-CCCCCCCCChhhHHHHHHHHHHHHHHHhhcCCCceeecCCCccceEecCCCCceeccccceeecCCCc
Q 045315 241 DEISFWYESYN-NPTKKGLLCWGTRVRIIEGIAQGLLYLHQYSRLRVIHRDLKASNILLDKDMNPKISDFGMARMFGGDE 319 (476)
Q Consensus 241 ~~~~l~~Ey~~-~~~~~~~L~~~~~~~i~~qIa~gL~yLH~~~~~~ivH~DLkp~NILld~~~~~kL~DFGla~~~~~~~ 319 (476)
+..|++.|-+. -...-+.+......-.+.||+.||.|||.++ .++|++|..+.|++++.|..||++|.++.......
T Consensus 82 ~~~ylvTErV~Pl~~~lk~l~~~~v~~Gl~qIl~AL~FL~~d~--~lvHgNv~~~SVfVn~~GeWkLggle~v~~~~~~~ 159 (690)
T KOG1243|consen 82 GTLYLVTERVRPLETVLKELGKEEVCLGLFQILAALSFLNDDC--NLVHGNVCKDSVFVNESGEWKLGGLELVSKASGFN 159 (690)
T ss_pred CceEEEeeccccHHHHHHHhHHHHHHHHHHHHHHHHHHHhccC--CeeeccEeeeeEEEcCCCcEEEeeeEEEeccccCC
Confidence 46788877553 1111112334455556899999999999765 49999999999999999999999999886543221
Q ss_pred ccccceeeeeccCCCChhhhccCCCCccceEEeehhhhhhhhhC
Q 045315 320 LQSNTKRIVGTYGYMSPEYALRGLFSIKSDVFSFGVLLLETLSS 363 (476)
Q Consensus 320 ~~~~~~~~~gt~~y~aPE~l~~~~~s~ksDVwSlGvvl~elltG 363 (476)
. ......--..|..|+.+... .-..|.|-|||+++|++.|
T Consensus 160 ~--~~~~~~~~~s~~~P~~~~~s--~~s~D~~~Lg~li~el~ng 199 (690)
T KOG1243|consen 160 A--PAKSLYLIESFDDPEEIDPS--EWSIDSWGLGCLIEELFNG 199 (690)
T ss_pred c--ccccchhhhcccChhhcCcc--ccchhhhhHHHHHHHHhCc
Confidence 1 11111222345666643221 1356999999999999998
|
|
| >KOG3741 consensus Poly(A) ribonuclease subunit [RNA processing and modification] | Back alignment and domain information |
|---|
Probab=97.30 E-value=0.001 Score=68.53 Aligned_cols=103 Identities=20% Similarity=0.318 Sum_probs=80.3
Q ss_pred ccceeeccCCC----------------------CCCCCCCChhhHHHHHHHHHHHHHHHhhcCCCceeecCCCccceEec
Q 045315 242 EISFWYESYNN----------------------PTKKGLLCWGTRVRIIEGIAQGLLYLHQYSRLRVIHRDLKASNILLD 299 (476)
Q Consensus 242 ~~~l~~Ey~~~----------------------~~~~~~L~~~~~~~i~~qIa~gL~yLH~~~~~~ivH~DLkp~NILld 299 (476)
-++++|+|.|. ...+.+++++..+.++.|+..||.++|+.| +.-+-|.+.+|+++
T Consensus 351 SlvlvYDYyP~s~TL~d~~F~~~~~t~~~n~~~~~~~~~~~e~~lW~y~~QLtaaL~sIHssG---LAck~L~~~kIlv~ 427 (655)
T KOG3741|consen 351 SLVLVYDYYPSSPTLYDLYFANPPFTKRTNSFYPSQNLKAPEEVLWSYISQLTAALYSIHSSG---LACKTLDLKKILVT 427 (655)
T ss_pred eEEEEEecCCCCchHHHHHccCCccccccccccccCCCCchHHHHHHHHHHHHHHHHHHHhcC---ceeecccHhHeEee
Confidence 47788999881 123456888999999999999999999999 88899999999999
Q ss_pred CCCCceeccccceeecCCCcccccceeeeeccCCCChhhhccCCCCccceEEeehhhhhhhhhCCCC
Q 045315 300 KDMNPKISDFGMARMFGGDELQSNTKRIVGTYGYMSPEYALRGLFSIKSDVFSFGVLLLETLSSKKN 366 (476)
Q Consensus 300 ~~~~~kL~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~s~ksDVwSlGvvl~elltG~~p 366 (476)
.+.+++|+..|.......+.. +| +.+ -.+-|.=.||.+++-|.||...
T Consensus 428 G~~RIriS~C~i~Dvl~~d~~--------------~~--le~---~Qq~D~~~lG~ll~aLAt~~~n 475 (655)
T KOG3741|consen 428 GKMRIRISGCGIMDVLQEDPT--------------EP--LES---QQQNDLRDLGLLLLALATGTEN 475 (655)
T ss_pred CcceEEEecccceeeecCCCC--------------cc--hhH---HhhhhHHHHHHHHHHHhhcccc
Confidence 999999988887766544321 11 111 2356777899999999999765
|
|
| >PRK04750 ubiB putative ubiquinone biosynthesis protein UbiB; Reviewed | Back alignment and domain information |
|---|
Probab=97.28 E-value=0.00017 Score=76.65 Aligned_cols=73 Identities=16% Similarity=0.127 Sum_probs=47.6
Q ss_pred ccceeeccCCCCCCCC--CCCh--hhHHHHHHHHHHH-HHHHhhcCCCceeecCCCccceEecCCC----Cceeccccce
Q 045315 242 EISFWYESYNNPTKKG--LLCW--GTRVRIIEGIAQG-LLYLHQYSRLRVIHRDLKASNILLDKDM----NPKISDFGMA 312 (476)
Q Consensus 242 ~~~l~~Ey~~~~~~~~--~L~~--~~~~~i~~qIa~g-L~yLH~~~~~~ivH~DLkp~NILld~~~----~~kL~DFGla 312 (476)
..+++|||++...-.. .+.. ..+..++...++. +..++..| ++|+|+||.||+++.++ .+++.|||++
T Consensus 235 ~~VLvmE~i~G~~l~d~~~l~~~g~d~~~la~~~v~~~~~Qif~~G---ffHaDpHPGNIlv~~~g~~~~~i~llDFGiv 311 (537)
T PRK04750 235 ETVMVMERMYGIPVSDVAALRAAGTDMKLLAERGVEVFFTQVFRDG---FFHADMHPGNIFVSYDPPENPRYIALDFGIV 311 (537)
T ss_pred CceEEEeeecCccHHhHHHHHhcCCCHHHHHHHHHHHHHHHHHhCC---eeeCCCChHHeEEecCCCCCCeEEEEecceE
Confidence 5679999997332110 0110 0122333333322 34455677 99999999999999888 8999999999
Q ss_pred eecCC
Q 045315 313 RMFGG 317 (476)
Q Consensus 313 ~~~~~ 317 (476)
..+..
T Consensus 312 g~l~~ 316 (537)
T PRK04750 312 GSLNK 316 (537)
T ss_pred EECCH
Confidence 87754
|
|
| >cd05154 ACAD10_11_like Acyl-CoA dehydrogenase (ACAD) 10 and 11, N-terminal domain, and similar proteins | Back alignment and domain information |
|---|
Probab=97.24 E-value=0.00072 Score=63.07 Aligned_cols=73 Identities=19% Similarity=0.255 Sum_probs=53.8
Q ss_pred ccceeeccCCCCCCC-----CCCChhhHHHHHHHHHHHHHHHhhcC----------------------------------
Q 045315 242 EISFWYESYNNPTKK-----GLLCWGTRVRIIEGIAQGLLYLHQYS---------------------------------- 282 (476)
Q Consensus 242 ~~~l~~Ey~~~~~~~-----~~L~~~~~~~i~~qIa~gL~yLH~~~---------------------------------- 282 (476)
..+++|||++...-. ..++..++..++.+++++|.+||+..
T Consensus 74 ~~~~v~e~i~G~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 153 (223)
T cd05154 74 TPFYVMERVDGRVLRDRLLRPELSPEERRALARALADTLAALHSVDPAAVGLGDLGRPGGYLERQVARWRRQYDASRTDE 153 (223)
T ss_pred CceEEEEEeCCEecCCCCCCCCCCHHHHHHHHHHHHHHHHHHhCCChhhcCCcccCCCCchHHHHHHHHHHHHHhhcccc
Confidence 346778888733221 24667777788888888888888421
Q ss_pred -------------------CCceeecCCCccceEecC--CCCceeccccceee
Q 045315 283 -------------------RLRVIHRDLKASNILLDK--DMNPKISDFGMARM 314 (476)
Q Consensus 283 -------------------~~~ivH~DLkp~NILld~--~~~~kL~DFGla~~ 314 (476)
...++|+|+++.||+++. ++.+.|+||+.+..
T Consensus 154 ~~~~~~~~~~~~~~~~~~~~~~l~HgD~~~~Nil~~~~~~~~~~iID~e~~~~ 206 (223)
T cd05154 154 PPAMERLLRWLEAHLPADSRPGLVHGDYRLGNVLFHPDEPRVVAVLDWELATL 206 (223)
T ss_pred cHHHHHHHHHHHhhCCCCCCcEEEECCCCcccEEEcCCCCcEEEEEecccccc
Confidence 256899999999999998 56678999998764
|
This subfamily is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). This subfamily is composed of bacterial and eukaryotic proteins with similarity to the N-terminal domains of vertebrate ACAD10 and ACAD11. ACADs are a family of flavoproteins that are involved in the beta-oxidation of fatty acyl-CoA derivatives. ACAD deficiency can cause metabolic disorders including muscle fatigue, hypoglycemia, and hepatic lipidosis, among them. There are at least 11 distinct ACADs, some of which show distinct substrate specificities to either straight-chain or branched-chain fatty acids. ACAD10 is widely expressed in human tissues and is highly expressed in liver, kidney, pancreas, and spleen. ACAD10 and ACAD11 contain |
| >PRK09902 hypothetical protein; Provisional | Back alignment and domain information |
|---|
Probab=96.90 E-value=0.0012 Score=61.42 Aligned_cols=55 Identities=13% Similarity=0.131 Sum_probs=48.6
Q ss_pred CCCChhhHHHHHHHHHHHHHHHhhcCCCceeecCCCccceEecCCCC--ceeccccceee
Q 045315 257 GLLCWGTRVRIIEGIAQGLLYLHQYSRLRVIHRDLKASNILLDKDMN--PKISDFGMARM 314 (476)
Q Consensus 257 ~~L~~~~~~~i~~qIa~gL~yLH~~~~~~ivH~DLkp~NILld~~~~--~kL~DFGla~~ 314 (476)
.+.+..++..++.+|++.++-||..+ +.|+|+.+.||+++.++. ++++||.-++.
T Consensus 123 ~~~~~~~k~~il~~va~~ia~LH~~G---v~Hgdly~khIll~~~g~~~v~lIDlEk~r~ 179 (216)
T PRK09902 123 SPYSDEVRQAMLKAVALAFKKMHSVN---RQHGCCYVRHIYVKTEGKAEAGFLDLEKSRR 179 (216)
T ss_pred CCcchHHHHHHHHHHHHHHHHHHHCC---CcCCCCCHhheeecCCCCeeEEEEEhhccch
Confidence 35677788899999999999999999 999999999999986666 89999987764
|
|
| >PF12260 PIP49_C: Protein-kinase domain of FAM69; InterPro: IPR022049 Family with sequence similarity 69 has three members (A, B and C) | Back alignment and domain information |
|---|
Probab=96.65 E-value=0.004 Score=57.26 Aligned_cols=74 Identities=15% Similarity=0.013 Sum_probs=59.8
Q ss_pred ccceeeccCCCC---------CCCCCCChhhHHHHHHHHHHHHHHHhhcCCCceeecCCCccceEecCCCCceeccccce
Q 045315 242 EISFWYESYNNP---------TKKGLLCWGTRVRIIEGIAQGLLYLHQYSRLRVIHRDLKASNILLDKDMNPKISDFGMA 312 (476)
Q Consensus 242 ~~~l~~Ey~~~~---------~~~~~L~~~~~~~i~~qIa~gL~yLH~~~~~~ivH~DLkp~NILld~~~~~kL~DFGla 312 (476)
|.+++.||.+.. .+--.-+|.+|.+|+.++++.+.+|+..-...+.-+|++++|+-+++++.+|+.|...+
T Consensus 30 G~~~v~E~~~~~~~~~~~~~l~~~~~~~w~~R~~iA~~lL~~l~~l~~~~~~~~~lcDv~~~nfgv~~~~~lk~iDld~v 109 (188)
T PF12260_consen 30 GRFYVVEYVGAGSLYGIYRPLSQFLQSPWEQRAKIALQLLELLEELDHGPLGFFYLCDVSPDNFGVNDDGRLKLIDLDDV 109 (188)
T ss_pred CCEEEEEeecCccccccccccccccccCHHHHHHHHHHHHHHHHHHhcCCCCcEEEeecchHHeEEeCCCcEEEEechhc
Confidence 345667887732 12235699999999999999999999855555999999999999999999999999877
Q ss_pred eec
Q 045315 313 RMF 315 (476)
Q Consensus 313 ~~~ 315 (476)
...
T Consensus 110 ~~~ 112 (188)
T PF12260_consen 110 FVE 112 (188)
T ss_pred chh
Confidence 543
|
Proteins in this uncharacterised family are described as transmembrane proteins. |
| >COG0478 RIO-like serine/threonine protein kinase fused to N-terminal HTH domain [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=96.48 E-value=0.0051 Score=58.95 Aligned_cols=72 Identities=18% Similarity=0.146 Sum_probs=54.2
Q ss_pred cccceeeccCCCCC-CCCCCChhhHHHHHHHHHHHHHHHhhcCCCceeecCCCccceEecCCCCceeccccceeec
Q 045315 241 DEISFWYESYNNPT-KKGLLCWGTRVRIIEGIAQGLLYLHQYSRLRVIHRDLKASNILLDKDMNPKISDFGMARMF 315 (476)
Q Consensus 241 ~~~~l~~Ey~~~~~-~~~~L~~~~~~~i~~qIa~gL~yLH~~~~~~ivH~DLkp~NILld~~~~~kL~DFGla~~~ 315 (476)
....++|||++... .+-+++.+..-.++..|++-+.-+-..| +||+|+++-||+++++|.+.++||-.+...
T Consensus 180 nRHaVvMe~ieG~eL~~~r~~~en~~~il~~il~~~~~~~~~G---iVHGDlSefNIlV~~dg~~~vIDwPQ~v~~ 252 (304)
T COG0478 180 NRHAVVMEYIEGVELYRLRLDVENPDEILDKILEEVRKAYRRG---IVHGDLSEFNILVTEDGDIVVIDWPQAVPI 252 (304)
T ss_pred ccceeeeehcccceeecccCcccCHHHHHHHHHHHHHHHHHcC---ccccCCchheEEEecCCCEEEEeCcccccC
Confidence 36788999998422 2223356666667777777666666677 999999999999999999999999766543
|
|
| >COG1718 RIO1 Serine/threonine protein kinase involved in cell cycle control [Signal transduction mechanisms / Cell division and chromosome partitioning] | Back alignment and domain information |
|---|
Probab=96.06 E-value=0.012 Score=55.89 Aligned_cols=71 Identities=21% Similarity=0.187 Sum_probs=55.1
Q ss_pred ccceeeccCCCCCC-CC-----CCChhhHHHHHHHHHHHHHHHhh-cCCCceeecCCCccceEecCCCCceeccccceee
Q 045315 242 EISFWYESYNNPTK-KG-----LLCWGTRVRIIEGIAQGLLYLHQ-YSRLRVIHRDLKASNILLDKDMNPKISDFGMARM 314 (476)
Q Consensus 242 ~~~l~~Ey~~~~~~-~~-----~L~~~~~~~i~~qIa~gL~yLH~-~~~~~ivH~DLkp~NILld~~~~~kL~DFGla~~ 314 (476)
.-+++|||+.+... .+ .+...+...+..++++.+.-|-. .+ +||+||+.-|||+. ++.+.|+|++.|..
T Consensus 140 ~nVLvMEfIg~~g~pAP~LkDv~~e~~e~~~~~~~~v~~~~~l~~~a~---LVHgDLSEyNiL~~-~~~p~iID~~QaV~ 215 (268)
T COG1718 140 NNVLVMEFIGDDGLPAPRLKDVPLELEEAEGLYEDVVEYMRRLYKEAG---LVHGDLSEYNILVH-DGEPYIIDVSQAVT 215 (268)
T ss_pred CCeEEEEeccCCCCCCCCcccCCcCchhHHHHHHHHHHHHHHHHHhcC---cccccchhhheEEE-CCeEEEEECccccc
Confidence 45789999984421 11 23333678888889999888877 55 99999999999999 78899999998875
Q ss_pred cC
Q 045315 315 FG 316 (476)
Q Consensus 315 ~~ 316 (476)
..
T Consensus 216 ~~ 217 (268)
T COG1718 216 ID 217 (268)
T ss_pred cC
Confidence 44
|
|
| >cd05150 APH Aminoglycoside 3'-phosphotransferase (APH) | Back alignment and domain information |
|---|
Probab=94.88 E-value=0.041 Score=52.49 Aligned_cols=31 Identities=29% Similarity=0.318 Sum_probs=27.0
Q ss_pred CCceeecCCCccceEecCCCCceecccccee
Q 045315 283 RLRVIHRDLKASNILLDKDMNPKISDFGMAR 313 (476)
Q Consensus 283 ~~~ivH~DLkp~NILld~~~~~kL~DFGla~ 313 (476)
...++|+|+.|.||+++++..+.|+||+.+.
T Consensus 162 ~~~l~HgD~~~~Nil~~~~~~~~iIDwe~a~ 192 (244)
T cd05150 162 DLVVTHGDACLPNIIVDPGKFSGFIDLGRLG 192 (244)
T ss_pred ceEEECCCCCCccEEEeCCcEEEEEEccccc
Confidence 3569999999999999987778899998775
|
The APH subfamily is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). APH catalyzes the transfer of the gamma-phosphoryl group from ATP to aminoglycoside antibiotics such as kanamycin, streptomycin, neomycin, and gentamicin, among others. The aminoglycoside antibiotics target the 30S ribosome and promote miscoding, leading to the production of defective proteins which insert into the bacterial membrane, resulting in membrane damage and the ultimate demise of the bacterium. Phosphorylation of the aminoglycoside antibiotics results in their inactivation, leading to bacterial antibiotic resistance. The APH gene is found on transposons and plasmids and is thought to have originated as a self-defense mechanism used by microorganisms that produce the antibio |
| >COG0661 AarF Predicted unusual protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=94.01 E-value=0.063 Score=56.96 Aligned_cols=71 Identities=21% Similarity=0.213 Sum_probs=49.8
Q ss_pred cccceeeccCCCCC-------CCCCCChhhHHHHHHHHHHH-HHHHhhcCCCceeecCCCccceEecCCCCceeccccce
Q 045315 241 DEISFWYESYNNPT-------KKGLLCWGTRVRIIEGIAQG-LLYLHQYSRLRVIHRDLKASNILLDKDMNPKISDFGMA 312 (476)
Q Consensus 241 ~~~~l~~Ey~~~~~-------~~~~L~~~~~~~i~~qIa~g-L~yLH~~~~~~ivH~DLkp~NILld~~~~~kL~DFGla 312 (476)
+.-+++|||+++.. +...++ +..++..++++ +..+-..| ++|+|.+|-||+++.++.+.+.|||+.
T Consensus 239 ~~~VLtmE~i~Gi~i~d~~~l~~~g~d---~k~ia~~~~~~f~~q~~~dg---ffHaDpHpGNi~v~~~g~i~~lDfGi~ 312 (517)
T COG0661 239 TRRVLTMEWIDGIKISDIAALKSAGID---RKELAELLVRAFLRQLLRDG---FFHADPHPGNILVRSDGRIVLLDFGIV 312 (517)
T ss_pred CCcEEEEEeeCCEecccHHHHHhcCCC---HHHHHHHHHHHHHHHHHhcC---ccccCCCccceEEecCCcEEEEcCcce
Confidence 46789999998211 122333 33444444443 33344456 999999999999999999999999999
Q ss_pred eecCC
Q 045315 313 RMFGG 317 (476)
Q Consensus 313 ~~~~~ 317 (476)
..+..
T Consensus 313 g~l~~ 317 (517)
T COG0661 313 GRLDP 317 (517)
T ss_pred ecCCH
Confidence 87754
|
|
| >KOG1035 consensus eIF-2alpha kinase GCN2 [Translation, ribosomal structure and biogenesis] | Back alignment and domain information |
|---|
Probab=93.09 E-value=0.11 Score=59.05 Aligned_cols=153 Identities=20% Similarity=0.202 Sum_probs=98.4
Q ss_pred CCCCCCChhhHHHHHHHHHHHHHHHhhcCCCceeecCCCcc---ceEecCCCCceec--cccceeecCCCcccccceeee
Q 045315 254 TKKGLLCWGTRVRIIEGIAQGLLYLHQYSRLRVIHRDLKAS---NILLDKDMNPKIS--DFGMARMFGGDELQSNTKRIV 328 (476)
Q Consensus 254 ~~~~~L~~~~~~~i~~qIa~gL~yLH~~~~~~ivH~DLkp~---NILld~~~~~kL~--DFGla~~~~~~~~~~~~~~~~ 328 (476)
.....++..+.+.+..++.+||+|+|+.. ..|.-+..+ +--.+.++...++ ||+..+......... ...
T Consensus 278 q~v~~i~~~~~r~~~~~~~~GL~~~h~~~---l~~v~L~~s~~~~~~~~~e~~~~~sl~~~~ss~~l~d~~~~~---~~~ 351 (1351)
T KOG1035|consen 278 QSVGSIPLETLRILHQKLLEGLAYLHSLS---LEHVVLSASSSKESTVDGEGVVAISLSDFDSSKPLPDNEKSF---SDL 351 (1351)
T ss_pred hhccccCHHHHHHHHHHHhhhHHHHHHhc---cceeEEecccccccccCccceeecchhhhcccccCCCcccch---hhc
Confidence 34567888899999999999999999975 555554444 3344555666665 887776654322111 122
Q ss_pred eccCCCChhhhccCCCC--ccceEEeehhhhhhhhhCCCCCCcCCCCchhhhhhhhhhhcCCCcccccCcccCCCCCHHH
Q 045315 329 GTYGYMSPEYALRGLFS--IKSDVFSFGVLLLETLSSKKNTHFYNTDSLTLLGHAWNLWNDGRTWELMDPISQNGASYPI 406 (476)
Q Consensus 329 gt~~y~aPE~l~~~~~s--~ksDVwSlGvvl~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~ 406 (476)
.+..+.+||......+. ...|+|++|.....+..|..+...... ...+++... .
T Consensus 352 ~~~~~~~~e~~~~~~~~~~r~~dL~~lgll~~~~~~~~~i~~~~~~-----------------~~~~l~~~~-----~-- 407 (1351)
T KOG1035|consen 352 LAEIRNADEDLKENTAKKSRLTDLWCLGLLLLQLSQGEDISEKSAV-----------------PVSLLDVLS-----T-- 407 (1351)
T ss_pred CccccccccccccccchhhhhhHHHHHHHHHhhhhhcCcccccccc-----------------hhhhhcccc-----c--
Confidence 34566777776655544 447999999999999988765322110 001111110 0
Q ss_pred HHHHHHHHHHchhhcccCCCCHHHHHHHHhc
Q 045315 407 LKRYINVALLCVQEKAADRPAMSEVVSMLSN 437 (476)
Q Consensus 407 ~~~l~~li~~Cl~~dP~~RPt~~eVl~~L~~ 437 (476)
....+...+|+..++++|+++.+++...-.
T Consensus 408 -~~~~d~~~~~~~~~~~~Rl~~~~ll~~~f~ 437 (1351)
T KOG1035|consen 408 -SELLDALPKCLDEDSEERLSALELLTHPFL 437 (1351)
T ss_pred -hhhhhhhhhhcchhhhhccchhhhhhchhc
Confidence 134566778999999999999999876433
|
|
| >PF00954 S_locus_glycop: S-locus glycoprotein family; InterPro: IPR000858 In Brassicaceae, self-incompatible plants have a self/non-self recognition system, which involves the inability of flowering plants to achieve self-fertilisation | Back alignment and domain information |
|---|
Probab=92.61 E-value=0.044 Score=45.58 Aligned_cols=34 Identities=32% Similarity=0.658 Sum_probs=24.3
Q ss_pred eecCCCCccccccCCccce---ehhhhhhhcccccccee
Q 045315 211 TCTGPWNGVAFGAAPTYTS---FLYEQVLVQSKDEISFW 246 (476)
Q Consensus 211 ~~sg~wng~~f~g~p~~~~---~~~~~~~~~~~~~~~l~ 246 (476)
||+|+|||..|+|+|+++. +.|.++.+ .++.++.
T Consensus 1 wrsG~WnG~~f~g~p~~~~~~~~~~~fv~~--~~e~~~t 37 (110)
T PF00954_consen 1 WRSGPWNGQRFSGIPEMSSNSLYNYSFVSN--NEEVYYT 37 (110)
T ss_pred CCccccCCeEECCcccccccceeEEEEEEC--CCeEEEE
Confidence 8999999999999999974 44445533 2444443
|
This is sporophytically controlled by multiple alleles at a single locus (S). There are a total of 50 different S alleles in Brassica oleracea. S-locus glycoproteins, as well as S-receptor kinases, are in linkage with the S-alleles []. Most of the proteins within this family contain apple-like domain (IPR003609 from INTERPRO), which is predicted to possess protein- and/or carbohydrate-binding functions.; GO: 0048544 recognition of pollen |
| >cd05156 ChoK_euk Choline Kinase (ChoK) in eukaryotes | Back alignment and domain information |
|---|
Probab=92.45 E-value=0.22 Score=49.16 Aligned_cols=33 Identities=33% Similarity=0.385 Sum_probs=28.1
Q ss_pred CCCceeecCCCccceEecCC----CCceeccccceee
Q 045315 282 SRLRVIHRDLKASNILLDKD----MNPKISDFGMARM 314 (476)
Q Consensus 282 ~~~~ivH~DLkp~NILld~~----~~~kL~DFGla~~ 314 (476)
....++|+|+.+.||+++++ +.++++||..|..
T Consensus 177 ~~~~lcH~Dl~~~Nil~~~~~~~~~~i~lIDwEya~~ 213 (302)
T cd05156 177 SPVVFCHNDLQEGNILLLNPSSETKKLVLIDFEYASY 213 (302)
T ss_pred CCceEEecCCCcCeEEecCCCCCCCcEEEEeeCCCCC
Confidence 34579999999999999974 7899999988753
|
The ChoK subfamily is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). It is composed of bacterial and eukaryotic choline kinases, as well as eukaryotic ethanolamine kinase. ChoK catalyzes the transfer of the gamma-phosphoryl group from ATP (or CTP) to its substrate, choline, producing phosphorylcholine (PCho), a precursor to the biosynthesis of two major membrane phospholipids, phosphatidylcholine (PC) and sphingomyelin (SM). Although choline is the preferred substrate, ChoK also shows substantial activity towards ethanolamine and its N-methylated derivatives. ChoK plays an important role in cell signaling pathways and the regulation of cell growth. Along with PCho, it is involved in malignant transformation through Ras oncogenes in various human cancer |
| >COG3173 Predicted aminoglycoside phosphotransferase [General function prediction only] | Back alignment and domain information |
|---|
Probab=92.07 E-value=0.3 Score=48.60 Aligned_cols=32 Identities=19% Similarity=0.438 Sum_probs=28.8
Q ss_pred CCceeecCCCccceEecCCCCceeccccceee
Q 045315 283 RLRVIHRDLKASNILLDKDMNPKISDFGMARM 314 (476)
Q Consensus 283 ~~~ivH~DLkp~NILld~~~~~kL~DFGla~~ 314 (476)
..+++|+|+++.|++++...-+-+.||+++..
T Consensus 197 ~~~lvHGD~~~gNlii~~~~~~gVlDwe~~~l 228 (321)
T COG3173 197 PPVLVHGDYRPGNLIIDPGRPTGVLDWELATL 228 (321)
T ss_pred CceeeeCCcccCCEEEeCCCeeEEEecccccc
Confidence 46899999999999999888889999999865
|
|
| >PF01636 APH: Phosphotransferase enzyme family This family is part of the larger protein kinase superfamily | Back alignment and domain information |
|---|
Probab=92.00 E-value=0.26 Score=45.89 Aligned_cols=33 Identities=39% Similarity=0.407 Sum_probs=22.2
Q ss_pred CCCceeecCCCccceEec-CCCCceeccccceee
Q 045315 282 SRLRVIHRDLKASNILLD-KDMNPKISDFGMARM 314 (476)
Q Consensus 282 ~~~~ivH~DLkp~NILld-~~~~~kL~DFGla~~ 314 (476)
....++|+|+.+.||+++ +++.+.|+||+.+..
T Consensus 164 ~~~~~~HgD~~~~Nil~~~~~~~i~iID~e~a~~ 197 (239)
T PF01636_consen 164 LPPVLIHGDLHPGNILVDPSDGRIGIIDFEDAGW 197 (239)
T ss_dssp SCEEEE-SS-SGGGEEEESSTTEEEE--GTT-EE
T ss_pred CCcEEEEeccccccceeeeccceeEEEecccceE
Confidence 345699999999999999 555557999988754
|
; InterPro: IPR002575 This entry consists of bacterial antibiotic resistance proteins, which confer resistance to various aminoglycosides they include:- aminoglycoside 3'-phosphotransferase or kanamycin kinase / neomycin-kanamycin phosphotransferase and streptomycin 3''-kinase or streptomycin 3''-phosphotransferase. The aminoglycoside phosphotransferases inactivate aminoglycoside antibiotics via phosphorylation []. The proteins are found in a range of taxonomic groups.; PDB: 2PPQ_A 2Q83_B 3TDV_B 3TDW_A 3I0O_A 3I0Q_A 3I1A_B 3Q2M_A 3HAV_C 2PUI_B .... |
| >COG5072 ALK1 Serine/threonine kinase of the haspin family [Cell division and chromosome partitioning] | Back alignment and domain information |
|---|
Probab=91.77 E-value=0.26 Score=49.50 Aligned_cols=57 Identities=23% Similarity=0.223 Sum_probs=48.5
Q ss_pred CCCCChhhHHHHHHHHHHHHHHHhhcCCCceeecCCCccceEecCCCCceeccccceeec
Q 045315 256 KGLLCWGTRVRIIEGIAQGLLYLHQYSRLRVIHRDLKASNILLDKDMNPKISDFGMARMF 315 (476)
Q Consensus 256 ~~~L~~~~~~~i~~qIa~gL~yLH~~~~~~ivH~DLkp~NILld~~~~~kL~DFGla~~~ 315 (476)
.+.-.+++.+.|+.+.+.-++-+..+ .+.=|||+...||||+ +|++.|+||-+++.-
T Consensus 315 ik~~~~~e~lsff~s~~sil~~lekk--f~fehrnlt~~niLId-~GnvtLIDfklsRl~ 371 (488)
T COG5072 315 IKADRSEEELSFFWSCISILDILEKK--FPFEHRNLTLDNILID-EGNVTLIDFKLSRLS 371 (488)
T ss_pred eecccHHHHHHHHHHHHHHHhhhhhc--CCcccccccccceeee-cCceEEEEeeeeecc
Confidence 44567899999999988888777764 4688999999999999 999999999999853
|
|
| >cd05155 APH_ChoK_like_1 Uncharacterized bacterial proteins with similarity to Aminoglycoside 3'-phosphotransferase (APH) and Choline kinase (ChoK) family members | Back alignment and domain information |
|---|
Probab=91.50 E-value=0.21 Score=47.39 Aligned_cols=32 Identities=25% Similarity=0.361 Sum_probs=26.7
Q ss_pred CCceeecCCCccceEecCCCCceeccccceee
Q 045315 283 RLRVIHRDLKASNILLDKDMNPKISDFGMARM 314 (476)
Q Consensus 283 ~~~ivH~DLkp~NILld~~~~~kL~DFGla~~ 314 (476)
...++|+|+.+.||+++.+....|+||+.+..
T Consensus 163 ~~~l~HGD~~~~Nvlv~~~~i~giIDw~~a~~ 194 (235)
T cd05155 163 PPVWFHGDLAPGNLLVQDGRLSAVIDFGCLGV 194 (235)
T ss_pred CceEEeCCCCCCcEEEECCCEEEEEeCcccCc
Confidence 45599999999999999776567999998753
|
The APH/ChoK subfamily is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). This family is composed of APH, ChoK, ethanolamine kinase (ETNK), macrolide 2'-phosphotransferase (MPH2'), an unusual homoserine kinase, and uncharacterized proteins with similarity to the N-terminal domain of acyl-CoA dehydrogenase 10 (ACAD10). The members of this family catalyze the transfer of the gamma-phosphoryl group from ATP (or CTP) to small molecule substrates, such as aminoglycosides, macrolides, choline, ethanolamine, and homoserine. Phosphorylation of the antibiotics, aminoglycosides, and macrolides leads to their inactivation and to bacterial antibiotic resista |
| >KOG1235 consensus Predicted unusual protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=91.43 E-value=0.18 Score=53.61 Aligned_cols=71 Identities=17% Similarity=0.202 Sum_probs=47.9
Q ss_pred cccceeeccCCCCC-------CCCCCChhhHHHHHHHHHHHHHH-HhhcCCCceeecCCCccceEecC----CCCceecc
Q 045315 241 DEISFWYESYNNPT-------KKGLLCWGTRVRIIEGIAQGLLY-LHQYSRLRVIHRDLKASNILLDK----DMNPKISD 308 (476)
Q Consensus 241 ~~~~l~~Ey~~~~~-------~~~~L~~~~~~~i~~qIa~gL~y-LH~~~~~~ivH~DLkp~NILld~----~~~~kL~D 308 (476)
..-+++||||++.. .+..++.. .++..+.++... +-..| ++|+|-+|-||++.. ++.+.+-|
T Consensus 275 t~RVLtME~~~G~~i~Dl~~i~~~gi~~~---~i~~~l~~~~~~qIf~~G---ffHaDPHPGNilv~~~~~~~~~ivllD 348 (538)
T KOG1235|consen 275 TKRVLTMEYVDGIKINDLDAIDKRGISPH---DILNKLVEAYLEQIFKTG---FFHADPHPGNILVRPNPEGDEEIVLLD 348 (538)
T ss_pred cceEEEEEecCCccCCCHHHHHHcCCCHH---HHHHHHHHHHHHHHHhcC---CccCCCCCCcEEEecCCCCCccEEEEc
Confidence 35689999998332 22334444 444444444322 23345 999999999999984 66789999
Q ss_pred ccceeecCC
Q 045315 309 FGMARMFGG 317 (476)
Q Consensus 309 FGla~~~~~ 317 (476)
||+...+..
T Consensus 349 hGl~~~is~ 357 (538)
T KOG1235|consen 349 HGLYAVISH 357 (538)
T ss_pred ccccccccH
Confidence 999887643
|
|
| >TIGR00938 thrB_alt homoserine kinase, Neisseria type | Back alignment and domain information |
|---|
Probab=90.71 E-value=0.27 Score=48.74 Aligned_cols=30 Identities=40% Similarity=0.473 Sum_probs=26.5
Q ss_pred CceeecCCCccceEecCCCCceecccccee
Q 045315 284 LRVIHRDLKASNILLDKDMNPKISDFGMAR 313 (476)
Q Consensus 284 ~~ivH~DLkp~NILld~~~~~kL~DFGla~ 313 (476)
..++|+|+++.||+++.++.+.|+||+.+.
T Consensus 187 ~~l~HgD~~~~Nvl~~~~~~~~vIDfd~~~ 216 (307)
T TIGR00938 187 RGVIHADLFPDNVLFDGDSVKGVIDFYFAC 216 (307)
T ss_pred CccCCCCCCcCcEEEECCceEEEeeccccc
Confidence 459999999999999988777899999874
|
Homoserine kinase is required in the biosynthesis of threonine from aspartate.The member of this family from Pseudomonas aeruginosa was shown by direct assay and complementation to act specifically as a homoserine kinase. |
| >KOG0576 consensus Mitogen-activated protein kinase kinase kinase kinase (MAP4K), germinal center kinase family [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=90.33 E-value=0.15 Score=54.40 Aligned_cols=94 Identities=20% Similarity=0.188 Sum_probs=73.0
Q ss_pred hHHHHHHHHHHHHHHHhhcCCCceeecCCCccceEecCCCCceeccccceeecCCCcccccceeeeeccCCCChhhhccC
Q 045315 263 TRVRIIEGIAQGLLYLHQYSRLRVIHRDLKASNILLDKDMNPKISDFGMARMFGGDELQSNTKRIVGTYGYMSPEYALRG 342 (476)
Q Consensus 263 ~~~~i~~qIa~gL~yLH~~~~~~ivH~DLkp~NILld~~~~~kL~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~ 342 (476)
+...+.+.-.+++++||+.. -+|+| ||+..+ ...|..+|+....+.... ......++..++|||.....
T Consensus 337 ~~~~~~r~et~~l~~l~~~~---~~~~d----~~l~s~-~~~~~~~~~v~~~L~~~~---~~~t~~~~~~~~~pev~~~~ 405 (829)
T KOG0576|consen 337 QFAYPLRKETRPLAELHSSY---KVHRD----NILGSE-EEVKLLDFAVPPQLTRTM---KPRTAIGTPEPLAPEVIQEN 405 (829)
T ss_pred hhhhhhhhhccccccccccc---ccCcc----cccccc-cccccccccCCcccCccc---ccccCCCCCCCCCchhhccc
Confidence 44455666778999999865 58998 777665 578999999987765443 23346789999999999999
Q ss_pred CCCccceEEeehhhhhhhhhCCCCC
Q 045315 343 LFSIKSDVFSFGVLLLETLSSKKNT 367 (476)
Q Consensus 343 ~~s~ksDVwSlGvvl~elltG~~p~ 367 (476)
.+..+.|+|++|+-.-++--|-+|.
T Consensus 406 ~~~~~p~~~~~~~~~~~~ap~~pPr 430 (829)
T KOG0576|consen 406 TIDGCPDSGSLAVSAIQMAPGLPPR 430 (829)
T ss_pred ccccCCCccCCCcchhhcCCCCCCC
Confidence 9999999999998777777666664
|
|
| >cd05157 ETNK_euk Ethanolamine kinase (ETNK) in eukaryotes | Back alignment and domain information |
|---|
Probab=90.23 E-value=0.31 Score=45.97 Aligned_cols=31 Identities=26% Similarity=0.402 Sum_probs=26.8
Q ss_pred CCceeecCCCccceEecC-CCCceecccccee
Q 045315 283 RLRVIHRDLKASNILLDK-DMNPKISDFGMAR 313 (476)
Q Consensus 283 ~~~ivH~DLkp~NILld~-~~~~kL~DFGla~ 313 (476)
...++|+|+++.||+++. +..+.++||..|.
T Consensus 169 ~~~l~H~Dl~~~Nil~~~~~~~~~lIDwe~a~ 200 (235)
T cd05157 169 PIVFCHNDLLSGNIIYNEEKNSVKFIDYEYAG 200 (235)
T ss_pred CEEEEcCCCCcCcEEEeCCCCCEEEEEcccCC
Confidence 346999999999999997 5789999998775
|
ETNK is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). ETNK catalyzes the transfer of the gamma-phosphoryl group from CTP to ethanolamine (Etn), the first step in the CDP-Etn pathway for the formation of the major phospholipid, phosphatidylethanolamine (PtdEtn). Unlike ChoK, ETNK shows specific activity for its substrate, and displays negligible activity towards N-methylated derivatives of Etn. The Drosophila ETNK is implicated in development and neuronal function. Mammals contain two ETNK proteins, ETNK1 and ETNK2. ETNK1 selectively increases Etn uptake and phosphorylation, as well as PtdEtn synthesis. ETNK2 is found primarily in the liver and reproductive tissues. It plays a critical role in regulating placental hemostasis to support late embryo |
| >PRK05231 homoserine kinase; Provisional | Back alignment and domain information |
|---|
Probab=90.10 E-value=0.38 Score=47.81 Aligned_cols=29 Identities=38% Similarity=0.456 Sum_probs=25.3
Q ss_pred ceeecCCCccceEecCCCCceecccccee
Q 045315 285 RVIHRDLKASNILLDKDMNPKISDFGMAR 313 (476)
Q Consensus 285 ~ivH~DLkp~NILld~~~~~kL~DFGla~ 313 (476)
.+||+|+++.||+++.+....|+||+.+.
T Consensus 188 ~liHgD~~~~Nil~~~~~~~~iIDf~~~~ 216 (319)
T PRK05231 188 GVIHADLFRDNVLFEGDRLSGFIDFYFAC 216 (319)
T ss_pred ccCCCCCCCCcEEEECCceEEEEeccccc
Confidence 49999999999999977656899999875
|
|
| >COG2334 Putative homoserine kinase type II (protein kinase fold) [General function prediction only] | Back alignment and domain information |
|---|
Probab=89.32 E-value=0.58 Score=46.94 Aligned_cols=29 Identities=38% Similarity=0.653 Sum_probs=25.7
Q ss_pred ceeecCCCccceEecCCCC-ceecccccee
Q 045315 285 RVIHRDLKASNILLDKDMN-PKISDFGMAR 313 (476)
Q Consensus 285 ~ivH~DLkp~NILld~~~~-~kL~DFGla~ 313 (476)
.+||+|+.|.||+++.+.. +.++||+-+.
T Consensus 198 ~iIH~D~~~~NVl~d~~~~~~g~iDFdDa~ 227 (331)
T COG2334 198 QIIHGDLHPDNVLFDDDTDVSGFIDFDDAG 227 (331)
T ss_pred eeeecCCCccceeEcCCCCeeeEEEccccc
Confidence 3999999999999998874 8899999875
|
|
| >cd05153 HomoserineK_II Homoserine Kinase, type II | Back alignment and domain information |
|---|
Probab=89.03 E-value=0.4 Score=47.00 Aligned_cols=30 Identities=40% Similarity=0.459 Sum_probs=26.3
Q ss_pred CceeecCCCccceEecCCCCceecccccee
Q 045315 284 LRVIHRDLKASNILLDKDMNPKISDFGMAR 313 (476)
Q Consensus 284 ~~ivH~DLkp~NILld~~~~~kL~DFGla~ 313 (476)
..++|+|+.|.||+++++..+.|+||+.+.
T Consensus 175 ~~l~HgD~~~~Nil~~~~~~~~iIDfe~a~ 204 (296)
T cd05153 175 RGVIHADLFRDNVLFDGDELSGVIDFYFAC 204 (296)
T ss_pred CcCCccCcCcccEEEeCCceEEEeehhhhc
Confidence 349999999999999988777899998875
|
Homoserine kinase is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). This subfamily is composed of unusual homoserine kinases, from a subset of bacteria, which have a PK fold. These proteins do not bear any similarity to the GHMP family homoserine kinases present in most bacteria and eukaryotes. Homoserine kinase catalyzes the transfer of the gamma-phosphoryl group from ATP to L-homoserine producing L-homoserine phosphate, an intermediate in the production of the amino acids threonine, methionine, and isoleucine. |
| >TIGR02172 Fb_sc_TIGR02172 Fibrobacter succinogenes paralogous family TIGR02172 | Back alignment and domain information |
|---|
Probab=88.71 E-value=0.31 Score=46.14 Aligned_cols=30 Identities=17% Similarity=0.213 Sum_probs=26.3
Q ss_pred CCceeecCCCccceEecCCCCceecccccee
Q 045315 283 RLRVIHRDLKASNILLDKDMNPKISDFGMAR 313 (476)
Q Consensus 283 ~~~ivH~DLkp~NILld~~~~~kL~DFGla~ 313 (476)
...++|+|+.|.||++++++ +.|+||+.+.
T Consensus 152 ~~~~~HgD~~~~Nii~~~~~-~~iIDwe~a~ 181 (226)
T TIGR02172 152 TSTCLHGDFQIGNLITSGKG-TYWIDLGDFG 181 (226)
T ss_pred CCceEecCCCCCcEEEcCCC-cEEEechhcC
Confidence 34579999999999999887 9999999875
|
This model describes a paralogous family of five proteins, likely to be enzymes, in the rumen bacterium Fibrobacter succinogenes S85. Members show homology to proteins described by PFAM model pfam01636, a phosphotransferase enzyme family associated with resistance to aminoglycoside antibiotics. However, members of this family score below the current trusted and noise cutoffs for pfam01636. |
| >TIGR02906 spore_CotS spore coat protein, CotS family | Back alignment and domain information |
|---|
Probab=88.55 E-value=0.65 Score=45.81 Aligned_cols=29 Identities=28% Similarity=0.346 Sum_probs=24.9
Q ss_pred CceeecCCCccceEecCCCCceecccccee
Q 045315 284 LRVIHRDLKASNILLDKDMNPKISDFGMAR 313 (476)
Q Consensus 284 ~~ivH~DLkp~NILld~~~~~kL~DFGla~ 313 (476)
..++|+|+++.||+++. +.+.|+||+.+.
T Consensus 187 ~~liHgD~~~~Nil~~~-~~i~lIDfd~~~ 215 (313)
T TIGR02906 187 RGFCHQDYAYHNILLKD-NEVYVIDFDYCT 215 (313)
T ss_pred CceEcCCCCcccEEEeC-CcEEEEECcccc
Confidence 45999999999999987 567899998764
|
Members of this family include the spore coat proteins CotS and YtaA from Bacillus subtilis and, from other endospore-forming bacteria, homologs that are more closely related to these two than to the spore coat proteins YutH and YsxE. The CotS family is more broadly distributed than YutH or YsxE, but still is not universal among spore-formers. |
| >PF01633 Choline_kinase: Choline/ethanolamine kinase; InterPro: IPR002573 Choline kinase, (ATP:choline phosphotransferase, 2 | Back alignment and domain information |
|---|
Probab=88.22 E-value=0.67 Score=43.08 Aligned_cols=31 Identities=42% Similarity=0.580 Sum_probs=21.9
Q ss_pred CceeecCCCccceEe-cCCCCceeccccceee
Q 045315 284 LRVIHRDLKASNILL-DKDMNPKISDFGMARM 314 (476)
Q Consensus 284 ~~ivH~DLkp~NILl-d~~~~~kL~DFGla~~ 314 (476)
..++|+|+.+.||++ +.++.++++||..|..
T Consensus 143 ~v~cHnDl~~~Nil~~~~~~~~~lIDfEya~~ 174 (211)
T PF01633_consen 143 LVFCHNDLNPGNILINNKDGEVKLIDFEYAGY 174 (211)
T ss_dssp EEEE-S--SGGGEEETSSSSCEEE--GTT-EE
T ss_pred ceEeeccCccccEEeccCCCeEEEecHHHHhh
Confidence 458899999999999 8889999999998864
|
7.1.32 from EC) belongs to the choline/ethanolamine kinase family. Ethanolamine and choline are major membrane phospholipids, in the form of glycerophosphoethanolamine and glycerophosphocholine. Ethanolamine is also a component of the glycosylphosphatidylinositol (GPI) anchor, which is necessary for cell-surface protein attachment []. The de novo synthesis of these phospholipids begins with the creation of phosphoethanolamine and phosphocholine by ethanolamine and choline kinases in the first step of the CDP-ethanolamine pathway [, ]. There are two putative choline/ethanolamine kinases (C/EKs) in the Trypanosoma brucei genome. Ethanolamine kinase has no choline kinase activity [] and its activity is inhibited by ADP []. Inositol supplementation represses ethanolamine kinase, decreasing the incorporation of ethanolamine into the CDP-ethanolamine pathway and into phosphatidylethanolamine and phosphatidylcholine []. ; GO: 0016773 phosphotransferase activity, alcohol group as acceptor; PDB: 3C5I_A 2IG7_A 3LQ3_A 3FEG_A 2QG7_E 3FI8_A 1NW1_A 3MES_A 3G15_A 2CKP_B .... |
| >PLN02876 acyl-CoA dehydrogenase | Back alignment and domain information |
|---|
Probab=88.09 E-value=1.2 Score=50.62 Aligned_cols=31 Identities=16% Similarity=0.407 Sum_probs=24.3
Q ss_pred CceeecCCCccceEecCC-CC-ceeccccceee
Q 045315 284 LRVIHRDLKASNILLDKD-MN-PKISDFGMARM 314 (476)
Q Consensus 284 ~~ivH~DLkp~NILld~~-~~-~kL~DFGla~~ 314 (476)
..+||+|+++.||+++.+ .. .-|.||.++..
T Consensus 225 ~~LvHGD~~~~Nvl~~~~~~~v~aVLDWE~a~~ 257 (822)
T PLN02876 225 TGIVHGDFRIDNLVFHPTEDRVIGILDWELSTL 257 (822)
T ss_pred cceEecCcccccEEEcCCCCeEEEEEeeecccc
Confidence 359999999999999853 33 46889988754
|
|
| >PRK10271 thiK thiamine kinase; Provisional | Back alignment and domain information |
|---|
Probab=87.57 E-value=0.37 Score=44.11 Aligned_cols=30 Identities=23% Similarity=0.327 Sum_probs=25.9
Q ss_pred CceeecCCCccceEecCCCCceeccccceee
Q 045315 284 LRVIHRDLKASNILLDKDMNPKISDFGMARM 314 (476)
Q Consensus 284 ~~ivH~DLkp~NILld~~~~~kL~DFGla~~ 314 (476)
...+|+|+.|.||++.+++ ++++||+.+..
T Consensus 77 ~~p~H~D~~~~N~~~~~~~-~~lIDwe~a~~ 106 (188)
T PRK10271 77 LAPLHMDVHAGNLVHSASG-LRLIDWEYAGD 106 (188)
T ss_pred eeeecCCCCCccEEEECCC-EEEEeCCcccC
Confidence 4579999999999998776 88999998853
|
|
| >TIGR02721 ycfN_thiK thiamine kinase | Back alignment and domain information |
|---|
Probab=87.52 E-value=0.38 Score=46.18 Aligned_cols=30 Identities=27% Similarity=0.354 Sum_probs=26.0
Q ss_pred CceeecCCCccceEecCCCCceeccccceee
Q 045315 284 LRVIHRDLKASNILLDKDMNPKISDFGMARM 314 (476)
Q Consensus 284 ~~ivH~DLkp~NILld~~~~~kL~DFGla~~ 314 (476)
..++|+|+.|.||++++++ +.|+||..+..
T Consensus 146 ~~l~H~Dl~~~Nil~~~~~-~~lIDwE~a~~ 175 (256)
T TIGR02721 146 LAPLHMDVHAYNLVVTPQG-LKLIDWEYASD 175 (256)
T ss_pred CeeecCCCCcCcEEEeCCC-CEEEeccccCc
Confidence 4599999999999999876 78999988753
|
Members of this family are the ycfN gene product of Escherichia coli, now identified as the salvage enzyme thiamine kinase (thiK), and additional proteobacterial homologs taken to be orthologs with equivalent function. |
| >KOG2268 consensus Serine/threonine protein kinase [Signal transduction mechanisms; General function prediction only] | Back alignment and domain information |
|---|
Probab=87.22 E-value=0.74 Score=45.72 Aligned_cols=67 Identities=16% Similarity=0.107 Sum_probs=44.6
Q ss_pred ccceeeccCCCCCC---CCCCChhhHHHHHHHHHHHHHHHhhcCCCceeecCCCccceEecCCCCceeccccceee
Q 045315 242 EISFWYESYNNPTK---KGLLCWGTRVRIIEGIAQGLLYLHQYSRLRVIHRDLKASNILLDKDMNPKISDFGMARM 314 (476)
Q Consensus 242 ~~~l~~Ey~~~~~~---~~~L~~~~~~~i~~qIa~gL~yLH~~~~~~ivH~DLkp~NILld~~~~~kL~DFGla~~ 314 (476)
....+||.+..-.- ....+..+.+ ..+..-+--|-.+| +||+|.+--||+++++..++++||-....
T Consensus 182 RH~Vvmelv~g~Pl~~v~~v~d~~~ly---~~lm~~Iv~la~~G---lIHgDFNEFNimv~dd~~i~vIDFPQmvS 251 (465)
T KOG2268|consen 182 RHCVVMELVDGYPLRQVRHVEDPPTLY---DDLMGLIVRLANHG---LIHGDFNEFNIMVKDDDKIVVIDFPQMVS 251 (465)
T ss_pred ceeeHHHhhcccceeeeeecCChHHHH---HHHHHHHHHHHHcC---ceecccchheeEEecCCCEEEeechHhhc
Confidence 56677877663222 2223333333 33333345566777 99999999999999999999999965543
|
|
| >PHA03111 Ser/Thr kinase; Provisional | Back alignment and domain information |
|---|
Probab=87.11 E-value=0.7 Score=45.91 Aligned_cols=34 Identities=29% Similarity=0.212 Sum_probs=21.8
Q ss_pred HHHHHHHHHHHHH-hhcCCCceeecCCCccceEec
Q 045315 266 RIIEGIAQGLLYL-HQYSRLRVIHRDLKASNILLD 299 (476)
Q Consensus 266 ~i~~qIa~gL~yL-H~~~~~~ivH~DLkp~NILld 299 (476)
-+..||+.-.-.+ .-.+....+|.||||+|||+-
T Consensus 283 fifLQiaLLyikIYelp~c~nF~H~DLKPdNILiF 317 (444)
T PHA03111 283 FIFLQIALLYIKIYELPCCDNFLHVDLKPDNILIF 317 (444)
T ss_pred HHHHHHHHHHHhhhcCCCcceeeeccCCCCcEEEe
Confidence 3556665543223 223234589999999999983
|
|
| >COG0510 ycfN Thiamine kinase and related kinases [Coenzyme transport and metabolism] | Back alignment and domain information |
|---|
Probab=85.32 E-value=1.1 Score=43.57 Aligned_cols=51 Identities=20% Similarity=0.236 Sum_probs=39.2
Q ss_pred hHHHHHHHHHHHHHHHhhcCCCceeecCCCccceEecCCCCceeccccceee
Q 045315 263 TRVRIIEGIAQGLLYLHQYSRLRVIHRDLKASNILLDKDMNPKISDFGMARM 314 (476)
Q Consensus 263 ~~~~i~~qIa~gL~yLH~~~~~~ivH~DLkp~NILld~~~~~kL~DFGla~~ 314 (476)
...+.+..+-.++.-.|..- ..++|+|+.|.|++.++.+.++|+||..|..
T Consensus 133 ~~~~~~~~l~~~l~~~~~~~-~v~cH~Dl~~~N~l~t~~~~l~LIDWEyAg~ 183 (269)
T COG0510 133 LLRKKLKELRRALEEVPKDD-LVPCHNDLNPGNLLLTDKGGLFLIDWEYAGL 183 (269)
T ss_pred HHHHHHHHHHHHhhhcCCCc-eeeecCCCCccceEEcCCCcEEEEecccCCC
Confidence 33445666666676666651 3599999999999999989999999987754
|
|
| >TIGR02904 spore_ysxE spore coat protein YsxE | Back alignment and domain information |
|---|
Probab=85.28 E-value=1.1 Score=44.34 Aligned_cols=32 Identities=25% Similarity=0.356 Sum_probs=28.0
Q ss_pred CCceeecCCCccceEecCCCCceeccccceee
Q 045315 283 RLRVIHRDLKASNILLDKDMNPKISDFGMARM 314 (476)
Q Consensus 283 ~~~ivH~DLkp~NILld~~~~~kL~DFGla~~ 314 (476)
+..++|+|+.++|++++.++.+.++||..+..
T Consensus 195 ~~~lcHgD~~~~Nvl~~~~~~~~iIDfd~~~~ 226 (309)
T TIGR02904 195 RTVLVHGKLSLSHFLYDETRGGYFINFEKASF 226 (309)
T ss_pred ceeeeCCCCcHHhEEEcCCCCEEEEEhhhccc
Confidence 34699999999999999998899999988754
|
Members of this family are homologs of the Bacillus subtilis spore coat protein CotS. Members of this family, designated YsxE, are found only in the family Bacillaceae, from among the endospore-forming members of the Firmicutes branch of the Bacteria. As a rule, the ysxE gene is found immediately downstream of spoVID, a gene necessary for spore coat assembly. The protein has been shown to be part of the spore coat. |
| >PLN02236 choline kinase | Back alignment and domain information |
|---|
Probab=85.07 E-value=0.95 Score=45.73 Aligned_cols=32 Identities=28% Similarity=0.456 Sum_probs=26.9
Q ss_pred CCceeecCCCccceEecC-CCCceeccccceee
Q 045315 283 RLRVIHRDLKASNILLDK-DMNPKISDFGMARM 314 (476)
Q Consensus 283 ~~~ivH~DLkp~NILld~-~~~~kL~DFGla~~ 314 (476)
...++|+|+++.||++++ ++.++++||..+..
T Consensus 199 ~~~~cH~Dl~~~Nil~~~~~~~~~lID~Eya~~ 231 (344)
T PLN02236 199 EIGFCHNDLQYGNIMIDEETRAITIIDYEYASY 231 (344)
T ss_pred CceEEeCCCCcCcEEEeCCCCcEEEEeehhccc
Confidence 345999999999999986 46799999988853
|
|
| >cd05152 MPH2' Macrolide 2'-Phosphotransferase (MPH2') | Back alignment and domain information |
|---|
Probab=84.64 E-value=0.59 Score=45.64 Aligned_cols=32 Identities=28% Similarity=0.535 Sum_probs=26.2
Q ss_pred CCceeecCCCccceEecCCCC-ceeccccceee
Q 045315 283 RLRVIHRDLKASNILLDKDMN-PKISDFGMARM 314 (476)
Q Consensus 283 ~~~ivH~DLkp~NILld~~~~-~kL~DFGla~~ 314 (476)
...++|+|+++.||++++++. .-|.||+.+..
T Consensus 184 ~~~lvHGD~~~~Nilv~~~~~~~gviDWe~a~i 216 (276)
T cd05152 184 HTVLVHGDLHPGHILIDEDARVTGLIDWTEAKV 216 (276)
T ss_pred CCeeEeCCCCCCcEEEeCCCCEEEEECcHhccc
Confidence 346999999999999997554 46999998864
|
MPH2' is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). MPH2' catalyzes the transfer of the gamma-phosphoryl group from ATP to the 2'-hydroxyl of macrolide antibiotics such as erythromycin, clarithromycin, and azithromycin, among others. Macrolides penetrate the bacterial cell and bind to ribosomes, where it interrupts protein elongation, leading ultimately to the demise of the bacterium. Phosphorylation of macrolides leads to their inactivation. Based on substrate specificity and amino acid sequence, MPH2' is divided into types I and II, encoded by mphA and mphB genes, respectively. MPH2'I inactivates 14-membered ring macrolides while MPH2'II inactivates both 14- and 16-membered ring macrolides. Enzymatic inactivation of macrolides has been reported |
| >PRK11138 outer membrane biogenesis protein BamB; Provisional | Back alignment and domain information |
|---|
Probab=84.59 E-value=17 Score=37.18 Aligned_cols=52 Identities=17% Similarity=0.338 Sum_probs=33.4
Q ss_pred ecCCceEEEcc-CCeEEEeecCCCCCC-------CceeeeccCCCeEEEeCCCCCCcCceeecc
Q 045315 94 SNNGNLVLLSQ-RNGIIWSSNMSRKAE-------NPIAQLLDTGNLVIRDNSSGHTTESYLWQS 149 (476)
Q Consensus 94 ~~~G~lvl~~~-~~~~vWss~~~~~~~-------~~~~~l~d~GNlVl~~~~~~~~~~~~~WqS 149 (476)
..+|.|+-+|. +|+++|+........ +.+..-..+|.|+-.|..+ +..+|+-
T Consensus 127 ~~~g~l~ald~~tG~~~W~~~~~~~~~ssP~v~~~~v~v~~~~g~l~ald~~t----G~~~W~~ 186 (394)
T PRK11138 127 SEKGQVYALNAEDGEVAWQTKVAGEALSRPVVSDGLVLVHTSNGMLQALNESD----GAVKWTV 186 (394)
T ss_pred cCCCEEEEEECCCCCCcccccCCCceecCCEEECCEEEEECCCCEEEEEEccC----CCEeeee
Confidence 35788888885 799999987654211 1222334456677777653 7889974
|
|
| >KOG1826 consensus Ras GTPase activating protein RasGAP/neurofibromin [Defense mechanisms] | Back alignment and domain information |
|---|
Probab=83.32 E-value=0.45 Score=55.93 Aligned_cols=95 Identities=12% Similarity=-0.014 Sum_probs=72.0
Q ss_pred HHHHHHHhh--cCCCceeecCCCccceEecCCCCceeccccceeecCCCcccccceeeeeccCCCChhhhccCCCCccce
Q 045315 272 AQGLLYLHQ--YSRLRVIHRDLKASNILLDKDMNPKISDFGMARMFGGDELQSNTKRIVGTYGYMSPEYALRGLFSIKSD 349 (476)
Q Consensus 272 a~gL~yLH~--~~~~~ivH~DLkp~NILld~~~~~kL~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~s~ksD 349 (476)
..+..-+|+ .+....+|+++|+-|.++..+..+|++++|+.+..... ........+++.|+.|+....-.++.++|
T Consensus 1345 vl~~~~~ls~tnlg~T~v~~~Lkf~lpmIVtny~v~~gk~gLdKIknp~--~sf~Gl~l~sp~~v~qli~N~ik~t~rsd 1422 (2724)
T KOG1826|consen 1345 VLNRNVILSLTNLGNTNVSKSLKFTLPMIVTNYNVKLGKGGLDKIKNPV--LSFFGLELCSPIYVLQLIKNEIKFTKRSD 1422 (2724)
T ss_pred HhccchhhhcccCCccchhhhhhhhccceecCCcccccccccccccCch--HhhhhhhhCCHHHHHHHHHHHHhhhhHHH
Confidence 444444443 22345789999999999999999999999999843221 12223356777889999888888999999
Q ss_pred EEeehhhhhhhhhCCCCCC
Q 045315 350 VFSFGVLLLETLSSKKNTH 368 (476)
Q Consensus 350 VwSlGvvl~elltG~~p~~ 368 (476)
+|..|+.+|+...|..+|-
T Consensus 1423 ilr~s~~ly~rs~~n~~fi 1441 (2724)
T KOG1826|consen 1423 ILRRSLSLYLRSDGNAYFI 1441 (2724)
T ss_pred HHHHHHHHHHHhcccHHHH
Confidence 9999999999988877653
|
|
| >PF07387 Seadorna_VP7: Seadornavirus VP7; InterPro: IPR009973 This family consists of several Seadornavirus specific VP7 proteins of around 305 residues in length | Back alignment and domain information |
|---|
Probab=82.37 E-value=1.2 Score=41.80 Aligned_cols=40 Identities=25% Similarity=0.240 Sum_probs=32.7
Q ss_pred HHHHHHHhhcCCCceeecCCCccceEecCCCCceeccccce
Q 045315 272 AQGLLYLHQYSRLRVIHRDLKASNILLDKDMNPKISDFGMA 312 (476)
Q Consensus 272 a~gL~yLH~~~~~~ivH~DLkp~NILld~~~~~kL~DFGla 312 (476)
..+|.-.|+.. ...+|+|..|+||+-|+.|.+||.|-+..
T Consensus 151 i~~L~~fH~~~-~~~lHGD~np~NiM~D~~G~lKlVDP~~L 190 (308)
T PF07387_consen 151 IKDLMDFHSEN-QHCLHGDCNPDNIMCDKFGYLKLVDPVCL 190 (308)
T ss_pred HHHHHHhhccC-CCeecCCCChhheeecCCCCEEecChhhh
Confidence 36677888543 35999999999999999999999996543
|
The function of this family is unknown. |
| >smart00587 CHK ZnF_C4 abd HLH domain containing kinases domain | Back alignment and domain information |
|---|
Probab=81.44 E-value=1 Score=41.55 Aligned_cols=31 Identities=29% Similarity=0.390 Sum_probs=25.3
Q ss_pred CceeecCCCccceEecCCC-----Cceeccccceee
Q 045315 284 LRVIHRDLKASNILLDKDM-----NPKISDFGMARM 314 (476)
Q Consensus 284 ~~ivH~DLkp~NILld~~~-----~~kL~DFGla~~ 314 (476)
..++|||+.+.||++..+. .+.+.||..++.
T Consensus 120 ~vl~HgD~~~~N~~~~~~~~~~~~~~~liDfq~~~~ 155 (196)
T smart00587 120 NVLNHGDLWANNIMFKYDDEGKPEDVALIDFQLSHY 155 (196)
T ss_pred eEEeeCCCCccceeeccCCCCCccceEEEecccCCc
Confidence 4699999999999997543 578999988753
|
subfamily of choline kinases |
| >PRK06148 hypothetical protein; Provisional | Back alignment and domain information |
|---|
Probab=80.49 E-value=2.5 Score=49.09 Aligned_cols=31 Identities=42% Similarity=0.514 Sum_probs=25.4
Q ss_pred CceeecCCCccceEecCCC--Cc-eeccccceee
Q 045315 284 LRVIHRDLKASNILLDKDM--NP-KISDFGMARM 314 (476)
Q Consensus 284 ~~ivH~DLkp~NILld~~~--~~-kL~DFGla~~ 314 (476)
..+||+|+++.||+++.+. .+ -|+|||-+..
T Consensus 203 ~~vIHgDln~~NiLv~~~~~~~isGiIDFgDa~~ 236 (1013)
T PRK06148 203 AQVIHNDANDYNILVDADDGERISGLIDFGDAVH 236 (1013)
T ss_pred cceECCCCCcccEEEcCCCCcceEEEEECccccc
Confidence 3499999999999999775 44 4999998753
|
|
Homologous Structure Templates
Structure Templates Detected by BLAST
Original result of BLAST against Protein Data Bank
| ID | Alignment Graph | Length |
Definition |
E-value | |
| Query | 476 | ||||
| 3tl8_A | 349 | The Avrptob-Bak1 Complex Reveals Two Structurally S | 9e-28 | ||
| 3uim_A | 326 | Structural Basis For The Impact Of Phosphorylation | 4e-27 | ||
| 2qkw_B | 321 | Structural Basis For Activation Of Plant Immunity B | 6e-24 | ||
| 3hgk_A | 327 | Crystal Structure Of Effect Protein Avrptob Complex | 6e-24 | ||
| 2nry_A | 307 | Crystal Structure Of Irak-4 Length = 307 | 5e-22 | ||
| 2nru_A | 307 | Crystal Structure Of Irak-4 Length = 307 | 5e-22 | ||
| 2oib_A | 301 | Crystal Structure Of Irak4 Kinase Domain Apo Form L | 5e-22 | ||
| 2o8y_A | 298 | Apo Irak4 Kinase Domain Length = 298 | 8e-22 | ||
| 3a4o_X | 286 | Lyn Kinase Domain Length = 286 | 1e-13 | ||
| 3dak_A | 290 | Crystal Structure Of Domain-Swapped Osr1 Kinase Dom | 1e-13 | ||
| 2vwi_A | 303 | Structure Of The Osr1 Kinase, A Hypertension Drug T | 1e-13 | ||
| 2zm1_A | 285 | Crystal Structure Of Imidazo Pyrazin 1 Bound To The | 3e-13 | ||
| 1qpe_A | 279 | Structural Analysis Of The Lymphocyte-Specific Kina | 3e-13 | ||
| 3kxz_A | 287 | The Complex Crystal Structure Of Lck With A Probe M | 4e-13 | ||
| 2pl0_A | 289 | Lck Bound To Imatinib Length = 289 | 4e-13 | ||
| 3kmm_A | 288 | Structure Of Human Lck Kinase With A Small Molecule | 6e-13 | ||
| 1qpd_A | 279 | Structural Analysis Of The Lymphocyte-specific Kina | 7e-13 | ||
| 1fmk_A | 452 | Crystal Structure Of Human Tyrosine-Protein Kinase | 9e-13 | ||
| 2h8h_A | 535 | Src Kinase In Complex With A Quinazoline Inhibitor | 9e-13 | ||
| 1y57_A | 452 | Structure Of Unphosphorylated C-Src In Complex With | 1e-12 | ||
| 1ksw_A | 452 | Structure Of Human C-Src Tyrosine Kinase (Thr338gly | 1e-12 | ||
| 1yi6_A | 276 | C-Term Tail Segment Of Human Tyrosine Kinase (258-5 | 1e-12 | ||
| 3bys_A | 277 | Co-Crystal Structure Of Lck And Aminopyrimidine Ami | 1e-12 | ||
| 2ofu_A | 273 | X-Ray Crystal Structure Of 2-Aminopyrimidine Carbam | 1e-12 | ||
| 2ofv_A | 277 | Crystal Structure Of Aminoquinazoline 1 Bound To Lc | 1e-12 | ||
| 3miy_A | 266 | X-Ray Crystal Structure Of Itk Complexed With Sunit | 1e-12 | ||
| 3dtc_A | 271 | Crystal Structure Of Mixed-Lineage Kinase Mlk1 Comp | 1e-12 | ||
| 3bym_A | 272 | X-Ray Co-Crystal Structure Aminobenzimidazole Triaz | 1e-12 | ||
| 3lck_A | 271 | The Kinase Domain Of Human Lymphocyte Kinase (Lck), | 1e-12 | ||
| 1yol_A | 283 | Crystal Structure Of Src Kinase Domain In Complex W | 2e-12 | ||
| 2of2_A | 271 | Crystal Structure Of Furanopyrimidine 8 Bound To Lc | 2e-12 | ||
| 2zv7_A | 279 | Lyn Tyrosine Kinase Domain, Apo Form Length = 279 | 2e-12 | ||
| 3u4w_A | 275 | Src In Complex With Dna-Templated Macrocyclic Inhib | 2e-12 | ||
| 2bdf_A | 279 | Src Kinase In Complex With Inhibitor Ap23451 Length | 2e-12 | ||
| 3dqw_A | 286 | C-Src Kinase Domain Thr338ile Mutant In Complex Wit | 2e-12 | ||
| 3d7u_B | 277 | Structural Basis For The Recognition Of C-Src By It | 2e-12 | ||
| 1yoj_A | 283 | Crystal Structure Of Src Kinase Domain Length = 283 | 2e-12 | ||
| 3oez_A | 286 | Crystal Structure Of The L317i Mutant Of The Chicke | 2e-12 | ||
| 2hwo_A | 286 | Crystal Structure Of Src Kinase Domain In Complex W | 2e-12 | ||
| 3svv_A | 286 | Crystal Structure Of T338c C-Src Covalently Bound T | 2e-12 | ||
| 2oiq_A | 286 | Crystal Structure Of Chicken C-Src Kinase Domain In | 2e-12 | ||
| 3g6h_A | 286 | Src Thr338ile Inhibited In The Dfg-Asp-Out Conforma | 2e-12 | ||
| 2qq7_A | 286 | Crystal Structure Of Drug Resistant Src Kinase Doma | 2e-12 | ||
| 2og8_A | 265 | Crystal Structure Of Aminoquinazoline 36 Bound To L | 2e-12 | ||
| 1sm2_A | 264 | Crystal Structure Of The Phosphorylated Interleukin | 3e-12 | ||
| 2ptk_A | 453 | Chicken Src Tyrosine Kinase Length = 453 | 3e-12 | ||
| 3v5j_A | 266 | Crystal Structure Of Interleukin-2 Inducible T-Cell | 3e-12 | ||
| 3t9t_A | 267 | Crystal Structure Of Btk Mutant (F435t,K596r) Compl | 3e-12 | ||
| 4hct_A | 269 | Crystal Structure Of Itk In Complex With Compound 5 | 4e-12 | ||
| 3geq_A | 286 | Structural Basis For The Chemical Rescue Of Src Kin | 4e-12 | ||
| 3qgw_A | 286 | Crystal Structure Of Itk Kinase Bound To An Inhibit | 5e-12 | ||
| 2dq7_X | 283 | Crystal Structure Of Fyn Kinase Domain Complexed Wi | 5e-12 | ||
| 3igo_A | 486 | Crystal Structure Of Cryptosporidium Parvum Cdpk1, | 6e-12 | ||
| 3dfa_A | 286 | Crystal Structure Of Kinase Domain Of Calcium-depen | 7e-12 | ||
| 2wei_A | 287 | Crystal Structure Of The Kinase Domain Of Cryptospo | 7e-12 | ||
| 3mpm_A | 267 | Lck Complexed With A Pyrazolopyrimidine Length = 26 | 8e-12 | ||
| 2eva_A | 307 | Structural Basis For The Interaction Of Tak1 Kinase | 9e-12 | ||
| 4gs6_A | 315 | Irreversible Inhibition Of Tak1 Kinase By 5z-7-oxoz | 1e-11 | ||
| 3c4x_A | 543 | Crystal Structure Of G Protein Coupled Receptor Kin | 2e-11 | ||
| 3t8o_A | 543 | Rhodopsin Kinase (grk1) L166k Mutant At 2.5a Resolu | 2e-11 | ||
| 3c4w_A | 543 | Crystal Structure Of G Protein Coupled Receptor Kin | 2e-11 | ||
| 3qc9_A | 543 | Crystal Structure Of Cross-Linked Bovine Grk1 T8cN4 | 2e-11 | ||
| 4a4x_A | 279 | Nek2-Ede Bound To Cct248662 Length = 279 | 2e-11 | ||
| 2qok_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y596f: | 2e-11 | ||
| 3cok_A | 278 | Crystal Structure Of Plk4 Kinase Length = 278 | 3e-11 | ||
| 2qon_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y596f: | 4e-11 | ||
| 3ppz_A | 309 | Crystal Structure Of Ctr1 Kinase Domain In Complex | 4e-11 | ||
| 2gsf_A | 373 | The Human Epha3 Receptor Tyrosine Kinase And Juxtam | 4e-11 | ||
| 3fxx_A | 371 | Human Epha3 Kinase And Juxtamembrane Region Bound T | 5e-11 | ||
| 3dzq_A | 361 | Human Epha3 Kinase Domain In Complex With Inhibitor | 5e-11 | ||
| 2qof_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y596f | 5e-11 | ||
| 2qod_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y602f | 5e-11 | ||
| 2qo7_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Dephos | 5e-11 | ||
| 2qoo_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y596f: | 5e-11 | ||
| 2qob_A | 344 | Human Epha3 Kinase Domain, Base Structure Length = | 5e-11 | ||
| 2qol_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y596:y | 5e-11 | ||
| 2qoi_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y596f: | 5e-11 | ||
| 2qoc_A | 344 | Human Epha3 Kinase Domain, Phosphorylated, Amp-Pnp | 5e-11 | ||
| 2w5a_A | 279 | Human Nek2 Kinase Adp-Bound Length = 279 | 5e-11 | ||
| 2hk5_A | 270 | Hck Kinase In Complex With Lck Targetted Inhibitor | 5e-11 | ||
| 2jav_A | 279 | Human Kinase With Pyrrole-Indolinone Ligand Length | 6e-11 | ||
| 3s95_A | 310 | Crystal Structure Of The Human Limk1 Kinase Domain | 7e-11 | ||
| 1qcf_A | 454 | Crystal Structure Of Hck In Complex With A Src Fami | 8e-11 | ||
| 1mqb_A | 333 | Crystal Structure Of Ephrin A2 (Epha2) Receptor Pro | 8e-11 | ||
| 3q6w_A | 307 | Structure Of Dually-phosphorylated Met Receptor Kin | 8e-11 | ||
| 2c30_A | 321 | Crystal Structure Of The Human P21-Activated Kinase | 9e-11 | ||
| 2hel_A | 306 | Crystal Structure Of A Mutant Epha4 Kinase Domain ( | 1e-10 | ||
| 2wd1_A | 292 | Human C-Met Kinase In Complex With Azaindole Inhibi | 1e-10 | ||
| 2rfn_A | 310 | X-ray Structure Of C-met With Inhibitor. Length = 3 | 1e-10 | ||
| 4gg5_A | 319 | Crystal Structure Of Cmet In Complex With Novel Inh | 1e-10 | ||
| 3q6u_A | 308 | Structure Of The Apo Met Receptor Kinase In The Dua | 1e-10 | ||
| 3i5n_A | 309 | Crystal Structure Of C-Met With Triazolopyridazine | 1e-10 | ||
| 3lq8_A | 302 | Structure Of The Kinase Domain Of C-Met Bound To Xl | 1e-10 | ||
| 2fb8_A | 281 | Structure Of The B-Raf Kinase Domain Bound To Sb-59 | 1e-10 | ||
| 3f66_A | 298 | Human C-Met Kinase In Complex With Quinoxaline Inhi | 1e-10 | ||
| 1uwh_A | 276 | The Complex Of Wild Type B-Raf And Bay439006 Length | 1e-10 | ||
| 4eqm_A | 294 | Structural Analysis Of Staphylococcus Aureus Serine | 1e-10 | ||
| 4dbn_A | 284 | Crystal Structure Of The Kinase Domain Of Human B-R | 1e-10 | ||
| 4h58_A | 275 | Braf In Complex With Compound 3 Length = 275 | 1e-10 | ||
| 2g15_A | 318 | Structural Characterization Of Autoinhibited C-Met | 1e-10 | ||
| 3cth_A | 314 | Crystal Structure Of The Tyrosine Kinase Domain Of | 1e-10 | ||
| 3q96_A | 282 | B-Raf Kinase Domain In Complex With A Tetrahydronap | 1e-10 | ||
| 2wgj_A | 306 | X-Ray Structure Of Pf-02341066 Bound To The Kinase | 1e-10 | ||
| 1r0p_A | 312 | Crystal Structure Of The Tyrosine Kinase Domain Of | 1e-10 | ||
| 3p86_A | 309 | Crystal Structure Of Ctr1 Kinase Domain Mutant D676 | 1e-10 | ||
| 3qti_A | 314 | C-Met Kinase In Complex With Nvp-Bvu972 Length = 31 | 1e-10 | ||
| 3dkc_A | 317 | Sgx Clone 5698a65kfg1h1 Length = 317 | 1e-10 | ||
| 3bbt_B | 328 | Crystal Structure Of The Erbb4 Kinase In Complex Wi | 1e-10 | ||
| 3a4p_A | 319 | Human C-Met Kinase Domain Complexed With 6-Benzylox | 1e-10 | ||
| 3ii5_A | 306 | The Complex Of Wild-Type B-Raf With Pyrazolo Pyrimi | 1e-10 | ||
| 3d4q_A | 307 | Pyrazole-Based Inhibitors Of B-Raf Kinase Length = | 1e-10 | ||
| 3dkg_A | 317 | Sgx Clone 5698a109kfg1h1 Length = 317 | 2e-10 | ||
| 3c1x_A | 373 | Crystal Structure Of The Tyrosine Kinase Domain Of | 2e-10 | ||
| 2r4b_A | 321 | Erbb4 Kinase Domain Complexed With A Thienopyrimidi | 2e-10 | ||
| 2y6m_A | 291 | Crystal Structure Of Epha4 Kinase Domain Length = 2 | 2e-10 | ||
| 2xyu_A | 285 | Crystal Structure Of Epha4 Kinase Domain In Complex | 2e-10 | ||
| 3i79_A | 484 | Calcium-Dependent Protein Kinase 1 From Toxoplasma | 2e-10 | ||
| 3ku2_A | 507 | Crystal Structure Of Inactivated Form Of Cdpk1 From | 2e-10 | ||
| 3pwy_A | 311 | Crystal Structure Of An Extender (Spd28345)-Modifie | 2e-10 | ||
| 3hx4_A | 508 | Crystal Structure Of Cdpk1 Of Toxoplasma Gondii, Tg | 2e-10 | ||
| 3ma6_A | 298 | Crystal Structure Of Kinase Domain Of Tgcdpk1 In Pr | 2e-10 | ||
| 3idp_A | 300 | B-Raf V600e Kinase Domain In Complex With An Aminoi | 2e-10 | ||
| 3f69_A | 311 | Crystal Structure Of The Mycobacterium Tuberculosis | 2e-10 | ||
| 2jed_A | 352 | The Crystal Structure Of The Kinase Domain Of The P | 2e-10 | ||
| 1uwj_A | 276 | The Complex Of Mutant V599e B-raf And Bay439006 Len | 2e-10 | ||
| 4g9r_A | 307 | B-Raf V600e Kinase Domain Bound To A Type Ii Dihydr | 2e-10 | ||
| 3orm_A | 311 | Mycobacterium Tuberculosis Pknb Kinase Domain D76a | 2e-10 | ||
| 3ori_A | 311 | Mycobacterium Tuberculosis Pknb Kinase Domain L33d | 2e-10 | ||
| 3f61_A | 311 | Crystal Structure Of M. Tuberculosis Pknb Leu33aspV | 2e-10 | ||
| 1mru_A | 311 | Intracellular SerTHR PROTEIN KINASE DOMAIN OF Mycob | 2e-10 | ||
| 2r2p_A | 295 | Kinase Domain Of Human Ephrin Type-A Receptor 5 (Ep | 3e-10 | ||
| 3i7c_A | 484 | Calcium-Dependent Protein Kinase 1 From Toxoplasma | 3e-10 | ||
| 2xik_A | 294 | Structure Of Human Ysk1 (Yeast Sps1-Ste20-Related K | 3e-10 | ||
| 1xjd_A | 345 | Crystal Structure Of Pkc-Theta Complexed With Staur | 3e-10 | ||
| 3ckw_A | 304 | Crystal Structure Of Sterile 20-Like Kinase 3 (Mst3 | 3e-10 | ||
| 3lij_A | 494 | Crystal Structure Of Full Length Cpcdpk3 (Cgd5_820) | 3e-10 | ||
| 3ggf_A | 301 | Crystal Structure Of Human SerineTHREONINE-Protein | 3e-10 | ||
| 3d5u_A | 317 | Crystal Structure Of A Wildtype Polo-Like Kinase 1 | 4e-10 | ||
| 1o6y_A | 299 | Catalytic Domain Of Pknb Kinase From Mycobacterium | 4e-10 | ||
| 3d5w_A | 317 | Crystal Structure Of A Phosphorylated Polo-Like Kin | 4e-10 | ||
| 3zhp_C | 294 | Human Mst3 (stk24) In Complex With Mo25beta Length | 4e-10 | ||
| 1h1w_A | 289 | High Resolution Crystal Structure Of The Human Pdk1 | 4e-10 | ||
| 3d5v_A | 317 | Crystal Structure Of An Activated (Thr->asp) Polo-L | 4e-10 | ||
| 1uu9_A | 286 | Structure Of Human Pdk1 Kinase Domain In Complex Wi | 5e-10 | ||
| 1rjb_A | 344 | Crystal Structure Of Flt3 Length = 344 | 5e-10 | ||
| 1z5m_A | 286 | Crystal Structure Of N1-[3-[[5-bromo-2-[[3-[(1-pyrr | 5e-10 | ||
| 3db6_A | 301 | Crystal Structure Of An Activated (Thr->asp) Polo-L | 5e-10 | ||
| 3nus_A | 286 | Phosphoinositide-Dependent Kinase-1 (Pdk1) With Fra | 5e-10 | ||
| 2xck_A | 309 | Crystal Structure Of Pdk1 In Complex With A Pyrazol | 5e-10 | ||
| 1uu3_A | 310 | Structure Of Human Pdk1 Kinase Domain In Complex Wi | 5e-10 | ||
| 3orx_A | 316 | Pdk1 Mutant Bound To Allosteric Disulfide Fragment | 5e-10 | ||
| 3iop_A | 312 | Pdk-1 In Complex With The Inhibitor Compound-8i Len | 5e-10 | ||
| 3rwp_A | 311 | Discovery Of A Novel, Potent And Selective Inhibito | 5e-10 | ||
| 2xch_A | 309 | Crystal Structure Of Pdk1 In Complex With A Pyrazol | 5e-10 | ||
| 3hrc_A | 311 | Crystal Structure Of A Mutant Of Human Pdk1 Kinase | 5e-10 | ||
| 2r7b_A | 312 | Crystal Structure Of The Phosphoinositide-Dependent | 5e-10 | ||
| 2biy_A | 310 | Structure Of Pdk1-S241a Mutant Kinase Domain Length | 5e-10 | ||
| 3h9o_A | 311 | Phosphoinositide-Dependent Protein Kinase 1 (Pdk-1) | 5e-10 | ||
| 3sc1_A | 311 | Novel Isoquinolone Pdk1 Inhibitors Discovered Throu | 5e-10 | ||
| 3qc4_A | 314 | Pdk1 In Complex With Dfg-Out Inhibitor Xxx Length = | 6e-10 | ||
| 3nun_A | 292 | Phosphoinositide-Dependent Kinase-1 (Pdk1) With Lea | 6e-10 | ||
| 3kul_B | 325 | Kinase Domain Of Human Ephrin Type-A Receptor 8 (Ep | 6e-10 | ||
| 3q4t_A | 322 | Crystal Structure Of Activin Receptor Type-Iia (Acv | 6e-10 | ||
| 1u5q_A | 348 | Crystal Structure Of The Tao2 Kinase Domain: Activa | 6e-10 | ||
| 4a07_A | 311 | Human Pdk1 Kinase Domain In Complex With Allosteric | 6e-10 | ||
| 3nay_A | 311 | Pdk1 In Complex With Inhibitor Mp6 Length = 311 | 6e-10 | ||
| 2gcd_A | 309 | Tao2 Kinase Domain-Staurosporine Structure Length = | 6e-10 | ||
| 3omv_A | 307 | Crystal Structure Of C-Raf (Raf-1) Length = 307 | 7e-10 | ||
| 3nax_A | 311 | Pdk1 In Complex With Inhibitor Mp7 Length = 311 | 7e-10 | ||
| 1ad5_A | 438 | Src Family Kinase Hck-Amp-Pnp Complex Length = 438 | 7e-10 | ||
| 3kul_A | 325 | Kinase Domain Of Human Ephrin Type-A Receptor 8 (Ep | 8e-10 | ||
| 2e9v_A | 268 | Structure Of H-Chk1 Complexed With A859017 Length = | 8e-10 | ||
| 2ghg_A | 269 | H-Chk1 Complexed With A431994 Length = 269 | 8e-10 | ||
| 4fsm_A | 279 | Crystal Structure Of The Chk1 Length = 279 | 9e-10 | ||
| 2r0u_A | 323 | Crystal Structure Of Chek1 In Complex With Inhibito | 9e-10 | ||
| 4fsn_A | 278 | Crystal Structure Of The Chk1 Length = 278 | 9e-10 | ||
| 2ayp_A | 269 | Crystal Structure Of Chk1 With An Indol Inhibitor L | 9e-10 | ||
| 2hog_A | 322 | Crystal Structure Of Chek1 In Complex With Inhibito | 9e-10 | ||
| 1zys_A | 273 | Co-Crystal Structure Of Checkpoint Kinase Chk1 With | 9e-10 | ||
| 4fsu_A | 279 | Crystal Structure Of The Chk1 Length = 279 | 9e-10 | ||
| 3jvr_A | 271 | Characterization Of The Chk1 Allosteric Inhibitor B | 9e-10 | ||
| 4fsy_A | 279 | Crystal Structure Of The Chk1 Length = 279 | 9e-10 | ||
| 2x8e_A | 276 | Discovery Of A Novel Class Of Triazolones As Checkp | 9e-10 | ||
| 3ot3_A | 273 | X-Ray Crystal Structure Of Compound 22k Bound To Hu | 1e-09 | ||
| 3fxz_A | 297 | Crystal Structure Of Pak1 Kinase Domain With Ruthen | 1e-09 | ||
| 2br1_A | 297 | Structure-Based Design Of Novel Chk1 Inhibitors: In | 1e-09 | ||
| 1ia8_A | 289 | The 1.7 A Crystal Structure Of Human Cell Cycle Che | 1e-09 | ||
| 1zlt_A | 295 | Crystal Structure Of Chk1 Complexed With A Hymenald | 1e-09 | ||
| 4fst_A | 269 | Crystal Structure Of The Chk1 Length = 269 | 1e-09 | ||
| 2qlu_A | 314 | Crystal Structure Of Activin Receptor Type Ii Kinas | 1e-09 | ||
| 4fsw_A | 279 | Crystal Structure Of The Chk1 Length = 279 | 1e-09 | ||
| 3c4c_A | 280 | B-Raf Kinase In Complex With Plx4720 Length = 280 | 1e-09 | ||
| 4ft3_A | 279 | Crystal Structure Of The Chk1 Length = 279 | 1e-09 | ||
| 4fsz_A | 279 | Crystal Structure Of The Chk1 Length = 279 | 1e-09 | ||
| 3a7f_A | 303 | Human Mst3 Kinase Length = 303 | 1e-09 | ||
| 3ckx_A | 304 | Crystal Structure Of Sterile 20-Like Kinase 3 (Mst3 | 1e-09 | ||
| 1yhv_A | 297 | Crystal Structure Of Pak1 Kinase Domain With Two Po | 1e-09 | ||
| 2zv2_A | 298 | Crystal Structure Of Human CalciumCALMODULIN-Depend | 1e-09 | ||
| 3pls_A | 298 | Ron In Complex With Ligand Amp-Pnp Length = 298 | 1e-09 | ||
| 2ydj_A | 276 | Discovery Of Checkpoint Kinase Inhibitor Azd7762 By | 1e-09 | ||
| 4fnz_A | 327 | Crystal Structure Of Human Anaplastic Lymphoma Kina | 2e-09 | ||
| 4fob_A | 353 | Crystal Structure Of Human Anaplastic Lymphoma Kina | 2e-09 | ||
| 4dce_A | 333 | Crystal Structure Of Human Anaplastic Lymphoma Kina | 2e-09 | ||
| 2yfx_A | 327 | Structure Of L1196m Mutant Anaplastic Lymphoma Kina | 2e-09 | ||
| 2yhv_A | 342 | Structure Of L1196m Mutant Anaplastic Lymphoma Kina | 2e-09 | ||
| 2y4i_C | 395 | Ksr2-Mek1 Heterodimer Length = 395 | 2e-09 | ||
| 2xp2_A | 327 | Structure Of The Human Anaplastic Lymphoma Kinase I | 2e-09 | ||
| 3aox_A | 344 | X-Ray Crystal Structure Of Human Anaplastic Lymphom | 2e-09 | ||
| 1f3m_C | 297 | Crystal Structure Of Human SerineTHREONINE KINASE P | 2e-09 | ||
| 3pp0_A | 338 | Crystal Structure Of The Kinase Domain Of Human Her | 2e-09 | ||
| 3q52_A | 306 | Structure Of Phosphorylated Pak1 Kinase Domain Leng | 2e-09 | ||
| 2itn_A | 327 | Crystal Structure Of Egfr Kinase Domain G719s Mutat | 2e-09 | ||
| 4fk3_A | 292 | B-Raf Kinase V600e Oncogenic Mutant In Complex With | 2e-09 | ||
| 3og7_A | 289 | B-Raf Kinase V600e Oncogenic Mutant In Complex With | 2e-09 | ||
| 2pml_X | 348 | Crystal Structure Of Pfpk7 In Complex With An Atp A | 2e-09 | ||
| 2p55_A | 333 | X-Ray Structure Of The Human Mitogen-Activated Prot | 2e-09 | ||
| 1m14_A | 333 | Tyrosine Kinase Domain From Epidermal Growth Factor | 2e-09 | ||
| 3aln_A | 327 | Crystal Structure Of Human Non-Phosphorylated Mkk4 | 2e-09 | ||
| 3bel_A | 315 | X-Ray Structure Of Egfr In Complex With Oxime Inhib | 2e-09 | ||
| 2rfd_A | 324 | Crystal Structure Of The Complex Between The Egfr K | 2e-09 | ||
| 3lzb_A | 327 | Egfr Kinase Domain Complexed With An Imidazo[2,1-B] | 2e-09 | ||
| 3l9p_A | 367 | Crystal Structure Of The Anaplastic Lymphoma Kinase | 2e-09 | ||
| 2jiu_A | 328 | Crystal Structure Of Egfr Kinase Domain T790m Mutat | 2e-09 | ||
| 2jiv_A | 328 | Crystal Structure Of Egfr Kinase Domain T790m Mutat | 2e-09 | ||
| 4fnw_A | 327 | Crystal Structure Of The Apo F1174l Anaplastic Lymp | 2e-09 | ||
| 3lct_A | 344 | Crystal Structure Of The Anaplastic Lymphoma Kinase | 2e-09 | ||
| 2xb7_A | 315 | Structure Of Human Anaplastic Lymphoma Kinase In Co | 2e-09 | ||
| 2j5f_A | 327 | Crystal Structure Of Egfr Kinase Domain In Complex | 2e-09 | ||
| 4hjo_A | 337 | Crystal Structure Of The Inactive Egfr Tyrosine Kin | 2e-09 | ||
| 4g5j_A | 330 | Crystal Structure Of Egfr Kinase In Complex With Bi | 2e-09 | ||
| 3gop_A | 361 | Crystal Structure Of The Egf Receptor Juxtamembrane | 2e-09 | ||
| 2jit_A | 327 | Crystal Structure Of Egfr Kinase Domain T790m Mutat | 2e-09 | ||
| 2j5e_A | 327 | Crystal Structure Of Egfr Kinase Domain In Complex | 2e-09 | ||
| 1s9j_A | 341 | X-Ray Structure Of The Human Mitogen-Activated Prot | 2e-09 | ||
| 3ika_A | 331 | Crystal Structure Of Egfr 696-1022 T790m Mutant Cov | 2e-09 | ||
| 4i24_A | 329 | Structure Of T790m Egfr Kinase Domain Co-crystalliz | 2e-09 | ||
| 4i23_A | 329 | Crystal Structure Of The Wild-type Egfr Kinase Doma | 2e-09 | ||
| 4g5p_A | 330 | Crystal Structure Of Egfr Kinase T790m In Complex W | 2e-09 | ||
| 2gs2_A | 330 | Crystal Structure Of The Active Egfr Kinase Domain | 2e-09 | ||
| 1xkk_A | 352 | Egfr Kinase Domain Complexed With A Quinazoline Inh | 2e-09 | ||
| 2yac_A | 311 | Crystal Structure Of Polo-Like Kinase 1 In Complex | 2e-09 | ||
| 2gs7_A | 330 | Crystal Structure Of The Inactive Egfr Kinase Domai | 2e-09 | ||
| 2v5q_A | 315 | Crystal Structure Of Wild-type Plk-1 Kinase Domain | 2e-09 | ||
| 3orn_A | 307 | Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In | 2e-09 | ||
| 3kb7_A | 311 | Crystal Structure Of Polo-Like Kinase 1 In Complex | 2e-09 | ||
| 2eb2_A | 334 | Crystal Structure Of Mutated Egfr Kinase Domain (G7 | 2e-09 | ||
| 3vjo_A | 334 | Crystal Structure Of The Wild-Type Egfr Kinase Doma | 3e-09 | ||
| 3ug1_A | 334 | Crystal Structure Of The Mutated Egfr Kinase Domain | 3e-09 | ||
| 2yjr_A | 342 | Structure Of F1174l Mutant Anaplastic Lymphoma Kina | 3e-09 | ||
| 3mbl_A | 328 | Crystal Structure Of The Human Mitogen-Activated Pr | 3e-09 | ||
| 3dv3_A | 322 | Mek1 With Pf-04622664 Bound Length = 322 | 3e-09 | ||
| 3sxr_A | 268 | Crystal Structure Of Bmx Non-Receptor Tyrosine Kina | 3e-09 | ||
| 3eqc_A | 360 | X-Ray Structure Of The Human Mitogen-Activated Prot | 3e-09 | ||
| 3sls_A | 304 | Crystal Structure Of Human Mek-1 Kinase In Complex | 3e-09 | ||
| 3thb_A | 333 | Structure Of Plk1 Kinase Domain In Complex With A B | 3e-09 | ||
| 2oh4_A | 316 | Crystal Structure Of Vegfr2 With A Benzimidazole-Ur | 4e-09 | ||
| 2rku_A | 294 | Structure Of Plk1 In Complex With Bi2536 Length = 2 | 4e-09 | ||
| 2ou7_A | 335 | Structure Of The Catalytic Domain Of Human Polo-Lik | 4e-09 | ||
| 1ywn_A | 316 | Vegfr2 In Complex With A Novel 4-amino-furo[2,3-d]p | 4e-09 | ||
| 3uiu_A | 306 | Crystal Structure Of Apo-Pkr Kinase Domain Length = | 4e-09 | ||
| 3lxn_A | 318 | Structural And Thermodynamic Characterization Of Th | 4e-09 | ||
| 2p2h_A | 314 | Crystal Structure Of The Vegfr2 Kinase Domain In Co | 4e-09 | ||
| 2p2i_A | 314 | Crystal Structure Of The Vegfr2 Kinase Domain In Co | 4e-09 | ||
| 2wqm_A | 310 | Structure Of Apo Human Nek7 Length = 310 | 4e-09 | ||
| 2rei_A | 318 | Kinase Domain Of Human Ephrin Type-a Receptor 7 (ep | 4e-09 | ||
| 4an2_A | 301 | Crystal Structures Of Human Mek1 With Carboxamide-B | 5e-09 | ||
| 2itt_A | 327 | Crystal Structure Of Egfr Kinase Domain L858r Mutat | 5e-09 | ||
| 4i20_A | 329 | Crystal Structure Of Monomeric (v948r) Primary Onco | 5e-09 | ||
| 1vr2_A | 316 | Human Vascular Endothelial Growth Factor Receptor 2 | 5e-09 | ||
| 4i21_A | 329 | Crystal Structure Of L858r + T790m Egfr Kinase Doma | 5e-09 | ||
| 4i1z_A | 329 | Crystal Structure Of The Monomeric (v948r) Form Of | 5e-09 | ||
| 3w2o_A | 331 | Egfr Kinase Domain T790m/l858r Mutant With Tak-285 | 5e-09 | ||
| 2y94_A | 476 | Structure Of An Active Form Of Mammalian Ampk Lengt | 6e-09 | ||
| 2eb3_A | 334 | Crystal Structure Of Mutated Egfr Kinase Domain (L8 | 6e-09 | ||
| 4gt4_A | 308 | Structure Of Unliganded, Inactive Ror2 Kinase Domai | 6e-09 | ||
| 4fnx_A | 327 | Crystal Structure Of The Apo R1275q Anaplastic Lymp | 6e-09 | ||
| 3cik_A | 689 | Human Grk2 In Complex With Gbetagamma Subunits Leng | 6e-09 | ||
| 1omw_A | 689 | Crystal Structure Of The Complex Between G Protein- | 6e-09 | ||
| 3psc_A | 695 | Bovine Grk2 In Complex With Gbetagamma Subunits Len | 6e-09 | ||
| 3krw_A | 688 | Human Grk2 In Complex With Gbetgamma Subunits And B | 6e-09 | ||
| 1k3a_A | 299 | Structure Of The Insulin-Like Growth Factor 1 Recep | 6e-09 | ||
| 1s9i_A | 354 | X-Ray Structure Of The Human Mitogen-Activated Prot | 6e-09 | ||
| 1ir3_A | 306 | Phosphorylated Insulin Receptor Tyrosine Kinase In | 6e-09 | ||
| 1p4o_A | 322 | Structure Of Apo Unactivated Igf-1r Kinase Domain A | 7e-09 | ||
| 3zzw_A | 289 | Crystal Structure Of The Kinase Domain Of Ror2 Leng | 7e-09 | ||
| 3i81_A | 315 | Crystal Structure Of Insulin-Like Growth Factor 1 R | 7e-09 | ||
| 2z8c_A | 303 | Phosphorylated Insulin Receptor Tyrosine Kinase In | 7e-09 | ||
| 1irk_A | 306 | Crystal Structure Of The Tyrosine Kinase Domain Of | 7e-09 | ||
| 3c4f_A | 302 | Fgfr Tyrosine Kinase Domain In Complex With 3-(3- M | 7e-09 | ||
| 1m7n_A | 322 | Crystal Structure Of Unactivated Apo Insulin-Like G | 7e-09 | ||
| 3qqu_A | 301 | Cocrystal Structure Of Unphosphorylated Igf With Py | 7e-09 | ||
| 2zm3_A | 308 | Complex Structure Of Insulin-Like Growth Factor Rec | 7e-09 | ||
| 1jqh_A | 308 | Igf-1 Receptor Kinase Domain Length = 308 | 7e-09 | ||
| 3o23_A | 305 | Human Unphosphorylated Igf1-R Kinase Domain In Comp | 7e-09 | ||
| 2xir_A | 316 | Crystal Structure Of The Vegfr2 Kinase Domain In Co | 7e-09 | ||
| 3lw0_A | 304 | Igf-1rk In Complex With Ligand Msc1609119a-1 Length | 7e-09 | ||
| 3com_A | 314 | Crystal Structure Of Mst1 Kinase Length = 314 | 7e-09 | ||
| 2oj9_A | 307 | Structure Of Igf-1r Kinase Domain Complexed With A | 7e-09 | ||
| 1rqq_A | 306 | Crystal Structure Of The Insulin Receptor Kinase In | 8e-09 | ||
| 4f0i_A | 300 | Crystal Structure Of Apo Trka Length = 300 | 8e-09 | ||
| 3gql_A | 326 | Crystal Structure Of Activated Receptor Tyrosine Ki | 8e-09 | ||
| 3c7q_A | 316 | Structure Of Vegfr2 Kinase Domain In Complex With B | 8e-09 | ||
| 3vnt_A | 318 | Crystal Structure Of The Kinase Domain Of Human Veg | 8e-09 | ||
| 3u6j_A | 314 | Crystal Structure Of The Vegfr2 Kinase Domain In Co | 8e-09 | ||
| 4aoj_A | 329 | Human Trka In Complex With The Inhibitor Az-23 Leng | 8e-09 | ||
| 2i0v_A | 335 | C-Fms Tyrosine Kinase In Complex With A Quinolone I | 8e-09 | ||
| 4gt5_A | 306 | Crystal Structure Of The Inactive Trka Kinase Domai | 9e-09 | ||
| 3q4z_A | 306 | Structure Of Unphosphorylated Pak1 Kinase Domain Le | 9e-09 | ||
| 3ewh_A | 314 | Crystal Structure Of The Vegfr2 Kinase Domain In Co | 9e-09 | ||
| 3gqi_A | 326 | Crystal Structure Of Activated Receptor Tyrosine Ki | 9e-09 | ||
| 3bea_A | 333 | Cfms Tyrosine Kinase (Tie2 Kid) In Complex With A P | 9e-09 | ||
| 4e20_A | 290 | Structure Of Mouse Tyk-2 Complexed To A 3-Aminoinda | 9e-09 | ||
| 4e1z_A | 291 | Structure Of Mouse Tyk-2 Complexed To A 3-Aminoinda | 9e-09 | ||
| 2i1m_A | 333 | Cfms Tyrosine Kinase (Tie2 Kid) In Complex With An | 9e-09 | ||
| 1fot_A | 318 | Structure Of The Unliganded Camp-Dependent Protein | 9e-09 | ||
| 3hng_A | 360 | Crystal Structure Of Vegfr1 In Complex With N-(4-ch | 1e-08 | ||
| 3lvp_A | 336 | Crystal Structure Of Bisphosphorylated Igf1-R Kinas | 1e-08 | ||
| 3rhx_B | 306 | Crystal Structure Of The Catalytic Domain Of Fgfr1 | 1e-08 | ||
| 4agc_A | 353 | Crystal Structure Of Vegfr2 (Juxtamembrane And Kina | 1e-08 | ||
| 3kxx_A | 317 | Structure Of The Mutant Fibroblast Growth Factor Re | 1e-08 | ||
| 1y6a_A | 366 | Crystal Structure Of Vegfr2 In Complex With A 2-Ani | 1e-08 | ||
| 3vhe_A | 359 | Crystal Structure Of Human Vegfr2 Kinase Domain Wit | 1e-08 | ||
| 1fgk_A | 310 | Crystal Structure Of The Tyrosine Kinase Domain Of | 1e-08 | ||
| 2z7q_A | 321 | Crystal Structure Of The N-Terminal Kinase Domain O | 1e-08 | ||
| 3eta_A | 317 | Kinase Domain Of Insulin Receptor Complexed With A | 1e-08 | ||
| 3cjg_A | 309 | Crystal Structure Of Vegfr2 In Complex With A 3,4,5 | 1e-08 | ||
| 3vhk_A | 368 | Crystal Structure Of The Vegfr2 Kinase Domain In Co | 1e-08 | ||
| 3vid_A | 356 | Crystal Structure Of Human Vegfr2 Kinase Domain Wit | 1e-08 | ||
| 4f63_A | 309 | Crystal Structure Of Human Fibroblast Growth Factor | 1e-08 | ||
| 3tt0_A | 382 | Co-Structure Of Fibroblast Growth Factor Receptor 1 | 1e-08 | ||
| 3js2_A | 317 | Crystal Structure Of Minimal Kinase Domain Of Fibro | 1e-08 | ||
| 2ogv_A | 317 | Crystal Structure Of The Autoinhibited Human C-Fms | 1e-08 | ||
| 2yjs_A | 342 | Structure Of C1156y Mutant Anaplastic Lymphoma Kina | 1e-08 | ||
| 3tub_A | 293 | Crystal Structure Of Syk Kinase Domain With 1-(5-(6 | 1e-08 | ||
| 3vf8_A | 299 | Crystal Structure Of Spleen Tyrosine Kinase Syk Cat | 1e-08 | ||
| 4dfl_A | 274 | Crystal Structure Of Spleen Tyrosine Kinase Complex | 1e-08 | ||
| 3srv_B | 277 | Crystal Structure Of Spleen Tyrosine Kinase (Syk) I | 1e-08 | ||
| 3srv_A | 277 | Crystal Structure Of Spleen Tyrosine Kinase (Syk) I | 1e-08 | ||
| 2jc6_A | 334 | Crystal Structure Of Human Calmodulin-Dependent Pro | 1e-08 | ||
| 3emg_A | 291 | Discovery And Sar Of Novel 4-Thiazolyl-2- Phenylami | 1e-08 | ||
| 3lcd_A | 329 | Inhibitor Bound To A Dfg-In Structure Of The Kinase | 1e-08 | ||
| 4f4p_A | 273 | Syk In Complex With Ligand Lasw836 Length = 273 | 1e-08 | ||
| 3lco_A | 324 | Inhibitor Bound To A Dfg-Out Structure Of The Kinas | 1e-08 | ||
| 1xba_A | 291 | Crystal Structure Of Apo Syk Tyrosine Kinase Domain | 2e-08 | ||
| 2a19_B | 284 | Pkr Kinase Domain- Eif2alpha- Amp-Pnp Complex. Leng | 2e-08 | ||
| 3qd2_B | 332 | Crsytal Structure Of Mouse Perk Kinase Domain Lengt | 2e-08 | ||
| 3iw4_A | 360 | Crystal Structure Of Pkc Alpha In Complex With Nvp- | 2e-08 | ||
| 3hzt_A | 467 | Crystal Structure Of Toxoplasma Gondii Cdpk3, Tgme4 | 2e-08 | ||
| 3d94_A | 301 | Crystal Structure Of The Insulin-Like Growth Factor | 2e-08 | ||
| 2ivt_A | 314 | Crystal Structure Of Phosphorylated Ret Tyrosine Ki | 2e-08 | ||
| 3dxn_A | 287 | Crystal Structure Of The Calcium-dependent Kinase F | 2e-08 | ||
| 3nyx_A | 302 | Non-Phosphorylated Tyk2 Jh1 Domain With Quinoline-T | 2e-08 | ||
| 3nz0_A | 302 | Non-Phosphorylated Tyk2 Kinase With Cmp6 Length = 3 | 2e-08 | ||
| 4fl3_A | 635 | Structural And Biophysical Characterization Of The | 2e-08 | ||
| 4fl2_A | 636 | Structural And Biophysical Characterization Of The | 2e-08 | ||
| 3cjf_A | 309 | Crystal Structure Of Vegfr2 In Complex With A 3,4,5 | 2e-08 | ||
| 2pvy_A | 324 | Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D | 2e-08 | ||
| 3nyn_A | 576 | Crystal Structure Of G Protein-Coupled Receptor Kin | 3e-08 | ||
| 3zuv_A | 364 | Crystal Structure Of A Designed Selected Ankyrin Re | 3e-08 | ||
| 2erk_A | 365 | Phosphorylated Map Kinase Erk2 Length = 365 | 3e-08 | ||
| 3g0f_A | 336 | Kit Kinase Domain Mutant D816h In Complex With Suni | 3e-08 | ||
| 2acx_A | 576 | Crystal Structure Of G Protein Coupled Receptor Kin | 3e-08 | ||
| 2ivs_A | 314 | Crystal Structure Of Non-Phosphorylated Ret Tyrosin | 3e-08 | ||
| 4fv6_A | 360 | Crystal Structure Of The Erk2 Complexed With E57 Le | 3e-08 | ||
| 1bi8_A | 326 | Mechanism Of G1 Cyclin Dependent Kinase Inhibition | 3e-08 | ||
| 2gph_A | 364 | Docking Motif Interactions In The Map Kinase Erk2 L | 3e-08 | ||
| 4fux_A | 360 | Crystal Structure Of The Erk2 Complexed With E75 Le | 3e-08 | ||
| 3tei_A | 362 | Crystal Structure Of Human Erk2 Complexed With A Ma | 3e-08 | ||
| 1gol_A | 364 | Coordinates Of Rat Map Kinase Erk2 With An Arginine | 3e-08 | ||
| 3zu7_A | 365 | Crystal Structure Of A Designed Selected Ankyrin Re | 3e-08 | ||
| 2z7l_A | 366 | Unphosphorylated Mitogen Activated Protein Kinase E | 3e-08 | ||
| 3c9w_A | 357 | Crystal Structure Of Erk-2 With Hypothemycin Covale | 3e-08 | ||
| 2fys_B | 364 | Crystal Structure Of Erk2 Complex With Kim Peptide | 3e-08 | ||
| 3r63_A | 358 | Structure Of Erk2 (Spe) Mutant (S246e) Length = 358 | 3e-08 | ||
| 2y9q_A | 362 | Crystal Structure Of Human Erk2 Complexed With A Ma | 3e-08 | ||
| 1yvj_A | 290 | Crystal Structure Of The Jak3 Kinase Domain In Comp | 3e-08 | ||
| 2ivv_A | 314 | Crystal Structure Of Phosphorylated Ret Tyrosine Ki | 3e-08 | ||
| 4fv7_A | 360 | Crystal Structure Of The Erk2 Complexed With E94 Le | 3e-08 | ||
| 3qyw_A | 364 | Crystal Structure Of Erk2 In Complex With An Inhibi | 3e-08 | ||
| 3gvu_A | 292 | The Crystal Structure Of Human Abl2 In Complex With | 3e-08 | ||
| 3o71_A | 358 | Crystal Structure Of Erk2DCC PEPTIDE COMPLEX Length | 3e-08 | ||
| 1i44_A | 306 | Crystallographic Studies Of An Activation Loop Muta | 3e-08 | ||
| 1jow_B | 308 | Crystal Structure Of A Complex Of Human Cdk6 And A | 3e-08 | ||
| 2ojg_A | 380 | Crystal Structure Of Erk2 In Complex With N,n-dimet | 3e-08 | ||
| 1ql6_A | 298 | The Catalytic Mechanism Of Phosphorylase Kinase Pro | 3e-08 | ||
| 1wzy_A | 368 | Crystal Structure Of Human Erk2 Complexed With A Py | 3e-08 | ||
| 1tvo_A | 368 | The Structure Of Erk2 In Complex With A Small Molec | 3e-08 | ||
| 3nup_A | 307 | Cdk6 (Monomeric) In Complex With Inhibitor Length = | 3e-08 | ||
| 1pme_A | 380 | Structure Of Penta Mutant Human Erk2 Map Kinase Com | 3e-08 | ||
| 1p14_A | 306 | Crystal Structure Of A Catalytic-Loop Mutant Of The | 4e-08 | ||
| 4gsb_A | 364 | Monoclinic Crystal Form Of The Apo-Erk2 Length = 36 | 4e-08 | ||
| 1jpa_A | 312 | Crystal Structure Of Unphosphorylated Ephb2 Recepto | 4e-08 | ||
| 3ekk_A | 307 | Insulin Receptor Kinase Complexed With An Inhibitor | 4e-08 | ||
| 3q5i_A | 504 | Crystal Structure Of Pbanka_031420 Length = 504 | 4e-08 | ||
| 3sa0_A | 360 | Complex Of Erk2 With Norathyriol Length = 360 | 4e-08 | ||
| 3pfq_A | 674 | Crystal Structure And Allosteric Activation Of Prot | 4e-08 | ||
| 3g51_A | 325 | Structural Diversity Of The Active Conformation Of | 4e-08 | ||
| 3is5_A | 285 | Crystal Structure Of Cdpk Kinase Domain From Toxopl | 4e-08 | ||
| 4h3q_A | 362 | Crystal Structure Of Human Erk2 Complexed With A Ma | 5e-08 | ||
| 3hyh_A | 275 | Crystal Structure Of The Protein Kinase Domain Of Y | 5e-08 | ||
| 3g0e_A | 336 | Kit Kinase Domain In Complex With Sunitinib Length | 5e-08 | ||
| 2fh9_A | 274 | Structure And Dimerization Of The Kinase Domain Fro | 5e-08 | ||
| 3dae_A | 283 | Crystal Structure Of Phosphorylated Snf1 Kinase Dom | 5e-08 | ||
| 3mn3_A | 271 | An Inhibited Conformation For The Protein Kinase Do | 5e-08 | ||
| 3oht_A | 389 | Crystal Structure Of Salmo Salar P38alpha Length = | 5e-08 | ||
| 4apc_A | 350 | Crystal Structure Of Human Nima-Related Kinase 1 (N | 5e-08 | ||
| 1t45_A | 331 | Structural Basis For The Autoinhibition And Sti-571 | 5e-08 | ||
| 2qnj_A | 328 | Kinase And Ubiquitin-Associated Domains Of Mark3PAR | 6e-08 | ||
| 3vn9_A | 340 | Rifined Crystal Structure Of Non-Phosphorylated Map | 6e-08 | ||
| 4el9_A | 305 | Structure Of N-Terminal Kinase Domain Of Rsk2 With | 6e-08 | ||
| 3ubd_A | 304 | Structure Of N-Terminal Domain Of Rsk2 Kinase In Co | 6e-08 | ||
| 3fe3_A | 328 | Crystal Structure Of The Kinase Mark3PAR-1: T211a-S | 6e-08 | ||
| 3qa8_A | 676 | Crystal Structure Of Inhibitor Of Kappa B Kinase Be | 6e-08 | ||
| 2i0e_A | 353 | Structure Of Catalytic Domain Of Human Protein Kina | 6e-08 | ||
| 1pkg_A | 329 | Structure Of A C-kit Kinase Product Complex Length | 6e-08 | ||
| 3rzf_A | 677 | Crystal Structure Of Inhibitor Of Kappab Kinase Bet | 6e-08 | ||
| 1t46_A | 313 | Structural Basis For The Autoinhibition And Sti-571 | 6e-08 | ||
| 4ejn_A | 446 | Crystal Structure Of Autoinhibited Form Of Akt1 In | 7e-08 | ||
| 3o96_A | 446 | Crystal Structure Of Human Akt1 With An Allosteric | 7e-08 | ||
| 4fg8_A | 315 | Crystal Structure Of Human Calcium/calmodulin-depen | 7e-08 | ||
| 3dk3_A | 293 | Crystal Structure Of Mutant Abl Kinase Domain In Co | 7e-08 | ||
| 1phk_A | 298 | Two Structures Of The Catalytic Domain Of Phosphory | 7e-08 | ||
| 3qri_A | 277 | The Crystal Structure Of Human Abl1 Kinase Domain I | 7e-08 | ||
| 2hz0_A | 270 | Abl Kinase Domain In Complex With Nvp-Aeg082 Length | 7e-08 | ||
| 4fg9_A | 320 | Crystal Structure Of Human Calcium/calmodulin-depen | 7e-08 | ||
| 2phk_A | 277 | The Crystal Structure Of A Phosphorylase Kinase Pep | 7e-08 | ||
| 4fg7_A | 293 | Crystal Structure Of Human Calcium/calmodulin-depen | 8e-08 | ||
| 2gqg_A | 278 | X-Ray Crystal Structure Of Dasatinib (Bms-354825) B | 8e-08 | ||
| 1a06_A | 332 | Calmodulin-Dependent Protein Kinase From Rat Length | 8e-08 | ||
| 3lxk_A | 327 | Structural And Thermodynamic Characterization Of Th | 8e-08 | ||
| 2hzi_A | 277 | Abl Kinase Domain In Complex With Pd180970 Length = | 8e-08 | ||
| 3v5q_A | 297 | Discovery Of A Selective Trk Inhibitor With Efficac | 8e-08 | ||
| 3qrj_A | 277 | The Crystal Structure Of Human Abl1 Kinase Domain T | 8e-08 | ||
| 3cly_A | 334 | Crystal Structure Of Fgf Receptor 2 (Fgfr2) Kinase | 8e-08 | ||
| 3pjc_A | 315 | Crystal Structure Of Jak3 Complexed With A Potent A | 8e-08 | ||
| 2yza_A | 276 | Crystal Structure Of Kinase Domain Of Human 5'-Amp- | 8e-08 | ||
| 2pvf_A | 334 | Crystal Structure Of Tyrosine Phosphorylated Activa | 8e-08 | ||
| 2hyy_A | 273 | Human Abl Kinase Domain In Complex With Imatinib (S | 8e-08 | ||
| 4hvd_A | 314 | Jak3 Kinase Domain In Complex With 2-cyclopropyl-5h | 8e-08 | ||
| 1gz8_A | 299 | Human Cyclin Dependent Kinase 2 Complexed With The | 8e-08 | ||
| 4e5a_X | 360 | The W197a Mutant Of P38a Map Kinase Length = 360 | 8e-08 | ||
| 4g31_A | 299 | Crystal Structure Of Gsk6414 Bound To Perk (R587-R1 | 8e-08 | ||
| 2v7a_A | 286 | Crystal Structure Of The T315i Abl Mutant In Comple | 9e-08 | ||
| 4erw_A | 306 | Cdk2 In Complex With Staurosporine Length = 306 | 9e-08 | ||
| 3oxz_A | 284 | Crystal Structure Of Abl Kinase Domain Bound With A | 9e-08 | ||
| 3dk7_A | 277 | Crystal Structure Of Mutant Abl Kinase Domain In Co | 9e-08 | ||
| 2hiw_A | 287 | Crystal Structure Of Inactive Conformation Abl Kina | 9e-08 | ||
| 3niz_A | 311 | Cryptosporidium Parvum Cyclin-Dependent Kinase Cgd5 | 9e-08 | ||
| 2g1t_A | 287 | A Src-Like Inactive Conformation In The Abl Tyrosin | 9e-08 | ||
| 3oy3_A | 284 | Crystal Structure Of Abl T315i Mutant Kinase Domain | 9e-08 | ||
| 3pyy_A | 298 | Discovery And Characterization Of A Cell-Permeable, | 9e-08 | ||
| 1fpu_A | 293 | Crystal Structure Of Abl Kinase Domain In Complex W | 9e-08 | ||
| 2qkr_A | 313 | Cryptosporidium Parvum Cyclin-Dependent Kinase Cgd5 | 1e-07 | ||
| 3dk6_A | 293 | Crystal Structure Of Mutant Abl Kinase Domain In Co | 1e-07 | ||
| 2e2b_A | 293 | Crystal Structure Of The C-Abl Kinase Domain In Com | 1e-07 | ||
| 2qoh_A | 288 | Crystal Structure Of Abl Kinase Bound With Ppy-a Le | 1e-07 | ||
| 3ri1_A | 313 | Crystal Structure Of The Catalytic Domain Of Fgfr2 | 1e-07 | ||
| 2z60_A | 288 | Crystal Structure Of The T315i Mutant Of Abl Kinase | 1e-07 | ||
| 1gii_A | 298 | Human Cyclin Dependent Kinase 2 Complexed With The | 1e-07 | ||
| 3cqu_A | 342 | Crystal Structure Of Akt-1 Complexed With Substrate | 1e-07 | ||
| 1oir_A | 299 | Imidazopyridines: A Potent And Selective Class Of C | 1e-07 | ||
| 1h01_A | 298 | Cdk2 In Complex With A Disubstituted 2, 4-Bis Anili | 1e-07 | ||
| 1pf8_A | 298 | Crystal Structure Of Human Cyclin-dependent Kinase | 1e-07 | ||
| 2w17_A | 299 | Cdk2 In Complex With The Imidazole Pyrimidine Amide | 1e-07 | ||
| 1gjo_A | 316 | The Fgfr2 Tyrosine Kinase Domain Length = 316 | 1e-07 | ||
| 3ezr_A | 300 | Cdk-2 With Indazole Inhibitor 17 Bound At Its Activ | 1e-07 | ||
| 3b2t_A | 311 | Structure Of Phosphotransferase Length = 311 | 1e-07 | ||
| 1fin_A | 298 | Cyclin A-Cyclin-Dependent Kinase 2 Complex Length = | 1e-07 | ||
| 1u59_A | 287 | Crystal Structure Of The Zap-70 Kinase Domain In Co | 1e-07 | ||
| 2q0b_A | 324 | Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D | 1e-07 | ||
| 2pzp_A | 324 | Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D | 1e-07 | ||
| 3ocb_A | 341 | Akt1 Kinase Domain With Pyrrolopyrimidine Inhibitor | 1e-07 | ||
| 2psq_A | 370 | Crystal Structure Of Unphosphorylated Unactivated W | 1e-07 | ||
| 4gv1_A | 340 | Pkb Alpha In Complex With Azd5363 Length = 340 | 1e-07 | ||
| 2pz5_A | 324 | Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D | 1e-07 | ||
| 3pxf_A | 306 | Cdk2 In Complex With Two Molecules Of 8-Anilino-1-N | 1e-07 | ||
| 3pj8_A | 299 | Structure Of Cdk2 In Complex With A Pyrazolo[4,3-D] | 1e-07 | ||
| 2pwl_A | 324 | Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D | 1e-07 | ||
| 2h6d_A | 276 | Protein Kinase Domain Of The Human 5'-Amp-Activated | 1e-07 | ||
| 1vyw_A | 309 | Structure Of Cdk2CYCLIN A WITH PNU-292137 Length = | 1e-07 | ||
| 2py3_A | 324 | Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D | 1e-07 | ||
| 3cd3_A | 377 | Crystal Structure Of Phosphorylated Human Feline Sa | 1e-07 | ||
| 2ghl_A | 348 | Mutant Mus Musculus P38 Kinase Domain In Complex Wi | 1e-07 | ||
| 1yw2_A | 360 | Mutated Mus Musculus P38 Kinase (Mp38) Length = 360 | 2e-07 | ||
| 1ywr_A | 360 | Crystal Structure Analysis Of Inactive P38 Kinase D | 2e-07 | ||
| 2fso_X | 367 | Mitogen Activated Protein Kinase P38alpha (D176a) A | 2e-07 | ||
| 2fst_X | 367 | Mitogen Activated Protein Kinase P38alpha (d176a+f3 | 2e-07 | ||
| 2fsl_X | 367 | Mitogen Activated Protein Kinase P38alpha (D176a+f3 | 2e-07 | ||
| 2zoq_A | 382 | Structural Dissection Of Human Mitogen-Activated Ki | 2e-07 | ||
| 1oit_A | 299 | Imidazopyridines: A Potent And Selective Class Of C | 2e-07 | ||
| 1luf_A | 343 | Crystal Structure Of The Musk Tyrosine Kinase: Insi | 2e-07 | ||
| 3txo_A | 353 | Pkc Eta Kinase In Complex With A Naphthyridine Leng | 2e-07 | ||
| 3bkb_A | 377 | Crystal Structure Of Human Feline Sarcoma Viral Onc | 2e-07 | ||
| 2hak_A | 328 | Catalytic And Ubiqutin-Associated Domains Of Mark1P | 2e-07 | ||
| 4aw5_A | 291 | Complex Of The Ephb4 Kinase Domain With An Oxindole | 2e-07 | ||
| 3nnx_A | 354 | Crystal Structure Of Phosphorylated P38 Alpha In Co | 2e-07 | ||
| 2dyl_A | 318 | Crystal Structure Of Human Mitogen-Activated Protei | 2e-07 | ||
| 2f4j_A | 287 | Structure Of The Kinase Domain Of An Imatinib-Resis | 2e-07 | ||
| 2g2f_A | 287 | A Src-Like Inactive Conformation In The Abl Tyrosin | 2e-07 | ||
| 3bhh_A | 295 | Crystal Structure Of Human Calcium/calmodulin-depen | 2e-07 | ||
| 3odz_X | 360 | Crystal Structure Of P38alpha Y323r Active Mutant L | 2e-07 | ||
| 3py3_A | 380 | Crystal Structure Of Phosphorylated P38alpha Map Ki | 2e-07 | ||
| 3ody_X | 360 | Crystal Structure Of P38alpha Y323q Active Mutant L | 2e-07 | ||
| 3oef_X | 360 | Crystal Structure Of Y323f Inactive Mutant Of P38al | 2e-07 | ||
| 3od6_X | 360 | Crystal Structure Of P38alpha Y323t Active Mutant L | 2e-07 | ||
| 1di9_A | 360 | The Structure Of P38 Mitogen-Activated Protein Kina | 2e-07 | ||
| 2baj_A | 365 | P38alpha Bound To Pyrazolourea Length = 365 | 2e-07 | ||
| 3hrb_A | 359 | P38 Kinase Crystal Structure In Complex With Small | 2e-07 | ||
| 2bal_A | 365 | P38alpha Map Kinase Bound To Pyrazoloamine Length = | 2e-07 | ||
| 2npq_A | 367 | A Novel Lipid Binding Site In The P38 Alpha Map Kin | 2e-07 | ||
| 3p4k_A | 370 | The Third Conformation Of P38a Map Kinase Observed | 2e-07 | ||
| 2vwu_A | 302 | Ephb4 Kinase Domain Inhibitor Complex Length = 302 | 2e-07 | ||
| 2baq_A | 365 | P38alpha Bound To Ro3201195 Length = 365 | 2e-07 | ||
| 1zmv_A | 327 | Catalytic And Ubiqutin-Associated Domains Of Mark2P | 2e-07 | ||
| 2f57_A | 317 | Crystal Structure Of The Human P21-activated Kinase | 2e-07 | ||
| 1lew_A | 360 | Crystal Structure Of Map Kinase P38 Complexed To Th | 2e-07 | ||
| 2r0i_A | 327 | Crystal Structure Of A Kinase Mark2PAR-1 Mutant Len | 2e-07 | ||
| 2puu_A | 348 | Crystal Structure Of P38 Complex With 1-(5-Tert-But | 2e-07 | ||
| 3hvc_A | 362 | Crystal Structure Of Human P38alpha Map Kinase Leng | 2e-07 | ||
| 1zmu_A | 327 | Catalytic And Ubiqutin-Associated Domains Of Mark2P | 2e-07 | ||
| 1ua2_A | 346 | Crystal Structure Of Human Cdk7 Length = 346 | 2e-07 | ||
| 2pzr_A | 324 | Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D | 2e-07 | ||
| 2oo8_X | 317 | Synthesis, Structural Analysis, And Sar Studies Of | 2e-07 | ||
| 3gcu_A | 360 | Human P38 Map Kinase In Complex With Rl48 Length = | 2e-07 | ||
| 2x7f_A | 326 | Crystal Structure Of The Kinase Domain Of Human Tra | 2e-07 | ||
| 3s3i_A | 349 | P38 Kinase Crystal Structure In Complex With Small | 2e-07 | ||
| 3hec_A | 348 | P38 In Complex With Imatinib Length = 348 | 2e-07 | ||
| 3d7z_A | 360 | Crystal Structure Of P38 Kinase In Complex With A B | 2e-07 | ||
| 2gtm_A | 348 | Mutated Mouse P38 Map Kinase Domain In Complex With | 2e-07 | ||
| 3zsg_A | 362 | X-Ray Structure Of P38alpha Bound To Tak-715 Length | 2e-07 | ||
| 3k3i_A | 350 | P38alpha Bound To Novel Dgf-Out Compound Pf-0021595 | 2e-07 | ||
| 3k3j_A | 362 | P38alpha Bound To Novel Dfg-Out Compound Pf-0041612 | 2e-07 | ||
| 1zzl_A | 351 | Crystal Structure Of P38 With Triazolopyridine Leng | 2e-07 | ||
| 3e92_A | 371 | Crystal Structure Of P38 Kinase In Complex With A B | 2e-07 | ||
| 2lgc_A | 359 | Joint Nmr And X-Ray Refinement Reveals The Structur | 2e-07 | ||
| 4ewq_A | 383 | Human P38 Alpha Mapk In Complex With A Pyridazine B | 2e-07 | ||
| 3nnu_A | 354 | Crystal Structure Of P38 Alpha In Complex With Dp13 | 2e-07 | ||
| 3d83_A | 360 | Crystal Structure Of P38 Kinase In Complex With A B | 2e-07 | ||
| 1m7q_A | 366 | Crystal Structure Of P38 Map Kinase In Complex With | 2e-07 | ||
| 1oz1_A | 372 | P38 Mitogen-Activated Kinase In Complex With 4-Azai | 3e-07 | ||
| 3lm0_A | 327 | Crystal Structure Of Human SerineTHREONINE KINASE 1 | 3e-07 | ||
| 2gfs_A | 372 | P38 Kinase Crystal Structure In Complex With Ro3201 | 3e-07 | ||
| 1bmk_A | 379 | The Complex Structure Of The Map Kinase P38SB218655 | 3e-07 | ||
| 3fi4_A | 372 | P38 Kinase Crystal Structure In Complex With Ro4499 | 3e-07 | ||
| 1fvr_A | 327 | Tie2 Kinase Domain Length = 327 | 3e-07 | ||
| 3iec_A | 319 | Helicobacter Pylori Caga Inhibits Par1MARK FAMILY K | 3e-07 | ||
| 1opk_A | 495 | Structural Basis For The Auto-Inhibition Of C-Abl T | 3e-07 | ||
| 3mpt_A | 371 | Crystal Structure Of P38 Kinase In Complex With A P | 3e-07 | ||
| 3tg1_A | 380 | Crystal Structure Of P38alpha In Complex With A Map | 3e-07 | ||
| 1bl6_A | 379 | The Complex Structure Of The Map Kinase P38SB216995 | 3e-07 | ||
| 3kq7_A | 380 | Structure Of Human P38alpha With N-[4-Methyl-3-(6-{ | 3e-07 | ||
| 1ian_A | 366 | Human P38 Map Kinase Inhibitor Complex Length = 366 | 3e-07 | ||
| 2fo0_A | 495 | Organization Of The Sh3-Sh2 Unit In Active And Inac | 3e-07 | ||
| 2oza_B | 366 | Structure Of P38alpha Complex Length = 366 | 3e-07 | ||
| 1zmw_A | 327 | Catalytic And Ubiqutin-Associated Domains Of Mark2P | 3e-07 | ||
| 3dt1_A | 383 | P38 Complexed With A Quinazoline Inhibitor Length = | 3e-07 | ||
| 4e4l_A | 302 | Jak1 Kinase (Jh1 Domain) In Complex With Compound 3 | 3e-07 | ||
| 2wzj_A | 327 | Catalytic And Uba Domain Of Kinase Mark2(PAR-1) K82 | 3e-07 | ||
| 1opl_A | 537 | Structural Basis For The Auto-Inhibition Of C-Abl T | 3e-07 | ||
| 3fme_A | 290 | Crystal Structure Of Human Mitogen-Activated Protei | 3e-07 | ||
| 2hen_A | 286 | Crystal Structure Of The Ephb2 Receptor Kinase Doma | 3e-07 | ||
| 3p08_A | 267 | Crystal Structure Of The Human Btk Kinase Domain Le | 3e-07 | ||
| 4asz_A | 299 | Crystal Structure Of Apo Trkb Kinase Domain Length | 3e-07 | ||
| 3gen_A | 283 | The 1.6 A Crystal Structure Of Human Bruton's Tyros | 3e-07 | ||
| 3eyg_A | 290 | Crystal Structures Of Jak1 And Jak2 Inhibitor Compl | 3e-07 | ||
| 2y8o_A | 362 | Crystal Structure Of Human P38alpha Complexed With | 3e-07 | ||
| 3qup_A | 323 | Inhibitor Bound Structure Of The Kinase Domain Of T | 4e-07 | ||
| 1ove_A | 366 | The Structure Of P38 Alpha In Complex With A Dihydr | 4e-07 | ||
| 3ocs_A | 271 | Crystal Structure Of Bruton's Tyrosine Kinase In Co | 4e-07 | ||
| 1k2p_A | 263 | Crystal Structure Of Bruton's Tyrosine Kinase Domai | 4e-07 | ||
| 3pix_A | 274 | Crystal Structure Of Btk Kinase Domain Complexed Wi | 4e-07 | ||
| 4fie_A | 423 | Full-Length Human Pak4 Length = 423 | 4e-07 | ||
| 4i3z_A | 296 | Structure Of Pcdk2CYCLINA BOUND TO ADP AND 2 MAGNES | 4e-07 | ||
| 3uc3_A | 361 | The Crystal Structure Of Snf1-Related Kinase 2.3 Le | 4e-07 | ||
| 1ob3_A | 288 | Structure Of P. Falciparum Pfpk5 Length = 288 | 4e-07 | ||
| 1e9h_A | 297 | Thr 160 Phosphorylated Cdk2-Human Cyclin A3 Complex | 4e-07 | ||
| 2jgz_A | 289 | Crystal Structure Of Phospho-Cdk2 In Complex With C | 4e-07 | ||
| 4eoi_A | 299 | Thr 160 Phosphorylated Cdk2 K89d, Q131e - Human Cyc | 4e-07 | ||
| 2iw6_A | 302 | Structure Of Human Thr160-Phospho Cdk2-Cyclin A Com | 4e-07 | ||
| 1w98_A | 298 | The Structural Basis Of Cdk2 Activation By Cyclin E | 4e-07 | ||
| 2iw8_A | 302 | Structure Of Human Thr160-Phospho Cdk2-Cyclin A F82 | 4e-07 | ||
| 4eos_A | 300 | Thr 160 Phosphorylated Cdk2 Wt - Human Cyclin A3 Co | 4e-07 | ||
| 4eoq_A | 301 | Thr 160 Phosphorylated Cdk2 Wt - Human Cyclin A3 Co | 4e-07 | ||
| 4eop_A | 300 | Thr 160 Phosphorylated Cdk2 Q131e - Human Cyclin A3 | 4e-07 | ||
| 4eom_A | 301 | Thr 160 Phosphorylated Cdk2 H84s, Q85m, Q131e - Hum | 4e-07 | ||
| 4bcq_A | 301 | Structure Of Cdk2 In Complex With Cyclin A And A 2- | 4e-07 | ||
| 1qmz_A | 299 | Phosphorylated Cdk2-Cyclyin A-Substrate Peptide Com | 4e-07 | ||
| 4eoo_A | 299 | Thr 160 Phosphorylated Cdk2 Q131e - Human Cyclin A3 | 4e-07 | ||
| 1ogu_A | 302 | Structure Of Human Thr160-phospho Cdk2/cyclin A Com | 4e-07 | ||
| 1jst_A | 298 | Phosphorylated Cyclin-Dependent Kinase-2 Bound To C | 4e-07 | ||
| 3qhr_A | 298 | Structure Of A Pcdk2CYCLINA TRANSITION-State Mimic | 4e-07 | ||
| 3bht_A | 300 | Structure Of Phosphorylated Thr160 Cdk2CYCLIN A IN | 4e-07 | ||
| 1h1p_A | 303 | Structure Of Human Thr160-Phospho Cdk2CYCLIN A COMP | 4e-07 | ||
| 4eoj_A | 302 | Thr 160 Phosphorylated Cdk2 H84s, Q85m, K89d - Huma | 5e-07 | ||
| 4eon_A | 300 | Thr 160 Phosphorylated Cdk2 H84s, Q85m, Q131e - Hum | 5e-07 | ||
| 4eok_A | 300 | Thr 160 Phosphorylated Cdk2 H84s, Q85m, K89d - Huma | 5e-07 | ||
| 3e62_A | 293 | Fragment Based Discovery Of Jak-2 Inhibitors Length | 5e-07 | ||
| 2w1i_A | 326 | Structure Determination Of Aurora Kinase In Complex | 5e-07 | ||
| 2q0n_A | 301 | Structure Of Human P21 Activating Kinase 4 (Pak4) I | 5e-07 | ||
| 4e4m_A | 302 | Jak2 Kinase (Jh1 Domain) In Complex With Compound 3 | 5e-07 | ||
| 2b7a_A | 293 | The Structural Basis Of Janus Kinase 2 Inhibition B | 5e-07 | ||
| 3tjc_A | 298 | Co-Crystal Structure Of Jak2 With Thienopyridine 8 | 5e-07 | ||
| 3q32_A | 301 | Structure Of Janus Kinase 2 With A Pyrrolotriazine | 5e-07 | ||
| 2xa4_A | 298 | Inhibitors Of Jak2 Kinase Domain Length = 298 | 5e-07 | ||
| 2clq_A | 295 | Structure Of Mitogen-Activated Protein Kinase Kinas | 5e-07 | ||
| 2cdz_A | 303 | Crystal Structure Of The Human P21-Activated Kinase | 5e-07 | ||
| 2bva_A | 292 | Crystal Structure Of The Human P21-Activated Kinase | 5e-07 | ||
| 4hge_A | 300 | Jak2 Kinase (Jh1 Domain) In Complex With Compound 8 | 5e-07 | ||
| 3lpb_A | 295 | Crystal Structure Of Jak2 Complexed With A Potent 2 | 5e-07 | ||
| 3mh2_A | 360 | Mutagenesis Of P38 Map Kinase Establishes Key Roles | 5e-07 | ||
| 4e6d_A | 298 | Jak2 Kinase (Jh1 Domain) Triple Mutant In Complex W | 5e-07 | ||
| 3rvg_A | 303 | Crystals Structure Of Jak2 With A 1-Amino-5h-Pyrido | 6e-07 | ||
| 4aqc_A | 301 | Triazolopyridine-Based Inhibitor Of Janus Kinase 2 | 6e-07 | ||
| 3k54_A | 283 | Structures Of Human Bruton's Tyrosine Kinase In Act | 6e-07 | ||
| 4fr4_A | 384 | Crystal Structure Of Human SerineTHREONINE-Protein | 6e-07 | ||
| 2ozo_A | 613 | Autoinhibited Intact Human Zap-70 Length = 613 | 6e-07 | ||
| 1v0o_A | 288 | Structure Of P. Falciparum Pfpk5-Indirubin-5-Sulpho | 6e-07 | ||
| 3jy9_A | 311 | Janus Kinase 2 Inhibitors Length = 311 | 6e-07 | ||
| 1v0b_A | 288 | Crystal Structure Of The T198a Mutant Of Pfpk5 Leng | 6e-07 | ||
| 3io7_A | 313 | 2-Aminopyrazolo[1,5-A]pyrimidines As Potent And Sel | 6e-07 | ||
| 4fif_A | 346 | Catalytic Domain Of Human Pak4 With Rpkplvdp Peptid | 6e-07 | ||
| 3oct_A | 265 | Crystal Structure Of Bruton's Tyrosine Kinase Mutan | 7e-07 | ||
| 2x4z_A | 296 | Crystal Structure Of The Human P21-Activated Kinase | 7e-07 | ||
| 3vw6_A | 269 | Crystal Structure Of Human Apoptosis Signal-Regulat | 7e-07 | ||
| 1o6l_A | 337 | Crystal Structure Of An Activated Akt/protein Kinas | 7e-07 | ||
| 2jdo_A | 342 | Structure Of Pkb-Beta (Akt2) Complexed With Isoquin | 7e-07 | ||
| 1o6k_A | 336 | Structure Of Activated Form Of Pkb Kinase Domain S4 | 8e-07 | ||
| 3udb_A | 317 | Crystal Structure Of Snrk2.6 Length = 317 | 8e-07 | ||
| 2w99_B | 306 | Crystal Structure Of Cdk4 In Complex With A D-Type | 9e-07 | ||
| 3e87_A | 335 | Crystal Structures Of The Kinase Domain Of Akt2 In | 9e-07 | ||
| 3g33_A | 308 | Crystal Structure Of Cdk4CYCLIN D3 Length = 308 | 9e-07 | ||
| 2w96_B | 306 | Crystal Structure Of Cdk4 In Complex With A D-Type | 9e-07 | ||
| 1gzk_A | 315 | Molecular Mechanism For The Regulation Of Protein K | 9e-07 | ||
| 4dym_A | 301 | Crystal Structure Of The Acvr1 Kinase Domain In Com | 9e-07 | ||
| 1mrv_A | 339 | Crystal Structure Of An Inactive Akt2 Kinase Domain | 1e-06 | ||
| 3ujg_A | 361 | Crystal Structure Of Snrk2.6 In Complex With Hab1 L | 1e-06 | ||
| 3uc4_A | 362 | The Crystal Structure Of Snf1-Related Kinase 2.6 Le | 1e-06 | ||
| 3mtf_A | 301 | Crystal Structure Of The Acvr1 Kinase In Complex Wi | 1e-06 | ||
| 2wqb_A | 324 | Structure Of The Tie2 Kinase Domain In Complex With | 1e-06 | ||
| 1gzn_A | 335 | Structure Of Pkb Kinase Domain Length = 335 | 1e-06 | ||
| 3h9r_A | 330 | Crystal Structure Of The Kinase Domain Of Type I Ac | 1e-06 | ||
| 3gcp_A | 360 | Human P38 Map Kinase In Complex With Sb203580 Lengt | 1e-06 | ||
| 3d7t_A | 269 | Structural Basis For The Recognition Of C-Src By It | 1e-06 | ||
| 2pk9_A | 317 | Structure Of The Pho85-pho80 Cdk-cyclin Complex Of | 1e-06 | ||
| 3lmg_A | 344 | Crystal Structure Of The Erbb3 Kinase Domain In Com | 1e-06 | ||
| 1y8g_A | 327 | Catalytic And Ubiqutin-Associated Domains Of Mark2P | 1e-06 | ||
| 2uv2_A | 287 | Crystal Structure Of Human Ste20-Like Kinase Bound | 1e-06 | ||
| 4ic7_A | 442 | Crystal Structure Of The Erk5 Kinase Domain In Comp | 1e-06 | ||
| 3kex_A | 325 | Crystal Structure Of The Catalytically Inactive Kin | 1e-06 | ||
| 3h4j_B | 336 | Crystal Structure Of Pombe Ampk Kdaid Fragment Leng | 1e-06 | ||
| 2y7j_A | 365 | Structure Of Human Phosphorylase Kinase, Gamma 2 Le | 2e-06 | ||
| 1k9a_A | 450 | Crystal Structure Analysis Of Full-Length Carboxyl- | 2e-06 | ||
| 3a60_A | 327 | Crystal Structure Of Unphosphorylated P70s6k1 (Form | 2e-06 | ||
| 3vul_A | 370 | Crystal Structure Of A Cysteine-deficient Mutant M1 | 2e-06 | ||
| 3o8p_A | 360 | Conformational Plasticity Of P38 Map Kinase Dfg Mot | 2e-06 | ||
| 3vum_A | 370 | Crystal Structure Of A Cysteine-deficient Mutant M7 | 2e-06 | ||
| 4b99_A | 398 | Crystal Structure Of Mapk7 (Erk5) With Inhibitor Le | 2e-06 | ||
| 2w9f_B | 306 | Crystal Structure Of Cdk4 In Complex With A D-Type | 2e-06 | ||
| 1cm8_A | 367 | Phosphorylated Map Kinase P38-Gamma Length = 367 | 2e-06 | ||
| 3v3v_A | 379 | Structural And Functional Analysis Of Quercetagetin | 2e-06 | ||
| 3mh0_A | 360 | Mutagenesis Of P38 Map Kinase Eshtablishes Key Role | 2e-06 | ||
| 2vz6_A | 313 | Structure Of Human Calcium Calmodulin Dependent Pro | 2e-06 | ||
| 3ugc_A | 295 | Structural Basis Of Jak2 Inhibition By The Type Ii | 2e-06 | ||
| 3gp0_A | 348 | Crystal Structure Of Human Mitogen Activated Protei | 2e-06 | ||
| 3d7u_A | 263 | Structural Basis For The Recognition Of C-Src By It | 2e-06 | ||
| 3mh3_A | 360 | Mutagenesis Of P38 Map Kinase Establishes Key Roles | 2e-06 | ||
| 4ec8_A | 373 | Structure Of Full Length Cdk9 In Complex With Cycli | 2e-06 | ||
| 3a62_A | 327 | Crystal Structure Of Phosphorylated P70s6k1 Length | 2e-06 | ||
| 1zrz_A | 364 | Crystal Structure Of The Catalytic Domain Of Atypic | 3e-06 | ||
| 2jfl_A | 325 | Crystal Structure Of Human Ste20-Like Kinase ( Diph | 3e-06 | ||
| 3ttj_A | 464 | Crystal Structure Of Jnk3 Complexed With Cc-359, A | 3e-06 | ||
| 1byg_A | 278 | Kinase Domain Of Human C-Terminal Src Kinase (Csk) | 3e-06 | ||
| 3gi3_A | 360 | Crystal Structure Of A N-Phenyl-N'-Naphthylurea Ana | 3e-06 | ||
| 2jfm_A | 325 | Crystal Structure Of Human Ste20-Like Kinase (Unlig | 3e-06 | ||
| 4dc2_A | 396 | Structure Of Pkc In Complex With A Substrate Peptid | 3e-06 | ||
| 3fzo_A | 277 | Crystal Structure Of Pyk2-Apo, Proline-Rich Tyrosin | 3e-06 | ||
| 2j51_A | 325 | Crystal Structure Of Human Ste20-Like Kinase Bound | 3e-06 | ||
| 3zh8_A | 349 | A Novel Small Molecule Apkc Inhibitor Length = 349 | 3e-06 | ||
| 3mh1_A | 360 | Mutagenesis Of P38 Map Kinase Establishes Key Roles | 3e-06 | ||
| 3a8w_A | 345 | Crystal Structure Of Pkciota Kinase Domain Length = | 3e-06 | ||
| 1jnk_A | 423 | The C-Jun N-Terminal Kinase (Jnk3s) Complexed With | 3e-06 | ||
| 4bcf_A | 331 | Structure Of Cdk9 In Complex With Cyclin T And A 2- | 3e-06 | ||
| 3oxi_A | 362 | Design And Synthesis Of Disubstituted Thiophene And | 3e-06 | ||
| 3blh_A | 331 | Crystal Structure Of Human Cdk9CYCLINT1 Length = 33 | 3e-06 | ||
| 2b1p_A | 355 | Inhibitor Complex Of Jnk3 Length = 355 | 3e-06 | ||
| 4h36_A | 356 | Crystal Structure Of Jnk3 In Complex With Atf2 Pept | 3e-06 | ||
| 1pmn_A | 364 | Crystal Structure Of Jnk3 In Complex With An Imidaz | 3e-06 | ||
| 3ptg_A | 363 | Design And Synthesis Of A Novel, Orally Efficacious | 3e-06 | ||
| 3cc6_A | 281 | Crystal Structure Of Kinase Domain Of Protein Tyros | 3e-06 | ||
| 2o0u_A | 364 | Crystal Structure Of Human Jnk3 Complexed With N-{3 | 3e-06 | ||
| 2ok1_A | 365 | Crystal Structure Of Jnk3 Bound To N-Benzyl-4-(4-(3 | 3e-06 | ||
| 2exc_X | 356 | Inhibitor Complex Of Jnk3 Length = 356 | 3e-06 | ||
| 4h1j_A | 293 | Crystal Structure Of Pyk2 With The Pyrazole 13a Len | 3e-06 | ||
| 2r9s_A | 356 | C-Jun N-Terminal Kinase 3 With 3,5-Disubstituted Qu | 3e-06 | ||
| 2w4o_A | 349 | Crystal Structure Of Human Camk4 In Complex With 4- | 3e-06 | ||
| 3mi9_A | 351 | Crystal Structure Of Hiv-1 Tat Complexed With Human | 3e-06 | ||
| 4bc6_A | 293 | Crystal Structure Of Human Serine Threonine Kinase- | 4e-06 | ||
| 3rgf_A | 405 | Crystal Structure Of Human Cdk8CYCC Length = 405 | 4e-06 | ||
| 3fi2_A | 353 | Crystal Structure Of Jnk3 With Amino-Pyrazole Inhib | 4e-06 | ||
| 3kvx_A | 364 | Jnk3 Bound To Aminopyrimidine Inhibitor, Sr-3562 Le | 4e-06 | ||
| 3enm_A | 316 | The Structure Of The Map2k Mek6 Reveals An Autoinhi | 4e-06 | ||
| 3fv8_A | 355 | Jnk3 Bound To Piperazine Amide Inhibitor, Sr2774 Le | 4e-06 | ||
| 3gc8_A | 370 | The Structure Of P38beta C162s In Complex With A Di | 4e-06 | ||
| 3gc9_A | 370 | The Structure Of P38beta C119s, C162s In Complex Wi | 4e-06 | ||
| 2j7t_A | 302 | Crystal Structure Of Human Serine Threonine Kinase- | 4e-06 | ||
| 3fi3_A | 364 | Crystal Structure Of Jnk3 With Indazole Inhibitor, | 4e-06 | ||
| 2xrw_A | 371 | Linear Binding Motifs For Jnk And For Calcineurin A | 4e-06 | ||
| 1ukh_A | 369 | Structural Basis For The Selective Inhibition Of Jn | 4e-06 | ||
| 3g2f_A | 336 | Crystal Structure Of The Kinase Domain Of Bone Morp | 4e-06 | ||
| 4bbe_A | 298 | Aminoalkylpyrimidine Inhibitor Complexes With Jak2 | 5e-06 | ||
| 3vud_A | 370 | Crystal Structure Of A Cysteine-deficient Mutant M1 | 5e-06 | ||
| 3o17_A | 370 | Crystal Structure Of Jnk1-Alpha1 Isoform Length = 3 | 5e-06 | ||
| 1vzo_A | 355 | The Structure Of The N-Terminal Kinase Domain Of Ms | 5e-06 | ||
| 3vug_A | 370 | Crystal Structure Of A Cysteine-deficient Mutant M2 | 5e-06 | ||
| 3pze_A | 358 | Jnk1 In Complex With Inhibitor Length = 358 | 5e-06 | ||
| 3mdy_A | 337 | Crystal Structure Of The Cytoplasmic Domain Of The | 5e-06 | ||
| 3elj_A | 369 | Jnk1 Complexed With A Bis-Anilino-Pyrrolopyrimidine | 5e-06 | ||
| 2xru_A | 280 | Aurora-A T288e Complexed With Pha-828300 Length = 2 | 5e-06 | ||
| 3vuh_A | 370 | Crystal Structure Of A Cysteine-deficient Mutant M3 | 5e-06 | ||
| 3vui_A | 370 | Crystal Structure Of A Cysteine-deficient Mutant M2 | 6e-06 | ||
| 3vuk_A | 370 | Crystal Structure Of A Cysteine-deficient Mutant M5 | 6e-06 | ||
| 1ol5_A | 282 | Structure Of Aurora-A 122-403, Phosphorylated On Th | 6e-06 | ||
| 2j4z_A | 306 | Structure Of Aurora-2 In Complex With Pha-680626 Le | 6e-06 | ||
| 2f2u_A | 402 | Crystal Structure Of The Rho-Kinase Kinase Domain L | 6e-06 | ||
| 3soa_A | 444 | Full-Length Human Camkii Length = 444 | 6e-06 | ||
| 2r5t_A | 373 | Crystal Structure Of Inactive Serum And Glucocortic | 6e-06 | ||
| 2bmc_A | 306 | Aurora-2 T287d T288d Complexed With Pha-680632 Leng | 7e-06 | ||
| 4f0f_A | 287 | Crystal Structure Of The Roco4 Kinase Domain Bound | 7e-06 | ||
| 1muo_A | 297 | Crystal Structure Of Aurora-2, An Oncogenic Serine- | 7e-06 | ||
| 3mfr_A | 351 | Cask-4m Cam Kinase Domain, Native Length = 351 | 7e-06 | ||
| 2v7o_A | 336 | Crystal Structure Of Human Calcium-Calmodulin-Depen | 7e-06 | ||
| 3unz_A | 279 | Aurora A In Complex With Rpm1679 Length = 279 | 7e-06 | ||
| 2j50_A | 280 | Structure Of Aurora-2 In Complex With Pha-739358 Le | 7e-06 | ||
| 4hzs_A | 341 | Crystal Structure Of Ack1 Kinase Domain With C-term | 8e-06 | ||
| 2x6d_A | 285 | Aurora-A Bound To An Inhibitor Length = 285 | 8e-06 | ||
| 2xng_A | 283 | Structure Of Aurora-A Bound To A Selective Imidazop | 8e-06 | ||
| 3nrm_A | 283 | Imidazo[1,2-A]pyrazine-Based Aurora Kinase Inhibito | 8e-06 | ||
| 3lau_A | 287 | Crystal Structure Of Aurora2 Kinase In Complex With | 8e-06 | ||
| 3fdn_A | 279 | Structure-Based Drug Design Of Novel Aurora Kinase | 8e-06 | ||
| 3zut_A | 362 | The Structure Of Ost1 (D160a) Kinase Length = 362 | 8e-06 | ||
| 2wtw_A | 285 | Aurora-A Inhibitor Structure (2nd Crystal Form) Len | 8e-06 | ||
| 3ha6_A | 268 | Crystal Structure Of Aurora A In Complex With Tpx2 | 9e-06 | ||
| 3npc_A | 364 | Crystal Structure Of Jnk2 Complexed With Birb796 Le | 9e-06 | ||
| 2g01_A | 370 | Pyrazoloquinolones As Novel, Selective Jnk1 Inhibit | 9e-06 | ||
| 2c6d_A | 275 | Aurora A Kinase Activated Mutant (T287d) In Complex | 9e-06 | ||
| 1xh9_A | 350 | Crystal Structures Of Protein Kinase B Selective In | 9e-06 | ||
| 2w1c_A | 275 | Structure Determination Of Aurora Kinase In Complex | 9e-06 | ||
| 3h0y_A | 268 | Aurora A In Complex With A Bisanilinopyrimidine Len | 9e-06 | ||
| 3e5a_A | 268 | Crystal Structure Of Aurora A In Complex With Vx-68 | 9e-06 | ||
| 2c6e_A | 283 | Aurora A Kinase Activated Mutant (T287d) In Complex | 9e-06 | ||
| 3zuu_A | 362 | The Structure Of Ost1 (D160a, S175d) Kinase In Comp | 9e-06 | ||
| 2wtv_A | 285 | Aurora-A Inhibitor Structure Length = 285 | 1e-05 | ||
| 2gnf_A | 350 | Protein Kinase A Fivefold Mutant Model Of Rho-Kinas | 1e-05 | ||
| 2gnj_A | 350 | Pka Three Fold Mutant Model Of Rho-Kinase With Y-27 | 1e-05 | ||
| 2gng_A | 350 | Protein Kinase A Fivefold Mutant Model Of Rho-Kinas | 1e-05 | ||
| 4ewh_B | 275 | Co-Crystal Structure Of Ack1 With Inhibitor Length | 1e-05 | ||
| 2wqe_A | 262 | Structure Of S155r Aurora-A Somatic Mutant Length = | 1e-05 | ||
| 3ama_A | 351 | Protein Kinase A Sixfold Mutant Model Of Aurora B W | 1e-05 | ||
| 1mq4_A | 272 | Crystal Structure Of Aurora-A Protein Kinase Length | 1e-05 | ||
| 2xs0_A | 386 | Linear Binding Motifs For Jnk And For Calcineurin A | 1e-05 | ||
| 3o50_A | 267 | Crystal Structure Of Benzamide 9 Bound To Auroraa L | 1e-05 | ||
| 3v8s_A | 410 | Human Rho-Associated Protein Kinase 1 (Rock 1) In C | 1e-05 | ||
| 2f9g_A | 353 | Crystal Structure Of Fus3 Phosphorylated On Tyr182 | 1e-05 | ||
| 2esm_A | 415 | Crystal Structure Of Rock 1 Bound To Fasudil Length | 1e-05 | ||
| 1zyc_A | 303 | Crystal Structure Of Eif2alpha Protein Kinase Gcn2: | 1e-05 | ||
| 3e7o_A | 360 | Crystal Structure Of Jnk2 Length = 360 | 1e-05 | ||
| 2w1d_A | 275 | Structure Determination Of Aurora Kinase In Complex | 1e-05 | ||
| 1u54_A | 291 | Crystal Structures Of The Phosphorylated And Unphos | 1e-05 | ||
| 2v55_A | 406 | Mechanism Of Multi-site Phosphorylation From A Rock | 1e-05 | ||
| 4hzr_A | 277 | Crystal Structure Of Ack1 Kinase Domain Length = 27 | 1e-05 | ||
| 4id7_A | 273 | Ack1 Kinase In Complex With The Inhibitor Cis-3-[8- | 1e-05 | ||
| 3qbn_A | 281 | Structure Of Human Aurora A In Complex With A Diami | 1e-05 | ||
| 1u46_A | 291 | Crystal Structure Of The Unphosphorylated Kinase Do | 1e-05 | ||
| 3r21_A | 271 | Design, Synthesis, And Biological Evaluation Of Pyr | 1e-05 | ||
| 3eqp_B | 276 | Crystal Structure Of Ack1 With Compound T95 Length | 1e-05 | ||
| 2b9h_A | 353 | Crystal Structure Of Fus3 With A Docking Motif From | 1e-05 | ||
| 1zy4_A | 303 | Crystal Structure Of Eif2alpha Protein Kinase Gcn2: | 1e-05 | ||
| 2b9f_A | 353 | Crystal Structure Of Non-Phosphorylated Fus3 Length | 1e-05 | ||
| 3f3z_A | 277 | Crystal Structure Of Cryptosporidium Parvum Calcium | 1e-05 | ||
| 2qg5_A | 294 | Cryptosporidium Parvum Calcium Dependent Protein Ki | 1e-05 | ||
| 4f1o_A | 287 | Crystal Structure Of The L1180t Mutant Roco4 Kinase | 1e-05 | ||
| 3d14_A | 272 | Crystal Structure Of Mouse Aurora A (Asn186->gly, L | 1e-05 | ||
| 3daj_A | 272 | Crystal Structure Of Aurora A Complexed With An Inh | 1e-05 | ||
| 4aw2_A | 437 | Crystal Structure Of Cdc42 Binding Protein Kinase A | 1e-05 | ||
| 2jam_A | 304 | Crystal Structure Of Human Calmodulin-Dependent Pro | 1e-05 | ||
| 1szm_A | 350 | Dual Binding Mode Of Bisindolylmaleimide 2 To Prote | 2e-05 | ||
| 2vo0_A | 351 | Structure Of Pka-Pkb Chimera Complexed With C-(4-(4 | 2e-05 | ||
| 2uvy_A | 351 | Structure Of Pka-pkb Chimera Complexed With Methyl- | 2e-05 | ||
| 1q61_A | 350 | Pka Triple Mutant Model Of Pkb Length = 350 | 2e-05 | ||
| 2jdt_A | 351 | Structure Of Pka-Pkb Chimera Complexed With Isoquin | 2e-05 | ||
| 4exu_A | 371 | Mapk13, Inactive Form Length = 371 | 2e-05 | ||
| 3l9m_A | 351 | Crystal Structure Of Pkab3 (Pka Triple Mutant V123a | 2e-05 | ||
| 2xk9_A | 322 | Structural Analysis Of Checkpoint Kinase 2 (Chk2) I | 2e-05 | ||
| 3coi_A | 353 | Crystal Structure Of P38delta Kinase Length = 353 | 2e-05 | ||
| 2dwb_A | 285 | Aurora-A Kinase Complexed With Amppnp Length = 285 | 2e-05 | ||
| 2ycr_A | 323 | Crystal Structure Of Checkpoint Kinase 2 In Complex | 2e-05 | ||
| 2ycf_A | 322 | Crystal Structure Of Checkpoint Kinase 2 In Complex | 2e-05 | ||
| 3i6w_A | 443 | Structure And Activation Mechanism Of The Chk2 Dna- | 2e-05 | ||
| 2w0j_A | 323 | Crystal Structure Of Chk2 In Complex With Nsc 10955 | 2e-05 | ||
| 4dn5_A | 356 | Crystal Structure Of Nf-kb-inducing Kinase (nik) Le | 2e-05 | ||
| 4dfx_E | 350 | Crystal Structure Of Myristoylated K7c Catalytic Su | 2e-05 | ||
| 3i6u_A | 419 | Structure And Activation Mechanism Of The Chk2 Dna- | 2e-05 | ||
| 3coh_A | 268 | Crystal Structure Of Aurora-A In Complex With A Pen | 2e-05 | ||
| 2qur_A | 350 | Crystal Structure Of F327aK285P MUTANT OF CAMP-Depe | 2e-05 | ||
| 2cn5_A | 329 | Crystal Structure Of Human Chk2 In Complex With Adp | 2e-05 | ||
| 3fhi_A | 350 | Crystal Structure Of A Complex Between The Catalyti | 2e-05 | ||
| 3qal_E | 350 | Crystal Structure Of Arg280ala Mutant Of Catalytic | 2e-05 | ||
| 4ae9_A | 343 | Structure And Function Of The Human Sperm-specific | 2e-05 | ||
| 4ae6_A | 343 | Structure And Function Of The Human Sperm-specific | 2e-05 | ||
| 1cdk_A | 350 | Camp-Dependent Protein Kinase Catalytic Subunit (E. | 2e-05 | ||
| 1cmk_E | 350 | Crystal Structures Of The Myristylated Catalytic Su | 2e-05 | ||
| 2qcs_A | 350 | A Complex Structure Between The Catalytic And Regul | 2e-05 | ||
| 1bkx_A | 350 | A Binary Complex Of The Catalytic Subunit Of Camp-D | 2e-05 | ||
| 1jbp_E | 350 | Crystal Structure Of The Catalytic Subunit Of Camp- | 2e-05 | ||
| 1l3r_E | 350 | Crystal Structure Of A Transition State Mimic Of Th | 2e-05 | ||
| 3nx8_A | 351 | Human Camp Dependent Protein Kinase In Complex With | 2e-05 | ||
| 1ctp_E | 350 | Structure Of The Mammalian Catalytic Subunit Of Cam | 2e-05 | ||
| 1apm_E | 350 | 2.0 Angstrom Refined Crystal Structure Of The Catal | 2e-05 | ||
| 1smh_A | 350 | Protein Kinase A Variant Complex With Completely Or | 2e-05 | ||
| 1q8w_A | 350 | The Catalytic Subunit Of Camp-Dependent Protein Kin | 2e-05 | ||
| 1stc_E | 350 | Camp-Dependent Protein Kinase, Alpha-Catalytic Subu | 2e-05 | ||
| 1xh7_A | 350 | Crystal Structures Of Protein Kinase B Selective In | 2e-05 | ||
| 1fmo_E | 350 | Crystal Structure Of A Polyhistidine-Tagged Recombi | 2e-05 | ||
| 2erz_E | 351 | Crystal Structure Of C-amp Dependent Kinase (pka) B | 2e-05 | ||
| 3pvb_A | 345 | Crystal Structure Of (73-244)ria:c Holoenzyme Of Ca | 2e-05 | ||
| 3agm_A | 351 | Complex Of Pka With The Bisubstrate Protein Kinase | 2e-05 | ||
| 3agl_A | 351 | Complex Of Pka With The Bisubstrate Protein Kinase | 2e-05 | ||
| 3dnd_A | 350 | Camp-Dependent Protein Kinase Pka Catalytic Subunit | 2e-05 | ||
| 2jds_A | 351 | Structure Of Camp-Dependent Protein Kinase Complexe | 2e-05 | ||
| 2c1a_A | 351 | Structure Of Camp-Dependent Protein Kinase Complexe | 2e-05 | ||
| 1svh_A | 350 | Crystal Structure Of Protein Kinase A In Complex Wi | 2e-05 | ||
| 2gu8_A | 337 | Discovery Of 2-pyrimidyl-5-amidothiophenes As Novel | 2e-05 | ||
| 1ydt_E | 350 | Structure Of Camp-Dependent Protein Kinase, Alpha-C | 3e-05 | ||
| 2qr7_A | 342 | 2.0a X-Ray Structure Of C-Terminal Kinase Domain Of | 3e-05 | ||
| 2uzt_A | 336 | Pka Structures Of Akt, Indazole-Pyridine Inhibitors | 3e-05 | ||
| 2f7e_E | 351 | Pka Complexed With (S)-2-(1h-Indol-3-Yl)-1-(5-Isoqu | 3e-05 | ||
| 4g3d_A | 371 | Crystal Structure Of Human Nf-kappab Inducing Kinas | 3e-05 | ||
| 4dg3_E | 371 | Crystal Structure Of R336a Mutant Of Camp-dependent | 3e-05 | ||
| 1zxe_A | 303 | Crystal Structure Of Eif2alpha Protein Kinase Gcn2: | 3e-05 | ||
| 1ol6_A | 282 | Structure Of Unphosphorylated D274n Mutant Of Auror | 3e-05 | ||
| 1j3h_A | 350 | Crystal Structure Of Apoenzyme Camp-Dependent Prote | 3e-05 | ||
| 3mvj_A | 371 | Human Cyclic Amp-Dependent Protein Kinase Pka Inhib | 3e-05 | ||
| 2xne_A | 272 | Structure Of Aurora-A Bound To An Imidazopyrazine I | 4e-05 | ||
| 3my0_A | 305 | Crystal Structure Of The Acvrl1 (Alk1) Kinase Domai | 4e-05 | ||
| 1yrp_A | 278 | Catalytic Domain Of Human Zip Kinase Phosphorylated | 4e-05 | ||
| 4f1m_A | 287 | Crystal Structure Of The G1179s Roco4 Kinase Domain | 4e-05 | ||
| 2wel_A | 327 | Crystal Structure Of Su6656-Bound CalciumCALMODULIN | 4e-05 | ||
| 1q24_A | 350 | Pka Double Mutant Model Of Pkb In Complex With Mgat | 4e-05 | ||
| 2vn9_A | 301 | Crystal Structure Of Human Calcium Calmodulin Depen | 4e-05 | ||
| 3p1a_A | 311 | Structure Of Human Membrane-Associated Tyrosine- An | 4e-05 | ||
| 4dfy_A | 371 | Crystal Structure Of R194a Mutant Of Camp-Dependent | 4e-05 | ||
| 3bhy_A | 283 | Crystal Structure Of Human Death Associated Protein | 4e-05 | ||
| 3rny_A | 346 | Crystal Structure Of Human Rsk1 C-Terminal Kinase D | 5e-05 | ||
| 2qr8_A | 342 | 2.0a X-ray Structure Of C-terminal Kinase Domain Of | 5e-05 | ||
| 3qfv_A | 415 | Mrck Beta In Complex With Tpca-1 Length = 415 | 5e-05 | ||
| 3tku_A | 433 | Mrck Beta In Complex With Fasudil Length = 433 | 5e-05 | ||
| 2j90_A | 304 | Crystal Structure Of Human Zip Kinase In Complex Wi | 5e-05 | ||
| 2wnt_A | 330 | Crystal Structure Of The Human Ribosomal Protein S6 | 6e-05 | ||
| 1syk_A | 350 | Crystal Structure Of E230q Mutant Of Camp-Dependent | 6e-05 | ||
| 3kk9_A | 282 | Camkii Substrate Complex B Length = 282 | 7e-05 | ||
| 3kl8_A | 269 | Camkiintide Inhibitor Complex Length = 269 | 7e-05 | ||
| 3o7l_B | 350 | Crystal Structure Of Phospholamban (1-19):pka C-Sub | 8e-05 | ||
| 3kk8_A | 284 | Camkii Substrate Complex A Length = 284 | 8e-05 | ||
| 2bdw_A | 362 | Crystal Structure Of The Auto-Inhibited Kinase Doma | 9e-05 | ||
| 2x4f_A | 373 | The Crystal Structure Of The Human Myosin Light Cha | 1e-04 | ||
| 3sdj_A | 448 | Structure Of Rnase-Inactive Point Mutant Of Oligome | 1e-04 | ||
| 3fbv_A | 448 | Crystal Structure Of The Oligomer Formed By The Kin | 1e-04 | ||
| 4g3c_A | 352 | Crystal Structure Of Apo Murine Nf-kappab Inducing | 1e-04 | ||
| 4g3f_A | 336 | Crystal Structure Of Murine Nf-kappab Inducing Kina | 1e-04 | ||
| 3qam_E | 350 | Crystal Structure Of Glu208ala Mutant Of Catalytic | 1e-04 | ||
| 4af3_A | 292 | Human Aurora B Kinase In Complex With Incenp And Vx | 1e-04 | ||
| 4g3g_A | 350 | Crystal Structure Of Murine Nf-kappab Inducing Kina | 1e-04 | ||
| 2rio_A | 434 | Structure Of The Dual Enzyme Ire1 Reveals The Basis | 2e-04 | ||
| 2xuu_A | 334 | Crystal Structure Of A Dap-Kinase 1 Mutant Length = | 2e-04 | ||
| 2bfy_A | 284 | Complex Of Aurora-B With Incenp And Hesperidin. Len | 2e-04 | ||
| 2vrx_A | 285 | Structure Of Aurora B Kinase In Complex With Zm4474 | 2e-04 | ||
| 2bfx_B | 284 | Mechanism Of Aurora-B Activation By Incenp And Inhi | 2e-04 | ||
| 1h4l_A | 292 | Structure And Regulation Of The Cdk5-P25(Nck5a) Com | 2e-04 | ||
| 3fpq_A | 290 | Crystal Structure Of The Kinase Domain Of Wnk1 Leng | 2e-04 | ||
| 1kob_A | 387 | Twitchin Kinase Fragment (Aplysia), Autoregulated P | 2e-04 | ||
| 2j0l_A | 276 | Crystal Structure Of A The Active Conformation Of T | 2e-04 | ||
| 1rdq_E | 350 | Hydrolysis Of Atp In The Crystal Of Y204a Mutant Of | 2e-04 | ||
| 1p4f_A | 293 | Death Associated Protein Kinase Catalytic Domain Wi | 3e-04 | ||
| 2p0c_A | 313 | Catalytic Domain Of The Proto-Oncogene Tyrosine-Pro | 3e-04 | ||
| 1ig1_A | 294 | 1.8a X-Ray Structure Of Ternary Complex Of A Cataly | 3e-04 | ||
| 3f5u_A | 295 | Crystal Structure Of The Death Associated Protein K | 3e-04 | ||
| 3nie_A | 429 | Crystal Structure Of Pf11_0147 Length = 429 | 3e-04 | ||
| 3dfc_B | 295 | Crystal Structure Of A Glycine-Rich Loop Mutant Of | 3e-04 | ||
| 3gu4_A | 295 | Crystal Structure Of Dapkq23v-Amppnp Length = 295 | 3e-04 | ||
| 3gu8_A | 295 | Crystal Structure Of Dapkl93g With N6-Cyclopentylad | 3e-04 | ||
| 3pg1_A | 362 | Map Kinase Lmampk10 From Leishmania Major (1.95 Ang | 3e-04 | ||
| 2h34_A | 309 | Apoenzyme Crystal Structure Of The Tuberculosis Ser | 3e-04 | ||
| 2x0g_A | 334 | X-ray Structure Of A Dap-kinase Calmodulin Complex | 3e-04 | ||
| 2yak_A | 285 | Structure Of Death-Associated Protein Kinase 1 (Dap | 4e-04 | ||
| 3uib_A | 362 | Map Kinase Lmampk10 From Leishmania Major In Comple | 4e-04 | ||
| 3lj0_A | 434 | Ire1 Complexed With Adp And Quercetin Length = 434 | 4e-04 | ||
| 2y0a_A | 326 | Structure Of Dapk1 Construct Residues 1-304 Length | 4e-04 | ||
| 3tac_A | 361 | Crystal Structure Of The Liprin-AlphaCASK COMPLEX L | 4e-04 | ||
| 2xzs_A | 312 | Death Associated Protein Kinase 1 Residues 1-312 Le | 4e-04 | ||
| 1wvw_A | 278 | Crystal Structures Of Kinase Domain Of Dap Kinase I | 4e-04 | ||
| 2w4j_A | 277 | X-Ray Structure Of A Dap-Kinase 2-277 Length = 277 | 4e-04 | ||
| 3c0g_A | 351 | Cask Cam-kinase Domain- 3'-amp Complex, P1 Form Len | 4e-04 | ||
| 2w4k_A | 302 | X-Ray Structure Of A Dap-Kinase 2-302 Length = 302 | 4e-04 | ||
| 4agu_A | 311 | Crystal Structure Of The Human Cdkl1 Kinase Domain | 4e-04 | ||
| 4ebw_A | 304 | Structure Of Focal Adhesion Kinase Catalytic Domain | 5e-04 | ||
| 3bz3_A | 276 | Crystal Structure Analysis Of Focal Adhesion Kinase | 5e-04 | ||
| 2jkm_A | 276 | Focal Adhesion Kinase Catalytic Domain In Complex W | 5e-04 | ||
| 1mp8_A | 281 | Crystal Structure Of Focal Adhesion Kinase (Fak) Le | 5e-04 | ||
| 2j0m_B | 276 | Crystal Structure A Two-Chain Complex Between The F | 5e-04 | ||
| 2etm_A | 281 | Crystal Structure Of Focal Adhesion Kinase Domain C | 5e-04 | ||
| 3pxk_A | 282 | Focal Adhesion Kinase Catalytic Domain In Complex W | 5e-04 | ||
| 1rw8_A | 301 | Crystal Structure Of Tgf-Beta Receptor I Kinase Wit | 5e-04 | ||
| 3oz6_A | 388 | Crystal Structure Of Mapk From Cryptosporidium Parv | 6e-04 | ||
| 1b6c_B | 342 | Crystal Structure Of The Cytoplasmic Domain Of The | 6e-04 | ||
| 1vjy_A | 303 | Crystal Structure Of A Naphthyridine Inhibitor Of H | 6e-04 | ||
| 3tzm_A | 309 | Tgf-Beta Receptor Type 1 In Complex With Sb431542 L | 6e-04 | ||
| 2wot_A | 306 | Alk5 In Complex With 4-((5,6-Dimethyl-2-(2-Pyridyl) | 6e-04 | ||
| 1py5_A | 326 | Crystal Structure Of Tgf-Beta Receptor I Kinase Wit | 6e-04 | ||
| 3rp9_A | 458 | Crystal Structure Of The Apo Mapk From Toxoplasma G | 8e-04 | ||
| 3say_A | 430 | Crystal Structure Of Human Glycogen Synthase Kinase | 8e-04 | ||
| 2j0j_A | 656 | Crystal Structure Of A Fragment Of Focal Adhesion K | 8e-04 | ||
| 2jkk_A | 276 | Focal Adhesion Kinase Catalytic Domain In Complex W | 9e-04 | ||
| 1ung_A | 292 | Structural Mechanism For The Inhibition Of Cdk5-P25 | 9e-04 |
| >pdb|3TL8|A Chain A, The Avrptob-Bak1 Complex Reveals Two Structurally Similar Kinaseinteracting Domains In A Single Type Iii Effector Length = 349 | Back alignment and structure |
|
| >pdb|3UIM|A Chain A, Structural Basis For The Impact Of Phosphorylation On Plant Receptor- Like Kinase Bak1 Activation Length = 326 | Back alignment and structure |
|
| >pdb|2QKW|B Chain B, Structural Basis For Activation Of Plant Immunity By Bacterial Effector Protein Avrpto Length = 321 | Back alignment and structure |
|
| >pdb|3HGK|A Chain A, Crystal Structure Of Effect Protein Avrptob Complexed With Kinase Pto Length = 327 | Back alignment and structure |
|
| >pdb|2NRY|A Chain A, Crystal Structure Of Irak-4 Length = 307 | Back alignment and structure |
|
| >pdb|2NRU|A Chain A, Crystal Structure Of Irak-4 Length = 307 | Back alignment and structure |
|
| >pdb|2OIB|A Chain A, Crystal Structure Of Irak4 Kinase Domain Apo Form Length = 301 | Back alignment and structure |
|
| >pdb|2O8Y|A Chain A, Apo Irak4 Kinase Domain Length = 298 | Back alignment and structure |
|
| >pdb|3A4O|X Chain X, Lyn Kinase Domain Length = 286 | Back alignment and structure |
|
| >pdb|3DAK|A Chain A, Crystal Structure Of Domain-Swapped Osr1 Kinase Domain Length = 290 | Back alignment and structure |
|
| >pdb|2VWI|A Chain A, Structure Of The Osr1 Kinase, A Hypertension Drug Target Length = 303 | Back alignment and structure |
|
| >pdb|2ZM1|A Chain A, Crystal Structure Of Imidazo Pyrazin 1 Bound To The Kinase Domain Of Human Lck, (Auto-Phosphorylated On Tyr394) Length = 285 | Back alignment and structure |
|
| >pdb|1QPE|A Chain A, Structural Analysis Of The Lymphocyte-Specific Kinase Lck In Complex With Non-Selective And Src Family Selective Kinase Inhibitors Length = 279 | Back alignment and structure |
|
| >pdb|3KXZ|A Chain A, The Complex Crystal Structure Of Lck With A Probe Molecule W259 Length = 287 | Back alignment and structure |
|
| >pdb|2PL0|A Chain A, Lck Bound To Imatinib Length = 289 | Back alignment and structure |
|
| >pdb|3KMM|A Chain A, Structure Of Human Lck Kinase With A Small Molecule Inhibitor Length = 288 | Back alignment and structure |
|
| >pdb|1QPD|A Chain A, Structural Analysis Of The Lymphocyte-specific Kinase Lck In Complex With Non-selective And Src Family Selective Kinase Inhibitors Length = 279 | Back alignment and structure |
|
| >pdb|1FMK|A Chain A, Crystal Structure Of Human Tyrosine-Protein Kinase C-Src Length = 452 | Back alignment and structure |
|
| >pdb|2H8H|A Chain A, Src Kinase In Complex With A Quinazoline Inhibitor Length = 535 | Back alignment and structure |
|
| >pdb|1Y57|A Chain A, Structure Of Unphosphorylated C-Src In Complex With An Inhibitor Length = 452 | Back alignment and structure |
|
| >pdb|1KSW|A Chain A, Structure Of Human C-Src Tyrosine Kinase (Thr338gly Mutant) In Complex With N6-Benzyl Adp Length = 452 | Back alignment and structure |
|
| >pdb|1YI6|A Chain A, C-Term Tail Segment Of Human Tyrosine Kinase (258-533) Length = 276 | Back alignment and structure |
|
| >pdb|3BYS|A Chain A, Co-Crystal Structure Of Lck And Aminopyrimidine Amide 10b Length = 277 | Back alignment and structure |
|
| >pdb|2OFU|A Chain A, X-Ray Crystal Structure Of 2-Aminopyrimidine Carbamate 43 Bound To Lck Length = 273 | Back alignment and structure |
|
| >pdb|2OFV|A Chain A, Crystal Structure Of Aminoquinazoline 1 Bound To Lck Length = 277 | Back alignment and structure |
|
| >pdb|3MIY|A Chain A, X-Ray Crystal Structure Of Itk Complexed With Sunitinib Length = 266 | Back alignment and structure |
|
| >pdb|3DTC|A Chain A, Crystal Structure Of Mixed-Lineage Kinase Mlk1 Complexed With Compound 16 Length = 271 | Back alignment and structure |
|
| >pdb|3BYM|A Chain A, X-Ray Co-Crystal Structure Aminobenzimidazole Triazine 1 Bound To Lck Length = 272 | Back alignment and structure |
|
| >pdb|3LCK|A Chain A, The Kinase Domain Of Human Lymphocyte Kinase (Lck), Activated Form (Auto-Phosphorylated On Tyr394) Length = 271 | Back alignment and structure |
|
| >pdb|1YOL|A Chain A, Crystal Structure Of Src Kinase Domain In Complex With Cgp77675 Length = 283 | Back alignment and structure |
|
| >pdb|2OF2|A Chain A, Crystal Structure Of Furanopyrimidine 8 Bound To Lck Length = 271 | Back alignment and structure |
|
| >pdb|2ZV7|A Chain A, Lyn Tyrosine Kinase Domain, Apo Form Length = 279 | Back alignment and structure |
|
| >pdb|3U4W|A Chain A, Src In Complex With Dna-Templated Macrocyclic Inhibitor Mc4b Length = 275 | Back alignment and structure |
|
| >pdb|2BDF|A Chain A, Src Kinase In Complex With Inhibitor Ap23451 Length = 279 | Back alignment and structure |
|
| >pdb|3DQW|A Chain A, C-Src Kinase Domain Thr338ile Mutant In Complex With Atpgs Length = 286 | Back alignment and structure |
|
| >pdb|3D7U|B Chain B, Structural Basis For The Recognition Of C-Src By Its Inactivator Csk Length = 277 | Back alignment and structure |
|
| >pdb|1YOJ|A Chain A, Crystal Structure Of Src Kinase Domain Length = 283 | Back alignment and structure |
|
| >pdb|3OEZ|A Chain A, Crystal Structure Of The L317i Mutant Of The Chicken C-Src Tyrosine Kinase Domain Complexed With Imatinib Length = 286 | Back alignment and structure |
|
| >pdb|2HWO|A Chain A, Crystal Structure Of Src Kinase Domain In Complex With Covalent Inhibitor Length = 286 | Back alignment and structure |
|
| >pdb|3SVV|A Chain A, Crystal Structure Of T338c C-Src Covalently Bound To Vinylsulfonamide- Pyrazolopyrimidine 9 Length = 286 | Back alignment and structure |
|
| >pdb|2OIQ|A Chain A, Crystal Structure Of Chicken C-Src Kinase Domain In Complex With The Cancer Drug Imatinib. Length = 286 | Back alignment and structure |
|
| >pdb|3G6H|A Chain A, Src Thr338ile Inhibited In The Dfg-Asp-Out Conformation Length = 286 | Back alignment and structure |
|
| >pdb|2QQ7|A Chain A, Crystal Structure Of Drug Resistant Src Kinase Domain With Irreversible Inhibitor Length = 286 | Back alignment and structure |
|
| >pdb|2OG8|A Chain A, Crystal Structure Of Aminoquinazoline 36 Bound To Lck Length = 265 | Back alignment and structure |
|
| >pdb|1SM2|A Chain A, Crystal Structure Of The Phosphorylated Interleukin-2 Tyrosine Kinase Catalytic Domain Length = 264 | Back alignment and structure |
|
| >pdb|2PTK|A Chain A, Chicken Src Tyrosine Kinase Length = 453 | Back alignment and structure |
|
| >pdb|3V5J|A Chain A, Crystal Structure Of Interleukin-2 Inducible T-Cell Kinase Itk Catalytic Domain With Thienopyrazolylindole Inhibitor 090 Length = 266 | Back alignment and structure |
|
| >pdb|3T9T|A Chain A, Crystal Structure Of Btk Mutant (F435t,K596r) Complexed With Imidazo[1,5-A]quinoxaline Length = 267 | Back alignment and structure |
|
| >pdb|4HCT|A Chain A, Crystal Structure Of Itk In Complex With Compound 52 Length = 269 | Back alignment and structure |
|
| >pdb|3GEQ|A Chain A, Structural Basis For The Chemical Rescue Of Src Kinase Activity Length = 286 | Back alignment and structure |
|
| >pdb|3QGW|A Chain A, Crystal Structure Of Itk Kinase Bound To An Inhibitor Length = 286 | Back alignment and structure |
|
| >pdb|2DQ7|X Chain X, Crystal Structure Of Fyn Kinase Domain Complexed With Staurosporine Length = 283 | Back alignment and structure |
|
| >pdb|3IGO|A Chain A, Crystal Structure Of Cryptosporidium Parvum Cdpk1, Cgd3_920 Length = 486 | Back alignment and structure |
|
| >pdb|3DFA|A Chain A, Crystal Structure Of Kinase Domain Of Calcium-dependent Protein Kinase Cgd3_920 From Cryptosporidium Parvum Length = 286 | Back alignment and structure |
|
| >pdb|2WEI|A Chain A, Crystal Structure Of The Kinase Domain Of Cryptosporidium Parvum Calcium Dependent Protein Kinase In Complex With 3- Mb-Pp1 Length = 287 | Back alignment and structure |
|
| >pdb|3MPM|A Chain A, Lck Complexed With A Pyrazolopyrimidine Length = 267 | Back alignment and structure |
|
| >pdb|2EVA|A Chain A, Structural Basis For The Interaction Of Tak1 Kinase With Its Activating Protein Tab1 Length = 307 | Back alignment and structure |
|
| >pdb|4GS6|A Chain A, Irreversible Inhibition Of Tak1 Kinase By 5z-7-oxozeaenol Length = 315 | Back alignment and structure |
|
| >pdb|3C4X|A Chain A, Crystal Structure Of G Protein Coupled Receptor Kinase 1 Bound To Atp And Magnesium Chloride At 2.9a Length = 543 | Back alignment and structure |
|
| >pdb|3T8O|A Chain A, Rhodopsin Kinase (grk1) L166k Mutant At 2.5a Resolution Length = 543 | Back alignment and structure |
|
| >pdb|3C4W|A Chain A, Crystal Structure Of G Protein Coupled Receptor Kinase 1 Bound To Atp And Magnesium Chloride At 2.7a Length = 543 | Back alignment and structure |
|
| >pdb|3QC9|A Chain A, Crystal Structure Of Cross-Linked Bovine Grk1 T8cN480C DOUBLE MUTANT Complexed With Adp And Mg Length = 543 | Back alignment and structure |
|
| >pdb|4A4X|A Chain A, Nek2-Ede Bound To Cct248662 Length = 279 | Back alignment and structure |
|
| >pdb|2QOK|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f:y602f:s768a Triple Mutant Length = 373 | Back alignment and structure |
|
| >pdb|3COK|A Chain A, Crystal Structure Of Plk4 Kinase Length = 278 | Back alignment and structure |
|
| >pdb|2QON|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f:y602f:y742a Triple Mutant Length = 373 | Back alignment and structure |
|
| >pdb|3PPZ|A Chain A, Crystal Structure Of Ctr1 Kinase Domain In Complex With Staurosporine Length = 309 | Back alignment and structure |
|
| >pdb|2GSF|A Chain A, The Human Epha3 Receptor Tyrosine Kinase And Juxtamembrane Region Length = 373 | Back alignment and structure |
|
| >pdb|3FXX|A Chain A, Human Epha3 Kinase And Juxtamembrane Region Bound To Substrate Kqwdnye[ptyr]iw Length = 371 | Back alignment and structure |
|
| >pdb|3DZQ|A Chain A, Human Epha3 Kinase Domain In Complex With Inhibitor Awl-Ii- 38.3 Length = 361 | Back alignment and structure |
|
| >pdb|2QOF|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f Mutant Length = 373 | Back alignment and structure |
|
| >pdb|2QOD|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y602f Mutant Length = 373 | Back alignment and structure |
|
| >pdb|2QO7|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Dephosphorylated, Amp-Pnp Bound Length = 373 | Back alignment and structure |
|
| >pdb|2QOO|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f:y602f:y742f Triple Mutant Length = 373 | Back alignment and structure |
|
| >pdb|2QOB|A Chain A, Human Epha3 Kinase Domain, Base Structure Length = 344 | Back alignment and structure |
|
| >pdb|2QOL|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596:y602:s768g Triple Mutant Length = 373 | Back alignment and structure |
|
| >pdb|2QOI|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f:y602f Double Mutant Length = 373 | Back alignment and structure |
|
| >pdb|2QOC|A Chain A, Human Epha3 Kinase Domain, Phosphorylated, Amp-Pnp Bound Structure Length = 344 | Back alignment and structure |
|
| >pdb|2W5A|A Chain A, Human Nek2 Kinase Adp-Bound Length = 279 | Back alignment and structure |
|
| >pdb|2HK5|A Chain A, Hck Kinase In Complex With Lck Targetted Inhibitor Pg- 1009247 Length = 270 | Back alignment and structure |
|
| >pdb|2JAV|A Chain A, Human Kinase With Pyrrole-Indolinone Ligand Length = 279 | Back alignment and structure |
|
| >pdb|3S95|A Chain A, Crystal Structure Of The Human Limk1 Kinase Domain In Complex With Staurosporine Length = 310 | Back alignment and structure |
|
| >pdb|1QCF|A Chain A, Crystal Structure Of Hck In Complex With A Src Family- Selective Tyrosine Kinase Inhibitor Length = 454 | Back alignment and structure |
|
| >pdb|1MQB|A Chain A, Crystal Structure Of Ephrin A2 (Epha2) Receptor Protein Kinase Length = 333 | Back alignment and structure |
|
| >pdb|3Q6W|A Chain A, Structure Of Dually-phosphorylated Met Receptor Kinase In Complex With An Mk-2461 Analog With Specificity For The Activated Receptor Length = 307 | Back alignment and structure |
|
| >pdb|2C30|A Chain A, Crystal Structure Of The Human P21-Activated Kinase 6 Length = 321 | Back alignment and structure |
|
| >pdb|2HEL|A Chain A, Crystal Structure Of A Mutant Epha4 Kinase Domain (Y742a) Length = 306 | Back alignment and structure |
|
| >pdb|2WD1|A Chain A, Human C-Met Kinase In Complex With Azaindole Inhibitor Length = 292 | Back alignment and structure |
|
| >pdb|2RFN|A Chain A, X-ray Structure Of C-met With Inhibitor. Length = 310 | Back alignment and structure |
|
| >pdb|4GG5|A Chain A, Crystal Structure Of Cmet In Complex With Novel Inhibitor Length = 319 | Back alignment and structure |
|
| >pdb|3Q6U|A Chain A, Structure Of The Apo Met Receptor Kinase In The Dually-Phosphorylated, Activated State Length = 308 | Back alignment and structure |
|
| >pdb|3I5N|A Chain A, Crystal Structure Of C-Met With Triazolopyridazine Inhibitor 13 Length = 309 | Back alignment and structure |
|
| >pdb|3LQ8|A Chain A, Structure Of The Kinase Domain Of C-Met Bound To Xl880 (Gsk1 Length = 302 | Back alignment and structure |
|
| >pdb|2FB8|A Chain A, Structure Of The B-Raf Kinase Domain Bound To Sb-590885 Length = 281 | Back alignment and structure |
|
| >pdb|3F66|A Chain A, Human C-Met Kinase In Complex With Quinoxaline Inhibitor Length = 298 | Back alignment and structure |
|
| >pdb|1UWH|A Chain A, The Complex Of Wild Type B-Raf And Bay439006 Length = 276 | Back alignment and structure |
|
| >pdb|4EQM|A Chain A, Structural Analysis Of Staphylococcus Aureus SerineTHREONINE KINASE Pknb Length = 294 | Back alignment and structure |
|
| >pdb|4DBN|A Chain A, Crystal Structure Of The Kinase Domain Of Human B-Raf With A [1, 3]thiazolo[5,4-B]pyridine Derivative Length = 284 | Back alignment and structure |
|
| >pdb|4H58|A Chain A, Braf In Complex With Compound 3 Length = 275 | Back alignment and structure |
|
| >pdb|2G15|A Chain A, Structural Characterization Of Autoinhibited C-Met Kinase Length = 318 | Back alignment and structure |
|
| >pdb|3CTH|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of The Hepatocyte Growth Factor Receptor C-Met In Complex With A Aminopyridine Based Inhibitor Length = 314 | Back alignment and structure |
|
| >pdb|3Q96|A Chain A, B-Raf Kinase Domain In Complex With A Tetrahydronaphthalene Inhibitor Length = 282 | Back alignment and structure |
|
| >pdb|2WGJ|A Chain A, X-Ray Structure Of Pf-02341066 Bound To The Kinase Domain Of C-Met Length = 306 | Back alignment and structure |
|
| >pdb|1R0P|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of The Hepatocyte Growth Factor Receptor C-Met In Complex With The Microbial Alkaloid K-252a Length = 312 | Back alignment and structure |
|
| >pdb|3P86|A Chain A, Crystal Structure Of Ctr1 Kinase Domain Mutant D676n In Complex With Staurosporine Length = 309 | Back alignment and structure |
|
| >pdb|3QTI|A Chain A, C-Met Kinase In Complex With Nvp-Bvu972 Length = 314 | Back alignment and structure |
|
| >pdb|3DKC|A Chain A, Sgx Clone 5698a65kfg1h1 Length = 317 | Back alignment and structure |
|
| >pdb|3BBT|B Chain B, Crystal Structure Of The Erbb4 Kinase In Complex With Lapatinib Length = 328 | Back alignment and structure |
|
| >pdb|3A4P|A Chain A, Human C-Met Kinase Domain Complexed With 6-Benzyloxyquinoline Inhibitor Length = 319 | Back alignment and structure |
|
| >pdb|3II5|A Chain A, The Complex Of Wild-Type B-Raf With Pyrazolo Pyrimidine Inhibitor Length = 306 | Back alignment and structure |
|
| >pdb|3D4Q|A Chain A, Pyrazole-Based Inhibitors Of B-Raf Kinase Length = 307 | Back alignment and structure |
|
| >pdb|3DKG|A Chain A, Sgx Clone 5698a109kfg1h1 Length = 317 | Back alignment and structure |
|
| >pdb|3C1X|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of The Hepatocyte Growth Factor Receptor C-Met In Complex With A Pyrrolotriazine Based Inhibitor Length = 373 | Back alignment and structure |
|
| >pdb|2R4B|A Chain A, Erbb4 Kinase Domain Complexed With A Thienopyrimidine Inhibitor Length = 321 | Back alignment and structure |
|
| >pdb|2Y6M|A Chain A, Crystal Structure Of Epha4 Kinase Domain Length = 291 | Back alignment and structure |
|
| >pdb|2XYU|A Chain A, Crystal Structure Of Epha4 Kinase Domain In Complex With Vuf 12058 Length = 285 | Back alignment and structure |
|
| >pdb|3I79|A Chain A, Calcium-Dependent Protein Kinase 1 From Toxoplasma Gondii (Tgcdpk1) Length = 484 | Back alignment and structure |
|
| >pdb|3KU2|A Chain A, Crystal Structure Of Inactivated Form Of Cdpk1 From Toxoplasma Gondii, Tgme49.101440 Length = 507 | Back alignment and structure |
|
| >pdb|3PWY|A Chain A, Crystal Structure Of An Extender (Spd28345)-Modified Human Pdk1 Complex 2 Length = 311 | Back alignment and structure |
|
| >pdb|3HX4|A Chain A, Crystal Structure Of Cdpk1 Of Toxoplasma Gondii, Tgme49_101440, In Presence Of Calcium Length = 508 | Back alignment and structure |
|
| >pdb|3MA6|A Chain A, Crystal Structure Of Kinase Domain Of Tgcdpk1 In Presence Of 3brb-Pp1 Length = 298 | Back alignment and structure |
|
| >pdb|3IDP|A Chain A, B-Raf V600e Kinase Domain In Complex With An Aminoisoquinoline Inhibitor Length = 300 | Back alignment and structure |
|
| >pdb|3F69|A Chain A, Crystal Structure Of The Mycobacterium Tuberculosis Pknb Mutant Kinase Domain In Complex With Kt5720 Length = 311 | Back alignment and structure |
|
| >pdb|2JED|A Chain A, The Crystal Structure Of The Kinase Domain Of The Protein Kinase C Theta In Complex With Nvp-Xaa228 At 2.32a Resolution. Length = 352 | Back alignment and structure |
|
| >pdb|1UWJ|A Chain A, The Complex Of Mutant V599e B-raf And Bay439006 Length = 276 | Back alignment and structure |
|
| >pdb|4G9R|A Chain A, B-Raf V600e Kinase Domain Bound To A Type Ii Dihydroquinazoline Inhibitor Length = 307 | Back alignment and structure |
|
| >pdb|3ORM|A Chain A, Mycobacterium Tuberculosis Pknb Kinase Domain D76a Mutant Length = 311 | Back alignment and structure |
|
| >pdb|3ORI|A Chain A, Mycobacterium Tuberculosis Pknb Kinase Domain L33d Mutant (Crystal Form 1) Length = 311 | Back alignment and structure |
|
| >pdb|3F61|A Chain A, Crystal Structure Of M. Tuberculosis Pknb Leu33aspVAL222ASP DOUBLE MUTANT IN COMPLEX WITH ADP Length = 311 | Back alignment and structure |
|
| >pdb|1MRU|A Chain A, Intracellular SerTHR PROTEIN KINASE DOMAIN OF Mycobacterium Tuberculosis Pknb. Length = 311 | Back alignment and structure |
|
| >pdb|2R2P|A Chain A, Kinase Domain Of Human Ephrin Type-A Receptor 5 (Epha5) Length = 295 | Back alignment and structure |
|
| >pdb|3I7C|A Chain A, Calcium-Dependent Protein Kinase 1 From Toxoplasma Gondii (Tgcdpk1) In Complex With Bumped Kinase Inhibitor Na-Pp2 Length = 484 | Back alignment and structure |
|
| >pdb|2XIK|A Chain A, Structure Of Human Ysk1 (Yeast Sps1-Ste20-Related Kinase 1) Length = 294 | Back alignment and structure |
|
| >pdb|1XJD|A Chain A, Crystal Structure Of Pkc-Theta Complexed With Staurosporine At 2a Resolution Length = 345 | Back alignment and structure |
|
| >pdb|3CKW|A Chain A, Crystal Structure Of Sterile 20-Like Kinase 3 (Mst3, Stk24) Length = 304 | Back alignment and structure |
|
| >pdb|3LIJ|A Chain A, Crystal Structure Of Full Length Cpcdpk3 (Cgd5_820) In Complex With Ca2+ And Amppnp Length = 494 | Back alignment and structure |
|
| >pdb|3GGF|A Chain A, Crystal Structure Of Human SerineTHREONINE-Protein Kinase Mst4 In Complex With An Quinazolin Length = 301 | Back alignment and structure |
|
| >pdb|3D5U|A Chain A, Crystal Structure Of A Wildtype Polo-Like Kinase 1 (Plk1) Catalytic Domain Length = 317 | Back alignment and structure |
|
| >pdb|1O6Y|A Chain A, Catalytic Domain Of Pknb Kinase From Mycobacterium Tuberculosis Length = 299 | Back alignment and structure |
|
| >pdb|3D5W|A Chain A, Crystal Structure Of A Phosphorylated Polo-Like Kinase 1 (Plk1) Catalytic Domain In Complex With Adp Length = 317 | Back alignment and structure |
|
| >pdb|3ZHP|C Chain C, Human Mst3 (stk24) In Complex With Mo25beta Length = 294 | Back alignment and structure |
|
| >pdb|1H1W|A Chain A, High Resolution Crystal Structure Of The Human Pdk1 Catalytic Domain Length = 289 | Back alignment and structure |
|
| >pdb|3D5V|A Chain A, Crystal Structure Of An Activated (Thr->asp) Polo-Like Kinase 1 (Plk1) Catalytic Domain. Length = 317 | Back alignment and structure |
|
| >pdb|1UU9|A Chain A, Structure Of Human Pdk1 Kinase Domain In Complex With Bim-3 Length = 286 | Back alignment and structure |
|
| >pdb|1RJB|A Chain A, Crystal Structure Of Flt3 Length = 344 | Back alignment and structure |
|
| >pdb|1Z5M|A Chain A, Crystal Structure Of N1-[3-[[5-bromo-2-[[3-[(1-pyrrolidinylcarbonyl) Amino]phenyl]amino]-4-pyrimidinyl]amino]propyl]-2,2- Dimethylpropanediamide Complexed With Human Pdk1 Length = 286 | Back alignment and structure |
|
| >pdb|3DB6|A Chain A, Crystal Structure Of An Activated (Thr->asp) Polo-Like Kinase 1 (Plk1) Catalytic Domain In Complex With Compound 902 Length = 301 | Back alignment and structure |
|
| >pdb|3NUS|A Chain A, Phosphoinositide-Dependent Kinase-1 (Pdk1) With Fragment8 Length = 286 | Back alignment and structure |
|
| >pdb|2XCK|A Chain A, Crystal Structure Of Pdk1 In Complex With A Pyrazoloquinazoline Inhibitor Length = 309 | Back alignment and structure |
|
| >pdb|1UU3|A Chain A, Structure Of Human Pdk1 Kinase Domain In Complex With Ly333531 Length = 310 | Back alignment and structure |
|
| >pdb|3ORX|A Chain A, Pdk1 Mutant Bound To Allosteric Disulfide Fragment Inhibitor 1f8 Length = 316 | Back alignment and structure |
|
| >pdb|3IOP|A Chain A, Pdk-1 In Complex With The Inhibitor Compound-8i Length = 312 | Back alignment and structure |
|
| >pdb|3RWP|A Chain A, Discovery Of A Novel, Potent And Selective Inhibitor Of 3- Phosphoinositide Dependent Kinase (Pdk1) Length = 311 | Back alignment and structure |
|
| >pdb|2XCH|A Chain A, Crystal Structure Of Pdk1 In Complex With A Pyrazoloquinazoline Inhibitor Length = 309 | Back alignment and structure |
|
| >pdb|3HRC|A Chain A, Crystal Structure Of A Mutant Of Human Pdk1 Kinase Domain In Complex With Atp Length = 311 | Back alignment and structure |
|
| >pdb|2R7B|A Chain A, Crystal Structure Of The Phosphoinositide-Dependent Kinase- 1 (Pdk-1)catalytic Domain Bound To A Dibenzonaphthyridine Inhibitor Length = 312 | Back alignment and structure |
|
| >pdb|2BIY|A Chain A, Structure Of Pdk1-S241a Mutant Kinase Domain Length = 310 | Back alignment and structure |
|
| >pdb|3H9O|A Chain A, Phosphoinositide-Dependent Protein Kinase 1 (Pdk-1) In Complex With Compound 9 Length = 311 | Back alignment and structure |
|
| >pdb|3SC1|A Chain A, Novel Isoquinolone Pdk1 Inhibitors Discovered Through Fragment-Based Lead Discovery Length = 311 | Back alignment and structure |
|
| >pdb|3QC4|A Chain A, Pdk1 In Complex With Dfg-Out Inhibitor Xxx Length = 314 | Back alignment and structure |
|
| >pdb|3NUN|A Chain A, Phosphoinositide-Dependent Kinase-1 (Pdk1) With Lead Compound Length = 292 | Back alignment and structure |
|
| >pdb|3KUL|B Chain B, Kinase Domain Of Human Ephrin Type-A Receptor 8 (Epha8) Length = 325 | Back alignment and structure |
|
| >pdb|3Q4T|A Chain A, Crystal Structure Of Activin Receptor Type-Iia (Acvr2a) Kinase Domain In Complex With Dorsomorphin Length = 322 | Back alignment and structure |
|
| >pdb|1U5Q|A Chain A, Crystal Structure Of The Tao2 Kinase Domain: Activation And Specifity Of A Ste20p Map3k Length = 348 | Back alignment and structure |
|
| >pdb|4A07|A Chain A, Human Pdk1 Kinase Domain In Complex With Allosteric Activator Ps171 Bound To The Pif-Pocket Length = 311 | Back alignment and structure |
|
| >pdb|3NAY|A Chain A, Pdk1 In Complex With Inhibitor Mp6 Length = 311 | Back alignment and structure |
|
| >pdb|2GCD|A Chain A, Tao2 Kinase Domain-Staurosporine Structure Length = 309 | Back alignment and structure |
|
| >pdb|3OMV|A Chain A, Crystal Structure Of C-Raf (Raf-1) Length = 307 | Back alignment and structure |
|
| >pdb|3NAX|A Chain A, Pdk1 In Complex With Inhibitor Mp7 Length = 311 | Back alignment and structure |
|
| >pdb|1AD5|A Chain A, Src Family Kinase Hck-Amp-Pnp Complex Length = 438 | Back alignment and structure |
|
| >pdb|3KUL|A Chain A, Kinase Domain Of Human Ephrin Type-A Receptor 8 (Epha8) Length = 325 | Back alignment and structure |
|
| >pdb|2E9V|A Chain A, Structure Of H-Chk1 Complexed With A859017 Length = 268 | Back alignment and structure |
|
| >pdb|2GHG|A Chain A, H-Chk1 Complexed With A431994 Length = 269 | Back alignment and structure |
|
| >pdb|4FSM|A Chain A, Crystal Structure Of The Chk1 Length = 279 | Back alignment and structure |
|
| >pdb|2R0U|A Chain A, Crystal Structure Of Chek1 In Complex With Inhibitor 54 Length = 323 | Back alignment and structure |
|
| >pdb|4FSN|A Chain A, Crystal Structure Of The Chk1 Length = 278 | Back alignment and structure |
|
| >pdb|2AYP|A Chain A, Crystal Structure Of Chk1 With An Indol Inhibitor Length = 269 | Back alignment and structure |
|
| >pdb|2HOG|A Chain A, Crystal Structure Of Chek1 In Complex With Inhibitor 20 Length = 322 | Back alignment and structure |
|
| >pdb|1ZYS|A Chain A, Co-Crystal Structure Of Checkpoint Kinase Chk1 With A Pyrrolo-Pyridine Inhibitor Length = 273 | Back alignment and structure |
|
| >pdb|4FSU|A Chain A, Crystal Structure Of The Chk1 Length = 279 | Back alignment and structure |
|
| >pdb|3JVR|A Chain A, Characterization Of The Chk1 Allosteric Inhibitor Binding Site Length = 271 | Back alignment and structure |
|
| >pdb|4FSY|A Chain A, Crystal Structure Of The Chk1 Length = 279 | Back alignment and structure |
|
| >pdb|2X8E|A Chain A, Discovery Of A Novel Class Of Triazolones As Checkpoint Kinase Inhibitors - Hit To Lead Exploration Length = 276 | Back alignment and structure |
|
| >pdb|3OT3|A Chain A, X-Ray Crystal Structure Of Compound 22k Bound To Human Chk1 Kinase Domain Length = 273 | Back alignment and structure |
|
| >pdb|3FXZ|A Chain A, Crystal Structure Of Pak1 Kinase Domain With Ruthenium Complex Lambda-Fl172 Length = 297 | Back alignment and structure |
|
| >pdb|2BR1|A Chain A, Structure-Based Design Of Novel Chk1 Inhibitors: Insights Into Hydrogen Bonding And Protein-Ligand Affinity Length = 297 | Back alignment and structure |
|
| >pdb|1IA8|A Chain A, The 1.7 A Crystal Structure Of Human Cell Cycle Checkpoint Kinase Chk1 Length = 289 | Back alignment and structure |
|
| >pdb|1ZLT|A Chain A, Crystal Structure Of Chk1 Complexed With A Hymenaldisine Analog Length = 295 | Back alignment and structure |
|
| >pdb|4FST|A Chain A, Crystal Structure Of The Chk1 Length = 269 | Back alignment and structure |
|
| >pdb|2QLU|A Chain A, Crystal Structure Of Activin Receptor Type Ii Kinase Domain From Human Length = 314 | Back alignment and structure |
|
| >pdb|4FSW|A Chain A, Crystal Structure Of The Chk1 Length = 279 | Back alignment and structure |
|
| >pdb|3C4C|A Chain A, B-Raf Kinase In Complex With Plx4720 Length = 280 | Back alignment and structure |
|
| >pdb|4FT3|A Chain A, Crystal Structure Of The Chk1 Length = 279 | Back alignment and structure |
|
| >pdb|4FSZ|A Chain A, Crystal Structure Of The Chk1 Length = 279 | Back alignment and structure |
|
| >pdb|3A7F|A Chain A, Human Mst3 Kinase Length = 303 | Back alignment and structure |
|
| >pdb|3CKX|A Chain A, Crystal Structure Of Sterile 20-Like Kinase 3 (Mst3, Stk24) In Complex With Staurosporine Length = 304 | Back alignment and structure |
|
| >pdb|1YHV|A Chain A, Crystal Structure Of Pak1 Kinase Domain With Two Point Mutations (K299r, T423e) Length = 297 | Back alignment and structure |
|
| >pdb|2ZV2|A Chain A, Crystal Structure Of Human CalciumCALMODULIN-Dependent Protein Kinase Kinase 2, Beta, Camkk2 Kinase Domain In Complex With Sto-609 Length = 298 | Back alignment and structure |
|
| >pdb|3PLS|A Chain A, Ron In Complex With Ligand Amp-Pnp Length = 298 | Back alignment and structure |
|
| >pdb|2YDJ|A Chain A, Discovery Of Checkpoint Kinase Inhibitor Azd7762 By Structure Based Design And Optimization Of Thiophene Carboxamide Ureas Length = 276 | Back alignment and structure |
|
| >pdb|4FNZ|A Chain A, Crystal Structure Of Human Anaplastic Lymphoma Kinase In Complex With Piperidine-Carboxamide Inhibitor 2 Length = 327 | Back alignment and structure |
|
| >pdb|4FOB|A Chain A, Crystal Structure Of Human Anaplastic Lymphoma Kinase In Complex With Acyliminobenzimidazole Inhibitor 1 Length = 353 | Back alignment and structure |
|
| >pdb|4DCE|A Chain A, Crystal Structure Of Human Anaplastic Lymphoma Kinase In Complex With A Piperidine-Carboxamide Inhibitor Length = 333 | Back alignment and structure |
|
| >pdb|2YFX|A Chain A, Structure Of L1196m Mutant Anaplastic Lymphoma Kinase In Complex With Crizotinib Length = 327 | Back alignment and structure |
|
| >pdb|2YHV|A Chain A, Structure Of L1196m Mutant Anaplastic Lymphoma Kinase Length = 342 | Back alignment and structure |
|
| >pdb|2Y4I|C Chain C, Ksr2-Mek1 Heterodimer Length = 395 | Back alignment and structure |
|
| >pdb|2XP2|A Chain A, Structure Of The Human Anaplastic Lymphoma Kinase In Complex With Crizotinib (Pf-02341066) Length = 327 | Back alignment and structure |
|
| >pdb|3AOX|A Chain A, X-Ray Crystal Structure Of Human Anaplastic Lymphoma Kinase In Complex With Ch5424802 Length = 344 | Back alignment and structure |
|
| >pdb|1F3M|C Chain C, Crystal Structure Of Human SerineTHREONINE KINASE PAK1 Length = 297 | Back alignment and structure |
|
| >pdb|3PP0|A Chain A, Crystal Structure Of The Kinase Domain Of Human Her2 (Erbb2). Length = 338 | Back alignment and structure |
|
| >pdb|3Q52|A Chain A, Structure Of Phosphorylated Pak1 Kinase Domain Length = 306 | Back alignment and structure |
|
| >pdb|2ITN|A Chain A, Crystal Structure Of Egfr Kinase Domain G719s Mutation In Complex With Amp-Pnp Length = 327 | Back alignment and structure |
|
| >pdb|4FK3|A Chain A, B-Raf Kinase V600e Oncogenic Mutant In Complex With Plx3203 Length = 292 | Back alignment and structure |
|
| >pdb|3OG7|A Chain A, B-Raf Kinase V600e Oncogenic Mutant In Complex With Plx4032 Length = 289 | Back alignment and structure |
|
| >pdb|2PML|X Chain X, Crystal Structure Of Pfpk7 In Complex With An Atp Analogue Length = 348 | Back alignment and structure |
|
| >pdb|2P55|A Chain A, X-Ray Structure Of The Human Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In A Complex With Ligand And Mgatp Length = 333 | Back alignment and structure |
|
| >pdb|1M14|A Chain A, Tyrosine Kinase Domain From Epidermal Growth Factor Receptor Length = 333 | Back alignment and structure |
|
| >pdb|3ALN|A Chain A, Crystal Structure Of Human Non-Phosphorylated Mkk4 Kinase Domain Complexed With Amp-Pnp Length = 327 | Back alignment and structure |
|
| >pdb|3BEL|A Chain A, X-Ray Structure Of Egfr In Complex With Oxime Inhibitor Length = 315 | Back alignment and structure |
|
| >pdb|2RFD|A Chain A, Crystal Structure Of The Complex Between The Egfr Kinase Domain And A Mig6 Peptide Length = 324 | Back alignment and structure |
|
| >pdb|3LZB|A Chain A, Egfr Kinase Domain Complexed With An Imidazo[2,1-B]thiazole Inhibitor Length = 327 | Back alignment and structure |
|
| >pdb|3L9P|A Chain A, Crystal Structure Of The Anaplastic Lymphoma Kinase Catalytic Domain Length = 367 | Back alignment and structure |
|
| >pdb|2JIU|A Chain A, Crystal Structure Of Egfr Kinase Domain T790m Mutation In Complex With Aee788 Length = 328 | Back alignment and structure |
|
| >pdb|2JIV|A Chain A, Crystal Structure Of Egfr Kinase Domain T790m Mutation In Compex With Hki-272 Length = 328 | Back alignment and structure |
|
| >pdb|4FNW|A Chain A, Crystal Structure Of The Apo F1174l Anaplastic Lymphoma Kinase Catalytic Domain Length = 327 | Back alignment and structure |
|
| >pdb|3LCT|A Chain A, Crystal Structure Of The Anaplastic Lymphoma Kinase Catalytic Domain Length = 344 | Back alignment and structure |
|
| >pdb|2XB7|A Chain A, Structure Of Human Anaplastic Lymphoma Kinase In Complex With Nvp- Tae684 Length = 315 | Back alignment and structure |
|
| >pdb|2J5F|A Chain A, Crystal Structure Of Egfr Kinase Domain In Complex With An Irreversible Inhibitor 34-Jab Length = 327 | Back alignment and structure |
|
| >pdb|4HJO|A Chain A, Crystal Structure Of The Inactive Egfr Tyrosine Kinase Domain With Erlotinib Length = 337 | Back alignment and structure |
|
| >pdb|4G5J|A Chain A, Crystal Structure Of Egfr Kinase In Complex With Bibw2992 Length = 330 | Back alignment and structure |
|
| >pdb|3GOP|A Chain A, Crystal Structure Of The Egf Receptor Juxtamembrane And Kinase Domains Length = 361 | Back alignment and structure |
|
| >pdb|2JIT|A Chain A, Crystal Structure Of Egfr Kinase Domain T790m Mutation Length = 327 | Back alignment and structure |
|
| >pdb|2J5E|A Chain A, Crystal Structure Of Egfr Kinase Domain In Complex With An Irreversible Inhibitor 13-Jab Length = 327 | Back alignment and structure |
|
| >pdb|1S9J|A Chain A, X-Ray Structure Of The Human Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In A Complex With Ligand And Mgatp Length = 341 | Back alignment and structure |
|
| >pdb|3IKA|A Chain A, Crystal Structure Of Egfr 696-1022 T790m Mutant Covalently Binding To Wz4002 Length = 331 | Back alignment and structure |
|
| >pdb|4I24|A Chain A, Structure Of T790m Egfr Kinase Domain Co-crystallized With Dacomitinib Length = 329 | Back alignment and structure |
|
| >pdb|4I23|A Chain A, Crystal Structure Of The Wild-type Egfr Kinase Domain In Complex With Dacomitinib (soaked) Length = 329 | Back alignment and structure |
|
| >pdb|4G5P|A Chain A, Crystal Structure Of Egfr Kinase T790m In Complex With Bibw2992 Length = 330 | Back alignment and structure |
|
| >pdb|2GS2|A Chain A, Crystal Structure Of The Active Egfr Kinase Domain Length = 330 | Back alignment and structure |
|
| >pdb|1XKK|A Chain A, Egfr Kinase Domain Complexed With A Quinazoline Inhibitor- Gw572016 Length = 352 | Back alignment and structure |
|
| >pdb|2YAC|A Chain A, Crystal Structure Of Polo-Like Kinase 1 In Complex With Nms-P937 Length = 311 | Back alignment and structure |
|
| >pdb|2GS7|A Chain A, Crystal Structure Of The Inactive Egfr Kinase Domain In Complex With Amp-Pnp Length = 330 | Back alignment and structure |
|
| >pdb|2V5Q|A Chain A, Crystal Structure Of Wild-type Plk-1 Kinase Domain In Complex With A Selective Darpin Length = 315 | Back alignment and structure |
|
| >pdb|3ORN|A Chain A, Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In Complex With Ch4987655 And Mgamp-Pnp Length = 307 | Back alignment and structure |
|
| >pdb|3KB7|A Chain A, Crystal Structure Of Polo-Like Kinase 1 In Complex With A Pyrazoloquinazoline Inhibitor Length = 311 | Back alignment and structure |
|
| >pdb|2EB2|A Chain A, Crystal Structure Of Mutated Egfr Kinase Domain (G719s) Length = 334 | Back alignment and structure |
|
| >pdb|3VJO|A Chain A, Crystal Structure Of The Wild-Type Egfr Kinase Domain In Complex With Amppnp Length = 334 | Back alignment and structure |
|
| >pdb|3UG1|A Chain A, Crystal Structure Of The Mutated Egfr Kinase Domain (G719sT790M) IN The Apo Form Length = 334 | Back alignment and structure |
|
| >pdb|2YJR|A Chain A, Structure Of F1174l Mutant Anaplastic Lymphoma Kinase Length = 342 | Back alignment and structure |
|
| >pdb|3MBL|A Chain A, Crystal Structure Of The Human Mitogen-Activated Protein Kinase Kinase 1 (Mek 1) In Complex With Ligand And Mgadp Length = 328 | Back alignment and structure |
|
| >pdb|3DV3|A Chain A, Mek1 With Pf-04622664 Bound Length = 322 | Back alignment and structure |
|
| >pdb|3SXR|A Chain A, Crystal Structure Of Bmx Non-Receptor Tyrosine Kinase Complex With Dasatinib Length = 268 | Back alignment and structure |
|
| >pdb|3EQC|A Chain A, X-Ray Structure Of The Human Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In A Ternary Complex With Compound 1, Atp-Gs And Mg2p Length = 360 | Back alignment and structure |
|
| >pdb|3SLS|A Chain A, Crystal Structure Of Human Mek-1 Kinase In Complex With Ucb1353770 And Amppnp Length = 304 | Back alignment and structure |
|
| >pdb|3THB|A Chain A, Structure Of Plk1 Kinase Domain In Complex With A Benzolactam-Derived Inhibitor Length = 333 | Back alignment and structure |
|
| >pdb|2OH4|A Chain A, Crystal Structure Of Vegfr2 With A Benzimidazole-Urea Inhibitor Length = 316 | Back alignment and structure |
|
| >pdb|2RKU|A Chain A, Structure Of Plk1 In Complex With Bi2536 Length = 294 | Back alignment and structure |
|
| >pdb|2OU7|A Chain A, Structure Of The Catalytic Domain Of Human Polo-Like Kinase 1 Length = 335 | Back alignment and structure |
|
| >pdb|1YWN|A Chain A, Vegfr2 In Complex With A Novel 4-amino-furo[2,3-d]pyrimidine Length = 316 | Back alignment and structure |
|
| >pdb|3UIU|A Chain A, Crystal Structure Of Apo-Pkr Kinase Domain Length = 306 | Back alignment and structure |
|
| >pdb|3LXN|A Chain A, Structural And Thermodynamic Characterization Of The Tyk2 And Jak3 Kinase Domains In Complex With Cp-690550 And Cmp-6 Length = 318 | Back alignment and structure |
|
| >pdb|2P2H|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With A Pyridinyl-Triazine Inhibitor Length = 314 | Back alignment and structure |
|
| >pdb|2P2I|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With A Nicotinamide Inhibitor Length = 314 | Back alignment and structure |
|
| >pdb|2WQM|A Chain A, Structure Of Apo Human Nek7 Length = 310 | Back alignment and structure |
|
| >pdb|2REI|A Chain A, Kinase Domain Of Human Ephrin Type-a Receptor 7 (epha7) Length = 318 | Back alignment and structure |
|
| >pdb|4AN2|A Chain A, Crystal Structures Of Human Mek1 With Carboxamide-Based Allosteric Inhibitor Xl518 (Gdc-0973), Or Related Analogs. Length = 301 | Back alignment and structure |
|
| >pdb|2ITT|A Chain A, Crystal Structure Of Egfr Kinase Domain L858r Mutation In Complex With Aee788 Length = 327 | Back alignment and structure |
|
| >pdb|4I20|A Chain A, Crystal Structure Of Monomeric (v948r) Primary Oncogenic Mutant L858r Egfr Kinase Domain Length = 329 | Back alignment and structure |
|
| >pdb|1VR2|A Chain A, Human Vascular Endothelial Growth Factor Receptor 2 (Kdr) Kinase Domain Length = 316 | Back alignment and structure |
|
| >pdb|4I21|A Chain A, Crystal Structure Of L858r + T790m Egfr Kinase Domain In Complex With Mig6 Peptide Length = 329 | Back alignment and structure |
|
| >pdb|4I1Z|A Chain A, Crystal Structure Of The Monomeric (v948r) Form Of The Gefitinib/erlotinib Resistant Egfr Kinase Domain L858r+t790m Length = 329 | Back alignment and structure |
|
| >pdb|3W2O|A Chain A, Egfr Kinase Domain T790m/l858r Mutant With Tak-285 Length = 331 | Back alignment and structure |
|
| >pdb|2Y94|A Chain A, Structure Of An Active Form Of Mammalian Ampk Length = 476 | Back alignment and structure |
|
| >pdb|2EB3|A Chain A, Crystal Structure Of Mutated Egfr Kinase Domain (L858r) In Complex With Amppnp Length = 334 | Back alignment and structure |
|
| >pdb|4GT4|A Chain A, Structure Of Unliganded, Inactive Ror2 Kinase Domain Length = 308 | Back alignment and structure |
|
| >pdb|4FNX|A Chain A, Crystal Structure Of The Apo R1275q Anaplastic Lymphoma Kinase Catalytic Domain Length = 327 | Back alignment and structure |
|
| >pdb|3CIK|A Chain A, Human Grk2 In Complex With Gbetagamma Subunits Length = 689 | Back alignment and structure |
|
| >pdb|1OMW|A Chain A, Crystal Structure Of The Complex Between G Protein-Coupled Receptor Kinase 2 And Heterotrimeric G Protein Beta 1 And Gamma 2 Subunits Length = 689 | Back alignment and structure |
|
| >pdb|3PSC|A Chain A, Bovine Grk2 In Complex With Gbetagamma Subunits Length = 695 | Back alignment and structure |
|
| >pdb|3KRW|A Chain A, Human Grk2 In Complex With Gbetgamma Subunits And Balanol (Soak) Length = 688 | Back alignment and structure |
|
| >pdb|1K3A|A Chain A, Structure Of The Insulin-Like Growth Factor 1 Receptor Kinase Length = 299 | Back alignment and structure |
|
| >pdb|1S9I|A Chain A, X-Ray Structure Of The Human Mitogen-Activated Protein Kinase Kinase 2 (Mek2)in A Complex With Ligand And Mgatp Length = 354 | Back alignment and structure |
|
| >pdb|1IR3|A Chain A, Phosphorylated Insulin Receptor Tyrosine Kinase In Complex With Peptide Substrate And Atp Analog Length = 306 | Back alignment and structure |
|
| >pdb|1P4O|A Chain A, Structure Of Apo Unactivated Igf-1r Kinase Domain At 1.5a Resolution. Length = 322 | Back alignment and structure |
|
| >pdb|3ZZW|A Chain A, Crystal Structure Of The Kinase Domain Of Ror2 Length = 289 | Back alignment and structure |
|
| >pdb|3I81|A Chain A, Crystal Structure Of Insulin-Like Growth Factor 1 Receptor (Igf-1r-Wt) Complex With Bms-754807 [1-(4-((5-Cyclopropyl- 1h-Pyrazol-3-Yl)amino)pyrrolo[2,1-F][1,2, 4]triazin-2-Yl)-N- (6-Fluoro-3-Pyridinyl)-2-Methyl-L-Prolinamide] Length = 315 | Back alignment and structure |
|
| >pdb|2Z8C|A Chain A, Phosphorylated Insulin Receptor Tyrosine Kinase In Complex With (4-{[5-Carbamoyl-4-(3-Methylanilino)pyrimidin-2- Yl]amino}phenyl)acetic Acid Length = 303 | Back alignment and structure |
|
| >pdb|1IRK|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of The Human Insulin Receptor Length = 306 | Back alignment and structure |
|
| >pdb|3C4F|A Chain A, Fgfr Tyrosine Kinase Domain In Complex With 3-(3- Methoxybenzyl)-7-Azaindole Length = 302 | Back alignment and structure |
|
| >pdb|1M7N|A Chain A, Crystal Structure Of Unactivated Apo Insulin-Like Growth Factor-1 Receptor Kinase Domain Length = 322 | Back alignment and structure |
|
| >pdb|3QQU|A Chain A, Cocrystal Structure Of Unphosphorylated Igf With Pyrimidine 8 Length = 301 | Back alignment and structure |
|
| >pdb|2ZM3|A Chain A, Complex Structure Of Insulin-Like Growth Factor Receptor And Isoquinolinedione Inhibitor Length = 308 | Back alignment and structure |
|
| >pdb|1JQH|A Chain A, Igf-1 Receptor Kinase Domain Length = 308 | Back alignment and structure |
|
| >pdb|3O23|A Chain A, Human Unphosphorylated Igf1-R Kinase Domain In Complex With An Hydantoin Inhibitor Length = 305 | Back alignment and structure |
|
| >pdb|2XIR|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With Pf-00337210 (N,2-Dimethyl-6-(7-(2-Morpholinoethoxy) Quinolin-4-Yloxy)benzofuran-3-Carboxamide) Length = 316 | Back alignment and structure |
|
| >pdb|3LW0|A Chain A, Igf-1rk In Complex With Ligand Msc1609119a-1 Length = 304 | Back alignment and structure |
|
| >pdb|3COM|A Chain A, Crystal Structure Of Mst1 Kinase Length = 314 | Back alignment and structure |
|
| >pdb|2OJ9|A Chain A, Structure Of Igf-1r Kinase Domain Complexed With A Benzimidazole Inhibitor Length = 307 | Back alignment and structure |
|
| >pdb|1RQQ|A Chain A, Crystal Structure Of The Insulin Receptor Kinase In Complex With The Sh2 Domain Of Aps Length = 306 | Back alignment and structure |
|
| >pdb|4F0I|A Chain A, Crystal Structure Of Apo Trka Length = 300 | Back alignment and structure |
|
| >pdb|3GQL|A Chain A, Crystal Structure Of Activated Receptor Tyrosine Kinase In Complex With Substrates Length = 326 | Back alignment and structure |
|
| >pdb|3C7Q|A Chain A, Structure Of Vegfr2 Kinase Domain In Complex With Bibf1120 Length = 316 | Back alignment and structure |
|
| >pdb|3VNT|A Chain A, Crystal Structure Of The Kinase Domain Of Human Vegfr2 With A [1, 3]thiazolo[5,4-B]pyridine Derivative Length = 318 | Back alignment and structure |
|
| >pdb|3U6J|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With A Pyrazolone Inhibitor Length = 314 | Back alignment and structure |
|
| >pdb|4AOJ|A Chain A, Human Trka In Complex With The Inhibitor Az-23 Length = 329 | Back alignment and structure |
|
| >pdb|2I0V|A Chain A, C-Fms Tyrosine Kinase In Complex With A Quinolone Inhibitor Length = 335 | Back alignment and structure |
|
| >pdb|4GT5|A Chain A, Crystal Structure Of The Inactive Trka Kinase Domain Length = 306 | Back alignment and structure |
|
| >pdb|3Q4Z|A Chain A, Structure Of Unphosphorylated Pak1 Kinase Domain Length = 306 | Back alignment and structure |
|
| >pdb|3EWH|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With A Pyridyl-Pyrimidine Benzimidazole Inhibitor Length = 314 | Back alignment and structure |
|
| >pdb|3GQI|A Chain A, Crystal Structure Of Activated Receptor Tyrosine Kinase In Complex With Substrates Length = 326 | Back alignment and structure |
|
| >pdb|3BEA|A Chain A, Cfms Tyrosine Kinase (Tie2 Kid) In Complex With A Pyrimidinopyridone Inhibitor Length = 333 | Back alignment and structure |
|
| >pdb|4E20|A Chain A, Structure Of Mouse Tyk-2 Complexed To A 3-Aminoindazole Inhibitor Length = 290 | Back alignment and structure |
|
| >pdb|4E1Z|A Chain A, Structure Of Mouse Tyk-2 Complexed To A 3-Aminoindazole Inhibitor Length = 291 | Back alignment and structure |
|
| >pdb|2I1M|A Chain A, Cfms Tyrosine Kinase (Tie2 Kid) In Complex With An Arylamide Inhibitor Length = 333 | Back alignment and structure |
|
| >pdb|1FOT|A Chain A, Structure Of The Unliganded Camp-Dependent Protein Kinase Catalytic Subunit From Saccharomyces Cerevisiae Length = 318 | Back alignment and structure |
|
| >pdb|3HNG|A Chain A, Crystal Structure Of Vegfr1 In Complex With N-(4-chlorophenyl)-2- ((pyridin-4-ylmethyl)amino)benzamide Length = 360 | Back alignment and structure |
|
| >pdb|3LVP|A Chain A, Crystal Structure Of Bisphosphorylated Igf1-R Kinase Domain (2p) In Complex With A Bis-Azaindole Inhibitor Length = 336 | Back alignment and structure |
|
| >pdb|3RHX|B Chain B, Crystal Structure Of The Catalytic Domain Of Fgfr1 Kinase In Complex With Arq 069 Length = 306 | Back alignment and structure |
|
| >pdb|4AGC|A Chain A, Crystal Structure Of Vegfr2 (Juxtamembrane And Kinase Domains) In Complex With Axitinib (Ag-013736) (N-Methyl-2-( 3-((E)-2-Pyridin-2-Yl-Vinyl)-1h-Indazol-6-Ylsulfanyl)- Benzamide) Length = 353 | Back alignment and structure |
|
| >pdb|3KXX|A Chain A, Structure Of The Mutant Fibroblast Growth Factor Receptor 1 Length = 317 | Back alignment and structure |
|
| >pdb|1Y6A|A Chain A, Crystal Structure Of Vegfr2 In Complex With A 2-Anilino-5-Aryl-Oxazole Inhibitor Length = 366 | Back alignment and structure |
|
| >pdb|3VHE|A Chain A, Crystal Structure Of Human Vegfr2 Kinase Domain With A Novel Pyrrolopyrimidine Inhibitor Length = 359 | Back alignment and structure |
|
| >pdb|1FGK|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of Fibroblast Growth Factor Receptor 1 Length = 310 | Back alignment and structure |
|
| >pdb|2Z7Q|A Chain A, Crystal Structure Of The N-Terminal Kinase Domain Of Human Rsk-1 Bound To Amp-Pcp Length = 321 | Back alignment and structure |
|
| >pdb|3ETA|A Chain A, Kinase Domain Of Insulin Receptor Complexed With A Pyrrolo Pyridine Inhibitor Length = 317 | Back alignment and structure |
|
| >pdb|3CJG|A Chain A, Crystal Structure Of Vegfr2 In Complex With A 3,4,5-Trimethoxy Aniline Containing Pyrimidine Length = 309 | Back alignment and structure |
|
| >pdb|3VHK|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With A Back Pocket Binder Length = 368 | Back alignment and structure |
|
| >pdb|3VID|A Chain A, Crystal Structure Of Human Vegfr2 Kinase Domain With Compound A Length = 356 | Back alignment and structure |
|
| >pdb|4F63|A Chain A, Crystal Structure Of Human Fibroblast Growth Factor Receptor 1 Kinase Domain In Complex With Compound 1 Length = 309 | Back alignment and structure |
|
| >pdb|3TT0|A Chain A, Co-Structure Of Fibroblast Growth Factor Receptor 1 Kinase Domain With 3-(2,6-Dichloro-3, 5-Dimethoxy-Phenyl)-1-{6-[4-(4-Ethyl-Piperazin-1- Yl)-Phenylamino]-Pyrimidin-4-Yl}-1-Methyl-Urea (Bgj398) Length = 382 | Back alignment and structure |
|
| >pdb|3JS2|A Chain A, Crystal Structure Of Minimal Kinase Domain Of Fibroblast Growth Factor Receptor 1 In Complex With 5-(2-Thienyl) Nicotinic Acid Length = 317 | Back alignment and structure |
|
| >pdb|2OGV|A Chain A, Crystal Structure Of The Autoinhibited Human C-Fms Kinase Domain Length = 317 | Back alignment and structure |
|
| >pdb|2YJS|A Chain A, Structure Of C1156y Mutant Anaplastic Lymphoma Kinase Length = 342 | Back alignment and structure |
|
| >pdb|3TUB|A Chain A, Crystal Structure Of Syk Kinase Domain With 1-(5-(6,7- Dimethoxyquinolin-4-Yloxy)pyridin-2-Yl)-3-((1r,2s)-2- Phenylcyclopropyl)urea Length = 293 | Back alignment and structure |
|
| >pdb|3VF8|A Chain A, Crystal Structure Of Spleen Tyrosine Kinase Syk Catalytic Domain With Pyrazolylbenzimidazole Inhibitor 416 Length = 299 | Back alignment and structure |
|
| >pdb|4DFL|A Chain A, Crystal Structure Of Spleen Tyrosine Kinase Complexed With A Sulfonamidopyrazine Piperidine Inhibitor Length = 274 | Back alignment and structure |
|
| >pdb|3SRV|B Chain B, Crystal Structure Of Spleen Tyrosine Kinase (Syk) In Complex With A Diaminopyrimidine Carboxamide Inhibitor Length = 277 | Back alignment and structure |
|
| >pdb|3SRV|A Chain A, Crystal Structure Of Spleen Tyrosine Kinase (Syk) In Complex With A Diaminopyrimidine Carboxamide Inhibitor Length = 277 | Back alignment and structure |
|
| >pdb|2JC6|A Chain A, Crystal Structure Of Human Calmodulin-Dependent Protein Kinase 1d Length = 334 | Back alignment and structure |
|
| >pdb|3EMG|A Chain A, Discovery And Sar Of Novel 4-Thiazolyl-2- Phenylaminopyrimidines As Potent Inhibitors Of Spleen Tyrosine Kinase (Syk) Length = 291 | Back alignment and structure |
|
| >pdb|3LCD|A Chain A, Inhibitor Bound To A Dfg-In Structure Of The Kinase Domain Of Csf-1r Length = 329 | Back alignment and structure |
|
| >pdb|4F4P|A Chain A, Syk In Complex With Ligand Lasw836 Length = 273 | Back alignment and structure |
|
| >pdb|3LCO|A Chain A, Inhibitor Bound To A Dfg-Out Structure Of The Kinase Domain Of Csf-1r Length = 324 | Back alignment and structure |
|
| >pdb|1XBA|A Chain A, Crystal Structure Of Apo Syk Tyrosine Kinase Domain Length = 291 | Back alignment and structure |
|
| >pdb|2A19|B Chain B, Pkr Kinase Domain- Eif2alpha- Amp-Pnp Complex. Length = 284 | Back alignment and structure |
|
| >pdb|3QD2|B Chain B, Crsytal Structure Of Mouse Perk Kinase Domain Length = 332 | Back alignment and structure |
|
| >pdb|3IW4|A Chain A, Crystal Structure Of Pkc Alpha In Complex With Nvp-Aeb071 Length = 360 | Back alignment and structure |
|
| >pdb|3HZT|A Chain A, Crystal Structure Of Toxoplasma Gondii Cdpk3, Tgme49_105860 Length = 467 | Back alignment and structure |
|
| >pdb|3D94|A Chain A, Crystal Structure Of The Insulin-Like Growth Factor-1 Receptor Kinase In Complex With Pqip Length = 301 | Back alignment and structure |
|
| >pdb|2IVT|A Chain A, Crystal Structure Of Phosphorylated Ret Tyrosine Kinase Domain Length = 314 | Back alignment and structure |
|
| >pdb|3DXN|A Chain A, Crystal Structure Of The Calcium-dependent Kinase From Toxoplasma Gondii, 541.m00134, Kinase Domain Length = 287 | Back alignment and structure |
|
| >pdb|3NYX|A Chain A, Non-Phosphorylated Tyk2 Jh1 Domain With Quinoline-Thiadiazole- Thiophene Inhibitor Length = 302 | Back alignment and structure |
|
| >pdb|3NZ0|A Chain A, Non-Phosphorylated Tyk2 Kinase With Cmp6 Length = 302 | Back alignment and structure |
|
| >pdb|4FL3|A Chain A, Structural And Biophysical Characterization Of The Syk Activation Switch Length = 635 | Back alignment and structure |
|
| >pdb|4FL2|A Chain A, Structural And Biophysical Characterization Of The Syk Activation Switch Length = 636 | Back alignment and structure |
|
| >pdb|3CJF|A Chain A, Crystal Structure Of Vegfr2 In Complex With A 3,4,5-Trimethoxy Aniline Containing Pyrimidine Length = 309 | Back alignment and structure |
|
| >pdb|2PVY|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic K659n Mutation Responsible For An Unclassified Craniosynostosis Syndrome. Length = 324 | Back alignment and structure |
|
| >pdb|3NYN|A Chain A, Crystal Structure Of G Protein-Coupled Receptor Kinase 6 In Complex With Sangivamycin Length = 576 | Back alignment and structure |
|
| >pdb|3ZUV|A Chain A, Crystal Structure Of A Designed Selected Ankyrin Repeat Protein In Complex With The Phosphorylated Map Kinase Erk2 Length = 364 | Back alignment and structure |
|
| >pdb|2ERK|A Chain A, Phosphorylated Map Kinase Erk2 Length = 365 | Back alignment and structure |
|
| >pdb|3G0F|A Chain A, Kit Kinase Domain Mutant D816h In Complex With Sunitinib Length = 336 | Back alignment and structure |
|
| >pdb|2ACX|A Chain A, Crystal Structure Of G Protein Coupled Receptor Kinase 6 Bound To Amppnp Length = 576 | Back alignment and structure |
|
| >pdb|2IVS|A Chain A, Crystal Structure Of Non-Phosphorylated Ret Tyrosine Kinase Domain Length = 314 | Back alignment and structure |
|
| >pdb|4FV6|A Chain A, Crystal Structure Of The Erk2 Complexed With E57 Length = 360 | Back alignment and structure |
|
| >pdb|1BI8|A Chain A, Mechanism Of G1 Cyclin Dependent Kinase Inhibition From The Structures Cdk6-P19ink4d Inhibitor Complex Length = 326 | Back alignment and structure |
|
| >pdb|2GPH|A Chain A, Docking Motif Interactions In The Map Kinase Erk2 Length = 364 | Back alignment and structure |
|
| >pdb|4FUX|A Chain A, Crystal Structure Of The Erk2 Complexed With E75 Length = 360 | Back alignment and structure |
|
| >pdb|3TEI|A Chain A, Crystal Structure Of Human Erk2 Complexed With A Mapk Docking Peptide Length = 362 | Back alignment and structure |
|
| >pdb|1GOL|A Chain A, Coordinates Of Rat Map Kinase Erk2 With An Arginine Mutation At Position 52 Length = 364 | Back alignment and structure |
|
| >pdb|3ZU7|A Chain A, Crystal Structure Of A Designed Selected Ankyrin Repeat Protein In Complex With The Map Kinase Erk2 Length = 365 | Back alignment and structure |
|
| >pdb|2Z7L|A Chain A, Unphosphorylated Mitogen Activated Protein Kinase Erk2 In Complex With (4-{[5-Carbamoyl-4-(3-Methylanilino)pyrimidin 2-Yl]amino}phenyl)acetic Acid Length = 366 | Back alignment and structure |
|
| >pdb|3C9W|A Chain A, Crystal Structure Of Erk-2 With Hypothemycin Covalently Bound Length = 357 | Back alignment and structure |
|
| >pdb|2FYS|B Chain B, Crystal Structure Of Erk2 Complex With Kim Peptide Derived From Mkp3 Length = 364 | Back alignment and structure |
|
| >pdb|3R63|A Chain A, Structure Of Erk2 (Spe) Mutant (S246e) Length = 358 | Back alignment and structure |
|
| >pdb|2Y9Q|A Chain A, Crystal Structure Of Human Erk2 Complexed With A Mapk Docking Peptide Length = 362 | Back alignment and structure |
|
| >pdb|1YVJ|A Chain A, Crystal Structure Of The Jak3 Kinase Domain In Complex With A Staurosporine Analogue Length = 290 | Back alignment and structure |
|
| >pdb|2IVV|A Chain A, Crystal Structure Of Phosphorylated Ret Tyrosine Kinase Domain Complexed With The Inhibitor Pp1 Length = 314 | Back alignment and structure |
|
| >pdb|4FV7|A Chain A, Crystal Structure Of The Erk2 Complexed With E94 Length = 360 | Back alignment and structure |
|
| >pdb|3QYW|A Chain A, Crystal Structure Of Erk2 In Complex With An Inhibitor Length = 364 | Back alignment and structure |
|
| >pdb|3GVU|A Chain A, The Crystal Structure Of Human Abl2 In Complex With Gleevec Length = 292 | Back alignment and structure |
|
| >pdb|3O71|A Chain A, Crystal Structure Of Erk2DCC PEPTIDE COMPLEX Length = 358 | Back alignment and structure |
|
| >pdb|1I44|A Chain A, Crystallographic Studies Of An Activation Loop Mutant Of The Insulin Receptor Tyrosine Kinase Length = 306 | Back alignment and structure |
|
| >pdb|1JOW|B Chain B, Crystal Structure Of A Complex Of Human Cdk6 And A Viral Cyclin Length = 308 | Back alignment and structure |
|
| >pdb|2OJG|A Chain A, Crystal Structure Of Erk2 In Complex With N,n-dimethyl-4-(4- Phenyl-1h-pyrazol-3-yl)-1h-pyrrole-2-carboxamide Length = 380 | Back alignment and structure |
|
| >pdb|1QL6|A Chain A, The Catalytic Mechanism Of Phosphorylase Kinase Probed By Mutational Studies Length = 298 | Back alignment and structure |
|
| >pdb|1WZY|A Chain A, Crystal Structure Of Human Erk2 Complexed With A Pyrazolopyridazine Derivative Length = 368 | Back alignment and structure |
|
| >pdb|1TVO|A Chain A, The Structure Of Erk2 In Complex With A Small Molecule Inhibitor Length = 368 | Back alignment and structure |
|
| >pdb|3NUP|A Chain A, Cdk6 (Monomeric) In Complex With Inhibitor Length = 307 | Back alignment and structure |
|
| >pdb|1PME|A Chain A, Structure Of Penta Mutant Human Erk2 Map Kinase Complexed With A Specific Inhibitor Of Human P38 Map Kinase Length = 380 | Back alignment and structure |
|
| >pdb|1P14|A Chain A, Crystal Structure Of A Catalytic-Loop Mutant Of The Insulin Receptor Tyrosine Kinase Length = 306 | Back alignment and structure |
|
| >pdb|4GSB|A Chain A, Monoclinic Crystal Form Of The Apo-Erk2 Length = 364 | Back alignment and structure |
|
| >pdb|1JPA|A Chain A, Crystal Structure Of Unphosphorylated Ephb2 Receptor Tyrosine Kinase And Juxtamembrane Region Length = 312 | Back alignment and structure |
|
| >pdb|3EKK|A Chain A, Insulin Receptor Kinase Complexed With An Inhibitor Length = 307 | Back alignment and structure |
|
| >pdb|3Q5I|A Chain A, Crystal Structure Of Pbanka_031420 Length = 504 | Back alignment and structure |
|
| >pdb|3SA0|A Chain A, Complex Of Erk2 With Norathyriol Length = 360 | Back alignment and structure |
|
| >pdb|3PFQ|A Chain A, Crystal Structure And Allosteric Activation Of Protein Kinase C Beta Ii Length = 674 | Back alignment and structure |
|
| >pdb|3G51|A Chain A, Structural Diversity Of The Active Conformation Of The N- Terminal Kinase Domain Of P90 Ribosomal S6 Kinase 2 Length = 325 | Back alignment and structure |
|
| >pdb|3IS5|A Chain A, Crystal Structure Of Cdpk Kinase Domain From Toxoplasma Gondii, Tgme49_018720 Length = 285 | Back alignment and structure |
|
| >pdb|4H3Q|A Chain A, Crystal Structure Of Human Erk2 Complexed With A Mapk Docking Peptide Length = 362 | Back alignment and structure |
|
| >pdb|3HYH|A Chain A, Crystal Structure Of The Protein Kinase Domain Of Yeast Amp-Activated Protein Kinase Snf1 Length = 275 | Back alignment and structure |
|
| >pdb|3G0E|A Chain A, Kit Kinase Domain In Complex With Sunitinib Length = 336 | Back alignment and structure |
|
| >pdb|2FH9|A Chain A, Structure And Dimerization Of The Kinase Domain From Yeast Snf1 Length = 274 | Back alignment and structure |
|
| >pdb|3DAE|A Chain A, Crystal Structure Of Phosphorylated Snf1 Kinase Domain Length = 283 | Back alignment and structure |
|
| >pdb|3MN3|A Chain A, An Inhibited Conformation For The Protein Kinase Domain Of The Saccharomyces Cerevisiae Ampk Homolog Snf1 Length = 271 | Back alignment and structure |
|
| >pdb|3OHT|A Chain A, Crystal Structure Of Salmo Salar P38alpha Length = 389 | Back alignment and structure |
|
| >pdb|4APC|A Chain A, Crystal Structure Of Human Nima-Related Kinase 1 (Nek1) Length = 350 | Back alignment and structure |
|
| >pdb|1T45|A Chain A, Structural Basis For The Autoinhibition And Sti-571 Inhibition Of C- Kit Tyrosine Kinase Length = 331 | Back alignment and structure |
|
| >pdb|2QNJ|A Chain A, Kinase And Ubiquitin-Associated Domains Of Mark3PAR-1 Length = 328 | Back alignment and structure |
|
| >pdb|3VN9|A Chain A, Rifined Crystal Structure Of Non-Phosphorylated Map2k6 In A Putative Auto-Inhibition State Length = 340 | Back alignment and structure |
|
| >pdb|4EL9|A Chain A, Structure Of N-Terminal Kinase Domain Of Rsk2 With Afzelin Length = 305 | Back alignment and structure |
|
| >pdb|3UBD|A Chain A, Structure Of N-Terminal Domain Of Rsk2 Kinase In Complex With Flavonoid Glycoside Sl0101 Length = 304 | Back alignment and structure |
|
| >pdb|3FE3|A Chain A, Crystal Structure Of The Kinase Mark3PAR-1: T211a-S215a Double Mutant Length = 328 | Back alignment and structure |
|
| >pdb|3QA8|A Chain A, Crystal Structure Of Inhibitor Of Kappa B Kinase Beta Length = 676 | Back alignment and structure |
|
| >pdb|2I0E|A Chain A, Structure Of Catalytic Domain Of Human Protein Kinase C Beta Ii Complexed With A Bisindolylmaleimide Inhibitor Length = 353 | Back alignment and structure |
|
| >pdb|1PKG|A Chain A, Structure Of A C-kit Kinase Product Complex Length = 329 | Back alignment and structure |
|
| >pdb|3RZF|A Chain A, Crystal Structure Of Inhibitor Of Kappab Kinase Beta (I4122) Length = 677 | Back alignment and structure |
|
| >pdb|1T46|A Chain A, Structural Basis For The Autoinhibition And Sti-571 Inhibition Of C-kit Tyrosine Kinase Length = 313 | Back alignment and structure |
|
| >pdb|4EJN|A Chain A, Crystal Structure Of Autoinhibited Form Of Akt1 In Complex With N-(4- (5-(3-Acetamidophenyl)-2-(2-Aminopyridin-3-Yl)-3h- Imidazo[4,5- B]pyridin-3-Yl)benzyl)-3-Fluorobenzamide Length = 446 | Back alignment and structure |
|
| >pdb|3O96|A Chain A, Crystal Structure Of Human Akt1 With An Allosteric Inhibitor Length = 446 | Back alignment and structure |
|
| >pdb|4FG8|A Chain A, Crystal Structure Of Human Calcium/calmodulin-dependent Protein Kinase I 1-315 In Complex With Atp Length = 315 | Back alignment and structure |
|
| >pdb|3DK3|A Chain A, Crystal Structure Of Mutant Abl Kinase Domain In Complex With Small Molecule Fragment Length = 293 | Back alignment and structure |
|
| >pdb|1PHK|A Chain A, Two Structures Of The Catalytic Domain Of Phosphorylase, Kinase: An Active Protein Kinase Complexed With Nucleotide, Substrate-Analogue And Product Length = 298 | Back alignment and structure |
|
| >pdb|3QRI|A Chain A, The Crystal Structure Of Human Abl1 Kinase Domain In Complex With Dcc- 2036 Length = 277 | Back alignment and structure |
|
| >pdb|2HZ0|A Chain A, Abl Kinase Domain In Complex With Nvp-Aeg082 Length = 270 | Back alignment and structure |
|
| >pdb|4FG9|A Chain A, Crystal Structure Of Human Calcium/calmodulin-dependent Protein Kinase I 1-320 In Complex With Atp Length = 320 | Back alignment and structure |
|
| >pdb|2PHK|A Chain A, The Crystal Structure Of A Phosphorylase Kinase Peptide Substrate Complex: Kinase Substrate Recognition Length = 277 | Back alignment and structure |
|
| >pdb|4FG7|A Chain A, Crystal Structure Of Human Calcium/calmodulin-dependent Protein Kinase I 1-293 In Complex With Atp Length = 293 | Back alignment and structure |
|
| >pdb|2GQG|A Chain A, X-Ray Crystal Structure Of Dasatinib (Bms-354825) Bound To Activated Abl Kinase Domain Length = 278 | Back alignment and structure |
|
| >pdb|1A06|A Chain A, Calmodulin-Dependent Protein Kinase From Rat Length = 332 | Back alignment and structure |
|
| >pdb|3LXK|A Chain A, Structural And Thermodynamic Characterization Of The Tyk2 And Jak3 Kinase Domains In Complex With Cp-690550 And Cmp-6 Length = 327 | Back alignment and structure |
|
| >pdb|2HZI|A Chain A, Abl Kinase Domain In Complex With Pd180970 Length = 277 | Back alignment and structure |
|
| >pdb|3V5Q|A Chain A, Discovery Of A Selective Trk Inhibitor With Efficacy In Rodent Cancer Tumor Models Length = 297 | Back alignment and structure |
|
| >pdb|3QRJ|A Chain A, The Crystal Structure Of Human Abl1 Kinase Domain T315i Mutant In Complex With Dcc-2036 Length = 277 | Back alignment and structure |
|
| >pdb|3CLY|A Chain A, Crystal Structure Of Fgf Receptor 2 (Fgfr2) Kinase Domains Trapped In Trans-Phosphorylation Reaction Length = 334 | Back alignment and structure |
|
| >pdb|3PJC|A Chain A, Crystal Structure Of Jak3 Complexed With A Potent Atp Site Inhibitor Showing High Selectivity Within The Janus Kinase Family Length = 315 | Back alignment and structure |
|
| >pdb|2YZA|A Chain A, Crystal Structure Of Kinase Domain Of Human 5'-Amp-Activated Protein Kinase Alpha-2 Subunit Mutant (T172d) Length = 276 | Back alignment and structure |
|
| >pdb|2PVF|A Chain A, Crystal Structure Of Tyrosine Phosphorylated Activated Fgf Receptor 2 (Fgfr2) Kinase Domain In Complex With Atp Analog And Substrate Peptide Length = 334 | Back alignment and structure |
|
| >pdb|2HYY|A Chain A, Human Abl Kinase Domain In Complex With Imatinib (Sti571, Glivec) Length = 273 | Back alignment and structure |
|
| >pdb|4HVD|A Chain A, Jak3 Kinase Domain In Complex With 2-cyclopropyl-5h-pyrrolo[2,3- B]pyrazine-7-carboxylic Acid ((s)-1,2,2-trimethyl-propyl)-amide Length = 314 | Back alignment and structure |
|
| >pdb|1GZ8|A Chain A, Human Cyclin Dependent Kinase 2 Complexed With The Inhibitor 2-Amino-6-(3'-Methyl-2'-Oxo)butoxypurine Length = 299 | Back alignment and structure |
|
| >pdb|4E5A|X Chain X, The W197a Mutant Of P38a Map Kinase Length = 360 | Back alignment and structure |
|
| >pdb|4G31|A Chain A, Crystal Structure Of Gsk6414 Bound To Perk (R587-R1092, Delete A660- T867) At 2.28 A Resolution Length = 299 | Back alignment and structure |
|
| >pdb|2V7A|A Chain A, Crystal Structure Of The T315i Abl Mutant In Complex With The Inhibitor Pha-739358 Length = 286 | Back alignment and structure |
|
| >pdb|4ERW|A Chain A, Cdk2 In Complex With Staurosporine Length = 306 | Back alignment and structure |
|
| >pdb|3OXZ|A Chain A, Crystal Structure Of Abl Kinase Domain Bound With A Dfg-Out Inhibitor Ap24534 Length = 284 | Back alignment and structure |
|
| >pdb|3DK7|A Chain A, Crystal Structure Of Mutant Abl Kinase Domain In Complex With Small Molecule Fragment Length = 277 | Back alignment and structure |
|
| >pdb|2HIW|A Chain A, Crystal Structure Of Inactive Conformation Abl Kinase Catalytic Domain Complexed With Type Ii Inhibitor Length = 287 | Back alignment and structure |
|
| >pdb|3NIZ|A Chain A, Cryptosporidium Parvum Cyclin-Dependent Kinase Cgd5_2510 With Adp Bound Length = 311 | Back alignment and structure |
|
| >pdb|2G1T|A Chain A, A Src-Like Inactive Conformation In The Abl Tyrosine Kinase Domain Length = 287 | Back alignment and structure |
|
| >pdb|3OY3|A Chain A, Crystal Structure Of Abl T315i Mutant Kinase Domain Bound With A Dfg- Out Inhibitor Ap24589 Length = 284 | Back alignment and structure |
|
| >pdb|3PYY|A Chain A, Discovery And Characterization Of A Cell-Permeable, Small-Molecule C- Abl Kinase Activator That Binds To The Myristoyl Binding Site Length = 298 | Back alignment and structure |
|
| >pdb|1FPU|A Chain A, Crystal Structure Of Abl Kinase Domain In Complex With A Small Molecule Inhibitor Length = 293 | Back alignment and structure |
|
| >pdb|2QKR|A Chain A, Cryptosporidium Parvum Cyclin-Dependent Kinase Cgd5_2510 With Indirubin 3'-Monoxime Bound Length = 313 | Back alignment and structure |
|
| >pdb|3DK6|A Chain A, Crystal Structure Of Mutant Abl Kinase Domain In Complex With Small Molecule Fragment Length = 293 | Back alignment and structure |
|
| >pdb|2E2B|A Chain A, Crystal Structure Of The C-Abl Kinase Domain In Complex With Inno-406 Length = 293 | Back alignment and structure |
|
| >pdb|2QOH|A Chain A, Crystal Structure Of Abl Kinase Bound With Ppy-a Length = 288 | Back alignment and structure |
|
| >pdb|3RI1|A Chain A, Crystal Structure Of The Catalytic Domain Of Fgfr2 Kinase In Complex With Arq 069 Length = 313 | Back alignment and structure |
|
| >pdb|2Z60|A Chain A, Crystal Structure Of The T315i Mutant Of Abl Kinase Bound With Ppy-A Length = 288 | Back alignment and structure |
|
| >pdb|1GII|A Chain A, Human Cyclin Dependent Kinase 2 Complexed With The Cdk4 Inhibitor Length = 298 | Back alignment and structure |
|
| >pdb|3CQU|A Chain A, Crystal Structure Of Akt-1 Complexed With Substrate Peptide And Inhibitor Length = 342 | Back alignment and structure |
|
| >pdb|1OIR|A Chain A, Imidazopyridines: A Potent And Selective Class Of Cyclin-Dependent Kinase Inhibitors Identified Through Structure-Based Hybridisation Length = 299 | Back alignment and structure |
|
| >pdb|1H01|A Chain A, Cdk2 In Complex With A Disubstituted 2, 4-Bis Anilino Pyrimidine Cdk4 Inhibitor Length = 298 | Back alignment and structure |
|
| >pdb|1PF8|A Chain A, Crystal Structure Of Human Cyclin-dependent Kinase 2 Complexed With A Nucleoside Inhibitor Length = 298 | Back alignment and structure |
|
| >pdb|2W17|A Chain A, Cdk2 In Complex With The Imidazole Pyrimidine Amide, Compound (S)-8b Length = 299 | Back alignment and structure |
|
| >pdb|1GJO|A Chain A, The Fgfr2 Tyrosine Kinase Domain Length = 316 | Back alignment and structure |
|
| >pdb|3EZR|A Chain A, Cdk-2 With Indazole Inhibitor 17 Bound At Its Active Site Length = 300 | Back alignment and structure |
|
| >pdb|3B2T|A Chain A, Structure Of Phosphotransferase Length = 311 | Back alignment and structure |
|
| >pdb|1FIN|A Chain A, Cyclin A-Cyclin-Dependent Kinase 2 Complex Length = 298 | Back alignment and structure |
|
| >pdb|1U59|A Chain A, Crystal Structure Of The Zap-70 Kinase Domain In Complex With Staurosporine Length = 287 | Back alignment and structure |
|
| >pdb|2Q0B|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic E565a Mutation Responsible For Pfeiffer Syndrome Length = 324 | Back alignment and structure |
|
| >pdb|2PZP|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic K526e Mutation Responsible For Crouzon Syndrome Length = 324 | Back alignment and structure |
|
| >pdb|3OCB|A Chain A, Akt1 Kinase Domain With Pyrrolopyrimidine Inhibitor Length = 341 | Back alignment and structure |
|
| >pdb|2PSQ|A Chain A, Crystal Structure Of Unphosphorylated Unactivated Wild Type Fgf Receptor 2 (Fgfr2) Kinase Domain Length = 370 | Back alignment and structure |
|
| >pdb|4GV1|A Chain A, Pkb Alpha In Complex With Azd5363 Length = 340 | Back alignment and structure |
|
| >pdb|2PZ5|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic N549t Mutation Responsible For Pfeiffer Syndrome Length = 324 | Back alignment and structure |
|
| >pdb|3PXF|A Chain A, Cdk2 In Complex With Two Molecules Of 8-Anilino-1-Naphthalene Sulfonate Length = 306 | Back alignment and structure |
|
| >pdb|3PJ8|A Chain A, Structure Of Cdk2 In Complex With A Pyrazolo[4,3-D]pyrimidine Bioisostere Of Roscovitine Length = 299 | Back alignment and structure |
|
| >pdb|2PWL|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic N549h Mutation Responsible For Crouzon Syndrome. Length = 324 | Back alignment and structure |
|
| >pdb|2H6D|A Chain A, Protein Kinase Domain Of The Human 5'-Amp-Activated Protein Kinase Catalytic Subunit Alpha-2 (Ampk Alpha-2 Chain) Length = 276 | Back alignment and structure |
|
| >pdb|1VYW|A Chain A, Structure Of Cdk2CYCLIN A WITH PNU-292137 Length = 309 | Back alignment and structure |
|
| >pdb|2PY3|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic E565g Mutation Responsible For Pfeiffer Syndrome Length = 324 | Back alignment and structure |
|
| >pdb|3CD3|A Chain A, Crystal Structure Of Phosphorylated Human Feline Sarcoma Viral Oncogene Homologue (V-Fes) In Complex With Staurosporine And A Consensus Peptide Length = 377 | Back alignment and structure |
|
| >pdb|2GHL|A Chain A, Mutant Mus Musculus P38 Kinase Domain In Complex With Inhibitor Pg-874743 Length = 348 | Back alignment and structure |
|
| >pdb|1YW2|A Chain A, Mutated Mus Musculus P38 Kinase (Mp38) Length = 360 | Back alignment and structure |
|
| >pdb|1YWR|A Chain A, Crystal Structure Analysis Of Inactive P38 Kinase Domain In Complex With A Monocyclic Pyrazolone Inhibitor Length = 360 | Back alignment and structure |
|
| >pdb|2FSO|X Chain X, Mitogen Activated Protein Kinase P38alpha (D176a) Activating Mutant Length = 367 | Back alignment and structure |
|
| >pdb|2FST|X Chain X, Mitogen Activated Protein Kinase P38alpha (d176a+f327l) Activating Mutant Length = 367 | Back alignment and structure |
|
| >pdb|2FSL|X Chain X, Mitogen Activated Protein Kinase P38alpha (D176a+f327s) Activating Mutant Form-A Length = 367 | Back alignment and structure |
|
| >pdb|2ZOQ|A Chain A, Structural Dissection Of Human Mitogen-Activated Kinase Erk1 Length = 382 | Back alignment and structure |
|
| >pdb|1OIT|A Chain A, Imidazopyridines: A Potent And Selective Class Of Cyclin-dependent Kinase Inhibitors Identified Through Structure-based Hybridisation Length = 299 | Back alignment and structure |
|
| >pdb|1LUF|A Chain A, Crystal Structure Of The Musk Tyrosine Kinase: Insights Into Receptor Autoregulation Length = 343 | Back alignment and structure |
|
| >pdb|3TXO|A Chain A, Pkc Eta Kinase In Complex With A Naphthyridine Length = 353 | Back alignment and structure |
|
| >pdb|3BKB|A Chain A, Crystal Structure Of Human Feline Sarcoma Viral Oncogene Homologue (V- Fes) Length = 377 | Back alignment and structure |
|
| >pdb|2HAK|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark1PAR-1 Length = 328 | Back alignment and structure |
|
| >pdb|4AW5|A Chain A, Complex Of The Ephb4 Kinase Domain With An Oxindole Inhibitor Length = 291 | Back alignment and structure |
|
| >pdb|3NNX|A Chain A, Crystal Structure Of Phosphorylated P38 Alpha In Complex With Dp802 Length = 354 | Back alignment and structure |
|
| >pdb|2DYL|A Chain A, Crystal Structure Of Human Mitogen-Activated Protein Kinase Kinase 7 Activated Mutant (S287d, T291d) Length = 318 | Back alignment and structure |
|
| >pdb|2F4J|A Chain A, Structure Of The Kinase Domain Of An Imatinib-Resistant Abl Mutant In Complex With The Aurora Kinase Inhibitor Vx-680 Length = 287 | Back alignment and structure |
|
| >pdb|2G2F|A Chain A, A Src-Like Inactive Conformation In The Abl Tyrosine Kinase Domain Length = 287 | Back alignment and structure |
|
| >pdb|3BHH|A Chain A, Crystal Structure Of Human Calcium/calmodulin-dependent Protein Kinase Iib Isoform 1 (camk2b) Length = 295 | Back alignment and structure |
|
| >pdb|3ODZ|X Chain X, Crystal Structure Of P38alpha Y323r Active Mutant Length = 360 | Back alignment and structure |
|
| >pdb|3PY3|A Chain A, Crystal Structure Of Phosphorylated P38alpha Map Kinase Length = 380 | Back alignment and structure |
|
| >pdb|3ODY|X Chain X, Crystal Structure Of P38alpha Y323q Active Mutant Length = 360 | Back alignment and structure |
|
| >pdb|3OEF|X Chain X, Crystal Structure Of Y323f Inactive Mutant Of P38alpha Map Kinase Length = 360 | Back alignment and structure |
|
| >pdb|3OD6|X Chain X, Crystal Structure Of P38alpha Y323t Active Mutant Length = 360 | Back alignment and structure |
|
| >pdb|1DI9|A Chain A, The Structure Of P38 Mitogen-Activated Protein Kinase In Complex With 4-[3-Methylsulfanylanilino]-6,7- Dimethoxyquinazoline Length = 360 | Back alignment and structure |
|
| >pdb|2BAJ|A Chain A, P38alpha Bound To Pyrazolourea Length = 365 | Back alignment and structure |
|
| >pdb|3HRB|A Chain A, P38 Kinase Crystal Structure In Complex With Small Molecule Inhibitor Length = 359 | Back alignment and structure |
|
| >pdb|2BAL|A Chain A, P38alpha Map Kinase Bound To Pyrazoloamine Length = 365 | Back alignment and structure |
|
| >pdb|2NPQ|A Chain A, A Novel Lipid Binding Site In The P38 Alpha Map Kinase Length = 367 | Back alignment and structure |
|
| >pdb|3P4K|A Chain A, The Third Conformation Of P38a Map Kinase Observed In Phosphorylated P38a And In Solution Length = 370 | Back alignment and structure |
|
| >pdb|2VWU|A Chain A, Ephb4 Kinase Domain Inhibitor Complex Length = 302 | Back alignment and structure |
|
| >pdb|2BAQ|A Chain A, P38alpha Bound To Ro3201195 Length = 365 | Back alignment and structure |
|
| >pdb|1ZMV|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark2PAR-1: K82r Mutant Length = 327 | Back alignment and structure |
|
| >pdb|2F57|A Chain A, Crystal Structure Of The Human P21-activated Kinase 5 Length = 317 | Back alignment and structure |
|
| >pdb|1LEW|A Chain A, Crystal Structure Of Map Kinase P38 Complexed To The Docking Site On Its Nuclear Substrate Mef2a Length = 360 | Back alignment and structure |
|
| >pdb|2R0I|A Chain A, Crystal Structure Of A Kinase Mark2PAR-1 Mutant Length = 327 | Back alignment and structure |
|
| >pdb|2PUU|A Chain A, Crystal Structure Of P38 Complex With 1-(5-Tert-Butyl-2-P- Tolyl-2h-Pyrazol-3-Yl)-3-[4-(6-Morpholin-4-Ylmethyl- Pyridin-3-Yl)naphthalen-1-Yl]urea Length = 348 | Back alignment and structure |
|
| >pdb|3HVC|A Chain A, Crystal Structure Of Human P38alpha Map Kinase Length = 362 | Back alignment and structure |
|
| >pdb|1ZMU|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark2PAR-1: Wild Type Length = 327 | Back alignment and structure |
|
| >pdb|1UA2|A Chain A, Crystal Structure Of Human Cdk7 Length = 346 | Back alignment and structure |
|
| >pdb|2PZR|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic K641r Mutation Responsible For Pfeiffer Syndrome Length = 324 | Back alignment and structure |
|
| >pdb|2OO8|X Chain X, Synthesis, Structural Analysis, And Sar Studies Of Triazine Derivatives As Potent, Selective Tie-2 Inhibitors Length = 317 | Back alignment and structure |
|
| >pdb|3GCU|A Chain A, Human P38 Map Kinase In Complex With Rl48 Length = 360 | Back alignment and structure |
|
| >pdb|2X7F|A Chain A, Crystal Structure Of The Kinase Domain Of Human Traf2- And Nck-Interacting Kinase With Wee1chk1 Inhibitor Length = 326 | Back alignment and structure |
|
| >pdb|3S3I|A Chain A, P38 Kinase Crystal Structure In Complex With Small Molecule Inhibitor Length = 349 | Back alignment and structure |
|
| >pdb|3HEC|A Chain A, P38 In Complex With Imatinib Length = 348 | Back alignment and structure |
|
| >pdb|3D7Z|A Chain A, Crystal Structure Of P38 Kinase In Complex With A Biphenyl Amide Inhibitor Length = 360 | Back alignment and structure |
|
| >pdb|2GTM|A Chain A, Mutated Mouse P38 Map Kinase Domain In Complex With Inhibitor Pg-892579 Length = 348 | Back alignment and structure |
|
| >pdb|3ZSG|A Chain A, X-Ray Structure Of P38alpha Bound To Tak-715 Length = 362 | Back alignment and structure |
|
| >pdb|3K3I|A Chain A, P38alpha Bound To Novel Dgf-Out Compound Pf-00215955 Length = 350 | Back alignment and structure |
|
| >pdb|3K3J|A Chain A, P38alpha Bound To Novel Dfg-Out Compound Pf-00416121 Length = 362 | Back alignment and structure |
|
| >pdb|1ZZL|A Chain A, Crystal Structure Of P38 With Triazolopyridine Length = 351 | Back alignment and structure |
|
| >pdb|3E92|A Chain A, Crystal Structure Of P38 Kinase In Complex With A Biaryl Amide Inhibitor Length = 371 | Back alignment and structure |
|
| >pdb|2LGC|A Chain A, Joint Nmr And X-Ray Refinement Reveals The Structure Of A Novel Dibenzo[a,D]cycloheptenone InhibitorP38 MAP KINASE COMPLEX IN Solution Length = 359 | Back alignment and structure |
|
| >pdb|4EWQ|A Chain A, Human P38 Alpha Mapk In Complex With A Pyridazine Based Inhibitor Length = 383 | Back alignment and structure |
|
| >pdb|3NNU|A Chain A, Crystal Structure Of P38 Alpha In Complex With Dp1376 Length = 354 | Back alignment and structure |
|
| >pdb|3D83|A Chain A, Crystal Structure Of P38 Kinase In Complex With A Biphenyl Amide Inhibitor Length = 360 | Back alignment and structure |
|
| >pdb|1M7Q|A Chain A, Crystal Structure Of P38 Map Kinase In Complex With A Dihydroquinazolinone Inhibitor Length = 366 | Back alignment and structure |
|
| >pdb|1OZ1|A Chain A, P38 Mitogen-Activated Kinase In Complex With 4-Azaindole Inhibitor Length = 372 | Back alignment and structure |
|
| >pdb|3LM0|A Chain A, Crystal Structure Of Human SerineTHREONINE KINASE 17B (STK17B) Length = 327 | Back alignment and structure |
|
| >pdb|2GFS|A Chain A, P38 Kinase Crystal Structure In Complex With Ro3201195 Length = 372 | Back alignment and structure |
|
| >pdb|1BMK|A Chain A, The Complex Structure Of The Map Kinase P38SB218655 Length = 379 | Back alignment and structure |
|
| >pdb|3FI4|A Chain A, P38 Kinase Crystal Structure In Complex With Ro4499 Length = 372 | Back alignment and structure |
|
| >pdb|1FVR|A Chain A, Tie2 Kinase Domain Length = 327 | Back alignment and structure |
|
| >pdb|3IEC|A Chain A, Helicobacter Pylori Caga Inhibits Par1MARK FAMILY KINASES BY Mimicking Host Substrates Length = 319 | Back alignment and structure |
|
| >pdb|1OPK|A Chain A, Structural Basis For The Auto-Inhibition Of C-Abl Tyrosine Kinase Length = 495 | Back alignment and structure |
|
| >pdb|3MPT|A Chain A, Crystal Structure Of P38 Kinase In Complex With A Pyrrole-2- Carboxamide Inhibitor Length = 371 | Back alignment and structure |
|
| >pdb|3TG1|A Chain A, Crystal Structure Of P38alpha In Complex With A Mapk Docking Partner Length = 380 | Back alignment and structure |
|
| >pdb|1BL6|A Chain A, The Complex Structure Of The Map Kinase P38SB216995 Length = 379 | Back alignment and structure |
|
| >pdb|3KQ7|A Chain A, Structure Of Human P38alpha With N-[4-Methyl-3-(6-{[2-(1- Methylpyrrolidin-2-Yl)ethyl]amino}pyridine-3- Amido)phenyl]- 2-(Morpholin-4-Yl)pyridine-4-Carboxamide Length = 380 | Back alignment and structure |
|
| >pdb|1IAN|A Chain A, Human P38 Map Kinase Inhibitor Complex Length = 366 | Back alignment and structure |
|
| >pdb|2OZA|B Chain B, Structure Of P38alpha Complex Length = 366 | Back alignment and structure |
|
| >pdb|1ZMW|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark2PAR-1: T208aS212A INACTIVE DOUBLE MUTANT Length = 327 | Back alignment and structure |
|
| >pdb|3DT1|A Chain A, P38 Complexed With A Quinazoline Inhibitor Length = 383 | Back alignment and structure |
|
| >pdb|4E4L|A Chain A, Jak1 Kinase (Jh1 Domain) In Complex With Compound 30 Length = 302 | Back alignment and structure |
|
| >pdb|2WZJ|A Chain A, Catalytic And Uba Domain Of Kinase Mark2(PAR-1) K82r, T208e Double Mutant Length = 327 | Back alignment and structure |
|
| >pdb|1OPL|A Chain A, Structural Basis For The Auto-Inhibition Of C-Abl Tyrosine Kinase Length = 537 | Back alignment and structure |
|
| >pdb|3FME|A Chain A, Crystal Structure Of Human Mitogen-Activated Protein Kinase Kinase 6 (Mek6) Activated Mutant (S207d, T211d) Length = 290 | Back alignment and structure |
|
| >pdb|2HEN|A Chain A, Crystal Structure Of The Ephb2 Receptor Kinase Domain In Complex With Adp Length = 286 | Back alignment and structure |
|
| >pdb|3P08|A Chain A, Crystal Structure Of The Human Btk Kinase Domain Length = 267 | Back alignment and structure |
|
| >pdb|4ASZ|A Chain A, Crystal Structure Of Apo Trkb Kinase Domain Length = 299 | Back alignment and structure |
|
| >pdb|3GEN|A Chain A, The 1.6 A Crystal Structure Of Human Bruton's Tyrosine Kinase Bound To A Pyrrolopyrimidine-Containing Compound Length = 283 | Back alignment and structure |
|
| >pdb|3EYG|A Chain A, Crystal Structures Of Jak1 And Jak2 Inhibitor Complexes Length = 290 | Back alignment and structure |
|
| >pdb|2Y8O|A Chain A, Crystal Structure Of Human P38alpha Complexed With A Mapk Docking Peptide Length = 362 | Back alignment and structure |
|
| >pdb|3QUP|A Chain A, Inhibitor Bound Structure Of The Kinase Domain Of The Murine Receptor Tyrosine Kinase Tyro3 (Sky) Length = 323 | Back alignment and structure |
|
| >pdb|1OVE|A Chain A, The Structure Of P38 Alpha In Complex With A Dihydroquinolinone Length = 366 | Back alignment and structure |
|
| >pdb|3OCS|A Chain A, Crystal Structure Of Bruton's Tyrosine Kinase In Complex With Inhibitor Cgi1746 Length = 271 | Back alignment and structure |
|
| >pdb|1K2P|A Chain A, Crystal Structure Of Bruton's Tyrosine Kinase Domain Length = 263 | Back alignment and structure |
|
| >pdb|3PIX|A Chain A, Crystal Structure Of Btk Kinase Domain Complexed With 2-Isopropyl-7- (4-Methyl-Piperazin-1-Yl)-4-(5-Methyl-2h-Pyrazol-3- Ylamino)-2h- Phthalazin-1-One Length = 274 | Back alignment and structure |
|
| >pdb|4FIE|A Chain A, Full-Length Human Pak4 Length = 423 | Back alignment and structure |
|
| >pdb|4I3Z|A Chain A, Structure Of Pcdk2CYCLINA BOUND TO ADP AND 2 MAGNESIUM IONS Length = 296 | Back alignment and structure |
|
| >pdb|3UC3|A Chain A, The Crystal Structure Of Snf1-Related Kinase 2.3 Length = 361 | Back alignment and structure |
|
| >pdb|1OB3|A Chain A, Structure Of P. Falciparum Pfpk5 Length = 288 | Back alignment and structure |
|
| >pdb|1E9H|A Chain A, Thr 160 Phosphorylated Cdk2-Human Cyclin A3 Complex With The Inhibitor Indirubin-5-Sulphonate Bound Length = 297 | Back alignment and structure |
|
| >pdb|2JGZ|A Chain A, Crystal Structure Of Phospho-Cdk2 In Complex With Cyclin B Length = 289 | Back alignment and structure |
|
| >pdb|4EOI|A Chain A, Thr 160 Phosphorylated Cdk2 K89d, Q131e - Human Cyclin A3 Complex With The Inhibitor Ro3306 Length = 299 | Back alignment and structure |
|
| >pdb|2IW6|A Chain A, Structure Of Human Thr160-Phospho Cdk2-Cyclin A Complexed With A Bisanilinopyrimidine Inhibitor Length = 302 | Back alignment and structure |
|
| >pdb|1W98|A Chain A, The Structural Basis Of Cdk2 Activation By Cyclin E Length = 298 | Back alignment and structure |
|
| >pdb|2IW8|A Chain A, Structure Of Human Thr160-Phospho Cdk2-Cyclin A F82h-L83v- H84d Mutant With An O6-Cyclohexylmethylguanine Inhibitor Length = 302 | Back alignment and structure |
|
| >pdb|4EOS|A Chain A, Thr 160 Phosphorylated Cdk2 Wt - Human Cyclin A3 Complex With The Inhibitor Ro3306 Length = 300 | Back alignment and structure |
|
| >pdb|4EOQ|A Chain A, Thr 160 Phosphorylated Cdk2 Wt - Human Cyclin A3 Complex With Atp Length = 301 | Back alignment and structure |
|
| >pdb|4EOP|A Chain A, Thr 160 Phosphorylated Cdk2 Q131e - Human Cyclin A3 Complex With The Inhibitor Ro3306 Length = 300 | Back alignment and structure |
|
| >pdb|4EOM|A Chain A, Thr 160 Phosphorylated Cdk2 H84s, Q85m, Q131e - Human Cyclin A3 Complex With Atp Length = 301 | Back alignment and structure |
|
| >pdb|4BCQ|A Chain A, Structure Of Cdk2 In Complex With Cyclin A And A 2-amino-4- Heteroaryl-pyrimidine Inhibitor Length = 301 | Back alignment and structure |
|
| >pdb|1QMZ|A Chain A, Phosphorylated Cdk2-Cyclyin A-Substrate Peptide Complex Length = 299 | Back alignment and structure |
|
| >pdb|4EOO|A Chain A, Thr 160 Phosphorylated Cdk2 Q131e - Human Cyclin A3 Complex With Atp Length = 299 | Back alignment and structure |
|
| >pdb|1OGU|A Chain A, Structure Of Human Thr160-phospho Cdk2/cyclin A Complexed With A 2-arylamino-4-cyclohexylmethyl-5-nitroso-6- aminopyrimidine Inhibitor Length = 302 | Back alignment and structure |
|
| >pdb|1JST|A Chain A, Phosphorylated Cyclin-Dependent Kinase-2 Bound To Cyclin A Length = 298 | Back alignment and structure |
|
| >pdb|3QHR|A Chain A, Structure Of A Pcdk2CYCLINA TRANSITION-State Mimic Length = 298 | Back alignment and structure |
|
| >pdb|3BHT|A Chain A, Structure Of Phosphorylated Thr160 Cdk2CYCLIN A IN COMPLEX WITH THE Inhibitor Meriolin 3 Length = 300 | Back alignment and structure |
|
| >pdb|1H1P|A Chain A, Structure Of Human Thr160-Phospho Cdk2CYCLIN A COMPLEXED With The Inhibitor Nu2058 Length = 303 | Back alignment and structure |
|
| >pdb|4EOJ|A Chain A, Thr 160 Phosphorylated Cdk2 H84s, Q85m, K89d - Human Cyclin A3 Complex With Atp Length = 302 | Back alignment and structure |
|
| >pdb|4EON|A Chain A, Thr 160 Phosphorylated Cdk2 H84s, Q85m, Q131e - Human Cyclin A3 Complex With The Inhibitor Ro3306 Length = 300 | Back alignment and structure |
|
| >pdb|4EOK|A Chain A, Thr 160 Phosphorylated Cdk2 H84s, Q85m, K89d - Human Cyclin A3 Complex With The Inhibitor Nu6102 Length = 300 | Back alignment and structure |
|
| >pdb|3E62|A Chain A, Fragment Based Discovery Of Jak-2 Inhibitors Length = 293 | Back alignment and structure |
|
| >pdb|2W1I|A Chain A, Structure Determination Of Aurora Kinase In Complex With Inhibitor Length = 326 | Back alignment and structure |
|
| >pdb|2Q0N|A Chain A, Structure Of Human P21 Activating Kinase 4 (Pak4) In Complex With A Consensus Peptide Length = 301 | Back alignment and structure |
|
| >pdb|4E4M|A Chain A, Jak2 Kinase (Jh1 Domain) In Complex With Compound 30 Length = 302 | Back alignment and structure |
|
| >pdb|2B7A|A Chain A, The Structural Basis Of Janus Kinase 2 Inhibition By A Potent And Specific Pan-Janus Kinase Inhibitor Length = 293 | Back alignment and structure |
|
| >pdb|3TJC|A Chain A, Co-Crystal Structure Of Jak2 With Thienopyridine 8 Length = 298 | Back alignment and structure |
|
| >pdb|3Q32|A Chain A, Structure Of Janus Kinase 2 With A Pyrrolotriazine Inhibitor Length = 301 | Back alignment and structure |
|
| >pdb|2XA4|A Chain A, Inhibitors Of Jak2 Kinase Domain Length = 298 | Back alignment and structure |
|
| >pdb|2CLQ|A Chain A, Structure Of Mitogen-Activated Protein Kinase Kinase Kinase 5 Length = 295 | Back alignment and structure |
|
| >pdb|2CDZ|A Chain A, Crystal Structure Of The Human P21-Activated Kinase 4 In Complex With Cgp74514a Length = 303 | Back alignment and structure |
|
| >pdb|2BVA|A Chain A, Crystal Structure Of The Human P21-Activated Kinase 4 Length = 292 | Back alignment and structure |
|
| >pdb|4HGE|A Chain A, Jak2 Kinase (Jh1 Domain) In Complex With Compound 8 Length = 300 | Back alignment and structure |
|
| >pdb|3LPB|A Chain A, Crystal Structure Of Jak2 Complexed With A Potent 2,8-Diaryl Quinoxaline Inhibitor Length = 295 | Back alignment and structure |
|
| >pdb|3MH2|A Chain A, Mutagenesis Of P38 Map Kinase Establishes Key Roles Of Phe169 In Function And Structural Dynamics And Reveals A Novel Dfg-Out State Length = 360 | Back alignment and structure |
|
| >pdb|4E6D|A Chain A, Jak2 Kinase (Jh1 Domain) Triple Mutant In Complex With Compound 7 Length = 298 | Back alignment and structure |
|
| >pdb|3RVG|A Chain A, Crystals Structure Of Jak2 With A 1-Amino-5h-Pyrido[4,3-B]indol-4- Carboxamide Inhibitor Length = 303 | Back alignment and structure |
|
| >pdb|4AQC|A Chain A, Triazolopyridine-Based Inhibitor Of Janus Kinase 2 Length = 301 | Back alignment and structure |
|
| >pdb|3K54|A Chain A, Structures Of Human Bruton's Tyrosine Kinase In Active And Inactive Conformations Suggests A Mechanism Of Activation For Tec Family Kinases Length = 283 | Back alignment and structure |
|
| >pdb|4FR4|A Chain A, Crystal Structure Of Human SerineTHREONINE-Protein Kinase 32a (Yank1) Length = 384 | Back alignment and structure |
|
| >pdb|2OZO|A Chain A, Autoinhibited Intact Human Zap-70 Length = 613 | Back alignment and structure |
|
| >pdb|1V0O|A Chain A, Structure Of P. Falciparum Pfpk5-Indirubin-5-Sulphonate Ligand Complex Length = 288 | Back alignment and structure |
|
| >pdb|3JY9|A Chain A, Janus Kinase 2 Inhibitors Length = 311 | Back alignment and structure |
|
| >pdb|1V0B|A Chain A, Crystal Structure Of The T198a Mutant Of Pfpk5 Length = 288 | Back alignment and structure |
|
| >pdb|3IO7|A Chain A, 2-Aminopyrazolo[1,5-A]pyrimidines As Potent And Selective Inhibitors Of Jak2 Length = 313 | Back alignment and structure |
|
| >pdb|4FIF|A Chain A, Catalytic Domain Of Human Pak4 With Rpkplvdp Peptide Length = 346 | Back alignment and structure |
|
| >pdb|3OCT|A Chain A, Crystal Structure Of Bruton's Tyrosine Kinase Mutant V555r In Complex With Dasatinib Length = 265 | Back alignment and structure |
|
| >pdb|2X4Z|A Chain A, Crystal Structure Of The Human P21-Activated Kinase 4 In Complex With Pf-03758309 Length = 296 | Back alignment and structure |
|
| >pdb|3VW6|A Chain A, Crystal Structure Of Human Apoptosis Signal-Regulating Kinase 1 (Ask1) With Imidazopyridine Inhibitor Length = 269 | Back alignment and structure |
|
| >pdb|1O6L|A Chain A, Crystal Structure Of An Activated Akt/protein Kinase B (pkb-pif Chimera) Ternary Complex With Amp-pnp And Gsk3 Peptide Length = 337 | Back alignment and structure |
|
| >pdb|2JDO|A Chain A, Structure Of Pkb-Beta (Akt2) Complexed With Isoquinoline-5- Sulfonic Acid (2-(2-(4-Chlorobenzyloxy) Ethylamino)ethyl) Amide Length = 342 | Back alignment and structure |
|
| >pdb|1O6K|A Chain A, Structure Of Activated Form Of Pkb Kinase Domain S474d With Gsk3 Peptide And Amp-Pnp Length = 336 | Back alignment and structure |
|
| >pdb|3UDB|A Chain A, Crystal Structure Of Snrk2.6 Length = 317 | Back alignment and structure |
|
| >pdb|2W99|B Chain B, Crystal Structure Of Cdk4 In Complex With A D-Type Cyclin Length = 306 | Back alignment and structure |
|
| >pdb|3E87|A Chain A, Crystal Structures Of The Kinase Domain Of Akt2 In Complex With Atp- Competitive Inhibitors Length = 335 | Back alignment and structure |
|
| >pdb|3G33|A Chain A, Crystal Structure Of Cdk4CYCLIN D3 Length = 308 | Back alignment and structure |
|
| >pdb|2W96|B Chain B, Crystal Structure Of Cdk4 In Complex With A D-Type Cyclin Length = 306 | Back alignment and structure |
|
| >pdb|1GZK|A Chain A, Molecular Mechanism For The Regulation Of Protein Kinase B Akt By Hydrophobic Motif Phosphorylation Length = 315 | Back alignment and structure |
|
| >pdb|4DYM|A Chain A, Crystal Structure Of The Acvr1 Kinase Domain In Complex With The Imidazo[1,2-B]pyridazine Inhibitor K00135 Length = 301 | Back alignment and structure |
|
| >pdb|1MRV|A Chain A, Crystal Structure Of An Inactive Akt2 Kinase Domain Length = 339 | Back alignment and structure |
|
| >pdb|3UJG|A Chain A, Crystal Structure Of Snrk2.6 In Complex With Hab1 Length = 361 | Back alignment and structure |
|
| >pdb|3UC4|A Chain A, The Crystal Structure Of Snf1-Related Kinase 2.6 Length = 362 | Back alignment and structure |
|
| >pdb|3MTF|A Chain A, Crystal Structure Of The Acvr1 Kinase In Complex With A 2- Aminopyridine Inhibitor Length = 301 | Back alignment and structure |
|
| >pdb|2WQB|A Chain A, Structure Of The Tie2 Kinase Domain In Complex With A Thiazolopyrimidine Inhibitor Length = 324 | Back alignment and structure |
|
| >pdb|1GZN|A Chain A, Structure Of Pkb Kinase Domain Length = 335 | Back alignment and structure |
|
| >pdb|3H9R|A Chain A, Crystal Structure Of The Kinase Domain Of Type I Activin Receptor (Acvr1) In Complex With Fkbp12 And Dorsomorphin Length = 330 | Back alignment and structure |
|
| >pdb|3GCP|A Chain A, Human P38 Map Kinase In Complex With Sb203580 Length = 360 | Back alignment and structure |
|
| >pdb|3D7T|A Chain A, Structural Basis For The Recognition Of C-Src By Its Inactivator Csk Length = 269 | Back alignment and structure |
|
| >pdb|2PK9|A Chain A, Structure Of The Pho85-pho80 Cdk-cyclin Complex Of The Phosphate-responsive Signal Transduction Pathway Length = 317 | Back alignment and structure |
|
| >pdb|3LMG|A Chain A, Crystal Structure Of The Erbb3 Kinase Domain In Complex With Amp-Pnp Length = 344 | Back alignment and structure |
|
| >pdb|1Y8G|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark2PAR-1: Inactive Double Mutant With Selenomethionine Length = 327 | Back alignment and structure |
|
| >pdb|4IC7|A Chain A, Crystal Structure Of The Erk5 Kinase Domain In Complex With An Mkk5 Binding Fragment Length = 442 | Back alignment and structure |
|
| >pdb|3KEX|A Chain A, Crystal Structure Of The Catalytically Inactive Kinase Domain Of The Human Epidermal Growth Factor Receptor 3 (Her3) Length = 325 | Back alignment and structure |
|
| >pdb|3H4J|B Chain B, Crystal Structure Of Pombe Ampk Kdaid Fragment Length = 336 | Back alignment and structure |
|
| >pdb|2Y7J|A Chain A, Structure Of Human Phosphorylase Kinase, Gamma 2 Length = 365 | Back alignment and structure |
|
| >pdb|1K9A|A Chain A, Crystal Structure Analysis Of Full-Length Carboxyl-Terminal Src Kinase At 2.5 A Resolution Length = 450 | Back alignment and structure |
|
| >pdb|3A60|A Chain A, Crystal Structure Of Unphosphorylated P70s6k1 (Form I) Length = 327 | Back alignment and structure |
|
| >pdb|3VUL|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M1 In Map Kinase Jnk1 Length = 370 | Back alignment and structure |
|
| >pdb|3O8P|A Chain A, Conformational Plasticity Of P38 Map Kinase Dfg Motif Mutants In Response To Inhibitor Binding Length = 360 | Back alignment and structure |
|
| >pdb|3VUM|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M7 In Map Kinase Jnk1 Length = 370 | Back alignment and structure |
|
| >pdb|4B99|A Chain A, Crystal Structure Of Mapk7 (Erk5) With Inhibitor Length = 398 | Back alignment and structure |
|
| >pdb|2W9F|B Chain B, Crystal Structure Of Cdk4 In Complex With A D-Type Cyclin Length = 306 | Back alignment and structure |
|
| >pdb|1CM8|A Chain A, Phosphorylated Map Kinase P38-Gamma Length = 367 | Back alignment and structure |
|
| >pdb|3V3V|A Chain A, Structural And Functional Analysis Of Quercetagetin, A Natural Jnk1 Inhibitor Length = 379 | Back alignment and structure |
|
| >pdb|3MH0|A Chain A, Mutagenesis Of P38 Map Kinase Eshtablishes Key Roles Of Phe169 In Function And Structural Dynamics And Reveals A Novel Dfg-Out State Length = 360 | Back alignment and structure |
|
| >pdb|2VZ6|A Chain A, Structure Of Human Calcium Calmodulin Dependent Protein Kinase Type Ii Alpha (Camk2a) In Complex With Indirubin E804 Length = 313 | Back alignment and structure |
|
| >pdb|3UGC|A Chain A, Structural Basis Of Jak2 Inhibition By The Type Ii Inhibtor Nvp-Bbt594 Length = 295 | Back alignment and structure |
|
| >pdb|3GP0|A Chain A, Crystal Structure Of Human Mitogen Activated Protein Kinase 11 (p38 Beta) In Complex With Nilotinib Length = 348 | Back alignment and structure |
|
| >pdb|3D7U|A Chain A, Structural Basis For The Recognition Of C-Src By Its Inactivator Csk Length = 263 | Back alignment and structure |
|
| >pdb|3MH3|A Chain A, Mutagenesis Of P38 Map Kinase Establishes Key Roles Of Phe169 In Function And Structural Dynamics And Reveals A Novel Dfg-Out State Length = 360 | Back alignment and structure |
|
| >pdb|4EC8|A Chain A, Structure Of Full Length Cdk9 In Complex With Cyclint And Drb Length = 373 | Back alignment and structure |
|
| >pdb|3A62|A Chain A, Crystal Structure Of Phosphorylated P70s6k1 Length = 327 | Back alignment and structure |
|
| >pdb|1ZRZ|A Chain A, Crystal Structure Of The Catalytic Domain Of Atypical Protein Kinase C-Iota Length = 364 | Back alignment and structure |
|
| >pdb|2JFL|A Chain A, Crystal Structure Of Human Ste20-Like Kinase ( Diphosphorylated Form) Bound To 5- Amino-3-((4-( Aminosulfonyl)phenyl)amino)-N-(2,6- Difluorophenyl)-1h-1,2, 4-Triazole-1-Carbothioamide Length = 325 | Back alignment and structure |
|
| >pdb|3TTJ|A Chain A, Crystal Structure Of Jnk3 Complexed With Cc-359, A Jnk Inhibitor For The Prevention Of Ischemia-Reperfusion Injury Length = 464 | Back alignment and structure |
|
| >pdb|1BYG|A Chain A, Kinase Domain Of Human C-Terminal Src Kinase (Csk) In Complex With Inhibitor Staurosporine Length = 278 | Back alignment and structure |
|
| >pdb|3GI3|A Chain A, Crystal Structure Of A N-Phenyl-N'-Naphthylurea Analog In Complex With P38 Map Kinase Length = 360 | Back alignment and structure |
|
| >pdb|2JFM|A Chain A, Crystal Structure Of Human Ste20-Like Kinase (Unliganded Form) Length = 325 | Back alignment and structure |
|
| >pdb|4DC2|A Chain A, Structure Of Pkc In Complex With A Substrate Peptide From Par-3 Length = 396 | Back alignment and structure |
|
| >pdb|3FZO|A Chain A, Crystal Structure Of Pyk2-Apo, Proline-Rich Tyrosine Kinase Length = 277 | Back alignment and structure |
|
| >pdb|2J51|A Chain A, Crystal Structure Of Human Ste20-Like Kinase Bound To 5- Amino-3-((4-(Aminosulfonyl)phenyl)amino)-N-(2,6- Difluorophenyl)-1h-1,2,4-Triazole-1-Carbothioamide Length = 325 | Back alignment and structure |
|
| >pdb|3ZH8|A Chain A, A Novel Small Molecule Apkc Inhibitor Length = 349 | Back alignment and structure |
|
| >pdb|3MH1|A Chain A, Mutagenesis Of P38 Map Kinase Establishes Key Roles Of Phe169 In Function And Structural Dynamics And Reveals A Novel Dfg-Out State Length = 360 | Back alignment and structure |
|
| >pdb|3A8W|A Chain A, Crystal Structure Of Pkciota Kinase Domain Length = 345 | Back alignment and structure |
|
| >pdb|1JNK|A Chain A, The C-Jun N-Terminal Kinase (Jnk3s) Complexed With Mgamp-Pnp Length = 423 | Back alignment and structure |
|
| >pdb|4BCF|A Chain A, Structure Of Cdk9 In Complex With Cyclin T And A 2-amino-4- Heteroaryl-pyrimidine Inhibitor Length = 331 | Back alignment and structure |
|
| >pdb|3OXI|A Chain A, Design And Synthesis Of Disubstituted Thiophene And Thiazole Based Inhibitors Of Jnk For The Treatment Of Neurodegenerative Diseases Length = 362 | Back alignment and structure |
|
| >pdb|3BLH|A Chain A, Crystal Structure Of Human Cdk9CYCLINT1 Length = 331 | Back alignment and structure |
|
| >pdb|2B1P|A Chain A, Inhibitor Complex Of Jnk3 Length = 355 | Back alignment and structure |
|
| >pdb|4H36|A Chain A, Crystal Structure Of Jnk3 In Complex With Atf2 Peptide Length = 356 | Back alignment and structure |
|
| >pdb|1PMN|A Chain A, Crystal Structure Of Jnk3 In Complex With An Imidazole- Pyrimidine Inhibitor Length = 364 | Back alignment and structure |
|
| >pdb|3PTG|A Chain A, Design And Synthesis Of A Novel, Orally Efficacious Tri-Substituted Thiophene Based Jnk Inhibitor Length = 363 | Back alignment and structure |
|
| >pdb|3CC6|A Chain A, Crystal Structure Of Kinase Domain Of Protein Tyrosine Kinase 2 Beta (ptk2b) Length = 281 | Back alignment and structure |
|
| >pdb|2O0U|A Chain A, Crystal Structure Of Human Jnk3 Complexed With N-{3-Cyano-6-[3-(1- Piperidinyl)propanoyl]-4,5,6,7-Tetrahydrothieno[2, 3-C]pyridin-2-Yl}- 1-Naphthalenecarboxamide Length = 364 | Back alignment and structure |
|
| >pdb|2OK1|A Chain A, Crystal Structure Of Jnk3 Bound To N-Benzyl-4-(4-(3- Chlorophenyl)-1h-Pyrazol-3-Yl)-1h-Pyrrole-2-Carboxamide Length = 365 | Back alignment and structure |
|
| >pdb|2EXC|X Chain X, Inhibitor Complex Of Jnk3 Length = 356 | Back alignment and structure |
|
| >pdb|4H1J|A Chain A, Crystal Structure Of Pyk2 With The Pyrazole 13a Length = 293 | Back alignment and structure |
|
| >pdb|2R9S|A Chain A, C-Jun N-Terminal Kinase 3 With 3,5-Disubstituted Quinoline Inhibitor Length = 356 | Back alignment and structure |
|
| >pdb|2W4O|A Chain A, Crystal Structure Of Human Camk4 In Complex With 4-Amino( Sulfamoyl-Phenylamino)-Triazole-Carbothioic Acid (2,6- Difluoro-Phenyl)-Amide) Length = 349 | Back alignment and structure |
|
| >pdb|3MI9|A Chain A, Crystal Structure Of Hiv-1 Tat Complexed With Human P-Tefb Length = 351 | Back alignment and structure |
|
| >pdb|4BC6|A Chain A, Crystal Structure Of Human Serine Threonine Kinase-10 Bound To Novel Bosutinib Isoform 1, Previously Thought To Be Bosutinib Length = 293 | Back alignment and structure |
|
| >pdb|3RGF|A Chain A, Crystal Structure Of Human Cdk8CYCC Length = 405 | Back alignment and structure |
|
| >pdb|3FI2|A Chain A, Crystal Structure Of Jnk3 With Amino-Pyrazole Inhibitor, Sr- 3451 Length = 353 | Back alignment and structure |
|
| >pdb|3KVX|A Chain A, Jnk3 Bound To Aminopyrimidine Inhibitor, Sr-3562 Length = 364 | Back alignment and structure |
|
| >pdb|3ENM|A Chain A, The Structure Of The Map2k Mek6 Reveals An Autoinhibitory Dimer Length = 316 | Back alignment and structure |
|
| >pdb|3FV8|A Chain A, Jnk3 Bound To Piperazine Amide Inhibitor, Sr2774 Length = 355 | Back alignment and structure |
|
| >pdb|3GC8|A Chain A, The Structure Of P38beta C162s In Complex With A Dihydroquinazolinone Length = 370 | Back alignment and structure |
|
| >pdb|3GC9|A Chain A, The Structure Of P38beta C119s, C162s In Complex With A Dihydroquinazolinone Inhibitor Length = 370 | Back alignment and structure |
|
| >pdb|2J7T|A Chain A, Crystal Structure Of Human Serine Threonine Kinase-10 Bound To Su11274 Length = 302 | Back alignment and structure |
|
| >pdb|3FI3|A Chain A, Crystal Structure Of Jnk3 With Indazole Inhibitor, Sr-3737 Length = 364 | Back alignment and structure |
|
| >pdb|2XRW|A Chain A, Linear Binding Motifs For Jnk And For Calcineurin Antagonistically Control The Nuclear Shuttling Of Nfat4 Length = 371 | Back alignment and structure |
|
| >pdb|1UKH|A Chain A, Structural Basis For The Selective Inhibition Of Jnk1 By The Scaffolding Protein Jip1 And Sp600125 Length = 369 | Back alignment and structure |
|
| >pdb|3G2F|A Chain A, Crystal Structure Of The Kinase Domain Of Bone Morphogenetic Protein Receptor Type Ii (Bmpr2) At 2.35 A Resolution Length = 336 | Back alignment and structure |
|
| >pdb|4BBE|A Chain A, Aminoalkylpyrimidine Inhibitor Complexes With Jak2 Length = 298 | Back alignment and structure |
|
| >pdb|3VUD|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M1 In Map Kinase Jnk1 Length = 370 | Back alignment and structure |
|
| >pdb|3O17|A Chain A, Crystal Structure Of Jnk1-Alpha1 Isoform Length = 370 | Back alignment and structure |
|
| >pdb|1VZO|A Chain A, The Structure Of The N-Terminal Kinase Domain Of Msk1 Reveals A Novel Autoinhibitory Conformation For A Dual Kinase Protein Length = 355 | Back alignment and structure |
|
| >pdb|3VUG|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M2 In Map Kinase Jnk1 Length = 370 | Back alignment and structure |
|
| >pdb|3PZE|A Chain A, Jnk1 In Complex With Inhibitor Length = 358 | Back alignment and structure |
|
| >pdb|3MDY|A Chain A, Crystal Structure Of The Cytoplasmic Domain Of The Bone Morp Protein Receptor Type-1b (Bmpr1b) In Complex With Fkbp12 An 193189 Length = 337 | Back alignment and structure |
|
| >pdb|3ELJ|A Chain A, Jnk1 Complexed With A Bis-Anilino-Pyrrolopyrimidine Inhibitor Length = 369 | Back alignment and structure |
|
| >pdb|2XRU|A Chain A, Aurora-A T288e Complexed With Pha-828300 Length = 280 | Back alignment and structure |
|
| >pdb|3VUH|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M3 In Map Kinase Jnk1 Length = 370 | Back alignment and structure |
|
| >pdb|3VUI|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M2 In Map Kinase Jnk1 Length = 370 | Back alignment and structure |
|
| >pdb|3VUK|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M5 In Map Kinase Jnk1 Length = 370 | Back alignment and structure |
|
| >pdb|1OL5|A Chain A, Structure Of Aurora-A 122-403, Phosphorylated On Thr287, Thr288 And Bound To Tpx2 1-43 Length = 282 | Back alignment and structure |
|
| >pdb|2J4Z|A Chain A, Structure Of Aurora-2 In Complex With Pha-680626 Length = 306 | Back alignment and structure |
|
| >pdb|2F2U|A Chain A, Crystal Structure Of The Rho-Kinase Kinase Domain Length = 402 | Back alignment and structure |
|
| >pdb|3SOA|A Chain A, Full-Length Human Camkii Length = 444 | Back alignment and structure |
|
| >pdb|2R5T|A Chain A, Crystal Structure Of Inactive Serum And Glucocorticoid- Regulated Kinase 1 In Complex With Amp-Pnp Length = 373 | Back alignment and structure |
|
| >pdb|2BMC|A Chain A, Aurora-2 T287d T288d Complexed With Pha-680632 Length = 306 | Back alignment and structure |
|
| >pdb|4F0F|A Chain A, Crystal Structure Of The Roco4 Kinase Domain Bound To Appcp From D. Discoideum Length = 287 | Back alignment and structure |
|
| >pdb|1MUO|A Chain A, Crystal Structure Of Aurora-2, An Oncogenic Serine- Threonine Kinase Length = 297 | Back alignment and structure |
|
| >pdb|3MFR|A Chain A, Cask-4m Cam Kinase Domain, Native Length = 351 | Back alignment and structure |
|
| >pdb|2V7O|A Chain A, Crystal Structure Of Human Calcium-Calmodulin-Dependent Protein Kinase Ii Gamma Length = 336 | Back alignment and structure |
|
| >pdb|3UNZ|A Chain A, Aurora A In Complex With Rpm1679 Length = 279 | Back alignment and structure |
|
| >pdb|2J50|A Chain A, Structure Of Aurora-2 In Complex With Pha-739358 Length = 280 | Back alignment and structure |
|
| >pdb|4HZS|A Chain A, Crystal Structure Of Ack1 Kinase Domain With C-terminal Sh3 Domain Length = 341 | Back alignment and structure |
|
| >pdb|2X6D|A Chain A, Aurora-A Bound To An Inhibitor Length = 285 | Back alignment and structure |
|
| >pdb|2XNG|A Chain A, Structure Of Aurora-A Bound To A Selective Imidazopyrazine Inhibitor Length = 283 | Back alignment and structure |
|
| >pdb|3NRM|A Chain A, Imidazo[1,2-A]pyrazine-Based Aurora Kinase Inhibitors Length = 283 | Back alignment and structure |
|
| >pdb|3LAU|A Chain A, Crystal Structure Of Aurora2 Kinase In Complex With A Gsk3beta Inhibitor Length = 287 | Back alignment and structure |
|
| >pdb|3FDN|A Chain A, Structure-Based Drug Design Of Novel Aurora Kinase A Inhibitors: Structure Basis For Potency And Specificity Length = 279 | Back alignment and structure |
|
| >pdb|3ZUT|A Chain A, The Structure Of Ost1 (D160a) Kinase Length = 362 | Back alignment and structure |
|
| >pdb|2WTW|A Chain A, Aurora-A Inhibitor Structure (2nd Crystal Form) Length = 285 | Back alignment and structure |
|
| >pdb|3HA6|A Chain A, Crystal Structure Of Aurora A In Complex With Tpx2 And Compound 10 Length = 268 | Back alignment and structure |
|
| >pdb|3NPC|A Chain A, Crystal Structure Of Jnk2 Complexed With Birb796 Length = 364 | Back alignment and structure |
|
| >pdb|2G01|A Chain A, Pyrazoloquinolones As Novel, Selective Jnk1 Inhibitors Length = 370 | Back alignment and structure |
|
| >pdb|2C6D|A Chain A, Aurora A Kinase Activated Mutant (T287d) In Complex With Adpnp Length = 275 | Back alignment and structure |
|
| >pdb|1XH9|A Chain A, Crystal Structures Of Protein Kinase B Selective Inhibitors In Complex With Protein Kinase A And Mutants Length = 350 | Back alignment and structure |
|
| >pdb|2W1C|A Chain A, Structure Determination Of Aurora Kinase In Complex With Inhibitor Length = 275 | Back alignment and structure |
|
| >pdb|3H0Y|A Chain A, Aurora A In Complex With A Bisanilinopyrimidine Length = 268 | Back alignment and structure |
|
| >pdb|3E5A|A Chain A, Crystal Structure Of Aurora A In Complex With Vx-680 And Tpx2 Length = 268 | Back alignment and structure |
|
| >pdb|2C6E|A Chain A, Aurora A Kinase Activated Mutant (T287d) In Complex With A 5-Aminopyrimidinyl Quinazoline Inhibitor Length = 283 | Back alignment and structure |
|
| >pdb|3ZUU|A Chain A, The Structure Of Ost1 (D160a, S175d) Kinase In Complex With Gold Length = 362 | Back alignment and structure |
|
| >pdb|2WTV|A Chain A, Aurora-A Inhibitor Structure Length = 285 | Back alignment and structure |
|
| >pdb|2GNF|A Chain A, Protein Kinase A Fivefold Mutant Model Of Rho-Kinase With Y- 27632 Length = 350 | Back alignment and structure |
|
| >pdb|2GNJ|A Chain A, Pka Three Fold Mutant Model Of Rho-Kinase With Y-27632 Length = 350 | Back alignment and structure |
|
| >pdb|2GNG|A Chain A, Protein Kinase A Fivefold Mutant Model Of Rho-Kinase Length = 350 | Back alignment and structure |
|
| >pdb|4EWH|B Chain B, Co-Crystal Structure Of Ack1 With Inhibitor Length = 275 | Back alignment and structure |
|
| >pdb|2WQE|A Chain A, Structure Of S155r Aurora-A Somatic Mutant Length = 262 | Back alignment and structure |
|
| >pdb|3AMA|A Chain A, Protein Kinase A Sixfold Mutant Model Of Aurora B With Inhibitor Jnj- 7706621 Length = 351 | Back alignment and structure |
|
| >pdb|1MQ4|A Chain A, Crystal Structure Of Aurora-A Protein Kinase Length = 272 | Back alignment and structure |
|
| >pdb|2XS0|A Chain A, Linear Binding Motifs For Jnk And For Calcineurin Antagonistically Control The Nuclear Shuttling Of Nfat4 Length = 386 | Back alignment and structure |
|
| >pdb|3O50|A Chain A, Crystal Structure Of Benzamide 9 Bound To Auroraa Length = 267 | Back alignment and structure |
|
| >pdb|3V8S|A Chain A, Human Rho-Associated Protein Kinase 1 (Rock 1) In Complex With Indazole Derivative (Compound 18) Length = 410 | Back alignment and structure |
|
| >pdb|2F9G|A Chain A, Crystal Structure Of Fus3 Phosphorylated On Tyr182 Length = 353 | Back alignment and structure |
|
| >pdb|2ESM|A Chain A, Crystal Structure Of Rock 1 Bound To Fasudil Length = 415 | Back alignment and structure |
|
| >pdb|1ZYC|A Chain A, Crystal Structure Of Eif2alpha Protein Kinase Gcn2: Wild- Type In Apo Form. Length = 303 | Back alignment and structure |
|
| >pdb|3E7O|A Chain A, Crystal Structure Of Jnk2 Length = 360 | Back alignment and structure |
|
| >pdb|2W1D|A Chain A, Structure Determination Of Aurora Kinase In Complex With Inhibitor Length = 275 | Back alignment and structure |
|
| >pdb|1U54|A Chain A, Crystal Structures Of The Phosphorylated And Unphosphorylated Kinase Domains Of The Cdc42-Associated Tyrosine Kinase Ack1 Bound To Amp-Pcp Length = 291 | Back alignment and structure |
|
| >pdb|2V55|A Chain A, Mechanism Of Multi-site Phosphorylation From A Rock-i:rhoe Complex Structure Length = 406 | Back alignment and structure |
|
| >pdb|4HZR|A Chain A, Crystal Structure Of Ack1 Kinase Domain Length = 277 | Back alignment and structure |
|
| >pdb|4ID7|A Chain A, Ack1 Kinase In Complex With The Inhibitor Cis-3-[8-amino-1-(4- Phenoxyphenyl)imidazo[1,5-a]pyrazin-3-yl]cyclobutanol Length = 273 | Back alignment and structure |
|
| >pdb|3QBN|A Chain A, Structure Of Human Aurora A In Complex With A Diaminopyrimidine Length = 281 | Back alignment and structure |
|
| >pdb|1U46|A Chain A, Crystal Structure Of The Unphosphorylated Kinase Domain Of The Tyrosine Kinase Ack1 Length = 291 | Back alignment and structure |
|
| >pdb|3R21|A Chain A, Design, Synthesis, And Biological Evaluation Of Pyrazolopyridine- Sulfonamides As Potent Multiple-Mitotic Kinase (Mmk) Inhibitors (Part I) Length = 271 | Back alignment and structure |
|
| >pdb|3EQP|B Chain B, Crystal Structure Of Ack1 With Compound T95 Length = 276 | Back alignment and structure |
|
| >pdb|2B9H|A Chain A, Crystal Structure Of Fus3 With A Docking Motif From Ste7 Length = 353 | Back alignment and structure |
|
| >pdb|1ZY4|A Chain A, Crystal Structure Of Eif2alpha Protein Kinase Gcn2: R794g Hyperactivating Mutant In Apo Form. Length = 303 | Back alignment and structure |
|
| >pdb|2B9F|A Chain A, Crystal Structure Of Non-Phosphorylated Fus3 Length = 353 | Back alignment and structure |
|
| >pdb|3F3Z|A Chain A, Crystal Structure Of Cryptosporidium Parvum Calcium Dependent Protein Kinase Cgd7_1840 In Presence Of Indirubin E804 Length = 277 | Back alignment and structure |
|
| >pdb|2QG5|A Chain A, Cryptosporidium Parvum Calcium Dependent Protein Kinase Cgd7_1840 Length = 294 | Back alignment and structure |
|
| >pdb|4F1O|A Chain A, Crystal Structure Of The L1180t Mutant Roco4 Kinase Domain From D. Discoideum Bound To Appcp Length = 287 | Back alignment and structure |
|
| >pdb|3D14|A Chain A, Crystal Structure Of Mouse Aurora A (Asn186->gly, Lys240->arg, Met302- >leu) In Complex With 1-{5-[2-(Thieno[3,2-D]pyrimidin-4-Ylamino)- Ethyl]- Thiazol-2-Yl}-3-(3-Trifluoromethyl-Phenyl)-Urea Length = 272 | Back alignment and structure |
|
| >pdb|3DAJ|A Chain A, Crystal Structure Of Aurora A Complexed With An Inhibitor Discovered Through Site-Directed Dynamic Tethering Length = 272 | Back alignment and structure |
|
| >pdb|4AW2|A Chain A, Crystal Structure Of Cdc42 Binding Protein Kinase Alpha (Mrck Alpha) Length = 437 | Back alignment and structure |
|
| >pdb|2JAM|A Chain A, Crystal Structure Of Human Calmodulin-Dependent Protein Kinase I G Length = 304 | Back alignment and structure |
|
| >pdb|1SZM|A Chain A, Dual Binding Mode Of Bisindolylmaleimide 2 To Protein Kinase A (Pka) Length = 350 | Back alignment and structure |
|
| >pdb|2VO0|A Chain A, Structure Of Pka-Pkb Chimera Complexed With C-(4-(4- Chlorophenyl)-1-(7h-Pyrrolo(2, 3-D)pyrimidin-4-Yl)piperidin- 4-Yl)methylamine Length = 351 | Back alignment and structure |
|
| >pdb|2UVY|A Chain A, Structure Of Pka-pkb Chimera Complexed With Methyl-(4-(9h- Purin-6-yl)-benzyl)-amine Length = 351 | Back alignment and structure |
|
| >pdb|1Q61|A Chain A, Pka Triple Mutant Model Of Pkb Length = 350 | Back alignment and structure |
|
| >pdb|2JDT|A Chain A, Structure Of Pka-Pkb Chimera Complexed With Isoquinoline-5- Sulfonic Acid (2-(2-(4-Chlorobenzyloxy) Ethylamino)ethyl) Amide Length = 351 | Back alignment and structure |
|
| >pdb|4EXU|A Chain A, Mapk13, Inactive Form Length = 371 | Back alignment and structure |
|
| >pdb|3L9M|A Chain A, Crystal Structure Of Pkab3 (Pka Triple Mutant V123a, L173m, Q181k) With Compound 18 Length = 351 | Back alignment and structure |
|
| >pdb|2XK9|A Chain A, Structural Analysis Of Checkpoint Kinase 2 (Chk2) In Complex With Inhibitor Pv1533 Length = 322 | Back alignment and structure |
|
| >pdb|3COI|A Chain A, Crystal Structure Of P38delta Kinase Length = 353 | Back alignment and structure |
|
| >pdb|2DWB|A Chain A, Aurora-A Kinase Complexed With Amppnp Length = 285 | Back alignment and structure |
|
| >pdb|2YCR|A Chain A, Crystal Structure Of Checkpoint Kinase 2 In Complex With Inhibitor Pv976 Length = 323 | Back alignment and structure |
|
| >pdb|2YCF|A Chain A, Crystal Structure Of Checkpoint Kinase 2 In Complex With Inhibitor Pv1531 Length = 322 | Back alignment and structure |
|
| >pdb|3I6W|A Chain A, Structure And Activation Mechanism Of The Chk2 Dna-Damage Checkpoint Kinase Length = 443 | Back alignment and structure |
|
| >pdb|2W0J|A Chain A, Crystal Structure Of Chk2 In Complex With Nsc 109555, A Specific Inhibitor Length = 323 | Back alignment and structure |
|
| >pdb|4DN5|A Chain A, Crystal Structure Of Nf-kb-inducing Kinase (nik) Length = 356 | Back alignment and structure |
|
| >pdb|4DFX|E Chain E, Crystal Structure Of Myristoylated K7c Catalytic Subunit Of Camp- Dependent Protein Kinase In Complex With Sp20 And Amp-Pnp Length = 350 | Back alignment and structure |
|
| >pdb|3I6U|A Chain A, Structure And Activation Mechanism Of The Chk2 Dna-Damage Checkpoint Kinase Length = 419 | Back alignment and structure |
|
| >pdb|3COH|A Chain A, Crystal Structure Of Aurora-A In Complex With A Pentacyclic Inhibitor Length = 268 | Back alignment and structure |
|
| >pdb|2QUR|A Chain A, Crystal Structure Of F327aK285P MUTANT OF CAMP-Dependent Protein Kinase Length = 350 | Back alignment and structure |
|
| >pdb|2CN5|A Chain A, Crystal Structure Of Human Chk2 In Complex With Adp Length = 329 | Back alignment and structure |
|
| >pdb|3FHI|A Chain A, Crystal Structure Of A Complex Between The Catalytic And Regulatory (Ri{alpha}) Subunits Of Pka Length = 350 | Back alignment and structure |
|
| >pdb|3QAL|E Chain E, Crystal Structure Of Arg280ala Mutant Of Catalytic Subunit Of Camp- Dependent Protein Kinase Length = 350 | Back alignment and structure |
|
| >pdb|4AE9|A Chain A, Structure And Function Of The Human Sperm-specific Isoform Of Protein Kinase A (pka) Catalytic Subunit C Alpha 2 Length = 343 | Back alignment and structure |
|
| >pdb|4AE6|A Chain A, Structure And Function Of The Human Sperm-specific Isoform Of Protein Kinase A (pka) Catalytic Subunit Calpha 2 Length = 343 | Back alignment and structure |
|
| >pdb|1CDK|A Chain A, Camp-Dependent Protein Kinase Catalytic Subunit (E.C.2.7.1.37) (Protein Kinase A) Complexed With Protein Kinase Inhibitor Peptide Fragment 5-24 (Pki(5-24) Isoelectric Variant Ca) And Mn2+ Adenylyl Imidodiphosphate (Mnamp-Pnp) At Ph 5.6 And 7c And 4c Length = 350 | Back alignment and structure |
|
| >pdb|1CMK|E Chain E, Crystal Structures Of The Myristylated Catalytic Subunit Of Camp- Dependent Protein Kinase Reveal Open And Closed Conformations Length = 350 | Back alignment and structure |
|
| >pdb|2QCS|A Chain A, A Complex Structure Between The Catalytic And Regulatory Subunit Of Protein Kinase A That Represents The Inhibited State Length = 350 | Back alignment and structure |
|
| >pdb|1BKX|A Chain A, A Binary Complex Of The Catalytic Subunit Of Camp-Dependent Protein Kinase And Adenosine Further Defines Conformational Flexibility Length = 350 | Back alignment and structure |
|
| >pdb|1JBP|E Chain E, Crystal Structure Of The Catalytic Subunit Of Camp- Dependent Protein Kinase Complexed With A Substrate Peptide, Adp And Detergent Length = 350 | Back alignment and structure |
|
| >pdb|1L3R|E Chain E, Crystal Structure Of A Transition State Mimic Of The Catalytic Subunit Of Camp-Dependent Protein Kinase Length = 350 | Back alignment and structure |
|
| >pdb|3NX8|A Chain A, Human Camp Dependent Protein Kinase In Complex With Phenol Length = 351 | Back alignment and structure |
|
| >pdb|1CTP|E Chain E, Structure Of The Mammalian Catalytic Subunit Of Camp-Dependent Protein Kinase And An Inhibitor Peptide Displays An Open Conformation Length = 350 | Back alignment and structure |
|
| >pdb|1APM|E Chain E, 2.0 Angstrom Refined Crystal Structure Of The Catalytic Subunit Of Camp-Dependent Protein Kinase Complexed With A Peptide Inhibitor And Detergent Length = 350 | Back alignment and structure |
|
| >pdb|1SMH|A Chain A, Protein Kinase A Variant Complex With Completely Ordered N- Terminal Helix Length = 350 | Back alignment and structure |
|
| >pdb|1Q8W|A Chain A, The Catalytic Subunit Of Camp-Dependent Protein Kinase In Complex With Rho-Kinase Inhibitor Fasudil (Ha-1077) Length = 350 | Back alignment and structure |
|
| >pdb|1STC|E Chain E, Camp-Dependent Protein Kinase, Alpha-Catalytic Subunit In Complex With Staurosporine Length = 350 | Back alignment and structure |
|
| >pdb|1XH7|A Chain A, Crystal Structures Of Protein Kinase B Selective Inhibitors In Complex With Protein Kinase A And Mutants Length = 350 | Back alignment and structure |
|
| >pdb|1FMO|E Chain E, Crystal Structure Of A Polyhistidine-Tagged Recombinant Catalytic Subunit Of Camp-Dependent Protein Kinase Complexed With The Peptide Inhibitor Pki(5-24) And Adenosine Length = 350 | Back alignment and structure |
|
| >pdb|2ERZ|E Chain E, Crystal Structure Of C-amp Dependent Kinase (pka) Bound To Hydroxyfasudil Length = 351 | Back alignment and structure |
|
| >pdb|3PVB|A Chain A, Crystal Structure Of (73-244)ria:c Holoenzyme Of Camp-Dependent Protein Kinase Length = 345 | Back alignment and structure |
|
| >pdb|3AGM|A Chain A, Complex Of Pka With The Bisubstrate Protein Kinase Inhibitor Arc-670 Length = 351 | Back alignment and structure |
|
| >pdb|3AGL|A Chain A, Complex Of Pka With The Bisubstrate Protein Kinase Inhibitor Arc-1039 Length = 351 | Back alignment and structure |
|
| >pdb|3DND|A Chain A, Camp-Dependent Protein Kinase Pka Catalytic Subunit With Pki-5-24 Length = 350 | Back alignment and structure |
|
| >pdb|2JDS|A Chain A, Structure Of Camp-Dependent Protein Kinase Complexed With A- 443654 Length = 351 | Back alignment and structure |
|
| >pdb|2C1A|A Chain A, Structure Of Camp-Dependent Protein Kinase Complexed With Isoquinoline-5-Sulfonic Acid (2-(2-(4-Chlorobenzyloxy) Ethylamino)ethyl)amide Length = 351 | Back alignment and structure |
|
| >pdb|1SVH|A Chain A, Crystal Structure Of Protein Kinase A In Complex With Azepane Derivative 8 Length = 350 | Back alignment and structure |
|
| >pdb|2GU8|A Chain A, Discovery Of 2-pyrimidyl-5-amidothiophenes As Novel And Potent Inhibitors For Akt: Synthesis And Sar Studies Length = 337 | Back alignment and structure |
|
| >pdb|1YDT|E Chain E, Structure Of Camp-Dependent Protein Kinase, Alpha-Catalytic Subunit In Complex With H89 Protein Kinase Inhibitor N-[2- (4-Bromocinnamylamino)ethyl]-5-Isoquinoline Length = 350 | Back alignment and structure |
|
| >pdb|2QR7|A Chain A, 2.0a X-Ray Structure Of C-Terminal Kinase Domain Of P90 Ribosomal S6 Kinase 2: Se-Met Derivative Length = 342 | Back alignment and structure |
|
| >pdb|2UZT|A Chain A, Pka Structures Of Akt, Indazole-Pyridine Inhibitors Length = 336 | Back alignment and structure |
|
| >pdb|2F7E|E Chain E, Pka Complexed With (S)-2-(1h-Indol-3-Yl)-1-(5-Isoquinolin-6- Yl-Pyridin-3-Yloxymethyl-Etylamine Length = 351 | Back alignment and structure |
|
| >pdb|4G3D|A Chain A, Crystal Structure Of Human Nf-kappab Inducing Kinase (nik) Length = 371 | Back alignment and structure |
|
| >pdb|4DG3|E Chain E, Crystal Structure Of R336a Mutant Of Camp-dependent Protein Kinase With Unphosphorylated Turn Motif Length = 371 | Back alignment and structure |
|
| >pdb|1ZXE|A Chain A, Crystal Structure Of Eif2alpha Protein Kinase Gcn2: D835n Inactivating Mutant In Apo Form Length = 303 | Back alignment and structure |
|
| >pdb|1OL6|A Chain A, Structure Of Unphosphorylated D274n Mutant Of Aurora-a Length = 282 | Back alignment and structure |
|
| >pdb|1J3H|A Chain A, Crystal Structure Of Apoenzyme Camp-Dependent Protein Kinase Catalytic Subunit Length = 350 | Back alignment and structure |
|
| >pdb|3MVJ|A Chain A, Human Cyclic Amp-Dependent Protein Kinase Pka Inhibitor Complex Length = 371 | Back alignment and structure |
|
| >pdb|2XNE|A Chain A, Structure Of Aurora-A Bound To An Imidazopyrazine Inhibitor Length = 272 | Back alignment and structure |
|
| >pdb|3MY0|A Chain A, Crystal Structure Of The Acvrl1 (Alk1) Kinase Domain Bound To Ldn- 193189 Length = 305 | Back alignment and structure |
|
| >pdb|1YRP|A Chain A, Catalytic Domain Of Human Zip Kinase Phosphorylated At Thr265 Length = 278 | Back alignment and structure |
|
| >pdb|4F1M|A Chain A, Crystal Structure Of The G1179s Roco4 Kinase Domain Bound To Appcp From D. Discoideum Length = 287 | Back alignment and structure |
|
| >pdb|2WEL|A Chain A, Crystal Structure Of Su6656-Bound CalciumCALMODULIN- Dependent Protein Kinase Ii Delta In Complex With Calmodulin Length = 327 | Back alignment and structure |
|
| >pdb|1Q24|A Chain A, Pka Double Mutant Model Of Pkb In Complex With Mgatp Length = 350 | Back alignment and structure |
|
| >pdb|2VN9|A Chain A, Crystal Structure Of Human Calcium Calmodulin Dependent Protein Kinase Ii Delta Isoform 1, Camkd Length = 301 | Back alignment and structure |
|
| >pdb|3P1A|A Chain A, Structure Of Human Membrane-Associated Tyrosine- And Threonine- Specific Cdc2-Inhibitory Kinase Myt1 (Pkmyt1) Length = 311 | Back alignment and structure |
|
| >pdb|4DFY|A Chain A, Crystal Structure Of R194a Mutant Of Camp-Dependent Protein Kinase With Unphosphorylated Activation Loop Length = 371 | Back alignment and structure |
|
| >pdb|3BHY|A Chain A, Crystal Structure Of Human Death Associated Protein Kinase 3 (Dapk3) In Complex With A Beta-Carboline Ligand Length = 283 | Back alignment and structure |
|
| >pdb|3RNY|A Chain A, Crystal Structure Of Human Rsk1 C-Terminal Kinase Domain Length = 346 | Back alignment and structure |
|
| >pdb|2QR8|A Chain A, 2.0a X-ray Structure Of C-terminal Kinase Domain Of P90 Ribosomal S6 Kinase 2 (rsk2) Length = 342 | Back alignment and structure |
|
| >pdb|3QFV|A Chain A, Mrck Beta In Complex With Tpca-1 Length = 415 | Back alignment and structure |
|
| >pdb|3TKU|A Chain A, Mrck Beta In Complex With Fasudil Length = 433 | Back alignment and structure |
|
| >pdb|2J90|A Chain A, Crystal Structure Of Human Zip Kinase In Complex With A Tetracyclic Pyridone Inhibitor (pyridone 6) Length = 304 | Back alignment and structure |
|
| >pdb|2WNT|A Chain A, Crystal Structure Of The Human Ribosomal Protein S6 Kinase Length = 330 | Back alignment and structure |
|
| >pdb|1SYK|A Chain A, Crystal Structure Of E230q Mutant Of Camp-Dependent Protein Kinase Reveals Unexpected Apoenzyme Conformation Length = 350 | Back alignment and structure |
|
| >pdb|3KK9|A Chain A, Camkii Substrate Complex B Length = 282 | Back alignment and structure |
|
| >pdb|3KL8|A Chain A, Camkiintide Inhibitor Complex Length = 269 | Back alignment and structure |
|
| >pdb|3O7L|B Chain B, Crystal Structure Of Phospholamban (1-19):pka C-Subunit:amp-Pnp:mg2+ Complex Length = 350 | Back alignment and structure |
|
| >pdb|3KK8|A Chain A, Camkii Substrate Complex A Length = 284 | Back alignment and structure |
|
| >pdb|2BDW|A Chain A, Crystal Structure Of The Auto-Inhibited Kinase Domain Of CalciumCALMODULIN ACTIVATED KINASE II Length = 362 | Back alignment and structure |
|
| >pdb|2X4F|A Chain A, The Crystal Structure Of The Human Myosin Light Chain Kinase Loc340156. Length = 373 | Back alignment and structure |
|
| >pdb|3SDJ|A Chain A, Structure Of Rnase-Inactive Point Mutant Of Oligomeric KinaseRNASE Ire1 Length = 448 | Back alignment and structure |
|
| >pdb|3FBV|A Chain A, Crystal Structure Of The Oligomer Formed By The Kinase-Ribonuclease Domain Of Ire1 Length = 448 | Back alignment and structure |
|
| >pdb|4G3C|A Chain A, Crystal Structure Of Apo Murine Nf-kappab Inducing Kinase (nik) Length = 352 | Back alignment and structure |
|
| >pdb|4G3F|A Chain A, Crystal Structure Of Murine Nf-kappab Inducing Kinase (nik) Bound To A 2-(aminothiazoly)phenol (cmp2) Length = 336 | Back alignment and structure |
|
| >pdb|3QAM|E Chain E, Crystal Structure Of Glu208ala Mutant Of Catalytic Subunit Of Camp- Dependent Protein Kinase Length = 350 | Back alignment and structure |
|
| >pdb|4AF3|A Chain A, Human Aurora B Kinase In Complex With Incenp And Vx-680 Length = 292 | Back alignment and structure |
|
| >pdb|4G3G|A Chain A, Crystal Structure Of Murine Nf-kappab Inducing Kinase (nik) V408l Bound To A 2-(aminothiazolyl)phenol (cmp3) Length = 350 | Back alignment and structure |
|
| >pdb|2RIO|A Chain A, Structure Of The Dual Enzyme Ire1 Reveals The Basis For Catalysis And Regulation Of Non-conventional Splicing Length = 434 | Back alignment and structure |
|
| >pdb|2XUU|A Chain A, Crystal Structure Of A Dap-Kinase 1 Mutant Length = 334 | Back alignment and structure |
|
| >pdb|2BFY|A Chain A, Complex Of Aurora-B With Incenp And Hesperidin. Length = 284 | Back alignment and structure |
|
| >pdb|2VRX|A Chain A, Structure Of Aurora B Kinase In Complex With Zm447439 Length = 285 | Back alignment and structure |
|
| >pdb|1H4L|A Chain A, Structure And Regulation Of The Cdk5-P25(Nck5a) Complex Length = 292 | Back alignment and structure |
|
| >pdb|3FPQ|A Chain A, Crystal Structure Of The Kinase Domain Of Wnk1 Length = 290 | Back alignment and structure |
|
| >pdb|1KOB|A Chain A, Twitchin Kinase Fragment (Aplysia), Autoregulated Protein Kinase Domain Length = 387 | Back alignment and structure |
|
| >pdb|2J0L|A Chain A, Crystal Structure Of A The Active Conformation Of The Kinase Domain Of Focal Adhesion Kinase With A Phosphorylated Activation Loop Length = 276 | Back alignment and structure |
|
| >pdb|1RDQ|E Chain E, Hydrolysis Of Atp In The Crystal Of Y204a Mutant Of Camp-Dependent Protein Kinase Length = 350 | Back alignment and structure |
|
| >pdb|1P4F|A Chain A, Death Associated Protein Kinase Catalytic Domain With Bound Inhibitor Fragment Length = 293 | Back alignment and structure |
|
| >pdb|2P0C|A Chain A, Catalytic Domain Of The Proto-Oncogene Tyrosine-Protein Kina Length = 313 | Back alignment and structure |
|
| >pdb|1IG1|A Chain A, 1.8a X-Ray Structure Of Ternary Complex Of A Catalytic Domain Of Death-Associated Protein Kinase With Atp Analogue And Mn. Length = 294 | Back alignment and structure |
|
| >pdb|3F5U|A Chain A, Crystal Structure Of The Death Associated Protein Kinase In Complex With Amppnp And Mg2+ Length = 295 | Back alignment and structure |
|
| >pdb|3NIE|A Chain A, Crystal Structure Of Pf11_0147 Length = 429 | Back alignment and structure |
|
| >pdb|3DFC|B Chain B, Crystal Structure Of A Glycine-Rich Loop Mutant Of The Death Associated Protein Kinase Catalytic Domain With Amppnp Length = 295 | Back alignment and structure |
|
| >pdb|3GU4|A Chain A, Crystal Structure Of Dapkq23v-Amppnp Length = 295 | Back alignment and structure |
|
| >pdb|3GU8|A Chain A, Crystal Structure Of Dapkl93g With N6-Cyclopentyladenosine Length = 295 | Back alignment and structure |
|
| >pdb|3PG1|A Chain A, Map Kinase Lmampk10 From Leishmania Major (1.95 Angs Resolution) Length = 362 | Back alignment and structure |
|
| >pdb|2H34|A Chain A, Apoenzyme Crystal Structure Of The Tuberculosis SerineTHREONINE Kinase, Pkne Length = 309 | Back alignment and structure |
|
| >pdb|2X0G|A Chain A, X-ray Structure Of A Dap-kinase Calmodulin Complex Length = 334 | Back alignment and structure |
|
| >pdb|2YAK|A Chain A, Structure Of Death-Associated Protein Kinase 1 (Dapk1) In Complex With A Ruthenium Octasporine Ligand (Osv) Length = 285 | Back alignment and structure |
|
| >pdb|3UIB|A Chain A, Map Kinase Lmampk10 From Leishmania Major In Complex With Sb203580 Length = 362 | Back alignment and structure |
|
| >pdb|3LJ0|A Chain A, Ire1 Complexed With Adp And Quercetin Length = 434 | Back alignment and structure |
|
| >pdb|2Y0A|A Chain A, Structure Of Dapk1 Construct Residues 1-304 Length = 326 | Back alignment and structure |
|
| >pdb|3TAC|A Chain A, Crystal Structure Of The Liprin-AlphaCASK COMPLEX Length = 361 | Back alignment and structure |
|
| >pdb|2XZS|A Chain A, Death Associated Protein Kinase 1 Residues 1-312 Length = 312 | Back alignment and structure |
|
| >pdb|1WVW|A Chain A, Crystal Structures Of Kinase Domain Of Dap Kinase In Complex With Small Molecular Inhibitors Length = 278 | Back alignment and structure |
|
| >pdb|2W4J|A Chain A, X-Ray Structure Of A Dap-Kinase 2-277 Length = 277 | Back alignment and structure |
|
| >pdb|3C0G|A Chain A, Cask Cam-kinase Domain- 3'-amp Complex, P1 Form Length = 351 | Back alignment and structure |
|
| >pdb|2W4K|A Chain A, X-Ray Structure Of A Dap-Kinase 2-302 Length = 302 | Back alignment and structure |
|
| >pdb|4AGU|A Chain A, Crystal Structure Of The Human Cdkl1 Kinase Domain Length = 311 | Back alignment and structure |
|
| >pdb|4EBW|A Chain A, Structure Of Focal Adhesion Kinase Catalytic Domain In Complex With Novel Allosteric Inhibitor Length = 304 | Back alignment and structure |
|
| >pdb|3BZ3|A Chain A, Crystal Structure Analysis Of Focal Adhesion Kinase With A Methanesulfonamide Diaminopyrimidine Inhibitor Length = 276 | Back alignment and structure |
|
| >pdb|2JKM|A Chain A, Focal Adhesion Kinase Catalytic Domain In Complex With Bis- Anilino Pyrimidine Inhibitor Length = 276 | Back alignment and structure |
|
| >pdb|1MP8|A Chain A, Crystal Structure Of Focal Adhesion Kinase (Fak) Length = 281 | Back alignment and structure |
|
| >pdb|2J0M|B Chain B, Crystal Structure A Two-Chain Complex Between The Ferm And Kinase Domains Of Focal Adhesion Kinase. Length = 276 | Back alignment and structure |
|
| >pdb|2ETM|A Chain A, Crystal Structure Of Focal Adhesion Kinase Domain Complexed With 7h-Pyrrolo [2,3-D] Pyrimidine Derivative Length = 281 | Back alignment and structure |
|
| >pdb|3PXK|A Chain A, Focal Adhesion Kinase Catalytic Domain In Complex With Pyrrolo[2,3- D]thiazole Length = 282 | Back alignment and structure |
|
| >pdb|1RW8|A Chain A, Crystal Structure Of Tgf-Beta Receptor I Kinase With Atp Site Inhibitor Length = 301 | Back alignment and structure |
|
| >pdb|3OZ6|A Chain A, Crystal Structure Of Mapk From Cryptosporidium Parvum, Cgd2_1960 Length = 388 | Back alignment and structure |
|
| >pdb|1B6C|B Chain B, Crystal Structure Of The Cytoplasmic Domain Of The Type I Tgf-Beta Receptor In Complex With Fkbp12 Length = 342 | Back alignment and structure |
|
| >pdb|1VJY|A Chain A, Crystal Structure Of A Naphthyridine Inhibitor Of Human Tgf- Beta Type I Receptor Length = 303 | Back alignment and structure |
|
| >pdb|3TZM|A Chain A, Tgf-Beta Receptor Type 1 In Complex With Sb431542 Length = 309 | Back alignment and structure |
|
| >pdb|2WOT|A Chain A, Alk5 In Complex With 4-((5,6-Dimethyl-2-(2-Pyridyl)-3- Pyridyl)oxy)-N-(3,4,5-Trimethoxyphenyl)pyridin-2-Amine Length = 306 | Back alignment and structure |
|
| >pdb|1PY5|A Chain A, Crystal Structure Of Tgf-Beta Receptor I Kinase With Inhibitor Length = 326 | Back alignment and structure |
|
| >pdb|3RP9|A Chain A, Crystal Structure Of The Apo Mapk From Toxoplasma Gondii, 25.M01780 Or Tgme49_007820 Length = 458 | Back alignment and structure |
|
| >pdb|3SAY|A Chain A, Crystal Structure Of Human Glycogen Synthase Kinase 3 Beta (Gsk3b) In Complex With Inhibitor 142 Length = 430 | Back alignment and structure |
|
| >pdb|2J0J|A Chain A, Crystal Structure Of A Fragment Of Focal Adhesion Kinase Containing The Ferm And Kinase Domains Length = 656 | Back alignment and structure |
|
| >pdb|2JKK|A Chain A, Focal Adhesion Kinase Catalytic Domain In Complex With Bis- Anilino Pyrimidine Inhibitor Length = 276 | Back alignment and structure |
|
| >pdb|1UNG|A Chain A, Structural Mechanism For The Inhibition Of Cdk5-P25 By Roscovitine, Aloisine And Indirubin. Length = 292 | Back alignment and structure |
|
Structure Templates Detected by RPS-BLAST
Original result of RPS-BLAST against PDB70 database
| >2nru_A Interleukin-1 receptor-associated kinase 4; inhibitor, IRAK, transferase; HET: TPO SEP T12; 2.00A {Homo sapiens} PDB: 2nry_A* 2oib_A* 2oic_A* 2oid_A* 2o8y_A* Length = 307 | Back alignment and structure |
|---|
Score = 242 bits (621), Expect = 4e-77
Identities = 64/187 (34%), Positives = 96/187 (51%), Gaps = 11/187 (5%)
Query: 253 PTKKGLLCWGTRVRIIEGIAQGLLYLHQYSRLRVIHRDLKASNILLDKDMNPKISDFGMA 312
L W R +I +G A G+ +LH+ IHRD+K++NILLD+ KISDFG+A
Sbjct: 124 LDGTPPLSWHMRCKIAQGAANGINFLHENH---HIHRDIKSANILLDEAFTAKISDFGLA 180
Query: 313 RMFGGDELQSNTKRIVGTYGYMSPEYALRGLFSIKSDVFSFGVLLLETLSSKKNTHFYNT 372
R T RIVGT YM+PE LRG + KSD++SFGV+LLE ++ +
Sbjct: 181 RASEKFAQTVMTSRIVGTTAYMAPEA-LRGEITPKSDIYSFGVVLLEIITGLPAVDE-HR 238
Query: 373 DSLTLLGHAWNLWNDGRTWE-LMDPISQNGASYPI--LKRYINVALLCVQEKAADRPAMS 429
+ LL + ++ +T E +D + ++ +VA C+ EK RP +
Sbjct: 239 EPQLLLDIKEEIEDEEKTIEDYIDKKMND---ADSTSVEAMYSVASQCLHEKKNKRPDIK 295
Query: 430 EVVSMLS 436
+V +L
Sbjct: 296 KVQQLLQ 302
|
| >3uim_A Brassinosteroid insensitive 1-associated receptor; kinase, protein kinase, transferase; HET: SEP TPO ANP; 2.20A {Arabidopsis thaliana} PDB: 3tl8_A* Length = 326 | Back alignment and structure |
|---|
Score = 239 bits (613), Expect = 9e-76
Identities = 71/194 (36%), Positives = 106/194 (54%), Gaps = 8/194 (4%)
Query: 250 YNNPTKKGLLCWGTRVRIIEGIAQGLLYLHQYSRLRVIHRDLKASNILLDKDMNPKISDF 309
P + L W R RI G A+GL YLH + ++IHRD+KA+NILLD++ + DF
Sbjct: 119 RERPESQPPLDWPKRQRIALGSARGLAYLHDHCDPKIIHRDVKAANILLDEEFEAVVGDF 178
Query: 310 GMARMFGGDELQSNTKRIVGTYGYMSPEYALRGLFSIKSDVFSFGVLLLETLSSKKNTHF 369
G+A++ + T + GT G+++PEY G S K+DVF +GV+LLE ++ ++
Sbjct: 179 GLAKLMDYKDTHVTT-AVRGTIGHIAPEYLSTGKSSEKTDVFGYGVMLLELITGQRAFDL 237
Query: 370 ---YNTDSLTLLGHAWNLWNDGRTWELMDPISQNGASYPI--LKRYINVALLCVQEKAAD 424
N D + LL L + + L+D Q +Y +++ I VALLC Q +
Sbjct: 238 ARLANDDDVMLLDWVKGLLKEKKLEALVDVDLQG--NYKDEEVEQLIQVALLCTQSSPME 295
Query: 425 RPAMSEVVSMLSNE 438
RP MSEVV ML +
Sbjct: 296 RPKMSEVVRMLEGD 309
|
| >2qkw_B Protein kinase; three-helix bundle motif, AVRPTO-PTO duplex, layered beta- sheets, transferas; HET: SEP TPO; 3.20A {Solanum pimpinellifolium} PDB: 3hgk_A* Length = 321 | Back alignment and structure |
|---|
Score = 203 bits (518), Expect = 8e-62
Identities = 61/187 (32%), Positives = 104/187 (55%), Gaps = 4/187 (2%)
Query: 250 YNNPTKKGLLCWGTRVRIIEGIAQGLLYLHQYSRLRVIHRDLKASNILLDKDMNPKISDF 309
Y + + W R+ I G A+GL YLH + +IHRD+K+ NILLD++ PKI+DF
Sbjct: 127 YGSDLPTMSMSWEQRLEICIGAARGLHYLHTRA---IIHRDVKSINILLDENFVPKITDF 183
Query: 310 GMARMFGGDELQSNTKRIVGTYGYMSPEYALRGLFSIKSDVFSFGVLLLETLSSKKNT-H 368
G+++ + + + GT GY+ PEY ++G + KSDV+SFGV+L E L ++
Sbjct: 184 GISKKGTELDQTHLSTVVKGTLGYIDPEYFIKGRLTEKSDVYSFGVVLFEVLCARSAIVQ 243
Query: 369 FYNTDSLTLLGHAWNLWNDGRTWELMDPISQNGASYPILKRYINVALLCVQEKAADRPAM 428
+ + L A N+G+ +++DP + L+++ + A+ C+ + DRP+M
Sbjct: 244 SLPREMVNLAEWAVESHNNGQLEQIVDPNLADKIRPESLRKFGDTAVKCLALSSEDRPSM 303
Query: 429 SEVVSML 435
+V+ L
Sbjct: 304 GDVLWKL 310
|
| >3soc_A Activin receptor type-2A; structural genomics consortium, SGC, transferase, protein KI; HET: GVD; 1.95A {Homo sapiens} PDB: 3q4t_A* 2qlu_A* Length = 322 | Back alignment and structure |
|---|
Score = 181 bits (461), Expect = 2e-53
Identities = 40/204 (19%), Positives = 77/204 (37%), Gaps = 23/204 (11%)
Query: 255 KKGLLCWGTRVRIIEGIAQGLLYLHQ-------YSRLRVIHRDLKASNILLDKDMNPKIS 307
K ++ W I E +A+GL YLH+ + + HRD+K+ N+LL ++ I+
Sbjct: 114 KANVVSWNELCHIAETMARGLAYLHEDIPGLKDGHKPAISHRDIKSKNVLLKNNLTACIA 173
Query: 308 DFGMARMFGGDELQSNTKRIVGTYGYMSPEYA-----LRGLFSIKSDVFSFGVLLLETLS 362
DFG+A F + +T VGT YM+PE + ++ D+++ G++L E S
Sbjct: 174 DFGLALKFEAGKSAGDTHGQVGTRRYMAPEVLEGAINFQRDAFLRIDMYAMGLVLWELAS 233
Query: 363 SKKNTHFYNTDSLTLLGHAWNLWNDGRTWELMD---------PISQNGASYPILKRYINV 413
+ + + ++ + + + +
Sbjct: 234 RCTAADGPVDEYMLPF--EEEIGQHPSLEDMQEVVVHKKKRPVLRDYWQKHAGMAMLCET 291
Query: 414 ALLCVQEKAADRPAMSEVVSMLSN 437
C A R + V ++
Sbjct: 292 IEECWDHDAEARLSAGCVGERITQ 315
|
| >3g2f_A Bone morphogenetic protein receptor type-2; kinase, structural genomics, structural genomics consortium, ATP-binding, disease mutation; HET: ADP; 2.35A {Homo sapiens} Length = 336 | Back alignment and structure |
|---|
Score = 154 bits (390), Expect = 4e-43
Identities = 38/225 (16%), Positives = 76/225 (33%), Gaps = 31/225 (13%)
Query: 255 KKGLLCWGTRVRIIEGIAQGLLYLHQ------YSRLRVIHRDLKASNILLDKDMNPKISD 308
W + R+ + +GL YLH + + + HRDL + N+L+ D ISD
Sbjct: 104 SLHTSDWVSSCRLAHSVTRGLAYLHTELPRGDHYKPAISHRDLNSRNVLVKNDGTCVISD 163
Query: 309 FGMARMFGG------DELQSNTKRIVGTYGYMSPEYALRGLFSI--------KSDVFSFG 354
FG++ G E + VGT YM+PE L G ++ + D+++ G
Sbjct: 164 FGLSMRLTGNRLVRPGEEDNAAISEVGTIRYMAPEV-LEGAVNLRDXESALKQVDMYALG 222
Query: 355 VLLLETLSSKKNTHFYNTDSLTLLGHAWNLWNDGRTWELMDPISQNGASYPI-------- 406
++ E + + + + N ++ +S+
Sbjct: 223 LIYWEIFMRCTDLFPGESVPEYQMAFQTEVGNHPTFEDMQVLVSREKQRPKFPEAWKENS 282
Query: 407 --LKRYINVALLCVQEKAADRPAMSEVVSMLSNEFVNLPAPQQPA 449
++ C + A R ++ + + +
Sbjct: 283 LAVRSLKETIEDCWDQDAEARLTAQXAEERMAELMMIWERNKSVS 327
|
| >2eva_A TAK1 kinase - TAB1 chimera fusion protein; transferase/transferase activator complex; HET: ADN; 2.00A {Homo sapiens} Length = 307 | Back alignment and structure |
|---|
Score = 133 bits (338), Expect = 7e-36
Identities = 52/213 (24%), Positives = 91/213 (42%), Gaps = 20/213 (9%)
Query: 251 NNPTKKGLLCWGTRVRIIEGIAQGLLYLHQYSRLRVIHRDLKASNILLDKDMN-PKISDF 309
+ + +QG+ YLH +IHRDLK N+LL KI DF
Sbjct: 91 HGAEPLPYYTAAHAMSWCLQCSQGVAYLHSMQPKALIHRDLKPPNLLLVAGGTVLKICDF 150
Query: 310 GMARMFGGDELQSNTKRIVGTYGYMSPEYALRGLFSIKSDVFSFGVLLLETLSSKKNTHF 369
G A ++Q++ G+ +M+PE +S K DVFS+G++L E ++ +K
Sbjct: 151 GTAC-----DIQTHMTNNKGSAAWMAPEVFEGSNYSEKCDVFSWGIILWEVITRRK---P 202
Query: 370 YNTDSLTLLGHAWNLWNDGRTWELMDPISQNGASYPILKRYINVALLCVQEKAADRPAMS 429
++ W + N R P+ +N + K ++ C + + RP+M
Sbjct: 203 FDEIGGPAFRIMWAVHNGTRP-----PLIKN-----LPKPIESLMTRCWSKDPSQRPSME 252
Query: 430 EVVSMLSNEFVNLPAPQQPA-FSCVNSTNMQSD 461
E+V ++++ P +P + C +S D
Sbjct: 253 EIVKIMTHLMRYFPGADEPLQYPCQHSLPPGED 285
|
| >3s95_A LIMK-1, LIM domain kinase 1; structural genomics, structural genomics consortium, SGC, PR kinase, transferase-antibiotic complex; HET: STU GOL; 1.65A {Homo sapiens} Length = 310 | Back alignment and structure |
|---|
Score = 130 bits (329), Expect = 1e-34
Identities = 44/219 (20%), Positives = 76/219 (34%), Gaps = 50/219 (22%)
Query: 254 TKKGLLCWGTRVRIIEGIAQGLLYLHQYSRLRVIHRDLKASNILLDKDMNPKISDFGMAR 313
+ W RV + IA G+ YLH + +IHRDL + N L+ ++ N ++DFG+AR
Sbjct: 100 SMDSQYPWSQRVSFAKDIASGMAYLHS---MNIIHRDLNSHNCLVRENKNVVVADFGLAR 156
Query: 314 MFGGDELQSNTKR------------IVGTYGYMSPEYALRGLFSIKSDVFSFGVLLLETL 361
+ ++ Q R +VG +M+PE + K DVFSFG++L E +
Sbjct: 157 LMVDEKTQPEGLRSLKKPDRKKRYTVVGNPYWMAPEMINGRSYDEKVDVFSFGIVLCEII 216
Query: 362 SSKKNTHFYNTDSLTLLGHAWNLWNDGRTWELMDPISQN-------GASYPILK----RY 410
P + + +
Sbjct: 217 GR------------------------VNADPDYLPRTMDFGLNVRGFLDRYCPPNCPPSF 252
Query: 411 INVALLCVQEKAADRPAMSEVVSMLSNEFVNLPAPQQPA 449
+ + C RP+ ++ L ++L
Sbjct: 253 FPITVRCCDLDPEKRPSFVKLEHWLETLRMHLAGHLPLG 291
|
| >3og7_A AKAP9-BRAF fusion protein; proto-oncogene, V600E, kinase, transferase; HET: 032; 2.45A {Homo sapiens} PDB: 3c4c_A* 3c4d_A* 3idp_A* 3ii5_A* 3d4q_A* 3ppj_A* 3ppk_A* 3prf_A* 3pri_A* 3psb_A* 3psd_A* 3q4c_A* 3skc_A* 3tv4_A* 3tv6_A* 2fb8_A* 4dbn_A* 1uwj_A* 1uwh_A* 3q96_A* Length = 289 | Back alignment and structure |
|---|
Score = 125 bits (316), Expect = 7e-33
Identities = 44/198 (22%), Positives = 82/198 (41%), Gaps = 44/198 (22%)
Query: 255 KKGLLCWGTRVRIIEGIAQGLLYLHQYSRLRVIHRDLKASNILLDKDMNPKISDFGMARM 314
+ + I A+G+ YLH +IHRDLK++NI L +D KI DFG+A
Sbjct: 113 SETKFEMKKLIDIARQTARGMDYLHA---KSIIHRDLKSNNIFLHEDNTVKIGDFGLATE 169
Query: 315 FGGDELQSNTKRIVGTYGYMSPE---YALRGLFSIKSDVFSFGVLLLETLSSKKNTHFYN 371
+++ G+ +M+PE +S +SDV++FG++L E ++ +
Sbjct: 170 KSRWSGSHQFEQLSGSILWMAPEVIRMQDSNPYSFQSDVYAFGIVLYELMTGQ------- 222
Query: 372 TDSLTLLGHAWNLWNDGRTWELMDPISQ------NGASYPIL--------KRYINVALLC 417
+ ++ Q G+ P L KR + C
Sbjct: 223 -----------------LPYSNINNRDQIIEMVGRGSLSPDLSKVRSNCPKRMKRLMAEC 265
Query: 418 VQEKAADRPAMSEVVSML 435
+++K +RP+ +++ +
Sbjct: 266 LKKKRDERPSFPRILAEI 283
|
| >3p86_A Serine/threonine-protein kinase CTR1; ETR1, ERS1, ETR2, phosphorylation, transferase; HET: STU; 2.50A {Arabidopsis thaliana} PDB: 3ppz_A* Length = 309 | Back alignment and structure |
|---|
Score = 122 bits (308), Expect = 1e-31
Identities = 45/189 (23%), Positives = 83/189 (43%), Gaps = 27/189 (14%)
Query: 252 NPTKKGLLCWGTRVRIIEGIAQGLLYLHQYSRLRVIHRDLKASNILLDKDMNPKISDFGM 311
+ L R+ + +A+G+ YLH ++HR+LK+ N+L+DK K+ DFG+
Sbjct: 127 KSGAREQLDERRRLSMAYDVAKGMNYLHN-RNPPIVHRNLKSPNLLVDKKYTVKVCDFGL 185
Query: 312 ARMFGGDELQSNTKRIVGTYGYMSPEYALRG-LFSIKSDVFSFGVLLLETLSSKKNTHFY 370
+R+ L S + GT +M+PE LR + KSDV+SFGV+L E + ++
Sbjct: 186 SRLKASTFLSSKSA--AGTPEWMAPE-VLRDEPSNEKSDVYSFGVILWELATLQQ----- 237
Query: 371 NTDSLTLLGHAWNLWNDGRTWELMDPISQNGASYPI----LKRYINVALLCVQEKAADRP 426
W + +++ + I + + C + RP
Sbjct: 238 -------------PWGNLNPAQVVAAVGFKCKRLEIPRNLNPQVAAIIEGCWTNEPWKRP 284
Query: 427 AMSEVVSML 435
+ + ++ +L
Sbjct: 285 SFATIMDLL 293
|
| >3dtc_A Mitogen-activated protein kinase kinase kinase 9; mixed-lineage kinase, MLK family, MLK1 and MLK3 subtype selective inhibitors; HET: VIN; 2.60A {Homo sapiens} Length = 271 | Back alignment and structure |
|---|
Score = 120 bits (302), Expect = 4e-31
Identities = 49/183 (26%), Positives = 82/183 (44%), Gaps = 26/183 (14%)
Query: 261 WGTRVRIIEGIAQGLLYLHQYSRLRVIHRDLKASNILLDKDMNP--------KISDFGMA 312
V IA+G+ YLH + + +IHRDLK+SNIL+ + + KI+DFG+A
Sbjct: 104 PDILVNWAVQIARGMNYLHDEAIVPIIHRDLKSSNILILQKVENGDLSNKILKITDFGLA 163
Query: 313 RMFGGDELQSNTKRIVGTYGYMSPEYALRGLFSIKSDVFSFGVLLLETLSSKKNTHFYNT 372
R + S G Y +M+PE +FS SDV+S+GVLL E L+ + +
Sbjct: 164 REWHRTTKMSAA----GAYAWMAPEVIRASMFSKGSDVWSYGVLLWELLTGEV---PF-- 214
Query: 373 DSLTLLGHAWNLWNDGRTWELMDPISQNGASYPILKRYINVALLCVQEKAADRPAMSEVV 432
+ L A+ + + + P + +++ C RP+ + ++
Sbjct: 215 RGIDGLAVAYGVAMNKLALPI--PSTCPEPFAKLMED-------CWNPDPHSRPSFTNIL 265
Query: 433 SML 435
L
Sbjct: 266 DQL 268
|
| >4f0f_A Serine/threonine-protein kinase ROCO4; LRRK2, ATP-binding, nucleotide serine/threonine-protein kinase, transferase, signaling Pro; HET: ACP; 1.80A {Dictyostelium discoideum} PDB: 4f0g_A 4f1t_A* 4f1m_A* 4f1o_A* Length = 287 | Back alignment and structure |
|---|
Score = 120 bits (302), Expect = 5e-31
Identities = 42/188 (22%), Positives = 78/188 (41%), Gaps = 25/188 (13%)
Query: 255 KKGLLCWGTRVRIIEGIAQGLLYLHQYSRLRVIHRDLKASNILLDK-----DMNPKISDF 309
K + W ++R++ IA G+ Y+ ++HRDL++ NI L + K++DF
Sbjct: 115 KAHPIKWSVKLRLMLDIALGIEYMQN-QNPPIVHRDLRSPNIFLQSLDENAPVCAKVADF 173
Query: 310 GMARMFGGDELQSNTKRIVGTYGYMSPE--YALRGLFSIKSDVFSFGVLLLETLSSKKNT 367
G+++ + + ++G + +M+PE A ++ K+D +SF ++L L+ +
Sbjct: 174 GLSQ-----QSVHSVSGLLGNFQWMAPETIGAEEESYTEKADTYSFAMILYTILTGEGP- 227
Query: 368 HFYNTDSLTLLGHAWNLWNDGRTWELMDPISQNGASYPILKRYINVALLCVQEKAADRPA 427
F + R I ++ R NV LC RP
Sbjct: 228 -FDEYSYGKIKFINMIREEGLRP-----TIPED-----CPPRLRNVIELCWSGDPKKRPH 276
Query: 428 MSEVVSML 435
S +V L
Sbjct: 277 FSYIVKEL 284
|
| >3q4u_A Activin receptor type-1; structural genomics consortium, SGC, protein kinase, transfe; HET: LDN FLC; 1.82A {Homo sapiens} PDB: 3mtf_A* 3oom_A* 4dym_A* 3h9r_A* 3my0_A* Length = 301 | Back alignment and structure |
|---|
Score = 117 bits (295), Expect = 7e-30
Identities = 45/207 (21%), Positives = 75/207 (36%), Gaps = 29/207 (14%)
Query: 255 KKGLLCWGTRVRIIEGIAQGLLYLH-----QYSRLRVIHRDLKASNILLDKDMNPKISDF 309
+ L + +RI+ IA GL +LH + + HRDLK+ NIL+ K+ I+D
Sbjct: 98 QLTTLDTVSCLRIVLSIASGLAHLHIEIFGTQGKPAIAHRDLKSKNILVKKNGQCCIADL 157
Query: 310 GMARMF--GGDELQSNTKRIVGTYGYMSPE------YALRGLFSIKSDVFSFGVLLLETL 361
G+A M ++L VGT YM+PE + D+++FG++L E
Sbjct: 158 GLAVMHSQSTNQLDVGNNPRVGTKRYMAPEVLDETIQVDCFDSYKRVDIWAFGLVLWEVA 217
Query: 362 SSKKNTHFYNTDSLTLLGHAWNLWNDGR-TWELMD----------PISQNGASYPILKRY 410
+ + ++E M I S P L
Sbjct: 218 RRMVSNGIVEDYKP-----PFYDVVPNDPSFEDMRKVVCVDQQRPNIPNRWFSDPTLTSL 272
Query: 411 INVALLCVQEKAADRPAMSEVVSMLSN 437
+ C + + R + L+
Sbjct: 273 AKLMKECWYQNPSARLTALRIKKTLTK 299
|
| >3kmu_A ILK, integrin-linked kinase; cell adhesion, ANK repeat, ATP-binding, cell junction, cell membrane, integrin-binding protein, membrane, nucleotide- binding; 1.80A {Homo sapiens} PDB: 3kmw_A* 3rep_A* Length = 271 | Back alignment and structure |
|---|
Score = 116 bits (293), Expect = 7e-30
Identities = 35/183 (19%), Positives = 70/183 (38%), Gaps = 35/183 (19%)
Query: 261 WGTRVRIIEGIAQGLLYLHQYSRLRVIHRDLKASNILLDKDMNPKISDFGMARMFGGDEL 320
V+ +A+G+ +LH L + L + ++++D+DM +IS + F
Sbjct: 110 QSQAVKFALDMARGMAFLHTLEPL-IPRHALNSRSVMIDEDMTARISMADVKFSF----- 163
Query: 321 QSNTKRIVGTYGYMSPEYALRG----LFSIKSDVFSFGVLLLETLSSKKNTHFYNTDSLT 376
+ + +++PE AL+ +D++SF VLL E ++ +
Sbjct: 164 --QSPGRMYAPAWVAPE-ALQKKPEDTNRRSADMWSFAVLLWELVTREV----------- 209
Query: 377 LLGHAWNLWNDGRTWELMDPISQNGASYPI----LKRYINVALLCVQEKAADRPAMSEVV 432
+ D E+ ++ G I + +C+ E A RP +V
Sbjct: 210 -------PFADLSNMEIGMKVALEGLRPTIPPGISPHVSKLMKICMNEDPAKRPKFDMIV 262
Query: 433 SML 435
+L
Sbjct: 263 PIL 265
|
| >2y4i_B KSR2, HKSR2, kinase suppressor of RAS 2; transferase, KSR1; HET: ATP; 3.46A {Homo sapiens} Length = 319 | Back alignment and structure |
|---|
Score = 116 bits (292), Expect = 2e-29
Identities = 44/194 (22%), Positives = 82/194 (42%), Gaps = 32/194 (16%)
Query: 255 KKGLLCWGTRVRIIEGIAQGLLYLHQYSRLRVIHRDLKASNILLDKDMNPKISDFGMARM 314
K +L +I + I +G+ YLH ++H+DLK+ N+ D + I+DFG+ +
Sbjct: 123 AKIVLDVNKTRQIAQEIVKGMGYLHA---KGILHKDLKSKNVFYD-NGKVVITDFGLFSI 178
Query: 315 FGGDELQSNTKRI---VGTYGYMSPEYALRGL----------FSIKSDVFSFGVLLLETL 361
G + ++ G +++PE +R L FS SDVF+ G + E
Sbjct: 179 SGVLQAGRREDKLRIQNGWLCHLAPEI-IRQLSPDTEEDKLPFSKHSDVFALGTIWYELH 237
Query: 362 SSKKNTHFYNTDSLTLLGHAWNLWNDGRTWELMDPISQNGASYPILKRYINVALLCVQEK 421
+ + F + + W + + +SQ G K ++ L C +
Sbjct: 238 ARE--WPFKTQPAEAI---IWQMGTGMKP-----NLSQIGMG----KEISDILLFCWAFE 283
Query: 422 AADRPAMSEVVSML 435
+RP ++++ ML
Sbjct: 284 QEERPTFTKLMDML 297
|
| >3mdy_A Bone morphogenetic protein receptor type-1B; complex (isomerase-protein kinase), receptor serine/threonin structural genomics consortium, SGC; HET: LDN; 2.05A {Homo sapiens} Length = 337 | Back alignment and structure |
|---|
Score = 114 bits (288), Expect = 1e-28
Identities = 46/207 (22%), Positives = 75/207 (36%), Gaps = 29/207 (14%)
Query: 255 KKGLLCWGTRVRIIEGIAQGLLYLH-----QYSRLRVIHRDLKASNILLDKDMNPKISDF 309
K L + +++ GL +LH + + HRDLK+ NIL+ K+ I+D
Sbjct: 127 KSTTLDAKSMLKLAYSSVSGLCHLHTEIFSTQGKPAIAHRDLKSKNILVKKNGTCCIADL 186
Query: 310 GMARMF--GGDELQSNTKRIVGTYGYMSPE------YALRGLFSIKSDVFSFGVLLLETL 361
G+A F +E+ VGT YM PE I +D++SFG++L E
Sbjct: 187 GLAVKFISDTNEVDIPPNTRVGTKRYMPPEVLDESLNRNHFQSYIMADMYSFGLILWEVA 246
Query: 362 SSKKNTHFYNTDSLTLLGHAW-NLWNDGRTWELMD----------PISQNGASYPILKRY 410
+ L + +L ++E M +S L++
Sbjct: 247 RRCVSGGIVEEYQL-----PYHDLVPSDPSYEDMREIVCIKKLRPSFPNRWSSDECLRQM 301
Query: 411 INVALLCVQEKAADRPAMSEVVSMLSN 437
+ C A R V L+
Sbjct: 302 GKLMTECWAHNPASRLTALRVKKTLAK 328
|
| >1b6c_B TGF-B superfamily receptor type I; complex (isomerase/protein kinase), receptor serine/threonine kinase; 2.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1ias_A 2x7o_A* 3faa_A* 3kcf_A* Length = 342 | Back alignment and structure |
|---|
Score = 112 bits (281), Expect = 1e-27
Identities = 39/203 (19%), Positives = 70/203 (34%), Gaps = 21/203 (10%)
Query: 255 KKGLLCWGTRVRIIEGIAQGLLYLHQ-----YSRLRVIHRDLKASNILLDKDMNPKISDF 309
+ + +++ A GL +LH + + HRDLK+ NIL+ K+ I+D
Sbjct: 132 NRYTVTVEGMIKLALSTASGLAHLHMEIVGTQGKPAIAHRDLKSKNILVKKNGTCCIADL 191
Query: 310 GMARMF--GGDELQSNTKRIVGTYGYMSPEYALRGL-------FSIKSDVFSFGVLLLET 360
G+A D + VGT YM+PE L ++D+++ G++ E
Sbjct: 192 GLAVRHDSATDTIDIAPNHRVGTKRYMAPE-VLDDSINMKHFESFKRADIYAMGLVFWEI 250
Query: 361 LSSKKNTHFYNTDSLTLLGHAWNLWNDGRTWELMD------PISQNGASYPILKRYINVA 414
+ L + + +++ I S L+ +
Sbjct: 251 ARRCSIGGIHEDYQLPYYDLVPSDPSVEEMRKVVCEQKLRPNIPNRWQSCEALRVMAKIM 310
Query: 415 LLCVQEKAADRPAMSEVVSMLSN 437
C A R + LS
Sbjct: 311 RECWYANGAARLTALRIKKTLSQ 333
|
| >2a19_B Interferon-induced, double-stranded RNA-activated kinase; transferase, protein biosynthesis, protein synthesis transferase complex; HET: TPO ANP; 2.50A {Homo sapiens} PDB: 2a1a_B* Length = 284 | Back alignment and structure |
|---|
Score = 105 bits (265), Expect = 6e-26
Identities = 47/182 (25%), Positives = 73/182 (40%), Gaps = 29/182 (15%)
Query: 266 RIIEGIAQGLLYLHQYSRLRVIHRDLKASNILLDKDMNPKISDFGMARMFGGDELQSNTK 325
+ E I +G+ Y+H ++I+RDLK SNI L KI DFG+ D
Sbjct: 126 ELFEQITKGVDYIHS---KKLINRDLKPSNIFLVDTKQVKIGDFGLVTSLKND---GKRT 179
Query: 326 RIVGTYGYMSPEYALRGLFSIKSDVFSFGVLLLETLSSKKNTHFYNTDSLTLLGHAWNLW 385
R GT YMSPE + + D+++ G++L E L + T +
Sbjct: 180 RSKGTLRYMSPEQISSQDYGKEVDLYALGLILAELLHVCD--TAFETS---------KFF 228
Query: 386 NDGRTWELMDPISQNGASYPILKRYINVALLCVQEKAADRPAMSEVVSMLSNEFVNLPAP 445
D R + D + K + + +K DRP SE+ L V +P
Sbjct: 229 TDLRDGIISDIFDKK------EKTLLQ---KLLSKKPEDRPNTSEI---LRTLTVWKKSP 276
Query: 446 QQ 447
++
Sbjct: 277 EK 278
|
| >3qd2_B Eukaryotic translation initiation factor 2-alpha; EIF2A kinase, phosphoryalation, gene regulation; HET: TPO; 2.81A {Mus musculus} Length = 332 | Back alignment and structure |
|---|
Score = 104 bits (262), Expect = 3e-25
Identities = 46/184 (25%), Positives = 72/184 (39%), Gaps = 33/184 (17%)
Query: 266 RIIEGIAQGLLYLHQYSRLRVIHRDLKASNILLDKDMNPKISDFGMARMFGGDELQSNTK 325
I IA+ + +LH ++HRDLK SNI D K+ DFG+ DE +
Sbjct: 168 HIFIQIAEAVEFLHS---KGLMHRDLKPSNIFFTMDDVVKVGDFGLVTAMDQDEEEQTVL 224
Query: 326 ----------RIVGTYGYMSPEYALRGLFSIKSDVFSFGVLLLETLSSKKNTHFYNTDSL 375
VGT YMSPE +S K D+FS G++L E L + ++T
Sbjct: 225 TPMPAYATHTGQVGTKLYMSPEQIHGNNYSHKVDIFSLGLILFELL------YSFSTQME 278
Query: 376 TLLGHAWNLWNDGRTWELMDPISQNGASYPILKRYINVALLCVQEKAADRPAMSEVVSML 435
+ + D R + +Q YP + + +RP +++ +
Sbjct: 279 RV-----RIITDVRNLKFPLLFTQ---KYPQEHMMVQ---DMLSPSPTERPEATDI---I 324
Query: 436 SNEF 439
N
Sbjct: 325 ENAI 328
|
| >4g31_A Eukaryotic translation initiation factor 2-alpha; deletion mutant, catalytic domain, synthetic inhibitor, TRAN transferase inhibitor complex; HET: 0WH; 2.28A {Homo sapiens} PDB: 4g34_A* Length = 299 | Back alignment and structure |
|---|
Score = 100 bits (252), Expect = 5e-24
Identities = 46/197 (23%), Positives = 68/197 (34%), Gaps = 34/197 (17%)
Query: 266 RIIEGIAQGLLYLHQYSRLRVIHRDLKASNILLDKDMNPKISDFGMARMFGGDELQSNTK 325
I IA+ + +LH ++HRDLK SNI D K+ DFG+ DE +
Sbjct: 122 HIFLQIAEAVEFLHS---KGLMHRDLKPSNIFFTMDDVVKVGDFGLVTAMDQDEEEQTVL 178
Query: 326 R----------IVGTYGYMSPEYALRGLFSIKSDVFSFGVLLLETLSSKKNTHFYNTDSL 375
VGT YMSPE +S K D+FS G++L E L F
Sbjct: 179 TPMPAYARHTGQVGTKLYMSPEQIHGNSYSHKVDIFSLGLILFELL-----YPFSTQMER 233
Query: 376 TLLGHAWNLWNDGRTWELMDPISQNGASYPILKRYINVALLCVQEKAADRPAMSEVVSML 435
+ + P+ YP + + +RP + +
Sbjct: 234 VRT---LTDVRNLK----FPPLFTQ--KYPCEYVMVQ---DMLSPSPMERPEAINI---I 278
Query: 436 SNEFV-NLPAPQQPAFS 451
N +L P +
Sbjct: 279 ENAVFEDLDFPGKTVLR 295
|
| >3cbl_A C-FES, proto-oncogene tyrosine-protein kinase FES/FPS; V-FES, fujinami, avian sarcoma, viral, feline virus, SGC; HET: STU; 1.75A {Homo sapiens} PDB: 3bkb_A* 3cd3_A* 4e93_A* Length = 377 | Back alignment and structure |
|---|
Score = 101 bits (253), Expect = 1e-23
Identities = 50/196 (25%), Positives = 81/196 (41%), Gaps = 41/196 (20%)
Query: 254 TKKGLLCWGTRVRIIEGIAQGLLYLHQYSRLRVIHRDLKASNILLDKDMNPKISDFGMAR 313
T+ L T ++++ A G+ YL IHRDL A N L+ + KISDFGM+R
Sbjct: 205 TEGARLRVKTLLQMVGDAAAGMEYLES---KCCIHRDLAARNCLVTEKNVLKISDFGMSR 261
Query: 314 MFGGDELQSNTKRIVGTYGYMSPEYALRGLFSIKSDVFSFGVLLLETLSSKKNTHFYNTD 373
++ + +PE G +S +SDV+SFG+LL ET S
Sbjct: 262 EEADGVYAASGGLRQVPVKWTAPEALNYGRYSSESDVWSFGILLWETFS----------- 310
Query: 374 SLTLLGHA--WNLWNDGRTWELMDPISQNG----------ASYPILKRYINVALLCVQEK 421
LG + NL N + + + + G A + ++++ C +
Sbjct: 311 ----LGASPYPNLSNQ----QTREFVEKGGRLPCPELCPDAVFRLMEQ-------CWAYE 355
Query: 422 AADRPAMSEVVSMLSN 437
RP+ S + L +
Sbjct: 356 PGQRPSFSTIYQELQS 371
|
| >3p1a_A MYT1 kinase, membrane-associated tyrosine- and threonine-speci inhibitory kinase; structural genomics, structural genomics consortium, SGC; 1.70A {Homo sapiens} Length = 311 | Back alignment and structure |
|---|
Score = 98.9 bits (247), Expect = 3e-23
Identities = 28/105 (26%), Positives = 46/105 (43%), Gaps = 9/105 (8%)
Query: 271 IAQGLLYLHQYSRLRVIHRDLKASNILLDKDMNPKISDFGMARMFGGDELQSNTKRIVGT 330
L +LH ++H D+K +NI L K+ DFG+ G + G
Sbjct: 166 TLLALAHLHS---QGLVHLDVKPANIFLGPRGRCKLGDFGLLVELGTAGA---GEVQEGD 219
Query: 331 YGYMSPEYALRGLFSIKSDVFSFGVLLLETLSSKKNTHFYNTDSL 375
YM+PE L+G + +DVFS G+ +LE + + + +
Sbjct: 220 PRYMAPE-LLQGSYGTAADVFSLGLTILEVACNME--LPHGGEGW 261
|
| >4eqm_A Protein kinase; transferase; HET: ANP; 3.00A {Staphylococcus aureus subsp} Length = 294 | Back alignment and structure |
|---|
Score = 97.3 bits (243), Expect = 8e-23
Identities = 36/107 (33%), Positives = 55/107 (51%), Gaps = 4/107 (3%)
Query: 255 KKGLLCWGTRVRIIEGIAQGLLYLHQYSRLRVIHRDLKASNILLDKDMNPKISDFGMARM 314
G L T + I G+ + H +R++HRD+K NIL+D + KI DFG+A+
Sbjct: 104 SHGPLSVDTAINFTNQILDGIKHAH---DMRIVHRDIKPQNILIDSNKTLKIFDFGIAKA 160
Query: 315 FGGDELQSNTKRIVGTYGYMSPEYALRGLFSIKSDVFSFGVLLLETL 361
L + T ++GT Y SPE A +D++S G++L E L
Sbjct: 161 LSETSL-TQTNHVLGTVQYFSPEQAKGEATDECTDIYSIGIVLYEML 206
|
| >2w5a_A Serine/threonine-protein kinase NEK2; Ser/Thr protein kinase, nucleus, meiosis, mitosis, cytoplasm, metal-binding, phosphoprotein; HET: ADP; 1.55A {Homo sapiens} PDB: 2wqo_A* 2xk3_A* 2xk4_A* 2xk6_A* 2xk7_A* 2xk8_A* 2xkc_A* 2xkd_A* 2xke_A* 2xkf_A* 2xnm_A* 2xnn_A* 2xno_A* 2xnp_A* 4afe_A* 2jav_A* 2w5b_A* 2w5h_A 4a4x_A* Length = 279 | Back alignment and structure |
|---|
Score = 95.4 bits (238), Expect = 3e-22
Identities = 37/91 (40%), Positives = 50/91 (54%), Gaps = 4/91 (4%)
Query: 271 IAQGLLYLHQ--YSRLRVIHRDLKASNILLDKDMNPKISDFGMARMFGGDELQSNTKRIV 328
+ L H+ V+HRDLK +N+ LD N K+ DFG+AR+ D + T V
Sbjct: 120 LTLALKECHRRSDGGHTVLHRDLKPANVFLDGKQNVKLGDFGLARILNHDTSFAKT--FV 177
Query: 329 GTYGYMSPEYALRGLFSIKSDVFSFGVLLLE 359
GT YMSPE R ++ KSD++S G LL E
Sbjct: 178 GTPYYMSPEQMNRMSYNEKSDIWSLGCLLYE 208
|
| >2h34_A Serine/threonine-protein kinase PKNE; apoenzyme, transferase; 2.80A {Mycobacterium tuberculosis} Length = 309 | Back alignment and structure |
|---|
Score = 95.8 bits (239), Expect = 3e-22
Identities = 30/98 (30%), Positives = 45/98 (45%), Gaps = 6/98 (6%)
Query: 265 VRIIEGIAQGLLYLHQYSRLRVIHRDLKASNILLDKDMNPKISDFGMARMFGGDEL-QSN 323
V I+ I L H HRD+K NIL+ D + DFG+A ++L Q
Sbjct: 137 VAIVRQIGSALDAAH---AAGATHRDVKPENILVSADDFAYLVDFGIASATTDEKLTQLG 193
Query: 324 TKRIVGTYGYMSPEYALRGLFSIKSDVFSFGVLLLETL 361
VGT YM+PE + ++D+++ +L E L
Sbjct: 194 N--TVGTLYYMAPERFSESHATYRADIYALTCVLYECL 229
|
| >1zy4_A Serine/threonine-protein kinase GCN2; translation regulator, signal transduction, acid starvation, starvation stress response; 1.95A {Saccharomyces cerevisiae} PDB: 1zy5_A* 1zyd_A* 1zyc_A* 1zxe_A Length = 303 | Back alignment and structure |
|---|
Score = 95.1 bits (237), Expect = 5e-22
Identities = 32/107 (29%), Positives = 49/107 (45%), Gaps = 16/107 (14%)
Query: 266 RIIEGIAQGLLYLHQYSRLRVIHRDLKASNILLDKDMNPKISDFGMARMF---------- 315
R+ I + L Y+H +IHRDLK NI +D+ N KI DFG+A+
Sbjct: 120 RLFRQILEALSYIHS---QGIIHRDLKPMNIFIDESRNVKIGDFGLAKNVHRSLDILKLD 176
Query: 316 --GGDELQSNTKRIVGTYGYMSPE-YALRGLFSIKSDVFSFGVLLLE 359
N +GT Y++ E G ++ K D++S G++ E
Sbjct: 177 SQNLPGSSDNLTSAIGTAMYVATEVLDGTGHYNEKIDMYSLGIIFFE 223
|
| >4apc_A Serine/threonine-protein kinase NEK1; transferase; 2.10A {Homo sapiens} Length = 350 | Back alignment and structure |
|---|
Score = 95.9 bits (239), Expect = 6e-22
Identities = 29/89 (32%), Positives = 49/89 (55%), Gaps = 5/89 (5%)
Query: 271 IAQGLLYLHQYSRLRVIHRDLKASNILLDKDMNPKISDFGMARMFGGDELQSNTKRIVGT 330
I L ++H +++HRD+K+ NI L KD ++ DFG+AR+ + +GT
Sbjct: 134 ICLALKHVHD---RKILHRDIKSQNIFLTKDGTVQLGDFGIARVLNSTVELARA--CIGT 188
Query: 331 YGYMSPEYALRGLFSIKSDVFSFGVLLLE 359
Y+SPE ++ KSD+++ G +L E
Sbjct: 189 PYYLSPEICENKPYNNKSDIWALGCVLYE 217
|
| >3eqc_A Dual specificity mitogen-activated protein kinase; MEK1 kinase, ATP-binding, disease mutation, nucleoti binding, phosphoprotein; HET: 3BM AGS; 1.80A {Homo sapiens} PDB: 3eqd_A* 3eqf_A* 3eqg_A* 3eqh_A* 3eqi_A* 2y4i_C* 3eqb_A* 2p55_A* 1s9j_A* 3dy7_A* 3e8n_A* 3dv3_A* 3mbl_A* 3pp1_A* 3orn_A* 3os3_A* 3sls_A* 1s9i_A* Length = 360 | Back alignment and structure |
|---|
Score = 94.9 bits (236), Expect = 1e-21
Identities = 33/94 (35%), Positives = 55/94 (58%), Gaps = 6/94 (6%)
Query: 266 RIIEGIAQGLLYLHQYSRLRVIHRDLKASNILLDKDMNPKISDFGMARMFGGDELQSNTK 325
++ + +GL YL + +++HRD+K SNIL++ K+ DFG++ G + S
Sbjct: 135 KVSIAVIKGLTYLR--EKHKIMHRDVKPSNILVNSRGEIKLCDFGVS----GQLIDSMAN 188
Query: 326 RIVGTYGYMSPEYALRGLFSIKSDVFSFGVLLLE 359
VGT YMSPE +S++SD++S G+ L+E
Sbjct: 189 SFVGTRSYMSPERLQGTHYSVQSDIWSMGLSLVE 222
|
| >3ugc_A Tyrosine-protein kinase JAK2; small molecule inhibitor, ATP binding, transferase-transfera inhibitor complex; HET: 046; 1.34A {} PDB: 3krr_A* 3lpb_A* 4aqc_A* 3q32_A* 3rvg_A* 3tjc_A* 3tjd_A* 2b7a_A* 3fup_A* 3e64_A* 3e62_A* 3e63_A* 2xa4_A* 3iok_A* 3io7_A* 3kck_A* 3jy9_A* Length = 295 | Back alignment and structure |
|---|
Score = 93.9 bits (234), Expect = 1e-21
Identities = 42/204 (20%), Positives = 80/204 (39%), Gaps = 39/204 (19%)
Query: 253 PTKKGLLCWGTRVRIIEGIAQGLLYLHQYSRLRVIHRDLKASNILLDKDMNPKISDFGMA 312
K + ++ I +G+ YL R IHRDL NIL++ + KI DFG+
Sbjct: 105 QKHKERIDHIKLLQYTSQICKGMEYL---GTKRYIHRDLATRNILVENENRVKIGDFGLT 161
Query: 313 RMFGGDE----LQSNTK---RIVGTYGYMSPEYALRGLFSIKSDVFSFGVLLLETLSSKK 365
++ D+ ++ + + +PE FS+ SDV+SFGV+L E + +
Sbjct: 162 KVLPQDKEFFKVKEPGESPIF------WYAPESLTESKFSVASDVWSFGVVLYELFTYIE 215
Query: 366 NTHFYNTDSLTLLGHA--WNLWNDGRTWELMDPISQNG----------ASYPILKRYINV 413
+ + + ++G+ + + L++ + NG Y I+
Sbjct: 216 KSKSPPAEFMRMIGNDKQGQMIV----FHLIELLKNNGRLPRPDGCPDEIYMIMTE---- 267
Query: 414 ALLCVQEKAADRPAMSEVVSMLSN 437
C RP+ ++ +
Sbjct: 268 ---CWNNNVNQRPSFRDLALRVDQ 288
|
| >2wqm_A Serine/threonine-protein kinase NEK7; ATP-binding, polymorphism, metal-binding, cell cycle kinase, mitosis, cytoplasm, magnesium, transferase; 2.10A {Homo sapiens} PDB: 2wqn_A* Length = 310 | Back alignment and structure |
|---|
Score = 93.9 bits (234), Expect = 1e-21
Identities = 41/163 (25%), Positives = 70/163 (42%), Gaps = 21/163 (12%)
Query: 271 IAQGLLYLHQYSRLRVIHRDLKASNILLDKDMNPKISDFGMARMFGGDELQSNTKRIVGT 330
+ L ++H RV+HRD+K +N+ + K+ D G+ R F +++ +VGT
Sbjct: 145 LCSALEHMHS---RRVMHRDIKPANVFITATGVVKLGDLGLGRFFSSKTTAAHS--LVGT 199
Query: 331 YGYMSPEYALRGLFSIKSDVFSFGVLLLETLSSKK--NTHFYNTDSLTLLGHAWNLWNDG 388
YMSPE ++ KSD++S G LL E + + N SL
Sbjct: 200 PYYMSPERIHENGYNFKSDIWSLGCLLYEMAALQSPFYGDKMNLYSLCKKI------EQC 253
Query: 389 RTWELMDPISQNGASYPILKRYINVALLCVQEKAADRPAMSEV 431
P+ + S L++ +N +C+ RP ++ V
Sbjct: 254 D----YPPLPSDHYS-EELRQLVN---MCINPDPEKRPDVTYV 288
|
| >3kul_A Ephrin type-A receptor 8; ATP-binding, kinase, nucleotide-binding, transfera phosphorylation, transmembrane, tyrosine-protein kinase; HET: PTR; 2.15A {Homo sapiens} Length = 325 | Back alignment and structure |
|---|
Score = 94.3 bits (235), Expect = 2e-21
Identities = 37/121 (30%), Positives = 55/121 (45%), Gaps = 26/121 (21%)
Query: 254 TKKGLLCWGTRVRIIEGIAQGLLYLHQYSRLRVIHRDLKASNILLDKDMNPKISDFGMAR 313
T G V ++ G+ G+ YL S L +HRDL A N+L+D ++ K+SDFG++R
Sbjct: 143 THDGQFTIMQLVGMLRGVGAGMRYL---SDLGYVHRDLAARNVLVDSNLVCKVSDFGLSR 199
Query: 314 MFGGDELQSNTKRIVGTYGY------------MSPEYALRGLFSIKSDVFSFGVLLLETL 361
+ D +PE FS SDV+SFGV++ E L
Sbjct: 200 VLEDDP-----------DAAYTTTGGKIPIRWTAPEAIAFRTFSSASDVWSFGVVMWEVL 248
Query: 362 S 362
+
Sbjct: 249 A 249
|
| >1u59_A Tyrosine-protein kinase ZAP-70; transferase; HET: STU; 2.30A {Homo sapiens} SCOP: d.144.1.7 Length = 287 | Back alignment and structure |
|---|
Score = 93.5 bits (233), Expect = 2e-21
Identities = 48/210 (22%), Positives = 78/210 (37%), Gaps = 48/210 (22%)
Query: 254 TKKGLLCWGTRVRIIEGIAQGLLYLHQYSRLRVIHRDLKASNILLDKDMNPKISDFGMAR 313
K+ + ++ ++ G+ YL +HRDL A N+LL KISDFG+++
Sbjct: 102 GKREEIPVSNVAELLHQVSMGMKYL---EEKNFVHRDLAARNVLLVNRHYAKISDFGLSK 158
Query: 314 MFGGDEL----QSNTKRIVGTYGYMSPEYALRGLFSIKSDVFSFGVLLLETLSSKKNTHF 369
G D+ +S K + + +PE FS +SDV+S+GV + E LS
Sbjct: 159 ALGADDSYYTARSAGKWPL---KWYAPECINFRKFSSRSDVWSYGVTMWEALS------- 208
Query: 370 YNTDSLTLLGHA--WNLWNDGRTWELMDPISQNG----------ASYPILKRYINVALLC 417
G + E+M I Q Y ++ C
Sbjct: 209 --------YGQKPYKKMKGP----EVMAFIEQGKRMECPPECPPELYALMSD-------C 249
Query: 418 VQEKAADRPAMSEVVSMLSNEFVNLPAPQQ 447
K DRP V + + +L + +
Sbjct: 250 WIYKWEDRPDFLTVEQRMRACYYSLASKVE 279
|
| >3fme_A Dual specificity mitogen-activated protein kinase; active mutant, structural genomics consortium, SCG, binding, nucleotide-binding, phosphoprotein; HET: STU; 2.26A {Homo sapiens} PDB: 3enm_A Length = 290 | Back alignment and structure |
|---|
Score = 93.5 bits (233), Expect = 2e-21
Identities = 33/98 (33%), Positives = 56/98 (57%), Gaps = 9/98 (9%)
Query: 266 RIIEGIAQGLLYLHQYSRLRVIHRDLKASNILLDKDMNPKISDFGMARMFGGDELQSNTK 325
+I I + L +LH S+L VIHRD+K SN+L++ K+ DFG++ D++ +
Sbjct: 113 KIAVSIVKALEHLH--SKLSVIHRDVKPSNVLINALGQVKMCDFGISGYL-VDDVAKDID 169
Query: 326 RIVGTYGYMSPE----YALRGLFSIKSDVFSFGVLLLE 359
G YM+PE + +S+KSD++S G+ ++E
Sbjct: 170 --AGCKPYMAPERINPELNQKGYSVKSDIWSLGITMIE 205
|
| >1mqb_A Ephrin type-A receptor 2; tyrosine protein kinase, transferase; HET: ANP; 2.30A {Homo sapiens} SCOP: d.144.1.7 Length = 333 | Back alignment and structure |
|---|
Score = 93.9 bits (234), Expect = 2e-21
Identities = 36/115 (31%), Positives = 60/115 (52%), Gaps = 14/115 (12%)
Query: 254 TKKGLLCWGTRVRIIEGIAQGLLYLHQYSRLRVIHRDLKASNILLDKDMNPKISDFGMAR 313
K G V ++ GIA G+ YL + + +HRDL A NIL++ ++ K+SDFG++R
Sbjct: 139 EKDGEFSVLQLVGMLRGIAAGMKYL---ANMNYVHRDLAARNILVNSNLVCKVSDFGLSR 195
Query: 314 MFGGDELQSNTKRIVGTYG------YMSPEYALRGLFSIKSDVFSFGVLLLETLS 362
+ D + T G + +PE F+ SDV+SFG+++ E ++
Sbjct: 196 VLEDDPEATYTTS-----GGKIPIRWTAPEAISYRKFTSASDVWSFGIVMWEVMT 245
|
| >1fmk_A C-SRC, P60-SRC, tyrosine-protein kinase SRC; tyrosine kinase, phosphorylation, SH2, SH3, phosphotyrosine, proto-oncogene, phosphotransferase; HET: PTR; 1.50A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1y57_A* 2src_A* 1ksw_A* 2ptk_A* 1yol_A* 2oiq_A* 3d7t_B* 3dqx_A* 3el7_A* 3el8_A* 3en4_A* 3en5_A* 3en6_A* 3en7_A* 3f6x_A* 3g6g_A* 3uqf_A* 3uqg_A* 4agw_A* 3oez_A* ... Length = 452 | Back alignment and structure |
|---|
Score = 95.2 bits (237), Expect = 2e-21
Identities = 49/194 (25%), Positives = 89/194 (45%), Gaps = 36/194 (18%)
Query: 265 VRIIEGIAQGLLYLHQYSRLRVIHRDLKASNILLDKDMNPKISDFGMARMFGGDELQSNT 324
V + IA G+ Y+ R+ +HRDL+A+NIL+ +++ K++DFG+AR+ +E +
Sbjct: 283 VDMAAQIASGMAYV---ERMNYVHRDLRAANILVGENLVCKVADFGLARLIEDNEYTARQ 339
Query: 325 KRIVGTYGYMSPEYALRGLFSIKSDVFSFGVLLLETLSSKKNTHFYNTDSLTLLGHA--W 382
+ +PE AL G F+IKSDV+SFG+LL E + G
Sbjct: 340 GAKF-PIKWTAPEAALYGRFTIKSDVWSFGILLTELTT---------------KGRVPYP 383
Query: 383 NLWNDGRTWELMDPISQN-------GASYPILKRYINVALLCVQEKAADRPAMSEVVSML 435
+ N E++D + + + + ++ C +++ +RP + + L
Sbjct: 384 GMVNR----EVLDQVERGYRMPCPPECPESL---H-DLMCQCWRKEPEERPTFEYLQAFL 435
Query: 436 SNEFVNLPAPQQPA 449
+ F + QP
Sbjct: 436 EDYFTSTEPQYQPG 449
|
| >2w1i_A JAK2; chromosomal rearrangement, nucleotide-binding, tyrosine-protein kinase, proto-oncogene, phosphoprotein, disease mutation, SH2 domain; HET: PTR L0I; 2.60A {Homo sapiens} Length = 326 | Back alignment and structure |
|---|
Score = 93.6 bits (233), Expect = 2e-21
Identities = 42/204 (20%), Positives = 79/204 (38%), Gaps = 39/204 (19%)
Query: 253 PTKKGLLCWGTRVRIIEGIAQGLLYLHQYSRLRVIHRDLKASNILLDKDMNPKISDFGMA 312
K + ++ I +G+ YL R IHRDL NIL++ + KI DFG+
Sbjct: 136 QKHKERIDHIKLLQYTSQICKGMEYL---GTKRYIHRDLATRNILVENENRVKIGDFGLT 192
Query: 313 RMFGGDE----LQSNTK---RIVGTYGYMSPEYALRGLFSIKSDVFSFGVLLLETLSSKK 365
++ D+ ++ + + +PE FS+ SDV+SFGV+L E + +
Sbjct: 193 KVLPQDKEYYKVKEPGESPIF------WYAPESLTESKFSVASDVWSFGVVLYELFTYIE 246
Query: 366 NTHFYNTDSLTLLGHA--WNLWNDGRTWELMDPISQNG----------ASYPILKRYINV 413
+ + + ++G+ + L++ + NG Y I+
Sbjct: 247 KSKSPPAEFMRMIGNDKQGQMIVF----HLIELLKNNGRLPRPDGCPDEIYMIMTE---- 298
Query: 414 ALLCVQEKAADRPAMSEVVSMLSN 437
C RP+ ++ +
Sbjct: 299 ---CWNNNVNQRPSFRDLALRVDQ 319
|
| >3ork_A Serine/threonine protein kinase; structural genomics, TB structural genomics consortium, TBSG domain, signal transduction; HET: AGS; 1.60A {Mycobacterium tuberculosis} PDB: 3ori_A* 3orl_A* 3oro_A* 3orp_A* 3ort_A* 3f61_A* 1mru_A* 3f69_A* 3orm_A* 1o6y_A* 2fum_A* Length = 311 | Back alignment and structure |
|---|
Score = 93.1 bits (232), Expect = 3e-21
Identities = 34/108 (31%), Positives = 54/108 (50%), Gaps = 4/108 (3%)
Query: 255 KKGLLCWGTRVRIIEGIAQGLLYLHQYSRLRVIHRDLKASNILLDKDMNPKISDFGMARM 314
+G + + +I Q L + H + +IHRD+K +NI++ K+ DFG+AR
Sbjct: 109 TEGPMTPKRAIEVIADACQALNFSH---QNGIIHRDVKPANIMISATNAVKVMDFGIARA 165
Query: 315 FGGDELQ-SNTKRIVGTYGYMSPEYALRGLFSIKSDVFSFGVLLLETL 361
+ T ++GT Y+SPE A +SDV+S G +L E L
Sbjct: 166 IADSGNSVTQTAAVIGTAQYLSPEQARGDSVDARSDVYSLGCVLYEVL 213
|
| >2h8h_A Proto-oncogene tyrosine-protein kinase SRC; SRC kinase, transferase; HET: PTR H8H; 2.20A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 Length = 535 | Back alignment and structure |
|---|
Score = 95.7 bits (238), Expect = 3e-21
Identities = 49/194 (25%), Positives = 89/194 (45%), Gaps = 36/194 (18%)
Query: 265 VRIIEGIAQGLLYLHQYSRLRVIHRDLKASNILLDKDMNPKISDFGMARMFGGDELQSNT 324
V + IA G+ Y+ R+ +HRDL+A+NIL+ +++ K++DFG+AR+ +E +
Sbjct: 366 VDMAAQIASGMAYV---ERMNYVHRDLRAANILVGENLVCKVADFGLARLIEDNEYTARQ 422
Query: 325 KRIVGTYGYMSPEYALRGLFSIKSDVFSFGVLLLETLSSKKNTHFYNTDSLTLLGHA--W 382
+ +PE AL G F+IKSDV+SFG+LL E + G
Sbjct: 423 GAKF-PIKWTAPEAALYGRFTIKSDVWSFGILLTELTT---------------KGRVPYP 466
Query: 383 NLWNDGRTWELMDPISQN-------GASYPILKRYINVALLCVQEKAADRPAMSEVVSML 435
+ N E++D + + + + ++ C +++ +RP + + L
Sbjct: 467 GMVNR----EVLDQVERGYRMPCPPECPESL---H-DLMCQCWRKEPEERPTFEYLQAFL 518
Query: 436 SNEFVNLPAPQQPA 449
+ F + QP
Sbjct: 519 EDYFTSTEPQYQPG 532
|
| >2ozo_A Tyrosine-protein kinase ZAP-70; inactive ZAP-70, tandem SH2, autoinhibition, ITAM, hydrogen bonding network, TCR signaling, transferase; HET: ANP; 2.60A {Homo sapiens} Length = 613 | Back alignment and structure |
|---|
Score = 95.8 bits (238), Expect = 4e-21
Identities = 47/212 (22%), Positives = 78/212 (36%), Gaps = 48/212 (22%)
Query: 254 TKKGLLCWGTRVRIIEGIAQGLLYLHQYSRLRVIHRDLKASNILLDKDMNPKISDFGMAR 313
K+ + ++ ++ G+ YL +HR+L A N+LL KISDFG+++
Sbjct: 428 GKREEIPVSNVAELLHQVSMGMKYL---EEKNFVHRNLAARNVLLVNRHYAKISDFGLSK 484
Query: 314 MFGGDE----LQSNTKRIVGTYGYMSPEYALRGLFSIKSDVFSFGVLLLETLSSKKNTHF 369
G D+ +S K + + +PE FS +SDV+S+GV + E LS
Sbjct: 485 ALGADDSYYTARSAGKWPL---KWYAPECINFRKFSSRSDVWSYGVTMWEALS------- 534
Query: 370 YNTDSLTLLGHA--WNLWNDGRTWELMDPISQNG----------ASYPILKRYINVALLC 417
G + E+M I Q Y ++ C
Sbjct: 535 --------YGQKPYKKMKGP----EVMAFIEQGKRMECPPECPPELYALMSD-------C 575
Query: 418 VQEKAADRPAMSEVVSMLSNEFVNLPAPQQPA 449
K DRP V + + +L + +
Sbjct: 576 WIYKWEDRPDFLTVEQRMRACYYSLASKVEGG 607
|
| >3kfa_A Tyrosine-protein kinase ABL1; CML, drug resistance, inhibitor, ATP-binding, nucleotide-binding, oncogene, TRAN; HET: B91; 1.22A {Mus musculus} PDB: 2qoh_A* 3kf4_A* 3k5v_A* 1fpu_A* 1m52_A* 1iep_A* 2hzn_A* 1opj_A* 3ms9_A* 3mss_A* 3ik3_A* 2z60_A* 2e2b_A* 3pyy_A* 3oxz_A* 2g1t_A* 3ue4_A* 3oy3_A* 2hiw_A* 2v7a_A* ... Length = 288 | Back alignment and structure |
|---|
Score = 92.3 bits (230), Expect = 4e-21
Identities = 33/113 (29%), Positives = 56/113 (49%), Gaps = 14/113 (12%)
Query: 255 KKGLLCWGTRVRIIEGIAQGLLYLHQYSRLRVIHRDLKASNILLDKDMNPKISDFGMARM 314
+ + + + I+ + YL + IHRDL A N L+ ++ K++DFG++R+
Sbjct: 104 NRQEVSAVVLLYMATQISSAMEYL---EKKNFIHRDLAARNCLVGENHLVKVADFGLSRL 160
Query: 315 FGGDELQSNTK-----RIVGTYGYMSPEYALRGLFSIKSDVFSFGVLLLETLS 362
GD ++ + + +PE FSIKSDV++FGVLL E +
Sbjct: 161 MTGDTYTAHAGAKFPIK------WTAPESLAYNKFSIKSDVWAFGVLLWEIAT 207
|
| >3gen_A Tyrosine-protein kinase BTK; bruton'S tyrosine kinase, 4-amino-5-(4-phenoxyphenyl)-5H- pyrrolo[3, 2-D]pyrimidin-7-YL-cyclopentane, TEC-family; HET: B43; 1.60A {Homo sapiens} PDB: 3k54_A* 3pj2_A* 3piy_A* 3piz_A* 3pj1_A* 3pix_A* 3pj3_A* 3p08_A 3ocs_A* 3oct_A* 1k2p_A Length = 283 | Back alignment and structure |
|---|
Score = 91.9 bits (229), Expect = 5e-21
Identities = 32/111 (28%), Positives = 53/111 (47%), Gaps = 8/111 (7%)
Query: 254 TKKGLLCWGTRVRIIEGIAQGLLYLHQYSRLRVIHRDLKASNILLDKDMNPKISDFGMAR 313
+ + + + + + + YL + +HRDL A N L++ K+SDFG++R
Sbjct: 112 EMRHRFQTQQLLEMCKDVCEAMEYL---ESKQFLHRDLAARNCLVNDQGVVKVSDFGLSR 168
Query: 314 MFGGDE--LQSNTKRIVGTYGYMSPEYALRGLFSIKSDVFSFGVLLLETLS 362
DE +K V + PE + FS KSD+++FGVL+ E S
Sbjct: 169 YVLDDEYTSSVGSKFPV---RWSPPEVLMYSKFSSKSDIWAFGVLMWEIYS 216
|
| >3t9t_A Tyrosine-protein kinase ITK/TSK; kinase domain, alpha/beta, ATP binding, phosphorylation, intracellular, transferase-transferase inhibitor complex; HET: IAQ; 1.65A {Homo sapiens} PDB: 3v5l_A* 3v5j_A* 3v8t_A* 3v8w_A* 1sm2_A* 1snu_A* 1snx_A 3qgw_A* 3qgy_A* 3miy_A* 3mj1_A* 3mj2_A* Length = 267 | Back alignment and structure |
|---|
Score = 91.5 bits (228), Expect = 5e-21
Identities = 42/111 (37%), Positives = 59/111 (53%), Gaps = 8/111 (7%)
Query: 254 TKKGLLCWGTRVRIIEGIAQGLLYLHQYSRLRVIHRDLKASNILLDKDMNPKISDFGMAR 313
T++GL T + + + +G+ YL VIHRDL A N L+ ++ K+SDFGM R
Sbjct: 96 TQRGLFAAETLLGMCLDVCEGMAYL---EEACVIHRDLAARNCLVGENQVIKVSDFGMTR 152
Query: 314 MFGGDE--LQSNTKRIVGTYGYMSPEYALRGLFSIKSDVFSFGVLLLETLS 362
D+ + TK V + SPE +S KSDV+SFGVL+ E S
Sbjct: 153 FVLDDQYTSSTGTKFPV---KWASPEVFSFSRYSSKSDVWSFGVLMWEVFS 200
|
| >1xbb_A Tyrosine-protein kinase SYK; gleevec, STI-571, imatinib, spleen typrosine kinase, active conformation, structural genomics, structural genomix; HET: STI; 1.57A {Homo sapiens} SCOP: d.144.1.7 PDB: 1xba_A* 1xbc_A* 3fqe_A* 3fqh_A* 3fqs_A* 3emg_A* 3srv_A* 4dfl_A* 4dfn_A* 3vf8_A* 3vf9_A* Length = 291 | Back alignment and structure |
|---|
Score = 91.5 bits (228), Expect = 7e-21
Identities = 37/112 (33%), Positives = 56/112 (50%), Gaps = 10/112 (8%)
Query: 255 KKGLLCWGTRVRIIEGIAQGLLYLHQYSRLRVIHRDLKASNILLDKDMNPKISDFGMARM 314
+ + + ++ ++ G+ YL +HRDL A N+LL KISDFG+++
Sbjct: 110 QNRHVKDKNIIELVHQVSMGMKYL---EESNFVHRDLAARNVLLVTQHYAKISDFGLSKA 166
Query: 315 FGGDE----LQSNTKRIVGTYGYMSPEYALRGLFSIKSDVFSFGVLLLETLS 362
DE Q++ K V + +PE FS KSDV+SFGVL+ E S
Sbjct: 167 LRADENYYKAQTHGKWPV---KWYAPECINYYKFSSKSDVWSFGVLMWEAFS 215
|
| >1qcf_A Haematopoetic cell kinase (HCK); tyrosine kinase-inhibitor complex, DOWN-regulated kinase, ordered activation loop; HET: PTR PP1; 2.00A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 2c0i_A* 2c0o_A* 2c0t_A* 1ad5_A* 2hck_A* 3nhn_A 3hck_A 1bu1_A 3rea_B 3rbb_B Length = 454 | Back alignment and structure |
|---|
Score = 94.0 bits (234), Expect = 8e-21
Identities = 37/100 (37%), Positives = 59/100 (59%), Gaps = 8/100 (8%)
Query: 265 VRIIEGIAQGLLYLHQYSRLRVIHRDLKASNILLDKDMNPKISDFGMARMFGGDELQSNT 324
+ IA+G+ ++ + IHRDL+A+NIL+ + KI+DFG+AR+ +E T
Sbjct: 287 IDFSAQIAEGMAFI---EQRNYIHRDLRAANILVSASLVCKIADFGLARVIEDNE---YT 340
Query: 325 KRIVGTYGY--MSPEYALRGLFSIKSDVFSFGVLLLETLS 362
R + +PE G F+IKSDV+SFG+LL+E ++
Sbjct: 341 AREGAKFPIKWTAPEAINFGSFTIKSDVWSFGILLMEIVT 380
|
| >2qol_A Ephrin receptor; receptor tyrosine kinase, juxtamembrane segment, structural genomics, mutant, structural genomics consortium, SGC, ATP- binding; 1.07A {Homo sapiens} PDB: 2qok_A 2qoi_A 2qoo_A 2qof_A 2qod_A 2qo9_A* 2gsf_A 2qo7_A* 2qo2_A* 2qoq_A* 2qon_A* 3fxx_A* 3fy2_A 2qoc_A* 2qob_A* 3dzq_A* 2r2p_A 2hel_A 2rei_A 3dko_A* ... Length = 373 | Back alignment and structure |
|---|
Score = 92.8 bits (231), Expect = 8e-21
Identities = 36/113 (31%), Positives = 56/113 (49%), Gaps = 10/113 (8%)
Query: 254 TKKGLLCWGTRVRIIEGIAQGLLYLHQYSRLRVIHRDLKASNILLDKDMNPKISDFGMAR 313
V ++ GIA G+ YL S + +HRDL A NIL++ ++ K+SDFG+ R
Sbjct: 139 KHDAQFTVIQLVGMLRGIASGMKYL---SDMGYVHRDLAARNILINSNLVCKVSDFGLGR 195
Query: 314 MFGGDE----LQSNTKRIVGTYGYMSPEYALRGLFSIKSDVFSFGVLLLETLS 362
+ D K + + SPE F+ SDV+S+G++L E +S
Sbjct: 196 VLEDDPEAAYTTRGGKIPI---RWTSPEAIAYRKFTSASDVWSYGIVLWEVMS 245
|
| >3sxs_A Cytoplasmic tyrosine-protein kinase BMX; transferase-transferase inhibitor complex; HET: PP2; 1.89A {Homo sapiens} PDB: 3sxr_A* Length = 268 | Back alignment and structure |
|---|
Score = 90.7 bits (226), Expect = 8e-21
Identities = 36/111 (32%), Positives = 56/111 (50%), Gaps = 8/111 (7%)
Query: 254 TKKGLLCWGTRVRIIEGIAQGLLYLHQYSRLRVIHRDLKASNILLDKDMNPKISDFGMAR 313
+ L + + + +G+ +L + IHRDL A N L+D+D+ K+SDFGM R
Sbjct: 96 SHGKGLEPSQLLEMCYDVCEGMAFL---ESHQFIHRDLAARNCLVDRDLCVKVSDFGMTR 152
Query: 314 MFGGDE--LQSNTKRIVGTYGYMSPEYALRGLFSIKSDVFSFGVLLLETLS 362
D+ TK V + +PE +S KSDV++FG+L+ E S
Sbjct: 153 YVLDDQYVSSVGTKFPV---KWSAPEVFHYFKYSSKSDVWAFGILMWEVFS 200
|
| >1fvr_A Tyrosine-protein kinase TIE-2; tyrosine kinase, transferase; 2.20A {Homo sapiens} SCOP: d.144.1.7 PDB: 2oo8_X* 2osc_A* 2p4i_A* 3l8p_A* 2wqb_A* Length = 327 | Back alignment and structure |
|---|
Score = 92.0 bits (229), Expect = 9e-21
Identities = 51/235 (21%), Positives = 97/235 (41%), Gaps = 56/235 (23%)
Query: 247 YESYNNPTKKGLLCWGTRVRIIEGIAQGLLYLHQYSRLRVIHRDLKASNILLDKDMNPKI 306
+ L + +A+G+ YL S+ + IHRDL A NIL+ ++ KI
Sbjct: 127 PAFAIANSTASTLSSQQLLHFAADVARGMDYL---SQKQFIHRDLAARNILVGENYVAKI 183
Query: 307 SDFGMARMFGGDELQSNTK-----RIVGTYGYMSPEYALRGLFSIKSDVFSFGVLLLETL 361
+DFG++R G + T R +M+ E +++ SDV+S+GVLL E +
Sbjct: 184 ADFGLSR--GQEVYVKKTMGRLPVR------WMAIESLNYSVYTTNSDVWSYGVLLWEIV 235
Query: 362 SSKKNTHFYNTDSLTLLGHA--WNLWNDGRTWELMDPISQNGASYPILKR--------YI 411
S LG + EL + + Q L++ Y
Sbjct: 236 S---------------LGGTPYCGMTC----AELYEKLPQGY----RLEKPLNCDDEVY- 271
Query: 412 NVALLCVQEKAADRPAMSEVVSML------SNEFVNLPAPQQPAFSCVNSTNMQS 460
++ C +EK +RP+ ++++ L +VN ++ ++ ++ + ++
Sbjct: 272 DLMRQCWREKPYERPSFAQILVSLNRMLEERKTYVNTTLYEKFTYAGIDCSAEEA 326
|
| >3f66_A Hepatocyte growth factor receptor; C-Met, protein kinase, quinoxaline, alternative splicing, ATP-binding, chromosomal rearrangement; HET: IHX; 1.40A {Homo sapiens} PDB: 3i5n_A* 3u6h_A* 3u6i_A* 3ccn_A* 2rfn_A* 2rfs_A* 3cd8_A* 3efj_A* 3efk_A* 3lq8_A* 3zxz_A* 2wkm_A* 2wgj_A* 3zze_A* 3q6w_A* 3r7o_A* 3q6u_A* 3cth_A* 3ce3_A* 3ctj_A* ... Length = 298 | Back alignment and structure |
|---|
Score = 91.6 bits (228), Expect = 9e-21
Identities = 51/194 (26%), Positives = 80/194 (41%), Gaps = 47/194 (24%)
Query: 265 VRIIEGIAQGLLYLHQYSRLRVIHRDLKASNILLDKDMNPKISDFGMARMFGGDELQSNT 324
+ +A+G+ YL + + +HRDL A N +LD+ K++DFG+AR D
Sbjct: 131 IGFGLQVAKGMKYL---ASKKFVHRDLAARNCMLDEKFTVKVADFGLAR----DMYDKEY 183
Query: 325 KRIVGTYG------YMSPEYALRGLFSIKSDVFSFGVLLLETLSSKKNTHFYNTDSLTLL 378
+ G +M+ E F+ KSDV+SFGVLL E ++
Sbjct: 184 YSVHNKTGAKLPVKWMALESLQTQKFTTKSDVWSFGVLLWELMT---------------R 228
Query: 379 GHA--WNLWNDGRTWELMDPISQNGASYPILKR--------YINVALLCVQEKAADRPAM 428
G ++ +++ + Q L + Y V L C KA RP+
Sbjct: 229 GAPPYPDVNT----FDITVYLLQGR----RLLQPEYCPDPLY-EVMLKCWHPKAEMRPSF 279
Query: 429 SEVVSMLSNEFVNL 442
SE+VS +S F
Sbjct: 280 SELVSRISAIFSTF 293
|
| >3aln_A Dual specificity mitogen-activated protein kinase; protein AMP-PNP complex, transferase; HET: ANP; 2.30A {Homo sapiens} PDB: 3alo_A* Length = 327 | Back alignment and structure |
|---|
Score = 92.0 bits (229), Expect = 9e-21
Identities = 37/99 (37%), Positives = 54/99 (54%), Gaps = 11/99 (11%)
Query: 266 RIIEGIAQGLLYLHQYSRLRVIHRDLKASNILLDKDMNPKISDFGMARMFGGDELQSNTK 325
+I + L +L L++IHRD+K SNILLD+ N K+ DFG++ G + S K
Sbjct: 129 KITLATVKALNHLK--ENLKIIHRDIKPSNILLDRSGNIKLCDFGIS----GQLVDSIAK 182
Query: 326 RI-VGTYGYMSPE----YALRGLFSIKSDVFSFGVLLLE 359
G YM+PE A R + ++SDV+S G+ L E
Sbjct: 183 TRDAGCRPYMAPERIDPSASRQGYDVRSDVWSLGITLYE 221
|
| >1qpc_A LCK kinase; alpha beta fold, transferase; HET: PTR ANP; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1qpe_A* 1qpj_A* 2pl0_A* 3kxz_A* 3ac1_A* 2zm4_A* 2zyb_A* 2zm1_A* 3ac2_A* 3ac3_A* 3ac4_A* 3ac5_A* 3ac8_A* 3acj_A* 3ack_A* 3ad4_A* 3ad5_A* 3ad6_A* 3kmm_A* 1qpd_A* ... Length = 279 | Back alignment and structure |
|---|
Score = 91.1 bits (227), Expect = 1e-20
Identities = 37/100 (37%), Positives = 59/100 (59%), Gaps = 8/100 (8%)
Query: 265 VRIIEGIAQGLLYLHQYSRLRVIHRDLKASNILLDKDMNPKISDFGMARMFGGDELQSNT 324
+ + IA+G+ ++ IHRDL+A+NIL+ ++ KI+DFG+AR+ +E T
Sbjct: 112 LDMAAQIAEGMAFI---EERNYIHRDLRAANILVSDTLSCKIADFGLARLIEDNEY---T 165
Query: 325 KRIVGTYGY--MSPEYALRGLFSIKSDVFSFGVLLLETLS 362
R + +PE G F+IKSDV+SFG+LL E ++
Sbjct: 166 AREGAKFPIKWTAPEAINYGTFTIKSDVWSFGILLTEIVT 205
|
| >3zzw_A Tyrosine-protein kinase transmembrane receptor RO; transferase, neurotrophic tyrosine kinase, receptor-related NTRKR2; 2.90A {Homo sapiens} Length = 289 | Back alignment and structure |
|---|
Score = 91.1 bits (227), Expect = 1e-20
Identities = 45/140 (32%), Positives = 69/140 (49%), Gaps = 21/140 (15%)
Query: 229 SFLYEQVLVQSKDEISFWYESYNNPTKKGLLCWGTRVRIIEGIAQGLLYLHQYSRLRVIH 288
FL + S + ++ T K L V ++ IA G+ YL S V+H
Sbjct: 101 EFL------VMRSPHSDVGSTDDDRTVKSALEPPDFVHLVAQIAAGMEYL---SSHHVVH 151
Query: 289 RDLKASNILLDKDMNPKISDFGMAR-MFGGD--ELQSNTK---RIVGTYGYMSPEYALRG 342
+DL N+L+ +N KISD G+ R ++ D +L N+ R +M+PE + G
Sbjct: 152 KDLATRNVLVYDKLNVKISDLGLFREVYAADYYKLLGNSLLPIR------WMAPEAIMYG 205
Query: 343 LFSIKSDVFSFGVLLLETLS 362
FSI SD++S+GV+L E S
Sbjct: 206 KFSIDSDIWSYGVVLWEVFS 225
|
| >1opk_A P150, C-ABL, proto-oncogene tyrosine-protein kinase ABL1; transferase; HET: MYR P16; 1.80A {Mus musculus} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1opl_A* 2fo0_A* 2abl_A Length = 495 | Back alignment and structure |
|---|
Score = 93.7 bits (233), Expect = 1e-20
Identities = 32/98 (32%), Positives = 53/98 (54%), Gaps = 4/98 (4%)
Query: 265 VRIIEGIAQGLLYLHQYSRLRVIHRDLKASNILLDKDMNPKISDFGMARMFGGDELQSNT 324
+ + I+ + YL + IHR+L A N L+ ++ K++DFG++R+ GD ++
Sbjct: 321 LYMATQISSAMEYL---EKKNFIHRNLAARNCLVGENHLVKVADFGLSRLMTGDTYTAHA 377
Query: 325 KRIVGTYGYMSPEYALRGLFSIKSDVFSFGVLLLETLS 362
+ +PE FSIKSDV++FGVLL E +
Sbjct: 378 GAKF-PIKWTAPESLAYNKFSIKSDVWAFGVLLWEIAT 414
|
| >3brb_A Proto-oncogene tyrosine-protein kinase MER; ATP-binding, disease mutation, glycoprotein, nucleot binding, phosphorylation, receptor; HET: ADP; 1.90A {Homo sapiens} PDB: 3bpr_A* 2p0c_A* Length = 313 | Back alignment and structure |
|---|
Score = 91.2 bits (227), Expect = 1e-20
Identities = 44/195 (22%), Positives = 77/195 (39%), Gaps = 49/195 (25%)
Query: 265 VRIIEGIAQGLLYLHQYSRLRVIHRDLKASNILLDKDMNPKISDFGMAR-MFGGDELQSN 323
++ + IA G+ YL S +HRDL A N +L DM ++DFG+++ ++ GD +
Sbjct: 150 LKFMVDIALGMEYL---SNRNFLHRDLAARNCMLRDDMTVCVADFGLSKKIYSGDYYRQG 206
Query: 324 TK-----RIVGTYGYMSPEYALRGLFSIKSDVFSFGVLLLETLSSKKNTHFYNTDSLTLL 378
+ +++ E +++ KSDV++FGV + E +
Sbjct: 207 RIAKMPVK------WIAIESLADRVYTSKSDVWAFGVTMWEIAT---------------R 245
Query: 379 GHA--WNLWNDGRTWELMDPISQNGASYPILKR--------YINVALLCVQEKAADRPAM 428
G + N E+ D + LK+ Y + C + DRP
Sbjct: 246 GMTPYPGVQN----HEMYDYLLHGH----RLKQPEDCLDELY-EIMYSCWRTDPLDRPTF 296
Query: 429 SEVVSMLSNEFVNLP 443
S + L +LP
Sbjct: 297 SVLRLQLEKLLESLP 311
|
| >3lzb_A Epidermal growth factor receptor; epidermal growth factor kinase domain, multitargeted small M kinase inhibitor; HET: ITI; 2.70A {Homo sapiens} Length = 327 | Back alignment and structure |
|---|
Score = 91.1 bits (227), Expect = 2e-20
Identities = 33/114 (28%), Positives = 59/114 (51%), Gaps = 15/114 (13%)
Query: 255 KKGLLCWGTRVRIIEGIAQGLLYLHQYSRLRVIHRDLKASNILLDKDMNPKISDFGMARM 314
K + + IA+G+ YL R++HRDL A N+L+ + KI+DFG+A++
Sbjct: 110 HKDNIGSQYLLNWCVQIAKGMNYL---EDRRLVHRDLAARNVLVKTPQHVKITDFGLAKL 166
Query: 315 FGGDEL---QSNTK---RIVGTYGYMSPEYALRGLFSIKSDVFSFGVLLLETLS 362
G +E K + +M+ E L +++ +SDV+S+GV + E ++
Sbjct: 167 LGAEEKEYHAEGGKVPIK------WMALESILHRIYTHQSDVWSYGVTVWELMT 214
|
| >1mp8_A Focal adhesion kinase 1; tyrosine protein kinase, transferase; HET: ADP; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 2ijm_A* 2etm_A* 3pxk_A* 2jkq_A* 2j0m_B* 2jkm_A* 2j0l_A* 3bz3_A* 2jko_A* 2jkk_A* Length = 281 | Back alignment and structure |
|---|
Score = 90.0 bits (224), Expect = 2e-20
Identities = 31/111 (27%), Positives = 50/111 (45%), Gaps = 8/111 (7%)
Query: 254 TKKGLLCWGTRVRIIEGIAQGLLYLHQYSRLRVIHRDLKASNILLDKDMNPKISDFGMAR 313
+K L + + ++ L YL R +HRD+ A N+L+ + K+ DFG++R
Sbjct: 108 VRKYSLDLASLILYAYQLSTALAYL---ESKRFVHRDIAARNVLVSSNDCVKLGDFGLSR 164
Query: 314 MFGGDE--LQSNTKRIVGTYGYMSPEYALRGLFSIKSDVFSFGVLLLETLS 362
S K + +M+PE F+ SDV+ FGV + E L
Sbjct: 165 YMEDSTYYKASKGKLPI---KWMAPESINFRRFTSASDVWMFGVCMWEILM 212
|
| >3cc6_A Protein tyrosine kinase 2 beta; focal adhesion kinase, structural genomics, structural genom consortium, SGC, ATP-binding, membrane; 1.60A {Homo sapiens} PDB: 3fzs_A* 3et7_A 3fzo_A* 3fzr_A* 3fzp_A* 3fzt_A* 3h3c_A* Length = 281 | Back alignment and structure |
|---|
Score = 89.9 bits (224), Expect = 2e-20
Identities = 33/114 (28%), Positives = 50/114 (43%), Gaps = 14/114 (12%)
Query: 254 TKKGLLCWGTRVRIIEGIAQGLLYLHQYSRLRVIHRDLKASNILLDKDMNPKISDFGMAR 313
K L T V I + + YL + +HRD+ NIL+ K+ DFG++R
Sbjct: 105 RNKNSLKVLTLVLYSLQICKAMAYL---ESINCVHRDIAVRNILVASPECVKLGDFGLSR 161
Query: 314 MFGGDE--LQSNTK---RIVGTYGYMSPEYALRGLFSIKSDVFSFGVLLLETLS 362
++ S T+ + +MSPE F+ SDV+ F V + E LS
Sbjct: 162 YIEDEDYYKASVTRLPIK------WMSPESINFRRFTTASDVWMFAVCMWEILS 209
|
| >3lxp_A Non-receptor tyrosine-protein kinase TYK2; JAK3, inflammation, cancer, PAN inhibitor, ATP-binding nucleotide-binding, phosphoprotein, SH2 domain; HET: PTR IZA; 1.65A {Homo sapiens} PDB: 3lxn_A* 3nz0_A* 3nyx_A* Length = 318 | Back alignment and structure |
|---|
Score = 90.5 bits (225), Expect = 2e-20
Identities = 50/203 (24%), Positives = 80/203 (39%), Gaps = 39/203 (19%)
Query: 265 VRIIEGIAQGLLYLHQYSRLRVIHRDLKASNILLDKDMNPKISDFGMARMFGGDE----L 320
+ + I +G+ YLH IHRDL A N+LLD D KI DFG+A+ +
Sbjct: 137 LLFAQQICEGMAYLHA---QHYIHRDLAARNVLLDNDRLVKIGDFGLAKAVPEGHEYYRV 193
Query: 321 QSNTK---RIVGTYGYMSPEYALRGLFSIKSDVFSFGVLLLETLSSKKNTHFYNTDSLTL 377
+ + + +PE F SDV+SFGV L E L+ ++ T L L
Sbjct: 194 REDGDSPVF------WYAPECLKEYKFYYASDVWSFGVTLYELLTHCDSSQSPPTKFLEL 247
Query: 378 LGHA-WNLWNDGRTWELMDPISQNG----------ASYPILKRYINVALLCVQEKAADRP 426
+G A + L + + + Y ++K C + +A+ RP
Sbjct: 248 IGIAQGQMTVL----RLTELLERGERLPRPDKCPAEVYHLMKN-------CWETEASFRP 296
Query: 427 AMSEVVSMLSNEFVNLPAPQQPA 449
++ +L Q P+
Sbjct: 297 TFENLIPILKTVHEKYQG-QAPS 318
|
| >3dzo_A Rhoptry kinase domain; parasitic disease, transferase, structural genomics, structural genomics consortium, SGC; 1.80A {Toxoplasma gondii} Length = 413 | Back alignment and structure |
|---|
Score = 92.0 bits (228), Expect = 2e-20
Identities = 17/114 (14%), Positives = 37/114 (32%), Gaps = 9/114 (7%)
Query: 253 PTKKGLLCWGTRVRIIEGIAQGLLYLHQYSRLRVIHRDLKASNILLDKDMNPKISDFGMA 312
+ L R+++ + + L LH ++H L+ +I+LD+ ++ F
Sbjct: 202 SSTHKSLVHHARLQLTLQVIRLLASLH---HYGLVHTYLRPVDIVLDQRGGVFLTGFEHL 258
Query: 313 RMFGGDELQSNTKRIVGTYGYMSPEYAL-----RGLFSIKSDVFSFGVLLLETL 361
G S R + L + D ++ G+ +
Sbjct: 259 VRD-GASAVSPIGRGFAPPETTAERMLPFGQHHPTLMTFAFDTWTLGLAIYWIW 311
|
| >2pzi_A Probable serine/threonine-protein kinase PKNG; ATP-recognition, kinase-INH complex, rubredoxin fold, TPR domain, transferase; HET: AXX; 2.40A {Mycobacterium tuberculosis} Length = 681 | Back alignment and structure |
|---|
Score = 93.0 bits (231), Expect = 3e-20
Identities = 23/97 (23%), Positives = 42/97 (43%), Gaps = 11/97 (11%)
Query: 265 VRIIEGIAQGLLYLHQYSRLRVIHRDLKASNILLDKDMNPKISDFGMARMFGGDELQSNT 324
+ + I L YLH + +++ DLK NI+L ++ K+ D G
Sbjct: 185 IAYLLEILPALSYLH---SIGLVYNDLKPENIMLTEE-QLKLIDLGAVSRINS------F 234
Query: 325 KRIVGTYGYMSPEYALRGLFSIKSDVFSFGVLLLETL 361
+ GT G+ +PE R ++ +D+++ G L
Sbjct: 235 GYLYGTPGFQAPEIV-RTGPTVATDIYTVGRTLAALT 270
|
| >3v5q_A NT-3 growth factor receptor; kinase domain, kinase, phosphorylation, transferase-transfer inhibitor complex; HET: 0F4; 2.20A {Homo sapiens} Length = 297 | Back alignment and structure |
|---|
Score = 90.0 bits (224), Expect = 3e-20
Identities = 55/216 (25%), Positives = 88/216 (40%), Gaps = 49/216 (22%)
Query: 244 SFWYESYNNPTKKGLLCWGTRVRIIEGIAQGLLYLHQYSRLRVIHRDLKASNILLDKDMN 303
+ KG L + I IA G++YL + +HRDL N L+ ++
Sbjct: 115 AMILVDGQPRQAKGELGLSQMLHIASQIASGMVYL---ASQHFVHRDLATRNCLVGANLL 171
Query: 304 PKISDFGMAR-MFGGD--ELQSNTK---RIVGTYGYMSPEYALRGLFSIKSDVFSFGVLL 357
KI DFGM+R ++ D + +T R +M PE + F+ +SDV+SFGV+L
Sbjct: 172 VKIGDFGMSRDVYSTDYYRVGGHTMLPIR------WMPPESIMYRKFTTESDVWSFGVIL 225
Query: 358 LETLSSKKNTHFYNTDSLTLLGHA--WNLWNDGRTWELMDPISQNGASYPILKR------ 409
E + G + L N E+++ I+Q +L+R
Sbjct: 226 WEIFT---------------YGKQPWFQLSN----TEVIECITQGR----VLERPRVCPK 262
Query: 410 --YINVALLCVQEKAADRPAMSEVVSMLSNEFVNLP 443
Y +V L C Q + R + E+ +L P
Sbjct: 263 EVY-DVMLGCWQREPQQRLNIKEIYKILHALGKATP 297
|
| >1u46_A ACK-1, activated CDC42 kinase 1; tyrosine kinase, transferase; 2.00A {Homo sapiens} SCOP: d.144.1.7 PDB: 1u4d_A* 1u54_A* 3eqr_A* 3eqp_B* Length = 291 | Back alignment and structure |
|---|
Score = 90.0 bits (224), Expect = 3e-20
Identities = 35/112 (31%), Positives = 49/112 (43%), Gaps = 8/112 (7%)
Query: 254 TKKGLLCWGTRVRIIEGIAQGLLYLHQYSRLRVIHRDLKASNILLDKDMNPKISDFGMAR 313
+G GT R +A+G+ YL R IHRDL A N+LL KI DFG+ R
Sbjct: 113 KHQGHFLLGTLSRYAVQVAEGMGYL---ESKRFIHRDLAARNLLLATRDLVKIGDFGLMR 169
Query: 314 MFGGDELQSNTKRIVGT---YGYMSPEYALRGLFSIKSDVFSFGVLLLETLS 362
++ + + + +PE FS SD + FGV L E +
Sbjct: 170 ALPQNDDHYVMQE--HRKVPFAWCAPESLKTRTFSHASDTWMFGVTLWEMFT 219
|
| >2pml_X PFPK7, Ser/Thr protein kinase; phosphorylati transferase, transferase; HET: ANP; 2.60A {Plasmodium falciparum} PDB: 2pmn_X* 2pmo_X* Length = 348 | Back alignment and structure |
|---|
Score = 90.6 bits (225), Expect = 3e-20
Identities = 30/98 (30%), Positives = 51/98 (52%), Gaps = 8/98 (8%)
Query: 266 RIIEGIAQGLLYLHQYSRLRVIHRDLKASNILLDKDMNPKISDFGMARMFGGDELQSNTK 325
II+ + Y+H + + HRD+K SNIL+DK+ K+SDFG + +++
Sbjct: 155 CIIKSVLNSFSYIH--NEKNICHRDVKPSNILMDKNGRVKLSDFGESEYMVDKKIKG--- 209
Query: 326 RIVGTYGYMSPE-YALRGLFS-IKSDVFSFGVLLLETL 361
GTY +M PE ++ ++ K D++S G+ L
Sbjct: 210 -SRGTYEFMPPEFFSNESSYNGAKVDIWSLGICLYVMF 246
|
| >2pvf_A Fibroblast growth factor receptor 2; kinase domain fold consisting of N- and C-lobes, transferase; HET: PTR ACP; 1.80A {Homo sapiens} PDB: 3cly_A* 2pzr_A* 2pzp_A* 2pvy_A* 2pz5_A* 2q0b_A* 2pwl_A* 2py3_A* 3ri1_A* 1gjo_A 1oec_A* 3b2t_A* 3gql_A* 3gqi_A* 1fgk_A 1fgi_A* 1agw_A 2fgi_A* 3js2_A* 3ky2_A ... Length = 334 | Back alignment and structure |
|---|
Score = 90.0 bits (224), Expect = 4e-20
Identities = 36/122 (29%), Positives = 62/122 (50%), Gaps = 15/122 (12%)
Query: 247 YESYNNPTKKGLLCWGTRVRIIEGIAQGLLYLHQYSRLRVIHRDLKASNILLDKDMNPKI 306
Y N + + + V +A+G+ YL + + IHRDL A N+L+ ++ KI
Sbjct: 142 YSYDINRVPEEQMTFKDLVSCTYQLARGMEYL---ASQKCIHRDLAARNVLVTENNVMKI 198
Query: 307 SDFGMAR-MFGGDELQSNTK-----RIVGTYGYMSPEYALRGLFSIKSDVFSFGVLLLET 360
+DFG+AR + D + T + +M+PE +++ +SDV+SFGVL+ E
Sbjct: 199 ADFGLARDINNIDYYKKTTNGRLPVK------WMAPEALFDRVYTHQSDVWSFGVLMWEI 252
Query: 361 LS 362
+
Sbjct: 253 FT 254
|
| >3cek_A Dual specificity protein kinase TTK; HMPS1, PYT, ESK, phosphotyros picked threonine kinase, SGC, structural genomics consortiu binding; HET: 7PE; 2.30A {Homo sapiens} PDB: 3gfw_A* 3h9f_A* 2x9e_A* 3hmp_A* 3hmn_A* 3hmo_A* Length = 313 | Back alignment and structure |
|---|
Score = 89.7 bits (223), Expect = 4e-20
Identities = 30/105 (28%), Positives = 44/105 (41%), Gaps = 15/105 (14%)
Query: 271 IAQGLLYLHQYSRLRVIHRDLKASNILLDKDMNPKISDFGMARMFGGDELQSNTKRIVGT 330
+ + + +HQ+ ++H DLK +N L+ K+ DFG+A D VGT
Sbjct: 136 MLEAVHTIHQH---GIVHSDLKPANFLIVDG-MLKLIDFGIANQMQPDTTSVVKDSQVGT 191
Query: 331 YGYMSPE-----------YALRGLFSIKSDVFSFGVLLLETLSSK 364
YM PE + S KSDV+S G +L K
Sbjct: 192 VNYMPPEAIKDMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGK 236
|
| >2dyl_A Dual specificity mitogen-activated protein kinase kinase 7; MKK7, activated mutant, ATP-binding, structural genomics, NPPSFA; 2.45A {Homo sapiens} Length = 318 | Back alignment and structure |
|---|
Score = 89.7 bits (223), Expect = 4e-20
Identities = 34/100 (34%), Positives = 52/100 (52%), Gaps = 12/100 (12%)
Query: 266 RIIEGIAQGLLYLHQYSRLRVIHRDLKASNILLDKDMNPKISDFGMARMFGGDELQSNTK 325
++ I + L YL + VIHRD+K SNILLD+ K+ DFG++ G + K
Sbjct: 128 KMTVAIVKALYYLK--EKHGVIHRDVKPSNILLDERGQIKLCDFGIS----GRLVDDKAK 181
Query: 326 RI-VGTYGYMSPE-----YALRGLFSIKSDVFSFGVLLLE 359
G YM+PE + + I++DV+S G+ L+E
Sbjct: 182 DRSAGCAAYMAPERIDPPDPTKPDYDIRADVWSLGISLVE 221
|
| >1t46_A HOMO sapiens V-KIT hardy-zuckerman 4 feline sarcoma viral oncogene homolog; kinase, structure, inhibitor, STI-571, gleevec, transferase activator; HET: STI; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1pkg_A* 1t45_A 3g0e_A* 3g0f_A* Length = 313 | Back alignment and structure |
|---|
Score = 89.6 bits (223), Expect = 4e-20
Identities = 31/93 (33%), Positives = 48/93 (51%), Gaps = 5/93 (5%)
Query: 271 IAQGLLYLHQYSRLRVIHRDLKASNILLDKDMNPKISDFGMAR-MFGGDELQSNTKRIVG 329
+A+G+ +L + IHRDL A NILL KI DFG+AR + +
Sbjct: 154 VAKGMAFL---ASKNCIHRDLAARNILLTHGRITKICDFGLARDIKNDSNYVVKGNARL- 209
Query: 330 TYGYMSPEYALRGLFSIKSDVFSFGVLLLETLS 362
+M+PE +++ +SDV+S+G+ L E S
Sbjct: 210 PVKWMAPESIFNCVYTFESDVWSYGIFLWELFS 242
|
| >2ivs_A Proto-oncogene tyrosine-protein kinase receptor RET; nucleotide-binding, hirschsprung disease, phosphorylation, disease mutation; HET: ACK; 2.00A {Homo sapiens} PDB: 2ivt_A* 2ivu_A* 2x2k_A* 2x2l_A* 2x2m_A* 2ivv_A* Length = 314 | Back alignment and structure |
|---|
Score = 89.6 bits (223), Expect = 5e-20
Identities = 33/98 (33%), Positives = 58/98 (59%), Gaps = 15/98 (15%)
Query: 271 IAQGLLYLHQYSRLRVIHRDLKASNILLDKDMNPKISDFGMAR-MFGGDELQSNTK---- 325
I+QG+ YL + ++++HRDL A NIL+ + KISDFG++R ++ D ++
Sbjct: 159 ISQGMQYL---AEMKLVHRDLAARNILVAEGRKMKISDFGLSRDVYEEDSYVKRSQGRIP 215
Query: 326 -RIVGTYGYMSPEYALRGLFSIKSDVFSFGVLLLETLS 362
+ +M+ E +++ +SDV+SFGVLL E ++
Sbjct: 216 VK------WMAIESLFDHIYTTQSDVWSFGVLLWEIVT 247
|
| >3pls_A Macrophage-stimulating protein receptor; protein kinase, CIS autophosphorylation conformation, recept tyrosine kinase, AMP-PNP, unphosphorylated; HET: ANP; 2.24A {Homo sapiens} Length = 298 | Back alignment and structure |
|---|
Score = 89.3 bits (222), Expect = 5e-20
Identities = 34/100 (34%), Positives = 52/100 (52%), Gaps = 5/100 (5%)
Query: 265 VRIIEGIAQGLLYLHQYSRLRVIHRDLKASNILLDKDMNPKISDFGMARMFGGDELQSNT 324
+ +A+G+ YL + + +HRDL A N +LD+ K++DFG+AR E S
Sbjct: 127 ISFGLQVARGMEYL---AEQKFVHRDLAARNCMLDESFTVKVADFGLARDILDREYYSVQ 183
Query: 325 KRIVGTY--GYMSPEYALRGLFSIKSDVFSFGVLLLETLS 362
+ + + E F+ KSDV+SFGVLL E L+
Sbjct: 184 QHRHARLPVKWTALESLQTYRFTTKSDVWSFGVLLWELLT 223
|
| >4e5w_A Tyrosine-protein kinase JAK1; kinase domain, transferase-transferase inhibit complex; HET: PTR 0NT; 1.86A {Homo sapiens} PDB: 4e4l_A* 4e4n_A* 3eyg_A* 3eyh_A* Length = 302 | Back alignment and structure |
|---|
Score = 89.3 bits (222), Expect = 6e-20
Identities = 33/117 (28%), Positives = 57/117 (48%), Gaps = 16/117 (13%)
Query: 253 PTKKGLLCWGTRVRIIEGIAQGLLYLHQYSRLRVIHRDLKASNILLDKDMNPKISDFGMA 312
P K + +++ I +G+ YL + +HRDL A N+L++ + KI DFG+
Sbjct: 117 PKNKNKINLKQQLKYAVQICKGMDYL---GSRQYVHRDLAARNVLVESEHQVKIGDFGLT 173
Query: 313 RMFGGDE----LQSNTK---RIVGTYGYMSPEYALRGLFSIKSDVFSFGVLLLETLS 362
+ D+ ++ + + +PE ++ F I SDV+SFGV L E L+
Sbjct: 174 KAIETDKEYYTVKDDRDSPVF------WYAPECLMQSKFYIASDVWSFGVTLHELLT 224
|
| >2psq_A Fibroblast growth factor receptor 2; kinase domain fold consisting of N- and C-lobes, transferase; 2.40A {Homo sapiens} SCOP: d.144.1.7 PDB: 1xr0_A Length = 370 | Back alignment and structure |
|---|
Score = 90.1 bits (224), Expect = 6e-20
Identities = 36/122 (29%), Positives = 62/122 (50%), Gaps = 15/122 (12%)
Query: 247 YESYNNPTKKGLLCWGTRVRIIEGIAQGLLYLHQYSRLRVIHRDLKASNILLDKDMNPKI 306
Y N + + + V +A+G+ YL + + IHRDL A N+L+ ++ KI
Sbjct: 188 YSYDINRVPEEQMTFKDLVSCTYQLARGMEYL---ASQKCIHRDLAARNVLVTENNVMKI 244
Query: 307 SDFGMAR-MFGGDELQSNTK-----RIVGTYGYMSPEYALRGLFSIKSDVFSFGVLLLET 360
+DFG+AR + D + T + +M+PE +++ +SDV+SFGVL+ E
Sbjct: 245 ADFGLARDINNIDYYKKTTNGRLPVK------WMAPEALFDRVYTHQSDVWSFGVLMWEI 298
Query: 361 LS 362
+
Sbjct: 299 FT 300
|
| >3lxl_A Tyrosine-protein kinase JAK3; TYK2, inflammation, cancer, PAN inhibitor, ATP-binding mutation, membrane, nucleotide-binding, phosphoprot SCID; HET: IZA; 1.74A {Homo sapiens} PDB: 3lxk_A* 3pjc_A* 1yvj_A* Length = 327 | Back alignment and structure |
|---|
Score = 89.3 bits (222), Expect = 6e-20
Identities = 47/213 (22%), Positives = 84/213 (39%), Gaps = 38/213 (17%)
Query: 270 GIAQGLLYLHQYSRLRVIHRDLKASNILLDKDMNPKISDFGMARMFGGDE----LQSNTK 325
I +G+ YL R +HRDL A NIL++ + + KI+DFG+A++ D+ ++ +
Sbjct: 135 QICKGMEYLGS---RRCVHRDLAARNILVESEAHVKIADFGLAKLLPLDKDYYVVREPGQ 191
Query: 326 ---RIVGTYGYMSPEYALRGLFSIKSDVFSFGVLLLETLS-SKKNTHFYNTDSLTLLGHA 381
+ +PE +FS +SDV+SFGV+L E + K+ +
Sbjct: 192 SPIF------WYAPESLSDNIFSRQSDVWSFGVVLYELFTYCDKSCSPSAEFLRMMGCER 245
Query: 382 WNLWNDGRTWELMDPISQNG----------ASYPILKRYINVALLCVQEKAADRPAMSEV 431
L++ + + + ++K C DRP+ S +
Sbjct: 246 DVPALS----RLLELLEEGQRLPAPPACPAEVHELMKL-------CWAPSPQDRPSFSAL 294
Query: 432 VSMLSNEFVNLPAPQQPAFSCVNSTNMQSDAFS 464
L + + AF+ S +FS
Sbjct: 295 GPQLDMLWSGSRGCETHAFTAHPEGKHHSLSFS 327
|
| >3dbq_A Dual specificity protein kinase TTK; MPS1 structure, kinase activation, phosphorylation, ATP- binding, nucleotide-binding, phosphoprotein; 2.70A {Homo sapiens} Length = 343 | Back alignment and structure |
|---|
Score = 89.4 bits (222), Expect = 8e-20
Identities = 30/105 (28%), Positives = 44/105 (41%), Gaps = 15/105 (14%)
Query: 271 IAQGLLYLHQYSRLRVIHRDLKASNILLDKDMNPKISDFGMARMFGGDELQSNTKRIVGT 330
+ + + +HQ+ ++H DLK +N L+ K+ DFG+A D VGT
Sbjct: 117 MLEAVHTIHQH---GIVHSDLKPANFLIVDG-MLKLIDFGIANQMQPDTTSVVKDSQVGT 172
Query: 331 YGYMSPE-----------YALRGLFSIKSDVFSFGVLLLETLSSK 364
YM PE + S KSDV+S G +L K
Sbjct: 173 VNYMPPEAIKDMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGK 217
|
| >1k9a_A Carboxyl-terminal SRC kinase; COOH-terminal SRC kinase, CSK, SFK, signal transduction, SH2, SH3, SRC homology, tyrosine kinase; 2.50A {Rattus norvegicus} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1jeg_A Length = 450 | Back alignment and structure |
|---|
Score = 90.5 bits (225), Expect = 9e-20
Identities = 33/98 (33%), Positives = 49/98 (50%), Gaps = 8/98 (8%)
Query: 265 VRIIEGIAQGLLYLHQYSRLRVIHRDLKASNILLDKDMNPKISDFGMARMFGGDELQSNT 324
++ + + + YL +HRDL A N+L+ +D K+SDFG+ + Q
Sbjct: 292 LKFSLDVCEAMEYL---EGNNFVHRDLAARNVLVSEDNVAKVSDFGLTKE--ASSTQDTG 346
Query: 325 KRIVGTYGYMSPEYALRGLFSIKSDVFSFGVLLLETLS 362
K V + +PE FS KSDV+SFG+LL E S
Sbjct: 347 KLPV---KWTAPEALREKKFSTKSDVWSFGILLWEIYS 381
|
| >2zmd_A Dual specificity protein kinase TTK; MPS1, T686A, ATP-binding, nucleotide-bindi phosphoprotein, serine/threonine-protein kinase; HET: 537 7PE; 2.88A {Homo sapiens} PDB: 2zmc_A* Length = 390 | Back alignment and structure |
|---|
Score = 89.9 bits (223), Expect = 1e-19
Identities = 30/105 (28%), Positives = 44/105 (41%), Gaps = 15/105 (14%)
Query: 271 IAQGLLYLHQYSRLRVIHRDLKASNILLDKDMNPKISDFGMARMFGGDELQSNTKRIVGT 330
+ + + +HQ+ ++H DLK +N L+ D K+ DFG+A D VG
Sbjct: 164 MLEAVHTIHQH---GIVHSDLKPANFLIV-DGMLKLIDFGIANQMQPDTTSVVKDSQVGA 219
Query: 331 YGYMSPE-----------YALRGLFSIKSDVFSFGVLLLETLSSK 364
YM PE + S KSDV+S G +L K
Sbjct: 220 VNYMPPEAIKDMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGK 264
|
| >2rku_A Serine/threonine-protein kinase PLK1; structure of PLK1, selectivity residues, POLO-like K structure based drug design, ATP-binding; HET: R78 TLA SRT TAR; 1.95A {Homo sapiens} PDB: 2v5q_A 2yac_A* 4a4l_A* 4a4o_A* 3kb7_A* 3d5w_A* 3d5u_A* 3d5v_A 3db8_A* 3dbc_A* 3dbd_A* 3d5x_A* 3db6_A* 3dbe_A* 3dbf_A* Length = 294 | Back alignment and structure |
|---|
Score = 88.4 bits (220), Expect = 1e-19
Identities = 34/92 (36%), Positives = 49/92 (53%), Gaps = 5/92 (5%)
Query: 266 RIIEGIAQGLLYLHQYSRLRVIHRDLKASNILLDKDMNPKISDFGMARMFGGDELQSNTK 325
+ I G YLH R RVIHRDLK N+ L++D+ KI DFG+A D +
Sbjct: 119 YYLRQIVLGCQYLH---RNRVIHRDLKLGNLFLNEDLEVKIGDFGLATKVEYDGERKKV- 174
Query: 326 RIVGTYGYMSPEYALRGLFSIKSDVFSFGVLL 357
+ GT Y++PE + S + DV+S G ++
Sbjct: 175 -LCGTPNYIAPEVLSKKGHSFEVDVWSIGCIM 205
|
| >2xir_A Vascular endothelial growth factor receptor 2; angiogenesis, nucleotide-binding, inhibitor, phosphorylation receptor, transferase, transmembrane; HET: 00J; 1.50A {Homo sapiens} PDB: 1vr2_A* 1ywn_A* 3vnt_A* 3c7q_A* 2oh4_A* 3u6j_A* 3efl_A* 2p2i_A* 3cjf_A* 3cjg_A* 3ewh_A* 2qu5_A* 2qu6_A* 2rl5_A* 3b8q_A* 3b8r_A* 2p2h_A* 3cp9_A* 3cpb_A* 3cpc_A* ... Length = 316 | Back alignment and structure |
|---|
Score = 88.9 bits (221), Expect = 1e-19
Identities = 35/98 (35%), Positives = 54/98 (55%), Gaps = 15/98 (15%)
Query: 271 IAQGLLYLHQYSRLRVIHRDLKASNILLDKDMNPKISDFGMAR-MFGGDELQSNTK---- 325
+A+G+ +L + + IHRDL A NILL + KI DFG+AR ++ +
Sbjct: 157 VAKGMEFL---ASRKCIHRDLAARNILLSEKNVVKICDFGLARDIYKDPDYVRKGDARLP 213
Query: 326 -RIVGTYGYMSPEYALRGLFSIKSDVFSFGVLLLETLS 362
+ +M+PE +++I+SDV+SFGVLL E S
Sbjct: 214 LK------WMAPETIFDRVYTIQSDVWSFGVLLWEIFS 245
|
| >1byg_A CSK, protein (C-terminal SRC kinase); protein kinase, phosphorylation, staurosporine, transferase; HET: STU; 2.40A {Homo sapiens} SCOP: d.144.1.7 PDB: 3d7u_A 3d7t_A* Length = 278 | Back alignment and structure |
|---|
Score = 88.0 bits (219), Expect = 1e-19
Identities = 30/104 (28%), Positives = 48/104 (46%), Gaps = 20/104 (19%)
Query: 265 VRIIEGIAQGLLYLHQYSRLRVIHRDLKASNILLDKDMNPKISDFGMARMFGGDELQSNT 324
++ + + + YL +HRDL A N+L+ +D K+SDFG+ + + +
Sbjct: 120 LKFSLDVCEAMEYL---EGNNFVHRDLAARNVLVSEDNVAKVSDFGLTK----EASST-- 170
Query: 325 KRIVGTYG------YMSPEYALRGLFSIKSDVFSFGVLLLETLS 362
+ +PE FS KSDV+SFG+LL E S
Sbjct: 171 -----QDTGKLPVKWTAPEALREKKFSTKSDVWSFGILLWEIYS 209
|
| >2owb_A Serine/threonine-protein kinase PLK1; catalytic domain, POLO-like kinase1, transfera; HET: 626; 2.10A {Homo sapiens} PDB: 2ou7_A* 3fc2_A* 3thb_A* Length = 335 | Back alignment and structure |
|---|
Score = 88.9 bits (221), Expect = 1e-19
Identities = 33/92 (35%), Positives = 49/92 (53%), Gaps = 5/92 (5%)
Query: 266 RIIEGIAQGLLYLHQYSRLRVIHRDLKASNILLDKDMNPKISDFGMARMFGGDELQSNTK 325
+ I G YLH+ RVIHRDLK N+ L++D+ KI DFG+A D +
Sbjct: 145 YYLRQIVLGCQYLHR---NRVIHRDLKLGNLFLNEDLEVKIGDFGLATKVEYDGERKKV- 200
Query: 326 RIVGTYGYMSPEYALRGLFSIKSDVFSFGVLL 357
+ GT Y++PE + S + DV+S G ++
Sbjct: 201 -LCGTPNYIAPEVLSKKGHSFEVDVWSIGCIM 231
|
| >3qup_A Tyrosine-protein kinase receptor TYRO3; protein kinase inhibitor, receptor tyrosine kinase, spirocyc kinase domain, phosphotransfer, GAS6 ligand; HET: LUN; 1.90A {Mus musculus} Length = 323 | Back alignment and structure |
|---|
Score = 88.5 bits (220), Expect = 1e-19
Identities = 43/203 (21%), Positives = 77/203 (37%), Gaps = 53/203 (26%)
Query: 265 VRIIEGIAQGLLYLHQYSRLRVIHRDLKASNILLDKDMNPKISDFGMAR-MFGGDELQSN 323
VR + IA G+ YL S IHRDL A N +L +DM ++DFG++R ++ GD +
Sbjct: 140 VRFMVDIACGMEYL---SSRNFIHRDLAARNCMLAEDMTVCVADFGLSRKIYSGDYYRQG 196
Query: 324 TK-----RIVGTYGYMSPEYALRGLFSIKSDVFSFGVLLLETLSSKKNTHFYNTDSLTLL 378
+ +++ E L+++ SDV++FGV + E ++
Sbjct: 197 CASKLPVK------WLALESLADNLYTVHSDVWAFGVTMWEIMT---------------R 235
Query: 379 GHA--WNLWNDGRTWELMDPISQNG----------ASYPILKRYINVALLCVQEKAADRP 426
G + N E+ + + Y ++ + C RP
Sbjct: 236 GQTPYAGIEN----AEIYNYLIGGNRLKQPPECMEEVYDLMYQ-------CWSADPKQRP 284
Query: 427 AMSEVVSMLSNEFVNLPAPQQPA 449
+ + + L N +L
Sbjct: 285 SFTCLRMELENILGHLSVLSTSQ 307
|
| >2i1m_A Macrophage colony-stimulating factor 1 receptor; kinase domain, kinase inhibitor complex, transferase; HET: 5CN; 1.80A {Homo sapiens} PDB: 3bea_A* 3lcd_A* 2i0y_A* 2i0v_A* 3dpk_A* 3krj_A* 3krl_A* 2ogv_A 3lco_A* Length = 333 | Back alignment and structure |
|---|
Score = 88.5 bits (220), Expect = 1e-19
Identities = 31/93 (33%), Positives = 50/93 (53%), Gaps = 5/93 (5%)
Query: 271 IAQGLLYLHQYSRLRVIHRDLKASNILLDKDMNPKISDFGMAR-MFGGDELQSNTKRIVG 329
+AQG+ +L + IHRD+ A N+LL KI DFG+AR + +
Sbjct: 173 VAQGMAFL---ASKNCIHRDVAARNVLLTNGHVAKIGDFGLARDIMNDSNYIVKGNARL- 228
Query: 330 TYGYMSPEYALRGLFSIKSDVFSFGVLLLETLS 362
+M+PE +++++SDV+S+G+LL E S
Sbjct: 229 PVKWMAPESIFDCVYTVQSDVWSYGILLWEIFS 261
|
| >3c1x_A Hepatocyte growth factor receptor; receptor tyrosine kinase, signal transduction, GRB2, SHC, ATP-binding, glycoprotein, membrane; HET: CKK; 2.17A {Homo sapiens} SCOP: d.144.1.7 Length = 373 | Back alignment and structure |
|---|
Score = 89.0 bits (221), Expect = 2e-19
Identities = 51/193 (26%), Positives = 81/193 (41%), Gaps = 45/193 (23%)
Query: 265 VRIIEGIAQGLLYLHQYSRLRVIHRDLKASNILLDKDMNPKISDFGMARMFGGDELQSNT 324
+ +A+G+ +L + + +HRDL A N +LD+ K++DFG+AR E S
Sbjct: 195 IGFGLQVAKGMKFL---ASKKFVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEFDSVH 251
Query: 325 KRIVGTYG-----YMSPEYALRGLFSIKSDVFSFGVLLLETLSSKKNTHFYNTDSLTLLG 379
+ T +M+ E F+ KSDV+SFGVLL E ++ G
Sbjct: 252 NK---TGAKLPVKWMALESLQTQKFTTKSDVWSFGVLLWELMT---------------RG 293
Query: 380 HA--WNLWNDGRTWELMDPISQNGASYPILKR--------YINVALLCVQEKAADRPAMS 429
++ +++ + Q L + Y V L C KA RP+ S
Sbjct: 294 APPYPDVNT----FDITVYLLQGR----RLLQPEYCPDPLY-EVMLKCWHPKAEMRPSFS 344
Query: 430 EVVSMLSNEFVNL 442
E+VS +S F
Sbjct: 345 ELVSRISAIFSTF 357
|
| >3kex_A Receptor tyrosine-protein kinase ERBB-3; kinase domain, inactive kinase, HER3, ATP-binding, cell membrane, membrane, nucleotide-binding; HET: ANP; 2.80A {Homo sapiens} PDB: 3lmg_A* Length = 325 | Back alignment and structure |
|---|
Score = 88.1 bits (219), Expect = 2e-19
Identities = 30/114 (26%), Positives = 54/114 (47%), Gaps = 13/114 (11%)
Query: 254 TKKGLLCWGTRVRIIEGIAQGLLYLHQYSRLRVIHRDLKASNILLDKDMNPKISDFGMAR 313
+G L + IA+G+ YL ++HR+L A N+LL +++DFG+A
Sbjct: 107 QHRGALGPQLLLNWGVQIAKGMYYL---EEHGMVHRNLAARNVLLKSPSQVQVADFGVAD 163
Query: 314 MFGGDELQSNTKRIVGTYG-----YMSPEYALRGLFSIKSDVFSFGVLLLETLS 362
+ D+ Q +M+ E G ++ +SDV+S+GV + E ++
Sbjct: 164 LLPPDDKQLLYSE-----AKTPIKWMALESIHFGKYTHQSDVWSYGVTVWELMT 212
|
| >4aoj_A High affinity nerve growth factor receptor; transferase, inhibitor; HET: V4Z; 2.75A {Homo sapiens} Length = 329 | Back alignment and structure |
|---|
Score = 88.1 bits (219), Expect = 2e-19
Identities = 38/120 (31%), Positives = 59/120 (49%), Gaps = 15/120 (12%)
Query: 249 SYNNPTKKGLLCWGTRVRIIEGIAQGLLYLHQYSRLRVIHRDLKASNILLDKDMNPKISD 308
+ G L G + + +A G++YL + L +HRDL N L+ + + KI D
Sbjct: 145 AGGEDVAPGPLGLGQLLAVASQVAAGMVYL---AGLHFVHRDLATRNCLVGQGLVVKIGD 201
Query: 309 FGMAR-MFGGD--ELQSNTK---RIVGTYGYMSPEYALRGLFSIKSDVFSFGVLLLETLS 362
FGM+R ++ D + T R +M PE L F+ +SDV+SFGV+L E +
Sbjct: 202 FGMSRDIYSTDYYRVGGRTMLPIR------WMPPESILYRKFTTESDVWSFGVVLWEIFT 255
|
| >3p23_A Serine/threonine-protein kinase/endoribonuclease; kinase domain, kinase and RNAse function, ATP binding ssRNA dephosphorylated, hydrolase; HET: ADP; 2.70A {Homo sapiens} Length = 432 | Back alignment and structure |
|---|
Score = 89.1 bits (221), Expect = 2e-19
Identities = 31/115 (26%), Positives = 50/115 (43%), Gaps = 16/115 (13%)
Query: 266 RIIEGIAQGLLYLHQYSRLRVIHRDLKASNILL-----DKDMNPKISDFGMARMFGGDEL 320
+++ GL +LH L ++HRDLK NIL+ + ISDFG+ +
Sbjct: 122 TLLQQTTSGLAHLHS---LNIVHRDLKPHNILISMPNAHGKIKAMISDFGLCKKLAVGRH 178
Query: 321 -QSNTKRIVGTYGYMSPEYALRGLF----SIKSDVFSFGVLLLETLSSKKNTHFY 370
S + GT G+++PE L + D+FS G + +S H +
Sbjct: 179 SFSRRSGVPGTEGWIAPEM-LSEDCKENPTYTVDIFSAGCVFYYVISEGS--HPF 230
|
| >3cok_A Serine/threonine-protein kinase PLK4; POLO-like kinase 4, SAK, STK18, PSI, structural genomics, protein structure initiative; HET: ANP; 2.25A {Homo sapiens} Length = 278 | Back alignment and structure |
|---|
Score = 86.8 bits (216), Expect = 2e-19
Identities = 37/96 (38%), Positives = 54/96 (56%), Gaps = 5/96 (5%)
Query: 266 RIIEGIAQGLLYLHQYSRLRVIHRDLKASNILLDKDMNPKISDFGMARMFGGDELQSNTK 325
+ I G+LYLH + ++HRDL SN+LL ++MN KI+DFG+A + T
Sbjct: 116 HFMHQIITGMLYLHSH---GILHRDLTLSNLLLTRNMNIKIADFGLATQLKMPHEKHYT- 171
Query: 326 RIVGTYGYMSPEYALRGLFSIKSDVFSFGVLLLETL 361
+ GT Y+SPE A R ++SDV+S G + L
Sbjct: 172 -LCGTPNYISPEIATRSAHGLESDVWSLGCMFYTLL 206
|
| >1luf_A Muscle-specific tyrosine kinase receptor MUSK; phosphorylation, signal transduction, MASS spectrometry, transferase; 2.05A {Rattus norvegicus} SCOP: d.144.1.7 Length = 343 | Back alignment and structure |
|---|
Score = 88.1 bits (219), Expect = 2e-19
Identities = 32/104 (30%), Positives = 56/104 (53%), Gaps = 15/104 (14%)
Query: 265 VRIIEGIAQGLLYLHQYSRLRVIHRDLKASNILLDKDMNPKISDFGMAR-MFGGDELQSN 323
+ I +A G+ YL S + +HRDL N L+ ++M KI+DFG++R ++ D +++
Sbjct: 177 LCIARQVAAGMAYL---SERKFVHRDLATRNCLVGENMVVKIADFGLSRNIYSADYYKAD 233
Query: 324 TK-----RIVGTYGYMSPEYALRGLFSIKSDVFSFGVLLLETLS 362
R +M PE ++ +SDV+++GV+L E S
Sbjct: 234 GNDAIPIR------WMPPESIFYNRYTTESDVWAYGVVLWEIFS 271
|
| >1p4o_A Insulin-like growth factor I receptor protein; IGF-1R, kinase domain, hormone-growth factor complex; 1.50A {Homo sapiens} SCOP: d.144.1.7 PDB: 1m7n_A 3lvp_A* 3lw0_A* 1jqh_A* 2zm3_A* 3f5p_A* 3i81_A* 2oj9_A* 3nw5_A* 3nw6_A* 3nw7_A* 3o23_A* 3qqu_A* 3d94_A* 1k3a_A* 2z8c_A* 1ir3_A* 1gag_A* 1irk_A 3bu3_A* ... Length = 322 | Back alignment and structure |
|---|
Score = 87.7 bits (218), Expect = 2e-19
Identities = 37/98 (37%), Positives = 53/98 (54%), Gaps = 15/98 (15%)
Query: 271 IAQGLLYLHQYSRLRVIHRDLKASNILLDKDMNPKISDFGMAR-MFGGDELQSNTK---- 325
IA G+ YL + + +HRDL A N ++ +D KI DFGM R ++ D + K
Sbjct: 147 IADGMAYL---NANKFVHRDLAARNCMVAEDFTVKIGDFGMTRDIYETDYYRKGGKGLLP 203
Query: 326 -RIVGTYGYMSPEYALRGLFSIKSDVFSFGVLLLETLS 362
R +MSPE G+F+ SDV+SFGV+L E +
Sbjct: 204 VR------WMSPESLKDGVFTTYSDVWSFGVVLWEIAT 235
|
| >3poz_A Epidermal growth factor receptor; kinase domain, anti-oncogene, ATP-binding, cell cycle, disea mutation, glycoprotein, membrane, nucleotide-binding; HET: 03P; 1.50A {Homo sapiens} PDB: 2itx_A* 2ity_A* 2j5f_A* 2j6m_A* 2itw_A* 1m14_A 1m17_A* 3vjo_A* 2gs6_A* 2gs2_A* 2rf9_A 1xkk_A* 2eb2_A 3gop_A 2eb3_A* 2itn_A* 2ito_A* 2itp_A* 2itq_A* 2jiu_A* ... Length = 327 | Back alignment and structure |
|---|
Score = 87.8 bits (218), Expect = 2e-19
Identities = 33/113 (29%), Positives = 61/113 (53%), Gaps = 13/113 (11%)
Query: 255 KKGLLCWGTRVRIIEGIAQGLLYLHQYSRLRVIHRDLKASNILLDKDMNPKISDFGMARM 314
K + + IA+G+ YL R++HRDL A N+L+ + KI+DFG+A++
Sbjct: 110 HKDNIGSQYLLNWCVQIAKGMNYL---EDRRLVHRDLAARNVLVKTPQHVKITDFGLAKL 166
Query: 315 FGGDELQSNTKRIVGTYG-----YMSPEYALRGLFSIKSDVFSFGVLLLETLS 362
G +E + + + G +M+ E L +++ +SDV+S+GV + E ++
Sbjct: 167 LGAEEKEYHAEG-----GKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMT 214
|
| >1rjb_A FL cytokine receptor; kinase, structure, autoinhibition, juxtamembrane domain, transferase; 2.10A {Homo sapiens} SCOP: d.144.1.7 Length = 344 | Back alignment and structure |
|---|
Score = 88.1 bits (219), Expect = 2e-19
Identities = 32/98 (32%), Positives = 50/98 (51%), Gaps = 15/98 (15%)
Query: 271 IAQGLLYLHQYSRLRVIHRDLKASNILLDKDMNPKISDFGMAR-MFGGDELQSNTK---- 325
+A+G+ +L +HRDL A N+L+ KI DFG+AR +
Sbjct: 181 VAKGMEFL---EFKSCVHRDLAARNVLVTHGKVVKICDFGLARDIMSDSNYVVRGNARLP 237
Query: 326 -RIVGTYGYMSPEYALRGLFSIKSDVFSFGVLLLETLS 362
+ +M+PE G+++IKSDV+S+G+LL E S
Sbjct: 238 VK------WMAPESLFEGIYTIKSDVWSYGILLWEIFS 269
|
| >3tt0_A Basic fibroblast growth factor receptor 1; kinase domain, transferase, transferase-transferase inhibito; HET: 07J; 2.80A {Homo sapiens} Length = 382 | Back alignment and structure |
|---|
Score = 88.2 bits (219), Expect = 3e-19
Identities = 35/98 (35%), Positives = 56/98 (57%), Gaps = 15/98 (15%)
Query: 271 IAQGLLYLHQYSRLRVIHRDLKASNILLDKDMNPKISDFGMAR-MFGGDELQSNTK---- 325
+A+G+ YL + + IHRDL A N+L+ +D KI+DFG+AR + D + T
Sbjct: 200 VARGMEYL---ASKKCIHRDLAARNVLVTEDNVMKIADFGLARDIHHIDYYKKTTNGRLP 256
Query: 326 -RIVGTYGYMSPEYALRGLFSIKSDVFSFGVLLLETLS 362
+ +M+PE +++ +SDV+SFGVLL E +
Sbjct: 257 VK------WMAPEALFDRIYTHQSDVWSFGVLLWEIFT 288
|
| >2zv2_A Calcium/calmodulin-dependent protein kinase kinas; beta, camkk2, E.C.2.7.11.17, phosphorylation, AMPKK, metabolism, binding, calmodulin-binding; HET: 609; 2.40A {Homo sapiens} Length = 298 | Back alignment and structure |
|---|
Score = 86.9 bits (216), Expect = 4e-19
Identities = 39/91 (42%), Positives = 57/91 (62%), Gaps = 10/91 (10%)
Query: 271 IAQGLLYLHQYSRLRVIHRDLKASNILLDKDMNPKISDFGMARMF-GGDELQSNTKRIVG 329
+ +G+ YLH ++IHRD+K SN+L+ +D + KI+DFG++ F G D L SNT VG
Sbjct: 146 LIKGIEYLH---YQKIIHRDIKPSNLLVGEDGHIKIADFGVSNEFKGSDALLSNT---VG 199
Query: 330 TYGYMSPE--YALRGLFS-IKSDVFSFGVLL 357
T +M+PE R +FS DV++ GV L
Sbjct: 200 TPAFMAPESLSETRKIFSGKALDVWAMGVTL 230
|
| >3q60_A ROP5B; pseudokinase, transferase; HET: ATP; 1.72A {Toxoplasma gondii} PDB: 3q5z_A* Length = 371 | Back alignment and structure |
|---|
Score = 87.8 bits (217), Expect = 4e-19
Identities = 11/111 (9%), Positives = 27/111 (24%), Gaps = 10/111 (9%)
Query: 253 PTKKGLLCWGTRVRIIEGIAQGLLYLHQYSRLRVIHRDLKASNILLDKDMNPKISDFGMA 312
+G + + + L ++H N+ + D + D
Sbjct: 185 YVFRGDEGILALHILTAQLIRLAANLQ---SKGLVHGHFTPDNLFIMPDGRLMLGDVSAL 241
Query: 313 RMFGGDELQSNTKRIVGTYGYMSPEYALRG--LFSIKSDVFSFGVLLLETL 361
G + Y E+ F+ + + G+ +
Sbjct: 242 WKVG-----TRGPASSVPVTYAPREFLNASTATFTHALNAWQLGLSIYRVW 287
|
| >2j0j_A Focal adhesion kinase 1; cell migration, FERM, transferase, integrin signaling; HET: 4ST; 2.80A {Gallus gallus} PDB: 2j0k_A* Length = 656 | Back alignment and structure |
|---|
Score = 89.5 bits (222), Expect = 4e-19
Identities = 30/109 (27%), Positives = 50/109 (45%), Gaps = 4/109 (3%)
Query: 254 TKKGLLCWGTRVRIIEGIAQGLLYLHQYSRLRVIHRDLKASNILLDKDMNPKISDFGMAR 313
+K L + + ++ L YL R +HRD+ A N+L+ + K+ DFG++R
Sbjct: 483 VRKFSLDLASLILYAYQLSTALAYL---ESKRFVHRDIAARNVLVSSNDCVKLGDFGLSR 539
Query: 314 MFGGDELQSNTKRIVGTYGYMSPEYALRGLFSIKSDVFSFGVLLLETLS 362
+K + +M+PE F+ SDV+ FGV + E L
Sbjct: 540 YMEDSTYYKASKGKL-PIKWMAPESINFRRFTSASDVWMFGVCMWEILM 587
|
| >3byv_A Rhoptry kinase; malaria, transferase, structural genomics, structural genomics consortium, SGC; 1.80A {Toxoplasma gondii} PDB: 2w1z_A Length = 377 | Back alignment and structure |
|---|
Score = 87.4 bits (216), Expect = 7e-19
Identities = 20/124 (16%), Positives = 44/124 (35%), Gaps = 20/124 (16%)
Query: 250 YNNPTKKGLLCWGTRVRIIEGIAQGLLYLHQYSRLRVIHRDLKASNILLDKDMNPKISDF 309
++ + L R+++ + + L LH Y ++H L+ +I+LD+ ++ F
Sbjct: 194 LSHSSTHKSLVHHARLQLTLQVIRLLASLHHY---GLVHTYLRPVDIVLDQRGGVFLTGF 250
Query: 310 GMARMFGGDELQSNTKRIVGTYGYMSPEYAL-----------RGLFSIKSDVFSFGVLLL 358
G + G+ PE R L + D ++ G+++
Sbjct: 251 EHLVRDG------ARVVSSVSRGFEPPELEARRATISYHRDRRTLMTFSFDAWALGLVIY 304
Query: 359 ETLS 362
Sbjct: 305 WIWC 308
|
| >3vhe_A Vascular endothelial growth factor receptor 2; kinase domain, kinase, transferase-transferase inhibitor COM; HET: 42Q; 1.55A {Homo sapiens} PDB: 1y6a_A* 1y6b_A* 3vid_A* 3hng_A* Length = 359 | Back alignment and structure |
|---|
Score = 86.9 bits (215), Expect = 7e-19
Identities = 52/213 (24%), Positives = 80/213 (37%), Gaps = 22/213 (10%)
Query: 151 DYPTDSLLEGMKLGWDLKNGLERYLSSWESTDDPSPGNFTFRLVIQVIP-KLCAYNGSVE 209
P ++E K G +L L + + + + IP L S+
Sbjct: 99 GGPLMVIVEFCKFG-NLSTYLRSKRNEFVPYKTKGARFRQGKDYVGAIPVDLKRRLDSIT 157
Query: 210 YTCTGPWNGVAFGAAPTYTSFLYEQVLVQSKDEISFWYESYNNPTKKGLLCWGTRVRIIE 269
+ + +G V+ K E K L +
Sbjct: 158 SSQSSASSGF-----------------VEEKSLSDVEEEEAPEDLYKDFLTLEHLICYSF 200
Query: 270 GIAQGLLYLHQYSRLRVIHRDLKASNILLDKDMNPKISDFGMARMFGGDELQSNTKRIVG 329
+A+G+ +L + + IHRDL A NILL + KI DFG+AR D
Sbjct: 201 QVAKGMEFL---ASRKCIHRDLAARNILLSEKNVVKICDFGLARDIYKDPDYVRKGDARL 257
Query: 330 TYGYMSPEYALRGLFSIKSDVFSFGVLLLETLS 362
+M+PE +++I+SDV+SFGVLL E S
Sbjct: 258 PLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFS 290
|
| >2buj_A Serine/threonine-protein kinase 16; transferase, ATP-binding, lipoprotein, myristate, PA phosphorylation; HET: STU; 2.6A {Homo sapiens} Length = 317 | Back alignment and structure |
|---|
Score = 84.7 bits (210), Expect = 2e-18
Identities = 46/199 (23%), Positives = 75/199 (37%), Gaps = 40/199 (20%)
Query: 266 RIIEGIAQGLLYLHQYSRLRVIHRDLKASNILLDKDMNPKISDFGMAR-----MFGGDEL 320
++ GI +GL +H HRDLK +NILL + P + D G + G +
Sbjct: 138 WLLLGICRGLEAIHA---KGYAHRDLKPTNILLGDEGQPVLMDLGSMNQACIHVEGSRQA 194
Query: 321 QSNTKRI--VGTYGYMSPE-YALRGLFSI--KSDVFSFGVLL--LETLSSKKNTHFYNTD 373
+ T Y +PE ++++ I ++DV+S G +L + + F D
Sbjct: 195 LTLQDWAAQRCTISYRAPELFSVQSHCVIDERTDVWSLGCVLYAMMFGEGPYDMVFQKGD 254
Query: 374 SLTLLGHAWNLWNDGRTWELMDPISQNGASYPILKRY----INVALLCVQEKAADRPAMS 429
S+ L QN S P R+ + + RP +
Sbjct: 255 SVAL-------------------AVQNQLSIPQSPRHSSALWQLLNSMMTVDPHQRPHIP 295
Query: 430 EVVSMLSNEFVNLPAPQQP 448
++S L E + PAP Q
Sbjct: 296 LLLSQL--EALQPPAPGQH 312
|
| >2rio_A Serine/threonine-protein kinase/endoribonuclease IRE1; protein-nucleotide complex, ATP-binding, endoplasmic reticulum, glycoprotein; HET: ADP; 2.40A {Saccharomyces cerevisiae} PDB: 3lj0_A* 3lj1_A* 3lj2_A* 3fbv_A* 3sdm_A* 3sdj_A* Length = 434 | Back alignment and structure |
|---|
Score = 85.2 bits (211), Expect = 4e-18
Identities = 33/121 (27%), Positives = 54/121 (44%), Gaps = 27/121 (22%)
Query: 266 RIIEGIAQGLLYLHQYSRLRVIHRDLKASNILLD-------------KDMNPKISDFGMA 312
++ IA G+ +LH L++IHRDLK NIL+ +++ ISDFG+
Sbjct: 119 SLLRQIASGVAHLHS---LKIIHRDLKPQNILVSTSSRFTADQQTGAENLRILISDFGLC 175
Query: 313 RMFGGDE--LQSNTKRIVGTYGYMSPEYALRGLFSI--------KSDVFSFGVLLLETLS 362
+ + ++N GT G+ +PE L ++ D+FS G + LS
Sbjct: 176 KKLDSGQSSFRTNLNNPSGTSGWRAPEL-LEESNNLQTKRRLTRSIDIFSMGCVFYYILS 234
Query: 363 S 363
Sbjct: 235 K 235
|
| >2yfx_A Tyrosine-protein kinase receptor; nucleotide-binding, transferase; HET: VGH; 1.70A {Homo sapiens} PDB: 2xp2_A* 3aox_A* 2yhv_A 3lcs_A* 3lct_A* 4dce_A* 2xba_A* 2xb7_A* Length = 327 | Back alignment and structure |
|---|
Score = 83.9 bits (208), Expect = 4e-18
Identities = 55/227 (24%), Positives = 86/227 (37%), Gaps = 55/227 (24%)
Query: 244 SFWYESYNNPTKKGLLCWGTRVRIIEGIAQGLLYLHQYSRLRVIHRDLKASNILLDK--- 300
SF E+ P++ L + + IA G YL IHRD+ A N LL
Sbjct: 122 SFLRETRPRPSQPSSLAMLDLLHVARDIACGCQYL---EENHFIHRDIAARNCLLTCPGP 178
Query: 301 DMNPKISDFGMARMFGGDELQSNTKRIVGTYGY-----MSPEYALRGLFSIKSDVFSFGV 355
KI DFGMAR ++ + G M PE + G+F+ K+D +SFGV
Sbjct: 179 GRVAKIGDFGMAR-----DIYRASYYRKGGCAMLPVKWMPPEAFMEGIFTSKTDTWSFGV 233
Query: 356 LLLETLSSKKNTHFYNTDSLTLLGHA--WNLWNDGRTWELMDPISQNGASYPILKR---- 409
LL E S LG+ + N E+++ ++ G +
Sbjct: 234 LLWEIFS---------------LGYMPYPSKSN----QEVLEFVTSGG----RMDPPKNC 270
Query: 410 ----YINVALLCVQEKAADRPAMSEVVSML-----SNEFVNLPAPQQ 447
Y + C Q + DRP + ++ + + +N P +
Sbjct: 271 PGPVY-RIMTQCWQHQPEDRPNFAIILERIEYCTQDPDVINTALPIE 316
|
| >1t4h_A Serine/threonine-protein kinase WNK1; protein serine/threonine kinase, transferase; 1.80A {Rattus norvegicus} SCOP: d.144.1.7 PDB: 3fpq_A Length = 290 | Back alignment and structure |
|---|
Score = 83.6 bits (207), Expect = 5e-18
Identities = 32/95 (33%), Positives = 50/95 (52%), Gaps = 7/95 (7%)
Query: 271 IAQGLLYLHQYSRLRVIHRDLKASNILLD-KDMNPKISDFGMARMFGGDELQSNTKRIVG 329
I +GL +LH +IHRDLK NI + + KI D G+A + S K ++G
Sbjct: 138 ILKGLQFLHT-RTPPIIHRDLKCDNIFITGPTGSVKIGDLGLATLKR----ASFAKAVIG 192
Query: 330 TYGYMSPEYALRGLFSIKSDVFSFGVLLLETLSSK 364
T +M+PE + DV++FG+ +LE +S+
Sbjct: 193 TPEFMAPEMYEEK-YDESVDVYAFGMCMLEMATSE 226
|
| >3fdn_A Serine/threonine-protein kinase 6; aurora kinase inhibitors, virtual screening, X-RAY CO- crystal analysis, structure-based drug design (SBDD); HET: MMH; 1.90A {Homo sapiens} PDB: 3k5u_A* 3m11_A* 2c6e_A* 1muo_A* 2bmc_A* 2j4z_A* 1ol6_A* 3up2_A* 3unz_A* 3uo5_A* 3uo6_A* 3uod_A* 3uoh_A* 3uoj_A* 3uok_A* 3uo4_A* 3uol_A* 3up7_A* 3lau_A* 2wtv_A* ... Length = 279 | Back alignment and structure |
|---|
Score = 82.6 bits (205), Expect = 7e-18
Identities = 33/96 (34%), Positives = 43/96 (44%), Gaps = 7/96 (7%)
Query: 266 RIIEGIAQGLLYLHQYSRLRVIHRDLKASNILLDKDMNPKISDFGMARMFGGDELQSNTK 325
I +A L Y H RVIHRD+K N+LL KI+DFG +
Sbjct: 113 TYITELANALSYCH---SKRVIHRDIKPENLLLGSAGELKIADFGWSVHAPSSRRTD--- 166
Query: 326 RIVGTYGYMSPEYALRGLFSIKSDVFSFGVLLLETL 361
+ GT Y+ PE + K D++S GVL E L
Sbjct: 167 -LCGTLDYLPPEMIEGRMHDEKVDLWSLGVLCYEFL 201
|
| >4fvq_A Tyrosine-protein kinase JAK2; janus protein kinase, pseudokinase, ATP binding, phosphoryla transferase; HET: ATP; 1.75A {Homo sapiens} PDB: 4fvp_A* 4fvr_A* Length = 289 | Back alignment and structure |
|---|
Score = 82.7 bits (205), Expect = 7e-18
Identities = 23/122 (18%), Positives = 46/122 (37%), Gaps = 28/122 (22%)
Query: 255 KKGLLCWGTRVRIIEGIAQGLLYLHQYSRLRVIHRDLKASNILLDKDMNP--------KI 306
K + ++ + + +A + +L +IH ++ A NILL ++ + K+
Sbjct: 106 NKNCINILWKLEVAKQLAAAMHFL---EENTLIHGNVCAKNILLIREEDRKTGNPPFIKL 162
Query: 307 SDFGMARMFGGDELQSNTKRIVGTYGY-----MSPEYAL-RGLFSIKSDVFSFGVLLLET 360
SD G++ + + PE ++ +D +SFG L E
Sbjct: 163 SDPGISITVLPKD-----------ILQERIPWVPPECIENPKNLNLATDKWSFGTTLWEI 211
Query: 361 LS 362
S
Sbjct: 212 CS 213
|
| >3qa8_A MGC80376 protein; kinase ubiquitin-like domain, phosphorylation, kinase domain ubiquitin-like domain, kinase, substrate binding; 3.60A {Xenopus laevis} PDB: 3qad_A* 3rzf_A* Length = 676 | Back alignment and structure |
|---|
Score = 85.5 bits (211), Expect = 7e-18
Identities = 33/90 (36%), Positives = 47/90 (52%), Gaps = 9/90 (10%)
Query: 271 IAQGLLYLHQYSRLRVIHRDLKASNILLD---KDMNPKISDFGMARMFGGDELQSNTKRI 327
I+ L YLH+ R+IHRDLK NI+L + + KI D G A+ EL
Sbjct: 130 ISSALRYLHE---NRIIHRDLKPENIVLQPGPQRLIHKIIDLGYAKELDQGEL---CTEF 183
Query: 328 VGTYGYMSPEYALRGLFSIKSDVFSFGVLL 357
VGT Y++PE + +++ D +SFG L
Sbjct: 184 VGTLQYLAPELLEQKKYTVTVDYWSFGTLA 213
|
| >3l9p_A Anaplastic lymphoma kinase; kinase domain, ATP-binding, glycoprotein, membrane, nucleotide-binding, phosphoprotein, proto-oncogene; 1.80A {Homo sapiens} Length = 367 | Back alignment and structure |
|---|
Score = 83.6 bits (207), Expect = 1e-17
Identities = 42/127 (33%), Positives = 55/127 (43%), Gaps = 16/127 (12%)
Query: 244 SFWYESYNNPTKKGLLCWGTRVRIIEGIAQGLLYLHQYSRLRVIHRDLKASNILLDK--- 300
SF E+ P++ L + + IA G YL IHRD+ A N LL
Sbjct: 163 SFLRETRPRPSQPSSLAMLDLLHVARDIACGCQYL---EENHFIHRDIAARNCLLTCPGP 219
Query: 301 DMNPKISDFGMARMFGGDELQSNTKRIVGTYGY-----MSPEYALRGLFSIKSDVFSFGV 355
KI DFGMAR ++ G M PE + G+F+ K+D +SFGV
Sbjct: 220 GRVAKIGDFGMAR-----DIYRAGYYRKGGCAMLPVKWMPPEAFMEGIFTSKTDTWSFGV 274
Query: 356 LLLETLS 362
LL E S
Sbjct: 275 LLWEIFS 281
|
| >3q5i_A Protein kinase; CDPK, malaria, phosphotransferase, structural genomics, structural genomic consortium, SGC, transferase; HET: ANP; 2.10A {Plasmodium berghei} Length = 504 | Back alignment and structure |
|---|
Score = 84.4 bits (209), Expect = 1e-17
Identities = 34/95 (35%), Positives = 55/95 (57%), Gaps = 10/95 (10%)
Query: 266 RIIEGIAQGLLYLHQYSRLRVIHRDLKASNILL---DKDMNPKISDFGMARMFGGDELQS 322
I++ I G+ YLH+ ++HRD+K NILL + +N KI DFG++ F D
Sbjct: 150 NIMKQILSGICYLHK---HNIVHRDIKPENILLENKNSLLNIKIVDFGLSSFFSKDYKL- 205
Query: 323 NTKRIVGTYGYMSPEYALRGLFSIKSDVFSFGVLL 357
+ +GT Y++PE L+ ++ K DV+S GV++
Sbjct: 206 --RDRLGTAYYIAPE-VLKKKYNEKCDVWSCGVIM 237
|
| >3pvu_A Beta-adrenergic receptor kinase 1; transferase, serine/threonine-protein kinase, ATP-binding, I membrane; HET: QRW; 2.48A {Bos taurus} PDB: 3psc_A* 3pvw_A* 1omw_A 1ym7_A 2bcj_A* 3cik_A 3krw_A* 3krx_A* 1bak_A Length = 695 | Back alignment and structure |
|---|
Score = 84.6 bits (209), Expect = 1e-17
Identities = 36/92 (39%), Positives = 52/92 (56%), Gaps = 8/92 (8%)
Query: 271 IAQGLLYLHQYSRLRVIHRDLKASNILLDKDMNPKISDFGMARMFGGDELQSNTKRIVGT 330
I GL ++H V++RDLK +NILLD+ + +ISD G+A F + VGT
Sbjct: 301 IILGLEHMHN---RFVVYRDLKPANILLDEHGHVRISDLGLACDFSKKK----PHASVGT 353
Query: 331 YGYMSPEYALRGLFSIKS-DVFSFGVLLLETL 361
+GYM+PE +G+ S D FS G +L + L
Sbjct: 354 HGYMAPEVLQKGVAYDSSADWFSLGCMLFKLL 385
|
| >3nyv_A Calmodulin-domain protein kinase 1; serine/threonine protein kinase, transferase, calcium-bindin binding, EF hand, bumped kinase inhibitor; HET: MSE DTQ; 1.88A {Toxoplasma gondii} PDB: 3i79_A* 3i7b_A* 3n51_A* 3i7c_A* 3sx9_A* 3sxf_A* 3t3u_A* 3t3v_A* 3upx_A* 3upz_A* 3v51_A* 3v5p_A* 3v5t_A* 3ku2_A* 3hx4_A* Length = 484 | Back alignment and structure |
|---|
Score = 84.0 bits (208), Expect = 2e-17
Identities = 37/95 (38%), Positives = 55/95 (57%), Gaps = 10/95 (10%)
Query: 266 RIIEGIAQGLLYLHQYSRLRVIHRDLKASNILL---DKDMNPKISDFGMARMFGGDELQS 322
RII + G+ Y+H+ +++HRDLK N+LL KD N +I DFG++ F +
Sbjct: 130 RIIRQVLSGITYMHK---NKIVHRDLKPENLLLESKSKDANIRIIDFGLSTHFEASKKM- 185
Query: 323 NTKRIVGTYGYMSPEYALRGLFSIKSDVFSFGVLL 357
K +GT Y++PE L G + K DV+S GV+L
Sbjct: 186 --KDKIGTAYYIAPE-VLHGTYDEKCDVWSTGVIL 217
|
| >1phk_A Phosphorylase kinase; glycogen metabolism, transferase, serine/threonine-protein, ATP-binding, calmodulin-binding; HET: ATP; 2.20A {Oryctolagus cuniculus} SCOP: d.144.1.7 PDB: 1ql6_A* 2phk_A* Length = 298 | Back alignment and structure |
|---|
Score = 81.9 bits (203), Expect = 2e-17
Identities = 31/98 (31%), Positives = 52/98 (53%), Gaps = 12/98 (12%)
Query: 266 RIIEGIAQGLLYLHQYSRLRVIHRDLKASNILLDKDMNPKISDFGMARMFGGDELQSNTK 325
+I+ + + + LH+ L ++HRDLK NILLD DMN K++DFG + E +
Sbjct: 128 KIMRALLEVICALHK---LNIVHRDLKPENILLDDDMNIKLTDFGFSCQLDPGEK---LR 181
Query: 326 RIVGTYGYMSPE------YALRGLFSIKSDVFSFGVLL 357
+ GT Y++PE + + D++S GV++
Sbjct: 182 EVCGTPSYLAPEIIECSMNDNHPGYGKEVDMWSTGVIM 219
|
| >3hko_A Calcium/calmodulin-dependent protein kinase with domain and 2 calmodulin-like EF...; structural genomics, protist parasite; HET: ANP; 1.80A {Cryptosporidium parvum iowa II} Length = 345 | Back alignment and structure |
|---|
Score = 82.6 bits (204), Expect = 2e-17
Identities = 30/99 (30%), Positives = 43/99 (43%), Gaps = 11/99 (11%)
Query: 266 RIIEGIAQGLLYLHQYSRLRVIHRDLKASNILL--DKDMNPKISDFGMARMFGGDELQSN 323
I+ I L YLH + HRD+K N L +K K+ DFG+++ F
Sbjct: 172 NIMRQIFSALHYLHN---QGICHRDIKPENFLFSTNKSFEIKLVDFGLSKEFYKLNNGEY 228
Query: 324 T--KRIVGTYGYMSPEYALRGL---FSIKSDVFSFGVLL 357
GT +++PE L + K D +S GVLL
Sbjct: 229 YGMTTKAGTPYFVAPE-VLNTTNESYGPKCDAWSAGVLL 266
|
| >3is5_A Calcium-dependent protein kinase; CDPK, structural genomics, parasitology, structural genomics consortium, SGC, ATP-binding, nucleotide-binding; HET: ANP; 2.55A {Toxoplasma gondii} Length = 285 | Back alignment and structure |
|---|
Score = 81.5 bits (202), Expect = 2e-17
Identities = 31/95 (32%), Positives = 46/95 (48%), Gaps = 10/95 (10%)
Query: 266 RIIEGIAQGLLYLHQYSRLRVIHRDLKASNILL---DKDMNPKISDFGMARMFGGDELQS 322
+++ + L Y H V+H+DLK NIL KI DFG+A +F DE
Sbjct: 128 ELMKQMMNALAYFHS---QHVVHKDLKPENILFQDTSPHSPIKIIDFGLAELFKSDEHS- 183
Query: 323 NTKRIVGTYGYMSPEYALRGLFSIKSDVFSFGVLL 357
GT YM+PE + + K D++S GV++
Sbjct: 184 --TNAAGTALYMAPE-VFKRDVTFKCDIWSAGVVM 215
|
| >3lij_A Calcium/calmodulin dependent protein kinase with A kinase domain and 4 calmodulin...; transferase, calcium dependent protein kinase; HET: ANP; 1.90A {Cryptosporidium parvum} PDB: 3hzt_A* 3dxn_A 3l19_A* Length = 494 | Back alignment and structure |
|---|
Score = 83.6 bits (207), Expect = 2e-17
Identities = 37/95 (38%), Positives = 55/95 (57%), Gaps = 10/95 (10%)
Query: 266 RIIEGIAQGLLYLHQYSRLRVIHRDLKASNILL---DKDMNPKISDFGMARMFGGDELQS 322
II+ + G+ YLH+ ++HRDLK N+LL +KD KI DFG++ +F +
Sbjct: 140 VIIKQVLSGVTYLHK---HNIVHRDLKPENLLLESKEKDALIKIVDFGLSAVFENQK--- 193
Query: 323 NTKRIVGTYGYMSPEYALRGLFSIKSDVFSFGVLL 357
K +GT Y++PE LR + K DV+S GV+L
Sbjct: 194 KMKERLGTAYYIAPE-VLRKKYDEKCDVWSIGVIL 227
|
| >3f3z_A Calcium/calmodulin-dependent protein kinase with domain and 4 calmodulin like EF...; calcium dependent protein kinase; HET: SEP DRK; 1.84A {Cryptosporidium parvum iowa II} PDB: 2qg5_A* Length = 277 | Back alignment and structure |
|---|
Score = 81.1 bits (201), Expect = 2e-17
Identities = 33/95 (34%), Positives = 50/95 (52%), Gaps = 10/95 (10%)
Query: 266 RIIEGIAQGLLYLHQYSRLRVIHRDLKASNILL---DKDMNPKISDFGMARMFGGDELQS 322
RI++ + + Y H+ L V HRDLK N L D K+ DFG+A F ++
Sbjct: 110 RIMKDVLSAVAYCHK---LNVAHRDLKPENFLFLTDSPDSPLKLIDFGLAARFKPGKMM- 165
Query: 323 NTKRIVGTYGYMSPEYALRGLFSIKSDVFSFGVLL 357
+ VGT Y+SP+ L GL+ + D +S GV++
Sbjct: 166 --RTKVGTPYYVSPQ-VLEGLYGPECDEWSAGVMM 197
|
| >3mwu_A Calmodulin-domain protein kinase 1; serine/threonine protein kinase, transferase, calcium-bindin binding, bumped kinase inhibitor, BKI; HET: BK3; 1.98A {Cryptosporidium parvum} PDB: 3igo_A* 3ncg_A* Length = 486 | Back alignment and structure |
|---|
Score = 82.8 bits (205), Expect = 3e-17
Identities = 39/95 (41%), Positives = 57/95 (60%), Gaps = 10/95 (10%)
Query: 266 RIIEGIAQGLLYLHQYSRLRVIHRDLKASNILL---DKDMNPKISDFGMARMFGGDELQS 322
RII+ + G+ Y+H+ ++HRDLK NILL +KD + KI DFG++ F +
Sbjct: 125 RIIKQVFSGITYMHK---HNIVHRDLKPENILLESKEKDCDIKIIDFGLSTCFQQNTKM- 180
Query: 323 NTKRIVGTYGYMSPEYALRGLFSIKSDVFSFGVLL 357
K +GT Y++PE LRG + K DV+S GV+L
Sbjct: 181 --KDRIGTAYYIAPE-VLRGTYDEKCDVWSAGVIL 212
|
| >4euu_A Serine/threonine-protein kinase TBK1; ATP binding, phosphorylation, transferase-transferas inhibitor complex; HET: SEP BX7; 1.80A {Homo sapiens} Length = 319 | Back alignment and structure |
|---|
Score = 81.3 bits (201), Expect = 3e-17
Identities = 24/109 (22%), Positives = 45/109 (41%), Gaps = 18/109 (16%)
Query: 266 RIIEGIAQGLLYLHQYSRLRVIHRDLKASNILL----DKDMNPKISDFGMARMFGGDELQ 321
++ + G+ +L + ++HR++K NI+ D K++DFG AR DE
Sbjct: 116 IVLRDVVGGMNHLRE---NGIVHRNIKPGNIMRVIGEDGQSVYKLTDFGAARELEDDEQ- 171
Query: 322 SNTKRIVGTYGYMSPE--------YALRGLFSIKSDVFSFGVLLLETLS 362
+ GT Y+ P+ + + D++S GV +
Sbjct: 172 --FVSLYGTEEYLHPDMYERAVLRKDHQKKYGATVDLWSIGVTFYHAAT 218
|
| >4eut_A Serine/threonine-protein kinase TBK1; ATP binding, phosphorylation, transferase-transferas inhibitor complex; HET: BX7; 2.60A {Homo sapiens} Length = 396 | Back alignment and structure |
|---|
Score = 81.8 bits (202), Expect = 4e-17
Identities = 24/104 (23%), Positives = 44/104 (42%), Gaps = 18/104 (17%)
Query: 266 RIIEGIAQGLLYLHQYSRLRVIHRDLKASNILL----DKDMNPKISDFGMARMFGGDELQ 321
++ + G+ +L + ++HR++K NI+ D K++DFG AR DE
Sbjct: 116 IVLRDVVGGMNHLRE---NGIVHRNIKPGNIMRVIGEDGQSVYKLTDFGAARELEDDEQ- 171
Query: 322 SNTKRIVGTYGYMSPE--------YALRGLFSIKSDVFSFGVLL 357
+ GT Y+ P+ + + D++S GV
Sbjct: 172 --FVSLYGTEEYLHPDMYERAVLRKDHQKKYGATVDLWSIGVTF 213
|
| >2wei_A Calmodulin-domain protein kinase 1, putative; nucleotide-binding, serine/threonine-protein kinase, CGD3_920, transferase; HET: VGG; 1.65A {Cryptosporidium parvum iowa II} PDB: 3dfa_A 3ma6_A* Length = 287 | Back alignment and structure |
|---|
Score = 80.4 bits (199), Expect = 4e-17
Identities = 39/95 (41%), Positives = 57/95 (60%), Gaps = 10/95 (10%)
Query: 266 RIIEGIAQGLLYLHQYSRLRVIHRDLKASNILL---DKDMNPKISDFGMARMFGGDELQS 322
RII+ + G+ Y+H+ ++HRDLK NILL +KD + KI DFG++ F +
Sbjct: 125 RIIKQVFSGITYMHK---HNIVHRDLKPENILLESKEKDCDIKIIDFGLSTCFQQNTK-- 179
Query: 323 NTKRIVGTYGYMSPEYALRGLFSIKSDVFSFGVLL 357
K +GT Y++PE LRG + K DV+S GV+L
Sbjct: 180 -MKDRIGTAYYIAPE-VLRGTYDEKCDVWSAGVIL 212
|
| >2y7j_A Phosphorylase B kinase gamma catalytic chain, testis/liver isoform; transferase; HET: B49; 2.50A {Homo sapiens} PDB: 1h0t_A 1lp1_B 1q2n_A 2spz_A 3mzw_B* 1ss1_A 2jwd_A 1bdc_A 1bdd_A 1fc2_C* 2b87_A 2b88_A 1h0t_B 1lp1_A 2b87_B 2b89_A 3s1k_A Length = 365 | Back alignment and structure |
|---|
Score = 81.7 bits (202), Expect = 4e-17
Identities = 29/98 (29%), Positives = 50/98 (51%), Gaps = 12/98 (12%)
Query: 266 RIIEGIAQGLLYLHQYSRLRVIHRDLKASNILLDKDMNPKISDFGMARMFGGDELQSNTK 325
I+ + + + +LH ++HRDLK NILLD +M ++SDFG + E +
Sbjct: 204 SIMRSLLEAVSFLHA---NNIVHRDLKPENILLDDNMQIRLSDFGFSCHLEPGEK---LR 257
Query: 326 RIVGTYGYMSPE------YALRGLFSIKSDVFSFGVLL 357
+ GT GY++PE + + D+++ GV+L
Sbjct: 258 ELCGTPGYLAPEILKCSMDETHPGYGKEVDLWACGVIL 295
|
| >3c4z_A Rhodopsin kinase; Ser/Thr kinase, RGS homology domain, G protein coupled recep kinase, GRK, GRK1, P-loop, autophosphoryl ADP, ATP-binding; HET: ADP; 1.84A {Bos taurus} PDB: 3c4x_A* 3c4y_A 3c4w_A* 3c50_A* 3c51_A* 3qc9_A* 2i94_B Length = 543 | Back alignment and structure |
|---|
Score = 81.8 bits (202), Expect = 1e-16
Identities = 35/91 (38%), Positives = 49/91 (53%), Gaps = 5/91 (5%)
Query: 271 IAQGLLYLHQYSRLRVIHRDLKASNILLDKDMNPKISDFGMARMFGGDELQSNTKRIVGT 330
I GL +LHQ +I+RDLK N+LLD D N +ISD G+A + ++ GT
Sbjct: 298 IVSGLEHLHQ---RNIIYRDLKPENVLLDDDGNVRISDLGLAVELKAGQTKTKG--YAGT 352
Query: 331 YGYMSPEYALRGLFSIKSDVFSFGVLLLETL 361
G+M+PE L + D F+ GV L E +
Sbjct: 353 PGFMAPELLLGEEYDFSVDYFALGVTLYEMI 383
|
| >4g3f_A NF-kappa-beta-inducing kinase; non-RD kinase, protein serine/threonine kinase, S based drug design, MAP3K14, transferase; HET: 0WB; 1.64A {Mus musculus} PDB: 4g3g_A* 4g3c_A 4dn5_A* Length = 336 | Back alignment and structure |
|---|
Score = 80.2 bits (198), Expect = 1e-16
Identities = 31/98 (31%), Positives = 47/98 (47%), Gaps = 7/98 (7%)
Query: 271 IAQGLLYLHQYSRLRVIHRDLKASNILLDKDMNP-KISDFGMARMFGGDELQSNTKR--- 326
+GL YLH R++H D+KA N+LL D + + DFG A D L +
Sbjct: 159 ALEGLEYLHT---RRILHGDVKADNVLLSSDGSRAALCDFGHALCLQPDGLGKSLLTGDY 215
Query: 327 IVGTYGYMSPEYALRGLFSIKSDVFSFGVLLLETLSSK 364
I GT +M+PE + K D++S ++L L+
Sbjct: 216 IPGTETHMAPEVVMGKPCDAKVDIWSSCCMMLHMLNGC 253
|
| >2vgo_A Serine/threonine-protein kinase 12-A; nucleotide-binding, serine/threonine-protein kinase, ATP-binding, transferase, coiled coil, cell division, kinase; HET: TPO AD5; 1.7A {Xenopus laevis} PDB: 2bfx_A* 2vgp_A* 3ztx_A* 2vrx_A* 2bfy_A* 4af3_A* 3dj6_A* 3d15_A* 3d2i_A* 3d2k_A* 3d14_A* 3dj5_A* 3dj7_A* 3daj_A* 1ol5_A* 1ol7_A* 2x6d_A* 2x6e_A* 2xng_A* 2dwb_A* ... Length = 284 | Back alignment and structure |
|---|
Score = 79.2 bits (196), Expect = 1e-16
Identities = 30/96 (31%), Positives = 44/96 (45%), Gaps = 7/96 (7%)
Query: 266 RIIEGIAQGLLYLHQYSRLRVIHRDLKASNILLDKDMNPKISDFGMARMFGGDELQSNTK 325
+E +A L Y H +VIHRD+K N+L+ KI+DFG + ++
Sbjct: 118 TFMEELADALHYCH---ERKVIHRDIKPENLLMGYKGELKIADFGWSVHAPSLRRRT--- 171
Query: 326 RIVGTYGYMSPEYALRGLFSIKSDVFSFGVLLLETL 361
+ GT Y+ PE K D++ GVL E L
Sbjct: 172 -MCGTLDYLPPEMIEGKTHDEKVDLWCAGVLCYEFL 206
|
| >1uu3_A HPDK1, 3-phosphoinositide dependent protein kinase-1; PKB, inhibitor, LY333531, diabetes, cancer, transferase, serine/threonine-protein kinase; HET: SEP LY4; 1.7A {Homo sapiens} SCOP: d.144.1.7 PDB: 1okz_A* 1oky_A* 1uu7_A* 1uu8_A* 2biy_A* 3rwp_A* 2xch_A* 3rwq_A* 3sc1_A* 3qd0_A* 2r7b_A* 3ion_A* 3qcq_A* 3qcs_A* 3qcx_A* 3qcy_A* 3iop_A* 3qd3_A* 3qd4_A* 3h9o_A* ... Length = 310 | Back alignment and structure |
|---|
Score = 79.6 bits (197), Expect = 1e-16
Identities = 33/92 (35%), Positives = 52/92 (56%), Gaps = 3/92 (3%)
Query: 271 IAQGLLYLHQYSRLRVIHRDLKASNILLDKDMNPKISDFGMARMFGGDELQSNTKRIVGT 330
I L YLH +IHRDLK NILL++DM+ +I+DFG A++ + Q+ VGT
Sbjct: 139 IVSALEYLHG---KGIIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANSFVGT 195
Query: 331 YGYMSPEYALRGLFSIKSDVFSFGVLLLETLS 362
Y+SPE SD+++ G ++ + ++
Sbjct: 196 AQYVSPELLTEKSACKSSDLWALGCIIYQLVA 227
|
| >3ll6_A Cyclin G-associated kinase; transferase, protein kinase, serine/threonine kinase, cyclin clathrine, membrane trafficking, structural genomics; 2.10A {Homo sapiens} Length = 337 | Back alignment and structure |
|---|
Score = 79.4 bits (196), Expect = 2e-16
Identities = 28/107 (26%), Positives = 44/107 (41%), Gaps = 14/107 (13%)
Query: 266 RIIEGIAQGLLYLHQYSRLRVIHRDLKASNILLDKDMNPKISDFGMARMFGGDELQSNTK 325
+I + + ++H + +IHRDLK N+LL K+ DFG A S +
Sbjct: 140 KIFYQTCRAVQHMH-RQKPPIIHRDLKVENLLLSNQGTIKLCDFGSATTISHYPDYSWSA 198
Query: 326 RI----------VGTYGYMSPE-YALRGLFSI--KSDVFSFGVLLLE 359
+ T Y +PE L F I K D+++ G +L
Sbjct: 199 QRRALVEEEITRNTTPMYRTPEIIDLYSNFPIGEKQDIWALGCILYL 245
|
| >2jam_A Calcium/calmodulin-dependent protein kinase type 1G; transferase, kinase, membrane, ATP-binding, prenylation, serine/threonine-protein kinase, alternative splicing; HET: J60; 1.7A {Homo sapiens} PDB: 2jc6_A* 1a06_A Length = 304 | Back alignment and structure |
|---|
Score = 78.8 bits (195), Expect = 2e-16
Identities = 27/95 (28%), Positives = 50/95 (52%), Gaps = 10/95 (10%)
Query: 266 RIIEGIAQGLLYLHQYSRLRVIHRDLKASNILL---DKDMNPKISDFGMARMFGGDELQS 322
+I+ + + YLH+ ++HRDLK N+L +++ I+DFG+++M + +
Sbjct: 110 LVIQQVLSAVKYLHE---NGIVHRDLKPENLLYLTPEENSKIMITDFGLSKMEQNGIMST 166
Query: 323 NTKRIVGTYGYMSPEYALRGLFSIKSDVFSFGVLL 357
GT GY++PE + +S D +S GV+
Sbjct: 167 ----ACGTPGYVAPEVLAQKPYSKAVDCWSIGVIT 197
|
| >3com_A Serine/threonine-protein kinase 4; MST1, STE20-like kinase, PSI, structural genomics, protein structure initiative; HET: TPO; 2.20A {Homo sapiens} Length = 314 | Back alignment and structure |
|---|
Score = 78.6 bits (194), Expect = 3e-16
Identities = 33/93 (35%), Positives = 56/93 (60%), Gaps = 5/93 (5%)
Query: 267 IIEGIAQGLLYLHQYSRLRVIHRDLKASNILLDKDMNPKISDFGMARMFGGDELQSNTKR 326
I++ +GL YLH +R IHRD+KA NILL+ + + K++DFG+A + NT
Sbjct: 130 ILQSTLKGLEYLHF---MRKIHRDIKAGNILLNTEGHAKLADFGVAGQLTDTMAKRNT-- 184
Query: 327 IVGTYGYMSPEYALRGLFSIKSDVFSFGVLLLE 359
++GT +M+PE ++ +D++S G+ +E
Sbjct: 185 VIGTPFWMAPEVIQEIGYNCVADIWSLGITAIE 217
|
| >2acx_A G protein-coupled receptor kinase 6; GRK, G transferase; HET: ANP; 2.60A {Homo sapiens} PDB: 3nyn_A* 3nyo_A* Length = 576 | Back alignment and structure |
|---|
Score = 80.2 bits (198), Expect = 3e-16
Identities = 35/91 (38%), Positives = 48/91 (52%), Gaps = 6/91 (6%)
Query: 271 IAQGLLYLHQYSRLRVIHRDLKASNILLDKDMNPKISDFGMARMFGGDELQSNTKRIVGT 330
I GL LH R R+++RDLK NILLD + +ISD G+A + K VGT
Sbjct: 295 ICCGLEDLH---RERIVYRDLKPENILLDDHGHIRISDLGLAVHVPEGQT---IKGRVGT 348
Query: 331 YGYMSPEYALRGLFSIKSDVFSFGVLLLETL 361
GYM+PE ++ D ++ G LL E +
Sbjct: 349 VGYMAPEVVKNERYTFSPDWWALGCLLYEMI 379
|
| >3fxz_A Serine/threonine-protein kinase PAK 1; transferase, ATP-binding, phosphorylation, allosteric enzyme, alternative splicing, apoptosis, cell junction; HET: TPO FLL; 1.64A {Homo sapiens} PDB: 3fy0_A* 4daw_A* 3q52_A* 3q53_A* 1yhw_A 1f3m_C 1yhv_A 2hy8_1* 3q4z_A* Length = 297 | Back alignment and structure |
|---|
Score = 78.1 bits (193), Expect = 3e-16
Identities = 32/93 (34%), Positives = 53/93 (56%), Gaps = 5/93 (5%)
Query: 267 IIEGIAQGLLYLHQYSRLRVIHRDLKASNILLDKDMNPKISDFGMARMFGGDELQSNTKR 326
+ Q L +LH +VIHRD+K+ NILL D + K++DFG ++ + +T
Sbjct: 121 VCRECLQALEFLHS---NQVIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQSKRST-- 175
Query: 327 IVGTYGYMSPEYALRGLFSIKSDVFSFGVLLLE 359
+VGT +M+PE R + K D++S G++ +E
Sbjct: 176 MVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIE 208
|
| >3fe3_A MAP/microtubule affinity-regulating kinase 3; serine/threonine protein kinase, MARK;PAR-1, UBA domai TAK1;P78;MARK3, ATP-binding; 1.90A {Homo sapiens} PDB: 2qnj_A 1y8g_A* 1zmw_A 1zmu_A 1zmv_A 2wzj_A 2r0i_A 2hak_A 3iec_A Length = 328 | Back alignment and structure |
|---|
Score = 78.5 bits (194), Expect = 4e-16
Identities = 35/93 (37%), Positives = 46/93 (49%), Gaps = 17/93 (18%)
Query: 271 IAQGLLYLHQYSRLRVIHRDLKASNILLDKDMNPKISDFGMARMFGGDELQSNTKRIVGT 330
I + Y H + R++HRDLKA N+LLD DMN KI+DFG + F G
Sbjct: 123 IVSAVQYCH---QKRIVHRDLKAENLLLDADMNIKIADFGFSNEFTVGGK---LDAFCGA 176
Query: 331 YGYMSPEYALRGLFS------IKSDVFSFGVLL 357
Y +PE LF + DV+S GV+L
Sbjct: 177 PPYAAPE-----LFQGKKYDGPEVDVWSLGVIL 204
|
| >3c0i_A Peripheral plasma membrane protein CASK; neurexin, Ca2+/calmodulin dependent protein kinase, Mg synaptic plasticity, pseudokinase, maguk; HET: 3AM; 1.85A {Homo sapiens} PDB: 3c0h_A* 3c0g_A* 3mfr_A* 3mfs_A* 3mft_A 3mfu_A* 3tac_A Length = 351 | Back alignment and structure |
|---|
Score = 78.5 bits (194), Expect = 4e-16
Identities = 28/95 (29%), Positives = 41/95 (43%), Gaps = 8/95 (8%)
Query: 266 RIIEGIAQGLLYLHQYSRLRVIHRDLKASNILL---DKDMNPKISDFGMARMFGGDELQS 322
+ I + L Y H +IHRD+K +LL + K+ FG+A G
Sbjct: 134 HYMRQILEALRYCHD---NNIIHRDVKPHCVLLASKENSAPVKLGGFGVAIQLGES--GL 188
Query: 323 NTKRIVGTYGYMSPEYALRGLFSIKSDVFSFGVLL 357
VGT +M+PE R + DV+ GV+L
Sbjct: 189 VAGGRVGTPHFMAPEVVKREPYGKPVDVWGCGVIL 223
|
| >2clq_A Mitogen-activated protein kinase kinase kinase 5; transferase, metal-binding, apoptosis; HET: STU; 2.3A {Homo sapiens} Length = 295 | Back alignment and structure |
|---|
Score = 77.3 bits (191), Expect = 5e-16
Identities = 33/98 (33%), Positives = 53/98 (54%), Gaps = 10/98 (10%)
Query: 271 IAQGLLYLHQYSRLRVIHRDLKASNILLD-KDMNPKISDFGMARMFGGDELQSNTKRIVG 329
I +GL YLH +++HRD+K N+L++ KISDFG ++ G + T+ G
Sbjct: 131 ILEGLKYLHDN---QIVHRDIKGDNVLINTYSGVLKISDFGTSKRLAG--INPCTETFTG 185
Query: 330 TYGYMSPE---YALRGLFSIKSDVFSFGVLLLETLSSK 364
T YM+PE RG + +D++S G ++E + K
Sbjct: 186 TLQYMAPEIIDKGPRG-YGKAADIWSLGCTIIEMATGK 222
|
| >3fhr_A MAP kinase-activated protein kinase 3; kinase-inhibitor complex, ATP-binding, cytoplasm, nucleotide-binding, nucleus, phosphoprotein, polymorphism; HET: P4O; 1.90A {Homo sapiens} PDB: 3fxw_A* 3r1n_A* 3she_A* 2oza_A 3fyk_X* 3fyj_X* 2p3g_X* 3ka0_A* 3fpm_A* 2pzy_A* 3a2c_A* 3kc3_A* 3gok_A* 2jbo_A* 2jbp_A* 3r2y_A* 3r30_A* 3r2b_A* Length = 336 | Back alignment and structure |
|---|
Score = 78.1 bits (193), Expect = 5e-16
Identities = 27/95 (28%), Positives = 46/95 (48%), Gaps = 10/95 (10%)
Query: 266 RIIEGIAQGLLYLHQYSRLRVIHRDLKASNILL---DKDMNPKISDFGMARMFGGDELQS 322
I+ I + +LH + HRD+K N+L +KD K++DFG A+ + LQ+
Sbjct: 132 EIMRDIGTAIQFLHS---HNIAHRDVKPENLLYTSKEKDAVLKLTDFGFAKETTQNALQT 188
Query: 323 NTKRIVGTYGYMSPEYALRGLFSIKSDVFSFGVLL 357
T Y++PE + D++S GV++
Sbjct: 189 ----PCYTPYYVAPEVLGPEKYDKSCDMWSLGVIM 219
|
| >3dls_A PAS domain-containing serine/threonine-protein KI; PAS kinase, PASK, protein kinase, drug discovery, ATP-bindin kinase, nucleotide-binding; HET: ADP; 2.30A {Homo sapiens} Length = 335 | Back alignment and structure |
|---|
Score = 77.8 bits (192), Expect = 5e-16
Identities = 25/88 (28%), Positives = 41/88 (46%), Gaps = 7/88 (7%)
Query: 271 IAQGLLYLHQYSRLRVIHRDLKASNILLDKDMNPKISDFGMARMFGGDELQSNTKRIVGT 330
+ + YL +IHRD+K NI++ +D K+ DFG A +L GT
Sbjct: 139 LVSAVGYLR---LKDIIHRDIKDENIVIAEDFTIKLIDFGSAAYLERGKL---FYTFCGT 192
Query: 331 YGYMSPEYALRGLFS-IKSDVFSFGVLL 357
Y +PE + + + +++S GV L
Sbjct: 193 IEYCAPEVLMGNPYRGPELEMWSLGVTL 220
|
| >3a7i_A MST3 kinase, serine/threonine kinase 24 (STE20 homolog, yeast); two-LOBE protein kinase fold, ATP-binding, nucleotid binding, transferase; HET: TPO ADE; 1.45A {Homo sapiens} PDB: 3a7g_A* 3a7h_A* 3a7f_A* 3a7j_A* 3ckw_A 3ckx_A* 3ggf_A* 2xik_A* Length = 303 | Back alignment and structure |
|---|
Score = 77.4 bits (191), Expect = 6e-16
Identities = 34/93 (36%), Positives = 56/93 (60%), Gaps = 5/93 (5%)
Query: 267 IIEGIAQGLLYLHQYSRLRVIHRDLKASNILLDKDMNPKISDFGMARMFGGDELQSNTKR 326
I+ I +GL YLH + IHRD+KA+N+LL + K++DFG+A +++ NT
Sbjct: 124 ILREILKGLDYLH---SEKKIHRDIKAANVLLSEHGEVKLADFGVAGQLTDTQIKRNT-- 178
Query: 327 IVGTYGYMSPEYALRGLFSIKSDVFSFGVLLLE 359
VGT +M+PE + + K+D++S G+ +E
Sbjct: 179 FVGTPFWMAPEVIKQSAYDSKADIWSLGITAIE 211
|
| >2c30_A Serine/threonine-protein kinase PAK 6; CRIB domain, ATP-binding, transferase, nucleotide-binding; HET: SEP; 1.6A {Homo sapiens} PDB: 2f57_A* 2j0i_A* 2cdz_A* 2q0n_A* 2x4z_A* 2bva_A* Length = 321 | Back alignment and structure |
|---|
Score = 77.8 bits (192), Expect = 6e-16
Identities = 34/93 (36%), Positives = 54/93 (58%), Gaps = 5/93 (5%)
Query: 267 IIEGIAQGLLYLHQYSRLRVIHRDLKASNILLDKDMNPKISDFGMARMFGGDELQSNTKR 326
+ E + Q L YLH VIHRD+K+ +ILL D K+SDFG D + +
Sbjct: 146 VCEAVLQALAYLHA---QGVIHRDIKSDSILLTLDGRVKLSDFGFCAQISKDVPKRKS-- 200
Query: 327 IVGTYGYMSPEYALRGLFSIKSDVFSFGVLLLE 359
+VGT +M+PE R L++ + D++S G++++E
Sbjct: 201 LVGTPYWMAPEVISRSLYATEVDIWSLGIMVIE 233
|
| >1x8b_A WEE1HU, WEE1-like protein kinase; cell cycle, transferase; HET: 824; 1.81A {Homo sapiens} PDB: 3bi6_A* 3biz_A* 3cqe_A* 3cr0_A* 2in6_A* 2io6_A* 2z2w_A* Length = 289 | Back alignment and structure |
|---|
Score = 77.0 bits (190), Expect = 6e-16
Identities = 22/110 (20%), Positives = 45/110 (40%), Gaps = 31/110 (28%)
Query: 271 IAQGLLYLHQYSRLRVIHRDLKASNILLDKDMNP-------------------KISDFGM 311
+ +GL Y+H + ++H D+K SNI + + P KI D G
Sbjct: 124 VGRGLRYIHS---MSLVHMDIKPSNIFISRTSIPNAASEEGDEDDWASNKVMFKIGDLGH 180
Query: 312 ARMFGGDELQSNTKRIVGTYGYMSPEYALRGLFS--IKSDVFSFGVLLLE 359
S+ + G +++ E L+ ++ K+D+F+ + ++
Sbjct: 181 VTRI------SSPQVEEGDSRFLANE-VLQENYTHLPKADIFALALTVVC 223
|
| >2vwi_A Serine/threonine-protein kinase OSR1; STE kinase, hypertension, transferase; HET: ANP; 2.15A {Homo sapiens} PDB: 3dak_A* Length = 303 | Back alignment and structure |
|---|
Score = 77.0 bits (190), Expect = 8e-16
Identities = 36/91 (39%), Positives = 56/91 (61%), Gaps = 7/91 (7%)
Query: 273 QGLLYLHQYSRLRVIHRDLKASNILLDKDMNPKISDFGM-ARMFGGDELQSNTKR--IVG 329
+GL YLH + IHRD+KA NILL +D + +I+DFG+ A + G ++ N R VG
Sbjct: 132 EGLEYLH---KNGQIHRDVKAGNILLGEDGSVQIADFGVSAFLATGGDITRNKVRKTFVG 188
Query: 330 TYGYMSPEYALRGL-FSIKSDVFSFGVLLLE 359
T +M+PE + + K+D++SFG+ +E
Sbjct: 189 TPCWMAPEVMEQVRGYDFKADIWSFGITAIE 219
|
| >2x4f_A Myosin light chain kinase family member 4; LUNG, breast cancer, transferase, serine/threonine-protein kinase, nucleotide-binding; HET: 16X 1PE; 2.67A {Homo sapiens} Length = 373 | Back alignment and structure |
|---|
Score = 77.8 bits (192), Expect = 9e-16
Identities = 30/95 (31%), Positives = 51/95 (53%), Gaps = 8/95 (8%)
Query: 265 VRIIEGIAQGLLYLHQYSRLRVIHRDLKASNILL-DKDMNP-KISDFGMARMFGGDELQS 322
+ ++ I +G+ ++HQ + ++H DLK NIL ++D KI DFG+AR + E
Sbjct: 190 ILFMKQICEGIRHMHQ---MYILHLDLKPENILCVNRDAKQIKIIDFGLARRYKPRE--- 243
Query: 323 NTKRIVGTYGYMSPEYALRGLFSIKSDVFSFGVLL 357
K GT +++PE S +D++S GV+
Sbjct: 244 KLKVNFGTPEFLAPEVVNYDFVSFPTDMWSVGVIA 278
|
| >3gni_B Strad alpha; kinase fold, pseudokinase, alpha helical repeat protein, ADA protein, ATP-binding, cell cycle, kinase, nucleotide-bindin nucleus; HET: ATP CIT; 2.35A {Homo sapiens} PDB: 2wtk_B* Length = 389 | Back alignment and structure |
|---|
Score = 77.6 bits (191), Expect = 1e-15
Identities = 26/100 (26%), Positives = 45/100 (45%), Gaps = 10/100 (10%)
Query: 267 IIEGIAQGLLYLHQYSRLRVIHRDLKASNILLDKDMNPKISDFGMARMFGGDELQSNT-- 324
I++G+ + L Y+H + +HR +KAS+IL+ D +S +
Sbjct: 133 ILQGVLKALDYIH---HMGYVHRSVKASHILISVDGKVYLSGLRSNLSMISHGQRQRVVH 189
Query: 325 ---KRIVGTYGYMSPEYALRGL--FSIKSDVFSFGVLLLE 359
K V ++SPE + L + KSD++S G+ E
Sbjct: 190 DFPKYSVKVLPWLSPEVLQQNLQGYDAKSDIYSVGITACE 229
|
| >2yex_A Serine/threonine-protein kinase CHK1; transferase, cell cycle; HET: YEX; 1.30A {Homo sapiens} PDB: 2x8e_A* 2ydk_A* 2ydj_A* 2yer_A* 2ydi_A* 1nvq_A* 1nvr_A* 1nvs_A* 2wmq_A* 2wmr_A* 2wms_A* 2wmt_A* 2wmu_A* 2wmv_A* 2wmw_A* 2wmx_A* 2x8d_A* 2x8i_A* 2xey_A* 2xez_A* ... Length = 276 | Back alignment and structure |
|---|
Score = 75.7 bits (187), Expect = 1e-15
Identities = 33/92 (35%), Positives = 52/92 (56%), Gaps = 8/92 (8%)
Query: 267 IIEGIAQGLLYLHQYSRLRVIHRDLKASNILLDKDMNPKISDFGMARMFGGDELQSNTKR 326
++ G+ YLH + + HRD+K N+LLD+ N KISDFG+A +F + + +
Sbjct: 114 LMAGVV----YLH---GIGITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNK 166
Query: 327 IVGTYGYMSPEYALRGLFS-IKSDVFSFGVLL 357
+ GT Y++PE R F DV+S G++L
Sbjct: 167 MCGTLPYVAPELLKRREFHAEPVDVWSCGIVL 198
|
| >1kob_A Twitchin; kinase, intrasteric regulation; 2.30A {Aplysia californica} SCOP: d.144.1.7 Length = 387 | Back alignment and structure |
|---|
Score = 77.1 bits (190), Expect = 2e-15
Identities = 26/95 (27%), Positives = 44/95 (46%), Gaps = 8/95 (8%)
Query: 265 VRIIEGIAQGLLYLHQYSRLRVIHRDLKASNILL-DKDMNP-KISDFGMARMFGGDELQS 322
+ + +GL ++H+ ++H D+K NI+ K + KI DFG+A DE
Sbjct: 152 INYMRQACEGLKHMHE---HSIVHLDIKPENIMCETKKASSVKIIDFGLATKLNPDE--- 205
Query: 323 NTKRIVGTYGYMSPEYALRGLFSIKSDVFSFGVLL 357
K T + +PE R +D+++ GVL
Sbjct: 206 IVKVTTATAEFAAPEIVDREPVGFYTDMWAIGVLG 240
|
| >3lm5_A Serine/threonine-protein kinase 17B; STK17B, serine/threonine kinase 17B, DRAK2, DAP kinase relat apoptosis-inducing protein kinase 2; HET: QUE; 2.29A {Homo sapiens} PDB: 3lm0_A* Length = 327 | Back alignment and structure |
|---|
Score = 76.5 bits (189), Expect = 2e-15
Identities = 32/96 (33%), Positives = 52/96 (54%), Gaps = 9/96 (9%)
Query: 265 VRIIEGIAQGLLYLHQYSRLRVIHRDLKASNILL---DKDMNPKISDFGMARMFGGDELQ 321
+R+I+ I +G+ YLHQ ++H DLK NILL + KI DFGM+R G
Sbjct: 134 IRLIKQILEGVYYLHQ---NNIVHLDLKPQNILLSSIYPLGDIKIVDFGMSRKIGHAC-- 188
Query: 322 SNTKRIVGTYGYMSPEYALRGLFSIKSDVFSFGVLL 357
+ I+GT Y++PE + +D+++ G++
Sbjct: 189 -ELREIMGTPEYLAPEILNYDPITTATDMWNIGIIA 223
|
| >2ycf_A Serine/threonine-protein kinase CHK2; transferase, anticancer, anticancer drug design; HET: YCF; 1.77A {Homo sapiens} PDB: 2yiq_A* 2w7x_A* 2ycq_A* 2ycs_A* 2w0j_A* 2yir_A* 2yit_A* 2wtj_A* 2cn8_A* 2wtc_A* 2wtd_A* 2wti_A* 2cn5_A* 2xbj_A* 2xm8_A* 2xm9_A* 2xk9_A* 2ycr_A* Length = 322 | Back alignment and structure |
|---|
Score = 76.2 bits (188), Expect = 2e-15
Identities = 30/98 (30%), Positives = 48/98 (48%), Gaps = 12/98 (12%)
Query: 266 RIIEGIAQGLLYLHQYSRLRVIHRDLKASNILL---DKDMNPKISDFGMARMFGGDELQS 322
+ + YLH +IHRDLK N+LL ++D KI+DFG +++ G L
Sbjct: 118 LYFYQMLLAVQYLH---ENGIIHRDLKPENVLLSSQEEDCLIKITDFGHSKILGETSL-- 172
Query: 323 NTKRIVGTYGYMSPE---YALRGLFSIKSDVFSFGVLL 357
+ + GT Y++PE ++ D +S GV+L
Sbjct: 173 -MRTLCGTPTYLAPEVLVSVGTAGYNRAVDCWSLGVIL 209
|
| >3tki_A Serine/threonine-protein kinase CHK1; cell checkpoint, transferase-transferase inhib complex; HET: S25; 1.60A {Homo sapiens} PDB: 2qhm_A* 2r0u_A* 3tkh_A* 2qhn_A* 2hy0_A* 2hog_A* 2hxq_A* 2hxl_A* 3f9n_A* Length = 323 | Back alignment and structure |
|---|
Score = 75.8 bits (187), Expect = 2e-15
Identities = 33/92 (35%), Positives = 52/92 (56%), Gaps = 8/92 (8%)
Query: 267 IIEGIAQGLLYLHQYSRLRVIHRDLKASNILLDKDMNPKISDFGMARMFGGDELQSNTKR 326
++ G+ YLH + + HRD+K N+LLD+ N KISDFG+A +F + + +
Sbjct: 114 LMAGVV----YLH---GIGITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNK 166
Query: 327 IVGTYGYMSPEYALRGLFS-IKSDVFSFGVLL 357
+ GT Y++PE R F DV+S G++L
Sbjct: 167 MCGTLPYVAPELLKRREFHAEPVDVWSCGIVL 198
|
| >3kk8_A Calcium/calmodulin dependent protein kinase II; ATP-binding, nucleotide-binding, serine/threonine-protein kinase, transferase; HET: TPO; 1.72A {Caenorhabditis elegans} PDB: 3kk9_A* 3kl8_A 2vn9_A* 3bhh_A* Length = 284 | Back alignment and structure |
|---|
Score = 75.3 bits (186), Expect = 2e-15
Identities = 30/95 (31%), Positives = 47/95 (49%), Gaps = 9/95 (9%)
Query: 266 RIIEGIAQGLLYLHQYSRLRVIHRDLKASNILL---DKDMNPKISDFGMARMFGGDELQS 322
I+ I + + Y H ++HR+LK N+LL K K++DFG+A E
Sbjct: 109 HCIQQILESIAYCHS---NGIVHRNLKPENLLLASKAKGAAVKLADFGLAIEVNDSEA-- 163
Query: 323 NTKRIVGTYGYMSPEYALRGLFSIKSDVFSFGVLL 357
GT GY+SPE + +S D+++ GV+L
Sbjct: 164 -WHGFAGTPGYLSPEVLKKDPYSKPVDIWACGVIL 197
|
| >3soa_A Calcium/calmodulin-dependent protein kinase type alpha with A beta 7 linker; phosphorylation, cytosolic, transferase-transferase inhibitor complex; HET: DB8; 3.55A {Homo sapiens} Length = 444 | Back alignment and structure |
|---|
Score = 77.0 bits (190), Expect = 3e-15
Identities = 32/95 (33%), Positives = 51/95 (53%), Gaps = 8/95 (8%)
Query: 266 RIIEGIAQGLLYLHQYSRLRVIHRDLKASNILL---DKDMNPKISDFGMARMFGGDELQS 322
I+ I + +L+ HQ + V+HR+LK N+LL K K++DFG+A G+ Q
Sbjct: 114 HCIQQILEAVLHCHQ---MGVVHRNLKPENLLLASKLKGAAVKLADFGLAIEVEGE--QQ 168
Query: 323 NTKRIVGTYGYMSPEYALRGLFSIKSDVFSFGVLL 357
GT GY+SPE + + D+++ GV+L
Sbjct: 169 AWFGFAGTPGYLSPEVLRKDPYGKPVDLWACGVIL 203
|
| >2bdw_A Hypothetical protein K11E8.1D; kinase, calmodulin activated, transferase; 1.80A {Caenorhabditis elegans} PDB: 2wel_A* 2v7o_A* 2vz6_A* 1cdm_B 1cm1_B 1cm4_B Length = 362 | Back alignment and structure |
|---|
Score = 76.2 bits (188), Expect = 3e-15
Identities = 30/95 (31%), Positives = 47/95 (49%), Gaps = 9/95 (9%)
Query: 266 RIIEGIAQGLLYLHQYSRLRVIHRDLKASNILL---DKDMNPKISDFGMARMFGGDELQS 322
I+ I + + Y H ++HR+LK N+LL K K++DFG+A E
Sbjct: 132 HCIQQILESIAYCHS---NGIVHRNLKPENLLLASKAKGAAVKLADFGLAIEVNDSEA-- 186
Query: 323 NTKRIVGTYGYMSPEYALRGLFSIKSDVFSFGVLL 357
GT GY+SPE + +S D+++ GV+L
Sbjct: 187 -WHGFAGTPGYLSPEVLKKDPYSKPVDIWACGVIL 220
|
| >2w4o_A Calcium/calmodulin-dependent protein kinase type IV; calmodulin-binding, nucleotide-binding, serine/threonine-protein kinase, ATP-binding; HET: DKI; 2.17A {Homo sapiens} Length = 349 | Back alignment and structure |
|---|
Score = 76.2 bits (188), Expect = 3e-15
Identities = 28/95 (29%), Positives = 49/95 (51%), Gaps = 9/95 (9%)
Query: 266 RIIEGIAQGLLYLHQYSRLRVIHRDLKASNILL---DKDMNPKISDFGMARMFGGDELQS 322
++ I + + YLH+ ++HRDLK N+L D KI+DFG++++ L
Sbjct: 152 DAVKQILEAVAYLHE---NGIVHRDLKPENLLYATPAPDAPLKIADFGLSKIVEHQVL-- 206
Query: 323 NTKRIVGTYGYMSPEYALRGLFSIKSDVFSFGVLL 357
K + GT GY +PE + + D++S G++
Sbjct: 207 -MKTVCGTPGYCAPEILRGCAYGPEVDMWSVGIIT 240
|
| >2y0a_A Death-associated protein kinase 1; transferase, calmodulin, esprit; HET: MES; 2.60A {Homo sapiens} Length = 326 | Back alignment and structure |
|---|
Score = 75.8 bits (187), Expect = 3e-15
Identities = 29/97 (29%), Positives = 45/97 (46%), Gaps = 10/97 (10%)
Query: 265 VRIIEGIAQGLLYLHQYSRLRVIHRDLKASNILL----DKDMNPKISDFGMARMFGGDEL 320
++ I G+ YLH L++ H DLK NI+L KI DFG+A
Sbjct: 117 TEFLKQILNGVYYLHS---LQIAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHKIDFGNE 173
Query: 321 QSNTKRIVGTYGYMSPEYALRGLFSIKSDVFSFGVLL 357
K I GT +++PE +++D++S GV+
Sbjct: 174 ---FKNIFGTPEFVAPEIVNYEPLGLEADMWSIGVIT 207
|
| >3kn6_A Ribosomal protein S6 kinase alpha-5; AMP-PNP, MSK1, MSK, ATP-binding, metal-binding, NUCL binding, serine/threonine-protein kinase, transferase; 2.00A {Homo sapiens} PDB: 3kn5_A Length = 325 | Back alignment and structure |
|---|
Score = 75.4 bits (186), Expect = 3e-15
Identities = 28/95 (29%), Positives = 46/95 (48%), Gaps = 8/95 (8%)
Query: 266 RIIEGIAQGLLYLHQYSRLRVIHRDLKASNILL---DKDMNPKISDFGMARMFGGDELQS 322
I+ + + ++H + V+HRDLK N+L + ++ KI DFG AR+ D
Sbjct: 110 YIMRKLVSAVSHMHD---VGVVHRDLKPENLLFTDENDNLEIKIIDFGFARLKPPDNQPL 166
Query: 323 NTKRIVGTYGYMSPEYALRGLFSIKSDVFSFGVLL 357
T T Y +PE + + D++S GV+L
Sbjct: 167 KT--PCFTLHYAAPELLNQNGYDESCDLWSLGVIL 199
|
| >1tki_A Titin; serine kinase, muscle, autoinhibition; 2.00A {Homo sapiens} SCOP: d.144.1.7 Length = 321 | Back alignment and structure |
|---|
Score = 75.3 bits (186), Expect = 4e-15
Identities = 22/95 (23%), Positives = 41/95 (43%), Gaps = 8/95 (8%)
Query: 265 VRIIEGIAQGLLYLHQYSRLRVIHRDLKASNILL--DKDMNPKISDFGMARMFGGDELQS 322
V + + + L +LH + H D++ NI+ + KI +FG AR +
Sbjct: 105 VSYVHQVCEALQFLHS---HNIGHFDIRPENIIYQTRRSSTIKIIEFGQARQLKPGDNF- 160
Query: 323 NTKRIVGTYGYMSPEYALRGLFSIKSDVFSFGVLL 357
+ + Y +PE + S +D++S G L+
Sbjct: 161 --RLLFTAPEYYAPEVHQHDVVSTATDMWSLGTLV 193
|
| >2qr7_A Ribosomal protein S6 kinase alpha-3; kinase domain, RSK2, autoinhibitory, ATP-binding, nucleotide phosphorylation, serine/threonine-protein kinase; 2.00A {Mus musculus} PDB: 2qr8_A 4d9t_A* 4d9u_A* 3rny_A 2wnt_A Length = 342 | Back alignment and structure |
|---|
Score = 75.4 bits (186), Expect = 4e-15
Identities = 33/96 (34%), Positives = 48/96 (50%), Gaps = 9/96 (9%)
Query: 266 RIIEGIAQGLLYLHQYSRLRVIHRDLKASNILL-DKDMNP---KISDFGMARMFGGDELQ 321
++ I + + YLH V+HRDLK SNIL D+ NP +I DFG A+ +
Sbjct: 120 AVLFTITKTVEYLHA---QGVVHRDLKPSNILYVDESGNPESIRICDFGFAKQLRAENGL 176
Query: 322 SNTKRIVGTYGYMSPEYALRGLFSIKSDVFSFGVLL 357
T T +++PE R + D++S GVLL
Sbjct: 177 LMT--PCYTANFVAPEVLERQGYDAACDIWSLGVLL 210
|
| >3bhy_A Death-associated protein kinase 3; death associated kinase, DAPK3, ZIP kinase, ZIPK, DAP kinase like kinase, DLK, structural genomics consortium; HET: 7CP; 1.24A {Homo sapiens} PDB: 3bqr_A* 2j90_A* 1yrp_A* 2yak_A* 2y4p_A* 3f5u_A* 1jks_A 1jkk_A* 1ig1_A* 1jkl_A 1jkt_A 3eh9_A* 3eha_A* 3f5g_A* 1p4f_A* 1wvw_A 1wvx_A* 1wvy_A* 2w4j_A* 3dgk_A ... Length = 283 | Back alignment and structure |
|---|
Score = 74.1 bits (183), Expect = 5e-15
Identities = 28/96 (29%), Positives = 46/96 (47%), Gaps = 10/96 (10%)
Query: 266 RIIEGIAQGLLYLHQYSRLRVIHRDLKASNILL----DKDMNPKISDFGMARMFGGDELQ 321
+ ++ I G+ YLH R+ H DLK NI+L + K+ DFG+A
Sbjct: 112 QFLKQILDGVHYLHS---KRIAHFDLKPENIMLLDKNVPNPRIKLIDFGIAHKIEAGN-- 166
Query: 322 SNTKRIVGTYGYMSPEYALRGLFSIKSDVFSFGVLL 357
K I GT +++PE +++D++S GV+
Sbjct: 167 -EFKNIFGTPEFVAPEIVNYEPLGLEADMWSIGVIT 201
|
| >2yab_A Death-associated protein kinase 2; apoptosis, transferase; HET: AMP; 1.90A {Mus musculus} PDB: 2yaa_A* 2ya9_A* Length = 361 | Back alignment and structure |
|---|
Score = 75.1 bits (185), Expect = 6e-15
Identities = 28/97 (28%), Positives = 45/97 (46%), Gaps = 10/97 (10%)
Query: 265 VRIIEGIAQGLLYLHQYSRLRVIHRDLKASNILL----DKDMNPKISDFGMARMFGGDEL 320
I+ I G+ YLH ++ H DLK NI+L + K+ DFG+A
Sbjct: 118 TSFIKQILDGVNYLHT---KKIAHFDLKPENIMLLDKNIPIPHIKLIDFGLAHEIEDGVE 174
Query: 321 QSNTKRIVGTYGYMSPEYALRGLFSIKSDVFSFGVLL 357
K I GT +++PE +++D++S GV+
Sbjct: 175 ---FKNIFGTPEFVAPEIVNYEPLGLEADMWSIGVIT 208
|
| >3i6u_A CDS1, serine/threonine-protein kinase CHK2; Ser/Thr protein kinase, FHA domain, ATP-binding, cell cycle, mutation, LI-fraumeni syndrome, magnesium; 3.00A {Homo sapiens} PDB: 3i6w_A Length = 419 | Back alignment and structure |
|---|
Score = 75.5 bits (186), Expect = 6e-15
Identities = 30/98 (30%), Positives = 49/98 (50%), Gaps = 12/98 (12%)
Query: 266 RIIEGIAQGLLYLHQYSRLRVIHRDLKASNILL---DKDMNPKISDFGMARMFGGDELQS 322
+ + YLH+ +IHRDLK N+LL ++D KI+DFG +++ G L
Sbjct: 243 LYFYQMLLAVQYLHE---NGIIHRDLKPENVLLSSQEEDCLIKITDFGHSKILGETSL-- 297
Query: 323 NTKRIVGTYGYMSPE---YALRGLFSIKSDVFSFGVLL 357
+ + GT Y++PE ++ D +S GV+L
Sbjct: 298 -MRTLCGTPTYLAPEVLVSVGTAGYNRAVDCWSLGVIL 334
|
| >2x7f_A TRAF2 and NCK-interacting protein kinase; serine/threonine-protein kinase, phosphoprotein; HET: 824; 2.80A {Homo sapiens} Length = 326 | Back alignment and structure |
|---|
Score = 74.3 bits (183), Expect = 7e-15
Identities = 33/98 (33%), Positives = 51/98 (52%), Gaps = 10/98 (10%)
Query: 267 IIEGIAQGLLYLHQYSRLRVIHRDLKASNILLDKDMNPKISDFGMARMFGGDELQSNTKR 326
I I +GL +LHQ +VIHRD+K N+LL ++ K+ DFG++ + NT
Sbjct: 134 ICREILRGLSHLHQ---HKVIHRDIKGQNVLLTENAEVKLVDFGVSAQLDRTVGRRNT-- 188
Query: 327 IVGTYGYMSPEYALRGLFS-----IKSDVFSFGVLLLE 359
+GT +M+PE KSD++S G+ +E
Sbjct: 189 FIGTPYWMAPEVIACDENPDATYDFKSDLWSLGITAIE 226
|
| >2wtk_C Serine/threonine-protein kinase 11; transferase-metal-binding protein complex, transferase metal protein complex, nucleus; HET: ANP; 2.65A {Homo sapiens} Length = 305 | Back alignment and structure |
|---|
Score = 74.2 bits (183), Expect = 7e-15
Identities = 27/93 (29%), Positives = 41/93 (44%), Gaps = 9/93 (9%)
Query: 267 IIEGIAQGLLYLHQYSRLRVIHRDLKASNILLDKDMNPKISDFGMARMFGGDELQSNTKR 326
+I+G+ YLH ++H+D+K N+LL KIS G+A +
Sbjct: 118 LIDGLE----YLH---SQGIVHKDIKPGNLLLTTGGTLKISALGVAEALHPFAADDTCRT 170
Query: 327 IVGTYGYMSPEYA--LRGLFSIKSDVFSFGVLL 357
G+ + PE A L K D++S GV L
Sbjct: 171 SQGSPAFQPPEIANGLDTFSGFKVDIWSAGVTL 203
|
| >3a99_A Proto-oncogene serine/threonine-protein kinase PI; PIM-1, P27KIP1, peptide drug, prostate cancer, transferase; HET: ANP; 1.60A {Homo sapiens} PDB: 3bgq_A* 3bgp_A* 2obj_A* 3bgz_A* 3t9i_A* 3dcv_A* 1xws_A* 2xj1_A* 2xix_A* 2xiz_A* 2xj0_A* 2xiy_A* 2xj2_A* 3f2a_A* 1xr1_A* 1xqz_A* 3cy2_A* 3cxw_A* 3cy3_A* 2bik_B* ... Length = 320 | Back alignment and structure |
|---|
Score = 74.3 bits (183), Expect = 8e-15
Identities = 24/89 (26%), Positives = 39/89 (43%), Gaps = 9/89 (10%)
Query: 271 IAQGLLYLHQYSRLRVIHRDLKASNILLDKD-MNPKISDFGMARMFGGDELQSNTKRIVG 329
+ + + + H V+HRD+K NIL+D + K+ DFG + G
Sbjct: 158 VLEAVRHCH---NCGVLHRDIKDENILIDLNRGELKLIDFGSGALLKDTVY----TDFDG 210
Query: 330 TYGYMSPEYALRGLFS-IKSDVFSFGVLL 357
T Y PE+ + + V+S G+LL
Sbjct: 211 TRVYSPPEWIRYHRYHGRSAAVWSLGILL 239
|
| >2j7t_A Serine/threonine-protein kinase 10; transferase, ATP-binding, cell cycle progression, phosphorylation, disease mutation, nucleotide- binding; HET: 274; 2.0A {Homo sapiens} PDB: 4aot_A* 3zz2_A* 2j51_A* 2jfl_A* 2jfm_A* 2uv2_A* Length = 302 | Back alignment and structure |
|---|
Score = 73.5 bits (181), Expect = 1e-14
Identities = 27/98 (27%), Positives = 53/98 (54%), Gaps = 10/98 (10%)
Query: 267 IIEGIAQGLLYLHQYSRLRVIHRDLKASNILLDKDMNPKISDFGMARMFGGDELQSNTKR 326
+ + + L +LH R+IHRDLKA N+L+ + + +++DFG++ + ++
Sbjct: 122 VCRQMLEALNFLHS---KRIIHRDLKAGNVLMTLEGDIRLADFGVSAKNLKTLQKRDS-- 176
Query: 327 IVGTYGYMSPEYALRGLFS-----IKSDVFSFGVLLLE 359
+GT +M+PE + K+D++S G+ L+E
Sbjct: 177 FIGTPYWMAPEVVMCETMKDTPYDYKADIWSLGITLIE 214
|
| >2r3i_A Cell division protein kinase 2; serine/threonine-protein kinase, cell cycle, inhibition, cyclin-dependent kinase, cancer, ATP-binding; HET: SCF; 1.28A {Homo sapiens} PDB: 2r3j_A* 2r3k_A* 2r3l_A* 2r3m_A* 2r3n_A* 2r3o_A* 2r3p_A* 2r3q_A* 1jvp_P* 1buh_A 1ckp_A* 1di8_A* 1dm2_A* 1f5q_A 1fin_A* 1fq1_B* 1fvt_A* 1fvv_A* 1g5s_A* 1gih_A* ... Length = 299 | Back alignment and structure |
|---|
Score = 73.3 bits (181), Expect = 1e-14
Identities = 27/65 (41%), Positives = 42/65 (64%), Gaps = 5/65 (7%)
Query: 273 QGLLYLHQYSRLRVIHRDLKASNILLDKDMNPKISDFGMARMFGGDELQSNTKRIVGTYG 332
QGL + H + RV+HRDLK N+L++ + K++DFG+AR F G +++ T +V T
Sbjct: 114 QGLAFCHSH---RVLHRDLKPQNLLINTEGAIKLADFGLARAF-GVPVRTYTHEVV-TLW 168
Query: 333 YMSPE 337
Y +PE
Sbjct: 169 YRAPE 173
|
| >2h6d_A 5'-AMP-activated protein kinase catalytic subunit alpha-2; ATP-binding, cholesterol biosynthesis, fatty acid biosynthesis;kinase, lipid synthesis; 1.85A {Homo sapiens} PDB: 3aqv_A* 2yza_A* Length = 276 | Back alignment and structure |
|---|
Score = 73.0 bits (180), Expect = 1e-14
Identities = 33/92 (35%), Positives = 49/92 (53%), Gaps = 11/92 (11%)
Query: 267 IIEGIAQGLLYLHQYSRLRVIHRDLKASNILLDKDMNPKISDFGMARMFGGDELQSNTKR 326
I+ + Y H R V+HRDLK N+LLD MN KI+DFG++ M E +
Sbjct: 120 ILSAVD----YCH---RHMVVHRDLKPENVLLDAHMNAKIADFGLSNMMSDGEFLRTS-- 170
Query: 327 IVGTYGYMSPEYALRGLFS-IKSDVFSFGVLL 357
G+ Y +PE L++ + D++S GV+L
Sbjct: 171 -CGSPNYAAPEVISGRLYAGPEVDIWSCGVIL 201
|
| >3o0g_A Cell division protein kinase 5; kinase activator complex, kinase inhibitor complex, transferase-transferase activator complex; HET: 3O0; 1.95A {Homo sapiens} PDB: 1unh_A* 1ung_A* 1unl_A* 1h4l_A Length = 292 | Back alignment and structure |
|---|
Score = 73.3 bits (181), Expect = 1e-14
Identities = 22/65 (33%), Positives = 39/65 (60%), Gaps = 5/65 (7%)
Query: 273 QGLLYLHQYSRLRVIHRDLKASNILLDKDMNPKISDFGMARMFGGDELQSNTKRIVGTYG 332
+GL + H V+HRDLK N+L++++ K+++FG+AR F G ++ + +V T
Sbjct: 112 KGLGFCHSR---NVLHRDLKPQNLLINRNGELKLANFGLARAF-GIPVRCYSAEVV-TLW 166
Query: 333 YMSPE 337
Y P+
Sbjct: 167 YRPPD 171
|
| >2a2a_A Death-associated protein kinase 2; autoinhibition, transferase; 1.47A {Homo sapiens} PDB: 2cke_A* 1wmk_A 1z9x_A 2a27_A 2x0g_A 2xuu_A* 2w4k_A* 2xzs_A Length = 321 | Back alignment and structure |
|---|
Score = 73.8 bits (182), Expect = 1e-14
Identities = 30/97 (30%), Positives = 48/97 (49%), Gaps = 10/97 (10%)
Query: 265 VRIIEGIAQGLLYLHQYSRLRVIHRDLKASNILL-DKDMNP---KISDFGMARMFGGDEL 320
I+ I G+ YLH ++ H DLK NI+L DK++ K+ DFG+A
Sbjct: 118 TSFIKQILDGVNYLHT---KKIAHFDLKPENIMLLDKNIPIPHIKLIDFGLAHEIEDGVE 174
Query: 321 QSNTKRIVGTYGYMSPEYALRGLFSIKSDVFSFGVLL 357
K I GT +++PE +++D++S GV+
Sbjct: 175 ---FKNIFGTPEFVAPEIVNYEPLGLEADMWSIGVIT 208
|
| >2iwi_A Serine/threonine-protein kinase PIM-2; nucleotide-binding, cancer, leukemia, transferase, ATP-binding, proto- oncogene, phosphorylation; HET: HB1; 2.80A {Homo sapiens} Length = 312 | Back alignment and structure |
|---|
Score = 73.5 bits (181), Expect = 1e-14
Identities = 25/89 (28%), Positives = 40/89 (44%), Gaps = 9/89 (10%)
Query: 271 IAQGLLYLHQYSRLRVIHRDLKASNILLDKDMNP-KISDFGMARMFGGDELQSNTKRIVG 329
+ + + H V+HRD+K NIL+D K+ DFG + + G
Sbjct: 148 VVAAIQHCH---SRGVVHRDIKDENILIDLRRGCAKLIDFGSGALLHDEPY----TDFDG 200
Query: 330 TYGYMSPEYALRGLFS-IKSDVFSFGVLL 357
T Y PE+ R + + + V+S G+LL
Sbjct: 201 TRVYSPPEWISRHQYHALPATVWSLGILL 229
|
| >3niz_A Rhodanese family protein; structural genomics, structural genomics consortium, SGC, phosphotransferase, cyclin dependent kinase; HET: ADP; 2.40A {Cryptosporidium parvum} PDB: 2qkr_A* Length = 311 | Back alignment and structure |
|---|
Score = 73.4 bits (181), Expect = 1e-14
Identities = 26/65 (40%), Positives = 43/65 (66%), Gaps = 5/65 (7%)
Query: 273 QGLLYLHQYSRLRVIHRDLKASNILLDKDMNPKISDFGMARMFGGDELQSNTKRIVGTYG 332
+G+ + HQ+ R++HRDLK N+L++ D K++DFG+AR F G ++S T +V T
Sbjct: 130 RGVAHCHQH---RILHRDLKPQNLLINSDGALKLADFGLARAF-GIPVRSYTHEVV-TLW 184
Query: 333 YMSPE 337
Y +P+
Sbjct: 185 YRAPD 189
|
| >3h4j_B AMPK kdaid, SNF1-like protein kinase SSP2; ATP-binding, nucleotide-binding, phosphoprotei serine/threonine-protein kinase, transferase; 2.80A {Schizosaccharomyces pombe} Length = 336 | Back alignment and structure |
|---|
Score = 73.5 bits (181), Expect = 2e-14
Identities = 31/92 (33%), Positives = 50/92 (54%), Gaps = 11/92 (11%)
Query: 267 IIEGIAQGLLYLHQYSRLRVIHRDLKASNILLDKDMNPKISDFGMARMFGGDELQSNTKR 326
II I Y H R +++HRDLK N+LLD ++N KI+DFG++ + +
Sbjct: 117 IICAIE----YCH---RHKIVHRDLKPENLLLDDNLNVKIADFGLSNIMTDGNFLKTS-- 167
Query: 327 IVGTYGYMSPEYALRGLFS-IKSDVFSFGVLL 357
G+ Y +PE L++ + DV+S G++L
Sbjct: 168 -CGSPNYAAPEVINGKLYAGPEVDVWSCGIVL 198
|
| >2pmi_A Negative RE, cyclin-dependent protein kinase PHO85; cyclin-dependent kinase, signaling protein,transfera cycle complex; HET: MES AGS; 2.90A {Saccharomyces cerevisiae} PDB: 2pk9_A* Length = 317 | Back alignment and structure |
|---|
Score = 72.6 bits (179), Expect = 3e-14
Identities = 24/65 (36%), Positives = 40/65 (61%), Gaps = 5/65 (7%)
Query: 273 QGLLYLHQYSRLRVIHRDLKASNILLDKDMNPKISDFGMARMFGGDELQSNTKRIVGTYG 332
QGL + H+ +++HRDLK N+L++K K+ DFG+AR F G + + + +V T
Sbjct: 119 QGLAFCHEN---KILHRDLKPQNLLINKRGQLKLGDFGLARAF-GIPVNTFSSEVV-TLW 173
Query: 333 YMSPE 337
Y +P+
Sbjct: 174 YRAPD 178
|
| >1ob3_A PFPK5, cell division control protein 2 homolog; transferase, serine/threonine-protein kinase, ATP-binding, phosphorylation, CDK; 1.9A {Plasmodium falciparum} SCOP: d.144.1.7 PDB: 1v0p_A* 1v0o_A* 1v0b_A Length = 288 | Back alignment and structure |
|---|
Score = 71.8 bits (177), Expect = 3e-14
Identities = 27/65 (41%), Positives = 40/65 (61%), Gaps = 5/65 (7%)
Query: 273 QGLLYLHQYSRLRVIHRDLKASNILLDKDMNPKISDFGMARMFGGDELQSNTKRIVGTYG 332
G+ Y H RV+HRDLK N+L++++ KI+DFG+AR F G ++ T IV T
Sbjct: 111 NGIAYCHDR---RVLHRDLKPQNLLINREGELKIADFGLARAF-GIPVRKYTHEIV-TLW 165
Query: 333 YMSPE 337
Y +P+
Sbjct: 166 YRAPD 170
|
| >1nxk_A MAP kinase-activated protein kinase 2; MK2, phosphorylation, staurosporine, transfe; HET: STU; 2.70A {Homo sapiens} SCOP: d.144.1.7 PDB: 1kwp_A* 1ny3_A* 2onl_C Length = 400 | Back alignment and structure |
|---|
Score = 72.8 bits (179), Expect = 4e-14
Identities = 25/96 (26%), Positives = 46/96 (47%), Gaps = 11/96 (11%)
Query: 266 RIIEGIAQGLLYLHQYSRLRVIHRDLKASNILL---DKDMNPKISDFGMARMF-GGDELQ 321
I++ I + + YLH + + HRD+K N+L + K++DFG A+ + L
Sbjct: 165 EIMKSIGEAIQYLHS---INIAHRDVKPENLLYTSKRPNAILKLTDFGFAKETTSHNSLT 221
Query: 322 SNTKRIVGTYGYMSPEYALRGLFSIKSDVFSFGVLL 357
+ T Y++PE + D++S GV++
Sbjct: 222 T----PCYTPYYVAPEVLGPEKYDKSCDMWSLGVIM 253
|
| >2y94_A 5'-AMP-activated protein kinase catalytic subunit; transferase, nucleotide-binding, staurosporine-binding, serine/threonine-protein kinase; HET: TPO STU AMP; 3.24A {Rattus norvegicus} Length = 476 | Back alignment and structure |
|---|
Score = 73.3 bits (180), Expect = 4e-14
Identities = 34/92 (36%), Positives = 50/92 (54%), Gaps = 11/92 (11%)
Query: 267 IIEGIAQGLLYLHQYSRLRVIHRDLKASNILLDKDMNPKISDFGMARMFGGDELQSNTKR 326
I+ G+ Y H R V+HRDLK N+LLD MN KI+DFG++ M E +
Sbjct: 125 ILSGVD----YCH---RHMVVHRDLKPENVLLDAHMNAKIADFGLSNMMSDGEFLRTS-- 175
Query: 327 IVGTYGYMSPEYALRGLFS-IKSDVFSFGVLL 357
G+ Y +PE L++ + D++S GV+L
Sbjct: 176 -CGSPNYAAPEVISGRLYAGPEVDIWSSGVIL 206
|
| >3uto_A Twitchin; kinase, muscle sarcomere, transferase; HET: FLC P33; 2.40A {Caenorhabditis elegans} PDB: 1koa_A Length = 573 | Back alignment and structure |
|---|
Score = 73.3 bits (180), Expect = 4e-14
Identities = 27/95 (28%), Positives = 44/95 (46%), Gaps = 8/95 (8%)
Query: 265 VRIIEGIAQGLLYLHQYSRLRVIHRDLKASNILL-DKDMNP-KISDFGMARMFGGDELQS 322
V + + +GL ++H+ +H DLK NI+ K N K+ DFG+ +
Sbjct: 258 VEYMRQVCKGLCHMHE---NNYVHLDLKPENIMFTTKRSNELKLIDFGLTAHLDPKQ--- 311
Query: 323 NTKRIVGTYGYMSPEYALRGLFSIKSDVFSFGVLL 357
+ K GT + +PE A +D++S GVL
Sbjct: 312 SVKVTTGTAEFAAPEVAEGKPVGYYTDMWSVGVLS 346
|
| >4fr4_A YANK1, serine/threonine-protein kinase 32A; structural genomics, structural genomics consortium, SGC, TR; HET: STU; 2.29A {Homo sapiens} Length = 384 | Back alignment and structure |
|---|
Score = 72.7 bits (179), Expect = 5e-14
Identities = 32/94 (34%), Positives = 44/94 (46%), Gaps = 9/94 (9%)
Query: 271 IAQGLLYLHQYSRLRVIHRDLKASNILLDKDMNPKISDFGMARMFGGDELQSNTKRIVGT 330
+ L YL R+IHRD+K NILLD+ + I+DF +A M + + GT
Sbjct: 124 LVMALDYLQN---QRIIHRDMKPDNILLDEHGHVHITDFNIAAMLPRETQ---ITTMAGT 177
Query: 331 YGYMSPEYALRGLFSIKS---DVFSFGVLLLETL 361
YM+PE + S D +S GV E L
Sbjct: 178 KPYMAPEMFSSRKGAGYSFAVDWWSLGVTAYELL 211
|
| >1ua2_A CAK, cell division protein kinase 7; cell cycle, phosphorylation, protein-protein interaction, PR kinase, cell cycle, transferase; HET: TPO ATP; 3.02A {Homo sapiens} SCOP: d.144.1.7 Length = 346 | Back alignment and structure |
|---|
Score = 71.8 bits (177), Expect = 6e-14
Identities = 29/65 (44%), Positives = 45/65 (69%), Gaps = 5/65 (7%)
Query: 273 QGLLYLHQYSRLRVIHRDLKASNILLDKDMNPKISDFGMARMFGGDELQSNTKRIVGTYG 332
QGL YLHQ+ ++HRDLK +N+LLD++ K++DFG+A+ F G ++ T ++V T
Sbjct: 123 QGLEYLHQH---WILHRDLKPNNLLLDENGVLKLADFGLAKSF-GSPNRAYTHQVV-TRW 177
Query: 333 YMSPE 337
Y +PE
Sbjct: 178 YRAPE 182
|
| >3mtl_A Cell division protein kinase 16; pctaire1, indirubin, structural genomics, structural consortium, SGC, transferase; HET: FEF; 2.40A {Homo sapiens} Length = 324 | Back alignment and structure |
|---|
Score = 71.5 bits (176), Expect = 7e-14
Identities = 22/65 (33%), Positives = 37/65 (56%), Gaps = 5/65 (7%)
Query: 273 QGLLYLHQYSRLRVIHRDLKASNILLDKDMNPKISDFGMARMFGGDELQSNTKRIVGTYG 332
+GL Y H+ +V+HRDLK N+L+++ K++DFG+AR ++ +V T
Sbjct: 111 RGLAYCHRQ---KVLHRDLKPQNLLINERGELKLADFGLARAK-SIPTKTYDNEVV-TLW 165
Query: 333 YMSPE 337
Y P+
Sbjct: 166 YRPPD 170
|
| >3mi9_A Cell division protein kinase 9; P-TEFB, HIV-1, protein binding; HET: TPO; 2.10A {Homo sapiens} PDB: 3mia_A* 3blh_A* 3blq_A* 3blr_A* 3lq5_A* 3my1_A* 3tn8_A* 3tnh_A* 3tni_A* Length = 351 | Back alignment and structure |
|---|
Score = 70.3 bits (173), Expect = 2e-13
Identities = 26/68 (38%), Positives = 41/68 (60%), Gaps = 7/68 (10%)
Query: 273 QGLLYLHQYSRLRVIHRDLKASNILLDKDMNPKISDFGMARMFG---GDELQSNTKRIVG 329
GL Y+H+ +++HRD+KA+N+L+ +D K++DFG+AR F + T R+V
Sbjct: 135 NGLYYIHRN---KILHRDMKAANVLITRDGVLKLADFGLARAFSLAKNSQPNRYTNRVV- 190
Query: 330 TYGYMSPE 337
T Y PE
Sbjct: 191 TLWYRPPE 198
|
| >1u5q_A Serine/threonine protein kinase TAO2; transferase; HET: SEP; 2.10A {Rattus norvegicus} SCOP: d.144.1.7 PDB: 1u5r_A* 2gcd_A* Length = 348 | Back alignment and structure |
|---|
Score = 70.5 bits (173), Expect = 2e-13
Identities = 35/99 (35%), Positives = 47/99 (47%), Gaps = 18/99 (18%)
Query: 267 IIEGIAQGLLYLHQYSRLRVIHRDLKASNILLDKDMNPKISDFGM-ARMFGGDELQSNTK 325
+ G QGL YLH +IHRD+KA NILL + K+ DFG + M
Sbjct: 159 VTHGALQGLAYLHS---HNMIHRDVKAGNILLSEPGLVKLGDFGSASIM---------AP 206
Query: 326 R--IVGTYGYMSPE---YALRGLFSIKSDVFSFGVLLLE 359
VGT +M+PE G + K DV+S G+ +E
Sbjct: 207 ANSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIE 245
|
| >2ac3_A MAP kinase-interacting serine/threonine kinase 2; DFD motif, transferase; 2.10A {Homo sapiens} PDB: 2hw7_A* 2ac5_A* 2hw6_A Length = 316 | Back alignment and structure |
|---|
Score = 70.0 bits (172), Expect = 2e-13
Identities = 27/106 (25%), Positives = 44/106 (41%), Gaps = 18/106 (16%)
Query: 266 RIIEGIAQGLLYLHQYSRLRVIHRDLKASNILL---DKDMNPKISDFGMARMFGGDELQS 322
+++ +A L +LH + HRDLK NIL ++ KI DF + + S
Sbjct: 115 VVVQDVASALDFLHN---KGIAHRDLKPENILCEHPNQVSPVKICDFDLGSGIKLNGDCS 171
Query: 323 NTKR-----IVGTYGYMSPEYALRGLFSI------KSDVFSFGVLL 357
G+ YM+PE + + D++S GV+L
Sbjct: 172 PISTPELLTPCGSAEYMAPE-VVEAFSEEASIYDKRCDLWSLGVIL 216
|
| >4ejn_A RAC-alpha serine/threonine-protein kinase; AKT1, autoinhibition, allosteric inhibitor, kinase inhibitor hydrophobic collapase, ATPase; HET: 0R4; 2.19A {Homo sapiens} PDB: 3o96_A* Length = 446 | Back alignment and structure |
|---|
Score = 70.9 bits (174), Expect = 2e-13
Identities = 36/103 (34%), Positives = 52/103 (50%), Gaps = 6/103 (5%)
Query: 271 IAQGLLYLHQYSRLRVIHRDLKASNILLDKDMNPKISDFGMARMFGGDELQSNTKRIVGT 330
I L YLH S V++RDLK N++LDKD + KI+DFG+ + D T GT
Sbjct: 257 IVSALDYLH--SEKNVVYRDLKLENLMLDKDGHIKITDFGLCKEGIKDGATMKT--FCGT 312
Query: 331 YGYMSPEYALRGLFSIKSDVFSFGVLLLETLSSKKNTHFYNTD 373
Y++PE + D + GV++ E + + FYN D
Sbjct: 313 PEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGR--LPFYNQD 353
|
| >3rgf_A Cyclin-dependent kinase 8; protein kinase complex, transferase,transcription; HET: BAX; 2.20A {Homo sapiens} Length = 405 | Back alignment and structure |
|---|
Score = 70.2 bits (172), Expect = 3e-13
Identities = 26/71 (36%), Positives = 36/71 (50%), Gaps = 10/71 (14%)
Query: 273 QGLLYLHQYSRLRVIHRDLKASNILLDKDMNP----KISDFGMARMFG--GDELQSNTKR 326
G+ YLH V+HRDLK +NIL+ + KI+D G AR+F L
Sbjct: 139 DGIHYLHAN---WVLHRDLKPANILVMGEGPERGRVKIADMGFARLFNSPLKPLADLDPV 195
Query: 327 IVGTYGYMSPE 337
+V T+ Y +PE
Sbjct: 196 VV-TFWYRAPE 205
|
| >1blx_A Cyclin-dependent kinase 6; inhibitor protein, cyclin-dependent kinase, cell cycle control, alpha/beta, complex (inhibitor protein/kinase); 1.90A {Homo sapiens} SCOP: d.144.1.7 PDB: 1bi7_A 1bi8_A 1g3n_A 2f2c_B* 1jow_B* 2euf_B* 1xo2_B* 3nup_A* 3nux_A* 2w9z_B 2w99_B 2w96_B 2w9f_B Length = 326 | Back alignment and structure |
|---|
Score = 69.5 bits (171), Expect = 3e-13
Identities = 20/44 (45%), Positives = 30/44 (68%), Gaps = 3/44 (6%)
Query: 273 QGLLYLHQYSRLRVIHRDLKASNILLDKDMNPKISDFGMARMFG 316
+GL +LH + RV+HRDLK NIL+ K++DFG+AR++
Sbjct: 131 RGLDFLHSH---RVVHRDLKPQNILVTSSGQIKLADFGLARIYS 171
|
| >3uc3_A Serine/threonine-protein kinase SRK2I; SNRK2, ABA signaling, transferase; 1.90A {Arabidopsis thaliana} PDB: 3zut_A 3zuu_A 3uc4_A 3ujg_A 3udb_A Length = 361 | Back alignment and structure |
|---|
Score = 69.7 bits (171), Expect = 3e-13
Identities = 30/94 (31%), Positives = 45/94 (47%), Gaps = 13/94 (13%)
Query: 267 IIEGIAQGLLYLHQYSRLRVIHRDLKASNILLDKD--MNPKISDFGMARMFGGDELQSNT 324
++ G++ Y H +++ HRDLK N LLD KI DFG ++ +T
Sbjct: 125 LLSGVS----YCH---SMQICHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKST 177
Query: 325 KRIVGTYGYMSPE-YALRGLFSIKSDVFSFGVLL 357
VGT Y++PE + +DV+S GV L
Sbjct: 178 ---VGTPAYIAPEVLLRQEYDGKIADVWSCGVTL 208
|
| >3g51_A Ribosomal protein S6 kinase alpha-3; N-terminal kinase domain of P90 ribosomal S6 kinase 2, ATP- binding, nucleotide-binding, phosphoprotein; HET: ANP; 1.80A {Mus musculus} PDB: 2z7q_A* 2z7r_A* 2z7s_A* Length = 325 | Back alignment and structure |
|---|
Score = 69.1 bits (170), Expect = 4e-13
Identities = 35/91 (38%), Positives = 55/91 (60%), Gaps = 5/91 (5%)
Query: 271 IAQGLLYLHQYSRLRVIHRDLKASNILLDKDMNPKISDFGMARMFGGDELQSNTKRIVGT 330
+A L +LH L +I+RDLK NILLD++ + K++DFG+++ E ++ + GT
Sbjct: 135 LALALDHLHS---LGIIYRDLKPENILLDEEGHIKLTDFGLSKESIDHEKKAYS--FCGT 189
Query: 331 YGYMSPEYALRGLFSIKSDVFSFGVLLLETL 361
YM+PE R + +D +SFGVL+ E L
Sbjct: 190 VEYMAPEVVNRRGHTQSADWWSFGVLMFEML 220
|
| >2vd5_A DMPK protein; serine/threonine-protein kinase, kinase, transferase, ATP-BI nucleotide-binding, cardiac contractility, muscle different; HET: BI8; 2.80A {Homo sapiens} Length = 412 | Back alignment and structure |
|---|
Score = 69.4 bits (170), Expect = 6e-13
Identities = 37/159 (23%), Positives = 65/159 (40%), Gaps = 22/159 (13%)
Query: 271 IAQGLLYLHQYSRLRVIHRDLKASNILLDKDMNPKISDFGMA-RMFGGDELQSNTKRIVG 329
I + +H+ L +HRD+K NILLD+ + +++DFG ++ ++S VG
Sbjct: 171 IVMAIDSVHR---LGYVHRDIKPDNILLDRCGHIRLADFGSCLKLRADGTVRSLV--AVG 225
Query: 330 TYGYMSPE-------YALRGLFSIKSDVFSFGVLLLETLSSKKNTHFYNTDSLTLLGHAW 382
T Y+SPE G + + D ++ GV E + T FY + G
Sbjct: 226 TPDYLSPEILQAVGGGPGTGSYGPECDWWALGVFAYEMFYGQ--TPFYADSTAETYGKIV 283
Query: 383 NLWNDGRTWELMDPISQNGASYPILKRYINVALLCVQEK 421
+ + + + + ++R LLC E
Sbjct: 284 HYKEHLSLPLVDEGVPEEARD--FIQR-----LLCPPET 315
|
| >4aw2_A Serine/threonine-protein kinase MRCK alpha; transferase, CDC42BPA; HET: 22E; 1.70A {Rattus norvegicus} PDB: 3tku_A* 3qfv_A* Length = 437 | Back alignment and structure |
|---|
Score = 69.4 bits (170), Expect = 6e-13
Identities = 34/110 (30%), Positives = 55/110 (50%), Gaps = 15/110 (13%)
Query: 271 IAQGLLYLHQYSRLRVIHRDLKASNILLDKDMNPKISDFGMA-RMFGGDELQSNTKRIVG 329
+ + +HQ L +HRD+K NIL+D + + +++DFG ++ +QS+ VG
Sbjct: 184 MVIAIDSVHQ---LHYVHRDIKPDNILMDMNGHIRLADFGSCLKLMEDGTVQSSV--AVG 238
Query: 330 TYGYMSPEYALRGLFSIKS------DVFSFGVLLLETLSSKKNTHFYNTD 373
T Y+SPE L+ + K D +S GV + E L + T FY
Sbjct: 239 TPDYISPE-ILQAMEGGKGRYGPECDWWSLGVCMYEMLYGE--TPFYAES 285
|
| >3g33_A Cell division protein kinase 4; Ser/Thr protein kinase, cell cycle, phosphorylation, ATP-BIN cell division, disease mutation, kinase; 3.00A {Homo sapiens} Length = 308 | Back alignment and structure |
|---|
Score = 68.4 bits (168), Expect = 7e-13
Identities = 18/44 (40%), Positives = 28/44 (63%), Gaps = 3/44 (6%)
Query: 273 QGLLYLHQYSRLRVIHRDLKASNILLDKDMNPKISDFGMARMFG 316
+GL +LH ++HRDLK NIL+ K++DFG+AR++
Sbjct: 131 RGLDFLHAN---CIVHRDLKPENILVTSGGTVKLADFGLARIYS 171
|
| >3a62_A Ribosomal protein S6 kinase beta-1; kinase domain, inactive, active, ribosomal S6 kinase, activation, alternative initiation, ATP-binding; HET: TPO STU; 2.35A {Homo sapiens} PDB: 3a61_A* 3a60_A* Length = 327 | Back alignment and structure |
|---|
Score = 68.3 bits (168), Expect = 7e-13
Identities = 31/91 (34%), Positives = 50/91 (54%), Gaps = 5/91 (5%)
Query: 271 IAQGLLYLHQYSRLRVIHRDLKASNILLDKDMNPKISDFGMARMFGGDELQSNTKRIVGT 330
I+ L +LHQ +I+RDLK NI+L+ + K++DFG+ + D ++T GT
Sbjct: 130 ISMALGHLHQ---KGIIYRDLKPENIMLNHQGHVKLTDFGLCKESIHDGTVTHT--FCGT 184
Query: 331 YGYMSPEYALRGLFSIKSDVFSFGVLLLETL 361
YM+PE +R + D +S G L+ + L
Sbjct: 185 IEYMAPEILMRSGHNRAVDWWSLGALMYDML 215
|
| >3gbz_A Kinase, CMGC CDK; ssgcid, ATP-binding, nucleotide-binding, serine/threonine-protein kinase, transferase; 1.85A {Giardia lamblia} PDB: 3gc0_A* Length = 329 | Back alignment and structure |
|---|
Score = 68.4 bits (168), Expect = 8e-13
Identities = 26/72 (36%), Positives = 35/72 (48%), Gaps = 10/72 (13%)
Query: 271 IAQGLLYLHQYSRLRVIHRDLKASNILLDKDMNP-----KISDFGMARMFGGDELQSNTK 325
+ G+ + H R +HRDLK N+LL KI DFG+AR F G ++ T
Sbjct: 141 LINGVNFCHSR---RCLHRDLKPQNLLLSVSDASETPVLKIGDFGLARAF-GIPIRQFTH 196
Query: 326 RIVGTYGYMSPE 337
I+ T Y PE
Sbjct: 197 EII-TLWYRPPE 207
|
| >1kj1_A Lectin I, lecgna 1; BULB lectin, mannose, plant protein; HET: MAN; 2.20A {Allium sativum} SCOP: b.78.1.1 PDB: 1bwu_P* 1kj1_D* 1bwu_Q* 1bwu_A* 1bwu_D* Length = 109 | Back alignment and structure |
|---|
Score = 63.7 bits (155), Expect = 8e-13
Identities = 24/126 (19%), Positives = 42/126 (33%), Gaps = 19/126 (15%)
Query: 27 DTITPETFIRDGEKLVSSSQRFELGFFSPRNSKNRYLGVWYKKIPDTVVWVANRNSPIFN 86
+ +T + G+ L + N V Y T VW +N
Sbjct: 2 NLLTNGEGLYAGQSLDVE--PYHFIMQEDCNL------VLYDH--STSVWASNTGILG-K 50
Query: 87 PNTALTFSNNGNLVLLSQRNGIIWSSNMSRKAENPIAQLLDTGNLVIRDNSSGHTTESYL 146
++GN V+ +W+S+ R N + L + GN+VI + +
Sbjct: 51 KGCKAVLQSDGNFVVYDAEGRSLWASHSVRGNGNYVLVLQEDGNVVIYGSD--------I 102
Query: 147 WQSFDY 152
W + Y
Sbjct: 103 WSTGTY 108
|
| >1o6l_A RAC-beta serine/threonine protein kinase; protein kinase, transferase, serine/threonine-protein kinase; HET: TPO ANP; 1.6A {Homo sapiens} SCOP: d.144.1.7 PDB: 2jdo_A* 2jdr_A* 2uw9_A* 2x37_A* 2x39_A* 2xh5_A* 3d0e_A* 3e87_A* 3e88_A* 3e8d_A* 1o6k_A* 1mrv_A 1mry_A 1gzn_A 1gzk_A 1gzo_A 3qkl_A* 3ocb_A* 3ow4_A* 3qkk_A* ... Length = 337 | Back alignment and structure |
|---|
Score = 68.0 bits (167), Expect = 9e-13
Identities = 34/105 (32%), Positives = 52/105 (49%), Gaps = 11/105 (10%)
Query: 271 IAQGLLYLHQYSRLRVIHRDLKASNILLDKDMNPKISDFGMAR--MFGGDELQSNTKRIV 328
I L YLH V++RD+K N++LDKD + KI+DFG+ + + G K
Sbjct: 114 IVSALEYLHS---RDVVYRDIKLENLMLDKDGHIKITDFGLCKEGISDGA----TMKTFC 166
Query: 329 GTYGYMSPEYALRGLFSIKSDVFSFGVLLLETLSSKKNTHFYNTD 373
GT Y++PE + D + GV++ E + + FYN D
Sbjct: 167 GTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGR--LPFYNQD 209
|
| >2i0e_A Protein kinase C-beta II; serine/threonine protein kinase, transferase; HET: TPO SEP PDS; 2.60A {Homo sapiens} PDB: 3iw4_A* Length = 353 | Back alignment and structure |
|---|
Score = 68.0 bits (167), Expect = 1e-12
Identities = 35/93 (37%), Positives = 51/93 (54%), Gaps = 9/93 (9%)
Query: 271 IAQGLLYLHQYSRLRVIHRDLKASNILLDKDMNPKISDFGMAR--MFGGDELQSNTKRIV 328
IA GL +L +I+RDLK N++LD + + KI+DFGM + ++ G TK
Sbjct: 130 IAIGLFFLQS---KGIIYRDLKLDNVMLDSEGHIKIADFGMCKENIWDGV----TTKTFC 182
Query: 329 GTYGYMSPEYALRGLFSIKSDVFSFGVLLLETL 361
GT Y++PE + D ++FGVLL E L
Sbjct: 183 GTPDYIAPEIIAYQPYGKSVDWWAFGVLLYEML 215
|
| >3pfq_A PKC-B, PKC-beta, protein kinase C beta type; phosphorylation, transferase; HET: TPO SEP ANP; 4.00A {Rattus norvegicus} PDB: 1tbn_A 1tbo_A 2e73_A Length = 674 | Back alignment and structure |
|---|
Score = 69.3 bits (169), Expect = 1e-12
Identities = 35/93 (37%), Positives = 51/93 (54%), Gaps = 9/93 (9%)
Query: 271 IAQGLLYLHQYSRLRVIHRDLKASNILLDKDMNPKISDFGMAR--MFGGDELQSNTKRIV 328
IA GL +L +I+RDLK N++LD + + KI+DFGM + ++ G TK
Sbjct: 451 IAIGLFFLQS---KGIIYRDLKLDNVMLDSEGHIKIADFGMCKENIWDGV----TTKTFC 503
Query: 329 GTYGYMSPEYALRGLFSIKSDVFSFGVLLLETL 361
GT Y++PE + D ++FGVLL E L
Sbjct: 504 GTPDYIAPEIIAYQPYGKSVDWWAFGVLLYEML 536
|
| >3a8x_A Protein kinase C IOTA type; transferase; HET: TPO; 2.00A {Homo sapiens} PDB: 3a8w_A* 1zrz_A* Length = 345 | Back alignment and structure |
|---|
Score = 67.6 bits (166), Expect = 1e-12
Identities = 31/94 (32%), Positives = 51/94 (54%), Gaps = 9/94 (9%)
Query: 271 IAQGLLYLHQYSRLRVIHRDLKASNILLDKDMNPKISDFGMAR--MFGGDELQSNTKRIV 328
I+ L YLH+ +I+RDLK N+LLD + + K++D+GM + + GD T
Sbjct: 119 ISLALNYLHE---RGIIYRDLKLDNVLLDSEGHIKLTDYGMCKEGLRPGDT----TSTFC 171
Query: 329 GTYGYMSPEYALRGLFSIKSDVFSFGVLLLETLS 362
GT Y++PE + D ++ GVL+ E ++
Sbjct: 172 GTPNYIAPEILRGEDYGFSVDWWALGVLMFEMMA 205
|
| >3txo_A PKC-L, NPKC-ETA, protein kinase C ETA type; phosphotransferase, transferase-transferase inhibito; HET: TPO 07U; 2.05A {Homo sapiens} Length = 353 | Back alignment and structure |
|---|
Score = 67.6 bits (166), Expect = 2e-12
Identities = 33/93 (35%), Positives = 48/93 (51%), Gaps = 9/93 (9%)
Query: 271 IAQGLLYLHQYSRLRVIHRDLKASNILLDKDMNPKISDFGMA--RMFGGDELQSNTKRIV 328
I L++LH +I+RDLK N+LLD + + K++DFGM + G T
Sbjct: 133 IISALMFLHD---KGIIYRDLKLDNVLLDHEGHCKLADFGMCKEGICNGVT----TATFC 185
Query: 329 GTYGYMSPEYALRGLFSIKSDVFSFGVLLLETL 361
GT Y++PE L+ D ++ GVLL E L
Sbjct: 186 GTPDYIAPEILQEMLYGPAVDWWAMGVLLYEML 218
|
| >1xjd_A Protein kinase C, theta type; PKC-theta, ATP, AMP,, transferase; HET: TPO SEP STU; 2.00A {Homo sapiens} SCOP: d.144.1.7 PDB: 2jed_A* Length = 345 | Back alignment and structure |
|---|
Score = 67.2 bits (165), Expect = 2e-12
Identities = 40/93 (43%), Positives = 52/93 (55%), Gaps = 9/93 (9%)
Query: 271 IAQGLLYLHQYSRLRVIHRDLKASNILLDKDMNPKISDFGMAR--MFGGDELQSNTKRIV 328
I GL +LH +++RDLK NILLDKD + KI+DFGM + M G T
Sbjct: 127 IILGLQFLHS---KGIVYRDLKLDNILLDKDGHIKIADFGMCKENMLGDA----KTNTFC 179
Query: 329 GTYGYMSPEYALRGLFSIKSDVFSFGVLLLETL 361
GT Y++PE L ++ D +SFGVLL E L
Sbjct: 180 GTPDYIAPEILLGQKYNHSVDWWSFGVLLYEML 212
|
| >4dc2_A Protein kinase C IOTA type; kinase, substrate, cell polarity, atypical PKC, trans transferase substrate complex; HET: TPO ADE; 2.40A {Mus musculus} Length = 396 | Back alignment and structure |
|---|
Score = 67.4 bits (165), Expect = 2e-12
Identities = 31/94 (32%), Positives = 51/94 (54%), Gaps = 9/94 (9%)
Query: 271 IAQGLLYLHQYSRLRVIHRDLKASNILLDKDMNPKISDFGMAR--MFGGDELQSNTKRIV 328
I+ L YLH+ +I+RDLK N+LLD + + K++D+GM + + GD T
Sbjct: 162 ISLALNYLHE---RGIIYRDLKLDNVLLDSEGHIKLTDYGMCKEGLRPGDT----TSTFC 214
Query: 329 GTYGYMSPEYALRGLFSIKSDVFSFGVLLLETLS 362
GT Y++PE + D ++ GVL+ E ++
Sbjct: 215 GTPNYIAPEILRGEDYGFSVDWWALGVLMFEMMA 248
|
| >4aaa_A Cyclin-dependent kinase-like 2; transferase, phospho-mimetic; HET: DKI; 1.53A {Homo sapiens} Length = 331 | Back alignment and structure |
|---|
Score = 66.9 bits (164), Expect = 2e-12
Identities = 21/67 (31%), Positives = 32/67 (47%), Gaps = 5/67 (7%)
Query: 271 IAQGLLYLHQYSRLRVIHRDLKASNILLDKDMNPKISDFGMARMFGGDELQSNTKRIVGT 330
I G+ + H + +IHRD+K NIL+ + K+ DFG AR + + T
Sbjct: 133 IINGIGFCHSH---NIIHRDIKPENILVSQSGVVKLCDFGFARTL-AAPGEVYDDEVA-T 187
Query: 331 YGYMSPE 337
Y +PE
Sbjct: 188 RWYRAPE 194
|
| >2r5t_A Serine/threonine-protein kinase SGK1; AGC protein kinase, apoptosis, ATP-binding, cytoplasm, endoplasmic reticulum, nucleotide-binding, nucleus; HET: ANP; 1.90A {Homo sapiens} PDB: 3hdm_A* 3hdn_A* Length = 373 | Back alignment and structure |
|---|
Score = 66.9 bits (164), Expect = 3e-12
Identities = 30/93 (32%), Positives = 45/93 (48%), Gaps = 9/93 (9%)
Query: 271 IAQGLLYLHQYSRLRVIHRDLKASNILLDKDMNPKISDFGMAR--MFGGDELQSNTKRIV 328
IA L YLH L +++RDLK NILLD + ++DFG+ + + T
Sbjct: 148 IASALGYLHS---LNIVYRDLKPENILLDSQGHIVLTDFGLCKENIEHNS----TTSTFC 200
Query: 329 GTYGYMSPEYALRGLFSIKSDVFSFGVLLLETL 361
GT Y++PE + + D + G +L E L
Sbjct: 201 GTPEYLAPEVLHKQPYDRTVDWWCLGAVLYEML 233
|
| >4agu_A Cyclin-dependent kinase-like 1; transferase, phospho-mimetic; HET: D15; 2.40A {Homo sapiens} Length = 311 | Back alignment and structure |
|---|
Score = 66.4 bits (163), Expect = 3e-12
Identities = 22/67 (32%), Positives = 31/67 (46%), Gaps = 5/67 (7%)
Query: 271 IAQGLLYLHQYSRLRVIHRDLKASNILLDKDMNPKISDFGMARMFGGDELQSNTKRIVGT 330
Q + + H++ IHRD+K NIL+ K K+ DFG AR+ + T
Sbjct: 111 TLQAVNFCHKH---NCIHRDVKPENILITKHSVIKLCDFGFARLL-TGPSDYYDDEVA-T 165
Query: 331 YGYMSPE 337
Y SPE
Sbjct: 166 RWYRSPE 172
|
| >3a0c_A Mannose/sialic acid-binding lectin; beta-prism II, sugar binding protein; 2.00A {Polygonatum cyrtonema} PDB: 3a0d_A* 3a0e_A* Length = 110 | Back alignment and structure |
|---|
Score = 61.4 bits (149), Expect = 7e-12
Identities = 27/123 (21%), Positives = 44/123 (35%), Gaps = 19/123 (15%)
Query: 27 DTITPETFIRDGEKLVSSSQRFELGFFSPRNSKNRYLGVWYKKIPDTVVWVANRNSPIFN 86
++++ + G L + L N V Y VW +N
Sbjct: 2 NSLSSPNSLFTGHSL-EVGPSYRLIMQGDCNF------VLYDS--GKPVWASNTGGL--G 50
Query: 87 PNTALTFSNNGNLVLLSQRNGIIWSSNMSRKAENPIAQLLDTGNLVIRDNSSGHTTESYL 146
LT NNGNLV+ Q N +IW + + K ++ + L N+VI +
Sbjct: 51 SGCRLTLHNNGNLVIYDQSNRVIWQTKTNGKEDHYVLVLQQDRNVVIYGPV--------V 102
Query: 147 WQS 149
W +
Sbjct: 103 WAT 105
|
| >3v8s_A RHO-associated protein kinase 1; dimerization, myosin, transferase, inhibitor, transf transferase inhibitor complex; HET: 0HD; 2.29A {Homo sapiens} PDB: 3tv7_A* 2etr_A* 2esm_A* 2eto_A* 2etk_A* 3d9v_A* 3ncz_A* 3ndm_A* 2v55_A* 2f2u_A* 2h9v_A* Length = 410 | Back alignment and structure |
|---|
Score = 65.9 bits (161), Expect = 8e-12
Identities = 36/108 (33%), Positives = 52/108 (48%), Gaps = 12/108 (11%)
Query: 271 IAQGLLYLHQYSRLRVIHRDLKASNILLDKDMNPKISDFGMA-RMFGGDELQSNTKRIVG 329
+ L +H + IHRD+K N+LLDK + K++DFG +M ++ +T VG
Sbjct: 177 VVLALDAIHS---MGFIHRDVKPDNMLLDKSGHLKLADFGTCMKMNKEGMVRCDT--AVG 231
Query: 330 TYGYMSPE----YALRGLFSIKSDVFSFGVLLLETLSSKKNTHFYNTD 373
T Y+SPE G + + D +S GV L E L T FY
Sbjct: 232 TPDYISPEVLKSQGGDGYYGRECDWWSVGVFLYEMLVGD--TPFYADS 277
|
| >2xrw_A Mitogen-activated protein kinase 8; transcription, MAPK signaling pathways, linear binding motif; HET: ANP; 1.33A {Homo sapiens} PDB: 1ukh_A 1uki_A* 2xs0_A* 3elj_A* 2h96_A* 2gmx_A* 2g01_A* 2no3_A* 3o2m_A* 3o17_A* 3pze_A* 3g9l_X* 2p33_A* 3cgf_A* 3cgo_A* 3g90_X* 2ok1_A* 3g9n_A* 1pmn_A* 1pmq_A* ... Length = 371 | Back alignment and structure |
|---|
Score = 65.5 bits (160), Expect = 1e-11
Identities = 31/91 (34%), Positives = 46/91 (50%), Gaps = 6/91 (6%)
Query: 274 GLLYLHQYSRLRVIHRDLKASNILLDKDMNPKISDFGMARMFGGDELQSNTKRIVGTYGY 333
G+ +LH +IHRDLK SNI++ D KI DFG+AR G + + V T Y
Sbjct: 139 GIKHLHSAG---IIHRDLKPSNIVVKSDCTLKILDFGLARTAGTSFMMTPY---VVTRYY 192
Query: 334 MSPEYALRGLFSIKSDVFSFGVLLLETLSSK 364
+PE L + D++S G ++ E +
Sbjct: 193 RAPEVILGMGYKENVDIWSVGCIMGEMIKGG 223
|
| >3e3p_A Protein kinase, putative glycogen synthase kinase; leishmaniasis, transferase; 2.00A {Leishmania major} Length = 360 | Back alignment and structure |
|---|
Score = 65.0 bits (159), Expect = 1e-11
Identities = 22/68 (32%), Positives = 34/68 (50%), Gaps = 5/68 (7%)
Query: 271 IAQGLLYLHQYSRLRVIHRDLKASNILLDKDMNP-KISDFGMARMFGGDELQSNTKRIVG 329
+ + + LH S + V HRD+K N+L+++ K+ DFG A+ E N I
Sbjct: 138 LIRSIGCLHLPS-VNVCHRDIKPHNVLVNEADGTLKLCDFGSAKKLSPSE--PNVAYICS 194
Query: 330 TYGYMSPE 337
Y Y +PE
Sbjct: 195 RY-YRAPE 201
|
| >3e7e_A HBUB1, BUB1A, mitotic checkpoint serine/threonine-protein kinas; spindle assembly checkpoint, mitosis, kinase, activation, KE CDC20, ATP-binding; HET: ATP; 2.31A {Homo sapiens} Length = 365 | Back alignment and structure |
|---|
Score = 65.0 bits (158), Expect = 1e-11
Identities = 16/105 (15%), Positives = 30/105 (28%), Gaps = 14/105 (13%)
Query: 271 IAQGLLYLHQYSRLRVIHRDLKASNILL-----------DKDMNPKISDFGMARMFGGDE 319
+ + +H +IH D+K N +L D + D G +
Sbjct: 181 MLYMIEQVHD---CEIIHGDIKPDNFILGNGFLEQDDEDDLSAGLALIDLGQSIDMKLFP 237
Query: 320 LQSNTKRIVGTYGYMSPEYALRGLFSIKSDVFSFGVLLLETLSSK 364
+ T G+ E ++ + D F + L
Sbjct: 238 KGTIFTAKCETSGFQCVEMLSNKPWNYQIDYFGVAATVYCMLFGT 282
|
| >1vzo_A Ribosomal protein S6 kinase alpha 5; protein kinase, transferase, phosphorylation, serine/threonine protein kinase; 1.8A {Homo sapiens} SCOP: d.144.1.7 Length = 355 | Back alignment and structure |
|---|
Score = 64.6 bits (158), Expect = 1e-11
Identities = 36/94 (38%), Positives = 55/94 (58%), Gaps = 8/94 (8%)
Query: 271 IAQGLLYLHQYSRLRVIHRDLKASNILLDKDMNPKISDFGMARMFGGDELQSNTKRIVGT 330
I L +LH+ L +I+RD+K NILLD + + ++DFG+++ F DE + GT
Sbjct: 168 IVLALEHLHK---LGIIYRDIKLENILLDSNGHVVLTDFGLSKEFVADETER-AYDFCGT 223
Query: 331 YGYMSPEYALRGLFS--IKS-DVFSFGVLLLETL 361
YM+P+ +RG S K+ D +S GVL+ E L
Sbjct: 224 IEYMAPD-IVRGGDSGHDKAVDWWSLGVLMYELL 256
|
| >1rdq_E PKA C-alpha, CAMP-dependent protein kinase, alpha-catalytic SU; CAMP-dependent protein kinase,catalytic mechanism, ATP hydro two nucleotide states; HET: TPO SEP ADP ATP; 1.26A {Mus musculus} SCOP: d.144.1.7 PDB: 2erz_E* 3fjq_E* 1bkx_A* 1atp_E* 1fmo_E* 1j3h_A* 1jlu_E* 1bx6_A* 1re8_A* 1rej_A* 1rek_A* 2cpk_E* 2qcs_A* 2qvs_E* 1l3r_E* 3idb_A* 3idc_A* 3o7l_D* 3ow3_A* 3tnp_C* ... Length = 350 | Back alignment and structure |
|---|
Score = 63.8 bits (156), Expect = 2e-11
Identities = 27/92 (29%), Positives = 47/92 (51%), Gaps = 8/92 (8%)
Query: 271 IAQGLLYLHQYSRLRVIHRDLKASNILLDKDMNPKISDFGMARMFGGDELQSNTKRIVGT 330
I YLH +I+RDLK N+L+D+ +++DFG A+ ++ T + GT
Sbjct: 150 IVLTFEYLHSLD---LIYRDLKPENLLIDQQGYIQVTDFGFAK-----RVKGRTWTLCGT 201
Query: 331 YGYMSPEYALRGLFSIKSDVFSFGVLLLETLS 362
++PE L ++ D ++ GVL+ E +
Sbjct: 202 PEALAPEIILSKGYNKAVDWWALGVLIYEMAA 233
|
| >1xd5_A Gastrodianin-1, antifungal protein GAFP-1; monocot mannose binding lectin, monomer, homogeneous beta- sheet; 2.00A {Gastrodia elata} SCOP: b.78.1.1 PDB: 1xd6_A Length = 112 | Back alignment and structure |
|---|
Score = 59.6 bits (144), Expect = 3e-11
Identities = 30/124 (24%), Positives = 48/124 (38%), Gaps = 18/124 (14%)
Query: 26 ADTITPETFIRDGEKLVSSSQRFELGFFSPRNSKNRYLGVWYKKIPDTVVWVANRNSPIF 85
+D + + G L + + N V Y + VW + N
Sbjct: 1 SDRLNSGHQLDTGGSLAE--GGYLFIIQNDCNL------VLYDN--NRAVWASGTNGK-- 48
Query: 86 NPNTALTFSNNGNLVLLSQRNGIIWSSNMSRKAENPIAQLLDTGNLVIRDNSSGHTTESY 145
L N+GNLV+ S + IW+SN +R+ N L N+VI DNS+ +
Sbjct: 49 ASGCVLKMQNDGNLVIYS-GSRAIWASNTNRQNGNYYLILQRDRNVVIYDNSN-----NA 102
Query: 146 LWQS 149
+W +
Sbjct: 103 IWAT 106
|
| >1xd5_A Gastrodianin-1, antifungal protein GAFP-1; monocot mannose binding lectin, monomer, homogeneous beta- sheet; 2.00A {Gastrodia elata} SCOP: b.78.1.1 PDB: 1xd6_A Length = 112 | Back alignment and structure |
|---|
Score = 42.6 bits (100), Expect = 2e-05
Identities = 18/72 (25%), Positives = 30/72 (41%), Gaps = 1/72 (1%)
Query: 81 NSPIFNPNTALTFSNNGNLVLLSQRNGIIWSSNMSRKAENPIAQLLDTGNLVIRDNSSGH 140
+ N+ NLVL N +W+S + KA + ++ + GNLVI S
Sbjct: 13 GGSLAEGGYLFIIQNDCNLVLYD-NNRAVWASGTNGKASGCVLKMQNDGNLVIYSGSRAI 71
Query: 141 TTESYLWQSFDY 152
+ Q+ +Y
Sbjct: 72 WASNTNRQNGNY 83
|
| >3rp9_A Mitogen-activated protein kinase; structural genomics, structural genomics consortium, SGC, TR; 2.40A {Toxoplasma gondii} Length = 458 | Back alignment and structure |
|---|
Score = 63.7 bits (155), Expect = 5e-11
Identities = 21/69 (30%), Positives = 36/69 (52%), Gaps = 3/69 (4%)
Query: 271 IAQGLLYLHQYSRLRVIHRDLKASNILLDKDMNPKISDFGMARMFGGDELQSNTKRIVGT 330
+ G+ Y+H S ++HRDLK +N L+++D + K+ DFG+AR E ++ I
Sbjct: 165 LLVGVKYVH--SA-GILHRDLKPANCLVNQDCSVKVCDFGLARTVDYPENGNSQLPISPR 221
Query: 331 YGYMSPEYA 339
M+
Sbjct: 222 EDDMNLVTF 230
|
| >3ttj_A Mitogen-activated protein kinase 10; JNK3, protein kinase in transferase-transferase inhibitor complex; HET: JBI; 2.10A {Homo sapiens} PDB: 3tti_A* 1jnk_A* Length = 464 | Back alignment and structure |
|---|
Score = 63.3 bits (154), Expect = 5e-11
Identities = 32/91 (35%), Positives = 47/91 (51%), Gaps = 6/91 (6%)
Query: 274 GLLYLHQYSRLRVIHRDLKASNILLDKDMNPKISDFGMARMFGGDELQSNTKRIVGTYGY 333
G+ +LH +IHRDLK SNI++ D KI DFG+AR G + + V T Y
Sbjct: 176 GIKHLHS---AGIIHRDLKPSNIVVKSDCTLKILDFGLARTAGTSFMMTPY---VVTRYY 229
Query: 334 MSPEYALRGLFSIKSDVFSFGVLLLETLSSK 364
+PE L + D++S G ++ E + K
Sbjct: 230 RAPEVILGMGYKENVDIWSVGCIMGEMVRHK 260
|
| >4e7w_A Glycogen synthase kinase 3; GSK3, PTyr195, transferase; HET: PTR; 3.30A {Ustilago maydis} Length = 394 | Back alignment and structure |
|---|
Score = 62.7 bits (153), Expect = 7e-11
Identities = 22/68 (32%), Positives = 34/68 (50%), Gaps = 7/68 (10%)
Query: 271 IAQGLLYLHQYSRLRVIHRDLKASNILLDKDMNP-KISDFGMARMFGGDELQSNTKRIVG 329
+ + L Y+H + + HRD+K N+LLD K+ DFG A++ + N I
Sbjct: 150 LLRSLAYIHS---IGICHRDIKPQNLLLDPPSGVLKLIDFGSAKIL--IAGEPNVSYICS 204
Query: 330 TYGYMSPE 337
Y Y +PE
Sbjct: 205 RY-YRAPE 211
|
| >1fot_A TPK1 delta, CAMP-dependent protein kinase type 1; open conformation, transferase; HET: TPO; 2.80A {Saccharomyces cerevisiae} SCOP: d.144.1.7 Length = 318 | Back alignment and structure |
|---|
Score = 62.2 bits (152), Expect = 7e-11
Identities = 34/92 (36%), Positives = 51/92 (55%), Gaps = 8/92 (8%)
Query: 271 IAQGLLYLHQYSRLRVIHRDLKASNILLDKDMNPKISDFGMARMFGGDELQSNTKRIVGT 330
+ L YLH +I+RDLK NILLDK+ + KI+DFG A+ + T + GT
Sbjct: 115 VCLALEYLHSKD---IIYRDLKPENILLDKNGHIKITDFGFAK-----YVPDVTYTLCGT 166
Query: 331 YGYMSPEYALRGLFSIKSDVFSFGVLLLETLS 362
Y++PE ++ D +SFG+L+ E L+
Sbjct: 167 PDYIAPEVVSTKPYNKSIDWWSFGILIYEMLA 198
|
| >1j1b_A Glycogen synthase kinase-3 beta; complex, TAU, AMPPNP, transferase; HET: ANP; 1.80A {Homo sapiens} SCOP: d.144.1.7 PDB: 1i09_A* 1j1c_A* 2jld_A* 3m1s_A* 3pup_A* 3du8_A* 1pyx_A* 1q41_A* 1q3w_A* 1q3d_A* 1q4l_A* 3q3b_A* 1q5k_A* 3i4b_A* 3l1s_A* 1r0e_A* 3zrk_A* 3zrl_A* 3zrm_A* 4dit_A* ... Length = 420 | Back alignment and structure |
|---|
Score = 62.4 bits (152), Expect = 1e-10
Identities = 24/68 (35%), Positives = 33/68 (48%), Gaps = 7/68 (10%)
Query: 271 IAQGLLYLHQYSRLRVIHRDLKASNILLDKDMNP-KISDFGMARMFGGDELQSNTKRIVG 329
+ + L Y+H + HRD+K N+LLD D K+ DFG A+ E N I
Sbjct: 165 LFRSLAYIHS---FGICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGE--PNVSYICS 219
Query: 330 TYGYMSPE 337
Y Y +PE
Sbjct: 220 RY-YRAPE 226
|
| >3eb0_A Putative uncharacterized protein; kinase cryptosporidium parvum, ATP-binding, kinase, nucleoti binding; HET: PTR DRK; 2.65A {Cryptosporidium parvum iowa II} Length = 383 | Back alignment and structure |
|---|
Score = 61.3 bits (149), Expect = 2e-10
Identities = 25/96 (26%), Positives = 47/96 (48%), Gaps = 8/96 (8%)
Query: 271 IAQGLLYLHQYSRLRVIHRDLKASNILLD-KDMNPKISDFGMARMFGGDELQSNTKRIVG 329
+ + + ++H L + HRD+K N+L++ KD K+ DFG A+ + + I
Sbjct: 150 LFRAVGFIHS---LGICHRDIKPQNLLVNSKDNTLKLCDFGSAKKL--IPSEPSVAYICS 204
Query: 330 TYGYMSPEYALRG-LFSIKSDVFSFGVLLLETLSSK 364
+ Y +PE L ++ D++S G + E + K
Sbjct: 205 RF-YRAPELMLGATEYTPSIDLWSIGCVFGELILGK 239
|
| >3dzw_A Agglutinin; lectin, mannobiose, mannose-alpha1, 3-mannose, D sugar binding protein; HET: MAN; 1.70A {Narcissus pseudonarcissus} PDB: 1npl_A* 1jpc_A* 1msa_A* 1niv_A* Length = 109 | Back alignment and structure |
|---|
Score = 56.8 bits (137), Expect = 2e-10
Identities = 28/123 (22%), Positives = 46/123 (37%), Gaps = 20/123 (16%)
Query: 27 DTITPETFIRDGEKLVSSSQRFELGFFSPRNSKNRYLGVWYKKIPDTVVWVANRNSPIFN 86
+ + + GE L ++ R+ N V Y D +W N +
Sbjct: 2 NILYSGETLSPGEFL--NNGRYVFIMQEDCNL------VLYDV--DKPIWATNTGGL--D 49
Query: 87 PNTALTFSNNGNLVLLSQRNGIIWSSNMSRKAENPIAQLLDTGNLVIRDNSSGHTTESYL 146
L+ ++GNLV+ S RN IW+SN + N + L N+VI +
Sbjct: 50 RRCHLSMQSDGNLVVYSPRNNPIWASNTGGENGNYVCVLQKDRNVVIYGTA--------R 101
Query: 147 WQS 149
W +
Sbjct: 102 WAT 104
|
| >2dpf_A Curculin; sweet taste, taste modifying, plant protein; 1.50A {Curculigo latifolia} PDB: 2d04_B* 2d04_A* Length = 115 | Back alignment and structure |
|---|
Score = 56.8 bits (137), Expect = 2e-10
Identities = 22/123 (17%), Positives = 36/123 (29%), Gaps = 20/123 (16%)
Query: 27 DTITPETFIRDGEKLVSSSQRFELGFFSPRNSKNRYLGVWYKKIPDTVVWVANRNSPIFN 86
+ + + L + + L + N V Y+ +W +N +
Sbjct: 3 NVLLSGQTLHADHSLQAG--AYTLTIQNKCNL------VKYQN--GRQIWASNTDRR--G 50
Query: 87 PNTALTFSNNGNLVLLSQRNGIIWSSNMSRKAENPIAQLLDTGNLVIRDNSSGHTTESYL 146
LT ++GNLV+ N +W S L G VI L
Sbjct: 51 SGCRLTLLSDGNLVIYDHNNNDVWGSACWGDNGKYALVLQKDGRFVIYGPV--------L 102
Query: 147 WQS 149
W
Sbjct: 103 WSL 105
|
| >3n9x_A Phosphotransferase; malaria kinase, structural genomics, structural genomics CON SGC; 2.05A {Plasmodium berghei} PDB: 3nie_A* Length = 432 | Back alignment and structure |
|---|
Score = 60.1 bits (146), Expect = 6e-10
Identities = 19/69 (27%), Positives = 33/69 (47%), Gaps = 3/69 (4%)
Query: 274 GLLYLHQYSRLRVIHRDLKASNILLDKDMNPKISDFGMARMFGGDELQSNTKRIVGTYGY 333
G ++H +IHRDLK +N LL++D + K+ DFG+AR ++ + +
Sbjct: 141 GENFIH--ES-GIIHRDLKPANCLLNQDCSVKVCDFGLARTINSEKDTNIVNDLEENEEP 197
Query: 334 MSPEYALRG 342
L+
Sbjct: 198 GPHNKNLKK 206
|
| >2b9h_A MAP kinase FUS3, mitogen-activated protein kinase FUS3; transferase; HET: ADP; 1.55A {Saccharomyces cerevisiae} PDB: 2b9i_A* 2b9j_A* 2f49_A 2fa2_A 2b9f_A* 2f9g_A* Length = 353 | Back alignment and structure |
|---|
Score = 59.6 bits (145), Expect = 6e-10
Identities = 23/65 (35%), Positives = 36/65 (55%), Gaps = 6/65 (9%)
Query: 274 GLLYLHQYSRLRVIHRDLKASNILLDKDMNPKISDFGMARMFGGDELQSNTKRIVGTYGY 333
+ LH + VIHRDLK SN+L++ + + K+ DFG+AR+ DE ++ G
Sbjct: 124 AVKVLHGSN---VIHRDLKPSNLLINSNCDLKVCDFGLARII--DESAADNSEPTGQQSG 178
Query: 334 MSPEY 338
M E+
Sbjct: 179 MV-EF 182
|
| >3pg1_A Mitogen-activated protein kinase, putative (MAP K protein); EPK Ser/Thr protein kinase fold, Ser/Thr protein kinase, TRA; 1.95A {Leishmania major} Length = 362 | Back alignment and structure |
|---|
Score = 59.6 bits (145), Expect = 6e-10
Identities = 30/95 (31%), Positives = 46/95 (48%), Gaps = 7/95 (7%)
Query: 271 IAQGLLYLHQYSRLRVIHRDLKASNILLDKDMNPKISDFGMARMFGGDELQSNTKRIVGT 330
I GL LH+ V+HRDL NILL + + I DF +AR D +++ V
Sbjct: 143 ILLGLHVLHEAG---VVHRDLHPGNILLADNNDITICDFNLAREDTADANKTHY---VTH 196
Query: 331 YGYMSPEYAL-RGLFSIKSDVFSFGVLLLETLSSK 364
Y +PE + F+ D++S G ++ E + K
Sbjct: 197 RWYRAPELVMQFKGFTKLVDMWSAGCVMAEMFNRK 231
|
| >3qyz_A Mitogen-activated protein kinase 1; transferase, serine/threonine-protein kinase, ATP-binding CE phosphorylation; HET: CME Z8B SO4; 1.46A {Rattus norvegicus} PDB: 2fys_B 1erk_A* 3qyi_A* 3erk_A* 3qyw_A* 4erk_A* 2z7l_A* 2erk_A* 1gol_A* 2gph_A 3o71_A 3r63_A 3c9w_A* 2y9q_A* 3sa0_A* 1wzy_A* 2e14_A* 1tvo_A* 2ojg_A* 2oji_A* ... Length = 364 | Back alignment and structure |
|---|
Score = 58.8 bits (143), Expect = 1e-09
Identities = 37/94 (39%), Positives = 54/94 (57%), Gaps = 7/94 (7%)
Query: 274 GLLYLHQYSRLRVIHRDLKASNILLDKDMNPKISDFGMARMFGGDELQSN--TKRIVGTY 331
GL Y+H S V+HRDLK SN+LL+ + KI DFG+AR+ D + T+ V T
Sbjct: 140 GLKYIH--SA-NVLHRDLKPSNLLLNTTCDLKICDFGLARVADPDHDHTGFLTEY-VATR 195
Query: 332 GYMSPEYAL-RGLFSIKSDVFSFGVLLLETLSSK 364
Y +PE L ++ D++S G +L E LS++
Sbjct: 196 WYRAPEIMLNSKGYTKSIDIWSVGCILAEMLSNR 229
|
| >3oz6_A Mitogen-activated protein kinase 1, serine/threon protein kinase; structural genomics consortium, SGC, transferase; 2.37A {Cryptosporidium parvum iowa II} Length = 388 | Back alignment and structure |
|---|
Score = 58.9 bits (143), Expect = 1e-09
Identities = 20/64 (31%), Positives = 35/64 (54%), Gaps = 3/64 (4%)
Query: 274 GLLYLHQYSRLRVIHRDLKASNILLDKDMNPKISDFGMARMFGGDELQSNTKRIVGTYGY 333
+ YLH S ++HRD+K SNILL+ + + K++DFG++R F +N +
Sbjct: 121 VIKYLH--SG-GLLHRDMKPSNILLNAECHVKVADFGLSRSFVNIRRVTNNIPLSINENT 177
Query: 334 MSPE 337
+ +
Sbjct: 178 ENFD 181
|
| >3nsz_A CK II alpha, casein kinase II subunit alpha; inhibitor, transferase-transferase inhibitor CO; HET: ANP; 1.30A {Homo sapiens} PDB: 2r7i_A 3pe1_A* 1jwh_A* 3pe2_A* 3r0t_A* 3h30_A* 3q9w_A* 3q9x_A* 3q9y_A* 3q9z_A* 3qa0_A 3bqc_A* 2rkp_A* 3c13_A* 3fwq_A 3rps_A* 3mb7_A* 3mb6_A* 3owj_A* 3owk_A* ... Length = 330 | Back alignment and structure |
|---|
Score = 58.0 bits (141), Expect = 2e-09
Identities = 25/103 (24%), Positives = 45/103 (43%), Gaps = 24/103 (23%)
Query: 273 QGLLYLHQYSRLRVIHRDLKASNILLD-KDMNPKISDFGMARMFGGDELQSNTKRIVGTY 331
+ L Y H S ++HRD+K N+++D + ++ D+G+A Q R+ Y
Sbjct: 141 KALDYCH--SM-GIMHRDVKPHNVMIDHEHRKLRLIDWGLAE--FYHPGQEYNVRVASRY 195
Query: 332 GYMSPE---------YALRGLFSIKSDVFSFGVLLLETLSSKK 365
+ PE Y+L D++S G +L + K+
Sbjct: 196 -FKGPELLVDYQMYDYSL--------DMWSLGCMLASMIFRKE 229
|
| >3coi_A Mitogen-activated protein kinase 13; P38D, P38delta, ERK, MAP kinase, PMK, STK26, stress-activated protein kinase, structural genomics, PSI; 2.09A {Homo sapiens} Length = 353 | Back alignment and structure |
|---|
Score = 58.1 bits (141), Expect = 2e-09
Identities = 31/95 (32%), Positives = 49/95 (51%), Gaps = 9/95 (9%)
Query: 271 IAQGLLYLHQYSRLRVIHRDLKASNILLDKDMNPKISDFGMARMFGGDELQSNTKRIVGT 330
+ +GL Y+H V+HRDLK N+ +++D KI DFG+AR + V T
Sbjct: 135 MLKGLKYIHSAG---VVHRDLKPGNLAVNEDCELKILDFGLARHADAEMTGY-----VVT 186
Query: 331 YGYMSPEYAL-RGLFSIKSDVFSFGVLLLETLSSK 364
Y +PE L ++ D++S G ++ E L+ K
Sbjct: 187 RWYRAPEVILSWMHYNQTVDIWSVGCIMAEMLTGK 221
|
| >1b2p_A Protein (lectin); mannose-binding lectin, monocot, aglutinin, bluebell bulbs, carbohydrate interactions, sugar binding protein; 1.70A {Hyacinthoides hispanica} SCOP: b.78.1.1 Length = 119 | Back alignment and structure |
|---|
Score = 54.1 bits (130), Expect = 2e-09
Identities = 18/85 (21%), Positives = 33/85 (38%), Gaps = 12/85 (14%)
Query: 65 VWYKKIPDTVVWVANRNSPIFNPNTALTFSNNGNLVLLSQRNGIIWSSNMSRKAENPIAQ 124
V Y + +W N +G LV+++ N +W S ++ KA + +
Sbjct: 43 VLYDN--NNPIWATNTGGL--GNGCRAVLQPDGVLVVITNENVTVWQSPVAGKAGHYVLV 98
Query: 125 LLDTGNLVIRDNSSGHTTESYLWQS 149
L N+VI ++ LW +
Sbjct: 99 LQPDRNVVIYGDA--------LWAT 115
|
| >1b2p_A Protein (lectin); mannose-binding lectin, monocot, aglutinin, bluebell bulbs, carbohydrate interactions, sugar binding protein; 1.70A {Hyacinthoides hispanica} SCOP: b.78.1.1 Length = 119 | Back alignment and structure |
|---|
Score = 48.4 bits (115), Expect = 3e-07
Identities = 18/88 (20%), Positives = 27/88 (30%), Gaps = 6/88 (6%)
Query: 62 YLGVWYKKIPDTVVWVANRNSPIFNPNTALTFSNNGNLVLLSQRNGIIWSSNMSRKAENP 121
+ P + + + NLV L N IW++N
Sbjct: 5 FSKQPDDNHPQILHATESLEILFGTHVYRFIMQTDCNLV-LYDNNNPIWATNTGGLGNGC 63
Query: 122 IAQLLDTGNLVIRDNSSGHTTESYLWQS 149
A L G LV+ N + +WQS
Sbjct: 64 RAVLQPDGVLVVITNEN-----VTVWQS 86
|
| >2fst_X Mitogen-activated protein kinase 14; active mutants, lipids, MAP kinase insertion, autophosphorylation, transferase; HET: BOG; 1.45A {Homo sapiens} PDB: 2fso_X* 2fsl_X* 2fsm_X* 2npq_A* 2bal_A* 2baj_A* 2bak_A* 2baq_A* 2qd9_A* 1ian_A* 2rg5_A* 2rg6_A* 3bv2_A* 3bv3_A* 3bx5_A* 3c5u_A* 3cg2_A* 3l8x_A* 3mvl_A* 3mvm_A* ... Length = 367 | Back alignment and structure |
|---|
Score = 58.1 bits (141), Expect = 2e-09
Identities = 32/95 (33%), Positives = 50/95 (52%), Gaps = 9/95 (9%)
Query: 271 IAQGLLYLHQYSRLRVIHRDLKASNILLDKDMNPKISDFGMARMFGGDELQSNTKRIVGT 330
I +GL Y+H +IHRDLK SN+ +++D KI DFG+AR + V T
Sbjct: 141 ILRGLKYIHSAD---IIHRDLKPSNLAVNEDCELKILDFGLARHTADEMTGY-----VAT 192
Query: 331 YGYMSPEYAL-RGLFSIKSDVFSFGVLLLETLSSK 364
Y +PE L ++ D++S G ++ E L+ +
Sbjct: 193 RWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGR 227
|
| >1cm8_A Phosphorylated MAP kinase P38-gamma; phosphorylation, transferase; HET: TPO PTR ANP; 2.40A {Homo sapiens} SCOP: d.144.1.7 Length = 367 | Back alignment and structure |
|---|
Score = 57.7 bits (140), Expect = 3e-09
Identities = 31/95 (32%), Positives = 49/95 (51%), Gaps = 9/95 (9%)
Query: 271 IAQGLLYLHQYSRLRVIHRDLKASNILLDKDMNPKISDFGMARMFGGDELQSNTKRIVGT 330
+ +GL Y+H +IHRDLK N+ +++D KI DFG+AR S V T
Sbjct: 137 MLKGLRYIHAAG---IIHRDLKPGNLAVNEDCELKILDFGLARQA-----DSEMTGYVVT 188
Query: 331 YGYMSPEYAL-RGLFSIKSDVFSFGVLLLETLSSK 364
Y +PE L ++ D++S G ++ E ++ K
Sbjct: 189 RWYRAPEVILNWMRYTQTVDIWSVGCIMAEMITGK 223
|
| >2i6l_A Mitogen-activated protein kinase 6; MAPK6, ERK3, extracellular signal regulated kinase 3, serine phosphorylation, threonine phosphorylation; 2.25A {Homo sapiens} Length = 320 | Back alignment and structure |
|---|
Score = 56.5 bits (137), Expect = 6e-09
Identities = 30/95 (31%), Positives = 51/95 (53%), Gaps = 8/95 (8%)
Query: 274 GLLYLHQYSRLRVIHRDLKASNILLD-KDMNPKISDFGMARMFGGDELQSN--TKRIVGT 330
GL Y+H + V+HRDLK +N+ ++ +D+ KI DFG+AR+ ++ +V T
Sbjct: 132 GLKYIHSAN---VLHRDLKPANLFINTEDLVLKIGDFGLARIMDPHYSHKGHLSEGLV-T 187
Query: 331 YGYMSPEYALRGL-FSIKSDVFSFGVLLLETLSSK 364
Y SP L ++ D+++ G + E L+ K
Sbjct: 188 KWYRSPRLLLSPNNYTKAIDMWAAGCIFAEMLTGK 222
|
| >3mez_B Mannose-specific lectin 3 chain 2; heterotetramer, sugar binding protein; 1.94A {Crocus vernus} Length = 113 | Back alignment and structure |
|---|
Score = 52.5 bits (126), Expect = 8e-09
Identities = 17/117 (14%), Positives = 40/117 (34%), Gaps = 10/117 (8%)
Query: 25 AADTITPETFIRDGEKLVSSSQRFELGFFSPRNSKNRYLGVWYKKIPDTVVWVANRNSPI 84
+ + + D +L +++ + L N V K +VW + +
Sbjct: 5 VRNVLFSSQVMYDNAQL--ATRDYSLVMRDDCNL------VLTKGSKTNIVWESGTSGR- 55
Query: 85 FNPNTALTFSNNGNLVLLSQRNGIIWSSNMSRKAENPIAQLLDTGNLVIRDNSSGHT 141
+ + ++G L + R ++ SN + + + L G V+ + T
Sbjct: 56 -GQHCFMRLGHSGELDITDDRLNTVFVSNTVGQEGDYVLILQINGQAVVYGPAVWST 111
|
| >1q8y_A SR protein kinase; transferase; HET: ADP ADE; 2.05A {Saccharomyces cerevisiae} SCOP: d.144.1.7 PDB: 1q8z_A 1q97_A* 1q99_A* 1how_A 2jd5_A Length = 373 | Back alignment and structure |
|---|
Score = 55.9 bits (135), Expect = 1e-08
Identities = 28/100 (28%), Positives = 48/100 (48%), Gaps = 13/100 (13%)
Query: 266 RIIEGIAQGLLYLHQYSRLRVIHRDLKASNILLDKDMNP------KISDFGMARMFGGDE 319
+I + + GL Y+H R +IH D+K N+L++ +P KI+D G A + +
Sbjct: 135 QISKQLLLGLDYMH--RRCGIIHTDIKPENVLMEIVDSPENLIQIKIADLGNA-CWYDEH 191
Query: 320 LQSNTKRIVGTYGYMSPEYALRGLFSIKSDVFSFGVLLLE 359
+ + T Y SPE L + +D++S L+ E
Sbjct: 192 YTN----SIQTREYRSPEVLLGAPWGCGADIWSTACLIFE 227
|
| >3r0e_B Lectin; carbohydrate binding, carbohydrate, sugar binding protein; 2.40A {Remusatia vivipara} Length = 110 | Back alignment and structure |
|---|
Score = 50.6 bits (121), Expect = 4e-08
Identities = 21/110 (19%), Positives = 36/110 (32%), Gaps = 13/110 (11%)
Query: 24 LAADTITPETFIRDGEKLVSSSQRFELGFFSPRNSKNRYLGVWYKKIPDTVVWVANRNSP 83
+ + + +L + + +L N V Y W +N +
Sbjct: 4 FTNNLLFSGQVLYGDGRLTA--KNHQLVMQGDCNL------VLYG---GKYGWQSNTHGN 52
Query: 84 IFNPNTALTFSNNGNLVLLSQRNGIIWSSNMSRKAENPIAQLLDTGNLVI 133
+ L ++ G L++ IWSS S K + L D G VI
Sbjct: 53 --GEHCFLRLNHKGELIIKDDDFKTIWSSRSSSKQGEYVLILQDDGFGVI 100
|
| >3r0e_B Lectin; carbohydrate binding, carbohydrate, sugar binding protein; 2.40A {Remusatia vivipara} Length = 110 | Back alignment and structure |
|---|
Score = 47.9 bits (114), Expect = 3e-07
Identities = 17/71 (23%), Positives = 27/71 (38%), Gaps = 7/71 (9%)
Query: 79 NRNSPIFNPNTALTFSNNGNLVLLSQRNGIIWSSNMSRKAENPIAQLLDTGNLVIRDNSS 138
+ + N L + NLVL + W SN E+ +L G L+I+D+
Sbjct: 16 YGDGRLTAKNHQLVMQGDCNLVLYGGK--YGWQSNTHGNGEHCFLRLNHKGELIIKDDDF 73
Query: 139 GHTTESYLWQS 149
+W S
Sbjct: 74 -----KTIWSS 79
|
| >3uqc_A Probable conserved transmembrane protein; structural genomics, TB structural genomics consortium, TBSG fold, FHAA, transferase; 2.26A {Mycobacterium tuberculosis} PDB: 3oun_B* 3otv_A 3ouk_A Length = 286 | Back alignment and structure |
|---|
Score = 53.6 bits (129), Expect = 4e-08
Identities = 23/186 (12%), Positives = 45/186 (24%), Gaps = 42/186 (22%)
Query: 265 VRIIEGIAQGLLYLHQYSRLRVIHRDLKASNILLDKDMNPKISDFGMARMFGGDELQSNT 324
+R ++ +A H R V S + + D + ++
Sbjct: 132 IRAMQSLAAAADAAH---RAGVALSIDHPSRVRVSIDGDVVLAYPA-------------- 174
Query: 325 KRIVGTYGYMSPEYALRGLFSIKSDVFSFGVLLLETLSSKKNTHFYNTDSLTLLGHAWNL 384
M + + D+ G L L ++ + L A
Sbjct: 175 --------TMPDA-------NPQDDIRGIGASLYALLVNR--WPLPEAGVRSGLAPAER- 216
Query: 385 WNDGRTWELMDPISQNGASYPILKRYINVALLCVQEKAADRPAMSEVVSMLSNEFVNLPA 444
T + P VA VQ R A S +++++
Sbjct: 217 ----DTAGQPIEPADIDRDIPFQIS--AVAARSVQGDGGIRSA-STLLNLMQQATAVADR 269
Query: 445 PQQPAF 450
+
Sbjct: 270 TEVLGP 275
|
| >3m2w_A MAP kinase-activated protein kinase 2; small molecule inhibitor, spiroazetidine-tetracycle, ATP-SIT inhibitor, novartis compound NVP-BXS169; HET: L8I; 2.41A {Homo sapiens} PDB: 3kga_A* 3m42_A* Length = 299 | Back alignment and structure |
|---|
Score = 52.7 bits (127), Expect = 9e-08
Identities = 16/50 (32%), Positives = 27/50 (54%), Gaps = 6/50 (12%)
Query: 266 RIIEGIAQGLLYLHQYSRLRVIHRDLKASNILL---DKDMNPKISDFGMA 312
I++ I + + YLH + + HRD+K N+L + K++DFG A
Sbjct: 121 EIMKSIGEAIQYLHS---INIAHRDVKPENLLYTSKRPNAILKLTDFGFA 167
|
| >3r0e_A Lectin; carbohydrate binding, carbohydrate, sugar binding protein; 2.40A {Remusatia vivipara} Length = 109 | Back alignment and structure |
|---|
Score = 48.7 bits (116), Expect = 1e-07
Identities = 21/126 (16%), Positives = 38/126 (30%), Gaps = 23/126 (18%)
Query: 24 LAADTITPETFIRDGEKLVSSSQRFELGFFSPRNSKNRYLGVWYKKIPDTVVWVANRNSP 83
L + + + L + F+L N V Y + R+
Sbjct: 1 LGTNYLLSGQTLDTEGHL--KNGDFDLVMQDDCNL------VLYNGNWQSNTANNGRDC- 51
Query: 84 IFNPNTALTFSNNGNLVLLSQRNGIIWSSNMSRKAENPIAQLLDTGNLVIRDNSSGHTTE 143
LT ++ G LV+ + +W S N A + G LV+ S
Sbjct: 52 ------KLTLTDYGELVIKNGDGSTVWKSGAQSVKGNYAAVVHPDGRLVVFGPS------ 99
Query: 144 SYLWQS 149
+++
Sbjct: 100 --VFKI 103
|
| >2vx3_A Dual specificity tyrosine-phosphorylation- regula kinase 1A; serine/threonine-protein kinase, minibrain homolog, nucleotide-binding, transferase; HET: PTR D15 P6G; 2.40A {Homo sapiens} PDB: 2wo6_A* 3anq_A* 3anr_A* Length = 382 | Back alignment and structure |
|---|
Score = 50.9 bits (122), Expect = 5e-07
Identities = 29/91 (31%), Positives = 42/91 (46%), Gaps = 8/91 (8%)
Query: 271 IAQGLLYLHQYSRLRVIHRDLKASNILLDKDMNP--KISDFGMARMFGGDELQSNTKRIV 328
+ LL+L L +IH DLK NILL KI DFG + G + +
Sbjct: 166 MCTALLFLAT-PELSIIHCDLKPENILLCNPKRSAIKIVDFGSS-CQLGQRIYQ----YI 219
Query: 329 GTYGYMSPEYALRGLFSIKSDVFSFGVLLLE 359
+ Y SPE L + + D++S G +L+E
Sbjct: 220 QSRFYRSPEVLLGMPYDLAIDMWSLGCILVE 250
|
| >1dlp_A Lectin scafet precursor; two-domain lectin, beta prism II fold, native, sugar binding protein; 3.30A {Hyacinthoides hispanica} SCOP: b.78.1.1 b.78.1.1 Length = 236 | Back alignment and structure |
|---|
Score = 47.6 bits (112), Expect = 3e-06
Identities = 18/78 (23%), Positives = 29/78 (37%), Gaps = 8/78 (10%)
Query: 72 DTVVWVANRNSPIFNPNTALTFSNNGNLVLLSQRNGIIWSSNMSRKAENPIAQLLDTGNL 131
D V + N+ NG + +L+ +N +W+S SR A + L NL
Sbjct: 166 DRDDRVWSTNTAGKGTGCRAVLQPNGRMDVLTNQNIAVWTSGNSRSAGRYVFVLQPDRNL 225
Query: 132 VIRDNSSGHTTESYLWQS 149
I + LW +
Sbjct: 226 AIYGGA--------LWTT 235
|
| >1dlp_A Lectin scafet precursor; two-domain lectin, beta prism II fold, native, sugar binding protein; 3.30A {Hyacinthoides hispanica} SCOP: b.78.1.1 b.78.1.1 Length = 236 | Back alignment and structure |
|---|
Score = 42.2 bits (98), Expect = 2e-04
Identities = 27/153 (17%), Positives = 44/153 (28%), Gaps = 13/153 (8%)
Query: 65 VWYKKIPDTVVWVANRNSPIFNPNTALTFSNNGNLVLLSQRNGIIWSSNMSRKAENPIAQ 124
V + D VW +N ++G LV+L+ +N I WSS N +
Sbjct: 39 VLFDS--DVRVWASNTAGA---TGCRAVLQSDGLLVILTAQNTIRWSSGTKGSIGNYVLV 93
Query: 125 LLDTGNLVIRDNSSGHTTESYLWQSFDYPTDSLLEGMKLGWDLKNGLERYLSSWESTDDP 184
L + I LW S S++ L +
Sbjct: 94 LQPDRTVTIYG--------PGLWDSGTSNKGSVVVANNGNSILYSTQGNDNHPQTLHATQ 145
Query: 185 SPGNFTFRLVIQVIPKLCAYNGSVEYTCTGPWN 217
S +RL ++ L ++ T
Sbjct: 146 SLQLSPYRLSMETDCNLVLFDRDDRVWSTNTAG 178
|
| >3kvw_A DYRK2, dual specificity tyrosine-phosphorylation-regulat 2; KI-(Y)-phosphorylation REG kinase 2, PSK-H2, kinase, structural genomics consortium; HET: SEP PTR IRB; 2.28A {Homo sapiens} PDB: 3k2l_A* Length = 429 | Back alignment and structure |
|---|
Score = 47.8 bits (114), Expect = 5e-06
Identities = 28/91 (30%), Positives = 44/91 (48%), Gaps = 10/91 (10%)
Query: 271 IAQGLLYLHQYSRLRVIHRDLKASNILLDKDMNP--KISDFGMARMFGGDELQSNTKRIV 328
I Q L LH + R+IH DLK NILL + K+ DFG + + + + +
Sbjct: 209 ILQCLDALH---KNRIIHCDLKPENILLKQQGRSGIKVIDFGSS-CYEHQRVYT----YI 260
Query: 329 GTYGYMSPEYALRGLFSIKSDVFSFGVLLLE 359
+ Y +PE L + + D++S G +L E
Sbjct: 261 QSRFYRAPEVILGARYGMPIDMWSLGCILAE 291
|
| >1wak_A Serine/threonine-protein kinase SPRK1; SRPK, transferase, alternative splicing, ATP-binding, chromosome partition, differentiation, mRNA processing; 1.73A {Homo sapiens} PDB: 1wbp_A* 3beg_A* 2x7g_A* Length = 397 | Back alignment and structure |
|---|
Score = 47.6 bits (113), Expect = 5e-06
Identities = 31/140 (22%), Positives = 51/140 (36%), Gaps = 13/140 (9%)
Query: 266 RIIEGIAQGLLYLHQYSRLRVIHRDLKASNILLDKDMNPKISDFGMARMFGGDELQSNTK 325
+II+ + QGL YLH ++ R+IH D+K NILL + A + +
Sbjct: 150 KIIQQVLQGLDYLH--TKCRIIHTDIKPENILLSVNEQYIRRLAAEATEWQRSGAPPPSG 207
Query: 326 RIVGTYGYMSPEYALRGLFSIKSDVFS--FGVLLLETLSSKKNTHFYNTDSL----TLLG 379
V T + + + L ++ L K T T L+G
Sbjct: 208 SAVSTAPATAGNFLVNPLEPKNAEKLKVKIADLGNACWVHKHFTEDIQTRQYRSLEVLIG 267
Query: 380 HAWN----LWNDG-RTWELM 394
+N +W+ +EL
Sbjct: 268 SGYNTPADIWSTACMAFELA 287
|
| >3m7h_A Putidacin L1; monocot mannose-binding lectin, bacteriocin, LLPA, pseudomon bacterial toxin, siras, antimicrobial protein; 2.20A {Pseudomonas SP} PDB: 3m7j_A* Length = 276 | Back alignment and structure |
|---|
Score = 46.2 bits (108), Expect = 9e-06
Identities = 17/82 (20%), Positives = 29/82 (35%), Gaps = 11/82 (13%)
Query: 72 DTVVWVANRNSPIFNPNTALTFSNNGNLVLLSQRNGIIWSSNMSRKAENPIAQLLDTGNL 131
W A F +GNLV+ N ++W S+ A + + +L G++
Sbjct: 183 GAATWNAGTQG---KGAVRAVFQGDGNLVVYGAGNAVLWHSHTGGHA-SAVLRLQANGSI 238
Query: 132 VIRDNSSGHTTESYLWQSFDYP 153
I D +W F +
Sbjct: 239 AILDEKP-------VWARFGFQ 253
|
| >3m7h_A Putidacin L1; monocot mannose-binding lectin, bacteriocin, LLPA, pseudomon bacterial toxin, siras, antimicrobial protein; 2.20A {Pseudomonas SP} PDB: 3m7j_A* Length = 276 | Back alignment and structure |
|---|
Score = 40.4 bits (93), Expect = 7e-04
Identities = 42/221 (19%), Positives = 61/221 (27%), Gaps = 29/221 (13%)
Query: 23 SLAADTITPETFIRDGEKLVSSSQRFELGFFSPRNSKNRYLGVWYKKIPDTVVWVANRNS 82
+ + + G+ L+S +QRF+L N V VWVAN
Sbjct: 11 GVGTSVLPAYQTLSAGQYLLSPNQRFKLLLQGDGNL------VIQD--NGATVWVANEQQ 62
Query: 83 PIF------NPNTALTFSNNGNLVLLSQRNGIIWSSNMSRKAENPIAQLLDTGNLVIRDN 136
P N L F L +W ++ S N Q T ++ D
Sbjct: 63 PFSSTIPLRNKKAPLAFYVQYGAFLDDYSRRRVWLTDNSTFTSN--DQWNRTHLVLQDDG 120
Query: 137 SSGHTTESYLWQSFDYPTDSLLEGMKLGWDLKNGLERYLSSWESTDDPSPGNFTFRLVIQ 196
+ LW L + L + + G +LV Q
Sbjct: 121 NIVLVDSLALWNGTPAIPLVPGAIDSLLLAPGSELVQGVVY---------GAGASKLVFQ 171
Query: 197 VIPKLCAYNGSVEYTCTGPWNGVAFGAAPTYTSFLYEQVLV 237
L AY + WN G F + LV
Sbjct: 172 GDGNLVAYGPNG----AATWNAGTQGKGAVRAVFQGDGNLV 208
|
| >3mez_A Mannose-specific lectin 3 chain 1; heterotetramer, sugar binding protein; 1.94A {Crocus vernus} Length = 111 | Back alignment and structure |
|---|
Score = 42.5 bits (100), Expect = 2e-05
Identities = 12/54 (22%), Positives = 21/54 (38%), Gaps = 2/54 (3%)
Query: 86 NPNTALTFSNNGNLVLLSQRNGIIWSSNMSRKAENPIAQLLDTGNLVIRDNSSG 139
+ A + NLVL + + SN + + +L + G L I +S
Sbjct: 19 YESAAFVMQGDCNLVLYN--EAGGFQSNTHGRGVDCTLRLNNRGQLEIHSANSN 70
|
| >2vuw_A Serine/threonine-protein kinase haspin; cell cycle, transferase, CAsp8, nucleotide binding; HET: MSE 5ID MPD; 1.80A {Homo sapiens} PDB: 3f2n_A* 3e7v_A* 3dlz_A* 3fmd_A* 3iq7_A* 2wb8_A Length = 336 | Back alignment and structure |
|---|
Score = 45.3 bits (106), Expect = 3e-05
Identities = 14/56 (25%), Positives = 19/56 (33%), Gaps = 2/56 (3%)
Query: 261 WGTRVRIIEGIAQGLLYLHQYSRLRVIHRDLKASNILLDKDMNPKISDFGMARMFG 316
T I+ + L LR HRDL N+LL K K+ +
Sbjct: 160 LATAKSILHQLTASLAVAEA--SLRFEHRDLHWGNVLLKKTSLKKLHYTLNGKSST 213
|
| >2v62_A Serine/threonine-protein kinase VRK2; transferase, ATP-binding, membrane, nucleotide-binding, TRAN; 1.7A {Homo sapiens} Length = 345 | Back alignment and structure |
|---|
Score = 42.0 bits (99), Expect = 2e-04
Identities = 15/66 (22%), Positives = 32/66 (48%), Gaps = 10/66 (15%)
Query: 277 YLHQYSRLRVIHRDLKASNILLDKDMNPKI--SDFGMARMFGGDEL-----QSNTKRIVG 329
Y+H+ +H D+KA+N+LL ++ +D+G++ + + ++ K G
Sbjct: 166 YIHENE---YVHGDIKAANLLLGYKNPDQVYLADYGLSYRYCPNGNHKQYQENPRKGHNG 222
Query: 330 TYGYMS 335
T + S
Sbjct: 223 TIEFTS 228
|
| >2eu9_A Dual specificity protein kinase CLK3; kinase domain, transferase; 1.53A {Homo sapiens} PDB: 2wu6_A* 2wu7_A* 3raw_A* 2exe_A 3nr9_A* Length = 355 | Back alignment and structure |
|---|
Score = 41.9 bits (99), Expect = 3e-04
Identities = 29/109 (26%), Positives = 42/109 (38%), Gaps = 29/109 (26%)
Query: 271 IAQGLLYLHQYSRLRVIHRDLKASNILLDKDMNP-------------------KISDFGM 311
+ L +LH ++ H DLK NIL +++DFG
Sbjct: 132 LCHALRFLH---ENQLTHTDLKPENILFVNSEFETLYNEHKSCEEKSVKNTSIRVADFGS 188
Query: 312 ARMFGGDELQSNTKRIVGTYGYMSPEYALRGL-FSIKSDVFSFGVLLLE 359
A F + + IV T Y PE L L ++ DV+S G +L E
Sbjct: 189 A-TFDHEHHTT----IVATRHYRPPEVIL-ELGWAQPCDVWSIGCILFE 231
|
| >3op5_A Serine/threonine-protein kinase VRK1; adenosine triphosphate, amino acid sequence, binding sites, domain, models, molecular; HET: REB; 2.40A {Homo sapiens} PDB: 2lav_A 2kty_A 2kul_A Length = 364 | Back alignment and structure |
|---|
Score = 41.7 bits (98), Expect = 3e-04
Identities = 16/66 (24%), Positives = 32/66 (48%), Gaps = 10/66 (15%)
Query: 277 YLHQYSRLRVIHRDLKASNILLDKDMNPKI--SDFGMARMFGGDEL-----QSNTKRIVG 329
Y+H++ +H D+KASN+LL+ ++ D+G+A + + + + G
Sbjct: 167 YIHEHE---YVHGDIKASNLLLNYKNPDQVYLVDYGLAYRYCPEGVHKAYAADPKRCHDG 223
Query: 330 TYGYMS 335
T + S
Sbjct: 224 TIEFTS 229
|
| >1vt4_I APAF-1 related killer DARK; drosophila apoptosome, apoptosis, programmed cell death; HET: DTP; 6.90A {Drosophila melanogaster} PDB: 3iz8_A* Length = 1221 | Back alignment and structure |
|---|
Score = 41.8 bits (97), Expect = 5e-04
Identities = 48/338 (14%), Positives = 86/338 (25%), Gaps = 122/338 (36%)
Query: 166 DLKNGLERYLSSWESTDD----PSPGNFTFRLVIQVIPKLCAYNGSVEYTCTGPWNGVAF 221
D+++ + LS E D + T RL L + + V
Sbjct: 37 DVQDMPKSILSK-EEIDHIIMSKDAVSGTLRLFW----TLLSKQEEMVQKF------VEE 85
Query: 222 GAAPTYTSFLYEQVLVQSKDE--ISFWYESYNNPTKKGLLCWGTRVRIIEGIAQGLLYLH 279
Y FL + + + ++ Y + + + +
Sbjct: 86 VLRINY-KFLMSPIKTEQRQPSMMTRMYIEQRDRL------YNDNQVFAK---------Y 129
Query: 280 QYSRLRVIHRDLKASNILLDKDMNPKISDFGMARMFGGDELQSNTKRIVGTYGYMSPEYA 339
SRL+ + L+ LL+ + G+ G G
Sbjct: 130 NVSRLQPYLK-LR--QALLELRPAKNVLIDGV----LG----------SG---------- 162
Query: 340 LRGLFSIKSDVFSFGVLLLETLSSKK-NTHFYNTDSLTLLGHAW-NLWNDGRTWELMDP- 396
K+ + L+ S K W NL N +++
Sbjct: 163 -------KT------WVALDVCLSYKVQCKMDF-------KIFWLNLKNCNSPETVLEML 202
Query: 397 ------ISQNGASYPILKRYINVALLCVQEKAADRPAMSE-------VVSMLSNEFVNLP 443
I N S N+ L +A R + +V L N
Sbjct: 203 QKLLYQIDPNWTSRS--DHSSNIKLRIHSIQAELRRLLKSKPYENCLLV--LLN------ 252
Query: 444 APQQPAFSCVNSTNMQSDAFSVNC---VT---HSVIDA 475
V + +AF+++C +T V D
Sbjct: 253 ---------VQNAKA-WNAFNLSCKILLTTRFKQVTDF 280
|
| >2jii_A Serine/threonine-protein kinase VRK3 molecule: VA related kinase 3; transferase, pseudo kinase domain, vaccinia related kinase, ATP-binding; 2.00A {Homo sapiens} Length = 352 | Back alignment and structure |
|---|
Score = 40.5 bits (95), Expect = 8e-04
Identities = 13/66 (19%), Positives = 27/66 (40%), Gaps = 10/66 (15%)
Query: 277 YLHQYSRLRVIHRDLKASNILLDKDMNPKI--SDFGMARMF---GGDELQSNTKR--IVG 329
+LH+ +H ++ A NI +D + ++ + +G A + G R G
Sbjct: 174 FLHENE---YVHGNVTAENIFVDPEDQSQVTLAGYGFAFRYCPSGKHVAYVEGSRSPHEG 230
Query: 330 TYGYMS 335
++S
Sbjct: 231 DLEFIS 236
|
Structure Templates Detected by HHsearch
Original result of HHsearch against PDB70 database
| ID | Alignment Graph | Length |
Definition |
Probability |
| Query | 476 | |||
| 3m7h_A | 276 | Putidacin L1; monocot mannose-binding lectin, bact | 100.0 | |
| 3omv_A | 307 | RAF proto-oncogene serine/threonine-protein kinas; | 100.0 | |
| 1dlp_A | 236 | Lectin scafet precursor; two-domain lectin, beta p | 100.0 | |
| 4asz_A | 299 | BDNF/NT-3 growth factors receptor; transferase, TR | 100.0 | |
| 4aoj_A | 329 | High affinity nerve growth factor receptor; transf | 100.0 | |
| 4gt4_A | 308 | Tyrosine-protein kinase transmembrane receptor RO; | 100.0 | |
| 4ase_A | 353 | Vascular endothelial growth factor receptor 2; tra | 100.0 | |
| 4g3f_A | 336 | NF-kappa-beta-inducing kinase; non-RD kinase, prot | 100.0 | |
| 3hmm_A | 303 | TGF-beta receptor type-1; ALK5, kinase, inhibitor, | 100.0 | |
| 4fih_A | 346 | Serine/threonine-protein kinase PAK 4; kinase doma | 100.0 | |
| 3fpq_A | 290 | Serine/threonine-protein kinase WNK1; protein seri | 100.0 | |
| 4b9d_A | 350 | Serine/threonine-protein kinase NEK1; transferase, | 100.0 | |
| 4aw0_A | 311 | HPDK1, 3-phosphoinositide-dependent protein kinase | 100.0 | |
| 4fie_A | 423 | Serine/threonine-protein kinase PAK 4; kinase doma | 100.0 | |
| 3ubd_A | 304 | Ribosomal protein S6 kinase alpha-3; kinase-inhibi | 99.98 | |
| 3hyh_A | 275 | Carbon catabolite-derepressing protein kinase; kin | 99.98 | |
| 4g31_A | 299 | Eukaryotic translation initiation factor 2-alpha; | 99.97 | |
| 2qkw_B | 321 | Protein kinase; three-helix bundle motif, AVRPTO-P | 99.97 | |
| 3uim_A | 326 | Brassinosteroid insensitive 1-associated receptor; | 99.97 | |
| 4b99_A | 398 | Mitogen-activated protein kinase 7; transferase, i | 99.97 | |
| 4f9c_A | 361 | Cell division cycle 7-related protein kinase; Ser/ | 99.97 | |
| 3v5w_A | 689 | G-protein coupled receptor kinase 2; inhibitor com | 99.96 | |
| 3poz_A | 327 | Epidermal growth factor receptor; kinase domain, a | 99.96 | |
| 3soc_A | 322 | Activin receptor type-2A; structural genomics cons | 99.96 | |
| 3lb7_A | 307 | RAF proto-oncogene serine/threonine-protein kinas; | 99.96 | |
| 3q4u_A | 301 | Activin receptor type-1; structural genomics conso | 99.96 | |
| 3p86_A | 309 | Serine/threonine-protein kinase CTR1; ETR1, ERS1, | 99.96 | |
| 1csn_A | 298 | Casein kinase-1; phosphotransferase; HET: ATP; 2.0 | 99.96 | |
| 2nru_A | 307 | Interleukin-1 receptor-associated kinase 4; inhibi | 99.96 | |
| 2psq_A | 370 | Fibroblast growth factor receptor 2; kinase domain | 99.96 | |
| 3uto_A | 573 | Twitchin; kinase, muscle sarcomere, transferase; H | 99.96 | |
| 3op5_A | 364 | Serine/threonine-protein kinase VRK1; adenosine tr | 99.95 | |
| 3s95_A | 310 | LIMK-1, LIM domain kinase 1; structural genomics, | 99.95 | |
| 3kex_A | 325 | Receptor tyrosine-protein kinase ERBB-3; kinase do | 99.95 | |
| 3og7_A | 289 | AKAP9-BRAF fusion protein; proto-oncogene, V600E, | 99.95 | |
| 3uzp_A | 296 | CKI-delta, CKID, casein kinase I isoform delta; CK | 99.95 | |
| 4hgt_A | 296 | Casein kinase I isoform delta; CK1D, inhibitor, tr | 99.95 | |
| 3lxp_A | 318 | Non-receptor tyrosine-protein kinase TYK2; JAK3, i | 99.95 | |
| 1rjb_A | 344 | FL cytokine receptor; kinase, structure, autoinhib | 99.95 | |
| 3kul_A | 325 | Ephrin type-A receptor 8; ATP-binding, kinase, nuc | 99.95 | |
| 3cbl_A | 377 | C-FES, proto-oncogene tyrosine-protein kinase FES/ | 99.95 | |
| 3vhe_A | 359 | Vascular endothelial growth factor receptor 2; kin | 99.95 | |
| 3tt0_A | 382 | Basic fibroblast growth factor receptor 1; kinase | 99.95 | |
| 3qup_A | 323 | Tyrosine-protein kinase receptor TYRO3; protein ki | 99.95 | |
| 3g2f_A | 336 | Bone morphogenetic protein receptor type-2; kinase | 99.95 | |
| 3brb_A | 313 | Proto-oncogene tyrosine-protein kinase MER; ATP-bi | 99.95 | |
| 3gxj_A | 303 | TGF-beta receptor type-1; ALK5, kinase, inhibitor, | 99.95 | |
| 3fxz_A | 297 | Serine/threonine-protein kinase PAK 1; transferase | 99.95 | |
| 3lzb_A | 327 | Epidermal growth factor receptor; epidermal growth | 99.95 | |
| 3mdy_A | 337 | Bone morphogenetic protein receptor type-1B; compl | 99.95 | |
| 3tki_A | 323 | Serine/threonine-protein kinase CHK1; cell checkpo | 99.95 | |
| 2eva_A | 307 | TAK1 kinase - TAB1 chimera fusion protein; transfe | 99.95 | |
| 3ugc_A | 295 | Tyrosine-protein kinase JAK2; small molecule inhib | 99.95 | |
| 1fmk_A | 452 | C-SRC, P60-SRC, tyrosine-protein kinase SRC; tyros | 99.95 | |
| 2jii_A | 352 | Serine/threonine-protein kinase VRK3 molecule: VA | 99.95 | |
| 2v62_A | 345 | Serine/threonine-protein kinase VRK2; transferase, | 99.95 | |
| 1t46_A | 313 | HOMO sapiens V-KIT hardy-zuckerman 4 feline sarcom | 99.95 | |
| 2ivs_A | 314 | Proto-oncogene tyrosine-protein kinase receptor RE | 99.95 | |
| 2izr_A | 330 | Casein kinase I isoform gamma-3; serine/threonine- | 99.95 | |
| 3dtc_A | 271 | Mitogen-activated protein kinase kinase kinase 9; | 99.95 | |
| 1qpc_A | 279 | LCK kinase; alpha beta fold, transferase; HET: PTR | 99.95 | |
| 3l9p_A | 367 | Anaplastic lymphoma kinase; kinase domain, ATP-bin | 99.95 | |
| 4eqm_A | 294 | Protein kinase; transferase; HET: ANP; 3.00A {Stap | 99.95 | |
| 1mp8_A | 281 | Focal adhesion kinase 1; tyrosine protein kinase, | 99.95 | |
| 1opk_A | 495 | P150, C-ABL, proto-oncogene tyrosine-protein kinas | 99.95 | |
| 3lxl_A | 327 | Tyrosine-protein kinase JAK3; TYK2, inflammation, | 99.95 | |
| 2qol_A | 373 | Ephrin receptor; receptor tyrosine kinase, juxtame | 99.95 | |
| 3g33_A | 308 | Cell division protein kinase 4; Ser/Thr protein ki | 99.95 | |
| 4hcu_A | 269 | Tyrosine-protein kinase ITK/TSK; transferase-trans | 99.95 | |
| 1qcf_A | 454 | Haematopoetic cell kinase (HCK); tyrosine kinase-i | 99.95 | |
| 3o0g_A | 292 | Cell division protein kinase 5; kinase activator c | 99.95 | |
| 3sxs_A | 268 | Cytoplasmic tyrosine-protein kinase BMX; transfera | 99.95 | |
| 1luf_A | 343 | Muscle-specific tyrosine kinase receptor MUSK; pho | 99.95 | |
| 3f66_A | 298 | Hepatocyte growth factor receptor; C-Met, protein | 99.95 | |
| 3niz_A | 311 | Rhodanese family protein; structural genomics, str | 99.95 | |
| 2i1m_A | 333 | Macrophage colony-stimulating factor 1 receptor; k | 99.94 | |
| 4e5w_A | 302 | Tyrosine-protein kinase JAK1; kinase domain, trans | 99.94 | |
| 4f0f_A | 287 | Serine/threonine-protein kinase ROCO4; LRRK2, ATP- | 99.94 | |
| 2zv2_A | 298 | Calcium/calmodulin-dependent protein kinase kinas; | 99.94 | |
| 3c1x_A | 373 | Hepatocyte growth factor receptor; receptor tyrosi | 99.94 | |
| 3dbq_A | 343 | Dual specificity protein kinase TTK; MPS1 structur | 99.94 | |
| 2xir_A | 316 | Vascular endothelial growth factor receptor 2; ang | 99.94 | |
| 3q60_A | 371 | ROP5B; pseudokinase, transferase; HET: ATP; 1.72A | 99.94 | |
| 3pls_A | 298 | Macrophage-stimulating protein receptor; protein k | 99.94 | |
| 1u59_A | 287 | Tyrosine-protein kinase ZAP-70; transferase; HET: | 99.94 | |
| 3e7e_A | 365 | HBUB1, BUB1A, mitotic checkpoint serine/threonine- | 99.94 | |
| 1b6c_B | 342 | TGF-B superfamily receptor type I; complex (isomer | 99.94 | |
| 3sv0_A | 483 | Casein kinase I-like; typical kinase domain fold, | 99.94 | |
| 4euu_A | 319 | Serine/threonine-protein kinase TBK1; ATP binding, | 99.94 | |
| 1nxk_A | 400 | MAP kinase-activated protein kinase 2; MK2, phosph | 99.94 | |
| 1k9a_A | 450 | Carboxyl-terminal SRC kinase; COOH-terminal SRC ki | 99.94 | |
| 2c30_A | 321 | Serine/threonine-protein kinase PAK 6; CRIB domain | 99.94 | |
| 3kfa_A | 288 | Tyrosine-protein kinase ABL1; CML, drug resistance | 99.94 | |
| 3ll6_A | 337 | Cyclin G-associated kinase; transferase, protein k | 99.94 | |
| 2pmi_A | 317 | Negative RE, cyclin-dependent protein kinase PHO85 | 99.94 | |
| 3gen_A | 283 | Tyrosine-protein kinase BTK; bruton'S tyrosine kin | 99.94 | |
| 1ob3_A | 288 | PFPK5, cell division control protein 2 homolog; tr | 99.94 | |
| 1p4o_A | 322 | Insulin-like growth factor I receptor protein; IGF | 99.94 | |
| 3cc6_A | 281 | Protein tyrosine kinase 2 beta; focal adhesion kin | 99.94 | |
| 3p1a_A | 311 | MYT1 kinase, membrane-associated tyrosine- and thr | 99.94 | |
| 2zmd_A | 390 | Dual specificity protein kinase TTK; MPS1, T686A, | 99.94 | |
| 2pvf_A | 334 | Fibroblast growth factor receptor 2; kinase domain | 99.94 | |
| 3zgw_A | 347 | Maternal embryonic leucine zipper kinase; transfer | 99.94 | |
| 2wqm_A | 310 | Serine/threonine-protein kinase NEK7; ATP-binding, | 99.94 | |
| 3fe3_A | 328 | MAP/microtubule affinity-regulating kinase 3; seri | 99.94 | |
| 3oz6_A | 388 | Mitogen-activated protein kinase 1, serine/threon | 99.94 | |
| 2y4i_B | 319 | KSR2, HKSR2, kinase suppressor of RAS 2; transfera | 99.94 | |
| 2h8h_A | 535 | Proto-oncogene tyrosine-protein kinase SRC; SRC ki | 99.94 | |
| 2a19_B | 284 | Interferon-induced, double-stranded RNA-activated | 99.94 | |
| 1tki_A | 321 | Titin; serine kinase, muscle, autoinhibition; 2.00 | 99.94 | |
| 3ork_A | 311 | Serine/threonine protein kinase; structural genomi | 99.94 | |
| 1wak_A | 397 | Serine/threonine-protein kinase SPRK1; SRPK, trans | 99.94 | |
| 3byv_A | 377 | Rhoptry kinase; malaria, transferase, structural g | 99.94 | |
| 3mtl_A | 324 | Cell division protein kinase 16; pctaire1, indirub | 99.94 | |
| 2yex_A | 276 | Serine/threonine-protein kinase CHK1; transferase, | 99.94 | |
| 3mi9_A | 351 | Cell division protein kinase 9; P-TEFB, HIV-1, pro | 99.94 | |
| 1o6l_A | 337 | RAC-beta serine/threonine protein kinase; protein | 99.94 | |
| 3fme_A | 290 | Dual specificity mitogen-activated protein kinase; | 99.94 | |
| 2y0a_A | 326 | Death-associated protein kinase 1; transferase, ca | 99.94 | |
| 2ozo_A | 613 | Tyrosine-protein kinase ZAP-70; inactive ZAP-70, t | 99.94 | |
| 3ttj_A | 464 | Mitogen-activated protein kinase 10; JNK3, protein | 99.94 | |
| 3soa_A | 444 | Calcium/calmodulin-dependent protein kinase type a | 99.94 | |
| 1xbb_A | 291 | Tyrosine-protein kinase SYK; gleevec, STI-571, ima | 99.94 | |
| 3txo_A | 353 | PKC-L, NPKC-ETA, protein kinase C ETA type; phosph | 99.94 | |
| 3kmu_A | 271 | ILK, integrin-linked kinase; cell adhesion, ANK re | 99.94 | |
| 1mqb_A | 333 | Ephrin type-A receptor 2; tyrosine protein kinase, | 99.94 | |
| 2buj_A | 317 | Serine/threonine-protein kinase 16; transferase, A | 99.94 | |
| 3t9t_A | 267 | Tyrosine-protein kinase ITK/TSK; kinase domain, al | 99.94 | |
| 3lm5_A | 327 | Serine/threonine-protein kinase 17B; STK17B, serin | 99.94 | |
| 3h4j_B | 336 | AMPK kdaid, SNF1-like protein kinase SSP2; ATP-bin | 99.94 | |
| 2bdw_A | 362 | Hypothetical protein K11E8.1D; kinase, calmodulin | 99.94 | |
| 4dc2_A | 396 | Protein kinase C IOTA type; kinase, substrate, cel | 99.94 | |
| 4e7w_A | 394 | Glycogen synthase kinase 3; GSK3, PTyr195, transfe | 99.94 | |
| 3llt_A | 360 | Serine/threonine kinase-1, pflammer; lammer kinase | 99.94 | |
| 2yab_A | 361 | Death-associated protein kinase 2; apoptosis, tran | 99.94 | |
| 1fvr_A | 327 | Tyrosine-protein kinase TIE-2; tyrosine kinase, tr | 99.94 | |
| 1byg_A | 278 | CSK, protein (C-terminal SRC kinase); protein kina | 99.94 | |
| 1kob_A | 387 | Twitchin; kinase, intrasteric regulation; 2.30A {A | 99.94 | |
| 1ua2_A | 346 | CAK, cell division protein kinase 7; cell cycle, p | 99.94 | |
| 2w4o_A | 349 | Calcium/calmodulin-dependent protein kinase type I | 99.94 | |
| 3gni_B | 389 | Strad alpha; kinase fold, pseudokinase, alpha heli | 99.94 | |
| 1j1b_A | 420 | Glycogen synthase kinase-3 beta; complex, TAU, AMP | 99.94 | |
| 3c0i_A | 351 | Peripheral plasma membrane protein CASK; neurexin, | 99.94 | |
| 2qr7_A | 342 | Ribosomal protein S6 kinase alpha-3; kinase domain | 99.94 | |
| 4fvq_A | 289 | Tyrosine-protein kinase JAK2; janus protein kinase | 99.93 | |
| 3kn6_A | 325 | Ribosomal protein S6 kinase alpha-5; AMP-PNP, MSK1 | 99.93 | |
| 4fl3_A | 635 | Tyrosine-protein kinase SYK; transferase; HET: ANP | 99.93 | |
| 3dls_A | 335 | PAS domain-containing serine/threonine-protein KI; | 99.93 | |
| 2i0e_A | 353 | Protein kinase C-beta II; serine/threonine protein | 99.93 | |
| 3cok_A | 278 | Serine/threonine-protein kinase PLK4; POLO-like ki | 99.93 | |
| 1vzo_A | 355 | Ribosomal protein S6 kinase alpha 5; protein kinas | 99.93 | |
| 3kvw_A | 429 | DYRK2, dual specificity tyrosine-phosphorylation-r | 99.93 | |
| 1xjd_A | 345 | Protein kinase C, theta type; PKC-theta, ATP, AMP, | 99.93 | |
| 4agu_A | 311 | Cyclin-dependent kinase-like 1; transferase, phosp | 99.93 | |
| 4eut_A | 396 | Serine/threonine-protein kinase TBK1; ATP binding, | 99.93 | |
| 1u46_A | 291 | ACK-1, activated CDC42 kinase 1; tyrosine kinase, | 99.93 | |
| 2h34_A | 309 | Serine/threonine-protein kinase PKNE; apoenzyme, t | 99.93 | |
| 3qd2_B | 332 | Eukaryotic translation initiation factor 2-alpha; | 99.93 | |
| 2x4f_A | 373 | Myosin light chain kinase family member 4; LUNG, b | 99.93 | |
| 2eue_A | 275 | Carbon catabolite derepressing protein kinase; kin | 99.93 | |
| 3a8x_A | 345 | Protein kinase C IOTA type; transferase; HET: TPO; | 99.93 | |
| 2yfx_A | 327 | Tyrosine-protein kinase receptor; nucleotide-bindi | 99.93 | |
| 2vx3_A | 382 | Dual specificity tyrosine-phosphorylation- regula | 99.93 | |
| 4fr4_A | 384 | YANK1, serine/threonine-protein kinase 32A; struct | 99.93 | |
| 1z57_A | 339 | Dual specificity protein kinase CLK1; protein tyro | 99.93 | |
| 3rp9_A | 458 | Mitogen-activated protein kinase; structural genom | 99.93 | |
| 2eu9_A | 355 | Dual specificity protein kinase CLK3; kinase domai | 99.93 | |
| 2w1i_A | 326 | JAK2; chromosomal rearrangement, nucleotide-bindin | 99.93 | |
| 4ejn_A | 446 | RAC-alpha serine/threonine-protein kinase; AKT1, a | 99.93 | |
| 1fot_A | 318 | TPK1 delta, CAMP-dependent protein kinase type 1; | 99.93 | |
| 1u5q_A | 348 | Serine/threonine protein kinase TAO2; transferase; | 99.93 | |
| 3gbz_A | 329 | Kinase, CMGC CDK; ssgcid, ATP-binding, nucleotide- | 99.93 | |
| 2wtk_C | 305 | Serine/threonine-protein kinase 11; transferase-me | 99.93 | |
| 3uc3_A | 361 | Serine/threonine-protein kinase SRK2I; SNRK2, ABA | 99.93 | |
| 1rdq_E | 350 | PKA C-alpha, CAMP-dependent protein kinase, alpha- | 99.93 | |
| 4aw2_A | 437 | Serine/threonine-protein kinase MRCK alpha; transf | 99.93 | |
| 2y94_A | 476 | 5'-AMP-activated protein kinase catalytic subunit; | 99.93 | |
| 3an0_A | 340 | Dual specificity mitogen-activated protein kinase; | 99.93 | |
| 2vwi_A | 303 | Serine/threonine-protein kinase OSR1; STE kinase, | 99.93 | |
| 3fdn_A | 279 | Serine/threonine-protein kinase 6; aurora kinase i | 99.93 | |
| 2r3i_A | 299 | Cell division protein kinase 2; serine/threonine-p | 99.93 | |
| 3rgf_A | 405 | Cyclin-dependent kinase 8; protein kinase complex, | 99.93 | |
| 3nsz_A | 330 | CK II alpha, casein kinase II subunit alpha; inhib | 99.93 | |
| 3v8s_A | 410 | RHO-associated protein kinase 1; dimerization, myo | 99.93 | |
| 3eb0_A | 383 | Putative uncharacterized protein; kinase cryptospo | 99.93 | |
| 2r5t_A | 373 | Serine/threonine-protein kinase SGK1; AGC protein | 99.93 | |
| 3kk8_A | 284 | Calcium/calmodulin dependent protein kinase II; AT | 99.93 | |
| 4aaa_A | 331 | Cyclin-dependent kinase-like 2; transferase, phosp | 99.93 | |
| 3c4z_A | 543 | Rhodopsin kinase; Ser/Thr kinase, RGS homology dom | 99.93 | |
| 3n9x_A | 432 | Phosphotransferase; malaria kinase, structural gen | 99.93 | |
| 3a7i_A | 303 | MST3 kinase, serine/threonine kinase 24 (STE20 hom | 99.93 | |
| 2vgo_A | 284 | Serine/threonine-protein kinase 12-A; nucleotide-b | 99.93 | |
| 2vd5_A | 412 | DMPK protein; serine/threonine-protein kinase, kin | 99.93 | |
| 3hko_A | 345 | Calcium/calmodulin-dependent protein kinase with d | 99.93 | |
| 2a2a_A | 321 | Death-associated protein kinase 2; autoinhibition, | 99.93 | |
| 3e3p_A | 360 | Protein kinase, putative glycogen synthase kinase; | 99.93 | |
| 2acx_A | 576 | G protein-coupled receptor kinase 6; GRK, G transf | 99.93 | |
| 3fhr_A | 336 | MAP kinase-activated protein kinase 3; kinase-inhi | 99.93 | |
| 3cek_A | 313 | Dual specificity protein kinase TTK; HMPS1, PYT, E | 99.93 | |
| 1blx_A | 326 | Cyclin-dependent kinase 6; inhibitor protein, cycl | 99.93 | |
| 2xrw_A | 371 | Mitogen-activated protein kinase 8; transcription, | 99.93 | |
| 2fst_X | 367 | Mitogen-activated protein kinase 14; active mutant | 99.93 | |
| 2ac3_A | 316 | MAP kinase-interacting serine/threonine kinase 2; | 99.93 | |
| 3a62_A | 327 | Ribosomal protein S6 kinase beta-1; kinase domain, | 99.93 | |
| 2clq_A | 295 | Mitogen-activated protein kinase kinase kinase 5; | 99.93 | |
| 3pfq_A | 674 | PKC-B, PKC-beta, protein kinase C beta type; phosp | 99.93 | |
| 1cm8_A | 367 | Phosphorylated MAP kinase P38-gamma; phosphorylati | 99.93 | |
| 3i6u_A | 419 | CDS1, serine/threonine-protein kinase CHK2; Ser/Th | 99.93 | |
| 3f3z_A | 277 | Calcium/calmodulin-dependent protein kinase with d | 99.93 | |
| 1x8b_A | 289 | WEE1HU, WEE1-like protein kinase; cell cycle, tran | 99.93 | |
| 2w5a_A | 279 | Serine/threonine-protein kinase NEK2; Ser/Thr prot | 99.93 | |
| 3is5_A | 285 | Calcium-dependent protein kinase; CDPK, structural | 99.93 | |
| 1q8y_A | 373 | SR protein kinase; transferase; HET: ADP ADE; 2.05 | 99.93 | |
| 3aln_A | 327 | Dual specificity mitogen-activated protein kinase; | 99.93 | |
| 1t4h_A | 290 | Serine/threonine-protein kinase WNK1; protein seri | 99.93 | |
| 2rku_A | 294 | Serine/threonine-protein kinase PLK1; structure of | 99.93 | |
| 3qyz_A | 364 | Mitogen-activated protein kinase 1; transferase, s | 99.92 | |
| 2pml_X | 348 | PFPK7, Ser/Thr protein kinase; phosphorylati trans | 99.92 | |
| 2rio_A | 434 | Serine/threonine-protein kinase/endoribonuclease I | 99.92 | |
| 2y7j_A | 365 | Phosphorylase B kinase gamma catalytic chain, test | 99.92 | |
| 2owb_A | 335 | Serine/threonine-protein kinase PLK1; catalytic do | 99.92 | |
| 3com_A | 314 | Serine/threonine-protein kinase 4; MST1, STE20-lik | 99.92 | |
| 2x7f_A | 326 | TRAF2 and NCK-interacting protein kinase; serine/t | 99.92 | |
| 3dzo_A | 413 | Rhoptry kinase domain; parasitic disease, transfer | 99.92 | |
| 2b9h_A | 353 | MAP kinase FUS3, mitogen-activated protein kinase | 99.92 | |
| 3pg1_A | 362 | Mitogen-activated protein kinase, putative (MAP K | 99.92 | |
| 3bhy_A | 283 | Death-associated protein kinase 3; death associate | 99.92 | |
| 3coi_A | 353 | Mitogen-activated protein kinase 13; P38D, P38delt | 99.92 | |
| 2dyl_A | 318 | Dual specificity mitogen-activated protein kinase | 99.92 | |
| 3eqc_A | 360 | Dual specificity mitogen-activated protein kinase; | 99.92 | |
| 2j0j_A | 656 | Focal adhesion kinase 1; cell migration, FERM, tra | 99.92 | |
| 2ycf_A | 322 | Serine/threonine-protein kinase CHK2; transferase, | 99.92 | |
| 3p23_A | 432 | Serine/threonine-protein kinase/endoribonuclease; | 99.92 | |
| 2jam_A | 304 | Calcium/calmodulin-dependent protein kinase type 1 | 99.92 | |
| 4exu_A | 371 | Mitogen-activated protein kinase 13; P38 kinase, t | 99.92 | |
| 3nyv_A | 484 | Calmodulin-domain protein kinase 1; serine/threoni | 99.92 | |
| 4h3o_A | 105 | Lectin; cadmium, plant protein; 2.17A {Allium sati | 99.92 | |
| 3lij_A | 494 | Calcium/calmodulin dependent protein kinase with A | 99.92 | |
| 1phk_A | 298 | Phosphorylase kinase; glycogen metabolism, transfe | 99.92 | |
| 2h6d_A | 276 | 5'-AMP-activated protein kinase catalytic subunit | 99.92 | |
| 3a99_A | 320 | Proto-oncogene serine/threonine-protein kinase PI; | 99.92 | |
| 3mwu_A | 486 | Calmodulin-domain protein kinase 1; serine/threoni | 99.92 | |
| 2i6l_A | 320 | Mitogen-activated protein kinase 6; MAPK6, ERK3, e | 99.92 | |
| 2j7t_A | 302 | Serine/threonine-protein kinase 10; transferase, A | 99.92 | |
| 1zy4_A | 303 | Serine/threonine-protein kinase GCN2; translation | 99.92 | |
| 3q5i_A | 504 | Protein kinase; CDPK, malaria, phosphotransferase, | 99.91 | |
| 2iwi_A | 312 | Serine/threonine-protein kinase PIM-2; nucleotide- | 99.91 | |
| 2wei_A | 287 | Calmodulin-domain protein kinase 1, putative; nucl | 99.91 | |
| 3a0c_A | 110 | Mannose/sialic acid-binding lectin; beta-prism II, | 99.9 | |
| 1b2p_A | 119 | Protein (lectin); mannose-binding lectin, monocot, | 99.9 | |
| 2pzi_A | 681 | Probable serine/threonine-protein kinase PKNG; ATP | 99.9 | |
| 3qa8_A | 676 | MGC80376 protein; kinase ubiquitin-like domain, ph | 99.89 | |
| 1xd5_A | 112 | Gastrodianin-1, antifungal protein GAFP-1; monocot | 99.88 | |
| 3m2w_A | 299 | MAP kinase-activated protein kinase 2; small molec | 99.88 | |
| 2dpf_A | 115 | Curculin; sweet taste, taste modifying, plant prot | 99.88 | |
| 3dzw_A | 109 | Agglutinin; lectin, mannobiose, mannose-alpha1, 3- | 99.86 | |
| 2vuw_A | 336 | Serine/threonine-protein kinase haspin; cell cycle | 99.86 | |
| 3uqc_A | 286 | Probable conserved transmembrane protein; structur | 99.85 | |
| 3r0e_B | 110 | Lectin; carbohydrate binding, carbohydrate, sugar | 99.83 | |
| 3mez_B | 113 | Mannose-specific lectin 3 chain 2; heterotetramer, | 99.83 | |
| 3r0e_A | 109 | Lectin; carbohydrate binding, carbohydrate, sugar | 99.8 | |
| 4azs_A | 569 | Methyltransferase WBDD; kinase; HET: AMP SAM; 2.15 | 99.77 | |
| 1xd5_A | 112 | Gastrodianin-1, antifungal protein GAFP-1; monocot | 99.75 | |
| 3mez_A | 111 | Mannose-specific lectin 3 chain 1; heterotetramer, | 99.73 | |
| 3a0c_A | 110 | Mannose/sialic acid-binding lectin; beta-prism II, | 99.73 | |
| 1b2p_A | 119 | Protein (lectin); mannose-binding lectin, monocot, | 99.69 | |
| 2dpf_A | 115 | Curculin; sweet taste, taste modifying, plant prot | 99.69 | |
| 3mez_B | 113 | Mannose-specific lectin 3 chain 2; heterotetramer, | 99.51 | |
| 3en9_A | 540 | Glycoprotease, O-sialoglycoprotein endopeptidase/p | 99.49 | |
| 3m7h_A | 276 | Putidacin L1; monocot mannose-binding lectin, bact | 99.46 | |
| 3mez_A | 111 | Mannose-specific lectin 3 chain 1; heterotetramer, | 99.43 | |
| 3dzw_A | 109 | Agglutinin; lectin, mannobiose, mannose-alpha1, 3- | 99.34 | |
| 3r0e_B | 110 | Lectin; carbohydrate binding, carbohydrate, sugar | 99.34 | |
| 1zar_A | 282 | RIO2 kinase; serine kinase, winged-helix, RIO doma | 99.33 | |
| 3r0e_A | 109 | Lectin; carbohydrate binding, carbohydrate, sugar | 99.32 | |
| 4h3o_A | 105 | Lectin; cadmium, plant protein; 2.17A {Allium sati | 99.13 | |
| 1zth_A | 258 | RIO1 serine protein kinase; ribosome biogenesis, r | 98.94 | |
| 1dlp_A | 236 | Lectin scafet precursor; two-domain lectin, beta p | 98.82 | |
| 4gyi_A | 397 | RIO2 kinase; protein kinase, ADP complex, phosphoa | 98.65 | |
| 1nd4_A | 264 | Aminoglycoside 3'-phosphotransferase; protein kina | 97.82 | |
| 3dxp_A | 359 | Putative acyl-COA dehydrogenase; protein kinase-li | 97.68 | |
| 3sg8_A | 304 | APH(2'')-ID; antibiotic resistance enzyme, transfe | 97.68 | |
| 3tm0_A | 263 | Aminoglycoside 3'-phosphotransferase; protein kina | 97.57 | |
| 3r70_A | 320 | Aminoglycoside phosphotransferase; structural geno | 96.82 | |
| 3ats_A | 357 | Putative uncharacterized protein; hypothetical pro | 96.23 | |
| 3tdw_A | 306 | Gentamicin resistance protein; kinase, phosphoryl | 95.98 | |
| 2yle_A | 229 | Protein spire homolog 1; actin-binding protein, ac | 95.81 | |
| 3ovc_A | 362 | Hygromycin-B 4-O-kinase; aminoglycoside phosphotra | 95.08 | |
| 4gkh_A | 272 | Aminoglycoside 3'-phosphotransferase APHA1-IAB; py | 94.57 | |
| 2q83_A | 346 | YTAA protein; 2635576, structural genomics, joint | 94.46 | |
| 2pyw_A | 420 | Uncharacterized protein; 5-methylthioribose kinase | 92.27 | |
| 3dxq_A | 301 | Choline/ethanolamine kinase family protein; NP_106 | 92.04 | |
| 3csv_A | 333 | Aminoglycoside phosphotransferase; YP_614837.1, ph | 90.82 | |
| 1zyl_A | 328 | Hypothetical protein YIHE; putative protein kinase | 89.46 | |
| 2ppq_A | 322 | HSK, HK, homoserine kinase; structural genomics, M | 89.42 | |
| 3no2_A | 276 | Uncharacterized protein; six-bladed beta-propeller | 88.43 | |
| 3i1a_A | 339 | Spectinomycin phosphotransferase; protein kinase, | 85.78 | |
| 2qg7_A | 458 | Ethanolamine kinase PV091845; malaria, SGC, struct | 85.66 | |
| 3c5i_A | 369 | Choline kinase; choline, kinase, malaria, transfer | 85.61 | |
| 3d1u_A | 288 | Putative fructosamine-3-kinase; YP_290396.1, struc | 85.13 | |
| 2olc_A | 397 | MTR kinase, methylthioribose kinase; kinase ADP-2H | 83.95 | |
| 1nw1_A | 429 | Choline kinase (49.2 KD); phospholipid synthesis, | 82.78 | |
| 4ano_A | 219 | ESSB; membrane protein, membrane secretion, ESS ty | 82.38 |
| >3m7h_A Putidacin L1; monocot mannose-binding lectin, bacteriocin, LLPA, pseudomon bacterial toxin, siras, antimicrobial protein; 2.20A {Pseudomonas SP} PDB: 3m7j_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5.6e-40 Score=317.99 Aligned_cols=172 Identities=22% Similarity=0.231 Sum_probs=149.4
Q ss_pred cccccCccCCCCcccCCCEEeeCCCeEEEEeeCCCCCCCeEEEEEEccCC-CceEEeecCCCCCCCC----CceEEEecC
Q 045315 22 LSLAADTITPETFIRDGEKLVSSSQRFELGFFSPRNSKNRYLGVWYKKIP-DTVVWVANRNSPIFNP----NTALTFSNN 96 (476)
Q Consensus 22 ~~~~~~~l~~g~~l~~~~~l~S~~g~f~lgf~~~~~~~~~~~~iw~~~~~-~~~vW~an~~~p~~~~----~~~l~~~~~ 96 (476)
+|++.|+|.+|++|++|++|+|++|.|+||||.++ ++|+ |+ + + +||+|||+.|+.++ +++|+|+.|
T Consensus 10 ~~~~~~~l~~g~~l~~~~~l~S~~g~F~lgf~~~~---~~~l---y~--~~~-vvW~Anr~~p~~~~~~~~~~~l~l~~~ 80 (276)
T 3m7h_A 10 NGVGTSVLPAYQTLSAGQYLLSPNQRFKLLLQGDG---NLVI---QD--NGA-TVWVANEQQPFSSTIPLRNKKAPLAFY 80 (276)
T ss_dssp CCTTSSEECTTEEBCTTCEEECTTSSEEEEECTTS---CEEE---EE--TTE-EEEECSTTSTTEEEEECCCTTCCSEEE
T ss_pred ccccCCEecCCCEecCCCEEEcCCCcEEEEEECCC---CeEE---EC--CCC-eEEECCCCCCcCCcccccceEEEEeCC
Confidence 35678999999999999999999999999999654 5777 76 6 6 99999999999775 789999999
Q ss_pred CceEE--EccCCeEEEeecCCCC-----CCCceeeeccCCCeEEEeCCCCCCcCceeeccccCCCcccccCCcccCCCCC
Q 045315 97 GNLVL--LSQRNGIIWSSNMSRK-----AENPIAQLLDTGNLVIRDNSSGHTTESYLWQSFDYPTDSLLEGMKLGWDLKN 169 (476)
Q Consensus 97 G~lvl--~~~~~~~vWss~~~~~-----~~~~~~~l~d~GNlVl~~~~~~~~~~~~~WqSFd~ptdtll~~~~l~~~~~~ 169 (476)
||||| .|+++.+||+|+++.. ..++.|+|+|+|||||++ +.++||| |||||+|||||+|.+.++
T Consensus 81 G~Lvl~~~~~~~~~vWst~~~~~~~~~~~~~~~a~L~d~GNlVl~~-------~~~lWqS--~ptdtlLpg~~~~~~l~~ 151 (276)
T 3m7h_A 81 VQYGAFLDDYSRRRVWLTDNSTFTSNDQWNRTHLVLQDDGNIVLVD-------SLALWNG--TPAIPLVPGAIDSLLLAP 151 (276)
T ss_dssp ESSSEEEEEGGGTEEEEECCCCCCCTTHHHHEEEEECTTSCEEEEE-------EEEEEES--CTTSCCCCSCTTCEEECS
T ss_pred CcEEEEEeCCCCCEEEEeCCCcccccccCCceEEEEeCCCCEEecC-------CceeeCc--cccccccccccccccccc
Confidence 99999 7788999999997652 235789999999999997 3589999 999999999999999999
Q ss_pred CcceEEEEeCCCCCCCCcccEEEEEecCcceEEEEc-CCcceeecCCCCc
Q 045315 170 GLERYLSSWESTDDPSPGNFTFRLVIQVIPKLCAYN-GSVEYTCTGPWNG 218 (476)
Q Consensus 170 g~~~~l~s~~~~~~~s~g~~~~~~~~~~~~~~~~~~-gs~~y~~sg~wng 218 (476)
|.. | ++.+||++|.|++.|+++|. ++++. ++.+||++|+|+.
T Consensus 152 g~~--L---~S~~dps~G~fsl~l~~dGn--lvLy~~~~~~yW~Sgt~~~ 194 (276)
T 3m7h_A 152 GSE--L---VQGVVYGAGASKLVFQGDGN--LVAYGPNGAATWNAGTQGK 194 (276)
T ss_dssp SEE--E---CTTCEEEETTEEEEECTTSC--EEEECTTSSEEEECCCTTT
T ss_pred Ccc--c---ccCCCCCCceEEEeecCCce--EEEEeCCCeEEEECCCCCC
Confidence 844 6 67899999999999999985 44555 4688999999875
|
| >3omv_A RAF proto-oncogene serine/threonine-protein kinas; serine/threonine-protein kinase, transferase; HET: SM5; 4.00A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-37 Score=307.34 Aligned_cols=191 Identities=25% Similarity=0.367 Sum_probs=141.8
Q ss_pred ccccceeeccCCCC-------CCCCCCChhhHHHHHHHHHHHHHHHhhcCCCceeecCCCccceEecCCCCceeccccce
Q 045315 240 KDEISFWYESYNNP-------TKKGLLCWGTRVRIIEGIAQGLLYLHQYSRLRVIHRDLKASNILLDKDMNPKISDFGMA 312 (476)
Q Consensus 240 ~~~~~l~~Ey~~~~-------~~~~~L~~~~~~~i~~qIa~gL~yLH~~~~~~ivH~DLkp~NILld~~~~~kL~DFGla 312 (476)
.+.++++|||++++ ..+.++++.++++|+.|||+||+|||+++ ||||||||+||||++++.+||+|||+|
T Consensus 103 ~~~~~iVmEy~~gGsL~~~l~~~~~~l~~~~~~~i~~qia~gL~yLH~~~---IiHRDlKp~NILl~~~~~~Ki~DFGla 179 (307)
T 3omv_A 103 KDNLAIVTQWCEGSSLYKHLHVQETKFQMFQLIDIARQTAQGMDYLHAKN---IIHRDMKSNNIFLHEGLTVKIGDFGLA 179 (307)
T ss_dssp SSSCEEEEECCSSCBHHHHHHTSCCCCCHHHHHHHHHHHHHHHHHHHHTT---CBCSCCCSSSEEEETTEEEEECCCSSC
T ss_pred CCeEEEEEEcCCCCCHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHHHCC---ccCCccCHHHEEECCCCcEEEeeccCc
Confidence 35688999999943 24567999999999999999999999998 999999999999999999999999999
Q ss_pred eecCCCcccccceeeeeccCCCChhhhcc---CCCCccceEEeehhhhhhhhhCCCCCCcCCCCchhhhhhhhhhhcCCC
Q 045315 313 RMFGGDELQSNTKRIVGTYGYMSPEYALR---GLFSIKSDVFSFGVLLLETLSSKKNTHFYNTDSLTLLGHAWNLWNDGR 389 (476)
Q Consensus 313 ~~~~~~~~~~~~~~~~gt~~y~aPE~l~~---~~~s~ksDVwSlGvvl~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~ 389 (476)
+...............||+.|||||++.+ ++|+.++|||||||++|||+||+.||....... .+.... ..+.
T Consensus 180 ~~~~~~~~~~~~~~~~GT~~ymAPE~l~~~~~~~y~~ksDVwS~Gvvl~Elltg~~Pf~~~~~~~-~~~~~~----~~~~ 254 (307)
T 3omv_A 180 TVKSRWSGSQQVEQPTGSVLWMAPEVIRMQDNNPFSFQSDVYSYGIVLYELMTGELPYSHINNRD-QIIFMV----GRGY 254 (307)
T ss_dssp BC------------CCCCTTSCCHHHHHCCSSCCCCHHHHHHHHHHHHHHHHHSSCTTTTCCCHH-HHHHHH----HTTC
T ss_pred eecccCCcceeecccccCCCccCHHHhhccCCCCCCcHHHhHhHHHHHHHHHHCCCCCCCCChHH-HHHHHH----hcCC
Confidence 87654333333445679999999999963 468999999999999999999999986543211 111111 1111
Q ss_pred cccccCcccCCCCCHHHHHHHHHHHHHchhhcccCCCCHHHHHHHHhccccCCC
Q 045315 390 TWELMDPISQNGASYPILKRYINVALLCVQEKAADRPAMSEVVSMLSNEFVNLP 443 (476)
Q Consensus 390 ~~~~~d~~~~~~~~~~~~~~l~~li~~Cl~~dP~~RPt~~eVl~~L~~~~~~~~ 443 (476)
. .+.. .......++.+.+++.+||+.||++||||.||++.|+.+...+|
T Consensus 255 ~----~p~~-~~~~~~~~~~l~~li~~cl~~dP~~RPs~~ei~~~Le~l~~~lp 303 (307)
T 3omv_A 255 A----SPDL-SKLYKNCPKAMKRLVADCVKKVKEERPLFPQILSSIELLQHSLP 303 (307)
T ss_dssp C----CCCS-TTSCTTSCHHHHHHHHHHTCSSSTTSCCHHHHHHHHHHHHTTCC
T ss_pred C----CCCc-ccccccchHHHHHHHHHHcCCCHhHCcCHHHHHHHHHHHhccCC
Confidence 1 0110 11122334678899999999999999999999999988754443
|
| >1dlp_A Lectin scafet precursor; two-domain lectin, beta prism II fold, native, sugar binding protein; 3.30A {Hyacinthoides hispanica} SCOP: b.78.1.1 b.78.1.1 | Back alignment and structure |
|---|
Probab=100.00 E-value=5.8e-36 Score=284.70 Aligned_cols=175 Identities=18% Similarity=0.231 Sum_probs=144.6
Q ss_pred cccCccCCCCcccCCCEEeeCCCeEEEEeeCCCCCCCeEEEEEEccCCCceEEeecCCCCCCCCCceEEEecCCceEEEc
Q 045315 24 LAADTITPETFIRDGEKLVSSSQRFELGFFSPRNSKNRYLGVWYKKIPDTVVWVANRNSPIFNPNTALTFSNNGNLVLLS 103 (476)
Q Consensus 24 ~~~~~l~~g~~l~~~~~l~S~~g~f~lgf~~~~~~~~~~~~iw~~~~~~~~vW~an~~~p~~~~~~~l~~~~~G~lvl~~ 103 (476)
++.|+|.+|++|++|++| ++|.|+|||+.+|+. ++|.. +++||+|||+.| ..++|+|+.||||||+|
T Consensus 6 ~~~~~i~~g~~L~~g~~l--~~g~f~l~f~~~gnl------~ly~~--~~~vW~an~~~~---~~~~l~l~~dGnLvl~d 72 (236)
T 1dlp_A 6 GLSHEGSHPQTLHAAQSL--ELSSFRFTMQSDCNL------VLFDS--DVRVWASNTAGA---TGCRAVLQSDGLLVILT 72 (236)
T ss_dssp CSSSSSCSCSCCCTTCEE--CSTTEEEEECTTSCE------EEEES--SSEEECCCCCSC---SCCBCCBCSSSCBCCBC
T ss_pred eccceeCCCCEECCCCEE--EcCCEEEEECCCCcE------EEEEC--CEEEEECCCCCC---CCeEEEEcCCCcEEEEc
Confidence 456999999999999999 499999999988774 23443 799999999988 57899999999999999
Q ss_pred cCCeEEEeecCCCCCCCceeeeccCCCeEEEeCCCCCCcCceeeccccCCCccc-ccCCcccCCC-CCCc-----ceEEE
Q 045315 104 QRNGIIWSSNMSRKAENPIAQLLDTGNLVIRDNSSGHTTESYLWQSFDYPTDSL-LEGMKLGWDL-KNGL-----ERYLS 176 (476)
Q Consensus 104 ~~~~~vWss~~~~~~~~~~~~l~d~GNlVl~~~~~~~~~~~~~WqSFd~ptdtl-l~~~~l~~~~-~~g~-----~~~l~ 176 (476)
++|.+||+|++......+.|+|+|+|||||++ .++||||||||||+ ||+| |.|. .+|+ .++|+
T Consensus 73 ~~~~~vW~s~~~~~~~~~~~~l~d~Gnlvl~~--------~~~W~S~~~p~~t~~lp~~--g~d~L~~gq~~~~~~~~L~ 142 (236)
T 1dlp_A 73 AQNTIRWSSGTKGSIGNYVLVLQPDRTVTIYG--------PGLWDSGTSNKGSVVVANN--GNSILYSTQGNDNHPQTLH 142 (236)
T ss_dssp TTTCCSCCCCCCCCSSCCEEEECSSSCEEEEC--------SEEEECSCCCSSCCCCSSC--CCEECCCC--CCCCCCEEC
T ss_pred CCCcEEEeCCccccCCcEEEEEeCCCCEEEec--------CCEEECCCCCCcccccCCc--cceEEecCCcCCCccceEE
Confidence 99999999998765556789999999999992 38999999999887 6665 5555 5554 46786
Q ss_pred EeCCCCCCCCcccEEEEEecCcceEEEEcCCcceeecCCCCccccccCCcc
Q 045315 177 SWESTDDPSPGNFTFRLVIQVIPKLCAYNGSVEYTCTGPWNGVAFGAAPTY 227 (476)
Q Consensus 177 s~~~~~~~s~g~~~~~~~~~~~~~~~~~~gs~~y~~sg~wng~~f~g~p~~ 227 (476)
+.+||++|.|++.++++| ++++++++.+||++++|++. +.+.+++
T Consensus 143 ---s~~d~s~G~~~l~l~~dG--~LvL~~~~~~~W~s~~~~~~-~~~~~~L 187 (236)
T 1dlp_A 143 ---ATQSLQLSPYRLSMETDC--NLVLFDRDDRVWSTNTAGKG-TGCRAVL 187 (236)
T ss_dssp ---SSCCCBCSSCEEEEETTT--EEEEEBTTBCCSCCCCCSSC-SSCEEEE
T ss_pred ---cCcEeecCcEEEEECCCC--cEEEEcCCEeEEeCCCcCCC-CceEEEE
Confidence 478999999999999998 57778888899999999754 4444444
|
| >4asz_A BDNF/NT-3 growth factors receptor; transferase, TRKA, TRKB; 1.70A {Homo sapiens} PDB: 4at3_A* 4at4_A* 4at5_A* 3v5q_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.5e-37 Score=303.18 Aligned_cols=183 Identities=23% Similarity=0.336 Sum_probs=146.0
Q ss_pred cccceeeccCCCC-------------------CCCCCCChhhHHHHHHHHHHHHHHHhhcCCCceeecCCCccceEecCC
Q 045315 241 DEISFWYESYNNP-------------------TKKGLLCWGTRVRIIEGIAQGLLYLHQYSRLRVIHRDLKASNILLDKD 301 (476)
Q Consensus 241 ~~~~l~~Ey~~~~-------------------~~~~~L~~~~~~~i~~qIa~gL~yLH~~~~~~ivH~DLkp~NILld~~ 301 (476)
+.++++|||++.+ .....|+|.++++|+.|||+||+|||+++ ||||||||+|||++++
T Consensus 88 ~~~~lV~Ey~~~G~L~~~l~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qia~gl~yLH~~~---iiHRDlKp~NILl~~~ 164 (299)
T 4asz_A 88 DPLIMVFEYMKHGDLNKFLRAHGPDAVLMAEGNPPTELTQSQMLHIAQQIAAGMVYLASQH---FVHRDLATRNCLVGEN 164 (299)
T ss_dssp SSEEEEEECCTTCBHHHHHHHTSHHHHHC----CCCCCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCSGGGEEECGG
T ss_pred CEEEEEEEcCCCCcHHHHHHhcCcccccccccCCCCCCCHHHHHHHHHHHHHHHHHHHhCC---cccCccCHhhEEECCC
Confidence 4688999999833 22457999999999999999999999998 9999999999999999
Q ss_pred CCceeccccceeecCCCcccccceeeeeccCCCChhhhccCCCCccceEEeehhhhhhhhh-CCCCCCcCCCCchhhhhh
Q 045315 302 MNPKISDFGMARMFGGDELQSNTKRIVGTYGYMSPEYALRGLFSIKSDVFSFGVLLLETLS-SKKNTHFYNTDSLTLLGH 380 (476)
Q Consensus 302 ~~~kL~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~s~ksDVwSlGvvl~ellt-G~~p~~~~~~~~~~~~~~ 380 (476)
+.+||+|||+|+...............||+.|||||.+.+..|+.++|||||||++|||+| |+.||..... ..+..
T Consensus 165 ~~~Ki~DFGla~~~~~~~~~~~~~~~~gt~~ymAPE~~~~~~~~~k~DVwS~Gvvl~Ellt~G~~Pf~~~~~--~~~~~- 241 (299)
T 4asz_A 165 LLVKIGDFGMSRDVYSTDYYRVGGHTMLPIRWMPPESIMYRKFTTESDVWSLGVVLWEIFTYGKQPWYQLSN--NEVIE- 241 (299)
T ss_dssp GCEEECCCSCHHHHTGGGCEEETTTEEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCTTTTSCH--HHHHH-
T ss_pred CcEEECCcccceecCCCCceeecCceecChhhcCHHHHcCCCCCchhhHHHHHHHHHHHHcCCCCCCCCCCH--HHHHH-
Confidence 9999999999987654433333344679999999999999999999999999999999998 8999865431 12221
Q ss_pred hhhhhcCCCcccccCcccCCCCCHHHHHHHHHHHHHchhhcccCCCCHHHHHHHHhccccC
Q 045315 381 AWNLWNDGRTWELMDPISQNGASYPILKRYINVALLCVQEKAADRPAMSEVVSMLSNEFVN 441 (476)
Q Consensus 381 ~~~~~~~~~~~~~~d~~~~~~~~~~~~~~l~~li~~Cl~~dP~~RPt~~eVl~~L~~~~~~ 441 (476)
....+.... .+...++.+.+++.+||+.||++|||++||++.|+++...
T Consensus 242 ---~i~~~~~~~---------~p~~~~~~~~~li~~cl~~dP~~RPs~~~i~~~L~~~~~~ 290 (299)
T 4asz_A 242 ---CITQGRVLQ---------RPRTCPQEVYELMLGCWQREPHMRKNIKGIHTLLQNLAKA 290 (299)
T ss_dssp ---HHHHTCCCC---------CCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHH
T ss_pred ---HHHcCCCCC---------CCccchHHHHHHHHHHcCCChhHCcCHHHHHHHHHHHHhc
Confidence 112222111 1122345788999999999999999999999999987643
|
| >4aoj_A High affinity nerve growth factor receptor; transferase, inhibitor; HET: V4Z; 2.75A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=7.1e-37 Score=304.97 Aligned_cols=182 Identities=25% Similarity=0.354 Sum_probs=136.4
Q ss_pred cccceeeccCCCCC---------------------CCCCCChhhHHHHHHHHHHHHHHHhhcCCCceeecCCCccceEec
Q 045315 241 DEISFWYESYNNPT---------------------KKGLLCWGTRVRIIEGIAQGLLYLHQYSRLRVIHRDLKASNILLD 299 (476)
Q Consensus 241 ~~~~l~~Ey~~~~~---------------------~~~~L~~~~~~~i~~qIa~gL~yLH~~~~~~ivH~DLkp~NILld 299 (476)
+.++++|||++.+. ...+|+|.++++|+.|||+||+|||+++ ||||||||+||||+
T Consensus 116 ~~~~lV~Ey~~~G~L~~~l~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qia~gl~yLH~~~---iiHRDLKp~NILl~ 192 (329)
T 4aoj_A 116 RPLLMVFEYMRHGDLNRFLRSHGPDAKLLAGGEDVAPGPLGLGQLLAVASQVAAGMVYLAGLH---FVHRDLATRNCLVG 192 (329)
T ss_dssp SSEEEEEECCTTCBHHHHHHTSSCC-----------CCSCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEEE
T ss_pred CEEEEEEEcCCCCcHHHHHHhcCcccccccccccccCCCCCHHHHHHHHHHHHHHHHHHhcCC---eecccccHhhEEEC
Confidence 46889999998321 2357999999999999999999999998 99999999999999
Q ss_pred CCCCceeccccceeecCCCcccccceeeeeccCCCChhhhccCCCCccceEEeehhhhhhhhh-CCCCCCcCCCCchhhh
Q 045315 300 KDMNPKISDFGMARMFGGDELQSNTKRIVGTYGYMSPEYALRGLFSIKSDVFSFGVLLLETLS-SKKNTHFYNTDSLTLL 378 (476)
Q Consensus 300 ~~~~~kL~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~s~ksDVwSlGvvl~ellt-G~~p~~~~~~~~~~~~ 378 (476)
+++.+||+|||+++...............||+.|||||++.+..++.++|||||||++|||+| |+.||..... ..+.
T Consensus 193 ~~~~~Ki~DFGla~~~~~~~~~~~~~~~~gt~~ymAPE~~~~~~~~~~sDvwS~Gvvl~Ellt~G~~Pf~~~~~--~~~~ 270 (329)
T 4aoj_A 193 QGLVVKIGDFGMSRDIYSTDYYRVGGRTMLPIRWMPPESILYRKFTTESDVWSFGVVLWEIFTYGKQPWYQLSN--TEAI 270 (329)
T ss_dssp TTTEEEECCCC----------------CCCCGGGCCHHHHTTCCCCHHHHHHHHHHHHHHHHTTSCCTTCSSCH--HHHH
T ss_pred CCCcEEEcccccceeccCCCcceecCcccccccccChhhhcCCCCCccccccchHHHHHHHHcCCCCCCCCCCH--HHHH
Confidence 999999999999987654443333445679999999999999999999999999999999998 8999865431 1122
Q ss_pred hhhhhhhcCCCcccccCcccCCCCCHHHHHHHHHHHHHchhhcccCCCCHHHHHHHHhcccc
Q 045315 379 GHAWNLWNDGRTWELMDPISQNGASYPILKRYINVALLCVQEKAADRPAMSEVVSMLSNEFV 440 (476)
Q Consensus 379 ~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~l~~li~~Cl~~dP~~RPt~~eVl~~L~~~~~ 440 (476)
.. ...+.... .+....+.+.+++.+||+.||++||||+||++.|+.+..
T Consensus 271 ~~----i~~g~~~~---------~p~~~~~~~~~li~~cl~~dP~~RPs~~ei~~~L~~l~~ 319 (329)
T 4aoj_A 271 DC----ITQGRELE---------RPRACPPEVYAIMRGCWQREPQQRHSIKDVHARLQALAQ 319 (329)
T ss_dssp HH----HHHTCCCC---------CCTTCCHHHHHHHHHHCCSSTTTSCCHHHHHHHHHHHHH
T ss_pred HH----HHcCCCCC---------CcccccHHHHHHHHHHcCcChhHCcCHHHHHHHHHHHhh
Confidence 11 11221111 112234578899999999999999999999999999763
|
| >4gt4_A Tyrosine-protein kinase transmembrane receptor RO; ATP binding, phosphorylation, transferase; 2.41A {Homo sapiens} PDB: 3zzw_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-36 Score=300.70 Aligned_cols=180 Identities=24% Similarity=0.347 Sum_probs=143.7
Q ss_pred cccceeeccCCCCC----------------------CCCCCChhhHHHHHHHHHHHHHHHhhcCCCceeecCCCccceEe
Q 045315 241 DEISFWYESYNNPT----------------------KKGLLCWGTRVRIIEGIAQGLLYLHQYSRLRVIHRDLKASNILL 298 (476)
Q Consensus 241 ~~~~l~~Ey~~~~~----------------------~~~~L~~~~~~~i~~qIa~gL~yLH~~~~~~ivH~DLkp~NILl 298 (476)
+..+++|||++.++ .+..|+|.++++|+.|||+||+|||+++ ||||||||+||||
T Consensus 102 ~~~~lV~Ey~~~G~L~~~L~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qia~gl~yLH~~~---iiHRDLK~~NILl 178 (308)
T 4gt4_A 102 QPLSMIFSYCSHGDLHEFLVMRSPHSDVGSTDDDRTVKSALEPPDFVHLVAQIAAGMEYLSSHH---VVHKDLATRNVLV 178 (308)
T ss_dssp SSCEEEEECCSSCBHHHHHHTTCSSCCCC-----CCEECCCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCSGGGEEE
T ss_pred CEEEEEEEcCCCCcHHHHHHhhCccccccccccccccccCCCHHHHHHHHHHHHHHHHHHHhCC---CCCCCccccceEE
Confidence 46789999998321 1346999999999999999999999998 9999999999999
Q ss_pred cCCCCceeccccceeecCCCcccccceeeeeccCCCChhhhccCCCCccceEEeehhhhhhhhh-CCCCCCcCCCCchhh
Q 045315 299 DKDMNPKISDFGMARMFGGDELQSNTKRIVGTYGYMSPEYALRGLFSIKSDVFSFGVLLLETLS-SKKNTHFYNTDSLTL 377 (476)
Q Consensus 299 d~~~~~kL~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~s~ksDVwSlGvvl~ellt-G~~p~~~~~~~~~~~ 377 (476)
++++.+||+|||+++...............||+.|||||++.++.|+.++|||||||++|||+| |+.||..... ..+
T Consensus 179 ~~~~~~Ki~DFGlar~~~~~~~~~~~~~~~gt~~ymAPE~l~~~~~s~ksDVwSfGvvl~El~t~g~~Pf~~~~~--~~~ 256 (308)
T 4gt4_A 179 YDKLNVKISDLGLFREVYAADYYKLLGNSLLPIRWMAPEAIMYGKFSIDSDIWSYGVVLWEVFSYGLQPYCGYSN--QDV 256 (308)
T ss_dssp CGGGCEEECCSCCBCGGGGGGCBCSSSSSCBCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCTTTTCCH--HHH
T ss_pred CCCCCEEECCcccceeccCCCceeEecccccCCcccCHHHHhCCCCCccchhhhHHHHHHHHHhCCCCCCCCCCH--HHH
Confidence 9999999999999987654433333444679999999999999999999999999999999998 8889865431 122
Q ss_pred hhhhhhhhcCCCcccccCcccCCCCCHHHHHHHHHHHHHchhhcccCCCCHHHHHHHHhcc
Q 045315 378 LGHAWNLWNDGRTWELMDPISQNGASYPILKRYINVALLCVQEKAADRPAMSEVVSMLSNE 438 (476)
Q Consensus 378 ~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~l~~li~~Cl~~dP~~RPt~~eVl~~L~~~ 438 (476)
.. ....+.... .+...+..+.+++.+||+.||++||||+||++.|+..
T Consensus 257 ~~----~i~~~~~~~---------~p~~~~~~~~~li~~C~~~dP~~RPs~~ei~~~L~a~ 304 (308)
T 4gt4_A 257 VE----MIRNRQVLP---------CPDDCPAWVYALMIECWNEFPSRRPRFKDIHSRLRAW 304 (308)
T ss_dssp HH----HHHTTCCCC---------CCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHTS
T ss_pred HH----HHHcCCCCC---------CcccchHHHHHHHHHHcCCChhHCcCHHHHHHHHHhc
Confidence 21 122222211 1222345788999999999999999999999999874
|
| >4ase_A Vascular endothelial growth factor receptor 2; transferase, angiogenesis, signaling protein, phosphorylatio receptor, inhibitor; HET: AV9; 1.83A {Homo sapiens} PDB: 4agd_A* 4asd_A* 4agc_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=7.1e-36 Score=300.25 Aligned_cols=181 Identities=28% Similarity=0.329 Sum_probs=144.7
Q ss_pred ccceeeccCCCC----------------------CCCCCCChhhHHHHHHHHHHHHHHHhhcCCCceeecCCCccceEec
Q 045315 242 EISFWYESYNNP----------------------TKKGLLCWGTRVRIIEGIAQGLLYLHQYSRLRVIHRDLKASNILLD 299 (476)
Q Consensus 242 ~~~l~~Ey~~~~----------------------~~~~~L~~~~~~~i~~qIa~gL~yLH~~~~~~ivH~DLkp~NILld 299 (476)
.++++|||++.+ ..+..|++.+++.++.|||+||+|||+++ ||||||||+|||++
T Consensus 143 ~~~iV~Ey~~~G~L~~~L~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qia~gl~yLH~~~---iiHRDLK~~NILl~ 219 (353)
T 4ase_A 143 PLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEHLICYSFQVAKGMEFLASRK---CIHRDLAARNILLS 219 (353)
T ss_dssp CCEEEEECCTTEEHHHHHHHTGGGBCCC-------CTTCBCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCSGGGEEEC
T ss_pred EEEEEEEcCCCCCHHHHHHhcccccccccccchhhccccCCHHHHHHHHHHHHHHHHhHhhCC---eecCccCccceeeC
Confidence 478999999821 12456999999999999999999999999 99999999999999
Q ss_pred CCCCceeccccceeecCCCcccccceeeeeccCCCChhhhccCCCCccceEEeehhhhhhhhh-CCCCCCcCCCCchhhh
Q 045315 300 KDMNPKISDFGMARMFGGDELQSNTKRIVGTYGYMSPEYALRGLFSIKSDVFSFGVLLLETLS-SKKNTHFYNTDSLTLL 378 (476)
Q Consensus 300 ~~~~~kL~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~s~ksDVwSlGvvl~ellt-G~~p~~~~~~~~~~~~ 378 (476)
+++.+||+|||+|+.+.............||+.|||||++.+..|+.++|||||||++|||+| |+.||........ +.
T Consensus 220 ~~~~vKi~DFGlar~~~~~~~~~~~~~~~gt~~ymAPE~l~~~~y~~ksDVwS~Gv~l~El~t~G~~Pf~~~~~~~~-~~ 298 (353)
T 4ase_A 220 EKNVVKICDFGLARDIYKDPDYVRKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYPGVKIDEE-FC 298 (353)
T ss_dssp GGGCEEECCCGGGSCTTTCTTSEEETTEEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHTTTSCCSSTTCCCSHH-HH
T ss_pred CCCCEEECcchhhhhcccCCCceeeccccccccccCHHHHhcCCCCCcccEeehHHHHHHHHhCCCCCCCCCCHHHH-HH
Confidence 999999999999997755444334445789999999999999999999999999999999998 8999875443221 11
Q ss_pred hhhhhhhcCCCcccccCcccCCCCCHHHHHHHHHHHHHchhhcccCCCCHHHHHHHHhccc
Q 045315 379 GHAWNLWNDGRTWELMDPISQNGASYPILKRYINVALLCVQEKAADRPAMSEVVSMLSNEF 439 (476)
Q Consensus 379 ~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~l~~li~~Cl~~dP~~RPt~~eVl~~L~~~~ 439 (476)
.....+..... +......+.+++.+||+.||++|||+.||++.|+.+.
T Consensus 299 ----~~i~~g~~~~~---------p~~~~~~~~~li~~c~~~dP~~RPt~~eil~~L~~ll 346 (353)
T 4ase_A 299 ----RRLKEGTRMRA---------PDYTTPEMYQTMLDCWHGEPSQRPTFSELVEHLGNLL 346 (353)
T ss_dssp ----HHHHHTCCCCC---------CTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHH
T ss_pred ----HHHHcCCCCCC---------CccCCHHHHHHHHHHcCcChhHCcCHHHHHHHHHHHH
Confidence 11222221111 1122356889999999999999999999999998865
|
| >4g3f_A NF-kappa-beta-inducing kinase; non-RD kinase, protein serine/threonine kinase, S based drug design, MAP3K14, transferase; HET: 0WB; 1.64A {Mus musculus} PDB: 4g3g_A* 4g3c_A 4dn5_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=9.7e-36 Score=296.38 Aligned_cols=192 Identities=20% Similarity=0.238 Sum_probs=146.5
Q ss_pred cccceeeccCCCCC------CCCCCChhhHHHHHHHHHHHHHHHhhcCCCceeecCCCccceEecCCC-Cceecccccee
Q 045315 241 DEISFWYESYNNPT------KKGLLCWGTRVRIIEGIAQGLLYLHQYSRLRVIHRDLKASNILLDKDM-NPKISDFGMAR 313 (476)
Q Consensus 241 ~~~~l~~Ey~~~~~------~~~~L~~~~~~~i~~qIa~gL~yLH~~~~~~ivH~DLkp~NILld~~~-~~kL~DFGla~ 313 (476)
+.++++|||++.+. +.+.|++.++..++.||+.||+|||+++ ||||||||+||||+.++ .+||+|||+|+
T Consensus 123 ~~~~ivmEy~~gg~L~~~l~~~~~l~e~~~~~~~~qi~~aL~ylH~~~---IiHRDlKp~NILl~~~g~~vKl~DFGla~ 199 (336)
T 4g3f_A 123 PWVNIFMELLEGGSLGQLIKQMGCLPEDRALYYLGQALEGLEYLHTRR---ILHGDVKADNVLLSSDGSRAALCDFGHAL 199 (336)
T ss_dssp TEEEEEECCCTTCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHTTT---EECSCCCGGGEEECTTSCCEEECCCTTCE
T ss_pred CEEEEEEeccCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCC---ceecccCHHHEEEeCCCCEEEEeeCCCCe
Confidence 56889999999542 3567999999999999999999999999 99999999999999987 69999999999
Q ss_pred ecCCCccc---ccceeeeeccCCCChhhhccCCCCccceEEeehhhhhhhhhCCCCCCcCCCCchhhhhhhhhhhcCCCc
Q 045315 314 MFGGDELQ---SNTKRIVGTYGYMSPEYALRGLFSIKSDVFSFGVLLLETLSSKKNTHFYNTDSLTLLGHAWNLWNDGRT 390 (476)
Q Consensus 314 ~~~~~~~~---~~~~~~~gt~~y~aPE~l~~~~~s~ksDVwSlGvvl~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~ 390 (476)
.+...... .......||+.|||||++.+..|+.++|||||||++|||++|+.||........ ... .......
T Consensus 200 ~~~~~~~~~~~~~~~~~~GT~~YmAPE~~~~~~y~~~~DiwSlGvilyemltG~~Pf~~~~~~~~--~~~---i~~~~~~ 274 (336)
T 4g3f_A 200 CLQPDGLGKSLLTGDYIPGTETHMAPEVVMGKPCDAKVDIWSSCCMMLHMLNGCHPWTQYFRGPL--CLK---IASEPPP 274 (336)
T ss_dssp EC------------CCCCCCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSSTTTCCSCC--HHH---HHHSCCG
T ss_pred EccCCCcccceecCCccccCccccCHHHHCCCCCCcHHHHHHHHHHHHHHHHCcCCCCCCCHHHH--HHH---HHcCCCC
Confidence 87543221 122335799999999999999999999999999999999999999975443221 111 1111110
Q ss_pred ccccCcccCCCCCHHHHHHHHHHHHHchhhcccCCCCHHHHHHHHhccccCCCCCCCC
Q 045315 391 WELMDPISQNGASYPILKRYINVALLCVQEKAADRPAMSEVVSMLSNEFVNLPAPQQP 448 (476)
Q Consensus 391 ~~~~d~~~~~~~~~~~~~~l~~li~~Cl~~dP~~RPt~~eVl~~L~~~~~~~~~p~~p 448 (476)
.. ..+......+.+++.+||+.||++|||+.|+++.|.....++..-+.|
T Consensus 275 ~~--------~~~~~~s~~~~~li~~~L~~dP~~R~sa~el~~~l~~~l~~~~~l~hP 324 (336)
T 4g3f_A 275 IR--------EIPPSCAPLTAQAIQEGLRKEPVHRASAMELRRKVGKALQEVGGLKSP 324 (336)
T ss_dssp GG--------GSCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHHTTSSCSC
T ss_pred ch--------hcCccCCHHHHHHHHHHccCCHhHCcCHHHHHHHHHHHHhhhhhccCC
Confidence 00 111223457889999999999999999999999998877665554444
|
| >3hmm_A TGF-beta receptor type-1; ALK5, kinase, inhibitor, quinazoline, aortic aneurysm, ATP-binding, craniosynostosis, disease mutation, disulfide bond; HET: 855; 1.70A {Homo sapiens} PDB: 1vjy_A* 3gxl_A* 3tzm_A* 2wot_A* 2wou_A* 1py5_A* 1rw8_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-35 Score=293.61 Aligned_cols=195 Identities=19% Similarity=0.205 Sum_probs=141.0
Q ss_pred ccceeeccCCCCC-----CCCCCChhhHHHHHHHHHHHHHHHhhcC-----CCceeecCCCccceEecCCCCceeccccc
Q 045315 242 EISFWYESYNNPT-----KKGLLCWGTRVRIIEGIAQGLLYLHQYS-----RLRVIHRDLKASNILLDKDMNPKISDFGM 311 (476)
Q Consensus 242 ~~~l~~Ey~~~~~-----~~~~L~~~~~~~i~~qIa~gL~yLH~~~-----~~~ivH~DLkp~NILld~~~~~kL~DFGl 311 (476)
..+++|||+++++ ++.+++|+++++++.|+++||+|||+++ .++||||||||+||||+.++.+||+|||+
T Consensus 75 ~~~lV~Ey~~~gsL~~~l~~~~l~~~~~~~i~~~ia~gl~ylH~~~~~~~~~~~IiHRDlKp~NILl~~~~~~Ki~DFGl 154 (303)
T 3hmm_A 75 QLWLVSDYHEHGSLFDYLNRYTVTVEGMIKLALSTASGLAHLHMEIVGTQGKPAIAHRDLKSKNILVKKNGTCCIADLGL 154 (303)
T ss_dssp EEEEEEECCTTCBHHHHHHHCCBCHHHHHHHHHHHHHHHHHHHCCBCSTTCBCCEECSCCCGGGEEECTTSCEEECCCTT
T ss_pred EEEEEecCCCCCcHHHHHHhCCCCHHHHHHHHHHHHHHHHHHHHhhhhccCCCCEeeccCCcccEEECCCCCEEEEeCCC
Confidence 4689999999543 3457999999999999999999999871 23499999999999999999999999999
Q ss_pred eeecCCCcc--cccceeeeeccCCCChhhhccC------CCCccceEEeehhhhhhhhhCCCCCCcCCCCchhhh-----
Q 045315 312 ARMFGGDEL--QSNTKRIVGTYGYMSPEYALRG------LFSIKSDVFSFGVLLLETLSSKKNTHFYNTDSLTLL----- 378 (476)
Q Consensus 312 a~~~~~~~~--~~~~~~~~gt~~y~aPE~l~~~------~~s~ksDVwSlGvvl~elltG~~p~~~~~~~~~~~~----- 378 (476)
|+....... ........||+.|||||++.+. .++.++|||||||++|||++|++|+...........
T Consensus 155 a~~~~~~~~~~~~~~~~~~GT~~ymAPE~l~~~~~~~~~~~~~k~DVwS~Gvvl~El~tg~~~~~~~~~~~~p~~~~~~~ 234 (303)
T 3hmm_A 155 AVRHDSATDTIDIAPNHRVGTKRYMAPEVLDDSINMKHFESFKRADIYAMGLVFWEIARRCSIGGIHEDYQLPYYDLVPS 234 (303)
T ss_dssp CEEEETTTTEESCC-----CCGGGCCHHHHTTCSCTTCHHHHHHHHHHHHHHHHHHHHHTBCBTTBCCCCCCTTTTTSCS
T ss_pred CccccCCCCceeeecccccccccccCHHHhcccccccCCccChhHhhhhHHHHHHHHHHCCCCCCccccccccchhcccc
Confidence 987654322 1223346799999999999754 467899999999999999999988754332111111
Q ss_pred ----hhhhhhhcCCCcccccCcccCC-CCCHHHHHHHHHHHHHchhhcccCCCCHHHHHHHHhcccc
Q 045315 379 ----GHAWNLWNDGRTWELMDPISQN-GASYPILKRYINVALLCVQEKAADRPAMSEVVSMLSNEFV 440 (476)
Q Consensus 379 ----~~~~~~~~~~~~~~~~d~~~~~-~~~~~~~~~l~~li~~Cl~~dP~~RPt~~eVl~~L~~~~~ 440 (476)
.........+ ..++.+.. ....+..+.+.+++.+||+.||++||||.||+++|+++..
T Consensus 235 ~~~~~~~~~~~~~~----~~rp~~p~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~ei~~~L~~l~~ 297 (303)
T 3hmm_A 235 DPSVEEMRKVVCEQ----KLRPNIPNRWQSCEALRVMAKIMRECWYANGAARLTALRIKKTLSQLSQ 297 (303)
T ss_dssp SCCHHHHHHHHTTS----CCCCCCCGGGGSSHHHHHHHHHHHTTCCSSGGGSCCHHHHHHHHHHHHH
T ss_pred cchHHHHHHHHhcc----cCCCCCCccccchHHHHHHHHHHHHHcccCHhHCcCHHHHHHHHHHHHH
Confidence 0011111111 11111111 1123456788999999999999999999999999998753
|
| >4fih_A Serine/threonine-protein kinase PAK 4; kinase domain, protein ATP binding, phosphorylation, transferase; HET: SEP; 1.97A {Homo sapiens} PDB: 4fig_A* 4fif_A* 4fii_A* 4fij_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-34 Score=288.91 Aligned_cols=175 Identities=23% Similarity=0.286 Sum_probs=138.7
Q ss_pred cccceeeccCCCCC-----CCCCCChhhHHHHHHHHHHHHHHHhhcCCCceeecCCCccceEecCCCCceeccccceeec
Q 045315 241 DEISFWYESYNNPT-----KKGLLCWGTRVRIIEGIAQGLLYLHQYSRLRVIHRDLKASNILLDKDMNPKISDFGMARMF 315 (476)
Q Consensus 241 ~~~~l~~Ey~~~~~-----~~~~L~~~~~~~i~~qIa~gL~yLH~~~~~~ivH~DLkp~NILld~~~~~kL~DFGla~~~ 315 (476)
+.++++|||++.+. .++.+++.++..++.||+.||+|||+++ ||||||||+||||+.++.+||+|||+|+.+
T Consensus 144 ~~~~ivmEy~~gg~L~~~l~~~~l~e~~~~~~~~qi~~aL~ylH~~~---IiHRDlKp~NILl~~~g~vKl~DFGla~~~ 220 (346)
T 4fih_A 144 DELWVVMEFLEGGALTDIVTHTRMNEEQIAAVCLAVLQALSVLHAQG---VIHRDIKSDSILLTHDGRVKLSDFGFCAQV 220 (346)
T ss_dssp TEEEEEECCCTTEEHHHHHHHSCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEECTTCCEEECCCTTCEEC
T ss_pred CEEEEEEeCCCCCcHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCC---cccccCCHHHEEECCCCCEEEecCcCceec
Confidence 57899999998432 2457999999999999999999999999 999999999999999999999999999987
Q ss_pred CCCcccccceeeeeccCCCChhhhccCCCCccceEEeehhhhhhhhhCCCCCCcCCCCchhhhhhhhhhhcCCCcccccC
Q 045315 316 GGDELQSNTKRIVGTYGYMSPEYALRGLFSIKSDVFSFGVLLLETLSSKKNTHFYNTDSLTLLGHAWNLWNDGRTWELMD 395 (476)
Q Consensus 316 ~~~~~~~~~~~~~gt~~y~aPE~l~~~~~s~ksDVwSlGvvl~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~d 395 (476)
..... ......||+.|||||++.+..|+.++|||||||++|||++|+.||.... ........ .....
T Consensus 221 ~~~~~--~~~~~~GTp~YmAPEvl~~~~y~~~~DiWSlGvilyeml~G~~PF~~~~--~~~~~~~i----~~~~~----- 287 (346)
T 4fih_A 221 SKEVP--RRKSLVGTPYWMAPELISRLPYGPEVDIWSLGIMVIEMVDGEPPYFNEP--PLKAMKMI----RDNLP----- 287 (346)
T ss_dssp CSSSC--CBCCCCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCTTTTSC--HHHHHHHH----HHSSC-----
T ss_pred CCCCC--cccccccCcCcCCHHHHCCCCCCcHHHHHHHHHHHHHHHHCCCCCCCcC--HHHHHHHH----HcCCC-----
Confidence 54322 2334689999999999999999999999999999999999999996432 11111111 11110
Q ss_pred cccCCCCCHHHHHHHHHHHHHchhhcccCCCCHHHHHH
Q 045315 396 PISQNGASYPILKRYINVALLCVQEKAADRPAMSEVVS 433 (476)
Q Consensus 396 ~~~~~~~~~~~~~~l~~li~~Cl~~dP~~RPt~~eVl~ 433 (476)
+.. .........+.+++.+||+.||++|||++|+++
T Consensus 288 ~~~--~~~~~~s~~~~dli~~~L~~dP~~R~ta~e~l~ 323 (346)
T 4fih_A 288 PRL--KNLHKVSPSLKGFLDRLLVRDPAQRATAAELLK 323 (346)
T ss_dssp CCC--SCGGGSCHHHHHHHHHHSCSSTTTSCCHHHHTT
T ss_pred CCC--CccccCCHHHHHHHHHHcCCChhHCcCHHHHhc
Confidence 000 111233467889999999999999999999875
|
| >3fpq_A Serine/threonine-protein kinase WNK1; protein serine/threonine kinase, transferase, ATP-BIND kinase, nucleotide-binding, phosphoprotein; 1.80A {Rattus norvegicus} | Back alignment and structure |
|---|
Probab=100.00 E-value=2e-34 Score=281.92 Aligned_cols=173 Identities=22% Similarity=0.321 Sum_probs=132.8
Q ss_pred ccceeeccCCCCC------CCCCCChhhHHHHHHHHHHHHHHHhhcCCCceeecCCCccceEec-CCCCceeccccceee
Q 045315 242 EISFWYESYNNPT------KKGLLCWGTRVRIIEGIAQGLLYLHQYSRLRVIHRDLKASNILLD-KDMNPKISDFGMARM 314 (476)
Q Consensus 242 ~~~l~~Ey~~~~~------~~~~L~~~~~~~i~~qIa~gL~yLH~~~~~~ivH~DLkp~NILld-~~~~~kL~DFGla~~ 314 (476)
..+++|||++.+. +.+.+++.++..++.||+.||+|||+++ .+||||||||+||||+ .++.+||+|||+|+.
T Consensus 103 ~~~lvmEy~~gg~L~~~l~~~~~l~~~~~~~~~~qi~~aL~ylH~~~-~~IiHRDlKp~NILl~~~~g~vKl~DFGla~~ 181 (290)
T 3fpq_A 103 CIVLVTELMTSGTLKTYLKRFKVMKIKVLRSWCRQILKGLQFLHTRT-PPIIHRDLKCDNIFITGPTGSVKIGDLGLATL 181 (290)
T ss_dssp EEEEEEECCCSCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHTSS-SCCCCCCCCGGGEEESSTTSCEEECCTTGGGG
T ss_pred EEEEEEeCCCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCC-CCEEecccChhheeEECCCCCEEEEeCcCCEe
Confidence 4689999999543 3568999999999999999999999976 4599999999999998 478999999999986
Q ss_pred cCCCcccccceeeeeccCCCChhhhccCCCCccceEEeehhhhhhhhhCCCCCCcCCCCchhhhhhhhhhhcCCCccccc
Q 045315 315 FGGDELQSNTKRIVGTYGYMSPEYALRGLFSIKSDVFSFGVLLLETLSSKKNTHFYNTDSLTLLGHAWNLWNDGRTWELM 394 (476)
Q Consensus 315 ~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~s~ksDVwSlGvvl~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 394 (476)
.... ......||+.|||||++.+ .|+.++|||||||++|||++|+.||...... ..+. .....+......
T Consensus 182 ~~~~----~~~~~~GTp~YmAPE~~~~-~y~~~~DiwSlGvilyelltg~~Pf~~~~~~-~~~~----~~i~~~~~~~~~ 251 (290)
T 3fpq_A 182 KRAS----FAKAVIGTPEFMAPEMYEE-KYDESVDVYAFGMCMLEMATSEYPYSECQNA-AQIY----RRVTSGVKPASF 251 (290)
T ss_dssp CCTT----SBEESCSSCCCCCGGGGGT-CCCTHHHHHHHHHHHHHHHHSSCTTTTCSSH-HHHH----HHHTTTCCCGGG
T ss_pred CCCC----ccCCcccCccccCHHHcCC-CCCcHHHHHHHHHHHHHHHHCCCCCCCCCcH-HHHH----HHHHcCCCCCCC
Confidence 4332 2344689999999998864 6999999999999999999999998643211 1111 111111111111
Q ss_pred CcccCCCCCHHHHHHHHHHHHHchhhcccCCCCHHHHHH
Q 045315 395 DPISQNGASYPILKRYINVALLCVQEKAADRPAMSEVVS 433 (476)
Q Consensus 395 d~~~~~~~~~~~~~~l~~li~~Cl~~dP~~RPt~~eVl~ 433 (476)
+ ......+.+++.+||+.||++|||++|+++
T Consensus 252 ~--------~~~~~~~~~li~~~L~~dP~~R~s~~e~l~ 282 (290)
T 3fpq_A 252 D--------KVAIPEVKEIIEGCIRQNKDERYSIKDLLN 282 (290)
T ss_dssp G--------GCCCHHHHHHHHHHSCSSGGGSCCHHHHHT
T ss_pred C--------ccCCHHHHHHHHHHccCChhHCcCHHHHhc
Confidence 1 111246789999999999999999999875
|
| >4b9d_A Serine/threonine-protein kinase NEK1; transferase, inhibitor; HET: CK7; 1.90A {Homo sapiens} PDB: 4apc_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-34 Score=289.85 Aligned_cols=173 Identities=22% Similarity=0.302 Sum_probs=137.7
Q ss_pred cccceeeccCCCC--------CCCCCCChhhHHHHHHHHHHHHHHHhhcCCCceeecCCCccceEecCCCCceeccccce
Q 045315 241 DEISFWYESYNNP--------TKKGLLCWGTRVRIIEGIAQGLLYLHQYSRLRVIHRDLKASNILLDKDMNPKISDFGMA 312 (476)
Q Consensus 241 ~~~~l~~Ey~~~~--------~~~~~L~~~~~~~i~~qIa~gL~yLH~~~~~~ivH~DLkp~NILld~~~~~kL~DFGla 312 (476)
+.++++|||++.+ .++..+++.+++.++.||+.||+|||+++ ||||||||+||||+.++.+||+|||+|
T Consensus 96 ~~~yiVmEy~~gg~L~~~i~~~~~~~~~e~~~~~~~~qi~~aL~ylH~~~---IiHRDlKp~NILl~~~g~vKl~DFGla 172 (350)
T 4b9d_A 96 GSLYIVMDYCEGGDLFKRINAQKGVLFQEDQILDWFVQICLALKHVHDRK---ILHRDIKSQNIFLTKDGTVQLGDFGIA 172 (350)
T ss_dssp TEEEEEEECCTTCBHHHHHHHTTTCCCCHHHHHHHHHHHHHHHHHHHHTT---CEETTCCGGGEEECTTCCEEECSTTEE
T ss_pred CEEEEEEeCCCCCcHHHHHHHcCCCCCCHHHHHHHHHHHHHHHHHHHHCC---eeeccCCHHHEEECCCCCEEEcccccc
Confidence 5689999999843 34456899999999999999999999999 999999999999999999999999999
Q ss_pred eecCCCcccccceeeeeccCCCChhhhccCCCCccceEEeehhhhhhhhhCCCCCCcCCCCchhhhhhhhhhhcCCCccc
Q 045315 313 RMFGGDELQSNTKRIVGTYGYMSPEYALRGLFSIKSDVFSFGVLLLETLSSKKNTHFYNTDSLTLLGHAWNLWNDGRTWE 392 (476)
Q Consensus 313 ~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~s~ksDVwSlGvvl~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~ 392 (476)
+.+.... .......||+.|||||++.+..|+.++|||||||++|||++|+.||...+. ..+... .. .+...
T Consensus 173 ~~~~~~~--~~~~~~~GT~~YmAPE~l~~~~y~~~~DiwSlGvilyemltG~~PF~~~~~--~~~~~~---i~-~~~~~- 243 (350)
T 4b9d_A 173 RVLNSTV--ELARACIGTPYYLSPEICENKPYNNKSDIWALGCVLYELCTLKHAFEAGSM--KNLVLK---II-SGSFP- 243 (350)
T ss_dssp SCCCHHH--HHHHHHHSCCTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCSCCCSSH--HHHHHH---HH-HTCCC-
T ss_pred eeecCCc--ccccccCCCccccCHHHHCCCCCCcHHHHHHHHHHHHHHHHCCCCCCCcCH--HHHHHH---HH-cCCCC-
Confidence 8764321 112335799999999999999999999999999999999999999975431 111111 11 11111
Q ss_pred ccCcccCCCCCHHHHHHHHHHHHHchhhcccCCCCHHHHHH
Q 045315 393 LMDPISQNGASYPILKRYINVALLCVQEKAADRPAMSEVVS 433 (476)
Q Consensus 393 ~~d~~~~~~~~~~~~~~l~~li~~Cl~~dP~~RPt~~eVl~ 433 (476)
..+......+.+++.+||+.||++|||++|+++
T Consensus 244 --------~~~~~~s~~~~~li~~~L~~dP~~R~s~~e~l~ 276 (350)
T 4b9d_A 244 --------PVSLHYSYDLRSLVSQLFKRNPRDRPSVNSILE 276 (350)
T ss_dssp --------CCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHT
T ss_pred --------CCCccCCHHHHHHHHHHccCChhHCcCHHHHhc
Confidence 111223457889999999999999999999975
|
| >4aw0_A HPDK1, 3-phosphoinositide-dependent protein kinase 1; transferase, allosteric regulation, allosteric site, phosphorylation, AGC protein kinase; HET: SEP ATP MJF; 1.43A {Homo sapiens} PDB: 3hrc_A* 3hrf_A* 4a06_A* 4a07_A* 3rcj_A* 4aw1_A* 3rwq_A* 3sc1_A* 3qd0_A* 2r7b_A* 3ion_A* 3qcq_A* 3qcs_A* 3qcx_A* 3qcy_A* 3iop_A* 3qd3_A* 3qd4_A* 3h9o_A* 1uu3_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=1.5e-34 Score=284.67 Aligned_cols=173 Identities=24% Similarity=0.300 Sum_probs=139.9
Q ss_pred cccceeeccCCCC------CCCCCCChhhHHHHHHHHHHHHHHHhhcCCCceeecCCCccceEecCCCCceeccccceee
Q 045315 241 DEISFWYESYNNP------TKKGLLCWGTRVRIIEGIAQGLLYLHQYSRLRVIHRDLKASNILLDKDMNPKISDFGMARM 314 (476)
Q Consensus 241 ~~~~l~~Ey~~~~------~~~~~L~~~~~~~i~~qIa~gL~yLH~~~~~~ivH~DLkp~NILld~~~~~kL~DFGla~~ 314 (476)
+.++++|||++.+ .+.+.|++.++..++.||+.||+|||+++ |+||||||+|||++.++.+||+|||+|+.
T Consensus 105 ~~~yivmEy~~gG~L~~~i~~~~~l~e~~~~~~~~qi~~al~ylH~~~---IiHRDlKPeNILl~~~g~vKl~DFGla~~ 181 (311)
T 4aw0_A 105 EKLYFGLSYAKNGELLKYIRKIGSFDETCTRFYTAEIVSALEYLHGKG---IIHRDLKPENILLNEDMHIQITDFGTAKV 181 (311)
T ss_dssp SEEEEEECCCTTEEHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEECTTSCEEECCCTTCEE
T ss_pred CEEEEEEecCCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCC---CccCCCCHHHeEEcCCCCEEEEEcCCcee
Confidence 5689999999843 23568999999999999999999999999 99999999999999999999999999998
Q ss_pred cCCCcccccceeeeeccCCCChhhhccCCCCccceEEeehhhhhhhhhCCCCCCcCCCCchhhhhhhhhhhcCCCccccc
Q 045315 315 FGGDELQSNTKRIVGTYGYMSPEYALRGLFSIKSDVFSFGVLLLETLSSKKNTHFYNTDSLTLLGHAWNLWNDGRTWELM 394 (476)
Q Consensus 315 ~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~s~ksDVwSlGvvl~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 394 (476)
+.............||+.|||||++.+..|+.++||||+||++|||++|+.||...+. ..+.... ..+.. .
T Consensus 182 ~~~~~~~~~~~~~~GTp~YmAPEvl~~~~y~~~~DiWSlGvilyeml~G~~PF~~~~~--~~~~~~i----~~~~~-~-- 252 (311)
T 4aw0_A 182 LSPESKQARANSFVGTAQYVSPELLTEKSACKSSDLWALGCIIYQLVAGLPPFRAGNE--GLIFAKI----IKLEY-D-- 252 (311)
T ss_dssp CCTTTTCCCBCCCCSCGGGCCHHHHHHSCBCHHHHHHHHHHHHHHHHHSSCSSCCSSH--HHHHHHH----HHTCC-C--
T ss_pred cCCCCCcccccCcccCcccCCHHHHcCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCH--HHHHHHH----HcCCC-C--
Confidence 7654444445557899999999999999999999999999999999999999965431 1221111 11111 1
Q ss_pred CcccCCCCCHHHHHHHHHHHHHchhhcccCCCCHHHHH
Q 045315 395 DPISQNGASYPILKRYINVALLCVQEKAADRPAMSEVV 432 (476)
Q Consensus 395 d~~~~~~~~~~~~~~l~~li~~Cl~~dP~~RPt~~eVl 432 (476)
.+......+.+++.+||+.||++|||++|++
T Consensus 253 -------~p~~~s~~~~dli~~lL~~dp~~R~t~~e~~ 283 (311)
T 4aw0_A 253 -------FPEKFFPKARDLVEKLLVLDATKRLGCEEME 283 (311)
T ss_dssp -------CCTTCCHHHHHHHHHHSCSSGGGSTTSGGGT
T ss_pred -------CCcccCHHHHHHHHHHccCCHhHCcChHHHc
Confidence 1112235688999999999999999999863
|
| >4fie_A Serine/threonine-protein kinase PAK 4; kinase domain, protein ATP binding, phosphorylation, transferase; HET: SEP ANP; 3.11A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=9.3e-34 Score=289.86 Aligned_cols=175 Identities=23% Similarity=0.291 Sum_probs=138.5
Q ss_pred cccceeeccCCCCC-----CCCCCChhhHHHHHHHHHHHHHHHhhcCCCceeecCCCccceEecCCCCceeccccceeec
Q 045315 241 DEISFWYESYNNPT-----KKGLLCWGTRVRIIEGIAQGLLYLHQYSRLRVIHRDLKASNILLDKDMNPKISDFGMARMF 315 (476)
Q Consensus 241 ~~~~l~~Ey~~~~~-----~~~~L~~~~~~~i~~qIa~gL~yLH~~~~~~ivH~DLkp~NILld~~~~~kL~DFGla~~~ 315 (476)
+.++++|||++.+. +.+.|++.++..++.||+.||+|||+++ ||||||||+||||+.++.+||+|||+|+.+
T Consensus 221 ~~~~iVmEy~~gG~L~~~i~~~~l~e~~~~~~~~qil~aL~ylH~~~---IiHRDiKp~NILl~~~g~vKl~DFGla~~~ 297 (423)
T 4fie_A 221 DELWVVMEFLEGGALTDIVTHTRMNEEQIAAVCLAVLQALSVLHAQG---VIHRDIKSDSILLTHDGRVKLSDFGFCAQV 297 (423)
T ss_dssp TEEEEEEECCTTEEHHHHHHHSCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSTTTEEECTTCCEEECCCTTCEEC
T ss_pred CEEEEEEeCCCCCcHHHHHhccCCCHHHHHHHHHHHHHHHHHHHHCC---eecccCCHHHEEEcCCCCEEEecCccceEC
Confidence 57899999998432 3456999999999999999999999999 999999999999999999999999999987
Q ss_pred CCCcccccceeeeeccCCCChhhhccCCCCccceEEeehhhhhhhhhCCCCCCcCCCCchhhhhhhhhhhcCCCcccccC
Q 045315 316 GGDELQSNTKRIVGTYGYMSPEYALRGLFSIKSDVFSFGVLLLETLSSKKNTHFYNTDSLTLLGHAWNLWNDGRTWELMD 395 (476)
Q Consensus 316 ~~~~~~~~~~~~~gt~~y~aPE~l~~~~~s~ksDVwSlGvvl~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~d 395 (476)
..... ......||+.|||||++.+..|+.++|||||||++|||++|+.||.... ........ .....
T Consensus 298 ~~~~~--~~~~~~GTp~YmAPEvl~~~~y~~~~DiWSlGvilyeml~G~~PF~~~~--~~~~~~~i----~~~~~----- 364 (423)
T 4fie_A 298 SKEVP--RRKSLVGTPYWMAPELISRLPYGPEVDIWSLGIMVIEMVDGEPPYFNEP--PLKAMKMI----RDNLP----- 364 (423)
T ss_dssp CSSCC--CBCCCEECTTTCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCTTTTSC--HHHHHHHH----HHSCC-----
T ss_pred CCCCc--cccccccCcCcCCHHHHCCCCCCcHHHHHHHHHHHHHHHHCCCCCCCcC--HHHHHHHH----HcCCC-----
Confidence 54332 2334689999999999999999999999999999999999999986432 11111111 11111
Q ss_pred cccCCCCCHHHHHHHHHHHHHchhhcccCCCCHHHHHH
Q 045315 396 PISQNGASYPILKRYINVALLCVQEKAADRPAMSEVVS 433 (476)
Q Consensus 396 ~~~~~~~~~~~~~~l~~li~~Cl~~dP~~RPt~~eVl~ 433 (476)
+.+. ........+.+++.+||+.||++|||++|+++
T Consensus 365 ~~~~--~~~~~s~~~~dli~~~L~~dP~~R~ta~ell~ 400 (423)
T 4fie_A 365 PRLK--NLHKVSPSLKGFLDRLLVRDPAQRATAAELLK 400 (423)
T ss_dssp CCCS--CTTSSCHHHHHHHHHHSCSSTTTSCCHHHHTT
T ss_pred CCCc--ccccCCHHHHHHHHHHcCCChhHCcCHHHHhc
Confidence 0110 11123457889999999999999999999876
|
| >3ubd_A Ribosomal protein S6 kinase alpha-3; kinase-inhibitor complex, induced FIT, transferase-transfera inhibitor complex; HET: SL0; 1.53A {Mus musculus} PDB: 4el9_A* 3g51_A* 2z7q_A* 2z7r_A* 2z7s_A* | Back alignment and structure |
|---|
Probab=99.98 E-value=1.4e-33 Score=277.33 Aligned_cols=172 Identities=23% Similarity=0.282 Sum_probs=134.2
Q ss_pred cccceeeccCCCCC------CCCCCChhhHHHHHHHHHHHHHHHhhcCCCceeecCCCccceEecCCCCceeccccceee
Q 045315 241 DEISFWYESYNNPT------KKGLLCWGTRVRIIEGIAQGLLYLHQYSRLRVIHRDLKASNILLDKDMNPKISDFGMARM 314 (476)
Q Consensus 241 ~~~~l~~Ey~~~~~------~~~~L~~~~~~~i~~qIa~gL~yLH~~~~~~ivH~DLkp~NILld~~~~~kL~DFGla~~ 314 (476)
+.++++|||++.+. +.+.+++.++..++.||+.||+|||+++ |+||||||+|||++.++.+||+|||+|+.
T Consensus 99 ~~~~ivmEy~~gg~L~~~l~~~~~l~e~~~~~~~~qi~~aL~ylH~~~---IiHRDlKp~NILl~~~g~vKl~DFGla~~ 175 (304)
T 3ubd_A 99 GKLYLILDFLRGGDLFTRLSKEVMFTEEDVKFYLAELALALDHLHSLG---IIYRDLKPENILLDEEGHIKLTDFGLSKE 175 (304)
T ss_dssp TEEEEEECCCTTCEEHHHHHHHCCCCHHHHHHHHHHHHHHHHHHHHTT---CCCSSCCGGGEEECTTSCEEEESSEEEEC
T ss_pred CEEEEEEEcCCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCC---CcCCCCCHHHeEEcCCCCEEeccccccee
Confidence 57899999998442 3567999999999999999999999999 99999999999999999999999999986
Q ss_pred cCCCcccccceeeeeccCCCChhhhccCCCCccceEEeehhhhhhhhhCCCCCCcCCCCchhhhhhhhhhhcCCCccccc
Q 045315 315 FGGDELQSNTKRIVGTYGYMSPEYALRGLFSIKSDVFSFGVLLLETLSSKKNTHFYNTDSLTLLGHAWNLWNDGRTWELM 394 (476)
Q Consensus 315 ~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~s~ksDVwSlGvvl~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 394 (476)
...... ......||+.|||||++.+..|+.++|||||||++|||++|+.||...+. ....... ..+..
T Consensus 176 ~~~~~~--~~~~~~GT~~YmAPE~~~~~~y~~~~DiwSlGvilyemltG~~PF~~~~~--~~~~~~i----~~~~~---- 243 (304)
T 3ubd_A 176 SIDHEK--KAYSFCGTVEYMAPEVVNRRGHTQSADWWSFGVLMFEMLTGTLPFQGKDR--KETMTMI----LKAKL---- 243 (304)
T ss_dssp -----C--CCCSCCCCGGGCCHHHHHTSCCCTHHHHHHHHHHHHHHHHSSCSSCCSSH--HHHHHHH----HHCCC----
T ss_pred ccCCCc--cccccccCcccCCHHHhccCCCCCCCcccchHHHHHHHHhCCCCCCCcCH--HHHHHHH----HcCCC----
Confidence 543322 22336799999999999999999999999999999999999999975432 1121111 11111
Q ss_pred CcccCCCCCHHHHHHHHHHHHHchhhcccCCCCH-----HHHHH
Q 045315 395 DPISQNGASYPILKRYINVALLCVQEKAADRPAM-----SEVVS 433 (476)
Q Consensus 395 d~~~~~~~~~~~~~~l~~li~~Cl~~dP~~RPt~-----~eVl~ 433 (476)
..+......+.+++.+||+.||++|||+ +|+++
T Consensus 244 ------~~p~~~s~~~~~li~~~L~~dP~~R~ta~~~~~~eil~ 281 (304)
T 3ubd_A 244 ------GMPQFLSPEAQSLLRMLFKRNPANRLGAGPDGVEEIKR 281 (304)
T ss_dssp ------CCCTTSCHHHHHHHHHHTCSSGGGSTTCSTTTHHHHHT
T ss_pred ------CCCCcCCHHHHHHHHHHcccCHHHCCCCCcCCHHHHHc
Confidence 0111234568899999999999999984 56653
|
| >3hyh_A Carbon catabolite-derepressing protein kinase; kinase domain, transferase, ATP-binding, carbohydrate metabo kinase, membrane; 2.20A {Saccharomyces cerevisiae} PDB: 3dae_A 2fh9_A 3mn3_A | Back alignment and structure |
|---|
Probab=99.98 E-value=1.3e-33 Score=273.94 Aligned_cols=171 Identities=24% Similarity=0.335 Sum_probs=127.5
Q ss_pred cccceeeccCCC-----CCCCCCCChhhHHHHHHHHHHHHHHHhhcCCCceeecCCCccceEecCCCCceeccccceeec
Q 045315 241 DEISFWYESYNN-----PTKKGLLCWGTRVRIIEGIAQGLLYLHQYSRLRVIHRDLKASNILLDKDMNPKISDFGMARMF 315 (476)
Q Consensus 241 ~~~~l~~Ey~~~-----~~~~~~L~~~~~~~i~~qIa~gL~yLH~~~~~~ivH~DLkp~NILld~~~~~kL~DFGla~~~ 315 (476)
+.++++|||++. ..++++|++.++..++.||+.||+|||+++ |+||||||+|||++.++.+||+|||+|+..
T Consensus 86 ~~~~ivmEy~~g~L~~~l~~~~~l~e~~~~~~~~qi~~al~ylH~~~---IiHRDiKP~NILl~~~~~vkl~DFGla~~~ 162 (275)
T 3hyh_A 86 DEIIMVIEYAGNELFDYIVQRDKMSEQEARRFFQQIISAVEYCHRHK---IVHRDLKPENLLLDEHLNVKIADFGLSNIM 162 (275)
T ss_dssp SEEEEEEECCCEEHHHHHHHSCSCCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCCTTTEEECTTCCEEECCSSCC---
T ss_pred CEEEEEEeCCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCC---cccccCChHHeEECCCCCEEEeecCCCeec
Confidence 578999999972 124568999999999999999999999999 999999999999999999999999999876
Q ss_pred CCCcccccceeeeeccCCCChhhhccCCC-CccceEEeehhhhhhhhhCCCCCCcCCCCchhhhhhhhhhhcCCCccccc
Q 045315 316 GGDELQSNTKRIVGTYGYMSPEYALRGLF-SIKSDVFSFGVLLLETLSSKKNTHFYNTDSLTLLGHAWNLWNDGRTWELM 394 (476)
Q Consensus 316 ~~~~~~~~~~~~~gt~~y~aPE~l~~~~~-s~ksDVwSlGvvl~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 394 (476)
.... ......||+.|+|||++.+..+ +.++||||+||++|||++|+.||.... ...+.... ..+.. .
T Consensus 163 ~~~~---~~~~~~GT~~Y~APE~~~~~~y~~~~~DiwSlGvily~lltg~~PF~~~~--~~~~~~~i----~~~~~-~-- 230 (275)
T 3hyh_A 163 TDGN---FLKTSCGSPNYAAPEVISGKLYAGPEVDVWSCGVILYVMLCRRLPFDDES--IPVLFKNI----SNGVY-T-- 230 (275)
T ss_dssp ---------------CTTSCHHHHSSSSCCCTHHHHHHHHHHHHHHHHSSCSSCCSS--HHHHHHHH----HHTCC-C--
T ss_pred CCCC---ccCCeeECcccCChhhhcCCCCCCChhhhHHHHHHHHHHHHCCCCCCCCC--HHHHHHHH----HcCCC-C--
Confidence 5332 2234679999999999998876 589999999999999999999996432 11111111 11111 0
Q ss_pred CcccCCCCCHHHHHHHHHHHHHchhhcccCCCCHHHHHH
Q 045315 395 DPISQNGASYPILKRYINVALLCVQEKAADRPAMSEVVS 433 (476)
Q Consensus 395 d~~~~~~~~~~~~~~l~~li~~Cl~~dP~~RPt~~eVl~ 433 (476)
.+....+.+.+++.+||+.||++|||++|+++
T Consensus 231 -------~p~~~s~~~~~li~~~L~~dP~~R~s~~eil~ 262 (275)
T 3hyh_A 231 -------LPKFLSPGAAGLIKRMLIVNPLNRISIHEIMQ 262 (275)
T ss_dssp -------CCTTSCHHHHHHHHHHSCSSGGGSCCHHHHHH
T ss_pred -------CCCCCCHHHHHHHHHHccCChhHCcCHHHHHc
Confidence 11122356889999999999999999999986
|
| >4g31_A Eukaryotic translation initiation factor 2-alpha; deletion mutant, catalytic domain, synthetic inhibitor, TRAN transferase inhibitor complex; HET: 0WH; 2.28A {Homo sapiens} PDB: 4g34_A* | Back alignment and structure |
|---|
Probab=99.97 E-value=3.1e-32 Score=268.04 Aligned_cols=172 Identities=23% Similarity=0.252 Sum_probs=120.2
Q ss_pred ccceeeccCCCCC------CC---CCCChhhHHHHHHHHHHHHHHHhhcCCCceeecCCCccceEecCCCCceeccccce
Q 045315 242 EISFWYESYNNPT------KK---GLLCWGTRVRIIEGIAQGLLYLHQYSRLRVIHRDLKASNILLDKDMNPKISDFGMA 312 (476)
Q Consensus 242 ~~~l~~Ey~~~~~------~~---~~L~~~~~~~i~~qIa~gL~yLH~~~~~~ivH~DLkp~NILld~~~~~kL~DFGla 312 (476)
.++++|||++.+. .+ ...++..++.++.||++||+|||+++ |+||||||+|||++.++.+||+|||+|
T Consensus 89 ~l~ivmE~~~gg~L~~~l~~~~~~~~~~~~~~~~i~~qi~~al~ylH~~~---IiHRDlKp~NILl~~~~~vKl~DFGla 165 (299)
T 4g31_A 89 YLYIQMQLCRKENLKDWMNGRCTIEERERSVCLHIFLQIAEAVEFLHSKG---LMHRDLKPSNIFFTMDDVVKVGDFGLV 165 (299)
T ss_dssp EEEEEEECCCSCCHHHHHHTCCSGGGSCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCCGGGEEECTTCCEEECCCCCC
T ss_pred EEEEEEecCCCCcHHHHHHhcCCCChhHHHHHHHHHHHHHHHHHHHHHCc---CccccCcHHHeEECCCCcEEEccCccc
Confidence 3678999998432 12 23455668899999999999999999 999999999999999999999999999
Q ss_pred eecCCCccc----------ccceeeeeccCCCChhhhccCCCCccceEEeehhhhhhhhhCCCCCCcCCCCchhhhhhhh
Q 045315 313 RMFGGDELQ----------SNTKRIVGTYGYMSPEYALRGLFSIKSDVFSFGVLLLETLSSKKNTHFYNTDSLTLLGHAW 382 (476)
Q Consensus 313 ~~~~~~~~~----------~~~~~~~gt~~y~aPE~l~~~~~s~ksDVwSlGvvl~elltG~~p~~~~~~~~~~~~~~~~ 382 (476)
+.+...... .......||+.|||||++.+..|+.++|||||||++|||++ ||.... .... ..
T Consensus 166 ~~~~~~~~~~~~~~~~~~~~~~~~~~GT~~YmAPE~~~~~~y~~~~DiwSlGvilyell~---Pf~~~~----~~~~-~~ 237 (299)
T 4g31_A 166 TAMDQDEEEQTVLTPMPAYARHTGQVGTKLYMSPEQIHGNSYSHKVDIFSLGLILFELLY---PFSTQM----ERVR-TL 237 (299)
T ss_dssp --------------------------CCCTTSCHHHHTTCCCCTHHHHHHHHHHHHHHHS---CCSSHH----HHHH-HH
T ss_pred eecCCCccccccccccccccccCCcccCccccCHHHHcCCCCCCHHHHHHHHHHHHHHcc---CCCCcc----HHHH-HH
Confidence 876543211 11233579999999999999999999999999999999996 553211 1110 00
Q ss_pred hhhcCCCcccccCcccCCCCCHHHHHHHHHHHHHchhhcccCCCCHHHHHH
Q 045315 383 NLWNDGRTWELMDPISQNGASYPILKRYINVALLCVQEKAADRPAMSEVVS 433 (476)
Q Consensus 383 ~~~~~~~~~~~~d~~~~~~~~~~~~~~l~~li~~Cl~~dP~~RPt~~eVl~ 433 (476)
.......... ........+.+++.+||+.||++|||+.|+++
T Consensus 238 ~~~~~~~~p~---------~~~~~~~~~~~li~~~L~~dP~~Rps~~eil~ 279 (299)
T 4g31_A 238 TDVRNLKFPP---------LFTQKYPCEYVMVQDMLSPSPMERPEAINIIE 279 (299)
T ss_dssp HHHHTTCCCH---------HHHHHCHHHHHHHHHHTCSSGGGSCCHHHHHT
T ss_pred HHHhcCCCCC---------CCcccCHHHHHHHHHHcCCChhHCcCHHHHhc
Confidence 1111111100 01122345678999999999999999999986
|
| >2qkw_B Protein kinase; three-helix bundle motif, AVRPTO-PTO duplex, layered beta- sheets, transferas; HET: SEP TPO; 3.20A {Solanum pimpinellifolium} PDB: 3hgk_A* | Back alignment and structure |
|---|
Probab=99.97 E-value=6.4e-31 Score=260.74 Aligned_cols=196 Identities=32% Similarity=0.551 Sum_probs=160.2
Q ss_pred cccceeeccCCCCC----------CCCCCChhhHHHHHHHHHHHHHHHhhcCCCceeecCCCccceEecCCCCceecccc
Q 045315 241 DEISFWYESYNNPT----------KKGLLCWGTRVRIIEGIAQGLLYLHQYSRLRVIHRDLKASNILLDKDMNPKISDFG 310 (476)
Q Consensus 241 ~~~~l~~Ey~~~~~----------~~~~L~~~~~~~i~~qIa~gL~yLH~~~~~~ivH~DLkp~NILld~~~~~kL~DFG 310 (476)
+..+++|||++.+. ....+++.+++.++.||+.||+|||+++ |+||||||+||+++.++.+||+|||
T Consensus 108 ~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~---ivH~dlkp~Nil~~~~~~~kl~Dfg 184 (321)
T 2qkw_B 108 NEMILIYKYMENGNLKRHLYGSDLPTMSMSWEQRLEICIGAARGLHYLHTRA---IIHRDVKSINILLDENFVPKITDFG 184 (321)
T ss_dssp TCCEEEEECCTTCBTGGGSSSSCCCSCCCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCCSTTEEECTTCCEEECCCT
T ss_pred CeEEEEEEcCCCCcHHHHHhccCCCccccCHHHHHHHHHHHHHHHHHhcCCC---eecCCCCHHHEEECCCCCEEEeecc
Confidence 46788899987321 1235999999999999999999999998 9999999999999999999999999
Q ss_pred ceeecCCCcccccceeeeeccCCCChhhhccCCCCccceEEeehhhhhhhhhCCCCCCcCC-CCchhhhhhhhhhhcCCC
Q 045315 311 MARMFGGDELQSNTKRIVGTYGYMSPEYALRGLFSIKSDVFSFGVLLLETLSSKKNTHFYN-TDSLTLLGHAWNLWNDGR 389 (476)
Q Consensus 311 la~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~s~ksDVwSlGvvl~elltG~~p~~~~~-~~~~~~~~~~~~~~~~~~ 389 (476)
+++...............|+..|+|||.+.+..++.++|||||||++|||++|+.||.... .+......+.......+.
T Consensus 185 ~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~ell~g~~p~~~~~~~~~~~~~~~~~~~~~~~~ 264 (321)
T 2qkw_B 185 ISKKGTELDQTHLSTVVKGTLGYIDPEYFIKGRLTEKSDVYSFGVVLFEVLCARSAIVQSLPREMVNLAEWAVESHNNGQ 264 (321)
T ss_dssp TCEECSSSSCCCCBCCCEEETTTCCHHHHHHCBCCTHHHHHHHHHHHHHHHHCCTTCSCSSSSSCCCHHHHTHHHHTTTC
T ss_pred cccccccccccccccccCCCccccCHHHhcCCCCCcccchHhHHHHHHHHHhCCCcccccCcHHHHHHHHHhhhcccccc
Confidence 9987654332333334568999999999999999999999999999999999999987554 222333333334444555
Q ss_pred cccccCcccCCCCCHHHHHHHHHHHHHchhhcccCCCCHHHHHHHHhccc
Q 045315 390 TWELMDPISQNGASYPILKRYINVALLCVQEKAADRPAMSEVVSMLSNEF 439 (476)
Q Consensus 390 ~~~~~d~~~~~~~~~~~~~~l~~li~~Cl~~dP~~RPt~~eVl~~L~~~~ 439 (476)
....+++.............+.+++.+||+.||++|||+.||++.|+.+.
T Consensus 265 ~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~L~~~l 314 (321)
T 2qkw_B 265 LEQIVDPNLADKIRPESLRKFGDTAVKCLALSSEDRPSMGDVLWKLEYAL 314 (321)
T ss_dssp CCSSSSSSCTTCSCHHHHHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHH
T ss_pred HHHhcChhhccccCHHHHHHHHHHHHHHcCCCcccCcCHHHHHHHHHHHh
Confidence 66667776666777888899999999999999999999999999999875
|
| >3uim_A Brassinosteroid insensitive 1-associated receptor; kinase, protein kinase, transferase; HET: SEP TPO ANP; 2.20A {Arabidopsis thaliana} PDB: 3ulz_A* 3tl8_A* | Back alignment and structure |
|---|
Probab=99.97 E-value=1e-30 Score=259.57 Aligned_cols=198 Identities=36% Similarity=0.548 Sum_probs=161.4
Q ss_pred cccceeeccCCCC----------CCCCCCChhhHHHHHHHHHHHHHHHhhcCCCceeecCCCccceEecCCCCceecccc
Q 045315 241 DEISFWYESYNNP----------TKKGLLCWGTRVRIIEGIAQGLLYLHQYSRLRVIHRDLKASNILLDKDMNPKISDFG 310 (476)
Q Consensus 241 ~~~~l~~Ey~~~~----------~~~~~L~~~~~~~i~~qIa~gL~yLH~~~~~~ivH~DLkp~NILld~~~~~kL~DFG 310 (476)
+..+++|||++.+ ....++++.++..++.||+.||+|||++....|+||||||+|||++.++.+||+|||
T Consensus 100 ~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~ivH~Dlkp~Nil~~~~~~~kl~Dfg 179 (326)
T 3uim_A 100 TERLLVYPYMANGSVASCLRERPESQPPLDWPKRQRIALGSARGLAYLHDHCDPKIIHRDVKAANILLDEEFEAVVGDFG 179 (326)
T ss_dssp SCCEEEEECCTTCBHHHHHHCCSTTCCCCCHHHHHHHHHHHHHHHHHHHHSSSSCEECCCCSGGGEEECTTCCEEECCCS
T ss_pred CceEEEEEeccCCCHHHHHHhccccCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeCCCchhhEEECCCCCEEeccCc
Confidence 4577899999732 234569999999999999999999999911129999999999999999999999999
Q ss_pred ceeecCCCcccccceeeeeccCCCChhhhccCCCCccceEEeehhhhhhhhhCCCCCCcCC---CCchhhhhhhhhhhcC
Q 045315 311 MARMFGGDELQSNTKRIVGTYGYMSPEYALRGLFSIKSDVFSFGVLLLETLSSKKNTHFYN---TDSLTLLGHAWNLWND 387 (476)
Q Consensus 311 la~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~s~ksDVwSlGvvl~elltG~~p~~~~~---~~~~~~~~~~~~~~~~ 387 (476)
+++........ ......||+.|+|||.+.+..++.++|||||||++|||++|+.||.... ........+.......
T Consensus 180 ~~~~~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~ 258 (326)
T 3uim_A 180 LAKLMDYKDTH-VTTAVRGTIGHIAPEYLSTGKSSEKTDVFGYGVMLLELITGQRAFDLARLANDDDVMLLDWVKGLLKE 258 (326)
T ss_dssp SCEECCSSSSC-EECCCCSCGGGCCHHHHHHSEECHHHHHHHHHHHHHHHHHCCCSBCHHHHTTTSCSBHHHHHTTTTSS
T ss_pred cccccCccccc-ccccccCCcCccCHHHhccCCCCccccchhHHHHHHHHHhCCCcccccccccccchhHHHHHHHHhhc
Confidence 99876543322 2223458999999999999899999999999999999999999996422 2333344445555566
Q ss_pred CCcccccCcccCCCCCHHHHHHHHHHHHHchhhcccCCCCHHHHHHHHhccc
Q 045315 388 GRTWELMDPISQNGASYPILKRYINVALLCVQEKAADRPAMSEVVSMLSNEF 439 (476)
Q Consensus 388 ~~~~~~~d~~~~~~~~~~~~~~l~~li~~Cl~~dP~~RPt~~eVl~~L~~~~ 439 (476)
.......+..............+.+++.+||+.||++|||+.||++.|++..
T Consensus 259 ~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~ell~~L~~~~ 310 (326)
T 3uim_A 259 KKLEALVDVDLQGNYKDEEVEQLIQVALLCTQSSPMERPKMSEVVRMLEGDG 310 (326)
T ss_dssp CCSTTSSCTTCTTSCCHHHHHHHHHHHHHHTCSCGGGSCCHHHHHHHHHTSS
T ss_pred hhhhhhcChhhccccCHHHHHHHHHHHHHHhCcCCccCCCHHHHHHHhcCcc
Confidence 6667777777777788888999999999999999999999999999999853
|
| >4b99_A Mitogen-activated protein kinase 7; transferase, inhibitor; HET: R4L; 2.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.97 E-value=1.2e-31 Score=273.79 Aligned_cols=188 Identities=20% Similarity=0.238 Sum_probs=135.4
Q ss_pred cccceeeccCCC-----CCCCCCCChhhHHHHHHHHHHHHHHHhhcCCCceeecCCCccceEecCCCCceeccccceeec
Q 045315 241 DEISFWYESYNN-----PTKKGLLCWGTRVRIIEGIAQGLLYLHQYSRLRVIHRDLKASNILLDKDMNPKISDFGMARMF 315 (476)
Q Consensus 241 ~~~~l~~Ey~~~-----~~~~~~L~~~~~~~i~~qIa~gL~yLH~~~~~~ivH~DLkp~NILld~~~~~kL~DFGla~~~ 315 (476)
+.++++|||++. ..+++.|++.++..++.||+.||+|||+++ ||||||||+|||++.++.+||+|||+|+.+
T Consensus 132 ~~~~ivmE~~~g~L~~~i~~~~~l~~~~~~~~~~qil~al~ylH~~~---iiHRDlKP~NIl~~~~~~~Ki~DFGla~~~ 208 (398)
T 4b99_A 132 KSVYVVLDLMESDLHQIIHSSQPLTLEHVRYFLYQLLRGLKYMHSAQ---VIHRDLKPSNLLVNENCELKIGDFGMARGL 208 (398)
T ss_dssp CCEEEEEECCSEEHHHHHTSSSCCCHHHHHHHHHHHHHHHHHHHHTT---CBCCCCCGGGEEECTTCCEEECCCTTCBCC
T ss_pred CEEEEEEeCCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCc---CcCCCcCccccccCCCCCEEEeecceeeec
Confidence 467899999982 234678999999999999999999999999 999999999999999999999999999876
Q ss_pred CCCc--ccccceeeeeccCCCChhhhccC-CCCccceEEeehhhhhhhhhCCCCCCcCCCCchhhhhhhhhhhcCCC---
Q 045315 316 GGDE--LQSNTKRIVGTYGYMSPEYALRG-LFSIKSDVFSFGVLLLETLSSKKNTHFYNTDSLTLLGHAWNLWNDGR--- 389 (476)
Q Consensus 316 ~~~~--~~~~~~~~~gt~~y~aPE~l~~~-~~s~ksDVwSlGvvl~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~--- 389 (476)
.... .........||+.|+|||++.+. .++.++||||+||++|||++|++||...+... .............
T Consensus 209 ~~~~~~~~~~~~~~~GT~~Y~APEv~~~~~~~~~~~DiWSlG~il~ell~G~~pF~g~~~~~--~l~~I~~~~g~p~~~~ 286 (398)
T 4b99_A 209 CTSPAEHQYFMTEYVATRWYRAPELMLSLHEYTQAIDLWSVGCIFGEMLARRQLFPGKNYVH--QLQLIMMVLGTPSPAV 286 (398)
T ss_dssp -------CCCCCSSCCCCTTCCHHHHTTCSCCCTHHHHHHHHHHHHHHHHTSCSSCCSSHHH--HHHHHHHHHCCCCGGG
T ss_pred ccCccccccccccceeChHhcCHHHhcCCCCCCChhheehhHHHHHHHHHCCCCCCCCCHHH--HHHHHHHhcCCCChHH
Confidence 4321 12223346899999999998875 56999999999999999999999997543111 1111110000000
Q ss_pred --------cccccCcc-cCCCCCH-----HHHHHHHHHHHHchhhcccCCCCHHHHHH
Q 045315 390 --------TWELMDPI-SQNGASY-----PILKRYINVALLCVQEKAADRPAMSEVVS 433 (476)
Q Consensus 390 --------~~~~~d~~-~~~~~~~-----~~~~~l~~li~~Cl~~dP~~RPt~~eVl~ 433 (476)
....+... .....+. .....+.+++.+||+.||++|||++|+++
T Consensus 287 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dLl~~mL~~dP~~R~ta~e~L~ 344 (398)
T 4b99_A 287 IQAVGAERVRAYIQSLPPRQPVPWETVYPGADRQALSLLGRMLRFEPSARISAAAALR 344 (398)
T ss_dssp TC-----CHHHHHHSSCCCCCCCHHHHSTTCCHHHHHHHHHHSCSSTTTSCCHHHHTT
T ss_pred hhhhhhhhhhhhhhcCCCcCCCCHHHhCCCCCHHHHHHHHHHCcCChhHCcCHHHHhc
Confidence 00000000 0000111 12356889999999999999999999876
|
| >4f9c_A Cell division cycle 7-related protein kinase; Ser/Thr protein kinase, transferase, phosphorylation, cell C cell division, mitosis, S phase; HET: 0SX; 2.08A {Homo sapiens} PDB: 4f99_A* 4f9b_A* 4f9a_A* | Back alignment and structure |
|---|
Probab=99.97 E-value=3.9e-31 Score=266.96 Aligned_cols=128 Identities=22% Similarity=0.326 Sum_probs=105.0
Q ss_pred cccceeeccCCCCCC---CCCCChhhHHHHHHHHHHHHHHHhhcCCCceeecCCCccceEecCC-CCceeccccceeecC
Q 045315 241 DEISFWYESYNNPTK---KGLLCWGTRVRIIEGIAQGLLYLHQYSRLRVIHRDLKASNILLDKD-MNPKISDFGMARMFG 316 (476)
Q Consensus 241 ~~~~l~~Ey~~~~~~---~~~L~~~~~~~i~~qIa~gL~yLH~~~~~~ivH~DLkp~NILld~~-~~~kL~DFGla~~~~ 316 (476)
+.++++|||++.+.- -+.+++.++..++.||+.||+|||+++ |+||||||+|||++.+ +.+||+|||+|+...
T Consensus 93 ~~~~lvmE~~~g~~L~~~~~~l~~~~~~~~~~qll~al~ylH~~g---IiHRDiKPeNiLl~~~~~~~kl~DFGla~~~~ 169 (361)
T 4f9c_A 93 DHVVIAMPYLEHESFLDILNSLSFQEVREYMLNLFKALKRIHQFG---IVHRDVKPSNFLYNRRLKKYALVDFGLAQGTH 169 (361)
T ss_dssp TEEEEEEECCCCCCHHHHHTTCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEEETTTTEEEECCCTTCEECT
T ss_pred CEEEEEEeCCCcccHHHHHcCCCHHHHHHHHHHHHHHHHHHHHCC---eEeCcCCHHHeEEeCCCCeEEECcCCCCcccC
Confidence 568899999984321 235999999999999999999999999 9999999999999876 789999999998654
Q ss_pred CCccc--------------------------ccceeeeeccCCCChhhhccC-CCCccceEEeehhhhhhhhhCCCCCCc
Q 045315 317 GDELQ--------------------------SNTKRIVGTYGYMSPEYALRG-LFSIKSDVFSFGVLLLETLSSKKNTHF 369 (476)
Q Consensus 317 ~~~~~--------------------------~~~~~~~gt~~y~aPE~l~~~-~~s~ksDVwSlGvvl~elltG~~p~~~ 369 (476)
..... .......||+.|+|||++.+. .++.++||||+||++|||++|+.||..
T Consensus 170 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~GT~~Y~APE~l~~~~~y~~~~DiWSlG~il~ell~G~~Pf~~ 249 (361)
T 4f9c_A 170 DTKIELLKFVQSEAQQERCSQNKCSICLSRRQQVAPRAGTPGFRAPEVLTKCPNQTTAIDMWSAGVIFLSLLSGRYPFYK 249 (361)
T ss_dssp TCSCGGGGGC--------------------------CCCCGGGCCHHHHTTCSCCCTHHHHHHHHHHHHHHHHTCSSSSC
T ss_pred CccccccccccccccccccccccccccccccccccccccCccccCHHHHcCCCCCCCccchhhhHHHHHHHHHCCCCCCC
Confidence 32111 112235799999999999875 489999999999999999999999854
Q ss_pred CC
Q 045315 370 YN 371 (476)
Q Consensus 370 ~~ 371 (476)
..
T Consensus 250 ~~ 251 (361)
T 4f9c_A 250 AS 251 (361)
T ss_dssp CS
T ss_pred CC
Confidence 43
|
| >3v5w_A G-protein coupled receptor kinase 2; inhibitor complex, protein kinase, beta propeller, RGS homol domain; HET: 8PR; 2.07A {Homo sapiens} PDB: 3cik_A* 3krw_A* 3krx_A* 1omw_A 1ym7_A 2bcj_A* 3uzs_A 3uzt_A 3pvu_A* 3psc_A* 3pvw_A* 1bak_A | Back alignment and structure |
|---|
Probab=99.96 E-value=3.6e-30 Score=275.30 Aligned_cols=173 Identities=25% Similarity=0.306 Sum_probs=136.7
Q ss_pred ccccceeeccCCCCC------CCCCCChhhHHHHHHHHHHHHHHHhhcCCCceeecCCCccceEecCCCCceecccccee
Q 045315 240 KDEISFWYESYNNPT------KKGLLCWGTRVRIIEGIAQGLLYLHQYSRLRVIHRDLKASNILLDKDMNPKISDFGMAR 313 (476)
Q Consensus 240 ~~~~~l~~Ey~~~~~------~~~~L~~~~~~~i~~qIa~gL~yLH~~~~~~ivH~DLkp~NILld~~~~~kL~DFGla~ 313 (476)
.+.++++|||++.+. +.+.|++.++..++.||+.||+|||+++ ||||||||+||||+.++.+||+|||+|+
T Consensus 264 ~~~lylVmEy~~GGdL~~~l~~~~~l~E~~a~~y~~qIl~aL~yLH~~g---IiHRDLKPeNILld~~G~vKL~DFGlA~ 340 (689)
T 3v5w_A 264 PDKLSFILDLMNGGDLHYHLSQHGVFSEADMRFYAAEIILGLEHMHNRF---VVYRDLKPANILLDEHGHVRISDLGLAC 340 (689)
T ss_dssp SSEEEEEECCCCSCBHHHHHHHHCCCCHHHHHHHHHHHHHHHHHHHTTT---EECCCCSGGGEEECTTSCEEECCCTTCE
T ss_pred CCEEEEEEecCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCC---ccccCCchHHeEEeCCCCEEecccceee
Confidence 357899999999543 3567999999999999999999999999 9999999999999999999999999999
Q ss_pred ecCCCcccccceeeeeccCCCChhhhcc-CCCCccceEEeehhhhhhhhhCCCCCCcCCCCch-hhhhhhhhhhcCCCcc
Q 045315 314 MFGGDELQSNTKRIVGTYGYMSPEYALR-GLFSIKSDVFSFGVLLLETLSSKKNTHFYNTDSL-TLLGHAWNLWNDGRTW 391 (476)
Q Consensus 314 ~~~~~~~~~~~~~~~gt~~y~aPE~l~~-~~~s~ksDVwSlGvvl~elltG~~p~~~~~~~~~-~~~~~~~~~~~~~~~~ 391 (476)
.+.... .....||+.|||||++.. ..|+.++|+|||||++|||++|+.||........ .+.... . ....
T Consensus 341 ~~~~~~----~~t~~GTp~YmAPEvl~~~~~y~~~vDiWSLGvilYEmLtG~~PF~~~~~~~~~~i~~~i---~-~~~~- 411 (689)
T 3v5w_A 341 DFSKKK----PHASVGTHGYMAPEVLQKGVAYDSSADWFSLGCMLFKLLRGHSPFRQHKTKDKHEIDRMT---L-TMAV- 411 (689)
T ss_dssp ECSSCC----CCSCCSCGGGCCHHHHSTTCCCCTHHHHHHHHHHHHHHHHSSCTTCGGGCCCHHHHHHHH---H-HCCC-
T ss_pred ecCCCC----CCCccCCcCccCHHHHhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHhh---c-CCCC-
Confidence 875433 233679999999999974 5799999999999999999999999975442221 111111 1 1100
Q ss_pred cccCcccCCCCCHHHHHHHHHHHHHchhhcccCCCC-----HHHHHH
Q 045315 392 ELMDPISQNGASYPILKRYINVALLCVQEKAADRPA-----MSEVVS 433 (476)
Q Consensus 392 ~~~d~~~~~~~~~~~~~~l~~li~~Cl~~dP~~RPt-----~~eVl~ 433 (476)
..+......+.+++.+||+.||++|++ ++||++
T Consensus 412 ---------~~p~~~S~~a~dLI~~lL~~dP~~Rl~~~~~ga~ei~~ 449 (689)
T 3v5w_A 412 ---------ELPDSFSPELRSLLEGLLQRDVNRRLGCLGRGAQEVKE 449 (689)
T ss_dssp ---------CCCTTSCHHHHHHHHHHTCSCGGGCTTCSSSTHHHHTT
T ss_pred ---------CCCccCCHHHHHHHHHHccCCHhHCCCCCCCCHHHHhc
Confidence 111223457889999999999999998 677754
|
| >3poz_A Epidermal growth factor receptor; kinase domain, anti-oncogene, ATP-binding, cell cycle, disea mutation, glycoprotein, membrane, nucleotide-binding; HET: 03P; 1.50A {Homo sapiens} SCOP: d.144.1.7 PDB: 2itx_A* 2ity_A* 2j5f_A* 2j6m_A* 2itw_A* 1m14_A 1m17_A* 3vjo_A* 2gs6_A* 2gs2_A* 2rf9_A 4g5j_A* 1xkk_A* 2eb2_A 3gop_A 2eb3_A* 2itn_A* 2ito_A* 2itp_A* 2itq_A* ... | Back alignment and structure |
|---|
Probab=99.96 E-value=1.3e-30 Score=259.61 Aligned_cols=181 Identities=22% Similarity=0.305 Sum_probs=139.5
Q ss_pred cccceeeccCCCC-------CCCCCCChhhHHHHHHHHHHHHHHHhhcCCCceeecCCCccceEecCCCCceecccccee
Q 045315 241 DEISFWYESYNNP-------TKKGLLCWGTRVRIIEGIAQGLLYLHQYSRLRVIHRDLKASNILLDKDMNPKISDFGMAR 313 (476)
Q Consensus 241 ~~~~l~~Ey~~~~-------~~~~~L~~~~~~~i~~qIa~gL~yLH~~~~~~ivH~DLkp~NILld~~~~~kL~DFGla~ 313 (476)
+..++++||++.+ ..+..+++.+++.++.||+.||+|||+++ |+||||||+|||++.++.+||+|||+++
T Consensus 89 ~~~~~v~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~qi~~~l~~LH~~~---ivH~Dikp~NIll~~~~~~kl~Dfg~a~ 165 (327)
T 3poz_A 89 STVQLITQLMPFGCLLDYVREHKDNIGSQYLLNWCVQIAKGMNYLEDRR---LVHRDLAARNVLVKTPQHVKITDFGLAK 165 (327)
T ss_dssp SSEEEEEECCTTCBHHHHHHHSTTSCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEEEETTEEEECCTTHHH
T ss_pred CCeEEEEEecCCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHhhCC---eeCCCCChheEEECCCCCEEEccCccee
Confidence 3466788888743 23567999999999999999999999998 9999999999999999999999999998
Q ss_pred ecCCCcccccceeeeeccCCCChhhhccCCCCccceEEeehhhhhhhhh-CCCCCCcCCCCchhhhhhhhhhhcCCCccc
Q 045315 314 MFGGDELQSNTKRIVGTYGYMSPEYALRGLFSIKSDVFSFGVLLLETLS-SKKNTHFYNTDSLTLLGHAWNLWNDGRTWE 392 (476)
Q Consensus 314 ~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~s~ksDVwSlGvvl~ellt-G~~p~~~~~~~~~~~~~~~~~~~~~~~~~~ 392 (476)
...............+|..|+|||.+.+..++.++|||||||++|||++ |+.||........ .. ....+..
T Consensus 166 ~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~p~~~~~~~~~--~~----~~~~~~~-- 237 (327)
T 3poz_A 166 LLGAEEKEYHAEGGKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPASEI--SS----ILEKGER-- 237 (327)
T ss_dssp HHTTTCC-------CCCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCGGGH--HH----HHHTTCC--
T ss_pred EccCCcccccccCCCccccccChHHhccCCCCchhhhhhhHHHHHHHHhcCCCCccCCCHHHH--HH----HHHcCCC--
Confidence 8765443333344557889999999999999999999999999999999 9999865432211 11 1111111
Q ss_pred ccCcccCCCCCHHHHHHHHHHHHHchhhcccCCCCHHHHHHHHhccc
Q 045315 393 LMDPISQNGASYPILKRYINVALLCVQEKAADRPAMSEVVSMLSNEF 439 (476)
Q Consensus 393 ~~d~~~~~~~~~~~~~~l~~li~~Cl~~dP~~RPt~~eVl~~L~~~~ 439 (476)
...+......+.+++.+||+.||++||++.+|++.|+.+.
T Consensus 238 -------~~~~~~~~~~~~~li~~~l~~~p~~Rps~~ell~~l~~~~ 277 (327)
T 3poz_A 238 -------LPQPPICTIDVYMIMVKCWMIDADSRPKFRELIIEFSKMA 277 (327)
T ss_dssp -------CCCCTTBCHHHHHHHHHHTCSCGGGSCCHHHHHHHHHHHH
T ss_pred -------CCCCccCCHHHHHHHHHHcCCChhhCCCHHHHHHHHHHHH
Confidence 1111223457889999999999999999999999998764
|
| >3soc_A Activin receptor type-2A; structural genomics consortium, SGC, transferase, protein KI; HET: GVD; 1.95A {Homo sapiens} PDB: 3q4t_A* 4asx_A* 2qlu_A* | Back alignment and structure |
|---|
Probab=99.96 E-value=3.5e-30 Score=255.90 Aligned_cols=192 Identities=21% Similarity=0.295 Sum_probs=142.4
Q ss_pred ccceeeccCCCCC-----CCCCCChhhHHHHHHHHHHHHHHHhhc----------CCCceeecCCCccceEecCCCCcee
Q 045315 242 EISFWYESYNNPT-----KKGLLCWGTRVRIIEGIAQGLLYLHQY----------SRLRVIHRDLKASNILLDKDMNPKI 306 (476)
Q Consensus 242 ~~~l~~Ey~~~~~-----~~~~L~~~~~~~i~~qIa~gL~yLH~~----------~~~~ivH~DLkp~NILld~~~~~kL 306 (476)
..+++|||++.++ +...+++.++..++.||+.||+|||+. + |+||||||+|||++.++.+||
T Consensus 96 ~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~i~~qi~~al~~LH~~~~~l~~~~~~~---ivH~Dlkp~Nill~~~~~~kL 172 (322)
T 3soc_A 96 DLWLITAFHEKGSLSDFLKANVVSWNELCHIAETMARGLAYLHEDIPGLKDGHKPA---ISHRDIKSKNVLLKNNLTACI 172 (322)
T ss_dssp EEEEEEECCTTCBHHHHHHHCCBCHHHHHHHHHHHHHHHHHHTCCEEEETTEEECE---EECSCCSGGGEEECTTCCEEE
T ss_pred eEEEEEecCCCCCHHHHHHhcCCCHHHHHHHHHHHHHHHHHHHhhccccccccCCC---EEeCCCChHhEEECCCCeEEE
Confidence 3688999998432 234699999999999999999999998 7 999999999999999999999
Q ss_pred ccccceeecCCCcccccceeeeeccCCCChhhhcc-----CCCCccceEEeehhhhhhhhhCCCCCCcCCCCc-hhhhhh
Q 045315 307 SDFGMARMFGGDELQSNTKRIVGTYGYMSPEYALR-----GLFSIKSDVFSFGVLLLETLSSKKNTHFYNTDS-LTLLGH 380 (476)
Q Consensus 307 ~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~l~~-----~~~s~ksDVwSlGvvl~elltG~~p~~~~~~~~-~~~~~~ 380 (476)
+|||+++...............||+.|+|||.+.+ ..++.++|||||||++|||++|+.||....... ......
T Consensus 173 ~DFg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DiwslG~il~el~tg~~pf~~~~~~~~~~~~~~ 252 (322)
T 3soc_A 173 ADFGLALKFEAGKSAGDTHGQVGTRRYMAPEVLEGAINFQRDAFLRIDMYAMGLVLWELASRCTAADGPVDEYMLPFEEE 252 (322)
T ss_dssp CCCTTCEEECTTSCCCCCTTCCCCGGGCCHHHHTTCCCCCHHHHHHHHHHHHHHHHHHHHTTBTTSSSCCCCCCCTTHHH
T ss_pred ccCCcccccccccCccccccCccCccccCHhhcccccccCcCCCccchhHHHHHHHHHHHhCCCCCCCCcchhccchhhh
Confidence 99999988765443333334578999999999986 356678999999999999999999987543211 111000
Q ss_pred ---------hhhhhcCCCcccccCcccCCCCCHHHHHHHHHHHHHchhhcccCCCCHHHHHHHHhccc
Q 045315 381 ---------AWNLWNDGRTWELMDPISQNGASYPILKRYINVALLCVQEKAADRPAMSEVVSMLSNEF 439 (476)
Q Consensus 381 ---------~~~~~~~~~~~~~~d~~~~~~~~~~~~~~l~~li~~Cl~~dP~~RPt~~eVl~~L~~~~ 439 (476)
.............+... .........+.+++.+||+.||++|||+.||++.|+.+.
T Consensus 253 ~~~~~~~~~~~~~~~~~~~~~~~~~~---~~~~~~~~~l~~li~~cl~~dP~~Rps~~ell~~L~~l~ 317 (322)
T 3soc_A 253 IGQHPSLEDMQEVVVHKKKRPVLRDY---WQKHAGMAMLCETIEECWDHDAEARLSAGCVGERITQMQ 317 (322)
T ss_dssp HCSSCCHHHHHHHHTTSCCCCCCCGG---GGSSHHHHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHH
T ss_pred hccCCchhhhhhhhhcccCCCCcccc---ccccchHHHHHHHHHHHccCChhhCcCHHHHHHHHHHHH
Confidence 00001111110101110 012345667999999999999999999999999999865
|
| >3q4u_A Activin receptor type-1; structural genomics consortium, SGC, protein kinase, transfe; HET: LDN FLC; 1.82A {Homo sapiens} PDB: 3mtf_A* 3oom_A* 4dym_A* 3h9r_A* 3my0_A* | Back alignment and structure |
|---|
Probab=99.96 E-value=2.2e-29 Score=246.67 Aligned_cols=190 Identities=23% Similarity=0.233 Sum_probs=139.8
Q ss_pred ccceeeccCCCCC-----CCCCCChhhHHHHHHHHHHHHHHHh--------hcCCCceeecCCCccceEecCCCCceecc
Q 045315 242 EISFWYESYNNPT-----KKGLLCWGTRVRIIEGIAQGLLYLH--------QYSRLRVIHRDLKASNILLDKDMNPKISD 308 (476)
Q Consensus 242 ~~~l~~Ey~~~~~-----~~~~L~~~~~~~i~~qIa~gL~yLH--------~~~~~~ivH~DLkp~NILld~~~~~kL~D 308 (476)
..++++||++.+. +...+++.++++++.||+.||+||| +.+ |+||||||+|||++.++.+||+|
T Consensus 80 ~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~~~~---ivH~Dlkp~Nill~~~~~~kl~D 156 (301)
T 3q4u_A 80 QLWLITHYHEMGSLYDYLQLTTLDTVSCLRIVLSIASGLAHLHIEIFGTQGKPA---IAHRDLKSKNILVKKNGQCCIAD 156 (301)
T ss_dssp EEEEEECCCTTCBHHHHHTTCCBCHHHHHHHHHHHHHHHHHHHSCBCSTTCBCE---EECSCCCGGGEEECTTSCEEECC
T ss_pred eeEEehhhccCCCHHHHHhhcccCHHHHHHHHHHHHHHHHHHHHhhhhccCCCC---eecCCCChHhEEEcCCCCEEEee
Confidence 4678999998432 3557999999999999999999999 777 99999999999999999999999
Q ss_pred ccceeecCCCccc--ccceeeeeccCCCChhhhccC------CCCccceEEeehhhhhhhhhC----------CCCCCcC
Q 045315 309 FGMARMFGGDELQ--SNTKRIVGTYGYMSPEYALRG------LFSIKSDVFSFGVLLLETLSS----------KKNTHFY 370 (476)
Q Consensus 309 FGla~~~~~~~~~--~~~~~~~gt~~y~aPE~l~~~------~~s~ksDVwSlGvvl~elltG----------~~p~~~~ 370 (476)
||+++........ .......||+.|+|||.+.+. .++.++|||||||++|||++| +.||...
T Consensus 157 fg~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~DvwslG~il~el~tg~~~~~~~~~~~~pf~~~ 236 (301)
T 3q4u_A 157 LGLAVMHSQSTNQLDVGNNPRVGTKRYMAPEVLDETIQVDCFDSYKRVDIWAFGLVLWEVARRMVSNGIVEDYKPPFYDV 236 (301)
T ss_dssp CTTCEEEETTTTEEECCCCCCCCCGGGCCHHHHTTCCCTTCHHHHHHHHHHHHHHHHHHHHTTBCBTTBCCCCCCTTTTT
T ss_pred CCCeeecccccccccccccccccccceeChhhhcCcCCCCcccCCchhhHHHHHHHHHHHHhhhcCcccccccccccccc
Confidence 9999876443221 112234789999999999876 456899999999999999999 6666543
Q ss_pred CCCchhhhhhhhhhhcCCCcccccCcccCCCCCHHHHHHHHHHHHHchhhcccCCCCHHHHHHHHhcc
Q 045315 371 NTDSLTLLGHAWNLWNDGRTWELMDPISQNGASYPILKRYINVALLCVQEKAADRPAMSEVVSMLSNE 438 (476)
Q Consensus 371 ~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~l~~li~~Cl~~dP~~RPt~~eVl~~L~~~ 438 (476)
........................ ...........+.+++.+||+.||++|||+.||++.|+++
T Consensus 237 ~~~~~~~~~~~~~~~~~~~~~~~~----~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~~i~~~L~~i 300 (301)
T 3q4u_A 237 VPNDPSFEDMRKVVCVDQQRPNIP----NRWFSDPTLTSLAKLMKECWYQNPSARLTALRIKKTLTKI 300 (301)
T ss_dssp SCSSCCHHHHHHHHTTSCCCCCCC----GGGGGSHHHHHHHHHHHHHCCSSGGGSCCHHHHHHHHHHH
T ss_pred CCCCcchhhhhHHHhccCCCCCCC----hhhccCccHHHHHHHHHHHhhcChhhCCCHHHHHHHHhcc
Confidence 322211111111111111111110 0111234667899999999999999999999999999874
|
| >3p86_A Serine/threonine-protein kinase CTR1; ETR1, ERS1, ETR2, phosphorylation, transferase; HET: STU; 2.50A {Arabidopsis thaliana} PDB: 3ppz_A* | Back alignment and structure |
|---|
Probab=99.96 E-value=8.4e-30 Score=251.94 Aligned_cols=189 Identities=24% Similarity=0.356 Sum_probs=133.0
Q ss_pred cccceeeccCCCCC------C---CCCCChhhHHHHHHHHHHHHHHHhhcCCCceeecCCCccceEecCCCCceeccccc
Q 045315 241 DEISFWYESYNNPT------K---KGLLCWGTRVRIIEGIAQGLLYLHQYSRLRVIHRDLKASNILLDKDMNPKISDFGM 311 (476)
Q Consensus 241 ~~~~l~~Ey~~~~~------~---~~~L~~~~~~~i~~qIa~gL~yLH~~~~~~ivH~DLkp~NILld~~~~~kL~DFGl 311 (476)
+..+++|||++.+. + ...+++.+++.++.||+.||+|||+++ .+|+||||||+||+++.++.+||+|||+
T Consensus 107 ~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~-~~ivH~Dikp~NIll~~~~~~kL~Dfg~ 185 (309)
T 3p86_A 107 PNLSIVTEYLSRGSLYRLLHKSGAREQLDERRRLSMAYDVAKGMNYLHNRN-PPIVHRNLKSPNLLVDKKYTVKVCDFGL 185 (309)
T ss_dssp TCCEEEEECCTTCBHHHHHHSTTHHHHSCHHHHHHHHHHHHHHHHHHHTSS-SCCCCTTCCGGGEEECTTCCEEECCCC-
T ss_pred CceEEEEecCCCCcHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHcCC-CCEECCCCChhhEEEeCCCcEEECCCCC
Confidence 45789999998431 1 224999999999999999999999975 3499999999999999999999999999
Q ss_pred eeecCCCcccccceeeeeccCCCChhhhccCCCCccceEEeehhhhhhhhhCCCCCCcCCCCchhhhhhhhhhhcCCCcc
Q 045315 312 ARMFGGDELQSNTKRIVGTYGYMSPEYALRGLFSIKSDVFSFGVLLLETLSSKKNTHFYNTDSLTLLGHAWNLWNDGRTW 391 (476)
Q Consensus 312 a~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~s~ksDVwSlGvvl~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~ 391 (476)
++....... ......||..|+|||.+.+..++.++|||||||++|||++|+.||...... ...... .......
T Consensus 186 a~~~~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~elltg~~Pf~~~~~~--~~~~~~---~~~~~~~ 258 (309)
T 3p86_A 186 SRLKASTFL--SSKSAAGTPEWMAPEVLRDEPSNEKSDVYSFGVILWELATLQQPWGNLNPA--QVVAAV---GFKCKRL 258 (309)
T ss_dssp ------------------CCTTSCHHHHTTCCCCTTHHHHHHHHHHHHHHHCCCTTTTSCHH--HHHHHH---HHSCCCC
T ss_pred Ccccccccc--ccccCCCCccccChhhhcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHH--HHHHHH---HhcCCCC
Confidence 986543221 123357899999999999999999999999999999999999998654321 111111 0011110
Q ss_pred cccCcccCCCCCHHHHHHHHHHHHHchhhcccCCCCHHHHHHHHhccccCCCCCC
Q 045315 392 ELMDPISQNGASYPILKRYINVALLCVQEKAADRPAMSEVVSMLSNEFVNLPAPQ 446 (476)
Q Consensus 392 ~~~d~~~~~~~~~~~~~~l~~li~~Cl~~dP~~RPt~~eVl~~L~~~~~~~~~p~ 446 (476)
..+......+.+++.+||+.||++|||+++|++.|+.+.....+||
T Consensus 259 ---------~~~~~~~~~l~~li~~~l~~dP~~Rps~~~ll~~L~~~~~~~~p~~ 304 (309)
T 3p86_A 259 ---------EIPRNLNPQVAAIIEGCWTNEPWKRPSFATIMDLLRPLIKSAVPPP 304 (309)
T ss_dssp ---------CCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHC------
T ss_pred ---------CCCccCCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHHhCCCCC
Confidence 1112233568899999999999999999999999999875543333
|
| >1csn_A Casein kinase-1; phosphotransferase; HET: ATP; 2.00A {Schizosaccharomyces pombe} SCOP: d.144.1.7 PDB: 1eh4_A* 2csn_A* | Back alignment and structure |
|---|
Probab=99.96 E-value=4e-29 Score=244.41 Aligned_cols=195 Identities=14% Similarity=0.113 Sum_probs=145.8
Q ss_pred cccceeeccCCC------CCCCCCCChhhHHHHHHHHHHHHHHHhhcCCCceeecCCCccceEecCCCC-----ceeccc
Q 045315 241 DEISFWYESYNN------PTKKGLLCWGTRVRIIEGIAQGLLYLHQYSRLRVIHRDLKASNILLDKDMN-----PKISDF 309 (476)
Q Consensus 241 ~~~~l~~Ey~~~------~~~~~~L~~~~~~~i~~qIa~gL~yLH~~~~~~ivH~DLkp~NILld~~~~-----~kL~DF 309 (476)
+..++++||+.. ...+.++++.++..++.||+.||+|||+++ |+||||||+||+++.++. +||+||
T Consensus 79 ~~~~lv~e~~~~~L~~~l~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~---ivH~Dlkp~NIl~~~~~~~~~~~~kl~Df 155 (298)
T 1csn_A 79 LHNVLVIDLLGPSLEDLLDLCGRKFSVKTVAMAAKQMLARVQSIHEKS---LVYRDIKPDNFLIGRPNSKNANMIYVVDF 155 (298)
T ss_dssp TEEEEEEECCCCBHHHHHHHTTTCCCHHHHHHHHHHHHHHHHHHHTTT---EECCCCCGGGEEECCSSSTTTTCEEECCC
T ss_pred ceeEEEEEecCCCHHHHHHHhccCCCHHHHHHHHHHHHHHHHHHHhCC---EecCCCCHHHEEeccCCCCCCCeEEEEEC
Confidence 456788999841 112456999999999999999999999999 999999999999987765 999999
Q ss_pred cceeecCCCccc-----ccceeeeeccCCCChhhhccCCCCccceEEeehhhhhhhhhCCCCCCcCCC-Cchhhhhhhhh
Q 045315 310 GMARMFGGDELQ-----SNTKRIVGTYGYMSPEYALRGLFSIKSDVFSFGVLLLETLSSKKNTHFYNT-DSLTLLGHAWN 383 (476)
Q Consensus 310 Gla~~~~~~~~~-----~~~~~~~gt~~y~aPE~l~~~~~s~ksDVwSlGvvl~elltG~~p~~~~~~-~~~~~~~~~~~ 383 (476)
|+++........ .......||..|+|||.+.+..++.++||||||+++|||++|+.||..... ...........
T Consensus 156 g~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~~~~~~~~~~~~~~ 235 (298)
T 1csn_A 156 GMVKFYRDPVTKQHIPYREKKNLSGTARYMSINTHLGREQSRRDDLEALGHVFMYFLRGSLPWQGLKAATNKQKYERIGE 235 (298)
T ss_dssp TTCEESBCTTTCCBCCCCCCCCCCSCTTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCTTSSCCSCCHHHHHHHHHH
T ss_pred ccccccccccccccccccCccCCCCCcccCCchhhcCCCCChHHHHHHHHHHHHHHHcCCCCcchhhccccHHHHHHHHh
Confidence 999877543221 122345789999999999999999999999999999999999999976542 22211111111
Q ss_pred hhcCCCcccccCcccCCCCCHHHHHHHHHHHHHchhhcccCCCCHHHHHHHHhccccCCCCCCC
Q 045315 384 LWNDGRTWELMDPISQNGASYPILKRYINVALLCVQEKAADRPAMSEVVSMLSNEFVNLPAPQQ 447 (476)
Q Consensus 384 ~~~~~~~~~~~d~~~~~~~~~~~~~~l~~li~~Cl~~dP~~RPt~~eVl~~L~~~~~~~~~p~~ 447 (476)
........+ .. ....+.+.+++.+||+.||++||++++|++.|+++..+......
T Consensus 236 ~~~~~~~~~-----~~----~~~~~~l~~li~~~l~~dp~~RP~~~~l~~~l~~~~~~~~~~~~ 290 (298)
T 1csn_A 236 KKQSTPLRE-----LC----AGFPEEFYKYMHYARNLAFDATPDYDYLQGLFSKVLERLNTTED 290 (298)
T ss_dssp HHHHSCHHH-----HT----TTSCHHHHHHHHHHHHCCTTCCCCHHHHHHHHHHHHHHTTCCSC
T ss_pred hccCccHHH-----HH----hhCcHHHHHHHHHHhcCCcccCCCHHHHHHHHHHHHHhcCCCCC
Confidence 100000000 00 11235788999999999999999999999999998766554433
|
| >2nru_A Interleukin-1 receptor-associated kinase 4; inhibitor, IRAK, transferase; HET: TPO SEP T12; 2.00A {Homo sapiens} PDB: 2nry_A* 2oib_A* 2oic_A* 2oid_A* 2o8y_A* | Back alignment and structure |
|---|
Probab=99.96 E-value=6.4e-29 Score=244.34 Aligned_cols=193 Identities=34% Similarity=0.492 Sum_probs=147.0
Q ss_pred cccceeeccCCCC---------CCCCCCChhhHHHHHHHHHHHHHHHhhcCCCceeecCCCccceEecCCCCceeccccc
Q 045315 241 DEISFWYESYNNP---------TKKGLLCWGTRVRIIEGIAQGLLYLHQYSRLRVIHRDLKASNILLDKDMNPKISDFGM 311 (476)
Q Consensus 241 ~~~~l~~Ey~~~~---------~~~~~L~~~~~~~i~~qIa~gL~yLH~~~~~~ivH~DLkp~NILld~~~~~kL~DFGl 311 (476)
+..+++|||++.. ....++++..++.++.||+.||+|||+++ |+||||||+||+++.++.+||+|||+
T Consensus 103 ~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~---i~H~dlkp~Nili~~~~~~kl~Dfg~ 179 (307)
T 2nru_A 103 DDLCLVYVYMPNGSLLDRLSCLDGTPPLSWHMRCKIAQGAANGINFLHENH---HIHRDIKSANILLDEAFTAKISDFGL 179 (307)
T ss_dssp SSCEEEEECCTTCBHHHHHHTGGGCCCCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCCGGGEEECTTCCEEECCCTT
T ss_pred CceEEEEEecCCCcHHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHhcCC---eecCCCCHHHEEEcCCCcEEEeeccc
Confidence 4678889999732 23457999999999999999999999999 99999999999999999999999999
Q ss_pred eeecCCCcccccceeeeeccCCCChhhhccCCCCccceEEeehhhhhhhhhCCCCCCcCCCCchhhhhhhhhhhc-CCCc
Q 045315 312 ARMFGGDELQSNTKRIVGTYGYMSPEYALRGLFSIKSDVFSFGVLLLETLSSKKNTHFYNTDSLTLLGHAWNLWN-DGRT 390 (476)
Q Consensus 312 a~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~s~ksDVwSlGvvl~elltG~~p~~~~~~~~~~~~~~~~~~~~-~~~~ 390 (476)
++...............|+..|+|||.+.+ .++.++||||||+++|+|++|+.||........ .......... ....
T Consensus 180 ~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~-~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~-~~~~~~~~~~~~~~~ 257 (307)
T 2nru_A 180 ARASEKFAQTVMTSRIVGTTAYMAPEALRG-EITPKSDIYSFGVVLLEIITGLPAVDEHREPQL-LLDIKEEIEDEEKTI 257 (307)
T ss_dssp CEECCSCSSCEECSSCCSCGGGCCHHHHTT-EECTHHHHHHHHHHHHHHHHCCCSBCTTBSSSB-TTHHHHHHHTTSCCH
T ss_pred ccccccccccccccccCCCcCcCChHHhcC-CCCccchhHHHHHHHHHHHHCCCCcccCcchHH-HHHHHHHhhhhhhhh
Confidence 987654332222333568999999998764 588999999999999999999999875542221 1111111111 1122
Q ss_pred ccccCcccCCCCCHHHHHHHHHHHHHchhhcccCCCCHHHHHHHHhccc
Q 045315 391 WELMDPISQNGASYPILKRYINVALLCVQEKAADRPAMSEVVSMLSNEF 439 (476)
Q Consensus 391 ~~~~d~~~~~~~~~~~~~~l~~li~~Cl~~dP~~RPt~~eVl~~L~~~~ 439 (476)
.+.++... ..........+.+++.+||+.||.+||++.+|++.|+++.
T Consensus 258 ~~~~~~~~-~~~~~~~~~~l~~li~~cl~~~p~~Rps~~~l~~~L~~l~ 305 (307)
T 2nru_A 258 EDYIDKKM-NDADSTSVEAMYSVASQCLHEKKNKRPDIKKVQQLLQEMT 305 (307)
T ss_dssp HHHSCSSC-SCCCHHHHHHHHHHHHHHTCSSTTTSCCHHHHHHHHHHHC
T ss_pred hhhccccc-cccchHHHHHHHHHHHHHcCCCcccCcCHHHHHHHHHHHh
Confidence 23333322 2345667788999999999999999999999999999864
|
| >2psq_A Fibroblast growth factor receptor 2; kinase domain fold consisting of N- and C-lobes, transferase; 2.40A {Homo sapiens} SCOP: d.144.1.7 PDB: 1xr0_A | Back alignment and structure |
|---|
Probab=99.96 E-value=2.4e-29 Score=255.06 Aligned_cols=181 Identities=23% Similarity=0.331 Sum_probs=142.0
Q ss_pred cccceeeccCCCCC----------------------CCCCCChhhHHHHHHHHHHHHHHHhhcCCCceeecCCCccceEe
Q 045315 241 DEISFWYESYNNPT----------------------KKGLLCWGTRVRIIEGIAQGLLYLHQYSRLRVIHRDLKASNILL 298 (476)
Q Consensus 241 ~~~~l~~Ey~~~~~----------------------~~~~L~~~~~~~i~~qIa~gL~yLH~~~~~~ivH~DLkp~NILl 298 (476)
+..+++|||++.+. ....+++.+++.++.||+.||+|||+++ |+||||||+|||+
T Consensus 160 ~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~---ivHrDlkp~NIll 236 (370)
T 2psq_A 160 GPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTFKDLVSCTYQLARGMEYLASQK---CIHRDLAARNVLV 236 (370)
T ss_dssp SSCEEEEECCTTCBHHHHHHHTCCC-----------CCCCCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCCGGGEEE
T ss_pred CCEEEEEEcCCCCCHHHHHHhhCCccccccccccccccccCCHHHHHHHHHHHHHHHHHHHhCC---eeccccchhhEEE
Confidence 46889999997321 1246899999999999999999999999 9999999999999
Q ss_pred cCCCCceeccccceeecCCCcccccceeeeeccCCCChhhhccCCCCccceEEeehhhhhhhhh-CCCCCCcCCCCchhh
Q 045315 299 DKDMNPKISDFGMARMFGGDELQSNTKRIVGTYGYMSPEYALRGLFSIKSDVFSFGVLLLETLS-SKKNTHFYNTDSLTL 377 (476)
Q Consensus 299 d~~~~~kL~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~s~ksDVwSlGvvl~ellt-G~~p~~~~~~~~~~~ 377 (476)
+.++.+||+|||+++...............+++.|+|||.+.+..++.++|||||||++|||++ |+.||....... +
T Consensus 237 ~~~~~~kl~DFG~a~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~DvwslG~il~ellt~g~~p~~~~~~~~--~ 314 (370)
T 2psq_A 237 TENNVMKIADFGLARDINNIDYYKKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFTLGGSPYPGIPVEE--L 314 (370)
T ss_dssp CTTCCEEECCCSSCEETTCCCTTCTTTTTTSCGGGCCHHHHHTCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCGGG--H
T ss_pred CCCCCEEEccccCCcccCcccceecccCCCcccceECHhHhcCCCCCcHHHHHHHHHHHHHHHcCCCCCCCCCCHHH--H
Confidence 9999999999999997755433222333456789999999999999999999999999999999 999986543211 1
Q ss_pred hhhhhhhhcCCCcccccCcccCCCCCHHHHHHHHHHHHHchhhcccCCCCHHHHHHHHhccc
Q 045315 378 LGHAWNLWNDGRTWELMDPISQNGASYPILKRYINVALLCVQEKAADRPAMSEVVSMLSNEF 439 (476)
Q Consensus 378 ~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~l~~li~~Cl~~dP~~RPt~~eVl~~L~~~~ 439 (476)
.. ....+... ..+......+.+++.+||+.||++||++.|+++.|+.+.
T Consensus 315 ~~----~~~~~~~~---------~~~~~~~~~l~~li~~~l~~dP~~Rpt~~ell~~L~~il 363 (370)
T 2psq_A 315 FK----LLKEGHRM---------DKPANCTNELYMMMRDCWHAVPSQRPTFKQLVEDLDRIL 363 (370)
T ss_dssp HH----HHHTTCCC---------CCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHH
T ss_pred HH----HHhcCCCC---------CCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHH
Confidence 11 11111111 111223457889999999999999999999999999875
|
| >3uto_A Twitchin; kinase, muscle sarcomere, transferase; HET: FLC P33; 2.40A {Caenorhabditis elegans} PDB: 1koa_A | Back alignment and structure |
|---|
Probab=99.96 E-value=3.1e-29 Score=267.79 Aligned_cols=175 Identities=21% Similarity=0.260 Sum_probs=137.4
Q ss_pred cccceeeccCCCC-------CCCCCCChhhHHHHHHHHHHHHHHHhhcCCCceeecCCCccceEecCC--CCceeccccc
Q 045315 241 DEISFWYESYNNP-------TKKGLLCWGTRVRIIEGIAQGLLYLHQYSRLRVIHRDLKASNILLDKD--MNPKISDFGM 311 (476)
Q Consensus 241 ~~~~l~~Ey~~~~-------~~~~~L~~~~~~~i~~qIa~gL~yLH~~~~~~ivH~DLkp~NILld~~--~~~kL~DFGl 311 (476)
+..+++|||++.+ .+...|++.++..++.||+.||+|||+++ |+||||||+|||++.+ +.+||+|||+
T Consensus 227 ~~~~iv~E~~~gg~L~~~i~~~~~~l~e~~~~~~~~qi~~al~ylH~~~---iiHRDlKp~Nill~~~~~~~vKl~DFG~ 303 (573)
T 3uto_A 227 NEMVMIYEFMSGGELFEKVADEHNKMSEDEAVEYMRQVCKGLCHMHENN---YVHLDLKPENIMFTTKRSNELKLIDFGL 303 (573)
T ss_dssp SEEEEEEECCCCCBHHHHHTCTTSCEEHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEESSSSCCCEEECCCSS
T ss_pred CEEEEEEeecCCCcHHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHCC---eeeccCChhhccccCCCCCCEEEeeccc
Confidence 5688999999843 34568999999999999999999999999 9999999999999854 7899999999
Q ss_pred eeecCCCcccccceeeeeccCCCChhhhccCCCCccceEEeehhhhhhhhhCCCCCCcCCCCchhhhhhhhhhhcCCCcc
Q 045315 312 ARMFGGDELQSNTKRIVGTYGYMSPEYALRGLFSIKSDVFSFGVLLLETLSSKKNTHFYNTDSLTLLGHAWNLWNDGRTW 391 (476)
Q Consensus 312 a~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~s~ksDVwSlGvvl~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~ 391 (476)
|+.+.... ......||+.|+|||++.+..|+.++|||||||++|||++|+.||...... ...... .....
T Consensus 304 a~~~~~~~---~~~~~~GT~~y~APEv~~~~~y~~~~DiWSlGvilyeml~G~~Pf~~~~~~--~~~~~i----~~~~~- 373 (573)
T 3uto_A 304 TAHLDPKQ---SVKVTTGTAEFAAPEVAEGKPVGYYTDMWSVGVLSYILLSGLSPFGGENDD--ETLRNV----KSCDW- 373 (573)
T ss_dssp CEECCTTS---EEEEECSSGGGCCHHHHTTCCBCHHHHHHHHHHHHHHHHHSCCSSCCSSHH--HHHHHH----HTTCC-
T ss_pred eeEccCCC---ceeeeEECccccCHHHhCCCCCCcHHHHHHHHHHHHHHHHCCCCCCCcCHH--HHHHHH----HhCCC-
Confidence 99875432 233467999999999999999999999999999999999999999754321 111111 11110
Q ss_pred cccCcccCCCCCHHHHHHHHHHHHHchhhcccCCCCHHHHHH
Q 045315 392 ELMDPISQNGASYPILKRYINVALLCVQEKAADRPAMSEVVS 433 (476)
Q Consensus 392 ~~~d~~~~~~~~~~~~~~l~~li~~Cl~~dP~~RPt~~eVl~ 433 (476)
...+. ......+.+.+|+.+||+.||++|||+.|+++
T Consensus 374 ~~~~~-----~~~~~s~~~~dli~~~L~~dp~~R~t~~e~l~ 410 (573)
T 3uto_A 374 NMDDS-----AFSGISEDGKDFIRKLLLADPNTRMTIHQALE 410 (573)
T ss_dssp CCCSG-----GGTTSCHHHHHHHHTTSCSSGGGSCCHHHHHH
T ss_pred CCCcc-----cccCCCHHHHHHHHHHccCChhHCcCHHHHhc
Confidence 00001 01122456889999999999999999999986
|
| >3op5_A Serine/threonine-protein kinase VRK1; adenosine triphosphate, amino acid sequence, binding sites, domain, models, molecular; HET: REB; 2.40A {Homo sapiens} PDB: 2lav_A 2kty_A 2kul_A | Back alignment and structure |
|---|
Probab=99.95 E-value=2.3e-29 Score=254.30 Aligned_cols=204 Identities=14% Similarity=0.121 Sum_probs=151.5
Q ss_pred ccceeeccCCC------CCCCCCCChhhHHHHHHHHHHHHHHHhhcCCCceeecCCCccceEec--CCCCceecccccee
Q 045315 242 EISFWYESYNN------PTKKGLLCWGTRVRIIEGIAQGLLYLHQYSRLRVIHRDLKASNILLD--KDMNPKISDFGMAR 313 (476)
Q Consensus 242 ~~~l~~Ey~~~------~~~~~~L~~~~~~~i~~qIa~gL~yLH~~~~~~ivH~DLkp~NILld--~~~~~kL~DFGla~ 313 (476)
..+++|||+.. ....+.+++.+++.++.||+.||+|||+++ |+||||||+|||++ .++.+||+|||+++
T Consensus 126 ~~~lv~e~~g~~L~~~~~~~~~~l~~~~~~~i~~qi~~~l~~lH~~~---iiHrDlkp~Nill~~~~~~~~kl~DFG~a~ 202 (364)
T 3op5_A 126 YRFMIMDRFGSDLQKIYEANAKRFSRKTVLQLSLRILDILEYIHEHE---YVHGDIKASNLLLNYKNPDQVYLVDYGLAY 202 (364)
T ss_dssp EEEEEEECEEEEHHHHHHHTTSCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEEESSCTTCEEECCCTTCE
T ss_pred eEEEEEeCCCCCHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHHCC---eEEecCCHHHEEEecCCCCeEEEEECCcce
Confidence 36788999841 123467999999999999999999999998 99999999999999 88999999999998
Q ss_pred ecCCCccc-----ccceeeeeccCCCChhhhccCCCCccceEEeehhhhhhhhhCCCCCCcCCCCchhhhhhhhhhhcCC
Q 045315 314 MFGGDELQ-----SNTKRIVGTYGYMSPEYALRGLFSIKSDVFSFGVLLLETLSSKKNTHFYNTDSLTLLGHAWNLWNDG 388 (476)
Q Consensus 314 ~~~~~~~~-----~~~~~~~gt~~y~aPE~l~~~~~s~ksDVwSlGvvl~elltG~~p~~~~~~~~~~~~~~~~~~~~~~ 388 (476)
.+...... .......||+.|+|||.+.+..++.++|||||||++|||++|+.||.....+..... ...... ..
T Consensus 203 ~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~g~~Pf~~~~~~~~~~~-~~~~~~-~~ 280 (364)
T 3op5_A 203 RYCPEGVHKAYAADPKRCHDGTIEFTSIDAHNGVAPSRRGDLEILGYCMIQWLTGHLPWEDNLKDPKYVR-DSKIRY-RE 280 (364)
T ss_dssp ESSGGGCCCCSSCCSSCCCCCCTTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSCCTTGGGTTCHHHHH-HHHHHH-HH
T ss_pred ecccCCcccccccCcccccCCCCCccCHHHhCCCCCCchhhHHHHHHHHHHHHhCCCCccccccCHHHHH-HHHHHh-hh
Confidence 76533211 111234599999999999999999999999999999999999999975433222111 111111 11
Q ss_pred CcccccCcccCCCCCHHHHHHHHHHHHHchhhcccCCCCHHHHHHHHhccccCCCCCCCCcceec
Q 045315 389 RTWELMDPISQNGASYPILKRYINVALLCVQEKAADRPAMSEVVSMLSNEFVNLPAPQQPAFSCV 453 (476)
Q Consensus 389 ~~~~~~d~~~~~~~~~~~~~~l~~li~~Cl~~dP~~RPt~~eVl~~L~~~~~~~~~p~~p~~~~~ 453 (476)
...+++++.+.. ......+.+++.+||+.||++||++.+|++.|+.+..+...+....+.+.
T Consensus 281 ~~~~~~~~~~~~---~~~~~~~~~li~~cl~~~p~~RP~~~~l~~~l~~~~~~~~~~~~~~~dw~ 342 (364)
T 3op5_A 281 NIASLMDKCFPA---ANAPGEIAKYMETVKLLDYTEKPLYENLRDILLQGLKAIGSKDDGKLDLS 342 (364)
T ss_dssp CHHHHHHHHSCT---TCCCHHHHHHHHHHHTCCTTCCCCHHHHHHHHHHHHHHTTCCCCCCCCC-
T ss_pred hHHHHHHHhccc---ccCHHHHHHHHHHHhcCCCCCCCCHHHHHHHHHHHHHHcCCCcCCccceE
Confidence 122222222211 11235688999999999999999999999999998877766665555544
|
| >3s95_A LIMK-1, LIM domain kinase 1; structural genomics, structural genomics consortium, SGC, PR kinase, transferase-antibiotic complex; HET: STU GOL; 1.65A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.95 E-value=2e-29 Score=248.61 Aligned_cols=187 Identities=25% Similarity=0.428 Sum_probs=141.8
Q ss_pred cccceeeccCCCCC-------CCCCCChhhHHHHHHHHHHHHHHHhhcCCCceeecCCCccceEecCCCCceecccccee
Q 045315 241 DEISFWYESYNNPT-------KKGLLCWGTRVRIIEGIAQGLLYLHQYSRLRVIHRDLKASNILLDKDMNPKISDFGMAR 313 (476)
Q Consensus 241 ~~~~l~~Ey~~~~~-------~~~~L~~~~~~~i~~qIa~gL~yLH~~~~~~ivH~DLkp~NILld~~~~~kL~DFGla~ 313 (476)
+..+++|||++... ....+++.++..++.||+.||+|||+++ |+||||||+||+++.++.+||+|||+++
T Consensus 80 ~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~qi~~al~~lH~~~---ivH~dlkp~Nil~~~~~~~kl~Dfg~~~ 156 (310)
T 3s95_A 80 KRLNFITEYIKGGTLRGIIKSMDSQYPWSQRVSFAKDIASGMAYLHSMN---IIHRDLNSHNCLVRENKNVVVADFGLAR 156 (310)
T ss_dssp TEEEEEEECCTTCBHHHHHHHCCTTSCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSTTSEEECTTSCEEECCCTTCE
T ss_pred CeeEEEEEecCCCcHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHhCC---ccCCCCCcCeEEECCCCCEEEeecccce
Confidence 45778999998432 3567999999999999999999999999 9999999999999999999999999998
Q ss_pred ecCCCcccc------------cceeeeeccCCCChhhhccCCCCccceEEeehhhhhhhhhCCCCCCcCCCCchhhhhhh
Q 045315 314 MFGGDELQS------------NTKRIVGTYGYMSPEYALRGLFSIKSDVFSFGVLLLETLSSKKNTHFYNTDSLTLLGHA 381 (476)
Q Consensus 314 ~~~~~~~~~------------~~~~~~gt~~y~aPE~l~~~~~s~ksDVwSlGvvl~elltG~~p~~~~~~~~~~~~~~~ 381 (476)
......... ......||+.|+|||.+.+..++.++||||||+++|||++|..|+..............
T Consensus 157 ~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~g~~~~~~~~~~~~~~~~~~ 236 (310)
T 3s95_A 157 LMVDEKTQPEGLRSLKKPDRKKRYTVVGNPYWMAPEMINGRSYDEKVDVFSFGIVLCEIIGRVNADPDYLPRTMDFGLNV 236 (310)
T ss_dssp ECC--------------------CCCCSCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHTCCSSTTTSCBCTTSSBCH
T ss_pred ecccccccccccccccccccccccccCCCcceeCHHHhcCCCCCcHHHHHHHHHHHHHHhcCCCCCcchhhhHHHHhhhh
Confidence 765432211 11135689999999999999999999999999999999999999865432221111111
Q ss_pred hhhhcCCCcccccCcccCCCCCHHHHHHHHHHHHHchhhcccCCCCHHHHHHHHhccccCCC
Q 045315 382 WNLWNDGRTWELMDPISQNGASYPILKRYINVALLCVQEKAADRPAMSEVVSMLSNEFVNLP 443 (476)
Q Consensus 382 ~~~~~~~~~~~~~d~~~~~~~~~~~~~~l~~li~~Cl~~dP~~RPt~~eVl~~L~~~~~~~~ 443 (476)
.... +.. .+......+.+++.+||+.||++|||+.++++.|+.+...++
T Consensus 237 ~~~~---------~~~----~~~~~~~~l~~li~~~l~~dP~~Rps~~~l~~~L~~l~~~~~ 285 (310)
T 3s95_A 237 RGFL---------DRY----CPPNCPPSFFPITVRCCDLDPEKRPSFVKLEHWLETLRMHLA 285 (310)
T ss_dssp HHHH---------HHT----CCTTCCTTHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHHHH
T ss_pred hccc---------ccc----CCCCCCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHHhcc
Confidence 0000 000 011122457889999999999999999999999998765443
|
| >3kex_A Receptor tyrosine-protein kinase ERBB-3; kinase domain, inactive kinase, HER3, ATP-binding, cell membrane, membrane, nucleotide-binding; HET: ANP; 2.80A {Homo sapiens} PDB: 3lmg_A* | Back alignment and structure |
|---|
Probab=99.95 E-value=1.2e-29 Score=252.37 Aligned_cols=182 Identities=20% Similarity=0.259 Sum_probs=140.5
Q ss_pred cccceeeccCCCCC-------CCCCCChhhHHHHHHHHHHHHHHHhhcCCCceeecCCCccceEecCCCCceecccccee
Q 045315 241 DEISFWYESYNNPT-------KKGLLCWGTRVRIIEGIAQGLLYLHQYSRLRVIHRDLKASNILLDKDMNPKISDFGMAR 313 (476)
Q Consensus 241 ~~~~l~~Ey~~~~~-------~~~~L~~~~~~~i~~qIa~gL~yLH~~~~~~ivH~DLkp~NILld~~~~~kL~DFGla~ 313 (476)
+..++++||++.+. .+..+++.+++.++.||+.||+|||+++ |+||||||+|||++.++.+||+|||+++
T Consensus 87 ~~~~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~---ivH~Dikp~Nil~~~~~~~kl~Dfg~a~ 163 (325)
T 3kex_A 87 SSLQLVTQYLPLGSLLDHVRQHRGALGPQLLLNWGVQIAKGMYYLEEHG---MVHRNLAARNVLLKSPSQVQVADFGVAD 163 (325)
T ss_dssp SSEEEEEECCTTCBSHHHHHSSGGGSCTTHHHHHHHHHHHHHHHHHHTT---CCCSCCSSTTEEESSSSCEEECSCSGGG
T ss_pred CccEEEEEeCCCCCHHHHHHHccccCCHHHHHHHHHHHHHHHHHHHhCC---CCCCccchheEEECCCCeEEECCCCccc
Confidence 45778899998432 3468999999999999999999999999 9999999999999999999999999998
Q ss_pred ecCCCcccccceeeeeccCCCChhhhccCCCCccceEEeehhhhhhhhh-CCCCCCcCCCCchhhhhhhhhhhcCCCccc
Q 045315 314 MFGGDELQSNTKRIVGTYGYMSPEYALRGLFSIKSDVFSFGVLLLETLS-SKKNTHFYNTDSLTLLGHAWNLWNDGRTWE 392 (476)
Q Consensus 314 ~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~s~ksDVwSlGvvl~ellt-G~~p~~~~~~~~~~~~~~~~~~~~~~~~~~ 392 (476)
...............++..|+|||.+.+..++.++|||||||++|||++ |+.||........ .. ....+....
T Consensus 164 ~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~~~~~~~~--~~----~~~~~~~~~ 237 (325)
T 3kex_A 164 LLPPDDKQLLYSEAKTPIKWMALESIHFGKYTHQSDVWSYGVTVWELMTFGAEPYAGLRLAEV--PD----LLEKGERLA 237 (325)
T ss_dssp GSCCCTTCCC-----CCTTTSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTSCTTHH--HH----HHHTTCBCC
T ss_pred ccCcccccccccCCCCcccccChHHhccCCCChhhHhHHhHHHHHHHHhCCCCCccccCHHHH--HH----HHHcCCCCC
Confidence 8755443333444678889999999999999999999999999999999 9999875432211 11 111111111
Q ss_pred ccCcccCCCCCHHHHHHHHHHHHHchhhcccCCCCHHHHHHHHhcccc
Q 045315 393 LMDPISQNGASYPILKRYINVALLCVQEKAADRPAMSEVVSMLSNEFV 440 (476)
Q Consensus 393 ~~d~~~~~~~~~~~~~~l~~li~~Cl~~dP~~RPt~~eVl~~L~~~~~ 440 (476)
. +......+.+++.+||+.||++||++.++++.|+.+..
T Consensus 238 ~---------~~~~~~~~~~li~~~l~~dp~~Rps~~el~~~l~~~~~ 276 (325)
T 3kex_A 238 Q---------PQICTIDVYMVMVKCWMIDENIRPTFKELANEFTRMAR 276 (325)
T ss_dssp C---------CTTBCTTTTHHHHHHTCSCTTTSCCHHHHHHHHHHHTT
T ss_pred C---------CCcCcHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHh
Confidence 0 01112346789999999999999999999999988753
|
| >3og7_A AKAP9-BRAF fusion protein; proto-oncogene, V600E, kinase, transferase; HET: 032; 2.45A {Homo sapiens} SCOP: d.144.1.7 PDB: 4fk3_A* 3c4c_A* 3c4d_A* 3idp_A* 4g9r_A* 3ii5_A* 4e26_A* 3ppj_A* 3ppk_A* 3prf_A* 3pri_A* 3psb_A* 3psd_A* 3q4c_A* 3skc_A* 3tv4_A* 3tv6_A* 3d4q_A* 4e4x_A* 4g9c_A* ... | Back alignment and structure |
|---|
Probab=99.95 E-value=5.3e-29 Score=243.21 Aligned_cols=187 Identities=23% Similarity=0.352 Sum_probs=131.4
Q ss_pred cccceeeccCCC-------CCCCCCCChhhHHHHHHHHHHHHHHHhhcCCCceeecCCCccceEecCCCCceecccccee
Q 045315 241 DEISFWYESYNN-------PTKKGLLCWGTRVRIIEGIAQGLLYLHQYSRLRVIHRDLKASNILLDKDMNPKISDFGMAR 313 (476)
Q Consensus 241 ~~~~l~~Ey~~~-------~~~~~~L~~~~~~~i~~qIa~gL~yLH~~~~~~ivH~DLkp~NILld~~~~~kL~DFGla~ 313 (476)
+..++++||++. ......+++.+++.++.||+.||+|||+.+ |+||||||+||+++.++.+||+|||++.
T Consensus 92 ~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~qi~~~L~~lH~~~---i~H~Dlkp~Nil~~~~~~~kl~Dfg~~~ 168 (289)
T 3og7_A 92 PQLAIVTQWCEGSSLYHHLHASETKFEMKKLIDIARQTARGMDYLHAKS---IIHRDLKSNNIFLHEDNTVKIGDFGLAT 168 (289)
T ss_dssp SSCEEEEECCCEEEHHHHHTTC---CCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEEETTTEEEECCCC---
T ss_pred CccEEEEEecCCCcHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHhCC---cccccCccceEEECCCCCEEEccceecc
Confidence 457789999972 234567999999999999999999999999 9999999999999999999999999998
Q ss_pred ecCCCcccccceeeeeccCCCChhhhc---cCCCCccceEEeehhhhhhhhhCCCCCCcCCCCchhhhhhhhhhhcCCCc
Q 045315 314 MFGGDELQSNTKRIVGTYGYMSPEYAL---RGLFSIKSDVFSFGVLLLETLSSKKNTHFYNTDSLTLLGHAWNLWNDGRT 390 (476)
Q Consensus 314 ~~~~~~~~~~~~~~~gt~~y~aPE~l~---~~~~s~ksDVwSlGvvl~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~ 390 (476)
...............|+..|+|||.+. +..++.++||||||+++|||++|+.||....... ..... ...+..
T Consensus 169 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~-~~~~~----~~~~~~ 243 (289)
T 3og7_A 169 EKSRWSGSHQFEQLSGSILWMAPEVIRMQDSNPYSFQSDVYAFGIVLYELMTGQLPYSNINNRD-QIIEM----VGRGSL 243 (289)
T ss_dssp ---------------CCCTTCCHHHHC----CCSCHHHHHHHHHHHHHHHHHSSCTTSSCCCHH-HHHHH----HHHTSC
T ss_pred ccccccccccccccCCCccccCchhhcccCCCCCCcccchHHHHHHHHHHHHCCCCccccchHH-HHHHH----hccccc
Confidence 654332222333457899999999986 6678999999999999999999999986543221 11111 111111
Q ss_pred ccccCcccCCCCCHHHHHHHHHHHHHchhhcccCCCCHHHHHHHHhcccc
Q 045315 391 WELMDPISQNGASYPILKRYINVALLCVQEKAADRPAMSEVVSMLSNEFV 440 (476)
Q Consensus 391 ~~~~d~~~~~~~~~~~~~~l~~li~~Cl~~dP~~RPt~~eVl~~L~~~~~ 440 (476)
..... .........+.+++.+||+.||++||++.+++++|+.+..
T Consensus 244 ~~~~~-----~~~~~~~~~l~~li~~~l~~~p~~Rps~~ell~~L~~l~~ 288 (289)
T 3og7_A 244 SPDLS-----KVRSNCPKRMKRLMAECLKKKRDERPSFPRILAEIEELAR 288 (289)
T ss_dssp CCCTT-----SSCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHTTC
T ss_pred Ccchh-----hccccCCHHHHHHHHHHccCChhhCCCHHHHHHHHHHHhh
Confidence 11000 1112234678899999999999999999999999998763
|
| >3uzp_A CKI-delta, CKID, casein kinase I isoform delta; CK1D, inhibitor, PF670462, transferase-transferase I complex; HET: 0CK; 1.94A {Homo sapiens} PDB: 3uys_A* 3uyt_A* 1cki_A 1ckj_A | Back alignment and structure |
|---|
Probab=99.95 E-value=1.4e-28 Score=240.25 Aligned_cols=193 Identities=18% Similarity=0.161 Sum_probs=144.7
Q ss_pred cccceeeccCCC------CCCCCCCChhhHHHHHHHHHHHHHHHhhcCCCceeecCCCccceEe---cCCCCceeccccc
Q 045315 241 DEISFWYESYNN------PTKKGLLCWGTRVRIIEGIAQGLLYLHQYSRLRVIHRDLKASNILL---DKDMNPKISDFGM 311 (476)
Q Consensus 241 ~~~~l~~Ey~~~------~~~~~~L~~~~~~~i~~qIa~gL~yLH~~~~~~ivH~DLkp~NILl---d~~~~~kL~DFGl 311 (476)
+..++++||+.. ...++.+++.++..++.||+.||+|||+++ |+||||||+||++ +.++.+||+|||+
T Consensus 78 ~~~~lv~e~~~~~L~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~---ivH~dlkp~NIl~~~~~~~~~~kl~Dfg~ 154 (296)
T 3uzp_A 78 DYNVMVMELLGPSLEDLFNFCSRKFSLKTVLLLADQMISRIEYIHSKN---FIHRDVKPDNFLMGLGKKGNLVYIIDFGL 154 (296)
T ss_dssp TEEEEEEECCCCBHHHHHHHTTTCCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCCGGGEEECCGGGTTCEEECCCTT
T ss_pred CceEEEEEecCCCHHHHHHhhccCCCHHHHHHHHHHHHHHHHHHHhCC---eeeCCCCHHHeEEecCCCCCeEEEeeCCC
Confidence 346788999841 113567999999999999999999999999 9999999999999 4888999999999
Q ss_pred eeecCCCcccc-----cceeeeeccCCCChhhhccCCCCccceEEeehhhhhhhhhCCCCCCcCCC-Cchhhhhhhhhhh
Q 045315 312 ARMFGGDELQS-----NTKRIVGTYGYMSPEYALRGLFSIKSDVFSFGVLLLETLSSKKNTHFYNT-DSLTLLGHAWNLW 385 (476)
Q Consensus 312 a~~~~~~~~~~-----~~~~~~gt~~y~aPE~l~~~~~s~ksDVwSlGvvl~elltG~~p~~~~~~-~~~~~~~~~~~~~ 385 (476)
+.......... ......|+..|+|||.+.+..++.++|||||||++|||++|+.||..... .............
T Consensus 155 ~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~ 234 (296)
T 3uzp_A 155 AKKYRDARTHQHIPYRENKNLTGTARYASINTHLGIEQSRRDDLESLGYVLMYFNLGSLPWQGLKAATKRQKYERISEKK 234 (296)
T ss_dssp CEECBCTTTCCBCCCCCSCCCCSCTTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCTTSSCCCSSSSSHHHHHHHHH
T ss_pred cccccccccccccccccccccccccccCChhhhcCCCCCcchhhHHHHHHHHHHHhCCCCCCCcCchhhhhhhhhhcccc
Confidence 98765433211 12345789999999999999999999999999999999999999976431 1111111111100
Q ss_pred cCCCcccccCcccCCCCCHHHHHHHHHHHHHchhhcccCCCCHHHHHHHHhccccCCCCC
Q 045315 386 NDGRTWELMDPISQNGASYPILKRYINVALLCVQEKAADRPAMSEVVSMLSNEFVNLPAP 445 (476)
Q Consensus 386 ~~~~~~~~~d~~~~~~~~~~~~~~l~~li~~Cl~~dP~~RPt~~eVl~~L~~~~~~~~~p 445 (476)
..... +... ......+.+++.+||+.||++||++++|++.|+.+..+...+
T Consensus 235 ~~~~~-----~~~~----~~~~~~l~~li~~~l~~dp~~Rps~~~l~~~l~~~~~~~~~~ 285 (296)
T 3uzp_A 235 MSTPI-----EVLC----KGYPSEFATYLNFCRSLRFDDKPDYSYLRQLFRNLFHRQGFS 285 (296)
T ss_dssp HHSCH-----HHHT----TTSCHHHHHHHHHHHTSCTTCCCCHHHHHHHHHHHHHHTTCC
T ss_pred cCCch-----HHHH----hhCCHHHHHHHHHHHhcCcCcCCCHHHHHHHHHHHHHhcCCc
Confidence 00000 0000 112356889999999999999999999999999987655444
|
| >4hgt_A Casein kinase I isoform delta; CK1D, inhibitor, transferase-transferase inhibitor C; HET: 15G; 1.80A {Homo sapiens} PDB: 3uys_A* 3uyt_A* 3uzp_A* 4hnf_A* 1cki_A 1ckj_A 4hni_A* 4hok_A | Back alignment and structure |
|---|
Probab=99.95 E-value=1.2e-28 Score=240.68 Aligned_cols=191 Identities=18% Similarity=0.172 Sum_probs=143.7
Q ss_pred cccceeeccCCCC------CCCCCCChhhHHHHHHHHHHHHHHHhhcCCCceeecCCCccceEe---cCCCCceeccccc
Q 045315 241 DEISFWYESYNNP------TKKGLLCWGTRVRIIEGIAQGLLYLHQYSRLRVIHRDLKASNILL---DKDMNPKISDFGM 311 (476)
Q Consensus 241 ~~~~l~~Ey~~~~------~~~~~L~~~~~~~i~~qIa~gL~yLH~~~~~~ivH~DLkp~NILl---d~~~~~kL~DFGl 311 (476)
+..+++|||+... .....+++.++..++.||+.||+|||+++ |+||||||+||++ +.++.+||+|||+
T Consensus 78 ~~~~lv~e~~~~~L~~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~---ivH~Dlkp~NIl~~~~~~~~~~kL~Dfg~ 154 (296)
T 4hgt_A 78 DYNVMVMELLGPSLEDLFNFCSRKFSLKTVLLLADQMISRIEYIHSKN---FIHRDVKPDNFLMGLGKKGNLVYIIDFGL 154 (296)
T ss_dssp TEEEEEEECCCCBHHHHHHHTTSCCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEECCGGGTTCEEECCCTT
T ss_pred CceEEEEEccCCCHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCCHHHeeeeccCCCCeEEEecCcc
Confidence 3567889998411 13557999999999999999999999999 9999999999999 7889999999999
Q ss_pred eeecCCCccc-----ccceeeeeccCCCChhhhccCCCCccceEEeehhhhhhhhhCCCCCCcCCCC-chhhhhhhhhhh
Q 045315 312 ARMFGGDELQ-----SNTKRIVGTYGYMSPEYALRGLFSIKSDVFSFGVLLLETLSSKKNTHFYNTD-SLTLLGHAWNLW 385 (476)
Q Consensus 312 a~~~~~~~~~-----~~~~~~~gt~~y~aPE~l~~~~~s~ksDVwSlGvvl~elltG~~p~~~~~~~-~~~~~~~~~~~~ 385 (476)
++........ .......|+..|+|||.+.+..++.++|||||||++|||++|+.||...... ............
T Consensus 155 a~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~ 234 (296)
T 4hgt_A 155 AKKYRDARTHQHIPYRENKNLTGTARYASINTHLGIEQSRRDDLESLGYVLMYFNLGSLPWQGLKAATKRQKYERISEKK 234 (296)
T ss_dssp CEECBCTTTCCBCCCCCSCCCCSCGGGCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCTTSSCCCSSSSSHHHHHHHHH
T ss_pred ceeccCcccCccCCCCcccccCCCccccchHHhcCCCCCchhHHHHHHHHHHHHhcCCCCCcccchhhhhhhhhhhhccc
Confidence 9876543221 1223457899999999999999999999999999999999999999764421 111111111000
Q ss_pred cCCCcccccCcccCCCCCHHHHHHHHHHHHHchhhcccCCCCHHHHHHHHhccccCCC
Q 045315 386 NDGRTWELMDPISQNGASYPILKRYINVALLCVQEKAADRPAMSEVVSMLSNEFVNLP 443 (476)
Q Consensus 386 ~~~~~~~~~d~~~~~~~~~~~~~~l~~li~~Cl~~dP~~RPt~~eVl~~L~~~~~~~~ 443 (476)
..... +.... .....+.+++.+||+.||++||++++|++.|+++..+..
T Consensus 235 ~~~~~-----~~~~~----~~~~~l~~li~~~l~~~p~~Rpt~~~l~~~l~~~~~~~~ 283 (296)
T 4hgt_A 235 MSTPI-----EVLCK----GYPSEFATYLNFCRSLRFDDKPDYSYLRQLFRNLFHRQG 283 (296)
T ss_dssp HHSCH-----HHHTT----TSCHHHHHHHHHHHTSCTTCCCCHHHHHHHHHHHHHHHT
T ss_pred ccchh-----hhhhc----cCCHHHHHHHHHHHhcCCCCCCCHHHHHHHHHHHHHHhC
Confidence 00000 00001 113578899999999999999999999999999875543
|
| >3lxp_A Non-receptor tyrosine-protein kinase TYK2; JAK3, inflammation, cancer, PAN inhibitor, ATP-binding nucleotide-binding, phosphoprotein, SH2 domain; HET: PTR IZA; 1.65A {Homo sapiens} PDB: 3lxn_A* 3nz0_A* 3nyx_A* 4e20_A* 4e1z_A* | Back alignment and structure |
|---|
Probab=99.95 E-value=5.2e-30 Score=254.13 Aligned_cols=202 Identities=24% Similarity=0.273 Sum_probs=143.7
Q ss_pred ccceeeccCCCCC-----CCCCCChhhHHHHHHHHHHHHHHHhhcCCCceeecCCCccceEecCCCCceeccccceeecC
Q 045315 242 EISFWYESYNNPT-----KKGLLCWGTRVRIIEGIAQGLLYLHQYSRLRVIHRDLKASNILLDKDMNPKISDFGMARMFG 316 (476)
Q Consensus 242 ~~~l~~Ey~~~~~-----~~~~L~~~~~~~i~~qIa~gL~yLH~~~~~~ivH~DLkp~NILld~~~~~kL~DFGla~~~~ 316 (476)
..+++|||++..+ .+..+++.+++.++.||+.||+|||+.+ |+||||||+||+++.++.+||+|||++....
T Consensus 109 ~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~i~~~l~~~l~~LH~~~---ivH~Dikp~Nil~~~~~~~kl~Dfg~a~~~~ 185 (318)
T 3lxp_A 109 SLQLVMEYVPLGSLRDYLPRHSIGLAQLLLFAQQICEGMAYLHAQH---YIHRDLAARNVLLDNDRLVKIGDFGLAKAVP 185 (318)
T ss_dssp EEEEEECCCTTCBHHHHGGGSCCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEECTTCCEEECCGGGCEECC
T ss_pred eEEEEEecccCCcHHHHHhhCCCCHHHHHHHHHHHHHHHHHHHhCC---ccCCCCchheEEEcCCCCEEECCcccccccc
Confidence 4678999997322 2345999999999999999999999999 9999999999999999999999999998875
Q ss_pred CCccc-ccceeeeeccCCCChhhhccCCCCccceEEeehhhhhhhhhCCCCCCcCCCCchhhhhhhhhhhcCCCcccccC
Q 045315 317 GDELQ-SNTKRIVGTYGYMSPEYALRGLFSIKSDVFSFGVLLLETLSSKKNTHFYNTDSLTLLGHAWNLWNDGRTWELMD 395 (476)
Q Consensus 317 ~~~~~-~~~~~~~gt~~y~aPE~l~~~~~s~ksDVwSlGvvl~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~d 395 (476)
..... .......++..|+|||.+.+..++.++||||||+++|||++|+.|+........................+.+.
T Consensus 186 ~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 265 (318)
T 3lxp_A 186 EGHEYYRVREDGDSPVFWYAPECLKEYKFYYASDVWSFGVTLYELLTHCDSSQSPPTKFLELIGIAQGQMTVLRLTELLE 265 (318)
T ss_dssp TTCSEEEC---CCCCGGGCCHHHHHHCEEEHHHHHHHHHHHHHHHHTTTCGGGSHHHHHHHHHCSCCHHHHHHHHHHHHH
T ss_pred ccccccccccCCCCCceeeChHHhcCCCCCcHHHHHHHHHHHHHHHhCCCcccccchhhhhhhcccccchhHHHHHHHHh
Confidence 43221 12233457888999999999999999999999999999999999976422110000000000000000001111
Q ss_pred cccCCCCCHHHHHHHHHHHHHchhhcccCCCCHHHHHHHHhccccCCCCCC
Q 045315 396 PISQNGASYPILKRYINVALLCVQEKAADRPAMSEVVSMLSNEFVNLPAPQ 446 (476)
Q Consensus 396 ~~~~~~~~~~~~~~l~~li~~Cl~~dP~~RPt~~eVl~~L~~~~~~~~~p~ 446 (476)
.......+......+.+++.+||+.||++|||+.|+++.|+.+......++
T Consensus 266 ~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~L~~l~~~~~~~~ 316 (318)
T 3lxp_A 266 RGERLPRPDKCPAEVYHLMKNCWETEASFRPTFENLIPILKTVHEKYQGQA 316 (318)
T ss_dssp TTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHHHHC--
T ss_pred cccCCCCCccccHHHHHHHHHHcCCCcccCcCHHHHHHHHHHHHHhhccCC
Confidence 111111222334678999999999999999999999999999875554433
|
| >1rjb_A FL cytokine receptor; kinase, structure, autoinhibition, juxtamembrane domain, transferase; 2.10A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=99.95 E-value=9.1e-29 Score=247.34 Aligned_cols=170 Identities=25% Similarity=0.380 Sum_probs=131.2
Q ss_pred CCCChhhHHHHHHHHHHHHHHHhhcCCCceeecCCCccceEecCCCCceeccccceeecCCCcccccceeeeeccCCCCh
Q 045315 257 GLLCWGTRVRIIEGIAQGLLYLHQYSRLRVIHRDLKASNILLDKDMNPKISDFGMARMFGGDELQSNTKRIVGTYGYMSP 336 (476)
Q Consensus 257 ~~L~~~~~~~i~~qIa~gL~yLH~~~~~~ivH~DLkp~NILld~~~~~kL~DFGla~~~~~~~~~~~~~~~~gt~~y~aP 336 (476)
..+++.+++.++.||+.||+|||+++ |+||||||+||+++.++.+||+|||++................+++.|+||
T Consensus 167 ~~l~~~~~~~i~~qi~~aL~~LH~~~---ivH~Dikp~NIll~~~~~~kL~Dfg~~~~~~~~~~~~~~~~~~~t~~y~aP 243 (344)
T 1rjb_A 167 NVLTFEDLLCFAYQVAKGMEFLEFKS---CVHRDLAARNVLVTHGKVVKICDFGLARDIMSDSNYVVRGNARLPVKWMAP 243 (344)
T ss_dssp --CCHHHHHHHHHHHHHHHHHHHHTT---EEETTCSGGGEEEETTTEEEECCCGGGSCGGGCTTSEEETTEEECGGGCCH
T ss_pred ccCCHHHHHHHHHHHHHHHHHHHhCC---cccCCCChhhEEEcCCCcEEeCCCccCcccccCccceeccCccCccCccCH
Confidence 34899999999999999999999999 999999999999999999999999999876543332233345678899999
Q ss_pred hhhccCCCCccceEEeehhhhhhhhh-CCCCCCcCCCCchhhhhhhhhhhcCCCcccccCcccCCCCCHHHHHHHHHHHH
Q 045315 337 EYALRGLFSIKSDVFSFGVLLLETLS-SKKNTHFYNTDSLTLLGHAWNLWNDGRTWELMDPISQNGASYPILKRYINVAL 415 (476)
Q Consensus 337 E~l~~~~~s~ksDVwSlGvvl~ellt-G~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~l~~li~ 415 (476)
|.+.+..++.++|||||||++|||++ |+.||........ .. .....+.. ...+......+.+++.
T Consensus 244 E~~~~~~~~~~~Di~slG~il~el~t~g~~p~~~~~~~~~-~~----~~~~~~~~---------~~~~~~~~~~l~~li~ 309 (344)
T 1rjb_A 244 ESLFEGIYTIKSDVWSYGILLWEIFSLGVNPYPGIPVDAN-FY----KLIQNGFK---------MDQPFYATEEIYIIMQ 309 (344)
T ss_dssp HHHHHCCCCHHHHHHHHHHHHHHHTTTSCCSSTTCCCSHH-HH----HHHHTTCC---------CCCCTTCCHHHHHHHH
T ss_pred HHhccCCCChhHhHHHHHHHHHHHHcCCCCCcccCCcHHH-HH----HHHhcCCC---------CCCCCCCCHHHHHHHH
Confidence 99999999999999999999999998 9999865442221 11 11111111 0111222457889999
Q ss_pred HchhhcccCCCCHHHHHHHHhccccCCC
Q 045315 416 LCVQEKAADRPAMSEVVSMLSNEFVNLP 443 (476)
Q Consensus 416 ~Cl~~dP~~RPt~~eVl~~L~~~~~~~~ 443 (476)
+||+.||++||++.+|++.|+.+....+
T Consensus 310 ~~l~~dp~~Rps~~~l~~~l~~~~~~~~ 337 (344)
T 1rjb_A 310 SCWAFDSRKRPSFPNLTSFLGCQLADAE 337 (344)
T ss_dssp HHTCSSGGGSCCHHHHHHHHHHHC----
T ss_pred HHcCCCchhCcCHHHHHHHHHHHHHHHH
Confidence 9999999999999999999999875443
|
| >3kul_A Ephrin type-A receptor 8; ATP-binding, kinase, nucleotide-binding, transfera phosphorylation, transmembrane, tyrosine-protein kinase; HET: PTR; 2.15A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.95 E-value=3.5e-29 Score=249.16 Aligned_cols=185 Identities=26% Similarity=0.374 Sum_probs=140.9
Q ss_pred cccceeeccCCCC-------CCCCCCChhhHHHHHHHHHHHHHHHhhcCCCceeecCCCccceEecCCCCceecccccee
Q 045315 241 DEISFWYESYNNP-------TKKGLLCWGTRVRIIEGIAQGLLYLHQYSRLRVIHRDLKASNILLDKDMNPKISDFGMAR 313 (476)
Q Consensus 241 ~~~~l~~Ey~~~~-------~~~~~L~~~~~~~i~~qIa~gL~yLH~~~~~~ivH~DLkp~NILld~~~~~kL~DFGla~ 313 (476)
+..+++|||++.. .....+++.+++.++.||+.||+|||+.+ |+||||||+|||++.++.+||+|||+++
T Consensus 123 ~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~---ivH~Dlkp~NIll~~~~~~kl~Dfg~a~ 199 (325)
T 3kul_A 123 RLAMIVTEYMENGSLDTFLRTHDGQFTIMQLVGMLRGVGAGMRYLSDLG---YVHRDLAARNVLVDSNLVCKVSDFGLSR 199 (325)
T ss_dssp GCCEEEEECCTTCBHHHHHHTTTTCSCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEECTTCCEEECCCSSCE
T ss_pred CccEEEeeCCCCCcHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHHCC---eeCCCCCcceEEECCCCCEEECCCCccc
Confidence 4678999999732 23467999999999999999999999999 9999999999999999999999999998
Q ss_pred ecCCCcccc-cceeeeeccCCCChhhhccCCCCccceEEeehhhhhhhhh-CCCCCCcCCCCchhhhhhhhhhhcCCCcc
Q 045315 314 MFGGDELQS-NTKRIVGTYGYMSPEYALRGLFSIKSDVFSFGVLLLETLS-SKKNTHFYNTDSLTLLGHAWNLWNDGRTW 391 (476)
Q Consensus 314 ~~~~~~~~~-~~~~~~gt~~y~aPE~l~~~~~s~ksDVwSlGvvl~ellt-G~~p~~~~~~~~~~~~~~~~~~~~~~~~~ 391 (476)
......... ......+|..|+|||.+.+..++.++|||||||++|||++ |+.||...... ..... ...+..
T Consensus 200 ~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~ell~~g~~p~~~~~~~--~~~~~----~~~~~~- 272 (325)
T 3kul_A 200 VLEDDPDAAYTTTGGKIPIRWTAPEAIAFRTFSSASDVWSFGVVMWEVLAYGERPYWNMTNR--DVISS----VEEGYR- 272 (325)
T ss_dssp ECC----CCEECC---CCGGGSCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCTTTTSCHH--HHHHH----HHTTCC-
T ss_pred ccccCccceeeccCCCCcccccCHhHhcCCCCCcHHHHHHHHHHHHHHHcCCCCCcccCCHH--HHHHH----HHcCCC-
Confidence 765432211 1222345778999999999999999999999999999999 99998643311 11111 111110
Q ss_pred cccCcccCCCCCHHHHHHHHHHHHHchhhcccCCCCHHHHHHHHhccccCCC
Q 045315 392 ELMDPISQNGASYPILKRYINVALLCVQEKAADRPAMSEVVSMLSNEFVNLP 443 (476)
Q Consensus 392 ~~~d~~~~~~~~~~~~~~l~~li~~Cl~~dP~~RPt~~eVl~~L~~~~~~~~ 443 (476)
...+......+.+++.+||+.||++||++.+|++.|+.+....+
T Consensus 273 --------~~~~~~~~~~l~~li~~~l~~dp~~Rps~~eil~~L~~l~~~~~ 316 (325)
T 3kul_A 273 --------LPAPMGCPHALHQLMLDCWHKDRAQRPRFSQIVSVLDALIRSPE 316 (325)
T ss_dssp --------CCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHSCC
T ss_pred --------CCCCCCcCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHhCcc
Confidence 11112234578899999999999999999999999999875433
|
| >3cbl_A C-FES, proto-oncogene tyrosine-protein kinase FES/FPS; V-FES, fujinami, avian sarcoma, viral, feline virus, SGC; HET: STU; 1.75A {Homo sapiens} PDB: 3bkb_A* 3cd3_A* 4e93_A* | Back alignment and structure |
|---|
Probab=99.95 E-value=2e-29 Score=256.21 Aligned_cols=181 Identities=25% Similarity=0.278 Sum_probs=140.6
Q ss_pred cccceeeccCCCCC-------CCCCCChhhHHHHHHHHHHHHHHHhhcCCCceeecCCCccceEecCCCCceecccccee
Q 045315 241 DEISFWYESYNNPT-------KKGLLCWGTRVRIIEGIAQGLLYLHQYSRLRVIHRDLKASNILLDKDMNPKISDFGMAR 313 (476)
Q Consensus 241 ~~~~l~~Ey~~~~~-------~~~~L~~~~~~~i~~qIa~gL~yLH~~~~~~ivH~DLkp~NILld~~~~~kL~DFGla~ 313 (476)
+..+++|||++.+. .+..+++.+++.++.||+.||+|||+++ |+||||||+|||++.++.+||+|||+++
T Consensus 185 ~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~qi~~~l~~LH~~~---ivHrDlkp~Nil~~~~~~~kl~DfG~s~ 261 (377)
T 3cbl_A 185 QPIYIVMELVQGGDFLTFLRTEGARLRVKTLLQMVGDAAAGMEYLESKC---CIHRDLAARNCLVTEKNVLKISDFGMSR 261 (377)
T ss_dssp SSCEEEEECCTTCBHHHHHHHHGGGCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEECTTCCEEECCGGGCE
T ss_pred CCcEEEEEcCCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCC---cCCcccCHHHEEEcCCCcEEECcCCCce
Confidence 46789999998432 2346999999999999999999999999 9999999999999999999999999998
Q ss_pred ecCCCcccccceeeeeccCCCChhhhccCCCCccceEEeehhhhhhhhh-CCCCCCcCCCCchhhhhhhhhhhcCCCccc
Q 045315 314 MFGGDELQSNTKRIVGTYGYMSPEYALRGLFSIKSDVFSFGVLLLETLS-SKKNTHFYNTDSLTLLGHAWNLWNDGRTWE 392 (476)
Q Consensus 314 ~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~s~ksDVwSlGvvl~ellt-G~~p~~~~~~~~~~~~~~~~~~~~~~~~~~ 392 (476)
...............++..|+|||.+.+..++.++|||||||++|||++ |+.||...... .... ....+...
T Consensus 262 ~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~il~el~t~g~~p~~~~~~~--~~~~----~~~~~~~~- 334 (377)
T 3cbl_A 262 EEADGVYAASGGLRQVPVKWTAPEALNYGRYSSESDVWSFGILLWETFSLGASPYPNLSNQ--QTRE----FVEKGGRL- 334 (377)
T ss_dssp ECTTSEEECCSSCCEEEGGGSCHHHHHHCEEEHHHHHHHHHHHHHHHHTTSCCSSTTSCHH--HHHH----HHHTTCCC-
T ss_pred ecCCCceeecCCCCCCCcCcCCHhHhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCHH--HHHH----HHHcCCCC-
Confidence 7554332222222346788999999999999999999999999999998 89888654311 1111 11111111
Q ss_pred ccCcccCCCCCHHHHHHHHHHHHHchhhcccCCCCHHHHHHHHhccc
Q 045315 393 LMDPISQNGASYPILKRYINVALLCVQEKAADRPAMSEVVSMLSNEF 439 (476)
Q Consensus 393 ~~d~~~~~~~~~~~~~~l~~li~~Cl~~dP~~RPt~~eVl~~L~~~~ 439 (476)
..+......+.+++.+||+.||++|||+++|++.|+.+.
T Consensus 335 --------~~~~~~~~~l~~li~~cl~~dP~~Rps~~~i~~~L~~i~ 373 (377)
T 3cbl_A 335 --------PCPELCPDAVFRLMEQCWAYEPGQRPSFSTIYQELQSIR 373 (377)
T ss_dssp --------CCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHH
T ss_pred --------CCCCCCCHHHHHHHHHHcCCCchhCcCHHHHHHHHHHHH
Confidence 111122356889999999999999999999999998864
|
| >3vhe_A Vascular endothelial growth factor receptor 2; kinase domain, kinase, transferase-transferase inhibitor COM; HET: 42Q; 1.55A {Homo sapiens} PDB: 1y6a_A* 1y6b_A* 3vhk_A* 3vid_A* 3hng_A* | Back alignment and structure |
|---|
Probab=99.95 E-value=1.2e-28 Score=247.80 Aligned_cols=165 Identities=30% Similarity=0.376 Sum_probs=131.1
Q ss_pred CCChhhHHHHHHHHHHHHHHHhhcCCCceeecCCCccceEecCCCCceeccccceeecCCCcccccceeeeeccCCCChh
Q 045315 258 LLCWGTRVRIIEGIAQGLLYLHQYSRLRVIHRDLKASNILLDKDMNPKISDFGMARMFGGDELQSNTKRIVGTYGYMSPE 337 (476)
Q Consensus 258 ~L~~~~~~~i~~qIa~gL~yLH~~~~~~ivH~DLkp~NILld~~~~~kL~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE 337 (476)
.+++.+++.++.||+.||+|||+++ |+||||||+|||++.++.+||+|||+++...............||..|+|||
T Consensus 189 ~l~~~~~~~~~~ql~~aL~~LH~~~---ivH~Dikp~NIll~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~t~~y~aPE 265 (359)
T 3vhe_A 189 FLTLEHLICYSFQVAKGMEFLASRK---CIHRDLAARNILLSEKNVVKICDFGLARDIYKDPDYVRKGDARLPLKWMAPE 265 (359)
T ss_dssp CBCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCSGGGEEECGGGCEEECCCGGGSCTTSCTTCEEC--CEECGGGCCHH
T ss_pred ccCHHHHHHHHHHHHHHHHHHHHCC---cccCCCChhhEEEcCCCcEEEEeccceeeecccccchhccccCCCceeEChh
Confidence 3999999999999999999999999 9999999999999999999999999998765443333344467899999999
Q ss_pred hhccCCCCccceEEeehhhhhhhhh-CCCCCCcCCCCchhhhhhhhhhhcCCCcccccCcccCCCCCHHHHHHHHHHHHH
Q 045315 338 YALRGLFSIKSDVFSFGVLLLETLS-SKKNTHFYNTDSLTLLGHAWNLWNDGRTWELMDPISQNGASYPILKRYINVALL 416 (476)
Q Consensus 338 ~l~~~~~s~ksDVwSlGvvl~ellt-G~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~l~~li~~ 416 (476)
.+.+..++.++|||||||++|||++ |+.||........ ... ....+.... .+......+.+++.+
T Consensus 266 ~~~~~~~~~~~Di~slG~il~ellt~g~~p~~~~~~~~~-~~~----~~~~~~~~~---------~~~~~~~~l~~li~~ 331 (359)
T 3vhe_A 266 TIFDRVYTIQSDVWSFGVLLWEIFSLGASPYPGVKIDEE-FCR----RLKEGTRMR---------APDYTTPEMYQTMLD 331 (359)
T ss_dssp HHHHCCCCHHHHHHHHHHHHHHHTTTSCCSSTTCCCSHH-HHH----HHHHTCCCC---------CCTTCCHHHHHHHHH
T ss_pred hhcCCCCCchhhhhhHHHHHHHHHhcCCCCCCccchhHH-HHH----HHHcCCCCC---------CCCCCCHHHHHHHHH
Confidence 9999999999999999999999998 9999875443221 111 111111111 111223568899999
Q ss_pred chhhcccCCCCHHHHHHHHhccc
Q 045315 417 CVQEKAADRPAMSEVVSMLSNEF 439 (476)
Q Consensus 417 Cl~~dP~~RPt~~eVl~~L~~~~ 439 (476)
||+.||++|||++||++.|+.+.
T Consensus 332 ~l~~dP~~Rps~~ell~~L~~~~ 354 (359)
T 3vhe_A 332 CWHGEPSQRPTFSELVEHLGNLL 354 (359)
T ss_dssp HTCSSGGGSCCHHHHHHHHHHHH
T ss_pred HccCChhhCCCHHHHHHHHHHHH
Confidence 99999999999999999999865
|
| >3tt0_A Basic fibroblast growth factor receptor 1; kinase domain, transferase, transferase-transferase inhibito; HET: 07J; 2.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.95 E-value=7e-29 Score=252.50 Aligned_cols=188 Identities=24% Similarity=0.301 Sum_probs=145.8
Q ss_pred cccceeeccCCCCC----------------------CCCCCChhhHHHHHHHHHHHHHHHhhcCCCceeecCCCccceEe
Q 045315 241 DEISFWYESYNNPT----------------------KKGLLCWGTRVRIIEGIAQGLLYLHQYSRLRVIHRDLKASNILL 298 (476)
Q Consensus 241 ~~~~l~~Ey~~~~~----------------------~~~~L~~~~~~~i~~qIa~gL~yLH~~~~~~ivH~DLkp~NILl 298 (476)
+..+++|||++.++ ....+++.+++.++.||+.||+|||+.+ |+||||||+|||+
T Consensus 148 ~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~---ivH~Dlkp~NIll 224 (382)
T 3tt0_A 148 GPLYVIVEYASKGNLREYLQARRPPGLEYSYNPSHNPEEQLSSKDLVSCAYQVARGMEYLASKK---CIHRDLAARNVLV 224 (382)
T ss_dssp SSCEEEEECCTTCBHHHHHHHTCCSSSSSCCCCCSSCCCCCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEE
T ss_pred CceEEEEEecCCCcHHHHHHHhcccccccccccccccccccCHHHHHHHHHHHHHHHHHHHhCC---EecCCCCcceEEE
Confidence 46788999997321 1346999999999999999999999999 9999999999999
Q ss_pred cCCCCceeccccceeecCCCcccccceeeeeccCCCChhhhccCCCCccceEEeehhhhhhhhh-CCCCCCcCCCCchhh
Q 045315 299 DKDMNPKISDFGMARMFGGDELQSNTKRIVGTYGYMSPEYALRGLFSIKSDVFSFGVLLLETLS-SKKNTHFYNTDSLTL 377 (476)
Q Consensus 299 d~~~~~kL~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~s~ksDVwSlGvvl~ellt-G~~p~~~~~~~~~~~ 377 (476)
+.++.+||+|||+++...............++..|+|||.+.+..++.++|||||||++|||++ |+.||..... ..+
T Consensus 225 ~~~~~~kL~DFG~a~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~DiwslG~il~ellt~g~~p~~~~~~--~~~ 302 (382)
T 3tt0_A 225 TEDNVMKIADFGLARDIHHIDYYKKTTNGRLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEIFTLGGSPYPGVPV--EEL 302 (382)
T ss_dssp CTTCCEEECSCSCCCCSSCCCTTCCCTTCCCGGGGSCHHHHHSCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCH--HHH
T ss_pred cCCCcEEEcccCcccccccccccccccCCCCCcceeCHHHhcCCCCCchhHHHHHHHHHHHHHhCCCCCCCCCCH--HHH
Confidence 9999999999999987654433333333567889999999999999999999999999999999 9998864431 111
Q ss_pred hhhhhhhhcCCCcccccCcccCCCCCHHHHHHHHHHHHHchhhcccCCCCHHHHHHHHhccccCCCCCC
Q 045315 378 LGHAWNLWNDGRTWELMDPISQNGASYPILKRYINVALLCVQEKAADRPAMSEVVSMLSNEFVNLPAPQ 446 (476)
Q Consensus 378 ~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~l~~li~~Cl~~dP~~RPt~~eVl~~L~~~~~~~~~p~ 446 (476)
. .....+.... .+......+.+++.+||+.||++|||++||++.|+.+........
T Consensus 303 ~----~~~~~~~~~~---------~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~L~~~~~~~~~~~ 358 (382)
T 3tt0_A 303 F----KLLKEGHRMD---------KPSNCTNELYMMMRDCWHAVPSQRPTFKQLVEDLDRIVALTSNQE 358 (382)
T ss_dssp H----HHHHTTCCCC---------CCSSCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHHSCSCC
T ss_pred H----HHHHcCCCCC---------CCccCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHHHHhcCC
Confidence 1 1111111111 111233578899999999999999999999999999875544444
|
| >3qup_A Tyrosine-protein kinase receptor TYRO3; protein kinase inhibitor, receptor tyrosine kinase, spirocyc kinase domain, phosphotransfer, GAS6 ligand; HET: LUN; 1.90A {Mus musculus} | Back alignment and structure |
|---|
Probab=99.95 E-value=6.7e-29 Score=246.15 Aligned_cols=180 Identities=21% Similarity=0.284 Sum_probs=131.8
Q ss_pred ceeeccCCCC------------CCCCCCChhhHHHHHHHHHHHHHHHhhcCCCceeecCCCccceEecCCCCceeccccc
Q 045315 244 SFWYESYNNP------------TKKGLLCWGTRVRIIEGIAQGLLYLHQYSRLRVIHRDLKASNILLDKDMNPKISDFGM 311 (476)
Q Consensus 244 ~l~~Ey~~~~------------~~~~~L~~~~~~~i~~qIa~gL~yLH~~~~~~ivH~DLkp~NILld~~~~~kL~DFGl 311 (476)
++++||++.+ .....+++.++..++.||+.||+|||+++ |+||||||+||+++.++.+||+|||+
T Consensus 107 ~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~i~~qi~~al~~LH~~~---ivH~Dikp~NIli~~~~~~kl~Dfg~ 183 (323)
T 3qup_A 107 MVILPFMKHGDLHAFLLASRIGENPFNLPLQTLVRFMVDIACGMEYLSSRN---FIHRDLAARNCMLAEDMTVCVADFGL 183 (323)
T ss_dssp EEEEECCTTCBHHHHHHHHHC---CCCCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCSGGGEEECTTSCEEECCCCC
T ss_pred EEEEEeccCCcHHHHHHhhhccccccccCHHHHHHHHHHHHHHHHHHHcCC---cccCCCCcceEEEcCCCCEEEeeccc
Confidence 7889998732 12236999999999999999999999999 99999999999999999999999999
Q ss_pred eeecCCCcccccceeeeeccCCCChhhhccCCCCccceEEeehhhhhhhhh-CCCCCCcCCCCchhhhhhhhhhhcCCCc
Q 045315 312 ARMFGGDELQSNTKRIVGTYGYMSPEYALRGLFSIKSDVFSFGVLLLETLS-SKKNTHFYNTDSLTLLGHAWNLWNDGRT 390 (476)
Q Consensus 312 a~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~s~ksDVwSlGvvl~ellt-G~~p~~~~~~~~~~~~~~~~~~~~~~~~ 390 (476)
++...............++..|+|||.+.+..++.++|||||||++|||++ |+.||....... .... ...+..
T Consensus 184 a~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ell~~g~~p~~~~~~~~--~~~~----~~~~~~ 257 (323)
T 3qup_A 184 SRKIYSGDYYRQGCASKLPVKWLALESLADNLYTVHSDVWAFGVTMWEIMTRGQTPYAGIENAE--IYNY----LIGGNR 257 (323)
T ss_dssp -----------------CCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCGGG--HHHH----HHTTCC
T ss_pred cccccccccccccccccCcccccCchhhcCCCCCCccchhhHHHHHHHHHhCCCCCccccChHH--HHHH----HhcCCC
Confidence 987654433333333456788999999999999999999999999999999 888886543221 1111 111111
Q ss_pred ccccCcccCCCCCHHHHHHHHHHHHHchhhcccCCCCHHHHHHHHhccccC
Q 045315 391 WELMDPISQNGASYPILKRYINVALLCVQEKAADRPAMSEVVSMLSNEFVN 441 (476)
Q Consensus 391 ~~~~d~~~~~~~~~~~~~~l~~li~~Cl~~dP~~RPt~~eVl~~L~~~~~~ 441 (476)
. .........+.+++.+||+.||++|||+.++++.|+++...
T Consensus 258 ~---------~~~~~~~~~l~~li~~~l~~dp~~Rps~~~l~~~l~~~l~~ 299 (323)
T 3qup_A 258 L---------KQPPECMEEVYDLMYQCWSADPKQRPSFTCLRMELENILGH 299 (323)
T ss_dssp C---------CCCTTCCHHHHHHHHHTTCSSGGGSCCHHHHHHHHHHHHHC
T ss_pred C---------CCCCccCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHHH
Confidence 0 11122335788999999999999999999999999998744
|
| >3g2f_A Bone morphogenetic protein receptor type-2; kinase, structural genomics, structural genomics consortium, ATP-binding, disease mutation; HET: ADP; 2.35A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.95 E-value=4.8e-29 Score=248.39 Aligned_cols=195 Identities=20% Similarity=0.267 Sum_probs=138.8
Q ss_pred ccceeeccCCCCC-----CCCCCChhhHHHHHHHHHHHHHHHhhc---------CCCceeecCCCccceEecCCCCceec
Q 045315 242 EISFWYESYNNPT-----KKGLLCWGTRVRIIEGIAQGLLYLHQY---------SRLRVIHRDLKASNILLDKDMNPKIS 307 (476)
Q Consensus 242 ~~~l~~Ey~~~~~-----~~~~L~~~~~~~i~~qIa~gL~yLH~~---------~~~~ivH~DLkp~NILld~~~~~kL~ 307 (476)
..+++|||++.+. +...+++.++.+++.||++||+|||+. + |+||||||+|||++.++.+||+
T Consensus 86 ~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~i~~qi~~~L~~LH~~~~~~~~~~~~---ivH~Dikp~Nill~~~~~~kL~ 162 (336)
T 3g2f_A 86 EYLLVMEYYPNGSLXKYLSLHTSDWVSSCRLAHSVTRGLAYLHTELPRGDHYKPA---ISHRDLNSRNVLVKNDGTCVIS 162 (336)
T ss_dssp EEEEEECCCTTCBHHHHHHHCCBCHHHHHHHHHHHHHHHHHHHCCBCCGGGCBCC---EECSSCSGGGEEECTTSCEEEC
T ss_pred eEEEEEecCCCCcHHHHHhhcccchhHHHHHHHHHHHHHHHHHhhhccccccccc---eeecccccceEEEcCCCcEEEe
Confidence 4678999997432 234568999999999999999999998 7 9999999999999999999999
Q ss_pred cccceeecCCCcc------cccceeeeeccCCCChhhhcc-------CCCCccceEEeehhhhhhhhhCCCCCCcCCCCc
Q 045315 308 DFGMARMFGGDEL------QSNTKRIVGTYGYMSPEYALR-------GLFSIKSDVFSFGVLLLETLSSKKNTHFYNTDS 374 (476)
Q Consensus 308 DFGla~~~~~~~~------~~~~~~~~gt~~y~aPE~l~~-------~~~s~ksDVwSlGvvl~elltG~~p~~~~~~~~ 374 (476)
|||+++.+..... ........||..|+|||.+.+ ..++.++|||||||++|||++|+.|+.......
T Consensus 163 DFG~a~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~DiwslG~il~ell~g~~p~~~~~~~~ 242 (336)
T 3g2f_A 163 DFGLSMRLTGNRLVRPGEEDNAAISEVGTIRYMAPEVLEGAVNLRDXESALKQVDMYALGLIYWEIFMRCTDLFPGESVP 242 (336)
T ss_dssp CCTTCEECSSSSCC---------CCTTSCGGGCCHHHHTTCCCGGGHHHHHHHHHHHHHHHHHHHHHTTBGGGSTTSCCC
T ss_pred eccceeecccccccCccccccccccCCCccceeCchhhcCCcccccccccccccchHHHHHHHHHHHhcCCcCCCccchh
Confidence 9999987654321 111223458999999999976 456789999999999999999987764332111
Q ss_pred hhhhhh------------hhhhhcCCCcccccCcccCCCCCHHHHHHHHHHHHHchhhcccCCCCHHHHHHHHhccccC
Q 045315 375 LTLLGH------------AWNLWNDGRTWELMDPISQNGASYPILKRYINVALLCVQEKAADRPAMSEVVSMLSNEFVN 441 (476)
Q Consensus 375 ~~~~~~------------~~~~~~~~~~~~~~d~~~~~~~~~~~~~~l~~li~~Cl~~dP~~RPt~~eVl~~L~~~~~~ 441 (476)
...... .............+.. ...........+.+++.+||+.||++|||+.|+++.|+.+...
T Consensus 243 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~--~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~e~l~~L~~ll~~ 319 (336)
T 3g2f_A 243 EYQMAFQTEVGNHPTFEDMQVLVSREKQRPKFPE--AWKENSLAVRSLKETIEDCWDQDAEARLTAQXAEERMAELMMI 319 (336)
T ss_dssp CCCCTTHHHHCSSCCHHHHHHHHTTSCCCCCCCT--TCCCCSHHHHHHHHHHHHHSCSSGGGSCCHHHHHHHHHHHHHC
T ss_pred HHHHhhhcccCCCchHHHHHhhhcccccCCCCCc--ccccccchHHHHHHHHHHHhcCChhhCcchHHHHHHHHHHHHH
Confidence 000000 0000000000000000 0112234567899999999999999999999999999997643
|
| >3brb_A Proto-oncogene tyrosine-protein kinase MER; ATP-binding, disease mutation, glycoprotein, nucleot binding, phosphorylation, receptor; HET: ADP; 1.90A {Homo sapiens} PDB: 3bpr_A* 2p0c_A* | Back alignment and structure |
|---|
Probab=99.95 E-value=7.5e-29 Score=244.67 Aligned_cols=184 Identities=21% Similarity=0.284 Sum_probs=135.4
Q ss_pred ccceeeccCCCC------------CCCCCCChhhHHHHHHHHHHHHHHHhhcCCCceeecCCCccceEecCCCCceeccc
Q 045315 242 EISFWYESYNNP------------TKKGLLCWGTRVRIIEGIAQGLLYLHQYSRLRVIHRDLKASNILLDKDMNPKISDF 309 (476)
Q Consensus 242 ~~~l~~Ey~~~~------------~~~~~L~~~~~~~i~~qIa~gL~yLH~~~~~~ivH~DLkp~NILld~~~~~kL~DF 309 (476)
.+++++||++.. .....+++.+++.++.||++||+|||+++ |+||||||+||+++.++.+||+||
T Consensus 115 ~~~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~---ivH~dikp~NIli~~~~~~kl~Df 191 (313)
T 3brb_A 115 KPMVILPFMKYGDLHTYLLYSRLETGPKHIPLQTLLKFMVDIALGMEYLSNRN---FLHRDLAARNCMLRDDMTVCVADF 191 (313)
T ss_dssp CEEEEEECCTTCBHHHHHHHTTBTTSCCCCCHHHHHHHHHHHHHHHHHHHTTT---CCCCCCSGGGEEECTTSCEEECSC
T ss_pred ccEEEEecccCCCHHHHHHHhhhhcCCccCCHHHHHHHHHHHHHHHHHHHhCC---cccCCCCcceEEEcCCCcEEEeec
Confidence 357888998721 34567999999999999999999999998 999999999999999999999999
Q ss_pred cceeecCCCcccccceeeeeccCCCChhhhccCCCCccceEEeehhhhhhhhh-CCCCCCcCCCCchhhhhhhhhhhcCC
Q 045315 310 GMARMFGGDELQSNTKRIVGTYGYMSPEYALRGLFSIKSDVFSFGVLLLETLS-SKKNTHFYNTDSLTLLGHAWNLWNDG 388 (476)
Q Consensus 310 Gla~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~s~ksDVwSlGvvl~ellt-G~~p~~~~~~~~~~~~~~~~~~~~~~ 388 (476)
|+++...............++..|+|||.+.+..++.++||||||+++|||++ |+.||....... .... ...+
T Consensus 192 g~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~g~~p~~~~~~~~--~~~~----~~~~ 265 (313)
T 3brb_A 192 GLSKKIYSGDYYRQGRIAKMPVKWIAIESLADRVYTSKSDVWAFGVTMWEIATRGMTPYPGVQNHE--MYDY----LLHG 265 (313)
T ss_dssp SCC----------------CCGGGSCHHHHHSSCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCGGG--HHHH----HHTT
T ss_pred CcceecccccccCcccccCCCccccCchhhcCCCccchhhhHHHHHHHHHHHhcCCCCCccCCHHH--HHHH----HHcC
Confidence 99987654332222333557889999999999999999999999999999999 888876543211 1111 1111
Q ss_pred CcccccCcccCCCCCHHHHHHHHHHHHHchhhcccCCCCHHHHHHHHhccccCCC
Q 045315 389 RTWELMDPISQNGASYPILKRYINVALLCVQEKAADRPAMSEVVSMLSNEFVNLP 443 (476)
Q Consensus 389 ~~~~~~d~~~~~~~~~~~~~~l~~li~~Cl~~dP~~RPt~~eVl~~L~~~~~~~~ 443 (476)
... ..+......+.+++.+||+.||++||++.++++.|+.+...+|
T Consensus 266 ~~~---------~~~~~~~~~l~~li~~~l~~dp~~Rps~~~l~~~L~~l~~~lp 311 (313)
T 3brb_A 266 HRL---------KQPEDCLDELYEIMYSCWRTDPLDRPTFSVLRLQLEKLLESLP 311 (313)
T ss_dssp CCC---------CCBTTCCHHHHHHHHHTTCSSGGGSCCHHHHHHHHHHHHHHC-
T ss_pred CCC---------CCCccccHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHHhcC
Confidence 111 1111233578899999999999999999999999999876554
|
| >3fxz_A Serine/threonine-protein kinase PAK 1; transferase, ATP-binding, phosphorylation, allosteric enzyme, alternative splicing, apoptosis, cell junction; HET: TPO FLL; 1.64A {Homo sapiens} SCOP: d.144.1.7 PDB: 3fy0_A* 4daw_A* 3q52_A* 3q53_A* 1yhw_A 1f3m_C 1yhv_A 2hy8_1* 3q4z_A* | Back alignment and structure |
|---|
Probab=99.95 E-value=8.6e-29 Score=243.15 Aligned_cols=175 Identities=25% Similarity=0.353 Sum_probs=136.4
Q ss_pred cccceeeccCCCCC-----CCCCCChhhHHHHHHHHHHHHHHHhhcCCCceeecCCCccceEecCCCCceeccccceeec
Q 045315 241 DEISFWYESYNNPT-----KKGLLCWGTRVRIIEGIAQGLLYLHQYSRLRVIHRDLKASNILLDKDMNPKISDFGMARMF 315 (476)
Q Consensus 241 ~~~~l~~Ey~~~~~-----~~~~L~~~~~~~i~~qIa~gL~yLH~~~~~~ivH~DLkp~NILld~~~~~kL~DFGla~~~ 315 (476)
+..+++|||++... ....+++.++..++.||+.||+|||+++ |+||||||+|||++.++.+||+|||++...
T Consensus 90 ~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~---i~H~Dlkp~Nil~~~~~~~kl~Dfg~~~~~ 166 (297)
T 3fxz_A 90 DELWVVMEYLAGGSLTDVVTETCMDEGQIAAVCRECLQALEFLHSNQ---VIHRDIKSDNILLGMDGSVKLTDFGFCAQI 166 (297)
T ss_dssp TEEEEEEECCTTCBHHHHHHHSCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEECTTCCEEECCCTTCEEC
T ss_pred CEEEEEEECCCCCCHHHHHhhcCCCHHHHHHHHHHHHHHHHHHHhCC---ceeCCCCHHHEEECCCCCEEEeeCCCceec
Confidence 46789999997432 2346999999999999999999999999 999999999999999999999999999876
Q ss_pred CCCcccccceeeeeccCCCChhhhccCCCCccceEEeehhhhhhhhhCCCCCCcCCCCchhhhhhhhhhhcCCCcccccC
Q 045315 316 GGDELQSNTKRIVGTYGYMSPEYALRGLFSIKSDVFSFGVLLLETLSSKKNTHFYNTDSLTLLGHAWNLWNDGRTWELMD 395 (476)
Q Consensus 316 ~~~~~~~~~~~~~gt~~y~aPE~l~~~~~s~ksDVwSlGvvl~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~d 395 (476)
...... .....||+.|+|||.+.+..++.++|||||||++|||++|+.||........ .. .....+.. ..
T Consensus 167 ~~~~~~--~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~--~~---~~~~~~~~-~~-- 236 (297)
T 3fxz_A 167 TPEQSK--RSTMVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMIEGEPPYLNENPLRA--LY---LIATNGTP-EL-- 236 (297)
T ss_dssp CSTTCC--BCCCCSCGGGCCHHHHHCSCBCTHHHHHHHHHHHHHHHHSSCTTTTSCHHHH--HH---HHHHHCSC-CC--
T ss_pred CCcccc--cCCccCCcCccChhhhcCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHH--HH---HHHhCCCC-CC--
Confidence 543322 2335789999999999999999999999999999999999999864431111 10 01111100 00
Q ss_pred cccCCCCCHHHHHHHHHHHHHchhhcccCCCCHHHHHH
Q 045315 396 PISQNGASYPILKRYINVALLCVQEKAADRPAMSEVVS 433 (476)
Q Consensus 396 ~~~~~~~~~~~~~~l~~li~~Cl~~dP~~RPt~~eVl~ 433 (476)
..+......+.+++.+||+.||++|||++|+++
T Consensus 237 -----~~~~~~~~~~~~li~~~l~~dp~~Rps~~ell~ 269 (297)
T 3fxz_A 237 -----QNPEKLSAIFRDFLNRCLEMDVEKRGSAKELLQ 269 (297)
T ss_dssp -----SCGGGSCHHHHHHHHHHSCSSTTTSCCHHHHTT
T ss_pred -----CCccccCHHHHHHHHHHccCChhHCcCHHHHhh
Confidence 111223456889999999999999999999876
|
| >3lzb_A Epidermal growth factor receptor; epidermal growth factor kinase domain, multitargeted small M kinase inhibitor; HET: ITI; 2.70A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.95 E-value=3.9e-29 Score=249.01 Aligned_cols=181 Identities=22% Similarity=0.293 Sum_probs=133.8
Q ss_pred ccceeeccCCCC-------CCCCCCChhhHHHHHHHHHHHHHHHhhcCCCceeecCCCccceEecCCCCceeccccceee
Q 045315 242 EISFWYESYNNP-------TKKGLLCWGTRVRIIEGIAQGLLYLHQYSRLRVIHRDLKASNILLDKDMNPKISDFGMARM 314 (476)
Q Consensus 242 ~~~l~~Ey~~~~-------~~~~~L~~~~~~~i~~qIa~gL~yLH~~~~~~ivH~DLkp~NILld~~~~~kL~DFGla~~ 314 (476)
..++++||++.+ ..+..+++.+++.++.||+.||+|||+++ |+||||||+|||++.++.+||+|||+++.
T Consensus 90 ~~~~v~~~~~~g~L~~~l~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~---ivH~Dikp~NIl~~~~~~~kL~DfG~a~~ 166 (327)
T 3lzb_A 90 TVQLITQLMPFGCLLDYVREHKDNIGSQYLLNWCVQIAKGMNYLEDRR---LVHRDLAARNVLVKTPQHVKITDFGLAKL 166 (327)
T ss_dssp SEEEEECCCSSCBHHHHHHHTTTCCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEEEETTEEEECCTTC---
T ss_pred CceEEEEecCCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHhhCC---CcCCCCCHHHEEEcCCCCEEEccCcceeE
Confidence 466778888733 23567999999999999999999999999 99999999999999999999999999987
Q ss_pred cCCCcccccceeeeeccCCCChhhhccCCCCccceEEeehhhhhhhhh-CCCCCCcCCCCchhhhhhhhhhhcCCCcccc
Q 045315 315 FGGDELQSNTKRIVGTYGYMSPEYALRGLFSIKSDVFSFGVLLLETLS-SKKNTHFYNTDSLTLLGHAWNLWNDGRTWEL 393 (476)
Q Consensus 315 ~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~s~ksDVwSlGvvl~ellt-G~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~ 393 (476)
..............++..|+|||.+.+..++.++|||||||++|||++ |+.||....... ... ....+..
T Consensus 167 ~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~ell~~g~~p~~~~~~~~--~~~----~~~~~~~--- 237 (327)
T 3lzb_A 167 LGAEEKEYHAEGGKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPASE--ISS----ILEKGER--- 237 (327)
T ss_dssp -------------CCCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCGGG--HHH----HHHTTCC---
T ss_pred ccCccccccccCCCccccccCHHHHcCCCCChHHHHHHHHHHHHHHHHCCCCCCCCCCHHH--HHH----HHHcCCC---
Confidence 654433333333456788999999999999999999999999999999 999986543221 111 1111111
Q ss_pred cCcccCCCCCHHHHHHHHHHHHHchhhcccCCCCHHHHHHHHhcccc
Q 045315 394 MDPISQNGASYPILKRYINVALLCVQEKAADRPAMSEVVSMLSNEFV 440 (476)
Q Consensus 394 ~d~~~~~~~~~~~~~~l~~li~~Cl~~dP~~RPt~~eVl~~L~~~~~ 440 (476)
...+......+.+++.+||+.||++||++.|+++.|+.+..
T Consensus 238 ------~~~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~~L~~~~~ 278 (327)
T 3lzb_A 238 ------LPQPPICTIDVYMIMRKCWMIDADSRPKFRELIIEFSKMAR 278 (327)
T ss_dssp ------CCCCTTBCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHT
T ss_pred ------CCCCccCCHHHHHHHHHHcCCChhHCcCHHHHHHHHHHHHh
Confidence 11112234568899999999999999999999999999763
|
| >3mdy_A Bone morphogenetic protein receptor type-1B; complex (isomerase-protein kinase), receptor serine/threonin structural genomics consortium, SGC; HET: LDN; 2.05A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=99.95 E-value=4.7e-28 Score=240.98 Aligned_cols=193 Identities=24% Similarity=0.249 Sum_probs=137.5
Q ss_pred cccceeeccCCCCC-----CCCCCChhhHHHHHHHHHHHHHHHhhc--------CCCceeecCCCccceEecCCCCceec
Q 045315 241 DEISFWYESYNNPT-----KKGLLCWGTRVRIIEGIAQGLLYLHQY--------SRLRVIHRDLKASNILLDKDMNPKIS 307 (476)
Q Consensus 241 ~~~~l~~Ey~~~~~-----~~~~L~~~~~~~i~~qIa~gL~yLH~~--------~~~~ivH~DLkp~NILld~~~~~kL~ 307 (476)
+..+++|||++.++ +...+++.+++.++.|++.||+|||++ + |+||||||+|||++.++.+||+
T Consensus 108 ~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~~~~---ivH~Dikp~Nill~~~~~~kl~ 184 (337)
T 3mdy_A 108 TQLYLITDYHENGSLYDYLKSTTLDAKSMLKLAYSSVSGLCHLHTEIFSTQGKPA---IAHRDLKSKNILVKKNGTCCIA 184 (337)
T ss_dssp CEEEEEECCCTTCBHHHHHHHCCBCHHHHHHHHHHHHHHHHHHHSCBCSTTCBCC---EECSCCCGGGEEECTTSCEEEC
T ss_pred CceEEEEeccCCCcHHHHhhccCCCHHHHHHHHHHHHHHHHHHHHhhhhhccCCC---EEecccchHHEEECCCCCEEEE
Confidence 35788999998432 234699999999999999999999998 7 9999999999999999999999
Q ss_pred cccceeecCCCcccc--cceeeeeccCCCChhhhccCCCCcc------ceEEeehhhhhhhhhCCC----------CCCc
Q 045315 308 DFGMARMFGGDELQS--NTKRIVGTYGYMSPEYALRGLFSIK------SDVFSFGVLLLETLSSKK----------NTHF 369 (476)
Q Consensus 308 DFGla~~~~~~~~~~--~~~~~~gt~~y~aPE~l~~~~~s~k------sDVwSlGvvl~elltG~~----------p~~~ 369 (476)
|||+++.+....... ......||..|+|||.+.+.....+ +|||||||++|||++|.. |+..
T Consensus 185 Dfg~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~DiwslG~il~el~tg~~~~~~~~~~~~p~~~ 264 (337)
T 3mdy_A 185 DLGLAVKFISDTNEVDIPPNTRVGTKRYMPPEVLDESLNRNHFQSYIMADMYSFGLILWEVARRCVSGGIVEEYQLPYHD 264 (337)
T ss_dssp CCTTCEECC---------CCSSCSCGGGCCHHHHTTCCCTTCTHHHHHHHHHHHHHHHHHHHTTBCBTTBCCCCCCTTTT
T ss_pred eCCCceeeccccccccCCCCCCccCcceeChhhcccccCCccccCccccchHHHHHHHHHHHhccCcccccccccccHhh
Confidence 999998765432211 1123468999999999987666554 999999999999999944 4432
Q ss_pred CCCCchhhhhhhhhhhcCCCcccccCcccCC-CCCHHHHHHHHHHHHHchhhcccCCCCHHHHHHHHhccccC
Q 045315 370 YNTDSLTLLGHAWNLWNDGRTWELMDPISQN-GASYPILKRYINVALLCVQEKAADRPAMSEVVSMLSNEFVN 441 (476)
Q Consensus 370 ~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~-~~~~~~~~~l~~li~~Cl~~dP~~RPt~~eVl~~L~~~~~~ 441 (476)
.......... .......... .+.... .........+.+++.+||+.||++|||+.||++.|+.+...
T Consensus 265 ~~~~~~~~~~-~~~~~~~~~~----~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~L~~l~~~ 332 (337)
T 3mdy_A 265 LVPSDPSYED-MREIVCIKKL----RPSFPNRWSSDECLRQMGKLMTECWAHNPASRLTALRVKKTLAKMSES 332 (337)
T ss_dssp TSCSSCCHHH-HHHHHTTSCC----CCCCCGGGGGSHHHHHHHHHHHHHSCSSGGGSCCHHHHHHHHHHHHHT
T ss_pred hcCCCCchhh-hHHHHhhhcc----CccccccchhhHHHHHHHHHHHHhhhhChhhCCCHHHHHHHHHHHHhh
Confidence 2211111110 0111111110 011100 01125677899999999999999999999999999997644
|
| >3tki_A Serine/threonine-protein kinase CHK1; cell checkpoint, transferase-transferase inhib complex; HET: S25; 1.60A {Homo sapiens} PDB: 2qhm_A* 2r0u_A* 3tkh_A* 2qhn_A* 2hy0_A* 2hog_A* 2hxq_A* 2hxl_A* 3f9n_A* | Back alignment and structure |
|---|
Probab=99.95 E-value=1.4e-28 Score=244.59 Aligned_cols=178 Identities=22% Similarity=0.291 Sum_probs=136.9
Q ss_pred cccceeeccCCC------CCCCCCCChhhHHHHHHHHHHHHHHHhhcCCCceeecCCCccceEecCCCCceeccccceee
Q 045315 241 DEISFWYESYNN------PTKKGLLCWGTRVRIIEGIAQGLLYLHQYSRLRVIHRDLKASNILLDKDMNPKISDFGMARM 314 (476)
Q Consensus 241 ~~~~l~~Ey~~~------~~~~~~L~~~~~~~i~~qIa~gL~yLH~~~~~~ivH~DLkp~NILld~~~~~kL~DFGla~~ 314 (476)
+..+++|||++. ......+++.++..++.||+.||+|||+.+ |+||||||+|||++.++.+||+|||++..
T Consensus 78 ~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~i~~qi~~aL~~LH~~g---ivH~Dlkp~NIll~~~~~~kl~Dfg~a~~ 154 (323)
T 3tki_A 78 NIQYLFLEYCSGGELFDRIEPDIGMPEPDAQRFFHQLMAGVVYLHGIG---ITHRDIKPENLLLDERDNLKISDFGLATV 154 (323)
T ss_dssp SEEEEEEECCTTEEGGGGSBTTTBCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEECTTCCEEECCCTTCEE
T ss_pred CeEEEEEEcCCCCcHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHHCC---ccccccchHHEEEeCCCCEEEEEeeccce
Confidence 456788999972 234557999999999999999999999999 99999999999999999999999999987
Q ss_pred cCCCcccccceeeeeccCCCChhhhccCCC-CccceEEeehhhhhhhhhCCCCCCcCCCCchhhhhhhhhhhcCCCcccc
Q 045315 315 FGGDELQSNTKRIVGTYGYMSPEYALRGLF-SIKSDVFSFGVLLLETLSSKKNTHFYNTDSLTLLGHAWNLWNDGRTWEL 393 (476)
Q Consensus 315 ~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~-s~ksDVwSlGvvl~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~ 393 (476)
+.............||+.|+|||.+.+..+ +.++|||||||++|||++|+.||.............. ....
T Consensus 155 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~~~~-----~~~~--- 226 (323)
T 3tki_A 155 FRYNNRERLLNKMCGTLPYVAPELLKRREFHAEPVDVWSCGIVLTAMLAGELPWDQPSDSCQEYSDWK-----EKKT--- 226 (323)
T ss_dssp CEETTEECCBCSCCSCGGGSCHHHHHCSSBCHHHHHHHHHHHHHHHHHHSSCSCSSSCTTSHHHHHHH-----TTCT---
T ss_pred eccCCcccccCCCccCcCccCcHHhccCCCCCCcccHHHHHHHHHHHHhCCCCCCCCchHHHHHHHHh-----cccc---
Confidence 643332223334678999999999987765 7899999999999999999999975543322222111 1100
Q ss_pred cCcccCCCCCHHHHHHHHHHHHHchhhcccCCCCHHHHHHH
Q 045315 394 MDPISQNGASYPILKRYINVALLCVQEKAADRPAMSEVVSM 434 (476)
Q Consensus 394 ~d~~~~~~~~~~~~~~l~~li~~Cl~~dP~~RPt~~eVl~~ 434 (476)
...........+.+++.+||+.||++|||+.|+++.
T Consensus 227 -----~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~eil~h 262 (323)
T 3tki_A 227 -----YLNPWKKIDSAPLALLHKILVENPSARITIPDIKKD 262 (323)
T ss_dssp -----TSTTGGGSCHHHHHHHHHHSCSSTTTSCCHHHHTTC
T ss_pred -----cCCccccCCHHHHHHHHHHccCChhhCcCHHHHhhC
Confidence 000112234567899999999999999999998763
|
| >2eva_A TAK1 kinase - TAB1 chimera fusion protein; transferase/transferase activator complex; HET: ADN; 2.00A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.95 E-value=2.2e-28 Score=241.24 Aligned_cols=190 Identities=24% Similarity=0.340 Sum_probs=137.2
Q ss_pred ccceeeccCCCC---------CCCCCCChhhHHHHHHHHHHHHHHHhhcCCCceeecCCCccceEecCCCC-ceeccccc
Q 045315 242 EISFWYESYNNP---------TKKGLLCWGTRVRIIEGIAQGLLYLHQYSRLRVIHRDLKASNILLDKDMN-PKISDFGM 311 (476)
Q Consensus 242 ~~~l~~Ey~~~~---------~~~~~L~~~~~~~i~~qIa~gL~yLH~~~~~~ivH~DLkp~NILld~~~~-~kL~DFGl 311 (476)
..+++|||++.. .....+++.+++.++.||++||+|||+.+...|+||||||+||+++.++. +||+|||+
T Consensus 73 ~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~qi~~~l~~LH~~~~~~ivH~dlkp~NIll~~~~~~~kl~Dfg~ 152 (307)
T 2eva_A 73 PVCLVMEYAEGGSLYNVLHGAEPLPYYTAAHAMSWCLQCSQGVAYLHSMQPKALIHRDLKPPNLLLVAGGTVLKICDFGT 152 (307)
T ss_dssp TTEEEEECCTTCBHHHHHHCSSSEECCCHHHHHHHHHHHHHHHHHHHTCSSSCCCCCCCSGGGEEEETTTTEEEECCCCC
T ss_pred CcEEEEEcCCCCCHHHHHhccCCCCccCHHHHHHHHHHHHHHHHHHHhCCCCCeecCCCChhHEEEeCCCCEEEEccccc
Confidence 467899999732 12235788999999999999999999932122999999999999998886 79999999
Q ss_pred eeecCCCcccccceeeeeccCCCChhhhccCCCCccceEEeehhhhhhhhhCCCCCCcCCCCchhhhhhhhhhhcCCCcc
Q 045315 312 ARMFGGDELQSNTKRIVGTYGYMSPEYALRGLFSIKSDVFSFGVLLLETLSSKKNTHFYNTDSLTLLGHAWNLWNDGRTW 391 (476)
Q Consensus 312 a~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~s~ksDVwSlGvvl~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~ 391 (476)
+...... .....|+..|+|||.+.+..++.++||||||+++|||++|+.||............ ... .+...
T Consensus 153 ~~~~~~~-----~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~~~~~~---~~~-~~~~~ 223 (307)
T 2eva_A 153 ACDIQTH-----MTNNKGSAAWMAPEVFEGSNYSEKCDVFSWGIILWEVITRRKPFDEIGGPAFRIMW---AVH-NGTRP 223 (307)
T ss_dssp -----------------CCTTSSCHHHHTCCCCCTHHHHHHHHHHHHHHHHTCCTTTTTCSSHHHHHH---HHH-TTCCC
T ss_pred ccccccc-----cccCCCCCceEChhhhCCCCCCcHHHHHHHHHHHHHHHHCCCCchhhCccHHHHHH---HHh-cCCCC
Confidence 9765432 12246899999999999999999999999999999999999998754332221111 111 11111
Q ss_pred cccCcccCCCCCHHHHHHHHHHHHHchhhcccCCCCHHHHHHHHhccccCCCCCCCCc
Q 045315 392 ELMDPISQNGASYPILKRYINVALLCVQEKAADRPAMSEVVSMLSNEFVNLPAPQQPA 449 (476)
Q Consensus 392 ~~~d~~~~~~~~~~~~~~l~~li~~Cl~~dP~~RPt~~eVl~~L~~~~~~~~~p~~p~ 449 (476)
. . .......+.+++.+||+.||++|||++++++.|+.+....+.+..|.
T Consensus 224 ~-----~----~~~~~~~l~~li~~~l~~dp~~Rps~~ell~~L~~~~~~~~~~~~~~ 272 (307)
T 2eva_A 224 P-----L----IKNLPKPIESLMTRCWSKDPSQRPSMEEIVKIMTHLMRYFPGADEPL 272 (307)
T ss_dssp C-----C----BTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHGGGCCCTTSCC
T ss_pred C-----c----ccccCHHHHHHHHHHhcCChhhCcCHHHHHHHHHHHHHhccCCCCcc
Confidence 1 1 11223568899999999999999999999999999876666555443
|
| >3ugc_A Tyrosine-protein kinase JAK2; small molecule inhibitor, ATP binding, transferase-transfera inhibitor complex; HET: 046; 1.34A {} PDB: 3krr_A* 3lpb_A* 4aqc_A* 4e4m_A* 4f08_A* 4f09_A* 3q32_A* 3rvg_A* 4hge_A* 3tjc_A* 3tjd_A* 4bbe_A* 4bbf_A* 2b7a_A* 3fup_A* 3e64_A* 3e62_A* 3e63_A* 2xa4_A* 3iok_A* ... | Back alignment and structure |
|---|
Probab=99.95 E-value=1e-29 Score=248.73 Aligned_cols=189 Identities=21% Similarity=0.284 Sum_probs=137.0
Q ss_pred ccceeeccCCCCC-------CCCCCChhhHHHHHHHHHHHHHHHhhcCCCceeecCCCccceEecCCCCceeccccceee
Q 045315 242 EISFWYESYNNPT-------KKGLLCWGTRVRIIEGIAQGLLYLHQYSRLRVIHRDLKASNILLDKDMNPKISDFGMARM 314 (476)
Q Consensus 242 ~~~l~~Ey~~~~~-------~~~~L~~~~~~~i~~qIa~gL~yLH~~~~~~ivH~DLkp~NILld~~~~~kL~DFGla~~ 314 (476)
..+++|||++..+ .+..+++.+++.++.||+.||+|||+.+ |+||||||+||+++.++.+||+|||+++.
T Consensus 87 ~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~---ivH~Dikp~Nil~~~~~~~kl~Dfg~~~~ 163 (295)
T 3ugc_A 87 NLKLIMEYLPYGSLRDYLQKHKERIDHIKLLQYTSQICKGMEYLGTKR---YIHRDLATRNILVENENRVKIGDFGLTKV 163 (295)
T ss_dssp SCEEEEECCTTCBHHHHHHHCGGGCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCSGGGEEEEETTEEEECCCCSCC-
T ss_pred ceEEEEEeCCCCCHHHHHHhcccccCHHHHHHHHHHHHHHHHHHhcCC---cccCCCCHhhEEEcCCCeEEEccCccccc
Confidence 4778999997432 3446999999999999999999999999 99999999999999999999999999987
Q ss_pred cCCCccc-ccceeeeeccCCCChhhhccCCCCccceEEeehhhhhhhhhCCCCCCcCCCC----------chhhhhhhhh
Q 045315 315 FGGDELQ-SNTKRIVGTYGYMSPEYALRGLFSIKSDVFSFGVLLLETLSSKKNTHFYNTD----------SLTLLGHAWN 383 (476)
Q Consensus 315 ~~~~~~~-~~~~~~~gt~~y~aPE~l~~~~~s~ksDVwSlGvvl~elltG~~p~~~~~~~----------~~~~~~~~~~ 383 (476)
....... .......++..|+|||.+.+..++.++||||||+++|||++|..|+...... ..........
T Consensus 164 ~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 243 (295)
T 3ugc_A 164 LPQDKEFFKVKEPGESPIFWYAPESLTESKFSVASDVWSFGVVLYELFTYIEKSKSPPAEFMRMIGNDKQGQMIVFHLIE 243 (295)
T ss_dssp ------------CTTCGGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHHTTCTTCSHHHHHHHHHCTTCCTHHHHHHHHH
T ss_pred ccCCcceeeeccCCCCccceeCcHHhcCCCCChHHHHHHHHHHHHHHHhcccccCCChHHHHhhhcCccccchhHHHHHH
Confidence 6543211 1122234677899999999999999999999999999999999887532110 0000001111
Q ss_pred hhcCCCcccccCcccCCCCCHHHHHHHHHHHHHchhhcccCCCCHHHHHHHHhccccCC
Q 045315 384 LWNDGRTWELMDPISQNGASYPILKRYINVALLCVQEKAADRPAMSEVVSMLSNEFVNL 442 (476)
Q Consensus 384 ~~~~~~~~~~~d~~~~~~~~~~~~~~l~~li~~Cl~~dP~~RPt~~eVl~~L~~~~~~~ 442 (476)
....+. ....+......+.+++.+||+.||++|||+.||++.|+.+..++
T Consensus 244 ~~~~~~---------~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~el~~~L~~l~~~l 293 (295)
T 3ugc_A 244 LLKNNG---------RLPRPDGCPDEIYMIMTECWNNNVNQRPSFRDLALRVDQIRDNM 293 (295)
T ss_dssp HHHTTC---------CCCCCTTCCHHHHHHHHHHSCSSGGGSCCHHHHHHHHHHHHHC-
T ss_pred HHhccC---------cCCCCcCcCHHHHHHHHHHcCCChhhCCCHHHHHHHHHHHHHhc
Confidence 111111 11112233467889999999999999999999999999876554
|
| >1fmk_A C-SRC, P60-SRC, tyrosine-protein kinase SRC; tyrosine kinase, phosphorylation, SH2, SH3, phosphotyrosine, proto-oncogene, phosphotransferase; HET: PTR; 1.50A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1y57_A* 2src_A* 1ksw_A* 2ptk_A* 1yol_A* 2oiq_A* 3d7t_B* 3dqx_A* 3el7_A* 3el8_A* 3en4_A* 3en5_A* 3en6_A* 3en7_A* 3f6x_A* 3g6g_A* 3uqf_A* 3uqg_A* 4agw_A* 3oez_A* ... | Back alignment and structure |
|---|
Probab=99.95 E-value=4.7e-29 Score=259.56 Aligned_cols=189 Identities=26% Similarity=0.398 Sum_probs=140.9
Q ss_pred cccceeeccCCCCC--------CCCCCChhhHHHHHHHHHHHHHHHhhcCCCceeecCCCccceEecCCCCceeccccce
Q 045315 241 DEISFWYESYNNPT--------KKGLLCWGTRVRIIEGIAQGLLYLHQYSRLRVIHRDLKASNILLDKDMNPKISDFGMA 312 (476)
Q Consensus 241 ~~~~l~~Ey~~~~~--------~~~~L~~~~~~~i~~qIa~gL~yLH~~~~~~ivH~DLkp~NILld~~~~~kL~DFGla 312 (476)
+.++++|||++.++ .+..+++.+++.++.||+.||+|||+++ |+||||||+|||++.++.+||+|||++
T Consensus 251 ~~~~iv~e~~~~gsL~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~---ivHrDlkp~Nill~~~~~~kl~DfG~a 327 (452)
T 1fmk_A 251 EPIYIVTEYMSKGSLLDFLKGETGKYLRLPQLVDMAAQIASGMAYVERMN---YVHRDLRAANILVGENLVCKVADFGLA 327 (452)
T ss_dssp SSCEEEECCCTTCBHHHHHSHHHHTTCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCSGGGEEECGGGCEEECCCCTT
T ss_pred CceEEEehhhcCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCC---eeCCCCChhhEEECCCCCEEECCCccc
Confidence 46789999998432 2346999999999999999999999999 999999999999999999999999999
Q ss_pred eecCCCcccccceeeeeccCCCChhhhccCCCCccceEEeehhhhhhhhh-CCCCCCcCCCCchhhhhhhhhhhcCCCcc
Q 045315 313 RMFGGDELQSNTKRIVGTYGYMSPEYALRGLFSIKSDVFSFGVLLLETLS-SKKNTHFYNTDSLTLLGHAWNLWNDGRTW 391 (476)
Q Consensus 313 ~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~s~ksDVwSlGvvl~ellt-G~~p~~~~~~~~~~~~~~~~~~~~~~~~~ 391 (476)
+........ ......++..|+|||.+.+..++.++|||||||++|||++ |+.||..... ...... ...+...
T Consensus 328 ~~~~~~~~~-~~~~~~~~~~y~aPE~~~~~~~~~~sDvwslG~~l~el~t~g~~P~~~~~~--~~~~~~----i~~~~~~ 400 (452)
T 1fmk_A 328 RLIEDNEYT-ARQGAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELTTKGRVPYPGMVN--REVLDQ----VERGYRM 400 (452)
T ss_dssp C---------------CCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCSSTTCCH--HHHHHH----HHTTCCC
T ss_pred eecCCCcee-cccCCcccccccCHhHHhcCCCCccccHHhHHHHHHHHHhCCCCCCCCCCH--HHHHHH----HHcCCCC
Confidence 876543221 1222456788999999999999999999999999999999 8988864331 111111 1111110
Q ss_pred cccCcccCCCCCHHHHHHHHHHHHHchhhcccCCCCHHHHHHHHhccccCCCCCCCC
Q 045315 392 ELMDPISQNGASYPILKRYINVALLCVQEKAADRPAMSEVVSMLSNEFVNLPAPQQP 448 (476)
Q Consensus 392 ~~~d~~~~~~~~~~~~~~l~~li~~Cl~~dP~~RPt~~eVl~~L~~~~~~~~~p~~p 448 (476)
..+....+.+.+++.+||+.||++|||+++|++.|+.+....+....|
T Consensus 401 ---------~~~~~~~~~l~~li~~cl~~dP~~Rpt~~~l~~~L~~~~~~~~~~~~~ 448 (452)
T 1fmk_A 401 ---------PCPPECPESLHDLMCQCWRKEPEERPTFEYLQAFLEDYFTSTEPQYQP 448 (452)
T ss_dssp ---------CCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHTTTSCSCCCCCC
T ss_pred ---------CCCCCCCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHhccCCccccc
Confidence 111223457889999999999999999999999999988665544444
|
| >2jii_A Serine/threonine-protein kinase VRK3 molecule: VA related kinase 3; transferase, pseudo kinase domain, vaccinia related kinase, ATP-binding; 2.00A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.95 E-value=2e-28 Score=246.11 Aligned_cols=198 Identities=13% Similarity=0.145 Sum_probs=147.6
Q ss_pred cccceeeccCC-------CCCCCCCCChhhHHHHHHHHHHHHHHHhhcCCCceeecCCCccceEecCCC--Cceeccccc
Q 045315 241 DEISFWYESYN-------NPTKKGLLCWGTRVRIIEGIAQGLLYLHQYSRLRVIHRDLKASNILLDKDM--NPKISDFGM 311 (476)
Q Consensus 241 ~~~~l~~Ey~~-------~~~~~~~L~~~~~~~i~~qIa~gL~yLH~~~~~~ivH~DLkp~NILld~~~--~~kL~DFGl 311 (476)
+.++++|||+. .......+++.+++.++.||+.||+|||+++ |+||||||+||+++.++ .+||+|||+
T Consensus 131 ~~~~lv~e~~~~~L~~~l~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~---ivH~Dikp~NIl~~~~~~~~~kl~Dfg~ 207 (352)
T 2jii_A 131 KYRFLVLPSLGRSLQSALDVSPKHVLSERSVLQVACRLLDALEFLHENE---YVHGNVTAENIFVDPEDQSQVTLAGYGF 207 (352)
T ss_dssp TEEEEEEECCCEEHHHHHHHSGGGCCCHHHHHHHHHHHHHHHHHHHHTT---CBCSCCCGGGEEEETTEEEEEEECCGGG
T ss_pred cEEEEEecCCCcCHHHHHHhCCcCCCCHHHHHHHHHHHHHHHHHHHhCC---ccCCCCCHHHEEEcCCCCceEEEecCcc
Confidence 45788999985 1112367999999999999999999999999 99999999999999988 899999999
Q ss_pred eeecCCCccc-----ccceeeeeccCCCChhhhccCCCCccceEEeehhhhhhhhhCCCCCCcCCCCchhhhhhhhhhhc
Q 045315 312 ARMFGGDELQ-----SNTKRIVGTYGYMSPEYALRGLFSIKSDVFSFGVLLLETLSSKKNTHFYNTDSLTLLGHAWNLWN 386 (476)
Q Consensus 312 a~~~~~~~~~-----~~~~~~~gt~~y~aPE~l~~~~~s~ksDVwSlGvvl~elltG~~p~~~~~~~~~~~~~~~~~~~~ 386 (476)
++.+...... .......|++.|+|||.+.+..++.++|||||||++|||++|+.||...................
T Consensus 208 a~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~ 287 (352)
T 2jii_A 208 AFRYCPSGKHVAYVEGSRSPHEGDLEFISMDLHKGCGPSRRSDLQSLGYCMLKWLYGFLPWTNCLPNTEDIMKQKQKFVD 287 (352)
T ss_dssp CBCSSGGGCCCCCCTTSSCTTCSCTTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSCCTTGGGTTCHHHHHHHHHHHHH
T ss_pred eeeccCCCccccccccccccccCCccccCHHHHccCCCCchhhHHHHHHHHHHHHhCCCCcccCCcCHHHHHHHHHhccC
Confidence 9876532211 11123478999999999999999999999999999999999999997654333222222111111
Q ss_pred CCCcccccCcccCCCCCHHHHHHHHHHHHHchhhcccCCCCHHHHHHHHhccccCCCCCC
Q 045315 387 DGRTWELMDPISQNGASYPILKRYINVALLCVQEKAADRPAMSEVVSMLSNEFVNLPAPQ 446 (476)
Q Consensus 387 ~~~~~~~~d~~~~~~~~~~~~~~l~~li~~Cl~~dP~~RPt~~eVl~~L~~~~~~~~~p~ 446 (476)
....+.+.... .......+.+++.+||+.||++||++++|++.|+++.......+
T Consensus 288 --~~~~~~~~~~~---~~~~~~~l~~li~~~l~~dp~~Rps~~~l~~~L~~~~~~~~~~~ 342 (352)
T 2jii_A 288 --KPGPFVGPCGH---WIRPSETLQKYLKVVMALTYEEKPPYAMLRNNLEALLQDLRVSP 342 (352)
T ss_dssp --SCCCEECTTSC---EECCCHHHHHHHHHHHTCCTTCCCCHHHHHHHHHHHHHHTTCCT
T ss_pred --Chhhhhhhccc---cCCCcHHHHHHHHHHHhCChhhCCCHHHHHHHHHHHHHhcCCCc
Confidence 11111111100 01123578899999999999999999999999999876655443
|
| >2v62_A Serine/threonine-protein kinase VRK2; transferase, ATP-binding, membrane, nucleotide-binding, TRAN; 1.7A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.95 E-value=3.4e-28 Score=243.91 Aligned_cols=191 Identities=18% Similarity=0.138 Sum_probs=141.0
Q ss_pred cccceeeccCCC-----CCCCCCCChhhHHHHHHHHHHHHHHHhhcCCCceeecCCCccceEecCCC--Cceecccccee
Q 045315 241 DEISFWYESYNN-----PTKKGLLCWGTRVRIIEGIAQGLLYLHQYSRLRVIHRDLKASNILLDKDM--NPKISDFGMAR 313 (476)
Q Consensus 241 ~~~~l~~Ey~~~-----~~~~~~L~~~~~~~i~~qIa~gL~yLH~~~~~~ivH~DLkp~NILld~~~--~~kL~DFGla~ 313 (476)
+.++++|||+.. ....+.+++.+++.++.||+.||+|||+++ |+||||||+|||++.++ .+||+|||+++
T Consensus 125 ~~~~lv~e~~~~~L~~~l~~~~~~~~~~~~~i~~qi~~aL~~LH~~~---ivH~Dlkp~NIll~~~~~~~~kL~Dfg~a~ 201 (345)
T 2v62_A 125 SYRFMVMERLGIDLQKISGQNGTFKKSTVLQLGIRMLDVLEYIHENE---YVHGDIKAANLLLGYKNPDQVYLADYGLSY 201 (345)
T ss_dssp EEEEEEEECEEEEHHHHCBGGGBCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEEESSSTTSEEECCCTTCE
T ss_pred cEEEEEEeccCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCC---eeCCCcCHHHEEEccCCCCcEEEEeCCCce
Confidence 457888898840 122348999999999999999999999998 99999999999999877 99999999998
Q ss_pred ecCCCccc-----ccceeeeeccCCCChhhhccCCCCccceEEeehhhhhhhhhCCCCCCcCCCCchhhhhhhhhhhcCC
Q 045315 314 MFGGDELQ-----SNTKRIVGTYGYMSPEYALRGLFSIKSDVFSFGVLLLETLSSKKNTHFYNTDSLTLLGHAWNLWNDG 388 (476)
Q Consensus 314 ~~~~~~~~-----~~~~~~~gt~~y~aPE~l~~~~~s~ksDVwSlGvvl~elltG~~p~~~~~~~~~~~~~~~~~~~~~~ 388 (476)
.+...... .......|+..|+|||.+.+..++.++|||||||++|||++|+.||.................. ..
T Consensus 202 ~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~-~~ 280 (345)
T 2v62_A 202 RYCPNGNHKQYQENPRKGHNGTIEFTSLDAHKGVALSRRSDVEILGYCMLRWLCGKLPWEQNLKDPVAVQTAKTNLL-DE 280 (345)
T ss_dssp ESSGGGCCCCCCCCGGGCSCSCTTTCCHHHHHTCCCCHHHHHHHHHHHHHHHHHSSCTTGGGTTCHHHHHHHHHHHH-HT
T ss_pred ecccccccccchhccccccCCCccccCHHHhcCCCCCchhhHHHHHHHHHHHHhCCCCccccccccHHHHHHHHhhc-cc
Confidence 76432211 1113357899999999999999999999999999999999999999653322222211111111 00
Q ss_pred CcccccCcccCCCCCHHHHHHHHHHHHHchhhcccCCCCHHHHHHHHhccc
Q 045315 389 RTWELMDPISQNGASYPILKRYINVALLCVQEKAADRPAMSEVVSMLSNEF 439 (476)
Q Consensus 389 ~~~~~~d~~~~~~~~~~~~~~l~~li~~Cl~~dP~~RPt~~eVl~~L~~~~ 439 (476)
....+..... .......+.+++.+||+.||++||++++|++.|+...
T Consensus 281 -~~~~~~~~~~---~~~~~~~l~~li~~~l~~dp~~Rps~~~l~~~L~~~~ 327 (345)
T 2v62_A 281 -LPQSVLKWAP---SGSSCCEIAQFLVCAHSLAYDEKPNYQALKKILNPHG 327 (345)
T ss_dssp -TTHHHHHHSC---TTSCCHHHHHHHHHHHTCCTTCCCCHHHHHHHHCTTC
T ss_pred -ccHHHHhhcc---ccccHHHHHHHHHHHhhcCcccCCCHHHHHHHHhccC
Confidence 0000000000 0122357889999999999999999999999999864
|
| >1t46_A HOMO sapiens V-KIT hardy-zuckerman 4 feline sarcoma viral oncogene homolog; kinase, structure, inhibitor, STI-571, gleevec, transferase activator; HET: STI; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1pkg_A* 1t45_A 3g0e_A* 3g0f_A* | Back alignment and structure |
|---|
Probab=99.95 E-value=1.2e-28 Score=242.67 Aligned_cols=167 Identities=24% Similarity=0.349 Sum_probs=132.5
Q ss_pred CCChhhHHHHHHHHHHHHHHHhhcCCCceeecCCCccceEecCCCCceeccccceeecCCCcccccceeeeeccCCCChh
Q 045315 258 LLCWGTRVRIIEGIAQGLLYLHQYSRLRVIHRDLKASNILLDKDMNPKISDFGMARMFGGDELQSNTKRIVGTYGYMSPE 337 (476)
Q Consensus 258 ~L~~~~~~~i~~qIa~gL~yLH~~~~~~ivH~DLkp~NILld~~~~~kL~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE 337 (476)
.+++.+++.++.||+.||+|||+++ |+||||||+||+++.++.+||+|||+++...............++..|+|||
T Consensus 141 ~~~~~~~~~~~~qi~~~l~~lH~~~---i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE 217 (313)
T 1t46_A 141 ALDLEDLLSFSYQVAKGMAFLASKN---CIHRDLAARNILLTHGRITKICDFGLARDIKNDSNYVVKGNARLPVKWMAPE 217 (313)
T ss_dssp CCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCSGGGEEEETTTEEEECCCGGGSCTTSCTTSEECSSSEECGGGCCHH
T ss_pred cCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCccceEEEcCCCCEEEccccccccccccccceeccCCCCcceeeChH
Confidence 5999999999999999999999999 9999999999999999999999999998776543332233356788999999
Q ss_pred hhccCCCCccceEEeehhhhhhhhh-CCCCCCcCCCCchhhhhhhhhhhcCCCcccccCcccCCCCCHHHHHHHHHHHHH
Q 045315 338 YALRGLFSIKSDVFSFGVLLLETLS-SKKNTHFYNTDSLTLLGHAWNLWNDGRTWELMDPISQNGASYPILKRYINVALL 416 (476)
Q Consensus 338 ~l~~~~~s~ksDVwSlGvvl~ellt-G~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~l~~li~~ 416 (476)
.+.+..++.++||||||+++|||++ |+.||........ .... ...+.. ...+......+.+++.+
T Consensus 218 ~~~~~~~~~~~Di~slG~il~ellt~g~~p~~~~~~~~~-~~~~----~~~~~~---------~~~~~~~~~~l~~li~~ 283 (313)
T 1t46_A 218 SIFNCVYTFESDVWSYGIFLWELFSLGSSPYPGMPVDSK-FYKM----IKEGFR---------MLSPEHAPAEMYDIMKT 283 (313)
T ss_dssp HHHHCCCCHHHHHHHHHHHHHHHHTTTCCSSTTCCSSHH-HHHH----HHHTCC---------CCCCTTSCHHHHHHHHH
T ss_pred HhcCCCCChHHHHHHHHHHHHHHHhCCCCCCCcccchhH-HHHH----hccCCC---------CCCcccCCHHHHHHHHH
Confidence 9999999999999999999999998 9999865442221 1111 111100 01112234578899999
Q ss_pred chhhcccCCCCHHHHHHHHhccccC
Q 045315 417 CVQEKAADRPAMSEVVSMLSNEFVN 441 (476)
Q Consensus 417 Cl~~dP~~RPt~~eVl~~L~~~~~~ 441 (476)
||+.||.+|||+.|+++.|+++..+
T Consensus 284 ~l~~dp~~Rps~~ell~~L~~~~~~ 308 (313)
T 1t46_A 284 CWDADPLKRPTFKQIVQLIEKQISE 308 (313)
T ss_dssp HTCSSGGGSCCHHHHHHHHHHHHHH
T ss_pred HcCCCchhCcCHHHHHHHHHHHHHH
Confidence 9999999999999999999987643
|
| >2ivs_A Proto-oncogene tyrosine-protein kinase receptor RET; nucleotide-binding, hirschsprung disease, phosphorylation, disease mutation; HET: ACK; 2.00A {Homo sapiens} PDB: 2ivt_A* 2ivu_A* 2x2k_A* 2x2l_A* 2x2m_A* 2ivv_A* | Back alignment and structure |
|---|
Probab=99.95 E-value=8.9e-29 Score=243.75 Aligned_cols=166 Identities=26% Similarity=0.393 Sum_probs=132.2
Q ss_pred CCCChhhHHHHHHHHHHHHHHHhhcCCCceeecCCCccceEecCCCCceeccccceeecCCCcccccceeeeeccCCCCh
Q 045315 257 GLLCWGTRVRIIEGIAQGLLYLHQYSRLRVIHRDLKASNILLDKDMNPKISDFGMARMFGGDELQSNTKRIVGTYGYMSP 336 (476)
Q Consensus 257 ~~L~~~~~~~i~~qIa~gL~yLH~~~~~~ivH~DLkp~NILld~~~~~kL~DFGla~~~~~~~~~~~~~~~~gt~~y~aP 336 (476)
..+++.+++.++.||++||+|||+++ |+||||||+||+++.++.+||+|||+++...............++..|+||
T Consensus 145 ~~~~~~~~~~i~~qi~~~l~~lH~~~---ivH~dikp~NIli~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aP 221 (314)
T 2ivs_A 145 RALTMGDLISFAWQISQGMQYLAEMK---LVHRDLAARNILVAEGRKMKISDFGLSRDVYEEDSYVKRSQGRIPVKWMAI 221 (314)
T ss_dssp CEECHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEEETTTEEEECCCTTCEECTTTSCEECSSCCCSCGGGCCH
T ss_pred cCcCHHHHHHHHHHHHHHHHHHHHCC---CcccccchheEEEcCCCCEEEccccccccccccccceeccCCCCcccccCh
Confidence 45899999999999999999999999 999999999999999999999999999877554333333334577889999
Q ss_pred hhhccCCCCccceEEeehhhhhhhhh-CCCCCCcCCCCchhhhhhhhhhhcCCCcccccCcccCCCCCHHHHHHHHHHHH
Q 045315 337 EYALRGLFSIKSDVFSFGVLLLETLS-SKKNTHFYNTDSLTLLGHAWNLWNDGRTWELMDPISQNGASYPILKRYINVAL 415 (476)
Q Consensus 337 E~l~~~~~s~ksDVwSlGvvl~ellt-G~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~l~~li~ 415 (476)
|.+.+..++.++|||||||++|||++ |+.||....... ... ....+... ..+......+.+++.
T Consensus 222 E~~~~~~~~~~~Di~slG~il~el~t~g~~p~~~~~~~~--~~~----~~~~~~~~---------~~~~~~~~~~~~li~ 286 (314)
T 2ivs_A 222 ESLFDHIYTTQSDVWSFGVLLWEIVTLGGNPYPGIPPER--LFN----LLKTGHRM---------ERPDNCSEEMYRLML 286 (314)
T ss_dssp HHHHHCEECHHHHHHHHHHHHHHHHTTSCCSSTTCCGGG--HHH----HHHTTCCC---------CCCTTCCHHHHHHHH
T ss_pred hhhcCCCcCchhhHHHHHHHHHHHHhCCCCCCCCCCHHH--HHH----HhhcCCcC---------CCCccCCHHHHHHHH
Confidence 99999999999999999999999999 999986543221 111 11111111 111223457889999
Q ss_pred HchhhcccCCCCHHHHHHHHhcccc
Q 045315 416 LCVQEKAADRPAMSEVVSMLSNEFV 440 (476)
Q Consensus 416 ~Cl~~dP~~RPt~~eVl~~L~~~~~ 440 (476)
+||+.||++||++.++++.|+++..
T Consensus 287 ~~l~~dp~~Rps~~~l~~~l~~~~~ 311 (314)
T 2ivs_A 287 QCWKQEPDKRPVFADISKDLEKMMV 311 (314)
T ss_dssp HHTCSSGGGSCCHHHHHHHHHHHHH
T ss_pred HHccCChhhCcCHHHHHHHHHHHHh
Confidence 9999999999999999999998763
|
| >2izr_A Casein kinase I isoform gamma-3; serine/threonine-protein kinase, transferase, ATP- binding, phosphorylation, nucleotide-binding; HET: BRK; 1.3A {Homo sapiens} PDB: 2izs_A* 2izt_A* 2izu_A* 2chl_A* 2c47_A* 2cmw_A* | Back alignment and structure |
|---|
Probab=99.95 E-value=2.8e-28 Score=242.76 Aligned_cols=186 Identities=18% Similarity=0.184 Sum_probs=140.7
Q ss_pred cccceeeccCCCC-------CCCCCCChhhHHHHHHHHHHHHHHHhhcCCCceeecCCCccceEecCCCC-----ceecc
Q 045315 241 DEISFWYESYNNP-------TKKGLLCWGTRVRIIEGIAQGLLYLHQYSRLRVIHRDLKASNILLDKDMN-----PKISD 308 (476)
Q Consensus 241 ~~~~l~~Ey~~~~-------~~~~~L~~~~~~~i~~qIa~gL~yLH~~~~~~ivH~DLkp~NILld~~~~-----~kL~D 308 (476)
+..+++|||+. . ..++.+++.+++.++.||+.||+|||+.+ |+||||||+|||++.++. +||+|
T Consensus 78 ~~~~lv~e~~~-~~L~~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~---iiHrDlkp~Nill~~~~~~~~~~~kl~D 153 (330)
T 2izr_A 78 KYNAMVLELLG-PSLEDLFDLCDRTFSLKTVLMIAIQLISRMEYVHSKN---LIYRDVKPENFLIGRPGNKTQQVIHIID 153 (330)
T ss_dssp TEEEEEEECCC-CBHHHHHHHTTTCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEECCGGGTCTTSEEECC
T ss_pred CccEEEEEeCC-CCHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhCC---eeccCCCHHHeeeccCCCCCCceEEEEE
Confidence 35678899984 2 12568999999999999999999999999 999999999999998876 99999
Q ss_pred ccceeecCCCcccc-----cceeeeeccCCCChhhhccCCCCccceEEeehhhhhhhhhCCCCCCcCCCCch-hhhhhhh
Q 045315 309 FGMARMFGGDELQS-----NTKRIVGTYGYMSPEYALRGLFSIKSDVFSFGVLLLETLSSKKNTHFYNTDSL-TLLGHAW 382 (476)
Q Consensus 309 FGla~~~~~~~~~~-----~~~~~~gt~~y~aPE~l~~~~~s~ksDVwSlGvvl~elltG~~p~~~~~~~~~-~~~~~~~ 382 (476)
||+++.+....... ......||..|+|||.+.+..++.++|||||||++|||++|+.||........ .......
T Consensus 154 Fg~a~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~ell~g~~Pf~~~~~~~~~~~~~~i~ 233 (330)
T 2izr_A 154 FALAKEYIDPETKKHIPYREHKSLTGTARYMSINTHLGKEQSRRDDLEALGHMFMYFLRGSLPWQGLKADTLKERYQKIG 233 (330)
T ss_dssp CTTCEESBCTTTCCBCCCCCCCCCCSCTTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCTTTTCCCSSHHHHHHHHH
T ss_pred cccceeeecCCCCccccccccCCcCCCccccChHHHcCCCCCchhHHHHHHHHHHHHhcCCCCccccccccHHHHHHHHH
Confidence 99999764432211 12346799999999999999999999999999999999999999976542221 1111110
Q ss_pred hhhcCCCcccccCcccCCCCCHHHHHHHHHHHHHchhhcccCCCCHHHHHHHHhcccc
Q 045315 383 NLWNDGRTWELMDPISQNGASYPILKRYINVALLCVQEKAADRPAMSEVVSMLSNEFV 440 (476)
Q Consensus 383 ~~~~~~~~~~~~d~~~~~~~~~~~~~~l~~li~~Cl~~dP~~RPt~~eVl~~L~~~~~ 440 (476)
........ ..... ... .+.+++.+||+.||.+||++.+|++.|+.+..
T Consensus 234 ~~~~~~~~-----~~~~~----~~p-~~~~li~~~l~~~p~~RP~~~~l~~~l~~~~~ 281 (330)
T 2izr_A 234 DTKRATPI-----EVLCE----NFP-EMATYLRYVRRLDFFEKPDYDYLRKLFTDLFD 281 (330)
T ss_dssp HHHHHSCH-----HHHTT----TCH-HHHHHHHHHHHCCTTCCCCHHHHHHHHHHHHH
T ss_pred hhhccCCH-----HHHhc----cCh-HHHHHHHHHHhCCCCCCCCHHHHHHHHHHHHH
Confidence 00000000 00000 012 78899999999999999999999999987654
|
| >3dtc_A Mitogen-activated protein kinase kinase kinase 9; mixed-lineage kinase, MLK family, MLK1 and MLK3 subtype selective inhibitors; HET: VIN; 2.60A {Homo sapiens} SCOP: d.144.1.0 | Back alignment and structure |
|---|
Probab=99.95 E-value=1.6e-28 Score=236.97 Aligned_cols=180 Identities=26% Similarity=0.354 Sum_probs=132.1
Q ss_pred cccceeeccCCCC-----CCCCCCChhhHHHHHHHHHHHHHHHhhcCCCceeecCCCccceEecC--------CCCceec
Q 045315 241 DEISFWYESYNNP-----TKKGLLCWGTRVRIIEGIAQGLLYLHQYSRLRVIHRDLKASNILLDK--------DMNPKIS 307 (476)
Q Consensus 241 ~~~~l~~Ey~~~~-----~~~~~L~~~~~~~i~~qIa~gL~yLH~~~~~~ivH~DLkp~NILld~--------~~~~kL~ 307 (476)
+..++++||++.. .+++.+++.++..++.|++.||+|||+++..+|+||||||+||+++. ++.+||+
T Consensus 79 ~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~i~~~l~~~l~~lH~~~~~~i~H~dikp~Nil~~~~~~~~~~~~~~~kl~ 158 (271)
T 3dtc_A 79 PNLCLVMEFARGGPLNRVLSGKRIPPDILVNWAVQIARGMNYLHDEAIVPIIHRDLKSSNILILQKVENGDLSNKILKIT 158 (271)
T ss_dssp --CEEEEECCTTEEHHHHHTSSCCCHHHHHHHHHHHHHHHHHHHHSSSSCCCCSCCSGGGEEESSCCSSSCCSSCCEEEC
T ss_pred CceEEEEEcCCCCCHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHhCCCCceeecCCchHHEEEecccccccccCcceEEc
Confidence 4577899999732 23567999999999999999999999988666899999999999986 6789999
Q ss_pred cccceeecCCCcccccceeeeeccCCCChhhhccCCCCccceEEeehhhhhhhhhCCCCCCcCCCCchhhhhhhhhhhcC
Q 045315 308 DFGMARMFGGDELQSNTKRIVGTYGYMSPEYALRGLFSIKSDVFSFGVLLLETLSSKKNTHFYNTDSLTLLGHAWNLWND 387 (476)
Q Consensus 308 DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~s~ksDVwSlGvvl~elltG~~p~~~~~~~~~~~~~~~~~~~~~ 387 (476)
|||++....... .....|+..|+|||.+.+..++.++||||||+++|||++|+.||........ . ......
T Consensus 159 Dfg~~~~~~~~~----~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~--~---~~~~~~ 229 (271)
T 3dtc_A 159 DFGLAREWHRTT----KMSAAGAYAWMAPEVIRASMFSKGSDVWSYGVLLWELLTGEVPFRGIDGLAV--A---YGVAMN 229 (271)
T ss_dssp CCCC-----------------CCGGGSCHHHHHHCCCSHHHHHHHHHHHHHHHHHCCCTTTTSCHHHH--H---HHHHTS
T ss_pred cCCccccccccc----ccCCCCccceeCHHHhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHH--H---HhhhcC
Confidence 999998654332 1235689999999999999999999999999999999999999865431111 1 111111
Q ss_pred CCcccccCcccCCCCCHHHHHHHHHHHHHchhhcccCCCCHHHHHHHHhcc
Q 045315 388 GRTWELMDPISQNGASYPILKRYINVALLCVQEKAADRPAMSEVVSMLSNE 438 (476)
Q Consensus 388 ~~~~~~~d~~~~~~~~~~~~~~l~~li~~Cl~~dP~~RPt~~eVl~~L~~~ 438 (476)
... ...+......+.+++.+||+.||++|||+.|+++.|+.+
T Consensus 230 ~~~---------~~~~~~~~~~~~~li~~~l~~~p~~Rps~~e~l~~L~~l 271 (271)
T 3dtc_A 230 KLA---------LPIPSTCPEPFAKLMEDCWNPDPHSRPSFTNILDQLTTI 271 (271)
T ss_dssp CCC---------CCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHC-
T ss_pred CCC---------CCCCcccCHHHHHHHHHHhcCCcccCcCHHHHHHHHhcC
Confidence 110 111122335788999999999999999999999999863
|
| >1qpc_A LCK kinase; alpha beta fold, transferase; HET: PTR ANP; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1qpe_A* 1qpj_A* 2pl0_A* 3kxz_A* 3ac1_A* 2zm4_A* 2zyb_A* 2zm1_A* 3ac2_A* 3ac3_A* 3ac4_A* 3ac5_A* 3ac8_A* 3acj_A* 3ack_A* 3ad4_A* 3ad5_A* 3ad6_A* 3kmm_A* 1qpd_A* ... | Back alignment and structure |
|---|
Probab=99.95 E-value=6.3e-29 Score=241.02 Aligned_cols=187 Identities=26% Similarity=0.390 Sum_probs=141.5
Q ss_pred cccceeeccCCCCC------C--CCCCChhhHHHHHHHHHHHHHHHhhcCCCceeecCCCccceEecCCCCceeccccce
Q 045315 241 DEISFWYESYNNPT------K--KGLLCWGTRVRIIEGIAQGLLYLHQYSRLRVIHRDLKASNILLDKDMNPKISDFGMA 312 (476)
Q Consensus 241 ~~~~l~~Ey~~~~~------~--~~~L~~~~~~~i~~qIa~gL~yLH~~~~~~ivH~DLkp~NILld~~~~~kL~DFGla 312 (476)
+.+++++||++..+ . ...+++.++..++.||+.||+|||+++ ++||||||+||+++.++.+||+|||++
T Consensus 80 ~~~~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~---i~H~dikp~Nil~~~~~~~kl~Dfg~~ 156 (279)
T 1qpc_A 80 EPIYIITEYMENGSLVDFLKTPSGIKLTINKLLDMAAQIAEGMAFIEERN---YIHRDLRAANILVSDTLSCKIADFGLA 156 (279)
T ss_dssp SSCEEEEECCTTCBHHHHTTSHHHHTCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEECTTSCEEECCCTTC
T ss_pred CCcEEEEecCCCCCHHHHHhcCCCCCCCHHHHHHHHHHHHHHHHHHHHCC---eeccCCCHhhEEEcCCCCEEECCCccc
Confidence 45789999997322 1 226999999999999999999999999 999999999999999999999999999
Q ss_pred eecCCCcccccceeeeeccCCCChhhhccCCCCccceEEeehhhhhhhhh-CCCCCCcCCCCchhhhhhhhhhhcCCCcc
Q 045315 313 RMFGGDELQSNTKRIVGTYGYMSPEYALRGLFSIKSDVFSFGVLLLETLS-SKKNTHFYNTDSLTLLGHAWNLWNDGRTW 391 (476)
Q Consensus 313 ~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~s~ksDVwSlGvvl~ellt-G~~p~~~~~~~~~~~~~~~~~~~~~~~~~ 391 (476)
.......... .....++..|+|||.+.+..++.++||||||+++|||++ |+.||..... ...... ...+..
T Consensus 157 ~~~~~~~~~~-~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~g~~p~~~~~~--~~~~~~----~~~~~~- 228 (279)
T 1qpc_A 157 RLIEDNEYTA-REGAKFPIKWTAPEAINYGTFTIKSDVWSFGILLTEIVTHGRIPYPGMTN--PEVIQN----LERGYR- 228 (279)
T ss_dssp EECSSSCEEC-CTTCCCCTTTSCHHHHHHCEECHHHHHHHHHHHHHHHHTTTCCSSTTCCH--HHHHHH----HHTTCC-
T ss_pred ccccCccccc-ccCCCCccCccChhhhccCCCCchhhhHHHHHHHHHHHhCCCCCCcccCH--HHHHHH----HhcccC-
Confidence 8775433221 122446788999999998899999999999999999999 8888864321 111111 111110
Q ss_pred cccCcccCCCCCHHHHHHHHHHHHHchhhcccCCCCHHHHHHHHhccccCCCCCC
Q 045315 392 ELMDPISQNGASYPILKRYINVALLCVQEKAADRPAMSEVVSMLSNEFVNLPAPQ 446 (476)
Q Consensus 392 ~~~d~~~~~~~~~~~~~~l~~li~~Cl~~dP~~RPt~~eVl~~L~~~~~~~~~p~ 446 (476)
. ..+......+.+++.+||+.||++|||+.++++.|+.+........
T Consensus 229 ----~----~~~~~~~~~l~~li~~~l~~~p~~Rps~~~l~~~l~~~~~~~~~~~ 275 (279)
T 1qpc_A 229 ----M----VRPDNCPEELYQLMRLCWKERPEDRPTFDYLRSVLEDFFTATEGQY 275 (279)
T ss_dssp ----C----CCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHHC----
T ss_pred ----C----CCcccccHHHHHHHHHHhccChhhCCCHHHHHHHHHHHHHhccCCC
Confidence 0 0111223578899999999999999999999999999875554333
|
| >3l9p_A Anaplastic lymphoma kinase; kinase domain, ATP-binding, glycoprotein, membrane, nucleotide-binding, phosphoprotein, proto-oncogene; 1.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.95 E-value=3.6e-29 Score=253.43 Aligned_cols=182 Identities=25% Similarity=0.286 Sum_probs=138.7
Q ss_pred cccceeeccCCCC-------------CCCCCCChhhHHHHHHHHHHHHHHHhhcCCCceeecCCCccceEecCCC---Cc
Q 045315 241 DEISFWYESYNNP-------------TKKGLLCWGTRVRIIEGIAQGLLYLHQYSRLRVIHRDLKASNILLDKDM---NP 304 (476)
Q Consensus 241 ~~~~l~~Ey~~~~-------------~~~~~L~~~~~~~i~~qIa~gL~yLH~~~~~~ivH~DLkp~NILld~~~---~~ 304 (476)
+..+++|||++.+ .....+++.+++.++.||+.||+|||+++ |+||||||+|||++.++ .+
T Consensus 147 ~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~---ivHrDlkp~NIll~~~~~~~~~ 223 (367)
T 3l9p_A 147 LPRFILLELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDIACGCQYLEENH---FIHRDIAARNCLLTCPGPGRVA 223 (367)
T ss_dssp SSCEEEEECCTTEEHHHHHHHHSCCSSSCCCCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEESCSSTTCCE
T ss_pred CCCEEEEEeCCCCCHHHHHHhhccccCccccccHHHHHHHHHHHHHHHHHHHhCC---eeCCCCChhhEEEecCCCCceE
Confidence 4578899999721 22356999999999999999999999999 99999999999999554 59
Q ss_pred eeccccceeecCCCcccccceeeeeccCCCChhhhccCCCCccceEEeehhhhhhhhh-CCCCCCcCCCCchhhhhhhhh
Q 045315 305 KISDFGMARMFGGDELQSNTKRIVGTYGYMSPEYALRGLFSIKSDVFSFGVLLLETLS-SKKNTHFYNTDSLTLLGHAWN 383 (476)
Q Consensus 305 kL~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~s~ksDVwSlGvvl~ellt-G~~p~~~~~~~~~~~~~~~~~ 383 (476)
||+|||+++...............+|+.|+|||.+.+..++.++|||||||++|||++ |+.||..... .....
T Consensus 224 kL~DFG~a~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~DvwslG~il~ellt~g~~pf~~~~~--~~~~~---- 297 (367)
T 3l9p_A 224 KIGDFGMARDIYRAGYYRKGGCAMLPVKWMPPEAFMEGIFTSKTDTWSFGVLLWEIFSLGYMPYPSKSN--QEVLE---- 297 (367)
T ss_dssp EECCCHHHHHHHHHSSCTTCCGGGSCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCH--HHHHH----
T ss_pred EECCCccccccccccccccCCCcCCcccEECHHHhcCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCCH--HHHHH----
Confidence 9999999986532222222333467889999999999999999999999999999998 9898865431 11111
Q ss_pred hhcCCCcccccCcccCCCCCHHHHHHHHHHHHHchhhcccCCCCHHHHHHHHhcccc
Q 045315 384 LWNDGRTWELMDPISQNGASYPILKRYINVALLCVQEKAADRPAMSEVVSMLSNEFV 440 (476)
Q Consensus 384 ~~~~~~~~~~~d~~~~~~~~~~~~~~l~~li~~Cl~~dP~~RPt~~eVl~~L~~~~~ 440 (476)
....+... ..+......+.+++.+||+.||++||++.+|++.|+....
T Consensus 298 ~i~~~~~~---------~~~~~~~~~l~~li~~~l~~dP~~Rps~~eil~~l~~~~~ 345 (367)
T 3l9p_A 298 FVTSGGRM---------DPPKNCPGPVYRIMTQCWQHQPEDRPNFAIILERIEYCTQ 345 (367)
T ss_dssp HHHTTCCC---------CCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHH
T ss_pred HHHcCCCC---------CCCccCCHHHHHHHHHHcCCCHhHCcCHHHHHHHHHHHhh
Confidence 11111111 1112223568899999999999999999999999988754
|
| >4eqm_A Protein kinase; transferase; HET: ANP; 3.00A {Staphylococcus aureus subsp} | Back alignment and structure |
|---|
Probab=99.95 E-value=1.9e-28 Score=240.17 Aligned_cols=186 Identities=27% Similarity=0.374 Sum_probs=137.7
Q ss_pred cccceeeccCCCCC------CCCCCChhhHHHHHHHHHHHHHHHhhcCCCceeecCCCccceEecCCCCceeccccceee
Q 045315 241 DEISFWYESYNNPT------KKGLLCWGTRVRIIEGIAQGLLYLHQYSRLRVIHRDLKASNILLDKDMNPKISDFGMARM 314 (476)
Q Consensus 241 ~~~~l~~Ey~~~~~------~~~~L~~~~~~~i~~qIa~gL~yLH~~~~~~ivH~DLkp~NILld~~~~~kL~DFGla~~ 314 (476)
+..+++|||++..+ ..+++++.++..++.||+.||+|||+++ |+||||||+||+++.++.+||+|||+++.
T Consensus 84 ~~~~lv~e~~~g~~L~~~l~~~~~~~~~~~~~~~~qi~~~l~~lH~~~---i~H~Dlkp~Nil~~~~~~~kl~Dfg~~~~ 160 (294)
T 4eqm_A 84 DCYYLVMEYIEGPTLSEYIESHGPLSVDTAINFTNQILDGIKHAHDMR---IVHRDIKPQNILIDSNKTLKIFDFGIAKA 160 (294)
T ss_dssp SEEEEEEECCCSCBHHHHHHHHCSCCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCCGGGEEECTTSCEEECCCSSSTT
T ss_pred CeEEEEEeCCCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCCHHHEEECCCCCEEEEeCCCccc
Confidence 45789999998432 2457999999999999999999999999 99999999999999999999999999986
Q ss_pred cCCCcccccceeeeeccCCCChhhhccCCCCccceEEeehhhhhhhhhCCCCCCcCCCCchhhhhhhhhhhcCCCccccc
Q 045315 315 FGGDELQSNTKRIVGTYGYMSPEYALRGLFSIKSDVFSFGVLLLETLSSKKNTHFYNTDSLTLLGHAWNLWNDGRTWELM 394 (476)
Q Consensus 315 ~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~s~ksDVwSlGvvl~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 394 (476)
...... .......||+.|+|||.+.+..++.++||||||+++|||++|+.||........ ......... ...
T Consensus 161 ~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~~l~~ll~g~~pf~~~~~~~~-----~~~~~~~~~-~~~- 232 (294)
T 4eqm_A 161 LSETSL-TQTNHVLGTVQYFSPEQAKGEATDECTDIYSIGIVLYEMLVGEPPFNGETAVSI-----AIKHIQDSV-PNV- 232 (294)
T ss_dssp C--------------CCSSCCHHHHHTCCCCTTHHHHHHHHHHHHHHHSSCSSCSSCHHHH-----HHHHHSSCC-CCH-
T ss_pred cccccc-cccCccccCccccCHhHhcCCCCCchHhHHHHHHHHHHHHhCCCCCCCCChHHH-----HHHHhhccC-CCc-
Confidence 643321 122335689999999999999999999999999999999999999865432111 111111110 000
Q ss_pred CcccCCCCCHHHHHHHHHHHHHchhhcccCCC-CHHHHHHHHhccccC
Q 045315 395 DPISQNGASYPILKRYINVALLCVQEKAADRP-AMSEVVSMLSNEFVN 441 (476)
Q Consensus 395 d~~~~~~~~~~~~~~l~~li~~Cl~~dP~~RP-t~~eVl~~L~~~~~~ 441 (476)
...........+.+++.+||+.||++|| +++++.+.|+....+
T Consensus 233 ----~~~~~~~~~~~l~~li~~~l~~dp~~R~~~~~~l~~~l~~~~~~ 276 (294)
T 4eqm_A 233 ----TTDVRKDIPQSLSNVILRATEKDKANRYKTIQEMKDDLSSVLHE 276 (294)
T ss_dssp ----HHHSCTTSCHHHHHHHHHHSCSSGGGSCSSHHHHHHHHHTSSSS
T ss_pred ----chhcccCCCHHHHHHHHHHhcCCHhHccccHHHHHHHHHHHHhh
Confidence 0001112345788999999999999998 899999999987643
|
| >1mp8_A Focal adhesion kinase 1; tyrosine protein kinase, transferase; HET: ADP; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 2ijm_A* 2etm_A* 3pxk_A* 2jkq_A* 2j0m_B* 2jkm_A* 2j0l_A* 3bz3_A* 2jko_A* 2jkk_A* | Back alignment and structure |
|---|
Probab=99.95 E-value=6.5e-29 Score=241.47 Aligned_cols=180 Identities=21% Similarity=0.287 Sum_probs=129.9
Q ss_pred cccceeeccCCCC-------CCCCCCChhhHHHHHHHHHHHHHHHhhcCCCceeecCCCccceEecCCCCceecccccee
Q 045315 241 DEISFWYESYNNP-------TKKGLLCWGTRVRIIEGIAQGLLYLHQYSRLRVIHRDLKASNILLDKDMNPKISDFGMAR 313 (476)
Q Consensus 241 ~~~~l~~Ey~~~~-------~~~~~L~~~~~~~i~~qIa~gL~yLH~~~~~~ivH~DLkp~NILld~~~~~kL~DFGla~ 313 (476)
+..+++|||++.. .++..+++.+++.++.||+.||+|||+++ |+||||||+||+++.++.+||+|||+++
T Consensus 88 ~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~---i~H~dlkp~Nil~~~~~~~kl~Dfg~~~ 164 (281)
T 1mp8_A 88 NPVWIIMELCTLGELRSFLQVRKYSLDLASLILYAYQLSTALAYLESKR---FVHRDIAARNVLVSSNDCVKLGDFGLSR 164 (281)
T ss_dssp SSCEEEEECCTTEEHHHHHHHTTTTSCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCSGGGEEEEETTEEEECC-----
T ss_pred CccEEEEecCCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCC---eecccccHHHEEECCCCCEEECcccccc
Confidence 4578899999832 23457999999999999999999999999 9999999999999999999999999998
Q ss_pred ecCCCcccccceeeeeccCCCChhhhccCCCCccceEEeehhhhhhhhh-CCCCCCcCCCCchhhhhhhhhhhcCCCccc
Q 045315 314 MFGGDELQSNTKRIVGTYGYMSPEYALRGLFSIKSDVFSFGVLLLETLS-SKKNTHFYNTDSLTLLGHAWNLWNDGRTWE 392 (476)
Q Consensus 314 ~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~s~ksDVwSlGvvl~ellt-G~~p~~~~~~~~~~~~~~~~~~~~~~~~~~ 392 (476)
........ ......+++.|+|||.+.+..++.++||||||+++|||++ |+.||....... .... ...+...
T Consensus 165 ~~~~~~~~-~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~ell~~g~~pf~~~~~~~--~~~~----i~~~~~~- 236 (281)
T 1mp8_A 165 YMEDSTYY-KASKGKLPIKWMAPESINFRRFTSASDVWMFGVCMWEILMHGVKPFQGVKNND--VIGR----IENGERL- 236 (281)
T ss_dssp ---------------CCGGGCCHHHHHHCCCSHHHHHHHHHHHHHHHHTTSCCTTTTCCGGG--HHHH----HHTTCCC-
T ss_pred ccCccccc-ccccCCCcccccChhhcccCCCCCccCchHHHHHHHHHHhcCCCCCCcCCHHH--HHHH----HHcCCCC-
Confidence 76543221 1223456788999999999999999999999999999996 888886543211 1111 1111111
Q ss_pred ccCcccCCCCCHHHHHHHHHHHHHchhhcccCCCCHHHHHHHHhccc
Q 045315 393 LMDPISQNGASYPILKRYINVALLCVQEKAADRPAMSEVVSMLSNEF 439 (476)
Q Consensus 393 ~~d~~~~~~~~~~~~~~l~~li~~Cl~~dP~~RPt~~eVl~~L~~~~ 439 (476)
..+......+.+++.+||+.||++||++.++++.|+.+.
T Consensus 237 --------~~~~~~~~~l~~li~~~l~~~p~~Rps~~~l~~~l~~~~ 275 (281)
T 1mp8_A 237 --------PMPPNCPPTLYSLMTKCWAYDPSRRPRFTELKAQLSTIL 275 (281)
T ss_dssp --------CCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHH
T ss_pred --------CCCCCCCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHH
Confidence 111223457889999999999999999999999999865
|
| >1opk_A P150, C-ABL, proto-oncogene tyrosine-protein kinase ABL1; transferase; HET: MYR P16; 1.80A {Mus musculus} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1opl_A* 2fo0_A* 2abl_A | Back alignment and structure |
|---|
Probab=99.95 E-value=1.7e-28 Score=258.24 Aligned_cols=181 Identities=23% Similarity=0.303 Sum_probs=141.8
Q ss_pred cccceeeccCCCC--------CCCCCCChhhHHHHHHHHHHHHHHHhhcCCCceeecCCCccceEecCCCCceeccccce
Q 045315 241 DEISFWYESYNNP--------TKKGLLCWGTRVRIIEGIAQGLLYLHQYSRLRVIHRDLKASNILLDKDMNPKISDFGMA 312 (476)
Q Consensus 241 ~~~~l~~Ey~~~~--------~~~~~L~~~~~~~i~~qIa~gL~yLH~~~~~~ivH~DLkp~NILld~~~~~kL~DFGla 312 (476)
+..+++|||++.+ ..+..+++..++.++.||+.||+|||+++ |+||||||+|||++.++.+||+|||++
T Consensus 289 ~~~~lv~E~~~~g~L~~~l~~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~---ivHrDlkp~NIll~~~~~~kl~DFG~a 365 (495)
T 1opk_A 289 PPFYIITEFMTYGNLLDYLRECNRQEVSAVVLLYMATQISSAMEYLEKKN---FIHRNLAARNCLVGENHLVKVADFGLS 365 (495)
T ss_dssp SSCEEEEECCTTCBHHHHHHHSCTTTSCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEECGGGCEEECCTTCE
T ss_pred CcEEEEEEccCCCCHHHHHHhcCcCCCCHHHHHHHHHHHHHHHHHHHhCC---cccCCCChhhEEECCCCcEEEeecccc
Confidence 4678999999832 23467999999999999999999999999 999999999999999999999999999
Q ss_pred eecCCCcccccceeeeeccCCCChhhhccCCCCccceEEeehhhhhhhhh-CCCCCCcCCCCchhhhhhhhhhhcCCCcc
Q 045315 313 RMFGGDELQSNTKRIVGTYGYMSPEYALRGLFSIKSDVFSFGVLLLETLS-SKKNTHFYNTDSLTLLGHAWNLWNDGRTW 391 (476)
Q Consensus 313 ~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~s~ksDVwSlGvvl~ellt-G~~p~~~~~~~~~~~~~~~~~~~~~~~~~ 391 (476)
+......... .....++..|+|||.+....++.++|||||||++|||++ |+.||....... +.. ....+..
T Consensus 366 ~~~~~~~~~~-~~~~~~~~~y~aPE~~~~~~~~~~sDvwSlG~~l~el~t~g~~p~~~~~~~~--~~~----~~~~~~~- 437 (495)
T 1opk_A 366 RLMTGDTYTA-HAGAKFPIKWTAPESLAYNKFSIKSDVWAFGVLLWEIATYGMSPYPGIDLSQ--VYE----LLEKDYR- 437 (495)
T ss_dssp ECCTTCCEEC-CTTCCCCGGGCCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCSSTTCCGGG--HHH----HHHTTCC-
T ss_pred eeccCCceee-cCCCcCCcceeCHhHHhcCCCCcHHhHHhHHHHHHHHHhCCCCCCCCCCHHH--HHH----HHHcCCC-
Confidence 8765432221 122345778999999999999999999999999999999 888886543211 111 1111111
Q ss_pred cccCcccCCCCCHHHHHHHHHHHHHchhhcccCCCCHHHHHHHHhcccc
Q 045315 392 ELMDPISQNGASYPILKRYINVALLCVQEKAADRPAMSEVVSMLSNEFV 440 (476)
Q Consensus 392 ~~~d~~~~~~~~~~~~~~l~~li~~Cl~~dP~~RPt~~eVl~~L~~~~~ 440 (476)
...+......+.+++.+||+.||++|||+.+|++.|+.+..
T Consensus 438 --------~~~~~~~~~~l~~li~~cl~~dP~~RPs~~el~~~L~~~~~ 478 (495)
T 1opk_A 438 --------MERPEGCPEKVYELMRACWQWNPSDRPSFAEIHQAFETMFQ 478 (495)
T ss_dssp --------CCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHTSCS
T ss_pred --------CCCCCCCCHHHHHHHHHHcCcChhHCcCHHHHHHHHHHHHh
Confidence 11112234578899999999999999999999999999763
|
| >3lxl_A Tyrosine-protein kinase JAK3; TYK2, inflammation, cancer, PAN inhibitor, ATP-binding mutation, membrane, nucleotide-binding, phosphoprot SCID; HET: IZA; 1.74A {Homo sapiens} PDB: 3lxk_A* 4hvd_A* 4hvg_A* 4hvh_A* 4hvi_A* 3pjc_A* 1yvj_A* | Back alignment and structure |
|---|
Probab=99.95 E-value=1.9e-29 Score=250.80 Aligned_cols=190 Identities=24% Similarity=0.317 Sum_probs=141.5
Q ss_pred cccceeeccCCCCC-------CCCCCChhhHHHHHHHHHHHHHHHhhcCCCceeecCCCccceEecCCCCceecccccee
Q 045315 241 DEISFWYESYNNPT-------KKGLLCWGTRVRIIEGIAQGLLYLHQYSRLRVIHRDLKASNILLDKDMNPKISDFGMAR 313 (476)
Q Consensus 241 ~~~~l~~Ey~~~~~-------~~~~L~~~~~~~i~~qIa~gL~yLH~~~~~~ivH~DLkp~NILld~~~~~kL~DFGla~ 313 (476)
+..+++|||++... .+..+++.+++.++.||+.||+|||+.+ |+||||||+||+++.++.+||+|||+++
T Consensus 99 ~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~qi~~al~~lH~~~---ivH~Dikp~NIl~~~~~~~kl~Dfg~~~ 175 (327)
T 3lxl_A 99 QSLRLVMEYLPSGCLRDFLQRHRARLDASRLLLYSSQICKGMEYLGSRR---CVHRDLAARNILVESEAHVKIADFGLAK 175 (327)
T ss_dssp CEEEEEEECCTTCBHHHHHHHHGGGCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEEEETTEEEECCGGGCE
T ss_pred ceEEEEEeecCCCCHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHhCC---ccCCCCChhhEEECCCCCEEEcccccce
Confidence 45778999997432 2456999999999999999999999999 9999999999999999999999999998
Q ss_pred ecCCCccc-ccceeeeeccCCCChhhhccCCCCccceEEeehhhhhhhhhCCCCCCcCCCCchh---------hhhhhhh
Q 045315 314 MFGGDELQ-SNTKRIVGTYGYMSPEYALRGLFSIKSDVFSFGVLLLETLSSKKNTHFYNTDSLT---------LLGHAWN 383 (476)
Q Consensus 314 ~~~~~~~~-~~~~~~~gt~~y~aPE~l~~~~~s~ksDVwSlGvvl~elltG~~p~~~~~~~~~~---------~~~~~~~ 383 (476)
........ .......++..|+|||.+.+..++.++||||||+++|+|++|+.|+.....+... .......
T Consensus 176 ~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~ 255 (327)
T 3lxl_A 176 LLPLDKDYYVVREPGQSPIFWYAPESLSDNIFSRQSDVWSFGVVLYELFTYCDKSCSPSAEFLRMMGCERDVPALSRLLE 255 (327)
T ss_dssp ECCTTCSEEECSSCCCSCGGGSCHHHHHHCEEEHHHHHHHHHHHHHHHHTTTCGGGSHHHHHHHHCC----CCHHHHHHH
T ss_pred ecccCCccceeeccCCccccccCHHHhccCCCChHHhHHHHHHHHHHHHhCCCCCccccchhhhhcccccccccHHHHHH
Confidence 76543221 1222345788899999999999999999999999999999999997542211000 0000111
Q ss_pred hhcCCCcccccCcccCCCCCHHHHHHHHHHHHHchhhcccCCCCHHHHHHHHhccccCC
Q 045315 384 LWNDGRTWELMDPISQNGASYPILKRYINVALLCVQEKAADRPAMSEVVSMLSNEFVNL 442 (476)
Q Consensus 384 ~~~~~~~~~~~d~~~~~~~~~~~~~~l~~li~~Cl~~dP~~RPt~~eVl~~L~~~~~~~ 442 (476)
....+ .....+......+.+++.+||+.||++|||+.|+++.|+.+....
T Consensus 256 ~~~~~---------~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~L~~~~~~~ 305 (327)
T 3lxl_A 256 LLEEG---------QRLPAPPACPAEVHELMKLCWAPSPQDRPSFSALGPQLDMLWSGS 305 (327)
T ss_dssp HHHTT---------CCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHC----
T ss_pred Hhhcc---------cCCCCCCcccHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHhhh
Confidence 11111 111122334467889999999999999999999999999987544
|
| >2qol_A Ephrin receptor; receptor tyrosine kinase, juxtamembrane segment, structural genomics, mutant, structural genomics consortium, SGC, ATP- binding; 1.07A {Homo sapiens} PDB: 2qok_A 2qoi_A 2qoo_A 2qof_A 2qod_A 2qo9_A* 2gsf_A 2qo7_A* 2qo2_A* 2qoq_A* 2qon_A* 3fxx_A* 3fy2_A 2qoc_A* 2qob_A* 3dzq_A* 2r2p_A 2hel_A 2rei_A 3dko_A* ... | Back alignment and structure |
|---|
Probab=99.95 E-value=8.7e-29 Score=251.21 Aligned_cols=182 Identities=25% Similarity=0.390 Sum_probs=129.9
Q ss_pred cccceeeccCCCC-------CCCCCCChhhHHHHHHHHHHHHHHHhhcCCCceeecCCCccceEecCCCCceecccccee
Q 045315 241 DEISFWYESYNNP-------TKKGLLCWGTRVRIIEGIAQGLLYLHQYSRLRVIHRDLKASNILLDKDMNPKISDFGMAR 313 (476)
Q Consensus 241 ~~~~l~~Ey~~~~-------~~~~~L~~~~~~~i~~qIa~gL~yLH~~~~~~ivH~DLkp~NILld~~~~~kL~DFGla~ 313 (476)
+..+++|||++.. .....+++.+++.++.||+.||+|||+++ |+||||||+|||++.++.+||+|||+++
T Consensus 119 ~~~~lv~e~~~~~sL~~~l~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~---ivH~Dlkp~NIll~~~~~~kl~Dfg~a~ 195 (373)
T 2qol_A 119 KPVMIVTEYMENGSLDSFLRKHDAQFTVIQLVGMLRGIASGMKYLSDMG---YVHRDLAARNILINSNLVCKVSDFGLGR 195 (373)
T ss_dssp SSCEEEEECCTTCBHHHHHHTTTTCSCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEECTTCCEEECCC----
T ss_pred CceEEEEeCCCCCcHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHHCC---eeCCCCCcceEEEcCCCCEEECcCcccc
Confidence 4678999999832 23457999999999999999999999999 9999999999999999999999999998
Q ss_pred ecCCCcccc-cceeeeeccCCCChhhhccCCCCccceEEeehhhhhhhhh-CCCCCCcCCCCchhhhhhhhhhhcCCCcc
Q 045315 314 MFGGDELQS-NTKRIVGTYGYMSPEYALRGLFSIKSDVFSFGVLLLETLS-SKKNTHFYNTDSLTLLGHAWNLWNDGRTW 391 (476)
Q Consensus 314 ~~~~~~~~~-~~~~~~gt~~y~aPE~l~~~~~s~ksDVwSlGvvl~ellt-G~~p~~~~~~~~~~~~~~~~~~~~~~~~~ 391 (476)
......... ......++..|+|||.+.+..++.++|||||||++|||++ |+.||..... ....... ..+.
T Consensus 196 ~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~SlG~il~ellt~g~~P~~~~~~--~~~~~~i----~~~~-- 267 (373)
T 2qol_A 196 VLEDDPEAAYTTRGGKIPIRWTSPEAIAYRKFTSASDVWSYGIVLWEVMSYGERPYWEMSN--QDVIKAV----DEGY-- 267 (373)
T ss_dssp ------------------CTTSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTC-CTTTTCCH--HHHHHHH----HTTE--
T ss_pred ccccCCccceeccCCCcCCCccChhhhccCCcCchhcHHHHHHHHHHHHhCCCCCCCCCCH--HHHHHHH----HcCC--
Confidence 765432211 1122335678999999999999999999999999999997 9999864321 1111111 1110
Q ss_pred cccCcccCCCCCHHHHHHHHHHHHHchhhcccCCCCHHHHHHHHhcccc
Q 045315 392 ELMDPISQNGASYPILKRYINVALLCVQEKAADRPAMSEVVSMLSNEFV 440 (476)
Q Consensus 392 ~~~d~~~~~~~~~~~~~~l~~li~~Cl~~dP~~RPt~~eVl~~L~~~~~ 440 (476)
...........+.+++.+||+.||++||++.+|+++|+.+..
T Consensus 268 -------~~~~~~~~~~~l~~li~~cl~~dp~~RPs~~~i~~~L~~~~~ 309 (373)
T 2qol_A 268 -------RLPPPMDCPAALYQLMLDCWQKDRNNRPKFEQIVSILDKLIR 309 (373)
T ss_dssp -------ECCCCTTCBHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHH
T ss_pred -------CCCCCccccHHHHHHHHHHhCcChhhCcCHHHHHHHHHHHHh
Confidence 011122334678899999999999999999999999998753
|
| >3g33_A Cell division protein kinase 4; Ser/Thr protein kinase, cell cycle, phosphorylation, ATP-BIN cell division, disease mutation, kinase; 3.00A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.95 E-value=3.7e-28 Score=239.27 Aligned_cols=183 Identities=21% Similarity=0.265 Sum_probs=133.8
Q ss_pred cceeeccCCC-------CCCCCCCChhhHHHHHHHHHHHHHHHhhcCCCceeecCCCccceEecCCCCceeccccceeec
Q 045315 243 ISFWYESYNN-------PTKKGLLCWGTRVRIIEGIAQGLLYLHQYSRLRVIHRDLKASNILLDKDMNPKISDFGMARMF 315 (476)
Q Consensus 243 ~~l~~Ey~~~-------~~~~~~L~~~~~~~i~~qIa~gL~yLH~~~~~~ivH~DLkp~NILld~~~~~kL~DFGla~~~ 315 (476)
.++++||++. ......+++.++..++.||+.||+|||+++ |+||||||+||+++.++.+||+|||+++..
T Consensus 94 ~~lv~e~~~~~L~~~~~~~~~~~~~~~~~~~i~~qi~~al~~lH~~~---ivH~Dlkp~Nil~~~~~~~kl~Dfg~a~~~ 170 (308)
T 3g33_A 94 VTLVFEHVDQDLRTYLDKAPPPGLPAETIKDLMRQFLRGLDFLHANC---IVHRDLKPENILVTSGGTVKLADFGLARIY 170 (308)
T ss_dssp EEEEEECCCCBHHHHHHTCCTTCSCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCTTTEEECTTSCEEECSCSCTTTS
T ss_pred EEEEehhhhcCHHHHHhhccCCCCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCCHHHEEEcCCCCEEEeeCcccccc
Confidence 6788888872 223345999999999999999999999999 999999999999999999999999999865
Q ss_pred CCCcccccceeeeeccCCCChhhhccCCCCccceEEeehhhhhhhhhCCCCCCcCCCCchhhhhhhhhhhc---CCCccc
Q 045315 316 GGDELQSNTKRIVGTYGYMSPEYALRGLFSIKSDVFSFGVLLLETLSSKKNTHFYNTDSLTLLGHAWNLWN---DGRTWE 392 (476)
Q Consensus 316 ~~~~~~~~~~~~~gt~~y~aPE~l~~~~~s~ksDVwSlGvvl~elltG~~p~~~~~~~~~~~~~~~~~~~~---~~~~~~ 392 (476)
..... .....||+.|+|||.+.+..++.++|||||||++|||++|+.||....... .......... ......
T Consensus 171 ~~~~~---~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~--~~~~i~~~~~~~~~~~~~~ 245 (308)
T 3g33_A 171 SYQMA---LTPVVVTLWYRAPEVLLQSTYATPVDMWSVGCIFAEMFRRKPLFCGNSEAD--QLGKIFDLIGLPPEDDWPR 245 (308)
T ss_dssp TTCCC---SGGGGCCCSSCCHHHHHTSCCCSTHHHHHHHHHHHHTTTSSCSCCCSSHHH--HHHHHHHHHCCCCTTTSCS
T ss_pred CCCcc---cCCccccccccCchHHcCCCCCchHHHHHHHHHHHHHHhCCCCCCCCCHHH--HHHHHHHHhCCCChhhccc
Confidence 43322 223568999999999999999999999999999999999999986543211 1111111110 000000
Q ss_pred ---ccCcccC--CCC-----CHHHHHHHHHHHHHchhhcccCCCCHHHHHH
Q 045315 393 ---LMDPISQ--NGA-----SYPILKRYINVALLCVQEKAADRPAMSEVVS 433 (476)
Q Consensus 393 ---~~d~~~~--~~~-----~~~~~~~l~~li~~Cl~~dP~~RPt~~eVl~ 433 (476)
....... ... .....+.+.+++.+||+.||++|||+.|+++
T Consensus 246 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~ 296 (308)
T 3g33_A 246 DVSLPRGAFPPRGPRPVQSVVPEMEESGAQLLLEMLTFNPHKRISAFRALQ 296 (308)
T ss_dssp SCSSCGGGSCCCCCCCHHHHSCSCCHHHHHHHHHHTCSSTTTSCCHHHHHT
T ss_pred hhhccccccCCCCCCcHHHhCccccHHHHHHHHHHhcCCCccCCCHHHHhc
Confidence 0000000 000 1123467889999999999999999999875
|
| >4hcu_A Tyrosine-protein kinase ITK/TSK; transferase-transferase inhibitor complex; HET: 13L; 1.43A {Homo sapiens} PDB: 4hct_A* 4hcv_A* 3t9t_A* 1sm2_A* 1snu_A* 1snx_A 3v5l_A* 3v5j_A* 3v8t_A* 3v8w_A* 3qgw_A* 3qgy_A* 3miy_A* 3mj1_A* 3mj2_A* | Back alignment and structure |
|---|
Probab=99.95 E-value=1.1e-28 Score=238.11 Aligned_cols=180 Identities=29% Similarity=0.389 Sum_probs=139.7
Q ss_pred cccceeeccCCCC-------CCCCCCChhhHHHHHHHHHHHHHHHhhcCCCceeecCCCccceEecCCCCceecccccee
Q 045315 241 DEISFWYESYNNP-------TKKGLLCWGTRVRIIEGIAQGLLYLHQYSRLRVIHRDLKASNILLDKDMNPKISDFGMAR 313 (476)
Q Consensus 241 ~~~~l~~Ey~~~~-------~~~~~L~~~~~~~i~~qIa~gL~yLH~~~~~~ivH~DLkp~NILld~~~~~kL~DFGla~ 313 (476)
+..+++|||++.. .....+++.++..++.|+++||+|||+.+ |+||||||+||+++.++.+||+|||+++
T Consensus 78 ~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~---i~H~dikp~Nil~~~~~~~kl~Dfg~~~ 154 (269)
T 4hcu_A 78 APICLVFEFMEHGCLSDYLRTQRGLFAAETLLGMCLDVCEGMAYLEEAC---VIHRDLAARNCLVGENQVIKVSDFGMTR 154 (269)
T ss_dssp SSEEEEEECCTTCBHHHHHHTTTTCCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEECGGGCEEECCTTGGG
T ss_pred CceEEEEEeCCCCcHHHHHHhcCcccCHHHHHHHHHHHHHHHHHHHhCC---eecCCcchheEEEcCCCCEEeccccccc
Confidence 4578899999843 34567999999999999999999999999 9999999999999999999999999998
Q ss_pred ecCCCcccccceeeeeccCCCChhhhccCCCCccceEEeehhhhhhhhh-CCCCCCcCCCCchhhhhhhhhhhcCCCccc
Q 045315 314 MFGGDELQSNTKRIVGTYGYMSPEYALRGLFSIKSDVFSFGVLLLETLS-SKKNTHFYNTDSLTLLGHAWNLWNDGRTWE 392 (476)
Q Consensus 314 ~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~s~ksDVwSlGvvl~ellt-G~~p~~~~~~~~~~~~~~~~~~~~~~~~~~ 392 (476)
......... .....++..|+|||.+.+..++.++||||||+++|||++ |+.||...... ...... ..+..
T Consensus 155 ~~~~~~~~~-~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~ll~~g~~p~~~~~~~--~~~~~~----~~~~~-- 225 (269)
T 4hcu_A 155 FVLDDQYTS-STGTKFPVKWASPEVFSFSRYSSKSDVWSFGVLMWEVFSEGKIPYENRSNS--EVVEDI----STGFR-- 225 (269)
T ss_dssp GBCCHHHHS-TTSTTCCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCHH--HHHHHH----HTTCC--
T ss_pred ccccccccc-ccCcccccccCCHHHhcCCCCCchhhhHHHHHHHHHHhcCCCCCCCCCCHH--HHHHHH----hcCcc--
Confidence 664432111 122346778999999999999999999999999999999 89888643311 111111 11100
Q ss_pred ccCcccCCCCCHHHHHHHHHHHHHchhhcccCCCCHHHHHHHHhccc
Q 045315 393 LMDPISQNGASYPILKRYINVALLCVQEKAADRPAMSEVVSMLSNEF 439 (476)
Q Consensus 393 ~~d~~~~~~~~~~~~~~l~~li~~Cl~~dP~~RPt~~eVl~~L~~~~ 439 (476)
...+......+.+++.+||+.||++||++.++++.|+++.
T Consensus 226 -------~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~ll~~l~~l~ 265 (269)
T 4hcu_A 226 -------LYKPRLASTHVYQIMNHCWRERPEDRPAFSRLLRQLAEIA 265 (269)
T ss_dssp -------CCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHH
T ss_pred -------CCCCCcCCHHHHHHHHHHccCCcccCcCHHHHHHHHHHHH
Confidence 0111112356889999999999999999999999998865
|
| >1qcf_A Haematopoetic cell kinase (HCK); tyrosine kinase-inhibitor complex, DOWN-regulated kinase, ordered activation loop; HET: PTR PP1; 2.00A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 2c0i_A* 2c0o_A* 2c0t_A* 1ad5_A* 2hck_A* 3nhn_A 3hck_A 1bu1_A 3rea_B 3rbb_B | Back alignment and structure |
|---|
Probab=99.95 E-value=5.7e-29 Score=259.05 Aligned_cols=183 Identities=25% Similarity=0.378 Sum_probs=141.8
Q ss_pred cccceeeccCCCCC--------CCCCCChhhHHHHHHHHHHHHHHHhhcCCCceeecCCCccceEecCCCCceeccccce
Q 045315 241 DEISFWYESYNNPT--------KKGLLCWGTRVRIIEGIAQGLLYLHQYSRLRVIHRDLKASNILLDKDMNPKISDFGMA 312 (476)
Q Consensus 241 ~~~~l~~Ey~~~~~--------~~~~L~~~~~~~i~~qIa~gL~yLH~~~~~~ivH~DLkp~NILld~~~~~kL~DFGla 312 (476)
+.++++|||++.+. ....+++.+++.++.||+.||+|||+++ |+||||||+|||++.++.+||+|||++
T Consensus 255 ~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~qi~~~l~~LH~~~---ivHrDlkp~Nill~~~~~~kl~DFG~a 331 (454)
T 1qcf_A 255 EPIYIITEFMAKGSLLDFLKSDEGSKQPLPKLIDFSAQIAEGMAFIEQRN---YIHRDLRAANILVSASLVCKIADFGLA 331 (454)
T ss_dssp SSCEEEECCCTTCBHHHHHHSHHHHTCCHHHHHHHHHHHHHHHHHHHHTT---CCCSSCSGGGEEECTTCCEEECSTTGG
T ss_pred CccEEEEeecCCCcHHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHhCC---ccCCCCCHHHEEECCCCcEEEeeCCCc
Confidence 46889999998432 2236899999999999999999999999 999999999999999999999999999
Q ss_pred eecCCCcccccceeeeeccCCCChhhhccCCCCccceEEeehhhhhhhhh-CCCCCCcCCCCchhhhhhhhhhhcCCCcc
Q 045315 313 RMFGGDELQSNTKRIVGTYGYMSPEYALRGLFSIKSDVFSFGVLLLETLS-SKKNTHFYNTDSLTLLGHAWNLWNDGRTW 391 (476)
Q Consensus 313 ~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~s~ksDVwSlGvvl~ellt-G~~p~~~~~~~~~~~~~~~~~~~~~~~~~ 391 (476)
+......... .....++..|+|||.+....++.++|||||||++|||++ |+.||..... ....... ..+..
T Consensus 332 ~~~~~~~~~~-~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~~l~el~t~g~~P~~~~~~--~~~~~~i----~~~~~- 403 (454)
T 1qcf_A 332 RVIEDNEYTA-REGAKFPIKWTAPEAINFGSFTIKSDVWSFGILLMEIVTYGRIPYPGMSN--PEVIRAL----ERGYR- 403 (454)
T ss_dssp GGBCCHHHHT-TCSSSSCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCH--HHHHHHH----HHTCC-
T ss_pred eEcCCCceec-cCCCcccccccCHHHhccCCCCcHHHHHhHHHHHHHHHhCCCCCCCCCCH--HHHHHHH----HcCCC-
Confidence 8764332111 122346778999999999999999999999999999999 9999865431 1111111 11110
Q ss_pred cccCcccCCCCCHHHHHHHHHHHHHchhhcccCCCCHHHHHHHHhccccCC
Q 045315 392 ELMDPISQNGASYPILKRYINVALLCVQEKAADRPAMSEVVSMLSNEFVNL 442 (476)
Q Consensus 392 ~~~d~~~~~~~~~~~~~~l~~li~~Cl~~dP~~RPt~~eVl~~L~~~~~~~ 442 (476)
...+......+.+++.+||+.||++|||+++|++.|+.+....
T Consensus 404 --------~~~~~~~~~~l~~li~~cl~~dp~~RPt~~~i~~~L~~~~~~~ 446 (454)
T 1qcf_A 404 --------MPRPENCPEELYNIMMRCWKNRPEERPTFEYIQSVLDDFYTAT 446 (454)
T ss_dssp --------CCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHTSSSSS
T ss_pred --------CCCCCCCCHHHHHHHHHHccCChhHCcCHHHHHHHHHHHHhcc
Confidence 0111223457889999999999999999999999999987543
|
| >3o0g_A Cell division protein kinase 5; kinase activator complex, kinase inhibitor complex, transferase-transferase activator complex; HET: 3O0; 1.95A {Homo sapiens} SCOP: d.144.1.7 PDB: 1unh_A* 1ung_A* 1unl_A* 1h4l_A | Back alignment and structure |
|---|
Probab=99.95 E-value=6.4e-28 Score=235.78 Aligned_cols=187 Identities=20% Similarity=0.233 Sum_probs=134.9
Q ss_pred cccceeeccCCCC------CCCCCCChhhHHHHHHHHHHHHHHHhhcCCCceeecCCCccceEecCCCCceeccccceee
Q 045315 241 DEISFWYESYNNP------TKKGLLCWGTRVRIIEGIAQGLLYLHQYSRLRVIHRDLKASNILLDKDMNPKISDFGMARM 314 (476)
Q Consensus 241 ~~~~l~~Ey~~~~------~~~~~L~~~~~~~i~~qIa~gL~yLH~~~~~~ivH~DLkp~NILld~~~~~kL~DFGla~~ 314 (476)
+..+++|||++.. ..++.+++.++..++.||+.||+|||+++ |+||||||+||+++.++.+||+|||+++.
T Consensus 74 ~~~~lv~e~~~~~l~~~~~~~~~~l~~~~~~~~~~ql~~~l~~lH~~~---ivH~dikp~Nil~~~~~~~kl~Dfg~~~~ 150 (292)
T 3o0g_A 74 KKLTLVFEFCDQDLKKYFDSCNGDLDPEIVKSFLFQLLKGLGFCHSRN---VLHRDLKPQNLLINRNGELKLANFGLARA 150 (292)
T ss_dssp TEEEEEEECCSEEHHHHHHHTTTCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEECTTSCEEECCCTTCEE
T ss_pred CEEEEEEecCCCCHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCCHHHEEEcCCCCEEEeeccccee
Confidence 4578899999821 23567999999999999999999999999 99999999999999999999999999987
Q ss_pred cCCCcccccceeeeeccCCCChhhhccCC-CCccceEEeehhhhhhhhhCCCCCCcCCCCchhhhhhhhhhhcC---CCc
Q 045315 315 FGGDELQSNTKRIVGTYGYMSPEYALRGL-FSIKSDVFSFGVLLLETLSSKKNTHFYNTDSLTLLGHAWNLWND---GRT 390 (476)
Q Consensus 315 ~~~~~~~~~~~~~~gt~~y~aPE~l~~~~-~s~ksDVwSlGvvl~elltG~~p~~~~~~~~~~~~~~~~~~~~~---~~~ 390 (476)
....... .....||..|+|||.+.+.. ++.++|||||||++|||++|+.|+........ ........... ...
T Consensus 151 ~~~~~~~--~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~~~~p~~~~~~~~~-~~~~i~~~~~~~~~~~~ 227 (292)
T 3o0g_A 151 FGIPVRC--YSAEVVTLWYRPPDVLFGAKLYSTSIDMWSAGCIFAELANAGRPLFPGNDVDD-QLKRIFRLLGTPTEEQW 227 (292)
T ss_dssp CCSCCSC--CCSCCSCGGGCCHHHHTTCSCCCTHHHHHHHHHHHHHHTTTSCCSCCCSSHHH-HHHHHHHHHCCCCTTTC
T ss_pred cCCcccc--ccCCccccCCcChHHHcCCCCcCchHHHHHHHHHHHHHHHcCCCCcCCCCHHH-HHHHHHHHhCCCChhhh
Confidence 6533221 22356899999999998765 79999999999999999999888643322111 11111111100 000
Q ss_pred ---ccccC---------cccCCCCCHHHHHHHHHHHHHchhhcccCCCCHHHHHH
Q 045315 391 ---WELMD---------PISQNGASYPILKRYINVALLCVQEKAADRPAMSEVVS 433 (476)
Q Consensus 391 ---~~~~d---------~~~~~~~~~~~~~~l~~li~~Cl~~dP~~RPt~~eVl~ 433 (476)
....+ ..............+.+++.+||+.||++|||++|+++
T Consensus 228 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~ 282 (292)
T 3o0g_A 228 PSMTKLPDYKPYPMYPATTSLVNVVPKLNATGRDLLQNLLKCNPVQRISAEEALQ 282 (292)
T ss_dssp TTGGGSTTCCCCCCCCTTCCCTTTSTTCCHHHHHHHHHHSCSSGGGSCCHHHHHT
T ss_pred hhhcccccccccccccCCcchhhcccccChHHHHHHHHHhccChhhCCCHHHHhc
Confidence 00000 00001111233467889999999999999999999886
|
| >3sxs_A Cytoplasmic tyrosine-protein kinase BMX; transferase-transferase inhibitor complex; HET: PP2; 1.89A {Homo sapiens} SCOP: d.144.1.7 PDB: 3sxr_A* | Back alignment and structure |
|---|
Probab=99.95 E-value=2.5e-28 Score=235.35 Aligned_cols=180 Identities=26% Similarity=0.336 Sum_probs=139.4
Q ss_pred cccceeeccCCCCC-------CCCCCChhhHHHHHHHHHHHHHHHhhcCCCceeecCCCccceEecCCCCceecccccee
Q 045315 241 DEISFWYESYNNPT-------KKGLLCWGTRVRIIEGIAQGLLYLHQYSRLRVIHRDLKASNILLDKDMNPKISDFGMAR 313 (476)
Q Consensus 241 ~~~~l~~Ey~~~~~-------~~~~L~~~~~~~i~~qIa~gL~yLH~~~~~~ivH~DLkp~NILld~~~~~kL~DFGla~ 313 (476)
+..+++|||++... ....+++.++..++.||+.||+|||+.+ |+||||||+||+++.++.+||+|||++.
T Consensus 76 ~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~---i~H~dikp~Nil~~~~~~~~l~Dfg~~~ 152 (268)
T 3sxs_A 76 YPIYIVTEYISNGCLLNYLRSHGKGLEPSQLLEMCYDVCEGMAFLESHQ---FIHRDLAARNCLVDRDLCVKVSDFGMTR 152 (268)
T ss_dssp SSEEEEEECCTTCBHHHHHHHHGGGCCHHHHHHHHHHHHHHHHHHHHTT---EEESSCSGGGEEECTTCCEEECCTTCEE
T ss_pred CceEEEEEccCCCcHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHHCC---eecCCcCcceEEECCCCCEEEccCccce
Confidence 45788999997432 2346999999999999999999999999 9999999999999999999999999998
Q ss_pred ecCCCcccccceeeeeccCCCChhhhccCCCCccceEEeehhhhhhhhh-CCCCCCcCCCCchhhhhhhhhhhcCCCccc
Q 045315 314 MFGGDELQSNTKRIVGTYGYMSPEYALRGLFSIKSDVFSFGVLLLETLS-SKKNTHFYNTDSLTLLGHAWNLWNDGRTWE 392 (476)
Q Consensus 314 ~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~s~ksDVwSlGvvl~ellt-G~~p~~~~~~~~~~~~~~~~~~~~~~~~~~ 392 (476)
......... .....++..|+|||.+.+..++.++||||||+++|||++ |+.||....... .... ...+..
T Consensus 153 ~~~~~~~~~-~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~~g~~p~~~~~~~~--~~~~----~~~~~~-- 223 (268)
T 3sxs_A 153 YVLDDQYVS-SVGTKFPVKWSAPEVFHYFKYSSKSDVWAFGILMWEVFSLGKMPYDLYTNSE--VVLK----VSQGHR-- 223 (268)
T ss_dssp ECCTTCEEE-CCSCCCCGGGCCHHHHHHSEEETTHHHHHHHHHHHHHHTTTCCTTTTSCHHH--HHHH----HHTTCC--
T ss_pred ecchhhhhc-ccCCCcCcccCCHHHHhccCCchhhhhHHHHHHHHHHHcCCCCCccccChHH--HHHH----HHcCCC--
Confidence 765443222 122345678999999998899999999999999999999 999986443211 1111 111110
Q ss_pred ccCcccCCCCCHHHHHHHHHHHHHchhhcccCCCCHHHHHHHHhccc
Q 045315 393 LMDPISQNGASYPILKRYINVALLCVQEKAADRPAMSEVVSMLSNEF 439 (476)
Q Consensus 393 ~~d~~~~~~~~~~~~~~l~~li~~Cl~~dP~~RPt~~eVl~~L~~~~ 439 (476)
... +......+.+++.+||+.||++|||+.++++.|+.+.
T Consensus 224 ~~~-------~~~~~~~l~~li~~~l~~~p~~Rps~~~ll~~L~~l~ 263 (268)
T 3sxs_A 224 LYR-------PHLASDTIYQIMYSCWHELPEKRPTFQQLLSSIEPLR 263 (268)
T ss_dssp CCC-------CTTSCHHHHHHHHHTTCSSGGGSCCHHHHHHHHGGGC
T ss_pred CCC-------CCcChHHHHHHHHHHcCCChhhCcCHHHHHHHHHHhh
Confidence 000 1112346889999999999999999999999999875
|
| >1luf_A Muscle-specific tyrosine kinase receptor MUSK; phosphorylation, signal transduction, MASS spectrometry, transferase; 2.05A {Rattus norvegicus} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=99.95 E-value=1.7e-28 Score=245.00 Aligned_cols=167 Identities=24% Similarity=0.353 Sum_probs=130.9
Q ss_pred CCCChhhHHHHHHHHHHHHHHHhhcCCCceeecCCCccceEecCCCCceeccccceeecCCCcccccceeeeeccCCCCh
Q 045315 257 GLLCWGTRVRIIEGIAQGLLYLHQYSRLRVIHRDLKASNILLDKDMNPKISDFGMARMFGGDELQSNTKRIVGTYGYMSP 336 (476)
Q Consensus 257 ~~L~~~~~~~i~~qIa~gL~yLH~~~~~~ivH~DLkp~NILld~~~~~kL~DFGla~~~~~~~~~~~~~~~~gt~~y~aP 336 (476)
..+++.+++.++.||++||+|||+++ |+||||||+||+++.++.+||+|||+++...............++..|+||
T Consensus 169 ~~l~~~~~~~i~~qi~~~l~~LH~~~---ivH~Dlkp~NIl~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~t~~y~aP 245 (343)
T 1luf_A 169 PPLSCAEQLCIARQVAAGMAYLSERK---FVHRDLATRNCLVGENMVVKIADFGLSRNIYSADYYKADGNDAIPIRWMPP 245 (343)
T ss_dssp CCCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCSGGGEEECGGGCEEECCCSCHHHHTGGGCBC----CCBCGGGCCH
T ss_pred CCCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCCcceEEECCCCeEEEeecCCCcccccCccccccCCCcccceecCh
Confidence 67999999999999999999999999 999999999999999999999999999876543322233345678899999
Q ss_pred hhhccCCCCccceEEeehhhhhhhhh-CCCCCCcCCCCchhhhhhhhhhhcCCCcccccCcccCCCCCHHHHHHHHHHHH
Q 045315 337 EYALRGLFSIKSDVFSFGVLLLETLS-SKKNTHFYNTDSLTLLGHAWNLWNDGRTWELMDPISQNGASYPILKRYINVAL 415 (476)
Q Consensus 337 E~l~~~~~s~ksDVwSlGvvl~ellt-G~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~l~~li~ 415 (476)
|.+.+..++.++||||||+++|||++ |+.||..... ..... ....+.... .+......+.+++.
T Consensus 246 E~~~~~~~~~~~Di~slG~il~el~t~g~~p~~~~~~--~~~~~----~~~~~~~~~---------~~~~~~~~l~~li~ 310 (343)
T 1luf_A 246 ESIFYNRYTTESDVWAYGVVLWEIFSYGLQPYYGMAH--EEVIY----YVRDGNILA---------CPENCPLELYNLMR 310 (343)
T ss_dssp HHHHHCCCCHHHHHHHHHHHHHHHHTTTCCTTTTSCH--HHHHH----HHHTTCCCC---------CCTTCCHHHHHHHH
T ss_pred hhhccCCcCcccccHHHHHHHHHHHhcCCCcCCCCCh--HHHHH----HHhCCCcCC---------CCCCCCHHHHHHHH
Confidence 99999999999999999999999999 9988864331 11111 111121111 11122357889999
Q ss_pred HchhhcccCCCCHHHHHHHHhccccC
Q 045315 416 LCVQEKAADRPAMSEVVSMLSNEFVN 441 (476)
Q Consensus 416 ~Cl~~dP~~RPt~~eVl~~L~~~~~~ 441 (476)
+||+.||++||++.+|++.|+++...
T Consensus 311 ~~l~~~p~~Rps~~~~~~~L~~~~~~ 336 (343)
T 1luf_A 311 LCWSKLPADRPSFCSIHRILQRMCER 336 (343)
T ss_dssp HHTCSSGGGSCCHHHHHHHHHHTTC-
T ss_pred HHcccCcccCCCHHHHHHHHHHHHhh
Confidence 99999999999999999999997643
|
| >3f66_A Hepatocyte growth factor receptor; C-Met, protein kinase, quinoxaline, alternative splicing, ATP-binding, chromosomal rearrangement; HET: IHX; 1.40A {Homo sapiens} PDB: 3i5n_A* 3u6h_A* 3u6i_A* 4deg_A* 4deh_A* 4dei_A* 3ccn_A* 2rfn_A* 2rfs_A* 3cd8_A* 3efj_A* 3efk_A* 3lq8_A* 3zxz_A* 2wkm_A* 2wgj_A* 3zze_A* 4aoi_A* 4ap7_A* 3q6w_A* ... | Back alignment and structure |
|---|
Probab=99.95 E-value=7e-28 Score=235.87 Aligned_cols=185 Identities=28% Similarity=0.285 Sum_probs=139.5
Q ss_pred cccceeeccCCCC-------CCCCCCChhhHHHHHHHHHHHHHHHhhcCCCceeecCCCccceEecCCCCceecccccee
Q 045315 241 DEISFWYESYNNP-------TKKGLLCWGTRVRIIEGIAQGLLYLHQYSRLRVIHRDLKASNILLDKDMNPKISDFGMAR 313 (476)
Q Consensus 241 ~~~~l~~Ey~~~~-------~~~~~L~~~~~~~i~~qIa~gL~yLH~~~~~~ivH~DLkp~NILld~~~~~kL~DFGla~ 313 (476)
+..++++||++.+ .....+++.++..++.||+.||+|||+++ |+||||||+||+++.++.+||+|||+++
T Consensus 100 ~~~~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~ql~~~l~~lH~~~---i~H~dikp~Nil~~~~~~~kl~Dfg~a~ 176 (298)
T 3f66_A 100 GSPLVVLPYMKHGDLRNFIRNETHNPTVKDLIGFGLQVAKGMKYLASKK---FVHRDLAARNCMLDEKFTVKVADFGLAR 176 (298)
T ss_dssp SCCEEEEECCTTCBHHHHHHCTTCCCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCSGGGEEECTTCCEEECSCGGGC
T ss_pred CceEEEEeCCCCCCHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHhCC---ccCCCCchheEEECCCCCEEECcccccc
Confidence 4567899999842 24567899999999999999999999999 9999999999999999999999999998
Q ss_pred ecCCCccc--ccceeeeeccCCCChhhhccCCCCccceEEeehhhhhhhhhCC-CCCCcCCCCchhhhhhhhhhhcCCCc
Q 045315 314 MFGGDELQ--SNTKRIVGTYGYMSPEYALRGLFSIKSDVFSFGVLLLETLSSK-KNTHFYNTDSLTLLGHAWNLWNDGRT 390 (476)
Q Consensus 314 ~~~~~~~~--~~~~~~~gt~~y~aPE~l~~~~~s~ksDVwSlGvvl~elltG~-~p~~~~~~~~~~~~~~~~~~~~~~~~ 390 (476)
........ .......++..|+|||.+.+..++.++||||||+++|||++|+ +|+........ .... ..+..
T Consensus 177 ~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~~~~~~~~~~~~~~~--~~~~----~~~~~ 250 (298)
T 3f66_A 177 DMYDKEYYSVHNKTGAKLPVKWMALESLQTQKFTTKSDVWSFGVLLWELMTRGAPPYPDVNTFDI--TVYL----LQGRR 250 (298)
T ss_dssp CCSCGGGCBC-----CCBCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTTSCTTTH--HHHH----HTTCC
T ss_pred cccccchhccccccCCCCCccccChHHhcCCCCChHHHHHHHHHHHHHHHhCCCCCCccCCHHHH--HHHH----hcCCC
Confidence 76543221 1222345778899999999999999999999999999999954 45443322211 1111 11111
Q ss_pred ccccCcccCCCCCHHHHHHHHHHHHHchhhcccCCCCHHHHHHHHhccccCCC
Q 045315 391 WELMDPISQNGASYPILKRYINVALLCVQEKAADRPAMSEVVSMLSNEFVNLP 443 (476)
Q Consensus 391 ~~~~d~~~~~~~~~~~~~~l~~li~~Cl~~dP~~RPt~~eVl~~L~~~~~~~~ 443 (476)
. ..+......+.+++.+||+.||++||++.|+++.|+.+..+..
T Consensus 251 ~---------~~~~~~~~~l~~li~~~l~~~p~~Rps~~ell~~L~~~~~~~~ 294 (298)
T 3f66_A 251 L---------LQPEYCPDPLYEVMLKCWHPKAEMRPSFSELVSRISAIFSTFI 294 (298)
T ss_dssp C---------CCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHTSC
T ss_pred C---------CCCccCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHHhhc
Confidence 0 0011123568899999999999999999999999999876544
|
| >3niz_A Rhodanese family protein; structural genomics, structural genomics consortium, SGC, phosphotransferase, cyclin dependent kinase; HET: ADP; 2.40A {Cryptosporidium parvum} SCOP: d.144.1.7 PDB: 2qkr_A* | Back alignment and structure |
|---|
Probab=99.95 E-value=5.3e-28 Score=239.05 Aligned_cols=186 Identities=19% Similarity=0.213 Sum_probs=134.5
Q ss_pred cccceeeccCCC------CCCCCCCChhhHHHHHHHHHHHHHHHhhcCCCceeecCCCccceEecCCCCceeccccceee
Q 045315 241 DEISFWYESYNN------PTKKGLLCWGTRVRIIEGIAQGLLYLHQYSRLRVIHRDLKASNILLDKDMNPKISDFGMARM 314 (476)
Q Consensus 241 ~~~~l~~Ey~~~------~~~~~~L~~~~~~~i~~qIa~gL~yLH~~~~~~ivH~DLkp~NILld~~~~~kL~DFGla~~ 314 (476)
+..+++|||++. ......+++.++..++.||+.||+|||+.+ |+||||||+|||++.++.+||+|||+++.
T Consensus 92 ~~~~lv~e~~~~~l~~~~~~~~~~~~~~~~~~~~~qi~~~l~~LH~~~---ivH~Dikp~NIl~~~~~~~kl~Dfg~a~~ 168 (311)
T 3niz_A 92 RCLTLVFEFMEKDLKKVLDENKTGLQDSQIKIYLYQLLRGVAHCHQHR---ILHRDLKPQNLLINSDGALKLADFGLARA 168 (311)
T ss_dssp SCEEEEEECCSEEHHHHHHTCTTCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEECTTCCEEECCCTTCEE
T ss_pred CEEEEEEcCCCCCHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCchHhEEECCCCCEEEccCcCcee
Confidence 457889999982 123456999999999999999999999999 99999999999999999999999999987
Q ss_pred cCCCcccccceeeeeccCCCChhhhcc-CCCCccceEEeehhhhhhhhhCCCCCCcCCCCchhhhhhhhhhhcCC---Cc
Q 045315 315 FGGDELQSNTKRIVGTYGYMSPEYALR-GLFSIKSDVFSFGVLLLETLSSKKNTHFYNTDSLTLLGHAWNLWNDG---RT 390 (476)
Q Consensus 315 ~~~~~~~~~~~~~~gt~~y~aPE~l~~-~~~s~ksDVwSlGvvl~elltG~~p~~~~~~~~~~~~~~~~~~~~~~---~~ 390 (476)
....... .....+|..|+|||.+.+ ..++.++|||||||++|||++|+.||......... .......... ..
T Consensus 169 ~~~~~~~--~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~--~~i~~~~~~~~~~~~ 244 (311)
T 3niz_A 169 FGIPVRS--YTHEVVTLWYRAPDVLMGSKKYSTSVDIWSIGCIFAEMITGKPLFPGVTDDDQL--PKIFSILGTPNPREW 244 (311)
T ss_dssp TTSCCC-----CCCCCCTTCCHHHHTTCCSCCTHHHHHHHHHHHHHHHHSSCSCCCSSTTTHH--HHHHHHHCCCCTTTS
T ss_pred cCCCccc--ccCCcccCCcCCHHHhcCCCCCCchHHhHHHHHHHHHHHhCCCCCCCCChHHHH--HHHHHHHCCCChHHh
Confidence 6533211 223468999999999876 56899999999999999999999999765432211 1111111000 00
Q ss_pred ccccC------ccc--CCCC-----CHHHHHHHHHHHHHchhhcccCCCCHHHHHH
Q 045315 391 WELMD------PIS--QNGA-----SYPILKRYINVALLCVQEKAADRPAMSEVVS 433 (476)
Q Consensus 391 ~~~~d------~~~--~~~~-----~~~~~~~l~~li~~Cl~~dP~~RPt~~eVl~ 433 (476)
....+ ... .... .......+.+++.+||+.||++|||++|+++
T Consensus 245 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~ 300 (311)
T 3niz_A 245 PQVQELPLWKQRTFQVFEKKPWSSIIPGFCQEGIDLLSNMLCFDPNKRISARDAMN 300 (311)
T ss_dssp GGGTTSHHHHSCCCCCCCCCCHHHHSTTCCHHHHHHHHHHSCSCTTTSCCHHHHHT
T ss_pred hhhhccchhhhcccccccCCcHHHhCcccCHHHHHHHHHHcCCChhHCCCHHHHhc
Confidence 00000 000 0000 0112356889999999999999999999986
|
| >2i1m_A Macrophage colony-stimulating factor 1 receptor; kinase domain, kinase inhibitor complex, transferase; HET: 5CN; 1.80A {Homo sapiens} PDB: 3bea_A* 3lcd_A* 2i0y_A* 2i0v_A* 3dpk_A* 3krj_A* 3krl_A* 2ogv_A 3lco_A* | Back alignment and structure |
|---|
Probab=99.94 E-value=1.8e-28 Score=244.08 Aligned_cols=182 Identities=24% Similarity=0.308 Sum_probs=139.7
Q ss_pred cccceeeccCCCCC--------------------CCCCCChhhHHHHHHHHHHHHHHHhhcCCCceeecCCCccceEecC
Q 045315 241 DEISFWYESYNNPT--------------------KKGLLCWGTRVRIIEGIAQGLLYLHQYSRLRVIHRDLKASNILLDK 300 (476)
Q Consensus 241 ~~~~l~~Ey~~~~~--------------------~~~~L~~~~~~~i~~qIa~gL~yLH~~~~~~ivH~DLkp~NILld~ 300 (476)
+..+++|||++.++ ....+++.+++.++.||+.||+|||+++ |+||||||+||+++.
T Consensus 123 ~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~---ivH~Dlkp~NIl~~~ 199 (333)
T 2i1m_A 123 GPVLVITEYCCYGDLLNFLRRKSRVLETDPAFAIANSTASTRDLLHFSSQVAQGMAFLASKN---CIHRDVAARNVLLTN 199 (333)
T ss_dssp SSCEEEEECCTTEEHHHHHHHHHHHHSCC-------CCCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGCEEEG
T ss_pred CceEEEEecCCCCcHHHHHHHhcccccccccccccccccCHHHHHHHHHHHHHHHHHHhcCC---cccCCcccceEEECC
Confidence 46788999987211 1346899999999999999999999998 999999999999999
Q ss_pred CCCceeccccceeecCCCcccccceeeeeccCCCChhhhccCCCCccceEEeehhhhhhhhh-CCCCCCcCCCCchhhhh
Q 045315 301 DMNPKISDFGMARMFGGDELQSNTKRIVGTYGYMSPEYALRGLFSIKSDVFSFGVLLLETLS-SKKNTHFYNTDSLTLLG 379 (476)
Q Consensus 301 ~~~~kL~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~s~ksDVwSlGvvl~ellt-G~~p~~~~~~~~~~~~~ 379 (476)
++.+||+|||+++...............++..|+|||.+.+..++.++|||||||++|||++ |..||........ ...
T Consensus 200 ~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~t~g~~p~~~~~~~~~-~~~ 278 (333)
T 2i1m_A 200 GHVAKIGDFGLARDIMNDSNYIVKGNARLPVKWMAPESIFDCVYTVQSDVWSYGILLWEIFSLGLNPYPGILVNSK-FYK 278 (333)
T ss_dssp GGEEEBCCCGGGCCGGGCTTSEECSSCEECGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHTTTSCCSSTTCCSSHH-HHH
T ss_pred CCeEEECccccccccccccceeecCCCCCCccccCHHHhccCCCChHHHHHHHHHHHHHHHcCCCCCCcccchhHH-HHH
Confidence 99999999999987644332222333567889999999999999999999999999999998 8888865432221 111
Q ss_pred hhhhhhcCCCcccccCcccCCCCCHHHHHHHHHHHHHchhhcccCCCCHHHHHHHHhccc
Q 045315 380 HAWNLWNDGRTWELMDPISQNGASYPILKRYINVALLCVQEKAADRPAMSEVVSMLSNEF 439 (476)
Q Consensus 380 ~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~l~~li~~Cl~~dP~~RPt~~eVl~~L~~~~ 439 (476)
....+.. ...+......+.+++.+||+.||.+|||+.||++.|+.+.
T Consensus 279 ----~~~~~~~---------~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~l~~~L~~~~ 325 (333)
T 2i1m_A 279 ----LVKDGYQ---------MAQPAFAPKNIYSIMQACWALEPTHRPTFQQICSFLQEQA 325 (333)
T ss_dssp ----HHHHTCC---------CCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHH
T ss_pred ----HHhcCCC---------CCCCCCCCHHHHHHHHHHhccChhhCcCHHHHHHHHHHHH
Confidence 1111110 0011112356889999999999999999999999998864
|
| >4e5w_A Tyrosine-protein kinase JAK1; kinase domain, transferase-transferase inhibit complex; HET: PTR 0NT; 1.86A {Homo sapiens} PDB: 4e4l_A* 4e4n_A* 4ehz_A* 4ei4_A* 4fk6_A* 3eyg_A* 3eyh_A* | Back alignment and structure |
|---|
Probab=99.94 E-value=3.3e-29 Score=245.62 Aligned_cols=187 Identities=20% Similarity=0.293 Sum_probs=140.3
Q ss_pred cccceeeccCCCC-------CCCCCCChhhHHHHHHHHHHHHHHHhhcCCCceeecCCCccceEecCCCCceecccccee
Q 045315 241 DEISFWYESYNNP-------TKKGLLCWGTRVRIIEGIAQGLLYLHQYSRLRVIHRDLKASNILLDKDMNPKISDFGMAR 313 (476)
Q Consensus 241 ~~~~l~~Ey~~~~-------~~~~~L~~~~~~~i~~qIa~gL~yLH~~~~~~ivH~DLkp~NILld~~~~~kL~DFGla~ 313 (476)
...++++||++.. .....+++.+++.++.||+.||+|||+++ |+||||||+||+++.++.+||+|||++.
T Consensus 98 ~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~---i~H~dikp~Nil~~~~~~~kl~Dfg~~~ 174 (302)
T 4e5w_A 98 NGIKLIMEFLPSGSLKEYLPKNKNKINLKQQLKYAVQICKGMDYLGSRQ---YVHRDLAARNVLVESEHQVKIGDFGLTK 174 (302)
T ss_dssp CCEEEEEECCTTCBHHHHHHHHTTTCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEEEETTEEEECCCTTCE
T ss_pred ceEEEEEEeCCCCcHHHHHHhccccCCHHHHHHHHHHHHHHHHHhhcCC---cccCCCchheEEEcCCCCEEECcccccc
Confidence 3467899999742 23457999999999999999999999999 9999999999999999999999999998
Q ss_pred ecCCCccc-ccceeeeeccCCCChhhhccCCCCccceEEeehhhhhhhhhCCCCCCcCCC---------Cchhhhhhhhh
Q 045315 314 MFGGDELQ-SNTKRIVGTYGYMSPEYALRGLFSIKSDVFSFGVLLLETLSSKKNTHFYNT---------DSLTLLGHAWN 383 (476)
Q Consensus 314 ~~~~~~~~-~~~~~~~gt~~y~aPE~l~~~~~s~ksDVwSlGvvl~elltG~~p~~~~~~---------~~~~~~~~~~~ 383 (476)
........ .......++..|+|||.+.+..++.++||||||+++|||++|+.|+..... ...........
T Consensus 175 ~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~ 254 (302)
T 4e5w_A 175 AIETDKEYYTVKDDRDSPVFWYAPECLMQSKFYIASDVWSFGVTLHELLTYCDSDSSPMALFLKMIGPTHGQMTVTRLVN 254 (302)
T ss_dssp ECCTTCCEEECCCCTTCCGGGCCHHHHHHCEEEHHHHHHHHHHHHHHHHTTTCGGGSHHHHHHHHHCSCCGGGHHHHHHH
T ss_pred cccCCCcceeccCCCCCCccccCCeeecCCCCCcchhHHHHHHHHHHHHHccCCCcchhhHHhhccCCcccccCHHHHHH
Confidence 77543221 122234577889999999999999999999999999999999988542110 00000001111
Q ss_pred hhcCCCcccccCcccCCCCCHHHHHHHHHHHHHchhhcccCCCCHHHHHHHHhccc
Q 045315 384 LWNDGRTWELMDPISQNGASYPILKRYINVALLCVQEKAADRPAMSEVVSMLSNEF 439 (476)
Q Consensus 384 ~~~~~~~~~~~d~~~~~~~~~~~~~~l~~li~~Cl~~dP~~RPt~~eVl~~L~~~~ 439 (476)
....+. ....+....+.+.+++.+||+.||++|||+.+++++|+.+.
T Consensus 255 ~~~~~~---------~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~L~~ll 301 (302)
T 4e5w_A 255 TLKEGK---------RLPCPPNCPDEVYQLMRKCWEFQPSNRTSFQNLIEGFEALL 301 (302)
T ss_dssp HHHTTC---------CCCCCTTCCHHHHHHHHHTTCSSGGGSCCHHHHHHHHHHHH
T ss_pred HHhccC---------CCCCCCCCCHHHHHHHHHHcCCCCCCCCCHHHHHHHHHHHh
Confidence 111111 11112233467889999999999999999999999998764
|
| >4f0f_A Serine/threonine-protein kinase ROCO4; LRRK2, ATP-binding, nucleotide serine/threonine-protein kinase, transferase, signaling Pro; HET: ACP; 1.80A {Dictyostelium discoideum} PDB: 4f0g_A 4f1t_A* 4f1m_A* 4f1o_A* | Back alignment and structure |
|---|
Probab=99.94 E-value=1.2e-27 Score=232.98 Aligned_cols=178 Identities=24% Similarity=0.394 Sum_probs=136.5
Q ss_pred cceeeccCCCC-------CCCCCCChhhHHHHHHHHHHHHHHHhhcCCCceeecCCCccceEecCCCC-----ceecccc
Q 045315 243 ISFWYESYNNP-------TKKGLLCWGTRVRIIEGIAQGLLYLHQYSRLRVIHRDLKASNILLDKDMN-----PKISDFG 310 (476)
Q Consensus 243 ~~l~~Ey~~~~-------~~~~~L~~~~~~~i~~qIa~gL~yLH~~~~~~ivH~DLkp~NILld~~~~-----~kL~DFG 310 (476)
.+++|||++.. .+...+++.++..++.|++.||+|||+++ .+|+||||||+||+++.++. +||+|||
T Consensus 96 ~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~-~~ivH~dikp~Nil~~~~~~~~~~~~kl~Dfg 174 (287)
T 4f0f_A 96 PRMVMEFVPCGDLYHRLLDKAHPIKWSVKLRLMLDIALGIEYMQNQN-PPIVHRDLRSPNIFLQSLDENAPVCAKVADFG 174 (287)
T ss_dssp TEEEEECCTTCBHHHHHHCTTSCCCHHHHHHHHHHHHHHHHHHHTSS-SCCBCSCCSGGGEEESCCCTTCSCCEEECCCT
T ss_pred CeEEEEecCCCCHHHHHhcccCCccHHHHHHHHHHHHHHHHHHHhCC-CCeecCCCCcceEEEeccCCCCceeEEeCCCC
Confidence 35788998732 24567999999999999999999999976 34999999999999987776 9999999
Q ss_pred ceeecCCCcccccceeeeeccCCCChhhhc--cCCCCccceEEeehhhhhhhhhCCCCCCcCCCCchhhhhhhhhhhcCC
Q 045315 311 MARMFGGDELQSNTKRIVGTYGYMSPEYAL--RGLFSIKSDVFSFGVLLLETLSSKKNTHFYNTDSLTLLGHAWNLWNDG 388 (476)
Q Consensus 311 la~~~~~~~~~~~~~~~~gt~~y~aPE~l~--~~~~s~ksDVwSlGvvl~elltG~~p~~~~~~~~~~~~~~~~~~~~~~ 388 (476)
+++..... .....|+..|+|||.+. ...++.++|||||||++|||++|+.||............... ..+
T Consensus 175 ~~~~~~~~-----~~~~~g~~~y~aPE~~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~~~~~~~---~~~ 246 (287)
T 4f0f_A 175 LSQQSVHS-----VSGLLGNFQWMAPETIGAEEESYTEKADTYSFAMILYTILTGEGPFDEYSYGKIKFINMIR---EEG 246 (287)
T ss_dssp TCBCCSSC-----EECCCCCCTTSCGGGSSCSSCEECHHHHHHHHHHHHHHHHHSSCTTTTCCCCHHHHHHHHH---HSC
T ss_pred cccccccc-----ccccCCCccccCchhhccCCCCcCchhhHHHHHHHHHHHHcCCCCCccccccHHHHHHHHh---ccC
Confidence 99754332 23356899999999984 456789999999999999999999999765433322221111 111
Q ss_pred CcccccCcccCCCCCHHHHHHHHHHHHHchhhcccCCCCHHHHHHHHhcc
Q 045315 389 RTWELMDPISQNGASYPILKRYINVALLCVQEKAADRPAMSEVVSMLSNE 438 (476)
Q Consensus 389 ~~~~~~d~~~~~~~~~~~~~~l~~li~~Cl~~dP~~RPt~~eVl~~L~~~ 438 (476)
.. ...+......+.+++.+||+.||++|||++|+++.|+++
T Consensus 247 ~~---------~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~L~~l 287 (287)
T 4f0f_A 247 LR---------PTIPEDCPPRLRNVIELCWSGDPKKRPHFSYIVKELSEL 287 (287)
T ss_dssp CC---------CCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHTC
T ss_pred CC---------CCCCcccCHHHHHHHHHHhcCChhhCcCHHHHHHHHHhC
Confidence 10 111122345788999999999999999999999999863
|
| >2zv2_A Calcium/calmodulin-dependent protein kinase kinas; beta, camkk2, E.C.2.7.11.17, phosphorylation, AMPKK, metabolism, binding, calmodulin-binding; HET: 609; 2.40A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.94 E-value=4.1e-28 Score=237.85 Aligned_cols=174 Identities=23% Similarity=0.291 Sum_probs=133.2
Q ss_pred cccceeeccCCCC-----CCCCCCChhhHHHHHHHHHHHHHHHhhcCCCceeecCCCccceEecCCCCceeccccceeec
Q 045315 241 DEISFWYESYNNP-----TKKGLLCWGTRVRIIEGIAQGLLYLHQYSRLRVIHRDLKASNILLDKDMNPKISDFGMARMF 315 (476)
Q Consensus 241 ~~~~l~~Ey~~~~-----~~~~~L~~~~~~~i~~qIa~gL~yLH~~~~~~ivH~DLkp~NILld~~~~~kL~DFGla~~~ 315 (476)
+..+++|||++.. ...+.+++.++..++.||+.||+|||+++ |+||||||+||+++.++.+||+|||+++..
T Consensus 111 ~~~~lv~e~~~~~~l~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~---ivH~Dlkp~Nil~~~~~~~kl~Dfg~~~~~ 187 (298)
T 2zv2_A 111 DHLYMVFELVNQGPVMEVPTLKPLSEDQARFYFQDLIKGIEYLHYQK---IIHRDIKPSNLLVGEDGHIKIADFGVSNEF 187 (298)
T ss_dssp SEEEEEEECCTTCBSCCSSCSSCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEECTTSCEEECCCTTCEEC
T ss_pred CEEEEEEecCCCCcHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHHCC---eeccCCCHHHEEECCCCCEEEecCCCcccc
Confidence 4578899999732 24567999999999999999999999999 999999999999999999999999999876
Q ss_pred CCCcccccceeeeeccCCCChhhhccCC---CCccceEEeehhhhhhhhhCCCCCCcCCCCchhhhhhhhhhhcCCCccc
Q 045315 316 GGDELQSNTKRIVGTYGYMSPEYALRGL---FSIKSDVFSFGVLLLETLSSKKNTHFYNTDSLTLLGHAWNLWNDGRTWE 392 (476)
Q Consensus 316 ~~~~~~~~~~~~~gt~~y~aPE~l~~~~---~s~ksDVwSlGvvl~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~ 392 (476)
...... .....||+.|+|||.+.+.. ++.++|||||||++|||++|+.||..... ...... ...... .
T Consensus 188 ~~~~~~--~~~~~gt~~y~aPE~~~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~--~~~~~~----~~~~~~-~ 258 (298)
T 2zv2_A 188 KGSDAL--LSNTVGTPAFMAPESLSETRKIFSGKALDVWAMGVTLYCFVFGQCPFMDERI--MCLHSK----IKSQAL-E 258 (298)
T ss_dssp SSSSCE--ECCCCSCGGGCCGGGCCTTCCCEESHHHHHHHHHHHHHHHHHSSCSSCCSSH--HHHHHH----HHHCCC-C
T ss_pred cccccc--ccCCcCCccccChhhhccCCCCCCCchhhhHhHHHHHHHHHHCCCCCCCccH--HHHHHH----HhcccC-C
Confidence 543221 22356899999999987654 47899999999999999999999864321 111111 111110 0
Q ss_pred ccCcccCCCCCHHHHHHHHHHHHHchhhcccCCCCHHHHHH
Q 045315 393 LMDPISQNGASYPILKRYINVALLCVQEKAADRPAMSEVVS 433 (476)
Q Consensus 393 ~~d~~~~~~~~~~~~~~l~~li~~Cl~~dP~~RPt~~eVl~ 433 (476)
.. ........+.+++.+||+.||++||++.|+++
T Consensus 259 ~~-------~~~~~~~~l~~li~~~l~~dp~~R~s~~e~l~ 292 (298)
T 2zv2_A 259 FP-------DQPDIAEDLKDLITRMLDKNPESRIVVPEIKL 292 (298)
T ss_dssp CC-------SSSCCCHHHHHHHHHHTCSCTTTSCCHHHHTT
T ss_pred CC-------CccccCHHHHHHHHHHhhcChhhCCCHHHHhc
Confidence 00 01122356889999999999999999999864
|
| >3c1x_A Hepatocyte growth factor receptor; receptor tyrosine kinase, signal transduction, GRB2, SHC, ATP-binding, glycoprotein, membrane; HET: CKK; 2.17A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=99.94 E-value=2.8e-28 Score=247.50 Aligned_cols=185 Identities=27% Similarity=0.307 Sum_probs=132.7
Q ss_pred cccceeeccCCCC-------CCCCCCChhhHHHHHHHHHHHHHHHhhcCCCceeecCCCccceEecCCCCceecccccee
Q 045315 241 DEISFWYESYNNP-------TKKGLLCWGTRVRIIEGIAQGLLYLHQYSRLRVIHRDLKASNILLDKDMNPKISDFGMAR 313 (476)
Q Consensus 241 ~~~~l~~Ey~~~~-------~~~~~L~~~~~~~i~~qIa~gL~yLH~~~~~~ivH~DLkp~NILld~~~~~kL~DFGla~ 313 (476)
+..++++||++.+ .....+++.+++.++.||++||+|||+++ |+||||||+|||++.++.+||+|||+++
T Consensus 164 ~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~---ivHrDlkp~NIll~~~~~~kL~DFG~a~ 240 (373)
T 3c1x_A 164 GSPLVVLPYMKHGDLRNFIRNETHNPTVKDLIGFGLQVAKGMKFLASKK---FVHRDLAARNCMLDEKFTVKVADFGLAR 240 (373)
T ss_dssp SCCEEEEECCTTCBHHHHHHCTTCCCBHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEECTTCCEEECCC----
T ss_pred CCeEEEEECCCCCCHHHHHhhcccCCCHHHHHHHHHHHHHHHHHHHHCC---EecCccchheEEECCCCCEEEeeccccc
Confidence 4678999999843 24557899999999999999999999999 9999999999999999999999999998
Q ss_pred ecCCCccc--ccceeeeeccCCCChhhhccCCCCccceEEeehhhhhhhhh-CCCCCCcCCCCchhhhhhhhhhhcCCCc
Q 045315 314 MFGGDELQ--SNTKRIVGTYGYMSPEYALRGLFSIKSDVFSFGVLLLETLS-SKKNTHFYNTDSLTLLGHAWNLWNDGRT 390 (476)
Q Consensus 314 ~~~~~~~~--~~~~~~~gt~~y~aPE~l~~~~~s~ksDVwSlGvvl~ellt-G~~p~~~~~~~~~~~~~~~~~~~~~~~~ 390 (476)
........ .......++..|+|||.+.+..++.++|||||||++|||++ |.+||........ ... ...+..
T Consensus 241 ~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwSlG~il~ellt~~~~p~~~~~~~~~--~~~----~~~~~~ 314 (373)
T 3c1x_A 241 DMYDKEFDSVHNKTGAKLPVKWMALESLQTQKFTTKSDVWSFGVLLWELMTRGAPPYPDVNTFDI--TVY----LLQGRR 314 (373)
T ss_dssp -----------------CCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSCTTSCSSCH--HHH----HHTTCC
T ss_pred cccccccccccccCCCCCcccccChHHhcCCCCCcHHHHHHHHHHHHHHHhCcCCCCCCCCHHHH--HHH----HHcCCC
Confidence 66433211 11223456788999999999999999999999999999999 5666654332211 111 111111
Q ss_pred ccccCcccCCCCCHHHHHHHHHHHHHchhhcccCCCCHHHHHHHHhccccCCC
Q 045315 391 WELMDPISQNGASYPILKRYINVALLCVQEKAADRPAMSEVVSMLSNEFVNLP 443 (476)
Q Consensus 391 ~~~~d~~~~~~~~~~~~~~l~~li~~Cl~~dP~~RPt~~eVl~~L~~~~~~~~ 443 (476)
. .. +......+.+++.+||+.||++||++.|+++.|+.+.....
T Consensus 315 ~--~~-------p~~~~~~l~~li~~cl~~dp~~RPs~~ell~~L~~i~~~~~ 358 (373)
T 3c1x_A 315 L--LQ-------PEYCPDPLYEVMLKCWHPKAEMRPSFSELVSRISAIFSTFI 358 (373)
T ss_dssp C--CC-------CTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHTCC
T ss_pred C--CC-------CCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHHhcc
Confidence 0 00 11223568899999999999999999999999999875544
|
| >3dbq_A Dual specificity protein kinase TTK; MPS1 structure, kinase activation, phosphorylation, ATP- binding, nucleotide-binding, phosphoprotein; 2.70A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.94 E-value=1.4e-28 Score=246.41 Aligned_cols=177 Identities=25% Similarity=0.261 Sum_probs=126.3
Q ss_pred cccceeeccCCC-----CCCCCCCChhhHHHHHHHHHHHHHHHhhcCCCceeecCCCccceEecCCCCceeccccceeec
Q 045315 241 DEISFWYESYNN-----PTKKGLLCWGTRVRIIEGIAQGLLYLHQYSRLRVIHRDLKASNILLDKDMNPKISDFGMARMF 315 (476)
Q Consensus 241 ~~~~l~~Ey~~~-----~~~~~~L~~~~~~~i~~qIa~gL~yLH~~~~~~ivH~DLkp~NILld~~~~~kL~DFGla~~~ 315 (476)
+.++++|||... ....+.+++.++..++.||+.||+|||+++ |+||||||+|||++ ++.+||+|||+++..
T Consensus 82 ~~~~lv~e~~~~~L~~~l~~~~~~~~~~~~~i~~qi~~al~~lH~~~---iiHrDikp~NIll~-~~~~kl~DFG~a~~~ 157 (343)
T 3dbq_A 82 QYIYMVMECGNIDLNSWLKKKKSIDPWERKSYWKNMLEAVHTIHQHG---IVHSDLKPANFLIV-DGMLKLIDFGIANQM 157 (343)
T ss_dssp SEEEEEECCCSEEHHHHHHHSCCCCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCCGGGEEEE-TTEEEECCCSSSCCC
T ss_pred CEEEEEEeCCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCCcceEEEE-CCcEEEeeccccccc
Confidence 356788886551 123457999999999999999999999999 99999999999997 578999999999876
Q ss_pred CCCcccccceeeeeccCCCChhhhcc-----------CCCCccceEEeehhhhhhhhhCCCCCCcCCCCchhhhhhhhhh
Q 045315 316 GGDELQSNTKRIVGTYGYMSPEYALR-----------GLFSIKSDVFSFGVLLLETLSSKKNTHFYNTDSLTLLGHAWNL 384 (476)
Q Consensus 316 ~~~~~~~~~~~~~gt~~y~aPE~l~~-----------~~~s~ksDVwSlGvvl~elltG~~p~~~~~~~~~~~~~~~~~~ 384 (476)
.............||+.|+|||++.+ ..++.++|||||||++|||++|+.||.........+ ...
T Consensus 158 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~----~~~ 233 (343)
T 3dbq_A 158 QPDTTSVVKDSQVGTVNYMPPEAIKDMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGKTPFQQIINQISKL----HAI 233 (343)
T ss_dssp ------------CCCCSSCCHHHHHHCC-----------CCHHHHHHHHHHHHHHHHHSSCTTTTCCSHHHHH----HHH
T ss_pred CcccccccCCCCcCCcCcCCHHHHhhccccccccccccCCCchhhHHHHHHHHHHHHhCCCcchhhhhHHHHH----HHH
Confidence 54433333344679999999999865 678999999999999999999999986432211111 111
Q ss_pred hcCCCcccccCcccCCCCCHHHHHHHHHHHHHchhhcccCCCCHHHHHHH
Q 045315 385 WNDGRTWELMDPISQNGASYPILKRYINVALLCVQEKAADRPAMSEVVSM 434 (476)
Q Consensus 385 ~~~~~~~~~~d~~~~~~~~~~~~~~l~~li~~Cl~~dP~~RPt~~eVl~~ 434 (476)
.. +......+......+.+++.+||+.||++|||+.|+++.
T Consensus 234 ~~---------~~~~~~~~~~~~~~l~~li~~~L~~dp~~Rpt~~e~l~h 274 (343)
T 3dbq_A 234 ID---------PNHEIEFPDIPEKDLQDVLKCCLKRDPKQRISIPELLAH 274 (343)
T ss_dssp HC---------TTSCCCCCCCSCHHHHHHHHHHTCSSTTTSCCHHHHHTS
T ss_pred hc---------CCcccCCcccCCHHHHHHHHHHcCCChhHCCCHHHHHhC
Confidence 11 111111111123568899999999999999999999864
|
| >2xir_A Vascular endothelial growth factor receptor 2; angiogenesis, nucleotide-binding, inhibitor, phosphorylation receptor, transferase, transmembrane; HET: 00J; 1.50A {Homo sapiens} PDB: 1vr2_A* 1ywn_A* 3vnt_A* 3c7q_A* 2oh4_A* 3u6j_A* 3efl_A* 2p2i_A* 3cjf_A* 3cjg_A* 3ewh_A* 2qu5_A* 2qu6_A* 2rl5_A* 3b8q_A* 3b8r_A* 2p2h_A* 3cp9_A* 3cpb_A* 3cpc_A* ... | Back alignment and structure |
|---|
Probab=99.94 E-value=5.5e-28 Score=238.32 Aligned_cols=165 Identities=30% Similarity=0.376 Sum_probs=131.2
Q ss_pred CCChhhHHHHHHHHHHHHHHHhhcCCCceeecCCCccceEecCCCCceeccccceeecCCCcccccceeeeeccCCCChh
Q 045315 258 LLCWGTRVRIIEGIAQGLLYLHQYSRLRVIHRDLKASNILLDKDMNPKISDFGMARMFGGDELQSNTKRIVGTYGYMSPE 337 (476)
Q Consensus 258 ~L~~~~~~~i~~qIa~gL~yLH~~~~~~ivH~DLkp~NILld~~~~~kL~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE 337 (476)
.+++.++..++.||+.||+|||+++ |+||||||+||+++.++.+||+|||+++...............++..|+|||
T Consensus 144 ~~~~~~~~~~~~qi~~al~~lH~~~---i~H~dikp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~t~~y~aPE 220 (316)
T 2xir_A 144 FLTLEHLICYSFQVAKGMEFLASRK---CIHRDLAARNILLSEKNVVKICDFGLARDIYKDPDYVRKGDARLPLKWMAPE 220 (316)
T ss_dssp CEEHHHHHHHHHHHHHHHHHHHHTT---CCCSCCSGGGEEECGGGCEEECCCGGGSCTTTCTTSEEETTEEECGGGCCHH
T ss_pred ccCHHHHHHHHHHHHHHHHHHHhCC---cccccCccceEEECCCCCEEECCCccccccccCccceeccCCCcceeecCch
Confidence 3899999999999999999999999 9999999999999999999999999998765443333333456889999999
Q ss_pred hhccCCCCccceEEeehhhhhhhhh-CCCCCCcCCCCchhhhhhhhhhhcCCCcccccCcccCCCCCHHHHHHHHHHHHH
Q 045315 338 YALRGLFSIKSDVFSFGVLLLETLS-SKKNTHFYNTDSLTLLGHAWNLWNDGRTWELMDPISQNGASYPILKRYINVALL 416 (476)
Q Consensus 338 ~l~~~~~s~ksDVwSlGvvl~ellt-G~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~l~~li~~ 416 (476)
.+.+..++.++||||||+++|||++ |+.||........ ... ....+.... .+......+.+++.+
T Consensus 221 ~~~~~~~~~~~Di~slG~il~~l~t~g~~p~~~~~~~~~-~~~----~~~~~~~~~---------~~~~~~~~l~~li~~ 286 (316)
T 2xir_A 221 TIFDRVYTIQSDVWSFGVLLWEIFSLGASPYPGVKIDEE-FCR----RLKEGTRMR---------APDYTTPEMYQTMLD 286 (316)
T ss_dssp HHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCCSHH-HHH----HHHHTCCCC---------CCTTCCHHHHHHHHH
T ss_pred hhccccccchhHHHHHHHHHHHHHhCCCCCCcccchhHH-HHH----HhccCccCC---------CCCCCCHHHHHHHHH
Confidence 9999999999999999999999998 9999865442221 111 111111111 111123568899999
Q ss_pred chhhcccCCCCHHHHHHHHhccc
Q 045315 417 CVQEKAADRPAMSEVVSMLSNEF 439 (476)
Q Consensus 417 Cl~~dP~~RPt~~eVl~~L~~~~ 439 (476)
||+.||++|||+.||++.|+.+.
T Consensus 287 ~l~~dp~~Rps~~ell~~L~~~~ 309 (316)
T 2xir_A 287 CWHGEPSQRPTFSELVEHLGNLL 309 (316)
T ss_dssp HTCSSGGGSCCHHHHHHHHHHHH
T ss_pred HcCCChhhCcCHHHHHHHHHHHH
Confidence 99999999999999999999875
|
| >3q60_A ROP5B; pseudokinase, transferase; HET: ATP; 1.72A {Toxoplasma gondii} PDB: 3q5z_A* | Back alignment and structure |
|---|
Probab=99.94 E-value=1.6e-28 Score=248.68 Aligned_cols=177 Identities=8% Similarity=0.008 Sum_probs=130.0
Q ss_pred ccceeeccCCC------CCCCCCCChhhH------HHHHHHHHHHHHHHhhcCCCceeecCCCccceEecCCCCceeccc
Q 045315 242 EISFWYESYNN------PTKKGLLCWGTR------VRIIEGIAQGLLYLHQYSRLRVIHRDLKASNILLDKDMNPKISDF 309 (476)
Q Consensus 242 ~~~l~~Ey~~~------~~~~~~L~~~~~------~~i~~qIa~gL~yLH~~~~~~ivH~DLkp~NILld~~~~~kL~DF 309 (476)
..+++|||++. ...+..+++..+ ..++.||+.||+|||+++ |+||||||+|||++.++.+||+||
T Consensus 162 ~~~lv~e~~~~~L~~~l~~~~~~~~~~~~~~~~vk~~i~~qi~~aL~~LH~~~---ivHrDikp~NIll~~~~~~kL~DF 238 (371)
T 3q60_A 162 NYLLLMPAASVDLELLFSTLDFVYVFRGDEGILALHILTAQLIRLAANLQSKG---LVHGHFTPDNLFIMPDGRLMLGDV 238 (371)
T ss_dssp EEEEEECCCSEEHHHHHHHHHHSCCCCHHHHHHHHHHHHHHHHHHHHHHHHTT---EEETTCSGGGEEECTTSCEEECCG
T ss_pred eEEEEecCCCCCHHHHHHHhccccchhhhhhhhhHHHHHHHHHHHHHHHHHCC---CccCcCCHHHEEECCCCCEEEEec
Confidence 47889999881 011334566677 788899999999999999 999999999999999999999999
Q ss_pred cceeecCCCcccccceeeeeccCCCChhhhcc--CCCCccceEEeehhhhhhhhhCCCCCCcCCCCchhhhhhhhhhhcC
Q 045315 310 GMARMFGGDELQSNTKRIVGTYGYMSPEYALR--GLFSIKSDVFSFGVLLLETLSSKKNTHFYNTDSLTLLGHAWNLWND 387 (476)
Q Consensus 310 Gla~~~~~~~~~~~~~~~~gt~~y~aPE~l~~--~~~s~ksDVwSlGvvl~elltG~~p~~~~~~~~~~~~~~~~~~~~~ 387 (476)
|+++...... ....+++.|+|||.+.+ ..++.++|||||||++|||++|+.||........... ..
T Consensus 239 G~a~~~~~~~-----~~~~~t~~y~aPE~~~~~~~~~~~~~DiwSlG~il~elltg~~Pf~~~~~~~~~~~-------~~ 306 (371)
T 3q60_A 239 SALWKVGTRG-----PASSVPVTYAPREFLNASTATFTHALNAWQLGLSIYRVWCLFLPFGLVTPGIKGSW-------KR 306 (371)
T ss_dssp GGEEETTCEE-----EGGGSCGGGCCHHHHTCSEEECCHHHHHHHHHHHHHHHHHSSCSTTBCCTTCTTCC-------CB
T ss_pred ceeeecCCCc-----cCccCCcCCcChhhccCCCCCcCccccHHHHHHHHHHHHhCCCCCCCcCcccccch-------hh
Confidence 9998765321 12356799999999987 6799999999999999999999999976532211100 00
Q ss_pred CCcccccCcccCCCCCHHHHHHHHHHHHHchhhcccCCCCHHHHHH
Q 045315 388 GRTWELMDPISQNGASYPILKRYINVALLCVQEKAADRPAMSEVVS 433 (476)
Q Consensus 388 ~~~~~~~d~~~~~~~~~~~~~~l~~li~~Cl~~dP~~RPt~~eVl~ 433 (476)
......................+.+++.+||+.||++|||+.++++
T Consensus 307 ~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~ 352 (371)
T 3q60_A 307 PSLRVPGTDSLAFGSCTPLPDFVKTLIGRFLNFDRRRRLLPLEAME 352 (371)
T ss_dssp CCTTSCCCCSCCCTTSSCCCHHHHHHHHHHTCSSTTTCCCHHHHTT
T ss_pred hhhhhccccccchhhccCCCHHHHHHHHHHcCCChhhCCCHHHHhc
Confidence 0000000001111111233467889999999999999999999864
|
| >3pls_A Macrophage-stimulating protein receptor; protein kinase, CIS autophosphorylation conformation, recept tyrosine kinase, AMP-PNP, unphosphorylated; HET: ANP; 2.24A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=99.94 E-value=7e-28 Score=235.54 Aligned_cols=185 Identities=23% Similarity=0.254 Sum_probs=140.1
Q ss_pred cceeeccCCCC-------CCCCCCChhhHHHHHHHHHHHHHHHhhcCCCceeecCCCccceEecCCCCceeccccceeec
Q 045315 243 ISFWYESYNNP-------TKKGLLCWGTRVRIIEGIAQGLLYLHQYSRLRVIHRDLKASNILLDKDMNPKISDFGMARMF 315 (476)
Q Consensus 243 ~~l~~Ey~~~~-------~~~~~L~~~~~~~i~~qIa~gL~yLH~~~~~~ivH~DLkp~NILld~~~~~kL~DFGla~~~ 315 (476)
.++++||+... .....+++.++..++.||+.||+|||+.+ ++||||||+||+++.++.+||+|||+++..
T Consensus 98 ~~~v~e~~~~~~L~~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~---i~H~dikp~Nili~~~~~~kl~Dfg~~~~~ 174 (298)
T 3pls_A 98 PHVLLPYMCHGDLLQFIRSPQRNPTVKDLISFGLQVARGMEYLAEQK---FVHRDLAARNCMLDESFTVKVADFGLARDI 174 (298)
T ss_dssp CEEEECCCTTCBHHHHHHCTTCCCBHHHHHHHHHHHHHHHHHHHHTT---CCCSCCSGGGEEECTTCCEEECCTTSSCTT
T ss_pred cEEEEecccCCCHHHHHhccccCCCHHHHHHHHHHHHHHHHHHHhCC---cccCCCCcceEEEcCCCcEEeCcCCCcccc
Confidence 47888998732 23567899999999999999999999999 999999999999999999999999999865
Q ss_pred CCCcc--cccceeeeeccCCCChhhhccCCCCccceEEeehhhhhhhhhCCCCCCcCCCCchhhhhhhhhhhcCCCcccc
Q 045315 316 GGDEL--QSNTKRIVGTYGYMSPEYALRGLFSIKSDVFSFGVLLLETLSSKKNTHFYNTDSLTLLGHAWNLWNDGRTWEL 393 (476)
Q Consensus 316 ~~~~~--~~~~~~~~gt~~y~aPE~l~~~~~s~ksDVwSlGvvl~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~ 393 (476)
..... ........++..|+|||.+.+..++.++||||||+++|||++|+.|+..... ........ ..+...
T Consensus 175 ~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~~~~~~~~-~~~~~~~~----~~~~~~-- 247 (298)
T 3pls_A 175 LDREYYSVQQHRHARLPVKWTALESLQTYRFTTKSDVWSFGVLLWELLTRGAPPYRHID-PFDLTHFL----AQGRRL-- 247 (298)
T ss_dssp TTGGGGCSCCSSCTTCGGGGSCHHHHTTCCCCHHHHHHHHHHHHHHHHHTSCCTTTTSC-GGGHHHHH----HTTCCC--
T ss_pred cCCcccccccCcCCCCCccccChhhhccCCCChhhchhhHHHHHHHHhhCCCCCCccCC-HHHHHHHh----hcCCCC--
Confidence 43321 1122234578899999999999999999999999999999996666432221 11111111 111110
Q ss_pred cCcccCCCCCHHHHHHHHHHHHHchhhcccCCCCHHHHHHHHhccccCCCC
Q 045315 394 MDPISQNGASYPILKRYINVALLCVQEKAADRPAMSEVVSMLSNEFVNLPA 444 (476)
Q Consensus 394 ~d~~~~~~~~~~~~~~l~~li~~Cl~~dP~~RPt~~eVl~~L~~~~~~~~~ 444 (476)
..+......+.+++.+||+.||.+|||+.++++.|+++..++..
T Consensus 248 -------~~~~~~~~~l~~li~~~l~~~p~~Rps~~~ll~~l~~~~~~l~~ 291 (298)
T 3pls_A 248 -------PQPEYCPDSLYQVMQQCWEADPAVRPTFRVLVGEVEQIVSALLG 291 (298)
T ss_dssp -------CCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHHCCS
T ss_pred -------CCCccchHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHHHHhc
Confidence 11112235788999999999999999999999999998766543
|
| >1u59_A Tyrosine-protein kinase ZAP-70; transferase; HET: STU; 2.30A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=99.94 E-value=1.7e-28 Score=239.27 Aligned_cols=187 Identities=23% Similarity=0.329 Sum_probs=144.7
Q ss_pred cccceeeccCCC-------CCCCCCCChhhHHHHHHHHHHHHHHHhhcCCCceeecCCCccceEecCCCCceecccccee
Q 045315 241 DEISFWYESYNN-------PTKKGLLCWGTRVRIIEGIAQGLLYLHQYSRLRVIHRDLKASNILLDKDMNPKISDFGMAR 313 (476)
Q Consensus 241 ~~~~l~~Ey~~~-------~~~~~~L~~~~~~~i~~qIa~gL~yLH~~~~~~ivH~DLkp~NILld~~~~~kL~DFGla~ 313 (476)
+..++++||++. ..++..+++.++..++.||+.||+|||+.+ |+||||||+||+++.++.+||+|||++.
T Consensus 82 ~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~---i~H~dlkp~Nili~~~~~~kl~Dfg~~~ 158 (287)
T 1u59_A 82 EALMLVMEMAGGGPLHKFLVGKREEIPVSNVAELLHQVSMGMKYLEEKN---FVHRDLAARNVLLVNRHYAKISDFGLSK 158 (287)
T ss_dssp SSEEEEEECCTTEEHHHHHTTCTTTSCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEEEETTEEEECCCTTCE
T ss_pred CCcEEEEEeCCCCCHHHHHHhCCccCCHHHHHHHHHHHHHHHHHHHHCC---EeeCCCchheEEEcCCCCEEECccccee
Confidence 457889999983 234567999999999999999999999999 9999999999999999999999999998
Q ss_pred ecCCCccc-ccceeeeeccCCCChhhhccCCCCccceEEeehhhhhhhhh-CCCCCCcCCCCchhhhhhhhhhhcCCCcc
Q 045315 314 MFGGDELQ-SNTKRIVGTYGYMSPEYALRGLFSIKSDVFSFGVLLLETLS-SKKNTHFYNTDSLTLLGHAWNLWNDGRTW 391 (476)
Q Consensus 314 ~~~~~~~~-~~~~~~~gt~~y~aPE~l~~~~~s~ksDVwSlGvvl~ellt-G~~p~~~~~~~~~~~~~~~~~~~~~~~~~ 391 (476)
........ .......++..|+|||.+.+..++.++||||||+++|||++ |+.||...... ..... ...+...
T Consensus 159 ~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~p~~~~~~~--~~~~~----i~~~~~~ 232 (287)
T 1u59_A 159 ALGADDSYYTARSAGKWPLKWYAPECINFRKFSSRSDVWSYGVTMWEALSYGQKPYKKMKGP--EVMAF----IEQGKRM 232 (287)
T ss_dssp ECTTCSCEECCCCSSCCCGGGCCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCTTTTCCTH--HHHHH----HHTTCCC
T ss_pred eeccCcceeeccccccccccccCHHHhccCCCCchhhHHHHHHHHHHHHcCCCCCcccCCHH--HHHHH----HhcCCcC
Confidence 77543221 11222346789999999998899999999999999999998 99998654321 11111 1111111
Q ss_pred cccCcccCCCCCHHHHHHHHHHHHHchhhcccCCCCHHHHHHHHhccccCCCCC
Q 045315 392 ELMDPISQNGASYPILKRYINVALLCVQEKAADRPAMSEVVSMLSNEFVNLPAP 445 (476)
Q Consensus 392 ~~~d~~~~~~~~~~~~~~l~~li~~Cl~~dP~~RPt~~eVl~~L~~~~~~~~~p 445 (476)
..+......+.+++.+||+.||++||++.++++.|+.+..+...+
T Consensus 233 ---------~~~~~~~~~l~~li~~~l~~~p~~Rps~~~l~~~l~~~~~~~~~~ 277 (287)
T 1u59_A 233 ---------ECPPECPPELYALMSDCWIYKWEDRPDFLTVEQRMRACYYSLASK 277 (287)
T ss_dssp ---------CCCTTCCHHHHHHHHHTTCSSGGGSCCHHHHHHHHHHHHHHHHTT
T ss_pred ---------CCCCCcCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHHhcCCc
Confidence 111223457889999999999999999999999999987554433
|
| >3e7e_A HBUB1, BUB1A, mitotic checkpoint serine/threonine-protein kinas; spindle assembly checkpoint, mitosis, kinase, activation, KE CDC20, ATP-binding; HET: ATP; 2.31A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.94 E-value=7.7e-28 Score=243.07 Aligned_cols=178 Identities=13% Similarity=0.116 Sum_probs=140.0
Q ss_pred cccceeeccCCCC-----------CCCCCCChhhHHHHHHHHHHHHHHHhhcCCCceeecCCCccceEecC---------
Q 045315 241 DEISFWYESYNNP-----------TKKGLLCWGTRVRIIEGIAQGLLYLHQYSRLRVIHRDLKASNILLDK--------- 300 (476)
Q Consensus 241 ~~~~l~~Ey~~~~-----------~~~~~L~~~~~~~i~~qIa~gL~yLH~~~~~~ivH~DLkp~NILld~--------- 300 (476)
+.++++|||++.+ .....+++.+++.++.||+.||+|||+++ |+||||||+|||++.
T Consensus 140 ~~~~lv~e~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~qi~~~L~~lH~~~---ivHrDiKp~NIll~~~~~~~~~~~ 216 (365)
T 3e7e_A 140 NGSVLVGELYSYGTLLNAINLYKNTPEKVMPQGLVISFAMRMLYMIEQVHDCE---IIHGDIKPDNFILGNGFLEQDDED 216 (365)
T ss_dssp SCEEEEECCCCSCBHHHHHHHHHTSTTCSCCHHHHHHHHHHHHHHHHHHHTTT---EECCCCSGGGEEECGGGTCC----
T ss_pred CCcEEEEeccCCCcHHHHHHHhhcccccCCCHHHHHHHHHHHHHHHHHHhhCC---eecCCCCHHHEEecccccCccccc
Confidence 5688999999832 13567999999999999999999999998 999999999999998
Q ss_pred --CCCceeccccceeecCCCcccccceeeeeccCCCChhhhccCCCCccceEEeehhhhhhhhhCCCCCCcCCCCchhhh
Q 045315 301 --DMNPKISDFGMARMFGGDELQSNTKRIVGTYGYMSPEYALRGLFSIKSDVFSFGVLLLETLSSKKNTHFYNTDSLTLL 378 (476)
Q Consensus 301 --~~~~kL~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~s~ksDVwSlGvvl~elltG~~p~~~~~~~~~~~~ 378 (476)
++.+||+|||+++.+.............||..|+|||++.+..++.++|||||||++|||++|+.||.........
T Consensus 217 ~~~~~~kl~DFG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~~~~~~-- 294 (365)
T 3e7e_A 217 DLSAGLALIDLGQSIDMKLFPKGTIFTAKCETSGFQCVEMLSNKPWNYQIDYFGVAATVYCMLFGTYMKVKNEGGECK-- 294 (365)
T ss_dssp --CTTEEECCCTTCEEGGGSCTTEEECCSSCTTSCCCHHHHTTCCBSTHHHHHHHHHHHHHHHHSSCCCEEEETTEEE--
T ss_pred cccCCEEEeeCchhhhhhccCCCceeeeecCCCCCCChHHhcCCCCCccccHHHHHHHHHHHHhCCCccccCCCCcee--
Confidence 8999999999998654322222233456999999999999999999999999999999999999998543221110
Q ss_pred hhhhhhhcCCCcccccCcccCCCCCHHHHHHHHHHHHHchhhcccCC-CCHHHHHHHHhccccC
Q 045315 379 GHAWNLWNDGRTWELMDPISQNGASYPILKRYINVALLCVQEKAADR-PAMSEVVSMLSNEFVN 441 (476)
Q Consensus 379 ~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~l~~li~~Cl~~dP~~R-Pt~~eVl~~L~~~~~~ 441 (476)
+....... ...+.+.+++..|++.+|.+| |++.++.+.|+.....
T Consensus 295 ---------------~~~~~~~~---~~~~~~~~~~~~~l~~~p~~r~~~~~~l~~~l~~~l~~ 340 (365)
T 3e7e_A 295 ---------------PEGLFRRL---PHLDMWNEFFHVMLNIPDCHHLPSLDLLRQKLKKVFQQ 340 (365)
T ss_dssp ---------------ECSCCTTC---SSHHHHHHHHHHHHCCCCTTCCCCHHHHHHHHHHHHHH
T ss_pred ---------------echhcccc---CcHHHHHHHHHHHcCCCCCCcchHHHHHHHHHHHHHHH
Confidence 01111111 124567788999999999999 6888999999887643
|
| >1b6c_B TGF-B superfamily receptor type I; complex (isomerase/protein kinase), receptor serine/threonine kinase; 2.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1ias_A 2x7o_A* 3faa_A* 3kcf_A* | Back alignment and structure |
|---|
Probab=99.94 E-value=6.9e-28 Score=240.47 Aligned_cols=192 Identities=19% Similarity=0.205 Sum_probs=139.7
Q ss_pred ccceeeccCCCCC-----CCCCCChhhHHHHHHHHHHHHHHHh--------hcCCCceeecCCCccceEecCCCCceecc
Q 045315 242 EISFWYESYNNPT-----KKGLLCWGTRVRIIEGIAQGLLYLH--------QYSRLRVIHRDLKASNILLDKDMNPKISD 308 (476)
Q Consensus 242 ~~~l~~Ey~~~~~-----~~~~L~~~~~~~i~~qIa~gL~yLH--------~~~~~~ivH~DLkp~NILld~~~~~kL~D 308 (476)
.+++++||++.++ ++..+++.+++.++.||+.||+||| +.+ |+||||||+||+++.++.+||+|
T Consensus 114 ~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~~~~---ivH~Dlkp~NIll~~~~~~kL~D 190 (342)
T 1b6c_B 114 QLWLVSDYHEHGSLFDYLNRYTVTVEGMIKLALSTASGLAHLHMEIVGTQGKPA---IAHRDLKSKNILVKKNGTCCIAD 190 (342)
T ss_dssp CEEEEECCCTTCBHHHHHHHCCBCHHHHHHHHHHHHHHHHHHHCCBCSTTCBCE---EECSCCSGGGEEECTTSCEEECC
T ss_pred eeEEEEeecCCCcHHHHHhccCccHHHHHHHHHHHHHHHHHHHHHHhhhcccCC---eeeCCCCHHHEEECCCCCEEEEE
Confidence 5788999998432 2346999999999999999999999 777 99999999999999999999999
Q ss_pred ccceeecCCCcccc--cceeeeeccCCCChhhhccC------CCCccceEEeehhhhhhhhhC----------CCCCCcC
Q 045315 309 FGMARMFGGDELQS--NTKRIVGTYGYMSPEYALRG------LFSIKSDVFSFGVLLLETLSS----------KKNTHFY 370 (476)
Q Consensus 309 FGla~~~~~~~~~~--~~~~~~gt~~y~aPE~l~~~------~~s~ksDVwSlGvvl~elltG----------~~p~~~~ 370 (476)
||++.......... ......|+..|+|||.+.+. .++.++|||||||++|||++| +.||...
T Consensus 191 fg~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~Di~slG~il~el~tg~~~~~~~~~~~~p~~~~ 270 (342)
T 1b6c_B 191 LGLAVRHDSATDTIDIAPNHRVGTKRYMAPEVLDDSINMKHFESFKRADIYAMGLVFWEIARRCSIGGIHEDYQLPYYDL 270 (342)
T ss_dssp CTTCEEEETTTTEEEECCCSCCCCGGGCCHHHHTSCCCTTCHHHHHHHHHHHHHHHHHHHHTTBCBTTBCCCCCCTTTTT
T ss_pred CCCceeccccccccccccccCCcCcccCCHhhhcccccccccccCCcccHHHHHHHHHHHHhccCcCCcccccccCcccc
Confidence 99998765432211 12335689999999999765 334789999999999999999 5555433
Q ss_pred CCCchhhhhhhhhhhcCCCcccccCcccCC-CCCHHHHHHHHHHHHHchhhcccCCCCHHHHHHHHhccccC
Q 045315 371 NTDSLTLLGHAWNLWNDGRTWELMDPISQN-GASYPILKRYINVALLCVQEKAADRPAMSEVVSMLSNEFVN 441 (476)
Q Consensus 371 ~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~-~~~~~~~~~l~~li~~Cl~~dP~~RPt~~eVl~~L~~~~~~ 441 (476)
.......... ......... .+.... .........+.+++.+||+.||++|||+.+|++.|+.+..+
T Consensus 271 ~~~~~~~~~~-~~~~~~~~~----~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rps~~~i~~~L~~i~~~ 337 (342)
T 1b6c_B 271 VPSDPSVEEM-RKVVCEQKL----RPNIPNRWQSCEALRVMAKIMRECWYANGAARLTALRIKKTLSQLSQQ 337 (342)
T ss_dssp SCSSCCHHHH-HHHHTTSCC----CCCCCGGGGTSHHHHHHHHHHHHHCCSSGGGSCCHHHHHHHHHHHHHT
T ss_pred CcCcccHHHH-HHHHHHHHh----CCCCcccccchhHHHHHHHHHHHHhccChhhCCCHHHHHHHHHHHHHH
Confidence 2111111111 111111111 111100 01235667899999999999999999999999999987643
|
| >3sv0_A Casein kinase I-like; typical kinase domain fold, cytosol, transferase; 2.00A {Oryza sativa japonica group} | Back alignment and structure |
|---|
Probab=99.94 E-value=6.8e-28 Score=252.46 Aligned_cols=187 Identities=18% Similarity=0.196 Sum_probs=141.9
Q ss_pred cccceeeccCCCC------CCCCCCChhhHHHHHHHHHHHHHHHhhcCCCceeecCCCccceEe---cCCCCceeccccc
Q 045315 241 DEISFWYESYNNP------TKKGLLCWGTRVRIIEGIAQGLLYLHQYSRLRVIHRDLKASNILL---DKDMNPKISDFGM 311 (476)
Q Consensus 241 ~~~~l~~Ey~~~~------~~~~~L~~~~~~~i~~qIa~gL~yLH~~~~~~ivH~DLkp~NILl---d~~~~~kL~DFGl 311 (476)
+..+++|||+... ...+.+++.+++.|+.||+.||+|||+++ |+||||||+|||+ +.++.+||+|||+
T Consensus 76 ~~~~lvme~~g~sL~~ll~~~~~~l~~~~~~~i~~qi~~aL~yLH~~g---IvHrDIKP~NILl~~~~~~~~vkL~DFGl 152 (483)
T 3sv0_A 76 DYNVLVMDLLGPSLEDLFNFCSRKLSLKTVLMLADQMINRVEFVHSKS---FLHRDIKPDNFLMGLGRRANQVYIIDFGL 152 (483)
T ss_dssp TEEEEEEECCCCBHHHHHHHTTTCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEECCGGGTTCEEECCCTT
T ss_pred CEEEEEEECCCCCHHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHHCC---EeecccCcceEEEecCCCCCeEEEEeCCc
Confidence 4567889998510 12567999999999999999999999999 9999999999999 6889999999999
Q ss_pred eeecCCCccc-----ccceeeeeccCCCChhhhccCCCCccceEEeehhhhhhhhhCCCCCCcCCCC-chhhhhhhhhhh
Q 045315 312 ARMFGGDELQ-----SNTKRIVGTYGYMSPEYALRGLFSIKSDVFSFGVLLLETLSSKKNTHFYNTD-SLTLLGHAWNLW 385 (476)
Q Consensus 312 a~~~~~~~~~-----~~~~~~~gt~~y~aPE~l~~~~~s~ksDVwSlGvvl~elltG~~p~~~~~~~-~~~~~~~~~~~~ 385 (476)
++.+...... .......||..|+|||.+.+..++.++|||||||++|||++|+.||...... ............
T Consensus 153 a~~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~s~~sDvwSlGvil~elltG~~Pf~~~~~~~~~~~~~~i~~~~ 232 (483)
T 3sv0_A 153 AKKYRDTSTHQHIPYRENKNLTGTARYASVNTHLGIEQSRRDDLESLGYVLMYFLRGSLPWQGLKAGTKKQKYEKISEKK 232 (483)
T ss_dssp CEECBCTTTCCBCCCCCCCCCCSCTTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCTTSSCCCSSHHHHHHHHHHHH
T ss_pred ceeccCCccccccccccccccCCCccccCHHHhcCCCCChHHHHHHHHHHHHHHHhCCCCCccccchhHHHHHHHHhhcc
Confidence 9977543321 1122467999999999999999999999999999999999999999765422 111111111110
Q ss_pred cCCCcccccCcccCCCCCHHHHHHHHHHHHHchhhcccCCCCHHHHHHHHhccc
Q 045315 386 NDGRTWELMDPISQNGASYPILKRYINVALLCVQEKAADRPAMSEVVSMLSNEF 439 (476)
Q Consensus 386 ~~~~~~~~~d~~~~~~~~~~~~~~l~~li~~Cl~~dP~~RPt~~eVl~~L~~~~ 439 (476)
.......+ .. .....+.+++.+||+.+|++||++.+|+++|+.+.
T Consensus 233 ~~~~~~~l-----~~----~~p~~l~~li~~cl~~dP~~RPs~~el~~~L~~l~ 277 (483)
T 3sv0_A 233 VATSIEAL-----CR----GYPTEFASYFHYCRSLRFDDKPDYSYLKRLFRDLF 277 (483)
T ss_dssp HHSCHHHH-----HT----TSCHHHHHHHHHHHTCCTTCCCCHHHHHHHHHHHH
T ss_pred ccccHHHH-----hc----CCcHHHHHHHHHHhcCChhhCcCHHHHHHHHHHHH
Confidence 00000000 01 11357889999999999999999999999998874
|
| >4euu_A Serine/threonine-protein kinase TBK1; ATP binding, phosphorylation, transferase-transferas inhibitor complex; HET: SEP BX7; 1.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.94 E-value=2.2e-27 Score=235.01 Aligned_cols=192 Identities=16% Similarity=0.157 Sum_probs=142.0
Q ss_pred ccceeeccCCCC---------CCCCCCChhhHHHHHHHHHHHHHHHhhcCCCceeecCCCccceEe----cCCCCceecc
Q 045315 242 EISFWYESYNNP---------TKKGLLCWGTRVRIIEGIAQGLLYLHQYSRLRVIHRDLKASNILL----DKDMNPKISD 308 (476)
Q Consensus 242 ~~~l~~Ey~~~~---------~~~~~L~~~~~~~i~~qIa~gL~yLH~~~~~~ivH~DLkp~NILl----d~~~~~kL~D 308 (476)
..+++|||++.. .....+++.+++.++.||+.||+|||+.+ |+||||||+||++ +.++.+||+|
T Consensus 83 ~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~---ivH~Dlkp~NIll~~~~~~~~~~kL~D 159 (319)
T 4euu_A 83 HKVLIMEFCPCGSLYTVLEEPSNAYGLPESEFLIVLRDVVGGMNHLRENG---IVHRNIKPGNIMRVIGEDGQSVYKLTD 159 (319)
T ss_dssp CEEEEEECCTTCBHHHHHHSGGGTTCCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEEEECTTSCEEEEECC
T ss_pred eEEEEEeCCCCCCHHHHHHHhccccCCCHHHHHHHHHHHHHHHHHHHHCC---EecCCCCHHHEEEeccCCCCceEEEcc
Confidence 567899999732 12334999999999999999999999999 9999999999999 7788899999
Q ss_pred ccceeecCCCcccccceeeeeccCCCChhhhc--------cCCCCccceEEeehhhhhhhhhCCCCCCcCCCCc--hhhh
Q 045315 309 FGMARMFGGDELQSNTKRIVGTYGYMSPEYAL--------RGLFSIKSDVFSFGVLLLETLSSKKNTHFYNTDS--LTLL 378 (476)
Q Consensus 309 FGla~~~~~~~~~~~~~~~~gt~~y~aPE~l~--------~~~~s~ksDVwSlGvvl~elltG~~p~~~~~~~~--~~~~ 378 (476)
||+++....... .....||..|+|||.+. +..++.++|||||||++|||++|+.||....... ....
T Consensus 160 fg~a~~~~~~~~---~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~~~ 236 (319)
T 4euu_A 160 FGAARELEDDEQ---FVSLYGTEEYLHPDMYERAVLRKDHQKKYGATVDLWSIGVTFYHAATGSLPFRPFEGPRRNKEVM 236 (319)
T ss_dssp CTTCEECCTTCC---BCCCCSCGGGCCHHHHHHHTSCCCCCCCBCTTHHHHHHHHHHHHHHHSSCSEECTTCGGGCHHHH
T ss_pred CCCceecCCCCc---eeecccCCCccCHHHhhhccccccccCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCccchhHHHH
Confidence 999987654332 22356899999999986 4778999999999999999999999986543211 1111
Q ss_pred hhhhhhhcCCCccc----------cc-CcccCCCCCHHHHHHHHHHHHHchhhcccCCCCHHHHHHHHhccc
Q 045315 379 GHAWNLWNDGRTWE----------LM-DPISQNGASYPILKRYINVALLCVQEKAADRPAMSEVVSMLSNEF 439 (476)
Q Consensus 379 ~~~~~~~~~~~~~~----------~~-d~~~~~~~~~~~~~~l~~li~~Cl~~dP~~RPt~~eVl~~L~~~~ 439 (476)
.............. .. +..............+.+++.+||+.||++|||++|+++...+..
T Consensus 237 ~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~ll~~~L~~dP~~R~s~~ell~h~~d~~ 308 (319)
T 4euu_A 237 YKIITGKPSGAISGVQKAENGPIDWSGDMPVSCSLSRGLQVLLTPVLANILEADQEKCWGFDQFFAETSDIL 308 (319)
T ss_dssp HHHHHHCCTTCCEEEECSTTCCEEEESSCCTTCSSCHHHHHHHHHHHHHHSCCCTTTSCCHHHHHHHHHHHT
T ss_pred HHHhcCCCcccchhhhcccCCccccCccCCcccccchhHHHHhHHHHHHhccCChhhhccHHHhhhccHHHh
Confidence 11111110000000 00 001112344567788999999999999999999999999988754
|
| >1nxk_A MAP kinase-activated protein kinase 2; MK2, phosphorylation, staurosporine, transfe; HET: STU; 2.70A {Homo sapiens} SCOP: d.144.1.7 PDB: 1kwp_A* 1ny3_A* 2onl_C | Back alignment and structure |
|---|
Probab=99.94 E-value=1.7e-27 Score=243.98 Aligned_cols=178 Identities=17% Similarity=0.219 Sum_probs=129.7
Q ss_pred cccceeeccCCCC--------CCCCCCChhhHHHHHHHHHHHHHHHhhcCCCceeecCCCccceEecC---CCCceeccc
Q 045315 241 DEISFWYESYNNP--------TKKGLLCWGTRVRIIEGIAQGLLYLHQYSRLRVIHRDLKASNILLDK---DMNPKISDF 309 (476)
Q Consensus 241 ~~~~l~~Ey~~~~--------~~~~~L~~~~~~~i~~qIa~gL~yLH~~~~~~ivH~DLkp~NILld~---~~~~kL~DF 309 (476)
+..+++|||++.+ .....+++.++..++.||+.||+|||+.+ |+||||||+|||++. ++.+||+||
T Consensus 132 ~~~~lv~E~~~gg~L~~~l~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~---ivHrDlkp~Nill~~~~~~~~~kl~DF 208 (400)
T 1nxk_A 132 KCLLIVMECLDGGELFSRIQDRGDQAFTEREASEIMKSIGEAIQYLHSIN---IAHRDVKPENLLYTSKRPNAILKLTDF 208 (400)
T ss_dssp EEEEEEEECCCSEEHHHHHHCC---CCBHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEESSSSTTCCEEECCC
T ss_pred cEEEEEEEeCCCCcHHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHHCC---ccccCcCcceEEEecCCCCccEEEEec
Confidence 3467899999832 22456999999999999999999999999 999999999999997 788999999
Q ss_pred cceeecCCCcccccceeeeeccCCCChhhhccCCCCccceEEeehhhhhhhhhCCCCCCcCCCCch--hhhhhhhhhhcC
Q 045315 310 GMARMFGGDELQSNTKRIVGTYGYMSPEYALRGLFSIKSDVFSFGVLLLETLSSKKNTHFYNTDSL--TLLGHAWNLWND 387 (476)
Q Consensus 310 Gla~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~s~ksDVwSlGvvl~elltG~~p~~~~~~~~~--~~~~~~~~~~~~ 387 (476)
|+++...... ......||..|+|||++.+..++.++|||||||++|||++|+.||........ ..... ...
T Consensus 209 G~a~~~~~~~---~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~~~~~----i~~ 281 (400)
T 1nxk_A 209 GFAKETTSHN---SLTTPCYTPYYVAPEVLGPEKYDKSCDMWSLGVIMYILLCGYPPFYSNHGLAISPGMKTR----IRM 281 (400)
T ss_dssp TTCEECC--------------CTTCCGGGSCCCCSSSHHHHHHHHHHHHHHHHSSCSCCCCTTCSSCCSHHHH----HHH
T ss_pred ccccccCCCC---ccccCCCCCCccCHhhcCCCCCCCcccHHHHHHHHHHHHhCCCCCCCCccccccHHHHHH----HHc
Confidence 9998764322 12345789999999999999999999999999999999999999975442111 11111 111
Q ss_pred CCcccccCcccCCCCCHHHHHHHHHHHHHchhhcccCCCCHHHHHHH
Q 045315 388 GRTWELMDPISQNGASYPILKRYINVALLCVQEKAADRPAMSEVVSM 434 (476)
Q Consensus 388 ~~~~~~~d~~~~~~~~~~~~~~l~~li~~Cl~~dP~~RPt~~eVl~~ 434 (476)
+.. .... .........+.+++.+||+.||++|||+.|+++.
T Consensus 282 ~~~-~~~~-----~~~~~~s~~~~~li~~~L~~dP~~Rpt~~eil~h 322 (400)
T 1nxk_A 282 GQY-EFPN-----PEWSEVSEEVKMLIRNLLKTEPTQRMTITEFMNH 322 (400)
T ss_dssp TCC-CCCT-----TTTTTSCHHHHHHHHTTSCSSGGGSCCHHHHHHS
T ss_pred Ccc-cCCC-----cccccCCHHHHHHHHHHCCCChhHCcCHHHHhcC
Confidence 111 0000 0111234578899999999999999999999874
|
| >1k9a_A Carboxyl-terminal SRC kinase; COOH-terminal SRC kinase, CSK, SFK, signal transduction, SH2, SH3, SRC homology, tyrosine kinase; 2.50A {Rattus norvegicus} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1jeg_A | Back alignment and structure |
|---|
Probab=99.94 E-value=4.6e-28 Score=251.98 Aligned_cols=175 Identities=23% Similarity=0.287 Sum_probs=137.5
Q ss_pred ccceeeccCCCCC--------CCCCCChhhHHHHHHHHHHHHHHHhhcCCCceeecCCCccceEecCCCCceecccccee
Q 045315 242 EISFWYESYNNPT--------KKGLLCWGTRVRIIEGIAQGLLYLHQYSRLRVIHRDLKASNILLDKDMNPKISDFGMAR 313 (476)
Q Consensus 242 ~~~l~~Ey~~~~~--------~~~~L~~~~~~~i~~qIa~gL~yLH~~~~~~ivH~DLkp~NILld~~~~~kL~DFGla~ 313 (476)
..+++|||++.++ ....+++.+++.++.||+.||+|||+++ |+||||||+|||++.++.+||+|||+++
T Consensus 261 ~~~iv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~qi~~~l~~LH~~~---ivHrDlkp~Nill~~~~~~kl~DfG~a~ 337 (450)
T 1k9a_A 261 GLYIVTEYMAKGSLVDYLRSRGRSVLGGDCLLKFSLDVCEAMEYLEGNN---FVHRDLAARNVLVSEDNVAKVSDFGLTK 337 (450)
T ss_dssp CEEEEEECCTTCBHHHHHHHHCTTTCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCCGGGEEECTTSCEEECCCTTCE
T ss_pred ceEEEEEecCCCcHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCC---eeCCCCCHhhEEECCCCCEEEeeCCCcc
Confidence 5789999998432 2345899999999999999999999999 9999999999999999999999999998
Q ss_pred ecCCCcccccceeeeeccCCCChhhhccCCCCccceEEeehhhhhhhhh-CCCCCCcCCCCchhhhhhhhhhhcCCCccc
Q 045315 314 MFGGDELQSNTKRIVGTYGYMSPEYALRGLFSIKSDVFSFGVLLLETLS-SKKNTHFYNTDSLTLLGHAWNLWNDGRTWE 392 (476)
Q Consensus 314 ~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~s~ksDVwSlGvvl~ellt-G~~p~~~~~~~~~~~~~~~~~~~~~~~~~~ 392 (476)
...... ....++..|+|||.+.+..++.++|||||||++|||++ |+.||....... ... ....+...
T Consensus 338 ~~~~~~-----~~~~~~~~y~aPE~~~~~~~~~~sDvwslG~~l~el~t~g~~P~~~~~~~~--~~~----~i~~~~~~- 405 (450)
T 1k9a_A 338 EASSTQ-----DTGKLPVKWTAPEALREKKFSTKSDVWSFGILLWEIYSFGRVPYPRIPLKD--VVP----RVEKGYKM- 405 (450)
T ss_dssp ECC-----------CCCTTTSCHHHHHSSCCCHHHHHHHHHHHHHHHHTTTCCSSTTSCTTT--HHH----HHHTTCCC-
T ss_pred cccccc-----cCCCCCcceeCHHHhcCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCCHHH--HHH----HHHcCCCC-
Confidence 643221 12356889999999999999999999999999999998 999987543221 111 11111111
Q ss_pred ccCcccCCCCCHHHHHHHHHHHHHchhhcccCCCCHHHHHHHHhccc
Q 045315 393 LMDPISQNGASYPILKRYINVALLCVQEKAADRPAMSEVVSMLSNEF 439 (476)
Q Consensus 393 ~~d~~~~~~~~~~~~~~l~~li~~Cl~~dP~~RPt~~eVl~~L~~~~ 439 (476)
..+......+.+++.+||+.||++|||+.+|++.|+.+.
T Consensus 406 --------~~p~~~~~~l~~li~~cl~~dp~~Rpt~~~l~~~L~~i~ 444 (450)
T 1k9a_A 406 --------DAPDGCPPAVYDVMKNCWHLDAATRPTFLQLREQLEHIR 444 (450)
T ss_dssp --------CCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHH
T ss_pred --------CCCCcCCHHHHHHHHHHcCCChhHCcCHHHHHHHHHHHH
Confidence 111223457889999999999999999999999999875
|
| >2c30_A Serine/threonine-protein kinase PAK 6; CRIB domain, ATP-binding, transferase, nucleotide-binding; HET: SEP; 1.6A {Homo sapiens} PDB: 2f57_A* 2j0i_A* 2cdz_A* 2q0n_A* 2x4z_A* 2bva_A* | Back alignment and structure |
|---|
Probab=99.94 E-value=6.5e-28 Score=239.58 Aligned_cols=176 Identities=24% Similarity=0.354 Sum_probs=136.7
Q ss_pred cccceeeccCCCCC-----CCCCCChhhHHHHHHHHHHHHHHHhhcCCCceeecCCCccceEecCCCCceeccccceeec
Q 045315 241 DEISFWYESYNNPT-----KKGLLCWGTRVRIIEGIAQGLLYLHQYSRLRVIHRDLKASNILLDKDMNPKISDFGMARMF 315 (476)
Q Consensus 241 ~~~~l~~Ey~~~~~-----~~~~L~~~~~~~i~~qIa~gL~yLH~~~~~~ivH~DLkp~NILld~~~~~kL~DFGla~~~ 315 (476)
+..+++|||++... ....+++.++..++.||+.||+|||+.+ |+||||||+||+++.++.+||+|||++...
T Consensus 115 ~~~~lv~e~~~~~~L~~~l~~~~l~~~~~~~i~~qi~~~L~~LH~~~---ivH~Dlkp~NIll~~~~~~kl~Dfg~~~~~ 191 (321)
T 2c30_A 115 EELWVLMEFLQGGALTDIVSQVRLNEEQIATVCEAVLQALAYLHAQG---VIHRDIKSDSILLTLDGRVKLSDFGFCAQI 191 (321)
T ss_dssp TEEEEEECCCCSCBHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEECTTCCEEECCCTTCEEC
T ss_pred CEEEEEEecCCCCCHHHHHHhcCCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCCHHHEEECCCCcEEEeeeeeeeec
Confidence 46789999998432 3457999999999999999999999998 999999999999999999999999999876
Q ss_pred CCCcccccceeeeeccCCCChhhhccCCCCccceEEeehhhhhhhhhCCCCCCcCCCCchhhhhhhhhhhcCCCcccccC
Q 045315 316 GGDELQSNTKRIVGTYGYMSPEYALRGLFSIKSDVFSFGVLLLETLSSKKNTHFYNTDSLTLLGHAWNLWNDGRTWELMD 395 (476)
Q Consensus 316 ~~~~~~~~~~~~~gt~~y~aPE~l~~~~~s~ksDVwSlGvvl~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~d 395 (476)
...... .....||..|+|||.+.+..++.++||||||+++|||++|+.||..... ...... ......
T Consensus 192 ~~~~~~--~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~il~el~~g~~pf~~~~~--~~~~~~----~~~~~~----- 258 (321)
T 2c30_A 192 SKDVPK--RKSLVGTPYWMAPEVISRSLYATEVDIWSLGIMVIEMVDGEPPYFSDSP--VQAMKR----LRDSPP----- 258 (321)
T ss_dssp CSSSCC--BCCCCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCTTTTSCH--HHHHHH----HHHSSC-----
T ss_pred ccCccc--cccccCCccccCHhhhcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCH--HHHHHH----HhcCCC-----
Confidence 543222 2335789999999999999999999999999999999999999864321 111111 111111
Q ss_pred cccCCCCCHHHHHHHHHHHHHchhhcccCCCCHHHHHHH
Q 045315 396 PISQNGASYPILKRYINVALLCVQEKAADRPAMSEVVSM 434 (476)
Q Consensus 396 ~~~~~~~~~~~~~~l~~li~~Cl~~dP~~RPt~~eVl~~ 434 (476)
+.. .........+.+++.+||+.||++|||+.|+++.
T Consensus 259 ~~~--~~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~h 295 (321)
T 2c30_A 259 PKL--KNSHKVSPVLRDFLERMLVRDPQERATAQELLDH 295 (321)
T ss_dssp CCC--TTGGGSCHHHHHHHHHHSCSSTTTSCCHHHHHTS
T ss_pred CCc--CccccCCHHHHHHHHHHccCChhhCcCHHHHhcC
Confidence 000 0111234568899999999999999999999863
|
| >3kfa_A Tyrosine-protein kinase ABL1; CML, drug resistance, inhibitor, ATP-binding, nucleotide-binding, oncogene, TRAN; HET: B91; 1.22A {Mus musculus} SCOP: d.144.1.7 PDB: 2qoh_A* 3kf4_A* 3k5v_A* 1fpu_A* 1m52_A* 1iep_A* 2hzn_A* 1opj_A* 3ms9_A* 3mss_A* 3ik3_A* 2z60_A* 2e2b_A* 3pyy_A* 3oxz_A* 2g1t_A* 3ue4_A* 3oy3_A* 2hiw_A* 2v7a_A* ... | Back alignment and structure |
|---|
Probab=99.94 E-value=3.2e-28 Score=236.94 Aligned_cols=181 Identities=23% Similarity=0.300 Sum_probs=141.5
Q ss_pred cccceeeccCCC--------CCCCCCCChhhHHHHHHHHHHHHHHHhhcCCCceeecCCCccceEecCCCCceeccccce
Q 045315 241 DEISFWYESYNN--------PTKKGLLCWGTRVRIIEGIAQGLLYLHQYSRLRVIHRDLKASNILLDKDMNPKISDFGMA 312 (476)
Q Consensus 241 ~~~~l~~Ey~~~--------~~~~~~L~~~~~~~i~~qIa~gL~yLH~~~~~~ivH~DLkp~NILld~~~~~kL~DFGla 312 (476)
+..++++||++. ......+++.+++.++.||+.||+|||+.+ |+||||||+||+++.++.+||+|||++
T Consensus 82 ~~~~~v~e~~~~~~L~~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~---i~H~dikp~Nil~~~~~~~~l~Dfg~~ 158 (288)
T 3kfa_A 82 PPFYIITEFMTYGNLLDYLRECNRQEVSAVVLLYMATQISSAMEYLEKKN---FIHRDLAARNCLVGENHLVKVADFGLS 158 (288)
T ss_dssp SSEEEEEECCTTEEHHHHHHHCCTTTSCHHHHHHHHHHHHHHHHHHHHHT---CCCSCCSGGGEEECGGGCEEECCCCGG
T ss_pred CCEEEEEEcCCCCcHHHHHHhcccCCccHhHHHHHHHHHHHHHHHHHHCC---ccCCCCCcceEEEcCCCCEEEccCccc
Confidence 457889999972 224567999999999999999999999999 999999999999999999999999999
Q ss_pred eecCCCcccccceeeeeccCCCChhhhccCCCCccceEEeehhhhhhhhh-CCCCCCcCCCCchhhhhhhhhhhcCCCcc
Q 045315 313 RMFGGDELQSNTKRIVGTYGYMSPEYALRGLFSIKSDVFSFGVLLLETLS-SKKNTHFYNTDSLTLLGHAWNLWNDGRTW 391 (476)
Q Consensus 313 ~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~s~ksDVwSlGvvl~ellt-G~~p~~~~~~~~~~~~~~~~~~~~~~~~~ 391 (476)
......... ......++..|+|||.+.+..++.++||||||+++|+|++ |+.||....... .... .....
T Consensus 159 ~~~~~~~~~-~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~ll~~g~~p~~~~~~~~--~~~~----~~~~~-- 229 (288)
T 3kfa_A 159 RLMTGDTYT-AHAGAKFPIKWTAPESLAYNKFSIKSDVWAFGVLLWEIATYGMSPYPGIDLSQ--VYEL----LEKDY-- 229 (288)
T ss_dssp GTSCSSSSE-EETTEEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCGGG--HHHH----HHTTC--
T ss_pred eeccCCccc-cccCCccccCcCChhhhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCHHH--HHHH----HhccC--
Confidence 876543322 2223457889999999999999999999999999999999 888886543221 1111 11110
Q ss_pred cccCcccCCCCCHHHHHHHHHHHHHchhhcccCCCCHHHHHHHHhcccc
Q 045315 392 ELMDPISQNGASYPILKRYINVALLCVQEKAADRPAMSEVVSMLSNEFV 440 (476)
Q Consensus 392 ~~~d~~~~~~~~~~~~~~l~~li~~Cl~~dP~~RPt~~eVl~~L~~~~~ 440 (476)
....+......+.+++.+||+.||++|||+.++++.|+.+..
T Consensus 230 -------~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~~~~~l~~~~~ 271 (288)
T 3kfa_A 230 -------RMERPEGCPEKVYELMRACWQWNPSDRPSFAEIHQAFETMFQ 271 (288)
T ss_dssp -------CCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHH
T ss_pred -------CCCCCCCCCHHHHHHHHHHhCCChhhCcCHHHHHHHHHHHHH
Confidence 011112234578899999999999999999999999988753
|
| >3ll6_A Cyclin G-associated kinase; transferase, protein kinase, serine/threonine kinase, cyclin clathrine, membrane trafficking, structural genomics; 2.10A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.94 E-value=3.2e-28 Score=241.82 Aligned_cols=189 Identities=20% Similarity=0.201 Sum_probs=126.0
Q ss_pred cccceeeccCCC--------CCCCCCCChhhHHHHHHHHHHHHHHHhhcCCCceeecCCCccceEecCCCCceeccccce
Q 045315 241 DEISFWYESYNN--------PTKKGLLCWGTRVRIIEGIAQGLLYLHQYSRLRVIHRDLKASNILLDKDMNPKISDFGMA 312 (476)
Q Consensus 241 ~~~~l~~Ey~~~--------~~~~~~L~~~~~~~i~~qIa~gL~yLH~~~~~~ivH~DLkp~NILld~~~~~kL~DFGla 312 (476)
..+++++||++. ......+++.+++.++.||+.||+|||+++ .+|+||||||+|||++.++.+||+|||++
T Consensus 107 ~~~~lv~e~~~g~L~~~l~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~-~~ivH~Dikp~NIl~~~~~~~kl~Dfg~~ 185 (337)
T 3ll6_A 107 AEFLLLTELCKGQLVEFLKKMESRGPLSCDTVLKIFYQTCRAVQHMHRQK-PPIIHRDLKVENLLLSNQGTIKLCDFGSA 185 (337)
T ss_dssp EEEEEEEECCSEEHHHHHHHHHTTCSCCHHHHHHHHHHHHHHHHHHHTSS-SCCBCCCCCGGGCEECTTSCEEBCCCTTC
T ss_pred ceEEEEEEecCCCHHHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHhCC-CCEEEccCCcccEEECCCCCEEEecCccc
Confidence 347788899872 123557999999999999999999999875 34999999999999999999999999999
Q ss_pred eecCCCcccc----------cceeeeeccCCCChhhh---ccCCCCccceEEeehhhhhhhhhCCCCCCcCCCCchhhhh
Q 045315 313 RMFGGDELQS----------NTKRIVGTYGYMSPEYA---LRGLFSIKSDVFSFGVLLLETLSSKKNTHFYNTDSLTLLG 379 (476)
Q Consensus 313 ~~~~~~~~~~----------~~~~~~gt~~y~aPE~l---~~~~~s~ksDVwSlGvvl~elltG~~p~~~~~~~~~~~~~ 379 (476)
+......... ......|++.|+|||.+ .+..++.++|||||||++|||++|+.||....... ..
T Consensus 186 ~~~~~~~~~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~~~Dv~slG~il~el~~g~~p~~~~~~~~--~~- 262 (337)
T 3ll6_A 186 TTISHYPDYSWSAQRRALVEEEITRNTTPMYRTPEIIDLYSNFPIGEKQDIWALGCILYLLCFRQHPFEDGAKLR--IV- 262 (337)
T ss_dssp BCCSSCC-------------------------------CCTTSCSSHHHHHHHHHHHHHHHHHSSCCC------------
T ss_pred eeccccCcccccccccccchhhccccCCCCcCChhhhhccccCCCChHHhHHHHHHHHHHHHhCCCCCcchhHHH--hh-
Confidence 8765432111 11134589999999998 56678999999999999999999999986432111 00
Q ss_pred hhhhhhcCCCcccccCcccCCCCCHHHHHHHHHHHHHchhhcccCCCCHHHHHHHHhccccCCCCCCCC
Q 045315 380 HAWNLWNDGRTWELMDPISQNGASYPILKRYINVALLCVQEKAADRPAMSEVVSMLSNEFVNLPAPQQP 448 (476)
Q Consensus 380 ~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~l~~li~~Cl~~dP~~RPt~~eVl~~L~~~~~~~~~p~~p 448 (476)
. +.. ...........+.+++.+||+.||++||++.|+++.|+.+....+.++.+
T Consensus 263 ------~-~~~--------~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~e~l~~l~~~~~~~~~~~~~ 316 (337)
T 3ll6_A 263 ------N-GKY--------SIPPHDTQYTVFHSLIRAMLQVNPEERLSIAEVVHQLQEIAAARNVNPKS 316 (337)
T ss_dssp ----------C--------CCCTTCCSSGGGHHHHHHHSCSSGGGSCCHHHHHHHHHHHHHHTTCCTTS
T ss_pred ------c-Ccc--------cCCcccccchHHHHHHHHHccCChhhCcCHHHHHHHHHHHHhccCCCCCc
Confidence 0 000 00001111234778999999999999999999999999987554444333
|
| >2pmi_A Negative RE, cyclin-dependent protein kinase PHO85; cyclin-dependent kinase, signaling protein,transfera cycle complex; HET: MES AGS; 2.90A {Saccharomyces cerevisiae} PDB: 2pk9_A* | Back alignment and structure |
|---|
Probab=99.94 E-value=1.6e-27 Score=236.10 Aligned_cols=186 Identities=23% Similarity=0.310 Sum_probs=133.5
Q ss_pred cccceeeccCCC-----------CCCCCCCChhhHHHHHHHHHHHHHHHhhcCCCceeecCCCccceEecCCCCceeccc
Q 045315 241 DEISFWYESYNN-----------PTKKGLLCWGTRVRIIEGIAQGLLYLHQYSRLRVIHRDLKASNILLDKDMNPKISDF 309 (476)
Q Consensus 241 ~~~~l~~Ey~~~-----------~~~~~~L~~~~~~~i~~qIa~gL~yLH~~~~~~ivH~DLkp~NILld~~~~~kL~DF 309 (476)
+..+++|||++. ......+++..+..++.||+.||+|||+++ |+||||||+|||++.++.+||+||
T Consensus 76 ~~~~lv~e~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~qi~~aL~~lH~~~---ivH~Dlkp~NIl~~~~~~~kl~Df 152 (317)
T 2pmi_A 76 NKLTLVFEFMDNDLKKYMDSRTVGNTPRGLELNLVKYFQWQLLQGLAFCHENK---ILHRDLKPQNLLINKRGQLKLGDF 152 (317)
T ss_dssp TEEEEEEECCCCBHHHHHHHHHSSSCCCCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEECTTCCEEECCC
T ss_pred CeEEEEEEecCCCHHHHHHhccccccccCCCHHHHHHHHHHHHHHHHHHHHCC---eeeCCCChHHeEEcCCCCEEECcC
Confidence 457888999872 122346999999999999999999999999 999999999999999999999999
Q ss_pred cceeecCCCcccccceeeeeccCCCChhhhcc-CCCCccceEEeehhhhhhhhhCCCCCCcCCCCchhhhhhhhhhhcC-
Q 045315 310 GMARMFGGDELQSNTKRIVGTYGYMSPEYALR-GLFSIKSDVFSFGVLLLETLSSKKNTHFYNTDSLTLLGHAWNLWND- 387 (476)
Q Consensus 310 Gla~~~~~~~~~~~~~~~~gt~~y~aPE~l~~-~~~s~ksDVwSlGvvl~elltG~~p~~~~~~~~~~~~~~~~~~~~~- 387 (476)
|+++....... ......||..|+|||.+.+ ..++.++|||||||++|||++|+.||....... ...........
T Consensus 153 g~~~~~~~~~~--~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~--~~~~i~~~~~~~ 228 (317)
T 2pmi_A 153 GLARAFGIPVN--TFSSEVVTLWYRAPDVLMGSRTYSTSIDIWSCGCILAEMITGKPLFPGTNDEE--QLKLIFDIMGTP 228 (317)
T ss_dssp SSCEETTSCCC--CCCCCCSCCTTCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHH--HHHHHHHHHCSC
T ss_pred ccceecCCCcc--cCCCCcccccccCchHhhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCChHH--HHHHHHHHhCCC
Confidence 99987653221 1223468999999999976 468999999999999999999999987543211 11111100000
Q ss_pred -CCcccc------cCccc------------CCCCCHHHHHHHHHHHHHchhhcccCCCCHHHHHH
Q 045315 388 -GRTWEL------MDPIS------------QNGASYPILKRYINVALLCVQEKAADRPAMSEVVS 433 (476)
Q Consensus 388 -~~~~~~------~d~~~------------~~~~~~~~~~~l~~li~~Cl~~dP~~RPt~~eVl~ 433 (476)
...... ..+.. ...........+.+++.+||+.||++|||++|+++
T Consensus 229 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dP~~Rpt~~e~l~ 293 (317)
T 2pmi_A 229 NESLWPSVTKLPKYNPNIQQRPPRDLRQVLQPHTKEPLDGNLMDFLHGLLQLNPDMRLSAKQALH 293 (317)
T ss_dssp CTTTCGGGGGCTTCCTTCCCCCCCCSHHHHGGGCSSCCCHHHHHHHHHHSCSSGGGSCCHHHHTT
T ss_pred ChhHhhhhhhhhhcccccccccchhHHHhhcccccccCCHHHHHHHHHHCCCCcccCCCHHHHhC
Confidence 000000 00000 00001122357889999999999999999999875
|
| >3gen_A Tyrosine-protein kinase BTK; bruton'S tyrosine kinase, 4-amino-5-(4-phenoxyphenyl)-5H- pyrrolo[3, 2-D]pyrimidin-7-YL-cyclopentane, TEC-family; HET: B43; 1.60A {Homo sapiens} PDB: 3k54_A* 3pj2_A* 3piy_A* 3piz_A* 3pj1_A* 3pix_A* 3pj3_A* 3p08_A 3ocs_A* 3oct_A* 1k2p_A | Back alignment and structure |
|---|
Probab=99.94 E-value=1.2e-28 Score=239.49 Aligned_cols=180 Identities=24% Similarity=0.323 Sum_probs=139.1
Q ss_pred cccceeeccCCCC-------CCCCCCChhhHHHHHHHHHHHHHHHhhcCCCceeecCCCccceEecCCCCceecccccee
Q 045315 241 DEISFWYESYNNP-------TKKGLLCWGTRVRIIEGIAQGLLYLHQYSRLRVIHRDLKASNILLDKDMNPKISDFGMAR 313 (476)
Q Consensus 241 ~~~~l~~Ey~~~~-------~~~~~L~~~~~~~i~~qIa~gL~yLH~~~~~~ivH~DLkp~NILld~~~~~kL~DFGla~ 313 (476)
+.++++|||++.. ..+..+++.++..++.||+.||+|||+++ |+||||||+||+++.++.+||+|||+++
T Consensus 92 ~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~---i~H~dikp~Nili~~~~~~kl~Dfg~~~ 168 (283)
T 3gen_A 92 RPIFIITEYMANGCLLNYLREMRHRFQTQQLLEMCKDVCEAMEYLESKQ---FLHRDLAARNCLVNDQGVVKVSDFGLSR 168 (283)
T ss_dssp SSEEEEECCCTTCBHHHHHHCGGGCCCHHHHHHHHHHHHHHHHHHHHTT---CCCSSCSGGGEEECTTSCEEECSTTGGG
T ss_pred CCeEEEEeccCCCcHHHHHHHhccCCCHHHHHHHHHHHHHHHHHHHHCC---ccCCCCccceEEEcCCCCEEEccccccc
Confidence 4678899999733 22467999999999999999999999999 9999999999999999999999999998
Q ss_pred ecCCCcccccceeeeeccCCCChhhhccCCCCccceEEeehhhhhhhhh-CCCCCCcCCCCchhhhhhhhhhhcCCCccc
Q 045315 314 MFGGDELQSNTKRIVGTYGYMSPEYALRGLFSIKSDVFSFGVLLLETLS-SKKNTHFYNTDSLTLLGHAWNLWNDGRTWE 392 (476)
Q Consensus 314 ~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~s~ksDVwSlGvvl~ellt-G~~p~~~~~~~~~~~~~~~~~~~~~~~~~~ 392 (476)
......... .....++..|+|||.+.+..++.++||||||+++|||++ |+.||...... ...... ..+..
T Consensus 169 ~~~~~~~~~-~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~~l~~l~t~g~~p~~~~~~~--~~~~~~----~~~~~-- 239 (283)
T 3gen_A 169 YVLDDEYTS-SVGSKFPVRWSPPEVLMYSKFSSKSDIWAFGVLMWEIYSLGKMPYERFTNS--ETAEHI----AQGLR-- 239 (283)
T ss_dssp GBCCHHHHS-TTSTTSCGGGCCHHHHHHCCCSHHHHHHHHHHHHHHHHTTTCCTTTTSCHH--HHHHHH----HTTCC--
T ss_pred ccccccccc-ccCCccCcccCCHHHhccCCCCchhhHHHHHHHHHHHHhCCCCCccccChh--HHHHHH----hcccC--
Confidence 664332111 112345778999999999999999999999999999998 99998654311 111111 11100
Q ss_pred ccCcccCCCCCHHHHHHHHHHHHHchhhcccCCCCHHHHHHHHhccc
Q 045315 393 LMDPISQNGASYPILKRYINVALLCVQEKAADRPAMSEVVSMLSNEF 439 (476)
Q Consensus 393 ~~d~~~~~~~~~~~~~~l~~li~~Cl~~dP~~RPt~~eVl~~L~~~~ 439 (476)
...+....+.+.+++.+||+.||++|||+.++++.|+++.
T Consensus 240 -------~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~ll~~L~~~~ 279 (283)
T 3gen_A 240 -------LYRPHLASEKVYTIMYSCWHEKADERPTFKILLSNILDVM 279 (283)
T ss_dssp -------CCCCTTCCHHHHHHHHHTTCSSGGGSCCHHHHHHHHHHHH
T ss_pred -------CCCCCcCCHHHHHHHHHHccCChhHCcCHHHHHHHHHHHh
Confidence 0011112356889999999999999999999999998865
|
| >1ob3_A PFPK5, cell division control protein 2 homolog; transferase, serine/threonine-protein kinase, ATP-binding, phosphorylation, CDK; 1.9A {Plasmodium falciparum} SCOP: d.144.1.7 PDB: 1v0p_A* 1v0o_A* 1v0b_A | Back alignment and structure |
|---|
Probab=99.94 E-value=7.3e-28 Score=235.02 Aligned_cols=186 Identities=20% Similarity=0.261 Sum_probs=131.5
Q ss_pred cccceeeccCCC------CCCCCCCChhhHHHHHHHHHHHHHHHhhcCCCceeecCCCccceEecCCCCceeccccceee
Q 045315 241 DEISFWYESYNN------PTKKGLLCWGTRVRIIEGIAQGLLYLHQYSRLRVIHRDLKASNILLDKDMNPKISDFGMARM 314 (476)
Q Consensus 241 ~~~~l~~Ey~~~------~~~~~~L~~~~~~~i~~qIa~gL~yLH~~~~~~ivH~DLkp~NILld~~~~~kL~DFGla~~ 314 (476)
+..+++|||++. ....+.+++.++..++.||+.||+|||+++ |+||||||+||+++.++.+||+|||+++.
T Consensus 73 ~~~~lv~e~~~~~l~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~---i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~ 149 (288)
T 1ob3_A 73 KRLVLVFEHLDQDLKKLLDVCEGGLESVTAKSFLLQLLNGIAYCHDRR---VLHRDLKPQNLLINREGELKIADFGLARA 149 (288)
T ss_dssp SCEEEEEECCSEEHHHHHHTSTTCCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEECTTSCEEECCTTHHHH
T ss_pred CeEEEEEEecCCCHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCCHHHEEEcCCCCEEEeECccccc
Confidence 467889999882 123467999999999999999999999999 99999999999999999999999999987
Q ss_pred cCCCcccccceeeeeccCCCChhhhcc-CCCCccceEEeehhhhhhhhhCCCCCCcCCCCchhhhhhhhhhhcCC---Cc
Q 045315 315 FGGDELQSNTKRIVGTYGYMSPEYALR-GLFSIKSDVFSFGVLLLETLSSKKNTHFYNTDSLTLLGHAWNLWNDG---RT 390 (476)
Q Consensus 315 ~~~~~~~~~~~~~~gt~~y~aPE~l~~-~~~s~ksDVwSlGvvl~elltG~~p~~~~~~~~~~~~~~~~~~~~~~---~~ 390 (476)
...... ......+|..|+|||.+.+ ..++.++|||||||++|||++|+.||....... ............ ..
T Consensus 150 ~~~~~~--~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~--~~~~~~~~~~~~~~~~~ 225 (288)
T 1ob3_A 150 FGIPVR--KYTHEIVTLWYRAPDVLMGSKKYSTTIDIWSVGCIFAEMVNGTPLFPGVSEAD--QLMRIFRILGTPNSKNW 225 (288)
T ss_dssp HCC-----------CCCTTCCHHHHTTCCSCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHH--HHHHHHHHHCCCCTTTS
T ss_pred cCcccc--ccccccccccccCchheeCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHH--HHHHHHHHHCCCChhhc
Confidence 643221 1223468999999999876 458999999999999999999999987543111 111111110000 00
Q ss_pred c-----cccCcccC-------CCCCHHHHHHHHHHHHHchhhcccCCCCHHHHHH
Q 045315 391 W-----ELMDPISQ-------NGASYPILKRYINVALLCVQEKAADRPAMSEVVS 433 (476)
Q Consensus 391 ~-----~~~d~~~~-------~~~~~~~~~~l~~li~~Cl~~dP~~RPt~~eVl~ 433 (476)
. ...++... ..........+.+++.+||+.||++|||++|+++
T Consensus 226 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~ 280 (288)
T 1ob3_A 226 PNVTELPKYDPNFTVYEPLPWESFLKGLDESGIDLLSKMLKLDPNQRITAKQALE 280 (288)
T ss_dssp TTGGGSTTCCTTCCCCCCCCGGGTCCSCCHHHHHHHHHHTCSSTTTSCCHHHHHT
T ss_pred hhhhcccccccccccccCccHHHHhhhcCHHHHHHHHHHcCCCcccCCCHHHHhc
Confidence 0 00000000 0011123467889999999999999999999875
|
| >1p4o_A Insulin-like growth factor I receptor protein; IGF-1R, kinase domain, hormone-growth factor complex; 1.50A {Homo sapiens} SCOP: d.144.1.7 PDB: 1m7n_A 3lvp_A* 3lw0_A* 1jqh_A* 2zm3_A* 3f5p_A* 3i81_A* 2oj9_A* 3nw5_A* 3nw6_A* 3nw7_A* 3o23_A* 3qqu_A* 3d94_A* 1k3a_A* 2z8c_A* 1ir3_A* 1gag_A* 1irk_A 3bu3_A* ... | Back alignment and structure |
|---|
Probab=99.94 E-value=5.7e-28 Score=239.19 Aligned_cols=181 Identities=24% Similarity=0.352 Sum_probs=140.1
Q ss_pred cccceeeccCCCCC----------------CCCCCChhhHHHHHHHHHHHHHHHhhcCCCceeecCCCccceEecCCCCc
Q 045315 241 DEISFWYESYNNPT----------------KKGLLCWGTRVRIIEGIAQGLLYLHQYSRLRVIHRDLKASNILLDKDMNP 304 (476)
Q Consensus 241 ~~~~l~~Ey~~~~~----------------~~~~L~~~~~~~i~~qIa~gL~yLH~~~~~~ivH~DLkp~NILld~~~~~ 304 (476)
+..+++|||++..+ ....+++.++++++.||+.||+|||+++ |+||||||+||+++.++.+
T Consensus 101 ~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~---i~H~dikp~NIli~~~~~~ 177 (322)
T 1p4o_A 101 QPTLVIMELMTRGDLKSYLRSLRPAMANNPVLAPPSLSKMIQMAGEIADGMAYLNANK---FVHRDLAARNCMVAEDFTV 177 (322)
T ss_dssp SSCEEEEECCTTCBHHHHHHHHHHHHHHCTTCCCCCHHHHHHHHHHHHHHHHHHHHTT---CBCSCCSGGGEEECTTCCE
T ss_pred CccEEEEEeCCCCcHHHHHHHhchhhccCCCCCCcCHHHHHHHHHHHHHHHHHHHHCC---CccCCCccceEEEcCCCeE
Confidence 45788899987321 1256799999999999999999999999 9999999999999999999
Q ss_pred eeccccceeecCCCcccccceeeeeccCCCChhhhccCCCCccceEEeehhhhhhhhh-CCCCCCcCCCCchhhhhhhhh
Q 045315 305 KISDFGMARMFGGDELQSNTKRIVGTYGYMSPEYALRGLFSIKSDVFSFGVLLLETLS-SKKNTHFYNTDSLTLLGHAWN 383 (476)
Q Consensus 305 kL~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~s~ksDVwSlGvvl~ellt-G~~p~~~~~~~~~~~~~~~~~ 383 (476)
||+|||+++...............++..|+|||.+.+..++.++||||||+++|||++ |+.||..... .....
T Consensus 178 kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~g~~p~~~~~~--~~~~~---- 251 (322)
T 1p4o_A 178 KIGDFGMTRDIYETDYYRKGGKGLLPVRWMSPESLKDGVFTTYSDVWSFGVVLWEIATLAEQPYQGLSN--EQVLR---- 251 (322)
T ss_dssp EECCTTCCCGGGGGGCEEGGGSSEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHHTSCCTTTTSCH--HHHHH----
T ss_pred EECcCccccccccccccccccCCCCCCCccChhhhccCCCCchhhHHHHHHHHHHHHhcCCCccccCCH--HHHHH----
Confidence 9999999986644332222333467889999999999999999999999999999999 7888764321 11111
Q ss_pred hhcCCCcccccCcccCCCCCHHHHHHHHHHHHHchhhcccCCCCHHHHHHHHhccc
Q 045315 384 LWNDGRTWELMDPISQNGASYPILKRYINVALLCVQEKAADRPAMSEVVSMLSNEF 439 (476)
Q Consensus 384 ~~~~~~~~~~~d~~~~~~~~~~~~~~l~~li~~Cl~~dP~~RPt~~eVl~~L~~~~ 439 (476)
....+.... ........+.+++.+||+.||++|||+.|+++.|++..
T Consensus 252 ~~~~~~~~~---------~~~~~~~~l~~li~~~l~~dp~~Rps~~e~l~~L~~~~ 298 (322)
T 1p4o_A 252 FVMEGGLLD---------KPDNCPDMLFELMRMCWQYNPKMRPSFLEIISSIKEEM 298 (322)
T ss_dssp HHHTTCCCC---------CCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHGGGS
T ss_pred HHHcCCcCC---------CCCCCCHHHHHHHHHHcCCCcccCcCHHHHHHHHHHhh
Confidence 111111111 11223456889999999999999999999999999875
|
| >3cc6_A Protein tyrosine kinase 2 beta; focal adhesion kinase, structural genomics, structural genom consortium, SGC, ATP-binding, membrane; 1.60A {Homo sapiens} PDB: 3fzs_A* 3et7_A 3fzo_A* 3fzr_A* 3fzp_A* 3fzt_A* 3h3c_A* | Back alignment and structure |
|---|
Probab=99.94 E-value=2e-28 Score=237.82 Aligned_cols=180 Identities=24% Similarity=0.330 Sum_probs=136.9
Q ss_pred cccceeeccCCCCC-------CCCCCChhhHHHHHHHHHHHHHHHhhcCCCceeecCCCccceEecCCCCceecccccee
Q 045315 241 DEISFWYESYNNPT-------KKGLLCWGTRVRIIEGIAQGLLYLHQYSRLRVIHRDLKASNILLDKDMNPKISDFGMAR 313 (476)
Q Consensus 241 ~~~~l~~Ey~~~~~-------~~~~L~~~~~~~i~~qIa~gL~yLH~~~~~~ivH~DLkp~NILld~~~~~kL~DFGla~ 313 (476)
+..++++||++... .+..+++.++..++.||+.||+|||+++ |+||||||+||+++.++.+||+|||++.
T Consensus 85 ~~~~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~---i~H~dlkp~Nil~~~~~~~kl~Dfg~~~ 161 (281)
T 3cc6_A 85 EPTWIIMELYPYGELGHYLERNKNSLKVLTLVLYSLQICKAMAYLESIN---CVHRDIAVRNILVASPECVKLGDFGLSR 161 (281)
T ss_dssp SSCEEEEECCTTCBHHHHHHHHTTTCCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCSGGGEEEEETTEEEECCCCGGG
T ss_pred CCCEEEEecCCCCCHHHHHHhccccCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCccceEEECCCCcEEeCccCCCc
Confidence 45678999988432 2456999999999999999999999999 9999999999999999999999999998
Q ss_pred ecCCCcccccceeeeeccCCCChhhhccCCCCccceEEeehhhhhhhhh-CCCCCCcCCCCchhhhhhhhhhhcCCCccc
Q 045315 314 MFGGDELQSNTKRIVGTYGYMSPEYALRGLFSIKSDVFSFGVLLLETLS-SKKNTHFYNTDSLTLLGHAWNLWNDGRTWE 392 (476)
Q Consensus 314 ~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~s~ksDVwSlGvvl~ellt-G~~p~~~~~~~~~~~~~~~~~~~~~~~~~~ 392 (476)
........ ......++..|+|||.+.+..++.++||||||+++|||++ |+.||....... ..... ..+....
T Consensus 162 ~~~~~~~~-~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~llt~g~~p~~~~~~~~--~~~~~----~~~~~~~ 234 (281)
T 3cc6_A 162 YIEDEDYY-KASVTRLPIKWMSPESINFRRFTTASDVWMFAVCMWEILSFGKQPFFWLENKD--VIGVL----EKGDRLP 234 (281)
T ss_dssp CC----------CCCCCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCTTTTSCGGG--HHHHH----HHTCCCC
T ss_pred cccccccc-ccccCCCCcceeCchhhccCCCCchhccHHHHHHHHHHHhCCCCCcccCChHH--HHHHH----hcCCCCC
Confidence 76543221 1222456788999999998999999999999999999998 999986443221 11111 1111100
Q ss_pred ccCcccCCCCCHHHHHHHHHHHHHchhhcccCCCCHHHHHHHHhccc
Q 045315 393 LMDPISQNGASYPILKRYINVALLCVQEKAADRPAMSEVVSMLSNEF 439 (476)
Q Consensus 393 ~~d~~~~~~~~~~~~~~l~~li~~Cl~~dP~~RPt~~eVl~~L~~~~ 439 (476)
.+......+.+++.+||+.||++||++.|+++.|+.+.
T Consensus 235 ---------~~~~~~~~l~~li~~~l~~~p~~Rps~~ell~~L~~~~ 272 (281)
T 3cc6_A 235 ---------KPDLCPPVLYTLMTRCWDYDPSDRPRFTELVCSLSDVY 272 (281)
T ss_dssp ---------CCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHH
T ss_pred ---------CCCCCCHHHHHHHHHHccCCchhCcCHHHHHHHHHHHH
Confidence 11112356889999999999999999999999998864
|
| >3p1a_A MYT1 kinase, membrane-associated tyrosine- and threonine-speci inhibitory kinase; structural genomics, structural genomics consortium, SGC; 1.70A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.94 E-value=1.5e-28 Score=242.85 Aligned_cols=169 Identities=20% Similarity=0.245 Sum_probs=128.7
Q ss_pred cccceeeccCCCC------CCCCCCChhhHHHHHHHHHHHHHHHhhcCCCceeecCCCccceEecCCCCceeccccceee
Q 045315 241 DEISFWYESYNNP------TKKGLLCWGTRVRIIEGIAQGLLYLHQYSRLRVIHRDLKASNILLDKDMNPKISDFGMARM 314 (476)
Q Consensus 241 ~~~~l~~Ey~~~~------~~~~~L~~~~~~~i~~qIa~gL~yLH~~~~~~ivH~DLkp~NILld~~~~~kL~DFGla~~ 314 (476)
+..+++|||+... ..+..+++.++..++.||+.||+|||+.+ |+||||||+|||++.++.+||+|||++..
T Consensus 130 ~~~~lv~e~~~~~L~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~---ivH~Dikp~NIll~~~~~~kl~DFG~a~~ 206 (311)
T 3p1a_A 130 GILYLQTELCGPSLQQHCEAWGASLPEAQVWGYLRDTLLALAHLHSQG---LVHLDVKPANIFLGPRGRCKLGDFGLLVE 206 (311)
T ss_dssp TEEEEEEECCCCBHHHHHHHHCSCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEECGGGCEEECCCTTCEE
T ss_pred CEEEEEEeccCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCC---EecCCCCHHHEEECCCCCEEEccceeeee
Confidence 4578899999621 12457999999999999999999999998 99999999999999999999999999987
Q ss_pred cCCCcccccceeeeeccCCCChhhhccCCCCccceEEeehhhhhhhhhCCCCCCcCCCCchhhhhhhhhhhcCCCccccc
Q 045315 315 FGGDELQSNTKRIVGTYGYMSPEYALRGLFSIKSDVFSFGVLLLETLSSKKNTHFYNTDSLTLLGHAWNLWNDGRTWELM 394 (476)
Q Consensus 315 ~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~s~ksDVwSlGvvl~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 394 (476)
...... .....||+.|+|||++.+ .++.++|||||||++|||++|..++.... . +.....+...
T Consensus 207 ~~~~~~---~~~~~gt~~y~aPE~~~~-~~~~~~DiwslG~il~el~~g~~~~~~~~----~-----~~~~~~~~~~--- 270 (311)
T 3p1a_A 207 LGTAGA---GEVQEGDPRYMAPELLQG-SYGTAADVFSLGLTILEVACNMELPHGGE----G-----WQQLRQGYLP--- 270 (311)
T ss_dssp CC---------CCCCCGGGCCGGGGGT-CCSTHHHHHHHHHHHHHHHHTCCCCSSHH----H-----HHHHTTTCCC---
T ss_pred cccCCC---CcccCCCccccCHhHhcC-CCCchhhHHHHHHHHHHHHhCCCCCCCcc----H-----HHHHhccCCC---
Confidence 654322 223468999999998875 78999999999999999999977654211 0 1111111110
Q ss_pred CcccCCCCCHHHHHHHHHHHHHchhhcccCCCCHHHHHH
Q 045315 395 DPISQNGASYPILKRYINVALLCVQEKAADRPAMSEVVS 433 (476)
Q Consensus 395 d~~~~~~~~~~~~~~l~~li~~Cl~~dP~~RPt~~eVl~ 433 (476)
+.. .......+.+++.+||+.||++|||++|+++
T Consensus 271 -~~~----~~~~~~~l~~li~~~L~~dP~~Rpt~~ell~ 304 (311)
T 3p1a_A 271 -PEF----TAGLSSELRSVLVMMLEPDPKLRATAEALLA 304 (311)
T ss_dssp -HHH----HTTSCHHHHHHHHHHSCSSTTTSCCHHHHHT
T ss_pred -ccc----ccCCCHHHHHHHHHHcCCChhhCcCHHHHHh
Confidence 000 0112357889999999999999999999985
|
| >2zmd_A Dual specificity protein kinase TTK; MPS1, T686A, ATP-binding, nucleotide-bindi phosphoprotein, serine/threonine-protein kinase; HET: 537 7PE; 2.88A {Homo sapiens} PDB: 2zmc_A* | Back alignment and structure |
|---|
Probab=99.94 E-value=3.6e-28 Score=248.13 Aligned_cols=177 Identities=24% Similarity=0.246 Sum_probs=127.3
Q ss_pred cccceeeccCCC-----CCCCCCCChhhHHHHHHHHHHHHHHHhhcCCCceeecCCCccceEecCCCCceeccccceeec
Q 045315 241 DEISFWYESYNN-----PTKKGLLCWGTRVRIIEGIAQGLLYLHQYSRLRVIHRDLKASNILLDKDMNPKISDFGMARMF 315 (476)
Q Consensus 241 ~~~~l~~Ey~~~-----~~~~~~L~~~~~~~i~~qIa~gL~yLH~~~~~~ivH~DLkp~NILld~~~~~kL~DFGla~~~ 315 (476)
+.++++|||... ..+...+++.++..++.||+.||+|||+.+ |+||||||+|||++ ++.+||+|||+++.+
T Consensus 129 ~~~~lv~E~~~~~L~~~l~~~~~~~~~~~~~i~~qi~~aL~~lH~~~---ivHrDlkp~NIll~-~~~~kl~DFG~a~~~ 204 (390)
T 2zmd_A 129 QYIYMVMECGNIDLNSWLKKKKSIDPWERKSYWKNMLEAVHTIHQHG---IVHSDLKPANFLIV-DGMLKLIDFGIANQM 204 (390)
T ss_dssp SEEEEEEECCSEEHHHHHHHCSSCCHHHHHHHHHHHHHHHHHHHTTT---CCCCCCCGGGEEES-SSCEEECCCSSSCCC
T ss_pred CEEEEEEecCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCC---eeecCCCHHHEEEE-CCeEEEEecCccccc
Confidence 357888896541 123457899999999999999999999999 99999999999996 578999999999876
Q ss_pred CCCcccccceeeeeccCCCChhhhcc-----------CCCCccceEEeehhhhhhhhhCCCCCCcCCCCchhhhhhhhhh
Q 045315 316 GGDELQSNTKRIVGTYGYMSPEYALR-----------GLFSIKSDVFSFGVLLLETLSSKKNTHFYNTDSLTLLGHAWNL 384 (476)
Q Consensus 316 ~~~~~~~~~~~~~gt~~y~aPE~l~~-----------~~~s~ksDVwSlGvvl~elltG~~p~~~~~~~~~~~~~~~~~~ 384 (476)
.............||+.|+|||++.+ ..++.++|||||||++|||++|+.||.........+ ...
T Consensus 205 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~~~~DiwSlGvil~ell~G~~Pf~~~~~~~~~~----~~~ 280 (390)
T 2zmd_A 205 QPDTTSVVKDSQVGAVNYMPPEAIKDMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGKTPFQQIINQISKL----HAI 280 (390)
T ss_dssp ---------CCSCCCGGGCCHHHHHCC------------CCHHHHHHHHHHHHHHHHHSSCTTTTCCCHHHHH----HHH
T ss_pred cCCCccccCCCCCcCCCccChHHhhhccccccccccccCCCChhhHHHHHHHHHHHHHCCCcchhhhHHHHHH----HHH
Confidence 54332222334579999999999865 468999999999999999999999986432211111 111
Q ss_pred hcCCCcccccCcccCCCCCHHHHHHHHHHHHHchhhcccCCCCHHHHHHH
Q 045315 385 WNDGRTWELMDPISQNGASYPILKRYINVALLCVQEKAADRPAMSEVVSM 434 (476)
Q Consensus 385 ~~~~~~~~~~d~~~~~~~~~~~~~~l~~li~~Cl~~dP~~RPt~~eVl~~ 434 (476)
...... ...+......+.+++.+||+.||++||++.|+++.
T Consensus 281 ~~~~~~---------~~~~~~~~~~~~~li~~~L~~dP~~Rps~~ell~h 321 (390)
T 2zmd_A 281 IDPNHE---------IEFPDIPEKDLQDVLKCCLKRDPKQRISIPELLAH 321 (390)
T ss_dssp HCTTSC---------CCCCCCSCHHHHHHHHHHTCSSTTTSCCHHHHHTS
T ss_pred hCcccc---------CCCCccchHHHHHHHHHHcccChhhCCCHHHHhhC
Confidence 111111 01111113568899999999999999999999863
|
| >2pvf_A Fibroblast growth factor receptor 2; kinase domain fold consisting of N- and C-lobes, transferase; HET: PTR ACP; 1.80A {Homo sapiens} PDB: 3cly_A* 2pzr_A* 2pzp_A* 2pvy_A* 2pz5_A* 2q0b_A* 2pwl_A* 2py3_A* 3ri1_A* 1gjo_A 1oec_A* 3b2t_A* 3gql_A* 3gqi_A* 1fgk_A 1fgi_A* 1agw_A 2fgi_A* 3js2_A* 3ky2_A ... | Back alignment and structure |
|---|
Probab=99.94 E-value=5.4e-28 Score=241.11 Aligned_cols=182 Identities=23% Similarity=0.308 Sum_probs=140.6
Q ss_pred cccceeeccCCCCC----------------------CCCCCChhhHHHHHHHHHHHHHHHhhcCCCceeecCCCccceEe
Q 045315 241 DEISFWYESYNNPT----------------------KKGLLCWGTRVRIIEGIAQGLLYLHQYSRLRVIHRDLKASNILL 298 (476)
Q Consensus 241 ~~~~l~~Ey~~~~~----------------------~~~~L~~~~~~~i~~qIa~gL~yLH~~~~~~ivH~DLkp~NILl 298 (476)
+..++++||++..+ ....+++.+++.++.||+.||+|||+.+ |+||||||+||++
T Consensus 114 ~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~---ivH~Dlkp~NIll 190 (334)
T 2pvf_A 114 GPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTFKDLVSCTYQLARGMEYLASQK---CIHRDLAARNVLV 190 (334)
T ss_dssp SCCEEEEECCTTCBHHHHHHTTSCTTCCSCC--------CCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEE
T ss_pred CceEEEEECCCCCcHHHHHHHhccccccccccccccccccCCHHHHHHHHHHHHHHHHHHHhCC---eeCCCCccceEEE
Confidence 46788999987311 1235899999999999999999999999 9999999999999
Q ss_pred cCCCCceeccccceeecCCCcccccceeeeeccCCCChhhhccCCCCccceEEeehhhhhhhhh-CCCCCCcCCCCchhh
Q 045315 299 DKDMNPKISDFGMARMFGGDELQSNTKRIVGTYGYMSPEYALRGLFSIKSDVFSFGVLLLETLS-SKKNTHFYNTDSLTL 377 (476)
Q Consensus 299 d~~~~~kL~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~s~ksDVwSlGvvl~ellt-G~~p~~~~~~~~~~~ 377 (476)
+.++.+||+|||+++...............++..|+|||.+.+..++.++||||||+++|||++ |+.||..... ..+
T Consensus 191 ~~~~~~kL~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~p~~~~~~--~~~ 268 (334)
T 2pvf_A 191 TENNVMKIADFGLARDINNIDYYKKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFTLGGSPYPGIPV--EEL 268 (334)
T ss_dssp CTTCCEEECCCTTCEECTTTSSEECCSCCCCCGGGCCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCSSTTCCH--HHH
T ss_pred cCCCCEEEccccccccccccccccccCCCCcccceeChHHhcCCCcChHHHHHHHHHHHHHHHhCCCCCcCcCCH--HHH
Confidence 9999999999999987765433233333456788999999999899999999999999999999 9998864431 111
Q ss_pred hhhhhhhhcCCCcccccCcccCCCCCHHHHHHHHHHHHHchhhcccCCCCHHHHHHHHhcccc
Q 045315 378 LGHAWNLWNDGRTWELMDPISQNGASYPILKRYINVALLCVQEKAADRPAMSEVVSMLSNEFV 440 (476)
Q Consensus 378 ~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~l~~li~~Cl~~dP~~RPt~~eVl~~L~~~~~ 440 (476)
... ...+... ..+......+.+++.+||+.||++||++.|+++.|+.+..
T Consensus 269 ~~~----~~~~~~~---------~~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~~L~~l~~ 318 (334)
T 2pvf_A 269 FKL----LKEGHRM---------DKPANCTNELYMMMRDCWHAVPSQRPTFKQLVEDLDRILT 318 (334)
T ss_dssp HHH----HHHTCCC---------CCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHH
T ss_pred HHH----HhcCCCC---------CCCccCCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHh
Confidence 111 1111110 1112233568899999999999999999999999999864
|
| >2wqm_A Serine/threonine-protein kinase NEK7; ATP-binding, polymorphism, metal-binding, cell cycle kinase, mitosis, cytoplasm, magnesium, transferase; 2.10A {Homo sapiens} PDB: 2wqn_A* | Back alignment and structure |
|---|
Probab=99.94 E-value=1e-27 Score=236.23 Aligned_cols=189 Identities=22% Similarity=0.296 Sum_probs=133.5
Q ss_pred cccceeeccCCCCC----------CCCCCChhhHHHHHHHHHHHHHHHhhcCCCceeecCCCccceEecCCCCceecccc
Q 045315 241 DEISFWYESYNNPT----------KKGLLCWGTRVRIIEGIAQGLLYLHQYSRLRVIHRDLKASNILLDKDMNPKISDFG 310 (476)
Q Consensus 241 ~~~~l~~Ey~~~~~----------~~~~L~~~~~~~i~~qIa~gL~yLH~~~~~~ivH~DLkp~NILld~~~~~kL~DFG 310 (476)
+..++++||++... .+..+++.++..++.||+.||+|||+.+ ++||||||+||+++.++.+||+|||
T Consensus 105 ~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~---i~H~dl~p~NIl~~~~~~~kl~Dfg 181 (310)
T 2wqm_A 105 NELNIVLELADAGDLSRMIKHFKKQKRLIPERTVWKYFVQLCSALEHMHSRR---VMHRDIKPANVFITATGVVKLGDLG 181 (310)
T ss_dssp TEEEEEEECCCSCBHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCCGGGEEECTTSCEEECCC-
T ss_pred CcEEEEEecCCCCCHHHHHHHhcccccCCCHHHHHHHHHHHHHHHHHHhhCC---eeCCCCcHHHEEEcCCCCEEEEecc
Confidence 46788999997421 3567999999999999999999999999 9999999999999999999999999
Q ss_pred ceeecCCCcccccceeeeeccCCCChhhhccCCCCccceEEeehhhhhhhhhCCCCCCcCCCCchhhhhhhhhhhcCCCc
Q 045315 311 MARMFGGDELQSNTKRIVGTYGYMSPEYALRGLFSIKSDVFSFGVLLLETLSSKKNTHFYNTDSLTLLGHAWNLWNDGRT 390 (476)
Q Consensus 311 la~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~s~ksDVwSlGvvl~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~ 390 (476)
++........ ......|+..|+|||.+.+..++.++||||||+++|||++|+.||............. ......
T Consensus 182 ~~~~~~~~~~--~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~~~~~----~~~~~~ 255 (310)
T 2wqm_A 182 LGRFFSSKTT--AAHSLVGTPYYMSPERIHENGYNFKSDIWSLGCLLYEMAALQSPFYGDKMNLYSLCKK----IEQCDY 255 (310)
T ss_dssp -------------------CCSSCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCTTC---CCHHHHHHH----HHTTCS
T ss_pred ceeeecCCCc--cccccCCCeeEeChHHhCCCCCCchhhHHHHHHHHHHHHhCCCCCcccchhHHHHHHH----hhcccC
Confidence 9987643321 1223568999999999999999999999999999999999999986543222222111 111111
Q ss_pred ccccCcccCCCCCHHHHHHHHHHHHHchhhcccCCCCHHHHHHHHhccccCCCCCC
Q 045315 391 WELMDPISQNGASYPILKRYINVALLCVQEKAADRPAMSEVVSMLSNEFVNLPAPQ 446 (476)
Q Consensus 391 ~~~~d~~~~~~~~~~~~~~l~~li~~Cl~~dP~~RPt~~eVl~~L~~~~~~~~~p~ 446 (476)
... ........+.+++.+||+.||++||++.+|++.|+++......|+
T Consensus 256 ~~~--------~~~~~~~~l~~li~~~l~~dp~~Rps~~~il~~l~~l~~~~~~~~ 303 (310)
T 2wqm_A 256 PPL--------PSDHYSEELRQLVNMCINPDPEKRPDVTYVYDVAKRMHACTASSL 303 (310)
T ss_dssp CCC--------CTTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHHHC---
T ss_pred CCC--------cccccCHHHHHHHHHHcCCChhhCCCHHHHHHHHHHHHHhhhhhh
Confidence 110 011223568899999999999999999999999999875544443
|
| >3fe3_A MAP/microtubule affinity-regulating kinase 3; serine/threonine protein kinase, MARK;PAR-1, UBA domai TAK1;P78;MARK3, ATP-binding; 1.90A {Homo sapiens} PDB: 2qnj_A 1y8g_A* 1zmw_A 1zmu_A 1zmv_A 2wzj_A 2r0i_A 2hak_A 3iec_A | Back alignment and structure |
|---|
Probab=99.94 E-value=6.5e-28 Score=240.52 Aligned_cols=172 Identities=24% Similarity=0.297 Sum_probs=135.0
Q ss_pred cccceeeccCCCCC------CCCCCChhhHHHHHHHHHHHHHHHhhcCCCceeecCCCccceEecCCCCceeccccceee
Q 045315 241 DEISFWYESYNNPT------KKGLLCWGTRVRIIEGIAQGLLYLHQYSRLRVIHRDLKASNILLDKDMNPKISDFGMARM 314 (476)
Q Consensus 241 ~~~~l~~Ey~~~~~------~~~~L~~~~~~~i~~qIa~gL~yLH~~~~~~ivH~DLkp~NILld~~~~~kL~DFGla~~ 314 (476)
+..+++|||++... ..+.+++.++..++.||+.||+|||+++ |+||||||+|||++.++.+||+|||+++.
T Consensus 87 ~~~~lv~e~~~~~~L~~~l~~~~~l~~~~~~~~~~qi~~al~~lH~~~---ivHrDlkp~NIll~~~~~~kl~DFG~a~~ 163 (328)
T 3fe3_A 87 KTLYLIMEYASGGEVFDYLVAHGRMKEKEARSKFRQIVSAVQYCHQKR---IVHRDLKAENLLLDADMNIKIADFGFSNE 163 (328)
T ss_dssp SEEEEEECCCTTCBHHHHHHHHCCCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEECTTSCEEECSTTCCGG
T ss_pred CEEEEEEECCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCC---EeccCCCHHHEEEcCCCCEEEeeccCcee
Confidence 46789999997432 2457999999999999999999999999 99999999999999999999999999986
Q ss_pred cCCCcccccceeeeeccCCCChhhhccCCCC-ccceEEeehhhhhhhhhCCCCCCcCCCCchhhhhhhhhhhcCCCcccc
Q 045315 315 FGGDELQSNTKRIVGTYGYMSPEYALRGLFS-IKSDVFSFGVLLLETLSSKKNTHFYNTDSLTLLGHAWNLWNDGRTWEL 393 (476)
Q Consensus 315 ~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~s-~ksDVwSlGvvl~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~ 393 (476)
...... .....||+.|+|||.+.+..+. .++|||||||++|||++|+.||...... ..... ...+..
T Consensus 164 ~~~~~~---~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~--~~~~~----i~~~~~--- 231 (328)
T 3fe3_A 164 FTVGGK---LDAFCGAPPYAAPELFQGKKYDGPEVDVWSLGVILYTLVSGSLPFDGQNLK--ELRER----VLRGKY--- 231 (328)
T ss_dssp GSSSCG---GGTTSSSGGGCCHHHHHTCCCCSHHHHHHHHHHHHHHHHHSSCSSCCSSHH--HHHHH----HHHCCC---
T ss_pred cCCCCc---cccccCCcceeCcccccCCCcCCchhhhhhhHHHHHHHHhCCCCCCCCCHH--HHHHH----HHhCCC---
Confidence 654322 2235689999999999887764 8999999999999999999998754311 11111 111111
Q ss_pred cCcccCCCCCHHHHHHHHHHHHHchhhcccCCCCHHHHHHH
Q 045315 394 MDPISQNGASYPILKRYINVALLCVQEKAADRPAMSEVVSM 434 (476)
Q Consensus 394 ~d~~~~~~~~~~~~~~l~~li~~Cl~~dP~~RPt~~eVl~~ 434 (476)
..+......+.+++.+||+.||.+|||++|+++.
T Consensus 232 -------~~p~~~s~~~~~li~~~L~~dP~~R~t~~eil~h 265 (328)
T 3fe3_A 232 -------RIPFYMSTDCENLLKRFLVLNPIKRGTLEQIMKD 265 (328)
T ss_dssp -------CCCTTSCHHHHHHHHHHCCSSTTTSCCHHHHTTC
T ss_pred -------CCCCCCCHHHHHHHHHHCCCChhHCcCHHHHhcC
Confidence 0111224568899999999999999999999863
|
| >3oz6_A Mitogen-activated protein kinase 1, serine/threon protein kinase; structural genomics consortium, SGC, transferase; 2.37A {Cryptosporidium parvum iowa II} | Back alignment and structure |
|---|
Probab=99.94 E-value=2.9e-28 Score=248.32 Aligned_cols=189 Identities=20% Similarity=0.249 Sum_probs=133.1
Q ss_pred cccceeeccCCCC----CCCCCCChhhHHHHHHHHHHHHHHHhhcCCCceeecCCCccceEecCCCCceeccccceeecC
Q 045315 241 DEISFWYESYNNP----TKKGLLCWGTRVRIIEGIAQGLLYLHQYSRLRVIHRDLKASNILLDKDMNPKISDFGMARMFG 316 (476)
Q Consensus 241 ~~~~l~~Ey~~~~----~~~~~L~~~~~~~i~~qIa~gL~yLH~~~~~~ivH~DLkp~NILld~~~~~kL~DFGla~~~~ 316 (476)
..++++|||++.. .+...+++..+..++.||+.||+|||+.+ |+||||||+|||++.++.+||+|||+++.+.
T Consensus 84 ~~~~lv~e~~~~~L~~~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~---ivHrDlkp~NIll~~~~~~kl~DFG~a~~~~ 160 (388)
T 3oz6_A 84 RDVYLVFDYMETDLHAVIRANILEPVHKQYVVYQLIKVIKYLHSGG---LLHRDMKPSNILLNAECHVKVADFGLSRSFV 160 (388)
T ss_dssp SCEEEEEECCSEEHHHHHHHTCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEECTTCCEEECCCTTCEESS
T ss_pred CEEEEEecccCcCHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHhCC---EEeCCCCHHHeEEcCCCCEEecCCccccccc
Confidence 3578999999821 12357999999999999999999999999 9999999999999999999999999998764
Q ss_pred CCc-------------------ccccceeeeeccCCCChhhhcc-CCCCccceEEeehhhhhhhhhCCCCCCcCCCCchh
Q 045315 317 GDE-------------------LQSNTKRIVGTYGYMSPEYALR-GLFSIKSDVFSFGVLLLETLSSKKNTHFYNTDSLT 376 (476)
Q Consensus 317 ~~~-------------------~~~~~~~~~gt~~y~aPE~l~~-~~~s~ksDVwSlGvvl~elltG~~p~~~~~~~~~~ 376 (476)
... .........||+.|+|||.+.+ ..++.++|||||||++|||++|++||...+...
T Consensus 161 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlG~il~ell~g~~pf~~~~~~~-- 238 (388)
T 3oz6_A 161 NIRRVTNNIPLSINENTENFDDDQPILTDYVATRWYRAPEILLGSTKYTKGIDMWSLGCILGEILCGKPIFPGSSTMN-- 238 (388)
T ss_dssp SCCCCCCCGGGCCC---------------CCCGGGGCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHH--
T ss_pred ccccccccccccccccccccccccccccCCcccCCcCCHHHhcCCCCCCChhhHHHHHHHHHHHHhCCCCCCCCCHHH--
Confidence 311 0111233579999999999986 678999999999999999999999997543111
Q ss_pred hhhhhhhhhcCCCcccc-----------c----------CcccCC------------CCCHHHHHHHHHHHHHchhhccc
Q 045315 377 LLGHAWNLWNDGRTWEL-----------M----------DPISQN------------GASYPILKRYINVALLCVQEKAA 423 (476)
Q Consensus 377 ~~~~~~~~~~~~~~~~~-----------~----------d~~~~~------------~~~~~~~~~l~~li~~Cl~~dP~ 423 (476)
................+ + ...... .........+.+++.+||+.||+
T Consensus 239 ~~~~i~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dll~~~L~~dP~ 318 (388)
T 3oz6_A 239 QLERIIGVIDFPSNEDVESIQSPFAKTMIESLKEKVEIRQSNKRDIFTKWKNLLLKINPKADCNEEALDLLDKLLQFNPN 318 (388)
T ss_dssp HHHHHHHHHCCCCHHHHHTSCCSSHHHHHHHHHHHCC-----CCCCHHHHHHHHHHHCTTCCCCHHHHHHHHHHCCSSGG
T ss_pred HHHHHHHhcCCCCHHHHHhccCHHHHHHHHhCcccccccCCCHHHhCcchhhhcccccccccCCHHHHHHHHHhhccCcc
Confidence 11111000000000000 0 000000 00001235688999999999999
Q ss_pred CCCCHHHHHHH
Q 045315 424 DRPAMSEVVSM 434 (476)
Q Consensus 424 ~RPt~~eVl~~ 434 (476)
+|||++|+++.
T Consensus 319 ~R~t~~e~l~H 329 (388)
T 3oz6_A 319 KRISANDALKH 329 (388)
T ss_dssp GSCCHHHHTTS
T ss_pred cCCCHHHHhCC
Confidence 99999998865
|
| >2y4i_B KSR2, HKSR2, kinase suppressor of RAS 2; transferase, KSR1; HET: ATP; 3.46A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.94 E-value=1.1e-27 Score=236.72 Aligned_cols=194 Identities=21% Similarity=0.287 Sum_probs=132.1
Q ss_pred cccceeeccCCC-------CCCCCCCChhhHHHHHHHHHHHHHHHhhcCCCceeecCCCccceEecCCCCceecccccee
Q 045315 241 DEISFWYESYNN-------PTKKGLLCWGTRVRIIEGIAQGLLYLHQYSRLRVIHRDLKASNILLDKDMNPKISDFGMAR 313 (476)
Q Consensus 241 ~~~~l~~Ey~~~-------~~~~~~L~~~~~~~i~~qIa~gL~yLH~~~~~~ivH~DLkp~NILld~~~~~kL~DFGla~ 313 (476)
+..++++||++. ...+..+++.++..++.||+.||+|||+++ ++||||||+||+++ ++.+||+|||++.
T Consensus 102 ~~~~iv~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~qi~~al~~lH~~~---i~H~dlkp~NIl~~-~~~~~l~Dfg~~~ 177 (319)
T 2y4i_B 102 PHLAIITSLCKGRTLYSVVRDAKIVLDVNKTRQIAQEIVKGMGYLHAKG---ILHKDLKSKNVFYD-NGKVVITDFGLFS 177 (319)
T ss_dssp SCEEEECBCCCSEEHHHHTTSSCCCCCSHHHHHHHHHHHHHHHHHHHTT---CCCCCCCSTTEEEC---CCEECCCSCCC
T ss_pred CceEEEeecccCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCC---ccccCCChhhEEEe-CCCEEEeecCCcc
Confidence 457889999972 223457999999999999999999999999 99999999999998 6799999999987
Q ss_pred ecCCCc---ccccceeeeeccCCCChhhhcc---------CCCCccceEEeehhhhhhhhhCCCCCCcCCCCchhhhhhh
Q 045315 314 MFGGDE---LQSNTKRIVGTYGYMSPEYALR---------GLFSIKSDVFSFGVLLLETLSSKKNTHFYNTDSLTLLGHA 381 (476)
Q Consensus 314 ~~~~~~---~~~~~~~~~gt~~y~aPE~l~~---------~~~s~ksDVwSlGvvl~elltG~~p~~~~~~~~~~~~~~~ 381 (476)
...... .........|+..|+|||.+.. ..++.++||||||+++|||++|+.||...... .....
T Consensus 178 ~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~--~~~~~- 254 (319)
T 2y4i_B 178 ISGVLQAGRREDKLRIQNGWLCHLAPEIIRQLSPDTEEDKLPFSKHSDVFALGTIWYELHAREWPFKTQPAE--AIIWQ- 254 (319)
T ss_dssp ----------CCSCBCCSGGGGTSCHHHHSCBSCC--CCCSCCCHHHHHHHHHHHHHHHHHSSCSSSSCCHH--HHHHH-
T ss_pred ccccccccccccccccCCCcccccChHHhhhccccccccccCCCchhhHHHHHHHHHHHHhCCCCCCCCCHH--HHHHH-
Confidence 653211 1112223458999999999864 45789999999999999999999998643321 11111
Q ss_pred hhhhcCCCcccccCcccCCCCCHHHHHHHHHHHHHchhhcccCCCCHHHHHHHHhccccCCCCCCCCccee
Q 045315 382 WNLWNDGRTWELMDPISQNGASYPILKRYINVALLCVQEKAADRPAMSEVVSMLSNEFVNLPAPQQPAFSC 452 (476)
Q Consensus 382 ~~~~~~~~~~~~~d~~~~~~~~~~~~~~l~~li~~Cl~~dP~~RPt~~eVl~~L~~~~~~~~~p~~p~~~~ 452 (476)
...+....... ......+.+++.+||+.||++|||+.+++++|+.+.........|+.+.
T Consensus 255 ---~~~~~~~~~~~--------~~~~~~l~~li~~~l~~~p~~Rpt~~~l~~~l~~l~~~~~~~~~~~~~~ 314 (319)
T 2y4i_B 255 ---MGTGMKPNLSQ--------IGMGKEISDILLFCWAFEQEERPTFTKLMDMLEKLPKRNRRLSHPGHFW 314 (319)
T ss_dssp ---HHTTCCCCCCC--------SSCCTTHHHHHHHHHCSSTTTSCCHHHHHHHHTTC--------------
T ss_pred ---hccCCCCCCCc--------CCCCHHHHHHHHHHhcCChhhCcCHHHHHHHHHHHHHhhccCCCCcccc
Confidence 11111111111 0122357899999999999999999999999999886666656665544
|
| >2h8h_A Proto-oncogene tyrosine-protein kinase SRC; SRC kinase, transferase; HET: PTR H8H; 2.20A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 | Back alignment and structure |
|---|
Probab=99.94 E-value=2.2e-28 Score=259.83 Aligned_cols=187 Identities=25% Similarity=0.386 Sum_probs=143.3
Q ss_pred cccceeeccCCCCC--------CCCCCChhhHHHHHHHHHHHHHHHhhcCCCceeecCCCccceEecCCCCceeccccce
Q 045315 241 DEISFWYESYNNPT--------KKGLLCWGTRVRIIEGIAQGLLYLHQYSRLRVIHRDLKASNILLDKDMNPKISDFGMA 312 (476)
Q Consensus 241 ~~~~l~~Ey~~~~~--------~~~~L~~~~~~~i~~qIa~gL~yLH~~~~~~ivH~DLkp~NILld~~~~~kL~DFGla 312 (476)
+.++++|||++.+. ....+++.+++.++.||+.||+|||+++ |+||||||+|||++.++.+||+|||++
T Consensus 334 ~~~~lv~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~---ivHrDlkp~NIll~~~~~~kl~DFG~a 410 (535)
T 2h8h_A 334 EPIYIVTEYMSKGSLLDFLKGETGKYLRLPQLVDMAAQIASGMAYVERMN---YVHRDLRAANILVGENLVCKVADFGLA 410 (535)
T ss_dssp SSCEEEECCCTTEEHHHHHSHHHHTTCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCSGGGEEECGGGCEEECCTTST
T ss_pred ccceEeeehhcCCcHHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHHhCC---eeCCCCCHhhEEEcCCCcEEEcccccc
Confidence 46789999998321 2346999999999999999999999999 999999999999999999999999999
Q ss_pred eecCCCcccccceeeeeccCCCChhhhccCCCCccceEEeehhhhhhhhh-CCCCCCcCCCCchhhhhhhhhhhcCCCcc
Q 045315 313 RMFGGDELQSNTKRIVGTYGYMSPEYALRGLFSIKSDVFSFGVLLLETLS-SKKNTHFYNTDSLTLLGHAWNLWNDGRTW 391 (476)
Q Consensus 313 ~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~s~ksDVwSlGvvl~ellt-G~~p~~~~~~~~~~~~~~~~~~~~~~~~~ 391 (476)
+......... .....++..|+|||.+....++.++|||||||++|||++ |+.||..... ...... ...+...
T Consensus 411 ~~~~~~~~~~-~~~~~~~~~y~aPE~~~~~~~~~~sDvwSlGv~l~el~t~g~~P~~~~~~--~~~~~~----i~~~~~~ 483 (535)
T 2h8h_A 411 RLIEDNEYTA-RQGAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELTTKGRVPYPGMVN--REVLDQ----VERGYRM 483 (535)
T ss_dssp TTCCCHHHHT-TCSTTSCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHTTTTCCSSTTCCH--HHHHHH----HHTTCCC
T ss_pred eecCCCceec-ccCCcCcccccCHHHhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCH--HHHHHH----HHcCCCC
Confidence 8664322111 112346778999999999999999999999999999999 8888864321 111111 1111110
Q ss_pred cccCcccCCCCCHHHHHHHHHHHHHchhhcccCCCCHHHHHHHHhccccCCCCCC
Q 045315 392 ELMDPISQNGASYPILKRYINVALLCVQEKAADRPAMSEVVSMLSNEFVNLPAPQ 446 (476)
Q Consensus 392 ~~~d~~~~~~~~~~~~~~l~~li~~Cl~~dP~~RPt~~eVl~~L~~~~~~~~~p~ 446 (476)
..+......+.+++.+||+.||++|||+++|++.|+.+........
T Consensus 484 ---------~~~~~~~~~l~~li~~cl~~dP~~RPt~~~l~~~L~~~~~~~~~~~ 529 (535)
T 2h8h_A 484 ---------PCPPECPESLHDLMCQCWRKEPEERPTFEYLQAFLEDYFTSTEPQY 529 (535)
T ss_dssp ---------CCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHTSSCCCSCSS
T ss_pred ---------CCCCCCCHHHHHHHHHHcCCChhHCcCHHHHHHHHHHHhhccCccc
Confidence 1112234578899999999999999999999999999876554433
|
| >2a19_B Interferon-induced, double-stranded RNA-activated kinase; transferase, protein biosynthesis, protein synthesis transferase complex; HET: TPO ANP; 2.50A {Homo sapiens} PDB: 2a1a_B* | Back alignment and structure |
|---|
Probab=99.94 E-value=1.9e-27 Score=230.67 Aligned_cols=176 Identities=26% Similarity=0.310 Sum_probs=138.1
Q ss_pred cccceeeccCCCC--------CCCCCCChhhHHHHHHHHHHHHHHHhhcCCCceeecCCCccceEecCCCCceeccccce
Q 045315 241 DEISFWYESYNNP--------TKKGLLCWGTRVRIIEGIAQGLLYLHQYSRLRVIHRDLKASNILLDKDMNPKISDFGMA 312 (476)
Q Consensus 241 ~~~~l~~Ey~~~~--------~~~~~L~~~~~~~i~~qIa~gL~yLH~~~~~~ivH~DLkp~NILld~~~~~kL~DFGla 312 (476)
+..+++|||++.. .....+++.++..++.||+.||+|||+++ |+||||||+||+++.++.+||+|||++
T Consensus 93 ~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~---i~H~dlkp~Nil~~~~~~~kl~Dfg~~ 169 (284)
T 2a19_B 93 KCLFIQMEFCDKGTLEQWIEKRRGEKLDKVLALELFEQITKGVDYIHSKK---LINRDLKPSNIFLVDTKQVKIGDFGLV 169 (284)
T ss_dssp EEEEEEECCCCSCBHHHHHHHGGGSCCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEEEETTEEEECCCTTC
T ss_pred ceEEEEEeccCCCCHHHHHhhccCCCCCHHHHHHHHHHHHHHHHHHHhCC---eeeccCCHHHEEEcCCCCEEECcchhh
Confidence 3467889998842 23457999999999999999999999999 999999999999999999999999999
Q ss_pred eecCCCcccccceeeeeccCCCChhhhccCCCCccceEEeehhhhhhhhhCCCCCCcCCCCchhhhhhhhhhhcCCCccc
Q 045315 313 RMFGGDELQSNTKRIVGTYGYMSPEYALRGLFSIKSDVFSFGVLLLETLSSKKNTHFYNTDSLTLLGHAWNLWNDGRTWE 392 (476)
Q Consensus 313 ~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~s~ksDVwSlGvvl~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~ 392 (476)
........ .....|+..|+|||.+.+..++.++||||||+++|||++|..|+.... . .......+..
T Consensus 170 ~~~~~~~~---~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~~~~~~~~~~----~----~~~~~~~~~~-- 236 (284)
T 2a19_B 170 TSLKNDGK---RTRSKGTLRYMSPEQISSQDYGKEVDLYALGLILAELLHVCDTAFETS----K----FFTDLRDGII-- 236 (284)
T ss_dssp EESSCCSC---CCCCCSCCTTSCHHHHHCSCCCTHHHHHHHHHHHHHHHSCCSSHHHHH----H----HHHHHHTTCC--
T ss_pred eecccccc---ccccCCcccccChhhhccCCCcchhhhHHHHHHHHHHHhcCCcchhHH----H----HHHHhhcccc--
Confidence 87654322 223468999999999999999999999999999999999998763210 0 1111111111
Q ss_pred ccCcccCCCCCHHHHHHHHHHHHHchhhcccCCCCHHHHHHHHhccccCC
Q 045315 393 LMDPISQNGASYPILKRYINVALLCVQEKAADRPAMSEVVSMLSNEFVNL 442 (476)
Q Consensus 393 ~~d~~~~~~~~~~~~~~l~~li~~Cl~~dP~~RPt~~eVl~~L~~~~~~~ 442 (476)
. ......+.+++.+||+.||++||++.|+++.|+.+....
T Consensus 237 ------~----~~~~~~~~~li~~~l~~dp~~Rps~~e~l~~l~~~~~~~ 276 (284)
T 2a19_B 237 ------S----DIFDKKEKTLLQKLLSKKPEDRPNTSEILRTLTVWKKSP 276 (284)
T ss_dssp ------C----TTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHTC--
T ss_pred ------c----ccCCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHhhCC
Confidence 1 112345789999999999999999999999999876443
|
| >1tki_A Titin; serine kinase, muscle, autoinhibition; 2.00A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=99.94 E-value=1.6e-27 Score=236.86 Aligned_cols=175 Identities=19% Similarity=0.242 Sum_probs=135.7
Q ss_pred cccceeeccCCCC-------CCCCCCChhhHHHHHHHHHHHHHHHhhcCCCceeecCCCccceEecC--CCCceeccccc
Q 045315 241 DEISFWYESYNNP-------TKKGLLCWGTRVRIIEGIAQGLLYLHQYSRLRVIHRDLKASNILLDK--DMNPKISDFGM 311 (476)
Q Consensus 241 ~~~~l~~Ey~~~~-------~~~~~L~~~~~~~i~~qIa~gL~yLH~~~~~~ivH~DLkp~NILld~--~~~~kL~DFGl 311 (476)
+..+++|||++.. .....+++.++..++.||+.||+|||+++ |+||||||+|||++. ++.+||+|||+
T Consensus 74 ~~~~lv~e~~~g~~L~~~l~~~~~~~~~~~~~~i~~qi~~al~~lH~~g---ivH~Dlkp~NIl~~~~~~~~~kl~Dfg~ 150 (321)
T 1tki_A 74 EELVMIFEFISGLDIFERINTSAFELNEREIVSYVHQVCEALQFLHSHN---IGHFDIRPENIIYQTRRSSTIKIIEFGQ 150 (321)
T ss_dssp TEEEEEECCCCCCBHHHHHTSSSCCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEESSSSCCCEEECCCTT
T ss_pred CEEEEEEEeCCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCC---CCcCCCCHHHEEEccCCCCCEEEEECCC
Confidence 4688999999832 23457999999999999999999999999 999999999999987 78999999999
Q ss_pred eeecCCCcccccceeeeeccCCCChhhhccCCCCccceEEeehhhhhhhhhCCCCCCcCCCCchhhhhhhhhhhcCCCcc
Q 045315 312 ARMFGGDELQSNTKRIVGTYGYMSPEYALRGLFSIKSDVFSFGVLLLETLSSKKNTHFYNTDSLTLLGHAWNLWNDGRTW 391 (476)
Q Consensus 312 a~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~s~ksDVwSlGvvl~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~ 391 (476)
++...... ......|++.|+|||.+.+..++.++|||||||++|+|++|+.||..... ....... . .+...
T Consensus 151 a~~~~~~~---~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~--~~~~~~i---~-~~~~~ 221 (321)
T 1tki_A 151 ARQLKPGD---NFRLLFTAPEYYAPEVHQHDVVSTATDMWSLGTLVYVLLSGINPFLAETN--QQIIENI---M-NAEYT 221 (321)
T ss_dssp CEECCTTC---EEEEEESCGGGSCHHHHTTCEECHHHHHHHHHHHHHHHHHSSCTTCCSSH--HHHHHHH---H-HTCCC
T ss_pred CeECCCCC---ccccccCChhhcCcHHhcCCCCCchhhHHHHHHHHHHHHhCCCCCcCCCH--HHHHHHH---H-cCCCC
Confidence 98875432 22346789999999999988899999999999999999999999865331 1111111 1 11000
Q ss_pred cccCcccCCCCCHHHHHHHHHHHHHchhhcccCCCCHHHHHH
Q 045315 392 ELMDPISQNGASYPILKRYINVALLCVQEKAADRPAMSEVVS 433 (476)
Q Consensus 392 ~~~d~~~~~~~~~~~~~~l~~li~~Cl~~dP~~RPt~~eVl~ 433 (476)
.+... .......+.+++.+||+.||++|||+.|+++
T Consensus 222 --~~~~~----~~~~s~~~~~li~~~L~~dp~~Rpt~~e~l~ 257 (321)
T 1tki_A 222 --FDEEA----FKEISIEAMDFVDRLLVKERKSRMTASEALQ 257 (321)
T ss_dssp --CCHHH----HTTSCHHHHHHHHTTSCSSGGGSCCHHHHHH
T ss_pred --CChhh----hccCCHHHHHHHHHHcCCChhHCcCHHHHhc
Confidence 00000 0112357889999999999999999999987
|
| >3ork_A Serine/threonine protein kinase; structural genomics, TB structural genomics consortium, TBSG domain, signal transduction; HET: AGS; 1.60A {Mycobacterium tuberculosis} PDB: 3ori_A* 3orl_A* 3oro_A* 3orp_A* 3ort_A* 3f61_A* 1mru_A* 3f69_A* 3orm_A* 1o6y_A* 2fum_A* | Back alignment and structure |
|---|
Probab=99.94 E-value=4.2e-28 Score=239.47 Aligned_cols=192 Identities=24% Similarity=0.332 Sum_probs=131.8
Q ss_pred cceeeccCCCC------CCCCCCChhhHHHHHHHHHHHHHHHhhcCCCceeecCCCccceEecCCCCceeccccceeecC
Q 045315 243 ISFWYESYNNP------TKKGLLCWGTRVRIIEGIAQGLLYLHQYSRLRVIHRDLKASNILLDKDMNPKISDFGMARMFG 316 (476)
Q Consensus 243 ~~l~~Ey~~~~------~~~~~L~~~~~~~i~~qIa~gL~yLH~~~~~~ivH~DLkp~NILld~~~~~kL~DFGla~~~~ 316 (476)
.+++|||++.. ...+.+++.++..++.||+.||+|||+++ |+||||||+||+++.++.+||+|||+++...
T Consensus 91 ~~lv~e~~~g~~L~~~l~~~~~~~~~~~~~~~~qi~~~l~~lH~~~---ivH~dlkp~Nil~~~~~~~kl~Dfg~a~~~~ 167 (311)
T 3ork_A 91 PYIVMEYVDGVTLRDIVHTEGPMTPKRAIEVIADACQALNFSHQNG---IIHRDVKPANIMISATNAVKVMDFGIARAIA 167 (311)
T ss_dssp EEEEEECCCEEEHHHHHHHHCSCCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCCGGGEEEETTSCEEECCCSCC----
T ss_pred cEEEEecCCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCC---CCcCCCCHHHEEEcCCCCEEEeeccCccccc
Confidence 37899999722 12457999999999999999999999999 9999999999999999999999999998765
Q ss_pred CCccc-ccceeeeeccCCCChhhhccCCCCccceEEeehhhhhhhhhCCCCCCcCCCCchhhhhhhhhhhcCCCcccccC
Q 045315 317 GDELQ-SNTKRIVGTYGYMSPEYALRGLFSIKSDVFSFGVLLLETLSSKKNTHFYNTDSLTLLGHAWNLWNDGRTWELMD 395 (476)
Q Consensus 317 ~~~~~-~~~~~~~gt~~y~aPE~l~~~~~s~ksDVwSlGvvl~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~d 395 (476)
..... .......|+..|+|||.+.+..++.++||||||+++|||++|+.||........ ...........
T Consensus 168 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~~l~~ll~g~~pf~~~~~~~~-----~~~~~~~~~~~---- 238 (311)
T 3ork_A 168 DSGNSVTQTAAVIGTAQYLSPEQARGDSVDARSDVYSLGCVLYEVLTGEPPFTGDSPVSV-----AYQHVREDPIP---- 238 (311)
T ss_dssp --------------CCTTCCHHHHHTCCCCHHHHHHHHHHHHHHHHHSSCSCCCSSHHHH-----HHHHHHCCCCC----
T ss_pred ccccccccccccCcCcccCCHHHhcCCCCCchHhHHHHHHHHHHHHhCCCCCCCCChHHH-----HHHHhcCCCCC----
Confidence 43211 222335689999999999999999999999999999999999999865432111 11111111110
Q ss_pred cccCCCCCHHHHHHHHHHHHHchhhcccCCCCHH-HHHHHHhccccCCCCCCCCcc
Q 045315 396 PISQNGASYPILKRYINVALLCVQEKAADRPAMS-EVVSMLSNEFVNLPAPQQPAF 450 (476)
Q Consensus 396 ~~~~~~~~~~~~~~l~~li~~Cl~~dP~~RPt~~-eVl~~L~~~~~~~~~p~~p~~ 450 (476)
+... .......+.+++.+||+.||++||++. ++...|...... ..|..|..
T Consensus 239 ~~~~---~~~~~~~l~~li~~~l~~dP~~R~~~~~~l~~~l~~~~~~-~~~~~~~~ 290 (311)
T 3ork_A 239 PSAR---HEGLSADLDAVVLKALAKNPENRYQTAAEMRADLVRVHNG-EPPEAPKV 290 (311)
T ss_dssp HHHH---STTCCHHHHHHHHHHTCSSGGGSCSSHHHHHHHHHHHHTT-CCCSSCCC
T ss_pred cccc---cCCCCHHHHHHHHHHHhcCHhhChhhHHHHHHHHHHHhcC-CCCCCCcc
Confidence 0000 011235688999999999999999655 455566665433 33444433
|
| >1wak_A Serine/threonine-protein kinase SPRK1; SRPK, transferase, alternative splicing, ATP-binding, chromosome partition, differentiation, mRNA processing; 1.73A {Homo sapiens} PDB: 1wbp_A* 3beg_A* 2x7g_A* | Back alignment and structure |
|---|
Probab=99.94 E-value=2.2e-27 Score=241.33 Aligned_cols=185 Identities=20% Similarity=0.218 Sum_probs=137.0
Q ss_pred cccceeeccCCC-------CCCCCCCChhhHHHHHHHHHHHHHHHhhc-CCCceeecCCCccceEecCCC----------
Q 045315 241 DEISFWYESYNN-------PTKKGLLCWGTRVRIIEGIAQGLLYLHQY-SRLRVIHRDLKASNILLDKDM---------- 302 (476)
Q Consensus 241 ~~~~l~~Ey~~~-------~~~~~~L~~~~~~~i~~qIa~gL~yLH~~-~~~~ivH~DLkp~NILld~~~---------- 302 (476)
...+++|||+.. ......+++.++..++.||+.||+|||++ + |+||||||+|||++.++
T Consensus 118 ~~~~lv~e~~~~~l~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~lH~~~g---ivHrDikp~NIll~~~~~~~~~~~~~~ 194 (397)
T 1wak_A 118 THICMVFEVLGHHLLKWIIKSNYQGLPLPCVKKIIQQVLQGLDYLHTKCR---IIHTDIKPENILLSVNEQYIRRLAAEA 194 (397)
T ss_dssp EEEEEEECCCCCBHHHHHHHTTTSCCCHHHHHHHHHHHHHHHHHHHHTTC---EECCCCSGGGEEECCCHHHHHHHHHHH
T ss_pred ceEEEEEeccCccHHHHHHhcccCCCCHHHHHHHHHHHHHHHHHHHHhCC---EecCCCCHHHeeEeccchhhhhhhhhh
Confidence 357789999972 12346799999999999999999999998 8 99999999999999775
Q ss_pred ---------------------------------------CceeccccceeecCCCcccccceeeeeccCCCChhhhccCC
Q 045315 303 ---------------------------------------NPKISDFGMARMFGGDELQSNTKRIVGTYGYMSPEYALRGL 343 (476)
Q Consensus 303 ---------------------------------------~~kL~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~ 343 (476)
.+||+|||++...... .....||..|+|||.+.+..
T Consensus 195 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~kl~DfG~a~~~~~~-----~~~~~gt~~y~aPE~~~~~~ 269 (397)
T 1wak_A 195 TEWQRSGAPPPSGSAVSTAPATAGNFLVNPLEPKNAEKLKVKIADLGNACWVHKH-----FTEDIQTRQYRSLEVLIGSG 269 (397)
T ss_dssp C---------------------CCTTSCCTTSGGGGGGCCEEECCGGGCEETTBC-----SCSCCSCGGGCCHHHHHTSC
T ss_pred HHHhhcCCCCCCCCccccCCcccccccccccccccccccceEecccccccccccc-----CccCCCCCcccCChhhcCCC
Confidence 7999999999876532 22246899999999999999
Q ss_pred CCccceEEeehhhhhhhhhCCCCCCcCCCCch----hhhhhhhhhhc-------------------CCCcccccCcc---
Q 045315 344 FSIKSDVFSFGVLLLETLSSKKNTHFYNTDSL----TLLGHAWNLWN-------------------DGRTWELMDPI--- 397 (476)
Q Consensus 344 ~s~ksDVwSlGvvl~elltG~~p~~~~~~~~~----~~~~~~~~~~~-------------------~~~~~~~~d~~--- 397 (476)
++.++|||||||++|||++|+.||........ ........... .+....+.+..
T Consensus 270 ~~~~~DiwslG~il~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 349 (397)
T 1wak_A 270 YNTPADIWSTACMAFELATGDYLFEPHSGEEYTRDEDHIALIIELLGKVPRKLIVAGKYSKEFFTKKGDLKHITKLKPWG 349 (397)
T ss_dssp CCTHHHHHHHHHHHHHHHHSSCSCCCCCCSSSCHHHHHHHHHHHHHCSCCHHHHHHCTTGGGTBCTTSSBSSCCCCCCCC
T ss_pred CCcHHHHHHHHHHHHHHhhCCCCCCCCcccccCchHHHHHHHHHhcCCCChHHhhcccccccccCCccccccccccCCcc
Confidence 99999999999999999999999976542211 01100000000 00000000000
Q ss_pred ------cCCCCCHHHHHHHHHHHHHchhhcccCCCCHHHHHH
Q 045315 398 ------SQNGASYPILKRYINVALLCVQEKAADRPAMSEVVS 433 (476)
Q Consensus 398 ------~~~~~~~~~~~~l~~li~~Cl~~dP~~RPt~~eVl~ 433 (476)
............+.+++.+||+.||++|||++|+++
T Consensus 350 ~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~ 391 (397)
T 1wak_A 350 LFEVLVEKYEWSQEEAAGFTDFLLPMLELIPEKRATAAECLR 391 (397)
T ss_dssp HHHHHHHTSCCCHHHHHHHHHHHGGGGCSSGGGSCCHHHHHT
T ss_pred hhHhhhhhcccchhhHHHHHHHHHHHhccChhhcCCHHHHhh
Confidence 001234566778999999999999999999999985
|
| >3byv_A Rhoptry kinase; malaria, transferase, structural genomics, structural genomics consortium, SGC; 1.80A {Toxoplasma gondii} PDB: 2w1z_A | Back alignment and structure |
|---|
Probab=99.94 E-value=7e-28 Score=244.61 Aligned_cols=162 Identities=16% Similarity=0.180 Sum_probs=124.4
Q ss_pred cceeeccCCC------------CCCCCCCChhhHHHHHHHHHHHHHHHhhcCCCceeecCCCccceEecCCCCceecccc
Q 045315 243 ISFWYESYNN------------PTKKGLLCWGTRVRIIEGIAQGLLYLHQYSRLRVIHRDLKASNILLDKDMNPKISDFG 310 (476)
Q Consensus 243 ~~l~~Ey~~~------------~~~~~~L~~~~~~~i~~qIa~gL~yLH~~~~~~ivH~DLkp~NILld~~~~~kL~DFG 310 (476)
.+++|||+.. ......+++..++.|+.||+.||+|||+++ |+||||||+|||++.++.+||+|||
T Consensus 175 ~~lv~E~~~g~L~~~l~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~---ivHrDikp~NIll~~~~~~kL~DFG 251 (377)
T 3byv_A 175 RFFLYPRMQSNLQTFGEVLLSHSSTHKSLVHHARLQLTLQVIRLLASLHHYG---LVHTYLRPVDIVLDQRGGVFLTGFE 251 (377)
T ss_dssp EEEEEECCSEEHHHHHHHHHHTTTTTHHHHHHHHHHHHHHHHHHHHHHHHTT---EECSCCCGGGEEECTTCCEEECCGG
T ss_pred EEEEEeccCCCHHHHHHhccccccccccccHHHHHHHHHHHHHHHHHHHhCC---eecCCCCHHHEEEcCCCCEEEEech
Confidence 6688898861 011234556889999999999999999999 9999999999999999999999999
Q ss_pred ceeecCCCcccccceeeeeccCCCChhhhccC-----------CCCccceEEeehhhhhhhhhCCCCCCcCCCCchhhhh
Q 045315 311 MARMFGGDELQSNTKRIVGTYGYMSPEYALRG-----------LFSIKSDVFSFGVLLLETLSSKKNTHFYNTDSLTLLG 379 (476)
Q Consensus 311 la~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~-----------~~s~ksDVwSlGvvl~elltG~~p~~~~~~~~~~~~~ 379 (476)
+++.... ......| ..|+|||.+.+. .++.++|||||||++|||++|+.||........ ..
T Consensus 252 ~a~~~~~-----~~~~~~g-~~y~aPE~~~~~~~~~~~~~~~~~~~~~~DvwSlG~il~elltg~~Pf~~~~~~~~--~~ 323 (377)
T 3byv_A 252 HLVRDGA-----RVVSSVS-RGFEPPELEARRATISYHRDRRTLMTFSFDAWALGLVIYWIWCADLPITKDAALGG--SE 323 (377)
T ss_dssp GCEETTC-----EEECCCC-TTCCCHHHHHHHTSTHHHHCCEEECCHHHHHHHHHHHHHHHHHSSCCC------CC--SG
T ss_pred hheecCC-----cccCCCC-cCccChhhhcccccccccccccccCChhhhHHHHHHHHHHHHHCCCCCcccccccc--hh
Confidence 9986433 1223457 999999999887 899999999999999999999999864331110 00
Q ss_pred hhhhhhcCCCcccccCcccCCCCCHHHHHHHHHHHHHchhhcccCCCCHHHHHH
Q 045315 380 HAWNLWNDGRTWELMDPISQNGASYPILKRYINVALLCVQEKAADRPAMSEVVS 433 (476)
Q Consensus 380 ~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~l~~li~~Cl~~dP~~RPt~~eVl~ 433 (476)
..... . ......+.+++.+||+.||++||++.|+++
T Consensus 324 ------------~~~~~--~----~~~~~~~~~li~~~L~~dp~~Rpt~~e~l~ 359 (377)
T 3byv_A 324 ------------WIFRS--C----KNIPQPVRALLEGFLRYPKEDRLLPLQAME 359 (377)
T ss_dssp ------------GGGSS--C----CCCCHHHHHHHHHHTCSSGGGCCCHHHHHT
T ss_pred ------------hhhhh--c----cCCCHHHHHHHHHHcCCCchhCCCHHHHhh
Confidence 00000 0 112356889999999999999999999985
|
| >3mtl_A Cell division protein kinase 16; pctaire1, indirubin, structural genomics, structural consortium, SGC, transferase; HET: FEF; 2.40A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.94 E-value=9.6e-28 Score=238.48 Aligned_cols=201 Identities=16% Similarity=0.209 Sum_probs=136.8
Q ss_pred cccceeeccCCC------CCCCCCCChhhHHHHHHHHHHHHHHHhhcCCCceeecCCCccceEecCCCCceeccccceee
Q 045315 241 DEISFWYESYNN------PTKKGLLCWGTRVRIIEGIAQGLLYLHQYSRLRVIHRDLKASNILLDKDMNPKISDFGMARM 314 (476)
Q Consensus 241 ~~~~l~~Ey~~~------~~~~~~L~~~~~~~i~~qIa~gL~yLH~~~~~~ivH~DLkp~NILld~~~~~kL~DFGla~~ 314 (476)
+..+++|||++. ...+..+++.++..++.||+.||+|||+.+ |+||||||+||+++.++.+||+|||+++.
T Consensus 73 ~~~~lv~e~~~~~l~~~~~~~~~~~~~~~~~~~~~qi~~aL~~LH~~~---ivH~Dikp~NIl~~~~~~~kl~Dfg~a~~ 149 (324)
T 3mtl_A 73 KSLTLVFEYLDKDLKQYLDDCGNIINMHNVKLFLFQLLRGLAYCHRQK---VLHRDLKPQNLLINERGELKLADFGLARA 149 (324)
T ss_dssp SCEEEEEECCSEEHHHHHHHTTTCCCHHHHHHHHHHHHHHHHHHHHTT---EEESSCCGGGEEECTTCCEEECSSSEEEC
T ss_pred CEEEEEecccccCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCC---ccCCCcCHHHEEECCCCCEEEccCccccc
Confidence 457889999982 123457999999999999999999999999 99999999999999999999999999986
Q ss_pred cCCCcccccceeeeeccCCCChhhhcc-CCCCccceEEeehhhhhhhhhCCCCCCcCCCCchhhhhhhhhhhcC---CCc
Q 045315 315 FGGDELQSNTKRIVGTYGYMSPEYALR-GLFSIKSDVFSFGVLLLETLSSKKNTHFYNTDSLTLLGHAWNLWND---GRT 390 (476)
Q Consensus 315 ~~~~~~~~~~~~~~gt~~y~aPE~l~~-~~~s~ksDVwSlGvvl~elltG~~p~~~~~~~~~~~~~~~~~~~~~---~~~ 390 (476)
...... ......||..|+|||.+.+ ..++.++|||||||++|||++|+.||....... ........... ...
T Consensus 150 ~~~~~~--~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~--~~~~i~~~~~~~~~~~~ 225 (324)
T 3mtl_A 150 KSIPTK--TYDNEVVTLWYRPPDILLGSTDYSTQIDMWGVGCIFYEMATGRPLFPGSTVEE--QLHFIFRILGTPTEETW 225 (324)
T ss_dssp C--------------CGGGCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHH--HHHHHHHHHCCCCTTTS
T ss_pred ccCCcc--ccccccCcccccChhhhcCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHH--HHHHHHHHhCCCChHhc
Confidence 543221 1223568999999999876 568999999999999999999999987543211 11111111100 000
Q ss_pred ccccC---------cccCCC----CCHHHHHHHHHHHHHchhhcccCCCCHHHHHH--HHhccccCCCCCCCC
Q 045315 391 WELMD---------PISQNG----ASYPILKRYINVALLCVQEKAADRPAMSEVVS--MLSNEFVNLPAPQQP 448 (476)
Q Consensus 391 ~~~~d---------~~~~~~----~~~~~~~~l~~li~~Cl~~dP~~RPt~~eVl~--~L~~~~~~~~~p~~p 448 (476)
..... +..... ........+.+++.+||+.||++|||++|+++ .+.+........+.+
T Consensus 226 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~hp~f~~~~~~~~~~~~~ 298 (324)
T 3mtl_A 226 PGILSNEEFKTYNYPKYRAEALLSHAPRLDSDGADLLTKLLQFEGRNRISAEDAMKHPFFLSLGERIHKLPDT 298 (324)
T ss_dssp TTGGGCHHHHHTCCCCCCCCCHHHHCTTSCHHHHHHHHHHSCSSGGGSCCHHHHTTSGGGGGGCSTTSSSCTT
T ss_pred hhhhcchhhcccccccccchhhhhhcCCCCHHHHHHHHHHcCcCcccCCCHHHHhcChhhhhcccccccCCCC
Confidence 00000 000000 01112356789999999999999999999987 465554443333333
|
| >2yex_A Serine/threonine-protein kinase CHK1; transferase, cell cycle; HET: YEX; 1.30A {Homo sapiens} PDB: 2x8e_A* 2ydk_A* 2ydj_A* 2yer_A* 2ydi_A* 1nvq_A* 1nvr_A* 1nvs_A* 2wmq_A* 2wmr_A* 2wms_A* 2wmt_A* 2wmu_A* 2wmv_A* 2wmw_A* 2wmx_A* 2x8d_A* 2x8i_A* 2xey_A* 2xez_A* ... | Back alignment and structure |
|---|
Probab=99.94 E-value=2.1e-27 Score=229.56 Aligned_cols=177 Identities=23% Similarity=0.322 Sum_probs=135.1
Q ss_pred cccceeeccCCCC------CCCCCCChhhHHHHHHHHHHHHHHHhhcCCCceeecCCCccceEecCCCCceeccccceee
Q 045315 241 DEISFWYESYNNP------TKKGLLCWGTRVRIIEGIAQGLLYLHQYSRLRVIHRDLKASNILLDKDMNPKISDFGMARM 314 (476)
Q Consensus 241 ~~~~l~~Ey~~~~------~~~~~L~~~~~~~i~~qIa~gL~yLH~~~~~~ivH~DLkp~NILld~~~~~kL~DFGla~~ 314 (476)
+..++++||++.. .....+++.++..++.||+.||+|||+++ ++|+||||+||+++.++.+||+|||++..
T Consensus 78 ~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~l~~lH~~~---i~H~dl~p~Nil~~~~~~~kl~dfg~~~~ 154 (276)
T 2yex_A 78 NIQYLFLEYCSGGELFDRIEPDIGMPEPDAQRFFHQLMAGVVYLHGIG---ITHRDIKPENLLLDERDNLKISDFGLATV 154 (276)
T ss_dssp TEEEEEEECCTTEEGGGGSBTTTBCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEECTTCCEEECCCTTCEE
T ss_pred CEEEEEEEecCCCcHHHHHhhccCCCHHHHHHHHHHHHHHHHHHHhCC---eeccCCChHHEEEccCCCEEEeeCCCccc
Confidence 3567888988721 23457999999999999999999999999 99999999999999999999999999987
Q ss_pred cCCCcccccceeeeeccCCCChhhhccCCC-CccceEEeehhhhhhhhhCCCCCCcCCCCchhhhhhhhhhhcCCCcccc
Q 045315 315 FGGDELQSNTKRIVGTYGYMSPEYALRGLF-SIKSDVFSFGVLLLETLSSKKNTHFYNTDSLTLLGHAWNLWNDGRTWEL 393 (476)
Q Consensus 315 ~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~-s~ksDVwSlGvvl~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~ 393 (476)
..............|+..|+|||.+.+..+ +.++||||||+++|||++|+.||.............. .....
T Consensus 155 ~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~-----~~~~~-- 227 (276)
T 2yex_A 155 FRYNNRERLLNKMCGTLPYVAPELLKRREFHAEPVDVWSCGIVLTAMLAGELPWDQPSDSCQEYSDWK-----EKKTY-- 227 (276)
T ss_dssp CEETTEECCBCCCCSCGGGCCGGGGTCSSBCHHHHHHHHHHHHHHHHHHSSCCCSCSCTTSHHHHHHH-----TTCTT--
T ss_pred cCCCcchhcccCCccccCccChHHHhcCCCCCCcchHHHHHHHHHHHHhCCCCCCCCchHHHHHHHhh-----hcccc--
Confidence 643322222334568999999999987665 7899999999999999999999976543322221111 11000
Q ss_pred cCcccCCCCCHHHHHHHHHHHHHchhhcccCCCCHHHHHH
Q 045315 394 MDPISQNGASYPILKRYINVALLCVQEKAADRPAMSEVVS 433 (476)
Q Consensus 394 ~d~~~~~~~~~~~~~~l~~li~~Cl~~dP~~RPt~~eVl~ 433 (476)
. .........+.+++.+||+.||++|||++|+++
T Consensus 228 ~------~~~~~~~~~~~~li~~~l~~~p~~Rps~~~il~ 261 (276)
T 2yex_A 228 L------NPWKKIDSAPLALLHKILVENPSARITIPDIKK 261 (276)
T ss_dssp S------TTGGGSCHHHHHHHHHHSCSSTTTSCCHHHHTT
T ss_pred c------CchhhcCHHHHHHHHHHCCCCchhCCCHHHHhc
Confidence 0 011123456889999999999999999999875
|
| >3mi9_A Cell division protein kinase 9; P-TEFB, HIV-1, protein binding; HET: TPO; 2.10A {Homo sapiens} PDB: 3mia_A* 4ec9_A* 4ec8_A* 3blh_A* 3blq_A* 3blr_A* 3lq5_A* 3my1_A* 3tn8_A* 3tnh_A* 3tni_A* 4bch_A* 4bci_A* 4bcj_A* 4bcf_A* | Back alignment and structure |
|---|
Probab=99.94 E-value=2.3e-27 Score=238.11 Aligned_cols=189 Identities=19% Similarity=0.251 Sum_probs=134.5
Q ss_pred cccceeeccCCC------CCCCCCCChhhHHHHHHHHHHHHHHHhhcCCCceeecCCCccceEecCCCCceeccccceee
Q 045315 241 DEISFWYESYNN------PTKKGLLCWGTRVRIIEGIAQGLLYLHQYSRLRVIHRDLKASNILLDKDMNPKISDFGMARM 314 (476)
Q Consensus 241 ~~~~l~~Ey~~~------~~~~~~L~~~~~~~i~~qIa~gL~yLH~~~~~~ivH~DLkp~NILld~~~~~kL~DFGla~~ 314 (476)
+..+++|||++. ......+++.++..++.||+.||+|||+++ |+||||||+|||++.++.+||+|||+++.
T Consensus 97 ~~~~lv~e~~~~~l~~~l~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~---ivH~Dlkp~NIl~~~~~~~kl~Dfg~a~~ 173 (351)
T 3mi9_A 97 GSIYLVFDFCEHDLAGLLSNVLVKFTLSEIKRVMQMLLNGLYYIHRNK---ILHRDMKAANVLITRDGVLKLADFGLARA 173 (351)
T ss_dssp CEEEEEEECCSEEHHHHHHCTTSCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEECTTSCEEECCCTTCEE
T ss_pred ceEEEEEeccCCCHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHHCC---eeCCCCCHHHEEEcCCCCEEEccchhccc
Confidence 357889999982 123456999999999999999999999999 99999999999999999999999999987
Q ss_pred cCCCcc--cccceeeeeccCCCChhhhcc-CCCCccceEEeehhhhhhhhhCCCCCCcCCCCchhhhhhhhhhhc---CC
Q 045315 315 FGGDEL--QSNTKRIVGTYGYMSPEYALR-GLFSIKSDVFSFGVLLLETLSSKKNTHFYNTDSLTLLGHAWNLWN---DG 388 (476)
Q Consensus 315 ~~~~~~--~~~~~~~~gt~~y~aPE~l~~-~~~s~ksDVwSlGvvl~elltG~~p~~~~~~~~~~~~~~~~~~~~---~~ 388 (476)
+..... ........||+.|+|||.+.+ ..++.++|||||||++|||++|+.||....... .......... ..
T Consensus 174 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~--~~~~i~~~~~~~~~~ 251 (351)
T 3mi9_A 174 FSLAKNSQPNRYTNRVVTLWYRPPELLLGERDYGPPIDLWGAGCIMAEMWTRSPIMQGNTEQH--QLALISQLCGSITPE 251 (351)
T ss_dssp CCCCSSSSCCCCCSSCSCGGGCCHHHHTTCCSCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHH--HHHHHHHHHCCCCTT
T ss_pred ccccccccccccCCcccccCccCchhhcCCCCCCcHhHHHHHHHHHHHHHhCCCCCCCCChHH--HHHHHHHHhCCCChh
Confidence 653211 112233568999999999876 568999999999999999999999987543211 1111111000 00
Q ss_pred --------CcccccCcccCCCCCHH-H------HHHHHHHHHHchhhcccCCCCHHHHHHH
Q 045315 389 --------RTWELMDPISQNGASYP-I------LKRYINVALLCVQEKAADRPAMSEVVSM 434 (476)
Q Consensus 389 --------~~~~~~d~~~~~~~~~~-~------~~~l~~li~~Cl~~dP~~RPt~~eVl~~ 434 (476)
...+............. . ...+.+++.+||+.||++|||++|+++.
T Consensus 252 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~h 312 (351)
T 3mi9_A 252 VWPNVDNYELYEKLELVKGQKRKVKDRLKAYVRDPYALDLIDKLLVLDPAQRIDSDDALNH 312 (351)
T ss_dssp TSTTGGGCGGGTSSCCCSSCCCCHHHHHHHHHCCHHHHHHHHHHSCSSGGGSCCHHHHHTS
T ss_pred hccccccchhhcccccccccccCHHHHhhhccCChHHHHHHHHHhcCChhhCCCHHHHhCC
Confidence 00000000000011111 1 2457899999999999999999998863
|
| >1o6l_A RAC-beta serine/threonine protein kinase; protein kinase, transferase, serine/threonine-protein kinase; HET: TPO ANP; 1.6A {Homo sapiens} SCOP: d.144.1.7 PDB: 2jdo_A* 2jdr_A* 2uw9_A* 2x37_A* 2x39_A* 2xh5_A* 3d0e_A* 3e87_A* 3e88_A* 3e8d_A* 1o6k_A* 1mrv_A 1mry_A 1gzn_A 1gzk_A 1gzo_A 3qkl_A* 3ocb_A* 3ow4_A* 3qkk_A* ... | Back alignment and structure |
|---|
Probab=99.94 E-value=1e-27 Score=240.06 Aligned_cols=172 Identities=22% Similarity=0.264 Sum_probs=135.3
Q ss_pred cccceeeccCCCCC------CCCCCChhhHHHHHHHHHHHHHHHhhcCCCceeecCCCccceEecCCCCceeccccceee
Q 045315 241 DEISFWYESYNNPT------KKGLLCWGTRVRIIEGIAQGLLYLHQYSRLRVIHRDLKASNILLDKDMNPKISDFGMARM 314 (476)
Q Consensus 241 ~~~~l~~Ey~~~~~------~~~~L~~~~~~~i~~qIa~gL~yLH~~~~~~ivH~DLkp~NILld~~~~~kL~DFGla~~ 314 (476)
+..+++|||++.+. +.+.+++.++..++.||+.||+|||+++ |+||||||+|||++.++.+||+|||+++.
T Consensus 78 ~~~~lv~E~~~gg~L~~~l~~~~~~~~~~~~~~~~qi~~aL~~LH~~~---ivHrDlkp~NIll~~~g~vkL~DFG~a~~ 154 (337)
T 1o6l_A 78 DRLCFVMEYANGGELFFHLSRERVFTEERARFYGAEIVSALEYLHSRD---VVYRDIKLENLMLDKDGHIKITDFGLCKE 154 (337)
T ss_dssp SEEEEEEECCTTCBHHHHHHHHSCCCHHHHHHHHHHHHHHHHHHHHTT---CBCCCCCGGGEEECTTSCEEECCCTTCBC
T ss_pred CEEEEEEeCCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCC---eecCcCCHHHEEECCCCCEEEeeccchhh
Confidence 46889999998432 3457999999999999999999999999 99999999999999999999999999986
Q ss_pred cCCCcccccceeeeeccCCCChhhhccCCCCccceEEeehhhhhhhhhCCCCCCcCCCCchhhhhhhhhhhcCCCccccc
Q 045315 315 FGGDELQSNTKRIVGTYGYMSPEYALRGLFSIKSDVFSFGVLLLETLSSKKNTHFYNTDSLTLLGHAWNLWNDGRTWELM 394 (476)
Q Consensus 315 ~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~s~ksDVwSlGvvl~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 394 (476)
..... .......||+.|+|||.+.+..++.++|+|||||++|||++|+.||..... ....... . .+..
T Consensus 155 ~~~~~--~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~Pf~~~~~--~~~~~~i---~-~~~~---- 222 (337)
T 1o6l_A 155 GISDG--ATMKTFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDH--ERLFELI---L-MEEI---- 222 (337)
T ss_dssp SCCTT--CCBCCCEECGGGCCGGGGSSSCBCTTHHHHHHHHHHHHHHHSSCSSCCSSH--HHHHHHH---H-HCCC----
T ss_pred cccCC--CcccccccChhhCChhhhcCCCCCchhhcccchhHHHHHhcCCCCCCCCCH--HHHHHHH---H-cCCC----
Confidence 43222 122346799999999999999999999999999999999999999864331 1111111 1 1110
Q ss_pred CcccCCCCCHHHHHHHHHHHHHchhhcccCCC-----CHHHHHH
Q 045315 395 DPISQNGASYPILKRYINVALLCVQEKAADRP-----AMSEVVS 433 (476)
Q Consensus 395 d~~~~~~~~~~~~~~l~~li~~Cl~~dP~~RP-----t~~eVl~ 433 (476)
..+......+.+++.+||+.||++|| +++||++
T Consensus 223 ------~~p~~~s~~~~~li~~lL~~dP~~R~g~~~~~~~ei~~ 260 (337)
T 1o6l_A 223 ------RFPRTLSPEAKSLLAGLLKKDPKQRLGGGPSDAKEVME 260 (337)
T ss_dssp ------CCCTTSCHHHHHHHHHHTCSSTTTSTTCSTTTHHHHHT
T ss_pred ------CCCCCCCHHHHHHHHHHhhcCHHHhcCCCCCCHHHHHc
Confidence 01112345688999999999999999 8999875
|
| >3fme_A Dual specificity mitogen-activated protein kinase; active mutant, structural genomics consortium, SCG, binding, nucleotide-binding, phosphoprotein; HET: STU; 2.26A {Homo sapiens} PDB: 3enm_A | Back alignment and structure |
|---|
Probab=99.94 E-value=7.2e-28 Score=234.51 Aligned_cols=174 Identities=23% Similarity=0.335 Sum_probs=125.0
Q ss_pred cccceeeccCCCC---------CCCCCCChhhHHHHHHHHHHHHHHHhhc-CCCceeecCCCccceEecCCCCceecccc
Q 045315 241 DEISFWYESYNNP---------TKKGLLCWGTRVRIIEGIAQGLLYLHQY-SRLRVIHRDLKASNILLDKDMNPKISDFG 310 (476)
Q Consensus 241 ~~~~l~~Ey~~~~---------~~~~~L~~~~~~~i~~qIa~gL~yLH~~-~~~~ivH~DLkp~NILld~~~~~kL~DFG 310 (476)
+..++++||++.. ..+..+++.++..++.||+.||+|||++ + |+||||||+||+++.++.+||+|||
T Consensus 79 ~~~~lv~e~~~~~l~~~l~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~~---i~H~dlkp~Nil~~~~~~~kl~Dfg 155 (290)
T 3fme_A 79 GDVWICMELMDTSLDKFYKQVIDKGQTIPEDILGKIAVSIVKALEHLHSKLS---VIHRDVKPSNVLINALGQVKMCDFG 155 (290)
T ss_dssp SSEEEEEECCSEEHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHHHSC---CCCCCCSGGGCEECTTCCEEBCCC-
T ss_pred CCEEEEEehhccchHHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHhhcCC---eecCCCCHHHEEECCCCCEEEeecC
Confidence 4678999999821 2456899999999999999999999998 8 9999999999999999999999999
Q ss_pred ceeecCCCcccccceeeeeccCCCChhhh----ccCCCCccceEEeehhhhhhhhhCCCCCCcCCCCchhhhhhhhhhhc
Q 045315 311 MARMFGGDELQSNTKRIVGTYGYMSPEYA----LRGLFSIKSDVFSFGVLLLETLSSKKNTHFYNTDSLTLLGHAWNLWN 386 (476)
Q Consensus 311 la~~~~~~~~~~~~~~~~gt~~y~aPE~l----~~~~~s~ksDVwSlGvvl~elltG~~p~~~~~~~~~~~~~~~~~~~~ 386 (476)
++........ .....|++.|+|||.+ .+..++.++||||||+++|||++|+.||............ ...
T Consensus 156 ~~~~~~~~~~---~~~~~~t~~y~aPE~~~~~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~----~~~ 228 (290)
T 3fme_A 156 ISGYLVDDVA---KDIDAGCKPYMAPERINPELNQKGYSVKSDIWSLGITMIELAILRFPYDSWGTPFQQLKQ----VVE 228 (290)
T ss_dssp -----------------CCCCCCSCHHHHSCCTTC--CCHHHHHHHHHHHHHHHHHTSCSSCCCSCHHHHHHH----HHH
T ss_pred Cccccccccc---ccccCCCccccChhhcChhhcCcCCCcHHHHHHHHHHHHHHHHCCCCccccCchHHHHHH----Hhc
Confidence 9987654322 2224689999999996 4567899999999999999999999998653322222111 111
Q ss_pred CCCcccccCcccCCCCCHHHHHHHHHHHHHchhhcccCCCCHHHHHH
Q 045315 387 DGRTWELMDPISQNGASYPILKRYINVALLCVQEKAADRPAMSEVVS 433 (476)
Q Consensus 387 ~~~~~~~~d~~~~~~~~~~~~~~l~~li~~Cl~~dP~~RPt~~eVl~ 433 (476)
.... . .........+.+++.+||+.||++|||+.|+++
T Consensus 229 ~~~~-~--------~~~~~~~~~~~~li~~~l~~~p~~Rpt~~e~l~ 266 (290)
T 3fme_A 229 EPSP-Q--------LPADKFSAEFVDFTSQCLKKNSKERPTYPELMQ 266 (290)
T ss_dssp SCCC-C--------CCTTTSCHHHHHHHHHHTCSSGGGSCCHHHHTT
T ss_pred cCCC-C--------cccccCCHHHHHHHHHHhhcChhhCcCHHHHHh
Confidence 1110 0 011122456889999999999999999999976
|
| >2y0a_A Death-associated protein kinase 1; transferase, calmodulin, esprit; HET: MES; 2.60A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.94 E-value=2.5e-27 Score=235.86 Aligned_cols=175 Identities=21% Similarity=0.227 Sum_probs=134.7
Q ss_pred cccceeeccCCCC------CCCCCCChhhHHHHHHHHHHHHHHHhhcCCCceeecCCCccceEecCCC----Cceecccc
Q 045315 241 DEISFWYESYNNP------TKKGLLCWGTRVRIIEGIAQGLLYLHQYSRLRVIHRDLKASNILLDKDM----NPKISDFG 310 (476)
Q Consensus 241 ~~~~l~~Ey~~~~------~~~~~L~~~~~~~i~~qIa~gL~yLH~~~~~~ivH~DLkp~NILld~~~----~~kL~DFG 310 (476)
+..+++|||++.. ...+.+++.++..++.||+.||+|||+.+ |+||||||+||+++.++ .+||+|||
T Consensus 87 ~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~i~~qi~~al~~lH~~~---ivH~Dlkp~NIll~~~~~~~~~~kl~Dfg 163 (326)
T 2y0a_A 87 TDVILILELVAGGELFDFLAEKESLTEEEATEFLKQILNGVYYLHSLQ---IAHFDLKPENIMLLDRNVPKPRIKIIDFG 163 (326)
T ss_dssp SEEEEEEECCCSCBHHHHHTTSSCCBHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEESCSSSSSCCEEECCCT
T ss_pred CEEEEEEEcCCCCCHHHHHHhcCCcCHHHHHHHHHHHHHHHHHHHHCC---eEcCCCCHHHEEEecCCCCCCCEEEEECC
Confidence 4688999999732 24567999999999999999999999999 99999999999999877 79999999
Q ss_pred ceeecCCCcccccceeeeeccCCCChhhhccCCCCccceEEeehhhhhhhhhCCCCCCcCCCCchhhhhhhhhhhcCCCc
Q 045315 311 MARMFGGDELQSNTKRIVGTYGYMSPEYALRGLFSIKSDVFSFGVLLLETLSSKKNTHFYNTDSLTLLGHAWNLWNDGRT 390 (476)
Q Consensus 311 la~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~s~ksDVwSlGvvl~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~ 390 (476)
+++....... .....||+.|+|||.+.+..++.++|||||||++|+|++|+.||...... ........ ...
T Consensus 164 ~a~~~~~~~~---~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~--~~~~~~~~----~~~ 234 (326)
T 2y0a_A 164 LAHKIDFGNE---FKNIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASPFLGDTKQ--ETLANVSA----VNY 234 (326)
T ss_dssp TCEECCTTSC---CCCCCSCTTTCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSCCSSCCSSHH--HHHHHHHH----TCC
T ss_pred CCeECCCCCc---cccccCCcCcCCceeecCCCCCcHHHHHHHHHHHHHHHHCcCCCCCCCHH--HHHHHHHh----cCC
Confidence 9987653321 22356899999999999899999999999999999999999998643311 11111100 000
Q ss_pred ccccCcccCCCCCHHHHHHHHHHHHHchhhcccCCCCHHHHHH
Q 045315 391 WELMDPISQNGASYPILKRYINVALLCVQEKAADRPAMSEVVS 433 (476)
Q Consensus 391 ~~~~d~~~~~~~~~~~~~~l~~li~~Cl~~dP~~RPt~~eVl~ 433 (476)
.. .... .......+.+++.+||+.||++|||+.|+++
T Consensus 235 -~~-~~~~----~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~ 271 (326)
T 2y0a_A 235 -EF-EDEY----FSNTSALAKDFIRRLLVKDPKKRMTIQDSLQ 271 (326)
T ss_dssp -CC-CHHH----HTTSCHHHHHHHHHHSCSSGGGSCCHHHHHH
T ss_pred -Cc-Cccc----cccCCHHHHHHHHHHccCChhhCCCHHHHhc
Confidence 00 0000 0112356789999999999999999999986
|
| >2ozo_A Tyrosine-protein kinase ZAP-70; inactive ZAP-70, tandem SH2, autoinhibition, ITAM, hydrogen bonding network, TCR signaling, transferase; HET: ANP; 2.60A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.94 E-value=6.8e-28 Score=259.92 Aligned_cols=183 Identities=22% Similarity=0.327 Sum_probs=139.4
Q ss_pred cccceeeccCCCC-------CCCCCCChhhHHHHHHHHHHHHHHHhhcCCCceeecCCCccceEecCCCCceecccccee
Q 045315 241 DEISFWYESYNNP-------TKKGLLCWGTRVRIIEGIAQGLLYLHQYSRLRVIHRDLKASNILLDKDMNPKISDFGMAR 313 (476)
Q Consensus 241 ~~~~l~~Ey~~~~-------~~~~~L~~~~~~~i~~qIa~gL~yLH~~~~~~ivH~DLkp~NILld~~~~~kL~DFGla~ 313 (476)
+..+++|||++.+ .++..+++.++..++.||+.||+|||+++ |+||||||+|||++.++.+||+|||+++
T Consensus 408 ~~~~lv~E~~~~g~L~~~l~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~---iiHrDlkp~NILl~~~~~vkL~DFGla~ 484 (613)
T 2ozo_A 408 EALMLVMEMAGGGPLHKFLVGKREEIPVSNVAELLHQVSMGMKYLEEKN---FVHRNLAARNVLLVNRHYAKISDFGLSK 484 (613)
T ss_dssp SSEEEEEECCTTCBHHHHHTTCTTTSCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCSGGGEEEEETTEEEECCCSTTT
T ss_pred CCeEEEEEeCCCCcHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHHCC---EEcCcCCHHHEEEcCCCcEEEeeccCcc
Confidence 4578999999832 24567999999999999999999999999 9999999999999999999999999998
Q ss_pred ecCCCccc-ccceeeeeccCCCChhhhccCCCCccceEEeehhhhhhhhh-CCCCCCcCCCCchhhhhhhhhhhcCCCcc
Q 045315 314 MFGGDELQ-SNTKRIVGTYGYMSPEYALRGLFSIKSDVFSFGVLLLETLS-SKKNTHFYNTDSLTLLGHAWNLWNDGRTW 391 (476)
Q Consensus 314 ~~~~~~~~-~~~~~~~gt~~y~aPE~l~~~~~s~ksDVwSlGvvl~ellt-G~~p~~~~~~~~~~~~~~~~~~~~~~~~~ 391 (476)
........ .......++..|+|||++.+..++.++|||||||++|||++ |+.||...... .+.. ....+...
T Consensus 485 ~~~~~~~~~~~~~~~~~~~~y~APE~~~~~~~~~~sDvwSlGv~l~ellt~G~~Pf~~~~~~--~~~~----~i~~~~~~ 558 (613)
T 2ozo_A 485 ALGADDSYYTARSAGKWPLKWYAPECINFRKFSSRSDVWSYGVTMWEALSYGQKPYKKMKGP--EVMA----FIEQGKRM 558 (613)
T ss_dssp TCC--------------CCTTSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCSH--HHHH----HHHTTCCC
T ss_pred cccCCCceeeeccCCCCccceeCHhhhcCCCCCcHHHHHHHHHHHHHHHHCCCCCCCCCCHH--HHHH----HHHcCCCC
Confidence 76433211 11122345689999999999999999999999999999998 99998754321 1111 11122111
Q ss_pred cccCcccCCCCCHHHHHHHHHHHHHchhhcccCCCCHHHHHHHHhccccC
Q 045315 392 ELMDPISQNGASYPILKRYINVALLCVQEKAADRPAMSEVVSMLSNEFVN 441 (476)
Q Consensus 392 ~~~d~~~~~~~~~~~~~~l~~li~~Cl~~dP~~RPt~~eVl~~L~~~~~~ 441 (476)
..+......+.+++.+||+.||++||++.+|++.|+..+..
T Consensus 559 ---------~~p~~~~~~l~~li~~cl~~dP~~RPs~~~l~~~L~~~~~~ 599 (613)
T 2ozo_A 559 ---------ECPPECPPELYALMSDCWIYKWEDRPDFLTVEQRMRACYYS 599 (613)
T ss_dssp ---------CCCTTCCHHHHHHHHHTTCSSTTTSCCHHHHHHHHHHHHHH
T ss_pred ---------CCCCcCCHHHHHHHHHHcCCChhHCcCHHHHHHHHHHHHHH
Confidence 11122346788999999999999999999999999987643
|
| >3ttj_A Mitogen-activated protein kinase 10; JNK3, protein kinase in transferase-transferase inhibitor complex; HET: JBI; 2.10A {Homo sapiens} PDB: 3tti_A* 1jnk_A* | Back alignment and structure |
|---|
Probab=99.94 E-value=2.4e-27 Score=247.49 Aligned_cols=185 Identities=20% Similarity=0.160 Sum_probs=130.6
Q ss_pred ccceeeccCCCC---CCCCCCChhhHHHHHHHHHHHHHHHhhcCCCceeecCCCccceEecCCCCceeccccceeecCCC
Q 045315 242 EISFWYESYNNP---TKKGLLCWGTRVRIIEGIAQGLLYLHQYSRLRVIHRDLKASNILLDKDMNPKISDFGMARMFGGD 318 (476)
Q Consensus 242 ~~~l~~Ey~~~~---~~~~~L~~~~~~~i~~qIa~gL~yLH~~~~~~ivH~DLkp~NILld~~~~~kL~DFGla~~~~~~ 318 (476)
..+++|||++.. .....+++.++..++.||+.||+|||+++ |+||||||+|||++.++.+||+|||+++.....
T Consensus 141 ~~~lv~E~~~~~l~~~~~~~l~~~~~~~~~~qil~aL~~lH~~~---iiHrDlkp~NIll~~~~~~kl~DFG~a~~~~~~ 217 (464)
T 3ttj_A 141 DVYLVMELMDANLCQVIQMELDHERMSYLLYQMLCGIKHLHSAG---IIHRDLKPSNIVVKSDCTLKILDFGLARTAGTS 217 (464)
T ss_dssp EEEEEEECCSEEHHHHHTSCCCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCCGGGEEECTTSCEEECCCCCC-----C
T ss_pred eEEEEEeCCCCCHHHHHhhcCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCChHhEEEeCCCCEEEEEEEeeeecCCC
Confidence 568999999821 11335999999999999999999999999 999999999999999999999999999876543
Q ss_pred cccccceeeeeccCCCChhhhccCCCCccceEEeehhhhhhhhhCCCCCCcCCCCchhhhhhhhhh--------------
Q 045315 319 ELQSNTKRIVGTYGYMSPEYALRGLFSIKSDVFSFGVLLLETLSSKKNTHFYNTDSLTLLGHAWNL-------------- 384 (476)
Q Consensus 319 ~~~~~~~~~~gt~~y~aPE~l~~~~~s~ksDVwSlGvvl~elltG~~p~~~~~~~~~~~~~~~~~~-------------- 384 (476)
. ......||+.|+|||++.+..++.++|||||||++|||++|+.||...+... ........
T Consensus 218 ~---~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~ell~g~~pF~g~~~~~--~~~~i~~~lg~p~~~~~~~~~~ 292 (464)
T 3ttj_A 218 F---MMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMVRHKILFPGRDYID--QWNKVIEQLGTPCPEFMKKLQP 292 (464)
T ss_dssp C---CC----CCCTTCCHHHHTTCCCCTTHHHHHHHHHHHHHHHSSCSSCCSSHHH--HHHHHHHHHCSCCHHHHTTSCH
T ss_pred c---ccCCCcccccccCHHHHcCCCCCHHHHHHHHHHHHHHHHhCCCCCCCCCHHH--HHHHHHHhcCCCCHHHHHHcch
Confidence 2 2234678999999999999999999999999999999999999997543111 00000000
Q ss_pred -----hcCC------CcccccCcccCCCC---CHHHHHHHHHHHHHchhhcccCCCCHHHHHHH
Q 045315 385 -----WNDG------RTWELMDPISQNGA---SYPILKRYINVALLCVQEKAADRPAMSEVVSM 434 (476)
Q Consensus 385 -----~~~~------~~~~~~d~~~~~~~---~~~~~~~l~~li~~Cl~~dP~~RPt~~eVl~~ 434 (476)
.... .............. .......+.+++.+||+.||++|||++|+++.
T Consensus 293 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dLl~~mL~~dP~~R~ta~e~L~H 356 (464)
T 3ttj_A 293 TVRNYVENRPKYAGLTFPKLFPDSLFPADSEHNKLKASQARDLLSKMLVIDPAKRISVDDALQH 356 (464)
T ss_dssp HHHHHHTTSCCCCCCCHHHHSCGGGSCCSSHHHHHHHHHHHHHHHHHSCSSTTTSCCHHHHHTS
T ss_pred hhhhHhhcccccCCCChHHhCcccccccccccccccCHHHHHHHHHHcCCChhhCCCHHHHhcC
Confidence 0000 00000000000000 11125678999999999999999999999863
|
| >3soa_A Calcium/calmodulin-dependent protein kinase type alpha with A beta 7 linker; phosphorylation, cytosolic, transferase-transferase inhibitor complex; HET: DB8; 3.55A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.94 E-value=3.5e-27 Score=244.68 Aligned_cols=176 Identities=21% Similarity=0.286 Sum_probs=135.8
Q ss_pred cccceeeccCCCCC------CCCCCChhhHHHHHHHHHHHHHHHhhcCCCceeecCCCccceEec---CCCCceeccccc
Q 045315 241 DEISFWYESYNNPT------KKGLLCWGTRVRIIEGIAQGLLYLHQYSRLRVIHRDLKASNILLD---KDMNPKISDFGM 311 (476)
Q Consensus 241 ~~~~l~~Ey~~~~~------~~~~L~~~~~~~i~~qIa~gL~yLH~~~~~~ivH~DLkp~NILld---~~~~~kL~DFGl 311 (476)
+..+++|||++.+. .++.+++.++..++.||+.||+|||+++ |+||||||+|||++ .++.+||+|||+
T Consensus 83 ~~~~lv~E~~~gg~L~~~i~~~~~~~e~~~~~i~~qil~aL~~lH~~g---ivHrDlKp~NIll~~~~~~~~vkL~DFG~ 159 (444)
T 3soa_A 83 GHHYLIFDLVTGGELFEDIVAREYYSEADASHCIQQILEAVLHCHQMG---VVHRNLKPENLLLASKLKGAAVKLADFGL 159 (444)
T ss_dssp SEEEEEECCCBCCBHHHHHHHCSCCCHHHHHHHHHHHHHHHHHHHHTT---CBCCCCSSTTEEESBSSTTCCEEECCCSS
T ss_pred CEEEEEEEeCCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCC---ccccCCCHHHEEEeccCCCCcEEEccCce
Confidence 56789999998432 3567999999999999999999999999 99999999999998 467899999999
Q ss_pred eeecCCCcccccceeeeeccCCCChhhhccCCCCccceEEeehhhhhhhhhCCCCCCcCCCCchhhhhhhhhhhcCCCcc
Q 045315 312 ARMFGGDELQSNTKRIVGTYGYMSPEYALRGLFSIKSDVFSFGVLLLETLSSKKNTHFYNTDSLTLLGHAWNLWNDGRTW 391 (476)
Q Consensus 312 a~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~s~ksDVwSlGvvl~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~ 391 (476)
+......... .....||+.|+|||.+.+..++.++|||||||++|+|++|+.||..... ...... ...+..
T Consensus 160 a~~~~~~~~~--~~~~~gt~~Y~APE~l~~~~~~~~~DIwSlGvilyell~G~~Pf~~~~~--~~~~~~----i~~~~~- 230 (444)
T 3soa_A 160 AIEVEGEQQA--WFGFAGTPGYLSPEVLRKDPYGKPVDLWACGVILYILLVGYPPFWDEDQ--HRLYQQ----IKAGAY- 230 (444)
T ss_dssp CBCCCTTCCB--CCCSCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSCCCSSH--HHHHHH----HHHTCC-
T ss_pred eEEecCCCce--eecccCCcccCCHHHhcCCCCCCccccHHHHHHHHHHHhCCCCCCCccH--HHHHHH----HHhCCC-
Confidence 9876543222 2235799999999999998999999999999999999999999864331 111111 111111
Q ss_pred cccCcccCCCCCHHHHHHHHHHHHHchhhcccCCCCHHHHHH
Q 045315 392 ELMDPISQNGASYPILKRYINVALLCVQEKAADRPAMSEVVS 433 (476)
Q Consensus 392 ~~~d~~~~~~~~~~~~~~l~~li~~Cl~~dP~~RPt~~eVl~ 433 (476)
....+ ........+.+++.+||+.||++|||+.|+++
T Consensus 231 ~~~~~-----~~~~~s~~~~~li~~~L~~dP~~Rpta~e~L~ 267 (444)
T 3soa_A 231 DFPSP-----EWDTVTPEAKDLINKMLTINPSKRITAAEALK 267 (444)
T ss_dssp CCCTT-----TTTTSCHHHHHHHHHHSCSSTTTSCCHHHHHH
T ss_pred CCCcc-----ccccCCHHHHHHHHHHcCCChhHCCCHHHHhc
Confidence 00011 11122457889999999999999999999986
|
| >1xbb_A Tyrosine-protein kinase SYK; gleevec, STI-571, imatinib, spleen typrosine kinase, active conformation, structural genomics, structural genomix; HET: STI; 1.57A {Homo sapiens} SCOP: d.144.1.7 PDB: 1xba_A* 1xbc_A* 3fqe_A* 3fqh_A* 3fqs_A* 3emg_A* 3srv_A* 4dfl_A* 4dfn_A* 3vf8_A* 3vf9_A* | Back alignment and structure |
|---|
Probab=99.94 E-value=5.6e-28 Score=236.05 Aligned_cols=184 Identities=24% Similarity=0.345 Sum_probs=141.3
Q ss_pred cccceeeccCCCC------CCCCCCChhhHHHHHHHHHHHHHHHhhcCCCceeecCCCccceEecCCCCceeccccceee
Q 045315 241 DEISFWYESYNNP------TKKGLLCWGTRVRIIEGIAQGLLYLHQYSRLRVIHRDLKASNILLDKDMNPKISDFGMARM 314 (476)
Q Consensus 241 ~~~~l~~Ey~~~~------~~~~~L~~~~~~~i~~qIa~gL~yLH~~~~~~ivH~DLkp~NILld~~~~~kL~DFGla~~ 314 (476)
+..++++||++.. ...+.+++.++..++.||+.||+|||+++ |+||||||+||+++.++.+||+|||++..
T Consensus 90 ~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~i~~qi~~~l~~LH~~~---i~H~dikp~Nil~~~~~~~kl~Dfg~~~~ 166 (291)
T 1xbb_A 90 ESWMLVMEMAELGPLNKYLQQNRHVKDKNIIELVHQVSMGMKYLEESN---FVHRDLAARNVLLVTQHYAKISDFGLSKA 166 (291)
T ss_dssp SSEEEEEECCTTEEHHHHHHHCTTCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEEEETTEEEECCCTTCEE
T ss_pred CCcEEEEEeCCCCCHHHHHHhCcCCCHHHHHHHHHHHHHHHHHHHhCC---eEcCCCCcceEEEeCCCcEEEccCCccee
Confidence 4578899999732 12456999999999999999999999999 99999999999999999999999999987
Q ss_pred cCCCcccc-cceeeeeccCCCChhhhccCCCCccceEEeehhhhhhhhh-CCCCCCcCCCCchhhhhhhhhhhcCCCccc
Q 045315 315 FGGDELQS-NTKRIVGTYGYMSPEYALRGLFSIKSDVFSFGVLLLETLS-SKKNTHFYNTDSLTLLGHAWNLWNDGRTWE 392 (476)
Q Consensus 315 ~~~~~~~~-~~~~~~gt~~y~aPE~l~~~~~s~ksDVwSlGvvl~ellt-G~~p~~~~~~~~~~~~~~~~~~~~~~~~~~ 392 (476)
........ ......++..|+|||.+.+..++.++||||||+++|||++ |+.||...... .... ....+...
T Consensus 167 ~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~~g~~p~~~~~~~--~~~~----~~~~~~~~- 239 (291)
T 1xbb_A 167 LRADENYYKAQTHGKWPVKWYAPECINYYKFSSKSDVWSFGVLMWEAFSYGQKPYRGMKGS--EVTA----MLEKGERM- 239 (291)
T ss_dssp CCTTCSEEEC----CCCGGGCCHHHHHHCEEEHHHHHHHHHHHHHHHHTTTCCSSTTCCHH--HHHH----HHHTTCCC-
T ss_pred eccCCCcccccccCCCCceeeChHHhccCCCChhhhHHHHHHHHHHHHhcCCCCCCCCCHH--HHHH----HHHcCCCC-
Confidence 65432211 1222345688999999998889999999999999999999 99998654321 1111 11111111
Q ss_pred ccCcccCCCCCHHHHHHHHHHHHHchhhcccCCCCHHHHHHHHhccccCC
Q 045315 393 LMDPISQNGASYPILKRYINVALLCVQEKAADRPAMSEVVSMLSNEFVNL 442 (476)
Q Consensus 393 ~~d~~~~~~~~~~~~~~l~~li~~Cl~~dP~~RPt~~eVl~~L~~~~~~~ 442 (476)
..+......+.+++.+||+.||++||++.+|++.|++++...
T Consensus 240 --------~~~~~~~~~l~~li~~~l~~dp~~Rps~~~l~~~L~~~~~~~ 281 (291)
T 1xbb_A 240 --------GCPAGCPREMYDLMNLCWTYDVENRPGFAAVELRLRNYYYDV 281 (291)
T ss_dssp --------CCCTTCCHHHHHHHHHHTCSSTTTSCCHHHHHHHHHHHHHHH
T ss_pred --------CCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHHHH
Confidence 111223457889999999999999999999999999987544
|
| >3txo_A PKC-L, NPKC-ETA, protein kinase C ETA type; phosphotransferase, transferase-transferase inhibito; HET: TPO 07U; 2.05A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.94 E-value=5.2e-28 Score=243.69 Aligned_cols=172 Identities=24% Similarity=0.282 Sum_probs=131.4
Q ss_pred cccceeeccCCCCC------CCCCCChhhHHHHHHHHHHHHHHHhhcCCCceeecCCCccceEecCCCCceeccccceee
Q 045315 241 DEISFWYESYNNPT------KKGLLCWGTRVRIIEGIAQGLLYLHQYSRLRVIHRDLKASNILLDKDMNPKISDFGMARM 314 (476)
Q Consensus 241 ~~~~l~~Ey~~~~~------~~~~L~~~~~~~i~~qIa~gL~yLH~~~~~~ivH~DLkp~NILld~~~~~kL~DFGla~~ 314 (476)
+..+++|||++.+. +.+.+++.++..++.||+.||+|||+++ |+||||||+|||++.++.+||+|||+++.
T Consensus 97 ~~~~lv~E~~~gg~L~~~l~~~~~~~~~~~~~~~~qi~~aL~~LH~~g---ivHrDlkp~NILl~~~g~ikL~DFG~a~~ 173 (353)
T 3txo_A 97 DRLFFVMEFVNGGDLMFHIQKSRRFDEARARFYAAEIISALMFLHDKG---IIYRDLKLDNVLLDHEGHCKLADFGMCKE 173 (353)
T ss_dssp SEEEEEEECCCSCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTT---CBCCCCCGGGEEECTTSCEEECCCTTCBC
T ss_pred CEEEEEEeCCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCC---CcccCCCHHHEEECCCCCEEEccccceee
Confidence 46889999998432 3467999999999999999999999999 99999999999999999999999999985
Q ss_pred cCCCcccccceeeeeccCCCChhhhccCCCCccceEEeehhhhhhhhhCCCCCCcCCCCchhhhhhhhhhhcCCCccccc
Q 045315 315 FGGDELQSNTKRIVGTYGYMSPEYALRGLFSIKSDVFSFGVLLLETLSSKKNTHFYNTDSLTLLGHAWNLWNDGRTWELM 394 (476)
Q Consensus 315 ~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~s~ksDVwSlGvvl~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 394 (476)
..... .......||+.|+|||++.+..++.++|||||||++|||++|+.||...... ...... . .+..
T Consensus 174 ~~~~~--~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~G~~Pf~~~~~~--~~~~~i---~-~~~~---- 241 (353)
T 3txo_A 174 GICNG--VTTATFCGTPDYIAPEILQEMLYGPAVDWWAMGVLLYEMLCGHAPFEAENED--DLFEAI---L-NDEV---- 241 (353)
T ss_dssp SCC-----------CCGGGCCHHHHHHHHCTTHHHHHHHHHHHHHHHHSSCSSCCSSHH--HHHHHH---H-HCCC----
T ss_pred cccCC--ccccccCCCcCeEChhhcCCCCcCCccCCCcchHHHHHHHhCCCCCCCCCHH--HHHHHH---H-cCCC----
Confidence 43222 2233467999999999999889999999999999999999999999754321 111111 1 1110
Q ss_pred CcccCCCCCHHHHHHHHHHHHHchhhcccCCCCH------HHHHH
Q 045315 395 DPISQNGASYPILKRYINVALLCVQEKAADRPAM------SEVVS 433 (476)
Q Consensus 395 d~~~~~~~~~~~~~~l~~li~~Cl~~dP~~RPt~------~eVl~ 433 (476)
..+......+.+++.+||+.||++||++ +|+++
T Consensus 242 ------~~p~~~~~~~~~li~~lL~~dP~~R~~~~~~~~~~~il~ 280 (353)
T 3txo_A 242 ------VYPTWLHEDATGILKSFMTKNPTMRLGSLTQGGEHAILR 280 (353)
T ss_dssp ------CCCTTSCHHHHHHHHHHTCSSGGGSTTSGGGTCTHHHHT
T ss_pred ------CCCCCCCHHHHHHHHHHhhhCHHHccCCcccCCHHHHhh
Confidence 0111233568899999999999999998 66654
|
| >3kmu_A ILK, integrin-linked kinase; cell adhesion, ANK repeat, ATP-binding, cell junction, cell membrane, integrin-binding protein, membrane, nucleotide- binding; 1.80A {Homo sapiens} SCOP: d.144.1.0 PDB: 3kmw_A* 3rep_A* | Back alignment and structure |
|---|
Probab=99.94 E-value=2.9e-27 Score=227.59 Aligned_cols=177 Identities=17% Similarity=0.215 Sum_probs=134.9
Q ss_pred cccceeeccCCCC--------CCCCCCChhhHHHHHHHHHHHHHHHhhcCCCceeecCCCccceEecCCCCceeccccce
Q 045315 241 DEISFWYESYNNP--------TKKGLLCWGTRVRIIEGIAQGLLYLHQYSRLRVIHRDLKASNILLDKDMNPKISDFGMA 312 (476)
Q Consensus 241 ~~~~l~~Ey~~~~--------~~~~~L~~~~~~~i~~qIa~gL~yLH~~~~~~ivH~DLkp~NILld~~~~~kL~DFGla 312 (476)
+..++++||++.+ ..+..+++.++..++.||+.||+|||+.+ .+++||||||+||+++.++.++|+|||++
T Consensus 82 ~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~-~~i~H~dikp~Nil~~~~~~~~l~~~~~~ 160 (271)
T 3kmu_A 82 PHPTLITHWMPYGSLYNVLHEGTNFVVDQSQAVKFALDMARGMAFLHTLE-PLIPRHALNSRSVMIDEDMTARISMADVK 160 (271)
T ss_dssp SSCEEEEECCTTCBHHHHHHSCSSCCCCHHHHHHHHHHHHHHHHHHTTSS-SCCTTCCCSGGGEEECTTSCEEEEGGGSC
T ss_pred CCeEeeecccCCCcHHHHHhhcccCCCCHHHHHHHHHHHHHHHHHHhcCC-CceecCCCccceEEEcCCcceeEEeccce
Confidence 4578899999832 22336999999999999999999999875 45999999999999999999999999887
Q ss_pred eecCCCcccccceeeeeccCCCChhhhccCCCC---ccceEEeehhhhhhhhhCCCCCCcCCCCchhhhhhhhhhhcCCC
Q 045315 313 RMFGGDELQSNTKRIVGTYGYMSPEYALRGLFS---IKSDVFSFGVLLLETLSSKKNTHFYNTDSLTLLGHAWNLWNDGR 389 (476)
Q Consensus 313 ~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~s---~ksDVwSlGvvl~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~ 389 (476)
...... ...||+.|+|||.+.+..++ .++||||||+++|||++|+.||........ .......+.
T Consensus 161 ~~~~~~-------~~~~t~~y~aPE~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~~-----~~~~~~~~~ 228 (271)
T 3kmu_A 161 FSFQSP-------GRMYAPAWVAPEALQKKPEDTNRRSADMWSFAVLLWELVTREVPFADLSNMEI-----GMKVALEGL 228 (271)
T ss_dssp CTTSCT-------TCBSCGGGSCHHHHHSCGGGSCHHHHHHHHHHHHHHHHHHCSCTTTTSCHHHH-----HHHHHHSCC
T ss_pred eeeccc-------CccCCccccChhhhccCCCCCCCchhhHHHHHHHHHHHHhCCCCccccChHHH-----HHHHHhcCC
Confidence 543221 24678999999999876544 489999999999999999999865432111 111111111
Q ss_pred cccccCcccCCCCCHHHHHHHHHHHHHchhhcccCCCCHHHHHHHHhccc
Q 045315 390 TWELMDPISQNGASYPILKRYINVALLCVQEKAADRPAMSEVVSMLSNEF 439 (476)
Q Consensus 390 ~~~~~d~~~~~~~~~~~~~~l~~li~~Cl~~dP~~RPt~~eVl~~L~~~~ 439 (476)
.. ..+......+.+++.+||+.||++|||++++++.|+.+.
T Consensus 229 ~~---------~~~~~~~~~~~~li~~~l~~~p~~Rps~~~il~~L~~l~ 269 (271)
T 3kmu_A 229 RP---------TIPPGISPHVSKLMKICMNEDPAKRPKFDMIVPILEKMQ 269 (271)
T ss_dssp CC---------CCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHC
T ss_pred CC---------CCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHhh
Confidence 11 111223456889999999999999999999999999865
|
| >1mqb_A Ephrin type-A receptor 2; tyrosine protein kinase, transferase; HET: ANP; 2.30A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=99.94 E-value=6.6e-28 Score=240.66 Aligned_cols=182 Identities=26% Similarity=0.404 Sum_probs=134.4
Q ss_pred cccceeeccCCCC-------CCCCCCChhhHHHHHHHHHHHHHHHhhcCCCceeecCCCccceEecCCCCceecccccee
Q 045315 241 DEISFWYESYNNP-------TKKGLLCWGTRVRIIEGIAQGLLYLHQYSRLRVIHRDLKASNILLDKDMNPKISDFGMAR 313 (476)
Q Consensus 241 ~~~~l~~Ey~~~~-------~~~~~L~~~~~~~i~~qIa~gL~yLH~~~~~~ivH~DLkp~NILld~~~~~kL~DFGla~ 313 (476)
+..+++|||++.. .....+++.+++.++.||+.||+|||+++ |+||||||+||+++.++.+||+|||+++
T Consensus 119 ~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~---ivH~Dikp~NIl~~~~~~~kl~Dfg~~~ 195 (333)
T 1mqb_A 119 KPMMIITEYMENGALDKFLREKDGEFSVLQLVGMLRGIAAGMKYLANMN---YVHRDLAARNILVNSNLVCKVSDFGLSR 195 (333)
T ss_dssp SSEEEEEECCTTEEHHHHHHHTTTCSCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEECTTCCEEECCCCC--
T ss_pred CCcEEEEeCCCCCcHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHhCC---eeCCCCChheEEECCCCcEEECCCCcch
Confidence 4678999999832 23467999999999999999999999999 9999999999999999999999999998
Q ss_pred ecCCCcccc-cceeeeeccCCCChhhhccCCCCccceEEeehhhhhhhhh-CCCCCCcCCCCchhhhhhhhhhhcCCCcc
Q 045315 314 MFGGDELQS-NTKRIVGTYGYMSPEYALRGLFSIKSDVFSFGVLLLETLS-SKKNTHFYNTDSLTLLGHAWNLWNDGRTW 391 (476)
Q Consensus 314 ~~~~~~~~~-~~~~~~gt~~y~aPE~l~~~~~s~ksDVwSlGvvl~ellt-G~~p~~~~~~~~~~~~~~~~~~~~~~~~~ 391 (476)
......... ......++..|+|||.+.+..++.++|||||||++|||++ |+.||..... ..... ....+...
T Consensus 196 ~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~pf~~~~~--~~~~~----~~~~~~~~ 269 (333)
T 1mqb_A 196 VLEDDPEATYTTSGGKIPIRWTAPEAISYRKFTSASDVWSFGIVMWEVMTYGERPYWELSN--HEVMK----AINDGFRL 269 (333)
T ss_dssp ---------------CCCGGGSCHHHHHSCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCH--HHHHH----HHHTTCCC
T ss_pred hhccccccccccCCCCccccccCchhcccCCCCchhhhHHHHHHHHHHHcCCCCCcccCCH--HHHHH----HHHCCCcC
Confidence 765432111 1222345778999999999999999999999999999998 9999864321 11111 11111110
Q ss_pred cccCcccCCCCCHHHHHHHHHHHHHchhhcccCCCCHHHHHHHHhcccc
Q 045315 392 ELMDPISQNGASYPILKRYINVALLCVQEKAADRPAMSEVVSMLSNEFV 440 (476)
Q Consensus 392 ~~~d~~~~~~~~~~~~~~l~~li~~Cl~~dP~~RPt~~eVl~~L~~~~~ 440 (476)
..+......+.+++.+||+.||++||++.+|++.|+.+..
T Consensus 270 ---------~~~~~~~~~l~~li~~~l~~~p~~Rps~~~l~~~L~~~~~ 309 (333)
T 1mqb_A 270 ---------PTPMDCPSAIYQLMMQCWQQERARRPKFADIVSILDKLIR 309 (333)
T ss_dssp ---------CCCTTCBHHHHHHHHHHTCSSTTTSCCHHHHHHHHHHHHH
T ss_pred ---------CCcccCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHh
Confidence 1112234578899999999999999999999999998764
|
| >2buj_A Serine/threonine-protein kinase 16; transferase, ATP-binding, lipoprotein, myristate, PA phosphorylation; HET: STU; 2.6A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.94 E-value=7.2e-28 Score=237.92 Aligned_cols=183 Identities=19% Similarity=0.180 Sum_probs=136.9
Q ss_pred cccceeeccCCCCC----------CCCCCChhhHHHHHHHHHHHHHHHhhcCCCceeecCCCccceEecCCCCceecccc
Q 045315 241 DEISFWYESYNNPT----------KKGLLCWGTRVRIIEGIAQGLLYLHQYSRLRVIHRDLKASNILLDKDMNPKISDFG 310 (476)
Q Consensus 241 ~~~~l~~Ey~~~~~----------~~~~L~~~~~~~i~~qIa~gL~yLH~~~~~~ivH~DLkp~NILld~~~~~kL~DFG 310 (476)
..+++++||++... .+..+++.+++.++.||++||+|||+++ |+||||||+||+++.++.+||+|||
T Consensus 103 ~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~---ivH~dlkp~NIl~~~~~~~kl~dfg 179 (317)
T 2buj_A 103 HEAWLLLPFFKRGTLWNEIERLKDKGNFLTEDQILWLLLGICRGLEAIHAKG---YAHRDLKPTNILLGDEGQPVLMDLG 179 (317)
T ss_dssp EEEEEEEECCTTCBHHHHHHHHHTTTCCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEECTTSCEEECCCS
T ss_pred ceeEEEEEeCCCCcHHHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCC---cccCCCCHHHEEEcCCCCEEEEecC
Confidence 46778999998422 3567999999999999999999999998 9999999999999999999999999
Q ss_pred ceeecCCCccc-------ccceeeeeccCCCChhhhccCC---CCccceEEeehhhhhhhhhCCCCCCcCCCCchhhhhh
Q 045315 311 MARMFGGDELQ-------SNTKRIVGTYGYMSPEYALRGL---FSIKSDVFSFGVLLLETLSSKKNTHFYNTDSLTLLGH 380 (476)
Q Consensus 311 la~~~~~~~~~-------~~~~~~~gt~~y~aPE~l~~~~---~s~ksDVwSlGvvl~elltG~~p~~~~~~~~~~~~~~ 380 (476)
++......... .......|+..|+|||.+.... ++.++||||||+++|||++|+.||.............
T Consensus 180 ~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~~~~~~~ 259 (317)
T 2buj_A 180 SMNQACIHVEGSRQALTLQDWAAQRCTISYRAPELFSVQSHCVIDERTDVWSLGCVLYAMMFGEGPYDMVFQKGDSVALA 259 (317)
T ss_dssp SCEESCEEEESHHHHHHHHHHHHHHSCGGGCCGGGSSCCSEEEECTHHHHHHHHHHHHHHHHSSCTTHHHHHTTSCHHHH
T ss_pred cchhcccccccccccccccccccccCCcccCCHhHhccCCCcCCCchhhHHHHHHHHHHHHhCCCChhhhhcccchhhHH
Confidence 98765321110 0011234689999999987543 6899999999999999999999986422111111110
Q ss_pred hhhhhcCCCcccccCcccCCCCCHHHHHHHHHHHHHchhhcccCCCCHHHHHHHHhccc
Q 045315 381 AWNLWNDGRTWELMDPISQNGASYPILKRYINVALLCVQEKAADRPAMSEVVSMLSNEF 439 (476)
Q Consensus 381 ~~~~~~~~~~~~~~d~~~~~~~~~~~~~~l~~li~~Cl~~dP~~RPt~~eVl~~L~~~~ 439 (476)
. ... ............+.+++.+||+.||.+||++.+|++.|+.+.
T Consensus 260 ~----~~~---------~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~L~~~~ 305 (317)
T 2buj_A 260 V----QNQ---------LSIPQSPRHSSALWQLLNSMMTVDPHQRPHIPLLLSQLEALQ 305 (317)
T ss_dssp H----HCC-----------CCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHTC
T ss_pred h----hcc---------CCCCccccCCHHHHHHHHHHhhcChhhCCCHHHHHHHhhhcC
Confidence 0 000 000111223457889999999999999999999999999875
|
| >3t9t_A Tyrosine-protein kinase ITK/TSK; kinase domain, alpha/beta, ATP binding, phosphorylation, intracellular, transferase-transferase inhibitor complex; HET: IAQ; 1.65A {Homo sapiens} PDB: 3v5l_A* 3v5j_A* 3v8t_A* 3v8w_A* 1sm2_A* 1snu_A* 1snx_A 3qgw_A* 3qgy_A* 3miy_A* 3mj1_A* 3mj2_A* | Back alignment and structure |
|---|
Probab=99.94 E-value=5.3e-28 Score=232.60 Aligned_cols=180 Identities=29% Similarity=0.380 Sum_probs=138.5
Q ss_pred cccceeeccCCCC-------CCCCCCChhhHHHHHHHHHHHHHHHhhcCCCceeecCCCccceEecCCCCceecccccee
Q 045315 241 DEISFWYESYNNP-------TKKGLLCWGTRVRIIEGIAQGLLYLHQYSRLRVIHRDLKASNILLDKDMNPKISDFGMAR 313 (476)
Q Consensus 241 ~~~~l~~Ey~~~~-------~~~~~L~~~~~~~i~~qIa~gL~yLH~~~~~~ivH~DLkp~NILld~~~~~kL~DFGla~ 313 (476)
+..++++||++.. ..+..+++.++..++.|++.||+|||+++ ++||||||+||+++.++.+||+|||++.
T Consensus 76 ~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~---i~H~dl~p~Nili~~~~~~kl~dfg~~~ 152 (267)
T 3t9t_A 76 APICLVTEFMEHGCLSDYLRTQRGLFAAETLLGMCLDVCEGMAYLEEAC---VIHRDLAARNCLVGENQVIKVSDFGMTR 152 (267)
T ss_dssp SSCEEEECCCTTCBHHHHHHHTTTCCCHHHHHHHHHHHHHHHHHHHHTT---CCCSSCCGGGEEECGGGCEEECCTTGGG
T ss_pred CCeEEEEeCCCCCcHHHHHhhCcccCCHHHHHHHHHHHHHHHHHHHhCC---cccCCCchheEEECCCCCEEEccccccc
Confidence 4578899999733 23457999999999999999999999999 9999999999999999999999999998
Q ss_pred ecCCCcccccceeeeeccCCCChhhhccCCCCccceEEeehhhhhhhhh-CCCCCCcCCCCchhhhhhhhhhhcCCCccc
Q 045315 314 MFGGDELQSNTKRIVGTYGYMSPEYALRGLFSIKSDVFSFGVLLLETLS-SKKNTHFYNTDSLTLLGHAWNLWNDGRTWE 392 (476)
Q Consensus 314 ~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~s~ksDVwSlGvvl~ellt-G~~p~~~~~~~~~~~~~~~~~~~~~~~~~~ 392 (476)
........ ......++..|+|||.+.+..++.++||||||+++|||++ |+.||..... ...... ...+..
T Consensus 153 ~~~~~~~~-~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~~g~~p~~~~~~--~~~~~~----i~~~~~-- 223 (267)
T 3t9t_A 153 FVLDDQYT-SSTGTKFPVKWASPEVFSFSRYSSKSDVWSFGVLMWEVFSEGKIPYENRSN--SEVVED----ISTGFR-- 223 (267)
T ss_dssp GBCCHHHH-STTSTTCCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCH--HHHHHH----HHTTCC--
T ss_pred cccccccc-ccccccccccccChhhhcCCCccchhchhhhHHHHHHHhccCCCCCCCCCH--HHHHHH----HhcCCc--
Confidence 65432211 1122346778999999998999999999999999999999 8888764321 111111 111110
Q ss_pred ccCcccCCCCCHHHHHHHHHHHHHchhhcccCCCCHHHHHHHHhccc
Q 045315 393 LMDPISQNGASYPILKRYINVALLCVQEKAADRPAMSEVVSMLSNEF 439 (476)
Q Consensus 393 ~~d~~~~~~~~~~~~~~l~~li~~Cl~~dP~~RPt~~eVl~~L~~~~ 439 (476)
. ..+......+.+++.+||+.||++||++.++++.|+++.
T Consensus 224 ~-------~~~~~~~~~l~~li~~~l~~~p~~Rps~~~ll~~L~~l~ 263 (267)
T 3t9t_A 224 L-------YKPRLASTHVYQIMNHCWRERPEDRPAFSRLLRQLAEIA 263 (267)
T ss_dssp C-------CCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHH
T ss_pred C-------CCCccCcHHHHHHHHHHccCChhhCcCHHHHHHHHHHHH
Confidence 0 011122356889999999999999999999999999865
|
| >3lm5_A Serine/threonine-protein kinase 17B; STK17B, serine/threonine kinase 17B, DRAK2, DAP kinase relat apoptosis-inducing protein kinase 2; HET: QUE; 2.29A {Homo sapiens} PDB: 3lm0_A* | Back alignment and structure |
|---|
Probab=99.94 E-value=4.7e-27 Score=233.82 Aligned_cols=176 Identities=22% Similarity=0.287 Sum_probs=132.4
Q ss_pred cccceeeccCCCC--------CCCCCCChhhHHHHHHHHHHHHHHHhhcCCCceeecCCCccceEecC---CCCceeccc
Q 045315 241 DEISFWYESYNNP--------TKKGLLCWGTRVRIIEGIAQGLLYLHQYSRLRVIHRDLKASNILLDK---DMNPKISDF 309 (476)
Q Consensus 241 ~~~~l~~Ey~~~~--------~~~~~L~~~~~~~i~~qIa~gL~yLH~~~~~~ivH~DLkp~NILld~---~~~~kL~DF 309 (476)
+..++++||++.+ ...+.+++.++..++.||+.||+|||+++ |+||||||+||+++. ++.+||+||
T Consensus 102 ~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~i~~ql~~~L~~LH~~g---ivH~Dikp~NIl~~~~~~~~~~kL~Df 178 (327)
T 3lm5_A 102 SEIILILEYAAGGEIFSLCLPELAEMVSENDVIRLIKQILEGVYYLHQNN---IVHLDLKPQNILLSSIYPLGDIKIVDF 178 (327)
T ss_dssp SEEEEEEECCTTEEGGGGGSSCC-CCCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCCGGGEEESCBTTBCCEEECCG
T ss_pred CeEEEEEEecCCCcHHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHHCC---eecCcCChHHEEEecCCCCCcEEEeeC
Confidence 4678899999732 33567999999999999999999999999 999999999999997 789999999
Q ss_pred cceeecCCCcccccceeeeeccCCCChhhhccCCCCccceEEeehhhhhhhhhCCCCCCcCCCCchhhhhhhhhhhcCCC
Q 045315 310 GMARMFGGDELQSNTKRIVGTYGYMSPEYALRGLFSIKSDVFSFGVLLLETLSSKKNTHFYNTDSLTLLGHAWNLWNDGR 389 (476)
Q Consensus 310 Gla~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~s~ksDVwSlGvvl~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~ 389 (476)
|+++....... .....|++.|+|||.+.+..++.++||||||+++|||++|+.||........ ....... ..
T Consensus 179 g~a~~~~~~~~---~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~--~~~i~~~--~~- 250 (327)
T 3lm5_A 179 GMSRKIGHACE---LREIMGTPEYLAPEILNYDPITTATDMWNIGIIAYMLLTHTSPFVGEDNQET--YLNISQV--NV- 250 (327)
T ss_dssp GGCEEC------------CCCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHH--HHHHHHT--CC-
T ss_pred ccccccCCccc---cccccCCcCccCCeeecCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCchHH--HHHHHhc--cc-
Confidence 99987654321 2235689999999999999999999999999999999999999865432111 1111000 00
Q ss_pred cccccCcccCCCCCHHHHHHHHHHHHHchhhcccCCCCHHHHHHH
Q 045315 390 TWELMDPISQNGASYPILKRYINVALLCVQEKAADRPAMSEVVSM 434 (476)
Q Consensus 390 ~~~~~d~~~~~~~~~~~~~~l~~li~~Cl~~dP~~RPt~~eVl~~ 434 (476)
.............+.+++.+||+.||++|||++++++.
T Consensus 251 -------~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~~ll~h 288 (327)
T 3lm5_A 251 -------DYSEETFSSVSQLATDFIQSLLVKNPEKRPTAEICLSH 288 (327)
T ss_dssp -------CCCTTTTTTSCHHHHHHHHHHSCSSGGGSCCHHHHTTC
T ss_pred -------ccCchhhcccCHHHHHHHHHHcCCChhhCcCHHHHhCC
Confidence 00011112234568899999999999999999999763
|
| >3h4j_B AMPK kdaid, SNF1-like protein kinase SSP2; ATP-binding, nucleotide-binding, phosphoprotei serine/threonine-protein kinase, transferase; 2.80A {Schizosaccharomyces pombe} | Back alignment and structure |
|---|
Probab=99.94 E-value=1.3e-27 Score=239.25 Aligned_cols=171 Identities=22% Similarity=0.293 Sum_probs=133.3
Q ss_pred cccceeeccCCCC-----CCCCCCChhhHHHHHHHHHHHHHHHhhcCCCceeecCCCccceEecCCCCceeccccceeec
Q 045315 241 DEISFWYESYNNP-----TKKGLLCWGTRVRIIEGIAQGLLYLHQYSRLRVIHRDLKASNILLDKDMNPKISDFGMARMF 315 (476)
Q Consensus 241 ~~~~l~~Ey~~~~-----~~~~~L~~~~~~~i~~qIa~gL~yLH~~~~~~ivH~DLkp~NILld~~~~~kL~DFGla~~~ 315 (476)
+..+++|||+... ..++.+++.++..++.||+.||+|||+.+ |+||||||+|||++.++.+||+|||++...
T Consensus 82 ~~~~lv~E~~~g~l~~~l~~~~~l~~~~~~~i~~qi~~aL~~LH~~g---ivH~Dlkp~NIll~~~~~~kl~DFG~s~~~ 158 (336)
T 3h4j_B 82 TDIVMVIEYAGGELFDYIVEKKRMTEDEGRRFFQQIICAIEYCHRHK---IVHRDLKPENLLLDDNLNVKIADFGLSNIM 158 (336)
T ss_dssp SEEEEEECCCCEEHHHHHHHHCSCCHHHHHHHHHHHHHHHHHHHHHT---CCCCCCSTTTEEECTTCCEEECCSSCTBTT
T ss_pred CEEEEEEECCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCC---eEecCCchhhEEEcCCCCEEEEEeccceec
Confidence 4678999999621 12457999999999999999999999999 999999999999999999999999999876
Q ss_pred CCCcccccceeeeeccCCCChhhhccCCC-CccceEEeehhhhhhhhhCCCCCCcCCCCchhhhhhhhhhhcCCCccccc
Q 045315 316 GGDELQSNTKRIVGTYGYMSPEYALRGLF-SIKSDVFSFGVLLLETLSSKKNTHFYNTDSLTLLGHAWNLWNDGRTWELM 394 (476)
Q Consensus 316 ~~~~~~~~~~~~~gt~~y~aPE~l~~~~~-s~ksDVwSlGvvl~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 394 (476)
..... .....||+.|+|||.+.+..+ +.++|||||||++|+|++|+.||........ . .....+.
T Consensus 159 ~~~~~---~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~Pf~~~~~~~~--~----~~i~~~~----- 224 (336)
T 3h4j_B 159 TDGNF---LKTSCGSPNYAAPEVINGKLYAGPEVDVWSCGIVLYVMLVGRLPFDDEFIPNL--F----KKVNSCV----- 224 (336)
T ss_dssp TTSBT---TCCCTTSTTTSCGGGSCCSGGGCHHHHHHHHHHHHHHHHHSSCSSBCSSSTTC--B----CCCCSSC-----
T ss_pred cCCcc---cccccCCcCcCCHHHHcCCCCCCCccchhHHHHHHHHHHhCCCCCCCccHHHH--H----HHHHcCC-----
Confidence 54322 223568999999999988776 7899999999999999999999865431110 0 0000000
Q ss_pred CcccCCCCCHHHHHHHHHHHHHchhhcccCCCCHHHHHH
Q 045315 395 DPISQNGASYPILKRYINVALLCVQEKAADRPAMSEVVS 433 (476)
Q Consensus 395 d~~~~~~~~~~~~~~l~~li~~Cl~~dP~~RPt~~eVl~ 433 (476)
...+......+.+++.+||+.||.+|||++|+++
T Consensus 225 -----~~~p~~~s~~~~~li~~~L~~dP~~Rpt~~eil~ 258 (336)
T 3h4j_B 225 -----YVMPDFLSPGAQSLIRRMIVADPMQRITIQEIRR 258 (336)
T ss_dssp -----CCCCTTSCHHHHHHHHTTSCSSGGGSCCHHHHTT
T ss_pred -----CCCcccCCHHHHHHHHHHcCCChhHCcCHHHHHh
Confidence 0111223456889999999999999999999976
|
| >2bdw_A Hypothetical protein K11E8.1D; kinase, calmodulin activated, transferase; 1.80A {Caenorhabditis elegans} PDB: 2wel_A* 2v7o_A* 2vz6_A* 1cdm_B 1cm1_B 1cm4_B | Back alignment and structure |
|---|
Probab=99.94 E-value=3.7e-27 Score=238.23 Aligned_cols=176 Identities=19% Similarity=0.277 Sum_probs=134.6
Q ss_pred cccceeeccCCCC------CCCCCCChhhHHHHHHHHHHHHHHHhhcCCCceeecCCCccceEecCC---CCceeccccc
Q 045315 241 DEISFWYESYNNP------TKKGLLCWGTRVRIIEGIAQGLLYLHQYSRLRVIHRDLKASNILLDKD---MNPKISDFGM 311 (476)
Q Consensus 241 ~~~~l~~Ey~~~~------~~~~~L~~~~~~~i~~qIa~gL~yLH~~~~~~ivH~DLkp~NILld~~---~~~kL~DFGl 311 (476)
+..+++|||++.+ ..++.+++.++..++.||+.||+|||+++ |+||||||+|||++.+ +.+||+|||+
T Consensus 101 ~~~~lv~e~~~gg~L~~~l~~~~~~~~~~~~~~~~qi~~al~~lH~~~---ivH~Dlkp~NIll~~~~~~~~~kl~DfG~ 177 (362)
T 2bdw_A 101 SFHYLVFDLVTGGELFEDIVAREFYSEADASHCIQQILESIAYCHSNG---IVHRNLKPENLLLASKAKGAAVKLADFGL 177 (362)
T ss_dssp SEEEEEECCCCSCBHHHHHTTCSCCCHHHHHHHHHHHHHHHHHHHHTT---CBCCCCSGGGEEESCSSTTCCEEECCCTT
T ss_pred CEEEEEEecCCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCC---eEeccCchHHEEEecCCCCCCEEEeecCc
Confidence 4578999999843 24567999999999999999999999999 9999999999999865 4599999999
Q ss_pred eeecCCCcccccceeeeeccCCCChhhhccCCCCccceEEeehhhhhhhhhCCCCCCcCCCCchhhhhhhhhhhcCCCcc
Q 045315 312 ARMFGGDELQSNTKRIVGTYGYMSPEYALRGLFSIKSDVFSFGVLLLETLSSKKNTHFYNTDSLTLLGHAWNLWNDGRTW 391 (476)
Q Consensus 312 a~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~s~ksDVwSlGvvl~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~ 391 (476)
+........ .....||+.|+|||++.+..++.++|||||||++|+|++|+.||..... ..+.... ..+..
T Consensus 178 a~~~~~~~~---~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~Pf~~~~~--~~~~~~i----~~~~~- 247 (362)
T 2bdw_A 178 AIEVNDSEA---WHGFAGTPGYLSPEVLKKDPYSKPVDIWACGVILYILLVGYPPFWDEDQ--HRLYAQI----KAGAY- 247 (362)
T ss_dssp CBCCTTCCS---CCCSCSCTTTCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSSCCSSH--HHHHHHH----HHTCC-
T ss_pred ceEecCCcc---cccCCCCccccCHHHHccCCCCchhhHHHHHHHHHHHHHCCCCCCCCCH--HHHHHHH----HhCCC-
Confidence 987654321 2235689999999999998999999999999999999999999864321 1111111 11111
Q ss_pred cccCcccCCCCCHHHHHHHHHHHHHchhhcccCCCCHHHHHHH
Q 045315 392 ELMDPISQNGASYPILKRYINVALLCVQEKAADRPAMSEVVSM 434 (476)
Q Consensus 392 ~~~d~~~~~~~~~~~~~~l~~li~~Cl~~dP~~RPt~~eVl~~ 434 (476)
....+ ........+.+++.+||+.||++||++.|+++.
T Consensus 248 ~~~~~-----~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~h 285 (362)
T 2bdw_A 248 DYPSP-----EWDTVTPEAKSLIDSMLTVNPKKRITADQALKV 285 (362)
T ss_dssp CCCTT-----GGGGSCHHHHHHHHHHSCSSGGGSCCHHHHTTS
T ss_pred CCCcc-----cccCCCHHHHHHHHHHcCCChhhCcCHHHHhcC
Confidence 00000 011234578899999999999999999998753
|
| >4dc2_A Protein kinase C IOTA type; kinase, substrate, cell polarity, atypical PKC, trans transferase substrate complex; HET: TPO ADE; 2.40A {Mus musculus} | Back alignment and structure |
|---|
Probab=99.94 E-value=2e-27 Score=242.77 Aligned_cols=173 Identities=20% Similarity=0.269 Sum_probs=131.9
Q ss_pred cccceeeccCCCCC------CCCCCChhhHHHHHHHHHHHHHHHhhcCCCceeecCCCccceEecCCCCceeccccceee
Q 045315 241 DEISFWYESYNNPT------KKGLLCWGTRVRIIEGIAQGLLYLHQYSRLRVIHRDLKASNILLDKDMNPKISDFGMARM 314 (476)
Q Consensus 241 ~~~~l~~Ey~~~~~------~~~~L~~~~~~~i~~qIa~gL~yLH~~~~~~ivH~DLkp~NILld~~~~~kL~DFGla~~ 314 (476)
+..+++|||++.+. +.+.+++.++..++.||+.||+|||+++ |+||||||+|||++.++.+||+|||+++.
T Consensus 126 ~~~~lV~E~~~gg~L~~~l~~~~~l~~~~~~~~~~qi~~aL~~LH~~g---ivHrDLKp~NILl~~~g~ikL~DFGla~~ 202 (396)
T 4dc2_A 126 SRLFFVIEYVNGGDLMFHMQRQRKLPEEHARFYSAEISLALNYLHERG---IIYRDLKLDNVLLDSEGHIKLTDYGMCKE 202 (396)
T ss_dssp SEEEEEEECCTTCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTT---CBCCCCCGGGEEECTTSCEEECCCTTCBC
T ss_pred CEEEEEEEcCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCC---EEeccCCHHHEEECCCCCEEEeecceeee
Confidence 46889999998432 3467999999999999999999999999 99999999999999999999999999985
Q ss_pred cCCCcccccceeeeeccCCCChhhhccCCCCccceEEeehhhhhhhhhCCCCCCcCCCCc---hhhhhhhhhhhcCCCcc
Q 045315 315 FGGDELQSNTKRIVGTYGYMSPEYALRGLFSIKSDVFSFGVLLLETLSSKKNTHFYNTDS---LTLLGHAWNLWNDGRTW 391 (476)
Q Consensus 315 ~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~s~ksDVwSlGvvl~elltG~~p~~~~~~~~---~~~~~~~~~~~~~~~~~ 391 (476)
..... .......||+.|+|||++.+..++.++|+|||||++|||++|+.||....... ................
T Consensus 203 ~~~~~--~~~~~~~gt~~Y~aPE~l~~~~~~~~~DiwslGvllyell~G~~Pf~~~~~~~~~~~~~~~~~~~~i~~~~~- 279 (396)
T 4dc2_A 203 GLRPG--DTTSTFCGTPNYIAPEILRGEDYGFSVDWWALGVLMFEMMAGRSPFDIVGSSDNPDQNTEDYLFQVILEKQI- 279 (396)
T ss_dssp CCCTT--CCBCCCCBCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSTTTTC------CCHHHHHHHHHHCCC-
T ss_pred cccCC--CccccccCCcccCCchhhcCCCCChHHHHHHHHHHHHHHHhCCCCCcccccccccchhhHHHHHHHHhcccc-
Confidence 32221 12334679999999999999999999999999999999999999996432111 0001111111111111
Q ss_pred cccCcccCCCCCHHHHHHHHHHHHHchhhcccCCCCH
Q 045315 392 ELMDPISQNGASYPILKRYINVALLCVQEKAADRPAM 428 (476)
Q Consensus 392 ~~~d~~~~~~~~~~~~~~l~~li~~Cl~~dP~~RPt~ 428 (476)
..+......+.+++.+||+.||++||++
T Consensus 280 ---------~~p~~~s~~~~~li~~lL~~dP~~R~~~ 307 (396)
T 4dc2_A 280 ---------RIPRSLSVKAASVLKSFLNKDPKERLGC 307 (396)
T ss_dssp ---------CCCTTSCHHHHHHHHHHTCSCTTTSTTC
T ss_pred ---------CCCCcCCHHHHHHHHHHhcCCHhHcCCC
Confidence 1112234568899999999999999985
|
| >4e7w_A Glycogen synthase kinase 3; GSK3, PTyr195, transferase; HET: PTR; 3.30A {Ustilago maydis} | Back alignment and structure |
|---|
Probab=99.94 E-value=2.7e-27 Score=241.97 Aligned_cols=185 Identities=16% Similarity=0.145 Sum_probs=133.7
Q ss_pred cceeeccCCCC---------CCCCCCChhhHHHHHHHHHHHHHHHhhcCCCceeecCCCccceEec-CCCCceeccccce
Q 045315 243 ISFWYESYNNP---------TKKGLLCWGTRVRIIEGIAQGLLYLHQYSRLRVIHRDLKASNILLD-KDMNPKISDFGMA 312 (476)
Q Consensus 243 ~~l~~Ey~~~~---------~~~~~L~~~~~~~i~~qIa~gL~yLH~~~~~~ivH~DLkp~NILld-~~~~~kL~DFGla 312 (476)
.+++|||++.. ..+..+++..+..++.||+.||+|||+++ |+||||||+|||++ .++.+||+|||++
T Consensus 113 ~~lv~e~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~qi~~aL~~LH~~~---ivHrDlkp~Nill~~~~~~~kL~DFG~a 189 (394)
T 4e7w_A 113 LNLVLEYVPETVYRASRHYAKLKQTMPMLLIKLYMYQLLRSLAYIHSIG---ICHRDIKPQNLLLDPPSGVLKLIDFGSA 189 (394)
T ss_dssp EEEEEECCSEEHHHHHHHHHHTTSCCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEEETTTTEEEECCCTTC
T ss_pred EEEEeeccCccHHHHHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHHCC---ccCCCCCHHHEEEcCCCCcEEEeeCCCc
Confidence 56889999821 23568999999999999999999999999 99999999999999 7899999999999
Q ss_pred eecCCCcccccceeeeeccCCCChhhhccC-CCCccceEEeehhhhhhhhhCCCCCCcCCCCchhhhhhhhh--------
Q 045315 313 RMFGGDELQSNTKRIVGTYGYMSPEYALRG-LFSIKSDVFSFGVLLLETLSSKKNTHFYNTDSLTLLGHAWN-------- 383 (476)
Q Consensus 313 ~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~-~~s~ksDVwSlGvvl~elltG~~p~~~~~~~~~~~~~~~~~-------- 383 (476)
+........ ....+|+.|+|||.+.+. .++.++|||||||++|||++|+.||........ +......
T Consensus 190 ~~~~~~~~~---~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlG~il~ell~g~~pf~~~~~~~~-l~~i~~~~g~p~~~~ 265 (394)
T 4e7w_A 190 KILIAGEPN---VSYICSRYYRAPELIFGATNYTTNIDIWSTGCVMAELMQGQPLFPGESGIDQ-LVEIIKVLGTPSREQ 265 (394)
T ss_dssp EECCTTCCC---CSSCSCGGGCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHH-HHHHHHHHCCCCHHH
T ss_pred ccccCCCCC---cccccCcCccCHHHHcCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHH-HHHHHHHhCCCCHHH
Confidence 876443221 234689999999998764 589999999999999999999999976431111 1100000
Q ss_pred ------hhcCCCcccccCcccCCCCCHHHHHHHHHHHHHchhhcccCCCCHHHHHHH
Q 045315 384 ------LWNDGRTWELMDPISQNGASYPILKRYINVALLCVQEKAADRPAMSEVVSM 434 (476)
Q Consensus 384 ------~~~~~~~~~~~d~~~~~~~~~~~~~~l~~li~~Cl~~dP~~RPt~~eVl~~ 434 (476)
..........................+.+++.+||+.||++|||+.|+++.
T Consensus 266 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~h 322 (394)
T 4e7w_A 266 IKTMNPNYMEHKFPQIRPHPFSKVFRPRTPPDAIDLISRLLEYTPSARLTAIEALCH 322 (394)
T ss_dssp HHHHCGGGSSSCCCCCCCCCHHHHSCTTCCHHHHHHHHHHCCSSGGGSCCHHHHHTS
T ss_pred HHhhChhhhhhccccccCCcHHHhccccCCHHHHHHHHHHhCCChhhCCCHHHHhcC
Confidence 000000000000000000111234578999999999999999999999863
|
| >3llt_A Serine/threonine kinase-1, pflammer; lammer kinase, malaria, structural GE structural genomics consortium, SGC, transferase; HET: ANP; 2.50A {Plasmodium falciparum 3D7} | Back alignment and structure |
|---|
Probab=99.94 E-value=1.1e-27 Score=241.07 Aligned_cols=122 Identities=28% Similarity=0.352 Sum_probs=104.8
Q ss_pred cccceeeccCCC-------CCCCCCCChhhHHHHHHHHHHHHHHHhhcCCCceeecCCCccceEecC-------------
Q 045315 241 DEISFWYESYNN-------PTKKGLLCWGTRVRIIEGIAQGLLYLHQYSRLRVIHRDLKASNILLDK------------- 300 (476)
Q Consensus 241 ~~~~l~~Ey~~~-------~~~~~~L~~~~~~~i~~qIa~gL~yLH~~~~~~ivH~DLkp~NILld~------------- 300 (476)
+..+++|||+.. ......+++.++..++.||+.||+|||+.+ |+||||||+|||++.
T Consensus 109 ~~~~lv~e~~~~~L~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~---ivHrDlkp~NIll~~~~~~~~~~~~~~~ 185 (360)
T 3llt_A 109 DHMCLIFEPLGPSLYEIITRNNYNGFHIEDIKLYCIEILKALNYLRKMS---LTHTDLKPENILLDDPYFEKSLITVRRV 185 (360)
T ss_dssp TEEEEEECCCCCBHHHHHHHTTTCCCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEESCTTCCEEEEEEECT
T ss_pred CeeEEEEcCCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHHCC---eeeCCCCcccEEEccccccccccchhcc
Confidence 457788999851 123346999999999999999999999999 999999999999975
Q ss_pred ------------CCCceeccccceeecCCCcccccceeeeeccCCCChhhhccCCCCccceEEeehhhhhhhhhCCCCCC
Q 045315 301 ------------DMNPKISDFGMARMFGGDELQSNTKRIVGTYGYMSPEYALRGLFSIKSDVFSFGVLLLETLSSKKNTH 368 (476)
Q Consensus 301 ------------~~~~kL~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~s~ksDVwSlGvvl~elltG~~p~~ 368 (476)
++.+||+|||++....... ....||+.|+|||.+.+..++.++|||||||++|||++|+.||.
T Consensus 186 ~~~~~~~~~~~~~~~~kl~DFG~a~~~~~~~-----~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~pf~ 260 (360)
T 3llt_A 186 TDGKKIQIYRTKSTGIKLIDFGCATFKSDYH-----GSIINTRQYRAPEVILNLGWDVSSDMWSFGCVLAELYTGSLLFR 260 (360)
T ss_dssp TTCCEEEEEEESCCCEEECCCTTCEETTSCC-----CSCCSCGGGCCHHHHTTCCCCTTHHHHHHHHHHHHHHHSSCSCC
T ss_pred cccccccccccCCCCEEEEeccCceecCCCC-----cCccCcccccCcHHHcCCCCCCccchHHHHHHHHHHHHCCCCCC
Confidence 7889999999998754322 23568999999999999999999999999999999999999986
Q ss_pred cC
Q 045315 369 FY 370 (476)
Q Consensus 369 ~~ 370 (476)
..
T Consensus 261 ~~ 262 (360)
T 3llt_A 261 TH 262 (360)
T ss_dssp CS
T ss_pred CC
Confidence 54
|
| >2yab_A Death-associated protein kinase 2; apoptosis, transferase; HET: AMP; 1.90A {Mus musculus} PDB: 2yaa_A* 2ya9_A* | Back alignment and structure |
|---|
Probab=99.94 E-value=3e-27 Score=238.84 Aligned_cols=175 Identities=21% Similarity=0.234 Sum_probs=135.1
Q ss_pred cccceeeccCCCC------CCCCCCChhhHHHHHHHHHHHHHHHhhcCCCceeecCCCccceEecCCC----Cceecccc
Q 045315 241 DEISFWYESYNNP------TKKGLLCWGTRVRIIEGIAQGLLYLHQYSRLRVIHRDLKASNILLDKDM----NPKISDFG 310 (476)
Q Consensus 241 ~~~~l~~Ey~~~~------~~~~~L~~~~~~~i~~qIa~gL~yLH~~~~~~ivH~DLkp~NILld~~~----~~kL~DFG 310 (476)
+..+++|||++.+ ..++.+++.++..++.||+.||+|||+.+ |+||||||+|||++.++ .+||+|||
T Consensus 88 ~~~~lv~e~~~gg~L~~~l~~~~~l~~~~~~~i~~qi~~aL~~LH~~g---ivHrDlkp~NIll~~~~~~~~~vkl~DFG 164 (361)
T 2yab_A 88 TDVVLILELVSGGELFDFLAQKESLSEEEATSFIKQILDGVNYLHTKK---IAHFDLKPENIMLLDKNIPIPHIKLIDFG 164 (361)
T ss_dssp SEEEEEEECCCSCBHHHHHTTCSCCBHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEESCTTSSSCCEEECCCS
T ss_pred CEEEEEEEcCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCCHHHEEEeCCCCCccCEEEEecC
Confidence 4688999999733 24567999999999999999999999999 99999999999998776 79999999
Q ss_pred ceeecCCCcccccceeeeeccCCCChhhhccCCCCccceEEeehhhhhhhhhCCCCCCcCCCCchhhhhhhhhhhcCCCc
Q 045315 311 MARMFGGDELQSNTKRIVGTYGYMSPEYALRGLFSIKSDVFSFGVLLLETLSSKKNTHFYNTDSLTLLGHAWNLWNDGRT 390 (476)
Q Consensus 311 la~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~s~ksDVwSlGvvl~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~ 390 (476)
++........ .....||+.|+|||.+.+..++.++|||||||++|+|++|+.||..... ...... +..+..
T Consensus 165 ~a~~~~~~~~---~~~~~gt~~y~aPE~~~~~~~~~~~DiwslGvil~~ll~g~~Pf~~~~~--~~~~~~----i~~~~~ 235 (361)
T 2yab_A 165 LAHEIEDGVE---FKNIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASPFLGDTK--QETLAN----ITAVSY 235 (361)
T ss_dssp SCEECCTTCC---CCCCCSCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSCCSSCCSSH--HHHHHH----HHTTCC
T ss_pred CceEcCCCCc---cccCCCCccEECchHHcCCCCCccccHHHHHHHHHHHHhCCCCCCCCCH--HHHHHH----HHhcCC
Confidence 9987654321 2235699999999999998999999999999999999999999865431 111111 111110
Q ss_pred ccccCcccCCCCCHHHHHHHHHHHHHchhhcccCCCCHHHHHH
Q 045315 391 WELMDPISQNGASYPILKRYINVALLCVQEKAADRPAMSEVVS 433 (476)
Q Consensus 391 ~~~~d~~~~~~~~~~~~~~l~~li~~Cl~~dP~~RPt~~eVl~ 433 (476)
. .++.. .......+.+++.+||+.||++|||+.|+++
T Consensus 236 -~-~~~~~----~~~~s~~~~~li~~~L~~dP~~R~t~~e~l~ 272 (361)
T 2yab_A 236 -D-FDEEF----FSQTSELAKDFIRKLLVKETRKRLTIQEALR 272 (361)
T ss_dssp -C-CCHHH----HTTSCHHHHHHHHHHSCSSTTTSCCHHHHHT
T ss_pred -C-CCchh----ccCCCHHHHHHHHHHCCCChhHCcCHHHHhc
Confidence 0 00000 0112356889999999999999999999874
|
| >1fvr_A Tyrosine-protein kinase TIE-2; tyrosine kinase, transferase; 2.20A {Homo sapiens} SCOP: d.144.1.7 PDB: 2oo8_X* 2osc_A* 2p4i_A* 3l8p_A* 2wqb_A* | Back alignment and structure |
|---|
Probab=99.94 E-value=3.1e-27 Score=234.83 Aligned_cols=181 Identities=23% Similarity=0.273 Sum_probs=138.4
Q ss_pred cccceeeccCCCC----------------------CCCCCCChhhHHHHHHHHHHHHHHHhhcCCCceeecCCCccceEe
Q 045315 241 DEISFWYESYNNP----------------------TKKGLLCWGTRVRIIEGIAQGLLYLHQYSRLRVIHRDLKASNILL 298 (476)
Q Consensus 241 ~~~~l~~Ey~~~~----------------------~~~~~L~~~~~~~i~~qIa~gL~yLH~~~~~~ivH~DLkp~NILl 298 (476)
+.++++|||++.. .....+++.+++.++.||++||+|||+++ |+||||||+||++
T Consensus 99 ~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~---ivH~dlkp~NIl~ 175 (327)
T 1fvr_A 99 GYLYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADVARGMDYLSQKQ---FIHRDLAARNILV 175 (327)
T ss_dssp TEEEEEECCCTTCBHHHHHHTTCHHHHCHHHHHHTTBSCSSCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEE
T ss_pred CceEEEEecCCCCCHHHHHHhcccccccccccccccccccCCHHHHHHHHHHHHHHHHHHHhCC---ccCCCCccceEEE
Confidence 4678899998732 12357999999999999999999999999 9999999999999
Q ss_pred cCCCCceeccccceeecCCCcccccceeeeeccCCCChhhhccCCCCccceEEeehhhhhhhhh-CCCCCCcCCCCchhh
Q 045315 299 DKDMNPKISDFGMARMFGGDELQSNTKRIVGTYGYMSPEYALRGLFSIKSDVFSFGVLLLETLS-SKKNTHFYNTDSLTL 377 (476)
Q Consensus 299 d~~~~~kL~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~s~ksDVwSlGvvl~ellt-G~~p~~~~~~~~~~~ 377 (476)
+.++.+||+|||+++..... .......++..|+|||.+.+..++.++||||||+++|||++ |+.||..... ...
T Consensus 176 ~~~~~~kL~Dfg~~~~~~~~---~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~pf~~~~~--~~~ 250 (327)
T 1fvr_A 176 GENYVAKIADFGLSRGQEVY---VKKTMGRLPVRWMAIESLNYSVYTTNSDVWSYGVLLWEIVSLGGTPYCGMTC--AEL 250 (327)
T ss_dssp CGGGCEEECCTTCEESSCEE---CCC----CCTTTCCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCTTTTCCH--HHH
T ss_pred cCCCeEEEcccCcCcccccc---ccccCCCCCccccChhhhccccCCchhcchHHHHHHHHHHcCCCCCCCCCcH--HHH
Confidence 99999999999999743221 11222456889999999998889999999999999999998 9999864331 111
Q ss_pred hhhhhhhhcCCCcccccCcccCCCCCHHHHHHHHHHHHHchhhcccCCCCHHHHHHHHhccccCC
Q 045315 378 LGHAWNLWNDGRTWELMDPISQNGASYPILKRYINVALLCVQEKAADRPAMSEVVSMLSNEFVNL 442 (476)
Q Consensus 378 ~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~l~~li~~Cl~~dP~~RPt~~eVl~~L~~~~~~~ 442 (476)
.. ....+.. ...+......+.+++.+||+.||++|||++++++.|+.+..+.
T Consensus 251 ~~----~~~~~~~---------~~~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~~L~~~~~~~ 302 (327)
T 1fvr_A 251 YE----KLPQGYR---------LEKPLNCDDEVYDLMRQCWREKPYERPSFAQILVSLNRMLEER 302 (327)
T ss_dssp HH----HGGGTCC---------CCCCTTBCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHSS
T ss_pred HH----HhhcCCC---------CCCCCCCCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHHhh
Confidence 11 1111110 0111223457889999999999999999999999999987543
|
| >1byg_A CSK, protein (C-terminal SRC kinase); protein kinase, phosphorylation, staurosporine, transferase; HET: STU; 2.40A {Homo sapiens} SCOP: d.144.1.7 PDB: 3d7u_A 3d7t_A* | Back alignment and structure |
|---|
Probab=99.94 E-value=9.3e-28 Score=232.80 Aligned_cols=176 Identities=23% Similarity=0.276 Sum_probs=131.6
Q ss_pred cccceeeccCCCCC--------CCCCCChhhHHHHHHHHHHHHHHHhhcCCCceeecCCCccceEecCCCCceeccccce
Q 045315 241 DEISFWYESYNNPT--------KKGLLCWGTRVRIIEGIAQGLLYLHQYSRLRVIHRDLKASNILLDKDMNPKISDFGMA 312 (476)
Q Consensus 241 ~~~~l~~Ey~~~~~--------~~~~L~~~~~~~i~~qIa~gL~yLH~~~~~~ivH~DLkp~NILld~~~~~kL~DFGla 312 (476)
+.+++++||++..+ ....+++.++..++.|++.||+|||+++ ++||||||+||+++.++.+||+|||++
T Consensus 88 ~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~---i~H~dlkp~Nil~~~~~~~~l~Dfg~~ 164 (278)
T 1byg_A 88 GGLYIVTEYMAKGSLVDYLRSRGRSVLGGDCLLKFSLDVCEAMEYLEGNN---FVHRDLAARNVLVSEDNVAKVSDFGLT 164 (278)
T ss_dssp -CCEEEECCCTTEEHHHHHHHHHHHHCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCSGGGEEECTTSCEEECCCCC-
T ss_pred CceEEEEecCCCCCHHHHHHhcccccCCHHHHHHHHHHHHHHHHHHHhCC---ccccCCCcceEEEeCCCcEEEeecccc
Confidence 35788999987321 1224899999999999999999999999 999999999999999999999999999
Q ss_pred eecCCCcccccceeeeeccCCCChhhhccCCCCccceEEeehhhhhhhhh-CCCCCCcCCCCchhhhhhhhhhhcCCCcc
Q 045315 313 RMFGGDELQSNTKRIVGTYGYMSPEYALRGLFSIKSDVFSFGVLLLETLS-SKKNTHFYNTDSLTLLGHAWNLWNDGRTW 391 (476)
Q Consensus 313 ~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~s~ksDVwSlGvvl~ellt-G~~p~~~~~~~~~~~~~~~~~~~~~~~~~ 391 (476)
....... ....++..|+|||.+.+..++.++||||||+++|||++ |+.||....... ... ....+..
T Consensus 165 ~~~~~~~-----~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~t~g~~p~~~~~~~~--~~~----~~~~~~~- 232 (278)
T 1byg_A 165 KEASSTQ-----DTGKLPVKWTAPEALREKKFSTKSDVWSFGILLWEIYSFGRVPYPRIPLKD--VVP----RVEKGYK- 232 (278)
T ss_dssp ----------------CCTTTSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSCTTSCGGG--HHH----HHTTTCC-
T ss_pred ccccccc-----cCCCccccccCHHHhCCCCCCchhcHHHHHHHHHHHHhCCCCCCCCCCHHH--HHH----HHhcCCC-
Confidence 7654321 12357889999999999999999999999999999998 999886543211 111 1111111
Q ss_pred cccCcccCCCCCHHHHHHHHHHHHHchhhcccCCCCHHHHHHHHhccc
Q 045315 392 ELMDPISQNGASYPILKRYINVALLCVQEKAADRPAMSEVVSMLSNEF 439 (476)
Q Consensus 392 ~~~d~~~~~~~~~~~~~~l~~li~~Cl~~dP~~RPt~~eVl~~L~~~~ 439 (476)
...+......+.+++.+||+.||++||++.++++.|+.+.
T Consensus 233 --------~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~l~~~L~~i~ 272 (278)
T 1byg_A 233 --------MDAPDGCPPAVYEVMKNCWHLDAAMRPSFLQLREQLEHIK 272 (278)
T ss_dssp --------CCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHH
T ss_pred --------CCCcccCCHHHHHHHHHHhcCChhhCCCHHHHHHHHHHHH
Confidence 0111223457889999999999999999999999999864
|
| >1kob_A Twitchin; kinase, intrasteric regulation; 2.30A {Aplysia californica} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=99.94 E-value=6.3e-27 Score=238.64 Aligned_cols=176 Identities=20% Similarity=0.232 Sum_probs=135.6
Q ss_pred cccceeeccCCCC-------CCCCCCChhhHHHHHHHHHHHHHHHhhcCCCceeecCCCccceEecC--CCCceeccccc
Q 045315 241 DEISFWYESYNNP-------TKKGLLCWGTRVRIIEGIAQGLLYLHQYSRLRVIHRDLKASNILLDK--DMNPKISDFGM 311 (476)
Q Consensus 241 ~~~~l~~Ey~~~~-------~~~~~L~~~~~~~i~~qIa~gL~yLH~~~~~~ivH~DLkp~NILld~--~~~~kL~DFGl 311 (476)
+.++++|||++.+ .....+++.++..++.||+.||+|||+++ |+||||||+|||++. ++.+||+|||+
T Consensus 121 ~~~~lv~E~~~gg~L~~~l~~~~~~l~~~~~~~i~~qi~~aL~~LH~~g---ivHrDlkp~NIll~~~~~~~vkL~DFG~ 197 (387)
T 1kob_A 121 YEMVLILEFLSGGELFDRIAAEDYKMSEAEVINYMRQACEGLKHMHEHS---IVHLDIKPENIMCETKKASSVKIIDFGL 197 (387)
T ss_dssp SEEEEEEECCCCCBHHHHTTCTTCCBCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEESSTTCCCEEECCCTT
T ss_pred CEEEEEEEcCCCCcHHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHhCC---eeecccchHHeEEecCCCCceEEEeccc
Confidence 5688999999832 23457999999999999999999999999 999999999999974 56799999999
Q ss_pred eeecCCCcccccceeeeeccCCCChhhhccCCCCccceEEeehhhhhhhhhCCCCCCcCCCCchhhhhhhhhhhcCCCcc
Q 045315 312 ARMFGGDELQSNTKRIVGTYGYMSPEYALRGLFSIKSDVFSFGVLLLETLSSKKNTHFYNTDSLTLLGHAWNLWNDGRTW 391 (476)
Q Consensus 312 a~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~s~ksDVwSlGvvl~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~ 391 (476)
++....... .....||+.|+|||++.+..++.++|||||||++|||++|+.||..... ........ ....
T Consensus 198 a~~~~~~~~---~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~elltg~~Pf~~~~~--~~~~~~i~----~~~~- 267 (387)
T 1kob_A 198 ATKLNPDEI---VKVTTATAEFAAPEIVDREPVGFYTDMWAIGVLGYVLLSGLSPFAGEDD--LETLQNVK----RCDW- 267 (387)
T ss_dssp CEECCTTSC---EEEECSSGGGCCHHHHTTCCBCHHHHHHHHHHHHHHHHHSCCSSCCSSH--HHHHHHHH----HCCC-
T ss_pred ceecCCCcc---eeeeccCCCccCchhccCCCCCCcccEeeHhHHHHHHHhCCCCCCCCCH--HHHHHHHH----hCCC-
Confidence 987654321 2335689999999999999999999999999999999999999865331 11111111 1100
Q ss_pred cccCcccCCCCCHHHHHHHHHHHHHchhhcccCCCCHHHHHHH
Q 045315 392 ELMDPISQNGASYPILKRYINVALLCVQEKAADRPAMSEVVSM 434 (476)
Q Consensus 392 ~~~d~~~~~~~~~~~~~~l~~li~~Cl~~dP~~RPt~~eVl~~ 434 (476)
. ............+.+++.+||+.||++|||+.|+++.
T Consensus 268 ~-----~~~~~~~~~s~~~~~li~~~L~~dP~~Rpt~~ell~h 305 (387)
T 1kob_A 268 E-----FDEDAFSSVSPEAKDFIKNLLQKEPRKRLTVHDALEH 305 (387)
T ss_dssp C-----CCSSTTTTSCHHHHHHHHTTSCSSGGGSCCHHHHHTS
T ss_pred C-----CCccccccCCHHHHHHHHHHcCCChhHCcCHHHHhhC
Confidence 0 0011111234578899999999999999999999873
|
| >1ua2_A CAK, cell division protein kinase 7; cell cycle, phosphorylation, protein-protein interaction, PR kinase, cell cycle, transferase; HET: TPO ATP; 3.02A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=99.94 E-value=6.1e-27 Score=234.82 Aligned_cols=187 Identities=23% Similarity=0.262 Sum_probs=135.4
Q ss_pred cccceeeccCCC------CCCCCCCChhhHHHHHHHHHHHHHHHhhcCCCceeecCCCccceEecCCCCceeccccceee
Q 045315 241 DEISFWYESYNN------PTKKGLLCWGTRVRIIEGIAQGLLYLHQYSRLRVIHRDLKASNILLDKDMNPKISDFGMARM 314 (476)
Q Consensus 241 ~~~~l~~Ey~~~------~~~~~~L~~~~~~~i~~qIa~gL~yLH~~~~~~ivH~DLkp~NILld~~~~~kL~DFGla~~ 314 (476)
+..++++||++. ......+++.++..++.||++||+|||+++ |+||||||+||+++.++.+||+|||+++.
T Consensus 85 ~~~~lv~e~~~~~l~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~---ivH~Dlkp~Nil~~~~~~~kl~Dfg~a~~ 161 (346)
T 1ua2_A 85 SNISLVFDFMETDLEVIIKDNSLVLTPSHIKAYMLMTLQGLEYLHQHW---ILHRDLKPNNLLLDENGVLKLADFGLAKS 161 (346)
T ss_dssp TCCEEEEECCSEEHHHHHTTCCSSCCSSHHHHHHHHHHHHHHHHHHTT---CCCCCCCGGGEEECTTCCEEECCCGGGST
T ss_pred CceEEEEEcCCCCHHHHHHhcCcCCCHHHHHHHHHHHHHHHHHHHHCC---EECCCCCHHHEEEcCCCCEEEEeccccee
Confidence 467889999982 234557999999999999999999999999 99999999999999999999999999987
Q ss_pred cCCCcccccceeeeeccCCCChhhhccC-CCCccceEEeehhhhhhhhhCCCCCCcCCCCchhhhhhhhhhhcC---CCc
Q 045315 315 FGGDELQSNTKRIVGTYGYMSPEYALRG-LFSIKSDVFSFGVLLLETLSSKKNTHFYNTDSLTLLGHAWNLWND---GRT 390 (476)
Q Consensus 315 ~~~~~~~~~~~~~~gt~~y~aPE~l~~~-~~s~ksDVwSlGvvl~elltG~~p~~~~~~~~~~~~~~~~~~~~~---~~~ 390 (476)
...... ......+|+.|+|||.+.+. .++.++|||||||++|||++|.+||...... ............ ...
T Consensus 162 ~~~~~~--~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~~~~~~~~~--~~~~~i~~~~~~~~~~~~ 237 (346)
T 1ua2_A 162 FGSPNR--AYTHQVVTRWYRAPELLFGARMYGVGVDMWAVGCILAELLLRVPFLPGDSDL--DQLTRIFETLGTPTEEQW 237 (346)
T ss_dssp TTSCCC--CCCCSCCCCTTCCHHHHTTCSCCCHHHHHHHHHHHHHHHHHSSCSSCCSSHH--HHHHHHHHHHCCCCTTTS
T ss_pred ccCCcc--cCCcccccccccCchHhhCCCCCCchhhhHhHHHHHHHHHHCCCCCCCCCHH--HHHHHHHHHcCCCChhhh
Confidence 643321 12235689999999998754 5899999999999999999999988654311 111111111100 000
Q ss_pred cc---ccCc---ccCCCCC-----HHHHHHHHHHHHHchhhcccCCCCHHHHHHH
Q 045315 391 WE---LMDP---ISQNGAS-----YPILKRYINVALLCVQEKAADRPAMSEVVSM 434 (476)
Q Consensus 391 ~~---~~d~---~~~~~~~-----~~~~~~l~~li~~Cl~~dP~~RPt~~eVl~~ 434 (476)
.. ..+. ......+ ......+.+++.+||+.||++|||+.|+++.
T Consensus 238 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~h 292 (346)
T 1ua2_A 238 PDMCSLPDYVTFKSFPGIPLHHIFSAAGDDLLDLIQGLFLFNPCARITATQALKM 292 (346)
T ss_dssp SSTTSSTTCCCCCCCCCCCHHHHCTTCCHHHHHHHHHHHCSSTTTSCCHHHHHTS
T ss_pred hhhccCcccccccccCCCChHHhhccCCHHHHHHHHHHhccChhhCCCHHHHhcC
Confidence 00 0000 0000011 1223678999999999999999999999874
|
| >2w4o_A Calcium/calmodulin-dependent protein kinase type IV; calmodulin-binding, nucleotide-binding, serine/threonine-protein kinase, ATP-binding; HET: DKI; 2.17A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.94 E-value=3.9e-27 Score=236.80 Aligned_cols=176 Identities=20% Similarity=0.261 Sum_probs=127.1
Q ss_pred cccceeeccCCCC------CCCCCCChhhHHHHHHHHHHHHHHHhhcCCCceeecCCCccceEecC---CCCceeccccc
Q 045315 241 DEISFWYESYNNP------TKKGLLCWGTRVRIIEGIAQGLLYLHQYSRLRVIHRDLKASNILLDK---DMNPKISDFGM 311 (476)
Q Consensus 241 ~~~~l~~Ey~~~~------~~~~~L~~~~~~~i~~qIa~gL~yLH~~~~~~ivH~DLkp~NILld~---~~~~kL~DFGl 311 (476)
+..+++|||++.. ..++.+++.++..++.||+.||+|||+.+ |+||||||+||+++. ++.+||+|||+
T Consensus 121 ~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~i~~qi~~~L~~LH~~~---ivH~Dikp~NIll~~~~~~~~~kl~Dfg~ 197 (349)
T 2w4o_A 121 TEISLVLELVTGGELFDRIVEKGYYSERDAADAVKQILEAVAYLHENG---IVHRDLKPENLLYATPAPDAPLKIADFGL 197 (349)
T ss_dssp SEEEEEECCCCSCBHHHHHTTCSSCCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCCGGGEEESSSSTTCCEEECCCC-
T ss_pred CeEEEEEEeCCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCC---eEecCCCcccEEEecCCCCCCEEEccCcc
Confidence 4678999999832 24567999999999999999999999999 999999999999975 88999999999
Q ss_pred eeecCCCcccccceeeeeccCCCChhhhccCCCCccceEEeehhhhhhhhhCCCCCCcCCCCchhhhhhhhhhhcCCCcc
Q 045315 312 ARMFGGDELQSNTKRIVGTYGYMSPEYALRGLFSIKSDVFSFGVLLLETLSSKKNTHFYNTDSLTLLGHAWNLWNDGRTW 391 (476)
Q Consensus 312 a~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~s~ksDVwSlGvvl~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~ 391 (476)
++...... ......||+.|+|||.+.+..++.++|||||||++|||++|+.||.......... . .......
T Consensus 198 a~~~~~~~---~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~-~----~i~~~~~- 268 (349)
T 2w4o_A 198 SKIVEHQV---LMKTVCGTPGYCAPEILRGCAYGPEVDMWSVGIITYILLCGFEPFYDERGDQFMF-R----RILNCEY- 268 (349)
T ss_dssp ------------------CGGGSCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCTTCCTTCHHHHH-H----HHHTTCC-
T ss_pred ccccCccc---ccccccCCCCccCHHHhcCCCCCcccchHHHHHHHHHHHhCCCCCCCCcccHHHH-H----HHHhCCC-
Confidence 98764322 1223568999999999999999999999999999999999999986443221111 1 1111111
Q ss_pred cccCcccCCCCCHHHHHHHHHHHHHchhhcccCCCCHHHHHH
Q 045315 392 ELMDPISQNGASYPILKRYINVALLCVQEKAADRPAMSEVVS 433 (476)
Q Consensus 392 ~~~d~~~~~~~~~~~~~~l~~li~~Cl~~dP~~RPt~~eVl~ 433 (476)
.... .........+.+++.+||+.||++|||+.|+++
T Consensus 269 ~~~~-----~~~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~ 305 (349)
T 2w4o_A 269 YFIS-----PWWDEVSLNAKDLVRKLIVLDPKKRLTTFQALQ 305 (349)
T ss_dssp CCCT-----TTTTTSCHHHHHHHHTTSCSSGGGSCCHHHHHH
T ss_pred ccCC-----chhhhCCHHHHHHHHHHccCChhhCcCHHHHhc
Confidence 0001 111223457889999999999999999999986
|
| >3gni_B Strad alpha; kinase fold, pseudokinase, alpha helical repeat protein, ADA protein, ATP-binding, cell cycle, kinase, nucleotide-bindin nucleus; HET: ATP CIT; 2.35A {Homo sapiens} PDB: 2wtk_B* | Back alignment and structure |
|---|
Probab=99.94 E-value=3.2e-27 Score=240.62 Aligned_cols=185 Identities=19% Similarity=0.210 Sum_probs=132.9
Q ss_pred cccceeeccCCCC--------CCCCCCChhhHHHHHHHHHHHHHHHhhcCCCceeecCCCccceEecCCCCceeccccce
Q 045315 241 DEISFWYESYNNP--------TKKGLLCWGTRVRIIEGIAQGLLYLHQYSRLRVIHRDLKASNILLDKDMNPKISDFGMA 312 (476)
Q Consensus 241 ~~~~l~~Ey~~~~--------~~~~~L~~~~~~~i~~qIa~gL~yLH~~~~~~ivH~DLkp~NILld~~~~~kL~DFGla 312 (476)
+..+++|||++.. .....+++.++..++.||+.||+|||+++ |+||||||+|||++.++.+||+|||.+
T Consensus 99 ~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~qi~~~l~~LH~~~---ivHrDlkp~NIll~~~~~~kl~dfg~~ 175 (389)
T 3gni_B 99 NELWVVTSFMAYGSAKDLICTHFMDGMNELAIAYILQGVLKALDYIHHMG---YVHRSVKASHILISVDGKVYLSGLRSN 175 (389)
T ss_dssp TEEEEEEECCTTCBHHHHHHHTCTTCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEECTTCCEEECCGGGC
T ss_pred CEEEEEEEccCCCCHHHHHhhhcccCCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCCHHHEEEcCCCCEEEcccccc
Confidence 4678999999832 23467999999999999999999999999 999999999999999999999999998
Q ss_pred eecCCCc-----ccccceeeeeccCCCChhhhcc--CCCCccceEEeehhhhhhhhhCCCCCCcCCCCchhhhhhhhhhh
Q 045315 313 RMFGGDE-----LQSNTKRIVGTYGYMSPEYALR--GLFSIKSDVFSFGVLLLETLSSKKNTHFYNTDSLTLLGHAWNLW 385 (476)
Q Consensus 313 ~~~~~~~-----~~~~~~~~~gt~~y~aPE~l~~--~~~s~ksDVwSlGvvl~elltG~~p~~~~~~~~~~~~~~~~~~~ 385 (476)
....... .........||..|+|||.+.+ ..++.++|||||||++|||++|+.||........... ...
T Consensus 176 ~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~-~~~--- 251 (389)
T 3gni_B 176 LSMISHGQRQRVVHDFPKYSVKVLPWLSPEVLQQNLQGYDAKSDIYSVGITACELANGHVPFKDMPATQMLLE-KLN--- 251 (389)
T ss_dssp EECEETTEECSCBCCCCTTCTTTGGGSCHHHHSTTSSCBCTHHHHHHHHHHHHHHHHSSCTTTTCCSTTHHHH-C-----
T ss_pred eeeccccccccccccccccccccccccCHHHHhccCCCCCcHhHHHHHHHHHHHHHHCCCCCCCCCHHHHHHH-Hhc---
Confidence 7542211 1111122467889999999987 6789999999999999999999999975442221110 000
Q ss_pred cCCCcccccCc------------------------------------ccCCCCCHHHHHHHHHHHHHchhhcccCCCCHH
Q 045315 386 NDGRTWELMDP------------------------------------ISQNGASYPILKRYINVALLCVQEKAADRPAMS 429 (476)
Q Consensus 386 ~~~~~~~~~d~------------------------------------~~~~~~~~~~~~~l~~li~~Cl~~dP~~RPt~~ 429 (476)
+......+. .............+.+++.+||+.||++|||++
T Consensus 252 --~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~Rpta~ 329 (389)
T 3gni_B 252 --GTVPCLLDTSTIPAEELTMSPSRSVANSGLSDSLTTSTPRPSNGDSPSHPYHRTFSPHFHHFVEQCLQRNPDARPSAS 329 (389)
T ss_dssp --------------------------------------------------------CCHHHHHHHHHHTCSCTTTSCCHH
T ss_pred --CCCCccccccccccccccccccccccccccccccccCccccccCCCCCCccccccCHHHHHHHHHHhhcCcccCCCHH
Confidence 000000000 000001122345688999999999999999999
Q ss_pred HHHHH
Q 045315 430 EVVSM 434 (476)
Q Consensus 430 eVl~~ 434 (476)
|+++.
T Consensus 330 ell~h 334 (389)
T 3gni_B 330 TLLNH 334 (389)
T ss_dssp HHTTS
T ss_pred HHhcC
Confidence 99854
|
| >1j1b_A Glycogen synthase kinase-3 beta; complex, TAU, AMPPNP, transferase; HET: ANP; 1.80A {Homo sapiens} SCOP: d.144.1.7 PDB: 1i09_A* 1j1c_A* 2jld_A* 3m1s_A* 3pup_A* 3du8_A* 1pyx_A* 1q41_A* 1q3w_A* 1q3d_A* 1q4l_A* 3q3b_A* 1q5k_A* 3i4b_A* 3l1s_A* 1r0e_A* 3zrk_A* 3zrl_A* 3zrm_A* 4dit_A* ... | Back alignment and structure |
|---|
Probab=99.94 E-value=3.6e-27 Score=243.01 Aligned_cols=184 Identities=20% Similarity=0.180 Sum_probs=132.3
Q ss_pred cceeeccCCCC---------CCCCCCChhhHHHHHHHHHHHHHHHhhcCCCceeecCCCccceEecCC-CCceeccccce
Q 045315 243 ISFWYESYNNP---------TKKGLLCWGTRVRIIEGIAQGLLYLHQYSRLRVIHRDLKASNILLDKD-MNPKISDFGMA 312 (476)
Q Consensus 243 ~~l~~Ey~~~~---------~~~~~L~~~~~~~i~~qIa~gL~yLH~~~~~~ivH~DLkp~NILld~~-~~~kL~DFGla 312 (476)
.++++||++.. ..+..+++..+..++.||++||+|||+++ |+||||||+|||++.+ +.+||+|||++
T Consensus 128 ~~lv~e~~~~~l~~~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~~---ivHrDlkp~NILl~~~~~~~kl~DFG~a 204 (420)
T 1j1b_A 128 LNLVLDYVPETVYRVARHYSRAKQTLPVIYVKLYMYQLFRSLAYIHSFG---ICHRDIKPQNLLLDPDTAVLKLCDFGSA 204 (420)
T ss_dssp EEEEEECCCEEHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHTTT---EECSCCSGGGEEEETTTTEEEECCCTTC
T ss_pred EEeehhcccccHHHHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHHCC---ccccCCChhhEEEeCCCCeEEeccchhh
Confidence 55789998821 23567999999999999999999999999 9999999999999965 56899999999
Q ss_pred eecCCCcccccceeeeeccCCCChhhhccC-CCCccceEEeehhhhhhhhhCCCCCCcCCCCchhhhhhhhhh-------
Q 045315 313 RMFGGDELQSNTKRIVGTYGYMSPEYALRG-LFSIKSDVFSFGVLLLETLSSKKNTHFYNTDSLTLLGHAWNL------- 384 (476)
Q Consensus 313 ~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~-~~s~ksDVwSlGvvl~elltG~~p~~~~~~~~~~~~~~~~~~------- 384 (476)
+.+..... .....||+.|+|||++.+. .++.++|||||||++|||++|+.||....... .+.......
T Consensus 205 ~~~~~~~~---~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlG~il~ell~G~~pf~~~~~~~-~l~~i~~~lg~p~~~~ 280 (420)
T 1j1b_A 205 KQLVRGEP---NVSYICSRYYRAPELIFGATDYTSSIDVWSAGCVLAELLLGQPIFPGDSGVD-QLVEIIKVLGTPTREQ 280 (420)
T ss_dssp EECCTTCC---CCSCCSCTTSCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHH-HHHHHHHHHCSCCHHH
T ss_pred hhcccCCC---ceeeeeCCCcCCHHHHcCCCCCCchhhhHHHHHHHHHHHhCCCCCCCCCHHH-HHHHHHHHhCCCCHHH
Confidence 87654322 1235689999999998764 78999999999999999999999997543111 111111000
Q ss_pred hc--CCCcccccCcccCCC-----CCHHHHHHHHHHHHHchhhcccCCCCHHHHHH
Q 045315 385 WN--DGRTWELMDPISQNG-----ASYPILKRYINVALLCVQEKAADRPAMSEVVS 433 (476)
Q Consensus 385 ~~--~~~~~~~~d~~~~~~-----~~~~~~~~l~~li~~Cl~~dP~~RPt~~eVl~ 433 (476)
+. .....+...+..... ........+.+++.+||+.||++||++.|+++
T Consensus 281 ~~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~Li~~~L~~dP~~R~t~~e~l~ 336 (420)
T 1j1b_A 281 IREMNPNYTEFKFPQIKAHPWTKVFRPRTPPEAIALCSRLLEYTPTARLTPLEACA 336 (420)
T ss_dssp HHHHCSCCCCCCCCCCCCCCHHHHSCTTSCHHHHHHHHHHSCSSGGGSCCHHHHHT
T ss_pred HHhhChhhhhhccCccCCCCHHHhcCCCCCHHHHHHHHHhccCChhHCCCHHHHhC
Confidence 00 000001101111000 11122467899999999999999999999985
|
| >3c0i_A Peripheral plasma membrane protein CASK; neurexin, Ca2+/calmodulin dependent protein kinase, Mg synaptic plasticity, pseudokinase, maguk; HET: 3AM; 1.85A {Homo sapiens} PDB: 3c0h_A* 3c0g_A* 3mfr_A* 3mfs_A* 3mft_A 3mfu_A* 3tac_A | Back alignment and structure |
|---|
Probab=99.94 E-value=1.4e-27 Score=240.22 Aligned_cols=175 Identities=23% Similarity=0.277 Sum_probs=133.5
Q ss_pred cccceeeccCCCCC----------CCCCCChhhHHHHHHHHHHHHHHHhhcCCCceeecCCCccceEecCCCC---ceec
Q 045315 241 DEISFWYESYNNPT----------KKGLLCWGTRVRIIEGIAQGLLYLHQYSRLRVIHRDLKASNILLDKDMN---PKIS 307 (476)
Q Consensus 241 ~~~~l~~Ey~~~~~----------~~~~L~~~~~~~i~~qIa~gL~yLH~~~~~~ivH~DLkp~NILld~~~~---~kL~ 307 (476)
+..+++|||++... ....+++..+..++.||+.||+|||+++ |+||||||+|||++.++. +||+
T Consensus 99 ~~~~lv~e~~~g~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~al~~lH~~~---ivHrDlkp~NIl~~~~~~~~~vkl~ 175 (351)
T 3c0i_A 99 GMLYMVFEFMDGADLCFEIVKRADAGFVYSEAVASHYMRQILEALRYCHDNN---IIHRDVKPHCVLLASKENSAPVKLG 175 (351)
T ss_dssp TEEEEEEECCSSCBHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEECSSSTTCCEEEC
T ss_pred CEEEEEEeCCCCCCHHHHHHHhcccCCCCCHHHHHHHHHHHHHHHHHHHHCC---ceeccCChHHeEEecCCCCCcEEEe
Confidence 46789999998332 2346899999999999999999999999 999999999999986554 9999
Q ss_pred cccceeecCCCcccccceeeeeccCCCChhhhccCCCCccceEEeehhhhhhhhhCCCCCCcCCCCchhhhhhhhhhhcC
Q 045315 308 DFGMARMFGGDELQSNTKRIVGTYGYMSPEYALRGLFSIKSDVFSFGVLLLETLSSKKNTHFYNTDSLTLLGHAWNLWND 387 (476)
Q Consensus 308 DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~s~ksDVwSlGvvl~elltG~~p~~~~~~~~~~~~~~~~~~~~~ 387 (476)
|||++......... .....||+.|+|||.+.+..++.++|||||||++|||++|+.||.... ...... ...
T Consensus 176 Dfg~a~~~~~~~~~--~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~---~~~~~~----i~~ 246 (351)
T 3c0i_A 176 GFGVAIQLGESGLV--AGGRVGTPHFMAPEVVKREPYGKPVDVWGCGVILFILLSGCLPFYGTK---ERLFEG----IIK 246 (351)
T ss_dssp CCTTCEECCTTSCB--CCCCCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCSSH---HHHHHH----HHH
T ss_pred cCcceeEecCCCee--ecCCcCCcCccCHHHHcCCCCCchHhhHHHHHHHHHHHHCCCCCCCcH---HHHHHH----HHc
Confidence 99999887643321 223579999999999999999999999999999999999999986432 111111 111
Q ss_pred CCcccccCcccCCCCCHHHHHHHHHHHHHchhhcccCCCCHHHHHH
Q 045315 388 GRTWELMDPISQNGASYPILKRYINVALLCVQEKAADRPAMSEVVS 433 (476)
Q Consensus 388 ~~~~~~~d~~~~~~~~~~~~~~l~~li~~Cl~~dP~~RPt~~eVl~ 433 (476)
+... ..+... ......+.+++.+||+.||++|||+.|+++
T Consensus 247 ~~~~--~~~~~~----~~~s~~~~~li~~~L~~dP~~R~s~~e~l~ 286 (351)
T 3c0i_A 247 GKYK--MNPRQW----SHISESAKDLVRRMLMLDPAERITVYEALN 286 (351)
T ss_dssp TCCC--CCHHHH----TTSCHHHHHHHHHHTCSSTTTSCCHHHHHT
T ss_pred CCCC--CCcccc----ccCCHHHHHHHHHHCCCChhHCcCHHHHhc
Confidence 1100 000000 112357889999999999999999999985
|
| >2qr7_A Ribosomal protein S6 kinase alpha-3; kinase domain, RSK2, autoinhibitory, ATP-binding, nucleotide phosphorylation, serine/threonine-protein kinase; 2.00A {Mus musculus} PDB: 2qr8_A 4d9t_A* 4d9u_A* 3rny_A 2wnt_A | Back alignment and structure |
|---|
Probab=99.94 E-value=4.2e-27 Score=235.98 Aligned_cols=178 Identities=21% Similarity=0.249 Sum_probs=134.6
Q ss_pred cccceeeccCCCCC------CCCCCChhhHHHHHHHHHHHHHHHhhcCCCceeecCCCccceEecCC-C---Cceecccc
Q 045315 241 DEISFWYESYNNPT------KKGLLCWGTRVRIIEGIAQGLLYLHQYSRLRVIHRDLKASNILLDKD-M---NPKISDFG 310 (476)
Q Consensus 241 ~~~~l~~Ey~~~~~------~~~~L~~~~~~~i~~qIa~gL~yLH~~~~~~ivH~DLkp~NILld~~-~---~~kL~DFG 310 (476)
+..+++|||++.+. +.+.+++.++..++.||+.||+|||+++ |+||||||+|||+..+ + .+||+|||
T Consensus 89 ~~~~lv~E~~~gg~L~~~i~~~~~~~~~~~~~~~~qi~~al~~lH~~g---ivHrDlkp~NIl~~~~~~~~~~~kl~Dfg 165 (342)
T 2qr7_A 89 KYVYVVTELMKGGELLDKILRQKFFSEREASAVLFTITKTVEYLHAQG---VVHRDLKPSNILYVDESGNPESIRICDFG 165 (342)
T ss_dssp SEEEEEECCCCSCBHHHHHHTCTTCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCCGGGEEESSSSCSGGGEEECCCT
T ss_pred CEEEEEEeCCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCC---cEeccCCHHHEEEecCCCCcCeEEEEECC
Confidence 46789999998432 4567999999999999999999999999 9999999999998533 2 48999999
Q ss_pred ceeecCCCcccccceeeeeccCCCChhhhccCCCCccceEEeehhhhhhhhhCCCCCCcCCCC-chhhhhhhhhhhcCCC
Q 045315 311 MARMFGGDELQSNTKRIVGTYGYMSPEYALRGLFSIKSDVFSFGVLLLETLSSKKNTHFYNTD-SLTLLGHAWNLWNDGR 389 (476)
Q Consensus 311 la~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~s~ksDVwSlGvvl~elltG~~p~~~~~~~-~~~~~~~~~~~~~~~~ 389 (476)
+++....... ......||+.|+|||.+.+..++.++|||||||++|||++|+.||.....+ ...+... ...+.
T Consensus 166 ~a~~~~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~Pf~~~~~~~~~~~~~~----i~~~~ 239 (342)
T 2qr7_A 166 FAKQLRAENG--LLMTPCYTANFVAPEVLERQGYDAACDIWSLGVLLYTMLTGYTPFANGPDDTPEEILAR----IGSGK 239 (342)
T ss_dssp TCEECBCTTC--CBCCSSCCSSCCCHHHHHHHHHHHHHHHHHHHHHHHHHHHSSCSSCSSTTSCHHHHHHH----HHHCC
T ss_pred CcccCcCCCC--ceeccCCCccccCHHHhcCCCCCCccCeeeHhHHHHHHhcCCCCCCCCCcCCHHHHHHH----HccCC
Confidence 9987654322 122356899999999998888999999999999999999999999754322 1122111 11111
Q ss_pred cccccCcccCCCCCHHHHHHHHHHHHHchhhcccCCCCHHHHHH
Q 045315 390 TWELMDPISQNGASYPILKRYINVALLCVQEKAADRPAMSEVVS 433 (476)
Q Consensus 390 ~~~~~d~~~~~~~~~~~~~~l~~li~~Cl~~dP~~RPt~~eVl~ 433 (476)
.. ............+.+++.+||+.||++||++.++++
T Consensus 240 ~~------~~~~~~~~~s~~~~~li~~~L~~dP~~R~t~~~il~ 277 (342)
T 2qr7_A 240 FS------LSGGYWNSVSDTAKDLVSKMLHVDPHQRLTAALVLR 277 (342)
T ss_dssp CC------CCSTTTTTSCHHHHHHHHHHTCSSTTTSCCHHHHTT
T ss_pred cc------cCccccccCCHHHHHHHHHHCCCChhHCcCHHHHhc
Confidence 10 011111223457889999999999999999999876
|
| >4fvq_A Tyrosine-protein kinase JAK2; janus protein kinase, pseudokinase, ATP binding, phosphoryla transferase; HET: ATP; 1.75A {Homo sapiens} PDB: 4fvp_A* 4fvr_A* | Back alignment and structure |
|---|
Probab=99.93 E-value=1.6e-27 Score=232.04 Aligned_cols=176 Identities=19% Similarity=0.236 Sum_probs=132.5
Q ss_pred cccceeeccCCCCC-------CCCCCChhhHHHHHHHHHHHHHHHhhcCCCceeecCCCccceEecCCCC--------ce
Q 045315 241 DEISFWYESYNNPT-------KKGLLCWGTRVRIIEGIAQGLLYLHQYSRLRVIHRDLKASNILLDKDMN--------PK 305 (476)
Q Consensus 241 ~~~~l~~Ey~~~~~-------~~~~L~~~~~~~i~~qIa~gL~yLH~~~~~~ivH~DLkp~NILld~~~~--------~k 305 (476)
+..+++|||++... ....+++.++..++.||+.||+|||+++ |+||||||+|||++.++. +|
T Consensus 85 ~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~---ivH~Dlkp~NIll~~~~~~~~~~~~~~k 161 (289)
T 4fvq_A 85 DENILVQEFVKFGSLDTYLKKNKNCINILWKLEVAKQLAAAMHFLEENT---LIHGNVCAKNILLIREEDRKTGNPPFIK 161 (289)
T ss_dssp TCCEEEEECCTTCBHHHHHHHTGGGCCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCCGGGEEEEECCBGGGTBCCEEE
T ss_pred CCCEEEEECCCCCCHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHhhCC---eECCCcCcceEEEecCCcccccccceee
Confidence 46788999998332 2345999999999999999999999999 999999999999998887 99
Q ss_pred eccccceeecCCCcccccceeeeeccCCCChhhhcc-CCCCccceEEeehhhhhhhhhCCCCCCcCCCCchhhhhhhhhh
Q 045315 306 ISDFGMARMFGGDELQSNTKRIVGTYGYMSPEYALR-GLFSIKSDVFSFGVLLLETLSSKKNTHFYNTDSLTLLGHAWNL 384 (476)
Q Consensus 306 L~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~l~~-~~~s~ksDVwSlGvvl~elltG~~p~~~~~~~~~~~~~~~~~~ 384 (476)
|+|||++...... ....++..|+|||.+.+ ..++.++||||||+++|||++|+.++...... .......
T Consensus 162 l~Dfg~~~~~~~~------~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~~~~~~~~~-~~~~~~~--- 231 (289)
T 4fvq_A 162 LSDPGISITVLPK------DILQERIPWVPPECIENPKNLNLATDKWSFGTTLWEICSGGDKPLSALDS-QRKLQFY--- 231 (289)
T ss_dssp ECCCCSCTTTSCH------HHHHHTTTTSCHHHHHCGGGCCHHHHHHHHHHHHHHHHTTTCCTTTTSCH-HHHHHHH---
T ss_pred eccCcccccccCc------cccCCcCcccCHHHhCCCCCCCchhHHHHHHHHHHHHHcCCCCCccccch-HHHHHHh---
Confidence 9999998654322 22457889999999987 77899999999999999999966554322111 1111100
Q ss_pred hcCCCcccccCcccCCCCCHHHHHHHHHHHHHchhhcccCCCCHHHHHHHHhccccC
Q 045315 385 WNDGRTWELMDPISQNGASYPILKRYINVALLCVQEKAADRPAMSEVVSMLSNEFVN 441 (476)
Q Consensus 385 ~~~~~~~~~~d~~~~~~~~~~~~~~l~~li~~Cl~~dP~~RPt~~eVl~~L~~~~~~ 441 (476)
...... +......+.+++.+||+.||++|||+.++++.|+.+...
T Consensus 232 ~~~~~~------------~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~l~~l~~p 276 (289)
T 4fvq_A 232 EDRHQL------------PAPKAAELANLINNCMDYEPDHRPSFRAIIRDLNSLFTP 276 (289)
T ss_dssp HTTCCC------------CCCSSCTTHHHHHHHSCSSGGGSCCHHHHHHHHHTCC--
T ss_pred hccCCC------------CCCCCHHHHHHHHHHcCCChhHCcCHHHHHHHHHHhcCC
Confidence 000000 001123577899999999999999999999999998743
|
| >3kn6_A Ribosomal protein S6 kinase alpha-5; AMP-PNP, MSK1, MSK, ATP-binding, metal-binding, NUCL binding, serine/threonine-protein kinase, transferase; 2.00A {Homo sapiens} PDB: 3kn5_A | Back alignment and structure |
|---|
Probab=99.93 E-value=1.1e-27 Score=238.39 Aligned_cols=182 Identities=22% Similarity=0.205 Sum_probs=117.3
Q ss_pred cccceeeccCCCCC------CCCCCChhhHHHHHHHHHHHHHHHhhcCCCceeecCCCccceEecCCC---Cceeccccc
Q 045315 241 DEISFWYESYNNPT------KKGLLCWGTRVRIIEGIAQGLLYLHQYSRLRVIHRDLKASNILLDKDM---NPKISDFGM 311 (476)
Q Consensus 241 ~~~~l~~Ey~~~~~------~~~~L~~~~~~~i~~qIa~gL~yLH~~~~~~ivH~DLkp~NILld~~~---~~kL~DFGl 311 (476)
+..+++|||++... .++.+++.++..++.||+.||+|||+++ |+||||||+|||++.++ .+||+|||+
T Consensus 79 ~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~i~~qi~~~l~~LH~~~---ivH~Dlkp~NIll~~~~~~~~~kl~Dfg~ 155 (325)
T 3kn6_A 79 LHTFLVMELLNGGELFERIKKKKHFSETEASYIMRKLVSAVSHMHDVG---VVHRDLKPENLLFTDENDNLEIKIIDFGF 155 (325)
T ss_dssp SEEEEEECCCCSCBHHHHHHHCSCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEEEC----CEEEECCCTT
T ss_pred CEEEEEEEccCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCC---CeecCCCHHHEEEecCCCcccEEEecccc
Confidence 46789999998432 3567999999999999999999999999 99999999999998665 799999999
Q ss_pred eeecCCCcccccceeeeeccCCCChhhhccCCCCccceEEeehhhhhhhhhCCCCCCcCCCCc-hhhhhhhhhhhcCCCc
Q 045315 312 ARMFGGDELQSNTKRIVGTYGYMSPEYALRGLFSIKSDVFSFGVLLLETLSSKKNTHFYNTDS-LTLLGHAWNLWNDGRT 390 (476)
Q Consensus 312 a~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~s~ksDVwSlGvvl~elltG~~p~~~~~~~~-~~~~~~~~~~~~~~~~ 390 (476)
++........ .....||..|+|||.+.+..++.++|||||||++|||++|+.||....... .............+..
T Consensus 156 a~~~~~~~~~--~~~~~~t~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~~~~~~~~i~~~~~ 233 (325)
T 3kn6_A 156 ARLKPPDNQP--LKTPCFTLHYAAPELLNQNGYDESCDLWSLGVILYTMLSGQVPFQSHDRSLTCTSAVEIMKKIKKGDF 233 (325)
T ss_dssp CEECCC------------------------CCCCHHHHHHHHHHHHHHHHHSSCTTC-------CCCHHHHHHHHTTTCC
T ss_pred ceecCCCCCc--ccccCCCcCccCHHHhcCCCCCCccchHHHHHHHHHHHhCCCCCCCCccccccccHHHHHHHHHcCCC
Confidence 9876543221 223568999999999999999999999999999999999999997543211 0000111111111111
Q ss_pred ccccCcccCCCCCHHHHHHHHHHHHHchhhcccCCCCHHHHHH
Q 045315 391 WELMDPISQNGASYPILKRYINVALLCVQEKAADRPAMSEVVS 433 (476)
Q Consensus 391 ~~~~d~~~~~~~~~~~~~~l~~li~~Cl~~dP~~RPt~~eVl~ 433 (476)
. ............+.+++.+||+.||++|||++|+++
T Consensus 234 ~------~~~~~~~~~s~~~~~li~~~L~~dP~~Rpt~~ell~ 270 (325)
T 3kn6_A 234 S------FEGEAWKNVSQEAKDLIQGLLTVDPNKRLKMSGLRY 270 (325)
T ss_dssp C------CCSHHHHTSCHHHHHHHHHHHCCCTTTCCCTTTSTT
T ss_pred C------CCcccccCCCHHHHHHHHHHCCCChhHCCCHHHHhc
Confidence 0 000000123467889999999999999999999874
|
| >4fl3_A Tyrosine-protein kinase SYK; transferase; HET: ANP; 1.90A {Homo sapiens} PDB: 4fl2_A* 1a81_A* 1csy_A* 1csz_A* | Back alignment and structure |
|---|
Probab=99.93 E-value=4.1e-28 Score=262.47 Aligned_cols=182 Identities=25% Similarity=0.343 Sum_probs=138.7
Q ss_pred cccceeeccCCCC------CCCCCCChhhHHHHHHHHHHHHHHHhhcCCCceeecCCCccceEecCCCCceeccccceee
Q 045315 241 DEISFWYESYNNP------TKKGLLCWGTRVRIIEGIAQGLLYLHQYSRLRVIHRDLKASNILLDKDMNPKISDFGMARM 314 (476)
Q Consensus 241 ~~~~l~~Ey~~~~------~~~~~L~~~~~~~i~~qIa~gL~yLH~~~~~~ivH~DLkp~NILld~~~~~kL~DFGla~~ 314 (476)
+..+++|||++.+ ..++.+++.+++.|+.||+.||+|||+++ |+||||||+|||++.++.+||+|||+++.
T Consensus 442 ~~~~lv~E~~~~g~L~~~l~~~~~l~~~~~~~i~~qi~~~L~yLH~~~---iiHrDLkp~NILl~~~~~~kL~DFGla~~ 518 (635)
T 4fl3_A 442 ESWMLVMEMAELGPLNKYLQQNRHVKDKNIIELVHQVSMGMKYLEESN---FVHRDLAARNVLLVTQHYAKISDFGLSKA 518 (635)
T ss_dssp SSEEEEEECCTTEEHHHHHHHCTTCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCSGGGEEEEETTEEEECCTTHHHH
T ss_pred CCEEEEEEccCCCCHHHHHhhCCCCCHHHHHHHHHHHHHHHHHHHHCC---EeCCCCChHhEEEeCCCCEEEEEcCCccc
Confidence 4578999999832 23567999999999999999999999999 99999999999999999999999999987
Q ss_pred cCCCccc-ccceeeeeccCCCChhhhccCCCCccceEEeehhhhhhhhh-CCCCCCcCCCCchhhhhhhhhhhcCCCccc
Q 045315 315 FGGDELQ-SNTKRIVGTYGYMSPEYALRGLFSIKSDVFSFGVLLLETLS-SKKNTHFYNTDSLTLLGHAWNLWNDGRTWE 392 (476)
Q Consensus 315 ~~~~~~~-~~~~~~~gt~~y~aPE~l~~~~~s~ksDVwSlGvvl~ellt-G~~p~~~~~~~~~~~~~~~~~~~~~~~~~~ 392 (476)
+...... .......++..|+|||++.+..++.++|||||||++|||++ |+.||...... ... .....+...
T Consensus 519 ~~~~~~~~~~~~~~~~t~~y~APE~~~~~~~~~~sDvwSlGv~l~ellt~G~~Pf~~~~~~--~~~----~~i~~~~~~- 591 (635)
T 4fl3_A 519 LRADENYYKAQTHGKWPVKWYAPECINYYKFSSKSDVWSFGVLMWEAFSYGQKPYRGMKGS--EVT----AMLEKGERM- 591 (635)
T ss_dssp TTC-------------CGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCSSTTCCHH--HHH----HHHHTTCCC-
T ss_pred cccCccccccccCCCCceeeeChhhhcCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCCHH--HHH----HHHHcCCCC-
Confidence 6543221 12223456788999999999999999999999999999998 99998654321 111 111112111
Q ss_pred ccCcccCCCCCHHHHHHHHHHHHHchhhcccCCCCHHHHHHHHhcccc
Q 045315 393 LMDPISQNGASYPILKRYINVALLCVQEKAADRPAMSEVVSMLSNEFV 440 (476)
Q Consensus 393 ~~d~~~~~~~~~~~~~~l~~li~~Cl~~dP~~RPt~~eVl~~L~~~~~ 440 (476)
..+......+.+++.+||+.||++||++++|++.|+....
T Consensus 592 --------~~p~~~~~~l~~li~~cl~~dP~~RPs~~~l~~~L~~~~~ 631 (635)
T 4fl3_A 592 --------GCPAGCPREMYDLMNLCWTYDVENRPGFAAVELRLRNYYY 631 (635)
T ss_dssp --------CCCTTCCHHHHHHHHHHTCSSTTTSCCHHHHHHHHHHHHH
T ss_pred --------CCCCCCCHHHHHHHHHHcCCCHhHCcCHHHHHHHHHHHHH
Confidence 1112234678899999999999999999999999998653
|
| >3dls_A PAS domain-containing serine/threonine-protein KI; PAS kinase, PASK, protein kinase, drug discovery, ATP-bindin kinase, nucleotide-binding; HET: ADP; 2.30A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.93 E-value=6.3e-27 Score=233.97 Aligned_cols=166 Identities=20% Similarity=0.289 Sum_probs=133.2
Q ss_pred cccceeeccCCCC-------CCCCCCChhhHHHHHHHHHHHHHHHhhcCCCceeecCCCccceEecCCCCceecccccee
Q 045315 241 DEISFWYESYNNP-------TKKGLLCWGTRVRIIEGIAQGLLYLHQYSRLRVIHRDLKASNILLDKDMNPKISDFGMAR 313 (476)
Q Consensus 241 ~~~~l~~Ey~~~~-------~~~~~L~~~~~~~i~~qIa~gL~yLH~~~~~~ivH~DLkp~NILld~~~~~kL~DFGla~ 313 (476)
+..++++||+..+ ...+.+++..+..++.||+.||+|||+++ |+||||||+|||++.++.+||+|||+++
T Consensus 102 ~~~~lv~e~~~~g~~l~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~---ivH~Dlkp~NIll~~~~~~kL~Dfg~a~ 178 (335)
T 3dls_A 102 GFFQLVMEKHGSGLDLFAFIDRHPRLDEPLASYIFRQLVSAVGYLRLKD---IIHRDIKDENIVIAEDFTIKLIDFGSAA 178 (335)
T ss_dssp SEEEEEEECCTTSCBHHHHHHTCCCCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEECTTSCEEECCCTTCE
T ss_pred CEEEEEEEeCCCCccHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCC---eEEeccCHHHEEEcCCCcEEEeecccce
Confidence 4577889988633 23557999999999999999999999999 9999999999999999999999999998
Q ss_pred ecCCCcccccceeeeeccCCCChhhhccCCC-CccceEEeehhhhhhhhhCCCCCCcCCCCchhhhhhhhhhhcCCCccc
Q 045315 314 MFGGDELQSNTKRIVGTYGYMSPEYALRGLF-SIKSDVFSFGVLLLETLSSKKNTHFYNTDSLTLLGHAWNLWNDGRTWE 392 (476)
Q Consensus 314 ~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~-s~ksDVwSlGvvl~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~ 392 (476)
....... .....||+.|+|||.+.+..+ +.++|||||||++|||++|+.||......
T Consensus 179 ~~~~~~~---~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~------------------- 236 (335)
T 3dls_A 179 YLERGKL---FYTFCGTIEYCAPEVLMGNPYRGPELEMWSLGVTLYTLVFEENPFCELEET------------------- 236 (335)
T ss_dssp ECCTTCC---BCEECSCGGGCCHHHHTTCCBCSHHHHHHHHHHHHHHHHHSSCSCSSGGGG-------------------
T ss_pred ECCCCCc---eeccCCCccccChhhhcCCCCCCCcccchhHHHHHHHHHhCCCchhhHHHH-------------------
Confidence 7654322 233578999999999988776 88999999999999999999998532110
Q ss_pred ccCcccCCCCCHHHHHHHHHHHHHchhhcccCCCCHHHHHHH
Q 045315 393 LMDPISQNGASYPILKRYINVALLCVQEKAADRPAMSEVVSM 434 (476)
Q Consensus 393 ~~d~~~~~~~~~~~~~~l~~li~~Cl~~dP~~RPt~~eVl~~ 434 (476)
...... .+......+.+++.+||+.||++|||++++++.
T Consensus 237 -~~~~~~--~~~~~~~~l~~li~~~L~~dP~~Rps~~ell~h 275 (335)
T 3dls_A 237 -VEAAIH--PPYLVSKELMSLVSGLLQPVPERRTTLEKLVTD 275 (335)
T ss_dssp -TTTCCC--CSSCCCHHHHHHHHHHTCSSGGGSCCHHHHHHC
T ss_pred -HhhccC--CCcccCHHHHHHHHHHccCChhhCcCHHHHhcC
Confidence 000000 011123568899999999999999999999874
|
| >2i0e_A Protein kinase C-beta II; serine/threonine protein kinase, transferase; HET: TPO SEP PDS; 2.60A {Homo sapiens} PDB: 3iw4_A* | Back alignment and structure |
|---|
Probab=99.93 E-value=3.9e-27 Score=237.28 Aligned_cols=172 Identities=26% Similarity=0.321 Sum_probs=134.0
Q ss_pred cccceeeccCCCCC------CCCCCChhhHHHHHHHHHHHHHHHhhcCCCceeecCCCccceEecCCCCceeccccceee
Q 045315 241 DEISFWYESYNNPT------KKGLLCWGTRVRIIEGIAQGLLYLHQYSRLRVIHRDLKASNILLDKDMNPKISDFGMARM 314 (476)
Q Consensus 241 ~~~~l~~Ey~~~~~------~~~~L~~~~~~~i~~qIa~gL~yLH~~~~~~ivH~DLkp~NILld~~~~~kL~DFGla~~ 314 (476)
+.++++|||++.+. +.+.+++.++..++.||+.||+|||+++ |+||||||+|||++.++.+||+|||+++.
T Consensus 94 ~~~~lv~E~~~gg~L~~~l~~~~~~~~~~~~~~~~qi~~aL~~LH~~g---ivHrDlkp~NIll~~~g~vkL~DFG~a~~ 170 (353)
T 2i0e_A 94 DRLYFVMEYVNGGDLMYHIQQVGRFKEPHAVFYAAEIAIGLFFLQSKG---IIYRDLKLDNVMLDSEGHIKIADFGMCKE 170 (353)
T ss_dssp SEEEEEEECCCSCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTT---CBCCCCCGGGEEECTTSCEEECCCTTCBC
T ss_pred CEEEEEEeCCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCC---EEeccCCHHHEEEcCCCcEEEEeCCcccc
Confidence 46889999998432 2357999999999999999999999999 99999999999999999999999999986
Q ss_pred cCCCcccccceeeeeccCCCChhhhccCCCCccceEEeehhhhhhhhhCCCCCCcCCCCchhhhhhhhhhhcCCCccccc
Q 045315 315 FGGDELQSNTKRIVGTYGYMSPEYALRGLFSIKSDVFSFGVLLLETLSSKKNTHFYNTDSLTLLGHAWNLWNDGRTWELM 394 (476)
Q Consensus 315 ~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~s~ksDVwSlGvvl~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 394 (476)
..... .......||+.|+|||.+.+..++.++|+|||||++|||++|+.||..... ....... . ....
T Consensus 171 ~~~~~--~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~G~~Pf~~~~~--~~~~~~i---~-~~~~---- 238 (353)
T 2i0e_A 171 NIWDG--VTTKTFCGTPDYIAPEIIAYQPYGKSVDWWAFGVLLYEMLAGQAPFEGEDE--DELFQSI---M-EHNV---- 238 (353)
T ss_dssp CCCTT--CCBCCCCSCGGGCCHHHHTTCCBSTHHHHHHHHHHHHHHHHSSCSSCCSSH--HHHHHHH---H-HCCC----
T ss_pred cccCC--cccccccCCccccChhhhcCCCcCCcccccchHHHHHHHHcCCCCCCCCCH--HHHHHHH---H-hCCC----
Confidence 43222 123346799999999999999999999999999999999999999865331 1111111 1 1111
Q ss_pred CcccCCCCCHHHHHHHHHHHHHchhhcccCCCC-----HHHHHH
Q 045315 395 DPISQNGASYPILKRYINVALLCVQEKAADRPA-----MSEVVS 433 (476)
Q Consensus 395 d~~~~~~~~~~~~~~l~~li~~Cl~~dP~~RPt-----~~eVl~ 433 (476)
..+......+.+++.+||+.||++||+ +++|++
T Consensus 239 ------~~p~~~s~~~~~li~~lL~~dP~~R~~~~~~~~~~i~~ 276 (353)
T 2i0e_A 239 ------AYPKSMSKEAVAICKGLMTKHPGKRLGCGPEGERDIKE 276 (353)
T ss_dssp ------CCCTTSCHHHHHHHHHHTCSCTTSCTTCSTTHHHHHHT
T ss_pred ------CCCCCCCHHHHHHHHHHhhcCHHHcCCCCCCCHHHHhc
Confidence 011123457889999999999999995 466654
|
| >3cok_A Serine/threonine-protein kinase PLK4; POLO-like kinase 4, SAK, STK18, PSI, structural genomics, protein structure initiative; HET: ANP; 2.25A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.93 E-value=5.1e-27 Score=227.38 Aligned_cols=172 Identities=26% Similarity=0.375 Sum_probs=113.9
Q ss_pred cccceeeccCCCC-------CCCCCCChhhHHHHHHHHHHHHHHHhhcCCCceeecCCCccceEecCCCCceecccccee
Q 045315 241 DEISFWYESYNNP-------TKKGLLCWGTRVRIIEGIAQGLLYLHQYSRLRVIHRDLKASNILLDKDMNPKISDFGMAR 313 (476)
Q Consensus 241 ~~~~l~~Ey~~~~-------~~~~~L~~~~~~~i~~qIa~gL~yLH~~~~~~ivH~DLkp~NILld~~~~~kL~DFGla~ 313 (476)
+..++++||++.. .....+++.++..++.||++||+|||+++ ++||||||+||+++.++.+||+|||++.
T Consensus 84 ~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~---i~H~dl~p~Nili~~~~~~kl~dfg~~~ 160 (278)
T 3cok_A 84 NYVYLVLEMCHNGEMNRYLKNRVKPFSENEARHFMHQIITGMLYLHSHG---ILHRDLTLSNLLLTRNMNIKIADFGLAT 160 (278)
T ss_dssp SEEEEEEECCTTEEHHHHHHTCSSCCCHHHHHHHHHHHHHHHHHHHHTT---EECSSCCGGGEEECTTCCEEECCCTTCE
T ss_pred CeEEEEEecCCCCcHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCCHHHEEEcCCCCEEEEeeccee
Confidence 4578899999732 23467999999999999999999999999 9999999999999999999999999998
Q ss_pred ecCCCcccccceeeeeccCCCChhhhccCCCCccceEEeehhhhhhhhhCCCCCCcCCCCchhhhhhhhhhhcCCCcccc
Q 045315 314 MFGGDELQSNTKRIVGTYGYMSPEYALRGLFSIKSDVFSFGVLLLETLSSKKNTHFYNTDSLTLLGHAWNLWNDGRTWEL 393 (476)
Q Consensus 314 ~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~s~ksDVwSlGvvl~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~ 393 (476)
........ .....|+..|+|||.+.+..++.++||||||+++|||++|+.||........ .. .. ...
T Consensus 161 ~~~~~~~~--~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~--~~---~~-~~~----- 227 (278)
T 3cok_A 161 QLKMPHEK--HYTLCGTPNYISPEIATRSAHGLESDVWSLGCMFYTLLIGRPPFDTDTVKNT--LN---KV-VLA----- 227 (278)
T ss_dssp ECC------------------------------CTHHHHHHHHHHHHHHSSCSSCCCSCC----------C-CSS-----
T ss_pred eccCCCCc--ceeccCCCCcCCcchhcCCCCCchhhHHHHHHHHHHHHhCCCCCCChhHHHH--HH---HH-hhc-----
Confidence 76532211 2235689999999999988899999999999999999999999865432111 00 00 000
Q ss_pred cCcccCCCCCHHHHHHHHHHHHHchhhcccCCCCHHHHHH
Q 045315 394 MDPISQNGASYPILKRYINVALLCVQEKAADRPAMSEVVS 433 (476)
Q Consensus 394 ~d~~~~~~~~~~~~~~l~~li~~Cl~~dP~~RPt~~eVl~ 433 (476)
+. ..+......+.+++.+||+.||++||+++++++
T Consensus 228 -~~----~~~~~~~~~~~~li~~~l~~dp~~Rps~~~~l~ 262 (278)
T 3cok_A 228 -DY----EMPSFLSIEAKDLIHQLLRRNPADRLSLSSVLD 262 (278)
T ss_dssp -CC----CCCTTSCHHHHHHHHHHSCSSGGGSCCHHHHTT
T ss_pred -cc----CCccccCHHHHHHHHHHcccCHhhCCCHHHHhc
Confidence 00 011122356889999999999999999999875
|
| >1vzo_A Ribosomal protein S6 kinase alpha 5; protein kinase, transferase, phosphorylation, serine/threonine protein kinase; 1.8A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=99.93 E-value=7.8e-27 Score=235.09 Aligned_cols=178 Identities=19% Similarity=0.247 Sum_probs=133.6
Q ss_pred cccceeeccCCCCC------CCCCCChhhHHHHHHHHHHHHHHHhhcCCCceeecCCCccceEecCCCCceeccccceee
Q 045315 241 DEISFWYESYNNPT------KKGLLCWGTRVRIIEGIAQGLLYLHQYSRLRVIHRDLKASNILLDKDMNPKISDFGMARM 314 (476)
Q Consensus 241 ~~~~l~~Ey~~~~~------~~~~L~~~~~~~i~~qIa~gL~yLH~~~~~~ivH~DLkp~NILld~~~~~kL~DFGla~~ 314 (476)
+..+++|||++... .+..+++.++..++.||+.||+|||+++ |+||||||+|||++.++.+||+|||+++.
T Consensus 132 ~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~qi~~aL~~LH~~~---ivH~Dlkp~NIll~~~~~~kl~DfG~a~~ 208 (355)
T 1vzo_A 132 TKLHLILDYINGGELFTHLSQRERFTEHEVQIYVGEIVLALEHLHKLG---IIYRDIKLENILLDSNGHVVLTDFGLSKE 208 (355)
T ss_dssp TEEEEEECCCCSCBHHHHHHHHSCCCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCCGGGEEECTTSCEEESCSSEEEE
T ss_pred ceEEEEeecCCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCCHHHEEECCCCcEEEeeCCCCee
Confidence 46789999998432 2457999999999999999999999999 99999999999999999999999999987
Q ss_pred cCCCcccccceeeeeccCCCChhhhcc--CCCCccceEEeehhhhhhhhhCCCCCCcCCCCchhhhhhhhhhhcCCCccc
Q 045315 315 FGGDELQSNTKRIVGTYGYMSPEYALR--GLFSIKSDVFSFGVLLLETLSSKKNTHFYNTDSLTLLGHAWNLWNDGRTWE 392 (476)
Q Consensus 315 ~~~~~~~~~~~~~~gt~~y~aPE~l~~--~~~s~ksDVwSlGvvl~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~ 392 (476)
+...... ......||+.|+|||++.+ ..++.++|||||||++|||++|+.||......... ..........
T Consensus 209 ~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~~~DvwslG~il~ell~g~~pf~~~~~~~~~-~~~~~~~~~~----- 281 (355)
T 1vzo_A 209 FVADETE-RAYDFCGTIEYMAPDIVRGGDSGHDKAVDWWSLGVLMYELLTGASPFTVDGEKNSQ-AEISRRILKS----- 281 (355)
T ss_dssp CCGGGGG-GGCGGGSCCTTCCHHHHTTCC---CTHHHHHHHHHHHHHHHHSSCTTSCTTSCCCH-HHHHHHHHHC-----
T ss_pred cccCCCC-cccCcccCcCccChhhhcCCCCCCCchhhHHHHHHHHHHHHHCCCCCccCCccchH-HHHHHHHhcc-----
Confidence 6433222 2223568999999999985 34789999999999999999999998754322111 1111111110
Q ss_pred ccCcccCCCCCHHHHHHHHHHHHHchhhcccCCC-----CHHHHHHH
Q 045315 393 LMDPISQNGASYPILKRYINVALLCVQEKAADRP-----AMSEVVSM 434 (476)
Q Consensus 393 ~~d~~~~~~~~~~~~~~l~~li~~Cl~~dP~~RP-----t~~eVl~~ 434 (476)
....+......+.+++.+||+.||++|| +++|+++.
T Consensus 282 ------~~~~~~~~~~~~~~li~~~L~~dP~~R~~~~~~s~~ell~h 322 (355)
T 1vzo_A 282 ------EPPYPQEMSALAKDLIQRLLMKDPKKRLGCGPRDADEIKEH 322 (355)
T ss_dssp ------CCCCCTTSCHHHHHHHHHHTCSSGGGSTTSSTTTHHHHHTS
T ss_pred ------CCCCCcccCHHHHHHHHHHhhhCHHHhcCCCCCCHHHHHcC
Confidence 0011122345688999999999999999 99998864
|
| >3kvw_A DYRK2, dual specificity tyrosine-phosphorylation-regulat 2; KI-(Y)-phosphorylation REG kinase 2, PSK-H2, kinase, structural genomics consortium; HET: SEP PTR IRB; 2.28A {Homo sapiens} PDB: 3k2l_A* 4azf_A* | Back alignment and structure |
|---|
Probab=99.93 E-value=2.5e-27 Score=244.88 Aligned_cols=123 Identities=25% Similarity=0.276 Sum_probs=106.1
Q ss_pred cccceeeccCCC-------CCCCCCCChhhHHHHHHHHHHHHHHHhhcCCCceeecCCCccceEecCCCC--ceeccccc
Q 045315 241 DEISFWYESYNN-------PTKKGLLCWGTRVRIIEGIAQGLLYLHQYSRLRVIHRDLKASNILLDKDMN--PKISDFGM 311 (476)
Q Consensus 241 ~~~~l~~Ey~~~-------~~~~~~L~~~~~~~i~~qIa~gL~yLH~~~~~~ivH~DLkp~NILld~~~~--~kL~DFGl 311 (476)
+..+++|||+.. ......+++..+..++.||+.||+|||+.+ |+||||||+|||++.++. +||+|||+
T Consensus 172 ~~~~lv~e~~~~~L~~~l~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~---ivHrDlKp~NILl~~~~~~~vkL~DFG~ 248 (429)
T 3kvw_A 172 NHICMTFELLSMNLYELIKKNKFQGFSLPLVRKFAHSILQCLDALHKNR---IIHCDLKPENILLKQQGRSGIKVIDFGS 248 (429)
T ss_dssp TEEEEEECCCCCBHHHHHHHTTTCCCCHHHHHHHHHHHHHHHHHHHHHT---EECSCCSGGGEEESSTTSCCEEECCCTT
T ss_pred CeEEEEEeccCCCHHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCCHHHeEEccCCCcceEEeeccc
Confidence 457789999972 123346999999999999999999999999 999999999999999887 99999999
Q ss_pred eeecCCCcccccceeeeeccCCCChhhhccCCCCccceEEeehhhhhhhhhCCCCCCcCC
Q 045315 312 ARMFGGDELQSNTKRIVGTYGYMSPEYALRGLFSIKSDVFSFGVLLLETLSSKKNTHFYN 371 (476)
Q Consensus 312 a~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~s~ksDVwSlGvvl~elltG~~p~~~~~ 371 (476)
+...... .....||+.|+|||++.+..++.++|||||||++|||++|++||....
T Consensus 249 a~~~~~~-----~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~elltG~~pf~~~~ 303 (429)
T 3kvw_A 249 SCYEHQR-----VYTYIQSRFYRAPEVILGARYGMPIDMWSLGCILAELLTGYPLLPGED 303 (429)
T ss_dssp CEETTCC-----CCSSCSCGGGCCHHHHHTBCCCTHHHHHHHHHHHHHHHHSSCSSCCSS
T ss_pred ceecCCc-----ccccCCCCCccChHHHhCCCCCchHHHHhHHHHHHHHHhCCCCCCCCC
Confidence 9765432 223568999999999999999999999999999999999999987543
|
| >1xjd_A Protein kinase C, theta type; PKC-theta, ATP, AMP,, transferase; HET: TPO SEP STU; 2.00A {Homo sapiens} SCOP: d.144.1.7 PDB: 2jed_A* | Back alignment and structure |
|---|
Probab=99.93 E-value=1.6e-27 Score=239.37 Aligned_cols=171 Identities=26% Similarity=0.321 Sum_probs=134.0
Q ss_pred cccceeeccCCCCC------CCCCCChhhHHHHHHHHHHHHHHHhhcCCCceeecCCCccceEecCCCCceeccccceee
Q 045315 241 DEISFWYESYNNPT------KKGLLCWGTRVRIIEGIAQGLLYLHQYSRLRVIHRDLKASNILLDKDMNPKISDFGMARM 314 (476)
Q Consensus 241 ~~~~l~~Ey~~~~~------~~~~L~~~~~~~i~~qIa~gL~yLH~~~~~~ivH~DLkp~NILld~~~~~kL~DFGla~~ 314 (476)
+..+++|||++.+. +.+.+++.++..++.||+.||+|||+++ |+||||||+|||++.++.+||+|||+++.
T Consensus 91 ~~~~lv~E~~~gg~L~~~l~~~~~~~~~~~~~~~~qi~~aL~~LH~~~---ivHrDlkp~NIll~~~g~vkL~DFG~a~~ 167 (345)
T 1xjd_A 91 ENLFFVMEYLNGGDLMYHIQSCHKFDLSRATFYAAEIILGLQFLHSKG---IVYRDLKLDNILLDKDGHIKIADFGMCKE 167 (345)
T ss_dssp SEEEEEEECCTTCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTT---CBCCCCCGGGEEECTTSCEEECCCTTCBC
T ss_pred CEEEEEEeCCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCC---eEeCCCChhhEEECCCCCEEEeEChhhhh
Confidence 46889999998432 2457999999999999999999999999 99999999999999999999999999986
Q ss_pred cCCCcccccceeeeeccCCCChhhhccCCCCccceEEeehhhhhhhhhCCCCCCcCCCCchhhhhhhhhhhcCCCccccc
Q 045315 315 FGGDELQSNTKRIVGTYGYMSPEYALRGLFSIKSDVFSFGVLLLETLSSKKNTHFYNTDSLTLLGHAWNLWNDGRTWELM 394 (476)
Q Consensus 315 ~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~s~ksDVwSlGvvl~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 394 (476)
..... .......||+.|+|||.+.+..++.++|+|||||++|||++|+.||..... ....... ..+..
T Consensus 168 ~~~~~--~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~Pf~~~~~--~~~~~~i----~~~~~---- 235 (345)
T 1xjd_A 168 NMLGD--AKTNTFCGTPDYIAPEILLGQKYNHSVDWWSFGVLLYEMLIGQSPFHGQDE--EELFHSI----RMDNP---- 235 (345)
T ss_dssp CCCTT--CCBCCCCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCCSSH--HHHHHHH----HHCCC----
T ss_pred cccCC--CcccCCCCCcccCChhhhcCCCCCChhhhHHHHHHHHHHhcCCCCCCCCCH--HHHHHHH----HhCCC----
Confidence 43222 123346799999999999999999999999999999999999999865432 1111111 11110
Q ss_pred CcccCCCCCHHHHHHHHHHHHHchhhcccCCCCHH-HHH
Q 045315 395 DPISQNGASYPILKRYINVALLCVQEKAADRPAMS-EVV 432 (476)
Q Consensus 395 d~~~~~~~~~~~~~~l~~li~~Cl~~dP~~RPt~~-eVl 432 (476)
. .+......+.+++.+||+.||++||++. +|+
T Consensus 236 --~----~p~~~s~~~~~li~~lL~~dp~~R~~~~~~i~ 268 (345)
T 1xjd_A 236 --F----YPRWLEKEAKDLLVKLFVREPEKRLGVRGDIR 268 (345)
T ss_dssp --C----CCTTSCHHHHHHHHHHSCSSGGGSBTTBSCGG
T ss_pred --C----CCcccCHHHHHHHHHHhcCCHhHcCCChHHHH
Confidence 0 1112235688999999999999999997 664
|
| >4agu_A Cyclin-dependent kinase-like 1; transferase, phospho-mimetic; HET: D15; 2.40A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.93 E-value=3.3e-27 Score=232.54 Aligned_cols=188 Identities=20% Similarity=0.230 Sum_probs=130.1
Q ss_pred cccceeeccCCCC------CCCCCCChhhHHHHHHHHHHHHHHHhhcCCCceeecCCCccceEecCCCCceeccccceee
Q 045315 241 DEISFWYESYNNP------TKKGLLCWGTRVRIIEGIAQGLLYLHQYSRLRVIHRDLKASNILLDKDMNPKISDFGMARM 314 (476)
Q Consensus 241 ~~~~l~~Ey~~~~------~~~~~L~~~~~~~i~~qIa~gL~yLH~~~~~~ivH~DLkp~NILld~~~~~kL~DFGla~~ 314 (476)
+..++++||++.. ...+.+++.++..++.|++.||+|||+.+ |+||||||+||+++.++.+||+|||++..
T Consensus 75 ~~~~lv~e~~~~~~l~~~~~~~~~~~~~~~~~i~~~l~~~l~~lH~~~---ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~ 151 (311)
T 4agu_A 75 RRLHLVFEYCDHTVLHELDRYQRGVPEHLVKSITWQTLQAVNFCHKHN---CIHRDVKPENILITKHSVIKLCDFGFARL 151 (311)
T ss_dssp TEEEEEEECCSEEHHHHHHHTSSCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEECTTSCEEECCCTTCEE
T ss_pred CeEEEEEEeCCCchHHHHHhhhcCCCHHHHHHHHHHHHHHHHHHHHCC---CcCCCCChhhEEEcCCCCEEEeeCCCchh
Confidence 4578899999832 23567999999999999999999999999 99999999999999999999999999987
Q ss_pred cCCCcccccceeeeeccCCCChhhhcc-CCCCccceEEeehhhhhhhhhCCCCCCcCCCCch-hhhhhh--------hhh
Q 045315 315 FGGDELQSNTKRIVGTYGYMSPEYALR-GLFSIKSDVFSFGVLLLETLSSKKNTHFYNTDSL-TLLGHA--------WNL 384 (476)
Q Consensus 315 ~~~~~~~~~~~~~~gt~~y~aPE~l~~-~~~s~ksDVwSlGvvl~elltG~~p~~~~~~~~~-~~~~~~--------~~~ 384 (476)
....... .....|+..|+|||.+.+ ..++.++||||||+++|+|++|+.||........ ...... ...
T Consensus 152 ~~~~~~~--~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~ 229 (311)
T 4agu_A 152 LTGPSDY--YDDEVATRWYRSPELLVGDTQYGPPVDVWAIGCVFAELLSGVPLWPGKSDVDQLYLIRKTLGDLIPRHQQV 229 (311)
T ss_dssp CC--------------GGGCCHHHHHTCSCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCSCCHHHHHH
T ss_pred ccCcccc--cCCCcCCccccChHHHhcCCCCCcchhhHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhcccccccccc
Confidence 6533221 223568999999999876 6789999999999999999999999875442111 100000 000
Q ss_pred hcCCCc---ccccCcccCCC---CCHHHHHHHHHHHHHchhhcccCCCCHHHHHH
Q 045315 385 WNDGRT---WELMDPISQNG---ASYPILKRYINVALLCVQEKAADRPAMSEVVS 433 (476)
Q Consensus 385 ~~~~~~---~~~~d~~~~~~---~~~~~~~~l~~li~~Cl~~dP~~RPt~~eVl~ 433 (476)
+..... ....++..... ........+.+++.+||+.||++|||++|+++
T Consensus 230 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~ 284 (311)
T 4agu_A 230 FSTNQYFSGVKIPDPEDMEPLELKFPNISYPALGLLKGCLHMDPTERLTCEQLLH 284 (311)
T ss_dssp HHTCGGGTTCCCCCCSSCCCHHHHCTTCCHHHHHHHHHHCCSSTTTSCCHHHHHT
T ss_pred cccccccccCcCCCccccchhhhhcccccHHHHHHHHHHccCChhhcCCHHHHhc
Confidence 000000 00001000000 00123456889999999999999999999985
|
| >4eut_A Serine/threonine-protein kinase TBK1; ATP binding, phosphorylation, transferase-transferas inhibitor complex; HET: BX7; 2.60A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.93 E-value=8.2e-27 Score=238.44 Aligned_cols=193 Identities=17% Similarity=0.166 Sum_probs=141.5
Q ss_pred ccceeeccCCCC---------CCCCCCChhhHHHHHHHHHHHHHHHhhcCCCceeecCCCccceEe----cCCCCceecc
Q 045315 242 EISFWYESYNNP---------TKKGLLCWGTRVRIIEGIAQGLLYLHQYSRLRVIHRDLKASNILL----DKDMNPKISD 308 (476)
Q Consensus 242 ~~~l~~Ey~~~~---------~~~~~L~~~~~~~i~~qIa~gL~yLH~~~~~~ivH~DLkp~NILl----d~~~~~kL~D 308 (476)
..+++|||++.+ .....+++.+++.++.||+.||+|||+.+ |+||||||+|||+ +.++.+||+|
T Consensus 83 ~~~lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~---ivH~Dlkp~NIll~~~~~~~~~~kL~D 159 (396)
T 4eut_A 83 HKVLIMEFCPCGSLYTVLEEPSNAYGLPESEFLIVLRDVVGGMNHLRENG---IVHRNIKPGNIMRVIGEDGQSVYKLTD 159 (396)
T ss_dssp CEEEEECCCTTEEHHHHTTSGGGTTCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEEEECTTSCEEEEECC
T ss_pred eeEEEEecCCCCCHHHHHHhhhcccCCCHHHHHHHHHHHHHHHHHHHHCC---EEECCcCHHHEEEeecCCCceeEEEec
Confidence 467899999721 12233999999999999999999999999 9999999999999 7778899999
Q ss_pred ccceeecCCCcccccceeeeeccCCCChhhhcc--------CCCCccceEEeehhhhhhhhhCCCCCCcCCCC--chhhh
Q 045315 309 FGMARMFGGDELQSNTKRIVGTYGYMSPEYALR--------GLFSIKSDVFSFGVLLLETLSSKKNTHFYNTD--SLTLL 378 (476)
Q Consensus 309 FGla~~~~~~~~~~~~~~~~gt~~y~aPE~l~~--------~~~s~ksDVwSlGvvl~elltG~~p~~~~~~~--~~~~~ 378 (476)
||+++....... .....||..|+|||.+.+ ..++.++|||||||++|||++|+.||...... .....
T Consensus 160 FG~a~~~~~~~~---~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~DiwSlG~il~el~tg~~Pf~~~~~~~~~~~~~ 236 (396)
T 4eut_A 160 FGAARELEDDEQ---FVSLYGTEEYLHPDMYERAVLRKDHQKKYGATVDLWSIGVTFYHAATGSLPFRPFEGPRRNKEVM 236 (396)
T ss_dssp GGGCEECCCGGG---SSCSSSCCTTCCHHHHHHHCC--CHHHHHHHHHHHHHHHHHHHHHHHSSCSEECTTCTTTCHHHH
T ss_pred CCCceEccCCCc---cccccCCccccCHHHhhccccccccccCCCcHHHHHHHHHHHHHHHHCCCCCCCCCcccchHHHH
Confidence 999987654332 223568999999999865 56788999999999999999999999754321 11111
Q ss_pred hhhhhhhcCCCcc----------ccc-CcccCCCCCHHHHHHHHHHHHHchhhcccCCCCHHHHHHHHhcccc
Q 045315 379 GHAWNLWNDGRTW----------ELM-DPISQNGASYPILKRYINVALLCVQEKAADRPAMSEVVSMLSNEFV 440 (476)
Q Consensus 379 ~~~~~~~~~~~~~----------~~~-d~~~~~~~~~~~~~~l~~li~~Cl~~dP~~RPt~~eVl~~L~~~~~ 440 (476)
............. ... +..............+.+++.+||+.||++||++.|+++.++.+..
T Consensus 237 ~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~l~~ll~~~L~~dP~~R~s~~e~l~~l~~il~ 309 (396)
T 4eut_A 237 YKIITGKPSGAISGVQKAENGPIDWSGDMPVSCSLSRGLQVLLTPVLANILEADQEKCWGFDQFFAETSDILH 309 (396)
T ss_dssp HHHHHSCCTTCCEEEECSTTCCEEEESSCCTTCSSCHHHHHHHHHHHHHHSCCCTTTSCCHHHHHHHHHHHHT
T ss_pred HHHhcCCCcccchhheeccCCCcccCccCCcccccchHHHhhchHHHHHhhccChhhhccHHHHHHHHHHHhh
Confidence 1111100000000 000 0011123345677888999999999999999999999999988763
|
| >1u46_A ACK-1, activated CDC42 kinase 1; tyrosine kinase, transferase; 2.00A {Homo sapiens} SCOP: d.144.1.7 PDB: 1u4d_A* 1u54_A* 3eqr_A* 3eqp_B* | Back alignment and structure |
|---|
Probab=99.93 E-value=1.6e-27 Score=232.15 Aligned_cols=181 Identities=25% Similarity=0.332 Sum_probs=137.7
Q ss_pred ccceeeccCCCCC-------CCCCCChhhHHHHHHHHHHHHHHHhhcCCCceeecCCCccceEecCCCCceeccccceee
Q 045315 242 EISFWYESYNNPT-------KKGLLCWGTRVRIIEGIAQGLLYLHQYSRLRVIHRDLKASNILLDKDMNPKISDFGMARM 314 (476)
Q Consensus 242 ~~~l~~Ey~~~~~-------~~~~L~~~~~~~i~~qIa~gL~yLH~~~~~~ivH~DLkp~NILld~~~~~kL~DFGla~~ 314 (476)
..++++||++... ....+++.++..++.||+.||+|||+++ ++|+||||+||+++.++.+||+|||++..
T Consensus 94 ~~~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~---i~H~dikp~Nili~~~~~~kl~Dfg~~~~ 170 (291)
T 1u46_A 94 PMKMVTELAPLGSLLDRLRKHQGHFLLGTLSRYAVQVAEGMGYLESKR---FIHRDLAARNLLLATRDLVKIGDFGLMRA 170 (291)
T ss_dssp SCEEEEECCTTCBHHHHHHHHGGGSCHHHHHHHHHHHHHHHHHHHHTT---EECSCCCGGGEEEEETTEEEECCCTTCEE
T ss_pred CceeeEecccCCCHHHHHHhccCCcCHHHHHHHHHHHHHHHHHHHhCC---cccCCCchheEEEcCCCCEEEcccccccc
Confidence 4678889987332 2356999999999999999999999999 99999999999999999999999999987
Q ss_pred cCCCccc-ccceeeeeccCCCChhhhccCCCCccceEEeehhhhhhhhh-CCCCCCcCCCCchhhhhhhhhhhcCCCccc
Q 045315 315 FGGDELQ-SNTKRIVGTYGYMSPEYALRGLFSIKSDVFSFGVLLLETLS-SKKNTHFYNTDSLTLLGHAWNLWNDGRTWE 392 (476)
Q Consensus 315 ~~~~~~~-~~~~~~~gt~~y~aPE~l~~~~~s~ksDVwSlGvvl~ellt-G~~p~~~~~~~~~~~~~~~~~~~~~~~~~~ 392 (476)
....... .......++..|+|||.+.+..++.++||||||+++|||++ |+.||...... .... .........
T Consensus 171 ~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~~g~~p~~~~~~~--~~~~---~~~~~~~~~- 244 (291)
T 1u46_A 171 LPQNDDHYVMQEHRKVPFAWCAPESLKTRTFSHASDTWMFGVTLWEMFTYGQEPWIGLNGS--QILH---KIDKEGERL- 244 (291)
T ss_dssp CCC-CCEEEC-----CCGGGCCHHHHHHCEEEHHHHHHHHHHHHHHHHTTSCCTTTTCCHH--HHHH---HHHTSCCCC-
T ss_pred ccccccchhhhccCCCCceeeCchhhcCCCCCchhhHHHHHHHHHHHHhCCCCCcccCCHH--HHHH---HHHccCCCC-
Confidence 6543221 12223457788999999998889999999999999999999 99998654311 1111 111111110
Q ss_pred ccCcccCCCCCHHHHHHHHHHHHHchhhcccCCCCHHHHHHHHhccc
Q 045315 393 LMDPISQNGASYPILKRYINVALLCVQEKAADRPAMSEVVSMLSNEF 439 (476)
Q Consensus 393 ~~d~~~~~~~~~~~~~~l~~li~~Cl~~dP~~RPt~~eVl~~L~~~~ 439 (476)
.........+.+++.+||+.||++||++.++++.|+++.
T Consensus 245 --------~~~~~~~~~l~~li~~~l~~~p~~Rps~~~l~~~l~~~~ 283 (291)
T 1u46_A 245 --------PRPEDCPQDIYNVMVQCWAHKPEDRPTFVALRDFLLEAQ 283 (291)
T ss_dssp --------CCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHC
T ss_pred --------CCCcCcCHHHHHHHHHHccCCcccCcCHHHHHHHHHHhC
Confidence 111223467889999999999999999999999999865
|
| >2h34_A Serine/threonine-protein kinase PKNE; apoenzyme, transferase; 2.80A {Mycobacterium tuberculosis} | Back alignment and structure |
|---|
Probab=99.93 E-value=4.7e-27 Score=231.83 Aligned_cols=189 Identities=20% Similarity=0.233 Sum_probs=130.0
Q ss_pred cccceeeccCCCC------CCCCCCChhhHHHHHHHHHHHHHHHhhcCCCceeecCCCccceEecCCCCceeccccceee
Q 045315 241 DEISFWYESYNNP------TKKGLLCWGTRVRIIEGIAQGLLYLHQYSRLRVIHRDLKASNILLDKDMNPKISDFGMARM 314 (476)
Q Consensus 241 ~~~~l~~Ey~~~~------~~~~~L~~~~~~~i~~qIa~gL~yLH~~~~~~ivH~DLkp~NILld~~~~~kL~DFGla~~ 314 (476)
+.+++++||++.. ...+.+++.++..++.||+.||+|||+.+ |+||||||+||+++.++.+||+|||++..
T Consensus 107 ~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~i~~qi~~~l~~lH~~~---i~H~dlkp~NIl~~~~~~~kl~Dfg~~~~ 183 (309)
T 2h34_A 107 GQLYVDMRLINGVDLAAMLRRQGPLAPPRAVAIVRQIGSALDAAHAAG---ATHRDVKPENILVSADDFAYLVDFGIASA 183 (309)
T ss_dssp TEEEEEEECCCCEEHHHHHHHHCSCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEECTTSCEEECSCCC---
T ss_pred CeEEEEEEecCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCc---CCcCCCChHHEEEcCCCCEEEecCccCcc
Confidence 4678899999732 12357999999999999999999999999 99999999999999999999999999987
Q ss_pred cCCCcccccceeeeeccCCCChhhhccCCCCccceEEeehhhhhhhhhCCCCCCcCCCCchhhhhhhhhhhcCCCccccc
Q 045315 315 FGGDELQSNTKRIVGTYGYMSPEYALRGLFSIKSDVFSFGVLLLETLSSKKNTHFYNTDSLTLLGHAWNLWNDGRTWELM 394 (476)
Q Consensus 315 ~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~s~ksDVwSlGvvl~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 394 (476)
....... ......|+..|+|||.+.+..++.++||||||+++|||++|+.||...... ... ........
T Consensus 184 ~~~~~~~-~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~--~~~----~~~~~~~~---- 252 (309)
T 2h34_A 184 TTDEKLT-QLGNTVGTLYYMAPERFSESHATYRADIYALTCVLYECLTGSPPYQGDQLS--VMG----AHINQAIP---- 252 (309)
T ss_dssp --------------CCGGGCCGGGTCC----CCCHHHHHHHHHHHHHHSSCSSCSCHHH--HHH----HHHHSCCC----
T ss_pred ccccccc-cccccCCCcCccCHHHHcCCCCCchHhHHHHHHHHHHHHHCCCCCCCchHH--HHH----HHhccCCC----
Confidence 6543221 122356899999999999989999999999999999999999998643211 111 11111100
Q ss_pred CcccCCCCCHHHHHHHHHHHHHchhhcccCCC-CHHHHHHHHhccccCCCCCC
Q 045315 395 DPISQNGASYPILKRYINVALLCVQEKAADRP-AMSEVVSMLSNEFVNLPAPQ 446 (476)
Q Consensus 395 d~~~~~~~~~~~~~~l~~li~~Cl~~dP~~RP-t~~eVl~~L~~~~~~~~~p~ 446 (476)
.+. .........+.+++.+||+.||++|| +++++++.|+..........
T Consensus 253 ~~~---~~~~~~~~~l~~li~~~l~~dP~~Rp~s~~~l~~~l~~~l~~~~~~~ 302 (309)
T 2h34_A 253 RPS---TVRPGIPVAFDAVIARGMAKNPEDRYVTCGDLSAAAHAALATADQDR 302 (309)
T ss_dssp CGG---GTSTTCCTHHHHHHHHHTCSSGGGSCSSHHHHHHHHHHTCC------
T ss_pred Ccc---ccCCCCCHHHHHHHHHhccCCHHHHHHhHHHHHHHHHHHHHhhcccc
Confidence 000 01112234688999999999999999 99999999999875544333
|
| >3qd2_B Eukaryotic translation initiation factor 2-alpha; EIF2A kinase, phosphoryalation, gene regulation; HET: TPO; 2.81A {Mus musculus} | Back alignment and structure |
|---|
Probab=99.93 E-value=2.9e-27 Score=234.45 Aligned_cols=172 Identities=24% Similarity=0.283 Sum_probs=128.2
Q ss_pred ccceeeccCCCC---------CCCCCCChhhHHHHHHHHHHHHHHHhhcCCCceeecCCCccceEecCCCCceeccccce
Q 045315 242 EISFWYESYNNP---------TKKGLLCWGTRVRIIEGIAQGLLYLHQYSRLRVIHRDLKASNILLDKDMNPKISDFGMA 312 (476)
Q Consensus 242 ~~~l~~Ey~~~~---------~~~~~L~~~~~~~i~~qIa~gL~yLH~~~~~~ivH~DLkp~NILld~~~~~kL~DFGla 312 (476)
-.+++|||++.. ......++..++.++.||+.||+|||+++ |+||||||+||+++.++.+||+|||++
T Consensus 135 ~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~---ivH~Dlkp~NIll~~~~~~kL~DfG~a 211 (332)
T 3qd2_B 135 YLYIQMQLCRKENLKDWMNRRCSLEDREHGVCLHIFIQIAEAVEFLHSKG---LMHRDLKPSNIFFTMDDVVKVGDFGLV 211 (332)
T ss_dssp EEEEEEECCCSSCHHHHHHTCCSGGGSCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEECTTCCEEECCCTTC
T ss_pred eEEEEEEecCCCCHHHHHhcccCccchhhHHHHHHHHHHHHHHHHHHhCC---eeecCCCcccEEEeCCCCEEEeecCcc
Confidence 477899999732 22344566678999999999999999999 999999999999999999999999999
Q ss_pred eecCCCccc----------ccceeeeeccCCCChhhhccCCCCccceEEeehhhhhhhhhCCCCCCcCCCCchhhhhhhh
Q 045315 313 RMFGGDELQ----------SNTKRIVGTYGYMSPEYALRGLFSIKSDVFSFGVLLLETLSSKKNTHFYNTDSLTLLGHAW 382 (476)
Q Consensus 313 ~~~~~~~~~----------~~~~~~~gt~~y~aPE~l~~~~~s~ksDVwSlGvvl~elltG~~p~~~~~~~~~~~~~~~~ 382 (476)
+........ .......||+.|+|||.+.+..++.++|||||||++|||++|..|+... ....
T Consensus 212 ~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~~~~~~~~----~~~~---- 283 (332)
T 3qd2_B 212 TAMDQDEEEQTVLTPMPAYATHTGQVGTKLYMSPEQIHGNNYSHKVDIFSLGLILFELLYSFSTQMER----VRII---- 283 (332)
T ss_dssp EECSCC--------------CCCSCC-CGGGSCHHHHHCCCCCTHHHHHHHHHHHHHHHSCCCCHHHH----HHHH----
T ss_pred cccccchhhccccccccccccccccCCCcCccChHHhcCCCCcchhhHHHHHHHHHHHHHcCCChhHH----HHHH----
Confidence 987543211 1122346899999999999999999999999999999999987664210 0000
Q ss_pred hhhcCCCcccccCcccCCCCCHHHHHHHHHHHHHchhhcccCCCCHHHHHH
Q 045315 383 NLWNDGRTWELMDPISQNGASYPILKRYINVALLCVQEKAADRPAMSEVVS 433 (476)
Q Consensus 383 ~~~~~~~~~~~~d~~~~~~~~~~~~~~l~~li~~Cl~~dP~~RPt~~eVl~ 433 (476)
......... .........+.+++.+||+.||++|||++|+++
T Consensus 284 ~~~~~~~~~---------~~~~~~~~~~~~li~~~l~~~p~~Rps~~~~l~ 325 (332)
T 3qd2_B 284 TDVRNLKFP---------LLFTQKYPQEHMMVQDMLSPSPTERPEATDIIE 325 (332)
T ss_dssp HHHHTTCCC---------HHHHHHCHHHHHHHHHHHCSSGGGSCCHHHHHH
T ss_pred HHhhccCCC---------cccccCChhHHHHHHHHccCCCCcCCCHHHHhh
Confidence 011111100 011223456789999999999999999999986
|
| >2x4f_A Myosin light chain kinase family member 4; LUNG, breast cancer, transferase, serine/threonine-protein kinase, nucleotide-binding; HET: 16X 1PE; 2.67A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.93 E-value=6.1e-27 Score=237.61 Aligned_cols=175 Identities=25% Similarity=0.248 Sum_probs=134.9
Q ss_pred cccceeeccCCCCC-------CCCCCChhhHHHHHHHHHHHHHHHhhcCCCceeecCCCccceEe--cCCCCceeccccc
Q 045315 241 DEISFWYESYNNPT-------KKGLLCWGTRVRIIEGIAQGLLYLHQYSRLRVIHRDLKASNILL--DKDMNPKISDFGM 311 (476)
Q Consensus 241 ~~~~l~~Ey~~~~~-------~~~~L~~~~~~~i~~qIa~gL~yLH~~~~~~ivH~DLkp~NILl--d~~~~~kL~DFGl 311 (476)
+..+++|||++... ....+++.++..++.||+.||+|||+.+ |+||||||+|||+ +.++.+||+|||+
T Consensus 159 ~~~~lv~E~~~~~~L~~~l~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~---ivH~Dlkp~NIll~~~~~~~~kl~DFG~ 235 (373)
T 2x4f_A 159 NDIVLVMEYVDGGELFDRIIDESYNLTELDTILFMKQICEGIRHMHQMY---ILHLDLKPENILCVNRDAKQIKIIDFGL 235 (373)
T ss_dssp SEEEEEEECCTTCEEHHHHHHTGGGCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEEEETTTTEEEECCCSS
T ss_pred CEEEEEEeCCCCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCC---cccccCCHHHEEEecCCCCcEEEEeCCC
Confidence 46889999998432 3456999999999999999999999999 9999999999999 5677899999999
Q ss_pred eeecCCCcccccceeeeeccCCCChhhhccCCCCccceEEeehhhhhhhhhCCCCCCcCCCCchhhhhhhhhhhcCCCcc
Q 045315 312 ARMFGGDELQSNTKRIVGTYGYMSPEYALRGLFSIKSDVFSFGVLLLETLSSKKNTHFYNTDSLTLLGHAWNLWNDGRTW 391 (476)
Q Consensus 312 a~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~s~ksDVwSlGvvl~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~ 391 (476)
++....... .....||+.|+|||++.+..++.++|||||||++|||++|+.||...... ...... ... ..
T Consensus 236 a~~~~~~~~---~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~~~--~~~~~i---~~~-~~- 305 (373)
T 2x4f_A 236 ARRYKPREK---LKVNFGTPEFLAPEVVNYDFVSFPTDMWSVGVIAYMLLSGLSPFLGDNDA--ETLNNI---LAC-RW- 305 (373)
T ss_dssp CEECCTTCB---CCCCCSSCTTCCHHHHTTCBCCHHHHHHHHHHHHHHHHHSSCTTCCSSHH--HHHHHH---HHT-CC-
T ss_pred ceecCCccc---cccccCCCcEeChhhccCCCCCcHHhHHHHHHHHHHHHhCCCCCCCCCHH--HHHHHH---Hhc-cC-
Confidence 998754332 22246899999999999899999999999999999999999998654311 111111 110 00
Q ss_pred cccCcccCCCCCHHHHHHHHHHHHHchhhcccCCCCHHHHHH
Q 045315 392 ELMDPISQNGASYPILKRYINVALLCVQEKAADRPAMSEVVS 433 (476)
Q Consensus 392 ~~~d~~~~~~~~~~~~~~l~~li~~Cl~~dP~~RPt~~eVl~ 433 (476)
...... .......+.+++.+||+.||++|||+.|+++
T Consensus 306 ~~~~~~-----~~~~~~~~~~li~~~L~~dp~~Rps~~e~l~ 342 (373)
T 2x4f_A 306 DLEDEE-----FQDISEEAKEFISKLLIKEKSWRISASEALK 342 (373)
T ss_dssp CSCSGG-----GTTSCHHHHHHHHTTSCSSGGGSCCHHHHHH
T ss_pred CCChhh-----hccCCHHHHHHHHHHcCCChhhCCCHHHHhc
Confidence 000000 0112357889999999999999999999987
|
| >3a8x_A Protein kinase C IOTA type; transferase; HET: TPO; 2.00A {Homo sapiens} PDB: 3a8w_A* 1zrz_A* | Back alignment and structure |
|---|
Probab=99.93 E-value=5.8e-27 Score=235.27 Aligned_cols=173 Identities=20% Similarity=0.267 Sum_probs=131.2
Q ss_pred cccceeeccCCCCC------CCCCCChhhHHHHHHHHHHHHHHHhhcCCCceeecCCCccceEecCCCCceeccccceee
Q 045315 241 DEISFWYESYNNPT------KKGLLCWGTRVRIIEGIAQGLLYLHQYSRLRVIHRDLKASNILLDKDMNPKISDFGMARM 314 (476)
Q Consensus 241 ~~~~l~~Ey~~~~~------~~~~L~~~~~~~i~~qIa~gL~yLH~~~~~~ivH~DLkp~NILld~~~~~kL~DFGla~~ 314 (476)
+..+++|||++.+. +.+.+++.++..++.||+.||+|||+++ |+||||||+|||++.++.+||+|||+++.
T Consensus 83 ~~~~lv~e~~~gg~L~~~l~~~~~l~~~~~~~~~~qi~~aL~~LH~~~---ivHrDlkp~NIll~~~g~~kL~DFG~a~~ 159 (345)
T 3a8x_A 83 SRLFFVIEYVNGGDLMFHMQRQRKLPEEHARFYSAEISLALNYLHERG---IIYRDLKLDNVLLDSEGHIKLTDYGMCKE 159 (345)
T ss_dssp SEEEEEECCCCSCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTT---CBCCCCCGGGEEECTTSCEEECCGGGCBC
T ss_pred CEEEEEEeCCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCC---ceecCCCHHHEEECCCCCEEEEecccccc
Confidence 46889999998432 2457999999999999999999999999 99999999999999999999999999986
Q ss_pred cCCCcccccceeeeeccCCCChhhhccCCCCccceEEeehhhhhhhhhCCCCCCcCCCCch---hhhhhhhhhhcCCCcc
Q 045315 315 FGGDELQSNTKRIVGTYGYMSPEYALRGLFSIKSDVFSFGVLLLETLSSKKNTHFYNTDSL---TLLGHAWNLWNDGRTW 391 (476)
Q Consensus 315 ~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~s~ksDVwSlGvvl~elltG~~p~~~~~~~~~---~~~~~~~~~~~~~~~~ 391 (476)
..... .......||+.|+|||.+.+..++.++|+|||||++|||++|+.||........ ...............
T Consensus 160 ~~~~~--~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~i~~~~~- 236 (345)
T 3a8x_A 160 GLRPG--DTTSTFCGTPNYIAPEILRGEDYGFSVDWWALGVLMFEMMAGRSPFDIVGSSDNPDQNTEDYLFQVILEKQI- 236 (345)
T ss_dssp SCCTT--CCBCCCCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCTTTTTTC-------CHHHHHHHHHHCCC-
T ss_pred ccCCC--CcccccCCCccccCccccCCCCCChHHhHHHHHHHHHHHHhCCCCcCCcccccccccccHHHHHHHHHcCCC-
Confidence 43221 123346799999999999999999999999999999999999999964321100 001111111111111
Q ss_pred cccCcccCCCCCHHHHHHHHHHHHHchhhcccCCCCH
Q 045315 392 ELMDPISQNGASYPILKRYINVALLCVQEKAADRPAM 428 (476)
Q Consensus 392 ~~~d~~~~~~~~~~~~~~l~~li~~Cl~~dP~~RPt~ 428 (476)
..+......+.+++.+||+.||++||++
T Consensus 237 ---------~~p~~~s~~~~~li~~lL~~dP~~R~~~ 264 (345)
T 3a8x_A 237 ---------RIPRSLSVKAASVLKSFLNKDPKERLGC 264 (345)
T ss_dssp ---------CCCTTSCHHHHHHHHHHTCSSTTTSTTC
T ss_pred ---------CCCCCCCHHHHHHHHHHhcCCHhHCCCC
Confidence 0111234568899999999999999995
|
| >2yfx_A Tyrosine-protein kinase receptor; nucleotide-binding, transferase; HET: VGH; 1.70A {Homo sapiens} PDB: 2xp2_A* 3aox_A* 2yhv_A 3lcs_A* 3lct_A* 4dce_A* 2xba_A* 2xb7_A* | Back alignment and structure |
|---|
Probab=99.93 E-value=2.4e-27 Score=235.63 Aligned_cols=182 Identities=25% Similarity=0.292 Sum_probs=136.1
Q ss_pred cccceeeccCCCC-------------CCCCCCChhhHHHHHHHHHHHHHHHhhcCCCceeecCCCccceEecC---CCCc
Q 045315 241 DEISFWYESYNNP-------------TKKGLLCWGTRVRIIEGIAQGLLYLHQYSRLRVIHRDLKASNILLDK---DMNP 304 (476)
Q Consensus 241 ~~~~l~~Ey~~~~-------------~~~~~L~~~~~~~i~~qIa~gL~yLH~~~~~~ivH~DLkp~NILld~---~~~~ 304 (476)
+..+++|||++.. .....+++.+++.++.||+.||+|||+++ |+||||||+||+++. +..+
T Consensus 106 ~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~i~~qi~~al~~LH~~~---i~H~dlkp~NIli~~~~~~~~~ 182 (327)
T 2yfx_A 106 LPRFILMELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDIACGCQYLEENH---FIHRDIAARNCLLTCPGPGRVA 182 (327)
T ss_dssp SSCEEEEECCTTEEHHHHHHHTSCCSSSTTSCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEESCSSTTCCE
T ss_pred CCcEEEEecCCCCcHHHHHHhhcccccccccccHHHHHHHHHHHHHHHHHHhhCC---eecCcCCHhHEEEecCCCcceE
Confidence 4578899998621 12256999999999999999999999999 999999999999984 4569
Q ss_pred eeccccceeecCCCcccccceeeeeccCCCChhhhccCCCCccceEEeehhhhhhhhh-CCCCCCcCCCCchhhhhhhhh
Q 045315 305 KISDFGMARMFGGDELQSNTKRIVGTYGYMSPEYALRGLFSIKSDVFSFGVLLLETLS-SKKNTHFYNTDSLTLLGHAWN 383 (476)
Q Consensus 305 kL~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~s~ksDVwSlGvvl~ellt-G~~p~~~~~~~~~~~~~~~~~ 383 (476)
||+|||++................++..|+|||.+.+..++.++||||||+++|||++ |+.||..... .....
T Consensus 183 kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~p~~~~~~--~~~~~---- 256 (327)
T 2yfx_A 183 KIGDFGMARDIYRASYYRKGGCAMLPVKWMPPEAFMEGIFTSKTDTWSFGVLLWEIFSLGYMPYPSKSN--QEVLE---- 256 (327)
T ss_dssp EECCCHHHHHHHC------CCGGGSCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCH--HHHHH----
T ss_pred EECccccccccccccccccCCCcCCCcceeCHhHhcCCCCCchhhHHHHHHHHHHHHcCCCCCCCCcCH--HHHHH----
Confidence 9999999976543322222223457889999999999999999999999999999998 8888864321 11111
Q ss_pred hhcCCCcccccCcccCCCCCHHHHHHHHHHHHHchhhcccCCCCHHHHHHHHhcccc
Q 045315 384 LWNDGRTWELMDPISQNGASYPILKRYINVALLCVQEKAADRPAMSEVVSMLSNEFV 440 (476)
Q Consensus 384 ~~~~~~~~~~~d~~~~~~~~~~~~~~l~~li~~Cl~~dP~~RPt~~eVl~~L~~~~~ 440 (476)
....+... .........+.+++.+||+.||++||++.+|++.|+.+..
T Consensus 257 ~~~~~~~~---------~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~l~~~~~ 304 (327)
T 2yfx_A 257 FVTSGGRM---------DPPKNCPGPVYRIMTQCWQHQPEDRPNFAIILERIEYCTQ 304 (327)
T ss_dssp HHHTTCCC---------CCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHH
T ss_pred HHhcCCCC---------CCCCCCCHHHHHHHHHHhcCChhhCcCHHHHHHHHHHHhc
Confidence 11111111 0111223568899999999999999999999999998753
|
| >2vx3_A Dual specificity tyrosine-phosphorylation- regula kinase 1A; serine/threonine-protein kinase, minibrain homolog, nucleotide-binding, transferase; HET: PTR D15 P6G; 2.40A {Homo sapiens} PDB: 2wo6_A* 3anq_A* 3anr_A* | Back alignment and structure |
|---|
Probab=99.93 E-value=2e-26 Score=234.37 Aligned_cols=123 Identities=27% Similarity=0.351 Sum_probs=104.5
Q ss_pred cccceeeccCCC-------CCCCCCCChhhHHHHHHHHHHHHHHHhh--cCCCceeecCCCccceEec--CCCCceeccc
Q 045315 241 DEISFWYESYNN-------PTKKGLLCWGTRVRIIEGIAQGLLYLHQ--YSRLRVIHRDLKASNILLD--KDMNPKISDF 309 (476)
Q Consensus 241 ~~~~l~~Ey~~~-------~~~~~~L~~~~~~~i~~qIa~gL~yLH~--~~~~~ivH~DLkp~NILld--~~~~~kL~DF 309 (476)
+..+++|||++. ....+.+++..+..++.||+.||+|||+ .+ |+||||||+|||++ .++.+||+||
T Consensus 129 ~~~~lv~e~~~~~L~~~l~~~~~~~~~~~~~~~i~~qi~~al~~lH~~~~~---ivHrDlkp~NIll~~~~~~~~kL~DF 205 (382)
T 2vx3_A 129 NHLCLVFEMLSYNLYDLLRNTNFRGVSLNLTRKFAQQMCTALLFLATPELS---IIHCDLKPENILLCNPKRSAIKIVDF 205 (382)
T ss_dssp TEEEEEEECCCCBHHHHHHHTTTSCCCHHHHHHHHHHHHHHHHHHTSTTTC---EECCCCSGGGEEESSTTSCCEEECCC
T ss_pred CceEEEEecCCCCHHHHHhhcCcCCCCHHHHHHHHHHHHHHHHHhccCCCC---EEcCCCCcccEEEecCCCCcEEEEec
Confidence 457789999972 1233569999999999999999999995 45 99999999999994 5778999999
Q ss_pred cceeecCCCcccccceeeeeccCCCChhhhccCCCCccceEEeehhhhhhhhhCCCCCCcCC
Q 045315 310 GMARMFGGDELQSNTKRIVGTYGYMSPEYALRGLFSIKSDVFSFGVLLLETLSSKKNTHFYN 371 (476)
Q Consensus 310 Gla~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~s~ksDVwSlGvvl~elltG~~p~~~~~ 371 (476)
|+++...... ....||+.|+|||++.+..++.++|||||||++|||++|+.||....
T Consensus 206 G~a~~~~~~~-----~~~~~t~~y~aPE~~~~~~~~~~~DiwSlG~il~elltg~~pf~~~~ 262 (382)
T 2vx3_A 206 GSSCQLGQRI-----YQYIQSRFYRSPEVLLGMPYDLAIDMWSLGCILVEMHTGEPLFSGAN 262 (382)
T ss_dssp TTCEETTCCC-----CSSCSCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSSCCSS
T ss_pred cCceeccccc-----ccccCCccccChHHHcCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCC
Confidence 9998765321 23568999999999999999999999999999999999999997543
|
| >4fr4_A YANK1, serine/threonine-protein kinase 32A; structural genomics, structural genomics consortium, SGC, TR; HET: STU; 2.29A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.93 E-value=9e-27 Score=237.12 Aligned_cols=173 Identities=22% Similarity=0.289 Sum_probs=134.3
Q ss_pred cccceeeccCCCC------CCCCCCChhhHHHHHHHHHHHHHHHhhcCCCceeecCCCccceEecCCCCceeccccceee
Q 045315 241 DEISFWYESYNNP------TKKGLLCWGTRVRIIEGIAQGLLYLHQYSRLRVIHRDLKASNILLDKDMNPKISDFGMARM 314 (476)
Q Consensus 241 ~~~~l~~Ey~~~~------~~~~~L~~~~~~~i~~qIa~gL~yLH~~~~~~ivH~DLkp~NILld~~~~~kL~DFGla~~ 314 (476)
+..++++||++.+ .....+++.++..++.||+.||+|||+.+ |+||||||+|||++.++.+||+|||++..
T Consensus 88 ~~~~lv~e~~~gg~L~~~l~~~~~l~~~~~~~~~~qi~~aL~~LH~~g---ivHrDlkp~NIll~~~g~vkL~DFG~a~~ 164 (384)
T 4fr4_A 88 EDMFMVVDLLLGGDLRYHLQQNVHFKEETVKLFICELVMALDYLQNQR---IIHRDMKPDNILLDEHGHVHITDFNIAAM 164 (384)
T ss_dssp SEEEEEECCCTTEEHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEECTTSCEEECCCTTCEE
T ss_pred CEEEEEEecCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCC---ceeccCcHHHeEECCCCCEEEeccceeee
Confidence 4678999999732 23567999999999999999999999999 99999999999999999999999999987
Q ss_pred cCCCcccccceeeeeccCCCChhhhcc---CCCCccceEEeehhhhhhhhhCCCCCCcCCCCch-hhhhhhhhhhcCCCc
Q 045315 315 FGGDELQSNTKRIVGTYGYMSPEYALR---GLFSIKSDVFSFGVLLLETLSSKKNTHFYNTDSL-TLLGHAWNLWNDGRT 390 (476)
Q Consensus 315 ~~~~~~~~~~~~~~gt~~y~aPE~l~~---~~~s~ksDVwSlGvvl~elltG~~p~~~~~~~~~-~~~~~~~~~~~~~~~ 390 (476)
..... ......||+.|+|||++.. ..++.++|||||||++|||++|+.||........ ...... ....
T Consensus 165 ~~~~~---~~~~~~gt~~Y~aPE~~~~~~~~~~~~~~DiwSlG~il~elltG~~Pf~~~~~~~~~~~~~~~----~~~~- 236 (384)
T 4fr4_A 165 LPRET---QITTMAGTKPYMAPEMFSSRKGAGYSFAVDWWSLGVTAYELLRGRRPYHIRSSTSSKEIVHTF----ETTV- 236 (384)
T ss_dssp CCTTC---CBCCCCSCGGGCCGGGTCCCSSCCBCTTHHHHHHHHHHHHHHHSSCSSCCCTTSCHHHHHHHH----HHCC-
T ss_pred ccCCC---ceeccCCCccccCCeeeccCCCCCCCccceeechHHHHHHHHhCCCCCCCCCCccHHHHHHHH----hhcc-
Confidence 65432 2234679999999999864 4589999999999999999999999975442221 111111 0000
Q ss_pred ccccCcccCCCCCHHHHHHHHHHHHHchhhcccCCCC-HHHHHH
Q 045315 391 WELMDPISQNGASYPILKRYINVALLCVQEKAADRPA-MSEVVS 433 (476)
Q Consensus 391 ~~~~d~~~~~~~~~~~~~~l~~li~~Cl~~dP~~RPt-~~eVl~ 433 (476)
...+......+.+++.+||+.||.+||+ +++|.+
T Consensus 237 ---------~~~p~~~s~~~~~li~~lL~~dP~~R~s~~~~l~~ 271 (384)
T 4fr4_A 237 ---------VTYPSAWSQEMVSLLKKLLEPNPDQRFSQLSDVQN 271 (384)
T ss_dssp ---------CCCCTTSCHHHHHHHHHHSCSSGGGSCCSHHHHHT
T ss_pred ---------cCCCCcCCHHHHHHHHHHhcCCHhHhcccHHHHHc
Confidence 0111223457889999999999999998 777654
|
| >1z57_A Dual specificity protein kinase CLK1; protein tyrosine kinase, splicing, human, 10Z-hymendialdisine, structural genomics; HET: DBQ; 1.70A {Homo sapiens} PDB: 2vag_A* | Back alignment and structure |
|---|
Probab=99.93 E-value=8.5e-27 Score=231.52 Aligned_cols=183 Identities=20% Similarity=0.220 Sum_probs=134.7
Q ss_pred cccceeeccCCC-------CCCCCCCChhhHHHHHHHHHHHHHHHhhcCCCceeecCCCccceEecC-------------
Q 045315 241 DEISFWYESYNN-------PTKKGLLCWGTRVRIIEGIAQGLLYLHQYSRLRVIHRDLKASNILLDK------------- 300 (476)
Q Consensus 241 ~~~~l~~Ey~~~-------~~~~~~L~~~~~~~i~~qIa~gL~yLH~~~~~~ivH~DLkp~NILld~------------- 300 (476)
+..+++|||+.. .....++++.++..++.||+.||+|||+++ |+||||||+||+++.
T Consensus 90 ~~~~lv~e~~~~~l~~~l~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~---ivH~Dlkp~Nil~~~~~~~~~~~~~~~~ 166 (339)
T 1z57_A 90 GHICIVFELLGLSTYDFIKENGFLPFRLDHIRKMAYQICKSVNFLHSNK---LTHTDLKPENILFVQSDYTEAYNPKIKR 166 (339)
T ss_dssp TEEEEEEECCCCBHHHHHHHTTTCCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEESCCCEEEEEC----C
T ss_pred CcEEEEEcCCCCCHHHHHHhcCCCCCcHHHHHHHHHHHHHHHHHHHHCC---CcCCCCCHHHEEEeccccccccCCcccc
Confidence 467889999961 123347899999999999999999999999 999999999999987
Q ss_pred ------CCCceeccccceeecCCCcccccceeeeeccCCCChhhhccCCCCccceEEeehhhhhhhhhCCCCCCcCCCCc
Q 045315 301 ------DMNPKISDFGMARMFGGDELQSNTKRIVGTYGYMSPEYALRGLFSIKSDVFSFGVLLLETLSSKKNTHFYNTDS 374 (476)
Q Consensus 301 ------~~~~kL~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~s~ksDVwSlGvvl~elltG~~p~~~~~~~~ 374 (476)
++.+||+|||+++...... ....||..|+|||.+.+..++.++|||||||++|||++|+.||.......
T Consensus 167 ~~~~~~~~~~kl~Dfg~~~~~~~~~-----~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~~~~ 241 (339)
T 1z57_A 167 DERTLINPDIKVVDFGSATYDDEHH-----STLVSTRHYRAPEVILALGWSQPCDVWSIGCILIEYYLGFTVFPTHDSKE 241 (339)
T ss_dssp EEEEESCCCEEECCCSSCEETTSCC-----CSSCSCGGGCCHHHHTTSCCCTHHHHHHHHHHHHHHHHSSCSCCCSCHHH
T ss_pred ccccccCCCceEeeCcccccCcccc-----ccccCCccccChHHhhCCCCCcchhhHHHHHHHHHHHhCCCCCCCCChHH
Confidence 6689999999998754321 23468999999999999899999999999999999999999997544211
Q ss_pred hhhhhhhhhhhcC--------CCcccc---------------------cCcc-cCCCCCHHHHHHHHHHHHHchhhcccC
Q 045315 375 LTLLGHAWNLWND--------GRTWEL---------------------MDPI-SQNGASYPILKRYINVALLCVQEKAAD 424 (476)
Q Consensus 375 ~~~~~~~~~~~~~--------~~~~~~---------------------~d~~-~~~~~~~~~~~~l~~li~~Cl~~dP~~ 424 (476)
........... ...... ..+. ..........+.+.+++.+||+.||++
T Consensus 242 --~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dP~~ 319 (339)
T 1z57_A 242 --HLAMMERILGPLPKHMIQKTRKRKYFHHDRLDWDEHSSAGRYVSRACKPLKEFMLSQDVEHERLFDLIQKMLEYDPAK 319 (339)
T ss_dssp --HHHHHHHHHCSCCHHHHHHCSCGGGEETTEECCCTTSHHHHHHHHHCCCGGGGCSCCSHHHHHHHHHHHHHTCSSTTT
T ss_pred --HHHHHHHHhCCCCHHHHhhccchhHHhhccccccccccccchhhhcCcchhhhcccchhhHHHHHHHHHHHhCcCccc
Confidence 11000000000 000000 0000 001123345678999999999999999
Q ss_pred CCCHHHHHH
Q 045315 425 RPAMSEVVS 433 (476)
Q Consensus 425 RPt~~eVl~ 433 (476)
|||+.|+++
T Consensus 320 Rpt~~ell~ 328 (339)
T 1z57_A 320 RITLREALK 328 (339)
T ss_dssp SCCHHHHTT
T ss_pred ccCHHHHhc
Confidence 999999875
|
| >3rp9_A Mitogen-activated protein kinase; structural genomics, structural genomics consortium, SGC, TR; 2.40A {Toxoplasma gondii} | Back alignment and structure |
|---|
Probab=99.93 E-value=1e-26 Score=242.09 Aligned_cols=120 Identities=28% Similarity=0.375 Sum_probs=97.7
Q ss_pred cccceeeccCCC-----CCCCCCCChhhHHHHHHHHHHHHHHHhhcCCCceeecCCCccceEecCCCCceeccccceeec
Q 045315 241 DEISFWYESYNN-----PTKKGLLCWGTRVRIIEGIAQGLLYLHQYSRLRVIHRDLKASNILLDKDMNPKISDFGMARMF 315 (476)
Q Consensus 241 ~~~~l~~Ey~~~-----~~~~~~L~~~~~~~i~~qIa~gL~yLH~~~~~~ivH~DLkp~NILld~~~~~kL~DFGla~~~ 315 (476)
+.+++++||+.. ......+++..+..++.||+.||+|||+.+ |+||||||+|||++.++.+||+|||+++..
T Consensus 130 ~~~~lv~e~~~~~L~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~~---iiHrDlKp~NILl~~~~~~kl~DFGla~~~ 206 (458)
T 3rp9_A 130 DELYVVLEIADSDFKKLFRTPVYLTELHIKTLLYNLLVGVKYVHSAG---ILHRDLKPANCLVNQDCSVKVCDFGLARTV 206 (458)
T ss_dssp CCEEEEECCCSEEHHHHHHSSCCCCHHHHHHHHHHHHHHHHHHHHTT---CBCCCCCGGGEEECTTCCEEECCCTTCBCT
T ss_pred ceEEEEEeccccchhhhcccCCCCCHHHHHHHHHHHHHHHHHHHhCC---cCCCCCChhhEEECCCCCEeecccccchhc
Confidence 457899999872 123457999999999999999999999999 999999999999999999999999999876
Q ss_pred CCCccc-------------------------ccceeeeeccCCCChhhh-ccCCCCccceEEeehhhhhhhhhC
Q 045315 316 GGDELQ-------------------------SNTKRIVGTYGYMSPEYA-LRGLFSIKSDVFSFGVLLLETLSS 363 (476)
Q Consensus 316 ~~~~~~-------------------------~~~~~~~gt~~y~aPE~l-~~~~~s~ksDVwSlGvvl~elltG 363 (476)
...... .......||+.|+|||++ ....++.++|||||||++|||++|
T Consensus 207 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~~~~~~DiwSlG~il~elltg 280 (458)
T 3rp9_A 207 DYPENGNSQLPISPREDDMNLVTFPHTKNLKRQLTGHVVTRWYRAPELILLQENYTEAIDVWSIGCIFAELLNM 280 (458)
T ss_dssp TSCTTCCCCCC---------------------------CCCTTCCHHHHTTCCCCCTHHHHHHHHHHHHHHHTT
T ss_pred cCccccccccccCccccccccccccccccccccccCCcccccccChHHhhCCCCCCcHhHHHHHHHHHHHHHHh
Confidence 422110 122345789999999986 456799999999999999999994
|
| >2eu9_A Dual specificity protein kinase CLK3; kinase domain, transferase; 1.53A {Homo sapiens} PDB: 2wu6_A* 2wu7_A* 3raw_A* 2exe_A 3nr9_A* | Back alignment and structure |
|---|
Probab=99.93 E-value=8.7e-27 Score=233.12 Aligned_cols=183 Identities=20% Similarity=0.206 Sum_probs=134.7
Q ss_pred cccceeeccCCC-------CCCCCCCChhhHHHHHHHHHHHHHHHhhcCCCceeecCCCccceEe---------------
Q 045315 241 DEISFWYESYNN-------PTKKGLLCWGTRVRIIEGIAQGLLYLHQYSRLRVIHRDLKASNILL--------------- 298 (476)
Q Consensus 241 ~~~~l~~Ey~~~-------~~~~~~L~~~~~~~i~~qIa~gL~yLH~~~~~~ivH~DLkp~NILl--------------- 298 (476)
+..+++|||+.. ......+++.++..++.||+.||+|||+++ |+||||||+|||+
T Consensus 95 ~~~~lv~e~~~~~l~~~l~~~~~~~~~~~~~~~i~~qi~~~L~~lH~~~---ivH~Dlkp~NIll~~~~~~~~~~~~~~~ 171 (355)
T 2eu9_A 95 GHMCIAFELLGKNTFEFLKENNFQPYPLPHVRHMAYQLCHALRFLHENQ---LTHTDLKPENILFVNSEFETLYNEHKSC 171 (355)
T ss_dssp TEEEEEEECCCCBHHHHHHHTTTCCCCHHHHHHHHHHHHHHHHHHHTTT---EECCCCCGGGEEESCCCEEEEECCC-CC
T ss_pred CeEEEEEeccCCChHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCCHHHEEEecccccccccccccc
Confidence 457789999972 123357999999999999999999999998 9999999999999
Q ss_pred ----cCCCCceeccccceeecCCCcccccceeeeeccCCCChhhhccCCCCccceEEeehhhhhhhhhCCCCCCcCCCCc
Q 045315 299 ----DKDMNPKISDFGMARMFGGDELQSNTKRIVGTYGYMSPEYALRGLFSIKSDVFSFGVLLLETLSSKKNTHFYNTDS 374 (476)
Q Consensus 299 ----d~~~~~kL~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~s~ksDVwSlGvvl~elltG~~p~~~~~~~~ 374 (476)
+.++.+||+|||+++...... ....||..|+|||.+.+..++.++|||||||++|||++|+.||.......
T Consensus 172 ~~~~~~~~~~kl~Dfg~~~~~~~~~-----~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~~~~ 246 (355)
T 2eu9_A 172 EEKSVKNTSIRVADFGSATFDHEHH-----TTIVATRHYRPPEVILELGWAQPCDVWSIGCILFEYYRGFTLFQTHENRE 246 (355)
T ss_dssp CEEEESCCCEEECCCTTCEETTSCC-----CSSCSCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHH
T ss_pred cccccCCCcEEEeecCccccccccc-----cCCcCCCcccCCeeeecCCCCCccchHHHHHHHHHHHhCCCCCCCCCHHH
Confidence 668899999999998754322 22468999999999999999999999999999999999999987543211
Q ss_pred hhhhhhhhhhhcC--------CCcccc---------------------cCc-ccCCCCCHHHHHHHHHHHHHchhhcccC
Q 045315 375 LTLLGHAWNLWND--------GRTWEL---------------------MDP-ISQNGASYPILKRYINVALLCVQEKAAD 424 (476)
Q Consensus 375 ~~~~~~~~~~~~~--------~~~~~~---------------------~d~-~~~~~~~~~~~~~l~~li~~Cl~~dP~~ 424 (476)
........... ...... ..+ .............+.+++.+||+.||++
T Consensus 247 --~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dP~~ 324 (355)
T 2eu9_A 247 --HLVMMEKILGPIPSHMIHRTRKQKYFYKGGLVWDENSSDGRYVKENCKPLKSYMLQDSLEHVQLFDLMRRMLEFDPAQ 324 (355)
T ss_dssp --HHHHHHHHHCCCCHHHHHHCSCGGGEETTEECCCTTSHHHHHHHHHCCCGGGGCSCCSHHHHHHHHHHHHHTCSSTTT
T ss_pred --HHHHHHHHcCCCcHHHhhhccchhhhcccccccccccchhccccccCCcccccccccchhHHHHHHHHHHHhcCChhh
Confidence 11000000000 000000 000 0001122344568899999999999999
Q ss_pred CCCHHHHHH
Q 045315 425 RPAMSEVVS 433 (476)
Q Consensus 425 RPt~~eVl~ 433 (476)
|||++|+++
T Consensus 325 Rpt~~e~l~ 333 (355)
T 2eu9_A 325 RITLAEALL 333 (355)
T ss_dssp SCCHHHHTT
T ss_pred CcCHHHHhc
Confidence 999999874
|
| >2w1i_A JAK2; chromosomal rearrangement, nucleotide-binding, tyrosine-protein kinase, proto-oncogene, phosphoprotein, disease mutation, SH2 domain; HET: PTR L0I; 2.60A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.93 E-value=6.7e-28 Score=239.63 Aligned_cols=187 Identities=20% Similarity=0.268 Sum_probs=139.6
Q ss_pred ccceeeccCCCC-------CCCCCCChhhHHHHHHHHHHHHHHHhhcCCCceeecCCCccceEecCCCCceeccccceee
Q 045315 242 EISFWYESYNNP-------TKKGLLCWGTRVRIIEGIAQGLLYLHQYSRLRVIHRDLKASNILLDKDMNPKISDFGMARM 314 (476)
Q Consensus 242 ~~~l~~Ey~~~~-------~~~~~L~~~~~~~i~~qIa~gL~yLH~~~~~~ivH~DLkp~NILld~~~~~kL~DFGla~~ 314 (476)
..++++||++.. ..+..+++.+++.++.||+.||+|||+.+ |+||||||+||+++.++.+||+|||++..
T Consensus 118 ~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~---ivH~dikp~NIli~~~~~~kL~Dfg~~~~ 194 (326)
T 2w1i_A 118 NLKLIMEYLPYGSLRDYLQKHKERIDHIKLLQYTSQICKGMEYLGTKR---YIHRDLATRNILVENENRVKIGDFGLTKV 194 (326)
T ss_dssp CCEEEECCCTTCBHHHHHHHSTTSSCHHHHHHHHHHHHHHHHHHHHTT---EECSCCCGGGEEEEETTEEEECCCTTCEE
T ss_pred ceEEEEECCCCCCHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHhCC---EeccCCCcceEEEcCCCcEEEecCcchhh
Confidence 577899999732 23456999999999999999999999998 99999999999999999999999999987
Q ss_pred cCCCccc-ccceeeeeccCCCChhhhccCCCCccceEEeehhhhhhhhhCCCCCCcCCC----------Cchhhhhhhhh
Q 045315 315 FGGDELQ-SNTKRIVGTYGYMSPEYALRGLFSIKSDVFSFGVLLLETLSSKKNTHFYNT----------DSLTLLGHAWN 383 (476)
Q Consensus 315 ~~~~~~~-~~~~~~~gt~~y~aPE~l~~~~~s~ksDVwSlGvvl~elltG~~p~~~~~~----------~~~~~~~~~~~ 383 (476)
....... .......++..|+|||.+.+..++.++||||||+++|||++|+.|+..... ...........
T Consensus 195 ~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~tg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 274 (326)
T 2w1i_A 195 LPQDKEYYKVKEPGESPIFWYAPESLTESKFSVASDVWSFGVVLYELFTYIEKSKSPPAEFMRMIGNDKQGQMIVFHLIE 274 (326)
T ss_dssp CCSSCSEEECSSCCSCCGGGCCHHHHHHCEEEHHHHHHHHHHHHHHHHHTTCGGGSHHHHHHHHHCTTCCTHHHHHHHHH
T ss_pred ccccccccccccCCCCceeEECchhhcCCCCCchhhHHHHHHHHHHHHhcCCCCCCCHHHHHHhhccccchhhhHHHHHH
Confidence 7543221 111223467789999999988899999999999999999999988753210 00000000111
Q ss_pred hhcCCCcccccCcccCCCCCHHHHHHHHHHHHHchhhcccCCCCHHHHHHHHhcccc
Q 045315 384 LWNDGRTWELMDPISQNGASYPILKRYINVALLCVQEKAADRPAMSEVVSMLSNEFV 440 (476)
Q Consensus 384 ~~~~~~~~~~~d~~~~~~~~~~~~~~l~~li~~Cl~~dP~~RPt~~eVl~~L~~~~~ 440 (476)
....+.. ...+......+.+++.+||+.||++||++.||++.|+.+..
T Consensus 275 ~~~~~~~---------~~~~~~~~~~l~~li~~cl~~dP~~Rps~~el~~~L~~l~~ 322 (326)
T 2w1i_A 275 LLKNNGR---------LPRPDGCPDEIYMIMTECWNNNVNQRPSFRDLALRVDQIRD 322 (326)
T ss_dssp HHHTTCC---------CCCCTTCCHHHHHHHHHHSCSSGGGSCCHHHHHHHHHHHHH
T ss_pred HhhcCCC---------CCCCCcccHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHH
Confidence 1111111 11122234678899999999999999999999999998653
|
| >4ejn_A RAC-alpha serine/threonine-protein kinase; AKT1, autoinhibition, allosteric inhibitor, kinase inhibitor hydrophobic collapase, ATPase; HET: 0R4; 2.19A {Homo sapiens} PDB: 3o96_A* | Back alignment and structure |
|---|
Probab=99.93 E-value=2.2e-27 Score=246.41 Aligned_cols=172 Identities=22% Similarity=0.266 Sum_probs=133.8
Q ss_pred cccceeeccCCCCC------CCCCCChhhHHHHHHHHHHHHHHHhh-cCCCceeecCCCccceEecCCCCceecccccee
Q 045315 241 DEISFWYESYNNPT------KKGLLCWGTRVRIIEGIAQGLLYLHQ-YSRLRVIHRDLKASNILLDKDMNPKISDFGMAR 313 (476)
Q Consensus 241 ~~~~l~~Ey~~~~~------~~~~L~~~~~~~i~~qIa~gL~yLH~-~~~~~ivH~DLkp~NILld~~~~~kL~DFGla~ 313 (476)
+..+++|||++... +.+.+++.++..++.||+.||+|||+ .+ |+||||||+|||++.++.+||+|||+++
T Consensus 221 ~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~qi~~aL~~LH~~~g---iiHrDlkp~NIll~~~~~~kl~DFG~a~ 297 (446)
T 4ejn_A 221 DRLCFVMEYANGGELFFHLSRERVFSEDRARFYGAEIVSALDYLHSEKN---VVYRDLKLENLMLDKDGHIKITDFGLCK 297 (446)
T ss_dssp TEEEEEECCCSSCBHHHHHHHHSCCCHHHHHHHHHHHHHHHHHHHHHTC---CCCCCCCGGGEEECSSSCEEECCCCCCC
T ss_pred CEEEEEEeeCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHhhcCC---EEECCCCHHHEEECCCCCEEEccCCCce
Confidence 46789999998432 24579999999999999999999998 88 9999999999999999999999999997
Q ss_pred ecCCCcccccceeeeeccCCCChhhhccCCCCccceEEeehhhhhhhhhCCCCCCcCCCCchhhhhhhhhhhcCCCcccc
Q 045315 314 MFGGDELQSNTKRIVGTYGYMSPEYALRGLFSIKSDVFSFGVLLLETLSSKKNTHFYNTDSLTLLGHAWNLWNDGRTWEL 393 (476)
Q Consensus 314 ~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~s~ksDVwSlGvvl~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~ 393 (476)
....... ......||+.|+|||++.+..++.++|||||||++|||++|+.||...... ...... .. ...
T Consensus 298 ~~~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~Pf~~~~~~--~~~~~i---~~-~~~--- 366 (446)
T 4ejn_A 298 EGIKDGA--TMKTFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHE--KLFELI---LM-EEI--- 366 (446)
T ss_dssp TTCC-------CCSSSCGGGCCHHHHHTSCCCTHHHHHHHHHHHHHHHHSSCSSCCSSHH--HHHHHH---HH-CCC---
T ss_pred eccCCCc--ccccccCCccccCHhhcCCCCCCCccchhhhHHHHHHHhhCCCCCCCCCHH--HHHHHH---Hh-CCC---
Confidence 5432221 123357999999999999999999999999999999999999998654321 111111 11 100
Q ss_pred cCcccCCCCCHHHHHHHHHHHHHchhhcccCCC-----CHHHHHH
Q 045315 394 MDPISQNGASYPILKRYINVALLCVQEKAADRP-----AMSEVVS 433 (476)
Q Consensus 394 ~d~~~~~~~~~~~~~~l~~li~~Cl~~dP~~RP-----t~~eVl~ 433 (476)
..+......+.+++.+||+.||++|| +++|+++
T Consensus 367 -------~~p~~~~~~~~~li~~~L~~dP~~R~~~~~~t~~ell~ 404 (446)
T 4ejn_A 367 -------RFPRTLGPEAKSLLSGLLKKDPKQRLGGGSEDAKEIMQ 404 (446)
T ss_dssp -------CCCTTSCHHHHHHHHHHTCSSTTTSTTCSTTTHHHHHT
T ss_pred -------CCCccCCHHHHHHHHHHcccCHHHhCCCCCCCHHHHHh
Confidence 01112235688999999999999999 9999985
|
| >1fot_A TPK1 delta, CAMP-dependent protein kinase type 1; open conformation, transferase; HET: TPO; 2.80A {Saccharomyces cerevisiae} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=99.93 E-value=8.6e-27 Score=231.39 Aligned_cols=169 Identities=24% Similarity=0.285 Sum_probs=134.6
Q ss_pred cccceeeccCCCCC------CCCCCChhhHHHHHHHHHHHHHHHhhcCCCceeecCCCccceEecCCCCceeccccceee
Q 045315 241 DEISFWYESYNNPT------KKGLLCWGTRVRIIEGIAQGLLYLHQYSRLRVIHRDLKASNILLDKDMNPKISDFGMARM 314 (476)
Q Consensus 241 ~~~~l~~Ey~~~~~------~~~~L~~~~~~~i~~qIa~gL~yLH~~~~~~ivH~DLkp~NILld~~~~~kL~DFGla~~ 314 (476)
+.++++|||++.+. +...+++..+..++.||+.||+|||+++ |+||||||+|||++.++.+||+|||+++.
T Consensus 79 ~~~~lv~e~~~gg~L~~~l~~~~~~~~~~~~~~~~qi~~aL~~LH~~~---ivHrDlkp~NIll~~~g~~kL~Dfg~a~~ 155 (318)
T 1fot_A 79 QQIFMIMDYIEGGELFSLLRKSQRFPNPVAKFYAAEVCLALEYLHSKD---IIYRDLKPENILLDKNGHIKITDFGFAKY 155 (318)
T ss_dssp SEEEEEECCCCSCBHHHHHHHTSSCCHHHHHHHHHHHHHHHHHHHTTT---EECCCCCGGGEEECTTSCEEECCCSSCEE
T ss_pred CEEEEEEeCCCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCC---ccccCCChheEEEcCCCCEEEeecCccee
Confidence 46889999998432 3567999999999999999999999999 99999999999999999999999999987
Q ss_pred cCCCcccccceeeeeccCCCChhhhccCCCCccceEEeehhhhhhhhhCCCCCCcCCCCchhhhhhhhhhhcCCCccccc
Q 045315 315 FGGDELQSNTKRIVGTYGYMSPEYALRGLFSIKSDVFSFGVLLLETLSSKKNTHFYNTDSLTLLGHAWNLWNDGRTWELM 394 (476)
Q Consensus 315 ~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~s~ksDVwSlGvvl~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 394 (476)
.... .....||+.|+|||.+.+..++.++|+|||||++|||++|+.||..... ..... .... +..
T Consensus 156 ~~~~-----~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~--~~~~~---~i~~-~~~---- 220 (318)
T 1fot_A 156 VPDV-----TYTLCGTPDYIAPEVVSTKPYNKSIDWWSFGILIYEMLAGYTPFYDSNT--MKTYE---KILN-AEL---- 220 (318)
T ss_dssp CSSC-----BCCCCSCTTTCCHHHHTTCCBCTTHHHHHHHHHHHHHHHSSCTTCCSSH--HHHHH---HHHH-CCC----
T ss_pred cCCc-----cccccCCccccCHhHhcCCCCCcccchhhhHHHHHHHHhCCCCCCCCCH--HHHHH---HHHh-CCC----
Confidence 6432 2235789999999999999999999999999999999999999864331 11111 1111 110
Q ss_pred CcccCCCCCHHHHHHHHHHHHHchhhcccCCC-----CHHHHHH
Q 045315 395 DPISQNGASYPILKRYINVALLCVQEKAADRP-----AMSEVVS 433 (476)
Q Consensus 395 d~~~~~~~~~~~~~~l~~li~~Cl~~dP~~RP-----t~~eVl~ 433 (476)
..+......+.+++.+||+.||++|| +++++++
T Consensus 221 ------~~p~~~~~~~~~li~~lL~~dp~~R~~~~~~~~~~i~~ 258 (318)
T 1fot_A 221 ------RFPPFFNEDVKDLLSRLITRDLSQRLGNLQNGTEDVKN 258 (318)
T ss_dssp ------CCCTTSCHHHHHHHHHHTCSCTTTCTTSSTTTTHHHHT
T ss_pred ------CCCCCCCHHHHHHHHHHhccCHHHcCCCcCCCHHHHhc
Confidence 01112235688999999999999999 8888874
|
| >1u5q_A Serine/threonine protein kinase TAO2; transferase; HET: SEP; 2.10A {Rattus norvegicus} SCOP: d.144.1.7 PDB: 1u5r_A* 2gcd_A* | Back alignment and structure |
|---|
Probab=99.93 E-value=2.1e-27 Score=238.76 Aligned_cols=171 Identities=30% Similarity=0.381 Sum_probs=132.9
Q ss_pred cccceeeccCCCC------CCCCCCChhhHHHHHHHHHHHHHHHhhcCCCceeecCCCccceEecCCCCceeccccceee
Q 045315 241 DEISFWYESYNNP------TKKGLLCWGTRVRIIEGIAQGLLYLHQYSRLRVIHRDLKASNILLDKDMNPKISDFGMARM 314 (476)
Q Consensus 241 ~~~~l~~Ey~~~~------~~~~~L~~~~~~~i~~qIa~gL~yLH~~~~~~ivH~DLkp~NILld~~~~~kL~DFGla~~ 314 (476)
+.++++|||++.. ..+..+++.++..++.||++||+|||+++ |+||||||+|||++.++.+||+|||++..
T Consensus 127 ~~~~lv~e~~~g~l~~~l~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~---ivH~Dlkp~NIll~~~~~~kL~DfG~a~~ 203 (348)
T 1u5q_A 127 HTAWLVMEYCLGSASDLLEVHKKPLQEVEIAAVTHGALQGLAYLHSHN---MIHRDVKAGNILLSEPGLVKLGDFGSASI 203 (348)
T ss_dssp TEEEEEEECCSEEHHHHHHHHTSCCCHHHHHHHHHHHHHHHHHHHHTT---CBCCCCSGGGEEEETTTEEEECCCTTCBS
T ss_pred CeEEEEEecCCCCHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCC---eeeCCCCHHHEEECCCCCEEEeeccCcee
Confidence 4678999999721 23567999999999999999999999999 99999999999999999999999999986
Q ss_pred cCCCcccccceeeeeccCCCChhhhc---cCCCCccceEEeehhhhhhhhhCCCCCCcCCCCchhhhhhhhhhhcCCCcc
Q 045315 315 FGGDELQSNTKRIVGTYGYMSPEYAL---RGLFSIKSDVFSFGVLLLETLSSKKNTHFYNTDSLTLLGHAWNLWNDGRTW 391 (476)
Q Consensus 315 ~~~~~~~~~~~~~~gt~~y~aPE~l~---~~~~s~ksDVwSlGvvl~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~ 391 (476)
.... ....||+.|+|||.+. ...++.++|||||||++|||++|+.||...... ... ........
T Consensus 204 ~~~~------~~~~gt~~y~aPE~~~~~~~~~~~~~~DiwslG~il~ell~g~~p~~~~~~~--~~~---~~~~~~~~-- 270 (348)
T 1u5q_A 204 MAPA------NSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAM--SAL---YHIAQNES-- 270 (348)
T ss_dssp SSSB------CCCCSCGGGCCHHHHHTTSSCCBCTHHHHHHHHHHHHHHHHSSCTTTTSCHH--HHH---HHHHHSCC--
T ss_pred cCCC------CcccCCcceeCHhhhccccCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCChH--HHH---HHHHhcCC--
Confidence 5432 2356899999999985 567899999999999999999999998643311 111 11111111
Q ss_pred cccCcccCCCCCHHHHHHHHHHHHHchhhcccCCCCHHHHHHH
Q 045315 392 ELMDPISQNGASYPILKRYINVALLCVQEKAADRPAMSEVVSM 434 (476)
Q Consensus 392 ~~~d~~~~~~~~~~~~~~l~~li~~Cl~~dP~~RPt~~eVl~~ 434 (476)
+... .......+.+++.+||+.||++|||++++++.
T Consensus 271 ----~~~~---~~~~~~~l~~li~~~l~~dP~~Rps~~~ll~h 306 (348)
T 1u5q_A 271 ----PALQ---SGHWSEYFRNFVDSCLQKIPQDRPTSEVLLKH 306 (348)
T ss_dssp ----CCCC---CTTSCHHHHHHHHHHTCSSGGGSCCHHHHTTC
T ss_pred ----CCCC---CCCCCHHHHHHHHHHcccChhhCcCHHHHhhC
Confidence 0011 11123567899999999999999999998764
|
| >3gbz_A Kinase, CMGC CDK; ssgcid, ATP-binding, nucleotide-binding, serine/threonine-protein kinase, transferase; 1.85A {Giardia lamblia} PDB: 3gc0_A* | Back alignment and structure |
|---|
Probab=99.93 E-value=2.9e-27 Score=235.48 Aligned_cols=186 Identities=19% Similarity=0.208 Sum_probs=127.0
Q ss_pred cccceeeccCCCC-----CCCCCCChhhHHHHHHHHHHHHHHHhhcCCCceeecCCCccceEec-----CCCCceecccc
Q 045315 241 DEISFWYESYNNP-----TKKGLLCWGTRVRIIEGIAQGLLYLHQYSRLRVIHRDLKASNILLD-----KDMNPKISDFG 310 (476)
Q Consensus 241 ~~~~l~~Ey~~~~-----~~~~~L~~~~~~~i~~qIa~gL~yLH~~~~~~ivH~DLkp~NILld-----~~~~~kL~DFG 310 (476)
+..+++|||++.. ...+.+++.++..++.||+.||+|||+++ |+||||||+|||++ .++.+||+|||
T Consensus 106 ~~~~lv~e~~~~~L~~~~~~~~~~~~~~~~~i~~ql~~~l~~LH~~~---ivH~Dlkp~NIll~~~~~~~~~~~kl~Dfg 182 (329)
T 3gbz_A 106 HRLHLIFEYAENDLKKYMDKNPDVSMRVIKSFLYQLINGVNFCHSRR---CLHRDLKPQNLLLSVSDASETPVLKIGDFG 182 (329)
T ss_dssp TEEEEEEECCSEEHHHHHHHCTTCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEEEC-----CCEEEECCTT
T ss_pred CEEEEEEecCCCCHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHhCC---EECCCCCHHHEEEecCCCCccceEEECcCC
Confidence 4678899999821 23456999999999999999999999999 99999999999994 45569999999
Q ss_pred ceeecCCCcccccceeeeeccCCCChhhhccC-CCCccceEEeehhhhhhhhhCCCCCCcCCCCchhhhhhhhhhhc---
Q 045315 311 MARMFGGDELQSNTKRIVGTYGYMSPEYALRG-LFSIKSDVFSFGVLLLETLSSKKNTHFYNTDSLTLLGHAWNLWN--- 386 (476)
Q Consensus 311 la~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~-~~s~ksDVwSlGvvl~elltG~~p~~~~~~~~~~~~~~~~~~~~--- 386 (476)
+++....... ......+|..|+|||.+.+. .++.++|||||||++|||++|+.||....... ..........
T Consensus 183 ~a~~~~~~~~--~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~--~~~~~~~~~~~~~ 258 (329)
T 3gbz_A 183 LARAFGIPIR--QFTHEIITLWYRPPEILLGSRHYSTSVDIWSIACIWAEMLMKTPLFPGDSEID--QLFKIFEVLGLPD 258 (329)
T ss_dssp HHHHHC-------------CCTTCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHH--HHHHHHHHHCCCC
T ss_pred CccccCCccc--ccCCCcCCccccCHHHhcCCCCCCcHHHHHHHHHHHHHHHHCCCCcCCCCHHH--HHHHHHHHhCCCc
Confidence 9987653321 12235679999999999874 58999999999999999999999987543211 1111100000
Q ss_pred CCCcc--------cccCcccCCCC-----CHHHHHHHHHHHHHchhhcccCCCCHHHHHH
Q 045315 387 DGRTW--------ELMDPISQNGA-----SYPILKRYINVALLCVQEKAADRPAMSEVVS 433 (476)
Q Consensus 387 ~~~~~--------~~~d~~~~~~~-----~~~~~~~l~~li~~Cl~~dP~~RPt~~eVl~ 433 (476)
..... ....+...... .......+.+++.+||+.||++|||++|+++
T Consensus 259 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~ 318 (329)
T 3gbz_A 259 DTTWPGVTALPDWKQSFPKFRGKTLKRVLGALLDDEGLDLLTAMLEMDPVKRISAKNALE 318 (329)
T ss_dssp TTTSTTGGGSTTCCTTCCCCCCCCHHHHHGGGSCHHHHHHHHHHTCSSGGGSCCHHHHHT
T ss_pred hhhhhhhhhhhhhhhhhhhhccccHhhhcccccCHHHHHHHHHHccCChhhCCCHHHHhC
Confidence 00000 00000000000 0012357889999999999999999999986
|
| >2wtk_C Serine/threonine-protein kinase 11; transferase-metal-binding protein complex, transferase metal protein complex, nucleus; HET: ANP; 2.65A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.93 E-value=1.8e-26 Score=226.51 Aligned_cols=175 Identities=18% Similarity=0.164 Sum_probs=134.4
Q ss_pred cccceeeccCCC-------CCCCCCCChhhHHHHHHHHHHHHHHHhhcCCCceeecCCCccceEecCCCCceecccccee
Q 045315 241 DEISFWYESYNN-------PTKKGLLCWGTRVRIIEGIAQGLLYLHQYSRLRVIHRDLKASNILLDKDMNPKISDFGMAR 313 (476)
Q Consensus 241 ~~~~l~~Ey~~~-------~~~~~~L~~~~~~~i~~qIa~gL~yLH~~~~~~ivH~DLkp~NILld~~~~~kL~DFGla~ 313 (476)
+..+++|||++. ......+++.++..++.||+.||+|||+++ |+||||||+||+++.++.+||+|||++.
T Consensus 81 ~~~~lv~e~~~~~l~~~~~~~~~~~~~~~~~~~~~~qi~~al~~LH~~~---i~H~dlkp~NIl~~~~~~~kl~dfg~~~ 157 (305)
T 2wtk_C 81 QKMYMVMEYCVCGMQEMLDSVPEKRFPVCQAHGYFCQLIDGLEYLHSQG---IVHKDIKPGNLLLTTGGTLKISALGVAE 157 (305)
T ss_dssp -CEEEEEECCSEEHHHHHHHSTTCSCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEECTTCCEEECCCTTCE
T ss_pred CeEEEEehhccCCHHHHHHhCcccccCHHHHHHHHHHHHHHHHHHHHCC---eeecCCCcccEEEcCCCcEEeecccccc
Confidence 467889999882 234567999999999999999999999999 9999999999999999999999999998
Q ss_pred ecCCCcccccceeeeeccCCCChhhhccCC--CCccceEEeehhhhhhhhhCCCCCCcCCCCchhhhhhhhhhhcCCCcc
Q 045315 314 MFGGDELQSNTKRIVGTYGYMSPEYALRGL--FSIKSDVFSFGVLLLETLSSKKNTHFYNTDSLTLLGHAWNLWNDGRTW 391 (476)
Q Consensus 314 ~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~--~s~ksDVwSlGvvl~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~ 391 (476)
...............|+..|+|||.+.+.. ++.++||||||+++|||++|+.||..... ..... ....+..
T Consensus 158 ~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~--~~~~~----~i~~~~~- 230 (305)
T 2wtk_C 158 ALHPFAADDTCRTSQGSPAFQPPEIANGLDTFSGFKVDIWSAGVTLYNITTGLYPFEGDNI--YKLFE----NIGKGSY- 230 (305)
T ss_dssp ECCTTCSSCEECCCCSCGGGCCHHHHTCCSCEESHHHHHHHHHHHHHHHHHSSCSCCCSSH--HHHHH----HHHHCCC-
T ss_pred ccCccccccccccCCCCCCCcChhhccCcccCCcchhhHHHHHHHHHHHHhCCCCCCCchH--HHHHH----HHhcCCC-
Confidence 765433233333456899999999987644 47899999999999999999999864321 11111 1111111
Q ss_pred cccCcccCCCCCHHHHHHHHHHHHHchhhcccCCCCHHHHHHH
Q 045315 392 ELMDPISQNGASYPILKRYINVALLCVQEKAADRPAMSEVVSM 434 (476)
Q Consensus 392 ~~~d~~~~~~~~~~~~~~l~~li~~Cl~~dP~~RPt~~eVl~~ 434 (476)
. .+......+.+++.+||+.||++|||++|+++.
T Consensus 231 ~---------~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~ 264 (305)
T 2wtk_C 231 A---------IPGDCGPPLSDLLKGMLEYEPAKRFSIRQIRQH 264 (305)
T ss_dssp C---------CCSSSCHHHHHHHHHHTCSSTTTSCCHHHHHHS
T ss_pred C---------CCCccCHHHHHHHHHHccCChhhCCCHHHHhcC
Confidence 0 111223567899999999999999999999963
|
| >3uc3_A Serine/threonine-protein kinase SRK2I; SNRK2, ABA signaling, transferase; 1.90A {Arabidopsis thaliana} PDB: 3zut_A 3zuu_A 3uc4_A 3ujg_A 3udb_A | Back alignment and structure |
|---|
Probab=99.93 E-value=6e-27 Score=236.57 Aligned_cols=178 Identities=22% Similarity=0.238 Sum_probs=124.2
Q ss_pred cccceeeccCCCCC------CCCCCChhhHHHHHHHHHHHHHHHhhcCCCceeecCCCccceEecCCCC--ceeccccce
Q 045315 241 DEISFWYESYNNPT------KKGLLCWGTRVRIIEGIAQGLLYLHQYSRLRVIHRDLKASNILLDKDMN--PKISDFGMA 312 (476)
Q Consensus 241 ~~~~l~~Ey~~~~~------~~~~L~~~~~~~i~~qIa~gL~yLH~~~~~~ivH~DLkp~NILld~~~~--~kL~DFGla 312 (476)
+..+++|||++.+. +.+.+++.++..++.||+.||+|||+++ |+||||||+||+++.++. +||+|||++
T Consensus 89 ~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~i~~ql~~~L~~LH~~~---ivH~Dlkp~Nill~~~~~~~~kl~Dfg~a 165 (361)
T 3uc3_A 89 THLAIIMEYASGGELYERICNAGRFSEDEARFFFQQLLSGVSYCHSMQ---ICHRDLKLENTLLDGSPAPRLKICDFGYS 165 (361)
T ss_dssp SEEEEEEECCCSCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTT---CCSCCCCGGGEEECSSSSCCEEECCCCCC
T ss_pred CEEEEEEEeCCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCCHHHEEEcCCCCceEEEeecCcc
Confidence 45788999997432 2457999999999999999999999999 999999999999987765 999999999
Q ss_pred eecCCCcccccceeeeeccCCCChhhhccCCCCcc-ceEEeehhhhhhhhhCCCCCCcCCCCchhhhhhhhhhhcCCCcc
Q 045315 313 RMFGGDELQSNTKRIVGTYGYMSPEYALRGLFSIK-SDVFSFGVLLLETLSSKKNTHFYNTDSLTLLGHAWNLWNDGRTW 391 (476)
Q Consensus 313 ~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~s~k-sDVwSlGvvl~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~ 391 (476)
+...... ......||+.|+|||.+.+..+..+ +|||||||++|+|++|+.||........ ........... ..
T Consensus 166 ~~~~~~~---~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~Pf~~~~~~~~-~~~~~~~~~~~-~~- 239 (361)
T 3uc3_A 166 KSSVLHS---QPKSTVGTPAYIAPEVLLRQEYDGKIADVWSCGVTLYVMLVGAYPFEDPEEPRD-YRKTIQRILSV-KY- 239 (361)
T ss_dssp ------------------CTTSCHHHHHCSSCCHHHHHHHHHHHHHHHHHHSSCSCC----CCC-HHHHHHHHHTT-CC-
T ss_pred ccccccC---CCCCCcCCCCcCChhhhcCCCCCCCeeeeehhHHHHHHHHhCCCCCCCCccHHH-HHHHHHHHhcC-CC-
Confidence 7533221 2233569999999999988877655 8999999999999999999975442111 11111111110 00
Q ss_pred cccCcccCCCCCHHHHHHHHHHHHHchhhcccCCCCHHHHHHH
Q 045315 392 ELMDPISQNGASYPILKRYINVALLCVQEKAADRPAMSEVVSM 434 (476)
Q Consensus 392 ~~~d~~~~~~~~~~~~~~l~~li~~Cl~~dP~~RPt~~eVl~~ 434 (476)
...........+.+++.+||+.||++|||+.|+++.
T Consensus 240 -------~~~~~~~~s~~~~~li~~~L~~dP~~Rps~~ell~h 275 (361)
T 3uc3_A 240 -------SIPDDIRISPECCHLISRIFVADPATRISIPEIKTH 275 (361)
T ss_dssp -------CCCTTSCCCHHHHHHHHHHSCSCTTTSCCHHHHHTS
T ss_pred -------CCCCcCCCCHHHHHHHHHHccCChhHCcCHHHHHhC
Confidence 000111223578899999999999999999999863
|
| >1rdq_E PKA C-alpha, CAMP-dependent protein kinase, alpha-catalytic SU; CAMP-dependent protein kinase,catalytic mechanism, ATP hydro two nucleotide states; HET: TPO SEP ADP ATP; 1.26A {Mus musculus} SCOP: d.144.1.7 PDB: 2erz_E* 3fjq_E* 1bkx_A* 1atp_E* 1fmo_E* 1j3h_A* 1jlu_E* 1bx6_A* 1re8_A* 1rej_A* 1rek_A* 2cpk_E* 2qcs_A* 2qvs_E* 1l3r_E* 3idb_A* 3idc_A* 3o7l_D* 3ow3_A* 3tnp_C* ... | Back alignment and structure |
|---|
Probab=99.93 E-value=6.9e-27 Score=235.19 Aligned_cols=169 Identities=20% Similarity=0.251 Sum_probs=134.6
Q ss_pred cccceeeccCCCCC------CCCCCChhhHHHHHHHHHHHHHHHhhcCCCceeecCCCccceEecCCCCceeccccceee
Q 045315 241 DEISFWYESYNNPT------KKGLLCWGTRVRIIEGIAQGLLYLHQYSRLRVIHRDLKASNILLDKDMNPKISDFGMARM 314 (476)
Q Consensus 241 ~~~~l~~Ey~~~~~------~~~~L~~~~~~~i~~qIa~gL~yLH~~~~~~ivH~DLkp~NILld~~~~~kL~DFGla~~ 314 (476)
+..+++|||++.+. +.+.+++.++..++.||+.||+|||+++ |+||||||+|||++.++.+||+|||+++.
T Consensus 114 ~~~~lv~e~~~gg~L~~~l~~~~~~~~~~~~~~~~qi~~aL~~LH~~~---ivHrDlkp~NIll~~~g~~kL~DFg~a~~ 190 (350)
T 1rdq_E 114 SNLYMVMEYVAGGEMFSHLRRIGRFSEPHARFYAAQIVLTFEYLHSLD---LIYRDLKPENLLIDQQGYIQVTDFGFAKR 190 (350)
T ss_dssp SEEEEEEECCTTCBHHHHHHHHCCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEECTTSCEEECCCTTCEE
T ss_pred CEEEEEEcCCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCC---cccccCccceEEECCCCCEEEccccccee
Confidence 46789999998432 2356999999999999999999999999 99999999999999999999999999987
Q ss_pred cCCCcccccceeeeeccCCCChhhhccCCCCccceEEeehhhhhhhhhCCCCCCcCCCCchhhhhhhhhhhcCCCccccc
Q 045315 315 FGGDELQSNTKRIVGTYGYMSPEYALRGLFSIKSDVFSFGVLLLETLSSKKNTHFYNTDSLTLLGHAWNLWNDGRTWELM 394 (476)
Q Consensus 315 ~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~s~ksDVwSlGvvl~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 394 (476)
.... .....||+.|+|||.+.+..++.++|+|||||++|||++|+.||..... ..... .+..+.. .
T Consensus 191 ~~~~-----~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~Pf~~~~~--~~~~~----~i~~~~~-~-- 256 (350)
T 1rdq_E 191 VKGR-----TWTLCGTPEALAPEIILSKGYNKAVDWWALGVLIYEMAAGYPPFFADQP--IQIYE----KIVSGKV-R-- 256 (350)
T ss_dssp CSSC-----BCCCEECGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCCSSH--HHHHH----HHHHCCC-C--
T ss_pred ccCC-----cccccCCccccCHHHhcCCCCCCcCCEecccHhHhHHhhCCCCCCCCCH--HHHHH----HHHcCCC-C--
Confidence 6532 2235799999999999999999999999999999999999999864331 11111 1111111 0
Q ss_pred CcccCCCCCHHHHHHHHHHHHHchhhcccCCCC-----HHHHHH
Q 045315 395 DPISQNGASYPILKRYINVALLCVQEKAADRPA-----MSEVVS 433 (476)
Q Consensus 395 d~~~~~~~~~~~~~~l~~li~~Cl~~dP~~RPt-----~~eVl~ 433 (476)
.+......+.+++.+||+.||++||+ +++|++
T Consensus 257 -------~p~~~~~~~~~li~~lL~~dp~~R~~~~~~~~~ei~~ 293 (350)
T 1rdq_E 257 -------FPSHFSSDLKDLLRNLLQVDLTKRFGNLKNGVNDIKN 293 (350)
T ss_dssp -------CCTTCCHHHHHHHHHHSCSCTTTCTTSSTTTTHHHHT
T ss_pred -------CCCCCCHHHHHHHHHHhhcCHHhccCCccCCHHHHHh
Confidence 11122456889999999999999998 888764
|
| >4aw2_A Serine/threonine-protein kinase MRCK alpha; transferase, CDC42BPA; HET: 22E; 1.70A {Rattus norvegicus} PDB: 3tku_A* 3qfv_A* | Back alignment and structure |
|---|
Probab=99.93 E-value=9.6e-27 Score=240.81 Aligned_cols=178 Identities=19% Similarity=0.235 Sum_probs=134.7
Q ss_pred cccceeeccCCCC-------CCCCCCChhhHHHHHHHHHHHHHHHhhcCCCceeecCCCccceEecCCCCceecccccee
Q 045315 241 DEISFWYESYNNP-------TKKGLLCWGTRVRIIEGIAQGLLYLHQYSRLRVIHRDLKASNILLDKDMNPKISDFGMAR 313 (476)
Q Consensus 241 ~~~~l~~Ey~~~~-------~~~~~L~~~~~~~i~~qIa~gL~yLH~~~~~~ivH~DLkp~NILld~~~~~kL~DFGla~ 313 (476)
+..+++|||++++ ...+.+++.++..++.||+.||+|||+.+ |+||||||+|||++.++.+||+|||+++
T Consensus 147 ~~~~lV~Ey~~gg~L~~~l~~~~~~l~e~~~~~~~~qi~~aL~~LH~~g---iiHrDLKp~NILl~~~g~vkL~DFGla~ 223 (437)
T 4aw2_A 147 NNLYLVMDYYVGGDLLTLLSKFEDRLPEEMARFYLAEMVIAIDSVHQLH---YVHRDIKPDNILMDMNGHIRLADFGSCL 223 (437)
T ss_dssp SEEEEEECCCTTCBHHHHHHTTTTCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEECTTSCEEECCCTTCE
T ss_pred CEEEEEEecCCCCcHHHHHHHccCCCCHHHHHHHHHHHHHHHHHHHhCC---eEecccCHHHeeEcCCCCEEEcchhhhh
Confidence 4688999999843 23567999999999999999999999999 9999999999999999999999999998
Q ss_pred ecCCCcccccceeeeeccCCCChhhhc-----cCCCCccceEEeehhhhhhhhhCCCCCCcCCCCchhhhhhhhhhhcCC
Q 045315 314 MFGGDELQSNTKRIVGTYGYMSPEYAL-----RGLFSIKSDVFSFGVLLLETLSSKKNTHFYNTDSLTLLGHAWNLWNDG 388 (476)
Q Consensus 314 ~~~~~~~~~~~~~~~gt~~y~aPE~l~-----~~~~s~ksDVwSlGvvl~elltG~~p~~~~~~~~~~~~~~~~~~~~~~ 388 (476)
........ ......||+.|+|||++. ...++.++|||||||++|||++|+.||...... .............
T Consensus 224 ~~~~~~~~-~~~~~~GT~~Y~APE~l~~~~~~~~~~~~~~DvwSlGvil~elltG~~Pf~~~~~~--~~~~~i~~~~~~~ 300 (437)
T 4aw2_A 224 KLMEDGTV-QSSVAVGTPDYISPEILQAMEGGKGRYGPECDWWSLGVCMYEMLYGETPFYAESLV--ETYGKIMNHKERF 300 (437)
T ss_dssp ECCTTSCE-ECCSCCSCGGGCCHHHHHHHHTSCCEECTHHHHHHHHHHHHHHHHSSCTTCCSSHH--HHHHHHHTHHHHC
T ss_pred hcccCCCc-ccccccCCcCeeChHHHhhcccCCCCCCCcCeeHHHHHHHHHHHhCCCCCCCCChh--HHHHhhhhccccc
Confidence 76543322 122357999999999987 467899999999999999999999999754311 1111111000000
Q ss_pred CcccccCcccCCCCCHHHHHHHHHHHHHchhhcccC--CCCHHHHHH
Q 045315 389 RTWELMDPISQNGASYPILKRYINVALLCVQEKAAD--RPAMSEVVS 433 (476)
Q Consensus 389 ~~~~~~d~~~~~~~~~~~~~~l~~li~~Cl~~dP~~--RPt~~eVl~ 433 (476)
.. +. ........+.+++.+||+.+|++ ||+++|+++
T Consensus 301 ---~~--p~----~~~~~s~~~~dLi~~lL~~~~~r~~r~~~~eil~ 338 (437)
T 4aw2_A 301 ---QF--PT----QVTDVSENAKDLIRRLICSREHRLGQNGIEDFKK 338 (437)
T ss_dssp ---CC--CS----SCCCSCHHHHHHHHTTSSCGGGCTTTTTTHHHHT
T ss_pred ---cC--Cc----ccccCCHHHHHHHHHHhcccccccCCCCHHHHhC
Confidence 00 00 00112356889999999888888 999999876
|
| >2y94_A 5'-AMP-activated protein kinase catalytic subunit; transferase, nucleotide-binding, staurosporine-binding, serine/threonine-protein kinase; HET: TPO STU AMP; 3.24A {Rattus norvegicus} | Back alignment and structure |
|---|
Probab=99.93 E-value=2.2e-26 Score=240.57 Aligned_cols=176 Identities=27% Similarity=0.377 Sum_probs=137.5
Q ss_pred cccceeeccCCC------CCCCCCCChhhHHHHHHHHHHHHHHHhhcCCCceeecCCCccceEecCCCCceeccccceee
Q 045315 241 DEISFWYESYNN------PTKKGLLCWGTRVRIIEGIAQGLLYLHQYSRLRVIHRDLKASNILLDKDMNPKISDFGMARM 314 (476)
Q Consensus 241 ~~~~l~~Ey~~~------~~~~~~L~~~~~~~i~~qIa~gL~yLH~~~~~~ivH~DLkp~NILld~~~~~kL~DFGla~~ 314 (476)
+..++++||++. ..+++.+++.++..++.||+.||+|||+++ |+||||||+|||++.++.+||+|||+++.
T Consensus 89 ~~~~lv~E~~~gg~L~~~l~~~~~l~~~~~~~i~~qi~~aL~~LH~~g---ivHrDLkp~NIll~~~~~vkL~DFG~a~~ 165 (476)
T 2y94_A 89 SDIFMVMEYVSGGELFDYICKNGRLDEKESRRLFQQILSGVDYCHRHM---VVHRDLKPENVLLDAHMNAKIADFGLSNM 165 (476)
T ss_dssp SEEEEEEECCSSEEHHHHTTSSSSCCHHHHHHHHHHHHHHHHHHHTTT---EECSCCSGGGEEECTTCCEEECCCSSCEE
T ss_pred CEEEEEEeCCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCC---CCcccccHHHEEEecCCCeEEEeccchhh
Confidence 468899999973 234567999999999999999999999999 99999999999999999999999999988
Q ss_pred cCCCcccccceeeeeccCCCChhhhccCCC-CccceEEeehhhhhhhhhCCCCCCcCCCCchhhhhhhhhhhcCCCcccc
Q 045315 315 FGGDELQSNTKRIVGTYGYMSPEYALRGLF-SIKSDVFSFGVLLLETLSSKKNTHFYNTDSLTLLGHAWNLWNDGRTWEL 393 (476)
Q Consensus 315 ~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~-s~ksDVwSlGvvl~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~ 393 (476)
...... .....||+.|+|||.+.+..+ +.++|||||||++|||++|+.||...... ..... ...+.. .
T Consensus 166 ~~~~~~---~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlGvil~elltG~~Pf~~~~~~--~~~~~----i~~~~~-~- 234 (476)
T 2y94_A 166 MSDGEF---LRTSCGSPNYAAPEVISGRLYAGPEVDIWSSGVILYALLCGTLPFDDDHVP--TLFKK----ICDGIF-Y- 234 (476)
T ss_dssp CCTTCC---BCCCCSCSTTCCHHHHTTCCBCSHHHHHHHHHHHHHHHHHSSCSSCCSSSH--HHHHH----HHTTCC-C-
T ss_pred cccccc---ccccCCCcCeEChhhccCCCCCCCcceehhhHHHHHHHhhCCCCCCCCCHH--HHHHH----HhcCCc-C-
Confidence 654322 223568999999999988765 78999999999999999999998654321 11111 111111 0
Q ss_pred cCcccCCCCCHHHHHHHHHHHHHchhhcccCCCCHHHHHH--HHhcc
Q 045315 394 MDPISQNGASYPILKRYINVALLCVQEKAADRPAMSEVVS--MLSNE 438 (476)
Q Consensus 394 ~d~~~~~~~~~~~~~~l~~li~~Cl~~dP~~RPt~~eVl~--~L~~~ 438 (476)
.+......+.+++.+||+.||++|||++|+++ .+...
T Consensus 235 --------~p~~~s~~~~~Li~~~L~~dP~~Rpt~~eil~hp~~~~~ 273 (476)
T 2y94_A 235 --------TPQYLNPSVISLLKHMLQVDPMKRATIKDIREHEWFKQD 273 (476)
T ss_dssp --------CCTTCCHHHHHHHHHHTCSSTTTSCCHHHHHTCHHHHTT
T ss_pred --------CCccCCHHHHHHHHHHcCCCchhCcCHHHHHhCHHhhhc
Confidence 01112356889999999999999999999987 45543
|
| >2vwi_A Serine/threonine-protein kinase OSR1; STE kinase, hypertension, transferase; HET: ANP; 2.15A {Homo sapiens} PDB: 3dak_A* | Back alignment and structure |
|---|
Probab=99.93 E-value=9.1e-27 Score=228.00 Aligned_cols=184 Identities=27% Similarity=0.410 Sum_probs=130.3
Q ss_pred cccceeeccCCCC--------------CCCCCCChhhHHHHHHHHHHHHHHHhhcCCCceeecCCCccceEecCCCCcee
Q 045315 241 DEISFWYESYNNP--------------TKKGLLCWGTRVRIIEGIAQGLLYLHQYSRLRVIHRDLKASNILLDKDMNPKI 306 (476)
Q Consensus 241 ~~~~l~~Ey~~~~--------------~~~~~L~~~~~~~i~~qIa~gL~yLH~~~~~~ivH~DLkp~NILld~~~~~kL 306 (476)
+..++++||++.. .....+++.++..++.||+.||+|||+++ ++||||||+||+++.++.+||
T Consensus 86 ~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~---i~H~dl~p~Nil~~~~~~~kl 162 (303)
T 2vwi_A 86 DELWLVMKLLSGGSVLDIIKHIVAKGEHKSGVLDESTIATILREVLEGLEYLHKNG---QIHRDVKAGNILLGEDGSVQI 162 (303)
T ss_dssp SCEEEEEECCTTCBHHHHHHHHHHTTTTTTCSSCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCSGGGEEECTTCCEEE
T ss_pred CCcEEEehhccCCchHHHHHHHhhccccccCCCCHHHHHHHHHHHHHHHHHHHhCC---CCCCCCChhhEEEcCCCCEEE
Confidence 4577888888632 23567999999999999999999999999 999999999999999999999
Q ss_pred ccccceeecCCCcc---cccceeeeeccCCCChhhhcc-CCCCccceEEeehhhhhhhhhCCCCCCcCCCCchhhhhhhh
Q 045315 307 SDFGMARMFGGDEL---QSNTKRIVGTYGYMSPEYALR-GLFSIKSDVFSFGVLLLETLSSKKNTHFYNTDSLTLLGHAW 382 (476)
Q Consensus 307 ~DFGla~~~~~~~~---~~~~~~~~gt~~y~aPE~l~~-~~~s~ksDVwSlGvvl~elltG~~p~~~~~~~~~~~~~~~~ 382 (476)
+|||++........ ........|+..|+|||.+.+ ..++.++||||||+++|||++|+.||.......... .
T Consensus 163 ~dfg~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~--~-- 238 (303)
T 2vwi_A 163 ADFGVSAFLATGGDITRNKVRKTFVGTPCWMAPEVMEQVRGYDFKADIWSFGITAIELATGAAPYHKYPPMKVLM--L-- 238 (303)
T ss_dssp CCCHHHHHCC---------------CCCTTCCHHHHHHHHCCCTHHHHHHHHHHHHHHHHSSCTTTTSCGGGHHH--H--
T ss_pred EeccchheeccCCCccchhhhcccCCCccccCHHHhccccCCCchhhHHHHHHHHHHHHhCCCCCccCchhhHHH--H--
Confidence 99999976543211 111233568999999999875 568999999999999999999999987543221111 0
Q ss_pred hhhcCCCcccccCcccCCCCCHHHHHHHHHHHHHchhhcccCCCCHHHHHH
Q 045315 383 NLWNDGRTWELMDPISQNGASYPILKRYINVALLCVQEKAADRPAMSEVVS 433 (476)
Q Consensus 383 ~~~~~~~~~~~~d~~~~~~~~~~~~~~l~~li~~Cl~~dP~~RPt~~eVl~ 433 (476)
... ......................+.+++.+||+.||++||++.++++
T Consensus 239 -~~~-~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~ll~ 287 (303)
T 2vwi_A 239 -TLQ-NDPPSLETGVQDKEMLKKYGKSFRKMISLCLQKDPEKRPTAAELLR 287 (303)
T ss_dssp -HHT-SSCCCTTC-----CCCCCCCHHHHHHHHHHCCSSGGGSCCHHHHHT
T ss_pred -Hhc-cCCCccccccccchhhhhhhHHHHHHHHHHccCChhhCcCHHHHhh
Confidence 011 1000000000001111122356889999999999999999999986
|
| >3fdn_A Serine/threonine-protein kinase 6; aurora kinase inhibitors, virtual screening, X-RAY CO- crystal analysis, structure-based drug design (SBDD); HET: MMH; 1.90A {Homo sapiens} SCOP: d.144.1.7 PDB: 3k5u_A* 3m11_A* 2c6e_A* 1muo_A* 2bmc_A* 2j4z_A* 1ol6_A* 3up2_A* 3unz_A* 3uo5_A* 3uo6_A* 3uod_A* 3uoh_A* 3uoj_A* 3uok_A* 3uo4_A* 3uol_A* 3up7_A* 4dea_A* 4deb_A* ... | Back alignment and structure |
|---|
Probab=99.93 E-value=5.1e-27 Score=227.71 Aligned_cols=171 Identities=23% Similarity=0.267 Sum_probs=131.1
Q ss_pred cccceeeccCCCCC------CCCCCChhhHHHHHHHHHHHHHHHhhcCCCceeecCCCccceEecCCCCceeccccceee
Q 045315 241 DEISFWYESYNNPT------KKGLLCWGTRVRIIEGIAQGLLYLHQYSRLRVIHRDLKASNILLDKDMNPKISDFGMARM 314 (476)
Q Consensus 241 ~~~~l~~Ey~~~~~------~~~~L~~~~~~~i~~qIa~gL~yLH~~~~~~ivH~DLkp~NILld~~~~~kL~DFGla~~ 314 (476)
+..+++|||++... ....+++.++..++.||+.||+|||+.+ |+||||||+||+++.++.+||+|||++..
T Consensus 82 ~~~~lv~e~~~~~~l~~~l~~~~~~~~~~~~~~~~qi~~~l~~LH~~~---i~H~dlkp~Nili~~~~~~~l~Dfg~~~~ 158 (279)
T 3fdn_A 82 TRVYLILEYAPLGTVYRELQKLSKFDEQRTATYITELANALSYCHSKR---VIHRDIKPENLLLGSAGELKIADFGWSVH 158 (279)
T ss_dssp SEEEEEECCCTTEEHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHTTT---CEECCCCGGGEEECTTSCEEECSCCEESC
T ss_pred CEEEEEEecCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCC---EecccCChHhEEEcCCCCEEEEecccccc
Confidence 45788999998322 2356999999999999999999999998 99999999999999999999999999865
Q ss_pred cCCCcccccceeeeeccCCCChhhhccCCCCccceEEeehhhhhhhhhCCCCCCcCCCCchhhhhhhhhhhcCCCccccc
Q 045315 315 FGGDELQSNTKRIVGTYGYMSPEYALRGLFSIKSDVFSFGVLLLETLSSKKNTHFYNTDSLTLLGHAWNLWNDGRTWELM 394 (476)
Q Consensus 315 ~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~s~ksDVwSlGvvl~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 394 (476)
..... .....|+..|+|||.+.+..++.++||||||+++|+|++|+.||...... ...... .....
T Consensus 159 ~~~~~----~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~--~~~~~~----~~~~~---- 224 (279)
T 3fdn_A 159 APSSR----RTDLCGTLDYLPPEMIEGRMHDEKVDLWSLGVLCYEFLVGKPPFEANTYQ--ETYKRI----SRVEF---- 224 (279)
T ss_dssp C------------CCCCTTCCHHHHTTCCCCTTHHHHHHHHHHHHHHHSSCTTCCSSHH--HHHHHH----HHTCC----
T ss_pred CCccc----ccccCCCCCccCHhHhccCCCCccchhHhHHHHHHHHHHCCCCCCCCcHH--HHHHHH----HhCCC----
Confidence 43322 22356899999999999999999999999999999999999998643311 111111 00000
Q ss_pred CcccCCCCCHHHHHHHHHHHHHchhhcccCCCCHHHHHHH
Q 045315 395 DPISQNGASYPILKRYINVALLCVQEKAADRPAMSEVVSM 434 (476)
Q Consensus 395 d~~~~~~~~~~~~~~l~~li~~Cl~~dP~~RPt~~eVl~~ 434 (476)
..+......+.+++.+||+.||++||+++|+++.
T Consensus 225 ------~~~~~~~~~~~~li~~~l~~~p~~Rps~~e~l~h 258 (279)
T 3fdn_A 225 ------TFPDFVTEGARDLISRLLKHNPSQRPMLREVLEH 258 (279)
T ss_dssp ------CCCTTSCHHHHHHHHHHCCSSGGGSCCHHHHHHC
T ss_pred ------CCCCcCCHHHHHHHHHHhccChhhCCCHHHHhhC
Confidence 0111223567899999999999999999999863
|
| >3rgf_A Cyclin-dependent kinase 8; protein kinase complex, transferase,transcription; HET: BAX; 2.20A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.93 E-value=1.4e-26 Score=237.31 Aligned_cols=128 Identities=28% Similarity=0.433 Sum_probs=98.3
Q ss_pred cccceeeccCCC--------------CCCCCCCChhhHHHHHHHHHHHHHHHhhcCCCceeecCCCccceEe----cCCC
Q 045315 241 DEISFWYESYNN--------------PTKKGLLCWGTRVRIIEGIAQGLLYLHQYSRLRVIHRDLKASNILL----DKDM 302 (476)
Q Consensus 241 ~~~~l~~Ey~~~--------------~~~~~~L~~~~~~~i~~qIa~gL~yLH~~~~~~ivH~DLkp~NILl----d~~~ 302 (476)
..++++|||++. ......+++.++..++.||+.||+|||+.+ |+||||||+|||+ +.++
T Consensus 93 ~~~~lv~e~~~~~l~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~---ivH~Dlkp~NIll~~~~~~~~ 169 (405)
T 3rgf_A 93 RKVWLLFDYAEHDLWHIIKFHRASKANKKPVQLPRGMVKSLLYQILDGIHYLHANW---VLHRDLKPANILVMGEGPERG 169 (405)
T ss_dssp TEEEEEEECCSEEHHHHHHHHHHHC-------CCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCCGGGEEECCSSTTTT
T ss_pred CeEEEEEeCCCCCHHHHHHHhccccccccccCCCHHHHHHHHHHHHHHHHHHHhCC---EeCCCcCHHHeEEecCCCCCC
Confidence 467889999871 122335999999999999999999999999 9999999999999 7788
Q ss_pred CceeccccceeecCCCcc-cccceeeeeccCCCChhhhcc-CCCCccceEEeehhhhhhhhhCCCCCCcCC
Q 045315 303 NPKISDFGMARMFGGDEL-QSNTKRIVGTYGYMSPEYALR-GLFSIKSDVFSFGVLLLETLSSKKNTHFYN 371 (476)
Q Consensus 303 ~~kL~DFGla~~~~~~~~-~~~~~~~~gt~~y~aPE~l~~-~~~s~ksDVwSlGvvl~elltG~~p~~~~~ 371 (476)
.+||+|||+++.+..... ........||+.|+|||.+.+ ..++.++|||||||++|||++|+.||....
T Consensus 170 ~~kl~Dfg~a~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlG~il~ell~g~~pf~~~~ 240 (405)
T 3rgf_A 170 RVKIADMGFARLFNSPLKPLADLDPVVVTFWYRAPELLLGARHYTKAIDIWAIGCIFAELLTSEPIFHCRQ 240 (405)
T ss_dssp CEEECCTTCCC----------------CCCTTCCHHHHTTCCSCCHHHHHHHHHHHHHHHHHSSCTTCCCC
T ss_pred cEEEEECCCceecCCCCcccccCCCceecCcccCchhhcCCCcccchhhhHHHHHHHHHHHhCCCCCCCcc
Confidence 999999999987653211 122234678999999999987 458999999999999999999999996543
|
| >3nsz_A CK II alpha, casein kinase II subunit alpha; inhibitor, transferase-transferase inhibitor CO; HET: ANP; 1.30A {Homo sapiens} SCOP: d.144.1.7 PDB: 2r7i_A 3pe1_A* 1jwh_A* 3pe2_A* 3r0t_A* 3h30_A* 3q9w_A* 3q9x_A* 3q9y_A* 3q9z_A* 3qa0_A 3bqc_A* 2rkp_A* 3c13_A* 3fwq_A 3rps_A* 3u9c_A* 4fbx_A* 3mb7_A* 3mb6_A* ... | Back alignment and structure |
|---|
Probab=99.93 E-value=1.8e-26 Score=229.21 Aligned_cols=187 Identities=16% Similarity=0.209 Sum_probs=134.8
Q ss_pred cccceeeccCCCCCC---CCCCChhhHHHHHHHHHHHHHHHhhcCCCceeecCCCccceEecCCC-CceeccccceeecC
Q 045315 241 DEISFWYESYNNPTK---KGLLCWGTRVRIIEGIAQGLLYLHQYSRLRVIHRDLKASNILLDKDM-NPKISDFGMARMFG 316 (476)
Q Consensus 241 ~~~~l~~Ey~~~~~~---~~~L~~~~~~~i~~qIa~gL~yLH~~~~~~ivH~DLkp~NILld~~~-~~kL~DFGla~~~~ 316 (476)
...+++|||++.... .+.+++.++..++.||+.||+|||+++ |+||||||+|||++.++ .+||+|||+++...
T Consensus 106 ~~~~lv~e~~~~~~l~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~---ivH~Dikp~Nil~~~~~~~~kl~Dfg~a~~~~ 182 (330)
T 3nsz_A 106 RTPALVFEHVNNTDFKQLYQTLTDYDIRFYMYEILKALDYCHSMG---IMHRDVKPHNVMIDHEHRKLRLIDWGLAEFYH 182 (330)
T ss_dssp CCEEEEEECCCCCCHHHHGGGCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEEETTTTEEEECCCTTCEECC
T ss_pred CceEEEEeccCchhHHHHHHhCCHHHHHHHHHHHHHHHHHHHhCC---eeeCCCCHHHEEEcCCCCEEEEEeCCCceEcC
Confidence 356789999984321 245899999999999999999999999 99999999999999776 79999999998765
Q ss_pred CCcccccceeeeeccCCCChhhhcc-CCCCccceEEeehhhhhhhhhCCCCCCcCCCCchhhhhhhh--------hhhcC
Q 045315 317 GDELQSNTKRIVGTYGYMSPEYALR-GLFSIKSDVFSFGVLLLETLSSKKNTHFYNTDSLTLLGHAW--------NLWND 387 (476)
Q Consensus 317 ~~~~~~~~~~~~gt~~y~aPE~l~~-~~~s~ksDVwSlGvvl~elltG~~p~~~~~~~~~~~~~~~~--------~~~~~ 387 (476)
.... .....++..|+|||.+.+ ..++.++|||||||++|||++|+.||.........+..... .....
T Consensus 183 ~~~~---~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~p~~~~~~~~~~l~~~~~~~~~~~~~~~~~~ 259 (330)
T 3nsz_A 183 PGQE---YNVRVASRYFKGPELLVDYQMYDYSLDMWSLGCMLASMIFRKEPFFHGHDNYDQLVRIAKVLGTEDLYDYIDK 259 (330)
T ss_dssp TTCC---CCSCCSCGGGCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHTCSSSSCCSSHHHHHHHHHHHHCHHHHHHHHHH
T ss_pred CCCc---cccccccccccChhhhcCCCcCCchhhHHHHHHHHHHHHhCCCCcccCCchHHHHHHHHHhcCCchhhhHHHH
Confidence 4322 223468899999999887 67899999999999999999999998543322111111000 00000
Q ss_pred --------------CCcccccCcccCCCCCHHHHHHHHHHHHHchhhcccCCCCHHHHHH
Q 045315 388 --------------GRTWELMDPISQNGASYPILKRYINVALLCVQEKAADRPAMSEVVS 433 (476)
Q Consensus 388 --------------~~~~~~~d~~~~~~~~~~~~~~l~~li~~Cl~~dP~~RPt~~eVl~ 433 (476)
......................+.+++.+||+.||++|||++|+++
T Consensus 260 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpta~e~l~ 319 (330)
T 3nsz_A 260 YNIELDPRFNDILGRHSRKRWERFVHSENQHLVSPEALDFLDKLLRYDHQSRLTAREAME 319 (330)
T ss_dssp TTCCCCTHHHHHHCCCCCCCGGGGCCTTTGGGCCHHHHHHHHTTSCSSGGGSCCHHHHHT
T ss_pred hccccccchhhhhhhccccchhhhccccccccCCHHHHHHHHHHhcCCcccCCCHHHHhc
Confidence 0000000111111112223567899999999999999999999986
|
| >3v8s_A RHO-associated protein kinase 1; dimerization, myosin, transferase, inhibitor, transf transferase inhibitor complex; HET: 0HD; 2.29A {Homo sapiens} PDB: 3twj_A* 3tv7_A* 2etr_A* 2esm_A* 2eto_A* 2etk_A* 3d9v_A* 3ncz_A* 3ndm_A* 2v55_A* 2f2u_A* 2h9v_A* | Back alignment and structure |
|---|
Probab=99.93 E-value=6.8e-27 Score=240.04 Aligned_cols=178 Identities=21% Similarity=0.229 Sum_probs=134.9
Q ss_pred cccceeeccCCCCC-----CCCCCChhhHHHHHHHHHHHHHHHhhcCCCceeecCCCccceEecCCCCceeccccceeec
Q 045315 241 DEISFWYESYNNPT-----KKGLLCWGTRVRIIEGIAQGLLYLHQYSRLRVIHRDLKASNILLDKDMNPKISDFGMARMF 315 (476)
Q Consensus 241 ~~~~l~~Ey~~~~~-----~~~~L~~~~~~~i~~qIa~gL~yLH~~~~~~ivH~DLkp~NILld~~~~~kL~DFGla~~~ 315 (476)
+..+++|||++.+. ++..+++..+..++.||+.||+|||+++ |+||||||+|||++.++.+||+|||+++..
T Consensus 142 ~~~~lV~E~~~gg~L~~~l~~~~~~e~~~~~~~~qi~~aL~~LH~~g---ivHrDLKp~NILl~~~g~ikL~DFG~a~~~ 218 (410)
T 3v8s_A 142 RYLYMVMEYMPGGDLVNLMSNYDVPEKWARFYTAEVVLALDAIHSMG---FIHRDVKPDNMLLDKSGHLKLADFGTCMKM 218 (410)
T ss_dssp SEEEEEECCCTTEEHHHHHHHCCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEECTTSCEEECCCTTCEEC
T ss_pred CEEEEEEeCCCCCcHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCC---eEeccCCHHHeeECCCCCEEEeccceeEee
Confidence 46789999998322 2346899999999999999999999999 999999999999999999999999999876
Q ss_pred CCCcccccceeeeeccCCCChhhhccCC----CCccceEEeehhhhhhhhhCCCCCCcCCCCchhhhhhhhhhhcCCCcc
Q 045315 316 GGDELQSNTKRIVGTYGYMSPEYALRGL----FSIKSDVFSFGVLLLETLSSKKNTHFYNTDSLTLLGHAWNLWNDGRTW 391 (476)
Q Consensus 316 ~~~~~~~~~~~~~gt~~y~aPE~l~~~~----~s~ksDVwSlGvvl~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~ 391 (476)
...... ......||+.|+|||++.+.. ++.++|||||||++|||++|+.||...+.. ....... ......
T Consensus 219 ~~~~~~-~~~~~~gt~~Y~APE~l~~~~~~~~~~~~~DiwSlGvilyell~G~~Pf~~~~~~--~~~~~i~---~~~~~~ 292 (410)
T 3v8s_A 219 NKEGMV-RCDTAVGTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLYEMLVGDTPFYADSLV--GTYSKIM---NHKNSL 292 (410)
T ss_dssp CTTSEE-ECCSCCSCGGGCCHHHHHTTTTTCEEETHHHHHHHHHHHHHHHHSSCTTCCSSHH--HHHHHHH---THHHHC
T ss_pred ccCCcc-cccCCcCCccccCHHHhhccCCCcCCCCcceEecchHHHHHHHhCCCCCCCCChh--hHHHHHH---hccccc
Confidence 543221 222367999999999998655 789999999999999999999998754311 1111110 000000
Q ss_pred cccCcccCCCCCHHHHHHHHHHHHHchhhcccC--CCCHHHHHHH
Q 045315 392 ELMDPISQNGASYPILKRYINVALLCVQEKAAD--RPAMSEVVSM 434 (476)
Q Consensus 392 ~~~d~~~~~~~~~~~~~~l~~li~~Cl~~dP~~--RPt~~eVl~~ 434 (476)
.. + ........+.+++.+||+.+|.+ ||+++||++.
T Consensus 293 ~~--p-----~~~~~s~~~~~li~~lL~~~~~rlgR~~~~ei~~H 330 (410)
T 3v8s_A 293 TF--P-----DDNDISKEAKNLICAFLTDREVRLGRNGVEEIKRH 330 (410)
T ss_dssp CC--C-----TTCCCCHHHHHHHHHHSSCGGGCTTSSCHHHHHTS
T ss_pred cC--C-----CcccccHHHHHHHHHHccChhhhCCCCCHHHHhcC
Confidence 00 0 01122356889999999999998 9999999864
|
| >3eb0_A Putative uncharacterized protein; kinase cryptosporidium parvum, ATP-binding, kinase, nucleoti binding; HET: PTR DRK; 2.65A {Cryptosporidium parvum iowa II} | Back alignment and structure |
|---|
Probab=99.93 E-value=1e-26 Score=236.53 Aligned_cols=184 Identities=17% Similarity=0.159 Sum_probs=133.2
Q ss_pred ccceeeccCCCC---------CCCCCCChhhHHHHHHHHHHHHHHHhhcCCCceeecCCCccceEec-CCCCceeccccc
Q 045315 242 EISFWYESYNNP---------TKKGLLCWGTRVRIIEGIAQGLLYLHQYSRLRVIHRDLKASNILLD-KDMNPKISDFGM 311 (476)
Q Consensus 242 ~~~l~~Ey~~~~---------~~~~~L~~~~~~~i~~qIa~gL~yLH~~~~~~ivH~DLkp~NILld-~~~~~kL~DFGl 311 (476)
-.+++|||++.. ..+..+++..+..++.||+.||+|||+++ |+||||||+||+++ .++.+||+|||+
T Consensus 112 ~~~lv~e~~~~~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~g---i~H~Dikp~Nil~~~~~~~~kl~Dfg~ 188 (383)
T 3eb0_A 112 YLNVIMEYVPDTLHKVLKSFIRSGRSIPMNLISIYIYQLFRAVGFIHSLG---ICHRDIKPQNLLVNSKDNTLKLCDFGS 188 (383)
T ss_dssp EEEEEECCCSEEHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHTTT---EECSCCCGGGEEEETTTTEEEECCCTT
T ss_pred EEEEEEecCCccHHHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCc---CccCccCHHHEEEcCCCCcEEEEECCC
Confidence 466899999821 24568999999999999999999999999 99999999999998 688999999999
Q ss_pred eeecCCCcccccceeeeeccCCCChhhhccC-CCCccceEEeehhhhhhhhhCCCCCCcCCCCchhhhhhhhhhhcC---
Q 045315 312 ARMFGGDELQSNTKRIVGTYGYMSPEYALRG-LFSIKSDVFSFGVLLLETLSSKKNTHFYNTDSLTLLGHAWNLWND--- 387 (476)
Q Consensus 312 a~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~-~~s~ksDVwSlGvvl~elltG~~p~~~~~~~~~~~~~~~~~~~~~--- 387 (476)
++....... .....++..|+|||.+.+. .++.++|||||||++|||++|+.||....... .+.. .......
T Consensus 189 a~~~~~~~~---~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~-~~~~-i~~~~g~p~~ 263 (383)
T 3eb0_A 189 AKKLIPSEP---SVAYICSRFYRAPELMLGATEYTPSIDLWSIGCVFGELILGKPLFSGETSID-QLVR-IIQIMGTPTK 263 (383)
T ss_dssp CEECCTTSC---CCCCCCCSSCCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHH-HHHH-HHHHHCCCCH
T ss_pred CcccCCCCC---CcCcccCCCccCHHHhcCCCCCCcchhhhhHHHHHHHHHhCCCCCCCCChHH-HHHH-HHHHhCCCCH
Confidence 987654332 2234689999999998865 48999999999999999999999987543111 1111 0000000
Q ss_pred -------CCcccccCcccC-----CCCCHHHHHHHHHHHHHchhhcccCCCCHHHHHH
Q 045315 388 -------GRTWELMDPISQ-----NGASYPILKRYINVALLCVQEKAADRPAMSEVVS 433 (476)
Q Consensus 388 -------~~~~~~~d~~~~-----~~~~~~~~~~l~~li~~Cl~~dP~~RPt~~eVl~ 433 (476)
....+..-+... ...+......+.+++.+||+.||++|||+.|+++
T Consensus 264 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~ 321 (383)
T 3eb0_A 264 EQMIRMNPHYTEVRFPTLKAKDWRKILPEGTPSLAIDLLEQILRYEPDLRINPYEAMA 321 (383)
T ss_dssp HHHHHHCTTC--CCCCCCCCCCHHHHSCTTCCHHHHHHHHHHCCSSGGGSCCHHHHHT
T ss_pred HHHHHhCcccccccCCccCcccHHhhCCCCCCHHHHHHHHHHccCChhhCCCHHHHhc
Confidence 000000000000 0011123456889999999999999999999974
|
| >2r5t_A Serine/threonine-protein kinase SGK1; AGC protein kinase, apoptosis, ATP-binding, cytoplasm, endoplasmic reticulum, nucleotide-binding, nucleus; HET: ANP; 1.90A {Homo sapiens} PDB: 3hdm_A* 3hdn_A* | Back alignment and structure |
|---|
Probab=99.93 E-value=4.8e-27 Score=238.35 Aligned_cols=170 Identities=23% Similarity=0.269 Sum_probs=132.4
Q ss_pred cccceeeccCCCCC------CCCCCChhhHHHHHHHHHHHHHHHhhcCCCceeecCCCccceEecCCCCceeccccceee
Q 045315 241 DEISFWYESYNNPT------KKGLLCWGTRVRIIEGIAQGLLYLHQYSRLRVIHRDLKASNILLDKDMNPKISDFGMARM 314 (476)
Q Consensus 241 ~~~~l~~Ey~~~~~------~~~~L~~~~~~~i~~qIa~gL~yLH~~~~~~ivH~DLkp~NILld~~~~~kL~DFGla~~ 314 (476)
+.++++|||++.+. +.+.+++.++..++.||+.||+|||+++ |+||||||+|||++.++.+||+|||+++.
T Consensus 112 ~~~~lv~E~~~gg~L~~~l~~~~~~~~~~~~~~~~qi~~aL~~LH~~g---ivHrDlkp~NIll~~~g~ikL~DFG~a~~ 188 (373)
T 2r5t_A 112 DKLYFVLDYINGGELFYHLQRERCFLEPRARFYAAEIASALGYLHSLN---IVYRDLKPENILLDSQGHIVLTDFGLCKE 188 (373)
T ss_dssp SEEEEEEECCCSCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCCGGGEEECTTSCEEECCCCBCGG
T ss_pred CEEEEEEeCCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCC---ceecCCCHHHEEECCCCCEEEeeCccccc
Confidence 46889999998432 2457899999999999999999999999 99999999999999999999999999986
Q ss_pred cCCCcccccceeeeeccCCCChhhhccCCCCccceEEeehhhhhhhhhCCCCCCcCCCCchhhhhhhhhhhcCCCccccc
Q 045315 315 FGGDELQSNTKRIVGTYGYMSPEYALRGLFSIKSDVFSFGVLLLETLSSKKNTHFYNTDSLTLLGHAWNLWNDGRTWELM 394 (476)
Q Consensus 315 ~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~s~ksDVwSlGvvl~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 394 (476)
..... .......||+.|+|||++.+..++.++|+|||||++|||++|+.||...+. ...... ... +.. .
T Consensus 189 ~~~~~--~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~G~~Pf~~~~~--~~~~~~---i~~-~~~-~-- 257 (373)
T 2r5t_A 189 NIEHN--STTSTFCGTPEYLAPEVLHKQPYDRTVDWWCLGAVLYEMLYGLPPFYSRNT--AEMYDN---ILN-KPL-Q-- 257 (373)
T ss_dssp GBCCC--CCCCSBSCCCCCCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCTTCCSBH--HHHHHH---HHH-SCC-C--
T ss_pred cccCC--CccccccCCccccCHHHhCCCCCCchhhhHHHHHHHHHHHcCCCCCCCCCH--HHHHHH---HHh-ccc-C--
Confidence 43222 123346799999999999999999999999999999999999999865331 111111 111 110 0
Q ss_pred CcccCCCCCHHHHHHHHHHHHHchhhcccCCCCHHHH
Q 045315 395 DPISQNGASYPILKRYINVALLCVQEKAADRPAMSEV 431 (476)
Q Consensus 395 d~~~~~~~~~~~~~~l~~li~~Cl~~dP~~RPt~~eV 431 (476)
.+......+.+++.+||+.||++||++.+.
T Consensus 258 -------~~~~~~~~~~~li~~lL~~dp~~R~~~~~~ 287 (373)
T 2r5t_A 258 -------LKPNITNSARHLLEGLLQKDRTKRLGAKDD 287 (373)
T ss_dssp -------CCSSSCHHHHHHHHHHTCSSGGGSTTTTTT
T ss_pred -------CCCCCCHHHHHHHHHHcccCHHhCCCCCCC
Confidence 011223568899999999999999998543
|
| >3kk8_A Calcium/calmodulin dependent protein kinase II; ATP-binding, nucleotide-binding, serine/threonine-protein kinase, transferase; HET: TPO; 1.72A {Caenorhabditis elegans} PDB: 3kk9_A* 3kl8_A 2vn9_A* 3bhh_A* | Back alignment and structure |
|---|
Probab=99.93 E-value=1.8e-26 Score=224.09 Aligned_cols=175 Identities=19% Similarity=0.282 Sum_probs=133.5
Q ss_pred cccceeeccCCCCC------CCCCCChhhHHHHHHHHHHHHHHHhhcCCCceeecCCCccceEecCCCC---ceeccccc
Q 045315 241 DEISFWYESYNNPT------KKGLLCWGTRVRIIEGIAQGLLYLHQYSRLRVIHRDLKASNILLDKDMN---PKISDFGM 311 (476)
Q Consensus 241 ~~~~l~~Ey~~~~~------~~~~L~~~~~~~i~~qIa~gL~yLH~~~~~~ivH~DLkp~NILld~~~~---~kL~DFGl 311 (476)
+..++++||++... .++.+++.++..++.||+.||+|||+.+ |+||||||+||+++.++. +||+|||+
T Consensus 78 ~~~~~v~e~~~~~~l~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~---i~H~dikp~Nil~~~~~~~~~~kl~Dfg~ 154 (284)
T 3kk8_A 78 SFHYLVFDLVTGGELFEDIVAREFYSEADASHCIQQILESIAYCHSNG---IVHRNLKPENLLLASKAKGAAVKLADFGL 154 (284)
T ss_dssp SEEEEEECCCCSCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCCGGGEEESSSSTTCCEEECCCTT
T ss_pred CEEEEEEecCCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCC---cCcCCCCHHHEEEecCCCCCcEEEeecee
Confidence 35678899997432 2456999999999999999999999999 999999999999986655 99999999
Q ss_pred eeecCCCcccccceeeeeccCCCChhhhccCCCCccceEEeehhhhhhhhhCCCCCCcCCCCchhhhhhhhhhhcCCCcc
Q 045315 312 ARMFGGDELQSNTKRIVGTYGYMSPEYALRGLFSIKSDVFSFGVLLLETLSSKKNTHFYNTDSLTLLGHAWNLWNDGRTW 391 (476)
Q Consensus 312 a~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~s~ksDVwSlGvvl~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~ 391 (476)
+........ .....|++.|+|||.+.+..++.++||||||+++|+|++|+.||...... ...... ..+..
T Consensus 155 ~~~~~~~~~---~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~--~~~~~~----~~~~~- 224 (284)
T 3kk8_A 155 AIEVNDSEA---WHGFAGTPGYLSPEVLKKDPYSKPVDIWACGVILYILLVGYPPFWDEDQH--RLYAQI----KAGAY- 224 (284)
T ss_dssp CEECCSSCB---CCCSCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHH--HHHHHH----HHTCC-
T ss_pred eEEcccCcc---ccCCCCCcCCcCchhhcCCCCCcccchHHHHHHHHHHHHCCCCCCCCchh--HHHHHH----Hhccc-
Confidence 987654322 12356899999999999999999999999999999999999998653311 111111 11110
Q ss_pred cccCcccCCCCCHHHHHHHHHHHHHchhhcccCCCCHHHHHH
Q 045315 392 ELMDPISQNGASYPILKRYINVALLCVQEKAADRPAMSEVVS 433 (476)
Q Consensus 392 ~~~d~~~~~~~~~~~~~~l~~li~~Cl~~dP~~RPt~~eVl~ 433 (476)
....+ ........+.+++.+||+.||++|||++|+++
T Consensus 225 ~~~~~-----~~~~~~~~~~~li~~~l~~dp~~Rps~~~~l~ 261 (284)
T 3kk8_A 225 DYPSP-----EWDTVTPEAKSLIDSMLTVNPKKRITADQALK 261 (284)
T ss_dssp CCCTT-----TTTTSCHHHHHHHHHHSCSSTTTSCCHHHHTT
T ss_pred cCCch-----hhcccCHHHHHHHHHHcccChhhCCCHHHHhc
Confidence 00000 01122356889999999999999999999986
|
| >4aaa_A Cyclin-dependent kinase-like 2; transferase, phospho-mimetic; HET: DKI; 1.53A {Homo sapiens} PDB: 4bbm_A* | Back alignment and structure |
|---|
Probab=99.93 E-value=2.8e-27 Score=235.69 Aligned_cols=187 Identities=21% Similarity=0.255 Sum_probs=130.2
Q ss_pred cccceeeccCCCC------CCCCCCChhhHHHHHHHHHHHHHHHhhcCCCceeecCCCccceEecCCCCceeccccceee
Q 045315 241 DEISFWYESYNNP------TKKGLLCWGTRVRIIEGIAQGLLYLHQYSRLRVIHRDLKASNILLDKDMNPKISDFGMARM 314 (476)
Q Consensus 241 ~~~~l~~Ey~~~~------~~~~~L~~~~~~~i~~qIa~gL~yLH~~~~~~ivH~DLkp~NILld~~~~~kL~DFGla~~ 314 (476)
+..+++|||++.. .....+++.++..++.||+.||+|||+.+ |+||||||+||+++.++.+||+|||+++.
T Consensus 97 ~~~~lv~e~~~~~~l~~~~~~~~~~~~~~~~~~~~qi~~~l~~LH~~~---ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~ 173 (331)
T 4aaa_A 97 KRWYLVFEFVDHTILDDLELFPNGLDYQVVQKYLFQIINGIGFCHSHN---IIHRDIKPENILVSQSGVVKLCDFGFART 173 (331)
T ss_dssp TEEEEEEECCSEEHHHHHHHSTTCCCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCCGGGEEECTTSCEEECCCTTC--
T ss_pred CEEEEEEecCCcchHHHHHhhccCCCHHHHHHHHHHHHHHHHHHHHCC---EEccCcChheEEEcCCCcEEEEeCCCcee
Confidence 4578899999821 23557999999999999999999999999 99999999999999999999999999986
Q ss_pred cCCCcccccceeeeeccCCCChhhhccC-CCCccceEEeehhhhhhhhhCCCCCCcCCCCchhhhhhhh----------h
Q 045315 315 FGGDELQSNTKRIVGTYGYMSPEYALRG-LFSIKSDVFSFGVLLLETLSSKKNTHFYNTDSLTLLGHAW----------N 383 (476)
Q Consensus 315 ~~~~~~~~~~~~~~gt~~y~aPE~l~~~-~~s~ksDVwSlGvvl~elltG~~p~~~~~~~~~~~~~~~~----------~ 383 (476)
...... ......|+..|+|||.+.+. .++.++|||||||++|||++|+.||........ +..... .
T Consensus 174 ~~~~~~--~~~~~~~t~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~-~~~~~~~~~~~~~~~~~ 250 (331)
T 4aaa_A 174 LAAPGE--VYDDEVATRWYRAPELLVGDVKYGKAVDVWAIGCLVTEMFMGEPLFPGDSDIDQ-LYHIMMCLGNLIPRHQE 250 (331)
T ss_dssp ------------CCCCCTTCCHHHHTTCTTCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHH-HHHHHHHHCSCCHHHHH
T ss_pred ecCCcc--ccCCCcCCccccCcccccCCCCcchHHHHHHHHHHHHHHHhCCCCCCCCCcHHH-HHHHHHHhCCCChhhhh
Confidence 543221 12234689999999999875 789999999999999999999999875432111 000000 0
Q ss_pred hhcCCC-cccccCcccCCCCC-----HHHHHHHHHHHHHchhhcccCCCCHHHHHH
Q 045315 384 LWNDGR-TWELMDPISQNGAS-----YPILKRYINVALLCVQEKAADRPAMSEVVS 433 (476)
Q Consensus 384 ~~~~~~-~~~~~d~~~~~~~~-----~~~~~~l~~li~~Cl~~dP~~RPt~~eVl~ 433 (476)
.+.... ......+....... ....+.+.+++.+||+.||++|||++|+++
T Consensus 251 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dP~~Rpt~~ell~ 306 (331)
T 4aaa_A 251 LFNKNPVFAGVRLPEIKEREPLERRYPKLSEVVIDLAKKCLHIDPDKRPFCAELLH 306 (331)
T ss_dssp HHHHCGGGTTCCCCCCSSCCCHHHHSTTSCHHHHHHHHHHTCSSGGGSCCGGGGGG
T ss_pred HhhhccccccccCccccccchhhhcccchhHHHHHHHHHHhccCcccCCCHHHHhc
Confidence 000000 00000011111111 123467899999999999999999998875
|
| >3c4z_A Rhodopsin kinase; Ser/Thr kinase, RGS homology domain, G protein coupled recep kinase, GRK, GRK1, P-loop, autophosphoryl ADP, ATP-binding; HET: ADP; 1.84A {Bos taurus} PDB: 3c4x_A* 3c4y_A 3c4w_A* 3c50_A* 3c51_A* 3qc9_A* 2i94_B | Back alignment and structure |
|---|
Probab=99.93 E-value=3.7e-26 Score=242.00 Aligned_cols=174 Identities=24% Similarity=0.302 Sum_probs=135.2
Q ss_pred cccceeeccCCCC----------CCCCCCChhhHHHHHHHHHHHHHHHhhcCCCceeecCCCccceEecCCCCceecccc
Q 045315 241 DEISFWYESYNNP----------TKKGLLCWGTRVRIIEGIAQGLLYLHQYSRLRVIHRDLKASNILLDKDMNPKISDFG 310 (476)
Q Consensus 241 ~~~~l~~Ey~~~~----------~~~~~L~~~~~~~i~~qIa~gL~yLH~~~~~~ivH~DLkp~NILld~~~~~kL~DFG 310 (476)
+..+++|||++.+ .....+++..+..++.||+.||+|||+++ |+||||||+|||++.++.+||+|||
T Consensus 258 ~~l~lVmE~~~gg~L~~~l~~~~~~~~~l~e~~~~~~~~qi~~aL~~LH~~g---IvHrDLKP~NILl~~~g~vkL~DFG 334 (543)
T 3c4z_A 258 TDLCLVMTIMNGGDIRYHIYNVDEDNPGFQEPRAIFYTAQIVSGLEHLHQRN---IIYRDLKPENVLLDDDGNVRISDLG 334 (543)
T ss_dssp SEEEEEECCCTTCBHHHHHHTSSTTSCSCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEECTTSCEEECCCT
T ss_pred CEEEEEEEeccCCCHHHHHHHhhcccccccHHHHHHHHHHHHHHHHHHHHcC---CcccCCChHHEEEeCCCCEEEeecc
Confidence 4688999999832 12457999999999999999999999999 9999999999999999999999999
Q ss_pred ceeecCCCcccccceeeeeccCCCChhhhccCCCCccceEEeehhhhhhhhhCCCCCCcCCCC--chhhhhhhhhhhcCC
Q 045315 311 MARMFGGDELQSNTKRIVGTYGYMSPEYALRGLFSIKSDVFSFGVLLLETLSSKKNTHFYNTD--SLTLLGHAWNLWNDG 388 (476)
Q Consensus 311 la~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~s~ksDVwSlGvvl~elltG~~p~~~~~~~--~~~~~~~~~~~~~~~ 388 (476)
+++.+...... .....||+.|+|||++.+..++.++|+|||||++|||++|+.||...... ...+... .. ..
T Consensus 335 la~~~~~~~~~--~~~~~GT~~Y~APE~l~~~~~~~~~DiwSlGvilyelltG~~PF~~~~~~~~~~~~~~~---i~-~~ 408 (543)
T 3c4z_A 335 LAVELKAGQTK--TKGYAGTPGFMAPELLLGEEYDFSVDYFALGVTLYEMIAARGPFRARGEKVENKELKQR---VL-EQ 408 (543)
T ss_dssp TCEECCTTCCC--BCCCCSCTTTSCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCCTTCCCCHHHHHHH---HH-HC
T ss_pred eeeeccCCCcc--cccccCCccccChhhhcCCCCChHHhcCcchHHHHHHHhCCCCCCCCccchhHHHHHHH---Hh-hc
Confidence 99876543322 22357999999999999999999999999999999999999999754321 1111111 11 11
Q ss_pred CcccccCcccCCCCCHHHHHHHHHHHHHchhhcccCCCCH-----HHHHH
Q 045315 389 RTWELMDPISQNGASYPILKRYINVALLCVQEKAADRPAM-----SEVVS 433 (476)
Q Consensus 389 ~~~~~~d~~~~~~~~~~~~~~l~~li~~Cl~~dP~~RPt~-----~eVl~ 433 (476)
.. ..+......+.+++.+||+.||++||++ ++|++
T Consensus 409 ~~----------~~p~~~s~~~~~li~~lL~~dP~~R~~~~~~~a~ei~~ 448 (543)
T 3c4z_A 409 AV----------TYPDKFSPASKDFCEALLQKDPEKRLGFRDGSCDGLRT 448 (543)
T ss_dssp CC----------CCCTTSCHHHHHHHHHHSCSSGGGSCCCBTTBSHHHHT
T ss_pred cc----------CCCcccCHHHHHHHHHhccCCHhHCCCCcccCHHHHHc
Confidence 00 1112234578899999999999999975 56653
|
| >3n9x_A Phosphotransferase; malaria kinase, structural genomics, structural genomics CON SGC; 2.05A {Plasmodium berghei} PDB: 3nie_A* | Back alignment and structure |
|---|
Probab=99.93 E-value=1.2e-26 Score=239.97 Aligned_cols=124 Identities=27% Similarity=0.389 Sum_probs=100.1
Q ss_pred cccceeeccCCC-----CCCCCCCChhhHHHHHHHHHHHHHHHhhcCCCceeecCCCccceEecCCCCceeccccceeec
Q 045315 241 DEISFWYESYNN-----PTKKGLLCWGTRVRIIEGIAQGLLYLHQYSRLRVIHRDLKASNILLDKDMNPKISDFGMARMF 315 (476)
Q Consensus 241 ~~~~l~~Ey~~~-----~~~~~~L~~~~~~~i~~qIa~gL~yLH~~~~~~ivH~DLkp~NILld~~~~~kL~DFGla~~~ 315 (476)
+..++++||++. ...+..+++.++..++.||+.||+|||+.+ |+||||||+|||++.++.+||+|||+++..
T Consensus 103 ~~~~lv~e~~~~~L~~~~~~~~~l~~~~~~~i~~qil~aL~~LH~~g---ivHrDlkp~NILl~~~~~~kL~DFGla~~~ 179 (432)
T 3n9x_A 103 DELYIVLEIADSDLKKLFKTPIFLTEEHIKTILYNLLLGENFIHESG---IIHRDLKPANCLLNQDCSVKVCDFGLARTI 179 (432)
T ss_dssp CCEEEEEECCSEEHHHHHHSSCCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEECTTCCEEECCCTTCEEC
T ss_pred CeEEEEEecCCcCHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHHCC---CCCCCCCHHHeEECCCCCEEEccCCCcccc
Confidence 357899999982 123457999999999999999999999999 999999999999999999999999999976
Q ss_pred CCCccc--------------------ccceeeeeccCCCChhhh-ccCCCCccceEEeehhhhhhhhhCCCCC
Q 045315 316 GGDELQ--------------------SNTKRIVGTYGYMSPEYA-LRGLFSIKSDVFSFGVLLLETLSSKKNT 367 (476)
Q Consensus 316 ~~~~~~--------------------~~~~~~~gt~~y~aPE~l-~~~~~s~ksDVwSlGvvl~elltG~~p~ 367 (476)
...... .......||+.|+|||.+ ....++.++|||||||++|||++|..|+
T Consensus 180 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~APE~~~~~~~~~~~~DiwSlG~il~ell~g~~p~ 252 (432)
T 3n9x_A 180 NSEKDTNIVNDLEENEEPGPHNKNLKKQLTSHVVTRWYRAPELILLQENYTKSIDIWSTGCIFAELLNMLQSH 252 (432)
T ss_dssp -------------------------------CCCCCTTCCHHHHTTCSCCCTHHHHHHHHHHHHHHHTTCTTT
T ss_pred cccccccccccccccccccccccchhccccCCCCCccccCHHHHhcCCCCCcccccchHHHHHHHHHhccccc
Confidence 543211 112446789999999986 4567999999999999999999865554
|
| >3a7i_A MST3 kinase, serine/threonine kinase 24 (STE20 homolog, yeast); two-LOBE protein kinase fold, ATP-binding, nucleotid binding, transferase; HET: TPO ADE; 1.45A {Homo sapiens} PDB: 3a7g_A* 3a7h_A* 3a7f_A* 3a7j_A* 3ckw_A 3ckx_A* 3ggf_A* 2xik_A* | Back alignment and structure |
|---|
Probab=99.93 E-value=4.6e-27 Score=230.74 Aligned_cols=174 Identities=24% Similarity=0.345 Sum_probs=135.9
Q ss_pred cccceeeccCCCC-----CCCCCCChhhHHHHHHHHHHHHHHHhhcCCCceeecCCCccceEecCCCCceeccccceeec
Q 045315 241 DEISFWYESYNNP-----TKKGLLCWGTRVRIIEGIAQGLLYLHQYSRLRVIHRDLKASNILLDKDMNPKISDFGMARMF 315 (476)
Q Consensus 241 ~~~~l~~Ey~~~~-----~~~~~L~~~~~~~i~~qIa~gL~yLH~~~~~~ivH~DLkp~NILld~~~~~kL~DFGla~~~ 315 (476)
+..++++||++.. -....+++.++..++.||+.||+|||+.+ |+||||||+||+++.++.+||+|||++...
T Consensus 93 ~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~---i~H~dl~p~Nil~~~~~~~kl~Dfg~~~~~ 169 (303)
T 3a7i_A 93 TKLWIIMEYLGGGSALDLLEPGPLDETQIATILREILKGLDYLHSEK---KIHRDIKAANVLLSEHGEVKLADFGVAGQL 169 (303)
T ss_dssp TEEEEEEECCTTEEHHHHHTTSCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEECTTSCEEECCCTTCEEC
T ss_pred CeEEEEEEeCCCCcHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCC---CccCCCChheEEECCCCCEEEeecccceec
Confidence 4578899999732 23467999999999999999999999999 999999999999999999999999999876
Q ss_pred CCCcccccceeeeeccCCCChhhhccCCCCccceEEeehhhhhhhhhCCCCCCcCCCCchhhhhhhhhhhcCCCcccccC
Q 045315 316 GGDELQSNTKRIVGTYGYMSPEYALRGLFSIKSDVFSFGVLLLETLSSKKNTHFYNTDSLTLLGHAWNLWNDGRTWELMD 395 (476)
Q Consensus 316 ~~~~~~~~~~~~~gt~~y~aPE~l~~~~~s~ksDVwSlGvvl~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~d 395 (476)
...... .....|+..|+|||.+.+..++.++||||||+++|||++|+.||...... ..... ......
T Consensus 170 ~~~~~~--~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~--~~~~~----~~~~~~----- 236 (303)
T 3a7i_A 170 TDTQIK--RNTFVGTPFWMAPEVIKQSAYDSKADIWSLGITAIELARGEPPHSELHPM--KVLFL----IPKNNP----- 236 (303)
T ss_dssp BTTBCC--BCCCCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCTTTTSCHH--HHHHH----HHHSCC-----
T ss_pred Cccccc--cCccCCCcCccCHHHHhcCCCCchhhhHHHHHHHHHHccCCCCCCCcCHH--HHHHH----hhcCCC-----
Confidence 543322 23356899999999999999999999999999999999999998643211 11111 111111
Q ss_pred cccCCCCCHHHHHHHHHHHHHchhhcccCCCCHHHHHHH
Q 045315 396 PISQNGASYPILKRYINVALLCVQEKAADRPAMSEVVSM 434 (476)
Q Consensus 396 ~~~~~~~~~~~~~~l~~li~~Cl~~dP~~RPt~~eVl~~ 434 (476)
+.. .......+.+++.+||+.||++|||+.++++.
T Consensus 237 ~~~----~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~ 271 (303)
T 3a7i_A 237 PTL----EGNYSKPLKEFVEACLNKEPSFRPTAKELLKH 271 (303)
T ss_dssp CCC----CSSCCHHHHHHHHHHCCSSGGGSCCHHHHTTC
T ss_pred CCC----ccccCHHHHHHHHHHcCCChhhCcCHHHHhhC
Confidence 111 11223568899999999999999999999864
|
| >2vgo_A Serine/threonine-protein kinase 12-A; nucleotide-binding, serine/threonine-protein kinase, ATP-binding, transferase, coiled coil, cell division, kinase; HET: TPO AD5; 1.7A {Xenopus laevis} PDB: 2bfx_A* 2vgp_A* 3ztx_A* 2vrx_A* 2bfy_A* 4af3_A* 3dj6_A* 3d15_A* 3d2i_A* 3d2k_A* 3d14_A* 3dj5_A* 3dj7_A* 3daj_A* 1ol5_A* 1ol7_A* 2x6d_A* 2x6e_A* 2xng_A* 2dwb_A* ... | Back alignment and structure |
|---|
Probab=99.93 E-value=1.3e-26 Score=225.39 Aligned_cols=175 Identities=21% Similarity=0.212 Sum_probs=136.1
Q ss_pred cccceeeccCCCCC------CCCCCChhhHHHHHHHHHHHHHHHhhcCCCceeecCCCccceEecCCCCceeccccceee
Q 045315 241 DEISFWYESYNNPT------KKGLLCWGTRVRIIEGIAQGLLYLHQYSRLRVIHRDLKASNILLDKDMNPKISDFGMARM 314 (476)
Q Consensus 241 ~~~~l~~Ey~~~~~------~~~~L~~~~~~~i~~qIa~gL~yLH~~~~~~ivH~DLkp~NILld~~~~~kL~DFGla~~ 314 (476)
+.+++++||++... ..+.+++.++..++.||+.||+|||+++ ++||||||+||+++.++.+||+|||++..
T Consensus 87 ~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~qi~~~l~~lH~~~---i~H~dl~p~Nil~~~~~~~kl~Dfg~~~~ 163 (284)
T 2vgo_A 87 KRIYLMLEFAPRGELYKELQKHGRFDEQRSATFMEELADALHYCHERK---VIHRDIKPENLLMGYKGELKIADFGWSVH 163 (284)
T ss_dssp SEEEEEECCCTTEEHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHTTT---EECCCCSGGGEEECTTCCEEECCCTTCEE
T ss_pred CEEEEEEEeCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCC---ceecCCCHHHEEEcCCCCEEEeccccccc
Confidence 46788999997321 2356999999999999999999999999 99999999999999999999999999976
Q ss_pred cCCCcccccceeeeeccCCCChhhhccCCCCccceEEeehhhhhhhhhCCCCCCcCCCCchhhhhhhhhhhcCCCccccc
Q 045315 315 FGGDELQSNTKRIVGTYGYMSPEYALRGLFSIKSDVFSFGVLLLETLSSKKNTHFYNTDSLTLLGHAWNLWNDGRTWELM 394 (476)
Q Consensus 315 ~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~s~ksDVwSlGvvl~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 394 (476)
..... .....|+..|+|||.+.+..++.++||||||+++|||++|+.||...... .... .......
T Consensus 164 ~~~~~----~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~--~~~~----~~~~~~~---- 229 (284)
T 2vgo_A 164 APSLR----RRTMCGTLDYLPPEMIEGKTHDEKVDLWCAGVLCYEFLVGMPPFDSPSHT--ETHR----RIVNVDL---- 229 (284)
T ss_dssp CSSSC----BCCCCSCGGGCCHHHHTTCCBCTTHHHHHHHHHHHHHHHSSCTTCCSSHH--HHHH----HHHTTCC----
T ss_pred Ccccc----cccccCCCCcCCHHHhccCCCCcccchhhHHHHHHHHHHCCCCCCCCCHh--HHHH----HHhcccc----
Confidence 54322 22356899999999999999999999999999999999999998643311 1111 1111110
Q ss_pred CcccCCCCCHHHHHHHHHHHHHchhhcccCCCCHHHHHH--HHhcc
Q 045315 395 DPISQNGASYPILKRYINVALLCVQEKAADRPAMSEVVS--MLSNE 438 (476)
Q Consensus 395 d~~~~~~~~~~~~~~l~~li~~Cl~~dP~~RPt~~eVl~--~L~~~ 438 (476)
..+......+.+++.+||+.||++||+++++++ .+...
T Consensus 230 ------~~~~~~~~~~~~li~~~l~~~p~~Rps~~~ll~h~~~~~~ 269 (284)
T 2vgo_A 230 ------KFPPFLSDGSKDLISKLLRYHPPQRLPLKGVMEHPWVKAN 269 (284)
T ss_dssp ------CCCTTSCHHHHHHHHHHSCSSGGGSCCHHHHHTCHHHHHH
T ss_pred ------CCCCcCCHHHHHHHHHHhhcCHhhCCCHHHHhhCHHHHhh
Confidence 011122356889999999999999999999986 45443
|
| >2vd5_A DMPK protein; serine/threonine-protein kinase, kinase, transferase, ATP-BI nucleotide-binding, cardiac contractility, muscle different; HET: BI8; 2.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.93 E-value=1.8e-26 Score=237.08 Aligned_cols=177 Identities=19% Similarity=0.224 Sum_probs=132.3
Q ss_pred cccceeeccCCCCC-------CCCCCChhhHHHHHHHHHHHHHHHhhcCCCceeecCCCccceEecCCCCceecccccee
Q 045315 241 DEISFWYESYNNPT-------KKGLLCWGTRVRIIEGIAQGLLYLHQYSRLRVIHRDLKASNILLDKDMNPKISDFGMAR 313 (476)
Q Consensus 241 ~~~~l~~Ey~~~~~-------~~~~L~~~~~~~i~~qIa~gL~yLH~~~~~~ivH~DLkp~NILld~~~~~kL~DFGla~ 313 (476)
+.++++|||++.+. .+..+++..+..++.||+.||+|||+++ |+||||||+|||++.++.+||+|||+++
T Consensus 134 ~~~~lVmE~~~gg~L~~~l~~~~~~l~~~~~~~~~~qi~~aL~~LH~~g---iiHrDLKp~NILld~~g~vkL~DFGla~ 210 (412)
T 2vd5_A 134 NYLYLVMEYYVGGDLLTLLSKFGERIPAEMARFYLAEIVMAIDSVHRLG---YVHRDIKPDNILLDRCGHIRLADFGSCL 210 (412)
T ss_dssp SEEEEEECCCCSCBHHHHHHHHSSCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEECTTSCEEECCCTTCE
T ss_pred CEEEEEEcCCCCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCC---eeecccCHHHeeecCCCCEEEeechhhe
Confidence 46889999998432 2357999999999999999999999999 9999999999999999999999999998
Q ss_pred ecCCCcccccceeeeeccCCCChhhhc-------cCCCCccceEEeehhhhhhhhhCCCCCCcCCCCchhhhhhhhhhhc
Q 045315 314 MFGGDELQSNTKRIVGTYGYMSPEYAL-------RGLFSIKSDVFSFGVLLLETLSSKKNTHFYNTDSLTLLGHAWNLWN 386 (476)
Q Consensus 314 ~~~~~~~~~~~~~~~gt~~y~aPE~l~-------~~~~s~ksDVwSlGvvl~elltG~~p~~~~~~~~~~~~~~~~~~~~ 386 (476)
........ ......||+.|+|||++. ...++.++|+|||||++|||++|+.||...... ...........
T Consensus 211 ~~~~~~~~-~~~~~~Gt~~Y~APE~l~~~~~~~~~~~~~~~~DiwSlGvilyelltG~~Pf~~~~~~--~~~~~i~~~~~ 287 (412)
T 2vd5_A 211 KLRADGTV-RSLVAVGTPDYLSPEILQAVGGGPGTGSYGPECDWWALGVFAYEMFYGQTPFYADSTA--ETYGKIVHYKE 287 (412)
T ss_dssp ECCTTSCE-ECSSCCSCGGGCCHHHHHHHHTCTTCSEECTHHHHHHHHHHHHHHHHSSCTTCCSSHH--HHHHHHHTHHH
T ss_pred eccCCCcc-ccceeccccCcCCHHHHhhcccCcCCCCCChHHhhhHHhHHHHHHHhCCCCCCCCCHH--HHHHHHHhccc
Confidence 76543221 122357999999999987 356899999999999999999999999654321 11111100000
Q ss_pred CCCcccccCcccCCCCCHHHHHHHHHHHHHchhhcccCC---CCHHHHHH
Q 045315 387 DGRTWELMDPISQNGASYPILKRYINVALLCVQEKAADR---PAMSEVVS 433 (476)
Q Consensus 387 ~~~~~~~~d~~~~~~~~~~~~~~l~~li~~Cl~~dP~~R---Pt~~eVl~ 433 (476)
. ..-+.. .......+.+++.+||+ +|++| |+++|+++
T Consensus 288 ~-----~~~p~~----~~~~s~~~~dli~~lL~-~p~~Rlgr~~~~ei~~ 327 (412)
T 2vd5_A 288 H-----LSLPLV----DEGVPEEARDFIQRLLC-PPETRLGRGGAGDFRT 327 (412)
T ss_dssp H-----CCCC--------CCCHHHHHHHHTTSS-CGGGCTTTTTHHHHHT
T ss_pred C-----cCCCcc----ccCCCHHHHHHHHHHcC-ChhhcCCCCCHHHHhc
Confidence 0 000100 11224578899999999 99998 58999875
|
| >3hko_A Calcium/calmodulin-dependent protein kinase with domain and 2 calmodulin-like EF...; structural genomics, protist parasite; HET: ANP; 1.80A {Cryptosporidium parvum iowa II} | Back alignment and structure |
|---|
Probab=99.93 E-value=1.2e-26 Score=231.83 Aligned_cols=161 Identities=20% Similarity=0.215 Sum_probs=118.5
Q ss_pred CCChhhHHHHHHHHHHHHHHHhhcCCCceeecCCCccceEecCCC--CceeccccceeecCCCcc--cccceeeeeccCC
Q 045315 258 LLCWGTRVRIIEGIAQGLLYLHQYSRLRVIHRDLKASNILLDKDM--NPKISDFGMARMFGGDEL--QSNTKRIVGTYGY 333 (476)
Q Consensus 258 ~L~~~~~~~i~~qIa~gL~yLH~~~~~~ivH~DLkp~NILld~~~--~~kL~DFGla~~~~~~~~--~~~~~~~~gt~~y 333 (476)
.+++..+..++.||+.||+|||+.+ |+||||||+||+++.++ .+||+|||+++.+..... ........|++.|
T Consensus 164 ~~~~~~~~~i~~qi~~~l~~LH~~~---ivH~Dlkp~NIll~~~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~~gt~~y 240 (345)
T 3hko_A 164 VQREKLISNIMRQIFSALHYLHNQG---ICHRDIKPENFLFSTNKSFEIKLVDFGLSKEFYKLNNGEYYGMTTKAGTPYF 240 (345)
T ss_dssp HHHHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEESCSSSCCEEECCCTTCEEGGGTTCC--------CCCGGG
T ss_pred cccHHHHHHHHHHHHHHHHHHHHCC---ccccCCChhhEEEecCCCceEEEeeccccccccccCccccccccccCCCccc
Confidence 3467788899999999999999999 99999999999998766 899999999987643211 1122345789999
Q ss_pred CChhhhcc--CCCCccceEEeehhhhhhhhhCCCCCCcCCCCchhhhhhhhhhhcCCCcccccCcccCCCCCHHHHHHHH
Q 045315 334 MSPEYALR--GLFSIKSDVFSFGVLLLETLSSKKNTHFYNTDSLTLLGHAWNLWNDGRTWELMDPISQNGASYPILKRYI 411 (476)
Q Consensus 334 ~aPE~l~~--~~~s~ksDVwSlGvvl~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~l~ 411 (476)
+|||.+.+ ..++.++|||||||++|||++|+.||....... .. ......... ...+ ........+.
T Consensus 241 ~aPE~~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~--~~---~~~~~~~~~--~~~~-----~~~~~~~~~~ 308 (345)
T 3hko_A 241 VAPEVLNTTNESYGPKCDAWSAGVLLHLLLMGAVPFPGVNDAD--TI---SQVLNKKLC--FENP-----NYNVLSPLAR 308 (345)
T ss_dssp CCHHHHTCSSSCCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHH--HH---HHHHHCCCC--TTSG-----GGGGSCHHHH
T ss_pred cCchhhccCCCCCCcHHHHHHHHHHHHHHHHCCCCCCCCChHH--HH---HHHHhcccc--cCCc-----ccccCCHHHH
Confidence 99999875 678999999999999999999999986543211 11 111111110 0000 0111245788
Q ss_pred HHHHHchhhcccCCCCHHHHHH
Q 045315 412 NVALLCVQEKAADRPAMSEVVS 433 (476)
Q Consensus 412 ~li~~Cl~~dP~~RPt~~eVl~ 433 (476)
+++.+||+.||.+||++.++++
T Consensus 309 ~li~~~l~~~p~~Rps~~~~l~ 330 (345)
T 3hko_A 309 DLLSNLLNRNVDERFDAMRALQ 330 (345)
T ss_dssp HHHHHHSCSCTTTSCCHHHHHH
T ss_pred HHHHHHcCCChhHCCCHHHHhc
Confidence 9999999999999999999987
|
| >2a2a_A Death-associated protein kinase 2; autoinhibition, transferase; 1.47A {Homo sapiens} PDB: 2cke_A* 1wmk_A 1z9x_A 2a27_A 2x0g_A 2xuu_A* 2w4k_A* 2xzs_A | Back alignment and structure |
|---|
Probab=99.93 E-value=2.4e-26 Score=227.93 Aligned_cols=175 Identities=21% Similarity=0.241 Sum_probs=134.5
Q ss_pred cccceeeccCCCC------CCCCCCChhhHHHHHHHHHHHHHHHhhcCCCceeecCCCccceEecCCC----Cceecccc
Q 045315 241 DEISFWYESYNNP------TKKGLLCWGTRVRIIEGIAQGLLYLHQYSRLRVIHRDLKASNILLDKDM----NPKISDFG 310 (476)
Q Consensus 241 ~~~~l~~Ey~~~~------~~~~~L~~~~~~~i~~qIa~gL~yLH~~~~~~ivH~DLkp~NILld~~~----~~kL~DFG 310 (476)
+..++++||++.. ...+.+++.++..++.||+.||+|||+.+ |+||||||+||+++.++ .+||+|||
T Consensus 88 ~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~i~~qi~~aL~~lH~~~---ivH~dikp~NIl~~~~~~~~~~~kl~Dfg 164 (321)
T 2a2a_A 88 TDVVLILELVSGGELFDFLAQKESLSEEEATSFIKQILDGVNYLHTKK---IAHFDLKPENIMLLDKNIPIPHIKLIDFG 164 (321)
T ss_dssp SEEEEEECCCCSCBHHHHHHTCSCEEHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEESCTTSSSCCEEECCCT
T ss_pred CEEEEEEEcCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCChHHEEEecCCCCcCCEEEccCc
Confidence 4678899999733 23567999999999999999999999999 99999999999999887 79999999
Q ss_pred ceeecCCCcccccceeeeeccCCCChhhhccCCCCccceEEeehhhhhhhhhCCCCCCcCCCCchhhhhhhhhhhcCCCc
Q 045315 311 MARMFGGDELQSNTKRIVGTYGYMSPEYALRGLFSIKSDVFSFGVLLLETLSSKKNTHFYNTDSLTLLGHAWNLWNDGRT 390 (476)
Q Consensus 311 la~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~s~ksDVwSlGvvl~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~ 390 (476)
++........ .....|++.|+|||.+.+..++.++||||||+++|+|++|+.||...... ...... .....
T Consensus 165 ~~~~~~~~~~---~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~--~~~~~i----~~~~~ 235 (321)
T 2a2a_A 165 LAHEIEDGVE---FKNIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASPFLGDTKQ--ETLANI----TSVSY 235 (321)
T ss_dssp TCEECCTTCC---CCCCCSCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSCCSSCCSSHH--HHHHHH----HTTCC
T ss_pred cceecCcccc---ccccCCCCCccCcccccCCCCCCccccHHHHHHHHHHHHCCCCCCCCCHH--HHHHHH----Hhccc
Confidence 9987654321 22346899999999999999999999999999999999999998643311 111111 11100
Q ss_pred ccccCcccCCCCCHHHHHHHHHHHHHchhhcccCCCCHHHHHH
Q 045315 391 WELMDPISQNGASYPILKRYINVALLCVQEKAADRPAMSEVVS 433 (476)
Q Consensus 391 ~~~~d~~~~~~~~~~~~~~l~~li~~Cl~~dP~~RPt~~eVl~ 433 (476)
. .++... ......+.+++.+||+.||++|||+.|+++
T Consensus 236 -~-~~~~~~----~~~~~~~~~li~~~l~~dp~~Rps~~e~l~ 272 (321)
T 2a2a_A 236 -D-FDEEFF----SHTSELAKDFIRKLLVKETRKRLTIQEALR 272 (321)
T ss_dssp -C-CCHHHH----TTCCHHHHHHHHTTSCSSTTTSCCHHHHHH
T ss_pred -c-cChhhh----cccCHHHHHHHHHHcCCChhhCcCHHHHhc
Confidence 0 000000 112356889999999999999999999986
|
| >3e3p_A Protein kinase, putative glycogen synthase kinase; leishmaniasis, transferase; 2.00A {Leishmania major} | Back alignment and structure |
|---|
Probab=99.93 E-value=1.1e-26 Score=233.64 Aligned_cols=188 Identities=17% Similarity=0.171 Sum_probs=135.8
Q ss_pred cceeeccCCCC---------CCCCCCChhhHHHHHHHHHHHHHHHh--hcCCCceeecCCCccceEecC-CCCceecccc
Q 045315 243 ISFWYESYNNP---------TKKGLLCWGTRVRIIEGIAQGLLYLH--QYSRLRVIHRDLKASNILLDK-DMNPKISDFG 310 (476)
Q Consensus 243 ~~l~~Ey~~~~---------~~~~~L~~~~~~~i~~qIa~gL~yLH--~~~~~~ivH~DLkp~NILld~-~~~~kL~DFG 310 (476)
.+++|||++.. .....+++..+..++.||+.||.||| +.+ |+||||||+|||++. ++.+||+|||
T Consensus 101 ~~lv~e~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~~~---ivH~Dlkp~NIll~~~~~~~kl~Dfg 177 (360)
T 3e3p_A 101 LNVVMEYVPDTLHRCCRNYYRRQVAPPPILIKVFLFQLIRSIGCLHLPSVN---VCHRDIKPHNVLVNEADGTLKLCDFG 177 (360)
T ss_dssp EEEEEECCSCBHHHHHHHHHTTTCCCCHHHHHHHHHHHHHHHHHHTSTTTC---CBCSCCCGGGEEEETTTTEEEECCCT
T ss_pred EEEEeecccccHHHHHHHHhhcccCCCHHHHHHHHHHHHHHHHHHhCCCCC---eecCcCCHHHEEEeCCCCcEEEeeCC
Confidence 56889999832 35667999999999999999999999 888 999999999999996 8999999999
Q ss_pred ceeecCCCcccccceeeeeccCCCChhhhccC-CCCccceEEeehhhhhhhhhCCCCCCcCCCCchhhhhhhhhhhc---
Q 045315 311 MARMFGGDELQSNTKRIVGTYGYMSPEYALRG-LFSIKSDVFSFGVLLLETLSSKKNTHFYNTDSLTLLGHAWNLWN--- 386 (476)
Q Consensus 311 la~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~-~~s~ksDVwSlGvvl~elltG~~p~~~~~~~~~~~~~~~~~~~~--- 386 (476)
+++........ ....||..|+|||.+.+. .++.++|||||||++|||++|+.||....... ..........
T Consensus 178 ~a~~~~~~~~~---~~~~gt~~y~aPE~~~~~~~~~~~~Di~slG~il~ell~g~~pf~~~~~~~--~~~~~~~~~~~~~ 252 (360)
T 3e3p_A 178 SAKKLSPSEPN---VAYICSRYYRAPELIFGNQHYTTAVDIWSVGCIFAEMMLGEPIFRGDNSAG--QLHEIVRVLGCPS 252 (360)
T ss_dssp TCBCCCTTSCC---CSTTSCGGGCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHH--HHHHHHHHHCCCC
T ss_pred CceecCCCCCc---ccccCCcceeCHHHHcCCCCCCcHHHHHHHHHHHHHHHhCCCCcCCCChHH--HHHHHHHHcCCCC
Confidence 99876543322 224579999999998765 48999999999999999999999987543211 1111110000
Q ss_pred --------C-CCcccccCc------ccCCCCCHHHHHHHHHHHHHchhhcccCCCCHHHHHHH--Hhcc
Q 045315 387 --------D-GRTWELMDP------ISQNGASYPILKRYINVALLCVQEKAADRPAMSEVVSM--LSNE 438 (476)
Q Consensus 387 --------~-~~~~~~~d~------~~~~~~~~~~~~~l~~li~~Cl~~dP~~RPt~~eVl~~--L~~~ 438 (476)
. .......+. .............+.+++.+||+.||++|||+.|+++. +.+.
T Consensus 253 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~hp~f~~~ 321 (360)
T 3e3p_A 253 REVLRKLNPSHTDVDLYNSKGIPWSNVFSDHSLKDAKEAYDLLSALLQYLPEERMKPYEALCHPYFDEL 321 (360)
T ss_dssp HHHHHHHCTTCCCGGGGCCCCCCHHHHTTTCCCTTHHHHHHHHHHHTCSSGGGSCCHHHHTTSGGGGGG
T ss_pred HHHHHhcccchhhccccccccCCcccccchhhccccHHHHHHHHHHhccCccccCCHHHHhcCcccccc
Confidence 0 000000000 00011122245689999999999999999999999863 4443
|
| >2acx_A G protein-coupled receptor kinase 6; GRK, G transferase; HET: ANP; 2.60A {Homo sapiens} PDB: 3nyn_A* 3nyo_A* | Back alignment and structure |
|---|
Probab=99.93 E-value=3.3e-26 Score=243.28 Aligned_cols=173 Identities=24% Similarity=0.272 Sum_probs=135.6
Q ss_pred cccceeeccCCCC--------CCCCCCChhhHHHHHHHHHHHHHHHhhcCCCceeecCCCccceEecCCCCceeccccce
Q 045315 241 DEISFWYESYNNP--------TKKGLLCWGTRVRIIEGIAQGLLYLHQYSRLRVIHRDLKASNILLDKDMNPKISDFGMA 312 (476)
Q Consensus 241 ~~~~l~~Ey~~~~--------~~~~~L~~~~~~~i~~qIa~gL~yLH~~~~~~ivH~DLkp~NILld~~~~~kL~DFGla 312 (476)
+..+++|||++.+ .....+++.++..++.||+.||+|||+++ |+||||||+|||++.++.+||+|||++
T Consensus 257 ~~l~lVmEy~~gg~L~~~l~~~~~~~l~e~~~~~i~~qIl~aL~yLH~~g---IvHrDLKPeNILld~~g~vKL~DFGla 333 (576)
T 2acx_A 257 DALCLVLTLMNGGDLKFHIYHMGQAGFPEARAVFYAAEICCGLEDLHRER---IVYRDLKPENILLDDHGHIRISDLGLA 333 (576)
T ss_dssp SEEEEEECCCCSCBHHHHHHSSSSCCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEECTTSCEEECCCTTC
T ss_pred CEEEEEEEcCCCCcHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHHCC---EeccCCchheEEEeCCCCeEEEecccc
Confidence 5688999999832 22345999999999999999999999999 999999999999999999999999999
Q ss_pred eecCCCcccccceeeeeccCCCChhhhccCCCCccceEEeehhhhhhhhhCCCCCCcCCCCc--hhhhhhhhhhhcCCCc
Q 045315 313 RMFGGDELQSNTKRIVGTYGYMSPEYALRGLFSIKSDVFSFGVLLLETLSSKKNTHFYNTDS--LTLLGHAWNLWNDGRT 390 (476)
Q Consensus 313 ~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~s~ksDVwSlGvvl~elltG~~p~~~~~~~~--~~~~~~~~~~~~~~~~ 390 (476)
+....... .....||+.|+|||++.+..++.++|||||||++|||++|+.||....... ..+.. ......
T Consensus 334 ~~~~~~~~---~~~~~GT~~Y~APEvl~~~~~~~~~DiwSLGvilyeLltG~~PF~~~~~~~~~~~i~~----~i~~~~- 405 (576)
T 2acx_A 334 VHVPEGQT---IKGRVGTVGYMAPEVVKNERYTFSPDWWALGCLLYEMIAGQSPFQQRKKKIKREEVER----LVKEVP- 405 (576)
T ss_dssp EECCTTCC---EECCCSCGGGCCHHHHTTCEESSHHHHHHHHHHHHHHHHSSCSSSCSSSCCCHHHHHH----HHHHCC-
T ss_pred eecccCcc---ccccCCCccccCHHHHcCCCCCccchHHHHHHHHHHHHhCCCCCcccccchhHHHHHH----Hhhccc-
Confidence 87654321 223579999999999999899999999999999999999999997644211 11111 111110
Q ss_pred ccccCcccCCCCCHHHHHHHHHHHHHchhhcccCCC-----CHHHHHH
Q 045315 391 WELMDPISQNGASYPILKRYINVALLCVQEKAADRP-----AMSEVVS 433 (476)
Q Consensus 391 ~~~~d~~~~~~~~~~~~~~l~~li~~Cl~~dP~~RP-----t~~eVl~ 433 (476)
...+......+.+++.+||+.||++|| +++||++
T Consensus 406 ---------~~~p~~~s~~~~dLI~~lL~~dP~~R~g~~~~sa~eil~ 444 (576)
T 2acx_A 406 ---------EEYSERFSPQARSLCSQLLCKDPAERLGCRGGSAREVKE 444 (576)
T ss_dssp ---------CCCCTTSCHHHHHHHHHHTCSSGGGSTTCSSSHHHHHHT
T ss_pred ---------ccCCccCCHHHHHHHHHhccCCHHHcCCCCCCCHHHHHh
Confidence 011122345788999999999999999 7888864
|
| >3fhr_A MAP kinase-activated protein kinase 3; kinase-inhibitor complex, ATP-binding, cytoplasm, nucleotide-binding, nucleus, phosphoprotein, polymorphism; HET: P4O; 1.90A {Homo sapiens} PDB: 3fxw_A* 3r1n_A* 3she_A* 2oza_A 3fyk_X* 3fyj_X* 2p3g_X* 3ka0_A* 3fpm_A* 2pzy_A* 3a2c_A* 3kc3_A* 3gok_A* 2jbo_A* 2jbp_A* 3r2y_A* 3r30_A* 3r2b_A* | Back alignment and structure |
|---|
Probab=99.93 E-value=1.1e-26 Score=232.08 Aligned_cols=182 Identities=16% Similarity=0.199 Sum_probs=116.0
Q ss_pred ccceeeccCCC--------CCCCCCCChhhHHHHHHHHHHHHHHHhhcCCCceeecCCCccceEecC---CCCceecccc
Q 045315 242 EISFWYESYNN--------PTKKGLLCWGTRVRIIEGIAQGLLYLHQYSRLRVIHRDLKASNILLDK---DMNPKISDFG 310 (476)
Q Consensus 242 ~~~l~~Ey~~~--------~~~~~~L~~~~~~~i~~qIa~gL~yLH~~~~~~ivH~DLkp~NILld~---~~~~kL~DFG 310 (476)
..+++|||++. ......+++.++..++.||+.||+|||+++ |+||||||+||+++. ++.+||+|||
T Consensus 100 ~~~lv~e~~~gg~L~~~l~~~~~~~l~~~~~~~i~~ql~~~l~~LH~~~---ivH~dlkp~NIll~~~~~~~~~kl~Dfg 176 (336)
T 3fhr_A 100 CLLIIMECMEGGELFSRIQERGDQAFTEREAAEIMRDIGTAIQFLHSHN---IAHRDVKPENLLYTSKEKDAVLKLTDFG 176 (336)
T ss_dssp EEEEEEECCTTEEHHHHHHTC-CCCCBHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEESCSSTTCCEEECCCT
T ss_pred eEEEEEeccCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCCHHHEEEEecCCCceEEEeccc
Confidence 46789999973 223457999999999999999999999999 999999999999976 4559999999
Q ss_pred ceeecCCCcccccceeeeeccCCCChhhhccCCCCccceEEeehhhhhhhhhCCCCCCcCCCCchhhhhhhhhhhcCCCc
Q 045315 311 MARMFGGDELQSNTKRIVGTYGYMSPEYALRGLFSIKSDVFSFGVLLLETLSSKKNTHFYNTDSLTLLGHAWNLWNDGRT 390 (476)
Q Consensus 311 la~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~s~ksDVwSlGvvl~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~ 390 (476)
+++...... .....+++.|+|||.+.+..++.++|||||||++|+|++|+.||........... .......+..
T Consensus 177 ~~~~~~~~~----~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~--~~~~~~~~~~ 250 (336)
T 3fhr_A 177 FAKETTQNA----LQTPCYTPYYVAPEVLGPEKYDKSCDMWSLGVIMYILLCGFPPFYSNTGQAISPG--MKRRIRLGQY 250 (336)
T ss_dssp TCEEC--------------------------CHHHHHHHHHHHHHHHHHHHHSSCCC-----------------------
T ss_pred cceeccccc----cccCCCCcCccChhhhCCCCCCchhhHHHHHHHHHHHHHCCCCCCCccchhhhhh--HHHhhhcccc
Confidence 998765322 2235689999999999888899999999999999999999999865432211000 0000000000
Q ss_pred ccccCcccCCCCCHHHHHHHHHHHHHchhhcccCCCCHHHHHH--HHhcc
Q 045315 391 WELMDPISQNGASYPILKRYINVALLCVQEKAADRPAMSEVVS--MLSNE 438 (476)
Q Consensus 391 ~~~~d~~~~~~~~~~~~~~l~~li~~Cl~~dP~~RPt~~eVl~--~L~~~ 438 (476)
.............+.+++.+||+.||++|||++|+++ .+.+.
T Consensus 251 ------~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~hp~~~~~ 294 (336)
T 3fhr_A 251 ------GFPNPEWSEVSEDAKQLIRLLLKTDPTERLTITQFMNHPWINQS 294 (336)
T ss_dssp ------CCCTTTSTTCCHHHHHHHHHHSCSSGGGSCCHHHHHHSHHHHTG
T ss_pred ------ccCchhhccCCHHHHHHHHHHCCCChhHCcCHHHHhcCcccccc
Confidence 0001111223457889999999999999999999998 55554
|
| >3cek_A Dual specificity protein kinase TTK; HMPS1, PYT, ESK, phosphotyros picked threonine kinase, SGC, structural genomics consortiu binding; HET: 7PE; 2.30A {Homo sapiens} PDB: 3gfw_A* 3h9f_A* 2x9e_A* 3hmp_A* 3hmn_A* 3hmo_A* | Back alignment and structure |
|---|
Probab=99.93 E-value=6.3e-27 Score=230.98 Aligned_cols=177 Identities=24% Similarity=0.239 Sum_probs=124.7
Q ss_pred cccceeeccCCC-----CCCCCCCChhhHHHHHHHHHHHHHHHhhcCCCceeecCCCccceEecCCCCceeccccceeec
Q 045315 241 DEISFWYESYNN-----PTKKGLLCWGTRVRIIEGIAQGLLYLHQYSRLRVIHRDLKASNILLDKDMNPKISDFGMARMF 315 (476)
Q Consensus 241 ~~~~l~~Ey~~~-----~~~~~~L~~~~~~~i~~qIa~gL~yLH~~~~~~ivH~DLkp~NILld~~~~~kL~DFGla~~~ 315 (476)
+..+++|||... ....+.+++.++..++.||++||+|||+++ |+||||||+||++++ +.+||+|||++...
T Consensus 101 ~~~~lv~e~~~~~L~~~l~~~~~~~~~~~~~i~~qi~~aL~~LH~~~---ivH~dlkp~NIl~~~-~~~kL~Dfg~~~~~ 176 (313)
T 3cek_A 101 QYIYMVMECGNIDLNSWLKKKKSIDPWERKSYWKNMLEAVHTIHQHG---IVHSDLKPANFLIVD-GMLKLIDFGIANQM 176 (313)
T ss_dssp SEEEEEECCCSEEHHHHHHHCSSCCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCCGGGEEEET-TEEEECCCSSSCC-
T ss_pred CEEEEEEecCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCC---ceecCCCcccEEEEC-CeEEEeeccccccc
Confidence 346778886541 113457999999999999999999999999 999999999999974 78999999999876
Q ss_pred CCCcccccceeeeeccCCCChhhhcc-----------CCCCccceEEeehhhhhhhhhCCCCCCcCCCCchhhhhhhhhh
Q 045315 316 GGDELQSNTKRIVGTYGYMSPEYALR-----------GLFSIKSDVFSFGVLLLETLSSKKNTHFYNTDSLTLLGHAWNL 384 (476)
Q Consensus 316 ~~~~~~~~~~~~~gt~~y~aPE~l~~-----------~~~s~ksDVwSlGvvl~elltG~~p~~~~~~~~~~~~~~~~~~ 384 (476)
.............|+..|+|||.+.+ ..++.++||||||+++|||++|+.||........... ..
T Consensus 177 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~~~~~~~~----~~ 252 (313)
T 3cek_A 177 QPDTTSVVKDSQVGTVNYMPPEAIKDMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGKTPFQQIINQISKLH----AI 252 (313)
T ss_dssp -------------CCGGGCCHHHHTTCC----------CCCHHHHHHHHHHHHHHHHHSSCTTTTCCSHHHHHH----HH
T ss_pred cCccccccccCCCCCCCcCCHHHHhhcccccccccccccCCchHHHHHHHHHHHHHHhCCCchhhHHHHHHHHH----HH
Confidence 54433222334568999999999875 4688999999999999999999999864322111111 11
Q ss_pred hcCCCcccccCcccCCCCCHHHHHHHHHHHHHchhhcccCCCCHHHHHHH
Q 045315 385 WNDGRTWELMDPISQNGASYPILKRYINVALLCVQEKAADRPAMSEVVSM 434 (476)
Q Consensus 385 ~~~~~~~~~~d~~~~~~~~~~~~~~l~~li~~Cl~~dP~~RPt~~eVl~~ 434 (476)
...... ...+......+.+++.+||+.||++||++.|+++.
T Consensus 253 ~~~~~~---------~~~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~h 293 (313)
T 3cek_A 253 IDPNHE---------IEFPDIPEKDLQDVLKCCLKRDPKQRISIPELLAH 293 (313)
T ss_dssp HCTTSC---------CCCCCCSCHHHHHHHHHHTCSSTTTSCCHHHHHTS
T ss_pred Hhcccc---------cCCcccchHHHHHHHHHHccCCcccCcCHHHHhcC
Confidence 111111 11111113568899999999999999999999863
|
| >1blx_A Cyclin-dependent kinase 6; inhibitor protein, cyclin-dependent kinase, cell cycle control, alpha/beta, complex (inhibitor protein/kinase); 1.90A {Homo sapiens} SCOP: d.144.1.7 PDB: 1bi7_A 1bi8_A 1g3n_A 2f2c_B* 1jow_B* 2euf_B* 1xo2_B* 3nup_A* 3nux_A* 2w9z_B 2w99_B 2w96_B 2w9f_B | Back alignment and structure |
|---|
Probab=99.93 E-value=1.5e-26 Score=229.25 Aligned_cols=185 Identities=22% Similarity=0.264 Sum_probs=134.7
Q ss_pred cccceeeccCCC-------CCCCCCCChhhHHHHHHHHHHHHHHHhhcCCCceeecCCCccceEecCCCCceecccccee
Q 045315 241 DEISFWYESYNN-------PTKKGLLCWGTRVRIIEGIAQGLLYLHQYSRLRVIHRDLKASNILLDKDMNPKISDFGMAR 313 (476)
Q Consensus 241 ~~~~l~~Ey~~~-------~~~~~~L~~~~~~~i~~qIa~gL~yLH~~~~~~ivH~DLkp~NILld~~~~~kL~DFGla~ 313 (476)
+..++++||++. ......+++.++..++.||+.||+|||+++ |+||||||+||+++.++.+||+|||+++
T Consensus 92 ~~~~lv~e~~~~~L~~~l~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~g---i~H~dlkp~Nili~~~~~~kl~Dfg~~~ 168 (326)
T 1blx_A 92 TKLTLVFEHVDQDLTTYLDKVPEPGVPTETIKDMMFQLLRGLDFLHSHR---VVHRDLKPQNILVTSSGQIKLADFGLAR 168 (326)
T ss_dssp EEEEEEEECCSCBHHHHHHHSCTTCSCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCCGGGEEECTTCCEEECSCCSCC
T ss_pred ceEEEEEecCCCCHHHHHHhcccCCCCHHHHHHHHHHHHHHHHHHHHCC---ceeccCCHHHeEEcCCCCEEEecCcccc
Confidence 357788999872 123445999999999999999999999999 9999999999999999999999999998
Q ss_pred ecCCCcccccceeeeeccCCCChhhhccCCCCccceEEeehhhhhhhhhCCCCCCcCCCCchhhhhhhhhhhcCC---Cc
Q 045315 314 MFGGDELQSNTKRIVGTYGYMSPEYALRGLFSIKSDVFSFGVLLLETLSSKKNTHFYNTDSLTLLGHAWNLWNDG---RT 390 (476)
Q Consensus 314 ~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~s~ksDVwSlGvvl~elltG~~p~~~~~~~~~~~~~~~~~~~~~~---~~ 390 (476)
...... ......|+..|+|||.+.+..++.++|||||||++|||++|+.||...... ............. ..
T Consensus 169 ~~~~~~---~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~--~~~~~i~~~~~~~~~~~~ 243 (326)
T 1blx_A 169 IYSFQM---ALTSVVVTLWYRAPEVLLQSSYATPVDLWSVGCIFAEMFRRKPLFRGSSDV--DQLGKILDVIGLPGEEDW 243 (326)
T ss_dssp CCCGGG---GGCCCCCCCTTCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHH--HHHHHHHHHHCCCCGGGS
T ss_pred cccCCC---CccccccccceeCHHHHhcCCCCcchhHHHHHHHHHHHHcCCCCCCCCCHH--HHHHHHHHHcCCCCcccC
Confidence 654322 223356899999999999999999999999999999999999998754311 1111111000000 00
Q ss_pred c-------cccCc---ccCCCCCHHHHHHHHHHHHHchhhcccCCCCHHHHHH
Q 045315 391 W-------ELMDP---ISQNGASYPILKRYINVALLCVQEKAADRPAMSEVVS 433 (476)
Q Consensus 391 ~-------~~~d~---~~~~~~~~~~~~~l~~li~~Cl~~dP~~RPt~~eVl~ 433 (476)
. ..... .............+.+++.+||+.||++||++.|+++
T Consensus 244 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~ 296 (326)
T 1blx_A 244 PRDVALPRQAFHSKSAQPIEKFVTDIDELGKDLLLKCLTFNPAKRISAYSALS 296 (326)
T ss_dssp CTTCSSCGGGSCCCCCCCGGGTCCSCCHHHHHHHHHHSCSSTTTSCCHHHHHT
T ss_pred ccccccchhhhcccCcchhhhccccCCHHHHHHHHHHcCCCcccCCCHHHHhc
Confidence 0 00000 0000111223457889999999999999999999984
|
| >2xrw_A Mitogen-activated protein kinase 8; transcription, MAPK signaling pathways, linear binding motif; HET: ANP; 1.33A {Homo sapiens} PDB: 1ukh_A 1uki_A* 2xs0_A* 3elj_A* 2h96_A* 2gmx_A* 2g01_A* 2no3_A* 3o2m_A* 3o17_A* 3pze_A* 3g9l_X* 2p33_A* 3cgf_A* 3cgo_A* 3g90_X* 2ok1_A* 3g9n_A* 1pmn_A* 1pmq_A* ... | Back alignment and structure |
|---|
Probab=99.93 E-value=1.6e-26 Score=234.22 Aligned_cols=184 Identities=20% Similarity=0.175 Sum_probs=125.9
Q ss_pred ccceeeccCCCCC---CCCCCChhhHHHHHHHHHHHHHHHhhcCCCceeecCCCccceEecCCCCceeccccceeecCCC
Q 045315 242 EISFWYESYNNPT---KKGLLCWGTRVRIIEGIAQGLLYLHQYSRLRVIHRDLKASNILLDKDMNPKISDFGMARMFGGD 318 (476)
Q Consensus 242 ~~~l~~Ey~~~~~---~~~~L~~~~~~~i~~qIa~gL~yLH~~~~~~ivH~DLkp~NILld~~~~~kL~DFGla~~~~~~ 318 (476)
..+++|||++... ....+++.++..++.||+.||+|||+++ |+||||||+|||++.++.+||+|||+++.....
T Consensus 104 ~~~lv~e~~~~~l~~~~~~~~~~~~~~~i~~qi~~al~~lH~~~---ivH~Dlkp~NIl~~~~~~~kl~Dfg~a~~~~~~ 180 (371)
T 2xrw_A 104 DVYIVMELMDANLCQVIQMELDHERMSYLLYQMLCGIKHLHSAG---IIHRDLKPSNIVVKSDCTLKILDFGLARTAGTS 180 (371)
T ss_dssp EEEEEEECCSEEHHHHHHSCCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEECTTSCEEECCCCC-------
T ss_pred ceEEEEEcCCCCHHHHHhhccCHHHHHHHHHHHHHHHHHHHHCC---eecccCCHHHEEEcCCCCEEEEEeecccccccc
Confidence 5688999998210 1245899999999999999999999999 999999999999999999999999999876432
Q ss_pred cccccceeeeeccCCCChhhhccCCCCccceEEeehhhhhhhhhCCCCCCcCCCCchhhhhhhhhhh-------------
Q 045315 319 ELQSNTKRIVGTYGYMSPEYALRGLFSIKSDVFSFGVLLLETLSSKKNTHFYNTDSLTLLGHAWNLW------------- 385 (476)
Q Consensus 319 ~~~~~~~~~~gt~~y~aPE~l~~~~~s~ksDVwSlGvvl~elltG~~p~~~~~~~~~~~~~~~~~~~------------- 385 (476)
. ......||..|+|||.+.+..++.++|||||||++|||++|+.||...+... .........
T Consensus 181 ~---~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~--~~~~i~~~~~~~~~~~~~~~~~ 255 (371)
T 2xrw_A 181 F---MMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMIKGGVLFPGTDHID--QWNKVIEQLGTPCPEFMKKLQP 255 (371)
T ss_dssp ------------CTTCCHHHHTTCCCCTTHHHHHHHHHHHHHHHSSCSSCCSSHHH--HHHHHHC-CCCCCHHHHTTSCH
T ss_pred c---ccCCceecCCccCHHHhcCCCCCchHhHHHHHHHHHHHHhCCCCCCCCCHHH--HHHHHHHHhCCCCHHHHHHhhh
Confidence 2 1223578999999999999999999999999999999999999987543111 000000000
Q ss_pred ------cCC------CcccccCcccCCCC---CHHHHHHHHHHHHHchhhcccCCCCHHHHHH
Q 045315 386 ------NDG------RTWELMDPISQNGA---SYPILKRYINVALLCVQEKAADRPAMSEVVS 433 (476)
Q Consensus 386 ------~~~------~~~~~~d~~~~~~~---~~~~~~~l~~li~~Cl~~dP~~RPt~~eVl~ 433 (476)
... .............. .......+.+++.+||+.||++|||++|+++
T Consensus 256 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~mL~~dP~~R~t~~e~l~ 318 (371)
T 2xrw_A 256 TVRTYVENRPKYAGYSFEKLFPDVLFPADSEHNKLKASQARDLLSKMLVIDASKRISVDEALQ 318 (371)
T ss_dssp HHHHHHHSSCCCCCCCHHHHSCGGGSCCSSHHHHHHHHHHHHHHHHHSCSSGGGSCCHHHHHH
T ss_pred HHHHHHhhCccccccchhhhcccccCcccccccccccHHHHHHHHHHCcCChhhCCCHHHHhC
Confidence 000 00000000000000 1123567899999999999999999999987
|
| >2fst_X Mitogen-activated protein kinase 14; active mutants, lipids, MAP kinase insertion, autophosphorylation, transferase; HET: BOG; 1.45A {Homo sapiens} PDB: 2fso_X* 2fsl_X* 2fsm_X* 2npq_A* 2bal_A* 2baj_A* 2bak_A* 2baq_A* 2qd9_A* 1ian_A* 2rg5_A* 2rg6_A* 3bv2_A* 3bv3_A* 3bx5_A* 3c5u_A* 3cg2_A* 3l8x_A* 3mvl_A* 3mvm_A* ... | Back alignment and structure |
|---|
Probab=99.93 E-value=2.5e-26 Score=232.57 Aligned_cols=184 Identities=21% Similarity=0.260 Sum_probs=122.9
Q ss_pred cccceeeccCC----CCCCCCCCChhhHHHHHHHHHHHHHHHhhcCCCceeecCCCccceEecCCCCceeccccceeecC
Q 045315 241 DEISFWYESYN----NPTKKGLLCWGTRVRIIEGIAQGLLYLHQYSRLRVIHRDLKASNILLDKDMNPKISDFGMARMFG 316 (476)
Q Consensus 241 ~~~~l~~Ey~~----~~~~~~~L~~~~~~~i~~qIa~gL~yLH~~~~~~ivH~DLkp~NILld~~~~~kL~DFGla~~~~ 316 (476)
..+++++||+. +..+...+++.++..++.||+.||+|||+.+ |+||||||+|||++.++.+||+|||+++...
T Consensus 107 ~~~~lv~e~~~~~L~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~g---ivH~Dlkp~NIll~~~~~~kL~DFG~a~~~~ 183 (367)
T 2fst_X 107 NDVYLVTHLMGADLNNIVKCQKLTDDHVQFLIYQILRGLKYIHSAD---IIHRDLKPSNLAVNEDCELKILDFGLARHTA 183 (367)
T ss_dssp CCCEEEEECCCEECC-----CCCCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCCGGGEEECTTCCEEECC--------
T ss_pred CeEEEEecccCCCHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCC---eeeCCCCHhhEEECCCCCEEEeecccccccc
Confidence 35678888886 1223467999999999999999999999999 9999999999999999999999999998654
Q ss_pred CCcccccceeeeeccCCCChhhhcc-CCCCccceEEeehhhhhhhhhCCCCCCcCCCCchhhhhhhhhhhcCCC------
Q 045315 317 GDELQSNTKRIVGTYGYMSPEYALR-GLFSIKSDVFSFGVLLLETLSSKKNTHFYNTDSLTLLGHAWNLWNDGR------ 389 (476)
Q Consensus 317 ~~~~~~~~~~~~gt~~y~aPE~l~~-~~~s~ksDVwSlGvvl~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~------ 389 (476)
.. .....||..|+|||.+.+ ..++.++|||||||++|||++|+.||...+.. ..............
T Consensus 184 ~~-----~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~--~~l~~i~~~~g~p~~~~~~~ 256 (367)
T 2fst_X 184 DE-----MTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHI--DQLKLILRLVGTPGAELLKK 256 (367)
T ss_dssp ------------CCCTTCCHHHHTTCCSCCTTHHHHHHHHHHHHHHHSSCSCCCSSHH--HHHHHHHHHHCSCCHHHHTT
T ss_pred cc-----CCCcCcCcCccChHHHcCCcCCCchhhHHHHHHHHHHHHhCCCCCCCCCHH--HHHHHHHHHhCCCCHHHHHH
Confidence 32 223578999999999886 67899999999999999999999999754311 11111111000000
Q ss_pred -----cccccCccc-CCCCCH-----HHHHHHHHHHHHchhhcccCCCCHHHHHHH
Q 045315 390 -----TWELMDPIS-QNGASY-----PILKRYINVALLCVQEKAADRPAMSEVVSM 434 (476)
Q Consensus 390 -----~~~~~d~~~-~~~~~~-----~~~~~l~~li~~Cl~~dP~~RPt~~eVl~~ 434 (476)
....+.... ...... .....+.+++.+||+.||++|||+.|+++.
T Consensus 257 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dLl~~mL~~dP~~R~t~~e~L~h 312 (367)
T 2fst_X 257 ISSESARNYIQSLTQMPKMNFANVFIGANPLAVDLLEKMLVLDSDKRITAAQALAH 312 (367)
T ss_dssp CCCHHHHHHHHTSCCCCCCCHHHHTTTCCHHHHHHHHHHSCSSGGGSCCHHHHHTS
T ss_pred hhhHHHHHHHhccCCCCCCCHHHHCCCCCHHHHHHHHHhCCCCcccCcCHHHHhcC
Confidence 000000000 000011 123568899999999999999999999863
|
| >2ac3_A MAP kinase-interacting serine/threonine kinase 2; DFD motif, transferase; 2.10A {Homo sapiens} PDB: 2hw7_A* 2ac5_A* 2hw6_A | Back alignment and structure |
|---|
Probab=99.93 E-value=3.3e-27 Score=233.01 Aligned_cols=184 Identities=21% Similarity=0.243 Sum_probs=129.0
Q ss_pred cccceeeccCCCCC------CCCCCChhhHHHHHHHHHHHHHHHhhcCCCceeecCCCccceEecCCCC---ceeccccc
Q 045315 241 DEISFWYESYNNPT------KKGLLCWGTRVRIIEGIAQGLLYLHQYSRLRVIHRDLKASNILLDKDMN---PKISDFGM 311 (476)
Q Consensus 241 ~~~~l~~Ey~~~~~------~~~~L~~~~~~~i~~qIa~gL~yLH~~~~~~ivH~DLkp~NILld~~~~---~kL~DFGl 311 (476)
+..+++|||++... +.+.+++.++..++.||+.||+|||+++ |+||||||+||+++.++. +||+|||+
T Consensus 84 ~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~i~~qi~~~l~~lH~~~---ivH~dlkp~Nil~~~~~~~~~~kl~Dfg~ 160 (316)
T 2ac3_A 84 DRFYLVFEKMRGGSILSHIHKRRHFNELEASVVVQDVASALDFLHNKG---IAHRDLKPENILCEHPNQVSPVKICDFDL 160 (316)
T ss_dssp TEEEEEEECCTTCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCCGGGEEESCSSSSCSEEECCTTC
T ss_pred CEEEEEEEcCCCCcHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHhCC---ceeCCCCHHHEEEccCCCcCceEEEEccC
Confidence 46889999998432 2457999999999999999999999999 999999999999998766 89999999
Q ss_pred eeecCCCcc-----cccceeeeeccCCCChhhhcc-----CCCCccceEEeehhhhhhhhhCCCCCCcCCCCchhh----
Q 045315 312 ARMFGGDEL-----QSNTKRIVGTYGYMSPEYALR-----GLFSIKSDVFSFGVLLLETLSSKKNTHFYNTDSLTL---- 377 (476)
Q Consensus 312 a~~~~~~~~-----~~~~~~~~gt~~y~aPE~l~~-----~~~s~ksDVwSlGvvl~elltG~~p~~~~~~~~~~~---- 377 (476)
+........ ........||..|+|||.+.+ ..++.++|||||||++|||++|+.||..........
T Consensus 161 ~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~~~~ 240 (316)
T 2ac3_A 161 GSGIKLNGDCSPISTPELLTPCGSAEYMAPEVVEAFSEEASIYDKRCDLWSLGVILYILLSGYPPFVGRCGSDCGWDRGE 240 (316)
T ss_dssp CC-------------------CCSGGGCCHHHHHHTSHHHHHHTTTHHHHHHHHHHHHHHHSSCSCCCCCCSCSCC----
T ss_pred ccccccCCccccccccccccccCCcCccChHHhhcccccccCCCcccccHhHHHHHHHHHHCCCCCcccccccccccccc
Confidence 976542211 111223458999999999875 557899999999999999999999997543221000
Q ss_pred -----hhhhhhhhcCCCcccccCcccCCCCCHHHHHHHHHHHHHchhhcccCCCCHHHHHH
Q 045315 378 -----LGHAWNLWNDGRTWELMDPISQNGASYPILKRYINVALLCVQEKAADRPAMSEVVS 433 (476)
Q Consensus 378 -----~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~l~~li~~Cl~~dP~~RPt~~eVl~ 433 (476)
..........+.. ...... .......+.+++.+||+.||++|||++|+++
T Consensus 241 ~~~~~~~~~~~~i~~~~~-~~~~~~-----~~~~~~~~~~li~~~L~~dP~~Rps~~e~l~ 295 (316)
T 2ac3_A 241 ACPACQNMLFESIQEGKY-EFPDKD-----WAHISCAAKDLISKLLVRDAKQRLSAAQVLQ 295 (316)
T ss_dssp CCHHHHHHHHHHHHHCCC-CCCHHH-----HTTSCHHHHHHHHHHSCSSTTTSCCHHHHHH
T ss_pred cchhHHHHHHHHHhccCc-ccCchh-----cccCCHHHHHHHHHHhhCChhhCCCHHHHhc
Confidence 0000011111110 000000 0012356889999999999999999999987
|
| >3a62_A Ribosomal protein S6 kinase beta-1; kinase domain, inactive, active, ribosomal S6 kinase, activation, alternative initiation, ATP-binding; HET: TPO STU; 2.35A {Homo sapiens} PDB: 3a61_A* 3a60_A* | Back alignment and structure |
|---|
Probab=99.93 E-value=8.1e-27 Score=232.25 Aligned_cols=172 Identities=23% Similarity=0.289 Sum_probs=129.6
Q ss_pred cccceeeccCCCCC------CCCCCChhhHHHHHHHHHHHHHHHhhcCCCceeecCCCccceEecCCCCceeccccceee
Q 045315 241 DEISFWYESYNNPT------KKGLLCWGTRVRIIEGIAQGLLYLHQYSRLRVIHRDLKASNILLDKDMNPKISDFGMARM 314 (476)
Q Consensus 241 ~~~~l~~Ey~~~~~------~~~~L~~~~~~~i~~qIa~gL~yLH~~~~~~ivH~DLkp~NILld~~~~~kL~DFGla~~ 314 (476)
+..+++|||++... +.+.+++.++..++.||+.||+|||+++ |+||||||+|||++.++.+||+|||+++.
T Consensus 94 ~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~qi~~al~~lH~~~---ivH~Dlkp~Nill~~~~~~kl~Dfg~~~~ 170 (327)
T 3a62_A 94 GKLYLILEYLSGGELFMQLEREGIFMEDTACFYLAEISMALGHLHQKG---IIYRDLKPENIMLNHQGHVKLTDFGLCKE 170 (327)
T ss_dssp SCEEEEEECCTTEEHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCCTTTEEECTTSCEEECCCSCC--
T ss_pred CEEEEEEeCCCCCcHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCC---EEcccCCHHHeEECCCCcEEEEeCCcccc
Confidence 46789999997321 2457899999999999999999999999 99999999999999999999999999976
Q ss_pred cCCCcccccceeeeeccCCCChhhhccCCCCccceEEeehhhhhhhhhCCCCCCcCCCCchhhhhhhhhhhcCCCccccc
Q 045315 315 FGGDELQSNTKRIVGTYGYMSPEYALRGLFSIKSDVFSFGVLLLETLSSKKNTHFYNTDSLTLLGHAWNLWNDGRTWELM 394 (476)
Q Consensus 315 ~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~s~ksDVwSlGvvl~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 394 (476)
...... ......||+.|+|||.+.+..++.++|||||||++|||++|+.||..... ....... .. ...
T Consensus 171 ~~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~--~~~~~~i---~~-~~~---- 238 (327)
T 3a62_A 171 SIHDGT--VTHTFCGTIEYMAPEILMRSGHNRAVDWWSLGALMYDMLTGAPPFTGENR--KKTIDKI---LK-CKL---- 238 (327)
T ss_dssp ----------CTTSSCCTTSCHHHHTTSCCCTHHHHHHHHHHHHHHHHSSCSCCCSSH--HHHHHHH---HH-TCC----
T ss_pred cccCCc--cccccCCCcCccCHhhCcCCCCCCcccchhHHHHHHHHHHCCCCCCCCCH--HHHHHHH---Hh-CCC----
Confidence 432221 12234689999999999998999999999999999999999999865431 1111111 11 100
Q ss_pred CcccCCCCCHHHHHHHHHHHHHchhhcccCCC-----CHHHHHH
Q 045315 395 DPISQNGASYPILKRYINVALLCVQEKAADRP-----AMSEVVS 433 (476)
Q Consensus 395 d~~~~~~~~~~~~~~l~~li~~Cl~~dP~~RP-----t~~eVl~ 433 (476)
..+......+.+++.+||+.||++|| ++.|+++
T Consensus 239 ------~~p~~~~~~~~~li~~~L~~dp~~R~~~~~~~~~e~l~ 276 (327)
T 3a62_A 239 ------NLPPYLTQEARDLLKKLLKRNAASRLGAGPGDAGEVQA 276 (327)
T ss_dssp ------CCCTTSCHHHHHHHHHHSCSCGGGSTTSSTTTHHHHHH
T ss_pred ------CCCCCCCHHHHHHHHHHHhcCHhhccCCCCCCHHHHHc
Confidence 01112345788999999999999999 7778765
|
| >2clq_A Mitogen-activated protein kinase kinase kinase 5; transferase, metal-binding, apoptosis; HET: STU; 2.3A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.93 E-value=1.8e-26 Score=225.14 Aligned_cols=175 Identities=22% Similarity=0.336 Sum_probs=130.4
Q ss_pred cccceeeccCCC---------CCCCCCCChhhHHHHHHHHHHHHHHHhhcCCCceeecCCCccceEecC-CCCceecccc
Q 045315 241 DEISFWYESYNN---------PTKKGLLCWGTRVRIIEGIAQGLLYLHQYSRLRVIHRDLKASNILLDK-DMNPKISDFG 310 (476)
Q Consensus 241 ~~~~l~~Ey~~~---------~~~~~~L~~~~~~~i~~qIa~gL~yLH~~~~~~ivH~DLkp~NILld~-~~~~kL~DFG 310 (476)
+..++++||++. ......+++..+..++.||+.||+|||+++ ++|+||||+||+++. ++.+||+|||
T Consensus 92 ~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~---i~H~dl~p~Nil~~~~~~~~kl~Dfg 168 (295)
T 2clq_A 92 GFIKIFMEQVPGGSLSALLRSKWGPLKDNEQTIGFYTKQILEGLKYLHDNQ---IVHRDIKGDNVLINTYSGVLKISDFG 168 (295)
T ss_dssp TEEEEEEECCSEEEHHHHHHHTTCCCTTCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEEETTTCCEEECCTT
T ss_pred CcEEEEEEeCCCCCHHHHHHhhccCCCccHHHHHHHHHHHHHHHHHHHhCC---EEccCCChhhEEEECCCCCEEEeecc
Confidence 457788999872 122345778899999999999999999999 999999999999987 8999999999
Q ss_pred ceeecCCCcccccceeeeeccCCCChhhhccCC--CCccceEEeehhhhhhhhhCCCCCCcCCCCchhhhhhhhhhhcCC
Q 045315 311 MARMFGGDELQSNTKRIVGTYGYMSPEYALRGL--FSIKSDVFSFGVLLLETLSSKKNTHFYNTDSLTLLGHAWNLWNDG 388 (476)
Q Consensus 311 la~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~--~s~ksDVwSlGvvl~elltG~~p~~~~~~~~~~~~~~~~~~~~~~ 388 (476)
++........ ......|+..|+|||.+.+.. ++.++||||||+++|||++|+.||.............. .. .
T Consensus 169 ~~~~~~~~~~--~~~~~~~~~~y~aPE~~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~--~~--~ 242 (295)
T 2clq_A 169 TSKRLAGINP--CTETFTGTLQYMAPEIIDKGPRGYGKAADIWSLGCTIIEMATGKPPFYELGEPQAAMFKVG--MF--K 242 (295)
T ss_dssp TCEESCC-------CCCCCCGGGCCHHHHHHGGGGCSHHHHHHHHHHHHHHHHHTSCTTGGGSSHHHHHHHHH--HH--C
T ss_pred cccccCCCCC--cccccCCCccccChhhhcCCCCCCCcHHHHHHHHHHHHHHHHCCCCccCCCchhHHHHhhc--cc--c
Confidence 9987654321 122356899999999997654 78999999999999999999999864332211111100 00 0
Q ss_pred CcccccCcccCCCCCHHHHHHHHHHHHHchhhcccCCCCHHHHHH
Q 045315 389 RTWELMDPISQNGASYPILKRYINVALLCVQEKAADRPAMSEVVS 433 (476)
Q Consensus 389 ~~~~~~d~~~~~~~~~~~~~~l~~li~~Cl~~dP~~RPt~~eVl~ 433 (476)
..+ ..+......+.+++.+||+.||++||+++++++
T Consensus 243 -----~~~----~~~~~~~~~~~~li~~~l~~dp~~Rps~~~ll~ 278 (295)
T 2clq_A 243 -----VHP----EIPESMSAEAKAFILKCFEPDPDKRACANDLLV 278 (295)
T ss_dssp -----CCC----CCCTTSCHHHHHHHHHTTCSSTTTSCCHHHHHT
T ss_pred -----ccc----cccccCCHHHHHHHHHHccCChhhCCCHHHHhc
Confidence 001 111223457889999999999999999999975
|
| >3pfq_A PKC-B, PKC-beta, protein kinase C beta type; phosphorylation, transferase; HET: TPO SEP ANP; 4.00A {Rattus norvegicus} PDB: 1tbn_A 1tbo_A 2e73_A | Back alignment and structure |
|---|
Probab=99.93 E-value=9.5e-27 Score=253.46 Aligned_cols=172 Identities=26% Similarity=0.336 Sum_probs=135.7
Q ss_pred cccceeeccCCCCC------CCCCCChhhHHHHHHHHHHHHHHHhhcCCCceeecCCCccceEecCCCCceeccccceee
Q 045315 241 DEISFWYESYNNPT------KKGLLCWGTRVRIIEGIAQGLLYLHQYSRLRVIHRDLKASNILLDKDMNPKISDFGMARM 314 (476)
Q Consensus 241 ~~~~l~~Ey~~~~~------~~~~L~~~~~~~i~~qIa~gL~yLH~~~~~~ivH~DLkp~NILld~~~~~kL~DFGla~~ 314 (476)
+..+++|||++.+. +.+.+++.++..++.||+.||+|||+++ |+||||||+||||+.++.+||+|||+++.
T Consensus 415 ~~~~lV~E~~~gg~L~~~l~~~~~~~~~~~~~~~~qi~~aL~~LH~~g---IiHrDLKp~NILl~~~g~ikL~DFGla~~ 491 (674)
T 3pfq_A 415 DRLYFVMEYVNGGDLMYHIQQVGRFKEPHAVFYAAEIAIGLFFLQSKG---IIYRDLKLDNVMLDSEGHIKIADFGMCKE 491 (674)
T ss_dssp SEEEEEEECCCSCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTS---EECCCCCSTTEEECSSSCEEECCCTTCEE
T ss_pred CEEEEEEeCcCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCC---eEeccCChhhEEEcCCCcEEEeecceeec
Confidence 46789999998432 2357999999999999999999999999 99999999999999999999999999986
Q ss_pred cCCCcccccceeeeeccCCCChhhhccCCCCccceEEeehhhhhhhhhCCCCCCcCCCCchhhhhhhhhhhcCCCccccc
Q 045315 315 FGGDELQSNTKRIVGTYGYMSPEYALRGLFSIKSDVFSFGVLLLETLSSKKNTHFYNTDSLTLLGHAWNLWNDGRTWELM 394 (476)
Q Consensus 315 ~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~s~ksDVwSlGvvl~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 394 (476)
...... ......||+.|+|||++.+..++.++|+|||||++|||++|+.||...+. ..+... .. ....
T Consensus 492 ~~~~~~--~~~~~~GT~~Y~APE~l~~~~~~~~~DvwSlGvilyelltG~~Pf~~~~~--~~~~~~---i~-~~~~---- 559 (674)
T 3pfq_A 492 NIWDGV--TTKTFCGTPDYIAPEIIAYQPYGKSVDWWAFGVLLYEMLAGQAPFEGEDE--DELFQS---IM-EHNV---- 559 (674)
T ss_dssp CCCTTC--CBCCCCSCSSSCCHHHHTCCCBSTHHHHHHHHHHHHHHHHSSCSSCCSSH--HHHHHH---HH-SSCC----
T ss_pred cccCCc--ccccccCCCcccCHhhhcCCCCCccceEechHHHHHHHHcCCCCCCCCCH--HHHHHH---HH-hCCC----
Confidence 433222 23346799999999999999999999999999999999999999975432 111111 11 1111
Q ss_pred CcccCCCCCHHHHHHHHHHHHHchhhcccCCCCH-----HHHHH
Q 045315 395 DPISQNGASYPILKRYINVALLCVQEKAADRPAM-----SEVVS 433 (476)
Q Consensus 395 d~~~~~~~~~~~~~~l~~li~~Cl~~dP~~RPt~-----~eVl~ 433 (476)
..+......+.+++.+||+.||++||++ +||++
T Consensus 560 ------~~p~~~s~~~~~li~~lL~~dP~~R~~~~~~~~~ei~~ 597 (674)
T 3pfq_A 560 ------AYPKSMSKEAVAICKGLMTKHPGKRLGCGPEGERDIKE 597 (674)
T ss_dssp ------CCCTTSCHHHHHHHHHHSCSSSTTCTTCSTTHHHHHHS
T ss_pred ------CCCccCCHHHHHHHHHHccCCHHHCCCCCCCcHHHHhc
Confidence 1112234678899999999999999997 66653
|
| >1cm8_A Phosphorylated MAP kinase P38-gamma; phosphorylation, transferase; HET: TPO PTR ANP; 2.40A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=99.93 E-value=7.8e-27 Score=236.25 Aligned_cols=186 Identities=21% Similarity=0.213 Sum_probs=134.9
Q ss_pred ccceeeccCCC----CCCCCCCChhhHHHHHHHHHHHHHHHhhcCCCceeecCCCccceEecCCCCceeccccceeecCC
Q 045315 242 EISFWYESYNN----PTKKGLLCWGTRVRIIEGIAQGLLYLHQYSRLRVIHRDLKASNILLDKDMNPKISDFGMARMFGG 317 (476)
Q Consensus 242 ~~~l~~Ey~~~----~~~~~~L~~~~~~~i~~qIa~gL~yLH~~~~~~ivH~DLkp~NILld~~~~~kL~DFGla~~~~~ 317 (476)
..+++|||+.. ..+...+++.++..++.||+.||+|||+.+ |+||||||+||+++.++.+||+|||+++....
T Consensus 104 ~~~lv~e~~~~~L~~~~~~~~l~~~~~~~~~~qi~~~L~~LH~~~---ivH~Dlkp~NIll~~~~~~kl~Dfg~a~~~~~ 180 (367)
T 1cm8_A 104 DFYLVMPFMGTDLGKLMKHEKLGEDRIQFLVYQMLKGLRYIHAAG---IIHRDLKPGNLAVNEDCELKILDFGLARQADS 180 (367)
T ss_dssp CCEEEEECCSEEHHHHHHHCCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEECTTCCEEECCCTTCEECCS
T ss_pred eEEEEEecCCCCHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCC---ccccCcCHHHEEEcCCCCEEEEeeeccccccc
Confidence 46889999851 112356999999999999999999999999 99999999999999999999999999987643
Q ss_pred CcccccceeeeeccCCCChhhhcc-CCCCccceEEeehhhhhhhhhCCCCCCcCCCCchhhhhhhhhhhcCC--------
Q 045315 318 DELQSNTKRIVGTYGYMSPEYALR-GLFSIKSDVFSFGVLLLETLSSKKNTHFYNTDSLTLLGHAWNLWNDG-------- 388 (476)
Q Consensus 318 ~~~~~~~~~~~gt~~y~aPE~l~~-~~~s~ksDVwSlGvvl~elltG~~p~~~~~~~~~~~~~~~~~~~~~~-------- 388 (476)
. .....+|..|+|||.+.+ ..++.++|||||||+++||++|+.||...+... ............
T Consensus 181 ~-----~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~--~l~~i~~~~g~~~~~~~~~~ 253 (367)
T 1cm8_A 181 E-----MTGYVVTRWYRAPEVILNWMRYTQTVDIWSVGCIMAEMITGKTLFKGSDHLD--QLKEIMKVTGTPPAEFVQRL 253 (367)
T ss_dssp S-----CCSSCSCGGGCCTHHHHTTTCCCTTHHHHHHHHHHHHHHHSSCSSCCSSHHH--HHHHHHHHHCCCCHHHHHTC
T ss_pred c-----cCcCcCCCCcCCHHHHhCCCCCChhhhHHHHHHHHHHHHhCCCCCCCCCHHH--HHHHHHHhcCCCCHHHHHHh
Confidence 2 223568999999999887 679999999999999999999999987543111 110000000000
Q ss_pred ---C-------cccccCcccCCCCCHHHHHHHHHHHHHchhhcccCCCCHHHHHH--HHhcc
Q 045315 389 ---R-------TWELMDPISQNGASYPILKRYINVALLCVQEKAADRPAMSEVVS--MLSNE 438 (476)
Q Consensus 389 ---~-------~~~~~d~~~~~~~~~~~~~~l~~li~~Cl~~dP~~RPt~~eVl~--~L~~~ 438 (476)
. ......... ..........+.+++.+||+.||++|||++|+++ .++..
T Consensus 254 ~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~ll~~mL~~dP~~R~t~~e~l~hp~f~~~ 314 (367)
T 1cm8_A 254 QSDEAKNYMKGLPELEKKDF-ASILTNASPLAVNLLEKMLVLDAEQRVTAGEALAHPYFESL 314 (367)
T ss_dssp SCHHHHHHHHHSCCCCCCCG-GGTCTTCCHHHHHHHHHHSCSSTTTSCCHHHHHHSGGGTTT
T ss_pred hhHHHHHHHHhCCCCCCCCH-HHHCCCCCHHHHHHHHHHccCChhHCCCHHHHhcChHHHhh
Confidence 0 000000000 0011122457889999999999999999999987 35544
|
| >3i6u_A CDS1, serine/threonine-protein kinase CHK2; Ser/Thr protein kinase, FHA domain, ATP-binding, cell cycle, mutation, LI-fraumeni syndrome, magnesium; 3.00A {Homo sapiens} PDB: 3i6w_A | Back alignment and structure |
|---|
Probab=99.93 E-value=3.5e-26 Score=235.56 Aligned_cols=176 Identities=22% Similarity=0.280 Sum_probs=127.1
Q ss_pred cccceeeccCCCC------CCCCCCChhhHHHHHHHHHHHHHHHhhcCCCceeecCCCccceEecCC---CCceeccccc
Q 045315 241 DEISFWYESYNNP------TKKGLLCWGTRVRIIEGIAQGLLYLHQYSRLRVIHRDLKASNILLDKD---MNPKISDFGM 311 (476)
Q Consensus 241 ~~~~l~~Ey~~~~------~~~~~L~~~~~~~i~~qIa~gL~yLH~~~~~~ivH~DLkp~NILld~~---~~~kL~DFGl 311 (476)
+..+++|||++.. ...+.+++.++..++.||+.||+|||+++ |+||||||+|||++.+ ..+||+|||+
T Consensus 212 ~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~i~~qi~~~l~~LH~~~---ivHrDlkp~NIll~~~~~~~~~kl~DFG~ 288 (419)
T 3i6u_A 212 EDYYIVLELMEGGELFDKVVGNKRLKEATCKLYFYQMLLAVQYLHENG---IIHRDLKPENVLLSSQEEDCLIKITDFGH 288 (419)
T ss_dssp SEEEEEEECCTTCBGGGGTSSSCCCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEESSSSSSCCEEECCSST
T ss_pred CceEEEEEcCCCCcHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHHCC---ccccCCChHhEEEecCCCcceEEEeeccc
Confidence 4578999999832 34567999999999999999999999999 9999999999999754 4599999999
Q ss_pred eeecCCCcccccceeeeeccCCCChhhhc---cCCCCccceEEeehhhhhhhhhCCCCCCcCCCCchhhhhhhhhhhcCC
Q 045315 312 ARMFGGDELQSNTKRIVGTYGYMSPEYAL---RGLFSIKSDVFSFGVLLLETLSSKKNTHFYNTDSLTLLGHAWNLWNDG 388 (476)
Q Consensus 312 a~~~~~~~~~~~~~~~~gt~~y~aPE~l~---~~~~s~ksDVwSlGvvl~elltG~~p~~~~~~~~~~~~~~~~~~~~~~ 388 (476)
++...... ......||+.|+|||++. ...++.++|||||||++|||++|+.||........ +.. ....+
T Consensus 289 a~~~~~~~---~~~~~~gt~~y~aPE~~~~~~~~~~~~~~DiwslG~il~~lltg~~pf~~~~~~~~-~~~----~i~~~ 360 (419)
T 3i6u_A 289 SKILGETS---LMRTLCGTPTYLAPEVLVSVGTAGYNRAVDCWSLGVILFICLSGYPPFSEHRTQVS-LKD----QITSG 360 (419)
T ss_dssp TTSCC--------------CTTCCTTTTC----CTTHHHHHHHHHHHHHHHHHHSSCSSCCCSSSCC-HHH----HHHTT
T ss_pred ceecCCCc---cccccCCCCCccCceeeecCCCCCCCchhhhHhHHHHHHHHHHCCCCCCCCcchHH-HHH----HHhcC
Confidence 98765322 223357999999999985 36788999999999999999999999975432211 111 11111
Q ss_pred CcccccCcccCCCCCHHHHHHHHHHHHHchhhcccCCCCHHHHHH
Q 045315 389 RTWELMDPISQNGASYPILKRYINVALLCVQEKAADRPAMSEVVS 433 (476)
Q Consensus 389 ~~~~~~d~~~~~~~~~~~~~~l~~li~~Cl~~dP~~RPt~~eVl~ 433 (476)
.... . +.. .......+.+++.+||+.||++||+++|+++
T Consensus 361 ~~~~-~-~~~----~~~~~~~~~~li~~~L~~dP~~Rps~~e~l~ 399 (419)
T 3i6u_A 361 KYNF-I-PEV----WAEVSEKALDLVKKLLVVDPKARFTTEEALR 399 (419)
T ss_dssp CCCC-C-HHH----HTTSCHHHHHHHHHHSCSSTTTSCCHHHHHH
T ss_pred CCCC-C-chh----hcccCHHHHHHHHHHccCChhHCcCHHHHhC
Confidence 1100 0 000 0112457889999999999999999999886
|
| >3f3z_A Calcium/calmodulin-dependent protein kinase with domain and 4 calmodulin like EF...; calcium dependent protein kinase; HET: SEP DRK; 1.84A {Cryptosporidium parvum iowa II} PDB: 2qg5_A* | Back alignment and structure |
|---|
Probab=99.93 E-value=2.5e-26 Score=222.42 Aligned_cols=174 Identities=21% Similarity=0.282 Sum_probs=132.1
Q ss_pred cccceeeccCCCCC------CCCCCChhhHHHHHHHHHHHHHHHhhcCCCceeecCCCccceEe---cCCCCceeccccc
Q 045315 241 DEISFWYESYNNPT------KKGLLCWGTRVRIIEGIAQGLLYLHQYSRLRVIHRDLKASNILL---DKDMNPKISDFGM 311 (476)
Q Consensus 241 ~~~~l~~Ey~~~~~------~~~~L~~~~~~~i~~qIa~gL~yLH~~~~~~ivH~DLkp~NILl---d~~~~~kL~DFGl 311 (476)
+..+++|||++... .++.+++.++..++.|++.||+|||+++ |+||||||+||++ +.++.+||+|||+
T Consensus 79 ~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~---i~H~dlkp~Nil~~~~~~~~~~~l~Dfg~ 155 (277)
T 3f3z_A 79 TDIYLVMELCTGGELFERVVHKRVFRESDAARIMKDVLSAVAYCHKLN---VAHRDLKPENFLFLTDSPDSPLKLIDFGL 155 (277)
T ss_dssp SEEEEEEECCCSCBHHHHHHHHCSCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEESSSSTTCCEEECCCTT
T ss_pred CeEEEEEeccCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCC---ccCCCCCHHHEEEecCCCCCcEEEEeccc
Confidence 45788999997432 2456999999999999999999999999 9999999999999 7889999999999
Q ss_pred eeecCCCcccccceeeeeccCCCChhhhccCCCCccceEEeehhhhhhhhhCCCCCCcCCCCchhhhhhhhhhhcCCCcc
Q 045315 312 ARMFGGDELQSNTKRIVGTYGYMSPEYALRGLFSIKSDVFSFGVLLLETLSSKKNTHFYNTDSLTLLGHAWNLWNDGRTW 391 (476)
Q Consensus 312 a~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~s~ksDVwSlGvvl~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~ 391 (476)
+........ .....|++.|+|||.+.+ .++.++||||||+++|||++|+.||...... ..... ...+...
T Consensus 156 ~~~~~~~~~---~~~~~~t~~y~aPE~~~~-~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~--~~~~~----~~~~~~~ 225 (277)
T 3f3z_A 156 AARFKPGKM---MRTKVGTPYYVSPQVLEG-LYGPECDEWSAGVMMYVLLCGYPPFSAPTDS--EVMLK----IREGTFT 225 (277)
T ss_dssp CEECCTTSC---BCCCCSCTTTCCHHHHTT-CBCTTHHHHHHHHHHHHHHHSSCSSCCSSHH--HHHHH----HHHCCCC
T ss_pred ceeccCccc---hhccCCCCCccChHHhcc-cCCchhhehhHHHHHHHHHHCCCCCCCCCHH--HHHHH----HHhCCCC
Confidence 987654322 223468999999998865 4899999999999999999999998653311 11111 1111100
Q ss_pred cccCcccCCCCCHHHHHHHHHHHHHchhhcccCCCCHHHHHH
Q 045315 392 ELMDPISQNGASYPILKRYINVALLCVQEKAADRPAMSEVVS 433 (476)
Q Consensus 392 ~~~d~~~~~~~~~~~~~~l~~li~~Cl~~dP~~RPt~~eVl~ 433 (476)
.... . .......+.+++.+||+.||++||++.++++
T Consensus 226 -~~~~-~----~~~~~~~~~~li~~~l~~dp~~R~s~~~~l~ 261 (277)
T 3f3z_A 226 -FPEK-D----WLNVSPQAESLIRRLLTKSPKQRITSLQALE 261 (277)
T ss_dssp -CCHH-H----HTTSCHHHHHHHHHHTCSSTTTSCCHHHHTT
T ss_pred -CCch-h----hhcCCHHHHHHHHHHccCChhhCcCHHHHhc
Confidence 0000 0 0012357889999999999999999999875
|
| >1x8b_A WEE1HU, WEE1-like protein kinase; cell cycle, transferase; HET: 824; 1.81A {Homo sapiens} PDB: 3bi6_A* 3biz_A* 3cqe_A* 3cr0_A* 2in6_A* 2io6_A* 2z2w_A* | Back alignment and structure |
|---|
Probab=99.93 E-value=1.1e-26 Score=225.27 Aligned_cols=166 Identities=17% Similarity=0.260 Sum_probs=126.9
Q ss_pred cccceeeccCCCCC----------CCCCCChhhHHHHHHHHHHHHHHHhhcCCCceeecCCCccceEecCC---------
Q 045315 241 DEISFWYESYNNPT----------KKGLLCWGTRVRIIEGIAQGLLYLHQYSRLRVIHRDLKASNILLDKD--------- 301 (476)
Q Consensus 241 ~~~~l~~Ey~~~~~----------~~~~L~~~~~~~i~~qIa~gL~yLH~~~~~~ivH~DLkp~NILld~~--------- 301 (476)
+..++++||++..+ ....+++.++..++.||+.||+|||+++ |+||||||+||+++.+
T Consensus 84 ~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~al~~lH~~~---ivH~Dikp~NIl~~~~~~~~~~~~~ 160 (289)
T 1x8b_A 84 DHMLIQNEYCNGGSLADAISENYRIMSYFKEAELKDLLLQVGRGLRYIHSMS---LVHMDIKPSNIFISRTSIPNAASEE 160 (289)
T ss_dssp TEEEEEEECCTTCBHHHHHHHHHHHTCCCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEEC-----------
T ss_pred CeEEEEEEecCCCcHHHHHHhhcccccCCCHHHHHHHHHHHHHHHHHHHhCC---EeecCCCHHHEEEcCCCCCcccccc
Confidence 46788999997432 1267999999999999999999999999 9999999999999844
Q ss_pred ----------CCceeccccceeecCCCcccccceeeeeccCCCChhhhccC-CCCccceEEeehhhhhhhhhCCCCCCcC
Q 045315 302 ----------MNPKISDFGMARMFGGDELQSNTKRIVGTYGYMSPEYALRG-LFSIKSDVFSFGVLLLETLSSKKNTHFY 370 (476)
Q Consensus 302 ----------~~~kL~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~-~~s~ksDVwSlGvvl~elltG~~p~~~~ 370 (476)
..+||+|||.+....... ...|+..|+|||.+.+. .++.++|||||||++|||++|.+++...
T Consensus 161 ~~~~~~~~~~~~~kl~Dfg~~~~~~~~~------~~~gt~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~~~~~~~~~ 234 (289)
T 1x8b_A 161 GDEDDWASNKVMFKIGDLGHVTRISSPQ------VEEGDSRFLANEVLQENYTHLPKADIFALALTVVCAAGAEPLPRNG 234 (289)
T ss_dssp ---------CCCEEECCCTTCEETTCSC------CCCCCGGGCCHHHHTTCCTTHHHHHHHHHHHHHHHHTTCCCCCSSS
T ss_pred cccccccCCceEEEEcccccccccCCcc------ccCCCccccChhHhcCCCCCCchhhHHHHHHHHHHHhcCCCCCcch
Confidence 478999999998765432 13489999999999865 6678999999999999999998765321
Q ss_pred CCCchhhhhhhhhhhcCCCcccccCcccCCCCCHHHHHHHHHHHHHchhhcccCCCCHHHHHH
Q 045315 371 NTDSLTLLGHAWNLWNDGRTWELMDPISQNGASYPILKRYINVALLCVQEKAADRPAMSEVVS 433 (476)
Q Consensus 371 ~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~l~~li~~Cl~~dP~~RPt~~eVl~ 433 (476)
. .. .....+.... .+......+.+++.+||+.||++|||+.|+++
T Consensus 235 ~----~~-----~~~~~~~~~~---------~~~~~~~~~~~li~~~l~~dp~~Rps~~~ll~ 279 (289)
T 1x8b_A 235 D----QW-----HEIRQGRLPR---------IPQVLSQEFTELLKVMIHPDPERRPSAMALVK 279 (289)
T ss_dssp H----HH-----HHHHTTCCCC---------CSSCCCHHHHHHHHHHTCSSGGGSCCHHHHHT
T ss_pred h----HH-----HHHHcCCCCC---------CCcccCHHHHHHHHHHhCCCcccCCCHHHHhh
Confidence 1 11 1111111111 11122356889999999999999999999875
|
| >2w5a_A Serine/threonine-protein kinase NEK2; Ser/Thr protein kinase, nucleus, meiosis, mitosis, cytoplasm, metal-binding, phosphoprotein; HET: ADP; 1.55A {Homo sapiens} PDB: 2wqo_A* 2xk3_A* 2xk4_A* 2xk6_A* 2xk7_A* 2xk8_A* 2xkc_A* 2xkd_A* 2xke_A* 2xkf_A* 2xnm_A* 2xnn_A* 2xno_A* 2xnp_A* 4afe_A* 2jav_A* 2w5b_A* 2w5h_A 4a4x_A* | Back alignment and structure |
|---|
Probab=99.93 E-value=3.2e-27 Score=228.83 Aligned_cols=180 Identities=27% Similarity=0.354 Sum_probs=134.0
Q ss_pred cccceeeccCCCC----------CCCCCCChhhHHHHHHHHHHHHHHHhhcC--CCceeecCCCccceEecCCCCceecc
Q 045315 241 DEISFWYESYNNP----------TKKGLLCWGTRVRIIEGIAQGLLYLHQYS--RLRVIHRDLKASNILLDKDMNPKISD 308 (476)
Q Consensus 241 ~~~~l~~Ey~~~~----------~~~~~L~~~~~~~i~~qIa~gL~yLH~~~--~~~ivH~DLkp~NILld~~~~~kL~D 308 (476)
+.+++++||++.. ..+..+++.+++.++.||+.||+|||+.+ ..+|+||||||+||+++.++.+||+|
T Consensus 80 ~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~ivH~dl~p~NIl~~~~~~~kl~d 159 (279)
T 2w5a_A 80 TTLYIVMEYCEGGDLASVITKGTKERQYLDEEFVLRVMTQLTLALKECHRRSDGGHTVLHRDLKPANVFLDGKQNVKLGD 159 (279)
T ss_dssp TEEEEEEECCTTEEHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHHHC------CCCCCSGGGEEECSSSCEEECC
T ss_pred ceEEEEEeCCCCCCHHHHHHhhcccCCCCCHHHHHHHHHHHHHHHHHHhcccCCCCeeEEeccchhhEEEcCCCCEEEec
Confidence 4678899999732 23456999999999999999999999976 23499999999999999999999999
Q ss_pred ccceeecCCCcccccceeeeeccCCCChhhhccCCCCccceEEeehhhhhhhhhCCCCCCcCCCCchhhhhhhhhhhcCC
Q 045315 309 FGMARMFGGDELQSNTKRIVGTYGYMSPEYALRGLFSIKSDVFSFGVLLLETLSSKKNTHFYNTDSLTLLGHAWNLWNDG 388 (476)
Q Consensus 309 FGla~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~s~ksDVwSlGvvl~elltG~~p~~~~~~~~~~~~~~~~~~~~~~ 388 (476)
||+++........ .....|+..|+|||.+.+..++.++||||||+++|||++|+.||..... ..... ....+
T Consensus 160 fg~~~~~~~~~~~--~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~--~~~~~----~i~~~ 231 (279)
T 2w5a_A 160 FGLARILNHDTSF--AKTFVGTPYYMSPEQMNRMSYNEKSDIWSLGCLLYELCALMPPFTAFSQ--KELAG----KIREG 231 (279)
T ss_dssp CCHHHHC---CHH--HHHHHSCCTTCCHHHHHCC-CCHHHHHHHHHHHHHHHHHSSCSSCCSSH--HHHHH----HHHHT
T ss_pred Cchheeecccccc--ccccCCCccccChHHhccCCCCchhhHHHHHHHHHHHHHCCCCCcccCH--HHHHH----HHhhc
Confidence 9999875433211 1224688999999999998999999999999999999999999865431 11111 11111
Q ss_pred CcccccCcccCCCCCHHHHHHHHHHHHHchhhcccCCCCHHHHHHHHhc
Q 045315 389 RTWELMDPISQNGASYPILKRYINVALLCVQEKAADRPAMSEVVSMLSN 437 (476)
Q Consensus 389 ~~~~~~d~~~~~~~~~~~~~~l~~li~~Cl~~dP~~RPt~~eVl~~L~~ 437 (476)
.... .+......+.+++.+||+.||++||++.||++.+..
T Consensus 232 ~~~~---------~~~~~~~~l~~li~~~l~~~p~~Rps~~~ll~~~~~ 271 (279)
T 2w5a_A 232 KFRR---------IPYRYSDELNEIITRMLNLKDYHRPSVEEILENPLI 271 (279)
T ss_dssp CCCC---------CCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHTSTTC
T ss_pred cccc---------CCcccCHHHHHHHHHHcCCCcccCCCHHHHHhChhh
Confidence 1111 111234578899999999999999999999987654
|
| >3is5_A Calcium-dependent protein kinase; CDPK, structural genomics, parasitology, structural genomics consortium, SGC, ATP-binding, nucleotide-binding; HET: ANP; 2.55A {Toxoplasma gondii} | Back alignment and structure |
|---|
Probab=99.93 E-value=9.8e-27 Score=226.78 Aligned_cols=173 Identities=23% Similarity=0.366 Sum_probs=126.8
Q ss_pred cccceeeccCCCCC----------CCCCCChhhHHHHHHHHHHHHHHHhhcCCCceeecCCCccceEe---cCCCCceec
Q 045315 241 DEISFWYESYNNPT----------KKGLLCWGTRVRIIEGIAQGLLYLHQYSRLRVIHRDLKASNILL---DKDMNPKIS 307 (476)
Q Consensus 241 ~~~~l~~Ey~~~~~----------~~~~L~~~~~~~i~~qIa~gL~yLH~~~~~~ivH~DLkp~NILl---d~~~~~kL~ 307 (476)
+..++++||++... ....+++.++..++.||+.||+|||+.+ |+||||||+||++ +.++.+||+
T Consensus 93 ~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~---ivH~dikp~NIl~~~~~~~~~~kl~ 169 (285)
T 3is5_A 93 HNMYIVMETCEGGELLERIVSAQARGKALSEGYVAELMKQMMNALAYFHSQH---VVHKDLKPENILFQDTSPHSPIKII 169 (285)
T ss_dssp SEEEEEECCCSCCBHHHHHHHHHHHTCCCCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCSGGGEEESSSSTTCCEEEC
T ss_pred CeEEEEEEeCCCCcHHHHHHhhhhcccCCCHHHHHHHHHHHHHHHHHHHhCC---EEECCCCHHHEEEecCCCCCCEEEE
Confidence 46788999997432 2467999999999999999999999999 9999999999999 456789999
Q ss_pred cccceeecCCCcccccceeeeeccCCCChhhhccCCCCccceEEeehhhhhhhhhCCCCCCcCCCCchhhhhhhhhhhcC
Q 045315 308 DFGMARMFGGDELQSNTKRIVGTYGYMSPEYALRGLFSIKSDVFSFGVLLLETLSSKKNTHFYNTDSLTLLGHAWNLWND 387 (476)
Q Consensus 308 DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~s~ksDVwSlGvvl~elltG~~p~~~~~~~~~~~~~~~~~~~~~ 387 (476)
|||++........ .....|+..|+|||.+. ..++.++||||||+++|||++|+.||....... ..... ....
T Consensus 170 Dfg~a~~~~~~~~---~~~~~~t~~y~aPE~~~-~~~~~~~Di~slG~il~~ll~g~~pf~~~~~~~--~~~~~--~~~~ 241 (285)
T 3is5_A 170 DFGLAELFKSDEH---STNAAGTALYMAPEVFK-RDVTFKCDIWSAGVVMYFLLTGCLPFTGTSLEE--VQQKA--TYKE 241 (285)
T ss_dssp CCCCCCC-------------CTTGGGCCHHHHT-TCCCHHHHHHHHHHHHHHHHHSSCSSCCSSHHH--HHHHH--HHCC
T ss_pred eeecceecCCccc---CcCcccccCcCChHHhc-cCCCcccCeehHHHHHHHHHhCCCCCCCCCHHH--HHhhh--ccCC
Confidence 9999987654321 22356899999999875 568999999999999999999999987543111 11110 0000
Q ss_pred CCcccccCcccCCCCCHHHHHHHHHHHHHchhhcccCCCCHHHHHH
Q 045315 388 GRTWELMDPISQNGASYPILKRYINVALLCVQEKAADRPAMSEVVS 433 (476)
Q Consensus 388 ~~~~~~~d~~~~~~~~~~~~~~l~~li~~Cl~~dP~~RPt~~eVl~ 433 (476)
... . . ........+.+++.+||+.||++|||+.|+++
T Consensus 242 ~~~-~-~-------~~~~~~~~~~~li~~~L~~dP~~Rps~~e~l~ 278 (285)
T 3is5_A 242 PNY-A-V-------ECRPLTPQAVDLLKQMLTKDPERRPSAAQVLH 278 (285)
T ss_dssp CCC-C-C---------CCCCHHHHHHHHHHTCSCTTTSCCHHHHHT
T ss_pred ccc-c-c-------ccCcCCHHHHHHHHHHccCChhhCcCHHHHhc
Confidence 000 0 0 00112356789999999999999999999985
|
| >1q8y_A SR protein kinase; transferase; HET: ADP ADE; 2.05A {Saccharomyces cerevisiae} SCOP: d.144.1.7 PDB: 1q8z_A 1q97_A* 1q99_A* 1how_A 2jd5_A | Back alignment and structure |
|---|
Probab=99.93 E-value=2.4e-26 Score=231.96 Aligned_cols=188 Identities=19% Similarity=0.220 Sum_probs=133.6
Q ss_pred ccceeeccCC-------CCCCCCCCChhhHHHHHHHHHHHHHHHhhc-CCCceeecCCCccceEec------CCCCceec
Q 045315 242 EISFWYESYN-------NPTKKGLLCWGTRVRIIEGIAQGLLYLHQY-SRLRVIHRDLKASNILLD------KDMNPKIS 307 (476)
Q Consensus 242 ~~~l~~Ey~~-------~~~~~~~L~~~~~~~i~~qIa~gL~yLH~~-~~~~ivH~DLkp~NILld------~~~~~kL~ 307 (476)
.+++++||+. .......+++.++..++.||+.||+|||++ + |+||||||+|||++ ..+.+||+
T Consensus 104 ~~~lv~e~~~~~L~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~lH~~~~---ivH~Dikp~NIll~~~~~~~~~~~~kl~ 180 (373)
T 1q8y_A 104 HVVMVFEVLGENLLALIKKYEHRGIPLIYVKQISKQLLLGLDYMHRRCG---IIHTDIKPENVLMEIVDSPENLIQIKIA 180 (373)
T ss_dssp EEEEEECCCCEEHHHHHHHTTTSCCCHHHHHHHHHHHHHHHHHHHHTTC---EECSCCSGGGEEEEEEETTTTEEEEEEC
T ss_pred eEEEEEecCCCCHHHHHHHhhccCCcHHHHHHHHHHHHHHHHHHHhcCC---EEecCCChHHeEEeccCCCcCcceEEEc
Confidence 4678888885 112345699999999999999999999998 8 99999999999995 34479999
Q ss_pred cccceeecCCCcccccceeeeeccCCCChhhhccCCCCccceEEeehhhhhhhhhCCCCCCcCCCCc----hhhhhhhhh
Q 045315 308 DFGMARMFGGDELQSNTKRIVGTYGYMSPEYALRGLFSIKSDVFSFGVLLLETLSSKKNTHFYNTDS----LTLLGHAWN 383 (476)
Q Consensus 308 DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~s~ksDVwSlGvvl~elltG~~p~~~~~~~~----~~~~~~~~~ 383 (476)
|||++....... ....||..|+|||.+.+..++.++|||||||++|||++|+.||....... .........
T Consensus 181 Dfg~a~~~~~~~-----~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~~ 255 (373)
T 1q8y_A 181 DLGNACWYDEHY-----TNSIQTREYRSPEVLLGAPWGCGADIWSTACLIFELITGDFLFEPDEGHSYTKDDDHIAQIIE 255 (373)
T ss_dssp CCTTCEETTBCC-----CSCCSCGGGCCHHHHHTCCCCTHHHHHHHHHHHHHHHHSSCCC---------CHHHHHHHHHH
T ss_pred ccccccccCCCC-----CCCCCCccccCcHHHhCCCCCchHhHHHHHHHHHHHHhCCCCCCCCcccccCChHHHHHHHHH
Confidence 999998765321 22468999999999999999999999999999999999999997543111 111111100
Q ss_pred hh------------------cCCCcccccCc----------ccCCCCCHHHHHHHHHHHHHchhhcccCCCCHHHHHH--
Q 045315 384 LW------------------NDGRTWELMDP----------ISQNGASYPILKRYINVALLCVQEKAADRPAMSEVVS-- 433 (476)
Q Consensus 384 ~~------------------~~~~~~~~~d~----------~~~~~~~~~~~~~l~~li~~Cl~~dP~~RPt~~eVl~-- 433 (476)
.. ........+.. ......+......+.+++.+||+.||++|||++|+++
T Consensus 256 ~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~hp 335 (373)
T 1q8y_A 256 LLGELPSYLLRNGKYTRTFFNSRGLLRNISKLKFWPLEDVLTEKYKFSKDEAKEISDFLSPMLQLDPRKRADAGGLVNHP 335 (373)
T ss_dssp HHCSCCHHHHHHCTTHHHHBCC--CBSSCCCCCBCCHHHHHHHTTCCCHHHHHHHHHHHGGGGCSSTTTCBCHHHHHTCG
T ss_pred hcCCCCHHHHhccchhhhhcCCcchhcccccccccchhhhhhhcccCCcchHHHHHHHHHHHhccCccccCCHHHHhhCh
Confidence 00 00000000000 0011234566788999999999999999999999987
Q ss_pred HHhc
Q 045315 434 MLSN 437 (476)
Q Consensus 434 ~L~~ 437 (476)
.+.+
T Consensus 336 ~f~~ 339 (373)
T 1q8y_A 336 WLKD 339 (373)
T ss_dssp GGTT
T ss_pred hhhc
Confidence 3444
|
| >3aln_A Dual specificity mitogen-activated protein kinase; protein AMP-PNP complex, transferase; HET: ANP; 2.30A {Homo sapiens} PDB: 3alo_A* | Back alignment and structure |
|---|
Probab=99.93 E-value=1e-26 Score=230.86 Aligned_cols=177 Identities=25% Similarity=0.347 Sum_probs=115.8
Q ss_pred cccceeeccCCCC----------CCCCCCChhhHHHHHHHHHHHHHHHhhc-CCCceeecCCCccceEecCCCCceeccc
Q 045315 241 DEISFWYESYNNP----------TKKGLLCWGTRVRIIEGIAQGLLYLHQY-SRLRVIHRDLKASNILLDKDMNPKISDF 309 (476)
Q Consensus 241 ~~~~l~~Ey~~~~----------~~~~~L~~~~~~~i~~qIa~gL~yLH~~-~~~~ivH~DLkp~NILld~~~~~kL~DF 309 (476)
+.+++++||++.. .....+++..+..++.|++.||.|||+. + |+||||||+||+++.++.+||+||
T Consensus 94 ~~~~lv~e~~~~~l~~~~~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~---ivH~dlkp~NIll~~~~~~kl~Df 170 (327)
T 3aln_A 94 GDCWICMELMSTSFDKFYKYVYSVLDDVIPEEILGKITLATVKALNHLKENLK---IIHRDIKPSNILLDRSGNIKLCDF 170 (327)
T ss_dssp SEEEEEECCCSEEHHHHHHHHHHTTCCCCCHHHHHHHHHHHHHHHHHHHHHHS---CCCSCCCGGGEEEETTTEEEECCC
T ss_pred CceEEEEeecCCChHHHHHHHHhhhcccCcHHHHHHHHHHHHHHHHHHhccCC---EeECCCCHHHEEEcCCCCEEEccC
Confidence 4678899999831 2357899999999999999999999998 8 999999999999999999999999
Q ss_pred cceeecCCCcccccceeeeeccCCCChhhh----ccCCCCccceEEeehhhhhhhhhCCCCCCcCCCCchhhhhhhhhhh
Q 045315 310 GMARMFGGDELQSNTKRIVGTYGYMSPEYA----LRGLFSIKSDVFSFGVLLLETLSSKKNTHFYNTDSLTLLGHAWNLW 385 (476)
Q Consensus 310 Gla~~~~~~~~~~~~~~~~gt~~y~aPE~l----~~~~~s~ksDVwSlGvvl~elltG~~p~~~~~~~~~~~~~~~~~~~ 385 (476)
|+++....... .....|+..|+|||.+ .+..++.++||||||+++|||++|+.||........... ..
T Consensus 171 g~~~~~~~~~~---~~~~~gt~~y~aPE~~~~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~----~~- 242 (327)
T 3aln_A 171 GISGQLVDSIA---KTRDAGCRPYMAPERIDPSASRQGYDVRSDVWSLGITLYELATGRFPYPKWNSVFDQLT----QV- 242 (327)
T ss_dssp SSSCC---------------------------------CCSHHHHHHHHHHHHHHHHSCCCSSCC-------C----CC-
T ss_pred CCceecccccc---cccCCCCccccCceeeccccCcCCCCchhhHHHHHHHHHHHHHCCCCCCCcchHHHHHH----HH-
Confidence 99987643321 2224689999999998 456789999999999999999999999875332111110 00
Q ss_pred cCCCcccccCcccCCCCCHHHHHHHHHHHHHchhhcccCCCCHHHHHH
Q 045315 386 NDGRTWELMDPISQNGASYPILKRYINVALLCVQEKAADRPAMSEVVS 433 (476)
Q Consensus 386 ~~~~~~~~~d~~~~~~~~~~~~~~l~~li~~Cl~~dP~~RPt~~eVl~ 433 (476)
..+... .+...........+.+++.+||+.||++||++.+|++
T Consensus 243 ~~~~~~-----~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~ 285 (327)
T 3aln_A 243 VKGDPP-----QLSNSEEREFSPSFINFVNLCLTKDESKRPKYKELLK 285 (327)
T ss_dssp CCSCCC-----CCCCCSSCCCCHHHHHHHHHHTCSSGGGSCCHHHHTT
T ss_pred hcCCCC-----CCCCcccccCCHHHHHHHHHHhhCChhhCcCHHHHHh
Confidence 011111 1111111223457889999999999999999999865
|
| >1t4h_A Serine/threonine-protein kinase WNK1; protein serine/threonine kinase, transferase; 1.80A {Rattus norvegicus} PDB: 3fpq_A | Back alignment and structure |
|---|
Probab=99.93 E-value=2.5e-26 Score=224.12 Aligned_cols=173 Identities=22% Similarity=0.319 Sum_probs=130.6
Q ss_pred ccceeeccCCCCC------CCCCCChhhHHHHHHHHHHHHHHHhhcCCCceeecCCCccceEec-CCCCceeccccceee
Q 045315 242 EISFWYESYNNPT------KKGLLCWGTRVRIIEGIAQGLLYLHQYSRLRVIHRDLKASNILLD-KDMNPKISDFGMARM 314 (476)
Q Consensus 242 ~~~l~~Ey~~~~~------~~~~L~~~~~~~i~~qIa~gL~yLH~~~~~~ivH~DLkp~NILld-~~~~~kL~DFGla~~ 314 (476)
..++++||++... ..+.+++..+..++.||+.||+|||+.+ .+|+||||||+||+++ .++.+||+|||++..
T Consensus 103 ~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~qi~~~l~~lH~~~-~~i~H~dikp~Nil~~~~~~~~kl~Dfg~~~~ 181 (290)
T 1t4h_A 103 CIVLVTELMTSGTLKTYLKRFKVMKIKVLRSWCRQILKGLQFLHTRT-PPIIHRDLKCDNIFITGPTGSVKIGDLGLATL 181 (290)
T ss_dssp EEEEEEECCCSCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHTSS-SCCCCSCCCGGGEEESSTTSCEEECCTTGGGG
T ss_pred eEEEEEEecCCCCHHHHHHHccCCCHHHHHHHHHHHHHHHHHHHcCC-CCEEECCCCHHHEEEECCCCCEEEeeCCCccc
Confidence 4678899997432 2367999999999999999999999975 3499999999999998 788999999999975
Q ss_pred cCCCcccccceeeeeccCCCChhhhccCCCCccceEEeehhhhhhhhhCCCCCCcCCCCchhhhhhhhhhhcCCCccccc
Q 045315 315 FGGDELQSNTKRIVGTYGYMSPEYALRGLFSIKSDVFSFGVLLLETLSSKKNTHFYNTDSLTLLGHAWNLWNDGRTWELM 394 (476)
Q Consensus 315 ~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~s~ksDVwSlGvvl~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 394 (476)
..... .....|+..|+|||.+. +.++.++||||||+++|+|++|+.||........ .. .....+......
T Consensus 182 ~~~~~----~~~~~~t~~y~aPE~~~-~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~-~~----~~~~~~~~~~~~ 251 (290)
T 1t4h_A 182 KRASF----AKAVIGTPEFMAPEMYE-EKYDESVDVYAFGMCMLEMATSEYPYSECQNAAQ-IY----RRVTSGVKPASF 251 (290)
T ss_dssp CCTTS----BEESCSSCCCCCGGGGG-TCCCTHHHHHHHHHHHHHHHHSSCTTTTCSSHHH-HH----HHHTTTCCCGGG
T ss_pred ccccc----cccccCCcCcCCHHHHh-ccCCCcchHHHHHHHHHHHHhCCCCCCCcCcHHH-HH----HHHhccCCcccc
Confidence 44322 23356899999999876 4589999999999999999999999865332111 11 111111111111
Q ss_pred CcccCCCCCHHHHHHHHHHHHHchhhcccCCCCHHHHHH
Q 045315 395 DPISQNGASYPILKRYINVALLCVQEKAADRPAMSEVVS 433 (476)
Q Consensus 395 d~~~~~~~~~~~~~~l~~li~~Cl~~dP~~RPt~~eVl~ 433 (476)
+ ......+.+++.+||+.||++|||++|+++
T Consensus 252 ~--------~~~~~~l~~li~~~l~~dp~~Rps~~ell~ 282 (290)
T 1t4h_A 252 D--------KVAIPEVKEIIEGCIRQNKDERYSIKDLLN 282 (290)
T ss_dssp G--------GCCCHHHHHHHHHHSCSSGGGSCCHHHHHT
T ss_pred C--------CCCCHHHHHHHHHHccCChhhCCCHHHHhh
Confidence 1 111246889999999999999999999985
|
| >2rku_A Serine/threonine-protein kinase PLK1; structure of PLK1, selectivity residues, POLO-like K structure based drug design, ATP-binding; HET: R78 TLA SRT TAR; 1.95A {Homo sapiens} PDB: 2v5q_A 2yac_A* 4a4l_A* 4a4o_A* 3kb7_A* 3d5w_A* 3d5u_A* 3d5v_A 3db8_A* 3dbc_A* 3dbd_A* 3d5x_A* 3db6_A* 3dbe_A* 3dbf_A* | Back alignment and structure |
|---|
Probab=99.93 E-value=2.2e-26 Score=224.97 Aligned_cols=173 Identities=25% Similarity=0.309 Sum_probs=135.0
Q ss_pred cccceeeccCCCCC------CCCCCChhhHHHHHHHHHHHHHHHhhcCCCceeecCCCccceEecCCCCceeccccceee
Q 045315 241 DEISFWYESYNNPT------KKGLLCWGTRVRIIEGIAQGLLYLHQYSRLRVIHRDLKASNILLDKDMNPKISDFGMARM 314 (476)
Q Consensus 241 ~~~~l~~Ey~~~~~------~~~~L~~~~~~~i~~qIa~gL~yLH~~~~~~ivH~DLkp~NILld~~~~~kL~DFGla~~ 314 (476)
+..++++||++... ..+.+++.++..++.||++||+|||+++ ++||||||+||+++.++.+||+|||++..
T Consensus 88 ~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~---i~H~dl~p~Nil~~~~~~~kl~dfg~~~~ 164 (294)
T 2rku_A 88 DFVFVVLELCRRRSLLELHKRRKALTEPEARYYLRQIVLGCQYLHRNR---VIHRDLKLGNLFLNEDLEVKIGDFGLATK 164 (294)
T ss_dssp SEEEEEEECCTTCBHHHHHHHHCSCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEECTTCCEEECCCTTCEE
T ss_pred CEEEEEEecCCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCC---ccccCCChHhEEEcCCCCEEEEeccCcee
Confidence 45788999998432 2357999999999999999999999999 99999999999999999999999999987
Q ss_pred cCCCcccccceeeeeccCCCChhhhccCCCCccceEEeehhhhhhhhhCCCCCCcCCCCchhhhhhhhhhhcCCCccccc
Q 045315 315 FGGDELQSNTKRIVGTYGYMSPEYALRGLFSIKSDVFSFGVLLLETLSSKKNTHFYNTDSLTLLGHAWNLWNDGRTWELM 394 (476)
Q Consensus 315 ~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~s~ksDVwSlGvvl~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 394 (476)
....... .....|+..|+|||.+.+..++.++||||||+++|||++|+.||....... ... ....... .
T Consensus 165 ~~~~~~~--~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~--~~~----~~~~~~~-~-- 233 (294)
T 2rku_A 165 VEYDGER--KKVLCGTPNYIAPEVLSKKGHSFEVDVWSIGCIMYTLLVGKPPFETSCLKE--TYL----RIKKNEY-S-- 233 (294)
T ss_dssp CCSTTCC--BCCCCSCCSSCCHHHHTTSCBCTHHHHHHHHHHHHHHHHSSCTTCCSSHHH--HHH----HHHTTCC-C--
T ss_pred cccCccc--cccccCCCCcCCcchhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHH--HHH----HHhhccC-C--
Confidence 6533221 223568999999999998889999999999999999999999986543111 110 1111110 0
Q ss_pred CcccCCCCCHHHHHHHHHHHHHchhhcccCCCCHHHHHHH
Q 045315 395 DPISQNGASYPILKRYINVALLCVQEKAADRPAMSEVVSM 434 (476)
Q Consensus 395 d~~~~~~~~~~~~~~l~~li~~Cl~~dP~~RPt~~eVl~~ 434 (476)
.+......+.+++.+||+.||++|||++|+++.
T Consensus 234 -------~~~~~~~~~~~li~~~l~~~p~~Rps~~~ll~~ 266 (294)
T 2rku_A 234 -------IPKHINPVAASLIQKMLQTDPTARPTINELLND 266 (294)
T ss_dssp -------CCTTSCHHHHHHHHHHTCSSGGGSCCGGGGGGS
T ss_pred -------CccccCHHHHHHHHHHcccChhhCcCHHHHhhC
Confidence 011223568899999999999999999999873
|
| >3qyz_A Mitogen-activated protein kinase 1; transferase, serine/threonine-protein kinase, ATP-binding CE phosphorylation; HET: CME Z8B SO4; 1.46A {Rattus norvegicus} PDB: 2fys_B 1erk_A* 3qyi_A* 3erk_A* 3qyw_A* 4erk_A* 4gsb_A* 4gt3_A* 4gva_A* 2z7l_A* 2erk_A* 1gol_A* 2gph_A 3zu7_A 3zuv_A* 3o71_A 3r63_A 3c9w_A* 2y9q_A* 4fmq_A* ... | Back alignment and structure |
|---|
Probab=99.92 E-value=7.8e-27 Score=235.69 Aligned_cols=187 Identities=22% Similarity=0.277 Sum_probs=133.7
Q ss_pred ccceeeccCCCC----CCCCCCChhhHHHHHHHHHHHHHHHhhcCCCceeecCCCccceEecCCCCceeccccceeecCC
Q 045315 242 EISFWYESYNNP----TKKGLLCWGTRVRIIEGIAQGLLYLHQYSRLRVIHRDLKASNILLDKDMNPKISDFGMARMFGG 317 (476)
Q Consensus 242 ~~~l~~Ey~~~~----~~~~~L~~~~~~~i~~qIa~gL~yLH~~~~~~ivH~DLkp~NILld~~~~~kL~DFGla~~~~~ 317 (476)
..++++||++.. .+...+++.++..++.||+.||+|||+++ |+||||||+||+++.++.+||+|||+++....
T Consensus 104 ~~~iv~e~~~~~L~~~l~~~~~~~~~~~~i~~qi~~aL~~LH~~~---ivH~Dikp~NIl~~~~~~~kl~Dfg~a~~~~~ 180 (364)
T 3qyz_A 104 DVYIVQDLMETDLYKLLKTQHLSNDHICYFLYQILRGLKYIHSAN---VLHRDLKPSNLLLNTTCDLKICDFGLARVADP 180 (364)
T ss_dssp CEEEEEECCSEEHHHHHHHCCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEECTTCCEEECCCTTCEECCG
T ss_pred eEEEEEcccCcCHHHHHHhCCCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCChHhEEECCCCCEEEEeCcceEecCC
Confidence 578899999821 12346999999999999999999999999 99999999999999999999999999987654
Q ss_pred Ccccc-cceeeeeccCCCChhhhcc-CCCCccceEEeehhhhhhhhhCCCCCCcCCCCchhhhhhhhhhhcCCCcc----
Q 045315 318 DELQS-NTKRIVGTYGYMSPEYALR-GLFSIKSDVFSFGVLLLETLSSKKNTHFYNTDSLTLLGHAWNLWNDGRTW---- 391 (476)
Q Consensus 318 ~~~~~-~~~~~~gt~~y~aPE~l~~-~~~s~ksDVwSlGvvl~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~---- 391 (476)
..... ......||+.|+|||.+.+ ..++.++|||||||++|||++|+.||........ ..............
T Consensus 181 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~--~~~i~~~~~~~~~~~~~~ 258 (364)
T 3qyz_A 181 DHDHTGFLTEYVATRWYRAPEIMLNSKGYTKSIDIWSVGCILAEMLSNRPIFPGKHYLDQ--LNHILGILGSPSQEDLNC 258 (364)
T ss_dssp GGCBCCTTCCCCSCGGGCCHHHHHTBCSCSTHHHHHHHHHHHHHHHHSSCSSCCSSGGGH--HHHHHHHHCSCCHHHHHT
T ss_pred CCCccccccccccccCCCCCHHhcCCCCCCcchhHHHHHHHHHHHHHCCCCCCCCChHHH--HHHHHHHhCCCCHHHHHH
Confidence 32211 1233578999999998764 5589999999999999999999999875442111 11110000000000
Q ss_pred -------cccCcc-cCCCCC-----HHHHHHHHHHHHHchhhcccCCCCHHHHHH
Q 045315 392 -------ELMDPI-SQNGAS-----YPILKRYINVALLCVQEKAADRPAMSEVVS 433 (476)
Q Consensus 392 -------~~~d~~-~~~~~~-----~~~~~~l~~li~~Cl~~dP~~RPt~~eVl~ 433 (476)
...... ...... ......+.+++.+||+.||++|||++|+++
T Consensus 259 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~ 313 (364)
T 3qyz_A 259 IINLKARNYLLSLPHKNKVPWNRLFPNADSKALDLLDKMLTFNPHKRIEVEQALA 313 (364)
T ss_dssp CCCHHHHHHHHTSCCCCCCCHHHHCTTSCHHHHHHHHHHTCSSTTTSCCHHHHHT
T ss_pred hhhhhHHHHHHhcCCccCCCHHHhCCCCCHHHHHHHHHHcCCChhhCCCHHHHhc
Confidence 000000 000000 112356889999999999999999999986
|
| >2pml_X PFPK7, Ser/Thr protein kinase; phosphorylati transferase, transferase; HET: ANP; 2.60A {Plasmodium falciparum} PDB: 2pmn_X* 2pmo_X* | Back alignment and structure |
|---|
Probab=99.92 E-value=6.8e-26 Score=226.68 Aligned_cols=181 Identities=24% Similarity=0.352 Sum_probs=134.2
Q ss_pred cccceeeccCCC------------CCC--CCCCChhhHHHHHHHHHHHHHHHhh-cCCCceeecCCCccceEecCCCCce
Q 045315 241 DEISFWYESYNN------------PTK--KGLLCWGTRVRIIEGIAQGLLYLHQ-YSRLRVIHRDLKASNILLDKDMNPK 305 (476)
Q Consensus 241 ~~~~l~~Ey~~~------------~~~--~~~L~~~~~~~i~~qIa~gL~yLH~-~~~~~ivH~DLkp~NILld~~~~~k 305 (476)
+.++++|||++. ... ...+++.++..++.||+.||+|||+ .+ |+||||||+||+++.++.+|
T Consensus 116 ~~~~lv~e~~~~~~L~~~~~~~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~~---i~H~dl~p~Nil~~~~~~~k 192 (348)
T 2pml_X 116 DEVYIIYEYMENDSILKFDEYFFVLDKNYTCFIPIQVIKCIIKSVLNSFSYIHNEKN---ICHRDVKPSNILMDKNGRVK 192 (348)
T ss_dssp SEEEEEEECCTTCBSSEESSSEESSCSSSCCCCCHHHHHHHHHHHHHHHHHHHHTSC---EECCCCCGGGEEECTTSCEE
T ss_pred CeEEEEEeccCCCcHHHHHHHhhhhhhccccCCCHHHHHHHHHHHHHHHHHHhccCC---EeecCCChHhEEEcCCCcEE
Confidence 467888999873 222 5689999999999999999999999 88 99999999999999999999
Q ss_pred eccccceeecCCCcccccceeeeeccCCCChhhhccC-CCCc-cceEEeehhhhhhhhhCCCCCCcCCCCchhhhhhhhh
Q 045315 306 ISDFGMARMFGGDELQSNTKRIVGTYGYMSPEYALRG-LFSI-KSDVFSFGVLLLETLSSKKNTHFYNTDSLTLLGHAWN 383 (476)
Q Consensus 306 L~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~-~~s~-ksDVwSlGvvl~elltG~~p~~~~~~~~~~~~~~~~~ 383 (476)
|+|||++....... .....|+..|+|||.+.+. .++. ++||||||+++|||++|+.||........ ....
T Consensus 193 l~dfg~~~~~~~~~----~~~~~~~~~y~aPE~~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~-~~~~--- 264 (348)
T 2pml_X 193 LSDFGESEYMVDKK----IKGSRGTYEFMPPEFFSNESSYNGAKVDIWSLGICLYVMFYNVVPFSLKISLVE-LFNN--- 264 (348)
T ss_dssp ECCCTTCEECBTTE----ECSSCSCGGGCCGGGGSSCCCEEHHHHHHHHHHHHHHHHHHSSCSSCCSSCSHH-HHHH---
T ss_pred Eecccccccccccc----ccCCCCCcCccCchhhcCCCCCCcchhhHHHHHHHHHHHHhCCCCCCCCCcHHH-HHHH---
Confidence 99999998765431 2235689999999999877 6666 99999999999999999999875443211 1111
Q ss_pred hhcCCCccc------ccCcccC---CCCCHHHHHHHHHHHHHchhhcccCCCCHHHHHH
Q 045315 384 LWNDGRTWE------LMDPISQ---NGASYPILKRYINVALLCVQEKAADRPAMSEVVS 433 (476)
Q Consensus 384 ~~~~~~~~~------~~d~~~~---~~~~~~~~~~l~~li~~Cl~~dP~~RPt~~eVl~ 433 (476)
...+.... ...+... ..........+.+++.+||+.||++||+++|+++
T Consensus 265 -i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dP~~Rps~~e~l~ 322 (348)
T 2pml_X 265 -IRTKNIEYPLDRNHFLYPLTNKKSTCSNNFLSNEDIDFLKLFLRKNPAERITSEDALK 322 (348)
T ss_dssp -HTSCCCCCCCSSSSSTTTTCC--------CCCHHHHHHHHHHCCSSGGGSCCHHHHHT
T ss_pred -HhccCcCCccchhhhhccccccccccchhhcCHHHHHHHHHHccCChhhCCCHHHHhc
Confidence 11111100 0000000 0001223467889999999999999999999986
|
| >2rio_A Serine/threonine-protein kinase/endoribonuclease IRE1; protein-nucleotide complex, ATP-binding, endoplasmic reticulum, glycoprotein; HET: ADP; 2.40A {Saccharomyces cerevisiae} PDB: 3lj0_A* 3lj1_A* 3lj2_A* 3fbv_A* 3sdm_A* 3sdj_A* | Back alignment and structure |
|---|
Probab=99.92 E-value=5.3e-26 Score=235.32 Aligned_cols=179 Identities=21% Similarity=0.276 Sum_probs=123.5
Q ss_pred cccceeeccCCC--------CC-CC---CCCChhhHHHHHHHHHHHHHHHhhcCCCceeecCCCccceEecCC-------
Q 045315 241 DEISFWYESYNN--------PT-KK---GLLCWGTRVRIIEGIAQGLLYLHQYSRLRVIHRDLKASNILLDKD------- 301 (476)
Q Consensus 241 ~~~~l~~Ey~~~--------~~-~~---~~L~~~~~~~i~~qIa~gL~yLH~~~~~~ivH~DLkp~NILld~~------- 301 (476)
+..++++||++. .. .. ...++.+++.++.||+.||+|||+++ |+||||||+|||++.+
T Consensus 82 ~~~~lv~E~~~gsL~~~l~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~---ivHrDLkp~NILl~~~~~~~~~~ 158 (434)
T 2rio_A 82 RFLYIALELCNLNLQDLVESKNVSDENLKLQKEYNPISLLRQIASGVAHLHSLK---IIHRDLKPQNILVSTSSRFTADQ 158 (434)
T ss_dssp SEEEEEECCCSEEHHHHHHTC------------CCHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEEECCHHHHSCC
T ss_pred CeEEEEEecCCCCHHHHHhccCCCchhhhhccchhHHHHHHHHHHHHHHHHHCC---ccccCCChHhEEEecCccccccc
Confidence 457788999861 10 11 12245567899999999999999999 9999999999999754
Q ss_pred ------CCceeccccceeecCCCccc--ccceeeeeccCCCChhhhcc-------CCCCccceEEeehhhhhhhhh-CCC
Q 045315 302 ------MNPKISDFGMARMFGGDELQ--SNTKRIVGTYGYMSPEYALR-------GLFSIKSDVFSFGVLLLETLS-SKK 365 (476)
Q Consensus 302 ------~~~kL~DFGla~~~~~~~~~--~~~~~~~gt~~y~aPE~l~~-------~~~s~ksDVwSlGvvl~ellt-G~~ 365 (476)
+.+||+|||+++........ .......||+.|+|||++.+ ..++.++|||||||++|||++ |+.
T Consensus 159 ~~~~~~~~~kL~DFG~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~DiwSlG~il~ellt~g~~ 238 (434)
T 2rio_A 159 QTGAENLRILISDFGLCKKLDSGQSSFRTNLNNPSGTSGWRAPELLEESNNLQTKRRLTRSIDIFSMGCVFYYILSKGKH 238 (434)
T ss_dssp TTCCCSCEEEECCCTTCEECCC--------------CCTTSCHHHHSCCCTTSCCCCCCTHHHHHHHHHHHHHHHTTSCC
T ss_pred ccCCCceEEEEcccccceecCCCCccceeeecCCCCCCCccCHHHhccccccccccCcchhhhhHhHHHHHHHHHhCCCC
Confidence 47999999999987543221 12234579999999999975 668999999999999999999 899
Q ss_pred CCCcCCCCchhhhhhhhhhhcCCCcccccCcccCCCCCHHHHHHHHHHHHHchhhcccCCCCHHHHHH
Q 045315 366 NTHFYNTDSLTLLGHAWNLWNDGRTWELMDPISQNGASYPILKRYINVALLCVQEKAADRPAMSEVVS 433 (476)
Q Consensus 366 p~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~l~~li~~Cl~~dP~~RPt~~eVl~ 433 (476)
||........... ...... +.............+.+++.+||+.||++|||+.+|++
T Consensus 239 Pf~~~~~~~~~i~-------~~~~~~----~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rps~~eil~ 295 (434)
T 2rio_A 239 PFGDKYSRESNII-------RGIFSL----DEMKCLHDRSLIAEATDLISQMIDHDPLKRPTAMKVLR 295 (434)
T ss_dssp TTCSTTTHHHHHH-------HTCCCC----CCCTTCCCHHHHHHHHHHHHHHTCSSGGGSCCHHHHHT
T ss_pred CCCCchhhHHHHh-------cCCCCc----ccccccccccchHHHHHHHHHHhhCChhhCCCHHHHHh
Confidence 9864322211111 000000 01111223456678999999999999999999999975
|
| >2y7j_A Phosphorylase B kinase gamma catalytic chain, testis/liver isoform; transferase; HET: B49; 2.50A {Homo sapiens} PDB: 1h0t_A 1lp1_B 1q2n_A 2spz_A 3mzw_B* 1ss1_A 2jwd_A 1bdc_A 1bdd_A 1fc2_C* 2b87_A 2b88_A 1h0t_B 1lp1_A 2b87_B 2b89_A 3s1k_A | Back alignment and structure |
|---|
Probab=99.92 E-value=4.7e-26 Score=230.28 Aligned_cols=175 Identities=21% Similarity=0.324 Sum_probs=133.2
Q ss_pred cccceeeccCCCCC------CCCCCChhhHHHHHHHHHHHHHHHhhcCCCceeecCCCccceEecCCCCceeccccceee
Q 045315 241 DEISFWYESYNNPT------KKGLLCWGTRVRIIEGIAQGLLYLHQYSRLRVIHRDLKASNILLDKDMNPKISDFGMARM 314 (476)
Q Consensus 241 ~~~~l~~Ey~~~~~------~~~~L~~~~~~~i~~qIa~gL~yLH~~~~~~ivH~DLkp~NILld~~~~~kL~DFGla~~ 314 (476)
+..+++|||++... .+..+++..+..++.||+.||+|||+.+ |+|+||||+||+++.++.+||+|||++..
T Consensus 173 ~~~~lv~e~~~g~~L~~~l~~~~~l~~~~~~~i~~qi~~~L~~LH~~g---i~H~Dlkp~NIl~~~~~~ikl~DfG~~~~ 249 (365)
T 2y7j_A 173 SFMFLVFDLMRKGELFDYLTEKVALSEKETRSIMRSLLEAVSFLHANN---IVHRDLKPENILLDDNMQIRLSDFGFSCH 249 (365)
T ss_dssp SEEEEEECCCTTCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEECTTCCEEECCCTTCEE
T ss_pred CEEEEEEEeCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCCHHHEEECCCCCEEEEecCcccc
Confidence 46789999998432 2457999999999999999999999999 99999999999999999999999999987
Q ss_pred cCCCcccccceeeeeccCCCChhhhcc------CCCCccceEEeehhhhhhhhhCCCCCCcCCCCchhhhhhhhhhhcCC
Q 045315 315 FGGDELQSNTKRIVGTYGYMSPEYALR------GLFSIKSDVFSFGVLLLETLSSKKNTHFYNTDSLTLLGHAWNLWNDG 388 (476)
Q Consensus 315 ~~~~~~~~~~~~~~gt~~y~aPE~l~~------~~~s~ksDVwSlGvvl~elltG~~p~~~~~~~~~~~~~~~~~~~~~~ 388 (476)
+..... .....||+.|+|||++.+ ..++.++|||||||++|||++|+.||..... ....... ..+
T Consensus 250 ~~~~~~---~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~Di~slG~il~ell~g~~pf~~~~~--~~~~~~i----~~~ 320 (365)
T 2y7j_A 250 LEPGEK---LRELCGTPGYLAPEILKCSMDETHPGYGKEVDLWACGVILFTLLAGSPPFWHRRQ--ILMLRMI----MEG 320 (365)
T ss_dssp CCTTCC---BCCCCSCGGGCCHHHHHHTTCTTSCCBCTTHHHHHHHHHHHHHHHSSCSSCCSSH--HHHHHHH----HHT
T ss_pred cCCCcc---cccCCCCCCccChhhccccccccCcCCCchhhHHhHHHHHHHHHHCCCCCCCCCH--HHHHHHH----HhC
Confidence 654322 223578999999999863 3588999999999999999999999864321 1111111 111
Q ss_pred CcccccCcccCCCCCHHHHHHHHHHHHHchhhcccCCCCHHHHHH
Q 045315 389 RTWELMDPISQNGASYPILKRYINVALLCVQEKAADRPAMSEVVS 433 (476)
Q Consensus 389 ~~~~~~d~~~~~~~~~~~~~~l~~li~~Cl~~dP~~RPt~~eVl~ 433 (476)
... ...+.. ......+.+++.+||+.||++||+++|+++
T Consensus 321 ~~~-~~~~~~-----~~~~~~~~~li~~~L~~dP~~Rps~~ell~ 359 (365)
T 2y7j_A 321 QYQ-FSSPEW-----DDRSSTVKDLISRLLQVDPEARLTAEQALQ 359 (365)
T ss_dssp CCC-CCHHHH-----SSSCHHHHHHHHHHSCSSTTTSCCHHHHHH
T ss_pred CCC-CCCccc-----ccCCHHHHHHHHHHcCCChhHCcCHHHHhc
Confidence 100 000000 012346889999999999999999999986
|
| >2owb_A Serine/threonine-protein kinase PLK1; catalytic domain, POLO-like kinase1, transfera; HET: 626; 2.10A {Homo sapiens} PDB: 2ou7_A* 3fc2_A* 3thb_A* | Back alignment and structure |
|---|
Probab=99.92 E-value=1.4e-26 Score=231.26 Aligned_cols=172 Identities=25% Similarity=0.315 Sum_probs=134.7
Q ss_pred cccceeeccCCCCC------CCCCCChhhHHHHHHHHHHHHHHHhhcCCCceeecCCCccceEecCCCCceeccccceee
Q 045315 241 DEISFWYESYNNPT------KKGLLCWGTRVRIIEGIAQGLLYLHQYSRLRVIHRDLKASNILLDKDMNPKISDFGMARM 314 (476)
Q Consensus 241 ~~~~l~~Ey~~~~~------~~~~L~~~~~~~i~~qIa~gL~yLH~~~~~~ivH~DLkp~NILld~~~~~kL~DFGla~~ 314 (476)
+..+++|||++... .++.+++.++..++.||+.||+|||+++ |+||||||+||+++.++.+||+|||++..
T Consensus 114 ~~~~lv~e~~~~~~L~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~---ivH~dlkp~NIl~~~~~~~kl~Dfg~~~~ 190 (335)
T 2owb_A 114 DFVFVVLELCRRRSLLELHKRRKALTEPEARYYLRQIVLGCQYLHRNR---VIHRDLKLGNLFLNEDLEVKIGDFGLATK 190 (335)
T ss_dssp SEEEEEECCCTTCBHHHHHHHHCSCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCCGGGEEECTTCCEEECCCTTCEE
T ss_pred CeEEEEEecCCCCCHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHHCC---CEecCCCchhEEEcCCCCEEEeeccCcee
Confidence 45788999998432 2357999999999999999999999999 99999999999999999999999999987
Q ss_pred cCCCcccccceeeeeccCCCChhhhccCCCCccceEEeehhhhhhhhhCCCCCCcCCCCchhhhhhhhhhhcCCCccccc
Q 045315 315 FGGDELQSNTKRIVGTYGYMSPEYALRGLFSIKSDVFSFGVLLLETLSSKKNTHFYNTDSLTLLGHAWNLWNDGRTWELM 394 (476)
Q Consensus 315 ~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~s~ksDVwSlGvvl~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 394 (476)
....... .....|+..|+|||.+.+..++.++||||||+++|||++|+.||....... ... ....... .
T Consensus 191 ~~~~~~~--~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~--~~~----~~~~~~~-~-- 259 (335)
T 2owb_A 191 VEYDGER--KKVLCGTPNYIAPEVLSKKGHSFEVDVWSIGCIMYTLLVGKPPFETSCLKE--TYL----RIKKNEY-S-- 259 (335)
T ss_dssp CCSTTCC--BCCCCSCCSSCCHHHHHTSCBCTHHHHHHHHHHHHHHHHSSCTTCCSSHHH--HHH----HHHHTCC-C--
T ss_pred cccCccc--ccccCCCccccCHHHhccCCCCchhhHHHHHHHHHHHHHCcCCCCCCCHHH--HHH----HHhcCCC-C--
Confidence 6533221 223568999999999999889999999999999999999999986543111 110 0111110 0
Q ss_pred CcccCCCCCHHHHHHHHHHHHHchhhcccCCCCHHHHHH
Q 045315 395 DPISQNGASYPILKRYINVALLCVQEKAADRPAMSEVVS 433 (476)
Q Consensus 395 d~~~~~~~~~~~~~~l~~li~~Cl~~dP~~RPt~~eVl~ 433 (476)
. +......+.+++.+||+.||++||+++|+++
T Consensus 260 ---~----~~~~~~~~~~li~~~l~~dp~~Rps~~ell~ 291 (335)
T 2owb_A 260 ---I----PKHINPVAASLIQKMLQTDPTARPTINELLN 291 (335)
T ss_dssp ---C----CTTSCHHHHHHHHHHTCSSGGGSCCGGGGGG
T ss_pred ---C----CccCCHHHHHHHHHHccCChhHCcCHHHHhc
Confidence 0 1112346788999999999999999999986
|
| >3com_A Serine/threonine-protein kinase 4; MST1, STE20-like kinase, PSI, structural genomics, protein structure initiative; HET: TPO; 2.20A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.92 E-value=2.7e-26 Score=226.28 Aligned_cols=175 Identities=20% Similarity=0.299 Sum_probs=135.1
Q ss_pred cccceeeccCCCC-------CCCCCCChhhHHHHHHHHHHHHHHHhhcCCCceeecCCCccceEecCCCCceecccccee
Q 045315 241 DEISFWYESYNNP-------TKKGLLCWGTRVRIIEGIAQGLLYLHQYSRLRVIHRDLKASNILLDKDMNPKISDFGMAR 313 (476)
Q Consensus 241 ~~~~l~~Ey~~~~-------~~~~~L~~~~~~~i~~qIa~gL~yLH~~~~~~ivH~DLkp~NILld~~~~~kL~DFGla~ 313 (476)
+..++++||++.. .....+++.++..++.||+.||+|||+.+ ++|+||||+||+++.++.+||+|||++.
T Consensus 97 ~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~---i~H~dl~p~Nil~~~~~~~kl~dfg~~~ 173 (314)
T 3com_A 97 TDLWIVMEYCGAGSVSDIIRLRNKTLTEDEIATILQSTLKGLEYLHFMR---KIHRDIKAGNILLNTEGHAKLADFGVAG 173 (314)
T ss_dssp TEEEEEEECCTTEEHHHHHHHHTCCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEECTTCCEEECCCTTCE
T ss_pred CEEEEEeecCCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCC---CcCCCcCHHHEEECCCCCEEEeecccch
Confidence 4578899998732 13567999999999999999999999999 9999999999999999999999999998
Q ss_pred ecCCCcccccceeeeeccCCCChhhhccCCCCccceEEeehhhhhhhhhCCCCCCcCCCCchhhhhhhhhhhcCCCcccc
Q 045315 314 MFGGDELQSNTKRIVGTYGYMSPEYALRGLFSIKSDVFSFGVLLLETLSSKKNTHFYNTDSLTLLGHAWNLWNDGRTWEL 393 (476)
Q Consensus 314 ~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~s~ksDVwSlGvvl~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~ 393 (476)
....... ......|+..|+|||.+.+..++.++||||||+++|+|++|+.||....... .. .... .......
T Consensus 174 ~~~~~~~--~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~--~~---~~~~-~~~~~~~ 245 (314)
T 3com_A 174 QLTDTMA--KRNTVIGTPFWMAPEVIQEIGYNCVADIWSLGITAIEMAEGKPPYADIHPMR--AI---FMIP-TNPPPTF 245 (314)
T ss_dssp ECBTTBS--CBCCCCSCGGGCCHHHHSSSCBCTTHHHHHHHHHHHHHHHSSCTTTTSCHHH--HH---HHHH-HSCCCCC
T ss_pred hhhhhcc--ccCccCCCCCccChhhcCCCCCCccccHHHHHHHHHHHHhCCCCCCCCChHH--HH---HHHh-cCCCccc
Confidence 7654322 1223568999999999999899999999999999999999999986433111 10 0000 0100000
Q ss_pred cCcccCCCCCHHHHHHHHHHHHHchhhcccCCCCHHHHHH
Q 045315 394 MDPISQNGASYPILKRYINVALLCVQEKAADRPAMSEVVS 433 (476)
Q Consensus 394 ~d~~~~~~~~~~~~~~l~~li~~Cl~~dP~~RPt~~eVl~ 433 (476)
. ........+.+++.+||+.||++|||+.++++
T Consensus 246 ~-------~~~~~~~~l~~li~~~l~~dp~~Rpt~~~ll~ 278 (314)
T 3com_A 246 R-------KPELWSDNFTDFVKQCLVKSPEQRATATQLLQ 278 (314)
T ss_dssp S-------SGGGSCHHHHHHHHHHTCSCTTTSCCHHHHTT
T ss_pred C-------CcccCCHHHHHHHHHHccCChhhCcCHHHHHh
Confidence 0 11122357889999999999999999999975
|
| >2x7f_A TRAF2 and NCK-interacting protein kinase; serine/threonine-protein kinase, phosphoprotein; HET: 824; 2.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.92 E-value=2.2e-26 Score=228.16 Aligned_cols=174 Identities=25% Similarity=0.331 Sum_probs=125.8
Q ss_pred cccceeeccCCCC--------CCCCCCChhhHHHHHHHHHHHHHHHhhcCCCceeecCCCccceEecCCCCceeccccce
Q 045315 241 DEISFWYESYNNP--------TKKGLLCWGTRVRIIEGIAQGLLYLHQYSRLRVIHRDLKASNILLDKDMNPKISDFGMA 312 (476)
Q Consensus 241 ~~~~l~~Ey~~~~--------~~~~~L~~~~~~~i~~qIa~gL~yLH~~~~~~ivH~DLkp~NILld~~~~~kL~DFGla 312 (476)
+..+++|||++.. .....+++..+..++.||+.||+|||+.+ |+|+||||+||+++.++.+||+|||++
T Consensus 100 ~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~---ivH~dlkp~NIl~~~~~~~kl~Dfg~~ 176 (326)
T 2x7f_A 100 DQLWLVMEFCGAGSVTDLIKNTKGNTLKEEWIAYICREILRGLSHLHQHK---VIHRDIKGQNVLLTENAEVKLVDFGVS 176 (326)
T ss_dssp CEEEEEEECCTTEEHHHHHHHSGGGCCCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCSGGGEEECTTCCEEECCCTTT
T ss_pred ceEEEEEEcCCCCcHHHHHHhcccCCCCHHHHHHHHHHHHHHHHHHHHCC---ccccCCcHHHEEEcCCCCEEEeeCcCc
Confidence 3578899999732 23457999999999999999999999999 999999999999999999999999999
Q ss_pred eecCCCcccccceeeeeccCCCChhhhc-----cCCCCccceEEeehhhhhhhhhCCCCCCcCCCCchhhhhhhhhhhcC
Q 045315 313 RMFGGDELQSNTKRIVGTYGYMSPEYAL-----RGLFSIKSDVFSFGVLLLETLSSKKNTHFYNTDSLTLLGHAWNLWND 387 (476)
Q Consensus 313 ~~~~~~~~~~~~~~~~gt~~y~aPE~l~-----~~~~s~ksDVwSlGvvl~elltG~~p~~~~~~~~~~~~~~~~~~~~~ 387 (476)
........ ......|+..|+|||.+. +..++.++|||||||++|+|++|+.||....... .. ......
T Consensus 177 ~~~~~~~~--~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~--~~---~~~~~~ 249 (326)
T 2x7f_A 177 AQLDRTVG--RRNTFIGTPYWMAPEVIACDENPDATYDFKSDLWSLGITAIEMAEGAPPLCDMHPMR--AL---FLIPRN 249 (326)
T ss_dssp C---------------CCGGGCCHHHHC--------CCTTHHHHHHHHHHHHHHHSSCTTTTSCHHH--HH---HHHHHS
T ss_pred eecCcCcc--ccccccCCccccChhhhccccccCcCCCccchHHHHHHHHHHHHhCCCCCCCCcHHH--HH---HHhhcC
Confidence 86543221 122356899999999987 5678999999999999999999999986433111 11 011111
Q ss_pred CCcccccCcccCCCCCHHHHHHHHHHHHHchhhcccCCCCHHHHHH
Q 045315 388 GRTWELMDPISQNGASYPILKRYINVALLCVQEKAADRPAMSEVVS 433 (476)
Q Consensus 388 ~~~~~~~d~~~~~~~~~~~~~~l~~li~~Cl~~dP~~RPt~~eVl~ 433 (476)
...... .......+.+++.+||+.||++||+++++++
T Consensus 250 -~~~~~~--------~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~ 286 (326)
T 2x7f_A 250 -PAPRLK--------SKKWSKKFQSFIESCLVKNHSQRPATEQLMK 286 (326)
T ss_dssp -CCCCCS--------CSCSCHHHHHHHHHHCCSSGGGSCCHHHHHT
T ss_pred -ccccCC--------ccccCHHHHHHHHHHhccChhhCCCHHHHhh
Confidence 110100 1112357889999999999999999999987
|
| >3dzo_A Rhoptry kinase domain; parasitic disease, transferase, structural genomics, structural genomics consortium, SGC; 1.80A {Toxoplasma gondii} | Back alignment and structure |
|---|
Probab=99.92 E-value=2.8e-26 Score=235.87 Aligned_cols=150 Identities=15% Similarity=0.169 Sum_probs=118.3
Q ss_pred CCCCCCChhhHHHHHHHHHHHHHHHhhcCCCceeecCCCccceEecCCCCceeccccceeecCCCcccccceeeeeccCC
Q 045315 254 TKKGLLCWGTRVRIIEGIAQGLLYLHQYSRLRVIHRDLKASNILLDKDMNPKISDFGMARMFGGDELQSNTKRIVGTYGY 333 (476)
Q Consensus 254 ~~~~~L~~~~~~~i~~qIa~gL~yLH~~~~~~ivH~DLkp~NILld~~~~~kL~DFGla~~~~~~~~~~~~~~~~gt~~y 333 (476)
...+.+++..++.++.||++||+|||+++ |+||||||+|||++.++.+||+|||+++..... .....| ..|
T Consensus 203 ~~~~~l~~~~~~~i~~qi~~aL~~LH~~~---iiHrDiKp~NILl~~~~~~kL~DFG~a~~~~~~-----~~~~~g-~~y 273 (413)
T 3dzo_A 203 STHKSLVHHARLQLTLQVIRLLASLHHYG---LVHTYLRPVDIVLDQRGGVFLTGFEHLVRDGAS-----AVSPIG-RGF 273 (413)
T ss_dssp TTSHHHHHHHHHHHHHHHHHHHHHHHHTT---EECSCCCGGGEEECTTCCEEECCGGGCEETTEE-----ECCCCC-TTT
T ss_pred ccCCCCCHHHHHHHHHHHHHHHHHHHhCC---cccCCcccceEEEecCCeEEEEeccceeecCCc-----cccCCC-Cce
Confidence 34567899999999999999999999999 999999999999999999999999999875432 223457 999
Q ss_pred CChhhh----------ccCCCCccceEEeehhhhhhhhhCCCCCCcCCCCchhhhhhhhhhhcCCCcccccCcccCCCCC
Q 045315 334 MSPEYA----------LRGLFSIKSDVFSFGVLLLETLSSKKNTHFYNTDSLTLLGHAWNLWNDGRTWELMDPISQNGAS 403 (476)
Q Consensus 334 ~aPE~l----------~~~~~s~ksDVwSlGvvl~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~ 403 (476)
+|||++ ....++.++|||||||++|||++|+.||........ .. ..+.. ..
T Consensus 274 ~aPE~~~~~~~~~~~~~~~~~~~~~DvwSlGvil~elltg~~Pf~~~~~~~~--~~------------~~~~~--~~--- 334 (413)
T 3dzo_A 274 APPETTAERMLPFGQHHPTLMTFAFDTWTLGLAIYWIWCADLPNTDDAALGG--SE------------WIFRS--CK--- 334 (413)
T ss_dssp CCHHHHHHHTSTTGGGCCEEECHHHHHHHHHHHHHHHHHSSCCCCTTGGGSC--SG------------GGGSS--CC---
T ss_pred eCchhhhccccccccccCcCCCchhhHHHHHHHHHHHHHCCCCCCCcchhhh--HH------------HHHhh--cc---
Confidence 999999 455688999999999999999999999864331110 00 00000 00
Q ss_pred HHHHHHHHHHHHHchhhcccCCCCHHHHH
Q 045315 404 YPILKRYINVALLCVQEKAADRPAMSEVV 432 (476)
Q Consensus 404 ~~~~~~l~~li~~Cl~~dP~~RPt~~eVl 432 (476)
...+.+.+++.+||+.||++||++.+++
T Consensus 335 -~~~~~~~~li~~~l~~dP~~Rpt~~~~l 362 (413)
T 3dzo_A 335 -NIPQPVRALLEGFLRYPKEDRLLPLQAM 362 (413)
T ss_dssp -CCCHHHHHHHHHHTCSSGGGSCCHHHHT
T ss_pred -cCCHHHHHHHHHHccCChhhCcCHHHHH
Confidence 1125688999999999999999976653
|
| >2b9h_A MAP kinase FUS3, mitogen-activated protein kinase FUS3; transferase; HET: ADP; 1.55A {Saccharomyces cerevisiae} PDB: 2b9i_A* 2b9j_A* 2f49_A 2fa2_A 2b9f_A* 2f9g_A* | Back alignment and structure |
|---|
Probab=99.92 E-value=1.4e-26 Score=232.08 Aligned_cols=188 Identities=22% Similarity=0.252 Sum_probs=131.5
Q ss_pred cccceeeccCCCC----CCCCCCChhhHHHHHHHHHHHHHHHhhcCCCceeecCCCccceEecCCCCceeccccceeecC
Q 045315 241 DEISFWYESYNNP----TKKGLLCWGTRVRIIEGIAQGLLYLHQYSRLRVIHRDLKASNILLDKDMNPKISDFGMARMFG 316 (476)
Q Consensus 241 ~~~~l~~Ey~~~~----~~~~~L~~~~~~~i~~qIa~gL~yLH~~~~~~ivH~DLkp~NILld~~~~~kL~DFGla~~~~ 316 (476)
+..++++||++.. ...+.+++.++..++.||+.||+|||+++ |+||||||+||+++.++.+||+|||+++...
T Consensus 87 ~~~~lv~e~~~~~L~~~~~~~~~~~~~~~~~~~qi~~~L~~LH~~~---ivH~Dlkp~Nil~~~~~~~kl~Dfg~a~~~~ 163 (353)
T 2b9h_A 87 NEVYIIQELMQTDLHRVISTQMLSDDHIQYFIYQTLRAVKVLHGSN---VIHRDLKPSNLLINSNCDLKVCDFGLARIID 163 (353)
T ss_dssp CCEEEEECCCSEEHHHHHHHCCCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCCGGGEEECTTCCEEECCCTTCEECC
T ss_pred ceEEEEEeccCccHHHHHhhcCCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCCHHHeEEcCCCcEEEEecccccccc
Confidence 3577889998721 12346999999999999999999999999 9999999999999999999999999998765
Q ss_pred CCcccc--------cceeeeeccCCCChhhhcc-CCCCccceEEeehhhhhhhhhCCCCCCcCCCCchhhhhhhhhhhcC
Q 045315 317 GDELQS--------NTKRIVGTYGYMSPEYALR-GLFSIKSDVFSFGVLLLETLSSKKNTHFYNTDSLTLLGHAWNLWND 387 (476)
Q Consensus 317 ~~~~~~--------~~~~~~gt~~y~aPE~l~~-~~~s~ksDVwSlGvvl~elltG~~p~~~~~~~~~~~~~~~~~~~~~ 387 (476)
...... ......||..|+|||.+.+ ..++.++|||||||++|||++|+.||........ ..........
T Consensus 164 ~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~--~~~~~~~~~~ 241 (353)
T 2b9h_A 164 ESAADNSEPTGQQSGMVEFVATRWYRAPEVMLTSAKYSRAMDVWSCGCILAELFLRRPIFPGRDYRHQ--LLLIFGIIGT 241 (353)
T ss_dssp ----------------CCCCCCGGGCCHHHHHSCCCCCHHHHHHHHHHHHHHHHHSSCSCCCSSHHHH--HHHHHHHHCC
T ss_pred cccccccCccccccchhhccccccccCCeeeccCCCccchhhHHHHHHHHHHHHhCCCCCCCCCcHHH--HHHHHHHhCC
Confidence 322111 1122468999999998764 7789999999999999999999999875431111 0000000000
Q ss_pred CC---cccc---------cCccc-CCCC-----CHHHHHHHHHHHHHchhhcccCCCCHHHHHH
Q 045315 388 GR---TWEL---------MDPIS-QNGA-----SYPILKRYINVALLCVQEKAADRPAMSEVVS 433 (476)
Q Consensus 388 ~~---~~~~---------~d~~~-~~~~-----~~~~~~~l~~li~~Cl~~dP~~RPt~~eVl~ 433 (476)
.. .... ..... .... .......+.+++.+||+.||++|||++|+++
T Consensus 242 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~ 305 (353)
T 2b9h_A 242 PHSDNDLRCIESPRAREYIKSLPMYPAAPLEKMFPRVNPKGIDLLQRMLVFDPAKRITAKEALE 305 (353)
T ss_dssp CCSTTTTTTCCCHHHHHHHHTSCCCCCCCHHHHSTTSCHHHHHHHHHHSCSSGGGSCCHHHHHT
T ss_pred CchhccccccccchhhHHhhcccCCCCcchhhhcccCCHHHHHHHHHhcCcCcccCCCHHHHhc
Confidence 00 0000 00000 0000 0122457889999999999999999999987
|
| >3pg1_A Mitogen-activated protein kinase, putative (MAP K protein); EPK Ser/Thr protein kinase fold, Ser/Thr protein kinase, TRA; 1.95A {Leishmania major} PDB: 3uib_A* | Back alignment and structure |
|---|
Probab=99.92 E-value=1.6e-26 Score=232.87 Aligned_cols=184 Identities=19% Similarity=0.201 Sum_probs=126.4
Q ss_pred ccceeeccCCC------CCCCCCCChhhHHHHHHHHHHHHHHHhhcCCCceeecCCCccceEecCCCCceeccccceeec
Q 045315 242 EISFWYESYNN------PTKKGLLCWGTRVRIIEGIAQGLLYLHQYSRLRVIHRDLKASNILLDKDMNPKISDFGMARMF 315 (476)
Q Consensus 242 ~~~l~~Ey~~~------~~~~~~L~~~~~~~i~~qIa~gL~yLH~~~~~~ivH~DLkp~NILld~~~~~kL~DFGla~~~ 315 (476)
.++++|||++. ...+..+++.++..++.||+.||+|||+++ |+||||||+||+++.++.+||+|||+++..
T Consensus 108 ~~~lv~e~~~~~l~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~---ivH~Dlkp~NIl~~~~~~~kl~Dfg~~~~~ 184 (362)
T 3pg1_A 108 KLYLVTELMRTDLAQVIHDQRIVISPQHIQYFMYHILLGLHVLHEAG---VVHRDLHPGNILLADNNDITICDFNLARED 184 (362)
T ss_dssp EEEEEEECCSEEHHHHHHCTTSCCCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCCGGGEEECTTCCEEECCTTC----
T ss_pred eEEEEEccCCCCHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHHCc---CEecCCChHHEEEcCCCCEEEEecCccccc
Confidence 46889999982 134557999999999999999999999999 999999999999999999999999999754
Q ss_pred CCCcccccceeeeeccCCCChhhhcc-CCCCccceEEeehhhhhhhhhCCCCCCcCCCCchhhhhhhhhhhcCCCc----
Q 045315 316 GGDELQSNTKRIVGTYGYMSPEYALR-GLFSIKSDVFSFGVLLLETLSSKKNTHFYNTDSLTLLGHAWNLWNDGRT---- 390 (476)
Q Consensus 316 ~~~~~~~~~~~~~gt~~y~aPE~l~~-~~~s~ksDVwSlGvvl~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~---- 390 (476)
.... ......++..|+|||.+.+ ..++.++|||||||++|+|++|+.||...... ...............
T Consensus 185 ~~~~---~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~--~~~~~i~~~~~~~~~~~~~ 259 (362)
T 3pg1_A 185 TADA---NKTHYVTHRWYRAPELVMQFKGFTKLVDMWSAGCVMAEMFNRKALFRGSTFY--NQLNKIVEVVGTPKIEDVV 259 (362)
T ss_dssp --------------CGGGCCHHHHTTCTTCCTHHHHHHHHHHHHHHHHSSCSCCCSSHH--HHHHHHHHHHCCCCHHHHH
T ss_pred cccc---ccceecccceecCcHHhcCCCCCCcHhHHHhHHHHHHHHHhCCCCCCCCCHH--HHHHHHHHHcCCCChHHhh
Confidence 4322 1233568999999999886 67899999999999999999999998754311 111111100000000
Q ss_pred -------ccccCcccCC-------CCCHHHHHHHHHHHHHchhhcccCCCCHHHHHH
Q 045315 391 -------WELMDPISQN-------GASYPILKRYINVALLCVQEKAADRPAMSEVVS 433 (476)
Q Consensus 391 -------~~~~d~~~~~-------~~~~~~~~~l~~li~~Cl~~dP~~RPt~~eVl~ 433 (476)
.+........ .........+.+++.+||+.||++|||+.|+++
T Consensus 260 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~ 316 (362)
T 3pg1_A 260 MFSSPSARDYLRNSLSNVPARAWTAVVPTADPVALDLIAKMLEFNPQRRISTEQALR 316 (362)
T ss_dssp HTSCHHHHHHTTTCCCCCCCCCHHHHSTTSCHHHHHHHHHHTCSSGGGSCCHHHHHT
T ss_pred hccchhhhHHHHhhcccCChhhHHhhCCCCCHHHHHHHHHHhcCChhhCCCHHHHHc
Confidence 0000000000 001112356889999999999999999999986
|
| >3bhy_A Death-associated protein kinase 3; death associated kinase, DAPK3, ZIP kinase, ZIPK, DAP kinase like kinase, DLK, structural genomics consortium; HET: 7CP; 1.24A {Homo sapiens} PDB: 3bqr_A* 2j90_A* 1yrp_A* 2yak_A* 2y4p_A* 3f5u_A* 1jks_A 1jkk_A* 1ig1_A* 1jkl_A 1jkt_A 3eh9_A* 3eha_A* 3f5g_A* 1p4f_A* 1wvw_A 1wvx_A* 1wvy_A* 2w4j_A* 3dgk_A ... | Back alignment and structure |
|---|
Probab=99.92 E-value=4.6e-26 Score=221.10 Aligned_cols=175 Identities=20% Similarity=0.238 Sum_probs=131.2
Q ss_pred cccceeeccCCCCC------CCCCCChhhHHHHHHHHHHHHHHHhhcCCCceeecCCCccceEecCCC----Cceecccc
Q 045315 241 DEISFWYESYNNPT------KKGLLCWGTRVRIIEGIAQGLLYLHQYSRLRVIHRDLKASNILLDKDM----NPKISDFG 310 (476)
Q Consensus 241 ~~~~l~~Ey~~~~~------~~~~L~~~~~~~i~~qIa~gL~yLH~~~~~~ivH~DLkp~NILld~~~----~~kL~DFG 310 (476)
+..++++||++... .+..+++.++..++.||+.||+|||+.+ ++||||||+||+++.++ .+||+|||
T Consensus 81 ~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~l~~lH~~~---i~H~dl~p~Nil~~~~~~~~~~~kl~dfg 157 (283)
T 3bhy_A 81 TDVVLILELVSGGELFDFLAEKESLTEDEATQFLKQILDGVHYLHSKR---IAHFDLKPENIMLLDKNVPNPRIKLIDFG 157 (283)
T ss_dssp SEEEEEEECCCSCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEESCSSSSSCCEEECCCT
T ss_pred CeEEEEEeecCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCC---ccCCCCChHHEEEecCCCCCCceEEEecc
Confidence 46788999997332 2457999999999999999999999999 99999999999998877 79999999
Q ss_pred ceeecCCCcccccceeeeeccCCCChhhhccCCCCccceEEeehhhhhhhhhCCCCCCcCCCCchhhhhhhhhhhcCCCc
Q 045315 311 MARMFGGDELQSNTKRIVGTYGYMSPEYALRGLFSIKSDVFSFGVLLLETLSSKKNTHFYNTDSLTLLGHAWNLWNDGRT 390 (476)
Q Consensus 311 la~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~s~ksDVwSlGvvl~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~ 390 (476)
++........ .....|+..|+|||.+.+..++.++||||||+++|+|++|+.||...... ..... ......
T Consensus 158 ~~~~~~~~~~---~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~--~~~~~----~~~~~~ 228 (283)
T 3bhy_A 158 IAHKIEAGNE---FKNIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASPFLGETKQ--ETLTN----ISAVNY 228 (283)
T ss_dssp TCEECC-----------CCCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCTTCCSSHH--HHHHH----HHTTCC
T ss_pred cceeccCCCc---ccccCCCcCccCcceecCCCCCcchhhhhHHHHHHHHHHCCCCCCCcchH--HHHHH----hHhccc
Confidence 9987654321 22346899999999999899999999999999999999999998653311 11111 111100
Q ss_pred ccccCcccCCCCCHHHHHHHHHHHHHchhhcccCCCCHHHHHH
Q 045315 391 WELMDPISQNGASYPILKRYINVALLCVQEKAADRPAMSEVVS 433 (476)
Q Consensus 391 ~~~~d~~~~~~~~~~~~~~l~~li~~Cl~~dP~~RPt~~eVl~ 433 (476)
. ...... ......+.+++.+||+.||++||++.|+++
T Consensus 229 -~-~~~~~~----~~~~~~~~~li~~~l~~dp~~Rps~~~~l~ 265 (283)
T 3bhy_A 229 -D-FDEEYF----SNTSELAKDFIRRLLVKDPKRRMTIAQSLE 265 (283)
T ss_dssp -C-CCHHHH----TTCCHHHHHHHHTTSCSSGGGSCCHHHHHH
T ss_pred -C-Ccchhc----ccCCHHHHHHHHHHccCCHhHCcCHHHHHh
Confidence 0 000000 112356889999999999999999999986
|
| >3coi_A Mitogen-activated protein kinase 13; P38D, P38delta, ERK, MAP kinase, PMK, STK26, stress-activated protein kinase, structural genomics, PSI; 2.09A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.92 E-value=4.6e-26 Score=228.88 Aligned_cols=181 Identities=19% Similarity=0.186 Sum_probs=129.8
Q ss_pred ccceeeccCCC---CCCCCCCChhhHHHHHHHHHHHHHHHhhcCCCceeecCCCccceEecCCCCceeccccceeecCCC
Q 045315 242 EISFWYESYNN---PTKKGLLCWGTRVRIIEGIAQGLLYLHQYSRLRVIHRDLKASNILLDKDMNPKISDFGMARMFGGD 318 (476)
Q Consensus 242 ~~~l~~Ey~~~---~~~~~~L~~~~~~~i~~qIa~gL~yLH~~~~~~ivH~DLkp~NILld~~~~~kL~DFGla~~~~~~ 318 (476)
..+++|||++. ......+++.++..++.||+.||+|||+++ |+||||||+||+++.++.+||+|||+++.....
T Consensus 103 ~~~lv~e~~~~~l~~~~~~~~~~~~~~~i~~qi~~al~~LH~~~---ivH~dlkp~NIl~~~~~~~kl~Dfg~~~~~~~~ 179 (353)
T 3coi_A 103 DFYLVMPFMQTDLQKIMGLKFSEEKIQYLVYQMLKGLKYIHSAG---VVHRDLKPGNLAVNEDCELKILDFGLARHADAE 179 (353)
T ss_dssp CCEEEEECCSEEGGGTTTSCCCHHHHHHHHHHHHHHHHHHHHTT---CCCSSCCGGGEEECTTCCEEECSTTCTTC----
T ss_pred eEEEEeccccCCHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCCHHHEeECCCCcEEEeecccccCCCCC
Confidence 35788999882 122346999999999999999999999999 999999999999999999999999999765432
Q ss_pred cccccceeeeeccCCCChhhhcc-CCCCccceEEeehhhhhhhhhCCCCCCcCCCCchhhhhhhhhhhc-----------
Q 045315 319 ELQSNTKRIVGTYGYMSPEYALR-GLFSIKSDVFSFGVLLLETLSSKKNTHFYNTDSLTLLGHAWNLWN----------- 386 (476)
Q Consensus 319 ~~~~~~~~~~gt~~y~aPE~l~~-~~~s~ksDVwSlGvvl~elltG~~p~~~~~~~~~~~~~~~~~~~~----------- 386 (476)
.....++..|+|||.+.+ ..++.++|||||||++|||++|+.||...... ...........
T Consensus 180 -----~~~~~~t~~y~aPE~~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~~~--~~~~~i~~~~~~~~~~~~~~~~ 252 (353)
T 3coi_A 180 -----MTGYVVTRWYRAPEVILSWMHYNQTVDIWSVGCIMAEMLTGKTLFKGKDYL--DQLTQILKVTGVPGTEFVQKLN 252 (353)
T ss_dssp ---------CCSBCCSCHHHHSCCSCCCTTHHHHHHHHHHHHHHHSSCSSBSSCHH--HHHHHHHHHHCBCCHHHHTTCS
T ss_pred -----ccccccCcCcCCHHHHhCcCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHH--HHHHHHHHHhCCCCHHHHHHHh
Confidence 223568999999999886 67899999999999999999999998754311 11111000000
Q ss_pred CC-------CcccccCcccCCCCCHHHHHHHHHHHHHchhhcccCCCCHHHHHH
Q 045315 387 DG-------RTWELMDPISQNGASYPILKRYINVALLCVQEKAADRPAMSEVVS 433 (476)
Q Consensus 387 ~~-------~~~~~~d~~~~~~~~~~~~~~l~~li~~Cl~~dP~~RPt~~eVl~ 433 (476)
.. .......... ..........+.+++.+||+.||++|||++|+++
T Consensus 253 ~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~li~~~L~~dp~~Rpt~~e~l~ 305 (353)
T 3coi_A 253 DKAAKSYIQSLPQTPRKDF-TQLFPRASPQAADLLEKMLELDVDKRLTAAQALT 305 (353)
T ss_dssp CHHHHHHHHTSCBCSSCCT-TTTCTTSCHHHHHHHHHHSCSCTTTSCCHHHHHT
T ss_pred hHHHHHHHHhCcCCCCccH-HHhcCCcCHHHHHHHHHHcCCCcccCCCHHHHhc
Confidence 00 0000000000 0111233567889999999999999999999985
|
| >2dyl_A Dual specificity mitogen-activated protein kinase kinase 7; MKK7, activated mutant, ATP-binding, structural genomics, NPPSFA; 2.45A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.92 E-value=3.7e-26 Score=225.41 Aligned_cols=175 Identities=25% Similarity=0.360 Sum_probs=123.5
Q ss_pred cccceeeccCCC------CCCCCCCChhhHHHHHHHHHHHHHHHhhc-CCCceeecCCCccceEecCCCCceecccccee
Q 045315 241 DEISFWYESYNN------PTKKGLLCWGTRVRIIEGIAQGLLYLHQY-SRLRVIHRDLKASNILLDKDMNPKISDFGMAR 313 (476)
Q Consensus 241 ~~~~l~~Ey~~~------~~~~~~L~~~~~~~i~~qIa~gL~yLH~~-~~~~ivH~DLkp~NILld~~~~~kL~DFGla~ 313 (476)
+..+++|||+.. ......+++.++..++.||++||+|||++ + ++||||||+||+++.++.+||+|||++.
T Consensus 97 ~~~~lv~e~~~~~~~~l~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~~---i~H~dlkp~Nil~~~~~~~kl~dfg~~~ 173 (318)
T 2dyl_A 97 TDVFIAMELMGTCAEKLKKRMQGPIPERILGKMTVAIVKALYYLKEKHG---VIHRDVKPSNILLDERGQIKLCDFGISG 173 (318)
T ss_dssp SEEEEEECCCSEEHHHHHHHHTSCCCHHHHHHHHHHHHHHHHHHHHHHC---CCCCCCCGGGEEECTTSCEEECCCTTC-
T ss_pred CcEEEEEeccCCcHHHHHHHhccCCCHHHHHHHHHHHHHHHHHHHhhCC---EEeCCCCHHHEEECCCCCEEEEECCCch
Confidence 457888999861 12246799999999999999999999995 8 9999999999999999999999999997
Q ss_pred ecCCCcccccceeeeeccCCCChhhhc-----cCCCCccceEEeehhhhhhhhhCCCCCCcCCCCchhhhhhhhhhhcCC
Q 045315 314 MFGGDELQSNTKRIVGTYGYMSPEYAL-----RGLFSIKSDVFSFGVLLLETLSSKKNTHFYNTDSLTLLGHAWNLWNDG 388 (476)
Q Consensus 314 ~~~~~~~~~~~~~~~gt~~y~aPE~l~-----~~~~s~ksDVwSlGvvl~elltG~~p~~~~~~~~~~~~~~~~~~~~~~ 388 (476)
....... .....++..|+|||.+. ...++.++||||||+++|||++|+.||........ .... ....
T Consensus 174 ~~~~~~~---~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~-~~~~---~~~~- 245 (318)
T 2dyl_A 174 RLVDDKA---KDRSAGCAAYMAPERIDPPDPTKPDYDIRADVWSLGISLVELATGQFPYKNCKTDFE-VLTK---VLQE- 245 (318)
T ss_dssp ----------------CCTTCCHHHHC--------CCTHHHHHHHHHHHHHHHHSSCTTTTCCSHHH-HHHH---HHHS-
T ss_pred hccCCcc---ccccCCCccccChhhcccccccccCCccccchhhHHHHHHHHHhCCCCCCCCCccHH-HHHH---Hhcc-
Confidence 6543321 22356899999999984 45688999999999999999999999865332211 1111 1111
Q ss_pred CcccccCcccCCCCCHHHHHHHHHHHHHchhhcccCCCCHHHHHH
Q 045315 389 RTWELMDPISQNGASYPILKRYINVALLCVQEKAADRPAMSEVVS 433 (476)
Q Consensus 389 ~~~~~~d~~~~~~~~~~~~~~l~~li~~Cl~~dP~~RPt~~eVl~ 433 (476)
....... .......+.+++.+||+.||++||+++++++
T Consensus 246 ~~~~~~~-------~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~ 283 (318)
T 2dyl_A 246 EPPLLPG-------HMGFSGDFQSFVKDCLTKDHRKRPKYNKLLE 283 (318)
T ss_dssp CCCCCCS-------SSCCCHHHHHHHHHHTCSCTTTSCCHHHHTT
T ss_pred CCCCCCc-------cCCCCHHHHHHHHHHccCChhHCcCHHHHhh
Confidence 1100000 0112356889999999999999999999875
|
| >3eqc_A Dual specificity mitogen-activated protein kinase; MEK1 kinase, ATP-binding, disease mutation, nucleoti binding, phosphoprotein; HET: 3BM AGS; 1.80A {Homo sapiens} PDB: 3eqd_A* 3eqf_A* 3eqg_A* 3eqh_A* 3eqi_A* 2y4i_C* 3eqb_A* 2p55_A* 1s9j_A* 3dy7_A* 3e8n_A* 3v01_A* 3v04_A* 3dv3_A* 3mbl_A* 3pp1_A* 3orn_A* 3os3_A* 3sls_A* 1s9i_A* ... | Back alignment and structure |
|---|
Probab=99.92 E-value=2.5e-26 Score=231.27 Aligned_cols=186 Identities=25% Similarity=0.370 Sum_probs=132.3
Q ss_pred cccceeeccCCCCC------CCCCCChhhHHHHHHHHHHHHHHHhhc-CCCceeecCCCccceEecCCCCceecccccee
Q 045315 241 DEISFWYESYNNPT------KKGLLCWGTRVRIIEGIAQGLLYLHQY-SRLRVIHRDLKASNILLDKDMNPKISDFGMAR 313 (476)
Q Consensus 241 ~~~~l~~Ey~~~~~------~~~~L~~~~~~~i~~qIa~gL~yLH~~-~~~~ivH~DLkp~NILld~~~~~kL~DFGla~ 313 (476)
+..+++|||++... ..+.+++..+..++.||+.||+|||+. + |+||||||+||+++.++.+||+|||++.
T Consensus 104 ~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~i~~~i~~~l~~lh~~~~---i~H~dlkp~Nil~~~~~~~kl~Dfg~~~ 180 (360)
T 3eqc_A 104 GEISICMEHMDGGSLDQVLKKAGRIPEQILGKVSIAVIKGLTYLREKHK---IMHRDVKPSNILVNSRGEIKLCDFGVSG 180 (360)
T ss_dssp TEEEEEECCCTTCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHHHC---CCCSCCSGGGEEECTTCCEEECCCCCCH
T ss_pred CEEEEEEECCCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHhCC---EEcCCccHHHEEECCCCCEEEEECCCCc
Confidence 46789999998432 235799999999999999999999995 7 9999999999999999999999999987
Q ss_pred ecCCCcccccceeeeeccCCCChhhhccCCCCccceEEeehhhhhhhhhCCCCCCcCCCCchhhhhhhh----------h
Q 045315 314 MFGGDELQSNTKRIVGTYGYMSPEYALRGLFSIKSDVFSFGVLLLETLSSKKNTHFYNTDSLTLLGHAW----------N 383 (476)
Q Consensus 314 ~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~s~ksDVwSlGvvl~elltG~~p~~~~~~~~~~~~~~~~----------~ 383 (476)
..... ......|+..|+|||.+.+..++.++|||||||++|||++|+.||............... .
T Consensus 181 ~~~~~----~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~ 256 (360)
T 3eqc_A 181 QLIDS----MANSFVGTRSYMSPERLQGTHYSVQSDIWSMGLSLVEMAVGRYPIPPPDAKELELMFGCQVEGDAAETPPR 256 (360)
T ss_dssp HHHHH----C----CCCCTTCCHHHHTTCCCSHHHHHHHHHHHHHHHHHTSCCSSCCCHHHHHHHHC-------------
T ss_pred ccccc----cccCCCCCCCeECHHHHcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHhcccccccCCCCCCC
Confidence 54321 122357899999999999999999999999999999999999998754321111000000 0
Q ss_pred hhcCC--------------CcccccC----cccCCCCCHHHHHHHHHHHHHchhhcccCCCCHHHHHH
Q 045315 384 LWNDG--------------RTWELMD----PISQNGASYPILKRYINVALLCVQEKAADRPAMSEVVS 433 (476)
Q Consensus 384 ~~~~~--------------~~~~~~d----~~~~~~~~~~~~~~l~~li~~Cl~~dP~~RPt~~eVl~ 433 (476)
....+ ...+..+ ..............+.+++.+||+.||++|||++|+++
T Consensus 257 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~ 324 (360)
T 3eqc_A 257 PRTPGRPLNKFGMDSRPPMAIFELLDYIVNEPPPKLPSGVFSLEFQDFVNKCLIKNPAERADLKQLMV 324 (360)
T ss_dssp -----------------CCCHHHHHHHHHHSCCCCCCTTTSCHHHHHHHHHHHCSSTTTSCCHHHHHT
T ss_pred cccCCCcccccccCCCCcccchhhhhHHhccCCCCCCcccccHHHHHHHHHHhhcChhhCCCHHHHhh
Confidence 00000 0000000 00000011112456889999999999999999999976
|
| >2j0j_A Focal adhesion kinase 1; cell migration, FERM, transferase, integrin signaling; HET: 4ST; 2.80A {Gallus gallus} PDB: 2j0k_A* | Back alignment and structure |
|---|
Probab=99.92 E-value=1.1e-26 Score=252.13 Aligned_cols=180 Identities=21% Similarity=0.286 Sum_probs=137.2
Q ss_pred cccceeeccCCCCC-------CCCCCChhhHHHHHHHHHHHHHHHhhcCCCceeecCCCccceEecCCCCceecccccee
Q 045315 241 DEISFWYESYNNPT-------KKGLLCWGTRVRIIEGIAQGLLYLHQYSRLRVIHRDLKASNILLDKDMNPKISDFGMAR 313 (476)
Q Consensus 241 ~~~~l~~Ey~~~~~-------~~~~L~~~~~~~i~~qIa~gL~yLH~~~~~~ivH~DLkp~NILld~~~~~kL~DFGla~ 313 (476)
+..+++|||++.+. ++..+++..++.++.||+.||+|||+++ |+||||||+|||++.++.+||+|||+++
T Consensus 463 ~~~~lv~E~~~~g~L~~~l~~~~~~l~~~~~~~i~~qi~~aL~~LH~~g---ivHrDikp~NILl~~~~~vkL~DFG~a~ 539 (656)
T 2j0j_A 463 NPVWIIMELCTLGELRSFLQVRKFSLDLASLILYAYQLSTALAYLESKR---FVHRDIAARNVLVSSNDCVKLGDFGLSR 539 (656)
T ss_dssp SSCEEEEECCTTCBHHHHHHHTTTTCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCSGGGEEEEETTEEEECCCCCCC
T ss_pred CceEEEEEcCCCCcHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHhCC---ccccccchHhEEEeCCCCEEEEecCCCe
Confidence 45789999998432 3456999999999999999999999999 9999999999999999999999999998
Q ss_pred ecCCCcccccceeeeeccCCCChhhhccCCCCccceEEeehhhhhhhhh-CCCCCCcCCCCchhhhhhhhhhhcCCCccc
Q 045315 314 MFGGDELQSNTKRIVGTYGYMSPEYALRGLFSIKSDVFSFGVLLLETLS-SKKNTHFYNTDSLTLLGHAWNLWNDGRTWE 392 (476)
Q Consensus 314 ~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~s~ksDVwSlGvvl~ellt-G~~p~~~~~~~~~~~~~~~~~~~~~~~~~~ 392 (476)
........ ......++..|+|||.+.+..++.++|||||||++|||++ |..||...... ..... ...+....
T Consensus 540 ~~~~~~~~-~~~~~~~t~~y~aPE~~~~~~~~~~~DiwSlG~il~ellt~g~~Pf~~~~~~--~~~~~----i~~~~~~~ 612 (656)
T 2j0j_A 540 YMEDSTYY-KASKGKLPIKWMAPESINFRRFTSASDVWMFGVCMWEILMHGVKPFQGVKNN--DVIGR----IENGERLP 612 (656)
T ss_dssp SCCC-----------CCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCHH--HHHHH----HHHTCCCC
T ss_pred ecCCCcce-eccCCCCCcceeCHHHhcCCCCCchhhHHHHHHHHHHHHHcCCCCCCCCCHH--HHHHH----HHcCCCCC
Confidence 76543221 1223456789999999999999999999999999999997 88888643311 11111 11111111
Q ss_pred ccCcccCCCCCHHHHHHHHHHHHHchhhcccCCCCHHHHHHHHhccc
Q 045315 393 LMDPISQNGASYPILKRYINVALLCVQEKAADRPAMSEVVSMLSNEF 439 (476)
Q Consensus 393 ~~d~~~~~~~~~~~~~~l~~li~~Cl~~dP~~RPt~~eVl~~L~~~~ 439 (476)
.+......+.+++.+||+.||++||++.+|++.|+.+.
T Consensus 613 ---------~~~~~~~~l~~li~~~l~~dP~~RPs~~el~~~L~~il 650 (656)
T 2j0j_A 613 ---------MPPNCPPTLYSLMTKCWAYDPSRRPRFTELKAQLSTIL 650 (656)
T ss_dssp ---------CCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHH
T ss_pred ---------CCccccHHHHHHHHHHcCCChhHCcCHHHHHHHHHHHH
Confidence 11223457889999999999999999999999998865
|
| >2ycf_A Serine/threonine-protein kinase CHK2; transferase, anticancer, anticancer drug design; HET: YCF; 1.77A {Homo sapiens} PDB: 2yiq_A* 2w7x_A* 2ycq_A* 2ycs_A* 2w0j_A* 2yir_A* 2yit_A* 2wtj_A* 2cn8_A* 2wtc_A* 2wtd_A* 2wti_A* 2cn5_A* 2xbj_A* 2xm8_A* 2xm9_A* 2xk9_A* 2ycr_A* | Back alignment and structure |
|---|
Probab=99.92 E-value=1.2e-25 Score=222.77 Aligned_cols=176 Identities=23% Similarity=0.306 Sum_probs=131.7
Q ss_pred cccceeeccCCCC------CCCCCCChhhHHHHHHHHHHHHHHHhhcCCCceeecCCCccceEecCCCC---ceeccccc
Q 045315 241 DEISFWYESYNNP------TKKGLLCWGTRVRIIEGIAQGLLYLHQYSRLRVIHRDLKASNILLDKDMN---PKISDFGM 311 (476)
Q Consensus 241 ~~~~l~~Ey~~~~------~~~~~L~~~~~~~i~~qIa~gL~yLH~~~~~~ivH~DLkp~NILld~~~~---~kL~DFGl 311 (476)
+..++++||++.. .....+++.++..++.||+.||+|||+++ |+||||||+||+++.++. +||+|||+
T Consensus 87 ~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~---ivH~dlkp~NIl~~~~~~~~~~kl~Dfg~ 163 (322)
T 2ycf_A 87 EDYYIVLELMEGGELFDKVVGNKRLKEATCKLYFYQMLLAVQYLHENG---IIHRDLKPENVLLSSQEEDCLIKITDFGH 163 (322)
T ss_dssp SSEEEEEECCTTEETHHHHSTTCCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEESSSSSSCCEEECCCTT
T ss_pred CceEEEEecCCCCcHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHHCC---eeccCCCHHHEEEecCCCCCeEEEccCcc
Confidence 3478899999732 23567999999999999999999999999 999999999999987654 99999999
Q ss_pred eeecCCCcccccceeeeeccCCCChhhhc---cCCCCccceEEeehhhhhhhhhCCCCCCcCCCCchhhhhhhhhhhcCC
Q 045315 312 ARMFGGDELQSNTKRIVGTYGYMSPEYAL---RGLFSIKSDVFSFGVLLLETLSSKKNTHFYNTDSLTLLGHAWNLWNDG 388 (476)
Q Consensus 312 a~~~~~~~~~~~~~~~~gt~~y~aPE~l~---~~~~s~ksDVwSlGvvl~elltG~~p~~~~~~~~~~~~~~~~~~~~~~ 388 (476)
++....... .....|+..|+|||.+. ...++.++|||||||++|||++|+.||........ +.... ..+
T Consensus 164 ~~~~~~~~~---~~~~~gt~~y~aPE~~~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~-~~~~~----~~~ 235 (322)
T 2ycf_A 164 SKILGETSL---MRTLCGTPTYLAPEVLVSVGTAGYNRAVDCWSLGVILFICLSGYPPFSEHRTQVS-LKDQI----TSG 235 (322)
T ss_dssp CEECCCCHH---HHHHHSCCTTCCHHHHHHTTTTTCTTHHHHHHHHHHHHHHHHSSCSSCSTTCSSC-HHHHH----HHT
T ss_pred ceecccccc---cccccCCcCccCchhhccCCCCCCCchhhHHHHHHHHHHHHhCCCCCcccchHHH-HHHHH----HhC
Confidence 987654321 12246899999999974 46789999999999999999999999875432211 11111 111
Q ss_pred CcccccCcccCCCCCHHHHHHHHHHHHHchhhcccCCCCHHHHHH
Q 045315 389 RTWELMDPISQNGASYPILKRYINVALLCVQEKAADRPAMSEVVS 433 (476)
Q Consensus 389 ~~~~~~d~~~~~~~~~~~~~~l~~li~~Cl~~dP~~RPt~~eVl~ 433 (476)
... . .+... ......+.+++.+||+.||++||++.++++
T Consensus 236 ~~~-~-~~~~~----~~~~~~~~~li~~~l~~dP~~Rps~~~~l~ 274 (322)
T 2ycf_A 236 KYN-F-IPEVW----AEVSEKALDLVKKLLVVDPKARFTTEEALR 274 (322)
T ss_dssp CCC-C-CHHHH----TTSCHHHHHHHHHHSCSSTTTSCCHHHHHT
T ss_pred ccc-c-Cchhh----hhcCHHHHHHHHHHcccCHhhCCCHHHHhh
Confidence 110 0 00000 112357889999999999999999999874
|
| >3p23_A Serine/threonine-protein kinase/endoribonuclease; kinase domain, kinase and RNAse function, ATP binding ssRNA dephosphorylated, hydrolase; HET: ADP; 2.70A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.92 E-value=1e-25 Score=232.94 Aligned_cols=177 Identities=19% Similarity=0.215 Sum_probs=124.0
Q ss_pred cccceeeccCCC------CCCCCCCChhhHHHHHHHHHHHHHHHhhcCCCceeecCCCccceEecC-----CCCceeccc
Q 045315 241 DEISFWYESYNN------PTKKGLLCWGTRVRIIEGIAQGLLYLHQYSRLRVIHRDLKASNILLDK-----DMNPKISDF 309 (476)
Q Consensus 241 ~~~~l~~Ey~~~------~~~~~~L~~~~~~~i~~qIa~gL~yLH~~~~~~ivH~DLkp~NILld~-----~~~~kL~DF 309 (476)
+..+++|||++. ......++..+++.++.||+.||+|||+++ |+||||||+|||++. ...+||+||
T Consensus 91 ~~~~lv~E~~~g~L~~~l~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~---ivHrDlKp~NIll~~~~~~~~~~~kL~DF 167 (432)
T 3p23_A 91 QFQYIAIELCAATLQEYVEQKDFAHLGLEPITLLQQTTSGLAHLHSLN---IVHRDLKPHNILISMPNAHGKIKAMISDF 167 (432)
T ss_dssp TEEEEEEECCSEEHHHHHHSSSCCCCSSCHHHHHHHHHHHHHHHHHTT---CCCCCCSTTSEEECCCBTTTBCCEEECCT
T ss_pred CEEEEEEECCCCCHHHHHHhcCCCccchhHHHHHHHHHHHHHHHHHCc---CEeCCCCHHHEEEecCCCCCceeEEEecc
Confidence 356788999871 123345666788899999999999999999 999999999999953 335789999
Q ss_pred cceeecCCCcc-cccceeeeeccCCCChhhhc---cCCCCccceEEeehhhhhhhhh-CCCCCCcCCCCchhhhhhhhhh
Q 045315 310 GMARMFGGDEL-QSNTKRIVGTYGYMSPEYAL---RGLFSIKSDVFSFGVLLLETLS-SKKNTHFYNTDSLTLLGHAWNL 384 (476)
Q Consensus 310 Gla~~~~~~~~-~~~~~~~~gt~~y~aPE~l~---~~~~s~ksDVwSlGvvl~ellt-G~~p~~~~~~~~~~~~~~~~~~ 384 (476)
|+++....... ........||+.|+|||.+. ...++.++|||||||++|||++ |+.||.......... .
T Consensus 168 G~a~~~~~~~~~~~~~~~~~gt~~y~APE~l~~~~~~~~t~~~DiwSlG~il~ellt~g~~pf~~~~~~~~~~------~ 241 (432)
T 3p23_A 168 GLCKKLAVGRHSFSRRSGVPGTEGWIAPEMLSEDCKENPTYTVDIFSAGCVFYYVISEGSHPFGKSLQRQANI------L 241 (432)
T ss_dssp TEEECC------------CCSCTTSCCGGGTSCC---CCCTHHHHHHHHHHHHHHHTTSCBTTBSTTTHHHHH------H
T ss_pred cceeeccCCCcceeeccccCCCcCccChhhhhcccccCCCcHHHHHHHHHHHHHHHcCCCCCcchhhHHHHHH------H
Confidence 99987653321 12233456999999999997 4567889999999999999999 888875432211111 1
Q ss_pred hcCCCcccccCcccCCCCCHHHHHHHHHHHHHchhhcccCCCCHHHHHH
Q 045315 385 WNDGRTWELMDPISQNGASYPILKRYINVALLCVQEKAADRPAMSEVVS 433 (476)
Q Consensus 385 ~~~~~~~~~~d~~~~~~~~~~~~~~l~~li~~Cl~~dP~~RPt~~eVl~ 433 (476)
. ....... ..........+.+++.+||+.||++|||++||++
T Consensus 242 ~-~~~~~~~------~~~~~~~~~~~~~li~~~L~~dP~~Rps~~evl~ 283 (432)
T 3p23_A 242 L-GACSLDC------LHPEKHEDVIARELIEKMIAMDPQKRPSAKHVLK 283 (432)
T ss_dssp T-TCCCCTT------SCTTCHHHHHHHHHHHHHSCSSGGGSCCHHHHHT
T ss_pred h-ccCCccc------cCccccccHHHHHHHHHHHhCCHhhCCCHHHHHh
Confidence 1 1100010 0112334556889999999999999999999983
|
| >2jam_A Calcium/calmodulin-dependent protein kinase type 1G; transferase, kinase, membrane, ATP-binding, prenylation, serine/threonine-protein kinase, alternative splicing; HET: J60; 1.7A {Homo sapiens} PDB: 2jc6_A* 1a06_A | Back alignment and structure |
|---|
Probab=99.92 E-value=6.2e-26 Score=222.94 Aligned_cols=178 Identities=20% Similarity=0.290 Sum_probs=135.6
Q ss_pred cccceeeccCCCCC------CCCCCChhhHHHHHHHHHHHHHHHhhcCCCceeecCCCccceEe---cCCCCceeccccc
Q 045315 241 DEISFWYESYNNPT------KKGLLCWGTRVRIIEGIAQGLLYLHQYSRLRVIHRDLKASNILL---DKDMNPKISDFGM 311 (476)
Q Consensus 241 ~~~~l~~Ey~~~~~------~~~~L~~~~~~~i~~qIa~gL~yLH~~~~~~ivH~DLkp~NILl---d~~~~~kL~DFGl 311 (476)
+.+++++||++... ..+.+++.++..++.||+.||+|||+.+ |+||||||+||++ +.++.+||+|||+
T Consensus 79 ~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~qi~~~l~~lH~~~---i~H~dikp~NIl~~~~~~~~~~kl~Dfg~ 155 (304)
T 2jam_A 79 THYYLVMQLVSGGELFDRILERGVYTEKDASLVIQQVLSAVKYLHENG---IVHRDLKPENLLYLTPEENSKIMITDFGL 155 (304)
T ss_dssp SEEEEEECCCCSCBHHHHHHHHSCCCHHHHHHHHHHHHHHHHHHHHTT---CCCCSCCGGGCEESSSSTTCCEEBCSCST
T ss_pred CEEEEEEEcCCCccHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCC---ccccCCCHHHEEEecCCCCCCEEEccCCc
Confidence 46788999997432 2457899999999999999999999999 9999999999999 7888999999999
Q ss_pred eeecCCCcccccceeeeeccCCCChhhhccCCCCccceEEeehhhhhhhhhCCCCCCcCCCCchhhhhhhhhhhcCCCcc
Q 045315 312 ARMFGGDELQSNTKRIVGTYGYMSPEYALRGLFSIKSDVFSFGVLLLETLSSKKNTHFYNTDSLTLLGHAWNLWNDGRTW 391 (476)
Q Consensus 312 a~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~s~ksDVwSlGvvl~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~ 391 (476)
+....... .....|+..|+|||.+.+..++.++||||||+++|||++|+.||..... ...... ...+..
T Consensus 156 ~~~~~~~~----~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~--~~~~~~----i~~~~~- 224 (304)
T 2jam_A 156 SKMEQNGI----MSTACGTPGYVAPEVLAQKPYSKAVDCWSIGVITYILLCGYPPFYEETE--SKLFEK----IKEGYY- 224 (304)
T ss_dssp TCCCCCBT----THHHHSCCCBCCTTTBSSCSCCHHHHHHHHHHHHHHHHHSSCTTTTSCH--HHHHHH----HHHCCC-
T ss_pred ceecCCCc----cccccCCCCccChHHhccCCCCchhhHHHHHHHHHHHHHCCCCCCCCCH--HHHHHH----HHcCCC-
Confidence 97644321 2224589999999999999999999999999999999999999864321 111111 111110
Q ss_pred cccCcccCCCCCHHHHHHHHHHHHHchhhcccCCCCHHHHHH--HHhc
Q 045315 392 ELMDPISQNGASYPILKRYINVALLCVQEKAADRPAMSEVVS--MLSN 437 (476)
Q Consensus 392 ~~~d~~~~~~~~~~~~~~l~~li~~Cl~~dP~~RPt~~eVl~--~L~~ 437 (476)
.. ...........+.+++.+||+.||++||+++|+++ .+++
T Consensus 225 ~~-----~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~~l~h~~~~~ 267 (304)
T 2jam_A 225 EF-----ESPFWDDISESAKDFICHLLEKDPNERYTCEKALSHPWIDG 267 (304)
T ss_dssp CC-----CTTTTTTSCHHHHHHHHHHHCSSTTTSCCHHHHHTSHHHHS
T ss_pred CC-----CccccccCCHHHHHHHHHHcCCChhHCcCHHHHhcCccccC
Confidence 00 00111223457889999999999999999999986 3444
|
| >4exu_A Mitogen-activated protein kinase 13; P38 kinase, transferase; 1.70A {Homo sapiens} PDB: 4eyj_A* 4eym_A* 3coi_A | Back alignment and structure |
|---|
Probab=99.92 E-value=2.1e-26 Score=233.36 Aligned_cols=182 Identities=18% Similarity=0.194 Sum_probs=128.2
Q ss_pred cceeeccCCC---CCCCCCCChhhHHHHHHHHHHHHHHHhhcCCCceeecCCCccceEecCCCCceeccccceeecCCCc
Q 045315 243 ISFWYESYNN---PTKKGLLCWGTRVRIIEGIAQGLLYLHQYSRLRVIHRDLKASNILLDKDMNPKISDFGMARMFGGDE 319 (476)
Q Consensus 243 ~~l~~Ey~~~---~~~~~~L~~~~~~~i~~qIa~gL~yLH~~~~~~ivH~DLkp~NILld~~~~~kL~DFGla~~~~~~~ 319 (476)
.++++||++. ......+++.++..++.||+.||+|||+.+ |+||||||+||+++.++.+||+|||+++.....
T Consensus 122 ~~lv~e~~~~~l~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~---ivH~Dikp~NIll~~~~~~kL~Dfg~a~~~~~~- 197 (371)
T 4exu_A 122 FYLVMPFMQTDLQKIMGMEFSEEKIQYLVYQMLKGLKYIHSAG---VVHRDLKPGNLAVNEDCELKILDFGLARHADAE- 197 (371)
T ss_dssp CEEEEECCCEEHHHHTTSCCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEECTTCCEEECSTTCC-------
T ss_pred EEEEEccccccHHHHhhcCCCHHHHHHHHHHHHHHHHHHHHCC---CcCCCcCHHHeEECCCCCEEEEecCcccccccC-
Confidence 4788999882 112445999999999999999999999999 999999999999999999999999999865432
Q ss_pred ccccceeeeeccCCCChhhhcc-CCCCccceEEeehhhhhhhhhCCCCCCcCCCCchhhhhhhhhhhcCCC---------
Q 045315 320 LQSNTKRIVGTYGYMSPEYALR-GLFSIKSDVFSFGVLLLETLSSKKNTHFYNTDSLTLLGHAWNLWNDGR--------- 389 (476)
Q Consensus 320 ~~~~~~~~~gt~~y~aPE~l~~-~~~s~ksDVwSlGvvl~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~--------- 389 (476)
.....||+.|+|||.+.+ ..++.++|||||||++|||++|+.||...... ..............
T Consensus 198 ----~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~--~~~~~i~~~~~~~~~~~~~~~~~ 271 (371)
T 4exu_A 198 ----MTGYVVTRWYRAPEVILSWMHYNQTVDIWSVGCIMAEMLTGKTLFKGKDYL--DQLTQILKVTGVPGTEFVQKLND 271 (371)
T ss_dssp ------CTTCCCTTSCHHHHSCCSCCCTTHHHHHHHHHHHHHHHSSCSCCCSSHH--HHHHHHHHHHCCCCHHHHTTCSC
T ss_pred ----cCCcccCccccCHHHhcCCCCCCcHHhHHHHHHHHHHHHhCCCCCCCCChH--HHHHHHHHHhCCCcHHHHHHhhh
Confidence 222467999999999987 67899999999999999999999998754311 11111100000000
Q ss_pred --cccc---cCcccCCC---CCHHHHHHHHHHHHHchhhcccCCCCHHHHHHH
Q 045315 390 --TWEL---MDPISQNG---ASYPILKRYINVALLCVQEKAADRPAMSEVVSM 434 (476)
Q Consensus 390 --~~~~---~d~~~~~~---~~~~~~~~l~~li~~Cl~~dP~~RPt~~eVl~~ 434 (476)
.... +....... ........+.+++.+||+.||++|||++|+++.
T Consensus 272 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~h 324 (371)
T 4exu_A 272 KAAKSYIQSLPQTPRKDFTQLFPRASPQAADLLEKMLELDVDKRLTAAQALTH 324 (371)
T ss_dssp HHHHHHHHHSCCCCCCCHHHHSTTSCHHHHHHHHHHSCSCTTTSCCHHHHHTS
T ss_pred hhhhhhhhccCCCcchhHHHhccccChHHHHHHHHHCCCChhhcCCHHHHhcC
Confidence 0000 00000000 001124678899999999999999999999863
|
| >3nyv_A Calmodulin-domain protein kinase 1; serine/threonine protein kinase, transferase, calcium-bindin binding, EF hand, bumped kinase inhibitor; HET: MSE DTQ; 1.88A {Toxoplasma gondii} PDB: 3i79_A* 3i7b_A* 3n51_A* 3i7c_A* 3sx9_A* 3sxf_A* 3t3u_A* 3t3v_A* 3upx_A* 3upz_A* 3v51_A* 3v5p_A* 3v5t_A* 3ku2_A* 3hx4_A* | Back alignment and structure |
|---|
Probab=99.92 E-value=8e-26 Score=237.00 Aligned_cols=174 Identities=25% Similarity=0.330 Sum_probs=133.3
Q ss_pred cccceeeccCCCCC------CCCCCChhhHHHHHHHHHHHHHHHhhcCCCceeecCCCccceEe---cCCCCceeccccc
Q 045315 241 DEISFWYESYNNPT------KKGLLCWGTRVRIIEGIAQGLLYLHQYSRLRVIHRDLKASNILL---DKDMNPKISDFGM 311 (476)
Q Consensus 241 ~~~~l~~Ey~~~~~------~~~~L~~~~~~~i~~qIa~gL~yLH~~~~~~ivH~DLkp~NILl---d~~~~~kL~DFGl 311 (476)
+..++++||++... .++.+++.++..++.||+.||+|||+++ |+||||||+|||+ +.++.+||+|||+
T Consensus 99 ~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~---ivH~Dlkp~Nil~~~~~~~~~~kl~Dfg~ 175 (484)
T 3nyv_A 99 GYFYLVGEVYTGGELFDEIISRKRFSEVDAARIIRQVLSGITYMHKNK---IVHRDLKPENLLLESKSKDANIRIIDFGL 175 (484)
T ss_dssp SEEEEEECCCCSCBHHHHHHTCSCCBHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEESSSSTTCCEEECCTTH
T ss_pred CEEEEEEecCCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCC---eeeCCCCHHHEEEecCCCCCcEEEEeeee
Confidence 46788999997432 3567999999999999999999999999 9999999999999 4678899999999
Q ss_pred eeecCCCcccccceeeeeccCCCChhhhccCCCCccceEEeehhhhhhhhhCCCCCCcCCCCchhhhhhhhhhhcCCCcc
Q 045315 312 ARMFGGDELQSNTKRIVGTYGYMSPEYALRGLFSIKSDVFSFGVLLLETLSSKKNTHFYNTDSLTLLGHAWNLWNDGRTW 391 (476)
Q Consensus 312 a~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~s~ksDVwSlGvvl~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~ 391 (476)
++.+..... .....||+.|+|||.+.+ .++.++|||||||++|+|++|+.||..... ....... ..+...
T Consensus 176 a~~~~~~~~---~~~~~gt~~y~aPE~~~~-~~~~~~DiwslG~il~~ll~g~~pf~~~~~--~~~~~~i----~~~~~~ 245 (484)
T 3nyv_A 176 STHFEASKK---MKDKIGTAYYIAPEVLHG-TYDEKCDVWSTGVILYILLSGCPPFNGANE--YDILKKV----EKGKYT 245 (484)
T ss_dssp HHHBCCCCS---HHHHTTGGGTCCHHHHHT-CCCTHHHHHHHHHHHHHHHHSSCSSCCSSH--HHHHHHH----HHCCCC
T ss_pred eEEcccccc---cccCCCCccccCceeecC-CCCCcceeHHHHHHHHHHHHCCCCCCCCCH--HHHHHHH----HcCCCC
Confidence 987654321 223468999999998865 689999999999999999999999875432 1111111 111110
Q ss_pred cccCcccCCCCCHHHHHHHHHHHHHchhhcccCCCCHHHHHH
Q 045315 392 ELMDPISQNGASYPILKRYINVALLCVQEKAADRPAMSEVVS 433 (476)
Q Consensus 392 ~~~d~~~~~~~~~~~~~~l~~li~~Cl~~dP~~RPt~~eVl~ 433 (476)
. ..+ ........+.+++.+||+.||++|||+.|+++
T Consensus 246 ~-~~~-----~~~~~s~~~~~li~~~L~~dp~~R~s~~e~l~ 281 (484)
T 3nyv_A 246 F-ELP-----QWKKVSESAKDLIRKMLTYVPSMRISARDALD 281 (484)
T ss_dssp C-CSG-----GGGGSCHHHHHHHHHHTCSSGGGSCCHHHHHT
T ss_pred C-CCc-----ccccCCHHHHHHHHHHCCCChhHCcCHHHHhh
Confidence 0 000 01123457889999999999999999999986
|
| >4h3o_A Lectin; cadmium, plant protein; 2.17A {Allium sativum} PDB: 1kj1_A* 1bwu_P* 1kj1_D* 1bwu_Q* 1bwu_A* 1bwu_D* | Back alignment and structure |
|---|
Probab=99.92 E-value=1.3e-24 Score=179.35 Aligned_cols=105 Identities=20% Similarity=0.370 Sum_probs=92.1
Q ss_pred cCccCCCCcccCCCEEeeCCCeEEEEeeCCCCCCCeEEEEEEccCCCceEEeecCCCCCCCCCceEEEecCCceEEEccC
Q 045315 26 ADTITPETFIRDGEKLVSSSQRFELGFFSPRNSKNRYLGVWYKKIPDTVVWVANRNSPIFNPNTALTFSNNGNLVLLSQR 105 (476)
Q Consensus 26 ~~~l~~g~~l~~~~~l~S~~g~f~lgf~~~~~~~~~~~~iw~~~~~~~~vW~an~~~p~~~~~~~l~~~~~G~lvl~~~~ 105 (476)
+|+|.+||.|.+|++|.| |.|.|.|+.+||. .++.. .++||+|||+.|. ...+.|+|+.||||||+|++
T Consensus 1 kn~L~~g~~L~~g~~L~s--g~y~l~~q~DgNL-----vly~~---~~~vW~ant~~~~-~~~~~L~l~~dGnLvL~d~~ 69 (105)
T 4h3o_A 1 RNILDNNEGLYAGQSLDV--EPYHFIMQDDCNL-----VLYDH---STSTWASNTEIGG-KSGCSAVLQSDGNFVVYDSS 69 (105)
T ss_dssp CCEECTTEEECTTCEEEE--TTEEEEECTTSCE-----EEEET---TEEEEECCCCCTT-CCSCEEEECTTSCEEEECTT
T ss_pred CCCcCCCCEEcCCCEEEE--CCEEEEECCCCeE-----EEEEC---CEEEEEecCCCCC-CccEEEEEeCCccEEEECCC
Confidence 478999999999999997 7899999999984 34332 6899999999996 45689999999999999999
Q ss_pred CeEEEeecCCCCCCCceeeeccCCCeEEEeCCCCCCcCceeecc
Q 045315 106 NGIIWSSNMSRKAENPIAQLLDTGNLVIRDNSSGHTTESYLWQS 149 (476)
Q Consensus 106 ~~~vWss~~~~~~~~~~~~l~d~GNlVl~~~~~~~~~~~~~WqS 149 (476)
+.+||+|++......+.|+|+||||||||+ .++|||
T Consensus 70 ~~~vWss~t~~~~~~~~l~L~ddGNlVly~--------~~~W~S 105 (105)
T 4h3o_A 70 GRSLWASHSTRGSGNYILILQDDGNVIIYG--------SDIWST 105 (105)
T ss_dssp CCEEEECCCCCCSSCEEEEECTTSCEEEEE--------SEEEEC
T ss_pred cEEEEEecCCCCCCCEEEEEeCCCeEEEEC--------CcEecC
Confidence 999999998876677889999999999994 469998
|
| >3lij_A Calcium/calmodulin dependent protein kinase with A kinase domain and 4 calmodulin...; transferase, calcium dependent protein kinase; HET: ANP; 1.90A {Cryptosporidium parvum} PDB: 3hzt_A* 3dxn_A 3l19_A* | Back alignment and structure |
|---|
Probab=99.92 E-value=1.7e-25 Score=235.17 Aligned_cols=174 Identities=24% Similarity=0.338 Sum_probs=132.2
Q ss_pred cccceeeccCCCCC------CCCCCChhhHHHHHHHHHHHHHHHhhcCCCceeecCCCccceEecC---CCCceeccccc
Q 045315 241 DEISFWYESYNNPT------KKGLLCWGTRVRIIEGIAQGLLYLHQYSRLRVIHRDLKASNILLDK---DMNPKISDFGM 311 (476)
Q Consensus 241 ~~~~l~~Ey~~~~~------~~~~L~~~~~~~i~~qIa~gL~yLH~~~~~~ivH~DLkp~NILld~---~~~~kL~DFGl 311 (476)
+..+++|||++.+. ++..+++.++..++.||+.||+|||+++ |+||||||+|||++. ++.+||+|||+
T Consensus 109 ~~~~lv~e~~~~g~L~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~---ivH~Dlkp~Nil~~~~~~~~~~kl~DfG~ 185 (494)
T 3lij_A 109 RNYYLVMECYKGGELFDEIIHRMKFNEVDAAVIIKQVLSGVTYLHKHN---IVHRDLKPENLLLESKEKDALIKIVDFGL 185 (494)
T ss_dssp SEEEEEEECCCSCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEESCSSTTCCEEECCCTT
T ss_pred CEEEEEEecCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCC---ceeccCChhhEEEeCCCCCCcEEEEECCC
Confidence 46789999998432 2457999999999999999999999999 999999999999976 44599999999
Q ss_pred eeecCCCcccccceeeeeccCCCChhhhccCCCCccceEEeehhhhhhhhhCCCCCCcCCCCchhhhhhhhhhhcCCCcc
Q 045315 312 ARMFGGDELQSNTKRIVGTYGYMSPEYALRGLFSIKSDVFSFGVLLLETLSSKKNTHFYNTDSLTLLGHAWNLWNDGRTW 391 (476)
Q Consensus 312 a~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~s~ksDVwSlGvvl~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~ 391 (476)
+........ .....||+.|+|||++. ..++.++|||||||++|+|++|+.||..... ....... ..+..
T Consensus 186 a~~~~~~~~---~~~~~gt~~y~aPE~l~-~~~~~~~DiwslG~il~~ll~g~~pf~~~~~--~~~~~~i----~~~~~- 254 (494)
T 3lij_A 186 SAVFENQKK---MKERLGTAYYIAPEVLR-KKYDEKCDVWSIGVILFILLAGYPPFGGQTD--QEILRKV----EKGKY- 254 (494)
T ss_dssp CEECBTTBC---BCCCCSCTTTCCHHHHT-TCBCTHHHHHHHHHHHHHHHHSSCSSCCSSH--HHHHHHH----HHTCC-
T ss_pred CeECCCCcc---ccccCCCcCeeCHHHHc-ccCCCchhHHHHHHHHHHHHhCCCCCCCCCH--HHHHHHH----HhCCC-
Confidence 987654322 22356999999999876 5689999999999999999999999875432 1111111 11111
Q ss_pred cccCcccCCCCCHHHHHHHHHHHHHchhhcccCCCCHHHHHH
Q 045315 392 ELMDPISQNGASYPILKRYINVALLCVQEKAADRPAMSEVVS 433 (476)
Q Consensus 392 ~~~d~~~~~~~~~~~~~~l~~li~~Cl~~dP~~RPt~~eVl~ 433 (476)
....+. .......+.+++.+||+.||++|||+.|+++
T Consensus 255 ~~~~~~-----~~~~s~~~~~li~~~L~~dp~~R~s~~e~l~ 291 (494)
T 3lij_A 255 TFDSPE-----WKNVSEGAKDLIKQMLQFDSQRRISAQQALE 291 (494)
T ss_dssp CCCSGG-----GTTSCHHHHHHHHHHTCSSTTTSCCHHHHHT
T ss_pred CCCchh-----cccCCHHHHHHHHHHCCCChhhCccHHHHhc
Confidence 000010 0122356889999999999999999999874
|
| >1phk_A Phosphorylase kinase; glycogen metabolism, transferase, serine/threonine-protein, ATP-binding, calmodulin-binding; HET: ATP; 2.20A {Oryctolagus cuniculus} SCOP: d.144.1.7 PDB: 1ql6_A* 2phk_A* | Back alignment and structure |
|---|
Probab=99.92 E-value=2.2e-25 Score=217.93 Aligned_cols=175 Identities=21% Similarity=0.310 Sum_probs=133.7
Q ss_pred cccceeeccCCCCC------CCCCCChhhHHHHHHHHHHHHHHHhhcCCCceeecCCCccceEecCCCCceeccccceee
Q 045315 241 DEISFWYESYNNPT------KKGLLCWGTRVRIIEGIAQGLLYLHQYSRLRVIHRDLKASNILLDKDMNPKISDFGMARM 314 (476)
Q Consensus 241 ~~~~l~~Ey~~~~~------~~~~L~~~~~~~i~~qIa~gL~yLH~~~~~~ivH~DLkp~NILld~~~~~kL~DFGla~~ 314 (476)
+..++++||++... .+..+++.++..++.||+.||+|||+++ ++|+||||+||+++.++.+||+|||++..
T Consensus 97 ~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~qi~~~l~~lH~~~---i~H~dl~p~Nil~~~~~~~kl~dfg~~~~ 173 (298)
T 1phk_A 97 TFFFLVFDLMKKGELFDYLTEKVTLSEKETRKIMRALLEVICALHKLN---IVHRDLKPENILLDDDMNIKLTDFGFSCQ 173 (298)
T ss_dssp SEEEEEEECCTTCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEECTTCCEEECCCTTCEE
T ss_pred CeEEEEEeccCCCcHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCCcceEEEcCCCcEEEecccchhh
Confidence 45788999997432 2457999999999999999999999999 99999999999999999999999999987
Q ss_pred cCCCcccccceeeeeccCCCChhhhc------cCCCCccceEEeehhhhhhhhhCCCCCCcCCCCchhhhhhhhhhhcCC
Q 045315 315 FGGDELQSNTKRIVGTYGYMSPEYAL------RGLFSIKSDVFSFGVLLLETLSSKKNTHFYNTDSLTLLGHAWNLWNDG 388 (476)
Q Consensus 315 ~~~~~~~~~~~~~~gt~~y~aPE~l~------~~~~s~ksDVwSlGvvl~elltG~~p~~~~~~~~~~~~~~~~~~~~~~ 388 (476)
...... .....++..|+|||.+. ...++.++||||||+++|||++|+.||..... ...... ...+
T Consensus 174 ~~~~~~---~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~--~~~~~~----~~~~ 244 (298)
T 1phk_A 174 LDPGEK---LREVCGTPSYLAPEIIECSMNDNHPGYGKEVDMWSTGVIMYTLLAGSPPFWHRKQ--MLMLRM----IMSG 244 (298)
T ss_dssp CCTTCC---BCCCCSCGGGCCHHHHHHHHCTTSCCBCTHHHHHHHHHHHHHHHHSSCSSCCSSH--HHHHHH----HHHT
T ss_pred cCCCcc---cccccCCccccCHHHhccccccccccCCcccccHhHHHHHHHHHHCCCCCcCccH--HHHHHH----HhcC
Confidence 654322 22356899999999885 45688999999999999999999999864331 111111 1111
Q ss_pred CcccccCcccCCCCCHHHHHHHHHHHHHchhhcccCCCCHHHHHH
Q 045315 389 RTWELMDPISQNGASYPILKRYINVALLCVQEKAADRPAMSEVVS 433 (476)
Q Consensus 389 ~~~~~~d~~~~~~~~~~~~~~l~~li~~Cl~~dP~~RPt~~eVl~ 433 (476)
.. .. ...........+.+++.+||+.||++|||+.|+++
T Consensus 245 ~~-~~-----~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~ 283 (298)
T 1phk_A 245 NY-QF-----GSPEWDDYSDTVKDLVSRFLVVQPQKRYTAEEALA 283 (298)
T ss_dssp CC-CC-----CTTTGGGSCHHHHHHHHHHCCSSGGGSCCHHHHTT
T ss_pred Cc-cc-----CcccccccCHHHHHHHHHHccCCcccCCCHHHHHh
Confidence 11 00 00111223467889999999999999999999875
|
| >2h6d_A 5'-AMP-activated protein kinase catalytic subunit alpha-2; ATP-binding, cholesterol biosynthesis, fatty acid biosynthesis;kinase, lipid synthesis; 1.85A {Homo sapiens} PDB: 3aqv_A* 2yza_A* | Back alignment and structure |
|---|
Probab=99.92 E-value=7.6e-26 Score=218.74 Aligned_cols=172 Identities=24% Similarity=0.338 Sum_probs=125.7
Q ss_pred cccceeeccCCCCC------CCCCCChhhHHHHHHHHHHHHHHHhhcCCCceeecCCCccceEecCCCCceeccccceee
Q 045315 241 DEISFWYESYNNPT------KKGLLCWGTRVRIIEGIAQGLLYLHQYSRLRVIHRDLKASNILLDKDMNPKISDFGMARM 314 (476)
Q Consensus 241 ~~~~l~~Ey~~~~~------~~~~L~~~~~~~i~~qIa~gL~yLH~~~~~~ivH~DLkp~NILld~~~~~kL~DFGla~~ 314 (476)
+..++++||++..+ ..+.+++.++..++.||+.||+|||+++ ++|+||||+||+++.++.+||+|||++..
T Consensus 84 ~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~qi~~~l~~lH~~~---i~H~dl~p~Nil~~~~~~~~l~dfg~~~~ 160 (276)
T 2h6d_A 84 TDFFMVMEYVSGGELFDYICKHGRVEEMEARRLFQQILSAVDYCHRHM---VVHRDLKPENVLLDAHMNAKIADFGLSNM 160 (276)
T ss_dssp SEEEEEEECCCSCBHHHHHHHHCSCCHHHHHHHHHHHHHHHHHHHHHC---SSCCCCCGGGEEECTTSCEEECCCCGGGC
T ss_pred CeEEEEEeccCCCcHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHHCC---CccCCCChhhEEECCCCCEEEeecccccc
Confidence 46788999997432 2356899999999999999999999999 99999999999999999999999999987
Q ss_pred cCCCcccccceeeeeccCCCChhhhccCCC-CccceEEeehhhhhhhhhCCCCCCcCCCCchhhhhhhhhhhcCCCcccc
Q 045315 315 FGGDELQSNTKRIVGTYGYMSPEYALRGLF-SIKSDVFSFGVLLLETLSSKKNTHFYNTDSLTLLGHAWNLWNDGRTWEL 393 (476)
Q Consensus 315 ~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~-s~ksDVwSlGvvl~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~ 393 (476)
...... .....++..|+|||.+.+..+ +.++||||||+++|+|++|+.||..... ..... ....+..
T Consensus 161 ~~~~~~---~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~--~~~~~----~~~~~~~--- 228 (276)
T 2h6d_A 161 MSDGEF---LRTSCGSPNYAAPEVISGRLYAGPEVDIWSCGVILYALLCGTLPFDDEHV--PTLFK----KIRGGVF--- 228 (276)
T ss_dssp CCC----------------CCTGGGTTSCCCHHHHHHHHHHHHHHHHHHSSCSSCCSSH--HHHHH----HHHHCCC---
T ss_pred cCCCcc---eecccCCccccCHHHHcCCCCCCccchHHHHHHHHHHHHhCCCCCCCCcH--HHHHH----HhhcCcc---
Confidence 654321 223468999999999987765 6899999999999999999999864321 11111 1111110
Q ss_pred cCcccCCCCCHHHHHHHHHHHHHchhhcccCCCCHHHHHHH
Q 045315 394 MDPISQNGASYPILKRYINVALLCVQEKAADRPAMSEVVSM 434 (476)
Q Consensus 394 ~d~~~~~~~~~~~~~~l~~li~~Cl~~dP~~RPt~~eVl~~ 434 (476)
..+......+.+++.+||+.||++|||++|+++.
T Consensus 229 -------~~~~~~~~~l~~li~~~l~~~p~~Rps~~~~l~h 262 (276)
T 2h6d_A 229 -------YIPEYLNRSVATLLMHMLQVDPLKRATIKDIREH 262 (276)
T ss_dssp -------CCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHS
T ss_pred -------cCchhcCHHHHHHHHHHccCChhhCCCHHHHHhC
Confidence 0011123568899999999999999999999873
|
| >3a99_A Proto-oncogene serine/threonine-protein kinase PI; PIM-1, P27KIP1, peptide drug, prostate cancer, transferase; HET: ANP; 1.60A {Homo sapiens} PDB: 3bgq_A* 3bgp_A* 2obj_A* 3bgz_A* 3t9i_A* 3dcv_A* 1xws_A* 2xj1_A* 2xix_A* 2xiz_A* 2xj0_A* 2xiy_A* 2xj2_A* 3f2a_A* 1xr1_A* 1xqz_A* 3cy2_A* 3cxw_A* 3cy3_A* 2bik_B* ... | Back alignment and structure |
|---|
Probab=99.92 E-value=3.8e-26 Score=226.59 Aligned_cols=164 Identities=21% Similarity=0.334 Sum_probs=129.2
Q ss_pred cccceeeccCCC-C------CCCCCCChhhHHHHHHHHHHHHHHHhhcCCCceeecCCCccceEec-CCCCceeccccce
Q 045315 241 DEISFWYESYNN-P------TKKGLLCWGTRVRIIEGIAQGLLYLHQYSRLRVIHRDLKASNILLD-KDMNPKISDFGMA 312 (476)
Q Consensus 241 ~~~~l~~Ey~~~-~------~~~~~L~~~~~~~i~~qIa~gL~yLH~~~~~~ivH~DLkp~NILld-~~~~~kL~DFGla 312 (476)
+..++++||+.. . ..++.+++.++..++.||++||+|||+.+ |+||||||+||+++ .++.+||+|||++
T Consensus 121 ~~~~lv~e~~~~~~~L~~~l~~~~~l~~~~~~~i~~qi~~~L~~LH~~~---ivH~Dlkp~NIll~~~~~~~kL~Dfg~~ 197 (320)
T 3a99_A 121 DSFVLILERPEPVQDLFDFITERGALQEELARSFFWQVLEAVRHCHNCG---VLHRDIKDENILIDLNRGELKLIDFGSG 197 (320)
T ss_dssp SEEEEEEECCSSEEEHHHHHHHHCSCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEEETTTTEEEECCCTTC
T ss_pred CcEEEEEEcCCCCccHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHHCC---cEeCCCCHHHEEEeCCCCCEEEeeCccc
Confidence 456778888762 1 12457999999999999999999999999 99999999999999 7889999999999
Q ss_pred eecCCCcccccceeeeeccCCCChhhhccCCC-CccceEEeehhhhhhhhhCCCCCCcCCCCchhhhhhhhhhhcCCCcc
Q 045315 313 RMFGGDELQSNTKRIVGTYGYMSPEYALRGLF-SIKSDVFSFGVLLLETLSSKKNTHFYNTDSLTLLGHAWNLWNDGRTW 391 (476)
Q Consensus 313 ~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~-s~ksDVwSlGvvl~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~ 391 (476)
+...... .....|+..|+|||.+.+..+ +.++||||||+++|||++|+.||.... ... .. ..
T Consensus 198 ~~~~~~~----~~~~~gt~~y~aPE~~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~----~~~-------~~-~~- 260 (320)
T 3a99_A 198 ALLKDTV----YTDFDGTRVYSPPEWIRYHRYHGRSAAVWSLGILLYDMVCGDIPFEHDE----EII-------RG-QV- 260 (320)
T ss_dssp EECCSSC----BCCCCSCGGGSCHHHHHHSCBCHHHHHHHHHHHHHHHHHHSSCSCCSHH----HHH-------HC-CC-
T ss_pred ccccccc----ccCCCCCccCCChHHhccCCCCCccchHHhHHHHHHHHHHCCCCCCChh----hhh-------cc-cc-
Confidence 8765432 223468999999999987665 788999999999999999999985321 000 00 00
Q ss_pred cccCcccCCCCCHHHHHHHHHHHHHchhhcccCCCCHHHHHH
Q 045315 392 ELMDPISQNGASYPILKRYINVALLCVQEKAADRPAMSEVVS 433 (476)
Q Consensus 392 ~~~d~~~~~~~~~~~~~~l~~li~~Cl~~dP~~RPt~~eVl~ 433 (476)
.. .......+.+++.+||+.||++|||++||++
T Consensus 261 -----~~----~~~~~~~~~~li~~~l~~dp~~Rps~~~ll~ 293 (320)
T 3a99_A 261 -----FF----RQRVSSECQHLIRWCLALRPSDRPTFEEIQN 293 (320)
T ss_dssp -----CC----SSCCCHHHHHHHHHHTCSSGGGSCCHHHHHT
T ss_pred -----cc----cccCCHHHHHHHHHHccCChhhCcCHHHHhc
Confidence 00 0112356889999999999999999999986
|
| >3mwu_A Calmodulin-domain protein kinase 1; serine/threonine protein kinase, transferase, calcium-bindin binding, bumped kinase inhibitor, BKI; HET: BK3; 1.98A {Cryptosporidium parvum} PDB: 3igo_A* 3ncg_A* | Back alignment and structure |
|---|
Probab=99.92 E-value=1.6e-25 Score=234.95 Aligned_cols=175 Identities=27% Similarity=0.341 Sum_probs=131.6
Q ss_pred cccceeeccCCCCC------CCCCCChhhHHHHHHHHHHHHHHHhhcCCCceeecCCCccceEec---CCCCceeccccc
Q 045315 241 DEISFWYESYNNPT------KKGLLCWGTRVRIIEGIAQGLLYLHQYSRLRVIHRDLKASNILLD---KDMNPKISDFGM 311 (476)
Q Consensus 241 ~~~~l~~Ey~~~~~------~~~~L~~~~~~~i~~qIa~gL~yLH~~~~~~ivH~DLkp~NILld---~~~~~kL~DFGl 311 (476)
+..++++||++... ..+.+++.++..++.||+.||+|||+++ |+||||||+|||++ .++.+||+|||+
T Consensus 94 ~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~i~~qi~~al~~lH~~~---ivH~Dlkp~Nil~~~~~~~~~~kl~Dfg~ 170 (486)
T 3mwu_A 94 SSFYIVGELYTGGELFDEIIKRKRFSEHDAARIIKQVFSGITYMHKHN---IVHRDLKPENILLESKEKDCDIKIIDFGL 170 (486)
T ss_dssp SEEEEEECCCCSCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCSGGGEEESSSSTTCCEEECSCSC
T ss_pred CEEEEEEEcCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCC---eEeccCchHHEEEecCCCCCCEEEEECCc
Confidence 46788999998432 2467999999999999999999999999 99999999999995 456799999999
Q ss_pred eeecCCCcccccceeeeeccCCCChhhhccCCCCccceEEeehhhhhhhhhCCCCCCcCCCCchhhhhhhhhhhcCCCcc
Q 045315 312 ARMFGGDELQSNTKRIVGTYGYMSPEYALRGLFSIKSDVFSFGVLLLETLSSKKNTHFYNTDSLTLLGHAWNLWNDGRTW 391 (476)
Q Consensus 312 a~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~s~ksDVwSlGvvl~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~ 391 (476)
++...... ......||+.|+|||++.+ .++.++|||||||++|+|++|+.||..... ....... ..+...
T Consensus 171 a~~~~~~~---~~~~~~gt~~y~aPE~~~~-~~~~~~DiwslG~il~~ll~g~~pf~~~~~--~~~~~~i----~~~~~~ 240 (486)
T 3mwu_A 171 STCFQQNT---KMKDRIGTAYYIAPEVLRG-TYDEKCDVWSAGVILYILLSGTPPFYGKNE--YDILKRV----ETGKYA 240 (486)
T ss_dssp TTTBCCC-------CCTTGGGGCCGGGGGS-CCCHHHHHHHHHHHHHHHHHSSCSSCCSSH--HHHHHHH----HHTCCC
T ss_pred CeECCCCC---ccCCCcCCCCCCCHHHhCC-CCCchhhHHHHHHHHHHHHhCCCCCCCCCH--HHHHHHH----HhCCCC
Confidence 98654332 1223568999999999875 589999999999999999999999865431 1111111 111110
Q ss_pred cccCcccCCCCCHHHHHHHHHHHHHchhhcccCCCCHHHHHHH
Q 045315 392 ELMDPISQNGASYPILKRYINVALLCVQEKAADRPAMSEVVSM 434 (476)
Q Consensus 392 ~~~d~~~~~~~~~~~~~~l~~li~~Cl~~dP~~RPt~~eVl~~ 434 (476)
. ..+ ........+.+++.+||+.||++|||+.|+++.
T Consensus 241 ~-~~~-----~~~~~s~~~~~li~~~L~~dp~~R~t~~~~l~h 277 (486)
T 3mwu_A 241 F-DLP-----QWRTISDDAKDLIRKMLTFHPSLRITATQCLEH 277 (486)
T ss_dssp S-CSG-----GGGGSCHHHHHHHHHHTCSSTTTSCCHHHHHHC
T ss_pred C-CCc-----ccCCCCHHHHHHHHHHcCCChhhCcCHHHHhcC
Confidence 0 000 011234578899999999999999999999873
|
| >2i6l_A Mitogen-activated protein kinase 6; MAPK6, ERK3, extracellular signal regulated kinase 3, serine phosphorylation, threonine phosphorylation; 2.25A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.92 E-value=1.5e-26 Score=227.98 Aligned_cols=188 Identities=20% Similarity=0.211 Sum_probs=130.0
Q ss_pred cccceeeccCCC----CCCCCCCChhhHHHHHHHHHHHHHHHhhcCCCceeecCCCccceEec-CCCCceeccccceeec
Q 045315 241 DEISFWYESYNN----PTKKGLLCWGTRVRIIEGIAQGLLYLHQYSRLRVIHRDLKASNILLD-KDMNPKISDFGMARMF 315 (476)
Q Consensus 241 ~~~~l~~Ey~~~----~~~~~~L~~~~~~~i~~qIa~gL~yLH~~~~~~ivH~DLkp~NILld-~~~~~kL~DFGla~~~ 315 (476)
+..++++||++. .-..+++++.++..++.||+.||+|||+++ |+||||||+||+++ +++.+||+|||+++..
T Consensus 95 ~~~~lv~e~~~~~L~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~---i~H~dlkp~Nil~~~~~~~~kl~Dfg~~~~~ 171 (320)
T 2i6l_A 95 NSVYIVQEYMETDLANVLEQGPLLEEHARLFMYQLLRGLKYIHSAN---VLHRDLKPANLFINTEDLVLKIGDFGLARIM 171 (320)
T ss_dssp SEEEEEEECCSEEHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHHTT---CBCCCCSGGGEEEETTTTEEEECCCTTCBCC
T ss_pred CceeEEeeccCCCHHHHhhcCCccHHHHHHHHHHHHHHHHHHHhCC---EecCCCCHHHEEEcCCCCeEEEccCcccccc
Confidence 457788999872 113457999999999999999999999999 99999999999997 5678999999999876
Q ss_pred CCCccc-ccceeeeeccCCCChhhhcc-CCCCccceEEeehhhhhhhhhCCCCCCcCCCCchhhhhhhhhhhcC------
Q 045315 316 GGDELQ-SNTKRIVGTYGYMSPEYALR-GLFSIKSDVFSFGVLLLETLSSKKNTHFYNTDSLTLLGHAWNLWND------ 387 (476)
Q Consensus 316 ~~~~~~-~~~~~~~gt~~y~aPE~l~~-~~~s~ksDVwSlGvvl~elltG~~p~~~~~~~~~~~~~~~~~~~~~------ 387 (476)
...... .......++..|+|||.+.+ ..++.++|||||||++|||++|+.||...... ............
T Consensus 172 ~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~~~--~~~~~~~~~~~~~~~~~~ 249 (320)
T 2i6l_A 172 DPHYSHKGHLSEGLVTKWYRSPRLLLSPNNYTKAIDMWAAGCIFAEMLTGKTLFAGAHEL--EQMQLILESIPVVHEEDR 249 (320)
T ss_dssp --------CCCGGGSCCTTCCHHHHHCTTCCCHHHHHHHHHHHHHHHHHSSCSSCCSSHH--HHHHHHHHHSCCCCHHHH
T ss_pred CCCcccccccccccccccccCcHHhcCcccCCchhhhHhHHHHHHHHHhCCCCCCCCCHH--HHHHHHHHhcCCCchhhh
Confidence 432111 11222456889999998875 67899999999999999999999998754311 111110000000
Q ss_pred ----CCcccccCcccC-CCCC-----HHHHHHHHHHHHHchhhcccCCCCHHHHHH
Q 045315 388 ----GRTWELMDPISQ-NGAS-----YPILKRYINVALLCVQEKAADRPAMSEVVS 433 (476)
Q Consensus 388 ----~~~~~~~d~~~~-~~~~-----~~~~~~l~~li~~Cl~~dP~~RPt~~eVl~ 433 (476)
......+..... .... ......+.+++.+||+.||++|||++|+++
T Consensus 250 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~ 305 (320)
T 2i6l_A 250 QELLSVIPVYIRNDMTEPHKPLTQLLPGISREAVDFLEQILTFSPMDRLTAEEALS 305 (320)
T ss_dssp HHHHTTSCHHHHHHTTSCCCCHHHHSTTCCHHHHHHHHTTSCSSGGGSCCHHHHHT
T ss_pred hhhhhcCcccccccccCCCCChhHhcchhhHHHHHHHHHHcCCCccccCCHHHHhC
Confidence 000000000000 0000 112457889999999999999999999986
|
| >2j7t_A Serine/threonine-protein kinase 10; transferase, ATP-binding, cell cycle progression, phosphorylation, disease mutation, nucleotide- binding; HET: 274; 2.0A {Homo sapiens} PDB: 4aot_A* 3zz2_A* 2j51_A* 2jfl_A* 2jfm_A* 2uv2_A* | Back alignment and structure |
|---|
Probab=99.92 E-value=2.4e-26 Score=225.17 Aligned_cols=175 Identities=19% Similarity=0.295 Sum_probs=129.1
Q ss_pred cccceeeccCCCC-------CCCCCCChhhHHHHHHHHHHHHHHHhhcCCCceeecCCCccceEecCCCCceecccccee
Q 045315 241 DEISFWYESYNNP-------TKKGLLCWGTRVRIIEGIAQGLLYLHQYSRLRVIHRDLKASNILLDKDMNPKISDFGMAR 313 (476)
Q Consensus 241 ~~~~l~~Ey~~~~-------~~~~~L~~~~~~~i~~qIa~gL~yLH~~~~~~ivH~DLkp~NILld~~~~~kL~DFGla~ 313 (476)
+..++++||++.. .....+++.++..++.||+.||+|||+.+ ++||||||+||+++.++.+||+|||++.
T Consensus 89 ~~~~lv~e~~~~~~l~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~---i~H~dlkp~Nil~~~~~~~kl~Dfg~~~ 165 (302)
T 2j7t_A 89 GKLWIMIEFCPGGAVDAIMLELDRGLTEPQIQVVCRQMLEALNFLHSKR---IIHRDLKAGNVLMTLEGDIRLADFGVSA 165 (302)
T ss_dssp -CEEEEEECCTTEEHHHHHHHHTSCCCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCSGGGEEECTTSCEEECCCHHHH
T ss_pred CeEEEEEEeCCCCcHHHHHHhhccCCCHHHHHHHHHHHHHHHHHHhcCC---cccCCCCHHHEEECCCCCEEEEECCCCc
Confidence 4678899999732 12467999999999999999999999999 9999999999999999999999999875
Q ss_pred ecCCCcccccceeeeeccCCCChhhhc-----cCCCCccceEEeehhhhhhhhhCCCCCCcCCCCchhhhhhhhhhhcCC
Q 045315 314 MFGGDELQSNTKRIVGTYGYMSPEYAL-----RGLFSIKSDVFSFGVLLLETLSSKKNTHFYNTDSLTLLGHAWNLWNDG 388 (476)
Q Consensus 314 ~~~~~~~~~~~~~~~gt~~y~aPE~l~-----~~~~s~ksDVwSlGvvl~elltG~~p~~~~~~~~~~~~~~~~~~~~~~ 388 (476)
...... .......|+..|+|||.+. +..++.++||||||+++|||++|+.|+....... ... .....
T Consensus 166 ~~~~~~--~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~--~~~---~~~~~- 237 (302)
T 2j7t_A 166 KNLKTL--QKRDSFIGTPYWMAPEVVMCETMKDTPYDYKADIWSLGITLIEMAQIEPPHHELNPMR--VLL---KIAKS- 237 (302)
T ss_dssp HHHHHH--HC-----CCGGGCCHHHHHHHHTTSTTTTTHHHHHHHHHHHHHHHHSSCTTTTSCHHH--HHH---HHHHS-
T ss_pred cccccc--cccccccCChhhcCCeeeccccCCCCCCchhhhHHHHHHHHHHHhcCCCCCccCCHHH--HHH---HHhcc-
Confidence 432111 1122356899999999984 5678999999999999999999999986543111 111 11111
Q ss_pred CcccccCcccCCCCCHHHHHHHHHHHHHchhhcccCCCCHHHHHH
Q 045315 389 RTWELMDPISQNGASYPILKRYINVALLCVQEKAADRPAMSEVVS 433 (476)
Q Consensus 389 ~~~~~~d~~~~~~~~~~~~~~l~~li~~Cl~~dP~~RPt~~eVl~ 433 (476)
...... .+......+.+++.+||+.||++|||+.++++
T Consensus 238 ~~~~~~-------~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~ 275 (302)
T 2j7t_A 238 DPPTLL-------TPSKWSVEFRDFLKIALDKNPETRPSAAQLLE 275 (302)
T ss_dssp CCCCCS-------SGGGSCHHHHHHHHHHSCSCTTTSCCHHHHTT
T ss_pred CCcccC-------CccccCHHHHHHHHHHcccChhhCCCHHHHhc
Confidence 110110 11222456889999999999999999999875
|
| >1zy4_A Serine/threonine-protein kinase GCN2; translation regulator, signal transduction, acid starvation, starvation stress response; 1.95A {Saccharomyces cerevisiae} PDB: 1zy5_A* 1zyd_A* 1zyc_A* 1zxe_A | Back alignment and structure |
|---|
Probab=99.92 E-value=1.8e-25 Score=218.31 Aligned_cols=176 Identities=22% Similarity=0.281 Sum_probs=124.3
Q ss_pred cccceeeccCCCCC-------CCCCCChhhHHHHHHHHHHHHHHHhhcCCCceeecCCCccceEecCCCCceecccccee
Q 045315 241 DEISFWYESYNNPT-------KKGLLCWGTRVRIIEGIAQGLLYLHQYSRLRVIHRDLKASNILLDKDMNPKISDFGMAR 313 (476)
Q Consensus 241 ~~~~l~~Ey~~~~~-------~~~~L~~~~~~~i~~qIa~gL~yLH~~~~~~ivH~DLkp~NILld~~~~~kL~DFGla~ 313 (476)
+..++++||++..+ ....+++.++..++.||+.||+|||+++ |+||||||+||+++.++.+||+|||++.
T Consensus 88 ~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~---i~H~dlkp~Nil~~~~~~~kl~dfg~~~ 164 (303)
T 1zy4_A 88 STLFIQMEYCENGTLYDLIHSENLNQQRDEYWRLFRQILEALSYIHSQG---IIHRDLKPMNIFIDESRNVKIGDFGLAK 164 (303)
T ss_dssp EEEEEEEECCCSCBHHHHHHHSCGGGCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEECTTSCEEECCCCCCS
T ss_pred CceEEEEecCCCCCHHHhhhccccccchHHHHHHHHHHHHHHHHHHhCC---eecccCCHHhEEEcCCCCEEEeeCcchh
Confidence 46788999997432 3456888999999999999999999999 9999999999999999999999999998
Q ss_pred ecCCCcc------------cccceeeeeccCCCChhhhccC-CCCccceEEeehhhhhhhhhCCCCCCcCCCCchhhhhh
Q 045315 314 MFGGDEL------------QSNTKRIVGTYGYMSPEYALRG-LFSIKSDVFSFGVLLLETLSSKKNTHFYNTDSLTLLGH 380 (476)
Q Consensus 314 ~~~~~~~------------~~~~~~~~gt~~y~aPE~l~~~-~~s~ksDVwSlGvvl~elltG~~p~~~~~~~~~~~~~~ 380 (476)
....... ........|+..|+|||.+.+. .++.++|||||||++|||++ |+.... +.....
T Consensus 165 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~---p~~~~~-~~~~~~-- 238 (303)
T 1zy4_A 165 NVHRSLDILKLDSQNLPGSSDNLTSAIGTAMYVATEVLDGTGHYNEKIDMYSLGIIFFEMIY---PFSTGM-ERVNIL-- 238 (303)
T ss_dssp CTTC-------------------------CTTSCHHHHTSCSCCCTHHHHHHHHHHHHHHHS---CCSSHH-HHHHHH--
T ss_pred hcccccchhccccccccccccccccCCCcccccCcccccCCCCCcchhhHHHHHHHHHHHHh---ccCCch-hHHHHH--
Confidence 6543210 1112335689999999999864 68999999999999999998 332111 111111
Q ss_pred hhhhhcCCCcccccCcccCCCCCHHHHHHHHHHHHHchhhcccCCCCHHHHHH
Q 045315 381 AWNLWNDGRTWELMDPISQNGASYPILKRYINVALLCVQEKAADRPAMSEVVS 433 (476)
Q Consensus 381 ~~~~~~~~~~~~~~d~~~~~~~~~~~~~~l~~li~~Cl~~dP~~RPt~~eVl~ 433 (476)
....... ..............+.+++.+||+.||++|||+.++++
T Consensus 239 --~~~~~~~------~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~ll~ 283 (303)
T 1zy4_A 239 --KKLRSVS------IEFPPDFDDNKMKVEKKIIRLLIDHDPNKRPGARTLLN 283 (303)
T ss_dssp --HHHHSTT------CCCCTTCCTTTSHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred --Hhccccc------cccCccccccchHHHHHHHHHHHhcCcccCcCHHHHhC
Confidence 1111110 01111222333456889999999999999999999986
|
| >3q5i_A Protein kinase; CDPK, malaria, phosphotransferase, structural genomics, structural genomic consortium, SGC, transferase; HET: ANP; 2.10A {Plasmodium berghei} | Back alignment and structure |
|---|
Probab=99.91 E-value=2.1e-25 Score=235.13 Aligned_cols=174 Identities=25% Similarity=0.330 Sum_probs=132.8
Q ss_pred cccceeeccCCCCC------CCCCCChhhHHHHHHHHHHHHHHHhhcCCCceeecCCCccceEecCCC---Cceeccccc
Q 045315 241 DEISFWYESYNNPT------KKGLLCWGTRVRIIEGIAQGLLYLHQYSRLRVIHRDLKASNILLDKDM---NPKISDFGM 311 (476)
Q Consensus 241 ~~~~l~~Ey~~~~~------~~~~L~~~~~~~i~~qIa~gL~yLH~~~~~~ivH~DLkp~NILld~~~---~~kL~DFGl 311 (476)
+..+++|||++.+. .+..+++.++..++.||+.||+|||+.+ |+||||||+|||++.++ .+||+|||+
T Consensus 119 ~~~~lv~e~~~gg~L~~~l~~~~~~~~~~~~~i~~qi~~~l~~lH~~~---ivH~Dlkp~Nil~~~~~~~~~~kl~Dfg~ 195 (504)
T 3q5i_A 119 KYFYLVTEFYEGGELFEQIINRHKFDECDAANIMKQILSGICYLHKHN---IVHRDIKPENILLENKNSLLNIKIVDFGL 195 (504)
T ss_dssp SEEEEEEECCTTCBHHHHHHHHSCCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEESSTTCCSSEEECCCTT
T ss_pred CEEEEEEecCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCC---eEeCCCcHHHEEEecCCCCccEEEEECCC
Confidence 46789999998432 2457999999999999999999999999 99999999999998775 689999999
Q ss_pred eeecCCCcccccceeeeeccCCCChhhhccCCCCccceEEeehhhhhhhhhCCCCCCcCCCCchhhhhhhhhhhcCCCcc
Q 045315 312 ARMFGGDELQSNTKRIVGTYGYMSPEYALRGLFSIKSDVFSFGVLLLETLSSKKNTHFYNTDSLTLLGHAWNLWNDGRTW 391 (476)
Q Consensus 312 a~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~s~ksDVwSlGvvl~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~ 391 (476)
+........ .....||+.|+|||.+. +.++.++|||||||++|+|++|+.||...... ...... ..+...
T Consensus 196 a~~~~~~~~---~~~~~gt~~y~aPE~~~-~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~--~~~~~i----~~~~~~ 265 (504)
T 3q5i_A 196 SSFFSKDYK---LRDRLGTAYYIAPEVLK-KKYNEKCDVWSCGVIMYILLCGYPPFGGQNDQ--DIIKKV----EKGKYY 265 (504)
T ss_dssp CEECCTTSC---BCCCCSCTTTCCHHHHT-TCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHH--HHHHHH----HHCCCC
T ss_pred CEEcCCCCc---cccccCCcCCCCHHHhc-cCCCchHHHHHHHHHHHHHHhCCCCCCCCCHH--HHHHHH----HcCCCC
Confidence 987754322 22356999999999876 56899999999999999999999998754321 111111 111110
Q ss_pred cccCcccCCCCCHHHHHHHHHHHHHchhhcccCCCCHHHHHH
Q 045315 392 ELMDPISQNGASYPILKRYINVALLCVQEKAADRPAMSEVVS 433 (476)
Q Consensus 392 ~~~d~~~~~~~~~~~~~~l~~li~~Cl~~dP~~RPt~~eVl~ 433 (476)
. +... .......+.+++.+||+.||.+|||++|+++
T Consensus 266 ~--~~~~----~~~~s~~~~~li~~~L~~dp~~R~t~~e~l~ 301 (504)
T 3q5i_A 266 F--DFND----WKNISDEAKELIKLMLTYDYNKRCTAEEALN 301 (504)
T ss_dssp C--CHHH----HTTSCHHHHHHHHHHTCSSTTTSCCHHHHHT
T ss_pred C--Cccc----cCCCCHHHHHHHHHHcCCChhHCCCHHHHhc
Confidence 0 0000 0112356889999999999999999999985
|
| >2iwi_A Serine/threonine-protein kinase PIM-2; nucleotide-binding, cancer, leukemia, transferase, ATP-binding, proto- oncogene, phosphorylation; HET: HB1; 2.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.91 E-value=1.1e-25 Score=221.82 Aligned_cols=164 Identities=23% Similarity=0.370 Sum_probs=127.6
Q ss_pred cccceeecc-CCCC------CCCCCCChhhHHHHHHHHHHHHHHHhhcCCCceeecCCCccceEec-CCCCceeccccce
Q 045315 241 DEISFWYES-YNNP------TKKGLLCWGTRVRIIEGIAQGLLYLHQYSRLRVIHRDLKASNILLD-KDMNPKISDFGMA 312 (476)
Q Consensus 241 ~~~~l~~Ey-~~~~------~~~~~L~~~~~~~i~~qIa~gL~yLH~~~~~~ivH~DLkp~NILld-~~~~~kL~DFGla 312 (476)
+..++++|| ++.. ..++.+++.++..++.||+.||+|||+++ |+||||||+||+++ .++.+||+|||++
T Consensus 111 ~~~~~v~e~~~~~~~L~~~l~~~~~~~~~~~~~~~~qi~~~l~~lH~~~---i~H~dlkp~Nil~~~~~~~~kl~dfg~~ 187 (312)
T 2iwi_A 111 EGFMLVLERPLPAQDLFDYITEKGPLGEGPSRCFFGQVVAAIQHCHSRG---VVHRDIKDENILIDLRRGCAKLIDFGSG 187 (312)
T ss_dssp --CEEEEECCSSEEEHHHHHHHHCSCCHHHHHHHHHHHHHHHHHHHHHT---EECCCCSGGGEEEETTTTEEEECCCSSC
T ss_pred CeEEEEEEecCCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCC---eeecCCChhhEEEeCCCCeEEEEEcchh
Confidence 456777887 4411 12456999999999999999999999999 99999999999999 8889999999999
Q ss_pred eecCCCcccccceeeeeccCCCChhhhccCCC-CccceEEeehhhhhhhhhCCCCCCcCCCCchhhhhhhhhhhcCCCcc
Q 045315 313 RMFGGDELQSNTKRIVGTYGYMSPEYALRGLF-SIKSDVFSFGVLLLETLSSKKNTHFYNTDSLTLLGHAWNLWNDGRTW 391 (476)
Q Consensus 313 ~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~-s~ksDVwSlGvvl~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~ 391 (476)
....... .....|+..|+|||.+.+..+ +.++||||||+++|||++|+.||.... ... . ...
T Consensus 188 ~~~~~~~----~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~----~~~-------~-~~~- 250 (312)
T 2iwi_A 188 ALLHDEP----YTDFDGTRVYSPPEWISRHQYHALPATVWSLGILLYDMVCGDIPFERDQ----EIL-------E-AEL- 250 (312)
T ss_dssp EECCSSC----BCCCCSCTTTSCHHHHHHSCBCHHHHHHHHHHHHHHHHHHSSCSCCSHH----HHH-------H-TCC-
T ss_pred hhcccCc----ccccCCcccccCceeeecCCCCCccchHHHHHHHHHHHHHCCCCCCChH----HHh-------h-hcc-
Confidence 8765432 223568999999999987666 459999999999999999999985321 000 0 000
Q ss_pred cccCcccCCCCCHHHHHHHHHHHHHchhhcccCCCCHHHHHH
Q 045315 392 ELMDPISQNGASYPILKRYINVALLCVQEKAADRPAMSEVVS 433 (476)
Q Consensus 392 ~~~d~~~~~~~~~~~~~~l~~li~~Cl~~dP~~RPt~~eVl~ 433 (476)
.........+.+++.+||+.||++||+++|+++
T Consensus 251 ---------~~~~~~~~~~~~li~~~l~~~p~~Rps~~e~l~ 283 (312)
T 2iwi_A 251 ---------HFPAHVSPDCCALIRRCLAPKPSSRPSLEEILL 283 (312)
T ss_dssp ---------CCCTTSCHHHHHHHHHHTCSSTTTSCCHHHHHH
T ss_pred ---------CCcccCCHHHHHHHHHHccCChhhCcCHHHHhc
Confidence 011122356889999999999999999999987
|
| >2wei_A Calmodulin-domain protein kinase 1, putative; nucleotide-binding, serine/threonine-protein kinase, CGD3_920, transferase; HET: VGG; 1.65A {Cryptosporidium parvum iowa II} PDB: 3dfa_A 3ma6_A* | Back alignment and structure |
|---|
Probab=99.91 E-value=7.6e-25 Score=213.36 Aligned_cols=174 Identities=26% Similarity=0.311 Sum_probs=130.0
Q ss_pred cccceeeccCCCCC------CCCCCChhhHHHHHHHHHHHHHHHhhcCCCceeecCCCccceEecCC---CCceeccccc
Q 045315 241 DEISFWYESYNNPT------KKGLLCWGTRVRIIEGIAQGLLYLHQYSRLRVIHRDLKASNILLDKD---MNPKISDFGM 311 (476)
Q Consensus 241 ~~~~l~~Ey~~~~~------~~~~L~~~~~~~i~~qIa~gL~yLH~~~~~~ivH~DLkp~NILld~~---~~~kL~DFGl 311 (476)
+..++++||++... +.+.+++.++..++.||+.||+|||+++ ++||||||+||+++.+ +.+||+|||+
T Consensus 94 ~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~i~~qi~~~l~~LH~~~---i~H~dl~p~NIlv~~~~~~~~~kL~Dfg~ 170 (287)
T 2wei_A 94 SSFYIVGELYTGGELFDEIIKRKRFSEHDAARIIKQVFSGITYMHKHN---IVHRDLKPENILLESKEKDCDIKIIDFGL 170 (287)
T ss_dssp SEEEEEECCCCSCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEESCSSTTCCEEECSTTG
T ss_pred CeEEEEEEccCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCC---eeccCCChhhEEEecCCCcccEEEeccCc
Confidence 46778899987432 2457999999999999999999999999 9999999999999754 4699999999
Q ss_pred eeecCCCcccccceeeeeccCCCChhhhccCCCCccceEEeehhhhhhhhhCCCCCCcCCCCchhhhhhhhhhhcCCCcc
Q 045315 312 ARMFGGDELQSNTKRIVGTYGYMSPEYALRGLFSIKSDVFSFGVLLLETLSSKKNTHFYNTDSLTLLGHAWNLWNDGRTW 391 (476)
Q Consensus 312 a~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~s~ksDVwSlGvvl~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~ 391 (476)
+........ .....++..|+|||.+.+ .++.++||||||+++|+|++|+.||..... ..... ....+...
T Consensus 171 ~~~~~~~~~---~~~~~~~~~y~aPE~~~~-~~~~~~Di~slG~~l~~l~~g~~p~~~~~~--~~~~~----~~~~~~~~ 240 (287)
T 2wei_A 171 STCFQQNTK---MKDRIGTAYYIAPEVLRG-TYDEKCDVWSAGVILYILLSGTPPFYGKNE--YDILK----RVETGKYA 240 (287)
T ss_dssp GGTBCCCSS---CSCHHHHHTTCCHHHHTT-CCCTHHHHHHHHHHHHHHHHSSCSSCCSSH--HHHHH----HHHHCCCC
T ss_pred ceeecCCCc---cccccCcccccChHHhcC-CCCCchhhHhHHHHHHHHHhCCCCCCCCCH--HHHHH----HHHcCCCC
Confidence 986643321 122458899999998865 489999999999999999999999865431 11111 11111110
Q ss_pred cccCcccCCCCCHHHHHHHHHHHHHchhhcccCCCCHHHHHH
Q 045315 392 ELMDPISQNGASYPILKRYINVALLCVQEKAADRPAMSEVVS 433 (476)
Q Consensus 392 ~~~d~~~~~~~~~~~~~~l~~li~~Cl~~dP~~RPt~~eVl~ 433 (476)
.. .+. .......+.+++.+||+.||++|||+.|+++
T Consensus 241 ~~-~~~-----~~~~~~~~~~li~~~l~~dp~~Rps~~ell~ 276 (287)
T 2wei_A 241 FD-LPQ-----WRTISDDAKDLIRKMLTFHPSLRITATQCLE 276 (287)
T ss_dssp CC-SGG-----GTTSCHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred CC-chh-----hhhcCHHHHHHHHHHcccChhhCcCHHHHhc
Confidence 00 000 0112356889999999999999999999987
|
| >3a0c_A Mannose/sialic acid-binding lectin; beta-prism II, sugar binding protein; 2.00A {Polygonatum cyrtonema} PDB: 3a0d_A* 3a0e_A* | Back alignment and structure |
|---|
Probab=99.90 E-value=8.8e-24 Score=176.09 Aligned_cols=110 Identities=25% Similarity=0.443 Sum_probs=97.4
Q ss_pred cCccCCCCcccCCCEEeeCCCeEEEEeeCCCCCCCeEEEEEEccCCCceEEeecCCCCCCCCCceEEEecCCceEEEccC
Q 045315 26 ADTITPETFIRDGEKLVSSSQRFELGFFSPRNSKNRYLGVWYKKIPDTVVWVANRNSPIFNPNTALTFSNNGNLVLLSQR 105 (476)
Q Consensus 26 ~~~l~~g~~l~~~~~l~S~~g~f~lgf~~~~~~~~~~~~iw~~~~~~~~vW~an~~~p~~~~~~~l~~~~~G~lvl~~~~ 105 (476)
+|+|.+|+.|.+|++|+ ++|.|+|+|+.+|+. ++|+. +++||++|++.| +..+.|+|+.||||||+|.+
T Consensus 1 ~d~l~~g~~L~~g~~l~-~~~~~~l~~~~dGnl------vl~~~--~~~vW~sn~~~~--~~~~~l~l~~dGNLVl~~~~ 69 (110)
T 3a0c_A 1 VNSLSSPNSLFTGHSLE-VGPSYRLIMQGDCNF------VLYDS--GKPVWASNTGGL--GSGCRLTLHNNGNLVIYDQS 69 (110)
T ss_dssp CCEEETTCEECTTCEEE-ETTTEEEEECTTSCE------EEEET--TEEEEECCCTTS--CSSCEEEECTTSCEEEECTT
T ss_pred CCEeCCCCEECCCCEEE-ECCCEEEEEcCCCcE------EEEEC--CEEEEECCCCCC--CCcEEEEEeCCCCEEEECCC
Confidence 37899999999999999 999999999999984 67763 799999999877 45689999999999999999
Q ss_pred CeEEEeecCCCCCCCceeeeccCCCeEEEeCCCCCCcCceeeccccCCC
Q 045315 106 NGIIWSSNMSRKAENPIAQLLDTGNLVIRDNSSGHTTESYLWQSFDYPT 154 (476)
Q Consensus 106 ~~~vWss~~~~~~~~~~~~l~d~GNlVl~~~~~~~~~~~~~WqSFd~pt 154 (476)
+.++|+|.+....+.+.++|+|+||||||+ .++||||+||.
T Consensus 70 ~~~~W~S~t~~~~g~~~l~l~~dGnlvl~~--------~~~W~S~~~~~ 110 (110)
T 3a0c_A 70 NRVIWQTKTNGKEDHYVLVLQQDRNVVIYG--------PVVWATGSGPA 110 (110)
T ss_dssp CCEEEECCCCCSSSCCEEEECTTSCEEEEC--------SEEEECSCCC-
T ss_pred CcEEEecCCCCCCCCEEEEEeCCccEEEEC--------CCEecCCCcCC
Confidence 999999998876667789999999999984 27999999983
|
| >1b2p_A Protein (lectin); mannose-binding lectin, monocot, aglutinin, bluebell bulbs, carbohydrate interactions, sugar binding protein; 1.70A {Hyacinthoides hispanica} SCOP: b.78.1.1 | Back alignment and structure |
|---|
Probab=99.90 E-value=1.2e-23 Score=177.52 Aligned_cols=108 Identities=19% Similarity=0.333 Sum_probs=96.6
Q ss_pred cccCccCCCCcccCCCEEe--eCCCeEEEEeeCCCCCCCeEEEEEEccCCCceEEeecCCCCCCCCCceEEEecCCceEE
Q 045315 24 LAADTITPETFIRDGEKLV--SSSQRFELGFFSPRNSKNRYLGVWYKKIPDTVVWVANRNSPIFNPNTALTFSNNGNLVL 101 (476)
Q Consensus 24 ~~~~~l~~g~~l~~~~~l~--S~~g~f~lgf~~~~~~~~~~~~iw~~~~~~~~vW~an~~~p~~~~~~~l~~~~~G~lvl 101 (476)
++.++|.+|++|.+|++|+ |++|.|+|+|+.+|+. +||++ +++||+|||+.| +.++.|+|+.||||||
T Consensus 6 ~~~~~l~~g~~L~~g~~l~~~S~~g~~~L~~~~dgnl------vly~~--~~~vW~sn~~~~--~~~~~l~l~~dGNLVl 75 (119)
T 1b2p_A 6 SKQPDDNHPQILHATESLEILFGTHVYRFIMQTDCNL------VLYDN--NNPIWATNTGGL--GNGCRAVLQPDGVLVV 75 (119)
T ss_dssp CSCSSSCCCCEEETTCEEEEEETTEEEEEEECTTSCE------EEEET--TEEEEECCCTTS--CSSCEEEECTTSCEEE
T ss_pred ecCcccCCCCEEcCCCEEEEeCCCCCEEEEEecCCCE------EEEEC--CEEEEeCCCccC--CCceEEEEccCCEEEE
Confidence 4568999999999999999 9999999999999874 57876 899999999977 5568999999999999
Q ss_pred EccCCeEEEeecCCCCCCCceeeeccCCCeEEEeCCCCCCcCceeecc
Q 045315 102 LSQRNGIIWSSNMSRKAENPIAQLLDTGNLVIRDNSSGHTTESYLWQS 149 (476)
Q Consensus 102 ~~~~~~~vWss~~~~~~~~~~~~l~d~GNlVl~~~~~~~~~~~~~WqS 149 (476)
+|.++.++|+|.+....+.+.++|+|+|||||++ .++|||
T Consensus 76 ~d~~~~~lW~S~~~~~~g~~~l~l~~~Gnlvl~~--------~~~W~S 115 (119)
T 1b2p_A 76 ITNENVTVWQSPVAGKAGHYVLVLQPDRNVVIYG--------DALWAT 115 (119)
T ss_dssp ECTTCCEEEECSCCCCSSCEEEEECTTSCEEEEE--------SEEEEC
T ss_pred EeCCCcEEEcCCCCCCCCCEEEEEECCCcEEEEC--------ccEeCC
Confidence 9999999999998766667789999999999995 379998
|
| >2pzi_A Probable serine/threonine-protein kinase PKNG; ATP-recognition, kinase-INH complex, rubredoxin fold, TPR domain, transferase; HET: AXX; 2.40A {Mycobacterium tuberculosis} | Back alignment and structure |
|---|
Probab=99.90 E-value=2.7e-24 Score=234.78 Aligned_cols=164 Identities=20% Similarity=0.265 Sum_probs=128.3
Q ss_pred cceeeccCCCC----CCCCCCChhhHHHHHHHHHHHHHHHhhcCCCceeecCCCccceEecCCCCceeccccceeecCCC
Q 045315 243 ISFWYESYNNP----TKKGLLCWGTRVRIIEGIAQGLLYLHQYSRLRVIHRDLKASNILLDKDMNPKISDFGMARMFGGD 318 (476)
Q Consensus 243 ~~l~~Ey~~~~----~~~~~L~~~~~~~i~~qIa~gL~yLH~~~~~~ivH~DLkp~NILld~~~~~kL~DFGla~~~~~~ 318 (476)
++++|||++.. .....+++.+++.++.||+.||+|||+++ |+||||||+|||++.+ .+||+|||+++.....
T Consensus 159 ~~lv~E~~~g~~L~~~~~~~l~~~~~~~~~~qi~~aL~~lH~~g---iiHrDlkp~NIll~~~-~~kl~DFG~a~~~~~~ 234 (681)
T 2pzi_A 159 GYIVMEYVGGQSLKRSKGQKLPVAEAIAYLLEILPALSYLHSIG---LVYNDLKPENIMLTEE-QLKLIDLGAVSRINSF 234 (681)
T ss_dssp EEEEEECCCCEECC----CCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEECSS-CEEECCCTTCEETTCC
T ss_pred eEEEEEeCCCCcHHHHHhCCCCHHHHHHHHHHHHHHHHHHHHCC---CeecccChHHeEEeCC-cEEEEecccchhcccC
Confidence 58999999832 22347999999999999999999999999 9999999999999986 8999999999876543
Q ss_pred cccccceeeeeccCCCChhhhccCCCCccceEEeehhhhhhhhhCCCCCCcCCCCchhhhhhhhhhhcCCCcccccCccc
Q 045315 319 ELQSNTKRIVGTYGYMSPEYALRGLFSIKSDVFSFGVLLLETLSSKKNTHFYNTDSLTLLGHAWNLWNDGRTWELMDPIS 398 (476)
Q Consensus 319 ~~~~~~~~~~gt~~y~aPE~l~~~~~s~ksDVwSlGvvl~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~ 398 (476)
....||+.|+|||++.+.. +.++|||||||++|+|++|.+|+........ .
T Consensus 235 ------~~~~gt~~y~aPE~~~~~~-~~~sDi~slG~~l~~l~~g~~~~~~~~~~~~----------------------~ 285 (681)
T 2pzi_A 235 ------GYLYGTPGFQAPEIVRTGP-TVATDIYTVGRTLAALTLDLPTRNGRYVDGL----------------------P 285 (681)
T ss_dssp ------SCCCCCTTTSCTTHHHHCS-CHHHHHHHHHHHHHHHHSCCCEETTEECSSC----------------------C
T ss_pred ------CccCCCccccCHHHHcCCC-CCceehhhhHHHHHHHHhCCCCCcccccccc----------------------c
Confidence 2356899999999987664 8999999999999999999887653211000 0
Q ss_pred CCCCCHHHHHHHHHHHHHchhhcccCCC-CHHHHHHHHhccc
Q 045315 399 QNGASYPILKRYINVALLCVQEKAADRP-AMSEVVSMLSNEF 439 (476)
Q Consensus 399 ~~~~~~~~~~~l~~li~~Cl~~dP~~RP-t~~eVl~~L~~~~ 439 (476)
...........+.+++.+||+.||++|| +++++...|.+..
T Consensus 286 ~~~~~~~~~~~l~~li~~~l~~dP~~R~~~~~~l~~~l~~~~ 327 (681)
T 2pzi_A 286 EDDPVLKTYDSYGRLLRRAIDPDPRQRFTTAEEMSAQLTGVL 327 (681)
T ss_dssp TTCHHHHHCHHHHHHHHHHTCSSGGGSCSSHHHHHHHHHHHH
T ss_pred ccccccccCHHHHHHHhhhccCChhhCCCHHHHHHHHHHHHH
Confidence 0011112345788999999999999999 4667777776653
|
| >3qa8_A MGC80376 protein; kinase ubiquitin-like domain, phosphorylation, kinase domain ubiquitin-like domain, kinase, substrate binding; 3.60A {Xenopus laevis} PDB: 3qad_A* 3rzf_A* | Back alignment and structure |
|---|
Probab=99.89 E-value=9.2e-24 Score=227.11 Aligned_cols=183 Identities=23% Similarity=0.239 Sum_probs=130.1
Q ss_pred cccceeeccCCCC---------CCCCCCChhhHHHHHHHHHHHHHHHhhcCCCceeecCCCccceEecCCCC---ceecc
Q 045315 241 DEISFWYESYNNP---------TKKGLLCWGTRVRIIEGIAQGLLYLHQYSRLRVIHRDLKASNILLDKDMN---PKISD 308 (476)
Q Consensus 241 ~~~~l~~Ey~~~~---------~~~~~L~~~~~~~i~~qIa~gL~yLH~~~~~~ivH~DLkp~NILld~~~~---~kL~D 308 (476)
+..+++|||++++ .....+++.++..++.||+.||+|||+.+ |+||||||+||+++.++. +||+|
T Consensus 91 ~~~~LVmEy~~ggsL~~~L~~~~~~~~lse~~i~~I~~QLl~aL~yLHs~g---IVHrDLKP~NILl~~~g~~~~vKL~D 167 (676)
T 3qa8_A 91 DLPLLAMEYCEGGDLRKYLNQFENCCGLKEGPIRTLLSDISSALRYLHENR---IIHRDLKPENIVLQPGPQRLIHKIID 167 (676)
T ss_dssp SSCCCEEECCSSCBHHHHHHSSSCTTCCCSSHHHHHHHHHHHHHHHHHHTT---BCCCCCCSTTEEEECCSSSCEEEECS
T ss_pred CeEEEEEEeCCCCCHHHHHHhcccCCCCCHHHHHHHHHHHHHHHHHHHHCC---CccCCCCHHHeEeecCCCceeEEEcc
Confidence 4567899999732 23346999999999999999999999999 999999999999997665 89999
Q ss_pred ccceeecCCCcccccceeeeeccCCCChhhhccCCCCccceEEeehhhhhhhhhCCCCCCcCCCCchhhhhhhh------
Q 045315 309 FGMARMFGGDELQSNTKRIVGTYGYMSPEYALRGLFSIKSDVFSFGVLLLETLSSKKNTHFYNTDSLTLLGHAW------ 382 (476)
Q Consensus 309 FGla~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~s~ksDVwSlGvvl~elltG~~p~~~~~~~~~~~~~~~~------ 382 (476)
||++........ .....|+..|+|||.+.+..++.++|||||||++|||++|+.||....... .......
T Consensus 168 FG~a~~~~~~~~---~~~~~gt~~Y~APE~l~~~~~s~ksDIwSLGviLyeLltG~~Pf~~~~~~~-~~~~~i~~~~~~~ 243 (676)
T 3qa8_A 168 LGYAKELDQGEL---CTEFVGTLQYLAPELLEQKKYTVTVDYWSFGTLAFECITGFRPFLPNWQPV-QWHGKVREKSNEH 243 (676)
T ss_dssp CCCCCBTTSCCC---CCCCCSCCTTCSSCSSCCSCCSTTHHHHHHHHHHHHHHSSCSSCCSSCHHH-HSSTTCC------
T ss_pred cccccccccccc---cccccCCcccCChHHhccCCCCchhHHHHHHHHHHHHHHCCCCCCcccchh-hhhhhhhcccchh
Confidence 999987654322 223578999999999999999999999999999999999999986431100 0000000
Q ss_pred -hhh--cCCCcccccCcccCCCCCHHHHHHHHHHHHHchhhcccCCCCHHH
Q 045315 383 -NLW--NDGRTWELMDPISQNGASYPILKRYINVALLCVQEKAADRPAMSE 430 (476)
Q Consensus 383 -~~~--~~~~~~~~~d~~~~~~~~~~~~~~l~~li~~Cl~~dP~~RPt~~e 430 (476)
... ..+.....-...............+.+++.+||+.||++|||+++
T Consensus 244 ~~~~~~l~g~~~~~~~lp~p~~l~~~ls~~L~dLI~~mL~~DP~kRPTa~e 294 (676)
T 3qa8_A 244 IVVYDDLTGAVKFSSVLPTPNHLSGILAGKLERWLQCMLMWHQRQRGTDPQ 294 (676)
T ss_dssp CCSCCCCSSSCCCCSSSCCSCCCCGGGHHHHHHHHHHHSCSSCC---CCTT
T ss_pred hhhhhhhccccccccccCCchhhchhhhHHHHHHHHHHccCCHhhCcCHHH
Confidence 000 000000000000112234456788999999999999999999977
|
| >1xd5_A Gastrodianin-1, antifungal protein GAFP-1; monocot mannose binding lectin, monomer, homogeneous beta- sheet; 2.00A {Gastrodia elata} SCOP: b.78.1.1 PDB: 1xd6_A | Back alignment and structure |
|---|
Probab=99.88 E-value=1.2e-22 Score=170.01 Aligned_cols=110 Identities=27% Similarity=0.455 Sum_probs=95.9
Q ss_pred cCccCCCCcccCCCEEeeCCCeEEEEeeCCCCCCCeEEEEEEccCCCceEEeecCCCCCCCCCceEEEecCCceEEEccC
Q 045315 26 ADTITPETFIRDGEKLVSSSQRFELGFFSPRNSKNRYLGVWYKKIPDTVVWVANRNSPIFNPNTALTFSNNGNLVLLSQR 105 (476)
Q Consensus 26 ~~~l~~g~~l~~~~~l~S~~g~f~lgf~~~~~~~~~~~~iw~~~~~~~~vW~an~~~p~~~~~~~l~~~~~G~lvl~~~~ 105 (476)
+|+|.+||.|.+|++| .+|.|+|+|+.+|+. ++|+. +++||++|++.+ +.++.|+|+.||||||+| +
T Consensus 1 tdtl~~gq~L~~g~~L--~~~~~~L~~~~dgnl------vl~~~--~~~vW~sn~~~~--~~~~~l~l~~~GNLvl~d-~ 67 (112)
T 1xd5_A 1 SDRLNSGHQLDTGGSL--AEGGYLFIIQNDCNL------VLYDN--NRAVWASGTNGK--ASGCVLKMQNDGNLVIYS-G 67 (112)
T ss_dssp CCEEETTEEECTTCEE--EETTEEEEECTTSCE------EEEET--TEEEEECCCTTS--CSSEEEEECTTSCEEEEE-T
T ss_pred CCCCCCCCEECCCCEE--eCCCEEEEEcCCCcE------EEEEC--CEEEEeCCCcCC--CCCEEEEEeCCCCEEEEc-C
Confidence 4899999999999999 489999999999984 45665 789999999864 456899999999999999 8
Q ss_pred CeEEEeecCCCCCCCceeeeccCCCeEEEeCCCCCCcCceeeccccCC
Q 045315 106 NGIIWSSNMSRKAENPIAQLLDTGNLVIRDNSSGHTTESYLWQSFDYP 153 (476)
Q Consensus 106 ~~~vWss~~~~~~~~~~~~l~d~GNlVl~~~~~~~~~~~~~WqSFd~p 153 (476)
+.++|+|.+......+.++|+++||||||+.. +.++||||++.
T Consensus 68 ~~~~W~S~~~~~~g~~~l~l~~dGnlvl~~~~-----~~~~W~S~~~~ 110 (112)
T 1xd5_A 68 SRAIWASNTNRQNGNYYLILQRDRNVVIYDNS-----NNAIWATHTNV 110 (112)
T ss_dssp TEEEEECCCCCSCCCCEEEECTTSCEEEECTT-----SCEEEECCCCC
T ss_pred CEEEEECCccCCCCCEEEEEeCCCcEEEECCC-----CceEEECCCcc
Confidence 89999999876666788999999999999754 67999999985
|
| >3m2w_A MAP kinase-activated protein kinase 2; small molecule inhibitor, spiroazetidine-tetracycle, ATP-SIT inhibitor, novartis compound NVP-BXS169; HET: L8I; 2.41A {Homo sapiens} PDB: 3kga_A* 3m42_A* | Back alignment and structure |
|---|
Probab=99.88 E-value=1.2e-23 Score=206.38 Aligned_cols=159 Identities=15% Similarity=0.195 Sum_probs=117.1
Q ss_pred cccceeeccCCCC--------CCCCCCChhhHHHHHHHHHHHHHHHhhcCCCceeecCCCccceEecC---CCCceeccc
Q 045315 241 DEISFWYESYNNP--------TKKGLLCWGTRVRIIEGIAQGLLYLHQYSRLRVIHRDLKASNILLDK---DMNPKISDF 309 (476)
Q Consensus 241 ~~~~l~~Ey~~~~--------~~~~~L~~~~~~~i~~qIa~gL~yLH~~~~~~ivH~DLkp~NILld~---~~~~kL~DF 309 (476)
+..+++|||++.+ .....+++.++..++.||+.||+|||+++ |+||||||+||+++. ++.+||+||
T Consensus 88 ~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~---i~H~dlkp~Nil~~~~~~~~~~kl~Df 164 (299)
T 3m2w_A 88 KCLLIVMECLDGGELFSRIQDRGDQAFTEREASEIMKSIGEAIQYLHSIN---IAHRDVKPENLLYTSKRPNAILKLTDF 164 (299)
T ss_dssp EEEEEEECCCCSCBHHHHHHHCTTCCCBHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEESSSSTTCCEEECCC
T ss_pred ceEEEEEeecCCCcHHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHhCC---cccCCCCHHHEEEecCCCCCcEEEecc
Confidence 3577899999732 23457999999999999999999999999 999999999999998 788999999
Q ss_pred cceeecCCCcccccceeeeeccCCCChhhhccCCCCccceEEeehhhhhhhhhCCCCCCcCCCCchhhhhhhhhhhcCCC
Q 045315 310 GMARMFGGDELQSNTKRIVGTYGYMSPEYALRGLFSIKSDVFSFGVLLLETLSSKKNTHFYNTDSLTLLGHAWNLWNDGR 389 (476)
Q Consensus 310 Gla~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~s~ksDVwSlGvvl~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~ 389 (476)
|++.... +..++.++|||||||++|||++|+.||.......... ........
T Consensus 165 g~a~~~~------------------------~~~~~~~~DiwslG~il~el~tg~~pf~~~~~~~~~~--~~~~~~~~-- 216 (299)
T 3m2w_A 165 GFAKETT------------------------GEKYDKSCDMWSLGVIMYILLCGYPPFYSNHGLAISP--GMKTRIRM-- 216 (299)
T ss_dssp TTCEECT------------------------TCGGGGHHHHHHHHHHHHHHHHSSCSCCC-------C--CSCCSSCT--
T ss_pred ccccccc------------------------cccCCchhhHHHHHHHHHHHHHCCCCCCCCcchhhhH--HHHHHHhh--
Confidence 9997543 2346789999999999999999999986443211000 00000000
Q ss_pred cccccCcccCCCCC----HHHHHHHHHHHHHchhhcccCCCCHHHHHH--HHhcc
Q 045315 390 TWELMDPISQNGAS----YPILKRYINVALLCVQEKAADRPAMSEVVS--MLSNE 438 (476)
Q Consensus 390 ~~~~~d~~~~~~~~----~~~~~~l~~li~~Cl~~dP~~RPt~~eVl~--~L~~~ 438 (476)
.. ...+ ......+.+++.+||+.||++|||+.|+++ .+.+.
T Consensus 217 ------~~--~~~~~~~~~~~~~~~~~li~~~l~~dP~~Rps~~e~l~hp~~~~~ 263 (299)
T 3m2w_A 217 ------GQ--YEFPNPEWSEVSEEVKMLIRNLLKTEPTQRMTITEFMNHPWIMQS 263 (299)
T ss_dssp ------TC--CSSCHHHHTTSCHHHHHHHHHHTCSSTTTSCCHHHHHTSHHHHTG
T ss_pred ------cc--ccCCchhcccCCHHHHHHHHHHcccChhhCCCHHHHhcChhhccc
Confidence 00 0001 112457889999999999999999999987 35443
|
| >2dpf_A Curculin; sweet taste, taste modifying, plant protein; 1.50A {Curculigo latifolia} PDB: 2d04_B* 2d04_A* | Back alignment and structure |
|---|
Probab=99.88 E-value=1.4e-22 Score=170.37 Aligned_cols=110 Identities=20% Similarity=0.321 Sum_probs=95.2
Q ss_pred cCccCCCCcccCCCEEeeCCCeEEEEeeCCCCCCCeEEEEEEccCCCceEEeecCCCCCCCCCceEEEecCCceEEEccC
Q 045315 26 ADTITPETFIRDGEKLVSSSQRFELGFFSPRNSKNRYLGVWYKKIPDTVVWVANRNSPIFNPNTALTFSNNGNLVLLSQR 105 (476)
Q Consensus 26 ~~~l~~g~~l~~~~~l~S~~g~f~lgf~~~~~~~~~~~~iw~~~~~~~~vW~an~~~p~~~~~~~l~~~~~G~lvl~~~~ 105 (476)
.|+|.+||+|.+|++|+ +|.|+|+|+.+|+. ++|+ ..++||+|||+.| +.++.|+|+.||||||+|.+
T Consensus 2 ~dtl~~gq~L~~g~~L~--~g~~~L~~~~dgnl------vly~--~~~~vW~sn~~~~--~~~~~l~l~~~GnLvl~d~~ 69 (115)
T 2dpf_A 2 DNVLLSGQTLHADHSLQ--AGAYTLTIQNKCNL------VKYQ--NGRQIWASNTDRR--GSGCRLTLLSDGNLVIYDHN 69 (115)
T ss_dssp CCEEETTCEEETTEEEE--ETTEEEEECTTSCE------EEEE--TTEEEEECSCTTS--CSSCEEEECTTSCEEEECTT
T ss_pred CCEeCCCCEECCCCEEE--CCCEEEEEcCCCcE------EEEe--CCEEEEeCCCCCC--CCceEEEECCCCcEEEECCC
Confidence 48999999999999998 89999999988874 2354 3789999999988 45789999999999999998
Q ss_pred CeEEEeecCCCCCCCceeeeccCCCeEEEeCCCCCCcCceeeccccCCCc
Q 045315 106 NGIIWSSNMSRKAENPIAQLLDTGNLVIRDNSSGHTTESYLWQSFDYPTD 155 (476)
Q Consensus 106 ~~~vWss~~~~~~~~~~~~l~d~GNlVl~~~~~~~~~~~~~WqSFd~ptd 155 (476)
+.++|+|++........++|+|+|||||++ . ++||||.++..
T Consensus 70 ~~~vW~S~~~~~~g~~~l~l~~dGnlvl~~-------~-~~W~S~~~~~~ 111 (115)
T 2dpf_A 70 NNDVWGSACWGDNGKYALVLQKDGRFVIYG-------P-VLWSLGPNGCR 111 (115)
T ss_dssp CCEEEECCCCCSSSCCEEEECTTSCEEEEC-------S-EEECSSTTCBC
T ss_pred ceEEEEcCCCCCCCCEEEEEeCCCeEEEEC-------C-CEEECCCCCCc
Confidence 999999998765567789999999999993 2 79999987654
|
| >3dzw_A Agglutinin; lectin, mannobiose, mannose-alpha1, 3-mannose, D sugar binding protein; HET: MAN; 1.70A {Narcissus pseudonarcissus} SCOP: b.78.1.1 PDB: 1npl_A* 1jpc_A* 1msa_A* 1niv_A* | Back alignment and structure |
|---|
Probab=99.86 E-value=8.3e-22 Score=163.89 Aligned_cols=104 Identities=27% Similarity=0.425 Sum_probs=90.0
Q ss_pred CccCCCCcccCCCEEeeCCCeEEEEeeCCCCCCCeEEEEEEccCCCceEEeecCCCCCCCCCceEEEecCCceEEEccCC
Q 045315 27 DTITPETFIRDGEKLVSSSQRFELGFFSPRNSKNRYLGVWYKKIPDTVVWVANRNSPIFNPNTALTFSNNGNLVLLSQRN 106 (476)
Q Consensus 27 ~~l~~g~~l~~~~~l~S~~g~f~lgf~~~~~~~~~~~~iw~~~~~~~~vW~an~~~p~~~~~~~l~~~~~G~lvl~~~~~ 106 (476)
++|.+||.|.+|++|+ +|.|.|+|+.+|+. +.|+. .++||++|++.+ +.++.|.|+.||||||+|.++
T Consensus 2 ntL~~gq~L~~g~~L~--~g~~~L~~q~dGnL------vly~~--~~~vW~snt~~~--~~~~~l~l~~dGNLvl~~~~~ 69 (109)
T 3dzw_A 2 NILYSGETLSPGEFLN--NGRYVFIMQEDCNL------VLYDV--DKPIWATNTGGL--DRRCHLSMQSDGNLVVYSPRN 69 (109)
T ss_dssp CEEETTEEECTTCEEE--ETTEEEEECTTSCE------EEEET--TEEEEECCCTTS--SSSCEEEECTTSCEEEECTTS
T ss_pred CCcCCCCEeCCCCEEE--CCCEEEEEcCCCcE------EEEeC--CEEEEECCcccC--CCCEEEEEeCCCCEEEECCCC
Confidence 6899999999999997 79999999999883 23554 689999999876 557899999999999999999
Q ss_pred eEEEeecCCCCCCCceeeeccCCCeEEEeCCCCCCcCceeeccc
Q 045315 107 GIIWSSNMSRKAENPIAQLLDTGNLVIRDNSSGHTTESYLWQSF 150 (476)
Q Consensus 107 ~~vWss~~~~~~~~~~~~l~d~GNlVl~~~~~~~~~~~~~WqSF 150 (476)
.++|+|++......+.|+|+||||||||+ .++|||=
T Consensus 70 ~~~W~S~t~~~~~~~~~~L~ddGNlvly~--------~~~W~s~ 105 (109)
T 3dzw_A 70 NPIWASNTGGENGNYVCVLQKDRNVVIYG--------TARWATG 105 (109)
T ss_dssp CEEEECCCCCSSSCEEEEECTTSCEEEEE--------SCCCCCC
T ss_pred CEEEECCCCCCCCCEEEEEeCCCEEEEEC--------CCEEeCC
Confidence 99999998765556789999999999995 3699983
|
| >2vuw_A Serine/threonine-protein kinase haspin; cell cycle, transferase, CAsp8, nucleotide binding; HET: MSE 5ID MPD; 1.80A {Homo sapiens} PDB: 3f2n_A* 3e7v_A* 3dlz_A* 3fmd_A* 3iq7_A* 2wb8_A | Back alignment and structure |
|---|
Probab=99.86 E-value=1.5e-22 Score=201.81 Aligned_cols=168 Identities=14% Similarity=0.055 Sum_probs=123.6
Q ss_pred cccceeeccCCCC-----CCCCCCChhhHHHHHHHHHHHHHHHh-hcCCCceeecCCCccceEecCCC------------
Q 045315 241 DEISFWYESYNNP-----TKKGLLCWGTRVRIIEGIAQGLLYLH-QYSRLRVIHRDLKASNILLDKDM------------ 302 (476)
Q Consensus 241 ~~~~l~~Ey~~~~-----~~~~~L~~~~~~~i~~qIa~gL~yLH-~~~~~~ivH~DLkp~NILld~~~------------ 302 (476)
+..+++|||++.+ -.++.+++.++..++.||+.||+||| +.+ |+||||||+|||++.++
T Consensus 135 ~~~~lv~E~~~~g~ll~~~~~~~~~~~~~~~i~~qi~~aL~~lH~~~~---ivHrDlKp~NILl~~~~~~~~~~~~~~~~ 211 (336)
T 2vuw_A 135 DQLFIVLEFEFGGIDLEQMRTKLSSLATAKSILHQLTASLAVAEASLR---FEHRDLHWGNVLLKKTSLKKLHYTLNGKS 211 (336)
T ss_dssp TCEEEEEEEECCCEETGGGTTTCCCHHHHHHHHHHHHHHHHHHHHHHC---CBCSCCCGGGEEEEECSCSEEEEEETTEE
T ss_pred CeEEEEEEecCCCccHHHHHhcCCCHHHHHHHHHHHHHHHHHHHHhCC---EeECCCCHHHEEEeccCCcceeeeccCcc
Confidence 5788999998732 13467899999999999999999999 898 99999999999999887
Q ss_pred --------CceeccccceeecCCCcccccceeeeeccCCCChhhhccCCCCccceEEeehhh-hhhhhhCCCCCCcCCCC
Q 045315 303 --------NPKISDFGMARMFGGDELQSNTKRIVGTYGYMSPEYALRGLFSIKSDVFSFGVL-LLETLSSKKNTHFYNTD 373 (476)
Q Consensus 303 --------~~kL~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~s~ksDVwSlGvv-l~elltG~~p~~~~~~~ 373 (476)
.+||+|||+++..... ...||..|+|||.+.+.. +.++||||++++ .++++.|..||......
T Consensus 212 ~~~~~~~~~vkL~DFG~a~~~~~~-------~~~gt~~y~aPE~~~g~~-~~~~Diwsl~~~~~~~~~~g~~p~~~~~~~ 283 (336)
T 2vuw_A 212 STIPSCGLQVSIIDYTLSRLERDG-------IVVFCDVSMDEDLFTGDG-DYQFDIYRLMKKENNNRWGEYHPYSNVLWL 283 (336)
T ss_dssp EEEECTTEEEEECCCTTCBEEETT-------EEECCCCTTCSGGGCCCS-SHHHHHHHHHHHHHTTCTTSCCTHHHHHHH
T ss_pred ccccCCCceEEEeeccccEecCCC-------cEEEeecccChhhhcCCC-ccceehhhhhCCCCcccccccCCCcchhhh
Confidence 8999999999876532 357999999999998766 899999998776 78899999887421000
Q ss_pred chhhhhhhhhhhcCCCcccccCcccCCCCCHHHHHHHHHHHHHchhhcccCCCCHHHHH
Q 045315 374 SLTLLGHAWNLWNDGRTWELMDPISQNGASYPILKRYINVALLCVQEKAADRPAMSEVV 432 (476)
Q Consensus 374 ~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~l~~li~~Cl~~dP~~RPt~~eVl 432 (476)
.... ......... ...............+.+++.+||+.| |++|++
T Consensus 284 -~~~~---~~~~~~~~~----~~~~~~~~~~~~s~~~~dli~~~L~~d-----sa~e~l 329 (336)
T 2vuw_A 284 -HYLT---DKMLKQMTF----KTKCNTPAMKQIKRKIQEFHRTMLNFS-----SATDLL 329 (336)
T ss_dssp -HHHH---HHHHHTCCC----SSCCCSHHHHHHHHHHHHHHHHGGGSS-----SHHHHH
T ss_pred -hHHH---Hhhhhhhcc----CcccchhhhhhcCHHHHHHHHHHhccC-----CHHHHH
Confidence 0000 011100000 000011112345778999999999966 888887
|
| >3uqc_A Probable conserved transmembrane protein; structural genomics, TB structural genomics consortium, TBSG fold, FHAA, transferase; 2.26A {Mycobacterium tuberculosis} PDB: 3oun_B* 3otv_A 3ouk_A | Back alignment and structure |
|---|
Probab=99.85 E-value=5e-22 Score=193.98 Aligned_cols=157 Identities=14% Similarity=0.011 Sum_probs=113.4
Q ss_pred cccceeeccCCCCC-----CCCCCChhhHHHHHHHHHHHHHHHhhcCCCceeecCCCccceEecCCCCceeccccceeec
Q 045315 241 DEISFWYESYNNPT-----KKGLLCWGTRVRIIEGIAQGLLYLHQYSRLRVIHRDLKASNILLDKDMNPKISDFGMARMF 315 (476)
Q Consensus 241 ~~~~l~~Ey~~~~~-----~~~~L~~~~~~~i~~qIa~gL~yLH~~~~~~ivH~DLkp~NILld~~~~~kL~DFGla~~~ 315 (476)
+..+++|||++... +.+ ....++.+++.||+.||+|||+++ |+||||||+|||++.++.+||++++
T Consensus 104 ~~~~lv~e~~~g~~L~~~l~~~-~~~~~~~~i~~ql~~aL~~lH~~g---ivH~Dikp~NIll~~~g~~kl~~~~----- 174 (286)
T 3uqc_A 104 AGGLVVAEWIRGGSLQEVADTS-PSPVGAIRAMQSLAAAADAAHRAG---VALSIDHPSRVRVSIDGDVVLAYPA----- 174 (286)
T ss_dssp TEEEEEEECCCEEEHHHHHTTC-CCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCSGGGEEEETTSCEEECSCC-----
T ss_pred CcEEEEEEecCCCCHHHHHhcC-CChHHHHHHHHHHHHHHHHHHHCC---CccCCCCcccEEEcCCCCEEEEecc-----
Confidence 46789999997221 122 355678999999999999999999 9999999999999999999987432
Q ss_pred CCCcccccceeeeeccCCCChhhhccCCCCccceEEeehhhhhhhhhCCCCCCcCCCCchhhhhhhhhhhcCCCcccccC
Q 045315 316 GGDELQSNTKRIVGTYGYMSPEYALRGLFSIKSDVFSFGVLLLETLSSKKNTHFYNTDSLTLLGHAWNLWNDGRTWELMD 395 (476)
Q Consensus 316 ~~~~~~~~~~~~~gt~~y~aPE~l~~~~~s~ksDVwSlGvvl~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~d 395 (476)
|++ +++.++|||||||++|||++|+.||.......... ........ .. ..
T Consensus 175 -----------------~~~-------~~~~~~Di~slG~il~elltg~~Pf~~~~~~~~~~--~~~~~~~~-~~---~~ 224 (286)
T 3uqc_A 175 -----------------TMP-------DANPQDDIRGIGASLYALLVNRWPLPEAGVRSGLA--PAERDTAG-QP---IE 224 (286)
T ss_dssp -----------------CCT-------TCCHHHHHHHHHHHHHHHHHSEECSCCCSBCCCSE--ECCBCTTS-CB---CC
T ss_pred -----------------ccC-------CCCchhHHHHHHHHHHHHHHCCCCCCcCCcchhhH--HHHHHhcc-CC---CC
Confidence 333 36899999999999999999999997544221100 00000000 00 00
Q ss_pred cccCCCCCHHHHHHHHHHHHHchhhcccCCCCHHHHHHHHhcccc
Q 045315 396 PISQNGASYPILKRYINVALLCVQEKAADRPAMSEVVSMLSNEFV 440 (476)
Q Consensus 396 ~~~~~~~~~~~~~~l~~li~~Cl~~dP~~RPt~~eVl~~L~~~~~ 440 (476)
+. .........+.+++.+||+.||++| |+.|+++.|+....
T Consensus 225 ~~---~~~~~~~~~l~~li~~~l~~dP~~R-s~~el~~~L~~~~~ 265 (286)
T 3uqc_A 225 PA---DIDRDIPFQISAVAARSVQGDGGIR-SASTLLNLMQQATA 265 (286)
T ss_dssp HH---HHCTTSCHHHHHHHHHHHCTTSSCC-CHHHHHHHHHHHHC
T ss_pred hh---hcccCCCHHHHHHHHHHcccCCccC-CHHHHHHHHHHHhc
Confidence 00 0011223568899999999999999 99999999998753
|
| >3r0e_B Lectin; carbohydrate binding, carbohydrate, sugar binding protein; 2.40A {Remusatia vivipara} | Back alignment and structure |
|---|
Probab=99.83 E-value=1.9e-20 Score=155.77 Aligned_cols=105 Identities=19% Similarity=0.299 Sum_probs=88.8
Q ss_pred cccCccCCCCcccCCCEEeeCCCeEEEEeeCCCCCCCeEEEEEEccCCCceEEeecCCCCCCCCCceEEEecCCceEEEc
Q 045315 24 LAADTITPETFIRDGEKLVSSSQRFELGFFSPRNSKNRYLGVWYKKIPDTVVWVANRNSPIFNPNTALTFSNNGNLVLLS 103 (476)
Q Consensus 24 ~~~~~l~~g~~l~~~~~l~S~~g~f~lgf~~~~~~~~~~~~iw~~~~~~~~vW~an~~~p~~~~~~~l~~~~~G~lvl~~ 103 (476)
++.|+|.+||.|..|+.|+| |.|.|.|..+|+. .+ |+. .+||++|++.. +..+.|+|+.||||||+|
T Consensus 4 ~~~dtL~~gq~L~~g~~L~s--g~~~L~~q~dGnL-----vl-~~~---~~vW~snt~~~--~~~~~l~l~~dGNLvl~d 70 (110)
T 3r0e_B 4 FTNNLLFSGQVLYGDGRLTA--KNHQLVMQGDCNL-----VL-YGG---KYGWQSNTHGN--GEHCFLRLNHKGELIIKD 70 (110)
T ss_dssp CBTTEEETTCEEETTEEEEC--SSCEEEECTTSCE-----EE-ECS---SSCEECCCTTS--SSSCEEEECTTSCEEEEC
T ss_pred cccCEECCCCEecCCCEEEe--CCEEEEEcCCCeE-----EE-ECC---eEEEECCCcCC--CcCEEEEEeCCCcEEEEe
Confidence 57799999999999999997 4588888888873 33 554 58999999873 556899999999999999
Q ss_pred cCCeEEEeecCCCCCCCceeeeccCCCeEEEeCCCCCCcCceeecc
Q 045315 104 QRNGIIWSSNMSRKAENPIAQLLDTGNLVIRDNSSGHTTESYLWQS 149 (476)
Q Consensus 104 ~~~~~vWss~~~~~~~~~~~~l~d~GNlVl~~~~~~~~~~~~~WqS 149 (476)
.++.++|+|++......+.|+|+||||||||+ .++|+|
T Consensus 71 ~~~~~iW~S~t~~~~~~~~~~L~~dGNlvly~--------~~~W~t 108 (110)
T 3r0e_B 71 DDFKTIWSSRSSSKQGEYVLILQDDGFGVIYG--------PAIFET 108 (110)
T ss_dssp TTCCEEEECCCCCSSSCCEEEECTTSCEEEEC--------SEEEES
T ss_pred CCCCEEEEcCCcCCCCCEEEEEcCCccEEEec--------CCEecC
Confidence 99999999998754556889999999999994 479987
|
| >3mez_B Mannose-specific lectin 3 chain 2; heterotetramer, sugar binding protein; 1.94A {Crocus vernus} SCOP: b.78.1.0 | Back alignment and structure |
|---|
Probab=99.83 E-value=4.2e-20 Score=154.47 Aligned_cols=108 Identities=15% Similarity=0.278 Sum_probs=91.2
Q ss_pred cccCccCCCCcccCCCEEeeCCCeEEEEeeCCCCCCCeEEEEEEccCCCceEEeecCCCCCCCCCceEEEecCCceEEEc
Q 045315 24 LAADTITPETFIRDGEKLVSSSQRFELGFFSPRNSKNRYLGVWYKKIPDTVVWVANRNSPIFNPNTALTFSNNGNLVLLS 103 (476)
Q Consensus 24 ~~~~~l~~g~~l~~~~~l~S~~g~f~lgf~~~~~~~~~~~~iw~~~~~~~~vW~an~~~p~~~~~~~l~~~~~G~lvl~~ 103 (476)
.+.|+|.+||.|.+|+.|. +|.|.|.|..+|+- .+ |.....++||.+|+..+ +..+.|.|+.||||||+|
T Consensus 4 ~~~~tL~~gq~L~~g~~L~--~g~~~L~~q~dGNL-----vL-~~~~~~~~vWssnt~~~--~~~~~l~l~~dGNLVl~d 73 (113)
T 3mez_B 4 RVRNVLFSSQVMYDNAQLA--TRDYSLVMRDDCNL-----VL-TKGSKTNIVWESGTSGR--GQHCFMRLGHSGELDITD 73 (113)
T ss_dssp CCSSEEETTCEEETTCEEE--ETTEEEEECTTSCE-----EE-EETTTTEEEEECCCTTS--CSSCEEEECTTSCEEEEC
T ss_pred ccCCEeCCCCEECCCCEeE--cCCEEEEEcCCCEE-----EE-EECCCCEEEEECCcccC--CcCEEEEEeCCCcEEEEC
Confidence 3568999999999999998 58899999988883 33 33223789999999876 456899999999999999
Q ss_pred cCCeEEEeecCCCCCCCceeeeccCCCeEEEeCCCCCCcCceeecc
Q 045315 104 QRNGIIWSSNMSRKAENPIAQLLDTGNLVIRDNSSGHTTESYLWQS 149 (476)
Q Consensus 104 ~~~~~vWss~~~~~~~~~~~~l~d~GNlVl~~~~~~~~~~~~~WqS 149 (476)
.++.++|+|++......+.|+|+||||||||+ .++|+|
T Consensus 74 ~~~~~iW~S~t~~~~~~~~~~L~~dGnlvly~--------~~~W~s 111 (113)
T 3mez_B 74 DRLNTVFVSNTVGQEGDYVLILQINGQAVVYG--------PAVWST 111 (113)
T ss_dssp TTSCEEEECSCCCSSSCCEEEECTTSCEEEEC--------SEEEES
T ss_pred CCCCEEEECCCcCCCCCEEEEEcCCceEEEec--------CCEecC
Confidence 99999999998765556889999999999994 479997
|
| >3r0e_A Lectin; carbohydrate binding, carbohydrate, sugar binding protein; 2.40A {Remusatia vivipara} | Back alignment and structure |
|---|
Probab=99.80 E-value=1.4e-19 Score=150.21 Aligned_cols=103 Identities=20% Similarity=0.334 Sum_probs=88.3
Q ss_pred cccCccCCCCcccCCCEEeeCCCeEEEEeeCCCCCCCeEEEEEEccCCCceEEeecCCCCCCCCCceEEEecCCceEEEc
Q 045315 24 LAADTITPETFIRDGEKLVSSSQRFELGFFSPRNSKNRYLGVWYKKIPDTVVWVANRNSPIFNPNTALTFSNNGNLVLLS 103 (476)
Q Consensus 24 ~~~~~l~~g~~l~~~~~l~S~~g~f~lgf~~~~~~~~~~~~iw~~~~~~~~vW~an~~~p~~~~~~~l~~~~~G~lvl~~ 103 (476)
+|.|+|.+||.|.+|+.|. +|.|.|.|+.+||. +.|.. +|.+|+..+ +..+.|+|+.||||||+|
T Consensus 1 ~~~dtL~~gq~L~~g~~L~--~g~~~L~~q~dGNL------vl~~~-----~Wssnt~~~--~~~~~l~l~~dGnLvl~d 65 (109)
T 3r0e_A 1 LGTNYLLSGQTLDTEGHLK--NGDFDLVMQDDCNL------VLYNG-----NWQSNTANN--GRDCKLTLTDYGELVIKN 65 (109)
T ss_dssp CCCSEEETTCEECTTCEEE--ETTEEEEECTTSCE------EEETT-----TEECCCTTS--CSSCEEEECTTSCEEEEC
T ss_pred CccCCcCCCCCcCCCCEeE--CCCEEEEEecCCeE------EEEeC-----eEEcCCCCC--CCcEEEEEcCCCeEEEEe
Confidence 3679999999999999994 79999999999985 33442 799999875 457899999999999999
Q ss_pred cCCeEEEeecCCCCCCCceeeeccCCCeEEEeCCCCCCcCceeecc
Q 045315 104 QRNGIIWSSNMSRKAENPIAQLLDTGNLVIRDNSSGHTTESYLWQS 149 (476)
Q Consensus 104 ~~~~~vWss~~~~~~~~~~~~l~d~GNlVl~~~~~~~~~~~~~WqS 149 (476)
.++.++|+|++......+.|+|+||||||||+ .++|+|
T Consensus 66 ~~~~~vWss~t~~~~~~~~~~L~~dGNlvly~--------~~~W~s 103 (109)
T 3r0e_A 66 GDGSTVWKSGAQSVKGNYAAVVHPDGRLVVFG--------PSVFKI 103 (109)
T ss_dssp TTSCEEEECCCCCSSSCCEEEEETTTEEEEEC--------SEEEEE
T ss_pred CCCCEEEcCCCcCCCcCEEEEEcCCCeEEEEe--------cCEECC
Confidence 99999999998764556789999999999994 479998
|
| >4azs_A Methyltransferase WBDD; kinase; HET: AMP SAM; 2.15A {Escherichia coli} PDB: 4azt_A* 4azv_A* 4azw_A* | Back alignment and structure |
|---|
Probab=99.77 E-value=1.8e-20 Score=199.93 Aligned_cols=118 Identities=15% Similarity=0.077 Sum_probs=81.8
Q ss_pred cccceeeccCCCC------CCCCCCChhhHHHHHHHHHHHHHHHhhcCCCceeecCCCccceEecCCCCceeccccceee
Q 045315 241 DEISFWYESYNNP------TKKGLLCWGTRVRIIEGIAQGLLYLHQYSRLRVIHRDLKASNILLDKDMNPKISDFGMARM 314 (476)
Q Consensus 241 ~~~~l~~Ey~~~~------~~~~~L~~~~~~~i~~qIa~gL~yLH~~~~~~ivH~DLkp~NILld~~~~~kL~DFGla~~ 314 (476)
+..+|||||++.+ ..+++++.. +|+.||+.||+|||++| ||||||||+|||++.++.+||+|||+|+.
T Consensus 315 ~~~yLVMEyv~G~~L~d~i~~~~~l~~~---~I~~QIl~AL~ylH~~G---IIHRDIKPeNILL~~dg~vKL~DFGlAr~ 388 (569)
T 4azs_A 315 QSGWLVMEKLPGRLLSDMLAAGEEIDRE---KILGSLLRSLAALEKQG---FWHDDVRPWNVMVDARQHARLIDFGSIVT 388 (569)
T ss_dssp SEEEEEEECCCSEEHHHHHHTTCCCCHH---HHHHHHHHHHHHHHHTT---CEESCCCGGGEEECTTSCEEECCCTTEES
T ss_pred CEEEEEEecCCCCcHHHHHHhCCCCCHH---HHHHHHHHHHHHHHHCC---ceeccCchHhEEECCCCCEEEeecccCee
Confidence 5789999999933 245567654 58999999999999999 99999999999999999999999999987
Q ss_pred cCCCcccccceeeeeccCCCChhhhccCCCCccceEEeehhhhhhhhhCCCCC
Q 045315 315 FGGDELQSNTKRIVGTYGYMSPEYALRGLFSIKSDVFSFGVLLLETLSSKKNT 367 (476)
Q Consensus 315 ~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~s~ksDVwSlGvvl~elltG~~p~ 367 (476)
....... .....||+.|+|||++.+ .+..++|+|++|++++++.++..++
T Consensus 389 ~~~~~~~--~~t~vGTp~YmAPE~l~g-~~~~~~d~~s~g~~~~~l~~~~~~~ 438 (569)
T 4azs_A 389 TPQDCSW--PTNLVQSFFVFVNELFAE-NKSWNGFWRSAPVHPFNLPQPWSNW 438 (569)
T ss_dssp CC---CC--SHHHHHHHHHHHHHHC------------------CCCCTTHHHH
T ss_pred CCCCCcc--ccCceechhhccHHHhCC-CCCCcccccccccchhhhccccchh
Confidence 6543322 233679999999998865 4677899999999999988776543
|
| >1xd5_A Gastrodianin-1, antifungal protein GAFP-1; monocot mannose binding lectin, monomer, homogeneous beta- sheet; 2.00A {Gastrodia elata} SCOP: b.78.1.1 PDB: 1xd6_A | Back alignment and structure |
|---|
Probab=99.75 E-value=4.2e-18 Score=142.22 Aligned_cols=93 Identities=25% Similarity=0.364 Sum_probs=78.2
Q ss_pred CCCceEEEecCCceEEEccCCeEEEeecCCCCCCCceeeeccCCCeEEEeCCCCCCcCceeeccccCCCcccccCCcccC
Q 045315 86 NPNTALTFSNNGNLVLLSQRNGIIWSSNMSRKAENPIAQLLDTGNLVIRDNSSGHTTESYLWQSFDYPTDSLLEGMKLGW 165 (476)
Q Consensus 86 ~~~~~l~~~~~G~lvl~~~~~~~vWss~~~~~~~~~~~~l~d~GNlVl~~~~~~~~~~~~~WqSFd~ptdtll~~~~l~~ 165 (476)
+....|.|+.||||||++. +.+||++++........|+|+++|||||++ + +.++||||+
T Consensus 18 ~~~~~L~~~~dgnlvl~~~-~~~vW~sn~~~~~~~~~l~l~~~GNLvl~d-~-----~~~~W~S~~-------------- 76 (112)
T 1xd5_A 18 EGGYLFIIQNDCNLVLYDN-NRAVWASGTNGKASGCVLKMQNDGNLVIYS-G-----SRAIWASNT-------------- 76 (112)
T ss_dssp ETTEEEEECTTSCEEEEET-TEEEEECCCTTSCSSEEEEECTTSCEEEEE-T-----TEEEEECCC--------------
T ss_pred CCCEEEEEcCCCcEEEEEC-CEEEEeCCCcCCCCCEEEEEeCCCCEEEEc-C-----CEEEEECCc--------------
Confidence 4467899999999999987 799999998754456789999999999998 4 679999993
Q ss_pred CCCCCcceEEEEeCCCCCCCCcccEEEEEecCcceEEEEc-CCcceeecCCCCc
Q 045315 166 DLKNGLERYLSSWESTDDPSPGNFTFRLVIQVIPKLCAYN-GSVEYTCTGPWNG 218 (476)
Q Consensus 166 ~~~~g~~~~l~s~~~~~~~s~g~~~~~~~~~~~~~~~~~~-gs~~y~~sg~wng 218 (476)
+|++|.|++.++++|.. +++. ++.+||++++|+|
T Consensus 77 -----------------~~~~g~~~l~l~~dGnl--vl~~~~~~~~W~S~~~~g 111 (112)
T 1xd5_A 77 -----------------NRQNGNYYLILQRDRNV--VIYDNSNNAIWATHTNVG 111 (112)
T ss_dssp -----------------CCSCCCCEEEECTTSCE--EEECTTSCEEEECCCCCC
T ss_pred -----------------cCCCCCEEEEEeCCCcE--EEECCCCceEEECCCccC
Confidence 45678999999999984 4554 5678999999986
|
| >3mez_A Mannose-specific lectin 3 chain 1; heterotetramer, sugar binding protein; 1.94A {Crocus vernus} SCOP: b.78.1.0 | Back alignment and structure |
|---|
Probab=99.73 E-value=1e-17 Score=139.45 Aligned_cols=103 Identities=17% Similarity=0.250 Sum_probs=85.2
Q ss_pred cCccCCCCcccCCCEEeeCCCeEEEEeeCCCCCCCeEEEEEEccCCCceEEeecCCCCCCCCCceEEEecCCceEEEccC
Q 045315 26 ADTITPETFIRDGEKLVSSSQRFELGFFSPRNSKNRYLGVWYKKIPDTVVWVANRNSPIFNPNTALTFSNNGNLVLLSQR 105 (476)
Q Consensus 26 ~~~l~~g~~l~~~~~l~S~~g~f~lgf~~~~~~~~~~~~iw~~~~~~~~vW~an~~~p~~~~~~~l~~~~~G~lvl~~~~ 105 (476)
.|+|.+||.|.+|+.|. +|.|.|.|..+|+. +.|.. .. ||.+|+..+ +..+.|.|+.||||||++.+
T Consensus 2 ~~~l~~gq~L~~g~~L~--~g~~~L~~q~dGnL------vl~~~--~~-vW~snt~~~--~~~~~l~l~~dGNLVl~~~~ 68 (111)
T 3mez_A 2 NNVLLTGDVIHTDNQLS--YESAAFVMQGDCNL------VLYNE--AG-GFQSNTHGR--GVDCTLRLNNRGQLEIHSAN 68 (111)
T ss_dssp TTEEETTCEECTTCEEE--ETTEEEEECTTSCE------EEECS--SC-CEECCCTTS--CSSCEEEECTTSCEEEECSS
T ss_pred cCEeCCCCEeCCCCEEe--cCCEEEEEccCCeE------EEECC--CC-EEECCcccC--CcCEEEEEcCCCcEEEEeCC
Confidence 47899999999999995 78999999999884 23443 34 999999876 45689999999999999988
Q ss_pred Ce-EEEeecCCC--CCCCceeeeccCCCeEEEeCCCCCCcCceeecc
Q 045315 106 NG-IIWSSNMSR--KAENPIAQLLDTGNLVIRDNSSGHTTESYLWQS 149 (476)
Q Consensus 106 ~~-~vWss~~~~--~~~~~~~~l~d~GNlVl~~~~~~~~~~~~~WqS 149 (476)
+. ++|+|++.. ....+.|+||+|||||||+ .++|+|
T Consensus 69 ~~~~vW~S~t~~~~~~~~~~l~Lq~dGNlvly~--------~~~W~s 107 (111)
T 3mez_A 69 SNTPVWVYPRSVNTVRGNYAATLGPDQHVTIYG--------PAIWST 107 (111)
T ss_dssp CSSCSEEESSSCCCCSSCCEEEECTTSCEEEEC--------SEEEEC
T ss_pred CCEEEEEeccccCCCCcCEEEEECCCCeEEEec--------cCEEcc
Confidence 76 599999642 2346789999999999994 479997
|
| >3a0c_A Mannose/sialic acid-binding lectin; beta-prism II, sugar binding protein; 2.00A {Polygonatum cyrtonema} PDB: 3a0d_A* 3a0e_A* | Back alignment and structure |
|---|
Probab=99.73 E-value=2.2e-17 Score=137.32 Aligned_cols=90 Identities=24% Similarity=0.365 Sum_probs=75.5
Q ss_pred CCCceEEEecCCceEEEccCCeEEEeecCCCCCCCceeeeccCCCeEEEeCCCCCCcCceeeccccCCCcccccCCcccC
Q 045315 86 NPNTALTFSNNGNLVLLSQRNGIIWSSNMSRKAENPIAQLLDTGNLVIRDNSSGHTTESYLWQSFDYPTDSLLEGMKLGW 165 (476)
Q Consensus 86 ~~~~~l~~~~~G~lvl~~~~~~~vWss~~~~~~~~~~~~l~d~GNlVl~~~~~~~~~~~~~WqSFd~ptdtll~~~~l~~ 165 (476)
+....|.|+.||||||++ .+.+||++++........|+|+|+|||||++.+ +.++||||
T Consensus 19 ~~~~~l~~~~dGnlvl~~-~~~~vW~sn~~~~~~~~~l~l~~dGNLVl~~~~-----~~~~W~S~--------------- 77 (110)
T 3a0c_A 19 GPSYRLIMQGDCNFVLYD-SGKPVWASNTGGLGSGCRLTLHNNGNLVIYDQS-----NRVIWQTK--------------- 77 (110)
T ss_dssp TTTEEEEECTTSCEEEEE-TTEEEEECCCTTSCSSCEEEECTTSCEEEECTT-----CCEEEECC---------------
T ss_pred CCCEEEEEcCCCcEEEEE-CCEEEEECCCCCCCCcEEEEEeCCCCEEEECCC-----CcEEEecC---------------
Confidence 446789999999999998 589999999876555678999999999999875 68999999
Q ss_pred CCCCCcceEEEEeCCCCCCCCcccEEEEEecCcceEEEEcCCcceeecCCC
Q 045315 166 DLKNGLERYLSSWESTDDPSPGNFTFRLVIQVIPKLCAYNGSVEYTCTGPW 216 (476)
Q Consensus 166 ~~~~g~~~~l~s~~~~~~~s~g~~~~~~~~~~~~~~~~~~gs~~y~~sg~w 216 (476)
+++++|.|++.++++|. ++++++ .||+++++
T Consensus 78 ----------------t~~~~g~~~l~l~~dGn--lvl~~~--~~W~S~~~ 108 (110)
T 3a0c_A 78 ----------------TNGKEDHYVLVLQQDRN--VVIYGP--VVWATGSG 108 (110)
T ss_dssp ----------------CCCSSSCCEEEECTTSC--EEEECS--EEEECSCC
T ss_pred ----------------CCCCCCCEEEEEeCCcc--EEEECC--CEecCCCc
Confidence 24667999999999998 445664 79999875
|
| >1b2p_A Protein (lectin); mannose-binding lectin, monocot, aglutinin, bluebell bulbs, carbohydrate interactions, sugar binding protein; 1.70A {Hyacinthoides hispanica} SCOP: b.78.1.1 | Back alignment and structure |
|---|
Probab=99.69 E-value=1.2e-16 Score=134.53 Aligned_cols=87 Identities=24% Similarity=0.288 Sum_probs=73.5
Q ss_pred CceEEEecCCceEEEccCCeEEEeecCCCCCCCceeeeccCCCeEEEeCCCCCCcCceeeccccCCCcccccCCcccCCC
Q 045315 88 NTALTFSNNGNLVLLSQRNGIIWSSNMSRKAENPIAQLLDTGNLVIRDNSSGHTTESYLWQSFDYPTDSLLEGMKLGWDL 167 (476)
Q Consensus 88 ~~~l~~~~~G~lvl~~~~~~~vWss~~~~~~~~~~~~l~d~GNlVl~~~~~~~~~~~~~WqSFd~ptdtll~~~~l~~~~ 167 (476)
...|.|+.|||||||+. +.+||++++........|+|+|+|||||++.+ +.++||||
T Consensus 31 ~~~L~~~~dgnlvly~~-~~~vW~sn~~~~~~~~~l~l~~dGNLVl~d~~-----~~~lW~S~----------------- 87 (119)
T 1b2p_A 31 VYRFIMQTDCNLVLYDN-NNPIWATNTGGLGNGCRAVLQPDGVLVVITNE-----NVTVWQSP----------------- 87 (119)
T ss_dssp EEEEEECTTSCEEEEET-TEEEEECCCTTSCSSCEEEECTTSCEEEECTT-----CCEEEECS-----------------
T ss_pred CEEEEEecCCCEEEEEC-CEEEEeCCCccCCCceEEEEccCCEEEEEeCC-----CcEEEcCC-----------------
Confidence 46799999999999987 89999999876555678999999999999865 68999999
Q ss_pred CCCcceEEEEeCCCCCCCCcccEEEEEecCcceEEEEcCCcceeecCC
Q 045315 168 KNGLERYLSSWESTDDPSPGNFTFRLVIQVIPKLCAYNGSVEYTCTGP 215 (476)
Q Consensus 168 ~~g~~~~l~s~~~~~~~s~g~~~~~~~~~~~~~~~~~~gs~~y~~sg~ 215 (476)
+||++|.|++.++++|.. ++++ ..||++|+
T Consensus 88 --------------~~~~~g~~~l~l~~~Gnl--vl~~--~~~W~Sg~ 117 (119)
T 1b2p_A 88 --------------VAGKAGHYVLVLQPDRNV--VIYG--DALWATQT 117 (119)
T ss_dssp --------------CCCCSSCEEEEECTTSCE--EEEE--SEEEECCC
T ss_pred --------------CCCCCCCEEEEEECCCcE--EEEC--ccEeCCCC
Confidence 356789999999999984 4455 37999986
|
| >2dpf_A Curculin; sweet taste, taste modifying, plant protein; 1.50A {Curculigo latifolia} PDB: 2d04_B* 2d04_A* | Back alignment and structure |
|---|
Probab=99.69 E-value=1.4e-16 Score=133.49 Aligned_cols=91 Identities=29% Similarity=0.396 Sum_probs=76.0
Q ss_pred CceEEEecCCceEEEccCCeEEEeecCCCCCCCceeeeccCCCeEEEeCCCCCCcCceeeccccCCCcccccCCcccCCC
Q 045315 88 NTALTFSNNGNLVLLSQRNGIIWSSNMSRKAENPIAQLLDTGNLVIRDNSSGHTTESYLWQSFDYPTDSLLEGMKLGWDL 167 (476)
Q Consensus 88 ~~~l~~~~~G~lvl~~~~~~~vWss~~~~~~~~~~~~l~d~GNlVl~~~~~~~~~~~~~WqSFd~ptdtll~~~~l~~~~ 167 (476)
...|.|+.||||||++ .+.+||++++.....+..++|+++|||||++.+ +.++||||++
T Consensus 21 ~~~L~~~~dgnlvly~-~~~~vW~sn~~~~~~~~~l~l~~~GnLvl~d~~-----~~~vW~S~~~--------------- 79 (115)
T 2dpf_A 21 AYTLTIQNKCNLVKYQ-NGRQIWASNTDRRGSGCRLTLLSDGNLVIYDHN-----NNDVWGSACW--------------- 79 (115)
T ss_dssp TEEEEECTTSCEEEEE-TTEEEEECSCTTSCSSCEEEECTTSCEEEECTT-----CCEEEECCCC---------------
T ss_pred CEEEEEcCCCcEEEEe-CCEEEEeCCCCCCCCceEEEECCCCcEEEECCC-----ceEEEEcCCC---------------
Confidence 4678899999999998 588999999876555678999999999999864 6799999986
Q ss_pred CCCcceEEEEeCCCCCCCCcccEEEEEecCcceEEEEcCCcceeecCCCCcc
Q 045315 168 KNGLERYLSSWESTDDPSPGNFTFRLVIQVIPKLCAYNGSVEYTCTGPWNGV 219 (476)
Q Consensus 168 ~~g~~~~l~s~~~~~~~s~g~~~~~~~~~~~~~~~~~~gs~~y~~sg~wng~ 219 (476)
+++|.|++.++++|. ++++++ .||++++|...
T Consensus 80 ----------------~~~g~~~l~l~~dGn--lvl~~~--~~W~S~~~~~~ 111 (115)
T 2dpf_A 80 ----------------GDNGKYALVLQKDGR--FVIYGP--VLWSLGPNGCR 111 (115)
T ss_dssp ----------------CSSSCCEEEECTTSC--EEEECS--EEECSSTTCBC
T ss_pred ----------------CCCCCEEEEEeCCCe--EEEECC--CEEECCCCCCc
Confidence 346889999999997 445554 79999999754
|
| >3mez_B Mannose-specific lectin 3 chain 2; heterotetramer, sugar binding protein; 1.94A {Crocus vernus} SCOP: b.78.1.0 | Back alignment and structure |
|---|
Probab=99.51 E-value=8e-14 Score=116.21 Aligned_cols=90 Identities=21% Similarity=0.314 Sum_probs=71.9
Q ss_pred CCCceEEEecCCceEEEcc-CCeEEEeecCCCCCCCceeeeccCCCeEEEeCCCCCCcCceeeccccCCCcccccCCccc
Q 045315 86 NPNTALTFSNNGNLVLLSQ-RNGIIWSSNMSRKAENPIAQLLDTGNLVIRDNSSGHTTESYLWQSFDYPTDSLLEGMKLG 164 (476)
Q Consensus 86 ~~~~~l~~~~~G~lvl~~~-~~~~vWss~~~~~~~~~~~~l~d~GNlVl~~~~~~~~~~~~~WqSFd~ptdtll~~~~l~ 164 (476)
+....|.|+.||||||++. .+.++|++++.....+..|+|+++|||||++.+ +.++|||=.+
T Consensus 23 ~g~~~L~~q~dGNLvL~~~~~~~~vWssnt~~~~~~~~l~l~~dGNLVl~d~~-----~~~iW~S~t~------------ 85 (113)
T 3mez_B 23 TRDYSLVMRDDCNLVLTKGSKTNIVWESGTSGRGQHCFMRLGHSGELDITDDR-----LNTVFVSNTV------------ 85 (113)
T ss_dssp ETTEEEEECTTSCEEEEETTTTEEEEECCCTTSCSSCEEEECTTSCEEEECTT-----SCEEEECSCC------------
T ss_pred cCCEEEEEcCCCEEEEEECCCCEEEEECCcccCCcCEEEEEeCCCcEEEECCC-----CCEEEECCCc------------
Confidence 4457899999999999998 589999999876555678999999999999875 6789998310
Q ss_pred CCCCCCcceEEEEeCCCCCCCCcccEEEEEecCcceEEEEcCCcceeecCC
Q 045315 165 WDLKNGLERYLSSWESTDDPSPGNFTFRLVIQVIPKLCAYNGSVEYTCTGP 215 (476)
Q Consensus 165 ~~~~~g~~~~l~s~~~~~~~s~g~~~~~~~~~~~~~~~~~~gs~~y~~sg~ 215 (476)
-..|.|.+.++.+|..+++ + .+.|.+|+
T Consensus 86 -------------------~~~~~~~~~L~~dGnlvly--~--~~~W~s~~ 113 (113)
T 3mez_B 86 -------------------GQEGDYVLILQINGQAVVY--G--PAVWSTAA 113 (113)
T ss_dssp -------------------CSSSCCEEEECTTSCEEEE--C--SEEEESCC
T ss_pred -------------------CCCCCEEEEEcCCceEEEe--c--CCEecCCC
Confidence 0125689999999988876 3 57898875
|
| >3en9_A Glycoprotease, O-sialoglycoprotein endopeptidase/protein kinase; endopeptidase activity, protein kinase activity; HET: TBR; 2.67A {Methanocaldococcus jannaschii} PDB: 3enh_A* 2vwb_A* | Back alignment and structure |
|---|
Probab=99.49 E-value=7.8e-16 Score=163.17 Aligned_cols=120 Identities=23% Similarity=0.239 Sum_probs=94.4
Q ss_pred cccceeeccCCCCCCCCCCChhhHHHHHHHHHHHHHHHhhcCCCceeecCCCccceEecCCCCceeccccceeecCCCcc
Q 045315 241 DEISFWYESYNNPTKKGLLCWGTRVRIIEGIAQGLLYLHQYSRLRVIHRDLKASNILLDKDMNPKISDFGMARMFGGDEL 320 (476)
Q Consensus 241 ~~~~l~~Ey~~~~~~~~~L~~~~~~~i~~qIa~gL~yLH~~~~~~ivH~DLkp~NILld~~~~~kL~DFGla~~~~~~~~ 320 (476)
+..+++|||++..+-...+.. +..++.||++||+|||+++ |+||||||+|||++. .+||+|||+++.......
T Consensus 412 ~~~~lVmE~~~ggsL~~~l~~--~~~i~~qi~~aL~~LH~~g---IiHrDiKp~NILl~~--~~kL~DFGla~~~~~~~~ 484 (540)
T 3en9_A 412 DNKRIMMSYINGKLAKDVIED--NLDIAYKIGEIVGKLHKND---VIHNDLTTSNFIFDK--DLYIIDFGLGKISNLDED 484 (540)
T ss_dssp TTTEEEEECCCSEEHHHHSTT--CTHHHHHHHHHHHHHHHTT---EECTTCCTTSEEESS--SEEECCCTTCEECCCHHH
T ss_pred CccEEEEECCCCCCHHHHHHH--HHHHHHHHHHHHHHHHHCc---CccCCCCHHHEEECC--eEEEEECccCEECCCccc
Confidence 467899999984332222221 6799999999999999999 999999999999998 999999999998764322
Q ss_pred cc-----cceeeeeccCCCChhhhcc--CCCCccceEEeehhhhhhhhhCCCCC
Q 045315 321 QS-----NTKRIVGTYGYMSPEYALR--GLFSIKSDVFSFGVLLLETLSSKKNT 367 (476)
Q Consensus 321 ~~-----~~~~~~gt~~y~aPE~l~~--~~~s~ksDVwSlGvvl~elltG~~p~ 367 (476)
.. ......||+.|+|||++.. ..|+.+.|+|+..+-.++-+.++.++
T Consensus 485 ~~~~~~~~~~~~~GT~~y~APEv~~~~~~~Y~~~~d~ws~vl~~l~~v~~r~rY 538 (540)
T 3en9_A 485 KAVDLIVFKKAVLSTHHEKFDEIWERFLEGYKSVYDRWEIILELMKDVERRARY 538 (540)
T ss_dssp HHHHHHHHHHHHHHHCGGGHHHHHHHHHHHHHHHCTTHHHHHHHHHHHHTCSCC
T ss_pred cccchhhhhhhhcCCCCcCCHHHHHHHHHHHHHHHhHHHHHHHHHHHHHhcccc
Confidence 11 1234679999999999986 56888899999888888877666543
|
| >3m7h_A Putidacin L1; monocot mannose-binding lectin, bacteriocin, LLPA, pseudomon bacterial toxin, siras, antimicrobial protein; 2.20A {Pseudomonas SP} PDB: 3m7j_A* | Back alignment and structure |
|---|
Probab=99.46 E-value=3.1e-13 Score=130.44 Aligned_cols=111 Identities=23% Similarity=0.464 Sum_probs=87.2
Q ss_pred cccCccCCCCc----ccCCCEEeeC----CCeEEEEeeCCCCCCCeEEEEEEccCCCceEEeecCCCCCCCCCceEEEec
Q 045315 24 LAADTITPETF----IRDGEKLVSS----SQRFELGFFSPRNSKNRYLGVWYKKIPDTVVWVANRNSPIFNPNTALTFSN 95 (476)
Q Consensus 24 ~~~~~l~~g~~----l~~~~~l~S~----~g~f~lgf~~~~~~~~~~~~iw~~~~~~~~vW~an~~~p~~~~~~~l~~~~ 95 (476)
..+|++.||+. |..|+.|.|+ .|.|.|.+...|+ .+ + |.+ ..+++|.+++..+ +. +.|.|+.
T Consensus 134 ~ptdtlLpg~~~~~~l~~g~~L~S~~dps~G~fsl~l~~dGn---lv--L-y~~-~~~~yW~Sgt~~~--~~-~~l~l~~ 203 (276)
T 3m7h_A 134 TPAIPLVPGAIDSLLLAPGSELVQGVVYGAGASKLVFQGDGN---LV--A-YGP-NGAATWNAGTQGK--GA-VRAVFQG 203 (276)
T ss_dssp CTTSCCCCSCTTCEEECSSEEECTTCEEEETTEEEEECTTSC---EE--E-ECT-TSSEEEECCCTTT--TC-CEEEECT
T ss_pred ccccccccccccccccccCcccccCCCCCCceEEEeecCCce---EE--E-EeC-CCeEEEECCCCCC--cc-EEEEEcC
Confidence 45699999999 8888888654 3566666654443 33 3 332 2589999999886 33 8999999
Q ss_pred CCceEEEccCCeEEEeecCCCCCCCceeeeccCCCeEEEeCCCCCCcCceeeccccC
Q 045315 96 NGNLVLLSQRNGIIWSSNMSRKAENPIAQLLDTGNLVIRDNSSGHTTESYLWQSFDY 152 (476)
Q Consensus 96 ~G~lvl~~~~~~~vWss~~~~~~~~~~~~l~d~GNlVl~~~~~~~~~~~~~WqSFd~ 152 (476)
|||||++|.++.++|++++... ....|+|++|||||||+. .++||||||
T Consensus 204 dGnLvl~d~~~~~vWsS~t~~~-~~~rl~Ld~dGnLvly~~-------~~~Wqsf~~ 252 (276)
T 3m7h_A 204 DGNLVVYGAGNAVLWHSHTGGH-ASAVLRLQANGSIAILDE-------KPVWARFGF 252 (276)
T ss_dssp TSCEEEECTTSCEEEECSCTTC-TTCEEEECTTSCEEEEEE-------EEEEESSSC
T ss_pred CCeEEEEeCCCcEEEEecCCCC-CCEEEEEcCCccEEEEcC-------CCeEEccCc
Confidence 9999999998899999997753 468899999999999953 479999997
|
| >3mez_A Mannose-specific lectin 3 chain 1; heterotetramer, sugar binding protein; 1.94A {Crocus vernus} SCOP: b.78.1.0 | Back alignment and structure |
|---|
Probab=99.43 E-value=3.1e-13 Score=112.20 Aligned_cols=91 Identities=19% Similarity=0.209 Sum_probs=71.1
Q ss_pred CCCceEEEecCCceEEEccCCeEEEeecCCCCCCCceeeeccCCCeEEEeCCCCCCcCceeeccccCCCcccccCCcccC
Q 045315 86 NPNTALTFSNNGNLVLLSQRNGIIWSSNMSRKAENPIAQLLDTGNLVIRDNSSGHTTESYLWQSFDYPTDSLLEGMKLGW 165 (476)
Q Consensus 86 ~~~~~l~~~~~G~lvl~~~~~~~vWss~~~~~~~~~~~~l~d~GNlVl~~~~~~~~~~~~~WqSFd~ptdtll~~~~l~~ 165 (476)
+....|.|+.||||||++.++ +|++++........|+|+++|||||++.+. ..++|||.-+
T Consensus 19 ~g~~~L~~q~dGnLvl~~~~~--vW~snt~~~~~~~~l~l~~dGNLVl~~~~~----~~~vW~S~t~------------- 79 (111)
T 3mez_A 19 YESAAFVMQGDCNLVLYNEAG--GFQSNTHGRGVDCTLRLNNRGQLEIHSANS----NTPVWVYPRS------------- 79 (111)
T ss_dssp ETTEEEEECTTSCEEEECSSC--CEECCCTTSCSSCEEEECTTSCEEEECSSC----SSCSEEESSS-------------
T ss_pred cCCEEEEEccCCeEEEECCCC--EEECCcccCCcCEEEEEcCCCcEEEEeCCC----CEEEEEeccc-------------
Confidence 345789999999999999876 999998765556789999999999998752 3469999721
Q ss_pred CCCCCcceEEEEeCCCCCCCCcccEEEEEecCcceEEEEcCCcceeecCC
Q 045315 166 DLKNGLERYLSSWESTDDPSPGNFTFRLVIQVIPKLCAYNGSVEYTCTGP 215 (476)
Q Consensus 166 ~~~~g~~~~l~s~~~~~~~s~g~~~~~~~~~~~~~~~~~~gs~~y~~sg~ 215 (476)
.....|.|.+.++.+|..+++ . .++|.++.
T Consensus 80 ----------------~~~~~~~~~l~Lq~dGNlvly--~--~~~W~s~t 109 (111)
T 3mez_A 80 ----------------VNTVRGNYAATLGPDQHVTIY--G--PAIWSTPA 109 (111)
T ss_dssp ----------------CCCCSSCCEEEECTTSCEEEE--C--SEEEECCC
T ss_pred ----------------cCCCCcCEEEEECCCCeEEEe--c--cCEEccCC
Confidence 011347899999999988876 3 67898875
|
| >3dzw_A Agglutinin; lectin, mannobiose, mannose-alpha1, 3-mannose, D sugar binding protein; HET: MAN; 1.70A {Narcissus pseudonarcissus} SCOP: b.78.1.1 PDB: 1npl_A* 1jpc_A* 1msa_A* 1niv_A* | Back alignment and structure |
|---|
Probab=99.34 E-value=4.2e-12 Score=105.08 Aligned_cols=87 Identities=21% Similarity=0.278 Sum_probs=68.6
Q ss_pred CceEEEecCCceEEEccCCeEEEeecCCCCCCCceeeeccCCCeEEEeCCCCCCcCceeeccccCCCcccccCCcccCCC
Q 045315 88 NTALTFSNNGNLVLLSQRNGIIWSSNMSRKAENPIAQLLDTGNLVIRDNSSGHTTESYLWQSFDYPTDSLLEGMKLGWDL 167 (476)
Q Consensus 88 ~~~l~~~~~G~lvl~~~~~~~vWss~~~~~~~~~~~~l~d~GNlVl~~~~~~~~~~~~~WqSFd~ptdtll~~~~l~~~~ 167 (476)
...|.|+.|||||||+. +.++|++++........++|+++|||||++.+ +.++|||...
T Consensus 20 ~~~L~~q~dGnLvly~~-~~~vW~snt~~~~~~~~l~l~~dGNLvl~~~~-----~~~~W~S~t~--------------- 78 (109)
T 3dzw_A 20 RYVFIMQEDCNLVLYDV-DKPIWATNTGGLDRRCHLSMQSDGNLVVYSPR-----NNPIWASNTG--------------- 78 (109)
T ss_dssp TEEEEECTTSCEEEEET-TEEEEECCCTTSSSSCEEEECTTSCEEEECTT-----SCEEEECCCC---------------
T ss_pred CEEEEEcCCCcEEEEeC-CEEEEECCcccCCCCEEEEEeCCCCEEEECCC-----CCEEEECCCC---------------
Confidence 46899999999999987 79999999876555678999999999999875 6799998521
Q ss_pred CCCcceEEEEeCCCCCCCCcccEEEEEecCcceEEEEcCCcceeecCC
Q 045315 168 KNGLERYLSSWESTDDPSPGNFTFRLVIQVIPKLCAYNGSVEYTCTGP 215 (476)
Q Consensus 168 ~~g~~~~l~s~~~~~~~s~g~~~~~~~~~~~~~~~~~~gs~~y~~sg~ 215 (476)
...+.|.+.++.+|...++ + .+.|.+|.
T Consensus 79 ----------------~~~~~~~~~L~ddGNlvly--~--~~~W~s~t 106 (109)
T 3dzw_A 79 ----------------GENGNYVCVLQKDRNVVIY--G--TARWATGT 106 (109)
T ss_dssp ----------------CSSSCEEEEECTTSCEEEE--E--SCCCCCCC
T ss_pred ----------------CCCCCEEEEEeCCCEEEEE--C--CCEEeCCC
Confidence 0125688899999987765 3 26787765
|
| >3r0e_B Lectin; carbohydrate binding, carbohydrate, sugar binding protein; 2.40A {Remusatia vivipara} | Back alignment and structure |
|---|
Probab=99.34 E-value=3.1e-12 Score=105.92 Aligned_cols=86 Identities=23% Similarity=0.331 Sum_probs=67.8
Q ss_pred CceEEEecCCceEEEccCCeEEEeecCCCCCCCceeeeccCCCeEEEeCCCCCCcCceeeccccCCCcccccCCcccCCC
Q 045315 88 NTALTFSNNGNLVLLSQRNGIIWSSNMSRKAENPIAQLLDTGNLVIRDNSSGHTTESYLWQSFDYPTDSLLEGMKLGWDL 167 (476)
Q Consensus 88 ~~~l~~~~~G~lvl~~~~~~~vWss~~~~~~~~~~~~l~d~GNlVl~~~~~~~~~~~~~WqSFd~ptdtll~~~~l~~~~ 167 (476)
...|.|+.|||||||+. .++|++++........++|+++|||||++.+ +.++|||-.+
T Consensus 25 ~~~L~~q~dGnLvl~~~--~~vW~snt~~~~~~~~l~l~~dGNLvl~d~~-----~~~iW~S~t~--------------- 82 (110)
T 3r0e_B 25 NHQLVMQGDCNLVLYGG--KYGWQSNTHGNGEHCFLRLNHKGELIIKDDD-----FKTIWSSRSS--------------- 82 (110)
T ss_dssp SCEEEECTTSCEEEECS--SSCEECCCTTSSSSCEEEECTTSCEEEECTT-----CCEEEECCCC---------------
T ss_pred CEEEEEcCCCeEEEECC--eEEEECCCcCCCcCEEEEEeCCCcEEEEeCC-----CCEEEEcCCc---------------
Confidence 36799999999999976 5899999876555678999999999999875 6799999521
Q ss_pred CCCcceEEEEeCCCCCCCCcccEEEEEecCcceEEEEcCCcceeecCC
Q 045315 168 KNGLERYLSSWESTDDPSPGNFTFRLVIQVIPKLCAYNGSVEYTCTGP 215 (476)
Q Consensus 168 ~~g~~~~l~s~~~~~~~s~g~~~~~~~~~~~~~~~~~~gs~~y~~sg~ 215 (476)
-..|.|.+.++.+|..+++ + .+.|.+|.
T Consensus 83 ----------------~~~~~~~~~L~~dGNlvly--~--~~~W~t~~ 110 (110)
T 3r0e_B 83 ----------------SKQGEYVLILQDDGFGVIY--G--PAIFETSS 110 (110)
T ss_dssp ----------------CSSSCCEEEECTTSCEEEE--C--SEEEESCC
T ss_pred ----------------CCCCCEEEEEcCCccEEEe--c--CCEecCCC
Confidence 0135588999999988765 3 36888764
|
| >1zar_A RIO2 kinase; serine kinase, winged-helix, RIO domain, ADP-Mn complex, rRNA processing, transferase; HET: ADP; 1.75A {Archaeoglobus fulgidus} SCOP: a.4.5.56 d.144.1.9 PDB: 1tqi_A* 1tqp_A* 1tqm_A* 1zao_A* | Back alignment and structure |
|---|
Probab=99.33 E-value=1.8e-13 Score=132.98 Aligned_cols=80 Identities=14% Similarity=0.063 Sum_probs=68.3
Q ss_pred cccceeeccCCCCCCCCCCChhhHHHHHHHHHHHHHHHhhcCCCceeecCCCccceEecCCCCceeccccceeecCCCcc
Q 045315 241 DEISFWYESYNNPTKKGLLCWGTRVRIIEGIAQGLLYLHQYSRLRVIHRDLKASNILLDKDMNPKISDFGMARMFGGDEL 320 (476)
Q Consensus 241 ~~~~l~~Ey~~~~~~~~~L~~~~~~~i~~qIa~gL~yLH~~~~~~ivH~DLkp~NILld~~~~~kL~DFGla~~~~~~~~ 320 (476)
+.++++|||++..+-.. +...+...++.||+.||+|||+.+ |+||||||+|||++ ++.+||+|||+++.
T Consensus 173 ~~~~lvmE~~~g~~L~~-l~~~~~~~i~~qi~~~l~~lH~~g---iiHrDlkp~NILl~-~~~vkl~DFG~a~~------ 241 (282)
T 1zar_A 173 EGNAVLMELIDAKELYR-VRVENPDEVLDMILEEVAKFYHRG---IVHGDLSQYNVLVS-EEGIWIIDFPQSVE------ 241 (282)
T ss_dssp ETTEEEEECCCCEEGGG-CCCSCHHHHHHHHHHHHHHHHHTT---EECSCCSTTSEEEE-TTEEEECCCTTCEE------
T ss_pred cceEEEEEecCCCcHHH-cchhhHHHHHHHHHHHHHHHHHCC---CEeCCCCHHHEEEE-CCcEEEEECCCCeE------
Confidence 46789999998544444 566778899999999999999999 99999999999999 99999999999964
Q ss_pred cccceeeeeccCCCChhhhc
Q 045315 321 QSNTKRIVGTYGYMSPEYAL 340 (476)
Q Consensus 321 ~~~~~~~~gt~~y~aPE~l~ 340 (476)
+..+.|||++.
T Consensus 242 ---------~~~~~a~e~l~ 252 (282)
T 1zar_A 242 ---------VGEEGWREILE 252 (282)
T ss_dssp ---------TTSTTHHHHHH
T ss_pred ---------CCCCCHHHHHH
Confidence 33578899875
|
| >3r0e_A Lectin; carbohydrate binding, carbohydrate, sugar binding protein; 2.40A {Remusatia vivipara} | Back alignment and structure |
|---|
Probab=99.32 E-value=5.2e-12 Score=104.39 Aligned_cols=88 Identities=25% Similarity=0.377 Sum_probs=69.6
Q ss_pred CCCceEEEecCCceEEEccCCeEEEeecCCCCCCCceeeeccCCCeEEEeCCCCCCcCceeeccccCCCcccccCCcccC
Q 045315 86 NPNTALTFSNNGNLVLLSQRNGIIWSSNMSRKAENPIAQLLDTGNLVIRDNSSGHTTESYLWQSFDYPTDSLLEGMKLGW 165 (476)
Q Consensus 86 ~~~~~l~~~~~G~lvl~~~~~~~vWss~~~~~~~~~~~~l~d~GNlVl~~~~~~~~~~~~~WqSFd~ptdtll~~~~l~~ 165 (476)
+....|.|+.||||||+++ +|+|++........++|+++|||||++.+ +.++|+|- |
T Consensus 20 ~g~~~L~~q~dGNLvl~~~----~Wssnt~~~~~~~~l~l~~dGnLvl~d~~-----~~~vWss~-----t--------- 76 (109)
T 3r0e_A 20 NGDFDLVMQDDCNLVLYNG----NWQSNTANNGRDCKLTLTDYGELVIKNGD-----GSTVWKSG-----A--------- 76 (109)
T ss_dssp ETTEEEEECTTSCEEEETT----TEECCCTTSCSSCEEEECTTSCEEEECTT-----SCEEEECC-----C---------
T ss_pred CCCEEEEEecCCeEEEEeC----eEEcCCCCCCCcEEEEEcCCCeEEEEeCC-----CCEEEcCC-----C---------
Confidence 4457899999999999984 79999886555688999999999999875 67899762 1
Q ss_pred CCCCCcceEEEEeCCCCCCCCcccEEEEEecCcceEEEEcCCcceeecCCCC
Q 045315 166 DLKNGLERYLSSWESTDDPSPGNFTFRLVIQVIPKLCAYNGSVEYTCTGPWN 217 (476)
Q Consensus 166 ~~~~g~~~~l~s~~~~~~~s~g~~~~~~~~~~~~~~~~~~gs~~y~~sg~wn 217 (476)
....+.|.+.++.+|..+++ . .+.|.+++|-
T Consensus 77 -----------------~~~~~~~~~~L~~dGNlvly--~--~~~W~s~t~~ 107 (109)
T 3r0e_A 77 -----------------QSVKGNYAAVVHPDGRLVVF--G--PSVFKIDPWV 107 (109)
T ss_dssp -----------------CCSSSCCEEEEETTTEEEEE--C--SEEEEECTTS
T ss_pred -----------------cCCCcCEEEEEcCCCeEEEE--e--cCEECCCCcc
Confidence 00235688999999987766 3 5789999874
|
| >4h3o_A Lectin; cadmium, plant protein; 2.17A {Allium sativum} PDB: 1kj1_A* 1bwu_P* 1kj1_D* 1bwu_Q* 1bwu_A* 1bwu_D* | Back alignment and structure |
|---|
Probab=99.13 E-value=2.4e-10 Score=93.60 Aligned_cols=77 Identities=26% Similarity=0.360 Sum_probs=61.0
Q ss_pred ceEEEecCCceEEEccCCeEEEeecCCCCC-CCceeeeccCCCeEEEeCCCCCCcCceeeccccCCCcccccCCcccCCC
Q 045315 89 TALTFSNNGNLVLLSQRNGIIWSSNMSRKA-ENPIAQLLDTGNLVIRDNSSGHTTESYLWQSFDYPTDSLLEGMKLGWDL 167 (476)
Q Consensus 89 ~~l~~~~~G~lvl~~~~~~~vWss~~~~~~-~~~~~~l~d~GNlVl~~~~~~~~~~~~~WqSFd~ptdtll~~~~l~~~~ 167 (476)
-.|.|+.|||||||+ .+.+||++++.... ....++|++||||||++.+ +.++|.|=.
T Consensus 21 y~l~~q~DgNLvly~-~~~~vW~ant~~~~~~~~~L~l~~dGnLvL~d~~-----~~~vWss~t---------------- 78 (105)
T 4h3o_A 21 YHFIMQDDCNLVLYD-HSTSTWASNTEIGGKSGCSAVLQSDGNFVVYDSS-----GRSLWASHS---------------- 78 (105)
T ss_dssp EEEEECTTSCEEEEE-TTEEEEECCCCCTTCCSCEEEECTTSCEEEECTT-----CCEEEECCC----------------
T ss_pred EEEEECCCCeEEEEE-CCEEEEEecCCCCCCccEEEEEeCCccEEEECCC-----cEEEEEecC----------------
Confidence 578999999999997 46899999986543 3567899999999999876 689998721
Q ss_pred CCCcceEEEEeCCCCCCCCcccEEEEEecCcceEE
Q 045315 168 KNGLERYLSSWESTDDPSPGNFTFRLVIQVIPKLC 202 (476)
Q Consensus 168 ~~g~~~~l~s~~~~~~~s~g~~~~~~~~~~~~~~~ 202 (476)
....+.+.+.++.+|...++
T Consensus 79 ---------------~~~~~~~~l~L~ddGNlVly 98 (105)
T 4h3o_A 79 ---------------TRGSGNYILILQDDGNVIIY 98 (105)
T ss_dssp ---------------CCCSSCEEEEECTTSCEEEE
T ss_pred ---------------CCCCCCEEEEEeCCCeEEEE
Confidence 01246688899999987765
|
| >1zth_A RIO1 serine protein kinase; ribosome biogenesis, rRNA, ADP, manganese, transferase; HET: ADP; 1.89A {Archaeoglobus fulgidus} PDB: 1zp9_A* 1ztf_A* | Back alignment and structure |
|---|
Probab=98.94 E-value=3.4e-10 Score=108.24 Aligned_cols=70 Identities=17% Similarity=0.108 Sum_probs=56.8
Q ss_pred cccceeeccCCC-CCC-------CCCCChhhHHHHHHHHHHHHHHHh-hcCCCceeecCCCccceEecCCCCceeccccc
Q 045315 241 DEISFWYESYNN-PTK-------KGLLCWGTRVRIIEGIAQGLLYLH-QYSRLRVIHRDLKASNILLDKDMNPKISDFGM 311 (476)
Q Consensus 241 ~~~~l~~Ey~~~-~~~-------~~~L~~~~~~~i~~qIa~gL~yLH-~~~~~~ivH~DLkp~NILld~~~~~kL~DFGl 311 (476)
+..+++|||+.. +.. ...+++.++..++.||+.||.||| +.+ |+||||||+|||++. .++|+|||+
T Consensus 141 ~~~~lVmE~~g~~g~~~~~L~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~g---ivHrDlkp~NILl~~--~~~liDFG~ 215 (258)
T 1zth_A 141 MKNVLLMEFIGEDELPAPTLVELGRELKELDVEGIFNDVVENVKRLYQEAE---LVHADLSEYNIMYID--KVYFIDMGQ 215 (258)
T ss_dssp ETTEEEEECCEETTEECCBHHHHGGGGGGSCHHHHHHHHHHHHHHHHHTSC---EECSSCSTTSEEESS--SEEECCCTT
T ss_pred CCCEEEEEecCCCCCccccHHHHhhccChHHHHHHHHHHHHHHHHHHHHCC---EEeCCCCHHHEEEcC--cEEEEECcc
Confidence 357799999942 110 011335588999999999999999 888 999999999999998 899999999
Q ss_pred eeec
Q 045315 312 ARMF 315 (476)
Q Consensus 312 a~~~ 315 (476)
|...
T Consensus 216 a~~~ 219 (258)
T 1zth_A 216 AVTL 219 (258)
T ss_dssp CEET
T ss_pred cccC
Confidence 9764
|
| >1dlp_A Lectin scafet precursor; two-domain lectin, beta prism II fold, native, sugar binding protein; 3.30A {Hyacinthoides hispanica} SCOP: b.78.1.1 b.78.1.1 | Back alignment and structure |
|---|
Probab=98.82 E-value=1e-08 Score=96.59 Aligned_cols=106 Identities=22% Similarity=0.358 Sum_probs=79.7
Q ss_pred cccCccCCCC-------cccCCCEEeeCCCeEEEEeeCCCCCCCeEEEEEEccCCCceEEeecCCCCCCCCCceEEEecC
Q 045315 24 LAADTITPET-------FIRDGEKLVSSSQRFELGFFSPRNSKNRYLGVWYKKIPDTVVWVANRNSPIFNPNTALTFSNN 96 (476)
Q Consensus 24 ~~~~~l~~g~-------~l~~~~~l~S~~g~f~lgf~~~~~~~~~~~~iw~~~~~~~~vW~an~~~p~~~~~~~l~~~~~ 96 (476)
+..|+|.+|| .|..++.+. +|.|.|.|...|+ +-+| +. ..++|.++.... ..++.++|+.+
T Consensus 123 ~g~d~L~~gq~~~~~~~~L~s~~d~s--~G~~~l~l~~dG~-----LvL~-~~--~~~~W~s~~~~~--~~~~~~~L~~~ 190 (236)
T 1dlp_A 123 NGNSILYSTQGNDNHPQTLHATQSLQ--LSPYRLSMETDCN-----LVLF-DR--DDRVWSTNTAGK--GTGCRAVLQPN 190 (236)
T ss_dssp CCCEECCCC--CCCCCCEECSSCCCB--CSSCEEEEETTTE-----EEEE-BT--TBCCSCCCCCSS--CSSCEEEEETT
T ss_pred ccceEEecCCcCCCccceEEcCcEee--cCcEEEEECCCCc-----EEEE-cC--CEeEEeCCCcCC--CCceEEEECCC
Confidence 3457789998 676666665 6899999887773 3344 32 368898887543 24578999999
Q ss_pred CceEEEccCCeEEEeecCCCCCCCceeeeccCCCeEEEeCCCCCCcCceeecc
Q 045315 97 GNLVLLSQRNGIIWSSNMSRKAENPIAQLLDTGNLVIRDNSSGHTTESYLWQS 149 (476)
Q Consensus 97 G~lvl~~~~~~~vWss~~~~~~~~~~~~l~d~GNlVl~~~~~~~~~~~~~WqS 149 (476)
|||++++.++.++|.+.+........++|+++|||++|. .++|+|
T Consensus 191 Gnl~ly~~~~~~vw~s~~~~~~~~~rl~Ld~dG~l~ly~--------~~~W~s 235 (236)
T 1dlp_A 191 GRMDVLTNQNIAVWTSGNSRSAGRYVFVLQPDRNLAIYG--------GALWTT 235 (236)
T ss_dssp TEEEEEETTTEEEEECCCCCSSSCCEEEECSSSCEEEEC--------CCCCBC
T ss_pred CcEEEEeCCCcEEEEeCCCCCCCCEEEEEcCCCcEEEeC--------CCCccC
Confidence 999999988899999887654456789999999999993 368876
|
| >4gyi_A RIO2 kinase; protein kinase, ADP complex, phosphoaspartate, acyl-phosphat ribosome biogenesis, Ser/Thr protein kinase; HET: PHD ADP; 2.20A {Chaetomium thermophilum} PDB: 4gyg_A | Back alignment and structure |
|---|
Probab=98.65 E-value=1.2e-08 Score=102.65 Aligned_cols=71 Identities=15% Similarity=0.197 Sum_probs=58.4
Q ss_pred ccceeeccCCCCCCCCCCChhhHHHHHHHHHHHHHHHhhcCCCceeecCCCccceEecCCCC----------ceeccccc
Q 045315 242 EISFWYESYNNPTKKGLLCWGTRVRIIEGIAQGLLYLHQYSRLRVIHRDLKASNILLDKDMN----------PKISDFGM 311 (476)
Q Consensus 242 ~~~l~~Ey~~~~~~~~~L~~~~~~~i~~qIa~gL~yLH~~~~~~ivH~DLkp~NILld~~~~----------~kL~DFGl 311 (476)
..+++|||++..........+....++.||+.+|.+||+.+ ||||||||.|||+++++. +.|+||+-
T Consensus 185 ~~~LVME~i~G~~L~~l~~~~~~~~l~~qll~~l~~lH~~g---IVHrDLKp~NILl~~dgd~~d~~~~~~~~~iID~~Q 261 (397)
T 4gyi_A 185 RHTIVMSLVDALPMRQVSSVPDPASLYADLIALILRLAKHG---LIHGDFNEFNILIREEKDAEDPSSITLTPIIIXFPQ 261 (397)
T ss_dssp TTEEEEECCSCEEGGGCCCCSCHHHHHHHHHHHHHHHHHTT---EECSCCSTTSEEEEEEECSSCTTSEEEEEEECCCTT
T ss_pred CceEEEEecCCccHhhhcccHHHHHHHHHHHHHHHHHHHCC---CcCCCCCHHHEEEeCCCCcccccccccceEEEEeCC
Confidence 45689999985444444555677889999999999999999 999999999999987763 78999998
Q ss_pred eeec
Q 045315 312 ARMF 315 (476)
Q Consensus 312 a~~~ 315 (476)
+...
T Consensus 262 ~V~~ 265 (397)
T 4gyi_A 262 MVSM 265 (397)
T ss_dssp CEET
T ss_pred cccC
Confidence 7653
|
| >1nd4_A Aminoglycoside 3'-phosphotransferase; protein kinase, ATPase, kanamycin; HET: KAN; 2.10A {Klebsiella pneumoniae} SCOP: d.144.1.6 | Back alignment and structure |
|---|
Probab=97.82 E-value=1.5e-05 Score=74.83 Aligned_cols=72 Identities=15% Similarity=0.098 Sum_probs=55.1
Q ss_pred cccceeeccCCCCCCCCCCChhhHHHHHHHHHHHHHHHhhcC--------------------------------------
Q 045315 241 DEISFWYESYNNPTKKGLLCWGTRVRIIEGIAQGLLYLHQYS-------------------------------------- 282 (476)
Q Consensus 241 ~~~~l~~Ey~~~~~~~~~L~~~~~~~i~~qIa~gL~yLH~~~-------------------------------------- 282 (476)
+..+++|||++...-. .+......++.++++.|+.||+..
T Consensus 88 ~~~~~v~e~i~G~~l~--~~~~~~~~~~~~l~~~l~~lh~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 165 (264)
T 1nd4_A 88 GRDWLLLGEVPGQDLL--SSHLAPAEKVSIMADAMRRLHTLDPATCPFDHQAKHRIERARTRMEAGLVDQDDLDEEHQGL 165 (264)
T ss_dssp SCEEEEEECCSSEETT--TSCCCHHHHHHHHHHHHHHHTTSCGGGCCCBCCHHHHHHHHHHHHHTTCCCTTSCCGGGTTC
T ss_pred CCCEEEEEecCCcccC--cCcCCHhHHHHHHHHHHHHHhCCCCCCCCCchHHHHHHHHHHHHHhcCCccchhhhhhccCc
Confidence 4578999999854332 333345578899999999999753
Q ss_pred -----------------CCceeecCCCccceEecCCCCceeccccceee
Q 045315 283 -----------------RLRVIHRDLKASNILLDKDMNPKISDFGMARM 314 (476)
Q Consensus 283 -----------------~~~ivH~DLkp~NILld~~~~~kL~DFGla~~ 314 (476)
...++|+|++|.||+++.+..++|+||+.+..
T Consensus 166 ~~~~~~~~l~~~~~~~~~~~l~HgDl~~~Nil~~~~~~~~liD~~~a~~ 214 (264)
T 1nd4_A 166 APAELFARLKARMPDGEDLVVTHGDACLPNIMVENGRFSGFIDCGRLGV 214 (264)
T ss_dssp CHHHHHHHHHHTCCSSCCEEEECSSCCGGGEEEETTEEEEECCCTTCEE
T ss_pred cHHHHHHHHHHhcCCCCCeEEECCCCCCCcEEEECCcEEEEEcchhccc
Confidence 12399999999999998776677999998864
|
| >3dxp_A Putative acyl-COA dehydrogenase; protein kinase-like fold, structural genomics, joint center structural genomics, JCSG; 2.32A {Ralstonia eutropha JMP134} | Back alignment and structure |
|---|
Probab=97.68 E-value=6.5e-05 Score=74.62 Aligned_cols=74 Identities=11% Similarity=0.183 Sum_probs=59.1
Q ss_pred cccceeeccCCCCCC----CCCCChhhHHHHHHHHHHHHHHHhhcC----------------------------------
Q 045315 241 DEISFWYESYNNPTK----KGLLCWGTRVRIIEGIAQGLLYLHQYS---------------------------------- 282 (476)
Q Consensus 241 ~~~~l~~Ey~~~~~~----~~~L~~~~~~~i~~qIa~gL~yLH~~~---------------------------------- 282 (476)
+..+++|||++...- ...++..++..++.++++.|+.||+..
T Consensus 114 g~~~~vme~v~G~~l~~~~~~~l~~~~~~~~~~~l~~~La~LH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 193 (359)
T 3dxp_A 114 GRAFYIMEFVSGRVLWDQSLPGMSPAERTAIYDEMNRVIAAMHTVDYQAIGLGDYGKPGNYFQRQIERWTKQYKLSETES 193 (359)
T ss_dssp SSCEEEEECCCCBCCCCTTCTTCCHHHHHHHHHHHHHHHHHHHHSCTTTTTCTTSSCCSCHHHHHHHHHHHHHHHHCCSC
T ss_pred CCeEEEEEecCCeecCCCccccCCHHHHHHHHHHHHHHHHHHhCCCchhccccccCCCCCchHHHHHHHHHHHHhcCCcC
Confidence 457789999984322 235778889999999999999999731
Q ss_pred ---------------------CCceeecCCCccceEecCCCC--ceeccccceee
Q 045315 283 ---------------------RLRVIHRDLKASNILLDKDMN--PKISDFGMARM 314 (476)
Q Consensus 283 ---------------------~~~ivH~DLkp~NILld~~~~--~kL~DFGla~~ 314 (476)
...++|+|+++.||+++.++. +.|+||+.+..
T Consensus 194 ~~~~~~~~~~l~~~~~~~~~~~~~lvHgD~~~~Nil~~~~~~~v~~viDwe~a~~ 248 (359)
T 3dxp_A 194 IPAMDSLMDWLPQHIPQEDADLTSIVHGDYRLDNLMFHPTEPRVLAVLDWELSTL 248 (359)
T ss_dssp CHHHHHHHHHGGGCCCSTTSSCCEEECSSCSGGGEEECSSSSCEEEECCCTTCEE
T ss_pred ChHHHHHHHHHHhcCCCccCCCceEEeCCCCCCcEEEeCCCCcEEEEECcccccc
Confidence 246999999999999997653 58999998864
|
| >3sg8_A APH(2'')-ID; antibiotic resistance enzyme, transferase, aminoglycoside, phosphorylation, transferase-antibiotic complex; HET: TOY; 1.80A {Enterococcus casseliflavus} PDB: 3sg9_A* 3n4v_A 3n4t_A 3n4u_A 3r81_A* 3r80_A* 3r7z_A* 3r82_A* 3vcq_A* 4dbx_A 4de4_A* 4dfb_A* 4dfu_A* 4dt9_A* 4dt8_A* 4dtb_A* 3sgc_A 4dta_A* 3lzh_A | Back alignment and structure |
|---|
Probab=97.68 E-value=6.5e-06 Score=80.02 Aligned_cols=123 Identities=19% Similarity=0.161 Sum_probs=78.0
Q ss_pred cceeeccCCCCCCC----CCCChhhHHHHHHHHHHHHHHHhhc-------------------------------------
Q 045315 243 ISFWYESYNNPTKK----GLLCWGTRVRIIEGIAQGLLYLHQY------------------------------------- 281 (476)
Q Consensus 243 ~~l~~Ey~~~~~~~----~~L~~~~~~~i~~qIa~gL~yLH~~------------------------------------- 281 (476)
.+++|||++...-. ..++.+++..++.++++.|+.||+.
T Consensus 91 ~~~vm~~i~G~~l~~~~~~~l~~~~~~~~~~~l~~~la~LH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 170 (304)
T 3sg8_A 91 SFAGFTKIKGVPLTPLLLNNLPKQSQNQAAKDLARFLSELHSINISGFKSNLVLDFREKINEDNKKIKKLLSRELKGPQM 170 (304)
T ss_dssp SCEEEECCCCEECCHHHHHTSCHHHHHHHHHHHHHHHHHHHHSCCTTSCGGGBCCHHHHHHHHHHHHHHHHTTTSCHHHH
T ss_pred ceEEEcccCCeECCccccccCCHHHHHHHHHHHHHHHHHHHcCCCCCCCccchhhHHHHHHHHHHHHHHHhcccCCcccH
Confidence 35678888743322 2466777888889999988888861
Q ss_pred ------------------CCCceeecCCCccceEecC--CCCceeccccceeecCCCcccccc------------eeeee
Q 045315 282 ------------------SRLRVIHRDLKASNILLDK--DMNPKISDFGMARMFGGDELQSNT------------KRIVG 329 (476)
Q Consensus 282 ------------------~~~~ivH~DLkp~NILld~--~~~~kL~DFGla~~~~~~~~~~~~------------~~~~g 329 (476)
....++|+|+++.||+++. ...+.|+||+.+..-....-.... .....
T Consensus 171 ~~l~~~~~~~l~~~~~~~~~~~~~HgD~~~~N~l~~~~~~~~~~~iD~~~~~~~~~~~Dl~~~~~~~~~~~~~~~~~~l~ 250 (304)
T 3sg8_A 171 KKVDDFYRDILENEIYFKYYPCLIHNDFSSDHILFDTEKNTICGIIDFGDAAISDPDNDFISLMEDDEEYGMEFVSKILN 250 (304)
T ss_dssp HHHHHHHHHHHTCGGGTCCCCEEECSCCCGGGEEEETTTTEEEEECCCTTCEEECTTHHHHTTCCTTTSCCHHHHHHHHH
T ss_pred HHHHHHHHHHHhccccccCCceeEeCCCCcccEEEeCCCCCEEEEEeCCCCccCChHHHHHHHHhhccccCHHHHHHHHH
Confidence 1245899999999999998 456789999998753221000000 00111
Q ss_pred ccCCCC-hhhhccCCCCccceEEeehhhhhhhhhCCCCC
Q 045315 330 TYGYMS-PEYALRGLFSIKSDVFSFGVLLLETLSSKKNT 367 (476)
Q Consensus 330 t~~y~a-PE~l~~~~~s~ksDVwSlGvvl~elltG~~p~ 367 (476)
.++... |+..... ....+.|+++.+++.+.+|..++
T Consensus 251 ~Y~~~~~~~~~~r~--~~~~~~~~l~~~~~~~~~g~~~~ 287 (304)
T 3sg8_A 251 HYKHKDIPTVLEKY--RMKEKYWSFEKIIYGKEYGYMDW 287 (304)
T ss_dssp HHTCSCHHHHHHHH--HHHHHHHHHHHHHHHHHTTCHHH
T ss_pred HcCCCCcHHHHHHH--HHHHHHHHHHHHHHHHHcCCHHH
Confidence 112223 3322211 22357899999999999998764
|
| >3tm0_A Aminoglycoside 3'-phosphotransferase; protein kinase, phosphorylation, transferase-antibiotic COMP; HET: ANP B31; 2.10A {Enterococcus faecalis} SCOP: d.144.1.6 PDB: 2b0q_A* 1l8t_A* 3q2j_A* 1j7i_A* 1j7u_A* 3h8p_A* 1j7l_A* 2bkk_A* | Back alignment and structure |
|---|
Probab=97.57 E-value=2.2e-05 Score=74.21 Aligned_cols=74 Identities=19% Similarity=0.137 Sum_probs=54.9
Q ss_pred cccceeeccCCCCCCCC-CCChhhHHHHHHHHHHHHHHHhhc--------------------------------------
Q 045315 241 DEISFWYESYNNPTKKG-LLCWGTRVRIIEGIAQGLLYLHQY-------------------------------------- 281 (476)
Q Consensus 241 ~~~~l~~Ey~~~~~~~~-~L~~~~~~~i~~qIa~gL~yLH~~-------------------------------------- 281 (476)
+..+++|||++...-.. ..+......++.+++++|+.||+.
T Consensus 83 ~~~~lv~e~i~G~~l~~~~~~~~~~~~~~~~l~~~l~~LH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 162 (263)
T 3tm0_A 83 GWSNLLMSEADGVLCSEEYEDEQSPEKIIELYAECIRLFHSIDISDCPYTNSLDSRLAELDYLLNNDLADVDCENWEEDT 162 (263)
T ss_dssp TEEEEEEECCSSEEHHHHCCTTTCHHHHHHHHHHHHHHHHHSCCTTCSCBCCHHHHHHHHHHHHHTTCSCCSGGGGSTTC
T ss_pred CceEEEEEecCCeehhhccCCcccHHHHHHHHHHHHHHHhCCCcccCCCcchHHHHHHHHHHHHhccccccccccccccc
Confidence 46789999998433211 113345568999999999999981
Q ss_pred ------------------CCCceeecCCCccceEecCCCCceeccccceee
Q 045315 282 ------------------SRLRVIHRDLKASNILLDKDMNPKISDFGMARM 314 (476)
Q Consensus 282 ------------------~~~~ivH~DLkp~NILld~~~~~kL~DFGla~~ 314 (476)
....++|+|+++.||+++.+..+.|+||+.+..
T Consensus 163 ~~~~~~~l~~~l~~~~~~~~~~l~HgDl~~~Nil~~~~~~~~lIDwe~a~~ 213 (263)
T 3tm0_A 163 PFKDPRELYDFLKTEKPEEELVFSHGDLGDSNIFVKDGKVSGFIDLGRSGR 213 (263)
T ss_dssp SSSSHHHHHHHHHHCCCCCCEEEECSSCCTTSEEEETTEEEEECCCTTCEE
T ss_pred cCCCHHHHHHHHHhcCCCCCceEECCCCCcCcEEEECCcEEEEEEchhccc
Confidence 114599999999999998765567999998753
|
| >3ats_A Putative uncharacterized protein; hypothetical protein, putative aminoglycoside phosphortransf transferase; 1.67A {Mycobacterium tuberculosis} PDB: 3att_A* | Back alignment and structure |
|---|
Probab=96.23 E-value=0.0074 Score=59.41 Aligned_cols=32 Identities=16% Similarity=0.243 Sum_probs=26.5
Q ss_pred CCceeecCCCccceEecCCCCceeccccceee
Q 045315 283 RLRVIHRDLKASNILLDKDMNPKISDFGMARM 314 (476)
Q Consensus 283 ~~~ivH~DLkp~NILld~~~~~kL~DFGla~~ 314 (476)
...++|+|+++.||+++++..+.|+||+.+..
T Consensus 221 ~~~l~HgDl~~~Nil~~~~~~~~vIDwe~a~~ 252 (357)
T 3ats_A 221 EPVLLWGDARVGNVLYRDFQPVAVLDWEMVAL 252 (357)
T ss_dssp CCEEECSSCSGGGEEEETTEEEEECCGGGCEE
T ss_pred CceEEeCCCCCCeEEEeCCcEEEEEccccccc
Confidence 35699999999999999644578999998864
|
| >3tdw_A Gentamicin resistance protein; kinase, phosphoryl transfer, antibiotic resistance, transfer; HET: GDP; 1.70A {Enterococcus gallinarum} PDB: 3tdv_A* | Back alignment and structure |
|---|
Probab=95.98 E-value=0.0093 Score=57.65 Aligned_cols=74 Identities=22% Similarity=0.241 Sum_probs=52.5
Q ss_pred cccceeeccCCCCCCC----CCCChhhHHHHHHHHHHHHHHHhhcC----------------------------------
Q 045315 241 DEISFWYESYNNPTKK----GLLCWGTRVRIIEGIAQGLLYLHQYS---------------------------------- 282 (476)
Q Consensus 241 ~~~~l~~Ey~~~~~~~----~~L~~~~~~~i~~qIa~gL~yLH~~~---------------------------------- 282 (476)
+..+++|||++...-. ..++..++..++.++++.|+.||+..
T Consensus 86 g~~~~v~e~i~G~~l~~~~~~~l~~~~~~~~~~~lg~~La~LH~~~~~~~~~~g~p~~~w~~~~~~~~~~~~~~~~~~l~ 165 (306)
T 3tdw_A 86 GNPFVGYRKVQGQILGEDGMAVLPDDAKDRLALQLAEFMNELSAFPVETAISAGVPVTNLKNKILLLSEAVEDQVFPLLD 165 (306)
T ss_dssp SCEEEEEECCCSEECHHHHHTTSCHHHHHHHHHHHHHHHHHHHHSCHHHHHHTTCCBCCHHHHHHHHHHHHHHHTGGGSC
T ss_pred CceEEEEeccCCeECchhhhhhCCHHHHHHHHHHHHHHHHHHhcCCcccccccCCChHHHHHHHHHHHHHHHHhcccccc
Confidence 3466888888743221 23566677777888888887777532
Q ss_pred -----------------------CCceeecCCCccceEecC---CCC-ceeccccceee
Q 045315 283 -----------------------RLRVIHRDLKASNILLDK---DMN-PKISDFGMARM 314 (476)
Q Consensus 283 -----------------------~~~ivH~DLkp~NILld~---~~~-~kL~DFGla~~ 314 (476)
...++|+|+++.||+++. ++. +.|+||+.+..
T Consensus 166 ~~~~~~l~~~~~~~l~~~~~~~~~~~~~HgD~~~~N~l~~~~~~~~~~~~~iD~~~a~~ 224 (306)
T 3tdw_A 166 ESLRDYLTLRFQSYMTHPVYTRYTPRLIHGDLSPDHFLTNLNSRQTPLTGIIDFGDAAI 224 (306)
T ss_dssp HHHHHHHHHHHHHHHHCHHHHCCCCEEECSCCSGGGEEECTTCSSCCEEEECCCTTCEE
T ss_pred hhhHHHHHHHHHHHHhCcccccCCCeeEeCCCCcccEEEecCCCCCceEEEEehhhcCC
Confidence 235699999999999987 455 47999998864
|
| >2yle_A Protein spire homolog 1; actin-binding protein, actin polymerization; 1.80A {Homo sapiens} PDB: 2ylf_A 3r7g_A 3rbw_A | Back alignment and structure |
|---|
Probab=95.81 E-value=0.011 Score=53.98 Aligned_cols=94 Identities=11% Similarity=0.010 Sum_probs=59.5
Q ss_pred CCCCCChhhHHHHHHHHHHHHHHHhhcCCCceeecCCCccceEecCCCCceeccccceeecCCCcccccceeeeeccCCC
Q 045315 255 KKGLLCWGTRVRIIEGIAQGLLYLHQYSRLRVIHRDLKASNILLDKDMNPKISDFGMARMFGGDELQSNTKRIVGTYGYM 334 (476)
Q Consensus 255 ~~~~L~~~~~~~i~~qIa~gL~yLH~~~~~~ivH~DLkp~NILld~~~~~kL~DFGla~~~~~~~~~~~~~~~~gt~~y~ 334 (476)
.+.+|++++++.++.|.+.+|.-+-... . -..+=+.|..|++..+|.+.+.+ ..+. .....+.
T Consensus 42 ~~~PlsEEqaWALc~Qc~~~L~~~~~~~-~-~~~~i~~~~~i~l~~dG~V~f~~-~~s~--------------~~~~~~~ 104 (229)
T 2yle_A 42 YNQPINEEQAWAVCYQCCGSLRAAARRR-Q-PRHRVRSAAQIRVWRDGAVTLAP-AADD--------------AGEPPPV 104 (229)
T ss_dssp HTSCCCHHHHHHHHHHHHHHHHHHHHTT-C-CCCCCCSGGGEEEETTSCEEECC-C------------------------
T ss_pred cCCCcCHHHHHHHHHHHHHHHHhhhhcc-c-CCceecCCcceEEecCCceeccc-cccc--------------ccccCCC
Confidence 4679999999999999999988762211 0 11223457899999999887653 1110 1223456
Q ss_pred ChhhhccCCCCccceEEeehhhhhhhhhCCCC
Q 045315 335 SPEYALRGLFSIKSDVFSFGVLLLETLSSKKN 366 (476)
Q Consensus 335 aPE~l~~~~~s~ksDVwSlGvvl~elltG~~p 366 (476)
|||... ...+.+.=|||||+++|..+-...+
T Consensus 105 ~pe~~~-~~~te~~~IysLG~tLY~ALDygL~ 135 (229)
T 2yle_A 105 AGKLGY-SQCMETEVIESLGIIIYKALDYGLK 135 (229)
T ss_dssp --CCSS-SSSCHHHHHHHHHHHHHHHHTTTCC
T ss_pred Chhhcc-ccchHHHHHHHHHHHHHHHhhcCCC
Confidence 887653 3446788899999999998865544
|
| >4gkh_A Aminoglycoside 3'-phosphotransferase APHA1-IAB; pyrazolopyrimidine, 1-Na-PP1, bumped kinase inhibitor, BKI, kinase inhibitor; HET: KAN 0J9; 1.86A {Acinetobacter baumannii} PDB: 4feu_A* 4few_A* 4fex_A* 4fev_A* 4gki_A* 4ej7_A* 3r78_A* | Back alignment and structure |
|---|
Probab=94.57 E-value=0.011 Score=55.50 Aligned_cols=30 Identities=23% Similarity=0.330 Sum_probs=26.1
Q ss_pred ceeecCCCccceEecCCCCceeccccceee
Q 045315 285 RVIHRDLKASNILLDKDMNPKISDFGMARM 314 (476)
Q Consensus 285 ~ivH~DLkp~NILld~~~~~kL~DFGla~~ 314 (476)
.++|+|+++.||+++..+.+-|+||+.+..
T Consensus 194 ~l~HGDl~~~Nil~~~~~~~~viDwe~a~~ 223 (272)
T 4gkh_A 194 VVTHGDFSLDNLIFDEGKLIGCIDVGRVGI 223 (272)
T ss_dssp EEECSCCCTTSEEEETTEEEEECCCTTCEE
T ss_pred EEEcCCCCCCeEEEECCeEEEEEECccccc
Confidence 489999999999999877677999998864
|
| >2q83_A YTAA protein; 2635576, structural genomics, joint center for structu genomics, JCSG, protein structure initiative, PSI-2, transf; HET: ADN CIT UNL; 2.50A {Bacillus subtilis} | Back alignment and structure |
|---|
Probab=94.46 E-value=0.028 Score=54.48 Aligned_cols=31 Identities=19% Similarity=0.293 Sum_probs=27.4
Q ss_pred CceeecCCCccceEecCCCCceeccccceee
Q 045315 284 LRVIHRDLKASNILLDKDMNPKISDFGMARM 314 (476)
Q Consensus 284 ~~ivH~DLkp~NILld~~~~~kL~DFGla~~ 314 (476)
..++|+|+++.||+++.++.+.|+||+.+..
T Consensus 222 ~~l~HgD~~~~Nil~~~~~~~~lIDfe~a~~ 252 (346)
T 2q83_A 222 PNLCHQDYGTGNTLLGENEQIWVIDLDTVSF 252 (346)
T ss_dssp CCEECSSCSTTSEEECGGGCEEECCCTTCEE
T ss_pred CceecCCCCcccEEEeCCCcEEEEehhhccc
Confidence 4599999999999998788899999998753
|
| >2pyw_A Uncharacterized protein; 5-methylthioribose kinase, plant methionine recycling, refol transferase; HET: SR1 ADP; 1.90A {Arabidopsis thaliana} | Back alignment and structure |
|---|
Probab=92.27 E-value=0.13 Score=51.86 Aligned_cols=31 Identities=19% Similarity=0.367 Sum_probs=27.1
Q ss_pred CCceeecCCCccceEecCCCCceeccccceee
Q 045315 283 RLRVIHRDLKASNILLDKDMNPKISDFGMARM 314 (476)
Q Consensus 283 ~~~ivH~DLkp~NILld~~~~~kL~DFGla~~ 314 (476)
...++|+|+++.||+++.++ ++|+||+.+..
T Consensus 231 ~~~liHGDl~~~Nil~~~~~-~~lID~e~a~~ 261 (420)
T 2pyw_A 231 AQALIHGDLHTGSVMVTQDS-TQVIDPEFSFY 261 (420)
T ss_dssp CCEEECSCCSGGGEEECSSC-EEECCCTTCEE
T ss_pred CCeEEecCCCCCcEEEeCCC-CEEEeCccccc
Confidence 34599999999999999776 99999998875
|
| >3dxq_A Choline/ethanolamine kinase family protein; NP_106042.1, STR genomics, joint center for structural genomics, JCSG, prote structure initiative; HET: MSE; 2.55A {Mesorhizobium loti} | Back alignment and structure |
|---|
Probab=92.04 E-value=0.27 Score=46.89 Aligned_cols=30 Identities=30% Similarity=0.313 Sum_probs=25.3
Q ss_pred CceeecCCCccceEecCCCCceeccccceee
Q 045315 284 LRVIHRDLKASNILLDKDMNPKISDFGMARM 314 (476)
Q Consensus 284 ~~ivH~DLkp~NILld~~~~~kL~DFGla~~ 314 (476)
..++|+|+.+.||+ ..++.+.++||..+..
T Consensus 173 ~~l~HgDl~~~Nil-~~~~~~~lID~e~a~~ 202 (301)
T 3dxq_A 173 LAACHCDPLCENFL-DTGERMWIVDWEYSGM 202 (301)
T ss_dssp CEEECSCCCGGGEE-ECSSCEEECCCTTCEE
T ss_pred ceeeccCCCcCCEE-ECCCCEEEEecccccC
Confidence 45899999999999 5566789999998864
|
| >3csv_A Aminoglycoside phosphotransferase; YP_614837.1, phosphotransferase enzyme family, structural genomics, JOIN for structural genomics, JCSG; HET: MSE; 2.15A {Silicibacter SP} | Back alignment and structure |
|---|
Probab=90.82 E-value=0.28 Score=47.44 Aligned_cols=32 Identities=28% Similarity=0.479 Sum_probs=27.3
Q ss_pred CCceeecCCCccceEecCC----CCceeccccceee
Q 045315 283 RLRVIHRDLKASNILLDKD----MNPKISDFGMARM 314 (476)
Q Consensus 283 ~~~ivH~DLkp~NILld~~----~~~kL~DFGla~~ 314 (476)
...++|+|+.+.||+++.+ ..+.|+||+.+..
T Consensus 182 ~~~lvHgD~~~~Nil~~~~~~~~~~~~lIDf~~a~~ 217 (333)
T 3csv_A 182 DMVFVHRDFHAQNLLWLPEREGLARVGVIDFQDAKL 217 (333)
T ss_dssp CCEEECSCCSGGGEEECTTSCGGGGEEECCCTTCEE
T ss_pred CCeeEeCCcCcccEEeccCcCCCCCeEEEeCCCcCc
Confidence 3469999999999999874 6789999998865
|
| >1zyl_A Hypothetical protein YIHE; putative protein kinase, structural genomics, PSI, protein structure initiative; 2.80A {Escherichia coli} SCOP: d.144.1.6 | Back alignment and structure |
|---|
Probab=89.46 E-value=0.38 Score=46.20 Aligned_cols=30 Identities=37% Similarity=0.474 Sum_probs=25.4
Q ss_pred CCceeecCCCccceEecCCCCceeccccceee
Q 045315 283 RLRVIHRDLKASNILLDKDMNPKISDFGMARM 314 (476)
Q Consensus 283 ~~~ivH~DLkp~NILld~~~~~kL~DFGla~~ 314 (476)
...++|+|+++.||+++ + .+.|+||+.+..
T Consensus 194 ~~~l~HgD~~~~Nil~~-~-~~~lIDfe~a~~ 223 (328)
T 1zyl_A 194 TVLRLHGDCHAGNILWR-D-GPMFVDLDDARN 223 (328)
T ss_dssp CCEECCSSCSGGGEEES-S-SEEECCCTTCCE
T ss_pred CeeeeeCCCCcccEeEc-C-CCEEEECCCCCc
Confidence 34589999999999999 4 789999988753
|
| >2ppq_A HSK, HK, homoserine kinase; structural genomics, MCSG, PSI-2, protein structure initiative; 2.00A {Agrobacterium tumefaciens str} SCOP: d.144.1.6 | Back alignment and structure |
|---|
Probab=89.42 E-value=0.19 Score=48.18 Aligned_cols=32 Identities=31% Similarity=0.298 Sum_probs=26.6
Q ss_pred CCceeecCCCccceEecCCCCceeccccceee
Q 045315 283 RLRVIHRDLKASNILLDKDMNPKISDFGMARM 314 (476)
Q Consensus 283 ~~~ivH~DLkp~NILld~~~~~kL~DFGla~~ 314 (476)
...++|+|+++.||+++.+..+.|+||+.+..
T Consensus 186 ~~~liHgDl~~~Nil~~~~~~~~lIDf~~a~~ 217 (322)
T 2ppq_A 186 PAGVIHADLFQDNVFFLGDELSGLIDFYFACN 217 (322)
T ss_dssp CEEEECSCCCGGGEEEETTEEEEECCCTTCEE
T ss_pred CcccCCCCCCccCEEEeCCceEEEecchhccC
Confidence 34699999999999999876568999987753
|
| >3no2_A Uncharacterized protein; six-bladed beta-propeller, structural genomics, joint center structural genomics, JCSG, protein structure initiative; HET: MSE CIT PEG; 1.35A {Bacteroides caccae} | Back alignment and structure |
|---|
Probab=88.43 E-value=2.1 Score=40.11 Aligned_cols=65 Identities=15% Similarity=0.261 Sum_probs=39.8
Q ss_pred CceEEeecCCCC--CC----CCCceEEEecCCceEEEccCCeEEEeecCCCCCCCceeeeccCCCeEEEeC
Q 045315 72 DTVVWVANRNSP--IF----NPNTALTFSNNGNLVLLSQRNGIIWSSNMSRKAENPIAQLLDTGNLVIRDN 136 (476)
Q Consensus 72 ~~~vW~an~~~p--~~----~~~~~l~~~~~G~lvl~~~~~~~vWss~~~~~~~~~~~~l~d~GNlVl~~~ 136 (476)
.+++|...+..+ +. .+.+.+-++.++.+..+|.+|+.+|.-..........+..+.+||+++-+.
T Consensus 25 G~~~w~~~~~~~~~~~~~~~~pdG~ilvs~~~~V~~~d~~G~~~W~~~~~~~~~~~~~~~~~dG~~lv~~~ 95 (276)
T 3no2_A 25 KEIVWEYPLEKGWECNSVAATKAGEILFSYSKGAKMITRDGRELWNIAAPAGCEMQTARILPDGNALVAWC 95 (276)
T ss_dssp TEEEEEEECCTTCCCCEEEECTTSCEEEECBSEEEEECTTSCEEEEEECCTTCEEEEEEECTTSCEEEEEE
T ss_pred CeEEEEeCCCccCCCcCeEECCCCCEEEeCCCCEEEECCCCCEEEEEcCCCCccccccEECCCCCEEEEec
Confidence 677888876541 10 123344445555666777889999988754222233456778888777654
|
| >3i1a_A Spectinomycin phosphotransferase; protein kinase, aminoglycoside phosphotransferase, antibiotic resistance; HET: MES PG4; 1.70A {Legionella pneumophila} PDB: 3i0q_A* 3i0o_A* 3q2m_A* | Back alignment and structure |
|---|
Probab=85.78 E-value=0.61 Score=45.41 Aligned_cols=32 Identities=22% Similarity=0.403 Sum_probs=27.9
Q ss_pred CCceeecCCCccceEecCCCCceeccccceee
Q 045315 283 RLRVIHRDLKASNILLDKDMNPKISDFGMARM 314 (476)
Q Consensus 283 ~~~ivH~DLkp~NILld~~~~~kL~DFGla~~ 314 (476)
...++|+|+.+.||+++.++.+.|+||+.+..
T Consensus 205 ~~~~~HgD~~~~N~l~~~~~~~~~iD~e~~~~ 236 (339)
T 3i1a_A 205 KYVLCHSDIHAGNVLVGNEESIYIIDWDEPML 236 (339)
T ss_dssp GCEEECSCCCGGGEEECGGGCEEECCCSSCEE
T ss_pred CceeEeCCCCcCCEEEeCCCeEEEEECCCCee
Confidence 35699999999999999888899999987754
|
| >2qg7_A Ethanolamine kinase PV091845; malaria, SGC, structural genomics consortium, transferase; 2.41A {Plasmodium vivax} | Back alignment and structure |
|---|
Probab=85.66 E-value=1 Score=45.91 Aligned_cols=17 Identities=35% Similarity=0.430 Sum_probs=15.3
Q ss_pred CCceeecCCCccceEec
Q 045315 283 RLRVIHRDLKASNILLD 299 (476)
Q Consensus 283 ~~~ivH~DLkp~NILld 299 (476)
...++|+|+.+.|||++
T Consensus 289 ~~v~cHnDl~~gNIL~~ 305 (458)
T 2qg7_A 289 PIVLCHCDLLSSNIINT 305 (458)
T ss_dssp CEEEECSCCCGGGEEEC
T ss_pred CeeEEecCCCCCcEEee
Confidence 45699999999999998
|
| >3c5i_A Choline kinase; choline, kinase, malaria, transferase, structural genomics, structural genomics consortium; 2.20A {Plasmodium knowlesi} PDB: 3fi8_A* | Back alignment and structure |
|---|
Probab=85.61 E-value=0.79 Score=44.96 Aligned_cols=31 Identities=23% Similarity=0.418 Sum_probs=25.2
Q ss_pred CCceeecCCCccceEecCCCCceeccccceee
Q 045315 283 RLRVIHRDLKASNILLDKDMNPKISDFGMARM 314 (476)
Q Consensus 283 ~~~ivH~DLkp~NILld~~~~~kL~DFGla~~ 314 (476)
...++|+|+++.||+++.+. +.|+||..+..
T Consensus 211 ~~~l~HgDl~~~Nil~~~~~-~~lID~e~a~~ 241 (369)
T 3c5i_A 211 TIVFCHNDLQENNIINTNKC-LRLIDFEYSGF 241 (369)
T ss_dssp CEEEECSCCCGGGEEECC-C-EEECCCTTCEE
T ss_pred CeEEEeCCCCcccEEecCCc-EEEEEecCCCC
Confidence 35699999999999998654 89999988753
|
| >2olc_A MTR kinase, methylthioribose kinase; kinase ADP-2HO complex, transferase; HET: CPS ADP; 2.00A {Bacillus subtilis} SCOP: d.144.1.6 PDB: 2pu8_A* 2pui_A* 2pul_A* 2pun_A* 2pup_A* | Back alignment and structure |
|---|
Probab=83.95 E-value=0.95 Score=44.84 Aligned_cols=30 Identities=27% Similarity=0.358 Sum_probs=25.6
Q ss_pred CceeecCCCccceEecCCCCceeccccceee
Q 045315 284 LRVIHRDLKASNILLDKDMNPKISDFGMARM 314 (476)
Q Consensus 284 ~~ivH~DLkp~NILld~~~~~kL~DFGla~~ 314 (476)
..++|+|+.+.||+++.+ .++++||..+..
T Consensus 227 ~~L~HGDl~~~Nil~~~~-~~~lID~e~a~~ 256 (397)
T 2olc_A 227 ETLIHGDLHTGSIFASEH-ETKVIDPEFAFY 256 (397)
T ss_dssp CEEECSCCSGGGEEECSS-CEEECCCTTCEE
T ss_pred CceeeCCCCcCcEEEeCC-CeEEEeCccccc
Confidence 459999999999999876 489999987764
|
| >1nw1_A Choline kinase (49.2 KD); phospholipid synthesis, protein kinase fold, transferase; 2.02A {Caenorhabditis elegans} SCOP: d.144.1.8 | Back alignment and structure |
|---|
Probab=82.78 E-value=0.96 Score=45.63 Aligned_cols=32 Identities=34% Similarity=0.441 Sum_probs=25.5
Q ss_pred CCceeecCCCccceEecCC----------------------------CCceeccccceee
Q 045315 283 RLRVIHRDLKASNILLDKD----------------------------MNPKISDFGMARM 314 (476)
Q Consensus 283 ~~~ivH~DLkp~NILld~~----------------------------~~~kL~DFGla~~ 314 (476)
...++|+|+.+.||+++.+ ..+.|+||..+..
T Consensus 248 ~~v~~H~Dl~~gNiL~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~lIDfEya~~ 307 (429)
T 1nw1_A 248 PVTFCHNDLQEGNILLPKASSGNIRMPSLSDETQALGNSLSAFNPADPRLVLIDFEYASY 307 (429)
T ss_dssp CEEEECSCCCGGGEEEEC------------------------------CCEECCCTTCEE
T ss_pred CeEEEeCCCCCCeEEeeCCccccccccccccccccccccccccccCCCeEEEEecccCCc
Confidence 4569999999999999875 6788999987753
|
| >4ano_A ESSB; membrane protein, membrane secretion, ESS type V secretion S; HET: MSE; 1.70A {Geobacillus thermodenitrificans ng80-2organism_taxid} | Back alignment and structure |
|---|
Probab=82.38 E-value=0.76 Score=41.85 Aligned_cols=52 Identities=10% Similarity=0.125 Sum_probs=43.1
Q ss_pred CCCChhhHHHHHHHHHHHHH-HHhhcCCCceeecCCCccceEecCCCCceecccccee
Q 045315 257 GLLCWGTRVRIIEGIAQGLL-YLHQYSRLRVIHRDLKASNILLDKDMNPKISDFGMAR 313 (476)
Q Consensus 257 ~~L~~~~~~~i~~qIa~gL~-yLH~~~~~~ivH~DLkp~NILld~~~~~kL~DFGla~ 313 (476)
+.++..++++++.+|+.-.. +++. -+|--|+|+||+++.++.++|.-.|+-.
T Consensus 80 ~~~~~~eKlrll~nl~~L~~~~~~~-----r~tf~l~P~NL~f~~~~~p~i~hRGi~~ 132 (219)
T 4ano_A 80 RKTTLLSRIRAAIHLVSKVKHHSAR-----RLIFIVCPENLMFNRALEPFFLHVGVKE 132 (219)
T ss_dssp HTSCHHHHHHHHHHHHHHHSSCCSS-----SEECCCCGGGEEECTTCCEEESCCEETT
T ss_pred HhcCHHHHHHHHHHHHHHHHHhhhC-----ceeEEEeCceEEEeCCCcEEEEEcCCcc
Confidence 45788899999999988776 5554 5788899999999999999998877643
|
Homologous Structure Domains
Structure Domains Detected by RPS-BLAST
Original result of RPS-BLAST against SCOP70(version1.75) database
| ID | Alignment Graph | Length |
Definition |
E-value |
| 476 | ||||
| d1uwha_ | 276 | d.144.1.7 (A:) B-Raf kinase {Human (Homo sapiens) | 2e-42 | |
| d1fmka3 | 285 | d.144.1.7 (A:249-533) c-src tyrosine kinase {Human | 3e-38 | |
| d1vjya_ | 303 | d.144.1.7 (A:) Type I TGF-beta receptor R4 {Human | 2e-37 | |
| d1lufa_ | 301 | d.144.1.7 (A:) Musk tyrosine kinase {Rat (Rattus n | 5e-36 | |
| d1rjba_ | 325 | d.144.1.7 (A:) Fl cytokine receptor {Human (Homo s | 7e-36 | |
| d1qpca_ | 272 | d.144.1.7 (A:) Lymphocyte kinase (lck) {Human (Hom | 3e-35 | |
| d1ywna1 | 299 | d.144.1.7 (A:818-1166) Vascular endothelial growth | 1e-34 | |
| d1mqba_ | 283 | d.144.1.7 (A:) epha2 receptor tyrosine kinase {Hum | 4e-34 | |
| d1u59a_ | 285 | d.144.1.7 (A:) Tyrosine-protein kinase ZAP-70 {Hum | 4e-34 | |
| d1xkka_ | 317 | d.144.1.7 (A:) EGF receptor tyrosine kinase, Erbb- | 7e-34 | |
| d1sm2a_ | 263 | d.144.1.7 (A:) Tyrosine-protein kinase Itk/Tsk {Hu | 7e-34 | |
| d1s9ja_ | 322 | d.144.1.7 (A:) Dual specificity mitogen-activated | 1e-33 | |
| d1xbba_ | 277 | d.144.1.7 (A:) Tyrosine-protein kinase SYK {Human | 2e-33 | |
| d1jpaa_ | 299 | d.144.1.7 (A:) ephb2 receptor tyrosine kinase {Mou | 2e-33 | |
| d1nvra_ | 271 | d.144.1.7 (A:) Cell cycle checkpoint kinase chk1 { | 2e-33 | |
| d1opja_ | 287 | d.144.1.7 (A:) Abelsone tyrosine kinase (abl) {Mou | 4e-33 | |
| d1byga_ | 262 | d.144.1.7 (A:) Carboxyl-terminal src kinase (csk) | 1e-32 | |
| d1r0pa_ | 311 | d.144.1.7 (A:) Hepatocyte growth factor receptor, | 1e-32 | |
| d1t46a_ | 311 | d.144.1.7 (A:) c-KIT receptor {Human (Homo sapiens | 2e-32 | |
| d1k2pa_ | 258 | d.144.1.7 (A:) Bruton's tyrosine kinase (Btk) {Hum | 2e-32 | |
| d1t4ha_ | 270 | d.144.1.7 (A:) Protein kinase wnk1 {Human (Homo sa | 5e-32 | |
| d1u46a_ | 273 | d.144.1.7 (A:) Activated CDC42 kinase 1, ACK1 {Hum | 1e-31 | |
| d1fvra_ | 309 | d.144.1.7 (A:) Tie2 kinase {Human (Homo sapiens) [ | 4e-31 | |
| d2j4za1 | 263 | d.144.1.7 (A:126-388) Aurora-related kinase 1 (aur | 1e-30 | |
| d2java1 | 269 | d.144.1.7 (A:3-271) Serine/threonine-protein kinas | 1e-30 | |
| d1fgka_ | 299 | d.144.1.7 (A:) Fibroblast growth factor receptor 1 | 3e-30 | |
| d1p4oa_ | 308 | d.144.1.7 (A:) Insulin-like growth factor 1 recept | 5e-30 | |
| d1u5ra_ | 309 | d.144.1.7 (A:) Serine/threonine protein kinase TAO | 5e-30 | |
| d2jfla1 | 288 | d.144.1.7 (A:21-308) STE20-like serine/threonine-p | 1e-28 | |
| d1mp8a_ | 273 | d.144.1.7 (A:) Focal adhesion kinase 1 (fak) {Huma | 2e-28 | |
| d1yhwa1 | 293 | d.144.1.7 (A:249-541) pak1 {Human (Homo sapiens) [ | 8e-28 | |
| d1ckia_ | 299 | d.144.1.7 (A:) Casein kinase-1, CK1 {Rat (Rattus n | 9e-24 | |
| d1uu3a_ | 288 | d.144.1.7 (A:) 3-phosphoinositide dependent protei | 3e-23 | |
| d1csna_ | 293 | d.144.1.7 (A:) Casein kinase-1, CK1 {Fission yeast | 3e-23 | |
| d1blxa_ | 305 | d.144.1.7 (A:) Cyclin-dependent PK, CDK6 {Human (H | 1e-22 | |
| d1phka_ | 277 | d.144.1.7 (A:) gamma-subunit of glycogen phosphory | 2e-22 | |
| d1fota_ | 316 | d.144.1.7 (A:) cAMP-dependent PK, catalytic subuni | 8e-22 | |
| d1kj1a_ | 109 | b.78.1.1 (A:) Lectin (agglutinin) {Garlic (Allium | 1e-21 | |
| d1koaa2 | 350 | d.144.1.7 (A:5915-6264) Twitchin, kinase domain {C | 7e-21 | |
| d1omwa3 | 364 | d.144.1.7 (A:186-549) G-protein coupled receptor k | 2e-20 | |
| d1xjda_ | 320 | d.144.1.7 (A:) Protein kinase C, theta type {Human | 2e-20 | |
| d1xwsa_ | 273 | d.144.1.7 (A:) Proto-oncogene serine/threonine-pro | 3e-20 | |
| d1koba_ | 352 | d.144.1.7 (A:) Twitchin, kinase domain {California | 5e-20 | |
| d1pmea_ | 345 | d.144.1.7 (A:) MAP kinase Erk2 {Human (Homo sapien | 6e-20 | |
| d1o6ya_ | 277 | d.144.1.7 (A:) Mycobacterial protein kinase PknB, | 7e-20 | |
| d1o6la_ | 337 | d.144.1.7 (A:) Pkb kinase (Akt-2) {Human (Homo sap | 9e-20 | |
| d1tkia_ | 321 | d.144.1.7 (A:) Titin, kinase domain {Human (Homo s | 7e-19 | |
| d2ozaa1 | 335 | d.144.1.7 (A:51-385) MAP kinase activated protein | 7e-19 | |
| d1ua2a_ | 299 | d.144.1.7 (A:) Cell division protein kinase 7, CDK | 9e-19 | |
| d3blha1 | 318 | d.144.1.7 (A:8-325) Cell division protein kinase 9 | 2e-18 | |
| d1unla_ | 292 | d.144.1.7 (A:) Cyclin-dependent PK, CDK5 {Human (H | 9e-18 | |
| d1a06a_ | 307 | d.144.1.7 (A:) Calmodulin-dependent protein kinase | 1e-17 | |
| d1gz8a_ | 298 | d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {Human (H | 2e-17 | |
| d1rdqe_ | 350 | d.144.1.7 (E:) cAMP-dependent PK, catalytic subuni | 2e-17 | |
| d1ob3a_ | 286 | d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {(Plasmod | 8e-17 | |
| d1jksa_ | 293 | d.144.1.7 (A:) Death-associated protein kinase, Da | 1e-16 | |
| d1q5ka_ | 350 | d.144.1.7 (A:) Glycogen synthase kinase-3 beta (Gs | 1e-15 | |
| d1vzoa_ | 322 | d.144.1.7 (A:) Ribosomal protein S6 kinase alpha 5 | 4e-15 | |
| d1cm8a_ | 346 | d.144.1.7 (A:) MAP kinase p38-gamma {Human (Homo s | 7e-15 | |
| d1jpca_ | 108 | b.78.1.1 (A:) Lectin (agglutinin) {Snowdrop (Galan | 3e-14 | |
| d1b2pa_ | 119 | b.78.1.1 (A:) Lectin (agglutinin) {Bluebell (Scill | 5e-14 | |
| d2b1pa1 | 355 | d.144.1.7 (A:46-400) c-jun N-terminal kinase (jnk3 | 8e-14 | |
| d1q8ya_ | 362 | d.144.1.7 (A:) Sky1p {Baker's yeast (Saccharomyces | 1e-13 | |
| d3bqca1 | 328 | d.144.1.7 (A:3-330) Protein kinase CK2, alpha subu | 4e-13 | |
| d1dlpa2 | 120 | b.78.1.1 (A:116-235) Fetuin-binding protein Scafet | 8e-13 | |
| d1dlpa2 | 120 | b.78.1.1 (A:116-235) Fetuin-binding protein Scafet | 5e-08 | |
| d1xd5a_ | 112 | b.78.1.1 (A:) Gastrodianin (antifungal protein) {G | 9e-13 | |
| d2gfsa1 | 348 | d.144.1.7 (A:5-352) MAP kinase p38 {Human (Homo sa | 1e-11 | |
| d1zara2 | 191 | d.144.1.9 (A:91-281) Rio2 serine protein kinase C- | 1e-10 | |
| d1dlpa1 | 115 | b.78.1.1 (A:1-115) Fetuin-binding protein Scafet p | 2e-07 |
| >d1uwha_ d.144.1.7 (A:) B-Raf kinase {Human (Homo sapiens) [TaxId: 9606]} Length = 276 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: B-Raf kinase species: Human (Homo sapiens) [TaxId: 9606]
Score = 149 bits (378), Expect = 2e-42
Identities = 45/192 (23%), Positives = 89/192 (46%), Gaps = 16/192 (8%)
Query: 255 KKGLLCWGTRVRIIEGIAQGLLYLHQYSRLRVIHRDLKASNILLDKDMNPKISDFGMARM 314
+ + I AQG+ YLH +IHRDLK++NI L +D+ KI DFG+A +
Sbjct: 97 IETKFEMIKLIDIARQTAQGMDYLHA---KSIIHRDLKSNNIFLHEDLTVKIGDFGLATV 153
Query: 315 FGGDELQSNTKRIVGTYGYMSPEYAL---RGLFSIKSDVFSFGVLLLETLSSKKNTHFYN 371
+++ G+ +M+PE + +S +SDV++FG++L E ++ + + N
Sbjct: 154 KSRWSGSHQFEQLSGSILWMAPEVIRMQDKNPYSFQSDVYAFGIVLYELMTGQLP--YSN 211
Query: 372 TDSLTLLGHAWNLWNDGRTWELMDPISQNGASYPILKRYINVALLCVQEKAADRPAMSEV 431
++ + + G + + N K + C+++K +RP ++
Sbjct: 212 INNRDQI---IFMVGRGYLSPDLSKVRSN-----CPKAMKRLMAECLKKKRDERPLFPQI 263
Query: 432 VSMLSNEFVNLP 443
++ + +LP
Sbjct: 264 LASIELLARSLP 275
|
| >d1fmka3 d.144.1.7 (A:249-533) c-src tyrosine kinase {Human (Homo sapiens) [TaxId: 9606]} Length = 285 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: c-src tyrosine kinase species: Human (Homo sapiens) [TaxId: 9606]
Score = 139 bits (350), Expect = 3e-38
Identities = 47/204 (23%), Positives = 86/204 (42%), Gaps = 18/204 (8%)
Query: 246 WYESYNNPTKKGLLCWGTRVRIIEGIAQGLLYLHQYSRLRVIHRDLKASNILLDKDMNPK 305
+ L V + IA G+ Y+ + +HRDL+A+NIL+ +++ K
Sbjct: 97 SLLDFLKGETGKYLRLPQLVDMAAQIASGMAYVERM---NYVHRDLRAANILVGENLVCK 153
Query: 306 ISDFGMARMFGGDELQSNTKRIVGTYGYMSPEYALRGLFSIKSDVFSFGVLLLETLSSKK 365
++DFG+AR+ +E + + +PE AL G F+IKSDV+SFG+LL E + +
Sbjct: 154 VADFGLARLIEDNEYTARQ-GAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELTTKGR 212
Query: 366 NTHFYNTDSLTLLGHAWNLWNDGRTWELMDPISQNGASYPILKRYINVALLCVQEKAADR 425
+ + L + G + ++ C +++ +R
Sbjct: 213 VPYPGMVNREVL-----DQVERGYRMPCPPECPE---------SLHDLMCQCWRKEPEER 258
Query: 426 PAMSEVVSMLSNEFVNLPAPQQPA 449
P + + L + F + QP
Sbjct: 259 PTFEYLQAFLEDYFTSTEPQYQPG 282
|
| >d1vjya_ d.144.1.7 (A:) Type I TGF-beta receptor R4 {Human (Homo sapiens) [TaxId: 9606]} Length = 303 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Type I TGF-beta receptor R4 species: Human (Homo sapiens) [TaxId: 9606]
Score = 137 bits (345), Expect = 2e-37
Identities = 39/202 (19%), Positives = 69/202 (34%), Gaps = 19/202 (9%)
Query: 255 KKGLLCWGTRVRIIEGIAQGLLYLHQ-----YSRLRVIHRDLKASNILLDKDMNPKISDF 309
+ + +++ A GL +LH + + HRDLK+ NIL+ K+ I+D
Sbjct: 93 NRYTVTVEGMIKLALSTASGLAHLHMEIVGTQGKPAIAHRDLKSKNILVKKNGTCCIADL 152
Query: 310 GMARMF--GGDELQSNTKRIVGTYGYMSPEYALRGL------FSIKSDVFSFGVLLLETL 361
G+A D + VGT YM+PE + ++D+++ G++ E
Sbjct: 153 GLAVRHDSATDTIDIAPNHRVGTKRYMAPEVLDDSINMKHFESFKRADIYAMGLVFWEIA 212
Query: 362 SSKKNTHFYNTDS-----LTLLGHAWNLWNDGRTWELMDP-ISQNGASYPILKRYINVAL 415
+ L + + + P I S L+ +
Sbjct: 213 RRCSIGGIHEDYQLPYYDLVPSDPSVEEMRKVVCEQKLRPNIPNRWQSCEALRVMAKIMR 272
Query: 416 LCVQEKAADRPAMSEVVSMLSN 437
C A R + LS
Sbjct: 273 ECWYANGAARLTALRIKKTLSQ 294
|
| >d1lufa_ d.144.1.7 (A:) Musk tyrosine kinase {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 301 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Musk tyrosine kinase species: Rat (Rattus norvegicus) [TaxId: 10116]
Score = 133 bits (334), Expect = 5e-36
Identities = 42/199 (21%), Positives = 74/199 (37%), Gaps = 17/199 (8%)
Query: 237 VQSKDEISFWYESYNNPTKKGLLCWGTRVRIIEGIAQGLLYLHQYSRLRVIHRDLKASNI 296
V S + + L ++ I +A G+ YL + + +HRDL N
Sbjct: 115 VCSLSHSDLSTRARVSSPGPPPLSCAEQLCIARQVAAGMAYLSER---KFVHRDLATRNC 171
Query: 297 LLDKDMNPKISDFGMARMFGGDELQSNTKRIVGTYGYMSPEYALRGLFSIKSDVFSFGVL 356
L+ ++M KI+DFG++R + +M PE ++ +SDV+++GV+
Sbjct: 172 LVGENMVVKIADFGLSRNIYSADYYKADGNDAIPIRWMPPESIFYNRYTTESDVWAYGVV 231
Query: 357 LLETLSSKKNTHFYNTDSLTLLGHAWNLWNDGRTWELMDPISQNGASYPILKRYINVALL 416
L E S ++ DG + N+ L
Sbjct: 232 LWEIFSYGLQPYYGMAHE-----EVIYYVRDGNILACPENCP---------LELYNLMRL 277
Query: 417 CVQEKAADRPAMSEVVSML 435
C + ADRP+ + +L
Sbjct: 278 CWSKLPADRPSFCSIHRIL 296
|
| >d1rjba_ d.144.1.7 (A:) Fl cytokine receptor {Human (Homo sapiens) [TaxId: 9606]} Length = 325 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Fl cytokine receptor species: Human (Homo sapiens) [TaxId: 9606]
Score = 133 bits (335), Expect = 7e-36
Identities = 46/211 (21%), Positives = 82/211 (38%), Gaps = 17/211 (8%)
Query: 229 SFLYEQVLVQSKDEISF-WYESYNNPTKKGLLCWGTRVRIIEGIAQGLLYLHQYSRLRVI 287
++L + S+DEI + + +L + + +A+G+ +L +
Sbjct: 130 NYLRSKREKFSEDEIEYENQKRLEEEEDLNVLTFEDLLCFAYQVAKGMEFLEF---KSCV 186
Query: 288 HRDLKASNILLDKDMNPKISDFGMARMFGGDELQSNTKRIVGTYGYMSPEYALRGLFSIK 347
HRDL A N+L+ KI DFG+AR D +M+PE G+++IK
Sbjct: 187 HRDLAARNVLVTHGKVVKICDFGLARDIMSDSNYVVRGNARLPVKWMAPESLFEGIYTIK 246
Query: 348 SDVFSFGVLLLETLSSKKNTHFYNTDSLTLLGHAWNLWNDGRTWELMDPISQNGASYPIL 407
SDV+S+G+LL E S + + L +G + +
Sbjct: 247 SDVWSYGILLWEIFSLGV-NPYPGIPVDANF---YKLIQNGFKMDQPFYAT--------- 293
Query: 408 KRYINVALLCVQEKAADRPAMSEVVSMLSNE 438
+ + C + RP+ + S L +
Sbjct: 294 EEIYIIMQSCWAFDSRKRPSFPNLTSFLGCQ 324
|
| >d1qpca_ d.144.1.7 (A:) Lymphocyte kinase (lck) {Human (Homo sapiens) [TaxId: 9606]} Length = 272 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Lymphocyte kinase (lck) species: Human (Homo sapiens) [TaxId: 9606]
Score = 130 bits (328), Expect = 3e-35
Identities = 49/194 (25%), Positives = 89/194 (45%), Gaps = 18/194 (9%)
Query: 246 WYESYNNPTKKGLLCWGTRVRIIEGIAQGLLYLHQYSRLRVIHRDLKASNILLDKDMNPK 305
+ L + + IA+G+ ++ + IHRDL+A+NIL+ ++ K
Sbjct: 93 SLVDFLKTPSGIKLTINKLLDMAAQIAEGMAFIEE---RNYIHRDLRAANILVSDTLSCK 149
Query: 306 ISDFGMARMFGGDELQSNTKRIVGTYGYMSPEYALRGLFSIKSDVFSFGVLLLETLSSKK 365
I+DFG+AR+ +E + + +PE G F+IKSDV+SFG+LL E ++ +
Sbjct: 150 IADFGLARLIEDNEYTARE-GAKFPIKWTAPEAINYGTFTIKSDVWSFGILLTEIVTHGR 208
Query: 366 NTHFYNTDSLTLLGHAWNLWNDGRTWELMDPISQNGASYPILKRYINVALLCVQEKAADR 425
+ T+ + N R + ++ P + + + LC +E+ DR
Sbjct: 209 IPYPGMTNPEV-------IQNLERGYRMVRPDN-------CPEELYQLMRLCWKERPEDR 254
Query: 426 PAMSEVVSMLSNEF 439
P + S+L + F
Sbjct: 255 PTFDYLRSVLEDFF 268
|
| >d1ywna1 d.144.1.7 (A:818-1166) Vascular endothelial growth factor receptor 2 (kdr) {Human (Homo sapiens) [TaxId: 9606]} Length = 299 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Vascular endothelial growth factor receptor 2 (kdr) species: Human (Homo sapiens) [TaxId: 9606]
Score = 129 bits (324), Expect = 1e-34
Identities = 52/202 (25%), Positives = 79/202 (39%), Gaps = 16/202 (7%)
Query: 236 LVQSKDEISFWYESYNNPTKKGLLCWGTRVRIIEGIAQGLLYLHQYSRLRVIHRDLKASN 295
++SK Y+ K L + +A+G+ +L + IHRDL A N
Sbjct: 108 YLRSKRNEFVPYKVAPEDLYKDFLTLEHLICYSFQVAKGMEFLAS---RKCIHRDLAARN 164
Query: 296 ILLDKDMNPKISDFGMARMFGGDELQSNTKRIVGTYGYMSPEYALRGLFSIKSDVFSFGV 355
ILL + KI DFG+AR D +M+PE +++I+SDV+SFGV
Sbjct: 165 ILLSEKNVVKICDFGLARDIYKDPDYVRKGDARLPLKWMAPETIFDRVYTIQSDVWSFGV 224
Query: 356 LLLETLSSKKNTHFYNTDSLTLLGHAWNLWNDGRTWELMDPISQNGASYPILKRYINVAL 415
LL E S + + + + +G D + L
Sbjct: 225 LLWEIFSLGASPY----PGVKIDEEFCRRLKEGTRMRAPDYTT---------PEMYQTML 271
Query: 416 LCVQEKAADRPAMSEVVSMLSN 437
C + + RP SE+V L N
Sbjct: 272 DCWHGEPSQRPTFSELVEHLGN 293
|
| >d1mqba_ d.144.1.7 (A:) epha2 receptor tyrosine kinase {Human (Homo sapiens) [TaxId: 9606]} Length = 283 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: epha2 receptor tyrosine kinase species: Human (Homo sapiens) [TaxId: 9606]
Score = 127 bits (320), Expect = 4e-34
Identities = 49/215 (22%), Positives = 90/215 (41%), Gaps = 26/215 (12%)
Query: 237 VQSKDEISFWYESYNNPT-------KKGLLCWGTRVRIIEGIAQGLLYLHQYSRLRVIHR 289
+ + E N K G V ++ GIA G+ YL + +HR
Sbjct: 78 ISKYKPMMIITEYMENGALDKFLREKDGEFSVLQLVGMLRGIAAGMKYLA---NMNYVHR 134
Query: 290 DLKASNILLDKDMNPKISDFGMARMFGGDELQSNT-KRIVGTYGYMSPEYALRGLFSIKS 348
DL A NIL++ ++ K+SDFG++R+ D + T + +PE F+ S
Sbjct: 135 DLAARNILVNSNLVCKVSDFGLSRVLEDDPEATYTTSGGKIPIRWTAPEAISYRKFTSAS 194
Query: 349 DVFSFGVLLLETLSSKKNTHFYNTDSLTLLGHAWNLWNDGRTWELMDPISQNGASYPILK 408
DV+SFG+++ E ++ + ++ ++ NDG
Sbjct: 195 DVWSFGIVMWEVMTYGERPYWELSNH-----EVMKAINDGFRLPTPMDCPS--------- 240
Query: 409 RYINVALLCVQEKAADRPAMSEVVSMLSNEFVNLP 443
+ + C Q++ A RP +++VS+L ++ + P
Sbjct: 241 AIYQLMMQCWQQERARRPKFADIVSIL-DKLIRAP 274
|
| >d1u59a_ d.144.1.7 (A:) Tyrosine-protein kinase ZAP-70 {Human (Homo sapiens) [TaxId: 9606]} Length = 285 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tyrosine-protein kinase ZAP-70 species: Human (Homo sapiens) [TaxId: 9606]
Score = 127 bits (320), Expect = 4e-34
Identities = 42/197 (21%), Positives = 74/197 (37%), Gaps = 18/197 (9%)
Query: 255 KKGLLCWGTRVRIIEGIAQGLLYLHQYSRLRVIHRDLKASNILLDKDMNPKISDFGMARM 314
K+ + ++ ++ G+ YL + +HRDL A N+LL KISDFG+++
Sbjct: 102 KREEIPVSNVAELLHQVSMGMKYLEE---KNFVHRDLAARNVLLVNRHYAKISDFGLSKA 158
Query: 315 FGGDELQSNTKR-IVGTYGYMSPEYALRGLFSIKSDVFSFGVLLLETLSSKKNTHFYNTD 373
G D+ + + +PE FS +SDV+S+GV + E LS + +
Sbjct: 159 LGADDSYYTARSAGKWPLKWYAPECINFRKFSSRSDVWSYGVTMWEALSYGQ-KPYKKMK 217
Query: 374 SLTLLGHAWNLWNDGRTWELMDPISQNGASYPILKRYINVALLCVQEKAADRPAMSEVVS 433
++ G+ E + C K DRP V
Sbjct: 218 GPEVM----AFIEQGKRMECPPECP---------PELYALMSDCWIYKWEDRPDFLTVEQ 264
Query: 434 MLSNEFVNLPAPQQPAF 450
+ + +L + +
Sbjct: 265 RMRACYYSLASKVEGHH 281
|
| >d1xkka_ d.144.1.7 (A:) EGF receptor tyrosine kinase, Erbb-1 {Human (Homo sapiens) [TaxId: 9606]} Length = 317 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: EGF receptor tyrosine kinase, Erbb-1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 127 bits (320), Expect = 7e-34
Identities = 45/211 (21%), Positives = 87/211 (41%), Gaps = 31/211 (14%)
Query: 255 KKGLLCWGTRVRIIEGIAQGLLYLHQYSRLRVIHRDLKASNILLDKDMNPKISDFGMARM 314
K + + IA+G+ YL R++HRDL A N+L+ + KI+DFG+A++
Sbjct: 104 HKDNIGSQYLLNWCVQIAKGMNYLED---RRLVHRDLAARNVLVKTPQHVKITDFGLAKL 160
Query: 315 FGGDELQSNTKRIVGTYGYMSPEYALRGLFSIKSDVFSFGVLLLETLSSKKNTHFYNTDS 374
G +E + + + +M+ E L +++ +SDV+S+GV + E ++ Y+
Sbjct: 161 LGAEEKEYHAEGGKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGS--KPYDGIP 218
Query: 375 LTLLGHAWNLWNDGRTWELMDPISQNGASYPILKRYINVALLCVQEKAADRPAMSEVVSM 434
+ + ++ G + + + C A RP E++
Sbjct: 219 ASEI---SSILEKGERLPQPPICT---------IDVYMIMVKCWMIDADSRPKFRELIIE 266
Query: 435 LS--------------NEFVNLPAPQQPAFS 451
S +E ++LP+P F
Sbjct: 267 FSKMARDPQRYLVIQGDERMHLPSPTDSNFY 297
|
| >d1sm2a_ d.144.1.7 (A:) Tyrosine-protein kinase Itk/Tsk {Human (Homo sapiens) [TaxId: 9606]} Length = 263 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tyrosine-protein kinase Itk/Tsk species: Human (Homo sapiens) [TaxId: 9606]
Score = 126 bits (317), Expect = 7e-34
Identities = 48/176 (27%), Positives = 79/176 (44%), Gaps = 18/176 (10%)
Query: 261 WGTRVRIIEGIAQGLLYLHQYSRLRVIHRDLKASNILLDKDMNPKISDFGMARMFGGDEL 320
T + + + +G+ YL + VIHRDL A N L+ ++ K+SDFGM R D+
Sbjct: 100 AETLLGMCLDVCEGMAYLEE---ACVIHRDLAARNCLVGENQVIKVSDFGMTRFVLDDQY 156
Query: 321 QSNTKRIVGTYGYMSPEYALRGLFSIKSDVFSFGVLLLETLSSKKNTHFYNTDSLTLLGH 380
+++ + SPE +S KSDV+SFGVL+ E S K + ++S
Sbjct: 157 -TSSTGTKFPVKWASPEVFSFSRYSSKSDVWSFGVLMWEVFSEGKIPYENRSNS------ 209
Query: 381 AWNLWNDGRTWELMDPISQNGASYPILKRYINVALLCVQEKAADRPAMSEVVSMLS 436
+ + + L P + + C +E+ DRPA S ++ L+
Sbjct: 210 -EVVEDISTGFRLYKPRLAS-------THVYQIMNHCWKERPEDRPAFSRLLRQLA 257
|
| >d1s9ja_ d.144.1.7 (A:) Dual specificity mitogen-activated protein kinase kinase 1, Mek1 {Human (Homo sapiens) [TaxId: 9606]} Length = 322 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Dual specificity mitogen-activated protein kinase kinase 1, Mek1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 127 bits (319), Expect = 1e-33
Identities = 45/188 (23%), Positives = 81/188 (43%), Gaps = 7/188 (3%)
Query: 255 KKGLLCWGTRVRIIEGIAQGLLYLHQYSRLRVIHRDLKASNILLDKDMNPKISDFGMARM 314
K G + ++ + +GL YL + +++HRD+K SNIL++ K+ DFG++
Sbjct: 97 KAGRIPEQILGKVSIAVIKGLTYLR--EKHKIMHRDVKPSNILVNSRGEIKLCDFGVSGQ 154
Query: 315 FGGDELQSNTKRIVGTYGYMSPEYALRGLFSIKSDVFSFGVLLLETLSSKKNTHFYNTDS 374
S VGT YMSPE +S++SD++S G+ L+E + +
Sbjct: 155 LI----DSMANSFVGTRSYMSPERLQGTHYSVQSDIWSMGLSLVEMAVGRYPIPPPDAKE 210
Query: 375 LTLLGHAWNLWNDGRTWELMDPISQNGASYPILKRYINVALLCVQEKAADRPAMSEVVSM 434
L L+ + T + +SY + R +A+ + + + P +
Sbjct: 211 LELMFGCQVEGDAAETPPRPRTPGRPLSSYGMDSRP-PMAIFELLDYIVNEPPPKLPSGV 269
Query: 435 LSNEFVNL 442
S EF +
Sbjct: 270 FSLEFQDF 277
|
| >d1xbba_ d.144.1.7 (A:) Tyrosine-protein kinase SYK {Human (Homo sapiens) [TaxId: 9606]} Length = 277 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tyrosine-protein kinase SYK species: Human (Homo sapiens) [TaxId: 9606]
Score = 125 bits (314), Expect = 2e-33
Identities = 41/189 (21%), Positives = 71/189 (37%), Gaps = 18/189 (9%)
Query: 255 KKGLLCWGTRVRIIEGIAQGLLYLHQYSRLRVIHRDLKASNILLDKDMNPKISDFGMARM 314
+ + + ++ ++ G+ YL + +HRDL A N+LL KISDFG+++
Sbjct: 100 QNRHVKDKNIIELVHQVSMGMKYLEE---SNFVHRDLAARNVLLVTQHYAKISDFGLSKA 156
Query: 315 FGGD-ELQSNTKRIVGTYGYMSPEYALRGLFSIKSDVFSFGVLLLETLSSKKNTHFYNTD 373
D + +PE FS KSDV+SFGVL+ E S + +
Sbjct: 157 LRADENYYKAQTHGKWPVKWYAPECINYYKFSSKSDVWSFGVLMWEAFSYGQ-KPYRGMK 215
Query: 374 SLTLLGHAWNLWNDGRTWELMDPISQNGASYPILKRYINVALLCVQEKAADRPAMSEVVS 433
+ + G + ++ LC +RP + V
Sbjct: 216 GSEVT----AMLEKGERMGCPAGCP---------REMYDLMNLCWTYDVENRPGFAAVEL 262
Query: 434 MLSNEFVNL 442
L N + ++
Sbjct: 263 RLRNYYYDV 271
|
| >d1jpaa_ d.144.1.7 (A:) ephb2 receptor tyrosine kinase {Mouse (Mus musculus) [TaxId: 10090]} Length = 299 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: ephb2 receptor tyrosine kinase species: Mouse (Mus musculus) [TaxId: 10090]
Score = 125 bits (315), Expect = 2e-33
Identities = 47/212 (22%), Positives = 83/212 (39%), Gaps = 33/212 (15%)
Query: 237 VQSKDEISFWYESYNNPT-------KKGLLCWGTRVRIIEGIAQGLLYLHQYSRLRVIHR 289
V + E N + G V ++ GIA G+ YL +HR
Sbjct: 96 VTKSTPVMIITEFMENGSLDSFLRQNDGQFTVIQLVGMLRGIAAGMKYLADM---NYVHR 152
Query: 290 DLKASNILLDKDMNPKISDFGMARMFGGDELQSNTKRIVG---TYGYMSPEYALRGLFSI 346
DL A NIL++ ++ K+SDFG++R D +G + +PE F+
Sbjct: 153 DLAARNILVNSNLVCKVSDFGLSRFLEDDTSDPTYTSALGGKIPIRWTAPEAIQYRKFTS 212
Query: 347 KSDVFSFGVLLLETLSSKKNTHFYNTDSLTLLGHAWNLWNDGRTWELMDPISQNGASYP- 405
SDV+S+G+++ E ++ + + D ++++ I Q+ P
Sbjct: 213 ASDVWSYGIVMWE-----------------VMSYGERPYWDMTNQDVINAIEQDYRLPPP 255
Query: 406 --ILKRYINVALLCVQEKAADRPAMSEVVSML 435
+ L C Q+ RP ++V+ L
Sbjct: 256 MDCPSALHQLMLDCWQKDRNHRPKFGQIVNTL 287
|
| >d1nvra_ d.144.1.7 (A:) Cell cycle checkpoint kinase chk1 {Human (Homo sapiens) [TaxId: 9606]} Length = 271 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cell cycle checkpoint kinase chk1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 125 bits (314), Expect = 2e-33
Identities = 44/193 (22%), Positives = 80/193 (41%), Gaps = 20/193 (10%)
Query: 255 KKGLLCWGTRVRIIEGIAQGLLYLHQYSRLRVIHRDLKASNILLDKDMNPKISDFGMARM 314
+ R + G++YLH + + HRD+K N+LLD+ N KISDFG+A +
Sbjct: 96 PDIGMPEPDAQRFFHQLMAGVVYLHG---IGITHRDIKPENLLLDERDNLKISDFGLATV 152
Query: 315 FGGDELQSNTKRIVGTYGYMSPEYALRGLF-SIKSDVFSFGVLLLETLSSKKNTHFYNTD 373
F + + ++ GT Y++PE R F + DV+S G++L L+ + +D
Sbjct: 153 FRYNNRERLLNKMCGTLPYVAPELLKRREFHAEPVDVWSCGIVLTAMLAGELP-WDQPSD 211
Query: 374 SLTLLGHAWNLWNDGRTWELMDPISQNGASYPILKRYINVALLCVQEKAADRPAMSEVVS 433
S W+ +D +L + + E + R + ++
Sbjct: 212 SCQEYSDWKEKKTYLNPWKKIDSAPLA-----LLHK-------ILVENPSARITIPDI-- 257
Query: 434 MLSNEFVNLPAPQ 446
+ + N P +
Sbjct: 258 -KKDRWYNKPLKK 269
|
| >d1opja_ d.144.1.7 (A:) Abelsone tyrosine kinase (abl) {Mouse (Mus musculus) [TaxId: 10090]} Length = 287 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Abelsone tyrosine kinase (abl) species: Mouse (Mus musculus) [TaxId: 10090]
Score = 124 bits (313), Expect = 4e-33
Identities = 43/209 (20%), Positives = 81/209 (38%), Gaps = 26/209 (12%)
Query: 237 VQSKDEISFWYE--------SYNNPTKKGLLCWGTRVRIIEGIAQGLLYLHQYSRLRVIH 288
+ E Y + + + + I+ + YL + IH
Sbjct: 82 CTREPPFYIITEFMTYGNLLDYLRECNRQEVSAVVLLYMATQISSAMEYLE---KKNFIH 138
Query: 289 RDLKASNILLDKDMNPKISDFGMARMFGGDELQSNTKRIVGTYGYMSPEYALRGLFSIKS 348
RDL A N L+ ++ K++DFG++R+ GD ++ + +PE FSIKS
Sbjct: 139 RDLAARNCLVGENHLVKVADFGLSRLMTGDTYTAHA-GAKFPIKWTAPESLAYNKFSIKS 197
Query: 349 DVFSFGVLLLETLSSKKNTHFYNTDSLTLLGHAWNLWNDGRTWELMDPISQNGASYPILK 408
DV++FGVLL E + + + + + +EL++ + +
Sbjct: 198 DVWAFGVLLWEIATYGMSP--------------YPGIDLSQVYELLEKDYRMERPEGCPE 243
Query: 409 RYINVALLCVQEKAADRPAMSEVVSMLSN 437
+ + C Q +DRP+ +E+
Sbjct: 244 KVYELMRACWQWNPSDRPSFAEIHQAFET 272
|
| >d1byga_ d.144.1.7 (A:) Carboxyl-terminal src kinase (csk) {Human (Homo sapiens) [TaxId: 9606]} Length = 262 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Carboxyl-terminal src kinase (csk) species: Human (Homo sapiens) [TaxId: 9606]
Score = 122 bits (308), Expect = 1e-32
Identities = 44/183 (24%), Positives = 68/183 (37%), Gaps = 22/183 (12%)
Query: 255 KKGLLCWGTRVRIIEGIAQGLLYLHQYSRLRVIHRDLKASNILLDKDMNPKISDFGMARM 314
+ +L ++ + + + YL +HRDL A N+L+ +D K+SDFG+ +
Sbjct: 96 GRSVLGGDCLLKFSLDVCEAMEYLE---GNNFVHRDLAARNVLVSEDNVAKVSDFGLTK- 151
Query: 315 FGGDELQSNTKRIVGTYGYMSPEYALRGLFSIKSDVFSFGVLLLETLSSKKNTHFYNTDS 374
E S + +PE FS KSDV+SFG+LL E S + Y
Sbjct: 152 ----EASSTQDTGKLPVKWTAPEALREKKFSTKSDVWSFGILLWEIYSFGR--VPYPRIP 205
Query: 375 LTLLGHAWNLWNDGRTWELMDPISQNGASYPILKRYINVALLCVQEKAADRPAMSEVVSM 434
L G + D V C AA RP+ ++
Sbjct: 206 LK---DVVPRVEKGYKMDAPDGCP---------PAVYEVMKNCWHLDAAMRPSFLQLREQ 253
Query: 435 LSN 437
L +
Sbjct: 254 LEH 256
|
| >d1r0pa_ d.144.1.7 (A:) Hepatocyte growth factor receptor, c-MET {Human (Homo sapiens) [TaxId: 9606]} Length = 311 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Hepatocyte growth factor receptor, c-MET species: Human (Homo sapiens) [TaxId: 9606]
Score = 123 bits (310), Expect = 1e-32
Identities = 49/184 (26%), Positives = 75/184 (40%), Gaps = 19/184 (10%)
Query: 255 KKGLLCWGTRVRIIEGIAQGLLYLHQYSRLRVIHRDLKASNILLDKDMNPKISDFGMARM 314
+ + +A+G+ + + +HRDL A N +LD+ K++DFG+AR
Sbjct: 123 ETHNPTVKDLIGFGLQVAKGM---KFLASKKFVHRDLAARNCMLDEKFTVKVADFGLARD 179
Query: 315 FGGDELQSNTKR--IVGTYGYMSPEYALRGLFSIKSDVFSFGVLLLETLSSKKNTHFYNT 372
E S + +M+ E F+ KSDV+SFGVLL E ++ Y
Sbjct: 180 MYDKEFDSVHNKTGAKLPVKWMALESLQTQKFTTKSDVWSFGVLLWELMTRGA--PPYPD 237
Query: 373 DSLTLLGHAWNLWNDGRTWELMDPISQNGASYPILKRYINVALLCVQEKAADRPAMSEVV 432
+ + L R L+ P V L C KA RP+ SE+V
Sbjct: 238 VNTFDI--TVYLLQGRR---LLQPEY-------CPDPLYEVMLKCWHPKAEMRPSFSELV 285
Query: 433 SMLS 436
S +S
Sbjct: 286 SRIS 289
|
| >d1t46a_ d.144.1.7 (A:) c-KIT receptor {Human (Homo sapiens) [TaxId: 9606]} Length = 311 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: c-KIT receptor species: Human (Homo sapiens) [TaxId: 9606]
Score = 123 bits (310), Expect = 2e-32
Identities = 40/208 (19%), Positives = 71/208 (34%), Gaps = 16/208 (7%)
Query: 231 LYEQVLVQSKDEISFWYESYNNPTKKGLLCWGTRVRIIEGIAQGLLYLHQYSRLRVIHRD 290
L + + I + L + +A+G+ +L IHRD
Sbjct: 114 LLNFLRRKRDSFICSKTSPAIMEDDELALDLEDLLSFSYQVAKGMAFLAS---KNCIHRD 170
Query: 291 LKASNILLDKDMNPKISDFGMARMFGGDELQSNTKRIVGTYGYMSPEYALRGLFSIKSDV 350
L A NILL KI DFG+AR D +M+PE +++ +SDV
Sbjct: 171 LAARNILLTHGRITKICDFGLARDIKNDSNYVVKGNARLPVKWMAPESIFNCVYTFESDV 230
Query: 351 FSFGVLLLETLSSKKNTHFYNTDSLTLLGHAWNLWNDGRTWELMDPISQNGASYPILKRY 410
+S+G+ L E S + + + + +G +
Sbjct: 231 WSYGIFLWELFSLGSSPYPGMPVDSKF----YKMIKEGFRMLSPEHAP---------AEM 277
Query: 411 INVALLCVQEKAADRPAMSEVVSMLSNE 438
++ C RP ++V ++ +
Sbjct: 278 YDIMKTCWDADPLKRPTFKQIVQLIEKQ 305
|
| >d1k2pa_ d.144.1.7 (A:) Bruton's tyrosine kinase (Btk) {Human (Homo sapiens) [TaxId: 9606]} Length = 258 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Bruton's tyrosine kinase (Btk) species: Human (Homo sapiens) [TaxId: 9606]
Score = 122 bits (306), Expect = 2e-32
Identities = 44/208 (21%), Positives = 80/208 (38%), Gaps = 25/208 (12%)
Query: 237 VQSKDEISFWYESYNN-------PTKKGLLCWGTRVRIIEGIAQGLLYLHQYSRLRVIHR 289
+ I E N + + + + + + + YL + +HR
Sbjct: 68 CTKQRPIFIITEYMANGCLLNYLREMRHRFQTQQLLEMCKDVCEAMEYLES---KQFLHR 124
Query: 290 DLKASNILLDKDMNPKISDFGMARMFGGDELQSNTKRIVGTYGYMSPEYALRGLFSIKSD 349
DL A N L++ K+SDFG++R DE S+ + PE + FS KSD
Sbjct: 125 DLAARNCLVNDQGVVKVSDFGLSRYVLDDEYTSSV-GSKFPVRWSPPEVLMYSKFSSKSD 183
Query: 350 VFSFGVLLLETLSSKKNTHFYNTDSLTLLGHAWNLWNDGRTWELMDPISQNGASYPILKR 409
+++FGVL+ E S K + + + T E + + + ++
Sbjct: 184 IWAFGVLMWEIYSLGK--------------MPYERFTNSETAEHIAQGLRLYRPHLASEK 229
Query: 410 YINVALLCVQEKAADRPAMSEVVSMLSN 437
+ C EKA +RP ++S + +
Sbjct: 230 VYTIMYSCWHEKADERPTFKILLSNILD 257
|
| >d1t4ha_ d.144.1.7 (A:) Protein kinase wnk1 {Human (Homo sapiens) [TaxId: 9606]} Length = 270 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Protein kinase wnk1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 121 bits (304), Expect = 5e-32
Identities = 36/180 (20%), Positives = 75/180 (41%), Gaps = 20/180 (11%)
Query: 255 KKGLLCWGTRVRIIEGIAQGLLYLHQYSRLRVIHRDLKASNILL-DKDMNPKISDFGMAR 313
+ ++ I +GL +LH + +IHRDLK NI + + KI D G+A
Sbjct: 105 RFKVMKIKVLRSWCRQILKGLQFLHTRTP-PIIHRDLKCDNIFITGPTGSVKIGDLGLAT 163
Query: 314 MFGGDELQSNTKRIVGTYGYMSPEYALRGLFSIKSDVFSFGVLLLETLSSKKNTHFYNTD 373
+ S K ++GT +M+PE + DV++FG+ +LE +S+ +
Sbjct: 164 LKRA----SFAKAVIGTPEFMAPEM-YEEKYDESVDVYAFGMCMLEMATSEYP--YSECQ 216
Query: 374 SLTLLGHAWNLWNDGRTWELMDPISQNGASYPILKRYINVALLCVQEKAADRPAMSEVVS 433
+ + + G D + + + C+++ +R ++ ++++
Sbjct: 217 NAAQI---YRRVTSGVKPASFDKV--------AIPEVKEIIEGCIRQNKDERYSIKDLLN 265
|
| >d1u46a_ d.144.1.7 (A:) Activated CDC42 kinase 1, ACK1 {Human (Homo sapiens) [TaxId: 9606]} Length = 273 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Activated CDC42 kinase 1, ACK1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 120 bits (301), Expect = 1e-31
Identities = 47/182 (25%), Positives = 69/182 (37%), Gaps = 17/182 (9%)
Query: 255 KKGLLCWGTRVRIIEGIAQGLLYLHQYSRLRVIHRDLKASNILLDKDMNPKISDFGMARM 314
+G GT R +A+G+ YL R IHRDL A N+LL KI DFG+ R
Sbjct: 104 HQGHFLLGTLSRYAVQVAEGMGYLES---KRFIHRDLAARNLLLATRDLVKIGDFGLMRA 160
Query: 315 FG-GDELQSNTKRIVGTYGYMSPEYALRGLFSIKSDVFSFGVLLLETLSSKKNTHFYNTD 373
D+ + + + +PE FS SD + FGV L E + + + +
Sbjct: 161 LPQNDDHYVMQEHRKVPFAWCAPESLKTRTFSHASDTWMFGVTLWEMFTYGQ-EPWIGLN 219
Query: 374 SLTLLGHAWNLWNDGRTWELMDPISQNGASYPILKRYINVALLCVQEKAADRPAMSEVVS 433
+L + +G + Q NV + C K DRP +
Sbjct: 220 GSQIL---HKIDKEGERLPRPEDCPQ---------DIYNVMVQCWAHKPEDRPTFVALRD 267
Query: 434 ML 435
L
Sbjct: 268 FL 269
|
| >d1fvra_ d.144.1.7 (A:) Tie2 kinase {Human (Homo sapiens) [TaxId: 9606]} Length = 309 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tie2 kinase species: Human (Homo sapiens) [TaxId: 9606]
Score = 119 bits (300), Expect = 4e-31
Identities = 46/209 (22%), Positives = 87/209 (41%), Gaps = 26/209 (12%)
Query: 254 TKKGLLCWGTRVRIIEGIAQGLLYLHQYSRLRVIHRDLKASNILLDKDMNPKISDFGMAR 313
+ L + +A+G+ YL Q + IHRDL A NIL+ ++ KI+DFG++R
Sbjct: 119 STASTLSSQQLLHFAADVARGMDYLSQ---KQFIHRDLAARNILVGENYVAKIADFGLSR 175
Query: 314 MFGGDELQSNTKRIVGTYGYMSPEYALRGLFSIKSDVFSFGVLLLETLSSKKNTHFYNTD 373
E+ +M+ E +++ SDV+S+GVLL E +S T +
Sbjct: 176 GQ---EVYVKKTMGRLPVRWMAIESLNYSVYTTNSDVWSYGVLLWEIVSLGG-TPYCGMT 231
Query: 374 SLTLLGHAWNLWNDGRTWELMDPISQNGASYPILKRYINVALLCVQEKAADRPAMSEVVS 433
L + G E ++ C +EK +RP+ ++++
Sbjct: 232 CAEL----YEKLPQGYRLEKPLNCDD---------EVYDLMRQCWREKPYERPSFAQILV 278
Query: 434 MLS------NEFVNLPAPQQPAFSCVNST 456
L+ +VN ++ ++ ++ +
Sbjct: 279 SLNRMLEERKTYVNTTLYEKFTYAGIDCS 307
|
| >d2j4za1 d.144.1.7 (A:126-388) Aurora-related kinase 1 (aurora-2) {Human (Homo sapiens) [TaxId: 9606]} Length = 263 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Aurora-related kinase 1 (aurora-2) species: Human (Homo sapiens) [TaxId: 9606]
Score = 117 bits (294), Expect = 1e-30
Identities = 43/181 (23%), Positives = 66/181 (36%), Gaps = 27/181 (14%)
Query: 255 KKGLLCWGTRVRIIEGIAQGLLYLHQYSRLRVIHRDLKASNILLDKDMNPKISDFGMARM 314
K I +A L Y H RVIHRD+K N+LL KI+DFG +
Sbjct: 99 KLSKFDEQRTATYITELANALSYCHS---KRVIHRDIKPENLLLGSAGELKIADFGWSVH 155
Query: 315 FGGDELQSNTKRIVGTYGYMSPEYALRGLFSIKSDVFSFGVLLLETLSSKKNTHFYNTDS 374
+ GT Y+ PE + K D++S GVL E L K
Sbjct: 156 APSSR----RTTLCGTLDYLPPEMIEGRMHDEKVDLWSLGVLCYEFLVGK---------- 201
Query: 375 LTLLGHAWNLWNDGRTWELMDPISQNGASYP--ILKRYINVALLCVQEKAADRPAMSEVV 432
+ E IS+ ++P + + ++ ++ + RP + EV+
Sbjct: 202 --------PPFEANTYQETYKRISRVEFTFPDFVTEGARDLISRLLKHNPSQRPMLREVL 253
Query: 433 S 433
Sbjct: 254 E 254
|
| >d2java1 d.144.1.7 (A:3-271) Serine/threonine-protein kinase Nek2 {Human (Homo sapiens) [TaxId: 9606]} Length = 269 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Serine/threonine-protein kinase Nek2 species: Human (Homo sapiens) [TaxId: 9606]
Score = 117 bits (294), Expect = 1e-30
Identities = 53/188 (28%), Positives = 78/188 (41%), Gaps = 27/188 (14%)
Query: 251 NNPTKKGLLCWGTRVRIIEGIAQGLLYLHQYSR--LRVIHRDLKASNILLDKDMNPKISD 308
++ L +R++ + L H+ S V+HRDLK +N+ LD N K+ D
Sbjct: 98 KGTKERQYLDEEFVLRVMTQLTLALKECHRRSDGGHTVLHRDLKPANVFLDGKQNVKLGD 157
Query: 309 FGMARMFGGDELQSNTKRIVGTYGYMSPEYALRGLFSIKSDVFSFGVLLLETLSSKKNTH 368
FG+AR+ D S K VGT YMSPE R ++ KSD++S G LL E
Sbjct: 158 FGLARILNHDT--SFAKAFVGTPYYMSPEQMNRMSYNEKSDIWSLGCLLYE--------- 206
Query: 369 FYNTDSLTLLGHAWNLWNDGRTWELMDPISQNGASYPILKRY----INVALLCVQEKAAD 424
L + EL I + G I RY + + K
Sbjct: 207 ---------LCALMPPFTAFSQKELAGKI-REGKFRRIPYRYSDELNEIITRMLNLKDYH 256
Query: 425 RPAMSEVV 432
RP++ E++
Sbjct: 257 RPSVEEIL 264
|
| >d1fgka_ d.144.1.7 (A:) Fibroblast growth factor receptor 1 {Human (Homo sapiens) [TaxId: 9606]} Length = 299 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Fibroblast growth factor receptor 1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 116 bits (292), Expect = 3e-30
Identities = 47/202 (23%), Positives = 79/202 (39%), Gaps = 17/202 (8%)
Query: 236 LVQSKDEISFWYESYNNPTKKGLLCWGTRVRIIEGIAQGLLYLHQYSRLRVIHRDLKASN 295
+Q++ Y + + L V +A+G+ YL + IHRDL A N
Sbjct: 109 YLQARRPPGLEYSYNPSHNPEEQLSSKDLVSCAYQVARGMEYLAS---KKCIHRDLAARN 165
Query: 296 ILLDKDMNPKISDFGMARMFGGDELQSNTKRIVGTYGYMSPEYALRGLFSIKSDVFSFGV 355
+L+ +D KI+DFG+AR + T +M+PE +++ +SDV+SFGV
Sbjct: 166 VLVTEDNVMKIADFGLARDIHHIDYYKKTTNGRLPVKWMAPEALFDRIYTHQSDVWSFGV 225
Query: 356 LLLETLSSKKNTHFYNTDSLTLLGHAWNLWNDGRTWELMDPISQNGASYPILKRYINVAL 415
LL E + Y + L + L +G + + +
Sbjct: 226 LLWEIFTLGG--SPYPGVPVEEL---FKLLKEGHRMDKPSNCT---------NELYMMMR 271
Query: 416 LCVQEKAADRPAMSEVVSMLSN 437
C + RP ++V L
Sbjct: 272 DCWHAVPSQRPTFKQLVEDLDR 293
|
| >d1p4oa_ d.144.1.7 (A:) Insulin-like growth factor 1 receptor {Human (Homo sapiens) [TaxId: 9606]} Length = 308 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Insulin-like growth factor 1 receptor species: Human (Homo sapiens) [TaxId: 9606]
Score = 116 bits (292), Expect = 5e-30
Identities = 47/212 (22%), Positives = 83/212 (39%), Gaps = 19/212 (8%)
Query: 240 KDEISFWYESYNNPTKKGLLCWGTRVRIIEGIAQGLLYLHQYSRLRVIHRDLKASNILLD 299
K + + N +++ IA G+ YL+ + +HRDL A N ++
Sbjct: 111 KSYLRSLRPAMANNPVLAPPSLSKMIQMAGEIADGMAYLNAN---KFVHRDLAARNCMVA 167
Query: 300 KDMNPKISDFGMARMFGGDELQSNTKRIVGTYGYMSPEYALRGLFSIKSDVFSFGVLLLE 359
+D KI DFGM R + + + +MSPE G+F+ SDV+SFGV+L E
Sbjct: 168 EDFTVKIGDFGMTRDIYETDYYRKGGKGLLPVRWMSPESLKDGVFTTYSDVWSFGVVLWE 227
Query: 360 TLSSKKNTHFYNTDSLTLLGHAWNLWNDGRTWELMDPISQNGASYPILKRYINVALLCVQ 419
+ + + ++ +G + D + +C Q
Sbjct: 228 IATLAEQPYQGLSNE-----QVLRFVMEGGLLDKPDNCPD---------MLFELMRMCWQ 273
Query: 420 EKAADRPAMSEVVSMLSNEFVNLPAPQQPAFS 451
RP+ E++S + E P ++ +F
Sbjct: 274 YNPKMRPSFLEIISSIKEEM--EPGFREVSFY 303
|
| >d1u5ra_ d.144.1.7 (A:) Serine/threonine protein kinase TAO2 {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 309 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Serine/threonine protein kinase TAO2 species: Rat (Rattus norvegicus) [TaxId: 10116]
Score = 116 bits (292), Expect = 5e-30
Identities = 52/196 (26%), Positives = 80/196 (40%), Gaps = 29/196 (14%)
Query: 255 KKGLLCWGTRVRIIEGIAQGLLYLHQYSRLRVIHRDLKASNILLDKDMNPKISDFGMARM 314
K L + G QGL YLH +IHRD+KA NILL + K+ DFG A +
Sbjct: 108 HKKPLQEVEIAAVTHGALQGLAYLHS---HNMIHRDVKAGNILLSEPGLVKLGDFGSASI 164
Query: 315 FGGDELQSNTKRIVGTYGYMSPEYAL---RGLFSIKSDVFSFGVLLLETLSSKKNTHFYN 371
+ VGT +M+PE L G + K DV+S G+ +E K +N
Sbjct: 165 M------APANSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERK--PPLFN 216
Query: 372 TDSLTLLGHAWNLWNDGRTWELMDPISQNGASYPILKRYINVALLCVQEKAADRPAMSEV 431
++++ L +++ + S+ + N C+Q+ DRP +
Sbjct: 217 MNAMSAL---YHIAQNESPALQSGHWSEY---------FRNFVDSCLQKIPQDRPTSEVL 264
Query: 432 VSMLSNEFVNLPAPQQ 447
L + FV P
Sbjct: 265 ---LKHRFVLRERPPT 277
|
| >d2jfla1 d.144.1.7 (A:21-308) STE20-like serine/threonine-protein kinase, SLK {Human (Homo sapiens) [TaxId: 9606]} Length = 288 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: STE20-like serine/threonine-protein kinase, SLK species: Human (Homo sapiens) [TaxId: 9606]
Score = 112 bits (281), Expect = 1e-28
Identities = 44/192 (22%), Positives = 80/192 (41%), Gaps = 26/192 (13%)
Query: 255 KKGLLCWGTRVRIIEGIAQGLLYLHQYSRLRVIHRDLKASNILLDKDMNPKISDFGMARM 314
+ L + + L YLH ++IHRDLKA NIL D + K++DFG++
Sbjct: 103 LERPLTESQIQVVCKQTLDALNYLHD---NKIIHRDLKAGNILFTLDGDIKLADFGVSAK 159
Query: 315 FGGDELQSNTKRIVGTYGYMSPEYAL-----RGLFSIKSDVFSFGVLLLETLSSKKNTHF 369
+ ++ +GT +M+PE + + K+DV+S G+ L+E +
Sbjct: 160 NTRTIQRRDS--FIGTPYWMAPEVVMCETSKDRPYDYKADVWSLGITLIEMAEIE--PPH 215
Query: 370 YNTDSLTLLGHAWNLWNDGRTWELMDPISQNGASYPILKRYINVALLCVQEKAADRPAMS 429
+ + + +L ++ T S N LK+ C+++ R S
Sbjct: 216 HELNPMRVLLKIAK--SEPPTLAQPSRWSSNFKD--FLKK-------CLEKNVDARWTTS 264
Query: 430 EVVSMLSNEFVN 441
++ L + FV
Sbjct: 265 QL---LQHPFVT 273
|
| >d1mp8a_ d.144.1.7 (A:) Focal adhesion kinase 1 (fak) {Human (Homo sapiens) [TaxId: 9606]} Length = 273 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Focal adhesion kinase 1 (fak) species: Human (Homo sapiens) [TaxId: 9606]
Score = 111 bits (278), Expect = 2e-28
Identities = 36/183 (19%), Positives = 66/183 (36%), Gaps = 18/183 (9%)
Query: 255 KKGLLCWGTRVRIIEGIAQGLLYLHQYSRLRVIHRDLKASNILLDKDMNPKISDFGMARM 314
+K L + + ++ L YL R +HRD+ A N+L+ + K+ DFG++R
Sbjct: 101 RKYSLDLASLILYAYQLSTALAYLE---SKRFVHRDIAARNVLVSSNDCVKLGDFGLSRY 157
Query: 315 FGGDELQSNTKRIVGTYGYMSPEYALRGLFSIKSDVFSFGVLLLETLSSKKNTHFYNTDS 374
+ + +M+PE F+ SDV+ FGV + E L ++
Sbjct: 158 MEDSTYYKAS-KGKLPIKWMAPESINFRRFTSASDVWMFGVCMWEILMHGVKPFQGVKNN 216
Query: 375 LTLLGHAWNLWNDGRTWELMDPISQNGASYPILKRYINVALLCVQEKAADRPAMSEVVSM 434
+G + ++ C + RP +E+ +
Sbjct: 217 -----DVIGRIENGERLPMPPNCPP---------TLYSLMTKCWAYDPSRRPRFTELKAQ 262
Query: 435 LSN 437
LS
Sbjct: 263 LST 265
|
| >d1yhwa1 d.144.1.7 (A:249-541) pak1 {Human (Homo sapiens) [TaxId: 9606]} Length = 293 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: pak1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 110 bits (275), Expect = 8e-28
Identities = 53/213 (24%), Positives = 88/213 (41%), Gaps = 26/213 (12%)
Query: 238 QSKDEISFWYESYNNPTKKGLLC-----WGTRVRIIEGIAQGLLYLHQYSRLRVIHRDLK 292
DE+ E + ++ G + Q L +LH +VIHRD+K
Sbjct: 87 LVGDELWVVMEYLAGGSLTDVVTETCMDEGQIAAVCRECLQALEFLHS---NQVIHRDIK 143
Query: 293 ASNILLDKDMNPKISDFGMARMFGGDELQSNTKRIVGTYGYMSPEYALRGLFSIKSDVFS 352
+ NILL D + K++DFG + QS +VGT +M+PE R + K D++S
Sbjct: 144 SDNILLGMDGSVKLTDFGFCAQITPE--QSKRSTMVGTPYWMAPEVVTRKAYGPKVDIWS 201
Query: 353 FGVLLLETLSSKKNTHFYNTDSLTLLGHAWNLWNDGRTWELMDPISQNGASYPILKRYIN 412
G++ +E + + + N + L L L T EL +P + L R
Sbjct: 202 LGIMAIEMIEGE--PPYLNENPLRAL----YLIATNGTPELQNPEKLSAIFRDFLNR--- 252
Query: 413 VALLCVQEKAADRPAMSEVVSMLSNEFVNLPAP 445
C+ R + E+ L ++F+ + P
Sbjct: 253 ----CLDMDVEKRGSAKEL---LQHQFLKIAKP 278
|
| >d1ckia_ d.144.1.7 (A:) Casein kinase-1, CK1 {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 299 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Casein kinase-1, CK1 species: Rat (Rattus norvegicus) [TaxId: 10116]
Score = 98.8 bits (245), Expect = 9e-24
Identities = 37/196 (18%), Positives = 62/196 (31%), Gaps = 19/196 (9%)
Query: 255 KKGLLCWGTRVRIIEGIAQGLLYLHQYSRLRVIHRDLKASNIL---LDKDMNPKISDFGM 311
T + + + + + Y+H IHRD+K N L K I DFG+
Sbjct: 96 CSRKFSLKTVLLLADQMISRIEYIH---SKNFIHRDVKPDNFLMGLGKKGNLVYIIDFGL 152
Query: 312 ARMFGGDELQSN-----TKRIVGTYGYMSPEYALRGLFSIKSDVFSFGVLLLETLSSKKN 366
A+ + + K + GT Y S L S + D+ S G +L+
Sbjct: 153 AKKYRDARTHQHIPYRENKNLTGTARYASINTHLGIEQSRRDDLESLGYVLMYFNLGSLP 212
Query: 367 THFYNTDSLTLLGHAWNLWNDGRTWELMDPISQNGASYPILKRYINVALLCVQEKAADRP 426
+ + ++ PI YP + C + D+P
Sbjct: 213 WQGLKAATK------RQKYERISEKKMSTPIEVLCKGYP--SEFATYLNFCRSLRFDDKP 264
Query: 427 AMSEVVSMLSNEFVNL 442
S + + N F
Sbjct: 265 DYSYLRQLFRNLFHRQ 280
|
| >d1uu3a_ d.144.1.7 (A:) 3-phosphoinositide dependent protein kinase-1 Pdk1 {Human (Homo sapiens) [TaxId: 9606]} Length = 288 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: 3-phosphoinositide dependent protein kinase-1 Pdk1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 97.0 bits (241), Expect = 3e-23
Identities = 36/168 (21%), Positives = 67/168 (39%), Gaps = 20/168 (11%)
Query: 266 RIIEGIAQGLLYLHQYSRLRVIHRDLKASNILLDKDMNPKISDFGMARMFGGDELQSNTK 325
A+ + L +IHRDLK NILL++DM+ +I+DFG A++ + Q+
Sbjct: 109 CTRFYTAEIVSALEYLHGKGIIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARAN 168
Query: 326 RIVGTYGYMSPEYALRGLFSIKSDVFSFGVLLLETLSSKKNTHFYNTDSLTLLGHAWNLW 385
VGT Y+SPE SD+++ G ++ + ++ +
Sbjct: 169 SFVGTAQYVSPELLTEKSACKSSDLWALGCIIYQLVAGL------------------PPF 210
Query: 386 NDGRTWELMDPISQNGASYP--ILKRYINVALLCVQEKAADRPAMSEV 431
G + + I + +P + ++ + A R E+
Sbjct: 211 RAGNEYLIFQKIIKLEYDFPEKFFPKARDLVEKLLVLDATKRLGCEEM 258
|
| >d1csna_ d.144.1.7 (A:) Casein kinase-1, CK1 {Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]} Length = 293 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Casein kinase-1, CK1 species: Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]
Score = 97.2 bits (241), Expect = 3e-23
Identities = 27/198 (13%), Positives = 58/198 (29%), Gaps = 21/198 (10%)
Query: 255 KKGLLCWGTRVRIIEGIAQGLLYLHQYSRLRVIHRDLKASNILLDKDMNP-----KISDF 309
T + + + +H+ +++RD+K N L+ + + + DF
Sbjct: 94 CGRKFSVKTVAMAAKQMLARVQSIHE---KSLVYRDIKPDNFLIGRPNSKNANMIYVVDF 150
Query: 310 GMARMFGGDELQSN-----TKRIVGTYGYMSPEYALRGLFSIKSDVFSFGVLLLETLSSK 364
GM + + + + K + GT YMS L S + D+ + G + + L
Sbjct: 151 GMVKFYRDPVTKQHIPYREKKNLSGTARYMSINTHLGREQSRRDDLEALGHVFMYFLRGS 210
Query: 365 KNTHFYNTDSLTLLGHAWNLWNDGRTWELMDPISQNGASYPILKRYINVALLCVQEKAAD 424
+ + G + +Y++
Sbjct: 211 LPWQGLKAAT-----NKQKYERIGEKKQSTPLRELCAGFPEEFYKYMH---YARNLAFDA 262
Query: 425 RPAMSEVVSMLSNEFVNL 442
P + + S L
Sbjct: 263 TPDYDYLQGLFSKVLERL 280
|
| >d1blxa_ d.144.1.7 (A:) Cyclin-dependent PK, CDK6 {Human (Homo sapiens) [TaxId: 9606]} Length = 305 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK6 species: Human (Homo sapiens) [TaxId: 9606]
Score = 95.7 bits (237), Expect = 1e-22
Identities = 41/199 (20%), Positives = 78/199 (39%), Gaps = 21/199 (10%)
Query: 246 WYESYNNPTKKGLLCWGTRVRIIEGIAQGLLYLHQYSRLRVIHRDLKASNILLDKDMNPK 305
+Y + + + T ++ + +GL +LH RV+HRDLK NIL+ K
Sbjct: 100 DLTTYLDKVPEPGVPTETIKDMMFQLLRGLDFLHS---HRVVHRDLKPQNILVTSSGQIK 156
Query: 306 ISDFGMARMFGGDELQSNTKRIVGTYGYMSPEYALRGLFSIKSDVFSFGVLLLETLSSKK 365
++DFG+AR++ Q +V T Y +PE L+ ++ D++S G + E K
Sbjct: 157 LADFGLARIY---SFQMALTSVVVTLWYRAPEVLLQSSYATPVDLWSVGCIFAEMFRRK- 212
Query: 366 NTHFYNTDSLTLLGHAWNLWNDGRTWELMDPISQNGASYPILKRY-------------IN 412
F + + LG ++ + ++ ++ +
Sbjct: 213 -PLFRGSSDVDQLGKILDVIGLPGEEDWPRDVALPRQAFHSKSAQPIEKFVTDIDELGKD 271
Query: 413 VALLCVQEKAADRPAMSEV 431
+ L C+ A R +
Sbjct: 272 LLLKCLTFNPAKRISAYSA 290
|
| >d1phka_ d.144.1.7 (A:) gamma-subunit of glycogen phosphorylase kinase (Phk) {Rabbit (Oryctolagus cuniculus) [TaxId: 9986]} Length = 277 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: gamma-subunit of glycogen phosphorylase kinase (Phk) species: Rabbit (Oryctolagus cuniculus) [TaxId: 9986]
Score = 94.4 bits (234), Expect = 2e-22
Identities = 39/183 (21%), Positives = 74/183 (40%), Gaps = 24/183 (13%)
Query: 255 KKGLLCWGTRVRIIEGIAQGLLYLHQYSRLRVIHRDLKASNILLDKDMNPKISDFGMARM 314
+K L +I+ + + + LH +L ++HRDLK NILLD DMN K++DFG +
Sbjct: 103 EKVTLSEKETRKIMRALLEVICALH---KLNIVHRDLKPENILLDDDMNIKLTDFGFSCQ 159
Query: 315 FGGDELQSNTKRIVGTYGYMSPEYAL------RGLFSIKSDVFSFGVLLLETLSSKKNTH 368
E + + GT Y++PE + + D++S GV++ L+
Sbjct: 160 LDPGE---KLREVCGTPSYLAPEIIECSMNDNHPGYGKEVDMWSTGVIMYTLLAGS--PP 214
Query: 369 FYNTDSLTLLGHAWNLWNDGRTWELMDPISQNGASYPILKRYINVALLCVQEKAADRPAM 428
F++ + +L + ++ P + ++ + + R
Sbjct: 215 FWHRKQMLMLRMIMS-----GNYQFGSPEWDD-----YSDTVKDLVSRFLVVQPQKRYTA 264
Query: 429 SEV 431
E
Sbjct: 265 EEA 267
|
| >d1fota_ d.144.1.7 (A:) cAMP-dependent PK, catalytic subunit {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]} Length = 316 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: cAMP-dependent PK, catalytic subunit species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]
Score = 93.6 bits (232), Expect = 8e-22
Identities = 40/145 (27%), Positives = 64/145 (44%), Gaps = 10/145 (6%)
Query: 237 VQSKDEISFWYESYNNPTKKGLLCWGTRVRIIEG---IAQGLLYLHQYSRLRVIHRDLKA 293
Q +I + LL R A+ L L +I+RDLK
Sbjct: 73 FQDAQQIFMIMDYIEGGELFSLLRKSQRFPNPVAKFYAAEVCLALEYLHSKDIIYRDLKP 132
Query: 294 SNILLDKDMNPKISDFGMARMFGGDELQSNTKRIVGTYGYMSPEYALRGLFSIKSDVFSF 353
NILLDK+ + KI+DFG A+ + T + GT Y++PE ++ D +SF
Sbjct: 133 ENILLDKNGHIKITDFGFAK-----YVPDVTYTLCGTPDYIAPEVVSTKPYNKSIDWWSF 187
Query: 354 GVLLLETLSSKKNTHFYNTDSLTLL 378
G+L+ E L+ FY+++++
Sbjct: 188 GILIYEMLAGYT--PFYDSNTMKTY 210
|
| >d1kj1a_ b.78.1.1 (A:) Lectin (agglutinin) {Garlic (Allium sativum) [TaxId: 4682]} Length = 109 | Back information, alignment and structure |
|---|
class: All beta proteins fold: beta-Prism II superfamily: alpha-D-mannose-specific plant lectins family: alpha-D-mannose-specific plant lectins domain: Lectin (agglutinin) species: Garlic (Allium sativum) [TaxId: 4682]
Score = 87.3 bits (216), Expect = 1e-21
Identities = 23/118 (19%), Positives = 46/118 (38%), Gaps = 13/118 (11%)
Query: 35 IRDGEKLVSSSQRFELGFFSPRNSKNRYLGVWYKKIPDTVVWVANRNSPIFNPNTALTFS 94
+ +GE L + Q ++ + ++ L ++ T VW +N
Sbjct: 4 LTNGEGL-YAGQSLDVEPYHFIMQEDCNLVLYD---HSTSVWASNTGILG-KKGCKAVLQ 58
Query: 95 NNGNLVLLSQRNGIIWSSNMSRKAENPIAQLLDTGNLVIRDNSSGHTTESYLWQSFDY 152
++GN V+ +W+S+ R N + L + GN+VI + +W + Y
Sbjct: 59 SDGNFVVYDAEGRSLWASHSVRGNGNYVLVLQEDGNVVIYGSD--------IWSTGTY 108
|
| >d1koaa2 d.144.1.7 (A:5915-6264) Twitchin, kinase domain {Caenorhabditis elegans, pjk4 [TaxId: 6239]} Length = 350 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Twitchin, kinase domain species: Caenorhabditis elegans, pjk4 [TaxId: 6239]
Score = 91.3 bits (226), Expect = 7e-21
Identities = 36/197 (18%), Positives = 72/197 (36%), Gaps = 24/197 (12%)
Query: 255 KKGLLCWGTRVRIIEGIAQGLLYLHQYSRLRVIHRDLKASNILLDKDMNP--KISDFGMA 312
+ + V + + +GL ++H +H DLK NI+ + K+ DFG+
Sbjct: 117 EHNKMSEDEAVEYMRQVCKGLCHMH---ENNYVHLDLKPENIMFTTKRSNELKLIDFGLT 173
Query: 313 RMFGGDELQSNTKRIVGTYGYMSPEYALRGLFSIKSDVFSFGVLLLETLSSKKNTHFYNT 372
+ + K GT + +PE A +D++S GVL LS + F
Sbjct: 174 AHLDPKQ---SVKVTTGTAEFAAPEVAEGKPVGYYTDMWSVGVLSYILLSGL--SPFGGE 228
Query: 373 DSLTLLGHAWNLWNDGRTWELMDPISQNGASYPILKRYINVALLCVQEKAADRPAMSEVV 432
+ L + + + IS++G +++ + R + +
Sbjct: 229 NDDETLRNVKS-CDWNMDDSAFSGISEDGKD--FIRK-------LLLADPNTRMTIHQA- 277
Query: 433 SMLSNEFVN-LPAPQQP 448
L + ++ AP +
Sbjct: 278 --LEHPWLTPGNAPGRD 292
|
| >d1omwa3 d.144.1.7 (A:186-549) G-protein coupled receptor kinase 2 {Cow (Bos taurus) [TaxId: 9913]} Length = 364 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: G-protein coupled receptor kinase 2 species: Cow (Bos taurus) [TaxId: 9913]
Score = 90.6 bits (224), Expect = 2e-20
Identities = 37/129 (28%), Positives = 59/129 (45%), Gaps = 8/129 (6%)
Query: 255 KKGLLCWGTRVRIIEGIAQGLLYLHQYSRLRVIHRDLKASNILLDKDMNPKISDFGMARM 314
+ G+ I GL ++H V++RDLK +NILLD+ + +ISD G+A
Sbjct: 100 QHGVFSEADMRFYAAEIILGLEHMHN---RFVVYRDLKPANILLDEHGHVRISDLGLACD 156
Query: 315 FGGDELQSNTKRIVGTYGYMSPEYALRGL-FSIKSDVFSFGVLLLETLSSKKNTHFYNTD 373
F + VGT+GYM+PE +G+ + +D FS G +L + L + T
Sbjct: 157 FS----KKKPHASVGTHGYMAPEVLQKGVAYDSSADWFSLGCMLFKLLRGHSPFRQHKTK 212
Query: 374 SLTLLGHAW 382
+
Sbjct: 213 DKHEIDRMT 221
|
| >d1xjda_ d.144.1.7 (A:) Protein kinase C, theta type {Human (Homo sapiens) [TaxId: 9606]} Length = 320 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Protein kinase C, theta type species: Human (Homo sapiens) [TaxId: 9606]
Score = 89.4 bits (221), Expect = 2e-20
Identities = 47/153 (30%), Positives = 68/153 (44%), Gaps = 13/153 (8%)
Query: 237 VQSKDEISFWYESYNNPT------KKGLLCWGTRVRIIEGIAQGLLYLHQYSRLRVIHRD 290
Q+K+ + F E N I GL +LH +++RD
Sbjct: 72 FQTKENLFFVMEYLNGGDLMYHIQSCHKFDLSRATFYAAEIILGLQFLHSK---GIVYRD 128
Query: 291 LKASNILLDKDMNPKISDFGMARMFGGDELQSNTKRIVGTYGYMSPEYALRGLFSIKSDV 350
LK NILLDKD + KI+DFGM + + ++NT GT Y++PE L ++ D
Sbjct: 129 LKLDNILLDKDGHIKIADFGMCKENMLGDAKTNT--FCGTPDYIAPEILLGQKYNHSVDW 186
Query: 351 FSFGVLLLETLSSKKNTHFYNTDSLTLLGHAWN 383
+SFGVLL E L + + F+ D L
Sbjct: 187 WSFGVLLYEMLIGQ--SPFHGQDEEELFHSIRM 217
|
| >d1xwsa_ d.144.1.7 (A:) Proto-oncogene serine/threonine-protein kinase Pim-1 {Human (Homo sapiens) [TaxId: 9606]} Length = 273 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Proto-oncogene serine/threonine-protein kinase Pim-1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 88.2 bits (218), Expect = 3e-20
Identities = 38/199 (19%), Positives = 73/199 (36%), Gaps = 35/199 (17%)
Query: 254 TKKGLLCWGTRVRIIEGIAQGLLYLHQYSRLRVIHRDLKASNILLDKD-MNPKISDFGMA 312
T++G L + + + + H V+HRD+K NIL+D + K+ DFG
Sbjct: 102 TERGALQEELARSFFWQVLEAVRHCHN---CGVLHRDIKDENILIDLNRGELKLIDFGSG 158
Query: 313 RMFGGDELQSNTKRIVGTYGYMSPEYAL-RGLFSIKSDVFSFGVLLLETLSSKKNTHFYN 371
+ + GT Y PE+ + V+S G+LL + + F +
Sbjct: 159 ALLK----DTVYTDFDGTRVYSPPEWIRYHRYHGRSAAVWSLGILLYDMVCGD--IPFEH 212
Query: 372 TDSLTLLGHAWNLWNDGRTWELMDPISQNGASYPILKRYINVALLCVQEKAADRPAMSEV 431
+ + + + E I C+ + +DRP E+
Sbjct: 213 DEEII---RGQVFFRQRVSSECQHLIRW-----------------CLALRPSDRPTFEEI 252
Query: 432 VSMLSNEFV-NLPAPQQPA 449
++ ++ ++ PQ+ A
Sbjct: 253 ---QNHPWMQDVLLPQETA 268
|
| >d1koba_ d.144.1.7 (A:) Twitchin, kinase domain {California sea hare (Aplysia californica), twk43 [TaxId: 6500]} Length = 352 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Twitchin, kinase domain species: California sea hare (Aplysia californica), twk43 [TaxId: 6500]
Score = 89.0 bits (220), Expect = 5e-20
Identities = 35/180 (19%), Positives = 66/180 (36%), Gaps = 20/180 (11%)
Query: 254 TKKGLLCWGTRVRIIEGIAQGLLYLHQYSRLRVIHRDLKASNILLDKDMNP--KISDFGM 311
+ + + + +GL ++H ++H D+K NI+ + KI DFG+
Sbjct: 119 AEDYKMSEAEVINYMRQACEGLKHMH---EHSIVHLDIKPENIMCETKKASSVKIIDFGL 175
Query: 312 ARMFGGDELQSNTKRIVGTYGYMSPEYALRGLFSIKSDVFSFGVLLLETLSSKKNTHFYN 371
A DE+ K T + +PE R +D+++ GVL LS + F
Sbjct: 176 ATKLNPDEI---VKVTTATAEFAAPEIVDREPVGFYTDMWAIGVLGYVLLSGL--SPFAG 230
Query: 372 TDSLTLLGHAWNLWNDGRTWELMDPISQNGASYPILKRYINVALLCVQEKAADRPAMSEV 431
D L L + + + +S +K +Q++ R + +
Sbjct: 231 EDDLETLQNVKR-CDWEFDEDAFSSVSPEAKD--FIKN-------LLQKEPRKRLTVHDA 280
|
| >d1pmea_ d.144.1.7 (A:) MAP kinase Erk2 {Human (Homo sapiens) [TaxId: 9606]} Length = 345 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase Erk2 species: Human (Homo sapiens) [TaxId: 9606]
Score = 88.4 bits (218), Expect = 6e-20
Identities = 53/183 (28%), Positives = 77/183 (42%), Gaps = 7/183 (3%)
Query: 255 KKGLLCWGTRVRIIEGIAQGLLYLHQYSRLRVIHRDLKASNILLDKDMNPKISDFGMARM 314
K L + I +GL Y+H V+HRDLK SN+LL+ + KI DFG+AR+
Sbjct: 102 KTQHLSNDHICYFLYQILRGLKYIHS---ANVLHRDLKPSNLLLNTTCDLKICDFGLARV 158
Query: 315 FGGDELQSNT-KRIVGTYGYMSPEYALRGLFSIKS-DVFSFGVLLLETLSSKKNTHFYNT 372
D + V T Y +PE L KS D++S G +L E LS++ F
Sbjct: 159 ADPDHDHTGFLTEYVATRWYRAPEIMLNSKGYTKSIDIWSVGCILAEMLSNR--PIFPGK 216
Query: 373 DSLTLLGHAWNLWNDGRTWELMDPISQNGASYPILKRYINVALLCVQEKAADRPAMSEVV 432
L L H + +L I+ +Y + + N AD A+ +
Sbjct: 217 HYLDQLNHILGILGSPSQEDLNCIINLKARNYLLSLPHKNKVPWNRLFPNADSKALDLLD 276
Query: 433 SML 435
ML
Sbjct: 277 KML 279
|
| >d1o6ya_ d.144.1.7 (A:) Mycobacterial protein kinase PknB, catalytic domain {Mycobacterium tuberculosis [TaxId: 1773]} Length = 277 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Mycobacterial protein kinase PknB, catalytic domain species: Mycobacterium tuberculosis [TaxId: 1773]
Score = 87.1 bits (215), Expect = 7e-20
Identities = 38/183 (20%), Positives = 75/183 (40%), Gaps = 17/183 (9%)
Query: 255 KKGLLCWGTRVRIIEGIAQGLLYLHQYSRLRVIHRDLKASNILLDKDMNPKISDFGMARM 314
+G + + +I Q L + H + +IHRD+K +NI++ K+ DFG+AR
Sbjct: 104 TEGPMTPKRAIEVIADACQALNFSH---QNGIIHRDVKPANIMISATNAVKVMDFGIARA 160
Query: 315 FG-GDELQSNTKRIVGTYGYMSPEYALRGLFSIKSDVFSFGVLLLETLSSKKNTHFYNTD 373
+ T ++GT Y+SPE A +SDV+S G +L E L+ + F
Sbjct: 161 IADSGNSVTQTAAVIGTAQYLSPEQARGDSVDARSDVYSLGCVLYEVLTGEPP--FTGDS 218
Query: 374 SLTLLGHAWNLWNDGRTWELMDPISQNGASYPILKRYINVALLCVQEKAADRP-AMSEVV 432
+++ + + + ++ + + + +R +E+
Sbjct: 219 PVSVA---YQHVREDPIPPSARHEGLSADLDAVVLK-------ALAKNPENRYQTAAEMR 268
Query: 433 SML 435
+ L
Sbjct: 269 ADL 271
|
| >d1o6la_ d.144.1.7 (A:) Pkb kinase (Akt-2) {Human (Homo sapiens) [TaxId: 9606]} Length = 337 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Pkb kinase (Akt-2) species: Human (Homo sapiens) [TaxId: 9606]
Score = 87.9 bits (217), Expect = 9e-20
Identities = 40/144 (27%), Positives = 62/144 (43%), Gaps = 7/144 (4%)
Query: 238 QSKDEISFWYESYNNPTKKGLL---CWGTRVRIIEGIAQGLLYLHQYSRLRVIHRDLKAS 294
Q+ D + F E N L T R A+ + L V++RD+K
Sbjct: 75 QTHDRLCFVMEYANGGELFFHLSRERVFTEERARFYGAEIVSALEYLHSRDVVYRDIKLE 134
Query: 295 NILLDKDMNPKISDFGMARMFGGDELQSNTKRIVGTYGYMSPEYALRGLFSIKSDVFSFG 354
N++LDKD + KI+DFG+ + D + K GT Y++PE + D + G
Sbjct: 135 NLMLDKDGHIKITDFGLCKEGISD--GATMKTFCGTPEYLAPEVLEDNDYGRAVDWWGLG 192
Query: 355 VLLLETLSSKKNTHFYNTDSLTLL 378
V++ E + + FYN D L
Sbjct: 193 VVMYEMMCGR--LPFYNQDHERLF 214
|
| >d1tkia_ d.144.1.7 (A:) Titin, kinase domain {Human (Homo sapiens) [TaxId: 9606]} Length = 321 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Titin, kinase domain species: Human (Homo sapiens) [TaxId: 9606]
Score = 85.1 bits (210), Expect = 7e-19
Identities = 38/182 (20%), Positives = 66/182 (36%), Gaps = 24/182 (13%)
Query: 254 TKKGLLCWGTRVRIIEGIAQGLLYLHQYSRLRVIHRDLKASNILLDKDMNP--KISDFGM 311
T L V + + + L +LH + H D++ NI+ + KI +FG
Sbjct: 94 TSAFELNEREIVSYVHQVCEALQFLHS---HNIGHFDIRPENIIYQTRRSSTIKIIEFGQ 150
Query: 312 ARMFGGDELQSNTKRIVGTYGYMSPEYALRGLFSIKSDVFSFGVLLLETLSSKKNTHFYN 371
AR + N + + Y +PE + S +D++S G L+ LS F
Sbjct: 151 ARQLKPGD---NFRLLFTAPEYYAPEVHQHDVVSTATDMWSLGTLVYVLLSGI--NPFLA 205
Query: 372 TDSLTLLGHAWNLWNDGRTW--ELMDPISQNGASYPILKRYINVALLCVQEKAADRPAMS 429
+ ++ N+ N T+ E IS + R + ++ R S
Sbjct: 206 ETNQQII---ENIMNAEYTFDEEAFKEISIEAMD--FVDR-------LLVKERKSRMTAS 253
Query: 430 EV 431
E
Sbjct: 254 EA 255
|
| >d2ozaa1 d.144.1.7 (A:51-385) MAP kinase activated protein kinase 2, mapkap2 {Human (Homo sapiens) [TaxId: 9606]} Length = 335 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase activated protein kinase 2, mapkap2 species: Human (Homo sapiens) [TaxId: 9606]
Score = 85.1 bits (210), Expect = 7e-19
Identities = 36/195 (18%), Positives = 74/195 (37%), Gaps = 22/195 (11%)
Query: 259 LCWGTRVRIIEGIAQGLLYLHQYSRLRVIHRDLKASNILLDKDMNP---KISDFGMARMF 315
I++ I + + YLH + + HRD+K N+L K++DFG A+
Sbjct: 108 FTEREASEIMKSIGEAIQYLHS---INIAHRDVKPENLLYTSKRPNAILKLTDFGFAKET 164
Query: 316 GGDELQSNTKRIVGTYGYMSPEYALRGLFSIKSDVFSFGVLLLETLSSKKNTHFYNTDSL 375
+ T Y++PE + D++S GV++ L FY+ L
Sbjct: 165 TSHNSLTTPCY---TPYYVAPEVLGPEKYDKSCDMWSLGVIMYILLCGY--PPFYSNHGL 219
Query: 376 TLLGHAWNLWNDGRTWELMDPISQNGASYPILKRYINVALLCVQEKAADRPAMSEVVSML 435
+ G+ +E +P + + + ++ + R ++E +
Sbjct: 220 AISPGMKTRIRMGQ-YEFPNPEWSE-----VSEEVKMLIRNLLKTEPTQRMTITEF---M 270
Query: 436 SNEFV--NLPAPQQP 448
++ ++ + PQ P
Sbjct: 271 NHPWIMQSTKVPQTP 285
|
| >d1ua2a_ d.144.1.7 (A:) Cell division protein kinase 7, CDK7 {Human (Homo sapiens) [TaxId: 9606]} Length = 299 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cell division protein kinase 7, CDK7 species: Human (Homo sapiens) [TaxId: 9606]
Score = 84.5 bits (208), Expect = 9e-19
Identities = 47/226 (20%), Positives = 77/226 (34%), Gaps = 30/226 (13%)
Query: 242 EISFWYESYNNPTKKGLLCWGTRVRIIEGIAQGLLYLHQYSRLRVIHRDLKASNILLDKD 301
+ +L + QGL YLHQ+ ++HRDLK +N+LLD++
Sbjct: 80 DFMETDLEVIIKDNSLVLTPSHIKAYMLMTLQGLEYLHQH---WILHRDLKPNNLLLDEN 136
Query: 302 MNPKISDFGMARMFGGDELQSNTKRIVGTYGYMSPEYALR-GLFSIKSDVFSFGVLLLET 360
K++DFG+A+ FG V T Y +PE ++ + D+++ G +L E
Sbjct: 137 GVLKLADFGLAKSFGSP--NRAYTHQVVTRWYRAPELLFGARMYGVGVDMWAVGCILAEL 194
Query: 361 LSSKKNTHFYNTDSLTLLGHAWNLWNDGRTWELMDPISQNGASYPILKRYINVALL---- 416
L L L + G E P + Y K + + L
Sbjct: 195 LLRV--PFLPGDSDLDQLTRIFETL--GTPTEEQWPDMCSLPDYVTFKSFPGIPLHHIFS 250
Query: 417 ------------CVQEKAADRPAMSEVVSMLSNEFV-NLPAPQQPA 449
R ++ L ++ N P P
Sbjct: 251 AAGDDLLDLIQGLFLFNPCARITATQA---LKMKYFSNRPGPTPGC 293
|
| >d3blha1 d.144.1.7 (A:8-325) Cell division protein kinase 9, CDK9 {Human (Homo sapiens) [TaxId: 9606]} Length = 318 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cell division protein kinase 9, CDK9 species: Human (Homo sapiens) [TaxId: 9606]
Score = 83.8 bits (206), Expect = 2e-18
Identities = 41/211 (19%), Positives = 80/211 (37%), Gaps = 26/211 (12%)
Query: 255 KKGLLCWGTRVRIIEGIAQGLLYLHQYSRLRVIHRDLKASNILLDKDMNPKISDFGMARM 314
R+++ + GL Y+H+ +++HRD+KA+N+L+ +D K++DFG+AR
Sbjct: 110 VLVKFTLSEIKRVMQMLLNGLYYIHRN---KILHRDMKAANVLITRDGVLKLADFGLARA 166
Query: 315 FGGDELQSNTKR--IVGTYGYMSPEYALRG-LFSIKSDVFSFGVLLLETLS------SKK 365
F + + V T Y PE L + D++ G ++ E +
Sbjct: 167 FSLAKNSQPNRYTNRVVTLWYRPPELLLGERDYGPPIDLWGAGCIMAEMWTRSPIMQGNT 226
Query: 366 NTHFYNTDSLTLLGHAWNLWNDGRTWELMDPISQNGASYPILKRYINVALL--------- 416
H S +W + +EL + + +K + +
Sbjct: 227 EQHQLALISQLCGSITPEVWPNVDNYELYEKLELVKGQKRKVKDRLKAYVRDPYALDLID 286
Query: 417 -CVQEKAADRPAMSEVVSMLSNE-FVNLPAP 445
+ A R + L+++ F + P P
Sbjct: 287 KLLVLDPAQRIDSDDA---LNHDFFWSDPMP 314
|
| >d1unla_ d.144.1.7 (A:) Cyclin-dependent PK, CDK5 {Human (Homo sapiens) [TaxId: 9606]} Length = 292 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK5 species: Human (Homo sapiens) [TaxId: 9606]
Score = 81.5 bits (200), Expect = 9e-18
Identities = 39/205 (19%), Positives = 74/205 (36%), Gaps = 20/205 (9%)
Query: 242 EISFWYESYNNPTKKGLLCWGTRVRIIEGIAQGLLYLHQYSRLRVIHRDLKASNILLDKD 301
E + G L + + +GL + H V+HRDLK N+L++++
Sbjct: 81 EFCDQDLKKYFDSCNGDLDPEIVKSFLFQLLKGLGFCHSR---NVLHRDLKPQNLLINRN 137
Query: 302 MNPKISDFGMARMFGGDELQSNTKRIVGTYGYMSPEYALRGLFSIKSDVFSFGVLLLETL 361
K+++FG+AR F G ++ + +V + L+S D++S G + E
Sbjct: 138 GELKLANFGLARAF-GIPVRCYSAEVVTLWYRPPDVLFGAKLYSTSIDMWSAGCIFAELA 196
Query: 362 SSKKNTHFYNTDSLTLLGHAWNL--------WNDGRTWELMDPISQNGASYPILKRYINV 413
++ + F D L + L W P A+ ++ +
Sbjct: 197 NAGR-PLFPGNDVDDQLKRIFRLLGTPTEEQWPSMTKLPDYKPYPMYPATTSLVNVVPKL 255
Query: 414 A-----LL--CVQEKAADRPAMSEV 431
LL ++ R + E
Sbjct: 256 NATGRDLLQNLLKCNPVQRISAEEA 280
|
| >d1a06a_ d.144.1.7 (A:) Calmodulin-dependent protein kinase {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 307 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Calmodulin-dependent protein kinase species: Rat (Rattus norvegicus) [TaxId: 10116]
Score = 81.6 bits (201), Expect = 1e-17
Identities = 41/180 (22%), Positives = 68/180 (37%), Gaps = 21/180 (11%)
Query: 255 KKGLLCWGTRVRIIEGIAQGLLYLHQYSRLRVIHRDLKASNILL---DKDMNPKISDFGM 311
+KG R+I + + YLH ++HRDLK N+L D+D ISDFG+
Sbjct: 100 EKGFYTERDASRLIFQVLDAVKYLHDL---GIVHRDLKPENLLYYSLDEDSKIMISDFGL 156
Query: 312 ARMFGGDELQSNTKRIVGTYGYMSPEYALRGLFSIKSDVFSFGVLLLETLSSKKNTHFYN 371
++M + GT GY++PE + +S D +S GV+ L FY+
Sbjct: 157 SKMEDPGSV---LSTACGTPGYVAPEVLAQKPYSKAVDCWSIGVIAYILLCGY--PPFYD 211
Query: 372 TDSLTLLGHAWNLWNDGRTWELMDPISQNGASYPILKRYINVALLCVQEKAADRPAMSEV 431
+ L D IS + ++ +++ R +
Sbjct: 212 ENDAKLFEQILK-AEYEFDSPYWDDISDSAKD--FIRH-------LMEKDPEKRFTCEQA 261
|
| >d1gz8a_ d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {Human (Homo sapiens) [TaxId: 9606]} Length = 298 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK2 species: Human (Homo sapiens) [TaxId: 9606]
Score = 80.7 bits (198), Expect = 2e-17
Identities = 42/221 (19%), Positives = 78/221 (35%), Gaps = 25/221 (11%)
Query: 243 ISFWYESYNNPTKKGLLCWGTRVRIIEGIAQGLLYLHQYSRLRVIHRDLKASNILLDKDM 302
+ + + + + + + + QGL + H + RV+HRDLK N+L++ +
Sbjct: 83 LHQDLKKFMDASALTGIPLPLIKSYLFQLLQGLAFCHSH---RVLHRDLKPQNLLINTEG 139
Query: 303 NPKISDFGMARMFGGDELQSNTKRIVGTYGYMSPE-YALRGLFSIKSDVFSFGVLLLETL 361
K++DFG+AR FG V T Y +PE +S D++S G + E +
Sbjct: 140 AIKLADFGLARAFGVPVRTYTH--EVVTLWYRAPEILLGCKYYSTAVDIWSLGCIFAEMV 197
Query: 362 SSKKNTHFYNTDSLTLLGHAWNLWNDGRTWELMDPISQNGASYPILKRYINVALL----- 416
+ + + D W + + S+P R ++
Sbjct: 198 TRRALFPGDSEIDQLFRIFRTLGTPDEVVWPGVTSMPDYKPSFPKWARQDFSKVVPPLDE 257
Query: 417 --------CVQEKAADRPAMSEVVSMLSNEF---VNLPAPQ 446
+ R + L++ F V P P
Sbjct: 258 DGRSLLSQMLHYDPNKRISAKAA---LAHPFFQDVTKPVPH 295
|
| >d1rdqe_ d.144.1.7 (E:) cAMP-dependent PK, catalytic subunit {Mouse (Mus musculus) [TaxId: 10090]} Length = 350 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: cAMP-dependent PK, catalytic subunit species: Mouse (Mus musculus) [TaxId: 10090]
Score = 81.0 bits (199), Expect = 2e-17
Identities = 30/129 (23%), Positives = 54/129 (41%), Gaps = 10/129 (7%)
Query: 255 KKGLLCWGTRVRIIEGIAQGLLYLHQYSRLRVIHRDLKASNILLDKDMNPKISDFGMARM 314
+ G I YLH L +I+RDLK N+L+D+ +++DFG A+
Sbjct: 134 RIGRFSEPHARFYAAQIVLTFEYLHS---LDLIYRDLKPENLLIDQQGYIQVTDFGFAKR 190
Query: 315 FGGDELQSNTKRIVGTYGYMSPEYALRGLFSIKSDVFSFGVLLLETLSSKKNTHFYNTDS 374
+ T + GT ++PE L ++ D ++ GVL+ E + F+
Sbjct: 191 V-----KGRTWTLCGTPEALAPEIILSKGYNKAVDWWALGVLIYEMAAGY--PPFFADQP 243
Query: 375 LTLLGHAWN 383
+ + +
Sbjct: 244 IQIYEKIVS 252
|
| >d1ob3a_ d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {(Plasmodium falciparum) [TaxId: 5833]} Length = 286 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK2 species: (Plasmodium falciparum) [TaxId: 5833]
Score = 78.4 bits (192), Expect = 8e-17
Identities = 36/204 (17%), Positives = 74/204 (36%), Gaps = 19/204 (9%)
Query: 242 EISFWYESYNNPTKKGLLCWGTRVRIIEGIAQGLLYLHQYSRLRVIHRDLKASNILLDKD 301
E +G L T + + G+ Y H RV+HRDLK N+L++++
Sbjct: 80 EHLDQDLKKLLDVCEGGLESVTAKSFLLQLLNGIAYCHDR---RVLHRDLKPQNLLINRE 136
Query: 302 MNPKISDFGMARMFGGDELQSNTKRIVGTYGYMSPEYAL-RGLFSIKSDVFSFGVLLLET 360
KI+DFG+AR FG + + T Y +P+ + +S D++S G + E
Sbjct: 137 GELKIADFGLARAFGIPVRKYTH--EIVTLWYRAPDVLMGSKKYSTTIDIWSVGCIFAEM 194
Query: 361 LSSKKNTHFYNTDSLTLLGHAWNLWNDGRTWELMDPISQNGASYPILKRYINVALL---- 416
++ + + + + W + + + ++ + + + L
Sbjct: 195 VNGTPLFPGVSEADQLMRIFRILGTPNSKNWPNVTELPKYDPNFTVYEPLPWESFLKGLD 254
Query: 417 ---------CVQEKAADRPAMSEV 431
++ R +
Sbjct: 255 ESGIDLLSKMLKLDPNQRITAKQA 278
|
| >d1jksa_ d.144.1.7 (A:) Death-associated protein kinase, Dap {Human (Homo sapiens) [TaxId: 9606]} Length = 293 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Death-associated protein kinase, Dap species: Human (Homo sapiens) [TaxId: 9606]
Score = 78.3 bits (192), Expect = 1e-16
Identities = 40/206 (19%), Positives = 75/206 (36%), Gaps = 26/206 (12%)
Query: 250 YNNPTKKGLLCWGTRVRIIEGIAQGLLYLHQYSRLRVIHRDLKASNILLDKDMNP----K 305
++ +K L ++ I G+ + L++ H DLK NI+L P K
Sbjct: 101 FDFLAEKESLTEEEATEFLKQILNGV---YYLHSLQIAHFDLKPENIMLLDRNVPKPRIK 157
Query: 306 ISDFGMARMFGGDELQSNTKRIVGTYGYMSPEYALRGLFSIKSDVFSFGVLLLETLSSKK 365
I DFG+A K I GT +++PE +++D++S GV+ LS
Sbjct: 158 IIDFGLAHKIDFGNE---FKNIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGAS 214
Query: 366 NTHFYNTDSLTLLGHAWNLWNDGRTWELMDPISQNGASYPILKRYINVALLCVQEKAADR 425
A N + + ++++ ++R + + R
Sbjct: 215 PFLGDTKQETLANVSAVNYEFEDEYFSNTSALAKD-----FIRR-------LLVKDPKKR 262
Query: 426 PAMSEVVSMLSNEFVNLPAPQQPAFS 451
+ + L + ++ P Q A S
Sbjct: 263 MTIQDS---LQHPWIK-PKDTQQALS 284
|
| >d1q5ka_ d.144.1.7 (A:) Glycogen synthase kinase-3 beta (Gsk3b) {Human (Homo sapiens) [TaxId: 9606]} Length = 350 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Glycogen synthase kinase-3 beta (Gsk3b) species: Human (Homo sapiens) [TaxId: 9606]
Score = 75.6 bits (185), Expect = 1e-15
Identities = 32/132 (24%), Positives = 54/132 (40%), Gaps = 8/132 (6%)
Query: 235 VLVQSKDEISFWYESYNNPTKKGLLCWGTRVRIIEGIAQGLLYLHQYSRLRVIHRDLKAS 294
LV + + + + K L + + + L Y+H + HRD+K
Sbjct: 95 NLVLDYVPETVYRVARHYSRAKQTLPVIYVKLYMYQLFRSLAYIHS---FGICHRDIKPQ 151
Query: 295 NILLDKD-MNPKISDFGMARMFGGDELQSNTKRIVGTYGYMSPEYALRGL-FSIKSDVFS 352
N+LLD D K+ DFG A+ E + + + Y +PE ++ DV+S
Sbjct: 152 NLLLDPDTAVLKLCDFGSAKQLVRGEPNVSY---ICSRYYRAPELIFGATDYTSSIDVWS 208
Query: 353 FGVLLLETLSSK 364
G +L E L +
Sbjct: 209 AGCVLAELLLGQ 220
|
| >d1vzoa_ d.144.1.7 (A:) Ribosomal protein S6 kinase alpha 5, Msk1 {Human (Homo sapiens) [TaxId: 9606]} Length = 322 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Ribosomal protein S6 kinase alpha 5, Msk1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 73.7 bits (180), Expect = 4e-15
Identities = 35/133 (26%), Positives = 60/133 (45%), Gaps = 6/133 (4%)
Query: 237 VQSKDEISFWYESYNNPTKKGLLCWGTRV---RIIEGIAQGLLYLHQYSRLRVIHRDLKA 293
Q++ ++ + N L R + + + +L L +L +I+RD+K
Sbjct: 98 FQTETKLHLILDYINGGELFTHLSQRERFTEHEVQIYVGEIVLALEHLHKLGIIYRDIKL 157
Query: 294 SNILLDKDMNPKISDFGMARMFGGDELQSNTKRIVGTYGYMSPEYALRGL--FSIKSDVF 351
NILLD + + ++DFG+++ F DE GT YM+P+ G D +
Sbjct: 158 ENILLDSNGHVVLTDFGLSKEFVADE-TERAYDFCGTIEYMAPDIVRGGDSGHDKAVDWW 216
Query: 352 SFGVLLLETLSSK 364
S GVL+ E L+
Sbjct: 217 SLGVLMYELLTGA 229
|
| >d1cm8a_ d.144.1.7 (A:) MAP kinase p38-gamma {Human (Homo sapiens) [TaxId: 9606]} Length = 346 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase p38-gamma species: Human (Homo sapiens) [TaxId: 9606]
Score = 73.3 bits (179), Expect = 7e-15
Identities = 44/189 (23%), Positives = 78/189 (41%), Gaps = 23/189 (12%)
Query: 255 KKGLLCWGTRVRIIEGIAQGLLYLHQYSRLRVIHRDLKASNILLDKDMNPKISDFGMARM 314
K L ++ + +GL Y+H +IHRDLK N+ +++D KI DFG+AR
Sbjct: 114 KHEKLGEDRIQFLVYQMLKGLRYIH---AAGIIHRDLKPGNLAVNEDCELKILDFGLAR- 169
Query: 315 FGGDELQSNTKRIVGTYGYMSPEYALRGL-FSIKSDVFSFGVLLLETLSSKKNTHFYNTD 373
+ S V T Y +PE L + ++ D++S G ++ E ++ K T F +D
Sbjct: 170 ----QADSEMTGYVVTRWYRAPEVILNWMRYTQTVDIWSVGCIMAEMITGK--TLFKGSD 223
Query: 374 SLTLLGHAWNLWNDGRTWELMDPISQNGASYPILKRYINVALLCVQEKAADRPAMSEVVS 433
L + G Q+ + +K + ++ + +++
Sbjct: 224 HLDQ--LKEIMKVTGTPPAEFVQRLQSDEAKNYMKGLPEL----------EKKDFASILT 271
Query: 434 MLSNEFVNL 442
S VNL
Sbjct: 272 NASPLAVNL 280
|
| >d1jpca_ b.78.1.1 (A:) Lectin (agglutinin) {Snowdrop (Galanthus nivalis) [TaxId: 4670]} Length = 108 | Back information, alignment and structure |
|---|
class: All beta proteins fold: beta-Prism II superfamily: alpha-D-mannose-specific plant lectins family: alpha-D-mannose-specific plant lectins domain: Lectin (agglutinin) species: Snowdrop (Galanthus nivalis) [TaxId: 4670]
Score = 66.6 bits (162), Expect = 3e-14
Identities = 25/126 (19%), Positives = 44/126 (34%), Gaps = 20/126 (15%)
Query: 27 DTITPETFIRDGEKLVSSSQRFELGFFSPRNSKNRYLGVWYKKIPDTVVWVANRNSPIFN 86
+ + + GE L + F N L ++ D +W N +
Sbjct: 2 NILYSGETLSTGEFL--NYGSFVFIMQEDCN-----LVLYD---VDKPIWATNTGGL--S 49
Query: 87 PNTALTFSNNGNLVLLSQRNGIIWSSNMSRKAENPIAQLLDTGNLVIRDNSSGHTTESYL 146
+ L+ +GNLV+ + N IW+SN + N + L N+VI
Sbjct: 50 RSCFLSMQTDGNLVVYNPSNKPIWASNTGGQNGNYVCILQKDRNVVIYGTD--------R 101
Query: 147 WQSFDY 152
W + +
Sbjct: 102 WATGTH 107
|
| >d1b2pa_ b.78.1.1 (A:) Lectin (agglutinin) {Bluebell (Scilla campanulata) [TaxId: 81759]} Length = 119 | Back information, alignment and structure |
|---|
class: All beta proteins fold: beta-Prism II superfamily: alpha-D-mannose-specific plant lectins family: alpha-D-mannose-specific plant lectins domain: Lectin (agglutinin) species: Bluebell (Scilla campanulata) [TaxId: 81759]
Score = 66.2 bits (161), Expect = 5e-14
Identities = 19/112 (16%), Positives = 39/112 (34%), Gaps = 18/112 (16%)
Query: 41 LVSSSQRFELGFFSPRNSKNRYLGVWYKKIPDTVVWVANRNSPIFNPNTALTFSNNGNLV 100
++ + + + N V Y + +W N +G LV
Sbjct: 25 ILFGTHVYRFIMQTDCNL------VLYD--NNNPIWATNTGG--LGNGCRAVLQPDGVLV 74
Query: 101 LLSQRNGIIWSSNMSRKAENPIAQLLDTGNLVIRDNSSGHTTESYLWQSFDY 152
+++ N +W S ++ KA + + L N+VI ++ LW +
Sbjct: 75 VITNENVTVWQSPVAGKAGHYVLVLQPDRNVVIYGDA--------LWATQTV 118
|
| >d2b1pa1 d.144.1.7 (A:46-400) c-jun N-terminal kinase (jnk3s) {Human (Homo sapiens) [TaxId: 9606]} Length = 355 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: c-jun N-terminal kinase (jnk3s) species: Human (Homo sapiens) [TaxId: 9606]
Score = 70.4 bits (171), Expect = 8e-14
Identities = 43/206 (20%), Positives = 75/206 (36%), Gaps = 6/206 (2%)
Query: 237 VQSKDEISFWYESYNNPTKKGLLCWGTRVRIIEGIAQGLLYLHQYSRLRVIHRDLKASNI 296
++ ++ E + + + R+ + Q L + +IHRDLK SNI
Sbjct: 91 LEEFQDVYLVMELMDANLCQVIQMELDHERMSYLLYQMLCGIKHLHSAGIIHRDLKPSNI 150
Query: 297 LLDKDMNPKISDFGMARMFGGDELQSNTKRIVGTYGYMSPEYALRGLFSIKSDVFSFGVL 356
++ D KI DFG+AR G + V T Y +PE L + D++S G +
Sbjct: 151 VVKSDCTLKILDFGLARTAGTSFM---MTPYVVTRYYRAPEVILGMGYKENVDIWSVGCI 207
Query: 357 LLETLSSKKNTHFYNTDSLTLLGHAWNLWNDGRTWELMDPISQNGASYPILKRYINVALL 416
+ E + K F D + E M + +Y +
Sbjct: 208 MGEMVRHK--ILFPGRDYIDQWNKVIEQLGT-PCPEFMKKLQPTVRNYVENRPKYAGLTF 264
Query: 417 CVQEKAADRPAMSEVVSMLSNEFVNL 442
+ PA SE + +++ +L
Sbjct: 265 PKLFPDSLFPADSEHNKLKASQARDL 290
|
| >d1q8ya_ d.144.1.7 (A:) Sky1p {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]} Length = 362 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Sky1p species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]
Score = 69.7 bits (169), Expect = 1e-13
Identities = 24/124 (19%), Positives = 50/124 (40%), Gaps = 3/124 (2%)
Query: 242 EISFWYESYNNPTKKGLLCWGTRVRIIEGIAQGLLYLHQYSRLRVIHRDLKASNILLDK- 300
+ + + + +I + + GL Y+H+ R +IH D+K N+L++
Sbjct: 105 VLGENLLALIKKYEHRGIPLIYVKQISKQLLLGLDYMHR--RCGIIHTDIKPENVLMEIV 162
Query: 301 DMNPKISDFGMARMFGGDELQSNTKRIVGTYGYMSPEYALRGLFSIKSDVFSFGVLLLET 360
D + +A + + + T Y SPE L + +D++S L+ E
Sbjct: 163 DSPENLIQIKIADLGNACWYDEHYTNSIQTREYRSPEVLLGAPWGCGADIWSTACLIFEL 222
Query: 361 LSSK 364
++
Sbjct: 223 ITGD 226
|
| >d3bqca1 d.144.1.7 (A:3-330) Protein kinase CK2, alpha subunit {Rattus norvegicus [TaxId: 10116]} Length = 328 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Protein kinase CK2, alpha subunit species: Rattus norvegicus [TaxId: 10116]
Score = 67.9 bits (165), Expect = 4e-13
Identities = 42/217 (19%), Positives = 84/217 (38%), Gaps = 18/217 (8%)
Query: 231 LYEQVLVQSKDEISFWYESYNNPTKKGL---LCWGTRVRIIEGIAQGLLYLHQYSRLRVI 287
L + V + +E NN K L L + I + L Y H + ++
Sbjct: 95 LADIVKDPVSRTPALVFEHVNNTDFKQLYQTLTDYDIRFYMYEILKALDYCHS---MGIM 151
Query: 288 HRDLKASNILLD-KDMNPKISDFGMARMFGGDELQSNTKRIVGTYGYMSPEYALR-GLFS 345
HRD+K N+++D + ++ D+G+A + + + V + + PE + ++
Sbjct: 152 HRDVKPHNVMIDHEHRKLRLIDWGLAEFYHPGQEYNV---RVASRYFKGPELLVDYQMYD 208
Query: 346 IKSDVFSFGVLLLETLSSKKNTHFYNTDSLTLLGHAWNLWNDGRTWELMDPISQNGASYP 405
D++S G +L + +K F+ D+ L + ++ +D +
Sbjct: 209 YSLDMWSLGCMLASMI-FRKEPFFHGHDNYDQLVRIAKVLGTEDLYDYIDKYNIE----- 262
Query: 406 ILKRYINVALLCVQEKAADRPAMSEVVSMLSNEFVNL 442
L N L K +R SE ++S E ++
Sbjct: 263 -LDPRFNDILGRHSRKRWERFVHSENQHLVSPEALDF 298
|
| >d1dlpa2 b.78.1.1 (A:116-235) Fetuin-binding protein Scafet precursor {Bluebell (Scilla campanulata) [TaxId: 81759]} Length = 120 | Back information, alignment and structure |
|---|
class: All beta proteins fold: beta-Prism II superfamily: alpha-D-mannose-specific plant lectins family: alpha-D-mannose-specific plant lectins domain: Fetuin-binding protein Scafet precursor species: Bluebell (Scilla campanulata) [TaxId: 81759]
Score = 62.6 bits (152), Expect = 8e-13
Identities = 18/88 (20%), Positives = 32/88 (36%), Gaps = 7/88 (7%)
Query: 65 VWYKKIP-DTVVWVANRNSPIFNPNTALTFSNNGNLVLLSQRNGIIWSSNMSRKAENPIA 123
+ Y D + + L+ + NLV L R+ +WS+N + K A
Sbjct: 12 ILYSTQGNDNHPQTLHATQSLQLSPYRLSMETDCNLV-LFDRDDRVWSTNTAGKGTGCRA 70
Query: 124 QLLDTGNLVIRDNSSGHTTESYLWQSFD 151
L G + + N + +W S +
Sbjct: 71 VLQPNGRMDVLTNQN-----IAVWTSGN 93
|
| >d1dlpa2 b.78.1.1 (A:116-235) Fetuin-binding protein Scafet precursor {Bluebell (Scilla campanulata) [TaxId: 81759]} Length = 120 | Back information, alignment and structure |
|---|
class: All beta proteins fold: beta-Prism II superfamily: alpha-D-mannose-specific plant lectins family: alpha-D-mannose-specific plant lectins domain: Fetuin-binding protein Scafet precursor species: Bluebell (Scilla campanulata) [TaxId: 81759]
Score = 49.2 bits (117), Expect = 5e-08
Identities = 20/96 (20%), Positives = 36/96 (37%), Gaps = 5/96 (5%)
Query: 42 VSSSQRFELGFFSPRNSKNRYLGVWYKKIPDTVVWVANRNSPIFNPNTALTFSNNGNLVL 101
+ ++Q +L + + L ++ D VW N NG + +
Sbjct: 26 LHATQSLQLSPYRLSMETDCNLVLFD---RDDRVWSTNTAGK--GTGCRAVLQPNGRMDV 80
Query: 102 LSQRNGIIWSSNMSRKAENPIAQLLDTGNLVIRDNS 137
L+ +N +W+S SR A + L NL I +
Sbjct: 81 LTNQNIAVWTSGNSRSAGRYVFVLQPDRNLAIYGGA 116
|
| >d1xd5a_ b.78.1.1 (A:) Gastrodianin (antifungal protein) {Gastrodia elata [TaxId: 91201]} Length = 112 | Back information, alignment and structure |
|---|
class: All beta proteins fold: beta-Prism II superfamily: alpha-D-mannose-specific plant lectins family: alpha-D-mannose-specific plant lectins domain: Gastrodianin (antifungal protein) species: Gastrodia elata [TaxId: 91201]
Score = 62.5 bits (151), Expect = 9e-13
Identities = 29/130 (22%), Positives = 48/130 (36%), Gaps = 18/130 (13%)
Query: 26 ADTITPETFIRDGEKLVSSSQRFELGFFSPRNSKNRYLGVWYKKIPDTVVWVANRNSPIF 85
+D + + G L + + N V Y + VW + N
Sbjct: 1 SDRLNSGHQLDTGGSLAEG--GYLFIIQNDCNL------VLYD--NNRAVWASGTNGK-- 48
Query: 86 NPNTALTFSNNGNLVLLSQRNGIIWSSNMSRKAENPIAQLLDTGNLVIRDNSSGHTTESY 145
L N+GNLV+ + IW+SN +R+ N L N+VI DNS+ +
Sbjct: 49 ASGCVLKMQNDGNLVIY-SGSRAIWASNTNRQNGNYYLILQRDRNVVIYDNSN-----NA 102
Query: 146 LWQSFDYPTD 155
+W + +
Sbjct: 103 IWATHTNVGN 112
|
| >d2gfsa1 d.144.1.7 (A:5-352) MAP kinase p38 {Human (Homo sapiens) [TaxId: 9606]} Length = 348 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase p38 species: Human (Homo sapiens) [TaxId: 9606]
Score = 63.4 bits (153), Expect = 1e-11
Identities = 42/135 (31%), Positives = 62/135 (45%), Gaps = 11/135 (8%)
Query: 245 FWYESYNNPTKKGLLCWGTRVRIIEGIAQGLLYLHQYSRLRVIHRDLKASNILLDKDMNP 304
NN K L +I I +GL Y+H +IHRDLK SN+ +++D
Sbjct: 104 LMGADLNNIVKCQKLTDDHVQFLIYQILRGLKYIHSA---DIIHRDLKPSNLAVNEDCEL 160
Query: 305 KISDFGMARMFGGDELQSNTKRIVGTYGYMSPEYALRGL-FSIKSDVFSFGVLLLETLSS 363
KI DFG+AR V T Y +PE L + ++ D++S G ++ E L+
Sbjct: 161 KILDFGLARHTD-----DEMTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTG 215
Query: 364 KKNTHFYNTDSLTLL 378
+ T F TD + L
Sbjct: 216 R--TLFPGTDHIDQL 228
|
| >d1zara2 d.144.1.9 (A:91-281) Rio2 serine protein kinase C-terminal domain {Archaeoglobus fulgidus [TaxId: 2234]} Length = 191 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: RIO1-like kinases domain: Rio2 serine protein kinase C-terminal domain species: Archaeoglobus fulgidus [TaxId: 2234]
Score = 58.3 bits (140), Expect = 1e-10
Identities = 17/115 (14%), Positives = 40/115 (34%), Gaps = 9/115 (7%)
Query: 245 FWYESYNNPTKKGLLCWGTRVRIIEGIAQGLLYLHQYSRLRVIHRDLKASNILLDKDMNP 304
+ + + +++ I + + + ++H DL N+L+ +
Sbjct: 86 AVLMELIDAKELYRVRVENPDEVLDMILEEVAKFYHR---GIVHGDLSQYNVLVS-EEGI 141
Query: 305 KISDFGMARMFGGDELQSNTKRIVGTYGYMSPEYALRGLFSIKSDVFSFGVLLLE 359
I DF + G + + +R V Y R + + D+ S +L+
Sbjct: 142 WIIDFPQSVEVGEEGWREILERDV----RNIITYFSRT-YRTEKDINSAIDRILQ 191
|
| >d1dlpa1 b.78.1.1 (A:1-115) Fetuin-binding protein Scafet precursor {Bluebell (Scilla campanulata) [TaxId: 81759]} Length = 115 | Back information, alignment and structure |
|---|
class: All beta proteins fold: beta-Prism II superfamily: alpha-D-mannose-specific plant lectins family: alpha-D-mannose-specific plant lectins domain: Fetuin-binding protein Scafet precursor species: Bluebell (Scilla campanulata) [TaxId: 81759]
Score = 47.2 bits (112), Expect = 2e-07
Identities = 19/79 (24%), Positives = 27/79 (34%), Gaps = 11/79 (13%)
Query: 71 PDTVVWVANRNSPIFNPNTALTFSNNGNLVLLSQRNGIIWSSNMSRKAENPIAQLLDTGN 130
D VW +N ++G LV+L+ +N I WSS N + L
Sbjct: 43 SDVRVWASNTAG---ATGCRAVLQSDGLLVILTAQNTIRWSSGTKGSIGNYVLVLQPDRT 99
Query: 131 LVIRDNSSGHTTESYLWQS 149
+ I LW S
Sbjct: 100 VTIYGPG--------LWDS 110
|
Homologous Domains Detected by HHsearch
Original result of HHsearch against SCOP70(version1.75) database
| ID | Alignment Graph | Length |
Definition |
Probability |
| Query | 476 | |||
| d1uwha_ | 276 | B-Raf kinase {Human (Homo sapiens) [TaxId: 9606]} | 100.0 | |
| d1qpca_ | 272 | Lymphocyte kinase (lck) {Human (Homo sapiens) [Tax | 100.0 | |
| d1fmka3 | 285 | c-src tyrosine kinase {Human (Homo sapiens) [TaxId | 100.0 | |
| d1rjba_ | 325 | Fl cytokine receptor {Human (Homo sapiens) [TaxId: | 100.0 | |
| d1nvra_ | 271 | Cell cycle checkpoint kinase chk1 {Human (Homo sap | 100.0 | |
| d1jpaa_ | 299 | ephb2 receptor tyrosine kinase {Mouse (Mus musculu | 100.0 | |
| d1ywna1 | 299 | Vascular endothelial growth factor receptor 2 (kdr | 100.0 | |
| d1sm2a_ | 263 | Tyrosine-protein kinase Itk/Tsk {Human (Homo sapie | 100.0 | |
| d1opja_ | 287 | Abelsone tyrosine kinase (abl) {Mouse (Mus musculu | 100.0 | |
| d1u59a_ | 285 | Tyrosine-protein kinase ZAP-70 {Human (Homo sapien | 100.0 | |
| d1mqba_ | 283 | epha2 receptor tyrosine kinase {Human (Homo sapien | 100.0 | |
| d1xbba_ | 277 | Tyrosine-protein kinase SYK {Human (Homo sapiens) | 99.98 | |
| d2j4za1 | 263 | Aurora-related kinase 1 (aurora-2) {Human (Homo sa | 99.98 | |
| d2java1 | 269 | Serine/threonine-protein kinase Nek2 {Human (Homo | 99.97 | |
| d1yhwa1 | 293 | pak1 {Human (Homo sapiens) [TaxId: 9606]} | 99.97 | |
| d1k2pa_ | 258 | Bruton's tyrosine kinase (Btk) {Human (Homo sapien | 99.97 | |
| d1xkka_ | 317 | EGF receptor tyrosine kinase, Erbb-1 {Human (Homo | 99.97 | |
| d1lufa_ | 301 | Musk tyrosine kinase {Rat (Rattus norvegicus) [Tax | 99.97 | |
| d1uu3a_ | 288 | 3-phosphoinositide dependent protein kinase-1 Pdk1 | 99.97 | |
| d1mp8a_ | 273 | Focal adhesion kinase 1 (fak) {Human (Homo sapiens | 99.97 | |
| d1t4ha_ | 270 | Protein kinase wnk1 {Human (Homo sapiens) [TaxId: | 99.97 | |
| d1fgka_ | 299 | Fibroblast growth factor receptor 1 {Human (Homo s | 99.97 | |
| d2jfla1 | 288 | STE20-like serine/threonine-protein kinase, SLK {H | 99.97 | |
| d1s9ja_ | 322 | Dual specificity mitogen-activated protein kinase | 99.97 | |
| d1u46a_ | 273 | Activated CDC42 kinase 1, ACK1 {Human (Homo sapien | 99.97 | |
| d1ua2a_ | 299 | Cell division protein kinase 7, CDK7 {Human (Homo | 99.97 | |
| d1t46a_ | 311 | c-KIT receptor {Human (Homo sapiens) [TaxId: 9606] | 99.97 | |
| d1a06a_ | 307 | Calmodulin-dependent protein kinase {Rat (Rattus n | 99.97 | |
| d1u5ra_ | 309 | Serine/threonine protein kinase TAO2 {Rat (Rattus | 99.97 | |
| d1r0pa_ | 311 | Hepatocyte growth factor receptor, c-MET {Human (H | 99.97 | |
| d1vjya_ | 303 | Type I TGF-beta receptor R4 {Human (Homo sapiens) | 99.97 | |
| d1byga_ | 262 | Carboxyl-terminal src kinase (csk) {Human (Homo sa | 99.97 | |
| d1koaa2 | 350 | Twitchin, kinase domain {Caenorhabditis elegans, p | 99.97 | |
| d1koba_ | 352 | Twitchin, kinase domain {California sea hare (Aply | 99.97 | |
| d1p4oa_ | 308 | Insulin-like growth factor 1 receptor {Human (Homo | 99.97 | |
| d1o6ya_ | 277 | Mycobacterial protein kinase PknB, catalytic domai | 99.97 | |
| d1fvra_ | 309 | Tie2 kinase {Human (Homo sapiens) [TaxId: 9606]} | 99.97 | |
| d1omwa3 | 364 | G-protein coupled receptor kinase 2 {Cow (Bos taur | 99.97 | |
| d2ozaa1 | 335 | MAP kinase activated protein kinase 2, mapkap2 {Hu | 99.97 | |
| d1o6la_ | 337 | Pkb kinase (Akt-2) {Human (Homo sapiens) [TaxId: 9 | 99.96 | |
| d1blxa_ | 305 | Cyclin-dependent PK, CDK6 {Human (Homo sapiens) [T | 99.96 | |
| d1rdqe_ | 350 | cAMP-dependent PK, catalytic subunit {Mouse (Mus m | 99.96 | |
| d1gz8a_ | 298 | Cyclin-dependent PK, CDK2 {Human (Homo sapiens) [T | 99.96 | |
| d1jksa_ | 293 | Death-associated protein kinase, Dap {Human (Homo | 99.96 | |
| d1fota_ | 316 | cAMP-dependent PK, catalytic subunit {Baker's yeas | 99.96 | |
| d1xjda_ | 320 | Protein kinase C, theta type {Human (Homo sapiens) | 99.96 | |
| d1ckia_ | 299 | Casein kinase-1, CK1 {Rat (Rattus norvegicus) [Tax | 99.96 | |
| d1phka_ | 277 | gamma-subunit of glycogen phosphorylase kinase (Ph | 99.96 | |
| d1xwsa_ | 273 | Proto-oncogene serine/threonine-protein kinase Pim | 99.96 | |
| d1q5ka_ | 350 | Glycogen synthase kinase-3 beta (Gsk3b) {Human (Ho | 99.96 | |
| d1tkia_ | 321 | Titin, kinase domain {Human (Homo sapiens) [TaxId: | 99.96 | |
| d3blha1 | 318 | Cell division protein kinase 9, CDK9 {Human (Homo | 99.95 | |
| d1csna_ | 293 | Casein kinase-1, CK1 {Fission yeast (Schizosacchar | 99.95 | |
| d1ob3a_ | 286 | Cyclin-dependent PK, CDK2 {(Plasmodium falciparum) | 99.95 | |
| d1cm8a_ | 346 | MAP kinase p38-gamma {Human (Homo sapiens) [TaxId: | 99.95 | |
| d3bqca1 | 328 | Protein kinase CK2, alpha subunit {Rattus norvegic | 99.95 | |
| d1vzoa_ | 322 | Ribosomal protein S6 kinase alpha 5, Msk1 {Human ( | 99.94 | |
| d1unla_ | 292 | Cyclin-dependent PK, CDK5 {Human (Homo sapiens) [T | 99.94 | |
| d1pmea_ | 345 | MAP kinase Erk2 {Human (Homo sapiens) [TaxId: 9606 | 99.94 | |
| d2b1pa1 | 355 | c-jun N-terminal kinase (jnk3s) {Human (Homo sapie | 99.93 | |
| d2gfsa1 | 348 | MAP kinase p38 {Human (Homo sapiens) [TaxId: 9606] | 99.92 | |
| d1xd5a_ | 112 | Gastrodianin (antifungal protein) {Gastrodia elata | 99.91 | |
| d1q8ya_ | 362 | Sky1p {Baker's yeast (Saccharomyces cerevisiae) [T | 99.91 | |
| d1jpca_ | 108 | Lectin (agglutinin) {Snowdrop (Galanthus nivalis) | 99.91 | |
| d1kj1a_ | 109 | Lectin (agglutinin) {Garlic (Allium sativum) [TaxI | 99.9 | |
| d1b2pa_ | 119 | Lectin (agglutinin) {Bluebell (Scilla campanulata) | 99.79 | |
| d1dlpa2 | 120 | Fetuin-binding protein Scafet precursor {Bluebell | 99.76 | |
| d1dlpa1 | 115 | Fetuin-binding protein Scafet precursor {Bluebell | 99.66 | |
| d1dlpa1 | 115 | Fetuin-binding protein Scafet precursor {Bluebell | 99.65 | |
| d1dlpa2 | 120 | Fetuin-binding protein Scafet precursor {Bluebell | 99.56 | |
| d1zara2 | 191 | Rio2 serine protein kinase C-terminal domain {Arch | 99.3 | |
| d1b2pa_ | 119 | Lectin (agglutinin) {Bluebell (Scilla campanulata) | 99.3 | |
| d1jpca_ | 108 | Lectin (agglutinin) {Snowdrop (Galanthus nivalis) | 99.25 | |
| d1kj1a_ | 109 | Lectin (agglutinin) {Garlic (Allium sativum) [TaxI | 99.14 | |
| d1xd5a_ | 112 | Gastrodianin (antifungal protein) {Gastrodia elata | 99.03 | |
| d2ppqa1 | 316 | Homoserine kinase ThrB {Agrobacterium tumefaciens | 91.53 | |
| d1j7la_ | 263 | Type IIIa 3',5"-aminoglycoside phosphotransferase | 89.72 | |
| d1nd4a_ | 255 | Aminoglycoside 3'-phosphotransferase IIa (Kanamyci | 89.3 | |
| d1zyla1 | 325 | RdoA {Escherichia coli [TaxId: 562]} | 86.02 | |
| d2pula1 | 392 | Methylthioribose kinase MtnK {Bacillus subtilis [T | 84.91 |
| >d1uwha_ d.144.1.7 (A:) B-Raf kinase {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: B-Raf kinase species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2.4e-36 Score=291.90 Aligned_cols=190 Identities=24% Similarity=0.358 Sum_probs=141.2
Q ss_pred cccceeeccCCCC-------CCCCCCChhhHHHHHHHHHHHHHHHhhcCCCceeecCCCccceEecCCCCceecccccee
Q 045315 241 DEISFWYESYNNP-------TKKGLLCWGTRVRIIEGIAQGLLYLHQYSRLRVIHRDLKASNILLDKDMNPKISDFGMAR 313 (476)
Q Consensus 241 ~~~~l~~Ey~~~~-------~~~~~L~~~~~~~i~~qIa~gL~yLH~~~~~~ivH~DLkp~NILld~~~~~kL~DFGla~ 313 (476)
+..+++|||++.+ ..+..+++.++++++.||++||+|||+++ ||||||||+|||++.++.+||+|||+|+
T Consensus 76 ~~~~lv~Ey~~~g~L~~~l~~~~~~~~~~~~~~i~~qi~~gl~yLH~~~---ivHrDlKp~NiLl~~~~~~Kl~DFGla~ 152 (276)
T d1uwha_ 76 PQLAIVTQWCEGSSLYHHLHIIETKFEMIKLIDIARQTAQGMDYLHAKS---IIHRDLKSNNIFLHEDLTVKIGDFGLAT 152 (276)
T ss_dssp SSCEEEEECCCEEEHHHHHHTSCCCCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEEETTSSEEECCCCCSC
T ss_pred cEEEEEEecCCCCCHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHhcCC---EeccccCHHHEEEcCCCCEEEcccccee
Confidence 4688999999822 34567999999999999999999999998 9999999999999999999999999998
Q ss_pred ecCCCcccccceeeeeccCCCChhhhcc---CCCCccceEEeehhhhhhhhhCCCCCCcCCCCchhhhhhhhhhhcCCCc
Q 045315 314 MFGGDELQSNTKRIVGTYGYMSPEYALR---GLFSIKSDVFSFGVLLLETLSSKKNTHFYNTDSLTLLGHAWNLWNDGRT 390 (476)
Q Consensus 314 ~~~~~~~~~~~~~~~gt~~y~aPE~l~~---~~~s~ksDVwSlGvvl~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~ 390 (476)
...............||+.|+|||++.+ ..++.++|||||||++|||++|+.||....... .+.... ..+..
T Consensus 153 ~~~~~~~~~~~~~~~gt~~y~APE~l~~~~~~~~~~~sDiwS~Gv~l~el~tg~~Pf~~~~~~~-~~~~~~----~~~~~ 227 (276)
T d1uwha_ 153 VKSRWSGSHQFEQLSGSILWMAPEVIRMQDKNPYSFQSDVYAFGIVLYELMTGQLPYSNINNRD-QIIFMV----GRGYL 227 (276)
T ss_dssp C------------CCCCGGGCCHHHHTTCSSCCCCHHHHHHHHHHHHHHHHHSSCTTTTCCCHH-HHHHHH----HHTSC
T ss_pred eccccCCcccccccccCcccCCHHHHhcccCCCCCchhhhhhhHHHHHHHHHCCCCCCCCChHH-HHHHHH----hcCCC
Confidence 7654433333445679999999999864 458999999999999999999999986543211 111111 11111
Q ss_pred ccccCcccCCCCCHHHHHHHHHHHHHchhhcccCCCCHHHHHHHHhccccCCC
Q 045315 391 WELMDPISQNGASYPILKRYINVALLCVQEKAADRPAMSEVVSMLSNEFVNLP 443 (476)
Q Consensus 391 ~~~~d~~~~~~~~~~~~~~l~~li~~Cl~~dP~~RPt~~eVl~~L~~~~~~~~ 443 (476)
. +.. ........+.+.+++.+||+.||++|||++||++.|+.+...+|
T Consensus 228 ~----p~~-~~~~~~~~~~l~~li~~cl~~dp~~RPt~~~il~~Le~l~~~~P 275 (276)
T d1uwha_ 228 S----PDL-SKVRSNCPKAMKRLMAECLKKKRDERPLFPQILASIELLARSLP 275 (276)
T ss_dssp C----CCG-GGSCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHTCC
T ss_pred C----Ccc-hhccccchHHHHHHHHHHcCCCHhHCcCHHHHHHHHHHHHHcCC
Confidence 0 000 01112234578899999999999999999999999999876665
|
| >d1qpca_ d.144.1.7 (A:) Lymphocyte kinase (lck) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Lymphocyte kinase (lck) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=7.6e-35 Score=280.82 Aligned_cols=181 Identities=28% Similarity=0.409 Sum_probs=140.6
Q ss_pred cccceeeccCCCCC--------CCCCCChhhHHHHHHHHHHHHHHHhhcCCCceeecCCCccceEecCCCCceeccccce
Q 045315 241 DEISFWYESYNNPT--------KKGLLCWGTRVRIIEGIAQGLLYLHQYSRLRVIHRDLKASNILLDKDMNPKISDFGMA 312 (476)
Q Consensus 241 ~~~~l~~Ey~~~~~--------~~~~L~~~~~~~i~~qIa~gL~yLH~~~~~~ivH~DLkp~NILld~~~~~kL~DFGla 312 (476)
+.++++|||++.+. ...+|++.++++|+.||++||+|||+++ |+||||||+||||++++.+||+|||+|
T Consensus 80 ~~~~iv~Ey~~~g~L~~~~~~~~~~~l~~~~~~~i~~qi~~gl~~lH~~~---ivHrDiKp~NIll~~~~~~Kl~DFGla 156 (272)
T d1qpca_ 80 EPIYIITEYMENGSLVDFLKTPSGIKLTINKLLDMAAQIAEGMAFIEERN---YIHRDLRAANILVSDTLSCKIADFGLA 156 (272)
T ss_dssp SSCEEEEECCTTCBHHHHTTSHHHHTCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEECTTSCEEECCCTTC
T ss_pred CCeEEEEEeCCCCcHHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHHhCC---cccCccchhheeeecccceeeccccce
Confidence 56789999998432 2235999999999999999999999998 999999999999999999999999999
Q ss_pred eecCCCcccccceeeeeccCCCChhhhccCCCCccceEEeehhhhhhhhhCCCCCCcCCCCchhhhhhhhhhhcCCCccc
Q 045315 313 RMFGGDELQSNTKRIVGTYGYMSPEYALRGLFSIKSDVFSFGVLLLETLSSKKNTHFYNTDSLTLLGHAWNLWNDGRTWE 392 (476)
Q Consensus 313 ~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~s~ksDVwSlGvvl~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~ 392 (476)
+......... .....|+..|+|||.+.++.++.++|||||||++|||+||+.|+..... ....... ...+....
T Consensus 157 ~~~~~~~~~~-~~~~~gt~~y~APE~~~~~~~~~~sDvwS~Gvvl~ellt~~~~~~~~~~-~~~~~~~----i~~~~~~~ 230 (272)
T d1qpca_ 157 RLIEDNEYTA-REGAKFPIKWTAPEAINYGTFTIKSDVWSFGILLTEIVTHGRIPYPGMT-NPEVIQN----LERGYRMV 230 (272)
T ss_dssp EECSSSCEEC-CTTCCCCTTTSCHHHHHHCEECHHHHHHHHHHHHHHHHTTTCCSSTTCC-HHHHHHH----HHTTCCCC
T ss_pred EEccCCcccc-ccccCCcccccChHHHhCCCCCchhhhhhhHHHHHHHHhCCCCCCCCCC-HHHHHHH----HHhcCCCC
Confidence 9876543222 2235689999999999999999999999999999999997666433221 1111111 11111111
Q ss_pred ccCcccCCCCCHHHHHHHHHHHHHchhhcccCCCCHHHHHHHHhccc
Q 045315 393 LMDPISQNGASYPILKRYINVALLCVQEKAADRPAMSEVVSMLSNEF 439 (476)
Q Consensus 393 ~~d~~~~~~~~~~~~~~l~~li~~Cl~~dP~~RPt~~eVl~~L~~~~ 439 (476)
.+....+.+.+++.+||+.||++||||+||+++|+..+
T Consensus 231 ---------~p~~~~~~l~~li~~cl~~~P~~Rpt~~ei~~~L~~~f 268 (272)
T d1qpca_ 231 ---------RPDNCPEELYQLMRLCWKERPEDRPTFDYLRSVLEDFF 268 (272)
T ss_dssp ---------CCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHH
T ss_pred ---------CcccChHHHHHHHHHHcCCCHhHCcCHHHHHHHhhhhh
Confidence 11123356889999999999999999999999998765
|
| >d1fmka3 d.144.1.7 (A:249-533) c-src tyrosine kinase {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: c-src tyrosine kinase species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=8.1e-35 Score=282.30 Aligned_cols=191 Identities=26% Similarity=0.398 Sum_probs=143.1
Q ss_pred cccceeeccCCCCC--------CCCCCChhhHHHHHHHHHHHHHHHhhcCCCceeecCCCccceEecCCCCceeccccce
Q 045315 241 DEISFWYESYNNPT--------KKGLLCWGTRVRIIEGIAQGLLYLHQYSRLRVIHRDLKASNILLDKDMNPKISDFGMA 312 (476)
Q Consensus 241 ~~~~l~~Ey~~~~~--------~~~~L~~~~~~~i~~qIa~gL~yLH~~~~~~ivH~DLkp~NILld~~~~~kL~DFGla 312 (476)
++++++|||++.+. ..+.++|.+++.++.||+.||+|||+++ |+||||||+||||+.++.+||+|||++
T Consensus 84 ~~~~lv~Ey~~~g~l~~~~~~~~~~~l~~~~~~~i~~~i~~gl~~LH~~~---ivH~DlKp~NIll~~~~~~kl~DfGla 160 (285)
T d1fmka3 84 EPIYIVTEYMSKGSLLDFLKGETGKYLRLPQLVDMAAQIASGMAYVERMN---YVHRDLRAANILVGENLVCKVADFGLA 160 (285)
T ss_dssp SSCEEEECCCTTCBHHHHHSHHHHTTCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCSGGGEEECGGGCEEECCCCTT
T ss_pred CCeEEEEEecCCCchhhhhhhcccccchHHHHHHHHHHHHHHHHHHhhhh---eecccccceEEEECCCCcEEEcccchh
Confidence 56899999999442 2356999999999999999999999999 999999999999999999999999999
Q ss_pred eecCCCcccccceeeeeccCCCChhhhccCCCCccceEEeehhhhhhhhhCCCCCCcCCCCchhhhhhhhhhhcCCCccc
Q 045315 313 RMFGGDELQSNTKRIVGTYGYMSPEYALRGLFSIKSDVFSFGVLLLETLSSKKNTHFYNTDSLTLLGHAWNLWNDGRTWE 392 (476)
Q Consensus 313 ~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~s~ksDVwSlGvvl~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~ 392 (476)
+........ ......||+.|+|||++..+.++.++|||||||++|||++|+.|+...... ....... ..+...
T Consensus 161 ~~~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~ksDI~S~Giil~el~t~~~p~~~~~~~-~~~~~~i----~~~~~~- 233 (285)
T d1fmka3 161 RLIEDNEYT-ARQGAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELTTKGRVPYPGMVN-REVLDQV----ERGYRM- 233 (285)
T ss_dssp C---------------CCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCSSTTCCH-HHHHHHH----HTTCCC-
T ss_pred hhccCCCce-eeccccccccccChHHHhCCCCCcHHhhhcchHHHHHHHhCCCCCCCCCCH-HHHHHHH----HhcCCC-
Confidence 876543322 223356899999999999999999999999999999999977765433221 1122111 111111
Q ss_pred ccCcccCCCCCHHHHHHHHHHHHHchhhcccCCCCHHHHHHHHhccccCCCCCCCCc
Q 045315 393 LMDPISQNGASYPILKRYINVALLCVQEKAADRPAMSEVVSMLSNEFVNLPAPQQPA 449 (476)
Q Consensus 393 ~~d~~~~~~~~~~~~~~l~~li~~Cl~~dP~~RPt~~eVl~~L~~~~~~~~~p~~p~ 449 (476)
..+....+.+.+++.+||+.||++||++++|+++|+......+++.+|.
T Consensus 234 --------~~~~~~~~~l~~li~~cl~~dP~~Rps~~~i~~~L~~~~~~~~p~~~p~ 282 (285)
T d1fmka3 234 --------PCPPECPESLHDLMCQCWRKEPEERPTFEYLQAFLEDYFTSTEPQYQPG 282 (285)
T ss_dssp --------CCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHTTTSCSCCCCCCS
T ss_pred --------CCCcccCHHHHHHHHHHcccCHhHCcCHHHHHHHHhhhhcCCCCCCCCC
Confidence 1112234578899999999999999999999999999887766555553
|
| >d1rjba_ d.144.1.7 (A:) Fl cytokine receptor {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Fl cytokine receptor species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.6e-34 Score=285.69 Aligned_cols=164 Identities=26% Similarity=0.388 Sum_probs=130.4
Q ss_pred CCCChhhHHHHHHHHHHHHHHHhhcCCCceeecCCCccceEecCCCCceeccccceeecCCCcccccceeeeeccCCCCh
Q 045315 257 GLLCWGTRVRIIEGIAQGLLYLHQYSRLRVIHRDLKASNILLDKDMNPKISDFGMARMFGGDELQSNTKRIVGTYGYMSP 336 (476)
Q Consensus 257 ~~L~~~~~~~i~~qIa~gL~yLH~~~~~~ivH~DLkp~NILld~~~~~kL~DFGla~~~~~~~~~~~~~~~~gt~~y~aP 336 (476)
..|++.+++.++.||++||+|||+++ ||||||||+|||++.++.+||+|||+|+...............||+.|+||
T Consensus 159 ~~l~~~~~~~i~~qi~~gl~yLH~~~---IiHRDlKp~Nill~~~~~~Kl~DFGla~~~~~~~~~~~~~~~~gt~~y~aP 235 (325)
T d1rjba_ 159 NVLTFEDLLCFAYQVAKGMEFLEFKS---CVHRDLAARNVLVTHGKVVKICDFGLARDIMSDSNYVVRGNARLPVKWMAP 235 (325)
T ss_dssp --CCHHHHHHHHHHHHHHHHHHHHTT---EEETTCSGGGEEEETTTEEEECCCGGGSCGGGCTTSEEETTEEECGGGCCH
T ss_pred CCCCHHHHHHHHHHHHHHHHHHHhCC---eeeccCchhccccccCCeEEEeeccccccccCCCceeeeccccCCCccCCh
Confidence 46899999999999999999999998 999999999999999999999999999876544333333446789999999
Q ss_pred hhhccCCCCccceEEeehhhhhhhhh-CCCCCCcCCCCchhhhhhhhhhhcCCCcccccCcccCCCCCHHHHHHHHHHHH
Q 045315 337 EYALRGLFSIKSDVFSFGVLLLETLS-SKKNTHFYNTDSLTLLGHAWNLWNDGRTWELMDPISQNGASYPILKRYINVAL 415 (476)
Q Consensus 337 E~l~~~~~s~ksDVwSlGvvl~ellt-G~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~l~~li~ 415 (476)
|.+.++.++.++|||||||++|||++ |+.||........ +. .....+... ..+....+.+.+++.
T Consensus 236 E~l~~~~~~~~~DiwS~Gvil~emlt~g~~Pf~~~~~~~~-~~----~~~~~~~~~---------~~p~~~~~~l~~li~ 301 (325)
T d1rjba_ 236 ESLFEGIYTIKSDVWSYGILLWEIFSLGVNPYPGIPVDAN-FY----KLIQNGFKM---------DQPFYATEEIYIIMQ 301 (325)
T ss_dssp HHHHHCCCCHHHHHHHHHHHHHHHTTTSCCSSTTCCCSHH-HH----HHHHTTCCC---------CCCTTCCHHHHHHHH
T ss_pred HHHcCCCCCcceeccchhHHHHHHHhCCCCCCCCCCHHHH-HH----HHHhcCCCC---------CCCCcCCHHHHHHHH
Confidence 99999999999999999999999997 8999875443221 11 111111111 112223457889999
Q ss_pred HchhhcccCCCCHHHHHHHHhc
Q 045315 416 LCVQEKAADRPAMSEVVSMLSN 437 (476)
Q Consensus 416 ~Cl~~dP~~RPt~~eVl~~L~~ 437 (476)
+||+.||++|||++||++.|..
T Consensus 302 ~cl~~dP~~RPt~~ei~~~L~~ 323 (325)
T d1rjba_ 302 SCWAFDSRKRPSFPNLTSFLGC 323 (325)
T ss_dssp HHTCSSGGGSCCHHHHHHHHHH
T ss_pred HHcCCChhHCcCHHHHHHHHhC
Confidence 9999999999999999999953
|
| >d1nvra_ d.144.1.7 (A:) Cell cycle checkpoint kinase chk1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cell cycle checkpoint kinase chk1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.6e-34 Score=278.26 Aligned_cols=177 Identities=23% Similarity=0.300 Sum_probs=137.9
Q ss_pred cccceeeccCCCC------CCCCCCChhhHHHHHHHHHHHHHHHhhcCCCceeecCCCccceEecCCCCceeccccceee
Q 045315 241 DEISFWYESYNNP------TKKGLLCWGTRVRIIEGIAQGLLYLHQYSRLRVIHRDLKASNILLDKDMNPKISDFGMARM 314 (476)
Q Consensus 241 ~~~~l~~Ey~~~~------~~~~~L~~~~~~~i~~qIa~gL~yLH~~~~~~ivH~DLkp~NILld~~~~~kL~DFGla~~ 314 (476)
+..+++|||++.+ .+++.+++.++..++.||++||+|||+++ |+||||||+|||+++++.+||+|||+|+.
T Consensus 76 ~~~~ivmEy~~gg~L~~~l~~~~~l~e~~~~~i~~qi~~al~ylH~~~---IiHrDiKp~NILl~~~~~~KL~DFG~a~~ 152 (271)
T d1nvra_ 76 NIQYLFLEYCSGGELFDRIEPDIGMPEPDAQRFFHQLMAGVVYLHGIG---ITHRDIKPENLLLDERDNLKISDFGLATV 152 (271)
T ss_dssp TEEEEEEECCTTEEGGGGSBTTTBCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCCGGGEEECTTCCEEECCCTTCEE
T ss_pred ceeEEEEeccCCCcHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHcC---CccCcccHHHEEECCCCCEEEccchhhee
Confidence 4578999999832 34568999999999999999999999999 99999999999999999999999999997
Q ss_pred cCCCcccccceeeeeccCCCChhhhccCCC-CccceEEeehhhhhhhhhCCCCCCcCCCCchhhhhhhhhhhcCCCcccc
Q 045315 315 FGGDELQSNTKRIVGTYGYMSPEYALRGLF-SIKSDVFSFGVLLLETLSSKKNTHFYNTDSLTLLGHAWNLWNDGRTWEL 393 (476)
Q Consensus 315 ~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~-s~ksDVwSlGvvl~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~ 393 (476)
..............||+.|+|||++.+..+ +.++|||||||++|||++|+.||.............. ....
T Consensus 153 ~~~~~~~~~~~~~~GT~~Y~APE~~~~~~~~~~~~DiwSlGvilyeml~G~~pf~~~~~~~~~~~~~~-----~~~~--- 224 (271)
T d1nvra_ 153 FRYNNRERLLNKMCGTLPYVAPELLKRREFHAEPVDVWSCGIVLTAMLAGELPWDQPSDSCQEYSDWK-----EKKT--- 224 (271)
T ss_dssp CEETTEECCBCCCCSCGGGSCTHHHHCSSBCHHHHHHHHHHHHHHHHHHSSCSCSSSSTTSHHHHHHH-----TTCT---
T ss_pred eccCCccccccceeeCcCccCHhHhcCCCCCCCceeeeHhHHHHHHHHhCCCCCCCCChHHHHHHHHh-----cCCC---
Confidence 754433333445679999999999988776 6789999999999999999999975443222221111 1100
Q ss_pred cCcccCCCCCHHHHHHHHHHHHHchhhcccCCCCHHHHHH
Q 045315 394 MDPISQNGASYPILKRYINVALLCVQEKAADRPAMSEVVS 433 (476)
Q Consensus 394 ~d~~~~~~~~~~~~~~l~~li~~Cl~~dP~~RPt~~eVl~ 433 (476)
...........+.+++.+||+.||++|||++|+++
T Consensus 225 -----~~~~~~~~s~~~~~li~~~L~~dP~~R~t~~eil~ 259 (271)
T d1nvra_ 225 -----YLNPWKKIDSAPLALLHKILVENPSARITIPDIKK 259 (271)
T ss_dssp -----TSTTGGGSCHHHHHHHHHHSCSSTTTSCCHHHHTT
T ss_pred -----CCCccccCCHHHHHHHHHHcCCChhHCcCHHHHhc
Confidence 00111223456789999999999999999999864
|
| >d1jpaa_ d.144.1.7 (A:) ephb2 receptor tyrosine kinase {Mouse (Mus musculus) [TaxId: 10090]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: ephb2 receptor tyrosine kinase species: Mouse (Mus musculus) [TaxId: 10090]
Probab=100.00 E-value=8.4e-35 Score=284.28 Aligned_cols=182 Identities=23% Similarity=0.352 Sum_probs=133.3
Q ss_pred cccceeeccCCCC-------CCCCCCChhhHHHHHHHHHHHHHHHhhcCCCceeecCCCccceEecCCCCceecccccee
Q 045315 241 DEISFWYESYNNP-------TKKGLLCWGTRVRIIEGIAQGLLYLHQYSRLRVIHRDLKASNILLDKDMNPKISDFGMAR 313 (476)
Q Consensus 241 ~~~~l~~Ey~~~~-------~~~~~L~~~~~~~i~~qIa~gL~yLH~~~~~~ivH~DLkp~NILld~~~~~kL~DFGla~ 313 (476)
+.++++|||++.+ ...+.+++.++++++.||++||+|||+++ |+||||||+||||+.++.+||+|||+++
T Consensus 100 ~~~~iv~Ey~~~g~L~~~~~~~~~~l~~~~~~~i~~qia~gl~yLH~~~---iiHrDlKp~NILl~~~~~~Kl~DFGla~ 176 (299)
T d1jpaa_ 100 TPVMIITEFMENGSLDSFLRQNDGQFTVIQLVGMLRGIAAGMKYLADMN---YVHRDLAARNILVNSNLVCKVSDFGLSR 176 (299)
T ss_dssp SSCEEEEECCTTEEHHHHHHTTTTCSCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEECTTCCEEECCC----
T ss_pred CEEEEEEEecCCCcceeeeccccCCCCHHHHHHHHHHHHHHHHHHhhCC---CccCccccceEEECCCCcEEECCcccce
Confidence 5789999999932 33567999999999999999999999998 9999999999999999999999999998
Q ss_pred ecCCCcccc---cceeeeeccCCCChhhhccCCCCccceEEeehhhhhhhhh-CCCCCCcCCCCchhhhhhhhhhhcCCC
Q 045315 314 MFGGDELQS---NTKRIVGTYGYMSPEYALRGLFSIKSDVFSFGVLLLETLS-SKKNTHFYNTDSLTLLGHAWNLWNDGR 389 (476)
Q Consensus 314 ~~~~~~~~~---~~~~~~gt~~y~aPE~l~~~~~s~ksDVwSlGvvl~ellt-G~~p~~~~~~~~~~~~~~~~~~~~~~~ 389 (476)
.+....... ......||+.|+|||.+.++.++.++|||||||++|||++ |+.||..... ..+.... ..+.
T Consensus 177 ~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~sDvwS~Gvvl~el~t~g~~Pf~~~~~--~~~~~~i----~~~~ 250 (299)
T d1jpaa_ 177 FLEDDTSDPTYTSALGGKIPIRWTAPEAIQYRKFTSASDVWSYGIVMWEVMSYGERPYWDMTN--QDVINAI----EQDY 250 (299)
T ss_dssp -------------------CGGGSCHHHHHSCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCH--HHHHHHH----HTTC
T ss_pred EccCCCCcceeeecccccCCccccCHHHHhcCCCCcccccccchHHHHHHHhCCCCCCCCCCH--HHHHHHH----HcCC
Confidence 765432221 1222457899999999999999999999999999999998 8888864331 1121111 1111
Q ss_pred cccccCcccCCCCCHHHHHHHHHHHHHchhhcccCCCCHHHHHHHHhcccc
Q 045315 390 TWELMDPISQNGASYPILKRYINVALLCVQEKAADRPAMSEVVSMLSNEFV 440 (476)
Q Consensus 390 ~~~~~d~~~~~~~~~~~~~~l~~li~~Cl~~dP~~RPt~~eVl~~L~~~~~ 440 (476)
. ...+....+.+.+++.+||+.||++|||+.||++.|+.+..
T Consensus 251 ~---------~~~~~~~~~~l~~li~~cl~~~P~~RPs~~ei~~~L~~~l~ 292 (299)
T d1jpaa_ 251 R---------LPPPMDCPSALHQLMLDCWQKDRNHRPKFGQIVNTLDKMIR 292 (299)
T ss_dssp C---------CCCCTTCCHHHHHHHHHHTCSSTTTSCCHHHHHHHHHHHHH
T ss_pred C---------CCCCccchHHHHHHHHHHcCCCHhHCcCHHHHHHHHHHHhc
Confidence 1 11122334678899999999999999999999999998763
|
| >d1ywna1 d.144.1.7 (A:818-1166) Vascular endothelial growth factor receptor 2 (kdr) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Vascular endothelial growth factor receptor 2 (kdr) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.5e-34 Score=282.44 Aligned_cols=182 Identities=27% Similarity=0.327 Sum_probs=135.7
Q ss_pred cccceeeccCCCCC----------------------CCCCCChhhHHHHHHHHHHHHHHHhhcCCCceeecCCCccceEe
Q 045315 241 DEISFWYESYNNPT----------------------KKGLLCWGTRVRIIEGIAQGLLYLHQYSRLRVIHRDLKASNILL 298 (476)
Q Consensus 241 ~~~~l~~Ey~~~~~----------------------~~~~L~~~~~~~i~~qIa~gL~yLH~~~~~~ivH~DLkp~NILl 298 (476)
+.++++|||++.+. .+..|++.+++.++.||++||+|||+++ |+||||||+|||+
T Consensus 91 ~~~~iv~E~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~gl~ylH~~~---ivHrDlKp~NILl 167 (299)
T d1ywna1 91 GPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEHLICYSFQVAKGMEFLASRK---CIHRDLAARNILL 167 (299)
T ss_dssp SCCEEEEECCTTCBHHHHHHHTGGGBCC-----------CBCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEE
T ss_pred CeEEEEEEecCCCcHHHHHHhccccccccccchhhhhcccCCHHHHHHHHHHHHHHHHHHHhCC---CcCCcCCccceeE
Confidence 35788899998221 2446999999999999999999999999 9999999999999
Q ss_pred cCCCCceeccccceeecCCCcccccceeeeeccCCCChhhhccCCCCccceEEeehhhhhhhhhCC-CCCCcCCCCchhh
Q 045315 299 DKDMNPKISDFGMARMFGGDELQSNTKRIVGTYGYMSPEYALRGLFSIKSDVFSFGVLLLETLSSK-KNTHFYNTDSLTL 377 (476)
Q Consensus 299 d~~~~~kL~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~s~ksDVwSlGvvl~elltG~-~p~~~~~~~~~~~ 377 (476)
+.++.+||+|||+|+...............||+.|+|||.+.+..++.++|||||||++|||++|. +||....... .+
T Consensus 168 ~~~~~~Kl~DFGla~~~~~~~~~~~~~~~~gt~~y~APE~l~~~~~~~~sDiwS~Gvil~ellt~~~~p~~~~~~~~-~~ 246 (299)
T d1ywna1 168 SEKNVVKICDFGLARDIYKDPDYVRKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYPGVKIDE-EF 246 (299)
T ss_dssp CGGGCEEECC------CCSCTTSCCTTSCCCGGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCCSH-HH
T ss_pred CCCCcEEEccCcchhhccccccccccCceeeCccccchhHhhcCCCCcccceeehHHHHHHHHhCCCCCCCCCCHHH-HH
Confidence 999999999999998765544444444567999999999999999999999999999999999875 4665433221 11
Q ss_pred hhhhhhhhcCCCcccccCcccCCCCCHHHHHHHHHHHHHchhhcccCCCCHHHHHHHHhccc
Q 045315 378 LGHAWNLWNDGRTWELMDPISQNGASYPILKRYINVALLCVQEKAADRPAMSEVVSMLSNEF 439 (476)
Q Consensus 378 ~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~l~~li~~Cl~~dP~~RPt~~eVl~~L~~~~ 439 (476)
.. ....+..... +....+.+.+++.+||+.||++|||++||++.|+.+.
T Consensus 247 ~~----~~~~~~~~~~---------~~~~~~~l~~li~~cl~~dP~~Rpt~~eil~~L~~il 295 (299)
T d1ywna1 247 CR----RLKEGTRMRA---------PDYTTPEMYQTMLDCWHGEPSQRPTFSELVEHLGNLL 295 (299)
T ss_dssp HH----HHHHTCCCCC---------CTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHH
T ss_pred HH----HHhcCCCCCC---------CccCCHHHHHHHHHHcCCChhHCcCHHHHHHHHHHHH
Confidence 11 1112211111 1122356889999999999999999999999998864
|
| >d1sm2a_ d.144.1.7 (A:) Tyrosine-protein kinase Itk/Tsk {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tyrosine-protein kinase Itk/Tsk species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.1e-34 Score=278.26 Aligned_cols=181 Identities=29% Similarity=0.411 Sum_probs=130.9
Q ss_pred cccceeeccCCCC-------CCCCCCChhhHHHHHHHHHHHHHHHhhcCCCceeecCCCccceEecCCCCceecccccee
Q 045315 241 DEISFWYESYNNP-------TKKGLLCWGTRVRIIEGIAQGLLYLHQYSRLRVIHRDLKASNILLDKDMNPKISDFGMAR 313 (476)
Q Consensus 241 ~~~~l~~Ey~~~~-------~~~~~L~~~~~~~i~~qIa~gL~yLH~~~~~~ivH~DLkp~NILld~~~~~kL~DFGla~ 313 (476)
+..+++|||++.+ ..+..++++++++++.|||+||+|||+++ |+||||||+|||+++++.+||+|||+++
T Consensus 73 ~~~~lv~E~~~~g~L~~~l~~~~~~~~~~~~~~i~~qia~gl~~lH~~~---iiHrDlKp~Nill~~~~~~Kl~DFGla~ 149 (263)
T d1sm2a_ 73 APICLVFEFMEHGCLSDYLRTQRGLFAAETLLGMCLDVCEGMAYLEEAC---VIHRDLAARNCLVGENQVIKVSDFGMTR 149 (263)
T ss_dssp SSCEEEEECCTTCBHHHHHHTTTTCCCHHHHHHHHHHHHHHHHHHHHTT---CCCTTCSGGGEEECGGGCEEECSCC---
T ss_pred CceEEEEEecCCCcHHHHhhccccCCCHHHHHHHHHHHHHHHHhhhccc---eeecccchhheeecCCCCeEecccchhe
Confidence 5688999999833 34567999999999999999999999999 9999999999999999999999999998
Q ss_pred ecCCCcccccceeeeeccCCCChhhhccCCCCccceEEeehhhhhhhhhCCCCCCcCCCCchhhhhhhhhhhcCCCcccc
Q 045315 314 MFGGDELQSNTKRIVGTYGYMSPEYALRGLFSIKSDVFSFGVLLLETLSSKKNTHFYNTDSLTLLGHAWNLWNDGRTWEL 393 (476)
Q Consensus 314 ~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~s~ksDVwSlGvvl~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~ 393 (476)
........ ......||..|+|||.+.+..++.++|||||||++|||++++.|+.... ....+.... ..+.. .
T Consensus 150 ~~~~~~~~-~~~~~~gt~~y~aPE~l~~~~~~~k~DVwS~Gvil~el~t~~~~~~~~~-~~~~~~~~i----~~~~~--~ 221 (263)
T d1sm2a_ 150 FVLDDQYT-SSTGTKFPVKWASPEVFSFSRYSSKSDVWSFGVLMWEVFSEGKIPYENR-SNSEVVEDI----STGFR--L 221 (263)
T ss_dssp ----------------CTTSCCHHHHTTCCCCHHHHHHHHHHHHHHHHTTSCCTTCSC-CHHHHHHHH----HHTCC--C
T ss_pred eccCCCce-eecceecCcccCChHHhcCCCCCchhhhcchHHHHHHHHHCCCCCCCCC-CHHHHHHHH----HhcCC--C
Confidence 76543322 2233578999999999999999999999999999999999655543222 111222111 11111 1
Q ss_pred cCcccCCCCCHHHHHHHHHHHHHchhhcccCCCCHHHHHHHHhccc
Q 045315 394 MDPISQNGASYPILKRYINVALLCVQEKAADRPAMSEVVSMLSNEF 439 (476)
Q Consensus 394 ~d~~~~~~~~~~~~~~l~~li~~Cl~~dP~~RPt~~eVl~~L~~~~ 439 (476)
..+ ....+++.+++.+||+.||++||||+||++.|+++.
T Consensus 222 ~~p-------~~~~~~l~~li~~cl~~~p~~Rps~~~il~~L~~i~ 260 (263)
T d1sm2a_ 222 YKP-------RLASTHVYQIMNHCWKERPEDRPAFSRLLRQLAEIA 260 (263)
T ss_dssp CCC-------TTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHH
T ss_pred CCc-------cccCHHHHHHHHHHccCCHhHCcCHHHHHHHHHHHH
Confidence 111 122357889999999999999999999999999864
|
| >d1opja_ d.144.1.7 (A:) Abelsone tyrosine kinase (abl) {Mouse (Mus musculus) [TaxId: 10090]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Abelsone tyrosine kinase (abl) species: Mouse (Mus musculus) [TaxId: 10090]
Probab=100.00 E-value=2e-34 Score=279.97 Aligned_cols=183 Identities=23% Similarity=0.289 Sum_probs=143.2
Q ss_pred cccceeeccCCCC--------CCCCCCChhhHHHHHHHHHHHHHHHhhcCCCceeecCCCccceEecCCCCceeccccce
Q 045315 241 DEISFWYESYNNP--------TKKGLLCWGTRVRIIEGIAQGLLYLHQYSRLRVIHRDLKASNILLDKDMNPKISDFGMA 312 (476)
Q Consensus 241 ~~~~l~~Ey~~~~--------~~~~~L~~~~~~~i~~qIa~gL~yLH~~~~~~ivH~DLkp~NILld~~~~~kL~DFGla 312 (476)
+..+++|||++.+ .....+++..++.++.||++||+|||+++ |+||||||+|||+++++.+||+|||++
T Consensus 86 ~~~~iv~E~~~~g~l~~~l~~~~~~~~~~~~~~~i~~qi~~gL~yLH~~~---iiHrDlKp~NILl~~~~~~Kl~DFG~a 162 (287)
T d1opja_ 86 PPFYIITEFMTYGNLLDYLRECNRQEVSAVVLLYMATQISSAMEYLEKKN---FIHRDLAARNCLVGENHLVKVADFGLS 162 (287)
T ss_dssp SSCEEEEECCTTCBHHHHHHHSCTTTSCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCSGGGEEECGGGCEEECCCCCT
T ss_pred CeeEEEeecccCcchHHHhhhccccchHHHHHHHHHHHHHHHHHHHHHCC---cccCccccCeEEECCCCcEEEccccce
Confidence 4678999999843 34568999999999999999999999998 999999999999999999999999999
Q ss_pred eecCCCcccccceeeeeccCCCChhhhccCCCCccceEEeehhhhhhhhhCCCCCCcCCCCchhhhhhhhhhhcCCCccc
Q 045315 313 RMFGGDELQSNTKRIVGTYGYMSPEYALRGLFSIKSDVFSFGVLLLETLSSKKNTHFYNTDSLTLLGHAWNLWNDGRTWE 392 (476)
Q Consensus 313 ~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~s~ksDVwSlGvvl~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~ 392 (476)
+......... .....|+..|+|||++.+..++.++|||||||++|||++|+.|+..... ...+. .....+..
T Consensus 163 ~~~~~~~~~~-~~~~~g~~~y~aPE~~~~~~~~~k~DiwS~Gv~l~ell~~~~p~~~~~~-~~~~~----~~i~~~~~-- 234 (287)
T d1opja_ 163 RLMTGDTYTA-HAGAKFPIKWTAPESLAYNKFSIKSDVWAFGVLLWEIATYGMSPYPGID-LSQVY----ELLEKDYR-- 234 (287)
T ss_dssp TTCCSSSSEE-ETTEEECGGGCCHHHHHHCCCSHHHHHHHHHHHHHHHHTTSCCSSTTCC-HHHHH----HHHHTTCC--
T ss_pred eecCCCCcee-eccccccccccChHHHcCCCCCchhhhhhHHHHHHHHHhCCCCCCCcch-HHHHH----HHHhcCCC--
Confidence 8765443222 2235688999999999999999999999999999999998776543221 11111 11111111
Q ss_pred ccCcccCCCCCHHHHHHHHHHHHHchhhcccCCCCHHHHHHHHhccccC
Q 045315 393 LMDPISQNGASYPILKRYINVALLCVQEKAADRPAMSEVVSMLSNEFVN 441 (476)
Q Consensus 393 ~~d~~~~~~~~~~~~~~l~~li~~Cl~~dP~~RPt~~eVl~~L~~~~~~ 441 (476)
...+....+.+.+++.+||+.||++|||++||++.|+.+..+
T Consensus 235 -------~~~~~~~~~~l~~li~~cl~~dP~~Rps~~ei~~~L~~~~~~ 276 (287)
T d1opja_ 235 -------MERPEGCPEKVYELMRACWQWNPSDRPSFAEIHQAFETMFQE 276 (287)
T ss_dssp -------CCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHTTSS
T ss_pred -------CCCCccchHHHHHHHHHHcCCCHhHCcCHHHHHHHHHHHHHh
Confidence 111122345788999999999999999999999999887543
|
| >d1u59a_ d.144.1.7 (A:) Tyrosine-protein kinase ZAP-70 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tyrosine-protein kinase ZAP-70 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2.1e-34 Score=279.45 Aligned_cols=181 Identities=24% Similarity=0.340 Sum_probs=144.4
Q ss_pred cccceeeccCCC-------CCCCCCCChhhHHHHHHHHHHHHHHHhhcCCCceeecCCCccceEecCCCCceecccccee
Q 045315 241 DEISFWYESYNN-------PTKKGLLCWGTRVRIIEGIAQGLLYLHQYSRLRVIHRDLKASNILLDKDMNPKISDFGMAR 313 (476)
Q Consensus 241 ~~~~l~~Ey~~~-------~~~~~~L~~~~~~~i~~qIa~gL~yLH~~~~~~ivH~DLkp~NILld~~~~~kL~DFGla~ 313 (476)
+..+++|||++. ...++.+++.++++++.||++||+|||+++ |+||||||+|||++.++.+||+|||+++
T Consensus 81 ~~~~lvmE~~~~g~L~~~l~~~~~~l~~~~~~~i~~qi~~gL~ylH~~~---iiHrDlKp~Nill~~~~~~Kl~DFGla~ 157 (285)
T d1u59a_ 81 EALMLVMEMAGGGPLHKFLVGKREEIPVSNVAELLHQVSMGMKYLEEKN---FVHRDLAARNVLLVNRHYAKISDFGLSK 157 (285)
T ss_dssp SSEEEEEECCTTEEHHHHHTTCTTTSCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEEEETTEEEECCCTTCE
T ss_pred CeEEEEEEeCCCCcHHHHhhccccCCCHHHHHHHHHHHHHHHHHHHhCC---eecCcCchhheeeccCCceeeccchhhh
Confidence 468899999993 234668999999999999999999999999 9999999999999999999999999999
Q ss_pred ecCCCccc-ccceeeeeccCCCChhhhccCCCCccceEEeehhhhhhhhh-CCCCCCcCCCCchhhhhhhhhhhcCCCcc
Q 045315 314 MFGGDELQ-SNTKRIVGTYGYMSPEYALRGLFSIKSDVFSFGVLLLETLS-SKKNTHFYNTDSLTLLGHAWNLWNDGRTW 391 (476)
Q Consensus 314 ~~~~~~~~-~~~~~~~gt~~y~aPE~l~~~~~s~ksDVwSlGvvl~ellt-G~~p~~~~~~~~~~~~~~~~~~~~~~~~~ 391 (476)
.+...... .......||+.|+|||.+.+..++.++|||||||++|||++ |+.||..... ..+.. ....+...
T Consensus 158 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDVwS~Gv~l~E~lt~G~~Pf~~~~~--~~~~~----~i~~~~~~ 231 (285)
T d1u59a_ 158 ALGADDSYYTARSAGKWPLKWYAPECINFRKFSSRSDVWSYGVTMWEALSYGQKPYKKMKG--PEVMA----FIEQGKRM 231 (285)
T ss_dssp ECTTCSCEECCCCSSCCCGGGCCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCTTTTCCT--HHHHH----HHHTTCCC
T ss_pred cccccccccccccccccCccccChHHHhCCCCCccchhhcchHHHHHHHhCCCCCCCCCCH--HHHHH----HHHcCCCC
Confidence 87654322 22233468899999999999999999999999999999998 8999875432 11211 12222221
Q ss_pred cccCcccCCCCCHHHHHHHHHHHHHchhhcccCCCCHHHHHHHHhccc
Q 045315 392 ELMDPISQNGASYPILKRYINVALLCVQEKAADRPAMSEVVSMLSNEF 439 (476)
Q Consensus 392 ~~~d~~~~~~~~~~~~~~l~~li~~Cl~~dP~~RPt~~eVl~~L~~~~ 439 (476)
+ .+...+..+.+++.+||+.||++|||+.+|++.|+..+
T Consensus 232 ~---------~p~~~~~~l~~li~~cl~~~p~~RPs~~~i~~~L~~~~ 270 (285)
T d1u59a_ 232 E---------CPPECPPELYALMSDCWIYKWEDRPDFLTVEQRMRACY 270 (285)
T ss_dssp C---------CCTTCCHHHHHHHHHTTCSSGGGSCCHHHHHHHHHHHH
T ss_pred C---------CCCcCCHHHHHHHHHHcCCCHhHCcCHHHHHHHHHHHH
Confidence 1 11223457889999999999999999999999998765
|
| >d1mqba_ d.144.1.7 (A:) epha2 receptor tyrosine kinase {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: epha2 receptor tyrosine kinase species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2.5e-34 Score=278.79 Aligned_cols=183 Identities=26% Similarity=0.391 Sum_probs=135.6
Q ss_pred cccceeeccCCCC-------CCCCCCChhhHHHHHHHHHHHHHHHhhcCCCceeecCCCccceEecCCCCceecccccee
Q 045315 241 DEISFWYESYNNP-------TKKGLLCWGTRVRIIEGIAQGLLYLHQYSRLRVIHRDLKASNILLDKDMNPKISDFGMAR 313 (476)
Q Consensus 241 ~~~~l~~Ey~~~~-------~~~~~L~~~~~~~i~~qIa~gL~yLH~~~~~~ivH~DLkp~NILld~~~~~kL~DFGla~ 313 (476)
+..++++||+... ...+.+++.++++++.||+.||+|||+++ |+||||||+||||+.++.+||+|||+++
T Consensus 82 ~~~~~v~e~~~~~~l~~~~~~~~~~~~~~~~~~i~~~i~~gl~~lH~~~---iiHrDlKp~NILl~~~~~~Kl~DFGla~ 158 (283)
T d1mqba_ 82 KPMMIITEYMENGALDKFLREKDGEFSVLQLVGMLRGIAAGMKYLANMN---YVHRDLAARNILVNSNLVCKVSDFGLSR 158 (283)
T ss_dssp SSEEEEEECCTTEEHHHHHHHTTTCSCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEECTTCCEEECCCCC--
T ss_pred CceEEEEEecccCcchhhhhcccccccHHHHHHHHHHHHHhhhhccccc---cccCccccceEEECCCCeEEEcccchhh
Confidence 4678899999832 24567999999999999999999999999 9999999999999999999999999998
Q ss_pred ecCCCccc-ccceeeeeccCCCChhhhccCCCCccceEEeehhhhhhhhhCCCCCCcCCCCchhhhhhhhhhhcCCCccc
Q 045315 314 MFGGDELQ-SNTKRIVGTYGYMSPEYALRGLFSIKSDVFSFGVLLLETLSSKKNTHFYNTDSLTLLGHAWNLWNDGRTWE 392 (476)
Q Consensus 314 ~~~~~~~~-~~~~~~~gt~~y~aPE~l~~~~~s~ksDVwSlGvvl~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~ 392 (476)
........ .......||..|+|||++.+..++.++|||||||++|||++++.|+...... ..+.. ....+..
T Consensus 159 ~~~~~~~~~~~~~~~~gt~~Y~APE~l~~~~~~~~sDI~S~Gvil~el~t~~~~~~~~~~~-~~~~~----~i~~~~~-- 231 (283)
T d1mqba_ 159 VLEDDPEATYTTSGGKIPIRWTAPEAISYRKFTSASDVWSFGIVMWEVMTYGERPYWELSN-HEVMK----AINDGFR-- 231 (283)
T ss_dssp ---------------CCCGGGSCHHHHHSCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCH-HHHHH----HHHTTCC--
T ss_pred cccCCCccceEeccCCCCccccCHHHHccCCCCCcccccccHHHHHHHHhCCCCccccCCH-HHHHH----HHhccCC--
Confidence 76543222 2223356899999999999999999999999999999999977665433221 11211 1112211
Q ss_pred ccCcccCCCCCHHHHHHHHHHHHHchhhcccCCCCHHHHHHHHhcccc
Q 045315 393 LMDPISQNGASYPILKRYINVALLCVQEKAADRPAMSEVVSMLSNEFV 440 (476)
Q Consensus 393 ~~d~~~~~~~~~~~~~~l~~li~~Cl~~dP~~RPt~~eVl~~L~~~~~ 440 (476)
...+......+.+++.+||+.||++||||.||+++|+.+..
T Consensus 232 -------~~~~~~~~~~l~~li~~cl~~~p~~RPt~~eil~~L~~l~~ 272 (283)
T d1mqba_ 232 -------LPTPMDCPSAIYQLMMQCWQQERARRPKFADIVSILDKLIR 272 (283)
T ss_dssp -------CCCCTTCBHHHHHHHHHHTCSSTTTSCCHHHHHHHHHHHHH
T ss_pred -------CCCchhhHHHHHHHHHHHCcCCHhHCcCHHHHHHHHHHHhh
Confidence 11122234678899999999999999999999999998763
|
| >d1xbba_ d.144.1.7 (A:) Tyrosine-protein kinase SYK {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tyrosine-protein kinase SYK species: Human (Homo sapiens) [TaxId: 9606]
Probab=99.98 E-value=2.8e-34 Score=277.49 Aligned_cols=181 Identities=24% Similarity=0.330 Sum_probs=141.6
Q ss_pred cccceeeccCCCC------CCCCCCChhhHHHHHHHHHHHHHHHhhcCCCceeecCCCccceEecCCCCceeccccceee
Q 045315 241 DEISFWYESYNNP------TKKGLLCWGTRVRIIEGIAQGLLYLHQYSRLRVIHRDLKASNILLDKDMNPKISDFGMARM 314 (476)
Q Consensus 241 ~~~~l~~Ey~~~~------~~~~~L~~~~~~~i~~qIa~gL~yLH~~~~~~ivH~DLkp~NILld~~~~~kL~DFGla~~ 314 (476)
+..+++|||++.+ .+...+++.++++++.||+.||+|||+++ |+||||||+|||++.++.+||+|||+++.
T Consensus 80 ~~~~lvmE~~~~g~L~~~l~~~~~l~~~~~~~i~~qi~~gl~ylH~~~---iiHrDlKp~Nill~~~~~~kl~DFGla~~ 156 (277)
T d1xbba_ 80 ESWMLVMEMAELGPLNKYLQQNRHVKDKNIIELVHQVSMGMKYLEESN---FVHRDLAARNVLLVTQHYAKISDFGLSKA 156 (277)
T ss_dssp SSEEEEEECCTTEEHHHHHHHCTTCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEEEETTEEEECCCTTCEE
T ss_pred CCEEEEEEcCCCCcHHHHHhhccCCCHHHHHHHHHHHHHHHhhHHhCC---cccCCCcchhhcccccCcccccchhhhhh
Confidence 4578999999843 23567999999999999999999999998 99999999999999999999999999997
Q ss_pred cCCCccc-ccceeeeeccCCCChhhhccCCCCccceEEeehhhhhhhhh-CCCCCCcCCCCchhhhhhhhhhhcCCCccc
Q 045315 315 FGGDELQ-SNTKRIVGTYGYMSPEYALRGLFSIKSDVFSFGVLLLETLS-SKKNTHFYNTDSLTLLGHAWNLWNDGRTWE 392 (476)
Q Consensus 315 ~~~~~~~-~~~~~~~gt~~y~aPE~l~~~~~s~ksDVwSlGvvl~ellt-G~~p~~~~~~~~~~~~~~~~~~~~~~~~~~ 392 (476)
+...... .......||+.|+|||.+.+..++.++|||||||++|||++ |+.||..... ..+.. ....+....
T Consensus 157 ~~~~~~~~~~~~~~~gt~~y~APE~l~~~~~~~~sDiwS~Gv~l~ellt~g~~Pf~~~~~--~~~~~----~i~~~~~~~ 230 (277)
T d1xbba_ 157 LRADENYYKAQTHGKWPVKWYAPECINYYKFSSKSDVWSFGVLMWEAFSYGQKPYRGMKG--SEVTA----MLEKGERMG 230 (277)
T ss_dssp CCTTCSEEEC----CCCGGGCCHHHHHHCEEEHHHHHHHHHHHHHHHHTTTCCSSTTCCH--HHHHH----HHHTTCCCC
T ss_pred ccccccccccccccCCCceecCchhhcCCCCCchhhhccchhhhhHHhhCCCCCCCCCCH--HHHHH----HHHcCCCCC
Confidence 6543222 22334568999999999999999999999999999999997 8999865431 11111 122222111
Q ss_pred ccCcccCCCCCHHHHHHHHHHHHHchhhcccCCCCHHHHHHHHhccc
Q 045315 393 LMDPISQNGASYPILKRYINVALLCVQEKAADRPAMSEVVSMLSNEF 439 (476)
Q Consensus 393 ~~d~~~~~~~~~~~~~~l~~li~~Cl~~dP~~RPt~~eVl~~L~~~~ 439 (476)
.+...+..+.+++.+||+.||++|||+++|+++|+..+
T Consensus 231 ---------~p~~~~~~~~~li~~cl~~dp~~RPs~~~i~~~L~~~~ 268 (277)
T d1xbba_ 231 ---------CPAGCPREMYDLMNLCWTYDVENRPGFAAVELRLRNYY 268 (277)
T ss_dssp ---------CCTTCCHHHHHHHHHHTCSSTTTSCCHHHHHHHHHHHH
T ss_pred ---------CCcccCHHHHHHHHHHcCCCHhHCcCHHHHHHHhhCHH
Confidence 11223457889999999999999999999999998754
|
| >d2j4za1 d.144.1.7 (A:126-388) Aurora-related kinase 1 (aurora-2) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Aurora-related kinase 1 (aurora-2) species: Human (Homo sapiens) [TaxId: 9606]
Probab=99.98 E-value=1.1e-33 Score=271.14 Aligned_cols=170 Identities=24% Similarity=0.264 Sum_probs=136.9
Q ss_pred cccceeeccCCCCC------CCCCCChhhHHHHHHHHHHHHHHHhhcCCCceeecCCCccceEecCCCCceeccccceee
Q 045315 241 DEISFWYESYNNPT------KKGLLCWGTRVRIIEGIAQGLLYLHQYSRLRVIHRDLKASNILLDKDMNPKISDFGMARM 314 (476)
Q Consensus 241 ~~~~l~~Ey~~~~~------~~~~L~~~~~~~i~~qIa~gL~yLH~~~~~~ivH~DLkp~NILld~~~~~kL~DFGla~~ 314 (476)
+..+++|||++.+. +.+.+++.++..++.||++||+|||+++ |+||||||+|||++.++.+||+|||+|+.
T Consensus 79 ~~~~ivmEy~~~g~L~~~l~~~~~l~e~~~~~i~~qi~~al~~lH~~~---ivHrDiKp~Nill~~~~~~kl~DFG~a~~ 155 (263)
T d2j4za1 79 TRVYLILEYAPLGTVYRELQKLSKFDEQRTATYITELANALSYCHSKR---VIHRDIKPENLLLGSAGELKIADFGWSVH 155 (263)
T ss_dssp SEEEEEEECCTTCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCCGGGEEECTTSCEEECCCCSCSC
T ss_pred CEEEEEEeecCCCcHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHHCC---eeeeeeccccceecCCCCEeecccceeee
Confidence 46789999998443 3567999999999999999999999999 99999999999999999999999999986
Q ss_pred cCCCcccccceeeeeccCCCChhhhccCCCCccceEEeehhhhhhhhhCCCCCCcCCCCchhhhhhhhhhhcCCCccccc
Q 045315 315 FGGDELQSNTKRIVGTYGYMSPEYALRGLFSIKSDVFSFGVLLLETLSSKKNTHFYNTDSLTLLGHAWNLWNDGRTWELM 394 (476)
Q Consensus 315 ~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~s~ksDVwSlGvvl~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 394 (476)
..... .....||+.|+|||++.+..++.++|||||||++|||++|+.||..... ...... ......
T Consensus 156 ~~~~~----~~~~~Gt~~Y~APE~~~~~~~~~~~DiwSlGvilyell~G~~Pf~~~~~--~~~~~~----i~~~~~---- 221 (263)
T d2j4za1 156 APSSR----RTTLCGTLDYLPPEMIEGRMHDEKVDLWSLGVLCYEFLVGKPPFEANTY--QETYKR----ISRVEF---- 221 (263)
T ss_dssp CCCCC----CEETTEEGGGCCHHHHTTCCCCTTHHHHHHHHHHHHHHHSSCTTCCSSH--HHHHHH----HHTTCC----
T ss_pred cCCCc----ccccCCCCcccCHHHHcCCCCCchhhhhhHhHHHHHHhcCCCCCCCCCH--HHHHHH----HHcCCC----
Confidence 65432 2345799999999999999999999999999999999999999864331 111111 111111
Q ss_pred CcccCCCCCHHHHHHHHHHHHHchhhcccCCCCHHHHHH
Q 045315 395 DPISQNGASYPILKRYINVALLCVQEKAADRPAMSEVVS 433 (476)
Q Consensus 395 d~~~~~~~~~~~~~~l~~li~~Cl~~dP~~RPt~~eVl~ 433 (476)
..+....+.+.+++.+||+.||++|||++|+++
T Consensus 222 ------~~p~~~s~~~~~li~~~L~~dp~~R~t~~eil~ 254 (263)
T d2j4za1 222 ------TFPDFVTEGARDLISRLLKHNPSQRPMLREVLE 254 (263)
T ss_dssp ------CCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHT
T ss_pred ------CCCccCCHHHHHHHHHHccCCHhHCcCHHHHHc
Confidence 011123457889999999999999999999986
|
| >d2java1 d.144.1.7 (A:3-271) Serine/threonine-protein kinase Nek2 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Serine/threonine-protein kinase Nek2 species: Human (Homo sapiens) [TaxId: 9606]
Probab=99.97 E-value=3.4e-34 Score=275.73 Aligned_cols=176 Identities=28% Similarity=0.378 Sum_probs=126.7
Q ss_pred cccceeeccCCCCC----------CCCCCChhhHHHHHHHHHHHHHHHhhcC--CCceeecCCCccceEecCCCCceecc
Q 045315 241 DEISFWYESYNNPT----------KKGLLCWGTRVRIIEGIAQGLLYLHQYS--RLRVIHRDLKASNILLDKDMNPKISD 308 (476)
Q Consensus 241 ~~~~l~~Ey~~~~~----------~~~~L~~~~~~~i~~qIa~gL~yLH~~~--~~~ivH~DLkp~NILld~~~~~kL~D 308 (476)
+.++++|||++.++ .++.+++.+++.++.||+.||+|||+++ ..+|+||||||+|||++.++.+||+|
T Consensus 78 ~~~~ivmEy~~~g~L~~~i~~~~~~~~~l~e~~~~~i~~qi~~al~ylH~~~~~~~~IiHrDiKp~NIll~~~~~vkl~D 157 (269)
T d2java1 78 TTLYIVMEYCEGGDLASVITKGTKERQYLDEEFVLRVMTQLTLALKECHRRSDGGHTVLHRDLKPANVFLDGKQNVKLGD 157 (269)
T ss_dssp -CEEEEEECCTTEEHHHHHHHHHHHTCCCCHHHHHHHHHHHHHHHHHHHHHCC---------CCGGGEEECTTSCEEECC
T ss_pred CEEEEEEecCCCCcHHHHHHhccccCCCCCHHHHHHHHHHHHHHHHHHHHhcCCCCCEEeCcCchhhcCcCCCCcEEEee
Confidence 45789999998322 3567999999999999999999999864 23499999999999999999999999
Q ss_pred ccceeecCCCcccccceeeeeccCCCChhhhccCCCCccceEEeehhhhhhhhhCCCCCCcCCCCchhhhhhhhhhhcCC
Q 045315 309 FGMARMFGGDELQSNTKRIVGTYGYMSPEYALRGLFSIKSDVFSFGVLLLETLSSKKNTHFYNTDSLTLLGHAWNLWNDG 388 (476)
Q Consensus 309 FGla~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~s~ksDVwSlGvvl~elltG~~p~~~~~~~~~~~~~~~~~~~~~~ 388 (476)
||+++.+..... ......||+.|+|||++.+..++.++|||||||++|||++|+.||..... ..+.. ....+
T Consensus 158 FG~a~~~~~~~~--~~~~~~gt~~Y~APE~l~~~~~~~~~DIwSlGvilyel~tg~~Pf~~~~~--~~~~~----~i~~~ 229 (269)
T d2java1 158 FGLARILNHDTS--FAKAFVGTPYYMSPEQMNRMSYNEKSDIWSLGCLLYELCALMPPFTAFSQ--KELAG----KIREG 229 (269)
T ss_dssp HHHHHHC-------------CCCSCCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCSCCCSSH--HHHHH----HHHHT
T ss_pred ccceeecccCCC--ccccCCCCcccCCHHHHcCCCCChHHHHHhhCHHHHHHhhCCCCCCCCCH--HHHHH----HHHcC
Confidence 999987654322 22346799999999999999999999999999999999999999864332 11111 11112
Q ss_pred CcccccCcccCCCCCHHHHHHHHHHHHHchhhcccCCCCHHHHHH
Q 045315 389 RTWELMDPISQNGASYPILKRYINVALLCVQEKAADRPAMSEVVS 433 (476)
Q Consensus 389 ~~~~~~d~~~~~~~~~~~~~~l~~li~~Cl~~dP~~RPt~~eVl~ 433 (476)
.... .+....+.+.+++.+||+.||++|||++|+++
T Consensus 230 ~~~~---------~~~~~s~~l~~li~~~L~~dp~~Rps~~ell~ 265 (269)
T d2java1 230 KFRR---------IPYRYSDELNEIITRMLNLKDYHRPSVEEILE 265 (269)
T ss_dssp CCCC---------CCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHT
T ss_pred CCCC---------CCcccCHHHHHHHHHHcCCChhHCcCHHHHHh
Confidence 2111 11123456889999999999999999999874
|
| >d1yhwa1 d.144.1.7 (A:249-541) pak1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: pak1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=99.97 E-value=1.9e-33 Score=273.63 Aligned_cols=175 Identities=25% Similarity=0.365 Sum_probs=137.7
Q ss_pred cccceeeccCCCCC-----CCCCCChhhHHHHHHHHHHHHHHHhhcCCCceeecCCCccceEecCCCCceeccccceeec
Q 045315 241 DEISFWYESYNNPT-----KKGLLCWGTRVRIIEGIAQGLLYLHQYSRLRVIHRDLKASNILLDKDMNPKISDFGMARMF 315 (476)
Q Consensus 241 ~~~~l~~Ey~~~~~-----~~~~L~~~~~~~i~~qIa~gL~yLH~~~~~~ivH~DLkp~NILld~~~~~kL~DFGla~~~ 315 (476)
+..+++|||++.+. .++.+++.++..++.||+.||+|||+++ |+||||||+|||++.++.+||+|||+++.+
T Consensus 90 ~~~~ivmEy~~gg~L~~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~~---iiHrDiKp~NILl~~~~~vkl~DFG~a~~~ 166 (293)
T d1yhwa1 90 DELWVVMEYLAGGSLTDVVTETCMDEGQIAAVCRECLQALEFLHSNQ---VIHRDIKSDNILLGMDGSVKLTDFGFCAQI 166 (293)
T ss_dssp TEEEEEEECCTTCBHHHHHHHSCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEECTTCCEEECCCTTCEEC
T ss_pred CEEEEEEEecCCCcHHHHhhccCCCHHHHHHHHHHHHHHHHHHHHCC---CcccCCcHHHeEECCCCcEeeccchhheee
Confidence 46889999998432 2457999999999999999999999999 999999999999999999999999999987
Q ss_pred CCCcccccceeeeeccCCCChhhhccCCCCccceEEeehhhhhhhhhCCCCCCcCCCCchhhhhhhhhhhcCCCcccccC
Q 045315 316 GGDELQSNTKRIVGTYGYMSPEYALRGLFSIKSDVFSFGVLLLETLSSKKNTHFYNTDSLTLLGHAWNLWNDGRTWELMD 395 (476)
Q Consensus 316 ~~~~~~~~~~~~~gt~~y~aPE~l~~~~~s~ksDVwSlGvvl~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~d 395 (476)
..... ......||+.|+|||++.+..++.++|||||||++|||++|+.||...... ... ......+.. ..
T Consensus 167 ~~~~~--~~~~~~gt~~Y~aPE~~~~~~~~~~~DiwSlGvilyemltG~~Pf~~~~~~--~~~---~~~~~~~~~-~~-- 236 (293)
T d1yhwa1 167 TPEQS--KRSTMVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMIEGEPPYLNENPL--RAL---YLIATNGTP-EL-- 236 (293)
T ss_dssp CSTTC--CBCCCCSCGGGCCHHHHSSSCBCTHHHHHHHHHHHHHHHHSSCTTTTSCHH--HHH---HHHHHHCSC-CC--
T ss_pred ccccc--cccccccCCCccChhhhcCCCCCchhceehHhHHHHHHhhCCCCCCCCCHH--HHH---HHHHhCCCC-CC--
Confidence 54332 223357999999999999999999999999999999999999998644311 111 111111110 00
Q ss_pred cccCCCCCHHHHHHHHHHHHHchhhcccCCCCHHHHHH
Q 045315 396 PISQNGASYPILKRYINVALLCVQEKAADRPAMSEVVS 433 (476)
Q Consensus 396 ~~~~~~~~~~~~~~l~~li~~Cl~~dP~~RPt~~eVl~ 433 (476)
..+......+.+++.+||+.||++|||++|+++
T Consensus 237 -----~~~~~~s~~~~~li~~~L~~dP~~R~s~~eil~ 269 (293)
T d1yhwa1 237 -----QNPEKLSAIFRDFLNRCLDMDVEKRGSAKELLQ 269 (293)
T ss_dssp -----SSGGGSCHHHHHHHHHHTCSSTTTSCCHHHHTT
T ss_pred -----CCcccCCHHHHHHHHHHccCChhHCcCHHHHhc
Confidence 111223467889999999999999999999875
|
| >d1k2pa_ d.144.1.7 (A:) Bruton's tyrosine kinase (Btk) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Bruton's tyrosine kinase (Btk) species: Human (Homo sapiens) [TaxId: 9606]
Probab=99.97 E-value=4.6e-33 Score=266.08 Aligned_cols=178 Identities=25% Similarity=0.344 Sum_probs=141.7
Q ss_pred cccceeeccCCCC-------CCCCCCChhhHHHHHHHHHHHHHHHhhcCCCceeecCCCccceEecCCCCceecccccee
Q 045315 241 DEISFWYESYNNP-------TKKGLLCWGTRVRIIEGIAQGLLYLHQYSRLRVIHRDLKASNILLDKDMNPKISDFGMAR 313 (476)
Q Consensus 241 ~~~~l~~Ey~~~~-------~~~~~L~~~~~~~i~~qIa~gL~yLH~~~~~~ivH~DLkp~NILld~~~~~kL~DFGla~ 313 (476)
+..+++|||++.+ .....+++..+++++.||++||+|||+++ |+||||||+||+++.++.+||+|||+++
T Consensus 72 ~~~~iv~Ey~~~g~l~~~~~~~~~~~~~~~~~~i~~qi~~gl~~LH~~~---iiH~dlk~~Nill~~~~~~kl~DfG~a~ 148 (258)
T d1k2pa_ 72 RPIFIITEYMANGCLLNYLREMRHRFQTQQLLEMCKDVCEAMEYLESKQ---FLHRDLAARNCLVNDQGVVKVSDFGLSR 148 (258)
T ss_dssp SSEEEEEECCTTEEHHHHHHSGGGCCCHHHHHHHHHHHHHHHHHHHHTT---BCCSCCSGGGEEECTTCCEEECCCSSCC
T ss_pred CceEEEEEccCCCcHHHhhhccccCCcHHHHHHHHHHHHHHHHHHhhcC---cccccccceeEEEcCCCcEEECcchhhe
Confidence 5789999999832 34567999999999999999999999998 9999999999999999999999999998
Q ss_pred ecCCCcccccceeeeeccCCCChhhhccCCCCccceEEeehhhhhhhhh-CCCCCCcCCCCchhhhhhhhhhhcCCCccc
Q 045315 314 MFGGDELQSNTKRIVGTYGYMSPEYALRGLFSIKSDVFSFGVLLLETLS-SKKNTHFYNTDSLTLLGHAWNLWNDGRTWE 392 (476)
Q Consensus 314 ~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~s~ksDVwSlGvvl~ellt-G~~p~~~~~~~~~~~~~~~~~~~~~~~~~~ 392 (476)
........ ......||..|+|||.+.+..++.++|||||||++|||+| |+.||...... .+... ...+..
T Consensus 149 ~~~~~~~~-~~~~~~~t~~y~aPE~~~~~~~~~ksDiwS~G~~l~el~t~g~~Pf~~~~~~--~~~~~----i~~~~~-- 219 (258)
T d1k2pa_ 149 YVLDDEYT-SSVGSKFPVRWSPPEVLMYSKFSSKSDIWAFGVLMWEIYSLGKMPYERFTNS--ETAEH----IAQGLR-- 219 (258)
T ss_dssp BCSSSSCC-CCCCSCCCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTSCHH--HHHHH----HHTTCC--
T ss_pred eccCCCce-eecccCCCCCcCCcHHhcCCCCCcceeecccchhhHhHHhcCCCCCCCCCHH--HHHHH----HHhCCC--
Confidence 76544322 2233568999999999999999999999999999999998 78888654321 12211 111111
Q ss_pred ccCcccCCCCCHHHHHHHHHHHHHchhhcccCCCCHHHHHHHHhc
Q 045315 393 LMDPISQNGASYPILKRYINVALLCVQEKAADRPAMSEVVSMLSN 437 (476)
Q Consensus 393 ~~d~~~~~~~~~~~~~~l~~li~~Cl~~dP~~RPt~~eVl~~L~~ 437 (476)
... +....+.+.+++.+||+.||++|||+++|++.|.+
T Consensus 220 ~~~-------p~~~~~~l~~li~~cl~~dP~~RPt~~eil~~L~d 257 (258)
T d1k2pa_ 220 LYR-------PHLASEKVYTIMYSCWHEKADERPTFKILLSNILD 257 (258)
T ss_dssp CCC-------CTTCCHHHHHHHHHTTCSSGGGSCCHHHHHHHHHC
T ss_pred CCC-------cccccHHHHHHHHHHccCCHhHCcCHHHHHHHhhC
Confidence 111 11223578899999999999999999999999865
|
| >d1xkka_ d.144.1.7 (A:) EGF receptor tyrosine kinase, Erbb-1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: EGF receptor tyrosine kinase, Erbb-1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=99.97 E-value=1.8e-33 Score=277.07 Aligned_cols=181 Identities=22% Similarity=0.309 Sum_probs=138.8
Q ss_pred cccceeeccCCCC-------CCCCCCChhhHHHHHHHHHHHHHHHhhcCCCceeecCCCccceEecCCCCceecccccee
Q 045315 241 DEISFWYESYNNP-------TKKGLLCWGTRVRIIEGIAQGLLYLHQYSRLRVIHRDLKASNILLDKDMNPKISDFGMAR 313 (476)
Q Consensus 241 ~~~~l~~Ey~~~~-------~~~~~L~~~~~~~i~~qIa~gL~yLH~~~~~~ivH~DLkp~NILld~~~~~kL~DFGla~ 313 (476)
+..++++||+..+ .+...+++.++++++.||+.||+|||+++ |+||||||+|||++.++.+||+|||+++
T Consensus 83 ~~~~~v~e~~~~~~l~~~~~~~~~~~~~~~~~~i~~qi~~gl~yLH~~~---iiHrDlKp~NIll~~~~~~kl~DFGla~ 159 (317)
T d1xkka_ 83 STVQLITQLMPFGCLLDYVREHKDNIGSQYLLNWCVQIAKGMNYLEDRR---LVHRDLAARNVLVKTPQHVKITDFGLAK 159 (317)
T ss_dssp SSEEEEEECCTTCBHHHHHHHTSSSCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEEEETTEEEECCCSHHH
T ss_pred CCeeEEEEeccCCcccccccccccCCCHHHHHHHHHHHHHHHHHHHHcC---cccCcchhhcceeCCCCCeEeeccccce
Confidence 3566777887733 34668999999999999999999999998 9999999999999999999999999999
Q ss_pred ecCCCcccccceeeeeccCCCChhhhccCCCCccceEEeehhhhhhhhh-CCCCCCcCCCCchhhhhhhhhhhcCCCccc
Q 045315 314 MFGGDELQSNTKRIVGTYGYMSPEYALRGLFSIKSDVFSFGVLLLETLS-SKKNTHFYNTDSLTLLGHAWNLWNDGRTWE 392 (476)
Q Consensus 314 ~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~s~ksDVwSlGvvl~ellt-G~~p~~~~~~~~~~~~~~~~~~~~~~~~~~ 392 (476)
...............||..|+|||.+.++.++.++|||||||++|||+| |++||....... +.. ....+...
T Consensus 160 ~~~~~~~~~~~~~~~gt~~y~APE~l~~~~~~~~sDvwS~Gvil~el~t~g~~p~~~~~~~~--~~~----~i~~~~~~- 232 (317)
T d1xkka_ 160 LLGAEEKEYHAEGGKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPASE--ISS----ILEKGERL- 232 (317)
T ss_dssp HTTTTCC--------CCTTTSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTSCGGG--HHH----HHHHTCCC-
T ss_pred ecccccccccccccccCccccChHHHhcCCCChhhhhhhHHHHHHHHHHCCCCCCCCCCHHH--HHH----HHHcCCCC-
Confidence 8765544444444678999999999999999999999999999999998 777776443221 111 11111111
Q ss_pred ccCcccCCCCCHHHHHHHHHHHHHchhhcccCCCCHHHHHHHHhccc
Q 045315 393 LMDPISQNGASYPILKRYINVALLCVQEKAADRPAMSEVVSMLSNEF 439 (476)
Q Consensus 393 ~~d~~~~~~~~~~~~~~l~~li~~Cl~~dP~~RPt~~eVl~~L~~~~ 439 (476)
..+......+.+++.+||+.||++|||+.||++.|+.+.
T Consensus 233 --------~~p~~~~~~~~~li~~cl~~dP~~RPs~~eil~~l~~~~ 271 (317)
T d1xkka_ 233 --------PQPPICTIDVYMIMVKCWMIDADSRPKFRELIIEFSKMA 271 (317)
T ss_dssp --------CCCTTBCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHH
T ss_pred --------CCCcccCHHHHHHHHHhCCCChhhCcCHHHHHHHHHHHH
Confidence 111223457889999999999999999999999988764
|
| >d1lufa_ d.144.1.7 (A:) Musk tyrosine kinase {Rat (Rattus norvegicus) [TaxId: 10116]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Musk tyrosine kinase species: Rat (Rattus norvegicus) [TaxId: 10116]
Probab=99.97 E-value=6.7e-33 Score=271.03 Aligned_cols=166 Identities=24% Similarity=0.343 Sum_probs=130.4
Q ss_pred CCCCChhhHHHHHHHHHHHHHHHhhcCCCceeecCCCccceEecCCCCceeccccceeecCCCcccccceeeeeccCCCC
Q 045315 256 KGLLCWGTRVRIIEGIAQGLLYLHQYSRLRVIHRDLKASNILLDKDMNPKISDFGMARMFGGDELQSNTKRIVGTYGYMS 335 (476)
Q Consensus 256 ~~~L~~~~~~~i~~qIa~gL~yLH~~~~~~ivH~DLkp~NILld~~~~~kL~DFGla~~~~~~~~~~~~~~~~gt~~y~a 335 (476)
...|++.+++.|+.||+.||+|||+++ ||||||||+|||++.++.+||+|||+++...............+++.|+|
T Consensus 134 ~~~l~~~~~~~i~~qi~~gl~ylH~~~---ivHrDlKp~NILld~~~~~Kl~DFGls~~~~~~~~~~~~~~~~~~~~y~a 210 (301)
T d1lufa_ 134 PPPLSCAEQLCIARQVAAGMAYLSERK---FVHRDLATRNCLVGENMVVKIADFGLSRNIYSADYYKADGNDAIPIRWMP 210 (301)
T ss_dssp -CCCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCSGGGEEECGGGCEEECCCSCHHHHTGGGCBC----CCBCGGGCC
T ss_pred CCCCCHHHHHHHHHHHHHHhhhcccCC---eEeeEEcccceEECCCCcEEEccchhheeccCCccccccCCCCcCcCcCC
Confidence 346899999999999999999999999 99999999999999999999999999987655444444445678899999
Q ss_pred hhhhccCCCCccceEEeehhhhhhhhhCCC-CCCcCCCCchhhhhhhhhhhcCCCcccccCcccCCCCCHHHHHHHHHHH
Q 045315 336 PEYALRGLFSIKSDVFSFGVLLLETLSSKK-NTHFYNTDSLTLLGHAWNLWNDGRTWELMDPISQNGASYPILKRYINVA 414 (476)
Q Consensus 336 PE~l~~~~~s~ksDVwSlGvvl~elltG~~-p~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~l~~li 414 (476)
||.+.+..++.++|||||||++|||++|.. ||.... ....... ...+.... .+...+.++.+|+
T Consensus 211 PE~~~~~~~t~ksDVwS~Gvvl~ell~~~~~p~~~~~--~~e~~~~----v~~~~~~~---------~p~~~~~~~~~li 275 (301)
T d1lufa_ 211 PESIFYNRYTTESDVWAYGVVLWEIFSYGLQPYYGMA--HEEVIYY----VRDGNILA---------CPENCPLELYNLM 275 (301)
T ss_dssp HHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCTTTTSC--HHHHHHH----HHTTCCCC---------CCTTCCHHHHHHH
T ss_pred HHHHccCCCChhhhhccchhhHHHHHccCCCCCCCCC--HHHHHHH----HHcCCCCC---------CCccchHHHHHHH
Confidence 999999999999999999999999999964 554332 2222211 22222211 1122335788999
Q ss_pred HHchhhcccCCCCHHHHHHHHhccc
Q 045315 415 LLCVQEKAADRPAMSEVVSMLSNEF 439 (476)
Q Consensus 415 ~~Cl~~dP~~RPt~~eVl~~L~~~~ 439 (476)
.+||+.||++||||.||+++|+++.
T Consensus 276 ~~cl~~~P~~RPt~~ev~~~L~~i~ 300 (301)
T d1lufa_ 276 RLCWSKLPADRPSFCSIHRILQRMC 300 (301)
T ss_dssp HHHTCSSGGGSCCHHHHHHHHHHTT
T ss_pred HHHcCCChhHCcCHHHHHHHHHHhc
Confidence 9999999999999999999999875
|
| >d1uu3a_ d.144.1.7 (A:) 3-phosphoinositide dependent protein kinase-1 Pdk1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: 3-phosphoinositide dependent protein kinase-1 Pdk1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=99.97 E-value=2.2e-33 Score=272.50 Aligned_cols=173 Identities=24% Similarity=0.304 Sum_probs=134.3
Q ss_pred cccceeeccCCCC------CCCCCCChhhHHHHHHHHHHHHHHHhhcCCCceeecCCCccceEecCCCCceeccccceee
Q 045315 241 DEISFWYESYNNP------TKKGLLCWGTRVRIIEGIAQGLLYLHQYSRLRVIHRDLKASNILLDKDMNPKISDFGMARM 314 (476)
Q Consensus 241 ~~~~l~~Ey~~~~------~~~~~L~~~~~~~i~~qIa~gL~yLH~~~~~~ivH~DLkp~NILld~~~~~kL~DFGla~~ 314 (476)
+..+++|||++.+ ...+.+++.++..++.||+.||+|||+.+ |+||||||+|||+++++.+||+|||+|+.
T Consensus 81 ~~~~ivmEy~~gg~L~~~~~~~~~l~e~~~~~~~~qi~~al~ylH~~~---iiHrDiKp~NIll~~~~~vkl~DFG~a~~ 157 (288)
T d1uu3a_ 81 EKLYFGLSYAKNGELLKYIRKIGSFDETCTRFYTAEIVSALEYLHGKG---IIHRDLKPENILLNEDMHIQITDFGTAKV 157 (288)
T ss_dssp SEEEEEECCCTTEEHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEECTTSCEEECCCTTCEE
T ss_pred CEEEEEEEccCCCCHHHhhhccCCCCHHHHHHHHHHHHHHHHhhcccc---EEcCcCCccccccCCCceEEeccccccee
Confidence 4678999999843 23568999999999999999999999999 99999999999999999999999999998
Q ss_pred cCCCcccccceeeeeccCCCChhhhccCCCCccceEEeehhhhhhhhhCCCCCCcCCCCchhhhhhhhhhhcCCCccccc
Q 045315 315 FGGDELQSNTKRIVGTYGYMSPEYALRGLFSIKSDVFSFGVLLLETLSSKKNTHFYNTDSLTLLGHAWNLWNDGRTWELM 394 (476)
Q Consensus 315 ~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~s~ksDVwSlGvvl~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 394 (476)
+.............||+.|+|||++.+..++.++|||||||++|||++|+.||...+. ...... ...+.. .
T Consensus 158 ~~~~~~~~~~~~~~GT~~Y~APE~~~~~~~~~~~DiwSlGvilyell~g~~Pf~~~~~--~~~~~~----i~~~~~-~-- 228 (288)
T d1uu3a_ 158 LSPESKQARANSFVGTAQYVSPELLTEKSACKSSDLWALGCIIYQLVAGLPPFRAGNE--YLIFQK----IIKLEY-D-- 228 (288)
T ss_dssp CC----------CCCCGGGCCHHHHHTCCCCHHHHHHHHHHHHHHHHHSSCSSCCSSH--HHHHHH----HHTTCC-C--
T ss_pred cccCCcccccccccCCccccCceeeccCCCCcccceehhhHHHHHHhhCCCCCCCcCH--HHHHHH----HHcCCC-C--
Confidence 7654433344456799999999999999999999999999999999999999875431 111111 111111 0
Q ss_pred CcccCCCCCHHHHHHHHHHHHHchhhcccCCCCHHHHH
Q 045315 395 DPISQNGASYPILKRYINVALLCVQEKAADRPAMSEVV 432 (476)
Q Consensus 395 d~~~~~~~~~~~~~~l~~li~~Cl~~dP~~RPt~~eVl 432 (476)
.+....+.+.+++.+||+.||++|||++|++
T Consensus 229 -------~p~~~s~~~~~li~~~L~~dP~~R~t~~e~~ 259 (288)
T d1uu3a_ 229 -------FPEKFFPKARDLVEKLLVLDATKRLGCEEME 259 (288)
T ss_dssp -------CCTTCCHHHHHHHHTTSCSSGGGSTTSGGGT
T ss_pred -------CCccCCHHHHHHHHHHccCCHhHCcCHHHHc
Confidence 1112345688999999999999999999864
|
| >d1mp8a_ d.144.1.7 (A:) Focal adhesion kinase 1 (fak) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Focal adhesion kinase 1 (fak) species: Human (Homo sapiens) [TaxId: 9606]
Probab=99.97 E-value=2.1e-33 Score=270.74 Aligned_cols=180 Identities=21% Similarity=0.288 Sum_probs=132.0
Q ss_pred cccceeeccCCCC-------CCCCCCChhhHHHHHHHHHHHHHHHhhcCCCceeecCCCccceEecCCCCceecccccee
Q 045315 241 DEISFWYESYNNP-------TKKGLLCWGTRVRIIEGIAQGLLYLHQYSRLRVIHRDLKASNILLDKDMNPKISDFGMAR 313 (476)
Q Consensus 241 ~~~~l~~Ey~~~~-------~~~~~L~~~~~~~i~~qIa~gL~yLH~~~~~~ivH~DLkp~NILld~~~~~kL~DFGla~ 313 (476)
+..+++|||++.+ .....+++.+++.++.||++||+|||+++ |+||||||+||+++.++.+||+|||+++
T Consensus 80 ~~~~iv~E~~~~g~l~~~~~~~~~~l~~~~~~~~~~qi~~gl~ylH~~~---iiHrDlKp~NIll~~~~~~Kl~DfG~a~ 156 (273)
T d1mp8a_ 80 NPVWIIMELCTLGELRSFLQVRKYSLDLASLILYAYQLSTALAYLESKR---FVHRDIAARNVLVSSNDCVKLGDFGLSR 156 (273)
T ss_dssp SSCEEEEECCTTEEHHHHHHHTTTTSCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCSGGGEEEEETTEEEECC-----
T ss_pred CeEEEEEEeccCCcHHhhhhccCCCCCHHHHHHHHHHHHHHhhhhcccC---eeccccchhheeecCCCcEEEccchhhe
Confidence 4678999999832 34567999999999999999999999999 9999999999999999999999999998
Q ss_pred ecCCCcccccceeeeeccCCCChhhhccCCCCccceEEeehhhhhhhhh-CCCCCCcCCCCchhhhhhhhhhhcCCCccc
Q 045315 314 MFGGDELQSNTKRIVGTYGYMSPEYALRGLFSIKSDVFSFGVLLLETLS-SKKNTHFYNTDSLTLLGHAWNLWNDGRTWE 392 (476)
Q Consensus 314 ~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~s~ksDVwSlGvvl~ellt-G~~p~~~~~~~~~~~~~~~~~~~~~~~~~~ 392 (476)
.+..... .......||+.|+|||.+.+..++.++|||||||++|||++ |.+|+...... .+... ...+....
T Consensus 157 ~~~~~~~-~~~~~~~gt~~y~apE~l~~~~~~~~~DiwSlGvil~e~lt~g~~P~~~~~~~--~~~~~----i~~~~~~~ 229 (273)
T d1mp8a_ 157 YMEDSTY-YKASKGKLPIKWMAPESINFRRFTSASDVWMFGVCMWEILMHGVKPFQGVKNN--DVIGR----IENGERLP 229 (273)
T ss_dssp ---------------CCGGGCCHHHHHHCCCSHHHHHHHHHHHHHHHHTTSCCTTTTCCGG--GHHHH----HHTTCCCC
T ss_pred eccCCcc-eeccceecCcccchhhHhccCCCCCccccccchHHHHHHHhcCCCCCCCCCHH--HHHHH----HHcCCCCC
Confidence 7654322 22334568999999999999999999999999999999998 78887654322 11111 11221111
Q ss_pred ccCcccCCCCCHHHHHHHHHHHHHchhhcccCCCCHHHHHHHHhccc
Q 045315 393 LMDPISQNGASYPILKRYINVALLCVQEKAADRPAMSEVVSMLSNEF 439 (476)
Q Consensus 393 ~~d~~~~~~~~~~~~~~l~~li~~Cl~~dP~~RPt~~eVl~~L~~~~ 439 (476)
.+....+.+.+++.+||+.||++|||+.||++.|+.+.
T Consensus 230 ---------~~~~~~~~~~~li~~cl~~dp~~Rps~~ei~~~L~~i~ 267 (273)
T d1mp8a_ 230 ---------MPPNCPPTLYSLMTKCWAYDPSRRPRFTELKAQLSTIL 267 (273)
T ss_dssp ---------CCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHH
T ss_pred ---------CCCCCCHHHHHHHHHHcCCCHhHCcCHHHHHHHHHHHH
Confidence 11223457889999999999999999999999998764
|
| >d1t4ha_ d.144.1.7 (A:) Protein kinase wnk1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Protein kinase wnk1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=99.97 E-value=8e-33 Score=266.13 Aligned_cols=173 Identities=22% Similarity=0.319 Sum_probs=132.0
Q ss_pred ccceeeccCCCCC------CCCCCChhhHHHHHHHHHHHHHHHhhcCCCceeecCCCccceEec-CCCCceeccccceee
Q 045315 242 EISFWYESYNNPT------KKGLLCWGTRVRIIEGIAQGLLYLHQYSRLRVIHRDLKASNILLD-KDMNPKISDFGMARM 314 (476)
Q Consensus 242 ~~~l~~Ey~~~~~------~~~~L~~~~~~~i~~qIa~gL~yLH~~~~~~ivH~DLkp~NILld-~~~~~kL~DFGla~~ 314 (476)
..+++|||++.++ +...+++.++..++.||++||+|||+++ .+|+||||||+|||++ +++.+||+|||+++.
T Consensus 86 ~~~ivmE~~~~g~L~~~l~~~~~~~~~~~~~~~~qi~~gl~yLH~~~-~~IiHrDiKp~NILl~~~~~~~Kl~DFGla~~ 164 (270)
T d1t4ha_ 86 CIVLVTELMTSGTLKTYLKRFKVMKIKVLRSWCRQILKGLQFLHTRT-PPIIHRDLKCDNIFITGPTGSVKIGDLGLATL 164 (270)
T ss_dssp EEEEEEECCCSCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHTSS-SCCCCSCCCGGGEEESSTTSCEEECCTTGGGG
T ss_pred EEEEEEeCCCCCcHHHHHhccccccHHHHHHHHHHHHHHHHHHHHCC-CCEEeCCcChhhceeeCCCCCEEEeecCccee
Confidence 4678999998442 3467999999999999999999999975 4599999999999996 578999999999986
Q ss_pred cCCCcccccceeeeeccCCCChhhhccCCCCccceEEeehhhhhhhhhCCCCCCcCCCCchhhhhhhhhhhcCCCccccc
Q 045315 315 FGGDELQSNTKRIVGTYGYMSPEYALRGLFSIKSDVFSFGVLLLETLSSKKNTHFYNTDSLTLLGHAWNLWNDGRTWELM 394 (476)
Q Consensus 315 ~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~s~ksDVwSlGvvl~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 394 (476)
.... ......||+.|+|||.+.+ .++.++|||||||++|||++|+.||...... ..+.. ....+......
T Consensus 165 ~~~~----~~~~~~GT~~Y~aPE~~~~-~~~~~~DIwSlGvilyel~~g~~Pf~~~~~~-~~~~~----~i~~~~~~~~~ 234 (270)
T d1t4ha_ 165 KRAS----FAKAVIGTPEFMAPEMYEE-KYDESVDVYAFGMCMLEMATSEYPYSECQNA-AQIYR----RVTSGVKPASF 234 (270)
T ss_dssp CCTT----SBEESCSSCCCCCGGGGGT-CCCTHHHHHHHHHHHHHHHHSSCTTTTCSSH-HHHHH----HHTTTCCCGGG
T ss_pred ccCC----ccCCcccCccccCHHHhCC-CCCCcCchhhHHHHHHHHHHCCCCCCCcccH-HHHHH----HHHcCCCCccc
Confidence 4332 2334679999999998865 6999999999999999999999998643211 11111 11111111111
Q ss_pred CcccCCCCCHHHHHHHHHHHHHchhhcccCCCCHHHHHH
Q 045315 395 DPISQNGASYPILKRYINVALLCVQEKAADRPAMSEVVS 433 (476)
Q Consensus 395 d~~~~~~~~~~~~~~l~~li~~Cl~~dP~~RPt~~eVl~ 433 (476)
+ ....+.+.+++.+||+.||++|||++|+++
T Consensus 235 ~--------~~~~~~~~~li~~~l~~dp~~R~s~~ell~ 265 (270)
T d1t4ha_ 235 D--------KVAIPEVKEIIEGCIRQNKDERYSIKDLLN 265 (270)
T ss_dssp G--------GCCCHHHHHHHHHHSCSSGGGSCCHHHHHT
T ss_pred C--------ccCCHHHHHHHHHHccCCHhHCcCHHHHhC
Confidence 1 112345789999999999999999999975
|
| >d1fgka_ d.144.1.7 (A:) Fibroblast growth factor receptor 1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Fibroblast growth factor receptor 1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=99.97 E-value=6.6e-33 Score=270.82 Aligned_cols=181 Identities=25% Similarity=0.330 Sum_probs=143.9
Q ss_pred cccceeeccCCCCC----------------------CCCCCChhhHHHHHHHHHHHHHHHhhcCCCceeecCCCccceEe
Q 045315 241 DEISFWYESYNNPT----------------------KKGLLCWGTRVRIIEGIAQGLLYLHQYSRLRVIHRDLKASNILL 298 (476)
Q Consensus 241 ~~~~l~~Ey~~~~~----------------------~~~~L~~~~~~~i~~qIa~gL~yLH~~~~~~ivH~DLkp~NILl 298 (476)
+.++++|||++.+. ....|++.++++++.||+.||+|||+++ ||||||||+|||+
T Consensus 92 ~~~~~v~e~~~~g~l~~~i~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~al~ylH~~~---ivHrDiKp~NiLl 168 (299)
T d1fgka_ 92 GPLYVIVEYASKGNLREYLQARRPPGLEYSYNPSHNPEEQLSSKDLVSCAYQVARGMEYLASKK---CIHRDLAARNVLV 168 (299)
T ss_dssp SSCEEEECCCTTCBHHHHHHTTSCC------------CCCCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCSGGGEEE
T ss_pred CeEEEEEEccCCCcHHHHHHhhcCCccccccccccCccccCCHHHHHHHHHHHHHHHHHhhhCC---EEeeeecccceee
Confidence 46788999998221 2356999999999999999999999999 9999999999999
Q ss_pred cCCCCceeccccceeecCCCcccccceeeeeccCCCChhhhccCCCCccceEEeehhhhhhhhh-CCCCCCcCCCCchhh
Q 045315 299 DKDMNPKISDFGMARMFGGDELQSNTKRIVGTYGYMSPEYALRGLFSIKSDVFSFGVLLLETLS-SKKNTHFYNTDSLTL 377 (476)
Q Consensus 299 d~~~~~kL~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~s~ksDVwSlGvvl~ellt-G~~p~~~~~~~~~~~ 377 (476)
+.++.+||+|||+++...............+++.|+|||.+.++.++.++|||||||++|||++ |.+||...... .+
T Consensus 169 ~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~l~~~~y~~k~DiwS~Gvvl~ell~~g~~p~~~~~~~--~~ 246 (299)
T d1fgka_ 169 TEDNVMKIADFGLARDIHHIDYYKKTTNGRLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEIFTLGGSPYPGVPVE--EL 246 (299)
T ss_dssp CTTCCEEECSTTCCCCGGGCCTTCCCTTSCCGGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCHH--HH
T ss_pred cCCCCeEeccchhhccccccccccccccCCCChhhhhhhHhcCCCCCchhhhHHhHHHHHHhccCCCCCCCCCCHH--HH
Confidence 9999999999999997765544444455678999999999999999999999999999999998 67776543321 11
Q ss_pred hhhhhhhhcCCCcccccCcccCCCCCHHHHHHHHHHHHHchhhcccCCCCHHHHHHHHhccc
Q 045315 378 LGHAWNLWNDGRTWELMDPISQNGASYPILKRYINVALLCVQEKAADRPAMSEVVSMLSNEF 439 (476)
Q Consensus 378 ~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~l~~li~~Cl~~dP~~RPt~~eVl~~L~~~~ 439 (476)
...+..+.... .+....+.+.+++.+||+.||++|||+.||++.|+++.
T Consensus 247 ----~~~i~~~~~~~---------~p~~~~~~l~~li~~cl~~dP~~Rps~~eil~~L~~i~ 295 (299)
T d1fgka_ 247 ----FKLLKEGHRMD---------KPSNCTNELYMMMRDCWHAVPSQRPTFKQLVEDLDRIV 295 (299)
T ss_dssp ----HHHHHTTCCCC---------CCSSCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHH
T ss_pred ----HHHHHcCCCCC---------CCccchHHHHHHHHHHccCCHhHCcCHHHHHHHHHHHh
Confidence 12222222111 11223457889999999999999999999999999875
|
| >d2jfla1 d.144.1.7 (A:21-308) STE20-like serine/threonine-protein kinase, SLK {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: STE20-like serine/threonine-protein kinase, SLK species: Human (Homo sapiens) [TaxId: 9606]
Probab=99.97 E-value=4.3e-33 Score=270.50 Aligned_cols=175 Identities=23% Similarity=0.310 Sum_probs=135.1
Q ss_pred cccceeeccCCCC-------CCCCCCChhhHHHHHHHHHHHHHHHhhcCCCceeecCCCccceEecCCCCceecccccee
Q 045315 241 DEISFWYESYNNP-------TKKGLLCWGTRVRIIEGIAQGLLYLHQYSRLRVIHRDLKASNILLDKDMNPKISDFGMAR 313 (476)
Q Consensus 241 ~~~~l~~Ey~~~~-------~~~~~L~~~~~~~i~~qIa~gL~yLH~~~~~~ivH~DLkp~NILld~~~~~kL~DFGla~ 313 (476)
+.++++|||++.+ ...++|++.++..++.||+.||+|||+++ |+||||||+|||++.++.+||+|||+|+
T Consensus 82 ~~~~lvmEy~~~g~L~~~~~~~~~~l~e~~~~~i~~qi~~gL~ylH~~~---ivHrDiKp~NIll~~~~~~Kl~DFG~a~ 158 (288)
T d2jfla1 82 NNLWILIEFCAGGAVDAVMLELERPLTESQIQVVCKQTLDALNYLHDNK---IIHRDLKAGNILFTLDGDIKLADFGVSA 158 (288)
T ss_dssp TEEEEEEECCTTEEHHHHHHHHTSCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEECTTSCEEECCCTTCE
T ss_pred CeEEEEEecCCCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCC---EEEeecChhheeECCCCCEEEEechhhh
Confidence 5688999999832 23567999999999999999999999999 9999999999999999999999999998
Q ss_pred ecCCCcccccceeeeeccCCCChhhhc-----cCCCCccceEEeehhhhhhhhhCCCCCCcCCCCchhhhhhhhhhhcCC
Q 045315 314 MFGGDELQSNTKRIVGTYGYMSPEYAL-----RGLFSIKSDVFSFGVLLLETLSSKKNTHFYNTDSLTLLGHAWNLWNDG 388 (476)
Q Consensus 314 ~~~~~~~~~~~~~~~gt~~y~aPE~l~-----~~~~s~ksDVwSlGvvl~elltG~~p~~~~~~~~~~~~~~~~~~~~~~ 388 (476)
...... .......||+.|+|||++. +..|+.++|||||||++|||++|+.||....... .... ... +
T Consensus 159 ~~~~~~--~~~~~~~Gt~~y~APE~l~~~~~~~~~y~~k~DiwSlGvilyemltg~~Pf~~~~~~~--~~~~---i~~-~ 230 (288)
T d2jfla1 159 KNTRTI--QRRDSFIGTPYWMAPEVVMCETSKDRPYDYKADVWSLGITLIEMAEIEPPHHELNPMR--VLLK---IAK-S 230 (288)
T ss_dssp ECHHHH--HHHTCCCSCCTTCCHHHHTTCSTTTSSTTTHHHHHHHHHHHHHHHHSSCTTTTSCGGG--HHHH---HHH-S
T ss_pred ccCCCc--ccccccccccccCCHHHHhhcccCCCCCChhhhHHHHHHHHHHHhhCCCCCCCCCHHH--HHHH---HHc-C
Confidence 653321 1122357999999999984 4568999999999999999999999986543221 1111 111 1
Q ss_pred CcccccCcccCCCCCHHHHHHHHHHHHHchhhcccCCCCHHHHHH
Q 045315 389 RTWELMDPISQNGASYPILKRYINVALLCVQEKAADRPAMSEVVS 433 (476)
Q Consensus 389 ~~~~~~d~~~~~~~~~~~~~~l~~li~~Cl~~dP~~RPt~~eVl~ 433 (476)
....+ ..+......+.+++.+||+.||++|||++|+++
T Consensus 231 ~~~~~-------~~~~~~s~~~~~li~~~L~~dp~~R~t~~ell~ 268 (288)
T d2jfla1 231 EPPTL-------AQPSRWSSNFKDFLKKCLEKNVDARWTTSQLLQ 268 (288)
T ss_dssp CCCCC-------SSGGGSCHHHHHHHHHHSCSSTTTSCCHHHHTT
T ss_pred CCCCC-------CccccCCHHHHHHHHHHccCChhHCcCHHHHhc
Confidence 11111 111233467889999999999999999999875
|
| >d1s9ja_ d.144.1.7 (A:) Dual specificity mitogen-activated protein kinase kinase 1, Mek1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Dual specificity mitogen-activated protein kinase kinase 1, Mek1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=99.97 E-value=6.4e-33 Score=273.70 Aligned_cols=186 Identities=26% Similarity=0.366 Sum_probs=134.4
Q ss_pred cccceeeccCCCC------CCCCCCChhhHHHHHHHHHHHHHHHhhc-CCCceeecCCCccceEecCCCCceecccccee
Q 045315 241 DEISFWYESYNNP------TKKGLLCWGTRVRIIEGIAQGLLYLHQY-SRLRVIHRDLKASNILLDKDMNPKISDFGMAR 313 (476)
Q Consensus 241 ~~~~l~~Ey~~~~------~~~~~L~~~~~~~i~~qIa~gL~yLH~~-~~~~ivH~DLkp~NILld~~~~~kL~DFGla~ 313 (476)
+..+++|||++.+ .+.+.+++.++..++.||+.||+|||++ + |+||||||+|||++.++.+||+|||+|+
T Consensus 77 ~~~~iVmEy~~gg~L~~~l~~~~~l~~~~~~~~~~qil~aL~yLH~~~~---IiHRDiKP~NILl~~~~~vkl~DFGla~ 153 (322)
T d1s9ja_ 77 GEISICMEHMDGGSLDQVLKKAGRIPEQILGKVSIAVIKGLTYLREKHK---IMHRDVKPSNILVNSRGEIKLCDFGVSG 153 (322)
T ss_dssp SEEEEEEECCTTEEHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHHHC---CCCSCCSGGGEEECTTCCEEECCCCCCH
T ss_pred CEEEEEEEcCCCCcHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHHhCC---EEccccCHHHeeECCCCCEEEeeCCCcc
Confidence 4678999999832 2355799999999999999999999974 7 9999999999999999999999999998
Q ss_pred ecCCCcccccceeeeeccCCCChhhhccCCCCccceEEeehhhhhhhhhCCCCCCcCCCCchhhhhhhhhhhcC------
Q 045315 314 MFGGDELQSNTKRIVGTYGYMSPEYALRGLFSIKSDVFSFGVLLLETLSSKKNTHFYNTDSLTLLGHAWNLWND------ 387 (476)
Q Consensus 314 ~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~s~ksDVwSlGvvl~elltG~~p~~~~~~~~~~~~~~~~~~~~~------ 387 (476)
..... ......||+.|+|||++.+..|+.++||||+||++|||++|+.||...+................
T Consensus 154 ~~~~~----~~~~~~GT~~Y~APEvl~~~~y~~~~DiWSlGvil~ell~G~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~ 229 (322)
T d1s9ja_ 154 QLIDS----MANSFVGTRSYMSPERLQGTHYSVQSDIWSMGLSLVEMAVGRYPIPPPDAKELELMFGCQVEGDAAETPPR 229 (322)
T ss_dssp HHHHH----TC---CCSSCCCCHHHHHCSCCCTTHHHHHHHHHHHHHHHSSCCSSCCCTTHHHHHC--------------
T ss_pred ccCCC----ccccccCCccccCchHHcCCCCCcHHHHHHHHHHHHHHHHCCCCCCCCCHHHHHHHHHHHhcCCcccCCcc
Confidence 65432 22346899999999999999999999999999999999999999976443221111000000000
Q ss_pred ----C--------------CcccccCccc----CCCCCHHHHHHHHHHHHHchhhcccCCCCHHHHHH
Q 045315 388 ----G--------------RTWELMDPIS----QNGASYPILKRYINVALLCVQEKAADRPAMSEVVS 433 (476)
Q Consensus 388 ----~--------------~~~~~~d~~~----~~~~~~~~~~~l~~li~~Cl~~dP~~RPt~~eVl~ 433 (476)
. ...+..+... ...........+.+++.+||+.||++|||++|+++
T Consensus 230 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~~L~~dP~~R~ta~e~L~ 297 (322)
T d1s9ja_ 230 PRTPGRPLSSYGMDSRPPMAIFELLDYIVNEPPPKLPSGVFSLEFQDFVNKCLIKNPAERADLKQLMV 297 (322)
T ss_dssp ----------------CCCCHHHHHHHHHTSCCCCCCBTTBCHHHHHHHHHHTCSSTTTSCCHHHHHT
T ss_pred cccccccccccccccccchhHHHHHhhhhccCCccCccccCCHHHHHHHHHHcCCChhHCcCHHHHhh
Confidence 0 0000000000 00000112356889999999999999999999986
|
| >d1u46a_ d.144.1.7 (A:) Activated CDC42 kinase 1, ACK1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Activated CDC42 kinase 1, ACK1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=99.97 E-value=9.7e-33 Score=266.04 Aligned_cols=181 Identities=25% Similarity=0.337 Sum_probs=139.0
Q ss_pred cccceeeccCCCCC-------CCCCCChhhHHHHHHHHHHHHHHHhhcCCCceeecCCCccceEecCCCCceecccccee
Q 045315 241 DEISFWYESYNNPT-------KKGLLCWGTRVRIIEGIAQGLLYLHQYSRLRVIHRDLKASNILLDKDMNPKISDFGMAR 313 (476)
Q Consensus 241 ~~~~l~~Ey~~~~~-------~~~~L~~~~~~~i~~qIa~gL~yLH~~~~~~ivH~DLkp~NILld~~~~~kL~DFGla~ 313 (476)
+..++++||++.+. +.+.|++..+++++.||+.||+|||+++ |+||||||+||+++.++.+||+|||+++
T Consensus 83 ~~~~lv~e~~~~~~l~~~~~~~~~~l~~~~~~~~~~qi~~gl~ylH~~~---iiHrDikp~NIll~~~~~vkl~DfGl~~ 159 (273)
T d1u46a_ 83 PPMKMVTELAPLGSLLDRLRKHQGHFLLGTLSRYAVQVAEGMGYLESKR---FIHRDLAARNLLLATRDLVKIGDFGLMR 159 (273)
T ss_dssp SSCEEEEECCTTCBHHHHHHHHGGGSCHHHHHHHHHHHHHHHHHHHHTT---EECSCCCGGGEEEEETTEEEECCCTTCE
T ss_pred cchheeeeeecCcchhhhhhcccCCCCHHHHHHHHHHHHHHHHHhhhCC---EeeeeecHHHhccccccceeeccchhhh
Confidence 35678999998432 3467999999999999999999999998 9999999999999999999999999999
Q ss_pred ecCCCcccc-cceeeeeccCCCChhhhccCCCCccceEEeehhhhhhhhh-CCCCCCcCCCCchhhhhhhhhhhcCCCcc
Q 045315 314 MFGGDELQS-NTKRIVGTYGYMSPEYALRGLFSIKSDVFSFGVLLLETLS-SKKNTHFYNTDSLTLLGHAWNLWNDGRTW 391 (476)
Q Consensus 314 ~~~~~~~~~-~~~~~~gt~~y~aPE~l~~~~~s~ksDVwSlGvvl~ellt-G~~p~~~~~~~~~~~~~~~~~~~~~~~~~ 391 (476)
......... ......|+..|+|||.+.+..++.++|||||||++|||++ |+.||...+.. ... ......+...
T Consensus 160 ~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~Di~S~Gvil~emlt~G~~Pf~~~~~~--~~~---~~i~~~~~~~ 234 (273)
T d1u46a_ 160 ALPQNDDHYVMQEHRKVPFAWCAPESLKTRTFSHASDTWMFGVTLWEMFTYGQEPWIGLNGS--QIL---HKIDKEGERL 234 (273)
T ss_dssp ECCC-CCEEEC-----CCGGGCCHHHHHHCEEEHHHHHHHHHHHHHHHHTTSCCTTTTCCHH--HHH---HHHHTSCCCC
T ss_pred hcccCCCcceecCccccCcccCCHHHHhCCCCCcchhhhhhHHHHHHHHhCCCCCCCCcCHH--HHH---HHHHhCCCCC
Confidence 875543222 2233567889999999999999999999999999999998 89998643311 111 1112222111
Q ss_pred cccCcccCCCCCHHHHHHHHHHHHHchhhcccCCCCHHHHHHHHhcc
Q 045315 392 ELMDPISQNGASYPILKRYINVALLCVQEKAADRPAMSEVVSMLSNE 438 (476)
Q Consensus 392 ~~~d~~~~~~~~~~~~~~l~~li~~Cl~~dP~~RPt~~eVl~~L~~~ 438 (476)
. .+......+.+++.+||+.||++|||+.||++.|++.
T Consensus 235 ~---------~~~~~~~~l~~li~~cl~~dp~~RPt~~ei~~~L~~~ 272 (273)
T d1u46a_ 235 P---------RPEDCPQDIYNVMVQCWAHKPEDRPTFVALRDFLLEA 272 (273)
T ss_dssp C---------CCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHH
T ss_pred C---------CcccccHHHHHHHHHHcCCChhHCcCHHHHHHHHHhc
Confidence 1 1112235688999999999999999999999999763
|
| >d1ua2a_ d.144.1.7 (A:) Cell division protein kinase 7, CDK7 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cell division protein kinase 7, CDK7 species: Human (Homo sapiens) [TaxId: 9606]
Probab=99.97 E-value=9.5e-32 Score=262.43 Aligned_cols=186 Identities=22% Similarity=0.242 Sum_probs=136.2
Q ss_pred cccceeeccCC------CCCCCCCCChhhHHHHHHHHHHHHHHHhhcCCCceeecCCCccceEecCCCCceeccccceee
Q 045315 241 DEISFWYESYN------NPTKKGLLCWGTRVRIIEGIAQGLLYLHQYSRLRVIHRDLKASNILLDKDMNPKISDFGMARM 314 (476)
Q Consensus 241 ~~~~l~~Ey~~------~~~~~~~L~~~~~~~i~~qIa~gL~yLH~~~~~~ivH~DLkp~NILld~~~~~kL~DFGla~~ 314 (476)
+..+++|||++ -...+..+++.++..++.||+.||+|||+++ |+||||||+|||++.++.+||+|||+++.
T Consensus 73 ~~~~ivmE~~~~~~~~~~~~~~~~l~~~~~~~~~~qil~aL~~lH~~~---iiHrDiKp~NIli~~~~~~KL~DFG~a~~ 149 (299)
T d1ua2a_ 73 SNISLVFDFMETDLEVIIKDNSLVLTPSHIKAYMLMTLQGLEYLHQHW---ILHRDLKPNNLLLDENGVLKLADFGLAKS 149 (299)
T ss_dssp TCCEEEEECCSEEHHHHHTTCCSSCCSSHHHHHHHHHHHHHHHHHHTT---CCCCCCCGGGEEECTTCCEEECCCGGGST
T ss_pred CceeehhhhhcchHHhhhhhcccCCCHHHHHHHHHHHHHHHHHhhccc---eecccCCcceEEecCCCccccccCccccc
Confidence 46889999998 2345678999999999999999999999999 99999999999999999999999999987
Q ss_pred cCCCcccccceeeeeccCCCChhhhcc-CCCCccceEEeehhhhhhhhhCCCCCCcCCCCchhhhhhhhhhhcC---CCc
Q 045315 315 FGGDELQSNTKRIVGTYGYMSPEYALR-GLFSIKSDVFSFGVLLLETLSSKKNTHFYNTDSLTLLGHAWNLWND---GRT 390 (476)
Q Consensus 315 ~~~~~~~~~~~~~~gt~~y~aPE~l~~-~~~s~ksDVwSlGvvl~elltG~~p~~~~~~~~~~~~~~~~~~~~~---~~~ 390 (476)
....... .....||+.|+|||.+.. ..++.++|||||||++|||++|+.||....... ......+.... ...
T Consensus 150 ~~~~~~~--~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlGvil~el~~g~~pf~~~~~~~--~l~~i~~~~~~~~~~~~ 225 (299)
T d1ua2a_ 150 FGSPNRA--YTHQVVTRWYRAPELLFGARMYGVGVDMWAVGCILAELLLRVPFLPGDSDLD--QLTRIFETLGTPTEEQW 225 (299)
T ss_dssp TTSCCCC--CCCSCCCCTTCCHHHHTTCSCCCHHHHHHHHHHHHHHHHHSSCSSCCSSHHH--HHHHHHHHHCCCCTTTS
T ss_pred cCCCccc--ccceecChhhccHHHHccCCCCChhhhhhhcchHHHHHHhCcCCCCCCCHHH--HHHHHHHhcCCCChhhc
Confidence 6543222 223578999999999875 467999999999999999999999986543211 11111111000 000
Q ss_pred c---cc---cCcccCCCCC-----HHHHHHHHHHHHHchhhcccCCCCHHHHHH
Q 045315 391 W---EL---MDPISQNGAS-----YPILKRYINVALLCVQEKAADRPAMSEVVS 433 (476)
Q Consensus 391 ~---~~---~d~~~~~~~~-----~~~~~~l~~li~~Cl~~dP~~RPt~~eVl~ 433 (476)
. .. .........+ ....+.+.+++.+||+.||++|||++|+++
T Consensus 226 ~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dll~~~L~~dP~~R~sa~e~L~ 279 (299)
T d1ua2a_ 226 PDMCSLPDYVTFKSFPGIPLHHIFSAAGDDLLDLIQGLFLFNPCARITATQALK 279 (299)
T ss_dssp SSTTSSTTCCCCCCCCCCCHHHHCTTCCHHHHHHHHHHHCSSTTTSCCHHHHHT
T ss_pred cchhccchhhhhccCCCCChHHhcccCCHHHHHHHHHHccCChhhCcCHHHHhC
Confidence 0 00 0000000111 112457899999999999999999999986
|
| >d1t46a_ d.144.1.7 (A:) c-KIT receptor {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: c-KIT receptor species: Human (Homo sapiens) [TaxId: 9606]
Probab=99.97 E-value=3e-32 Score=267.58 Aligned_cols=184 Identities=21% Similarity=0.269 Sum_probs=142.1
Q ss_pred cccceeeccCCCC------------------------CCCCCCChhhHHHHHHHHHHHHHHHhhcCCCceeecCCCccce
Q 045315 241 DEISFWYESYNNP------------------------TKKGLLCWGTRVRIIEGIAQGLLYLHQYSRLRVIHRDLKASNI 296 (476)
Q Consensus 241 ~~~~l~~Ey~~~~------------------------~~~~~L~~~~~~~i~~qIa~gL~yLH~~~~~~ivH~DLkp~NI 296 (476)
+..+++|||++.+ .....+++.++.+++.||++||+|||+++ ++||||||+||
T Consensus 100 ~~~~lvmE~~~~g~l~~~l~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~gl~~LH~~~---ivHrDLKp~NI 176 (311)
T d1t46a_ 100 GPTLVITEYCCYGDLLNFLRRKRDSFICSKTSPAIMEDDELALDLEDLLSFSYQVAKGMAFLASKN---CIHRDLAARNI 176 (311)
T ss_dssp SSCEEEEECCTTEEHHHHHHHTTTTC--------------CCCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCSGGGE
T ss_pred CEEEEEEEcCCCCCHHHHHHhccccccccccccccccccccCCCHHHHHHHHHHHHHHHHHHHhCC---eeecccccccc
Confidence 4578899999822 12346999999999999999999999999 99999999999
Q ss_pred EecCCCCceeccccceeecCCCcccccceeeeeccCCCChhhhccCCCCccceEEeehhhhhhhhhCCCCCCcCCCCchh
Q 045315 297 LLDKDMNPKISDFGMARMFGGDELQSNTKRIVGTYGYMSPEYALRGLFSIKSDVFSFGVLLLETLSSKKNTHFYNTDSLT 376 (476)
Q Consensus 297 Lld~~~~~kL~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~s~ksDVwSlGvvl~elltG~~p~~~~~~~~~~ 376 (476)
+++.++.+||+|||+++...............||+.|+|||.+.++.++.++|||||||++|||++++.|+.........
T Consensus 177 l~~~~~~~ki~DfG~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DIwS~G~~l~ellt~g~p~~~~~~~~~~ 256 (311)
T d1t46a_ 177 LLTHGRITKICDFGLARDIKNDSNYVVKGNARLPVKWMAPESIFNCVYTFESDVWSYGIFLWELFSLGSSPYPGMPVDSK 256 (311)
T ss_dssp EEETTTEEEECCCGGGSCTTSCTTSEECSSSEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCSSTTCCSSHH
T ss_pred cccccCcccccccchheeccCCCcceEeeecccChHHcCHHHhcCCCCCCcccccchHHHHHHHHhCCCCCCCCCCHHHH
Confidence 99999999999999999876544444444568999999999999999999999999999999999955554332222221
Q ss_pred hhhhhhhhhcCCCcccccCcccCCCCCHHHHHHHHHHHHHchhhcccCCCCHHHHHHHHhcccc
Q 045315 377 LLGHAWNLWNDGRTWELMDPISQNGASYPILKRYINVALLCVQEKAADRPAMSEVVSMLSNEFV 440 (476)
Q Consensus 377 ~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~l~~li~~Cl~~dP~~RPt~~eVl~~L~~~~~ 440 (476)
+.... ..+.. ...+......+.+++.+||+.||++||||+||+++|++...
T Consensus 257 ~~~~i----~~~~~---------~~~~~~~~~~l~~Li~~cl~~dP~~RPs~~~il~~L~~~i~ 307 (311)
T d1t46a_ 257 FYKMI----KEGFR---------MLSPEHAPAEMYDIMKTCWDADPLKRPTFKQIVQLIEKQIS 307 (311)
T ss_dssp HHHHH----HHTCC---------CCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHH
T ss_pred HHHHH----hcCCC---------CCCcccccHHHHHHHHHHcCCChhHCcCHHHHHHHHHHhhc
Confidence 21111 11111 11112234678999999999999999999999999987653
|
| >d1a06a_ d.144.1.7 (A:) Calmodulin-dependent protein kinase {Rat (Rattus norvegicus) [TaxId: 10116]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Calmodulin-dependent protein kinase species: Rat (Rattus norvegicus) [TaxId: 10116]
Probab=99.97 E-value=8.1e-32 Score=263.86 Aligned_cols=175 Identities=21% Similarity=0.269 Sum_probs=126.1
Q ss_pred cccceeeccCCCCC------CCCCCChhhHHHHHHHHHHHHHHHhhcCCCceeecCCCccceEec---CCCCceeccccc
Q 045315 241 DEISFWYESYNNPT------KKGLLCWGTRVRIIEGIAQGLLYLHQYSRLRVIHRDLKASNILLD---KDMNPKISDFGM 311 (476)
Q Consensus 241 ~~~~l~~Ey~~~~~------~~~~L~~~~~~~i~~qIa~gL~yLH~~~~~~ivH~DLkp~NILld---~~~~~kL~DFGl 311 (476)
+.++++|||++.++ .++.+++.++..++.||+.||+|||+++ |+||||||+||++. +++.+||+|||+
T Consensus 80 ~~~~lvmE~~~gg~L~~~l~~~~~l~e~~~~~~~~qi~~al~ylH~~~---iiHrDiKp~Nil~~~~~~~~~vkl~DFG~ 156 (307)
T d1a06a_ 80 GHLYLIMQLVSGGELFDRIVEKGFYTERDASRLIFQVLDAVKYLHDLG---IVHRDLKPENLLYYSLDEDSKIMISDFGL 156 (307)
T ss_dssp SEEEEEECCCCSCBHHHHHHTCSCCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEESSSSTTCCEEECCC--
T ss_pred CEEEEEEeccCCCcHHHhhhcccCCCHHHHHHHHHHHHHHHHhhhhce---eeeEEecccceeecccCCCceEEEeccce
Confidence 56889999998432 4668999999999999999999999999 99999999999994 578899999999
Q ss_pred eeecCCCcccccceeeeeccCCCChhhhccCCCCccceEEeehhhhhhhhhCCCCCCcCCCCchhhhhhhhhhhcCCCcc
Q 045315 312 ARMFGGDELQSNTKRIVGTYGYMSPEYALRGLFSIKSDVFSFGVLLLETLSSKKNTHFYNTDSLTLLGHAWNLWNDGRTW 391 (476)
Q Consensus 312 a~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~s~ksDVwSlGvvl~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~ 391 (476)
++....... .....||+.|+|||.+.+..++.++|||||||++|||++|+.||..... ....... . .+..
T Consensus 157 a~~~~~~~~---~~~~~GT~~y~APE~~~~~~~~~~~DiwSlGvilyell~g~~Pf~~~~~--~~~~~~i---~-~~~~- 226 (307)
T d1a06a_ 157 SKMEDPGSV---LSTACGTPGYVAPEVLAQKPYSKAVDCWSIGVIAYILLCGYPPFYDEND--AKLFEQI---L-KAEY- 226 (307)
T ss_dssp -------------------CTTSCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSCCCSSH--HHHHHHH---H-TTCC-
T ss_pred eEEccCCCe---eeeeeeCccccCcHHHcCCCCCcHHHhhhhhHHHHHHHhCCCCCCCCCH--HHHHHHH---h-ccCC-
Confidence 987654322 2336799999999999999999999999999999999999999864331 1111111 1 1111
Q ss_pred cccCcccCCCCCHHHHHHHHHHHHHchhhcccCCCCHHHHHH
Q 045315 392 ELMDPISQNGASYPILKRYINVALLCVQEKAADRPAMSEVVS 433 (476)
Q Consensus 392 ~~~d~~~~~~~~~~~~~~l~~li~~Cl~~dP~~RPt~~eVl~ 433 (476)
...........+.+.+++.+||+.||++|||++|+++
T Consensus 227 -----~~~~~~~~~~s~~~~~li~~~L~~dP~~R~s~~eil~ 263 (307)
T d1a06a_ 227 -----EFDSPYWDDISDSAKDFIRHLMEKDPEKRFTCEQALQ 263 (307)
T ss_dssp -----CCCTTTTTTSCHHHHHHHHHHSCSSGGGSCCHHHHHH
T ss_pred -----CCCCccccCCCHHHHHHHHHHccCCHhHCcCHHHHhc
Confidence 0011111223457889999999999999999999987
|
| >d1u5ra_ d.144.1.7 (A:) Serine/threonine protein kinase TAO2 {Rat (Rattus norvegicus) [TaxId: 10116]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Serine/threonine protein kinase TAO2 species: Rat (Rattus norvegicus) [TaxId: 10116]
Probab=99.97 E-value=1.3e-32 Score=269.67 Aligned_cols=170 Identities=29% Similarity=0.377 Sum_probs=133.7
Q ss_pred cccceeeccCCCC------CCCCCCChhhHHHHHHHHHHHHHHHhhcCCCceeecCCCccceEecCCCCceeccccceee
Q 045315 241 DEISFWYESYNNP------TKKGLLCWGTRVRIIEGIAQGLLYLHQYSRLRVIHRDLKASNILLDKDMNPKISDFGMARM 314 (476)
Q Consensus 241 ~~~~l~~Ey~~~~------~~~~~L~~~~~~~i~~qIa~gL~yLH~~~~~~ivH~DLkp~NILld~~~~~kL~DFGla~~ 314 (476)
+.++++|||++.+ ..++++++.++..++.||+.||+|||+++ |+||||||+|||++.++.+||+|||+|+.
T Consensus 88 ~~~~iv~E~~~~g~l~~~~~~~~~l~e~~~~~i~~qi~~aL~yLH~~~---iiHrDiKp~NILl~~~~~~Kl~DFG~a~~ 164 (309)
T d1u5ra_ 88 HTAWLVMEYCLGSASDLLEVHKKPLQEVEIAAVTHGALQGLAYLHSHN---MIHRDVKAGNILLSEPGLVKLGDFGSASI 164 (309)
T ss_dssp TEEEEEEECCSEEHHHHHHHHTSCCCHHHHHHHHHHHHHHHHHHHHTT---CBCCCCSGGGEEEETTTEEEECCCTTCBS
T ss_pred CEEEEEEEecCCCchHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCC---EeccCCCcceEEECCCCCEEEeecccccc
Confidence 5688999999832 23568999999999999999999999999 99999999999999999999999999986
Q ss_pred cCCCcccccceeeeeccCCCChhhhcc---CCCCccceEEeehhhhhhhhhCCCCCCcCCCCchhhhhhhhhhhcCCCcc
Q 045315 315 FGGDELQSNTKRIVGTYGYMSPEYALR---GLFSIKSDVFSFGVLLLETLSSKKNTHFYNTDSLTLLGHAWNLWNDGRTW 391 (476)
Q Consensus 315 ~~~~~~~~~~~~~~gt~~y~aPE~l~~---~~~s~ksDVwSlGvvl~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~ 391 (476)
.... ....||+.|+|||++.+ ..|+.++|||||||++|||++|+.||..... .... ...... ...
T Consensus 165 ~~~~------~~~~GT~~Y~APE~~~~~~~~~y~~~~DiwSlGvilyel~~g~~Pf~~~~~--~~~~---~~i~~~-~~~ 232 (309)
T d1u5ra_ 165 MAPA------NSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNA--MSAL---YHIAQN-ESP 232 (309)
T ss_dssp SSSB------CCCCSCGGGCCHHHHTTTTSCCBCTHHHHHHHHHHHHHHHHSSCTTTTSCH--HHHH---HHHHHS-CCC
T ss_pred cCCC------CccccCccccCHHHHhccCCCCcCchhhhhhHHHHHHHHHHCCCCCCCCCH--HHHH---HHHHhC-CCC
Confidence 5432 23579999999999864 4689999999999999999999999864321 1111 111111 111
Q ss_pred cccCcccCCCCCHHHHHHHHHHHHHchhhcccCCCCHHHHHH
Q 045315 392 ELMDPISQNGASYPILKRYINVALLCVQEKAADRPAMSEVVS 433 (476)
Q Consensus 392 ~~~d~~~~~~~~~~~~~~l~~li~~Cl~~dP~~RPt~~eVl~ 433 (476)
. .. +....+.+.+++.+||+.||++|||++|+++
T Consensus 233 ~-----~~---~~~~s~~~~~li~~~L~~dP~~Rpt~~ell~ 266 (309)
T d1u5ra_ 233 A-----LQ---SGHWSEYFRNFVDSCLQKIPQDRPTSEVLLK 266 (309)
T ss_dssp C-----CS---CTTSCHHHHHHHHHHTCSSGGGSCCHHHHTT
T ss_pred C-----CC---CCCCCHHHHHHHHHHCcCChhHCcCHHHHHh
Confidence 1 11 1122357889999999999999999999976
|
| >d1r0pa_ d.144.1.7 (A:) Hepatocyte growth factor receptor, c-MET {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Hepatocyte growth factor receptor, c-MET species: Human (Homo sapiens) [TaxId: 9606]
Probab=99.97 E-value=6.4e-32 Score=265.13 Aligned_cols=184 Identities=27% Similarity=0.298 Sum_probs=142.0
Q ss_pred cccceeeccCCCC-------CCCCCCChhhHHHHHHHHHHHHHHHhhcCCCceeecCCCccceEecCCCCceecccccee
Q 045315 241 DEISFWYESYNNP-------TKKGLLCWGTRVRIIEGIAQGLLYLHQYSRLRVIHRDLKASNILLDKDMNPKISDFGMAR 313 (476)
Q Consensus 241 ~~~~l~~Ey~~~~-------~~~~~L~~~~~~~i~~qIa~gL~yLH~~~~~~ivH~DLkp~NILld~~~~~kL~DFGla~ 313 (476)
+.++++|||++.+ .....+++.++++++.|++.||.|||+.+ |+||||||+|||+++++.+||+|||+++
T Consensus 102 ~~~~lv~E~~~~g~l~~~~~~~~~~~~~~~~~~i~~qia~gL~~lH~~~---iiHrDLK~~NILl~~~~~~kL~DFG~~~ 178 (311)
T d1r0pa_ 102 GSPLVVLPYMKHGDLRNFIRNETHNPTVKDLIGFGLQVAKGMKFLASKK---FVHRDLAARNCMLDEKFTVKVADFGLAR 178 (311)
T ss_dssp TEEEEEEECCTTCBHHHHHHCTTCCCBHHHHHHHHHHHHHHHHHHHHTT---CCCSCCSGGGEEECTTCCEEECSSGGGC
T ss_pred CceEEEEEEeecCchhhhhccccccchHHHHHHHHHHHHHhhhhhcccC---cccCCccHHhEeECCCCCEEEecccchh
Confidence 4578999999833 34557889999999999999999999999 9999999999999999999999999998
Q ss_pred ecCCCccc--ccceeeeeccCCCChhhhccCCCCccceEEeehhhhhhhhhCCCCCCcCCCCchhhhhhhhhhhcCCCcc
Q 045315 314 MFGGDELQ--SNTKRIVGTYGYMSPEYALRGLFSIKSDVFSFGVLLLETLSSKKNTHFYNTDSLTLLGHAWNLWNDGRTW 391 (476)
Q Consensus 314 ~~~~~~~~--~~~~~~~gt~~y~aPE~l~~~~~s~ksDVwSlGvvl~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~ 391 (476)
........ .......||..|+|||.+....++.++||||||+++|||++|+.|+....... ..... ...+...
T Consensus 179 ~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDI~SfGivl~El~t~~~p~~~~~~~~-~~~~~----i~~g~~~ 253 (311)
T d1r0pa_ 179 DMYDKEFDSVHNKTGAKLPVKWMALESLQTQKFTTKSDVWSFGVLLWELMTRGAPPYPDVNTF-DITVY----LLQGRRL 253 (311)
T ss_dssp CTTTTTCCCTTCTTCSSCCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSCC-------CHHH----HHTTCCC
T ss_pred hccccccccceecccccccccccChHHHhcCCCCChhHhhhhHHHHHHHHHCCCCCCCCCCHH-HHHHH----HHcCCCC
Confidence 76543222 22233568999999999999999999999999999999999888875432111 11111 1122111
Q ss_pred cccCcccCCCCCHHHHHHHHHHHHHchhhcccCCCCHHHHHHHHhccccC
Q 045315 392 ELMDPISQNGASYPILKRYINVALLCVQEKAADRPAMSEVVSMLSNEFVN 441 (476)
Q Consensus 392 ~~~d~~~~~~~~~~~~~~l~~li~~Cl~~dP~~RPt~~eVl~~L~~~~~~ 441 (476)
. .+ ....+.+.+++.+||+.||++||+|.||++.|+++...
T Consensus 254 ~--~p-------~~~~~~l~~li~~cl~~dP~~RPs~~ei~~~L~~i~~~ 294 (311)
T d1r0pa_ 254 L--QP-------EYCPDPLYEVMLKCWHPKAEMRPSFSELVSRISAIFST 294 (311)
T ss_dssp C--CC-------TTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHT
T ss_pred C--Cc-------ccCcHHHHHHHHHHcCCCHhHCcCHHHHHHHHHHHHHh
Confidence 1 11 12235688999999999999999999999999998643
|
| >d1vjya_ d.144.1.7 (A:) Type I TGF-beta receptor R4 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Type I TGF-beta receptor R4 species: Human (Homo sapiens) [TaxId: 9606]
Probab=99.97 E-value=2.8e-32 Score=266.76 Aligned_cols=194 Identities=20% Similarity=0.228 Sum_probs=139.2
Q ss_pred ccceeeccCCCCC-----CCCCCChhhHHHHHHHHHHHHHHHhhcC-----CCceeecCCCccceEecCCCCceeccccc
Q 045315 242 EISFWYESYNNPT-----KKGLLCWGTRVRIIEGIAQGLLYLHQYS-----RLRVIHRDLKASNILLDKDMNPKISDFGM 311 (476)
Q Consensus 242 ~~~l~~Ey~~~~~-----~~~~L~~~~~~~i~~qIa~gL~yLH~~~-----~~~ivH~DLkp~NILld~~~~~kL~DFGl 311 (476)
..+++|||++.+. ++..++|.++++++.|+|.||+|||+.. ..+|+||||||+||||+.++.+||+|||+
T Consensus 75 ~~~lv~Ey~~~g~L~~~l~~~~l~~~~~~~~~~~ia~gl~~lH~~~~~~~~~~~IvHrDlKp~NILl~~~~~~Kl~DFGl 154 (303)
T d1vjya_ 75 QLWLVSDYHEHGSLFDYLNRYTVTVEGMIKLALSTASGLAHLHMEIVGTQGKPAIAHRDLKSKNILVKKNGTCCIADLGL 154 (303)
T ss_dssp EEEEEEECCTTCBHHHHHHHCCBCHHHHHHHHHHHHHHHHHHHCCBCSTTCBCEEECSCCCGGGEEECTTSCEEECCCTT
T ss_pred EEEEEEecccCCCHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHhhhhhccCCCeeccccCccceEEcCCCCeEEEecCc
Confidence 4678999998432 2447999999999999999999999741 13499999999999999999999999999
Q ss_pred eeecCCCcc--cccceeeeeccCCCChhhhccCC------CCccceEEeehhhhhhhhhCCCCCCcCCCCchhhhh----
Q 045315 312 ARMFGGDEL--QSNTKRIVGTYGYMSPEYALRGL------FSIKSDVFSFGVLLLETLSSKKNTHFYNTDSLTLLG---- 379 (476)
Q Consensus 312 a~~~~~~~~--~~~~~~~~gt~~y~aPE~l~~~~------~s~ksDVwSlGvvl~elltG~~p~~~~~~~~~~~~~---- 379 (476)
++....... ........||+.|+|||++.+.. ++.++|||||||++|||++|..|+............
T Consensus 155 ~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~k~Di~S~Gvvl~el~tg~~~~~~~~~~~~~~~~~~~~ 234 (303)
T d1vjya_ 155 AVRHDSATDTIDIAPNHRVGTKRYMAPEVLDDSINMKHFESFKRADIYAMGLVFWEIARRCSIGGIHEDYQLPYYDLVPS 234 (303)
T ss_dssp CEEEETTTTEECC----CCSCGGGCCHHHHTTCSCTTCHHHHHHHHHHHHHHHHHHHHHTBCBTTBCCCCCCTTTTTSCS
T ss_pred cccccCCCcceeccccceecccCcCChhhccccccccCCCcCcchhhhhhHHHHHHHhhCCCCCCcccccccchhhcccc
Confidence 987754322 22233467999999999987542 678999999999999999999887543211111110
Q ss_pred -----hhhhhhcCCCcccccCcccCC-CCCHHHHHHHHHHHHHchhhcccCCCCHHHHHHHHhccc
Q 045315 380 -----HAWNLWNDGRTWELMDPISQN-GASYPILKRYINVALLCVQEKAADRPAMSEVVSMLSNEF 439 (476)
Q Consensus 380 -----~~~~~~~~~~~~~~~d~~~~~-~~~~~~~~~l~~li~~Cl~~dP~~RPt~~eVl~~L~~~~ 439 (476)
........+. .++.+.. ....+....+.+++.+||+.||++|||+.||++.|+++.
T Consensus 235 ~~~~~~~~~~~~~~~----~~p~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rps~~ei~~~L~~i~ 296 (303)
T d1vjya_ 235 DPSVEEMRKVVCEQK----LRPNIPNRWQSCEALRVMAKIMRECWYANGAARLTALRIKKTLSQLS 296 (303)
T ss_dssp SCCHHHHHHHHTTSC----CCCCCCGGGGGCHHHHHHHHHHHTTCCSSGGGSCCHHHHHHHHHHHH
T ss_pred cchHHHHHHHHhccc----cCCCCCcccCChHHHHHHHHHHHHHcccCHhHCcCHHHHHHHHHHHH
Confidence 0011111111 1111111 112345567899999999999999999999999998865
|
| >d1byga_ d.144.1.7 (A:) Carboxyl-terminal src kinase (csk) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Carboxyl-terminal src kinase (csk) species: Human (Homo sapiens) [TaxId: 9606]
Probab=99.97 E-value=2.8e-32 Score=261.17 Aligned_cols=176 Identities=23% Similarity=0.284 Sum_probs=132.3
Q ss_pred cccceeeccCCCCC--------CCCCCChhhHHHHHHHHHHHHHHHhhcCCCceeecCCCccceEecCCCCceeccccce
Q 045315 241 DEISFWYESYNNPT--------KKGLLCWGTRVRIIEGIAQGLLYLHQYSRLRVIHRDLKASNILLDKDMNPKISDFGMA 312 (476)
Q Consensus 241 ~~~~l~~Ey~~~~~--------~~~~L~~~~~~~i~~qIa~gL~yLH~~~~~~ivH~DLkp~NILld~~~~~kL~DFGla 312 (476)
+..+++|||++.+. ....+++.++++|+.||+.||+|||+.+ |+||||||+|||++.++.+||+|||++
T Consensus 74 ~~~~lv~ey~~~g~L~~~l~~~~~~~l~~~~~~~i~~~i~~al~ylH~~~---ivH~dlkp~Nil~~~~~~~kl~dfg~s 150 (262)
T d1byga_ 74 GGLYIVTEYMAKGSLVDYLRSRGRSVLGGDCLLKFSLDVCEAMEYLEGNN---FVHRDLAARNVLVSEDNVAKVSDFGLT 150 (262)
T ss_dssp -CCEEEECCCTTEEHHHHHHHHHHHHCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCSGGGEEECTTSCEEECCCCC-
T ss_pred CcEEEEEeccCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHhhccccccCc---eeccccchHhheecCCCCEeecccccc
Confidence 45789999998432 2346999999999999999999999998 999999999999999999999999999
Q ss_pred eecCCCcccccceeeeeccCCCChhhhccCCCCccceEEeehhhhhhhhh-CCCCCCcCCCCchhhhhhhhhhhcCCCcc
Q 045315 313 RMFGGDELQSNTKRIVGTYGYMSPEYALRGLFSIKSDVFSFGVLLLETLS-SKKNTHFYNTDSLTLLGHAWNLWNDGRTW 391 (476)
Q Consensus 313 ~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~s~ksDVwSlGvvl~ellt-G~~p~~~~~~~~~~~~~~~~~~~~~~~~~ 391 (476)
+..... .....++..|+|||++.++.++.++|||||||++|||++ |+.|+...... .+... ...+...
T Consensus 151 ~~~~~~-----~~~~~~~~~y~aPE~l~~~~~t~~sDIwSfG~il~el~t~~~~p~~~~~~~--~~~~~----i~~~~~~ 219 (262)
T d1byga_ 151 KEASST-----QDTGKLPVKWTAPEALREKKFSTKSDVWSFGILLWEIYSFGRVPYPRIPLK--DVVPR----VEKGYKM 219 (262)
T ss_dssp ----------------CCTTTSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSCTTSCGG--GHHHH----HTTTCCC
T ss_pred eecCCC-----CccccccccCCChHHHhCCCCChHHHHHhHHHHHHHHHHCCCCCCCCCCHH--HHHHH----HHcCCCC
Confidence 865432 222467899999999999999999999999999999998 67666543221 22211 1122111
Q ss_pred cccCcccCCCCCHHHHHHHHHHHHHchhhcccCCCCHHHHHHHHhccc
Q 045315 392 ELMDPISQNGASYPILKRYINVALLCVQEKAADRPAMSEVVSMLSNEF 439 (476)
Q Consensus 392 ~~~d~~~~~~~~~~~~~~l~~li~~Cl~~dP~~RPt~~eVl~~L~~~~ 439 (476)
+ .+.....++.+++.+||+.||++||||.+|+++|+.+.
T Consensus 220 ~---------~~~~~~~~~~~li~~cl~~dP~~Rps~~~l~~~L~~i~ 258 (262)
T d1byga_ 220 D---------APDGCPPAVYEVMKNCWHLDAAMRPSFLQLREQLEHIK 258 (262)
T ss_dssp C---------CCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHH
T ss_pred C---------CCccCCHHHHHHHHHHcccCHhHCcCHHHHHHHHHHHH
Confidence 1 12223357889999999999999999999999998763
|
| >d1koaa2 d.144.1.7 (A:5915-6264) Twitchin, kinase domain {Caenorhabditis elegans, pjk4 [TaxId: 6239]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Twitchin, kinase domain species: Caenorhabditis elegans, pjk4 [TaxId: 6239]
Probab=99.97 E-value=2.7e-31 Score=264.61 Aligned_cols=176 Identities=20% Similarity=0.231 Sum_probs=137.6
Q ss_pred cccceeeccCCCC-------CCCCCCChhhHHHHHHHHHHHHHHHhhcCCCceeecCCCccceEec--CCCCceeccccc
Q 045315 241 DEISFWYESYNNP-------TKKGLLCWGTRVRIIEGIAQGLLYLHQYSRLRVIHRDLKASNILLD--KDMNPKISDFGM 311 (476)
Q Consensus 241 ~~~~l~~Ey~~~~-------~~~~~L~~~~~~~i~~qIa~gL~yLH~~~~~~ivH~DLkp~NILld--~~~~~kL~DFGl 311 (476)
+.++++|||++.+ ...++|++.++..++.||+.||+|||+++ ||||||||+|||++ .++.+||+|||+
T Consensus 96 ~~~~ivmE~~~gg~L~~~l~~~~~~l~e~~~~~i~~qi~~aL~ylH~~~---iiHrDiKp~NIll~~~~~~~vkL~DFG~ 172 (350)
T d1koaa2 96 NEMVMIYEFMSGGELFEKVADEHNKMSEDEAVEYMRQVCKGLCHMHENN---YVHLDLKPENIMFTTKRSNELKLIDFGL 172 (350)
T ss_dssp TEEEEEECCCCSCBHHHHHTCTTSCBCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEESSTTSCCEEECCCTT
T ss_pred CEEEEEEEcCCCCCHHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHhcC---CeeeeechhHeeeccCCCCeEEEeecch
Confidence 5788999999832 34567999999999999999999999999 99999999999996 467899999999
Q ss_pred eeecCCCcccccceeeeeccCCCChhhhccCCCCccceEEeehhhhhhhhhCCCCCCcCCCCchhhhhhhhhhhcCCCcc
Q 045315 312 ARMFGGDELQSNTKRIVGTYGYMSPEYALRGLFSIKSDVFSFGVLLLETLSSKKNTHFYNTDSLTLLGHAWNLWNDGRTW 391 (476)
Q Consensus 312 a~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~s~ksDVwSlGvvl~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~ 391 (476)
++.+.... ......||+.|+|||++.+..++.++|||||||++|||++|+.||...+. ........ ....
T Consensus 173 a~~~~~~~---~~~~~~gT~~Y~aPEv~~~~~~~~~~DiwSlGvilyell~G~~Pf~~~~~--~~~~~~i~----~~~~- 242 (350)
T d1koaa2 173 TAHLDPKQ---SVKVTTGTAEFAAPEVAEGKPVGYYTDMWSVGVLSYILLSGLSPFGGEND--DETLRNVK----SCDW- 242 (350)
T ss_dssp CEECCTTS---CEEEECSCTTTCCHHHHHTCCBCHHHHHHHHHHHHHHHHHSSCSSCCSSH--HHHHHHHH----HTCC-
T ss_pred heeccccc---ccceecCcccccCHHHHcCCCCChhHhhhhhhHHHHHHHhCCCCCCCCCH--HHHHHHHH----hCCC-
Confidence 99875432 23346799999999999999999999999999999999999999864431 11111111 1100
Q ss_pred cccCcccCCCCCHHHHHHHHHHHHHchhhcccCCCCHHHHHHH
Q 045315 392 ELMDPISQNGASYPILKRYINVALLCVQEKAADRPAMSEVVSM 434 (476)
Q Consensus 392 ~~~d~~~~~~~~~~~~~~l~~li~~Cl~~dP~~RPt~~eVl~~ 434 (476)
. ..........+.+.+++.+||+.||++|||++|+++.
T Consensus 243 ~-----~~~~~~~~~s~~~~~li~~~L~~dP~~R~t~~eil~h 280 (350)
T d1koaa2 243 N-----MDDSAFSGISEDGKDFIRKLLLADPNTRMTIHQALEH 280 (350)
T ss_dssp C-----SCCGGGGGCCHHHHHHHHHHCCSSGGGSCCHHHHHHS
T ss_pred C-----CCcccccCCCHHHHHHHHHHccCChhHCcCHHHHhcC
Confidence 0 0001111234578899999999999999999999873
|
| >d1koba_ d.144.1.7 (A:) Twitchin, kinase domain {California sea hare (Aplysia californica), twk43 [TaxId: 6500]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Twitchin, kinase domain species: California sea hare (Aplysia californica), twk43 [TaxId: 6500]
Probab=99.97 E-value=2.5e-31 Score=265.08 Aligned_cols=183 Identities=21% Similarity=0.233 Sum_probs=141.4
Q ss_pred cccceeeccCCCC-------CCCCCCChhhHHHHHHHHHHHHHHHhhcCCCceeecCCCccceEec--CCCCceeccccc
Q 045315 241 DEISFWYESYNNP-------TKKGLLCWGTRVRIIEGIAQGLLYLHQYSRLRVIHRDLKASNILLD--KDMNPKISDFGM 311 (476)
Q Consensus 241 ~~~~l~~Ey~~~~-------~~~~~L~~~~~~~i~~qIa~gL~yLH~~~~~~ivH~DLkp~NILld--~~~~~kL~DFGl 311 (476)
+.++++|||++.+ .++.+|++.++..|+.||+.||+|||+++ |+||||||+|||++ .++.+||+|||+
T Consensus 99 ~~~~ivmE~~~gg~L~~~~~~~~~~l~e~~~~~i~~qi~~aL~ylH~~~---iiHRDiKp~NILl~~~~~~~vkL~DFGl 175 (352)
T d1koba_ 99 YEMVLILEFLSGGELFDRIAAEDYKMSEAEVINYMRQACEGLKHMHEHS---IVHLDIKPENIMCETKKASSVKIIDFGL 175 (352)
T ss_dssp SEEEEEEECCCCCBHHHHTTCTTCCBCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEESSTTCCCEEECCCTT
T ss_pred CEEEEEEEcCCCChHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCC---eeecccccccccccccCCCeEEEeeccc
Confidence 5688999999832 23457999999999999999999999999 99999999999998 678999999999
Q ss_pred eeecCCCcccccceeeeeccCCCChhhhccCCCCccceEEeehhhhhhhhhCCCCCCcCCCCchhhhhhhhhhhcCCCcc
Q 045315 312 ARMFGGDELQSNTKRIVGTYGYMSPEYALRGLFSIKSDVFSFGVLLLETLSSKKNTHFYNTDSLTLLGHAWNLWNDGRTW 391 (476)
Q Consensus 312 a~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~s~ksDVwSlGvvl~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~ 391 (476)
|+.+.... ......||+.|+|||++.+..++.++|||||||++|||++|+.||..... ....... ..+..
T Consensus 176 a~~~~~~~---~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvilyelltG~~Pf~~~~~--~~~~~~i----~~~~~- 245 (352)
T d1koba_ 176 ATKLNPDE---IVKVTTATAEFAAPEIVDREPVGFYTDMWAIGVLGYVLLSGLSPFAGEDD--LETLQNV----KRCDW- 245 (352)
T ss_dssp CEECCTTS---CEEEECSSGGGCCHHHHTTCCBCHHHHHHHHHHHHHHHHHSCCSSCCSSH--HHHHHHH----HHCCC-
T ss_pred ceecCCCC---ceeeccCcccccCHHHHcCCCCCCccchHHHHHHHHHHHhCCCCCCCCCH--HHHHHHH----HhCCC-
Confidence 99876432 23346799999999999999999999999999999999999999965431 1111111 11110
Q ss_pred cccCcccCCCCCHHHHHHHHHHHHHchhhcccCCCCHHHHHHH--HhccccC
Q 045315 392 ELMDPISQNGASYPILKRYINVALLCVQEKAADRPAMSEVVSM--LSNEFVN 441 (476)
Q Consensus 392 ~~~d~~~~~~~~~~~~~~l~~li~~Cl~~dP~~RPt~~eVl~~--L~~~~~~ 441 (476)
.............+.+++.+||+.||.+|||++|+++. +++....
T Consensus 246 -----~~~~~~~~~~s~~~~~li~~~L~~dp~~R~s~~eil~Hp~~~~~~~~ 292 (352)
T d1koba_ 246 -----EFDEDAFSSVSPEAKDFIKNLLQKEPRKRLTVHDALEHPWLKGDHSN 292 (352)
T ss_dssp -----CCCSSTTTTSCHHHHHHHHTTSCSSGGGSCCHHHHHTSTTTSSCCTT
T ss_pred -----CCCcccccCCCHHHHHHHHHHccCChhHCcCHHHHhcCHhhCCCcch
Confidence 00111112234578899999999999999999999873 5554433
|
| >d1p4oa_ d.144.1.7 (A:) Insulin-like growth factor 1 receptor {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Insulin-like growth factor 1 receptor species: Human (Homo sapiens) [TaxId: 9606]
Probab=99.97 E-value=2.8e-31 Score=260.27 Aligned_cols=181 Identities=24% Similarity=0.341 Sum_probs=142.3
Q ss_pred cccceeeccCCCC----------------CCCCCCChhhHHHHHHHHHHHHHHHhhcCCCceeecCCCccceEecCCCCc
Q 045315 241 DEISFWYESYNNP----------------TKKGLLCWGTRVRIIEGIAQGLLYLHQYSRLRVIHRDLKASNILLDKDMNP 304 (476)
Q Consensus 241 ~~~~l~~Ey~~~~----------------~~~~~L~~~~~~~i~~qIa~gL~yLH~~~~~~ivH~DLkp~NILld~~~~~ 304 (476)
+..+++|||++.+ .....+++.++.+++.|+++||+|||+++ |+||||||+|||++.++.+
T Consensus 96 ~~~~lv~e~~~~g~l~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~ia~gl~~LH~~~---ivHrDlk~~NiLld~~~~~ 172 (308)
T d1p4oa_ 96 QPTLVIMELMTRGDLKSYLRSLRPAMANNPVLAPPSLSKMIQMAGEIADGMAYLNANK---FVHRDLAARNCMVAEDFTV 172 (308)
T ss_dssp SSCEEEEECCTTCBHHHHHHHHHHHHHHCTTCCCCCHHHHHHHHHHHHHHHHHHHHTT---CBCSCCSGGGEEECTTCCE
T ss_pred CceeEEEeecCCCCHHHHHHhcccccccccccCCCCHHHHHHHHHHHHHHHHHHhhCC---eeeceEcCCceeecCCceE
Confidence 4688899999833 12345799999999999999999999998 9999999999999999999
Q ss_pred eeccccceeecCCCcccccceeeeeccCCCChhhhccCCCCccceEEeehhhhhhhhhCC-CCCCcCCCCchhhhhhhhh
Q 045315 305 KISDFGMARMFGGDELQSNTKRIVGTYGYMSPEYALRGLFSIKSDVFSFGVLLLETLSSK-KNTHFYNTDSLTLLGHAWN 383 (476)
Q Consensus 305 kL~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~s~ksDVwSlGvvl~elltG~-~p~~~~~~~~~~~~~~~~~ 383 (476)
||+|||+++...............+|+.|+|||.+.+..++.++|||||||++|||++|+ .|+.... ......
T Consensus 173 Kl~DFGla~~~~~~~~~~~~~~~~~t~~y~aPe~l~~~~~~~~~Dv~S~G~il~El~t~~~~p~~~~~--~~~~~~---- 246 (308)
T d1p4oa_ 173 KIGDFGMTRDIYETDYYRKGGKGLLPVRWMSPESLKDGVFTTYSDVWSFGVVLWEIATLAEQPYQGLS--NEQVLR---- 246 (308)
T ss_dssp EECCTTCCCGGGGGGCEEGGGSSEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHHTSCCTTTTSC--HHHHHH----
T ss_pred EEeecccceeccCCcceeeccceecccccCCHHHHccCCCCcccccccHHHHHHHHHhCCCCCCCCCC--HHHHHH----
Confidence 999999998775544444444467899999999999999999999999999999999986 5554322 111111
Q ss_pred hhcCCCcccccCcccCCCCCHHHHHHHHHHHHHchhhcccCCCCHHHHHHHHhccc
Q 045315 384 LWNDGRTWELMDPISQNGASYPILKRYINVALLCVQEKAADRPAMSEVVSMLSNEF 439 (476)
Q Consensus 384 ~~~~~~~~~~~d~~~~~~~~~~~~~~l~~li~~Cl~~dP~~RPt~~eVl~~L~~~~ 439 (476)
....+..... +......+.+++.+||+.+|++|||+++|+++|++..
T Consensus 247 ~i~~~~~~~~---------p~~~~~~l~~li~~cl~~~P~~RPs~~~il~~L~~~~ 293 (308)
T d1p4oa_ 247 FVMEGGLLDK---------PDNCPDMLFELMRMCWQYNPKMRPSFLEIISSIKEEM 293 (308)
T ss_dssp HHHTTCCCCC---------CTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHGGGS
T ss_pred HHHhCCCCCC---------cccchHHHHHHHHHHcCCChhHCcCHHHHHHHHHHhc
Confidence 1112221111 1122357899999999999999999999999998864
|
| >d1o6ya_ d.144.1.7 (A:) Mycobacterial protein kinase PknB, catalytic domain {Mycobacterium tuberculosis [TaxId: 1773]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Mycobacterial protein kinase PknB, catalytic domain species: Mycobacterium tuberculosis [TaxId: 1773]
Probab=99.97 E-value=1.2e-31 Score=258.96 Aligned_cols=182 Identities=24% Similarity=0.312 Sum_probs=133.5
Q ss_pred ccceeeccCCCC------CCCCCCChhhHHHHHHHHHHHHHHHhhcCCCceeecCCCccceEecCCCCceeccccceeec
Q 045315 242 EISFWYESYNNP------TKKGLLCWGTRVRIIEGIAQGLLYLHQYSRLRVIHRDLKASNILLDKDMNPKISDFGMARMF 315 (476)
Q Consensus 242 ~~~l~~Ey~~~~------~~~~~L~~~~~~~i~~qIa~gL~yLH~~~~~~ivH~DLkp~NILld~~~~~kL~DFGla~~~ 315 (476)
..+++|||++.. ...+++++.+++.++.||+.||+|||+++ |+||||||+|||++.++..+|+|||.+...
T Consensus 85 ~~~lvmE~~~g~~L~~~~~~~~~l~~~~~~~i~~qi~~al~~lH~~~---iiHrDiKP~NIll~~~~~~~l~d~~~~~~~ 161 (277)
T d1o6ya_ 85 LPYIVMEYVDGVTLRDIVHTEGPMTPKRAIEVIADACQALNFSHQNG---IIHRDVKPANIMISATNAVKVMDFGIARAI 161 (277)
T ss_dssp EEEEEEECCCEEEHHHHHHHHCSCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEEETTSCEEECCCTTCEEC
T ss_pred eEEEEEECCCCCEehhhhcccCCCCHHHHHHHHHHHHHHHHHHHhCC---ccCccccCcccccCccccceeehhhhhhhh
Confidence 367999999832 23557999999999999999999999999 999999999999999999999999998765
Q ss_pred CCCc-ccccceeeeeccCCCChhhhccCCCCccceEEeehhhhhhhhhCCCCCCcCCCCchhhhhhhhhhhcCCCccccc
Q 045315 316 GGDE-LQSNTKRIVGTYGYMSPEYALRGLFSIKSDVFSFGVLLLETLSSKKNTHFYNTDSLTLLGHAWNLWNDGRTWELM 394 (476)
Q Consensus 316 ~~~~-~~~~~~~~~gt~~y~aPE~l~~~~~s~ksDVwSlGvvl~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 394 (476)
.... .........||+.|+|||++.+..++.++|||||||++|||++|+.||...... .. ...........
T Consensus 162 ~~~~~~~~~~~~~~Gt~~Y~aPE~~~~~~~~~~~DiwSlGvilyelltG~~Pf~~~~~~--~~---~~~~~~~~~~~--- 233 (277)
T d1o6ya_ 162 ADSGNSVTQTAAVIGTAQYLSPEQARGDSVDARSDVYSLGCVLYEVLTGEPPFTGDSPV--SV---AYQHVREDPIP--- 233 (277)
T ss_dssp C----------------TTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCSCCCSSHH--HH---HHHHHHCCCCC---
T ss_pred ccccccccccccccCcccccCHHHHcCCCCCcceecccchHHHHHHHhCCCCCCCcCHH--HH---HHHHHhcCCCC---
Confidence 4322 222334467999999999999999999999999999999999999998643311 11 11111111111
Q ss_pred CcccCCCCCHHHHHHHHHHHHHchhhcccCCC-CHHHHHHHHhcc
Q 045315 395 DPISQNGASYPILKRYINVALLCVQEKAADRP-AMSEVVSMLSNE 438 (476)
Q Consensus 395 d~~~~~~~~~~~~~~l~~li~~Cl~~dP~~RP-t~~eVl~~L~~~ 438 (476)
+. .......+.+.+++.+||+.||++|| |++++++.|.++
T Consensus 234 -~~---~~~~~~s~~l~~li~~~L~~dp~~R~~sa~~l~~~l~r~ 274 (277)
T d1o6ya_ 234 -PS---ARHEGLSADLDAVVLKALAKNPENRYQTAAEMRADLVRV 274 (277)
T ss_dssp -GG---GTSSSCCHHHHHHHHHHTCSSGGGSCSSHHHHHHHHHHH
T ss_pred -Cc---hhccCCCHHHHHHHHHHccCCHhHCHhHHHHHHHHHHHH
Confidence 00 01112235788999999999999999 899999988764
|
| >d1fvra_ d.144.1.7 (A:) Tie2 kinase {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tie2 kinase species: Human (Homo sapiens) [TaxId: 9606]
Probab=99.97 E-value=3e-31 Score=260.12 Aligned_cols=180 Identities=23% Similarity=0.279 Sum_probs=139.8
Q ss_pred cccceeeccCCCC----------------------CCCCCCChhhHHHHHHHHHHHHHHHhhcCCCceeecCCCccceEe
Q 045315 241 DEISFWYESYNNP----------------------TKKGLLCWGTRVRIIEGIAQGLLYLHQYSRLRVIHRDLKASNILL 298 (476)
Q Consensus 241 ~~~~l~~Ey~~~~----------------------~~~~~L~~~~~~~i~~qIa~gL~yLH~~~~~~ivH~DLkp~NILl 298 (476)
+..+++|||++.+ .....|++.++.+++.||+.||.|||+++ |+||||||+|||+
T Consensus 84 ~~~~iV~ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qia~gl~~lH~~~---iiHrDlkp~NIL~ 160 (309)
T d1fvra_ 84 GYLYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADVARGMDYLSQKQ---FIHRDLAARNILV 160 (309)
T ss_dssp TEEEEEECCCTTCBHHHHHHTTCHHHHCHHHHHHTTBSCSSCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEE
T ss_pred CeeEEEEEecCCCcHHHHHhhccccccchhhhccccccCCCCHHHHHHHHHHHHHHHHhhhcCC---ccccccccceEEE
Confidence 5688999999832 23467999999999999999999999998 9999999999999
Q ss_pred cCCCCceeccccceeecCCCcccccceeeeeccCCCChhhhccCCCCccceEEeehhhhhhhhhCCC-CCCcCCCCchhh
Q 045315 299 DKDMNPKISDFGMARMFGGDELQSNTKRIVGTYGYMSPEYALRGLFSIKSDVFSFGVLLLETLSSKK-NTHFYNTDSLTL 377 (476)
Q Consensus 299 d~~~~~kL~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~s~ksDVwSlGvvl~elltG~~-p~~~~~~~~~~~ 377 (476)
+.++.+||+|||+++...... ......||..|+|||.+.+..++.++|||||||++|||++|.. ||.... ...+
T Consensus 161 ~~~~~~kl~DfG~a~~~~~~~---~~~~~~gt~~y~aPE~l~~~~~~~~sDvwSfGvil~ell~~~~~p~~~~~--~~~~ 235 (309)
T d1fvra_ 161 GENYVAKIADFGLSRGQEVYV---KKTMGRLPVRWMAIESLNYSVYTTNSDVWSYGVLLWEIVSLGGTPYCGMT--CAEL 235 (309)
T ss_dssp CGGGCEEECCTTCEESSCEEC---CC----CCTTTCCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCTTTTCC--HHHH
T ss_pred cCCCceEEccccccccccccc---cccceecCCcccchHHhccCCCCccceeehhHHHHHHHHhcCCCCCCCCC--HHHH
Confidence 999999999999998654321 2223568999999999999999999999999999999999765 454322 2222
Q ss_pred hhhhhhhhcCCCcccccCcccCCCCCHHHHHHHHHHHHHchhhcccCCCCHHHHHHHHhccccC
Q 045315 378 LGHAWNLWNDGRTWELMDPISQNGASYPILKRYINVALLCVQEKAADRPAMSEVVSMLSNEFVN 441 (476)
Q Consensus 378 ~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~l~~li~~Cl~~dP~~RPt~~eVl~~L~~~~~~ 441 (476)
...+ ..+... ..+....+.+.+++.+||+.||++||||+||++.|+++.++
T Consensus 236 ~~~i----~~~~~~---------~~~~~~~~~~~~li~~cl~~dP~~RPs~~eil~~L~~i~~~ 286 (309)
T d1fvra_ 236 YEKL----PQGYRL---------EKPLNCDDEVYDLMRQCWREKPYERPSFAQILVSLNRMLEE 286 (309)
T ss_dssp HHHG----GGTCCC---------CCCTTBCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHS
T ss_pred HHHH----HhcCCC---------CCCccCCHHHHHHHHHHcCCChhHCcCHHHHHHHHHHHHhc
Confidence 2111 111111 11122346788999999999999999999999999998744
|
| >d1omwa3 d.144.1.7 (A:186-549) G-protein coupled receptor kinase 2 {Cow (Bos taurus) [TaxId: 9913]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: G-protein coupled receptor kinase 2 species: Cow (Bos taurus) [TaxId: 9913]
Probab=99.97 E-value=3.7e-31 Score=265.11 Aligned_cols=173 Identities=25% Similarity=0.293 Sum_probs=135.5
Q ss_pred cccceeeccCCCCC------CCCCCChhhHHHHHHHHHHHHHHHhhcCCCceeecCCCccceEecCCCCceeccccceee
Q 045315 241 DEISFWYESYNNPT------KKGLLCWGTRVRIIEGIAQGLLYLHQYSRLRVIHRDLKASNILLDKDMNPKISDFGMARM 314 (476)
Q Consensus 241 ~~~~l~~Ey~~~~~------~~~~L~~~~~~~i~~qIa~gL~yLH~~~~~~ivH~DLkp~NILld~~~~~kL~DFGla~~ 314 (476)
+..+++|||++.+. +...+++.++..++.||+.||+|||+++ ||||||||+|||++.++.+||+|||+|+.
T Consensus 80 ~~~~ivmE~~~gg~L~~~l~~~~~~~e~~~~~~~~qi~~aL~ylH~~~---iiHrDlKP~NILl~~~g~iKl~DFGla~~ 156 (364)
T d1omwa3 80 DKLSFILDLMNGGDLHYHLSQHGVFSEADMRFYAAEIILGLEHMHNRF---VVYRDLKPANILLDEHGHVRISDLGLACD 156 (364)
T ss_dssp SEEEEEECCCCSCBHHHHHHHHCSCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEECSSSCEEECCCTTCEE
T ss_pred CEEEEEEEecCCCcHHHHHHhcccccHHHHHHHHHHHHHHHHHHHHCC---ccceeeccceeEEcCCCcEEEeeeceeee
Confidence 46889999998442 3567899999999999999999999999 99999999999999999999999999997
Q ss_pred cCCCcccccceeeeeccCCCChhhhcc-CCCCccceEEeehhhhhhhhhCCCCCCcCCCCchhhhhhhhhhhcCCCcccc
Q 045315 315 FGGDELQSNTKRIVGTYGYMSPEYALR-GLFSIKSDVFSFGVLLLETLSSKKNTHFYNTDSLTLLGHAWNLWNDGRTWEL 393 (476)
Q Consensus 315 ~~~~~~~~~~~~~~gt~~y~aPE~l~~-~~~s~ksDVwSlGvvl~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~ 393 (476)
+.... .....||+.|+|||++.. ..++.++|||||||++|||++|+.||........... ........
T Consensus 157 ~~~~~----~~~~~GT~~y~APE~~~~~~~~~~~~DiwSlGvilyemltG~~Pf~~~~~~~~~~~---~~~~~~~~---- 225 (364)
T d1omwa3 157 FSKKK----PHASVGTHGYMAPEVLQKGVAYDSSADWFSLGCMLFKLLRGHSPFRQHKTKDKHEI---DRMTLTMA---- 225 (364)
T ss_dssp CSSSC----CCSCCSCGGGCCHHHHSTTCCCCTHHHHHHHHHHHHHHHHSSCSSCSSCSSCHHHH---HHHSSSCC----
T ss_pred cCCCc----ccccccccccchhHHhhcCCCCCcccchhHHHHHHHHHHhCCCCCCCCCHHHHHHH---HHhcccCC----
Confidence 76433 223579999999999975 5689999999999999999999999976543222111 00100000
Q ss_pred cCcccCCCCCHHHHHHHHHHHHHchhhcccCCCC-----HHHHHH
Q 045315 394 MDPISQNGASYPILKRYINVALLCVQEKAADRPA-----MSEVVS 433 (476)
Q Consensus 394 ~d~~~~~~~~~~~~~~l~~li~~Cl~~dP~~RPt-----~~eVl~ 433 (476)
...+....+.+.+++.+||+.||++||| ++|+++
T Consensus 226 ------~~~~~~~s~~~~~li~~~L~~dP~~R~t~~~~~a~eil~ 264 (364)
T d1omwa3 226 ------VELPDSFSPELRSLLEGLLQRDVNRRLGCLGRGAQEVKE 264 (364)
T ss_dssp ------CCCCSSSCHHHHHHHHHHTCSSTTTSTTTSSSTHHHHHT
T ss_pred ------CCCCCCCCHHHHHHHHHHcccCHHHhCCCcccCHHHHHc
Confidence 0111123456889999999999999999 688864
|
| >d2ozaa1 d.144.1.7 (A:51-385) MAP kinase activated protein kinase 2, mapkap2 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase activated protein kinase 2, mapkap2 species: Human (Homo sapiens) [TaxId: 9606]
Probab=99.97 E-value=3.1e-31 Score=262.80 Aligned_cols=179 Identities=17% Similarity=0.182 Sum_probs=135.5
Q ss_pred cccceeeccCCCC--------CCCCCCChhhHHHHHHHHHHHHHHHhhcCCCceeecCCCccceEecC---CCCceeccc
Q 045315 241 DEISFWYESYNNP--------TKKGLLCWGTRVRIIEGIAQGLLYLHQYSRLRVIHRDLKASNILLDK---DMNPKISDF 309 (476)
Q Consensus 241 ~~~~l~~Ey~~~~--------~~~~~L~~~~~~~i~~qIa~gL~yLH~~~~~~ivH~DLkp~NILld~---~~~~kL~DF 309 (476)
...+++|||++++ .....|++.++..++.||+.||+|||+++ |+||||||+|||++. .+.+||+||
T Consensus 82 ~~~~ivmEy~~gg~L~~~i~~~~~~~l~e~~~~~i~~qi~~al~ylH~~~---iiHRDiKp~NIll~~~~~~~~~Kl~DF 158 (335)
T d2ozaa1 82 KCLLIVMECLDGGELFSRIQDRGDQAFTEREASEIMKSIGEAIQYLHSIN---IAHRDVKPENLLYTSKRPNAILKLTDF 158 (335)
T ss_dssp EEEEEEEECCCSEEHHHHHHSCSCCCEEHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEESCSSTTCCEEECCC
T ss_pred CEEEEEEECCCCCcHHHHHHhcCCCCcCHHHHHHHHHHHHHHHHHHHHcC---Ccccccccccccccccccccccccccc
Confidence 3478999999832 22457999999999999999999999999 999999999999985 557999999
Q ss_pred cceeecCCCcccccceeeeeccCCCChhhhccCCCCccceEEeehhhhhhhhhCCCCCCcCCCCchhhhhhhhhhhcCCC
Q 045315 310 GMARMFGGDELQSNTKRIVGTYGYMSPEYALRGLFSIKSDVFSFGVLLLETLSSKKNTHFYNTDSLTLLGHAWNLWNDGR 389 (476)
Q Consensus 310 Gla~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~s~ksDVwSlGvvl~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~ 389 (476)
|+|+....... .....||+.|+|||++.+..|+.++|||||||++|||++|+.||........ ..........+.
T Consensus 159 G~a~~~~~~~~---~~~~~gt~~y~aPE~~~~~~y~~~~DiwSlGvily~lltg~~Pf~~~~~~~~--~~~~~~~i~~~~ 233 (335)
T d2ozaa1 159 GFAKETTSHNS---LTTPCYTPYYVAPEVLGPEKYDKSCDMWSLGVIMYILLCGYPPFYSNHGLAI--SPGMKTRIRMGQ 233 (335)
T ss_dssp TTCEECCCCCC---CCCCSCCCSSCCCCCCCGGGGSHHHHHHHHHHHHHHHTTSSCSCEETTCC----------CCCSCS
T ss_pred ceeeeccCCCc---cccccCCcccCCcHHHcCCCCCHHHHHHhhchhHHHHhhCCCCCCCCCHHHH--HHHHHHHHhcCC
Confidence 99987654332 2335799999999999999999999999999999999999999975432111 000000000000
Q ss_pred cccccCcccCCCCCHHHHHHHHHHHHHchhhcccCCCCHHHHHH
Q 045315 390 TWELMDPISQNGASYPILKRYINVALLCVQEKAADRPAMSEVVS 433 (476)
Q Consensus 390 ~~~~~d~~~~~~~~~~~~~~l~~li~~Cl~~dP~~RPt~~eVl~ 433 (476)
. ...........+.+.+++.+||+.||++|||+.|+++
T Consensus 234 ~------~~~~~~~~~~s~~~~~li~~~L~~dP~~R~s~~eil~ 271 (335)
T d2ozaa1 234 Y------EFPNPEWSEVSEEVKMLIRNLLKTEPTQRMTITEFMN 271 (335)
T ss_dssp S------SCCTTHHHHSCHHHHHHHHHHSCSSTTTSCCHHHHHH
T ss_pred C------CCCCcccccCCHHHHHHHHHHccCChhHCcCHHHHHc
Confidence 0 0000111233567899999999999999999999987
|
| >d1o6la_ d.144.1.7 (A:) Pkb kinase (Akt-2) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Pkb kinase (Akt-2) species: Human (Homo sapiens) [TaxId: 9606]
Probab=99.96 E-value=4.3e-31 Score=261.73 Aligned_cols=172 Identities=23% Similarity=0.277 Sum_probs=136.8
Q ss_pred cccceeeccCCCCC------CCCCCChhhHHHHHHHHHHHHHHHhhcCCCceeecCCCccceEecCCCCceeccccceee
Q 045315 241 DEISFWYESYNNPT------KKGLLCWGTRVRIIEGIAQGLLYLHQYSRLRVIHRDLKASNILLDKDMNPKISDFGMARM 314 (476)
Q Consensus 241 ~~~~l~~Ey~~~~~------~~~~L~~~~~~~i~~qIa~gL~yLH~~~~~~ivH~DLkp~NILld~~~~~kL~DFGla~~ 314 (476)
+..+++|||++.+. +.+.+++.++..++.||+.||+|||+++ |+||||||+|||+++++.+||+|||+|+.
T Consensus 78 ~~~~iv~ey~~gg~L~~~~~~~~~~~e~~~~~~~~qil~al~ylH~~~---iiHRDlKP~NILl~~~g~vkl~DFG~a~~ 154 (337)
T d1o6la_ 78 DRLCFVMEYANGGELFFHLSRERVFTEERARFYGAEIVSALEYLHSRD---VVYRDIKLENLMLDKDGHIKITDFGLCKE 154 (337)
T ss_dssp SEEEEEEECCTTCBHHHHHHHHSCCCHHHHHHHHHHHHHHHHHHHHTT---CBCCCCCGGGEEECTTSCEEECCCTTCBC
T ss_pred cccccceeccCCCchhhhhhcccCCcHHHHHHHHHHHhhhhhhhhhcC---ccccccCHHHeEecCCCCEEEeecccccc
Confidence 46889999999542 3567999999999999999999999999 99999999999999999999999999987
Q ss_pred cCCCcccccceeeeeccCCCChhhhccCCCCccceEEeehhhhhhhhhCCCCCCcCCCCchhhhhhhhhhhcCCCccccc
Q 045315 315 FGGDELQSNTKRIVGTYGYMSPEYALRGLFSIKSDVFSFGVLLLETLSSKKNTHFYNTDSLTLLGHAWNLWNDGRTWELM 394 (476)
Q Consensus 315 ~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~s~ksDVwSlGvvl~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 394 (476)
...... ......||+.|+|||++.+..|+.++|+|||||++|||++|+.||...+.. .+.. ....+..
T Consensus 155 ~~~~~~--~~~~~~GT~~Y~aPE~~~~~~y~~~~DiwSlGvilyeml~G~~pf~~~~~~--~~~~----~i~~~~~---- 222 (337)
T d1o6la_ 155 GISDGA--TMKTFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHE--RLFE----LILMEEI---- 222 (337)
T ss_dssp SCCTTC--CBCCCEECGGGCCGGGGSSSCBCTTHHHHHHHHHHHHHHHSSCSSCCSSHH--HHHH----HHHHCCC----
T ss_pred cccCCc--ccccceeCHHHhhhhhccCCCCChhhcccchhhHHHHHHHCCCCCCCcCHH--HHHH----HHhcCCC----
Confidence 543322 233468999999999999999999999999999999999999998754421 1111 1111111
Q ss_pred CcccCCCCCHHHHHHHHHHHHHchhhcccCCCC-----HHHHHH
Q 045315 395 DPISQNGASYPILKRYINVALLCVQEKAADRPA-----MSEVVS 433 (476)
Q Consensus 395 d~~~~~~~~~~~~~~l~~li~~Cl~~dP~~RPt-----~~eVl~ 433 (476)
..+......+.+++.+||+.||++||+ ++|+++
T Consensus 223 ------~~p~~~s~~~~dli~~~L~~dP~~R~~~~~~~~~eil~ 260 (337)
T d1o6la_ 223 ------RFPRTLSPEAKSLLAGLLKKDPKQRLGGGPSDAKEVME 260 (337)
T ss_dssp ------CCCTTSCHHHHHHHHHHTCSSTTTSTTCSTTTHHHHHT
T ss_pred ------CCCccCCHHHHHHHHhhccCCchhhcccccccHHHHHc
Confidence 011223456889999999999999995 778765
|
| >d1blxa_ d.144.1.7 (A:) Cyclin-dependent PK, CDK6 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK6 species: Human (Homo sapiens) [TaxId: 9606]
Probab=99.96 E-value=4.5e-31 Score=258.16 Aligned_cols=184 Identities=22% Similarity=0.276 Sum_probs=135.8
Q ss_pred ccceeeccCCC-------CCCCCCCChhhHHHHHHHHHHHHHHHhhcCCCceeecCCCccceEecCCCCceeccccceee
Q 045315 242 EISFWYESYNN-------PTKKGLLCWGTRVRIIEGIAQGLLYLHQYSRLRVIHRDLKASNILLDKDMNPKISDFGMARM 314 (476)
Q Consensus 242 ~~~l~~Ey~~~-------~~~~~~L~~~~~~~i~~qIa~gL~yLH~~~~~~ivH~DLkp~NILld~~~~~kL~DFGla~~ 314 (476)
..++++||++. ......+++..+..++.||+.||+|||+++ |+||||||+|||++.++.+||+|||+++.
T Consensus 89 ~~~~~~e~~~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~aL~yLH~~~---ivHrDiKp~NILi~~~~~~kl~dfg~~~~ 165 (305)
T d1blxa_ 89 KLTLVFEHVDQDLTTYLDKVPEPGVPTETIKDMMFQLLRGLDFLHSHR---VVHRDLKPQNILVTSSGQIKLADFGLARI 165 (305)
T ss_dssp EEEEEEECCSCBHHHHHHHSCTTCSCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCCGGGEEECTTCCEEECSCCSCCC
T ss_pred eEEEEEEeccCCchhhhhhccCCCCCHHHHHHHHHHHHHHHHHHHhCC---EEecCCCccEEEEcCCCCeeecchhhhhh
Confidence 46788899872 235667999999999999999999999999 99999999999999999999999999986
Q ss_pred cCCCcccccceeeeeccCCCChhhhccCCCCccceEEeehhhhhhhhhCCCCCCcCCCCchhhhhhhhhhh--------c
Q 045315 315 FGGDELQSNTKRIVGTYGYMSPEYALRGLFSIKSDVFSFGVLLLETLSSKKNTHFYNTDSLTLLGHAWNLW--------N 386 (476)
Q Consensus 315 ~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~s~ksDVwSlGvvl~elltG~~p~~~~~~~~~~~~~~~~~~~--------~ 386 (476)
..... ......||+.|+|||++.+..++.++||||+||++|||++|+.||...... .......... .
T Consensus 166 ~~~~~---~~~~~~gT~~Y~APE~~~~~~y~~~~DiwSlG~il~ell~g~~pf~~~~~~--~~~~~i~~~~~~~~~~~~~ 240 (305)
T d1blxa_ 166 YSFQM---ALTSVVVTLWYRAPEVLLQSSYATPVDLWSVGCIFAEMFRRKPLFRGSSDV--DQLGKILDVIGLPGEEDWP 240 (305)
T ss_dssp CCGGG---GGCCCCCCCTTCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHH--HHHHHHHHHHCCCCGGGSC
T ss_pred hcccc---cCCCcccChhhcCcchhcCCCCChhehhhchHHHHHHHHHCCCCCCCCCHH--HHHHHHHHhhCCCchhccc
Confidence 54322 233467999999999999999999999999999999999999999754311 1111110000 0
Q ss_pred CC-Ccc-ccc-C--cccCCCCCHHHHHHHHHHHHHchhhcccCCCCHHHHHH
Q 045315 387 DG-RTW-ELM-D--PISQNGASYPILKRYINVALLCVQEKAADRPAMSEVVS 433 (476)
Q Consensus 387 ~~-~~~-~~~-d--~~~~~~~~~~~~~~l~~li~~Cl~~dP~~RPt~~eVl~ 433 (476)
.. ... ... . ............+.+.+++.+||+.||++|||++|+++
T Consensus 241 ~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~mL~~dP~~R~sa~e~L~ 292 (305)
T d1blxa_ 241 RDVALPRQAFHSKSAQPIEKFVTDIDELGKDLLLKCLTFNPAKRISAYSALS 292 (305)
T ss_dssp TTCSSCGGGSCCCCCCCGGGTCCSCCHHHHHHHHHHSCSSTTTSCCHHHHHT
T ss_pred ccccchhhhhccccccchhhccccCCHHHHHHHHHHCcCChhHCcCHHHHhc
Confidence 00 000 000 0 00000111123456889999999999999999999875
|
| >d1rdqe_ d.144.1.7 (E:) cAMP-dependent PK, catalytic subunit {Mouse (Mus musculus) [TaxId: 10090]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: cAMP-dependent PK, catalytic subunit species: Mouse (Mus musculus) [TaxId: 10090]
Probab=99.96 E-value=1.3e-30 Score=259.85 Aligned_cols=189 Identities=20% Similarity=0.258 Sum_probs=143.9
Q ss_pred cccceeeccCCCCC------CCCCCChhhHHHHHHHHHHHHHHHhhcCCCceeecCCCccceEecCCCCceeccccceee
Q 045315 241 DEISFWYESYNNPT------KKGLLCWGTRVRIIEGIAQGLLYLHQYSRLRVIHRDLKASNILLDKDMNPKISDFGMARM 314 (476)
Q Consensus 241 ~~~~l~~Ey~~~~~------~~~~L~~~~~~~i~~qIa~gL~yLH~~~~~~ivH~DLkp~NILld~~~~~kL~DFGla~~ 314 (476)
+.+++++||+..+. +.+.+++.++..++.||+.||.|||+++ ||||||||+|||++.++.+||+|||+|+.
T Consensus 114 ~~~~~v~e~~~~g~l~~~l~~~~~l~e~~~~~i~~qi~~aL~yLH~~~---iiHRDIKP~NILl~~~g~ikL~DFG~a~~ 190 (350)
T d1rdqe_ 114 SNLYMVMEYVAGGEMFSHLRRIGRFSEPHARFYAAQIVLTFEYLHSLD---LIYRDLKPENLLIDQQGYIQVTDFGFAKR 190 (350)
T ss_dssp SEEEEEEECCTTCBHHHHHHHHCCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEECTTSCEEECCCTTCEE
T ss_pred cccccccccccccchhhhHhhcCCCCHHHHHHHHHHHHHHHHHHHhCC---EecCcCCHHHcccCCCCCEEeeeceeeee
Confidence 46788999998432 3457999999999999999999999999 99999999999999999999999999998
Q ss_pred cCCCcccccceeeeeccCCCChhhhccCCCCccceEEeehhhhhhhhhCCCCCCcCCCCchhhhhhhhhhhcCCCccccc
Q 045315 315 FGGDELQSNTKRIVGTYGYMSPEYALRGLFSIKSDVFSFGVLLLETLSSKKNTHFYNTDSLTLLGHAWNLWNDGRTWELM 394 (476)
Q Consensus 315 ~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~s~ksDVwSlGvvl~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 394 (476)
+... .....||+.|+|||++.+..++.++|||||||++|||++|+.||.... ........ ..+..
T Consensus 191 ~~~~-----~~~~~Gt~~Y~APE~~~~~~~~~~~DiwSlGvilyemltG~~Pf~~~~--~~~~~~~i----~~~~~---- 255 (350)
T d1rdqe_ 191 VKGR-----TWTLCGTPEALAPEIILSKGYNKAVDWWALGVLIYEMAAGYPPFFADQ--PIQIYEKI----VSGKV---- 255 (350)
T ss_dssp CSSC-----BCCCEECGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCCSS--HHHHHHHH----HHCCC----
T ss_pred cccc-----cccccCccccCCHHHHcCCCCCccccccchhHHHHHHHhCCCCCCCcC--HHHHHHHH----hcCCC----
Confidence 6532 223679999999999999999999999999999999999999996432 11111111 11111
Q ss_pred CcccCCCCCHHHHHHHHHHHHHchhhcccCCC-----CHHHHHH--HHhcc------ccCCCCCCCCcceec
Q 045315 395 DPISQNGASYPILKRYINVALLCVQEKAADRP-----AMSEVVS--MLSNE------FVNLPAPQQPAFSCV 453 (476)
Q Consensus 395 d~~~~~~~~~~~~~~l~~li~~Cl~~dP~~RP-----t~~eVl~--~L~~~------~~~~~~p~~p~~~~~ 453 (476)
..+......+.+++.+||+.||.+|+ |++++++ .+.+. ...+++|-.|.+...
T Consensus 256 ------~~p~~~s~~~~~li~~~L~~dP~kR~~~~r~t~~ell~Hp~f~~~~~~~~~~~~~~~p~~p~~~~~ 321 (350)
T d1rdqe_ 256 ------RFPSHFSSDLKDLLRNLLQVDLTKRFGNLKNGVNDIKNHKWFATTDWIAIYQRKVEAPFIPKFKGP 321 (350)
T ss_dssp ------CCCTTCCHHHHHHHHHHSCSCTTTCTTSSTTTTHHHHTSGGGTTCCHHHHHTTCSCCSCCCCCCST
T ss_pred ------CCCccCCHHHHHHHHHHhhhCHHhccccccccHHHHHcCccccCCCHHHHHhcCCCcCccCCCCCc
Confidence 01112345688999999999999994 8999975 23221 124555655655443
|
| >d1gz8a_ d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK2 species: Human (Homo sapiens) [TaxId: 9606]
Probab=99.96 E-value=6.6e-31 Score=256.33 Aligned_cols=187 Identities=20% Similarity=0.228 Sum_probs=136.3
Q ss_pred cccceeeccCC-------CCCCCCCCChhhHHHHHHHHHHHHHHHhhcCCCceeecCCCccceEecCCCCceecccccee
Q 045315 241 DEISFWYESYN-------NPTKKGLLCWGTRVRIIEGIAQGLLYLHQYSRLRVIHRDLKASNILLDKDMNPKISDFGMAR 313 (476)
Q Consensus 241 ~~~~l~~Ey~~-------~~~~~~~L~~~~~~~i~~qIa~gL~yLH~~~~~~ivH~DLkp~NILld~~~~~kL~DFGla~ 313 (476)
+.++++|||+. .....+.|++.++..++.||+.||+|||+++ ||||||||+|||++.++.+||+|||+|+
T Consensus 74 ~~~~iv~e~~~~~~~~~~~~~~~~~l~e~~~~~~~~qil~~L~yLH~~~---IiHrDiKpeNIl~~~~~~~kl~DFG~a~ 150 (298)
T d1gz8a_ 74 NKLYLVFEFLHQDLKKFMDASALTGIPLPLIKSYLFQLLQGLAFCHSHR---VLHRDLKPQNLLINTEGAIKLADFGLAR 150 (298)
T ss_dssp TEEEEEEECCSEEHHHHHHHTTTTCCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEECTTSCEEECSTTHHH
T ss_pred cceeEEEeecCCchhhhhhhhcccCCCHHHHHHHHHHHHHHHHHhhcCC---EEccccCchheeecccCcceeccCCcce
Confidence 56889999998 2345667999999999999999999999999 9999999999999999999999999998
Q ss_pred ecCCCcccccceeeeeccCCCChhhhccCC-CCccceEEeehhhhhhhhhCCCCCCcCCCCchhhhhhhhhhhc---CCC
Q 045315 314 MFGGDELQSNTKRIVGTYGYMSPEYALRGL-FSIKSDVFSFGVLLLETLSSKKNTHFYNTDSLTLLGHAWNLWN---DGR 389 (476)
Q Consensus 314 ~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~-~s~ksDVwSlGvvl~elltG~~p~~~~~~~~~~~~~~~~~~~~---~~~ 389 (476)
........ .....||+.|+|||.+.... ++.++|||||||++|+|++|+.||...+... .......... +..
T Consensus 151 ~~~~~~~~--~~~~~gt~~y~apE~~~~~~~~~~~~DiwSlGvily~m~~G~~Pf~~~~~~~--~~~~i~~~~~~~~~~~ 226 (298)
T d1gz8a_ 151 AFGVPVRT--YTHEVVTLWYRAPEILLGCKYYSTAVDIWSLGCIFAEMVTRRALFPGDSEID--QLFRIFRTLGTPDEVV 226 (298)
T ss_dssp HHCCCSBC--TTCCBCCCTTCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHH--HHHHHHHHHCCCCTTT
T ss_pred eccCCccc--ceeecccceeeehhhhccccCCCccccccccchhhhHHhhCCCCCCCCCHHH--HHHHHHHhcCCCchhh
Confidence 76543222 22357999999999887655 5889999999999999999999997543111 1110000000 000
Q ss_pred c---ccccC--cc---cCCC----CCHHHHHHHHHHHHHchhhcccCCCCHHHHHHH
Q 045315 390 T---WELMD--PI---SQNG----ASYPILKRYINVALLCVQEKAADRPAMSEVVSM 434 (476)
Q Consensus 390 ~---~~~~d--~~---~~~~----~~~~~~~~l~~li~~Cl~~dP~~RPt~~eVl~~ 434 (476)
. ....+ .. .... ......+.+.+++.+||+.||++|||++|+++-
T Consensus 227 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dll~~mL~~dP~~R~t~~ell~H 283 (298)
T d1gz8a_ 227 WPGVTSMPDYKPSFPKWARQDFSKVVPPLDEDGRSLLSQMLHYDPNKRISAKAALAH 283 (298)
T ss_dssp STTGGGSTTCCTTSCCCCCCCHHHHSTTCCHHHHHHHHHHTCSSTTTSCCHHHHHTS
T ss_pred ccccccccccccccccccccchhhhccCCCHHHHHHHHHHccCChhHCcCHHHHhCC
Confidence 0 00000 00 0000 001223578899999999999999999999874
|
| >d1jksa_ d.144.1.7 (A:) Death-associated protein kinase, Dap {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Death-associated protein kinase, Dap species: Human (Homo sapiens) [TaxId: 9606]
Probab=99.96 E-value=1.1e-30 Score=254.23 Aligned_cols=175 Identities=21% Similarity=0.234 Sum_probs=135.4
Q ss_pred cccceeeccCCCCC------CCCCCChhhHHHHHHHHHHHHHHHhhcCCCceeecCCCccceEecCCC----Cceecccc
Q 045315 241 DEISFWYESYNNPT------KKGLLCWGTRVRIIEGIAQGLLYLHQYSRLRVIHRDLKASNILLDKDM----NPKISDFG 310 (476)
Q Consensus 241 ~~~~l~~Ey~~~~~------~~~~L~~~~~~~i~~qIa~gL~yLH~~~~~~ivH~DLkp~NILld~~~----~~kL~DFG 310 (476)
+.++++|||++.+. .++.+++.++..++.||+.||+|||+++ |+||||||+||+++.++ .+||+|||
T Consensus 86 ~~~~iv~E~~~gg~L~~~i~~~~~l~~~~~~~~~~qi~~al~yLH~~~---ivHrDiKp~Nill~~~~~~~~~vkl~DfG 162 (293)
T d1jksa_ 86 TDVILILELVAGGELFDFLAEKESLTEEEATEFLKQILNGVYYLHSLQ---IAHFDLKPENIMLLDRNVPKPRIKIIDFG 162 (293)
T ss_dssp SEEEEEEECCCSCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEESCSSSSSCCEEECCCT
T ss_pred CEEEEEEEcCCCccccchhccccccchhHHHHHHHHHHHHHHhhhhcc---eeecccccceEEEecCCCcccceEecchh
Confidence 56889999998432 3467999999999999999999999999 99999999999998776 48999999
Q ss_pred ceeecCCCcccccceeeeeccCCCChhhhccCCCCccceEEeehhhhhhhhhCCCCCCcCCCCchhhhhhhhhhhcCCCc
Q 045315 311 MARMFGGDELQSNTKRIVGTYGYMSPEYALRGLFSIKSDVFSFGVLLLETLSSKKNTHFYNTDSLTLLGHAWNLWNDGRT 390 (476)
Q Consensus 311 la~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~s~ksDVwSlGvvl~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~ 390 (476)
++........ .....||+.|+|||.+.+..++.++|||||||++|||++|+.||...... ...... .....
T Consensus 163 ~a~~~~~~~~---~~~~~~t~~y~APE~~~~~~~~~~~DiwSlGvilyell~g~~Pf~~~~~~--~~~~~i----~~~~~ 233 (293)
T d1jksa_ 163 LAHKIDFGNE---FKNIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASPFLGDTKQ--ETLANV----SAVNY 233 (293)
T ss_dssp TCEECTTSCB---CSCCCCCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHH--HHHHHH----HTTCC
T ss_pred hhhhcCCCcc---ccccCCCCcccCHHHHcCCCCCCcccchhhhHHHHHHHcCCCCCCCCCHH--HHHHHH----HhcCC
Confidence 9988754322 22356899999999999999999999999999999999999998754311 111111 11110
Q ss_pred ccccCcccCCCCCHHHHHHHHHHHHHchhhcccCCCCHHHHHH
Q 045315 391 WELMDPISQNGASYPILKRYINVALLCVQEKAADRPAMSEVVS 433 (476)
Q Consensus 391 ~~~~d~~~~~~~~~~~~~~l~~li~~Cl~~dP~~RPt~~eVl~ 433 (476)
.. .... .......+.+++.+||+.||++|||++|+++
T Consensus 234 -~~-~~~~----~~~~s~~~~~li~~~L~~dP~~R~s~~eil~ 270 (293)
T d1jksa_ 234 -EF-EDEY----FSNTSALAKDFIRRLLVKDPKKRMTIQDSLQ 270 (293)
T ss_dssp -CC-CHHH----HTTSCHHHHHHHHTTSCSSGGGSCCHHHHHH
T ss_pred -CC-Cchh----cCCCCHHHHHHHHHHccCChhHCcCHHHHhc
Confidence 00 0000 0112356889999999999999999999986
|
| >d1fota_ d.144.1.7 (A:) cAMP-dependent PK, catalytic subunit {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: cAMP-dependent PK, catalytic subunit species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]
Probab=99.96 E-value=1.4e-30 Score=255.92 Aligned_cols=169 Identities=24% Similarity=0.274 Sum_probs=135.6
Q ss_pred cccceeeccCCCCC------CCCCCChhhHHHHHHHHHHHHHHHhhcCCCceeecCCCccceEecCCCCceeccccceee
Q 045315 241 DEISFWYESYNNPT------KKGLLCWGTRVRIIEGIAQGLLYLHQYSRLRVIHRDLKASNILLDKDMNPKISDFGMARM 314 (476)
Q Consensus 241 ~~~~l~~Ey~~~~~------~~~~L~~~~~~~i~~qIa~gL~yLH~~~~~~ivH~DLkp~NILld~~~~~kL~DFGla~~ 314 (476)
+.++++|||++.+. .+..+++.++..++.||+.||+|||+++ |+||||||+|||++.++.+||+|||+|+.
T Consensus 77 ~~~~ivmE~~~gg~l~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~---iiHrDiKp~NILl~~~g~vkL~DFG~a~~ 153 (316)
T d1fota_ 77 QQIFMIMDYIEGGELFSLLRKSQRFPNPVAKFYAAEVCLALEYLHSKD---IIYRDLKPENILLDKNGHIKITDFGFAKY 153 (316)
T ss_dssp SEEEEEECCCCSCBHHHHHHHTSSCCHHHHHHHHHHHHHHHHHHHTTT---EECCCCCGGGEEECTTSCEEECCCSSCEE
T ss_pred CeeeeEeeecCCccccccccccccccccHHHHHHHHHHHhhhhhccCc---EEccccCchheeEcCCCCEEEecCccceE
Confidence 56899999998432 3567899999999999999999999999 99999999999999999999999999988
Q ss_pred cCCCcccccceeeeeccCCCChhhhccCCCCccceEEeehhhhhhhhhCCCCCCcCCCCchhhhhhhhhhhcCCCccccc
Q 045315 315 FGGDELQSNTKRIVGTYGYMSPEYALRGLFSIKSDVFSFGVLLLETLSSKKNTHFYNTDSLTLLGHAWNLWNDGRTWELM 394 (476)
Q Consensus 315 ~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~s~ksDVwSlGvvl~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 394 (476)
.... .....||+.|+|||++.+..++.++|||||||++|||++|+.||...+. ....... . .+..
T Consensus 154 ~~~~-----~~~~~Gt~~Y~APE~l~~~~y~~~~DiwSlGvilyemltG~~Pf~~~~~--~~~~~~i---~-~~~~---- 218 (316)
T d1fota_ 154 VPDV-----TYTLCGTPDYIAPEVVSTKPYNKSIDWWSFGILIYEMLAGYTPFYDSNT--MKTYEKI---L-NAEL---- 218 (316)
T ss_dssp CSSC-----BCCCCSCTTTCCHHHHTTCCBCTTHHHHHHHHHHHHHHHSSCTTCCSSH--HHHHHHH---H-HCCC----
T ss_pred eccc-----cccccCcccccCHHHHcCCCCCchhhccccchhHHHHHhCCCCCCCcCH--HHHHHHH---H-cCCC----
Confidence 6543 2236799999999999999999999999999999999999999865431 1111111 1 1111
Q ss_pred CcccCCCCCHHHHHHHHHHHHHchhhcccCCC-----CHHHHHH
Q 045315 395 DPISQNGASYPILKRYINVALLCVQEKAADRP-----AMSEVVS 433 (476)
Q Consensus 395 d~~~~~~~~~~~~~~l~~li~~Cl~~dP~~RP-----t~~eVl~ 433 (476)
..+....+.+.+++.+||+.||.+|| |++++++
T Consensus 219 ------~~p~~~s~~~~~li~~~L~~dp~~R~~~~r~t~~~il~ 256 (316)
T d1fota_ 219 ------RFPPFFNEDVKDLLSRLITRDLSQRLGNLQNGTEDVKN 256 (316)
T ss_dssp ------CCCTTSCHHHHHHHHHHTCSCTTTCTTSSTTTTHHHHT
T ss_pred ------CCCCCCCHHHHHHHHHHhhhCHHhccccchhhHHHHHc
Confidence 01112235688999999999999996 8999875
|
| >d1xjda_ d.144.1.7 (A:) Protein kinase C, theta type {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Protein kinase C, theta type species: Human (Homo sapiens) [TaxId: 9606]
Probab=99.96 E-value=4.9e-31 Score=259.75 Aligned_cols=172 Identities=26% Similarity=0.313 Sum_probs=136.4
Q ss_pred cccceeeccCCCCC------CCCCCChhhHHHHHHHHHHHHHHHhhcCCCceeecCCCccceEecCCCCceeccccceee
Q 045315 241 DEISFWYESYNNPT------KKGLLCWGTRVRIIEGIAQGLLYLHQYSRLRVIHRDLKASNILLDKDMNPKISDFGMARM 314 (476)
Q Consensus 241 ~~~~l~~Ey~~~~~------~~~~L~~~~~~~i~~qIa~gL~yLH~~~~~~ivH~DLkp~NILld~~~~~kL~DFGla~~ 314 (476)
+..+++|||++.+. ....+++.++..++.||+.||+|||+++ |+||||||+|||+++++.+||+|||+++.
T Consensus 76 ~~~yivmEy~~~g~L~~~i~~~~~~~e~~~~~~~~qi~~al~ylH~~~---iiHrDikp~NiL~~~~~~~kl~DFG~a~~ 152 (320)
T d1xjda_ 76 ENLFFVMEYLNGGDLMYHIQSCHKFDLSRATFYAAEIILGLQFLHSKG---IVYRDLKLDNILLDKDGHIKIADFGMCKE 152 (320)
T ss_dssp SEEEEEEECCTTCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTT---CBCCCCCGGGEEECTTSCEEECCCTTCBC
T ss_pred CceeEEEeecCCCcHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHhCC---eeeccCcccceeecCCCceeccccchhhh
Confidence 56889999998432 3567999999999999999999999999 99999999999999999999999999986
Q ss_pred cCCCcccccceeeeeccCCCChhhhccCCCCccceEEeehhhhhhhhhCCCCCCcCCCCchhhhhhhhhhhcCCCccccc
Q 045315 315 FGGDELQSNTKRIVGTYGYMSPEYALRGLFSIKSDVFSFGVLLLETLSSKKNTHFYNTDSLTLLGHAWNLWNDGRTWELM 394 (476)
Q Consensus 315 ~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~s~ksDVwSlGvvl~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 394 (476)
...... ......||+.|+|||++.+..++.++|||||||++|||++|+.||...... .+.... ..+..
T Consensus 153 ~~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvilyemltG~~PF~~~~~~--~~~~~i----~~~~~---- 220 (320)
T d1xjda_ 153 NMLGDA--KTNTFCGTPDYIAPEILLGQKYNHSVDWWSFGVLLYEMLIGQSPFHGQDEE--ELFHSI----RMDNP---- 220 (320)
T ss_dssp CCCTTC--CBCCCCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHH--HHHHHH----HHCCC----
T ss_pred cccccc--cccccCCCCCcCCHHHHcCCCCCchhhhhhhhHHHHHHHhCCCCCCCCCHH--HHHHHH----HcCCC----
Confidence 544322 223357999999999999999999999999999999999999999754321 111111 11111
Q ss_pred CcccCCCCCHHHHHHHHHHHHHchhhcccCCCCHH-HHHH
Q 045315 395 DPISQNGASYPILKRYINVALLCVQEKAADRPAMS-EVVS 433 (476)
Q Consensus 395 d~~~~~~~~~~~~~~l~~li~~Cl~~dP~~RPt~~-eVl~ 433 (476)
..+......+.+++.+||+.||++||++. ++++
T Consensus 221 ------~~p~~~s~~~~dli~~~L~~dP~~R~s~~~~l~~ 254 (320)
T d1xjda_ 221 ------FYPRWLEKEAKDLLVKLFVREPEKRLGVRGDIRQ 254 (320)
T ss_dssp ------CCCTTSCHHHHHHHHHHSCSSGGGSBTTBSCGGG
T ss_pred ------CCCccCCHHHHHHHHHhcccCCCCCcCHHHHHHh
Confidence 01112245688999999999999999995 6753
|
| >d1ckia_ d.144.1.7 (A:) Casein kinase-1, CK1 {Rat (Rattus norvegicus) [TaxId: 10116]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Casein kinase-1, CK1 species: Rat (Rattus norvegicus) [TaxId: 10116]
Probab=99.96 E-value=1.5e-30 Score=253.71 Aligned_cols=187 Identities=19% Similarity=0.187 Sum_probs=139.1
Q ss_pred cccceeeccCCCC------CCCCCCChhhHHHHHHHHHHHHHHHhhcCCCceeecCCCccceEec---CCCCceeccccc
Q 045315 241 DEISFWYESYNNP------TKKGLLCWGTRVRIIEGIAQGLLYLHQYSRLRVIHRDLKASNILLD---KDMNPKISDFGM 311 (476)
Q Consensus 241 ~~~~l~~Ey~~~~------~~~~~L~~~~~~~i~~qIa~gL~yLH~~~~~~ivH~DLkp~NILld---~~~~~kL~DFGl 311 (476)
+..+++|||+... ...+.+++.+++.++.|++.||+|||+++ |+||||||+|||++ .+..+||+|||+
T Consensus 76 ~~~~ivme~~~~~l~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~---iiHrDiKp~NIl~~~~~~~~~vkl~DFG~ 152 (299)
T d1ckia_ 76 DYNVMVMELLGPSLEDLFNFCSRKFSLKTVLLLADQMISRIEYIHSKN---FIHRDVKPDNFLMGLGKKGNLVYIIDFGL 152 (299)
T ss_dssp TEEEEEEECCCCBHHHHHHHTTTCCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCCGGGEEECCGGGTTCEEECCCSS
T ss_pred CEEEEEEEEcCCchhhhhhhccCCCcHHHHHHHHHHHHHHHHHHHHCC---eeeccCCHhhccccccCCCceeeeeccCc
Confidence 4577889998722 24567999999999999999999999999 99999999999975 456799999999
Q ss_pred eeecCCCccc-----ccceeeeeccCCCChhhhccCCCCccceEEeehhhhhhhhhCCCCCCcCCCCchhh-hhhhhhhh
Q 045315 312 ARMFGGDELQ-----SNTKRIVGTYGYMSPEYALRGLFSIKSDVFSFGVLLLETLSSKKNTHFYNTDSLTL-LGHAWNLW 385 (476)
Q Consensus 312 a~~~~~~~~~-----~~~~~~~gt~~y~aPE~l~~~~~s~ksDVwSlGvvl~elltG~~p~~~~~~~~~~~-~~~~~~~~ 385 (476)
|+.+...... .......||+.|+|||.+.+..++.++|||||||++|||++|+.||.......... ........
T Consensus 153 a~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~~l~el~tg~~P~~~~~~~~~~~~~~~~~~~~ 232 (299)
T d1ckia_ 153 AKKYRDARTHQHIPYRENKNLTGTARYASINTHLGIEQSRRDDLESLGYVLMYFNLGSLPWQGLKAATKRQKYERISEKK 232 (299)
T ss_dssp CEECBCTTTCCBCCCCBCCSCCCCSSSCCHHHHTTBCCCHHHHHHHHHHHHHHHHHSSCTTCCCC-------HHHHHHHH
T ss_pred ceeccccccccceeccccCCcCCCccccCHHHHhCCCCCChhhEEecCHHHHHHHhCCCcccccchHHHHHHHHHhhccc
Confidence 9987543221 12234679999999999999999999999999999999999999997654222111 11100000
Q ss_pred cCCCcccccCcccCCCCCHHHHHHHHHHHHHchhhcccCCCCHHHHHHHHhccc
Q 045315 386 NDGRTWELMDPISQNGASYPILKRYINVALLCVQEKAADRPAMSEVVSMLSNEF 439 (476)
Q Consensus 386 ~~~~~~~~~d~~~~~~~~~~~~~~l~~li~~Cl~~dP~~RPt~~eVl~~L~~~~ 439 (476)
..... +.... ..++.+.+++.+||+.+|++||+++++.+.|+...
T Consensus 233 ~~~~~-----~~~~~----~~p~~~~~li~~cl~~~p~~RP~~~~i~~~l~~~~ 277 (299)
T d1ckia_ 233 MSTPI-----EVLCK----GYPSEFATYLNFCRSLRFDDKPDYSYLRQLFRNLF 277 (299)
T ss_dssp HHSCH-----HHHTT----TSCHHHHHHHHHHHHSCTTCCCCHHHHHHHHHHHH
T ss_pred CCCCh-----hHhcc----CCCHHHHHHHHHHccCChhHCcCHHHHHHHHHHHH
Confidence 00000 00111 12356889999999999999999999999888765
|
| >d1phka_ d.144.1.7 (A:) gamma-subunit of glycogen phosphorylase kinase (Phk) {Rabbit (Oryctolagus cuniculus) [TaxId: 9986]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: gamma-subunit of glycogen phosphorylase kinase (Phk) species: Rabbit (Oryctolagus cuniculus) [TaxId: 9986]
Probab=99.96 E-value=3.3e-30 Score=248.67 Aligned_cols=175 Identities=22% Similarity=0.300 Sum_probs=136.4
Q ss_pred cccceeeccCCCC------CCCCCCChhhHHHHHHHHHHHHHHHhhcCCCceeecCCCccceEecCCCCceeccccceee
Q 045315 241 DEISFWYESYNNP------TKKGLLCWGTRVRIIEGIAQGLLYLHQYSRLRVIHRDLKASNILLDKDMNPKISDFGMARM 314 (476)
Q Consensus 241 ~~~~l~~Ey~~~~------~~~~~L~~~~~~~i~~qIa~gL~yLH~~~~~~ivH~DLkp~NILld~~~~~kL~DFGla~~ 314 (476)
+..+++|||++.+ ..++++++.++..++.||++||+|||+++ |+||||||+|||++.++.+||+|||+++.
T Consensus 83 ~~~~ivmE~~~~g~L~~~l~~~~~l~e~~~~~~~~qi~~al~~lH~~~---ivHrDlkp~Nill~~~~~~kl~DFG~a~~ 159 (277)
T d1phka_ 83 TFFFLVFDLMKKGELFDYLTEKVTLSEKETRKIMRALLEVICALHKLN---IVHRDLKPENILLDDDMNIKLTDFGFSCQ 159 (277)
T ss_dssp SEEEEEEECCTTCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEECTTCCEEECCCTTCEE
T ss_pred cceEEEEEcCCCchHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHcC---CcccccccceEEEcCCCCeEEccchheeE
Confidence 5688999999843 23568999999999999999999999999 99999999999999999999999999998
Q ss_pred cCCCcccccceeeeeccCCCChhhhcc------CCCCccceEEeehhhhhhhhhCCCCCCcCCCCchhhhhhhhhhhcCC
Q 045315 315 FGGDELQSNTKRIVGTYGYMSPEYALR------GLFSIKSDVFSFGVLLLETLSSKKNTHFYNTDSLTLLGHAWNLWNDG 388 (476)
Q Consensus 315 ~~~~~~~~~~~~~~gt~~y~aPE~l~~------~~~s~ksDVwSlGvvl~elltG~~p~~~~~~~~~~~~~~~~~~~~~~ 388 (476)
+..... .....||..|+|||++.+ ..++.++||||+||++|||++|+.||..... ..... ....+
T Consensus 160 ~~~~~~---~~~~~gt~~y~~PE~~~~~~~~~~~~~~~~~DiwslGvilyeml~g~~Pf~~~~~--~~~~~----~i~~~ 230 (277)
T d1phka_ 160 LDPGEK---LREVCGTPSYLAPEIIECSMNDNHPGYGKEVDMWSTGVIMYTLLAGSPPFWHRKQ--MLMLR----MIMSG 230 (277)
T ss_dssp CCTTCC---BCCCCSCGGGCCHHHHHHHHCTTSCCBCTHHHHHHHHHHHHHHHHSSCSSCCSSH--HHHHH----HHHHT
T ss_pred ccCCCc---eeeeeccCCCCCHHHhhccccccCCCCCchheEcccchhhhhhccCCCCCCCCCH--HHHHH----HHHhC
Confidence 765332 233579999999999863 3578899999999999999999999975432 11111 11111
Q ss_pred CcccccCcccCCCCCHHHHHHHHHHHHHchhhcccCCCCHHHHHH
Q 045315 389 RTWELMDPISQNGASYPILKRYINVALLCVQEKAADRPAMSEVVS 433 (476)
Q Consensus 389 ~~~~~~d~~~~~~~~~~~~~~l~~li~~Cl~~dP~~RPt~~eVl~ 433 (476)
... ..........+.+.+++.+||+.||++|||++||++
T Consensus 231 ~~~------~~~~~~~~~s~~~~~li~~~L~~~p~~R~s~~eil~ 269 (277)
T d1phka_ 231 NYQ------FGSPEWDDYSDTVKDLVSRFLVVQPQKRYTAEEALA 269 (277)
T ss_dssp CCC------CCTTTGGGSCHHHHHHHHHHCCSSGGGSCCHHHHTT
T ss_pred CCC------CCCcccccCCHHHHHHHHHHccCChhHCcCHHHHHc
Confidence 110 011111233467889999999999999999999865
|
| >d1xwsa_ d.144.1.7 (A:) Proto-oncogene serine/threonine-protein kinase Pim-1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Proto-oncogene serine/threonine-protein kinase Pim-1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=99.96 E-value=5.6e-31 Score=253.68 Aligned_cols=164 Identities=21% Similarity=0.347 Sum_probs=130.0
Q ss_pred cccceeeccCCCC-------CCCCCCChhhHHHHHHHHHHHHHHHhhcCCCceeecCCCccceEecCC-CCceeccccce
Q 045315 241 DEISFWYESYNNP-------TKKGLLCWGTRVRIIEGIAQGLLYLHQYSRLRVIHRDLKASNILLDKD-MNPKISDFGMA 312 (476)
Q Consensus 241 ~~~~l~~Ey~~~~-------~~~~~L~~~~~~~i~~qIa~gL~yLH~~~~~~ivH~DLkp~NILld~~-~~~kL~DFGla 312 (476)
+..+++|||+... .++..+++.++..++.||++||+|||+++ |+||||||+|||++.+ +.+||+|||++
T Consensus 82 ~~~~lv~e~~~~~~~l~~~~~~~~~l~e~~~~~~~~qi~~al~~lH~~~---iiHrDiKp~NIll~~~~~~vkl~DFG~a 158 (273)
T d1xwsa_ 82 DSFVLILERPEPVQDLFDFITERGALQEELARSFFWQVLEAVRHCHNCG---VLHRDIKDENILIDLNRGELKLIDFGSG 158 (273)
T ss_dssp SEEEEEEECCSSEEEHHHHHHHHCSCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEEETTTTEEEECCCTTC
T ss_pred CeEEEEEEeccCcchHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHHCC---CccccCcccceEEecCCCeEEECccccc
Confidence 4678889988621 23567999999999999999999999999 9999999999999854 78999999999
Q ss_pred eecCCCcccccceeeeeccCCCChhhhccCCC-CccceEEeehhhhhhhhhCCCCCCcCCCCchhhhhhhhhhhcCCCcc
Q 045315 313 RMFGGDELQSNTKRIVGTYGYMSPEYALRGLF-SIKSDVFSFGVLLLETLSSKKNTHFYNTDSLTLLGHAWNLWNDGRTW 391 (476)
Q Consensus 313 ~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~-s~ksDVwSlGvvl~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~ 391 (476)
+...... .....||+.|+|||++.+..+ +.++|||||||++|||++|+.||.... ... . +..
T Consensus 159 ~~~~~~~----~~~~~GT~~y~aPE~~~~~~~~~~~~DiwSlGvilyell~g~~Pf~~~~----~i~-------~-~~~- 221 (273)
T d1xwsa_ 159 ALLKDTV----YTDFDGTRVYSPPEWIRYHRYHGRSAAVWSLGILLYDMVCGDIPFEHDE----EII-------R-GQV- 221 (273)
T ss_dssp EECCSSC----BCCCCSCGGGSCHHHHHHSCBCHHHHHHHHHHHHHHHHHHSSCSCCSHH----HHH-------H-CCC-
T ss_pred eeccccc----ccccccCCCcCCHHHHcCCCCCCcccccccceeeehhHhhCCCCCCCch----HHh-------h-ccc-
Confidence 8764332 223579999999999987665 677999999999999999999986421 110 0 000
Q ss_pred cccCcccCCCCCHHHHHHHHHHHHHchhhcccCCCCHHHHHH
Q 045315 392 ELMDPISQNGASYPILKRYINVALLCVQEKAADRPAMSEVVS 433 (476)
Q Consensus 392 ~~~d~~~~~~~~~~~~~~l~~li~~Cl~~dP~~RPt~~eVl~ 433 (476)
... ......+.+++.+||+.||++|||++|+++
T Consensus 222 -----~~~----~~~s~~~~~li~~~L~~dp~~R~s~~eil~ 254 (273)
T d1xwsa_ 222 -----FFR----QRVSSECQHLIRWCLALRPSDRPTFEEIQN 254 (273)
T ss_dssp -----CCS----SCCCHHHHHHHHHHTCSSGGGSCCHHHHHT
T ss_pred -----CCC----CCCCHHHHHHHHHHccCCHhHCcCHHHHhc
Confidence 011 112356889999999999999999999976
|
| >d1q5ka_ d.144.1.7 (A:) Glycogen synthase kinase-3 beta (Gsk3b) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Glycogen synthase kinase-3 beta (Gsk3b) species: Human (Homo sapiens) [TaxId: 9606]
Probab=99.96 E-value=1.3e-29 Score=252.82 Aligned_cols=184 Identities=19% Similarity=0.158 Sum_probs=133.2
Q ss_pred cceeeccCCCC---------CCCCCCChhhHHHHHHHHHHHHHHHhhcCCCceeecCCCccceEecCCC-Cceeccccce
Q 045315 243 ISFWYESYNNP---------TKKGLLCWGTRVRIIEGIAQGLLYLHQYSRLRVIHRDLKASNILLDKDM-NPKISDFGMA 312 (476)
Q Consensus 243 ~~l~~Ey~~~~---------~~~~~L~~~~~~~i~~qIa~gL~yLH~~~~~~ivH~DLkp~NILld~~~-~~kL~DFGla 312 (476)
.+++|||++.. .....+++.++..++.||+.||+|||+++ |+||||||+|||++.++ .+||+|||++
T Consensus 94 ~~lv~Ey~~~~~~~~l~~~~~~~~~l~~~~~~~i~~qil~aL~yLH~~~---IiHrDiKp~NILl~~~~~~~kl~DFG~a 170 (350)
T d1q5ka_ 94 LNLVLDYVPETVYRVARHYSRAKQTLPVIYVKLYMYQLFRSLAYIHSFG---ICHRDIKPQNLLLDPDTAVLKLCDFGSA 170 (350)
T ss_dssp EEEEEECCSEEHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHTTT---EECCCCCGGGEEECTTTCCEEECCCTTC
T ss_pred EEEEEeccCCccHHHHHhhhhccCCCCHHHHHHHHHHHHHHHHHHHhcC---CcccCCCcceEEEecCCCceeEecccch
Confidence 56789999821 24567999999999999999999999999 99999999999999775 8999999999
Q ss_pred eecCCCcccccceeeeeccCCCChhhhcc-CCCCccceEEeehhhhhhhhhCCCCCCcCCCCchhhhhhh----------
Q 045315 313 RMFGGDELQSNTKRIVGTYGYMSPEYALR-GLFSIKSDVFSFGVLLLETLSSKKNTHFYNTDSLTLLGHA---------- 381 (476)
Q Consensus 313 ~~~~~~~~~~~~~~~~gt~~y~aPE~l~~-~~~s~ksDVwSlGvvl~elltG~~p~~~~~~~~~~~~~~~---------- 381 (476)
+.+...... ....|+..|+|||.+.+ ..++.++||||+||++|||++|+.||....... .+....
T Consensus 171 ~~~~~~~~~---~~~~gt~~y~aPE~~~~~~~~~~~~DIwSlG~il~el~~g~~pf~~~~~~~-~l~~i~~~~g~~~~~~ 246 (350)
T d1q5ka_ 171 KQLVRGEPN---VSYICSRYYRAPELIFGATDYTSSIDVWSAGCVLAELLLGQPIFPGDSGVD-QLVEIIKVLGTPTREQ 246 (350)
T ss_dssp EECCTTSCC---CSCCSCTTSCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHTSCSSCCSSHHH-HHHHHHHHHCCCCHHH
T ss_pred hhccCCccc---ccccccccccChHHhhcccCCCcceeecccceEEEehhhCCCCCCCCCHHH-HHHHHHHHhCCChHHh
Confidence 877543322 23578999999998875 568999999999999999999999997543111 010000
Q ss_pred hhhhc----CCCcccccCcccCCCCCHHHHHHHHHHHHHchhhcccCCCCHHHHHH
Q 045315 382 WNLWN----DGRTWELMDPISQNGASYPILKRYINVALLCVQEKAADRPAMSEVVS 433 (476)
Q Consensus 382 ~~~~~----~~~~~~~~d~~~~~~~~~~~~~~l~~li~~Cl~~dP~~RPt~~eVl~ 433 (476)
+.... .......................+.+++.+||+.||++|||+.|+++
T Consensus 247 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dLl~~mL~~dP~~R~ta~e~L~ 302 (350)
T d1q5ka_ 247 IREMNPNYTEFKFPQIKAHPWTKVFRPRTPPEAIALCSRLLEYTPTARLTPLEACA 302 (350)
T ss_dssp HHHHCC---CCCCCCCCCCCGGGTSCTTSCHHHHHHHHHHSCSSGGGSCCHHHHHT
T ss_pred hhhhccchhhccccccccCchhhhcccCCCHHHHHHHHHHccCChhHCcCHHHHhc
Confidence 00000 00000000000000111223456889999999999999999999986
|
| >d1tkia_ d.144.1.7 (A:) Titin, kinase domain {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Titin, kinase domain species: Human (Homo sapiens) [TaxId: 9606]
Probab=99.96 E-value=1.2e-29 Score=249.96 Aligned_cols=175 Identities=20% Similarity=0.256 Sum_probs=135.2
Q ss_pred cccceeeccCCCC-------CCCCCCChhhHHHHHHHHHHHHHHHhhcCCCceeecCCCccceEecC--CCCceeccccc
Q 045315 241 DEISFWYESYNNP-------TKKGLLCWGTRVRIIEGIAQGLLYLHQYSRLRVIHRDLKASNILLDK--DMNPKISDFGM 311 (476)
Q Consensus 241 ~~~~l~~Ey~~~~-------~~~~~L~~~~~~~i~~qIa~gL~yLH~~~~~~ivH~DLkp~NILld~--~~~~kL~DFGl 311 (476)
+.++++|||++.+ .++..+++.++..++.||++||+|||+++ |+||||||+|||++. ...+||+|||+
T Consensus 74 ~~~~lvmE~~~gg~L~~~i~~~~~~l~e~~~~~i~~qi~~al~yLH~~~---iiHrDlKp~NIll~~~~~~~ikl~DFG~ 150 (321)
T d1tkia_ 74 EELVMIFEFISGLDIFERINTSAFELNEREIVSYVHQVCEALQFLHSHN---IGHFDIRPENIIYQTRRSSTIKIIEFGQ 150 (321)
T ss_dssp TEEEEEECCCCCCBHHHHHTSSSCCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEESSSSCCCEEECCCTT
T ss_pred CEEEEEEecCCCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHcC---CCcccccccceeecCCCceEEEEcccch
Confidence 5789999999843 23447999999999999999999999999 999999999999985 44789999999
Q ss_pred eeecCCCcccccceeeeeccCCCChhhhccCCCCccceEEeehhhhhhhhhCCCCCCcCCCCchhhhhhhhhhhcCCCcc
Q 045315 312 ARMFGGDELQSNTKRIVGTYGYMSPEYALRGLFSIKSDVFSFGVLLLETLSSKKNTHFYNTDSLTLLGHAWNLWNDGRTW 391 (476)
Q Consensus 312 a~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~s~ksDVwSlGvvl~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~ 391 (476)
++...... ......+++.|+|||.+.+..++.++|||||||++|||++|+.||...... ...... .. +..
T Consensus 151 ~~~~~~~~---~~~~~~~t~~y~ape~~~~~~~~~~~DiWSlGvily~ll~G~~Pf~~~~~~--~~~~~i---~~-~~~- 220 (321)
T d1tkia_ 151 ARQLKPGD---NFRLLFTAPEYYAPEVHQHDVVSTATDMWSLGTLVYVLLSGINPFLAETNQ--QIIENI---MN-AEY- 220 (321)
T ss_dssp CEECCTTC---EEEEEESCGGGSCHHHHTTCEECHHHHHHHHHHHHHHHHHSSCTTCCSSHH--HHHHHH---HH-TCC-
T ss_pred hhccccCC---cccccccccccccchhccCCCCCchhhcccHHHHHHHHHhCCCCCCCCCHH--HHHHHH---Hh-CCC-
Confidence 98765432 233467899999999999999999999999999999999999998754321 111111 11 110
Q ss_pred cccCcccCCCCCHHHHHHHHHHHHHchhhcccCCCCHHHHHH
Q 045315 392 ELMDPISQNGASYPILKRYINVALLCVQEKAADRPAMSEVVS 433 (476)
Q Consensus 392 ~~~d~~~~~~~~~~~~~~l~~li~~Cl~~dP~~RPt~~eVl~ 433 (476)
. .+... .......+.+++.+||+.||++|||+.|+++
T Consensus 221 ~-~~~~~----~~~~s~~~~~li~~~L~~dp~~R~s~~eil~ 257 (321)
T d1tkia_ 221 T-FDEEA----FKEISIEAMDFVDRLLVKERKSRMTASEALQ 257 (321)
T ss_dssp C-CCHHH----HTTSCHHHHHHHHTTSCSSGGGSCCHHHHHH
T ss_pred C-CChhh----ccCCCHHHHHHHHHHccCChhHCcCHHHHhc
Confidence 0 00000 0012356889999999999999999999987
|
| >d3blha1 d.144.1.7 (A:8-325) Cell division protein kinase 9, CDK9 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cell division protein kinase 9, CDK9 species: Human (Homo sapiens) [TaxId: 9606]
Probab=99.95 E-value=2.9e-29 Score=246.70 Aligned_cols=189 Identities=19% Similarity=0.234 Sum_probs=133.6
Q ss_pred cccceeeccCC------CCCCCCCCChhhHHHHHHHHHHHHHHHhhcCCCceeecCCCccceEecCCCCceeccccceee
Q 045315 241 DEISFWYESYN------NPTKKGLLCWGTRVRIIEGIAQGLLYLHQYSRLRVIHRDLKASNILLDKDMNPKISDFGMARM 314 (476)
Q Consensus 241 ~~~~l~~Ey~~------~~~~~~~L~~~~~~~i~~qIa~gL~yLH~~~~~~ivH~DLkp~NILld~~~~~kL~DFGla~~ 314 (476)
+..+++|||++ .......++..++..++.||++||+|||+++ |+||||||+|||++.++.+||+|||+++.
T Consensus 90 ~~~~iv~e~~~~~~~~~~~~~~~~~~~~~~~~i~~qil~~l~~lH~~~---ivHrDlKp~NILl~~~~~~kl~dfg~~~~ 166 (318)
T d3blha1 90 GSIYLVFDFCEHDLAGLLSNVLVKFTLSEIKRVMQMLLNGLYYIHRNK---ILHRDMKAANVLITRDGVLKLADFGLARA 166 (318)
T ss_dssp -CEEEEEECCCEEHHHHHTCTTCCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEECTTSCEEECCCTTCEE
T ss_pred ceEEEEEeccCCCccchhhhcccccccHHHHHHHHHHHHHHHHhccCC---EEecCcCchheeecCCCcEEeeecceeee
Confidence 35678899988 2345668999999999999999999999999 99999999999999999999999999987
Q ss_pred cCCCccc--ccceeeeeccCCCChhhhccC-CCCccceEEeehhhhhhhhhCCCCCCcCCCCchhhhhhhhhhhc---C-
Q 045315 315 FGGDELQ--SNTKRIVGTYGYMSPEYALRG-LFSIKSDVFSFGVLLLETLSSKKNTHFYNTDSLTLLGHAWNLWN---D- 387 (476)
Q Consensus 315 ~~~~~~~--~~~~~~~gt~~y~aPE~l~~~-~~s~ksDVwSlGvvl~elltG~~p~~~~~~~~~~~~~~~~~~~~---~- 387 (476)
+...... .......||+.|+|||.+.+. .++.++|||||||++|||++|+.||..... ............ .
T Consensus 167 ~~~~~~~~~~~~~~~~gT~~Y~aPE~~~~~~~~~~k~DiwSlGvil~el~~g~~pf~~~~~--~~~~~~i~~~~~~~~~~ 244 (318)
T d3blha1 167 FSLAKNSQPNRYTNRVVTLWYRPPELLLGERDYGPPIDLWGAGCIMAEMWTRSPIMQGNTE--QHQLALISQLCGSITPE 244 (318)
T ss_dssp CCC-----CCCCCSCCSCGGGCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHSSCSCCCSSH--HHHHHHHHHHHCCCCTT
T ss_pred cccccccccccccceecCHHHhhHHHHcCCCCCCcHHHcccCCceeeeHhhCCCCCCCCCH--HHHHHHHHHhcCCCChh
Confidence 6543211 122335689999999998765 689999999999999999999999865431 111111111110 0
Q ss_pred -------CCcccccCcccCCCCCHH-------HHHHHHHHHHHchhhcccCCCCHHHHHHH
Q 045315 388 -------GRTWELMDPISQNGASYP-------ILKRYINVALLCVQEKAADRPAMSEVVSM 434 (476)
Q Consensus 388 -------~~~~~~~d~~~~~~~~~~-------~~~~l~~li~~Cl~~dP~~RPt~~eVl~~ 434 (476)
.................. ....+++++.+||+.||++|||++|+++.
T Consensus 245 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dLl~~mL~~dP~~R~sa~elL~H 305 (318)
T d3blha1 245 VWPNVDNYELYEKLELVKGQKRKVKDRLKAYVRDPYALDLIDKLLVLDPAQRIDSDDALNH 305 (318)
T ss_dssp TSTTCCCC-------CCSSCCBCHHHHHHHHHCCHHHHHHHHHHSCSSTTTSCCHHHHHHS
T ss_pred hccccchhhhhhhhcccccccccchhhhccccCCHHHHHHHHHHCcCChhHCcCHHHHHcC
Confidence 000000000001111111 12456789999999999999999998853
|
| >d1csna_ d.144.1.7 (A:) Casein kinase-1, CK1 {Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Casein kinase-1, CK1 species: Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]
Probab=99.95 E-value=4.4e-29 Score=242.76 Aligned_cols=191 Identities=15% Similarity=0.122 Sum_probs=141.9
Q ss_pred cccceeeccCCC------CCCCCCCChhhHHHHHHHHHHHHHHHhhcCCCceeecCCCccceEecC-----CCCceeccc
Q 045315 241 DEISFWYESYNN------PTKKGLLCWGTRVRIIEGIAQGLLYLHQYSRLRVIHRDLKASNILLDK-----DMNPKISDF 309 (476)
Q Consensus 241 ~~~~l~~Ey~~~------~~~~~~L~~~~~~~i~~qIa~gL~yLH~~~~~~ivH~DLkp~NILld~-----~~~~kL~DF 309 (476)
+..+++|||+.. ...+..++..++..++.|++.||+|||+++ |+||||||+|||++. ++.+||+||
T Consensus 74 ~~~~~vme~~~~~l~~~~~~~~~~~~~~~~~~i~~q~~~~l~~lH~~g---iiHrDiKp~Nili~~~~~~~~~~vkl~DF 150 (293)
T d1csna_ 74 LHNVLVIDLLGPSLEDLLDLCGRKFSVKTVAMAAKQMLARVQSIHEKS---LVYRDIKPDNFLIGRPNSKNANMIYVVDF 150 (293)
T ss_dssp TEEEEEEECCCCBHHHHHHHTTTCCCHHHHHHHHHHHHHHHHHHHTTT---EECCCCCGGGEEECCSSSTTTTCEEECCC
T ss_pred CccEEEEEecCCCHHHHHHhhccchhhHHHHHHHHHHHHHHHHHHHCC---ceeccCCccceeecCcccccCCceEEccc
Confidence 456788899861 123457999999999999999999999999 999999999999974 567999999
Q ss_pred cceeecCCCccc-----ccceeeeeccCCCChhhhccCCCCccceEEeehhhhhhhhhCCCCCCcCCCC-chhhhhhhhh
Q 045315 310 GMARMFGGDELQ-----SNTKRIVGTYGYMSPEYALRGLFSIKSDVFSFGVLLLETLSSKKNTHFYNTD-SLTLLGHAWN 383 (476)
Q Consensus 310 Gla~~~~~~~~~-----~~~~~~~gt~~y~aPE~l~~~~~s~ksDVwSlGvvl~elltG~~p~~~~~~~-~~~~~~~~~~ 383 (476)
|+|+.+...... .......||+.|+|||.+.+..++.++|||||||++|||++|+.||...... ..........
T Consensus 151 G~a~~~~~~~~~~~~~~~~~~~~~GT~~y~aPE~~~~~~~~~~~DiwSlG~~l~elltg~~Pf~~~~~~~~~~~~~~i~~ 230 (293)
T d1csna_ 151 GMVKFYRDPVTKQHIPYREKKNLSGTARYMSINTHLGREQSRRDDLEALGHVFMYFLRGSLPWQGLKAATNKQKYERIGE 230 (293)
T ss_dssp TTCEESBCTTTCCBCCCCCCCCCCSCTTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCTTSSCCSCCHHHHHHHHHH
T ss_pred ceeEEcccCccccceeecccCceEEchhhcCHHHhcCCCCChHHHHHHhhHHHHHHHhCCCcCCCccchhHHHHHHHHHh
Confidence 999986533211 1233467999999999999999999999999999999999999999765422 2111111111
Q ss_pred hhcCCCcccccCcccCCCCCHHHHHHHHHHHHHchhhcccCCCCHHHHHHHHhccccCCC
Q 045315 384 LWNDGRTWELMDPISQNGASYPILKRYINVALLCVQEKAADRPAMSEVVSMLSNEFVNLP 443 (476)
Q Consensus 384 ~~~~~~~~~~~d~~~~~~~~~~~~~~l~~li~~Cl~~dP~~RPt~~eVl~~L~~~~~~~~ 443 (476)
........+ +... .++++.+++..|++.+|++||+.+.+.+.|+.+.....
T Consensus 231 ~~~~~~~~~-----l~~~----~p~~l~~ii~~~~~~~~~~rP~y~~l~~~l~~~~~~~~ 281 (293)
T d1csna_ 231 KKQSTPLRE-----LCAG----FPEEFYKYMHYARNLAFDATPDYDYLQGLFSKVLERLN 281 (293)
T ss_dssp HHHHSCHHH-----HTTT----SCHHHHHHHHHHHHCCTTCCCCHHHHHHHHHHHHHHTT
T ss_pred ccCCCChHH-----hcCC----CCHHHHHHHHHHhcCCcccCcCHHHHHHHHHHHHHHcC
Confidence 100001111 1111 12468889999999999999999999998887664443
|
| >d1ob3a_ d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {(Plasmodium falciparum) [TaxId: 5833]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK2 species: (Plasmodium falciparum) [TaxId: 5833]
Probab=99.95 E-value=2.3e-29 Score=243.81 Aligned_cols=186 Identities=19% Similarity=0.298 Sum_probs=131.2
Q ss_pred cccceeeccCCC------CCCCCCCChhhHHHHHHHHHHHHHHHhhcCCCceeecCCCccceEecCCCCceeccccceee
Q 045315 241 DEISFWYESYNN------PTKKGLLCWGTRVRIIEGIAQGLLYLHQYSRLRVIHRDLKASNILLDKDMNPKISDFGMARM 314 (476)
Q Consensus 241 ~~~~l~~Ey~~~------~~~~~~L~~~~~~~i~~qIa~gL~yLH~~~~~~ivH~DLkp~NILld~~~~~kL~DFGla~~ 314 (476)
+..++++||+.. ...++.|++.++..++.||+.||+|||+.+ ||||||||+|||++.++.+||+|||.+..
T Consensus 73 ~~~~i~~e~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~---IvHrDiKp~NIll~~~~~~kl~DfG~a~~ 149 (286)
T d1ob3a_ 73 KRLVLVFEHLDQDLKKLLDVCEGGLESVTAKSFLLQLLNGIAYCHDRR---VLHRDLKPQNLLINREGELKIADFGLARA 149 (286)
T ss_dssp SCEEEEEECCSEEHHHHHHTSTTCCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEECTTSCEEECCTTHHHH
T ss_pred CceeEEEEeehhhhHHHHHhhcCCcchhhhHHHHHHHHHHHHHhccCc---EEecCCCCceeeEcCCCCEEeccccccee
Confidence 456777888872 234678999999999999999999999998 99999999999999999999999999987
Q ss_pred cCCCcccccceeeeeccCCCChhhhcc-CCCCccceEEeehhhhhhhhhCCCCCCcCCCCchhhhhhhhhhhcC------
Q 045315 315 FGGDELQSNTKRIVGTYGYMSPEYALR-GLFSIKSDVFSFGVLLLETLSSKKNTHFYNTDSLTLLGHAWNLWND------ 387 (476)
Q Consensus 315 ~~~~~~~~~~~~~~gt~~y~aPE~l~~-~~~s~ksDVwSlGvvl~elltG~~p~~~~~~~~~~~~~~~~~~~~~------ 387 (476)
...... ......+++.|+|||.+.+ ..++.++|||||||++|||++|+.||....... ...........
T Consensus 150 ~~~~~~--~~~~~~~~~~y~~pE~~~~~~~~~~~~DiwslGv~l~el~~G~~pf~~~~~~~--~~~~i~~~~~~~~~~~~ 225 (286)
T d1ob3a_ 150 FGIPVR--KYTHEIVTLWYRAPDVLMGSKKYSTTIDIWSVGCIFAEMVNGTPLFPGVSEAD--QLMRIFRILGTPNSKNW 225 (286)
T ss_dssp HCC-----------CCCTTCCHHHHTTCCSCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHH--HHHHHHHHHCCCCTTTS
T ss_pred cccCcc--ccceecccchhhhHHHHhCCCCCCcceeehhcCcHHHHHHHCCCCCCCCCHHH--HHHHHHHhhCCCChhhc
Confidence 654322 2233568999999999875 456999999999999999999999986543111 11111100000
Q ss_pred ------CCc---ccccCcccCCCCCHHHHHHHHHHHHHchhhcccCCCCHHHHHH
Q 045315 388 ------GRT---WELMDPISQNGASYPILKRYINVALLCVQEKAADRPAMSEVVS 433 (476)
Q Consensus 388 ------~~~---~~~~d~~~~~~~~~~~~~~l~~li~~Cl~~dP~~RPt~~eVl~ 433 (476)
... .....+...........+.+.+++.+||+.||++|||++|+++
T Consensus 226 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~~L~~dP~~R~s~~ell~ 280 (286)
T d1ob3a_ 226 PNVTELPKYDPNFTVYEPLPWESFLKGLDESGIDLLSKMLKLDPNQRITAKQALE 280 (286)
T ss_dssp TTGGGSTTCCTTCCCCCCCCGGGTCCSCCHHHHHHHHHHTCSSTTTSCCHHHHHT
T ss_pred cchhhhhhcccccccccCcchhhhcccCCHHHHHHHHHHccCChhHCcCHHHHhc
Confidence 000 0000000000111122457889999999999999999999974
|
| >d1cm8a_ d.144.1.7 (A:) MAP kinase p38-gamma {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase p38-gamma species: Human (Homo sapiens) [TaxId: 9606]
Probab=99.95 E-value=5.1e-29 Score=247.89 Aligned_cols=187 Identities=21% Similarity=0.202 Sum_probs=135.9
Q ss_pred ccceeeccCCC----CCCCCCCChhhHHHHHHHHHHHHHHHhhcCCCceeecCCCccceEecCCCCceeccccceeecCC
Q 045315 242 EISFWYESYNN----PTKKGLLCWGTRVRIIEGIAQGLLYLHQYSRLRVIHRDLKASNILLDKDMNPKISDFGMARMFGG 317 (476)
Q Consensus 242 ~~~l~~Ey~~~----~~~~~~L~~~~~~~i~~qIa~gL~yLH~~~~~~ivH~DLkp~NILld~~~~~kL~DFGla~~~~~ 317 (476)
..+++|||+.. ..+...|++..+..++.||+.||+|||+++ |+||||||+|||++.++.+|++|||+++....
T Consensus 97 ~~~lv~e~~~~~l~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~~---IiHrDiKp~NIL~~~~~~~kl~Dfg~a~~~~~ 173 (346)
T d1cm8a_ 97 DFYLVMPFMGTDLGKLMKHEKLGEDRIQFLVYQMLKGLRYIHAAG---IIHRDLKPGNLAVNEDCELKILDFGLARQADS 173 (346)
T ss_dssp CCEEEEECCSEEHHHHHHHCCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEECTTCCEEECCCTTCEECCS
T ss_pred eEEEEEecccccHHHHHHhccccHHHHHHHHHHHHHHHHHHHhCC---CcccccCcchhhcccccccccccccceeccCC
Confidence 46889999972 123457999999999999999999999999 99999999999999999999999999987654
Q ss_pred CcccccceeeeeccCCCChhhhccC-CCCccceEEeehhhhhhhhhCCCCCCcCCCCchhhhhhhhhhhc--------CC
Q 045315 318 DELQSNTKRIVGTYGYMSPEYALRG-LFSIKSDVFSFGVLLLETLSSKKNTHFYNTDSLTLLGHAWNLWN--------DG 388 (476)
Q Consensus 318 ~~~~~~~~~~~gt~~y~aPE~l~~~-~~s~ksDVwSlGvvl~elltG~~p~~~~~~~~~~~~~~~~~~~~--------~~ 388 (476)
.. ....||+.|+|||.+.+. .++.++||||+||++|||++|+.||...+.... + ........ ..
T Consensus 174 ~~-----~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlGvil~ell~g~~pf~~~~~~~~-~-~~~~~~~~~~~~~~~~~~ 246 (346)
T d1cm8a_ 174 EM-----TGYVVTRWYRAPEVILNWMRYTQTVDIWSVGCIMAEMITGKTLFKGSDHLDQ-L-KEIMKVTGTPPAEFVQRL 246 (346)
T ss_dssp SC-----CSSCSCGGGCCTHHHHTTTCCCTTHHHHHHHHHHHHHHHSSCSSCCSSHHHH-H-HHHHHHHCCCCHHHHHTC
T ss_pred cc-----ccccccccccCHHHHcCCCCCCccchhhcchHHHHHHHHCcCCCCCCChHHH-H-HHHHhccCCCcHHHHhhh
Confidence 32 235689999999998764 568999999999999999999999865431110 0 00000000 00
Q ss_pred C----------cccccCcccCCCCCHHHHHHHHHHHHHchhhcccCCCCHHHHHHH--Hhccc
Q 045315 389 R----------TWELMDPISQNGASYPILKRYINVALLCVQEKAADRPAMSEVVSM--LSNEF 439 (476)
Q Consensus 389 ~----------~~~~~d~~~~~~~~~~~~~~l~~li~~Cl~~dP~~RPt~~eVl~~--L~~~~ 439 (476)
. ..+...... ..........+.+++.+||+.||++|||++|+++. ++.+.
T Consensus 247 ~~~~~~~~~~~~~~~~~~~~-~~~~~~~s~~~~dli~~mL~~dP~~R~ta~eiL~Hp~f~~~~ 308 (346)
T d1cm8a_ 247 QSDEAKNYMKGLPELEKKDF-ASILTNASPLAVNLLEKMLVLDAEQRVTAGEALAHPYFESLH 308 (346)
T ss_dssp SCHHHHHHHHHSCCCCCCCG-GGTCTTCCHHHHHHHHHHSCSSTTTSCCHHHHHHSGGGTTTC
T ss_pred cchhhhhhhccCCcccccch-HHhccCCCHHHHHHHHHHCcCChhHCcCHHHHhcChhhCcCC
Confidence 0 000000000 00111223567899999999999999999999874 65543
|
| >d3bqca1 d.144.1.7 (A:3-330) Protein kinase CK2, alpha subunit {Rattus norvegicus [TaxId: 10116]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Protein kinase CK2, alpha subunit species: Rattus norvegicus [TaxId: 10116]
Probab=99.95 E-value=3.5e-28 Score=239.96 Aligned_cols=187 Identities=16% Similarity=0.209 Sum_probs=134.2
Q ss_pred cccceeeccCCCC---CCCCCCChhhHHHHHHHHHHHHHHHhhcCCCceeecCCCccceEecCCC-CceeccccceeecC
Q 045315 241 DEISFWYESYNNP---TKKGLLCWGTRVRIIEGIAQGLLYLHQYSRLRVIHRDLKASNILLDKDM-NPKISDFGMARMFG 316 (476)
Q Consensus 241 ~~~~l~~Ey~~~~---~~~~~L~~~~~~~i~~qIa~gL~yLH~~~~~~ivH~DLkp~NILld~~~-~~kL~DFGla~~~~ 316 (476)
...+++|||++.. ...+.|++.++..++.||+.||+|||+++ |+||||||+|||++.++ .+||+|||+|+...
T Consensus 105 ~~~~~v~e~~~~~~L~~~~~~l~e~~i~~i~~qil~aL~~LH~~g---IvHrDiKp~NILi~~~~~~vkl~DFG~a~~~~ 181 (328)
T d3bqca1 105 RTPALVFEHVNNTDFKQLYQTLTDYDIRFYMYEILKALDYCHSMG---IMHRDVKPHNVMIDHEHRKLRLIDWGLAEFYH 181 (328)
T ss_dssp CSEEEEEECCCSCBGGGTTTSCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEEETTTTEEEECCGGGCEECC
T ss_pred CceeEEEeecCCCcHHHHhcCCCHHHHHHHHHHHHHHHHHHhhcc---cccccccccceEEcCCCCeeeecccccceecc
Confidence 3578899999833 23457999999999999999999999999 99999999999998655 58999999998765
Q ss_pred CCcccccceeeeeccCCCChhhhccC-CCCccceEEeehhhhhhhhhCCCCCCcCCCCchhhhhhhh-----------hh
Q 045315 317 GDELQSNTKRIVGTYGYMSPEYALRG-LFSIKSDVFSFGVLLLETLSSKKNTHFYNTDSLTLLGHAW-----------NL 384 (476)
Q Consensus 317 ~~~~~~~~~~~~gt~~y~aPE~l~~~-~~s~ksDVwSlGvvl~elltG~~p~~~~~~~~~~~~~~~~-----------~~ 384 (476)
.... .....+|..|+|||.+.+. .++.++||||+||+++|+++|+.||............... ..
T Consensus 182 ~~~~---~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~~l~e~~~g~~pf~~~~~~~~~~~~i~~~~g~~~~~~~~~~ 258 (328)
T d3bqca1 182 PGQE---YNVRVASRYFKGPELLVDYQMYDYSLDMWSLGCMLASMIFRKEPFFHGHDNYDQLVRIAKVLGTEDLYDYIDK 258 (328)
T ss_dssp TTCC---CCSCCSCGGGCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHTCSSSSCCSSHHHHHHHHHHHHCHHHHHHHHHH
T ss_pred CCCc---ccccccCccccCcccccCCCCCCcccchhhhhhhhHHhccCCCCCCCCchhHHHHHHHHHHHCCchhhhhhhh
Confidence 4332 2235689999999998765 5799999999999999999999998654322111100000 00
Q ss_pred hcCC-----------CcccccCcccCCCCCHHHHHHHHHHHHHchhhcccCCCCHHHHHH
Q 045315 385 WNDG-----------RTWELMDPISQNGASYPILKRYINVALLCVQEKAADRPAMSEVVS 433 (476)
Q Consensus 385 ~~~~-----------~~~~~~d~~~~~~~~~~~~~~l~~li~~Cl~~dP~~RPt~~eVl~ 433 (476)
.... .....................+.+++.+||+.||++|||++|+++
T Consensus 259 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~mL~~dP~~R~ta~e~L~ 318 (328)
T d3bqca1 259 YNIELDPRFNDILGRHSRKRWERFVHSENQHLVSPEALDFLDKLLRYDHQSRLTAREAME 318 (328)
T ss_dssp TTCCCCGGGGGTCCCCCCCCGGGGCCTTTGGGCCHHHHHHHHHHSCSSGGGSCCHHHHHT
T ss_pred cccccCcccchhcccccccchhhcccccccccCCHHHHHHHHHHccCChhHCcCHHHHhc
Confidence 0000 000000001111111223467889999999999999999999976
|
| >d1vzoa_ d.144.1.7 (A:) Ribosomal protein S6 kinase alpha 5, Msk1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Ribosomal protein S6 kinase alpha 5, Msk1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=99.94 E-value=7.9e-28 Score=236.86 Aligned_cols=177 Identities=20% Similarity=0.237 Sum_probs=133.5
Q ss_pred cccceeeccCCCC------CCCCCCChhhHHHHHHHHHHHHHHHhhcCCCceeecCCCccceEecCCCCceeccccceee
Q 045315 241 DEISFWYESYNNP------TKKGLLCWGTRVRIIEGIAQGLLYLHQYSRLRVIHRDLKASNILLDKDMNPKISDFGMARM 314 (476)
Q Consensus 241 ~~~~l~~Ey~~~~------~~~~~L~~~~~~~i~~qIa~gL~yLH~~~~~~ivH~DLkp~NILld~~~~~kL~DFGla~~ 314 (476)
+..++++||+..+ ...+.++...+..++.||+.||+|||+.+ |+||||||+|||++.++.+||+|||+++.
T Consensus 102 ~~~~~v~e~~~~~~L~~~i~~~~~~~e~~~~~~~~Qi~~al~~lH~~~---ivHrDiKp~Nill~~~~~vkL~DFG~a~~ 178 (322)
T d1vzoa_ 102 TKLHLILDYINGGELFTHLSQRERFTEHEVQIYVGEIVLALEHLHKLG---IIYRDIKLENILLDSNGHVVLTDFGLSKE 178 (322)
T ss_dssp TEEEEEECCCCSCBHHHHHHHHSCCCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCCGGGEEECTTSCEEESCSSEEEE
T ss_pred CceeeeeecccccHHHHHHHhcccccHHHHHHHHHHHHHHHHHhhcCC---EEeccCCccceeecCCCCEEEeeccchhh
Confidence 4678889999843 23457788999999999999999999999 99999999999999999999999999987
Q ss_pred cCCCcccccceeeeeccCCCChhhhccC--CCCccceEEeehhhhhhhhhCCCCCCcCCCCchhhhhhhhhhhcCCCccc
Q 045315 315 FGGDELQSNTKRIVGTYGYMSPEYALRG--LFSIKSDVFSFGVLLLETLSSKKNTHFYNTDSLTLLGHAWNLWNDGRTWE 392 (476)
Q Consensus 315 ~~~~~~~~~~~~~~gt~~y~aPE~l~~~--~~s~ksDVwSlGvvl~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~ 392 (476)
+....... .....|++.|++||.+.+. .++.++|||||||++|||++|+.||........... .........
T Consensus 179 ~~~~~~~~-~~~~~g~~~~~~pe~~~~~~~~~~~ksDIWSlG~iLyelltG~~PF~~~~~~~~~~~--i~~~~~~~~--- 252 (322)
T d1vzoa_ 179 FVADETER-AYDFCGTIEYMAPDIVRGGDSGHDKAVDWWSLGVLMYELLTGASPFTVDGEKNSQAE--ISRRILKSE--- 252 (322)
T ss_dssp CCGGGGGG-GCGGGSCCTTCCHHHHTTCC---CTHHHHHHHHHHHHHHHHSSCTTSCTTSCCCHHH--HHHHHHHCC---
T ss_pred hccccccc-ccccccccccchhHHhhcCCcCCCchhhhHHHHHHHHHHHhCCCCCCCCCHHHHHHH--HHHhcccCC---
Confidence 65433222 2335789999999999754 468899999999999999999999976542221111 111110000
Q ss_pred ccCcccCCCCCHHHHHHHHHHHHHchhhcccCCC-----CHHHHHH
Q 045315 393 LMDPISQNGASYPILKRYINVALLCVQEKAADRP-----AMSEVVS 433 (476)
Q Consensus 393 ~~d~~~~~~~~~~~~~~l~~li~~Cl~~dP~~RP-----t~~eVl~ 433 (476)
...+......+.+++.+||+.||++|| |++|+++
T Consensus 253 -------~~~~~~~s~~~~~li~~~l~~dP~~R~s~~~~t~~eil~ 291 (322)
T d1vzoa_ 253 -------PPYPQEMSALAKDLIQRLLMKDPKKRLGCGPRDADEIKE 291 (322)
T ss_dssp -------CCCCTTSCHHHHHHHHHHTCSSGGGSTTSSTTTHHHHHT
T ss_pred -------CCCcccCCHHHHHHHHHHcccCHHHcCCCCcccHHHHHc
Confidence 011122346788999999999999999 4788875
|
| >d1unla_ d.144.1.7 (A:) Cyclin-dependent PK, CDK5 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK5 species: Human (Homo sapiens) [TaxId: 9606]
Probab=99.94 E-value=1.2e-27 Score=231.83 Aligned_cols=187 Identities=20% Similarity=0.233 Sum_probs=133.0
Q ss_pred cccceeeccCCC------CCCCCCCChhhHHHHHHHHHHHHHHHhhcCCCceeecCCCccceEecCCCCceeccccceee
Q 045315 241 DEISFWYESYNN------PTKKGLLCWGTRVRIIEGIAQGLLYLHQYSRLRVIHRDLKASNILLDKDMNPKISDFGMARM 314 (476)
Q Consensus 241 ~~~~l~~Ey~~~------~~~~~~L~~~~~~~i~~qIa~gL~yLH~~~~~~ivH~DLkp~NILld~~~~~kL~DFGla~~ 314 (476)
+.+++++||+.. ....+.+++.++..++.|+++||+|||+++ |+||||||+|||++.++.+||+|||.++.
T Consensus 74 ~~~~iv~~~~~~~~l~~~~~~~~~~~~~~~~~~~~q~~~aL~~lH~~~---IvHrDiKP~NIli~~~~~~kl~DFG~a~~ 150 (292)
T d1unla_ 74 KKLTLVFEFCDQDLKKYFDSCNGDLDPEIVKSFLFQLLKGLGFCHSRN---VLHRDLKPQNLLINRNGELKLANFGLARA 150 (292)
T ss_dssp SEEEEEEECCSEEHHHHHHHTTTCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEECTTCCEEECCCTTCEE
T ss_pred cceeEEeeeccccccccccccccccchhHHHHHHHHHHHHHHHhhcCC---EeeecccCcccccccCCceeeeecchhhc
Confidence 356677888772 134568899999999999999999999999 99999999999999999999999999998
Q ss_pred cCCCcccccceeeeeccCCCChhhhccCC-CCccceEEeehhhhhhhhhCCCCCCcCCCCchhhhhhhhhhhcCC---Cc
Q 045315 315 FGGDELQSNTKRIVGTYGYMSPEYALRGL-FSIKSDVFSFGVLLLETLSSKKNTHFYNTDSLTLLGHAWNLWNDG---RT 390 (476)
Q Consensus 315 ~~~~~~~~~~~~~~gt~~y~aPE~l~~~~-~s~ksDVwSlGvvl~elltG~~p~~~~~~~~~~~~~~~~~~~~~~---~~ 390 (476)
....... .....++..|+|||.+.... ++.++|||||||++|||++|+.||....... ............. ..
T Consensus 151 ~~~~~~~--~~~~~~~~~~~~pe~~~~~~~~~~~~DiwSlG~il~ell~g~~p~~~~~~~~-~~~~~~~~~~~~~~~~~~ 227 (292)
T d1unla_ 151 FGIPVRC--YSAEVVTLWYRPPDVLFGAKLYSTSIDMWSAGCIFAELANAGRPLFPGNDVD-DQLKRIFRLLGTPTEEQW 227 (292)
T ss_dssp CCSCCSC--CCSCCSCGGGCCHHHHTTCSCCCTHHHHHHHHHHHHHHTTTSCCSCCCSSHH-HHHHHHHHHHCCCCTTTC
T ss_pred ccCCCcc--ceeeccccchhhhhHhccCCCCCchhhccccchHHHHHhhCCCCCCCCCCHH-HHHHHHHhhcCCCChhhh
Confidence 7543322 22245788999999987655 6899999999999999999999974332211 1111111111000 00
Q ss_pred ---ccc--------cC-cccCCCCCHHHHHHHHHHHHHchhhcccCCCCHHHHHH
Q 045315 391 ---WEL--------MD-PISQNGASYPILKRYINVALLCVQEKAADRPAMSEVVS 433 (476)
Q Consensus 391 ---~~~--------~d-~~~~~~~~~~~~~~l~~li~~Cl~~dP~~RPt~~eVl~ 433 (476)
... .. ............+.+.+++.+||+.||.+|||++|+++
T Consensus 228 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dll~~mL~~dP~~R~sa~e~L~ 282 (292)
T d1unla_ 228 PSMTKLPDYKPYPMYPATTSLVNVVPKLNATGRDLLQNLLKCNPVQRISAEEALQ 282 (292)
T ss_dssp TTGGGSTTCCCCCCCCTTCCCTTTSTTCCHHHHHHHHHHSCSSGGGSCCHHHHTT
T ss_pred hhhhhcccccccccccccchhhhccccCCHHHHHHHHHHccCChhHCcCHHHHhc
Confidence 000 00 00001112223457889999999999999999999875
|
| >d1pmea_ d.144.1.7 (A:) MAP kinase Erk2 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase Erk2 species: Human (Homo sapiens) [TaxId: 9606]
Probab=99.94 E-value=1.8e-28 Score=243.84 Aligned_cols=174 Identities=24% Similarity=0.283 Sum_probs=124.9
Q ss_pred CCCCChhhHHHHHHHHHHHHHHHhhcCCCceeecCCCccceEecCCCCceeccccceeecCCCcc-cccceeeeeccCCC
Q 045315 256 KGLLCWGTRVRIIEGIAQGLLYLHQYSRLRVIHRDLKASNILLDKDMNPKISDFGMARMFGGDEL-QSNTKRIVGTYGYM 334 (476)
Q Consensus 256 ~~~L~~~~~~~i~~qIa~gL~yLH~~~~~~ivH~DLkp~NILld~~~~~kL~DFGla~~~~~~~~-~~~~~~~~gt~~y~ 334 (476)
...+++.++..++.||+.||+|||+++ ||||||||+|||++.++.+||+|||+++....... ........|++.|+
T Consensus 103 ~~~l~~~~i~~i~~qil~al~yLH~~~---iiHRDIKp~NILl~~~~~~kl~DfG~a~~~~~~~~~~~~~~~~~gt~~y~ 179 (345)
T d1pmea_ 103 TQHLSNDHICYFLYQILRGLKYIHSAN---VLHRDLKPSNLLLNTTCDLKICDFGLARVADPDHDHTGFLTEYVATRWYR 179 (345)
T ss_dssp HCCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEECTTCCEEECCCTTCEECCGGGCBCCTTCCCCSCGGGC
T ss_pred cCCCCHHHHHHHHHHHHHHHHHHHHCC---CcCCCCCcceEEECCCCCEEEcccCceeeccCCCccceeeccccccceec
Confidence 346999999999999999999999999 99999999999999999999999999987644322 22234467999999
Q ss_pred Chhhhc-cCCCCccceEEeehhhhhhhhhCCCCCCcCCCCchhhhhhhhhhhcCCCcc-----------c-ccCcccCCC
Q 045315 335 SPEYAL-RGLFSIKSDVFSFGVLLLETLSSKKNTHFYNTDSLTLLGHAWNLWNDGRTW-----------E-LMDPISQNG 401 (476)
Q Consensus 335 aPE~l~-~~~~s~ksDVwSlGvvl~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~-----------~-~~d~~~~~~ 401 (476)
|||.+. ...++.++||||+||++|||++|+.||........ .............. . .........
T Consensus 180 aPE~l~~~~~~~~~~DiwSlG~il~eml~g~~pf~~~~~~~~--~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 257 (345)
T d1pmea_ 180 APEIMLNSKGYTKSIDIWSVGCILAEMLSNRPIFPGKHYLDQ--LNHILGILGSPSQEDLNCIINLKARNYLLSLPHKNK 257 (345)
T ss_dssp CGGGTTTBCSCSTHHHHHHHHHHHHHHHHSSCSCCCSSHHHH--HHHHHHHHCSCCHHHHHTCCCHHHHHHHHTSCCCCC
T ss_pred hHHHhhcCCCCCchhhhhccCceehHHhhCCCCCCCCCHHHH--HHHHhhhccCCChhhhhhhhhhhhhcccccCCccCC
Confidence 999985 45678999999999999999999999865431111 00000000000000 0 000000000
Q ss_pred CC-----HHHHHHHHHHHHHchhhcccCCCCHHHHHHH
Q 045315 402 AS-----YPILKRYINVALLCVQEKAADRPAMSEVVSM 434 (476)
Q Consensus 402 ~~-----~~~~~~l~~li~~Cl~~dP~~RPt~~eVl~~ 434 (476)
.+ .....++++++.+||+.||++|||++|+++.
T Consensus 258 ~~~~~~~~~~s~~~~~li~~~L~~dP~~R~ta~e~L~h 295 (345)
T d1pmea_ 258 VPWNRLFPNADSKALDLLDKMLTFNPHKRIEVEQALAH 295 (345)
T ss_dssp CCHHHHCTTSCHHHHHHHHHHSCSSTTTSCCHHHHHTS
T ss_pred CCHHHhCCCCCHHHHHHHHHHccCChhHCcCHHHHhcC
Confidence 00 1112468899999999999999999999874
|
| >d2b1pa1 d.144.1.7 (A:46-400) c-jun N-terminal kinase (jnk3s) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: c-jun N-terminal kinase (jnk3s) species: Human (Homo sapiens) [TaxId: 9606]
Probab=99.93 E-value=1.7e-27 Score=237.76 Aligned_cols=188 Identities=20% Similarity=0.158 Sum_probs=129.3
Q ss_pred cccceeeccCCCC---CCCCCCChhhHHHHHHHHHHHHHHHhhcCCCceeecCCCccceEecCCCCceeccccceeecCC
Q 045315 241 DEISFWYESYNNP---TKKGLLCWGTRVRIIEGIAQGLLYLHQYSRLRVIHRDLKASNILLDKDMNPKISDFGMARMFGG 317 (476)
Q Consensus 241 ~~~~l~~Ey~~~~---~~~~~L~~~~~~~i~~qIa~gL~yLH~~~~~~ivH~DLkp~NILld~~~~~kL~DFGla~~~~~ 317 (476)
..++++|||+... .....+++.++..++.||+.||+|||+.+ |+||||||+|||++.++.+|++|||+++....
T Consensus 95 ~~~~iv~Ey~~~~l~~~~~~~~~~~~i~~~~~qil~gl~~LH~~g---iiHrDlKP~Nil~~~~~~~kl~df~~~~~~~~ 171 (355)
T d2b1pa1 95 QDVYLVMELMDANLCQVIQMELDHERMSYLLYQMLCGIKHLHSAG---IIHRDLKPSNIVVKSDCTLKILDFGLARTAGT 171 (355)
T ss_dssp CEEEEEEECCSEEHHHHHTSCCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEECTTCCEEECCCCC------
T ss_pred ceeEEEEeccchHHHHhhhcCCCHHHHHHHHHHHHHHHHHhhhcc---cccccCCccccccccccceeeechhhhhcccc
Confidence 4678999999821 12456899999999999999999999999 99999999999999999999999999887654
Q ss_pred CcccccceeeeeccCCCChhhhccCCCCccceEEeehhhhhhhhhCCCCCCcCCCCch-hhhh----------------h
Q 045315 318 DELQSNTKRIVGTYGYMSPEYALRGLFSIKSDVFSFGVLLLETLSSKKNTHFYNTDSL-TLLG----------------H 380 (476)
Q Consensus 318 ~~~~~~~~~~~gt~~y~aPE~l~~~~~s~ksDVwSlGvvl~elltG~~p~~~~~~~~~-~~~~----------------~ 380 (476)
.. ......+|+.|+|||.+.+..++.++||||+||+++||++|+.||...+.... .... .
T Consensus 172 ~~---~~~~~~~t~~y~aPE~l~~~~~~~~~DiwSlG~~l~ell~g~~pF~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~ 248 (355)
T d2b1pa1 172 SF---MMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMVRHKILFPGRDYIDQWNKVIEQLGTPCPEFMKKLQPT 248 (355)
T ss_dssp ------------CCTTCCHHHHTTCCCCTTHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCCCCHHHHTTSCHH
T ss_pred cc---ccccccccccccChhhhcCCCCCCCcccccccchHHHHhhCCCCCCCCCHHHHHHHHHHhccCCCHHHHHHhhhh
Confidence 32 22335789999999999999999999999999999999999999864431100 0000 0
Q ss_pred hhhhhcCC------CcccccCcccCCC---CCHHHHHHHHHHHHHchhhcccCCCCHHHHHHH
Q 045315 381 AWNLWNDG------RTWELMDPISQNG---ASYPILKRYINVALLCVQEKAADRPAMSEVVSM 434 (476)
Q Consensus 381 ~~~~~~~~------~~~~~~d~~~~~~---~~~~~~~~l~~li~~Cl~~dP~~RPt~~eVl~~ 434 (476)
........ ............. ........+.+++.+||+.||++|||++|+++.
T Consensus 249 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dll~~mL~~dP~~R~ta~elL~H 311 (355)
T d2b1pa1 249 VRNYVENRPKYAGLTFPKLFPDSLFPADSEHNKLKASQARDLLSKMLVIDPAKRISVDDALQH 311 (355)
T ss_dssp HHHHHHTSCCCCCCCHHHHSCGGGSCCSSHHHHHHHHHHHHHHHHHSCSSTTTSCCHHHHHTS
T ss_pred HHHHhhcCccccccccccccccccccccccccccCCHHHHHHHHHHCcCChhHCcCHHHHhcC
Confidence 00000000 0000111111111 122346678999999999999999999999854
|
| >d2gfsa1 d.144.1.7 (A:5-352) MAP kinase p38 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase p38 species: Human (Homo sapiens) [TaxId: 9606]
Probab=99.92 E-value=2.7e-27 Score=235.39 Aligned_cols=173 Identities=21% Similarity=0.256 Sum_probs=120.9
Q ss_pred CCCCChhhHHHHHHHHHHHHHHHhhcCCCceeecCCCccceEecCCCCceeccccceeecCCCcccccceeeeeccCCCC
Q 045315 256 KGLLCWGTRVRIIEGIAQGLLYLHQYSRLRVIHRDLKASNILLDKDMNPKISDFGMARMFGGDELQSNTKRIVGTYGYMS 335 (476)
Q Consensus 256 ~~~L~~~~~~~i~~qIa~gL~yLH~~~~~~ivH~DLkp~NILld~~~~~kL~DFGla~~~~~~~~~~~~~~~~gt~~y~a 335 (476)
.++|++.++..++.||+.||+|||+++ |+||||||+|||++.++.+|++|||++...... .....|+..|+|
T Consensus 115 ~~~l~e~~~~~i~~qil~aL~~LH~~g---iiHrDiKp~NILi~~~~~~kl~dfg~a~~~~~~-----~~~~~g~~~y~a 186 (348)
T d2gfsa1 115 CQKLTDDHVQFLIYQILRGLKYIHSAD---IIHRDLKPSNLAVNEDCELKILDFGLARHTDDE-----MTGYVATRWYRA 186 (348)
T ss_dssp TCCCCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCCGGGEEECTTCCEEECCC----CCTGG-----GSSSCHHHHTSC
T ss_pred cccccHHHHHHHHHHHHHHHHHHHhCC---CcccccCCccccccccccccccccchhcccCcc-----cccccccccccC
Confidence 457999999999999999999999999 999999999999999999999999999765322 223568999999
Q ss_pred hhhhccC-CCCccceEEeehhhhhhhhhCCCCCCcCCCCchhhhhhhhhhhcCCC-----------cccccCccc-CCCC
Q 045315 336 PEYALRG-LFSIKSDVFSFGVLLLETLSSKKNTHFYNTDSLTLLGHAWNLWNDGR-----------TWELMDPIS-QNGA 402 (476)
Q Consensus 336 PE~l~~~-~~s~ksDVwSlGvvl~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~-----------~~~~~d~~~-~~~~ 402 (476)
||...+. .++.++|||||||++|+|++|+.||...+... ............. ......... ....
T Consensus 187 pE~~~~~~~~~~~~DiwSlGv~l~~ll~g~~pF~~~~~~~--~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 264 (348)
T d2gfsa1 187 PEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHID--QLKLILRLVGTPGAELLKKISSESARNYIQSLTQMPKM 264 (348)
T ss_dssp HHHHTTCSCCCTTHHHHHHHHHHHHHHHSSCSCCCSSHHH--HHHHHHHHHCCCCHHHHTTCCCHHHHHHHTTSCCCCCC
T ss_pred chhhcCCccCCcccchhhhhHHHHHHHhCCCCCCCCCHHH--HHHHHHHhcCCCChHHhhhccchhhhhhhhhcccCCCc
Confidence 9987765 46899999999999999999999987543111 0000000000000 000000000 0000
Q ss_pred C-----HHHHHHHHHHHHHchhhcccCCCCHHHHHH--HHhcc
Q 045315 403 S-----YPILKRYINVALLCVQEKAADRPAMSEVVS--MLSNE 438 (476)
Q Consensus 403 ~-----~~~~~~l~~li~~Cl~~dP~~RPt~~eVl~--~L~~~ 438 (476)
. ......+.+++.+||+.||++|||++|+++ .+.+.
T Consensus 265 ~~~~~~~~~s~~~~dli~~mL~~dP~~R~ta~elL~Hp~f~~~ 307 (348)
T d2gfsa1 265 NFANVFIGANPLAVDLLEKMLVLDSDKRITAAQALAHAYFAQY 307 (348)
T ss_dssp CHHHHSTTCCHHHHHHHHHHSCSSGGGSCCHHHHHTSGGGTTT
T ss_pred chhhhcCCCCHHHHHHHHHHCcCChhhCcCHHHHhcCHhhCCC
Confidence 0 112356889999999999999999999987 45543
|
| >d1xd5a_ b.78.1.1 (A:) Gastrodianin (antifungal protein) {Gastrodia elata [TaxId: 91201]} | Back information, alignment and structure |
|---|
class: All beta proteins fold: beta-Prism II superfamily: alpha-D-mannose-specific plant lectins family: alpha-D-mannose-specific plant lectins domain: Gastrodianin (antifungal protein) species: Gastrodia elata [TaxId: 91201]
Probab=99.91 E-value=1.7e-24 Score=179.13 Aligned_cols=112 Identities=25% Similarity=0.409 Sum_probs=97.3
Q ss_pred cCccCCCCcccCCCEEeeCCCeEEEEeeCCCCCCCeEEEEEEccCCCceEEeecCCCCCCCCCceEEEecCCceEEEccC
Q 045315 26 ADTITPETFIRDGEKLVSSSQRFELGFFSPRNSKNRYLGVWYKKIPDTVVWVANRNSPIFNPNTALTFSNNGNLVLLSQR 105 (476)
Q Consensus 26 ~~~l~~g~~l~~~~~l~S~~g~f~lgf~~~~~~~~~~~~iw~~~~~~~~vW~an~~~p~~~~~~~l~~~~~G~lvl~~~~ 105 (476)
+|+|.|||.|.+|++|+ +|.|.|.|+.+||. .++. +.++||.||++.| .+.+.|.|+.||+|||++.
T Consensus 1 tDtL~~gq~L~~g~~l~--~g~~~l~~q~DGNL-----vly~---~~~~vW~s~~~~~--~~~~~l~l~~dGnLvl~~~- 67 (112)
T d1xd5a_ 1 SDRLNSGHQLDTGGSLA--EGGYLFIIQNDCNL-----VLYD---NNRAVWASGTNGK--ASGCVLKMQNDGNLVIYSG- 67 (112)
T ss_dssp CCEEETTEEECTTCEEE--ETTEEEEECTTSCE-----EEEE---TTEEEEECCCTTS--CSSEEEEECTTSCEEEEET-
T ss_pred CCEecCCCEecCCCEEE--ECCEEEEEcCCCCE-----EEEc---CCcEEEEccCccC--CCCcEEEEeccccEEEEec-
Confidence 48999999999999998 59999999999984 3443 2789999999988 5568999999999999986
Q ss_pred CeEEEeecCCCCCCCceeeeccCCCeEEEeCCCCCCcCceeeccccCCCc
Q 045315 106 NGIIWSSNMSRKAENPIAQLLDTGNLVIRDNSSGHTTESYLWQSFDYPTD 155 (476)
Q Consensus 106 ~~~vWss~~~~~~~~~~~~l~d~GNlVl~~~~~~~~~~~~~WqSFd~ptd 155 (476)
+.++|+|+++.....+.|+|+|+||||||+.+ +.++|||+.||+|
T Consensus 68 ~~~~w~s~t~~~~~~~~l~L~ddGNlvly~~~-----~~~~W~S~t~~~n 112 (112)
T d1xd5a_ 68 SRAIWASNTNRQNGNYYLILQRDRNVVIYDNS-----NNAIWATHTNVGN 112 (112)
T ss_dssp TEEEEECCCCCSCCCCEEEECTTSCEEEECTT-----SCEEEECCCCCCC
T ss_pred CCeEEEEeeccCCCceEEEEcCCCCEEEECCC-----CcEEecCCCccCC
Confidence 57889888877667788999999999999875 6899999999986
|
| >d1q8ya_ d.144.1.7 (A:) Sky1p {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Sky1p species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]
Probab=99.91 E-value=6.6e-25 Score=218.88 Aligned_cols=189 Identities=18% Similarity=0.198 Sum_probs=131.7
Q ss_pred CCCCCCChhhHHHHHHHHHHHHHHHhh-cCCCceeecCCCccceEecCCCC------ceeccccceeecCCCccccccee
Q 045315 254 TKKGLLCWGTRVRIIEGIAQGLLYLHQ-YSRLRVIHRDLKASNILLDKDMN------PKISDFGMARMFGGDELQSNTKR 326 (476)
Q Consensus 254 ~~~~~L~~~~~~~i~~qIa~gL~yLH~-~~~~~ivH~DLkp~NILld~~~~------~kL~DFGla~~~~~~~~~~~~~~ 326 (476)
.....+++..+..++.||+.||+|||+ .+ |+||||||+|||++.++. +|++|||.+...... ...
T Consensus 117 ~~~~~~~~~~i~~i~~qil~al~~lh~~~~---IvHrDlKp~NIll~~~~~~~~~~~~kl~dfg~s~~~~~~-----~~~ 188 (362)
T d1q8ya_ 117 YEHRGIPLIYVKQISKQLLLGLDYMHRRCG---IIHTDIKPENVLMEIVDSPENLIQIKIADLGNACWYDEH-----YTN 188 (362)
T ss_dssp TTTSCCCHHHHHHHHHHHHHHHHHHHHTTC---EECSCCSGGGEEEEEEETTTTEEEEEECCCTTCEETTBC-----CCS
T ss_pred ccccCCcHHHHHHHHHHHHHHHHHHhhhcC---cccccCChhHeeeeccCcccccceeeEeecccccccccc-----ccc
Confidence 356678999999999999999999998 77 999999999999986553 899999999865432 223
Q ss_pred eeeccCCCChhhhccCCCCccceEEeehhhhhhhhhCCCCCCcCCCC-c----hhhhhhhhh-----------------h
Q 045315 327 IVGTYGYMSPEYALRGLFSIKSDVFSFGVLLLETLSSKKNTHFYNTD-S----LTLLGHAWN-----------------L 384 (476)
Q Consensus 327 ~~gt~~y~aPE~l~~~~~s~ksDVwSlGvvl~elltG~~p~~~~~~~-~----~~~~~~~~~-----------------~ 384 (476)
..||+.|+|||.+....++.++|+||+||+++||++|+.||...... . ..+...... .
T Consensus 189 ~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~el~~g~~pF~~~~~~~~~~~~~~~~~~~~~lg~~~~~~~~~~~~~~~~ 268 (362)
T d1q8ya_ 189 SIQTREYRSPEVLLGAPWGCGADIWSTACLIFELITGDFLFEPDEGHSYTKDDDHIAQIIELLGELPSYLLRNGKYTRTF 268 (362)
T ss_dssp CCSCGGGCCHHHHHTCCCCTHHHHHHHHHHHHHHHHSSCCC---------CHHHHHHHHHHHHCSCCHHHHHHCTTHHHH
T ss_pred ccccccccChhhccccCCCccccccchHHHHHHHHHCCCCCCCCccccccchhHHHHHHHHHhCCCCHHHhhcccccccc
Confidence 56899999999999999999999999999999999999998654311 0 001000000 0
Q ss_pred hcCCCcccccCc----------ccCCCCCHHHHHHHHHHHHHchhhcccCCCCHHHHHHH--Hhcc--ccCCCCCCCCcc
Q 045315 385 WNDGRTWELMDP----------ISQNGASYPILKRYINVALLCVQEKAADRPAMSEVVSM--LSNE--FVNLPAPQQPAF 450 (476)
Q Consensus 385 ~~~~~~~~~~d~----------~~~~~~~~~~~~~l~~li~~Cl~~dP~~RPt~~eVl~~--L~~~--~~~~~~p~~p~~ 450 (476)
.........+.. ...........+.+.+++.+||+.||.+|||++|+++. +++. ..++..|+.|..
T Consensus 269 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dll~~mL~~dP~~Rpta~e~L~Hp~f~~~~~~~~~~~p~~~~~ 348 (362)
T d1q8ya_ 269 FNSRGLLRNISKLKFWPLEDVLTEKYKFSKDEAKEISDFLSPMLQLDPRKRADAGGLVNHPWLKDTLGMEEIRVPDRELY 348 (362)
T ss_dssp BCC--CBSSCCCCCBCCHHHHHHHTTCCCHHHHHHHHHHHGGGGCSSTTTCBCHHHHHTCGGGTTCTTCTTCCCTTSCTT
T ss_pred cccchhhhccccccCCchhhhcccccccCcccCHHHHHHHHHHCCCChhHCcCHHHHhcCcccCCCCCcccCCCCCcccC
Confidence 000000000000 00112345567889999999999999999999999873 4432 234455555544
|
| >d1jpca_ b.78.1.1 (A:) Lectin (agglutinin) {Snowdrop (Galanthus nivalis) [TaxId: 4670]} | Back information, alignment and structure |
|---|
class: All beta proteins fold: beta-Prism II superfamily: alpha-D-mannose-specific plant lectins family: alpha-D-mannose-specific plant lectins domain: Lectin (agglutinin) species: Snowdrop (Galanthus nivalis) [TaxId: 4670]
Probab=99.91 E-value=1.6e-24 Score=177.80 Aligned_cols=107 Identities=23% Similarity=0.340 Sum_probs=94.4
Q ss_pred cCccCCCCcccCCCEEeeCCCeEEEEeeCCCCCCCeEEEEEEccCCCceEEeecCCCCCCCCCceEEEecCCceEEEccC
Q 045315 26 ADTITPETFIRDGEKLVSSSQRFELGFFSPRNSKNRYLGVWYKKIPDTVVWVANRNSPIFNPNTALTFSNNGNLVLLSQR 105 (476)
Q Consensus 26 ~~~l~~g~~l~~~~~l~S~~g~f~lgf~~~~~~~~~~~~iw~~~~~~~~vW~an~~~p~~~~~~~l~~~~~G~lvl~~~~ 105 (476)
.|+|.+||.|.+|++|. +|.|.|.|+.+|| |.++.. .++||.||++.| ++.+.|.|+.||||||++++
T Consensus 1 ~~~L~~g~~L~~G~~l~--ng~~~l~~q~DGN-----Lvly~~---~~~vW~s~~~~~--~~~~~l~l~~~Gnlvl~~~~ 68 (108)
T d1jpca_ 1 DNILYSGETLSTGEFLN--YGSFVFIMQEDCN-----LVLYDV---DKPIWATNTGGL--SRSCFLSMQTDGNLVVYNPS 68 (108)
T ss_dssp CCEEETTEEECTTCEEE--ETTEEEEECTTSC-----EEEEET---TEEEEECCCTTS--CSSCEEEECTTSCEEEECTT
T ss_pred CCCccCCCEecCCCEEE--cCCEEEEECCCCe-----EEEEeC---CceeeEeCCCCC--CCccEEEEeccceEEEECCC
Confidence 37899999999999996 7999999999998 445443 689999999988 66789999999999999999
Q ss_pred CeEEEeecCCCCCCCceeeeccCCCeEEEeCCCCCCcCceeeccccC
Q 045315 106 NGIIWSSNMSRKAENPIAQLLDTGNLVIRDNSSGHTTESYLWQSFDY 152 (476)
Q Consensus 106 ~~~vWss~~~~~~~~~~~~l~d~GNlVl~~~~~~~~~~~~~WqSFd~ 152 (476)
+.+||+|++......+.|+|+||||||||+ .++||||+|
T Consensus 69 g~~vWsS~t~~~~~~~~l~L~ddGNlVly~--------~~~W~S~t~ 107 (108)
T d1jpca_ 69 NKPIWASNTGGQNGNYVCILQKDRNVVIYG--------TDRWATGTH 107 (108)
T ss_dssp CCEEEECCCCCSCSCEEEEECTTSCEEEEE--------CCCCCCCCC
T ss_pred ccceEEccccCCCCcEEEEEcCCCCEEEeC--------CCcccCCCC
Confidence 999999998776677789999999999994 359999987
|
| >d1kj1a_ b.78.1.1 (A:) Lectin (agglutinin) {Garlic (Allium sativum) [TaxId: 4682]} | Back information, alignment and structure |
|---|
class: All beta proteins fold: beta-Prism II superfamily: alpha-D-mannose-specific plant lectins family: alpha-D-mannose-specific plant lectins domain: Lectin (agglutinin) species: Garlic (Allium sativum) [TaxId: 4682]
Probab=99.90 E-value=1.1e-23 Score=172.76 Aligned_cols=108 Identities=22% Similarity=0.364 Sum_probs=93.3
Q ss_pred cCccCCCCcccCCCEEeeCCCeEEEEeeCCCCCCCeEEEEEEccCCCceEEeecCCCCCCCCCceEEEecCCceEEEccC
Q 045315 26 ADTITPETFIRDGEKLVSSSQRFELGFFSPRNSKNRYLGVWYKKIPDTVVWVANRNSPIFNPNTALTFSNNGNLVLLSQR 105 (476)
Q Consensus 26 ~~~l~~g~~l~~~~~l~S~~g~f~lgf~~~~~~~~~~~~iw~~~~~~~~vW~an~~~p~~~~~~~l~~~~~G~lvl~~~~ 105 (476)
.|+|.+||.|.+|++|. +|.|.|+|+.+||. .+ |. ..++||+||++.|. ...+.|.|+.||||||+|++
T Consensus 1 ~~~L~~g~~L~~g~~l~--~g~~~l~~q~dgnL-----vl-~~--~~~~vW~ant~~~~-~~~~~l~l~~dGnLvl~~~~ 69 (109)
T d1kj1a_ 1 RNLLTNGEGLYAGQSLD--VEPYHFIMQEDCNL-----VL-YD--HSTSVWASNTGILG-KKGCKAVLQSDGNFVVYDAE 69 (109)
T ss_dssp CCEEETTCEEETTCEEE--ETTEEEEECTTSCE-----EE-EE--TTEEEEECCCCCTT-CCCCEEEECTTSCEEEECSS
T ss_pred CCCccCCCEEeCCCEEE--eCCEEEEecCCCeE-----EE-Ee--CCEEEEEeCCCCCC-ceeEEEEEcCCceEEEEeCC
Confidence 37899999999999997 58899999999884 33 33 26899999999997 55789999999999999999
Q ss_pred CeEEEeecCCCCCCCceeeeccCCCeEEEeCCCCCCcCceeeccccC
Q 045315 106 NGIIWSSNMSRKAENPIAQLLDTGNLVIRDNSSGHTTESYLWQSFDY 152 (476)
Q Consensus 106 ~~~vWss~~~~~~~~~~~~l~d~GNlVl~~~~~~~~~~~~~WqSFd~ 152 (476)
|.+||+|+++.....+.|+||||||||||+ ..+|||+-|
T Consensus 70 g~~vW~s~t~~~~~~~~l~L~ddGNlvly~--------~~~W~S~t~ 108 (109)
T d1kj1a_ 70 GRSLWASHSVRGNGNYVLVLQEDGNVVIYG--------SDIWSTGTY 108 (109)
T ss_dssp SCEEEECCCCCCSSCCEEEECTTSCEEEEC--------CEEEECCCC
T ss_pred CcEEEEEeeECCCCCEEEEEeCCCcEEEEC--------CCEecCCCc
Confidence 999999998876677889999999999993 469999854
|
| >d1b2pa_ b.78.1.1 (A:) Lectin (agglutinin) {Bluebell (Scilla campanulata) [TaxId: 81759]} | Back information, alignment and structure |
|---|
class: All beta proteins fold: beta-Prism II superfamily: alpha-D-mannose-specific plant lectins family: alpha-D-mannose-specific plant lectins domain: Lectin (agglutinin) species: Bluebell (Scilla campanulata) [TaxId: 81759]
Probab=99.79 E-value=3.1e-19 Score=147.91 Aligned_cols=101 Identities=21% Similarity=0.379 Sum_probs=83.9
Q ss_pred CcccCCCEE--eeCCCeEEEEeeCCCCCCCeEEEEEEccCCCceEEeecCCCCCCCCCceEEEecCCceEEEccCCeEEE
Q 045315 33 TFIRDGEKL--VSSSQRFELGFFSPRNSKNRYLGVWYKKIPDTVVWVANRNSPIFNPNTALTFSNNGNLVLLSQRNGIIW 110 (476)
Q Consensus 33 ~~l~~~~~l--~S~~g~f~lgf~~~~~~~~~~~~iw~~~~~~~~vW~an~~~p~~~~~~~l~~~~~G~lvl~~~~~~~vW 110 (476)
|.|.+||+| .+..|+|.|.|+.+||. +.|. +.++||.+|+..+ +..+.|.|+.||||||+|+++.+||
T Consensus 15 ~~l~~~q~l~~~~~~~~y~l~mQ~DGNL------VLy~--~~~~vWssnt~~~--~~~~~l~l~~dGnLvL~d~~g~~vW 84 (119)
T d1b2pa_ 15 QILHATESLEILFGTHVYRFIMQTDCNL------VLYD--NNNPIWATNTGGL--GNGCRAVLQPDGVLVVITNENVTVW 84 (119)
T ss_dssp CEEETTCEEEEEETTEEEEEEECTTSCE------EEEE--TTEEEEECCCTTS--CSSCEEEECTTSCEEEECTTCCEEE
T ss_pred CEEeCCCeEEEecCCceEEEEECCCCcE------EEEE--CCeEEEEecCCCC--CcceEEEEEeCCCEEEECCCCcEEE
Confidence 455555554 56799999999999994 2343 2789999999887 5568999999999999999999999
Q ss_pred eecCCCCCCCceeeeccCCCeEEEeCCCCCCcCceeecccc
Q 045315 111 SSNMSRKAENPIAQLLDTGNLVIRDNSSGHTTESYLWQSFD 151 (476)
Q Consensus 111 ss~~~~~~~~~~~~l~d~GNlVl~~~~~~~~~~~~~WqSFd 151 (476)
++++......+.|+|||||||||| +.++|||-.
T Consensus 85 sS~t~~~~~~~~l~Lq~DGNlvlY--------g~~~W~S~T 117 (119)
T d1b2pa_ 85 QSPVAGKAGHYVLVLQPDRNVVIY--------GDALWATQT 117 (119)
T ss_dssp ECSCCCCSSCEEEEECTTSCEEEE--------ESEEEECCC
T ss_pred ECCCcCCCCceEEEEcCCCCEEEE--------CCCEeccCC
Confidence 999887667788999999999999 457999963
|
| >d1dlpa2 b.78.1.1 (A:116-235) Fetuin-binding protein Scafet precursor {Bluebell (Scilla campanulata) [TaxId: 81759]} | Back information, alignment and structure |
|---|
class: All beta proteins fold: beta-Prism II superfamily: alpha-D-mannose-specific plant lectins family: alpha-D-mannose-specific plant lectins domain: Fetuin-binding protein Scafet precursor species: Bluebell (Scilla campanulata) [TaxId: 81759]
Probab=99.76 E-value=5.8e-19 Score=146.69 Aligned_cols=101 Identities=21% Similarity=0.305 Sum_probs=87.4
Q ss_pred EEEccCC-CceEEeecCCCCCCCCCceEEEecCCceEEEccCCeEEEeecCCCCCCCceeeeccCCCeEEEeCCCCCCcC
Q 045315 65 VWYKKIP-DTVVWVANRNSPIFNPNTALTFSNNGNLVLLSQRNGIIWSSNMSRKAENPIAQLLDTGNLVIRDNSSGHTTE 143 (476)
Q Consensus 65 iw~~~~~-~~~vW~an~~~p~~~~~~~l~~~~~G~lvl~~~~~~~vWss~~~~~~~~~~~~l~d~GNlVl~~~~~~~~~~ 143 (476)
|||.+++ .+.+|+++++.|+......|.|+.||||||++. +.++|++++...+....|+|+++|||||++.+ +
T Consensus 12 il~~~~~~~~~~~~l~~~q~l~~g~y~L~~q~DGNLvL~~~-~~~vW~s~t~~~~~~~~~~l~~~GnLvl~d~~-----~ 85 (120)
T d1dlpa2 12 ILYSTQGNDNHPQTLHATQSLQLSPYRLSMETDCNLVLFDR-DDRVWSTNTAGKGTGCRAVLQPNGRMDVLTNQ-----N 85 (120)
T ss_dssp ECCCC--CCCCCCEECSSCCCBCSSCEEEEETTTEEEEEBT-TBCCSCCCCCSSCSSCEEEEETTTEEEEEETT-----T
T ss_pred EEEcCCCCCCcccEEcCCCeeEcCCEEEEEcCCCcEEEecC-CcEEEEEccccCCCcEEEEEeCCeeEEEEcCC-----C
Confidence 8999888 899999999999977777999999999999985 67899999887777788999999999999886 7
Q ss_pred ceeeccccCCCcccccCCcccCCCCCCcceEEEEeCCCCCCCCcccEEEEEecCcceEE
Q 045315 144 SYLWQSFDYPTDSLLEGMKLGWDLKNGLERYLSSWESTDDPSPGNFTFRLVIQVIPKLC 202 (476)
Q Consensus 144 ~~~WqSFd~ptdtll~~~~l~~~~~~g~~~~l~s~~~~~~~s~g~~~~~~~~~~~~~~~ 202 (476)
.++||||. +.++|.|.+.++++|...+|
T Consensus 86 ~~lW~S~t-------------------------------~~~~~~~~l~Lq~DGnlvlY 113 (120)
T d1dlpa2 86 IAVWTSGN-------------------------------SRSAGRYVFVLQPDRNLAIY 113 (120)
T ss_dssp EEEEECCC-------------------------------CCSSSCCEEEECSSSCEEEE
T ss_pred CEEEEeCC-------------------------------CCCCCcEEEEECCCCcEEEe
Confidence 89999982 24568899999999988875
|
| >d1dlpa1 b.78.1.1 (A:1-115) Fetuin-binding protein Scafet precursor {Bluebell (Scilla campanulata) [TaxId: 81759]} | Back information, alignment and structure |
|---|
class: All beta proteins fold: beta-Prism II superfamily: alpha-D-mannose-specific plant lectins family: alpha-D-mannose-specific plant lectins domain: Fetuin-binding protein Scafet precursor species: Bluebell (Scilla campanulata) [TaxId: 81759]
Probab=99.66 E-value=7.2e-17 Score=132.55 Aligned_cols=100 Identities=23% Similarity=0.342 Sum_probs=82.6
Q ss_pred CCCCcccCCCEEeeCCCeEEEEeeCCCCCCCeEEEEEEccCCCceEEeecCCCCCCCCCceEEEecCCceEEEccCCeEE
Q 045315 30 TPETFIRDGEKLVSSSQRFELGFFSPRNSKNRYLGVWYKKIPDTVVWVANRNSPIFNPNTALTFSNNGNLVLLSQRNGII 109 (476)
Q Consensus 30 ~~g~~l~~~~~l~S~~g~f~lgf~~~~~~~~~~~~iw~~~~~~~~vW~an~~~p~~~~~~~l~~~~~G~lvl~~~~~~~v 109 (476)
...|+|.+|+.|. +|.|.|.|+.+||. .++ + +..+||.+|+..+ ..+.+.|+.||||||+|.++.+|
T Consensus 12 ~~~~tl~~~~~l~--~g~~~l~~q~DGNL-----vL~-~--~~~~vW~s~t~~~---~~~~l~l~~dGNLvl~d~~~~~v 78 (115)
T d1dlpa1 12 SHPQTLHAAQSLE--LSSFRFTMQSDCNL-----VLF-D--SDVRVWASNTAGA---TGCRAVLQSDGLLVILTAQNTIR 78 (115)
T ss_dssp CSCSCCCTTCEEC--STTEEEEECTTSCE-----EEE-E--SSSEEECCCCCSC---SCCBCCBCSSSCBCCBCTTTCCS
T ss_pred CCcceecCCCcEE--cCCEEEEECCCCeE-----EEE-c--CCeeEEEcccCCC---CceEEEEeccCCEEEEccCCCEE
Confidence 3446777777774 78899999999993 343 3 3688999998653 46899999999999999999999
Q ss_pred EeecCCCCCCCceeeeccCCCeEEEeCCCCCCcCceeeccc
Q 045315 110 WSSNMSRKAENPIAQLLDTGNLVIRDNSSGHTTESYLWQSF 150 (476)
Q Consensus 110 Wss~~~~~~~~~~~~l~d~GNlVl~~~~~~~~~~~~~WqSF 150 (476)
|+|.+......+.++||+||||||| +.++|+|-
T Consensus 79 WsS~t~~~~g~y~l~Lq~DGNlvlY--------~~~~Wssg 111 (115)
T d1dlpa1 79 WSSGTKGSIGNYVLVLQPDRTVTIY--------GPGLWDSG 111 (115)
T ss_dssp CCCCCCCCSSCCEEEECSSSCEEEE--------CSEEEECS
T ss_pred EEcCCCCCCCCEEEEECCCCcEEEe--------CCCeecCC
Confidence 9999887777888999999999999 45799985
|
| >d1dlpa1 b.78.1.1 (A:1-115) Fetuin-binding protein Scafet precursor {Bluebell (Scilla campanulata) [TaxId: 81759]} | Back information, alignment and structure |
|---|
class: All beta proteins fold: beta-Prism II superfamily: alpha-D-mannose-specific plant lectins family: alpha-D-mannose-specific plant lectins domain: Fetuin-binding protein Scafet precursor species: Bluebell (Scilla campanulata) [TaxId: 81759]
Probab=99.65 E-value=5e-17 Score=133.54 Aligned_cols=109 Identities=20% Similarity=0.224 Sum_probs=89.2
Q ss_pred EEEccCC-CceEEeecCCCCCCCCCceEEEecCCceEEEccCCeEEEeecCCCCCCCceeeeccCCCeEEEeCCCCCCcC
Q 045315 65 VWYKKIP-DTVVWVANRNSPIFNPNTALTFSNNGNLVLLSQRNGIIWSSNMSRKAENPIAQLLDTGNLVIRDNSSGHTTE 143 (476)
Q Consensus 65 iw~~~~~-~~~vW~an~~~p~~~~~~~l~~~~~G~lvl~~~~~~~vWss~~~~~~~~~~~~l~d~GNlVl~~~~~~~~~~ 143 (476)
|||.-.+ .+..|+.+.+.++.....+|.|+.||||||++ .+.++|++++.. ..+..|.|+++|||||++.. +
T Consensus 3 ~~~~~~~~~~~~~tl~~~~~l~~g~~~l~~q~DGNLvL~~-~~~~vW~s~t~~-~~~~~l~l~~dGNLvl~d~~-----~ 75 (115)
T d1dlpa1 3 ILFGLSHEGSHPQTLHAAQSLELSSFRFTMQSDCNLVLFD-SDVRVWASNTAG-ATGCRAVLQSDGLLVILTAQ-----N 75 (115)
T ss_dssp CCBCSSSSSCSCSCCCTTCEECSTTEEEEECTTSCEEEEE-SSSEEECCCCCS-CSCCBCCBCSSSCBCCBCTT-----T
T ss_pred EEEecCCCCCCcceecCCCcEEcCCEEEEECCCCeEEEEc-CCeeEEEcccCC-CCceEEEEeccCCEEEEccC-----C
Confidence 4555333 67779999999998877899999999999997 467899999775 55778999999999999876 6
Q ss_pred ceeeccccCCCcccccCCcccCCCCCCcceEEEEeCCCCCCCCcccEEEEEecCcceEEEEcCCcceeecCC
Q 045315 144 SYLWQSFDYPTDSLLEGMKLGWDLKNGLERYLSSWESTDDPSPGNFTFRLVIQVIPKLCAYNGSVEYTCTGP 215 (476)
Q Consensus 144 ~~~WqSFd~ptdtll~~~~l~~~~~~g~~~~l~s~~~~~~~s~g~~~~~~~~~~~~~~~~~~gs~~y~~sg~ 215 (476)
.++|||+. +.+.|.|.+.|+++|...++ +.++|.+|.
T Consensus 76 ~~vWsS~t-------------------------------~~~~g~y~l~Lq~DGNlvlY----~~~~Wssgt 112 (115)
T d1dlpa1 76 TIRWSSGT-------------------------------KGSIGNYVLVLQPDRTVTIY----GPGLWDSGT 112 (115)
T ss_dssp CCSCCCCC-------------------------------CCCSSCCEEEECSSSCEEEE----CSEEEECSC
T ss_pred CEEEEcCC-------------------------------CCCCCCEEEEECCCCcEEEe----CCCeecCCC
Confidence 89999872 34679999999999987665 346899876
|
| >d1dlpa2 b.78.1.1 (A:116-235) Fetuin-binding protein Scafet precursor {Bluebell (Scilla campanulata) [TaxId: 81759]} | Back information, alignment and structure |
|---|
class: All beta proteins fold: beta-Prism II superfamily: alpha-D-mannose-specific plant lectins family: alpha-D-mannose-specific plant lectins domain: Fetuin-binding protein Scafet precursor species: Bluebell (Scilla campanulata) [TaxId: 81759]
Probab=99.56 E-value=4.4e-15 Score=122.88 Aligned_cols=99 Identities=22% Similarity=0.353 Sum_probs=79.8
Q ss_pred CCCcccCCCEEeeCCCeEEEEeeCCCCCCCeEEEEEEccCCCceEEeecCCCCCCCCCceEEEecCCceEEEccCCeEEE
Q 045315 31 PETFIRDGEKLVSSSQRFELGFFSPRNSKNRYLGVWYKKIPDTVVWVANRNSPIFNPNTALTFSNNGNLVLLSQRNGIIW 110 (476)
Q Consensus 31 ~g~~l~~~~~l~S~~g~f~lgf~~~~~~~~~~~~iw~~~~~~~~vW~an~~~p~~~~~~~l~~~~~G~lvl~~~~~~~vW 110 (476)
+.+.|.+++.|. .|.|.|.|..+||. .+ |. ...+||.++.... +..+.+.|+.+|||||+|.+++++|
T Consensus 22 ~~~~l~~~q~l~--~g~y~L~~q~DGNL-----vL-~~--~~~~vW~s~t~~~--~~~~~~~l~~~GnLvl~d~~~~~lW 89 (120)
T d1dlpa2 22 HPQTLHATQSLQ--LSPYRLSMETDCNL-----VL-FD--RDDRVWSTNTAGK--GTGCRAVLQPNGRMDVLTNQNIAVW 89 (120)
T ss_dssp CCCEECSSCCCB--CSSCEEEEETTTEE-----EE-EB--TTBCCSCCCCCSS--CSSCEEEEETTTEEEEEETTTEEEE
T ss_pred cccEEcCCCeeE--cCCEEEEEcCCCcE-----EE-ec--CCcEEEEEccccC--CCcEEEEEeCCeeEEEEcCCCCEEE
Confidence 446666666664 67799999988884 23 33 2678999987654 5678999999999999999999999
Q ss_pred eecCCCCCCCceeeeccCCCeEEEeCCCCCCcCceeecc
Q 045315 111 SSNMSRKAENPIAQLLDTGNLVIRDNSSGHTTESYLWQS 149 (476)
Q Consensus 111 ss~~~~~~~~~~~~l~d~GNlVl~~~~~~~~~~~~~WqS 149 (476)
+|++......+.++|++||||||| +.++|.|
T Consensus 90 ~S~t~~~~~~~~l~Lq~DGnlvlY--------~~~~W~t 120 (120)
T d1dlpa2 90 TSGNSRSAGRYVFVLQPDRNLAIY--------GGALWTT 120 (120)
T ss_dssp ECCCCCSSSCCEEEECSSSCEEEE--------CCCCCBC
T ss_pred EeCCCCCCCcEEEEECCCCcEEEe--------CCCcccC
Confidence 999887777888999999999999 3468976
|
| >d1zara2 d.144.1.9 (A:91-281) Rio2 serine protein kinase C-terminal domain {Archaeoglobus fulgidus [TaxId: 2234]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: RIO1-like kinases domain: Rio2 serine protein kinase C-terminal domain species: Archaeoglobus fulgidus [TaxId: 2234]
Probab=99.30 E-value=1.9e-13 Score=122.69 Aligned_cols=99 Identities=14% Similarity=0.136 Sum_probs=72.9
Q ss_pred ccceeeccCCCCCCCCCCChhhHHHHHHHHHHHHHHHhhcCCCceeecCCCccceEecCCCCceeccccceeecCCCccc
Q 045315 242 EISFWYESYNNPTKKGLLCWGTRVRIIEGIAQGLLYLHQYSRLRVIHRDLKASNILLDKDMNPKISDFGMARMFGGDELQ 321 (476)
Q Consensus 242 ~~~l~~Ey~~~~~~~~~L~~~~~~~i~~qIa~gL~yLH~~~~~~ivH~DLkp~NILld~~~~~kL~DFGla~~~~~~~~~ 321 (476)
+..++|||++... ...++.....+++.|++++|+|||+++ |+||||||+|||+++++ ++|+|||+|.........
T Consensus 84 ~~~lvme~~~~~~-~~~l~~~~~~~i~~ql~~~l~~lH~~g---iiHrDiKP~NILv~~~~-~~liDFG~a~~~~~~~~~ 158 (191)
T d1zara2 84 GNAVLMELIDAKE-LYRVRVENPDEVLDMILEEVAKFYHRG---IVHGDLSQYNVLVSEEG-IWIIDFPQSVEVGEEGWR 158 (191)
T ss_dssp TTEEEEECCCCEE-GGGCCCSCHHHHHHHHHHHHHHHHHTT---EECSCCSTTSEEEETTE-EEECCCTTCEETTSTTHH
T ss_pred CCEEEEEeecccc-ccchhhHHHHHHHHHHHHHHHHHhhCC---EEEccCChhheeeeCCC-EEEEECCCcccCCCCCcH
Confidence 4568899998432 334778888999999999999999999 99999999999999654 899999999865432111
Q ss_pred ccceeeeeccCCCC------hhhhccCCCCccceEEeehhh
Q 045315 322 SNTKRIVGTYGYMS------PEYALRGLFSIKSDVFSFGVL 356 (476)
Q Consensus 322 ~~~~~~~gt~~y~a------PE~l~~~~~s~ksDVwSlGvv 356 (476)
.|.. .++ ....|+.++|+||..--
T Consensus 159 ----------~~l~rd~~~~~~~-f~r~y~~~~d~~s~~~~ 188 (191)
T d1zara2 159 ----------EILERDVRNIITY-FSRTYRTEKDINSAIDR 188 (191)
T ss_dssp ----------HHHHHHHHHHHHH-HHHHHCCCCCHHHHHHH
T ss_pred ----------HHHHHHHHHHHHH-HcCCCCCcccHHHHHHH
Confidence 1111 111 13567888999986533
|
| >d1b2pa_ b.78.1.1 (A:) Lectin (agglutinin) {Bluebell (Scilla campanulata) [TaxId: 81759]} | Back information, alignment and structure |
|---|
class: All beta proteins fold: beta-Prism II superfamily: alpha-D-mannose-specific plant lectins family: alpha-D-mannose-specific plant lectins domain: Lectin (agglutinin) species: Bluebell (Scilla campanulata) [TaxId: 81759]
Probab=99.30 E-value=5.6e-12 Score=103.58 Aligned_cols=85 Identities=24% Similarity=0.286 Sum_probs=69.1
Q ss_pred eEEEecCCceEEEccCCeEEEeecCCCCCCCceeeeccCCCeEEEeCCCCCCcCceeeccccCCCcccccCCcccCCCCC
Q 045315 90 ALTFSNNGNLVLLSQRNGIIWSSNMSRKAENPIAQLLDTGNLVIRDNSSGHTTESYLWQSFDYPTDSLLEGMKLGWDLKN 169 (476)
Q Consensus 90 ~l~~~~~G~lvl~~~~~~~vWss~~~~~~~~~~~~l~d~GNlVl~~~~~~~~~~~~~WqSFd~ptdtll~~~~l~~~~~~ 169 (476)
.|.|+.||||||++. +.++|++++........+.|+++|||||++.+ +.++|+|.-
T Consensus 33 ~l~mQ~DGNLVLy~~-~~~vWssnt~~~~~~~~l~l~~dGnLvL~d~~-----g~~vWsS~t------------------ 88 (119)
T d1b2pa_ 33 RFIMQTDCNLVLYDN-NNPIWATNTGGLGNGCRAVLQPDGVLVVITNE-----NVTVWQSPV------------------ 88 (119)
T ss_dssp EEEECTTSCEEEEET-TEEEEECCCTTSCSSCEEEECTTSCEEEECTT-----CCEEEECSC------------------
T ss_pred EEEECCCCcEEEEEC-CeEEEEecCCCCCcceEEEEEeCCCEEEECCC-----CcEEEECCC------------------
Confidence 789999999999965 67999999887666788999999999999876 789998741
Q ss_pred CcceEEEEeCCCCCCCCcccEEEEEecCcceEEEEcCCcceeecCC
Q 045315 170 GLERYLSSWESTDDPSPGNFTFRLVIQVIPKLCAYNGSVEYTCTGP 215 (476)
Q Consensus 170 g~~~~l~s~~~~~~~s~g~~~~~~~~~~~~~~~~~~gs~~y~~sg~ 215 (476)
.-+.|.|.+.|+.+|...++ +.+.|.++.
T Consensus 89 -------------~~~~~~~~l~Lq~DGNlvlY----g~~~W~S~T 117 (119)
T d1b2pa_ 89 -------------AGKAGHYVLVLQPDRNVVIY----GDALWATQT 117 (119)
T ss_dssp -------------CCCSSCEEEEECTTSCEEEE----ESEEEECCC
T ss_pred -------------cCCCCceEEEEcCCCCEEEE----CCCEeccCC
Confidence 11346788999999988876 246888775
|
| >d1jpca_ b.78.1.1 (A:) Lectin (agglutinin) {Snowdrop (Galanthus nivalis) [TaxId: 4670]} | Back information, alignment and structure |
|---|
class: All beta proteins fold: beta-Prism II superfamily: alpha-D-mannose-specific plant lectins family: alpha-D-mannose-specific plant lectins domain: Lectin (agglutinin) species: Snowdrop (Galanthus nivalis) [TaxId: 4670]
Probab=99.25 E-value=1.4e-11 Score=99.57 Aligned_cols=86 Identities=22% Similarity=0.333 Sum_probs=68.4
Q ss_pred ceEEEecCCceEEEccCCeEEEeecCCCCCCCceeeeccCCCeEEEeCCCCCCcCceeeccccCCCcccccCCcccCCCC
Q 045315 89 TALTFSNNGNLVLLSQRNGIIWSSNMSRKAENPIAQLLDTGNLVIRDNSSGHTTESYLWQSFDYPTDSLLEGMKLGWDLK 168 (476)
Q Consensus 89 ~~l~~~~~G~lvl~~~~~~~vWss~~~~~~~~~~~~l~d~GNlVl~~~~~~~~~~~~~WqSFd~ptdtll~~~~l~~~~~ 168 (476)
-.|.|+.||||||++ .+.+||++++...+....++|+++|||||++.+ +.++|+|=
T Consensus 21 ~~l~~q~DGNLvly~-~~~~vW~s~~~~~~~~~~l~l~~~Gnlvl~~~~-----g~~vWsS~------------------ 76 (108)
T d1jpca_ 21 FVFIMQEDCNLVLYD-VDKPIWATNTGGLSRSCFLSMQTDGNLVVYNPS-----NKPIWASN------------------ 76 (108)
T ss_dssp EEEEECTTSCEEEEE-TTEEEEECCCTTSCSSCEEEECTTSCEEEECTT-----CCEEEECC------------------
T ss_pred EEEEECCCCeEEEEe-CCceeeEeCCCCCCCccEEEEeccceEEEECCC-----ccceEEcc------------------
Confidence 478999999999997 568999999887666778999999999999876 78999871
Q ss_pred CCcceEEEEeCCCCCCCCcccEEEEEecCcceEEEEcCCcceeecCC
Q 045315 169 NGLERYLSSWESTDDPSPGNFTFRLVIQVIPKLCAYNGSVEYTCTGP 215 (476)
Q Consensus 169 ~g~~~~l~s~~~~~~~s~g~~~~~~~~~~~~~~~~~~gs~~y~~sg~ 215 (476)
...+.+.|.+.|+.+|...++ +.+.|.++.
T Consensus 77 -------------t~~~~~~~~l~L~ddGNlVly----~~~~W~S~t 106 (108)
T d1jpca_ 77 -------------TGGQNGNYVCILQKDRNVVIY----GTDRWATGT 106 (108)
T ss_dssp -------------CCCSCSCEEEEECTTSCEEEE----ECCCCCCCC
T ss_pred -------------ccCCCCcEEEEEcCCCCEEEe----CCCcccCCC
Confidence 112356788899999988776 234677664
|
| >d1kj1a_ b.78.1.1 (A:) Lectin (agglutinin) {Garlic (Allium sativum) [TaxId: 4682]} | Back information, alignment and structure |
|---|
class: All beta proteins fold: beta-Prism II superfamily: alpha-D-mannose-specific plant lectins family: alpha-D-mannose-specific plant lectins domain: Lectin (agglutinin) species: Garlic (Allium sativum) [TaxId: 4682]
Probab=99.14 E-value=1.4e-10 Score=93.67 Aligned_cols=87 Identities=24% Similarity=0.352 Sum_probs=67.2
Q ss_pred ceEEEecCCceEEEccCCeEEEeecCCCCC-CCceeeeccCCCeEEEeCCCCCCcCceeeccccCCCcccccCCcccCCC
Q 045315 89 TALTFSNNGNLVLLSQRNGIIWSSNMSRKA-ENPIAQLLDTGNLVIRDNSSGHTTESYLWQSFDYPTDSLLEGMKLGWDL 167 (476)
Q Consensus 89 ~~l~~~~~G~lvl~~~~~~~vWss~~~~~~-~~~~~~l~d~GNlVl~~~~~~~~~~~~~WqSFd~ptdtll~~~~l~~~~ 167 (476)
-.|.|+.||||||+. .+.+||++++.... ....+.|+++|||||++.+ +.++|+|=
T Consensus 21 ~~l~~q~dgnLvl~~-~~~~vW~ant~~~~~~~~~l~l~~dGnLvl~~~~-----g~~vW~s~----------------- 77 (109)
T d1kj1a_ 21 YHFIMQEDCNLVLYD-HSTSVWASNTGILGKKGCKAVLQSDGNFVVYDAE-----GRSLWASH----------------- 77 (109)
T ss_dssp EEEEECTTSCEEEEE-TTEEEEECCCCCTTCCCCEEEECTTSCEEEECSS-----SCEEEECC-----------------
T ss_pred EEEEecCCCeEEEEe-CCEEEEEeCCCCCCceeEEEEEcCCceEEEEeCC-----CcEEEEEe-----------------
Confidence 568899999999996 56899999987543 3567899999999999876 78999871
Q ss_pred CCCcceEEEEeCCCCCCCCcccEEEEEecCcceEEEEcCCcceeecCCC
Q 045315 168 KNGLERYLSSWESTDDPSPGNFTFRLVIQVIPKLCAYNGSVEYTCTGPW 216 (476)
Q Consensus 168 ~~g~~~~l~s~~~~~~~s~g~~~~~~~~~~~~~~~~~~gs~~y~~sg~w 216 (476)
...+.|.|.+.++.+|...++ . .+.|.|+.+
T Consensus 78 --------------t~~~~~~~~l~L~ddGNlvly--~--~~~W~S~t~ 108 (109)
T d1kj1a_ 78 --------------SVRGNGNYVLVLQEDGNVVIY--G--SDIWSTGTY 108 (109)
T ss_dssp --------------CCCCSSCCEEEECTTSCEEEE--C--CEEEECCCC
T ss_pred --------------eECCCCCEEEEEeCCCcEEEE--C--CCEecCCCc
Confidence 111246788999999988765 2 357887653
|
| >d1xd5a_ b.78.1.1 (A:) Gastrodianin (antifungal protein) {Gastrodia elata [TaxId: 91201]} | Back information, alignment and structure |
|---|
class: All beta proteins fold: beta-Prism II superfamily: alpha-D-mannose-specific plant lectins family: alpha-D-mannose-specific plant lectins domain: Gastrodianin (antifungal protein) species: Gastrodia elata [TaxId: 91201]
Probab=99.03 E-value=7.6e-10 Score=89.82 Aligned_cols=89 Identities=25% Similarity=0.359 Sum_probs=67.4
Q ss_pred CceEEEecCCceEEEccCCeEEEeecCCCCCCCceeeeccCCCeEEEeCCCCCCcCceeeccccCCCcccccCCcccCCC
Q 045315 88 NTALTFSNNGNLVLLSQRNGIIWSSNMSRKAENPIAQLLDTGNLVIRDNSSGHTTESYLWQSFDYPTDSLLEGMKLGWDL 167 (476)
Q Consensus 88 ~~~l~~~~~G~lvl~~~~~~~vWss~~~~~~~~~~~~l~d~GNlVl~~~~~~~~~~~~~WqSFd~ptdtll~~~~l~~~~ 167 (476)
.-.|.|+.||||||++ .+.+||++++.....+..++|+.+|||||++. +..+|.|=
T Consensus 20 ~~~l~~q~DGNLvly~-~~~~vW~s~~~~~~~~~~l~l~~dGnLvl~~~------~~~~w~s~----------------- 75 (112)
T d1xd5a_ 20 GYLFIIQNDCNLVLYD-NNRAVWASGTNGKASGCVLKMQNDGNLVIYSG------SRAIWASN----------------- 75 (112)
T ss_dssp TEEEEECTTSCEEEEE-TTEEEEECCCTTSCSSEEEEECTTSCEEEEET------TEEEEECC-----------------
T ss_pred CEEEEEcCCCCEEEEc-CCcEEEEccCccCCCCcEEEEeccccEEEEec------CCeEEEEe-----------------
Confidence 3578999999999996 56899999987766677899999999999985 35677551
Q ss_pred CCCcceEEEEeCCCCCCCCcccEEEEEecCcceEEEEcCCcceeecCC
Q 045315 168 KNGLERYLSSWESTDDPSPGNFTFRLVIQVIPKLCAYNGSVEYTCTGP 215 (476)
Q Consensus 168 ~~g~~~~l~s~~~~~~~s~g~~~~~~~~~~~~~~~~~~gs~~y~~sg~ 215 (476)
..-..|.|.+.++.+|...++= ..+.+.|.|+.
T Consensus 76 --------------t~~~~~~~~l~L~ddGNlvly~-~~~~~~W~S~t 108 (112)
T d1xd5a_ 76 --------------TNRQNGNYYLILQRDRNVVIYD-NSNNAIWATHT 108 (112)
T ss_dssp --------------CCCSCCCCEEEECTTSCEEEEC-TTSCEEEECCC
T ss_pred --------------eccCCCceEEEEcCCCCEEEEC-CCCcEEecCCC
Confidence 1123467889999999877652 22456888765
|
| >d2ppqa1 d.144.1.6 (A:5-320) Homoserine kinase ThrB {Agrobacterium tumefaciens [TaxId: 358]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: APH phosphotransferases domain: Homoserine kinase ThrB species: Agrobacterium tumefaciens [TaxId: 358]
Probab=91.53 E-value=0.071 Score=48.98 Aligned_cols=48 Identities=25% Similarity=0.128 Sum_probs=34.0
Q ss_pred HHHHHHHHHHHHHhhc-CCCceeecCCCccceEecCCCCceecccccee
Q 045315 266 RIIEGIAQGLLYLHQY-SRLRVIHRDLKASNILLDKDMNPKISDFGMAR 313 (476)
Q Consensus 266 ~i~~qIa~gL~yLH~~-~~~~ivH~DLkp~NILld~~~~~kL~DFGla~ 313 (476)
..+..+...+...+.. -+..+||+|+.+.||+++.+...-|.||+.+.
T Consensus 164 ~~l~~~~~~~~~~~~~~L~~giIHgDl~~dNvl~~~~~v~gvIDF~~~~ 212 (316)
T d2ppqa1 164 EEIRPEIDYLAAHWPKDLPAGVIHADLFQDNVFFLGDELSGLIDFYFAC 212 (316)
T ss_dssp HHHHHHHHHHHHHCCCSSCEEEECSCCCGGGEEEETTEEEEECCCTTCE
T ss_pred HHHHHHHHhhhccCccccccccccCCcchhhhhcccccceeEecccccc
Confidence 3344444444444432 24469999999999999988777899999885
|
| >d1j7la_ d.144.1.6 (A:) Type IIIa 3',5"-aminoglycoside phosphotransferase {Enterococcus faecalis [TaxId: 1351]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: APH phosphotransferases domain: Type IIIa 3',5"-aminoglycoside phosphotransferase species: Enterococcus faecalis [TaxId: 1351]
Probab=89.72 E-value=0.09 Score=46.56 Aligned_cols=31 Identities=29% Similarity=0.350 Sum_probs=26.4
Q ss_pred CceeecCCCccceEecCCCCceeccccceee
Q 045315 284 LRVIHRDLKASNILLDKDMNPKISDFGMARM 314 (476)
Q Consensus 284 ~~ivH~DLkp~NILld~~~~~kL~DFGla~~ 314 (476)
..++|+|+.|.||+++++..+.|+||+.+..
T Consensus 183 ~~l~HgD~~~~Nil~~~~~~~~lIDwe~a~~ 213 (263)
T d1j7la_ 183 LVFSHGDLGDSNIFVKDGKVSGFIDLGRSGR 213 (263)
T ss_dssp EEEECSCCCTTSEEEETTEEEEECCCTTCEE
T ss_pred cEEEEeeccCcceeecCCceEEEeechhccc
Confidence 4589999999999999876667999988753
|
| >d1nd4a_ d.144.1.6 (A:) Aminoglycoside 3'-phosphotransferase IIa (Kanamycin kinase) {Bacteria (Klebsiella pneumoniae) [TaxId: 573]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: APH phosphotransferases domain: Aminoglycoside 3'-phosphotransferase IIa (Kanamycin kinase) species: Bacteria (Klebsiella pneumoniae) [TaxId: 573]
Probab=89.30 E-value=0.096 Score=46.13 Aligned_cols=32 Identities=25% Similarity=0.286 Sum_probs=27.0
Q ss_pred CCceeecCCCccceEecCCCCceeccccceee
Q 045315 283 RLRVIHRDLKASNILLDKDMNPKISDFGMARM 314 (476)
Q Consensus 283 ~~~ivH~DLkp~NILld~~~~~kL~DFGla~~ 314 (476)
...++|+|+.|.||+++.+..+.|+||+.+..
T Consensus 174 ~~~liHgD~~~~Nvl~~~~~~~~iID~~~~~~ 205 (255)
T d1nd4a_ 174 DLVVTHGDACLPNIMVENGRFSGFIDCGRLGV 205 (255)
T ss_dssp CEEEECSSCCGGGEEEETTEEEEECCCTTCEE
T ss_pred CceEEeCCCCCcceEEeCCceEEEEEchhccc
Confidence 44589999999999999876678999988753
|
| >d1zyla1 d.144.1.6 (A:4-328) RdoA {Escherichia coli [TaxId: 562]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: APH phosphotransferases domain: RdoA species: Escherichia coli [TaxId: 562]
Probab=86.02 E-value=0.48 Score=43.47 Aligned_cols=30 Identities=33% Similarity=0.424 Sum_probs=24.3
Q ss_pred CCceeecCCCccceEecCCCCceeccccceee
Q 045315 283 RLRVIHRDLKASNILLDKDMNPKISDFGMARM 314 (476)
Q Consensus 283 ~~~ivH~DLkp~NILld~~~~~kL~DFGla~~ 314 (476)
...+||+|+.+.|||++++ ..++||+-+..
T Consensus 191 p~~liHgDlh~~NvL~~~~--~~~IDFdd~~~ 220 (325)
T d1zyla1 191 TVLRLHGDCHAGNILWRDG--PMFVDLDDARN 220 (325)
T ss_dssp CCEECCSSCSGGGEEESSS--EEECCCTTCCE
T ss_pred CceeecCCCCcccEEEeCC--ceEEechhccc
Confidence 4568999999999999754 46889998753
|
| >d2pula1 d.144.1.6 (A:5-396) Methylthioribose kinase MtnK {Bacillus subtilis [TaxId: 1423]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: APH phosphotransferases domain: Methylthioribose kinase MtnK species: Bacillus subtilis [TaxId: 1423]
Probab=84.91 E-value=0.38 Score=45.56 Aligned_cols=31 Identities=26% Similarity=0.340 Sum_probs=26.3
Q ss_pred CCceeecCCCccceEecCCCCceeccccceee
Q 045315 283 RLRVIHRDLKASNILLDKDMNPKISDFGMARM 314 (476)
Q Consensus 283 ~~~ivH~DLkp~NILld~~~~~kL~DFGla~~ 314 (476)
...++|+|+++.|||++++ .++|+||..+..
T Consensus 222 ~~~LiHGDl~~gNIlv~~~-~~~vID~E~a~~ 252 (392)
T d2pula1 222 AETLIHGDLHTGSIFASEH-ETKVIDPEFAFY 252 (392)
T ss_dssp CCEEECSCCCGGGEEECSS-CEEECCCTTCEE
T ss_pred CcceeccCCcCCceeEcCC-ceEEechhhccc
Confidence 3469999999999999976 489999988864
|